<SEC-DOCUMENT>0001193125-24-003477.txt : 20240105
<SEC-HEADER>0001193125-24-003477.hdr.sgml : 20240105
<ACCEPTANCE-DATETIME>20240105171647
ACCESSION NUMBER:		0001193125-24-003477
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		96
FILED AS OF DATE:		20240105
DATE AS OF CHANGE:		20240105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Metagenomi Technologies, LLC
		CENTRAL INDEX KEY:			0001785279
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				832735153
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276413
		FILM NUMBER:		24517522

	BUSINESS ADDRESS:	
		STREET 1:		1545 PARK AVENUE
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 871-4880

	MAIL ADDRESS:	
		STREET 1:		5959 HORTON STREET
		STREET 2:		FLOOR 7
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>d425213ds1.htm
<DESCRIPTION>S-1
<TEXT>
<HTML><HEAD>
<TITLE>S-1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on January 5, 2024. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333&#150;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-1</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Metagenomi Technologies, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(to be succeeded by Metagenomi, Inc. in the reorganization) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:6pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>2836</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">83-2735153</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Metagenomi Technologies, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>1545 Park Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Emeryville, California 94608 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(510) <FONT STYLE="white-space:nowrap">871-4880</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code, and telephone number, including area code, of registrant&#146;s principal executive offices) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Brian C. Thomas, Ph.D. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Metagenomi Technologies, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>1545 Park Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Emeryville, California 94608 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(510) <FONT STYLE="white-space:nowrap">871-4880</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Mitchell S. Bloom</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Edwin M. O&#146;Connor</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Justin S. Platt</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Goodwin
Procter LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>100 Northern Avenue</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Boston, Massachusetts 02210</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">(617)&nbsp;570-1000</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Richard D. Truesdell, Jr.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Yasin Keshvargar</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Davis
Polk&nbsp;&amp; Wardwell LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>450 Lexington Avenue</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10017</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(212) <FONT STYLE="white-space:nowrap">450-4000</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public</B>: As soon as practicable after the effective date of this registration statement. </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933,
as amended, check the following box.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)
under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If this Form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">Large&nbsp;Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging growth company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>The registrant hereby amends
this registration statement on such date or dates as may be necessary to delay its effective date until the registrant files a further amendment which specifically states that this registration statement shall thereafter become effective in
accordance with Section&nbsp;8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&nbsp;8(a), may determine.
</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi Technologies, LLC, the registrant whose name appears on the cover of this registration statement, is a Delaware limited liability company. Prior to the
effectiveness of this registration statement, Metagenomi Technologies, LLC will complete a series of transactions pursuant to which Metagenomi Technologies, LLC will merge with and into its wholly-owned subsidiary, Metagenomi, Inc., a Delaware
corporation, with Metagenomi, Inc. continuing as the surviving corporation. We refer to this reorganization throughout the prospectus included in this registration statement as the &#147;Reorganization.&#148; Except as disclosed in the prospectus,
the consolidated financial statements and summary consolidated financial data and other financial information included in this registration statement are those of Metagenomi Technologies, LLC and its subsidiaries and do not give effect to the
Reorganization. Shares of the common stock of Metagenomi, Inc. are being offered by the prospectus included in this registration statement. </P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><FONT COLOR="#8b3f4e"><B>The information in this preliminary prospectus is not complete and may be changed. We may not
sell these securities until the Securities and Exchange Commission declares our registration statement effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any
jurisdiction where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:arial"><FONT COLOR="#8b3f4e"><B>Subject to completion, dated January 5, 2024 </B></FONT></P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:11pt; font-family:arial"><B>PRELIMINARY PROSPECTUS </B></P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:18pt; font-family:arial"><B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares </I></B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g425213g00s01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:18pt; font-family:arial"><B><I>Common Stock </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This is an initial
public offering of shares of common stock of Metagenomi, Inc. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are offering
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock. We expect that the initial public offering price will be between
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Prior to this offering, there has been no public market for our common stock. We have applied to list our common stock on the Nasdaq Global Select Market under the
symbol &#147;MGX.&#148; We believe that upon the completion of this offering, we will meet the standards for listing on the Nasdaq Global Select Market, and the closing of this offering is contingent upon such listing. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are an &#147;emerging growth company&#148; under the federal securities laws and, as such, we have elected to comply with certain reduced public company reporting
requirements for this prospectus and for future filings. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Per&nbsp;share</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Initial public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Underwriting discounts and commissions(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">$</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Proceeds, before expenses, to Metagenomi, Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See &#147;Underwriting&#148; beginning on page&nbsp;268 of this prospectus for additional information regarding underwriting compensation. </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have granted the underwriters an option for a period of 30 days to purchase an additional
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock from us at the initial public offering price, less underwriting discounts and commissions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Investing in our common stock involves a high degree of risk. Before buying any shares, you should read carefully the discussion of the material risks of investing in
our common stock under the heading &#147;<A HREF="#toc425213_4">Risk Factors</A>&#148; starting on page 18 of this prospectus. </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Neither the Securities and
Exchange Commission nor any state securities commission has approved or disapproved of these securities, or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The underwriters expect to deliver the shares against payment in New York, New York on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:13pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:13pt">
<TD VALIGN="top"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Jefferies</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>TD&nbsp;Cowen</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>Wells&nbsp;Fargo&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>BMO&nbsp;Capital&nbsp;Markets</B></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:14pt; font-family:arial" ALIGN="center"><B>Chardan </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:11pt; font-family:arial"><B>Prospectus
dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc"></A>Table of contents </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_1">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_2">The Offering</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_3">Summary Consolidated Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_4">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_5">Special Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_6">Reorganization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_7">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_8">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_9">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_10">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_11">Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_12">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">129</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_13">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">227</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_14">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">237</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_15">Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">248</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_16">Certain Relationships and Related Person Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_17">Principal Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">254</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_18">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">256</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_19">Shares Eligible for Future Sale</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">262</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_20">Material U.S. Federal Income Tax Considerations for <FONT STYLE="white-space:nowrap">Non-U.S.
</FONT> Holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">264</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_21">Underwriting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">268</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_22">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">282</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_23">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">282</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_23a">Changes in Independent Registered Public Accounting Firm </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">282</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_24">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">283</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc425213_25">Index to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">F-1</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have not, and the underwriters have not, authorized anyone to provide any information or to make any representation other than those
contained in this prospectus, any amendment or supplement to this prospectus or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We and the underwriters take no responsibility for, and can provide no
assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of common stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so.
The information contained in this prospectus, any amendment or supplement to this prospectus or any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of shares of our common stock. Our
business, financial condition, results of operations and prospects may have changed since that date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For investors outside the United States: We have not, and the underwriters have not, done anything that would permit
this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform
themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside the United States. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Market data and certain other statistical information used throughout this prospectus are based on independent industry publications, governmental publications, reports
by market research firms, or other independent sources that we believe to be reliable sources. Industry publications and third-party research, surveys, and studies generally indicate that their information has been obtained from sources believed to
be reliable, although they do not guarantee the accuracy or completeness of such information. We are responsible for all of the disclosure contained in this prospectus, and we believe that these sources are reliable; however, we have not
independently verified the information contained in such publications. While we are not aware of any misstatements regarding any third-party information presented in this prospectus, their estimates, in particular, as they relate to projections,
involve numerous assumptions, are subject to risks and uncertainties, and are subject to change based on various factors, including those discussed under the section entitled &#147;Risk&nbsp;Factors&#148; and elsewhere in this prospectus. Some data
are also based on our good faith estimates. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We intend to apply for various trademarks that we use in connection with the operation of our business. This prospectus
may also contain trademarks, service marks and trade names of third parties, which are the property of their respective owners. Our use or display of third parties&#146; trademarks, service marks, trade names or products in this prospectus is not
intended to, and does not imply a relationship with, or endorsement or sponsorship by us. Solely for convenience, the trademarks, service marks and trade names referred to in this prospectus may appear without the TM or SM symbols, but the omission
of such references is not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable owner of these trademarks, service marks and trade names. </P>
<P STYLE="font-size:16pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>This summary highlights information contained in greater detail elsewhere in this prospectus and does not contain all of the information that you should consider in
making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus, including our consolidated financial statements and the related notes thereto included elsewhere in this prospectus. You should
also consider, among other things, the information set forth under the sections entitled &#147;Risk Factors,&#148; &#147;Special Note Regarding Forward-Looking Statements,&#148; and &#147;Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations,&#148; in each case included elsewhere in this prospectus. </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Prior to the effectiveness of this registration statement, we
will complete a series of transactions pursuant to which Metagenomi Technologies, LLC will merge with and into its wholly-owned subsidiary, Metagenomi, Inc., a Delaware corporation, with Metagenomi, Inc. continuing as the surviving corporation. See
&#147;Reorganization.&#148; Except where the context otherwise requires or where otherwise indicated, the terms &#147;Metagenomi,&#148; &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; &#147;our company,&#148; &#147;the company,&#148; and &#147;our
business&#148; refer, prior to the Reorganization discussed below, to Metagenomi Technologies, LLC and, after the Reorganization, to Metagenomi, Inc. </I></P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Overview </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are a precision genetic medicines company committed to
developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering
approaches to date. Genetic mutations are seen in a variety of forms, including deletions, insertions, single-base-pair changes and sequence repeats, and are found throughout the genome and across a variety of different cell types, tissues, and
organ systems. Additionally, many diseases lack a genetic origin but have the potential to be effectively and permanently addressed through genome editing. We are harnessing the power of metagenomics, the study of genetic material recovered from the
natural environment, to unlock four billion years of microbial evolution to discover and develop a suite of novel editing tools capable of correcting any type of genetic mutation found anywhere in the genome. Our comprehensive genome editing toolbox
includes programmable nucleases, base editors, and RNA and <FONT STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat
(&#147;CRISPR&#148;)-associated transposases (&#147;CASTs&#148;)). We believe our diverse and modular toolbox positions us to access the entire genome and select the optimal tool to unlock the full potential of genome editing for patients. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The company was founded by pioneers in the field of metagenomics, a powerful science that allows us to tap into the diversity of microbial life on this planet. The
metagenomics process starts by collecting samples from microbe-rich ecosystems ranging from simple home gardens to extreme locations such as hydrothermal vents below the ocean. We then extract the DNA from these environmental samples and deeply
sequence them to fully reconstruct the genomes of the resident microbes. Each sample may include thousands of distinct genomes from previously unknown organisms revealing novel cellular machinery that we utilize as building blocks for our editing
systems. Using high-throughput screening, artificial intelligence (&#147;AI&#148;), and proprietary algorithms, we rapidly mine through billions of novel proteins from our genome-resolved metagenomics database to create genome editing tools. To
date, we have analyzed over 460 trillion base pairs, predicted over 7.4&nbsp;billion proteins, including over 322&nbsp;million CRISPR-associated (&#147;Cas&#148;) proteins and over 1.75&nbsp;million CRISPRs, which we estimate has resulted in the
identification of over 20,000 novel genome editing systems. Simultaneously, we have assembled extensive libraries of millions of nucleases, deaminases, reverse transcriptases (&#147;RTs&#148;) and over one thousand CASTs. Our platform is designed to
enable us to rapidly and </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
effectively find, screen, and select tools with the highest potential targetability, specificity, and efficiency in order to develop them into genetic medicines. The iterative nature of our
process, underpinned by AI, allows us to continuously push the boundaries of innovation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our proprietary toolbox of editing systems<U></U> </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have developed an expansive and modular toolbox of next-generation genome editing systems that will allow us to interact with the human genome in a site-specific
manner, where each tool can be matched to specific disease targets. Figure 1 summarizes our diverse and versatile toolbox of different editing capabilities with the potential to address the full spectrum of genetic diseases.<B> </B> </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial"><B>Figure 1.</B> Our Toolbox. </P> <P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g12u12.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our programmable nucleases are the backbone of our broad set of genome editing tools. These novel nucleases including type II and
type V Cas nucleases, of which some are ultra-small systems that we call SMall Arginine-Rich sysTems (&#147;SMART&#148;) nucleases, have unique targeting abilities and can be programmed by guide RNAs (&#147;gRNA&#148;) to target and cut at specific
locations in any genome sequence. Targeted genomic breaks trigger DNA repair pathways that can be used for genome editing, for example, to integrate a gene at a target site <FONT STYLE="white-space:nowrap">(knock-in)</FONT> or for gene inactivation
(knockdown). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our toolbox contains thousands of CRISPR nucleases with diverse abilities to target different parts of the genome, allowing us to select the ideal
nuclease for targeting any given gene in a site-specific manner and potentially overcome a major limitation of first-generation CRISPR/Cas9 systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We also modify
our nucleases to either nick the genome (i.e., a nickase that cuts one strand of the DNA) or to simply bind to target sites (i.e., a nuclease dead variant). These capabilities (e.g., searching, cutting, nicking, and binding) can be leveraged as a
chassis by adding on additional effector enzymes to create base editors for single nucleotide changes and RNA-mediated integration systems (&#147;RIGS&#148;) for both small and large genomic </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
integrations using &#147;Little RIGS&#148; for prime editing and &#147;Big RIGS&#148; for large integrations. Using modular engineering, we match nickases with deaminases and RTs for base editing
and RIGS, respectively. Furthermore, nucleases can be engineered by swapping the search modules of the enzyme to expand the targetability of the chassis, which is critical for site-specific genomic modifications. Given the measured targeting density
of our toolbox, we believe that essentially any codon in the human genome could be addressed with our gene editing systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our highly active nucleases have gone
through extensive preclinical evaluation for both <I>in vivo</I> and <I>ex vivo</I> applications, with demonstration of broad potency of these systems across human primary cells, mouse, and nonhuman primate (&#147;NHP&#148;) models. Our base
editors, RIGS, and CAST systems have demonstrated activity across various cell-based models. In addition to evaluating system activity, we have undertaken detailed characterization of guide-specific on- and off-target effects. We routinely identify
guides that have no or minimal verifiable off-target editing, thus overcoming another limitation of first-generation CRISPR/Cas9 systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to overcoming
the activity, targetability, and specificity limitations of first-generation systems, our nuclease toolbox was designed to have broad compatibility with viral and nonviral delivery technologies. This compatibility is accomplished by having a variety
of nuclease and gRNA structures, which range in terms of their size and biochemistry. For example, small guides for some type V Cas systems streamline manufacturing for delivery by lipid nanoparticle (&#147;LNP&#148;) approaches, and SMART nickases
can be used to construct base editors that are small enough to fit within the packaging limitations of adeno-associated viruses (&#147;AAV&#148;). SpCas9, which is currently used in most base editing applications, is roughly three times the size of
some of our smallest SMART nickases and cannot be efficiently packaged into a single AAV. Combined, we believe these features will facilitate delivery of our genome editing tools to previously inaccessible tissue types and organ systems. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">While nucleases, base editors, and prime editors can precisely address a wide variety of genomic modifications required to treat disease, the fact that many diseases are
caused by a multitude of mutations across a gene means that a diverse set of editing tools are required to fully address these patient populations. The integration of a complete and functional gene through targeted genome editing may provide a way
in which every patient with a given disease could potentially be treated by a single genetic medicine. Big RIGS and CASTs are novel genome editing systems that are under development to achieve what has been a major challenge for the genome editing
field&#151;large, targeted genomic integrations. Initial preclinical readouts conducted in mammalian cells indicate that these systems could potentially have a major impact on how diseases caused by <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">loss-of-function</FONT></FONT> mutations, the most common cause of genetic diseases, can be addressed through genome editing. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Therapeutic translation roadmap and initial programs<U></U> </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are
taking a stepwise approach deploying our genome editing toolbox to develop potentially curative therapies for patients. Our lead programs are selected to both address important diseases and to establish new standards in targetability, precision,
efficiency, and scope of editing capabilities. Figure 2 summarizes the portfolio of programs that we and our partners are advancing, as we aim to match the optimal genome editing tools for each indication. Each of these indications were chosen based
on our conviction in the underlying biology, existence of validating preclinical and clinical data, availability of pharmacodynamic and translational tools to assess early proof-of-concept, relevant value supporting outcome measures, and ongoing
clinical unmet need. While we do not currently have any approved products and all of our product candidates are preclinical, our lead programs capture an ever-growing set of translational learnings and insights that will inform and accelerate future
programs. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial"><B>Figure 2:</B> <I></I>Therapeutic Translation<I></I>. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g30v84.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Hemophilia A&#151;novel, durable, knock-in approach for expression of Factor VIII </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Hemophilia A is the most common X-linked inherited bleeding disorder and is caused by mutations in the Factor VIII (&#147;FVIII&#148;) gene leading to loss of functional
FVIII protein that impacts the body&#146;s ability to form normal clots in response to injury. FVIII is normally produced in the liver within sinusoidal endothelial cells and is then secreted into the bloodstream where it acts as a cofactor for the
catalytic activation of Factor X in the clotting pathway. The lack of functional FVIII disrupts the normal clotting cascade and predisposes patients to increased risk of bleeding, either spontaneously or in response to injury or surgery. Repeated
bleeding episodes in joints or soft tissues can lead to progressive joint damage, inflammation, pain, and mobility impairment. Intracranial bleeding is of greatest concern as this can be rapidly fatal or lead to major morbidity. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Rather than provide the FVIII gene in an episomal location, which risks dilution from cell division or cell death as well as episomal transcriptional silencing, our
approach is to insert a FVIII DNA cassette into a "safe harbor location," within an intron of the albumin gene that is not expected to have deleterious effects. FVIII expression is then driven by the strong native albumin promoter. This approach has
previously been demonstrated in preclinical studies to lead to therapeutically relevant expression of a different clotting factor (Factor IX) with negligible impact to systemic circulating albumin levels. Our FVIII knock-in approach is designed to
provide stable expression and clinically relevant circulating levels of FVIII, even at low integration rates because of the strength of the albumin promoter. We have demonstrated the feasibility of the FVIII gene knock-in approach in mice with
several mouse specific guides and different FVIII DNA donor cassettes, with integration of the FVIII gene leading to FVIII mRNA expression and therapeutically relevant levels of FVIII protein in the blood. In an ongoing NHP study we demonstrated
integration of a surrogate cynomolgus-FVIII cassette (used to avoid immune response that would occur with a foreign human FVIII protein) and observed therapeutically relevant levels of the cyno-FVIII protein encoded by the integrated cassette in all
3 treated animals that has extended for 4.5 months following a single dose of the AAV-cFVIII virus followed five weeks later by a liver trophic LNP encapsulating the mRNA encoding MG29-1 and guide 2 at a dose of 1mg/kg body weight. We intend to
continue measuring FVIII levels in these monkeys up to the 12 month time point to generate a robust data set on durability. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Evaluation of different human FVIII donor DNA cassettes has been completed in mice resulting in the selection of 2
lead cassettes that will be compared in another NHP study, potentially leading to a development candidate selection anticipated in Q2 2024. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In parallel, we are
manufacturing mRNA, gRNA, AAV and LNP to support future investigational new drug (&#147;IND&#148;) enabling studies. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Primary Hyperoxaluria, Type 1
(&#147;PH1&#148;)&#151;a durable knockdown of HAO1 for substrate reduction therapy </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">PH1 is a rare autosomal recessive metabolic disease arising from loss of
function mutations in the alanine-glyoxylate aminotransferase (&#147;AGXT&#148;) gene that encodes alanine glyoxylate aminotransferase. This enzyme is found in peroxisomes of the liver where it catalyzes the conversion of glyoxylate to glycine and
pyruvate. Lack of functional AGXT leads to an accumulation of glyoxylate substrate, which is then converted to oxalate and excreted in the kidney. The excess urinary oxalate forms an insoluble complex with urinary calcium that leads to the
production of calcium oxalate crystal precipitates. This pathologic process results in the formation of repeated calcium oxalate urolithiasis and nephrolithiasis, which in turn leads to obstructive uropathy, inflammation, fibrosis, tubular toxicity,
and progressive loss of kidney function. PH1 is a serious disease that causes kidney failure. More than 70% of individuals with PH1 mutations will develop end-stage renal disease, with a median age in young adulthood. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The goal of our genome editing approach is to durably knock down HAO1 resulting in stable and permanent reduction of oxalate levels to effect a lifelong benefit. We have
performed nuclease and guide screening to select an optimal nuclease and gRNA combination. Along with our partner ModernaTX, Inc. (&#147;Moderna&#148;), we have achieved preclinical proof-of-concept in an AGXT knock-out mouse which is an accepted
disease model of PH1. We are in the final stages of confirming the candidate to take into NHP studies and expect to have NHP data in 2024 to support final development candidate selection. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Transthyretin Amyloidosis&#151;a single treatment to knockdown TTR gene expression </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Transthyretin amyloidosis is a disease of misfolded and aggregated transthyretin (&#147;TTR&#148;) protein that can deposit in tissues causing organ dysfunction,
primarily in the heart and/or peripheral nerves. The TTR protein is normally produced in the liver and circulates in a homotetramer (four copies of the same TTR protein bound together) where it serves as a carrier protein for vitamin A and
thyroxine. Certain mutations have been identified that can cause TTR homotetramers to fall apart, misfold, and aggregate into insoluble fibrils that deposit in cardiac tissue and peripheral nerves. However, more commonly, the normal aging process is
associated with an increased propensity for TTR misfolding and aggregation in the heart without any known genetic sequence variation. These distinctions lead to TTR amyloidosis being characterized as either hereditary transthyretin amyloidosis
(&#147;ATTRv&#148;) caused by mutations in TTR, or wild-type ATTR amyloidosis (&#147;ATTRwt&#148;). It is estimated that globally there are approximately 50,000 patients with ATTRv and between 300,000 and 500,000 patients with ATTRwt. Among the
larger ATTRwt patient population, the most common presentation is a rapidly progressive, restrictive, and hypertrophic cardiomyopathy due to progressive deposition of insoluble TTR fibrils, which result in thickening of the myocardium and stiffening
of the ventricles. These pathologic processes lead to impaired diastolic function and progressive cardiomyopathy that typically leads to progressive heart failure and often death within three to five years from disease onset. Although cardiac
manifestations are more common and severe, patients with neurologic manifestations also experience significant morbidity, loss of functionality, and impaired quality of life. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Using our novel nucleases, we aim to provide efficient TTR knockdown and halt further deposition of amyloid fibrils. Previous experience suggests a clinical correlation
between the degree of TTR knockdown and potential </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
for benefit in familial forms of the disease, which are expected to translate similarly to wild type forms. The high degree of <I>in vivo</I> editing efficiency and specificity of our nuclease
platform suggest the potential for a single treatment to knockdown TTR gene expression and remove the requirement for life-long therapy. Along with our partner Ionis Pharmaceuticals, Inc. (&#147;Ionis&#148;), we are currently in advanced stages of
nuclease and guide selection, having achieved more than 90% knockdown of human TTR protein after a single dose in a humanized TTR mouse model, and expect to move into NHP studies in 2024. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><I>Further areas of therapeutic activity and interest </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In parallel with
our translation efforts in our lead programs using our novel programmable nucleases to <FONT STYLE="white-space:nowrap">knock-in</FONT> or knockdown gene expression in liver-associated targets, we are developing more complex editing systems for
liver associated targets as well as moving beyond the liver. Given that our genome editing toolbox contains small editing systems designed to be amenable to viral vector delivery, and given the progress established in targeting the central nervous
system and muscle with established AAV capsids, our first extrahepatic indications will be neurodegenerative and neuromuscular diseases. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Building on our experience
delivering our nucleases to the liver via LNP systems, we are extending that experience delivering novel RIGS to the liver to potentially correct ATP7B mutations in Wilson&#146;s disease and PiZ mutations in <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">alpha-1-antitrypsin</FONT></FONT> deficiency (&#147;A1AT deficiency&#148;). We are also exploring addressing A1AT deficiency via a base editor approach given the predominant mutation involves a single base pair. Both of
these liver diseases have well-defined biology, readily available translational biomarkers for early proof-of-concept, established development pathways based on prior drug approvals, and important unmet medical needs. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Building on our experience with our novel type II and type V programmable nucleases, we are extending that experience by working to deliver these nucleases via AAV to
the central nervous system to potentially knockdown genetic targets important for both spontaneous and familial amyotrophic lateral sclerosis (SOD1, ATXN2) and Charcot-Marie-Tooth Type 1a (PMP22). In addition, we are working to address a series of
mutations common in Duchenne Muscular Dystrophy with our programmable nucleases through exon skipping approaches. In diseases outside of the liver, we intend to initially leverage known biology and clinical validation achieved with <FONT
STYLE="white-space:nowrap">RNA-targeted</FONT> approaches like antisense and small interfering RNA (&#147;siRNA&#148;) to advance more potent and definitive <FONT STYLE="white-space:nowrap">one-time</FONT> genome editing treatments. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Building on our experience with both <FONT STYLE="white-space:nowrap">knock-in</FONT> gene expression and smaller gene corrections with RIGS, we are progressing our
larger <FONT STYLE="white-space:nowrap">RNA-</FONT> and <FONT STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems to potentially provide a single curative approach to cystic fibrosis. As opposed to currently-available therapies
limited to subsets of patients with individual mutations, we intend to deliver a full copy of a functional cystic fibrosis transmembrane conductance regulator (&#147;CFTR&#148;) gene. This approach can similarly be pursued across many other diseases
characterized by loss of function mutations. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our Team </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have
assembled a world-class team that is driven by a passion to create potentially curative genetic medicines through the discovery of novel genome editing technologies by harnessing the power of metagenomics. Key members of our executive and leadership
team include: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Brian C. Thomas, Ph.D., Chief Executive Officer and Founder,</B> prior to
<FONT STYLE="white-space:nowrap">co-founding</FONT> the company, Dr. Thomas spent more than 20 years in academic research at UC Berkeley helping to pioneer the field of metagenomics. Dr. Thomas has been cited over 16,000 times and listed as an
inventor in 28 patent families. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Jian Irish, Ph.D., MBA, President and Chief Operating Officer</B>, has held biopharma executive leadership roles for
nearly 20 years at Kite Pharma / Gilead, Sanofi, and Amgen in drug development and global operations, and has helped launch several breakthrough medicines. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Pamela Wapnick, MBA, Chief Financial Officer,</B> has over 20 years of diversified financial leadership experience
spanning strategic and operational finance roles at public and private companies including life sciences and biotechnology companies, Diality Inc, Capsida Biotherapeutics, True North Therapeutics and Amgen. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Sarah Noonberg, M.D., Ph.D., Chief Medical Officer</B>, has spent more than 20 years in translational and clinical
development leadership roles with a track record of advancing therapeutic programs from discovery to commercialization, including at Medivation and BioMarin. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Simon Harnest, Chief Investment Officer and SVP of Strategy</B>, has held leadership roles in corporate finance and
strategy in the life sciences sector, having raised over $1 billion in public and private capital, including leading Cellectis&#146; U.S. IPO and subsequent <FONT STYLE="white-space:nowrap">spin-out</FONT> and IPO of Calyxt. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Luis G. Borges, Ph.D., Chief Scientific Officer</B>, has over 27&nbsp;years of experience in the biotechnology industry,
including Amgen, Five Prime Therapeutics, Cell Medica, and Century Therapeutics, where he held leadership roles in the research and development of multiple therapeutic candidates. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Simren Delaney, Ph.D., LLM, VP of Legal,</B> is specialized in Intellectual Property and Patent law, having previously
worked at Wilson Sonsini Goodrich&nbsp;&amp; Rosati, and plays an instrumental role in driving the development of the company&#146;s growing IP portfolio. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Christopher T. Brown, Ph.D., VP of Discovery,</B> is a former scientist at the Jill F. Banfield laboratory at UC
Berkeley and an expert in using metagenomics to discover novel microbial systems for use in genome editing. Dr. Brown&#146;s research has resulted in over 35 publications and over 20 patent family filings. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Michael Conway, MBA, CPA, VP of Finance</B>, has spent nearly 20 years in finance leadership positions at life science
and technology companies, including Adamas Pharmaceuticals, InterMune, and Intel. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Alan Brooks, Ph.D., SVP of Preclinical</B>, has worked on genetic medicines providing scientific leadership in
translational research for more than 25 years, including at Casebia Therapeutics and Bayer Healthcare. Dr.&nbsp;Brooks&#146; research has led to 20 publications and numerous patent filings. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our company is supported by our board of directors, Scientific Advisory Board, and a leading syndicate of investors, with more than 30 funds supporting our Series B and
Series B-1 preferred unit financings. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our Strategy </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our goal is
to harness the power of our proprietary metagenomics platform to create curative genetic medicines for patients.&nbsp;Key components of our strategy to achieve this goal include: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Leverage our leadership position in metagenomics to continually advance and expand innovative genome editing tools.
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Develop and deliver products that make precise modifications to the human genome to cure disease. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Build a fully integrated genome editing company. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Expand therapeutic impact to patients through continued investment in business development and enabling partnerships,
including with our existing partners Moderna, Ionis, and <FONT STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Maintain our entrepreneurial outlook, scientifically rigorous approach, and culture of tireless commitment to patients.
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Risks Associated with Our Business </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">We have incurred significant losses since inception. We expect to incur losses for the foreseeable future and may never
achieve or maintain profitability. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">We have never generated revenue from product sales and may never become profitable. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">We will need substantial additional funding in addition to the net proceeds we receive from this offering. If we are unable
to raise additional capital when needed on acceptable terms, or at all, we may be forced to delay, reduce, or terminate certain research and product development programs, future commercialization efforts or other operations. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">We are very early in our development efforts, and we have not yet initiated IND-enabling studies or clinical development of
any product candidate. As a result, we expect it will be many years before we commercialize any product candidate, if ever. If we are unable to advance our current or future product candidates into and through clinical trials, obtain regulatory
approval and ultimately commercialize our product candidates or experience significant delays in doing so, our business will be materially harmed. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">We are subject to additional development challenges and risks due to the novel nature of our genome editing technology.
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Clinical drug development involves a lengthy and expensive process, with an uncertain outcome. Because genome editing is
novel and the regulatory landscape that will govern our potential product candidates is uncertain and may change, we cannot predict the time and cost of obtaining regulatory approval, if we receive it at all, for our potential product candidates.
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">The genome editing field is relatively new and is evolving rapidly. We are focusing our research and development efforts on
genome editing using programmable nucleases, base editing, and RNA and <FONT STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems (including prime editors and Cas transposases), but other genome editing technologies may be discovered
that provide significant advantages over such technologies, which could materially harm our business. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">If any of the product candidates we may develop or the delivery modes we rely on cause undesirable side effects, it could
delay or prevent their regulatory approval, limit the commercial potential or result in significant negative consequences following any potential regulatory approval. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Positive results from early preclinical studies of any product candidates we may develop are not necessarily predictive of
the results of later preclinical studies and any future clinical trials of such product candidates. If we cannot replicate the positive results from our earlier preclinical studies of any product candidates we may develop in our later preclinical
studies and future clinical trials, we may be unable to successfully develop, obtain regulatory approval for and commercialize such product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">We may find it difficult to enroll patients in our future clinical trials given the limited number of patients who have the
diseases any product candidates we identify or develop are intended to target. If we experience delays or difficulties in the enrollment of patients in clinical trials, our clinical development activities and our receipt of necessary regulatory
approvals could be delayed or prevented. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Genetic therapies are novel, and any product candidates we develop may be complex and difficult to manufacture. We could
experience delays in satisfying regulatory authorities or production problems that result in delays in our development programs, limit the supply of the product candidates we may develop or otherwise harm our business. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">We face significant competition in an environment of rapid technological change, and there is a possibility that our
competitors may achieve regulatory approval before us or develop therapies that are safer or more advanced or effective than ours, which may harm our financial condition and our ability to successfully market or commercialize any product candidates
we may develop. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">While we intend to seek designations for our potential product candidates with the U.S. Food and Drug Administration (the
&#147;FDA&#148;) and comparable foreign regulatory authorities that are intended to confer benefits such as a faster development process or an accelerated regulatory pathway, there can be no assurance that we will successfully obtain such
designations. In addition, even if one or more of our potential product candidates are granted such designations, we may not be able to realize the intended benefits of such designations. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Because we are developing product candidates in the field of genetic medicines in which there is little clinical
experience, there is increased risk that the FDA, the European Medicines Agency or other regulatory authorities may not consider the endpoints of our clinical trials to provide clinically meaningful results and that these results may be difficult to
analyze. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">If preclinical studies or clinical trials of any product candidates we may identify and develop fail to demonstrate safety
and efficacy to the satisfaction of regulatory authorities or do not otherwise produce positive results, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of
such product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Even if we complete the necessary clinical trials, we cannot predict when, or if, we will obtain regulatory approval to
commercialize a product candidate we may develop in the United States or any other jurisdiction, and any such approval may be for a more narrow indication than we seek. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">If conflicts arise between us and our collaborators or strategic partners, these parties may act in a manner adverse to us
and could limit our ability to implement our strategies. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">We have entered into collaborations, and may enter into additional collaborations, with third parties for the research,
development, manufacture and commercialization of programs or product candidates. If these collaborations are not successful, our business could be adversely affected. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Our collaborators and strategic partners may control aspects of our clinical trials, which could result in delays and other
obstacles in the commercialization of our proposed products and materially harm our results of operations. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Our future success depends on our ability to retain our Chief Executive Officer and other key executives and to attract,
retain, and motivate qualified personnel. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Our commercial success depends on our ability to obtain, maintain, enforce, and otherwise protect our intellectual property
and proprietary technology, and if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors or other third parties could develop and commercialize products and product candidates similar to ours and our
ability to successfully develop and commercialize our genome editing systems may be adversely affected. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Intellectual property rights do not necessarily address all potential threats to our business. </P></TD></TR></TABLE>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Corporate Information </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We commenced our current operations and converted to a
Delaware limited liability company in September 2018. We were originally founded as Metagenomi.co, a Delaware corporation, in September 2016. Prior to the </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
effectiveness of this registration statement, we intend to engage in a series of transactions, which we refer to collectively as the Reorganization. As a result of the Reorganization, Metagenomi
Technologies, LLC will merge with and into its wholly-owned subsidiary, Metagenomi, Inc., a Delaware corporation, with Metagenomi, Inc. continuing as the surviving corporation. In connection with the Reorganization, (i)&nbsp;all of the outstanding
common unitholders of Metagenomi Technologies, LLC will receive shares of common stock of Metagenomi, Inc., (ii) all of the outstanding preferred unitholders of Metagenomi Technologies, LLC will receive shares of preferred stock of Metagenomi, Inc.
and (iii)&nbsp;all of the outstanding holders of profits interest units in Metagenomi Technologies, LLC will receive shares of common stock and restricted common stock in Metagenomi, Inc. as determined by the applicable provisions of the Metagenomi
Technologies, LLC operating agreement in effect immediately prior to the Reorganization. Immediately prior to the completion of this offering, all outstanding shares of preferred stock of Metagenomi, Inc. will be converted into shares of common
stock. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi, Inc. will become the registrant for purposes of this offering, and our consolidated financial statements will be reported from Metagenomi, Inc.
See &#147;Reorganization&#148; and &#147;Description of Capital Stock&#148; for additional information, including a description of the terms of our capital stock following the Reorganization and the terms of our amended and restated certificate of
incorporation and amended and restated bylaws that will be in effect upon the completion of this offering. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our principal executive offices are located at 1545 Park
Avenue Emeryville, California 94608, and our telephone number is (510) <FONT STYLE="white-space:nowrap">871-4880.</FONT> </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our website address is
https://www.metagenomi.co. The information contained in or accessible from our website is not incorporated into this prospectus, and you should not consider it part of this prospectus. We have included our website address in this prospectus solely
as an inactive textual reference. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Implications of Being an Emerging Growth Company </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We qualify as an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012, as amended (the &#147;JOBS Act&#148;). As an emerging
growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">being permitted to present only two years of audited financial statements, in addition to any required unaudited interim
financial statements, with correspondingly reduced &#147;Management&#146;s discussion and analysis of financial condition and results of operations&#148; disclosure in this prospectus; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reduced disclosure about our executive compensation arrangements; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">not being required to hold advisory votes on executive compensation or to obtain stockholder approval of any golden
parachute arrangements not previously approved; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">an exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting
pursuant to the Sarbanes-Oxley Act of 2002; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">an exemption from compliance with the requirements of the Public Company Accounting Oversight Board regarding the
communication of critical audit matters in the auditor&#146;s report on the financial statements. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may take advantage of these exemptions for up
to five years or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company on the date that is the earliest of </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
(i)&nbsp;the last day of the fiscal year in which we have total annual gross revenues of $1.235&nbsp;billion or more; (ii)&nbsp;the last day of our fiscal year following the fifth anniversary of
the date of the completion of this offering; (iii)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in nonconvertible debt during the previous three years; or (iv)&nbsp;the date on which we are deemed to be a large accelerated filer
under the rules of the Securities and Exchange Commission (the &#147;SEC&#148;). We may choose to take advantage of some but not all of these exemptions. We have taken advantage of reduced reporting requirements in this prospectus. Accordingly, the
information contained herein may be different from the information you receive from other public companies in which you hold stock. Additionally, the JOBS Act provides that an emerging growth company can take advantage of an extended transition
period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail
ourselves of this exemption and, therefore, while we are an emerging growth company we will not be subject to new or revised accounting standards at the same time that they become applicable to other public companies that are not emerging growth
companies. As a result of this election, our financial statements may not be comparable to those of other public companies that comply with new or revised accounting pronouncements as of public company effective dates. We may choose to early adopt
any new or revised accounting standards whenever such early adoption is permitted for private companies. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_2"></A>THE OFFERING </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="28%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B></B>Shares of common stock offered by us<B> </B></P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="28%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B></B>Shares of our common stock to be outstanding after this offering<B> </B></P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares if the underwriters exercise their
option to purchase additional shares in full). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="28%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B></B>Underwriters&#146; option to purchase additional shares<B> </B></P></TD>
<TD>We have granted the underwriters a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of our common stock at
the initial public offering price, less underwriting discounts and commissions on the same terms as set forth in this prospectus. </TD></TR></TABLE> <P STYLE="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="28%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B></B>Use of proceeds<B> </B></P></TD>
<TD>We estimate that the net proceeds to us from the sale&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock in this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million if the underwriters exercise their option to purchase additional shares in full, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share,
the estimated midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We intend to use the net proceeds of this
offering, together with our existing cash and cash equivalents and available-for-sale marketable securities, to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and for general
corporate purposes. See &#147;Use of Proceeds.&#148; </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="28%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B></B>Proposed Nasdaq Global Select Market symbol<B> </B></P></TD>
<TD>We have applied to list our common stock on the Nasdaq Global Select Market under the symbol &#147;MGX.&#148; The closing of this offering is contingent upon such listing. </TD></TR></TABLE>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="28%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B></B>Risk factors<B> </B></P></TD>
<TD>Investment in our common stock involves substantial risks. You should read this prospectus carefully, including the section entitled &#147;Risk Factors&#148; and the consolidated financial statements and the related notes to those statements
included in this prospectus, before investing in our common stock. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The number of shares of our common stock outstanding after this offering assumes
the Reorganization takes place prior to the effectiveness of this registration statement and is based on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock (including
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of unvested restricted common stock) issued in exchange for common units and profits interests outstanding as of September 30, 2023, and after
giving effect to the conversion of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our redeemable convertible preferred stock, issued in connection with the Reorganization in exchange for
redeemable convertible preferred units outstanding as of September 30, 2023, into an equivalent number of shares of our common stock immediately prior to the completion of this offering: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The number of shares of common stock to be outstanding after this offering excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock
reserved for future issuance under our 2024 Stock Option and Incentive Plan, which will become effective on the date immediately prior to execution of the underwriting agreement related to this offering; and </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock
reserved for future issuance under our 2024 Employee Stock Purchase Plan, which will become effective immediately prior to execution of the underwriting agreement related to this offering. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Except as otherwise noted, all information in this prospectus: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">assumes no vesting of the restricted common stock described above; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">assumes no exercise of the underwriters&#146; option to purchase up to
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares of common stock in this offering; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">assumes the filing of our amended and restated certificate of incorporation and the effectiveness of our amended and
restated bylaws, which will occur upon the closing of this offering; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">assumes a
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-for-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reverse stock split of our common stock effected
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_3"></A>SUMMARY CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following tables present the summary consolidated financial data for Metagenomi Technologies, LLC and its consolidated subsidiary. You should read the following
summary consolidated financial data together with our consolidated financial statements and the related notes appearing elsewhere in this prospectus and the &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations&#148; section of this prospectus. We have derived the consolidated statements of operations for the years ended December 31, 2022 and 2021 from our audited consolidated financial statements appearing elsewhere in this prospectus. The
consolidated statements of operations for the nine months ended September&nbsp;30, 2023 and 2022 and the consolidated balance sheet data as of September&nbsp;30, 2023 have been derived from our unaudited condensed consolidated financial statements
appearing elsewhere in this prospectus, which have been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, the unaudited data reflect all adjustments, consisting only of normal recurring
adjustments, necessary for a fair statement of the financial information in those statements. Our historical results are not necessarily indicative of the results that may be expected in any future period. The summary consolidated financial data
included in this section are not intended to replace the consolidated financial statements and the related notes included elsewhere in this prospectus. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Nine Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="right"><B>(in thousands, except share and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Consolidated Statements of Operations Data:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">32,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,947</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,640</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,874</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in fair value of long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss before provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,243</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,660</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,569</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,723</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,301</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(43,593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(28,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,961</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss per unit attributable to common unitholders, basic and diluted(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3.77</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7.34</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.88</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8.23</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted-average common units outstanding, basic and diluted(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,691,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,938,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,935,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma net loss per share attributable to common stockholders, basic and diluted (unaudited)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma weighted-average common stock outstanding, basic and diluted (unaudited)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:2pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See Note 16 to our audited consolidated financial statements and Note 14 to our unaudited condensed consolidated financial statements included elsewhere in this prospectus for details on the calculation of basic and
diluted net loss per unit attributable to common unitholders. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See &#147;Unaudited Pro Forma Net Loss Per Share Attributable to Common Stockholders&#148; subsection below for details on our unaudited pro forma calculations. </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Unaudited Pro Forma Net Loss Per Share Attributable to Common Stockholders </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The unaudited pro forma basic and diluted net loss per share attributable to common stockholders for the year ended December 31, 2022 and for the nine months ended
September&nbsp;30, 2023 has been computed to give effect to (i)&nbsp;the Reorganization, (ii)&nbsp;the conversion of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our redeemable convertible preferred stock outstanding as of December 31, 2022 and September&nbsp;30, 2023, respectively, into an equivalent
number of shares of our common stock as if such conversion occurred on January&nbsp;1, 2022 and (iii)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation that will be in effect immediately prior to
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the completion of this offering. The unaudited pro forma net loss attributable to common stockholders gives effect to the adjustments described below. The unaudited pro forma net loss per share
attributable to common stockholders, basic and diluted, does not include the effect of the shares of our common stock expected to be sold in this offering. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
following table sets forth the computation of the unaudited pro forma basic and diluted net loss per share assuming the offering is completed on January 1, 2022: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,&nbsp;2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>(unaudited)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>(unaudited)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(43,593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,961</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted-average common units outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,938,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma adjustment to reflect the issuance of common stock in exchange for common units in connection with
the Reorganization(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma adjustment to reflect the issuance of common stock in exchange for vested profits interests in
connection with the Reorganization(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma adjustment to reflect the conversion of redeemable convertible preferred stock issued in
connection with the conversion of the redeemable convertible preferred units from the Reorganization into common stock(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma weighted-average common shares outstanding, basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma net loss per share attributable to common stockholders, basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects the exchange of (i) 5,947,500 common units for &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock and
(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vested profits interests for &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common
stock in connection with the Reorganization, as if such exchange had occurred on January&nbsp;1, 2022. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects the conversion of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our redeemable convertible preferred stock, issued in connection with the
Reorganization in exchange for redeemable convertible preferred units, into an equivalent number of shares of our common stock, as if such conversion had occurred on January 1, 2022. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="12" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of September&nbsp;30, 2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Pro&nbsp;Forma(1)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="center"><B>Pro&nbsp;Forma</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="center"><B>As&nbsp;Adjusted(2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Condensed Consolidated Balance Sheet Data:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">101,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Working capital(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">386,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">154,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Redeemable convertible preferred units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,650</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total members&#146;/shareholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00px solid #000000" ALIGN="right">(119,021</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The consolidated pro forma balance sheet data gives effect to (i)&nbsp;the Reorganization, (ii)&nbsp;the conversion of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our redeemable convertible preferred
stock, issued in connection with the Reorganization in exchange for redeemable convertible preferred units outstanding as of September&nbsp;30, 2023, into an equivalent number of shares of our common stock immediately prior to the closing of this
offering, and (iii)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation upon the closing of this offering. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The pro forma as adjusted consolidated balance sheet data gives effect to the pro forma adjustments set forth in footnote (1)&nbsp;above and our issuance and sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of our common stock offered in this offering at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the estimated midpoint of the price range set forth on the cover page of this
prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. The pro forma as adjusted information set forth in the table above is illustrative only and will be adjusted based on the
actual initial public offering price and other terms of this offering as determined at pricing. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We define working capital as current assets less current liabilities. See our consolidated financial statements included elsewhere in this prospectus for further details regarding our current assets and current
liabilities. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
share, which is the estimated midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the pro forma as adjusted amount of each of our cash and cash equivalents, working capital, total
assets, and total members&#146;/shareholders&#146; equity (deficit) by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same
and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase or decrease of 1,000,000 shares in the number of shares offered by us as set forth on the cover page of this
prospectus, would increase or decrease, as applicable, the pro forma as adjusted amount of each of cash and cash equivalents, working capital, total assets, and total members&#146;/shareholders&#146; equity (deficit) by
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming no change in the assumed initial public offering price per share and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below together with all of the other
information contained in this prospectus, including our consolidated financial statements and related notes appearing at the end of this prospectus, before deciding to invest in our common stock. If any of the events or developments described below
were to occur, our business, prospects, operating results and financial condition could suffer materially, the trading price of our common stock could decline and you could lose all or part of your investment. The risks and uncertainties described
below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. </I></P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Risks Related to Financial Position and Need for Capital </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We have
incurred significant losses since inception. We expect to incur losses for the foreseeable future and may never achieve or maintain profitability. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Since
inception, we have incurred significant operating losses. Our net loss was $21.4&nbsp;million and $43.6&nbsp;million for the years ended December&nbsp;31, 2021 and 2022, and $29.0 million and $49.0 million for the nine months ended September 30,
2022 and 2023, respectively. As of September 30, 2023, we had an accumulated deficit of $125.7&nbsp;million. We have financed our operations primarily through issuing redeemable convertible preferred units and convertible promissory notes and
entering into collaboration agreements. Substantially all of our losses have resulted from expenses incurred in connection with our research and development and from general and administrative costs associated with our operations. We expect to
continue to incur significant expenses and increasing operating losses for the foreseeable future. The net losses we incur may fluctuate significantly from quarter to quarter. We anticipate that our expenses will increase substantially if and as we:
</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">advance our&nbsp;current research activities and further develop our platform; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">continue preclinical development and initiate clinical trials for any product candidates we may identify;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">seek regulatory approval for any product candidates for which we successfully complete clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establish our manufacturing capabilities, including internal manufacturing facilities and contracting with other vendors;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">ultimately, commercialize our future product candidates requiring significant marketing, sales, and distribution
infrastructure expenses; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">hire additional research and development, clinical, commercial, general and administration personnel;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">develop, maintain, expand, protect, and enforce our intellectual property portfolio; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> product candidates, intellectual property and technologies;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">confirm, maintain or obtain freedom to operate for any of our owned or licensed technologies and product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establish and maintain collaborations; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">add operational, financial and management information systems and personnel; or </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">incur additional legal, audit, accounting, compliance, insurance, investor relations and other expenses to operate as a
public company that we did not incur as a private company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth
strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings, or other capital sources, which may include collaborations with other
companies or other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and
when needed, we may have to significantly delay, reduce or eliminate the development and commercialization of our platform or delay our pursuit of potential <FONT STYLE="white-space:nowrap">in-licenses</FONT> or acquisitions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have not initiated clinical development of any potential product candidate and expect that it will be many years, if ever, before we have a product candidate ready
for commercialization. To become and remain profitable, we must develop and, either directly or through collaborators, eventually commercialize a therapy or therapies with market potential. This will require us to be successful in a range of
challenging activities, including identifying product candidates, completing preclinical studies and clinical trials of product candidates, obtaining regulatory approval for these product candidates, manufacturing, marketing and selling those
therapies for which we may obtain regulatory approval and satisfying any post-marketing requirements. We may never succeed in these activities and, even if we do, may never generate revenues that are significant or large enough to achieve
profitability. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Because of the numerous risks and uncertainties associated with developing our technology and any potential product candidates, we are unable to
predict the extent of any future losses or when we will become profitable, if at all. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable
would decrease the value of our company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value of our company could also cause you to lose
all or part of your investment. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We have never generated revenue from product sales and may never become profitable. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our ability to generate revenue from product sales and achieve profitability depends on our ability, alone or with collaborative partners, to successfully complete the
development of, and obtain the regulatory approvals necessary to commercialize, product candidates we may identify for development. We may not generate revenues from product sales for many years, if ever. Our ability to generate future revenues from
product sales depends heavily on our or our collaborators&#146; ability to successfully: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">identify product candidates and successfully complete research development of any product candidates we may identify;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">seek and obtain regulatory approvals for any product candidates for which we successfully complete clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">launch and commercialize any product candidates for which we may obtain regulatory approval by establishing a sales force,
marketing and distribution infrastructure, or alternatively, collaborating with a commercialization partner; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">qualify for adequate coverage and reimbursement by government and third-party payors for any product candidates for which
we may obtain regulatory approval; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establish and maintain supply and manufacturing relationships with third parties that can provide adequate, in both amount
and quality, products and services to support clinical development and the market demand for any product candidates for which we obtain regulatory approval; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">develop, maintain and enhance a sustainable, scalable, reproducible and transferable manufacturing process for the product
candidates we may develop; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">address competing technological and market developments; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">negotiate favorable terms in any collaboration, licensing or other arrangements into which we may enter and performing our
obligations in such collaborations; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">receive market acceptance by physicians, patients, healthcare payors, and others in the medical community;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">maintain, protect, enforce, defend and expand our portfolio of intellectual property and other proprietary rights,
including patents, trade secrets and <FONT STYLE="white-space:nowrap">know-how;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">defend against third-party intellectual property claims of infringement, misappropriation or other violation; and
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">attract, hire and retain qualified personnel. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our expenses could increase beyond expectations if we are required by the U.S. Food and Drug Administration (the &#147;FDA&#148;) or other regulatory authorities to
perform preclinical studies or clinical trials in addition to those that we currently anticipate. Even if one or more of the product candidates we may develop are approved for commercial sale, we anticipate incurring significant costs associated
with commercializing any approved product candidate. Additionally, such products may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives. Even if we are able to generate revenues
from the sale of any approved product candidates, we may not become profitable and may need to obtain additional funding to continue operations. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We will need
substantial additional funding in addition to the net proceeds we receive from this offering. If we are unable to raise additional capital when needed on acceptable terms, or at all, we may be forced to delay, reduce, or terminate certain of our
research and product development programs, future commercialization efforts or other operations. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Developing gene editing products, including conducting
preclinical studies and clinical trials, is a very time-consuming, expensive and uncertain process that takes years to complete. Our operations have consumed substantial amounts of cash since inception, and we expect our expenses to increase in
connection with our ongoing activities, particularly as we identify, continue the research and development of, initiate and conduct clinical trials of, and seek regulatory approval for, any product candidates we may identify. In addition, if we
obtain regulatory approval for any product candidates we may identify, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing, and distribution to the extent that such sales, marketing,
manufacturing, and distribution are not the responsibility of a collaborator. Other unanticipated costs may also arise. Furthermore, upon the closing of this offering, we expect to incur additional costs associated with operating as a public
company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our
research and product development programs, future commercialization efforts or other operations. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September 30, 2023, our cash, cash equivalents and
available-for-sale marketable securities were $292.9&nbsp;million. We expect that the net proceeds from this offering, together with our existing cash, cash equivalents, and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, will enable us to fund our operating expenses and capital expenditure requirements
into&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. However, our operating plan may change as a result of factors currently unknown to us, and we may need to seek funding sooner than planned. Our
future capital requirements will depend on many factors, including: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the timing and progress of research and development, preclinical&nbsp;and clinical development activities;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the number, scope and duration of clinical trials required for regulatory approval of our future product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs, timing, and outcome of regulatory review of any of our future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs of manufacturing clinical and commercial supplies of our future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales and
distribution, for any of our future product candidates for which we receive regulatory approval; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs of preparing, filing and prosecuting our patent applications, maintaining and enforcing our patents and other
intellectual property rights and defending intellectual property-related claims; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to maintain existing, and establish new, strategic collaborations, licensing or other arrangements, and the
financial terms of any such agreements, including the timing and amount of any future milestone, royalty or other payments due under any such agreement; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to establish and maintain collaboration and license agreements on favorable terms, if at all;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the extent to which we acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> other product candidates and
technologies; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any product liability or other lawsuits related to our future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our implementation of various computerized informational systems and efforts to enhance operational systems;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">expenses incurred to attract, hire and retain skilled personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs of operating as a public company; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to establish a commercially viable pricing structure and obtain approval for coverage and adequate
reimbursement from third-party and government payers; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the extent to which we acquire or invest in businesses, products, and technologies; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the effect of competing technological and market developments; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, as well as other factors, including economic
uncertainty and geopolitical tensions, which may exacerbate the magnitude of the factors discussed above. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Identifying potential product candidates
and conducting preclinical testing and clinical trials is a time-consuming, expensive, and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain regulatory approval and achieve
product sales. In addition, our future product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for many years, if
at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. In addition, we may seek additional capital
due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt
securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing, if available, may involve agreements that
include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, declaring dividends, and possibly other restrictions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any additional fundraising efforts may divert our management from their <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities, which may adversely affect our ability to develop and commercialize our product candidates. We have no committed sources of additional capital and, if we are unable to raise additional
capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of our future product candidates or other research and development initiatives. Without
sufficient funding, our license agreements and any future collaboration agreements may also be terminated if we are unable to meet the payment or other obligations under such agreements. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce, or terminate our product
development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. Additionally, if we raise funds through additional collaborations, strategic
alliances, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates we develop, or we may have to grant licenses on terms that may
not be favorable to us and/or that may reduce the value of our common stock. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our short operating history may make it difficult for you to evaluate the success
of our business to date and to assess our future viability. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are an early-stage company. We commenced our operations in September 2018. Our operations to
date have been limited to organizing and staffing our company, business planning, raising capital, and research and development activities such as acquiring and developing our platform and technology and identifying and beginning to advance
preclinical testing of potential product candidates. All of our programs are still in the research or lead optimization stage of development and their risk of failure is high. We have not yet demonstrated an ability to initiate or successfully
complete any clinical trials, including large-scale, pivotal clinical trials, obtain regulatory approvals, manufacture a commercial-scale therapy, arrange for a third party to do so on our behalf or conduct sales and marketing activities necessary
for successful commercialization. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our limited operating history, particularly in light of the rapidly evolving genome editing field, may make it difficult to
evaluate our technology and industry and predict our future performance. Our short history as an operating company makes any assessment of our future success or viability subject to significant uncertainty. We will encounter risks and difficulties
frequently experienced by very early stage companies in rapidly evolving fields. If we do not address these risks successfully, our business will suffer. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In
addition, as a new business that is rapidly growing, we may encounter other unforeseen expenses, difficulties, complications, and delays in our product development. We will need to transition from a company with a research focus to a company capable
of conducting clinical trials and ultimately supporting commercial activities if any of our future product candidates are approved. We may not be successful in such a transition. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our future ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Since our inception, we have incurred losses and we may never achieve profitability. As of December&nbsp;31, 2022, we had U.S. federal net operating loss carryforwards
of $0.02&nbsp;million (which are not subject to expiration) and state net operating loss carryforwards of $8.3&nbsp;million (which begin to expire in various amounts in 2037), and $2.8 million of research credit carryforwards for state income tax
purposes (which do not expire and can be carried forward indefinitely). To the extent that we continue to generate taxable losses, under current law, our unused U.S. federal net operating losses (&#147;NOLs&#148;) may be carried forward to offset a
portion of future taxable income, if any. Additionally, we continue to generate business tax credits, including research and development tax credits, which generally may be carried forward to offset a portion of future taxable income, if any,
subject </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
to expiration of such credit carryforwards. Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), if a corporation undergoes an &#147;ownership
change,&#148; generally defined as one or more shareholders or groups of shareholders who own at least 5&nbsp;percent of the corporation&#146;s equity increasing their equity ownership in the aggregate by more than 50 percentage points (by value)
over a three-year period, the corporation&#146;s ability to use its <FONT STYLE="white-space:nowrap">pre-change</FONT> NOLs and other <FONT STYLE="white-space:nowrap">pre-change</FONT> tax attributes (such as research and development tax credits) to
offset its post-change income or taxes may be limited. Similar rules may apply under state tax laws. Our prior equity offerings and other changes in our stock ownership have resulted in such ownership changes in the past. In addition, we may
experience ownership changes in the future as a result of this offering or subsequent shifts in our stock ownership, some of which are outside of our control. As a result, if we earn net taxable income, our ability to use our <FONT
STYLE="white-space:nowrap">pre-change</FONT> NOLs or other <FONT STYLE="white-space:nowrap">pre-change</FONT> tax attributes to offset U.S. federal taxable income may be subject to limitations, which could potentially result in increased future tax
liability to us. Additional limitations on our ability to utilize our NOLs to offset future taxable income may arise as a result of our corporate structure whereby NOLs generated by our subsidiary may not be available to offset taxable income earned
by our subsidiary. There is a risk that due to changes under the tax law, regulatory changes or other unforeseen reasons, our existing NOLs or business tax credits could expire or otherwise be unavailable to offset future income tax liabilities. At
the state level, there may also be periods during which the use of NOLs or business tax credits is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. For these reasons, we may not be able to realize a
tax benefit from the use of our NOLs or tax credits, even if we attain profitability. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Changes in tax laws or in their implementation or interpretation may
adversely affect our business and financial condition. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The rules dealing with U.S. federal, state and local income taxation are constantly under review by
persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect our business and our financial condition.
In recent years, many such changes have been made and changes are likely to continue to occur in the future. We cannot predict whether, when, in what form or with what effective dates, tax laws, regulations and rulings may be enacted, promulgated or
decided or whether they could increase our tax liability or require changes in the manner in which we operate in order to minimize increases in our tax liability. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Risks Related to Business, Technology, and Industry </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are very early
in our development efforts, and we have not yet initiated <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies or clinical development of any product candidate. As a result, we expect it will be many years before we commercialize any product
candidate, if ever. If we are unable to advance our future product candidates into and through clinical trials, obtain regulatory approval and ultimately commercialize our product candidates or experience significant delays in doing so, our business
will be materially harmed. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are very early in our development efforts and have focused our research and development efforts to date on research efforts
including preclinical studies. Currently, all of our programs are still in the research or lead optimization stage of development. Our ability to generate product revenues, which we do not expect will occur for many years, if ever, will depend
heavily on the successful development, regulatory approval and eventual commercialization of our future product candidates, which may never occur. We have not yet generated revenue from product sales, and we may never be able to develop or
commercialize a marketable product. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Commencing clinical trials in the United States is subject to acceptance by the FDA of an investigational new drug
(&#147;IND&#148;) application and finalizing the trial design based on discussions with the FDA. In the event that the FDA requires us to complete additional preclinical studies or we are required to satisfy other FDA requests prior
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
to commencing clinical trials, the start of our first clinical trials may be delayed or we may be unsuccessful obtaining clearance to proceed into clinical development. Even after we receive and
incorporate guidance from the FDA, the FDA could disagree that we have satisfied their requirements to commence any clinical trial or change their position on the acceptability of our trial design or the clinical endpoints selected, which may
require us to complete additional preclinical studies or clinical trials, delay the enrollment of our clinical trials, abandon our clinical development plans or meet stricter approval conditions than we currently expect. There are equivalent
processes and risks applicable to clinical trial applications in other countries, including countries in the European Union. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, clinical trials conducted
in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not guarantee regulatory approval in any other country. We may conduct one or more of our clinical trials with one or more
trial sites that are located outside the United States. Although the FDA may accept data from clinical trials conducted outside the United States, acceptance of these data is subject to conditions imposed by the FDA, and there can be no assurance
that the FDA will accept data from trials conducted outside of the United States. If the FDA does not accept the data from any trial that we conduct outside the United States, it would likely result in the need for additional trials, which would be
costly and time-consuming and could delay or permanently halt our development of the applicable product candidates. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Commercialization of any product candidates we
may develop will require preclinical and clinical development; regulatory approval in multiple jurisdictions; manufacturing supply, capacity and expertise; a commercial organization; and significant marketing efforts. The success of product
candidates we may identify and develop will depend on many factors, including the following: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">timely and successful completion of preclinical studies, including toxicology studies, biodistribution studies and
minimally efficacious dose studies in animals, where applicable; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">effective INDs or comparable foreign applications that allow commencement of our planned clinical trials or future clinical
trials for any product candidates we may develop; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">successful enrollment and completion of clinical trials, including under the FDA&#146;s current Good Clinical Practices
(&#147;GCPs&#148;), current Good Laboratory Practices (&#147;GLPs&#148;), and any additional regulatory requirements from foreign regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">positive results from our future clinical trials that support a finding of safety and effectiveness and an acceptable
risk-benefit profile in the intended populations; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">receipt of regulatory approvals from applicable regulatory authorities; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establishment of arrangements through our own facilities or with third-party manufacturers for clinical supply and, where
applicable, commercial manufacturing capabilities; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establishment, maintenance, defense and enforcement of patent, trademark, trade secret and other intellectual property
protection or regulatory exclusivity for any product candidates we may develop; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">commercial launch of any product candidates we may develop, if approved, whether alone or in collaboration with others;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">acceptance of the benefits and use of our product candidates we may develop, including method of administration, if and
when approved, by patients, the medical community and third-party payors; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">effective competition with other therapies; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">maintenance of a continued acceptable safety, tolerability and efficacy profile of any product candidates we may develop
following approval; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establishment and maintenance of healthcare coverage and adequate reimbursement by payors. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we do not succeed in one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize
any product candidates we may develop, which would materially harm our business. If we are unable to advance our product candidates to clinical development, obtain regulatory approval and ultimately commercialize our product candidates, or
experience significant delays in doing so, our business will be materially harmed. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are subject to additional development challenges and risks due to the
novel nature of our genome editing technology. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Because our <I>in vivo</I> technology potentially involves genome editing across multiple cell and tissue
types, we are subject to many of the challenges and risks that other genome editing therapeutics and gene therapies face, including: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">regulatory guidance regarding the requirements governing gene and genome editing therapy product candidates have changed
and may continue to change in the future; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">to date, only a limited number of products that involve <I>in vivo</I> gene transfer have been approved globally;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">improper modulation of a gene sequence, including unintended editing events or insertion of a sequence into certain
locations in a patient&#146;s chromosome, could lead to cancer, other aberrantly functioning cells or other diseases, including death; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">corrective expression of a missing protein in patients&#146; cells could result in the protein being recognized as foreign,
and lead to a sustained immunological reaction against the expressed protein or expressing cells, which could be severe or life-threatening; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">regulatory agencies may require extended <FONT STYLE="white-space:nowrap">follow-up</FONT> observation periods of patients
who receive treatment using genome editing product candidates including, for example, the FDA&#146;s recommended <FONT STYLE="white-space:nowrap">15-year</FONT> <FONT STYLE="white-space:nowrap">follow-up</FONT> observation period for these patients,
and we will need to adopt such observation periods for product candidates we develop if required by the relevant regulatory agency, which could vary by country or region. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Furthermore, our technology has potential application for <I>ex vivo</I> immune cell editing strategies. Because <I>ex vivo</I> application of our technology potentially
involves editing human cells and then delivering modified cells to patients, we may be subject to many of the challenges and risks that engineered cell therapies face. For example, clinical trials using engineered cell-based gene therapies may
require unique products to be created for each patient and such individualistic manufacturing may be both inefficient and cost-prohibitive. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Clinical drug
development involves a lengthy and expensive process, with an uncertain outcome. Because genome editing is novel and the regulatory landscape that will govern our potential product candidates is uncertain and may change, we cannot predict the time
and cost of obtaining regulatory approval, if we receive it at all, for our potential product candidates. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The time required to obtain approval for any of
our potential product candidates from the FDA, the European Medicines Agency (&#147;EMA&#148;) or other comparable foreign regulatory authorities is unpredictable but typically takes many years following the commencement of clinical trials and
depends upon numerous factors, including the substantial discretion of regulatory authorities. For more information on the regulatory approval process, see &#147;Business&#151;Government Regulation.&#148; Clinical trials may fail to demonstrate that
our product candidates are safe for humans and effective for indicated uses. Even if initial clinical trials in any of any product candidates we may develop are successful, such product candidates may fail to show the desired safety and efficacy in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
later stages of clinical development despite having successfully advanced through preclinical studies and initial clinical trials. There is a high failure rate for drugs and biologics proceeding
through clinical trials. A number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in later stage clinical trials even after achieving promising results in earlier stage clinical trials. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Because genome editing is novel, the regulatory requirements that will govern any novel genome editing product candidates we develop may continue to evolve. Within the
broader genetic therapy field, a limited number of gene therapy products have received marketing authorization from the FDA and the EMA to date. Even with respect to more established products that fit into the categories of gene therapies or cell
therapies, the regulatory landscape is still developing. Regulatory requirements governing gene therapy products and cell therapy products have changed frequently and may continue to change in the future. For example, in January 2020, the FDA issued
several new guidance documents on gene therapy products, and in March 2022, the FDA published a draft guidance document providing recommendations for human genome editing gene therapy products. Moreover, there is substantial, and sometimes
uncoordinated, overlap in those responsible for regulation of existing gene therapy products and cell therapy products. For example, in the United States, the FDA has established the Office of Therapeutic Products (&#147;OTP&#148;) within its Center
for Biologics Evaluation and Research (&#147;CBER&#148;) to consolidate the review of gene therapy and related products, and the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER on its review. Gene therapy clinical trials may
also be subject to review and oversight by an institutional biosafety committee (&#147;IBC&#148;), a local institutional committee that reviews and oversees certain basic and clinical research conducted at the institution participating in the
clinical trial. Although the FDA decides whether individual gene therapy protocols may proceed, the review process and determinations of other reviewing bodies, such as an IBC or institutional review board (&#147;IRB&#148;), can impede or delay the
initiation of a clinical trial, even if the FDA has reviewed the trial and approved its initiation. For example, more recently, some genome editing companies have seen significant delays in receiving FDA authorization to allow the initiation of
their clinical trials, and has suspended ongoing trials, due to the FDA&#146;s placement of clinical holds on their INDs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The same applies in the European Union.
The EMA&#146;s Committee for Advanced Therapies (&#147;CAT&#148;) is responsible for assessing the quality, safety and efficacy of advanced-therapy medicinal products (i.e. gene therapy, somatic-cell therapy or tissue-engineered medicines). The role
of the CAT is to prepare a draft opinion on an application for marketing authorization for a gene therapy medicinal candidate that is submitted to the Committee for Medicinal Products for Human Use (&#147;CHMP&#148;) before CHMP adopts its opinion
which is submitted to the European Commission for the final decision on whether to grant a marketing authorization or not. In the European Union, the EMA publishes guidelines for the development and evaluation of gene therapy medicinal products to
assist in preparing marketing authorization applications, however these are continually under review. The EMA may issue new guidelines concerning the development and marketing authorization for gene therapy medicinal products and require that we
comply with these new guidelines. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Adverse developments in post-marketing experience or in clinical trials conducted by others of gene therapy products, cell therapy
products or products developed through the application of genome editing technology may cause the FDA, the EMA and other regulatory bodies to revise the requirements for development or approval of our potential product candidates or limit the use of
products utilizing genome editing technologies, either of which could materially harm our business. In addition, the clinical trial requirements of the FDA, the EMA and other regulatory authorities and the criteria these regulators use to determine
the safety and efficacy of a product candidate vary substantially according to the type, complexity, novelty and intended use and market of the potential products. The regulatory approval process for novel product candidates can be more expensive
and take longer than for other, better known or more extensively studied pharmaceutical or other product candidates. Regulatory agencies administering existing or future regulations or legislation may not allow production and marketing of products
utilizing genome editing technology in a timely manner or under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
technically or commercially feasible conditions. In addition, regulatory action or private litigation could result in expenses, delays or other impediments to our research programs or the
commercialization of resulting products. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The regulatory review committees and advisory groups described above and any new guidelines they promulgate may lengthen
the regulatory review process, require us to perform additional studies or trials, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of these treatment
candidates or lead to significant post-approval limitations or restrictions. As we advance our research programs and develop future product candidates, we will be required to consult with these regulatory and advisory groups and to comply with
applicable guidelines. If we fail to do so, we may be required to delay or discontinue development of any product candidates we identify and develop. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The
genome editing field is relatively new and is evolving rapidly. We are focusing our research and development efforts on genome editing using programmable nucleases, base editing, and RNA and <FONT STYLE="white-space:nowrap">DNA-mediated</FONT>
integration systems (including prime editors and CRISPR-associated (&#147;Cas&#148;) transposases), but other genome editing technologies may be discovered that provide significant advantages over such technologies, which could materially harm our
business. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To date, we have focused our efforts on genome editing technologies using programmable nucleases, base editing, and RNA and <FONT
STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems (including prime editors and Cas transposases backed by our metagenomics database. Other companies have previously undertaken research and development of genome editing technologies
using zinc finger nucleases, engineered meganucleases and transcription activator-like effector nucleases, but to date none have obtained regulatory approval for a product candidate. There can be no certainty that genome editing technology will lead
to the development of genetic medicines or that other genome editing technologies will not be considered better or more attractive for the development of medicines. A number of alternative approaches are being developed by others. Our investments
may not be consistent with the expectations of our stockholders and may not produce the benefits that we expect, in which case our growth, business, financial condition, and results of operations could be adversely affected. See &#147;Risk
Factors&#151;Risks Related to Business, Technology and Industry&#151;We face significant competition in an environment of rapid technological change, and there is a possibility that our competitors may achieve regulatory approval before us or
develop therapies that are safer or more advanced or effective than ours, which may harm our financial condition and our ability to successfully market or commercialize any product candidates we may develop.&#148; Similarly, another new genome
editing technology that has not been discovered yet may be more attractive than programmable nucleases, base editing, and RNA and <FONT STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems. Moreover, if we decide to develop genome
editing technologies other than those involving such technologies, we cannot be certain we will be able to obtain rights to such technologies. Any of these factors could reduce or eliminate our commercial opportunity, and could have a material
adverse effect on our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If any of the product candidates we may develop or the delivery
modes we rely on cause undesirable side effects, it could delay or prevent their development or potential regulatory approval, limit the commercial potential or result in significant negative consequences following any potential regulatory approval.
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To date, we have not evaluated any product candidates in human clinical trials. It is impossible to predict when or if any product candidates we may develop
will ultimately prove safe in humans. In the genomic medicine field, there have been several significant adverse events from gene therapy treatments in the past, including reported cases of leukemia and death. Product candidates we may develop may
be associated with undesirable side effects, unexpected characteristics or other serious adverse events, including <FONT STYLE="white-space:nowrap">off-target</FONT> cuts of DNA, or the introduction of cuts in DNA at locations other than the target
sequence. These <FONT STYLE="white-space:nowrap">off-target</FONT> cuts could lead to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
disruption of a gene or a genetic regulatory sequence at an unintended site in the DNA, or, in those instances where we also provide a segment of DNA to serve as a repair template, it is possible
that following <FONT STYLE="white-space:nowrap">off-target</FONT> cut events, DNA from such repair template could be integrated into the genome at an unintended site, potentially disrupting another important gene or genomic element. There is also
the potential risk of delayed adverse events following exposure to genome editing therapy due to persistent biologic activity of the genetic material or other components of products used to carry the genetic material. Possible adverse side effects
that could occur with treatment with genome editing products include an immunologic reaction after administration which could substantially limit the effectiveness of the treatment If any of our genome editing technologies demonstrate a similar
effect, we may decide or be required to halt or delay preclinical development or clinical development of any product candidates we may develop. In addition to serious adverse events or side effects caused by any product candidate we may develop, the
administration process or related procedures also can cause undesirable side effects. If any such events occur, our preclinical studies or clinical trials could be delayed, suspended or terminated. There can be no assurance that our genome editing
technologies will not cause severe or undesirable side effects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If in the future we are unable to demonstrate that such adverse events were caused by factors other
than our product candidate, the FDA, the EMA or other comparable foreign regulatory authorities could order us to cease further clinical studies of, or deny approval of, any product candidates we develop for any or all targeted indications. Even if
we are able to demonstrate that all future serious adverse events are not product-related, such occurrences could affect patient recruitment or the ability of enrolled patients to complete the trial. Moreover, if we elect, or are required, to delay,
suspend or terminate any clinical trial of any product candidate we may develop, the commercial prospects of such product candidates may be harmed and our ability to generate product revenues from any of these product candidates may be delayed or
eliminated. Any of these occurrences may harm our ability to identify and develop product candidates, and may harm our business, financial condition, result of operations and prospects significantly. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Viral vectors, including the adeno-associated virus (&#147;AAV&#148;), which are relatively new approaches used for disease treatment, also have known side effects, and
for which additional risks could develop in the future. In past clinical trials that were conducted by others with <FONT STYLE="white-space:nowrap">non-AAV</FONT> vectors, significant side effects were caused by gene therapy treatments, including
reported cases of myelodysplasia, leukemia and death. Other potential side effects could include an immunologic reaction and insertional oncogenesis, which is the process whereby the insertion of a functional gene near a gene that is important in
cell growth or division results in uncontrolled cell division, which could potentially enhance the risk of cancer. If the vectors we use demonstrate a similar side effect, or other adverse events, we may be required to halt or delay further clinical
development of any potential product candidates. Such delayed adverse events may also occur in other viral vectors, including AAV vectors. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to side
effects and adverse events caused by our product candidates, the conditioning, administration process or related procedures which may be used to condition a patient for gene therapy treatment also can cause adverse side effects and adverse events. A
gene therapy patient is generally administered cytotoxic drugs to remove stem cells from the bone marrow to create sufficient space in the bone marrow for the modified stem cells to engraft and produce new cells. This procedure compromises the
patient&#146;s immune system, and conditioning regimens have been associated with adverse events in clinical trial participants. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Additionally, if we successfully
develop a product candidate and it receives regulatory approval, the FDA could require us to adopt a Risk Evaluation and Mitigation Strategy (&#147;REMS&#148;) to ensure that the benefits of treatment with such product candidate outweighs the risks
for each potential patient, which may include, among other things, a medication guide outlining the risks of the product for distribution to patients, a communication plan </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
to healthcare practitioners, extensive patient monitoring, or distribution systems and processes that are highly controlled, restrictive, and more costly than what is typical for the industry.
Furthermore, if we or others later identify undesirable side effects caused by any product candidate that we may develop that receives regulatory approval, several potentially significant negative consequences could result, including: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">regulatory authorities may revoke licenses or suspend, vary or withdraw approvals of such product candidate;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">regulatory authorities may require additional warnings on the label; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we may be required to change the way a product candidate is administered or conduct additional clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we could be sued and held liable for harm caused to patients; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our reputation may suffer. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any of these events could prevent us from achieving or maintaining market acceptance of our genome editing technology and any product candidates we may identify and
develop and could have a material adverse effect on our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Positive results from early
preclinical studies of any product candidates we may develop may not necessarily be predictive of the results of later preclinical studies and any future clinical trials of such product candidates. If we cannot replicate the positive results from
our earlier preclinical studies of any product candidates we may develop in our later preclinical studies and future clinical trials, we may be unable to successfully develop, obtain regulatory approval for and commercialize such product candidates.
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any positive results from our preclinical studies of any product candidates we may develop may not necessarily be predictive of the results from later
preclinical studies and clinical trials of such product candidates. Similarly, even if we are able to complete our planned preclinical studies or any future clinical trials of any product candidates we may develop according to our current
development timeline, the positive results from such preclinical studies and clinical trials of our product candidates may not be replicated in subsequent preclinical studies or clinical trial results. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials after achieving positive results in
early-stage development and we cannot be certain that we will not face similar setbacks. These setbacks have been caused by, among other things, preclinical findings made while clinical trials were underway or safety or efficacy observations made in
preclinical studies and clinical trials, including previously unreported adverse events. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses and many companies that believed their product candidates
performed satisfactorily in preclinical studies and clinical trials nonetheless failed to obtain regulatory approval. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may also consider additional delivery
modes, which may carry additional known and unknown risks. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may also consider additional delivery modes, which may carry additional known and unknown
risks. For example, we intend to use lipid nanoparticles (&#147;LNPs&#148;) to deliver our nucleases. While LNPs have been used to deliver smaller molecules, such as small interfering RNA (&#147;siRNA&#148;), they have not been clinically proven to
deliver large RNA molecules. Furthermore, as with many <FONT STYLE="white-space:nowrap">AAV-mediated</FONT> gene therapy approaches, certain patients&#146; immune systems might prohibit the successful delivery, thereby potentially limiting treatment
outcomes of these patients. Even if initial clinical trials in any of our potential product candidates we may develop are successful, these product candidates we may develop may fail to show the desired safety and efficacy in later stages of
clinical development despite having successfully advanced through preclinical studies and initial clinical trials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may find it difficult to enroll patients in our future clinical trials given the limited number of patients
who have the diseases any product candidates we identify or develop are intended to target. If we experience delays or difficulties in the enrollment of patients in clinical trials, our clinical development activities and our receipt of necessary
regulatory approvals could be delayed or prevented. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As we progress our programs, we may not be able to initiate or continue clinical trials for any product
candidates we identify or develop if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA, the EMA or other comparable regulatory authorities outside the United States, or
as needed to provide appropriate statistical power for a given trial. Enrollment may be particularly challenging for some of the rare genetically defined diseases we are targeting in some of our discovery programs. In addition, if patients are
unwilling to participate in our genome editing trials because of negative publicity from adverse events related to the biotechnology, gene therapy or genome editing fields, competitive clinical trials for similar patient populations, clinical trials
in competing product candidates or for other reasons, the timeline for recruiting patients, conducting studies and obtaining regulatory approval of our potential product candidates may be delayed. Moreover, some of our competitors may have ongoing
clinical trials for product candidates that would treat the same indications as our potential product candidates, and patients who would otherwise be eligible for our future clinical trials may instead enroll in clinical trials of our
competitors&#146; product candidates. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Patient enrollment is also affected by other factors, some of which may include: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">severity of the disease under investigation; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">size of the patient population and process for identifying patients, including proximity and availability of clinical trial
sites for prospective patients with conditions that have small patient pools; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">design of the trial protocol, including efforts to facilitate timely enrollment in clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">availability and efficacy of approved medications for the disease under investigation; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">availability of genetic testing for potential patients and ability to monitor patients adequately during and after
treatment; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">ability to obtain and maintain patient informed consent; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">risk that enrolled patients will drop out before completion of the trial; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">eligibility and exclusion criteria for the trial in question; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">perceived risks and benefits of the product candidate under trial and genome editing as a therapeutic approach; and
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">patient referral practices of physicians. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, our ability to successfully initiate, enroll and complete a clinical trial in any foreign country is subject to numerous risks unique to conducting business
in foreign countries, some of which may include: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">difficulty in establishing or managing relationships with clinical research organizations (&#147;CROs&#148;) and
physicians; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">different standards for the conduct of clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">different <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">standard-of-care</FONT></FONT> for patients
with a particular disease; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">difficulty in locating qualified local consultants, physicians and partners; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">potential burden of complying with a variety of foreign laws, medical standards and regulatory requirements, including the
regulation of pharmaceutical and biotechnology products and treatment and of genome editing technologies. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Enrollment delays in our future clinical trials may result in increased development costs for our potential product
candidates, which would cause the value of our company to decline and limit our ability to obtain additional financing. If we or our collaborators have difficulty enrolling a sufficient number of patients to conduct our future clinical trials as
planned, we may need to delay, limit or terminate ongoing or planned clinical trials or entire clinical programs, any of which would have an adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Genetic therapies are novel, and any product candidates we develop may be complex and difficult to manufacture. We could experience delays in satisfying regulatory
authorities or production problems that result in delays in our development programs, limit the supply of the product candidates we may develop or otherwise harm our business. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any product candidates we may develop will likely require processing steps that are more complex than those required for most chemical pharmaceuticals. Moreover, unlike
chemical pharmaceuticals, the physical and chemical properties of a biologic such as the product candidates we intend to develop generally cannot be fully characterized. As a result, assays of the finished product candidate may not be sufficient to
ensure that the product candidate will perform in the intended manner. Problems with the manufacturing process, even minor deviations from the normal process, could result in product defects or manufacturing failures that result in lot failures,
product recalls, product liability claims, insufficient inventory or potentially delay progression of our potential IND filings. If we successfully develop product candidates, we may encounter problems achieving adequate quantities and quality of
clinical-grade materials that meet the FDA, the EMA or other comparable applicable foreign standards or specifications with consistent and acceptable production yields and costs. For example, the current approach of manufacturing AAV vectors may
fall short of supplying required number of doses needed for advanced stages of preclinical studies or clinical trials, and the FDA may ask us to demonstrate that we have the appropriate manufacturing processes in place to support the higher-dose
group in our preclinical studies or clinical trials. In addition, any product candidates we may develop will require complicated delivery methods, each of which will introduce additional complexities in the manufacturing process. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, the FDA, the EMA and other regulatory authorities may require us to submit samples of any lot of any approved product together with the protocols showing
the results of applicable tests at any time. Under some circumstances, the FDA, the EMA or other regulatory authorities may require that we not distribute a lot until the agency authorizes its release. Slight deviations in the manufacturing process,
including those affecting quality attributes and stability, may result in unacceptable changes in the product that could result in lot failures or product recalls. Lot failures or product recalls could cause us to delay clinical trials or product
launches, which could be costly to us and otherwise harm our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Given the nature of biologics
manufacturing there is a risk of contamination during manufacturing. Any contamination could materially harm our ability to produce product candidates on schedule and could harm our results of operations and cause reputational damage. Some of the
raw materials that we anticipate will be required in our manufacturing process are derived from biologic sources. Such raw materials are difficult to procure and may be subject to contamination or recall. A material shortage, contamination, recall
or restriction on the use of biologically derived substances in the manufacture of any product candidates we may develop could adversely impact or disrupt the commercial manufacturing or the production of clinical material, which could materially
harm our development timelines and our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any problems in our manufacturing process or the
facilities with which we contract could make us a less attractive collaborator for potential partners, including larger pharmaceutical companies and academic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
research institutions, which could limit our access to additional attractive development programs. Problems in third-party manufacturing process or facilities also could restrict our ability to
ensure sufficient clinical material for any clinical trials we may be conducting or are planning to conduct and meet market demand for any product candidates we develop and commercialize. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We face significant competition in an environment of rapid technological change, and there is a possibility that our competitors may achieve regulatory approval
before us or develop therapies that are safer or more advanced or effective than ours, which may harm our financial condition and our ability to successfully market or commercialize any product candidates we may develop. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The development and commercialization of new drug products is highly competitive. Moreover, the genome editing field is characterized by rapidly changing technologies,
significant competition and a strong emphasis on intellectual property. We will face competition with respect to any product candidates that we may seek to develop or commercialize in the future from major pharmaceutical companies, specialty
pharmaceutical companies and biotechnology companies worldwide. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent or other
intellectual property protection and establish collaborative arrangements for research, development, manufacturing and commercialization. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There are a number of
large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of products for the treatment of the disease indications for which we have research programs. Some of these competitive products
and therapies are based on scientific approaches that are the same as or similar to our approach, while others are based on entirely different approaches. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Amongst
publicly traded peers, there are several companies utilizing CRISPR/Cas technology, including Caribou Biosciences, Inc., Editas Medicine, Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc. and Graphite Bio, Inc. Several additional companies
such as Sangamo Therapeutics, Inc., Precision BioSciences, Inc., bluebird bio, Inc., and Cellectis Inc. utilize alternative nuclease-based genome editing technologies, including zinc finger nucleases (&#147;ZFNs&#148;), engineered meganucleases and
transcription-activator like effector nucleases (&#147;TALENs&#148;). Beam Therapeutics utilizes base editing technology. Prime Medicine utilizes prime editing technology. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, other private companies such as Tessera Therapeutics, Inc. and Tome Biosciences, Inc. have announced their work in recombinase DNA and RNA gene writers,
although little is known publicly about their science or portfolio. Other companies have announced intentions to enter the genome editing field, such as Moderna, Inc. and Pfizer Inc. Most recently, new epigenetic editing companies have emerged, such
as Chroma Medicine, Inc. and Tune Therapeutics, Inc. In addition, we face competition from companies utilizing gene therapy, oligonucleotides and cell therapy therapeutic approaches. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Several private companies such as Arbor Biotechnologies, Inc., Scribe Therapeutics Inc., and Mammoth Biosciences, Inc. are actively searching for novel genome editing
components and have reported the discovery of new <FONT STYLE="white-space:nowrap">DNA-cutting</FONT> enzymes. Other companies are active in LNP delivery technologies and advancing those into therapeutics using genetic therapies, including Recode
Therapeutics, Inc., Verve Therapeutics, Inc., Generation Bio Co. and Beam Therapeutics, among others. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any product candidates that we successfully develop and
commercialize will compete with existing therapies and new therapies that may become available in the future that are approved to treat the same diseases for which we may obtain approval for any product candidates we may develop. This may include
other types of therapies, such as small molecule, antibody and/or protein therapies. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Many of our current or potential competitors, either alone or with their
collaboration partners, may have significantly greater financial resources and expertise in research and development, manufacturing, conducting preclinical studies and clinical trials, obtaining regulatory approvals and marketing approved products
than we do. Mergers and acquisitions in the pharmaceutical, biotechnology and gene therapy industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting
and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our commercial
opportunity could be reduced or eliminated if our competitors develop and commercialize product candidates that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any product candidates
that we may develop or that would render any product candidates that we may develop obsolete or <FONT STYLE="white-space:nowrap">non-competitive.</FONT> Our competitors also may obtain FDA or other regulatory approval for their product candidates
more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. Additionally, technologies developed by our competitors may render our potential
product candidates uneconomical or obsolete, and we may not be successful in marketing any product candidates we may develop against competitors. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, as a
result of the expiration or successful challenge of our patent or other intellectual property rights, we could face risks relating to our ability to successfully prevent or delay launch of competitors&#146; products. The availability of our
competitors&#146; products could limit the demand and the price we are able to charge for any product candidates that we may develop and commercialize. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Adverse public perception of genome editing and cellular therapy products may negatively impact demand for, or regulatory approval of, any product candidates we
may develop. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The product candidates we may develop will involve editing the human genome. The clinical and commercial success of any product candidates we
may develop will depend in part on public acceptance of the use of genome editing therapies for the prevention or treatment of human diseases. Public attitudes may be influenced by claims that genome editing is unsafe, unethical, or immoral, and,
consequently, our products may not gain the acceptance of the public or the medical community. Negative public reaction to gene therapy in general could result in greater government regulation and stricter labeling requirements of genome editing
products, including any of our product candidates, and could cause a decrease in the demand for any products we may develop. Adverse public attitudes may adversely impact our ability to enroll clinical trials. Additionally, ethical, social and legal
concerns about genome editing and gene therapy could result in additional regulations restricting or prohibiting any product candidates we may develop. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The
commercial success of any of the product candidates we may develop will depend upon the degree of market acceptance by physicians, patients, third-party payors and others in the medical community. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Even if we obtain the requisite approvals from the FDA in the United States, the EMA in the European Union and other regulatory authorities internationally, the
commercial success of any product candidates we may develop will depend, in part, on the acceptance of physicians, patients and health care payors of genome editing and gene therapy products in general, and our product candidates in particular, as
medically necessary, cost-effective and safe. Any product that we commercialize may not gain acceptance by physicians, patients, health care payors and others in the medical community who may opt for existing treatments with which they are already
familiar and for which greater clinical data may be available. The degree of market acceptance of genome editing and gene therapy products and, in particular, any product candidates we may develop, if approved for commercial sale, will depend on
several factors, including: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the efficacy, durability and safety of such product candidates as demonstrated in any future clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the potential and perceived advantages of such product candidates over alternative treatments; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the cost of treatment relative to alternative treatments; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the clinical indications for which the product candidate is approved by the FDA, the EMA or other regulatory authorities;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">patient awareness of, and willingness to seek, genotyping; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the willingness of physicians to prescribe new therapies; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the willingness of the target patient population to try new therapies; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the prevalence and severity of any side effects; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">product labeling or product insert requirements of the FDA, the EMA or other regulatory authorities, including any
limitations or warnings contained in a product&#146;s approved labeling; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">relative convenience and ease of administration; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the strength of marketing and distribution support; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the timing of market introduction of competitive products; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">publicity concerning our products or competing products and treatments; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">sufficient third-party payor coverage and reimbursement. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Even if a potential product displays a favorable efficacy and safety profile in preclinical studies and future clinical trials, market acceptance of the product will not
be fully known until after it is launched. If any product candidates we may develop do not achieve an adequate level of acceptance following regulatory approval, if ever, we may not generate significant product revenue and may not become profitable.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that
may be more profitable or for which there is a greater likelihood of success. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have limited financial and managerial resources. As a result, we may forego
or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to timely capitalize on viable commercial products
or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial
potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us
to retain sole development and commercialization rights to such product candidate. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If, in the future, we are unable to establish sales and marketing
capabilities or enter into agreements with third parties to sell and market products based on our technologies, we may not be successful in commercializing our future product candidates if and when any such product candidates are approved and we may
not be able to generate any revenue. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We do not currently have a sales or marketing infrastructure and, as a company, have no experience in the sale,
marketing or distribution of therapeutic products. To achieve commercial success for any potential approved product candidate for which we retain sales and marketing responsibilities, we must build our sales, marketing, managerial and other <FONT
STYLE="white-space:nowrap">non-technical</FONT> capabilities or make arrangements with third parties to perform these services. In the future, we may choose to build a focused sales and marketing infrastructure to sell, or participate in sales
activities with our collaborators for, some of our product candidates if and when they are approved. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There are risks involved with both establishing our own sales and marketing capabilities and entering into
arrangements with third parties to perform these services. For example, recruiting and training a sales force is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a
sales force and establish marketing capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly and our investment would be lost if we cannot
retain or reposition our sales and marketing personnel. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Factors that may inhibit our efforts to commercialize our product candidates on our own include: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our inability to recruit, train and retain adequate numbers of effective sales and marketing personnel;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the inability of sales personnel to obtain access to physicians or persuade adequate numbers of physicians to prescribe any
future product that we may develop; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the lack of complementary treatments to be offered by sales personnel, which may put us at a competitive disadvantage
relative to companies with more extensive product lines; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">unforeseen costs and expenses associated with creating an independent sales and marketing organization.
</P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we enter into arrangements with third parties to perform sales, marketing and distribution services, our product revenue or the profitability
to us from these revenue streams is likely to be lower than if we were to market and sell any product candidates that we develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell and market our
product candidates or may be unable to do so on terms that are favorable to us. We likely will have little control over such third parties and any of them may fail to devote the necessary resources and attention to sell and market our product
candidates effectively. If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we may not be successful in commercializing our product candidates. Further, our business,
results of operations, financial condition and prospects will be materially adversely affected. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Due to the novel nature of our technology and the potential
for any product candidates we may develop to offer therapeutic benefit in a single administration or limited number of administrations, we face uncertainty related to pricing and reimbursement for such product candidates. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our initial target patient populations are relatively small, as a result of which the pricing and reimbursement of any product candidates we may develop, if approved,
must be adequate to support the necessary commercial infrastructure. If we are unable to obtain adequate levels of reimbursement, our ability to successfully market and sell any such product candidates will be adversely affected. The manner and
level at which reimbursement is provided for services related to any product candidates we may develop (e.g., for administration of our product candidate to patients) is also important. Inadequate reimbursement for such services may lead to
physician and payor resistance and adversely affect our ability to market or sell our product candidates. In addition, we may need to develop new reimbursement models in order to realize adequate value. Payors may not be able or willing to adopt
such new models, and patients may be unable to afford that portion of the cost that such models may require them to bear. If we determine such new models are necessary but we are unsuccessful in developing them, or if such models are not adopted by
payors, our business, financial condition, results of operations, and prospects could be adversely affected. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We expect the cost of a single administration of a
genome editing therapy, such as those we are seeking to develop, to be substantial, when and if they achieve regulatory approval. We expect that coverage and reimbursement by government and private payors will be essential for most patients to be
able to afford these treatments. Accordingly, sales of any such product candidates will depend substantially, both domestically and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
abroad, on the extent to which the costs of any of our product candidates will be paid by government authorities, private health plans, and other third-party payors. Payors may not be willing to
pay high prices for a single administration. Coverage and reimbursement by a third-party payor may depend upon several factors, including the third-party payor&#146;s determination that use of a product is: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">a covered benefit under its health plan; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">safe, effective, and medically necessary; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">appropriate for the specific patient; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">cost-effective; and </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">neither experimental nor investigational. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Obtaining coverage and reimbursement for a product from third-party payors is a time-consuming and costly process that could require us to provide to the payor
supporting scientific, clinical, and cost-effectiveness data. There is significant uncertainty related to third-party coverage and reimbursement of newly approved products. We may not be able to provide data sufficient to gain acceptance with
respect to coverage and reimbursement. If coverage and reimbursement are not available, or are available only at limited levels, we may not be able to successfully commercialize any of our product candidates. Even if coverage is provided, the
approved reimbursement amount may not be adequate to realize a sufficient return on our investment. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the United States, no uniform policy exists for coverage and
reimbursement for products among third-party payors. Therefore, decisions regarding the extent of coverage and amount of reimbursement to be provided can differ significantly from payor to payor. The process for determining whether a payor will
provide coverage for a product may be separate from the process for setting the reimbursement rate a payor will pay for the product. One third-party payor&#146;s decision to cover a particular product or service does not ensure that other payors
will also provide coverage for the medical product or service. Third-party payors may limit coverage to specific products on an approved list or formulary, which may not include all <FONT STYLE="white-space:nowrap">FDA-approved</FONT> products for a
particular indication. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Further, third-party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical
products and services, in addition to their safety and efficacy. In order to secure coverage and reimbursement for any product that might be approved for sale, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the
medical necessity and cost-effectiveness of any product candidates we may develop, in addition to the costs required to obtain FDA or comparable regulatory approvals. Additionally, we may also need to provide discounts to purchasers, private health
plans or government healthcare programs. Despite our best efforts, any product candidates we may develop may not be considered medically necessary or cost-effective. If third-party payors do not consider a product to be cost-effective compared to
other available therapies, they may not cover an approved product as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow us to sell our products at a profit. A decision by a third-party payor not to cover
a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, our operations and financial condition. Finally, in some foreign countries, the proposed pricing for a product candidate must be
approved before it may be lawfully marketed. The requirements governing product pricing vary widely from country to country. For example, in the EU, pricing and reimbursement of pharmaceutical products are regulated at a national level under the
individual EU Member States&#146; social security systems. Some foreign countries provide options to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and can control the prices of
medicinal products for human use. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost effectiveness of a particular product candidate to currently available
therapies. A country may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. There can be no assurance
that any country that has price </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
controls or reimbursement limitations for products will allow favorable reimbursement and pricing arrangements for any of our product candidates. Even if approved for reimbursement, historically,
product candidates launched in some foreign countries, such as some countries in the EU, do not follow price structures of the United States and prices generally tend to be significantly lower. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we are not able to establish collaborations on a timely basis, on commercially reasonable terms, or at all, we may have to alter, reduce or delay our
development and commercialization plans, or increase our expenditures to fund development or commercialization activities at our own expense. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For some of
the product candidates we may develop, we may decide to collaborate with other pharmaceutical and biotechnology companies for the development and potential commercialization of those product candidates. We face significant competition in seeking
appropriate collaborations and collaborations are complex and time-consuming to negotiate and document. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#146;s
resources and expertise, the terms and conditions of the proposed collaboration, and the proposed collaborator&#146;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval
by the FDA, the EMA or similar regulatory authorities outside the United States, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of
competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge, and industry and market conditions generally. The
collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may also be restricted under existing collaboration agreements from entering into future collaboration agreements on certain terms with potential collaborators. In
addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators, which further increases competition we face in seeking
potential collaborations. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have
to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any
sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may
need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to develop product candidates or bring them to market and generate product revenue. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our results of operations could be adversely affected by general conditions in the global economy, geopolitical tensions and in the global financial markets. A severe or
prolonged economic downturn or additional global financial and political crises could result in a variety of risks to our business, including weakened demand for any product candidates we develop or our ability to raise additional capital when
needed on acceptable terms, if at all. A weak or declining economy could also strain our suppliers or other third parties and create import and export issues, possibly resulting in supply disruption. Any of the foregoing could harm our business and
we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We face risks related to health epidemics, pandemics and other widespread outbreaks of contagious disease,
including the COVID-19 pandemic, which could significantly disrupt our operations, impact our financial results or otherwise adversely impact our business. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Significant outbreaks of contagious diseases and other adverse public health developments could have a material impact on our business operations and operating results.
For example, the spread of COVID-19 has affected segments of the global economy and our operations. As a result of the COVID-19 pandemic or similar public health crises that may arise, we may experience disruptions that could adversely impact our
operations, research and development, and as we continue developing, any preclinical studies, clinical trials and manufacturing activities we may conduct, some of which may include: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">delays or disruptions in research programs, preclinical studies, clinical trials or IND-enabling studies that we or our
collaborators may conduct; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">interruption or delays in the operations of the FDA, the EMA and comparable foreign regulatory agencies;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">interruption of, or delays in receiving and distributing, supplies of drug substance and drug product from our contract
manufacturing organizations (&#147;CMOs&#148;), to preclinical or clinical research sites or delays or disruptions in any preclinical studies or clinical trials performed by CROs; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">limitations imposed on our business operations by local, state or federal authorities to address a pandemic or similar
public health crises; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">business disruptions caused by potential workplace, laboratory and office closures and an increased reliance on employees
working from home, disruptions to or delays in ongoing laboratory experiments and operations, staffing shortages, travel limitations, and cybersecurity and data accessibility or security issues. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, the trading prices for biopharmaceutical companies have been highly volatile as a result of the COVID-19 pandemic and we may face similar volatility in our
stock price after we complete this public offering. We cannot predict the scope and severity of any economic recovery after the COVID-19 pandemic abates, including following any additional &#147;waves&#148; or other intensifying of the pandemic. If
we or any of the third parties with whom we engage were to experience additional shutdowns or other business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively
affected, which could have a material adverse impact on our business, financial condition, our results of operations and prospects. Furthermore, the COVID-19 pandemic could exacerbate the other risks described in this section. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our operations are vulnerable to interruption by disasters, terrorist activity, pandemics and other events beyond our control, which could harm our business.
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our facilities are located in California. We have not undertaken a systematic analysis of the potential consequences to our business and financial results
from a major flood, power loss, terrorist activity, pandemics or other regional or global disasters and generally do not have a recovery plan for such events. In addition, we do not carry sufficient insurance to compensate us for actual losses from
interruption of our business that may occur, and any losses or damages incurred by us could harm our business. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and
expenses. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may use artificial intelligence in our business, and challenges with properly managing its use, as well as uncertainty regarding the legal
landscape surrounding the use of AI could result in reputational harm, competitive harm, and legal liability, and adversely affect our results of operations. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We incorporate artificial intelligence (&#147;AI&#148;) solutions into our platform, and these applications may become important in our operations over time. There are
significant risks involved in utilizing AI and no assurance can be provided that the usage of such AI will enhance our business or assist our business in being more efficient or profitable. Known risks of AI currently include inaccuracy, bias,
toxicity, intellectual property infringement or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
misappropriation, data privacy and cybersecurity and data provenance. In addition, AI may have errors or inadequacies that are not easily detectable. AI may also be subject to data herding and
interconnectedness (i.e., multiple market participants utilizing the same data), which may adversely impact our business. If the data used to train AI or the content, analyses, or recommendations that AI applications assist in producing are or are
alleged to be deficient, inaccurate, incomplete, overbroad or biased, our business, financial condition, and results of operations may be adversely affected. The legal landscape and subsequent legal protection for the use of AI remains uncertain,
and development of the law in this area could impact our ability to enforce our proprietary rights or protect against infringing uses. If we do not have sufficient rights to use the data on which AI relies or to the outputs produced by AI
applications, we may incur liability through the violation of certain laws, third-party privacy or other rights or contracts to which we are a party. Our use of AI applications may also, in the future, result in cybersecurity incidents that
implicate the personal data of customers or patients. Any such cybersecurity incidents related to our use of AI applications could adversely affect our reputation and results of operations. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Risks Related to Regulatory, Legal, and Clinical Trials </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>While we
intend to seek designations for our potential product candidates with the FDA and comparable foreign regulatory authorities that are intended to confer benefits such as a faster development process or an accelerated regulatory pathway, there can be
no assurance that we will successfully obtain such designations. In addition, even if one or more of our potential product candidates are granted such designations, we may not be able to realize the intended benefits of such designations.
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The FDA and comparable foreign regulatory authorities offer certain designations for product candidates that are designed to encourage the research and
development of product candidates that are intended to address conditions with significant unmet medical need. These designations may confer benefits such as additional interaction with regulatory authorities, a potentially accelerated regulatory
pathway and priority review. However, there can be no assurance that we will successfully obtain such designations for any potential product candidates. In addition, while such designations could expedite the development or approval process, they
generally do not change the standards for approval. Even if we obtain such designations for one or more of our potential product candidates, there can be no assurance that we will realize their intended benefits. For example, we may seek fast track
designation for some of our potential product candidates. If a therapy is intended for the treatment of a serious or life threatening condition and the therapy nonclinical or clinical data demonstrates the potential to address unmet medical needs
for this condition, the therapy sponsor may apply for fast track designation. The FDA has broad discretion whether or not to grant this designation, so even if we believe a particular product candidate is eligible for this designation, there can be
no assurance that the FDA would decide to grant it. Even if we do receive fast track designation, we may not experience a faster development process, review or approval compared to conventional FDA procedures, and receiving a fast track designation
does not provide assurance of ultimate FDA approval. In addition, the FDA may withdraw fast track designation if it believes that the designation is no longer supported by data from our clinical development program. Additionally, we may seek a
breakthrough therapy designation for some of our potential product candidates. A breakthrough therapy is defined as a therapy that is intended, alone or in combination with one or more other therapies, to treat a serious or life-threatening disease
or condition, and preliminary clinical evidence indicates that the therapy may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in
clinical development. For therapies that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while
minimizing the number of patients placed in ineffective control regimens. Therapies designated as breakthrough therapies by the FDA may also be eligible for accelerated approval. Designation as a breakthrough therapy is within the discretion of the
FDA. Accordingly, even if we believe one of our potential product candidates meets the criteria for designation as a breakthrough therapy, the FDA may disagree and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
instead determine not to make such designation. In any event, the receipt of a breakthrough therapy designation for a product candidate may not result in a faster development process, review or
approval compared to therapies considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our potential product candidates qualify as breakthrough therapies, the
FDA may later decide that such product candidates no longer meet the conditions for qualification. In addition, we may seek a regenerative medicine advanced therapy (&#147;RMAT&#148;) designation for some of our potential product candidates. An RMAT
is defined as cell therapies, therapeutic tissue engineering products, human cell and tissue products and combination products using any such therapies or products. Gene therapies, including genetically modified cells that lead to a durable
modification of cells or tissues may meet the definition of a regenerative medicine therapy. The RMAT program is intended to facilitate efficient development and expedite review of RMATs, which are intended to treat, modify, reverse or cure a
serious or life-threatening disease or condition. A new drug application or a biologics license application (&#147;BLA&#148;) for an RMAT may be eligible for priority review or accelerated approval through (1)&nbsp;surrogate or intermediate
endpoints reasonably likely to predict long-term clinical benefit or (2)&nbsp;reliance upon data obtained from a meaningful number of sites. Benefits of such designation also include early interactions with the FDA to discuss any potential surrogate
or intermediate endpoint to be used to support accelerated approval. A regenerative medicine therapy that is granted accelerated approval and is subject to post-approval requirements may fulfill such requirements through the submission of clinical
evidence, clinical trials, patient registries or other sources of real world evidence, such as electronic health records; the collection of larger confirmatory data sets; or post-approval monitoring of all patients treated with such therapy prior to
its approval. RMAT designation is within the discretion of the FDA. Accordingly, even if we believe one of our potential product candidates meets the criteria for designation as a regenerative medicine advanced therapy, the FDA may disagree and
instead determine not to make such designation. In any event, the receipt of RMAT designation for a product candidate may not result in a faster development process, review or approval compared to drugs considered for approval under conventional FDA
procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our potential product candidates qualify as for RMAT designation, the FDA may later decide that the biological products no longer meet the conditions
for qualification. We may also seek rare pediatric disease designation for some of our potential product candidates. The FDA defines &#147;rare pediatric disease&#148; as a (i)&nbsp;serious or life-threatening disease in which the serious or
life-threatening manifestations primarily affect individuals aged from birth to 18 years, including age groups often called neonates, infants, children, and adolescents; and (ii)&nbsp;a rare disease or condition within the meaning of the Orphan Drug
Act. Designation of a product candidate as a product for a rare pediatric disease does not guarantee that a marketing application for such product candidate will meet the eligibility criteria for a rare pediatric disease priority review voucher
(&#147;PRV&#148;) at the time the application is approved. Under the U.S. Federal Food, Drug, and Cosmetic Act (&#147;FDCA&#148;), we will need to request a rare pediatric disease PRV in our original marketing application for any potential product
candidates for which we have received rare pediatric disease designation. The FDA may determine that a marketing application for any such product candidates, if approved, does not meet the eligibility criteria for a PRV. Under the current statutory
sunset provisions, after September&nbsp;30, 2024, the FDA may only award a PRV for an approved rare pediatric disease product application if the sponsor has rare pediatric disease designation for the drug or biologic that is the subject of such
application, and that designation was granted by September&nbsp;30, 2024. After September&nbsp;30, 2026, the FDA may not award any rare pediatric disease PRVs. However, it is possible the authority for FDA to award rare pediatric disease PRV will be
further extended by Congress. As such, if we do not obtain approval of a marketing application for any of our potential product candidates on or before September&nbsp;30, 2026, and if the PRV program is not extended by Congressional action, we may
not receive a PRV. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the future, we may also seek approval of product candidates under the FDA&#146;s accelerated approval pathway. A product may be eligible for
accelerated approval if it is designed to treat a serious or life-threatening disease or condition and generally provides a meaningful advantage over available therapies upon a determination that the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
product candidate has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical benefit or on a clinical endpoint that can be measured
earlier than irreversible morbidity or mortality (&#147;IMM&#148;) that is reasonably likely to predict an effect on IMM or other clinical benefit. The FDA considers a clinical benefit to be a positive therapeutic effect that is clinically
meaningful in the context of a given disease, such as IMM. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict
clinical benefit, but is not itself a measure of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality that is reasonably likely to predict an
effect on irreversible morbidity or mortality or other clinical benefit. The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct therapeutic advantage, but is a clinically
important improvement from a patient and public health perspective. If granted, accelerated approval is usually contingent on the sponsor&#146;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verity and
describe the drug&#146;s clinical benefit. Under the Food and Drug Omnibus Reform Act of 2022 (&#147;FDORA&#148;), the FDA is permitted to require, as appropriate, that a post-approval confirmatory study or studies be underway prior to approval or
within a specified time period after the date of approval for a product granted accelerated approval. FDORA also requires sponsors to send updates to the FDA every 180 days on the status of such studies, including progress toward enrollment targets,
and the FDA must promptly post this information publicly. FDORA also gives the FDA increased authority to withdraw approval of a drug or biologic granted accelerated approval on an expedited basis if the sponsor fails to conduct such studies in a
timely manner, send the necessary updates to the FDA, or if such post-approval studies fail to verify the drug&#146;s predicted clinical benefit. Under FDORA, the FDA is empowered to take action, such as issuing fines, against companies that fail to
conduct with due diligence any post-approval confirmatory study or submit timely reports to the agency on their progress. There can be no assurance that the FDA would allow any of the product candidates we may develop to proceed on an accelerated
approval pathway, and even if the FDA did allow such pathway, there can be no assurance that such submission or application will be accepted or that any expedited development, review or approval will be granted on a timely basis, or at all.
Moreover, even if we received accelerated approval, any post-approval studies required to confirm and verify clinical benefit may not show such benefit, which could lead to withdrawal of any approvals we have obtained. Receiving accelerated approval
does not assure that the product&#146;s accelerated approval will eventually be converted to a traditional approval. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If the FDA determines that a product candidate
offers a treatment for a serious condition and, if approved, the product would provide a significant improvement in safety or effectiveness, the FDA may designate the product candidate for priority review. A priority review designation means that
the goal for the FDA to review an application is six months, rather than the standard review period of ten months. We may request priority review for the product candidates that we may develop. The FDA has broad discretion with respect to whether or
not to grant priority review status to a product candidate, so even if we believe a particular product candidate is eligible for such designation or status, the FDA may decide not to grant it. Moreover, a priority review designation does not
necessarily result in an expedited regulatory review or approval process or necessarily confer any advantage with respect to approval compared to conventional FDA procedures. Receiving priority review from the FDA does not guarantee approval within
the <FONT STYLE="white-space:nowrap">six-month</FONT> review cycle or at all. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, in the European Union, we may seek to participate in the PRIority
Medicines (&#147;PRIME&#148;) scheme for our potential product candidates. The PRIME scheme is intended to encourage development of products in areas of unmet medical need and provides accelerated assessment of products representing substantial
innovation, where the marketing authorization application will be made through the centralized procedure in the European Union. Products from small-and <FONT STYLE="white-space:nowrap">medium-sized</FONT> enterprises may qualify for earlier entry
into the PRIME scheme than larger companies on the basis of compelling <FONT STYLE="white-space:nowrap">non-clinical</FONT> data and tolerability data from initial clinical trials. Eligible products must target conditions for which there is an unmet
medical need (no treatment option exists in the European Union or, they can offer a major therapeutic advantage over existing treatments). Many benefits accrue to sponsors of product candidates with PRIME designation, including but not
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and accelerated marketing authorization
application assessment once a dossier has been submitted. There is no guarantee, however, that our potential product candidates would be deemed eligible for the PRIME scheme and even if we do participate in the PRIME scheme, where during the course
of development a product no longer meets the eligibility criteria, support under the PRIME scheme may be withdrawn. PRIME eligibility does not change the standards for product approval, and there is no assurance that any such designation or
eligibility will result in expedited review or approval. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Healthcare and other reform legislation may increase the difficulty and cost for us and any
collaborators we may have to obtain regulatory approval of and commercialize any product candidates we may develop and affect the prices we, or they, may obtain. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the United States and some foreign jurisdictions, there have been and continue to be ongoing efforts to implement legislative and regulatory changes regarding the
healthcare system. Such changes could prevent or delay regulatory approval of any product candidates that we may develop, restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we
obtain regulatory approval. Although we cannot predict what healthcare or other reform efforts will be successful, such efforts may result in more rigorous coverage criteria, in additional downward pressure on the price that we, or our future
collaborators, may receive for any approved products or in other consequences that may adversely affect our ability to achieve or maintain profitability. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Within the
United States, the federal government and individual states have aggressively pursued healthcare reform, as evidenced by the passing of the Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively,
the &#147;ACA&#148;), and the ongoing efforts to modify or repeal that legislation. The ACA significantly changed the way healthcare is financed by both governmental and private insurers and contains a number of provisions that affect coverage and
reimbursement of drug products and/or that could potentially reduce the demand for pharmaceutical products such as increasing drug rebates under state Medicaid programs for brand name prescription drugs and extending those rebates to Medicaid
managed care and assessing a fee on manufacturers and importers of brand name prescription drugs reimbursed under certain government programs, including Medicare and Medicaid. Other aspects of healthcare reform, such as expanded government
enforcement authority and heightened standards that could increase compliance-related costs, could also affect our business. Modifications have been implemented under the former Trump administration and additional modifications or repeal may occur.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There have also been executive, judicial, and congressional challenges to certain aspects of the ACA. It is unclear how other healthcare reform measures of the
Biden administration or other efforts, if any, to challenge, repeal or replace the ACA will impact our business. There is no assurance that federal or state healthcare reform will not adversely affect our future business and financial results, and
we cannot predict how future federal or state legislative, judicial or administrative changes relating to healthcare reform will affect our business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition,
other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example, the American Rescue Plan Act of 2021 eliminates the statutory Medicaid drug rebate cap, currently set at 100&nbsp;percent of a
drug&#146;s average manufacturer price, for single source and innovator multiple source drugs, beginning January&nbsp;1, 2024. The U.S. Budget Control Act of 2011 and subsequent legislation, among other things, included aggregate reductions of
Medicare payments to providers of 2% per fiscal year, which remain in effect through 2032. The American Taxpayer Relief Act of 2012 further reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment
centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Additionally, there has
been increasing legislative and enforcement interest in the United States with respect to drug pricing practices, which has resulted in several U.S. Congressional inquiries and federal and state legislation designed to, among other things, bring
more transparency to drug pricing, reduce the cost of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
prescription drugs, and review the relationship between pricing and manufacturer patient programs. The Inflation Reduction Act of 2022 (the &#147;IRA&#148;), for example, includes several
provisions that may impact our business to varying degrees, including provisions that reduce the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> spending cap for Medicare Part D beneficiaries to $2,000
starting in 2025, eliminating the prescription drug coverage gap; impose new manufacturer financial liability on certain drugs under Medicare Part D, allow the U.S. government to negotiate Medicare Part B and Part D price caps for certain high-cost
drugs and biologics without generic or biosimilar competition; require companies to pay rebates to Medicare for certain drug prices that increase faster than inflation; and delay until January&nbsp;1, 2032 the implementation of an HHS rebate rule
that would have limited the fees that pharmacy benefit managers can charge. Further, under the IRA, orphan drugs are exempted from the Medicare drug price negotiation program, but only if they have one orphan designation and for which the only
approved indication is for that disease or condition. If a product receives multiple orphan designations or has multiple approved indications, it may not qualify for the orphan drug exemption. The effects of the IRA on our business and the
healthcare industry in general is not yet known. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, President Biden has issued multiple executive orders that have sought to reduce prescription drug
costs. In February 2023, HHS issued a proposal in response to an October 2022 Biden executive order that proposes a Medicare drug pricing model that will test whether targeted Medicare payment adjustments will sufficiently incentivize manufacturers
to complete confirmatory trials for drugs approved through the FDA&#146;s accelerated approval pathway. Although a number of these and other proposed measures may require authorization through additional legislation to become effective, and the
Biden administration may reverse or otherwise change these measures, both the Biden administration and Congress have indicated that they will continue to seek new legislative measures to control drug costs. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We cannot predict the initiatives that may be adopted in the future. The continuing efforts of the government, insurance companies, managed care organizations and other
payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the demand for our product candidates, if we obtain regulatory approval; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to set a price that we believe is fair for our approved products; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to generate revenue and achieve or maintain profitability; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the level of taxes that we are required to pay; and </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the availability of capital. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors, which may adversely affect
our future profitability. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Individual states in the United States have also become increasingly active in passing legislation and implementing regulations designed
to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain drug access and marketing cost disclosure and transparency measures, and designed to encourage
importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third-party payors or other restrictions could harm our business, financial condition, results of operations and prospects. In addition,
regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. This could
reduce the ultimate demand for our drugs or put pressure on our drug pricing, which could negatively affect our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Because we are developing product candidates in the field of genetic medicines in which there is little clinical experience, there is increased risk that the FDA,
the EMA or other regulatory authorities may not consider the endpoints of our clinical trials to provide clinically meaningful results and that these results may be difficult to analyze. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In order to proceed into clinical development of any product candidates we identify, we will need to submit INDs or clinical trial applications to regulatory authorities
and obtain regulatory clearance to commence clinical </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
development. Because the product candidates we identify are based on novel gene-editing technology, we may be unsuccessful in obtaining clearance from regulatory authorities to proceed into
clinical development. In order to commence clinical development, we will need to identify success criteria and endpoints such that the FDA, the EMA or other regulatory authorities will be able to determine the clinical efficacy and safety profile of
any product candidates we may develop. As we are initially seeking to identify and develop product candidates to treat diseases in which there is little clinical experience using new technologies, and while we may have opportunities to discuss our
clinical development plans with regulatory authorities prior to commencing clinical development, there is heightened risk that the FDA, the EMA or other regulatory authorities may not consider the clinical trial endpoints that we propose to provide
clinically meaningful results (reflecting a tangible benefit to patients). In addition, the resulting clinical data and results may be difficult to analyze. Even if the FDA does find our success criteria to be sufficiently validated and clinically
meaningful, we may not achieve the <FONT STYLE="white-space:nowrap">pre-specified</FONT> endpoints to a degree of statistical significance. This may be a particularly significant risk for many of the genetically defined diseases for which we plan to
develop product candidates because many of these diseases such as PH1 have small patient populations, and designing and executing a rigorous clinical trial with appropriate statistical power is more difficult than with diseases that have larger
patient populations. Furthermore, even if we do achieve the <FONT STYLE="white-space:nowrap">pre-specified</FONT> criteria, we may produce results that are unpredictable or inconsistent with the results of the
<FONT STYLE="white-space:nowrap">non-primary</FONT> endpoints or other relevant data. The FDA also weighs the benefits of a product against its risks, and the FDA may view the efficacy results in the context of safety as not being supportive of
regulatory approval. Other regulatory authorities in the European Union and other countries may make similar comments with respect to these endpoints and data. Any product candidates we may develop will be based on a novel technology that makes it
difficult to predict the time and cost of development and of subsequently obtaining regulatory approval. No genome editing therapeutic product has been approved in the United States or in Europe. Within the broader genome product field, only a
limited number of gene therapy products, such as uniQure N.V.&#146;s Glybera and Abecma from Bristol Myers Squibb and bluebird bio, have received marketing authorization or regulatory approval from the European Commission or the FDA. Some of these
products have taken years to register and have had to deal with significant issues in their post-marketing experience. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If preclinical studies or clinical
trials of any product candidates we may identify and develop fail to demonstrate safety and efficacy to the satisfaction of regulatory authorities or do not otherwise produce positive results, we may incur additional costs or experience delays in
completing, or ultimately be unable to complete, the development and commercialization of such product candidates. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Before obtaining regulatory approval from
regulatory authorities for the sale of any product candidates we may identify and develop, we must complete preclinical development and then conduct extensive clinical trials to demonstrate the safety and efficacy in humans. Clinical testing is
expensive, difficult to design and implement, can take many years to complete, and is uncertain as to outcome. A failure of one or more clinical trials can occur at any stage of testing. The outcome of preclinical testing and early clinical trials
may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Moreover,
preclinical and clinical data are often susceptible to varying interpretations and analyses. Many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to
obtain regulatory approval of their product candidates. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We and our collaborators, if any, may experience numerous unforeseen events during, or as a result of,
clinical trials that could delay or prevent our ability to receive regulatory approval or commercialize any product candidates we may identify and develop, including: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">delays in reaching a consensus with regulators on trial design; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">regulators, IRBs, or independent ethics committees may not authorize us or our investigators to commence a clinical trial
or conduct a clinical trial at a prospective trial site; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">delays in reaching or failing to reach agreement on acceptable clinical trial contracts or clinical trial protocols with
prospective CROs and clinical trial sites; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">clinical trials of any product candidates we may develop may produce negative or inconclusive results, and we may decide,
or regulators may require us, to conduct additional clinical trials or abandon product development or research programs; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">difficulty in designing well-controlled clinical trials due to ethical considerations which may render it inappropriate to
conduct a trial with a control arm that can be effectively compared to a treatment arm; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">difficulty in designing clinical trials and selecting endpoints for diseases that have not been well-studied and for which
the natural history and course of the disease is poorly understood; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the number of patients required for clinical trials of any product candidates we may develop may be larger than we
anticipate; enrollment of suitable participants in these clinical trials, which may be particularly challenging for some of the rare genetically defined diseases we are targeting in our most advanced programs, may be delayed or slower than we
anticipate; or patients may drop out of these clinical trials at a higher rate than we anticipate; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in
a timely manner, or at all; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">regulators, IRBs, or independent ethics committees may require that we or our investigators suspend or terminate clinical
research or clinical trials of any product candidates we may develop for various reasons, including noncompliance with regulatory requirements, a finding of undesirable side effects or other unexpected characteristics, or that the participants are
being exposed to unacceptable health risks or after an inspection of our clinical trial operations or trial sites; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the cost of clinical trials of any product candidates we may develop may be greater than we anticipate;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the supply or quality of any product candidates we may develop or other materials necessary to conduct preclinical studies
or clinical trials of any product candidates we may develop may be insufficient or inadequate, including as a result of delays in the testing, validation, manufacturing, and delivery of any product candidates we may develop to the preclinical study
sites or clinical sites by us or by third parties with whom we have contracted to perform certain of those functions; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">delays in having patients complete participation in a trial or return for post-treatment
<FONT STYLE="white-space:nowrap">follow-up;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">clinical trial sites dropping out of a trial; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">selection of clinical endpoints that require prolonged periods of clinical observation or analysis of the resulting data;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">occurrence of serious adverse events associated with any product candidates we may develop that are viewed to outweigh
their potential benefits; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">occurrence of serious adverse events in trials of the same class of agents conducted by other sponsors; and
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols.
</P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we or our collaborators are required to conduct additional clinical trials or other testing of any product candidates we may develop beyond
those that we currently contemplate, if we or our collaborators are unable to successfully complete clinical trials or other testing of any product candidates we may develop, or if the results of these trials or tests are not positive or are only
modestly positive or if there are safety concerns, we or our collaborators may: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">be delayed in obtaining regulatory approval for any such product candidates we may develop or not obtain regulatory
approval at all; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">obtain approval for indications or patient populations that are not as broad as intended or desired; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">obtain approval with labeling that includes significant use or distribution restrictions or safety warnings, including
boxed warnings; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">be subject to changes in the way the product is administered; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">be required to perform additional clinical trials to support approval or be subject to additional post-marketing testing
requirements; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">have regulatory authorities withdraw, or suspend, their approval of the product or impose restrictions on its distribution
in the form of a REMS, or through modification to an existing REMS; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">be sued; or </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">experience damage to our reputation. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Product development costs will also increase if we or our collaborators experience delays in clinical trials or other testing or in obtaining regulatory approvals. We do
not know whether any clinical trials will begin as planned, will need to be restructured, or will be completed on schedule, or at all. Significant clinical trial delays also could shorten any periods during which we may have the exclusive right to
commercialize any product candidates we may develop, could allow our competitors to bring products to market before we do, and could impair our ability to successfully commercialize any product candidates we may develop, any of which may harm our
business, financial condition, results of operations, and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Failure to access or a significant delay in accessing animal research models may
materially adversely affect our ability to advance our preclinical programs and successfully develop any product candidates we may identify, which could result in significant harm to our business. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Consistent with various rules, regulations and current good manufacturing practices (&#147;cGMP&#148;), our ability to advance our preclinical programs and successfully
develop any product candidates we may identify requires access to animal research models sufficient to assess safety and in some cases to establish the rationale for therapeutic use. Failure to access or a significant delay in accessing animal
research models that meet our needs or that fulfil regulatory requirements may materially adversely affect our ability to advance our preclinical programs and successfully develop any product candidates we may identify and this could result in
significant harm to our business. During the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, researchers and CROs (including those engaged by us) experienced significant limitations in their access to animal research models, specifically
including a sharp reduction in the availability of <FONT STYLE="white-space:nowrap">non-human</FONT> primates (&#147;NHPs&#148;) originating from breeding farms in Southeast Asia and limited access to the generation of genetically-modified rodent
models used in efficacy evaluations. Prior to the pandemic, China was the leading exporter of NHPs employed in basic and applied research; however, early in 2020, China ceased exportation of cynomolgus monkeys, the species most commonly involved in
pharmaceutical product development. This change in the world supply of a critical research model has resulted in increased demand from breeding farms principally located in Cambodia, Vietnam, and Mauritius Island, with a resultant marked increase in
unit pricing. Consequently, this has further exacerbated an already constrained NHP supply for research purposes. If we are unable to obtain NHPs in sufficient quantities and in a timely manner to meet the needs of our preclinical research programs,
if the price of NHPs that are available increases significantly, or if our suppliers are unable to ship the NHPs in their possession that are reserved for us, our ability to advance our preclinical programs and successfully develop any preclinical
candidates we may identify may be materially adversely affected or significantly delayed. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Even if we complete the necessary clinical trials, we cannot predict
when, or if, we will obtain regulatory approval to commercialize a product candidate we may develop in the United States or any other jurisdiction, and any such approval may be for a more narrow indication than we seek. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We cannot commercialize a product candidate until the appropriate regulatory authorities have reviewed and approved the product candidate. Even if our product candidates
meet their safety and efficacy endpoints in clinical trials, the regulatory authorities may not complete their review processes in a timely manner, or we may not be able to obtain regulatory approval. Additional delays may result if an FDA advisory
committee or other regulatory authority recommends <FONT STYLE="white-space:nowrap">non-approval</FONT> or restrictions on approval. In addition, we may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
experience delays or rejections based upon additional government regulation from future legislation or administrative action, or changes in regulatory authority policy during the period of
product development, clinical trials, and the review process. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Regulatory authorities also may approve a product candidate for more limited indications than
requested or they may impose significant limitations in the form of narrow indications, warnings or a REMS. These regulatory authorities may require labeling that includes precautions or contraindications with respect to conditions of use, or may
grant approval subject to the performance of costly post-marketing clinical trials. In addition, regulatory authorities may not approve the labeling claims that are necessary or desirable for the successful commercialization of our product
candidates. Any of the foregoing scenarios could materially harm the commercial prospects for our product candidates and materially adversely affect our business, financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Regulatory approval by the FDA in the United States, if obtained, does not ensure approval by regulatory authorities in other countries or jurisdictions. In addition,
clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not guarantee regulatory approval in any other country. Approval processes vary among countries
and can involve additional product candidate testing and validation and additional administrative review periods. Seeking regulatory approval outside the United States could result in difficulties and costs for us and require additional preclinical
studies or clinical trials which could be costly and time-consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our product candidates in those countries. The foreign regulatory
approval process involves all of the risks associated with FDA approval. We do not have any product candidates approved for sale in any jurisdiction, including international markets, and we do not have experience in obtaining regulatory approval in
international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, our target market will be reduced and
our ability to realize the full market potential of our product candidates will be unrealized. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Even if we, or any of our collaborators or strategic partners,
obtain regulatory approvals for any product candidates we may develop, the terms of approvals and ongoing regulation of such product candidates could require the substantial expenditure of resources and may limit how we, or they, manufacture and
market such product candidates, which could materially impair our ability to generate revenue. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any product candidate for which we obtain regulatory
approval, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review by the FDA, the EMA and other regulatory
authorities. These requirements include submissions of safety and other post-marketing information and reports, facility registration and drug listing requirements, cGMP relating to quality control, quality assurance and corresponding maintenance of
records and documents, applicable product tracking and tracing requirements and requirements regarding the distribution of samples to physicians and recordkeeping. In addition, our manufacturing and testing facilities will be required to undergo <FONT
STYLE="white-space:nowrap">pre-license</FONT> inspections and <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspections. Even if regulatory approval of a product candidate is granted, the approval may be subject to limitations on the
indicated uses for which the products may be marketed or to the conditions of approval, or contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the products. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Accordingly, assuming we, or any collaborators we may have, receive regulatory approval for one or more product candidates we develop, we, and such collaborators, and
our and their contract manufacturers will continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance and quality control. If we and such collaborators are not able to
comply with post-approval regulatory requirements, we and such collaborators could have the regulatory approvals for our products withdrawn by regulatory authorities and our, or such collaborators&#146;, ability to market any future
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
products could be limited, which could adversely affect our ability to achieve or sustain profitability. Furthermore, the cost of compliance with post-approval regulations may have a negative
effect on our business, operating results, financial condition and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may not be able to obtain orphan drug designation or exclusivity for our
potential product candidates, and even if we do, that designation may not provide an expedited development or regulatory review or approval process and any orphan drug exclusivity we may receive for approved products may not prevent the FDA or the
EMA from approving other competing products. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the Orphan Drug Act, the FDA may designate a product candidate as an orphan drug if it is a drug or
biologic intended to treat a rare disease or condition. A similar regulatory scheme governs approval of orphan product candidates by the EMA in the European Union. Generally, if a product with an orphan drug designation subsequently receives the
first regulatory approval for the indication for which it has such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA or the EMA (as applicable) from approving another marketing application for another
similar product candidate for the same orphan therapeutic indication for that time period. The applicable period is seven years in the United States and ten years in the European Union. The exclusivity period in the European Union can be reduced to
six years if at the end of the fifth year it is determined that a product no longer meets the criteria for orphan designation, including if the product is sufficiently profitable so that market exclusivity is no longer justified. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In order for the FDA to grant orphan drug exclusivity to one of our potential product candidates, the agency must find that the product candidate is indicated for the
treatment of a condition or disease that affects fewer than 200,000 individuals in the United States or that affects 200,000 or more individuals in the United States and for which there is no reasonable expectation that the cost of developing and
making the product candidate available for the disease or condition will be recovered from sales of the product in the United States. The FDA may conclude that the condition or disease for which we seek orphan drug exclusivity does not meet this
standard. Even if we obtain orphan drug exclusivity for a product candidate, that exclusivity may not effectively protect the product candidate from competition because different product candidates can be approved for the same condition. In
addition, even after an orphan drug is approved, the FDA can subsequently approve the same product candidate for the same condition if the FDA concludes that the later product candidate is clinically superior in that it is shown to be safer, more
effective or makes a major contribution to patient care compared with the product that has orphan exclusivity. Orphan drug exclusivity may also be lost if the FDA or EMA determines that the request for designation was materially defective or if the
manufacturer is unable to assure sufficient quantity of the product to meet the needs of the patients with the rare disease or condition. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are subject to
U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations. Compliance with these legal standards could impair our ability to compete in domestic and international
markets. We can face criminal liability and other serious consequences for violations, which can harm our business. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are subject to export control and
import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, various economic and trade sanctions regulations administered by the U.S. Treasury Department&#146;s Office of Foreign Assets Control, the
U.S. Foreign Corrupt Practices Act of 1977, as amended (the &#147;FCPA&#148;), the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act, and other state and national anti-bribery and anti-money
laundering laws in the countries in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, contractors, and other collaborators from authorizing, promising, offering, or
providing, directly or indirectly, improper payments or anything else of value to recipients in the public or private sector. We may engage third parties to sell our products outside the United States, to conduct clinical trials, and/or to obtain
necessary permits, licenses, patent registrations, and other regulatory approvals. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
and other organizations. We can be held liable for the corrupt or other illegal activities of our employees, agents, contractors, and other collaborators, even if we do not explicitly authorize
or have actual knowledge of such activities. Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax
reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we or any contract manufacturers and suppliers we engage
fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We and any contract manufacturers and suppliers we engage are subject to numerous federal, state, and local environmental, health, and safety laws, regulations, and
permitting requirements, including those governing laboratory procedures; the generation, handling, use, storage, treatment, and disposal of hazardous and regulated materials and wastes; the emission and discharge of hazardous materials into the
ground, air, and water; and employee health and safety. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste. We generally contract with third
parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for
any resulting damages, and any liability could exceed our resources. Under certain environmental laws, we could be held responsible for costs relating to any contamination at our current or past facilities and at third-party facilities. We also
could incur significant costs associated with civil or criminal fines and penalties. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Compliance with applicable environmental laws and regulations may be expensive,
and current or future environmental laws and regulations may impair our research and product development efforts. In addition, we cannot entirely eliminate the risk of accidental injury or contamination from these materials or wastes. Although we
maintain workers&#146; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential
liabilities. We carry pollution insurance to protect against possible biological or hazardous waste accidents. However, in the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount exceeding
our resources, and our clinical trials or regulatory approvals could be suspended, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, we may incur substantial costs in order to comply with current or future environmental, health, and safety laws, regulations, and permitting requirements.
These current or future laws, regulations, and permitting requirements may impair our research, development, or production efforts. Failure to comply with these laws, regulations, and permitting requirements also may result in substantial fines,
penalties, or other sanctions or business disruption, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any third-party contract manufacturers and suppliers we engage will also be subject to these and other environmental, health, and safety laws and regulations.
Liabilities they incur pursuant to these laws and regulations could result in significant costs or an interruption in operations, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our employees, principal investigators, consultants and commercial partners may engage in misconduct or other improper activities, including <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with regulatory standards and requirements and insider trading. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are exposed to the risk of fraud or
other misconduct by our employees, consultants and commercial partners, and, if we commence clinical trials, our principal investigators. Misconduct by these parties could </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
include intentional failures to comply with FDA regulations or the regulations applicable in the European Union and other jurisdictions, provide accurate information to the FDA, the EMA and other
regulatory authorities, comply with healthcare fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and
business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations restrict or prohibit a wide range
of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Such misconduct also could involve the improper use of information obtained in the course of clinical trials or
interactions with the FDA, the EMA or other regulatory authorities, which could result in regulatory sanctions and cause serious harm to our reputation. We are also exposed to risks in connection with any insider trading violations by employees or
others affiliated with us. Upon the effectiveness of this registration statement, we will adopt a code of conduct and an insider trading policy applicable to all of our employees, but it is not always possible to identify and deter employee
misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from government investigations or other actions or lawsuits stemming from a
failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, financial
condition, results of operations and prospects, including the imposition of significant fines or other sanctions. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Product liability lawsuits against us could
cause us to incur substantial liabilities and could limit commercialization of any product candidates that we may develop. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We will face an inherent risk of
product liability exposure related to the testing of any product candidates we may develop in human clinical trials and will face an even greater risk if we commercially sell such product candidates. If we cannot successfully defend ourselves
against claims that our product candidates caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">decreased demand for any product candidates that we may develop; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">injury to our reputation and significant negative media attention; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">withdrawal of clinical trial participants; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">significant costs to defend the related litigation; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">substantial monetary awards to trial participants or patients; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">loss of revenue; and </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the inability to commercialize any product candidates that we may develop. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We anticipate that we will need to increase our insurance coverage when we begin clinical trials and if we successfully commercialize any product candidate. Insurance
coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our internal computer and information technology systems, or those of our third-party vendors, collaborators, contractors, consultants or other third parties, may
fail, become unavailable, or suffer security incidents or data breaches, loss or leakage of data and other disruptions, which could result in a material disruption of our product development programs, compromise confidential, sensitive or personal
information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our internal computer and information technology systems and those of our current and any future third-party vendors, collaborators, contractors, consultants or other
third parties, are vulnerable to damage or interruption </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
from, among other things, computer viruses, computer hackers, phishing attacks, ransomware, malware, social engineering, service interruptions, system malfunction, malicious code, employee theft,
fraud, misconduct or misuse, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">denial-of-service</FONT></FONT> attacks, sophisticated nation-state and nation-state-supported actors, unauthorized access, natural disasters, terrorism,
war and telecommunication and electrical failures. While we seek to protect our information technology systems from system failure, accident and security breach, we have in the past and may in the future experience phishing and other security
incidents which could result in a disruption of our development programs and our business operations, whether due to a loss of our trade secrets or other proprietary, personal or confidential information or other disruptions. For example, the loss
of clinical trial data from future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Controls employed by our information technology department and other third parties could prove inadequate, and our ability to monitor such third parties&#146; data
security practices is limited. Due to applicable laws, rules, regulations and standards or contractual obligations, we may be held responsible for any information security failure or cybersecurity attack attributed to our third-party vendors as they
relate to the information we share with them. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we were to experience a cybersecurity breach or other security incident relating to our information systems or
data, the costs, time and effort associated with the investigation, remediation and potential notification of the breach to counterparties, regulators and data subjects could be material. We may incur significant costs in an effort to detect and
prevent security incidents, and we may face increased costs and requirements to expend substantial resources in the event of an actual or perceived security incident. In addition, techniques used to sabotage or to obtain unauthorized access to
networks in which data is stored or through which data is transmitted change frequently, become more complex over time and generally are not recognized until launched against a target. The risk of a security breach or disruption, particularly
through cyberattacks including supply chain attacks such as SolarWinds or cyber intrusion, including by computer hackers, foreign governments, and cyber terrorists, has generally increased as the number, intensity, and sophistication of attempted
attacks and intrusions from around the world have increased. As a result, we and our third-party vendors may be unable to anticipate these techniques or implement adequate preventative measures quickly enough to prevent either an electronic
intrusion into our systems or services or a compromise of critical information. We cannot guarantee that we will be able to detect or prevent any such incidents, and, our remediation efforts may not be successful or timely. Our efforts to improve
security and protect data from compromise may also identify previously undiscovered instances of data breaches or other cybersecurity incidents. If we do not allocate and effectively manage the resources necessary to build and sustain the proper
technology and cybersecurity infrastructure, we could suffer significant business disruption, including transaction errors, supply chain or manufacturing interruptions, processing inefficiencies, data loss or the loss of or damage to intellectual
property or other proprietary, personal or confidential information. Additionally, we do not currently maintain cybersecurity insurance, and any insurance we may maintain in the future against the risk of this type of loss in the future may not be
sufficient to cover actual losses, or may not apply to the circumstances relating to any particular loss. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To the extent that any disruption or security breach were
to result in a loss of, or damage to, our or our third-party vendors&#146;, collaborators&#146;, contractors&#146;, consultants&#146; or other third parties&#146; data, including personal data, or applications or inappropriate disclosure, loss,
destruction or alteration of, or access to, confidential, personal or proprietary information, we could incur significant liability including litigation exposure, substantial penalties and fines, we could become the subject of regulatory action,
inquiry or investigation, our competitive position could be harmed, we could incur significant reputational damage and the further development and commercialization of any product candidates we may develop could be delayed. Any of the above could
have a material adverse effect on our business, financial condition, results of operations or prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Laws and regulations governing any international operations we may have in the future may preclude us from
developing, manufacturing and selling certain product candidates we may identify outside of the United States and require us to develop and implement costly compliance programs. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are subject to numerous laws and regulations in each jurisdiction outside the United States in which we operate. The creation, implementation and maintenance of
international business practices compliance programs is costly and such programs are difficult to enforce, particularly where reliance on third parties is required. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The FCPA, prohibits any U.S. individual or business from paying, offering, authorizing payment or offering of anything of value, directly or indirectly, to any foreign
official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are
listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise
and maintain an adequate system of internal accounting controls for international operations. The anti-bribery provisions of the FCPA are enforced primarily by the Department of Justice. The SEC is involved with enforcement of the books and records
provisions of the FCPA. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Similarly, the U.K. Bribery Act 2010 has extra-territorial effect for companies and individuals having a connection with the United Kingdom.
The U.K. Bribery Act prohibits inducements both to public officials and private individuals and organizations. Compliance with the FCPA and the U.K. Bribery Act is expensive and difficult, particularly in countries in which corruption is a
recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials.
Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Various laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. Our expansion outside of the United States has required, and
will continue to require, us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing or selling certain drugs and drug candidates outside of the United States, which could limit our
growth potential and increase our development costs. The failure to comply with laws governing international business practices may result in substantial penalties, including suspension or debarment from government contracting. Violation of the FCPA
can result in significant civil and criminal penalties. Indictment alone under the FCPA can lead to suspension of the right to do business with the U.S. government until the pending claims are resolved. Conviction of a violation of the FCPA can
result in long-term disqualification as a government contractor. The termination of a government contract or relationship as a result of our failure to satisfy any of our obligations under laws governing international business practices would have a
negative impact on our operations and harm our reputation and ability to procure government contracts. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#146;s accounting provisions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are subject to stringent and often unsettled laws, rules, regulations, policies, standards and contractual obligations related to data privacy and security and
changes in such laws, rules, regulations, policies, standards and contractual obligations could adversely affect our business. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are subject to data
privacy and protection laws, rules, regulations, policies, standards and contractual obligations that apply to the collection, transmission, storage, use, disclosure, transfer, maintenance and other </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
processing of sensitive, personal and personally-identifying information, which, among other things, impose certain requirements relating to the privacy, security, transmission and other
processing of personal information, including comprehensive regulatory systems in the United States and European Union. The legislative and regulatory landscape for privacy and data protection continues to evolve in jurisdictions worldwide, and
there has been an increasing focus on privacy and data protection issues with the potential to affect our business. However, our data privacy program is in its early stages and we have not yet assessed the applicability of and our compliance with
data privacy-related laws, rules and regulations. As a result, we cannot guarantee that we are and have been in compliance with all applicable data privacy and protection laws, rules regulations, policies and standards, and we may need to expend
significant resources to implement privacy compliance measures. Additionally, we rely on certain third-party vendors to process certain confidential, sensitive or personal information on our behalf. Failure by us or our third-party vendors to comply
with any of these laws, rules, regulations, contractual obligations or standards could result in notification obligations, enforcement actions, regulatory investigations or inquiries, significant fines, imprisonment of company officials and public
censure, litigation and claims for damages by affected individuals, customers or business partners, damage to our reputation and loss of goodwill, any of which could have a material adverse effect on our business, financial condition, results of
operations or prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There are numerous U.S. federal and state laws, rules and regulations related to the privacy and security of personal information. In
particular, regulations promulgated pursuant to the Health Insurance Portability and Accountability Act of 1996 (&#147;HIPAA&#148;), establish privacy and security standards that limit the use and disclosure of individually identifiable health
information, or protected health information, and require the implementation of administrative, physical and technological safeguards to protect the privacy of protected health information and ensure the confidentiality, integrity and availability
of electronic protected health information. The Genetic Information Nondiscrimination Act of 2008 (&#147;GINA&#148;), which clarified that genetic information is protected under HIPAA and restricts the use and disclosure of genetic information. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Additionally, laws in all 50 states require businesses to provide notice to customers whose personally identifiable information has been disclosed as a result of a data
breach. These laws are not consistent, and compliance in the event of a widespread data breach is difficult and may be costly. Moreover, states have been frequently amending existing laws, requiring attention to changing regulatory requirements. We
also may be contractually required to notify patients or other counterparties of a security breach. Although we may have contractual protections with our service providers, any actual or perceived security breach could harm our reputation and brand,
expose us to potential liability or require us to expend significant resources on data security and in responding to any such actual or perceived breach. Any contractual protections we may have from our service providers may not be sufficient to
adequately protect us from any such liabilities and losses, and we may be unable to enforce any such contractual protections. In addition to government regulation, privacy advocates and industry groups have and may in the future propose
self-regulatory standards from time to time. These and other industry standards may legally or contractually apply to us, or we may elect to comply with such standards. Determining whether personal information has been handled in compliance with
applicable privacy standards and our contractual obligations can be complex and may be subject to changing interpretation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we are unable to properly protect the
privacy and security of personal information, we could be alleged or actually found to have breached our contracts. Furthermore, if we fail to comply with applicable privacy laws, including applicable HIPAA privacy and security standards, we could
face significant administrative, civil and criminal penalties. HHS has the discretion to impose penalties without attempting to resolve violations through informal means, and such enforcement activity can result in financial liability and
reputational harm, and responses to such enforcement activity can consume significant internal resources. In addition, state attorneys general are authorized to bring civil actions seeking either injunctions or damages in response to violations that
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
threaten the privacy or security of the personal information of state residents. We cannot be sure how these laws, rules and regulations will be interpreted, enforced or applied to our
operations. In addition to the risks associated with enforcement activities and potential contractual liabilities, our ongoing efforts to comply with evolving laws, rules and regulations at the international, federal and state level may be costly
and require ongoing modifications to our policies, procedures and systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We make public statements about our use, collection, disclosure and other processing of
personal information through our privacy policies and information provided on our website. Although we endeavor to comply with our public statements and documentation, we may at times fail to do so or be alleged to have failed to do so. The
publication of our privacy policies and other statements that provide promises and assurances about data privacy and security can subject us to potential government or legal action if they are found to be deceptive, unfair or misrepresentative of
our actual practices. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Data privacy remains an evolving landscape at both the domestic and international level, with new laws, rules and regulations coming into
effect and continued legal challenges. For example, California enacted the California Consumer Privacy Act of 2018 (&#147;CCPA&#148;), which went into effect on January&nbsp;1, 2020 and, among other things, requires companies that process
information on California residents to make new disclosures to consumers about their data collection, use and sharing practices, allow consumers to opt out of certain data sharing with third parties and provide a new cause of action for data
breaches. Additionally, California voters approved the California Privacy Rights Act (&#147;CPRA&#148;), which went into effect on January&nbsp;1, 2023. The CPRA significantly modifies the CCPA, including by introducing additional obligations such
as data minimization and storage limitations and granting additional rights to California residents such as correction of personal information and additional <FONT STYLE="white-space:nowrap">opt-out</FONT> rights. The CPRA also creates a new state
agency that will be vested with authority to implement and enforce the CCPA and the CPRA. The enactment of the CCPA is prompting a wave of similar legislative developments in other states and at the federal level, reflecting a trend toward more
stringent privacy legislation in the United States. For example, at least four such state laws (in Virginia, Colorado, Connecticut and Utah) have taken effect, or are scheduled to take effect in 2023. Certain state laws may be more stringent or
broader in scope, or offer greater individual rights, with respect to confidential, sensitive and personal information than federal, international or other state laws, and such laws may differ from each other, which may complicate compliance
efforts. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our efforts to comply with the evolving data protection laws, rules and regulations may be unsuccessful. It is possible that these laws, rules and
regulations may be interpreted and applied in a manner that is inconsistent with our practices and our efforts to comply with the evolving data protection rules may be unsuccessful. The laws are not consistent, and compliance in the event of a
widespread data breach is costly and time-consuming. States are also frequently amending existing laws, requiring attention to frequently changing regulatory requirements. We must devote significant resources to understanding and complying with this
changing landscape. Failure by us or our third-party vendors to comply with laws, rules and regulations regarding data privacy and protection would expose us to risk of enforcement actions taken by data protection authorities and carries with it the
potential for significant penalties if we are found to be <FONT STYLE="white-space:nowrap">non-compliant.</FONT> Similarly, failure to comply with federal and state laws, rules and regulations in the United States regarding privacy and security of
personal information could expose us to penalties under such laws, rules and regulations. Any such failure by us or our third-party vendors to comply with data protection and privacy laws, rules and regulations could result in significant
government-imposed fines or orders requiring that we change our practices, claims for damages or other liabilities, regulatory investigations and enforcement action, litigation and significant costs for remediation, any of which could adversely
affect our business. Even if we are not determined to have violated these laws, rules or regulations, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could
harm our business, financial condition, results of operations or prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Risks Related to Third Party Relationships </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If conflicts arise between us and our collaborators or strategic partners, these parties may act in a manner adverse to us and could limit our ability to implement
our strategies. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If conflicts arise between our collaborators and corporate or strategic partners and us, the other party may act in a manner adverse to us
and could limit our ability to implement our strategies. Some of our collaborators and strategic partners are conducting multiple product development efforts within each area that is the subject of the collaboration with us. Our collaborators or
strategic partners, however, may develop, either alone or with others, products in related fields that are competitive with the product candidates we may develop that are the subject of these collaborations with us. Competing products, either
developed by the collaborators or strategic partners or to which the collaborators or strategic partners have rights, may result in the withdrawal of partner support for any product candidates we may develop. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Additionally, some of our collaborators or strategic partners could also become our competitors in the future. Our collaborators or strategic partners could develop
competing products, preclude us from entering into collaborations with their competitors, fail to obtain timely regulatory approvals, prevent us from obtaining timely regulatory approvals, terminate their agreements with us prematurely or fail to
devote sufficient resources to the collaboration efforts, including development, delivery, manufacturing and commercialization of products. Any of these developments could harm our company and product development efforts. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We have entered into collaborations, and may enter into additional collaborations, with third parties for the research, development, manufacture and
commercialization of programs or product candidates. If these collaborations are not successful, our business could be adversely affected. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As part of our
strategy, we have entered into collaborations and intend to seek to enter into additional collaborations with third parties for one or more of our programs or product candidates we may develop. For example, in October 2021, we entered into a
Strategic Collaboration and License Agreement with ModernaTX, Inc. (&#147;Moderna&#148;), focused on advancing new genome editing system for <I>in vivo</I> human therapeutic applications, in June 2022, we entered into a Development, Option and
License Agreement with <FONT STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics, Inc. <FONT STYLE="white-space:nowrap">(&#147;Affini-T&#148;)</FONT> to develop and commercialize gene edited T-cell receptor
<FONT STYLE="white-space:nowrap">(&#147;TCR&#148;)-based</FONT> therapeutic products exclusively in the field of treatment, prevention or diagnosis of any human cancer using products with any engineered primary TCR alpha/beta T cells and
non-exclusively in the field of treatment, prevention or diagnosis of any human cancer using products with certain other engineered immune cells worldwide, and in November 2022, we entered into a Collaboration and License Agreement with Ionis
Pharmaceuticals, Inc. (&#147;Ionis&#148;) to research, develop and commercialize investigational medicines using genome editing technologies. Our likely collaborators for any other collaboration arrangements include large and <FONT
STYLE="white-space:nowrap">mid-size</FONT> pharmaceutical companies, regional and national pharmaceutical companies and biotechnology companies. We have under these agreements, and we may have under any other arrangements that we may enter into with
any third parties, limited control over the amount and timing of resources that collaborators dedicate to the development or commercialization of our product candidates. Our ability to generate revenue from these arrangements may depend on our
collaborators&#146; abilities to successfully perform the functions assigned to them in these arrangements. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Collaborations that we enter into may not be successful,
and any success will depend heavily on the efforts and activities of such collaborators. Collaborations pose a number of risks, including the following: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborators have significant discretion in determining the amount and timing of efforts and resources that they will
apply to these collaborations; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborators may not perform their obligations as expected; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborators may not pursue development of our product candidates or may elect not to continue or renew development
programs based on results of clinical trials or other studies, changes in the collaborators&#146; strategic focus or available funding, or external factors, such as an acquisition, that divert resources or create competing priorities;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborators may not pursue commercialization of any product candidates that achieve regulatory approval or may elect not
to continue or renew commercialization programs based on results of clinical trials or other studies, changes in the collaborators&#146; strategic focus or available funding, or external factors, such as an acquisition, that may divert resources or
create competing priorities; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborators may delay preclinical studies and clinical trials, provide insufficient funding for a preclinical study or
clinical trial program, stop a preclinical study or clinical trial or abandon a product candidate, repeat or conduct new preclinical studies or clinical trials or require a new formulation of a product candidate for preclinical or clinical testing;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we may not have access to, or may be restricted from disclosing, certain information regarding product candidates being
developed or commercialized under a collaboration and, consequently, may have limited ability to inform our stockholders about the status of such product candidates on a discretionary basis; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with
our product candidates and products if the collaborators believe that the competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">product candidates discovered in collaboration with us may be viewed by our collaborators as competitive with their own
product candidates or products, which may cause collaborators to cease to devote resources to the commercialization of our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">a collaborator may fail to comply with applicable regulatory requirements regarding the development, manufacture,
distribution or marketing of a product candidate or product; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">a collaborator with marketing and distribution rights to one or more of our product candidates that achieve regulatory
approval may not commit sufficient resources to the marketing and distribution of such product or products; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">disagreements with collaborators, including disagreements over intellectual property or proprietary rights, contract
interpretation or the preferred course of development, might cause delays or terminations of the research, development or commercialization of product candidates, might lead to additional responsibilities for us with respect to product candidates,
or might result in litigation or arbitration, any of which would be time-consuming and expensive; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborators may not properly obtain, maintain, enforce, defend or protect our intellectual property or proprietary rights
or may use our proprietary information in such a way as to potentially lead to disputes or legal proceedings that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential litigation;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">disputes may arise with respect to the ownership of intellectual property or other rights developed pursuant to our
collaborations; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborators may infringe, misappropriate or otherwise violate the intellectual property or proprietary rights of third
parties, which may expose us to litigation and potential liability; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">collaborations may be terminated for the convenience of the collaborator, and, if terminated, we could be required to raise
additional capital to pursue further development or commercialization of the applicable product candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Collaboration agreements may not lead
to development or commercialization of product candidates in the most efficient manner, or at all. If any current or future collaborations do not result in the successful development and commercialization of products or if one of our collaborators
terminates its agreement with us, we may not receive any future research funding or milestone or royalty payments under the collaboration. If we do not receive the funding we expect under these agreements, our development of our product candidates
could be delayed and we may need additional resources to develop our product candidates. All of the risks relating to product development, regulatory approval and commercialization described in this prospectus also apply to the activities of our
collaborators. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Collaboration agreements may require us to incur <FONT STYLE="white-space:nowrap">non-recurring</FONT> and other charges, increase our near- and
long-term expenditures, issue securities that dilute our existing stockholders, or disrupt our management and business. For more information, see the section titled &#147;Business&#151;Our License and Collaboration Agreements.&#148; </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We could face significant competition in seeking appropriate collaborators, and the negotiation process is time-consuming and complex. Our ability to reach a definitive
collaboration agreement will depend, among other things, upon our assessment of the collaborator&#146;s resources and expertise, the terms and conditions of the proposed collaboration, and the proposed collaborator&#146;s evaluation of several
factors. If we license rights to any product candidates we or our collaborators may develop, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company
culture. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may also be restricted under existing collaboration agreements from entering into future collaboration agreements on certain terms with potential
collaborators. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators, which further increases competition we
face in seeking potential collaborations. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Additionally, subject to its contractual obligations to us, if a collaborator of ours is involved in a business
combination, the collaborator might deemphasize or terminate the development or commercialization of any product candidate licensed to it by us. If one of our collaborators terminates its agreement with us, we may find it more difficult to attract
new collaborators and our perception in the business and financial communities could be adversely affected. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our collaborators and strategic partners may
control aspects of our clinical trials, which could result in delays and other obstacles in the commercialization of our proposed products and materially harm our results of operations. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For some programs, we will depend on third party collaborators and strategic partners to design and conduct our clinical trials. As a result, we may not be able to
conduct these programs in the manner or on the time schedule we currently contemplate, which may negatively impact our business operations. In addition, if any of these collaborators or strategic partners withdraw support for our programs or
proposed products or otherwise impair their development, our business could be negatively affected. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In October 2021, we entered into a Strategic Collaboration and
License Agreement with Moderna focused on advancing new genome editing system for <I>in vivo</I> human therapeutic applications, in June 2022, we entered into a Development, Option and License Agreement with
<FONT STYLE="white-space:nowrap">Affini-T</FONT> to develop and commercialize gene edited <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapeutic products exclusively in the field of treatment, prevention or diagnosis of any human cancer using
products with any engineered primary TCR alpha/beta T cells and non-exclusively in the field of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
treatment, prevention or diagnosis of any human cancer using products with certain other engineered immune cells worldwide, and in November 2022, we entered into a Collaboration and License
Agreement with Ionis to research, develop and commercialize investigational medicines for up to eight potential genetic targets using genome editing technologies. Our lack of control over the clinical development in our agreements with Moderna, <FONT
STYLE="white-space:nowrap">Affini-T</FONT> and Ionis could cause delays or other difficulties in the development and commercialization of product candidates, which may prevent completion of intended IND applications in a timely fashion, if at all.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, the termination of these agreements would prevent us from receiving any milestone, royalty payments and other benefits under that agreement, which
would have a materially adverse effect on our results of operations. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our collaborators or strategic partners may decide to adopt alternative technologies or
may be unable to develop commercially viable products with our technology, which would negatively impact our revenues and our strategy to develop these products. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our collaborators or strategic partners may adopt alternative technologies, which could decrease the marketability of our genome editing technology. Additionally,
because our current or future collaborators or strategic partners are likely to be working on more than one development project, they could choose to shift their resources to projects other than those they are working on with us. If they do so, this
would delay our ability to test our technology and would delay or terminate the development of potential products based on our genome editing technology. Further, our collaborators and strategic partners may elect not to develop products arising out
of our collaborative and strategic partnering arrangements or to devote sufficient resources to the development, manufacturing, marketing or sale of these products. The failure to develop and commercialize a product candidate pursuant to our
agreements with our current or future collaborators would prevent us from receiving future milestone and royalty payments which would negatively impact our revenues. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We expect to rely on third parties to conduct our clinical trials and some aspects of our research, as well as some aspects of our delivery methods, and those
third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We expect to rely
on third parties, such as CROs, clinical data management organizations, medical institutions, preclinical laboratories and clinical investigators, to conduct some aspects of our research. For example, we may rely on a third party to supply LNPs or
AAVs, or to conduct our preclinical animal experiments. Any of these third parties may terminate their engagements with us at any time under certain criteria. If we need to enter into alternative arrangements, it may delay our product development
activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our reliance on these third parties for clinical research and other development activities will reduce our control over these activities but will not
relieve us of our responsibilities. For example, we will remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA, the EMA and
other regulatory authorities require us and the study sites and investigators we work with to comply with standards, commonly referred to as GLPs and GCPs for conducting, recording and reporting the results of preclinical studies and clinical trials
to assure, amongst other things, that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. In the United States, we also are required to register certain clinical
trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Although we intend to design the preclinical studies and clinical trials for our potential product candidates, CROs will conduct some or all of the preclinical studies
and clinical trials. As a result, many important aspects of our development programs, including their conduct and timing, will be outside of our direct control. Our reliance on third </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
parties to conduct preclinical studies and future clinical trials will also result in less direct control over the management of data developed through preclinical studies and clinical trials
than would be the case if we were relying entirely upon our own staff. Communicating with outside parties can also be challenging, potentially leading to mistakes as well as difficulties in coordinating activities. Among other reasons that may delay
or impact the development of our potential product candidates, outside parties may: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">have staffing difficulties; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">fail to comply with contractual obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">experience regulatory compliance issues; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">undergo changes in priorities or become financially distressed; or </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">form relationships with other entities, some of which may be our competitors. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These factors may materially adversely affect the willingness or ability of third parties to conduct our preclinical studies and clinical trials and may subject us to
unexpected cost increases that are beyond our control. If the CROs and other third parties do not perform such preclinical studies and future clinical trials in a satisfactory manner, breach their obligations to us or fail to comply with regulatory
requirements, the development, regulatory approval and commercialization of our potential product candidates may be delayed, we may not be able to obtain regulatory approval and commercialize our potential product candidates or our development
programs may be materially and irreversibly harmed. If we are unable to rely on preclinical and clinical data collected by our CROs and other third parties, we could be required to repeat, extend the duration of or increase the size of any
preclinical studies or clinical trials we conduct and this could significantly delay commercialization and require greater expenditures. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may also expect to rely
on other third parties to store and distribute drug supplies for our future clinical trials. Any performance failure on the part of our distributors could delay clinical development or regulatory approval of any product candidates we may develop or
commercialization of our therapies, producing additional losses and depriving us of potential product revenue. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Manufacturing biologic products is complex and
subject to product loss for a variety of reasons. We contract with third parties for the manufacture of certain materials for our development programs and expect to continue to do so for clinical trials and commercialization. This reliance on third
parties increases the risk that we will not have sufficient quantities of our future product candidates or products or such quantities at an acceptable cost or quality, which could delay, prevent or impair our development or commercialization
efforts. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We operate and are expanding our cGMP manufacturing facility which is currently capable of manufacturing clinical grade nucleases and mRNA to
supply both wholly-owned and collaboration programs. We also partner with CMOs for guide RNA (&#147;gRNA&#148;) and DNA template development and supply. We also rely, and expect to continue to rely, on third parties for gRNA and DNA template
development and supply, as well as for preclinical and clinical testing and commercial manufacture if any of our product candidates receive regulatory approval. We also expect to rely on these third parties for certain logistics, including
packaging, labeling, storage, and distribution. This reliance on third parties increases the risk that we will not have sufficient quantities of our materials or future product candidates or products or such quantities at an acceptable cost or
quality, which could delay, prevent or impair our development or commercialization efforts. We may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able to establish agreements with
third-party manufacturers, reliance on third-party manufacturers entails additional risks, including: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reliance on the third party for regulatory compliance and quality assurance; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the possible breach of the manufacturing agreement by the third party; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the possible misappropriation of our proprietary information, including our trade secrets and know-how; and
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us.
</P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We or our third-party manufacturers may encounter shortages in the raw materials or active pharmaceutical ingredients necessary to produce our
future product candidates in the quantities needed for our preclinical studies or clinical trials or, if our future product candidates are approved, in sufficient quantities for commercialization or to meet an increase in demand, as a result of
capacity constraints or delays or disruptions in the market for the raw materials or active pharmaceutical ingredients, including shortages caused by the purchase of such raw materials or active pharmaceutical ingredient by our competitors or
others. The failure of us or our third-party manufacturers to obtain the raw materials or active pharmaceutical ingredients necessary to manufacture sufficient quantities of our future product candidates may have a material adverse effect on our
business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Components of a finished therapeutic product approved for commercial sale or used in late-stage clinical trials must be manufactured in accordance with
cGMP. We, along with our third-party manufacturers, are subject to inspection and approval by regulatory authorities before we can commence the manufacture and sale of any of our future product candidates, and thereafter subject to ongoing
inspection from time to time. We or our third-party manufacturers may not be able to comply with cGMP or similar regulatory requirements outside of the United States. Our failure, or the failure of our third-party manufacturers, to comply with
applicable regulations could result in regulatory actions, such as the issuance of FDA Form 483 notices of observations, warning letters or sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays,
suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our products. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Manufacturing biologic products, such as the product candidates we intend to develop, is complex, especially in large quantities. Biologic products must be made
consistently and in compliance with a clearly defined manufacturing process. Accordingly, it is essential to be able to validate and control the manufacturing process to assure that it is reproducible. Any product candidates and products that we may
develop may compete with other product candidates and products for access to manufacturing facilities. As a result, we may not obtain access to these facilities on a priority basis or at all. There are a limited number of manufacturers that operate
under cGMP and that might be capable of manufacturing for us. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any performance failure on the part of our existing or future manufacturers could delay clinical
development or regulatory approval. We do not currently have arrangements in place for redundant supply or a source for bulk drug substance nor do we have any agreements with third-party manufacturers for long-term commercial supply. If any of our
contract manufacturers cannot perform as agreed, we may be required to replace such manufacturers. Although we believe that there are several potential alternative manufacturers who could manufacture materials or future product candidates or
products we may develop, we may incur added costs and delays in identifying and qualifying any such replacement or be unable to reach agreement with an alternative manufacturer. If we are required to change third party-manufacturers for any reason,
we will be required to verify that the new third party-manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations. We will also need to verify, such as through a manufacturing
comparability study, that any new manufacturing process will produce our materials or future product candidates or products according to the specifications previously submitted to the FDA or another regulatory authority. The delays associated with
the verification of a new third party-manufacturer could negatively affect our ability to develop product candidates or commercialize our products in a timely manner or within budget. Furthermore, a third party-manufacturer may possess technology
related to the manufacture of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
our materials or future product candidates or products that such third party-manufacturer owns independently. This would increase our reliance on such third party-manufacturer or require us to
obtain a license from such third party-manufacturer in order to have another third party-manufacturer manufacture our materials or future product candidates or products, which may not be available on commercially reasonable terms, or at all. In
addition, changes in manufacturers often involve changes in manufacturing procedures and processes, which could require that we conduct bridging studies between our prior clinical supply used in our clinical trials and that of any new manufacturer.
We may be unsuccessful in demonstrating the comparability of clinical supplies which could require the conduct of additional clinical trials. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our current and
anticipated future dependence upon others for the manufacture of materials and any future product candidates or products we may develop may adversely affect our future profit margins and our ability to commercialize any products that receive
regulatory approval on a timely and competitive basis. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our relationships with healthcare providers, physicians, and third-party payors will be subject to applicable
anti-kickback, fraud and abuse, anti-bribery and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm, and diminished profits and future earnings. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our relationships with healthcare providers, physicians, and third-party payors will be subject to applicable anti-kickback, fraud and abuse, anti-bribery and other
healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm, and diminished profits and future earnings. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Healthcare providers, including physicians, and third-party payors play a primary role in the recommendation and prescription of any product candidates that we may
develop for which we obtain regulatory approval and marketing approval. Our current and future arrangements with third-party payors, healthcare providers and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and
regulations that may constrain the business or financial arrangements and relationships through which we market, sell, and distribute our products for which we obtain regulatory approval. Restrictions under applicable federal and state healthcare
laws and regulations, including certain laws and regulations applicable only if we have marketed products, include the following: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the civil FCA, prohibits knowingly presenting or causing the presentation of a false, fictitious or fraudulent claim for
payment to the U.S. government. Actions under the FCA may be brought by the Attorney General or as a qui tam action by a private individual in the name of the government. Violations of the FCA can result in very significant monetary penalties, for
each false claim and treble the amount of the government&#146;s damages. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false
or fraudulent claims; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the federal Anti-Kickback Statute prohibits, among other things, persons from soliciting, receiving or providing
remuneration, directly or indirectly, to induce either the referral of an individual, for an item or service or the purchasing or ordering of a good or service, for which payment may be made under federal healthcare programs such as Medicare and
Medicaid. The federal Anti-Kickback Statute has been interpreted to apply to arrangements between manufacturers on one hand and prescribers, purchasers, and formulary managers on the other. A person or entity does not need to have actual knowledge
of the statute or specific intent to violate it in order to have committed a violation. A violation of the federal Anti-Kickback Statute can also form the basis for FCA liability; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">HIPAA, which, in addition to privacy protections applicable to healthcare providers and other entities, prohibits executing
a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent
to violate it in order to have committed a violation; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (&#147;HITECH&#148;),
and its implementing regulations, including the final omnibus rule published on January&nbsp;25, 2013, imposes, among other things, certain requirements relating to the privacy, security and transmission of individually identifiable health
information. Among other things, HITECH makes HIPAA&#146;s privacy and security standards directly applicable to &#147;business associates,&#148; defined as independent contractors or agents of covered entities that create, receive, maintain,
transmit, or obtain, protected health information in connection with providing a service for or on behalf of a covered entity, and their covered subcontractors. HITECH also increased the civil and criminal penalties that may be imposed against
covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney&#146;s fees and
costs associated with pursuing federal civil actions; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the FDCA, which among other things, strictly regulates drug marketing, prohibits manufacturers from marketing such products
for <FONT STYLE="white-space:nowrap">off-label</FONT> use and regulates the distribution of samples; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">federal laws that require pharmaceutical manufacturers to report certain calculated product prices to the government or
provide certain discounts or rebates to government authorities or private entities, often as a condition of reimbursement under government healthcare programs; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">federal transparency laws, including the federal Physician Payment Sunshine Act created under the Patient Protection and
Affordable Care Act as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the ACA), and its implementing regulations, which requires manufacturers of certain drugs, devices, medical supplies, and biologics, among
others, to track and disclose payments under Medicare, Medicaid or the Children&#146;s Health Insurance Program (with certain exceptions) and other transfers of value they make to U.S. physicians (defined to include doctors, dentists, optometrists,
podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January&nbsp;1, 2022, these reporting obligations will extend to include transfers
of value made to certain <FONT STYLE="white-space:nowrap">non-physician</FONT> providers such as physician assistants and nurse practitioners. This information is subsequently made publicly available in a searchable format on a Centers for
Medicare&nbsp;&amp; Medicaid Services (&#147;CMS&#148;) website. Failure to disclose required information may result in civil monetary penalties for all payments, transfers of value or ownership or investment interests that are not timely,
accurately and completely reported in an annual submission. Certain states also mandate implementation of compliance programs, impose restrictions on drug manufacturer marketing practices and/or require the tracking and reporting of gifts,
compensation and other remuneration to physicians and/or other healthcare providers; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">analogous state and foreign laws and regulations, such as state anti-kickback, anti-bribery and false claims laws, which
may apply to healthcare items or services that are reimbursed by <FONT STYLE="white-space:nowrap">non-governmental</FONT> third-party payors, including private insurers. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Some state laws also require pharmaceutical companies to comply with specific compliance standards, restrict financial interactions between pharmaceutical companies and
healthcare providers or require pharmaceutical companies to report information related to payments to healthcare providers or marketing expenditures. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Efforts to
ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Given the breadth of the laws and regulations, limited guidance for certain laws and regulations and
evolving government interpretations of the laws and regulations, governmental authorities may possibly conclude that our business practices may not comply with healthcare laws and regulations. If our operations are found to be in violation of any of
the laws described above or any other government regulations that apply to us, we may be subject to significant penalties, including civil and </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">criminal penalties,
damages, fines, exclusion from participation in government healthcare programs, such as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Medicare and Medicaid, individual imprisonment, and the curtailment or restructuring of our operations, any of which could adversely affect our business, financial condition, results of
operations, and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase,
supply, order, or use of medicinal products is prohibited in the European Union. The provision of benefits or advantages to also induce or reward improper performance generally is governed by the national anti-bribery laws of European Union Member
States, and the Bribery Act 2010 in the United Kingdom. Infringement of these laws could result in substantial fines and imprisonment. EU Directive 2001/83/EC, which is the EU Directive governing medicinal products for human use, further provides
that, where medicinal products are being promoted to persons qualified to prescribe or supply them, no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to such persons unless they are inexpensive and relevant to
the practice of medicine or pharmacy. This provision has been transposed into the Human Medicines Regulations 2012 and so remains applicable in the United Kingdom despite its departure from the EU. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Payments made to physicians in certain European Union Member States must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior
notification and approval by the physician&#146;s employer, his or her competent professional organization, and/or the regulatory authorities of the individual European Union Member States. These requirements are provided in the national laws,
industry codes, or professional codes of conduct applicable in the European Union Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Risks Related to Personnel, Operations, and Growth </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our future success
depends on our ability to retain our Chief Executive Officer and other key executives and to attract, retain, and motivate qualified personnel. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are
highly dependent on Brian C. Thomas, our Chief Executive Officer as well as the other principal members of our management and scientific teams. Dr.&nbsp;Thomas and such other principal members are engaged &#147;at will,&#148; meaning we or they may
terminate the relationship at any time. We do not maintain &#147;key person&#148; insurance for any of our executives or other employees. The loss of the services of any of these persons could impede the achievement of our research, development and
commercialization objectives. For us to successfully compete and grow, we must recruit, retain, and develop talent who can provide the necessary expertise across a broad spectrum of disciplines. In addition, we must develop, maintain and, as
necessary, implement appropriate succession plans to ensure we have the necessary human capital capable of maintaining continuity in our business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Recruiting and
retaining qualified scientific, clinical, manufacturing and sales and marketing personnel will also be critical to our success. In addition, our company-building efforts and establishment of a company culture will also be important to developing an
innovative company in a high-evolving area. We may not be able to succeed in these efforts to build Metagenomi as an attractive and exciting place to build a career or to attract and retain these types of personnel on acceptable terms given the
competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on
consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors, including our scientific
<FONT STYLE="white-space:nowrap">co-founders,</FONT> may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. We may also encounter
problems hiring and retaining the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
experienced scientific, quality control and manufacturing personnel needed to manage our manufacturing process, which could result in delays in our production or difficulties in maintaining
compliance with applicable regulatory requirements. The inability to recruit, or loss of services of, certain executives, key employees, consultants or advisors, may impede the progress of our research, development and commercialization objectives
and have a material adverse effect on our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We expect to expand our research, development,
delivery, manufacturing, commercialization, regulatory, and future sales and marketing capabilities over time, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may fail to manage our growth effectively. As of September&nbsp;30, 2023, we had 223 full-time employees, of which 74 have M.D. or Ph.D. degrees. Within our
workforce, 187 employees are engaged in research and development and 36 are engaged in business development, finance, legal, and general management and administration. In connection with the growth and advancement of our pipeline and becoming a
public company, we expect to increase the number of our employees and the scope of our operations, particularly in the areas of research and clinical development, regulatory affairs and, if any of our future product candidates receive regulatory
approval, sales and marketing. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities, and continue to recruit and train additional qualified
personnel. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expected expansion of our operations or recruit and
train additional qualified personnel. Moreover, the expected physical expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the
execution of our business plans or disrupt our operations. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As a growing biotechnology company, we are actively developing our platform technology and pursuing
development of future product candidates in many therapeutic areas and across a wide range of diseases. Successfully developing product candidates for and fully understanding the regulatory and manufacturing pathways to all of these therapeutic
areas and disease states requires a significant depth of talent, resources and corporate processes in order to allow simultaneous execution across multiple areas. We will need to transition from a company with a research focus to a company capable
of conducting clinical trials and ultimately supporting commercial activities if any of our product candidates are approved. We may not be successful in such a transition. Due to our limited resources, we may not be able to effectively manage this
simultaneous execution and the expansion of our operations or recruit and train additional qualified personnel. This may result in weaknesses in our infrastructure, give rise to operational mistakes, legal or regulatory compliance failures, loss of
business opportunities, loss of employees and reduced productivity among remaining employees. The physical expansion of our operations may lead to significant costs and may divert financial resources from other projects, such as the development of
our potential product candidates. If our management is unable to effectively manage our expected development and expansion, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced and we may not
be able to implement our business strategy. Our future financial performance and our ability to compete effectively and commercialize any product candidates we may develop will depend in part on our ability to effectively manage the future
development and expansion of our company, and may prevent us from achieving or maintaining profitability. We cannot assure you that we will be able to compete effectively in the future against existing or new competitors, and our failure to do so
could harm our business, financial condition, and results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could
hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved, or commercialized in a timely manner or at all, which could negatively impact our
business. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels,
statutory, regulatory, and policy changes, the FDA&#146;s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#146;s ability to perform routine functions. Average review
times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and
unpredictable. Disruptions at the FDA and other agencies may also slow the time necessary for biologics or modifications to approved biologics to be reviewed and/or approved by necessary government agencies, which would adversely affect our
business. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Risks Related to Our Intellectual Property </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our
commercial success depends on our ability to obtain, maintain, enforce, and otherwise protect our intellectual property and proprietary technology, and if the scope of the intellectual property protection obtained is not sufficiently broad, our
competitors or other third parties could develop and commercialize products and product candidates similar to ours and our ability to successfully develop and commercialize our genome editing systems may be adversely affected. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our commercial success depends, in large part, on our ability to obtain and maintain intellectual property rights protection through patents, trademarks, and trade
secrets in the United States and other countries with respect to our proprietary genome editing systems. If we do not adequately protect our intellectual property rights, competitors or other third parties may be able to erode, negate or preempt any
competitive advantage we may have, which could harm our business and ability to achieve profitability. To protect our proprietary position, we have filed patent applications and may file other patent applications in the United States or abroad
related to our genome editing systems that are important to our business; we may also license or purchase patents or patent applications filed by others. The patent application process is expensive, time-consuming and complex. We may not be able to
file, prosecute, maintain, enforce or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may not be able to
obtain patents on certain inventions if those inventions are publicly disclosed prior to our filing a patent application covering them. We enter into nondisclosure and confidentiality agreements with parties who have access to confidential
information, including confidential information regarding inventions not yet disclosed in patent applications. We cannot guarantee that any of these parties will not breach these confidentiality agreements and publicly disclose any of our inventions
before a patent application is filed covering such inventions. If such confidential information is publicly disclosed, we may not be able to successfully patent it and consequently, we may not be able to prevent third parties from using such
inventions. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If the scope of the patent protection we obtain is not sufficiently broad, we may not be able to prevent others from developing and commercializing
technology and products similar or identical to ours. The degree of patent protection we require to successfully compete in the marketplace may be unavailable or severely limited in some cases and may not adequately protect our rights or permit us
to gain or keep any competitive advantage. We cannot provide any assurances that any of our patents have, or that any of our pending owned patent applications that mature into issued patents will include claims with a scope sufficient to protect our
proprietary genome editing systems or otherwise provide any competitive advantage. Other parties have developed or may develop technologies that may be related or competitive with our approach, and may have
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
filed or may file patent applications and may have been issued or may be issued patents with claims that overlap or conflict with our patent portfolio, either by claiming the same compounds,
formulations or methods or by claiming subject matter that could dominate our patent position. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. Furthermore, patents have a
limited lifespan. In the United States, the natural expiration of a patent is generally twenty years after it is filed. Various extensions may be available; however, the life of a patent, and the protection it affords, is limited. Given the amount
of time required for the development, testing and regulatory review of new genome editing systems, patents protecting such genome editing systems might expire before or shortly after such genome editing systems are commercialized. As a result, our
patent portfolio may not provide us with adequate and continuing patent protection sufficient to exclude others from commercializing products similar or identical to ours. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Even if they are unchallenged, our owned patents and pending patent applications, if issued, may not provide us with any meaningful protection or prevent competitors
from designing around our patent claims to circumvent our patent portfolio by developing similar or alternative genome editing systems in a <FONT STYLE="white-space:nowrap">non-infringing</FONT> manner. For example, a third party may develop a
genome editing system that provides benefits similar to our genome editing systems but falls outside the scope of our patent protection or license rights. If the patent protection provided by the patent and patent applications we hold or pursue with
respect to our genome editing systems is not sufficiently broad to impede such competition, our ability to successfully commercialize our product genome editing systems could be negatively affected, which would harm our business. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We, or any future partners, collaborators, or licensees, may fail to identify patentable aspects of inventions made in the course of development and commercialization
activities before it is too late to obtain patent protection on them. Therefore, we may miss potential opportunities to strengthen our patent position. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">It is
possible that defects of form in the preparation or filing of our patent portfolio may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we
or our partners, collaborators, or licensees whether current or future, fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If our partners, collaborators, or
licensees are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. If there are material defects in the form, preparation, prosecution, or
enforcement of our patent portfolio, such patents may be invalid and/or unenforceable, and such applications may never result in valid, enforceable patents. Periodic maintenance fees, renewal fees, annuity fees and various other government fees on
patents and/or applications will be due to be paid to the U.S. Patent and Trademark Office (&#147;USPTO&#148;) and various government patent agencies outside of the United States over the lifetime of our owned or licensed patents and patent
applications. We rely on our outside counsel or our licensing partners to pay these fees due to U.S. and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> patent agencies. The USPTO and various <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
government patent agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. Any of these outcomes could impair our ability to prevent competition from third
parties, which may have an adverse impact on our business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The patent position of biotechnology and pharmaceutical companies carries uncertainty. In addition, the
determination of patent rights with respect to genome editing technologies commonly involves complex legal and factual questions, which are dependent upon the current legal and intellectual property context, extant legal precedent and
interpretations of the law by individuals. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are characterized by uncertainty. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pending patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such
applications. Assuming the other requirements for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
patentability are met, currently, the first to file a patent application is generally entitled to the patent. However, prior to March&nbsp;16, 2013, in the United States, the first to invent was
entitled to the patent. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are not published until 18 months after filing, or in some
cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patent portfolio, or that we were the first to file for patent protection of such inventions. If third parties have filed prior patent
applications on inventions claimed in our patent portfolio that were filed on or before March&nbsp;15, 2013, an interference proceeding in the United States can be initiated by such third parties to determine who was the first to invent any of the
subject matter covered by our patent portfolio. If third parties have filed such prior applications after March&nbsp;15, 2013, a derivation proceeding in the United States can be initiated by such third parties to determine whether our invention was
derived from theirs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Moreover, because the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, our patents may be
challenged in the courts or patent offices in the United States and abroad. There is no assurance that all the potentially relevant prior art relating to our patent portfolio has been found. Publications of discoveries in the scientific literature
often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing or, in some cases, not at all. Therefore, we cannot know with certainty whether we
were the first to make the inventions claimed in our patent portfolio, or that we were the first to file for patent protection of such inventions. If such prior art exists, it may be used to invalidate a patent, or may prevent a patent from issuing
from a pending patent application. For example, such patent filings may be subject to a third-party submission of prior art to the USPTO, or to other patent offices around the world. Alternately or additionally, we may become involved in post-grant
review procedures, oppositions, derivation proceedings, ex parte reexaminations, inter partes review, supplemental examinations, or interference proceedings or challenges before the USPTO or in district court in the United States, or similar
proceedings in various foreign jurisdictions, including both national and regional, challenging patents or patent applications in which we have rights, including patents on which we rely to protect our business. An adverse determination in any such
challenges may result in loss of the patent or claims in the patent portfolio being narrowed, invalidated or held unenforceable, in whole or in part, or in denial of the patent application or loss or reduction in the scope of one or more claims of
the patent portfolio, any of which could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and products. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pending and future patent applications may not result in patents being issued that protect our business, in whole or in part, or which effectively prevent others from
commercializing competitive products. Competitors may also be able to design around our patents. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or
narrow the scope of our patent protection. In addition, the laws of foreign countries may not protect our rights to the same extent or in the same manner as the laws of the United States. For example, patent laws in various jurisdictions, including
jurisdiction covering significant commercial markets, such as the European Patent Office, China, and Japan, restrict the patentability of methods of treatment of the human body more than United States law does. If these developments were to occur,
they could have a material adverse effect on our ability to generate revenue. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The patent application process is subject to numerous risks and uncertainties, and
there can be no assurance that we or any of our future development partners will be successful in protecting our genome editing systems by obtaining and defending patents. These risks and uncertainties include the following: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee
payment and other provisions during the patent process. There are situations in which noncompliance, whether intentional or not, can result in abandonment or lapse of a patent or patent
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">
application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier than would otherwise have
been the case; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">patent applications may not result in any patents being issued; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Company-owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents that have been issued or may be issued in the
future may be challenged, invalidated, modified, revoked, circumvented, found to be unenforceable or otherwise may not provide any competitive advantage; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our competitors, many of whom have substantially greater resources and many of whom have made significant investments in
competing technologies, may seek or may have already obtained patents that will limit, interfere with or eliminate our ability to make, use, and sell our genome editing systems; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">there may be significant pressure on the U.S. government and international governmental bodies to limit the scope of patent
protection both inside and outside the United States for disease treatments that prove successful, as a matter of public policy regarding worldwide health concerns; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">countries other than the United States may have patent laws less favorable to patentees than those upheld by U.S. courts,
allowing foreign competitors a better opportunity to create, develop and market competing products; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">countries other than the U.S. may, under certain circumstances, force us to grant a license under our patents to a
competitor, thus allowing the competitor to compete with us in that jurisdiction or forcing us to lower the price of our drug in that jurisdiction. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Issued patents that we have or may obtain or license may not provide us with any meaningful protection, prevent competitors from competing with us or otherwise provide
us with any competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative technologies or products in a <FONT STYLE="white-space:nowrap">non-infringing</FONT> manner. Our competitors may also seek
approval to market their own products similar to or otherwise competitive with our products. In these circumstances, we may need to defend or assert our patents, or both, including by filing lawsuits alleging patent infringement. In any of these
types of proceedings, a court or other agency with jurisdiction may find our patents invalid or unenforceable, or that our competitors do not infringe our patents. Thus, even if we have valid and enforceable patents, these patents still may not
provide protection against competing products or processes sufficient to achieve our business objectives. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We maintain certain information as company trade secrets.
This information may relate to inventions that are not patentable or not optimally protected with patents. We use commercially acceptable practices to protect this information, including, for example, limiting access to the information and requiring
passwords for our computers. Additionally, we execute confidentiality agreements with any third parties to whom we may provide access to the information and with our employees, consultants, scientific advisors, collaborators, vendors, contractors,
and advisors. We cannot provide any assurances that all such agreements have been duly executed, and third parties may still obtain this information or may come upon this or similar information independently. It is possible that technology relevant
to our business will be independently developed by a person who is not a party to such a confidentiality or invention assignment agreement. If any of our trade secrets were to be independently developed by a competitor or other third party, we would
have no right to prevent such competitor or third party, or those to whom they communicate such independently developed information, from using that information to compete with us. We may not be able to prevent the unauthorized disclosure or use of
our technical knowledge or trade secrets by contract manufacturers, consultants, collaborators, vendors, advisors, former employees and current employees. Monitoring unauthorized uses and disclosures is difficult and we do not know whether the steps
we have taken to protect our proprietary technologies will be effective. Furthermore, if the parties to our confidentiality agreements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
breach or violate the terms of these agreements, we may not have adequate remedies for any such breach or violation, and we could lose our trade secrets as a consequence of such breaches or
violations. Our trade secrets could otherwise become known or be independently discovered by our competitors. Additionally, if the steps taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse against third
parties for misappropriating our trade secrets. If any of these events occurs or if we otherwise lose protection for our trade secrets, our business, financial condition, results of operation and prospects may be materially and adversely harmed.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>It is difficult and costly to protect our intellectual property and our proprietary technologies, and we may not be able to ensure their protection.
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our commercial success will depend in part on obtaining and maintaining patent protection and trade secret protection for our proprietary genome editing
systems, as well as on successfully defending these patents against potential third-party challenges. Our ability to protect our genome editing systems from unauthorized making, using, selling, offering to sell or importing by third parties is
dependent on the extent to which we have rights under valid and enforceable patents that cover these activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The patent positions of pharmaceutical,
biotechnology and other life sciences companies can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved and have in recent years been the subject of much litigation. Changes in
either the patent laws or in interpretations of patent laws in the United States and other countries may diminish the value of our intellectual property. Over the past decade, U.S. federal courts have increasingly invalidated pharmaceutical and
biotechnology patents during litigation often based on changing interpretations of patent law. Further, the determination that a patent application or patent claim meets all the requirements for patentability is a subjective determination based on
the application of law and jurisprudence. The ultimate determination by the USPTO or by a court or other trier of fact in the United States, or corresponding foreign national patent offices or courts, on whether a claim meets all requirements of
patentability cannot be assured. Although we have conducted searches for third-party publications, patents and other information that may affect the patentability of claims in our patent portfolio, we cannot be certain that all relevant information
has been identified. Accordingly, we cannot predict the breadth of claims that may be allowed or enforced in our own patent portfolio. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We cannot provide assurances
that any of our patent applications will be found to be patentable, including over our own prior art publications or patent literature, or will issue as patents. Neither can we make assurances as to the scope of any claims that may issue from our
pending and future patent applications nor to the outcome of any proceedings by any potential third parties that could challenge the patentability, validity or enforceability of our patent portfolio in the United States or foreign jurisdictions. Any
such challenge, if successful, could limit patent protection for our genome editing systems and/or materially harm our business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to challenges during
litigation, third parties can challenge the validity of our patents in the United States using post-grant review and inter partes review proceedings, which some third parties have been using to cause the cancellation of selected or all claims of
issued patents of competitors. For a patent filed March&nbsp;16, 2013 or later, a petition for post-grant review can be filed by a third party in a nine-month window from issuance of the patent. A petition for inter partes review can be filed
immediately following the issuance of a patent if the patent has an effective filing date prior to March&nbsp;16, 2013. A petition for inter partes review can be filed after the nine-month period for filing a post-grant review petition has expired
for a patent with an effective filing date of March&nbsp;16, 2013 or later. Post-grant review proceedings can be brought on any ground of invalidity, whereas inter partes review proceedings can only raise an invalidity challenge based on published
prior art and patents. These adversarial actions at the USPTO review patent claims without the presumption of validity afforded to U.S. patents in lawsuits in U.S. federal courts and use a lower burden of proof than used in litigation in U.S.
federal courts. Therefore, it is generally </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
considered easier for a competitor or third party to have a U.S. patent invalidated in a USPTO post-grant review or inter partes review proceeding than invalidated in a litigation in a U.S.
federal court. If any of our patents are challenged by a third party in such a USPTO proceeding, there is no guarantee that we will be successful in defending the patent, which may result in a loss of the challenged patent right to us. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or
permit us to gain or keep our competitive advantage. For example: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we may not be able to generate sufficient data to support full patent applications that protect the entire breadth of
developments in one or more of our programs; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">it is possible that one or more of our pending patent applications will not become an issued patent or, if issued, that the
patent(s) claims will have sufficient scope to protect our technology, provide us with commercially viable patent protection or provide us with any competitive advantages; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">if our pending applications issue as patents, they may be challenged by third parties as invalid or unenforceable under
United States or foreign laws; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we may not successfully commercialize our genome editing systems, if approved, before our relevant patents expire;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we may not be the first to make the inventions covered by our patent portfolio; or </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we may not develop additional proprietary technologies or genome editing systems that are separately patentable.
</P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, to the extent that we are unable to obtain and maintain patent protection for our genome editing systems, or in the event that such
patent protection expires, it may no longer be cost-effective to extend our portfolio by pursuing additional development of any of our genome editing systems for <FONT STYLE="white-space:nowrap">follow-on</FONT> indications. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Patent terms may be inadequate to protect our competitive position on our products for an adequate amount of time. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its
earliest U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> filing date. The patent term of a U.S. patent may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the United States Patent and
Trademark Office in granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier-filed patent. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Various extensions may be available,
but the life of a patent, and the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new genome editing systems, patents protecting such genome editing systems might expire
before or shortly after such genome editing systems are commercialized. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the United States, the Drug Price Competition and Patent Term Restoration Act of 1984
permits a Patent Term Extension (&#147;PTE&#148;) of up to five years beyond the normal expiration of the patent to compensate patent owners for loss of enforceable patent term due to the lengthy regulatory approval process. A PTE grant cannot
extend the remaining term of a patent beyond a total of 14 years from the date of the product approval. Further, PTE may only be applied once per product, and only with respect to an approved indication&#151;in other words, only one patent (for
example, covering the product itself, an approved use of said product, or a method of manufacturing said product) can be extended by PTE. We anticipate applying for PTE in the United States. Similar extensions may be available in other countries
where we are prosecuting patents and we likewise anticipate applying for such extensions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The granting of such patent term extensions is not guaranteed and is subject to numerous requirements. We might not be
granted an extension because of, for example, failure to apply within applicable periods, failure to apply prior to the expiration of relevant patents or otherwise failure to satisfy any of the numerous applicable requirements. In addition, to the
extent we wish to pursue patent term extension based on a patent that we <FONT STYLE="white-space:nowrap">in-license</FONT> from a third party, we would need the cooperation of that third party. Moreover, the applicable authorities, including the
FDA and the USPTO in the United States, and any equivalent regulatory authority in other countries, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more
limited extensions than we request. If this occurs, our competitors may be able to obtain approval of competing products following our patent expiration by referencing our clinical and preclinical data and launch their product earlier than might
otherwise be the case. If this were to occur, it could have a material adverse effect on our ability to generate revenue. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Changes in the interpretation of
patent law in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The United States Congress is responsible for passing laws establishing patentability standards. As with any laws, implementation is left to federal agencies and the
federal courts based on their interpretations of the laws. Interpretation of patent standards can vary significantly within the USPTO, and across the various federal courts, including the U.S. Supreme Court. Recently, the Supreme Court has ruled on
several patent cases, generally limiting the types of inventions that can be patented. Further, there are open questions regarding interpretation of patentability standards that the Supreme Court has yet to decisively address. Absent clear guidance
from the Supreme Court, the USPTO has become increasingly conservative in its interpretation of patent laws and standards. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to increasing uncertainty
with regard to our ability to obtain patents in the future, the legal landscape in the U.S. has created uncertainty with respect to the value of patents. Depending on any actions by Congress, and future decisions by the lower federal courts and the
U.S. Supreme Court, along with interpretations by the USPTO, the laws and regulations governing patents could change in unpredictable ways and could weaken our ability to obtain new patents or to enforce our existing patents and patents that we
might obtain in the future. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The U.S. Supreme Court has ruled on several patent cases in recent years; these cases often narrow the scope of patent protection
available to inventions in the biotechnology and pharmaceutical spaces. For example, in <I>Association for Molecular Pathology v. Myriad Genetics, Inc.</I> (&#147;<I>Myriad</I>&#148;), the Supreme Court ruled that a &#147;naturally occurring DNA
segment is a product of nature and not patent eligible merely because it has been isolated,&#148; and invalidated Myriad Genetics&#146; claims on the isolated BRCA1 and BRCA2 genes. Certain claims of our patent portfolio relate to genome editing
systems. While we believe that our proprietary genome editing systems involve significant human intervention, components of the system, such as the isolated nucleases with no modifications, are derived from naturally-occurring products. To the
extent that such claims are deemed to be directed to natural products, or to lack an inventive concept above and beyond an isolated natural product, a court may decide the claims are directed to patent-ineligible subject matter and are invalid. The
application of <I>Myriad</I> to biotechnology inventions has continued to develop and may continue to change over time. Subsequent rulings in cases or guidance or procedures issued by the USPTO relating to patent eligibility may have a negative
impact on our business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In <I>Amgen Inc. v. Sanofi</I> (&#147;<I>Amgen</I>&#148;), the U.S. Supreme Court held that certain of Amgen&#146;s patent claims defined a
class of antibodies by their function of binding to a particular antigen. The U.S. Supreme Court further wrote that because the patent claims defined the claimed class of antibodies only by their function of binding to a particular antigen, a
skilled artisan would have to use significant trial and error to identify and make all of the molecules in that class. The U.S. Supreme Court ultimately held that Amgen failed to properly enable its patent
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
claims. Certain claims of our patent portfolio relate to broad classes of gene editors. To the extent that a court finds that the skilled artisan would need significant trial and error to
identify all the gene editors in that class, the court may find the claims invalid under <I>Amgen</I>. Depending on future actions by the U.S. Congress, the U.S. courts, the USPTO and the relevant <FONT STYLE="white-space:nowrap">law-making</FONT>
bodies in other countries, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Further, a new court system recently became operational in the European Union. The Unified Patent Court (&#147;UPC&#148;) began accepting patent cases on June&nbsp;1,
2023. The UPC is a common patent court with jurisdiction over patent infringement and revocation proceedings effective for multiple member states of the European Union. The broad geographic reach of the UPC could enable third parties to seek
revocation of any of our European patents in a single proceeding at the UPC rather than through multiple proceedings in each of the individual European Union member states in which the European patent is validated. Under the UPC, a successful
revocation proceeding for a European Patent under the UPC would result in loss of patent protection in those European Union countries. Accordingly, a single proceeding under the UPC could result in the partial or complete loss of patent protection
in numerous European Union countries. Such a loss of patent protection could have a material adverse impact on our business and our ability to commercialize our technology and product candidates and, resultantly, on our business, financial
condition, prospects and results of operations. Moreover, the controlling laws and regulations of the UPC will develop over time and we cannot predict what the outcomes of cases tried before the UPC will be. The case law of the UPC may adversely
affect our ability to enforce or defend the validity of our European patents. Patent owners have the option to <FONT STYLE="white-space:nowrap">opt-out</FONT> their European Patents from the jurisdiction of the UPC, defaulting to <FONT
STYLE="white-space:nowrap">pre-UPC</FONT> enforcement mechanisms. We have decided to opt out certain European patents and patent applications from the UPC. However, if certain formalities and requirements are not met, our European patents and patent
applications could be subject to the jurisdiction of the UPC. We cannot be certain that our European patents and patent applications will avoid falling under the jurisdiction of the UPC, if we decide to opt out of the UPC. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may not be able to seek or obtain patent protection throughout the world or enforce such patent protection once obtained. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Filing, prosecuting, enforcing, and defending patents protecting our genome editing systems in all countries throughout the world would be prohibitively expensive, and
our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. The requirements for patentability may differ in certain countries, particularly in developing countries; thus, even
in countries where we do pursue patent protection, there can be no assurance that any patents will issue with claims that cover our products. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Moreover, our ability
to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in foreign intellectual property laws. Additionally, laws of some countries outside of the United States and Europe do not afford intellectual
property protection to the same extent as the laws of the United States and Europe. Many companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. This could make it
difficult for us to stop the infringement of our patents or the misappropriation of our other intellectual property rights. For example, many foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third
parties. Consequently, we may not be able to prevent third parties from practicing our inventions in certain countries outside the United States and Europe or from selling or importing products made from our inventions in and into the United States
or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop and market their own products and, further, may export otherwise infringing products to territories where we have
patent protection, if our ability to enforce our patents to stop infringing activities is inadequate. These products may compete with our products, and our patents or other intellectual property rights may not be effective or sufficient to prevent
them from competing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Proceedings to enforce our patent rights, whether successful or not, could result in substantial costs and divert our
efforts and resources from other aspects of our business. Further, such proceedings could put our patents at risk of being invalidated, held unenforceable or interpreted narrowly; put our pending patent applications at risk of not issuing; and
provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Furthermore, while we intend to protect our intellectual
property rights in major markets for our products, we cannot ensure that we will be able to initiate or maintain similar efforts in all jurisdictions in which we may wish to market our products, if approved. Accordingly, our efforts to protect our
intellectual property rights in such countries may be inadequate. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>In order to protect our competitive position around our future product candidates, we may
become involved in lawsuits to enforce our patents or other intellectual property, which could be expensive, time consuming and unsuccessful and which may result in our patents being found invalid or unenforceable. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Competitors may seek to commercialize competitive products to our genome editing systems. In order to protect our competitive position, we may become involved in
lawsuits asserting infringement of our patents, or misappropriation or other violations of other of our intellectual property rights. Litigation is expensive and time consuming and would likely divert the time and attention of our management and
scientific personnel. There can be no assurance that we will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for years before they are concluded. Even if we ultimately prevail in such
claims, the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh any benefit we receive as a result of the proceedings. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we file a patent infringement lawsuit against a perceived infringer, such a lawsuit could provoke the defendant to counterclaim that we infringe their patents and/or
that our patents are invalid and/or unenforceable. In patent litigation in the United States, it is commonplace for a defendant to counterclaim alleging invalidity and/or unenforceability. In any patent litigation there is a risk that a court will
decide that the asserted patents are invalid or unenforceable, in whole or in part, and that we do not have the right to stop the defendant from using the invention at issue. With respect to a counterclaim of invalidity, we cannot be certain that
there is no invalidating prior art of which we and the patent examiner were unaware during prosecution. There is also a risk that, even if the validity of such patents is upheld, the court will construe the patent claims narrowly or decide that we
do not have the right to stop the other party from using the invention at issue on the grounds that our patent claims do not cover the invention. If any of our patents are found invalid or unenforceable, or construed narrowly, our ability to stop
the other party from launching a competitive product would be materially impaired. Further, such adverse outcomes could limit our ability to assert those patents against future competitors. Loss of patent protection would have a material adverse
impact on our business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Even if we establish infringement of any of our patents by a competitive product, a court may decide not to grant an injunction against
further infringing activity, thus allowing the competitive product to continue to be marketed by the competitor. It is difficult to obtain an injunction in U.S. litigation and a court could decide that the competitor should instead pay us a
&#147;reasonable royalty&#148; as determined by the court, and/or other monetary damages. A reasonable royalty or other monetary damages may or may not be an adequate remedy. Loss of exclusivity and/or competition from a related product would have a
material adverse impact on our business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Litigation often involves significant amounts of public disclosures. Such disclosures could have a materially adverse
impact on our competitive position or our stock prices. During any litigation we would be required to produce voluminous records related to our patents and our research and development activities in a process called discovery. The discovery process
may result in the disclosure of some of our confidential information. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these
results to be negative, it could adversely affect the price of our common shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Litigation is inherently expensive, and the outcome is often uncertain. Any litigation likely would substantially
increase our operating losses and reduce our resources available for development activities. Further, we may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able
to sustain the costs of such litigation or proceedings more effectively than we can because of their substantially greater financial resources. As a result, we may conclude that even if a competitor is infringing any of our patents, the
risk-adjusted cost of bringing and enforcing such a claim or action may be too high or not in the best interest of our company or our stockholders. In such cases, we may decide that the more prudent course of action is to simply monitor the
situation or initiate or seek some other <FONT STYLE="white-space:nowrap">non-litigious</FONT> action or solution. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If in the future, we <FONT
STYLE="white-space:nowrap">in-license</FONT> any patent rights, we may not have the right to file a lawsuit for infringement and may have to rely on a licensor to enforce these rights for us. If we are not able to directly assert our licensed patent
rights against infringers or if a licensor does not vigorously prosecute any infringement claims on our behalf, we may have difficulty competing in certain markets where such potential infringers conduct their business, and our commercialization
efforts may suffer as a result. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Concurrently with an infringement litigation, third parties may also be able to challenge the validity of our patents before
administrative bodies in the United States or abroad. Such mechanisms include <FONT STYLE="white-space:nowrap">re-examination,</FONT> post grant review and equivalent proceedings in foreign jurisdictions, e.g., opposition proceedings. Such
proceedings could result in revocation or amendment of our patents in such a way that they no longer cover our products, potentially negatively impacting any concurrent litigation. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we are sued for infringing intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from
developing or commercializing our genome editing systems. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our commercial success depends, in part, on our ability to develop, manufacture, market and sell
our genome editing systems without infringing, misappropriating or otherwise violating the intellectual property and other proprietary rights of third parties. However, our research, development and commercialization activities may be subject to
claims that we infringe, misappropriate or otherwise violate patents or other intellectual property rights owned or controlled by third parties. Third parties may have U.S. and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> issued patents and
pending patent applications relating to compounds, methods of manufacturing compounds and/or methods of use for the treatment of the disease indications for which we are developing our genome editing systems. If any third-party patents or patent
applications are found to cover our genome editing systems, or their methods of use or manufacture, we may not be free to manufacture or market such genome editing systems as planned without obtaining a license, which may not be available on
commercially reasonable terms, or at all. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There is a substantial amount of intellectual property litigation in the biotechnology and pharmaceutical industries, and
we may become party to, or threatened with, litigation or other adversarial proceedings regarding intellectual property rights with respect to our genome editing systems, including patent infringement lawsuits in the U.S. or abroad. There may be
third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the composition, use or manufacture of our genome editing systems. Third parties may assert infringement
claims against us based on existing patents that they own or <FONT STYLE="white-space:nowrap">in-license</FONT> or patents that may grant to them (or which they may <FONT STYLE="white-space:nowrap">in-license)</FONT> in the future, regardless of the
merit of such patents or infringement claims. If our defenses to such assertions of infringement were unsuccessful, we could be liable for a court-determined reasonable royalty on our existing sales and further damages to the patent owner (or
licensee), such as lost profits. Such royalties and damages could be significant. If we are found to have willfully infringed the claims of a third party&#146;s patent, the third party could be awarded treble damages and attorney&#146;s fees.
Further, unless we obtain a license to such patent, we may be precluded from commercializing the infringing genome editing system. Any of the aforementioned could have a material adverse effect on our business, financial condition, results of
operations and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">While we perform periodic searches for relevant patents and patent applications with respect to our genome editing
systems, including Cas proteins and therapeutic applications, we cannot guarantee the completeness or thoroughness of any of our patent searches or analyses including, but not limited to, the identification of relevant patents, the scope of patent
claims or the expiration of relevant patents, nor can we be certain that we have identified each and every patent and pending application in the United States and abroad that is relevant to or necessary for the commercialization of any of our genome
editing systems in any jurisdiction. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that any of our genome editing systems may be accused of
infringing. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. Accordingly, third parties may assert infringement claims against us based on intellectual property rights
that exist now or arise in the future. The outcome of intellectual property litigation is subject to uncertainties that cannot be adequately quantified in advance. The pharmaceutical and biotechnology industries have produced a significant number of
patents, and it may not always be clear to industry participants, including us, which patents cover various types of products or methods of use or manufacture. The scope of protection afforded by a patent is subject to interpretation by the courts,
and the interpretation is not always uniform. If we were sued for patent infringement, we would need to demonstrate that the relevant product or methods of using the product either do not infringe the patent claims of the relevant patent or that the
patent claims are invalid or unenforceable, and we may not be able to do this. Proving invalidity is difficult. For example, in the United States, proving invalidity requires a showing of clear and convincing evidence to overcome the presumption of
validity enjoyed by issued patents. Even if we are successful in these proceedings, we may incur substantial costs and the time and attention of our management and scientific personnel could be diverted in pursuing these proceedings, which could
significantly harm our business and operating results. In addition, parties making claims against us may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources, and we
may not have sufficient resources to bring these actions to a successful conclusion. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Numerous third-party U.S. and foreign issued patents and pending patent
applications exist in the fields in which we are developing genome editing systems. Our genome editing systems make use of CRISPR-based technology, which is a field that is highly active for patent filings and complex litigation. As of June 2019, it
was reported that approximately 2072 patent families worldwide related to CRISPR genome editing inventions and their uses. That number has continued to increase. The extensive patent filings related to CRISPR make it difficult for us to assess the
full extent of relevant patents and pending applications that may cover our genome editing systems and their use or manufacture. There may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture
or methods for treatment related to the use or manufacture of our genome editing systems. We are aware of multiple patents and patent applications directed to CRISPR technologies, Cas molecules, and their uses in genome editing. For example, we are
aware of patent portfolios related to CRISPR/Cas genome editing systems that are owned or <FONT STYLE="white-space:nowrap">co-owned</FONT> by Sigma Aldrich, Stanford University and Agilent Technologies, the Broad Institute and/or Harvard University
and/or the Massachusetts Institute of Technology (&#147;MIT&#148;), and Targetgene Biotechnologies. We are also aware of patent portfolios related to base editing systems that are owned or <FONT STYLE="white-space:nowrap">co-owned</FONT> by Beam
Therapeutics, the Broad Institute and/or Harvard University and/or MIT, the University of California, Duke University, Kobe University, the Max Planck Institute, Wageningen University, and Bioray Laboratories. We are also aware of patent portfolios
related to CRISPR associated transposase/retro-transposase (&#147;CAST&#148;) systems that are owned or <FONT STYLE="white-space:nowrap">co-owned</FONT> by the Broad Institute, Arbor Biotechnologies, and the University of Rochester. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Intellectual property litigation is common in the biotechnology space and multiple parties have engaged in litigation to protect and enforce their CRISPR/Cas related
patent estates. For example, patents and patent applications directed to catalytically-active Cas9 systems have been the subject of extensive adversarial patent office proceedings. These proceedings include U.S. Patent and Trademark Office Patent
Trial and Appeal Board </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
(&#147;PTAB&#148;) proceedings involving the Broad Institute and the University of California regarding the priority of inventions with respect to certain U.S. patents and patent applications
each owns directed to catalytically-active Cas9. Our genome editing technologies do not use catalytically-active Cas9 and we are not aware of any third-party patents or patent applications that we believe cover our
<FONT STYLE="white-space:nowrap">Cas-related</FONT> genome editing system and proprietary technology. However, we may not have identified all relevant third-party patents and patent applications. Therefore, there can be no assurance that third
parties will not assert patents against us in the future or that our patents and patent applications will not be challenged. Any litigation brought against us or our patents or patent applications, even if meritless, could have a material adverse
effect on our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we are found to infringe, misappropriate or otherwise violate a third
party&#146;s intellectual property rights, we could be forced, including by court order, to cease developing, manufacturing or commercializing the infringing product. Alternatively, we may be required to obtain a license from such third party in
order to use the infringing technology and continue developing, manufacturing or marketing the infringing product. If we were required to obtain a license to continue to manufacture or market the affected product, we may be required to pay
substantial royalties or grant cross-licenses to our patents. Even if we were able to obtain a license, it could be nonexclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us. We cannot assure
you that any such license will be available on acceptable terms, if at all. Ultimately, we could be prevented from commercializing a product, or be forced to cease some aspect of our business operations as a result of claims of patent infringement
or violation of other intellectual property rights, Further, the outcome of intellectual property litigation is subject to uncertainties that cannot be adequately quantified in advance, including the demeanor and credibility of witnesses and the
identity of any adverse party. This is especially true in intellectual property cases that may turn on the testimony of experts as to technical facts upon which experts may reasonably disagree. Furthermore, we may not be able to obtain any required
license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> thereby giving our competitors access to the same technologies licensed to us;
alternatively or additionally it could include terms that impede or destroy our ability to compete successfully in the commercial marketplace. In addition, we could be found liable for significant monetary damages, including treble damages and
attorneys&#146; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing a product or force us to cease some of our business operations, which could harm our business. Claims that we
have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business. Furthermore, because of the substantial amount of discovery required in connection with intellectual property
litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have
material adverse effect on our ability to raise additional funds or otherwise have a material adverse effect on our business, results of operations, financial condition and prospects. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Others may challenge inventorship or claim an ownership interest in our intellectual property which could expose it to litigation and have a significant adverse
effect on its prospects. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Determinations of inventorship can be subjective. While we undertake to accurately identify correct inventorship of inventions made
on our behalf by our employees, consultants and contractors, an employee, consultant or contractor may disagree with our determination of inventorship and assert a claim of inventorship. Any disagreement over inventorship could result in our being
forced to defend our determination of inventorship in a legal action which could result in substantial costs and be a distraction to our senior management and scientific personnel. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">While we typically require employees, consultants and contractors who may develop intellectual property on our behalf to execute agreements assigning such intellectual
property to us, we may be unsuccessful in obtaining </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
execution of assignment agreements with each party who in fact develops intellectual property that we regard as our own. Moreover, even when we obtain agreements assigning intellectual property
to us, the assignment of intellectual property rights may not be self-executing or the assignment agreements may be breached. In either case, we may be forced to bring claims against third parties, or defend claims that they may bring against us, to
determine the ownership of what we regard as our intellectual property. Furthermore, individuals executing agreements with us may have preexisting or competing obligations to a third party, such as an academic institution, and thus an agreement with
us may be ineffective in perfecting ownership of inventions developed by that individual. If we are unsuccessful in obtaining assignment agreements from an employee, consultant or contractor who develops intellectual property on our behalf, the
employee, consultant or contractor may later claim ownership of the invention. Any disagreement over ownership of intellectual property could result in our losing ownership, or exclusive ownership, of the contested intellectual property, paying
monetary damages and/or being enjoined from clinical testing, manufacturing and marketing of the affected product candidate(s). Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs
and be a distraction to our senior management and scientific personnel. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may be subject to claims by third parties asserting that our employees or we have
misappropriated their intellectual property or claiming ownership of what we regard as our own intellectual property. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Many of our current and former
employees and our licensors&#146; current and former employees, including our senior management, were previously employed at universities or at other biotechnology or pharmaceutical companies, including some which may be competitors or potential
competitors. Although we take commercially reasonable steps to ensure that our employees do not use the proprietary information, <FONT STYLE="white-space:nowrap">know-how</FONT> or trade secrets of others in their work for us, including
incorporating such intellectual property into our genome editing systems, we may be subject to claims that we or these employees have misappropriated the intellectual property of a third party. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we or any of our employees are accused of misappropriating the proprietary information, <FONT STYLE="white-space:nowrap">know-how</FONT> or trade secrets of a third
party, we may be forced to defend such claims in litigation. If we are found to have misappropriated the intellectual property rights of a third party, we may be forced to pay monetary damages, sustain reputational damage, lose key personnel, or
lose valuable intellectual property rights. Further, it may become necessary for us to obtain a license from such third party to commercialize any of our genome editing systems. Such a license may not be available on commercially reasonable terms or
at all. Any of the aforementioned could materially affect the commercialization of any of our genome editing systems. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to
management. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We consider proprietary trade secrets or confidential <FONT STYLE="white-space:nowrap">know-how</FONT> and unpatented <FONT STYLE="white-space:nowrap">know-how</FONT> to
be important to our business. We may rely on trade secrets or confidential <FONT STYLE="white-space:nowrap">know-how</FONT> to protect our technology, especially where patent protection is believed by us to be of limited value. We expect to rely on
third parties for future manufacturing of our genome editing systems, and any future genome editing systems. We also expect to collaborate with third parties on the development of our genome editing systems and any future genome editing systems. As
a result of the aforementioned collaborations, we must, at times, share trade secrets with our collaborators. We also conduct joint research and development programs that may require us to share trade secrets under the terms of our research and
development partnerships or similar agreements. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Trade secrets or confidential <FONT STYLE="white-space:nowrap">know-how</FONT> can be difficult to maintain as
confidential. To protect this type of information against disclosure or appropriation by competitors, our policy is to require our employees, consultants, contractors and advisors to enter into confidentiality agreements and, if applicable, material
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
transfer agreements, consulting agreements or other similar agreements with us prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of
the third parties to use or disclose our confidential information, including our trade secrets. However, current or former employees, consultants, contractors and advisers may unintentionally or willfully disclose our confidential information to
competitors, and confidentiality agreements may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. The need to share trade secrets and other confidential information increases the risk that such trade
secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our <FONT
STYLE="white-space:nowrap">know-how</FONT> and trade secrets, a competitor&#146;s discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have an adverse effect on our business and results
of operations. Enforcing a claim that a third party obtained illegally and is using trade secrets or confidential <FONT STYLE="white-space:nowrap">know-how</FONT> is expensive, time consuming and unpredictable. The enforceability of confidentiality
agreements may vary from jurisdiction to jurisdiction. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, these agreements typically restrict the ability of our advisors, employees, third-party
contractors and consultants to publish data potentially relating to our trade secrets, although our agreements may contain certain limited publication rights. Despite our efforts to protect our trade secrets, our competitors may discover our trade
secrets, either through breach of our agreements with third parties, independent development or publication of information by any of our third-party collaborators. A competitor&#146;s discovery of our trade secrets would impair our competitive
position and have an adverse impact on our business. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may need to acquire or license additional intellectual property from third parties, and such licenses
may not be available or may not be available on commercially reasonable terms. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A third party may hold intellectual property, including patent rights that
are important or necessary to the development of our genome editing systems. It may be necessary for us to use the patented or proprietary technology of one or more third parties to commercialize our current and future product candidates. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies may pursue strategies to
license or acquire third-party intellectual property rights that we may consider attractive. These established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development. If we are unable to
acquire such intellectual property outright, or obtain licenses to such intellectual property from such third parties when needed or on commercially reasonable terms, our ability to commercialize our genome editing systems, if approved, would likely
be delayed or we may have to abandon development of that product genome editing systems or program and our business and financial condition could suffer. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If we <FONT
STYLE="white-space:nowrap">in-license</FONT> additional genome editing systems in the future, we might become dependent on proprietary rights from third parties with respect to those genome editing systems. Any termination of such licenses could
result in the loss of significant rights and would cause material adverse harm to our ability to develop and commercialize any genome editing systems subject to such licenses. Even if we are able to <FONT STYLE="white-space:nowrap">in-license</FONT>
any such necessary intellectual property, it could be on nonexclusive terms, including with respect to the use, field or territory of the licensed intellectual property, thereby giving our competitors and other third parties access to the same
intellectual property licensed to us. <FONT STYLE="white-space:nowrap">In-licensing</FONT> IP rights could require us to make substantial licensing and royalty payments. Patents licensed to us could be put at risk of being invalidated or interpreted
narrowly in litigation filed by or against our licensors or another licensee or in administrative proceedings. If any <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents are invalidated or held unenforceable, we may not be able to prevent
competitors or other third parties from developing and commercializing competitive products. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may not have the right to control the prosecution, maintenance,
enforcement or defense of patents and patent applications that we license from third parties. In such cases, we would be reliant on the licensor to take </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
any necessary actions. We cannot be certain that such licensor would act with our best interests in mind, or in compliance with applicable laws and regulations, or that their actions would result
in valid and enforceable patents. For example, it is possible that a licensor&#146;s actions in enforcing and/or defending a patent licensed by use may be less vigorous than had we conducted them ourselves. Any of the foregoing could have a material
adverse effect on our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Disputes may also arise between us and our licensors regarding
intellectual property subject to a license agreement, including: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the scope of rights granted under the license agreement and other interpretation-related issues; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our financial or other obligations under the license agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">whether and the extent to which our technology and processes infringe intellectual property of the licensor that is not
subject to the licensing agreement; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our right to sublicense patent and other rights to third parties under collaborative development relationships;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our diligence obligations with respect to the use of licensed technology in relation to our development and
commercialization of our genome editing systems and what activities satisfy those diligence obligations; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the ownership of inventions and <FONT STYLE="white-space:nowrap">know-how</FONT> resulting from the joint creation or use
of intellectual property by our licensors and us and our partners; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the priority of invention of patented technology. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be
unable to successfully develop and commercialize the affected genome editing systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The risks described elsewhere pertaining to our intellectual property rights
also apply to the intellectual property rights that we may own or <FONT STYLE="white-space:nowrap">in-license</FONT> now or in the future, and any failure by us or our licensors to obtain, maintain, defend and enforce these rights could have an
adverse effect on our business. In some cases we may not have control over the prosecution, maintenance or enforcement of the patents that we license, and may not have sufficient ability to provide input into the patent prosecution, maintenance and
defense process with respect to such patents, and potential future licensors may fail to take the steps that we believe are necessary or desirable in order to obtain, maintain, defend and enforce the licensed patents. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our trademarks of interest and our business
may be adversely affected. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on
other marks. We rely on both registration and common law protection for our trademarks. As a means to enforce our trademark rights and prevent infringement, we may be required to file trademark claims against third parties or initiate trademark
opposition proceedings. This can be expensive and time-consuming, particularly for a company of our size. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name
recognition by potential partners or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In
addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be
adversely affected. During trademark registration proceedings, we may receive rejections. Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in
comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our
trademarks, and our trademarks may not survive such proceedings. Moreover, any name we propose to use for our products in the United States must be approved by the FDA, regardless of whether we have registered it, or applied to register it, as a
trademark. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. If the FDA objects to any of our proposed product names, we may be required to expend significant
additional resources in an effort to identify a usable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. If we are unable to establish name recognition
based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Intellectual property rights do
not necessarily address all potential threats to our business. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The degree of future protection afforded by our intellectual property rights is uncertain
because intellectual property rights have limitations, and may not adequately protect our business, or permit us to maintain our competitive advantage. The following examples are illustrative: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">others may be able to make products that are competitive to our genome editing systems or any of our future genome editing
systems but that are not covered by the claims of our patent portfolio; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">others may independently develop similar or alternative technologies or otherwise circumvent any of our technologies
without infringing our patent portfolio; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we or any of our collaborators might not have been the first to invent the inventions covered by our patent portfolio;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we or any of our collaborators might not have been the first to file patent applications covering certain of the patents or
patent applications that we or they own or have obtained a license, or will own or will have obtained a license; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">it is possible that our pending patent applications or those that we may file in the future will not lead to issued
patents; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">others may have access to the same intellectual property rights licensed to us on a
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> basis in the future; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">issued patents that we own may not provide us with any competitive advantage, or may be held invalid or unenforceable,
including as a result of legal challenges by our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our competitors might conduct research and development activities in countries where we do not have patent rights, or in
countries where research and development safe harbor laws exist, and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">ownership of our patent portfolio may be challenged by third parties; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the patents of third parties or pending or future applications of third parties, if issued, may have an adverse effect on
our business; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">patent enforcement is expensive and time-consuming and difficult to predict; thus, we may not be able to enforce any of our
patents against a competitor; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we may choose not to file a patent application for certain inventions, instead choosing to rely on trade secret protection,
and a third party may subsequently file a patent covering such intellectual property. </P></TD></TR></TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Risks Related to the Offering, our Common Stock, and
Operating as a Public Company </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>You will incur immediate and substantial dilution as a result of this offering. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If you purchase common stock in this offering, you will incur immediate and substantial dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share,
representing the difference between the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the estimated midpoint of the price range set forth on the cover page of this prospectus, and our pro forma
as adjusted net tangible book value per share as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2023 after giving effect to this offering. To the extent the underwriters exercise their option to
purchase additional shares or our restricted common stock issued in the Reorganization vests, you will incur further dilution. For a further description of the dilution you will experience immediately after this offering, see &#147;Dilution.&#148;
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The market price of our common stock may be volatile, which could result in substantial losses for investors purchasing shares in this offering. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The initial public offering price for our common stock was determined through negotiations with the underwriters. This initial public offering price may vary from the
market price of our common stock after the offering. As a result, you may not be able to sell your common stock at or above the initial public offering price. The market price for our common stock may be influenced by those factors discussed in this
&#147;Risk Factors&#148; section and many others, some of which may include: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the success of existing or new competitive product candidates or technologies; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the timing and results of preclinical studies and clinical trials for any product candidates we may develop;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">failure or discontinuation of any of our development and research programs; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">results of any preclinical studies, clinical trials or regulatory approvals of product candidates of our competitors, or
announcements about new research programs or product candidates of our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">developments or changing views regarding the use of genetic therapies, including those that involve genome editing;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">commencement or termination of collaborations for our product development and research programs; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">regulatory or legal developments in the United States and other countries; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">developments or disputes concerning patent applications, issued patents or other intellectual property or proprietary
rights; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the recruitment or departure of key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the level of expenses related to any of our research programs, clinical development programs or product candidates that we
may develop; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the results of our efforts to develop product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities
analysts, if any, that cover our stock; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">announcement or expectation of additional financing efforts; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">sales of our common stock by us, our insiders or other stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">expiration of market <FONT STYLE="white-space:nowrap">stand-off</FONT> or <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreements; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">variations in our financial results or those of companies that are perceived to be similar to us; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">changes in the structure of healthcare payment systems; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">market conditions in the pharmaceutical and biotechnology sectors; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">general economic, industry and market conditions, including <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the
ongoing geopolitical conflict in Ukraine and the Israel-Hamas war, tensions in U.S.-China relations, rising interest rates and inflation; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the other factors described in this &#147;Risk Factors&#148; section. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In recent years, the stock market in general and the market for pharmaceutical and biotechnology companies in particular, has experienced extreme price and volume
fluctuations that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations. In particular, in relation to uncertainty around inflation and
the U.S. Federal Reserve&#146;s measures to slow inflation, the stock market has been exceptionally volatile. Market and industry factors may seriously affect the market price of our common stock, regardless of our actual operating performance.
These fluctuations may be even more pronounced in the trading market for our stock shortly following this offering. Following periods of such volatility in the market price of a company&#146;s securities, securities class action litigation has often
been brought against that company. Because of the potential volatility of our stock price, we may become the target of securities litigation in the future. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Securities litigation could result in substantial costs and divert management&#146;s attention and resources from our business. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We have wide discretion in the use of the net proceeds from this offering and may not use them effectively. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We cannot specify with certainty the particular uses of the net proceeds we will receive from this offering. Our management will have wide discretion in the application
of the net proceeds, including for any of the purposes described in &#147;Use of Proceeds.&#148; Accordingly, you will have to rely upon the judgment of our management with respect to the use of the proceeds, with only limited information concerning
management&#146;s specific intentions. Our management may spend a portion or all of the net proceeds from this offering in ways that our stockholders may not desire or that may not yield a favorable return. The failure by our management to apply
these funds effectively could harm our business, financial condition, results of operations and prospects. Pending their use, we may invest the net proceeds from this offering in a manner that does not produce income or that loses value. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance
initiatives and corporate governance practices. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As a public company, and particularly after we are no longer an &#147;emerging growth company,&#148; we will
incur significant legal, accounting and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act of 2002 (&#147;SOX&#148;), the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of the
Nasdaq Global Select Market and other applicable securities rules and regulations impose </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. We expect that we will need to
hire additional accounting, finance and other personnel in connection with our becoming, and our efforts to comply with the requirements of being, a public company. Our management and other personnel will need to devote a substantial amount of time
towards maintaining compliance with these requirements. These requirements will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that the rules and regulations
applicable to us as a public company may make it more difficult and more expensive for us to obtain director and officer liability insurance, which could make it more difficult for us to attract and retain qualified members of our board of
directors. We are currently evaluating these rules and regulations and cannot predict or estimate the amount of additional costs we may incur or the timing of such costs. These rules and regulations are often subject to varying interpretations, in
many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance
matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to SOX Section&nbsp;404, we will be required to furnish
a report by our management on our internal control over financial reporting beginning with our second filing of an Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> with the SEC after we become a public company. However, while we
remain an emerging growth company, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with SOX Section&nbsp;404
within the prescribed period, we will be engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources,
potentially engage outside consultants, adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls
are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude, within the prescribed timeframe or
at all, that our internal control over financial reporting is effective as required by SOX Section&nbsp;404. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial
statements. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We do not know whether a market will develop for our common stock or what the market price of our common stock will be, and, as a result, it may
be difficult for you to sell your shares of our common stock. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Before this offering, there was no public trading market for our common stock. Although we
have applied to list our common stock on the Nasdaq Global Select Market, an active trading market for our shares may never develop or be sustained following this offering. If a market for our common stock does not develop or is not sustained, it
may be difficult for you to sell your shares of common stock at an attractive price or at all. We cannot predict the prices at which our common stock will trade. It is possible that in one or more future periods our results of operations may be
below the expectations of public market analysts and investors, and, as a result of these and other factors, the price of our common stock may fall. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If
securities analysts do not publish research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The trading market for our common stock will rely in part on the research and reports that industry or financial analysts publish about us or our business. We do not
currently have and may never obtain research coverage by industry or financial analysts. If no or few analysts commence coverage of us, the trading price of our stock would likely decrease. Even if we do obtain analyst coverage, if one or more of
the analysts covering our business downgrade their evaluations of our stock, the price of our stock could decline. If one or more of these analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could
cause our stock price to decline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Future sales of our common stock in the public market could cause our stock price to fall. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our stock price could decline as a result of sales of a large number of shares of our common stock after this offering or the perception that these sales could occur.
These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon completion of this offering,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock will be
outstanding (or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock will be outstanding assuming exercise in full of the underwriters&#146; option to purchase additional shares),
based on our shares outstanding as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024. All shares of common stock expected to be sold in this offering will be freely tradable without restriction
or further registration under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), unless held by our &#147;affiliates,&#148; as that term is defined in Rule&nbsp;144 under the Securities Act. The resale of the
remaining&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, or approximately&nbsp;&nbsp;&nbsp;&nbsp;% of our outstanding shares after this offering, is currently prohibited or otherwise restricted as a
result of securities law provisions, market standoff agreements entered into by our stockholders with us, profits interests agreements entered into by our employees with us, unit purchase agreement lock-ups, or
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreements entered into by our stockholders with the underwriters. However, subject to applicable securities law restrictions and excluding shares of restricted common stock that will remain unvested,
these shares will be able to be sold in the public market beginning 180&nbsp;days after the date of this prospectus. Shares of unvested restricted common stock that were issued and outstanding as of the date of this prospectus will become available
for sale immediately upon the vesting of such shares, as applicable, and the expiration of any applicable market <FONT STYLE="white-space:nowrap">stand-off</FONT> or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. Shares issued upon the
exercise of stock options pursuant to future awards that may be granted under our equity incentive plans or pursuant to future awards granted under those plans will become available for sale in the public market to the extent permitted by the
provisions of applicable vesting schedules, any applicable market <FONT STYLE="white-space:nowrap">stand-off</FONT> and <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and Rule 144 and Rule 701 under the Securities Act. For more
information see the section entitled &#147;Shares Eligible for Future Sale&#148; included elsewhere in this prospectus. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon completion of this offering, the
holders of approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares, or approximately&nbsp;&nbsp;&nbsp;&nbsp;%, of our common stock, will have rights, subject to some conditions, to require
us to file registration statements covering the sale of their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We also intend to register the offer and sale of all shares of common
stock that we may issue under our equity compensation plans. Once we register the offer and sale of shares for the holders of registration rights and shares to be issued under our equity incentive plans, they can be freely sold in the public market
upon issuance, subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described in the section entitled &#147;Underwriting&#148; included elsewhere in this prospectus. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, in the future, we may issue additional shares of common stock or other equity or debt securities convertible into common stock in connection with a
financing, acquisition, litigation settlement, employee arrangements or otherwise. Any such issuance could result in substantial dilution to our existing stockholders and could cause our stock price to decline. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are an &#147;emerging growth company&#148; and the reduced disclosure requirements applicable to emerging growth companies may make our common stock less
attractive to investors. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#147;JOBS
Act&#148;), and may remain an emerging growth company for up to five years. For so long as we remain an emerging growth company, we are permitted and plan to rely on exemptions from certain disclosure requirements that are applicable to other public
companies that are not emerging growth companies. These exemptions include not being required to comply with the auditor attestation requirements of SOX Section&nbsp;404, not being required to comply with any requirement for a supplement to the
auditor&#146;s report providing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
additional information about the audit and the financial statements, reduced disclosure obligations regarding executive compensation and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, the information we provide stockholders will be different than the information that is available with respect to
other public companies. In this prospectus, we have not included all of the executive compensation related information that would be required if we were not an emerging growth company. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting
standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption, and, therefore, while we
are an emerging growth company we will not be subject to the new or revised accounting standards at the same time that they become applicable to other public companies that are not emerging growth companies. As a result of this election, our
financial statements may not be comparable to those of other public companies that comply with new or revised accounting pronouncements as of public company effective dates. We may choose to early adopt any new or revised accounting standards
whenever such early adoption is permitted for private companies. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We cannot predict whether investors will find our common stock less attractive if we rely on these
exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Insiders will continue to have substantial influence over us after this offering, which could limit your ability to affect the outcome of key transactions,
including a change of control. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">After this offering, our directors and executive officers and their affiliates will beneficially own shares representing
approximately&nbsp;&nbsp;&nbsp;&nbsp;% percent of our outstanding common stock. As a result, these stockholders, if they act together, will be able to influence our management and affairs and all matters requiring stockholder approval. For example,
these stockholders may be able to control elections of directors, amendments of our organizational documents or approval of any merger, sale of assets or other major corporate transaction. This concentration of ownership may have the effect of
delaying or preventing a change in control of our company and might affect the market price of our common stock. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We do not expect to pay any dividends for the
foreseeable future. Investors in this offering may never obtain a return on their investment. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">You should not rely on an investment in our common stock to
provide dividend income. We do not anticipate that we will pay any dividends to holders of our common stock in the foreseeable future. Instead, we plan to retain any earnings to maintain and expand our existing operations. In addition, any future
credit facility may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on our common stock. Accordingly, investors must rely on sales of their common stock after price appreciation, which may never occur, as
the only way to realize any return on their investment. As a result, investors seeking cash dividends should not purchase our common stock. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we fail to
establish and maintain proper and effective internal control over financial reporting, our operating results and our ability to operate our business could be harmed. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis
is a costly and time-consuming effort that needs to be <FONT STYLE="white-space:nowrap">re-evaluated</FONT> frequently. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
in accordance with generally accepted accounting principles. In connection with this offering, we intend to begin the process of documenting, reviewing and improving our internal controls and
procedures for compliance with SOX Section&nbsp;404, which will require annual management assessment of the effectiveness of our internal control over financial reporting starting with our second filing of an Annual Report on Form 10-K. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Implementing any appropriate changes to our internal controls may distract our officers and employees, entail substantial costs to modify our existing processes and take
significant time to complete. These changes may not, however, be effective in maintaining the adequacy of our internal controls, and any failure to maintain that adequacy or consequent inability to produce accurate financial statements on a timely
basis could increase our operating costs and harm our business. In addition, investors&#146; perceptions that our internal controls are inadequate or that we are unable to produce accurate financial statements on a timely basis cause investors to
lose confidence in the accuracy and completeness of our financial reports and could cause the market price of our common stock to decline significantly. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our
disclosure controls and procedures may not prevent or detect all errors or acts of fraud. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon the closing of this offering, we will become subject to the
periodic reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to
management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how
well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These inherent limitations
include the facts that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people
or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our amended and restated bylaws that will become effective upon the effectiveness of our registration statement designate specific courts as the exclusive forum
for certain litigation that may be initiated by our stockholders, which could limit stockholders&#146; ability to obtain a favorable judicial forum for disputes with us. </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to our amended and restated bylaws that will become effective upon the effectiveness of our registration statement, unless we consent in writing to the
selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for any state law claims for (i)&nbsp;any derivative action or proceeding brought on our behalf; (ii)&nbsp;any action asserting a claim
of or based on a breach of a fiduciary duty owed by any director, officer or other employee of ours to us or our stockholders; (iii)&nbsp;any action asserting a claim pursuant to any provision of the DGCL, our amended and restated certificate of
incorporation or our amended and restated bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; or (iv)&nbsp;any action asserting a claim governed by the internal affairs doctrine (the &#147;Delaware
Forum Provision&#148;). The Delaware Forum Provision will not apply to any causes of action arising under the Securities Act or the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). Our amended and restated bylaws further
provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the
Securities Act, the Exchange Act, the respective rules and regulations promulgated thereunder or the Federal Forum Provision. In addition, our amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any
interest in shares of our capital stock is deemed to have notice of and consented to the Delaware Forum Provision and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations
thereunder. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We recognize that the Delaware Forum Provision and the Federal Forum Provision in our amended and restated bylaws may impose additional litigation costs
on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware. Additionally, the forum selection clauses in our amended and restated bylaws may limit our stockholders&#146; ability to
bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage the filing of lawsuits against us and our directors, officers and employees, even though an action, if
successful, might benefit our stockholders. In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court are
&#147;facially valid&#148; under Delaware law, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. If the Federal Forum Provision is found to be unenforceable, we may incur additional costs associated with
resolving such matters. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid. The Court of Chancery of the State of Delaware and the federal district
courts of the United States may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be
more or less favorable to us than our stockholders. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Provisions in our amended and restated certificate of incorporation and amended and restated bylaws that
will become effective upon the effectiveness of our registration statement and Delaware law may have anti-takeover effects that could discourage an acquisition of us by others, even if an acquisition would be beneficial to our stockholders, and may
prevent attempts by our stockholders to replace or remove our current management. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our amended and restated certificate of incorporation and amended and
restated bylaws that will become effective upon the effectiveness of our registration statement and Delaware law contain provisions that may have the effect of discouraging, delaying or preventing a change in control of us or changes in our
management that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. Our amended and restated certificate of incorporation, which will become effective immediately prior to the
closing of this offering, and amended and restated bylaws, which will become effective upon the effectiveness of the registration statement of which this prospectus is a part, include provisions that: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">authorize &#147;blank check&#148; preferred stock, which could be issued by our board of directors without stockholder
approval and may contain voting, liquidation, dividend and other rights superior to our common stock; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">create a classified board of directors whose members serve staggered three-year terms; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">specify that special meetings of our stockholders can be called only by our board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">prohibit stockholder action by written consent; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders,
including proposed nominations of persons for election to our board of directors; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though
less than a quorum; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">provide that our directors may be removed only for cause; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">specify that no stockholder is permitted to cumulate votes at any election of directors; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">expressly authorized our board of directors to make, alter, amend or repeal our amended and restated bylaws; and
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">require supermajority votes of the holders of our common stock to amend specified provisions of our amended and restated
certificate of incorporation and amended and restated bylaws. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These provisions, alone or together, could delay or prevent hostile takeovers and
changes in control or changes in our management. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, because we are incorporated in the State of Delaware, we are governed by the provisions of Section&nbsp;203 of the DGCL, which prohibits a person who owns
in excess of 15&nbsp;percent of our outstanding voting stock from merging or combining with us for a period of three years after the date of the transaction in which the person acquired in excess of 15&nbsp;percent of our outstanding voting stock,
unless the merger or combination is approved in a prescribed manner. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any provision of our amended and restated certificate of incorporation, amended and restated
bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock and could also affect the price that some investors
are willing to pay for our common stock. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Adverse developments affecting the financial services industry could adversely affect our current and projected
business operations and our financial condition and results of operations. </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Adverse developments that affect financial institutions, such as events involving
liquidity that are rumored or actual, have in the past and may in the future lead to bank failures and market-wide liquidity problems. For example, on March&nbsp;10, 2023, Silicon Valley Bank (&#147;SVB&#148;) was closed by the California Department
of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#147;FDIC&#148;) as receiver. Similarly, on March&nbsp;12, 2023, Signature Bank was also swept into receivership. The U.S. Department of Treasury,
the Federal Reserve Board (the &#147;Federal Reserve&#148;), and the FDIC released a statement that indicated that all depositors of SVB would have access to all of their funds, including funds held in uninsured deposit accounts, after only one
business day of closure. The U.S. Department of Treasury, FDIC and Federal Reserve have announced a program to provide up to $25&nbsp;billion of loans to financial institutions secured by certain of such government securities held by financial
institutions to mitigate the risk of potential losses on the sale of such instruments, widespread demands for customer withdrawals or other liquidity needs of financial institutions for immediately liquidity may exceed the capacity of such program.
There is no guarantee, however, that the U.S. Department of Treasury, FDIC and Federal Reserve will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions, or that they would do so in a
timely fashion. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">At this time, we hold substantially all of our cash on deposit at SVB (which has been assumed by First Citizens) and we have not experienced any
adverse impact to our current and projected business operations, financial condition or results of operations as a result of the closure of SVB or any other banks. We plan to diversify our cash deposit holdings between multiple financial
institutions. However, uncertainty remains over liquidity concerns in the broader financial services industry, and our business, our business partners, or industry as a whole may be adversely impacted in ways that we cannot predict at this time. If,
for example, other banks and financial institutions enter receivership or become insolvent in the future in response to financial conditions affecting the banking system and financial markets, our ability to access our existing cash, cash
equivalents and available-for-sale marketable securities may be threatened. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Although we expect to assess our banking relationships as we believe necessary or
appropriate, our access to cash in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we have banking
relationships, and in turn, us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or
arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could also include factors
involving financial markets or the financial services industry generally. The results of events or concerns that involve one or more of these factors could include a variety of material and adverse impacts on our current and projected business
operations and our financial condition and results of operations. These could include, but may not be limited to, delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets; or termination of
cash management arrangements and/or delays in accessing or actual loss of funds subject to cash management arrangements. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, widespread investor concerns
regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and
liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to
meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our financial and/or contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any
other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our current and/or projected business operations and financial condition and
results of operations. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, one or more of our critical vendors, third party manufacturers, or other business partners could be adversely affected by any of
the liquidity or other risks that are described above, which in turn, could have a material adverse effect on our current and/or projected business operations and results of operations and financial condition. Any business partner bankruptcy or
insolvency, or any breach or default by a business partner, or the loss of any significant supplier relationships, could result in material adverse impacts on our current and/or projected business operations and financial condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_5"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This prospectus, including the sections entitled &#147;Prospectus Summary,&#148; &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations,&#148; and &#147;Business,&#148; contains express or implied forward-looking statements that are based on our management&#146;s belief and assumptions and on information currently available to our management.
Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties
and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements in
this prospectus include, but are not limited to, statements about: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the initiation, timing, progress and results of our research and development programs, preclinical studies and future
clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to demonstrate, and the timing of, preclinical
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> <I>in vivo</I> and <I>ex vivo </I>for multiple programs; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to advance any product candidates that we may identify and successfully complete any clinical studies,
including the manufacture of any such product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to quickly leverage programs within our initial target indications and to progress additional programs to
further develop our pipeline; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the timing of our IND applications submissions; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the implementation of our strategic plans for our business, programs and technology; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our genome editing
technology and platform; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">developments related to our competitors and our industry; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to leverage the clinical, regulatory, and manufacturing advancements made by genome editing programs to
accelerate our clinical trials and approval of product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to identify and enter into future license agreements and collaborations; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">developments related to our genome editing technology and platform; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">regulatory developments in the United States and foreign countries; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to attract and retain key scientific and management personnel; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our use of proceeds from this offering, estimates of our expenses, capital requirements, and needs for additional
financing. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In some cases, you can identify forward-looking statements by terminology such as &#147;may,&#148; &#147;should,&#148;
&#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;predicts,&#148; &#147;potential,&#148; &#147;continue&#148; or the negative of these terms or other comparable
terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond our control and
which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the section entitled &#147;Risk Factors&#148; and elsewhere in this
prospectus. If one or more of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking
statements. No forward-looking statement is a guarantee of future performance. You should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement, of which
this prospectus forms a part, completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The forward-looking statements in this prospectus represent our views as of the date of this prospectus. We anticipate that subsequent events and developments will cause
our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should therefore not rely on these
forward-looking statements as representing our views as of any date subsequent to the date of this prospectus. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This prospectus also contains estimates, projections
and other information concerning our industry, our business and the markets for our product candidates. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties
and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market, and other data from our own internal
estimates and research as well as from reports, research surveys, studies, and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources. While we are not
aware of any misstatements regarding any third-party information presented in this prospectus, their estimates, in particular, as they relate to projections, involve numerous assumptions, are subject to risks and uncertainties and are subject to
change based on various factors, including those discussed under the section entitled &#147;Risk Factors&#148; and elsewhere in this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_6"></A>REORGANIZATION </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Prior to the effectiveness of this registration statement, we intend to engage in a series of transactions pursuant to which Metagenomi Technologies, LLC, the sole
stockholder and holding company parent of Metagenomi, Inc., will merge with and into Metagenomi, Inc., and Metagenomi, Inc. will continue to exist as the surviving corporation. Throughout this prospectus, we refer to these transactions and the
related transactions enumerated below collectively as the &#147;Reorganization.&#148; To consummate the Reorganization, we will file a certificate of merger and amended and restated certificate of incorporation with the Secretary of State of the
State of Delaware. In connection with the Reorganization: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding Series <FONT STYLE="white-space:nowrap">A-1</FONT> redeemable
convertible preferred units (&#147;Series&nbsp;A-1 preferred units&#148;) will receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;share of <FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT>
redeemable convertible preferred stock (&#147;Series&nbsp;A-1 preferred stock&#148;) of Metagenomi, Inc. for each Series <FONT STYLE="white-space:nowrap">A-1</FONT> preferred unit held immediately prior to the Reorganization, with an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series <FONT STYLE="white-space:nowrap">A-1</FONT> redeemable convertible preferred stock issued in the Reorganization;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding Series <FONT STYLE="white-space:nowrap">A-2</FONT> redeemable
convertible preferred units (&#147;Series&nbsp;A-2 preferred units&#148;) will receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;share of Series <FONT STYLE="white-space:nowrap">A-2</FONT>
redeemable convertible preferred stock <FONT STYLE="white-space:nowrap">(&#147;Series&nbsp;A-2</FONT> preferred stock&#148;) of Metagenomi, Inc. for each Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred unit held immediately prior to the
Reorganization, with an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series <FONT STYLE="white-space:nowrap">A-2</FONT> redeemable convertible preferred stock issued in the
Reorganization; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding Series <FONT STYLE="white-space:nowrap">A-3</FONT> redeemable
convertible preferred units (&#147;Series&nbsp;A-3 preferred units&#148;) will receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;share of Series <FONT STYLE="white-space:nowrap">A-3</FONT>
redeemable convertible preferred stock <FONT STYLE="white-space:nowrap">(&#147;Series&nbsp;A-3</FONT> preferred stock&#148;) of Metagenomi, Inc. for each Series <FONT STYLE="white-space:nowrap">A-3</FONT> preferred unit held immediately prior to the
Reorganization, with an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series <FONT STYLE="white-space:nowrap">A-3</FONT> redeemable convertible preferred stock issued in the
Reorganization; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding Series <FONT STYLE="white-space:nowrap">A-4</FONT> redeemable
convertible preferred units (&#147;Series&nbsp;A-4 preferred units&#148;) will receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;share of Series <FONT STYLE="white-space:nowrap">A-4</FONT>
redeemable convertible preferred stock <FONT STYLE="white-space:nowrap">(&#147;Series&nbsp;A-4</FONT> preferred stock&#148;) of Metagenomi, Inc. for each Series <FONT STYLE="white-space:nowrap">A-4</FONT> preferred unit held immediately prior to the
Reorganization, with an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our <FONT STYLE="white-space:nowrap">Series&nbsp;A-4</FONT> redeemable convertible preferred stock issued
in the Reorganization; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable
convertible preferred units (&#147;Series&nbsp;A-5 preferred units&#148;) will receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;share of Series <FONT STYLE="white-space:nowrap">A-5</FONT>
redeemable convertible preferred stock <FONT STYLE="white-space:nowrap">(&#147;Series&nbsp;A-5</FONT> preferred stock&#148;) of Metagenomi, Inc. for each Series <FONT STYLE="white-space:nowrap">A-5</FONT> preferred unit held immediately prior to the
Reorganization, with an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred stock issued in the
Reorganization; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding Series B redeemable convertible preferred units
(&#147;Series&nbsp;B preferred units&#148;) will receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;share of Series B redeemable convertible preferred stock (&#147;Series&nbsp;B preferred
stock&#148;) of Metagenomi, Inc. for each Series B preferred unit held immediately prior to the Reorganization, with an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series
B redeemable convertible preferred stock issued in the Reorganization; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable
convertible preferred units (&#147;Series&nbsp;B-1 preferred units&#148;) will receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;share of Series <FONT STYLE="white-space:nowrap">B-1</FONT>
redeemable convertible preferred stock (&#147;Series&nbsp;B-1 preferred stock&#148;) of Metagenomi, Inc. for each Series <FONT STYLE="white-space:nowrap">B-1</FONT> preferred unit held immediately prior to the Reorganization, with an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred stock issued in the Reorganization;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding common units will
receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock of Metagenomi, Inc. for each common unit held immediately prior to the Reorganization, with an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock (which includes
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of unvested restricted common stock) issued in the Reorganization; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">holders of Metagenomi Technologies, LLC&#146;s outstanding profits interests will
receive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock of Metagenomi, Inc. for each profits interest held immediately prior to the Reorganization, with an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock issued (which
includes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of unvested restricted common stock) in the Reorganization. Vesting terms of outstanding profits interests will
not change. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi, Inc.&#146;s Series <FONT STYLE="white-space:nowrap">A-1</FONT> preferred stock, Series
<FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock, Series <FONT STYLE="white-space:nowrap">A-3</FONT> preferred stock, Series <FONT STYLE="white-space:nowrap">A-4</FONT> preferred stock, Series <FONT STYLE="white-space:nowrap">A-5</FONT>
preferred stock, and Series B preferred stock and Series <FONT STYLE="white-space:nowrap">B-1</FONT> preferred stock will be designated as preferred stock under Metagenomi, Inc.&#146;s amended and restated certificate of incorporation. All
outstanding shares of our redeemable convertible preferred stock will be convertible into shares of common stock on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;basis.</FONT></FONT> </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with the Reorganization, by operation of law, Metagenomi, Inc. will acquire all assets of Metagenomi Technologies, LLC, and assume all of its liabilities
and obligations. The purpose of the Reorganization is to reorganize our corporate structure so that Metagenomi, Inc. will continue as a corporation and the existing investors of Metagenomi Technologies, LLC will own Metagenomi, Inc. capital stock
rather than members&#146; equity interests in Metagenomi Technologies, LLC. The Reorganization generally is intended to not result in a taxable event to Metagenomi, Inc. for U.S. income tax purposes. Except as context otherwise requires, all
information included in this prospectus is presented giving effect to the Reorganization. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We estimate that the net proceeds to us from the sale of shares of our common stock in this offering will be approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million if the underwriters exercise in full their option to purchase additional shares, assuming an initial public offering
price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the estimated midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated
offering expenses payable by us. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A $1.00 increase (decrease) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
share, the estimated midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the net proceeds to us from this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming the number of
shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. An increase (decrease) of 1,000,000 shares
in the number of shares offered by us, as set forth on the cover page of this prospectus, would increase (decrease) net proceeds to us from this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming no change in the assumed
initial public offering price per share, the estimated midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We
do not expect that a change in the offering price or the number of shares by these amounts would have a material effect on our intended uses of the net proceeds from this offering, although it may impact the amount of time prior to which we may need
to seek additional capital. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September 30, 2023, we had cash and cash equivalents and available-for-sale marketable securities of $292.9&nbsp;million. We
currently intend to use the net proceeds from this offering, together with our existing cash and cash equivalents and available-for-sale marketable securities, as follows: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million for
continued research and development of our therapeutic portfolio, including preclinical studies and advancement through potential preclinical proof-of-concept; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million for
IND-enabling studies and potential initiation of clinical studies for certain of our current programs; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million to
advance our gene editing platform discovery and early-stage research for other potential programs; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million to
advance manufacturing capabilities to support early stage clinical development; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the remainder for general corporate purposes. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Based on our current plans, we believe our existing cash and cash equivalents and available-for-sale marketable securities, together with the net proceeds from this
offering, will be sufficient to fund our operations and capital expenditure requirements into&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">All of our programs are currently in preclinical stage of development. The expected use of the net proceeds from this offering represents our intentions based upon our
current plans and business conditions, which could change in the future as our plans and business conditions evolve. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received
upon the closing of this offering or the amounts that we will actually spend on the uses set forth above. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the progress of our research
and development, the status of and results from <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies or clinical trials we may commence in the future, as well as any collaborations that we may enter into with third parties for our product
candidates or strategic opportunities that become available to us, and any unforeseen cash needs. As a result, our management will retain broad discretion over the allocation of the net proceeds from this offering. We expect the net proceeds from
this offering, together with our existing cash and cash equivalents, and available-for-sale marketable securities, will not be sufficient for us to advance any of our programs through regulatory approval, and we will need to raise additional capital
to complete the development and potential commercialization of any of our programs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pending our use of proceeds from this offering, we intend to invest the net
proceeds in a variety of capital preservation instruments, including short-term, investment-grade, interest-bearing financial instruments and U.S. government securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_8"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have never declared or paid any cash dividends on our members&#146; capital. We currently intend to retain any future earnings to fund the development and expansion
of our business, and therefore we do not anticipate paying cash dividends on our common stock in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our results of
operations, financial condition, capital requirements and other factors deemed relevant by our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_9"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table sets forth our cash, cash equivalents, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable
securities and our capitalization as of September&nbsp;30, 2023: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">on an actual basis; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">on a pro forma basis to give effect to (i)&nbsp;the Reorganization, (ii)&nbsp;the conversion of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our redeemable convertible preferred stock, issued in connection with the Reorganization in exchange for redeemable convertible preferred
units outstanding as of September&nbsp;30, 2023, in connection with the Reorganization, into an equivalent number of shares of our common stock, immediately prior to the completion of this offering and (iii)&nbsp;the filing and effectiveness of our
amended and restated certificate of incorporation immediately prior to the completion of this offering, in each case as if such events had occurred on September&nbsp;30, 2023; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">on a pro forma as adjusted basis to give further effect to our issuance and sale of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock in this offering at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the estimated
midpoint of the price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The pro forma as adjusted information below is illustrative only, and our capitalization following the completion of this offering will be adjusted based on the actual
initial public offering price and other terms of this offering determined at pricing. You should read the information in this table together with our consolidated financial statements and the related notes included elsewhere in this prospectus and
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; section of this prospectus. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="12" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of September&nbsp;30, 2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Pro&nbsp;forma</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Pro&nbsp;forma<BR>as&nbsp;adjusted</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 101,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total cash, cash equivalents and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 292,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Redeemable convertible preferred units; no par value; 41,813,375 units authorized, 41,813,375 units issued
and outstanding, actual; no units authorized issued and outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Redeemable Convertible preferred stock; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; par value; no
shares authorized, issued and outstanding, actual; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized and no shares issued and outstanding, pro forma; and no shares authorized, issued and outstanding, pro forma
as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Members&#146;/Stockholders&#146; equity (deficit):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits interests, no par value; 14,604,165 units authorized, 9,556,687 units issued and outstanding,
actual; no units authorized, issued and outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common units, no par value; 66,000,000 units authorized, 5,947,500 units issued and outstanding, actual; no
units authorized, issued and outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Preferred stock, $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; par value; no shares authorized, issued
or outstanding, actual and pro forma; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized and no shares issued or outstanding, pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common stock, $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; par value; no shares authorized, issued and
outstanding, actual; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, pro forma;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(359</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,650</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total members&#146;/stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(119,021</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 231,737</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each $1.00 increase (decrease) in the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the estimated midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of cash and cash
equivalents, total stockholders&#146; equity (deficit) and total capitalization by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains
the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Each increase (decrease) of 1,000,000 shares in the number of shares offered by us, as set forth on the cover page of this
prospectus, would increase (decrease) the pro forma as adjusted amount of each of cash and cash equivalents, total stockholders&#146; equity (deficit) and total capitalization by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming no
change in the assumed initial public offering price per share and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">You should read the information in this table together with our consolidated financial statements and the related notes included elsewhere in this prospectus and
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; section of this prospectus. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The number of shares of our
common stock outstanding after this offering assumes the Reorganization takes place immediately prior to the effectiveness of this registration statement and is based
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock (including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
unvested restricted common stock) issued in exchange for common units and profits interests outstanding as of September&nbsp;30, 2023, and after giving effect to the conversion of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our redeemable convertible preferred stock, issued in connection with the Reorganization in exchange for redeemable convertible preferred units
outstanding as of September&nbsp;30, 2023, into an equivalent number of shares of our common stock immediately prior to the completion of this offering. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The number
of shares of common stock to be outstanding after this offering excludes: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock
reserved for future issuance under our 2024 Stock Option and Incentive Plan (the &#147;2024 Plan&#148;), which will become effective on the date immediately prior to execution of the underwriting agreement related to this offering; and
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock
reserved for future issuance under our 2024 Employee Stock Purchase Plan (the &#147;ESPP&#148;), which will become effective on the date immediately prior to the execution of the underwriting agreement related to this offering.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_10"></A>DILUTION </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If you invest in our common stock in this offering, your ownership interest will be diluted immediately to the extent of the difference between the initial public
offering price per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock immediately after this offering. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our historical net tangible book value (deficit) as of September&nbsp;30, 2023 was $(123.4) million, or $(20.75) per our common unit. Our historical net tangible book
value (deficit) is the amount of our total tangible assets less our total liabilities and the carrying values of our redeemable convertible preferred units, which is not included within members&#146; deficit. Our historical net tangible book value
(deficit) per unit represents historical net tangible book value (deficit) divided by 5,947,500 of our common units outstanding as of September&nbsp;30, 2023. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our
pro forma net tangible book value as of September&nbsp;30, 2023 was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share of our common stock. Pro forma net tangible book value
represents the amount of our total tangible assets less our total liabilities, after giving effect to (i)&nbsp;the Reorganization, (ii)&nbsp;the conversion of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our redeemable convertible preferred stock, issued in connection with the Reorganization in exchange for redeemable convertible preferred units
into an equivalent number of shares of our common stock immediately prior to the completion of this offering, and (iii)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation immediately prior to the completion of
this offering. Pro forma net tangible book value per share represents pro forma net tangible book value divided by the total number of shares outstanding as of September&nbsp;30, 2023, after giving effect to the pro forma adjustments described
above. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">After giving further effect to our issuance and sale of shares of our common stock in this offering at an assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the estimated midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering
expenses payable by us, our pro forma as adjusted net tangible book value as of September&nbsp;30, 2023 would have been $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. This
amount represents an immediate increase in pro forma as adjusted net tangible book value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share to our existing stockholders and immediate dilution in pro forma as adjusted net tangible book
value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share to new investors purchasing common stock in this offering. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Dilution per share to new investors
is determined by subtracting pro forma as adjusted net tangible book value per share after this offering from the initial public offering price per share paid by new investors. The following table illustrates this dilution on a per share basis
(without giving effect to any exercise by the underwriters of their option to purchase additional shares): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom"><B>Assumed initial public offering price per share</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Historical net tangible book value (deficit) per common unit as of September&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(20.75</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Increase per share attributable to the pro forma adjustments described above</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma net tangible book value per share as of September&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Increase in pro forma as adjusted net tangible book value per share attributable to new investors
participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma as adjusted net tangible book value per share immediately after this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Dilution per share to new investors participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The dilution information discussed above is illustrative only and will change based on the actual initial public
offering price and other terms of this offering determined at pricing. Each $1.00 increase (decrease) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the estimated midpoint of the
price range set forth on the cover page of this prospectus, would increase (decrease) our pro forma as adjusted net tangible book value per share after this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and dilution per share to new
investors purchasing common stock in this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting
estimated underwriting discounts and commissions and estimated offering expenses payable by us. Each increase of 1,000,000 shares in the number of shares offered by us, as set forth on the cover page of this prospectus, would increase our pro forma
as adjusted net tangible book value per share after this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and decrease dilution per share to new investors purchasing common stock in this offering by
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming no change in the assumed initial public offering price per share and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Each
decrease of 1,000,000 shares in the number of shares offered by us, as set forth on the cover page of this prospectus, would decrease our pro forma as adjusted net tangible book value per share after this offering by
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and increase dilution per share to new investors purchasing common stock in this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming no change in the assumed initial public
offering price and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If the underwriters exercise
their option to purchase additional shares in full, our pro forma as adjusted net tangible book value per share after this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;, representing an immediate increase in pro forma as adjusted net tangible book
value per share of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to existing stockholders and immediate dilution in pro forma as adjusted net tangible book value per share of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to new investors
purchasing common stock in this offering, based on the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share and after deducting estimated underwriting discounts and commissions and estimated offering
expenses payable by us. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes on the pro forma as adjusted basis described above, the total number of shares of common stock purchased from
us on an as converted to common stock basis, the total consideration paid or to be paid, and the average price per share paid or to be paid by existing members/stockholders and by new investors in this offering at an assumed initial public offering
price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the estimated midpoint of the estimated price range set forth on the cover of this prospectus, before deducting estimated underwriting discounts and commissions and
estimated offering expenses payable by us. As the table shows, new investors purchasing common stock in this offering will pay an average price per share substantially higher than our existing members/ stockholders paid. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Units/Shares&nbsp;Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1.00px solid #000000" ALIGN="center"><B>Average&nbsp;Price</B>
<P ALIGN="right" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:9pt"><B>Per&nbsp;Unit/Share</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Existing members/stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">47,760,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$351,637,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$7.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Investors participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="17" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="17" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="17" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The table above assumes no exercise of the underwriters&#146; option to purchase additional shares in this offering. If the
underwriters&#146; option to purchase additional shares is exercised in full, the number of shares of our common stock held by existing stockholders would be reduced to percent of the total number of shares of our common stock outstanding after this
offering, and the number of shares of common stock held by new investors purchasing common stock in this offering would be increased to percent of the total number of shares of our common stock outstanding after this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The discussion and tables above assume the Reorganization takes place prior to the effectiveness of this registration
statement and are based on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock (including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of unvested restricted common
stock) issued in exchange for common units and profits interests outstanding as of September&nbsp;30, 2023, and after giving effect to the conversion of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our redeemable
convertible preferred stock, issued in connection with the Reorganization, in exchange for redeemable convertible preferred units outstanding as of September&nbsp;30, 2023, into an equivalent number of shares of our common stock immediately prior to
the completion of this offering. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The number of shares of common stock to be outstanding after this offering excludes: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock
reserved for future issuance under the 2024 Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock
reserved for future issuance under the ESPP. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To the extent that new stock options are issued, or we issue additional shares of common stock in the
future, there will be further dilution to new investors. In addition, we may choose to raise additional capital because of market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future
operating plans. If we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_11"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated
financial statements and unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this prospectus. This discussion and other parts of this prospectus contain forward-looking statements that involve risks and
uncertainties, such as statements regarding our plans, objectives, expectations, intentions and projections. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute
to such differences include, but are not limited to, those discussed in the &#147;Risk Factors&#148; section of this prospectus. Our historical results are not necessarily indicative of the results that may be expected for any period in the future.
</I></P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Overview </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are a precision genetic medicines company committed to
developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering
approaches to date. Genetic mutations are seen in a variety of forms, including deletions, insertions, single-base-pair changes and sequence repeats, and are found throughout the genome and across a variety of different cell types, tissues, and
organ systems. Additionally, many diseases lack a genetic origin but have the potential to be effectively and permanently addressed through genome editing. We are harnessing the power of metagenomics, the study of genetic material recovered from the
natural environment, to unlock four billion years of microbial evolution to discover and develop a suite of novel editing tools capable of correcting any type of genetic mutation found anywhere in the genome. Our comprehensive genome editing toolbox
includes programmable nucleases, base editors, and RNA and <FONT STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat
(&#147;CRISPR&#148;)-associated transposases (&#147;CASTs&#148;)). We believe our diverse and modular toolbox positions us to access the entire genome and select the optimal tool to unlock the full potential of genome editing for patients. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Since our inception, we have devoted substantially all of our resources to organizing and staffing our company, business planning, raising capital, research and
development activities, building our intellectual property portfolio and providing general and administrative support for these operations. We have historically financed our operations primarily through issuing redeemable convertible preferred units
and convertible promissory notes and entering into collaboration agreements, which generate collaboration revenue. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have incurred significant operating losses
since inception and we expect to continue to incur substantial losses for the foreseeable future. Our net losses were $21.4&nbsp;million and $43.6&nbsp;million for the years ended December&nbsp;31, 2021 and 2022, respectively. Our net losses were
$29.0&nbsp;million and $49.0&nbsp;million for the nine months ended September&nbsp;30, 2022 and 2023, respectively. As of September&nbsp;30, 2023, we had an accumulated deficit of $125.7&nbsp;million. We anticipate that our expenses and operating
losses will increase substantially for the foreseeable future as we: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">advance our&nbsp;current research activities and further develop our platform; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">develop, maintain, expand, and protect our intellectual property portfolio; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">continue preclinical development and initiate clinical trials for any product candidates we may identify;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">seek regulatory approval for any product candidates for which we successfully complete clinical trials;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establish our manufacturing capabilities, including internal manufacturing facilities and contracting with other vendors;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">ultimately, commercialize any future product candidates for which we receive regulatory approval, requiring significant
marketing, sales, and distribution infrastructure expenses; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">hire additional research and development, clinical, commercial, general and administrative personnel;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> product candidates, intellectual property and technologies;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establish and maintain collaborations; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">add operational, financial and management information systems and personnel; or </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">incur additional legal, audit, accounting, compliance, insurance, investor relations and other expenses to operate as a
public company that we did not incur as a private company. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We will not generate revenue from product sales unless and until we successfully
initiate and complete clinical development and obtain regulatory approval for one or more product candidates. If we obtain regulatory approval for any product candidate and do not enter into a commercialization partnership, we expect to incur
significant expenses related to developing our commercialization capability to support product sales, manufacturing, marketing, and distribution. As a result, we will need substantial additional funding to support our continuing operations and
pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations, strategic alliances, and
marketing, distribution or licensing arrangements with third parties. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into
such agreements as and when needed, we may have to significantly delay, reduce or eliminate the development and commercialization of our platform or delay our pursuit of potential <FONT STYLE="white-space:nowrap">in-licenses</FONT> or acquisitions.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September&nbsp;30, 2023, we had cash, cash equivalents and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities of $292.9&nbsp;million. We believe that the anticipated net proceeds from this offering, together with our existing cash, cash equivalents and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities will be sufficient to fund our operating expenses and capital expenditure requirements through
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. See
&#147;Liquidity and Capital Resources&#148; and &#147;Risk Factors&#151;Risks Related To Our Financial Position and Need for Additional Capital.&#148; </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Macroeconomic Trends </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Unfavorable conditions in the economy in the United
States and abroad may negatively affect the growth of our business and our results of operations. For example, macroeconomic events, including, rising inflation, tensions in U.S.-China relations, the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic, the U.S. Federal Reserve raising interest rates, recent and potential future disruptions in access to bank deposits and lending commitments due to bank failures and the effects of the ongoing geopolitical conflict in Ukraine and the
Israel-Hamas war, have led to economic uncertainty and volatility globally. The effect of macroeconomic conditions may not be fully reflected in our results of operations until future periods. To date, the macroeconomic trends discussed above have
not had a material adverse impact on our business, financial condition or results of operations. If, however, economic uncertainty increases or the global economy worsens, our business, financial condition and results of operations may be harmed.
For further discussion of the potential impacts of macroeconomic events on our business, financial condition, and operating results, refer to the section titled &#147;Risk Factors&#148; included elsewhere in this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Collaboration and License Agreements </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Moderna Strategic Collaboration and License Agreement </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On
October&nbsp;29, 2021, the effective date, we entered into a Strategic Collaboration and License Agreement (the &#147;Moderna Agreement&#148;) with Moderna. We will collaborate with Moderna on the research and development of <I>in vivo</I> genome
editing therapies directed at certain targets and the commercialization of such genome editing therapies. The collaboration provides Moderna with exclusive access to our technology platform during the research period in (1)&nbsp;the field of <I>in
vivo </I>gene editing technology for a therapeutic, ameliorative or prophylactic application by way of <FONT STYLE="white-space:nowrap">knock-out</FONT> through InDel formation or base editing or insertion of an exogenous DNA template (such field,
&#147;DT Field&#148;) and (2)&nbsp;the field of <I>in vivo</I> gene editing technology for a therapeutic, ameliorative or prophylactic application outside the use of (a)&nbsp;DNA donor templates and (b)&nbsp;no exogenous template at all but
including (c)&nbsp;correction by base editing (such field, &#147;RT Field&#148;). We formed a joint steering committee, a joint research subcommittee and a joint patent subcommittee to oversee the collaboration activities. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the terms of the Moderna Agreement, we and Moderna will collaborate on one or more programs in the RT Field (the &#147;Moderna RT program&#148;) and two programs
in the DT Field (the &#147;Moderna DT program&#148; and the &#147;DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program&#148;). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">With respect to the Moderna RT
and Moderna DT programs, we will collaborate on the research and development of product candidates under the approved research plans. The initial research term of the Moderna RT program is four years, which may be extended by Moderna for an
additional three years upon written notice and a payment of extension fees. The initial research term of the Moderna DT program is four years. We granted to Moderna an option to obtain an exclusive license to develop, manufacture and commercialize
up to ten Moderna RT program candidates and up to two Moderna DT program candidates at any time during the research term and prior to filing of an IND application with the FDA or any similar application filed with a regulatory authority in a country
other than the United States (&#147;U.S.&#148;), subject to Moderna&#146;s payment of an option exercise fee of $10.0&nbsp;million per target. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">With respect to the
DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program, we will work together with Moderna on the <FONT STYLE="white-space:nowrap">co-development</FONT> and commercialization of products and share costs and profits equally. We maintain
commercialization rights in the U.S. (subject to Moderna&#146;s right to appoint up to 50% of the U.S. sales force for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program), while Moderna maintains these rights in countries other than the
U.S. The initial research term for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program is four years, and each party has a right to <FONT STYLE="white-space:nowrap">opt-out</FONT> of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
program at any time, at which point the other party has the right to solely continue the development and commercialization activities. If there is no development candidate nomination by the end of the initial research term, the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> program will expire, unless we have mutually agreed to continue the program. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the year ended December&nbsp;31, 2021,
we received a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payment of $40.0&nbsp;million and a $5.0&nbsp;million payment for the first year of research costs. Concurrent with the Moderna Collaboration Agreement, Moderna also
provided $30.0&nbsp;million in cash in the form of a convertible promissory note (see Note 9 in our audited consolidated financial statements included elsewhere in this prospectus) pursuant to a convertible promissory note agreement dated
October&nbsp;29, 2021 (the &#147;Moderna Convertible Promissory Note Agreement&#148;). The convertible promissory note was converted into shares of Series B redeemable convertible preferred units in January 2022. Moderna will reimburse us up to
$5.0&nbsp;million in annual research and development costs related to the Moderna DT and Moderna RT programs, or up to the agreed amount of expenses per the budget. As of September&nbsp;30, 2023, we have received a total of $49.6&nbsp;million under
the Moderna Collaboration Agreement, not including cost-sharing payments under the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For the Moderna RT and Moderna DT programs, we are eligible to receive (i)&nbsp;technology milestone fees related to
the achievement of certain preclinical research objectives of up to $75.0&nbsp;million, (ii)&nbsp;development and regulatory milestones of up to $100.0&nbsp;million per target, (iii)&nbsp;sales milestones of up to $200.0&nbsp;million per target, and
(iv)&nbsp;royalties ranging from a <FONT STYLE="white-space:nowrap">mid-single</FONT> digit to a <FONT STYLE="white-space:nowrap">low-teens</FONT> percentage of annual net sales of a licensed product. Any profits and losses from the co-development
and commercialization of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program are shared equally between us and Moderna. With respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program for which the <FONT
STYLE="white-space:nowrap">opt-out</FONT> party has exercised its <FONT STYLE="white-space:nowrap">opt-out</FONT> right, the continuing party will pay to the <FONT STYLE="white-space:nowrap">opt-out</FONT> party, certain development, regulatory and
sales milestone payments that will not exceed an aggregate $239.0&nbsp;million per DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> target, and <FONT STYLE="white-space:nowrap">opt-out</FONT> royalties ranging from a high-single digit to a <FONT
STYLE="white-space:nowrap">low-teens</FONT> percentage of annual net sales of a licensed product. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of the Moderna Agreement will continue on a licensed <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, until the expiration of the
applicable royalty term. The royalty term commences on the first commercial sale of a licensed product and terminates on the latest of: (a)&nbsp;the expiration or abandonment of the last valid claim of a patent within the licensed Moderna DT or RT
technology; (b)&nbsp;10 years after the first commercial sale of a licensed product; and (c)&nbsp;expiration of the regulatory exclusivity. Upon the expiration of the term of a licensed product in the Moderna DT or Moderna RT program, the licenses
granted to Moderna will survive and become perpetual, fully paid and royalty-free. Each party may terminate the Moderna Agreement on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">program-by-program</FONT></FONT> basis upon
written notice to the other party for an uncured material breach or insolvency. We may terminate the Moderna Agreement upon written notice to Moderna for a patent challenge. Additionally, Moderna may terminate the agreement at its convenience with
respect to Moderna DT or Moderna RT programs for any reason upon at least: (a)&nbsp;60 days&#146; prior written notice if a first commercial sale has not occurred for the products in such program, or (b)&nbsp;180 days&#146; prior written notice if a
first commercial sale of a product in such program has occurred. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We concluded that the Moderna DT and Moderna RT programs are in the scope of ASC 606. We determined
that the licenses granted to Moderna, and its participation in the joint steering committee are not capable of being distinct from the preclinical research and development services and therefore concluded that there are two performance obligations:
(1)&nbsp;the Moderna RT program and (2)&nbsp;the Moderna DT program. We also concluded that the option to obtain an exclusive license and options to extend Moderna RT program term do not include significant incremental discounts, and as such, the
options do not provide material rights. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We concluded the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program research activities are within the scope of ASC
808, as we and Moderna are both active participants in the research, development and commercialization activities, are exposed to significant risks and rewards that are dependent on the success of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
program activities and share costs and profits equally. We determined that the guidance in ASC 730, <I>Research and Development</I>, was appropriate to apply to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program research activities by
analogy, based on the nature of the cost sharing provisions of the agreement. We concluded that DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program is one unit of accounting, as the <FONT STYLE="white-space:nowrap">co-exclusive</FONT> license
is not distinct from the research and development and the participation in joint steering committee activities. We recognize payments to or from Moderna related to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program cost sharing research
activities as an increase to or reduction of research and development expenses, respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We concluded that the Moderna Collaboration Agreement and the Moderna
Convertible Promissory Note Agreement should be combined and treated as a single arrangement for accounting purposes as the agreements were entered into contemporaneously and in contemplation of one another. We estimated the contract consideration
to be $90.0&nbsp;million, which consisted of: 1) the <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront collaboration payment of $40.0&nbsp;million received in 2021, 2) $30.0&nbsp;million in cash received in 2021 in exchange for the
convertible promissory note and 3) the estimated cost reimbursements for Moderna DT and Moderna RT programs of $20.0&nbsp;million. We constrained future milestones, as we assessed that it is probable that the inclusion of such variable consideration
could result in a significant reversal of cumulative revenue in future </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
periods. During the year ended December&nbsp;31, 2021, we recorded $30.0&nbsp;million of the contract consideration for the convertible promissory note based on the fair value (see Note 9 in our
audited consolidated financial statements included elsewhere in this prospectus) and allocated the transaction price of $60.0&nbsp;million to each of the following programs on a relative standalone selling price basis: 1) $49.5&nbsp;million to the
Moderna RT program, 2) $5.5&nbsp;million to the Moderna DT program, and 3) $5.0&nbsp;million to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
variable consideration is reevaluated at each reporting period and as changes in circumstances occur. We recognize revenue for each of the Moderna DT and Moderna RT programs as collaboration revenue based on the measure of progress using an
estimated cost-based input method each reporting period. We also amortize the allocation consideration for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program of $5.0&nbsp;million as a credit to research and development expenses during the
discovery and lead optimization phases for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We recognized collaboration revenue of $0.2&nbsp;million
and $14.5&nbsp;million in the consolidated statements of operations and comprehensive loss for the years ended December&nbsp;31, 2021 and 2022, respectively. We recognized collaboration revenue of $10.7&nbsp;million and $14.2&nbsp;million in the
condensed consolidated statements of operations and comprehensive loss for the nine months ended September&nbsp;30, 2022 and 2023, respectively. As of September&nbsp;30, 2023, the Company recorded $1.5&nbsp;million in accounts receivable on the
condensed consolidated balance sheet, related to services performed. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, deferred revenue related to the Moderna Agreement was $30.2&nbsp;million and $17.2&nbsp;million, respectively.
Collaboration revenue recognized during the nine months ended September&nbsp;30, 2022 and 2023 included $10.7&nbsp;million and $14.2&nbsp;million that was included in deferred revenue as of December&nbsp;31, 2021 and 2022, respectively. The value of
the transaction price allocated to the remaining unsatisfied portion of the performance obligations was approximately $27.8&nbsp;million as of September&nbsp;30, 2023, which we expect to recognize as revenue over the next <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">two-to-three</FONT></FONT> years. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We recognized $0.2&nbsp;million and $0.3&nbsp;million in credits to
research and development expenses related to cost sharing allocation and amortization of the collaboration advance, respectively, within research and development expenses in the consolidated statement of operations and comprehensive loss during the
year ended December&nbsp;31, 2021. We recognized $0.9&nbsp;million and $3.5&nbsp;million in credits to research and development expenses related to cost sharing allocation and amortization of the collaboration advance, respectively, during the year
ended December&nbsp;31, 2022. We recognized $0.5&nbsp;million and $2.7&nbsp;million in credits to research and development expenses related to cost sharing allocation and amortization of the collaboration advance, respectively, within research and
development expenses in the condensed consolidated statement of operations and comprehensive loss during the nine months ended September&nbsp;30, 2022. We recognized $0.3&nbsp;million and $0.5&nbsp;million in credits to research and development
expenses related to cost sharing allocation and amortization of the collaboration advance during the nine months ended September&nbsp;30, 2023, respectively. As of December&nbsp;31, 2022, the collaboration advance balance was $1.1&nbsp;million,
partially offset by the cost-sharing receivable balance of $0.4&nbsp;million, which was presented as a collaboration advance on our condensed consolidated balance sheet. As of September&nbsp;30, 2023, the collaboration advance balance was
$0.7&nbsp;million, partially offset by the cost-sharing receivable balance of $0.2&nbsp;million, which was presented as a collaboration advance on our condensed consolidated balance sheet. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For additional information regarding the Moderna Agreement, please see the section titled &#147;Business&#151;Our License and Collaboration Agreements.&#148; </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I><FONT STYLE="white-space:nowrap">Affini-T</FONT> Development, Option and License Agreement </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On June&nbsp;14, 2022, the effective date, we entered into a Development, Option and License Agreement (the <FONT STYLE="white-space:nowrap">&#147;Affini-T</FONT>
Agreement&#148;) with <FONT STYLE="white-space:nowrap">Affini-T.</FONT> Pursuant to the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement, we and <FONT STYLE="white-space:nowrap">Affini-T</FONT> have agreed to identify,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
develop or optimize certain reagents using our proprietary technology for <FONT STYLE="white-space:nowrap">Affini-T</FONT> to use such reagents to develop and commercialize gene edited <FONT
STYLE="white-space:nowrap">TCR-based</FONT> therapeutic products exclusively in the field of treatment, prevention or diagnosis of any human cancer using products with any engineered primary TCR alpha/beta T cells and
<FONT STYLE="white-space:nowrap">non-exclusively</FONT> in the field of treatment, prevention or diagnosis of any human cancer using products with certain other engineered immune cells worldwide. A joint steering committee was established by both
parties to assign alliance managers and project leaders to oversee the collaboration activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the <FONT STYLE="white-space:nowrap">Affini-T</FONT>
Agreement, we granted <FONT STYLE="white-space:nowrap">Affini-T</FONT> options to receive, on a <FONT STYLE="white-space:nowrap">pre-specified</FONT>
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">target-by-pre-specified</FONT></FONT></FONT> target basis, for up to six <FONT STYLE="white-space:nowrap">pre-specified</FONT> targets, either
(i)&nbsp;an exclusive, royalty-bearing, sublicensable worldwide license under all of our applicable intellectual property to research, develop, manufacture, use, commercialize and otherwise exploit any
<FONT STYLE="white-space:nowrap">TCR-based</FONT> therapy, preventative treatment, or diagnostic for humans that is directed to such <FONT STYLE="white-space:nowrap">pre-specified</FONT> target, contains or comprises Primary TCR alpha/beta T Cells
and is derived from <I>ex vivo </I>application of our reagent (the &#147;Exclusive Option&#148;) or (ii)&nbsp;a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-bearing, sublicensable worldwide license under all our applicable
intellectual property to research, develop, manufacture, use commercialize and otherwise exploit any <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapy, preventative treatment, or diagnostic for humans that is directed to such <FONT
STYLE="white-space:nowrap">pre-specified</FONT> target, contains or comprises TCR natural killer (&#147;NK&#148;) cells derived from iPSC immune cells or TCR T cells derived from donor-derived or iPSC immune cells.
<FONT STYLE="white-space:nowrap">Affini-T</FONT> can exercise its options for either an exclusive license or a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license, or both, for each <FONT STYLE="white-space:nowrap">pre-specified</FONT>
target by providing written notice prior to the earlier of (x)&nbsp;the end of the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement term or (y) 90 days following the filing of an IND for a licensed product directed to a <FONT
STYLE="white-space:nowrap">pre-specified</FONT> target, subject to the payment of certain fees per each option exercised. After the option exercise, <FONT STYLE="white-space:nowrap">Affini-T</FONT> has agreed to use commercially reasonable efforts
to conduct all development and commercialization activities for a licensed product, and development and commercialization of all licensed products will be at <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> sole cost and expense. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement, we received upfront equity consideration of 719,920 shares of <FONT
STYLE="white-space:nowrap">Affini-T&#146;s</FONT> common stock with an estimated fair value of $1.3&nbsp;million in June 2022. The fair value of <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> shares of common stock was estimated by our
management, considering the most recent third-party valuation. <FONT STYLE="white-space:nowrap">Affini-T</FONT> has also agreed to reimburse us for expenses incurred while performing research activities under the research plans. As of
September&nbsp;30, 2023, we received a total of $3.2&nbsp;million from <FONT STYLE="white-space:nowrap">Affini-T</FONT> related to reimbursable expenses. Additionally, we are eligible to receive (i) 933,650 shares of
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> common stock upon the achievement of a regulatory milestone, which is the earlier of a submission of a drug master file to the FDA or an acceptance of an IND filing for a licensed product by
the FDA, (ii)&nbsp;up to $18.8&nbsp;million in future developmental milestone payments depending on the completion of or the number of patients dosed in, the relevant human clinical trial, or the initiation of a pivotal trial, and $40.6&nbsp;million
in future regulatory approval milestone payments, which include regulatory approvals in the U.S. and other markets for licensed products directed to a <FONT STYLE="white-space:nowrap">pre-specified</FONT> target if options for both exclusive and <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> licenses are exercised with respect to such target, (iii)&nbsp;up to $250.0&nbsp;million in sales-based milestones for aggregate sales of all licensed products directed to a given <FONT
STYLE="white-space:nowrap">pre-specified</FONT> target and (iv)&nbsp;royalties ranging from a <FONT STYLE="white-space:nowrap">low-single</FONT> digit to high-single digit percentage of worldwide annual net sales of licensed products. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The initial term of the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement is five years from the effective date. If
<FONT STYLE="white-space:nowrap">Affini-T</FONT> exercises an Exclusive Option with respect to any <FONT STYLE="white-space:nowrap">pre-specified</FONT> target during the initial term, the initial term will be extended by an additional five years.
Following the expiration of the extended term, if any, the agreement will continue on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">target-by-target</FONT></FONT> basis and expire with respect to such target upon the expiration
of the royalty term for all licensed products directed to such target. The <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement may be terminated during the term by either party for an uncured material breach by, or bankruptcy of, the other
party. Additionally, <FONT STYLE="white-space:nowrap">Affini-T</FONT> may terminate the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement for convenience, in its entirety, on a research <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">plan-by-research</FONT></FONT> plan basis, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">target-by-target</FONT></FONT> basis or on a licensed <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product basis, by providing prior written notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We concluded that the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement is in the scope of ASC 606 and that
there is one performance obligation to perform research activities under the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement. Exclusive and <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses are optional contingent purchases
that do not include significant incremental discounts, and therefore do not provide a material right. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">At the effective date, the transaction price consisted of the
upfront equity consideration with an estimated fair value of $1.3&nbsp;million and estimated research reimbursement costs. Research reimbursement costs represent variable consideration, and our management estimates what portion to include in total
consideration at the end of each reporting period. Other payments under the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement, including additional equity consideration and development and regulatory milestones, also represent variable
consideration, and are constrained to the extent that the inclusion of such variable consideration could result in a significant reversal of cumulative revenue in future periods. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, additional
equity consideration and future development and regulatory milestone payments were excluded from the estimated total transaction price as they were considered constrained. The transaction price is reevaluated in each reporting period and as changes
in circumstances occur. We recognize revenue each reporting period based on the measure of progress using an estimated cost-based input method. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We recognized
$2.6&nbsp;million in collaboration revenue in the consolidated statements of operations and comprehensive loss during the year ended December&nbsp;31, 2022. We recognized $0.9&nbsp;million and $3.7&nbsp;million in collaboration revenue in the
condensed consolidated statements of operations and comprehensive loss during the nine months ended September&nbsp;30, 2022 and 2023, respectively. As of December&nbsp;31, 2022, we recorded $1.3&nbsp;million in contract assets on the consolidated
balance sheet, related to services performed but not invoiced. There was no contract asset related to services performed as of September&nbsp;30, 2023. As of September&nbsp;30, 2023, we recorded $2.4&nbsp;million in accounts receivable on the
condensed consolidated balance sheet, related to services performed. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, deferred revenue related to the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement was zero and $0.6&nbsp;million,
respectively. In June 2023, the joint steering committee approved the budget for estimated research reimbursement costs for the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement, which resulted in a $2.4&nbsp;million reduction to variable
consideration. The value of the transaction price allocated to the remaining unsatisfied portion of the performance obligation was approximately $2.1&nbsp;million as of September&nbsp;30, 2023, which we expect to recognize as revenue over the next <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">four-to-five</FONT></FONT> years. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For additional information regarding the <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Agreement, please see the section titled &#147;Business&#151;Our License and Collaboration Agreements.&#148; </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Ionis
Collaboration and License Agreement </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On November&nbsp;10, 2022, the effective date, we entered into a Collaboration and License Agreement (the &#147;Ionis
Agreement&#148;) with Ionis to collaborate on drug discovery and exploratory research activities to advance new medicines using gene editing strategies, with the goal of discovering novel medicines. Pursuant to the terms of the Ionis Agreement, we
granted Ionis and its affiliates a worldwide exclusive, royalty-bearing license, with the right to grant sublicenses, to use all licensed systems and licensed products in the field of <I>in vivo</I> gene editing for all therapeutic, prophylactic,
palliative, and analgesic uses in humans. In connection with the Ionis Agreement, we also have the right to exercise an exclusive option to <FONT STYLE="white-space:nowrap">co-develop</FONT> and
<FONT STYLE="white-space:nowrap">co-commercialize</FONT> certain products under a drug discovery program. A joint steering committee was established by both parties to coordinate, oversee, and monitor the research and drug discovery activities under
the Ionis Agreement. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We will collaborate to discover therapeutic products under a drug discovery program and develop a drug discovery plan for each target, selected
by Ionis. The target selection is divided into two waves: up to four targets in Wave 1 and up to four targets in Wave 2. For each drug discovery program, once the parties identify a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
development candidate that is suitable for further development, Ionis will be responsible for the development and commercialization of products resulting from such program. Per the terms of the
Ionis Agreement, at any time prior to the designation of a development candidate for a drug discovery program and for any reason, Ionis may replace the collaboration target, provided such target has not previously been substituted out. Ionis may
substitute (i)&nbsp;up to two Wave 1 targets and (ii)&nbsp;up to two Wave 2 targets. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The drug discovery activities for a program commence on the selection of a
target and expire upon the earlier of (a)&nbsp;completion of all drug discovery activities for such program, (b)&nbsp;the fifth anniversary of the effective date and (c)&nbsp;selection of a development candidate for such drug discovery program. If
one or more Wave 2 targets become collaboration targets as a result of the parties achieving enabled delivery and less than two years are remaining in the drug discovery term, then the term will be extended to the earlier of (i)&nbsp;the time that
we complete all of our activities under the applicable drug discovery plan and (ii)&nbsp;the seventh anniversary of the effective date, subject to our consent. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We
will also conduct an exploratory research program, and will jointly optimize gRNA and select delivery technologies and other activities. The exploratory research activities commence on the effective date and expire upon the earlier of
(a)&nbsp;completion of all exploratory research activities established in the exploratory research plan, and (b)&nbsp;the fifth anniversary of the effective date. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have the exclusive option to <FONT STYLE="white-space:nowrap">co-develop</FONT> and <FONT STYLE="white-space:nowrap">co-commercialize</FONT> the licensed products
under a drug discovery program (the <FONT STYLE="white-space:nowrap">&#147;Co-Co</FONT> Option&#148;) with Ionis. The <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option may be exercised for (a)&nbsp;the initial Wave 1 target (&#147;Target
1&#148;), (b)&nbsp;no more than one of the other three discovery programs for the Wave 1 targets, and (c)&nbsp;no more than two drug discovery programs for the Wave 2 targets that become collaboration targets. If we exercise the <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Option for a particular drug discovery program, that drug discovery program will automatically be deemed a <FONT STYLE="white-space:nowrap">&#147;Co-Co</FONT> Program&#148;, all corresponding licensed products
be deemed <FONT STYLE="white-space:nowrap">&#147;Co-Co</FONT> Products,&#148; we will be obligated to pay Ionis an option exercise fee, and we and Ionis will enter into a separate <FONT STYLE="white-space:nowrap">co-development</FONT> and <FONT
STYLE="white-space:nowrap">co-commercialization</FONT> agreement. The <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option exercise fee will equal 50% of Ionis&#146; internal costs and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred in the conduct of the drug discovery activities prior to the exercise of the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option and be
reduced by 50% of our corresponding costs incurred. Future development and commercialization costs will be shared equally. We may elect to reduce our cost-share percentage anywhere between 50% and 25% on a
<FONT STYLE="white-space:nowrap">go-forward</FONT> basis, provided we will continue to bear 50% of the costs of any clinical trials ongoing at the time of the election through the completion of the clinical trials. We will manufacture all licensed
systems and certain components of the applicable licensed products that are needed by Ionis for use in its development activities and all of our manufactured components needed by Ionis for use in its commercialization activities. We will provide the
manufactured components at a price that represents the cost of goods plus 15%. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the terms of the Ionis Agreement, we have also been granted an option to
obtain a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-bearing license, with the right to grant sublicenses, for certain Ionis&#146; background technology to use in up to eight therapeutic products discovered by us in the field of
<I>in vivo</I> gene editing and directed to a Collaboration Target (each such product, a &#147;Metagenomi Product&#148; and each such option an &#147;Ionis IP Option&#148;), but subject to encumbrance checks with respect to particular targets. A
Collaboration Target is a target that is selected by Ionis, and, with respect to us, is not the subject of discussions with a third party, is not the subject of a contractual grant of rights to a third party nor the subject of an internal research
and development program. If we exercise our Ionis IP Option, we will pay to Ionis up to several million dollars per Metagenomi Product upon achievement of certain clinical and regulatory milestones. We are also obligated to pay Ionis royalties in an
amount equal to a low single-digit royalty on the net sales of the applicable Metagenomi Product on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In November 2022, we received an $80.0&nbsp;million upfront payment from Ionis for the Wave 1 drug discovery research
collaboration and selected Target 1. Ionis selected its second target (&#147;Target 2&#148;) in Wave 1 in December 2022 and its third target (&#147;Target 3&#148;) in Wave 1 in November 2023. In November 2023, we agreed to extend the period during
which we expect Ionis will select its fourth target (&#147;Target 4&#148;) in Wave 1 by an additional three months from the <FONT STYLE="white-space:nowrap">12-month</FONT> anniversary of the effective date, as permitted under the arrangement. Ionis
has an option to select up to four Wave 2 targets at any time during the drug discovery term, if (a)&nbsp;an IND for any licensed product directed to a Wave 1 target is filed with the applicable regulatory authority or (b)&nbsp;the parties achieve
enabled delivery for a <FONT STYLE="white-space:nowrap">non-liver</FONT> target under the exploratory research activities, by providing written notice and by paying a Wave 2 target selection fee of $15.0&nbsp;million or $30.0&nbsp;million, depending
on and per the selected target. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Ionis is obligated to reimburse us for all internal costs and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred in the performance of the exploratory research activities, up to an aggregate of $10.0&nbsp;million, which is payable in quarterly
installments of $0.5&nbsp;million during the exploratory research term. As of September&nbsp;30, 2023, we received a total of $1.5&nbsp;million related to the reimbursable expenses. We are also eligible to receive (a)&nbsp;up to $29.0&nbsp;million
in future development milestone payments for each licensed product; (b)&nbsp;up to $60.0&nbsp;million in future regulatory milestone payments for each licensed product; (c)&nbsp;up to $250.0&nbsp;million in sales-based milestones for each licensed
product; and (d)&nbsp;royalties on annual net sales of licensed products from a <FONT STYLE="white-space:nowrap">mid-single-digit</FONT> to <FONT STYLE="white-space:nowrap">low-teens</FONT> percentage, subject to customary reductions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of the Ionis Agreement will continue (i)&nbsp;with respect to the drug discovery programs, until the expiration of all applicable royalty terms for a licensed
product, (ii)&nbsp;with respect to the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Programs, until the parties cease all exploitation for the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products that are the subject to such <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program, and (iii)&nbsp;with respect to the Metagenomi Products, until the expiration of the royalty term for a Metagenomi Product. The royalty term ends on the latest of the following two dates: (i)&nbsp;the
expiration of (A)&nbsp;the last claim of any issued and unexpired patent, or (B)&nbsp;a claim within a patent application that has not been pending for more than seven years from the earliest date to which the claim or applicable patent application
is entitled to claim priority and which claim has not been revoked, cancelled, withdrawn, held invalid, or abandoned, or (ii)&nbsp;12 years following the first commercial sale of a licensed product. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Ionis Agreement may be terminated during the term by either party for an uncured material breach or bankruptcy by the other party. Additionally, Ionis may terminate
the Ionis Agreement for convenience and without penalty, in its entirety or on a licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product basis, by providing 90 days&#146; written notice.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We concluded that the Ionis Agreement is in the scope of ASC 606 at the effective date and until we exercise our <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Option for any drug discovery program, which was determined to not be probable at the effective date and as of December&nbsp;31, 2022 and September&nbsp;30, 2023. We also concluded that exclusive licenses and participation in a joint steering
committee are not distinct from discovery research services and should thus be combined into one performance obligation (the &#147;discovery program&#148;). We also concluded that exploratory research services are a separate and distinct performance
obligation (the &#147;exploratory program&#148;). As the Ionis options for Wave 2 targets are optional purchases and do not have significant incremental discounts, as such, the options do not provide material rights. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We allocated the total estimated transaction price of $90.0&nbsp;million, which consisted of an $80.0&nbsp;million upfront payment received in November 2022 and a
$10.0&nbsp;million reimbursement for research costs, into two performance obligations, and was determined based on their estimated standalone selling prices. We concluded that future development and commercial supply agreements are at market terms,
as the terms were consistent with industry standards as of the effective date. We constrain future milestone payments under the arrangement to the extent that the inclusion of such variable consideration could result in a significant reversal
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
of cumulative revenue in future periods. We constrained all development and regulatory milestone payments at the effective date and as of December&nbsp;31, 2022 and September&nbsp;30, 2023. We
are recognizing revenue of $80.0&nbsp;million related to the discovery program and of $10.0&nbsp;million related to exploratory program over the research terms using an estimated cost-based input method as a measure of progress for each obligation.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We recognized $0.1&nbsp;million in collaboration revenue in the consolidated statements of operations and comprehensive loss during the year ended December&nbsp;31,
2022. We recognized $14.4&nbsp;million in collaboration revenue in the condensed consolidated statements of operations and comprehensive loss during the nine months ended September&nbsp;30, 2023, which was included in deferred revenue as of
December&nbsp;31, 2022. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, deferred revenue related to the Ionis Agreement was $79.9&nbsp;million and $67.0&nbsp;million, respectively. The value of the transaction price allocated to the
remaining performance obligations was approximately $75.5&nbsp;million as of September&nbsp;30, 2023, which we expect to recognize as revenue over the next <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">four-to-five</FONT></FONT>
years. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For additional information regarding the lonis Agreement, please see the section titled &#147;Business&#151;Our License and Collaboration Agreements.&#148;
</P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Amendment to the LLC Agreement </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our LLC Agreement was amended on
July&nbsp;31, 2023 to provide for <FONT STYLE="white-space:nowrap">&#147;catch-up&#148;</FONT> distributions for profits interests once the applicable <FONT STYLE="white-space:nowrap">catch-up</FONT> threshold amount for such profits interests was
met (the &#147;Amendment to the LLC Agreement&#148;). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The LLC Agreement provides each profits interest with a distribution threshold amount, which is determined on
the date of issuance and represents the amount that would be distributed if, immediately after issuance, we sold all of our assets at fair market value and distributed the net proceeds in liquidation. A profits interest does not participate in our
distributions until an amount equal to its distribution threshold amount has been distributed to our other members with units that either have a lower threshold amount or no threshold amount. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Once the applicable distribution threshold amount has been met for a particular profits interest, such profits interest will participate in our distributions on a pro
rata basis until the <FONT STYLE="white-space:nowrap">catch-up</FONT> threshold amount has been met. Once the <FONT STYLE="white-space:nowrap">catch-up</FONT> threshold amount has been met, subsequent
<FONT STYLE="white-space:nowrap">&#147;catch-up&#148;</FONT> distributions will be made solely to holders of profits interests until such holders have received an amount equal to the amount such holders would have received had the distribution
threshold not existed. Once the profits interest holders have received distributions in an amount equal to what they would have received had the distribution threshold not existed, all subsequent distributions are made on a pro rata basis with
common unitholders.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The <FONT STYLE="white-space:nowrap">catch-up</FONT> threshold amount of $11.84 per unit reflected the estimated fair
value of the common unit as of July&nbsp;31, 2023, as determined by our board of managers, with input from management, and considering our most recently available third-party valuation of common units. The amendment to the LLC Agreement resulted in
a change to the fair value of the profits interests and is accounted for as a modification of the profits interests&#146; awards. We estimated total modification expense of $10.3&nbsp;million. We recognized $1.1&nbsp;million associated unit-based
compensation expense related to vested profits interests as of the modification date, and the remaining $9.2&nbsp;million is expected to be recognized over the next 3.3 years, as profits interests continue to vest. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Reorganization </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We currently operate as a Delaware limited liability company
under the name Metagenomi Technologies, LLC. Prior to the effectiveness of this registration statement, we intend to complete a series of transactions pursuant to which Metagenomi Technologies, LLC will merge with and into its wholly-owned
subsidiary, Metagenomi, Inc., a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Delaware corporation, with Metagenomi, Inc. continuing as the surviving corporation. In connection with the Reorganization (i)&nbsp;all of the outstanding common unitholders of Metagenomi
Technologies, LLC will receive shares of common stock of Metagenomi, Inc., (ii) all of the outstanding redeemable convertible preferred unitholders of Metagenomi Technologies, LLC will receive shares of redeemable convertible preferred stock of
Metagenomi, Inc. and (iii)&nbsp;all of the outstanding holders of profits interests in Metagenomi Technologies, LLC will receive shares of common stock or restricted common stock in Metagenomi, Inc. For more information on the Reorganization, see
the section titled &#147;Reorganization&#148; included elsewhere in this prospectus. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Components of Results of Operations </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Collaboration Revenue </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have not generated any revenue from product
sales and do not expect to generate any revenue from the sale of products for the foreseeable future. Our ability to generate product revenues will depend on the successful development and eventual commercialization of any product candidates that we
identify. If we fail to complete the development of any future product candidates in a timely manner or to obtain regulatory approval for such product candidates, our ability to generate future revenue and our results of operations and financial
position would be materially adversely affected. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To date, all of our revenue consists of collaboration revenue, earned from collaboration agreements with Moderna,
Ionis and <FONT STYLE="white-space:nowrap">Affini-T.</FONT> These agreements may include the following types of promised goods or services: (i)&nbsp;grants of licenses, (ii)&nbsp;performance of research and development services and
(iii)&nbsp;participation on joint research and/or development committees. They also may include options to obtain licenses to our intellectual property or to extend the term of the research activities. Our revenues under such collaboration
agreements were $0.2&nbsp;million and $17.2&nbsp;million for the years ended December&nbsp;31, 2021 and 2022, respectively. Our revenues under collaboration agreements were $11.6&nbsp;million and $32.4&nbsp;million for the nine months ended
September&nbsp;30, 2022 and 2023, respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For additional information about our revenue recognition policy related to our collaboration agreements, refer to
Note 2 in our audited consolidated financial statements included elsewhere in this prospectus. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Operating Expenses </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our operating expenses consist of (i)&nbsp;research and development expenses and (ii)&nbsp;general and administrative expenses. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Research and Development </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The largest component of our total operating
expenses since our inception has been research and development activities. Research and development expenses consist primarily of compensation and benefits for research and development employees, including unit-based&nbsp;compensation; the costs of
acquiring research and development supplies and services; manufacturing process development costs; the research and development expenses that we share with our collaboration partners for <FONT STYLE="white-space:nowrap">co-development</FONT>
programs; other outside services and consulting costs; and allocated facilities, information technology and overhead expenses. Research and development costs are expensed as&nbsp;incurred. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have not reported program costs since our inception because we have not historically tracked or recorded our research and development expenses on <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">a&nbsp;program-by-program&nbsp;basis.</FONT></FONT> We use our personnel and infrastructure resources across the breadth of our research and development activities, which are directed
toward developing our platform. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We expect our research and development expenses to increase substantially for the foreseeable future as we continue to
invest in research and development activities related to developing our platform, including investments in manufacturing, as we advance our programs and conduct clinical trials. The process of conducting the necessary clinical research to obtain
regulatory approval is costly and time-consuming, and the successful development of our platform is highly uncertain. As a result, we are unable to determine the duration and completion costs of our research and development projects, the costs of
related clinical development costs or when and to what extent we will generate revenue from the commercialization of our platform. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>General and Administrative
</I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">General and administrative expenses consist primarily of personnel costs, including unit-based compensation expense and other expenses for outside professional
services, including legal fees relating to intellectual property and corporate matters; professional fees for accounting, auditing, consulting and tax services; insurance costs; administrative travel expenses; website development costs; marketing
and public relations costs; and facilities, information technology and other allocated overhead costs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We anticipate that our general and administrative expenses
will increase in the future as we increase our headcount to support development of our platform and our continued research activities. We also anticipate that we will incur increased accounting, audit, legal, regulatory, compliance and director and
officer insurance costs as well as investor and public relations expenses associated with being a public company. We also expect our intellectual property expenses to increase as we expand our intellectual property portfolio. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Total Other Income, Net </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Total other income, net includes interest
income from our investments in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, grant income, change in fair value of our investments in the
<FONT STYLE="white-space:nowrap">Affini-T</FONT> convertible note, preferred stock and common stock shares related to our investment in <FONT STYLE="white-space:nowrap">Affini-T</FONT> interest expense on the Moderna convertible note issued in
November 2021, which was converted into redeemable convertible preferred units in January 2022. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Provision for Income Taxes </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi Technologies, LLC is taxed under the provisions of Subchapter K &#151; Partners and Partnerships of the Internal Revenue Code. Under those provisions,
Metagenomi Technologies, LLC does not pay federal or state corporate income taxes on its taxable income. Instead, each member includes net operating income or loss for Metagenomi on its individual return. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The wholly owned subsidiary of Metagenomi Technologies, LLC, Metagenomi Inc., is a corporation for tax purposes and is subject to income taxes. We recognized income tax
expense for the year ended December&nbsp;31, 2022 and for the nine months ended September&nbsp;30, 2022 and 2023 for domestic federal and state income taxes. After giving effect to this offering, Metagenomi, Inc. will continue as the surviving
corporation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022, we had net operating loss carryforwards of $0.02&nbsp;million and $8.3&nbsp;million for federal and state income tax
purposes, respectively, available to reduce future taxable income, if any. The federal net operating loss carryforwards do not expire. State net operating loss carryforwards begin expiring in 2037. As of December&nbsp;31, 2022, we had state research
and development credit carryforwards of $2.8&nbsp;million, which do not expire. As of December&nbsp;31, 2022, we had no federal research and development credit carryforwards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A valuation allowance is provided for deferred tax assets where the recoverability of the assets is uncertain. The
determination to provide a valuation allowance is dependent upon the assessment of whether it is more likely than not that sufficient future taxable income will be generated to utilize the deferred tax assets. Based on the weight of the available
evidence, which includes our consolidated entities&#146; historical operating losses and forecast of future losses, we have provided a full valuation allowance against the deferred tax assets resulting from the tax loss and credits carried forward.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Utilization of the net operating loss and credit carryforwards may be subject to a substantial annual limitation due to an ownership change limitation as provided
by section 382 of the Internal Revenue Code, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. In the event that we have a change of ownership,
utilization of the net operating loss and tax credit carryforwards may be restricted. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Results of Operations </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Comparison of the Nine Months Ended September&nbsp;30, 2022 and 2023 </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes our results of operations for the nine months ended September&nbsp;30, 2022 and 2023 (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine Months ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">32,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,752</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,874</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,422</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in fair value of long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss before provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,243</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,660</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,723</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,301</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,578</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(28,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,961</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19,995</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Collaboration Revenue </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our revenue
consists of collaboration revenue recognized under our agreements with Moderna, <FONT STYLE="white-space:nowrap">Affini-T</FONT> and Ionis. We recognize revenue as the performance obligations are satisfied. Collaboration revenue increased by
$20.8&nbsp;million, from $11.6&nbsp;million for the nine months ended September&nbsp;30, 2022 to $32.4&nbsp;million for the nine months ended September&nbsp;30, 2023. The increase in collaboration revenue for the nine months ended September&nbsp;30,
2023, was primarily driven by an increase in revenue of $14.4&nbsp;million related to the Ionis agreement, which we entered in November 2022. We did not recognize revenue under this agreement during the nine months ended September&nbsp;30, 2022.
Collaboration revenue related to Moderna and <FONT STYLE="white-space:nowrap">Affini-T</FONT> agreements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
increased by $6.3&nbsp;million for the nine months ended September&nbsp;30, 2023 compared to the nine months ended September&nbsp;30, 2022, as we performed more services and our collaboration
activities progressed. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The collaboration revenue for the nine months ended September&nbsp;30, 2022 and 2023 included the following (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine Months ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Moderna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Affini-T</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Ionis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">32,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,752</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Research and Development Expenses </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
following table summarizes our research and development expenses for the periods indicated (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine Months ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Personnel-related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Laboratory materials and supplies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,059</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Facilities and overhead costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other research and development expenses and consulting costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">792</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Research and development expenses increased by $41.6&nbsp;million, from $28.1&nbsp;million for the nine months ended September&nbsp;30,
2022 to $69.6&nbsp;million for the nine months ended September&nbsp;30, 2023. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Personnel-related costs, including employee payroll and related expenses, increased by
$13.0&nbsp;million, including a $1.6&nbsp;million increase in unit-based compensation expense, as a result of increased headcount in our research and development organization, increase in fair value of common units and recognition of modification
expense resulting from the Amendment to the LLC Agreement in July 2023. Laboratory materials and supplies increased by $8.1&nbsp;million due to significant expansion of our research and development operations. Facilities and allocated overhead
costs, including rent and facilities, depreciation and amortization, repairs and maintenance and information technology-related expenses allocated to research and development increased by $10.6&nbsp;million, including a $5.8&nbsp;million increase in
rent and facilities expenses as we entered into a new lease agreement in November 2022 that commenced in January 2023, and a $1.9&nbsp;million increase in depreciation and amortization expense as we continue investing in our manufacturing facility.
Other research and development and consulting costs increased by $10.0&nbsp;million mainly due to external research and development costs of $5.9&nbsp;million and consulting services of $1.6&nbsp;million to support our research and <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> development activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Other research and development and consulting costs include expenses related to the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> program under the Moderna Agreement. Each quarter, a <FONT STYLE="white-space:nowrap">true-up</FONT> is performed to calculate how much is owed by us or Moderna to equally split the costs incurred during the
quarter towards the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program. When Moderna owes a payment to us, we account for this as a reduction of research and development expense. When we owe a </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
payment to Moderna, we account for this as an addition to research and development expense. For the nine months ended September&nbsp;30, 2022 and 2023, the total cost <FONT
STYLE="white-space:nowrap">true-ups</FONT> reduced our research and development expenses by $0.5&nbsp;million and $0.3&nbsp;million, respectively. Additionally, we amortized $2.7&nbsp;million and $0.5&nbsp;million of the upfront $5.0&nbsp;million
payment received from Moderna allocated to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program to offset our share of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> development costs for the nine months ended September&nbsp;30, 2022
and 2023, respectively. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>General and Administrative Expenses </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">General and administrative expenses increased by $8.6&nbsp;million, from $12.4&nbsp;million for the nine months ended September&nbsp;30, 2022 to $21.0&nbsp;million for
the nine months ended September&nbsp;30, 2023, as we continued expanding our operations to support our business strategy and the development of therapeutic programs utilizing our metagenomics platform. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Employee payroll and related expenses increased by $4.5&nbsp;million, including a $1.7&nbsp;million increase in unit-based compensation expense, as a result of increase
in headcount of our executives and administrative personnel, increase in fair value of common units and recognition of modification expense resulting from the Amendment to the LLC Agreement in July 2023. Expenses related to professional consulting
services increased by $3.7&nbsp;million due to increased spending on consulting and outside services to support our growing operations. Other general and administrative expenses, including rent, facilities, insurance, information technology, office
supplies, subscriptions and licenses and other miscellaneous expenses, increased by $0.4&nbsp;million. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Total Other Income, Net </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Total other income, net, increased by $13.0&nbsp;million, from $1.6&nbsp;million net income for the nine months ended September&nbsp;30, 2022 to $14.6&nbsp;million for
the nine months ended September&nbsp;30, 2023. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Interest income, which includes interest income and amortization of premiums and discounts on our investments in <FONT
STYLE="white-space:nowrap">available-for</FONT> sale marketable securities, increased by $10.3&nbsp;million from $1.5&nbsp;million for the nine months ended September&nbsp;30, 2022 to $11.8&nbsp;million for the nine months ended September&nbsp;30,
2023, due to increased investment activity and higher interest rates during the nine months ended September&nbsp;30, 2023. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The change in fair value of long-term
investments increased by $2.8&nbsp;million, from $0.1&nbsp;million for the nine months ended September&nbsp;30, 2022 to $2.9&nbsp;million for the nine months ended September&nbsp;30, 2023, as our investment in
<FONT STYLE="white-space:nowrap">Affini-T</FONT> was <FONT STYLE="white-space:nowrap">re-measured</FONT> at fair value. For more details on our investment in <FONT STYLE="white-space:nowrap">Affini-T,</FONT> refer to Note 5 in our unaudited
condensed consolidated financial statements included elsewhere in this prospectus. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Provision for Income Taxes </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We recognized an income tax provision as a result of our taxable income related to upfront payments received under the Moderna and Ionis agreements and the change in the
net capitalization of our research and development expenses under the newly enacted Internal Revenue Code Section&nbsp;174 (&#147;Section&nbsp;174&#148;), which became effective on January&nbsp;1, 2022. Section&nbsp;174 changed the tax treatment of
research and experimentation (R&amp;E) expenditures, which requires the capitalization of R&amp;E expenditures over a period of five years for R&amp;E paid or incurred in the United States and 15 years for R&amp;E paid or incurred outside of the
United States. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For the nine months ended September&nbsp;30, 2022 and 2023, we recorded a provision for income taxes of $1.7&nbsp;million and $5.3&nbsp;million by
applying the estimated annual effective tax rate to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-to-date</FONT></FONT> measure of ordinary income, respectively. The increase in the income tax provision during the nine
months ended September&nbsp;30, 2023 is primarily due to the increase in forecasted research and development spend, which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
results in corresponding increases to Section&nbsp;174 capitalization, and taxable income related to the Ionis upfront payment which is partially offset by an increase in forecasted research and
development credit. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Comparison of the Years Ended December&nbsp;31, 2021 and 2022 </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes our results of operations for the years ended December&nbsp;31, 2021 and 2022 (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,957</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,947</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,640</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,693</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,376</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in fair value of long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,666</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss before provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,582</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,569</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,569</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(43,593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(22,151</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Collaboration Revenue </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our revenue
consists of collaboration revenue recognized under our agreements with Moderna, <FONT STYLE="white-space:nowrap">Affini-T</FONT> and Ionis. We recognize revenue as the performance obligations are satisfied. Collaboration revenue increased by
$17.0&nbsp;million, from $0.2&nbsp;million for the year ended December&nbsp;31, 2021 to $17.2&nbsp;million for the year ended December&nbsp;31, 2022. The increase in collaboration revenue for the year ended December&nbsp;31, 2022, was primarily
driven by a $14.3&nbsp;million increase in revenue related to the Moderna Agreement as our research and collaboration activities progressed and a $2.7&nbsp;million increase related to the <FONT STYLE="white-space:nowrap">Affini-T</FONT> and Ionis
agreements, which we entered into in June and November 2022, respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The collaboration revenue for the years ended December&nbsp;31, 2021 and 2022 included
the following: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Moderna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Affini-T</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Ionis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,957</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes our research and development expenses for the periods indicated (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Personnel-related costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,436</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Laboratory materials and supplies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,004</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Facilities and overhead costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other research and development expenses and consulting costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total research and development expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">43,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Research and development expenses increased by $28.7&nbsp;million, from $14.5&nbsp;million for the year ended December&nbsp;31, 2021 to
$43.1&nbsp;million for the year ended December&nbsp;31, 2022. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Personnel-related costs, including employee payroll and related expenses, increased by
$15.5&nbsp;million, including a $0.7&nbsp;million increase in unit-based compensation expense, as a result of increased headcount in our research and development organization. Laboratory materials and supplies increased by $7.0&nbsp;million due to
significant expansion of our research and development operations. Facilities and allocated overhead, including rent, repairs and maintenance costs, common facilities and information technology related expenses allocated to research and development
increased by $4.2&nbsp;million as a result of the expansion of our business operations. Other research and development and consulting costs increased by $2.0&nbsp;million due to increases in external consulting services to support our research and <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> development activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Other research and development and consulting costs include expenses related to the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> program under our collaboration agreement with Moderna. Each quarter, a <FONT STYLE="white-space:nowrap">true-up</FONT> is performed to calculate how much is owed by us or Moderna to equally split the costs
incurred during the quarter towards the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program. When Moderna owes a payment to us, we account for this as a reduction of research and development expense. When we owe a payment to Moderna, we account
for this as an addition to research and development expense. For the years ended December&nbsp;31, 2021 and 2022, the total cost <FONT STYLE="white-space:nowrap">true-ups</FONT> reduced our research and development expenses by $0.2&nbsp;million and
$0.9&nbsp;million, respectively. Additionally, for the year ended December&nbsp;31, 2021, $5.0&nbsp;million of the upfront payment received under the Moderna Agreement in November 2021 was allocated to the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> program, which was presented as a collaboration advance on our consolidated balance sheet. For&nbsp;the years ended December&nbsp;31, 2021 and 2022, $0.3&nbsp;million and $3.5&nbsp;million of this
upfront payment was amortized, respectively, to offset our share of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> development costs. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>General and
Administrative Expenses </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">General and administrative expenses increased by $9.0&nbsp;million, from $9.7&nbsp;million for the year ended December&nbsp;31, 2021
to $18.7&nbsp;million for the year ended December&nbsp;31, 2022. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Employee payroll and related expenses increased by $3.3&nbsp;million, including a $0.7&nbsp;million
increase in unit-based compensation expense, as a result of increase in headcount of our executives and administrative personnel. Expenses related to professional consulting services increased by $4.1&nbsp;million due to increased spending on
consulting and outside services to support our growing operations. Other general and administrative expenses, including insurance, information technology, office supplies, subscriptions and licenses, and other miscellaneous expenses, increased by
$1.6&nbsp;million as we continued expanding our operations to support our business strategy and the development of therapeutic programs utilizing our metagenomics platform. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Total Other Income, Net </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Total other income, net, increased by $1.1&nbsp;million, from $2.5&nbsp;million net income for the year ended December&nbsp;31, 2021 to $3.6&nbsp;million for the year
ended December&nbsp;31, 2022. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Interest income, which includes interest income and amortization of premiums and discounts on our investment in <FONT
STYLE="white-space:nowrap">available-for</FONT> sale marketable securities, increased by $3.4&nbsp;million from $0.04&nbsp;million for the year ended December&nbsp;31, 2021 to $3.4&nbsp;million for the year ended December&nbsp;31, 2022, due to
increased investment activity and higher interest rates during the year ended December&nbsp;31, 2022. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The change in fair value of long-term investments decreased by
$2.7&nbsp;million, from $2.8&nbsp;million for the year ended December&nbsp;31, 2021 to $0.1&nbsp;million for the year ended December&nbsp;31, 2022, as our investment in the <FONT STYLE="white-space:nowrap">Affini-T</FONT> convertible promissory note
was <FONT STYLE="white-space:nowrap">re-measured</FONT> at fair value and converted to preferred stock shares of <FONT STYLE="white-space:nowrap">Affini-T</FONT> in March 2022. For more details on our investment in the
<FONT STYLE="white-space:nowrap">Affini-T</FONT> convertible promissory note, refer to Note 5 in our audited consolidated financial statements included elsewhere in this prospectus. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Provision for Income Taxes </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We recognized an income tax provision of
$2.6&nbsp;million for the year ended December&nbsp;31, 2022 as a result of our taxable income related to an upfront payment received under the Moderna Agreement and the change in the net capitalization of our research and development expenses under
the newly enacted Internal Revenue Code Section&nbsp;174 (&#147;Section&nbsp;174&#148;), which became effective on January&nbsp;1, 2022. Section&nbsp;174 changed the tax treatment of research and experimentation (R&amp;E) expenditures, which
requires the capitalization of R&amp;E expenditures over a period of five years for R&amp;E paid or incurred in the United States and 15 years for R&amp;E paid or incurred outside of the United States. We did not recognize income taxes for the year
ended December&nbsp;31, 2021. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Sources of Liquidity </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Since our inception, we have incurred significant
operating losses. We have historically funded our operations primarily through sales of our redeemable convertible preferred units and convertible promissory notes, which generated approximately $351.6&nbsp;million in aggregate gross proceeds.
Additionally, through September&nbsp;30, 2023, we received approximately $120.0&nbsp;million upfront cash payments from collaboration and licensing agreements. As of September&nbsp;30, 2023, we had $292.9&nbsp;million in cash, cash equivalents and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Future Funding Requirements </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance the development of our platform. In addition, upon
the completion of this offering, we expect to incur additional costs associated with operating as a public company. The timing and amount of our operating expenditures will depend largely on: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the timing and progress of research and development, preclinical&nbsp;and clinical development activities;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the number, scope and duration of clinical trials required for regulatory approval of our future product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs, timing, and outcome of regulatory review of any of our future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs of manufacturing clinical and commercial supplies of our future product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales and
distribution, for any of our future product candidates for which we receive regulatory approval; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the cost of filing and prosecuting our patent applications, and maintaining and enforcing our patents and other
intellectual property rights; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to maintain existing, and establish new, strategic collaborations, licensing or other arrangements, and the
financial terms of any such agreements, including the timing and amount of any future milestone, royalty or other payments due under any such agreement; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any product liability or other lawsuits related to our future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our implementation of various computerized informational systems and efforts to enhance operational systems;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">expenses incurred to attract, hire and retain skilled personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the costs of operating as a public company; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our ability to establish a commercially viable pricing structure and obtain approval for coverage and adequate
reimbursement from third-party and government payers; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the extent to which we acquire or invest in businesses, products, and technologies; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the effect of competing technological and market developments; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, as well as other factors, including inflation,
economic uncertainty and geopolitical tensions, which may exacerbate the magnitude of the factors discussed above. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September&nbsp;30, 2023,
we had $292.9&nbsp;million in cash, cash equivalents and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities. We believe that our existing cash, cash equivalents and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities will be sufficient to fund our current operating plan for at least the next 12 months. Based on our current operating plan, we
estimate that our existing cash, cash equivalents and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, together with the estimated net proceeds from this offering, will be
sufficient to fund our projected operating expenses and capital expenditure requirements into&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. We have based this estimate on assumptions that may prove
to be wrong, and we could exhaust our available capital resources sooner than we expect. We expect that we will require additional funding to: continue our current research development activities; develop, maintain, expand and protect our
intellectual property portfolio; further develop our platform; and hire additional research, clinical and scientific personnel. If we receive regulatory approval for any of our product candidates, we expect to incur significant commercialization
expenses related to product manufacturing, sales, marketing and distribution, depending on where we choose to commercialize our products. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Until such time, if ever,
as we can generate substantial product revenue, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances, and marketing, distribution or licensing arrangements with third
parties. To the extent that we raise additional capital through the sale of equity or convertible debt securities, ownership interest for existing investors may be materially diluted, and the terms of such securities could include liquidation or
other preferences that adversely affect existing investors&#146; rights as a stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include restrictive covenants that limit our ability to take specified
actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to
relinquish valuable rights to our technologies, future revenue streams, research programs or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we
may be required to delay, reduce or eliminate our product development or future commercialization efforts, or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Cash Flows </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes our sources and uses of
cash for the periods presented (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years&nbsp;ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;Months&nbsp;ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash provided by (used in) operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(38,009</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(70,817</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,316</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(122,200</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,898</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net (decrease) increase in cash, cash equivalents and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10,137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">147,118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(83,369</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Cash Flows from Operating Activities </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net
cash used in operating activities for the nine months ended September&nbsp;30, 2022 was $38.0&nbsp;million. This was primarily due to our net loss for the period of $29.0&nbsp;million, decreased by net
<FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $3.2&nbsp;million and increased by a net reduction of $12.2&nbsp;million in our net operating assets and liabilities. The net <FONT STYLE="white-space:nowrap">non-cash</FONT> charges
primarily consisted of $1.4&nbsp;million in unit-based compensation expense, $1.0&nbsp;million in <FONT STYLE="white-space:nowrap">non-cash</FONT> lease expense and $1.0&nbsp;million in depreciation and amortization expense. The net change in our
operating assets and liabilities primarily consisted of a $14.3&nbsp;million decrease in deferred revenue and collaboration advances as we recognized collaboration revenue under the Moderna and <FONT STYLE="white-space:nowrap">Affini-T</FONT>
agreements and a $1.4&nbsp;million increase in prepaid expenses and other current assets, partially offset by a $2.1&nbsp;million increase in accrued expenses and other current liabilities, a $1.0&nbsp;million increase in income tax payable and a
$0.7&nbsp;million increase in other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash used in operating activities for the nine months ended
September&nbsp;30, 2023 was $70.8&nbsp;million. This was primarily due to our net loss of $49.0&nbsp;million, decreased by net <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $0.2&nbsp;million and increased by a net reduction of
$22.1&nbsp;million in our net operating assets and liabilities. The net <FONT STYLE="white-space:nowrap">non-cash</FONT> charges consisted of $4.5&nbsp;million in unit-based compensation expense, $3.1&nbsp;million in
<FONT STYLE="white-space:nowrap">non-cash</FONT> lease expense and $3.0&nbsp;million in depreciation and amortization expense, all partially offset by $6.9&nbsp;million credit related to amortization of the discounts on <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, $2.9&nbsp;million for the change in fair value of our investments in <FONT STYLE="white-space:nowrap">Affini-T</FONT> and
$0.7&nbsp;million in amortization of <FONT STYLE="white-space:nowrap">non-cash</FONT> collaboration revenue related to the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement. The net change in our operating assets and liabilities primarily
consisted of a $25.0&nbsp;million decrease in deferred revenue and collaboration advances as we recognized revenue under our collaboration agreements, and a $3.9&nbsp;million increase in accounts receivable related to the <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Agreement and the Moderna Agreement, a $1.0&nbsp;million decrease in operating lease liabilities due to recurring payments under the existing lease agreements, all partially offset by a $2.4&nbsp;million
increase in accounts payable due to the timing of payments to our vendors, a $2.4&nbsp;million increase in other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities, a $1.3&nbsp;million decrease in contract assets related to the <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Agreement, a $0.7&nbsp;million increase in accrued expenses and other current liabilities, a $0.6&nbsp;million increase in income tax payable due to additional tax expense, and a $0.4&nbsp;million decrease
in prepaid expenses and other current assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash provided by operating activities for the year ended December&nbsp;31, 2021 was $24.3&nbsp;million. This is
primarily due to our net loss for the period of $21.4&nbsp;million adjusted by net <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $0.6&nbsp;million and a net change of $46.3&nbsp;million in our net operating assets and liabilities. The <FONT
STYLE="white-space:nowrap">non-cash</FONT> charges primarily consisted of $2.8&nbsp;million for the change in fair value of our investment in the <FONT STYLE="white-space:nowrap">Affini-T</FONT> convertible note and $0.9&nbsp;million for <FONT
STYLE="white-space:nowrap">non-cash</FONT> lease expense. The changes in our net operating assets and liabilities primarily consisted of a $44.2&nbsp;million increase in deferred revenue primarily due to the receipt of an upfront payment under the
Moderna Agreement, a $1.9&nbsp;million increase in accrued expenses and other current liabilities and a $0.7&nbsp;million increase in accounts payable, partially offset by a $0.5&nbsp;million increase in prepaid expenses and other current assets.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash provided by operating activities for the year ended December&nbsp;31, 2022 was $29.7&nbsp;million. This was primarily due to our net loss of
$43.6&nbsp;million, adjusted by net <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $3.8&nbsp;million and a net change of $69.5&nbsp;million in our net operating assets and liabilities. The
<FONT STYLE="white-space:nowrap">non-cash</FONT> charges primarily consisted of $2.0&nbsp;million of unit-based compensation expense, $1.7&nbsp;million of depreciation expense and $1.3&nbsp;million for
<FONT STYLE="white-space:nowrap">non-cash</FONT> lease expense, reduced by $1.1&nbsp;million for the amortization of the discount on our investment in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities. The changes in our net operating assets and liabilities primarily consisted of a $65.7&nbsp;million increase in deferred revenue primarily due to the receipt of an upfront payment under the Ionis Agreement, a $4.5&nbsp;million
increase in accrued expenses and other current liabilities, a $1.5&nbsp;million increase in income tax payable and a $1.0&nbsp;million increase in other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities, partially offset by an increase
of $2.5&nbsp;million in prepaid expenses and other current assets and an increase of $1.3&nbsp;million in contract assets. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Cash Flows from Investing Activities
</I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash used in investing activities for the nine months ended September&nbsp;30, 2022 was $83.3&nbsp;million, which consisted of $136.6&nbsp;million of
purchases of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities and $10.5&nbsp;million of purchases of property and equipment, partially offset by $63.8&nbsp;million in proceeds
from maturities and sales of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash used
in investing activities for the nine months ended September&nbsp;30, 2023 was $14.9&nbsp;million, which consisted of $169.0&nbsp;million of purchases of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities and $8.1&nbsp;million of purchases of property and equipment, partially offset by $162.2&nbsp;million in proceeds from
maturities and sales of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash used in
investing activities for the year ended December&nbsp;31, 2021 was $74.3&nbsp;million, which consisted of $69.3&nbsp;million of purchases of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities, $2.9&nbsp;million of purchases of property and equipment and $2.2&nbsp;million investment in preferred stock of ViTToria Biotherapeutics, Inc. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash used in investing activities for the year ended December&nbsp;31, 2022 was $122.2&nbsp;million, which consisted of $214.9&nbsp;million of purchases of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, $14.0&nbsp;million of purchases of property and equipment, partially offset by $106.6&nbsp;million in proceeds from maturities and
sales of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Cash Flows from Financing
Activities </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash provided by financing activities for the nine months ended September&nbsp;30, 2022 was $144.3&nbsp;million, which consisted of net cash
proceeds received from the issuance of Series B redeemable convertible preferred units. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash provided by financing activities for the nine months ended September&nbsp;30, 2023 was $2.3&nbsp;million,
which consisted of $4.3&nbsp;million of net cash proceeds from our issuance of Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred units, partially offset by $1.9&nbsp;million payments of initial public offering
costs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash provided by financing activities for the year ended December&nbsp;31, 2021 was $39.9&nbsp;million, which consisted of $30.0&nbsp;million net cash
proceeds received from the issuance of a convertible note and $9.9&nbsp;million net cash proceeds from our issuance of Series <FONT STYLE="white-space:nowrap">A-5</FONT> preferred units. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Net cash provided by financing activities for the year ended December&nbsp;31, 2022 was $239.6&nbsp;million, which consisted of net cash proceeds from our issuance of
Series B and Series <FONT STYLE="white-space:nowrap">B-1</FONT> preferred units. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Contractual Obligations and Commitments </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Leases </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022, our future remaining operating lease
payments were $3.3&nbsp;million within the next twelve months and $23.9&nbsp;million for the remainder of the leases&#146; terms, with respect to leases already commenced as of such date. In addition, we entered into a lease in November 2022 with a
lease commencement date in January 2023, for which we are obligated to make lease payments of $2.9&nbsp;million in the next twelve months and $46.2&nbsp;million through March 2031. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September&nbsp;30, 2023, we leased our office and laboratory space under three lease agreements with a weighted-average remaining lease term of 7.4 years.
Remaining lease obligations under our <FONT STYLE="white-space:nowrap">non-cancellable</FONT> leases were $72.3&nbsp;million as of September&nbsp;30, 2023, including $1.6&nbsp;million payable through December&nbsp;31, 2023 and $70.7&nbsp;million for
the reminder of the leases&#146; terms. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Refer to Note 10 in our audited consolidated financial statements and Note 8 in our unaudited condensed consolidated
financial statements included elsewhere in this prospectus for more information on our lease obligations. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Recently Issued Accounting Pronouncements </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A description of recently issued accounting pronouncements that may potentially impact our financial position, results of operations or cash flows is disclosed in Note 2
to our consolidated financial statements included elsewhere in this prospectus. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Critical Accounting Policies and Significant Judgments and Estimates </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our management&#146;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in
accordance with generally accepted accounting principles (&#147;GAAP&#148;). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of
contingent assets and liabilities at the date of the financial statements, as well as the reported expenses incurred during the reporting periods. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On an ongoing
basis, we evaluate our estimates and judgments, including but not limited to those related to revenue recognition under our collaboration agreements, accrued research and development costs, the fair value of common units and unit-based compensation
expense, the valuation of deferred tax assets, and uncertain income tax positions. These estimates and assumptions are monitored and analyzed by us for changes in facts and circumstances, and material changes in these estimates and assumptions could
occur in the future. Our estimates are based on our historical experience and on various other factors that we believe </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other
sources. Changes in estimates are reflected in reported results for the period in which they become known. Actual results may differ from these estimates under different assumptions or conditions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">While our significant accounting policies are described in more detail in Note&nbsp;2 to our audited consolidated financial statements and unaudited condensed
consolidated financial statements included elsewhere in this prospectus, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Collaboration Arrangements and Revenue Recognition </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We apply judgment
to determine whether a collaboration agreement is within the scope of revenue recognition, Accounting Standard Codification Topic 606, <I>Revenue from Contract with Customers</I>, or other accounting guidance at the effective date and throughout the
term of the agreement. We perform the following five steps in determining the appropriate amount of revenue to be recognized as we fulfill our obligations under each of these agreements: 1) identification of the promised goods and services in the
contract; 2) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; 3) measurement of the transaction price, including any constraint on variable
consideration; 4) allocation of the transaction price to the performance obligations; and 5) recognition of revenue when, or as, we satisfy each performance obligation. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Promises in collaboration agreements may include (i)&nbsp;grants of licenses, (ii)&nbsp;performance of research and development services, and (iii)&nbsp;participation on
joint research and/or development committees. They also may include options to obtain licenses to our intellectual property or to extend the term of the research activities. We assess whether each promise is a distinct performance obligation and
should be accounted for separately or should be combined with other promises into one performance obligation. Judgment is required to determine whether the license to intellectual property is distinct from the research and development services or
participation on steering committees. The event-based milestone payments, royalties and cost reimbursements represent variable consideration. We evaluate the probability that the event-based milestones will be achieved and estimates the amount to be
included in the transaction price using the most likely amount method. We include cost reimbursement in the transaction price using the expected value method. Unlike other contingency payments, sales-based milestones and royalties are not included
in the transaction price based on estimates at the inception of the contract, but rather, are included when sales or usage occur. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To estimate the transaction price,
we include upfront payment and variable consideration, such as research and development milestones, reimbursement for our services, that is subject to a constraint. Amounts of variable consideration are included in the transaction price to the
extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur and when the uncertainty associated with the variable consideration is subsequently resolved. These estimates are <FONT
STYLE="white-space:nowrap">re-assessed</FONT> each reporting period as required. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">After we estimate the transaction price, we allocate it to the identified
performance obligations based on the standalone selling price (&#147;SSP&#148;) of each distinct performance obligation. Judgment is required to determine the SSP. In instances where the SSP is not directly observable, such as when a license or
service is not sold separately, the SSP is determined using information that may include market conditions and other observable inputs. When licenses are combined with other promises, we utilize our judgment to assess the nature of the combined
performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If we conclude over time, we recognize revenue based on the measure of progress
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
using an estimated cost-based input method each reporting period. In applying the cost-based input method, we measure actual costs incurred relative to budgeted costs to fulfill our performance
obligation.&nbsp;These budgeted costs consist of our employee full-time equivalent hours plus allowable external (third-party) costs incurred. Management applies considerable judgment in estimating expected costs as such costs are key inputs when
applying the cost-based input method. We recognize revenue based on actual costs incurred as a percentage of total budgeted costs as we complete a performance obligation applied to the transaction price. A significant change in the estimate of
expected costs for the remainder of a contract term could have a material impact on revenue recognized, including the possible reversal of previously recognized revenue, at each reporting period, as well as a related impact on contract assets and
liabilities. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Accrued Research and Development Expenses </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Research
and development expenses are recognized as services are performed and as costs occur. Research and development expense accruals are estimated based on the level of services performed, progress of the work orders, including the phase or completion of
events, and contracted costs. We make significant judgments and estimates in determining the accrual balance at each reporting period. If the actual timing of the performance of services or the level of effort varies from the original estimates, we
will adjust the accrual accordingly. To date, there have been no material differences between estimates of such expenses and the amounts actually incurred. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are capitalized and recorded in prepaid
expenses and other current assets, and then expensed as the related goods are delivered or the services are performed. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Unit-Based Compensation Expense
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Unit-based compensation expense related to the profits interests granted to employees, consultants and our board of managers members is measured at the
grant date based on the fair value of the profits interests. Compensation expense for those awards is recognized over the requisite service period, which is generally the vesting period. We use the straight-line method to record the expense of
awards with service-based vesting conditions. We account for forfeitures as they occur. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Prior to July&nbsp;31, 2023, we used the Black-Scholes option-pricing model
to determine the fair value of profits interests. The following summarizes the inputs used: </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Common Unit Fair Value</I>&nbsp;&#151; See the subsection titled
&#147;&#151;Determination of Fair Value of Common Units&#148; below. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Expected Volatility</I><I></I>&nbsp;&#151;&nbsp;Expected volatility was estimated by
studying the volatility of the prices of shares of common stock of comparable public companies for similar terms. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Expected
Term</I><I></I>&nbsp;&#151;&nbsp;Expected term represents the period that our profits interests were expected to be outstanding and expected exit/liquidation term. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Risk-Free Interest Rate</I><I></I>&nbsp;&#151;&nbsp;The risk-free interest rate is based on the U.S.&nbsp;Treasury <FONT STYLE="white-space:nowrap">zero-coupon</FONT>
bonds issued in effect at the time of grant for periods corresponding with the expected term of the option. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Expected Dividend</I><I></I>&nbsp;&#151;&nbsp;The
Black-Scholes valuation model calls for a single expected dividend yield as an input. To date, we have not declared or paid any dividends. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The grant date fair value
of profits interests issued and modified beginning from July&nbsp;31, 2023 was estimated using the valuation model based on the Probability Weighted Expected Return Method (&#147;PWERM&#148;), which is
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
further discussed in the section below &#147;Determination of Fair Value of Common Units&#148;. The estimated equity fair value was allocated via the distribution waterfall in accordance with the
Amendment to the LLC Agreement to all outstanding redeemable convertible preferred units, common units and profits interests. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We recorded unit-based compensation
expense of $0.4&nbsp;million and $2.0&nbsp;million for the&nbsp;years ended December&nbsp;31, 2021 and 2022, respectively. We recorded unit-based compensation expense of $1.4&nbsp;million and $4.5&nbsp;million for the&nbsp;nine months ended
September&nbsp;30, 2022 and 2023, respectively. As of September&nbsp;30, 2023, there was $19.3&nbsp;million of total unrecognized unit-based compensation expense, which we expect to recognize over a remaining weighted-average period of 2.9 years. We
expect to continue to grant these awards in the future, and to the extent that we do, our unit-based compensation expense recognized in future periods will likely increase. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The intrinsic value of all outstanding profits interests as of September&nbsp;30, 2023 was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million based on the assumed
initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the estimated midpoint of the price range set forth on the cover page of this prospectus, of which approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million related to vested profits interests and approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million related to unvested profits interests. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Profits Units Grants </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes by grant date the
number of profits interests granted from January&nbsp;1, 2022, the per unit participating threshold amount and the estimated fair value of the common unit on each grant date: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Grant date</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Number&nbsp;of&nbsp;profits</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>interests&nbsp;granted</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Threshold</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>amount&nbsp;per&nbsp;unit</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Estimated&nbsp;fair</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>value&nbsp;per</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>common&nbsp;unit</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">April 25, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">941,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">May 26, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,224,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">July 12, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">October 28, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">519,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">March 24, 2023*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">462,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">June 25, 2023*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">June 26, 2023*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,247,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">September&nbsp;4, 2023*</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">274,830</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">11.84</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">12.32</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The fair value per common unit for grants during the 2023 fiscal year was interpolated between the valuation reports&#146; dates in connection with a retrospective fair value assessment for accounting purposes.
</TD></TR></TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Determination of Fair Value of Common Units </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As
there has been no public market for our common units to date, the estimated fair value of our common units has been determined by our board of managers as of the date of each award grant with input from management, considering our most recently
available third-party valuations of common unit, and our board of managers&#146; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent valuation through
the date of the grant. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#146; Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity
Securities Issued as Compensation (&#145;the Practice Aid&#148;). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For valuations performed prior to December&nbsp;20, 2022, in accordance with the Practice Aid, we
determined the option-pricing method (&#147;OPM&#148;) was the most appropriate method for determining the fair value of our common unit based on our stage of development and other relevant factors, which used a market approach to estimate
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
our enterprise value. Within the OPM framework, the backsolve method for inferring the total equity value implied by a recent financing transaction involves the construction of an allocation
model that takes into account our capital structure and the rights, preferences and privileges of each class of unit then assumes reasonable inputs for the other OPM variables (expected time to liquidity, volatility and risk-free rate). The total
equity value is then iterated in the model until the model output value for the equity class sold in a recent financing round equals the price paid in that round. The OPM is generally utilized when specific future liquidity events are difficult to
forecast (i.e., the enterprise has many choices and options available), and the enterprise&#146;s value depends on how well it follows an uncharted path through the various possible opportunities and challenges. In determining the estimated fair
value of the common stock, our board of managers also considered the fact that the stockholders could not freely trade the common stock in the public markets. Accordingly, we applied discounts to reflect the lack of marketability of its common stock
based on the weighted-average expected time to liquidity. The estimated fair value of the common stock at each grant date reflected <FONT STYLE="white-space:nowrap">a&nbsp;non-marketability&nbsp;discount</FONT> partially based on the anticipated
likelihood and timing of a future liquidity event. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For valuations performed after December&nbsp;20, 2022, in accordance with the Practice Aid, we determined the
hybrid method was the most appropriate method for determining the fair value of our common unit based on our stage of development and other relevant factors. The hybrid method is a PWERM, where the equity value in one or more scenarios is calculated
using an OPM. The PWERM is a scenario-based methodology that estimates the fair value of common unit based upon an analysis of future values for the company, assuming various outcomes. The common unit value is based on the probability-weighted
present value of expected future investment returns considering each of the possible outcomes available as well as the rights of each class of members&#146; units. The future value of the common unit under each outcome is discounted back to the
valuation date at an appropriate risk-adjusted discount rate and probability weighted to arrive at an indication of value for the common unit. A discount for lack of marketability of the common unit is then applied to arrive at an indication of
value for the common unit. In addition to considering the results of independent third-party valuations, our board of managers considered various objective and subjective factors to determine the thresholds for the profits interests as of each grant
date, including: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the prices at which we sold shares of redeemable convertible preferred units and the superior rights and preferences of the
redeemable convertible preferred units relative to our common units at the time of each grant; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the progress of our research and development programs; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">milestones achieved by us; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the state of the industry and the economy; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our stage of development and commercialization and our business strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">external market conditions affecting the biopharmaceutical industry and trends within the biopharmaceutical industry;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our financial position, including cash on hand, and our historical and forecasted performance and operating results;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the lack of an active public market for our common stock and our preferred stock; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the likelihood of achieving a liquidity event, such as an initial public offering (&#147;IPO&#148;), or our sale in light
of prevailing market conditions; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the analysis of IPOs and the market performance of similar companies in the biopharmaceutical industry.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The assumptions underlying these valuations are highly complex and subjective and represent management&#146;s best
estimates, which involved inherent uncertainties and the application of management&#146;s judgment. As a result, if we had used significantly different assumptions or estimates, the fair value of our common unit and our unit-based compensation
expense could be materially different. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Once a public trading market for our common stock has been established in connection with the completion of this offering, it
will no longer be necessary for our board of managers to estimate the fair value of our common unit in connection with our accounting for granted profits interests and other such awards we may grant, as the fair value of our common unit or stock
will be determined based on the quoted market price of our common unit or stock. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Income Taxes </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are taxed under the provisions of Subchapter K&#151;Partners and Partnerships of the Internal Revenue Code. Under those provisions, we do not pay federal or state
corporate income taxes on our taxable income. Instead, each member includes net operating income or loss for us on its individual tax return. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi, Inc., our
wholly-owned subsidiary, accounts for income taxes using the asset and liability method. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in our audited consolidated
financial statements and unaudited condensed consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the accounting and tax basis of assets and liabilities using enacted
tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax assets will not be
realized. We assess the need for a valuation allowance against our deferred tax assets based on all available evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, results of
recent operations, and our historical earnings experience by taxing jurisdiction. Significant judgment is required in making this assessment. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Tax benefits related
to uncertain tax positions are recognized when it is more likely than not that a tax position will be sustained during an audit. Uncertain tax positions are recorded based upon certain recognition and measurement criteria. Significant judgment is
required in making this assessment, and, therefore, we <FONT STYLE="white-space:nowrap">re-evaluate</FONT> uncertain tax positions and consider various factors, including, but not limited to, changes in tax law, the measurement of tax positions
taken or expected to be taken in tax returns, and changes in facts or circumstances related to a tax position. We adjust the amount of the liability to reflect any subsequent changes in the relevant facts and circumstances surrounding the uncertain
tax positions. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the periods presented we did not have, nor do we currently have, any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements as defined in the
rules and regulations of the SEC. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Quantitative and Qualitative Disclosures About Market Risks </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Interest Rate Risk </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The primary objectives of our investment activities
are to ensure liquidity and to preserve capital. We are exposed to market risks related to changes in interest rates of our cash equivalents and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities. However, due to the nature of these cash equivalents and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, we do not believe that a hypothetical 10%
increase or decrease in interest rates during any of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
periods presented would have had a material effect on our audited consolidated financial statements and unaudited condensed consolidated financial statements included elsewhere in this
prospectus. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Effects of Inflation </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Inflation generally affects us
by increasing our cost of labor and research and development costs. We do not believe that inflation had a material effect on our business, results of operations, or financial condition, or on our audited consolidated financial statements and
unaudited condensed consolidated financial statements included elsewhere in this prospectus. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Emerging Growth Company Status </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We qualify as an &#147;emerging growth company,&#148; as defined in the JOBS Act. As an emerging growth company, we may take advantage of specified reduced disclosure
and other requirements that are otherwise applicable generally to public companies. These provisions include: (i)&nbsp;being permitted to present only two years of audited financial statements, in addition to any required unaudited interim financial
statements, with correspondingly reduced &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; disclosure in this prospectus; (ii)&nbsp;reduced disclosure about our executive compensation
arrangements; (iii)&nbsp;not being required to hold advisory votes on executive compensation or to obtain stockholder approval of any golden parachute arrangements not previously approved; (iv)&nbsp;an exemption from the auditor attestation
requirement in the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002; and (v)&nbsp;an exemption from compliance with the requirements of the Public Company Accounting Oversight Board regarding the
communication of critical audit matters in the auditor&#146;s report on the financial statements. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may take advantage of these exemptions for up to five years or
such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company on the date that is the earliest of (i)&nbsp;the last day of the fiscal year in which we have total annual gross revenues of
$1.235&nbsp;billion or more; (ii)&nbsp;the last day of our fiscal year following the fifth anniversary of the date of the completion of this offering; (iii)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in nonconvertible debt
during the previous three years; or (iv)&nbsp;the date on which we are deemed to be a large accelerated filer under the rules of the SEC. We may choose to take advantage of some but not all of these exemptions. We have taken advantage of reduced
reporting requirements in this prospectus. Accordingly, the information contained herein may be different from the information you receive from other public companies in which you hold stock. Additionally, the JOBS Act provides that an emerging
growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would
otherwise apply to private companies. We have elected to avail ourselves of this exemption and, therefore, while we are an emerging growth company we will not be subject to new or revised accounting standards at the same time that they become
applicable to other public companies that are not emerging growth companies. As a result of this election, our audited consolidated financial statements and unaudited condensed consolidated financial statements may not be comparable to those of
other public companies that comply with new or revised accounting pronouncements as of public company effective dates. We may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private
companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_12"></A>BUSINESS </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Overview </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are a precision genetic medicines company committed to
developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering
approaches to date. Genetic mutations are seen in a variety of forms, including deletions, insertions, single-base-pair changes and sequence repeats, and are found throughout the genome and across a variety of different cell types, tissues, and
organ systems. Additionally, many diseases lack a genetic origin but have the potential to be effectively and permanently addressed through genome editing. We are harnessing the power of metagenomics, the study of genetic material recovered from the
natural environment, to unlock four billion years of microbial evolution to discover and develop a suite of novel editing tools capable of correcting any type of genetic mutation found anywhere in the genome. Our comprehensive genome editing toolbox
includes programmable nucleases, base editors, and RNA and <FONT STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat
(&#147;CRISPR&#148;)-associated transposases (&#147;CASTs&#148;)). We believe our diverse and modular toolbox positions us to access the entire genome and select the optimal tool to unlock the full potential of genome editing for patients. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The company was founded by pioneers in the field of metagenomics, a powerful science that allows us to tap into the diversity of microbial life on this planet. The
metagenomics process starts by collecting samples from microbe-rich ecosystems ranging from simple home gardens to extreme locations such as hydrothermal vents below the ocean. We then extract the DNA from these environmental samples and deeply
sequence them to fully reconstruct the genomes of the resident microbes. Each sample may include thousands of distinct genomes from previously unknown organisms revealing novel cellular machinery that we utilize as building blocks for our editing
systems. Using high-throughput screening, artificial intelligence (&#147;AI&#148;), and proprietary algorithms, we rapidly mine through billions of novel proteins from our genome-resolved metagenomics database to create genome editing tools. To
date, we have analyzed over 460&nbsp;trillion base pairs of DNA sequencing data, predicted over 7.4&nbsp;billion proteins, including over 322&nbsp;million CRISPR-associated (&#147;Cas&#148;) proteins, and identified over 1.75&nbsp;million CRISPRs,
which we estimate has resulted in the identification of over 20,000 novel genome editing systems. Simultaneously, we have assembled extensive libraries of millions of nucleases, deaminases, reverse transcriptases (&#147;RTs&#148;) and over one
thousand CASTs. Our platform enables us to rapidly and effectively find, screen, and select tools with the highest targetability, specificity, and efficiency in order to develop them into genetic medicines. The iterative nature of our process,
underpinned by AI, allows us to continuously push the boundaries of innovation. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our proprietary toolbox of editing systems </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have developed an expansive and modular toolbox of next-generation genome editing systems that will allow us to interact with the human genome in a site-specific
manner, where each tool can be matched to specific disease targets. Figure 1 summarizes our diverse and versatile toolbox of different editing capabilities with the potential to address the full spectrum of genetic diseases.<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 1</B>. Our Toolbox. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g12u12.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our programmable nucleases are the backbone of our broad set of genome editing tools. These novel nucleases including type II and type
V Cas nucleases, of which some are ultra-small systems that we call SMall Arginine-Rich sysTems (&#147;SMART&#148;) nucleases, have unique targeting abilities and can be programmed by guide RNAs (&#147;gRNAs&#148;) to target and cut at specific
locations in any genome sequence. Targeted genomic breaks trigger DNA repair pathways that can be used for genome editing, for example, to integrate a gene at a target site <FONT STYLE="white-space:nowrap">(knock-in)</FONT> or for gene inactivation
(knockdown). </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our toolbox contains thousands of CRISPR nucleases with diverse abilities to target different parts of the genome, allowing us to potentially select
the ideal nuclease for targeting any given gene in a site-specific manner and overcome a major limitation of first-generation CRISPR/Cas9 systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We also modify
our nucleases to either nick the genome (i.e., a nickase that cuts one strand of the DNA) or to simply bind to target sites (i.e., a nuclease dead variant). These capabilities (searching, cutting, nicking, and binding) can be leveraged as a chassis
by adding on additional effector enzymes to create base editors for single nucleotide changes, RNA-mediated integration systems (&#147;RIGS&#148;) for both small and large genomic integrations using &#147;Little RIGS&#148; for prime editing and
&#147;Big RIGS&#148; for large integrations. Using modular engineering, we match nickases with deaminases and RTs for base editing and RIGS, respectively. Furthermore, nucleases can be engineered by swapping the search modules of the enzyme to
expand the targetability of the chassis, which is critical for site-specific genomic modifications. Given the measured targeting density of our toolbox, we believe that essentially any codon in the human genome could be addressed with our gene
editing systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our highly active nucleases have gone through extensive preclinical evaluation for both <I>in vivo</I> and <I>ex vivo</I> applications, with
demonstration of broad potency of these systems across human primary cells, mouse, and nonhuman primate (&#147;NHP&#148;) models. Our base editors, RIGS, and CAST systems have demonstrated activity across various cell-based models. In addition to
evaluating system activity, we have undertaken detailed characterization of guide-specific on-and off-target effects. We routinely identify guides that have no or minimal verifiable <FONT STYLE="white-space:nowrap">off-target</FONT> editing, thus
overcoming another limitation of first-generation CRISPR/Cas9 systems. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to overcoming the activity, targetability, and specificity limitations of first-generation systems, our
nuclease toolbox was designed to have broad compatibility with viral and nonviral delivery technologies. This compatibility is accomplished by having a variety of nuclease and gRNA structures, which range in terms of their size and biochemistry. For
example, small guides for some type V Cas systems streamline manufacturing for delivery by lipid nanoparticle (&#147;LNP&#148;) approaches, and SMART nickases can be used to construct base editors that are small enough to fit within the packaging
limitations of adeno-associated viruses (&#147;AAV&#148;). SpCas9, which is currently used in most base editing applications, is roughly three times the size of some of the smallest SMART nickases and cannot be efficiently packaged into a single
AAV. Combined, we believe these features will facilitate delivery of our genome editing tools to previously inaccessible tissue types and organ systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">While
nucleases, base editors, and prime editors can precisely address a wide variety of genomic modifications required to treat disease, the fact that many diseases are caused by a multitude of mutations across a gene means that a diverse set of editing
tools are required to fully address these patient populations. The integration of a complete and functional gene through targeted genome editing may provide a way in which every patient with a given disease could potentially be treated by a single
genetic medicine. Big RIGS and CASTs are novel genome editing systems that are under development to achieve what has been a major challenge for the genome editing field &#151; large, targeted genomic integrations. Initial preclinical readouts
conducted in mammalian cells indicate that these systems could potentially have a major impact on how diseases caused by <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">loss-of-function</FONT></FONT> mutations, the most common
cause of genetic diseases, can be addressed through genome editing. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Therapeutic translation roadmap and initial programs </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are taking a stepwise approach deploying our genome editing toolbox to develop potentially curative therapies for patients. Our lead programs are selected to both
address important diseases and to establish new standards in targetability, precision, efficiency, and scope of editing capabilities. Figure 2 summarizes the portfolio of programs that we and our partners are advancing, as we aim to match the
optimal genome editing tools for each indication. Each of these indications were chosen based on our conviction in the underlying biology, existence of validating preclinical and clinical data, availability of pharmacodynamic and translational tools
to assess early proof-of-concept, relevant value supporting outcome measures, and ongoing clinical unmet need. While we do not currently have any approved products and all of our product candidates are preclinical, our lead programs capture an
ever-growing set of translational learnings and insights that will inform and accelerate future programs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial"><B>Figure 2</B>. Therapeutic Translation. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g30v84.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Hemophilia A&#151;novel, durable , knock-in approach for expression of Factor VIII </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Hemophilia A is the most common X-linked inherited bleeding disorder and is caused by mutations in the Factor&nbsp;VIII (&#147;FVIII&#148;) gene leading to loss of
functional FVIII protein that impacts the body&#146;s ability to form normal clots in response to injury. FVIII is normally produced in the liver within sinusoidal endothelial cells and is then secreted into the bloodstream where it acts as a
cofactor for the catalytic activation of Factor X in the clotting pathway. The lack of functional FVIII disrupts the normal clotting cascade and predisposes patients to increased risk of bleeding, either spontaneously or in response to injury or
surgery. Repeated bleeding episodes in joints or soft tissues can lead to progressive joint damage, inflammation, pain, and mobility impairment. Intracranial bleeding is of greatest concern as this can be rapidly fatal or lead to major morbidity.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The standard of care for patients with severe hemophilia A, involves lifelong repeated intravenous (&#147;IV&#148;) infusions of recombinant FVIII preparations
prophylactically and in response to bleeding events. The major limitation of this approach is fluctuating FVIII activity levels, with trough values that can still result in breakthrough microscopic and macroscopic bleeding events, particularly
within sensitive and previously damaged joints. Additionally, frequent FVIII infusions are inconvenient, which can be associated with suboptimal compliance, and in some patients result in inhibitor formation (antibodies against FVIII) that
compromise efficacy. More recently, emicizumab, a bispecific antibody, has been approved for hemophilia A in the United States. Valoctocogene roxaparvovec, the first hemophilia A gene therapy, was conditionally approved for use in Europe in August
2022 and was approved in the United States in June 2023. This genetic medicine delivers a FVIII gene construct to the liver using an AAV vector; however, longitudinal clinical data has demonstrated that FVIII levels drop over time. Importantly, AAV
gene therapy is also not a feasible treatment approach for infants or children due to the high degree of liver growth during pre-adulthood that would dilute out the episomal FVIII levels during progressive rounds of liver cell division. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Rather than provide the FVIII gene in an episomal location, which risks dilution from cell division or cell death as well as episomal transcriptional silencing, our
approach is to insert a FVIII DNA cassette into a "safe harbor location," within an intron of the albumin gene that is not expected to have deleterious effects. FVIII expression is then driven off the strength of the native albumin promoter. This
approach has previously been demonstrated in preclinical studies to lead to therapeutically relevant expression of a different clotting factor (Factor IX) with negligible impact to systemic circulating albumin levels. Our FVIII knock-in approach is
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
designed to provide stable expression and clinically relevant circulating levels of FVIII, even at low integration rates because of the strength of the albumin promoter. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have demonstrated the feasibility of the FVIII gene knock-in approach in mice with several mouse specific guides and different FVIII DNA donor cassettes, with
integration of the FVIII gene leading to FVIII mRNA expression and therapeutically relevant levels of FVIII protein in the blood. In an ongoing NHP study we demonstrated integration of a surrogate cynomolgus-FVIII cassette (used to avoid immune
response that would occur with a foreign human FVIII protein) and observed therapeutically relevant levels of the cyno-FVIII protein encoded by the integrated cassette in all 3 treated animals that has extended for 4.5 months following a single dose
of the AAV-cFVIII virus followed five weeks later by a liver trophic LNP encapsulating the mRNA encoding MG29-1 and guide 2 at a dose of 1mg/kg body weight. We intend to continue measuring FVIII levels in these monkeys up to the 12 month time point
to generate a robust data set on durability. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Evaluation of different human FVIII donor DNA cassettes has been completed in mice resulting in the selection of 2 lead
cassettes that will be compared in another NHP study, potentially leading to a development candidate selection anticipated in Q2 2024. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In parallel, we are
manufacturing mRNA, gRNA, AAV and LNP to support future investigational new drug (&#147;IND&#148;) enabling studies. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Primary Hyperoxaluria, Type 1
(&#147;PH1&#148;)&#151;a durable knockdown of HAO1 for substrate reduction therapy </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">PH1 is a rare autosomal recessive metabolic disease arising from loss of
function mutations in the alanine-glyoxylate aminotransferase (&#147;AGXT&#148;) gene that encodes alanine glyoxylate aminotransferase. This enzyme is found in peroxisomes of the liver where it catalyzes the conversion of glyoxylate to glycine and
pyruvate. Lack of functional AGXT leads to an accumulation of glyoxylate substrate, which is then converted to oxalate and excreted in the kidney. The excess urinary oxalate forms an insoluble complex with urinary calcium that leads to the
production of calcium oxalate crystal precipitates. This pathologic process results in the formation of repeated calcium oxalate urolithiasis and nephrolithiasis, which in turn leads to obstructive uropathy, inflammation, fibrosis, tubular toxicity,
and progressive loss of kidney function. PH1 is a serious disease that causes kidney failure. More than 70% of individuals with PH1 mutations will develop end-stage renal disease, with a median age in young adulthood. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Until recently, the standard of care for treating PH1 was primarily supportive in nature, with hydration and diuretics used to reduce urinary oxalate concentration,
pyridoxine (vitamin B6) to enhance residual function of alanine glyoxylate aminotransferase catalytic activity, and hemodialysis once renal function progressed to end stage. More recently, the standard of care has been updated to include treatment
with lumasiran, a small interfering RNA (&#147;siRNA&#148;) therapeutic approved in adults and children with PH1 that acts to reduce the levels of urinary oxalate. Using a therapeutic approach known as substrate reduction therapy, lumasiran targets
mRNA from a separate gene, HAO1, that encodes glycolate oxidase (&#147;GO&#148;). Lumasiran has been generally well tolerated in clinical studies of adults and children with PH1 but as a siRNA therapy, it requires repeat subcutaneous administration
indefinitely in order to maintain its effect. An additional RNAi drug, Nedosiran, which targets LDH, a different enzyme in the same pathway as HAO1, was also given FDA approval for adults and children with PH1 in October 2023. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The goal of our genome editing approach is to durably knock down HAO1 resulting in stable and permanent reduction of oxalate levels to effect a lifelong benefit. We have
performed nuclease and guide screening to select an optimal nuclease and gRNA combination. Along with our partner ModernaTX, Inc. (&#147;Moderna&#148;) we have achieved preclinical proof-of-concept in an AGXT knock-out mouse which is an accepted
disease model of PH1. We are in the final stages of confirming the candidate to take into NHP studies and expect to have NHP data in 2024 to support final development candidate selection. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Transthyretin Amyloidosis&#151;a single treatment to knockdown TTR gene expression </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Transthyretin amyloidosis is a disease of misfolded and aggregated transthyretin (&#147;TTR&#148;) protein that can deposit in tissues causing organ dysfunction,
primarily in the heart and/or peripheral nerves. The TTR protein is normally produced in the liver and circulates in a homotetramer (four copies of the same TTR protein bound together) where it serves as a carrier protein for vitamin A and
thyroxine. Certain mutations have been identified that can cause TTR homotetramers to fall apart, misfold, and aggregate into insoluble fibrils that deposit in cardiac tissue and peripheral nerves. However, more commonly, the normal aging process is
associated with an increased propensity for TTR misfolding and aggregation in the heart without any known genetic sequence variation. These distinctions lead to TTR amyloidosis being characterized as either hereditary transthyretin amyloidosis
(&#147;ATTRv&#148;) caused by mutations in TTR, or wild-type ATTR amyloidosis (&#147;ATTRwt&#148;). It is estimated that globally there are approximately 50,000 patients with ATTRv and between 300,000 and 500,000 patients with ATTRwt. Among the
larger ATTRwt patient population, the most common presentation is a rapidly progressive, restrictive, and hypertrophic cardiomyopathy due to progressive deposition of insoluble TTR fibrils, which result in thickening of the myocardium and stiffening
of the ventricles. These pathologic processes lead to impaired diastolic function and progressive cardiomyopathy that typically leads to progressive heart failure and often death within three to five years from disease onset. Although cardiac
manifestations are more common and severe, patients with neurologic manifestations also experience significant morbidity, loss of functionality, and impaired quality of life. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Using our novel nucleases, we aim to provide efficient TTR knockdown and halt further deposition of amyloid fibrils. Previous experience suggests a clinical correlation
between the degree of TTR knockdown and potential for benefit in familial forms of the disease, which are expected to translate similarly to wild type forms. The high degree of <I>in vivo</I> editing efficiency and specificity of our nuclease
platform suggest the potential for a single treatment to knockdown TTR gene expression and remove the requirement for life-long therapy. Along with our partner Ionis Pharmaceuticals, Inc. (&#147;Ionis&#148;), we are currently in advanced stages of
nuclease and guide selection, having achieved more than 90% knockdown of human TTR protein in a humanized TTR mouse model, and expect to move into NHP studies in 2024. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Further areas of therapeutic activity and interest </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In parallel with
our translation efforts in our lead programs using our novel programmable nucleases to <FONT STYLE="white-space:nowrap">knock-in</FONT> or knockdown gene expression in liver-associated targets, we are developing more complex editing systems for
liver associated targets as well as moving beyond the liver. Given that our genome editing toolbox contains small editing systems designed to be amenable to viral vector delivery, and given the progress established in targeting the central nervous
system and muscle with established AAV capsids, our first extrahepatic indications will be neurodegenerative and neuromuscular diseases. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Building on our experience
delivering our nucleases to the liver via LNP systems, we are extending that experience delivering novel RIGS to the liver to potentially correct ATP7B mutations in Wilson&#146;s disease and PiZ mutations in <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">alpha-1-antitrypsin</FONT></FONT> deficiency (&#147;A1AT deficiency&#148;). We are also exploring addressing A1AT deficiency via a base editor approach given the predominant mutation involves a single base pair. Both of
these liver diseases have well-defined biology, readily available translational biomarkers for early proof-of-concept, established development pathways based on prior drug approvals, and important unmet medical needs. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Building on our experience with our novel type II and type V programmable nucleases, we are extending that experience by working to deliver these nucleases via AAV to
the central nervous system to potentially knock down genetic targets important for both spontaneous and familial amyotrophic lateral sclerosis (SOD1, ATXN2) and Charcot-Marie-Tooth Type 1a (PMP22). In addition, we are working to address
a&nbsp;series of mutations </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
common in Duchenne Muscular Dystrophy with our programmable nucleases through exon skipping approaches. In diseases outside of the liver, we intend to initially leverage known biology and
clinical validation achieved with <FONT STYLE="white-space:nowrap">RNA-targeted</FONT> approaches like antisense and siRNA to advance more potent and definitive <FONT STYLE="white-space:nowrap">one-time</FONT> genome editing treatments. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Building on our experience with both <FONT STYLE="white-space:nowrap">knock-in</FONT> gene expression and smaller gene corrections with RIGS, we are progressing our
larger <FONT STYLE="white-space:nowrap">RNA-</FONT> and <FONT STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems to potentially provide a single curative approach to cystic fibrosis. As opposed to currently-available therapies
limited to subsets of patients with individual mutations, we intend to deliver a full copy of a functional cystic fibrosis transmembrane conductance regulator (&#147;CFTR&#148;) gene. This approach can similarly be pursued across many other diseases
characterized by loss of function mutations. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our Team </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have
assembled a world-class team that is driven by a passion to create potentially curative genetic medicines through the discovery of novel genome editing technologies by harnessing the power of metagenomics. Key members of our executive and leadership
team include: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Brian C. Thomas, Ph.D., Chief Executive Officer and Founder</B>, prior to co-founding the company, Dr. Thomas spent more
than 20&nbsp;years in academic research at UC Berkeley helping to pioneer the field of metagenomics. Dr.&nbsp;Thomas has been cited over 16,000 times and listed as an inventor in 28 patent families. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Jian Irish, Ph.D., MBA, President and Chief Operating Officer</B>, has held biopharma executive leadership roles for
nearly 20 years at Kite Pharma / Gilead, Sanofi, and Amgen in drug development and global operations, and has helped launch several breakthrough medicines. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Pamela Wapnick, MBA, Chief Financial Officer</B>, has over 20 years of diversified financial leadership experience
spanning strategic and operational finance roles at public and private companies including life sciences and biotechnology companies, Diality Inc, Capsida Biotherapeutics, True North Therapeutics and Amgen. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Sarah Noonberg, M.D., Ph.D., Chief Medical Officer</B>, has spent more than 20 years in translational and clinical
development leadership roles with a track record of advancing therapeutic programs from discovery to commercialization, including at Medivation and BioMarin. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Simon Harnest, Chief Investment Officer and SVP of Strategy</B>, has held leadership roles in corporate finance and
strategy in the life sciences sector, having raised over $1 billion in public and private capital, including leading Cellectis&#146; U.S. IPO and subsequent <FONT STYLE="white-space:nowrap">spin-out</FONT> and IPO of Calyxt. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Luis G. Borges, Ph.D., Chief Scientific Officer</B>, has over 27&nbsp;years of experience in the biotechnology industry,
including Amgen, Five Prime Therapeutics, Cell Medica, and Century Therapeutics, where he held leadership roles in the research and development of multiple therapeutic candidates. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Simren Delaney, Ph.D., LLM, VP of Legal,</B> is specialized in Intellectual Property and Patent law, having previously
worked at Wilson Sonsini Goodrich&nbsp;&amp; Rosati, and plays an instrumental role in driving the development of the company&#146;s growing IP portfolio. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Christopher T. Brown, Ph.D., VP of Discovery,</B> is a former scientist at the Jillian F. Banfield laboratory at UC
Berkeley and an expert in using metagenomics to discover novel microbial systems for use in genome editing. Dr. Brown&#146;s research has resulted in over 35 publications and over 20 patent family filings. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Michael Conway, MBA, CPA, VP of Finance,</B> has spent nearly 20 years in finance leadership positions at life science
and technology companies, including Adamas Pharmaceuticals, InterMune, and Intel. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Alan Brooks, Ph.D., SVP of Preclinical</B>, has worked on genetic medicines providing scientific leadership in
translational research for more than 25 years, including at Casebia Therapeutics and Bayer Healthcare. Dr.&nbsp;Brooks&#146; research has led to 20 publications and numerous patent filings. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our company is supported by our board of directors, Scientific Advisory Board, and a leading syndicate of investors, with more than 30&nbsp;funds supporting our Series B
preferred unit and Series B-1 preferred unit financings (collectively, the &#147;Series B preferred unit financing&#148;). </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our Strategy </U></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our goal is to harness the power of our proprietary metagenomics platform to create curative genetic medicines for patients. Key components of our strategy to achieve
this goal include: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Leverage our leadership position in metagenomics to continually advance and expand innovative genome editing tools.
</B>We expect to build on the diversity and versatility of our toolbox through continuous interrogation of novel microbial genomic information, identification of highly active natural enzymes, design and optimization of genome editing systems, and
continuous integration of learnings to accelerate development. In connection with these discoveries, we will continue to strenuously file and protect our intellectual property. Coupled with our trade secret protection around our discovery platform,
our broad intellectual property estate creates a significant barrier to entry. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Develop and deliver products that make precise modifications to the human genome to cure disease.</B> We focus on
disease areas with well understood disease biology, readily available translational biomarkers for early proof-of-concept, clear development pathways, and important unmet medical need. We are taking a stepwise approach deploying our genome editing
toolbox to develop potentially curative therapies for patients. Along with our development efforts using our novel programmable nucleases to knock-in or knockdown gene expression in liver-associated targets, we are leveraging our toolbox to deliver
more complex editing systems to targets in and outside the liver. Our approach allows us to systematically incorporate knowledge and insights from our initial development programs, thereby accelerating therapeutic translation across our genome
editing technologies. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Build a fully integrated genome editing company. </B>Our team includes experts in discovery, preclinical and clinical
development, encompassing all major functions necessary to take a molecule from target identification through registrational clinical trials. To rapidly translate editing technologies into genetic medicines, we strategically invest in automation,
characterization, and manufacturing capabilities. This applies not only to process development and manufacturing for clinical trial materials, but also high throughput automated screening and genome sequencing, and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">state-of-the-art</FONT></FONT></FONT> characterization assays. We believe our ability to develop and characterize complex human genome editing components is essential to pursue a successful
regulatory pathway for genetic medicine development. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Expand therapeutic impact to patients through continued investment in business development and enabling partnerships.
</B>We carefully consider opportunities for business development such as collaborations and partnerships with industry leaders that have unique strengths and we may pursue additional partnership opportunities which complement our technologies, with
the objective of accelerating our programs and pushing forward our therapeutic translation efforts. Our existing partnerships with Moderna, Ionis, and Affini-T Therapeutics, Inc. (&#147;Affini-T&#148;) demonstrate our thoughtful approach to
collaborating with industry pioneers to accelerate and optimize the development of our genetic therapeutic candidates. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B>Maintain our entrepreneurial outlook, scientifically rigorous approach, and culture of tireless commitment to patients.
</B>We are a team of experienced drug discoverers, developers, and company builders who are united by our mission and passion to unlock the full potential of genome editing for patients with high unmet needs. We are dedicated to attracting and
retaining top talent and partnerships at the intersection of academia and industry. We are unwavering in our commitment to deliver cutting-edge technology and unlock the long-awaited, transformative potential of genome editing.
</P></TD></TR></TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Introduction to Genome Editing and Limitations with Current Approaches </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Genome editing is a new treatment modality that has the potential to revolutionize healthcare by creating permanent, <FONT STYLE="white-space:nowrap">one-time</FONT>
treatments that address disease at the genomic level. Genome editing involves the alteration of genetic material of a living organism by inserting, replacing, converting, or deleting nucleotides within the DNA. Several approaches and technologies
are being studied and developed in order to perform these edits, including: </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><B><I>Nuclease-based genome editing:</I></B> Several genome editing
methods rely on a class of enzymes called nucleases to create double-stranded breaks in DNA at a targeted location to cause gene inactivation, gene insertion, or alter gene splicing. Examples of nucleases include CRISPR associated nucleases, zinc
finger nucleases (&#147;ZFNs&#148;), engineered meganucleases, and transcription-activator like effector nucleases (&#147;TALENs&#148;). The discovery and characterization of a particular nuclease, Cas protein&nbsp;9 from <I>Streptococcus
pyogenes</I> (&#147;SpCas9&#148;), has been leveraged to develop a number of different therapeutic approaches. Importantly, additional novel and distinct Cas nucleases exist in nature and have the potential to be developed into tools for genome
editing. When introduced at target sites in a genome sequence, genomic breaks trigger DNA repair pathways that can be used for genome editing. If a&nbsp;DNA template is provided, the DNA repair machinery may incorporate the sequence at the site of
the genomic break, resulting in a site-specific <FONT STYLE="white-space:nowrap">knock-in.</FONT> If not, the cut will lead to the disruption of a gene sequence and subsequent knock-down of the encoded protein. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><B><I>Base editing:</I></B> Base editing is a genome editing approach that relies on using deaminases to chemically convert specific nucleotides in a
genome. Deaminases are enzymes that catalyze chemical reactions to remove an amino group. Multiple programmable nuclease platforms, such as CRISPR nucleases, have been harnessed for base editing by using the programmable nature of these enzymes to
direct deaminases to specific genomic target sites. In these cases, the nuclease activity is deactivated, thus creating a&nbsp;nicking or nuclease-dead version that does not disrupt the ability of the enzyme to be programmed to target specific
genomic sites for editing. There are two primary types of base editors: adenine base editors (&#147;ABEs&#148;) and cytosine base editors (&#147;CBEs&#148;). ABEs convert adenine-thymine base pairs to guanine-cytosine base pairs. CBEs target
cytosine-guanine and convert them to thymine-adenine. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><B><I><FONT STYLE="white-space:nowrap">RNA-mediated</FONT> integration, including prime
editing: </I></B><FONT STYLE="white-space:nowrap">RNA-mediated</FONT> integration systems (&#147;RIGS&#148;) are genome editing systems that make programmable genomic modifications that are encoded in RNA templates.<B><I> </I></B>Because the
modifications are encoded in RNA, these systems have the ability to repair diverse mutations, including insertions, deletions, and all types of point mutations. These systems rely on RTs to convert messages encoded as RNA into DNA. CRISPR systems
are used to direct RTs to genomic target sites. Some systems use a nickase to create a target-specific site that primes the activity of the RT and results in the corrected genomic sequence encoded in the RNA to be incorporated into the genome. Prime
editing can be accomplished with RIGS, as can large, targeted genomic integrations. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><B><I><FONT STYLE="white-space:nowrap">DNA-mediated</FONT>
integration, including CAST: </I></B>CASTs are a class of genome editing systems that provide directed and programmable genomic integration of large DNA templates. CASTs are naturally occurring systems that have been engineered to accomplish large
integrations for genome editing in various cell </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial">
types and for therapeutic applications. The systems consist of a catalytically dead Cas effector that can be programmed by gRNAs to target a transposase to integrate large DNA cargos into
specific genomic target sites. DNA-templated integrations can be accomplished with other transposase and recombinase systems; however, these systems typically require extensive protein engineering in order to alter their targetability, or need to be
used in concert with other genome editing tools such as prime editing systems in order to incorporate targeting motifs into specific genomic sites. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There have been
significant advancements in genome editing since the seminal research that led to the discovery of CRISPR SpCas9 and its application in humans. However, there remain key limitations that must be addressed to unlock the full potential of genome
editing. We believe the key limitations facing current genome editing platforms are: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>1)</I></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><B><I>First-generation technology lacks the ability and flexibility for accomplishing complex genome editing. </I></B>The majority of genome editing platforms are limited to a single genome editing approach, such
as gene insertions/deletions, single nucleotide changes, or small gene corrections. As a result, they are faced with inherent limitations including the diversity of edits in which they can employ and, as a result, an inability to address a range of
diseases. In addition, they lack the flexibility to tailor their genome editing system to a broad range of genomic targets of interest. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>2)</I></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><B><I>Lack specificity and control over resulting edits. </I></B>Current genome editing platforms have a narrow armamentarium of genome editing systems and therefore limited access to systems capable of high
activity and specificity at desired target sites. This lack of control and specificity is often measured by <FONT STYLE="white-space:nowrap">&#147;off-target&#148;</FONT> edits which can pose a risk for undesirable side effects or unexpected safety
findings. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">3)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Size of current genome editing technologies limits </I></B><B>in vivo</B><B><I> delivery methods and target organs.</I></B> First-generation SpCas9 systems are about 1,300 amino acids (&#147;aa&#148;) in length
and as such are not feasible to package into many delivery vectors such as AAV. As such, their delivery is largely limited to LNP systems, which precludes delivery to many tissues outside of the liver. </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>4)</I></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><B><I>Inability to access certain sequences in the genome.</I></B> SpCas9 is only able to target DNA sequences which contain a flanking sequence of &#147;NGG&#148;, restricting the range in genetic targets it can
be programmed to locate, and subsequently limiting the ability to address certain underlying mutations that drive disease. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>5)</I><I></I></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><B><I>Substantial engineering requirements. </I></B>Limited access to highly active natural nucleases and effectors drives the need for substantial modifications to make a system operate at
therapeutically-relevant levels, resulting in long lead times from discovery to candidate nomination. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>6)</I></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><B><I>Narrow terms of license agreement from academic institutions. </I></B>The majority of genome editing platforms have been formed as a result of a licensing agreement for specific genome editing systems or
technology from academic institutions and are therefore limited to the confines of that technology arrangement. Alternatively, genome editing tools developed by us are built from highly novel components derived from our metagenomics database, and
thus are not subject to these constraints. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In order to address these broad challenges with current genome editing approaches, we have leveraged our
deep expertise with metagenomics to develop a proprietary discovery platform that is designed to continuously identify novel editing systems and optimize our expansive editing toolbox. Starting at the microbial level, our multifaceted platform
enables discovery beyond nucleases, translating highly active natural enzymes into powerful genome editing systems optimized for efficiency and specificity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our Metagenomics Platform </U></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We believe genome editing tools with capabilities that go beyond the current technology landscape will be required in order to treat the vast majority of genetic
diseases. Our goal is to unlock the full potential of genome editing by developing tools with new capabilities using novel cellular machinery discovered from the natural environment. Our company was founded by Brian C. Thomas and Jillian F.
Banfield, pioneers in the field of metagenomics. They recognized the power that naturally evolved microbial systems could have in revolutionizing access to enhanced genome editing technologies to create potentially highly efficacious and curative
genetic medicines. Our metagenomics discovery platform is foundational to our business and therapeutic pipeline. This platform enables us to rapidly and effectively find and engineer highly active natural enzymes sourced from nature into genome
editing tools that are highly specific, efficient, and have enhanced targetability. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">CRISPR systems, having been studied for decades, are known to be ubiquitous in
the microbial world. However, it was not until the recent discovery and characterization of CRISPR-SpCas9 that it became possible to use these systems as tools for genome editing. SpCas9 is only a single representative of the CRISPR systems that
exist in nature, leaving open the potential to identify and develop new genome editing tools through continued and systematic discovery efforts. The vast majority of microbes, including bacteria, archaea, viruses, fungi, and single-celled
eukaryotes, are extremely difficult, and potentially impossible, to study using traditional laboratory methods. We aim to address the limitations of traditional laboratory methods through a process whereby microbes are recovered from the natural
environment and studied based on their genetic blueprint-their genome sequences. This approach has supported the ability to characterize the extent of CRISPR biology on the planet, and to expand beyond CRISPR to identify a vast collection of novel
enzymes and other cellular machinery. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Samples from diverse climates and geographies have been used to build a metagenomic database that is continuously analyzed via
high-throughput screening that utilizes AI and proprietary algorithms to direct our discovery efforts. This continuous genome mining process generates expansive libraries of novel systems, including nucleases, deaminases, RTs, and CAST systems
(together, &#147;effector enzymes&#148;), that make up the foundational building blocks necessary to assemble a modular, novel genome editing toolbox that can be harnessed to make precise changes to the human genome to address a variety of important
diseases with curative intent. We have simultaneously developed a modular approach to engineering that involves interchanging key components in a high-speed process to translate the discovery of novel nucleases and other effector enzymes into
optimized genome editing systems with substantially reduced translation time compared with previously described systems. We estimate that our metagenomics platform and modular engineering process has resulted in the discovery of over 20,000 novel
genome editing systems, to which we are seeking coverage through our pending patent portfolio. These systems span hundreds of novel nuclease families and fuel a growing genome editing toolbox. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Mining Our Natural Environment to Create an Expansive Genomics Database</U> </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We
aim to harness the power of the metagenome by using our continuous genome mining process to assemble a&nbsp;broad, diverse library of novel genome editing nucleases and other effector enzymes. This is accomplished by studying all the DNA from
microbial communities at the same time. Our mining process begins with proprietary sampling in which our scientists collect samples from diverse climates and geographies to build a database that spans broad biodiversity including, but not limited to
our local natural environments and extreme environments such as from high-altitudes, high-temperatures, and hydrothermal vents below the ocean. Samples collected in a&nbsp;natural environment may contain billions of cells representing tens of
thousands of distinct species. Every sample collected from a&nbsp;natural environment is subjected to deep DNA sequencing and bioinformatics analysis to identify and functionally analyze recovered microbial genomes for the discovery of genetic
elements of interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Through our metagenomics process, DNA is extracted from these environmental samples and sequenced in order to
reconstruct the genomes of the resident microbes. The process of DNA extraction and sequencing results in the fragmentation of each individual microbial genome into small sections which are blended into a&nbsp;backdrop of all other sequences
present. Due to the clonal replication of the organisms in microbial communities, multiple copies of nearly-identical genome sequences are recovered, and the overlap between these sequences provides the information needed to reconstruct the original
genomes. This complex process is only the beginning. Once reconstructed, it is necessary to predict the function of each section of the newly reconstructed genomes. Our platform has facilitated the discovery of vast sequences and functional
components that, to our knowledge, have never been published before. These novel components have resulted from the unique selective pressures that microbes face from different environments and that drive immense genomic diversification. The
evolutionary process of natural selection provides highly optimized enzymes that require little, if any, protein engineering. The novelty of the genomes recovered from metagenomics requires the de novo prediction of genes, proteins, <FONT
STYLE="white-space:nowrap">non-coding</FONT> RNAs, and other essential features. This is challenging and necessary due to the fact that previously studied &#145;reference&#146; sequences do not provide enough information to sufficiently guide this
process. Considering that these evolutionary processes have been at work for billions of years, there is considerable genetic diversity to mine for the development of highly-optimized genome editing tools. Our industry-leading database of novel
microbial genetic sequences provides the basis for our discovery process. To date, our continuous genome mining process has analyzed over 460&nbsp;trillion base pairs of DNA sequence, an amount of data roughly equivalent to what would be required to
sequence hundreds of thousands of human genomes, and resulted in the prediction of over 7.4&nbsp;billion proteins and over 1.75&nbsp;million CRISPRs &#150; including over 322&nbsp;million Cas proteins. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial"><U>Leveraging AI and High-Throughput Screening to Identify Novel Editing Systems</U> </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To interrogate our metagenomics database, our platform combines AI, including machine learning, and proprietary algorithms run on expansive cloud computing
infrastructure to screen for novel CRISPR nucleases and other effector enzymes at high speed. The screening process consists of high-throughput sequencing that allows us to quickly analyze large amounts of genomic data and subsequently synthesize
the identified components, building blocks, into functioning CRISPR nucleases and other effector enzymes that can be interrogated biochemically and in mammalian cells. Once extensively characterized, novel nucleases and other effector enzymes are
categorized into our ever-expanding library. Through the metagenomics-driven discovery process we have characterized one of the largest known libraries of novel nucleases, which we estimate includes 20,000 novel genome editing systems from hundreds
of nuclease families. We have also assembled a robust library of other effector enzymes to design and engineer the next generation of genome editing systems that are fit for essentially any therapeutic purpose. Our effector enzyme library includes
over three million deaminases, over five&nbsp;million RTs, and thousands of CAST systems, as shown in Figure 3 below. The continuous interrogation of an ever-expanding database of programmable nucleases and other enzyme effectors accelerates the
pace of learning and insights to feedback into proprietary machine learning algorithms and further separates us from peer companies. As we continue to build upon our metagenomic library, we expect to make additional discoveries of novel genome
editing technology and expand our toolbox.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 3</B>. Our Effector Enzyme Library. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g61f03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">From this library, we select our lead nucleases and other effector enzymes through a funnel of stringent performance and safety
criteria that involves testing in a series of cell-free, cell-based, and <I>in vivo</I> experiments. Ultimately, we prioritize editing systems that exhibit high editing efficiency and precision, and have a compact size that will optimize their
delivery. Because most systems added to our genome editing toolbox have different genomic targeting specifications, we believe that our expanding toolbox could enable us to target every base pair in the human genome. This process, highlighted in
Figure 4, helps us to identify highly active natural enzymes that require minimal engineering and optimization to translate into potentially curative genetic medicine. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 4</B>. Overview of High-Throughput Screening Process. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g62f04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial"><U>Modular Engineering Translates Metagenomic Discoveries into Genetic Medicines</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our metagenomics platform and modular engineering process has supported the discovery and development of our broad
genome editing toolbox at a rapid pace since our company&#146;s founding in 2018. By selecting highly active nucleases from our library, our process requires minimal optimization to develop genome editing systems. We utilize a modular engineering
approach to match lead nuclease candidates with an optimal gRNA and targeting domain in order to optimize targeting, specificity, and editing efficiency. Furthermore, additional effector enzymes can be included to modify the function of the system,
for example by adding a deaminase to a nickase variant for base editing. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In order to achieve these modifications, we leverage our vast library of editing systems to
perform targeting domain swaps between enzymes, substituting domains from less-active enzymes into the backbone of highly-active nucleases. This results in chimeric enzymes that can provide high efficiency editing at gene loci. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The modular engineering process is accelerated using <I>in silico</I> screening algorithms to predict the optimal chimera. This predicative, high-speed engineering
process allows us to continually iterate across each component of the genome editing system to quickly develop an engineered system that is optimized for various therapeutic applications. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Modular engineering can be used to adjust the targeting of high-performing systems by leveraging the diverse targeting capabilities of diverse Metagenomi nucleases.
Given the measured targeting density of our toolbox, we believe that essentially any codon and ultimately every base pair in the human genome could be addressed with our gene editing systems. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Genome editing remains in the early stages of development and our platform allows us to continuously learn, iterate, and optimize our genome editing toolbox in pursuit
of curative genome editing medicines. The increasing insights from our modular engineering and target domain swapping are captured and further interrogated and organized by our proprietary AI platform to accelerate the pace of future development and
further separate us from our peers. As the genetic medicine field continues to rapidly evolve, our platform positions us to be at the forefront of unlocking the full potential of genome editing through the continuous discovery of new editing systems
and the development of the next wave of genetic medicines. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our Solution: Proprietary Toolbox Derived from Our Metagenomic Approach </U></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Our Platform of Genome Editing Technologies </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="53%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Gene Edit</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="center"><B>Metagenomi&nbsp;(&#147;MG&#148;)&nbsp;Tools</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Key Attributes</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px dashed #000000"><B>Type II Nucleases</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px dashed #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Extensive targetability (Alexander et al 2023,
Lamothe et al 2023)</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Can be converted
to nickases for base editing and RIGS</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial"><B>Double-strand DNA break</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial"><B>(e.g for knockdown, <FONT
STYLE="white-space:nowrap">knock-in,</FONT> gene activation, and exon skipping)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px dashed #000000"><B>Type V Nucleases</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px dashed #000000"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Systems with small gRNAs (Goltsman et al 2020)</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Includes ultra-small systems that expand
delivery approaches (e.g.,&nbsp;AAV)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000"><B>SMART Nucleases</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Ultra&#150;small systems expand delivery approaches (e.g.,&nbsp;AAV) (Goltsman et al 2022)</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Can be converted to nickases for base
editing and RIGS</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Nucleotide changes<BR></B>(i.e. base editing)<B></B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000"><B>ABE and CBE</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Engineered from MG nickase and MG deaminase</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;CBE also include MG uracil glycosylase
inhibitor (&#147;UGI&#148;)</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Base
editors engineered from type II have extensive genomic targetability</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;SMART base editors are smallest nickase-based systems characterized to date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000"><B></B><B>Small changes (1-100 base<BR>pair replacement,<BR>insertion, or deletion, i.e.&nbsp;prime editing)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Little RIGS</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Engineered from MG nickase and MG RT</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Ultra-small RTs are highly active and accurate for prime editing</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Enabled by extensive targetability and
deliverability of MG nickases</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Large insertions<BR></B>(&gt;100&nbsp;base pair<BR>integrations)<B></B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px dashed #000000"><B>RNA-templated: Big RIGS</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px dashed #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px dashed #000000"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Engineered from MG nickase and MG RT</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;MG RT are accurate, and can convert &gt;4,000 bp RNA templates into DNA</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Programmable integration of large
transgenes delivered as RNA</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000"><B>DNA-templated: CAST and other systems</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;CASTs are naturally occurring programmable transposase systems</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Ability to site-specifically integrate
large transgenes delivered as DNA, possibly including templates much larger than 4,000 bp</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">&#149;&#8194;&#8202;Potential to addresses any genetic disease driven by loss of function</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">143 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">All components of our toolbox have been discovered and derived from our proprietary metagenomics library. We have
assembled a full suite of differentiated tools that, together, can potentially effectuate any desired gene modification &#150; gene knockdown, gene <FONT STYLE="white-space:nowrap">knock-in</FONT> and replacements. We believe there is no other
single platform enabling the breadth and differentiation of genome editing technologies as our toolbox. All elements of our toolbox are wholly owned, and we have constructed a broad patent estate that protects our intellectual property, and it will
continue to expand as we discover, interrogate, and optimize our novel editing systems. As we continue to expand our metagenomic library, we expect to make additional discoveries of novel genome editing technology. The core technologies in our
toolbox to date are outlined in the above table. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Key Attributes of Our Proprietary Toolbox </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Key advantages of our platform and technologies are: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Potential to create a full spectrum of genetic medicines </I></B><B>&#150; </B>Our broad suite of genome editing technologies include: programmable nucleases, base editors, RIGS and CASTs, that, together, can
potentially effectuate any desired modification to the genome &#150; gene <FONT STYLE="white-space:nowrap">knock-down,</FONT> gene <FONT STYLE="white-space:nowrap">knock-in,</FONT> and replacements. This allows us to address a diverse set of
mutations by matching the right tool to a specific target, with limited unintended effects such as <FONT STYLE="white-space:nowrap">off-target</FONT> editing. As such, we intend to prosecute a genetic medicine therapeutic development strategy across
a broad array of diseases and target organs including liver, central nervous system, muscle, kidney, and lung. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Potential next generation genome editing systems </I></B>&#150; Our scientific underpinnings based in metagenomics provide a continuous engine for discovering and developing potential next generation genome
editing systems. For example, RIGS and CAST. As we continue to build upon our metagenomic library we expect to expand our toolbox as we make more discoveries. We have constructed a broad patent estate that protects our intellectual property, and it
will continue to expand as we discover, interrogate, and optimize our novel editing systems. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>3)</I></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I></I><B><I>Ultra-small nuclease platform to expand </I></B><B>in vivo</B> <B><I>delivery of multiple genome editing systems </I></B>&#150; Compact systems create potential advantages for delivery, manufacturing, and
dosing. For example, at 429 aa in length, one of our SMART nucleases is a fraction of the size of the industry-standard SpCas9 system, which is 1,300 aa and exceeds the delivery capacity of standard AAV vectors. The ability to package our systems
into a single AAV will enable more efficient targeting of organs and diseases beyond what is currently possible with LNP delivery. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">4)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Designed to edit any target in the human genome</I></B><I> </I>&#150; Our metagenomics library contains hundreds of nucleases with diverse targeting abilities that allow us to address a diverse set of mutations
that cause disease, including those found at sites that often cannot be targeted by first-generation nucleases. This allows us to select the ideal nuclease for any target site of interest. Given the measured targeting density of our toolbox, we
believe that essentially any codon in the human genome could be addressed with our gene editing systems. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">5)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Shortened optimization period &#150;</I></B> We benefit from a diverse set of highly-active nucleases and effectors which have required little <FONT STYLE="white-space:nowrap">-if</FONT> <FONT
STYLE="white-space:nowrap">any-</FONT> protein engineering to optimize. These highly active natural enzymes allow us to quickly identify systems for therapeutic development. As a result of not having to heavily engineer systems to be active in human
genome editing applications, we are able to move quickly from discovery to candidate nomination for particular genetic disease applications. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">6)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><B><I>Ability to target large gene integrations into the genome using our RIGS and CAST systems &#150;</I></B> Our novel
RIGS and CAST systems allow for programmable, large gene insertions, an outcome which has been a major challenge for the genome editing field. RIGS are a proprietary genome editing system engineered from nickases and RTs, while CAST are systems that
exist in nature but have required engineering to allow </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">144 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">
for mammalian genome editing. We believe we are the first to demonstrate targeted genomic integration in human cells using compact CAST systems. While CAST have the theoretical capability to
integrate very large DNA templates into the genome, RIGS are also being developed in order to achieve targeted, large genomic integrations when all components need to be delivered as RNA, for example when using standard LNP delivery technology.
</P></TD></TR></TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Specific Components of Our Toolbox </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><I><U>Programmable Nucleases </U></I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial">Overview </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 5</B>. Schematic Showing
Programmable Nucleases and Their Use for Genome Editing. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g63f05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are building a toolbox that includes programmable nucleases that are selected to target any site in the human genome with high
precision. Most therapeutic genome editing applications to date use CRISPR/SpCas9 as the programmable nuclease. However, this system has several limitations that prevent its broad use across the thousands of genetic diseases that impact patients.
Most importantly, SpCas9 is limited by where it can be targeted in the human genome and in some cases has a lack of specificity that leads to frequent <FONT STYLE="white-space:nowrap">off-target</FONT> editing. In addition, the size of the SpCas9
enzyme complicates options for delivery using industry-standard methods. We have explored diverse programmable nucleases found in nature in order to identify novel systems that overcome all of these limitations (Figure&nbsp;5). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The discovery of new CRISPR enzymes with unique functionality and structure may offer the potential to further disrupt genome editing technologies, improving speed,
specificity, functionality, and ease of use. CRISPR systems are commonly organized into two classes, six types and an expanding number of subtypes based on functional characteristics and evolutionary relatedness. We focus our attention on CRISPR
type II and type V systems, owing to the simplicity of these programmable nucleases. Type II and type V nucleases are <FONT STYLE="white-space:nowrap">RNA-guided</FONT> enzymes that can be programmed to target specific sequences of DNA, and
sometimes RNA. Unlike type II nucleases, type V nucleases are more likely to generate staggered versus <FONT STYLE="white-space:nowrap">blunt-end</FONT> cuts in double stranded DNA. Nucleases from both of these systems are extensively used in
biotechnology, despite limitations that prevent their more widespread use in therapeutic applications. Our type II and type V CRISPR systems are distinct from previously studied CRISPR enzymes (based on their protein sequence, size, and
biochemistry), while maintaining the core functionality of being programmable nucleases. Our lead systems have undergone extensive study across multiple mammalian cell types and animal models, demonstrating their utility as genome editing tools in
both <I>in vivo</I> and <I>ex vivo</I> applications. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Throughout our search for novel programmable nucleases, we have identified several new types of ultra-small
nucleases that range in size from approximately 450 aa to 1,000 aa, compared with type II and type V nucleases which are typically between 1,000 aa and 1,500 aa in length (for comparison, the most studied SpCas9 enzyme is 1,368 aa). Our
newly-discovered, ultra-small nucleases include new types that we collectively refer to as SMART, as well as those that come from novel type V sub-groups. Given their small size, these new systems have the potential to be delivered to additional
therapeutic target sites that expand beyond what is possible with first-generation systems. In adapting these novel systems into potential precision genetic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">145 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
medicines, our programmable nucleases are designed to have the capability to target essentially any therapeutically relevant genomic site with a high level of specificity (i.e. with limited <FONT
STYLE="white-space:nowrap">off-target</FONT> editing), while expanding compatibility with available delivery technologies. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our Approach </U></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To date, we have identified thousands of novel CRISPR type II, type V and SMART nucleases, including ultra-small systems, expanding the collection of known programmable
nucleases by mining our proprietary metagenomics database. Using high-throughput <I>in vitro</I> testing, we have validated the activity of hundreds of novel nucleases. This has led to the identification of highly-active natural nucleases while also
enabling us to catalog the unique targeting capabilities of each system. We select for natural, <FONT STYLE="white-space:nowrap">un-engineered</FONT> systems with high activity and specificity. Our best-characterized nucleases have demonstrated
activity levels meeting and often greatly exceeding SpCas9 while exhibiting low levels of <FONT STYLE="white-space:nowrap">off-target</FONT> editing in mammalian cells. Given the measured targeting density of our toolbox, we believe that essentially
any codon in the human genome could be addressed with our gene editing systems. The targeting density (frequency of targetable sites in the human genome) of the toolbox greatly increases the likelihood of identifying a highly active and specific
nuclease and gRNA combination for any therapeutically relevant genomic target. We can use these programmable nucleases for genome editing, and also as a chassis for developing base editors and RIGS. The diverse biochemistry of these novel systems,
including their size and DNA cutting profiles, makes it possible to link editing systems to the particular genomic target, edit type, and delivery technology we believe are required to develop genetic medicines. Additional discovery and
characterization of programmable nucleases will further expand the targeting density of our toolbox, improving the overall activity and specificity of lead systems identified for therapeutic development. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our best-characterized type II and type V nucleases are suitable for a wide variety of genome editing applications </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Nucleases with the activity and specificity required for potential therapeutic genome editing applications are identified through a series of high-throughput screening
and characterization steps. Novel protein and gRNAs are first predicted bioinformatically and then validated in both cell-free and mammalian cell screens. These steps validate the activity of a system and provide an accurate measure of targeting and
specificity profiles. This approach has been applied to both type II and type V CRISPR nucleases in order to establish an expanding collection of well-characterized systems. In addition to discovery of novel nucleases with distinct targeting
capabilities, a modular protein engineering approach is also used in order to create chimeric systems. The chimera approach leverages the high activity of <FONT STYLE="white-space:nowrap">top-performing</FONT> systems but changes where they can edit
by incorporating distinct targeting domains from related systems. Through continuous discovery and refinement, this collection of systems will expand, with the potential to target essentially every site in the human genome, while also creating a
chassis to support the accelerated development of base editing, prime editing, and targeted integration systems. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">146 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Given the measured targeting density of our toolbox, we believe that essentially any codon in the human genome
could be addressed with our gene editing systems. </I></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>Figure 6</B>. Our Expanding Nuclease Toolbox is Designed to Enable Extensive Targeting throughout the Human Genome.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><B>Figure 6a</B>. Our nucleases have shown high editing efficiency in mammalian cells.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 6b</B>. Given the measured targeting density of our toolbox, we believe that essentially any codon in the human genome could be addressed
with our gene editing systems.</P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom"> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:59pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-right:0.60em" ALIGN="center">


<IMG SRC="g425213g01c01.jpg" ALT="LOGO">
</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Editing efficiency was determined based on the frequency of InDels detected by next generation sequencing
(&#147;NGS&#148;) at genomic sites targeted by each nuclease.</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Graph depicts editing efficiency for the top five guides for each of six nucleases.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g00b06.jpg" ALT="LOGO">
</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Graph depicts cumulative targetability.</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Targeting density (targetability) is the average distance between nuclease target sites in the human genome.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our nucleases are capable of highly efficient genome editing in mammalian cells. Systems are tested across a collection of gRNAs designed
based on the unique requirements and targeting preferences determined for each system. If a nuclease is routinely capable of editing at near-saturating levels, sometimes up to 99% editing efficiency, the system will go through further
characterization and therapeutic development. Figure 6a shows the high editing efficiency of six systems observed in mammalian cells, indicating that they have the potential for broad use in therapeutic development given an ability to rapidly
identify high performing guides that require minimal optimization. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Given that each nuclease has distinct genomic targeting capabilities, we are able to determine
which sites in the human genome can be addressed by each system. Figure 6b shows how the targeting density of our toolbox increases with each new system. Given the measured targeting density of our toolbox, we believe that essentially any codon in
the human genome could be addressed with our gene editing systems. This collection of systems includes both natural enzymes as well as chimeric forms that have been engineered to alter the targetability of the nuclease. For reference, SpCas9 is able
to target roughly every ten base pairs in the human genome. The targeting density of the toolbox increases the likelihood of identifying a highly-potent guide for any desired genome edit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">147 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our nuclease toolbox is on track to target anywhere in the human genome </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 7</B>. Our Nucleases are Compact with Diverse Targeting Sequence Motifs, Selected to Enable Broad Genome Editing Applications. </P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g00k01.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Graph depicts a selection of our nucleases, including their size in aa on the horizontal axis and their corresponding targeting motifs shown as sequence logos (PAM and TAM sequences), compared to SpCas9.
</TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Multiple parameters are considered when screening and promoting nucleases for further development, including the size of the system, activity across
various assays and cell types, and targeting. For CRISPR systems, nuclease targeting is limited by a PAM sequence, or protospacer adjacent motif. The PAM is a short DNA sequence motif that must be present next to a target sequence in order for the
nuclease to cut at the target site. Other systems have similar requirements that go by different names. For example, some SMART nucleases recognize functionally similar sequences called target-adjacent motifs (&#147;TAMs&#148;). Figure 7 shows the
diversity of protein sizes and targeting motifs recognized by our nucleases. The vast diversity of the protein size and targeting motif requirements of our nucleases continues to fuel toolbox development and will enable the identification of
additional systems that could make it possible to target nearly every base pair in the human genome. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our nucleases are highly active across many human cell types
which may indicate broad potential utility for human therapeutic applications </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Beyond initial nuclease benchmarking conducted in immortalized mammalian cell
lines, we have conducted extensive surveys to show that these systems can be used in a variety of primary cells important for preclinical studies (i.e., T cells, natural killer (&#147;NK&#148;) cells, B cells, hematopoietic stem cells
(&#147;HSCs&#148;) and induced pluripotent stem cells (&#147;iPSCs&#148;)), as illustrated by Figure 8 below. The versatility of these exemplary systems indicates their potential use in broad therapeutic applications. These benchmarks against SpCas9
also indicate that our systems may have potency advantages in which fewer genome editing reagents will need to be delivered in order to achieve high levels of genome editing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">148 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 8</B>. Our Nucleases Show High Editing Efficiency in Human T Cells, NK Cells, B Cells, HSCs, and iPSCs. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g17k03.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Two example nucleases are shown, type II <FONT STYLE="white-space:nowrap">MG3-6</FONT> and type V <FONT STYLE="white-space:nowrap">MG29-1.</FONT> </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Editing efficiency was determined based on the frequency of InDels detected by NGS at genomic sites targeted by each nuclease. </TD></TR></TABLE>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our nucleases exhibit high specificity when benchmarked in multiple mammalian cell types </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our therapeutic development of genome editing systems require that they exhibit high activity and specificity across multiple cell-based models. We employ a broad set of
specificity and off-target assessment methodologies, including <I>in silico</I>, biochemical, and cell-based approaches. Figure 9 shows peer-reviewed and published <FONT STYLE="white-space:nowrap">off-target</FONT> assessments conducted using an
unbiased, industry standard, cell-based, oligonucleotide capture method. In Figure 9a we show that two of our nucleases are more specific than SpCas9 when compared across multiple guides, and in Figure 9b we show that we can identify guides with no
to minimal detectable <FONT STYLE="white-space:nowrap">off-targets</FONT> with two lead nucleases tested in both immortalized and primary human cells. This trend has continued, and we are able to identify guides that have minimal or no detectable
off-target activity for therapeutic targets. It is expected that the higher specificity of these systems will translate into better safety profiles across various therapeutic genome editing applications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">149 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 9</B>. Our Nucleases are Highly Specific. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 9a</B>. Our nucleases are highly specific in multiple mammalian cell types. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g01a17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 9b</B>. Our best-characterized nucleases have guides that showed no to minimal detectable
<FONT STYLE="white-space:nowrap">off-target</FONT> edits when assayed in immortalized and primary human cells. </P> <P STYLE="font-size:16pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center"><B>


<IMG SRC="g425213g01b17.jpg" ALT="LOGO">
 </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Figure 9a: <FONT STYLE="white-space:nowrap">Off-target</FONT> analysis showed that our type II <FONT STYLE="white-space:nowrap">MG3-6</FONT> and <FONT STYLE="white-space:nowrap">MG3-8</FONT> nucleases have high
specificity in multiple mammalian cell types as measured by the number of <FONT STYLE="white-space:nowrap">off-target</FONT> sites and the fraction of <FONT STYLE="white-space:nowrap">on-target</FONT> reads. The target sites are the same between the
three nucleases, including SpCas9. <FONT STYLE="white-space:nowrap">Off-target</FONT> experiments were conducted at N &#061; 2, and reads for both replicates were summed for analysis. Double strand break (&#147;DSB&#148;) discovery via capture of a
double-stranded oligonucleotide in primary T cells using the same <FONT STYLE="white-space:nowrap">MG3-6</FONT> and <FONT STYLE="white-space:nowrap">MG29-1</FONT> guides from (A; averaged across three biological replicates). Source: Alexander et al
2023 CRISPR Journal </TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Figure 9b: DSB discovery via capture of a double-stranded oligonucleotide in HEK293T cells with SpCas9 (on target read in gray), guides <FONT STYLE="white-space:nowrap">MG3-6</FONT> TRAC B2, TRAC D2, TRAC 6, and GR 3
(on target in blue), and <FONT STYLE="white-space:nowrap">MG29-1</FONT> guides TRAC 9, TRAC 19, TRAC 35, and GR 13 (on target in yellow) across three biological replicates. Source: Lamothe et al 2023 CRISPR Journal </TD></TR></TABLE>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our nucleases enable highly efficient and specific </I>in vivo<I> genome editing in preclinical evaluations </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Type II MG3-6/8 is our chimeric nuclease that has been extensively characterized <I>in vitro</I> and <I>in vivo</I>. This system is engineered from the <FONT
STYLE="white-space:nowrap">MG3-6</FONT> chassis, which was discovered from the genome of a commensal, <FONT STYLE="white-space:nowrap">non-pathogenic</FONT> representative of the human microbiome that showed high editing efficiencies when tested
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">150 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
across multiple mammalian cell types (see Figures 6, 8 and 9 above). The engineering involved changing the PAM interacting domain of the chassis, which enables the enzyme to be targeted to new
sites in the human genome. Figure 10 shows that this system is suitable for <I>in vivo</I> applications, based on saturating levels of editing achieved in a mouse study with a single administration of nuclease mRNA and guide encapsulated in a LNP
with tropism to the liver. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 10</B>. <I>In Vivo</I> Editing in Mice with MG3-6/8 Nuclease. </P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom">Editing efficiency was determined based on the<BR>frequency of InDels detected by NGS at genomic sites<BR>targeted by each nuclease.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">


<IMG SRC="g425213g01a99.jpg" ALT="LOGO">
</TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Delivery by mRNA and LNP, dosing at 1 mg/kg. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mean of 79% genome editing efficiency as measured by the frequency of InDels detected by NGS at the targeted genomic site. </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, one of our most highly characterized type V nucleases, <FONT STYLE="white-space:nowrap">MG29-1,</FONT> demonstrated high activity and specificity during
multiple preclinical studies spanning from <I>in vitro</I> to NHP. Originating from a bacterial genome found in a deep sea hydrothermal vent, <FONT STYLE="white-space:nowrap">MG29-1</FONT> has a smaller protein (1,280 aa) and gRNA (~70 nt) compared
with <FONT STYLE="white-space:nowrap">MG3-6</FONT> (1,135 aa and ~110 nt) and SpCas9 (1,368 aa and ~100 nt). <FONT STYLE="white-space:nowrap">MG29-1</FONT> has demonstrated up to 97% editing in primary mouse hepatocytes in culture (Figure 11a),
superior liver editing to an exemplary SpCas9 guide targeting an overlapping genomic site when delivered to mice using a LNP that delivers primarily to the hepatocytes in the liver (Figure 11b), and on average 50% editing in the whole liver of NHP
when delivered in a LNP that delivers primarily to the hepatocytes in the liver (Figure 11c, guide 2). Approximately 76% of the genomes in mouse liver are from hepatocytes based upon a published analysis of gene editing in whole liver compared to
hepatocytes isolated from the same edited mice. Using this conversion factor of 76% (1/0.76), we achieved 100% editing of hepatocytes with MG3-6/3-8 (Figure 10) and 94% editing of hepatocytes with MG29-1 (Figure 11b). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In cynomolgus monkeys, it is estimated that hepatocytes make up 60% of the cells in the liver. Therefore, 50% editing in the whole liver achieved with MG29-1 in NHP
(Figure 11c, guide 2) translates to editing of approximately 80% of the hepatocyte genomes which are the therapeutically relevant target cell. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">151 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 11</B>. Our Type V <FONT STYLE="white-space:nowrap">MG29-1</FONT> Nuclease is a Highly Active Natural Enzyme
for <I>In Vivo</I> Genome Editing. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:12pt ;"><B>Figure 11a</B>. <FONT STYLE="white-space:nowrap">MG29-1</FONT> achieved saturating levels of editing in primary mouse hepatocytes.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:12pt ;"><B>Figure 11b</B>. <FONT STYLE="white-space:nowrap">MG29-1</FONT> has higher <I></I>potency than SpCas9 when editing mouse liver cell genomes <I>in vivo.</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:12pt ;"><B>Figure 11c</B>. MG29-1 demonstrates successful editing in NHPs.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g18a19.jpg" ALT="LOGO">
</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g18b20.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g18c21.jpg" ALT="LOGO">
</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;50% whole liver editing &#061; 80% hepatocytes editing.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial"><FONT
STYLE="white-space:nowrap">*&#8195;&#8194;MG29-1</FONT> and SpCas9 were delivered by LNP with <FONT STYLE="white-space:nowrap">co-formulated</FONT> mRNA and gRNA.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;gRNAs for both <FONT STYLE="white-space:nowrap">MG29-1</FONT> and SpCas9 have overlapping target sites.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;mRNAs for both nucleases use the same
overall design and were codon optimized with the same algorithm.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;The SpCas9 gRNA incorporated extensive optimizations published in the literature.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;InDels were analyzed by NGS four days after
IV infusion.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;L, M, H, refer to low,
medium and high doses.</P></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We use multiple unbiased, industry standard methods to identify putative <FONT STYLE="white-space:nowrap">off-target</FONT> edits, which
are then investigated using sensitive targeted sequencing. To date no detectable off-target editing has been observed for the <FONT STYLE="white-space:nowrap">MG29-1</FONT> lead guide for two of our therapeutic programs at therapeutically relevant
doses, which is consistent with MG29-1 being a highly efficient, specific and programmable nuclease suitable for broad <I>in vivo</I> genome editing applications. Beyond <FONT STYLE="white-space:nowrap">MG29-1,</FONT> the multitude of nucleases in
our toolbox enables us to screen an extensive guide library for any genomic locus of interest. For exemplary lead guides that have been examined for off-target editing we observe minimal or no detectable
<FONT STYLE="white-space:nowrap">off-target</FONT> editing. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our ultra-small nucleases are efficient genome editors that unlock additional delivery modalities
</I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Delivery of genome editing payloads is often restricted by the size limitations of the delivery vehicle. Therefore, we leverage our metagenomics database to
find new nucleases that are significantly smaller than current systems. After searching through billions of predicted proteins from bioinformatically reconstructed microbial genomes, we uncovered several distinct types of ultra-small nucleases. Our
lead ultra-small nucleases are significantly smaller than CRISPR SpCas9, enabling new and improved <I>in vivo</I> delivery methods and new possibilities for building base editing systems and prime editors that can be packaged in <FONT
STYLE="white-space:nowrap">size-constrained</FONT> delivery vehicles. Typical CRISPR Cas9 systems are about 1,300 aa in length whereas some of these new systems are just over 450&nbsp;aa. Compact systems create potential advantages for delivery,
manufacturing, and dosing. Furthermore, they can be delivered to organs and tissues currently only accessible by AAV, given that the nucleases are well-within the packaging limitations of these delivery vectors. The smaller size of these nucleases
compared to previous systems potentially unlock target indications beyond applications in the liver. Because of their novel biochemistry and divergence from typical type II, we refer to some of these ultra-small nucleases as SMART. In addition, we
identified several novel families of ultra-small type V nucleases. Unlike compact type V, and all other previously studied type V, SMART have a dual catalytic domain structure that enables engineering of nickase variants that can be used for base
and prime editing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">152 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Figure 12 shows that genome editing efficiencies achieved for SMART and compact type V nucleases are comparable to
other lead systems. These results show that our ultra-small nucleases are highly efficient genome editing systems that have the potential for extensive therapeutic applications, including for those in which delivery is a limiting factor. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"><B>Figure 12</B>. Our Ultra-Small Nucleases are Designed to be Highly Efficient Genome Editing Systems that Are Well-Within the Packaging Limits of AAV Vectors.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><B>Figure 12a</B>. Schematic representation of how our ultra-small nucleases are a fraction of the size of a typical CRISPR SpCas9 nuclease.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Figure 12b</B>. SMART nuclease showed high editing efficiency in mammalian cells, prior to optimization.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Figure 12c</B>. Compact type V nuclease showed high editing efficiency in mammalian cells, prior to optimization.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g29a65.jpg" ALT="LOGO">
</P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center"><SUP STYLE="font-size:75%; vertical-align:top">


<IMG SRC="g425213g05n05.jpg" ALT="LOGO">
</SUP></P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g29c87.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> *&#8195;&#8194;InDels are measured by NGS.<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:7.5pt">*&#8195;&#8194;Each bar represents
a distinct guide.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:7.5pt">*&#8195;&#8194;MG3-6 used as internal control.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> *&#8195;&#8194;InDels are measured by NGS.<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:7.5pt">*&#8195;&#8194;Each bar represents
a distinct guide.</P></TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Base Editors </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Overview </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 13</B>. Schematic Showing the Two Primary Types of Base Editors under Development. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g29e65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We leverage our toolbox of programmable nucleases to develop a highly targetable and flexible base editing platform compatible with
various delivery technologies. Base editing modifies individual bases in the genome without making double-stranded breaks in the DNA. This approach uses a chemical reaction designed to create precise, predictable, and efficient genetic outcomes at
the targeted sequence. These precise changes to individual base pairs in the genome can be used to correct or change genomic sequence in order to address disease. Notably, the most common class of genetic mutations are errors of a single base, known
as point mutations. These point mutations, many of which could be addressed with a base editor, represent approximately 58% of all the known genetic errors associated with disease. Furthermore, base editors can be used to precisely knockdown genes
by introducing premature stop codons or interrupting gene splice sites. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">153 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There are two types of base editors: ABEs and CBEs. ABEs convert adenine-thymine base pairs to guanine-cytosine base
pairs. CBEs target cytosine-guanine and convert them to thymine-adenine. We are developing both ABEs and CBEs, which have been validated across multiple mammalian cell types and <I>in vivo</I>, to enable broad use of the base editing approach for
addressing disease (Figure 13). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Base editors are composed of a targeting enzyme, typically a programmable nuclease that has been engineered to localize to a
specific site in the genome but not cause a dsDNA break, and a deaminase, which is responsible for the chemical conversion of targeted genomic bases. Base editors can be engineered using modified nickase programmable nucleases that have been
engineered to nick rather than cut genomic targets (i.e. a nickase variant). The nickase recognizes and binds to specific DNA sequences, determined by a gRNA, enabling deaminases that are fused to the nickase to modify the targeted bases. Typically,
the modified bases are found on the single-stranded DNA that is exposed at a target site when the gRNA is bound to one of the strands of DNA. The efficiency of cytosine base editors can be improved by the addition of another enzyme called a UGI. The
UGI protects edited bases against DNA repair machinery that would otherwise remove them and revert the edited sequence back to its original form. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Base editing
results in one or more mismatched bases in the dsDNA, which are resolved by DNA repair mechanisms in the cell. Nickases are typically used such that the DNA strand opposite to the modified bases is nicked, thus biasing DNA repair pathways to favor
the modified strand over the original sequence. The result is a precise change in one or more targeted bases without creating double-stranded breaks or requiring a donor template. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B></B><I>Our Approach</I><B> </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are leveraging our toolbox of programmable
nucleases and our metagenomics discovery platform to develop next generation base editing tools. Our programmable nucleases provide the ability to efficiently and precisely target locations in the genome required in order to potentially create a
wide-variety of genetic medicines. In addition, the availability of ultra-small SMART effectors enables us to develop base editors that could be delivered to various target tissues and organs. While established base editing systems using SpCas9
require splitting the system into two AAV vectors for delivery, those developed from SMART are designed to be within the packaging limitations of a single AAV. We have discovered and engineered what we believe to be two of the smallest base editors
developed to date, one SMART ABE that is 623 aa in length and another SMART ABE that is 969 aa. These systems provide substantial opportunities for vector optimization compared with SpCas9 ABEs that are 1,588 aa. Furthermore, the flexibility of the
modular, chimeric nuclease platform, enables rapid optimization of base editors capable of editing at a multitude of target sites, since engineering and optimization applied to one base editor can rapidly be applied to other systems with the
capability of targeting to new genomic sites. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Given that base editors require deaminases, and a UGI in the case of cytosine base editors, substantial enzyme
discovery beyond programmable nucleases has been required in order to develop highly efficient base editors that have the potential to overcome the limitations of the current technology. We have mined over three million deaminases in order to
identify enzymes with the capability to function as part of base editing systems. In many cases these novel deaminases have required minimal protein engineering to achieve therapeutically-relevant editing efficiencies in multiple studies. The
ability of our metagenomics discovery platform to identify novel enzymes with high activity makes it possible to rapidly develop differentiated technology that surpasses first-generation systems. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">154 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B></B><I>Our base editors are highly active in mammalian cells across various genomic targets</I><B> </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>Figure 14</B> ABE and CBE Developed from Type II <FONT STYLE="white-space:nowrap">MG3-6</FONT> System Have Been Shown to be Highly Active in Mammalian Cells, with Extensive Genome Targetability to Enable Potential
<I>In Vivo</I> and <I>Ex Vivo</I> Therapeutic Development.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"><B>Figure 14a.</B> PAM interacting domain engineering was used to develop a suite of chimeric MG3-6 base editors with extensive genome targetability.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Figure 14b.</B> ABE screening identified guides capable of achieving saturating levels of A-to-G genome editing in mammalian cells.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g425213g61g01.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g425213g86y35.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;ABE: SpCas9 &#061; 18% and MG3-6 &#061; 95% targetability.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;CBE (not shown): SpCas9 &#061; 5% and MG3-6
&#061; 53%.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Optimized ABE construct tested in Hepa 1-6 cells with mRNA delivery.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B>Figure 14c.</B> CBE screening identified highly active deaminases for C-to-T editing, compared to published control.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B>Figure 14d.</B> MG3-6 PAM chimera ABE and CBE achieved efficient editing at splice-sites for enacting therapeutically-relevant knock-out of genes
in human cells.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g62c06.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g61g02.jpg" ALT="LOGO">
 </P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Unoptimized CBE construct tested in HEK293T cells with plasmid delivery.</P>
<P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;CBE control uses hyperactive CDA
A0A2K5RDN7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Top three guides shown for each target and system.</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Constructs tested in HEK293T cells with
mRNA delivery for the BE along with chemically synthesized guides.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">155 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B>Figure 14e.</B> MG3-6 CBEs are efficient for multiplexed knock-outs in primary human T cells with no impact on cell viability.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g425213g61g03.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Top panel shows two guides that were used to knock out two different proteins, either when
edited independently or when multiplexed.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Experiments were conducted in primary human T cells using mRNA delivery for the BE along with chemically
synthesized guides.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our base editors are highly active and progressing towards <I>in vivo</I> therapeutic applications. Both of our ABE and CBE systems have
been tested in mammalian cells in order to determine editing efficiency, where a large collection of guides spanning various genomic loci were tested for each system. Figure 14 shows the development of a highly efficient and targetable base editing
platform established from the MG3-6 nuclease chassis. Using PAM interacting domain engineering, the theoretical targetability of the ABE and CBE was shown to be significantly greater than that of typical base editors developed from SpCas9. Based on
PAM availability the ABE was able to target over 95% of the adenine bases in the human genome, and the CBE was able to target over 50% of the cytosine bases, compared with approximately 18% and 5%, respectively, for SpCas9. Furthermore, over 95%
editing efficiency was achieved with both an optimized ABE and CBE construct delivered by mRNA. Initial CBE testing without construct optimization using a less-efficient plasmid delivery approach achieved up to 58% editing efficiency, which was
notable because it outperformed an industry-standard control CBE by several fold in the benchmarking experiment shown in Figure 14. We demonstrated that these efficient ABE and CBE systems could be used for creating edits that have the potential to
result in protein knockdown, which could be applied for therapeutically relevant editing <I>in vivo</I>. Furthermore, we believe the observed CBE multiplexing in primary T cells shows that this platform has the potential to advance <I>ex vivo</I>
cell therapy development by making it possible to efficiently knock out multiple proteins without impacting cell viability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">156 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our base editing platform has broad <I>in vivo</I> therapeutic potential </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>Figure 15</B>. Lead ABE System Developed from Type II <FONT STYLE="white-space:nowrap">MG3-6</FONT> System Demonstrated High Activity in Primary Cells and in an <I>in vivo</I> Mouse Model.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial"><B>Figure 15a</B>. Our lead ABE system efficiently edited primary mouse hepatocytes at example target sites.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Figure 15b</B>. Our lead ABE system demonstrated activity <I>in vivo</I> when delivered to mouse livers by mRNA and LNP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g25i26.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g20j89.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In order to demonstrate the utility of the <FONT STYLE="white-space:nowrap">MG3-6</FONT> ABE platform for <I>in vivo</I> base editing, a
lead construct design was tested both in primary cells and in mice. Multiple guides were tested in each study, designed to target different genomic loci. Figure 15 shows the results of these evaluations of the ABE platform, where up to 60% editing
efficiency was demonstrated in primary hepatocytes and 35% efficiency was achieved across all liver cells in an initial <I>in vivo</I> study using mRNA and LNP delivery. Given that approximately 70% of liver cells are hepatocytes, and therefore
targetable by the LNP platform, this editing experiment suggests that approximately 50% of all targetable cells were successfully edited. We believe this level of editing, which is comparable to other initial <I>in vivo</I> base editing studies,
supports the potential to rapidly progress towards therapeutic applications. Given that both the ABE and CBE data shown in Figures 14 and 15 are based on a chimeric <FONT STYLE="white-space:nowrap">MG3-6</FONT> nickase, we anticipate that the broad
targetability of this system will enable rapid development of multiple potential new therapeutic applications of base editing technology. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">157 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our SMART have been engineered to create ultra-small base editors, expanding the potential deliverability of base
editing technology </I></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"><B>Figure 16</B>. SMART Can be Engineered into Ultra-Small Base Editors with Naturally High Editing Efficiency and AAV Compatibility.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"><B>Figure 16a</B>. Ultra-small SMART base editors are a fraction of the size of a typical Cas9 system, enabling AAV delivery.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Figure 16b</B>. SMART ABE exhibited a similar editing profile <I>in vitro </I>compared to SpCas9.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Figure 16c</B>. SMART ABE were active in mammalian cells.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g50a51.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g50a52.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g50a53.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">*&#8195;&#8194;SMART <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ABE-MG34-1</FONT></FONT> base editing at four<BR>genomic targets loci in <I>E. coli.</I> vs.<BR> reference SpCas9
system.<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:7.5pt">*&#8195;&#8194;Heatmap values represent the mean of<BR>two independent
experiments.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">*&#8195;&#8194;SMART ABE achieved up to 22% base<BR> editing efficiency in human cells.<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:7.5pt">*&#8195;&#8194;Base editing efficiency shown at three<BR>genomic targets tested in human<BR>HEK293T cells.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:7.5pt">*&#8195;&#8194;Heatmap values represent the mean of<BR>three independent
experiments.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> *&#8195;&#8194;The target sequence for each locus is shown above the heatmap.<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:7.5pt">*&#8195;&#8194;Heatmaps represent the percentage of NGS reads supporting an edit at each position.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">Source:</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Goltsman et al 2022 Nature Communications </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">158 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"><B>Figure 16d</B>. SMART ABE optimization improved editing efficiency in human cells.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom">


<IMG SRC="g425213g10n10.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Top guide shown for each SMART ABE system. </TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Figure 16 illustrates how our ultra-small SMART nucleases provide an
opportunity to develop compact base editors with the potential to improve delivery using existing AAV technology. Our engineered, but unoptimized SMART ABE systems were observed to edit target loci at levels comparable to reference SpCas9 systems,
and with up to 22% editing efficiency in mammalian cells. Achieving this level of efficiency with an unoptimized system, comparable to initial base editing readouts achieved with SpCas9, indicates the potential of this novel CRISPR platform.
Additional optimization enabled editing in human cells at over 80% efficiency. The SMART ABE highlighted in Figure&nbsp;16 is one of the smallest nickase-based systems with activity in mammalian cells (969 aa), and at 623 aa another SMART ABE under
development is even smaller. Together, these systems provide us with unique opportunities to optimize base editors using the naturally compact, precise, and programmable SMART platform. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">159 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><FONT STYLE="white-space:nowrap">RNA-Mediated</FONT> Integration Systems: RIGS for prime editing and large genomic
integrations </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I></I></B><I>Overview</I><B><I> </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 17</B>.
Schematic Showing Application of RIGS for Small Replacements and Large Integrations. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g27i06.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Programmable nucleases, which use dsDNA breaks to trigger DNA repair machinery to enact specific genomic changes, and base editors,
which use chemical modifications to convert specific base pairs in the human genome, cannot address all mutations that cause disease. RIGS are being developed in order to encode any type of genomic modification in an RNA template, and thus create
any type of genome modification necessary to address a disease (Figure 17). RIGS involve using RTs to convert genomic corrections encoded in RNA into DNA, and are engineered with programmable nucleases or nickases to incorporate newly synthesized
DNA messages into the genome at specified target sites. Importantly, any genomic modification can be encoded in the RNA template. Furthermore, the potential for having an <FONT STYLE="white-space:nowrap">all-RNA</FONT> format for the system,
including delivery of the protein components as mRNA, could simplify delivery for some applications. For example, the <FONT STYLE="white-space:nowrap">all-RNA</FONT> format could enable use of LNPs for delivery of systems to the liver for large,
targeted genomic integrations. The enzymatic nature of the genome integration, combined with the ability to deliver the entire system as RNA is of particular importance when considering large integrations, since the delivery of DNA templates at
concentrations required for integration mediated by DNA repair machinery can be toxic. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">One implementation of RIGS is to use our programmable nickases and RTs for
prime editing. Prime editing can repair diverse mutations, including all types of point mutations, deletion mutations, insertion and duplication mutations and insertion-deletion mutations. As with other genome editing approaches, prime editing
systems, and RIGS more broadly, create permanent modifications at natural genomic locations, resulting in durable edits that are passed on through cell divisions and that are expressed under natural mechanisms specific to the gene or target of
interest. One key aspect of prime editing is the modification of a CRISPR gRNA to create a pegRNA (&#147;prime editing gRNA&#148;). In this design, the typical backbone and targeting components of the gRNA are maintained; however, additional
sequence is added to the guide in order to code for a desired genomic correction and to prime a RT to begin synthesizing new DNA sequence. During prime editing a portion of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">160 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
pegRNA containing the genomic modification is copied into DNA at a specific site in the genome sequence. Once the RT has incorporated the new DNA sequence into the target site, DNA repair
machinery will finalize the genome edit by removing the corresponding section of the original sequence, synthesizing any required complementary DNA, and ligating the ends of the nicked DNA strands. We have discovered a collection of novel RTs that
can be combined with our nickases to perform prime editing in mammalian cells at levels and with accuracy that surpasses industry-standard systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Current prime
editing and RNA-templated editing approaches are limited by the size of the RNA template that can be incorporated into a genomic site. This limitation is based on multiple aspects of the system design, including 1) the need to encode gRNA and RT
template sequences in a single pegRNA, and 2) the processivity and fidelity of the RT. The first constraint can be addressed by creating new system designs in which the gRNA and repair template are encoded in separate RNA molecules, where additional
engineering ensures that the templates and RT are able to <FONT STYLE="white-space:nowrap">co-localize</FONT> to the nucleus, and more specifically, to targeted sites in the genome. Regarding the second point, processivity and fidelity are
biochemical characteristics that relate to the ability of an RT to traverse through large and structurally complex RNA templates (processivity) and to do so without introducing errors (fidelity). We have identified and developed novel RTs that we
believe surpass the processivity and fidelity requirements for therapeutic delivery of transgenes as RNA templates, for example in order to treat diseases by introducing a complete and correct copy of a gene in order to overcome a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">loss-of-function</FONT></FONT> mutation. Furthermore, we are engineering these RTs with programmable nucleases and nickases to achieve large, targeted genomic integrations. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Similar to base editing, development of RIGS leverages our
expansive platform of programmable nucleases that can be converted into nickases, including ultra-small SMART, as well as a metagenomics discovery approach that enables the rapid identification of novel RTs that have the specific characteristics
necessary for different genome editing applications. The targetability of our toolbox of programmable nucleases will enable essentially any target sites of interest to be addressed, and compatibility with ultra-small SMART effectors could expand the
deliverability of RIGS to therapeutically relevant tissues and organs. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Little RIGS describes
systems used for prime editing (e.g., for small genomic replacements such as transversions, transitions, insertions, and deletions), while Big RIGS describes systems capable of making large targeted genomic integrations. The mechanisms driving these
systems differ from one another, but both are based on using a reverse transcriptase to incorporate genomic corrections encoded in RNA into target sites in the genome identified by a programmable nickase or nuclease. We identified five million RT
candidates from novel families in order to find systems for Little and Big RIGS development. RTs found in nature are highly diverse, but typically do not have all the characteristics suited towards being useful in a therapeutic context. Based on
measured enzyme characteristics such as fidelity and processivity, RTs are nominated and combined with our programmable nucleases/nickases for either Little and/or Big RIGS engineering. Our Little RIGS are benchmarked against industry-standard prime
editing systems in order to rapidly identify <FONT STYLE="white-space:nowrap">top-performing</FONT> systems. Currently, we believe no genome editing system has been described that is comparable to Big RIGS. Our Big and Little RIGS are undergoing
indication-specific optimization. We believe that this combination of discovery and system optimization will enable the rapid development of best genome editing systems that, together, can enact any type of genomic edit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">161 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our RIGS have shown complex prime editing in mammalian cells </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 18</B>. Our RTs Outperformed Benchmarks for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">G-to-T</FONT></FONT> Prime Editing in Mammalian
Cells.<I> </I>Graph Depicts a Broad Range of RTs that Exhibited Higher Natural Activity than Unengineered Prime Editing RT. </P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g425213g55v25.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Unengineered prime editing control RT is from Moloney murine leukemia virus (&#147;MMLV&#148;). </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">RTs were cloned into a plasmid backbone that was <FONT STYLE="white-space:nowrap">co-transfected</FONT> with chemically synthesized pegRNAs designed to edit the genome of human HEK293T cells. </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Genomic DNA was isolated 72 hours post transfection and target loci were amplified for NGS to evaluate editing outcomes. </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our RTs are benchmarked against natural and engineered variants of an RT widely used for prime editing in order to identify highly active natural enzymes for further
optimization along with our programmable nickases. Figure 18 shows that our natural RTs are more active than a control RT when used for prime editing. In addition, our minimally engineered RTs demonstrated up to 6 times higher activity than the
unengineered control RT for a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">G-to-T</FONT></FONT> change. This indicates that we can potentially optimize gene editing activity quicker than comparable prime editing RTs.
Figure&nbsp;19 shows that a minimally engineered Metagenomi RT has editing efficiencies equivalent to or better than engineered, industry-standard prime editing RT. Notably, this has been achieved with an ultra-small RT that is only 251 aa in
length, compared with the 671 aa of the standard prime editing RT. For therapeutic applications, complex corrections must be precise, and the precision of RIGS depends on the unique characteristics of the reverse transcriptase used. Figure&nbsp;19
also shows that one of our RTs has demonstrated significantly higher editing accuracy compared to the engineered, industry-standard control. In order to measure optimal activity for new systems, multiple primer binding sequence (&#147;PBS&#148;)
lengths must be tested. In some case, Metagenomi RT are more active across a broader range and with smaller PBS lengths compared with the control, providing more flexibility around pegRNA design. We believe our RIGS are distinguished from typical
systems used for prime editing by the high efficiency and accuracy of the RTs, as well as the broad targetability of our programmable nickases. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">162 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Figure 19</B>.<I> </I>Our Ultra-Small RTs are Efficient and Accurate Systems for Conducting Complex Genomic Corrections in Human Cells.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">


<IMG SRC="g425213g41s00.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;The
engineered prime editing benchmark RT is the MMLV variant used in PE2 prime editing systems.</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;RT were tested with an unoptimized plasmid delivery system that enables high-throughput benchmarking of novel RT
to identify leads.</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Plasmids encoding RT
and Cas were <FONT STYLE="white-space:nowrap">co-transfected</FONT> with chemically synthesized pegRNAs designed to edit the genome of human HEK293T cells.</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Genomic DNA was isolated 72 hours post transfection and target loci were amplified for NGS to evaluate editing
outcomes.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 19d.</B> 5 bp Replacement </P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g12n12.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The engineered prime editing benchmark RT is the MMLV variant used in PE2 prime editing systems. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Our ultra-small MG RT was fused to MG Cas and tested with mRNA delivery and chemically synthesized pegRNAs designed to edit the genome of human HEK293T cells. </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Co-transfection with chemically synthesized guides designed to program the Cas to create a nick in the vicinity of the edit were included to bias DNA repair towards the edited strand. </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Genomic DNA was isolated 72 hours post transfection and target loci were amplified for NGS to evaluate editing outcomes. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">163 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our novel RTs are selected to enable the development of Big RIGS for RNA-templated, large, targeted therapeutic
transgene integration </I></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Figure 20</B>. Our RTs Have Been Observed to be Active, Processive, and High-Fidelity.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><B>Figure 20a</B>. Our RTs were more processive than RT typically used for prime editing, enabling transcriptions of large gene templates in mammalian cells.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Figure 20b</B>. Our RTs were more accurate than industry-standard RT.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g00a13.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g00a14.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Prime editing benchmark RT is MMLV.</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Processivity was measured by quantitative
polymerase chain reaction (&#147;qPCR&#148;) quantification of cDNA produced in mammalian cells from 4 kb templates.</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Typically, less than 1% of 4 kb templates are fully transcribed by MMLV.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Template modifications are <FONT STYLE="white-space:nowrap">N1-methylpseudouridine.</FONT></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Fidelity was measured by NGS.</P></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 20c.</B> Our RT can be combined with our Cas to achieve targeted integration of &gt;900 bp in human cells. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g01a13.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Targeted integration confirmed by Sanger sequencing. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Our MG RT was combined with MG Cas and tested using mRNA delivery along with chemically synthesized gRNA and the RNA integration template. </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Integration was targeted to an engineered landing pad located in the genome of HEK293T cells. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our RTs were screened
based on their activity and processivity in mammalian cells in order to identify highly active systems capable of reverse transcribing RNA templates over 4,000 base pairs in length (&gt;4 kbp). We chose the 4 kb benchmark as many potential
therapeutic targets could be addressed with a genomic integration of this size (current prime editing systems are limited to RNA-templated integration around 100 bp). In Figure 20, our best-characterized RTs were compared with industry standard
systems in order to benchmark their activity, processivity, and fidelity. When tested in mammalian cells, our RTs were routinely able to fully transcribe a 4 kbp template into DNA. In Figure 20a, we show that our RTs demonstrated orders of magnitude
more processivity than control RT when tested on these large templates, which we believe is a strong indication of being able to convert therapeutically relevant templates delivered as RNA into DNA for genomic integration. Importantly, Figure 20b
also shows that on average our RTs transcribed over 4 kbp without introducing errors. Furthermore, template modifications <FONT STYLE="white-space:nowrap">(N1-methylpseudouridine),</FONT> which could enable delivery of RNA templates
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">164 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
less likely to trigger an immune response, improved fidelity. We are engineering our RTs along with our programmable nucleases and nickases for targeted genomic integration of a donor template
delivered as RNA. Initial readouts show that when combined with a CRISPR effector and targeting gRNA, Metagenomi RT are able to incorporate newly synthesized DNA from an RNA template into a target site. In Figure 20c, we report what we believe to be
the first-ever targeted integration of &gt;900 bp in human cells with all-RNA delivery. In principle, these systems, which represent a major step forward in the genome editing space, could be delivered entirely as RNA and could enable large,
targeted exogenous gene integrations. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><FONT STYLE="white-space:nowrap">DNA-Mediated</FONT> Integration Systems: CAST and other approaches to achieving large
genomic integrations </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Overview </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 21</B>. Schematic Showing
Application of CAST for Large, Targeted Genomic Integrations. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g01a14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Genome editing approaches based on nucleases, base editing, and prime editing are capable of precisely modifying the genome to address
disease. However, for therapeutic approaches that necessitate expression of an exogenous gene or complete gene correction, large integration approaches are needed. Many individual diseases are associated with a wide variety of genetic mutations and
thus may require an entire healthy gene to counteract each of the many different underlying causes. For example, there are over 1,800 mutations in the CFTR gene associated with cystic fibrosis. While in theory most of these mutations could be
addressed using distinct and mutation-specific base or prime editing systems, this would require the optimization and translation of a large number of genome editing therapies. Alternatively, integration of a complete and correct copy of the CFTR
gene could potentially cure patients with varying mutations in a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-and-done</FONT></FONT> treatment. Directed DNA integration has largely been considered the ultimate goal of
corrective genome editing, where enzymatic systems with this capability could provide safe and sustained therapeutic protein expression. By developing <FONT STYLE="white-space:nowrap">DNA-mediated</FONT> integration systems and RIGS, we are at the
forefront of creating a new class of genome editing therapeutics. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Many efforts over the past decades have sought to achieve direct DNA integration in order to
develop treatments that work across diverse tissues, cell types, and genetic variants. Established transposase and lentiviral systems are efficient at inserting large DNA cargos into the human genome but result in
<FONT STYLE="white-space:nowrap">non-specific</FONT> and sometimes hyperactive integrations that have led to severe adverse events during clinical trials. Furthermore, recombinases have gained attention recently as a possible solution, given that
they are able to incorporate large (&gt;10 kbp) genomic cargos in a <FONT STYLE="white-space:nowrap">non-random,</FONT> site-specific manner in mammalian cells. However, these systems typically require additional genome editing tools, such as prime
editing systems, in order to first install recognition sites into the genome. These recognition sites are required by the recombinase and thus control where the enzyme can incorporate new genomic material. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">165 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">CASTs are a new technology that is exciting because of their programmable, site-specific, and enzymatic integration
capabilities. While these systems have been challenging to translate for mammalian cell and human therapeutic applications, we have had recent breakthrough success by demonstrating that the most compact type of CAST, based on catalytically dead
nucleases, are capable of programmable and targeted DNA integration into the genome of human cells. Our CASTs are being developed in order to enable large (&gt;10 kbp), targeted genomic integrations for therapeutic applications. This technology has
the potential to address a large collection of complex genetic diseases driven by a loss of function mutation, such as cystic fibrosis. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are pursuing multiple approaches to achieve targeted, large genomic integrations, including both RNA and DNA templated systems. Unlike RNA-templated systems that
undergo a copying mechanism in order to integrate into the genome, DNA templated systems orchestrate the direct mobilization of the template into the genome. This direct integration avoids copying mechanisms that may be inhibited by certain template
features, and thus allows for the incorporation of much larger templates compared with <FONT STYLE="white-space:nowrap">RNA-mediated</FONT> systems. Given that RNA-templated systems may have delivery advantages for some applications, we are
developing both technologies to have the broadest potential to address diseases through targeted integration of large transgenes. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The development of our novel CAST
systems was made possible by the discovery and engineering of active natural variants from our metagenomic library. CASTs are being developed to achieve accurate and efficient integration of large DNA cargos at a target locus, without depending on
dsDNA breaks. CASTs are unique in that they combine the programmability of a CRISPR effector with the enzymatic integration capability of a transposase. We hypothesized that activity in human cells could be accomplished by combining novel system
discovery with systematic development designed to tune the systems to the mammalian nuclear environment. We conducted a detailed survey of newly-discovered CAST systems and demonstrated the ability of novel systems for programmable integration of a
transgene <I>in vitro</I> and in <I>E. coli</I>. The high efficiency of our systems enabled us to demonstrate directed transposase activity into single copy, safe harbor loci in the genome of human cells, as shown in Figure&nbsp;21. Our results will
enable the rapid development and optimization of CASTs to address unmet therapeutic and biotechnological needs. We believe we are the first to achieve this milestone using the most compact variety of CASTs. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are also developing systems based on recombinases and other mobile elements that can be used in combination with programmable nucleases, including catalytically dead
variants, as well as with Little RIGS in order to affect large, targeted genomic integrations under circumstances where CASTs are not the ideal genome editing technology. Beyond therapeutic use, novel systems with these capabilities could enable
synthetic biology, antibody discovery, functional genomics, animal model development, and various other unmet needs in the biotechnology space. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our novel and
engineered CASTs are capable of integrating large DNA cargo at a safe-harbor locus in the human genome </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have shown preclinical
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-capability</FONT></FONT> for our CASTs by demonstrating targeted integration of a large DNA template in the genome of mammalian cells. Translation from bacteria to human cell
editing required protein engineering to mitigate the complex coordination between multiple protein and nucleotide components. Figure 22 shows polymerase chain reaction (&#147;PCR&#148;)-based confirmation achieved by detecting the junction between
the donor DNA template and the target sequence in the genome of HEK293T cells. Targeted integration was achieved by delivering the CAST system as an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">all-in-one</FONT></FONT> plasmid,
while the DNA donor is delivered on a second plasmid. In addition, NGS was used to both confirm and quantify integration efficiency, which showed that about 1.5% of sequencing reads had evidence of target-specific integration. We believe the ability
to target payloads to a single copy, safe-harbor locus now allows for further therapeutic-driven optimization and development. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">166 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 22.</B> Our CASTs Demonstrated Targeted Integration of a DNA Template at a Safe-harbor Locus in the Genome
of Human Cells. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 22a.</B> Targeted integration confirmed by PCR. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g85l79.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">PCR of junction between template and target confirms integration at target loci in HEK293T cells. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Successful transposition is indicated by a band of the correct size in the gel in treated samples, but not in the null target (control) sample. </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Sequencing of PCR products from the junction between the template and target confirmed integration. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 22b.</B>
Integration efficiency measured by NGS. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g16a16.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">On-target integration efficiency measured by NGS sequencing. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Quantified integration efficiencies are shown as the mean (bar) of six AAVS1 or three &#147;No Target&#148; biological replicates (dots) with one standard deviation (whisker). &#147;No Target&#148; represents the
non-targeting spacer (negative control), AAVS1 is the targeted safe-harbor locus. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">167 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Future Novel Editing System Discoveries </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our scientific underpinnings based in metagenomics provides a continuous engine for discovering and developing potentially next generation genome editing systems. As we
continue to build upon our metagenomic library, we expect to make additional discoveries of novel technology, and expand our toolbox to further unlock the field of genome editing. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our Pipeline </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are taking a stepwise approach deploying our genome
editing toolbox to develop potentially curative therapies for patients. Our lead programs are selected to both address important diseases and to establish new standards in targetability, precision, efficiency, and scope of editing capabilities.
Figure 23 summarizes the portfolio of programs that we and our partners are advancing, as we aim to match the optimal genome editing tools for each indication. Each of these indications were chosen based on our conviction in the underlying biology,
existence of validating preclinical and clinical data, availability of pharmacodynamic and translational tools to assess early proof-of-concept, relevant value-supporting outcome measures, and ongoing clinical unmet need. Our lead programs capture
an ever-growing set of translational learnings and insights that will inform and accelerate future programs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 23.</B> Therapeutic Translation. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g30v84.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Hemophilia A&#151;novel, durable, knock-in approach for expression of Factor VIII </U></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Hemophilia A is the most common
<FONT STYLE="white-space:nowrap">X-linked</FONT> inherited bleeding disorder and is caused by mutations in the FVIII gene leading to loss of functional FVIII protein that impacts the body&#146;s ability to form normal clots in response to injury.
FVIII is normally produced in the liver within sinusoidal endothelial cells and is then secreted into the bloodstream where it acts as a cofactor for the catalytic activation of Factor X in the clotting pathway. The lack of functional FVIII disrupts
the normal clotting cascade and predisposes patients to increased risk of bleeding, either spontaneously or in response to injury or surgery. Repeated bleeding episodes in joints or soft tissues can lead to progressive joint damage, inflammation,
pain, and mobility impairment. Intracranial bleeding is of greatest concern as this can be rapidly fatal or lead to major morbidity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">168 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The severity of hemophilia A is directly correlated to the amount of residual FVIII activity. Severe hemophilia is
defined as less than 1% of normal FVIII activity, moderate hemophilia defined as <FONT STYLE="white-space:nowrap">1-5%</FONT> of normal FVIII activity and mild hemophilia defined as 5 to 40% of normal FVIII activity. There are estimated to be nearly
30,000 patients with hemophilia A in the United States and more than 500,000 patients with hemophilia A globally. Of these, approximately 60% have severe disease and are at the greatest risk of spontaneous life-threatening bleeding events. In these
patients, diagnosis typically occurs in infancy due to exaggerated bleeding in response to minor injury or routine medical procedures. As the inheritance of hemophilia A is <FONT STYLE="white-space:nowrap">X-linked,</FONT> the vast majority of
patients are male. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Approaches </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The standard of
care for patients with severe hemophilia A involves life-long repeated IV infusions of recombinant FVIII preparations prophylactically and in response to bleeding events. The major limitation of this approach is fluctuating FVIII activity levels,
with trough values that can still result in breakthrough microscopic and macroscopic bleeding events, particularly within sensitive and previously damaged joints. Additionally, frequent FVIII infusions are inconvenient, which can be associated with
suboptimal compliance, and in some patients result in inhibitor formation (antibodies against FVIII) that compromise efficacy. More recently, emicizumab, a bispecific antibody, has been approved for hemophilia A in the United States that acts as
functional FVIII mimetic in binding Factors IXa and X to support catalytic activation. This antibody approach has the benefit of a longer half-life than typical recombinant FVIII protein infusions that allows for less frequent administration but has
the drawback of not being a true FVIII protein replacement therapy and breakthrough bleeding has been reported. Both the bispecific antibody and FVIII protein replacement approaches have a high economic burden (estimated lifetime cost of $15 to
18&nbsp;million per patient). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Valoctocogene roxaparvovec, the first hemophilia A gene therapy, was conditionally approved for use in Europe in August 2022 and was
approved in the United States in June 2023. This genetic medicine delivers a FVIII gene construct to the liver using an AAV vector. Once transduction of liver cells occurs, the FVIII gene resides in an episomal state (meaning not integrated in the
genome) where it is transcribed from an artificial engineered exogenous promoter to produce FVIII mRNA which is translated into FVIII protein. This gene therapy approach has the potential benefit of constant production of FVIII protein by the liver;
however, longitudinal clinical data has demonstrated that FVIII levels drop over time. To date, repeat dosing of a gene therapy has not been possible due to the production of high titers of neutralizing antibodies to the AAV vector. Importantly, AAV
gene therapy is also not a feasible treatment approach for infants or children due to the high degree of liver growth during pre-adulthood that would dilute out the episomal FVIII gene during progressive rounds of liver cell division. Thus, there
continues to be a significant unmet need in hemophilia A for a curative therapy that can provide life-long protection from bleeding events and joint damage in adults and children. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach and Results </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Experience with early hemophilia A gene therapy
approaches suggest that morbidity and mortality from the disease can be markedly reduced by achieving only moderate amounts of stable FVIII expression. For instance, achieving stable FVIII activity above <FONT STYLE="white-space:nowrap">5-10%</FONT>
of normal activity level has the potential to convert a patient with severe hemophilia at risk of catastrophic bleeding into a patient only at risk for bleeding in the setting of major trauma or surgery. Achieving stable levels of FVIII above 15%
activity level could provide complete joint protection and may allow patients to have a functional cure from their disease. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Rather than provide the FVIII gene in an
episomal location, which risks dilution from cell division or cell death as well as episomal transcriptional silencing, our approach is to insert a FVIII DNA cassette into a &#147;safe harbor location,&#148; within an intron of the albumin gene that
is not expected to have deleterious effects. FVIII expression is then driven by the strong native albumin promoter. This approach has previously been demonstrated in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">169 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
preclinical studies to lead to therapeutically relevant expression of a different clotting factor (Factor IX) with negligible impact to systemic circulating albumin levels. Our FVIII knock-in
approach is designed to provide stable expression and clinically relevant circulating levels of FVIII, even at low integration rates because of the strength of the albumin promoter. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our approach is fundamentally different from the AAV gene therapy approaches. AAV gene therapy approaches use a viral vector to deliver a replacement FVIII gene driven
off a <FONT STYLE="white-space:nowrap">non-natural</FONT> promoter that exists in an episomal state (not integrated in the genome). This AAV FVIII gene therapy approach has been associated with the loss of FVIII expression over time in patients, a
phenomenon hypothesized to be due to a combination of loss of the DNA encoding the FVIII gene (due to liver cell replication) and silencing of the episomal FVIII expression. Because our approach is designed to permanently integrate the FVIII gene
into the genome of the patient, the FVIII gene should not be lost from the liver when the liver cells divide (because it is integrated in the genome and therefore transferred to the daughter cells during cell division), which may allow for a
therapeutic option for children with hemophilia. Silencing of expression may be less likely to occur with our approach because we are using an endogenous albumin promoter rather than a synthetically designed promoter in a <FONT
STYLE="white-space:nowrap">non-natural</FONT> episomal state. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As shown in Figure 24, our hemophilia A genome editing program has two components: a LNP component
that is designed to deliver mRNA along with a gRNA to the liver to produce a highly efficient and specific nuclease to create a precise cut at the albumin safe harbor gene locus; and an AAV vector that is designed to deliver the donor template FVIII
DNA that becomes inserted into the nuclease cut site by the naturally occurring DNA repair process called <FONT STYLE="white-space:nowrap">non-homologous</FONT> end joining. The DNA template encodes a FVIII protein, and the sequence has been
optimized to improve expression. In both preclinical mouse and NHP models we have demonstrated that this FVIII <FONT STYLE="white-space:nowrap">knock-in</FONT> approach leads to stable integration and clinically relevant circulating levels of FVIII.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 24</B>. Therapeutic Approach to Hemophilia A Genome Editing. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g19a10.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">170 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have performed gRNA screening in human and mouse cells to identify both candidate clinical guides and mouse
surrogate guides. In the case of the human guide screen, a total of 77 guides for three of our nucleases were screened against albumin intron 1 in liver cell lines, and two guides (called guide 1 and guide 2) were selected as leads. Primary human
hepatocytes (&#147;PHH&#148;) isolated from the livers of deceased individuals are the most appropriate preclinical model to evaluate human liver genome editing. Guide 1 and guide 2 displayed dose dependent editing in PHH with guide 2 exhibiting the
highest potency (Figure 25). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 25</B>. Editing at the Human Albumin Locus by Lead Nuclease and Guides in Primary Human Hepatocytes. Each Set of Four Bars is
a Dose Response (from High Dose to Low Dose Going from Left to Right) Performed at Three Different Molar Ratios of mRNA to gRNA. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:0%" ALIGN="center">


<IMG SRC="g425213g01a19.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each set of four bars is a dose response (from high dose to low dose going from left to right) performed at three different molar ratios of mRNA to gRNA. </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Genome editing nucleases can edit at sites other than the intended target site, an activity that is dependent on the specific nuclease and guide. Editing at non-target
sites (called off-target editing) is undesirable due to the potential to cause damage to the host cell DNA (sometimes called &#147;genotoxicity&#148;). In accordance with recent FDA guidelines and insights from the FDA workshop we have applied a
combination of 3 methods; in-cell oligo integration in PHH, a biochemical assay, and in silico prediction (using an algorithm called CRISPRitz) to identify potential off-target sites for our two lead guides. These combined methods nominated a total
of 372 potential off-target sites for guide 1 and 113 potential off-target sites for guide 2. Editing at these potential off-target sites was then evaluated in PHH by amplicon sequencing in which a pair of PCR primers flanking each predicted
off-target site is used to PCR amplify that site followed by next generation sequencing. To efficiently analyze all of the potential off-target sites, sets of barcoded PCR primers to multiple sites are carefully designed and combined in a single PCR
amplification (a methodology called rhAMP-Seq). Any sites that failed to be detected from the rhAMP-Seq panels were re-tested as single amplicons. The sequence data was analyzed using the CRISPResso software to quantify InDels in each of the
amplicons representing the potential off-target sites. The sensitivity of this method is high because of the depth of sequencing reads that can be readily achieved, typically enabling detection of InDels at frequencies as low as 0.1% (i.e. 1 InDel
in 1,000 sequencing reads). Because double strand breaks can occur naturally in cells and because of sequence specific background signals arising from PCR primer slippage we compared the InDel rates in PHH edited at a dose that results in saturating
editing (1x dose) and at a 27-fold higher dose (27x dose) to the InDel rate in un-edited PHH. We used LNP to deliver the MG29-1 mRNA and gRNA to mimic in vivo delivery and because it provided high editing efficiency and low toxicity. We believe the
cells edited with the dose 27-fold higher than that which results in saturating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">171 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
editing provides an additional safety margin for the detection of off-target editing that may occur at undetectable frequencies at saturating doses but is detectable at a higher dose. The InDel
frequencies of the potential off-target sites were plotted as a scatter plot (Figure 26). InDel frequencies that are the same in the edited and unedited cells lie on the diagonal axis of Figure 26. Sites that have a higher InDel frequency in the
edited cells than in the un-edited cells and thus represent a true off-target edit will appear as a point significantly above the diagonal axis of Figure 26. In addition, real off-target sites will have InDel frequencies higher than the lower limit
of detection of the assay of 0.1%. Only the on-target site lies above the diagonal axis of the scatter plot in Figure 26 having a InDel rate in both 1x and 27x treated cells of 60% to 90% and an InDel rate in untreated cells of 0.01 to 0.05%. No
editing significantly above the signal in the control cells was detected at any of the off-target sites for either guide 1 or guide 2. The InDel frequency for the majority of potential off-target sites was below 0.05% which is below the limit of
detection of 0.1%. The small number of potential off-target sites with InDel frequencies above 0.1% had near identical InDel rates in both treated and un-treated cells indicating that they are not a result of the gene editing but are likely due to
either natural hot spots of DNA damage or primer slippage during PCR amplification. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In summary, no editing was detectable at any of the potential off-target sites
for the lead albumin targeting guides in the most relevant human cell, primary human hepatocytes, including at a super saturating dose that is 27-fold higher than that required for saturating editing. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are expanding the number of potential off-target sites to be evaluated by amplicon sequencing by including sites from in silico prediction with a wider cutoff (more
mismatches) as well as from a variant aware version of in silico prediction called CRISPRme that evaluates the impact of naturally occurring sequence variation within the human population on predicted off-target sites. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 26:</B> Measurement of editing at potential off-target sites for the two lead guides for Hemophilia A in PHH using amplicon sequencing. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g00a20.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">372 and 113 sites were nominated and evaluated for guide 1 and guide 2, respectively at both a 1x and a 27x saturating dose. For each potential off-target site as well as the on-target site, the InDel frequency was
plotted for 1x compared to untreated (black points) and for 27x compared to untreated (blue points). For Guide 2 the on-target site for 1x vs untreated (black dot) and 27x vs untreated (blue dot) overlap and so appear as only a blue dot.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">172 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have demonstrated the feasibility of the human FVIII gene <FONT STYLE="white-space:nowrap">knock-in</FONT> approach
in mice with a mouse specific guide and 11 different FVIII DNA donor cassettes as shown in Figure 27, which shows the human FVIII protein levels achieved in the blood at day 10 post LNP dosing. A FVIII level of 1 IU/ml is equivalent to 100% of the
normal level of FVIII in humans. FVIII levels ranged from 0.02 IU/ml (2% of normal) to 0.75 IU/ml (75% of normal). Seven of the 11 FVIII donor designs achieved human FVIII levels at or above 15% of normal, a level that would be sufficient to prevent
the majority of bleeding events in hemophilia patients. We quantified integration of the FVIII gene in the liver in the correct (forward) orientation at the target site in the albumin locus in selected groups of mice at the end of the study (day 14
post LNP). The mean forward integration frequency in these groups was between approximately 0.5% and 2.5% (meaning approximately 0.5 to 2.5 copies per 100 mouse genomes, Figure 28). The finding that different human FVIII donor designs resulted in a
range of FVIII levels in the blood of mice despite similar levels of integration implicate the donor DNA design as a critical component to maximize FVIII protein expression and these learnings are being incorporated into FVIII donor designs that
will be evaluated in NHP studies to enable final development candidate selection. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Figure 27. Expression of FVIII in Mice after Genome Editing. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:24%" ALIGN="center">


<IMG SRC="g425213g01a21.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">173 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Figure 28. Integration of FVIII in Mice after genome editing. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g01b21.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Results are from a subset of the groups of Mice in Figure 27 (Integration was only measured for selected donors for technical reasons). </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The editing efficiency of the two lead gRNA sequences (guide 1 and guide 2) were evaluated in non-human primates (&#147;NHPs&#148;). Guide 1 is a perfect match to the
target sequence in the NHP genome while guide 2 required a single nucleotide change in the spacer to match perfectly to the target sequence in NHPs. The same nuclease mRNA sequence was used with both guides and the guide and mRNA were <FONT
STYLE="white-space:nowrap">co-delivered</FONT> with the same LNP formulation by IV infusion of three cynomolgus macaques per group at a dose of 1.25 mg RNA per kg body weight. The editing efficiency in five different regions of the liver
(representing the different liver lobes) were measured by determining the InDels at the target site using next generation sequencing in each of the three animals per treatment group as shown in Figure 29. Editing levels were similar across the five
liver regions (represented by the five dots in each bar) demonstrating that editing was homogenous across the entire liver. Guide 2 resulted in a mean editing efficiency of 50% amongst the three animals. This represents editing in approximately 80%
of hepatocytes because hepatocytes make up about 60% of the cells in the liver of NHPs and the LNP delivers primarily to hepatocytes. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 29</B>. Efficient
Editing in NHPs at the Safe Harbor Locus for the Hemophilia A Program. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g00a22.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each bar is an animal and each datapoint represents a different lobe of the liver. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">174 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To evaluate our FVIII gene integration approach in a more relevant preclinical species we performed combined AAV-FVIII
and LNP dosing in three NHP (cynomolgus macaques). The monkeys were pre-screened for neutralizing antibodies (&#147;NaB&#148;) against AAV and only animals with a titre of less than 1:5 (meaning that no Nab were detected at a 1:5 fold dilution of
the monkey plasma) were selected for the study. The target site in albumin intron 1 was sequenced from each animal to confirm the absence of sequence differences that might otherwise impact recognition by the gRNA. Plasma was collected prior to
dosing to provide a baseline for the FVIII activity assay. A small amount of liver tissue was collected by biopsy two weeks prior to dosing to provide a baseline for the measurement of FVIII mRNA in the liver. The three animals were given a single
dose of the anti-inflammatory drug dexamethasone (2 mg/kg) prior to AAV dosing and again prior to LNP dosing. It is well known that human FVIII is immunogenic in monkeys resulting in generation of anti-human-FVIII antibodies (typically within weeks
to months of exposure) which prevents the detection of the human FVIII protein. A cellular immune response against human FVIII is also likely to occur in monkeys which may result in the destruction of liver cells expressing the human FVIII. We
therefore used the cynomolgus FVIII gene in the AAV construct to ensure that the monkeys would not have an immune response against the FVIII protein expressed from the integrated FVIII gene and thereby enable a long term evaluation of the durability
of FVIII expression. The AAV construct was designed with a codon optimized B-domain deleted cynomolgus FVIII (cFVIII) coding sequence with a single amino acid change that had no observed impact on the function of the cFVIII protein but enables the
specific detection of the AAV encoded cFVIII protein in the background of the endogenous cFVIII protein. All three monkeys received a single dose of the AAV-cFVIII virus followed five weeks later by a liver trophic LNP encapsulating the mRNA
encoding MG29-1 and guide 2 at a dose of 1 mg/kg body weight. Plasma was collected either weekly or bi-weekly starting at 14 days post LNP dosing and assayed for the vector derived cFVIII using a commercial activity assay (chromogenic assay). As of
the November 11, 2023 data cutoff date, we have collected and assayed cFVIII activity up to day 126 post LNP (18 weeks, 4.5 months) and results are shown in Table 1. The plasma for each post-LNP time point was assayed multiple times (between 5 and 7
times) and the mean value and standard deviation were calculated. Plasma collected prior to dosing (day -14, n&#061;3 replicates) had no detectable cFVIII using this assay, demonstrating that the assay method does not detect endogenous cFVIII. The
mean FVIII activity derived from the administered c-FVIII gene over the time period from day 14 to 126 was 0.75 IU/ml, 0.13 IU/ml and 0.29 IU/ml in the 3 animals which corresponds to 75%, 13%, and 29% of normal FVIII activity in humans. These
average levels of FVIII are within the desirable therapeutic range (approximately 10% to 150% of normal). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Samples of liver tissue were collected on day 7 and day 70
post LNP dosing by biopsy of all three NHP. The day 7 liver biopsy was analyzed for editing at the target site in albumin intron by NGS which revealed that the cleavage by MG29-1 was efficient and consistent, with InDel frequencies of 45%, 50%, and
55% in the 3 animals, similar to what was observed in our earlier editing only study in NHP with the same guide 2 (Figure 29). Integration of the cFVIII gene encoded in the AAV at the target site in albumin intron 1 was quantified by a digital
droplet PCR assay that specifically detects the junction between the albumin intron 1 sequence at the target site and the 5&#146; end of the AAV encoded cFVIII gene. Integration was detected in all 3 animals and the integration frequency ranged from
0.7 to 2.9 copies per 100 genomes, similar to the frequency observed in mice. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The specific albumin-cFVIII hybrid mRNA that is generated by the precise splicing
between albumin exon 1 and the 5&#146; end of the integrated cFVIII gene derived from the AAV was quantified in liver tissue from the day 7 and day 70 biopsies as well as the pre-dose biopsy using a digital droplet PCR assay. No signal was detected
in the liver tissue from the pre-dose biopsy as expected, demonstrating that this assay does not detect endogenous cFVIII mRNA. The specific albumin-cFVIII hybrid mRNA was clearly detected in all three animals at both the day 7 and day 70 timepoints
with no significant change in the mRNA level between day 7 and day 70. The mean of the albumin-cFVIII hybrid mRNA levels at day 7 and day 70 post LNP dose were 177, 79, and 131 in the 3 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">175 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
animals (the units are percentage of an endogenous control mRNA that was quantified in the same samples). The integration frequency and the hybrid albumin-cFVIII mRNA levels correlated with the
plasma FVIII activity. The data in Table 1 provides important proof of concept for our gene editing approach in a relevant NHP model. We intend to continue this study up to 12 months with continued measurement of FVIII activity to evaluate the
durability of FVIII expression from the integrated cFVIII gene. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Table 1</B>. cFVIII donor integration frequency, FVIII mRNA level and Mean FVIII activity level
in NHPs. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Animal ID</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Editing&nbsp;in<BR>the
liver</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>(InDel<BR>%)<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>FVIII&nbsp;gene&nbsp;integration<BR>frequency</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>(copies per 100<BR>genomes)<SUP STYLE="font-size:75%; vertical-align:top">2</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>FVIII&nbsp;mRNA</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>(%&nbsp;of&nbsp;endogenous<BR>control mRNA)<SUP STYLE="font-size:75%; vertical-align:top">3</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Mean&nbsp;FVIII&nbsp;activity</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>% of normal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>(d14 to d126)<SUP STYLE="font-size:75%; vertical-align:top">4</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">1001</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75&nbsp;&#043;/-&nbsp;9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">1002</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13&nbsp;&#043;/-&nbsp;4</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">1003</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">55%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">1.4</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">29&nbsp;&#043;/-&nbsp;5</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Table footnotes: (1) InDelS at the on-target site in albumin intron 1 were measured by NGS in a liver biopsy taken at day 7 post LNP
dosing. (2) The FVIII donor gene integration frequency in the forward orientation was quantified by droplet digital PCR analysis of the liver biopsy at day 7 post LNP and is normalized to an endogenous single copy gene. (3) FVIII mRNA was quantified
with a digital droplet PCR assay specific for the hybrid mRNA created by correct splicing between albumin exon 1 and the 5&#146; end of the FVIII gene and is the average of the levels in the liver biopsy at day 7 and day 70 post LNP dosing and is
normalized to the levels of an endogenous mRNA. (4) The mean of the FVIII activity in IU/ml measured at each time point between day 14 and day 126 was calculated and converted to the percentage of normal by multiplying by 100 (1 IU/ml is
approximately 100% FVIII activity in a healthy human being). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">No safety signals of concern were observed during this NHP study as of the November 11, 2023 cut-off
date. A comprehensive set of safety markers were measured in the blood of the monkeys after both AAV and LNP dosing. These included assays for coagulation, serum chemistry and hematology as well as liver enzymes (transaminases and bilirubin levels)
and a panel of 10 cytokines. We observed mild and transient elevations of alanine aminotransferases (&#147;ALT&#148;) and aspartate aminotransferase (&#147;AST&#148;) and no significant change in total bilirubin post AAV and post LNP (Figure 30).
Importantly we observed no changes in serum albumin levels over the course of the study demonstrating that the high level of editing in albumin intron 1 (mean 48% InDels which converts to approximately 78% of hepatocytes) did not alter expression of
the albumin protein. Three cytokines (IL-6, MCP-1 and IL-12/IL-23) exhibited mild and transient increases in the blood post AAV and post LNP. The data for IL-6 is shown in Figure 31. As of the data cut-off date, all three animals in the study
remained healthy, without notable clinical observations, and continued to gain weight as expected. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 30a</B>: ALT, AST, and total bilirubin levels in the
blood of NHP up to day 8 after AAV dosing in the integration study. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g45t15.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">176 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 30b:</B> ALT and AST levels in the blood of NHP up to day 10 after LNP dosing in the integration study. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g45t16.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 30c:</B> ALT, AST and total bilirubin levels in the blood of NHP throughout the study to the data cut-off date. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g45t17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 30: </B>Albumin levels in the blood of the 3 NHP after AAV and LNP dosing in the integration study. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g12g50.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 31</B>: Levels of the cytokine IL-6 in the blood of the 3 NHP in the integration study post AAV dosing and post LNP dosing.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">177 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 31a: </B>Levels of the cytokine IL-6 in the blood of the 3 NHP in the integration study post AAV dosing.
</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g12g51.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 31b:</B> Levels of the cytokine IL-6 in the blood of the 3 NHP in the integration study post LNP dosing. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g12g52.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Next Steps </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have selected two human
FVIII donor DNA cassette designs, and are in the process of producing the AAV, mRNA and gRNA to perform a second NHP integration study to select a single donor and guide and expect to nominate a development candidate by Q2 2024. In parallel, we are
initiating GxP manufacturing of mRNA, gRNA, AAV and LNP to support future IND-enabling studies. The progress we have made on this program not only validates the efficiency and specificity of our novel nucleases in rodent and NHP models, but also
supports our ongoing efforts with other large gene integration approaches. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Primary Hyperoxaluria, Type 1&#151;a durable knockdown of HAO1 for substrate reduction
therapy </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">PH1 is a rare autosomal recessive metabolic disease
arising from loss of function mutations in the AGXT gene that encodes alanine glyoxylate aminotransferase. This enzyme is found in peroxisomes of the liver where it catalyzes the conversion of glyoxylate to glycine and pyruvate. Lack of functional
AGXT leads to an accumulation of glyoxylate substrate, which is then converted to oxalate and excreted in the kidney. The excess urinary oxalate forms an insoluble complex with urinary calcium that leads to the production of calcium oxalate crystal
precipitates. This pathologic process results in the formation of repeated calcium oxalate urolithiasis and nephrolithiasis, which in turn leads to obstructive uropathy, inflammation, fibrosis, tubular toxicity, and progressive loss of kidney
function. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">PH1 is a serious disease that causes kidney failure. More than 70% of individuals with PH1 mutations will develop end-stage renal disease, with a median
age in young adulthood. Patients with PH1 continue to experience morbidity and mortality even after the development of <FONT STYLE="white-space:nowrap">end-stage</FONT> renal disease due to progressive
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">178 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
systemic calcium oxalate precipitation in various organs (systemic oxalosis). Despite renal replacement therapy or kidney transplantation, patients with PH1 have an overall shorter lifespan than
patients with other causes of renal failure, highlighting the progressive and severe nature of this metabolic disease. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">PH1 is the most common of the primary
hyperoxalurias but is a rare disease with an estimated prevalence of approximately one to three in 1,000,000 individuals. While epidemiologic data on PH1 is limited, these estimates suggest there are approximately 1,000 to 3,000 patients in both the
United States and Europe, and possibly up to 20,000 patients globally. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Approaches </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Until recently, the standard of care for treating PH1 was primarily supportive in nature, with hydration and diuretics used to reduce urinary oxalate concentration,
pyridoxine (vitamin B6) to enhance residual function of alanine glyoxylate aminotransferase catalytic activity, and hemodialysis once renal function progressed to end stage. Liver transplantation has also been explored as a means of providing
patients with a normal copy of AGXT and has been used alone in early-stage patients or as a combined liver-kidney transplant in more advanced patients. Transplantation approaches have limitations due to donor availability, morbidity associated with
the surgical procedure, and lifelong immunosuppression required to inhibit graft rejection. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">More recently, the standard of care has been updated to include
treatment with lumasiran, a siRNA therapeutic approved in adults and children with PH1 that acts to reduce the levels of urinary oxalate. Using a therapeutic approach known as substrate reduction therapy, lumasiran targets mRNA from a separate gene,
HAO1, that encodes GO. By inhibiting GO, levels of glyoxylate are reduced, which results in reduced downstream levels of oxalate. As a result, lower urinary oxalate results in decreased urinary calcium oxalate stone formation. It is anticipated that
inhibition of renal oxalate accumulation and stone formation can slow or prevent continued loss of renal function. Lumasiran has been generally well tolerated in clinical studies of adults and children with PH1 but it requires repeat subcutaneous
administration indefinitely in order to maintain its effect. In addition, injection site reactions are common among patients taking lumasiran and the degree of urinary oxalate reduction has been observed to not reach normal levels in many patients.
An additional RNAi drug, Nedosiran, which targets LDH, a different enzyme in the same pathway as HAO1, was also granted marketing approval by the FDA for adults and children with PH1 in October 2023. Thus, there is a potential to improve clinical
outcomes for PH1 patients with a <FONT STYLE="white-space:nowrap">one-time</FONT> administration of a therapy that inhibits urinary oxalate accumulation, prevents calcium oxalate stone formation, and protects renal function. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach and Results </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The goal of our genome editing approach is to
durably knock down HAO1 resulting in stable and permanent reduction of oxalate levels to effect a lifelong benefit. We plan to deliver mRNA for one of our lead nucleases and a guide encapsulated within a single LNP as shown in Figure 32 below. We
expect the mRNA and HAO1 gRNA will be released in hepatocytes (the cell type in the liver that expresses the HAO1 gene) where the mRNA will be expressed into the nuclease that forms a complex with the guide and create a double stranded break in the
HAO1 gene and inhibits gene expression. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">179 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 32</B>. Genome Editing Strategy for Targeting HAO1. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g47c44.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The safety of this durable knockdown of HAO1 is supported by human genetic observations of an individual lacking a functional copy of
the HAO1 gene with no evidence of a pathologic phenotype. The safety of this approach is also supported by up to three years of clinical data using a siRNA approach to silence this gene. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have performed nuclease and guide screening to select an optimal nuclease and gRNA combination. The double strand break created by the selected nuclease has been
observed to be efficiently and rapidly repaired by the cell via a process that introduces small InDels to the sequence at the target site. When these InDels alter the reading frame of the gene (so called &#147;out of frame&#148; InDels) this results
in degradation of the HAO1 mRNA. Because different nucleases and guides generate distinct InDel profiles, we included analysis of the InDel profile as a selection criterion during our nuclease /gRNA screen. In addition to the InDel profile, we also
screened for the efficiency of HAO1 mRNA reduction and impact on the HAO1 mRNA sequences using whole transcriptome RNA sequencing (&#147;RNAseq&#148;). This screening process resulted in selection of a lead guide that targets an identical sequence
in humans and mice which enables the evaluation of the lead human guide in mouse models. The potency of this lead nuclease and guide was tested in PHH <I>in vitro</I> as shown in Figure&nbsp;29, demonstrating dose-dependent editing when delivered by
a LNP with tropism to the liver. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">180 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 33</B>. Editing Dose Response in Primary Human Hepatocytes with the Lead Nuclease mRNA and Guide Targeting
HAO1 Delivered in a LNP. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g01m24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The off-target profile of the lead human guide targeting HAO1 is being evaluated in accordance with FDA guidelines published in March
2022. Potential off-target sites were identified using a combination of <I>in silico</I> prediction, biochemical discovery assays, and a cell-based discovery assay. To predict potential off-target sites <I>in silico</I> we used the variant aware
CRISPRme software using a permissive PAM for MG29-1 (TYYN) and permitting up to 4 changes from the HAO1 reference protospacer to identify potential off-target sites referencing both the GRCh38 human genome reference and a variant call file (vcf) for
more than 2,000 alternative genomes from the 1000 genomes consortium. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We applied two biochemical off-target discovery methods, Digenome-seq and SITE-Seq both of
which digest purified human genomic DNA with the editing nuclease/guide complex <I>in vitro</I>. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To identify potential off-target sites with a cell-based discovery
method we transfected primary human hepatocytes with MG29-1 and the lead guide together with a short double stranded oligonucleotide that integrates into the genome of cells at double strand breaks. Using a PCR based method we selectively amplified
the DNA junction between the integrated oligonucleotide and the human genome and evaluated the profile of potential off-target sites by NGS. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A total of 318
potential sites were identified by the combination of the three methods; the overlap of potential off-target sites identified from each of these methods is shown in Figure 34. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">181 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 34:</B> Venn diagram demonstrating the overlap in potential off-target sites nominated for the lead HAO1
targeting guide. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt"><B>


<IMG SRC="g425213g13a10.jpg" ALT="LOGO">
 </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These 318 potential off-target sites were tested in primary human hepatocytes that had been edited by MG29-1 and the lead
<I>HAO1</I> targeting gRNA using LNP delivery. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Off-target editing at all 318 potential off-target sites was measured in the genomic DNA from primary human
hepatocytes edited by MG29-1 and the lead <I>HAO1</I> targeting gRNA. No editing was detectable at any of the 318 potential off-target sites for the lead <I>HAO1</I> targeting guide in the most relevant human cell, primary human hepatocytes,
indicating that MG29-1 in combination with the lead HAO1 targeting gRNA is highly specific. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In normal mice we have demonstrated dose dependent saturating levels of
hepatocyte genome editing of HAO1 and up to 90% reduction of target GO protein, providing strong preclinical proof-of-concept as shown in Figure&nbsp;35. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure
35</B>. Dose Dependent Editing, mRNA Knockdown and Protein Knockdown of HAO1 in Normal Mice after a Single Administration of the Lead Nuclease mRNA and Lead Guide Encapsulated in a LNP with Tropism to the Liver. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:11%" ALIGN="center">


<IMG SRC="g425213g22m02.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Additionally, along with our partner Moderna, we have achieved
preclinical proof-of-concept in an AGXT knock-out mouse which is an accepted disease model of PH1 (Figure 36). AGXT knock-out mice have elevated oxalate in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">182 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the urine (measured with a mass spec assay) of about 500 mg per gram of creatinine compared to about 190 mg per gram of creatinine in mice of the same strain (BL/6) with a wild type AGXT
genotype. Cohorts of male and female mice were given a single administration of the lead nuclease mRNA and gRNA encapsulated in a LNP with tropism to the liver. Dose dependent editing at the target site in HAO1 in the liver was measured at the end
of this study (when the mice were sacrificed). The editing of HAO1 had the expected effect of dose dependently reducing urinary oxalate, with the highest dose achieving oxalate levels comparable to that of wild type mice. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 36.</B> Preclinical Proof of Concept in PH1 Disease Model (AGXT -/- mice). </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="57%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><B>Figure 36a. </B>Dose dependent editing of the HAO1 gene in AGXT -/- mice.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Figure 36b. </B>Dose-dependent reduction in urinary oxalate reaching normalization at highest dose.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g425213g22m03.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g425213g22m04.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top">Source: Moderna</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Source: Moderna</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The durability of this approach was demonstrated by continued knockdown of GO protein even after partial hepatectomy (removal of about
two thirds of the liver) and rapid liver <FONT STYLE="white-space:nowrap">re-growth</FONT> (Figure 37). In this study wild type mice were given a single injection of either buffer or a liver tropic LNP encapsulating the MG nuclease mRNA and the lead
gRNA targeting HAO1. As a control a Cas9 mRNA and a potent Cas9 guide targeting HAO1 from a published source were also packaged in the LNP with tropism to the liver and tested at a single dose. Eight days after dosing a liver hepatectomy was
performed in which about two thirds of the liver was removed. This stimulates the majority of the remaining liver cells to enter cell division and results in rapid re-growth of the liver that restores the normal liver size within 7 to 10 days. Eight
days after partial hepatectomy the levels of GO protein (the product of the HAO1 gene) in the liver were reduced by more than 90%, the same as the level of knockdown in edited mice that did not undergo hepatectomy. This result demonstrates that the
knockdown of HAO1 expression was not compromised by extensive liver growth and that the fitness of edited hepatocytes was not impacted by editing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">183 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 37.</B> Knockdown of the Protein Encoded by HAO1 after HAO1 Gene Editing was Maintained Following Partial
Hepatectomy. Control Mice were Injected with Buffer as a Control. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g22m05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:2%; text-indent:-1%; font-size:8pt; font-family:arial">Source: Moderna </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Next Steps </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are in the final stages of confirming the candidate to take
into NHP studies and expect to have NHP data in 2024 to support final development candidate selection. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This program is partnered with Moderna for both development
and commercialization. The partnership enables us to leverage Moderna&#146;s expertise in mRNA and LNP technology to ensure efficient delivery of our nuclease to hepatocytes. In turn, we provide the novel programmable nuclease and guide chemistry to
support precise targeting of the HAO1 gene. In addition to further validating our therapeutic platform, to the best of our knowledge this program represents the first time a type V nuclease is being developed for a therapeutic <I>in</I> <I>vivo</I>
genome editing approach. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial"><U>Transthyretin Amyloidosis&#151;a single treatment to knockdown TTR gene expression</U> </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Transthyretin amyloidosis is a disease of misfolded and
aggregated TTR protein that can deposit in tissues causing organ dysfunction, primarily in the heart and/or peripheral nerves. The TTR protein is normally produced in the liver and circulates in a homotetramer (four copies of the same TTR protein
bound together) where it serves as a carrier protein for vitamin A and thyroxine. Certain mutations have been identified that can cause TTR homotetramers to fall apart, misfold, and aggregate into insoluble fibrils that deposit in cardiac tissue and
peripheral nerves. However, more commonly, the normal aging process is associated with an increased propensity for TTR misfolding and aggregation in the heart without any known genetic sequence variation. These distinctions lead to TTR amyloidosis
being characterized as either ATTRv caused by mutations in TTR, or ATTRwt. It is estimated that globally there are approximately 50,000 patients with ATTRv and between 300,000 and 500,000 patients with ATTRwt. Among the larger ATTRwt patient
population, the most common presentation is a rapidly progressive, restrictive, and hypertrophic cardiomyopathy due to progressive deposition of insoluble TTR fibrils, which result in thickening of the myocardium and stiffening of the ventricles.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">184 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
These pathologic processes lead to impaired diastolic function and progressive cardiomyopathy that typically leads to progressive heart failure and often death within three to five years from
disease onset. Although cardiac manifestations are more common and severe, patients with neurologic manifestations also experience significant morbidity, loss of functionality, and impaired quality of life. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Approaches </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To date, treatment options for patients
with TTR amyloidosis, including those with either cardiomyopathy or polyneuropathy manifestations, consist of efforts to stabilize the TTR tetramer with a small molecule (tafamadis) or knock down TTR levels through antisense oligonucleotides (i.e.,
inotersen and eplontersen which is currently under regulatory review in the U.S.) or siRNA strategies (i.e., patisiran and vutrisiran). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Tafamadis was studied in a
randomized trial of patients with either ATTRv and ATTRwt cardiomyopathy and demonstrated reductions in <FONT STYLE="white-space:nowrap">all-cause</FONT> mortality and cardiovascular-related hospitalizations and reduced the decline in quality of
life and functional capacity over 30 months compared to placebo. Tafamadis is currently approved to treat patients with ATTR cardiomyopathy in the U.S. and patients with ATTRv and ATTR cardiomyopathy in the EU and in other parts of the world.
Inotersen has demonstrated benefit in patients with ATTRv and polyneuropathy and is approved in the U.S., EU, and in other parts of the world. Eplontersen has demonstrated benefit in patients with ATTRv and polyneuropathy and is currently under
regulatory review in the U.S. Eplontersen is also being studied in a Phase 3 trial for patients with ATTR cardiomyopathy. Patisiran is approved for the treatment of polyneuropathy of ATTRv in adults in the U.S., EU, and other parts of the world.
Patisiran is currently under regulatory review for the treatment of patients with ATTR cardiomyopathy based on a randomized study demonstrating improvement in the <FONT STYLE="white-space:nowrap">6-Minute</FONT> Walk Test and quality of life over 12
months compared to placebo. Vutrisiran has demonstrated benefit in patients with ATTRv and polyneuropathy and is approved for use in ATTRv in the U.S., EU, and other parts of the world. Although these approaches have improved clinical outcomes for
patients with TTR amyloidosis, the disease is still associated with significant morbidity and mortality and requires lifelong therapy to maintain therapeutic benefit. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next Steps </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">More recently, early-stage third-party studies have
demonstrated the feasibility of knocking down TTR (wild type or mutated versions) using a CRISPR based genome editing approach in a small number of patients. Clinical validation of this TTR knockdown approach is provided by antisense and siRNA
clinical experience and further suggests the potential longer-term safety and tolerability of this approach. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Using our novel nucleases, we aim to provide efficient
TTR knockdown and halt further deposition of amyloid fibrils. Previous experience suggests a clinical correlation between the degree of TTR knockdown and potential for benefit in familial forms of the disease, which are expected to translate
similarly to wild type forms. The high degree of <I>in vivo</I> editing efficiency and specificity of our nuclease platform suggest the potential for a single treatment to knockdown TTR gene expression and remove the requirement for life-long
therapy. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Along with our partner Ionis, we are currently in advanced stages of nuclease and guide selection and expect to move into NHP studies in 2024. We believe
one of the strengths of our technology platform is applying our multiple nucleases that have distinct <FONT STYLE="white-space:nowrap">non-overlapping</FONT> PAMs to create a larger number of guides for a given target. Starting with a larger number
of guides should increase the chance of finding highly active and specific guides/nuclease combinations. Leveraging multiple nucleases with a diversity of PAMs enabled a high targeting density for the TTR gene as illustrated in Figure 38a. By
comparison significantly fewer <FONT STYLE="white-space:nowrap">(3.8-fold</FONT> fewer) guides are available when using SpCas9 (Figure 38b). We have screened more than 500 guides against the human TTR gene using six of our nucleases. With one
additional nuclease in progress we will ultimately have screened 535 guides. Our high throughput screening platform has enabled us to screen approximately 500 guides in a four-month time span. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">185 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 38a</B>. High density of gRNA targeting the coding and regulatory regions of the TTR gene enabled by our
platform of nucleases with diverse PAMs. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g01a35.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 38b</B>. Density of SpCas9 gRNA targeting the coding and regulatory regions of the TTR gene. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g01a36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are in the process of selecting lead guides and nucleases for evaluation in mouse models that carry the human TTR gene. Promising
early leads have shown potent TTR mRNA knockdown in primary human hepatocytes. We plan to deliver our programmable nuclease and its associated gRNA to the liver using LNP technology, which has been shown to be highly selective for hepatocytes. This
program not only provides a novel nuclease approach to knocking down TTR levels, but also leverages our partner&#146;s long-standing clinical development expertise in the TTR amyloidosis field to accelerate our efforts. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A preliminary evaluation of the in vivo potency of lead human guides was performed in a humanized mouse model in which multiple copies of the human TTR gene were
integrated at random sites in the mouse genome. These mice express human TTR protein which can be measured in the blood using an assay specific for the human TTR protein. In this study, Lead 1 reduced the human TTR mRNA and protein by 75% and 88%,
respectively. Leads 2 and 3 both reduced the human TTR mRNA and protein by 97% and 98%, respectively. Leads 2 and 3 are particularly attractive because these guides and mRNA have undergone only minimal sequence and chemistry optimization to date.
Additional leads are currently being evaluated in this mouse model. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">186 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 39</B>. Proof of concept for knockdown of human TTR protein by lead nucleases/guides in human TTR transgenic
Mice. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213g01a37.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Cardiovascular Disease &#150; a gene editing solution to eliminate angiotensinogen gene expression </U></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Cardiovascular disease is the leading cause of death worldwide
and implicated in the deaths of approximately 17.9&nbsp;million individuals each year. Although cardiovascular diseases are not genetically defined diseases, there are well validated gene targets and signaling pathways that address potent sources of
vasoconstriction allowing for the creation of an important genetic medicine for these common diseases.&nbsp;Among the most important of these signaling pathways that have demonstrated marked clinical benefit in both hypertension and heart failure is
the renin-angiotensin-aldosterone system (RAS) pathway, that has been successfully targeted by a number of important medications including renin inhibitors, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and aldosterone
antagonists.&nbsp;Beyond its effect on blood pressure control, inhibitors of the RAS pathway have been shown to provide meaningful clinical benefit in ischemic heart disease and chronic heart failure as well as in diabetic nephropathy, and other
forms of chronic renal insufficiency. However, continuous <FONT STYLE="white-space:nowrap">24-hour</FONT> inhibition of the RAS pathway with oral agents is not always successful, especially if compliance is suboptimal. Importantly, despite use of
RAS inhibitors, diurnal variability in blood pressure and nocturnal blood pressure elevations can still occur. Recent early stage clinical studies using antisense and siRNA approaches to durably suppress the RAS pathway by targeting liver derived
angiotensinogen provides important clinical validation of this approach as a means of safely reducing blood pressure without incurring hypotension, hypokalemia, or acute renal injury. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Therapy </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Although there are numerous approved classes
of drugs that have demonstrated clinical benefit in patients with cardiovascular disease and refractory hypertension patients, many patients do not reach their blood pressure </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">187 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
goals or continue to have cardiovascular disease progression. In addition to contributions from underlying stiffened arteries and/or increased sympathetic tone, patients may have suboptimal
adherence in taking a large number of daily oral pills. Importantly, current treatments often do not fully provide reliable and consistent <FONT STYLE="white-space:nowrap">24-hour</FONT> control of blood pressure which can leave patients exposed to
diurnal variation and early morning blood pressure surges associated with cardiovascular events. Adverse effects of polypharmacy approaches and complicated food effects or drug-drug interactions can further negatively affect compliance and lead to
poor outcomes. Therefore, despite the availability of oral medications, there remains a significant unmet need for a well-tolerated, durable approach to blood pressure control and cardiovascular protection with a clinically validated target.</P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next Steps </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our goal is to knockdown the expression of
angiotensinogen in the liver using one of our programmable nucleases to generate a durable reduction in blood pressure from a single treatment. Angiotensinogen, encoded by the gene AGT, is at the top of the RAS pathway and the precursor to highly
vasoconstrictive peptides angiotensin I and II and is thus an attractive and novel target for reduction of blood pressure. Inhibiting angiotensinogen protein production from the liver has the advantage of minimizing inhibition of the RAS pathway in
the kidney which will provide a better safety profile by keeping the small amount of kidney production of AGT intact and thus avoiding renal dysfunction that is common with current medications and ensuring adequate vasoactive homeostasis in stress
situations. A second potential advantage of targeting AGT is that it may limit escape mechanisms that restore angiotensin II levels or angiotensin II signaling. Clinical proof of concept for reduction of AGT protein levels comes from ongoing
clinical trials of antisense <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(IONIS-AGT-L</FONT></FONT><SUB STYLE="font-size:75%; vertical-align:bottom">Rx</SUB>) and siRNA <FONT STYLE="white-space:nowrap">(ALN-AGT)</FONT> drug
candidates that have shown reduced mRNA levels of AGT in the liver and consequently reduced levels of AGT protein in the blood. We plan to deliver a programmable nuclease and its associated gRNA to the liver using LNP technology. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Along with our partner Ionis Pharmaceuticals we are currently in advanced stages of nuclease and guide screening and expect to move into NHP studies in late 2024 or
early 2025. We believe one of the strengths of our technology platform is being able to access a larger proportion of the human genome by applying our multiple nucleases that have distinct <FONT STYLE="white-space:nowrap">non-overlapping</FONT>
PAMs.&nbsp;We have the potential to screen up to 1,490 guides using six MG nucleases against the AGT gene. To date we have screened 441 guides and are planning to screen an additional 420 guides.&nbsp;Leveraging the multiple MG nucleases with a
diversity of PAMs enables a high targeting density as illustrated for the seven MG nucleases that are being screened against AGT. By comparison significantly fewer guides <FONT STYLE="white-space:nowrap">(2.5-fold</FONT> fewer) are available when
using spCas9. Multiple guides with potent editing of the AGT gene in human cells were identified in our initial guide screen against the coding sequence. We are in the process of completing the guide screen and selecting lead guides/nucleases for
evaluation in mouse models that carry the human AGT gene. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We believe that this program is expected to be one of the first
<FONT STYLE="white-space:nowrap">co-development</FONT> efforts to develop a gene editing therapy for more common, <FONT STYLE="white-space:nowrap">non-genetically</FONT> defined cardiovascular indications. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A preliminary evaluation of the in vivo potency of lead human guides was performed in a humanized mouse model in which multiple copies of the human AGT gene were
integrated at random sites in the mouse genome. These mice express human AGT protein which can be measured in the blood using an assay specific for the human AGT protein. In this study, human AGT protein in the blood and the human AGT mRNA in the
livers were measured 7 days post LNP dosing at both 1 and 0.3 mg/kg (Figure 40). At a dose of 1 mg/kg, lead 1 reduced the human AGT mRNA and protein by 85% and 93%, respectively. Lead 2 reduced the human AGT mRNA and protein by 91% and 92%,
respectively. Additional leads are currently being evaluated in this mouse model. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">188 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 40.</B> Proof of concept for knockdown of human AGT protein by lead nucleases/guides in transgenic human AGT
mice. </P> <P STYLE="font-size:16pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center"><B>


<IMG SRC="g425213g44m01.jpg" ALT="LOGO">
 </B></P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>A1AT Deficiency </U></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease
</I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A1AT deficiency is an autosomal recessive disease arising from loss of the normal A1AT protein encoded by the gene SERPINA1. Clinical manifestations of A1AT
deficiency are primarily in the lung due to the toxic loss of normal function of A1AT, and occasionally in the liver due to the toxic effects of accumulation of abnormal A1AT. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">AIAT is a highly abundant plasma protein that acts as an inhibitor of the potent proteolytic enzyme neutrophil elastase. Neutrophil elastase is involved in the host
response to infection, but when unchecked can degrade connective tissue. In the lung, clinical manifestations of A1AT deficiency include emphysema and bronchiectasis from destruction of normal alveolar connective tissue. In patients with liver
disease, the primary pathophysiology is liver inflammation and cirrhosis due to buildup of abnormal A1AT protein. Liver disease is more often found in children with A1AT deficiency, and lung disease is more often found in adults with A1AT. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A1AT deficiency is a clinically underrecognized disease, especially those with pulmonary manifestations as it is often mistaken for other forms of chronic obstructive
pulmonary disease. Recent estimates from genetic screening suggest that 80,000 to 100,000 individuals in the United States have severe deficiencies of A1AT and approximately 40,000 to 60,000 have clinically manifest emphysema caused by A1AT
deficiency. As not all individuals with A1AT deficiency present similarly, it is believed that environmental factors such as exposure to smoke, allergens, chemicals, and other environmental factors likely impact the severity and clinical
manifestations. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Therapy </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Patients with A1AT
deficiency are often treated with protein augmentation therapy. The goal of augmentation therapy is to increase circulating levels of A1AT sufficiently to balance the adverse effects of unchecked </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">189 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
neutrophil elastase and slow the progression of emphysema. Augmentation therapy consists of an IV infusion of purified pooled donor plasma enriched for A1AT protein levels given weekly. While
studies have demonstrated the ability to achieve higher circulating levels of A1AT with augmentation therapy, longer term impacts on protecting lung function are limited. This approach is also costly and not available for many patients. Infusions
have also been associated with adverse events including <FONT STYLE="white-space:nowrap">flu-like</FONT> reactions, fever, and rarely anaphylaxis. In severe cases of lung or liver disease, organ transplantation may be required to preserve life but
are associated with post-transplant risks and long-term immunosuppression requirements. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next Steps </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The most frequent mutation responsible for A1AT deficiency is the PiZ mutation that changes the normal amino acid at position 342, which is glutamic acid, to lysine
(E342K). Patients that are homozygous for the PiZ allele (called ZZ allele) make up more than 90% of the patients globally. We propose to correct this mutation back to normal using either an adenine base editor or Little RIGS. Because individuals
that are heterozygous for the PiZ mutation (so called ZM allele) have minimal pathology, it is expected that editing of 50% of the alleles would be therapeutic. The most common DNA sequence change that creates the E342K mutation is a G to A change
at the first position of the codon; GAG (normal) to <U>A</U>AG (PiZ). Converting the PiZ sequence (<U>A</U>AG) to the normal sequence (GAG) requires changing the underlined A to G which can be achieved using an adenine base editor. For this approach
to be successful, a potent gRNA needs to be identified that targets the editing window to the ABE at the precise location of the codon for amino acid 342. There are five additional A bases within 5 bp on either side of the target A base in the 342
codon which could be subject to bystander edits (defined as edits at non-target bases within the site targeted by the guide), several of which would change additional aa with unpredictable impacts on the structure and function of the protein. Given
the complexity of this edit, we will evaluate multiple genome editing systems, including base editors and RIGS, in order to advance the most effective genome editing approach. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Wilson&#146;s Disease </U></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Wilson&#146;s disease is an autosomal recessive disease of copper metabolism resulting from impaired function of the intracellular copper transporter encoded by the gene
ATP7B. Mutations in ATP7B lead to impaired biliary excretion of copper, leading to copper accumulation in multiple organs including liver, brain, and eye. Given the large size of the gene and allelic heterogeneity, the disease has been difficult to
target with any genetic medicine to date. While impaired copper excretion begins at birth, the effect is typically not observed clinically until later in childhood or early adulthood and the majority of patients are diagnosed between ages five and
35. The most common manifestation is chronic active hepatitis that can progress to liver cirrhosis; however, a variety of neurologic and psychiatric manifestations may also be present and undiagnosed. Such symptoms may include dysarthria, gait
impairment, dystonia, depression, irritability, and personality changes. Diagnosis is typically suggested by abnormalities in blood ceruloplasmin and/or <FONT STYLE="white-space:nowrap">24-hour</FONT> urine copper as well as the presence of
Kayser-Fleisher rings on ocular examination. Additional diagnostic certainty can come from liver biopsy and ATP7B sequencing. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Wilson&#146;s disease has an estimated
global prevalence of one patient per 10,000 to 30,000 individuals although recent genotyping studies suggest that the actual genetic prevalence may be substantially higher. This estimate suggests that there are more than 30,000 patients with
Wilson&#146;s disease in the United States alone. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Therapy </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Wilson&#146;s disease is a serious disease that is fatal if left untreated, typically from cirrhosis and liver failure. Once diagnosed, the standard of care for
Wilson&#146;s disease involves chronic treatments to try and remove copper from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">190 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the body using copper chelators and efforts to minimize copper absorption from the gastrointestinal tract. Treatment must be lifelong to prevent copper reaccumulation and side effects from
chelator therapy (e.g. hypersensitivity reactions, fever, changes to blood counts) are common and can lead to treatment discontinuation. If treatment is discontinued, patients are at risk for hepatic decompensation or the development of new
neurologic symptoms. In patients with delayed diagnosis or rapidly progressive disease, liver transplant may be required with associated post-transplant risks and need for immunosuppression. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There are no genetic medicines approved for Wilson&#146;s disease. A genetic medicine has the potential to eliminate the need for life-long therapy and copper monitoring
as well as reduce the risk for adverse events. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next Steps </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Wilson&#146;s disease is inherited in a recessive manner meaning that heterozygotes (people having one mutant allele and one wild type allele) are not affected. This
means that correction of only one of the two mutant alleles should be sufficient to confer a normal phenotype on the hepatocyte, the cell type in the liver in which the ATP7B gene performs its function. Patients with Wilson&#146;s disease have a
diverse spectrum of different mutation types (point mutations, deletions, splice site mutations) that are located throughout the ATP7B gene although different ethnic groups bear different predominant mutations. Common mutations in specific
population groups include H1069Q (30-70% of Wilson&#146;s disease patients in Germany, 30-70% in US Caucasians), M645R (approximately 30% of Wilson&#146;s disease patients in Spain), R778L (40% of Wilson&#146;s disease patients in Korea,
approximately 30% in China). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are working to treat Wilson&#146;s disease using a Big RIGS insertion, potentially the first known instance of a targeted large gene
insertion with this approach. We believe this represents the ideal approach for genome editing for Wilson&#146;s disease because we expect that it could enable the majority of patients to be treated with the same therapy irrespective of their
specific mutation(s) in ATP7B. The ATP7B gene spans 76,000 bp of DNA in the human genome, and the protein coding sequence of ATP7B is 4,398 bp in length which encodes a protein of 1,465 aa. The majority of the pathogenic mutations identified in
ATP7B are located in the <FONT STYLE="white-space:nowrap">C-terminal</FONT> half of the protein between amino acid positions 645 and 1373 which are encoded in exons 6 to 21 (Figure&nbsp;41). This region includes the three most frequent mutations
(H1069Q, R778L, M645R, I1148T) as well as many other less common mutations. We are evaluating a genome editing approach in which a donor template that encodes exons 6 to 21 of the ATP7B gene (2460 bp) is inserted in to the ATP7B locus at intron 6
(downstream of exon 5) such that exons 1 through 5 of the endogenous gene are functionally fused to the inserted wild type exons 6 to 21. We believe this will generate a wild type ATP7B protein driven from the endogenous ATP7B promoter thereby
preserving the normal levels of ATP7B and normal regulation of expression. This approach should be applicable to all Wilson&#146;s disease patients except for those with mutations in exons 1 to 5 which represent only a small fraction of the patient
population. This approach leverages an all RNA based editing system such that the editing components could theoretically be delivered in a single LNP that is taken up by the hepatocytes of the liver. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 41</B>. Genome Editing Strategy for Wilson&#146;s Disease. </P> <P STYLE="font-size:16pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g425213g30g42.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">191 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Familial Amyotrophic Lateral Sclerosis (&#147;ALS&#148;) </U></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">ALS is a rapidly progressive neurodegenerative disorder of upper
and lower motor neurons leading to weakness, disability, and death. The prevalence of ALS is approximately four to six patients per 100,000 individuals and it is estimated that over 5,000 patients are diagnosed each year in the United States. While
the majority of ALS cases have no known family history, it is estimated that approximately 10% of cases are due to inherited causes. Of these, among the more prominent causes is from a mutation in the gene superoxide dismutase 1 (&#147;SOD1&#148;).
SOD1 ALS (occasionally referred to as ALS1), is an autosomal dominant condition associated with toxic gain of function of SOD1 leading to protein misfolding and intraneuronal cytotoxicity. While the mechanism of action of SOD1 pathophysiology is
poorly understood, it is unique in that histopathologically it does not contain typical cytoplasmic inclusions of the nuclear binding protein <FONT STYLE="white-space:nowrap">TDP-43</FONT> seen in other spontaneous and familial forms of ALS. The
median age of diagnosis of SOD1 ALS is <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mid-to-late</FONT></FONT> 40s, and similar to other forms of ALS, progressive weakness and loss of voluntary function is rapid with a median
survival after diagnosis of approximately three years. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Therapy </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Despite significant investment in research over recent decades, the standard of care for treating all forms of ALS is suboptimal and there remains no cure. There are
currently three drugs approved in the United States to treat all forms of ALS (riluzole, sodium phenylbutyrate and taurursodiol, edaravone), and one recent accelerated drug approval for SOD1 ALS (tofersen). To date, only modest benefit in slowing
disease progression or improving survival has been observed, and all of these medications require repeat administration or dosing and are associated with adverse effects. In a Phase 3 clinical trial, tofersen, which is an antisense olignonucleotide
targeting SOD1 delivered directly to the cerebrospinal fluid and that requires repeated lumbar puncture monthly, did not result in a statistically significant change on clinical measures after 28 weeks of treatment, but did show a nominally
statistically significant benefit on a biomarker, neurofilament light chain, and longer term administration was associated with slowing of disease. Clinically significant adverse reactions with tofersen include myositis and/or radiculitis,
papilledema and elevated intracranial pressure, and aseptic meningitis, and additionally adverse reactions can occur from repeated lumbar puncture procedures. Thus, despite this precision medicine approach, there remains significant unmet need for
effective therapies that can halt disease progression and improve overall survival from SOD1 ALS. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next Steps </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our approach is to build upon the data generated by tofersen and use one of our programmable nucleases to durably knock down SOD1 levels with a single administration,
thus capturing durable benefit with a clinically validated disease target without requiring the patient burden of repeat intrathecal administrations of an oligonucleotide. We plan to deliver the nuclease and associated guide using an AAV vector with
sufficient tropism for lower motor neurons. We have performed guide screening with 8 of our small MG nucleases that can fit in a single AAV. A total of 99 lead guides were identified for SOD1 and 60 leads for ATXN2 which are being evaluated in
neuronal cells in culture. We are in the process of optimizing AAV vector designs to package and efficiently express our small nucleases and gRNA from a single virus to enable evaluation of lead SOD1 and ATXN2 guides in mouse models. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">192 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Spontaneous ALS </U></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The
Disease and Limitations of Current Therapy </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As noted above, ALS is a relentless and ultimately fatal disease of motor neurons with no known cure. Approximately
90% of ALS does not have a known family history or clear genetic cause. While the underlying cause of ALS in most cases is unknown, a common histopathologic finding involves misfolded cytoplasmic protein aggregates that include <FONT
STYLE="white-space:nowrap">TDP-43.</FONT> As <FONT STYLE="white-space:nowrap">TDP-43</FONT> is a highly conserved nuclear RNA and DNA binding protein involved in RNA processing, the clinical manifestations of ALS may arise both from the toxic
cytoplasmic <FONT STYLE="white-space:nowrap">TDP-43</FONT> aggregates as well as RNA processing abnormalities from the loss of normal nuclear functions of <FONT STYLE="white-space:nowrap">TDP-43.</FONT> The initial symptom of ALS is a gradual onset
of muscle weakness that is typically painless. These symptoms are often followed by muscle twitching, loss of coordination, falls, and fatigue that impair functionality. As the disease progresses, loss of ambulation, spasticity, and diaphragmatic
weakness progresses with the most common cause of death being respiratory failure. Despite the approval of several classes of oral compounds for spontaneous ALS, effects on preserving clinical functionality and survival are modest. There remains
significant unmet need for safe and effective therapies that can halt disease progression and improve overall survival from spontaneous ALS. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next
Steps </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">TDP-43</FONT> intracytoplasmic inclusions and proteinopathy are hallmarks of the vast majority of ALS histopathology;
however, targeting <FONT STYLE="white-space:nowrap">TDP-43</FONT> directly has not been feasible due to its critical role in RNA processing and other cellular functions. We intend to develop an ALS therapy that targets the ATXN2 gene, which we
believe is an attractive target based on strong third-party preclinical data targeting the gene ATXN2, which encodes the protein Ataxin 2, and has been shown to be a powerful genetic modifier of <FONT STYLE="white-space:nowrap">TDP-43</FONT> in
yeast and flies, and importantly, knockdown of Ataxin 2, either by antisense oligonucleotides or by genetic manipulation has improved survival and motor function in a mouse model of ALS. A Phase 1/2 clinical trial of an investigational antisense
oligonucleotide targeting Ataxin 2 in adults with ALS that is administered intrathecally is in progress, which will provide further information about the safety and efficacy of this approach. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our plan is to deliver a nuclease and associated guide using an AAV vector with sufficient tropism for lower motor neurons. We are currently initiating guide screening
efforts to potently and selectively knock down Ataxin 2 levels and determining the appropriate nuclease/guide system for AAV packaging. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Charcot-Marie-Tooth Type
1a (&#147;CMT1a&#148;) </U></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">CMT1a is part of a larger
classification of hereditary peripheral motor and sensory neuropathies caused by pathogenic mutations in proteins associated with myelin formation and axonal signal propagation. CMT1a is an autosomal dominant disease arising from a gene duplication
of PMP22 (peripheral myelin <FONT STYLE="white-space:nowrap">protein-22)</FONT> and overexpression of PMP22 protein. PMP22 is tightly regulated and expressed in Schwann cells that control the production of myelin sheaths around axons. Patients with
CMT1a have altered myelination that impairs nerve conduction and neuromuscular function. Patients typically present in the first or second decade of life with lower extremity weakness, atrophy, falls, and sensory deficits. The disease is slowly
progressive and impairs mobility, and can also involve changes to distal upper extremities and limb deformities. Although life expectancy is typically preserved, CMT1a leads to significant disability and impaired quality of life. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Although exact prevalence estimates vary, CMT is believed to affect one patient per 2,500 individuals, with approximately 126,000 patients in the United States alone. Of
those approximately half are believed to have CMT1a, the most common form of the disease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">193 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Therapy </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The treatment of CMT1a and other forms of CMT are largely supportive and there are no approved treatments. Existing standard of care involves physical therapy,
stretching, orthotics, and occasional foot surgery to improve deformities that impair ambulation. Patients should be screened for conditions that can exacerbate neuropathies such as vitamin deficiencies or diabetes in an attempt to mitigate against
more rapid progression. There are investigational efforts for RNA targeted therapeutics to reduce PMP22 overexpression with strong preclinical data to support the approach, but clinical studies are very early and therapies would need to be given
lifelong. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next Steps </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our approach to CMT1A is a permanent
reduction of PMP22 protein levels to the normal range by knockdown of PMP22 expression using our nuclease platform. There is preclinical proof-of-concept for this approach in a mouse model of CMT1A using AAV9 to express a siRNA against PMP22. We
intend to use our novel nucleases to introduce InDels in the promoter region of PMP22 that lead to a reproducible reduction of PMP22 expression to the normal range. We anticipate that this editing approach will be delivered via an AAV with the goal
of achieving uniformly high levels of genome editing while minimizing the risk of toxicity resulting from reducing PMP22 levels to below normal at a cellular level. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We believe the diversity of our nuclease platforms including type V systems such as <FONT STYLE="white-space:nowrap">MG29-1</FONT> that create larger deletions and are
more likely to inactivate promoters by eliminating transcription factor binding sites, lends itself to identification of nuclease guide combinations that are efficient and result in partial reduction in the expression of the PMP22 gene. We plan to
perform a guide screen targeting the promoter region first in HEK293 cells (a cell line that expresses PMP22 mRNA) and active guides with promising InDel profiles and editing potency will be further evaluated for PMP22 mRNA knockdown. Lead systems
will be vectorized into AAV9 viruses and evaluated in the CMT1a mouse model. Once reduction of PMP22 expression is confirmed, the therapeutic benefit can be evaluated via various endpoints including tissue morphology, nerve conduction velocity,
circulating biomarkers and behavioral tests to support candidate selection. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Duchenne Muscular Dystrophy (&#147;DMD&#148;) </U></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>The Disease </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">DMD is an <FONT STYLE="white-space:nowrap">X-linked</FONT>
recessive myopathic disease involving loss of function mutations of dystrophin, a large protein critical for the stabilization and protection of muscle fibers encoded by the DMD gene. In the setting of absent or abnormal dystrophin, muscle fibers
are prone to injury, degeneration, fibrosis, and ultimately fatty infiltration and replacement. DMD typically presents in early childhood with initial symptoms of muscle weakness and progresses rapidly to loss of ambulation as well as respiratory
muscle fatigue and cardiomyopathy. In general, large proximal muscles are affected earlier than smaller distal muscles, and lower extremity muscles are affected earlier than upper extremity muscles. Patients are often wheelchair bound before teen
years and often die in their late teens and early twenties from cardiopulmonary complications. Prior to clinically overt findings, patients typically have marked elevations in the muscle enzyme creatine kinase that can serve as the earliest
indicator of muscle inflammation and degeneration. DMD is estimated to occur in one of every 3,500 live births, and as an x linked recessive disease is observed almost entirely in males. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">DMD is the largest gene identified in humans to date spanning approximately 2.3 Mbp, and the severity of clinical manifestations of the muscular dystrophy is in part
related to the location and type of dystrophin mutation and resulting residual amount of dystrophin present. Accordingly, <FONT STYLE="white-space:nowrap">in-frame</FONT> mutations with residual dystrophin of
<FONT STYLE="white-space:nowrap">5-50%</FONT> are associated with a less severe clinical course than early truncating mutations with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">194 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
residual dystrophin levels of 0-5%. These findings have led to drug development efforts to restore out of frame mutations into <FONT STYLE="white-space:nowrap">in-frame</FONT> mutations that
result in an abnormal but partially effective dystrophin protein. Additionally, it has been observed that <FONT STYLE="white-space:nowrap">in-frame</FONT> deletions of large portions of the central part of the dystrophin protein coding region are
well tolerated, which has provided the basis for gene transfer approaches of a &#147;microdystrophin&#148; protein. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations of Current Approaches </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Despite significant efforts to develop precision medicines for DMD, results to date have not led to meaningful improvements in the standard of care for patients. The
mainstay of treatment for DMD is glucocorticoids to address muscle inflammation and improve proximal muscle strength and respiratory function. However, the benefits of glucocorticoids have to be weighed against their long-term risks that include
excessive weight gain, impact on growth, cataract formation, bone loss/fracture risk, and behavioral changes. More recently several genetic therapies that induce exon skipping have been approved in the United States to address specific mutations
(e.g., exon 45 (casimersen), exon 51 (etiplirsen), exon 53 (golodirsen)) or induce readthrough of stop mutations (ataluren). These therapies have shown modest improvement in muscle dystrophin levels but their overall impact on clinical outcomes has
not been established. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next Steps </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">DMD patients often have
deletions of entire exons (frequently in the hotspot region of exons <FONT STYLE="white-space:nowrap">45-55)</FONT> which results in the flanking exons being spliced out of frame at the mRNA level. Approved therapies have aimed to correct these
mutations by restoring the open reading frame through &#147;exon skipping&#148;, thus avoiding degradation of the mRNA and/or premature protein termination. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our
proposed genome editing approach is to more effectively facilitate exon skipping by making permanent changes at the DNA level using genome editing that inactivate the splice acceptor (5&#146; exon splice junction sequence) of the exon that follows
the deleted exon such that after transcription the RNA splicing machinery &#147;skips&#148; over that exon, splices to the following exon, and restores the proper reading frame. The resulting proteins will lack the domains encoded by the mutated and
skipped exons but these are known to function nearly as well as normal dystrophin. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For example, one common mutation is deletion of exon 44, which results in exon 43
being aberrantly spliced to exon 45 and an out of frame mRNA (designated as &#147;STOP&#148; in Figure 42) which is then degraded or translated into a truncated protein. As shown in the Figure 42 below, skipping of exon 45 results in splicing from
exon 43 to 46 and restores protein expression. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">195 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Figure 42</B>. Example of Exon Skipping Approach for Dystrophin Exon 45 that Results in Splicing of Exon 43 to 46
Thereby Restoring the Correct Translational Reading Frame and Thus Dystrophin Function. </P> <P STYLE="font-size:16pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g425213g12c11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We believe a similar strategy can be employed for deletions of exons 50, 51, and 53, creating a franchise of development programs for
DMD. We are in the process of initiating a guide screen using our toolbox of DSB nucleases and base editors that are small enough to package in a single AAV vector to inactivate the splice acceptors of the various exons within this hotspot region.
The splice acceptor sequence is short (composed of a poly-pyrimidine tract of about 10 to 15 bases followed a short distance away by the three base consensus sequence
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">C/T-A-G)</FONT></FONT> which limits the number of guides that can be designed to inactivate the splice acceptor when using a single nuclease. We are leveraging our collection of small
nucleases that have a variety of different PAMs to enable more guides to be designed against each splice acceptor. Hits from this guide screen will be assayed in cardiac and/or skeletal muscle cells <I>in vitro</I>. The nuclease/guide combinations
that show potent activity in muscle cells will then be evaluated in human cells in which the DMD gene contains the relevant pathogenic mutations to evaluate exon skipping activity. <I>In vivo</I> evaluation of leads will be performed in mouse models
of DMD. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Because DMD affects skeletal and cardiac muscles throughout the body of DMD patients, effective therapy will require delivery to a large proportion of these
muscles with the diaphragm and heart muscle being of particular importance. To date the only delivery system that is able to deliver to these tissues is AAV, with AAV serotype 9 showing the most promising delivery profile. Because a maximum of up to
5 kb of DNA can be packaged inside the AAV virus it is not possible to deliver SpCas9 and a guide or current SpCas9 derived base editors and a guide in a single AAV. While these larger systems can be split between two AAVs, this reduces potency due
to the dose limiting toxicity of AAV and the need to administer two viruses (effectively doubling the dose). A dual AAV approach also increases manufacturing complexity and costs. We are leveraging our collection of smaller editing systems that can
be packaged in a single AAV (currently three nucleases). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The potential therapeutic benefit of editing the DMD gene in mouse models will be assayed at the mRNA and
protein level, and by functional endpoints such as maximum force output. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><U>Cystic fibrosis </U></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Cystic fibrosis is an autosomal recessive lung disease caused by mutations in the CFTR gene. Mutations impact electrolyte transport in cells that produce mucus, sweat,
and digestive fluids causing these secretions to be thicker and more viscous than normal. As a result, these secretions become sticky and can clog passageways and ducts, particularly in the lung and pancreas. Over time, these thick mucus secretions
in the lung cause </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">196 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
chronic lung infections, inflammation, fibrosis and ultimately destructive bronchoalveolar lung disease resulting in progressive pulmonary failure. The pancreas is similarly affected and blockage
of ducts in the pancreas lead to loss of exocrine function and pancreatic insufficiency. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The overall incidence of cystic fibrosis is estimated at one patient in
3,000 to 6,000 live births in the US and Europe, but rates depend strongly on geographic location and ethnicity with higher rates in Caucasians of northern European descent and much lower rates in Asians. It is estimated that there are approximately
30,000 individuals living with cystic fibrosis in the US and 70,000 individuals worldwide. Over the past few decades, improvements in antibiotic treatments, supportive measures, multidisciplinary care centers, and newer targeted medications have
increased the overall life expectancy from late childhood to the fourth decade. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Limitations in Current Approaches </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">One of the challenges in developing precision medicines for cystic fibrosis is the large nature of the gene and the varied mutations along the gene that result in loss
of protein expression, loss of function, misfolding and mislocalization within the cell. Accordingly, therapeutic efforts have required individualized approaches tailored to certain mutations to improve CFTR function. Although such medications have
improved rates of lung function decline, not all patients have mutations amenable to CFTR targeted therapies. Further, none of these therapies offer a true cure to the underlying gene mutation, and patients continue to experience morbidity and
mortality from cystic fibrosis disease progression. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Our Approach/Next Steps </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our goal for a genome editing based treatment for cystic fibrosis is <FONT STYLE="white-space:nowrap">two-fold:</FONT> (1)&nbsp;a permanent curative therapy from a
single treatment, and (2)&nbsp;a therapy that is applicable to the majority of cystic fibrosis patients. We believe this could be achieved by integrating a functional version of the CFTR gene into the genome of the lung basal stem cells
(alternatively called bronchioalveolar stem cells). The basal stem cells are believed to give rise to the lung epithelial cells that are the site of CFTR expression that is defective in cystic fibrosis patients. Stem cells are a specialized
population of cells that are maintained for a person&#146;s lifetime and are the source for renewal of differentiated cells. Editing the stem cells should ensure that the introduced functional CFTR gene is not lost over time due to the shedding of
differentiated epithelial cells. By integrating a functional CFTR gene rather than correcting individual cystic fibrosis causing mutations, a single therapy could treat the majority of cystic fibrosis patients. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We intend to explore two of our genome editing modalities in cystic fibrosis. The Big RIGS technology and CAST systems both have the potential to integrate large pieces
of DNA (in this case encoding a CFTR gene) into a specific site in the genome. For the Big RIGS approach, the CFTR gene would be delivered as an RNA that is reverse transcribed into DNA to provide the DNA template for integration. In the case of
CAST, the CFTR gene would be delivered as double stranded DNA that is recognized by the CAST system and integrated at the desired site by the transposase. Delivery to the basal stem cells of the lungs can theoretically be achieved by IV dosing. We
may also evaluate a <FONT STYLE="white-space:nowrap">non-viral</FONT> delivery system for lung delivery. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We believe the Big RIGS system has the advantage that it
can be delivered using only RNA for which <FONT STYLE="white-space:nowrap">non-viral</FONT> RNA delivery technologies such as LNP are well established. In contrast, delivery of DNA (that would be required for CAST) by
<FONT STYLE="white-space:nowrap">non-viral</FONT> delivery vectors is not well established with the main barrier being transit of the DNA into the nucleus. However, in a preliminary study we have recently demonstrated delivery of a 4.6 kb double
stranded DNA to the nuclei of cells in the liver of mice by IV administered LNP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">197 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Cell Therapy Applications Using Our Platform </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Identifying and optimizing novel nucleases from our metagenomics platform has involved a series of stringent efficiency, activity, and specificity testing in a variety
of immune cell types which yields a comprehensive dataset that demonstrates our genome editing capabilities for cell therapy applications. Many cell therapies require multiple simultaneous genome edits to enhance efficacy, safety, and/or durability
of these products. In the allogeneic cell therapy setting, additional gene edits are required to decrease the immunogenicity of the cell therapies to prevent rejection by the host immune system. Our toolbox provides an important advantage compared
to the current cell therapy landscape as we are able to use either single or multiple genome editing enzymes to implement multiple gene edits (&#147;multiplex editing&#148;) with high efficiency and specificity. These gene edits could be either
knock outs or knock ins. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are currently working on various discovery stage projects in-house and with collaborators to evaluate the efficacy and specificity of
our enzymes for the engineering CAR-T and TCR-T cell product candidates. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our initial lead nucleases can be used to efficiently engineer primary human T&nbsp;cells,
demonstrating utility for cell therapy applications. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our programmable nucleases have achieved key requirements for T cell engineering, including genome editing
dsDNA-break induced <FONT STYLE="white-space:nowrap">knock-in</FONT> of a chimeric antigen receptor (CAR, Figure 43). </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><B>Figure 43</B>. Example of Two Lead Nucleases, Type II <FONT STYLE="white-space:nowrap">MG3-6</FONT> and Type V <FONT STYLE="white-space:nowrap">MG29-1,</FONT> Capable of Engineering Primary Human T Cells.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g425213g08c16.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Nucleases were delivered as RNP and CAR donor template by AAV.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Nucleases were programmed to target the
TRAC locus.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;CAR integration into T
cells from 10 T cell donors with <FONT STYLE="white-space:nowrap">MG3-6</FONT> and <FONT STYLE="white-space:nowrap">MG29-1</FONT> and either 5E4 or 1E5 MOI.</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7.5pt; font-family:arial">Data generated by Metagenomi.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">198 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our <FONT STYLE="white-space:nowrap">MG29-1</FONT> nuclease is a highly active and specific nuclease being used for
<I>ex vivo</I> T cell engineering in collaboration with Affini-T Therapeutics. <FONT STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics is developing a cell therapy based on engineering the TCR of T cells to recognize mutant KRAS for the
treatment of patients with solid tumors. <FONT STYLE="white-space:nowrap">Affini-T</FONT> scientists showed that the knock-out of the endogenous TCR improved expression of a transgenic TCR, and that <FONT STYLE="white-space:nowrap">MG29-1</FONT> can
be used to engineer functional TCR T&nbsp;cells by <FONT STYLE="white-space:nowrap">knock-in</FONT> of a transgene into the TRAC locus. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><B>Figure 44a</B>. <FONT STYLE="white-space:nowrap">MG29-1</FONT> tested in primary human CD4/CD8 T cells showed specificity in two loci.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Figure 44b</B>. Oligonucleotide capture in primary T cells identified putative <FONT STYLE="white-space:nowrap">MG29-1</FONT> <FONT STYLE="white-space:nowrap">off-targets.</FONT> More sensitive methods did not verify such
results.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g425213g77j52.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g425213g39m50.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;InDel formation was evaluated for 590 computationally predicted off-targets across TRAC and
TRBC, allowing for up to six mismatches.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Off-targets had <FONT STYLE="white-space:nowrap">100-fold</FONT> fewer barcodes compared with
target sites.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;Off-target sites could
not be validated with amplicon-based NGS sequencing.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:7.5pt; font-family:arial">*&#8195;&#8194;The presence of &gt;9 mismatches in the off-target sites may indicate that they are not likely to be true
positives.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Data generated by <FONT STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics.</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We plan to use our gene editing enzymes to engineer different T cell subsets with either chimeric antigen receptors (CARs) or engineered
TCRs targeting antigens expressed in various tumor indications, including hematological and solid tumor malignancies. We are currently investigating different tumor targets and tumor indications to select future T cell therapy product candidates. In
addition, we plan to use CAR-T cells in auto-immune diseases driven by the production of autoantibodies, including conditions such as systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis, autoimmune hemolytic anemia, immune-mediated
thrombotic thrombocytopenic purpura, and possibly others. We will use T cells engineered with chimeric antigen receptors against B cell markers to deplete the B cell compartment and eliminate the production of autoantibodies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">199 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Our License and Collaboration Agreements </U></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Moderna Strategic Collaboration and License Agreement </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On October 29,
2021, the effective date, we entered into a Strategic Collaboration and License Agreement (the &#147;Moderna Agreement&#148;) with Moderna. We will collaborate with Moderna on the research and development of <I>in vivo</I> genome editing therapies
directed at certain targets and the commercialization of such genome editing therapies. The collaboration provides Moderna with exclusive access to our technology platform during the research period in (1) the field of <I>in vivo</I> gene editing
technology for a therapeutic, ameliorative or prophylactic application by way of knock-out through InDel formation or base editing or insertion of an exogenous DNA template (such field, &#147;DT Field&#148;) and (2) the field of <I>in vivo</I> gene
editing technology for a therapeutic, ameliorative or prophylactic application outside the use of (a) DNA donor templates and (b) no exogenous template at all but including (c) correction by base editing (such field, &#147;RT Field&#148;). We formed
a joint steering committee, a joint research subcommittee and a joint patent subcommittee to oversee the collaboration activities. Each of us and Moderna must use commercially reasonable efforts to perform and complete our respective activities
under research plans and commercialization plans approved by the joint steering committee. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the terms of the Moderna Agreement, we and Moderna will collaborate
on one or more programs in the RT Field (the &#147;Moderna RT program&#148;) and two programs in the DT Field (the &#147;Moderna DT program&#148; and the &#147;DT Co-Co program&#148;). We and Moderna have each granted the other party a non-exclusive
license in such party&#146;s (i) background technology, including intellectual property rights controlled by each party related to each respective program, and (ii) the know-how and patents that come into control of each party relating to the
program and during the respective program term, in each case to carry out activities in the applicable research programs. We shall own certain intellectual property that relates to our technology platform (&#147;Metagenomi Program Technology&#148;).
Moderna shall own certain intellectual property that relates to Moderna&#146;s technology platform (&#147;Moderna Program Technology&#148;). Any intellectual property discovered, invented, conceived or created during an applicable research term that
is not Metagenomi Program Technology or Moderna Program Technology shall be jointly owned by us and Moderna. Further, we granted Moderna a perpetual, irrevocable, royalty-free, nonexclusive license under Metagenomi Program Technology to the extent
pertaining to the exploitation of donor templates or guides to which Moderna has any inventive contribution. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">With respect to the Moderna RT and Moderna DT programs,
we will collaborate on the research and development of product candidates under the approved research plans. The initial research term of the Moderna RT program is four years, which may be extended by Moderna for an additional three years upon
written notice and a payment of extension fees. The initial research term of the Moderna DT program is four years. We granted to Moderna an option to obtain an exclusive license to develop, manufacture and commercialize up to ten Moderna RT program
candidates and up to two Moderna DT program candidates at any time during the research term and prior to filing of an investigational new drug (&#147;IND&#148;) application with the Food and Drug Administration (&#147;FDA&#148;) or any similar
application filed with a regulatory authority in a country other than the United States (&#147;U.S.&#148;), subject to Moderna&#146;s payment of an option exercise fee of $10.0 million per target. If we or any of our affiliates wish to grant any
third party rights in certain targets in the DT Program prior to the earlier of the (a) second anniversary of the agreement or (b) 90 days after achievement of certain readiness standards, we shall provide Moderna with written notice thereof and
Moderna shall have a right of first negotiation to negotiate an agreement on the terms of a collaboration and license agreement for such targets. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">With respect to
the DT Co-Co program, we will work together with Moderna on the co-development and commercialization of products and share costs and profits equally. We granted Moderna a co-exclusive (with us and our affiliates) license under our patents and
know-how related to PH1, the DT Co-Co target, to exploit all applications </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">200 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
of such target in the DT Co-Co program. We maintain commercialization rights in the U.S. (subject to Moderna&#146;s right to appoint up to 50% of the U.S. sales force for the DT Co-Co program),
while Moderna maintains these rights in countries other than the U.S. The initial research term for the DT Co-Co program is four years, and each party has a right to opt-out of the DT Co-Co program at any time, at which point the other party has the
right to solely continue the development and commercialization activities, provided that the party which has opted-out shall have a right of first offer in the event that the other party wishes to grant a license or sublicense to a third party with
respect to the DT Co-Co program. If there is no development candidate nomination by the end of the initial research term, the DT Co-Co program will expire, unless we have mutually agreed to continue the program. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the year ended December 31, 2021, we received a non-refundable upfront payment of $40.0&nbsp;million and a $5.0 million payment for the first year of research
costs. Concurrent with the Moderna Collaboration Agreement, Moderna also provided $30.0 million in cash in the form of a convertible promissory note (see Note&nbsp;9 in our audited consolidated financial statements included elsewhere in this
prospectus) pursuant to a convertible promissory note agreement dated October 29, 2021 (the &#147;Moderna Convertible Promissory Note Agreement&#148;). The convertible promissory note was converted into shares of Series B redeemable convertible
preferred units in January 2022. Moderna will reimburse us up to $5.0 million in annual research and development costs related to the Moderna DT and Moderna RT programs, or up to the agreed amount of expenses per the budget. As of September&nbsp;30,
2023, we have received a total of $49.6&nbsp;million under the Moderna Collaboration Agreement, not including cost-sharing payments under the DT Co-Co program. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For
the Moderna RT and Moderna DT programs, we are eligible to receive (i) technology milestone fees related to the achievement of certain preclinical research objectives of up to $75.0 million, (ii) development and regulatory milestones of up to $100.0
million per target, (iii) sales milestones of up to $200.0 million per target, and (iv) royalties ranging from a mid-single digit to a low-teens percentage of annual net sales of a licensed product. Any profits and losses from the co-development and
commercialization of the DT Co-Co program are shared equally between us and Moderna. With respect to the DT Co-Co program for which the opt-out party has exercised its opt-out right, the continuing party will pay to the opt-out party, certain
development, regulatory and sales milestone payments that will not exceed an aggregate $239.0 million per DT Co-Co target, and opt-out royalties ranging from a high-single digit to a low-teens percentage of annual net sales of a licensed product.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of the Moderna Agreement will continue on a licensed product-by-licensed product and country-by-country basis, until the expiration of the applicable
royalty term. The royalty term commences on the first commercial sale of a licensed product and terminates on the latest of: (a) the expiration or abandonment of the last valid claim of a patent within the licensed Moderna DT or RT technology; (b)
10 years after the first commercial sale of a licensed product; and (c) expiration of the regulatory exclusivity. Upon the expiration of the term of a licensed product in the Moderna DT or Moderna RT program, the licenses granted to Moderna will
survive and become perpetual, fully paid and royalty-free. Each party may terminate the Moderna Agreement on a program-by-program basis upon written notice to the other party for an uncured material breach or insolvency. In lieu of termination for
our material breach, Moderna may, upon written notice, continue the agreement with respect to the relevant collaboration target at Moderna&#146;s amounts payable reduced by 50%, or in the case of a DT Co-Co-Target, Moderna may propose, subject to
arbitration, to adjust the profit and loss share for DT Co-Co Products to provide Moderna with an additional share of the net profits (not to exceed 75% of the total net profits). We may terminate the Moderna Agreement upon written notice to Moderna
for a patent challenge. Additionally, Moderna may terminate the agreement at its convenience with respect to Moderna DT or Moderna RT programs for any reason upon at least: (a) 60 days&#146; prior written notice if a first commercial sale has not
occurred for the products in such program, or (b) 180 days&#146; prior written notice if a first commercial sale of a product in such program has occurred. Upon termination, all licenses granted under the agreement with respect to the applicable
products under the agreement shall terminate, subject to an orderly wind-down period, provided that any permitted sublicense granted to a third party shall survive (provided such third party did not cause the termination through uncured material
breach). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">201 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Affini-T Development, Option and License Agreement </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On June 14, 2022, the effective date, we entered into a Development, Option and License Agreement (the &#147;Affini-T Agreement&#148;) with Affini-T. Pursuant to the
Affini-T Agreement, we and Affini-T have agreed to identify, develop or optimize certain reagents using our proprietary technology for Affini-T to use such reagents to develop and commercialize gene edited TCR-based therapeutic products exclusively
in the field of treatment, prevention or diagnosis of any human cancer using products with any engineered primary TCR alpha/beta T cells and <FONT STYLE="white-space:nowrap">non-exclusively</FONT> in the field of treatment, prevention or diagnosis
of any human cancer using products with certain other engineered immune cells worldwide. A joint steering committee was established by both parties to assign alliance managers and project leaders to oversee the collaboration activities. We must use
commercially reasonable efforts to perform and complete our obligations under research plans approved by the joint steering committee. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the Affini-T
Agreement, we granted Affini-T options to receive, on a pre-specified target-by-pre-specified target basis, for up to six pre-specified targets, either (i) an exclusive, royalty-bearing, sublicensable worldwide license under all of our applicable
intellectual property to research, develop, manufacture, use, commercialize and otherwise exploit any TCR-based therapy, preventative treatment, or diagnostic for humans that is directed to such pre-specified target, contains or comprises Primary
TCR alpha/beta T Cells and is derived from <I>ex vivo </I>application of our reagent (the &#147;Exclusive Option&#148;) or (ii) a non-exclusive, royalty-bearing, sublicensable worldwide license under all our applicable intellectual property to
research, develop, manufacture, use commercialize and otherwise exploit any TCR-based therapy, preventative treatment, or diagnostic for humans that is directed to such pre-specified target, contains or comprises TCR natural killer (&#147;NK&#148;)
cells derived from iPSC immune cells or TCR T cells derived from donor-derived or iPSC immune cells. Affini-T can exercise its options for either an exclusive license or a non-exclusive license, or both, for each pre-specified target by providing
written notice prior to the earlier of (x) the end of the Affini-T Agreement term or (y) 90&nbsp;days following the filing of an IND for a licensed product directed to a pre-specified target, subject to the payment of certain fees per each option
exercised. After the option exercise, Affini-T has agreed to use commercially reasonable efforts to conduct all development and commercialization activities for a licensed product, and development and commercialization of all licensed products will
be at Affini-T&#146;s sole cost and expense. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On a target-by-target basis, (1) until the earlier of Affini-T&#146;s (a) exercise of an Exclusive Option, (b) written
notice not to exercise an Exclusive Option or (c) expiration of an applicable Exclusive Option or (2) upon exercise of an Exclusive Option, we and our affiliates shall not exploit, or work with any third party to exploit, any <I>ex vivo</I> gene
edited products directed to the applicable target covered by such Exclusive Option. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with the Affini-T Agreement, we received upfront equity
consideration of 719,920 shares of Affini-T&#146;s common stock with an estimated fair value of $1.3&nbsp;million in June 2022. The fair value of Affini-T&#146;s shares of common stock was estimated by our management, considering the most recent
third-party valuation. Affini-T has also agreed to reimburse us for expenses incurred while performing research activities under the research plans. As of September&nbsp;30, 2023, we received a total of $3.2&nbsp;million from Affini-T related to
reimbursable expenses. Additionally, we are eligible to receive (i) 933,650 shares of Affini-T&#146;s common stock upon the achievement of a regulatory milestone, which is the earlier of a submission of a drug master file to the FDA or an acceptance
of an IND filing for a licensed product by the FDA, (ii) up to $18.8 million in future developmental milestone payments depending on the completion of or the number of patients dosed in, the relevant human clinical trial, or the initiation of a
pivotal trial, and $40.6 million in future regulatory approval milestone payments, which include regulatory approvals in the U.S. and other markets for licensed products directed to a pre-specified target if options for both exclusive and
non-exclusive licenses are exercised with respect to such target, (iii) up to $250.0 million in sales-based milestones for aggregate sales of all licensed products directed to a given pre-specified target and (iv) royalties ranging from a low-single
digit to high-single digit percentage of worldwide annual net sales of licensed products.</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The initial term of the Affini-T Agreement is five years from the effective
date. If Affini-T exercises an Exclusive Option with respect to any pre-specified target during the initial term, the initial term will be extended by an additional five years. Following the expiration of the extended term, if any, the agreement
will continue on a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">202 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
target-by-target basis and expire with respect to such target upon the expiration of the royalty term for all licensed products directed to such target. The Affini-T Agreement may be terminated
during the term by either party for an uncured material breach by, or bankruptcy of, the other party. Additionally, Affini-T may terminate the Affini-T Agreement for convenience, in its entirety, on a research plan-by-research plan basis, on a
target-by-target basis or on a licensed product-by-licensed product basis, by providing prior written notice. Upon a material breach and with written notice to us, in lieu of termination, Affini-T shall have the right to continue the agreement at
payments payable at a certain percentage reduction. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Ionis Collaboration and License Agreement </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On November 10, 2022, the effective date, we entered into a Collaboration and License Agreement (the &#147;Ionis Agreement&#148;) with Ionis to collaborate on drug
discovery and exploratory research activities to advance new medicines using gene editing strategies, with the goal of discovering novel medicines. Pursuant to the terms of the Ionis Agreement, we granted Ionis and its affiliates a worldwide
exclusive, royalty-bearing license, with the right to grant sublicenses, to use all licensed systems and licensed products in the field of <I>in vivo</I> gene editing for all therapeutic, prophylactic, palliative, and analgesic uses in humans. In
connection with the Ionis Agreement, we also have the right to exercise an exclusive option to co-develop and co-commercialize certain products under a drug discovery program. A joint steering committee was established by both parties to coordinate,
oversee, and monitor the research and drug discovery activities under the Ionis Agreement. Each party must use commercially reasonable efforts to perform and complete its respective activities under the applicable program plans approved by the joint
steering committee. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We will collaborate to discover therapeutic products under a drug discovery program and develop a drug discovery plan for each target, selected
by Ionis. The target selection is divided into two waves: up to four targets in Wave 1 and up to four targets in Wave 2. For each drug discovery program, once the parties identify a development candidate that is suitable for further development,
Ionis will be responsible for the development and commercialization of products resulting from such program. Per the terms of the Ionis Agreement, at any time prior to the designation of a development candidate for a drug discovery program and for
any reason, Ionis may replace the collaboration target, provided such target has not previously been substituted out. Ionis may substitute (i) up to two Wave 1 targets and (ii) up to two Wave 2 targets. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The drug discovery activities for a program commence on the selection of a target and expire upon the earlier of (a)&nbsp;completion of all drug discovery activities for
such program, (b) the fifth anniversary of the effective date and (c)&nbsp;selection of a development candidate for such drug discovery program. If one or more Wave 2 targets become collaboration targets as a result of the parties achieving enabled
delivery and less than two years are remaining in the drug discovery term, then the term will be extended to the earlier of (i) the time that we complete all of our activities under the applicable drug discovery plan and (ii) the seventh anniversary
of the effective date, subject to our consent. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We will also conduct an exploratory research program, and will jointly optimize gRNA and select delivery technologies
and other activities. The exploratory research activities commence on the effective date and expire upon the earlier of (a) completion of all exploratory research activities established in the exploratory research plan, and (b) the fifth anniversary
of the effective date. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have the exclusive option to co-develop and co-commercialize the licensed products under a drug discovery program (the &#147;Co-Co
Option&#148;) with Ionis. The Co-Co Option may be exercised for (a) the initial Wave 1 target (&#147;Target 1&#148;), (b) no more than one of the other three discovery programs for the Wave 1 targets, and (c)&nbsp;no more than two drug discovery
programs for the Wave 2 targets that become collaboration targets. If we exercise the Co-Co Option for a particular drug discovery program, that drug discovery program will automatically be deemed a &#147;Co-Co Program&#148;, all corresponding
licensed products be deemed &#147;Co-Co Products,&#148; we will be obligated to pay Ionis an option exercise fee, and we and Ionis will enter into a separate co-development and co-commercialization agreement. The Co-Co Option exercise fee will equal
50% of Ionis&#146; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">203 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
internal costs and out-of-pocket costs incurred in the conduct of the drug discovery activities prior to the exercise of the Co-Co Option and be reduced by 50% of our corresponding costs
incurred. Future development and commercialization costs will be shared equally. We may elect to reduce our cost-share percentage anywhere between 50% and 25% on a go-forward basis, provided we will continue to bear 50% of the costs of any clinical
trials ongoing at the time of the election through the completion of the clinical trials. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We will manufacture all licensed systems and certain components of the
applicable licensed products that are needed by Ionis for use in its development activities and all of our manufactured components needed by Ionis for use in its commercialization activities. We will provide the manufactured components at a price
that represents the cost of goods plus 15%. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the terms of the Ionis Agreement, we have also been granted an option to obtain a non-exclusive,
royalty-bearing license, with the right to grant sublicenses, for certain Ionis&#146; background technology to use in up to eight therapeutic products discovered by us in the field of <I>in vivo</I> gene editing and directed to a Collaboration
Target (each such product, a &#147;Metagenomi Product&#148; and each such option an &#147;Ionis IP Option&#148;), but subject to encumbrance checks with respect to particular targets. A Collaboration Target is a target that is selected by Ionis,
and, with respect to us, is not the subject of discussions with a third party, is not the subject of a contractual grant of rights to a third party nor the subject of an internal research and development program. If we exercise our Ionis IP Option,
we will pay to Ionis up to several million dollars per Metagenomi Product upon achievement of certain clinical and regulatory milestones. We are also obligated to pay Ionis royalties in an amount equal to a low single-digit royalty on the net sales
of the applicable Metagenomi Product on <FONT STYLE="white-space:nowrap">product-by-product</FONT> and country-by-country basis. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In November 2022, we received an
$80.0 million upfront payment from Ionis for the Wave 1 drug discovery research collaboration and selected Target 1. Ionis selected its second target (&#147;Target 2&#148;) in Wave 1 in December 2022 and its third target (&#147;Target 3&#148;) in
Wave 1 in November 2023. In November 2023, we agreed to extend the period during which we expect Ionis will select its fourth target (&#147;Target 4&#148;) in Wave 1 by an additional three months from the 12-month anniversary of the effective date,
as permitted under the arrangement. Ionis has an option to select up to four Wave 2 targets at any time during the drug discovery term, if (a) an IND for any licensed product directed to a Wave 1 target is filed with the applicable regulatory
authority or (b) the parties achieve enabled delivery for a non-liver target under the exploratory research activities, by providing written notice and by paying a Wave&nbsp;2 target selection fee of $15.0 million or $30.0 million, depending on and
per the selected target. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Ionis is obligated to reimburse us for all internal costs and out-of-pocket costs incurred in the performance of the exploratory research
activities, up to an aggregate of $10.0 million, which is payable in quarterly installments of $0.5&nbsp;million during the exploratory research term. As of September&nbsp;30, 2023, we received a total of $1.5&nbsp;million related to the
reimbursable expenses. We are also eligible to receive (a)&nbsp;up to $29.0&nbsp;million in future development milestone payments for each licensed product; (b)&nbsp;up to $60.0&nbsp;million in future regulatory milestone payments for each licensed
product; (c)&nbsp;up to $250.0 million in sales-based milestones for each licensed product; and (d)&nbsp;royalties on annual net sales of licensed products from a mid-single-digit to <FONT STYLE="white-space:nowrap">low-teens</FONT> percentage,
subject to customary reductions.</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of the Ionis Agreement will continue (i) with respect to the drug discovery programs, until the expiration of all
applicable royalty terms for a licensed product, (ii) with respect to the Co-Co Programs, until the parties cease all exploitation for the Co-Co Products that are the subject to such Co-Co Program, and (iii)&nbsp;with respect to the Metagenomi
Products, until the expiration of the royalty term for a Metagenomi Product. The royalty term ends on the latest of the following two dates: (i) the expiration of (A) the last claim of any issued and unexpired patent, or (B) a claim within a patent
application that has not been pending for more than seven years from the earliest date to which the claim or applicable patent application is entitled to claim priority and which claim has not been revoked, cancelled, withdrawn, held invalid, or
abandoned, or (ii) 12&nbsp;years following the first commercial sale of a licensed product. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">204 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Ionis Agreement may be terminated during the term by either party for an uncured material breach or bankruptcy by
the other party. Additionally, Ionis may terminate the Ionis Agreement for convenience and without penalty, in its entirety or on a licensed product-by-licensed product basis, by providing 90 days&#146; written notice. Upon termination, Ionis will
transfer to us ownership of all regulatory approvals, and all licenses granted under the agreement with respect to the applicable products under the agreement shall terminate, subject to an orderly wind-down period and a right for Ionis to sell or
otherwise dispose of applicable products on hand at the time of such termination. Upon our written request within 30 days following termination, Ionis will grant us an exclusive, royalty-bearing (as agreed by the parties at such time), right and
license, with the right to grant sublicenses through multiple tiers, to patent rights and know-how controlled by Ionis and used in the development, commercialization, or exploitation of terminated products, solely for the exploitation of such
terminated products in the terminated countries. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Competition </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
pharmaceutical and biotechnology industries, including the gene therapy and genome editing fields, are characterized by rapidly advancing technologies, intense competition, and a reliance on strong intellectual property. We believe our metagenomics
powered discovery platform along with our expertise in genome editing, drug discovery, clinical development, manufacturing and our ever-increasing IP portfolio, provide us with several key competitive advantages over our peers. Despite our
competitive advantages, we face competition from several companies. There are numerous publicly traded companies utilizing CRISPR/Cas nuclease technology, including Caribou Biosciences, Inc., Editas Medicine, Inc., CRISPR Therapeutics AG, Intellia
Therapeutics, Inc., and Graphite Bio, Inc., among others. Beam Therapeutics Inc. and Verve Therapeutics, Inc. utilize base editing technology and Prime Medicine utilizes prime editing technology. Several other companies such as Sangamo Therapeutics,
Inc., Precision BioSciences, Inc., Cellectis S.A., and bluebird bio, Inc. utilize first-generation nuclease-based genome editing technologies, including ZFNs, engineered meganucleases and TALENs. We also face competition from companies utilizing
gene therapy, oligonucleotides, and <FONT STYLE="white-space:nowrap">CAR-T</FONT> therapeutic approaches. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There are several other private companies such as Arbor
Biotech, Chroma Medicine, Inc., Mammoth Biosciences, Scribe Therapeutics, Tessera Therapeutics, Tome Biosciences, and Tune Therapeutics, Inc. that have announced they are working on genome- and epigenome-editing therapies. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any product candidates that we successfully develop and commercialize will compete with existing therapies and new therapies that may become available in the future that
are approved to treat the same diseases for which we may obtain approval for our product candidates. This may include other genome editing companies using antiquated or next generation genome editing approaches or other types of therapies, such as
small molecule, antibody, and/or protein therapies. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, many of our current or potential competitors, either alone or with their collaboration partners,
have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials and approved products than we do today. Mergers and acquisitions in the pharmaceutical,
biotechnology and gene therapy industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through
collaborative arrangements with large and established companies. We also compete with these companies in recruiting, hiring, and retaining qualified scientific and management talent, establishing clinical trial sites and patient registration for
clinical trials, obtaining manufacturing slots at contract manufacturing organizations. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, particularly if
they represent cures, have fewer or less severe side effects, are more convenient, or are less expensive than </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">205 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
any products that we may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our
competitors establishing a strong market position before we are able to enter the market. The key competitive factors affecting the success of all of our programs are likely to be their efficacy, safety, convenience, and availability of
reimbursement. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Manufacturing </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our genome editing technology is
composed of multiple genome editing components including the nuclease, mRNA, gRNA, and in some instances may include a donor DNA or RNA template for insertions. We have extensively characterized each of these components and have made significant
investment in scalable manufacturing and process automation to meet stringent current good manufacturing practices (&#147;cGMP&#148;). Our <FONT STYLE="white-space:nowrap">in-house</FONT> cGMP facility is capable of manufacturing clinical grade
nucleases and mRNA to supply both wholly-owned and collaboration programs. We partner with contact manufacturing organizations (&#147;CMOs&#148;) for gRNA and DNA template development and supply and continue to invest in both viral and <FONT
STYLE="white-space:nowrap">non-viral</FONT> delivery technologies internally and with partners. We believe our ability to develop, characterize, and manufacture complex human genome editing components is essential to maintaining a competitive edge
while pursuing a successful regulatory pathway for genetic medicine. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Intellectual Property </U></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our success depends in large part upon our ability to obtain and maintain our technology and intellectual property. To protect our intellectual property rights, we
primarily rely on patents and trade secret laws, confidentiality procedures, and employee disclosure and invention assignment agreements. Our intellectual property is critical to our business and we strive to protect it through a variety of
approaches, including by obtaining and maintaining patent protection in various countries for our genome editing technology and other inventions that are important to our business. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Patents have a limited lifespan. In the United States, the natural expiration of a patent is generally 20 years from its earliest U.S.
<FONT STYLE="white-space:nowrap">non-provisional</FONT> filing date. The time required for development, testing, and regulatory review of our genome editing systems limits the commercially useful lifespan of our patents. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The patent positions of companies like ours are generally uncertain and involve complex legal and factual questions. No consistent policy regarding the scope of
patentable claims in the field of genome editing has emerged, for example, in the United States and in Europe. Changes in the patent laws and rules, either by legislation, judicial decisions, or regulatory interpretation may diminish our ability to
protect our inventions and enforce our intellectual property rights. These changes could affect the scope and value of our intellectual property. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Filing,
prosecuting, enforcing, and defending patents protecting our genome editing systems in all countries throughout the world would be prohibitively expensive. We cannot seek patent protection for our genome editing systems throughout the world.
Furthermore, the intellectual property rights we obtain in some countries outside the United States can be less extensive than those obtained in the United States. The requirements for patentability may differ in certain countries, particularly in
developing countries; thus, even in countries where we do pursue patent protection, there can be no assurance that any patents will issue with claims that cover our products. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our ability to stop third parties from infringing any of our patented inventions, either directly or indirectly, will depend in part on our success in obtaining,
defending, and enforcing patent claims that cover our genome editing systems. We cannot be sure that any patents will be granted with respect to any of our pending patent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">206 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
applications or with respect to any patent applications filed by us in the future. We cannot be sure that any of our existing patents or any patents that may be granted to us in the future will
be found by a court to be enforceable. Protecting our competitive position around our genome editing systems may involve lawsuits to enforce our patents or other intellectual property, which is expensive and time consuming, and may ultimately be
unsuccessful. Furthermore, our issued patents and those that may issue in the future may be challenged, narrowed, circumvented, or invalidated, which could limit our ability to stop competitors from marketing related genome editing systems or limit
the length of the term of patent protection that we may have for our genome editing systems and future gene therapies. We cannot be sure that any of our existing patents or any patents that may be granted to us in the future will be useful in
protecting our commercialized genome editing systems. The rights granted under any issued patents may not provide us with complete protection or competitive advantages against competitors with similar but not identical technology or technologies
that achieve similar outcomes but with different approaches. For these reasons, we may have competition for our genome editing systems. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our issued patents and those
that may issue in the future do not guarantee us the right to practice our genome editing systems. Third parties may have issued patents or be granted patents in the future that could block our ability to commercialize our genome editing systems.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We and third parties rely on trade secrets to protect certain aspects of our genome editing systems. If we are unable to protect the confidentiality of our trade
secrets, our competitive position could be harmed. Furthermore, reliance on trade secrets does not prevent third parties from independently inventing those aspects of our genome editing systems. While we take commercially reasonable steps to ensure
that our employees do not use the trade secrets of third parties, third parties may file claims asserting that we or our employees have misappropriated their trade secret. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For this and other risks related to our technology, inventions, improvements, platforms, and genome editing technology, please see the section entitled &#147;Risk
Factors&#151;Risks Related to Our Intellectual Property.&#148; </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Patent Portfolio </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September&nbsp;30, 2023, we own three issued U.S. patents, 15 pending U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications, 36 pending
U.S. provisional patent applications, six issued foreign patents in Great Britain, Hong Kong, Mexico and Australia, 94 pending foreign patent applications, including in Australia, Canada, China, Europe, Great Britain, Hong Kong, India, Japan, Korea,
Mexico and Brazil, and 20 Patent Cooperation Treaty (&#147;PCT&#148;) patent applications. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The patent portfolios for our genome editing systems as of
September&nbsp;30, 2023 are summarized below. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our type II CRISPR systems are protected by two issued U.S. patents with composition of matter claims covering genome
editing systems using Type II nucleases, four pending U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications with composition of matter claims covering genome editing systems using Type II nucleases and methods of using
them, and one pending U.S. provisional patent application with composition of matter claims covering genome editing systems using Type II nucleases and methods of using them. Our type II CRISPR systems are also protected by three issued foreign
patents with composition of matter claims covering genome editing systems using Type II nucleases, including in Great Britain, Australia and Mexico, 25 pending foreign patent applications with composition of matter claims covering genome editing
systems using Type II nucleases and methods of using them, including in Australia, Canada, China, Europe, Great Britain, Hong Kong, India, Japan, Korea, Mexico, and Brazil, and two PCT patent applications with composition of matter claims covering
genome editing systems using Type II nucleases and methods of using them. The aforementioned issued US patents will expire on February&nbsp;14, 2040, and the issued foreign patents will expire on February&nbsp;14, 2040. If issued, the aforementioned
patent applications are expected to expire between February&nbsp;14, 2040 and May&nbsp;6, 2041. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">207 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our type V CRISPR systems are protected by one issued U.S. patent and two pending U.S.
<FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications with composition of matter claims covering genome editing systems using Type V nucleases and one pending U.S. provisional patent application with composition of matter
claims covering genome editing systems using Type V nucleases and methods of using them. Our type V CRISPR systems are also protected by two issued foreign patents with composition of matter claims covering genome editing systems using Type V
nucleases, including in Great Britain and Hong Kong, 11 pending foreign patent applications with composition of matter claims covering genome editing systems using Type V nucleases and methods of using them, including in Australia, Brazil, Canada,
China, Europe, Great Britain, Hong&nbsp;Kong, India, Japan, South Korea, and Mexico, and two PCT patent applications with composition of matter claims covering genome editing systems using Type V nucleases and methods of using them. If issued, the
aforementioned patent applications are expected to expire between March&nbsp;6, 2041 and July&nbsp;29, 2043. The aforementioned issued foreign patents will expire on March&nbsp;6, 2041. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our base editor systems are protected by four pending U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications with composition of matter claims
covering genome editing systems using nucleases and base editors and methods of using them, and two pending U.S. provisional patent applications with composition of matter claims covering genome editing systems using nucleases and base editors and
methods of using them. Our base editor systems are also protected by 12 pending foreign patent applications with composition of matter claims covering genome editing systems using nucleases and base editors and methods of using them, including in
Australia, Canada, China, Europe, Great Britain, Hong&nbsp;Kong, India, Japan, Korea, Mexico, and Brazil, and one PCT patent applications with composition of matter claims covering genome editing systems using nucleases and base editors and methods
of using them. If issued, the aforementioned patent applications are expected to expire on September&nbsp;10, 2041. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our CAST systems are protected by two pending
U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications with composition of matter claims covering genome editing systems using nucleases in combination with either recombinases or transposases and methods of using them, and
one pending U.S. provisional patent application with composition of matter claims covering genome editing systems using nucleases in combination with either recombinases or transposases and methods of using them. Our CAST systems are also protected
by 20 pending foreign patent applications with composition of matter claims covering genome editing systems using nucleases in combination with either recombinases or transposases and methods of using them, including in Australia, Brazil, Canada,
China, Europe, Great Britain, Hong Kong, India, Japan, South Korea, and Mexico, and two PCT patent applications with composition of matter claims covering genome editing systems using nucleases in combination with either recombinases or transposases
and methods of using them. If issued, the aforementioned patent applications are expired to expire between August&nbsp;23, 2041 and March&nbsp;23, 2043. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our Cas
chimera systems are protected by one pending U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application with composition of matter claims covering genome editing systems using chimeric nucleases and methods of using them. Our
Cas chimera systems are also protected by one issued foreign patent in Great Britain and ten pending foreign patent applications, including in Australia, Brazil, Canada, China, Europe, India, Japan, South Korea, Mexico and Hong Kong with composition
of matter claims covering genome editing systems using chimeric nucleases, one PCT patent application with composition of matter claims covering genome editing systems using chimeric nucleases and two PCT patent applications with composition of
matter claims covering genome editing systems using chimeric nucleases and methods of using them. If issued, the aforementioned patent applications are expected to expire on January&nbsp;21, 2042. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our SMART nuclease systems are protected by two pending U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications with composition of matter
claims covering genome editing systems using small nucleases, and one pending U.S. provisional patent application with composition of matter covering genome editing systems using small nucleases and methods of using them. Our SMART nuclease systems
are also protected by 10 pending foreign </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">208 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
patent applications with composition of matter covering genome editing systems using small nucleases and methods of using them, including in Australia, Canada, China, Europe, Great Britain, Hong
Kong, India, Japan, Korea, and Mexico, and two PCT patent applications with composition of matter claims covering genome editing systems using small nucleases and methods of using them. If issued, the aforementioned patent applications are expected
to expire on March&nbsp;31, 2040. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We cannot predict whether the patent applications we pursue or may license in the future will issue as patents in any particular
jurisdiction or whether the claims of any issued patents will provide any protection from competitors. Even if our pending patent applications are granted as issued patents, those patents, as well as any patents we may license in the future from
third parties now or in the future, may be challenged, circumvented or invalidated by third parties. Consequently, we may not obtain or maintain adequate patent protection for any of our programs and genome editing systems. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, the patent
term is 20 years from the earliest date of filing of a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application. In the United States, the patent term of a patent may be extended by patent term adjustment, which compensates the
patent owner for patent office delays. Additionally, in the United States, patents that cover an <FONT STYLE="white-space:nowrap">FDA-approved</FONT> drug or biologic may also be eligible for patent term extension, which permits patent term
restoration as compensation for the patent term lost during FDA regulatory review process. The Hatch-Waxman Act permits a patent term extension of up to five years beyond the expiration of the patent. The length of the patent term extension is
related to the length of time the drug or biologic is under regulatory review. Patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent applicable to an approved
drug or biologic may be extended and only those claims covering the approved drug or biologic, a method for using it, or a method for manufacturing it may be extended. Similar provisions are available in European Member States and other foreign
jurisdictions to extend the term of a patent that covers an approved drug or biologic. In the future, if our investigational gene therapies receive FDA approval, we expect to apply for patent term extensions where applicable on patents covering
those products. We plan to seek patent term extensions to any of our issued patents in any jurisdiction where these are available, however there is no guarantee that the applicable authorities, including the U.S. Patent and Trademark Office
(&#147;USPTO&#148;) in the United States, will agree with our assessment of whether these extensions should be granted, and if granted, the length of these extensions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our intellectual property is critical to our business and we strive to protect it through a variety of approaches, including by obtaining and maintaining patent
protection in various countries for our genome editing technology and other inventions that are important to our business. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Trademarks </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September&nbsp;30, 2023, we own the trademark registrations for Metagenomi in the United States. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Trade Secrets and Proprietary Information </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to our reliance on
patent protection for our inventions, investigational gene therapies and research programs, we also rely on trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> confidentiality agreements and continuing technological innovation to
develop and maintain our competitive position. Although we take steps to protect our proprietary information and trade secrets, including through contractual means with our employees, advisors and consultants, these agreements may be breached and we
may not have adequate remedies for any breach. In addition, third parties may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets or disclose our technology. As a
result, we may not be able to meaningfully protect our trade secrets. It is our policy to require our employees, consultants, outside </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">209 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
scientific collaborators, sponsored researchers and other advisors to execute confidentiality agreements upon the commencement of employment or consulting relationships with us. These agreements
provide that all confidential information concerning our business or financial affairs developed or made known to the individual or entity during the course of the party&#146;s relationship with us is to be kept confidential and not disclosed to
third parties except in specific circumstances. In the case of employees, the agreements provide that all inventions conceived of by the individual during the course of employment, and which relate to or are reasonably capable or being used in our
current or planned business or research and development are our exclusive property. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of our technology by
third parties. However, such agreements and policies may be breached and we may not have adequate remedies for such breaches. For more information regarding the risks related to our intellectual property, see &#147;Risk Factors&#151;Risks Related to
Our Intellectual Property.&#148; </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Government Regulation </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the
United States, biological products, including gene therapy products, are subject to regulation under the Federal Food, Drug, and Cosmetic Act (&#147;FD&amp;C Act&#148;), and the Public Health Service Act (&#147;PHS Act&#148;), and other federal,
state, local and foreign statutes and regulations. Both the FD&amp;C Act and the PHS Act and their corresponding regulations govern, among other things, the research, development, clinical trial, testing, manufacturing, safety, efficacy, labeling,
packaging, storage, record keeping, distribution, reporting, advertising, and other promotional practices involving biological products. Each clinical trial protocol for a gene therapy product must be reviewed by the FDA. FDA approval must be
obtained before the marketing of biological products. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local and foreign statutes and regulations require the expenditure of substantial time
and financial resources and we may not be able to obtain the required regulatory approvals. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>U.S. Biological Product Development Process </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The process required by the FDA before a biological product candidate may be marketed in the United States generally involves the following: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">completion of nonclinical laboratory tests and animal studies according to good laboratory practices (&#147;GLPs&#148;),
unless justified and applicable requirements for the humane use of laboratory animals or other applicable regulations; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">submission to the FDA of an application for an IND, which must become effective before human clinical trials may begin;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">approval of the protocol and related documentation by an independent institutional review board (&#147;IRB&#148;), or
ethics committee at each clinical trial site before each study may be initiated; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">performance of adequate and well-controlled human clinical trials according to the FDA&#146;s regulations commonly referred
to as good clinical practices (&#147;GCPs&#148;), and any additional requirements for the protection of human research subjects and their health information, to establish the safety and efficacy of the proposed biological product for its intended
use; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">submission to the FDA of a biologics license application (&#147;BLA&#148;), for regulatory approval that includes
sufficient evidence of establishing the safety, purity and potency of the proposed biological product for its intended indication, including from results of nonclinical testing and clinical trials; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">210 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">satisfactory completion of an FDA inspection of the manufacturing facility or facilities where the biological product is
produced to assess compliance with cGMP, to assure that the facilities, methods and controls are adequate to preserve the biological product&#146;s identity, strength, quality and purity and, if applicable, the FDA&#146;s current good tissue
practices (&#147;CGTPs&#148;), for the use of human cellular and tissue products; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">potential FDA audit of the nonclinical study and clinical trial sites that generated the data in support of the BLA in
accordance with any applicable expedited programs or designations; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">review of the product candidate by an FDA advisory committee, where appropriate or if applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">payment of user fees for FDA review of the BLA (unless a fee waiver applies); and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">FDA review and approval, or licensure, of the BLA. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Before testing any biological product candidate, including a gene therapy product, in humans, the product candidate enters the preclinical testing stage. Preclinical
tests, also referred to as nonclinical studies, include laboratory evaluations of product biological characteristics, chemistry, toxicity, and formulation, as well as animal studies to assess the potential safety and activity of the product
candidate. The conduct of the preclinical tests must comply with federal regulations and requirements including GLPs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">An IND is an exemption from the FD&amp;C Act
that allows an investigational product candidate to be shipped in interstate commerce for use in a clinical trial and a request for FDA authorization to administer such investigational product candidate to humans. Such authorization must be secured
prior to interstate shipment and administration of any product candidate that is not the subject of an approved BLA. In support of a request for an IND, applicants must submit a protocol for each clinical trial and any subsequent protocol amendments
must be submitted to the FDA as part of the IND. In addition, the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and plans for clinical trials, among other
things, must be submitted to the FDA as part of an IND. The FDA requires a <FONT STYLE="white-space:nowrap">30-day</FONT> waiting period after the filing of each IND before clinical trials may begin. This waiting period is designed to allow the FDA
to review the IND to determine whether human research subjects will be exposed to unreasonable health risks. At any time during this <FONT STYLE="white-space:nowrap">30-day</FONT> period the FDA may raise concerns or questions about the conduct of
the trials as outlined in the IND and impose a clinical hold or partial clinical hold. In this case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical trials can begin. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Following commencement of a clinical trial, the FDA may also place a clinical hold or partial clinical hold on that trial. A clinical hold is an order issued by the FDA
to the sponsor to delay a proposed clinical investigation or to suspend an ongoing investigation. A partial clinical hold is a delay or suspension of only part of the clinical work requested under the IND. No more than 30 days after imposition of a
clinical hold or partial clinical hold, the FDA will provide the sponsor a written explanation of the basis for the hold. Following issuance of a clinical hold or partial clinical hold, an investigation may only resume after the FDA has notified the
sponsor that the investigation may proceed. There also are requirements governing the reporting of ongoing clinical trials and completed clinical trial results to public registries. Information about certain clinical trials, including clinical trial
results, must be submitted within specific timeframes for publication on the www.clinicaltrials.gov website. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A sponsor may choose, but is not required, to conduct a
foreign clinical trial under an IND. When a foreign clinical trial is conducted under an IND, all FDA IND requirements must be met unless waived. When a foreign clinical trial is not conducted under an IND, the sponsor must ensure that the study
complies with certain regulatory requirements of the FDA in order to use the study as support for an IND or application for regulatory approval or licensing. In particular, such studies must be conducted in accordance with GCP, including review and
approval by an independent ethics committee (&#147;IEC&#148;), and informed consent from subjects. The FDA must be able to validate the data through an onsite inspection, if deemed necessary by the FDA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">211 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">An IRB representing each institution participating in the clinical trial must review and approve the plan for any
clinical trial before it commences at that institution, and the IRB must conduct continuing review and reapprove the study at least annually. The IRB must review and approve, among other things, the study protocol and informed consent information to
be provided to study subjects. An IRB must operate in compliance with FDA regulations. An IRB can suspend or terminate approval of a clinical trial at its institution, or an institution it represents, if the clinical trial is not being conducted in
accordance with the IRB&#146;s requirements or if the product candidate has been associated with unexpected serious harm to patients. Some trials are overseen by an independent group of qualified experts organized by the trial sponsor, known as a
data safety monitoring board or committee (&#147;DSMB&#148;). This group provides authorization as to whether or not a trial may move forward at designated check points based on access that only the group maintains to available data from the study.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to the submission of an IND to the FDA before initiation of a clinical trial in the United States, certain human clinical trials involving recombinant
or synthetic nucleic acid molecules may be subject to oversight of institutional biosafety committees (&#147;IBCs&#148;), as set forth in the National Institutes of Health (&#147;NIH&#148;), Guidelines for Research Involving Recombinant or Synthetic
Nucleic Acid Molecules (&#147;NIH Guidelines&#148;). Under the NIH Guidelines, recombinant and synthetic nucleic acids are defined as: (i)&nbsp;molecules that are constructed by joining nucleic acid molecules that can replicate in a living cell
(i.e., recombinant nucleic acids); (ii) nucleic acid molecules that are chemically or by other means synthesized or amplified, including those that are chemically or otherwise modified but can base pair with naturally occurring nucleic acid
molecules (i.e., synthetic nucleic acids); or (iii)&nbsp;molecules that result from the replication of those described in (i)&nbsp;or (ii). Specifically, under the NIH Guidelines, supervision of human gene transfer trials includes evaluation and
assessment by an IBC, a local institutional committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid molecules at that institution. The IBC assesses the safety of the research and identifies any potential risk to
public health or the environment, and such review may result in some delay before initiation of a clinical trial. While the NIH Guidelines are not mandatory unless the research in question is being conducted at or sponsored by institutions receiving
NIH funding for recombinant or synthetic nucleic acid molecule research, many companies and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Clinical trials typically are conducted in three sequential phases that may overlap or be combined: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Phase 1. The biological product candidate is initially introduced into healthy human subjects and tested for safety. In the
case of some biological product candidates for severe or life-threatening diseases, especially when the product candidate may be too inherently toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in
patients. </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Phase 2. The biological product candidate is evaluated in a limited patient population to identify possible adverse effects
and safety risks, to preliminarily evaluate the efficacy of the product candidate for specific targeted diseases and to determine dosage tolerance, optimal dosage and dosing schedule. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Phase 3. Clinical trials are undertaken to further evaluate dosage, clinical efficacy, potency and safety in an expanded
patient population at geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the product candidate and provide an adequate basis for approval and product labeling.
</P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Post-approval clinical trials, sometimes referred to as Phase&nbsp;4 clinical trials, may be conducted after initial regulatory approval. These
clinical trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication, particularly for long-term safety <FONT STYLE="white-space:nowrap">follow-up.</FONT> The FDA generally recommends that
sponsors&nbsp;of human gene therapy product candidates and genome editing product candidates observe subjects for potential gene therapy-related delayed adverse events for up to a <FONT STYLE="white-space:nowrap">15-year</FONT> period, including
five years of annual examinations followed by ten years of annual queries, either by telephone or by questionnaire, of study subjects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">212 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During all phases of clinical development, the FDA requires extensive monitoring and auditing of all clinical
activities, clinical data, and clinical trial investigators. Annual progress reports detailing the results of the clinical trials must be submitted to the FDA. Written IND safety reports must be promptly submitted to the FDA and the investigators
for serious and unexpected suspected adverse events, any findings from other studies, tests in laboratory animals or<I>&nbsp;in vitro</I>&nbsp;testing that suggest a significant risk for human subjects, or any clinically important increase in the
rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must submit an IND safety report within 15 calendar days after the sponsor determines that the information qualifies for reporting.
The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction within seven calendar days after the sponsor&#146;s initial receipt of the information. The FDA or the sponsor, acting on its own or based on
a recommendation from the sponsor&#146;s data safety monitoring board may suspend a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Similarly, an IRB can
suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#146;s requirements or if the biological product candidate has been associated with unexpected serious harm
to patients. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Concurrent with clinical trials, companies usually complete additional animal studies and also must develop additional information about the physical
characteristics of the biological product candidate as well as finalize a process for manufacturing the product candidate in commercial quantities in accordance with cGMP. To help reduce the risk of the introduction of adventitious agents with use
of biological product candidates, the PHS Act emphasizes the importance of manufacturing control for product candidates whose attributes cannot be precisely defined. The manufacturing process must be capable of consistently producing quality batches
of the product candidate and, among other things, the sponsor must develop methods for testing the identity, strength, quality, potency, and purity of the final biological product. Additionally, appropriate packaging must be selected and tested and
stability studies must be conducted to demonstrate that the biological product candidate does not undergo unacceptable deterioration over its shelf life. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>U.S.
Review and Approval Processes </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">After the completion of clinical trials of a biological product candidate, FDA approval of a BLA must be obtained before
commercial marketing of the biological product. The BLA must include results of product development, laboratory and animal studies, human studies, information on the manufacture and composition of the product, proposed labeling and other relevant
information. The testing and approval processes require substantial time and effort and there can be no assurance that the FDA will accept the BLA for filing and, even if filed, that any approval will be granted on a timely basis, if at all. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Within 60 days following submission of the application, the FDA reviews a BLA to determine if it is substantially complete before the FDA accepts it for filing. The FDA
may refuse to file any BLA that it deems incomplete or not properly reviewable at the time of submission and may request additional information. In this event, the BLA must be resubmitted with the additional information. The resubmitted application
also is subject to review before the FDA accepts it for filing. In most cases, the submission of a BLA is subject to a substantial application user fee, although the fee may be waived under certain circumstances. Under the performance goals and
policies implemented by the FDA under the Prescription Drug User Fee Act (&#147;PDUFA&#148;), for original BLAs, the FDA targets ten months from the filing date in which to complete its initial review of a standard application and respond to the
applicant, and six months from the filing date for an application with priority review. The FDA does not always meet its PDUFA goal dates, and the review process is often significantly extended by FDA requests for additional information or
clarification. This review typically takes 12 months from the date the BLA is submitted to the FDA because the FDA has approximately two months to make a &#145;&#145;filing&#146;&#146; decision. The review process and the PDUFA goal date may be
extended by three months if the FDA requests or the BLA sponsor otherwise provides additional information or clarification regarding information already provided in the submission within the last three months before the PDUFA goal date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">213 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Once the submission is accepted for filing, the FDA begins an <FONT STYLE="white-space:nowrap">in-depth</FONT>
substantive review of the BLA. The FDA reviews the BLA to determine, among other things, whether the proposed product is safe, pure, and potent for its intended use, and whether the product is being manufactured in accordance with cGMP to ensure the
continued safety, purity, and potency of such product. The FDA may refer applications for novel biological products or biological products that present difficult or novel questions of safety or efficacy to an advisory committee, typically a panel
that includes clinicians and other experts, for review, evaluation, and a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it
considers such recommendations carefully when making decisions. During the biological product approval process, the FDA also will determine whether a Risk Evaluation and Mitigation Strategy (&#147;REMS&#148;), is necessary to assure the safe use of
the biological product. If the FDA concludes a REMS is needed, the sponsor of the BLA must submit a proposed REMS; the FDA will not approve the BLA without a REMS, if required. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Before approving a BLA, the FDA typically will inspect the facilities at which the product is manufactured. The FDA will not approve the product unless it determines
that the manufacturing processes and facilities are in compliance with cGMP and adequate to assure consistent production of the product within required specifications. For a gene therapy product, the FDA also will not approve the product if the
manufacturer is not in compliance with the CGTPs. These are FDA regulations that govern the methods used in, and the facilities and controls used for, the manufacture of human cells, tissues, and cellular and tissue-based products
(&#147;HCT/Ps&#148;), which are human cells or tissue intended for implantation, transplant, infusion, or transfer into a human recipient. The primary intent of the CGTP requirements is to ensure that cell and tissue-based products are manufactured
in a manner designed to prevent the introduction, transmission and spread of communicable disease. FDA regulations also require tissue establishments to register and list their HCT/Ps with the FDA and, when applicable, to evaluate donors through
appropriate screening and testing. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure that the clinical trials were conducted in compliance with IND study requirements and GCP requirements. To
assure cGMP, CGTP and GCP compliance, an applicant must incur significant expenditure of time, money, and effort in the areas of training, record keeping, production and quality control. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the Pediatric Research Equity Act (&#147;PREA&#148;), a BLA or supplement to a BLA for a novel product (e.g., new active ingredient, new indication, etc.) must
contain data to assess the safety and effectiveness of the biological product for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is
safe and effective. The FDA may grant deferrals for submission of data or full or partial waivers. Unless otherwise required by regulation, PREA does not apply to any biological product for an indication for which orphan designation has been
granted. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">After the FDA evaluates a BLA and conducts inspections of manufacturing facilities where the biological product will be manufactured, the FDA may issue an
approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the
application is complete, and the application will not be approved in its present form. A Complete Response Letter will usually describe all of the deficiencies that the FDA has identified in the BLA, except that where the FDA determines that the
data supporting the application are inadequate to support approval, the FDA may issue the Complete Response Letter without first conducting required inspections, testing submitted product lots and/or reviewing proposed labeling. In issuing the
Complete Response Letter, the FDA may recommend actions that the applicant might take to place the BLA in condition for approval, including requests for additional information or clarification, which may include the potential requirement for
additional preclinical studies or clinical trials or additional manufacturing activities. If a Complete Response Letter is issued, the applicant may either resubmit the BLA, addressing all of the deficiencies identified in the letter, or withdraw
the application or request an opportunity for a hearing. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">214 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
FDA may delay or refuse approval of a BLA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to
monitor safety or efficacy of a product. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If a product receives regulatory approval, the approval may be significantly limited to specific diseases and dosages or
the indications for use may otherwise be limited, including to subpopulations of patients, which could restrict the commercial value of the product. Further, the FDA may require that certain contraindications, warnings precautions or interactions be
included in the product labeling. The FDA may impose restrictions and conditions on product distribution, prescribing or dispensing in the form of a REMS, or otherwise limit the scope of any approval. In addition, the FDA may require post-marketing
clinical trials, sometimes referred to as Phase&nbsp;4 clinical trials, designed to further assess a biological product&#146;s safety and effectiveness, and testing and surveillance programs to monitor the safety of approved products that have been
commercialized. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Orphan Drug Designation </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the Orphan Drug Act, the
FDA may grant orphan designation to a drug or biological product candidate intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or more than
200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making a drug or biological product candidate available in the United States for this type of disease or condition will be
recovered from sales of the product. Orphan product designation must be requested before submitting a BLA. After the FDA grants orphan product designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by
the FDA. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If a product candidate that has orphan drug designation subsequently receives the first FDA approval for the disease or condition for which it has such
designation, the product is entitled to orphan drug exclusive approval (or exclusivity), which means that the FDA may not approve any other applications, including a full BLA, to market the same product for the same indication for seven years,
except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity by means of greater effectiveness, greater safety or providing a major contribution to patient care or if the holder of the orphan
drug exclusivity cannot assure the availability of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the product was designated. Orphan drug exclusivity does not prevent the FDA from
approving a different drug or biologic for the same disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the
BLA application fee. A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan drug designation. In addition, exclusive marketing rights in the
United States may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or
condition. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Expedited Development and Review Programs </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The FDA has
various programs, including fast track designation, breakthrough therapy designation, priority review and accelerated approval, that are intended to expedite or simplify the process for the development and FDA review of drugs and biologics that are
intended for the treatment of serious or life-threatening diseases or conditions. These programs do not change the standards for approval but may help expedite the development or approval process. To be eligible for fast track designation, new drugs
and biological products must be intended to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition. Fast track designation applies to the combination of the product and the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">215 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
specific indication for which it is being studied. The sponsor of a new drug or biologic may request the FDA to designate the drug or biologic as a fast track product at any time during the
clinical development of the product. One benefit of fast track designation, for example, is that the FDA may consider for review sections of the marketing application for a product that has received fast track designation on a rolling basis before
the complete application is submitted. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the FDA&#146;s breakthrough therapy program, products intended to treat a serious or life-threatening disease or
condition may be eligible for the benefits of the fast track program when preliminary clinical evidence demonstrates that such product may have substantial improvement on one or more clinically significant endpoints over existing therapies.
Additionally, the FDA will seek to ensure the sponsor of a breakthrough therapy product receives timely advice and interactive communications to help the sponsor design and conduct a development program as efficiently as possible. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any product is eligible for priority review if it has the potential to provide safe and effective therapy where no satisfactory alternative therapy exists or a
significant improvement in the treatment, diagnosis or prevention of a disease compared to marketed products. The FDA will attempt to direct additional resources to the evaluation of an application for a new drug or biological product designated for
priority review in an effort to facilitate the review. Under priority review, the FDA&#146;s goal is to review an application in six months once it is filed, compared to ten months for a standard review. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Additionally, a product may be eligible for accelerated approval. Drug or biological products studied for their safety and effectiveness in treating serious or
life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may receive accelerated approval, which means that they may be approved on the basis of adequate and well-controlled clinical trials establishing
that the product has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit, or on the basis of an effect on an intermediate clinical endpoint other than survival or irreversible morbidity. As a condition of
approval, the FDA may require that a sponsor of a drug or biological product receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials with due diligence, and, under the Food and Drug Omnibus Reform Act of
2022 (&#147;FDORA&#148;), the FDA is now permitted to require, as appropriate, that such trials be underway prior to approval or within a specific time period after the date of approval for a product granted accelerated approval. Under FDORA, the
FDA has increased authority for expedited procedures to withdraw approval of a product or indication approved under accelerated approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In
addition, for products being considered for accelerated approval, the FDA generally requires, unless otherwise informed by the agency, that all advertising and promotional materials intended for dissemination or publication be submitted to the
agency for review, which could adversely affect the timing of the commercial launch of the product. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>RMAT Designation </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As part of the 21<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> Century Cures Act, Congress amended the FD&amp;C Act to facilitate an efficient development
program for and expedite review of regenerative medicine advanced therapies (&#147;RMAT&#148;), which include cell and gene therapies, therapeutic tissue engineering products, human cell and tissue products and combination products using any such
therapies or products. RMAT do not include those HCT/Ps regulated solely under section&nbsp;361 of the PHS Act and 21&nbsp;CFR Part&nbsp;1271. This program is intended to facilitate efficient development and expedite review of regenerative medicine
therapies, which are intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition and qualify for RMAT designation. A drug sponsor may request that FDA designate a drug as a RMAT concurrently with or at any time
after submission of an IND. FDA has 60 calendar days to determine whether the drug meets the criteria, including whether there is preliminary clinical evidence indicating that the drug has the potential to address unmet medical needs for a serious
or life-threatening disease </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">216 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
or condition. A BLA for a regenerative medicine therapy that has received RMAT designation may be eligible for priority review or accelerated approval through use of surrogate or intermediate
endpoints reasonably likely to predict long-term clinical benefit, or reliance upon data obtained from a meaningful number of sites.&nbsp;Benefits of RMAT designation also include early interactions with FDA to discuss any potential surrogate or
intermediate endpoint to be used to support accelerated approval.&nbsp;A regenerative medicine therapy with RMAT designation that is granted accelerated approval and is subject to post-approval requirements may fulfill such requirements through the
submission of clinical evidence from clinical trials, patient registries, or other sources of real world evidence, such as electronic health records; the collection of larger confirmatory data sets; or post-approval monitoring of all patients
treated with such therapy prior to its approval. Like some of the FDA&#146;s other expedited development programs, RMAT designation does not change the standards for approval but may help expedite the development or approval process. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Rare Pediatric Disease Designation and Priority Review Vouchers </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the or
FD&amp;C Act, as amended, the FDA incentivizes the development of product candidates that meet the definition of a &#147;rare pediatric disease,&#148; defined to mean a serious or life-threatening disease in which the serious of life-threatening
manifestations primarily affect individuals aged from birth to 18 years and the disease affects fewer than 200,000 individuals in the United States or affects 200,000 or more in the United States and for which there is no reasonable expectation that
the cost of developing and making in the United States a drug or biologic for such disease or condition will be received from sales in the United States of such drug or biologic. The sponsor of a product candidate for a rare pediatric disease may be
eligible for a voucher that can be used to obtain a priority review for a subsequent marketing application after the date of approval of the rare pediatric disease drug product. A sponsor may request rare pediatric disease designation from the FDA
prior to the submission of its BLA. A rare pediatric disease designation does not guarantee that a sponsor will receive a priority review voucher (&#147;PRV&#148;) upon approval of its BLA. Moreover, a sponsor who chooses not to submit a rare
pediatric disease designation request may nonetheless receive a PRV upon approval of their marketing application if they request such a voucher in their original marketing application and meet all of the eligibility criteria. If a PRV is received,
it may be sold or transferred an unlimited number of times. Congress has extended the PRV program until September&nbsp;30, 2024, with the potential for PRVs to be granted until September&nbsp;30, 2026. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Post-Approval Requirements </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Maintaining substantial compliance with
applicable federal, state and local statutes and regulations requires the expenditure of substantial time and financial resources. Products manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by
the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. If there are any modifications to
the product, including changes in indications, labeling or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new BLA or BLA supplement, which may require the development of additional data or
preclinical studies and clinical trials. Such regulatory reviews can result in denial or modification of the planned changes, or requirements to conduct additional tests or evaluations that can substantially delay or increase the cost of the planned
changes. The FDA may also impose a number of post-approval requirements as a condition of approval of a BLA. For example, the FDA may require post-marketing testing, including Phase 4 clinical trials, and surveillance to further assess and monitor
the product&#146;s safety and effectiveness after commercialization. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Manufacturers of biological products are required to comply with applicable requirements in the
cGMP, including quality control and quality assurance and maintenance of records and documentation. Other post-approval requirements applicable to biological products include reporting of cGMP deviations that may affect
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">217 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the identity, potency, purity and overall safety of a distributed product, record-keeping requirements, reporting of adverse effects, reporting updated safety and efficacy information, and
complying with&nbsp;electronic record and signature requirements. After a BLA is approved, the product also may be subject to official lot release. As part of the manufacturing process, the manufacturer is required to perform certain tests on each
lot of the product before it is released for distribution. If the product is subject to official release by the FDA, the manufacturer submits samples of each lot of product to the FDA together with a release protocol showing a summary of the history
of manufacture of the lot and the results of all of the manufacturer&#146;s tests performed on the lot. The FDA also may perform certain confirmatory tests on lots of some products, such as viral vaccines, before releasing the lots for distribution
by the manufacturer. In addition, the FDA conducts laboratory research related to the regulatory standards on the safety, purity, potency, and effectiveness of biological products. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We also must comply with the FDA&#146;s advertising and promotion requirements, such as those related to
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">direct-to-consumer</FONT></FONT> advertising, the prohibition on promoting products for uses or in patient populations that are not described in the product&#146;s approved labeling
(known as <FONT STYLE="white-space:nowrap">&#147;off-label</FONT> use&#148;), industry-sponsored scientific and educational activities, and promotional activities involving the internet. Discovery of previously unknown problems or the failure to
comply with the applicable regulatory requirements may result in restrictions on the marketing of a product or withdrawal of the product from the market as well as possible civil or criminal sanctions. Failure to comply with the applicable U.S.
requirements at any time during the product development process, approval process or after approval, may subject an applicant or manufacturer to administrative or judicial civil or criminal sanctions and adverse publicity. FDA sanctions could
include refusal to approve pending applications, withdrawal of an approval, clinical holds, warning or untitled letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of
government contracts, mandated corrective advertising or communications with doctors or other stakeholders, debarment, restitution, disgorgement of profits, or civil or criminal penalties. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Biological product manufacturers and other entities involved in the manufacture and distribution of approved biological products, and those supplying products,
ingredients, and components of them, are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other
laws. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance. Discovery of problems with a product after approval may result in restrictions on a product,
manufacturer, or holder of an approved BLA, including withdrawal of the product from the market. In addition, changes to the manufacturing process or facility generally require prior FDA approval before being implemented and other types of changes
to the approved product, such as adding new indications and additional labeling claims, are also subject to further FDA review and approval. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>U.S. Patent Term
Restoration and Marketing Exclusivity </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Depending upon the timing, duration, and specifics of the FDA approval of the use of our product candidates, some U.S.
patents that may issue from our pending patent applications may be eligible for limited patent term extension under the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent restoration term of up to five years as compensation for
patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&#146;s approval date. The patent term
restoration period is generally <FONT STYLE="white-space:nowrap">one-half</FONT> the time between the effective date of an IND and the submission date of a BLA plus the time between the submission date of a BLA and the approval of that application,
except that the review period is reduced by any time during which the applicant failed to exercise due diligence. Only one patent applicable to an approved biological product is eligible for the extension and the application for the extension must
be submitted prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">218 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the expiration of the patent. In addition, only those claims covering the approved product, a method for using it, or a method for manufacturing it may be extended, and a patent can only be
extended once and only for a single product. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we may apply for restoration of patent term for one of the
patents that may issue from our pending patent applications, if and as applicable, to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the
relevant BLA. However, there can be no assurance that our pending patent applications will issue or that we will benefit from any patent term extension or favorable adjustments to the terms of any patents we may own or
<FONT STYLE="white-space:nowrap">in-license</FONT> in the future. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A biological product can obtain pediatric market exclusivity in the United States. Pediatric
exclusivity, if granted, adds six months to existing exclusivity periods and may be granted based on the voluntary completion of a pediatric study in accordance with an <FONT STYLE="white-space:nowrap">FDA-issued</FONT> &#147;Written Request&#148;
for such a study. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Biologics Price Competition and Innovation Act of 2009 created an abbreviated approval pathway for biological products shown to be similar to,
or interchangeable with, an <FONT STYLE="white-space:nowrap">FDA-licensed</FONT> reference biological product. This amendment to the PHS Act attempts to minimize duplicative testing. Biosimilarity, which requires that there be no clinically
meaningful differences between the biological product and the reference product in terms of safety, purity, and potency, can be shown through analytical studies, animal studies and a clinical trial or trials. Interchangeability requires that a
product is biosimilar to the reference product and the product must demonstrate that it can be expected to produce the same clinical results as the reference product and, for products&nbsp;administered multiple times, the biologic and the reference
biologic may be switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A reference biological product is granted four- and <FONT STYLE="white-space:nowrap">12-year</FONT> exclusivity periods from the time of first licensure of the product.
FDA will not accept an application for a biosimilar or interchangeable product based on the reference biological product until four years after the date of first licensure of the reference product, and FDA will not approve an application for a
biosimilar or interchangeable product based on the reference biological product until twelve years after the date of first licensure of the reference product. &#147;First licensure&#148; typically means the initial date the particular product at
issue was licensed in the United States. Date of first licensure does not include the date of licensure of (and a new period of exclusivity is not available for) a biological product if the licensure is for a supplement for the biological product or
for a subsequent application by the same sponsor or manufacturer of the biological product (or licensor, predecessor in interest, or other related entity) for a change (not including a modification to the structure of the biological product) that
results in a new indication, route of administration, dosing schedule, dosage form, delivery system, delivery device or strength, or for a modification to the structure of the biological product that does not result in a change in safety, purity, or
potency. Therefore, one must determine whether a new product includes a modification to the structure of a previously licensed product that results in a change in safety, purity, or potency to assess whether the licensure of the new product is a
first licensure that triggers its own period of exclusivity. Whether a subsequent application, if approved, warrants exclusivity as the &#147;first licensure&#148; of a biological product is determined on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis with data submitted by the sponsor. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Regulation Outside of the United States </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to regulations in the United States, we are subject to a variety of regulations in other jurisdictions governing clinical studies, commercial sales, and
distribution of our products. Most countries outside of the United States require that clinical trial applications be submitted to and approved by the local regulatory authority for each clinical study. In the European Union, for example, an
application must be submitted to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">219 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
national competent authority and an independent ethics committee in each country in which we intend to conduct clinical trials, much like the FDA and IRB, respectively. Under the new Clinical
Trials Regulation (EU) No 536/2014, which replaced the Clinical Trials Directive 2001/20/EC on January&nbsp;31, 2022, a single application is now made through the Clinical Trials Information System (&#147;CTIS&#148;) for clinical trial authorization
in up to 30 EU/EEA countries at the same time and with a single set of documentation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The assessment of applications for clinical trials is divided into two parts
(Part I contains scientific and medicinal product documentation and Part II contains the national and patient-level documentation). Part I is assessed by a coordinated review by the competent authorities of all European Union Member States in which
an application for authorization of a clinical trial has been submitted (Member States concerned) of a draft report prepared by a Reference Member State. Part II is assessed separately by each Member State concerned. The role of the relevant ethics
committees in the assessment procedure will continue to be governed by the national law of the Member State concerned, however overall related timelines are defined by the Clinical Trials Regulation. The new Clinical Trials Regulation also provides
for simplified reporting procedures for clinical trial sponsors. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, whether or not we obtain FDA approval for a product, we must obtain approval of a
product by the comparable regulatory authorities of countries outside the United States before we can commence marketing of the product in those countries. The approval process and requirements vary from country to country, so the number and type of
nonclinical, clinical, and manufacturing studies needed may differ, and the time may be longer or shorter than that required for FDA approval. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To obtain regulatory
approval of our medicinal products under the European Union regulatory system, we are required to submit a marketing authorization application (&#147;MAA&#148;), to be assessed in the centralized procedure. The centralized procedure allows
applicants to obtain a marketing authorization (&#147;MA&#148;) that is valid throughout the European Union, and the additional Member States of the European Economic Area (Iceland, Liechtenstein and Norway) (&#147;EEA&#148;). It is compulsory for
medicinal products manufactured using biotechnological processes, orphan medicinal products, advanced therapy medicinal products (gene-therapy, somatic cell-therapy or tissue-engineered medicines) and human products containing a new active substance
which is not authorized in the European Union and which is intended for the treatment of HIV, AIDS, cancer, neurodegenerative disorders, auto-immune and other immune dysfunctions, viral diseases or diabetes. The centralized procedure is optional for
any other products containing new active substances not authorized in the European Union or for products which constitute a significant therapeutic, scientific, or technical innovation or for which a centralized authorization is in the interests of
patients at European Union level. When a company wishes to place on the market a medicinal product that is eligible for the centralized procedure, it sends an application directly to the European Medicines Agency (&#147;EMA&#148;), to be assessed by
the Committee for Medicinal Products for Human Use (&#147;CHMP&#148;). The CHMP is responsible for conducting the assessment of whether a medicine meets the required quality, safety, and efficacy requirements, and whether the product has a positive
risk/benefit profile. The procedure results in a European Commission decision, which is valid in all European Union Member States. The centralized procedure is as follows: full copies of the MAA are sent to a rapporteur and a <FONT
STYLE="white-space:nowrap">co-rapporteur</FONT> designated by the competent EMA scientific committee. They coordinate the EMA&#146;s scientific assessment of the medicinal product and prepare draft reports. Once the draft reports are prepared (other
experts might be called upon for this purpose), they are sent to the CHMP, whose comments or objections are communicated to the applicant. The rapporteur is therefore the privileged interlocutor of the applicant and continues to play this role, even
after the MA has been granted. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The rapporteur and <FONT STYLE="white-space:nowrap">co-rapporteur</FONT> then assess the applicant&#146;s replies, submit them for
discussion to the CHMP, and taking into account the conclusions of this debate, prepare a final assessment report. Once the evaluation is completed, the CHMP gives a favorable or unfavorable opinion as to whether to grant the authorization. When the
opinion is favorable, it shall include the draft summary of product characteristics (&#147;SmPC&#148;), the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">220 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
package leaflet, and the texts proposed for the various packaging materials. The time limit for the evaluation procedure is 210 days (excluding clock stops, when additional written or oral
information is to be provided by the applicant in response to questions asked by the CHMP). The EMA then has fifteen days to forward its opinion to the European Commission, which will make a binding decision on the grant of an MA within 67 days of
the receipt of the CHMP opinion. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There are two other procedures in the European Union for the grant of an MA in multiple European Union Member States. The
decentralized procedure provides for approval by one or more other, or Concerned Member States, of an assessment of an application performed by one Member State, known as the Reference Member State. Under this procedure, an applicant submits an
application, or dossier, and related materials including a draft SmPC, and draft labeling and package leaflet, to the Reference Member State and Concerned Member States. The Reference Member State prepares a draft assessment and drafts of the
related materials within 120 days after receipt of a valid application. Within 90 days of receiving the Reference Member State&#146;s assessment report, each Concerned Member State must decide whether to approve the assessment report and related
materials. If a Member State cannot approve the assessment report and related materials on the grounds of potential serious risk to the public health, the disputed points may eventually be referred to the European Commission, whose decision is
binding on all Member States. Where a product has already been authorized for marketing in a European Union Member State, this national MA can be recognized in other Member States through the mutual recognition procedure. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The criteria for designating an &#147;orphan medicinal product&#148; in the European Union are similar in principle to those in the United States. Under Article 3 of
Regulation (EC) 141/2000, a medicinal product may be designated as an orphan medicinal product if it is intended for the diagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition that affects no more than five
in 10,000 persons in the European Union when the application is made. In addition, orphan designation can be granted if the product is intended for a life threatening, seriously debilitating, or serious and chronic condition in the European Union
and, without incentives, it is unlikely that sales of the product in the European Union would be sufficient to justify the necessary investment in its development. Orphan designation is only available if there is no other satisfactory method
approved in the European Union of diagnosing, preventing, or treating the applicable orphan condition, or if such a method exists, the proposed orphan medicinal product will be of significant benefit to patients affected by such condition, as
defined in Regulation (EC) 847/2000. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Orphan designation provides opportunities for fee reductions, protocol assistance, and access to the centralized procedure. Fee
reductions are limited to the first year after an MA, except for small and medium enterprises. In addition, if a product which has an orphan designation subsequently receives a centralized MA for the indication for which it has such designation, the
product is entitled to orphan market exclusivity, which means the EMA may not approve any other application to market a similar medicinal product for the same indication for a period of ten years. A &#147;similar medicinal product&#148; is defined
as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. The exclusivity period may be reduced to six years if, at
the end of the fifth year, it is shown that the designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity. Additionally, an MA may be granted to a
similar medicinal product for the same indication at any time if: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the second applicant can establish that its product, although similar to the authorized product, is safer, more effective
or otherwise clinically superior; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the MA holder of the authorized product consents to a second orphan medicinal product application; or
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the MA holder of the authorized product cannot supply enough orphan medicinal product. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">221 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A pediatric investigation plan (&#147;PIP&#148;), in the European Union is aimed at ensuring that the necessary data
are obtained to support the authorization of a medicine for children, through studies in children. All applications for Mas for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because
of a deferral or waiver. This requirement also applies when an MA holder wants to add a new indication, pharmaceutical form, or route of administration for a medicine that is already authorized and covered by intellectual property rights. Several
rewards and incentives for the development of pediatric medicines for children are available in the European Union. Medicines authorized across the European Union with the results of studies from a PIP included in the product information are
eligible for an extension of their supplementary protection certificate (&#147;SPC&#148;) by six months (provided an application for such extension is made at the same time as filing the SPC application for the product, or at any point up to two
years before the SPC expires). This is the case even when the studies&#146; results are negative. For orphan medicinal products, the incentive is an additional two years of market exclusivity. Scientific advice and protocol assistance at the EMA are
free of charge for questions relating to the development of pediatric medicines. Medicines developed specifically for children that are already authorized but are not protected by a patent or supplementary protection certificate are eligible for a <FONT
STYLE="white-space:nowrap">pediatric-use</FONT> MA (&#147;PUMA&#148;). If a PUMA is granted, the product will benefit from ten&nbsp;years of market protection as an incentive. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In March 2016, the EMA launched an initiative, the PRIority Medicines (&#147;PRIME&#148;) scheme, to facilitate development of product candidates in indications, often
rare, for which few or no therapies currently exist. The PRIME scheme is intended to encourage development of products in areas of unmet medical need and provides accelerated assessment of products representing substantial innovation reviewed under
the centralized procedure. Products from small- and <FONT STYLE="white-space:nowrap">medium-sized</FONT> enterprises may qualify for earlier entry into the PRIME scheme than larger companies on the basis of compelling
<FONT STYLE="white-space:nowrap">non-clinical</FONT> data and tolerability data from initial clinical trials. Many benefits accrue to sponsors of product candidates with PRIME designation, including but not limited to, early and proactive regulatory
dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and potentially accelerated MAA assessment once a dossier has been submitted. Importantly, once a candidate medicine has been selected for
the PRIME scheme, a dedicated contact and rapporteur from the CHMP or from the Committee for Advanced Therapies (&#147;CAT&#148;) are appointed early in the PRIME scheme facilitating increased understanding of the product at EMA&#146;s committee
level. An initial meeting with the CHMP/CAT rapporteur initiates these relationships and includes a team of multidisciplinary experts at the EMA to provide guidance on the overall development and regulatory strategies. PRIME eligibility does not
change the standards for product approval, and there is no assurance that any such designation or eligibility will result in expedited review or approval. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
aforementioned European Union rules are generally applicable in the EEA. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The United Kingdom left the European Union on January&nbsp;31, 2020, and the United Kingdom
and the European Union have concluded a trade and cooperation agreement (&#147;TCA&#148;) which was provisionally applicable since January&nbsp;1, 2021 and has been formally applicable since May&nbsp;1, 2021. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The TCA includes specific provisions concerning pharmaceuticals, which include the mutual recognition of GMP, inspections of manufacturing facilities for medicinal
products and GMP documents issued, but does not provide for wholesale mutual recognition of United Kingdom and European Union pharmaceutical regulations. At present, Great Britain has implemented European Union legislation on the marketing,
promotion and sale of medicinal products through the Human Medicines Regulations 2012 (as amended). Except in respect of the new European Union Clinical Trials Regulation, the regulatory regime in Great Britain therefore largely aligns with current
European Union medicines regulations, however it is possible that these regimes will diverge more significantly in future now that Great Britain&#146;s regulatory system is independent from the European Union and the TCA does not provide for mutual
recognition of United Kingdom and European Union pharmaceutical </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">222 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
legislation. However, notwithstanding that there is no wholesale recognition of European Union pharmaceutical legislation under the TCA, under a new framework mentioned below which will be put in
place by the Medicines and Healthcare products Regulatory Agency (&#147;MHRA&#148;), the United Kingdom&#146;s medicines regulator, from January&nbsp;1, 2024, the MHRA has stated that it will take into account decisions on the approval of Mas from
the EMA (and certain other regulators) when considering an application for a Great Britain MA. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On February&nbsp;27, 2023, the United Kingdom government and the
European Commission announced a political agreement in principle to replace the Northern Ireland Protocol with a new set of arrangements, known as the &#147;Windsor Framework&#148;. This new framework fundamentally changes the existing system under
the Northern Ireland Protocol, including with respect to the regulation of medicinal products in the United Kingdom. In particular, the MHRA will be responsible for approving all medicinal products destined for the United Kingdom market (i.e., Great
Britain and Northern Ireland), and the EMA will no longer have any role in approving medicinal products destined for Northern Ireland. A single United Kingdom-wide MA will be granted by the MHRA for all medicinal products to be sold in the United
Kingdom, enabling products to be sold in a single pack and under a single authorization throughout the United Kingdom. The Windsor Framework was approved by the European Union-United Kingdom Joint Committee on March&nbsp;24, 2023, so the United
Kingdom government and the European Union will enact legislative measures to bring it into law. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The MHRA has introduced changes to national licensing procedures,
including procedures to prioritize access to new medicines that will benefit patients, an accelerated assessment procedure and new routes of evaluation for novel products and biotechnological products. All existing European Union Mas for centrally
authorized products were automatically converted (grandfathered) into United Kingdom Mas free of charge on January&nbsp;1, 2021. For a period of three years from January&nbsp;1, 2021, the MHRA may&nbsp;rely on a decision taken by the European
Commission on the approval of a new MA in the centralized procedure, in order to more quickly grant a new Great Britain MA. A separate application will, however, still be required. On January&nbsp;24, 2023, the MHRA announced that a new
international recognition framework will be put in place from January&nbsp;1, 2024, which will have regard to decisions on the approval of Mas made by the EMA and certain other regulators when determining an application for a new Great Britain MA.
There is now no <FONT STYLE="white-space:nowrap">pre-MA</FONT> orphan designation in Great Britain. Instead, the MHRA reviews applications for orphan designation in parallel to the corresponding MAA. The criteria are essentially the same, but have
been tailored for the Great Britain market, i.e., the prevalence of the condition in Great Britain (rather than the European Union) must not be more than five in 10,000. Should an orphan designation be granted, the period of market exclusivity will
be set from the date of first approval of the product in Great Britain. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Other Healthcare Laws and Compliance Requirements </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Other Healthcare Laws </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Biotechnology companies are subject to additional
healthcare laws in the jurisdictions in which they conduct their business that may constrain the financial arrangements and relationships through which we research, as well as, in the future sell, market and distribute any products for which we
obtain regulatory approval. Such laws include, without limitation, state and federal patient data privacy and security laws, federal and state anti-kickback laws, physician-self referral laws, false claims and transparency laws and regulations with
respect to drug pricing and payments and other transfers of value made to physicians and other health care providers, and similar healthcare laws and regulations in the EU and other jurisdictions. Violations of any of such laws or any other
governmental regulations that apply may result in significant penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, disgorgement, the curtailment or restructuring of operations, integrity oversight
and reporting obligations to resolve allegations of noncompliance, and exclusion from participation in federal and state healthcare programs and imprisonment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">223 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Coverage and Reimbursement </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Sales of any product depend, in part, on the extent to which such product will be covered by third-party payors, such as federal, state, and foreign government
healthcare programs, commercial insurance and managed healthcare organizations, and the level of reimbursement for such product by third-party payors. Decisions regarding the extent of coverage and amount of reimbursement to be provided are made on
a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">plan-by-plan</FONT></FONT> basis. These third-party payors are increasingly reducing coverage and reimbursement for medical products, drugs and services. For products administered
under the supervision of a physician, obtaining coverage and adequate reimbursement may be particularly difficult because of the higher prices often associated with such drugs. Additionally, separate reimbursement for the product itself or the
treatment or procedure in which the product is used may not be available, which may impact physician utilization. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The U.S. government, state legislatures and
foreign governments have also continued implementing cost-containment programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic (or biosimilar) products. Adoption of price controls
and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of any product. Decreases in third-party reimbursement for any product or a decision by a
third-party payor not to cover a product could reduce physician usage and patient demand for the product and also have a material adverse effect on sales. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Healthcare Reform </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the United States, in March 2010, the Patient Protection
and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, each as amended, collectively known as the ACA, was enacted, which substantially changed the way healthcare is financed by both governmental and private
insurers, and significantly affected the pharmaceutical industry. The ACA contained a number of provisions, including those governing enrollment in federal healthcare programs, reimbursement adjustments and changes to fraud and abuse laws. Since its
enactment, there have been judicial and Congressional challenges to certain aspects of the ACA. Other legislative changes have been proposed and adopted since the ACA was enacted, including aggregate reductions of Medicare payments to providers of
2% per fiscal year. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Additionally, President Biden has issued multiple executive orders that have sought to reduce prescription drug costs. There has also been
increasing legislative and enforcement interest in the United States with respect to drug pricing practices. Specifically, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products,
which has resulted in several U.S. Congressional inquiries and proposed and enacted federal and state legislation. The Inflation Reduction Act of 2022 (&#147;IRA&#148;), includes several provisions that impact the pharmaceutical industry, including
provisions that reduce the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> spending cap for Medicare Part D beneficiaries to $2,000 starting in 2025; impose new manufacturer financial liability on
certain drugs under Medicare Part D, allow the U.S. government to negotiate Medicare Part B and Part D price caps for certain high-cost drugs and biologics without generic or biosimilar competition; require companies to pay rebates to Medicare for
drug prices that increase faster than inflation; and delay until January&nbsp;1, 2032 the implementation of the HHS rebate rule that would have limited the fees that pharmacy benefit managers can charge. Further, under the IRA, orphan drugs are
exempted from the Medicare drug price negotiation program, but only if they have one orphan designation and for which the only approved indication is for that disease or condition. If a product receives multiple orphan designations or has multiple
approved indications, it may not qualify for the orphan drug exemption. The effects of the IRA on our business and the healthcare industry in general is not yet known. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could impact the amounts that federal and state
governments and other third-party payors will pay for healthcare products and services. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">224 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Data Privacy&nbsp;&amp; Security </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Numerous state, federal and foreign laws govern the collection, dissemination, use, access to, confidentiality and security of personal information, including
health-related information. As our operations and business grow, we may become subject to or affected by U.S. federal and state laws and regulations, including the Health Information Portability and Accountability Act of 1996, and its implementing
regulations, as amended (&#147;HIPAA&#148;), that govern the collection, use, disclosure, and protection of health-related and other personal information. In California the California Consumer Protection Act (&#147;CCPA&#148;), which went into
effect on January&nbsp;1, 2020 and was amended effective January&nbsp;1, 2023, establishes a new privacy framework for covered businesses by creating an expanded definition of personal information, establishing new data privacy rights for consumers
in the State of California, imposing special rules on the collection of consumer data from minors, and creating a new and potentially severe statutory damages framework for violations of the CCPA and for businesses that fail to implement reasonable
security procedures and practices to prevent data breaches. While clinical trial data and information governed by HIPAA are currently exempt from the current version of the CCPA, other personal information may be applicable and possible changes to
the CCPA may broaden its scope. Other states, including Virginia (effective January&nbsp;1, 2023), Colorado (effective July&nbsp;1, 2023), Connecticut (effective July&nbsp;1, 2023), and Utah (effective December&nbsp;31, 2023) have passed privacy
legislation and more states may do so in the future, including Iowa, where the Iowa state legislature passed a comprehensive privacy legislation on March&nbsp;15, 2023. State and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> laws, including for
example the EU General Data Protection Regulation, also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating
compliance efforts. Failure to comply with these laws, where applicable, can result in the imposition of significant civil and/or criminal penalties and private litigation. Privacy and security laws, regulations, and other obligations are constantly
evolving, may conflict with each other to complicate compliance efforts, and can result in investigations, proceedings, or actions that lead to significant civil and/or criminal penalties and restrictions on data processing. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Employees and Human Capital Resources </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September&nbsp;30, 2023,
we had 223 full-time employees, of which 74 have M.D. or Ph.D. degrees. Within our workforce, 187 employees are engaged in research and development and 36 are engaged in business development, finance, legal, and general management and
administration. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors
and consultants. The principal purposes of our equity incentive plans are to attract, retain and reward personnel through the granting of equity-based compensation awards in order to increase shareholder value and the success of our company by
motivating such individuals to perform to the best of their abilities and achieve our objectives. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Facilities </U></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our corporate headquarters is located in Emeryville, California, where we lease and occupy approximately 23,851 square feet of laboratory and office space at 1545 Park
Avenue, Emeryville, California 94608. The current term of our lease expires in February 2031. The company also leases approximately 23,155 square feet of office space at 1485 Park Avenue, Emeryville, California 94608 and subleases approximately
75,662 square feet of combined office, research and laboratory space at 5959 Horton Street, Emeryville, California 94608. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">225 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We believe that our facilities are adequate for our current needs and for the foreseeable future. To meet the future
needs of our business, we may lease additional or alternate space. We believe that suitable additional or substitute space at commercially reasonable terms will be available as needed to accommodate any future expansion of our operations. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><U>Legal proceedings </U></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">From time to time, we may become involved in legal
proceedings arising from the ordinary course of business. We record a liability for such matters when it is probable that future losses will be incurred and that such losses can be reasonably estimated. Significant judgment by us is required to
determine both probability and the estimated amount. Our management is currently not aware of any legal matters that could have a material adverse effect on our financial position, results of operations or cash flows. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">226 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_13"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table sets forth information about our executive officers and directors as of the date of this prospectus. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="66%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Name</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Position(s)</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"><I>Executive Officers</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Brian C. Thomas, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Jian Irish, Ph.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Operating Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pamela Wapnick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sarah Noonberg, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Medical Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Simon Harnest, M.Sc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Investment Officer and Senior Vice President of Strategy</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Luis G. Borges, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Scientific Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Simren Delaney, Ph.D., LLM</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President of Legal</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Juergen Eckhardt, M.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sebasti&aacute;n Bernales, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Risa Stack, Ph.D.<SUP STYLE="font-size:75%; vertical-align:top"> (1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Willard Dere, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Santhosh Palani, Ph.D.<SUP STYLE="font-size:75%; vertical-align:top"> (2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Other Key Personnel</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Christopher T. Brown, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President of Discovery</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Michael Conway, MBA, CPA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President of Finance</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Alan Brooks, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President of Preclinical</TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:10pt">
<TD COLSPAN="7" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Dr. Stack has notified us that she will resign from our board of directors effective immediately prior to the effectiveness of the registration statement of which this prospectus forms a part. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Dr. Palani has notified us that he will resign from our board of directors effective immediately prior to the effectiveness of the registration statement of which this prospectus forms a part. </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following is a biographical summary of the experience of our executive officers and directors. There are no family relationships among any of our executive officers
or directors. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Executive Officers </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Brian C. Thomas, Ph.D.</I></B>,
is our founder and has served as our Chief Executive Officer since September 2016. Since December 2022, Dr.&nbsp;Thomas has served as Chairman of the Board of Directors of Haya Therapeutics, Inc. Previously, from 2001 to 2017, Dr.&nbsp;Thomas served
as a program manager at University of California, Berkeley. From 1999 to 2001, Dr.&nbsp;Thomas served as a lead bioinformatics scientist at EOS Biotechnology (now PDL, Inc.). Dr.&nbsp;Thomas received his B.Sc. in cellular biology and his Ph.D. in
biochemistry from University of Kansas and completed his post-doctoral research in computational biology at University of California, Berkeley. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">227 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors believes that Dr.&nbsp;Thomas is qualified to serve as a director because of his considerable
academic and research expertise, as well as his expansive knowledge about our Company as our founder and Chief Executive Officer. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Jian Irish, Ph.D.,
MBA</I></B>, has served as our President since November 2021 and our Chief Operating Officer since January 2021. Prior to joining us, Dr.&nbsp;Irish held positions as Senior Vice President, Global Head of Manufacturing and Senior Vice President of
Supply Chain at Kite Pharma (now a subsidiary of Gilead) from September 2016 to December 2020. Dr. Irish served as Interim Chief Operating Officer of Affini-T Therapeutics from January 2021 to January 2022. Dr. Irish also served as Interim Chief
Technology Officer and a board member for Fosun Kite, a joint venture between Kite Pharma and Fosun Pharma, from October 2018 to April 2020. From December 2014 to August 2016, Dr. Irish held positions as Vice President of Biologics Supply,
Outsourcing, Partnerships, and External Manufacturing and Vice President of Product Development at Sanofi. From January 2000 to September 2014, Dr. Irish held various leadership positions at Amgen in operations, including Executive Director of JAPAC
Supply, Executive Director of Contract Manufacturing, Officer for Kirin-Amgen JV, and Global Operations Team Leader. Dr.&nbsp;Irish currently serves as an advisor to Ori Biotech, ORCA Biosystems, and ViTToria Biotherapeutics. Dr.&nbsp;Irish received
a B.S. in chemical engineering from East China University of Science and Technology, an M.S. and Ph.D. in pharmaceutical sciences from Chiba University, and an MBA from University of California, Los Angeles, Anderson School of Management. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Pamela Wapnick</I></B>, has served as our Chief Financial Officer since September 2023. Prior to joining us, Ms.&nbsp;Wapnick served as Chief Financial Officer of
Diality Inc. from June 2022 to September 2023, as Chief Financial Officer of Capsida Biotherapeutics from November 2019 to June 2022, and as Chief Financial Officer of Graybug Vision from December 2017 to October 2019. Prior to these roles,
Ms.&nbsp;Wapnick served as Chief Financial Officer of True North Therapeutics and held various positions at Amgen Inc. (Nasdaq: AMGN). Ms.&nbsp;Wapnick received her B.A. in economics from Wellesley College and her MBA in finance from Columbia
Business School. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Sarah Noonberg, M.D., Ph.D.</I></B>, has served as our Chief Medical Officer since January 2023. Prior to joining us, Dr.&nbsp;Noonberg
served as the Chief Medical Officer at Maze Therapeutics, Nohla Therapeutics and Prothena Corporation plc (Nasdaq: PRTA) from July 2020 to September 2022, May 2018 to May 2019 and May 2017 to May 2018, respectively. Dr.&nbsp;Noonberg served as Group
Vice President and Head of Global Clinical Development at BioMarin Pharmaceuticals Inc. (Nasdaq: BMRN) from August 2015 to March 2017. From May 2007 to August 2015, she held several positions at Medivation, Inc., a biopharmaceutical company,
culminating in the position of Senior Vice President of Early Development. Dr.&nbsp;Noonberg currently serves on the board of directors of Neurogene Inc. (Nasdaq: NGNE) and Marinus Pharmaceuticals (Nasdaq: MRNS). She has also previously served on
the board of directors of Neoleukin Therapeutics (Nasdaq: NLTX) and Protagonist Therapeutics, Inc. (Nasdaq: PTGX) from August 2019 to December 2023 and December 2017 to May 2023, respectively. Dr.&nbsp;Noonberg received her B.S. in engineering at
Dartmouth College, her Ph.D. in bioengineering from the University of California, Berkeley and her M.D. from the University of California, San Francisco. Dr.&nbsp;Noonberg is a board-certified internist and completed her residency at Johns Hopkins
Hospital. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Simon Harnest, M.Sc</I></B>, has served as our Chief Investment Officer and Senior Vice President of Strategy since July 2021. Prior to joining us,
Mr.&nbsp;Harnest held various positions, most recently as Chief Investment Officer and Senior Vice President of Strategy and Finance, at Cellectis Inc. from April 2015 to July 2021. Mr. Harnest also served as Vice President, Corporate Strategy and
Finance at Calyxt from March 2016 to December 2019. Mr.&nbsp;Harnest received his B.Sc in economics from University of Westminster, Westminster Business School and his M.Sc in social studies from London School of Economics, London. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Luis G. Borges, Ph.D.</I></B>, has served as our Chief Scientific Officer since joining Metagenomi in August 2023. Prior to this, Dr.&nbsp;Borges served as Chief
Scientific Officer at Century Therapeutics, Inc. (Nasdaq: IPSC) from April 2019 to July 2023 and as Chief Scientific Officer at Cell Medica Limited from August 2017 to March 2019. Dr.&nbsp;Borges </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">228 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
served in positions of increasing responsibility at Five Prime Therapeutics, Inc. from 2014 to 2017, most recently as Senior Vice President of Research. Dr.&nbsp;Borges also served in positions
of increasing responsibility at Amgen Inc. (Nasdaq: AMGN) from 2002 to 2014. Dr.&nbsp;Borges received a B.S. in marine biology from the University of Lisbon and a Ph.D. in pathology from the University of Washington. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Simren Delaney, Ph.D., LLM</I></B>, has served as our Vice President of Legal since February 2020 and previously served as our Chief of Staff from January 2022 to
December 2022. Prior to joining us, Dr.&nbsp;Delaney was an associate at Wilson Sonsini Goodrich&nbsp;&amp; Rosati from October 2016 to February 2020. Dr.&nbsp;Delaney received her B.Sc in science, LL.B. and Ph.D. in organic chemistry from Deakin
University, and her LL.M. from University of California, College of the Law, San Francisco. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors
</B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Juergen Eckhardt, M.D., MBA</I></B>, has served as our Chairman of the Board of Directors since September 2020. Dr.&nbsp;Eckhardt has served as Head of
Leaps at Bayer AG since February 2019 and previously served as Head of Venture Investments from September 2016 to February 2019. He currently serves on the boards of Dewpoint Therapeutics, Khloris Biosciences, Oerth Bio, and a few other private
biotechnology companies and foundations. Previously, Dr.&nbsp;Eckhardt served as a management consultant and Associate Partner at McKinsey&nbsp;&amp; Co. and a member of McKinsey&#146;s Healthcare Leadership Team from 1994 to 2002. Dr.&nbsp;Eckhardt
received his M.D. from the University of Basel and his MBA from INSEAD in Fontainebleau, France. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors believes that Dr.&nbsp;Eckhardt is qualified
to serve as a director because of his extensive experience in strategy, finance, leadership and drug development. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Sebasti&aacute;n Bernales, Ph.D.</I></B>,
has served on our board of directors since December 2020 and previously served as a Director of Metagenomi, Inc. from September 2016 to April 2020. Dr.&nbsp;Bernales has been a General Partner at Humboldt Fund since February 2020 and has been a
Venture Partner at DROIA Ventures since August 2020. He has served as the Chief Executive Officer of Praxis Biotech LLC since July 2016 and a member of Sake Holdings LLC since May 2020. Dr. Bernales is also the founder of Merken Biotech. Dr.
Bernales is a member of the boards of directors of PhageLab, Botanical Solutions, Momentum, Vedra, Alesta, and a few other private biotechnology companies and foundations. Dr. Bernales currently serves as an advisor to NotCo, Levita Magnetics, and
Leyden Labs. From 2007 to 2016, Dr.&nbsp;Bernales worked at Medivation Inc., culminating in the position of Vice President of Discovery Biology. He received his B.S. from Catholic University in Chile and his Ph.D. in cell biology at the University
of California in San Francisco. He completed his postdoctoral training at the University of California in San Francisco. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors believes that
Dr.&nbsp;Bernales is qualified to serve as a director because of his significant experience in biotechnology industry. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Risa Stack, Ph.D.</I></B>, has served
on our board of directors since April 2022. Dr. Stack has been a Partner at The Production Board since May 2022. Previously, Dr. Stack was a Venture Partner at RA Capital from September 2020 to March 2022. Dr.&nbsp;Stack was a founder and served as
Chairperson of Menlo Microsystems from December 2016 to September 2018, and served as a General Manager at General Electric from January 2013 to September 2018. Dr.&nbsp;Stack was a Partner at Kleiner Perkins from June 2003 to December 2012. Before
joining Kleiner Perkins, Dr. Stack was a Principal at JP Morgan Partners from September 1996 to May 2003. Dr. Stack currently serves on the Board of Directors of COPD Foundation. Dr.&nbsp;Stack received her B.S. in genetics and development from the
University of Illinois and her Ph.D. in immunology from the University of Chicago. Dr.&nbsp;Stack was a member of the second class of Kauffman Fellows. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of
directors believes that Dr.&nbsp;Stack is qualified to serve as a director because of her extensive investment experience, knowledge of financial markets and expertise in personalized medicine, therapeutics and platform technology companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">229 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Dr. Stack has notified us that she will resign from our board of directors effective immediately prior to the
effectiveness of the registration statement of which this prospectus forms a part. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Willard Dere, M.D.</I></B>, has served on our board of directors since
August 2021. Dr.&nbsp;Dere currently serves as Chief Advisor and Chief Medical Officer at Angitia since July 2022, and on the board of directors of BioMarin, Seres and Mersana. He also serves on the Scientific Advisory Boards of Surrozen, AliveGen
and Heranova Lifesciences Dr. Dere served as a Professor of Internal Medicine from November 2014 to July 2022 at the University of Utah School of Medicine, and is currently Professor Emeritus, a position he has held since July 2022. Dr. Dere also
served as Associate Vice President for Research, Co-Director of The Center for Genomic Medicine and Co-Director of the Utah Clinical and Translational Science Institute at the University of Utah Health Sciences Center during this time period. Before
joining the University of Utah, Dr. Dere held various positions at Amgen, Inc., including Senior Vice President of Global Development and Corporate, then International Chief Medical Officer, from July 2003 to October 2014. From 1989 to 2003, Dr.
Dere held multiple positions in clinical research, and regulatory affairs and safety at Eli Lilly and Company. He was also an assistant professor from 1989 to 1999 and a clinical associate professor from 1999 to 2009 at the Indiana University School
of Medicine. Dr. Dere received his B.A. in history, zoology and M.D. from the University of California, Davis; he completed his postdoctoral training at the University of Utah in internal medicine, and at the University of California, San Francisco
in endocrinology and metabolism. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors believes that Dr.&nbsp;Dere is qualified to serve as a director because of extensive experience in drug
development, and as a board of directors member on several public companies. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Santhosh Palani, Ph.D.</I></B>, has served on our board of directors since
January 2022. Dr.&nbsp;Palani is currently an investment partner at PFM Health Sciences since June 2020. He was a Principal at New Enterprise Associates from May 2018 to May 2020. From 2016 to 2018, Dr.&nbsp;Palani was a Vice President at Cowen and
Company. He previously served as an Associate Director in Oncology Clinical Development at Pfizer from 2013 to 2016 and as a Scientist in Oncology Preclinical Development at Takeda Pharmaceuticals from 2012 to 2013. Dr. Palani currently serves on
the Board of Directors of Turnstone Biologics. Dr.&nbsp;Palani received his B.S. and M.S. in chemical engineering from the University of Madras and Texas A&amp;M University, respectively. Dr.&nbsp;Palani received his Ph.D. in Bioengineering from the
University of Pennsylvania and completed his postdoctoral work in biochemistry and molecular biophysics at Columbia University. Dr.&nbsp;Palani is a CFA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Charterholder. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors believes that Dr.&nbsp;Palani is qualified to serve as a director because of his strong financial background and significant industry experience
in the fields of internal medicine and endocrinology. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Dr. Palani has notified us that he will resign from our board of directors effective immediately prior to the
effectiveness of the registration statement of which this prospectus forms a part. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Other Key Personnel </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Alan Brooks, Ph.D.</I></B>, has served as our Senior Vice President of Preclinical since January 2023 and previously served as our Director of Preclinical and Vice
President of Preclinical from November 2019 to January 2023. Prior to joining us, Dr.&nbsp;Brooks served as a principal scientist at Casebia Therapeutics from August 2017 to August 2019. From October 2007 to August 2017, Dr.&nbsp;Brooks held various
positions at Bayer AG, including scientist, senior scientist and principal scientist. Dr.&nbsp;Brooks received his B.Sc in biological sciences from University of Leicester, UK and his Ph.D. in molecular and developmental biology from University of
Warwick, UK. He completed his postdoctoral fellowship at the Gladstone Institute/University of California, San Francisco. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Michael Conway, MBA, CPA</I></B>,
has served as our Vice President of Finance since March 2022. Prior to joining us, Mr.&nbsp;Conway served as Senior Director of Financial Planning and Analysis and Vice President of Finance at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">230 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Adamas Pharmaceuticals, Inc. from March 2016 to December 2021, where he was responsible for leading the accounting and financial planning and analysis functions. Mr.&nbsp;Conway received his BBA
in management information systems from University of Notre Dame, his MBA from University of Michigan, Ross School of Business, and is a certified public accountant in the state of California. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Christopher T. Brown, Ph.D.</I></B>, has served as our Vice President of Discovery since January 2023 and previously served as our Senior Bioinformatics Scientist,
Director of Discovery and Senior Director of Discovery from September 2018 to December 2022. Prior to joining us, Dr.&nbsp;Brown conducted <FONT STYLE="white-space:nowrap">post-doctoral</FONT> research at the University of California, Berkeley from
January 2017 to August 2018. He received his B.Sc in microbiology from the University of Florida and his Ph.D. in plant and microbial biology from the University of California, Berkeley. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Board Composition </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of managers currently consists of 6 members,
each of whom is a member pursuant to the board composition provisions of our current certificate of incorporation and agreements with our stockholders, which agreements are described in the section of this prospectus entitled &#147;Certain
Relationships and Related Person Transactions.&#148; These board composition provisions will terminate upon the closing of this offering. Upon the termination of these provisions, there will be no further contractual obligations regarding the
election of our directors. Our nomination and corporate governance committee and our board of directors may therefore consider a broad range of factors relating to the qualifications and background of nominees. Our nomination and corporate
governance committee&#146;s and our board of directors&#146; priority in selecting board members is identification of persons who will further the interests of our stockholders through their established record of professional accomplishment, the
ability to contribute positively to the collaborative culture among board members, knowledge of our business, understanding of the competitive landscape, professional and personal experiences and expertise relevant to our growth strategy. Our
directors hold office until their successors have been elected and qualified or until their earlier resignation or removal. Our amended and restated certificate of incorporation and amended and restated bylaws that will become effective upon the
closing of this offering also provide that our directors may be removed only for cause by the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the votes that all our stockholders would be entitled to
cast in an annual election of directors, and that any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Staggered Board </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In accordance with the terms of our amended and restated
certificate of incorporation and our amended and restated bylaws that will become effective upon the closing of this offering, our board of directors will be divided into three staggered classes of directors and each director will be assigned to one
of the three classes. At each annual meeting of the stockholders, one class of directors will be elected for a three-year term to succeed the directors of the same class whose terms are then expiring. The terms of the directors will expire upon the
election and qualification of successor directors at the annual meeting of stockholders to be held during the years 2024 for Class&nbsp;I directors, 2025 for Class&nbsp;II directors and 2026 for Class&nbsp;III directors. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Our Class&nbsp;I directors will
be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Our Class&nbsp;II directors will
be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;; and </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Our Class&nbsp;III directors will
be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our amended and restated certificate of
incorporation and amended and restated bylaws that will become effective upon the closing of this offering will provide that the number of our directors shall be fixed from time to time by a resolution of the majority of our board of directors. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The division of our board of directors into three classes with staggered three-year terms may delay or prevent stockholder efforts to effect a change of our management
or a change in control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">231 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Director Independence </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We
have applied to list our common stock on the Nasdaq Global Select Market. Under the Nasdaq listing rules, independent directors must comprise a majority of a listed company&#146;s board of directors within twelve months from the date of listing. In
addition, the Nasdaq listing rules require that, subject to specified exceptions, each member of a listed company&#146;s audit, compensation and nominating and governance committees be independent within twelve months from the date of listing. Audit
committee members must also satisfy additional independence criteria, including those set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;), and compensation
committee members must also satisfy the independence criteria set forth in Rule <FONT STYLE="white-space:nowrap">10C-1</FONT> under the Exchange Act. Under Nasdaq listing rules, a director will only qualify as an &#147;independent director&#148; if,
in the opinion of that company&#146;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In order to be considered
independent for purposes of Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of
directors, or any other board committee: (i)&nbsp;accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries, other than compensation for board service; or (ii)&nbsp;be an
affiliated person of the listed company or any of its subsidiaries. In order to be considered independent for purposes of Rule <FONT STYLE="white-space:nowrap">10C-1,</FONT> the board of directors must consider, for each member of a compensation
committee of a listed company, all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#146;s ability to be independent from management in connection with the duties
of a compensation committee member, including, but not limited to: the source of compensation of the director, including any consulting advisory or other compensatory fee paid by such company to the director, and whether the director is affiliated
with the company or any of its subsidiaries or affiliates. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; 2024, our board of directors
undertook a review of the composition of our board of directors and its committees and the independence of each director. Based upon information requested from and provided by each director concerning his background, employment and affiliations,
including family relationships, our board of directors has determined that all members of our board of directors, except &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, are independent directors,
including for purposes of Nasdaq and the SEC rules. In making that determination, our board of directors considered the relationships that each director has with us and all other facts and circumstances the board of directors deemed relevant in
determining independence, including the potential deemed beneficial ownership of our capital stock by each director, including <FONT STYLE="white-space:nowrap">non-employee</FONT> directors that are affiliated with certain of our major stockholders.
Upon the completion of this offering, we expect that the composition and functioning of our board of directors and each of our committees will comply with all applicable requirements of Nasdaq and the rules and regulations of the SEC. There are no
family relationships among any of our executive officers and directors. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We intend to adopt a policy, subject to and effective upon the effectiveness of the
registration statement of which this prospectus forms a part, that outlines a process for our securityholders to send communications to the board of directors. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Board Committees </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors will establish an audit committee, a
compensation committee and a nomination and corporate governance committee, each of which will operate pursuant to a charter to be adopted by our board of directors and will be effective upon the effectiveness of the registration statement of which
this prospectus forms a part. We believe that the composition and functioning of all of our committees will comply with the applicable requirements of Nasdaq, the Sarbanes-Oxley Act of 2002 and SEC rules and regulations that will be applicable to
us. We intend to comply with future requirements to the extent they become applicable to us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">232 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Following the consummation of this offering, the full text of our audit committee charter, compensation committee
charter and nomination and corporate governance committee charter will be posted on the investor relations portion of our website at https://www.metagenomi.co. We do not incorporate the information contained on, or accessible through, our corporate
website into this prospectus, and you should not consider it a part of this prospectus. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Audit Committee </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon the effectiveness of the registration statement of which this prospectus forms a part, our audit committee will consist of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and will be chaired by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The functions of the audit
committee will include: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">appointing, approving the compensation of, and assessing the independence of our independent registered public accounting
firm; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> auditing and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services, and the terms of such services, to be provided by our independent registered public accounting firm; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing the overall audit plan with our independent registered public accounting firm and members of management
responsible for preparing our financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing and discussing with management and our independent registered public accounting firm our annual and quarterly
financial statements and related disclosures as well as critical accounting policies and practices used by us; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">recommending based upon the audit committee&#146;s review and discussions with management and our independent registered
public accounting firm whether our audited financial statements shall be included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they
relate to our financial statements and accounting matters; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">preparing the audit committee report required by SEC rules to be included in our annual proxy statement;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing all related person transactions for potential conflict of interest situations and approving all such
transactions; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing quarterly earnings releases. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">All members of our audit committee will meet the requirements for financial literacy under the applicable rules and regulations of the SEC and the Nasdaq listing rules.
Our board of directors has determined that &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; qualifies as an &#147;audit committee financial expert&#148; within the meaning of applicable SEC
regulations. In making this determination, our board of directors considered the nature and scope of experience that &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; has previously had with public
reporting companies, including service as &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. Our board of directors has determined that all of the directors that will become members of our audit
committee upon the effectiveness of the registration statement of which this prospectus forms a part satisfy the relevant independence requirements for service on the audit committee set forth in the rules of the SEC and the Nasdaq listing rules.
Both our independent registered public accounting firm and management will periodically meet privately with our audit committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">233 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Compensation Committee </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon the effectiveness of the registration statement of which this prospectus forms a part, our compensation committee will consist of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and will be chaired by &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The functions of the
compensation committee will include: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">annually reviewing and recommending to the board of directors the corporate goals and objectives relevant to the
compensation of our Chief Executive Officer; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">evaluating the performance of our Chief Executive Officer in light of such corporate goals and objectives and based on such
evaluation (i)&nbsp;reviewing and determining the cash compensation of our Chief Executive Officer and (ii)&nbsp;reviewing and approving grants and awards to our Chief Executive Officer under equity-based plans; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing and approving the compensation of our other executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing and establishing our overall management compensation, philosophy and policy; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">overseeing and administering our compensation and similar plans; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">evaluating and assessing potential and current compensation advisors in accordance with the independence standards
identified in the applicable Nasdaq listing rules; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing and approving our policies and procedures for the grant of equity-based awards; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing and recommending to the board of directors the compensation of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">preparing our compensation committee report if and when required by SEC rules; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing and discussing annually with management our &#147;Compensation Discussion and Analysis,&#148; if and when
required, to be included in our annual proxy statement; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing and approving the retention or termination of any consulting firm or outside advisor to assist in the evaluation
of compensation matters. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each member of our compensation committee will be a <FONT STYLE="white-space:nowrap">non-employee</FONT> director, as
defined in Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act, and an outside director, as defined pursuant to Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;). </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Nominating and Corporate Governance Committee </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon the effectiveness of the
registration statement of which this prospectus forms a part, our nominating and corporate governance committee will consist of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and will be chaired by
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The functions of the nominating and corporate governance committee will include: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">developing and recommending to the board of directors criteria for board and committee membership; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">establishing procedures for identifying and evaluating board of director candidates, including nominees recommended by
stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">reviewing the composition of the board of directors to ensure that it is composed of members containing the appropriate
skills and expertise to advise us; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">identifying individuals qualified to become members of the board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">recommending to the board of directors the persons to be nominated for election as directors and to each of the
board&#146;s committees; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">234 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">developing and recommending to the board of directors a code of business conduct and ethics and a set of corporate
governance guidelines; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">overseeing the evaluation of our board of directors and management. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors may from time to time establish other committees. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Compensation Committee Interlocks and Insider Participation </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">None of the
members of our compensation committee is, or has at any time during the prior three years been, one of our officers or employees. None of our executive officers currently serve, or have in the past fiscal year served, as a member of the board of
directors or compensation committee of any entity that has one or more of its executive officers serving as a member of our board of directors or our compensation committee. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Code of Business Conduct and Ethics </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors intends to adopt,
subject to and effective upon the effectiveness of the registration statement of which this prospectus forms a part, a Code of Business Conduct and Ethics in connection with this offering. The Code of Business Conduct and Ethics will apply to all of
our employees, officers (including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions), agents and representatives, including directors and consultants.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We intend to disclose future amendments to certain provisions of our Code of Business Conduct and Ethics and our Code of Ethics on our website identified below.
Upon the completion of this offering, the full text of our Code of Business Conduct and Ethics and our Code of Ethics will be posted on our website at https://www. Metagenomi.co. The inclusion of our website address in this prospectus does not
include or incorporate by reference the information on our website into this prospectus, and you should not consider that information a part of this prospectus. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Limitations on Liability and Indemnification Agreements </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As permitted by
Delaware law, provisions in our amended and restated certificate of incorporation and amended and restated bylaws, both of which will become effective upon the closing of this offering, limit or eliminate the personal liability of directors for a
breach of their fiduciary duty of care as a director. The duty of care generally requires that, when acting on behalf of the corporation, a director exercise an informed business judgment based on all material information reasonably available to him
or her. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director, except for liability for: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any act related to unlawful stock repurchases, redemptions or other distributions or payments of dividends; or
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These limitations of liability do not limit or eliminate our rights or any stockholder&#146;s rights to seek <FONT STYLE="white-space:nowrap">non-monetary</FONT> relief,
such as injunctive relief or rescission. These provisions will not alter a director&#146;s liability under other laws, such as the federal securities laws or other state or federal laws. Our amended and restated certificate of incorporation that
will become effective upon the closing of this offering also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">235 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As permitted by Delaware law, our amended and restated bylaws to be effective upon the consummation of this offering
will provide that: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we will indemnify our directors, officers, employees and other agents to the fullest extent permitted by law;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we must advance expenses to our directors and officers, and may advance expenses to our employees and other agents, in
connection with a legal proceeding to the fullest extent permitted by law; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the rights provided in our amended and restated bylaws are not exclusive. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If Delaware law is amended to authorize corporate action further eliminating or limiting the personal liability of a director or officer, then the liability of our
directors or officers will be so eliminated or limited to the fullest extent permitted by Delaware law, as so amended. Our amended and restated bylaws will also permit us to secure insurance on behalf of any officer, director, employee or other
agent for any liability arising out of his or her actions in connection with their services to us, regardless of whether our amended and restated bylaws permit such indemnification. We have obtained such insurance. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition to the indemnification that will be provided for in our amended and restated certificate of incorporation and amended and restated bylaws, we plan to enter
into separate indemnification agreements with each of our directors and executive officers, which may be broader than the specific indemnification provisions contained in the Delaware General Corporation Law. These indemnification agreements may
require us, among other things, to indemnify our directors and executive officers for some expenses, including attorneys&#146; fees, expenses, judgments, fines and settlement amounts incurred by a director or executive officer in any action or
proceeding arising out of his service as one of our directors or executive officers or any other company or enterprise to which the person provides services at our request. We believe that these provisions and agreements are necessary to attract and
retain qualified individuals to serve as directors and executive officers. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This description of the indemnification provisions of our amended and restated
certificate of incorporation, our amended and restated bylaws and our indemnification agreements is qualified in its entirety by reference to these documents, each of which is attached as an exhibit to the registration statement of which this
prospectus forms a part. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Insofar as indemnification for liabilities arising under the Securities Act, may be permitted to our directors, officers and controlling
persons pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There is no pending litigation or proceeding naming any of our directors or officers as to which indemnification is being sought, nor are we aware of any pending or
threatened litigation that may result in claims for indemnification by any director or officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">236 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_14"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following discussion contains forward looking statements that are based on our current plans, considerations, expectations and determinations regarding our future
compensation programs. The actual amount and form of compensation and the compensation policies and practices that we adopt in the future may differ materially from currently planned programs as summarized in this discussion. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As an emerging growth company, we have opted to comply with the executive compensation disclosure rules applicable to &#147;smaller reporting companies,&#148; as such
term is defined in the rules promulgated under the Securities Act. The compensation provided to our named executive officers for the fiscal year ended December&nbsp;31, 2023 is detailed in the 2023 Summary Compensation Table and accompanying
footnotes and narrative that follow. Our named executive officers for the fiscal year ended December&nbsp;31, 2023 are: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Brian C. Thomas, Ph.D., our Chief Executive Officer; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Jian Irish, Ph.D., MBA, our President and Chief Operating Officer; and </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">Sarah Noonberg, M.D., Ph.D., our Chief Medical Officer. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To date, the compensation of our named executive officers has consisted of a combination of base salary, cash bonuses and equity awards in the form of profits interests,
as described below. Our named executive officers, like all of our full-time employees, are eligible to participate in our health and welfare benefit plans. As we transition from a private company to a publicly traded company, we intend to evaluate
our compensation values and philosophy and compensation plans and arrangements as circumstances require. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>2023 Summary Compensation Table </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table shows the total compensation earned by, or paid to, our named executive officers for services rendered to us in all capacities during the years
listed below. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial"><B>Name&nbsp;and&nbsp;Principal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial"><B>Position</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Salary</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>($)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Bonus(1)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>($)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Stock</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Awards(2)</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>($)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive Plan<BR>Compensation(3)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>($)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>All
Other<BR>Compensation(4)</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>($)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Total</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>($)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Brian C. Thomas, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:arial"><I>Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">516,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,966,519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,517,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,223,129</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,156,629</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Jian Irish, Ph.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><I>President and Chief Operating Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">465,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,783,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,266,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">260,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,084,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sarah Noonberg, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><I>Chief Medical Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">388,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,447,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,854,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:8pt">
<TD COLSPAN="28" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported in this column reflect one time special bonuses paid to Dr. Thomas and Dr. Irish for performance during the fiscal year ended December 31, 2022. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported in this column represent the aggregate grant date fair value of profits interests granted to the named executive officers during the applicable fiscal year, as calculated in accordance with
Financial Accounting Standards Board (&#147;FASB&#148;), Accounting Standards Codification (&#147;ASC&#148;), Topic 718. Such grant date value does not take into account any estimated forfeitures related to service-based vesting conditions. On
July&nbsp;31, 2023, as a result of the amendment to the LLC agreement to include a &#147;catch-up&#148; feature, the Company remeasured the fair value of its profits interests as required under ASC 718 resulting in increases to the originally
calculated fair values, in the aggregate amount of $4,564,081. The assumptions used in the grant date fair value of the awards in this column are described in Note 11 &#150; Profits interest plan to our unaudited consolidated financial statements as
of September 30, 2023 and for the nine months ended September 30, 2022 and 2023. These assumptions are included elsewhere in this prospectus. These awards are described in more detail under &#147;Narrative Disclosure to Summary Compensation Table
&#150; Equity-Based Compensation&#148; below. </TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported represent annual bonuses under our annual cash bonus program based on achievement of company performance and individual performance during the applicable fiscal year. Such amounts for fiscal year
2023 have not yet been determined, but are expected to be determined and paid in the first quarter of 2024 and will be reported at such time as required by SEC rules. </TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(4)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported for fiscal year 2023 reflect an employer matching contribution on the employee&#146;s behalf under our 401(k) plan. The amount for Dr. Thomas also includes $18,102 related to reimbursement of
certain legal fees incurred by Dr. Thomas in connection with the negotiation of his employment contract with the Company. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">237 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Narrative Disclosure to Summary Compensation Table </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>2023 Base Salaries </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our named executive officers each receive a base
salary to compensate them for services rendered to our Company. The base salary payable to each named executive officer is intended to provide a fixed component of&nbsp;compensation reflecting the executive&#146;s skill set, experience, role and
responsibilities. Base salaries may be&nbsp;adjusted from time to time to realign salaries with market levels after taking into account individual responsibilities, performance and experience. The base salary for Dr.&nbsp;Thomas was adjusted
effective as of March&nbsp;1, 2023 from $500,000 to $520,000. The base salary for Dr. Irish was adjusted effective March 1, 2023 from $450,000 to $468,000. Dr.&nbsp;Noonberg joined the Company January&nbsp;30, 2023 and her base salary was not
adjusted during the calendar year 2023. As of December&nbsp;31, 2023, the base salaries for Dr.&nbsp;Thomas, Dr.&nbsp;Irish, and Dr.&nbsp;Noonberg were $520,000, $468,000, and $420,000, respectively. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>2023 Cash Bonuses </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For the fiscal year ended December&nbsp;31, 2023,
each of the named executive officers is eligible to earn an annual cash bonus determined by our board of directors in its sole discretion, based on achievement of certain individual and corporate performance goals, relating primarily to research and
development goals, clinical milestones, business development and organizational goals. The target annual bonus for each of our named executive officers for the fiscal year ended December&nbsp;31, 2023 was equal to the percentage of the
executive&#146;s respective annual base salary specified below: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Name</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Target&nbsp;Bonus<BR>Percentage</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Brian C. Thomas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Jian Irish</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sarah Noonberg</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:10pt">
<TD COLSPAN="4" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The annual cash bonuses earned by each named executive office for the fiscal year ended December 31, 2023 have not yet been determined,
but are expected to be determined and paid in the first quarter of 2024 and will be reported at such time as required by SEC rules. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Equity-Based Compensation
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Although we do not yet have a formal policy with respect to the grant of equity incentive awards to our executive officers, we believe that equity grants
provide our executives with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executives and our unitholders. We have granted our named executive officers profits interests under our 2019
Equity Incentive Plan (the &#147;2019 Plan&#148;). These profits interests are subject to time-based vesting conditions and are intended to be treated as &#147;profits interests&#148; for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with the Reorganization, profits interests will be exchanged for shares of common stock and restricted common stock of Metagenomi, Inc. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For additional information regarding outstanding equity awards held by our named executive officers as of December&nbsp;31, 2023, see the &#147;<I>Outstanding Equity
Awards at 2023 Fiscal Year End</I>&#148; table below. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Perquisites/Personal Benefits </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Perquisites or other personal benefits are not a significant component of our executive compensation program. Accordingly, we do not provide significant perquisites or
other personal benefits to our executive officers, including our named executive officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">238 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>401(k) Plan </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We
maintain a retirement savings plan (&#147;401(k) plan&#148;) that is intended to qualify for favorable tax treatment under Section&nbsp;401(a) of the Code and contains a cash or deferred feature that is intended to meet the requirements of
Section&nbsp;401(k) of the Code. U.S. employees are generally eligible to participate in the 401(k) plan, subject to certain criteria. Participants may make <FONT STYLE="white-space:nowrap">pre-tax</FONT> and certain
<FONT STYLE="white-space:nowrap">after-tax</FONT> (Roth) salary deferral contributions to the plan from their eligible earnings up to the statutorily prescribed annual limit under the Code. Participants who are 50 years of age or older may
contribute additional amounts based on the statutory limits for <FONT STYLE="white-space:nowrap">catch-up</FONT> contributions. Participant contributions are held in trust as required by law. We provide employer matching contributions of 100% on the
first 5% of participant&#146;s compensation contributed to our 401(k) plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">239 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Outstanding Equity Awards at 2023 Fiscal Year End </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table lists all outstanding equity awards held by our named executive officers as of December&nbsp;31, 2023. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="16" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Stock Awards(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Name</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Grant&nbsp;Date</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Vesting<BR>Commencement<BR>Date</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>or Units of Stock<BR>That Have Not<BR>Vested (#)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Market&nbsp;Value&nbsp;of<BR>Shares&nbsp;or&nbsp;Units&nbsp;of<BR>Stock That Have</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Not&nbsp;Vested&nbsp;($)(2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Equity&nbsp;Incentive<BR>Plan awards:<BR>Number of<BR>Unearned&nbsp;Shares,<BR>Units&nbsp;or&nbsp;Other<BR>Rights&nbsp;That&nbsp;Have<BR>Not&nbsp;Vested
(#)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Equity&nbsp;Incentive<BR>Plan awards:<BR>Market Value of<BR>Unearned&nbsp;Shares,<BR>Units&nbsp;or&nbsp;Other<BR>Rights&nbsp;That&nbsp;Have<BR>Not&nbsp;Vested
($)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Brian C. Thomas, Ph.D.(3)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">11/2/21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">11/1/21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">60,604</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><I>Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/26/22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/21/22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/26/23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/20/23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">590,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Jian Irish, Ph.D., MBA(4)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/26/21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/5/21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><I>President and Chief </I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/2/21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/1/21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><I>Operating Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/26/22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/21/22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/26/23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/20/23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Sarah Noonberg, M.D.,Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/24/23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/30/23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><I>Chief Medical Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:arial; font-size:10pt">
<TD COLSPAN="24" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All awards in this table consist of profits interests granted under the 2019 Plan that are intended to qualify as &#147;profits interests&#148; for U.S. tax purposes. They do not require the payment of an exercise price
and will only obtain value as value of the underlying security rises above its grant date value, which is referred to as the &#147;Threshold Amount.&#148; The profits interests vest as follows: 25% vest on the one year anniversary of the vesting
commencement date; and then the remaining 75% of the total profits interests vest in substantially equal amounts on each monthly anniversary of the vesting commencement date thereafter, until fully vested on the fourth anniversary of the vesting
commencement date, based upon the participant&#146;s continued service on each applicable vesting date. </TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents the fair market value of profits interests that were unvested as of December&nbsp;31, 2023. The fair market value assumes an initial public offering prior of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the estimated midpoint of the price range set forth on the cover page of this prospectus. </TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Awards held by Dr.&nbsp;Thomas are subject to certain acceleration provisions, as summarized below under &#147;Employment Arrangements in Place Prior to the Offering for Named Executive Officers.&#148;
</TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Awards held by Dr.&nbsp;Irish are subject to certain acceleration provisions, as summarized below under &#147;Employment Arrangements in Place Prior to the Offering for Named Executive Officers.&#148; </TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">240 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Executive Compensation Arrangements </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have entered into offer letters and/or employment agreements with each of our named executive officers. Each offer letter or employment agreement provides for <FONT
STYLE="white-space:nowrap">&#147;at-will&#148;</FONT> employment and the compensation and benefits described below. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Employment Arrangements in Place Prior to
The Offering for Named Executive Officers </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Brian C. Thomas </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On
March&nbsp;20, 2023, the Company executed an executive employment agreement with Dr.&nbsp;Thomas (the &#147;Thomas Employment Agreement&#148;), for the position of Chief Executive Officer. The Thomas Employment Agreement provides for
Dr.&nbsp;Thomas&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> employment. Dr.&nbsp;Thomas&#146;s current base salary is $520,000 and he is eligible to receive an annual bonus with an annual target amount of 50% of his annual base salary.
Dr.&nbsp;Thomas is eligible to participate in the employee benefit plans available to our employees, subject to the terms of such plans. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon termination of
Dr.&nbsp;Thomas&#146;s employment by us without Cause or his resignation for Good Reason outside of the Change in Control Period, as such terms are defined in the Thomas Employment Agreement, subject to (i)&nbsp;Dr.&nbsp;Thomas resigning from all
positions, (ii)&nbsp;signing a general release of claims in favor of the Company and (iii)&nbsp;not breaching any of the post-employment covenants and contractual obligations to the Company, Dr.&nbsp;Thomas shall be entitled to (A)&nbsp;a lump sum
payment equal to nine (9)&nbsp;months of his then current base salary and <FONT STYLE="white-space:nowrap">pro-rated</FONT> target bonus, based on the number of days he was employed in such year, divided by 365, payable within sixty (60)&nbsp;days
following his termination, and (B)&nbsp;if Dr.&nbsp;Thomas was participating in the Company&#146;s group health plan immediately prior to the termination date, a monthly cash payment for nine (9)&nbsp;months in an amount equal to
Dr.&nbsp;Thomas&#146;s and his eligible dependents monthly COBRA premium. In addition, and subject to the same conditions, upon a termination by us without Cause or his resignation for Good Reason during the Change in Control Period, he shall be
entitled to (A)&nbsp;a lump sum payment equal to twelve (12)&nbsp;months of his then current base salary and <FONT STYLE="white-space:nowrap">pro-rated</FONT> target bonus, based on the number of days he was employed in such year, divided by 365,
payable within sixty (60)&nbsp;days following his termination, (B)&nbsp;if Dr.&nbsp;Thomas was participating in the Company&#146;s group health plan immediately prior to the termination date, a monthly cash payment for twelve (12)&nbsp;months in an
amount equal to Dr.&nbsp;Thomas&#146;s and his eligible dependents monthly COBRA premium, and (C)&nbsp;full acceleration of his then outstanding and unvested equity awards. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Jian Irish </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On January&nbsp;19, 2021, the Company executed an offer letter
with Dr.&nbsp;Irish (the &#147;Irish Offer Letter&#148;), for the position of Chief Operations Officer. The Irish Offer Letter provides for Dr.&nbsp;Irish&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> employment. Dr.&nbsp;Irish was promoted
to President and Chief Operating Officer effective November&nbsp;1, 2021. Dr.&nbsp;Irish&#146;s current base salary is $468,000 and she is eligible to receive an annual bonus with an annual target amount of 45% of her annual salary. Dr.&nbsp;Irish
is eligible to participate in the employee benefit plans available to our employees, subject to the terms of such plans. The Irish Offer Letter provides for Dr.&nbsp;Irish&#146;s eligibility to receive a grant of profits interests under the 2019
Plan, which will be subject to full acceleration upon the occurrence of a Change of Control (as defined in the Irish Offer Letter). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon a termination of
Dr.&nbsp;Irish&#146;s agreement by us without Cause, or her resignation for Good Reason, as such terms are defined in the Irish Offer Letter, she will be eligible to receive six (6)&nbsp;months of base salary,
<FONT STYLE="white-space:nowrap">pro-rated</FONT> annual bonus, and six (6)&nbsp;months vesting acceleration. </P> <P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">241 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Dr.&nbsp;Irish entered into an Employee Invention Assignment and Confidentiality Agreement that contains various
restrictive covenants, including <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions that apply during her employment and for a period of twelve months thereafter. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Sarah Noonberg </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On January&nbsp;30, 2023, the Company executed an offer
letter with Dr.&nbsp;Noonberg (the &#147;Noonberg Offer Letter&#148;), for the position of Chief Medical Officer. The Noonberg Offer Letter provides for Dr.&nbsp;Noonberg&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> employment.
Dr.&nbsp;Noonberg&#146;s current base salary is $420,000 and she is eligible to receive an annual bonus with an annual target amount of 40% of her base salary, the target amount for 2023 is prorated given Dr. Noonberg&#146;s employment start date in
January 2023. Dr. Noonberg is eligible to participate in the employee benefit plans available to our employees, subject to the terms of such plans. The Noonberg Offer Letter provides for Dr. Noonberg&#146;s eligibility to receive a grant of profits
interests under the 2019 Plan. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Dr.&nbsp;Noonberg entered into an Employee Invention Assignment and Confidentiality Agreement that contains various restrictive
covenants, including <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions that apply during his employment and for a period of twelve months thereafter. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Employee Benefit and Equity Compensation Plans </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>2019 Equity Incentive
Plan </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The 2019 Plan was initially approved by the board of managers of the Company in March 2019. The 2019 Plan provided for the grant of profits interests,
restricted common units, options to purchase common units and restricted equity units to selected employees, officers, directors and consultants of the Company. The total number of common units available for grant and issuance under the 2019 Plan is
14,604,165 common units. Common units that are (i)&nbsp;cancelled, forfeited, settled in cash, used to pay withholding obligations or that expire by their terms at any time and (ii)&nbsp;that are reacquired by the Company pursuant to a right of
first refusal or repurchase by the Company, will again become available for issuance under the 2019 Plan. Our board of managers administers the 2019 Plan and has the authority to take any action necessary or advisable for the administration of the
2019 Plan. Our board has the right and discretion to grant awards under the 2019 Plan to participants. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Common units designated as profits interests by the board of
managers are intended to meet the definition of a &#147;profits interests&#148; set forth in IRS Revenue Procedures <FONT STYLE="white-space:nowrap">93-27</FONT> and <FONT STYLE="white-space:nowrap">2001-43.</FONT> Accordingly, such profits
interests do not give the holder a share of the proceeds if the Company&#146;s assets were sold at fair market value and the proceeds of such disposition were distributed in a complete liquidation of the Company immediately after the date of grant,
but give the holder a right to share in the appreciation in the value of a common unit from the date of receipt to the future, as determined by the applicable provisions of the Company&#146;s operating agreement in effect immediately prior to the
Reorganization. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon a liquidation event, as defined in the 2019 Plan, the board of managers may in its sole discretion, cancel all outstanding and unexercised
awards, including profits interests and other unvested awards, in each case, without consideration, as of the date of such liquidation event. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The 2019 Plan will
terminate automatically ten (10)&nbsp;years after the later of (i)&nbsp;the date when the board adopted the 2019 Plan and (ii)&nbsp;the date when the board approved the most recent increase in the number of common units reserved under the 2019 Plan,
which was also subsequently approved by the members of the company. The board of managers may amend, suspend or terminate the 2019 Plan at any time and for any reason; provided, that any amendment that would materially adversely impact an award
shall only be effective with respect to such award if the holder thereof so consents prior to the date of the amendment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">242 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>2024 Stock Option and Incentive Plan </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our 2024 Plan was adopted by our board of directors on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024, approved by our stockholders on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024, and will become effective upon the date immediately preceding the date on which the registration statement of which this prospectus is part is declared effective by the
SEC. The 2024 Plan will replace the 2019 Plan. The 2024 Plan provides flexibility to our compensation committee to use various equity-based incentive awards as compensation tools to motivate our workforce. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have initially reserved &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock for the issuance
of awards under the 2024 Plan, or the Initial Limit. The 2024 Plan provides that the number of shares reserved and available for issuance under the 2024 Plan will automatically increase on January&nbsp;1, 2025 and each January&nbsp;1 thereafter, by
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5% of the outstanding number of shares of our common stock on the immediately preceding December&nbsp;31, or such lesser number of shares as determined
by our compensation committee, or the Annual Increase. The number of shares reserved under the 2024 Plan is subject to adjustment in the event of a stock split, stock dividend, or other change in our capitalization. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares we issue under the 2024 Plan will be authorized but unissued shares or shares that we reacquire. The shares of common stock underlying any awards under the
2024 Plan that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without the issuance of stock, or are otherwise terminated
(other than by exercise) will be added back to the shares of common stock available for issuance under the 2024 Plan. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The maximum aggregate number of shares that
may be issued in the form of incentive stock options shall not exceed the Initial Limit, cumulatively increased on January&nbsp;1, 2025 and on each January&nbsp;1 thereafter by the lesser of the Annual Increase for such year or
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The grant date fair value of all awards
made under our 2024 Plan and all other cash compensation paid by us to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director in any calendar year for services as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director shall not
exceed $800,000; provided, however, that such amount shall be $1,000,000 for the calendar year in which the applicable <FONT STYLE="white-space:nowrap">non-employee</FONT> director is initially elected or appointed to the board of directors. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The 2024 Plan will be administered by our compensation committee. Our compensation committee has the full power to select, from among the individuals eligible for
awards, the individuals to whom awards will be granted and the number of shares subject to such awards, to make any combination of awards to participants, to accelerate at any time the exercisability or vesting of any award, to impose any
limitations and/or vesting conditions on each award, and to determine the specific terms and conditions of each award, subject to the provisions of the 2024 Plan. Persons eligible to participate in the 2024 Plan will be those full or part-time
officers, employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, and consultants as selected from time to time by our compensation committee in its discretion. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The 2024 Plan permits the granting of both options to purchase common stock intended to qualify as incentive stock options under Section&nbsp;422 of the Code and options
that do not so qualify. The option exercise price of each option will be determined by our compensation committee but may not be less than 100% of the fair market value of our common stock on the date of grant unless the option (i)&nbsp;is granted
pursuant to a transaction described in, and in a manner consistent with, Section&nbsp;424(a) of the Code, (ii)&nbsp;is granted to an individual who is not subject to United States income tax, or (iii)&nbsp;complies with Section&nbsp;409A of the
Code. The term of each option will be fixed by our compensation committee and may not exceed ten years from the date of grant. Our compensation committee will determine at what time or times each option may be exercised. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">243 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our compensation committee may award stock appreciation rights subject to such conditions and restrictions as it may
determine. Stock appreciation rights entitle the recipient to shares of common stock, or cash, equal to the value of the appreciation in our stock price over the exercise price. The exercise price of each stock appreciation right may not be less
than 100% of the fair market value of our common stock on the date of grant unless the stock appreciation right (i)&nbsp;is granted pursuant to a transaction described in, and in a manner consistent with, Section&nbsp;424(a) of the Code,
(ii)&nbsp;is granted to an individual who is not subject to United States income tax, or (iii)&nbsp;complies with Section&nbsp;409A of the Code. The term of each stock appreciation right will be fixed by our compensation committee and may not exceed
ten years from the date of grant. Our compensation committee will determine at what time or times each stock appreciation right may be exercised. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our compensation
committee may award restricted shares of common stock and restricted stock units to participants subject to such conditions and restrictions as it may determine. These conditions and restrictions may include the achievement of certain performance
goals and/or continued employment with us through a specified vesting period. Our compensation committee may also grant shares of common stock that are free from any restrictions under the 2024 Plan. Unrestricted stock may be granted to participants
in recognition of past services or for other valid consideration and may be issued in lieu of cash compensation due to such participant. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our compensation committee
may grant dividend equivalent rights to participants that entitle the recipient to receive credits for dividends that would be paid if the recipient had held a specified number of shares of our common stock. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our compensation committee may grant cash bonuses under the 2024 Plan to participants, subject to the achievement of certain performance goals. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The 2024 Plan provides that upon the effectiveness of a &#147;sale event,&#148; as defined in the 2024 Plan, an acquirer or successor entity may assume, continue, or
substitute outstanding awards under the 2024 Plan. To the extent that awards granted under the 2024 Plan are not assumed, continued, or substituted by the successor entity, upon the effective time of the sale event, such awards shall terminate. In
such case, except as may be otherwise provided in the relevant award agreement, all awards with time-based vesting, conditions, or restrictions shall become fully vested and exercisable or nonforfeitable as of the effective time of the sale event,
and all awards with conditions and restrictions relating to the attainment of performance goals may become vested and exercisable or nonforfeitable in connection with a sale event in the administrator&#146;s discretion or to the extent specified in
the relevant award agreement. In the event of such termination, individuals holding options and stock appreciation rights (i) may be permitted to exercise such options and stock appreciation rights (to the extent exercisable) within a specified
period of time prior to the sale event or (ii)&nbsp;we may make or provide for a payment, in cash or in kind, to participants holding vested and exercisable options and stock appreciation rights equal&nbsp;to the difference between the per share
consideration payable to stockholders in the sale event and the exercise price of the options or stock appreciation rights. In addition, we may make or provide for a payment, in cash or in kind, to participants holding other vested awards. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors may amend or discontinue the 2024 Plan and our compensation committee may amend or cancel outstanding awards for purposes of satisfying changes in
law or any other lawful purpose but no such action may materially adversely affect rights under an award without the holder&#146;s consent. Certain amendments to the 2024 Plan require the approval of our stockholders. The administrator of the 2024
Plan is specifically authorized to exercise its discretion to reduce the exercise price of outstanding stock options and stock appreciation rights or effect the repricing of such awards through cancellation and
<FONT STYLE="white-space:nowrap">re-grants</FONT> without stockholder consent. No awards may be granted under the 2024 Plan after the date that is ten years from the effective date of the 2024 Plan. No awards have been made under the 2024 Plan prior
to the date of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">244 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>2024 Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The 2024 Employee Stock Purchase Plan, or 2024 ESPP, was adopted by our board of directors on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024, approved by our stockholders on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024, and will
become effective on the date immediately preceding the date on which the registration statement of which this prospectus is part is declared effective by the SEC. The 2024 ESPP includes two components: a Code Section 423 Component, or the 423
Component, and a non-Code Section 423 Component, or the Non-423 Component. The 423 Component is intended to qualify as an &#147;employee stock purchase plan&#148; under Section 423 of the Code. Under the Non-423 Component, which does not qualify as
an &#147;employee stock purchase plan&#148; within the meaning of Section 423 of the Code, options will be granted pursuant to rules adopted by the administrator of the ESPP designed to achieve tax or securities laws, or other objectives for
eligible employees. The 2024 ESPP initially reserves and authorizes the issuance of up to a total of shares of common stock to participating employees. The 2024 ESPP provides that the number of shares reserved and available for issuance will
automatically increase on January 1, 2025 and each January thereafter through January 1, 2034, by the least of (i) shares of common stock, (ii) 1% of the outstanding number of shares of our common stock on the immediately preceding December 31, or
(iii) such number of shares of common stock as determined by the administrator of the 2023 ESPP. The number of shares reserved under the 2024 ESPP is subject to adjustment in the event of a stock split, stock dividend, or other change in our
capitalization. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">All individuals classified as employees on the payroll records of the Company or a &#147;designated company.&#148; as defined in the 2024 ESPP, as
of the first day of the applicable offering period, or the Offering Date, are eligible to participate in the 2024 ESPP; provided that the administrator of the ESPP may determine, in advance of any offering period, that employees are eligible only
if, as of the Offering Date, they (a) are customarily employed by us or a Designated Company for more than 20 hours a week, (b) are customarily employed by us or a Designated Company for more than five months per calendar year, and/or (c) have
completed at least six months of employment (or other such period as determined by the administrator of the 2024 ESPP, provided such service requirement does not exceed two years of employment). No person who owns or holds, or as a result of
participation in the 2024 ESPP would own or hold, common stock or options to purchase common stock, that together equal 5% or more of total outstanding common stock is entitled to participate in the 2024 ESPP. No employee may exercise an option
granted under the 2024 ESPP that permits the employee to purchase common stock having a value of more than $25,000 (determined using the fair market value of our common stock at the time such option is granted) in any calendar year. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We may make one or more offerings each year to our employees to purchase shares under the 2024 ESPP. The first offering period under the ESPP will begin and end on the
dates determined by the administrator of the 2024 ESPP. Shares are purchased on the last business day of each offering period. Each eligible employee will be able to elect to participate in any offering by submitting an enrollment form by such
deadline as is established by the administrator of the 2024 ESPP. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each employee who is a participant in the 2024 ESPP will be able to purchase shares by authorizing
payroll deductions of up to 15% of such employee&#146;s eligible compensation during an offering period. Unless the participating employee has previously withdrawn from the offering, such employee&#146;s accumulated payroll deductions will be used
to purchase shares of common stock on the last business day of the offering period at a price equal to 85% of the fair market value of the shares on the first business day or the last business day of the offering period, whichever is lower, provided
that no more than a number of shares of common stock determined by dividing $25,000 by the fair market value of the common stock on the first day of the offering may be purchased by any one employee during any offering period. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the case of and subject to the consummation of a &#147;sale event,&#148; as defined in the 2024 ESPP, the administrator of the 2024 ESPP, in its discretion, and on
such terms and conditions as it deems appropriate, is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">245 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
authorized to take any one or more of the following actions under the 2024 ESPP or with respect to any right under the 2024 ESPP or to facilitate such transactions or events: (a) provide for
either (i) termination of any outstanding option in exchange for an amount of cash, if any, equal to the amount that would have been obtained upon the exercise of such option had such option been currently exercisable or (ii) the replacement of such
outstanding option with other options or property selected by the administrator of the 2024 ESPP in its sole discretion; (b) provide that the outstanding options under the 2024 ESPP shall be assumed by the successor or survivor corporation, or a
parent or subsidiary thereof, or shall be substituted for similar options covering the stock of the successor or survivor corporation, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and prices;
(c) make adjustments in the number and type of shares of common stock (or other securities or property) subject to outstanding options under the 2024 ESPP and/or in terms and conditions of outstanding options and options that may be granted in the
future; (d) provide that the offering with respect to which an option relates will be shortened by setting a new exercise date on which such offering period will end; and (e) provide that all outstanding options shall terminate without being
exercised and all amounts in the accounts of participants shall be promptly refunded. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The accumulated payroll deductions of any employee who is not a participant on
the last day of an offering period will be refunded. An employee&#146;s rights under the 2024 ESPP will terminate upon voluntary withdrawal from the 2024 ESPP or when the employee ceases employment with us for any reason. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The 2024 ESPP may be terminated or amended by our board of directors at any time. An amendment that increases the number of shares of common stock authorized under the
2024 ESPP and certain other amendments will require the approval of our stockholders. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Senior Executive Cash Incentive Bonus Plan </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024, our board of directors adopted the Senior Executive Cash
Incentive Bonus Plan, or the Bonus Plan. The Bonus Plan provides for cash bonus payments based upon Company and individual performance targets established by our compensation committee. The payment targets will be related to financial and
operational measures or objectives with respect to our company, or the Corporate Performance Goals, as well as individual performance objectives. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our compensation
committee may select Corporate Performance Goals from among the following: research, pre-clinical, non-clinical, developmental, publication, clinical or regulatory milestones; scientific or technological advances; R&amp;D capabilities;&nbsp;cash
flow (including, but not limited to, operating cash flow and free cash flow); revenue; corporate revenue; earnings before interest, taxes, depreciation and amortization; net income (loss) (either before or after interest, taxes, depreciation and/or
amortization); changes in the market price of the Company&#146;s common stock; economic value-added; acquisitions or strategic transactions; operating income (loss); return on capital, assets, equity, or investment; stockholder returns; return on
sales; gross or net profit levels; productivity; expense efficiency; margins; operating efficiency; customer satisfaction; working capital; earnings (loss) per share of the Company&#146;s common stock; bookings, new bookings or renewals; sales or
market shares; number of customers, number of new customers or customer references; operating income and/or net annual recurring revenue; or any other performance goal selected by the Compensation Committee, any of which may be (A)&nbsp;measured in
absolute terms or compared to any incremental increase, (B) measured in terms of growth, (C) compared to another company or companies or to results of a peer group, (D) measured against the market as a whole and/or as compared to applicable market
indices and/or (E) measured on a pre-tax or post-tax basis (if applicable). Further, any Corporate Performance Goals may be used to measure the performance of the Company as a whole or a business unit or other segment of the Company, or one or more
product lines or specific markets.&nbsp;The Corporate Performance Goals may differ from Covered Executive to Covered Executive and from performance period to performance period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">246 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each executive officer who is selected to participate in the Bonus Plan will have a target bonus opportunity set for
each performance period. The bonus formulas will be adopted in each performance period by the compensation committee and communicated to each executive. The Corporate Performance Goals will be measured at the end of each performance period after our
financial reports have been published or such other appropriate time as the compensation committee determines. If the corporate performance goals and individual performance objectives are met, payments will be made as soon as practicable following
the end of each performance period, but not later than 74 days after the end of the fiscal year in which such performance period ends. Subject to any rights contained in any agreement between the executive officer and us, an executive officer shall
be required to be employed by us on the bonus payment date to be eligible to receive a bonus payment under the Bonus Plan. The Bonus Plan also permits the compensation committee to approve additional bonuses to executive officers in its sole
discretion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">247 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_15"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>2023 Director Compensation Table </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table presents the total
compensation paid by the Company to <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our board of managers during the fiscal year ended December&nbsp;31, 2023. Other than as set forth in the table and described more fully below, we
did not pay any compensation, make any equity awards or <FONT STYLE="white-space:nowrap">non-equity</FONT> awards to, or pay any other compensation to any of the members of our board of managers in 2023 for their services as members of the board of
managers. Dr.&nbsp;Thomas, our Chief Executive Officer, does not receive any compensation from the Company for his service on our board of managers. See the section titled &#147;Executive Compensation&#148; for more information on the compensation
paid to or earned by Dr.&nbsp;Thomas as an employee for year ended December&nbsp;31, 2023. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Name</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Fees&nbsp;Earned<BR>or Paid in<BR>Cash ($)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>All&nbsp;Other<BR>Compensati<BR>on(3)&nbsp;($)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Total&nbsp;($)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sebasti&aacute;n Bernales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Willard H. Dere(1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Juergen Eckhardt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Santosh Palani</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Risa Stack(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="16" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Dr.&nbsp;Dere and Dr.&nbsp;Stack each held 21,080 and 10,540 unvested profits interests granted under the 2019 Plan as of December&nbsp;31, 2023. None of our other <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors held any equity awards as of December&nbsp;31, 2023. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We entered into an Independent Manager Offer Letter with Dr.&nbsp;Dere, pursuant to which he is eligible to receive cash compensation of $30,000 for each calendar year for his services to our board of managers.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported in this column represent amounts paid to Dr. Dere in 2023 under his consulting agreement with the Company, which terminated in July 2023. </TD></TR></TABLE>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Policy </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with this offering, we intend to adopt a new <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy that will become effective
as of the completion of this offering and will be designed to enable us to attract and retain, on a long-term basis, highly qualified <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the policy, <FONT STYLE="white-space:nowrap">our&nbsp;non-employee&nbsp;directors</FONT> will be eligible to receive cash retainers (which will be payable
quarterly in arrears and prorated for partial years of service) and equity awards as set forth below: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Annual Retainer for Board Membership</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">for general availability and participation in meetings and conference calls of our Board of
Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Additional Annual Retainer for Committee Membership</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Audit Committee Chairperson: </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Audit Committee member (other than Chairperson): </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Compensation Committee Chairperson: </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Compensation Committee member (other than Chairperson): </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Nominating and Corporate Governance Committee Chairperson: </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Nominating and Corporate Governance Committee member (other than Chairperson): </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Science&nbsp;&amp; Technology Committee Chairperson: </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Science&nbsp;&amp; Technology Committee member (other than Chairperson): </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Additional Retainer
for</B><B></B><B><FONT STYLE="white-space:nowrap">&nbsp;Non-Executive</FONT></B><B></B><B>&nbsp;Chairperson of the Board</B>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">248 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, our policy will provide that, upon initial election or appointment to our board of directors, each <FONT
STYLE="white-space:nowrap">new&nbsp;non-employee&nbsp;director</FONT> will be granted <FONT STYLE="white-space:nowrap">a&nbsp;one-time&nbsp;grant</FONT> of <FONT STYLE="white-space:nowrap">a&nbsp;non-statutory&nbsp;stock</FONT> option to purchase
shares of our common stock equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in value on the date of such director&#146;s election or appointment to the board of directors (the &#147;Director Initial Grant&#148;). The Director Initial
Grant will vest&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, subject to the <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s continued services to the us. On the date of each
annual meeting of stockholders of our company following the completion of this offering, each non-employee director who will continue as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director following such meeting will be granted an annual
award of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option to purchase shares of common stock equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in value (the &#147;Director Annual Grant&#148;). The Director Annual
Grant will vest in full on the earlier of the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the grant date or on the date of our next annual meeting of stockholders, subject to the
<FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s continued services to us. Such awards are subject to full acceleration vesting upon the sale of our company. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The aggregate amount of compensation, including both equity compensation and cash compensation, paid to
<FONT STYLE="white-space:nowrap">any&nbsp;non-employee&nbsp;director</FONT> for service as <FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> in a calendar year period will not exceed
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in the first calendar year such individual becomes <FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> and
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in any other calendar year. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We will reimburse all <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">reasonable&nbsp;out-of-pocket&nbsp;expenses</FONT></FONT> incurred by directors for their attendance at meetings of our board of directors or any committee thereof. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Employee directors will receive no additional compensation for their service as a director. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">249 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_16"></A>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following is a description of transactions or series of transactions since January&nbsp;1, 2020, to which we were or will be a party, in which: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the amount involved in the transaction exceeds, or will exceed, $120,000; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">in which any of our executive officers, directors or holder of five percent or more of any class of our capital stock,
including their immediate family members or affiliated entities, had or will have a direct or indirect material interest. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Compensation
arrangements for our named executive officers and our directors are described elsewhere in this prospectus under &#147;Executive Compensation&#148; and &#147;Director Compensation.&#148; </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Series&nbsp;A-4 and Series&nbsp;A-5 Preferred Unit Financings </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">From 2020 to
2021, we sold an aggregate of 9,861,297 Series A-4 and Series A-5 preferred units in multiple closings, consisting of (i) 8,280,360 Series <FONT STYLE="white-space:nowrap">A-4</FONT> preferred units sold at a purchase price of $4.84875 per unit for
an aggregate amount of $40.1&nbsp;million and (ii) 1,580,937 Series <FONT STYLE="white-space:nowrap">A-5</FONT> preferred units sold at a purchase price of $6.32536 per unit for an aggregate amount of $10.0&nbsp;million, for total aggregate proceeds
of $50.1&nbsp;million. The following table summarizes purchases of our Series A-4 and Series A-5 preferred units as described above by related persons: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Stockholder</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Numbers&nbsp;of&nbsp;Series&nbsp;A-4/Series&nbsp;A-5</FONT></FONT></B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>preferred units</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Total purchase<BR>price</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Bayer HealthCare LLC(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,062,387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,999,998.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Humboldt Fund I, LP(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,062,387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,999,998.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Entities affiliated with RA Capital(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,999,995.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sake Holdings LLC(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">929,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,504,813.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Entities affiliated with Sozo Ventures(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">710,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,447,010.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="8" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Juergen Eckhardt, a manager on our board of managers, is an affiliate of Bayer Consumer Care AG, which is an affiliate of Bayer HealthCare LLC. Bayer HealthCare LLC holds more than 5 percent of our voting securities.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Sebasti&aacute;n Bernales, a manager on our board of managers, is an affiliate of Humboldt Fund. Humboldt Fund I, LP is an affiliated fund of Humboldt Fund. Humboldt Fund I, LP holds more than 5 percent of our voting
securities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents 1,343,796 Series A-5 preferred units purchased by RA Capital Healthcare Fund, L.P. and 237,141 Series A-5 preferred units purchased by RA Capital Nexus Fund II, L.P. Entities affiliated with RA Capital
collectively hold more than 5 percent of our voting securities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Sebasti&aacute;n Bernales, a manager on our board of managers, is an affiliate of Sake Holdings LLC. Sake Holdings LLC holds more than 5 percent of our voting securities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(5)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents 319,908 Series A-4 preferred units purchased by Sozo Ventures &#150; Truebridge Fund II, L.P. and 390,999 Series A-4 preferred units purchased by Sozo Ventures II-S, L.P. Entities affiliated with Sozo
Ventures collectively hold more than 5 percent of our voting securities. </TD></TR></TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Series B Preferred Unit Financing </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In 2022 and 2023, we sold an aggregate of 22,162,743 Series B and Series B-1 preferred units in multiple closings, consisting of (i) 15,054,263 Series&nbsp;B preferred
units, which includes (a) 12,446,876 Series B preferred units sold at a purchase price of $11.64951 per unit and (b) 2,607,387 Series B preferred units which converted pursuant to a promissory note with a principal amount of $30.0&nbsp;million and
accrued interest of $0.4 million </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">250 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
between the Company and ModernaTx, Inc., for an aggregate amount of $175.4&nbsp;million and (ii) 7,108,480 Series <FONT STYLE="white-space:nowrap">B-1</FONT> preferred units sold at a purchase
price of $14.06770 per unit for an aggregate amount of $100.0&nbsp;million, for total aggregate proceeds of $275.4&nbsp;million. The following table summarizes purchases of our Series B and Series B-1 preferred units by related persons: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Stockholder</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B><FONT STYLE="white-space:nowrap">Numbers&nbsp;of&nbsp;Series&nbsp;B/Series&nbsp;B-1</FONT></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>preferred&nbsp;units</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Total purchase<BR>price</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">ModernaTX, Inc.(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,982,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,655,978.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Bayer HealthCare LLC(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,920,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,529,689.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Humboldt Fund I, LP(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,825,929.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Entities affiliated with RA Capital(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,000,002.54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Entities affiliated with Sozo Ventures(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,442,237.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="8" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents 2,607,387 Series B preferred units and 375,413 Series B-1 preferred units. ModernaTX, Inc. holds more than 5 percent of our voting securities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents 1,030,086 Series B preferred units and 890,671 Series B-1 preferred units. Juergen Eckhardt, a manager on our board of managers, is an affiliate of Bayer Consumer Care AG, which is an affiliate of Bayer
HealthCare LLC. Bayer HealthCare LLC holds more than 5 percent of our voting securities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents 1,143,905 Series B preferred units and 106,627 Series B-1 preferred units. Sebasti&aacute;n Bernales, a manager on our board of managers, is an affiliate of Humboldt Fund. Humboldt Fund I, LP is an affiliated
fund of Humboldt Fund. Humboldt Fund I, LP holds more than 5 percent of our voting securities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents 600,883 Series B preferred units and 99,519 Series B-1 preferred units purchased by RA Capital Healthcare Fund, L.P., and 257,522 Series B preferred units and 42,651 Series B-1 preferred units purchased by RA
Capital Nexus Fund II, L.P. Entities affiliated with RA Capital collectively hold more than 5&nbsp;percent of our voting securities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(5)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents 429,202 Series B preferred units and 386,861 Series B-1 preferred units purchased by Sozo Ventures lll, L.P. Entities affiliated with Sozo Ventures collectively hold more than 5 percent of our voting
securities. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Agreements with Unitholders </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with
our Series&nbsp;A-1, Series&nbsp;A-2, Series&nbsp;A-3, Series&nbsp;A-4, and Series&nbsp;A-5 preferred unit financings and our Series&nbsp;B preferred unit financing, we entered into investors&#146; rights, voting and right of first refusal and <FONT
STYLE="white-space:nowrap">co-sale</FONT> agreements containing registration rights, information rights, voting rights and rights of first refusal, among other things, with certain holders of our preferred units and certain holders of our common
units. These unitholder agreements will terminate upon the closing of this offering, except for the registration rights granted under our investors&#146; rights agreement, as more fully described in &#147;Description of Capital
Stock&#151;Registration Rights.&#148; </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with our Series <FONT STYLE="white-space:nowrap">A-4</FONT> preferred unit financing, we entered into a side
letter agreement (the &#147;Humboldt Side Letter&#148;), with Humboldt Fund I, LP (&#147;Humboldt&#148;). Pursuant to the Humboldt Side Letter, we represented and warranted to Humboldt regarding certain U.S. tax status and CFIUS matters. We agreed
that Humboldt would not be deemed a competitor for any purpose under the financing agreements. We further agreed to use commercially reasonable efforts to comply with all record-keeping, reporting and other reasonable request necessary to comply
with any applicable U.S. tax law or to allow Humboldt and its Partners to comply with the applicable provisions of U.S. tax law with respect to the direct or indirect ownership of the Company. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with our Series A-5 preferred unit financing, we entered into a side letter agreement (the &#147;RA Capital Side Letter&#148;), with RA Capital Healthcare
Fund, L.P. and RA Capital Nexus Fund II, L.P. (collectively, &#147;RA Capital&#148;). Pursuant to the RA Capital Side Letter, RA Capital is entitled to purchase a portion of the preferred units in the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">251 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
event that the Company sells preferred units in a single transaction or series of related transactions following the date of the RA Capital Side Letter, primarily for capital raising purposes,
with gross proceeds to the Company in excess of $10,000,000. In addition, the Series A-5 preferred units held by RA Capital shall not be automatically converted into common units without the prior written approval of RA Capital, but shall remain
subject to conversion immediately upon the closing of this offering. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We entered into a research and development master service agreement (the &#147;Bayer R&amp;D
Agreement&#148;), with Bayer Healthcare LLC (&#147;Bayer&#148;), in November 2019. Bayer was performing research and development services under the Bayer R&amp;D Agreement in accordance with the statement of works agreed by the parties. Services
under the Bayer R&amp;D Agreement were completed as of December&nbsp;31, 2020, and we accrued $0.2&nbsp;million in accrued expenses and other current liabilities as of December&nbsp;31, 2020. We paid $0.2&nbsp;million to Bayer in February and March
2021 in connection with the Bayer R&amp;D Agreement. </P> <P STYLE="font-size:16pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Convertible Promissory Note with <FONT
STYLE="white-space:nowrap">Affini-T</FONT> </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In December 2020, we entered into a convertible promissory note agreement and a side letter with <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics, Inc. <FONT STYLE="white-space:nowrap">(&#147;Affini-T&#148;),</FONT> a private biotechnology company. We paid cash of $1.5&nbsp;million as a principal amount of the promissory note with 6%
annual interest and maturity in December 2021. The promissory note was convertible in <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> next qualifying round of financing at a conversion price equal to the lesser of (i)&nbsp;85% of the price
per share paid by other investors (or 80% if the qualified financing occurs after June&nbsp;24, 2021) or (ii)&nbsp;the price per share obtained by dividing $30.0&nbsp;million by the number of shares of common stock of
<FONT STYLE="white-space:nowrap">Affini-T</FONT> outstanding immediately prior to the qualified financing. In accordance with the side letter, we were engaged to perform the certain services for <FONT STYLE="white-space:nowrap">Affini-T.</FONT> As a
consideration for services, we received 1,867,300 shares of <FONT STYLE="white-space:nowrap">Affini-T</FONT> common stock, of which 10% of such shares were vested at the issuance date and 90% of such shares were subject to forfeiture if no genome
editing licensing agreement was finalized between us and <FONT STYLE="white-space:nowrap">Affini-T</FONT> by October&nbsp;31, 2021. Effective November&nbsp;1, 2021, 1,653,570 common stock shares issued to us were forfeited and cancelled as the
license agreement was not signed between the parties. When we entered into the convertible promissory note, our chief business officer at the time also served as chief executive officer of <FONT STYLE="white-space:nowrap">Affini-T.</FONT> Our chief
business officer departed the company in November 2021 and <FONT STYLE="white-space:nowrap">Affini-T</FONT> was no longer a related party of the company as of December&nbsp;31, 2021. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In March 2022, <FONT STYLE="white-space:nowrap">Affini-T</FONT> closed a qualified round of financing, and the convertible promissory note and accrued interest were
converted into 527,035 shares of Series A convertible preferred stock of <FONT STYLE="white-space:nowrap">Affini-T.</FONT> </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Equity Grants to Executive Officers
</B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have historically granted profits interests to our named executive officers as more fully described in the section entitled &#147;Executive
Compensation&#148;. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Indemnification Agreements </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with this
offering, we intend to enter into new agreements to indemnify our directors and executive officers. These agreements will, among other things, require us to indemnify these individuals for certain expenses (including attorneys&#146; fees),
judgments, fines and settlement amounts reasonably incurred by such person in any action or proceeding, including any action by or in our right, on account of any services undertaken by such person on behalf of our company or that person&#146;s
status as a member of our board of directors to the maximum extent allowed under Delaware law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">252 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Policies for Approval of Related Party Transactions </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our board of directors reviews and approves transactions with directors, officers, and holders of five percent or more of our voting securities and their affiliates,
each a related party. Prior to this offering, the material facts as to the related party&#146;s relationship or interest in the transaction were disclosed to our board of directors prior to their consideration of such transaction, and the
transaction was not considered approved by our board of directors unless a majority of the directors who are not interested in the transaction approved the transaction. Further, when stockholders are entitled to vote on a transaction with a related
party, the material facts of the related party&#146;s relationship or interest in the transaction were disclosed to the stockholders, who must approve the transaction in good faith. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with this offering, we expect to adopt a written related party transactions policy that will provide that such transactions must be approved by our audit
committee. This policy will become effective on the date on which the registration statement of which this prospectus forms a part is declared effective by the SEC. Pursuant to this policy, the audit committee has the primary responsibility for
reviewing and approving or disapproving &#147;related party transactions,&#148; which are transactions between us and related persons in which the aggregate amount involved exceeds or may be expected to exceed $120,000 and in which a related person
has or will have a direct or indirect material interest. For purposes of this policy, a related person will be defined as a director, executive officer, nominee for director, or greater than 5&nbsp;percent beneficial owner of our common stock, in
each case since the beginning of the most recently completed year, and their immediate family members. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">253 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_17"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table sets forth, as of September&nbsp;30, 2023, information regarding the beneficial ownership of our common stock by: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">each person, or group of affiliated persons, who is known by us to be the beneficial owner of five percent or more of our
outstanding common stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to common stock basis); </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">each of our directors; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">each of our named executive officers; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">all of our current directors and executive officers as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The information in the following table gives effect to the Reorganization and is calculated based
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock deemed to be outstanding before this offering
and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock outstanding after this offering, assuming no exercise by the underwriters of their option to purchase additional shares of
common stock. The number of shares outstanding is based on the number of shares of common stock outstanding (including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of unvested restricted
common stock) as of September&nbsp;30, 2023 as adjusted to give effect to: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the conversion of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares
of our redeemable convertible preferred stock outstanding as of September&nbsp;30, 2023 into an equivalent number of shares of our common stock, which will occur immediately prior to the completion of this offering; and </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the sale of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common
stock in this offering (assuming no exercise of the underwriters&#146; option to purchase additional shares). </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each individual or entity shown on
the table has furnished information with respect to beneficial ownership. Except as otherwise indicated below, the address of each officer, director and five percent stockholder listed below is c/o Metagenomi Technologies, LLC, 1545 Park Avenue,
Emeryville, California 94608. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">254 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have determined beneficial ownership in accordance with the rules of the SEC, and the information is not
necessarily indicative of beneficial ownership for any other purpose. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities as well
as any shares of common stock that the person has the right to acquire within 60&nbsp;days of September&nbsp;30, 2023 through the exercise of stock options or other rights. These shares are deemed to be outstanding and beneficially owned by the
person holding those options for the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Unless otherwise indicated, the
persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1.00px solid #000000"><B>Shares of<BR>common&nbsp;stock<BR>beneficially<BR>owned</B></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Percentage&nbsp;of&nbsp;shares<BR>beneficially&nbsp;owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Before&nbsp;offering</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>After&nbsp;offering</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>5% or Greater Stockholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Bayer HealthCare LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Humboldt Fund I, LP (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">ModernaTX, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sake Holdings LLC (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Entities affiliated with Sozo Ventures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Entities affiliated with RA Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Directors, Named Executive Officers and Other Executive Officers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Brian C. Thomas, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Juergen Eckhardt, M.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sebasti&aacute;n Bernales, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Risa Stack, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Willard Dere, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Santhosh Palani, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Jian Irish, Ph.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Simon Harnest, MSc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">All executive officers and directors as a group (12
persons)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Less than one percent. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of redeemable convertible preferred stock held by Humboldt Fund I, LP. Humboldt Fund I, LP is solely managed by Humboldt
Capital, LLC, which is in turn managed by Sebastian Bernales, Francisco Dopazo and Benjamin Quiroga. As a result, each such individual may be deemed to share voting and dispositive power with respect to the shares held by Humboldt Fund I, LP. Each
of Mr.&nbsp;Bernales, Dopazo and Quiroga expressly disclaims beneficial ownership of the shares held by Humboldt Fund I, LP, except to the extent of his pecuniary interest in such shares. The address for Humboldt Fund I, LP is 477&nbsp;Madison Ave.,
6th&nbsp;Floor, New York, NY&nbsp;10022. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of redeemable convertible preferred stock held by Sake Holdings LLC. Sake Holdings LLC is managed by its board of directors
which consists of Sebastian Bernales and Eduardo Ergas. As a result, each such individual may be deemed to share voting and dispositive power with respect to the shares held by Sake Holdings LLC. Each of Mr.&nbsp;Bernales and Mr.&nbsp;Ergas
expressly disclaims beneficial ownership of the shares held by Sake Holdings LLC, except to the extent of his pecuniary interest in such shares. The address for Sake Holdings LLC is 1700 Owens Street, Suite&nbsp;515, San Francisco, CA&nbsp;94158.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">255 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_18"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following descriptions are summaries of the material terms of our amended and restated certificate of incorporation and amended and restated bylaws, which will be
effective immediately upon the closing of this offering. The descriptions of the common stock and preferred stock give effect to changes to our capital structure, including the Reorganization, that will occur prior to the effectiveness of this
registration statement. We refer in this section to our amended and restated certificate of incorporation as our certificate of incorporation, and we refer to our amended and restated bylaws as our bylaws. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>General </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon completion of this offering, our authorized capital stock will
consist of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock, par value $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share,
and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of preferred stock, par value $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, all of which shares of preferred stock will be
undesignated. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of September 30, 2023,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock
were outstanding and held of record by&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;stockholders, after giving effect to the Reorganization. This amount assumes the conversion of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our redeemable convertible preferred stock outstanding as of September 30, 2023 into an equivalent number of shares of our common stock, which
will occur immediately prior to the closing of this offering. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Common Stock </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the common stockholders. The holders of our common
stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any dividends declared by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights
of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in all assets remaining after payment of all
debts and other liabilities and any liquidation preference of any outstanding preferred stock. The shares to be issued by us in this offering will be, when issued and paid for, validly issued, fully paid and
<FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Preferred Stock </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Immediately prior to the completion of this offering, all outstanding shares of our preferred stock will be converted into shares of our common stock. Upon the closing
of this offering, our board of directors will have the authority, without further action by our stockholders, to issue up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of preferred stock in
one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences,
sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of common stock. The issuance of our preferred stock could adversely affect the voting power of holders
of common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our
company or other corporate action. Immediately after consummation of this offering, no shares of preferred stock will be outstanding, and we have no present plan to issue any shares of preferred stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">256 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Options </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We expect to
reserve&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock for future issuance under the 2024 Plan. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Registration Rights </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon the completion of this offering, the holders
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, including those issuable upon the conversion of preferred stock upon closing of this offering, will be entitled to rights
with respect to the registration of these securities under the Securities Act. These rights are provided under the terms of an amended and restated investors&#146; rights agreement between us, certain holders of our common stock and holders of our
preferred stock. The amended and restated investors&#146; rights agreement includes demand registration rights, short-form registration rights and piggyback registration rights. All fees, costs, and expenses of underwritten registrations under this
agreement will be borne by us and all selling expenses, including underwriting discounts and selling commissions, will be borne by the holders of the shares being registered. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Demand Registration Rights </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Beginning 180 days after the effective
date of this registration statement, the holders of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, including those issuable upon the conversion of shares of our preferred
units upon closing of this offering, are entitled to demand registration rights. Under the terms of the amended and restated investors&#146; rights agreement, we will be required, upon the written request of holders of at least a majority of the
securities eligible for registration then outstanding to file a registration statement with respect to at least a majority of the securities eligible for registration then outstanding, we will be required to file a registration statement within 60
days of such request covering all securities eligible for registration that our securityholders request to be included in such registration. We are required to effect only one registration pursuant to this provision of the amended and restated
investors&#146; rights agreement in any twelve-month period. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Short-Form Registration Rights </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the amended and restated investors&#146; rights agreement, if we are eligible to file a registration statement on Form
<FONT STYLE="white-space:nowrap">S-3,</FONT> upon the written request of securityholders holding at least twenty percent of the securities eligible for registration then outstanding we will be required to file a Form
<FONT STYLE="white-space:nowrap">S-3</FONT> registration restatement with respect to outstanding securities of such securityholders having an aggregate price to the public of at least $5&nbsp;million. We are required to effect only two registrations
in any twelve-month period pursuant to this provision of the amended and restated investors&#146; rights agreement. The right to have such shares registered on Form <FONT STYLE="white-space:nowrap">S-3</FONT> is further subject to other specified
conditions and limitations. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Piggyback Registration Rights </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the amended and restated investors&#146; rights agreement, if we register any of our securities either for our own account or for the account of other
security holders, the holders of our common stock, including those issuable upon the conversion of our preferred units, are entitled to include their shares in the registration. Subject to certain exceptions contained in the amended and restated
investors&#146; rights agreement, we and the underwriters may limit the number of shares included in the underwritten offering to the number of shares which we and the underwriters determine in our sole discretion will not jeopardize the success of
the offering. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Indemnification </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our amended and restated
investors&#146; rights agreement contains customary cross-indemnification provisions, under which we are obligated to indemnify holders of registrable securities in the event of material misstatements
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">257 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
or omissions in the registration statement attributable to us, and they are obligated to indemnify us for material misstatements or omissions attributable to them. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Expiration of Registration Rights </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The demand registration rights, and
short form registration rights granted under the amended and restated investors&#146; rights agreement will terminate on the earliest to occur of (a)&nbsp;the closing of certain liquidation events, (b)&nbsp;the fifth anniversary of the completion of
this offering or (c)&nbsp;at such time after this offering when the holders&#146; shares may be sold without restriction pursuant to Rule 144 under the Securities Act within a three month period. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Expenses </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Ordinarily, other than underwriting discounts and
commissions, we are generally required to pay all expenses incurred by us related to any registration effected pursuant to the exercise of these registration rights. These expenses may include all registration and filing fees, printing expenses,
fees and disbursements of our counsel, reasonable fees, and disbursements of a counsel for the selling security holders and <FONT STYLE="white-space:nowrap">blue-sky</FONT> fees and expenses. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Anti-Takeover Effects of Delaware Law and Certain Provisions of Our Certificate of Incorporation and Bylaws to be in Effect Upon the Completion of this Offering
</B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Some provisions of Delaware law include, and our certificate of incorporation and bylaws to be in effect upon the completion of this offering will include a
number of provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our
board of directors rather than pursue <FONT STYLE="white-space:nowrap">non-negotiated</FONT> takeover attempts. These provisions include the items described below. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Board Composition and Filling Vacancies </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our certificate of
incorporation will provide for the division of our board of directors into three classes serving staggered three-year terms, with one class being elected each year. Our certificate of incorporation also will provide that directors may be removed
only for cause and then only by the affirmative vote of the holders of <FONT STYLE="white-space:nowrap">two-thirds</FONT> or more of the shares then entitled to vote at an election of directors. Furthermore, any vacancy on our board of directors,
however occurring, including a vacancy resulting from an increase in the size of our board, may only be filled by the affirmative vote of a majority of our directors then in office even if less than a quorum. The classification of directors,
together with the limitations on removal of directors and treatment of vacancies, has the effect of making it more difficult for stockholders to change the composition of our board of directors. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>No Written Consent of Stockholders </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our certificate of incorporation
will provide that all stockholder actions are required to be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the
amount of time required to take stockholder actions and would prevent the amendment of our bylaws or removal of directors by our stockholders without holding a meeting of stockholders. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Meetings of Stockholders </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our certificate of incorporation and bylaws
will provide that only a majority of the members of our board of directors then in office may call special meetings of stockholders and only those matters set forth in the notice </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">258 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
of the special meeting may be considered or acted upon at a special meeting of stockholders. Our bylaws will limit the business that may be conducted at an annual meeting of stockholders to those
matters properly brought before the meeting. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Advance Notice Requirements </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our bylaws will establish advance notice procedures with regard to stockholder proposals relating to the nomination of candidates for election as directors or new
business to be brought before meetings of our stockholders. These procedures will provide that notice of stockholder proposals must be timely given in writing to our corporate secretary prior to the meeting at which the action is to be taken.
Generally, to be timely, notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the annual meeting for the preceding year. Our bylaws will specify the
requirements as to form and content of all stockholders&#146; notices. These requirements may preclude stockholders from bringing matters before the stockholders at an annual or special meeting. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Amendment to Certificate of Incorporation and Bylaws </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any amendment of
our certificate of incorporation must first be approved by a majority of our board of directors, and if required by law or our certificate of incorporation, must thereafter be approved by a majority of the outstanding shares entitled to vote on the
amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of the provisions relating to stockholder action, board composition, limitation of liability and the amendment of our
bylaws and certificate of incorporation must be approved by not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares entitled to vote on the amendment, and not less than
<FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares of each class entitled to vote thereon as a class. Our bylaws may be amended by the affirmative vote of a majority of the directors then in office, subject to any
limitations set forth in the bylaws; and may also be amended by the affirmative vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares entitled to vote on the amendment, or, if our board of directors recommends
that the stockholders approve the amendment, by the affirmative vote of the majority of the outstanding shares entitled to vote on the amendment, in each case voting together as a single class. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Undesignated Preferred Stock </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our certificate of incorporation will
provide for&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;authorized shares of preferred stock. The existence of authorized but unissued shares of preferred stock may enable our board of directors to
discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not
in the best interests of our stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of
the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our certificate of incorporation will grant our board of directors broad power to establish the rights and preferences of authorized and unissued shares of
preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including
voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Delaware Anti-Takeover Statute
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon completion of this offering, we will be subject to the provisions of Section&nbsp;203 of the Delaware General Corporation Law. In general,
Section&nbsp;203 prohibits a publicly held Delaware corporation from engaging in a </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">&#147;business combination&#148; with an &#147;interested stockholder&#148; for a
three-year period following the time that this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">259 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section&nbsp;203, a business combination between a corporation and an
interested stockholder is prohibited unless it satisfies one of the following conditions: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">before the stockholder became interested, our board of directors approved either the business combination or the
transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested
stockholder owned at least 85&nbsp;percent of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and
also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">at or after the time the stockholder became interested, the business combination was approved by our board of directors and
authorized at an annual or special meeting of the stockholders by the affirmative vote of at <FONT STYLE="white-space:nowrap">least&nbsp;two-thirds&nbsp;of</FONT> the outstanding voting stock which is not owned by the interested stockholder.
</P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Section&nbsp;203 defines a business combination to include: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any merger or consolidation involving the corporation and the interested stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any sale, transfer, lease, pledge, exchange, mortgage or other disposition involving the interested stockholder of
10&nbsp;percent or more of the assets of the corporation; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the
corporation to the interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial
benefits provided by or through the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In general, Section&nbsp;203 defines an interested stockholder as any entity or person
beneficially owning 15&nbsp;percent or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Choice of Forum </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our bylaws will provide that, unless we consent in writing
to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any state law claims for (1)&nbsp;any derivative action or proceeding brought on our behalf, (2)&nbsp;any action
asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, and employees to us or our stockholders, (3)&nbsp;any action asserting a claim arising pursuant to the Delaware General Corporation Law, our certificate of
incorporation or our bylaws (including the interpretation, validity or enforceability thereof), or (4)&nbsp;any action asserting a claim that is governed by the internal affairs doctrine; provided, however, that the this provision shall not apply to
any causes of action arising under the Securities Act or Exchange Act. In addition, our bylaws will provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the
sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. Any person or entity purchasing or otherwise acquiring any interest in our securities shall be deemed to have notice of and consented
to these forum provisions. These forum provisions may impose additional costs on stockholders, may limit our stockholders&#146; ability to bring a claim in a forum they find favorable, and the designated courts may reach different judgments or
results than other courts.&nbsp;In addition, there is uncertainty as to whether the federal forum provision for Securities Act claims will be enforced, which may impose additional costs on us and our stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">260 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Stock Exchange Listing </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We
have applied to list our common stock on the Nasdaq Global Select Market under the proposed trading symbol &#147;MGX.&#148; The closing of this offering is contingent upon such listing. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Transfer Agent and Registrar </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Transfer Agent and Registrar for our common
stock will be&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">261 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_19"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Prior to this offering, there has been no public market for our shares. Future sales of our common stock in the public market, or the availability of such shares for
sale in the public market, could adversely affect market prices prevailing from time to time. As described below, only a limited number of shares will be available for sale shortly after this offering due to contractual and legal restrictions on
resale. Nevertheless, sales of shares of our common stock in the public market after such restrictions lapse, or the perception that those sales may occur, could adversely affect the prevailing market price at such time and our ability to raise
equity capital in the future. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Based on the number of shares outstanding as of September 30, 2023, upon the completion of this offering and after giving effect to
the Reorganization,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock will be outstanding, assuming the issuance
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares offered by us in this offering, no exercise of the underwriters&#146; option to purchase additional shares and no exercise of outstanding
options. Of the outstanding shares, all of the shares sold in this offering will be freely tradable, except that any shares held by our affiliates, as that term is defined in Rule&nbsp;144 under the Securities Act, may only be sold in compliance
with the limitations described below, and&nbsp;restricted shares of common stock are subject to time-based vesting terms. All remaining shares of common stock held by existing stockholders immediately prior to the completion of this offering will be
&#147;restricted securities&#148; as such term is defined in Rule 144 under the Securities Act. These restricted securities were issued and sold by us in private transactions and are eligible for public sale only if registered under the Securities
Act or if they qualify for an exemption from registration under the Securities Act, including the exemptions provided by Rule 144 or Rule 701, summarized below. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Rule&nbsp;144 </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In general, a person who has beneficially owned restricted
stock for at least six months would be entitled to sell their securities provided that (i)&nbsp;such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90 days preceding, a sale and (ii)&nbsp;we are
subject to the periodic reporting requirements of the Exchange Act for at least 90 days before the sale. Persons who have beneficially owned restricted shares for at least six months but who are our affiliates at the time of, or any time during the
90 days preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of either of the following: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">1&nbsp;percent of the number of shares then outstanding, which will equal
approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares immediately after this offering, assuming no exercise of the underwriters&#146; option to purchase additional shares, based on the
number of shares outstanding as of September 30, 2023; or </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the average weekly trading volume of our common stock on the Nasdaq Global Select Market during the four calendar weeks
preceding the filing of a notice on Form&nbsp;144 with respect to the sale; </P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">provided, in each case, that we are subject to the periodic reporting
requirements of the Exchange Act for at least 90&nbsp;days before the sale. Such sales both by affiliates and by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> must also comply with the manner of sale, current public information and notice
provisions of Rule&nbsp;144. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Rule&nbsp;701 </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Rule&nbsp;701 under the
Securities Act, as in effect on the date of this prospectus, permits resales of shares in reliance upon Rule&nbsp;144 but without compliance with certain restrictions of Rule&nbsp;144, including the holding period requirement. Most of our employees,
executive officers or directors who purchased shares under a written compensatory plan or contract may be entitled to rely on the resale provisions of Rule&nbsp;701, but all holders of Rule&nbsp;701 shares are required to wait until 90 days after
the date of this prospectus before selling their shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">262 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">However, substantially all Rule&nbsp;701 shares are subject to <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreements as described below and under &#147;Underwriting&#148; included elsewhere in this prospectus and will become eligible for sale upon the expiration of the restrictions set forth in those agreements. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We, all of our
directors and officers, and substantially all of our stockholders have agreed not to sell or otherwise transfer or dispose of any of our securities for a period of 180 days from the date of this prospectus, subject to certain exceptions. The
representatives of the underwriters may, in their sole discretion, permit early release of shares subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. See the section entitled &#147;Underwriting,&#148; included elsewhere in
this prospectus for more information. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Registration Rights </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon
completion of this offering, certain holders of our securities will be entitled to various rights with respect to registration of their shares under the Securities Act.&nbsp;Registration of these shares under the Securities Act would result in these
shares becoming fully tradable without restriction under the Securities Act immediately upon the effectiveness of the registration.&nbsp;See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; included elsewhere in
this prospectus for more information. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Equity Incentive Plans </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We intend
to file one or more registration statements on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> under the Securities Act to register our shares issued or reserved for issuance under our equity incentive plans. The first such registration
statement is expected to be filed soon after the date of this prospectus and will automatically become effective upon filing with the SEC. Accordingly, shares registered under such registration statement will be available for sale in the open
market, unless such shares are subject to vesting restrictions with us or the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions described above. As of the date of this prospectus, we estimate that such registration statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> will cover approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">263 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_20"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR
<FONT STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following discussion is a summary of certain material U.S. federal income tax considerations
applicable to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as defined below) with respect to their ownership and disposition of shares of our common stock issued pursuant to this offering, referred to below as &#147;our common
stock&#148;. For purposes of this discussion, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder means a beneficial owner of our common stock that is for U.S. federal income tax purposes: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">a <FONT STYLE="white-space:nowrap">non-resident</FONT> alien individual; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">a foreign corporation or other foreign organization taxable as a corporation; or </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">a foreign trust or estate the income of which is not subject to U.S. federal income tax on a net income basis.
</P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This discussion does not address the tax treatment of partnerships or other entities that are pass-through entities for U.S. federal income tax
purposes or persons that hold their common stock through partnerships or other pass-through entities. A partner in a partnership or other pass-through entity that will hold our common stock should consult his, her or its tax advisor regarding the
tax consequences of acquiring, holding and disposing of our common stock through a partnership or other pass-through entity, as applicable. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This discussion is based
on current provisions of the U.S. Internal Revenue Code of 1986, as amended, which we refer to as the Code, existing and proposed U.S. Treasury Regulations promulgated thereunder, current administrative rulings and judicial decisions, all as in
effect as of the date of this prospectus and, all of which are subject to change or to differing interpretation, possibly with retroactive effect. Any such change or differing interpretation could alter the tax consequences to <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holders described in this prospectus. There can be no assurance that the Internal Revenue Service, which we refer to as the IRS, will not challenge one or more of the tax consequences described herein. We
assume in this discussion that a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds shares of our common stock as a capital asset within the meaning of Section&nbsp;1221 of the Code, generally property held for investment. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder
in light of that <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s individual circumstances nor does it address any aspects of U.S. state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, the alternative minimum tax, the
Medicare contribution tax on net investment income, the rules regarding qualified small business stock within the meaning of Section&nbsp;1202 of the Code, or any other aspect of any U.S. federal tax other than income taxes. This discussion also
does not consider any specific facts or circumstances that may apply to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and does not address the special tax rules applicable to particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holders, such as: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">insurance companies; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> or governmental organizations; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">financial institutions; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">brokers or dealers in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&#147;regulated investment companies&#148; and &#147;real estate investment trusts&#148;; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">pension plans; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; and corporations that
accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">&#147;qualified foreign pension funds,&#148; or entities wholly owned by a &#147;qualified foreign pension fund&#148;;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">264 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and partners
and investors therein); </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">persons deemed to sell our common stock under the constructive sale provisions of the Code; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">persons who have elected to mark securities to market for U.S. federal income tax purposes; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">persons that hold our common stock as part of a straddle, conversion transaction, synthetic security, or other integrated
investment; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">U.S. expatriates. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This discussion is for general information only and is not tax advice. Accordingly, all prospective <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders of our
common stock should consult their tax advisors with respect to the U.S. federal, state, local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences of the purchase, ownership and disposition of our common stock. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Distributions on Our Common Stock </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have never declared or paid any cash
distributions on our members&#146; capital, and we do not anticipate paying cash distributions on our common stock for the foreseeable future. Distributions, if any, on our common stock will generally constitute dividends for U.S. federal income tax
purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a <FONT
STYLE="white-space:nowrap">tax-free</FONT> return of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s investment, up to such holder&#146;s tax basis in the common stock. Any remaining excess will be treated as capital gain, subject
to the tax treatment described below in &#147;Gain on Sale or Other Taxable Disposition of Our Common Stock.&#148; Any such distributions will also be subject to the discussions below under the sections entitled &#147;Backup Withholding and
Information Reporting&#148; and &#147;Withholding and Information Reporting Requirements&#151;FATCA.&#148; </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Subject to the discussion in the following two paragraphs
in this section, dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to withholding of U.S. federal income tax at a 30&nbsp;percent rate or a reduced rate specified by an applicable income tax treaty
between the United States and such holder&#146;s country of residence. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Dividends that are treated as effectively connected with a trade or business conducted by a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States, are generally exempt from the 30&nbsp;percent withholding tax if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder satisfies applicable certification
requirements. However, such U.S. effectively connected income, net of specified deductions and credits, is taxed at the same graduated U.S. federal income tax rates applicable to United States persons (as defined in the Code). Any U.S. effectively
connected income received by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a corporation may also, under certain circumstances, be subject to an additional &#147;branch profits tax&#148; at a 30&nbsp;percent rate or a reduced
rate specified by an applicable income tax treaty between the United States and such holder&#146;s country of residence. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of our common stock who claims the benefit of an applicable income tax treaty between the United States and such holder&#146;s country of residence generally will be required to provide a
properly executed IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or other applicable or successor form) to the applicable withholding agent and
satisfy applicable certification and other requirements. Any documentation provided to an applicable withholding agent may need to be updated in certain circumstances. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult
their tax advisors regarding their entitlement to benefits under a relevant income tax treaty. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is eligible for a reduced rate of U.S. withholding tax under an income tax treaty may
obtain a refund or credit of any excess amounts withheld by timely filing an appropriate claim with the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">265 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Gain on Sale or Other Taxable Disposition of Our Common Stock </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Subject to the discussions below under &#147;Backup Withholding and Information Reporting&#148; and &#147;Withholding and Information Reporting
Requirements&#151;FATCA,&#148; a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to any U.S. federal income or withholding tax on any gain realized upon such holder&#146;s sale or other taxable disposition of
shares of our common stock unless: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a U.S.
trade or business and, if an applicable income tax treaty so provides, is attributable to a permanent establishment or a fixed base maintained by such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States, in which case the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be taxed on a net income basis at the graduated U.S. federal income tax rates applicable to United States persons (as defined in the Code) and, if the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a foreign corporation, the branch profits tax described above in &#147;Distributions on Our Common Stock&#148; also may apply; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a nonresident alien individual who is present in the United
States for a period or periods aggregating 183 days or more in the taxable year of the disposition and certain other conditions are met, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to a 30&nbsp;percent
tax (or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder&#146;s country of residence) on the net gain derived from the disposition, which may be offset by certain U.S. source capital
losses of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, if any (even though the individual is not considered a resident of the United States), provided that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has timely filed
U.S. federal income tax returns with respect to such losses; or </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we are, or have been, at any time during the five-year period preceding such sale or other taxable disposition (or the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period, if shorter) a &#147;U.S. real property holding corporation,&#148; as described below, unless our common stock is regularly traded on an established securities market and the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder holds no more than 5&nbsp;percent of our outstanding common stock, directly or indirectly, actually or constructively, during the shorter of the <FONT STYLE="white-space:nowrap">5-year</FONT> period
ending on the date of the disposition or the period that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder held our common stock. Generally, a corporation is a U.S. real property holding corporation if the fair market value of its U.S.
real property interests, as defined in the Code and applicable Treasury regulations, equals or exceeds 50&nbsp;percent of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade
or business. Although there can be no assurance, we do not believe that we are, or have been, a U.S. real property holding corporation, or that we are likely to become one in the future. No assurance can be provided that our common stock will be
regularly traded on an established securities market for purposes of the rules described above. </P></TD></TR></TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Backup Withholding and Information Reporting
</B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We (or the applicable paying agent) must report annually to the IRS and to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder the gross amount of the
distributions on our common stock paid to such holder and the tax withheld, if any, with respect to such distributions. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder may have to comply with specific certification procedures to establish
that the holder is not a United States person (as defined in the Code) in order to avoid backup withholding at the applicable rate with respect to dividends on our common stock. Dividends paid to <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holders subject to withholding of U.S. federal income tax, as described above in &#147;Distributions on Our Common Stock,&#148; generally will be exempt from U.S. backup withholding. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Information reporting and backup withholding will generally apply to the proceeds of a disposition of our common stock by a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder effected by or through the U.S. office of any broker, U.S. or foreign, unless the holder certifies its status as a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and satisfies certain
other requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder where the transaction
is effected outside the United States through </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">266 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker. However, for information reporting purposes, dispositions effected through a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the application of the information reporting and backup withholding
rules to them. Copies of information returns may be made available to the tax authorities of the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is incorporated under the provisions of a specific treaty or
agreement. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder can be refunded or credited against the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S. federal income tax liability, if any, provided that an appropriate claim is filed with the IRS in a timely manner. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Withholding and Information Reporting Requirements&#151;FATCA </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Provisions of
the Code commonly referred to as the Foreign Account Tax Compliance Act (FATCA) generally impose a U.S. federal withholding tax at a rate of 30&nbsp;percent on payments of dividends on, or, subject to the discussion of certain proposed U.S. Treasury
regulations below, gross proceeds from the sale or other disposition of, our common stock paid to a foreign entity unless (i)&nbsp;if the foreign entity is a &#147;foreign financial institution,&#148; such foreign entity undertakes certain due
diligence, reporting, withholding, and certification obligations, (ii)&nbsp;if the foreign entity is not a &#147;foreign financial institution,&#148; such foreign entity identifies certain of its U.S. investors, if any, or (iii)&nbsp;the foreign
entity is otherwise exempt under FATCA. However, the U.S. Treasury released proposed regulations which, if finalized in their present form, would eliminate the federal withholding tax of 30&nbsp;percent applicable to the gross proceeds of a sale or
other disposition of our common stock. In the preamble to such proposed regulations, the U.S. Treasury stated that taxpayers (including withholding agents) may generally rely on the proposed regulations until final regulations are issued. Under
certain circumstances, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder may be eligible for refunds or credits of this withholding tax. An intergovernmental agreement between the United&nbsp;States and an applicable foreign country may
modify the requirements described in this paragraph. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the possible implications of this legislation on their investment in our common stock and the
entities through which they hold our common stock, including, without limitation, the process and deadlines for meeting the applicable requirements to prevent the imposition of the 30&nbsp;percent withholding tax under FATCA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">267 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_21"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are offering the shares of common stock described in this prospectus through a number of underwriters. J.P. Morgan Securities LLC, Jefferies LLC, Cowen and Company,
LLC, Wells Fargo Securities, LLC, and BMO Capital Markets Corp. are acting as joint book-running managers of the offering and as representatives of the underwriters. We have entered into an underwriting agreement with the underwriters. Subject to
the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth on the
cover page of this prospectus, the number of shares of common stock listed next to its name in the following table: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Number&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>shares&nbsp;of</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>common&nbsp;stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="4" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Jefferies LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cowen and Company, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">BMO Capital Markets Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Chardan Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The underwriters are committed to purchase all the shares of common stock offered by us if they purchase any shares of common stock. The
underwriting agreement also provides that if an underwriter defaults, the purchase commitments of <FONT STYLE="white-space:nowrap">non-defaulting</FONT> underwriters may also be increased, or the offering may be terminated. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The underwriters propose to offer the shares of common stock directly to the public at the initial public offering price set forth on the cover page of this prospectus
and to certain dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. Any such dealers may resell shares of common stock to certain other brokers or dealers at a discount of up to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share from the initial public offering price. After the initial offering of the shares of common stock to the public, if all of the shares of common stock are not sold at the initial public
offering price, the underwriters may change the offering price and the other selling terms. Sales of any shares of common stock made outside of the United States may be made by affiliates of the underwriters. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The underwriters have an option to buy up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
additional shares of common stock from us to cover sales of shares of common stock by the underwriters which exceed the number of shares of common stock specified in the table above. The underwriters have 30&nbsp;days from the date of this
prospectus to exercise this option to purchase additional shares of common stock. If any shares of common stock are purchased with this option to purchase additional shares of common stock, the underwriters will purchase shares of common stock in
approximately the same proportion as shown in the table above. If any additional shares of common stock are purchased, the underwriters will offer the additional shares of common stock on the same terms as those on which the shares of common stock
are being offered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">268 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The underwriting fee is equal to the public offering price per share of common stock less the amount paid by the
underwriters to us per share of common stock. The underwriting fee is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. The following table shows the per share and total underwriting discounts and commissions to be paid to the
underwriters assuming both no exercise and full exercise of the underwriters&#146; option to purchase additional shares of common stock. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Without</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>option&nbsp;to</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>purchase</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>additional</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>shares&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>common&nbsp;stock</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>exercise</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>With&nbsp;full</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>option to</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>purchase</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>additional</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>shares of<BR>common&nbsp;stock</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>exercise</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Per Common Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We estimate that the total expenses of this offering, including registration, filing, and listing fees, printing fees and legal and
accounting expenses, but excluding the underwriting discounts and commissions, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million. We have agreed to reimburse the underwriters for expenses relating to clearance of this
offering with the Financial Industry Regulatory Authority, Inc. of up to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A prospectus in electronic format may be
made available on the web sites maintained by one or more underwriters, or selling group members, if any, participating in the offering. The underwriters may agree to allocate a number of shares of common stock to underwriters and selling group
members for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters and selling group members that may make Internet distributions on the same basis as other allocations. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have agreed that we will not (i)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant
any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the SEC a registration statement under the Securities Act relating to, any of our shares of common stock or
securities convertible into or exercisable or exchangeable for any of our shares of common stock, or publicly disclose the intention to make any offer, sale, pledge, loan, disposition or filing, or (ii)&nbsp;enter into any swap or other arrangement
that transfers all or a portion of the economic consequences associated with the ownership of any shares of common stock or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of shares of
common stock or such other securities, in cash or otherwise), in each case without the prior written consent of the representatives for a period of 180&nbsp;days after the date of this prospectus, other than the shares of our common stock to be sold
in this offering. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our directors and executive officers, and substantially all of our stockholders (such persons, the
<FONT STYLE="white-space:nowrap">&#147;lock-up</FONT> parties&#148;) have entered into <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the underwriters prior to the commencement of this offering pursuant to which each <FONT
STYLE="white-space:nowrap">lock-up</FONT> party, with limited exceptions, for a period of 180 days after the date of this prospectus (such period, the &#147;restricted period&#148;), may not (and may not cause any of their direct or indirect
affiliates to), without the prior written consent of the representatives, (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to
purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable for our common stock (including without limitation, common stock or such
other securities which may be deemed to be beneficially owned by such <FONT STYLE="white-space:nowrap">lock-up</FONT> parties in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a stock option
or warrant (collectively with the common stock, the <FONT STYLE="white-space:nowrap">&#147;lock-up</FONT> securities&#148;), (2) enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic
consequences of ownership of the <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, whether any such transaction described in clause (1)&nbsp;or (2) above is to be settled by delivery of <FONT STYLE="white-space:nowrap">lock-up</FONT>
securities, in cash or otherwise, (3)&nbsp;make any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">269 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
demand for, or exercise any right with respect to, the registration of any <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, or (4)&nbsp;publicly disclose the intention to do any of the
foregoing. Such persons or entities have further acknowledged that these undertakings preclude them from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or
entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or
disposition or transfer (by any person or entity, whether or not a signatory to such agreement) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any <FONT STYLE="white-space:nowrap">lock-up</FONT>
securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, in cash or otherwise. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The restrictions described in the immediately preceding paragraph and contained In the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements between the
underwriters and the <FONT STYLE="white-space:nowrap">lock-up</FONT> parties do not apply, subject in certain cases to various conditions, to certain transactions, including (a)&nbsp;transfers or disposals of
<FONT STYLE="white-space:nowrap">lock-up</FONT> securities: (i)&nbsp;as bona fide gifts, or for bona fide estate planning purposes, (ii)&nbsp;by will or intestacy or any other testamentary document, (iii)&nbsp;to any trust for the direct or indirect
benefit of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or any immediate family member, (iv)&nbsp;to a corporation, partnership, limited liability company, investment fund or other entity (A)&nbsp;of which the <FONT
STYLE="white-space:nowrap">lock-up</FONT> party and/or its immediate family members are the legal and beneficial owner of all of the outstanding equity securities or similar interests, or (B)&nbsp;controlled by, or under common control with, the
undersigned or the immediate family of the undersigned (v)&nbsp;to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i)&nbsp;through (iv), (vi) in the case of a corporation,
partnership, limited liability company, trust or other business entity, (A)&nbsp;to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate of the
<FONT STYLE="white-space:nowrap">lock-up</FONT> party, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control with the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or its
affiliates or (B)&nbsp;as part of a distribution to limited members, members or stockholders of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party; (vii)&nbsp;by operation of law, (viii)&nbsp;to us from an employee upon death, disability or
termination of employment of such employee, (ix)&nbsp;as part of a sale of <FONT STYLE="white-space:nowrap">lock-up</FONT> securities acquired in open market transactions after the completion of this offering, (x)&nbsp;to us in connection with the
vesting, settlement or exercise of restricted stock units, options, warrants or other rights to purchase shares of our common stock (including &#147;net&#148; or &#147;cashless&#148; exercise), including for the payment of exercise price and tax and
remittance payments, or (xi)&nbsp;pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction approved by our board of directors and made to all shareholders involving a change in control, provided that if
such transaction is not completed, all such <FONT STYLE="white-space:nowrap">lock-up</FONT> securities would remain subject to the restrictions in the immediately preceding paragraph; provided that (A)&nbsp;in the case of any transfer or
distribution pursuant to clause (a)(i), (ii), (iii), (iv), (v), (vi) and (vii), such transfer shall not involve a disposition for value and each donee, devisee, transferee or distributee shall execute and deliver to the representatives a <FONT
STYLE="white-space:nowrap">lock-up</FONT> letter in the form of the <FONT STYLE="white-space:nowrap">lock-up</FONT> letter, (B)&nbsp;in the case of any transfer or distribution pursuant to clause (a), (iii), (iv), (v), (vi), (ix) and (x)&nbsp;no
filing by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Exchange Act, or other public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution
(other than a filing on a Form 5 or a filing required pursuant to Section&nbsp;13 of the Exchange Act and the rules and regulations promulgated thereunder made after the expiration of the restricted period referred to above) and (C)&nbsp;in the case
of any transfer or distribution pursuant to clause (a)(i), (ii), (vii) and (viii)&nbsp;it shall be a condition to such transfer that no public filing, report or announcement shall be voluntarily made and if any filing under Section&nbsp;16(a) of the
Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of common stock in connection with such transfer or distribution shall be legally required during the restricted period, such
filing, report or announcement shall clearly indicate in the footnotes thereto the nature and conditions of such transfer; (b)&nbsp;exercise of the options, settlement of RSUs or other equity awards, or the exercise of warrants granted pursuant to
plans described in in this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">270 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
prospectus, provided that any <FONT STYLE="white-space:nowrap">lock-up</FONT> securities received upon such exercise, vesting or settlement would be subject to restrictions similar to those in
the immediately preceding paragraph; (c)&nbsp;the conversion of outstanding preferred stock, warrants to acquire preferred stock, or convertible securities into shares of our common stock or warrants to acquire shares of our common stock, provided
that any common stock or warrant received upon such conversion would be subject to restrictions similar to those in the immediately preceding paragraph; and (d)&nbsp;the establishment by <FONT STYLE="white-space:nowrap">lock-up</FONT> parties of
trading plans under Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act, provided that such plan does not provide for the transfer of <FONT STYLE="white-space:nowrap">lock-up</FONT> securities during the restricted period.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The representatives, in their sole discretion, may release the securities subject to any of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the
underwriters described above, in whole or in part at any time. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under
the Securities Act. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have applied to have our common stock approved for listing/quotation on the Nasdaq Global Select Market under the symbol &#147;MGX.&#148; The
closing of this offering is contingent upon such listing. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves
making bids for, purchasing and selling shares of common stock in the open market for the purpose of preventing or retarding a decline in the market price of the common stock while this offering is in progress. These stabilizing transactions may
include making short sales of common stock, which involves the sale by the underwriters of a greater number of shares of common stock than they are required to purchase in this offering, and purchasing shares of common stock on the open market to
cover positions created by short sales. Short sales may be &#147;covered&#148; shorts, which are short positions in an amount not greater than the underwriters&#146; option to purchase additional shares of common stock referred to above, or may be
&#147;naked&#148; shorts, which are short positions in excess of that amount. The underwriters may close out any covered short position either by exercising their option to purchase additional shares, in whole or in part, or by purchasing shares of
common stock in the open market. In making this determination, the underwriters will consider, among other things, the price of shares of common stock available for purchase in the open market compared to the price at which the underwriters may
purchase shares of common stock through the option to purchase additional shares of common stock. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common
stock in the open market that could adversely affect investors who purchase in this offering. To the extent that the underwriters create a naked short position, they will purchase shares of common stock in the open market to cover the position. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The underwriters have advised us that, pursuant to Regulation&nbsp;M of the Securities Act, they may also engage in other activities that stabilize, maintain or
otherwise affect the price of the common stock, including the imposition of penalty bids. This means that if the representatives of the underwriters purchase common stock in the open market in stabilizing transactions or to cover short sales, the
representatives can require the underwriters that sold those shares of common stock as part of this offering to repay the underwriting discount received by them. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These activities may have the effect of raising or maintaining the market price of the common stock or preventing or retarding a decline in the market price of the
common stock, and, as a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. If the underwriters commence these activities, they may discontinue them at any time. The underwriters may
carry out these transactions on the open market, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">271 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Prior to this offering, there has been no public market for our common stock. The initial public offering price will
be determined by negotiations between us and the representatives of the underwriters. In determining the initial public offering price, we and the representatives of the underwriters expect to consider a number of factors including: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the information set forth in this prospectus and otherwise available to the representatives; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our prospects and the history and prospects for the industry in which we compete; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">an assessment of our management; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">our prospects for future earnings; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the general condition of the securities markets at the time of this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">the recent market prices of, and demand for, publicly traded common stock of generally comparable companies; and
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">other factors deemed relevant by the underwriters and us. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Neither we nor the underwriters can assure investors that an active trading market will develop for our shares of common stock, or that the shares of common stock will
trade in the public market at or above the initial public offering price. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Other than in the United States, no action has been taken by us or the underwriters that
would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this
prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable
rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus
does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Certain of the underwriters and their affiliates have provided in the past to us and our affiliates and may provide from time to time in the future certain commercial
banking, financial advisory, investment banking and other services for us and such affiliates in the ordinary course of their business, for which they have received and may continue to receive customary fees and commissions. In addition, from time
to time, certain of the underwriters and their affiliates may effect transactions for their own account or the account of customers, and hold on behalf of themselves or their customers, long or short positions in our debt or equity securities or
loans, and may do so in the future. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in the European Economic Area </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In relation to each Member State of the European Economic Area (each a &#147;Relevant State&#148;), no shares of our common stock have been offered or will be offered
pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares of our common stock which has been approved by the competent authority in that Relevant State or, where appropriate,
approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation), except that offers of shares of common stock may be made to the public in that Relevant State at
any time under the following exemptions under the Prospectus Regulation: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">a)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to any legal entity which is a qualified investor as defined under the Prospectus Regulation; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">272 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">b)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or
</TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">c)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">provided that no such offer of
shares of common stock shall require the Issuer or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each person in a Relevant State who initially acquires any shares of common stock or to whom any offer is made will be deemed to have represented, acknowledged and
agreed to and with the Company and the underwriters that it is a qualified investor within the meaning of the Prospectus Regulation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the case of any shares of
common stock being offered to a financial intermediary as that term is used in Article 5(1) of the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares of common stock
acquired by it in the offer have not been acquired on a <FONT STYLE="white-space:nowrap">non-discretionary</FONT> basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise
to an offer to the public other than their offer or resale in a Relevant State to qualified investors, in circumstances in which the prior consent of the underwriters has been obtained to each such proposed offer or resale. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company, the underwriters and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to any shares of common stock in any Relevant State means the
communication in any form and by any means of sufficient information on the terms of the offer and any shares of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock, and the
expression &#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in the United Kingdom </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In relation to the United Kingdom (the &#147;UK&#148;), no shares of our common stock have been offered or will be offered pursuant to the offering to the public in the
UK prior to the publication of a prospectus in relation to the shares of common stock which has been approved by the Financial Conduct Authority in the UK in accordance with the UK Prospectus Regulation and the FSMA, except that offers of shares of
common stock may be made to the public in the UK at any time under the following exemptions under the UK Prospectus Regulation and the FSMA: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(a)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to any legal entity which is a qualified investor as defined under the UK Prospectus Regulation; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(b)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to fewer than 150 natural or legal persons (other than qualified investors as defined under the UK Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or
</TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(c)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at any time in other circumstances falling within section 86 of the FSMA, </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">provided that no such offer of shares of
common stock shall require the Issuer or any underwriter to publish a prospectus pursuant to Section&nbsp;85 of the FSMA or Article 3 of the UK Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each person in the UK who initially acquires any shares of common stock or to whom any offer is made will be deemed to have represented, acknowledged and agreed to
and with the Company and the underwriters that it is a qualified investor within the meaning of the UK Prospectus Regulation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">273 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the case of any shares of common stock being offered to a financial intermediary as that term is used in Article
5(1) of the UK Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares of common stock acquired by it in the offer have not been acquired on a
<FONT STYLE="white-space:nowrap">non-discretionary</FONT> basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or
resale in the UK to qualified investors, in circumstances in which the prior consent of the underwriters has been obtained to each such proposed offer or resale. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company, the underwriters and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to any shares of our common stock in the UK means the communication in
any form and by any means of sufficient information on the terms of the offer and any shares of our common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of our common stock, the expression &#147;UK
Prospectus Regulation&#148; means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, and the expression &#147;FSMA&#148; means the Financial Services and Markets Act 2000. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This document is for distribution only to persons who (i)&nbsp;have professional experience in matters relating to investments and who qualify as investment
professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the &#147;Financial Promotion Order&#148;), (ii) are persons falling within Article 49(2)(a) to (d)
(&#147;high net worth companies, unincorporated associations etc.&#148;) of the Financial Promotion Order, (iii)&nbsp;are outside the United Kingdom, or (iv)&nbsp;are persons to whom an invitation or inducement to engage in investment activity
(within the meaning of Section&nbsp;21 of the FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as &#147;relevant
persons&#148;). This document is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only to relevant
persons and will be engaged in only with relevant persons. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Canada </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National
Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection&nbsp;73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National
<FONT STYLE="white-space:nowrap">Instrument&nbsp;31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares of common stock must be made in accordance with an exemption from, or in a transaction
not subject to, the prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Securities legislation in certain provinces or territories of Canada may provide a
purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed
by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or
consult with a legal advisor. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to section 3A.3 of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> Underwriting Conflicts (&#147;NI <FONT
STYLE="white-space:nowrap">33-105&#148;),</FONT> the underwriters are not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this
offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">274 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Switzerland </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of common stock may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#147;SIX&#148;), or on any other stock exchange
or regulated trading facility in Switzerland. This document does not constitute a prospectus within the meaning of, and has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss
Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other
offering or marketing material relating to the shares of common stock, or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Neither this document nor any other offering or marketing material relating to the offering, the Company, the shares of common stock have been or will be filed with or
approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares of common stock will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (&#147;FINMA&#148;), and the
offer of shares of common stock has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#147;CISA&#148;). The investor protection afforded to acquirers of interests in collective investment schemes
under the CISA does not extend to acquirers of shares of common stock. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Hong Kong </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of common stock have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a)&nbsp;to
&#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) (&#147;SFO&#148;), of Hong Kong and any rules made thereunder; or (b)&nbsp;in other circumstances which do not result in the
document being a &#147;prospectus&#148; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap.&nbsp;32) of Hong Kong) (&#147;CO&#148;), or which do not constitute an offer to the public within the meaning of the CO. No
advertisement, invitation or document relating to the shares of common stock has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the
contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares of common stock which are or are intended to be disposed of only
to persons outside Hong Kong or only to &#147;professional investors&#148; as defined in the SFO and any rules made thereunder. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors
in Singapore </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each joint book-running manager has acknowledged that this prospectus has not been registered as a prospectus with the Monetary Authority of
Singapore. Accordingly, each joint book-running manager has represented and agreed that it has not offered or sold any shares of common stock or caused the shares of common stock to be made the subject of an invitation for subscription or purchase
and will not offer or sell any shares of common stock or cause the shares of common stock to be made the subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute, this
prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares of common stock, whether directly or indirectly, to any person in Singapore other than: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(a)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to an institutional investor (as defined in Section&nbsp;4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time (the &#147;SFA&#148;)) pursuant to Section&nbsp;274 of
the SFA; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(b)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to a relevant person (as defined in Section&nbsp;275(2) of the SFA) pursuant to Section&nbsp;275(1) of the SFA, or any person pursuant to Section&nbsp;275(1A) of the SFA, and in accordance with the conditions specified
in Section&nbsp;275 of the SFA; or </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">275 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(c)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Where the
shares of common stock are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(a)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals,
each of whom is an accredited investor; or </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(b)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, securities or securities-based
derivatives contracts (each term as defined in Section&nbsp;2(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or
that trust has acquired the shares of common stock pursuant to an offer made under Section&nbsp;275 of the SFA except: </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section&nbsp;275(1A) or Section&nbsp;276(4)(i)(B) of the SFA; </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">where no consideration is or will be given for the transfer; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">where the transfer is by operation of law; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">as specified in Section&nbsp;276(7) of the SFA; or </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations 2018. </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Singapore SFA Product Classification&#151;In connection with Section&nbsp;309B of the SFA and the CMP Regulations 2018, unless otherwise specified before an offer of
shares of common stock, we have determined, and hereby notify all relevant persons (as defined in Section&nbsp;309A(1) of the SFA), that the shares of common stock are &#145;&#145;prescribed capital markets products&#146;&#146; (as defined in the
CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products and MAS Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on
Recommendations on Investment Products). </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Japan </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of common stock have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Act. Accordingly, none
of the shares of common stock nor any interest therein may be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any &#147;resident&#148; of Japan (which term as used herein means any person resident in Japan, including
any corporation or other entity organized under the laws of Japan), or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to or for the benefit of a resident of Japan, except pursuant to
an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, regulations and ministerial guidelines of Japan in effect at the relevant time. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in the United Arab Emirates </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of
common stock have not been, and are not being, publicly offered, sold, promoted or advertised in the United Arab Emirates (including the Dubai International Financial Centre) other than in compliance with the laws of the United Arab Emirates (and
the Dubai International Financial Centre) governing the issue, offering and sale of securities. Further, this prospectus does not constitute a public offer of securities in the United Arab </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">276 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. This prospectus has not been approved by or filed with the Central Bank of the United Arab
Emirates, the Securities and Commodities Authority or the Dubai Financial Services Authority. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Israel </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the State of Israel this prospectus shall not be regarded as an offer to the public to purchase shares of common stock under the Israeli Securities Law,
5728&#151;1968, which requires a prospectus to be published and authorized by the Israel Securities Authority, if it complies with certain provisions of Section&nbsp;15 of the Israeli Securities Law, 5728&#150;1968, including, inter alia, if:
(i)&nbsp;the offer is made, distributed or directed to not more than 35 investors, subject to certain conditions (the &#147;Addressed Investors&#148;); or (ii)&nbsp;the offer is made, distributed or directed to certain qualified investors defined in
the First Addendum of the Israeli Securities Law, 5728&#151;1968, subject to certain conditions (the &#147;Qualified Investors&#148;).&nbsp;The Qualified Investors shall not be taken into account in the count of the Addressed Investors and may be
offered to purchase securities in addition to the 35 Addressed Investors.&nbsp;We have not and will not take any action that would require it to publish a prospectus in accordance with and subject to the Israeli Securities Law,
5728&#151;1968.&nbsp;We have not and will not distribute this prospectus or make, distribute or direct an offer to subscribe for our shares of common stock to any person within the State of Israel, other than to Qualified Investors and up to 35
Addressed Investors. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Qualified Investors may have to submit written evidence that they meet the definitions set out in of the First Addendum to the Israeli
Securities Law, 5728&#151;1968.&nbsp;In particular, we may request, as a condition to be offered shares of common stock, that Qualified Investors will each represent, warrant and certify to us and/or to anyone acting on our behalf: (i)&nbsp;that it
is an investor falling within one of the categories listed in the First Addendum to the Israeli Securities Law, 5728&#151;1968; (ii)&nbsp;which of the categories listed in the First Addendum to the Israeli Securities Law, 5728&#151;1968 regarding
Qualified Investors is applicable to it; (iii)&nbsp;that it will abide by all provisions set forth in the Israeli Securities Law, 5728&#151;1968 and the regulations promulgated thereunder in connection with the offer to be issued shares of common
stock; (iv)&nbsp;that the shares of common stock that it will be issued are, subject to exemptions available under the Israeli Securities Law, 5728&#151;1968: (a) for its own account; (b)&nbsp;for investment purposes only; and (c)&nbsp;not issued
with a view to resale within the State of Israel, other than in accordance with the provisions of the Israeli Securities Law, 5728&#151;1968; and (v)&nbsp;that it is willing to provide further evidence of its Qualified Investor
status.&nbsp;Addressed Investors may have to submit written evidence in respect of their identity and may have to sign and submit a declaration containing, inter alia, the Addressed Investor&#146;s name, address and passport number or Israeli
identification number. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Australia </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This prospectus: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(a)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">does not constitute a disclosure document or a prospectus under Chapter 6D.2 of the Corporations Act 2001 (Cth) (the &#147;Corporations Act&#148;); </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(b)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">has not been, and will not be, lodged with the Australian Securities and Investments Commission (&#147;ASIC&#148;), as a disclosure document for the purposes of the Corporations Act and does not purport to include the
information required of a disclosure document for the purposes of the Corporations Act; and </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(c)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">may only be provided in Australia to select investors who are able to demonstrate that they fall within one or more of the categories of investors, available under section 708 of the Corporations Act (&#147;Exempt
Investors&#148;). </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of common stock may not be directly or indirectly offered for subscription or purchased or sold, and no invitations to
subscribe for or buy the shares of common stock may be issued, and no draft or definitive offering </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">277 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
memorandum, advertisement or other offering material relating to any shares of common stock may be distributed in Australia, except where disclosure to investors is not required under Chapter 6D
of the Corporations Act or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an application for the shares of common stock, you represent and warrant to us that you are an Exempt Investor. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As any offer of shares of common stock under this document will be made without disclosure in Australia under Chapter 6D.2 of the Corporations Act, the offer of those
securities for resale in Australia within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under Chapter&nbsp;6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the shares
of common stock you undertake to us that you will not, for a period of 12 months from the date of issue of the shares of common stock, offer, transfer, assign or otherwise alienate those shares of common stock to investors in Australia except in
circumstances where disclosure to investors is not required under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in China </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This prospectus will not be
circulated or distributed in the PRC and the shares of common stock will not be offered or sold, and will not be offered or sold to any person for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale directly or indirectly to any residents
of the PRC except pursuant to any applicable laws and regulations of the PRC. Neither this prospectus nor any advertisement or other offering material may be distributed or published in the PRC, except under circumstances that will result in
compliance with applicable laws and regulations. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Korea </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of common stock have not been and will not be registered under the Financial Investments Services and Capital Markets Act of Korea and the decrees and
regulations thereunder (&#147;FSCMA&#148;), and the shares of common stock have been and will be offered in Korea as a private placement under the FSCMA. None of the shares of common stock may be offered, sold or delivered directly or indirectly, or
offered or sold to any person for re-offering or resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws and regulations of Korea, including the FSCMA and the Foreign Exchange Transaction Law of
Korea and the decrees and regulations thereunder (&#147;FETL&#148;). Furthermore, the purchaser of the shares of common stock shall comply with all applicable regulatory requirements (including but not limited to requirements under the FETL) in
connection with the purchase of the shares of common stock. By the purchase of the shares of common stock, the relevant holder thereof will be deemed to represent and warrant that if it is in Korea or is a resident of Korea, it purchased the shares
of common stock pursuant to the applicable laws and regulations of Korea. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Saudi Arabia </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This document may not be distributed in the Kingdom of Saudi Arabia except to such persons as are permitted under the Offers of Securities Regulations as issued by the
board of the Saudi Arabian Capital Market Authority (&#147;CMA&#148;), pursuant to resolution number <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">2-11-2004</FONT></FONT> dated 4&nbsp;October 2004 as amended by resolution number <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-28-2008,</FONT></FONT> as amended (the &#147;CMA Regulations&#148;). The CMA does not make any representation as to the accuracy or completeness of this document and expressly disclaims
any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. Prospective purchasers of the shares of common stock offered hereby should conduct their own due diligence on the accuracy of the
information relating to the securities. If you do not understand the contents of this document, you should consult an authorized financial adviser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">278 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in the Dubai International Financial Centre (&#147;DIFC&#148;) </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This document relates to an Exempt Offer in accordance with the Markets Rules 2012 of the Dubai Financial Services Authority (&#147;DFSA&#148;). This document is
intended for distribution only to persons of a type specified in the Markets Rules 2012 of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in
connection with Exempt Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for this document. The shares of common stock to which this document relates may
be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares of common stock offered should conduct their own due diligence on the securities. If you do not understand the contents of this document, you should
consult an authorized financial advisor. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In relation to its use in the DIFC, this document is strictly private and confidential and is being distributed to a
limited number of investors and must not be provided to any person other than the original recipient, and may not be reproduced or used for any other purpose. The interests in the securities may not be offered or sold directly or indirectly to the
public in the DIFC. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to Prospective Investors in Bermuda </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Shares
of common stock may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act of 2003 of Bermuda which regulates the sale of securities in Bermuda. Additionally,
<FONT STYLE="white-space:nowrap">non-Bermudian</FONT> persons (including companies) may not carry on or engage in any trade or business in Bermuda unless such persons are permitted to do so under applicable Bermuda legislation. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to prospective investors in the British Virgin Islands </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of
common stock are not being and may not be offered to the public or to any person in the British Virgin Islands for purchase or subscription by or on behalf of us. The shares of common stock may be offered to companies incorporated under the BVI
Business Companies Act, 2004 (British Virgin Islands) (BVI Companies), but only where the offer will be made to, and received by, the relevant BVI Company entirely outside of the British Virgin Islands. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to prospective investors in Taiwan </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of common stock have
not been and will not be registered with the Financial Supervisory Commission of Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within Taiwan through a public offering or in circumstances which
constitutes an offer within the meaning of the Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorized to offer, sell, give
advice regarding or otherwise intermediate the offering and sale of the shares of common stock in Taiwan. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to prospective investors in South Africa
</B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Due to restrictions under the securities laws of South Africa, no &#147;offer to the public&#148; (as such term is defined in the South African Companies Act,
No.&nbsp;71 of 2008 (as amended or <FONT STYLE="white-space:nowrap">re-enacted)</FONT> (the South African Companies Act), is being made in connection with the issue of the shares of common stock in South Africa. Accordingly, this document does not,
nor is it intended to, constitute a &#147;registered prospectus&#148; (as that term is defined in the South African Companies Act) prepared and registered under the South African Companies Act and has not been approved by, and/or filed with, the
South African Companies and Intellectual Property Commission or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">279 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
other regulatory authority in South Africa. The shares of common stock are not offered, and the offer shall not be transferred, sold, renounced or delivered, in South Africa or to a person with
an address in South Africa, unless one or other of the following exemptions stipulated in section 96 (1) applies: </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial">Section&nbsp;96
(1) (a) the offer, transfer, sale, renunciation or delivery is to: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(i)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons whose ordinary business, or part of whose ordinary business, is to deal in securities, as principal or agent; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the South African Public Investment Corporation; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons or entities regulated by the Reserve Bank of South Africa; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">authorized financial service providers under South African law; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(v)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">financial institutions recognized as such under South African law; </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a wholly-owned subsidiary of any person or entity contemplated in (iii), (iv) or (v), acting as agent in the capacity of an authorized portfolio manager for a pension fund, or as manager for a collective investment
scheme (in each case duly registered as such under South African law); or </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any combination of the person in (i)&nbsp;to (vi); or </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Section&nbsp;96 (1) (b) the total contemplated acquisition cost of
the shares of common stock, for any single addressee acting as principal is equal to or greater than ZAR1,000,000 or such higher amount as may be promulgated by notice in the Government Gazette of South Africa pursuant to section 96(2)(a) of the
South African Companies Act. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Information made available in this prospectus should not be considered as &#147;advice&#148; as defined in the South African Financial
Advisory and Intermediary Services Act, 2002. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to prospective investors in Malaysia </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">No prospectus or other offering material or document in connection with the offer and sale of the shares of common stock has been or will be registered with the
Securities Commission of Malaysia (&#147;Commission&#148;), for the Commission&#146;s approval pursuant to the Capital Markets and Services Act 2007. Accordingly, this prospectus and any other document or material in connection with the offer or
sale, or invitation for subscription or purchase, of the shares of common stock may not be circulated or distributed, nor may the shares of common stock be offered or sold, or be made the subject of an invitation for subscription or purchase,
whether directly or indirectly, to persons in Malaysia other than (i)&nbsp;a closed end fund approved by the Commission; (ii)&nbsp;a holder of a Capital Markets Services License; (iii)&nbsp;a person who acquires the shares of common stock, as
principal, if the offer is on terms that the shares of common stock may only be acquired at a consideration of not less than RM250,000 (or its equivalent in foreign currencies) for each transaction; (iv)&nbsp;an individual whose total net personal
assets or total net joint assets with his or her spouse exceeds RM3&nbsp;million (or its equivalent in foreign currencies), excluding the value of the primary residence of the individual; (v)&nbsp;an individual who has a gross annual income
exceeding RM300,000 (or its equivalent in foreign currencies) per annum in the preceding twelve months; (vi)&nbsp;an individual who, jointly with his or her spouse, has a gross annual income of RM400,000 (or its equivalent in foreign currencies),
per annum in the preceding twelve months; (vii)&nbsp;a corporation with total net assets exceeding RM10&nbsp;million (or its equivalent in a foreign currencies) based on the last audited accounts; (viii)&nbsp;a partnership with total net assets
exceeding RM10&nbsp;million (or its equivalent in foreign currencies); (ix) a bank licensee or insurance licensee as defined in the Labuan Financial Services and Securities Act 2010; (x) an Islamic bank licensee or takaful licensee as defined in the
Labuan Financial Services and Securities Act 2010; and (xi)&nbsp;any other person as may be specified by the Commission; provided that, in the each of the preceding categories (i)&nbsp;to (xi), the distribution of the shares of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">280 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
common stock is made by a holder of a Capital Markets Services License who carries on the business of dealing in securities. The distribution in Malaysia of this prospectus is subject to
Malaysian laws. This prospectus does not constitute and may not be used for the purpose of public offering or an issue, offer for subscription or purchase, invitation to subscribe for or purchase any securities requiring the registration of a
prospectus with the Commission under the Capital Markets and Services Act 2007. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Notice to prospective investors in Qatar </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The shares of common stock described in this prospectus have not been, and will not be, offered, sold or delivered, at any time, directly or indirectly in the State of
Qatar in a manner that would constitute a public offering. This prospectus has not been, and will not be, registered with or approved by the Qatar Financial Markets Authority or Qatar Central Bank and may not be publicly distributed. This prospectus
is intended for the original recipient only and must not be provided to any other person. It is not for general circulation in the State of Qatar and may not be reproduced or used for any other purpose. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">281 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_22"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The validity of the shares of common stock offered by this prospectus will be passed upon for us by Goodwin Procter LLP, Boston, Massachusetts. Certain legal matters
relating to this offering will be passed upon for the underwriters by Davis Polk&nbsp;&amp; Wardwell LLP, New York, New York. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_23"></A>EXPERTS
</B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The financial statements as of December 31, 2022 and 2021 and for the years then ended included in this Prospectus have been so included in reliance on the
report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with their engagement, PricewaterhouseCoopers LLP (&#147;PwC&#148;) notified us that a business relationship existed between a PwC member firm and a
beneficial owner that has significant influence (&#147;BOSI&#148;) over the Company, whereby the BOSI participated in an online platform operated and maintained by the PwC member firm and had access to dedicated space at the PwC member firm&#146;s
physical location in which the BOSI and other business partners and innovators participated on such platform and/or within the physical location to exchange experiences and ideas, search for technologies, pose challenges to others to provide
proposed solutions, make direct contacts and to meet virtually or in person. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The existence of this business relationship identified is inconsistent with SEC and
PCAOB auditor independence rules provided in Rule 2-01 of Regulation S-X. The matter was resolved on June 7, 2023, upon the termination of the business relationship between the BOSI and the PwC member firm. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">PwC provided an overview of the facts and circumstances surrounding the business relationship to our audit committee and management, including that the entity involved
was a BOSI and not an affiliate of the Company, and other relevant facts. The PwC audit engagement team members did not participate in the PwC member firm&#146;s activities and engagements with the BOSI or any entity that is part of the PwC member
firm&#146;s business relationship with the BOSI, and the business relationship was not quantitatively or qualitatively material to the PwC member firm or the BOSI. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Considering the facts presented, our audit committee and PwC have concluded that the business relationship would not impair PwC&#146;s application of objective and
impartial judgment on any matters encompassed within the audit engagement performed by PwC for our consolidated financial statements as of and for the fiscal years ended December 31, 2022 and 2021, and the review for the interim periods for the nine
months ended September&nbsp;30, 2023 and 2022, and that a reasonable investor with knowledge of all relevant facts and circumstances would conclude that PwC is capable of remaining objective and impartial with respect to the audit and reviews of the
Company&#146;s consolidated financial statements. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_23a"></A>CHANGES IN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On September 24, 2021, KPMG, LLP (&#147;KPMG&#148;) was engaged as the independent registered public accounting firm&nbsp;to audit our consolidated financial statements
for the fiscal year ended December 31, 2020 in accordance with auditing standards generally accepted in the United States. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the two fiscal years ended
December&nbsp;31, 2020 and 2019 and the subsequent interim period through September&nbsp;24, 2021 we did not consult with KPMG on (i) matters that involved the application of accounting principles to a specified transaction either completed or
proposed, or the type of audit opinion that might be rendered on our consolidated financial statements, and neither a written report nor oral advice was provided to us that KPMG concluded was an important factor considered by us in reaching a
decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was either the subject of a &#147;disagreement&#148; or a &#147;reportable event&#148; (as defined in Item 304(a)(1)(iv) and Item 304(a)(1)(v) of
Regulation&nbsp;S-K and the related instructions, respectively). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">282 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On April&nbsp;28, 2022, our audit committee dismissed KPMG as our independent registered public accounting firm.</P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">KPMG has never issued an audit report on our consolidated financial statements. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the two fiscal years ended December 31, 2021 and 2020, and the subsequent period through April 28, 2022, (1) there were no disagreements (as that term is used in
Item&nbsp;304(a)(1)(iv) of Regulation S-K and the related instructions) between us and KPMG on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to
the satisfaction of KPMG, would have caused KPMG to make reference thereto in a report on our financial statements for the year ended December 31, 2020 if a report were to be issued, and (2) there were no &#147;reportable events&#148; as such term
is defined in Item 304(a)(1)(v) of Regulation S-K.</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have provided KPMG with a copy of the disclosures set forth under the heading &#147;Changes in Independent
Registered Public Accounting Firm&#148; and have requested that KPMG furnish a letter addressed to the SEC stating whether or not KPMG agrees with such statements. A copy of the letter is filed as&nbsp;Exhibit 16.1&nbsp;to the registration statement
of which this prospectus forms a part.</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On April 28, 2022, PwC was approved as the independent registered public accounting firm for the fiscal year ended December
31, 2021.</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the two most recent fiscal years ended December 31, 2021 and the subsequent interim period through April 28, 2022 we did not consult with PwC on (i)
matters that involved the application of accounting principles to a specified transaction either completed or proposed, or the type of audit opinion that might be rendered on our consolidated financial statements, and neither a written report nor
oral advice was provided to us that PwC concluded was an important factor considered by us in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was either the subject of a
&#147;disagreement&#148; or a &#147;reportable event&#148; (as defined in Item 304(a)(1)(iv) and Item 304(a)(1)(v) of Regulation S-K and the related instructions, respectively). </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="toc425213_24"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have filed
with the SEC a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File Number <FONT STYLE="white-space:nowrap">333-</FONT>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) under the Securities Act with respect to the common stock we are offering by this prospectus. This prospectus, which constitutes part of the
registration statement, does not contain all of the information included in the registration statement. For further information pertaining to us and our common stock, you should refer to the registration statement and to its exhibits. Whenever we
make reference in this prospectus to any of our contracts, agreements or other documents, the references are not necessarily complete, and you should refer to the exhibits attached to the registration statement for copies of the actual contract,
agreement or other document. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Upon the completion of the offering, we will be subject to the informational requirements of the Exchange Act and will file annual,
quarterly and current reports, proxy statements and other information with the SEC. You can read our SEC filings, including the registration statement, at the SEC&#146;s website at www.sec.gov. We also maintain a website at https://www.metagenomi.co
and upon completion of the offering, you may access, free of charge, our annual reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> current reports on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> and any amendments to those reports, as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information contained in, or that can be accessed through,
our website is not part of, and is not incorporated into, this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">283 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="index"></A><A NAME="toc425213_25"></A>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Index to Consolidated Financial Statements as of December 2021 and 2022 and for the years ended December&nbsp;31, 2021 and 2022: </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_1">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_2">Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_3">Consolidated Statements of Operations and Comprehensive Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_4">Consolidated Statements of Redeemable Convertible Preferred Units and Members&#146; Deficit
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_5">Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_6">Notes to the Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Index to Unaudited Condensed Consolidated Financial Statements as of September 30, 2023 and for the nine months ended September 30,
2022 and 2023: </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_7">Condensed Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_8">Condensed Consolidated Statements of Operations and Comprehensive Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_9">Condensed Consolidated Statements of Redeemable Convertible Preferred Units and Members&#146;
 Deficit</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_10">Condensed Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin425213_11">Notes to the Unaudited Condensed Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_1"></A>Report of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To the Board of Managers and Members of Metagenomi Technologies, LLC </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Opinion on
the Financial Statements </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have audited the accompanying consolidated balance sheets of Metagenomi Technologies, LLC and its subsidiary (the
&#147;Company&#148;) as of December&nbsp;31, 2022 and 2021, and the related consolidated statements of operations and comprehensive loss, of redeemable convertible preferred units and members&#146; deficit, and of cash flows for the years then
ended, including the related notes (collectively referred to as the &#147;consolidated financial statements&#148;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
as of December&nbsp;31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Basis for Opinion </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These consolidated financial statements are the
responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the Company&#146;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting
Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">/s/ PricewaterhouseCoopers LLP </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">San Jose, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">August&nbsp;3, 2023 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have served as the Company&#146;s auditor since 2022. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_2"></A>Consolidated Balance Sheets </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands, except units) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 39,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;184,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Contract assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,916</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">366,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating lease <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT>
assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,736</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">141,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 414,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Liabilities, redeemable convertible preferred units and members&#146; deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Current portion of operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Collaboration advance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Convertible promissory note and accrued interest, net of discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion of operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Collaboration advance, <FONT STYLE="white-space:nowrap">non-current</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred revenue, <FONT STYLE="white-space:nowrap">non-current</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commitments and contingencies (Note 10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Redeemable convertible preferred units: 19,650,632 and 41,813,375 units authorized as of December&nbsp;31,
2021 and 2022, respectively; 19,650,632 and 41,478,621 units issued and outstanding as of December&nbsp;31, 2021 and 2022, respectively. Liquidation preference $76,669 and $347,335 as of December&nbsp;31, 2021 and 2022, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">346,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Members&#146; deficit:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common units: 32,000,000 and 66,000,000 units authorized as of December&nbsp;31, 2021 and 2022,
respectively; 5,947,500 units issued and outstanding as of December&nbsp;31, 2021 and 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits interests: 6,020,644 and 14,604,165 units authorized as of December&nbsp;31, 2021 and 2022,
respectively; 5,783,758 and 7,516,073 units issued and outstanding as of December&nbsp;31, 2021 and 2022, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(274</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(33,096</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total members&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,544</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,428</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total liabilities, redeemable convertible preferred units and members&#146;
deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">141,992</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"> 414,486</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_3"></A>Consolidated Statements of Operations and Comprehensive Loss </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands, except units and per unit data) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 17,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,947</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,640</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in fair value of long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss before provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,569</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (43,593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other comprehensive loss:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unrealized loss on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (21,463</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (43,846</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss per unit attributable to common unitholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (3.77</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (7.34</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average common units outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">5,691,431</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">5,938,654</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:200pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_4"></A>Consolidated Statements of Redeemable Convertible Preferred Units and Members&#146;
Deficit </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands, except units) </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Redeemable<BR>Convertible Preferred<BR>Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Common Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Profits Interests</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1.00px solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive</B><br><B>Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1.00px solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;border-bottom:1.00px solid #000000"><B>Total<BR>Members&#146;</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial"><B>BALANCE&#151;January 1, 2021</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,069,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">66,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,302,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(11,654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(11,456</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of Series A-5 redeemable convertible preferred units, net of issuance costs of $52</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,550,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Cancellation and forfeiture of profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(69,335</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="25" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial"><B>BALANCE&#151;December 31, 2021</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,650,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">76,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,783,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(33,096</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(32,544</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="25" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of Series B redeemable convertible preferred units for cash, net of</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">issuance costs of $697</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,446,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of Series B redeemable convertible preferred units upon conversion of convertible note and accrued
interest</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,607,387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of Series B-1 redeemable convertible preferred units, net of issuance costs of $361</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,773,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,763,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Cancellation and forfeiture of profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,031,041</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="25" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial"><B>BALANCE&#151;December 31, 2022</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">41,478,621</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">346,103</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">7,516,073</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">2,509</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">(274</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">(76,689</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">(74,428</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="25" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="25" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_5"></A>Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Cash flows from operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(43,593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Adjustments to reconcile net loss to net cash provided by operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Loss on fixed assets <FONT STYLE="white-space:nowrap">write-off</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-cash</FONT> lease expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Amortization of premiums and discounts on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,129</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Amortization of <FONT STYLE="white-space:nowrap">non-cash</FONT> collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(314</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-cash</FONT> interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in fair value of long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,760</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(502</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,465</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Contract assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,274</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(173</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred revenue and collaboration advance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;44,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;65,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(88</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(81</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash provided by operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Cash flows from investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,903</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,977</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Purchases of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(69,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,850</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Purchases of long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,155</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturities and sales of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,316</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(122,200</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Cash flows from financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Proceeds from issuance of redeemable convertible preferred units, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Proceeds from issuance of convertible promissory note, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net change in cash, cash equivalents and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147,118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash, cash equivalents and restricted cash at the beginning of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash, cash equivalents and restricted cash at the end of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 43,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 190,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Reconciliation of cash, cash equivalents and restricted cash</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 39,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 184,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash, cash equivalents and restricted cash at the end of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"> 43,396</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"> 190,514</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Consolidated Statements of Cash Flows</B>&nbsp;(Continued)<B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Supplemental cash flow information</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Issuance of Series B redeemable convertible preferred units upon conversion of convertible promissory note
and accrued interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;30,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common shares of <FONT STYLE="white-space:nowrap">Affini-T</FONT> received for collaboration
revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating lease <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT>
assets obtained in exchange for new lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;18,659</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-cash</FONT> expense related to a lease modification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,059</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred finance issuance costs included in other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unpaid finance issuance costs included in accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Purchases of property and equipment included in
accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000" ALIGN="right"> 725</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000" ALIGN="right"> 1,247</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:400pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_6"></A>Notes to the consolidated financial statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>1. Description of business, organization and liquidity </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Organization
and business </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi Technologies, LLC (&#147;Metagenomi&#148;), together with its wholly owned subsidiary Metagenomi, Inc. (&#147;Metagenomi Inc.&#148;)
(together, the &#147;Company&#148;) is a gene editing biotechnology company developing &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; therapeutics by leveraging a toolbox of next-generation gene
editing systems to accurately edit DNA. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Formation and group reorganizations </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi.co was incorporated in September 2016 in the State of Delaware and is headquartered in Emeryville, California. In September 2018, Metagenomi.co formed a
subsidiary, Metagenomi Technologies, LLC, as its sole member. In November 2018, the two companies completed a reorganization where Metagenomi Technologies, LLC became the parent of Metagemoni.co. The reorganization was a transaction of entities
under common control and did not change the group. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In December 2018, Metagenomi formed another wholly owned subsidiary, Metagenomi IP Technologies, LLC. Metagenomi
IP Technologies, LLC did not have any operations except for the initial transfer of IP from Metagenomi.co and an ongoing license of its technology to Metagenomi.co. Key activities of Metagenomi were raising capital to support operations of
Metagenomi.co. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In April 2020, Metagenomi.co changed its name to Metagenomi, Inc. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In December 2021, the group completed another <FONT STYLE="white-space:nowrap">tax-free</FONT> reorganization, whereby Metagenomi IP Technologies, LLC merged with and
into Metagenomi, Inc. As of December&nbsp;31, 2022, the group consisted of two entities: Metagenomi Technologies, LLC and its subsidiary, Metagenomi Inc. Both 2018 and 2021 reorganizations were accounted as transactions under common control at
historical carrying values. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Liquidity and going concern </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
Company has incurred significant losses from operations since its inception. During the years ended December&nbsp;31, 2021 and 2022, the Company incurred net losses of $21.4&nbsp;million and $43.6&nbsp;million, respectively. As of December&nbsp;31,
2022, the Company had an accumulated deficit of $76.7&nbsp;million. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has historically financed its operations primarily through issuance of redeemable
convertible preferred units, convertible promissory notes and its collaboration agreements with Moderna, Affini-T and Ionis (see Note 7). The Company expects to continue to incur substantial losses, and its ability to achieve and sustain
profitability will depend on the successful development, approval, and commercialization of any product candidates it may develop, and on the achievement of sufficient revenue to support its cost structure. The Company may never achieve
profitability and, unless and until it does, it will need to continue to raise additional capital. Management expects that existing cash and cash equivalents and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities of $362.1&nbsp;million as of December&nbsp;31, 2022, will be sufficient to fund its current operating plan for at least the next
12 months from the date of issuance of these consolidated financial statements. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>2. Summary of significant accounting policies </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Basis of presentation </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These consolidated financial statements have
been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;). The accompanying consolidated financial statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
include the accounts of Metagenomi and Metagenomi Inc., a wholly owned subsidiary. All intercompany balances and transactions have been eliminated in consolidation. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#147;ASC&#148;) and
Accounting Standards Updates (&#147;ASU&#148;) of the Financial Accounting Standards Board (&#147;FASB&#148;). </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Use of estimates </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. On an ongoing basis, the Company evaluates estimates and assumptions,
including but not limited to those related to revenue recognition under its collaboration agreements, the fair value of its common and redeemable convertible preferred units, the fair value of derivative liabilities, unit-based compensation expense,
accruals for research and development expenses, the fair value of long-term investments and convertible promissory notes in private companies, the valuation of deferred tax assets, and uncertain income tax positions. Management bases its estimates
on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily
apparent from other sources. Actual results may differ materially from those estimates. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Segment and geographical information </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company operates and manages its business as one reportable and operating segment, which is the business of developing next generation gene-editing technologies and
therapies. The chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance. All of the Company&#146;s long-lived
assets are located in the United States. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Risks and uncertainties </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company is subject to certain risks and uncertainties, including, but not limited to, changes in any of the following areas that the Company believes could have a
material adverse effect on the future financial position or results of operations: the Company&#146;s ability to advance the development of its next generation gene-editing platform, timing and ability to advance any product candidates it may
develop into and through <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical development; costs and timelines associated with the manufacturing of clinical supplies of any product candidates the Company may develop; regulatory
approval, market acceptance of, and reimbursement for any product candidates the Company may develop; performance of third-party vendors; competition from pharmaceutical or other gene-editing companies with greater financial resources or expertise;
protection of intellectual property; litigation or claims against the Company based on intellectual property or other factors; and its ability to attract and retain employees necessary to support its growth. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s business and operations may be affected by worldwide economic conditions, which may continue to be impacted by global macroeconomic challenges such as
the effects of the ongoing geopolitical conflicts in Ukraine, tensions in U.S.-China relations, the COVID-19 pandemic, uncertainty in the markets, including disruptions in the banking industry, and inflationary trends. Fiscal year 2022 was marked by
significant market uncertainty, increasing inflationary pressures. These market dynamics may continue into 2023 and these and similar adverse market conditions may negatively impact the Company&#146;s operations and financial position. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Cash and cash equivalents </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Cash equivalents are defined as short-term, highly liquid investments with original maturities of 90 days or less at the date of purchase. As of December&nbsp;31, 2021
and 2022, the Company&#146;s cash and cash equivalents consisted of deposit accounts and investments in money market funds. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Marketable securities
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Investments with original maturities of greater than 90 days are classified as
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities on the consolidated balance sheets and consist primarily of U.S. Treasury, corporate debt obligations, commercial paper,
government agency obligations and asset-backed securities. As&nbsp;the Company&#146;s entire investment portfolio is considered available for use in current operations, the Company classifies all investments as <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> and as current assets, even though the stated maturity may be more than one year from the current consolidated balance sheets date. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Available-for-sale</FONT></FONT> securities are carried at fair value, with unrealized gains and losses reported in accumulated other comprehensive loss, which is a separate component of members&#146; deficit in the
consolidated balance sheets. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity, which are both
recorded to interest income in the consolidated statements of operations and comprehensive loss. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Changes in the fair value of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities are reflected within unrealized loss on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, net in the
consolidated statements of operations and comprehensive loss. Realized gains and losses on the sale of securities are determined by specific identification of each security&#146;s cost basis. The Company regularly reviews its investment portfolio to
determine if any security is impaired, which would require it to record an allowance for credit losses or an impairment charge in the period any such determination is made. In making this judgment, the Company evaluates, among other things, the
extent to which the fair value of a security is less than its amortized cost, its intent to sell or whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis, the financial
condition of the issuer and any changes thereto, and, as necessary, the portion of a decline in fair value that is credit-related. This assessment could change in the future due to new developments or changes in assumptions related to any particular
security. Realized gains and losses, allowances for credit losses and impairments on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities, if any, are recorded to interest expense, net in the
consolidated statements of operations and comprehensive loss.</P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Long-term investments </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company determines at the inception of each arrangement whether an investment or other interest is considered a variable interest entity (&#147;VIE&#148;). If the
investment or other interest is determined to be a VIE, the Company evaluates whether it is considered the primary beneficiary. The primary beneficiary of a VIE is the party that meets both of the following criteria: (i)&nbsp;has the power to direct
the activities that most significantly impact the VIE&#146;s economic performance; and (ii)&nbsp;has the obligation to absorb losses or the right to receive benefits from the VIE. For investments in VIEs in which the Company is considered the
primary beneficiary, the assets, liabilities and results of operations of the VIE are included in the Company&#146;s consolidated financial statements. As of December&nbsp;31, 2021 and 2022, there were&nbsp;no&nbsp;VIEs for which the Company was the
primary beneficiary. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">If the Company concludes that it exercises significant influence over an investees&#146; operations, it may account for its investment either
using the equity method of accounting or fair value method. The election to account for an investment at fair value is irrevocable unless an event occurs creating a new election date. If the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Company does not have a significant influence, it accounts for its investment at fair value and may elect to account for an equity security without a readily determinable fair value using the
measurement alternative method. The measurement alternative method allows the Company to measure the equity investment at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for
the identical or a similar investment of the same issuer. Changes in fair value and impairment losses are recognized as other income (expenses) in the consolidated statements of operations and comprehensive loss. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Restricted cash </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Restricted cash of $4.1&nbsp;million and
$6.1&nbsp;million as of December&nbsp;31, 2021 and 2022, respectively, represents security deposits in the form of a letter of credit issued in connection with the Company&#146;s leases (see Note 10). </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Concentration of credit risk </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Cash and cash equivalents, marketable
securities and investments in convertible promissory notes are financial instruments that potentially subject the Company to concentrations of credit risk. As of December&nbsp;31, 2021 and 2022, cash consists of cash deposited with one financial
institution, Silicon Valley Bank (&#147;SVB&#148;), and account balances exceed federally insured limits. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On March&nbsp;10, 2023, SVB was closed by the California
Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#147;FDIC&#148;) as receiver. On March&nbsp;12, 2023 the FDIC transferred all deposits, both insured and uninsured, and substantially all
assets from the former SVB to a newly created, full-service FDIC-operated &#147;bridge bank&#148;, Silicon Valley Bridge Bank, N.A. (&#147;SVBB&#148;) and the FDIC, Treasury Department, and Federal Reserve announced that all deposits will be fully
protected, whether or not they had been insured by the FDIC. On March&nbsp;27, 2023, First-Citizens Bank&nbsp;&amp; Trust Company assumed all of SVBB&#146;s customer deposits and certain other liabilities and acquired substantially all of
SVBB&#146;s loans and certain other assets from the FDIC. As of the date of the issuance of these consolidated financial statements, the Company has full access to and control over all its cash, cash equivalents and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company also has investments in money market funds, U.S. Treasuries,
corporate debt obligations, commercial paper, government agency obligations and asset-backed securities, which can be subject to certain credit risks. The Company mitigates the risks by investing in high-grade instruments, limiting its exposure to
any one issuer and monitoring the ongoing creditworthiness of the financial institutions and issuers. The Company has not experienced any losses on its financial instruments. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Concentration of collaboration revenue and contract assets </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
following table summarizes the percentages of collaboration revenues and of contract assets from each of the Company&#146;s customers that individually accounted for 10% or more of its collaboration revenues: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Collaboration&nbsp;revenue</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Contract&nbsp;assets</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Customer A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Customer B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company reviews its contract assets for impairment. No&nbsp;contract asset impairment was recorded as of
December&nbsp;31, 2022. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Fair value measurements </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Fair value is
defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The carrying amounts of cash equivalents, prepaid expenses and other current
assets, accounts payable, accrued expenses and other liabilities, approximate fair value due to their short-term maturities. Financial instruments, such as money market funds, marketable securities and certain equity and long-term investments are
measured at fair value at each reporting date (see Note 3). </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Deferred finance issuance costs </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Deferred finance issuance&nbsp;costs, consisting of legal fees relating <FONT STYLE="white-space:nowrap">to&nbsp;in-process&nbsp;equity</FONT> financings or offerings
are capitalized. The&nbsp;deferred finance issuance&nbsp;costs will be offset against&nbsp;offering&nbsp;proceeds upon the completion of the&nbsp;financing or the offering. In the event the&nbsp;financing or the offering&nbsp;is terminated or
delayed,&nbsp;deferred finance issuance&nbsp;costs will be expensed immediately as a charge to general and administrative expenses in the consolidated statements of operations and comprehensive loss. As of December&nbsp;31, 2021, the Company
capitalized and recorded $0.1&nbsp;million in issuance costs related to its Series B preferred unit financing in other assets in the consolidated balance sheets, which closed in January 2022. There were no deferred finance issuance costs as of
December&nbsp;31, 2022. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Property and equipment, net </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Property and
equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally three to five years, and leasehold improvements are
amortized over the shorter of the lease term or the estimated useful life of the asset. Repairs and maintenance expenditures, which are not considered improvements and do not extend the useful life of property and equipment, are expensed as
incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gain or loss is reflected in the consolidated statements of
operations and comprehensive loss in the period realized. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Leases </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company determines whether an arrangement is or contains a lease at the inception of the arrangement and whether such a lease should be classified as a financing
lease or operating lease at the commencement date of the lease. Leases with a term greater than one year are recognized on the consolidated balance sheets as operating
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset (&#147;ROU asset&#148;) and operating lease liabilities. We elected not to recognize the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and lease liabilities for leases with lease terms of one year or less (short-term leases). Lease liabilities and their corresponding ROU assets are recorded based on the present value of
lease payments over the lease term. The Company considers the lease term to be the noncancelable period that it has the right to use the underlying asset, together with any periods where it is reasonably certain it will exercise an option to extend
(or not terminate) the lease. As the interest rate implicit in the Company&#146;s lease contracts is not readily determinable, the Company utilizes its incremental borrowing rate (&#147;IBR&#148;) based on the information available at the
commencement date to determine the present value of lease payments. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Rent expense for operating leases is recognized on a straight-line basis over the lease term.
The Company has elected to not separate lease and <FONT STYLE="white-space:nowrap">non-lease</FONT> components for its real estate leases and instead accounts for each </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
separate lease component and the <FONT STYLE="white-space:nowrap">non-lease</FONT> components associated with that lease component as a single lease component. Variable lease payments are
recognized as incurred. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2021 and 2022, the Company had no finance leases. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Impairment of long-lived assets </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company reviews long-lived assets
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparing the carrying amount to the future undiscounted net cash flows which the assets
are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows generated by the
assets. There have been no such impairments of long-lived assets in the years ended December&nbsp;31, 2021 and 2022. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Redeemable convertible preferred units
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company records redeemable convertible preferred units at their respective fair values on the dates of issuance, net of issuance costs. The redeemable
convertible preferred units are recorded outside of permanent equity because while it is not mandatory, redemption is contingent upon the occurrence of certain events considered not solely within the Company&#146;s control. The Company has not
adjusted the carrying values of the redeemable convertible preferred units to the liquidation preferences of such units because it is uncertain whether or when a deemed liquidation event would occur that would obligate the Company to pay the
liquidation preferences to holders of redeemable convertible preferred units. Subsequent adjustments to the carrying values to the liquidation preferences will be made only when it becomes probable that such a deemed liquidation event will occur.
</P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Collaboration arrangements and revenue recognition </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">At the
inception of an agreement, the Company evaluates if an agreement is a collaborative arrangement within the scope of ASC 808, <I>Collaborative Arrangements</I> (&#147;ASC 808&#148;). For collaborative arrangements that fall within the scope of ASC
808, the Company first determines which elements of the collaboration are deemed to be a performance obligation with a customer within the scope of ASC Topic 606, <I>Revenue from Contracts with Customers</I> (&#147;ASC 606&#148;). For elements of
collaboration arrangements that are accounted for pursuant to ASC 808 and are not subject to the guidance in ASC 606, the Company applies the revenue recognition model under ASC 606 or other guidance, as deemed appropriate. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company <FONT STYLE="white-space:nowrap">re-evaluates</FONT> whether the license agreement continues to be a collaborative arrangement, or whether the license
agreement becomes a collaborative arrangement, whenever there is a change in either the roles of the participants in the arrangement or the participants&#146; exposure to significant risks and rewards dependent on the ultimate commercial success of
the endeavor. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under ASC 606, the Company recognizes revenue when the Company&#146;s customer obtains control of promised goods or services, in an amount that
reflects the consideration which the Company expects to receive in exchange for those goods and services. To determine revenue recognition for arrangements within the scope of ASC 606, the Company performs the following five steps: (i)&nbsp;identify
the contract(s) with a customer; (ii)&nbsp;identify the performance obligations in the contract; (iii)&nbsp;determine the transaction price, including the constraint on variable consideration; (iv)&nbsp;allocate the transaction price to the
performance obligations in the contract; and (v)&nbsp;recognize revenue when or as the Company satisfies a performance obligation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s revenue is
primarily derived through its license, research, development and option agreements. These agreements may include the following types of promised goods or services: (i)&nbsp;grants of licenses, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
(ii)&nbsp;performance of research and development services, and (iii)&nbsp;participation on joint research and/or development committees. They also may include options to obtain licenses to the
Company&#146;s intellectual property or to extend the term of the research activities. Payments to the Company under these arrangements typically include one or more of the following: <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront
payments; reimbursement for research services; research, development or regulatory milestone payments; profit-sharing arrangements; and royalty and commercial sales milestone payments. The event-based milestone payments, royalties and cost
reimbursements represent variable consideration. The Company evaluates the probability that the event-based milestones will be achieved and estimates the amount to be included in the transaction price using the most likely amount method. The Company
includes cost reimbursement in the transaction price using the expected value method. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A performance obligation is a promise in a contract to transfer a distinct
good or service to the customer and is the unit of account in ASC 606. The Company allocates the total transaction price, including variable consideration that is not constrained, to each performance obligation based on the estimated standalone
selling price and recognizes revenue when, or as, the performance obligation is satisfied. Amounts of variable consideration are included in the transaction price to the extent that it is probable that a significant reversal in the amount of
cumulative revenue recognized will not occur. At the end of each reporting period, the Company <FONT STYLE="white-space:nowrap">re-evaluates</FONT> the estimated variable consideration included in the transaction price and any related constraint,
and if necessary, adjusts its estimate of the overall transaction price. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s collaboration and license agreements include contingent payments related
to sales-based milestones and royalties. Sales-based milestones and royalties are typically payable when annual sales of a covered product reach specified levels and sales occur. When intellectual property license is determined to be a predominant
promise in the arrangement, sales-based milestones and royalties are recognized at the later of when the associated performance obligation has been satisfied or when the sales occur. Unlike other contingency payments, such as regulatory milestones,
sales-based milestones and royalties are not included in the transaction price based on estimates at the inception of the contract, but rather, are included when the sales or usage occur. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In cases when upfront payment contains a material right for the optional services the Company may provide in the future, the material right is treated as a separate
performance obligation. The value allocated to such material right is deferred and recognized as revenue when the performance obligation is satisfied, and the optional services are provided, or when the right expires. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Contract assets and contract liabilities </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A contract asset is a right
to consideration in exchange for goods or services that the Company has transferred to a customer when that right is conditional and is not just subject to the passage of time. A receivable is recorded on the consolidated balance sheets when the
Company has unconditional rights to consideration. As of December&nbsp;31, 2022, the contract asset balance of $1.3&nbsp;million related to revenue recognized and unbilled under the Affini-T Agreement (Note 7). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A contract liability is an obligation to transfer goods or services for which the Company has received consideration, or for which an amount of consideration is due from
the customer. Contract liabilities consist of deferred revenue and relate to amounts invoiced to, or advance consideration received from, licensees that precede the Company&#146;s satisfaction of the associated performance obligations. The
Company&#146;s deferred revenue primarily results from upfront payments received relating to the performance obligations that are satisfied over time under the Company&#146;s revenue arrangements (Note 7). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s contract balances are reported in a net contract asset or liability position on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">contract-by-contract</FONT></FONT> basis at the end of each reporting period. Changes in the contract assets and the contract </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
liabilities balances during the period are the result of the issuance of invoices, receipts of <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payments and recognition of deferred
revenues. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Research and development expenses </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Research and
development costs are expensed as incurred. Research and development costs include salaries, unit-based compensation, and benefits for employees performing research and development activities, an allocation of facility and overhead expenses,
expenses incurred under agreements with consultants, third-party organizations and vendors that conduct research and <FONT STYLE="white-space:nowrap">pre-clinical</FONT> activities, regulatory support activities, manufacturing process development
activities and provide supplies. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Research and development expenses accruals are estimated based on the level of services performed, progress of the work orders,
including the phase or completion of events, and contracted costs. The estimated costs of research and development services provided, but not yet invoiced, are included in accrued expenses and other current liabilities in the consolidated balance
sheets. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual accordingly. To date, there have been no material differences between estimates of such
expenses and the amounts actually incurred. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Nonrefundable advance payments for goods or services to be received in the future for use in research and development
activities are capitalized and recorded in prepaid expenses and other current assets, and then expensed as the related goods are delivered or the services are performed. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Patent costs </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">All patent-related costs incurred in connection with
filing and prosecuting patent applications are expensed as incurred due to the uncertainty of the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses in the consolidated statements of operations and
comprehensive loss. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Unit-based compensation expense </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
Company&#146;s unit-based equity awards include issuance of profits interests that are granted to employees and consultants under the 2019 Equity Incentive Plan. Profits interests usually vest over four years and are a separate class of equity with
defined rights within the LLC Agreement. A profits interest is an interest in the increase in the value of the Company over the threshold amount, as determined at the time of grant on a per unit basis. The holder, therefore, has the right to
participate in distributions of profits only in excess of the threshold amount. The threshold amount is based on the valuation of the common units on or around the grant date. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company accounts for profits interests granted in accordance with ASC 718, <I>Compensation-Stock Compensation</I> (ASC 718). In accordance with ASC 718, compensation
expense is measured at the estimated fair value of the profits interest using the Black-Scholes option-pricing model and is included as compensation expense over the vesting period during which an employee or a consultant provides service in
exchange for the award. Unit-based compensation expense is recognized over the awards&#146; vesting period on a straight-line basis and recorded as either research and development or general and administrative expenses in the consolidated statements
of operations and comprehensive loss based on the function to which the related services are provided. Forfeitures are accounted for as they occur. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Income
taxes </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi is taxed under the provisions of Sub chapter K- Partners and Partnerships of the Internal Revenue Code. Under those provisions, Metagenomi
does not pay federal or state corporate income taxes on its taxable income. Instead, each member includes net operating income or loss for Metagenomi on its individual return. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi Inc. uses the liability method to account for income taxes. Under this method, deferred tax assets and
liabilities are determined based on differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases. Deferred tax assets and liabilities are measured using enacted tax rates applied to taxable
income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi Inc. assesses the likelihood of deferred tax assets being realized. It provides a valuation allowance when it is more likely than not that some portion or all
of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the temporary differences representing net future deductible amounts
become deductible. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Tax benefits related to uncertain tax positions are recognized when it is more likely than not that a tax position will be sustained during an
audit. Tax positions that meet the <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> threshold are measured at the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement with the taxing authority.
Interest and penalties related to unrecognized tax benefits are included within the provision for income tax. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Net loss per unit </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company calculates basic and diluted net loss per unit in conformity with the <FONT STYLE="white-space:nowrap">two-class</FONT> method required for participating
securities. Under the <FONT STYLE="white-space:nowrap">two-class</FONT> method, basic net loss per unit is computed by dividing the net loss by the weighted average number of common units outstanding during the period, without consideration of
potentially dilutive securities. Diluted net loss per unit is computed by dividing the net loss by the sum of the weighted average number of common units outstanding during the period plus the dilutive effects of potentially dilutive securities
outstanding during the period. Potentially dilutive securities include incentive units, unvested restricted common units and redeemable convertible preferred units. The dilutive effect of incentive units and unvested restricted common units is
computed using the treasury stock method and the dilutive effect of redeemable convertible preferred units is calculated using the <FONT STYLE="white-space:nowrap">if-converted</FONT> method. For all periods presented, diluted net loss per unit is
the same as basic net loss per unit since the effect of including potential dilutive securities is anti-dilutive and incentive units&#146; participation thresholds were not met. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Comprehensive loss </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Comprehensive income (loss) is defined as a change
in equity of a business enterprise during a period resulting from transactions from <FONT STYLE="white-space:nowrap">non-owner</FONT> sources. The Company&#146;s other comprehensive income (loss) is comprised solely of unrealized gains (losses) on <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities. The Company has not recorded any reclassifications from other comprehensive income (loss) to net loss during the periods presented.
</P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Recently issued accounting pronouncements </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company noted no
recently issued accounting pronouncements that will impact its consolidated financial statements and were not adopted by the Company. No new accounting pronouncements were adopted during the year ended December&nbsp;31, 2022. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>3. Fair value measurements </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Assets and liabilities recorded at fair value on a
recurring basis in the consolidated balance sheets, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and
requires certain </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
disclosures about how fair value is determined. The accounting guidance establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair
value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level
hierarchy for the inputs to valuation techniques is briefly summarized as follows: </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><I>Level</I><I></I><I>&nbsp;1 </I>&#151; Inputs are unadjusted,
quoted prices in active markets for identical assets or liabilities at the measurement date; </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><I>Level</I><I></I><I>&nbsp;2 </I>&#151; Inputs are
observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be
corroborated by observable market data for substantially the full term of the related assets or liabilities; and </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><I>Level</I><I></I><I>&nbsp;3
</I><B>&#151; </B>Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. An
assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. Changes in the ability to observe valuation inputs may
result in a reclassification of levels of certain securities within the fair value hierarchy. The Company recognizes transfers into and out of levels within the fair value hierarchy in the period in which the actual event or change in circumstances
that caused the transfer occurs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s financial instruments measured at fair value on a recurring basis consist of Level&nbsp;1, Level&nbsp;2, and
Level&nbsp;3 financial instruments. Usually, marketable securities are considered Level&nbsp;2 when their fair values are determined using inputs that are observable in the market or can be derived principally from or corroborated by observable
market data such as pricing for similar securities, recently executed transactions, cash flow models with yield curves, and benchmark securities. In addition, Level&nbsp;2 financial instruments are valued using comparisons to like-kind financial
instruments and models that use readily observable market data as their basis. U.S. Government bonds, corporate debt obligations, commercial paper, government agency obligations and asset-backed securities are valued primarily using market prices of
comparable securities, bid/ask quotes, interest rate yields and prepayment spreads and are included in Level&nbsp;2. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Financial assets and liabilities are considered
Level&nbsp;3 when their fair values are determined using pricing models, discounted cash flow methodologies, or similar techniques, and at least one significant model assumption or input is unobservable. The Company&#146;s investments in a
convertible promissory note, preferred stock shares and restricted common stock of Affini-T Therapeutics Inc. (&#147;Affini-T&#148;) (see Note 5) are Level&nbsp;3 financial assets. </P>
<P STYLE="font-size:8pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the estimated fair value of the financial instruments that were measured at fair value
on a recurring basis by level within the fair value hierarchy as of December&nbsp;31, 2021 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="16" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds (included in cash and cash equivalents)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 34,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Government agency obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate debt obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commercial paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Asset-backed securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term investments (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total fair value of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">108,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,929</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">65,869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, restricted cash of $4.1&nbsp;million as of December&nbsp;31, 2021, collateralized by the Company&#146;s cash equivalents,
are financial assets measured at fair value and is a Level&nbsp;1 financial instruments under the fair value hierarchy. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the estimated
fair value of the financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy as of December&nbsp;31, 2022 (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="16" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31, 2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds (included in cash and cash equivalents)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Government bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Government agency obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate debt obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commercial paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Asset-backed securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term investments (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total fair value of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">365,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">197,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">162,869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, restricted cash of $6.1&nbsp;million as of December&nbsp;31, 2022, collateralized by the Company&#146;s cash equivalents,
are financial assets measured at fair value and is a Level&nbsp;1 financial instruments under the fair value hierarchy. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In December 2020, the Company entered into a
convertible promissory note agreement and a side letter with Affini-T (see Note 5), and recorded an aggregate $1.5&nbsp;million investment in Affini-T within long-term investments on the consolidated balance sheet related to (i)&nbsp;the Affini-T
Convertible Promissory Note and (ii)&nbsp;shares of Affini-T&#146;s common stock. The Company concluded it exercised significant influence over Affini-T, and the Company elected the fair value method to account for the investment in Affini-T. The
fair value of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
common stock shares was estimated by the Company&#146;s management, considering the most recent third-party valuation, which was based on an option-pricing model and Affini-T&#146;s most recent
round of financing. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the year ended December&nbsp;31, 2021, the Company recognized an aggregate $2.8&nbsp;million change in fair value of its investment in
Affini-T within the change in fair value of long-term investments in the consolidated statement of operations and comprehensive loss consisting of a $2.5&nbsp;million change in fair value of the Affini-T Convertible Promissory Note and a
$0.3&nbsp;million change in fair value of the shares of Affini-T common stock. As of December&nbsp;31, 2021, the aggregate fair value of the Company&#146;s investment in Affini-T was $4.3&nbsp;million, of which $4.0&nbsp;million related to the
Affini-T Convertible Promissory Note and $0.3&nbsp;million related to the shares of Affini-T common stock. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In March 2022, the Company&#146;s investment in the
Affini-T Convertible Promissory Note was converted into shares of convertible preferred stock, resulting in no convertible note outstanding as of December&nbsp;31, 2022 (see Note 5). The fair value of the convertible preferred stock shares was based
on cash paid per share by third party investors. During the year ended December&nbsp;31, 2022, the Company recognized a change in fair value of the Affini-T Convertible Promissory Note of $0.1&nbsp;million within the change in fair value of
long-term investments in the consolidated statement of operations and comprehensive loss. There was no change in the fair value of the shares of Affini-T common stock during the year ended December&nbsp;31, 2022. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2021, the fair value of the Affini-T Convertible Promissory Note was estimated using the fair value of preferred stock using Affini-T&#146;s
recent valuation and future payments discounted at a rate of 6%. As of the date of the conversion, the fair value was estimated as $4.1&nbsp;million, which was the fair value of the convertible preferred stock issued upon the conversion and as of
December&nbsp;31, 2022. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There were no transfers between Level&nbsp;1 and Level&nbsp;2 categories in the years ended December&nbsp;31, 2021 and 2022. As of
December&nbsp;31, 2021 and 2022, the Company&#146;s investments in Affini-T were accounted as Level&nbsp;3 investments and recorded at fair value. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>4. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Available-for-sale</FONT></FONT> marketable securities </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the amortized
cost, unrealized gains (losses) and estimated fair value of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities as of December&nbsp;31, 2021 (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amortized<BR>cost</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Unrealized<BR>gains</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Unrealized<BR>losses</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Estimated<BR>fair value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 34,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 34,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Government agency obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate debt obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commercial paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Asset-backed securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: amounts classified as cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,940</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,940</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 68,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 68,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the amortized cost, unrealized gains (losses) and estimated fair value of the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities as of December&nbsp;31, 2022 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amortized<BR>cost</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Unrealized<BR>gains</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Unrealized<BR>losses</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Estimated<BR>fair value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Government bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(69</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Government agency obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate debt obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(151</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commercial paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Asset-backed securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(105</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: amounts classified as cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(182,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(182,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 177,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 177,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2021 and 2022, no significant facts or circumstances were present to indicate a deterioration in the
creditworthiness of the issuers of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities, and the Company has no requirement or intention to sell these securities before maturity or
recovery of their amortized cost basis. The Company considered the current and expected future economic and market conditions and determined that its investments were not significantly impacted. For all securities with a fair value less than its
amortized cost basis, the Company determined the decline in fair value below amortized cost basis to be immaterial and <FONT STYLE="white-space:nowrap">non-credit</FONT> related, and therefore no allowance for losses has been recorded.&nbsp;During
the years ended&nbsp;December 31, 2021 and 2022, the Company did not recognize any impairment losses on its investments. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s policy is to exclude the
applicable accrued interest from both the fair value and the amortized cost basis of its <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities for purposes of identifying and measuring an
impairment. The Company presents accrued interest receivable related to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities in prepaid expenses and other current assets, separate from
available-for-sale marketable securities in the consolidated balance sheets. As of December&nbsp;31, 2021 and 2022, accrued interest receivable was $0.2&nbsp;million and $0.3&nbsp;million, respectively. The Company&#146;s accounting policy is to not
measure an allowance for credit losses for accrued interest receivables and to <FONT STYLE="white-space:nowrap">write-off</FONT> any uncollectible accrued interest receivable as a reversal of interest income in a timely manner, which it considers to
be in the period in which the Company determines the accrued interest will not be collected. The Company has&nbsp;not written off any accrued interest receivables for the years ended December&nbsp;31, 2021 and 2022. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The amortized cost and fair value of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities by
contractual maturity were as follows as of December&nbsp;31, 2021 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amortized<BR>cost</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Estimated<BR>fair&nbsp;value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturing within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">67,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">67,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturing in one to five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">68,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">68,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The amortized cost and fair value of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities by contractual maturity were as follows as of December&nbsp;31, 2022 (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amortized<BR>cost</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Estimated<BR>fair&nbsp;value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturing within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">163,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">163,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturing in one to five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">177,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">177,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>5. Long-term investments </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Affini-T
investment </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In December 2020, the Company entered into a convertible promissory note agreement and a side letter with Affini-T, a private biotechnology
company. The Company participated with other investors in Affini-T&#146;s convertible notes financing and paid cash of $1.5&nbsp;million as a principal amount of a convertible promissory note with 6% annual interest and maturity in December 2021.
The Affini-T Convertible Promissory Note was convertible in Affini-T&#146;s next qualifying round of financing at a conversion price equal to the lesser of (i) 85% of the price per share paid by other investors (or 80% if the qualified financing
occurs after June&nbsp;24, 2021) or (ii)&nbsp;the price per share obtained by dividing $30.0&nbsp;million by the number of shares of common stock of Affini-T outstanding immediately prior to the qualified financing. In accordance with the side
letter, the Company was engaged to perform the testing of its gene editing system to <FONT STYLE="white-space:nowrap">knock-in</FONT> <FONT STYLE="white-space:nowrap">T-cell</FONT> receptor (&#147;TCR&#148;) targets in primary <FONT
STYLE="white-space:nowrap">T-cells</FONT> as selected by Affini-T. As consideration for services, the Company received 1,867,300 shares of restricted common stock of Affini-T, of which 10% of the shares vested on the issuance date and 90% shares
were subject to forfeiture if no gene editing licensing agreement was finalized between the Company and Affini-T by October&nbsp;31, 2021. Effective November&nbsp;1, 2021, 1,653,570 shares of restricted common stock issued to the Company were
forfeited and cancelled as a license agreement was not signed between the parties. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In March 2022, Affini-T closed a qualifying round of financing, and the Affini-T
Convertible Promissory Note and accrued interest were converted into 527,035 Series A convertible preferred stock shares of Affini-T. The Company accounted for its investments in the Affini-T Convertible Promissory Note and convertible preferred
stock at fair value (see Note 3). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company performed a VIE analysis and concluded that it was not a primary beneficiary of Affini-T. The Company concluded that
it exercised significant influence over Affini-T until November 2021, when shares of restricted common stock were forfeited and the Company&#146;s former chief business officer, who was also the founder and chief executive officer of Affini-T,
resigned. The Company accounted for its investment in 213,730 shares of Affini-T common stock at fair value of $0.3&nbsp;million for each of the periods ending December&nbsp;31, 2021 and 2022 (see Note 3). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In June 2022, the Company entered into a Development, Option and License Agreement with Affini-T to perform research and development activities (see Note 7). The Company
received an upfront equity consideration of 719,920 shares of Affini-T&#146;s common stock with an estimated fair value of $1.3&nbsp;million in June 2022. The fair value of common shares was estimated by the Company&#146;s management, considering
the most recent third-party valuation. No impairment loss was recognized on the Company&#146;s investment in Affini-T as of December&nbsp;31, 2021 and 2022. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>ViTToria investment </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company purchased 603,262 Series <FONT
STYLE="white-space:nowrap">Seed-2</FONT> convertible preferred stock shares of ViTToria Biotherapeutics, Inc. (&#147;Vittoria&#148;), a private biotechnology company, for a total of $2.2&nbsp;million cash in July and December 2021.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
During the years ended December&nbsp;31, 2021 and 2022, the Company did not have a board seat and owned less than 20% of outstanding voting shares of Vittoria. The investment in Vittoria does not
provide the Company the ability to control or have significant influence over Vittoria&#146;s operations. The Company accounted for the investment in Vittoria&#146;s Series <FONT STYLE="white-space:nowrap">Seed-2</FONT> convertible preferred stock
using the measurement alternative method. The fair value of the investment was estimated by management using per share price of $3.57, which was the price paid for convertible preferred stock shares by other investors. As of December&nbsp;31, 2021
and 2022, the carrying value of Vittoria&#146;s investment was $2.2&nbsp;million and no impairment was recognized. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>6. Consolidated balance sheets components
</B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Property and equipment, net consists of the following (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Useful&nbsp;life</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">lesser&nbsp;of<BR>useful&nbsp;life&nbsp;or<BR>the&nbsp;lease&nbsp;term</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">293</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Computers and related equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Construction in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: Accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The depreciation and amortization expense was $0.4&nbsp;million and $1.7&nbsp;million for the years ended December&nbsp;31, 2021 and
2022, respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Prepaid expenses and other current assets consist of the following (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Payroll tax credit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest receivable on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Prepaid research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Grant income receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Other assets consist of the following (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating lease deposit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Prepaid property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term prepaid services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred finance issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Accrued expenses and other current liabilities consist of the following (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued personnel related expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued legal and professional services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">414</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">896</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>7. Significant agreements </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Moderna
strategic collaboration and license agreement </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Terms of the agreement </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On October&nbsp;29, 2021, the effective date, the Company entered into a Strategic Collaboration and License Agreement (the &#147;Moderna Agreement&#148;) with
ModernaTX, Inc. (&#147;Moderna&#148;). The parties will collaborate on the research and development of <I>in vivo</I> genome editing therapies directed at certain targets and the commercialization of such genome editing therapies. The collaboration
provides Moderna with exclusive access to the Company&#146;s technology platform during the research period in (1)&nbsp;the field of <I>in vivo</I> gene editing technology for a therapeutic, ameliorative or prophylactic application by way of
knock-out through InDel formation or base editing or insertion of an exogenous DNA template (such field, &#147;DT Field&#148;) and (2)&nbsp;the field of <I>in vivo</I> gene editing technology for a therapeutic, ameliorative or prophylactic
application outside the use of (a) DNA donor templates and (b) no exogenous template at all but including (c) correction by base editing (such field, &#147;RT Field&#148;). The parties formed a joint steering committee, a joint research subcommittee
and a joint patent subcommittee to oversee the collaboration activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the terms of the Moderna Agreement, the parties will collaborate on one or more
programs in the RT Field (the &#147;Moderna RT program&#148;) and two programs in the DT Field (the &#147;Moderna DT program&#148; and the &#147;DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program&#148;). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">With respect to the Moderna RT and Moderna DT programs, the parties will collaborate on the research and development of product candidates under the approved research
plans. The initial research term of the Moderna RT program is four years, which may be extended by Moderna for an additional three years upon written notice and a payment of extension fees. The initial research term of the Moderna DT program is four
years. The Company granted to Moderna an option to obtain an exclusive license to develop, manufacture and commercialize up to ten Moderna RT program candidates and up to two Moderna DT program candidates at any time during the research term and
prior to filing of an investigational new drug (&#147;IND&#148;) application with the Food Drug and Administration (&#147;FDA&#148;) or any similar application filed with a regulatory authority in a country other than the United States
(&#147;U.S.&#148;), subject to Moderna&#146;s payment of an option exercise fee of $10.0 million per target. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">With respect to the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> program, the parties will work together on the <FONT STYLE="white-space:nowrap">co-development</FONT> and commercialization of products and share costs and profits equally. The Company maintains
commercialization rights in the U.S. (subject to Moderna&#146;s right to appoint up to 50% of the U.S. sales force for the DT Co-Co program), while Moderna maintains these rights in countries other than the U.S. The initial research term for the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> program is four years, and each party has a right to <FONT STYLE="white-space:nowrap">opt-out</FONT> of the DT Co-Co program at any time, at which point the other party has the right to solely continue the
development and commercialization activities. If there is no development candidate nomination by the end of the initial research term, the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program will expire, unless the parties have mutually agreed
to continue the program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the year ended December 31, 2021, the Company received a <FONT STYLE="white-space:nowrap">non-refundable</FONT>
upfront payment of $40.0&nbsp;million and a $5.0&nbsp;million payment for the first year of research costs. Concurrent with the Moderna Collaboration Agreement, Moderna also provided $30.0&nbsp;million in cash in the form of a convertible promissory
note (see Note 9) pursuant to a convertible promissory note agreement dated October&nbsp;29, 2021 (the &#147;Moderna Convertible Promissory Note Agreement&#148;). Moderna will reimburse the Company up to $5.0&nbsp;million in annual research and
development costs related to the Moderna DT and Moderna RT programs, or up to the agreed amount of expenses per the budget. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For the Moderna RT and Moderna DT
programs, the Company is eligible to receive (i)&nbsp;technology milestone fees related to the achievement of certain preclinical research objectives of up to $75.0&nbsp;million, (ii)&nbsp;development and regulatory milestones of up to $100.0
million per target, (iii) sales milestones of up to $200.0&nbsp;million per target, and (iv)&nbsp;royalties ranging from a <FONT STYLE="white-space:nowrap">mid-single</FONT> digit to a low-teens percentage of annual net sales of a licensed product.
Any profits and losses from the co-development and commercialization of the DT Co-Co program are shared equally between the Company and Moderna. With respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program for which the <FONT
STYLE="white-space:nowrap">opt-out</FONT> party has exercised its <FONT STYLE="white-space:nowrap">opt-out</FONT> right, the continuing party will pay to the <FONT STYLE="white-space:nowrap">opt-out</FONT> party, certain development, regulatory and
sales milestone payments that will not exceed an aggregate $239.0&nbsp;million per DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> target, and <FONT STYLE="white-space:nowrap">opt-out</FONT> royalties ranging from a high-single digit to a <FONT
STYLE="white-space:nowrap">low-teens</FONT> percentage of annual net sales of a licensed product. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of the Moderna Agreement will continue on a licensed <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, until the expiration of the
applicable royalty term. The royalty term commences on the first commercial sale of a licensed product and terminates on the latest of: (a)&nbsp;the expiration or abandonment of the last valid claim of a patent within the licensed Moderna DT or RT
technology; (b) 10 years after the first commercial sale of a licensed product; and (c)&nbsp;expiration of the regulatory exclusivity. Upon the expiration of the term of a licensed product in the Moderna DT or Moderna RT program, the licenses
granted to Moderna will survive and become perpetual, fully paid and royalty-free. Each party may terminate the Moderna Agreement on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">program-by-program</FONT></FONT> basis upon
written notice to the other party for an uncured material breach or insolvency. The Company may terminate the Moderna Agreement upon written notice to Moderna for a patent challenge. Additionally, Moderna may terminate the agreement at its
convenience with respect to Moderna DT or Moderna RT programs for any reason upon at least: (a) 60 days&#146; prior written notice if a first commercial sale has not occurred for the products in such program, or (b) 180 days&#146; prior written
notice if a first commercial sale of a product in such program has occurred. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Accounting analysis and revenue recognition </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded that the Moderna DT and Moderna RT programs are in the scope of ASC 606. The Company determined that the licenses granted to Moderna, and its
participation in the joint steering committee are not capable of being distinct from the preclinical research and development services and therefore concluded that there are two performance obligations: (1)&nbsp;the Moderna RT program and
(2)&nbsp;the Moderna DT program. The Company also concluded that the option to obtain an exclusive license and options to extend Moderna RT program term do not include significant incremental discounts, and as such, the options do not provide
material rights. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program research activities are within the scope of ASC 808, as the
Company and Moderna are both active participants in the research, development and commercialization activities, are exposed to significant risks and rewards that are dependent on the success of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
program activities and share costs and profits equally. The Company determined that the guidance in ASC 730, <I>Research and Development</I>, was appropriate to apply to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program research
activities by analogy, based on the nature of the cost sharing provisions of the agreement. The Company concluded that DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
program is one unit of accounting, as the co-exclusive license is not distinct from the research and development and the participation in joint steering committee activities. The Company
recognizes payments to or from Moderna related to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program cost sharing research activities as an increase to or reduction of research and development expenses, respectively. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded that the Moderna Collaboration Agreement and the Moderna Convertible Promissory Note Agreement should be combined and treated as a single
arrangement for accounting purposes as the agreements were entered into contemporaneously and in contemplation of one another. The Company estimated the contract consideration to be $90.0&nbsp;million, which consisted of: 1) the <FONT
STYLE="white-space:nowrap">non-refundable</FONT> upfront collaboration payment of $40.0&nbsp;million received in 2021, 2) $30.0&nbsp;million in cash received in 2021 in exchange for the convertible promissory note and 3) the estimated cost
reimbursements for Moderna DT and Moderna RT programs of $20.0&nbsp;million. The Company constrained future milestones, as it assessed that it is probable that the inclusion of such variable consideration could result in a significant reversal of
cumulative revenue in future periods. During the year ended December 31, 2021, the Company recorded $30.0&nbsp;million of the contract consideration for the convertible promissory note based on the fair value (see Note 9) and allocated the
transaction price of $60.0&nbsp;million to each of the following programs on a relative standalone selling price basis: 1) $49.5&nbsp;million to the Moderna RT program, 2) $5.5&nbsp;million to the Moderna DT program, and 3) $5.0&nbsp;million to the
DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The variable consideration is reevaluated at each reporting period and as changes in circumstances occur.
The Company recognizes revenue for each of the Moderna DT and Moderna RT programs as collaboration revenue based on the measure of progress using an estimated cost-based input method each reporting period. The Company also amortizes the allocation
consideration for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program of $5.0&nbsp;million as a credit to research and development expenses during the discovery and lead optimization phases for the DT Co-Co program. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company recognized collaboration revenue of $0.2&nbsp;million and $14.5&nbsp;million in the consolidated statements of operations and comprehensive loss for the
years ended December&nbsp;31, 2021 and 2022, respectively. As of December&nbsp;31, 2021 and 2022, deferred revenue related to Moderna was $39.7&nbsp;million and $30.2&nbsp;million, respectively. Collaboration revenue recognized during the year ended
December&nbsp;31, 2022 included $14.5&nbsp;million that was included in deferred revenue as of December&nbsp;31, 2021. The value of the transaction price allocated to the remaining unsatisfied portion of the performance obligations was approximately
$41.9&nbsp;million as of December&nbsp;31, 2022, which the Company expects to recognize as revenue over the next <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">three-to-four</FONT></FONT> years. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company recognized $0.2&nbsp;million and $0.3&nbsp;million in credits to research and development expenses related to cost sharing allocation and amortization of the
collaboration advance, respectively, within research and development expenses in the consolidated statement of operations and comprehensive loss during the year ended December&nbsp;31, 2021. The Company recognized $0.9&nbsp;million and
$3.5&nbsp;million in credits to research and development expenses related to cost sharing allocation and amortization of the collaboration advance, respectively, during the year ended December&nbsp;31, 2022. As of December&nbsp;31, 2021, the
collaboration advance balance was $4.7&nbsp;million, partially offset by the cost-sharing receivable balance of $0.2&nbsp;million, which was presented as a collaboration advance on the Company&#146;s consolidated balance sheet. As of
December&nbsp;31, 2022, the collaboration advance balance was $1.1&nbsp;million, partially offset by the cost-sharing receivable balance of $0.4&nbsp;million, which was presented as a collaboration advance on the Company&#146;s consolidated balance
sheet. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Affini-T development, option and license agreement </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Terms of the agreement </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On June&nbsp;14, 2022, the effective date, the Company
entered into a Development, Option and License Agreement (the &#147;Affini-T Agreement&#148;) with Affini-T. Pursuant to the Affini-T Agreement, the parties have agreed to identify, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
develop or optimize certain reagents using the Company&#146;s proprietary technology for Affini-T to use such reagents to develop and commercialize gene edited
<FONT STYLE="white-space:nowrap">T-cell</FONT> receptor (&#147;TCR&#148;)-based therapeutic products exclusively in the field of treatment, prevention or diagnosis of any human cancer using products with any engineered primary TCR alpha/beta T cells
and non-exclusively in the field of treatment, prevention or diagnosis of any human cancer using products with certain other engineered immune cells worldwide. A joint steering committee was established by both parties to assign alliance managers
and project leaders to oversee the collaboration activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the Affini-T Agreement, the Company granted Affini-T options to receive, on a pre-specified
target-by-pre-specified target basis, for up to six pre-specified targets, either (i) an exclusive, royalty-bearing, sublicensable worldwide license under all of the Company&#146;s applicable intellectual property to research, develop, manufacture,
use, commercialize and otherwise exploit any TCR-based therapy, preventative treatment, or diagnostic for humans that is directed to such pre-specified target, contains or comprises Primary TCR alpha/beta T Cells and is derived from <I>ex vivo
</I>application of a Company reagent (the &#147;Exclusive Option&#148;) or (ii) a non-exclusive, royalty-bearing, sublicensable worldwide license under all of the Company&#146;s applicable intellectual property to research, develop, manufacture, use
commercialize and otherwise exploit any TCR-based therapy, preventative treatment, or diagnostic for humans that is directed to such pre-specified target, contains or comprises TCR natural killer (&#147;NK&#148;) cells derived from iPSC immune cells
or TCR T cells derived from donor-derived or iPSC immune cells. Affini-T can exercise its options for either an exclusive license or a non-exclusive license, or both, for each pre-specified target by providing written notice prior to the earlier of
(x) the end of the Affini-T Agreement term or (y) 90 days following the filing of an IND for a licensed product directed to a pre-specified target, subject to the payment of certain fees per each option exercised. After the option exercise, Affini-T
has agreed to use commercially reasonable efforts to conduct all development and commercialization activities for a licensed product, and development and commercialization of all licensed products will be at Affini-T&#146;s sole cost and expense.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with the Affini-T Agreement, the Company received upfront equity consideration of 719,920 shares of Affini-T&#146;s common stock with an estimated
fair value of $1.3&nbsp;million in June 2022. The fair value of Affini-T&#146;s shares of common stock was estimated by the Company&#146;s management, considering the most recent third-party valuation. Affini-T has also agreed to reimburse the
Company for expenses incurred while performing research activities under the research plans. Additionally, the Company is eligible to receive (i) 933,650 shares of Affini-T&#146;s common stock upon the achievement of a regulatory milestone, which is
the earlier of a submission of a drug master file to the FDA or an acceptance of an IND filing for a licensed product by the FDA, (ii)&nbsp;up to $18.8&nbsp;million in future developmental milestone payments depending on the completion of or the
number of patients dosed in, the relevant human clinical trial, or the initiation of a pivotal trial, and $40.6&nbsp;million in future regulatory approval milestone payments, which include regulatory approvals in the U.S. and other markets for
licensed products directed to a pre-specified target if options for both exclusive and <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses are exercised with respect to such target, (iii)&nbsp;up to $250.0&nbsp;million in sales-based
milestones for aggregate sales of all licensed products directed to a given pre-specified target and (iv)&nbsp;royalties ranging from a <FONT STYLE="white-space:nowrap">low-single</FONT> digit to high-single digit percentage of worldwide annual net
sales of licensed products.</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The initial term of the Affini-T Agreement is five years from the effective date. If Affini-T exercises an Exclusive Option with respect
to any pre-specified target during the initial term, the initial term will be extended by an additional five years. Following the expiration of the extended term, if any, the agreement will continue on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">target-by-target</FONT></FONT> basis and expire with respect to such target upon the expiration of the royalty term for all licensed products directed to such target. The Affini-T Agreement may be terminated during the
term by either party for an uncured material breach by, or bankruptcy of, the other party. Additionally, Affini-T may terminate the Affini-T Agreement for convenience, in its entirety, on a research plan-by-research plan basis, on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">target-by-target</FONT></FONT> basis or on a licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product basis, by providing prior
written notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Accounting analysis and revenue recognition </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded that the Affini-T Agreement is in the scope of ASC 606 and that there is one performance obligation to perform research activities under the
Affini-T Agreement. Exclusive and <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses are optional contingent purchases that do not include significant incremental discounts, and therefore do not provide a material right. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">At the effective date, the transaction price consisted of the upfront equity consideration with an estimated fair value of $1.3&nbsp;million and estimated research
reimbursement costs. Research reimbursement costs represent variable consideration, and the Company&#146;s management estimates what portion to include in total consideration at the end of each reporting period. Other payments under the Affini-T
Agreement, including additional equity consideration and development and regulatory milestones, also represent variable consideration, and are constrained to the extent that the inclusion of such variable consideration could result in a significant
reversal of cumulative revenue in future periods. As of December&nbsp;31, 2022, additional equity consideration and future development and regulatory milestone payments were excluded from the estimated total transaction price as they were considered
constrained. The transaction price is reevaluated in each reporting period and as changes in circumstances occur. The Company recognizes revenue each reporting period based on the measure of progress using an estimated cost-based input method. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company recognized $2.6&nbsp;million in collaboration revenue in the consolidated statements of operations and comprehensive loss during the year ended
December&nbsp;31, 2022. As of December&nbsp;31, 2022, the Company recorded $1.3&nbsp;million in contract assets on the consolidated balance sheet, related to services performed but not invoiced. There was no deferred revenue related to the Affini-T
Agreement as of December&nbsp;31, 2022. The value of the transaction price allocated to the remaining unsatisfied portion of the performance obligation was approximately $8.0&nbsp;million as of December&nbsp;31, 2022, which the Company expects to
recognize as revenue over the next <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">five-to-six</FONT></FONT> years. In June 2023, the joint steering committee approved the budget for estimated research reimbursement costs for the
Affini-T Agreement, which resulted in a $2.4 million reduction to variable consideration. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Ionis collaboration and license agreement </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Terms of the agreement </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On November&nbsp;10, 2022, the effective date, the
Company entered into a Collaboration and License Agreement (the &#147;Ionis Agreement&#148;) with Ionis Pharmaceuticals, Inc. (&#147;Ionis&#148;) to collaborate on drug discovery and exploratory research activities to advance new medicines using
gene editing strategies, with the goal of discovering novel medicines. Pursuant to the terms of the Ionis Agreement, the Company granted Ionis and its affiliates a worldwide exclusive, royalty-bearing license, with the right to grant sublicenses, to
use all licensed systems and licensed products in the field of <I>in vivo</I> gene editing for all therapeutic, prophylactic, palliative, and analgesic uses in humans. In connection with the Ionis Agreement, the Company also has the right to
exercise an exclusive option to <FONT STYLE="white-space:nowrap">co-develop</FONT> and <FONT STYLE="white-space:nowrap">co-commercialize</FONT> certain products under a drug discovery program. A joint steering committee was established by both
parties to coordinate, oversee, and monitor the research and drug discovery activities under the Ionis Agreement. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The parties will collaborate to discover
therapeutic products under a drug discovery program and develop a drug discovery plan for each target, selected by Ionis. The target selection is divided into two waves: up to four targets in Wave 1 and up to four targets in Wave 2. For each drug
discovery program, once the parties identify a development candidate that is suitable for further development, Ionis will be responsible for the development and commercialization of products resulting from such program. Per the terms of the Ionis
Agreement, at any time prior to the designation of a development candidate for a drug discovery program and for any reason, Ionis may replace the collaboration target, provided such target has not previously been substituted out. Ionis may
substitute (i)&nbsp;up to two Wave 1 targets and (ii)&nbsp;up to two Wave 2 targets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The drug discovery activities for a program commence on the selection of a target and expire upon the earlier of
(a)&nbsp;completion of all drug discovery activities for such program, (b)&nbsp;the fifth anniversary of the effective date and (c)&nbsp;selection of a development candidate for such drug discovery program. If one or more Wave 2 targets become
collaboration targets as a result of the parties achieving enabled delivery and less than two years are remaining in the drug discovery term, then the term will be extended to the earlier of (i)&nbsp;the time that the Company completes all of its
activities under the applicable drug discovery plan and (ii)&nbsp;the seventh anniversary of the effective date, subject to the Company&#146;s consent. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The parties
will also conduct an exploratory research program, and will jointly optimize gRNA and select delivery technologies and other activities. The exploratory research activities commence on the effective date and expire upon the earlier of
(a)&nbsp;completion of all exploratory research activities established in the exploratory research plan, and (b)&nbsp;the fifth anniversary of the effective date. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has the exclusive option to <FONT STYLE="white-space:nowrap">co-develop</FONT> and <FONT STYLE="white-space:nowrap">co-commercialize</FONT> the licensed
products under a drug discovery program (the <FONT STYLE="white-space:nowrap">&#147;Co-Co</FONT> Option&#148;) with Ionis. The <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option may be exercised for (a)&nbsp;the initial Wave 1 target (&#147;Target
1&#148;), (b) no more than one of the other three discovery programs for the Wave 1 targets, and (c)&nbsp;no more than two drug discovery programs for the Wave 2 targets that become collaboration targets. If the Company exercises the <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Option for a particular drug discovery program, that drug discovery program will automatically be deemed a <FONT STYLE="white-space:nowrap">&#147;Co-Co</FONT> Program&#148;, all corresponding licensed products
be deemed <FONT STYLE="white-space:nowrap">&#147;Co-Co</FONT> Products,&#148; the Company will be obligated to pay Ionis an option exercise fee, and the parties will enter into a separate <FONT STYLE="white-space:nowrap">co-development</FONT> and
co-commercialization agreement. The <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option exercise fee will equal 50% of Ionis&#146; internal costs and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
costs incurred in the conduct of the drug discovery activities prior to the exercise of the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option and be reduced by 50% of the Company&#146;s corresponding costs incurred. Future development and
commercialization costs will be shared equally. The Company may elect to reduce its cost-share percentage anywhere between 50% and 25% on a <FONT STYLE="white-space:nowrap">go-forward</FONT> basis, provided the Company will continue to bear 50% of
the costs of any clinical trials ongoing at the time of the election through the completion of the clinical trials. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company will manufacture all licensed
systems and certain components of the applicable licensed products that are needed by Ionis for use in its development activities and all of the Company&#146;s manufactured components needed by Ionis for use in its commercialization activities. The
Company will provide the manufactured components at a price that represents the cost of goods plus 15%. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the terms of the Ionis Agreement, the Company
has also been granted an option to obtain a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-bearing license, with the right to grant sublicenses, for certain Ionis&#146; background technology to use in up to eight therapeutic products
discovered by the Company in the field of <I>in vivo</I> gene editing and directed to a Collaboration Target (each such product, a &#147;Metagenomi Product&#148; and each such option an &#147;Ionis IP Option&#148;), but subject to encumbrance checks
with respect to particular targets. A Collaboration Target is a target that is selected by Ionis, and, with respect to the Company is not the subject of discussions with a third party, is not the subject of a contractual grant of rights to a third
party nor the subject of a Company bona fide research and development program. If the Company exercises its Ionis IP Option, the Company will pay to Ionis up to several million dollars per Metagenomi Product upon achievement of certain clinical and
regulatory milestones. The Company is also obligated to pay Ionis royalties in an amount equal to a low single-digit royalty on the net sales of the applicable Metagenomi Product on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In November 2022, the Company received an $80.0&nbsp;million upfront payment from Ionis for the Wave 1 drug discovery research collaboration and selected Target 1. Ionis
selected its second target (&#147;Target 2&#148;) in Wave 1 in December 2022, and will select two final additional Wave 1 targets (&#147;Target 3&#148; and &#147;Target 4&#148;) within the 12 months from the effective date, as permitted under the
arrangement. Ionis has an option to select up to four </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Wave 2 targets at any time during the drug discovery term, if (a)&nbsp;an IND for any licensed product directed to a Wave 1 target is filed with the applicable regulatory authority or
(b)&nbsp;the parties achieve enabled delivery for a <FONT STYLE="white-space:nowrap">non-liver</FONT> target under the exploratory research activities, by providing written notice and by paying a Wave 2 target selection fee of $15.0&nbsp;million or
$30.0&nbsp;million, depending on and per the selected target. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Ionis is obligated to reimburse the Company for all internal costs and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred in the performance of the exploratory research activities, up to an aggregate of $10.0&nbsp;million, which is payable in quarterly
installments of $0.5&nbsp;million during the exploratory research term. The Company is also eligible to receive (a)&nbsp;up to $29.0&nbsp;million in future development milestone payments for each licensed product; (b)&nbsp;up to $60.0&nbsp;million
in future regulatory milestone payments for each licensed product; (c)&nbsp;up to $250.0&nbsp;million in sales-based milestones for each licensed product; and (d)&nbsp;royalties on annual net sales of licensed products from a <FONT
STYLE="white-space:nowrap">mid-single-digit</FONT> to <FONT STYLE="white-space:nowrap">low-teens</FONT> percentage, subject to customary reductions.</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of the
Ionis Agreement will continue (i)&nbsp;with respect to the drug discovery programs, until the expiration of all applicable royalty terms for a licensed product, (ii)&nbsp;with respect to the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Programs,
until the parties cease all exploitation for the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products that are the subject to such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, and (iii)&nbsp;with respect to the Metagenomi Products, until
the expiration of the royalty term for a Metagenomi Product. The royalty term ends on the latest of the following two dates: (i)&nbsp;the expiration of (A)&nbsp;the last claim of any issued and unexpired patent, or (B)&nbsp;a claim within a patent
application that has not been pending for more than seven years from the earliest date to which the claim or applicable patent application is entitled to claim priority and which claim has not been revoked, cancelled, withdrawn, held invalid, or
abandoned, or (ii) 12 years following the first commercial sale of a licensed product. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Ionis Agreement may be terminated during the term by either party for an
uncured material breach or bankruptcy by the other party. Additionally, Ionis may terminate the Ionis Agreement for convenience and without penalty, in its entirety or on a licensed
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product basis, by providing 90 days&#146; written notice. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Accounting analysis and revenue recognition </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded that the
Ionis Agreement is in the scope of ASC 606 at the effective date and until the Company exercises its <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option for any drug discovery program, which was determined to not be probable at the effective date
and as of December&nbsp;31, 2022. The Company also concluded that exclusive licenses and participation in a joint steering committee are not distinct from discovery research services and should thus be combined into one performance obligation (the
&#147;discovery program&#148;). The Company also concluded that exploratory research services are a separate and distinct performance obligation (the &#147;exploratory program&#148;). As the Ionis options for Wave 2 targets are optional purchases
and do not have significant incremental discounts, as such, the options do not provide material rights. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company allocated the total estimated transaction price
of $90.0&nbsp;million, which consisted of an $80.0&nbsp;million upfront payment received in November 2022 and a $10.0&nbsp;million reimbursement for research costs, into two performance obligations, and was determined based on their estimated
standalone selling prices. The Company concluded that future development and commercial supply agreements are at market terms, as the terms were consistent with industry standards as of the effective date. The Company constrains future milestone
payments under the arrangement to the extent that the inclusion of such variable consideration could result in a significant reversal of cumulative revenue in future periods. The Company constrained all development and regulatory milestone payments
at the effective date and as of December&nbsp;31, 2022. The Company is recognizing revenue of $80.0&nbsp;million related to the discovery program and of $10.0&nbsp;million related to exploratory program over the research terms using an estimated
cost-based input method as a measure of progress for each obligation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company recognized $0.1&nbsp;million in collaboration revenue in the consolidated
statements of operations and comprehensive loss during the year ended December&nbsp;31, 2022. As of December&nbsp;31, 2022, deferred revenue </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
related to the Ionis Agreement was $79.9&nbsp;million. The value of the transaction price allocated to the remaining performance obligations was approximately $89.9&nbsp;million as of
December&nbsp;31, 2022, which the Company expects to recognize as revenue over the next <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">five-to-six</FONT></FONT> years. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>8. Cystic fibrosis foundation grant income </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In April 2021, the Company
received an award of $0.6&nbsp;million to finance a development program (the &#147;CFF Grant Letter&#148;), to discover and use novel gene-editing systems to correct cystic fibrosis transmembrane conductance regulator mutations, from Cystic Fibrosis
Foundation (&#147;CFF&#148;), a <FONT STYLE="white-space:nowrap">non-profit</FONT> organization. In accordance with CFF Grant Letter, the Company received $0.4&nbsp;million upon initiation of the development program in June 2021 and expects to
receive $0.2&nbsp;million upon the program completion in 2023 fiscal year. The award was provided to the Company without a provision for financial return to CFF. However, in the event that CFF provides additional funding to the Company, pursuant to
a separate agreement between CFF and the Company (a &#147;Future Funding Agreement&#148;), CFF may receive royalty rights, an equity interest, a debt instrument or other consideration of economic value that is based on the amount of funding CFF has
provided to the Company, the award amount actually paid to the Company under the current award will be treated as an advance towards, and included in, the award amount, investment amount, principal amount or other similar term representing the
amount of funding provided by CFF to the Company under the Future Funding Agreement. The Company does not expect to receive any future funding from CFF and concluded that funds received are <FONT STYLE="white-space:nowrap">non-refundable.</FONT> The
Company recognized $0.2&nbsp;million and $0.3&nbsp;million related to the progress of a development program during the years ended December&nbsp;31, 2021 and 2022, respectively, as other income (expense), net, in the consolidated statements of
operations and comprehensive loss, as this grant is not considered an ongoing major and central operation of the Company&#146;s business. The Company recognized $0.2&nbsp;million and zero of deferred grant income in accrued expenses and other
current liabilities in the consolidated balance sheet as of December&nbsp;31, 2021 and December&nbsp;31, 2022, respectively. The Company recognized $0.1&nbsp;million of grant income receivable in prepaid expenses and other current assets in the
consolidated balance sheets as of December&nbsp;31, 2022. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>9. Convertible promissory note </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In October 2021, together with the Moderna Agreement, the Company issued a convertible promissory note for $30.0&nbsp;million to Moderna with 6.0% annual interest
payable upon the note maturity in April 2023. The Company cannot prepay the convertible promissory note without Moderna&#146;s consent. The outstanding principal amount and any unpaid accrued interest is automatically convertible into redeemable
convertible preferred units sold in a private financing with total gross cash proceeds of not less than $50.0&nbsp;million (the &#147;Qualified Financing&#148;) at a conversion price equal to the purchase price per unit that depends on the timing of
the qualified financing: i) 100% of the lowest price paid per unit by investors in the qualified financing, if the qualified financing occurs within three months from the note issuance date; ii) 95% of the lowest price paid per unit by investors in
the qualified financing, if the qualified financing occurs between three and six months from the note issuance date; iii) 90% of the lowest price paid per unit by investors in the qualified financing, if the qualified financing occurs between six
and twelve months from the note issuance date; iv) 85% of the lowest price paid per unit by investors in the qualified financing, if the qualified financing occurs after twelve months from the note issuance date. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Moderna also had an option to convert the note on similar terms in the event of a <FONT STYLE="white-space:nowrap">non-qualified</FONT> financing using the conversion
price upon a qualified financing. Upon maturity, the outstanding principal and accrued interest is either due and payable in full or converted in the Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units (or the
most senior redeemable convertible preferred units of the Company then outstanding) at a conversion price equal to the original issue price of the Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units (or the most
senior units of the Company then outstanding). Principal and accrued interest of the note were payable in cash in an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
event of default. In a deemed liquidation event the outstanding principal and accrued and unpaid interest is either due and payable in full, plus 50% on the outstanding principal amount of the
note or were convertible into the common units of the Company at a conversion price equal to the original issue price of the Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units (or the most senior units of the
Company then outstanding). In the event that the Company closes its initial public offering of its common units or common stock or other equity securities with total gross proceeds of not less than $50.0&nbsp;million (&#147;Qualified IPO&#148;), the
principal and unpaid accrued interest then outstanding is convertible automatically into the same type of the Company&#146;s securities issued upon IPO at 90% of the lowest purchase price paid per equity securities in the Qualified IPO. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The convertible promissory note is carried at amortized cost, which management estimates approximates its fair value. On the issuance date of the convertible promissory
note, the Company concluded that certain embedded unit-settled conversion put features, qualified IPO features and deemed liquidation put features were derivatives that required bifurcation. The Company estimated the fair value of embedded
derivatives was minimal due to the low probability of settlement events for these features. The Company recognized $34,000 of issuance costs as a debt discount related to legal fees, which was amortized to interest expense over the term of the note
using effective interest method. The Company recognized $0.3&nbsp;million and $0.1&nbsp;million of accrued interest expense in the consolidated statements of operations and comprehensive loss for the years ended December&nbsp;31, 2021 and 2022,
respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The convertible promissory note and all accrued interest were converted, upon the Qualified Financing, into 2,607,387 Series B redeemable convertible
preferred units without any discount in January 2022 (see Note 11) and no gain or loss was recognized on the conversion. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>10. Commitments and contingencies
</B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Operating leases </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In November 2019, the Company entered into a
<FONT STYLE="white-space:nowrap">5-year</FONT> operating lease for laboratory and office space in Emeryville, California. In conjunction with signing the lease, the Company secured a letter of credit in favor of the lessor in the amount of
$0.2&nbsp;million. The lease agreement includes a renewal provision allowing the Company to extend this lease for an additional 5 years at the prevailing rental rate, which the Company was not reasonably certain to exercise. In addition to base
rent, the Company was obligated to pay variable costs related to its share of operating expenses and taxes as well as parking fees for unreserved parking spaces in a shared lot. In March 2021, this lease was modified to shorten the lease term to
terminate in April 2021. Lease payments made related to this lease in 2021 totaled $0.1&nbsp;million. In May 2021, the letter of credit related to this lease was canceled. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In January 2021, the Company entered into a <FONT STYLE="white-space:nowrap">ten-year</FONT> operating lease for laboratory and office space in Emeryville, California.
The lease commencement date was in February 2021. In conjunction with signing this lease, the Company secured a letter of credit for $3.3&nbsp;million, which is recorded as noncurrent restricted cash in the consolidated balance sheets. The lease
agreement includes a renewal provision allowing the Company to extend this lease for an additional five years, which the Company is not reasonably certain to exercise. In addition to base rent, the Company pays variable costs related to operating
expenses and taxes, which are recognized as incurred. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In September 2021, the Company entered into a <FONT STYLE="white-space:nowrap">9.25-year</FONT> operating
lease for office space in Emeryville, California, with a lease commencement date in November 2021. In conjunction with signing the lease, the Company secured a letter of credit for $0.8&nbsp;million, which is recorded as noncurrent restricted cash
in the consolidated balance sheets. In addition to base rent, the Company will pay variable costs related to operating expenses and taxes, which are recognized as incurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In November 2022, the Company entered into an <FONT STYLE="white-space:nowrap">8.25-year</FONT> sublease for office,
research and laboratory space in Emeryville, California, with a lease commencement date in January 2023. In conjunction with signing the lease, the Company secured a letter of credit for $2.0&nbsp;million, which is recorded as restricted cash in the
consolidated balance sheet as of December&nbsp;31, 2022. Payments for base rent required under this lease are expected to total approximately $49.3&nbsp;million over the term, of which $2.9&nbsp;million is payable within the 12 months. In addition
to base rent, the Company will pay variable costs related to its share of operating expenses and taxes. As this lease has not yet commenced as of December&nbsp;31, 2022, no <FONT STYLE="white-space:nowrap">right-of</FONT> use asset or lease
liability is recorded. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Operating lease cost for the years ended December&nbsp;31, 2021 and 2022, totaled $2.2&nbsp;million and $3.5&nbsp;million, respectively,
including $0.5&nbsp;million and $0.4&nbsp;million of variable lease cost, respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Supplemental information related to the Company&#146;s operating leases is
as follows (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended<BR>December&nbsp;31</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash paid for amounts included in the measurement of lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average remaining lease term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted-average discount rate</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">10.1%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">10.1%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes a maturity analysis of the Company&#146;s operating lease liabilities showing the aggregate lease payments
as of December&nbsp;31, 2022 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:2.00pt solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2023</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000" ALIGN="right"> 3,279</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2027</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total future lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,633</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total lease liability balance(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: current operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,515</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-current</FONT> operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Total lease liability as of December&nbsp;31, 2022 excludes lease payments of $49.3&nbsp;million for a lease signed but not yet commenced. </TD></TR></TABLE>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Legal contingencies </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">From time to time, the Company may become
involved in legal proceedings arising from the ordinary course of business. The Company records a liability for such matters when it is probable that future losses will be incurred and that such losses can be reasonably estimated. Significant
judgment by the Company is required to determine both probability and the estimated amount. Management is currently not aware of any legal matters that could have a material adverse effect on the Company&#146;s financial position, results of
operations or cash flows. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Guarantees and indemnifications </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the
normal course of business, the Company enters into agreements that contain a variety of representations and provide for general indemnification. Its exposure under these agreements is unknown because it involves claims that may be made against the
Company in the future. To the extent permitted under Delaware law, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Company has agreed to indemnify its directors and officers for certain events or occurrences while the director or officer is, or was serving, at a request in such capacity. To date, the Company
has not paid any claims or been required to defend any action related to its indemnification obligations. As of December&nbsp;31, 2021 and 2022, the Company did not have any material indemnification claims that were probable or reasonably possible
and consequently has not recorded related liabilities. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>11. Redeemable convertible preferred units </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On March&nbsp;15, 2021, the Company closed the Series <FONT STYLE="white-space:nowrap">A-5</FONT> financing and issued 1,580,937 shares of the Series <FONT
STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units for gross cash proceeds of $10.0&nbsp;million. The Company incurred $0.1&nbsp;million in issuance costs. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On January&nbsp;21, 2022, the Company closed the Series B financing and issued 12,446,876 shares of the Series B redeemable convertible preferred units for gross cash
proceeds of $145.0&nbsp;million. The Company incurred $0.7&nbsp;million in issuance costs. Concurrently with the closing of the Series B financing, the outstanding Moderna convertible promissory note and accrued interest of $30.4&nbsp;million was
converted into 2,607,387 Series B Preferred Units, at a conversion price equal to the price per unit paid by the Series B investors. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On December&nbsp;20, 2022, the
Company entered into Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred unit purchase agreement to sell up to 7,108,480 Series B redeemable convertible preferred units at the purchase price of $14.06770. In December
2022, the Company sold and issued 6,773,726 shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred units for gross cash proceeds of $95.3&nbsp;million in the initial closing. The Company incurred
$0.4&nbsp;million issuance costs. Additional shares may be sold within 90 days of the initial closing. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022, the Company operated under the
Amended and Restated Limited Liability Company Agreement dated December&nbsp;20, 2022 (the &#147;LLC Agreement&#148;). The LLC Agreement provides for eight classes of units: common units, Series <FONT STYLE="white-space:nowrap">A-1</FONT> redeemable
convertible preferred units (Series <FONT STYLE="white-space:nowrap">A-1),</FONT> Series <FONT STYLE="white-space:nowrap">A-2</FONT> redeemable convertible preferred units (Series <FONT STYLE="white-space:nowrap">A-2),</FONT> Series <FONT
STYLE="white-space:nowrap">A-3</FONT> redeemable convertible preferred units (Series <FONT STYLE="white-space:nowrap">A-3),</FONT> Series <FONT STYLE="white-space:nowrap">A-4</FONT> redeemable convertible preferred units (Series <FONT
STYLE="white-space:nowrap">A-4),</FONT> Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units (Series <FONT STYLE="white-space:nowrap">A-5),</FONT> Series B redeemable convertible preferred units (Series B) and
Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred units (Series <FONT STYLE="white-space:nowrap">B-1).</FONT> </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The redeemable
convertible preferred units as of December&nbsp;31, 2021, consisted of the following (in thousands, except unit data): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units<BR>authorized</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units issued<BR>and<BR>outstanding</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Aggregate<BR>liquidation<BR>preference</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Net<BR>carrying<BR>value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,501,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,501,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-2</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-3</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,513,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,513,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-4</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,280,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,280,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-5</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,650,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,650,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">76,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">76,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The redeemable convertible preferred units as of December&nbsp;31, 2022, consisted of the following (in thousands,
except unit data): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units<BR>authorized</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units issued<BR>and<BR>outstanding</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Aggregate<BR>liquidation<BR>preference</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Net<BR>carrying<BR>value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,501,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,501,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 24,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 24,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-2</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-3</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,513,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,513,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-4</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,280,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,280,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-5</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,054,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,054,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,678</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">B-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,108,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,773,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,813,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,478,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">347,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">346,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The holders of the redeemable convertible preferred units have various rights and preference as follows: </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Voting rights </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each redeemable convertible preferred unit is entitled
to one vote for each common unit into which such redeemable convertible preferred unit is then convertible. The redeemable convertible preferred unitholders and the common unitholders vote together on all matters as a single class, except as
otherwise provided by law or the provisions of the LLC Agreement. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Board of Managers consists of up to seven individuals. As long as at least 618,716 Series <FONT
STYLE="white-space:nowrap">A-1</FONT> redeemable convertible preferred units, Series <FONT STYLE="white-space:nowrap">A-2</FONT> redeemable convertible preferred units and/or Series <FONT STYLE="white-space:nowrap">A-3</FONT> redeemable convertible
preferred units remain outstanding, the members holding a majority of the outstanding Series <FONT STYLE="white-space:nowrap">A-1</FONT> redeemable convertible preferred units, Series <FONT STYLE="white-space:nowrap">A-2</FONT> redeemable
convertible preferred units and Series <FONT STYLE="white-space:nowrap">A-3</FONT> redeemable convertible preferred units, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, are entitled to elect one
manager. As long as at least 1,654,555 Series <FONT STYLE="white-space:nowrap">A-4</FONT> redeemable convertible preferred units remain outstanding, the members holding a majority of the Series <FONT STYLE="white-space:nowrap">A-4</FONT> redeemable
convertible preferred units, voting as a single class, are entitled to elect one manager. As long as at least 316,187 Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units remain outstanding, the members holding a
majority of the Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units, voting as a single class, are entitled to elect one manager. As long as at least 3,010,852 Series B redeemable convertible preferred units
remain outstanding, the members holding a majority of the Series B redeemable convertible preferred units, voting as a single class, are entitled to elect one manager. The members holding a majority of the common units, voting as a single class are
entitled to elect one manager. The members holding a majority of the units then outstanding, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to common units basis are entitled to elect any remaining
managers. As of December&nbsp;31, 2021 and 2022, respectively, the Company&#146;s Board of Managers consisted of five and six individuals, respectively. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Conversion </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each redeemable convertible preferred unit is convertible
into common units at the option of a holder at the then applicable conversion price, which is equal the original purchase price, subject to adjustments for recapitalization and others. The original purchase price is equal to $3.2325 per Series <FONT
STYLE="white-space:nowrap">A-1</FONT> Preferred Unit, $0.6456 per Series <FONT STYLE="white-space:nowrap">A-2</FONT> Preferred Unit, $1.1713 per Series <FONT STYLE="white-space:nowrap">A-3</FONT> Preferred Unit, $4.84875 per Series <FONT
STYLE="white-space:nowrap">A-4</FONT> Preferred Unit, $6.32536 per Series <FONT STYLE="white-space:nowrap">A-5</FONT> Preferred Unit, $11.64951 per Series B Preferred Unit, and $14.06770 per Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Unit. As of December&nbsp;31, 2021 and 2022, the redeemable convertible preferred units were convertible into common units at a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> conversion ratio.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each redeemable convertible preferred unit is automatically convertible into common units (or shares of common stock,
if the Company is converted into a corporation), based on the then-effective applicable conversion rate (A)&nbsp;at any time upon the affirmative vote or written consent of (i)&nbsp;the members holding a majority of the redeemable convertible
preferred units then outstanding, (ii)&nbsp;the members holding a majority of the Series B redeemable convertible preferred units then outstanding, and (iii)&nbsp;the members holding a majority of the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred units then outstanding, or (B)&nbsp;immediately upon the closing of a firmly underwritten public offering pursuant to an effective registration statement under the
Securities Act of 1933, as amended, covering the offer and sale of common units (or other common securities) with the gross cash proceeds to the Company, before underwriting discounts, commissions and offering expenses, are at least
$100.0&nbsp;million, or (C)&nbsp;the closing of a merger, acquisition or other business combination involving the Company and a publicly traded special purpose acquisition company (&#147;SPAC&#148;) or its subsidiary or affiliate in which the
surviving public company has available immediately cash of at least $100.0&nbsp;million in the aggregate greater than the cash on the Company&#146;s consolidated balance sheets as of immediately prior to such merger, acquisition or other business
combination (including proceeds of a private investment in public equity transaction that is substantially contemporaneous with or conditioned on such merger, acquisition or other business combination, and any redemptions from the SPAC&#146;s trust
account). </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Anti-dilution and other protective provisions </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
holders of the redeemable convertible preferred units have proportional anti-dilution protection right for unit splits, unit dividends and similar recapitalizations, subject to certain exclusions, anti-dilution price protection for additional sales
of securities by the Company for consideration per unit less than the applicable conversion price per unit of any series of the redeemable convertible preferred units, on a broad-based weighted average basis. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The holders of the redeemable convertible preferred units have certain protective rights. The Company shall not, either directly or by amendment, merger, consolidation
or otherwise, without the prior written approval of members holding a majority of the redeemable convertible preferred units then outstanding to alter or change the rights, preferences or privileges of the redeemable convertible preferred units;
consummate a liquidation or a deemed liquidation event; change the Company&#146;s LLC Agreement; authorize or create any new class or series of units or other equity security; increase or decrease the authorized number of the common units or the
redeemable convertible preferred units or any series; redeem, acquire or repurchase any, or make any distribution on, any common units or redeemable convertible preferred units; change the compensation or equity awards granted to executive officers
of the Company, unless such transaction is approved by the Board of Managers; increase or decrease the authorized number of managers constituting the Board of Managers and amend other rights or enter into certain transactions. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Liquidation preference </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the event of a liquidation, a deemed
liquidation event (including a consolidation, merger or reorganization or a sale, lease, transfer, exclusive irrevocable license or other disposition of all or substantially all of the assets of the Company), dissolution or <FONT
STYLE="white-space:nowrap">winding-up</FONT> of the Company, the funds are distributed first to the members holding the redeemable convertible preferred units in proportion to and to the extent of their unreturned original purchase price per
redeemable convertible preferred unit, until each member holding the redeemable convertible preferred units has received cumulative distributions in an amount equal to the unreturned original purchase price for each of such member&#146;s redeemable
convertible preferred unit. Second, to the members holding common units and the redeemable convertible preferred units pro rata based on the number of units held by each such holder, assuming for this purpose that all the redeemable convertible
preferred units have been converted into common units as of the date of such operating distribution or distribution of net proceeds </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
or assets available for distribution, whether in cash or in other property. Third, the amounts that would otherwise be distributed to any redeemable convertible preferred unit holder pursuant to
the liquidation preference on <FONT STYLE="white-space:nowrap">as-converted</FONT> to common units basis will be reduced by an amount equal to the remaining preferred participation threshold amount for such redeemable convertible preferred unit. The
preferred participation threshold amount for a redeemable convertible preferred unit is equal to the original purchase price, reduced by distributions paid. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Distributions preference </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Distributions, when determined by the Board
of Managers, are payable to the members holding the redeemable convertible preferred units, pro rata in proportion to the liquidation preference amounts in respect of the redeemable convertible preferred units held by such members; thereafter, to
the members in proportion to the number of shares held by such members, on as converted basis. No distributions were declared or made from inception and during the years ended December&nbsp;31, 2021 and 2022. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Redemption </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The redeemable convertible preferred units are not
redeemable except in the event of certain effected deemed liquidation events, that are not in the Company&#146;s control. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>12. Common units </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2021 and 2022, the Company was authorized to issue 32,000,000 and 66,000,000 common units, respectively. Each common unit is entitled to cast one
vote. The holders of common units are also entitled to receive distributions whenever funds are legally available and when declared by the Company&#146;s Board of Managers, subject to prior rights of the holders of the redeemable convertible
preferred units. No distributions have been declared from inception to date. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2021 and 2022, the Company reserved common units for future
issuance as follows: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Outstanding redeemable convertible preferred units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,650,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,478,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Outstanding profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,783,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,516,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Units available for grants under 2019 Equity Incentive Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">236,886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,088,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total common units reserved for future issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,671,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,082,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Founders and investors common units </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In June&nbsp;2017, Metagenomi Inc. issued 4,687,500 shares of its common stock at a purchase price of $0.0001 per share to its founders and investors for services, which
was an estimated fair value determined by the Board of Managers at the issuance date. Pursuant to the terms of the stock purchase agreements, 25% of the shares vested on the first anniversary of the vesting start date and monthly over the next
36&nbsp;months. Vesting of shares is accelerated upon a change of control event (including an acquisition of the Company by another entity by means of any transaction or series of related transactions, or a sale of all or substantially all of the
assets of the Company). The Company has a right to repurchase unvested shares upon termination of services provided by the founders to the Company at the price lower of i) the purchase price or ii) the fair value at the date of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
repurchase. In November 2018, in connection with the reorganization, common stock issued by Metagenomi Inc. was exchanged for common units of Metagenomi with the same terms. The estimated fair
value of common unit at the modification date was determined to be $0.02 per unit, based on the Company&#146;s recent common unit valuation, and the modification expense was immaterial. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In March 2019, the Company issued 1,260,000 common units to an investor for services with a purchase price of $0.02 per unit, which was based on the recent
Company&#146;s common stock valuation. As long as the investor continues to provide services, 25% of the shares vested immediately and the remainder vested monthly over the next 36&nbsp;months. Vesting of shares is accelerated upon a change of
control event. The Company has a right to repurchase unvested shares upon termination of services provided by the founders to the Company at the price lower of i) the purchase price or ii) the fair value at the date of repurchase. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company accounts for issued common units as unit-based&nbsp;compensation to founders and investors as service providers and recognizes unit-based&nbsp;compensation
expense of $0.1&nbsp;million over the vesting period. The Company had 494,689 and 78,750 common units vested during the years ended December&nbsp;31, 2021 and December&nbsp;31, 2022, respectively, each having fair value of less than
$0.1&nbsp;million. 78,750 and zero common units were unvested as of December&nbsp;31, 2021 and 2022, respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table provides a summary of common
units with vesting conditions activity during the year ended December&nbsp;31, 2022: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Number&nbsp;of<BR>common<BR>units<BR>unvested</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Weighted-<BR>average<BR>grant&nbsp;date<BR>fair value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unvested as of January&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common Units vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unvested as of December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>13. Profits interests plan </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company
grants profits interests under the 2019 Equity Incentive Plan, adopted on March&nbsp;13, 2019 (the &#147;2019 Plan&#148;). The Company may grant profits interests with a threshold amount, which may be zero, established by the Board of Managers on
the date of issuance. Accordingly, such profits interests do not give a holder a share of the proceeds if the Company&#146;s assets were sold at fair market value and the proceeds of such disposition were distributed in complete liquidation of the
Company immediately after the date of grant but give a holder a right to share in the appreciation in the value of a common unit from the date of receipt to the future, as specifically provided in the LLC Agreement. The 2019 Plan allows for grants
of profits interests to the Company&#146;s officers, employees, directors and consultants. Profits interests generally vest monthly over four years, with or without <FONT STYLE="white-space:nowrap">one-</FONT> year cliff vesting in the first year.
In the event of a profits interest holder&#146;s termination, the unvested portion of such profits interest is automatically forfeited and cancelled without any additional consideration. Additionally, the Company has the right to repurchase the
vested portion of such profits interest at its fair market value, which is based on the fair market value of a common unit (as determined by the Board of Managers), less the applicable profits interest threshold amount, at any time during the <FONT
STYLE="white-space:nowrap">12-month</FONT> period after termination of a profits interest holder&#146;s service to the Company. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The number of common units reserved
for issuance under the 2019 Plan was 6,020,644 and 14,604,165 at December&nbsp;31, 2021, and 2022, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The table below presents a summary of activities and a reconciliation of common units authorized and remaining for
grant under the 2019 Plan during the year ended December&nbsp;31, 2022: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units<BR>available for<BR>grants</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Profits<BR>interests</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Weighted-<BR>average</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>threshold<BR>amount</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Aggregate<BR>intrinsic value<BR>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Outstanding as of January&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">236,886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,783,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Authorized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,583,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits interests granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,763,356</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,763,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Forfeited and expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,031,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,031,041</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Outstanding as of December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,088,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,516,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Vested and expected to vest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,088,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,516,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The aggregate intrinsic value is calculated as the positive difference between the threshold amount of the profits interests and the fair
value of the Company&#146;s common unit as of December&nbsp;31, 2021 and 2022. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the years ended December&nbsp;31, 2021 and 2022, the Company granted 3,550,854
and 2,763,356 profits interests with a weighted average grant date fair value of $1.03 and $1.90, respectively. The total fair value of the profits interests vested during the years ended December&nbsp;31, 2021 and 2022 was $0.2&nbsp;million and
$1.1&nbsp;million, respectively. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Unit-based compensation expense </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company estimated the fair value of profits interests on the grant date using the Black-Scholes option-pricing model based on the following assumptions for the years
ended December&nbsp;31, 2021 and 2022: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended December&nbsp;31</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79.62%&nbsp;&#151;&nbsp;91.19%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79.57%&nbsp;&#151;&nbsp;82.60%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.66&nbsp;&#151;&nbsp;6.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.51&nbsp;&#151;&nbsp;4.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.18%&nbsp;&#151; 0.94%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.65%&nbsp;&#151; 4.33%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Threshold range</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">0.34&nbsp;&#151;&nbsp;$0.51</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Expected volatility</I></B>&#151;The Company is a private company and lacks company-specific historical and implied volatility
information. Therefore, the Company estimates its expected unit&#146;s volatility based on the historical volatility of a publicly traded set of peer companies and expect to continue to do so until the Company has adequate historical data regarding
the volatility of the Company&#146;s traded unit or stock price. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Expected term</I></B>&#151;The expected term of profits interests has been determined based
on the expected time to liquidity and expected vesting term. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Risk-free interest rate</I></B>&#151;The risk-free interest rate is determined by reference to
the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Dividends</I></B>&#151;Expected dividend yield is zero because the Company does not pay cash dividends on common units and does not expect to pay any cash
dividends in the foreseeable future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The grant date fair value of common units utilized in the Black-Scholes model is determined by the Company&#146;s
Board of Managers with the assistance of management. The grant date fair value of common units is determined using valuation methodologies which utilizes certain assumptions including probability weighting of expected exit events, volatility, time
to liquidation, a risk-free interest rate and an assumption for a discount for lack of marketability. In determining the fair value of the common units, the methodologies used to estimate the enterprise value were performed using methodologies,
approaches, and assumptions consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table presents the classification of unit -based compensation expense for the years ended December&nbsp;31, 2021 and 2022 (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The above unit-based compensation expense related to the following unit-based awards for the years ended December&nbsp;31, 2021 and 2022
(in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits Interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There was $3.3 million and $5.7&nbsp;million in unrecognized unit-based compensation expense related to the profits interests as of
December&nbsp;31, 2021 and 2022, respectively, that was expected to be recognized over a weighted-average period of 3.81 and 3.03 years, respectively. There was less than $0.1&nbsp;million unrecognized unit-based compensation expense related to the
common units with vesting conditions as of December&nbsp;31, 2021, that was expected to be recognized over a weighted-average period of 0.2 years. As of December&nbsp;31, 2022, there was no unrecognized expense related to the common units with
vesting conditions.<B> </B> </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>14. Related party transactions </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
Company&#146;s former chief business officer was a founder, and a chief executive officer of Affini-T. Affini-T was a related party when the Company exercised significant influence until November 2021. In November 2021, certain common stock shares
were forfeited, and the chief business officer resigned from the Company. As of December&nbsp;31, 2021, Affini-T is no longer a related party of the Company (see Note 5). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Bayer Healthcare LLC (&#147;Bayer&#148;) is a significant investor in the Company and has a Board seat. The Company and Bayer entered into a research and development
master service agreement in November 2019. Bayer was performing research and development services under the agreement in accordance with the statement of works agreed by the parties. Services under this agreement were completed as of
December&nbsp;31, 2020, and the Company accrued $0.2&nbsp;million in accrued expenses and other current liabilities as of December&nbsp;31, 2020. The Company paid $0.2&nbsp;million to Bayer in February and March 2021 and there were no other services
provided by Bayer to the Company during the years ended December&nbsp;31, 2021 and December&nbsp;31, 2022. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with Series B and Series <FONT STYLE="white-space:nowrap">B-1</FONT> financings, the Company reimbursed
certain investors for finance issuance costs that they incurred totaling $0.4&nbsp;million. As of December&nbsp;31, 2022, $0.1&nbsp;million of Series <FONT STYLE="white-space:nowrap">B-1</FONT> financing costs reimbursable to investors is recorded
in accrued expenses and other current liabilities in the consolidated balance sheets. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>15. Income taxes </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi is treated as a partnership for tax purposes, and thus, is not subject to income taxes. It is the responsibility of the LLC members to report their
proportionate share of any taxable income or loss generated by Metagenomi to the appropriate taxing authorities and pay the associated taxes, if any. With respect to the Company&#146;s subsidiary, Metagenomi Inc. is a corporation for tax purposes
and is subject to income taxes which have been included in the consolidated financial statements. <FONT STYLE="white-space:nowrap">All&nbsp;pre-tax&nbsp;losses</FONT> have been incurred in the United States. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the year ended December&nbsp;31, 2022, income tax expense consisted of the following (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:2.00pt solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Current:</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">State</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total current tax expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Deferred:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">State</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total deferred tax expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total tax expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company recognized an income tax provision of $2.6&nbsp;million for the year ended December&nbsp;31, 2022 as a result of their
taxable income related to an upfront payment received under the Moderna Agreement and capitalization of their research and development expenses under the newly enacted Internal Revenue Code Section&nbsp;174 (&#147;Section&nbsp;174&#148;), which
became effective on January&nbsp;1, 2022. Section&nbsp;174 changed the tax treatment of research and experimentation (R&amp;E) expenditures, which requires the capitalization of R&amp;E expenditures over a period of five years for R&amp;E paid or
incurred in the United States and 15&nbsp;years for R&amp;E paid or incurred outside of the United States. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the year ended December&nbsp;31, 2021, the Company
had no income tax expense, and all losses were from the U.S. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The effective tax rate of the Company&#146;s provision for income taxes differs from the federal
statutory rate of 21%&nbsp;for the years ended December&nbsp;31, 2021 and 2022, is as follows: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Statutory rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Nontaxable LLC losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15.99</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.13</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">State tax rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Permanent and other adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.31</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6.49</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41.02</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6.26</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Significant components of the deferred tax assets for federal and state income taxes as of December&nbsp;31, 2021 and
2022, are as follows (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Deferred Tax Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net operating loss carry forwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,601</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Reserves and accruals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Capitalized research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,901</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Deferred Tax Liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(607</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,583</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,051</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,685</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total gross deferred tax liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,658</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,268</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,019</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,846</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">A valuation allowance is required to be established when it is more likely than not that all or a portion of a deferred tax asset will
not be realized. Realization of deferred tax assets is dependent upon future earnings, the timing and amount of which are uncertain. Metagenomi Inc. believes that, based on a number of factors such as the history of operating losses, it is more
likely than not that the deferred tax assets will not be fully realized, such that a full valuation allowance has been recorded. The valuation allowance increased by $1.4&nbsp;million and $16.8&nbsp;million for the years ended December&nbsp;31, 2021
and 2022, respectively, primarily due to the increase in deferred revenue and capitalization of research and development expenses under newly enacted Section 174. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022, Metagenomi Inc. had $0.02&nbsp;million and $8.3&nbsp;million of net operating loss carryforwards for federal and state income tax purposes,
respectively. Federal net operating loss carryforwards do not expire. State net operating loss carryforwards begin expiring in 2037. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022,
Metagenomi Inc. had $0 and $2.8&nbsp;million of research credit carryforwards for federal and state income tax purposes, respectively. State research credit carryforwards do not expire and can be carried forward indefinitely. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Utilization of some of the federal and state net operating losses and credit carryforwards may be subject to annual limitations due to the change in ownership provisions
of the Internal Revenue Code of 1986 (&#147;Internal Revenue Code&#148;) and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. As of December&nbsp;31, 2022, the
Company has completed an IRC Section&nbsp;382 analysis from inception through the year ended December&nbsp;31, 2022. The Company experienced two ownership changes in August 2019 and January 2022. Net operating losses generated prior to
December&nbsp;31, 2017, of $0.3 million are permanently limited for federal tax purposes. Net federal operating losses generated after December&nbsp;31, 2017 are not limited as they can be carried forward indefinitely, subject to an 80% income
limitation. Net operating losses of $0.1&nbsp;million are permanently limited for California tax purposes. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi Inc. uses the &#147;more likely than not&#148;
criterion for recognizing the income tax benefit of uncertain income tax positions and establishing measurement criteria for income tax benefits. Although it is reasonably </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
possible that certain unrecognized tax benefits may increase or decrease within the next twelve months due to tax examination changes, settlement activities, expirations of statute of
limitations, or the impact on recognition and measurement considerations related to the results of published tax cases or other similar activities, Metagenomi Inc. does not anticipate significant changes to unrecognized tax benefits over the next 12
months. During the years ended December&nbsp;31, 2021 and 2022, no interest or penalties were recognized relating to unrecognized tax benefits. In the event Metagenomi Inc. should need to recognize interest and penalties related to unrecognized
income tax liabilities, this amount will be recorded as an accrued liability and an increase to income tax expense. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The changes in the balance of gross unrecognized
tax benefits, which excludes interest and penalties, for the years ended December&nbsp;31, 2021 and 2022, are as follows (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Beginning balance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross increases&#151;tax position in current period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross increases&#151;tax position in prior periods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Reductions for tax positions of prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(33</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Ending balance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi Inc. files tax returns in the U.S. and California. Metagenomi Inc. is not currently under examination in any of these
jurisdictions and all its tax years remain effectively open to examination due to net operating losses from inception. Metagenomi Inc. recognized $1.0&nbsp;million of uncertain tax positions as other
<FONT STYLE="white-space:nowrap">non-current</FONT> liabilities and $0.8&nbsp;million was netted against deferred tax assets. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In accordance with the Tax Cuts and
Jobs Act of 2017, research and experimental (R&amp;E) expenses under Internal Revenue Code Section&nbsp;174 are required to be capitalized beginning in 2022. R&amp;E expenses are required to be amortized over a period of 5 years for domestic
expenses and 15 years for foreign expenses. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On August&nbsp;16, 2022, President Biden signed into law the Inflation Reduction Act of 2022, which includes an
Alternative Minimum Tax based on the Adjusted Financial Statement Income of Applicable Corporations. Based on an initial evaluation, the Company does not believe the Inflation Reduction Act will have a material impact on the income tax provision and
cash taxes. The Company will continue to monitor the changes in tax laws and regulations to evaluate their potential impact on the business. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>16. Net loss per
unit </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Basic and diluted net loss per unit attributable to common unitholders is calculated as follows (in thousands except share and per share amounts): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended December&nbsp;31</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss attributable to common members</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21,442</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(43,593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average common units outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: Weighted-average unvested common units subject to repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(256,069</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,846</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average units used to computing basic and diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,691,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,938,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss per unit attributable to common unitholders&#151;basic and diluted:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3.77</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7.34</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss
per unit, as their effect is anti-dilutive: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Redeemable convertible preferred units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,650,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,478,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,783,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,516,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unvested common units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,513,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,994,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>17. Employee retirement plan </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has
a defined contribution plan under Section&nbsp;401(k) of the Internal Revenue Code (the &#147;401(k) Plan&#148;), covering its employees. Employees may contribute a percentage of their annual compensation to this plan, subject to the maximum
allowable amount set by the Internal Revenue Service. The 401(k) Plan provides that the Company matches each participant&#146;s contribution at 100% up to the first 5% of the employee&#146;s eligible compensation. The Company&#146;s contributions to
the 401(k) Plan were $0.2&nbsp;million and $0.6&nbsp;million for the years ended December&nbsp;31, 2021 and 2022, respectively. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>18. Subsequent events </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has reviewed and evaluated subsequent events through August&nbsp;3, 2023, the date that the consolidated financial statements were available to be issued.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In January 2023, the Company sold an additional 334,754 Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred units in accordance with
the Series <FONT STYLE="white-space:nowrap">B-1</FONT> purchase agreement and received gross cash proceeds of $4.7&nbsp;million. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In March and June 2023, the Company
granted 450,860 and 1,530,523 profits interests to officers, employees and consultants with a threshold amount of $5.75 and $7.40, respectively. These profits interests vest over a period of two to four years. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>19. Subsequent events (unaudited) </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has reviewed and evaluated
subsequent events through December 8, 2023, the date that the consolidated financial statements were available to be reissued. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Profits Interests Grants
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In September 2023, the Company granted 274,830 profits interests awards to officers, employees and consultants with a threshold amount of $11.84. In July
and September 2023, the Company canceled and re-issued 781,312 profits interests awards with thresholds of $7.40 and $11.84. Issued profits interests vest over a period of two to four years. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Amendment to the LLC Agreement </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s LLC Agreement was
amended on July 31, 2023 to provide for &#147;catch-up&#148; distributions for profits interests once the applicable catch-up threshold amount for such profits interests was met (the &#147;Amendment to the LLC Agreement&#148;). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The LLC Agreement provides each profits interest with a distribution threshold amount, which is determined on the date of issuance and represents the amount that would
be distributed if, immediately after issuance, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Company sold all of its assets at fair market value and distributed the net proceeds in liquidation. A profits interest does not participate in Company distributions until an amount equal to its
distribution threshold amount has been distributed to other members of the Company with units that either have a lower threshold amount or no threshold amount. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Once
the applicable distribution threshold amount has been met for a particular profits interest, such profits interest will participate in Company distributions on a pro rata basis until the catchup threshold amount has been met. Once the catch-up
threshold amount has been met, subsequent &#147;catch-up&#148; distributions will be made solely to holders of profits interests until such holders have received an amount equal to the amount such holders would have received had the distribution
threshold not existed. Once the profits interest holders have received distributions in an amount equal to what they would have received had the distribution threshold not existed, all subsequent distributions are made on a pro rata basis with
common unitholders. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The catch-up threshold amount of $11.84 per unit reflected the estimated fair value of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Company&#146;s common unit as of July 31, 2023, as determined by the Company&#146;s board of managers, with input from management, and considering the Company&#146;s
most recently available third-party valuations of common units. The amendment to the LLC Agreement resulted in a change to the fair value of the profits interests and will be accounted for as a modification of the profits interests&#146; awards.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Ionis Agreement </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In November 2023, Ionis selected its third target
(&#147;Target 3&#148;) in Wave 1 and the Company agreed to extend the period during which the Company expects Ionis will select its fourth target (&#147;Target 4&#148;) in Wave 1 by an additional three months from the 12-month anniversary of the
effective date, as permitted under the arrangement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_7"></A>Condensed Consolidated Balance Sheets </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands, except units) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(unaudited) </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">184,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">101,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Contract assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">366,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating lease <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT>
assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,736</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">414,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 386,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Liabilities, redeemable convertible preferred units and members&#146; deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,799</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Current portion of operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Collaboration advance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">430</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-current</FONT> portion of operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred revenue, <FONT STYLE="white-space:nowrap">non-current</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">154,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commitments and contingencies (Note 8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Redeemable convertible preferred units: 41,813,375 units authorized as of December&nbsp;31, 2022 and
September&nbsp;30, 2023; 41,478,621 and 41,813,375 units issued and outstanding as of December&nbsp;31, 2022 and September&nbsp;30, 2023, respectively. Liquidation preference $347,335 and $352,044 as of December&nbsp;31, 2022 and September&nbsp;30,
2023, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">346,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Members&#146; deficit:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common units: 66,000,000 units authorized as of December&nbsp;31, 2022 and September&nbsp;30, 2023;
5,947,500 units issued and outstanding as of December&nbsp;31, 2022 and September&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits interests: 14,604,165 units authorized as of December&nbsp;31, 2022 and September&nbsp;30, 2023;
7,516,073 and 9,556,687 units issued and outstanding as of December&nbsp;31, 2022 and September&nbsp;30, 2023, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(274</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(359</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,650</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total members&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,428</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(119,021</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total liabilities, redeemable convertible preferred units and members&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">414,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 386,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_8"></A>Condensed Consolidated Statements of Operations and Comprehensive Loss </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands, except units and per unit data) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(unaudited) </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;Months&nbsp;Ended&nbsp;September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">32,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,874</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in fair value of long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss before provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,243</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,660</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,723</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,301</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(28,966)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,961)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other comprehensive loss:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unrealized loss on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(301</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,267)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(49,046)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss per unit attributable to common unitholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.88)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8.23)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average common units outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">5,935,673</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:199pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_9"></A>Condensed Consolidated Statements of Redeemable Convertible Preferred Units and
Members&#146; Deficit </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands, except units) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(unaudited)
</B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Redeemable<BR>Convertible&nbsp;Preferred<BR>Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Common Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Profits Interests</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Accumulated<BR>Other<BR>Comprehensive</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Loss</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Accumulated</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Deficit</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Total<BR>Members&#146;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="right"><B>Deficit</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">BALANCE&#151;January 1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,650,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">76,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,783,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(33,096</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(32,544</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of Series B redeemable convertible preferred units for cash, net of issuance costs of $697</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,446,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of Series B redeemable convertible preferred units upon conversion of convertible note and accrued
interest</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,607,387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,244,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Cancellation and forfeiture of profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(942,677</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(301</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(301</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">BALANCE&#151;September 30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,704,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">251,173</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,085,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(62,062</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(60,420</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="25" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">BALANCE&#151;January 1, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,478,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">346,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,516,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(274</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(74,428</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred units, net of
issuance costs of $54</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">334,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Issuance of profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,267,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Cancellation and forfeiture of profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(227,199</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,961</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,961</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">BALANCE&#151;September 30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,813,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">350,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,556,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(359</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(125,650</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(119,021</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="25" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="25" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_10"></A>Condensed Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(unaudited) </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Cash flows from operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(28,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,961</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Adjustments to reconcile net loss to net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Loss on fixed assets <FONT STYLE="white-space:nowrap">write-off</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-cash</FONT> lease expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Amortization of premiums and discounts on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,852</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Amortization of <FONT STYLE="white-space:nowrap">non-cash</FONT> collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(265</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(654</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-cash</FONT> interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in fair value of long-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,870</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,924</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Contract assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,398</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred revenue and collaboration advance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,330</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,039</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(972</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">692</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(38,009</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70,817</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Cash flows from investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,077</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Purchases of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(136,634</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(168,977</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturities and sales of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,326</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,898</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Cash flows from financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Payments of initial public offering costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,949</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Proceeds from issuance of redeemable convertible preferred units, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net change in cash, cash equivalents and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,369</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash, cash equivalents and restricted cash at the beginning of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash, cash equivalents and restricted cash at the end of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 66,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 107,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Reconciliation of cash, cash equivalents and restricted cash</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 62,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 101,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash, cash equivalents and restricted cash at the end of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"> 66,365</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"> 107,145</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these unaudited condensed consolidated financial statements </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Condensed Consolidated Statements of Cash Flows (continued) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(in thousands) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>(unaudited) </B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Supplemental cash flow information</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Issuance of Series B redeemable convertible preferred units upon conversion of convertible promissory note
and accrued interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common shares of <FONT STYLE="white-space:nowrap">Affini-T</FONT> received for collaboration
revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Purchases of property and equipment included in accounts payable and accrued expenses and other current
liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating lease <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT>
assets obtained in exchange for new lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;30,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred initial public offering costs included
in accounts payable and accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000">$</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000" ALIGN="right"> 2,456</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:380pt; margin-bottom:0pt; font-size:7.5pt; font-family:arial"><I>The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="fin425213_11"></A>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>1. Description of business, organization and liquidity </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Organization
and business </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi Technologies, LLC (&#147;Metagenomi&#148;), together with its wholly owned subsidiary Metagenomi, Inc. (&#147;Metagenomi Inc.&#148;)
(together, the &#147;Company&#148;) is a gene editing biotechnology company developing therapeutics by leveraging a toolbox of next-generation gene editing systems to accurately edit DNA. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Liquidity and going concern </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has incurred significant
losses from operations since its inception. During the nine months ended September&nbsp;30, 2022 and 2023, the Company incurred net losses of $29.0&nbsp;million and $49.0&nbsp;million, respectively. As of September&nbsp;30, 2023, the Company had an
accumulated deficit of $125.7&nbsp;million. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has historically financed its operations primarily through issuance of redeemable convertible preferred
units, convertible promissory notes and its collaboration agreements with Moderna, <FONT STYLE="white-space:nowrap">Affini-T</FONT> and Ionis (see Note 7). The Company expects to continue to incur substantial losses, and its ability to achieve and
sustain profitability will depend on the successful development, approval, and commercialization of any product candidates it may develop, and on the achievement of sufficient revenue to support its cost structure. The Company may never achieve
profitability and, unless and until it does, it will need to continue to raise additional capital. Management expects that existing cash, cash equivalents and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities of $292.9&nbsp;million as of September&nbsp;30, 2023, will be sufficient to fund its current operating plan for at least the
next 12 months from the date of issuance of these condensed consolidated financial statements. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>2. Summary of significant accounting policies </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Basis of presentation </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These condensed consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;) and pursuant to the rules and regulations of the Securities and Exchanges Commission (&#147;SEC&#148;)
regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Metagenomi and Metagenomi Inc., a wholly owned subsidiary. All intercompany balances and transactions have been eliminated in
consolidation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The interim condensed consolidated balance sheet as of September&nbsp;30, 2023, and the condensed consolidated statements of operations and
comprehensive loss, and cash flows for the nine months ended September&nbsp;30, 2022 and 2023 are unaudited. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial
statements and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for the fair statement of the Company&#146;s financial position as of September&nbsp;30, 2023 and its results of operations and
cash flows for the nine months ended September&nbsp;30, 2022 and 2023. The financial data and the other financial information disclosed in these notes to the condensed consolidated financial statements related to the nine-month periods are also
unaudited. The results of operations for the nine months ended September&nbsp;30, 2023 are not necessarily indicative of the results to be expected for the year ending December&nbsp;31, 2023, or for any other future annual or interim period. The
condensed consolidated balance sheet as of December&nbsp;31, 2022, included herein was derived from the audited consolidated financial statements as of that date. Certain information and footnote disclosures normally included in financial statements
prepared in accordance with U.S. GAAP have been </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
condensed or omitted from these interim condensed consolidated financial statements. These unaudited condensed financial statements should be read in conjunction with the Company&#146;s audited
consolidated financial statements included elsewhere in this prospectus. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Any reference in these notes to applicable guidance is meant to refer to the authoritative
GAAP as found in the Accounting Standards Codification (&#147;ASC&#148;) and Accounting Standards Updates (&#147;ASU&#148;) of the Financial Accounting Standards Board (&#147;FASB&#148;). </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Use of estimates </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The preparation of financial statements in
conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported
amounts of expenses during the reporting period. On an ongoing basis, the Company evaluates estimates and assumptions, including but not limited to those related to revenue recognition under its collaboration agreements, the fair value of its common
and redeemable convertible preferred units, the fair value of derivative liabilities, unit-based compensation expense, accruals for research and development expenses, the fair value of long-term investments, the valuation of deferred tax assets and
uncertain income tax positions. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the
carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from those estimates. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Risks
and uncertainties </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company is subject to certain risks and uncertainties, including, but not limited to, changes in any of the following areas that the
Company believes could have a material adverse effect on the future financial position or results of operations: the Company&#146;s ability to advance the development of its next generation gene-editing platform, timing and ability to advance any
product candidates it may develop into and through <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical development; costs and timelines associated with the manufacturing of clinical supplies of any product candidates the Company may
develop; regulatory approval, market acceptance of, and reimbursement for any product candidates the Company may develop; performance of third-party vendors; competition from pharmaceutical or other gene-editing companies with greater financial
resources or expertise; protection of intellectual property; litigation or claims against the Company based on intellectual property or other factors; and its ability to attract and retain employees necessary to support its growth. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s business and operations may be affected by worldwide economic conditions, which may continue to be impacted by global macroeconomic challenges such as
the effects of the ongoing geopolitical conflict in Ukraine and the Israel-Hamas war, tensions in U.S.-China relations, the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, uncertainty in the markets, including disruptions in the banking
industry, and inflationary trends. Fiscal year 2022 was marked by significant market uncertainty, increasing inflationary pressures. These market dynamics may continue into 2023 and these and similar adverse market conditions may negatively impact
the Company&#146;s operations and financial position. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Concentration of credit risk </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Cash and cash equivalents, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities and preferred and
common stock shares related to our investment in <FONT STYLE="white-space:nowrap">Affini-T</FONT> (Note 5) are financial instruments that potentially subject the Company to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
concentrations of credit risk. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, cash consists of cash deposited with three financial institutions, and account balances exceed federally
insured limits. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On March&nbsp;10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit
Insurance Corporation (&#147;FDIC&#148;) as receiver. On March&nbsp;12, 2023 the FDIC transferred all deposits, both insured and uninsured, and substantially all assets from the former SVB to a newly created, full-service FDIC-operated &#147;bridge
bank&#148;, Silicon Valley Bridge Bank, N.A. (&#147;SVBB&#148;) and the FDIC, Treasury Department, and Federal Reserve announced that all deposits will be fully protected, whether or not they had been insured by the FDIC. On March&nbsp;27, 2023,
First-Citizens Bank&nbsp;&amp; Trust Company assumed all of SVBB&#146;s customer deposits and certain other liabilities and acquired substantially all of SVBB&#146;s loans and certain other assets from the FDIC. As of September&nbsp;30, 2023, the
Company&#146;s held cash and cash equivalents of $6.7&nbsp;million at SVB. As of the date of the issuance of these condensed consolidated financial statements, the Company has full access to and control over all its cash, cash equivalents and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company also has investments in money market
funds, U.S. Treasuries, corporate debt obligations, commercial paper, government agency obligations and asset-backed securities, which can be subject to certain credit risks. The Company mitigates the risks by investing in high-grade instruments,
limiting its exposure to any one issuer and monitoring the ongoing creditworthiness of the financial institutions and issuers. The Company has not experienced any losses on its financial instruments. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Concentration of collaboration revenue, accounts receivable and contract assets </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the percentages of collaboration revenues, accounts receivable and contract assets from each of the Company&#146;s customers that
individually accounted for 10% or more of its collaboration revenues, accounts receivable and contract assets: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Collaboration&nbsp;revenue</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;months&nbsp;ended&nbsp;September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Customer A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Customer B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Customer C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Contract&nbsp;assets</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>December&nbsp;31,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>2022</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>September&nbsp;30,<BR>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Customer B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100%</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>*</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Accounts&nbsp;receivable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>December&nbsp;31,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>2022</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>September&nbsp;30,<BR>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Customer A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Customer B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>*</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100%</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>the customer did not account for 10% or more of the Company&#146;s collaboration revenues, accounts receivable or contract assets during the respective fiscal period</I> </TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company reviews its accounts receivable and contract assets for impairment and credit loss allowance. No&nbsp;impairment or credit loss allowance was recorded as of
December&nbsp;31, 2022 and September&nbsp;30, 2023. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Deferred finance issuance costs </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Deferred finance issuance&nbsp;costs, consisting of legal fees relating <FONT STYLE="white-space:nowrap">to&nbsp;in-process&nbsp;equity</FONT> financings and initial
public offering are capitalized. The&nbsp;deferred finance issuance&nbsp;costs will be offset against&nbsp;offering&nbsp;proceeds upon the completion of the&nbsp;financing or the offering. In the event the&nbsp;financing or the offering&nbsp;is
terminated or delayed,&nbsp;deferred finance issuance&nbsp;costs will be expensed immediately as a charge to general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss. The Company had no
deferred finance issuance costs capitalized and $4.4&nbsp;million of deferred finance issuance costs as of December&nbsp;31, 2022 and September&nbsp;30, 2023, respectively, included in other assets in the condensed consolidated balance sheets. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Recently issued accounting pronouncements </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company noted no
recently issued accounting pronouncements that will impact its condensed consolidated financial statements and were not adopted by the Company. No new accounting pronouncements were adopted during the nine months ended September&nbsp;30, 2023. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>3. Fair value measurements </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Assets and liabilities recorded at fair value on
a recurring basis in the condensed consolidated balance sheets, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair
value and requires certain disclosures about how fair value is determined. The accounting guidance establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such
inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation
techniques is briefly summarized as follows: </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><I>Level</I><I></I><I>&nbsp;1 </I>&#151; Inputs are unadjusted, quoted prices in active markets for
identical assets or liabilities at the measurement date; </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><I>Level</I><I></I><I>&nbsp;2 </I>&#151; Inputs are observable, unadjusted quoted prices in
active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for
substantially the full term of the related assets or liabilities; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:arial"><I>Level</I><I></I><I>&nbsp;3 </I><B>&#151; </B>Unobservable inputs that are significant to the
measurement of the fair value of the assets or liabilities that are supported by little or no market data. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Assets and liabilities measured at fair value are
classified in their entirety based on the lowest level of input that is significant to the fair value measurement. An assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make
judgments and consider factors specific to the asset or liability. Changes in the ability to observe valuation inputs may result in a reclassification of levels of certain securities within the fair value hierarchy. The Company recognizes transfers
into and out of levels within the fair value hierarchy in the period in which the actual event or change in circumstances that caused the transfer occurs. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
Company&#146;s financial instruments measured at fair value on a recurring basis consist of Level&nbsp;1, Level&nbsp;2, and Level&nbsp;3 financial instruments. Usually, marketable securities are considered Level&nbsp;2 when their fair values are
determined using inputs that are observable in the market or can be derived principally from or corroborated by observable market data such as pricing for similar securities, recently executed transactions, cash flow models with yield curves, and
benchmark securities. In addition, Level&nbsp;2 financial instruments are valued using comparisons to like-kind financial instruments and models that use readily observable market data as their basis. U.S. Government bonds, corporate debt
obligations, commercial paper, government agency obligations and asset-backed securities are valued primarily using market prices of comparable securities, bid/ask quotes, interest rate yields and prepayment spreads and are included in Level&nbsp;2.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Financial assets and liabilities are considered Level&nbsp;3 when their fair values are determined using pricing models, discounted cash flow methodologies, or
similar techniques, and at least one significant model assumption or input is unobservable. The Company&#146;s investments in preferred stock and common stock shares of <FONT STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics Inc. <FONT
STYLE="white-space:nowrap">(&#147;Affini-T&#148;)</FONT> (see Note 5) are Level&nbsp;3 financial assets. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the estimated fair value of
the financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy as of December&nbsp;31, 2022 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="16" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31, 2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds (included in cash and cash equivalents)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury bills(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Government bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Government agency obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate debt obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commercial paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Asset-backed securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term investments (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total fair value of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">365,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">177,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Certain prior period amounts have been reclassified to conform to the current period presentation </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the estimated fair value of the financial instruments that were measured at fair value
on a recurring basis by level within the fair value hierarchy as of September&nbsp;30, 2023 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="16" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>September&nbsp;30, 2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds (included in cash and cash equivalents)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Government bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Government agency obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate debt obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commercial paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Asset-backed securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Foreign debt securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term investments (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total fair value of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">295,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">191,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, restricted cash of $6.1&nbsp;million and $5.2&nbsp;million as of December&nbsp;31, 2022 and September&nbsp;30, 2023,
respectively, collateralized by the Company&#146;s cash equivalents, are financial assets measured at fair value and are Level&nbsp;1 financial instruments under the fair value hierarchy. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s investments in shares of <FONT STYLE="white-space:nowrap">Affini-T</FONT> common stock and preferred stock are accounted at fair value and are
Level&nbsp;3 investments. The fair value is estimated based on information available to management including recent financing transactions, capitalization and rights and preferences of outstanding securities and is based on option-pricing model. The
estimated fair value of the Company&#146;s investment in <FONT STYLE="white-space:nowrap">Affini-T</FONT> was $5.7&nbsp;million and $8.5&nbsp;million as of December&nbsp;31, 2022 and September&nbsp;30, 2023, respectively. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table sets forth a summary of the changes in the fair value of the Company&#146;s Level&nbsp;3 financial assets (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Fair value as of January&nbsp;1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in fair value included in other income (expense)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Fair value of investment received as collaboration consideration (Note 7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Fair value as of September&nbsp;30</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There were no transfers within the fair value hierarchy during the nine months ended September&nbsp;30, 2022 and 2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>4. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Available-for-sale</FONT></FONT> marketable
securities </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the amortized cost, unrealized gains (losses) and estimated fair value of the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities as of December&nbsp;31, 2022 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amortized<BR>cost</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Unrealized<BR>gains</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Unrealized<BR>losses</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Estimated<BR>fair value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">182,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Government bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(69</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Government agency obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate debt obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(151</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commercial paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Asset-backed securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(105</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: amounts classified as cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(182,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(182,441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">177,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">177,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes the amortized cost, unrealized gains (losses) and estimated fair value of the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities as of September&nbsp;30, 2023 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amortized<BR>cost</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Unrealized<BR>gains</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Unrealized<BR>losses</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Estimated<BR>fair value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Government bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Government agency obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,732</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate debt obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Commercial paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Asset-backed securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Foreign debt securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,462</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">287,142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">286,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: amounts classified as cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(95,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(95,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">191,389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">191,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022 and September&nbsp;30, 2023, no significant facts or circumstances were present to indicate a deterioration
in the creditworthiness of the issuers of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities, and the Company has no requirement or intention to sell these securities before maturity or
recovery of their amortized cost basis. The Company considered the current and expected future economic and market conditions and determined that its investments were not significantly impacted. For all securities with a fair value less than its
amortized cost basis, the Company determined the decline in fair value below amortized cost basis to be immaterial and <FONT STYLE="white-space:nowrap">non-credit</FONT> related, and therefore no allowance for losses has been recorded.&nbsp;During
the nine months ended September&nbsp;30, 2022 and 2023, the Company did not recognize any impairment losses on its investments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s policy is to exclude the applicable accrued interest from both the fair value and the amortized cost
basis of its <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities for purposes of identifying and measuring an impairment. The Company presents accrued interest receivable related to the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities in prepaid expenses and other current assets, separate from
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities in the condensed consolidated balance sheets. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, accrued interest
receivable was $0.3&nbsp;million and $0.7&nbsp;million, respectively. The Company&#146;s accounting policy is to not measure an allowance for credit losses for accrued interest receivable and to <FONT STYLE="white-space:nowrap">write-off</FONT> any
uncollectible accrued interest receivable as a reversal of interest income in a timely manner, which it considers to be in the period in which the Company determines the accrued interest will not be collected. The Company has&nbsp;not written off
any accrued interest receivable for the nine months ended September&nbsp;30, 2022 and 2023. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The amortized cost and fair value of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities by contractual maturity were as follows as of December&nbsp;31, 2022 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amortized<BR>cost</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Estimated<BR>fair&nbsp;value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturing within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">163,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">163,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturing in one to five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">177,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">177,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The amortized cost and fair value of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities by contractual maturity were as follows as of September&nbsp;30, 2023 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Amortized<BR>cost</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Estimated<BR>fair&nbsp;value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturing within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">187,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">187,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Maturing in one to five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">191,389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">191,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>5. Long-term investments </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I><FONT
STYLE="white-space:nowrap">Affini-T</FONT> investment </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022 and September&nbsp;30, 2023, the Company had investments in shares of
preferred stock and common stock of <FONT STYLE="white-space:nowrap">Affini-T.</FONT> The Company performed a VIE analysis and concluded that it was not a primary beneficiary of <FONT STYLE="white-space:nowrap">Affini-T</FONT> as of
December&nbsp;31, 2022 and September&nbsp;30, 2023. The Company is using the fair value method to account for its investments in <FONT STYLE="white-space:nowrap">Affini-T</FONT> with changes in fair value recorded to the condensed consolidated
statements of operations and other comprehensive loss (see Note 3). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022, the fair value of common stock shares was estimated by management,
considering the most recent third-party valuation, and the fair value of preferred stock shares was estimated based on recent sales of similar preferred stock to another investor for cash. As of June&nbsp;30, 2023, the fair values of common stock
and preferred stock shares were estimated by management using an option-pricing valuation model and recent financing transactions at <FONT STYLE="white-space:nowrap">Affini-T.</FONT> The Company noted no changes in estimated fair value of <FONT
STYLE="white-space:nowrap">Affini-T</FONT> preferred and common stock from June&nbsp;30, 2023 to September&nbsp;30, 2023. The Company recognized changes in fair value of $0.1&nbsp;million and of $2.9&nbsp;million for the nine months ended
September&nbsp;30, 2022 and 2023, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">No impairment loss was recognized on the Company&#146;s investment in <FONT STYLE="white-space:nowrap">Affini-T</FONT>
as of December&nbsp;31, 2022 or September&nbsp;30, 2023. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>ViTToria investment </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022 and September&nbsp;30, 2023, the Company had investment in shares of preferred stock of ViTToria Biotherapeutics, Inc.
(&#147;Vittoria&#148;), a private biotechnology company. The Company accounts for its investment in Vittoria using the measurement alternative method. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, the carrying value of Vittoria&#146;s
investment was $2.2&nbsp;million and no impairment was recognized. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>6. Condensed consolidated balance sheets components </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Property and equipment, net consists of the following (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Useful&nbsp;life</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">lesser&nbsp;of<BR>useful&nbsp;life&nbsp;or<BR>the&nbsp;lease&nbsp;term</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,810</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">3-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Computers and related equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">3-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Construction in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: Accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,234</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Depreciation and amortization expense was $1.0&nbsp;million and $3.0&nbsp;million for the nine months ended September&nbsp;30, 2022 and
2023, respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Other assets consist of the following (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating lease deposit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term prepaid services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred finance issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,405</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Accrued expenses and other current liabilities consist of the following (in thousands): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued personnel related expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued legal and professional services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">896</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,799</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>7. Significant agreements </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Moderna
strategic collaboration and license agreement </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Terms of the agreement </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On October&nbsp;29, 2021, the effective date, the Company entered into a Strategic Collaboration and License Agreement (the &#147;Moderna Agreement&#148;) with
ModernaTX, Inc. (&#147;Moderna&#148;). The parties will collaborate on the research and development of <FONT STYLE="white-space:nowrap">in-vivo</FONT> genome editing therapies directed at certain targets and the commercialization of such genome
editing therapies. The collaboration provides Moderna with exclusive access to the Company&#146;s technology platform during the research period in (1)&nbsp;the field of in vivo gene editing technology for a therapeutic, ameliorative or prophylactic
application by way of <FONT STYLE="white-space:nowrap">knock-out</FONT> through InDel formation or base editing or insertion of an exogenous DNA template (such field, &#147;DT Field&#148;) and (2)&nbsp;the field of in vivo gene editing technology
for a therapeutic, ameliorative or prophylactic application outside the use of (a)&nbsp;DNA donor templates and (b)&nbsp;no exogenous template at all but including (c)&nbsp;correction by base editing (such field, &#147;RT Field&#148;). The parties
formed a joint steering committee, a joint research subcommittee and a joint patent subcommittee to oversee the collaboration activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Under the terms of the
Moderna Agreement, the parties will collaborate on one or more programs in the RT Field (the &#147;Moderna RT program&#148;) and two programs in the DT Field (the &#147;Moderna DT program&#148; and the &#147;DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> program&#148;). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">With respect to the Moderna RT and Moderna DT programs, the parties will collaborate on the research
and development of product candidates under the approved research plans. The initial research term of the Moderna RT program is four years, which may be extended by Moderna for an additional three years upon written notice and a payment of extension
fees. The initial research term of the Moderna DT program is four years. The Company granted to Moderna an option to obtain an exclusive license to develop, manufacture and commercialize up to ten Moderna RT program candidates and up to two Moderna
DT program candidates at any time during the research term and prior to filing of an investigational new drug (&#147;IND&#148;) application with the Food and Drug Administration (&#147;FDA&#148;) or any similar application filed with a regulatory
authority in a country other than the United States (&#147;U.S.&#148;), subject to Moderna&#146;s payment of an option exercise fee of $10.0&nbsp;million per target. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">With respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program, the parties will work together on the
<FONT STYLE="white-space:nowrap">co-development</FONT> and commercialization of products and share costs and profits equally. The Company maintains commercialization rights in the U.S. (subject to Moderna&#146;s right to appoint up to 50% of the
U.S. sales force for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program), while Moderna maintains these rights in countries other than the U.S. The initial research term for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program is four years, and each party has a right to <FONT STYLE="white-space:nowrap">opt-out</FONT> of the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> program at any time, at which point the other party has the right to solely continue the development and commercialization activities. If there is no development candidate nomination by the end of the
initial research term, the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program will expire, unless the parties have mutually agreed to continue the program. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the year ended December&nbsp;31, 2021, the Company received a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payment of $40.0&nbsp;million and a
$5.0&nbsp;million payment for the first year of research costs. Concurrent with the Moderna Collaboration Agreement, Moderna also provided $30.0&nbsp;million in cash in the form of a convertible promissory note pursuant to a convertible promissory
note agreement dated October&nbsp;29, 2021 (the &#147;Moderna Convertible Promissory Note Agreement&#148;). The convertible promissory note was converted into shares of Series B redeemable convertible preferred units in January 2022 (see Note 9).
Moderna will reimburse the Company up to $5.0&nbsp;million in annual research and development costs related to the Moderna DT and Moderna RT programs, or up to the agreed amount of expenses per the budget. As of September&nbsp;30, 2023, the Company
has received a total of $49.6&nbsp;million under the Moderna Agreement, not including cost-sharing payments under the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For the Moderna RT and Moderna DT programs, the Company is eligible to receive (i)&nbsp;technology milestone fees related to the achievement of certain preclinical
research objectives, of up to $75.0&nbsp;million, (ii)&nbsp;development and regulatory milestones of up to $100.0&nbsp;million per target, (iii)&nbsp;sales milestones of up to $200.0&nbsp;million per target and (iv)&nbsp;royalties ranging from a <FONT
STYLE="white-space:nowrap">mid-single</FONT> digit to a <FONT STYLE="white-space:nowrap">low-teens</FONT> percentage of annual net sales of a licensed product. Any profits and losses from the co-development and commercialization of the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> program are shared equally between the Company and Moderna. With respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program for which the <FONT STYLE="white-space:nowrap">opt-out</FONT> party has
exercised its <FONT STYLE="white-space:nowrap">opt-out</FONT> right, the continuing party will pay to the <FONT STYLE="white-space:nowrap">opt-out</FONT> party, certain development, regulatory and sales milestone payments that will not exceed an
aggregate $239.0&nbsp;million per DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> target, and <FONT STYLE="white-space:nowrap">opt-out</FONT> royalties ranging from a high-single digit to a <FONT STYLE="white-space:nowrap">low-teens</FONT>
percentage of annual net sales of a licensed product. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of the Moderna Agreement will continue on a licensed <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, until the expiration of the applicable royalty term. The royalty term
commences on the first commercial sale of a licensed product and terminates on the latest of: (a)&nbsp;the expiration or abandonment of the last valid claim of a patent within the licensed Moderna DT or RT technology; (b) 10 years after the first
commercial sale of a licensed product; and (c)&nbsp;expiration of the regulatory exclusivity. Upon the expiration of the term of a licensed product in the Moderna DT or Moderna RT program, the licenses granted to Moderna will survive and become
perpetual, fully paid and royalty-free. Each party may terminate the Moderna Agreement on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">program-by-program</FONT></FONT> basis upon written notice to the other party for an
uncured material breach or insolvency. The Company may terminate the Moderna Agreement upon written notice to Moderna for a patent challenge. Additionally, Moderna may terminate the agreement at its convenience with respect to Moderna DT or Moderna
RT programs for any reason upon at least: (a) 60 days&#146; prior written notice if a first commercial sale has not occurred for the products in such program, or (b) 180 days&#146; prior written notice if a first commercial sale of a product in such
program has occurred. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Accounting analysis and revenue recognition </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
Company concluded that the Moderna DT and Moderna RT programs are in the scope of ASC 606. The Company determined that the licenses granted to Moderna, and its participation in the joint steering committee are not capable of being distinct from the
preclinical research and development services and therefore concluded that there are two performance obligations: (1)&nbsp;the Moderna RT program and (2)&nbsp;the Moderna DT </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
program. The Company also concluded that the option to obtain an exclusive license and options to extend Moderna RT program term do not include significant incremental discounts, and as such, the
options do not provide material rights. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program research activities are within the scope
of ASC 808, as the Company and Moderna are both active participants in the research, development and commercialization activities, are exposed to significant risks and rewards that are dependent on the success of the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> program activities and share costs and profits equally. The Company determined that the guidance in ASC 730, <I>Research and Development</I>, was appropriate to apply to the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> program research activities by analogy, based on the nature of the cost sharing provisions of the agreement. The Company concluded that DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program is one
unit of accounting, as the <FONT STYLE="white-space:nowrap">co-exclusive</FONT> license is not distinct from the research and development and the participation in joint steering committee activities. The Company recognizes payments to or from
Moderna related to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program cost sharing research activities as an increase to or reduction of research and development expenses, respectively. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded that the Moderna Collaboration Agreement and the Moderna Convertible Promissory Note Agreement should be combined and treated as a single
arrangement for accounting purposes as the agreements were entered into contemporaneously and in contemplation of one another. The Company estimated the contract consideration to be $90.0&nbsp;million, which consisted of: 1) the <FONT
STYLE="white-space:nowrap">non-refundable</FONT> upfront collaboration payment of $40.0&nbsp;million received in 2021, 2) $30.0&nbsp;million in cash received in 2021 in exchange for the convertible promissory note and 3) the estimated cost
reimbursements for Moderna DT and Moderna RT programs of $20.0&nbsp;million. The Company constrained future milestones, as it assessed that it is probable that the inclusion of such variable consideration could result in a significant reversal of
cumulative revenue in future periods. During the year ended December&nbsp;31, 2021, the Company recorded $30.0&nbsp;million of the contract consideration for the convertible promissory note based on the fair value and allocated the transaction price
of $60.0&nbsp;million to each of the following programs on a relative standalone selling price basis: 1) $49.5&nbsp;million to the Moderna RT program, 2) $5.5&nbsp;million to the Moderna DT program and 3) $5.0&nbsp;million to the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> program. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The variable consideration is reevaluated at each reporting period and as changes in circumstances occur. The
Company recognizes revenue for each of the Moderna DT and Moderna RT programs as collaboration revenue based on the measure of progress using an estimated cost-based input method each reporting period. The Company also amortizes the allocation
consideration for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> program of $5.0&nbsp;million as a credit to research and development expenses during the discovery and lead optimization phases for the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> program. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company recognized collaboration revenue of $10.7&nbsp;million and $14.2&nbsp;million in the condensed
consolidated statements of operations and comprehensive loss for the nine months ended September&nbsp;30, 2022 and 2023, respectively. As of September&nbsp;30, 2023, the Company recorded $1.5&nbsp;million in accounts receivable on the condensed
consolidated balance sheet, related to services performed. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, deferred revenue related to the Moderna Agreement was $30.2&nbsp;million and $17.2&nbsp;million, respectively. Collaboration revenue
recognized during the nine months ended September&nbsp;30, 2022 and 2023 included $10.7&nbsp;million and $14.2&nbsp;million that was included in deferred revenue as of December&nbsp;31, 2021 and 2022, respectively. The value of the transaction price
allocated to the remaining unsatisfied portion of the performance obligations was approximately $27.8&nbsp;million as of September&nbsp;30, 2023, which the Company expects to recognize as revenue over the next <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">two-to-three</FONT></FONT> years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company recognized $0.5&nbsp;million and $2.7&nbsp;million in credits to research and development expenses related
to cost sharing allocation and amortization of the collaboration advance, respectively, within research and development expenses in the condensed consolidated statement of operations and comprehensive loss during the nine months ended
September&nbsp;30, 2022. The Company recognized $0.3&nbsp;million and $0.5&nbsp;million in credits to research and development expenses related to cost sharing allocation and amortization of the collaboration advance during the nine months ended
September&nbsp;30, 2023, respectively. As of December&nbsp;31, 2022, the collaboration advance balance was $1.1&nbsp;million, partially offset by the cost-sharing receivable balance of $0.4&nbsp;million, which was presented as a collaboration
advance on the Company&#146;s condensed consolidated balance sheet. As of September&nbsp;30, 2023, the collaboration advance balance was $0.7&nbsp;million, partially offset by the cost-sharing receivable balance of $0.2&nbsp;million, which was
presented as a collaboration advance on the Company&#146;s condensed consolidated balance sheet. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I><FONT STYLE="white-space:nowrap">Affini-T</FONT>
development, option and license agreement </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Terms of the agreement </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On June&nbsp;14, 2022, the effective date, the Company entered into a Development, Option and License Agreement (the
<FONT STYLE="white-space:nowrap">&#147;Affini-T</FONT> Agreement&#148;) with <FONT STYLE="white-space:nowrap">Affini-T.</FONT> Pursuant to the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement, the parties have agreed to identify, develop
or optimize certain reagents using the Company&#146;s proprietary technology for <FONT STYLE="white-space:nowrap">Affini-T</FONT> to use such reagents to develop and commercialize gene edited <FONT STYLE="white-space:nowrap">T-cell</FONT> receptor
(&#147;TCR&#148;)-based therapeutic products exclusively in the field of treatment, prevention or diagnosis of any human cancer using products with any engineered primary TCR alpha/beta T cells and
<FONT STYLE="white-space:nowrap">non-exclusively</FONT> in the field of treatment, prevention or diagnosis of any human cancer using products with certain other engineered immune cells worldwide. A joint steering committee was established by both
parties to assign alliance managers and project leaders to oversee the collaboration activities. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the <FONT STYLE="white-space:nowrap">Affini-T</FONT>
Agreement, the Company granted <FONT STYLE="white-space:nowrap">Affini-T</FONT> options to receive, on a <FONT STYLE="white-space:nowrap">pre-specified</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">target-by-pre-specified</FONT></FONT></FONT> target basis, for up to six <FONT STYLE="white-space:nowrap">pre-specified</FONT> targets, either (i)&nbsp;an exclusive, royalty-bearing, sublicensable worldwide license under
all of the Company&#146;s applicable intellectual property to research, develop, manufacture, use, commercialize and otherwise exploit any <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapy, preventative treatment, or diagnostic for humans
that is directed to such <FONT STYLE="white-space:nowrap">pre-specified</FONT> target, contains or comprises Primary TCR alpha/beta T Cells and is derived from ex vivo application of a Company reagent (the &#147;Exclusive Option&#148;) or
(ii)&nbsp;a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-bearing, sublicensable worldwide license under all of the Company&#146;s applicable intellectual property to research, develop, manufacture, use commercialize and otherwise
exploit any <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapy, preventative treatment, or diagnostic for humans that is directed to such <FONT STYLE="white-space:nowrap">pre-specified</FONT> target, contains or comprises TCR natural killer
(&#147;NK&#148;) cells derived from iPSC immune cells or TCR T cells derived from donor-derived or iPSC immune cells. <FONT STYLE="white-space:nowrap">Affini-T</FONT> can exercise its options for either an exclusive license or a <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> license, or both, for each <FONT STYLE="white-space:nowrap">pre-specified</FONT> target by providing written notice prior to the earlier of (x)&nbsp;the end of the
<FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement term or (y) 90 days following the filing of an IND for a licensed product directed to a <FONT STYLE="white-space:nowrap">pre-specified</FONT> target, subject to the payment of certain fees
per each option exercised. After the option exercise, <FONT STYLE="white-space:nowrap">Affini-T</FONT> has agreed to use commercially reasonable efforts to conduct all development and commercialization activities for a licensed product, and
development and commercialization of all licensed products will be at <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> sole cost and expense. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection
with the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement, the Company received upfront equity consideration of 719,920 shares of <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> common stock with an estimated fair value of
$1.3&nbsp;million in June 2022. The fair value of <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> shares of common stock was estimated by management, considering the most recent third-party </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
valuation. <FONT STYLE="white-space:nowrap">Affini-T</FONT> has also agreed to reimburse the Company for expenses incurred while performing research activities under the research plans. As of
September&nbsp;30, 2023, the Company received a total of $3.2&nbsp;million from <FONT STYLE="white-space:nowrap">Affini-T</FONT> related to reimbursable expenses. Additionally, the Company is eligible to receive (i) 933,650 shares of <FONT
STYLE="white-space:nowrap">Affini-T&#146;s</FONT> common stock upon the achievement of a regulatory milestone, which is the earlier of a submission of a drug master file to the FDA or an acceptance of an IND filing for a licensed product by the FDA,
(ii)&nbsp;up to $18.8&nbsp;million in future developmental milestone payments depending on the completion of or the number of patients dosed in, the relevant human clinical trial, or the initiation of a pivotal trial, and $40.6&nbsp;million in
future regulatory approval milestone payments, which include regulatory approvals in the U.S. and other markets for licensed products directed to a <FONT STYLE="white-space:nowrap">pre-specified</FONT> target if options for both exclusive and <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> licenses are exercised with respect to such target, (iii)&nbsp;up to $250.0&nbsp;million in sales-based milestones for aggregate sales of all licensed products directed to a given <FONT
STYLE="white-space:nowrap">pre-specified</FONT> target and (iv)&nbsp;royalties ranging from a <FONT STYLE="white-space:nowrap">low-single</FONT> digit to high-single digit percentage of worldwide annual net sales of licensed products.</P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The initial term of the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement is five years from the effective date. If
<FONT STYLE="white-space:nowrap">Affini-T</FONT> exercises an Exclusive Option with respect to any <FONT STYLE="white-space:nowrap">pre-specified</FONT> target during the initial term, the initial term will be extended by an additional five years.
Following the expiration of the extended term, if any, the agreement will continue on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">target-by-target</FONT></FONT> basis and expire with respect to such target upon the expiration
of the royalty term for all licensed products directed to such target. The <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement may be terminated during the term by either party for an uncured material breach by, or bankruptcy of, the other
party. Additionally, <FONT STYLE="white-space:nowrap">Affini-T</FONT> may terminate the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement for convenience, in its entirety, on a research <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">plan-by-research</FONT></FONT> plan basis, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">target-by-target</FONT></FONT> basis or on a licensed <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product basis, by providing prior written notice. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Accounting analysis and revenue recognition
</I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded that the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement is in the scope of ASC 606 and that there is one performance
obligation to perform research activities under the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement. Exclusive and <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses are optional contingent purchases that do not include
significant incremental discounts, and therefore do not provide a material right. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">At the effective date, the transaction price consisted of the upfront equity
consideration with an estimated fair value of $1.3&nbsp;million and estimated research reimbursement costs. Research reimbursement costs represent variable consideration, and the Company&#146;s management estimates what portion to include in total
consideration at the end of each reporting period. Other payments under the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement, including additional equity consideration and development and regulatory milestones, also represent variable
consideration, and are constrained to the extent that the inclusion of such variable consideration could result in a significant reversal of cumulative revenue in future periods. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, additional
equity consideration and future development and regulatory milestone payments were excluded from the estimated total transaction price as they were considered constrained. The transaction price is reevaluated in each reporting period and as changes
in circumstances occur. The Company recognizes revenue each reporting period based on the measure of progress using an estimated cost-based input method. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The
Company recognized $0.9&nbsp;million and $3.7&nbsp;million in collaboration revenue in the condensed consolidated statements of operations and comprehensive loss during the nine months ended September&nbsp;30, 2022 and 2023, respectively. As of
December&nbsp;31, 2022, the Company recorded $1.3&nbsp;million in contract assets on the condensed consolidated balance sheet, related to services performed but not invoiced. There was no contract asset related to services performed as of
September&nbsp;30, 2023. As of September&nbsp;30, 2023, the Company recorded $2.4&nbsp;million in accounts receivable on the condensed consolidated balance sheet, related to services performed. As of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
December&nbsp;31, 2022 and September&nbsp;30, 2023, deferred revenue related to the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement was zero and $0.6&nbsp;million, respectively. In
June 2023, the joint steering committee approved the budget for estimated research reimbursement costs for the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement, which resulted in a $2.4&nbsp;million reduction to variable consideration. The
value of the transaction price allocated to the remaining unsatisfied portion of the performance obligation was approximately $2.1&nbsp;million as of September&nbsp;30, 2023, which the Company expects to recognize as revenue over the next <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">four-to-five</FONT></FONT> years. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Ionis collaboration and license agreement </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Terms of the agreement </I></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On November&nbsp;10, 2022, the effective date, the
Company entered into a Collaboration and License Agreement (the &#147;Ionis Agreement&#148;) with Ionis Pharmaceuticals, Inc. (&#147;Ionis&#148;) to collaborate on drug discovery and exploratory research activities to advance new medicines using
gene editing strategies, with the goal of discovering novel medicines. Pursuant to the terms of the Ionis Agreement, the Company granted Ionis and its affiliates a worldwide exclusive, royalty-bearing license, with the right to grant sublicenses, to
use all licensed systems and licensed products in the field of in vivo gene editing for all therapeutic, prophylactic, palliative, and analgesic uses in humans. In connection with the Ionis Agreement, the Company also has the right to exercise an
exclusive option to <FONT STYLE="white-space:nowrap">co-develop</FONT> and <FONT STYLE="white-space:nowrap">co-commercialize</FONT> certain products under a drug discovery program. A joint steering committee was established by both parties to
coordinate, oversee and monitor the research and drug discovery activities under the Ionis Agreement. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The parties will collaborate to discover therapeutic products
under a drug discovery program and develop a drug discovery plan for each target, selected by Ionis. The target selection is divided into two waves: up to four targets in Wave 1 and up to four targets in Wave 2. For each drug discovery program, once
the parties identify a development candidate that is suitable for further development, Ionis will be responsible for the development and commercialization of products resulting from such program. Per the terms of the Ionis Agreement, at any time
prior to the designation of a development candidate for a drug discovery program and for any reason, Ionis may replace the collaboration target, provided such target has not previously been substituted out. Ionis may substitute (i)&nbsp;up to two
Wave 1 targets and (ii)&nbsp;up to two Wave 2 targets. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The drug discovery activities for a program commence on the selection of a target and expire upon the earlier
of (a)&nbsp;completion of all drug discovery activities for such program, (b)&nbsp;the fifth anniversary of the effective date and (c)&nbsp;selection of a development candidate for such drug discovery program. If one or more Wave 2 targets become
collaboration targets as a result of the parties achieving enabled delivery and less than two years are remaining in the drug discovery term, then the term will be extended to the earlier of (i)&nbsp;the time that the Company completes all of its
activities under the applicable drug discovery plan and (ii)&nbsp;the seventh anniversary of the effective date, subject to the Company&#146;s consent. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The parties
will also conduct an exploratory research program, and will jointly optimize gRNA and select delivery technologies and other activities. The exploratory research activities commence on the effective date and expire upon the earlier of
(a)&nbsp;completion of all exploratory research activities established in the exploratory research plan, and (b)&nbsp;the fifth anniversary of the effective date. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has the exclusive option to <FONT STYLE="white-space:nowrap">co-develop</FONT> and <FONT STYLE="white-space:nowrap">co-commercialize</FONT> the licensed
products under a drug discovery program (the <FONT STYLE="white-space:nowrap">&#147;Co-Co</FONT> Option&#148;) with Ionis. The <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option may be exercised for (a)&nbsp;the initial Wave 1 target (&#147;Target
1&#148;), (b) no more than one of the other three discovery programs for the Wave 1 targets, and (c)&nbsp;no more than two drug discovery programs for the Wave 2 targets that become collaboration targets. If the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Company exercises the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option for a particular drug discovery program, that drug discovery program will automatically be deemed a <FONT
STYLE="white-space:nowrap">&#147;Co-Co</FONT> Program&#148;, all corresponding licensed products be deemed <FONT STYLE="white-space:nowrap">&#147;Co-Co</FONT> Products,&#148; the Company will be obligated to pay Ionis an option exercise fee, and the
parties will enter into a separate <FONT STYLE="white-space:nowrap">co-development</FONT> and co-commercialization agreement. The <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option exercise fee will equal 50% of Ionis&#146; internal costs and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred in the conduct of the drug discovery activities prior to the exercise of the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Option and be reduced
by 50% of the Company&#146;s corresponding costs incurred. Future development and commercialization costs will be shared equally. The Company may elect to reduce its cost-share percentage anywhere between 50% and 25% on a <FONT
STYLE="white-space:nowrap">go-forward</FONT> basis, provided the Company will continue to bear 50% of the costs of any clinical trials ongoing at the time of the election through the completion of the clinical trials. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company will manufacture all licensed systems and certain components of the applicable licensed products that are needed by Ionis for use in its development
activities and all of the Company&#146;s manufactured components needed by Ionis for use in its commercialization activities. The Company will provide the manufactured components at a price that represents the cost of goods plus 15%. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the terms of the Ionis Agreement, the Company has also been granted an option to obtain a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT>
royalty-bearing license, with the right to grant sublicenses, for certain Ionis&#146; background technology to use in up to eight therapeutic products discovered by the Company in the field of in vivo gene editing and directed to a Collaboration
Target (each such product, a &#147;Metagenomi Product&#148; and each such option an &#147;Ionis IP Option&#148;), but subject to encumbrance checks with respect to particular targets. A Collaboration Target is a target that is selected by Ionis,
and, with respect to the Company is not the subject of discussions with a third party, is not the subject of a contractual grant of rights to a third party nor the subject to an internal research and development program. If the Company exercises its
Ionis IP Option, the Company will pay to Ionis up to several million dollars per Metagenomi Product upon achievement of certain clinical and regulatory milestones. The Company is also obligated to pay Ionis royalties in an amount equal to a low
single-digit royalty on the net sales of the applicable Metagenomi Product on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In November 2022, the Company received an
$80.0&nbsp;million upfront payment from Ionis for the Wave 1 drug discovery research collaboration and selected Target 1. Ionis selected its second target (&#147;Target 2&#148;) in Wave 1 in December 2022 and its third target (&#147;Target 3&#148;)
in Wave 1 in November 2023. In November 2023, the Company agreed to extend the period during which the Company expects Ionis will select its fourth target (&#147;Target 4&#148;) in Wave 1 by an additional three months from the <FONT
STYLE="white-space:nowrap">12-month</FONT> anniversary of the effective date, as permitted under the arrangement. Ionis has an option to select up to four Wave 2 targets at any time during the drug discovery term, if (a)&nbsp;an IND for any licensed
product directed to a Wave 1 target is filed with the applicable regulatory authority or (b)&nbsp;the parties achieve enabled delivery for a <FONT STYLE="white-space:nowrap">non-liver</FONT> target under the exploratory research activities, by
providing written notice and by paying a Wave 2 target selection fee of $15.0&nbsp;million or $30.0&nbsp;million, depending on and per the selected target. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Ionis is
obligated to reimburse the Company for all internal costs and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred in the performance of the exploratory research activities, up to an aggregate
of $10.0&nbsp;million, which is payable in quarterly installments of $0.5&nbsp;million during the exploratory research term. As of September&nbsp;30, 2023, the Company received a total of $1.5&nbsp;million related to the reimbursable expenses. The
Company is also eligible to receive (a)&nbsp;up to $29.0&nbsp;million in future development milestone payments for each licensed product; (b)&nbsp;up to $60.0&nbsp;million in future regulatory milestone payments for each licensed product;
(c)&nbsp;up to $250.0&nbsp;million in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
sales-based milestones for each licensed product. and (d)&nbsp;royalties on annual net sales of licensed products from a <FONT STYLE="white-space:nowrap">mid-single-digit</FONT> to <FONT
STYLE="white-space:nowrap">low-teens</FONT> percentage, subject to customary reductions.</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The term of the Ionis Agreement will continue (i)&nbsp;with respect to the
drug discovery programs, until the expiration of all applicable royalty terms for a licensed product, (ii)&nbsp;with respect to the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Programs, until the parties cease all exploitation for the <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products that are the subject to such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, and (iii)&nbsp;with respect to the Metagenomi Products, until the expiration of the royalty term for a Metagenomi
Product. The royalty term ends on the latest of the following two dates: (i)&nbsp;the expiration of (A)&nbsp;the last claim of any issued and unexpired patent, or (B)&nbsp;a claim within a patent application that has not been pending for more than
seven years from the earliest date to which the claim or applicable patent application is entitled to claim priority and which claim has not been revoked, cancelled, withdrawn, held invalid, or abandoned, or (ii) 12 years following the first
commercial sale of a licensed product. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Ionis Agreement may be terminated during the term by either party for an uncured material breach or bankruptcy by the
other party. Additionally, Ionis may terminate the Ionis Agreement for convenience and without penalty, in its entirety or on a licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product
basis, by providing 90 days&#146; written notice. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Accounting analysis and revenue recognition </I></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company concluded that the Ionis Agreement is in the scope of ASC 606 at the effective date and until the Company exercises its
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Option for any drug discovery program, which was determined to not be probable at the effective date and as of December&nbsp;31, 2022 and September&nbsp;30, 2023. The Company also concluded that
exclusive licenses and participation in a joint steering committee are not distinct from discovery research services and should thus be combined into one performance obligation (the &#147;discovery program&#148;). The Company also concluded that
exploratory research services are a separate and distinct performance obligation (the &#147;exploratory program&#148;). As the Ionis options for Wave 2 targets are optional purchases and do not have significant incremental discounts, as such, the
options do not provide material rights. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company allocated the total estimated transaction price of $90.0&nbsp;million, which consisted of an $80.0&nbsp;million
upfront payment received in November 2022 and a $10.0&nbsp;million reimbursement for research costs, into two performance obligations, and was determined based on their estimated standalone selling prices. The Company concluded that future
development and commercial supply agreements are at market terms, as the terms were consistent with industry standards as of the effective date. The Company constrains future milestone payments under the arrangement to the extent that the inclusion
of such variable consideration could result in a significant reversal of cumulative revenue in future periods. The Company constrained all development and regulatory milestone payments at the effective date and as of December&nbsp;31, 2022 and
September&nbsp;30, 2023. The Company is recognizing revenue of $80.0&nbsp;million related to the discovery program and of $10.0&nbsp;million related to exploratory program over the research terms using an estimated cost-based input method as a
measure of progress for each obligation. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company recognized $14.4&nbsp;million in collaboration revenue in the condensed consolidated statements of operations
and comprehensive loss during the nine months ended September&nbsp;30, 2023, which was included in deferred revenue as of December&nbsp;31, 2022. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, deferred revenue related to the Ionis
Agreement was $79.9&nbsp;million and $67.0&nbsp;million, respectively. The value of the transaction price allocated to the remaining performance obligations was approximately $75.5&nbsp;million as of September&nbsp;30, 2023, which the Company
expects to recognize as revenue over the next <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">four-to-five</FONT></FONT> years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>8. Commitments and contingencies </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Operating leases </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In January 2021, the Company entered into a <FONT
STYLE="white-space:nowrap">ten-year</FONT> operating lease for laboratory and office space in Emeryville, California. The lease commencement date was in February 2021. In conjunction with signing this lease, the Company secured a letter of credit
for $3.3&nbsp;million, which is recorded as noncurrent restricted cash in the condensed consolidated balance sheets. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, the balance of this letter of credit was $3.3&nbsp;million and
$2.5&nbsp;million, respectively. The lease agreement includes a renewal provision allowing the Company to extend this lease for an additional five years, which the Company is not reasonably certain to exercise. In addition to base rent, the Company
pays variable costs related to its share of operating expenses and taxes, which are recognized as incurred. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In September 2021, the Company entered into a <FONT
STYLE="white-space:nowrap">9.25-year</FONT> operating lease for office space in Emeryville, California, with a lease commencement date in November 2021. In conjunction with signing the lease, the Company secured a letter of credit for
$0.8&nbsp;million, which is recorded as noncurrent restricted cash in the condensed consolidated balance sheets as of December&nbsp;31, 2022 and September&nbsp;30, 2023. In addition to base rent, the Company pays variable costs related to its share
of operating expenses and taxes, which are recognized as incurred. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In November 2022, the Company entered into an <FONT STYLE="white-space:nowrap">8.25-year</FONT>
sublease for office, research and laboratory space in Emeryville, California, with a lease commencement date in January 2023. In conjunction with signing the lease, the Company secured a letter of credit for $2.0&nbsp;million, which is recorded as
noncurrent restricted cash in the condensed consolidated balance sheet as of December&nbsp;31, 2022 and September&nbsp;30, 2023. Monthly base rent under the lease is approximately $0.5&nbsp;million and is subject to annual escalation. During the
initial 18 months from the lease commencement date, 50% of the monthly base rent is abated. In addition to base rent, the Company pays variable costs related to its share of operating expenses and taxes, which are recognized as incurred. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Operating lease costs for the nine months ended September&nbsp;30, 2022 and 2023 totaled $4.1&nbsp;million and $8.5&nbsp;million, respectively, including
$0.4&nbsp;million and $2.1&nbsp;million of variable lease cost, respectively. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Supplemental information related to the Company&#146;s operating leases is as follows
(in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;months&nbsp;ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash paid for amounts included in the measurement of lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,663</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average remaining lease term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted-average discount rate</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">10.1%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">11.3%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table summarizes a maturity analysis of the Company&#146;s operating lease liabilities showing the
aggregate lease payments as of September&nbsp;30, 2023 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:2.00pt solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2023 (remaining)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000" ALIGN="right">1,617</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2027</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,283</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total future lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,067</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total lease liability balance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: current operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,269</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><FONT STYLE="white-space:nowrap">Non-current</FONT> operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Legal contingencies </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">From time to
time, the Company may become involved in legal proceedings arising from the ordinary course of business. The Company records a liability for such matters when it is probable that future losses will be incurred and that such losses can be reasonably
estimated. Significant judgment by the Company is required to determine both probability and the estimated amount. Management is currently not aware of any legal matters that could have a material adverse effect on the Company&#146;s financial
position, results of operations or cash flows. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Guarantees and indemnifications </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the normal course of business, the Company enters into agreements that contain a variety of representations and provide for general indemnification. Its exposure
under these agreements is unknown because it involves claims that may be made against the Company in the future. To the extent permitted under Delaware law, the Company has agreed to indemnify its directors and officers for certain events or
occurrences while the director or officer is, or was serving, at a request in such capacity. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. As of December&nbsp;31, 2022
and September&nbsp;30, 2023, the Company did not have any material indemnification claims that were probable or reasonably possible and consequently has not recorded related liabilities. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>9. Redeemable convertible preferred units </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On January&nbsp;21, 2022, the
Company closed the Series B financing and issued 12,446,876 shares of the Series B redeemable convertible preferred units for gross cash proceeds of $145.0&nbsp;million. The Company incurred $0.7&nbsp;million in issuance costs. Concurrently with the
closing of the Series B financing, the outstanding Moderna convertible promissory note and accrued interest of $30.4&nbsp;million was converted into 2,607,387 Series B Preferred Units, at a conversion price equal to the price per unit paid by the
Series B investors. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">On December&nbsp;20, 2022, the Company entered into Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred unit
purchase agreement to sell up to 7,108,480 Series B redeemable convertible preferred units at the purchase price of $14.06770. In December 2022, the Company sold and issued 6,773,726 shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT>
redeemable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
convertible preferred units for gross cash proceeds of $95.3&nbsp;million in the initial closing. The Company incurred $0.4&nbsp;million issuance costs. Additional shares may be sold within 90
days of the initial closing. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In January 2023, the Company sold an additional 334,754 Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible
preferred units in accordance with the Series <FONT STYLE="white-space:nowrap">B-1</FONT> purchase agreement and received gross cash proceeds of $4.7&nbsp;million. The Company incurred $0.1&nbsp;million in issuance costs. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022, the Company operated under the Amended and Restated Limited Liability Company Agreement dated December&nbsp;20, 2022 (the &#147;LLC
Agreement&#148;). As of September&nbsp;30, 2023, the Company operated under the LLC Agreement, as amended on July&nbsp;31, 2023 (see Note 11 for details around the amendment). The LLC Agreement provides for eight classes of units: common units,
Series <FONT STYLE="white-space:nowrap">A-1</FONT> redeemable convertible preferred units (Series <FONT STYLE="white-space:nowrap">A-1),</FONT> Series <FONT STYLE="white-space:nowrap">A-2</FONT> redeemable convertible preferred units (Series <FONT
STYLE="white-space:nowrap">A-2),</FONT> Series <FONT STYLE="white-space:nowrap">A-3</FONT> redeemable convertible preferred units (Series <FONT STYLE="white-space:nowrap">A-3),</FONT> Series <FONT STYLE="white-space:nowrap">A-4</FONT> redeemable
convertible preferred units (Series <FONT STYLE="white-space:nowrap">A-4),</FONT> Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units (Series <FONT STYLE="white-space:nowrap">A-5),</FONT> Series B redeemable
convertible preferred units (Series B) and Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred units (Series <FONT STYLE="white-space:nowrap">B-1).</FONT> </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The redeemable convertible preferred units as of December&nbsp;31, 2022, consisted of the following (in thousands, except unit data): </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units<BR>authorized</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units issued<BR>and<BR>outstanding</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Aggregate<BR>liquidation<BR>preference</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Net<BR>carrying<BR>value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,501,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,501,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-2</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-3</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,513,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,513,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-4</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,280,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,280,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-5</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,054,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,054,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,678</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">B-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,108,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,773,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,813,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,478,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">347,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">346,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The redeemable convertible preferred units as of September&nbsp;30, 2023, consisted of the following (in thousands, except unit data):
</P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units<BR>authorized</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units issued<BR>and<BR>outstanding</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Aggregate<BR>liquidation<BR>preference</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Net<BR>carrying<BR>value</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,501,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,501,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-2</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">774,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-3</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,513,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,513,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-4</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,280,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,280,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">A-5</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,580,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,054,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,054,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,678</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series <FONT STYLE="white-space:nowrap">B-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,108,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,108,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,813,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,813,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">352,044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">350,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The holders of the redeemable convertible preferred units have various rights and preference as follows: </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Voting rights </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each redeemable convertible preferred unit is entitled
to one vote for each common unit into which such redeemable convertible preferred unit is then convertible. The redeemable convertible preferred unitholders and the common unitholders vote together on all matters as a single class, except as
otherwise provided by law or the provisions of the LLC Agreement. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Board of Managers consists of up to seven individuals. As long as at least 618,716 Series <FONT
STYLE="white-space:nowrap">A-1</FONT> redeemable convertible preferred units, Series <FONT STYLE="white-space:nowrap">A-2</FONT> redeemable convertible preferred units and/or Series <FONT STYLE="white-space:nowrap">A-3</FONT> redeemable convertible
preferred units remain outstanding, the members holding a majority of the outstanding Series <FONT STYLE="white-space:nowrap">A-1</FONT> redeemable convertible preferred units, Series <FONT STYLE="white-space:nowrap">A-2</FONT> redeemable
convertible preferred units and Series <FONT STYLE="white-space:nowrap">A-3</FONT> redeemable convertible preferred units, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, are entitled to elect one
manager. As long as at least 1,654,555 Series <FONT STYLE="white-space:nowrap">A-4</FONT> redeemable convertible preferred units remain outstanding, the members holding a majority of the Series <FONT STYLE="white-space:nowrap">A-4</FONT> redeemable
convertible preferred units, voting as a single class, are entitled to elect one manager. As long as at least 316,187 Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units remain outstanding, the members holding a
majority of the Series <FONT STYLE="white-space:nowrap">A-5</FONT> redeemable convertible preferred units, voting as a single class, are entitled to elect one manager. As long as at least 3,010,852 Series B redeemable convertible preferred units
remain outstanding, the members holding a majority of the Series B redeemable convertible preferred units, voting as a single class, are entitled to elect one manager. The members holding a majority of the common units, voting as a single class are
entitled to elect one manager. The members holding a majority of the units then outstanding, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to common units basis are entitled to elect any remaining
managers. As of each December&nbsp;31, 2022 and September&nbsp;30, 2023 the Company&#146;s Board of Managers consisted of six individuals. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Conversion
</I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each redeemable convertible preferred unit is convertible into common units at the option of a holder at the then applicable conversion price, which is
equal the original purchase price, subject to adjustments for recapitalization and others. The original purchase price is equal to $3.2325 per Series <FONT STYLE="white-space:nowrap">A-1</FONT> Preferred Unit, $0.6456 per Series <FONT
STYLE="white-space:nowrap">A-2</FONT> Preferred Unit, $1.1713 per Series <FONT STYLE="white-space:nowrap">A-3</FONT> Preferred Unit, $4.84875 per Series <FONT STYLE="white-space:nowrap">A-4</FONT> Preferred Unit, $6.32536 per Series <FONT
STYLE="white-space:nowrap">A-5</FONT> Preferred Unit, $11.64951 per Series B Preferred Unit, and $14.06770 per Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Unit. As of December&nbsp;31, 2022 and September&nbsp;30, 2023, the
redeemable convertible preferred units were convertible into common units at a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> conversion ratio. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Each redeemable convertible preferred unit is automatically convertible into common units (or shares of common stock, if the Company is converted into a corporation),
based on the then-effective applicable conversion rate (A)&nbsp;at any time upon the affirmative vote or written consent of (i)&nbsp;the members holding a majority of the redeemable convertible preferred units then outstanding, (ii)&nbsp;the members
holding a majority of the Series B redeemable convertible preferred units then outstanding, and (iii)&nbsp;the members holding a majority of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> redeemable convertible preferred units then
outstanding, or (B)&nbsp;immediately upon the closing of a firmly underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale of common units (or other common
securities) with the gross cash proceeds to the Company, before underwriting discounts, commissions and offering expenses, are at least $100.0&nbsp;million, or (C)&nbsp;the closing of a merger, acquisition or other business combination involving the
Company and a publicly traded special purpose acquisition company (&#147;SPAC&#148;) or its subsidiary or affiliate in which the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
surviving public company has available immediately cash of at least $100.0&nbsp;million in the aggregate greater than the cash on the Company&#146;s condensed consolidated balance sheets as of
immediately prior to such merger, acquisition or other business combination (including proceeds of a private investment in public equity transaction that is substantially contemporaneous with or conditioned on such merger, acquisition or other
business combination, and any redemptions from the SPAC&#146;s trust account). </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Anti-dilution and other protective provisions </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The holders of the redeemable convertible preferred units have proportional anti-dilution protection right for unit splits, unit dividends and similar recapitalizations,
subject to certain exclusions, anti-dilution price protection for additional sales of securities by the Company for consideration per unit less than the applicable conversion price per unit of any series of the redeemable convertible preferred
units, on a broad-based weighted average basis. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The holders of the redeemable convertible preferred units have certain protective rights. The Company shall not,
either directly or by amendment, merger, consolidation or otherwise, without the prior written approval of members holding a majority of the redeemable convertible preferred units then outstanding to alter or change the rights, preferences or
privileges of the redeemable convertible preferred units; consummate a liquidation or a deemed liquidation event; change the Company&#146;s LLC Agreement; authorize or create any new class or series of units or other equity security; increase or
decrease the authorized number of the common units or the redeemable convertible preferred units or any series; redeem, acquire or repurchase any, or make any distribution on, any common units or redeemable convertible preferred units; change the
compensation or equity awards granted to executive officers of the Company, unless such transaction is approved by the Board of Managers; increase or decrease the authorized number of managers constituting the Board of Managers and amend other
rights or enter into certain transactions. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Liquidation preference </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the event of a liquidation, a deemed liquidation event (including a consolidation, merger or reorganization or a sale, lease, transfer, exclusive irrevocable license
or other disposition of all or substantially all of the assets of the Company), dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of the Company, the funds are distributed first to the members holding the redeemable convertible
preferred units in proportion to and to the extent of their unreturned original purchase price per redeemable convertible preferred unit, until each member holding the redeemable convertible preferred units has received cumulative distributions in
an amount equal to the unreturned original purchase price for each of such member&#146;s redeemable convertible preferred unit. Second, to the members holding common units and the redeemable convertible preferred units pro rata based on the number
of units held by each such holder, assuming for this purpose that all the redeemable convertible preferred units have been converted into common units as of the date of such operating distribution or distribution of net proceeds or assets available
for distribution, whether in cash or in other property. Third, the amounts that would otherwise be distributed to any redeemable convertible preferred unit holder pursuant to the liquidation preference on
<FONT STYLE="white-space:nowrap">as-converted</FONT> to common units basis will be reduced by an amount equal to the remaining preferred participation threshold amount for such redeemable convertible preferred unit. The preferred participation
threshold amount for a redeemable convertible preferred unit is equal to the original purchase price, reduced by distributions paid. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Distributions preference </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Distributions, when determined by the Board of Managers, are payable to the members holding the redeemable convertible preferred units, pro rata in proportion to the
liquidation preference amounts in respect of the redeemable convertible preferred units held by such members; thereafter, to the members in proportion to the number of shares held by such members, on as converted basis. No distributions were
declared or made from inception and during the nine months ended September&nbsp;30, 2022 and 2023. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Redemption </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The redeemable convertible preferred units are not redeemable except in the event of certain effected deemed liquidation events, that are not in the Company&#146;s
control. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>10. Common units </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022 and
September&nbsp;30, 2023, the Company was authorized to issue 66,000,000 common units. Each common unit is entitled to cast one vote. The holders of common units are also entitled to receive distributions whenever funds are legally available and when
declared by the Company&#146;s Board of Managers, subject to prior rights of the holders of the redeemable convertible preferred units. No distributions have been declared from inception to date. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As of December&nbsp;31, 2022 and September&nbsp;30, 2023, the Company reserved common units for future issuance as follows: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Outstanding redeemable convertible preferred units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,478,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,813,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Outstanding profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,516,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,556,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Units available for grants under 2019 Equity Incentive Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,088,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,047,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total common units reserved for future issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,082,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,417,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Founders and investors common units </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In June&nbsp;2017, Metagenomi Inc. issued 4,687,500 shares of its common stock at a purchase price of $0.0001 per share to its founders and investors for services, which
was an estimated fair value determined by the Board of Managers at the issuance date. Pursuant to the terms of the stock purchase agreements, 25% of the shares vested on the first anniversary of the vesting start date and monthly over the next
36&nbsp;months. Vesting of shares is accelerated upon a change of control event (including an acquisition of the Company by another entity by means of any transaction or series of related transactions, or a sale of all or substantially all of the
assets of the Company). The Company has a right to repurchase unvested shares upon termination of services provided by the founders to the Company at the price lower of i) the purchase price or ii) the fair value at the date of repurchase. In
November 2018, in connection with the reorganization, common stock issued by Metagenomi Inc. was exchanged for common units of Metagenomi with the same terms. The estimated fair value of common unit at the modification date was determined to be
$0.02 per unit, based on the Company&#146;s recent common unit valuation, and the modification expense was immaterial. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In March 2019, the Company issued 1,260,000
common units to an investor for services with a purchase price of $0.02 per unit, which was based on the recent Company&#146;s common stock valuation. As long as the investor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
continues to provide services, 25% of the shares vested immediately and the remainder vested monthly over the next 36&nbsp;months. Vesting of shares is accelerated upon a change of control event.
The Company has a right to repurchase unvested shares upon termination of services provided by the founders to the Company at the price lower of i) the purchase price or ii) the fair value at the date of repurchase. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company accounts for issued common units as unit-based&nbsp;compensation to founders and investors as service providers and recognizes unit-based&nbsp;compensation
expense of $0.1&nbsp;million over the vesting period. The Company had 78,750 common units vested during the nine months ended September&nbsp;30, 2022, having a fair value of less than $0.1&nbsp;million. There were no common units unvested as of
December&nbsp;31, 2022 and September&nbsp;30, 2023. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>11. Profits interests plan </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company grants profits interests under the 2019 Equity Incentive Plan, adopted on March&nbsp;13, 2019 (the &#147;2019 Plan&#148;). The Company may grant profits
interests with a threshold amount, which may be zero, established by the Board of Managers on the date of issuance. Accordingly, such profits interests do not give a holder a share of the proceeds if the Company&#146;s assets were sold at fair
market value and the proceeds of such disposition were distributed in complete liquidation of the Company immediately after the date of grant but give a holder a right to share in the appreciation in the value of a common unit from the date of
receipt to the future, as specifically provided in the LLC Agreement. The 2019 Plan allows for grants of profits interests to the Company&#146;s officers, employees, directors and consultants. Profits interests generally vest monthly over four
years, with or without <FONT STYLE="white-space:nowrap">one-</FONT> year cliff vesting in the first year. In the event of a profits interest holder&#146;s termination, the unvested portion of such profits interest is automatically forfeited and
cancelled without any additional consideration. Additionally, the Company has the right to repurchase the vested portion of such profits interest at its fair market value, which is based on the fair market value of a common unit (as determined by
the Board of Managers), less the applicable profits interest threshold amount, at any time during the <FONT STYLE="white-space:nowrap">12-month</FONT> period after termination of a profits interest holder&#146;s service to the Company. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company&#146;s LLC Agreement was amended on July&nbsp;31, 2023 to provide for <FONT STYLE="white-space:nowrap">&#147;catch-up&#148;</FONT> distributions for profits
interests once the applicable <FONT STYLE="white-space:nowrap">catch-up</FONT> threshold amount for such profits interests was met (the &#147;Amendment to the LLC Agreement&#148;). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The LLC Agreement provides each profits interest with a distribution threshold amount, which is determined on the date of issuance and represents the amount that would
be distributed if, immediately after issuance, the Company sold all of its assets at fair market value and distributed the net proceeds in liquidation. A profits interest does not participate in Company distributions until an amount equal to its
distribution threshold amount has been distributed to other members of the Company with units that either have a lower threshold amount or no threshold amount. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In
accordance with the Amendment to the LLC Agreement, once the applicable distribution threshold amount has been met for a particular profits interest, such profits interest will participate in Company distributions on a pro rata basis until the <FONT
STYLE="white-space:nowrap">catch-up</FONT> threshold amount has been met. Once the <FONT STYLE="white-space:nowrap">catch-up</FONT> threshold amount has been met, subsequent <FONT STYLE="white-space:nowrap">&#147;catch-up&#148;</FONT> distributions
will be made solely to holders of profits interests until such holders have received an amount equal to the amount such holders would have received had the distribution threshold not existed. Once the profits interest holders have received
distributions in an amount equal to what they would have received had the distribution threshold not existed, all subsequent distributions are made on a pro rata basis with common unitholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As a result of the amendment, the Board approved an $11.84 <FONT STYLE="white-space:nowrap">catch-up</FONT> threshold
amount, which was based on the estimated fair value of the Company&#146;s common unit as of July&nbsp;31, 2023. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Refer below for discussion around the accounting
treatment and financial statement impact of the <FONT STYLE="white-space:nowrap">catch-up.</FONT> </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The number of common units reserved for issuance under the 2019
Plan was 14,604,165 as of September&nbsp;30, 2023. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The table below presents a summary of activities and a reconciliation of common units authorized and remaining
for grant under the 2019 Plan during the nine months ended September&nbsp;30, 2023: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Units<BR>available&nbsp;for<BR>grants</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Profits<BR>interests</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial" ALIGN="right"><B>Weighted-<BR>average</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:arial" ALIGN="right"><B>threshold<BR>amount</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Aggregate<BR>intrinsic&nbsp;value<BR>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Outstanding as of January&nbsp;1, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,088,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,516,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits interests granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,267,813</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,267,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Forfeited and expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(227,199</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Outstanding as of September&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,047,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,556,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">92,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Vested and expected to vest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,047,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,556,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">92,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="13" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The aggregate intrinsic value is calculated as the positive difference between the threshold amount of the profits interests and the fair
value of the Company&#146;s common unit as of September&nbsp;30, 2023. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">During the nine months ended September&nbsp;30, 2022 and 2023, the Company granted 2,244,356
and 2,267,813 profits interests with a weighted average grant date fair value of $1.89 and $6.73, respectively. The total fair value of the profits interests vested during the nine months ended September&nbsp;30, 2022 and 2023 was $0.4&nbsp;million
and $2.2&nbsp;million, respectively. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Unit-based compensation expense </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The grant date fair value of common units issued prior to July&nbsp;31, 2023 utilized in the Black-Scholes model is determined by the Company&#146;s Board of Managers
with the assistance of management. The grant date fair value of common units is determined using valuation methodologies which utilizes certain assumptions including probability weighting of expected exit events, volatility, time to liquidation, a
risk-free interest rate and an assumption for a discount for lack of marketability. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">After giving the effect to the Amendment to the LLC Agreement, the grant date
fair value of profits interests issued after July&nbsp;31, 2023 and profits interests at the modification date was estimated using the valuation model based on the Probability Weighted Expected Return Method (&#147;PWERM&#148;). The estimated equity
fair value was allocated via the distribution waterfall in accordance with the Amendment to the LLC Agreement to all outstanding redeemable convertible preferred units, common units and profits interests. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The value of profits interests calculated using the Black-Scholes model and the option-pricing model within the PWERM
model was based on the following assumptions for the nine months ended September&nbsp;30, 2022 and 2023: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;months&nbsp;ended</B><br><B>September&nbsp;30,&nbsp;2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>From&nbsp;January&nbsp;1&nbsp;to</B><br><B>July&nbsp;30, 2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>From&nbsp;July&nbsp;31&nbsp;to</B><br><B>September&nbsp;30,&nbsp;2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79.57%&nbsp;&#151;&nbsp;82.60%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78.57%&nbsp;&#151;&nbsp;86.33%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85.00%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.52&nbsp;&#151;&nbsp;4.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.00&nbsp;&#151;&nbsp;4.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.65%&nbsp;&#151;&nbsp;3.05%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.50%&nbsp;&#151;&nbsp;4.47%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.00%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Threshold range</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">5.75&nbsp;&#151;&nbsp;7.40</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">11.84</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Expected volatility</I></B>&#151;The Company is a private company and lacks company-specific historical and implied volatility
information. Therefore, the Company estimates its expected unit&#146;s volatility based on the historical volatility of a publicly traded set of peer companies and expect to continue to do so until the Company has adequate historical data regarding
the volatility of the Company&#146;s traded unit or stock price. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Expected term</I></B>&#151;The expected term of profits interests has been determined based
on the expected time to liquidity and expected vesting term. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Risk-free interest rate</I></B>&#151;The risk-free interest rate is determined by reference to
the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Dividends</I></B>&#151;Expected dividend yield is zero because the Company does not pay cash dividends on common units and does not expect to pay any cash
dividends in the foreseeable future. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The PWERM is the hybrid method, where the equity value in one or more scenarios is calculated using an option pricing model.
The PWERM is a scenario based methodology that estimates the fair value of common unit based upon an analysis of future values for the company, assuming various outcomes. The common unit value is based on the probability-weighted present value of
expected future investment returns considering each of the possible outcomes available as well as the rights of each class of members&#146; units. The future value of the common unit under each outcome is discounted back to the valuation date at an
appropriate risk-adjusted discount rate and probability weighted to arrive at an indication of value for the common unit. A discount for lack of marketability of the common unit is then applied to arrive at an indication of value for the common
unit. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In determining the fair value of the common units, the methodologies used to estimate the enterprise value were performed using methodologies, approaches, and
assumptions consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table presents the classification of unit-based compensation expense for the nine months ended
September&nbsp;30, 2022 and 2023 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;months&nbsp;ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">896</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The above unit-based compensation expense related to the following unit-based awards for the nine months ended September&nbsp;30, 2022
and 2023 (in thousands): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;months&nbsp;ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits Interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total unit-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">As part of the <FONT STYLE="white-space:nowrap">catch-up</FONT> and Amendment to the LLC Agreement, the Company modified the terms and
conditions of the profits interest, which resulted in a change in the fair value of the awards.&nbsp;The change was treated as a modification under ASC 718,<I>&nbsp;Stock Compensation,</I><I></I>&nbsp;in which the fair value of the profits interests
were remeasured at the modification date and compared to the fair value of the modified award immediately prior to the modification, with the difference resulting in incremental compensation expense. The Company estimated total modification expense
of $10.3&nbsp;million. The company recognized $1.1&nbsp;million of this expense related to vested profits interests as of the modification date and the remaining $9.2&nbsp;million is expected to be recognized over the next 3.3 years as profits
interests continue to vest. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">There was $5.3&nbsp;million and $19.3&nbsp;million in unrecognized unit-based compensation expense related to the profits interests as
of September&nbsp;30, 2022 and 2023, respectively, that is expected to be recognized over a weighted-average period of 3.2 and 2.9 years, respectively. There was no unrecognized unit-based compensation expense related to the common units as of
December&nbsp;31, 2022 and September&nbsp;30, 2023, as all common units were fully vested.<B> </B> </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>12. Related party transactions </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with Series B financing, the Company reimbursed certain investors for finance issuance costs that they incurred totaling $0.3&nbsp;million during the nine
months ended September&nbsp;30, 2022. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In connection with Series <FONT STYLE="white-space:nowrap">B-1</FONT> financing, the Company reimbursed certain investors for
finance issuance costs that they incurred totaling $0.1&nbsp;million during the year ended December&nbsp;31, 2022. As of December&nbsp;31, 2022, $0.1&nbsp;million of Series <FONT STYLE="white-space:nowrap">B-1</FONT> financing costs reimbursable to
investors is recorded in accrued expenses and other current liabilities in the condensed consolidated balance sheets. The reimbursable Series <FONT STYLE="white-space:nowrap">B-1</FONT> financing costs were fully paid during the nine months ended
September&nbsp;30, 2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>13. Income taxes </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Metagenomi
is treated as a partnership for tax purposes, and thus, is not subject to income taxes. It is the responsibility of the LLC members to report their proportionate share of any taxable income or loss generated by Metagenomi to the appropriate taxing
authorities and pay the associated taxes, if any. With respect to the Company&#146;s subsidiary, Metagenomi Inc. is a corporation for tax purposes and is subject to income taxes which have been included in the condensed consolidated financial
statements. All <FONT STYLE="white-space:nowrap">pre-tax</FONT> losses have been incurred in the United States. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company provides for income taxes in interim
periods based on the estimated annual effective tax rate for the year, adjusting for discrete items in the quarter in which they arise. The income tax provision for the nine months ended September&nbsp;30, 2022 and 2023 was related to the timing
differences of the recognition of upfront payments received under the Company&#146;s collaboration agreements for tax and financial reporting purposes and capitalization of its research and development expenses under the newly enacted Internal
Revenue Code Section&nbsp;174 (&#147;Section&nbsp;174&#148;), which became effective on January&nbsp;1, 2022. The effective tax rate differs from the U.S. statutory rate primarily due to the full valuation allowances on the Company&#146;s net
deferred tax assets as it is more likely than not that all of the deferred tax assets will not be realized. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">For the nine months ended September&nbsp;30, 2022 and
2023, the Company recorded a provision for income taxes of $1.7&nbsp;million and $5.3&nbsp;million by applying its estimated annual effective tax rate to its
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-to-date</FONT></FONT> measure of ordinary income, respectively. The increase in the provision for income taxes during the nine months ended September&nbsp;30, 2023 is primarily
due to the increase in forecasted research and development spend, which results in corresponding increases to Section&nbsp;174 capitalization, and taxable income related to the Ionis upfront payment which is partially offset by an increase in
forecasted research and development credit. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>14. Net loss per unit </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Basic
and diluted net loss per unit attributable to common unitholders is calculated as follows (in thousands except share and per share amounts): </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;months&nbsp;ended&nbsp;September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss attributable to common members</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(28,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,961</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted-average common units outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: Weighted-average unvested common units subject to repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,827</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted-average units used to compute basic and diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,935,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,947,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net loss per unit attributable to common unitholders&#151;basic and diluted:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.88</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8.23</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Notes to the Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss
per unit, as their effect is anti-dilutive: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="8" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="right" STYLE="border-bottom:1.00px solid #000000"><B>Nine&nbsp;months&nbsp;ended&nbsp;September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:9pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Redeemable convertible preferred units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,704,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,813,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Profits interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,085,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,556,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,790,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,370,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-BOTTOM:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>15. Subsequent events </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company has
reviewed and evaluated subsequent events and concluded there were no subsequent events through December 8, 2023, the date that the condensed consolidated financial statements were available to be issued, except for the selection of Target 3 in Wave
1 and the extension of the Target 4 selection period under the Ionis Agreement in November 2023 as discussed in Note 7. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:arial" ALIGN="center"><B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares </I></B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:96pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center"><B>


<IMG SRC="g425213g00s01.jpg" ALT="LOGO">
 </B></P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:18pt; font-family:arial" ALIGN="center"><B><I>Common Stock </I></B></P>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:24pt; font-family:arial" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:13pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:13pt">
<TD VALIGN="top"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Jefferies</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>TD&nbsp;Cowen</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Wells&nbsp;Fargo&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>BMO&nbsp;Capital&nbsp;Markets</B></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:13pt; font-family:arial" ALIGN="center"><B>Chardan </B></P>
<P STYLE="margin-top:48pt; margin-bottom:0pt; font-size:10pt; font-family:arial">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024 </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Through and including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024 (the 25th day after the date of this prospectus), all dealers
that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#146; obligation to deliver a prospectus when acting as underwriters and with
respect to their unsold allotments or subscriptions. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Part II </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Information Not
Required in Prospectus </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Item&nbsp;13. Other Expenses of Issuance and Distribution </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The following table sets forth the costs and expenses, other than underwriting discounts and commissions, to be paid by us in connection with the sale of the shares of
common stock being registered hereby. All amounts shown are estimates except for the SEC registration fee, the FINRA filing fee and the Nasdaq Global Market initial listing fee. </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:1pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Nasdaq listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Printing and engraving expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Transfer agent and registrar fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="4" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To be provided by amendment. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Item&nbsp;14. Indemnification of Directors and Officers </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Section&nbsp;145 of the Delaware General Corporation Law (the &#147;DGCL&#148;) authorizes a corporation to indemnify its directors and officers against liabilities
arising out of actions, suits and proceedings to which they are made or threatened to be made a party by reason of the fact that they have served or are currently serving as a director or officer to a corporation. The indemnity may cover expenses
(including attorneys&#146; fees) judgments, fines and amounts paid in settlement actually and reasonably incurred by the director or officer in connection with any such action, suit or proceeding. Section&nbsp;145 permits corporations to pay
expenses (including attorneys&#146; fees) incurred by directors and officers in advance of the final disposition of such action, suit or proceeding. In addition, Section&nbsp;145 provides that a corporation has the power to purchase and maintain
insurance on behalf of its directors and officers against any liability asserted against them and incurred by them in their capacity as a director or officer, or arising out of their status as such, whether or not the corporation would have the
power to indemnify the director or officer against such liability under Section&nbsp;145. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have adopted provisions in our amended and restated certificate of
incorporation and amended and restated bylaws to be in effect upon the effectiveness of this registration statement that limit or eliminate the personal liability of our directors to the fullest extent permitted by the DGCL, as it now exists or may
in the future be amended. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director, except for liability for: </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any unlawful payments related to dividends or unlawful stock purchases, redemptions or other distributions; or
</P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">These limitations of liability do not alter director liability under the federal securities laws and do not affect the
availability of equitable remedies such as an injunction or rescission. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, our amended and restated bylaws to be in effect upon the effectiveness of this
registration statement provide that: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we will indemnify our directors, officers and, in the discretion of our board of directors, certain employees to the
fullest extent permitted by the DGCL, as it now exists or may in the future be amended; and </P></TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:arial; font-size:10pt">we will advance reasonable expenses, including attorneys&#146; fees, to our directors and, in the discretion of our board
of directors, to our officers and certain employees, in connection with legal proceedings relating to their service for or on behalf of us, subject to limited exceptions. </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We intend to enter into indemnification agreements with each of our directors and executive officers. These agreements provide that we will indemnify each of our
directors, certain of our executive officers and, at times, their affiliates to the fullest extent permitted by Delaware law. We will advance expenses, including attorneys&#146; fees (but excluding judgments, fines and settlement amounts), to each
indemnified director or executive officer in connection with any proceeding in which indemnification is available and we will indemnify our directors and officers for any action or proceeding arising out of that person&#146;s services as a director
or officer brought on behalf of us or in furtherance of our rights. Additionally, certain of our directors or officers may have certain rights to indemnification, advancement of expenses or insurance provided by their affiliates or other third
parties, which indemnification relates to and might apply to the same proceedings arising out of such director&#146;s or officer&#146;s services as a director referenced herein. Nonetheless, we have agreed in the indemnification agreements that our
obligations to those same directors or officers are primary and any obligation of such affiliates or other third parties to advance expenses or to provide indemnification for the expenses or liabilities incurred by those directors are secondary.
</P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We also maintain general liability insurance which covers certain liabilities of our directors and officers arising out of claims based on acts or omissions in
their capacities as directors or officers, including liabilities under the Securities Act. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The underwriting agreement filed as Exhibit 1.1 to this registration
statement provides for indemnification of us and our directors and officers by the underwriters against certain liabilities under the Securities Act and the Exchange Act. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Item&nbsp;15. Recent Sales of Unregistered Securities </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In the three years
preceding the filing of this registration statement, we have issued the following securities that were not registered under the Securities Act: </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>(a) Preferred
Units </I></B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">From 2020 to 2021, we sold an aggregate of 9,861,297 Series A preferred units in multiple closings, consisting of (i) 8,280,360 Series <FONT
STYLE="white-space:nowrap">A-4</FONT> preferred units sold at a purchase price of $4.84875 per unit for an aggregate amount of $40.1&nbsp;million and (ii) 1,580,937 Series <FONT STYLE="white-space:nowrap">A-5</FONT> preferred units sold at a
purchase price of $6.32536 per unit for an aggregate amount of $10.0&nbsp;million, for total aggregate proceeds of $50.1&nbsp;million. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In 2022 and 2023, we sold an
aggregate of 22,162,743 Series B preferred units in multiple closings, consisting of (i) 15,054,263 Series B preferred units, which includes (a) 12,446,876 Series B preferred units sold at a purchase price of $11.64951 per unit and (b) 2,607,387
Series B preferred units which converted pursuant to a promissory note with a principal amount of $30.0&nbsp;million and accrued interest of $0.4&nbsp;million between the Company and ModernaTx, Inc., for an aggregate amount of $175.4&nbsp;million
and (ii) 7,108,480 Series <FONT STYLE="white-space:nowrap">B-1</FONT> preferred units sold at a purchase price of $14.06770 per unit for an aggregate amount of $100.0&nbsp;million, for total aggregate proceeds of $275.4&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">No underwriters were involved in the foregoing sales of securities. The sales of securities described above were
deemed to be exempt from registration pursuant to Section&nbsp;4(a)(2) of the Securities Act, including Regulation&nbsp;D and Rule&nbsp;506 promulgated thereunder, as transactions by an issuer not involving a public offering. All of the purchasers
in these transactions represented to us in connection with their purchase that they were acquiring the securities for investment and not distribution, that they could bear the risks of the investment and could hold the securities for an indefinite
period of time. Such purchasers received written disclosures that the securities had not been registered under the Securities Act and that any resale must be made pursuant to a registration or an available exemption from such registration. All of
the foregoing securities are deemed restricted securities for the purposes of the Securities Act. </P> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>(b) Profits Interests </I></B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Since January&nbsp;1, 2020, we have granted an aggregate of 9,903,897 profits interests, with profits interests threshold amounts ranging from $0.08 to $11.84 per unit,
to employees, directors and consultants pursuant to the 2019 Plan. No common units have been issued pursuant to the 2019 Plan. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The issuances of the securities under
the 2019 Plan described above were deemed to be exempt from registration pursuant to Section&nbsp;4(a)(2) of the Securities Act or Rule 701 promulgated under the Securities Act as transactions pursuant to compensatory benefit plans. The profits
interests are deemed to be restricted securities for purposes of the Securities Act. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The issuance of securities described above to employees and consultants outside
of the 2019 Plan were deemed exempt from registration pursuant to Section&nbsp;4(a)(2) of the Securities Act as transactions by an issuer not involving a public offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Item&nbsp;16. Exhibits and Financial Statement Schedules </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Exhibits. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="89%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Exhibit table</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;1.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Form of Underwriting Agreement</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;3.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect</P></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;3.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Form of Amended and Restated Certificate of Incorporation of the Registrant (to be effective upon the
closing of this offering)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;3.3*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Amended and Restated Bylaws, as currently in effect</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;3.4*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Form of Amended and Restated <FONT STYLE="white-space:nowrap">By-laws</FONT> (to be effective upon the
closing of this offering)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;4.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Amended and Restated Investors&#146; Rights Agreement among the Registrant and certain of its
stockholders, dated December&nbsp;20, 2022</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;4.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Form of Common Stock Certificate</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Opinion of Goodwin Procter LLP</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.1#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2019 Equity Incentive Plan, as amended, and forms of award agreements thereunder</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.2#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2024 Stock Option and Incentive Plan and forms of award agreements thereunder</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.3#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2024 Employee Stock Purchase Plan</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.4#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Form of Officer Indemnification Agreement</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.5#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Form of Director Indemnification Agreement</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.6&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex106.htm">Strategic Collaboration and License Agreement by and between the Registrant and
 ModernaTX, Inc., dated October&nbsp;29, 2021 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.7&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex107.htm">Collaboration and License Agreement by and between the Registrant and Ionis Pharmaceuticals,
 Inc., dated November&nbsp;10, 2022 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.8&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex108.htm">Development, Option and License Agreement by and between the Registrant and Affini-T
 Therapeutics, Inc., dated June 14, 2022 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex109.htm">Lease Agreement between EPL Halleck Investors LLC and Metagenomi, Inc., dated January&nbsp;22,
2021 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex1010.htm">Sublease Agreement between Zymergen Inc. and Metagenomi, Inc., dated November&nbsp;11,
 2022 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex1011.htm">Lease Agreement between Park Avenue Building LLC and Metagenomi, Inc., dated September&nbsp;29,&nbsp;2021
</A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.12#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex1012.htm">Employment Agreement between the Registrant and Brian C. Thomas, dated as of March&nbsp;20,
2023 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.13#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex1013.htm">Offer of Employment between the Registrant and Jian Irish, dated as of January&nbsp;19,
 2021 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.14#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex1014.htm">Offer of Employment between the Registrant and Sarah Noonberg, dated as of January&nbsp;30,
 2023 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.15#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex1015.htm">Form of Confidentiality and Invention Assignment Agreement
</A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.16#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Form of Executive Employment Agreement</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;10.17#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex1017.htm">Manager Offer Letter between the Registrant and Willard Dere, dated as of August
 19, 2021 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;16.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex161.htm">Letter from KPMG LLP to the Securities and Exchange Commission dated August&nbsp;3,
 2023 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;21.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Subsidiaries of the Registrant</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dex231.htm">Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting
 Firm </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Consent of Goodwin Procter LLP (included in Exhibit
5.1)</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Exhibit table</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#sig">Power of Attorney (included on signature page to this registration statement)
</A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">107</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="d425213dexfilingfees.htm">Filing Fees Exhibit </A></P></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To be filed by amendment. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">#</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Indicates a management contract or any compensatory plan, contract or arrangement </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:7.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Portions of this exhibit (indicated by asterisks) have been omitted in accordance with the rules of the SEC because the Registrant has determined that information is not material and would be competitively harmful if
publicly disclosed. </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Financial Statement Schedules. </TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">None. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:arial"><B>Item&nbsp;17. Undertakings </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The undersigned Registrant hereby undertakes to
provide to the underwriters at the closing specified in the Underwriting Agreement certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to
the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The undersigned Registrant hereby undertakes that: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of
prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. </TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B>Signatures </B></P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the
requirements of the Securities Act, Metagenomi Technologies, LLC has duly caused this registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of
Emeryville, California, on the 5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day of January, 2024. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Metagenomi Technologies, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:arial">/s/ Brian C. Thomas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Brian C. Thomas, Ph.D.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:arial">Chief Executive Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">II-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:arial"><B><A NAME="sig"></A>Signatures and Power of Attorney </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Brian C. Thomas and Pamela Wapnick, and each of them, either
of whom may act without the joinder of the other, as his or her true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents with full power of substitution and <FONT
STYLE="white-space:nowrap">re-substitution,</FONT> for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to sign
any registration statement for the same offering covered by the registration statement that is to be effective upon filing pursuant to Rule&nbsp;462(b) promulgated under the Securities Act, and all post-effective amendments thereto, and to file the
same, with all exhibits thereto and all documents in connection therewith, with the SEC, granting unto said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, and each of them, full power
and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents or any of them, or his or her or their substitute or substitutes, may lawfully do or cause to be done or by virtue hereof. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities indicated on the 5<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> day of January, 2024. </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="45%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Title</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:arial">/s/ Brian C. Thomas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">Brian C. Thomas, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(Principal Executive Officer)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:arial">/s/ Pamela Wapnick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">Pamela Wapnick, MBA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(Principal Financial Officer and Principal Accounting Officer)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:arial">/s/ Juergen Eckhardt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">Juergen Eckhardt, M.D., MBA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:arial">/s/ Sebasti&aacute;n Bernales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">Sebasti&aacute;n Bernales, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:arial">/s/ Risa Stack</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">Risa Stack, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:arial">/s/ Willard Dere</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">Willard Dere, M.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:arial">/s/ Santhosh Palani</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:10pt">
<TD VALIGN="top">Santhosh Palani, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">II-7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>2
<FILENAME>d425213dex106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.6 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>CONFIDENTIAL </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STRATEGIC
COLLABORATION AND LICENSE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Between </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MODERNATX, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>METAGENOMI, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>October&nbsp;29, 2021 </B></P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 1 DEFINITIONS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 2 GOVERNANCE AND JOINT STEERING COMMITTEE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ALLIANCE MANAGER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>WORKING GROUPS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>JOINT STEERING COMMITTEE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SPECIFIC RESPONSIBILITIES OF THE JSC</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MEETINGS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>JOINT RESEARCH COMMITTEE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>JOINT DEVELOPMENT COMMITTEE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>JOINT COMMERCIALIZATION COMMITTEE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>JOINT PATENT COMMITTEE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DECISIONS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>AUTHORITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DISCONTINUATION OF JSC</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 3 RT RESEARCH ACTIVITIES AND OPTION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>GOALS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT TECHNOLOGY RESEARCH PLAN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT PRECLINICAL RESEARCH PLAN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>OBLIGATIONS DURING THE RT RESEARCH TERM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT RESEARCH TERM COSTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SUBCONTRACTORS FOR THE RT PLANS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RECORDS AND REPORTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT RESEARCH TERM EXTENSION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT OPTION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>METAGENOMI BEC PROGRAMS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 4 MODERNA DT RESEARCH ACTIVITIES AND OPTION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RESERVED DT TARGET DISCONTINUANCE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RIGHT OF FIRST NEGOTIATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT TARGET EVALUATION PLAN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT MODERNA RESEARCH PLAN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>OBLIGATIONS DURING THE DT MODERNA RESEARCH TERM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT MODERNA RESEARCH TERM COSTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SUBCONTRACTORS FOR THE DT PLANS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RECORDS AND REPORTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT OPTION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 5 LICENSES; EXCLUSIVITY; MANUFACTURE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT RESEARCH TERM LICENSE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT PRECLINICAL RESEARCH TECHNOLOGY TRANSFER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT MODERNA RESEARCH TERM LICENSE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT MODERNA RESEARCH TERM TECHNOLOGY TRANSFER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> PROGRAM LICENSE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> RESEARCH TECHNOLOGY TRANSFER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SUBLICENSING</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RESPONSIBILITY FOR SUBLICENSEES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SUBCONTRACTING FOR DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> PLANS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>THIRD PARTY <FONT STYLE="white-space:nowrap">IN-LICENSES</FONT> IN THE DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> PROGRAM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>THIRD PARTY <FONT STYLE="white-space:nowrap">IN-LICENSES</FONT> IN RT PROGRAMS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>THIRD PARTY <FONT STYLE="white-space:nowrap">IN-LICENSES</FONT> IN DT PROGRAMS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>LICENSE TO MODERNA UPON EXERCISE OF THE RT OPTION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT TECHNOLOGY TRANSFER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>LICENSE TO MODERNA UPON EXERCISE OF THE DT OPTION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT TECHNOLOGY TRANSFER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>METAGENOMI LICENSED COLLABORATION TECHNOLOGY UPDATE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>COLLABORATION MATERIALS TRANSFER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>NO OTHER RIGHTS AND RETAINED RIGHTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RT EXCLUSIVITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT EXCLUSIVITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> TARGET EXCLUSIVITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MANUFACTURE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>GOVERNMENT APPROVALS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>PAYMENTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 6 COLLABORATION ACTIVITIES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>LEAD PARTY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> PLANS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> PRODUCT RESEARCH ACTIVITIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> PRODUCT DEVELOPMENT ACTIVITIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>REGULATORY AFFAIRS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MEDICAL AFFAIRS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>COMMERCIALIZATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B><FONT STYLE="white-space:nowrap">OPT-OUT</FONT> RIGHT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>PRESERVATION OF PROGRAM ASSETS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SAFETY CONCERN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 7 FEES, ROYALTIES, &amp; PAYMENTS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>UPFRONT PAYMENT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>CONVERTIBLE NOTE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RESEARCH FUNDING</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B><FONT STYLE="white-space:nowrap">CO-CO</FONT> PRODUCTS PROFIT AND LOSS SHARE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>APPORTIONMENT OF COSTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ACCOUNTING; AUDIT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DISPUTED PAYMENTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MILESTONE PAYMENTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ROYALTIES ON PRODUCTS DIRECTED AGAINST AN RT TARGET</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ROYALTIES ON PRODUCTS DIRECTED AGAINST A DT MODERNA TARGET</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B><FONT STYLE="white-space:nowrap">OPT-OUT</FONT> MILESTONES AND ROYALTIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>PAYMENT; REPORTS; ROYALTY MINIMUM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>METHOD OF PAYMENT; FOREIGN EXCHANGE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RECORDS AND AUDITS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DEFAULT INTEREST</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TAXES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 8 INTELLECTUAL PROPERTY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>OWNERSHIP OF INTELLECTUAL PROPERTY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>PATENT PROSECUTION AND MAINTENANCE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INFRINGEMENT BY THIRD PARTIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DEFENSE AND SETTLEMENT OF THIRD PARTY CLAIMS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>PATENT EXTENSION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>UNIFIED PATENT COURT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>COMMON INTEREST</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TRADEMARKS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 9 REPRESENTATIONS, WARRANTIES AND COVENANTS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MUTUAL REPRESENTATIONS AND WARRANTIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>METAGENOMI REPRESENTATIONS AND WARRANTIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MODERNA REPRESENTATIONS AND WARRANTIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>COVENANTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>COMPLIANCE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DISCLAIMER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 10 INDEMNIFICATION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INDEMNITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>LOSSES IN THE TERRITORY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INSURANCE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 11 CONFIDENTIALITY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>CONFIDENTIAL INFORMATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>PUBLICITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>PUBLICATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 12 TERM&nbsp;&amp; TERMINATION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TERM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TERMINATION FOR MATERIAL BREACH OR INSOLVENCY OR PATENT CHALLENGE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MODERNA OPTION TO CONTINUE IN LIEU OF TERMINATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TERMINATION FOR CONVENIENCE BY MODERNA</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TERMINATION FOR CONVENIENCE BY PRIMARY PARTY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>EFFECTS OF TERMINATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SURVIVAL</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>BANKRUPTCY CODE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 13 GOVERNING LAW; DISPUTE RESOLUTION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iv- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>GOVERNING LAWS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>DISPUTES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ARBITRATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>BASEBALL ARBITRATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>EQUITABLE RELIEF; REMEDY FOR BREACH OF EXCLUSIVITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>EXCLUDED CLAIMS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 14 MISCELLANEOUS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ENTIRE AGREEMENT; AMENDMENT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>LIMITATION OF LIABILITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INDEPENDENT CONTRACTORS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>NOTICE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SEVERABILITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B><FONT STYLE="white-space:nowrap">NON-USE</FONT> OF NAMES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ASSIGNMENT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ACQUISITION OF EXISTING COMPETING PROGRAMS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>METAGENOMI CHANGE OF CONTROL</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ACQUIRER ENGAGED IN COMPETING PROGRAM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>FIREWALLED PROGRAMS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>FIREWALL AUDITS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>WAIVERS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>FORCE MAJEURE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INTERPRETATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>EXPENSES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>FURTHER ASSURANCES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>NO THIRD PARTY BENEFICIARY RIGHTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>CONSTRUCTION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>CUMULATIVE REMEDIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>EXTENSION TO AFFILIATES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>OTHER ACTIVITIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>COUNTERPARTS; ELECTRONIC SIGNATURES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-v- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Listing of Schedules </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule A: DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule B: Manufacturing Cost </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule C: Certain Technology
Milestones </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule D: Reserved DT Targets </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule E:
Approved Subcontractors </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule F: Existing <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">In-Licenses</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule G: Existing RT <FONT STYLE="white-space:nowrap">In-Licenses</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule H: Existing DT <FONT STYLE="white-space:nowrap">In-Licenses</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule I: Material Transfer Record </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule J: <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products Profit and Loss Share </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule K: Existing Patents </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule L: RT Technology Research Plan </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule M:
Partnership Tax Matters </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule N: Joint Press Release </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule O: DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STRATEGIC COLLABORATION AND LICENSE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <B>STRATEGIC COLLABORATION AND LICENSE AGREEMENT </B>(this &#147;<B>Agreement</B>&#148;) is entered into as of October&nbsp;29, 2021 (the
&#147;<B>Effective Date</B>&#148;) by and between <B>METAGENOMI, INC.</B>, a company incorporated under the laws of Delaware having an address at 1545 Park Ave, Emeryville, CA 94608 (&#147;<B>Metagenomi</B>&#148;), and <B>MODERNATX, INC.</B>, a
corporation organized and existing under the laws of Delaware, with its principal business office located at 200 Technology Square, Cambridge, MA 02139 (&#147;<B>Moderna</B>&#148;). Moderna and Metagenomi are each hereafter referred to individually
as a &#147;<B>Party</B>&#148; and together as the &#147;<B>Parties</B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, Metagenomi is
a biotechnology company focused on using metagenomics and machine learning to discover novel genome editing systems; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, Moderna is a pharmaceutical company engaged in the research, development, manufacturing,
marketing and distribution of mRNA-based therapeutic products; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, Moderna and Metagenomi
desire to establish a collaboration to discover novel genome editing technologies for use as <I>in vivo</I> genome editing therapies; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, Metagenomi and Moderna desire to collaborate in the research and development of <I>in vivo</I>
genome editing therapies directed at certain targets as well as the commercialization of such genome editing therapies all as set forth in the Program Plans (as defined below); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, Moderna will provide an equity investment in Metagenomi in the form of a convertible note
pursuant to the Convertible Note Instruments dated October&nbsp;29, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>N<SMALL>OW</SMALL>,
T<SMALL>HEREFORE</SMALL></B><SMALL></SMALL>, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereby agree as follows:
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized
terms used in this Agreement and the Schedules hereto shall have the following meanings (or as defined elsewhere in this Agreement): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1
&#147;<B>Affiliate</B>&#148; means, with respect to a Person (including a Party), any entity that, at the relevant time (whether as of the Effective Date or thereafter), directly or indirectly through one or more intermediaries, controls, is
controlled by, or is under common control with such Person, for so long as such control exists. As used in this Section&nbsp;1.1, &#147;control&#148; means: (a)&nbsp;to possess, directly or indirectly, the power to direct or cause the direction of
the management or policies of an entity, whether through ownership of voting securities or by contract relating to voting rights or corporate governance; or (b)&nbsp;direct or indirect ownership of more than fifty percent (50%) (or such lesser
percentage that is the maximum allowed to be owned by a foreign entity in a particular jurisdiction) of the voting share capital or other equity interest in such entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 &#147;<B>Allowable Overruns</B>&#148; means, for a particular DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Candidate or DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, as applicable, any amount that is less than [***] (or such other percentage as may be approved by the JSC) above the most recent budgeted
costs and expenses for a Calendar Year on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-to-date</FONT></FONT> basis set forth in any applicable Research Budget, Development Budget, Medical Affairs Budget, or
Commercialization Budget, as applicable, for such Calendar Year; provided that such amount is not attributable to (a) the breach of this Agreement or (b) the gross negligence or willful misconduct of either Party or any of its Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3 &#147;<B>Applicable Laws</B>&#148; means the applicable provisions of any and all federal, national, supranational, regional, state and
local laws, treaties, statutes, rules, regulations, guidelines or requirements, administrative codes, guidance, ordinances, judgments, decrees, directives, injunctions, orders, or permits of or from any court, arbitrator, Regulatory Authority,
Governmental Authority, data protection authority, taxing authority, national securities exchange or exchange listing organization having jurisdiction over or related to the relevant subject item that may be in effect from time to time during the
Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4 &#147;<B>Approved Labeling</B>&#148; means, with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product:
(a)&nbsp;the Regulatory Authority-approved full prescribing information for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product; and (b)&nbsp;the Regulatory Authority-approved labels and other written, printed, or graphic materials on any
container, wrapper, or any package insert that is used with or for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5
&#147;<B>Background Technology</B>&#148; means, with respect to a Party, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-</FONT></FONT> Program basis, any and all materials, Patents,
<FONT STYLE="white-space:nowrap">Know-How</FONT> and other intellectual property rights Controlled by such Party or any of its Affiliates as of the Effective Date or that comes into the Control of such Party or any of its Affiliates during the Term
(other than Program Technology), in each case related to or otherwise pertaining to such Program, and in the case of Moderna, to the extent Moderna makes any of the foregoing available to Metagenomi pursuant to this Agreement. Background Technology
shall not include any materials, Patents, <FONT STYLE="white-space:nowrap">Know-How</FONT> or other intellectual property rights Controlled by a New Affiliate of a Party and not also Controlled by such Party or any of its Affiliates, provided that
such New Affiliate is not utilizing the Metagenomi Licensed Collaboration Technology or the Moderna Licensed Collaboration Technology with respect to the activity that would otherwise be restricted under Sections 5.20 (RT Exclusivity), 5.21 (DT
Exclusivity), or 5.22 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target Exclusivity), as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6 &#147;<B>Base
Editing</B>&#148; means [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.7 &#147;<B>Base Editing Correction Readiness</B>&#148; means the criteria for Base Editing correction as
specified in part 2 of the Base Editing Readiness Milestones in <B>Schedule C </B>(Certain Technology Milestones). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.8 &#147;<B>Base
Editing Knockout Readiness</B>&#148; means the criteria for Base Editing knockout as specified in part 1 of the Base Editing Readiness Milestones in <B>Schedule C </B>(Certain Technology Milestones). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.9 &#147;<B>Base Editing Readiness Milestone</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.10 &#147;<B>BEC</B>&#148; means [***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.11 &#147;<B>Biosimilar Application</B>&#148; means an application submitted to the FDA
under subsection (k)&nbsp;of Section&nbsp;351 of the PHSA, or any analogous application submitted to a Regulatory Authority in the U.S. or in another country in the world. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.12 &#147;<B>Biosimilar Product</B>&#148; means, with respect to a Product, and on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Product-by-Product</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, any product (including a &#147;generic product,&#148; &#147;biogeneric,&#148; <FONT
STYLE="white-space:nowrap">&#147;follow-on</FONT> biologic,&#148; <FONT STYLE="white-space:nowrap">&#147;follow-on</FONT> biological product,&#148; <FONT STYLE="white-space:nowrap">&#147;follow-on</FONT> protein product,&#148; &#147;similar
biological medicinal product,&#148; or &#147;biosimilar product&#148;) approved by way of an abbreviated regulatory mechanism by the relevant Regulatory Authority in a country in reference to such Product, that in each case: (a)&nbsp;is sold in the
same country (or is commercially available in the same country via import from another country) as such Product by any Third Party that is not a Sublicensee of the applicable Party or any of its Affiliates and that did not purchase such product in a
chain of distribution that included any of the applicable Party or any of its Affiliates or its Sublicensees; and (b)&nbsp;meets the equivalency determination by the applicable Regulatory Authority in such country (including a determination that the
product is &#147;comparable,&#148; &#147;interchangeable,&#148; &#147;bioequivalent,&#148; &#147;biosimilar&#148; or other term of similar meaning, with respect to the Product), in each case, as is necessary to permit substitution of such product
for the Product under Applicable Law in such country, including, with respect to the U.S., to an Abbreviated New Drug Applications under Section&nbsp;505(j) of the FD&amp;C Act (21 USC 355(j)) or is approved as a &#147;Biosimilar Biologic
Product&#148; under Title VII, Subtitle A Biologics Price Competition and Innovation Act of 2009, Section&nbsp;42 U.S.C. 262, Section&nbsp;351 of the PHSA, or, outside the U.S., in accordance with European Directive 2001/83/EC on the Community Code
for medicinal products (Article 10(4) and Section&nbsp;4, Part II of Annex I) and European Regulation EEC/2309/93 establishing the Community procedures for the authorization and evaluation of medicinal products, each as amended, and together with
all associated guidance, and any counterparts thereof or equivalent process inside or outside of the U.S. or EU to the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.13
&#147;<B>Business Day</B>&#148; means any day other than Saturday, Sunday, or any day that banks are authorized or required to be closed in the state of New York or the Commonwealth of Massachusetts or the state of California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.14 &#147;<B>Calendar Quarter</B>&#148; means each respective period of three (3)&nbsp;consecutive months ending on March&nbsp;31,
June&nbsp;30, September&nbsp;30 and December&nbsp;31 of any Calendar Year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.15 &#147;<B>Calendar Year</B>&#148; means each respective
period of twelve (12)&nbsp;consecutive months commencing on January&nbsp;1 and ending on December 31. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.16 &#147;<B>Candidate</B>&#148;
means a BEC Candidate, an RT Candidate, a DT Moderna Candidate or a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidate, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.17 &#147;<B>Change of Control</B>&#148; means, with respect to either Party: (i)&nbsp;the acquisition by a Third Party, in one transaction
or a series of related transactions, of direct or indirect beneficial ownership of more than fifty percent (50%) of the outstanding voting equity securities of such Party (excluding, for clarity, an acquisition by a Third Party where the
stockholders of such acquired Party immediately prior to such transaction hold a majority of the voting shares of outstanding capital stock of the surviving entity immediately following such transaction); (ii) a merger or consolidation involving
such Party, as a result of which a Third Party acquires direct or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indirect beneficial ownership of more than fifty percent (50%) of the voting power of the surviving entity immediately after such merger, reorganization or consolidation; or (iii)&nbsp;a sale of
all or substantially all of the assets of such Party in one transaction or a series of related transactions to a Third Party. The acquiring or combining Third Party in any of (i), (ii) or (iii), and any of such Third Party&#146;s Affiliates (whether
in existence as of or any time following the applicable transaction, but other than the acquired Party and its Affiliates as in existence prior to the applicable transaction or other Affiliates such Party or its Affiliates controls (directly or
indirectly) after the applicable transaction) are referred to collectively herein as the &#147;<B>Acquirer</B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, with
respect to Metagenomi, the term &#147;Change of Control&#148; shall not include (i)&nbsp;any sale of shares of capital stock of Metagenomi or any of its Affiliates, in a single transaction or series of related transactions, in which Metagenomi or
its applicable Affiliate issues new securities for cash or the cancellation or conversion of indebtedness or a combination thereof, or (ii)&nbsp;any merger or consolidation of Metagenomi or any of its Affiliates (including a special purpose
acquisition company (SPAC)), in each case ((i) and (ii)) where such transaction(s) are conducted primarily for <I>bona fide</I> equity financing purposes or for becoming a publicly listed company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.18 &#147;<B>Clinical Trial&#148; </B>means a Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial, or any
post-Regulatory Approval human clinical trial, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.19 &#147;<B>CMC</B>&#148; means Chemistry and Manufacturing Controls,
which includes (a)&nbsp;Manufacturing process development records for products, (b)&nbsp;all chemistry, Manufacturing and control procedures necessary for Manufacture of products, and (c)&nbsp;sourcing and testing of all raw materials and components
used in the Manufacture of products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.20 &#147;<B>CMC Activities</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.21 &#147;<B>CMC Matters</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.22 &#147;<B><FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">In-License</FONT></B>&#148; means <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements or <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements, as applicable.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.23 &#147;<B>Collaboration Materials</B>&#148; means any tangible <FONT STYLE="white-space:nowrap">(non-document)</FONT> materials
Controlled by a Party or any of its Affiliates that are delivered to the other Party under this Agreement, including to conduct Research as set forth in an applicable Program Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.24 &#147;<B>Collaboration Target</B>&#148; means an RT Target, a DT Moderna Target or the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Target, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.25 &#147;<B>Commercial Overhead Charge</B>&#148; means[***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.26 &#147;<B>Commercialization</B>&#148; means any and all activities directed to the offering for sale and sale of a Product, including:
(a)&nbsp;activities directed to storing, marketing, promoting, detailing, distributing, importing, exporting, selling and offering to sell (including receiving, accepting, and filling orders); (b) handling all returns; (c)&nbsp;controlling
invoicing, order processing, and collection of accounts receivable for the sales; (d)&nbsp;booking and recording sales in its books of account; (e)&nbsp;distributing and managing inventory; (f)&nbsp;interacting with Regulatory Authorities regarding
any of the foregoing; and (g)&nbsp;seeking Pricing and Reimbursement Approvals (as applicable). When used as a verb, &#147;to <B>Commercialize</B>&#148; and &#147;<B>Commercializing</B>&#148; means to engage in Commercialization and
&#147;<B>Commercialized</B>&#148; has a corresponding meaning. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.27 &#147;<B>Commercialization Budget</B>&#148; means, the budget for activities under the
applicable Commercialization Plan for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.28 &#147;<B>Commercialization
Costs</B>&#148; means [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding any provision to the contrary set forth in this Agreement no Milestone Payment shall be considered a
Commercialization Cost, and no expense included as a Commercialization Cost shall be included as an Eligible Development Cost, Eligible Medical Affairs Cost, Cost of Sales, or Other Operating Expense. Commercialization Costs specifically exclude any
costs or expenses of a Party or its Affiliates to the extent caused by such Party or its Affiliate&#146;s breach of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.29
&#147;<B>Commercially Reasonable Efforts</B>&#148; means [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.30 &#147;<B>Control</B>&#148; or &#147;<B>Controlled</B>&#148; means,
with respect to any materials, <FONT STYLE="white-space:nowrap">Know-How,</FONT> Patents, or other intellectual property rights, that a Party or any of its Affiliates has the legal authority or right (whether by ownership, license, or otherwise) to
grant to the other Party a license, covenant not to sue, sublicense, access, or right to use (as applicable) under such materials, <FONT STYLE="white-space:nowrap">Know-How,</FONT> Patents, or other intellectual property rights, on the terms and
conditions set forth herein, in each case without violating any obligations of the granting Party owed to a Third Party, breaching the terms of any agreement with a Third Party or subjecting the granting Party to any fee or charge in addition to the
fees or charges the Parties have agreed to pay pursuant to this Agreement. Notwithstanding the foregoing, any New Affiliate of a Party shall not be considered an Affiliate of such Party for the purposes of this definition, provided that such New
Affiliate is not utilizing the Metagenomi Licensed Collaboration Technology or the Moderna Licensed Collaboration Technology with respect to the activity that would otherwise be restricted under Sections 5.20 (RT Exclusivity), 5.21 (DT Exclusivity),
or 5.22 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target Exclusivity), as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.31 &#147;<B>Cost of Sales</B>&#148;
means, with respect to a given Calendar Quarter, the aggregate Manufacturing Costs (calculated in accordance with U.S. GAAP) for all DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products sold in the Territory during such Calendar Quarter. Cost
of Sales also includes royalties payable to Third Parties, if any, cost of shipping to customers, and applicable warehousing and insurance costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.32 &#147;<B>Cover</B>&#148; means, with respect to a claim of a Patent and a given Collaboration Target or Product or a given item of <FONT
STYLE="white-space:nowrap">Know-How,</FONT> that such claim would be infringed, absent a license, by the making, use, importation, exportation, offering for sale, sale, or other Exploitation of such Collaboration Target or Product or such item of <FONT
STYLE="white-space:nowrap">Know-How</FONT> (considering claims of patent applications to be issued as then pending). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.33 &#147;<B>Data
Package</B>&#148; means, on a Collaboration <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Collaboration</FONT></FONT> Target basis, the package of data (e.g., results, data (including raw data and summaries thereof),
conclusions and findings) to be generated pursuant to the Program Plan for such Collaboration Target, including for purposes of demonstrating achievement of indicated success criteria. For clarity, the specific contents of each Data Package shall be
determined by the JSC and set forth in the applicable Program Plan and ownership of the contents shall be determined in accordance with Section&nbsp;8.1.2 (Ownership of Intellectual Property). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.34 &#147;<B>DC Nomination</B>&#148; means the nomination of a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Candidate by the JSC to advance to <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies, including, without limitation, any GLP Toxicology Studies. A DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Candidate that has been so nominated shall become a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.35
&#147;<B>Development</B>&#148; means all internal and external research, development, and regulatory activities regarding pharmaceutical or biologic products, including (a)&nbsp;research, <FONT STYLE="white-space:nowrap">non-</FONT> clinical
testing, toxicology, route of synthesis, <FONT STYLE="white-space:nowrap">non-clinical</FONT> activities, <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies, and Clinical Trials (including any Phase IV Required Clinical Trial, but
expressly excluding Phase IV Optional Clinical Trials), and (b)&nbsp;preparation, submission, review, and development of data or information for the purpose of submission to a Regulatory Authority to obtain authorization to conduct Clinical Trials
and to obtain, support, or maintain Regulatory Approval of a Product, but excluding activities directed to Manufacturing or Commercialization. Development shall include development and regulatory activities for additional forms, formulations, or
Indications for a Product after receipt of Regulatory Approval of such Product, including Clinical Trials initiated following receipt of Regulatory Approval or any Clinical Trial to be conducted after receipt of Regulatory Approval that was mandated
by the applicable Regulatory Authority as a condition of such Regulatory Approval with respect to an approved formulation or Indication (such as post-marketing studies and observational studies, if required by any Regulatory Authority in any country
in the Territory to support or maintain Regulatory Approval for a Product in such country). &#147;<B>Develop</B>,&#148; &#147;<B>Developing</B>,&#148; and &#147;<B>Developed</B>&#148; shall be construed accordingly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.36 &#147;<B>Development Budget</B>&#148; means, the budget for activities under the applicable Development Plan for each DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.37 &#147;<B>Development Costs</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.38 &#147;<B>Directed Against</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.39 &#147;<B>Distribution Matters</B>&#148; means all issues and decisions regarding the distribution of DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, including decisions as to whether and with which wholesalers and distributors to contract, and the terms of contracts with such wholesalers and distributors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.40 &#147;<B>Divestiture</B>&#148; means the sale or transfer of rights to the Competing Program by Metagenomi (or its Affiliate) to a Third
Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.41 &#147;<B>DMF</B>&#148; means any drug master file filed with the FDA, and any equivalent filing in other countries or
regulatory jurisdictions, or any other mechanism for achieving the purposes of a drug master file in any jurisdiction where there is no equivalent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.42 &#147;<B>Dollar</B>&#148; means a U.S. dollar, and &#147;<B>$</B>&#148; is to be interpreted accordingly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.43 &#147;<B>Donor Template</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.44 <B>&#147;DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidate&#148; </B>means [***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.45 <B>&#147;DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product</B>&#148; means a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Candidate nominated through DC Nomination for further Development in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.46 &#147;<B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Costs</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.47 &#147;<B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target</B>&#148; means the target identified in <B>Schedule A </B>(DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Target). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.48 &#147;<B>DT Field</B>&#148; means <I>in vivo</I> Gene Editing for a therapeutic,
ameliorative or prophylactic application by way [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.49 &#147;<B>DT <FONT STYLE="white-space:nowrap">In-Licenses</FONT></B>&#148;
means DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements or DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.50 &#147;<B>DT Moderna Research Term</B>&#148; means the period that commences on the Effective Date and continuing until four
(4)&nbsp;years after the Effective Date, unless earlier terminated pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.51 &#147;<B>DT Option Fee&#148;
</B>means ten million Dollars ($10,000,000) for each DT Moderna Research Program with respect to which Moderna has exercised a DT Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.52 &#147;<B>DT Program <FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148; means, with respect to a Party, on a DT <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-</FONT></FONT> DT Program basis, all materials and <FONT STYLE="white-space:nowrap">Know-How</FONT> that comes into the Control of such Party or any of its Affiliates during the
Term for such DT Moderna Research Program that relates or otherwise pertains to such DT Program, including that (a)&nbsp;relates or otherwise pertains to the DT Moderna Target of such DT Program, (b)&nbsp;is otherwise necessary or useful in
Researching, Developing, Manufacturing, Commercializing or otherwise Exploiting Licensed Products Directed Against such DT Moderna Target in the DT Field in the Territory or (c) [***] (a), (b) and (c)&nbsp;to the extent Moderna makes any of the
foregoing available to Metagenomi pursuant to this Agreement. For clarity, &#147;DT Program <FONT STYLE="white-space:nowrap">Know-How&#148;</FONT> includes all of such Party&#146;s rights in its solely-owned Program Technology constituting materials
and <FONT STYLE="white-space:nowrap">Know-How</FONT> that satisfy the foregoing, and any jointly-owned <FONT STYLE="white-space:nowrap">Know-How</FONT> within the Program Technology that satisfies the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.53 &#147;<B>DT Program Patents</B>&#148; means all Patents that Cover any of the DT Program
<FONT STYLE="white-space:nowrap">Know-How.</FONT> For clarity, DT Program Patents include any Joint Patents that satisfy the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.54 &#147;<B>DT Program Technology</B>&#148; means the DT Program <FONT STYLE="white-space:nowrap">Know-How</FONT> and the DT Program
Patents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.55 &#147;<B>DT Targets</B>&#148; means the DT Moderna Targets and the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.56 &#147;<B>Eligible <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Cost</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.57 &#147;<B>Eligible Development Costs</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.58 &#147;<B>Eligible Medical Affairs Costs</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.59 &#147;<B>EMA</B>&#148; means the European Medicines Agency or any successor agency thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.60 &#147;<B>E.U.</B>&#148; means the European Union. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.61 &#147;<B><FONT STYLE="white-space:nowrap">Ex-U.S.</FONT></B>&#148; means all countries in the Territory other than the U.S. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.62 &#147;<B>Executive Officers</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.63 &#147;<B>Exploit</B>&#148; means to make, use, offer to sell, sell, import, export, practice, research, develop, manufacture,
commercialize or otherwise exploit (including Research, Develop, Manufacture, perform Medical Affairs activities and Commercialize Products), and have others do the same. &#147;<B>Exploitation</B>&#148; and &#147;<B>Exploiting</B>&#148; shall be
construed accordingly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.64 &#147;<B>External Costs</B>&#148; mean [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.65 &#147;<B>FD&amp;C Act</B>&#148; means the United States Federal Food, Drug and Cosmetic Act, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.66 &#147;<B>FDA</B>&#148; means the United States Food and Drug Administration or any successor agency thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.67 &#147;<B>Field</B>&#148; means all uses, including any and all uses for the diagnosis, prevention, amelioration, and treatment of any
disease or medical condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.68 &#147;<B>Firewall Period</B>&#148; means, with respect to a Competing Program of an Acquirer of a
Party, the period commencing on the applicable Firewall Event and ending on the earlier of: (a)&nbsp;Divestiture of the Competing Program by such Acquirer; and (b)&nbsp;the expiration of such Party&#146;s exclusivity obligations under this Agreement
(in respect of the relevant Competing Program). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.69 &#147;<B>Firewalls</B>&#148; means effective walls and screens established between a
Party, on the one hand, and on the other hand, an Acquirer of such Party which has a Competing Program, to ensure that no <FONT STYLE="white-space:nowrap">non-public</FONT> information, materials (such as lab notebooks, document management systems
or other documented or memorialized <FONT STYLE="white-space:nowrap">Know-How)</FONT> or <FONT STYLE="white-space:nowrap">non-personnel</FONT> resources directly relating to any RT Targets, DT Targets, Candidates, Products, or the Program, or any <FONT
STYLE="white-space:nowrap">non-public</FONT> information, materials or <FONT STYLE="white-space:nowrap">non-personnel</FONT> resources relating to Patents provided, or made accessible, to such Party by the other Party are accessible by personnel of
the Acquirer working on the Competing Program during the Firewall Period. For purposes of this definition, &#147;Firewalls&#148; shall include, during the Firewall Period, as necessary to satisfy this definition: (a)&nbsp;walls and screens (whether
technical or physical) between (i)&nbsp;on the one hand, personnel of such Party performing Research or Development activities under, or otherwise working on or involved with, the Program or having access to any of the other Party&#146;s Licensed
Collaboration Technology, <FONT STYLE="white-space:nowrap">non-public</FONT> materials (such as lab notebooks, document management systems or other forms in which such <FONT STYLE="white-space:nowrap">Know-How</FONT> may be memorialized) or <FONT
STYLE="white-space:nowrap">non-personnel</FONT> resources, in each case, directly relating to the Program (all of the foregoing, collectively, &#147;<B>Collaboration Personnel</B>&#148;) and (ii)&nbsp;on the other hand, personnel of an Acquirer
working on the Competing Program, or having access to any nonpublic materials (such as lab notebooks, document management systems or other forms in which such <FONT STYLE="white-space:nowrap">Know-How</FONT> may be memorialized) or <FONT
STYLE="white-space:nowrap">non-personnel</FONT> resources, in each case, directly relating to the Competing Program (all of the foregoing, collectively, &#147;<B>Competing Program Personnel</B>&#148;); and (b)&nbsp;processes ensuring that
(i)&nbsp;Collaboration Personnel do not perform any Research or Development activities under the Competing Program or have access to any <FONT STYLE="white-space:nowrap">non-public</FONT> materials </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(such as lab notebooks, document management systems or other forms in which such <FONT STYLE="white-space:nowrap">Know-How</FONT> may be memorialized) or
<FONT STYLE="white-space:nowrap">non-personnel</FONT> resources, in each case, directly relating to the Competing Program and (ii)&nbsp;Competing Program Personnel do not perform Research or Development activities or any other work under the Program
or have access to any of the other Party&#146;s Licensed Collaboration Technology, <FONT STYLE="white-space:nowrap">non-public</FONT> materials (such as lab notebooks, document management systems or other forms in which such <FONT
STYLE="white-space:nowrap">Know-How</FONT> may be memorialized) or <FONT STYLE="white-space:nowrap">non-personnel</FONT> resources, in each case, directly relating to the Program. Notwithstanding the foregoing, &#147;<B>Firewalls</B>&#148; shall not
(i)&nbsp;require activities specific to the Program to be performed in a separate facility than activities that are specific to the Competing Program, provided that the activities specific to the Program are performed in a different location within
such facility than the activities specific to the Competing Program, (ii)&nbsp;restrict Collaboration Personnel from working together with Competing Program Personnel on Exploitation of any compound or product that is neither the subject of the
Program nor the subject of the Competing Program, or (iii)&nbsp;restrict executive officers or members of the board of directors of such Party or its Affiliates, including the Acquirer, from accessing or receiving disclosure of information solely as
necessary to enable executive officers and the board of directors to comply with (x)&nbsp;their fiduciary obligations to such Party or its Affiliates or (y)&nbsp;Applicable Laws; provided that such executive officers or members of the board of
directors are prohibited from using any information pertaining to the Program or any other activities covered under this Agreement to inform or make decisions regarding or relating to any Competing Programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.70 &#147;<B>First Commercial Sale</B>&#148; means the first sale of a Product by a Party or its Affiliates or their Sublicensees to a Third
Party (excluding any Sublicensee) for end use or consumption of such Product in a given country after Regulatory Approval and any Pricing and Reimbursement Approvals required to market and sell the Product has been granted with respect to such
Product in such country in which such Product is sold. Furthermore, for purposes of clarity, the term &#147;First Commercial Sale&#148; as used in this Agreement shall not include: (a)&nbsp;sales for purposes of testing any Product, or of any
Product samples; (b)&nbsp;any distribution or other sale solely for <FONT STYLE="white-space:nowrap">so-</FONT> called treatment investigational new drug sales, named patient sales, compassionate or emergency use sales or <FONT
STYLE="white-space:nowrap">pre-license</FONT> sales, in each case provided that such Product is distributed without charge or sold at or below cost; (c)&nbsp;any sale of a Product by a Party to its Affiliate (or their Sublicensees), unless there is
a subsequent resale of the Product by such Affiliate or Sublicensee; nor (d)&nbsp;other similar <FONT STYLE="white-space:nowrap">non-commercial</FONT> sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.71 &#147;<B>FTE</B>&#148; means a qualified full time person, or more than one person working the equivalent of a full-time person
performing activities under a Program Plan, where &#147;full time&#148; is based upon a total of [***] working hours per Calendar Year. For clarity, no individual person can ever constitute more than a single FTE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.72 &#147;<B>FTE Rate</B>&#148; means [***] per FTE per Calendar Year, which shall be prorated for the period beginning on the Effective Date
and ending on December&nbsp;31, 2021, and which rate is subject to annual adjustment in each Calendar Year during the Term as agreed by the JSC based on the percentage increase or decrease in the Consumer Price Index for All Urban Consumers <FONT
STYLE="white-space:nowrap">(CPI-U)</FONT> published by the U.S. Bureau of Labor Statistics as of December&nbsp;31 of each Calendar Year, over the level of such Consumer Price Index as of December&nbsp;31 of the prior Calendar Year, with the first
such increase to be effective on January&nbsp;1, 2022. Notwithstanding the foregoing, for any Calendar Year during the Term that is less than a full year, the above referenced rate shall be proportionately reduced to reflect such portion of such
full Calendar Year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.73 &#147;<B>Gene Editing</B>&#148; or &#147;<B>Gene-Editing</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.74 &#147;<B>GLP Tox Commitment Date</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.75 &#147;<B>GLP Toxicology Study</B>&#148; means, with respect to a Candidate or a Product, an <I>in vivo</I> toxicology study that is
conducted in compliance with then-current Good Laboratory Practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.76 &#147;<B>Good Clinical Practices</B>&#148; or
&#147;<B>GCP</B>&#148; means the then-current good clinical practice standards, practices, and procedures promulgated or endorsed by the applicable Regulatory Authority as set forth in the guidelines imposed by such Regulatory Authority or
Applicable Law, as each may be updated from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time,</FONT></FONT> to the extent such standards are not less stringent than applicable U.S. standards or ICH Guidelines, including
ICH E6. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.77 &#147;<B>Good Laboratory Practices</B>&#148; or &#147;<B>GLPs</B>&#148; means all applicable Good Laboratory Practice
standards, including, as applicable: (a)&nbsp;as set forth in the then-current good laboratory practice standards promulgated or endorsed by the FDA as defined in 21 C.F.R. Part 58; and (b)&nbsp;the equivalent Applicable Laws in any relevant
country, each as may be amended and applicable from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.78 &#147;<B>Good Manufacturing Practices</B>&#148; or
&#147;<B>GMP</B>&#148; means the then-current good manufacturing practice standards, practices, and procedures promulgated or endorsed by the applicable Regulatory Authority as set forth in the guidelines imposed by such Regulatory Authority or
Applicable Law, as each may be updated from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time,</FONT></FONT> to the extent such standards are not less stringent than applicable U.S. standards as provided in, but not
limited to, 21 C.F.R. Parts 210 and 211, or ICH Guidelines, including ICH Q7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.79 &#147;<B>Good Research Practices</B>&#148; or
&#147;<B>GRP</B>&#148; means research practices consistent with the Research Quality Association (RQA), 2014 Quality in Research Guidelines for Working in <FONT STYLE="white-space:nowrap">Non-Regulated</FONT> Research, as may be amended and
applicable from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.80 &#147;<B>Government Official</B>&#148; means: (i)&nbsp;any officer, employee (including physicians,
hospital administrators, or other healthcare professionals), agent, representative, department, agency, de facto official, representative, corporate entity, instrumentality or subdivision of any government, military or international organization,
including any ministry or department of health or any state-owned or affiliated company or hospital; (ii)&nbsp;any candidate for political office, any political party or any official of a political party, in each case for the purpose of obtaining or
retaining business for or with, or directing business to, any Person, including either Party; or (iii)&nbsp;any Person acting in an official capacity on behalf of any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.81 &#147;<B>Governmental Authority</B>&#148; means any national, international, federal, state, provincial or local government, or political
subdivision thereof, or any multinational organization or any authority, agency or commission entitled to exercise any administrative, executive, judicial, legislative, police, regulatory or taxing authority or power, and any court or tribunal (or
any department, bureau or division thereof, or any governmental arbitrator or arbitral body). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.82 &#147;<B>Guide</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.83 &#147;<B>IND</B>&#148; means an investigational new drug application filed with the FDA or any similar application filed with a
Regulatory Authority in a country other than the U.S. required to commence Clinical Trials of a pharmaceutical product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.84 &#147;<B>IND
Filing</B>&#148; means, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis, the filing of an IND for a Product in such Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.85 &#147;<B>Indication</B>&#148; means a disease (a)&nbsp;for which a Product is indicated for treatment and (b)&nbsp;that is described in
the Product label as required by the Regulatory Approval granted by the applicable Regulatory Authority. An Indication is only distinct from another Indication if (a)&nbsp;the diseases associated with such Indications are listed in two different
blocks of the <FONT STYLE="white-space:nowrap">ICD-10</FONT> and (b)&nbsp;Regulatory Approvals are based, in whole or in part, on separate clinical studies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.86 &#147;<B>Initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term</B>&#148; means the period that commences on the
Effective Date and continuing until [***] after the Effective Date, unless earlier terminated pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.87
&#147;<B>Initiation</B>&#148; means, with respect to a Clinical Trial, the first dosing in the first human subject in such Clinical Trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.88 &#147;<B>Internal Compliance Codes</B>&#148; means a Party&#146;s internal policies and procedures intended to ensure that a Party
complies with Applicable Laws, Party-Specific Regulations, and such Party&#146;s internal ethical, medical and similar standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.89
&#147;<B>Internal Costs</B>&#148; means [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.90 &#147;<B>Joint Patents</B>&#148; means any Patents that Cover any Joint IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.91 &#147;<B><FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148; means any proprietary scientific or technical information,
inventions, discoveries, results and data of any type whatsoever, in any tangible or intangible form, including inventions, discoveries, databases, safety information, practices, methods, instructions, techniques, processes, drawings, documentation,
specifications, formulations, formulae, knowledge, knowhow, trade secrets, materials, skill, experience, test data and other information and technology applicable to formulations, compositions or products or to their manufacture, development,
registration, use, marketing or sale or to methods of assaying or testing them, including pharmacological, pharmaceutical, medicinal chemistry, biological, chemical, biochemical, toxicological and clinical test data, physical and analytical, safety,
quality control data, manufacturing, and stability data, materials, studies and procedures, and manufacturing process and development information, results and data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.92 &#147;<B>Licensed Collaboration Technology</B>&#148; means the Metagenomi Licensed Collaboration Technology or the Moderna Licensed
Collaboration Technology, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.93 &#147;<B>Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology</B>&#148;
means the Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology or the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.94 &#147;<B>Licensed DT Product</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.95 &#147;<B>Licensed Product</B>&#148; means a Licensed DT Product or a Licensed RT Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.96 &#147;<B>Licensed RT Product</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.97 &#147;<B>Licensing Income</B>&#148; means all amounts (including upfront payments, license fees, and milestone payments) received by a
Party or any of its Affiliates from any licensee or sublicensee in consideration for the grant by such Party or any of its Affiliates of a license or sublicense of any of the rights granted under this Agreement with respect to a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory in accordance with Section&nbsp;5.7.1 (Rights to Grant Licenses and Sublicenses in the Territory). Notwithstanding the foregoing, Licensing Income shall exclude any such payment
received by a Party or any of its Affiliates from any such sublicensee in return for, as payment or consideration for, or otherwise in respect of: (a)&nbsp;equity or debt of a Party or its Affiliate purchased by such sublicensee at or below the fair
market value of such equity or debt as of the date of the purchase, (b)&nbsp;reimbursement of such Party or its Affiliates&#146; actual Manufacturing Costs of DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products with no markup,
(c)&nbsp;reimbursement with no markup for the performance of services by such Party or its Affiliate under any such sublicense, (d)&nbsp;reimbursement of such Party&#146;s or its Affiliate&#146;s External Costs and other expenses, including patent
expenses, (e)&nbsp;the sale of a Party or its Affiliate in whole or in part to a Third Party, or (f)&nbsp;a bona-fide loan, provided that any loan amounts that are forgiven shall be included in Licensing Income to the extent not otherwise captured
in the foregoing clauses (a) &#150; (e). Licensing Income in the form of <FONT STYLE="white-space:nowrap">non-cash</FONT> consideration shall be valued at fair market value at the time of receipt by the relevant Party. In addition, (i)&nbsp;to the
extent that a payment not explicitly tied to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product is made under a sublicense agreement that grants rights to both the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product and one or more
other products (<I>e.g.</I>, an upfront payment), then a <I>pro rata</I> portion of such payment shall be determined by agreement of the Parties reached in good faith based on an equitable method of determining the same that takes into account the
relative fair market value of the sublicense, which shall be considered Licensing Income which such <I>pro rata</I> portion shall be calculated based on the number of products with respect to which rights are granted under such a sublicense
agreement and (ii)&nbsp;to the extent that a payment is made under a sublicense that grants rights to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, then a <I>pro rata</I> portion of such payment shall be considered
Licensing Income, which <I>pro rata</I> portion shall be allocated based on the value of the rights granted in the Territory, in each case ((i) and (ii)), only if such amounts have not also been shared by the Parties as Eligible Development Costs,
Eligible Medical Affairs Costs, Commercialization Costs, or Other Operating Expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.98 &#147;<B>LNP</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.99 &#147;<B>Mammalian Cell Milestone</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.100 &#147;<B>Manufacture</B>&#148; means, with respect to a Product, those manufacturing-related activities that support the Development
(including the seeking and obtaining of Regulatory Approvals) and Commercialization of such Product, including manufacturing process development and <FONT STYLE="white-space:nowrap">scale-up,</FONT> validation, qualification and audit of clinical
and commercial manufacturing facilities, bulk production and fill/finish work, related quality assurance technical support activities and CMC Activities, and including the synthesis, manufacturing, processing, formulating, packaging, labeling,
holding, quality control testing and release of such Product. &#147;Manufacturing&#148; and &#147;Manufactured&#148; have a correlative meaning. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.101 &#147;<B>Manufacturing Cost</B>&#148; has the meaning set forth in <B>Schedule B
</B>(Manufacturing Cost). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.102 &#147;<B>Material Communications</B>&#148; means written, telephonic, or
<FONT STYLE="white-space:nowrap">in-person</FONT> communications from or with any Regulatory Authority (including any meeting minutes from any meetings with any Regulatory Authority) concerning any of the following: key product quality attributes
(<I>e</I>.<I>g</I>., purity), safety findings affecting the platform (<I>e</I>.<I>g</I>., Serious Adverse Events, emerging safety signals), clinical or <FONT STYLE="white-space:nowrap">non-clinical</FONT> findings affecting patient safety, lack of
efficacy, receipt or denial of Regulatory Approval, the design of Clinical Trials, or the need for additional <FONT STYLE="white-space:nowrap">non-clinical</FONT> studies or <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies
(<I>e</I>.<I>g</I>., additional toxicology or carcinogenicity studies). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.103 &#147;<B>Materials</B>&#148; means any tangible chemical or
biological material, including any compounds, DNA and RNA, mRNA Constructs, polypeptides, clones, cells, plasmids, lipids, vectors, receptors, any other nucleic acids and Polynucleotides, proteins, peptides and any expression product, progeny,
derivative or other improvement thereto, along with any tangible chemical or biological material embodying any <FONT STYLE="white-space:nowrap">Know-How.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.104 &#147;<B>Medical Affairs</B>&#148; means activities conducted by, on behalf of, or in consultation with a Party&#146;s medical
scientific affairs departments, including medical affairs, field medical (medical scientific liaisons and payor liaisons), medical information and health economics outcomes research, development and execution of strategic and tactical medical
product plans, generation of clinical and health economic outcomes data via post hoc analyses, Phase IV Optional Clinical Trials and real world evidence studies; development of economic models, production of value dossiers, key opinion leader
strategy development and communications, generation and execution of responses to medical information requests, publication of scientific findings, presentations at medical scientific congresses and virtual medical engagements; medical education,
symposia, congresses, advisory boards (to the extent related to Medical Affairs or clinical guidance), conducting health economics and outcomes research, conducting medical science liaison activities, activities performed in connection with patient
registries, and other medical programs and communications, including continuing education grants, and research grants (including conducting investigator-initiated studies), to the extent related to medical scientific affairs and not to other
activities that involve the promotion, marketing, sale, or other Commercialization of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.105 &#147;<B>Medical Affairs Budget</B>&#148; means, the budget for activities under the applicable Medical Affairs Plan for each DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.106 &#147;<B>Medical Affairs Costs</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.107 &#147;<B>Metagenomi Housemarks</B>&#148; means (a)&nbsp;the corporate logo of Metagenomi, (b)&nbsp;the trademark &#147;Metagenomi&#148;,
(c) any other Trademark, trade name, or service mark (whether registered or unregistered) containing the word &#147;Metagenomi&#148;, (d) any other corporate logo or Trademark of Metagenomi used by Metagenomi to identify Metagenomi or any of its
Affiliates, and (e)&nbsp;all intellectual property rights and goodwill associated with any and all of the foregoing in clauses (a)&nbsp;through (e). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.108 &#147;<B>Metagenomi Licensed Collaboration Technology</B>&#148; means the Metagenomi
Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology, Licensed RT Technology and Licensed DT Moderna Technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.109
&#147;<B>Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148; means all materials and <FONT STYLE="white-space:nowrap">Know-How</FONT> that Metagenomi or any of its
Affiliates Control as of the Effective Date or during the Term that (a)&nbsp;relates or otherwise pertains to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target or (b)&nbsp;is otherwise necessary or useful in Researching, Developing,
Manufacturing, Commercializing or otherwise Exploiting DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the DT Field in the Territory, in each case of
(a)&nbsp;and (b), to the extent Metagenomi makes available or is required to make available to Moderna pursuant to this Agreement. For clarity, &#147;Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
<FONT STYLE="white-space:nowrap">Know-How&#148;</FONT> includes all of Metagenomi&#146;s rights in the Metagenomi Program Technology constituting materials and <FONT STYLE="white-space:nowrap">Know-How</FONT> that satisfy the foregoing and
Metagenomi&#146;s interest in any jointly-owned materials or <FONT STYLE="white-space:nowrap">Know-How</FONT> within the Program Technology that satisfies the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.110 &#147;<B>Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Patent</B>&#148; means any Patent that Metagenomi or any
of its Affiliates Control as of the Effective Date or during the Term that (a)&nbsp;Covers any of the Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">Know-How,</FONT> (b)&nbsp;Covers or claims
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target or (c)&nbsp;would otherwise Cover any of the Research, Development, Manufacture, Commercialization or other Exploitation of one or more DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Products Directed Against such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the DT Field in the Territory, in each case of (a), (b) and (c), to the extent Metagenomi makes available or is required to make available to Moderna pursuant
to this Agreement. For clarity, &#147;Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Patent&#148; includes all of Metagenomi&#146;s rights in the Metagenomi Program Technology constituting Patents that satisfy the foregoing,
and Metagenomi&#146;s interest in any Joint Patent that satisfies the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.111 &#147;<B>Metagenomi Licensed DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Technology</B>&#148; means, individually or collectively, the Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Patents and Metagenomi Licensed DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">Know-How.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.112 &#147;<B>Moderna
Housemarks</B>&#148; means (a)&nbsp;the corporate logo of Moderna, (b)&nbsp;the trademark &#147;Moderna&#148;, (c) any other Trademark, trade name, or service mark (whether registered or unregistered) containing the word &#147;Moderna&#148;, (d) any
other corporate logo or Trademark of Moderna used by Moderna to identify Moderna or any of its Affiliates, and (e)&nbsp;all intellectual property rights and goodwill associated with any and all of the foregoing in clauses (a)&nbsp;through (e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.113 &#147;<B>Moderna Licensed Collaboration Technology</B>&#148; means Moderna&#146;s Background Technology, RT Program Technology, and DT
Program Technology, and the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.114 &#147;<B>Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT
STYLE="white-space:nowrap">Know-How</FONT></B>&#148; means all materials and <FONT STYLE="white-space:nowrap">Know-How</FONT> that Moderna or any of its Affiliates Control as of the Effective Date or during the Term that (a)&nbsp;relates or
otherwise pertains to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target or (b)&nbsp;is otherwise necessary or useful in Researching, Developing, Manufacturing, Commercializing or otherwise Exploiting DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the DT Field in the Territory, in each case of (a)&nbsp;and (b), to the extent Moderna makes available to
Metagenomi pursuant to this Agreement. For clarity, &#147;Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">Know-How&#148;</FONT> includes all of Moderna&#146;s rights in the Moderna Program
Technology constituting materials and <FONT STYLE="white-space:nowrap">Know-How</FONT> that satisfy the foregoing, and Moderna&#146;s interest in any jointly-owned materials or <FONT STYLE="white-space:nowrap">Know-How</FONT> within the Program
Technology that satisfies the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.115 &#147;<B>Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Patent</B>&#148; means any Patent that Moderna or any of its Affiliates Control as of the Effective Date or during the Term that (a)&nbsp;Covers any of the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT
STYLE="white-space:nowrap">Know-How,</FONT> (b)&nbsp;Covers or claims the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target or (c)&nbsp;would otherwise Cover any of the Research, Development, Manufacture, Commercialization or other
Exploitation of one or more DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the DT Field in the Territory, in each case of (a), (b) and (c), to the extent
Moderna makes available to Metagenomi pursuant to this Agreement. For clarity, &#147;Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Patent&#148; includes all of Moderna&#146;s rights in the Moderna Program Technology constituting
Patents that satisfy the foregoing and Moderna&#146;s interest in any Joint Patent that satisfies the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.116 &#147;<B>Moderna
Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology</B>&#148; means, individually or collectively, the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Patents and Moderna Licensed DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">Know-How.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.117 &#147;<B>mRNA Construct</B>&#148;
means [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.118 &#147;<B><FONT STYLE="white-space:nowrap">mRNA-LNP</FONT> Technology</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.119 &#147;<B>Mutual Confidentiality Agreement</B>&#148; means that certain Mutual Confidentiality Agreement entered into between the Parties
as of March&nbsp;1, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.120 &#147;<B>NDA</B>&#148; means (a)&nbsp;any New Drug Application (as defined in the FD&amp;C Act), any
Biologics License Application (&#147;<B>BLA</B>&#148;) (as defined in the PHSA) and applicable regulations promulgated thereunder by the FDA filed with the FDA to gain approval to market a pharmaceutical product in the U.S., (b) a marketing
authorization application (&#147;<B>MAA</B>&#148;) filed with (i)&nbsp;the EMA under the centralized EMA filing procedure to gain approval to market a biopharmaceutical in the E.U., or (ii)&nbsp;a Regulatory Authority in any E.U. country if the
centralized EMA filing procedure is not used to gain approval to market a biopharmaceutical in the E.U., or (c)&nbsp;any other equivalent or related Regulatory Filing filed in support of approval to market a biopharmaceutical in any country outside
of the U.S. or E.U., and, in each case ((a) through (c)), including any amendments thereto, and supplemental applications, but excluding applications for Reimbursement Approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.121 &#147;<B>Net Sales</B>&#148; means, with respect to any Product, the gross amounts invoiced by a Party (including any Affiliate of such
Party) or any Sublicensee thereof (each, a &#147;<B>Selling Party</B>&#148;) to Third Party customers for sales of such Product in the Territory, less the following deductions actually incurred, allowed, paid, accrued or specifically allocated in
its financial statements for such Product, all in accordance with U.S. GAAP, consistently applied, for: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such amounts shall be determined from the books and records of such Party or its Sublicensee
maintained in accordance with U.S. GAAP or, in the case of Sublicensees, such similar accounting principles, consistently applied. Net Sales shall not be imputed to transfers of Products for use in clinical trials,
<FONT STYLE="white-space:nowrap">non-clinical</FONT> development activities or other development activities with respect to Products, as applicable, by or on behalf of the Parties, for bona fide charitable purposes or for compassionate use, patient
program or for Product samples, if no monetary consideration exceeding the cost of goods for such Product is received for such transfers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the Product is sold as part of a Combination Product (where &#147;<B>Combination Product</B>&#148; means [***], the Net
Sales of such Product, for the purposes of determining royalty payments, shall be determined by multiplying the Net Sales of the Combination Product by the fraction, A / (A+B), where A is the weighted average sale price of the Product when sold
separately for the same dosage as contained in the Combination Product in finished form, and B is the weighted average sale price of the Other Product(s) sold separately in finished form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the weighted average sale price of the Product can be determined but the weighted average sale price of the Other Product(s)
cannot be determined, Net Sales for purposes of determining royalty payments shall be calculated by multiplying the Net Sales of the Combination Product by the fraction A / C where A is the weighted average sale price of the Product when sold
separately in finished form and C is the weighted average sale price of the Combination Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the weighted average
sale price of the Other Product(s) can be determined but the weighted average sale price of the Product cannot be determined, Net Sales for purposes of determining royalty payments shall be calculated by multiplying the Net Sales of the Combination
Product by the following formula: one (1)&nbsp;minus (B / C) where B is the weighted average sale price of the Other Product(s) when sold separately in finished form and C is the weighted average sale price of the Combination Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the weighted average sale price of both the Product and the Other Product(s) in the Combination Product cannot be
determined, the Parties shall enter into good faith negotiations to determine the appropriate value to be allocated to the Product and the Other Product(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The weighted average sale price for a Product, Other Product, or Combination Product shall be calculated once each Calendar Year and such
price shall be used during all applicable royalty reporting periods for the entire following Calendar Year. When determining the weighted average sale price of a Product, Other Product or Combination Product, the weighted average sale price shall be
calculated by dividing the sales dollars (translated into U.S. dollars) by the units of active ingredient sold during the twelve (12)&nbsp;months (or the number of months sold in a partial Calendar Year) of the preceding Calendar Year for the
respective Product, Other Product or Combination Product. In the initial Calendar Year, a forecasted weighted average sale price shall be used for the Product, Other Products or Combination Product. Any over or under payment in the initial year due
to a difference between forecasted and actual weighted average sale prices shall be paid or credited in the first royalty payment of the following Calendar Year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjuvants and excipients shall not be deemed to be &#147;active compound(s) or
ingredients&#148; except where such adjuvant or excipient is recognized by the FDA as an active ingredient in accordance with 21 C.F.R. &#167; 210.3(b)(7). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.122 &#147;<B>New Affiliate</B>&#148; means a Third Party that becomes an Affiliate of a Party after the Effective Date through or after a
Change of Control of such Party, other than (i)&nbsp;such Party, (ii) any Affiliates of such Party immediately before the consummation of such Change of Control, or (iii)&nbsp;any other Affiliates such Party or its
<FONT STYLE="white-space:nowrap">pre-consummation</FONT> Affiliates controls (directly or indirectly) after such Change of Control (including any direct or indirect subsidiaries of such Party or any such
<FONT STYLE="white-space:nowrap">pre-consummation</FONT> Affiliates). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.123 &#147;<B>NHP Milestone</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.124 &#147;<B><FONT STYLE="white-space:nowrap">Non-Orphan</FONT> Indication</B>&#148; mean an Indication other than an Orphan Indication.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.125 &#147;<B>Nonclinical Studies</B>&#148; means all <FONT STYLE="white-space:nowrap">non-human</FONT> animal studies, including
preclinical studies and toxicology studies, of Products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.126 &#147;<B>Operating Profits or Losses</B>&#148; means the profits or losses
for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory calculated in accordance with Section&nbsp;7.4 <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.127 &#147;<B>Orphan Indication</B>&#148; means an Indication for use of a drug to treat a rare disease or condition where the number of
people affected by the disease or condition in the U.S. is less than two hundred thousand (200,000) persons or where the Indication for use otherwise meets the criteria for orphan drug designation under section 526(a) of the FD&amp;C Act and 21
C.F.R. 316.21. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.128 &#147;<B>Other Operating Expenses</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No expense included as an Other Operating Expense shall also be included as a deduction under Net Sales, Commercialization Cost, Eligible Development Cost,
Cost of Sales, or Eligible Medical Affairs Cost. Other Operating Expenses specifically exclude any costs or expenses of a Party or its Affiliates to the extent caused by such Party or its Affiliate&#146;s breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.129 &#147;<B>Overspend</B>&#148; means, for a particular DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, any amount that exceeds
Allowable Overruns for a Calendar Year on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-to-date</FONT></FONT> basis set forth in any Research Budget, Development Budget, Medical Affairs Budget, or Commercialization Budget,
as applicable, for such Calendar Year; provided that such amount is not attributable to (a)&nbsp;the breach of this Agreement or (b)&nbsp;the gross negligence or willful misconduct of either Party or any of its Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.130 &#147;<B>Packaging and Labeling</B>&#148; means primary, secondary, or tertiary packaging and labeling of a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product (in its commercial packaging presentation) for sale or use in the Territory, consistent with respect to the Commercialization Plan, including the Approved Labeling and insertion of materials such as
patient inserts, patient medication guides, and professional inserts and any other written, printed, or graphic materials accompanying such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product and any brand security or anti-counterfeiting
measures included in the packaging elements for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product considered to be part of the finished packaged DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, and all testing and release
thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.131 &#147;<B>Patents</B>&#148; means: (a)&nbsp;pending patent applications, issued
patents, utility models and designs; (b)&nbsp;reissues, substitutions, confirmations, registrations, validations, <FONT STYLE="white-space:nowrap">re-examinations,</FONT> additions, continuations, continued prosecution applications, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> or divisions of or to any of the foregoing; and (c)&nbsp;extensions, renewals or restorations of any of the foregoing by existing or future extension,
renewal or restoration mechanisms, including supplementary protection certificates or the equivalent thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.132
&#147;<B>Person</B>&#148; means any corporation, limited or general partnership, limited liability company, joint venture, trust, unincorporated association, governmental body, authority, bureau or agency, any other entity or body, or an individual.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.133 &#147;<B>Pharmacovigilance Costs</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.134 &#147;<B>Phase I Clinical Trial</B>&#148; means a clinical trial of a Product generally consistent with 21 C.F.R. &#167; 312.21(a) (or
the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> equivalent thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.135 &#147;<B>Phase I Readout</B>&#148; means the
substantially final biostatistical analysis of primary and secondary clinical outcomes or endpoints, as applicable, for a Phase I Clinical Trial prior to the publication of the final clinical study report for such Phase I Clinical Trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.136 &#147;<B>Phase II Clinical Trial</B>&#148; means a clinical trial of a Product generally consistent with 21 C.F.R. &#167; 312.21(b) (or
the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> equivalent thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.137 &#147;<B>Phase III Clinical Trial</B>&#148; means a
clinical trial of a Product generally consistent with 21 C.F.R. &#167; 312.21(c) (or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> equivalent thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.138 &#147;<B>Phase IV Optional Clinical Trial</B>&#148; means any post-approval clinical study for a pharmaceutical or biologic product in a
country with respect to any Indication for which Regulatory Approval has been received in a particular country, and that is principally intended to support the Commercialization of a product, including (a)&nbsp;investigator-initiated clinical
studies initiated after Regulatory Approval of a product, (b)&nbsp;post-marketing surveillance studies of a product, and (c)&nbsp;any health and economic outcomes research and other reviews/analyses/studies relating to value and access issues, in
each case, that is not a Phase IV Required Clinical Trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.139 &#147;<B>Phase IV Required Clinical Trial</B>&#148; means any
post-approval clinical study initiated following receipt of Regulatory Approval for a pharmaceutical or biologic product in a country in an Indication or to be conducted after receipt of Regulatory Approval of a product in an Indication, in each
case, that was required by the applicable Regulatory Authority in any country in the Territory as a condition of receiving or maintaining a Regulatory Approval for such product with respect to such Indication in such country (such as post-marketing
approval studies and observational studies, if required by any Regulatory Authority in any country in the Territory to support or maintain Regulatory Approval for such product in such Indication in such country). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.140 &#147;<B>PHSA</B>&#148; means the United States Public Health Service Act, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.141 &#147;<B>Pivotal Trial</B>&#148; means any (a)&nbsp;Clinical Trial in humans that
meets the requirements of 21 C.F.R. &#167; 312.21(c), as amended (or its successor regulation), or, with respect to any other country or jurisdiction, the equivalent of such a clinical trial in such other country or jurisdiction, or (b)&nbsp;other
Clinical Trial of a pharmaceutical or biologic product, the results of which, together with prior data and information concerning such product, are intended to be or otherwise are sufficient, without any additional Clinical Trial, to meet the
evidentiary standard for demonstrating the safety, efficacy, and of such active substance of such product established by a Regulatory Authority in any particular jurisdiction and is intended to support, or otherwise supports, the submission of an
MAA in such jurisdiction (including any bridging study). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.142 &#147;<B>Polynucleotide</B>&#148;, [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.143 &#147;<B>Pricing and Reimbursement Approval</B>&#148; means an approval, agreement, determination, or other decision by the applicable
Governmental Authority that establishes prices charged to <FONT STYLE="white-space:nowrap">end-users</FONT> for biopharmaceutical products that a pharmaceutical or biologic product shall be reimbursed by the Governmental Authorities or Regulatory
Authorities in the Territory or any other approvals related to pricing, reimbursement, or access to a pharmaceutical or biologic product (including all activities related to tenders and contracts). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.144 &#147;<B>Pricing Matters</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.145 &#147;<B>Product</B>&#148; means Licensed Product or DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.146 &#147;<B>Product Marks</B>&#148; means any Trademark (whether registered or unregistered) for use on, with, or to refer to a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product or used with patient support or other information or services or Product Materials associated with a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory during the Term, including
related internet domain names. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.147 &#147;<B>Product Materials</B>&#148; means any and all promotional materials, training materials,
medical education materials, Packaging and Labeling, and all other literature or other information related to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product for use in the Territory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.148 &#147;<B>Program</B>&#148; means the RT Technology Research Program, the RT Preclinical Research Programs, the DT Target Evaluation
Program, the DT Moderna Research Programs and the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, as the case may be. For clarity, references to a Program (and the underlying definitions) hereunder refer to such Program both during the
Research Term and thereafter for the Term (including the applicable Collaboration Target and related Products). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.149 &#147;<B>Program
Patents</B>&#148; means all Patents that Cover any of the Program Technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.150 &#147;<B>Program Plan</B>&#148; means the RT
Technology Research Plan, the RT Preclinical Research Plan, the DT Target Evaluation Plan, the DT Moderna Research Plan or a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plan, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.151 &#147;<B>Prosecute and Maintain</B>&#148; or &#147;<B>Prosecution and Maintenance</B>&#148; with respect to a particular Patent, means
all activities associated with the preparation, filing, prosecution and maintenance of such Patent, together with the conduct of interferences, derivation proceedings, <I>inter partes</I> review and post-grant review, the defense of oppositions and
other similar proceedings with respect to that Patent, but not including any activities associated with claims, including as a counterclaim or declaratory judgment action, of unpatentability, invalidity or unenforceability of such Patent that are
brought by a Third Party, in connection with an Infringement under Section&nbsp;8.3 (Infringement by Third Parties) or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.152 &#147;<B>Region</B>&#148; means (A)&nbsp;with respect to Moderna, <FONT
STYLE="white-space:nowrap">Ex-U.S.,</FONT> and (B)&nbsp;with respect to Metagenomi, U.S. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.153 &#147;<B>Regulatory Approval</B>&#148;
means, collectively, any and all approvals (including supplements, amendments, <FONT STYLE="white-space:nowrap">pre-</FONT> and post-approvals, Pricing and Reimbursement Approvals), licenses, registrations, permits, notifications, and authorizations
(including marketing and labeling authorizations) or waivers of any Regulatory Authority that are necessary for the testing, research, development, registration, manufacture (including formulation), use, storage, import, export, transport,
promotion, marketing, distribution, offer for sale, sale or other commercialization of a pharmaceutical product (including any Product) in any country or jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.154 &#147;<B>Regulatory Authority</B>&#148; means any Governmental Authority that has responsibility in its applicable jurisdiction over the
testing, research, development, registration, manufacture (including formulation), use, storage, import, export, transport, promotion, marketing, distribution, offer for sale, sale or other commercialization of pharmaceutical products (including any
Product) in a given jurisdiction. For countries where governmental approval is required for pricing or reimbursement for a pharmaceutical product (including any Product) to be reimbursed by national health insurance (or its local equivalent),
Regulatory Authority includes any Governmental Authority whose review or approval of pricing or reimbursement of such product is required. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.155 &#147;<B>Regulatory Costs</B>&#148; means Internal Costs and External Costs incurred by either Party (or their Affiliates), as
applicable, in connection with the preparation or maintenance of Regulatory Documentation with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, including any meetings with Regulatory Authorities in connection therewith and
any filing, user, maintenance and other fees paid to Regulatory Authorities, preparation of Regulatory Filings for, and the obtaining and maintenance of Regulatory Approvals including compliance with Regulatory Approvals and requirements of such
Regulatory Authorities, adverse event recordation and reporting and regulatory affairs activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.156 &#147;<B>Regulatory
Documentation</B>&#148; means all: (a)&nbsp;applications (including all INDs and applications for Regulatory Approval), registrations, licenses, authorizations and approvals (including Regulatory Approvals); (b) correspondence and reports submitted
to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all adverse event files and
complaint files; (c)&nbsp;supplements or changes to any of the foregoing following Regulatory Approval; and (d)&nbsp;clinical and other data, including Clinical Trial data, contained or relied upon in any of the foregoing; in each case ((a), (b),
(c) and (d)) relating to a Collaboration Target and Products Directed Against a Collaboration Target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.157 &#147;<B>Regulatory
Exclusivity</B>&#148; means, with respect to each Product in any country in the Territory, a period of exclusivity (other than Patents exclusivity) granted or afforded by Applicable Laws or by a Regulatory Authority in such country that prevents the
approval or marketing of any Biosimilar Product of such Licensed Product in such country, including reference product exclusivity under Section&nbsp;351(k)(7)(C) of the PHSA and pediatric exclusivity under Section&nbsp;351(m) of the same and any
foreign equivalents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.158 &#147;<B>Regulatory Filings</B>&#148; means all applications, filings, and dossiers,
and other documents, data, results, and materials submitted to a Regulatory Authority in support of Development or Commercialization of a pharmaceutical or biologic product for an Indication, including for the purpose of obtaining Regulatory
Approval from that Regulatory Authority. Regulatory Filings include all INDs, NDAs, BLAs and other applications for Regulatory Approval and their equivalents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.159 &#147;<B>Regulatory Responsible Party</B>&#148; means, with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis in the Territory, (i)&nbsp;the Lead Party prior to any <FONT STYLE="white-space:nowrap">Opt-Out</FONT> and the
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Date or (ii)&nbsp;the Primary Party after the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.160 &#147;<B>Reimbursement Approval</B>&#148; means an approval, agreement, determination, or other decision by the applicable Governmental
Authority that establishes prices charged to <FONT STYLE="white-space:nowrap">end-users</FONT> for biopharmaceutical products that a pharmaceutical or biologic product shall be reimbursed by the Governmental Authorities or Regulatory Authorities in
the Territory or any other approvals related to pricing, reimbursement, or access to a pharmaceutical or biologic product (including all activities related to tenders and contracts). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.161 &#147;<B>Research</B>&#148; means, with respect to a Collaboration Target, any research and <FONT STYLE="white-space:nowrap">pre-</FONT>
clinical activities through delivery of a Data Package for such Collaboration Target, as set forth in the applicable Program Plan for such Collaboration Target. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.162 &#147;<B>Research Budget</B>&#148; means RT Research Budget, DT Moderna Research Budget, or DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Budget, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.163 &#147;<B>Research Costs&#148; </B>means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.164 &#147;<B>Research Term</B>&#148; means (i)&nbsp;with respect to the RT Programs, the RT Research Term, (ii)&nbsp;with respect to the DT
Programs, the DT Moderna Research Term, or (iii)&nbsp;with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, the Term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.165 &#147;<B>Reserved DT Targets</B>&#148; means any of the nine (9)&nbsp;targets identified in <B>Schedule</B><B></B><B>&nbsp;D
</B>(Reserved DT Targets). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.166 &#147;<B>Results</B>&#148; means all data (including raw data that has not undergone any processing,
either manually or through automated computer software, processed, distilled, analyzed or summarized data, and all representations of part or all of the data), results, findings, analyses and observations that are created or in any way generated by
a Party or Third Parties acting on a Party&#146;s behalf pursuant to this Agreement in the applicable Program. Results do not include Patents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.167 &#147;<B>Rodent Milestone</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.168 &#147;<B>RT Field</B>&#148; means <I>in vivo</I> Gene Editing for a therapeutic, ameliorative or prophylactic application [***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.169 &#147;<B>RT <FONT STYLE="white-space:nowrap">In-Licenses</FONT></B>&#148; means RT
Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements or RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.170 &#147;<B>RT Option Fee</B>&#148; means ten million Dollars ($10,000,000) for each RT Preclinical Research Program with respect to which
Moderna has exercised an RT Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.171 &#147;<B>RT Program <FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148; means, with
respect to a Party, on an RT <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-</FONT></FONT> RT Program basis, all materials and <FONT STYLE="white-space:nowrap">Know-How</FONT> that comes into the Control of such Party
or any of its Affiliates during the Term that relates or otherwise pertains to such RT Program, including that (a)&nbsp;relates or otherwise pertains to the RT Target of such RT Program, (b)&nbsp;is otherwise necessary or useful in Researching,
Developing, Manufacturing, Commercializing or otherwise Exploiting Licensed Products Directed Against such RT Target in the RT Field in the Territory, or (c)&nbsp;relates to novel delivery technology relevant to the RT Field, and in the case of
Moderna, for each of (a), (b) and (c)&nbsp;to the extent Moderna makes any of the foregoing available to Metagenomi pursuant to this Agreement. For clarity, &#147;RT Program <FONT STYLE="white-space:nowrap">Know-How&#148;</FONT> includes all of such
Party&#146;s rights in its solely-owned Program Technology constituting materials and <FONT STYLE="white-space:nowrap">Know-How</FONT> that satisfy the foregoing, and any jointly-owned materials or <FONT STYLE="white-space:nowrap">Know-How</FONT>
within the Program Technology that satisfies the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.172 &#147;<B>RT Program Patents</B>&#148; means all Patents that Cover any
of the RT Program <FONT STYLE="white-space:nowrap">Know-How.</FONT> For clarity, RT Program Patents include any Joint Patents that satisfy the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.173 &#147;<B>RT Program Technology</B>&#148; means the RT Program <FONT STYLE="white-space:nowrap">Know-How</FONT> and the RT Program
Patents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.174 &#147;<B>RT Research Term</B>&#148; means the period that commences on the Effective Date and continuing until [***] after
the Effective Date (the &#147;<B>Initial RT Research Term</B>&#148;), as may be extended by Moderna pursuant to Section&nbsp;3.8 (RT Research Term Extension), unless earlier terminated pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.175 &#147;<B>RT Research Term Extension Fee</B>&#148; means, with respect to (i)&nbsp;extension of the Initial RT Research Term by [***];
(ii) extension of the Initial RT Research Term by [***]; and (iii)&nbsp;extension of the Initial RT Research Term by [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.176
&#147;<B>RT Target</B>&#148; means [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.177 &#147;<B>RT Technology Milestones</B>&#148; means, collectively, the Mammalian Cell
Milestones, the Rodent Milestones and the NHP Milestones. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.178 &#147;<B>Safety Concern</B>&#148; means, with respect to any Product,
(a)&nbsp;any safety concern required to be reported under 21 C.F.R. &#167; 312.32 if an IND with respect to such product was open at the time of the observation (or that would be so reportable if an IND was not open at such time), or (b)&nbsp;a
toxicity or drug safety issue or a Serious Adverse Event reasonably related to or observed in connection with Development or Commercialization activities with respect to a Product, as determined by either Party, in accordance with its standard
operating procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.179 &#147;<B>Sales Force</B>&#148; means the full set of sales representatives, field managers, district
managers, regional managers, national sales managers, regional trainers, medical science trainers and the training department and other personnel assigned by the Parties for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.180 &#147;<B>Serious Adverse Event</B>&#148; means an adverse drug experience or
circumstance that results in any of the following outcomes (a)&nbsp;death, (b) life threatening condition, (c)&nbsp;inpatient hospitalization or a prolongation of existing hospitalization, (d)&nbsp;persistent or significant disability or incapacity
or substantial disruption of the ability to conduct normal life functions, (e)&nbsp;or a congenital anomaly/birth defect, (f)&nbsp;significant intervention required to prevent permanent impairment or damage, or (g)&nbsp;a medical event that may not
result in death, be life threatening, or require hospitalization but, based on appropriate medical judgment, that may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes described in
clauses (a)&nbsp;through (f). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.181 &#147;<B>Sublicensee</B>&#148; means a Third Party that is granted a license or sublicense to
research, develop, make, have made, use, keep, import, export, offer for sale, sell, or otherwise exploit one or more Products in the Field in the Territory (including any option to any of the foregoing), beyond the mere right to purchase such
Products from a Party and its Affiliates, and excludes each Party&#146;s Affiliates or Third Party subcontractors that act solely for such Party or its Affiliates in the supply chain or that perform discrete services (as opposed to being granted
broad rights or responsibilities) on behalf of such Party or its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.182 &#147;<B>Territory</B>&#148; means worldwide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.183 &#147;<B>Third Party</B>&#148; means a Person other than (a)&nbsp;Moderna or its Affiliates and (b)&nbsp;Metagenomi or its Affiliates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.184 &#147;<B>Third Party Payment</B>&#148; means all milestone, royalty, and other payments (including required reimbursement for costs
incurred in connection with enforcement or other actions and required sharing of certain recoveries) paid by a Party to any Third Party pursuant to a <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">In-License.</FONT>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.185 &#147;<B>Trademark</B>&#148; means any trademark, trade name, service mark, service name, product name, brand, domain name, trade
dress, logo, slogan, or other indicia of origin or ownership, and (a)&nbsp;all registrations, applications for registrations, and other intellectual property rights associated with any of the foregoing, and (b)&nbsp;the goodwill associated with each
of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.186 &#147;<B>U.S.</B>&#148; means the United States of America and its territories and possessions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.187 &#147;<B>U.S. GAAP</B>&#148; means generally accepted accounting principles as practiced in the U.S., as generally and consistently
applied throughout each Party&#146;s organization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.188 &#147;<B>Valid Claim</B>&#148; means a claim of any pending Patent application
or any issued, unexpired U.S. or granted foreign Patent that has not been dedicated to the public, disclaimed, abandoned or held invalid or unenforceable by a court or other body of competent jurisdiction from which no further appeal can be taken,
and that has not been explicitly disclaimed, or admitted in writing to be invalid or unenforceable or of a scope not Covering a particular product or service through reissue, disclaimer or otherwise, provided <I>that</I> if a particular claim has
not issued within seven (7)&nbsp;years of its initial priority date, it shall not be considered a Valid Claim for purposes of this Agreement unless and until such claim is included in an issued or granted Patent, notwithstanding the foregoing
definition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.189 <B>Additional Definitions</B>. These additional definitions have the meaning set forth
in the following Sections: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquirer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.17</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preamble</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alliance Manager</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Research Funding Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.3.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Filings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.24.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.24.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed Commercialization Activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.7.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed Development Activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.6</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed Medical Affairs Activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.6.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BEC Candidates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.10.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Breaching Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change of Control Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>14.9.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.1.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clinical Supply Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.23</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi
<FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.10.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna
<FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.10.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.8</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Collaboration Personnel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.69</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Combination Product</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.121</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Combination Product Development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.8</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Combination Product Development Proposal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.8</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercial Supply Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.23</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercialization Activities Cure Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.7.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercialization Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.2.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Competing Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>14.8</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Competing Program Personnel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.69</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidential Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11.1.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible Note Instruments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cure Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Designated Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.3.6(a)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Development Activities Cure Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.6</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Development Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.2.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disclosing Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11.1.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discontinued Target</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discontinued Target ROFN Exercise Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discontinued Target ROFN Exercise Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.2.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discontinued Target ROFN Negotiation Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.2.2</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discontinued Target ROFN Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dispute</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>13.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DOJ</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.24.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Exclusivity Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.21</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT License</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.15</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.12.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Candidate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Excess Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.6</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.12.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.8.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Research Budgets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.6</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Research Licensed Technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.3</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Research Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Research Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.4</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Research Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Results</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.8.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Royalty Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.10.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Target</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.4</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Target Development and Regulatory Milestone Event</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.8.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Moderna Target Sales Milestone Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.8.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Option Exercise Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.9</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Option Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.4</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Programs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Reduction Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DT Target Evaluation Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preamble</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>13.6</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existing Patents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>9.2.5(a)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Firewall Event</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>14.11</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FTC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.24.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.24.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Clearance Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.24.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Filing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.24.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ICC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>13.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ICC Arbitration Rules</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>13.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnitee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.1.3</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnitor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.1.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Infringement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.3.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial RT Research Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.174</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JCC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.3</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JDC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joint IP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.1.2(d)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JPC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JRC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.3</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JSC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JSC <FONT STYLE="white-space:nowrap">Co-Chair</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.3</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Know-How</FONT> Transfer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>14.9.2(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lead Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">License Effective Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.24.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licensed DT Moderna Technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.15</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licensed RT Technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.1.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MAA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.120</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Transfer Record</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.18</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Affairs Activities Cure Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.6.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Affairs Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.2.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Affairs Working Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.7.2(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Metagenomi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preamble</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Metagenomi Development Cost Share Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.4(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Metagenomi Indemnitee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.1.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Metagenomi Program Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Metagenomi Program Technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.1.2(b)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milestone Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.8.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Moderna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preamble</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Moderna Development Cost Share Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.4(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Moderna Indemnitee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.1.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Moderna Program Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Moderna Program Technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.1.2(c)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New Collaboration Development Activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.7(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New Development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.7(a)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New Development Activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New Development Proposal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.7(a)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Breaching</FONT> Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices and Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>9.2.11</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-In</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.5</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-In</FONT> Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.5</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-In</FONT> Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.5.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-In</FONT> Right</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.5</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-In</FONT> Transition Activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.5.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-In</FONT> Transition Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.5.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Milestone Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.11.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Product Development and Regulatory Milestone Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.11.1</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Product Sales Milestone Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.11.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Royalty Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.11.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Transition Activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.2(b)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Transition Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.2(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Trigger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Product(s)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.121</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Preamble</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Party-Specific Regulations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>9.5.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.16.3</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pharmacovigilance Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.5.7</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Primary Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Profit and Loss Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Program Technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.1.2(a)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proposed Combination Product</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.4.8</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Publishing Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11.3.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Publishing Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11.3.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Receiving Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11.1.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Working Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.7.2(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research Continuance Scenario</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>14.9.2(b)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research Transfer Scenario</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>14.9.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reversion Product</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.6.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROFN Exercise Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROFN Exercise Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.2.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROFN Negotiation Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROFN Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.2.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROFO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROFO License Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.3(b)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROFO Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROFO Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.8.3(b)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Candidate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Excess Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.5</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Exclusivity Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.20</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT License</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.13</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.11.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.11.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Option Exercise Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.9</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Option Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.3</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Preclinical Research Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Preclinical Research Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.1</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Programs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.7.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Research Budgets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.5</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Research Licensed Technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Research Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.174</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Results</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.7.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Royalty Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.9.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Target Development and Regulatory Milestone Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.8.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Target Sales Milestone Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.8.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Technology Research Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.2</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RT Technology Research Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>1.121</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shared Infringement Defense Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.4.3(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shared Patent Defense Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.4.3(a)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shared Patent Enforcement Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.3.7</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shared Patent Term Extension Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.5</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Notice Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.6.3</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party Patent Challenge</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.4</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trademark Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.7.10(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transition Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12.6.4</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>9.2.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Upfront Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.1</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>2.2</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GOVERNANCE AND JOINT STEERING COMMITTEE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <B>Alliance Manager</B>. Within thirty (30)&nbsp;days following the Effective Date, each Party shall appoint an individual to act as the
Alliance Manager for such Party (each, an &#147;<B>Alliance Manager</B>&#148;). Each Alliance Manager shall thereafter be permitted to attend meetings of the JSC or any of its subcommittees as a nonvoting observer. The Alliance Managers shall be the
primary point of contact for the Parties regarding the collaboration activities contemplated under this Agreement and shall help facilitate all such activities hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <B>Working Groups</B>. The Parties shall establish one or more working groups (each, a &#147;<B>Working Group</B>&#148;) to oversee the
activities of the Program Plans. In addition, from time to time, the Parties may establish a Working Group to oversee particular additional projects or activities. Each Working Group shall undertake the activities delegated to it by the JSC. During
the process of establishing each Working Group, such Working Group and the JSC shall agree regarding which matters such Working Group shall resolve on its own and which matters such Working Group shall advise the JSC regarding (and with respect to
which such advice-specific matters the JSC shall resolve). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <B>Joint Steering Committee</B>. Within thirty (30)&nbsp;days after the Effective Date,
the Parties shall establish a cross-functional, joint steering committee (the &#147;<B>JSC</B>&#148;) composed of up to three (3)&nbsp;senior representatives from each Party that shall oversee and manage the collaboration between the Parties with
respect to each Program during the applicable Term. The JSC may, from time to time, establish subcommittees as it deems necessary to further the purposes of this Agreement; provided that the JSC shall in any event establish (i)&nbsp;a joint research
subcommittee (&#147;<B>JRC</B>&#148;) in accordance with Section&nbsp;2.6 (Joint Research Committee), (ii) a joint development subcommittee (&#147;<B>JDC</B>&#148;) in accordance with Section&nbsp;2.7 (Joint Development Committee), (iii) a joint
commercialization subcommittee (&#147;<B>JCC</B>&#148;) in accordance with Section&nbsp;2.8 (Joint Commercialization Committee), and (iv)&nbsp;a joint patent subcommittee (&#147;<B>JPC</B>&#148;) in accordance with Section&nbsp;2.9 (Joint Patent
Committee). Each Party shall appoint its respective representatives to the JSC from time to time, and may change its representatives, in its sole discretion, effective upon notice to the other Party designating such change. The representatives from
each Party shall have appropriate technical credentials, experience and knowledge pertaining to and ongoing familiarity with the Research and the applicable Programs. One (1)&nbsp;of the Moderna representatives and one (1)&nbsp;of the Metagenomi
representatives on the JSC shall be designated the JSC <FONT STYLE="white-space:nowrap">Co-Chairs</FONT> (each, a &#147;<B>JSC <FONT STYLE="white-space:nowrap">Co-Chair</FONT></B>&#148;). The JSC <FONT STYLE="white-space:nowrap">Co-Chairs</FONT>
shall be responsible for calling meetings of the JSC, circulating agendas and performing administrative tasks required to assure efficient operation of the JSC but shall not have any extra or additional vote. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <B>Specific Responsibilities of the JSC</B>. The JSC shall: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.1 discuss, and approve each Research Budget and applicable Program Plan (including the specific contents of each Data Package) and, for
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, the criteria for DC Nomination, and review, discuss, and approve any amendments that may be necessary or desired to each Research Budget and applicable Program Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.2 address issues arising in the performance of the applicable Program Plans; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.3 determine whether a Program Plan has been completed; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.4 establish subcommittees, direct and oversee any operating subcommittee on all significant issues, and resolve disputed matters that may
arise at the subcommittees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.5 review, discuss, and determine whether to approve the Commercial Overhead Charge, as described in
Section&nbsp;1.25 (&#147;<B>Commercial Overhead Charge</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.6 review, discuss, and determine whether to approve as Allowable
Overruns any amounts that are more than [***] above the most recent <FONT STYLE="white-space:nowrap">JSC-approved</FONT> budgeted costs and expenses for a Calendar Year on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-to-date</FONT></FONT> basis set forth in any Research Budget, Development Budget, Medical Affairs Budget, or Commercialization Budget, as applicable, for such Calendar Year, as
described in Section&nbsp;1.2 (&#147;<B>Allowable Overruns</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.7 review, discuss, and determine whether to approve any
changes in the FTE Rate, as described in Section&nbsp;1.72 (&#147;<B>FTE Rate</B>&#148;); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.8 review, discuss, and determine whether to approve each update to each applicable
Program Plan, including any significant financial review, in each case, proposed by the Parties or a JSC subcommittee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.9 review,
discuss, and determine whether to approve any Overspend for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, as described in Sections 6.3.2 (Eligible <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Cost), 6.4.4(a) (Eligible
Development Costs), 6.6.3 (Medical Affairs Costs) and 6.7.3 (Commercialization Costs and Expenses); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.10 review, discuss, and determine
whether to approve any proposal to add a Proposed Combination Product to the Development Plan for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, as described in Section&nbsp;6.4.8 (Combination Products); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.11 review, discuss, and determine whether to approve Pricing and Reimbursement Approvals for the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in accordance with Section&nbsp;6.7.5 (Pricing Matters; Pricing and Reimbursement Approvals; Information Sharing; Pricing Strategy); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.12 perform such other functions as appropriate, and direct each subcommittee to perform such other functions as appropriate, to further
the purposes of this Agreement, in each case as agreed in writing by the Parties; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.13 resolve all matters that are in dispute as
escalated to the JSC by a subcommittee that cannot be resolved by such subcommittee; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4.14 perform any and all tasks and
responsibilities that are expressly attributed to the JSC under this Agreement or as otherwise agreed by the Parties in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5
<B>Meetings</B>. The JSC and each of its subcommittees shall each meet at least once per Calendar Quarter during the Research Term, and more often as may be necessary. The JSC and each of its subcommittees may conduct such meetings by telephone,
videoconference, internet meeting or in person, as determined by their members for each meeting. Each Party may call special meetings of the JSC or any of its subcommittees with at least ten (10)&nbsp;Business Days&#146; prior written notice, or a
shorter time period in exigent circumstances, to resolve particular matters requested by such Party that are within the purview of the JSC or the subcommittee, as applicable. Each Party may invite a reasonable number of participants, in addition to
its representatives, to attend JSC and subcommittee meetings in a nonvoting capacity; provided that if either Party intends to have any Third Party (including any consultant) attend such a meeting, such Party shall provide prior written notice to
the other Party. Such Party shall ensure that such Third Party is bound by confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> obligations consistent with the terms of this Agreement. Each Party is responsible for its own expenses
incurred in connection with participating in and attending all such meetings. Each Party&#146;s Alliance Manager or his/her designee shall keep minutes of each JSC and subcommittee meeting that records in writing all decisions made, action items
assigned or completed and other appropriate matters. Each Party&#146;s Alliance Manager shall help consolidate and then send meeting minutes to all members of the JSC or the subcommittee, as applicable, promptly after a meeting for review. Each
member shall have ten (10)&nbsp;Business Days from receipt in which to comment on and to approve the minutes (such approval not to be unreasonably withheld, conditioned or delayed). If a member, within such time period, does not notify either
Party&#146;s Alliance Manager that s/he does not approve of the minutes, the minutes shall be deemed to have been approved by such member. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 <B>Joint Research Committee</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.6.1 The JSC shall establish the JRC, consisting of an equal number of subject matter experts from each of Moderna and Metagenomi, within
five (5)&nbsp;days after the establishment of the JSC (or such longer period of time as mutually agreed by the Parties), each Party shall designate in writing three such representatives for the JRC. The JRC may elect to vary the number of
representatives from time to time. Either Party may replace its representatives with similarly qualified individuals at any time upon prior written notice to the other Party (including via email notification). If agreed by the JRC on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis (such agreement not to be unreasonably withheld, conditioned, or delayed), the JRC may invite other personnel of either Party from relevant support
functions to participate in the discussions and meetings of the JRC, provided that such participants shall have no voting authority at the JRC and that any <FONT STYLE="white-space:nowrap">non-employee</FONT> participants are bound by written
obligations of <FONT STYLE="white-space:nowrap">non-use</FONT> and confidentiality and obligations to assign intellectual property that are at least as restrictive or protective of the Parties and their respective intellectual property and
Confidential Information as those set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.6.2 <B>Specific responsibilities of the JRC</B>. The JRC shall have the
following responsibilities: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) discuss, prepare and submit to the JSC for approval each Research Budget and Program Plan (including the
specific contents of each Data Package) and, for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, the criteria for DC Nomination, and all annual and interim amendments to each Research Budget and Program Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) determine whether a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidate has met the approved criteria for DC Nomination; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) monitor and report the progress of the Research activities and ensuring open and frequent exchange between the Parties; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) identify and resolve any scientific or technical conflicts between the Parties; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) review, modify and oversee the implementation of each Program Plan including coordination of Research activities between the Parties;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) coordinate with the JPC all patent activities as they relate to the results of the Research activities in keeping with the overall
patent strategy delineated by the JPC; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) take such action that is contemplated for the JRC to take under this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) perform such other functions as directed by the JSC in accordance with Section&nbsp;2.4.12 (Specific Responsibilities of the JSC). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 <B>Joint Development Committee</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.7.1 <B>General</B>. Within thirty (30)&nbsp;days after DC Nomination, or earlier as determined by the JSC, the Parties shall establish the
JDC to coordinate the Development activities (including the related regulatory activities) of the Parties related to the Development of DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidate in accordance with the Development Plan. Each Party
shall initially appoint three (3)&nbsp;representatives to the JDC, with each representative having knowledge and expertise in the development of compounds and products similar to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidates and
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products and having sufficient seniority within the applicable Party to make decisions arising within the scope of the JDC&#146;s responsibilities. The JDC may change its size from time to time;
provided, that the JDC shall consist at all times of an equal number of representatives of each Party. Each Party may replace any of its JDC representatives with a qualified employee of such Party at any time upon written notice to the other Party.
The JDC may invite <FONT STYLE="white-space:nowrap">non-members</FONT> to participate in the discussions and meetings of the JDC; provided, that such participants shall have no voting authority at the JDC and shall be bound by the confidentiality
obligations no less stringent than those provided in this Agreement. The JDC shall have two <FONT STYLE="white-space:nowrap">(2)&nbsp;co-chairpersons,</FONT> one from each Party. The role of the
<FONT STYLE="white-space:nowrap">co-chairpersons</FONT> shall be to convene and preside at meetings of such JDC. The Alliance Managers shall work with the <FONT STYLE="white-space:nowrap">co-chairpersons</FONT> to prepare and circulate agendas and
to ensure the preparation of minutes. The <FONT STYLE="white-space:nowrap">co-chairpersons</FONT> shall have no additional powers or rights beyond those held by the other JDC representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.7.2 <B>Specific Responsibilities of the JDC</B>. The JDC shall have the following responsibilities: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) discuss, prepare and submit to the JSC for approval of the Development Plan and Development Budget and all annual and interim amendments
to the Development Plan and Development Budget. For clarity, (i)&nbsp;Metagenomi will be responsible for preparing any regional Development Plans and regional Development Budget in the U.S. and (ii)&nbsp;Moderna will be responsible for preparing any
regional Development Plans and regional Development Budget in all countries in the Territory other than the U.S. Such regional Development Plans are to be part of the Development Plan and Development Budget and thereby subject to comments and
proposed changes by the other Party and approval by the JSC as part of the global Development Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) oversee the conduct of the
Development Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) create, implement and review the overall strategy for Development and the design of all Clinical Trials, and
Nonclinical Studies conducted under the Development Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) oversee the conduct of a Working Group created by the JSC related to
regulatory activities in the Territory (&#147;<B>Regulatory Working Group</B>&#148;) in accordance with Section&nbsp;6.5 (Regulatory Affairs), which shall consist of equal representatives from each Party; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) oversee the conduct of a Working Group created by the JSC related to Medical Affairs activities in the Territory (&#147;<B>Medical
Affairs Working Group</B>&#148;) in accordance with Section&nbsp;6.6 (Medical Affairs), which shall consist of equal representatives from each Party;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) decide whether and when to initiate or discontinue any Clinical Trial and any
Nonclinical Study under the Development Plan, and initiate or discontinue any Clinical Trial and any Nonclinical Study; provided, that nothing is intended to limit a Party&#146;s ability to comply with Applicable Laws or manage subject safety; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) allocate budgeted resources and determine priorities for each Clinical Trial and Nonclinical Study under the Development Plan, and
oversee the conduct of all Clinical Trials and Nonclinical Studies under the Development Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) discuss and coordinate roles and
responsibilities between the Parties for Development activities in the Territory; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) facilitate the flow of information between the
Parties with respect to the Development of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, including any Manufacturing updates related to clinical supply; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) review the overall strategy regarding Regulatory Approval of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) discuss, review and oversee the conduct of any Clinical Trials in the Territory that may be included in a Development Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) review and approve terms (other than those set forth in Sections 3.6 (Subcontractors for the RT Plans) and 4.7 (Subcontractors for the DT
Plans)) between a Party and a Third Party subcontractor with respect to any Development work to be conducted by such subcontractor; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m) perform such other functions as directed by the JSC in accordance with Section&nbsp;2.4.12 (Specific Responsibilities of the JSC). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 <B>Joint Commercialization Committee</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.8.1 <B>Formation</B>. No later than twelve (12)&nbsp;months prior to the anticipated first NDA or BLA filing, as applicable, for the first
DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, the Parties shall establish the JCC to oversee and manage the Commercialization with respect to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.8.2 <B>Composition</B>. Each Party shall initially appoint three (3)&nbsp;representatives to the JCC, with each representative having
knowledge and expertise working with products similar to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, and having sufficient seniority within the applicable Party to make decisions arising within the scope of the JCC&#146;s
responsibilities. The JCC may change its size from time to time by mutual consent of its members; provided, that the JCC shall consist at all times of an equal number of representatives of each of Metagenomi and Moderna. Each Party may replace any
of its JCC representatives with a qualified employee of such Party at any time upon written notice to the other Party. The JCC may invite <FONT STYLE="white-space:nowrap">non-members</FONT> to participate in the discussions and meetings of the JCC;
provided that such participants shall have no voting authority at the JCC and shall be bound by the confidentiality obligations no less stringent than those provided in this Agreement. The JCC shall have two
<FONT STYLE="white-space:nowrap">(2)&nbsp;co-chairpersons,</FONT> one from each Party. The role of the chairpersons shall be to convene and preside at meetings of the JCC and to ensure the preparation of minutes, but the chairpersons shall have no
additional powers or rights beyond those held by the other JCC representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.8.3 <B>Specific Responsibilities of the JCC</B>. The JCC shall have the following
responsibilities: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) discuss, prepare and submit to the JSC for approval of the Commercialization Plan (including Commercialization
Budget) and all annual and interim amendments to such Commercialization Plan (including Commercialization Budget). For clarity, (i)&nbsp;Metagenomi will be responsible for preparing any regional Commercialization Plan and regional Commercialization
Budget in the U.S. and (ii)&nbsp;Moderna will be responsible for any regional Commercialization Plan and regional Commercialization Budget in all countries in the Territory other than the U.S. Such regional Commercialization Plans are to be part of
the Commercialization Plan and Commercialization Budget and thereby subject to comments and proposed changes by the other Party and approval by the JSC as part of the global Commercialization Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) monitor and discuss Commercialization of DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory, including
Distribution Matters; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) discuss, review and approve changes to the Parties&#146; Commercialization responsibilities, including <FONT
STYLE="white-space:nowrap">re-allocating</FONT> and potentially shifting (based on mutual agreement of both Parties and not subject to escalation) responsibilities between the Parties in relation to each Party&#146;s capabilities in a given aspect
of Commercialization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) establish policies and procedures and a joint promotional review Working Group, for review and approval of any
promotional materials for any DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, including with respect to the resolution of any disagreement between the Parties at the joint promotional review working; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) discuss, review and approve the use of Product Marks in any packages and labels for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Product; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) discuss, review and approve Pricing Matters in the Territory in accordance with the Commercialization Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) review and approve terms (other than those set forth in Sections 3.6 (Subcontractors for the RT Plans) and 4.7 (Subcontractors for the DT
Plans)) between a Party and a Third Party subcontractor with respect to any Commercialization work to be conducted by such subcontractor; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) perform such other functions as directed by the JSC in accordance with Section&nbsp;2.4.12 (Specific Responsibilities of the JSC). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 <B>Joint Patent Committee</B>. The JSC shall establish the JPC, consisting of one
(1)&nbsp;subject matter expert from each Party or such other number as the JSC may agree upon (with an equal number of experts from each of Moderna and Metagenomi), within five (5)&nbsp;days after the establishment of the JSC. The JPC shall be
responsible for evaluating technology arising during the applicable Research Term under this Agreement, including (a)&nbsp;making initial determination of inventorship, (b)&nbsp;determining whether such technology is Metagenomi Program Technology or
Moderna Program Technology (including whether certain technologies can be separately categorized and separately patentable and subject to separate assignment and license obligations hereunder), and (c)&nbsp;coordination of the Parties with respect
to managing the preparation, filing, prosecution, maintenance, enforcement and defense of Joint IP (and determining whether any such Joint IP should be maintained as trade secret in lieu of patenting), including in accordance with the provisions set
forth in Article 8 (Intellectual Property); provided that disputes at the JPC with respect to Patent strategy with respect to Article 8 (Intellectual Property) shall be resolved in accordance with Article 8 (Intellectual Property) and shall not be
escalated to the JSC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 <B>Decisions</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.10.1 <B>Decision-making Generally</B>. The JSC, subcommittees, including the JRC, JDC, JCC and JPC, and Working Groups shall endeavor to
make decisions by consensus, with the representatives of each Party having, collectively, one (1)&nbsp;vote on behalf of that Party (which vote shall, with respect to the JSC, be exercised by the respective JSC
<FONT STYLE="white-space:nowrap">Co-Chairs).</FONT> Unless expressly provided for herein, JSC decisions shall not be subject to a <FONT STYLE="white-space:nowrap">tie-breaking</FONT> vote. Deadlocks in the case of subcommittees and Working Groups
(except, for clarity, deadlocks at the JPC with respect to Patent strategy under Article 8 (Intellectual Property), which shall be resolved in accordance with Article 8 (Intellectual Property)) shall be referred to the JSC for final disposition. If
the JSC cannot reach consensus or a dispute arises that cannot be resolved within the JSC, either Party may refer such dispute to the Executive Officers for discussion and attempted resolution in good faith. If consensus cannot be reached with
respect to a decision within thirty (30)&nbsp;days after attempted resolution by the Executive Officers, then, subject to Section&nbsp;2.10.2 (Decision-making for DT CoCo Plans): (a) Moderna has the deciding vote with respect to [***]; provided that
Moderna shall not resolve any such matter under the foregoing clause (a)&nbsp;in a manner that would [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.10.2 <B>Decision-making for
DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans</B>. All matters within the purview of the JSC with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans shall be decided by consensus, with no
<FONT STYLE="white-space:nowrap">tie-breaking</FONT> vote, and any failure to reach consensus shall be resolved in accordance with Section&nbsp;13.4 (Baseball Arbitration) with the goal of advancing the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Program in an expedited fashion, provided that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Moderna shall have the deciding vote
on [***]; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Metagenomi shall have the deciding vote on all matters related to the application of Metagenomi Licensed DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Technology to Metagenomi&#146;s activities under the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.10.3 <B>Disputes for Achievement of Milestones</B>. If the JSC is unable to reach consensus on whether [***] Milestone or [***] Milestone
has been achieved, and if Moderna exercises its decision-making right pursuant to [***] then at the request of Metagenomi such dispute shall be resolved in accordance with Section&nbsp;13.4 (Baseball Arbitration) provided that Metagenomi shall only
have the right to request arbitration one (1)&nbsp;time for achievement of each [***] Milestone. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11 <B>Authority</B>. The JSC, the JSC <FONT STYLE="white-space:nowrap">Co-Chairs</FONT>
and each subcommittee have only the powers assigned expressly to them in this Article 2 (Governance and Joint Steering Committee) and elsewhere in this Agreement, and does not have any power to amend, modify or waive compliance with this Agreement.
Each Party retains the rights, powers and discretion granted to it under this Agreement and neither Party may delegate or vest such rights, powers or discretion in the JSC or subcommittee unless expressly provided for in this Agreement or the
Parties expressly so agree in writing. The JSC shall not have the power to amend, waive or modify any term of this Agreement, and no decision of the JSC shall be in contravention of any terms and conditions of this Agreement. It is understood and
agreed that issues to be formally decided by the JSC are limited to those specific issues that are expressly provided in this Agreement to be decided by the JSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12 <B>Discontinuation of JSC</B>. The JSC will continue, on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis, until the expiration or termination of the Research Term for such Program. Upon disbanding of the JSC with respect to a Program, any
subcommittees and Working Groups with respect to such Program shall be promptly disbanded with immediate effect (unless the Parties otherwise mutually agree). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 3 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RT RESEARCH
ACTIVITIES AND OPTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <B>Goals</B>. The objectives for the RT Research Term are for the Parties: (i)&nbsp;to discover and advance
Gene Editing technology within the RT Field to meet the RT Technology Milestones (the &#147;<B>RT Technology Research Program</B>&#148;); and (ii)&nbsp;to discover and advance Licensed Product candidates within the RT Field (each, a &#147;<B>RT
Candidate</B>&#148;) Directed Against specific RT Targets identified in the RT Preclinical Research Plans in order to permit Moderna to evaluate whether to exercise the RT Option with respect to any such RT Target (with respect to each specific RT
Target, an &#147;<B>RT Preclinical Research Program</B>&#148;; together with the RT Technology Research Program, the &#147;<B>RT Programs</B>&#148;). Notwithstanding anything to the contrary herein, the Parties may also perform Research under the RT
Technology Research Program involving specific targets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <B>RT Technology Research Plan</B>. During the RT Research Term, the Research
activities in the RT Technology Research Program shall follow a research plan and budget detailing principal objectives and the activities to be undertaken by both Parties, which includes: (a)&nbsp;the responsibilities of the Parties, and (b)&nbsp;a
timeline showing the key activities and timeframes in which such activities are expected to be completed (the &#147;<B>RT Technology Research Plan</B>&#148;). The initial RT Technology Research Plan appended in <B>Schedule L </B>(RT Technology
Research Plan) shall be presented by the Parties to the JSC for approval within thirty (30)&nbsp;days after the Effective Date. Moderna shall have the right to modify or amend the RT Technology Research Plan, provided that any modifications or
amendments to the RT Technology Research Plan shall be subject to review by the JRC and approval by the JSC. The RT Technology Research Plan shall provide for achieving the [***] milestone. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <B>RT Preclinical Research Plan</B>. At any time during the RT Research Term, Moderna
may initiate one or more RT Preclinical Research Programs by written notice to Metagenomi. Upon receiving such a written notice, the Parties shall jointly propose a research and development plan and budget detailing principal objectives and the
activities to be undertaken by both Parties in the RT Preclinical Research Program(s), which includes: (a)&nbsp;the responsibilities of the Parties, and (b)&nbsp;a timeline showing the key activities and timeframes in which such activities are
expected to be completed (each, an &#147;<B>RT Preclinical Research Plan</B>&#148;; together with the RT Technology Research Plan, the &#147;<B>RT Plans</B>&#148;). The initial RT Preclinical Research Plan shall be reviewed by the JRC and approved
by the JSC. Moderna shall have the right to modify or amend the RT Preclinical Research Plan, provided that any modifications or amendments to the RT Preclinical Research Plan shall be subject to review by the JRC and approval by the JSC. Moderna
shall use Commercially Reasonable Efforts to identify potential programs in the RT Field and to establish RT Plans for such programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4
<B>Obligations During the RT Research Term</B>. Each Party shall use Commercially Reasonable Efforts to perform and complete (itself or through its Affiliates or by permitted subcontracting) its obligations under the RT Plans. Neither Party shall be
required to perform any work which is not contemplated by any RT Plan, unless such additional work is reflected in a mutually agreed amendment to the applicable RT Plan. Without limiting the generality of the foregoing, on an RT Preclinical Research
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Preclinical Research Program basis, each Party shall use Commercially Reasonable Efforts to perform and complete its activities under the applicable RT
Preclinical Research Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5 <B>RT Research Term Costs</B>. Metagenomi&#146;s Research Costs incurred under the RT Technology Research
Plan and any RT Preclinical Research Plan shall, on an annual basis, first be credited against the Annual Research Funding Amounts. Upon fully consuming the Annual Research Funding Amount for any given year by Metagenomi&#146;s Research Costs
(which, for the avoidance of doubt, include Research Costs incurred under the DT Plans), Moderna shall pay Metagenomi for Metagenomi&#146;s Research Costs incurred under the RT Plans which are not covered by the Annual Research Funding Amount (the
&#147;<B>RT Excess Costs</B>&#148;) so long as the aggregate Research Costs incurred by Metagenomi in the RT Programs do not exceed the aggregate budgets therefor set forth in the RT Plans (the &#147;<B>RT Research Budgets</B>&#148;), provided
<I>that</I> Moderna&#146;s obligation to compensate Metagenomi for RT Excess Costs shall be subject to Metagenomi&#146;s obligation to provide reports describing all of Metagenomi&#146;s Research Costs incurred under the RT Technology Research Plan
and any RT Preclinical Research Plan, including any RT Excess Costs. Within [***] after the end of each Calendar Quarter, Metagenomi shall send such a report to Moderna describing all of Metagenomi&#146;s Research Costs incurred under the RT
Technology Research Plan and any RT Preclinical Research Plan, including any RT Excess Costs, for such Calendar Quarter. Moderna may reasonably request additional supporting documentation for Metagenomi&#146;s Research Costs described in such
reports and Metagenomi shall provide such documentation (e.g. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost breakdowns and general allocation of FTEs). No later than [***] after receipt of any
such invoice from Metagenomi, Moderna shall make payment of undisputed amounts for the RT Excess Costs for such Calendar Quarter. Reimbursement of any RT Excess Costs in excess of the RT Research Budgets shall be subject to approval by the JSC.
Metagenomi shall use the Annual Research Funding Amounts it receives from Moderna under this Agreement solely to carry out its activities in the RT Technology Research Program, the RT Preclinical Research Programs, the DT Target Evaluation Program,
and the DT Moderna Research Programs in accordance with the applicable Program Plans therefor and the terms and conditions of this Agreement and for no other purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 <B>Subcontractors for the RT Plans</B>. Subject to the remainder of this
Section&nbsp;3.6 (Subcontractors for the RT Plans), each Party may engage subcontractors to perform its obligations under the applicable RT Plan. In all cases, such Party shall ensure that (a)&nbsp;it remains responsible for the work allocated to
such subcontractors to the same extent it would if it had done such work itself, (b)&nbsp;the subcontractor undertakes in writing obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> regarding Confidential Information
that are at least as protective as those undertaken by such Party with respect to Confidential Information pursuant to Article 11 (Confidentiality), and (c)&nbsp;the subcontractor undertakes in writing to assign or exclusively license back (with the
right to sublicense through multiple tiers) all intellectual property with respect to all Results and all other intellectual property arising out of such subcontracted activities, in each case in the course of performing any such work under the
applicable RT Plan to such Party such that such Party shall Control such intellectual property. Without limiting the generality of the foregoing, each Party may subcontract any of its obligations under the applicable RT Plan to a university or
academic institution on reasonable and customary terms, provided that, (a)&nbsp;such Party shall use reasonable efforts to ensure that such subcontracting relationship is consistent with, and such university or academic institution abides by, the
terms and obligations set forth in this Section&nbsp;3.6 (Subcontractors for the RT Plans) (or such revisions to such terms or obligations as the Parties may mutually agree) and (b)&nbsp;neither the U.S. government nor any agency thereof has funded
or will fund any part of such subcontracting relationship. The engagement of any subcontractor in compliance with this Section&nbsp;3.6 (Subcontractors for the RT Plans) shall not relieve either Party of its obligations under the applicable RT Plan
or this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7 <B>Records and Reports</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.7.1 <B>Records</B>. Metagenomi and Moderna shall maintain, or cause to be maintained, during the RT Research Term and for a reasonable
period of time thereafter that is consistent with industry standards, complete and accurate written (or electronic) records of its activities under each RT Plan in sufficient detail and in a good scientific manner appropriate for scientific, patent
and regulatory purposes, which records shall reasonably reflect all work performed by or on behalf of such Party under the applicable RT Plan (the &#147;<B>RT Records</B>&#148;). Moderna may request a copy of any RT Records of Metagenomi. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.7.2 <B>Reports</B>. Metagenomi and Moderna shall report on a Calendar Quarter basis to the other Party through the JRC its Results in
conducting activities under the RT Plans (the &#147;<B>RT Results</B>&#148;). In addition, for each RT Program, each Party shall provide the JRC with, on a Calendar Quarter basis during the RT Research Term, all RT Results generated by or on behalf
of such Party in performance of its activities under the applicable RT Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.7.3 <B>Ownership; Confidentiality</B>. Each Party shall
own all rights, title and interest (including all intellectual property rights) in and to the RT Results and the RT Records generated by or for it in accordance with Section&nbsp;8.1.2 (Ownership of Intellectual Property). The RT Results and RT
Records constitute Confidential Information and shall in each case be subject to the rights and obligations of the Parties under this Agreement, including Article 11 (Confidentiality) and the licenses granted hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8 <B>RT Research Term Extension</B>. Notwithstanding anything to the contrary, Moderna
may, in its sole discretion, extend the RT Research Term by one (1)&nbsp;year for up to three (3) separate times each upon (i)&nbsp;written notice to Metagenomi provided at least [***] prior to the expiration of the existing RT Research Term and
(ii)&nbsp;payment of the applicable RT Research Term Extension Fee. If Moderna desires that Metagenomi conduct additional Research activities within the RT Field after the expiration of the RT Research Term and Metagenomi agrees to conduct such
additional activities, the Parties shall negotiate in good faith the terms and conditions of Metagenomi&#146;s conduct of such additional activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.9 <B>RT Option</B>. On an RT Preclinical Research
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Preclinical Research Program basis, Metagenomi hereby grants to Moderna the right, but not the obligation, to exercise an exclusive option, exercisable at
any time during the Term but [***] (the &#147;<B>RT Option Period</B>&#148;), to obtain the licenses set forth in Section&nbsp;5.13 (License to Moderna Upon Exercise of the RT Option) with respect to such RT Preclinical Research Program (the
&#147;<B>RT Option</B>&#148;). Moderna may exercise the RT Option up to ten (10)&nbsp;times, each with respect to an RT Target under an RT Preclinical Research Program at its own choosing in its sole discretion. No later than thirty (30)&nbsp;days
after the beginning of the RT Option Period for each RT Preclinical Research Program, Metagenomi shall (a)&nbsp;provide to Moderna the Data Package for such RT Preclinical Research Program, and (b)&nbsp;afford reasonable access during normal
business hours to Metagenomi&#146;s personnel by Moderna and its representatives as Moderna may reasonably request to assist Moderna in deciding whether to exercise the RT Option. Moderna may exercise the RT Option with respect to an RT Preclinical
Research Program by delivering an RT Option exercise notice in respect of such RT Option to Metagenomi at any time during the Term prior to the expiration of the applicable RT Option Period for such RT Preclinical Research Program (the date of such
delivery, the &#147;<B>RT Option Exercise Date</B>&#148;). The RT Option exercise notice shall include the RT Target that is the subject of such RT Option, to be designated as follows: (i)&nbsp;an election of a set of up to [***] genes that are
reasonably known or hypothesized in the scientific arts (A) [***]. Within [***] after the RT Option Exercise Date, Moderna shall pay the RT Option Fee for such RT Preclinical Research Program to Metagenomi. For clarity, on an RT Preclinical Research
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Preclinical Research Program basis, after Moderna exercises its RT Option with respect to such RT Preclinical Research Program, Moderna shall be solely
responsible and have sole authority for all Development (including IND Filing), Manufacturing and Commercialization of all Licensed RT Products for such RT Preclinical Research Program, and Moderna shall use Commercially Reasonable Efforts to
Develop and Commercialize one or more Licensed RT Products for each such RT Preclinical Research Program. For the avoidance of doubt, Moderna may exercise the RT Option with respect to such RT Preclinical Research Program during the RT Option
Period, regardless of whether the applicable RT Preclinical Research Plan has been put in place and whether activities under the applicable RT Preclinical Research Plan have been completed or carried out at all. If Moderna does not exercise the RT
Option during the RT Option Period, then Metagenomi shall have no further obligation to Moderna with respect to such RT Preclinical Research Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10 <B>Metagenomi BEC Programs</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.10.1 Starting [***] after the Effective Date and during the Initial RT Research Term, Metagenomi may from time to time propose to the JSC in
writing an RT Target for use in the RT Field, if such RT Target is not already included in an ongoing RT Preclinical Research Program, for which Metagenomi wishes to initiate a research program to discover and advance candidates Directed Against
such RT Target in the RT Field through BEC (each such research </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
program, a, &#147;<B>Metagenomi BEC Program</B>&#148; and such candidates, the &#147;<B>BEC Candidates</B>&#148;) along with written justification of why such RT Target is amenable to a BEC
approach in the RT Field, in sufficient detail for the JSC to assess the feasibility and prospect of applying BEC in the RT Field on such RT Target. If, within [***] days after the JSC&#146;s receipt of the written proposal and justification,
Moderna (a)&nbsp;has not provided written notice to Metagenomi to initiate an RT Preclinical Research Program for such RT Target in the RT Field or (b)&nbsp;has provided Metagenomi with written notice that it does not have an intent to do so,
Metagenomi may initiate such Metagenomi BEC Program at its own cost and expense, provided that Metagenomi may not initiate more than [***] Metagenomi BEC Programs during each Calendar Year during the Initial Research Term. Metagenomi will
periodically (through the JSC) thereafter provide information about the status and activities of such Metagenomi BEC Program promptly upon (and in any event within [***] after) Moderna&#146;s reasonable request, in sufficient detail to allow Moderna
to assess the status and to review the activities of such Metagenomi BEC Program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.10.2 Subject to the remainder of this
Section&nbsp;3.10.2 (Metagenomi BEC Programs), Metagenomi may engage subcontractors to perform its activities in the Metagenomi BEC Programs. In all cases, Metagenomi shall ensure that (a)&nbsp;it remains responsible for the work allocated to such
subcontractors to the same extent it would if it had done such work itself, (b)&nbsp;the subcontractor undertakes in writing obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> regarding Confidential Information that
are at least as protective as those undertaken by Metagenomi with respect to Confidential Information pursuant to Article 11 (Confidentiality), and (c)&nbsp;the subcontractor undertakes in writing to assign or exclusively license back (with the
right to sublicense through multiple tiers) all intellectual property with respect to all data (including raw data that has not undergone any processing, either manually or through automated computer software, processed, distilled, analyzed or
summarized data, and all representations of part or all of the data), results, findings, analyses and observations, and all other intellectual property arising out of such subcontracted activities, in each case in the course of performing any such
work in the applicable Metagenomi BEC Programs such that Metagenomi shall Control such intellectual property. Except as expressly set forth in this Section&nbsp;3.10, (Metagenomi BEC Programs) Metagenomi and its Affiliates shall not, itself or with
or through any Third Party, nor authorize, (sub)license (including granting any option, covenant not to sue, or other like right thereto) or otherwise enable any Third Party to, directly or indirectly, design, identify, research, manufacture,
develop, commercialize or otherwise exploit any candidate or product in connection with the application of BEC in the RT Field during the Initial RT Research Term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.10.3 Moderna may at any time during the Initial RT Research Program initiate an RT Preclinical Research Program for an RT Target which is
also the subject of a Metagenomi BEC Program by written notice to Metagenomi, and within [***] days after receiving such written notice, (a)&nbsp;Metagenomi will cooperate with Moderna to transfer the activities of such Metagenomi BEC Program to
such RT Preclinical Research Program, (b)&nbsp;the Parties shall jointly propose an RT Preclinical Research Plan for such RT Preclinical Research Program, taking into account the activities that have been conducted in such Metagenomi BEC Program,
and (c)&nbsp;Moderna shall pay to Metagenomi an amount equal to Metagenomi&#146;s costs incurred to date in such Metagenomi BEC Program that is transferred to Moderna upon the earlier of (i)&nbsp;the Base Editing system generated under such
Metagenomi BEC Program achieving during the Initial RT Research Term the Base Editing Correction Readiness milestone for the RT Target of such Metagenomi BEC Program or (ii)&nbsp;Moderna exercises the RT Option with respect to such RT Preclinical
Research Program; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provided that such payment under this clause (c)&nbsp;by Moderna may also be made by crediting any unused amounts from the Annual Research Funding Amount and shall not exceed [***]. From and
after the end of the thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> period, the Parties&#146; rights and obligations with respect to RT Preclinical Research Programs under this Agreement (including, without limitation, those under Sections
3.4 (Obligations During the RT Research Term) through 3.9 (RT Option) and the applicable licenses granted under Article 5 (Licenses; Exclusivity; Manufacture)) shall apply to such RT Preclinical Research Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.10.4 During the Initial RT Research Term, Metagenomi will notify Moderna in writing no later than [***] days prior to the anticipated GLP
Tox Commitment Date of any Metagenomi BEC Program of the upcoming GLP Tox Commitment Date, together with a full data package for the Metagenomi BEC Program, with sufficient data (e.g., results, data (including raw data and summaries thereof),
conclusions and findings), consistent with industry standard, for purposes of demonstrating achievement of indicated success criteria for GLP Toxicology Study, for Moderna to review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) If within [***] of receiving such notice and data package, Moderna has not provided written notice to Metagenomi of Moderna&#146;s
intention to initiate an RT Preclinical Research Program for the RT Target that is also the subject of such Metagenomi BEC Program, (i)&nbsp;Metagenomi is free to pursue such Metagenomi BEC Program without any further obligation to Moderna under
this Agreement and the applicable RT Target in such Metagenomi BEC Program with respect to BEC, and (ii)&nbsp;the RT Target in such Metagenomi BEC Program shall remain available to Moderna for purposes of initiating an RT Preclinical Research
Program, provided, however, such RT Preclinical Research Program directed to such RT Target shall not include BEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) If within [***]
of receiving such notice and data package, Moderna provides a written notice to Metagenomi of Moderna&#146;s intention to initiate an RT Preclinical Research Program for the RT Target that is also the subject of such Metagenomi BEC Program,
(i)&nbsp;Metagenomi will cooperate with Moderna to transfer the activities of such Metagenomi BEC Program to the newly established RT Preclinical Research Program, (ii)&nbsp;the Parties shall jointly propose an RT Preclinical Research Plan for such
RT Preclinical Research Program, taking into account the activities that have been conducted in such Metagenomi BEC Program, and (iii)&nbsp;Moderna shall pay to Metagenomi an amount equal to Metagenomi&#146;s costs incurred to date in such
Metagenomi BEC Program that is transferred to Moderna upon the earlier of (A)&nbsp;the Base Editing system generated under such Metagenomi BEC Program during the Initial RT Research Term achieving the [***] milestone for the RT Target of such
Metagenomi BEC Program or (B)&nbsp;Moderna exercises the RT Option with respect to such RT Preclinical Research Program; provided that such payment under this clause (iii)&nbsp;by Moderna may also be made by crediting any unused amounts from the
Annual Research Funding Amount and shall not exceed [***]. From and after the end of the [***] period, the Parties&#146; rights and obligations with respect to RT Preclinical Research Programs under this Agreement (including, without limitation,
those under Sections 3.4 (Obligations During the RT Research Term) through 3.9 (RT Option) and the applicable licenses granted under Article 5 (Licenses; Exclusivity; Manufacture)) shall apply to such RT Preclinical Research Program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.10.5 For clarity, Moderna is not obligated to provide any funding to Metagenomi or its
Affiliates in connection with the Metagenomi BEC Programs, and Metagenomi and its Affiliates shall not use any Annual Research Funding Amounts (or any portion thereof) or any other funding provided by Moderna under this Agreement in connection with
the Metagenomi BEC Programs. Moderna and its Affiliates are not obligated to grant, and do not and shall not grant, Metagenomi or its Affiliates any license under any intellectual property, or otherwise provide to Metagenomi or its Affiliates any
technology (including, without limitation, any <FONT STYLE="white-space:nowrap">mRNA-LNP</FONT> Technology), in each case in connection with the Metagenomi BEC Programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.10.6 For clarity, after the end of the Initial RT Research Term, Metagenomi is free to pursue BEC in the RT Field without any further
obligation to Moderna with respect to BEC in the RT Field under this Agreement except in relation to any RT Options exercised before the expiration of the applicable RT Option Period. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 4 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MODERNA DT
RESEARCH ACTIVITIES AND OPTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <B>Reserved DT Target Discontinuance</B>. Within [***] after the earlier of (i) [***] after
achieving Base Editing Knockout Readiness or (ii)&nbsp;the [***] anniversary of the Effective Date, but in no event earlier than the [***] of the Effective Date (the &#147;<B>DT Reduction Date</B>&#148;), in the event the number of Reserved DT
Targets remaining as of the DT Reduction Date is greater than [***], Moderna shall reduce the number of Reserved DT Targets remaining to [***] by selecting, at its own choosing, the appropriate number of targets from among the remaining [***] for
exclusion from the [***]. Notwithstanding the foregoing, within [***], in the event the number of Reserved DT Targets remaining as of the [***] of the Effective Date is greater than [***] Moderna shall reduce the number of Reserved DT Targets
remaining to [***] by selecting, at its own choosing, the appropriate number of targets from among the remaining Reserved DT [***] for exclusion from the Reserved DT Targets. Within [***] after the [***] of the Effective Date, in the event the
number of Reserved DT Targets remaining as of the [***] of the Effective Date is greater than [***], Moderna shall reduce the number of Reserved DT Targets remaining to [***] by selecting, at its own choosing, the appropriate number of targets from
among the remaining Reserved DT Targets for exclusion from the Reserved DT Targets. Any Reserved DT Target selected by Moderna for exclusion from the Reserved DT Targets pursuant to this Section&nbsp;4.1 (Reserved DT Target Discontinuance) shall,
from and after such selection, be referred to as a &#147;<B>Discontinued Target</B>&#148; and cease to be a Reserved DT Target. In the event such Reserved DT Target is the subject of an ongoing DT Moderna Research Program at the time Moderna selects
it for exclusion, the DT Moderna Research Program is deemed to have been terminated by Moderna pursuant to Section&nbsp;12.4 (Termination for Convenience by Moderna), and such Reserved DT Target shall cease to be a DT Moderna Target, in each case as
of the date of such selection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <B>Right of First Negotiation</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2.1 If, (a)&nbsp;at any time prior to the earlier of (i) [***] after achieving Base Editing Knockout Readiness or (ii)&nbsp;the [***] of the
Effective Date, Metagenomi or any of its Affiliates wishes to grant any Third Party any rights related to the target [***] within the DT Field in the Territory, (b)&nbsp;at any time prior to the earlier of (i) [***] after achieving Base Editing
Knockout Readiness or (ii)&nbsp;the [***] of the Effective Date, Metagenomi or any of its Affiliates wishes to grant any Third Party any rights related to the target [***] within the DT Field in the Territory, or (c)&nbsp;at any time prior to the
[***] of the Effective Date, Metagenomi or any of its Affiliates wishes </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to grant any Third Party any rights related to [***] (each time period in (a), (b) or (c), a &#147;<B>ROFN Period</B>&#148;), Metagenomi shall provide Moderna with written notice thereof, which
notice shall identify the rights Metagenomi or its applicable Affiliate wishes to grant, and the applicable countries or regions of the Territory to which the applicable grant of rights would apply, together with such information and data in
Metagenomi&#146;s or its applicable Affiliate&#146;s Control that would be reasonably useful for Moderna to determine wither to exercise its right under this Section&nbsp;4.2.1 (Right of First Negotiation) (the &#147;<B>ROFN Notice</B>&#148;).
Moderna shall have a right of first negotiation on the terms and conditions set forth in this Section&nbsp;4.2.1 (Right of First Negotiation). In the event Moderna wishes to exercise its right of first negotiation with respect to such target [***],
as applicable, identified in the ROFN Notice, it shall do so in writing (the &#147;<B>ROFN Exercise Notice</B>&#148;) no later than [***] after Moderna&#146;s receipt of the applicable ROFN Notice (the &#147;<B>ROFN Exercise Period</B>&#148;). Upon
Metagenomi&#146;s receipt of the applicable ROFN Exercise Notice, Metagenomi and Moderna shall negotiate in good faith to attempt to reach agreement on the terms of a collaboration and license agreement for the target [***] as applicable, in the
applicable countries or regions of the Territory similar to the terms related to DT Moderna Research Programs in this Agreement as if the target [***] as applicable, were a DT Moderna Target. If (A)&nbsp;the Parties do not enter into such
collaboration and license agreement within [***] of Metagenomi&#146;s receipt of the applicable ROFN Exercise Notice (the &#147;<B>ROFN Negotiation Period</B>&#148;), (B) Moderna fails to respond during the applicable ROFN Exercise Period, or
(C)&nbsp;Moderna notifies Metagenomi that it elects not to exercise such negotiation right, Metagenomi or its applicable Affiliate shall be free to seek to enter into an agreement granting rights to the target [***] as applicable, in the countries
or regions in the Territory with the Third Party, each as identified in the applicable ROFN Notice; provided that in the event Metagenomi or its applicable Affiliate does not enter into such an agreement within [***] days from (x)&nbsp;in the case
of clause (A), expiration of the applicable ROFN Negotiation Period, or (y)&nbsp;in the case of clauses (B)&nbsp;and (C), expiration of the applicable ROFN Exercise Period (or earlier delivery of notice by Moderna to Metagenomi that it elects not to
exercise such negotiation right), Metagenomi shall thereafter be obligated to, prior to entering into any such agreement, resubmit the ROFN Notice and enter into good faith negotiations with Moderna regarding such rights as specified above in this
Section&nbsp;4.2.1 (Right of First Negotiation) at Moderna&#146;s request, so long as the applicable ROFN Period has not expired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2.2
If, at any time within [***] after a Discontinued Target becomes a Discontinued Target (the &#147;<B>Discontinued Target ROFN Period</B>&#148;), Metagenomi or any of its Affiliates wishes to grant any Third Party any rights related to such
Discontinued Target within the DT Field in the Territory, Metagenomi shall provide Moderna with written notice thereof, which notice shall identify the rights Metagenomi or its applicable Affiliate wishes to grant, and the applicable countries or
regions of the Territory to which the applicable grant of rights would apply, together with such information and data in Metagenomi&#146;s or its applicable Affiliate&#146;s Control that would be reasonably useful for Moderna to determine wither to
exercise its right under this Section&nbsp;4.2.2 (Right of First Negotiation) (the &#147;<B>Discontinued Target ROFN Notice</B>&#148;). Moderna shall have a right of first negotiation on the terms and conditions set forth in this Section&nbsp;4.2.2
(Right of First Negotiation). In the event Moderna wishes to exercise its right of first negotiation with respect to such Discontinued Target identified in the Discontinued Target ROFN Notice, it shall do so in writing (the &#147;<B>Discontinued
Target ROFN Exercise Notice</B>&#148;) no later than [***] after Moderna&#146;s receipt of the applicable Discontinued Target ROFN Notice (the &#147;<B>Discontinued Target ROFN Exercise Period</B>&#148;). Upon Metagenomi&#146;s receipt of the
applicable Discontinued Target ROFN Exercise Notice, Metagenomi and Moderna shall negotiate in good </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
faith to attempt to reach agreement on the terms of a collaboration and license agreement for the Discontinued Target in the applicable countries or regions of the Territory similar to the terms
related to DT Moderna Research Programs in this Agreement as if the Discontinued Target were a DT Moderna Target. If (A)&nbsp;the Parties do not enter into such collaboration and license agreement within [***] of Metagenomi&#146;s receipt of the
applicable Discontinued Target ROFN Exercise Notice (the &#147;<B>Discontinued Target ROFN Negotiation Period</B>&#148;), (B) Moderna fails to respond during the applicable Discontinued Target ROFN Exercise Period, or (C)&nbsp;Moderna notifies
Metagenomi that it elects not to exercise such negotiation right, Metagenomi or its applicable Affiliate shall be free to seek to enter into an agreement granting rights to the Discontinued Target in the countries or regions in the Territory with
the Third Party, each as identified in the applicable Discontinued Target ROFN Notice; provided that in the event Metagenomi or its applicable Affiliate does not enter into such an agreement within [***] from (x)&nbsp;in the case of clause (A),
expiration of the applicable Discontinued Target ROFN Negotiation Period, or (y)&nbsp;in the case of clauses (B)&nbsp;and (C), expiration of the applicable Discontinued Target ROFN Exercise Period (or earlier delivery of notice by Moderna to
Metagenomi that it elects not to exercise such negotiation right), Metagenomi shall thereafter be obligated to, prior to entering into any such agreement, resubmit the Discontinued Target ROFN Notice and enter into good faith negotiations with
Moderna regarding such rights as specified above in this Section&nbsp;4.2.2 (Right of First Negotiation) at Moderna&#146;s request, so long as the applicable Discontinued Target ROFN Period has not expired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <B>DT Target Evaluation Plan</B>. Within [***] after the Effective Date, the Parties shall promptly establish a research program to
advance Base Editing technology towards achieving the Base Editing Knockout Readiness and to evaluate the Reserved DT Targets (the &#147;<B>DT Target Evaluation Program</B>&#148;). The Research activities in the DT Target Evaluation Program shall
follow a research plan and budget detailing principal objectives and the activities to be undertaken by both Parties, which includes: (a)&nbsp;the responsibilities of the Parties, and (b)&nbsp;a timeline showing the key activities and timeframes in
which such activities are expected to be completed (the &#147;<B>DT Target Evaluation Plan</B>&#148;). Moderna shall have the right to modify or amend the DT Target Evaluation Plan, provided that any modifications or amendments to the DT Target
Evaluation Plan shall be subject to review by the JRC and approval by the JSC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <B>DT Moderna Research Plan</B>. Upon written request
by Moderna at any time during the DT Moderna Research Term, the Parties shall promptly establish a research program to discover and advance Licensed Product candidates within the DT Field (each, a &#147;<B>DT Moderna Candidate</B>&#148;) Directed
Against a Reserved DT Target selected by Moderna in its sole discretion in such written request (each Reserved DT Target so selected by Moderna, a &#147;<B>DT Moderna Target</B>&#148;) in order to advance such DT Moderna Candidates to IND Filing
(the &#147;<B>DT Moderna Research Program</B>&#148;; together with the DT Target Evaluation Program, the &#147;<B>DT Programs</B>&#148;). Notwithstanding the foregoing, upon the earlier of completion of the DT Target Evaluation Program or [***]
after the Effective Date, the Parties shall establish DT Moderna Research Programs for each then-current Reserved DT Target. To facilitate the foregoing, the Parties shall jointly propose a research and development plan and budget detailing
principal objectives and the activities to be undertaken by both Parties in such DT Moderna Research Program, which includes: (a)&nbsp;the responsibilities of the Parties, (b)&nbsp;a timeline showing the key activities and timeframes in which such
activities are expected to be completed, and (c)&nbsp;the criteria for a [***] (the &#147;<B>DT Moderna Research Plan</B>&#148;; together with the DT Target Evaluation Plan, the &#147;<B>DT Plans</B>&#148;). The initial DT Moderna Research Plan
shall be reviewed by the JRC and approved by the JSC. Moderna shall have the right to modify or amend the DT Moderna Research Plan, provided that any modifications or amendments to the DT Moderna Research Plan shall be subject to review by the JRC
and approval by the JSC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <B>Obligations During the DT Moderna Research Term</B>. Each Party shall use
Commercially Reasonable Efforts to perform and complete (itself or through its Affiliates or by permitted subcontracting) its obligations under the DT Plans. Neither Party shall be required to perform any work which is not contemplated by any DT
Plan, unless such additional work is reflected in a mutually agreed amendment to the applicable DT Plan. Without limiting the generality of the foregoing, on a DT Moderna Research
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Moderna Research Program basis, each Party shall use Commercially Reasonable Efforts to perform and complete its activities under the DT Plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <B>DT Moderna Research Term Costs</B>. Metagenomi&#146;s Research Costs incurred under the DT Target Evaluation Plan and any DT Moderna
Research Plan shall, on an annual basis, first be credited against the Annual Research Funding Amounts. Upon fully consuming the Annual Research Funding Amount for any given year by Metagenomi&#146;s Research Costs (which, for the avoidance of
doubt, include Research Costs incurred under the RT Plans), Moderna shall pay Metagenomi for Metagenomi&#146;s Research Costs incurred under the DT Plans which are not covered by the Annual Research Funding Amount (the &#147;<B>DT Moderna Excess
Costs</B>&#148;) so long as the aggregate Research Costs incurred by Metagenomi in the DT Programs do not exceed the aggregate budgets therefor set forth in the DT Plans (the &#147;<B>DT Moderna Research Budgets</B>&#148;), provided <I>that</I>
Moderna&#146;s obligation to compensate Metagenomi for DT Moderna Excess Costs shall be subject to Metagenomi&#146;s obligation to provide reports describing all of Metagenomi&#146;s Research Costs incurred under the DT Target Evaluation Plan and
any DT Moderna Research Plan, including any DT Moderna Excess Costs. Within [***] after the end of each Calendar Quarter, Metagenomi shall send such a report to Moderna describing all of Metagenomi&#146;s Research Costs incurred under the DT Target
Evaluation Plan and any DT Moderna Research Plan, including any DT Moderna Excess Costs, for such Calendar Quarter. Moderna may reasonably request additional supporting documentation for Metagenomi&#146;s Research Costs described in such reports and
Metagenomi shall provide such documentation (e.g. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost breakdowns and general allocation of FTEs). No later than [***] after receipt of any such invoice
from Metagenomi, Moderna shall make payment of undisputed amounts for the DT Moderna Excess Costs for such Calendar Quarter. Reimbursement of any DT Moderna Excess Costs in excess of the DT Moderna Research Budgets shall be subject to approval by
the JSC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <B>Subcontractors for the DT Plans</B>. Subject to the remainder of this Section&nbsp;4.7 (Subcontractors for the DT Plans),
each Party may engage subcontractors to perform its obligations under the applicable DT Plan. In all cases, such Party shall ensure that (a)&nbsp;it remains responsible for the work allocated to such subcontractors to the same extent it would if it
had done such work itself, (b)&nbsp;the subcontractor undertakes in writing obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> regarding Confidential Information that are at least as protective as those undertaken by
such Party with respect to Confidential Information pursuant to Article 11 (Confidentiality), and (c)&nbsp;the subcontractor undertakes in writing to assign or exclusively license back (with the right to sublicense through multiple tiers) all
intellectual property with respect to all Results and all other intellectual property arising out of such subcontracted activities, in each case in the course of performing any such work under the applicable DT Plan to such Party such that such
Party shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Control such intellectual property. Without limiting the generality of the foregoing, each Party may subcontract any of its obligations under the applicable DT Plan to a university or academic
institution on reasonable and customary terms, provided <I>that</I>, (a)&nbsp;such Party shall use reasonable efforts to ensure that such subcontracting relationship is consistent with, and such university or academic institution abides by, the
terms and obligations set forth in this Section&nbsp;4.7 (Subcontractors for the DT Plans) (or such revisions to such terms or obligations as the Parties may mutually agree) and (b)&nbsp;neither the U.S. government nor any agency thereof has funded
or will fund any part of such subcontracting relationship. The engagement of any subcontractor in compliance with this Section&nbsp;4.7 (Subcontractors for the DT Plans) shall not relieve either Party of its obligations under the applicable DT Plan
or this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <B>Records and Reports</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.8.1 <B>Records</B>. Metagenomi and Moderna shall maintain, or cause to be maintained, during the DT Moderna Research Term and for a
reasonable period of time thereafter that is consistent with industry standards, complete and accurate written (or electronic) records of its activities under each DT Plan in sufficient detail and in a good scientific manner appropriate for
scientific, patent and regulatory purposes, which records shall reasonably reflect all work performed by or on behalf of such Party under the applicable DT Plan (the &#147;<B>DT Moderna Records</B>&#148;). Moderna may request a copy of any DT
Moderna Records of Metagenomi. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.8.2 <B>Reports</B>. Metagenomi and Moderna shall report on a Calendar Quarter basis to the other Party
through the JRC its Results in conducting activities under the DT Plans (the &#147;<B>DT Moderna Results</B>&#148;). In addition, for each DT Program, each Party shall provide the JRC with, on a Calendar Quarter basis during the DT Moderna Research
Term, all DT Moderna Results generated by or on behalf of such Party in performance of its activities under the applicable DT Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.8.3
<B>Ownership; Confidentiality</B>. Each Party shall own all rights, title and interest (including all intellectual property rights) in and to the DT Moderna Results and the DT Moderna Records generated by or for it in accordance with
Section&nbsp;8.1.2 (Ownership of Intellectual Property). The DT Moderna Results and DT Moderna Records constitute Confidential Information and shall in each case be subject to the rights and obligations of the Parties under this Agreement, including
Article 11 (Confidentiality) and the licenses granted hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.9 <B>DT Option</B>. On a DT Moderna Research <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Moderna Research Program basis, in the event this Agreement has not expired or been terminated with respect to such DT Moderna Research Program, Metagenomi
hereby grants to Moderna the right, but not the obligation, to exercise an exclusive option, exercisable at any time during the Term but no later than [***] (the &#147;<B>DT Option Period</B>&#148;) to obtain the licenses set forth in
Section&nbsp;5.15 (License to Moderna Upon Exercise of the DT Option) with respect to such DT Moderna Research Program (the &#147;<B>DT Option</B>&#148;). Moderna may exercise the DT Option up to two (2)&nbsp;times for a total of two (2)&nbsp;DT
Moderna Targets under this Agreement, each with respect to a DT Moderna Research Program at its own choosing in its sole discretion. No later than [***] after the beginning of the DT Option Period for each DT Moderna Research Program, Metagenomi
shall (a)&nbsp;provide to Moderna the Data Package for such DT Moderna Research Program, and (b)&nbsp;afford reasonable access during normal business hours to Metagenomi&#146;s personnel by Moderna and its
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
representatives as Moderna may reasonably request to assist Moderna in deciding whether to exercise the DT Option. Moderna may exercise the DT Option with respect to a DT Moderna Research Program
by delivering a DT Option exercise notice in respect of such DT Option to Metagenomi at any time during the Term prior to the expiration of the DT Option Period for such DT Moderna Research Program (the date of such delivery, the &#147;<B>DT Option
Exercise Date</B>&#148;). Within [***] after the DT Option Exercise Date, Moderna shall pay the DT Option Fee for such DT Moderna Research Program to Metagenomi. For clarity, on a DT Moderna Research <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Moderna Research Program basis, after Moderna exercises its DT Option with respect to such DT Moderna Research Program, Moderna shall be solely responsible and have sole authority for all
Development (including IND Filing), Manufacturing and Commercialization of all Licensed DT Products for such DT Moderna Research Program, and Moderna shall use Commercially Reasonable Efforts to Develop and Commercialize one or more Licensed DT
Products for each such DT Moderna Research Program. For the avoidance of doubt, Moderna may exercise the DT Option with respect to such DT Moderna Research Program during the DT Option Period, regardless of whether the applicable DT Moderna Research
Plan has been put in place and whether the activities under the applicable DT Moderna Research Plan have been completed or carried out at all. If Moderna does not exercise the DT Option during the DT Option Period, then Metagenomi shall have no
further obligation to Moderna with respect to such DT Moderna Research Program. Notwithstanding anything herein to the contrary, if Moderna exercises an RT Option and a DT Option with respect to the same target, then the DT Option Fee or the RT
Option Fee, as applicable, for the later exercise shall be reduced by [***] and the two applicable Programs will be treated as one for purposes of Moderna&#146;s Commercially Reasonable Efforts obligations. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 5 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LICENSES;
EXCLUSIVITY; MANUFACTURE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <B>RT Research Term License</B>. On an RT <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Program basis, each Party agrees to grant, and hereby grants, the other Party, during the RT Research Term, a nonexclusive license under such Party&#146;s Background Technology and RT Program
Technology (including RT Results and RT Records generated by or for such Party in conducting activities under all RT Plans) (collectively, such Party&#146;s &#147;<B>RT Research Licensed Technology</B>&#148;), to carry out the other Party&#146;s
activities under the RT Plan in such RT Program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <B>RT Preclinical Research Technology Transfer</B>. On an RT <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Program basis: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2.1 from time to time during the
Term for such RT Program, each Party shall provide to the other Party such Party&#146;s RT Research Licensed Technology to be used based on the applicable RT Plan or as utilized under such RT Program in such Party&#146;s possession or Control but
was not previously provided in form and by means to be mutually agreed by the Parties; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2.2 during the Term for such RT Program,
such Party shall reasonably cooperate with the other Party to facilitate the technology transfer of such Party&#146;s RT Research Licensed Technology to be used based on the applicable RT Plan or as utilized under such RT Program to the other Party.
Such cooperation shall include providing the other Party with reasonable access by teleconference or <FONT STYLE="white-space:nowrap">in-person</FONT> at such Party&#146;s facilities to appropriate personnel from such Party to provide the other
Party with technical assistance and consultation in connection with the transfer of such Party&#146;s RT Research Licensed Technology for such RT Program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Section&nbsp;5.2 (RT Preclinical Research Technology
Transfer) or anything else herein to the contrary, Moderna&#146;s obligation to transfer its RT Research Licensed Technology to Metagenomi under this Section&nbsp;5.2 (RT Preclinical Research Technology Transfer) shall be limited to the RT Research
Licensed Technology that Moderna determines at its sole discretion is necessary or reasonably useful for Metagenomi to carry out its activities under the applicable RT Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <B>DT Moderna Research Term License</B>. On a DT
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Program basis, each Party agrees to grant, and hereby grants, the other Party, during the DT Moderna Research Term, a
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> license under such Party&#146;s Background Technology and DT Program Technology (including DT Moderna Results and DT Moderna Records generated by or for such Party in conducting activities under
all DT Plans) (collectively, such Party&#146;s &#147;<B>DT Moderna Research Licensed Technology</B>&#148;), to carry out the other Party&#146;s activities under the DT Plan in such DT Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <B>DT Moderna Research Term Technology Transfer</B>. On a DT
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Program basis: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4.1 as soon as reasonably
practicable but in any event no less than [***] after the initiation of such DT Program, each Party shall provide to the other Party with such Party&#146;s DT Moderna Research Licensed Technology to be used based on the applicable DT Plan or as
utilized under such DT Program in such Party&#146;s possession or Control as of the Effective Date in form and by means to be mutually agreed by the Parties; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4.2 from time to time during the Term for such DT Program, such Party shall provide to the other Party such Party&#146;s DT Moderna Research
Licensed Technology to be used based on the applicable DT Plan or as utilized under such DT Program in such Party&#146;s possession or Control but was not previously provided in form and by means to be mutually agreed by the Parties; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4.3 during the Term for such DT Program, such Party shall reasonably cooperate with the other Party to facilitate the technology transfer of
such Party&#146;s DT Moderna Research Licensed Technology for such DT Program to the other Party. Such cooperation shall include providing the other Party with reasonable access by teleconference or <FONT STYLE="white-space:nowrap">in-person</FONT>
at such Party&#146;s facilities to appropriate personnel from such Party to provide the other Party with technical assistance and consultation in connection with the transfer of such Party&#146;s DT Moderna Research Licensed Technology for such DT
Program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Section&nbsp;5.4 (DT Moderna Research Term Technology Transfer) or anything else herein to the
contrary, Moderna&#146;s obligation to transfer its DT Moderna Research Licensed Technology to Metagenomi under this Section&nbsp;5.4 (DT Moderna Research Term Technology Transfer) shall be limited to the DT Moderna Research Licensed Technology that
Moderna determines in its sole discretion is necessary or reasonably useful for Metagenomi to carry out its activities under the applicable DT Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program License</B>. Metagenomi
agrees to grant, and hereby grants, to Moderna, during the Term, a <FONT STYLE="white-space:nowrap">co-exclusive</FONT> license (with Metagenomi and its Affiliates) under the Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Technology, to Exploit all applications of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, including all DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidates in such
DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, for any use in the DT Field in the Territory during the Term, provided that (i)&nbsp;Moderna shall only exercise such license to carry out its activities under the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Plans for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program; and (ii)&nbsp;Metagenomi shall only practice its rights under the <FONT STYLE="white-space:nowrap">co-exclusively</FONT> licensed
Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology to carry out its activities under the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. Moderna
agrees to grant, and hereby grants, to Metagenomi, during the Term, a license under the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology, to carry out Metagenomi&#146;s activities under the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Plans for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. Such license shall be <FONT STYLE="white-space:nowrap">non-exclusive</FONT> prior to DC Nomination and
<FONT STYLE="white-space:nowrap">co-exclusive</FONT> (with Moderna and its Affiliates) after DC Nomination with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product nominated in such DC Nomination, and shall not include the right
to Manufacture or have Manufactured the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product other than the rights of Moderna set forth in Section&nbsp;5.23 (Manufacture). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Technology Transfer</B>. With respect to the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.6.1 as soon as reasonably practicable but in any event no less than thirty
(30)&nbsp;days after the Effective Date, each Party shall provide to the other Party with such Party&#146;s Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program in
such Party&#146;s possession or Control as of the Effective Date in form and by means to be mutually agreed by the Parties; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.6.2 from
time to time during the Term, such Party shall provide to the other Party such Party&#146;s Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program in such Party&#146;s
possession or Control but was not previously provided in form and by means to be mutually agreed by the Parties; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.6.3 during the
Term, such Party shall reasonably cooperate with the other Party to facilitate the technology transfer of such Party&#146;s Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology for such DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Program to the other Party. Such cooperation shall include providing the other Party with reasonable access by teleconference or <FONT STYLE="white-space:nowrap">in-person</FONT> at such Party&#146;s
facilities to appropriate personnel from such Party to provide the other Party with technical assistance and consultation in connection with the transfer of such Party&#146;s Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology for
such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Section&nbsp;5.6 (DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Research Technology Transfer) or anything else herein to the contrary, (a)&nbsp;Moderna&#146;s obligation to transfer its Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology to Metagenomi
under this Section&nbsp;5.6 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Technology Transfer) shall be limited to its Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology that Moderna determines in its sole discretion
is necessary or reasonably useful for Metagenomi to carry out its activities under the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans, and (b)&nbsp;Metagenomi&#146;s obligation to transfer its Licensed DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Technology to Moderna under this Section&nbsp;5.6 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Technology Transfer) shall be limited to its Licensed DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology that Metagenomi determines in its sole discretion is necessary or reasonably useful for Moderna to carry out its activities under the applicable DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans, provided, however, notwithstanding anything herein to the contrary, (i)&nbsp;in the event of an <FONT STYLE="white-space:nowrap">Opt-Out</FONT> by Metagenomi pursuant to Section&nbsp;6.8 <FONT
STYLE="white-space:nowrap">(Opt-Out</FONT> Right), the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
foregoing clause (b)&nbsp;shall no longer apply with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program from which Metagenomi has exercised the
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right, and Metagenomi shall transfer or otherwise provide all of its Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology to Moderna in accordance with Sections 5.6.2 (DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Research Technology Transfer), 5.6.3 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Technology Transfer), and 5.17 (Metagenomi Licensed Collaboration Technology Update); and (ii)&nbsp;in the event
of an <FONT STYLE="white-space:nowrap">Opt-Out</FONT> by Moderna pursuant to Section&nbsp;6.8.1 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right) prior to DC Nomination in such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, the
foregoing clause (a)&nbsp;shall continue to apply but the scope of the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology under this Section&nbsp;5.6 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Technology
Transfer) shall be expanded to additionally include Moderna&#146;s DT Moderna Research Licensed Technology being Exploited by Moderna as of the expiration of the Initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term. Notwithstanding
the foregoing provisions of this Section&nbsp;5.6.3 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Technology Transfer) or anything else herein to the contrary, Metagenomi acknowledges, understands and agrees that no CMC or
Manufacturing-related <FONT STYLE="white-space:nowrap">Know-How</FONT> shall be provided by Moderna to Metagenomi under this Agreement, including this Section&nbsp;5.6.3 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Technology
Transfer). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <B>Sublicensing</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.7.1 <B>Rights to Grant Licenses and Sublicenses in the Territory</B>. Except as permitted under this Section&nbsp;5.7 (Sublicensing),
without the prior approval of the other Party, neither Party shall grant a sublicense of the rights granted to such Party under Section&nbsp;5.5 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program License), to Develop, Manufacture, perform
Medical Affairs with respect to, or Commercialize the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory. If either Party wishes to grant a license or sublicense (as applicable) to a Third Party to Develop, Manufacture,
perform Medical Affairs with respect to, or Commercialize any DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory (except as permitted under this Section&nbsp;5.7 (Sublicensing)), then such Party shall notify the other Party
through the JSC, and the other Party shall review such proposal and determine whether to approve the extension of rights to such licensee or sublicensee. Following any such approval by the applicable JSC subcommittee of a proposed licensee or
sublicensee in the Territory, unless otherwise agreed by the applicable JSC subcommittee, such Party shall have the right to lead discussions with potential licensees or sublicensees, negotiate terms, and execute the agreement with such licensee or
sublicensee, provided that such Party shall provide the final form of any such agreement to the applicable JSC subcommittee for the applicable JSC subcommittee&#146;s approval prior to execution thereof. In addition, the Parties shall coordinate
through the applicable JSC subcommittee with respect to the performance or any such licensees or sublicensees, as applicable, to ensure the efficient Development, Manufacture, performance of Medical Affairs with respect to, and Commercialization of
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products throughout the Territory. Notwithstanding the foregoing, if a Party has exercised its <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right pursuant to Section&nbsp;6.8 <FONT
STYLE="white-space:nowrap">(Opt-Out</FONT> Right), then the foregoing restrictions on sublicensing shall not apply and, subject to Section&nbsp;6.8.3 (Right of First Offer After <FONT STYLE="white-space:nowrap">Opt-Out),</FONT> the Primary Party
shall have the right to sublicense the rights granted under Section&nbsp;5.5 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program License) without the prior approval of the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party, provided,
however, notwithstanding anything herein to the contrary, in the event Moderna exercises its <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right pursuant to Section&nbsp;6.8 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right), Moderna shall
retain its right to Manufacture under Section&nbsp;5.23 (Manufacture). Notwithstanding anything herein to the contrary, Metagenomi shall not grant a sublicense of the rights granted to it under Section&nbsp;5.5 (DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Program License) to Manufacture any DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.7.2 <B>Costs and Income from Sublicensing Activities in the Territory</B>. The External
Costs incurred in connection with the negotiation of an agreement with any such Third Party licensee or sublicensee (including legal costs and attorneys&#146; fees) in the Territory as approved by the JSC shall be shared equally by the Parties as
Other Operating Expenses in accordance with Section&nbsp;7.4 <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share). Any Licensing Income received from such Third Party licensee or sublicensee with respect to the Development,
Manufacture, Commercialization or Medical Affairs activities performed by such Third Party licensee or sublicensee in the Territory shall be shared by the Parties as part of the Operating Profits or Losses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.7.3 <B>Sublicense Agreements</B>. Each sublicense to a Third Party granted by a Party pursuant to this Section&nbsp;5.7 (Sublicensing) shall
(a)&nbsp;be subject and subordinate to this Agreement, (b)&nbsp;be consistent with the terms of this Agreement, (c)&nbsp;include obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> applicable to the Confidential
Information of the other Party that are at least as stringent as those set forth in Article 11 (Confidentiality), and (d)&nbsp;include terms that are consistent with and no less restrictive with respect to the intellectual property provisions set
forth in this Agreement, unless, in each case, the Parties agree otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <B>Responsibility for Sublicensees</B>. Notwithstanding
any sublicense, the Party that grants rights to such licensee or sublicensee (as applicable) shall remain primarily liable to the other Party for the performance of all of its obligations under, and such Party&#146;s compliance with all provisions
of, this Agreement. Each Party agrees that it shall be fully responsible and liable for any breach of the terms of this Agreement by any of its licensees or sublicensees (as applicable) to the same extent as if such Party itself has committed any
such breach. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <B>Subcontracting for DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.9.1 <B>Subcontracting Rights</B>. Either Party may engage a Third Party to perform services on a fee for service basis in connection with
the performance of its obligations or exercise of its rights under the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans in the Territory; provided that (a)&nbsp;any subcontractor engaged to perform Development activities with respect to a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product must be set forth in the Development Plan for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, (b)&nbsp;any subcontractor engaged to perform Medical Affairs with respect to a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in or for the Territory must be set forth in the Medical Affairs Plan for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, and (c)&nbsp;any subcontractor engaged to perform
Commercialization activities with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in or for the Territory must be set forth in the Commercialization Plan for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.9.2 <B>Subcontracting Requirements</B>. No subcontracting by either Party in accordance with Section&nbsp;5.9.1 (Subcontracting Rights)
shall relieve the subcontracting Party of its obligations under this Agreement or any liability hereunder. Each agreement with any Third Party subcontractor engaged in accordance with Section&nbsp;5.9.1 (Subcontracting Rights) must (a)&nbsp;be
consistent with the terms of this Agreement, (b)&nbsp;include obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> applicable to the Confidential Information of the other Party that are at least as stringent as those
set forth in Article 11 (Confidentiality), and (c)&nbsp;include terms that are consistent with the intellectual property provisions set forth in this Agreement. As soon as reasonably practicable thereafter each Party shall provide the other Party
with a copy of any executed agreement with a Third Party subcontractor that shall perform Development, Manufacturing, Commercialization, or Medical Affairs activities under this Agreement in the Territory (which copy may be redacted to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
remove provisions that are not necessary to monitor compliance with this Section&nbsp;5.9 (Subcontracting for DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans)). <B>Schedule E </B>(Approved
Subcontractors) sets forth a list of <FONT STYLE="white-space:nowrap">pre-approved</FONT> subcontractors that may be engaged by either Party to perform activities hereunder in the Territory. Each Party shall remain directly responsible for any
uncured material breach of this Agreement by a subcontractor and shall terminate promptly any such subcontractor with notice to the other Party of such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10 <B>Third Party <FONT STYLE="white-space:nowrap">In-Licenses</FONT> in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program</B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10.1 <B>Existing <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">In-Licenses</FONT></B>. The Parties
agree that the agreements listed on <B>Schedule F </B>(Existing <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">In-Licenses)</FONT> are existing <FONT STYLE="white-space:nowrap">in-licenses</FONT> entered into by each
Party that relate or pertain to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. Each stipulates and agrees that the rights and licenses granted to it under this Agreement are subject to the applicable terms of all such existing <FONT
STYLE="white-space:nowrap">in-licenses</FONT> of the other Party as such terms exist on the Effective Date with respect to the other Party&#146;s Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology that is being sublicensed
thereunder, and such Party hereby agrees to comply with those terms. The Party that is a party to such an existing <FONT STYLE="white-space:nowrap">in-license</FONT> has provided to the other Party a true and correct copy of such <FONT
STYLE="white-space:nowrap">in-license</FONT> prior to the Effective Date. Each Party further stipulates and agrees that the other Party&#146;s ability to comply with its obligations, and grant rights and licenses to such Party, under this Agreement
may be limited by requirements and restrictions imposed on the other Party under such existing <FONT STYLE="white-space:nowrap">in-licenses,</FONT> and notwithstanding any provision to the contrary set forth in this Agreement, the other Party shall
not be required to take any action that would cause it to be in breach of any such existing <FONT STYLE="white-space:nowrap">in-license.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10.2 <B>Future DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">In-Licenses</FONT></B>. Except as otherwise
expressly provided herein, each Party shall have the right, in its sole discretion, to independently negotiate, obtain and maintain rights to use any and all Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> held by a Third Party (whether
through acquisition or license) that relates or otherwise pertains to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. Subject to the provisions of this Agreement, each Party shall be responsible for all obligations under the agreements
with the relevant Third Parties to acquire such rights. Such agreements shall be referred to as &#147;<B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>&#148; in the event such
Party is Moderna (or any of its Affiliates) and &#147;<B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>&#148; in the event such Party is Metagenomi (or any of its
Affiliates). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10.3 <B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT>
Agreements</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT>
Agreements</B>. Notwithstanding any provision in this Agreement to the contrary, during the Term for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, Moderna shall have the right to determine, in its sole discretion, whether any Patents
or <FONT STYLE="white-space:nowrap">Know-How</FONT> under any <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement can and should be sublicensed to Metagenomi for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program. If Moderna determines that any such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> can and should be sublicensed to Metagenomi for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Program, then Moderna shall disclose to Metagenomi the terms of such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement (including by providing a copy of such <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement to Metagenomi), subject to applicable confidentiality obligations and reasonable redaction of provisions that do not relate to the potential
use of such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> for the performance by Metagenomi of its existing or future activities in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. After Metagenomi has had an opportunity
to review the terms of such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement and has agreed in writing to be subject to such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terms, (i)&nbsp;such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> shall be deemed &#147;Controlled&#148; by Moderna or its Affiliates for purposes of this Agreement and shall be
included in the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology, (ii)&nbsp;the Parties shall allocate any royalty or other payment obligations to the applicable Third Party in connection with such Patents or <FONT
STYLE="white-space:nowrap">Know-How</FONT> in accordance with Section&nbsp;5.10.3(b) (Payments under <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements), and (iii)&nbsp;Metagenomi
stipulates and agrees that the rights and licenses granted to it under this Agreement are subject to the applicable terms of such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, and
Metagenomi hereby agrees to comply with those terms. Metagenomi further stipulates and agrees that Moderna&#146;s ability to comply with its obligations, and grant rights and licenses to Metagenomi, under this Agreement may be limited by
requirements and restrictions imposed on Moderna under such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, and notwithstanding any provision to the contrary set forth in this
Agreement, Moderna shall not be required to take any action that would cause it to be in breach of any such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement. If Moderna does not
notify Metagenomi of a <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, then no Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under such
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement shall be deemed &#147;Controlled&#148; by Moderna or its Affiliates for purposes of this Agreement, and they shall be excluded from
the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Payments under
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>. In the event the subject matter of a <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna
<FONT STYLE="white-space:nowrap">In-License</FONT> Agreement is broader than the Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> thereunder that is included in the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Technology pursuant to Section&nbsp;5.10.3(a) <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements), the Parties shall negotiate in good faith and reasonably allocate to Metagenomi the
obligation to pay that portion of Moderna&#146;s Third Party Payment under such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement that is attributable to Metagenomi&#146;s exercise of
its licenses or rights to such Patents or <FONT STYLE="white-space:nowrap">Know-How,</FONT> subject to Section&nbsp;5.10.5 (Metagenomi Payments for Certain Technology). A disagreement between the Parties on such payment allocation shall be resolved
in accordance with Section&nbsp;13.4 (Baseball Arbitration). In the event a Party exercises the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right under Section&nbsp;6.8 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right), from and after the <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Date, the Primary Party shall pay [***] of Moderna&#146;s Third Party Payment under such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement,
subject to Section&nbsp;7.11.2(d) (Third Party Payments). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10.4 <B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements</B>. Notwithstanding any provision in this Agreement to the contrary, during the Term for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, Metagenomi shall have the right to
determine, in its sole discretion, whether any Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under any <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement can and should
be sublicensed to Moderna for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. If Metagenomi determines that any such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> can and should be sublicensed to Moderna for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program, then Metagenomi shall disclose to Moderna the terms of such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement (including by
providing a copy of such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement to Moderna), subject to applicable confidentiality obligations and reasonable redaction of provisions that
do not relate to the potential use of such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> for the performance by Moderna of its existing or future activities in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. After
Moderna has had an opportunity to review the terms of such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement and has agreed in writing to be subject to such terms, (i)&nbsp;such
Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> shall be deemed &#147;Controlled&#148; by Metagenomi or its Affiliates for purposes of this Agreement and shall be included in the Metagenomi Licensed
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology, (ii)&nbsp;the Parties shall allocate any royalty or other payment obligations to the applicable Third Party in connection with such
Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> in accordance with Section&nbsp;5.10.4(b) (Payments under <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements), and
(iii)&nbsp;Moderna stipulates and agrees that the rights and licenses granted to it under this Agreement are subject to the applicable terms of such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi
<FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, and Moderna hereby agrees to comply with those terms. Moderna further stipulates and agrees that Metagenomi&#146;s ability to comply with its obligations, and grant rights and licenses to
Moderna, under this Agreement may be limited by requirements and restrictions imposed on Metagenomi under such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, and notwithstanding
any provision to the contrary set forth in this Agreement, Metagenomi shall not be required to take any action that would cause it to be in breach of any such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi
<FONT STYLE="white-space:nowrap">In-License</FONT> Agreement. If Metagenomi does not notify Moderna of a <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, then no Patents or <FONT
STYLE="white-space:nowrap">Know-How</FONT> under such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement shall be deemed &#147;Controlled&#148; by Metagenomi or its Affiliates for
purposes of this Agreement, and they shall be excluded from the Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Payments under <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT>
Agreements</B>. In the event the subject matter of a <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement is broader than the Patents and
<FONT STYLE="white-space:nowrap">Know-How</FONT> thereunder that is included in the Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology pursuant to Section&nbsp;5.10.4(a) <FONT STYLE="white-space:nowrap">(Co-Co</FONT>
Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements), the Parties shall negotiate in good faith and reasonably allocate to Moderna the obligation to pay that portion of Metagenomi&#146;s Third Party Payment under such <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement that is attributable to Moderna&#146;s exercise of its licenses or rights to such Patents or
<FONT STYLE="white-space:nowrap">Know-How,</FONT> subject to Section&nbsp;5.10.5 (Metagenomi Payments for Certain Technology). A disagreement between the Parties on such payment allocation shall be resolved in accordance with Section&nbsp;13.4
(Baseball Arbitration). In the event a Party exercises the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right under Section&nbsp;6.8 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right), from and after the
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Date, the Primary Party shall pay [***] of Metagenomi&#146;s Third Party Payment under such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT>
Agreement, subject to Section&nbsp;7.11.2(d) (Third Party Payments). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10.5 <B>Metagenomi Payments for Certain Technology</B>.
Notwithstanding the foregoing provisions of this Section&nbsp;5.10 (Third Party <FONT STYLE="white-space:nowrap">In-Licenses</FONT> in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program), if and to the extent any Patents or <FONT
STYLE="white-space:nowrap">Know-How</FONT> under a <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement is necessary or reasonably useful to Exploit any Gene-Editing proteins
(including the making or using thereof), that are the preferred choice for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, by reference to scientific merit, manufacturing ease, clinical safety and effectiveness,
patentability and other relevant factors, Metagenomi shall bear [***] of the Third Party Payments under such <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement attributable to each
Party&#146;s Exploitation thereof in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program; provided that, from and after Metagenomi <FONT STYLE="white-space:nowrap">Opts-Out</FONT> of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Program, Moderna shall bear [***] of the Third Party Payments attributable to its continued Exploitation of the Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> under the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreement, subject to Section&nbsp;7.11.2(d) (Third Party Payments), provided further that, notwithstanding anything else herein to the contrary, and without prejudicing Moderna&#146;s rights under
Section&nbsp;7.11.2(d) (Third Party Payments), [***] of such Third Party Payments may be deducted from any royalty payments to Metagenomi under Section&nbsp;7.11.2 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Royalties) for the applicable DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product provided such deduction may not result in a reduction in excess of [***] of the royalties that otherwise would have been due and payable to Metagenomi under Section&nbsp;7.11.2 <FONT
STYLE="white-space:nowrap">(Opt-Out</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Royalties). In addition, notwithstanding anything else herein to the contrary, and without prejudicing Moderna&#146;s rights under Section&nbsp;7.11.2(d) (Third Party Payments), from and after
Metagenomi <FONT STYLE="white-space:nowrap">Opts-Out</FONT> of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, [***] of Moderna&#146;s Third Party Payments under any and all <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements for Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> necessary to Exploit any Gene-Editing proteins (including the making or using thereof) due to the Metagenomi Gene-Editing
proteins being Covered by such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> or due to the Metagenomi Gene-Editing proteins being materially less efficacious than the Third Party Gene-Editing proteins, may be deducted from any royalty
payments to Metagenomi under Section&nbsp;7.11.2 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Royalties) for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product provided such deduction may not result in a reduction in excess
of [***] of the royalties that otherwise would have been due and payable to Metagenomi under Section&nbsp;7.11.2 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Royalties). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10.6 <B>Moderna Payments for Certain Technology</B>. Notwithstanding the foregoing provisions of this Section&nbsp;5.10 (Third Party <FONT
STYLE="white-space:nowrap">In-Licenses</FONT> in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program), if and to the extent any Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under a
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement is necessary or reasonably useful to Exploit any <FONT STYLE="white-space:nowrap">mRNA-LNP</FONT> Technology (including the making or
using thereof), that are the preferred choice for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, by reference to scientific merit, manufacturing ease, clinical safety and effectiveness, patentability and other relevant
factors, Moderna shall bear [***] of the Third Party Payments attributable to each Party&#146;s Exploitation thereof in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, provided that, from and after Moderna <FONT
STYLE="white-space:nowrap">Opts-Out</FONT> of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, Metagenomi shall bear [***] of the Third Party Payments attributable to its continued Exploitation of the Patents and <FONT
STYLE="white-space:nowrap">Know-How</FONT> under the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, subject to Section&nbsp;7.11.2(d) (Third Party Payments). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11 <B>Third Party <FONT STYLE="white-space:nowrap">In-Licenses</FONT> in RT Programs</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.11.1 <B>Existing RT <FONT STYLE="white-space:nowrap">In-Licenses</FONT></B>. The Parties agree that the agreements listed on <B>Schedule G
</B>(Existing RT <FONT STYLE="white-space:nowrap">In-Licenses)</FONT> are existing <FONT STYLE="white-space:nowrap">in-licenses</FONT> entered into by each Party that relate or pertain to the RT Programs. Each stipulates and agrees that the rights
and licenses granted to it under this Agreement are subject to the applicable terms of all such existing <FONT STYLE="white-space:nowrap">in-licenses</FONT> of the other Party as such terms exist on the Effective Date, and such Party hereby agrees
to comply with those terms. The Party that is a party to such an existing <FONT STYLE="white-space:nowrap">in-license</FONT> has provided to the other Party a true and correct copy of such <FONT STYLE="white-space:nowrap">in-license</FONT> prior to
the Effective Date. Each Party further stipulates and agrees that the other Party&#146;s ability to comply with its obligations, and grant rights and licenses to such Party under this Agreement may be limited by requirements and restrictions imposed
on the other Party under such existing <FONT STYLE="white-space:nowrap">in-licenses,</FONT> and notwithstanding any provision to the contrary set forth in this Agreement, the other Party shall not be required to take any action that would cause it
to be in breach of any such existing <FONT STYLE="white-space:nowrap">in-license.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.11.2 <B>Future RT <FONT
STYLE="white-space:nowrap">In-Licenses</FONT></B>. Except as otherwise expressly provided herein, each Party shall have the right, in its sole discretion, to independently negotiate, obtain and maintain rights to use any and all Patents or <FONT
STYLE="white-space:nowrap">Know-How</FONT> held by a Third Party (whether through acquisition or license) that relates or otherwise pertains to the RT Programs. Subject to the provisions of this Agreement, each Party shall be responsible for all
obligations under the agreements with the relevant Third Parties to acquire such rights. Such agreements shall be referred to as &#147;<B>RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>&#148; in the event such Party is
Moderna (or any of its Affiliates) and &#147;<B>RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>&#148; in the event such Party is Metagenomi (or any of its Affiliates). </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.11.3 <B>RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>.
Notwithstanding any provision in this Agreement to the contrary, on an RT <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Program basis, during the RT Research Term, Moderna shall have the right to
determine, in its sole discretion, whether any Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under any RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement can and should be sublicensed to Metagenomi for such RT
Program. If Moderna determines that any such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> can and should sublicensed to Metagenomi for such RT Program, then Moderna shall disclose to Metagenomi the terms of such RT Moderna <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreement (including by providing a copy of such RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement to Metagenomi), subject to applicable confidentiality obligations and reasonable
redaction of provisions that do not relate to the potential use of such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> for the performance by Metagenomi of its existing or future activities under the RT Plan. Upon such disclosure,
(i)&nbsp;such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> shall be deemed &#147;Controlled&#148; by Moderna or its Affiliates for purposes of this Agreement and shall be included in Moderna&#146;s RT Research Licensed Technology and
(ii)&nbsp;subject to Section&nbsp;5.11.5 (Metagenomi Payments for Certain Technology), Moderna shall pay all (subject to Section&nbsp;7.9.4 (Third Party Payments)) Third Party Payments under such RT Moderna
<FONT STYLE="white-space:nowrap">In-License</FONT> Agreement. After Metagenomi has had an opportunity to review the terms of such RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement and has agreed in writing to be subject to such
terms (provided that Metagenomi may only object to being subjected to such terms if it would have a material impact on Metagenomi&#146;s business outside the collaboration contemplated by this Agreement), Metagenomi stipulates and agrees that the
rights and licenses granted to it under this Agreement are subject to the applicable terms of such RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, and Metagenomi hereby agrees to comply with those terms. Metagenomi further
stipulates and agrees that Moderna&#146;s ability to comply with its obligations, and grant rights and licenses to Metagenomi, under this Agreement may be limited by requirements and restrictions imposed on Moderna under such RT Moderna <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreement, and notwithstanding any provision to the contrary set forth in this Agreement, Moderna shall not be required to take any action that would cause it to be in breach of any such RT Moderna <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreement. If Moderna does not notify Metagenomi of an RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, no Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under such RT
Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement shall be &#147;Controlled&#148; by Moderna or its Affiliates for purposes of this Agreement, and they shall be excluded from Moderna&#146;s RT Research Licensed Technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.11.4 <B>RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>. Notwithstanding any provision in this Agreement to
the contrary, on a RT <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Program basis, during the RT Research Term, Metagenomi shall disclose to Moderna all RT Metagenomi
<FONT STYLE="white-space:nowrap">In-License</FONT> Agreements (including by providing a copy of such RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement to Moderna). Metagenomi shall use reasonable efforts to ensure that any
such rights acquired under any RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement are freely sublicensable to Moderna hereunder, provided if Metagenomi (or any of its Affiliates) is unable to obtain the right to grant a
sublicense to Moderna for any RT Program under all intellectual property rights licensed to Metagenomi (or its Affiliate) under such RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, then Metagenomi (or its Affiliate) shall
exclude any such intellectual property rights for the applicable RT Program from the scope of such RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement and shall promptly notify Moderna that it has entered into such RT
Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement. In the event Moderna so elects, and to the extent such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> are sublicensable, (i)&nbsp;the applicable Patents and <FONT
STYLE="white-space:nowrap">Know-How</FONT> under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement shall be deemed &#147;Controlled&#148; by Metagenomi or its Affiliates for purposes of this Agreement as part of
Metagenomi&#146;s RT Program Technology and (ii)&nbsp;subject to Sections 5.11.5 (Metagenomi Payments for Certain Technology), 5.11.6 (Moderna Payments for Certain Technology) and 7.9.4 (Third Party Payments), Moderna shall pay all Third Party
Payments under such RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement. Moderna stipulates and agrees that the rights and licenses granted to it under this Agreement are subject to the applicable terms of such RT Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements, and Moderna hereby agrees to comply with those terms. Moderna further stipulates and agrees that Metagenomi&#146;s ability to comply with its obligations, and grant rights and licenses to
Moderna, under this Agreement may be limited by requirements and restrictions imposed on Metagenomi under such RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements, and notwithstanding any provision to the contrary set forth
in this Agreement, Metagenomi shall not be required to take any action that would cause it to be in breach of any such RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.11.5 <B>Metagenomi Payments for Certain Technology</B>. Notwithstanding the foregoing provisions of this Section&nbsp;5.11 (Third Party <FONT
STYLE="white-space:nowrap">In-Licenses</FONT> in RT Programs), if and to the extent any Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under an RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement is necessary to
Exploit any Gene-Editing proteins (including the making or using thereof) that are the preferred choice for the applicable Licensed RT Products, by reference to scientific merit, manufacturing ease, clinical safety and effectiveness, patentability
and other relevant factors, Metagenomi shall bear [***] of the Third Party Payments attributable to each Party&#146;s Exploitation thereof in the applicable RT Programs. Moderna shall bear [***] of the Third Party Payments attributable to each
Party&#146;s Exploitation of any Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under an RT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement necessary to Exploit any Gene-Editing proteins (including the making or
using thereof), in each case where such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> is necessary either due to the Metagenomi Gene-Editing proteins being covered by such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> or
due to the Metagenomi Gene-Editing proteins being materially less efficacious than the Third Party Gene-Editing proteins, subject to Section&nbsp;7.9.4 (Third Party Payments), provided that, notwithstanding anything else herein to the contrary, and
without prejudicing Moderna&#146;s rights under Section&nbsp;7.9.4 (Third Party Payments), [***] of such Third Party Payments may be deducted from any royalty payments to Metagenomi under Section&nbsp;7.9 (Royalties on Products Directed Against an
RT Target) and for the applicable Licensed RT Product provided such deduction may not result in a reduction in excess of [***] of the royalties that otherwise would have been due and payable to Metagenomi under Section&nbsp;7.9 (Royalties on
Products Directed Against an RT Target). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.11.6 <B>Moderna Payments for Certain Technology</B>. After Moderna exercises the RT Option for
such RT Program, the Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> elected by Moderna pursuant to Section&nbsp;5.11.4 (RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements) shall automatically be included in
Metagenomi&#146;s Licensed RT Technology with respect to such RT Program. Subject to Section&nbsp;5.11.5 (Metagenomi Payments for Certain Technology), in the event the subject matter of the relevant RT Metagenomi
<FONT STYLE="white-space:nowrap">In-License</FONT> Agreement is broader than such Patents and <FONT STYLE="white-space:nowrap">Know-How,</FONT> the Parties shall negotiate in good faith and reasonably allocate to Moderna the obligation to pay that
portion of Metagenomi&#146;s Third Party Payment under the applicable RT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement that is attributable to Moderna&#146;s exercise of its licenses or rights to such Patents or <FONT
STYLE="white-space:nowrap">Know-How</FONT> after Moderna exercises the RT Option. Moderna&#146;s such payment obligations are subject to Section&nbsp;7.9.4 (Third Party Payments) as if such payments constituted Moderna&#146;s payments to a Third
Party contemplated by Section&nbsp;7.9.4 (Third Party Payments), provided Moderna shall pay Metagenomi additional payments to reflect the effect of Section&nbsp;7.9.4 (Third Party Payments) had Moderna been the Party to such RT Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreement and paid all payments to the Third Party thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.12 <B>Third Party <FONT STYLE="white-space:nowrap">In-Licenses</FONT> in DT Programs</B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.12.1 <B>Existing DT <FONT STYLE="white-space:nowrap">In-Licenses</FONT></B>. The Parties agree that the agreements listed on
<B>Schedule H </B>(Existing DT <FONT STYLE="white-space:nowrap">In-Licenses)</FONT> are existing <FONT STYLE="white-space:nowrap">in-licenses</FONT> entered into by each Party that relate or pertain to the DT Programs. Each stipulates and agrees
that the rights and licenses granted to it under this Agreement are subject to the applicable terms of all such existing <FONT STYLE="white-space:nowrap">in-licenses</FONT> of the other Party as such terms exist on the Effective Date, and such Party
hereby agrees to comply with those terms. The Party that is a party to such an existing <FONT STYLE="white-space:nowrap">in-license</FONT> has provided to the other Party a true and correct copy of such
<FONT STYLE="white-space:nowrap">in-license</FONT> prior to the Effective Date. Each Party further stipulates and agrees that the other Party&#146;s ability to comply with its obligations, and grant rights and licenses to such Party under this
Agreement may be limited by requirements and restrictions imposed on the other Party under such existing <FONT STYLE="white-space:nowrap">in-licenses,</FONT> and notwithstanding any provision to the contrary set forth in this Agreement, the other
Party shall not be required to take any action that would cause it to be in breach of any such existing <FONT STYLE="white-space:nowrap">in-license.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.12.2 <B>Future DT <FONT STYLE="white-space:nowrap">In-Licenses</FONT></B>. Except as otherwise expressly provided herein, each Party shall
have the right, in its sole discretion, to independently negotiate, obtain and maintain rights to use any and all Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> held by a Third Party (whether through acquisition or license) that relates
or otherwise pertains to the DT Programs. Subject to the provisions of this Agreement, each Party shall be responsible for all obligations under the agreements with the relevant Third Parties to acquire such rights. Such agreements shall be referred
to as &#147;<B>DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>&#148; in the event such Party is Moderna (or any of its Affiliates) and &#147;<B>DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT>
Agreements</B>&#148; in the event such Party is Metagenomi (or any of its Affiliates). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.12.3 <B>DT Moderna <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements</B>. Notwithstanding any provision in this Agreement to the contrary, on a DT <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Program basis, during
the DT Moderna Research Term, Moderna shall have the right to determine, in its sole discretion, whether any Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under any DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT>
Agreement can and should be sublicensed to Metagenomi for such DT Program. If Moderna determines that any such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> can and should be sublicensed to Metagenomi for such DT Program, then Moderna
shall disclose to Metagenomi the terms of such DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement (including by providing a copy of such DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement to Metagenomi),
subject to applicable confidentiality obligations and reasonable redaction of provisions that do not relate to the potential use of such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> for the performance by Metagenomi of its existing
or future activities under the DT Plan. Upon such disclosure, (i)&nbsp;such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> shall be deemed &#147;Controlled&#148; by Moderna or its Affiliates for purposes of this Agreement and shall be
included in Moderna&#146;s DT Moderna Research Licensed Technology and (ii)&nbsp;subject to Section&nbsp;5.12.5 (Metagenomi Payments for Certain Technology), Moderna shall pay all (subject to Section&nbsp;7.10.4 (Third Party Payments)) Third Party
Payments under such DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement. After Metagenomi has had an opportunity to review the terms of such DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement and has agreed
in writing to be subject to such terms (provided that Metagenomi may only object to being subjected to such terms if it would have a material </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
impact on Metagenomi&#146;s business outside the collaboration contemplated by this Agreement), Metagenomi stipulates and agrees that the rights and licenses granted to it under this Agreement
are subject to the applicable terms of such DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, and Metagenomi hereby agrees to comply with those terms. Metagenomi further stipulates and agrees that Moderna&#146;s ability to
comply with its obligations, and grant rights and licenses to Metagenomi, under this Agreement may be limited by requirements and restrictions imposed on Moderna under such DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, and
notwithstanding any provision to the contrary set forth in this Agreement, Moderna shall not be required to take any action that would cause it to be in breach of any such DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement. If
Moderna does not notify Metagenomi of a DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, no Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under such DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT>
Agreement shall be &#147;Controlled&#148; by Moderna or its Affiliates for purposes of this Agreement, and they shall be excluded from Moderna&#146;s DT Moderna Research Licensed Technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.12.4 <B>DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements</B>. Notwithstanding any provision in this Agreement to
the contrary, on a DT <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-</FONT></FONT> DT Program basis, during the DT Moderna Research Term, Metagenomi shall disclose to Moderna all DT Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements (including by providing a copy of such DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement to Moderna). Metagenomi shall use reasonable efforts to ensure that any such
rights acquired under any DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement are freely sublicensable to Moderna hereunder, provided if Metagenomi (or any of its Affiliates) is unable to obtain the right to grant a sublicense
to Moderna for any DT Program under all intellectual property rights licensed to Metagenomi (or its Affiliate) under such DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement, then Metagenomi (or its Affiliate) shall exclude
any such intellectual property rights for the applicable DT Program from the scope of such DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement and shall promptly notify Moderna that it has entered into such DT Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreement. In the event Moderna so elects, and to the extent such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> are sublicensable, (i)&nbsp;the applicable Patents and <FONT
STYLE="white-space:nowrap">Know-How</FONT> under such DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement shall be deemed &#147;Controlled&#148; by Metagenomi or its Affiliates for purposes of this Agreement as part of
Metagenomi&#146;s DT Program Technology and (ii)&nbsp;subject to Sections 5.12.5 (Metagenomi Payments for Certain Technology), 5.12.6 (Moderna Payments for Certain Technology) and 7.10.4 (Third Party Payments), Moderna shall pay all Third Party
Payments under such DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement. Moderna stipulates and agrees that the rights and licenses granted to it under this Agreement are subject to the applicable terms of such DT Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements, and Moderna hereby agrees to comply with those terms. Moderna further stipulates and agrees that Metagenomi&#146;s ability to comply with its obligations, and grant rights and licenses to
Moderna, under this Agreement may be limited by requirements and restrictions imposed on Metagenomi under such DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements, and notwithstanding any provision to the contrary set forth
in this Agreement, Metagenomi shall not be required to take any action that would cause it to be in breach of any such DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.12.5 <B>Metagenomi Payments for Certain Technology</B>. Notwithstanding the foregoing provisions of this Section&nbsp;5.12 (Third Party <FONT
STYLE="white-space:nowrap">In-Licenses</FONT> in DT Programs), if and to the extent any Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under a DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement is necessary to
Exploit Gene-Editing proteins (including the making or using thereof) that are the preferred choice for the applicable Licensed DT Products, by reference to scientific merit, manufacturing ease, clinical safety and effectiveness, patentability and
other relevant factors, Metagenomi shall bear </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
[***] of the Third Party Payments attributable to each Party&#146;s Exploitation thereof in the applicable DT Programs. Moderna shall bear [***] of the Third Party Payments attributable to each
Party&#146;s Exploitation of any Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> under a DT Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement necessary to Exploit any Gene-Editing proteins (including the making or
using thereof) in each case where such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> is necessary either due to the Metagenomi Gene-Editing proteins being covered by such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> or
due to the Metagenomi Gene-Editing proteins being materially less efficacious than the Third Party Gene-Editing protein, subject to Section&nbsp;7.10.4 (Third Party Payments), provided that, notwithstanding anything else herein to the contrary, and
without prejudicing Moderna&#146;s rights under Section&nbsp;7.10.4 (Third Party Payments), [***] of such Third Party Payments may be deducted from any royalty payments to Metagenomi under Section&nbsp;7.10 (Royalties on Products Directed Against a
DT Moderna Target) for the applicable Licensed DT Product provided such deduction may not result in a reduction in excess of [***] of the royalties that otherwise would have been due and payable to Metagenomi under Section&nbsp;7.10 (Royalties on
Products Directed Against a DT Moderna Target). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.12.6 <B>Moderna Payments for Certain Technology</B>. After Moderna exercises the DT
Option for such DT Program, the Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> elected by Moderna pursuant to Section&nbsp;5.12.4 (DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements) shall automatically be
included in Metagenomi&#146;s Licensed DT Moderna Technology with respect to such DT Program. Subject to Section&nbsp;5.12.5 (Metagenomi Payments for Certain Technology), in the event the subject matter of the relevant DT Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreement is broader than such Patents and <FONT STYLE="white-space:nowrap">Know-How,</FONT> the Parties shall negotiate in good faith and reasonably allocate to Moderna the obligation to pay that portion
of Metagenomi&#146;s Third Party Payment under the applicable DT Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreement that is attributable to Moderna&#146;s exercise of its licenses or rights to such Patents or <FONT
STYLE="white-space:nowrap">Know-How</FONT> after Moderna exercises the DT Option. Moderna&#146;s such payment obligations are subject to Section&nbsp;7.10.4 (Third Party Payments) as if such payments constituted Moderna&#146;s payments to a Third
Party contemplated by Section&nbsp;7.10.4 (Third Party Payments), provided Moderna shall pay Metagenomi additional payments to reflect the effect of Section&nbsp;7.10.4 (Third Party Payments) had Moderna been the Party to such DT Metagenomi <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreement and paid all payments to the Third Party thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.13 <B>License to Moderna
Upon Exercise of the RT Option</B>. On an RT Preclinical Research <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Preclinical Research Program basis, upon Moderna&#146;s exercise of the RT Option
(pursuant to Section&nbsp;3.9 (RT Option)) with respect to the RT Target under such RT Preclinical Research Program, effective as of the applicable License Effective Date, all RT Candidates in such RT Preclinical Research Program shall become
Licensed RT Products in such RT Preclinical Research Program, and Metagenomi agrees to grant and hereby grants to Moderna an exclusive (even as to Metagenomi and its Affiliates) license, with the right to sublicense through multiple tiers, under
Metagenomi&#146;s Background Technology, Metagenomi&#146;s RT Program Technology with respect to such RT Preclinical Research Program, and all other Metagenomi Program Technology and Metagenomi&#146;s interest in any Joint IP, in each case relevant
to such RT Preclinical Research Program (collectively, the &#147;<B>Licensed RT Technology</B>&#148;), to Exploit all applications of the RT Target in such RT Preclinical Research Program, including all Licensed RT Products in such RT Preclinical
Research Program, for any use in the Territory in the RT Field during the Term (the &#147;<B>RT License</B>&#148;). During the Term, Metagenomi shall ensure that it Controls all <FONT STYLE="white-space:nowrap">Know-How</FONT> or Patents claiming or
Covering Gene Editing conceived, discovered, invented or created by or on behalf of Metagenomi (including jointly with others) so as to be able to grant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Moderna the foregoing license. For clarity, on an RT Preclinical Research <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Preclinical Research
Program basis, with respect to the RT Target in the RT Field in an RT Preclinical Research Program for which Moderna has not exercised an RT Option by the end of the applicable RT Option Period, (i)&nbsp;the foregoing license does not grant and
shall not grant any rights to Moderna with respect to such RT Target in the RT Field, and (ii)&nbsp;Metagenomi shall retain all rights to Metagenomi Program Technology and Metagenomi&#146;s interest in any Joint IP (a)&nbsp;with respect to such RT
Target in the RT Field and (b)&nbsp;with respect to any Field other than the RT Field, except as expressly set forth herein otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.14 <B>RT Technology Transfer</B>. On an RT Preclinical Research
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-RT</FONT></FONT> Preclinical Research Program basis: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.14.1
as soon as reasonably practicable but in any event no less than thirty (30)&nbsp;days after the RT Option Exercise Date for such RT Preclinical Research Program, Metagenomi shall provide to Moderna with (i)&nbsp;one (1) electronic copy of all of
Metagenomi&#146;s RT Records and RT Results created or generated in all RT Programs as of the RT Option Exercise Date; (ii)&nbsp;one (1) electronic copy of all documents, data or other <FONT STYLE="white-space:nowrap">Know-How</FONT> in
Metagenomi&#146;s possession or Control as of the RT Option Exercise Date that describes or contains the Licensed RT Technology; (iii)&nbsp;all Materials within the Licensed RT Technology in Metagenomi&#146;s possession or Control as of the RT
Option Exercise Date, and (iv)&nbsp;the RT Target and Licensed RT Products in such RT Preclinical Research Program designed, created, synthesized or otherwise Manufactured by or on behalf of Metagenomi as of the RT Option Exercise Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.14.2 following the receipt of the RT Option Fee for such RT Preclinical Research Program, from time to time during the Term, Metagenomi
shall provide to Moderna one (1)&nbsp;electronic copy of all documents, data or other <FONT STYLE="white-space:nowrap">Know-How</FONT> in Metagenomi&#146;s possession or Control that describes or contains the Licensed RT Technology and all Materials
within the Licensed RT Technology in Metagenomi&#146;s possession or Control for such RT Preclinical Research Program but was not previously provided; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.14.3 following the receipt of the RT Option Fee for such RT Preclinical Research Program, during the Term, Metagenomi shall reasonably
cooperate with Moderna to facilitate the technology transfer of the Licensed RT Technology, RT Candidates and the RT Target in such RT Preclinical Research Program to Moderna to enable the Development, Manufacture or Commercialization of such RT
Candidates and the RT Target in the RT Field in the Territory. Such cooperation shall include providing Moderna with reasonable access by teleconference or <FONT STYLE="white-space:nowrap">in-person</FONT> at Metagenomi&#146;s facilities to
appropriate personnel from Metagenomi to provide Moderna with technical assistance and consultation in connection with the transfer of such Licensed RT Technology, RT Candidates and RT Target. Metagenomi shall provide such cooperation for no
additional consideration during the RT Research Term, and for [***] thereafter. After the expiration of such [***] period, Moderna shall reimburse Metagenomi for its reasonable costs to provide such cooperation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.15 <B>License to Moderna Upon Exercise of the DT Option</B>. On a DT Moderna Research <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Moderna Research Program basis, upon Moderna&#146;s exercise of the DT Option (pursuant to Section&nbsp;4.9 (DT Option)) with respect to the DT Target under such
DT Moderna Research Program, effective as of the applicable License Effective Date, all DT Moderna Candidates in such DT Moderna Research Program shall become Licensed DT Products, and Metagenomi agrees to grant and hereby grants to Moderna an
exclusive (even as to Metagenomi and its Affiliates) license, with the right to sublicense through multiple tiers, under Metagenomi&#146;s Background Technology, Metagenomi&#146;s DT Program Technology with respect to such DT Moderna Research
Program, and all other Metagenomi Program Technology and Metagenomi&#146;s interest in any Joint IP, in each case relevant to such DT Moderna Research Program (collectively, the &#147;<B>Licensed DT Moderna Technology</B>&#148;), to Exploit all
applications of the DT Moderna Target in such DT Moderna Research Program, including all Licensed DT Products in such DT Moderna Research Program, for any use in the Territory in the DT Field during the Term (the &#147;<B>DT License</B>&#148;).
During the Term, Metagenomi shall ensure that it Controls all <FONT STYLE="white-space:nowrap">Know-How</FONT> or Patents claiming or Covering Gene Editing conceived, discovered, invented or created by or on behalf of Metagenomi (including jointly
with others) so as to be able to grant Moderna the foregoing license. For clarity, on a DT Moderna Research <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Moderna Research Program basis, with respect to
the DT Moderna Target in the DT Field in a DT Moderna Research Program for which Moderna has not exercised a DT Option by the end of the applicable DT Option Period, (i)&nbsp;the foregoing license does not grant and shall not grant any rights to
Moderna with respect to such DT Target in the DT Field, and (ii)&nbsp;Metagenomi shall retain all rights to Metagenomi Program Technology and Metagenomi&#146;s interest in any Joint IP (a)&nbsp;with respect to such DT Target in the DT Field, and
(b)&nbsp;with respect to any Field other than the DT Field except as expressly set forth herein otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.16 <B>DT Technology
Transfer</B>. On a DT Moderna Research <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-DT</FONT></FONT> Moderna Research Program basis: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.16.1 as soon as reasonably practicable but in any event no less than thirty (30)&nbsp;days after the DT Option Exercise Date for such DT
Moderna Research Program, Metagenomi shall provide to Moderna with (i)&nbsp;one (1) electronic copy of all of Metagenomi&#146;s DT Moderna Records and DT Moderna Results created or generated in all DT Programs as of the DT Option Exercise Date;
(ii)&nbsp;one (1) electronic copy of all documents, data or other <FONT STYLE="white-space:nowrap">Know-How</FONT> in Metagenomi&#146;s possession or Control as of the DT Option Exercise Date that describes or contains the Licensed DT Moderna
Technology; (iii)&nbsp;all Materials within the Licensed DT Moderna Technology in Metagenomi&#146;s possession or Control as of the DT Option Exercise Date; and (iv)&nbsp;the DT Moderna Target and Licensed DT Products in such DT Moderna Research
Program designed, created, synthesized or otherwise Manufactured by or on behalf of Metagenomi as of the DT Option Exercise Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.16.2
following the receipt of the DT Option Fee for such DT Moderna Research Program, from time to time during the Term, Metagenomi shall provide to Moderna one (1)&nbsp;electronic copy of all documents, data or other
<FONT STYLE="white-space:nowrap">Know-How</FONT> in Metagenomi&#146;s possession or Control that describes or contains the Licensed DT Moderna Technology and all Materials within the Licensed DT Moderna Technology in Metagenomi&#146;s possession or
Control for such DT Moderna Research Program but was not previously provided; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.16.3 following the receipt of the DT Option Fee for such DT Moderna Research Program,
during the Term, Metagenomi shall reasonably cooperate with Moderna to facilitate the technology transfer of the Licensed DT Moderna Technology, Licensed DT Products and the DT Moderna Target in such DT Moderna Research Program to Moderna to enable
the Development, Manufacture or Commercialization of such Licensed DT Product and the DT Moderna Target in the DT Field in the Territory. Such cooperation shall include providing Moderna with reasonable access by teleconference or <FONT
STYLE="white-space:nowrap">in-person</FONT> at Metagenomi&#146;s facilities to appropriate personnel from Metagenomi to provide Moderna with technical assistance and consultation in connection with the transfer of such Licensed DT Moderna
Technology, Licensed DT Products and DT Moderna Target. Metagenomi shall provide such cooperation for no additional consideration during the DT Moderna Research Term, and for [***]. After the expiration of such [***] period, Moderna shall reimburse
Metagenomi for its reasonable costs to provide such cooperation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Section&nbsp;5.16 (DT Technology
Transfer), Metagenomi&#146;s obligations under this Section&nbsp;5.16 (DT Technology Transfer) and Section&nbsp;5.17 (Metagenomi Licensed Collaboration Technology Update) with respect to Licensed DT Moderna Technology shall be limited to
(i)&nbsp;Licensed DT Moderna Technology that comes into the Control of Metagenomi or any of its Affiliates prior to the [***] of the expiration of the DT Moderna Research Term (including, for the avoidance of doubt, prior to or during the DT Moderna
Research Term), (ii) any and all improvements to such Licensed DT Moderna Technology that comes into the Control of Metagenomi or any of its Affiliates within [***] after the expiration of the DT Moderna Research Term, and (iii)&nbsp;in the event
there is any fundamental issue with any of the foregoing Licensed DT Moderna Technology, as reasonably determined by Moderna, that prevents Moderna from Exploiting Licensed DT Products in such DT Moderna Research Program, any Licensed DT Moderna
Technology that may resolve such issue and that comes into the Control of Metagenomi or any of its Affiliates within [***]n (10)&nbsp;years after the expiration of the DT Moderna Research Term, in each case ((i)-(iii)), including any and all Patents
within Licensed DT Moderna Technology that Cover the Licensed DT Moderna Technology in each of (i)-(iii), and any and all Patents claiming priority, directly or indirectly, to the foregoing Patents, regardless of when any of the foregoing Patent is
filed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.17 <B>Metagenomi Licensed Collaboration Technology Update</B>. Without prejudice to any other obligations of Metagenomi under
this Agreement, during the Term, Metagenomi shall (a)&nbsp;provide regular and detailed updates to Moderna and the JSC regarding developments relating to Metagenomi&#146;s Background Technology and Metagenomi Licensed Collaboration Technology
(including any improvements or modifications thereto) that may have applicability to the Research, Development or Commercialization of any Products, which updates shall be (i)&nbsp;no less frequently than quarterly prior to the [***] of the
Effective Date, (ii)&nbsp;on a biannual basis after the [***] of the Effective Date and continuing until the expiration of the Research Term, and (iii) [***] thereafter, and (b)&nbsp;provide Moderna with reasonable access by teleconference or <FONT
STYLE="white-space:nowrap">in-person</FONT> at Metagenomi&#146;s facilities to appropriate personnel from Metagenomi to provide Moderna with technical assistance and consultation in connection with such updates or to otherwise support the
advancement of the applicable Program. For the avoidance of doubt, to the extent within the definitions of Metagenomi&#146;s Background Technology or Metagenomi Licensed Collaboration Technology, as the case may be, such developments shall be
automatically included in the licenses granted to Moderna under this Article 5 (Licenses; Exclusivity; Manufacture) without any action on the part of or additional consideration from Moderna. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.18 <B>Collaboration Materials Transfer</B>. If either Party is required to transfer to the
other Party any Collaboration Materials pursuant to an applicable Program Plan, the terms of this Section&nbsp;5.18 (Collaboration Materials Transfer) shall apply. The transferring Party shall provide the other Party with the applicable
Collaboration Materials in accordance with the Program Plan. Any Collaboration Materials provided pursuant to the Program Plan shall be accompanied by a material transfer record substantially in the form of <B>Schedule I </B>attached hereto
(&#147;<B>Material Transfer Record</B>&#148;). Each such Material Transfer Record shall be signed by an authorized representative of the providing Party, and then signed by an authorized representative of the receiving Party and returned to the
providing Party. The receiving Party shall use the Collaboration Materials solely to conduct the activities contemplated under the Program Plan and for no other purpose. The receiving Party shall not sell, transfer, disclose or otherwise provide
access to the Collaboration Materials without the written consent of the providing Party, except that the receiving Party may allow access to the Collaboration Materials to its Affiliates and its and their respective employees and officers who
require such access to perform its activities under this Agreement and solely for purposes consistent with this Agreement; provided that the receiving Party binds such Affiliates, employees and officers by written agreement to retain and use the
Collaboration Materials only in a manner that is consistent with the terms of this Agreement and the applicable Material Transfer Record. THE COLLABORATION MATERIALS ARE PROVIDED &#147;AS IS.&#148; NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR
IMPLIED, OF ANY KIND, ARE GIVEN BY THE PROVIDING PARTY WITH RESPECT TO ANY OF THE COLLABORATION MATERIALS, INCLUDING THEIR CONDITION, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. The receiving Party acknowledges the experimental nature of
the Collaboration Materials and that accordingly, not all characteristics of the Collaboration Materials are necessarily known. The Collaboration Materials transfer to be undertaken under this Section&nbsp;5.18 (Collaboration Materials Transfer)
shall be overseen by a Working Group established for such purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.19 <B>No Other Rights and Retained Rights</B>. Nothing in this
Agreement shall be interpreted to grant a Party any rights under any intellectual property rights owned or Controlled by the other Party, in each case, that are not expressly granted herein, whether by implication, estoppel, or otherwise. Metagenomi
shall not practice the Moderna Licensed Collaboration Technology other than as expressly licensed and permitted under this Agreement. Any rights not expressly granted to Metagenomi by Moderna under this Agreement with respect to the Moderna Licensed
Collaboration Technology are hereby retained by Moderna, and Moderna hereby expressly retains the right (on behalf of itself, its Affiliates, and its licensees) to (a)&nbsp;Manufacture the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products
worldwide, and (b)&nbsp;perform Moderna&#146;s other obligations under this Agreement. Moderna shall not practice the Metagenomi Licensed Collaboration Technology other than as expressly licensed and permitted under this Agreement. Any rights not
expressly granted to Moderna by Metagenomi under this Agreement with respect to the Metagenomi Licensed Collaboration Technology are hereby retained by Metagenomi. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.20 <B>RT Exclusivity</B>. During the RT Research Term and within [***] thereafter (collectively, the &#147;<B>RT Exclusivity
Period</B>&#148;), except as otherwise required under or expressly set forth in this Agreement, Metagenomi and its Affiliates shall not, itself or with or through any Third Party, nor authorize, (sub)license (including granting any option, covenant
not to sue, or other like right thereto) or otherwise enable any Third Party to, directly or indirectly, design, identify, research, manufacture, develop, commercialize or otherwise exploit any candidate or product in the RT Field. After the
expiration of the RT Exclusivity Period, for the remainder of the Term of this Agreement, on a RT <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-RT</FONT></FONT> Target basis, except as otherwise required under this
Agreement, Metagenomi and its Affiliates shall not, itself or with or through any Third Party, nor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
authorize, (sub)license (including granting any option, covenant not to sue, or other like right thereto) or otherwise enable any Third Party to, directly or indirectly, design, identify,
research, manufacture, develop, commercialize or otherwise exploit in the RT Field any candidate or product Directed Against any RT Targets with respect to which Moderna has exercised the RT Option. During the RT Research Term, except as otherwise
required under this Agreement, Metagenomi and its Affiliates shall not, itself or with or through any Third Party, nor authorize, (sub)license (including granting any option, covenant not to sue, or other like right thereto) or otherwise enable any
Third Party to, directly or indirectly, design, identify, research, manufacture, develop, commercialize or otherwise exploit any Guide or Donor Template that is specific to any RT Candidate (and, for clarity, excluding Guides and general homology of
Donor Templates that are used generally to <FONT STYLE="white-space:nowrap">knock-in</FONT> a gene but are not specific to the corresponding target). During the Term, except as otherwise required under this Agreement, Metagenomi and its Affiliates
shall not, itself or with or through any Third Party, nor authorize, (sub)license (including granting any option, covenant not to sue, or other like right thereto) or otherwise enable any Third Party to, directly or indirectly, design, identify,
research, manufacture, develop, commercialize or otherwise exploit any Guide or Donor Template that is specific to any Licensed RT Product from any RT Preclinical Research Program for which Moderna has exercised an RT Option (and, for clarity,
excluding Guides and general homology of Donor Templates that are used generally to <FONT STYLE="white-space:nowrap">knock-in</FONT> a gene but are not specific to the corresponding target). The obligations and restrictions in this Section&nbsp;5.20
(RT Exclusivity) shall not apply to any New Affiliate of Metagenomi, provided that such New Affiliate is not utilizing the applicable Metagenomi Licensed Collaboration Technology or Moderna Licensed Collaboration Technology with respect to the
activity that would otherwise be restricted under this Section&nbsp;5.20 (RT Exclusivity). Notwithstanding the foregoing provisions of this Section&nbsp;5.20 (RT Exclusivity), after [***], the term &#147;RT Field&#148; for purposes of this
Section&nbsp;5.20 (RT Exclusivity) shall no longer include BEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.21 <B>DT Exclusivity</B>. During the DT Moderna Research Term and
within [***] thereafter (collectively, the &#147;<B>DT Exclusivity Period</B>&#148;), except as otherwise required under this Agreement, Metagenomi and its Affiliates shall not, itself or with or through any Third Party, nor authorize, (sub)license
(including granting any option thereto) or otherwise enable any Third Parties to, directly or indirectly, design, identify, research, manufacture, develop, commercialize or otherwise exploit any candidate or product in the DT Field Directed Against
any of the Reserved DT Targets or any of the DT Moderna Targets that is not a Discontinued Target. After the expiration of the DT Exclusivity Period, for the remainder of the Term of this Agreement, on a DT Moderna <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Target-by-DT</FONT></FONT> Moderna Target basis, except as otherwise required under this Agreement, Metagenomi and its Affiliates shall not, itself or with or through any Third Party, nor authorize, (sub)license (including
granting any option thereto) or otherwise enable any Third Party to, directly or indirectly, design, identify, research, manufacture, develop, commercialize or otherwise exploit any candidate or product Directed Against any DT Moderna Targets in the
DT Field with respect to which Moderna has exercised the DT Option. Until the first anniversary of the Effective Date, except as otherwise required under this Agreement, Metagenomi and its Affiliates shall not, itself or with or through any Third
Party, nor authorize, (sub)license (including granting any option, covenant not to sue, or other like right thereto) or otherwise enable any Third Party to, directly or indirectly, design, identify, research, manufacture, develop, commercialize or
otherwise exploit in the in vivo Gene Editing field any Guide or Donor Template that is specific to any DT Moderna Candidate (and, for clarity, excluding Guides and general homology of Donor Templates that are used generally to <FONT
STYLE="white-space:nowrap">knock-in</FONT> a gene but are not specific to the corresponding target). After </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the first anniversary of the Effective Date and during the remainder of the DT Moderna Research Term, except as otherwise required under this Agreement, Metagenomi and its Affiliates shall not,
itself or with or through any Third Party, nor authorize, (sub)license (including granting any option, covenant not to sue, or other like right thereto) or otherwise enable any Third Party to, directly or indirectly, design, identify, research,
manufacture, develop, commercialize or otherwise exploit in the in vivo Gene Editing field any Guide or Donor Template specific to any DT Moderna Candidate Directed Against any Reserved DT Target or DT Moderna Target (and, for clarity, excluding
Guides and general homology of Donor Templates that are used generally to <FONT STYLE="white-space:nowrap">knock-in</FONT> a gene but are not specific to the corresponding target). During the Term, except as otherwise required under this Agreement,
Metagenomi and its Affiliates shall not, itself or with or through any Third Party, nor authorize, (sub)license (including granting any option, covenant not to sue, or other like right thereto) or otherwise enable any Third Party to, directly or
indirectly, design, identify, research, manufacture, develop, commercialize or otherwise exploit any Guide or Donor Template specific to any Licensed DT Product from any DT Moderna Research Program for which Moderna has exercised a DT Option (and,
for clarity, excluding Guides and general homology of Donor Templates that are used generally to <FONT STYLE="white-space:nowrap">knock-in</FONT> a gene but are not specific to the corresponding target). The obligations and restrictions in this
Section&nbsp;5.21.1 (DT Exclusivity) shall not apply to any New Affiliate of Metagenomi, provided that such New Affiliate is not utilizing the applicable Metagenomi Licensed Collaboration Technology or Moderna Licensed Collaboration Technology with
respect to the activity that would otherwise be restricted under this Section&nbsp;5.21 (DT Exclusivity). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.22 <B>DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Target Exclusivity</B>. During the Term of this Agreement, except as otherwise required under this Agreement, Metagenomi and its Affiliates shall not, itself or with or through any Third Party, nor authorize,
(sub)license (including granting any option thereto) or otherwise enable any Third Party to, directly or indirectly, design, identify, research, manufacture, develop, commercialize or otherwise exploit in the DT Field any candidate or product
Directed Against the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target, or any Guide or Donor Template specific to any DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidates or DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products
(and, for clarity, excluding Guides and general homology of Donor Templates that are used generally to <FONT STYLE="white-space:nowrap">knock-in</FONT> a gene but are not specific to the corresponding target). [***]. For clarity, Metagenomi&#146;s
obligations under this Section&nbsp;5.22 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target Exclusivity) shall continue to apply in the event Metagenomi exercises its <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right under Section&nbsp;6.8
<FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right). Notwithstanding anything herein to the contrary, in the event Moderna exercises its <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right under Section&nbsp;6.8
<FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right), its obligations under this Section&nbsp;5.22 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target Exclusivity) with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target
and the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program shall terminate, effective as of the applicable <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Date. The obligations
and restrictions in this Section&nbsp;5.22 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target Exclusivity) shall not apply to a New Affiliate of a Party, provided that such New Affiliate is not utilizing the Metagenomi Licensed Collaboration
Technology or the Moderna Licensed Collaboration Technology with respect to the activity that would otherwise be restricted under this Section&nbsp;5.22 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target Exclusivity). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.23 <B>Manufacture</B>. Except as expressly set forth otherwise in this Agreement or in any Program Plan, Moderna shall be responsible for
Manufacturing and supply of all <FONT STYLE="white-space:nowrap">non-GMP</FONT> and GMP mRNA Constructs and LNP formulated Candidates and Products for all Research, Development, and Commercialization activities contemplated under this Agreement or
any Program Plan. All decisions concerning such Manufacturing are within the sole discretion of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Moderna. Upon the first DC Nomination under a given DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, the Parties shall enter a supply agreement to facilitate the activities related to
clinical supply contemplated under the applicable Development Plan (a &#147;<B>Clinical Supply Agreement</B>&#148;). No later than [***] prior to the anticipated First Commercial Sale of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in
the Territory, the Parties shall enter a supply agreement to facilitate the activities related to commercial supply contemplated under the applicable Commercialization Plan (a &#147;<B>Commercial Supply Agreement</B>&#148;). The Parties may also
enter to one or more quality agreements in conjunction with the foregoing. [***]. Notwithstanding anything herein to the contrary, Moderna may in its sole discretion cease performance of the Manufacturing activities (including any related CMC
Activities), if Moderna determines in its sole discretion that there is a Safety Concern with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product or Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.24 <B>Government Approvals</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.24.1 <B>Efforts</B>. Each Party will use its commercially reasonable good faith efforts to eliminate any concern on the part of any
Governmental Authority regarding the legality of the RT License or the DT License prior to their becoming effective, under any Antitrust Law, including, if required by federal or state antitrust authorities, promptly taking commercially reasonable
steps to secure government antitrust clearance, including cooperating in good faith with any government investigation, including by making an appropriate response to any request (including a second request) by a Governmental Authority for documents
or information. Notwithstanding the foregoing, this Section&nbsp;5.24.1 (Efforts) and the term &#147;commercially reasonable good faith efforts&#148; do not require that either Party (a)&nbsp;offer, negotiate, commit to or effect, by consent decree,
hold separate order, trust or otherwise, the sale, divestiture, license or other disposition of any capital stock, assets, rights, products or businesses of either Party or their respective Affiliates, (b)&nbsp;agree to any restrictions on the
businesses of either Party or their respective Affiliates, or (c)&nbsp;pay any amount or take any other action to prevent, effect the dissolution of, vacate, or lift any decree, order, judgment, injunction, temporary restraining order, or other
order in any suit or proceeding that would otherwise have the effect of preventing or delaying the transactions contemplated by the RT License or the DT License. For purposes of this Section&nbsp;5.24 (Government Approvals), &#147;<B>Antitrust
Laws</B>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the &#147;<B>HSR Act</B>&#148;), and any other laws of the U.S. (or a state or territory thereof) or any
other Governmental Authority that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.24.2 <B>Antitrust Filings</B>. On a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT>
basis, at the written request of Moderna during the applicable RT Option Period or DT Option Period, each Party will, or will cause their applicable Affiliate(s) to, prepare and file with the U.S. Federal Trade Commission (&#147;<B>FTC</B>&#148;)
and the Antitrust Division of the U.S. Department of Justice (&#147;<B>DOJ</B>&#148;) any HSR Filing required of such Party under the HSR Act and any other filings, notices, applications or other submissions required of such Party under Antitrust
Laws (collectively, &#147;<B>Antitrust Filings</B>&#148;), in each case the necessity of which has been determined in the reasonable opinion of Moderna with respect to the transactions contemplated by a RT License or DT License with respect to such
Program. The Parties will cooperate with one another to the extent necessary in the preparation of any such Antitrust Filings. Each Party will be responsible for its own costs, expenses, and filing fees associated with any Antitrust Filing;
provided, further, that the Parties will equally share all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fees (other than penalties that may be incurred as a result of actions or omissions on the part of a Party, which penalties will be the sole financial responsibility of such Party) required to be
paid to any Governmental Authority in connection with making any such Antitrust Filing. In the event that the Parties make any Antitrust Filing(s) under this Section&nbsp;5.24.2 (Antitrust Filings), but (a)&nbsp;FTC or DOJ obtains a preliminary
injunction under the HSR Act against the Parties to enjoin the transactions contemplated by the RT License or the DT License, as applicable, or any other Governmental Authority enjoins the transactions contemplated by the RT License or the DT
License, as applicable, in accordance with Antitrust Laws, or (b)&nbsp;the HSR Clearance Date has not occurred and any other applicable antitrust clearances have not been obtained on or prior to three hundred and sixty-five (365)&nbsp;days after the
beginning of the RT Option Period or the DT Option Period, as applicable, then within thirty (30)&nbsp;days after the earlier to occur of (a)&nbsp;or (b), Moderna may exercise the RT Option or the DT Option, as applicable, again, with respect to a
different RT Target or a different DT Moderna Target, as applicable, and the applicable RT Preclinical Research Program or DT Moderna Research Program will continue. Notwithstanding anything to the contrary contained herein, except for the terms and
conditions of this Section&nbsp;5.24.2 (Antitrust Filings), the RT License or the DT License (including any and all of Moderna&#146;s obligations, including payment obligations, thereunder), will not be effective until the &#147;<B>License Effective
Date</B>,&#148; which is agreed and understood to mean the later of (i)&nbsp;the applicable RT Option Exercise Date or DT Option Exercise Date, or (ii)&nbsp;if a determination is made by Moderna pursuant to this Section&nbsp;5.24.2 (Antitrust
Filings) that any Antitrust Filing(s) is required, the receipt of any such required antitrust clearance(s). As used herein: (1) &#147;<B>HSR Clearance Date</B>&#148; means the earliest date that all applicable waiting periods under the HSR Act with
respect to the transactions contemplated by the applicable RT License or DT License have expired or have been terminated; and (2) &#147;<B>HSR Filing</B>&#148; means a filing by the Parties or their ultimate parent entities as that term is defined
in the HSR Act with the FTC and the DOJ of a Notification and Report Form for Certain Mergers and Acquisitions (as that term is defined in the HSR Act) with respect to the matters under the applicable RT License or DT License together with all
required documentary attachments thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.24.3 <B>Information Exchange</B>. Each Party will, in connection with any Antitrust Filing:
(a)&nbsp;reasonably cooperate with each other in connection with any communication, filing or submission and in connection with any investigation or other inquiry, including any proceeding initiated by a private party; (b)&nbsp;keep the other Party
or its counsel informed of any communication (and if in writing, provide a copy to the other Party or its counsel) received by such Party from or given by such Party to the FTC, the DOJ or any other Governmental Authority or in connection with any
proceeding by a private party, in each case regarding the transactions contemplated by any RT License or DT License; (c)&nbsp;consult with each other in advance of any meeting or conference with the FTC, the DOJ or any other Governmental Authority
or, in connection with any proceeding by a private party, with such private party, and to the extent permitted by the FTC, the DOJ or such other Governmental Authority or such private party, give the Parties or their counsel the opportunity to
attend and participate in such meetings and conferences; and (d)&nbsp;permit the other Party or its counsel to review in advance any submission, filing or communication (and documents submitted therewith) intended to be given by it to the FTC, the
DOJ or any other Governmental Authority, or, in connection with any proceeding by a private party, to such private party; provided, that (i)&nbsp;materials may be redacted to remove references concerning the valuation of the business of Moderna or
any Program, and (ii)&nbsp;neither Party is required to share with the other Party its HSR Filing and the documents produced by such Party in response to Items 4c or 4d of its HSR Filing. The Parties, as each deems advisable and necessary, may
designate any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
competitively sensitive material to be provided to the other under this Section&nbsp;5.24.3 (Information Exchange) as &#147;Antitrust Counsel Only Material&#148;. Such materials and the
information contained therein will be given only to the outside antitrust counsel of the recipient and will not be disclosed by such outside counsel to employees, officers or directors of the recipient unless express permission is obtained in
advance from the source of the materials (Moderna or Metagenomi, as the case may be) or the applicable Party&#146;s legal counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.24.4
<B>Assistance</B>. Subject to this Section&nbsp;5.24 (Government Approvals), at the reasonable request of Moderna, the Parties will cooperate and use respectively all reasonable efforts to make all other registrations, filings and applications, to
give all notices and to obtain as soon as practicable all governmental or other consents, transfers, approvals, orders, qualifications, authorizations, permits and waivers, if any, and to do all other things necessary or desirable for the
consummation of the transactions as contemplated by an RT License or DT License in accordance with applicable Antitrust Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.25
<B>Payments</B>. Payments payable under this Article 5 (Licenses; Exclusivity; Manufacture) shall be invoiced by the Party entitled to such payment on a [***] basis to the other Party by delivering an invoice to the other Party within [***] after
the end of each applicable Calendar Quarter for the payment due in connection with such Calendar Quarter. No later than [***] after receipt of any such invoice from such Party, the other Party shall make payment of undisputed invoiced amounts for
such Calendar Quarter. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 6 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COLLABORATION ACTIVITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <B>Lead Party</B>. Subject to the remainder of this Article 6 (Collaboration Activities) and Article 2 (Governance And Joint Steering
Committee), with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program and DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, the Parties acknowledge and agree that each respective Party will lead the following activities
(the &#147;<B>Lead Party</B>&#148;): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.1.1 <B>Moderna as Lead Party</B>. Moderna shall be the Lead Party for the following in the <FONT
STYLE="white-space:nowrap">Ex-U.S.</FONT> countries: Development (including Clinical Trials), Medical Affairs, Regulatory Filings and Commercialization activities related to DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.1.2 <B>Metagenomi as Lead Party</B>. Metagenomi shall be the Lead Party for Development (including Clinical Trials but subject to
Section&nbsp;2.10.2(a) (Decision-making for DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans)), Medical Affairs, Regulatory Filings and Commercialization activities related to DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products solely in
the U.S.; provided that Moderna may appoint [***] of all medical science liaisons in accordance with Section&nbsp;6.6.2 (Performance of Medical Affairs) and fifty percent (50%) of the deployed Sales Force in the U.S. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.2.1 Promptly after the Effective Date, the Parties shall establish a program to discover, Research, Develop and Commercialize DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products within the DT Field Directed Against the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target (the &#147;<B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program</B>&#148;). To that end, the
Parties shall jointly propose, as applicable, (i)&nbsp;a research plan and budget (the &#147;<B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Budget</B>&#148;) detailing principal discovery and Research activities to be undertaken by
both Parties in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discovery and Research of DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidates, which includes the criteria for DC Nomination (the &#147;<B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Research Plan</B>&#148;); (ii) on a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-DT</FONT></FONT> <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product basis, for
clarity, subsequent to DC Nomination, a Development plan and budget detailing principal Development objectives and the activities to be undertaken by both Parties in the Development of such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in
the Territory (the &#147;<B>Development Plan</B>&#148;); (iii) on a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product- <FONT STYLE="white-space:nowrap">by-DT</FONT> <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product basis, a written plan
for the specific Medical Affairs activities to be performed by the Parties for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory (the &#147;<B>Medical Affairs Plan</B>&#148;); and (iv)&nbsp;on a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-DT</FONT></FONT> <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product basis, if applicable, a global Commercialization Plan for
such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product (the &#147;<B>Commercialization Plan</B>&#148;; together with the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan, the Development Plan(s) and the Medical Affairs Plan(s),
the &#147;<B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans</B>&#148;). Each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plan shall include: (a)&nbsp;the responsibilities of the Parties, and (b)&nbsp;a timeline showing the key
activities and timeframes in which such activities are expected to be completed. The initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan appended in <B>Schedule O </B>(DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research
Plan) shall be presented by the Parties to the JSC for approval within [***] after the Effective Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <B>DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product Research Activities</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.3.1 <B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Research Plan</B>. The initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan shall be reviewed by the JRC and presented to the JSC for approval. Each Party will have the right to propose modifications or amendments to the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Research Plan, provided that any modifications or amendments to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan shall be subject to review by the JRC and approval by the JSC. Each Party
shall use Commercially Reasonable Efforts to perform and complete (itself or through its Affiliates or by permitted subcontracting) its obligations under the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan. Neither Party shall be
required to perform any work which is not contemplated by the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan, unless such additional work is reflected in a mutually agreed amendment to the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan. Without limiting the JRC&#146;s rights to review and discuss and the JSC&#146;s rights to approve the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan and update thereto, the
Party to whom a particular Research activity is allocated under the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan shall have the right, without seeking JRC review or JSC approval, to make operational decisions with respect to the
performance of such Research activity to the extent consistent with the then-current DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan. Without limiting the generality of the foregoing, each Party shall use Commercially Reasonable
Efforts to reach a DC Nomination during the Initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If there is no DC Nomination by the
end of the Initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term, the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program will expire at the end of the Initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term,
regardless of whether Moderna has exercised its <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right with respect to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program prior to the end of the Initial DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term, unless the Parties have expressed their mutual wish to continue with the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program and negotiated and agreed on whether to revise the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Research Plan, in each case prior to the end of the Initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term. After the expiration of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program,
neither Party shall use, nor allow or enable any others to use, any Program Technology specific to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program in the DT Field for
[***], provided that the foregoing shall not apply to Moderna in the event it has exercised its <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right prior to the expiration of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.3.2 <B>Eligible <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Costs</B>. Subject
to the last sentence of Section&nbsp;7.3 (Research Funding), the Parties shall share [***] the Eligible <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Costs of all Research activities incurred by or on behalf of either Party that are set
forth in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Budget; provided that to the extent that any Research Budget Overspend is not an Allowable Overrun, within [***] after the end of the appliable Calendar Quarter, the JSC shall
determine if such Overspend was caused by circumstances within the relevant Party&#146;s reasonable control, then, unless otherwise approved by the JSC, such Party shall be solely responsible for such Overspend (and the other Party shall not be
responsible for any portion of such Overspend), and if the JSC determines that such Overspend was caused by circumstances outside of the relevant Party&#146;s reasonable control or is otherwise approved by the JSC, then each Party shall be
responsible for [***] of the Overspend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 <B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development Activities</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.1 <B>Overview</B>. The Lead Party shall lead the conduct of each standalone Clinical Trial in its respective Region with respect to the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory. In the case of international multi-site Clinical Trials involving at least one site in each of the U.S. and at least one country
<FONT STYLE="white-space:nowrap">Ex-U.S.,</FONT> the Parties will discuss and agree which Party would lead the conduct for such Clinical Trial taking into consideration the capabilities of each Party to operationally lead such Clinical Trial. Except
as expressly set forth otherwise in the Development Plan, Moderna shall be responsible for all CMC Matters and Manufacturing related to the clinical supply of DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products. Notwithstanding anything to the
contrary in this Agreement, the Parties may elect to conduct Development activities jointly and allocate specific operational activities in accordance with the Development Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.2 <B>Diligence</B>. Moderna and Metagenomi shall each use Commercially Reasonable Efforts to perform all obligations allocated to such
Party under each Development Plan for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory. The applicable Development Plan shall specify which Party shall lead the conduct of each Clinical Trial set forth in the applicable
Development Plan and all Clinical Trials and Development activities shall be conducted as set forth in the Development Plan for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory. Subject to Section&nbsp;6.4.7 (New
Development) and Section&nbsp;6.4.8 (Combination Products), the Parties shall not perform any Development activities in the Territory for any formulation, Indication, or Combination Product with respect to any DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product other than those formulations, Indications, or Combination Products set forth in the applicable Development Plan in accordance with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.3 <B>Development Plans</B>. The initial Development Plan, which will set forth in reasonable detail the anticipated Development activities
for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory and the corresponding Development Budget, shall be reviewed by the JDC and presented to the JSC for approval. Subject to comments and proposed changes by
the other Party, each Party will be responsible for the Development Plan for such Party&#146;s respective Region. The development plans for each Region will be incorporated into the overall Development Plan. On at least a [***] basis during the Term
(or more frequently as may be required), the JDC shall review and update each Development Plan and corresponding Development Budget based on the currently available information and data, including to add (a)&nbsp;any New Collaboration Development
Activities that have not yet been included in the Development Plan and Development Budget for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, including the proposed timelines and budget for such New Collaboration Development Activities
set forth in the applicable New Development Proposal approved by JDC (as may be amended by the JDC), or (b)&nbsp;any applicable new formulations or Indications pursuant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to Section&nbsp;6.4.7(a) (New Development Activities) or new Combination Products proposed by the JDC in accordance with Section&nbsp;6.4.8 (Combination Products). The JDC shall review, discuss,
and determine whether to present any such update to any Development Plan or Development Budget for approval by the JSC. Each such update to a Development Plan and corresponding Development Budget shall become effective and shall supersede the
previous Development Plan and corresponding Development Budget upon approval thereof by the JSC. Notwithstanding any provision to the contrary set forth in this Agreement, if either Party proposes to include Development activities for a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product for a particular formulation or Indication in the applicable Development Plan because those Development activities are required or requested by a Regulatory Authority in the Territory, then the JSC
shall approve the inclusion of such Development activities in the applicable Development Plan (and corresponding Development Budget). Without limiting the JDC&#146;s rights to review and discuss and the JSC&#146;s rights to approve each Development
Plan and update thereto, the Party to whom a particular Development activity is allocated under the Development Plan shall have the right, without seeking JDC review or JSC approval, to make operational decisions with respect to the performance of
such Development activity to the extent consistent with the then-current Development Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.4 <B>Development Cost Sharing</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Eligible Development Costs</B>. The Parties shall [***] the Eligible Development Costs of all Development activities for DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory incurred by or on behalf of either Party that are set forth in the Development Budget; provided that to the extent that any Development Budget Overspend is not an Allowable Overrun,
within [***] after the end of the appliable Calendar Quarter, the JSC shall determine if such Overspend was caused by circumstances within the relevant Party&#146;s reasonable control, then, unless otherwise approved by the JSC, such Party shall be
solely responsible for such Overspend (and the other Party shall not be responsible for any portion of such Overspend), and if the JSC determines that such Overspend was caused by circumstances outside of the relevant Party&#146;s reasonable control
or is otherwise approved by the JSC, then each Party shall be responsible for [***] of the Overspend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Quarterly Reconciliation of
Development Costs for DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products</B>. With respect to each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, no later than [***] after the end of each Calendar Quarter, each Party shall deliver
to the other Party a written report of the Eligible Development Costs incurred by or on behalf of such Party in connection with the performance of Development activities during such Calendar Quarter (for Moderna, the &#147;<B>Moderna Development
Cost Share Notice</B>&#148; and for Metagenomi, the &#147;<B>Metagenomi Development Cost Share Notice</B>&#148;). For each Calendar Quarter: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) If the actual amount set forth in the Metagenomi Development Cost Share Notice exceeds the actual amount set forth in the Moderna
Development Cost Share Notice, then no later than [***] after Moderna&#146;s receipt of the Metagenomi Development Cost Share Notice for such Calendar Quarter, Moderna shall pay to Metagenomi [***] of the difference between the actual amount set
forth in the Metagenomi Development Cost Share Notice and the actual amount set forth in the Moderna Development Cost Share Notice for such Calendar Quarter, such that each Party bears [***] of the aggregate Eligible Development Costs incurred by or
on behalf of the Parties during such Calendar Quarter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) If the actual amount set forth in the Moderna Development Cost Share Notice exceeds
the actual amount set forth in the Metagenomi Development Cost Share Notice, then no later than [***] after Metagenomi&#146;s receipt of the Moderna Development Cost Share Notice for such Calendar Quarter, Metagenomi shall pay to Moderna [***] of
the difference between the actual amount set forth in the Moderna Development Cost Share Notice and the actual amount set forth in the Metagenomi Development Cost Share Notice for such Calendar Quarter, such that each Party bears [***] of the
aggregate Eligible Development Costs incurred by or on behalf of the Parties during such Calendar Quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.5 <B>Development
Reports</B>. At each JDC meeting, (a)&nbsp;Moderna and Metagenomi shall each provide the JDC with a written report summarizing the Development activities for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products conducted by or on behalf of
each Party since the last JDC meeting, including (i)&nbsp;patient enrollment and the ongoing status of all Clinical Trials, in each case, under any Development Plan and (ii)&nbsp;the status of each pending and proposed Regulatory Filing set forth in
the Development Plan for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, to the extent not already provided, and without limiting the obligations under Section&nbsp;6.5 (Regulatory Affairs), (b) Metagenomi shall
provide the JDC a summary of the progress and results of Metagenomi Development activities for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, and (c)&nbsp;Moderna shall provide the JDC a summary of the progress and results of Moderna
Development activities for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. Each Party shall also promptly provide written notice to the other Party, through the JDC or Alliance Managers, of any significant Development events in the
Territory (<I>e.g.</I>, Clinical Trial initiation or completion, clinical holds, and Regulatory Approvals) that the reporting Party reasonably believes is of interest to the other Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.6 <B>Assumed Development Activities</B>. If either Party has defaulted on its obligations to perform one or more Development activities
allocated to such Party under a Development Plan in a manner that delays the performance of such matters for a period of more than [***] beyond the timeline set forth in such Development Plan, then the other Party shall provide such defaulting Party
with written notice regarding such failure to perform, and upon receipt of such notice the defaulting Party shall have a [***] period to commence the performance of such Development activities in accordance with the terms hereof and the applicable
Development Plan (the &#147;<B>Development Activities Cure Period</B>&#148;), in any case subject to Section&nbsp;6.5.1(c) (CMC Matters). If (a)&nbsp;the defaulting Party has not commenced performance of such Development activities during the
applicable Development Activities Cure Period, (b)&nbsp;the defaulting Party notifies the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party in writing that the defaulting Party anticipates that it shall be unable to perform such
Development activities, or (c)&nbsp;the defaulting Party does not perform such Development activities in accordance with the applicable Development Plan or otherwise in accordance with this Section&nbsp;6.4 (DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development Activities), within a reasonable period of time in accordance with the terms hereof, then, in each case ((a)-(c)), the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party
may, upon written notice to the defaulting Party, assume those Development activities that are the subject of such default by the defaulting Party (the &#147;<B>Assumed Development Activities</B>&#148;). In connection with the defaulting
Party&#146;s failure to perform such activities or default of such obligations and the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party&#146;s assumption thereof: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) the defaulting Party shall work collaboratively and in good faith with the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Party, and make its personnel reasonably available to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party, in each case, in order to (a)&nbsp;transfer of any applicable technology,
materials, or contracts with subcontractors to the other Party that are necessary or reasonably useful for the performance of the applicable Assumed Development Activities, and (b)&nbsp;provide such other assistance so as to enable the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Party to assume performance of the applicable Assumed Development Activities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Party shall thereafter have the right to make operational decisions with respect to the performance of such Assumed Development Activities to the extent consistent with the then-current Development
Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) the JDC shall update the applicable Development Plan to allocate performance of the Assumed Development Activities to the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Party; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) for the avoidance of doubt, Eligible Development Costs incurred in
connection with the performance of Assumed Development Activities shall be shared [***] by the Parties as set forth in Section&nbsp;6.4.4(a) (Eligible Development Costs). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.7 <B>New Development</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>New Development Activities</B>. If either Party proposes to Develop in the Territory, (a)&nbsp;a new formulation of any DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product or (b)&nbsp;any DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product for a new Indication (including any different patient population or line of therapy, which shall be deemed to be a different
Indication for purposes of this Section&nbsp;6.4.7 (New Development)), in each case ((a) and (b)), other than the formulations and Indications set forth in the applicable Development Plan for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Product ((a) and (b), &#147;<B>New Development</B>&#148;), then the proposing Party shall present to the JDC, to review and discuss, a proposal to add such New Development to the Development Plan, for the applicable DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, including the countries in which such activities would be conducted and the allocation of performance of such activities between the Parties (a &#147;<B>New Development Proposal</B>&#148;). Each
New Development Proposal shall describe in reasonable detail the applicable <FONT STYLE="white-space:nowrap">non-clinical</FONT> studies, <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies, and Clinical Trials, in each case, that the
proposing Party desires to conduct as part of such New Development, including a synopsis of the trial or activities, the proposed enrollment criteria, the number of patients to be included, the endpoints to be measured, and the statistical design
and powering (the &#147;<B>New Development Activities</B>&#148;), as well as a proposed timeline and budget and an analysis of the business opportunity and revenue potential for such New Development Activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>JDC and JSC Decision Regarding New Development Activities</B>. No later than sixty (60)&nbsp;days after receipt thereof from the
proposing Party, the JDC shall review, discuss, and determine whether to present to the JSC for approval, each New Development Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) If the JSC approves a New Development Proposal, upon such an approval, then: (i)&nbsp;the New Development Activities set forth in such
New Development Proposal shall be deemed &#147;<B>New Collaboration Development Activities</B>&#148; for purposes of this Agreement and (ii)&nbsp;the JDC shall update the Development Plan for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Product to include such New Collaboration Development Activities for those countries agreed by the JSC, including the proposed timelines and budget, in each case, for such New Development Activities set forth in such New Development Proposal (as may
be amended by the JDC and approved by the JSC). Any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
New Development Activities included in a Development Plan pursuant to this Section&nbsp;6.4.7 (New Development) shall be deemed to be Development activities for all purposes under this
Section&nbsp;6.4 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development Activities). If the JSC does not approve a New Development Proposal, then the New Development Activities proposed in the New Development Proposal shall not be
included in any Development Plan, and the proposing Party shall not conduct such New Development Activities in the Territory. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.8
<B>Combination Products</B>. [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.9 <B>Standards of Conduct; Development Records</B>. Moderna and Metagenomi shall perform, and
each shall ensure that their Affiliates and licensees and permitted sublicensees (as applicable), and subcontractors perform, all Development activities under each Development Plan, as the case may be, in a good scientific manner, in accordance with
GLP, GMP, and GCP, as applicable, and in compliance with Applicable Laws. Each Party and its Affiliates shall maintain written or electronic records, in sufficient detail, in a good scientific manner (in accordance with GLP, GCP, and GMP, as
applicable), and appropriate for regulatory and patent purposes, and that are complete and accurate in all material respects and reflect all Development work performed and results achieved, in each case, by or on behalf of such Party and its
Affiliates under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4.10 <B>Access to Data</B>. In addition to its adverse event and safety data reporting obligations set
forth in Section&nbsp;6.5.7 (Pharmacovigilance and Adverse Event Reporting), each Party shall promptly provide the other Party with copies of all data and results and all supporting documentation (<I>e.g.</I>, protocols, Investigator&#146;s
Brochures, case report forms, analysis plans) Controlled by such Party that are generated by or on behalf of such Party or its Affiliates, sublicensees, or subcontractors, if applicable, in the Development of each DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, to the extent necessary or reasonably useful for the performance of the other Party&#146;s Development activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5 <B>Regulatory Affairs</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5.1 <B>Regulatory Responsibilities</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Territory</B>. Pursuant to the Development Plan, the Parties shall collaborate on a regulatory strategy for DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory, subject to Section&nbsp;6.5.1(c) (CMC Matters). The JDC shall review and discuss, the overall strategy for obtaining, supporting, and maintaining Regulatory Approval of each DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory (which strategy shall be reflected in each Development Plan) and the JDC shall oversee the implementation of and discuss the progress regarding the same. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Regulatory Responsibilities</B>. Subject to [***] and on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Region-by-Region</FONT></FONT> basis, the Regulatory Responsible Party shall lead all regulatory matters relating to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in
accordance with the Development Plan. The Regulatory Responsible Party may file for in its name, and shall own, all Regulatory Documentations with respect to each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the applicable country in
the Region. Subject to this Section&nbsp;6.5 (Regulatory Affairs) and on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Region-by-Region</FONT></FONT> basis, the Regulatory Responsible Party shall have the sole right to
(a)&nbsp;oversee, monitor, and coordinate all regulatory actions, communications and filings with, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
submissions to, each Regulatory Authority in the Region with respect to each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product; (b)&nbsp;interface, correspond, and meet with each
Regulatory Authority in the Region with respect to each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product; and (c)&nbsp;seek and maintain all Regulatory Approvals in the Region with respect to each DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. In addition, notwithstanding any provision to the contrary set forth in this Agreement, the Regulatory Responsible Party shall (i)&nbsp;not be required to delay any actions, communications, or
filings with, or submissions to any Regulatory Authorities in the Region in a manner that affects such Regulatory Responsible Party&#146;s ability to comply with any Regulatory Authority requirement or deadline or Applicable Laws in the Territory or
that would delay receipt of Regulatory Approval for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory and (ii)&nbsp;have final say on the content of all Regulatory Filings (including Material Communications) with Regulatory
Authorities in the Region. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <B>CMC Matters</B>. Notwithstanding anything to the contrary in this Agreement: (i)&nbsp;Moderna shall be
solely responsible for all CMC Matters under this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) Moderna is not required to disclose to Metagenomi or any of its
Affiliates any CMC Matters or any information related to the design of mRNA Constructs (including any applicable bioinformatics technology); and (iii)&nbsp;unless authorized in writing by Moderna, Metagenomi or its Affiliates shall not have the
right to access, review, use, copy, distribute or retain any Moderna&#146;s Confidential Information related to CMC Matters or the design of mRNA Constructs (including any applicable bioinformatics technology). In the event Metagenomi or any of its
Affiliates receive any knowledge or information regarding CMC Matters or the design of mRNA Constructs related to this Agreement from a Regulatory Authority or another Third Party, Metagenomi or its Affiliates shall immediately convey such knowledge
or information directly to Moderna and promptly and properly delete or destroy all records and documentation regarding any such CMC Matters or mRNA Construct design in its possession, or return them to Moderna, in each case as instructed by Moderna
in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <B>Cooperation and Coordination</B>. At the Regulatory Responsible Party&#146;s request, the other Party shall
diligently cooperate with the Regulatory Responsible Party in connection with any Regulatory Filings and other regulatory compliance related activities with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, including
harmonization of any Regulatory Documentation and Regulatory Filings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5.2 <B>Communications with Regulatory Authorities</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Prompt Disclosures</B>. Subject to Section&nbsp;6.5.1(c) (CMC Matters), each Party shall inform the other Party within [***], or such
shorter time as is necessary to comply with the reporting requirements of any applicable Regulatory Authority or under Applicable Laws, of notification of any action by, or notification or other information that it receives (directly or indirectly)
from any Regulatory Authority in the Territory to the extent such information: (a)&nbsp;raises any material concerns regarding the safety or efficacy of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product; (b)&nbsp;indicates or suggests a
potential material liability of either Party to Third Parties in connection with a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product; (c)&nbsp;is reasonably likely to lead to a clinical hold, recall, market withdrawal, or field alert with
respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product; or (d)&nbsp;relates to expedited and periodic reports of adverse events with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, or DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product complaints, and may have an adverse impact on the receipt or maintenance of Regulatory Approval or the continued </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Commercialization of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. The Parties shall reasonably cooperate with and assist each other in complying with regulatory obligations and
communications, including by providing to the applicable Regulatory Responsible Party, within two (2)&nbsp;Business Days after a request, such information and documentation that is in the other Party&#146;s possession as may be necessary or helpful
for such Regulatory Responsible Party to prepare a response to an inquiry from a Regulatory Authority in the Territory with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. Each Party shall also promptly provide the other Party
with a copy of all correspondence received from a Regulatory Authority in the Territory specifically regarding the matters referred to above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Other Material Communications</B>. To the extent not provided pursuant to Section&nbsp;6.5.2(a) (Prompt Disclosures), subject to
Section&nbsp;6.5.1(c) (CMC Matters), and on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Region-by-Region</FONT></FONT> basis, the Regulatory Responsible Party shall provide the JDC for its review and discussion a brief
description in English of the principal issues raised in each Material Communication with Regulatory Authorities with respect to any DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Region promptly after receipt thereof, but in any
event within fifteen (15)&nbsp;Business Days after receipt thereof. The Regulatory Responsible Party shall allow the other Party a reasonable opportunity to review and comment on the Regulatory Responsible Party&#146;s proposed response to any
Material Communications with any Regulatory Authority in the Region with respect to any DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in advance of the transmission of such response, and the Regulatory Responsible Party shall reasonably
consider all comments timely provided by the other Party in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <B>Other Disclosures</B>. In addition to its
obligations under this Agreement, each Party shall promptly disclose to the other Party the following regulatory information, subject to Section&nbsp;6.5.1(c) (CMC Matters): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) <B>Regulatory Actions</B>. All material information Controlled by such Party pertaining to actions taken by Regulatory Authorities
related to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, including any notice, audit notice, notice of initiation by Regulatory Authorities of investigations, inspections, detentions, seizures, or injunctions
concerning a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, notice of violation letter (<I>i.e.</I>, an untitled letter), warning letter, service of process, or other inquiry; provided that a Party shall be entitled to
redact those portions thereof to the extent not related to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)
<B>Regulatory <FONT STYLE="white-space:nowrap">Non-Compliance</FONT></B>. All information Controlled by such Party pertaining to notices from Regulatory Authorities in the Territory of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with
Applicable Laws in connection with a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, including receipt of a warning letter or other notice of alleged material <FONT STYLE="white-space:nowrap">non-compliance</FONT> from any Regulatory
Authority relating to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product; provided that a Party shall be entitled to redact those portions thereof to the extent not related to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5.3 <B>Regulatory Meetings</B>. The Regulatory Responsible Party shall provide the other Party with reasonable advance notice of all
substantive meetings with the Regulatory Authorities in the applicable Region pertaining to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, or with as much advance notice as practicable under the circumstances. Upon the other
Party&#146;s request, the Regulatory Responsible Party shall include the other Party in the preparation and strategy for such substantive meeting and in any discussions and actions relating to the outcome thereof. Notwithstanding any provision to
the contrary set forth in this Section&nbsp;6.5.3 (Regulatory Meetings), (a) if required by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the applicable Regulatory Authority at any meeting with such Regulatory Authority, then attendance by the other Party shall be permitted; (b)&nbsp;attendance by the representatives of the other
Party shall not prevent participation of a representative of the Regulatory Responsible Party for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product due to restrictions imposed by Regulatory Authorities on the number of
attendees; and (c)&nbsp;the Regulatory Responsible Party for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product shall not be obligated to change the schedule of such meeting in order to accommodate the schedule of the other
Party&#146;s representatives. The <FONT STYLE="white-space:nowrap">non-Regulatory</FONT> Responsible Party shall strictly follow the applicable Regulatory Responsible Party&#146;s instructions with respect to any such meeting that it attends, and
shall not discuss the contents of any such meeting with any Third Party or Regulatory Authority except as required by Applicable Laws or authorized by the Regulatory Responsible Party in writing. If either Party requires an interpreter or other
translation services in connection with its participation in any such meeting with Regulatory Authorities, then the requiring Party shall be responsible for the costs of such translation services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5.4 <B>Regulatory Filings</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Regulatory Filings</B>. Subject to Section&nbsp;6.5.1(c) (CMC Matters), the Regulatory Responsible Party for each Region shall provide
the other Party with a copy of all proposed Regulatory Filings to be filed with or submitted to any Regulatory Authority in the Region for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product for the other Party&#146;s review and
comment sufficiently in advance of, but in any event, unless not practicable, at least [***] prior to, the Regulatory Responsible Party&#146;s filing or submission thereof, and the Regulatory Responsible Party for the Region shall reasonably
consider incorporating any reasonable comments received from the other Party into such Regulatory Filings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Other Submissions</B>.
In addition, the Regulatory Responsible Party for each Region shall provide the other Party with written notice of each of the following events with regard to each applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product throughout the
Region (to the extent not already provided pursuant to Section&nbsp;6.5.4(a) (Regulatory Filings)), subject to Section&nbsp;6.5.1(c) (CMC Matters): within a reasonable period of time, but in any event, unless not practicable, at least [***],
following the occurrence thereof (a)&nbsp;the submission of any applications for Regulatory Approval of such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product to any Regulatory Authority in the Region, and (b)&nbsp;receipt of or denial of
Regulatory Approval for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product (or inquiries from the applicable Regulatory Authority related to the Regulatory Approval process); provided that the Regulatory Responsible Party shall inform the
other Party of any such event under (a)&nbsp;or (b) prior to public disclosure of such event by the other Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <B>CMC Filings</B>.
Notwithstanding anything to the contrary in this Section&nbsp;6.5 (Regulatory Affairs), Moderna shall be responsible for all <FONT STYLE="white-space:nowrap">CMC-related</FONT> components of all Regulatory Filings for the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory. If not previously prepared and filed, Moderna will, at Metagenomi&#146;s written request, prepare and file with the FDA a DMF containing required CMC information for DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products in the U.S. Metagenomi and its Affiliates may refer to such DMF in any Regulatory Filing made in connection with obtaining or maintaining a Regulatory Approval for applicable DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in the U.S. [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5.5 <B>Costs of Regulatory Affairs</B>. [***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5.6 <B>Right of Reference</B>. Subject to the rules of the relevant Regulatory Authority
and the terms of this Agreement, each Party hereby grants to the other Party a &#147;Right of Reference,&#148; as that term is defined in 21 C.F.R. &#167; 314.3(b) (or any successor rule or analogous Applicable Laws recognized outside of the U.S.)
to, and a right to copy, access, and otherwise use, all information and data relating to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in any Regulatory Filings or Regulatory Approval Controlled by such Party during the Term, solely
for the other Party&#146;s or its Affiliates&#146; use in the Development and Commercialization of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in their respective Region during the Term in accordance with this Agreement. All such
information and data contained in any such Regulatory Filings or Regulatory Approvals shall be considered Confidential Information of such Party and subject to the terms of Article 11 (Confidentiality). If requested by the other Party, such Party
shall provide a signed statement to this effect in accordance with 21 C.F.R. &#167; 314.50(g)(3) (or any successor rule or analogous Applicable Laws outside of the U.S.) to give effect to the intent of this Section&nbsp;6.5.6 (Right of Reference).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5.7 <B>Pharmacovigilance and Adverse Event Reporting</B>. The Parties shall cooperate with regard to the reporting and handling of
safety information involving the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in accordance with the Applicable Laws, regulatory requirements, and regulations on pharmacovigilance and clinical safety. The Regulatory Responsible Party
for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in a given Region shall be responsible for all processing of information related to any adverse events for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product for the Region.
Each Party shall provide to the other Party the relevant safety information it receives (either directly or indirectly) related to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product within such time to ensure that all regulatory requirements
and timelines are met in the respective territories. The Parties shall negotiate in good faith and enter into a Pharmacovigilance Agreement, which shall define the pharmacovigilance responsibilities of the Parties and include safety data exchange
procedures governing the exchange of information affecting the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products (<I>e</I>.<I>g</I>., Serious Adverse Events, emerging safety issues) to enable each Party to comply with all of its legal and
regulatory obligations related to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products (the &#147;<B>Pharmacovigilance Agreement</B>&#148;). Moderna shall own and maintain the global safety database for all DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products provided that the Pharmacovigilance Agreement shall provide Metagenomi access to such database and real time notifications and reporting of adverse events, as needed for pharmacovigilance obligations.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5.8 <B>Recalls, Withdrawal, or Field Alert of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Notification and Determination</B>. In the event that any Governmental Authority threatens in writing or initiates any action to
remove a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product from the market (in whole or in part) in the Territory, the Party receiving notice thereof shall notify the other Party of such communication immediately, but in no event later than
two Business Days after receipt thereof. Notwithstanding the foregoing, in all cases the Regulatory Responsible Party for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in a Region shall determine whether to initiate any recall,
withdrawal, or field alert of such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the applicable Region, including the scope of such recall or withdrawal (<I>e.g.</I>, a full or partial recall, or a temporary or permanent recall) or
field alert. Before the Regulatory Responsible Party initiates a recall, withdrawal, or field alert for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in a Region, as applicable, the Parties shall use reasonable efforts to promptly meet
and discuss in good faith the reasons therefor, provided that such discussions shall not delay any action that such Regulatory Responsible Party reasonably believes should be taken in relation to any actual or potential recall, withdrawal, or field
alert. In the event of any such recall, withdrawal, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
field alert, the Regulatory Responsible Party for the applicable Region shall determine the necessary actions to be taken and shall implement such action. Without limiting the foregoing, either
Party shall have the right to propose that a recall, withdrawal, or field alert for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product should be initiated by such Party, but the Regulatory Responsible Party for the applicable Region shall
have the right to make the final decision as to whether or not to initiate the recall, withdrawal, or field alert. Notwithstanding the foregoing, if a recall, withdrawal, or field alert is reasonably necessary due to a Manufacturing issue related to
a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, Moderna shall promptly notify Metagenomi of such issue and provide relevant information on such Manufacturing issue. Upon written request by Moderna for such recall, withdrawal, or field
alert, such request to include the scope of the recall or withdrawal, as applicable, Metagenomi (if Metagenomi is the Regulatory Responsible Party for the applicable Region), shall initiate such recall, withdrawal, or field alert in accordance with
Moderna&#146;s request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Cost Allocation</B>. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6 <B>Medical Affairs</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6.1 <B>Medical Affairs Plans</B>. No later than [***] before the submission of the first Regulatory Filing seeking the first Regulatory
Approval for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, the Medical Affairs Working Group shall prepare and submit to the JDC a Medical Affairs Plan for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory
for the following [***], including the corresponding Medical Affairs Budget. The Medical Affairs Plan shall contain a [***] rolling annual plan for the Medical Affairs activities for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in
the Territory. Subject to comments and proposed changes by the other Party, each Party will be responsible for the Medical Affairs Plan for its respective Region. The Medical Affairs Plans for each Region will be incorporated into the overall
Medical Affairs Plan. The JDC shall prepare, review, discuss and determine whether to present each Medical Affairs Plan and Medical Affairs Budget, including the allocation of activities between the Parties set forth therein, to the JSC for
approval. On an annual basis during the Term (or more frequently as may be required), the JDC shall review and update, or have a Party review and update, each Medical Affairs Plan and Medical Affairs Budget based on the currently available
information and data, including for any applicable new formulations or Indications that that were added to a Development Plan pursuant to Section&nbsp;6.4.7(b) (JDC and JSC Decision Regarding New Development Activities) or new Combination Products
approved by the JSC in accordance with Section&nbsp;6.4.8 (Combination Products), in each case, that are not included in the then-current Medical Affairs Plan for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. The JDC shall
review and discuss and determine whether to present any such update to the Medical Affairs Plans and Medical Affairs Budgets to the JSC for approval. Each such update to a Medical Affairs Plan and corresponding Medical Affairs Budget shall become
effective and shall supersede the previous Medical Affairs Plan and corresponding Medical Affairs Budget upon approval thereof by the JSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6.2 <B>Performance of Medical Affairs</B>. The Lead Party shall lead the performance of Medical Affairs activities in its respective Region
for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, and, without seeking JDC review or approval, shall have the right to make operational decisions with respect to the performance of such Medical Affairs activities to the extent
consistent with the then-current Medical Affairs Plan provided that Moderna may appoint up to [***] of all medical science liaisons for the U.S. Notwithstanding anything to the contrary herein, the Parties may elect to conduct Medical Affairs
activities jointly and allocate specific operational activities in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accordance with the Medical Affairs Plan. If a particular Medical Affairs activity is allocated to both Parties to perform jointly under a Medical Affairs Plan, then both Parties shall conduct
such activity in collaboration with each other as directed by the JDC. Each Party shall use reasonable efforts in the Territory to cobrand all sponsorships, booths, and similar activities in accordance with branding terms set forth in the applicable
Commercialization Plan and to the extent the same are solely related to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products and such cobranding is permitted under Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6.3 <B>Medical Affairs Costs</B>. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6.4 <B>Assumed Medical Affairs Activities</B>. If either Party has defaulted on its obligations to perform one or more Medical Affairs
activities allocated to such Party under a Medical Affairs Plan in a manner that delays the performance of such matters for a period of more than [***] beyond the timeline set forth in such Medical Affairs Plan, then the other Party shall provide
such defaulting Party with written notice regarding such failure to perform, and upon receipt of such notice the defaulting Party shall have a [***] period to commence the performance of such Medical Affairs activities in accordance with the terms
hereof and the applicable Medical Affairs Plan (the &#147;<B>Medical Affairs Activities Cure Period</B>&#148;). If (i)&nbsp;the defaulting Party has not commenced performance of such Medical Affairs activities during the applicable Medical Affairs
Activities Cure Period, (ii)&nbsp;the defaulting Party notifies the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party in writing that the defaulting Party anticipates that it shall be unable to perform such Medical Affairs activities, or
(iii)&nbsp;the defaulting Party does not perform such Medical Affairs activities in accordance with the applicable Medical Affairs Plan or otherwise in accordance with this Section&nbsp;6.6 (Medical Affairs), within a reasonable period of time in
accordance with the terms hereof, then, in each case ((i)-(iii)), the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party may, upon written notice to the defaulting Party, assume those Medical Affairs activities that are the subject of such
default by the defaulting Party (the &#147;<B>Assumed Medical Affairs Activities</B>&#148;). In connection with the defaulting Party&#146;s failure to perform such activities or default of such obligations and the
<FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party&#146;s assumption thereof: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) the defaulting Party shall work
collaboratively and in good faith with the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party, and make its personnel reasonably available to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party, in each case, in order to
(i)&nbsp;transfer of any applicable technology, materials, or contracts with subcontractors to the other Party that are necessary or reasonably useful for the performance of the applicable Assumed Medical Affairs Activities, and (ii)&nbsp;provide
such other assistance so as to enable the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party to assume performance of the applicable Assumed Medical Affairs Activities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party shall thereafter have the right to make operational decisions with
respect to the performance of such Assumed Medical Affairs Activities to the extent consistent with the then-current Medical Affairs Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) the JDC shall update the applicable Medical Affairs Plan to allocate performance of the Assumed Medical Affairs Activities to the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Party; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) for the avoidance of doubt, Eligible Medical Affairs Costs incurred in
connection with the performance of Assumed Medical Affairs Activities shall [***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6.5 <B>Medical Affairs Updates</B>. At each meeting of the JDC, each Party shall provide
to the applicable JDC a summary of the Medical Affairs activities performed by such Party for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory during the period since the last JDC meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6.6 <B>Standards of Conduct; Compliance</B>. Each Party shall perform, or shall ensure that each of its Affiliates, sublicensees, and
subcontractors perform, all Medical Affairs activities in a professional and ethical business manner and in compliance with Applicable Laws, the Approved Labeling, and any applicable Medical Affairs Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.7 <B>Commercialization</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.1 <B>Commercialization Plan</B>. No later than [***] prior to the anticipated First Commercial Sale of a DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, Moderna and Metagenomi shall prepare and submit to the JCC, an initial Commercialization Plan for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, which will set
forth a reasonably detailed description of anticipated Commercialization activities for the applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory, including the corresponding Commercialization Budget. The
Commercialization Plan shall also contain a [***] rolling annual plan for the global Commercialization activities for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory and the Commercialization Budget shall include a
[***] financial forecast reflecting reasonably anticipated Commercialization Costs in accordance with the Commercialization Plan. Subject to comments and proposed changes by the other Party, each Party will be responsible for the Commercialization
Plan for its respective Region. The Commercialization Plans for each Region will be incorporated into the overall Commercialization Plan. The Commercialization Plan may discuss certain matters on an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Indication-by-Indication</FONT></FONT> basis and shall address (to the extent applicable given the stage of Commercialization and estimated anticipated First Commercial Sale)&nbsp;(a) the Product Marks, global usage
guidelines for the Product Marks, global key positioning, and messaging strategy for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such Indication, and guidelines for the Product Materials prepared in accordance with
Section&nbsp;6.7.9 (Product Materials) and (b)&nbsp;the general pricing and market access strategy (including discounts, rebates and other price reductions) globally and for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product for such
Indication in each country in the Territory. The JCC shall prepare, review, and discuss, and the JSC shall review, discuss, and determine whether to approve, each Commercialization Plan for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product.
Moderna shall have the sole right to select the Product Marks for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product to be used in Moderna&#146;s Region and included in the applicable Commercialization Plan and may decide to develop and
adopt certain distinctive colors, logos, images, symbols, and trade dress to be used (in addition to the Product Marks) in connection with the Commercialization of each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in Moderna&#146;s
Region. The Parties shall jointly select the Product Marks for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product to be used in Metagenomi&#146;s Region and included in the applicable Commercialization Plan and may jointly decide to
develop and adopt certain distinctive colors, logos, images, symbols, and trade dress to be used (in addition to the Product Marks) in connection with the Commercialization of each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in
Metagenomi&#146;s Region. The JCC shall prepare, review, and discuss, and the JSC shall review, discuss, and determine whether to approve, each Commercialization Plan and Commercialization Budget. On an annual basis during the Term (or more
frequently as may be required), the JCC shall review and update each Commercialization Plan and Commercialization Budget based on the currently available information and data, including for any applicable new formulations or Indications that that
were added to a Development Plan pursuant to Section&nbsp;6.4.7(b) (JDC and JSC Decision Regarding New Development Activities) or new Combination Products approved by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
JSC in accordance with Section&nbsp;6.4.8 (Combination Products), in each case, that are not included in the then-current Commercialization Plan for the applicable DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product. The JSC shall review, discuss, and determine whether to approve any such update to the applicable Commercialization Plan and corresponding Commercialization Budget. Each such update to a
Commercialization Plan and corresponding Commercialization Budget shall become effective and shall supersede the previous Commercialization Plan and corresponding Commercialization Budget upon approval thereof by the JSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.2 <B>Commercialization Activities</B>. The Parties shall Commercialize the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in
the Territory in accordance with the Commercialization Plan for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. The Lead Party shall lead the performance of Commercialization activities in its respective Region, and, without seeking
JCC review or approval, shall have the right to make operational decisions with respect to the performance of such Commercialization activities to the extent consistent with the then-current Commercialization Plan provided that Moderna may appoint
up to fifty percent (50%) of the deployed Sales Force for the U.S. Notwithstanding anything to the contrary herein, the Parties may elect to conduct Commercialization activities jointly and allocate specific operational activities in accordance with
the Commercialization Plan. Without limiting the generality of the foregoing, in connection with the Commercialization of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in its respective Region, The Lead Party shall be solely
responsible for (a)&nbsp;receiving, accepting, and filling orders for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, (b)&nbsp;handling all returns of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, (c)&nbsp;controlling
invoicing, order processing, and collection of accounts receivable for the sales of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, (d)&nbsp;booking and recording sales of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products
in its books of account, and (e)&nbsp;distributing and managing inventory of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products. If a particular Commercialization activity is allocated to both Parties to perform jointly under a
Commercialization Plan, then both Parties shall coordinate to jointly conduct such activity in collaboration with each other. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.3
<B>Commercialization Costs and Expenses</B>. [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.4 <B>Assumed Commercialization Activities</B>. If either Party has defaulted on
its obligations to perform one or more Commercialization activities allocated to such Party under a Commercialization Plan in a manner that delays the performance of such matters for a period of more than [***] beyond the timeline set forth in such
Commercialization Plan, then the other Party shall provide such defaulting Party with written notice regarding such failure to perform, and upon receipt of such notice the defaulting Party shall have a [***] period to commence the performance of
such Development activities in accordance with the terms hereof and the applicable Commercialization Plan (the &#147;<B>Commercialization Activities Cure Period</B>&#148;). If (a)&nbsp;the defaulting Party has not commenced performance of such
Commercialization activities during the applicable Commercialization Activities Cure Period, (b)&nbsp;the defaulting Party notifies the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party in writing that the defaulting Party anticipates
that it shall be unable to perform such Commercialization activities, or (c)&nbsp;the defaulting Party does not perform such Commercialization activities in accordance with the applicable Commercialization Plan or otherwise in accordance with this
Section&nbsp;6.7 (Commercialization), within a reasonable period of time in accordance with the terms hereof, then, in each case ((a)-(c)), the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party may, upon written notice to the defaulting
Party, assume those Commercialization activities that are the subject of such default by the defaulting Party (the &#147;<B>Assumed Commercialization Activities</B>&#148;). In connection with the defaulting Party&#146;s failure to perform such
activities or default of such obligations and the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party&#146;s assumption thereof: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) the defaulting Party shall work collaboratively and in good faith with the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Party, and make its personnel reasonably available to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party, in each case, in order to (i)&nbsp;transfer of any applicable technology,
materials, or contracts with subcontractors to the other Party that are necessary or reasonably useful for the performance of the applicable Assumed Commercialization Activities and (ii)&nbsp;provide such other assistance so as to enable the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Party to assume performance of the applicable Assumed Commercialization Activities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)
the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party shall thereafter have the right to make operational decisions with respect to the performance of such Assumed Commercialization Activities to the extent consistent with the
then-current Commercialization Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) the applicable JSC subcommittee shall update the applicable Commercialization Plan to allocate
performance of the Assumed Commercialization Activities to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Party; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)
[***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.5 <B>Pricing Matters; Pricing and Reimbursement Approvals; Information Sharing; Pricing Strategy</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Moderna shall be responsible for preparing the overall pricing strategy for the Territory, including establishing various pricing bands
for each country in the Territory, which is to be included in the Commercialization Plan subject to JCC review and JSC approval. Metagenomi shall have the right to comment, which Moderna shall consider in good faith in Moderna&#146;s proposed
pricing strategy. The Regulatory Responsible Party will be responsible for all Pricing Matters in its respective Region within the guidelines, such as pricing bands, set by the overall pricing strategy; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The Regulatory Responsible Party shall be solely responsible for negotiating, obtaining, and maintaining all Pricing and Reimbursement
Approvals for the DT CoCo Products in any country or regulatory jurisdiction in its respective Region where required in its own name or in the name of its Affiliate, subject to JSC approval; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Upon either Party&#146;s reasonable request, but subject to local anticompetition laws and any obligations of confidentiality between a
Party and any Third Party, the Parties, through the JCC, shall discuss key market research and relevant sections of DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product national reimbursement dossiers (or their equivalent) in the Territory, as
well as other relevant Commercialization information regarding the Territory collected or prepared by or on behalf of such Party relating to each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product that such Party agrees to share with the JCC
for discussion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.6 <B>Commercialization Reports</B>. At each meeting of the JCC, each Party shall provide to the JCC a summary of the
Commercialization activities performed by such Party for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory, during the period since the last JCC meeting. In addition, at each meeting of the JCC following the First
Commercial Sale of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in a country in a Region, the respective Lead Party shall present sales forecasts, sales performance reports, and other information for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in such country in the Region. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.7 <B>Commercialization Diligence Obligations</B>. Following receipt of Regulatory
Approval of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in a country within the Territory each Party shall use Commercially Reasonable Efforts to perform, or cause to be performed, the activities for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product assigned to it in the applicable Commercialization Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.8 <B>Standards of Conduct;
Compliance</B>. Each Party shall perform, or shall ensure that each of its Affiliates, sublicensees, and subcontractors perform, all Commercialization activities in a professional and ethical business manner and in compliance with Applicable Laws,
the Approved Labeling, and any applicable Commercialization Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.9 <B>Product Materials</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Creation; Ownership; Use</B>. Unless otherwise agreed by the Parties or as otherwise set forth in the Commercialization Plan, the Lead
Party shall create and develop all Product Materials in accordance with the Approved Labeling, applicable Regulatory Approvals, and Applicable Laws for all countries in its respective Region and submit such Product Materials to the JCC for review,
discussion, and approval. The Lead Party shall own all rights, title, and interests in and to any Product Materials for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products for its respective Region, excluding any Moderna Housemarks or
Metagenomi Housemarks as may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <B><FONT STYLE="white-space:nowrap">Co-Branding</FONT> of Product Materials</B>. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.10 <B>Product Marks</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Ownership; Trademark License</B>. [***] inures to the benefit of Moderna, regardless of which Party uses Moderna Housemarks in which
Region, and (ii)&nbsp;Metagenomi reserves all rights, title or interests in and to Metagenomi Housemarks, and all goodwill developed by virtue of the use of Metagenomi Housemarks inures to the benefit of Metagenomi, regardless of which Party uses
Metagenomi Housemarks in which Region. Upon a Party&#146;s reasonable request from time to time, the other Party shall provide to such Party for its review all materials that include any Product Marks, provided that all subsequent uses of any
materials already provided to such Party for review may be used without additional review. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Use</B>. Each Party agrees that it and
its Affiliates and Sublicensees shall Commercialize each of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory in a manner consistent with the Commercialization Plan and shall ensure that all DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products that are sold bearing the Product Marks are of a high quality consistent with industry standards for global pharmaceutical and biologic therapeutic products. Metagenomi agrees that it and its
Affiliates and Sublicensees shall (a)&nbsp;not use any Product Marks in a way that might materially prejudice their distinctiveness or validity or the goodwill of Moderna therein and shall include the trademark registration symbol <SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> or <SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> as appropriate; (b)&nbsp;ensure that each use of the Product Marks is in accordance with the guidelines with respect to manner of
use set forth in the Commercialization Plan; (c)&nbsp;not directly or indirectly, attack, dispute, or contest the validity of or ownership of such Product Marks anywhere in the Territory or any registrations issued or issuing with respect thereto;
(d)&nbsp;not use any trademarks or trade names so resembling any of such Product Marks as to be likely to cause confusion or deception; and (e)&nbsp;place and display the Product Marks on and in connection with the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in a way that acknowledges Moderna&#146;s role in discovering the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products and that such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product
is under license from Moderna. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <B>Required Use</B>. On a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-DT</FONT></FONT> <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product basis, Metagenomi shall promote and sell such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in
the U.S. only under the applicable Product Marks for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products as set forth herein and in the applicable Medical Affairs Plan, Commercialization Plan, and if a sublicensee is approved pursuant to
Section&nbsp;5.7.1 (Rights to Grant Licenses and Sublicenses in the Territory) then such sublicensee&#146;s trademarks, and no other Trademarks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <B>Registration, Maintenance, and Enforcement</B>. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.11 <B>Patent Marking</B>. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7.12 <B>Copyright License</B>. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.8 <B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.8.1 <B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right</B>. With respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Program, (a)&nbsp;Metagenomi may, at any time during the Term of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, and (b)&nbsp;Moderna may, at any time during the Term of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program (in
the case of (a), Metagenomi shall be the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party</B>&#148; and in the case of (b), Moderna shall be the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party</B>&#148;), elect to <FONT
STYLE="white-space:nowrap">opt-out</FONT> of its obligations under such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program (the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Program</B>&#148;) (in the case of Moderna being the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party, subject to Section&nbsp;6.8.2(e) (Effects of <FONT STYLE="white-space:nowrap">Opt-Out)),</FONT> and the other Party (the &#147;<B>Primary
Party</B>&#148;) shall have the right to continue the Development and Commercialization activities in the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program in the Territory (&#147;<B><FONT
STYLE="white-space:nowrap">Opt-Out</FONT></B>,&#148; and such right to <FONT STYLE="white-space:nowrap">Opt-Out,</FONT> the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right</B>&#148;). Metagenomi may exercise its <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Right by providing written notice to Moderna of such election at any time during the Term of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, and Moderna may exercise its <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Right by providing written notice to Metagenomi of such election at any time during the Term of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. Any exercise by either Party of its <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Right in accordance with the foregoing sentence shall become effective [***] after the delivery of the written notice (the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Date</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.8.2 <B>Effects of <FONT STYLE="white-space:nowrap">Opt-Out</FONT></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">[***] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.8.3 <B>Right of First
Offer After <FONT STYLE="white-space:nowrap">Opt-Out</FONT></B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">[***] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.9 <B>Preservation of Program Assets</B>. On a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis, except as otherwise permitted under this Agreement, during the Term of such Program, Metagenomi (i)&nbsp;shall not and shall ensure that its
Affiliates do not, (a)&nbsp;assign, transfer, convey or dispose of, or enter into any agreement with any Affiliate or Third Party to assign, transfer, convey or dispose of (or agree to do any of the foregoing), the Collaboration Targets, any
Candidates or Products, or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Metagenomi Licensed Collaboration Technology, including its interest in any Program Technology, in each case in connection with such Program (the &#147;<B>Metagenomi Program
Assets</B>&#148;), or (b)&nbsp;license, option or grant to any Affiliate or Third Party, or agree to license, option or grant to a Third Party, any rights to or otherwise encumber any Metagenomi Program Assets, in each case ((a)-(b)) that would
impair or conflict in any respect with any of the rights or licenses granted or to be granted to Moderna hereunder, (ii)&nbsp;shall, under Article 5 (Licenses; Exclusivity; Manufacture), transfer or otherwise provide the most advanced version of the
Metagenomi Licensed Collaboration Technology to Moderna or the JSC, as applicable, and (iii)&nbsp;shall include such most advanced version of the Metagenomi Licensed Collaboration Technology in the applicable Program Plan. Without limiting the
generality of the foregoing, until the end of the Research Term, Metagenomi will not <FONT STYLE="white-space:nowrap">spin-off</FONT> or agree to <FONT STYLE="white-space:nowrap">spin-off</FONT> (by any means) any Patents or <FONT
STYLE="white-space:nowrap">Know-How</FONT> relevant to the licenses granted by Metagenomi hereunder into any Affiliate of Metagenomi (at the time of such spin) without ensuring that any newly invented Patents or
<FONT STYLE="white-space:nowrap">Know-How</FONT> arising (directly or indirectly) from the practice of any such spun Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> (or improvements thereto) remain &#147;Controlled&#148; by Metagenomi
under this Agreement. For clarity, Metagenomi&#146;s obligations under this Section&nbsp;6.9 (Preservation of Program Assets) shall continue to apply in the event Metagenomi exercises its <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right under
Section&nbsp;6.8 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right). With respect to each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, except as otherwise permitted under this Agreement, during the Term of such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program, Moderna shall not and shall ensure that its Affiliates do not, (A)&nbsp;assign, transfer, convey or dispose of, or enter into any agreement with any Affiliate or Third Party to assign, transfer,
convey or dispose of (or agree to do any of the foregoing), the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target, any Candidates or Products, or any of the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology,
including its interest in any Program Technology, in each case in connection with such Program (the &#147;<B>Moderna Program Assets</B>&#148;), or (B)&nbsp;license, option or grant to any Affiliate or Third Party, or agree to license, option or
grant to a Third Party, any rights to or otherwise encumber any Moderna Program Assets, in each case ((A)-(B)) that would impair or conflict in any respect with any of the rights or licenses granted or to be granted to Metagenomi in such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program. For clarity, Moderna&#146;s obligations under this Section&nbsp;6.9 (Preservation of Program Assets) shall continue to apply in the event Moderna exercises its
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right under Section&nbsp;6.8 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.10 <B>Safety Concern</B>. Notwithstanding anything to the contrary herein or in the applicable DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Plan for a given DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, if, at any time during or after the Term of such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, Moderna reasonably
believes that there is a Safety Concern with respect to a Product in such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, then Moderna will immediately (and in any event within five (5)&nbsp;Business Days after the date it determines there
is a Safety Concern) provide written notice to Metagenomi of such Safety Concern, following which neither Party may conduct any further Development or Commercialization activities with respect to the Product that gave rise to the Safety Concern
until such Safety Concern is resolved; provided that if the Parties do not mutually agree how to resolve such Safety Concern within a [***] period, then Moderna shall have the right to determine whether there will be any further Development or
Commercialization activities with respect to such Product, and the extent of those activities, including the right to cease or suspend or cause the cessation or suspension of the conduct of any ongoing or future Clinical Trials of the Product, and
in the event Moderna determines that there will be no further Development or Commercialization activities with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program,
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program shall terminate with respect to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product to the extent it has not already expired or been terminated otherwise, and the Parties shall
cooperate with each other to wind-down their respective existing activities with respect to such Product. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 7 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FEES, ROYALTIES, &amp; PAYMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <B>Upfront Payment</B>. As partial consideration for the rights granted by Metagenomi to Moderna pursuant to the terms of this Agreement,
within [***] of the Effective Date, Moderna shall pay to Metagenomi (i)&nbsp;a <FONT STYLE="white-space:nowrap">non-refundable,</FONT> <FONT STYLE="white-space:nowrap">non-creditable,</FONT> unencumbered cash payment equal to forty million Dollars
($40,000,000) (the &#147;<B>Upfront Payment</B>&#148;) and (ii)&nbsp;the first payment of the Annual Research Funding Amount as described in Section&nbsp;7.3 (Research Funding), provided that, promptly (and in no event later than [***]) after the
Effective Date, Metagenomi provides Moderna with a properly completed and signed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> and an invoice for each of items (i)&nbsp;and (ii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <B>Convertible Note</B>. Pursuant to those convertible note financing agreements (collectively, &#147;<B>Convertible Note
Instruments</B>&#148;) entered into by the Parties dated as of even date herewith, and in accordance with the terms and conditions set forth therein, Moderna shall purchase convertible notes from Metagenomi in the amount of thirty million Dollars
($30,000,000) in principal converting to equity at the next Qualified Financing, as defined in the Convertible Note Instruments, on the terms and conditions set forth therein. The Convertible Note Instruments shall further provide that Moderna shall
have the right to designate one (1)&nbsp;observer to Metagenomi&#146;s Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <B>Research Funding</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.3.1 As additional consideration for the rights and license granted herein, Moderna shall pay Metagenomi an amount of five million Dollars
($5,000,000) within [***] after the Effective Date and at least five million Dollars ($5,000,000) within [***] after each anniversary of the Effective Date (each, the &#147;<B>Annual Research Funding Amount</B>&#148;), for Metagenomi&#146;s Research
Costs under the RT Technology Research Plan, the RT Preclinical Research Plans, the DT Target Evaluation Plan and the DT Moderna Research Plans. Notwithstanding the above or anything else herein to the contrary, should the Annual Research Funding
Amount for a specific year after the Effective Date not be fully consumed by Metagenomi&#146;s Research Costs incurred under the RT Technology Research Plan, the RT Preclinical Research Plans, the DT Target Evaluation Plan and the DT Moderna
Research Plans during such year, Metagenomi shall promptly notify Moderna of same after the applicable anniversary of the Effective Date, and Moderna may credit its own DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Costs under the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Research Plans for such year against any remainder of the Annual Research Funding Amount for such year. Any remaining DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Costs thereafter shall be subject
to sharing with Metagenomi pursuant to 6.4.4 (Development Cost Sharing). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.3.2 <B>Research Funding Audit</B>. In accordance with
Section&nbsp;7.6 (Accounting; Audit), Moderna may audit any invoices and expense reports provided by Metagenomi under Section&nbsp;3.5 (RT Research Term Costs) and Section&nbsp;4.6 (DT Moderna Research Term Costs). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Profit and Loss Share</B>.
Subject to Sections 6.8 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right), Moderna and Metagenomi shall share in Operating Profits or Losses with respect to Commercialization activities, Medical Affairs activities, the activities set forth
under Other Operating Expenses and other related activities for the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory as follows: Each Party shall bear (and be entitled to) fifty percent (50%) of such Operating Profits or
Losses (the &#147;<B>Profit and Loss Share</B>&#148;). <B>Schedule J </B><FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share) sets forth the procedures for reporting of actual results for each Calendar Quarter and review
and discussion of potential discrepancies, reconciliation, reasonable forecasting, and other finance and accounting matters, and to the extent such matters are not set forth in <B>Schedule J </B><FONT STYLE="white-space:nowrap">(Co-Co</FONT>
Products Profit and Loss Share), the JSC shall determine such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <B>Apportionment of Costs</B>. If any Commercialization Costs,
Development Costs, External Costs, Medical Affairs Costs, Cost of Sales, or Other Operating Expenses benefit both (a)&nbsp;a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, and (b)&nbsp;any other product or activities of a
Party outside of this Agreement, then the applicable Party incurring such costs shall apportion such costs in a manner that fairly and reasonably reflects the benefit to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory
and the other products or activities of such Party outside of this Agreement, as applicable. Each Party shall keep records of the total costs incurred and the apportionment pursuant to the records required under Section&nbsp;7.6 (Accounting; Audit).
At the request of the other Party, the Party making the apportionment shall provide reasonable additional supporting documentation and make its personnel reasonably available to answer any questions, and if the other Party disputes the
apportionment, then the JSC shall review, discuss, and determine what percentage of the total costs in question can be included as Commercialization Costs, Eligible Development Costs, Cost of Sales, Eligible Medical Affairs Costs, or Other Operating
Expenses, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6 <B>Accounting; Audit</B>. Each Party agrees to keep full, clear, and accurate records in accordance with
U.S. GAAP, consistently applied, for a period of at least [***] after the relevant payment is owed pursuant to this Agreement, setting forth Research Costs (including Eligible <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Costs, RT Excess
Costs, DT Moderna Excess Costs), Development Costs (including Eligible Development Costs), Medical Affairs Costs (including Eligible Medical Affairs Costs) Manufacturing Costs, Commercialization Costs, Other Operating Expenses, royalties, sales of
the Products, and other amounts payable to the other Party hereunder in sufficient detail to enable amounts owed or payable to the other Party hereunder to be determined. Each Party further agrees to permit its books and records to be examined by an
independent accounting firm selected by the other Party and reasonably acceptable to the audited Party to verify the accuracy of any of the foregoing; provided that such independent accounting firm is subject to written obligations of
confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> applicable to each Party&#146;s Confidential Information that are at least as stringent as those set forth described in Article 11 (Confidentiality). Such audit shall not be
(a)&nbsp;performed more frequently than [***], (b) conducted for any Calendar Year more than [***] after the end of such year, or (c)&nbsp;repeated for any Calendar Year or with respect to the same set of records (unless a discrepancy with respect
to such records is discovered during a prior audit). Such examination is to be made at the expense of the auditing Party, except in the event that the results of the audit reveal an underpayment or overcharge by the audited Party of [***] or more
during the period being audited, in which case reasonable audit fees for such examination shall be paid by the audited Party. The underpaid Party shall be entitled to recover any shortfall in payments as determined by such audit, plus interest
thereon, calculated in accordance with Section&nbsp;7.15 (Default Interest). If such examination of records reveals any overpayment by a Party, then the other Party shall credit the amount overpaid against future amounts due to the other Party by
the overpaying Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7 <B>Disputed Payments</B>. If a Party disputes an invoice or other payment obligation
under this Agreement, then such Party shall timely pay the undisputed amount of the invoice or other payment obligation, and the Parties shall resolve such dispute in accordance with Section&nbsp;13.4 (Baseball Arbitration). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.8 <B>Milestone Payments</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.8.1 <B>General</B>. Moderna shall pay to Metagenomi certain milestone payments (&#147;<B>Milestone Payments</B>&#148;) set forth in this
Section&nbsp;7.8 (Milestone Payments): within [***] following the receipt of an invoice from Metagenomi for the applicable Milestone Payment in respect of (i)&nbsp;the first achievement of an RT Technology Milestone during the RT Research Term or
Base Editing Correction Readiness during the Initial RT Research Term or Base Editing Knockout Readiness during the DT Moderna Research Term, pursuant to Section&nbsp;7.8.2 (Technology Milestone Fees), (ii) the first Product for each RT Preclinical
Research Program achieving an RT Target development and regulatory milestone event set forth in Section&nbsp;7.8.3 (RT Target Development Milestones) (the &#147;<B>RT Target Development and Regulatory Milestone Event</B>&#148;), (iii) the first
Product for each DT Moderna Target achieving a DT Moderna Target development and regulatory milestone event set forth in Section&nbsp;7.8.5 (DT Target Development Milestones) (the &#147;<B>DT Moderna Target Development and Regulatory Milestone
Event</B>&#148;), (iv)&nbsp;the first occurrence of all Products Directed Against a given RT Target collectively achieving the sales milestone events set forth in Section&nbsp;7.8.4 (RT Target Sales Milestones) (the &#147;<B>RT Target Sales
Milestone Events</B>&#148;), and (v)&nbsp;the first occurrence of all Products Directed Against a given DT Moderna Target collectively achieving the sales milestone events set forth in Section&nbsp;7.8.6 (DT Moderna Target Sales Milestones) (the
&#147;<B>DT Moderna Target Sales Milestone Events</B>&#148;). For clarity, the maximum number of each RT Target Development and Regulatory Milestone Event achievable is ten (10) (i.e., only once per each RT Target subject to this Agreement), and the
maximum number of each DT Moderna Target Development and Regulatory Milestone Event achievable is two (2) (i.e., only once per each DT Moderna Target subject to this Agreement). Each Milestone Payment made under this Section&nbsp;7.8 (Milestone
Payments) shall be <FONT STYLE="white-space:nowrap">non-</FONT> refundable, <FONT STYLE="white-space:nowrap">non-creditable</FONT> and not subject to <FONT STYLE="white-space:nowrap">set-off</FONT> hereunder. Notwithstanding anything else herein to
the contrary, any pharmaceutical product (A)&nbsp;Developed with the intent to be Commercialized as a single-priced pharmaceutical product, (B)&nbsp;Commercialized as a single-priced pharmaceutical product, in each case of (A)&nbsp;and (B), by or on
behalf of Moderna or any of its Affiliates or Sublicensees, which comprises two or more Licensed RT Products, each Directed Against a different RT Target, shall be deemed one Licensed RT Product Directed Against only one RT Target, for purposes of
this Section&nbsp;7.8 (Milestone Payments), and any pharmaceutical product, (C)&nbsp;Developed with the intent to be Commercialized as a single-priced pharmaceutical product, or (D)&nbsp;Commercialized as a single-priced pharmaceutical product, in
each case of (C)&nbsp;and (D), by or on behalf of Moderna or any of its Affiliates or Sublicensees, which comprises two or more Licensed DT Products, each Directed Against a different DT Moderna Target, shall be deemed one Licensed DT Product
Directed Against only one DT Moderna Target, for purposes of this Section&nbsp;7.8 (Milestone Payments). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.8.2 <B>Technology Milestone Fees</B>. The Milestone Payments to be made by Moderna to
Metagenomi pursuant to Section&nbsp;7.8.1 (Milestone Payments, General) with respect to first achieving an RT Technology Milestone described below during the RT Research Term, or Base Editing Correction Readiness described below during the Initial
RT Research Term, or Base Editing Knockout Readiness described below during the DT Moderna Research Term are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Technology</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Milestone Event</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Achieved During the</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>RT Research Term,</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>the Initial RT</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Research Term or</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>the DT Moderna</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Research Term, each</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>as applicable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum<BR>Total<BR>Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Milestone<BR>Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum total amount payable under this Section&nbsp;7.8.2 (Technology Milestone Fees) shall not exceed seventy-five
million Dollars ($75,000,000). Metagenomi shall provide prompt written notice to the JSC upon achievement of an RT Technology Milestone during the RT Research Term, upon achievement of Base Editing Knockout Readiness during the DT Moderna Research
Term, and upon achievement of Base Editing Correction Readiness during the Initial RT Research Term, in each case together with sufficient data and other information for the JSC to confirm such achievement. The JSC shall notify Metagenomi and
Moderna of its confirmation within [***] after receiving the written notice from Metagenomi. Metagenomi shall send an invoice for the applicable Milestone Payment within [***] after receiving the confirmation from the JSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.8.3 <B>RT Target Development Milestones</B>. The Milestone Payments to be made by Moderna to Metagenomi pursuant to Section&nbsp;7.8.1
(Milestone Payments, General) with respect to the first Product for each RT Preclinical Research Program to achieve the applicable RT Target Development and Regulatory Milestone Event described below during the Term are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>RT Target Development and Regulatory Milestone Events</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Milestone<BR>Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum total amount payable under this Section&nbsp;7.8.3 (RT Target Development Milestones) shall not exceed one hundred
million Dollars ($100,000,000) per RT Target subject to this Agreement pursuant to Section&nbsp;7.8.1 (Milestone Payments, General). For clarity, no Milestone Payment is payable for subsequent or repeated achievements of the same RT Target
Development and Regulatory Milestone Event with respect to the same Licensed Product (including formulations), or any subsequent Licensed Products with respect to an RT Target for which an RT </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Target Development and Regulatory Milestone Event has occurred (see, e.g., the following example set forth in the remainder of this Section&nbsp;7.8.3 (RT Target Development Milestones)). By way
of example and not limitation, assume that a Licensed Product achieves the first RT Target Development and Regulatory Milestone Event for the first (1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>) RT Target, and immediately after the
Initiation of the Phase II Clinical Trial for such Licensed Product, Moderna decides to discontinue the Development of such Licensed Product Directed Against that RT Target. In such case, Moderna would pay Metagenomi the Milestone Payment
corresponding to the first RT Target Development and Regulatory Milestone Event set forth in the table above upon the attainment of such first RT Target Development and Regulatory Milestone Event by such Licensed Product. Then, assume that a
different Licensed Product for the same RT Target achieves the first RT Target Development and Regulatory Milestone Event. In such case, no Milestone Payment is due upon the attainment of the first RT Target Development and Regulatory Milestone
Event with respect to the second Licensed Product, and Moderna would pay Metagenomi the Milestone Payments corresponding to the second RT Target Development and Regulatory Milestone Event set forth in the table above upon the attainment of such
second RT Target Development and Regulatory Milestone Event by such second Licensed Product. With respect to each RT Target Development and Regulatory Milestone Event that has two potential options of either (i)&nbsp;or (ii) in the table above, if
the first achievement is for the RT Target Development and Regulatory Milestone Event under clause (ii), and if there is a subsequent achievement for the clause (i)&nbsp;version of the same RT Target Development and Regulatory Milestone Event, then
upon the occurrence of such subsequent achievement the difference between the amount of clauses (i)&nbsp;and (ii) shall be payable. By way of example, if the first Pricing and Reimbursement Approval in the United Kingdom is obtained for a Licensed
Product Directed Against a particular RT Target in an Orphan Indication (a clause (ii)&nbsp;occurrence), then [***] would be owing in accordance with the table above, and if subsequently Pricing and Reimbursement Approval in the United Kingdom is
obtained for a Licensed Product Directed Against the same RT Target in a <FONT STYLE="white-space:nowrap">Non-Orphan</FONT> Indication, then an additional [***] would be due [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moderna shall provide prompt written notice to Metagenomi upon achievement of an RT Target Development and Regulatory Milestone Event. Metagenomi shall send
an invoice for the applicable Milestone Payment within sixty (60)&nbsp;days after receiving the written notice from Moderna. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.8.4 <B>RT
Target Sales Milestones</B>. The Milestone Payments to be made by Moderna to Metagenomi pursuant to Section&nbsp;7.8.1 (Milestone Payments, General) with respect to the first occurrence of all Licensed Products Directed Against a given RT Target
collectively achieving the below RT Target Sales Milestone Events are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>RT Target Sales Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Milestone&nbsp;Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all Licensed Products Directed Against such RT
Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all Licensed Products Directed Against such RT
Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all Licensed Products Directed Against such RT
Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First two consecutive Calendar Years in each of which annual Net Sales of all Licensed Products
Directed Against such RT Target in the Territory exceed one and [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum total amount payable under this Section&nbsp;7.8.4 (RT Target Sales Milestones) shall not exceed
two hundred million Dollars ($200,000,000) per RT Target subject to this Agreement pursuant to Section&nbsp;7.8.1 (Milestone Payments, General). If more than one RT Target Sales Milestone Event is achieved in the same Calendar Year, Moderna shall
pay Metagenomi all Milestone Payments for such RT Target Sales Milestone Events achieved in such Calendar Year in accordance with this Section&nbsp;7.8.4 (RT Target Development Milestones). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moderna shall provide prompt written notice to Metagenomi upon achievement of an RT Target Sales Milestone Event. Metagenomi shall send an invoice for the
applicable Milestone Payment within sixty (60)&nbsp;days after receiving the written notice from Moderna. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.8.5 <B>DT Moderna Target
Development Milestones</B>. The Milestone Payments to be made by Moderna to Metagenomi pursuant to Section&nbsp;7.8.1 (Milestone Payments, General) with respect to the first Product for each DT Moderna Target achieving a DT Moderna Target
Development and Regulatory Milestone Event described below during the Term are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>DT Moderna Target Development and Regulatory Milestone
Events</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Milestone&nbsp;Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum total amount payable under this Section&nbsp;7.8.5 (DT Moderna Target Development Milestones) shall not exceed one
hundred million Dollars ($100,000,000) per DT Moderna Target subject to this Agreement pursuant to Section&nbsp;7.8.1 (Milestone Payments, General). For clarity, no Milestone Payment is payable for subsequent or repeated achievements of the same DT
Moderna Target Development and Regulatory Milestone Event with respect to the same Licensed Product (including formulations), or any subsequent Licensed Products with respect to a DT Moderna Target (or multiple targets that include the same DT
Moderna Target) for which a DT Moderna Target Development and Regulatory Milestone Event has occurred (see, e.g., the following example set forth in the remainder of this Section&nbsp;7.8.5 (DT Moderna Target Development Milestones)). By way of
example and not limitation, assume that a Licensed Product achieves the first DT Moderna Target Development and Regulatory Milestone Event for the first (1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>) DT Moderna Target, and immediately
after the Initiation of the Phase II Clinical Trial for such Licensed Product, Moderna decides to discontinue the Development of such Licensed Product Directed Against that DT Moderna Target. In such case, Moderna would pay Metagenomi the Milestone
Payment corresponding to the first DT Moderna Target Development and Regulatory Milestone Event set forth in the table above upon the attainment of such DT Moderna Target Development and Regulatory Milestone Event by such Licensed Product. Then,
assume that a different Licensed Product for the same DT Moderna Target achieves the first DT Moderna Target </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Development and Regulatory Milestone Event. In such case, no Milestone Payment is due upon the attainment of the first DT Moderna Target Development and Regulatory Milestone Event with respect to
the second Licensed Product, and Moderna would pay Metagenomi the Milestone Payment corresponding to the second DT Moderna Target Development and Regulatory Milestone Event set forth in the table above upon the attainment of such second DT Moderna
Target Development and Regulatory Milestone Event by such second Licensed Product. With respect to each DT Moderna Target Development and Regulatory Milestone Event that has two potential options of either (i)&nbsp;or (ii) in the table above, if the
first achievement is for the DT Moderna Target Development and Regulatory Milestone Event under clause (ii), and if there is a subsequent achievement for the clause (i)&nbsp;version of the same DT Moderna Target Development and Regulatory Milestone
Event, then upon the occurrence of such subsequent achievement the difference between the amount of clauses (i)&nbsp;and (ii) shall be payable. By way of example, if the first Pricing and Reimbursement Approval in the United Kingdom is obtained for
a Licensed Product Directed Against a particular DT Moderna Target in an Orphan Indication (a clause (ii)&nbsp;occurrence), then [***] would be owing in accordance with the table above, and if subsequently Pricing and Reimbursement Approval in the
United Kingdom is obtained for a Licensed Product Directed Against the same DT Moderna Target in a <FONT STYLE="white-space:nowrap">Non-Orphan</FONT> Indication, then an additional [***] would be due [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moderna shall provide prompt written notice to Metagenomi upon achievement of a DT Moderna Target Development and Regulatory Milestone Event. Metagenomi shall
send an invoice for the applicable Milestone Payment within [***] after receiving the written notice from Moderna. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.8.6 <B>DT Moderna
Target Sales Milestones</B>. The Milestone Payments to be made by Moderna to Metagenomi pursuant to Section&nbsp;7.8.1 (Milestone Payments, General) with respect to the first occurrence of all Licensed Products Directed Against a given DT Moderna
Target collectively achieving the below DT Moderna Target Sales Milestone Events are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>DT Moderna Target Sales Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Milestone&nbsp;Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all Licensed Products Directed Against such DT
Moderna Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all Licensed Products Directed Against such DT
Moderna Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all Licensed Products Directed Against such DT
Moderna Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First two Consecutive Calendar Years in each of which annual Net Sales of all Licensed Products
Directed Against such DT Moderna Target exceed one and [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum total amount payable under this Section&nbsp;7.8.6 (DT Moderna Target Sales Milestones) shall not exceed two
hundred million Dollars ($200,000,000) per DT Moderna Target subject to this Agreement pursuant to Section&nbsp;7.8.1 (Milestone Payments, General). If more than one DT Moderna Target Sales Milestone Event is achieved in the same Calendar Year,
Moderna shall pay Metagenomi all Milestone Payments for such DT Moderna Target Sales Milestone Events achieved in such Calendar Year in accordance with this Section&nbsp;7.8.6 (DT Moderna Target Sales Milestones). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moderna shall provide prompt written notice to Metagenomi upon achievement of a DT Moderna Target Sales
Milestone Event. Metagenomi shall send an invoice for the applicable Milestone Payment within sixty (60)&nbsp;days after receiving the written notice from Moderna. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.9 <B>Royalties on Products Directed Against an RT Target</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.9.1 <B>Royalties</B>. Subject to the remainder of this Section&nbsp;7.9 (Royalties on Products Directed Against an RT Target), on an RT <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-RT</FONT></FONT> Target basis, Moderna shall pay Metagenomi royalties as set forth below on aggregate annual Net Sales of Licensed Products Directed Against an RT Target with
respect to which Moderna has exercised the RT Option pursuant to Section&nbsp;3.9 (RT Option) in the Territory, as calculated by multiplying the applicable royalty rate set forth below by the corresponding portion of aggregate annual Net Sales of
such Licensed Products in the Territory, during the period of time, on a Licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, beginning on the First Commercial Sale of any such Licensed Product in such country and continuing until the latest of: (a)&nbsp;the expiration or abandonment of the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">last-to-expire</FONT></FONT> Valid Claim of a Patent within the Licensed RT Technology in such country [***], contained in such Licensed Product; (b)&nbsp;ten (10) years after the First
Commercial Sale of such Licensed Product in such country; and (c)&nbsp;expiration of the Regulatory Exclusivity in such country with respect to such Licensed Product (the &#147;<B>RT Royalty Term</B>&#148;). Notwithstanding anything else herein to
the contrary, any pharmaceutical product Commercialized as a single-priced pharmaceutical product by or on behalf of Moderna or any of its Affiliates or Sublicensees, which comprises two or more Licensed RT Products, each Directed Against a
different RT Target, shall be deemed one Licensed RT Product Directed Against only one RT Target of Moderna&#146;s choosing, for purposes of this Section&nbsp;7.9 (Royalties on Products Directed Against an RT Target), provided that the RT Royalty
Term for such Licensed RT Product shall be the longest of the RT Royalty Terms for each of the Licensed RT Products in such pharmaceutical product if they were separate Licensed RT Products. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Aggregate Annual Net Sales of all Licensed Products Directed Against
an RT Target in the<BR>Territory</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Royalty&nbsp;Rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against such RT
Target less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against such RT
Target greater than one hundred and [***] and less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against such RT
Target greater than [***] and less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against such RT
Target greater than [***] and less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against such RT
Target greater than [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.9.2 <B>Valid Claim</B>. On a Licensed <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, with respect to a Licensed Product Directed Against an RT Target that
is subject to royalties under this Section&nbsp;7.9 (Royalties on Products Directed Against an RT Target), at any time during the RT Royalty Term when no Valid Claim (including in the event of expiration) of any Patent within the Licensed RT
Technology Covers such Licensed Product in a country, the royalty rates provided in Section&nbsp;7.9.1 (Royalties) for such Licensed Product shall immediately be reduced in such country by [***] and shall remain so reduced for the remainder of the
RT Royalty Term for so long as there is no such Valid Claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.9.3 <B>Biosimilar Products</B>. On a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> and Licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product basis, with respect to a Licensed Product Directed Against an RT
Target that is subject to royalties under this Section&nbsp;7.9 (Royalties on Products Directed Against an RT Target), from and after the first Calendar Year in which a Biosimilar Product is sold in a given country and has achieved (i) [***] unit
sales in such country in the market segment in which such Licensed Product competes in such country, the royalties payable pursuant to Section&nbsp;7.9.1 (Royalties) for such Licensed Product shall be reduced in such country by [***] of the
royalties otherwise payable under Section&nbsp;7.9.1 (Royalties) and (ii) [***] unit sales in such country in the market segment in which such Licensed Product competes in such country, the royalties payable pursuant to Section&nbsp;7.9.1
(Royalties) for such Licensed Product shall be reduced in such country by [***] of the royalties otherwise payable under Section&nbsp;7.9.1 (Royalties). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.9.4 <B>Third Party Payments</B>. Without prejudicing Moderna&#146;s right under Section&nbsp;5.11.3 (RT Moderna <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements), if Moderna or any of its Affiliates or sublicensees <FONT STYLE="white-space:nowrap">in-licenses</FONT> any intellectual property from a Third Party that is necessary or reasonably useful to
conduct the Research, Development, Commercialization, making, having made, use, keeping, importation, exportation, offering for sale, sale or other Exploitation of a Licensed RT Product in the Territory that is subject to royalties under this
Section&nbsp;7.9 (Royalties on Products Directed Against an RT Target) or milestone payments to Metagenomi under Sections 7.8.2 (Technology Milestone Fees) through 7.8.4 (RT Target Sales Milestones), Moderna may deduct [***] of any and all
milestone, royalty, and other payments (including required reimbursement for costs incurred in connection with enforcement or other actions and required sharing of certain recoveries) paid by it to such Third Party from any royalty payments to
Metagenomi under this Section&nbsp;7.9 (Royalties on Products Directed Against an RT Target) or milestone payments to Metagenomi under Sections 7.8.2 (Technology Milestone Fees) through 7.8.4 (RT Target Sales Milestones) for each Licensed RT
Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.9.5 <B>Cumulative Reductions Floor</B>. In no event will the aggregate amount of royalties due to Metagenomi for a Licensed
Product Directed Against an RT Target in a country in the Territory in any given Calendar Quarter during the RT Royalty Term for such Licensed Product Directed Against an RT Target in such country be reduced by more than [***] of the amount that
otherwise would have been due and payable to Metagenomi in such Calendar Quarter for such Licensed Product Directed Against an RT Target in such country as a result of the reductions set forth in Section&nbsp;7.9.2 (Valid Claims), Section&nbsp;7.9.3
(Biosimilar Products) and Section&nbsp;7.9.4 (Third Party Payments), except in the event of Section&nbsp;5.11.5 (Metagenomi Payments for Certain Technology) or Section&nbsp;7.9.3(ii) (Biosimilar Products), which, for clarity, may result in up to
[***] reduction of the royalties. Moderna may carry forward any such reductions permitted in accordance with Section&nbsp;5.11.5 (Metagenomi Payments for Certain Technology), Section&nbsp;7.9.2 (Valid Claims), Section&nbsp;7.9.3 (Biosimilar
Products) and Section&nbsp;7.9.4 (Third Party Payments) that are incurred or accrued in a Calendar Quarter but that are not applied against royalties due to Metagenomi for such Licensed Product Directed Against an RT Target in such country in such
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Calendar Quarter as a result of the foregoing floor and apply such amounts against royalties due to Metagenomi for such Licensed Product Directed Against an RT Target in such country in any
subsequent Calendar Quarter (subject to the minimum floor set forth in this Section&nbsp;7.9.5 (Cumulative Reductions Floor)) until the amount of such reduction has been fully applied against royalties due to Metagenomi for such Licensed Product
Directed Against an RT Target in such country. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.10 <B>Royalties on Products Directed Against a DT Moderna Target</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.10.1 <B>Royalties</B>. On a DT Moderna <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-DT</FONT></FONT> Moderna
Target basis, Moderna shall pay Metagenomi royalties as set forth below on aggregate annual Net Sales of Licensed Products Directed Against a DT Moderna Target with respect to which Moderna has exercised the DT Option pursuant to Section&nbsp;4.9
(DT Option) in the Territory, as calculated by multiplying the applicable royalty rate set forth below by the corresponding portion of aggregate annual Net Sales of such Licensed Products in the Territory, during the period of time, on a Licensed <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, beginning on the First Commercial
Sale of any such Licensed Product in such country and continuing until the latest of: (a)&nbsp;the expiration or abandonment of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">last-to-expire</FONT></FONT> Valid Claim of a
Patent within the Licensed DT Moderna Technology in such country [***], contained in such Licensed Product; (b)&nbsp;ten (10) years after the First Commercial Sale of such Licensed Product in such country; and (c)&nbsp;expiration of the Regulatory
Exclusivity in such country with respect to such Licensed Product (the &#147;<B>DT Moderna Royalty Term</B>&#148;). Notwithstanding anything else herein to the contrary, any pharmaceutical product Commercialized as a single-priced pharmaceutical
product by or on behalf of Moderna or any of its Affiliates or Sublicensees, which comprises two or more Licensed DT Products, each Directed Against a different DT Moderna Target, shall be deemed one Licensed DT Product Directed Against only one DT
Moderna Target of Moderna&#146;s choosing, for purposes of this Section&nbsp;7.10 (Royalties on Products Directed Against a DT Moderna Target), provided that the DT Moderna Royalty Term for such Licensed DT Product shall be the longest of the DT
Moderna Royalty Terms for each of the Licensed DT Products in such pharmaceutical product if they were separate Licensed DT Products. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Aggregate Annual Net Sales of all Licensed Products Directed Against
a DT Moderna Target in the<BR>Territory</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Royalty<BR>Rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against a DT
Moderna Target less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against a DT
Moderna Target greater than [***] and less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against a DT
Moderna Target greater than [***] and less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against a DT
Moderna Target greater than [***] and less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">For that portion of aggregate annual Net Sales of all Licensed Products Directed Against a DT
Moderna Target greater than [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.10.2 <B>Valid Claim</B>. On a Licensed <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, with respect to a Licensed Product Directed Against a DT Moderna
Target that is subject to royalties under this Section&nbsp;7.10 (Royalties on Products Directed Against a DT Moderna Target), at any time during the DT Moderna Royalty Term when no Valid Claim (including in the event of expiration) of any Patent
within the Licensed DT Moderna Technology Covers such Licensed Product in a country, the royalty rates provided in Section&nbsp;7.10.1 (Royalties) for such Licensed Product shall immediately be reduced in such country by [***] and shall remain so
reduced for the remainder of the DT Moderna Royalty Term for so long as there is no such Valid Claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.10.3 <B>Biosimilar Products</B>.
On a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> and Licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product basis, with respect to a
Licensed Product Directed Against a DT Moderna Target that is subject to royalties under this Section&nbsp;7.10 (Royalties on Products Directed Against a DT Moderna Target), from and after the first Calendar Year in which a Biosimilar Product is
sold in a given country and has achieved (i) [***] unit sales in such country in the market segment in which such Licensed Product competes in such country, the royalties payable pursuant to Section&nbsp;7.10.1 (Royalties) for such Licensed Product
shall be reduced in such country by [***] of the royalties otherwise payable under Section&nbsp;7.10.1 (Royalties) and (ii) [***] unit sales in such country in the market segment in which such Licensed Product competes in such country, the royalties
payable pursuant to Section&nbsp;7.10.1 (Royalties) for such Licensed Product shall be reduced in such country by [***] of the royalties otherwise payable under Section&nbsp;7.10.1 (Royalties). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.10.4 <B>Third Party Payments</B>. Without prejudicing Moderna&#146;s right under Section&nbsp;5.12.3 (DT Moderna <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements), if Moderna or any of its Affiliates or sublicensees <FONT STYLE="white-space:nowrap">in-licenses</FONT> any intellectual property from a Third Party that is necessary or reasonably useful to
conduct the Research, Development, Commercialization, making, having made, use, keeping, importation, exportation, offering for sale, sale or other Exploitation of a Licensed DT Product in the Territory that is subject to royalties under this
Section&nbsp;7.10 (Royalties on Products Directed Against a DT Moderna Target) or milestone payments to Metagenomi under Sections 7.8.5 (DT Moderna Target Development Milestones) or 7.8.6 (DT Moderna Target Sales Milestones), Moderna may deduct
[***] of any and all milestone, royalty, and other payments (including required reimbursement for costs incurred in connection with enforcement or other actions and required sharing of certain recoveries) paid by it to such Third Party from any
royalty payments to Metagenomi under this Section&nbsp;7.10 (Royalties on Products Directed Against a DT Moderna Target) or milestone payments to Metagenomi under Sections 7.8.5 (DT Moderna Target Development Milestones) and 7.8.6 (DT Moderna Target
Sales Milestones) for each Licensed DT Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.10.5 <B>Cumulative Reductions Floor</B>. In no event will the aggregate amount of
royalties due to Metagenomi for a Licensed Product Directed Against a DT Moderna Target in a country in the Territory in any given Calendar Quarter during the DT Moderna Royalty Term for such Licensed Product Directed Against a DT Moderna Target in
such country be reduced by more than [***] of the amount that otherwise would have been due and payable to Metagenomi in such Calendar Quarter for such Licensed Product Directed Against a DT Moderna Target in such country as a result of the
reductions set forth in Section&nbsp;7.10.2 (Valid Claims), Section&nbsp;7.10.3 (Biosimilar Products) and Section&nbsp;7.10.4 (Third Party Payments), except in the event of Section&nbsp;5.12.5 (Metagenomi Payments for Certain Technology) or
Section&nbsp;7.10.3(ii) (Biosimilar Products), which, for clarity, may result in up to [***] reduction of the royalties. Moderna may carry forward any such reductions permitted in accordance with Section&nbsp;5.12.5 (Metagenomi Payments for Certain
Technology), Section&nbsp;7.10.2 (Valid Claims), Section&nbsp;7.10.3 (Biosimilar Products) and Section&nbsp;7.10.4 (Third Party Payments) that are incurred or accrued in a Calendar </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Quarter but that are not applied against royalties due to Metagenomi for such Licensed Product Directed Against a DT Moderna Target in such country in such Calendar Quarter as a result of the
foregoing floor and apply such amounts against royalties due to Metagenomi for such Licensed Product Directed Against a DT Moderna Target in such country in any subsequent Calendar Quarter (subject to the minimum floor set forth in this
Section&nbsp;7.10.5 (Cumulative Reductions Floor)) until the amount of such reduction has been fully applied against royalties due to Metagenomi for such Licensed Product Directed Against a DT Moderna Target in such country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.11 <B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Milestones and Royalties</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.11.1 <B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Milestones</B>. With respect to each DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Program for which the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party has exercised its <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Right pursuant to Section&nbsp;6.8 <FONT
STYLE="white-space:nowrap">(Opt-Out</FONT> Right), the Primary Party shall pay to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party, certain milestone payments set forth in this Section&nbsp;7.11.1
<FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Milestones) (the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Milestone Payments</B>&#148;) within sixty (60)&nbsp;days following the
receipt of an invoice from the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party for the applicable <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Milestone Payment in respect of (a)&nbsp;the
first DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program achieving a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product development and regulatory milestone event set forth
in Section&nbsp;7.11.1(a) <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development and Regulatory Milestone Events) (the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product Development and Regulatory Milestone Events</B>&#148;), and (b)&nbsp;the first occurrence of all DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Target in such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program collectively achieving the sales milestone events set forth in Section&nbsp;7.11.1(b) <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales Milestone Events) (the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales Milestone Events</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development and Regulatory
Milestone Events</B>. The <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Milestone Payments to be made by the Primary Party to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party pursuant to
Section&nbsp;7.11.1 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Milestones) with respect to the first DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program achieving a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product Development and Regulatory Milestone Event described below during the Term are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="37%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development and
Regulatory</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Opt-Out&nbsp;DT&nbsp;Co-Co&nbsp;Milestone&nbsp;Payment</FONT></FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Primary Party shall provide prompt written notice to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party upon
achievement of an <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development and Regulatory Milestone Event. The <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party shall send an invoice
for the applicable <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Milestone Payment within [***] after receiving the written notice from the Primary Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales Milestone Events</B>.
The <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Milestone Payments to be made by the Primary Party to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party pursuant to Section&nbsp;7.11.1 <FONT
STYLE="white-space:nowrap">(Opt-Out</FONT> Milestones) with respect to the first occurrence of all DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target of such <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program collectively achieving the below <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales
Milestone Events are as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="37%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product Sales Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Opt-Out&nbsp;DT&nbsp;Co-Co&nbsp;Milestone&nbsp;Payment</FONT></FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Calendar Year in which annual Net Sales of all DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First two consecutive Calendar Years in each of which annual Net Sales of all DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the Territory exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum total amount payable under this Section&nbsp;7.11.1 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Milestones)
shall not exceed two hundred million Dollars ($200,000,000) per DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target. If more than one <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales
Milestone Event is achieved in the same Calendar Year, the Primary Party shall pay the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party all <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Milestone Payments for such <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales Milestone Events achieved in such Calendar Year in accordance with this Section&nbsp;7.11.1 <FONT
STYLE="white-space:nowrap">(Opt-Out</FONT> Milestones). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Primary Party shall provide prompt written notice to the
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party upon achievement of an <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales Milestone Event. The
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party shall send an invoice for the applicable <FONT STYLE="white-space:nowrap">Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Milestone Payment within sixty (60)&nbsp;days after
receiving the written notice from the Primary Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.11.2 <B><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Royalties</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Royalties</B>. The Primary Party shall pay the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party, on a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-DT</FONT></FONT> <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, royalties as set forth below on annual Net Sales of such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Directed Against the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program in the Territory, as calculated by multiplying the applicable royalty rate set forth below by the corresponding portion of annual
Net Sales of such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such country, until the latest to occur of (i)&nbsp;the date of expiration of the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">last-to-expire</FONT></FONT> Valid Claim of any Patents within the Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology licensed by the
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party to the Primary Party under Section&nbsp;5.5 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program License) that Cover the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">composition-of-matter</FONT></FONT> or use of at least one (1)&nbsp;mRNA Construct, or a Gene Editing protein encoded by a mRNA Construct, contained in such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in such country in the Territory, (ii)&nbsp;the date of expiration of marketing or Regulatory Exclusivity for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such country in the
Territory, or (iii)&nbsp;the date that is ten (10)&nbsp;years from First Commercial Sale of such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such country in the Territory (the &#147;<B><FONT STYLE="white-space:nowrap">Opt-Out</FONT>
Royalty Term</B>&#148;): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="22%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>If <FONT STYLE="white-space:nowrap">Opt-Out</FONT>
Occurs</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Opt-Out&nbsp;Royalty&nbsp;Rate</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Valid Claim</B>. On a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-DT</FONT></FONT> <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT>
basis, with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product that is subject to royalties under this Section&nbsp;7.11.2 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Royalties), at any time during the <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Royalty Term when no Valid Claim (including in the event of expiration) of any Patents within the Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology licensed by the <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Party to the Primary Party Covers such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in a country, the royalty rates provided in Section&nbsp;7.11.2(a) (Royalties) for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product shall immediately be reduced in such country by [***] and shall remain so reduced for the remainder of the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Royalty Term for so long as there is no such
Valid Claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <B>Biosimilar Products</B>. On a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> and DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-DT</FONT></FONT> <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product basis, with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product that is subject to royalties under this Section&nbsp;7.11.2 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT>
Royalties), from and after the first Calendar Year in which a Biosimilar Product is sold in a given country and has achieved (i) [***] unit sales in such country in the market segment in which such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Product competes in such country, the royalties payable pursuant to Section&nbsp;7.11.2(a) (Royalties) for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product shall be reduced in such country by [***] of the royalties otherwise payable
under Section&nbsp;7.11.2(a) (Royalties) and (ii) [***] unit sales in such country in the market segment in which such Licensed Product competes in such country, the royalties payable pursuant to Section&nbsp;7.11.2(a) (Royalties) for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product shall be reduced in such country by [***] of the royalties otherwise payable under Section&nbsp;7.11.2(a) (Royalties). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <B>Third Party Payments</B>. If the Primary Party or any of its Affiliates or sublicensees
<FONT STYLE="white-space:nowrap">in-licenses</FONT> any right to any intellectual property from a Third Party that is necessary or reasonably useful to conduct the Research, Development, Commercialization, making, having made, use, keeping,
importation, exportation, offering for sale, sale or other Exploitation of an applicable DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory that is subject to royalties under this Section&nbsp;7.11.2 <FONT
STYLE="white-space:nowrap">(Opt-Out</FONT> Royalties) (or milestone payments under Sections 7.11.1(a) <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development and Regulatory Milestone
Events)) or 7.11.1(b) <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales Milestone Events), the Primary Party may deduct [***] of any and all milestone, royalty, and other payments
(including required reimbursement for costs incurred in connection with enforcement or other actions and required sharing of certain recoveries) paid by it to such Third Party (which, for the avoidance of doubt, include the Primary Party&#146;s
Third Party Payment pursuant to the last sentence of Sections 5.10.3(b) (Payments under <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements) and 5.10.4(b) (Payments under <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements), respectively, Moderna&#146;s Third Party Payment pursuant to Section&nbsp;5.10.5 (Metagenomi Payments for Certain Technology) and
Metagenomi&#146;s Third Party Payment pursuant to 5.10.6 (Moderna Payments for Certain Technology), as applicable) from any royalty payments to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party under this Section&nbsp;7.11.2 <FONT
STYLE="white-space:nowrap">(Opt-Out</FONT> Royalties) or milestone payments under Sections 7.11.1(a) <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Development and Regulatory Milestone
Events) or 7.11.1(b) <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product Sales Milestone Events) for each such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <B>Cumulative Reductions Floor</B>. In no event will the aggregate amount of royalties due to the
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party for a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in a country in the Territory in any given Calendar Quarter during the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Royalty Term
for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such country be reduced by more than [***] of the amount that otherwise would have been due and payable to the Primary Party in such Calendar Quarter for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in such country as a result of the reductions set forth in Section&nbsp;7.11.2(b) (Valid Claims), Section&nbsp;7.11.2(c) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(Biosimilar Products) and Section&nbsp;7.11.2(d) (Third Party Payments), except in the event of Section&nbsp;5.10.5 (Metagenomi Payments for Certain Technology) or Section&nbsp;7.11.2(c)(ii)
(Biosimilar Products), which, for clarity, may result in up to [***] reduction of the royalties. The Primary Party may carry forward any such reductions permitted in accordance with Section&nbsp;7.11.2(b) (Valid Claims), Section&nbsp;7.11.2(c)
(Biosimilar Products) and Section&nbsp;7.11.2(d) (Third Party Payments) that are incurred or accrued in a Calendar Quarter but that are not applied against royalties due to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in such country in such Calendar Quarter as a result of the foregoing floor and apply such amounts against royalties due to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product in such country in any subsequent Calendar Quarter (subject to the minimum floor set forth in this Section&nbsp;7.11.2(e) (Cumulative Reductions Floor)) until the amount of such reduction has been
fully applied against royalties due to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.12 <B>Payment; Reports; Royalty Minimum</B>. Royalty payments due under this Article 7 (Fees; Royalties, &amp; Payments) shall be
calculated, reported and invoiced for each Calendar Quarter. Within [***] after the end of each Calendar Quarter, Moderna (or the Primary Party, as the case may be) shall provide Metagenomi (or the <FONT STYLE="white-space:nowrap">Opt-Out</FONT>
Party, as the case may be) a report setting forth Net Sales and royalty for each applicable Product in the Territory or <FONT STYLE="white-space:nowrap">Ex-U.S.,</FONT> as applicable, in such Calendar Quarter. Metagenomi (or the <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Party, as the case may be) shall send an invoice for the applicable royalty payment within [***] after receiving the report from Moderna (or the Primary Party, as the case may be). The applicable royalty
payments shall be paid within [***] following the receipt of the invoice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.13 <B>Method of Payment; Foreign Exchange</B>. Unless
otherwise agreed by the Parties, all payments due under this Agreement shall be paid in Dollars by wire transfer or electronic funds transfer of immediately available funds to an account designated by the payee; provided that each Party shall only
be required to disburse funds to the payee&#146;s jurisdiction of incorporation or to a jurisdiction in which the payee has a significant business presence. For any currency conversion required in determining the amount of payments due hereunder,
such conversion shall be made as follows: (a)&nbsp;when calculating Net Sales, the amount of such sales in foreign currencies shall be converted into Dollars using the average rate of exchange over the applicable Calendar Quarter as reported in The
Wall Street Journal, Internet U.S. Edition at www.wsj.com, as of the last day of the applicable reporting period (or, if unavailable on such date, the first date thereafter on which such rate is available), and (b)&nbsp;when calculating all other
sums due under this Agreement, the amount in foreign currencies shall be converted into Dollars using the average rate of exchange for the applicable month as reported in The Wall Street Journal, Internet U.S. Edition at www.wsj.com, as of the last
day of the applicable month (or, if unavailable on such date, the first date thereafter on which such rate is available). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.14 <B>Records
and Audits</B>. Each Party shall keep, and shall cause its Affiliates and Sublicensees to keep, complete and accurate records which may be necessary to ascertain properly and to verify the royalty payments due hereunder. Such records shall be kept
for such period of time required by Applicable Laws. Within the Term, the other Party shall not more than once each year have the right to have its independent, certified public accountant inspect such Party&#146;s records for the purpose of
determining the accuracy of royalty payments for a period covering not more than [***] following the Calendar Quarter to which they pertain. No period shall be audited more than once. The other Party shall submit an audit plan, including audit
scope, to such Party for its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
approval, which shall not be unreasonably withheld, conditioned or delayed, prior to audit implementation. The independent, certified public accountant selected shall keep confidential any
information obtained during such inspection and shall report to the Parties only the amounts of Net Sales and royalties due and payable. Such audits may be exercised during normal business hours upon reasonable prior written notice to such Party. If
determined that additional royalties are owed, or that royalties were overpaid, during such period, such Party shall pay the other Party the additional royalties or the other Party shall pay such Party the overpaid royalties, as applicable, within
[***] of the date the independent, certified public accountant&#146;s written report is received by the paying Party. The fees charged by the accounting firm of such accountant shall be paid by the auditing Party unless any additional royalties owed
exceed [***] and [***] of the royalties paid for the royalty period subject to the audit, in which case the audited Party shall pay the reasonable fees of such accounting firm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.15 <B>Default Interest</B>. If and to the extent that either Party fails to make any payment hereunder when due in accordance with the
applicable provisions of this Agreement (excluding any payment made due to a good faith error identified via an audit conducted by an independent, certified public accountant pursuant to Section&nbsp;7.14 (Records and Audits)), such Party shall pay
to the other Party default interest at a rate of [***] as from the due date (as reported in <I>The Wall Street Journal</I> (Eastern U.S. edition)) or the maximum rate allowable by Applicable Law, whichever is less. Interest shall be paid on a simple
annual interest rate. From and after the Effective Date, the Parties shall meet in good faith and agree on an appropriate replacement for the LIBOR rate to be used in substitution hereunder (with such agreed replacement to be appropriately
documented in writing and termed as expressly superseding the operation of this Section&nbsp;7.15 (Default Interest)), with such agreed replacement to be implemented prior to the [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.16 <B>Taxes</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.16.1
<B>Partnership Tax Matters</B>. Each Party shall be solely responsible for the payment of all taxes imposed on its share of income arising directly or indirectly from the collaborative efforts of the Parties under this Agreement. The Parties intend
that the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program gives rise to a partnership solely for U.S. federal and applicable state and local income tax purposes, and shall be governed by the terms of <B>Schedule M </B>(Partnership Tax
Matters) with respect to the tax matters set forth therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.16.2 <B>Cooperation and Coordination</B>. Except as set forth in
Section&nbsp;7.16.1 (Partnership Tax Matters) or <B>Schedule M </B>(Partnership Tax Matters) with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, the Parties acknowledge and agree that it is their mutual objective and intent
to minimize, to the extent feasible and in compliance with Applicable Laws, taxes payable with respect to their collaborative efforts under this Agreement and that they shall use reasonable efforts to cooperate and coordinate with each other to
achieve such objective. Each Party shall provide the other with reasonable assistance to enable the recovery, as permitted by Applicable Law, of withholding taxes resulting from payments made under this Agreement, such recovery to be for the benefit
of the Party bearing such withholding tax. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.16.3 <B>Payment of Tax</B>. Except as set forth in Section&nbsp;7.16.1 (Partnership Tax
Matters) or <B>Schedule M </B>(Partnership Tax Matters) with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, the upfront, milestones, royalties and other amounts payable by one Party to the other Party under this Agreement
(each, a &#147;<B>Payment</B>&#148;) shall be paid free and clear of any and all taxes, except for any withholding taxes required by Applicable Law. Except as provided in this Section&nbsp;7.16.3 (Payment of Tax), the payee shall be solely
responsible for paying any and all taxes (other than withholding taxes required by Applicable Law to be deducted from Payments and remitted by the payor) levied on account of, or measured in whole or in part by reference to, any Payments it
receives. The payor shall deduct or withhold from the Payments any taxes that it is required by Applicable Law to deduct or withhold. Notwithstanding the foregoing, if the payee is entitled under any applicable tax treaty to a reduction of rate of,
or the elimination of, applicable withholding tax, it may deliver to the payor or the appropriate Governmental Authority (with the assistance of the payor to the extent that this is reasonably required and is expressly requested in writing) the
prescribed forms necessary to reduce the applicable rate of withholding or to relieve the payor of its obligation to withhold such tax and the payor shall apply the reduced rate of withholding or dispense with withholding as the case may be;
provided that the payor has received evidence, in a form satisfactory to the payor, of the payee&#146;s delivery of all applicable forms (and, if necessary, its receipt of appropriate governmental authorization) at least [***] prior to the time
Payments are due. If in accordance with the foregoing, the payor withholds any amounts of tax, it shall pay to the payee the balance when due, make timely payment to the proper tax authority of the withheld amount and send to the payee proof of such
payment within [***] following such payments. If the paying party failed to deduct or withhold tax required by Applicable Law, the payee shall indemnify and hold harmless the paying party from any such taxes and further, shall assist the paying
party with regard to all procedures required in order to obtain relief and, if appropriate, reimbursement by tax authorities (including providing proof, if applicable, that the appropriate tax has in fact been paid by the payee) or, in case tax
authorities will not reimburse withholding tax to the paying party, the payee will immediately pay to the paying party (for remittance to the appropriate taxing authority to the extent not previously paid to such authorities by the paying party) the
amount of such tax not previously paid by the payee to the appropriate taxing authority. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 8 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTELLECTUAL PROPERTY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1
<B>Ownership of Intellectual Property</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1.1 <B>Inventorship</B><I>.</I> Inventorship as between the Parties shall be determined in
accordance with U.S. patent laws. All such determinations shall be documented to ensure any patent applications and patents reflect appropriate inventorship. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1.2 <B>Ownership of Intellectual Property</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Except as expressly set forth herein otherwise, as between the Parties, any and all Results and
<FONT STYLE="white-space:nowrap">Know-How,</FONT> whether patentable or not, conceived, discovered, invented or created in the course of performing the activities or exercising their rights under this Agreement solely by a Party or jointly by the
Parties, their Affiliates, or Third Parties acting on its or their behalf, and all intellectual property rights inherent therein and appurtenant thereto, including all Patents, copyrights, trademarks, and trade secrets arising therefrom
(collectively, &#147;<B>Program Technology</B>&#148;) shall be owned in accordance with inventorship rules under U.S. patent law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein to the contrary, Metagenomi shall solely own all right,
title and interest to any Program Technology [***] (collectively, &#147;<B>Metagenomi Program Technology</B>&#148;). Moderna hereby assigns, transfers and conveys to Metagenomi, or its designee, all of Moderna&#146;s worldwide right, title and
interest in and to any and all Metagenomi Program Technology. Metagenomi agrees to grant and hereby grants Moderna and its Affiliates a perpetual, irrevocable, worldwide, royalty-free, sublicensable (through multiple tiers of sublicensees),
transferable (solely in accordance with Section&nbsp;14.7 (Assignment)), <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license, under all Metagenomi Program Technology to the extent pertaining to [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything herein to the contrary, Moderna shall solely own all right, title and interest to any Program Technology [***]
(&#147;<B>Moderna Program Technology</B>&#148;). Metagenomi hereby assigns, transfers and conveys to Moderna, or its designee, all of Metagenomi&#146;s worldwide right, title and interest in and to any and all Moderna Program Technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything herein to the contrary, any Program Technology discovered, invented, conceived or created during the applicable
Research Term that is neither Metagenomi Program Technology nor Moderna Program Technology shall be jointly owned by Moderna and Metagenomi (&#147;<B>Joint IP</B>&#148;). Each Party shall and hereby does assign to the other Party an undivided <FONT
STYLE="white-space:nowrap">one-half</FONT> interest in such first Party&#146;s right, title, and interest in and to all Joint IP made by or on behalf of such first Party. Subject to the licenses granted hereunder and the other terms and conditions
of this Agreement, each Party may exercise its ownership rights in and to Joint IP, including the right to license and sublicense or otherwise to exploit, transfer or encumber its ownership interest, throughout the world, without an accounting or
obligation (including paying royalties) to, or consent required from, the other Party. At the reasonable written request of a Party, the other Party shall take such further actions to confirm that no such accounting is required or to otherwise
effect the foregoing regarding Joint IP. Each Party agrees to hold Joint IP (and any <FONT STYLE="white-space:nowrap">Know-How</FONT> therein) in confidence subject to the same permitted disclosures set forth in Article 11 (Confidentiality) (applied
<I>mutatis mutandis</I> to the Joint IP consistent with each Party&#146;s rights to exploit the Joint IP) and shall not disclose such <FONT STYLE="white-space:nowrap">Know-How</FONT> to a Third Party unless under terms of confidentiality that
preserve the Parties&#146; ability to pursue Patents as set forth hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1.3 <B>Assignment Obligation</B>. Each Party shall cause
all employees, independent contractors, consultants, and others who perform activities for such Party under this Agreement to be under an obligation to assign to such Party their rights in and to any Program Technology and all intellectual property
rights therein, except where Applicable Laws requires otherwise and except in the case of governmental, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> and public institutions that have standard
policies against such an assignment (in which case a Party shall obtain a suitable license, preferably exclusive, or right to obtain such a license). Each Party shall use reasonable efforts to promptly disclose to the other Party all Program
Technology, including any invention disclosures, or other similar documents, submitted to it by its employees, agents or independent contractors describing such Program Technology, and all information relating to such Program Technology to the
extent necessary or useful for the preparation, filing and maintenance of any Patent with respect to such Program Technology. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <B>Patent Prosecution and Maintenance</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2.1 <B>Generally</B>. Subject to the remainder of this Section&nbsp;8.2 (Patent Prosecution and Maintenance), each Party shall control the
Prosecution and Maintenance of Patents that such Party Controls (other than Control obtained pursuant to a grant of rights under this Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2.2 <B>Patents Within Metagenomi&#146;s Background Technology</B>. As between the Parties, Metagenomi shall have the first right, but not
the obligation, to Prosecute and Maintain any Patents within Metagenomi&#146;s Background Technology, at its sole expense. Metagenomi shall keep Moderna reasonably informed of the status of all Patents relevant to an applicable Program and shall
promptly provide Moderna with all material correspondence received from any patent authority in connection therewith. In addition, Metagenomi shall provide Moderna with drafts of all proposed material filings and correspondence to any patent
authority with respect to any such Patents for Moderna&#146;s review with reasonable time for Moderna to provide comments prior to the submission of such proposed filings and correspondences, and Metagenomi shall consider Moderna&#146;s reasonable
comments in good faith. Notwithstanding anything herein to the contrary, in connection with such Prosecution and Maintenance, Metagenomi shall take all reasonable steps to ensure that such Patents Cover the applicable Products. Metagenomi shall
notify Moderna of its intention to suspend or cease any Prosecution and Maintenance of any such Patents. Metagenomi shall provide such notice at least [***] prior to any filing or payment due date in connection with such Patents. In such event,
Metagenomi shall permit Moderna, at Moderna&#146;s discretion and at its sole expense, to continue Prosecution and Maintenance of such Patents, subject to the foregoing information sharing obligation and review and comment rights applied <I>mutatis
mutandis</I>. The Parties shall in good faith cooperate through the JPC (or as otherwise agreed in an applicable Working Group or by the Parties) to effect the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2.3 <B>Program Patents Exclusively Licensed to Moderna</B>. As between the Parties, Moderna shall have the first right, but not the
obligation, to Prosecute and Maintain any Program Patents licensed exclusively to Moderna by Metagenomi under this Agreement, and Moderna shall bear the cost of such Prosecution and Maintenance. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2.4 <B>Joint Patents</B>. Subject to Section&nbsp;8.2.3 (Program Patents Exclusively Licensed to Moderna), the JPC shall determine which
Party has the first right, but not the obligation, to Prosecute and Maintain all Joint Patents. [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2.5 <B>Cooperation of the
Parties</B>. Each Party shall cooperate fully with the other Party, through the JPC, in the Prosecution and Maintenance of Patents under this Section&nbsp;8.2 (Patent Prosecution and Maintenance) at its own cost (except as expressly set forth
otherwise in this Article 8 (Intellectual Property)), including by: (a)&nbsp;executing all papers and instruments, or requiring its employees or contractors, to execute such papers and instruments, to enable the other Party to apply for and to
Prosecute and Maintain such Patents in any country as permitted by this Section&nbsp;8.2 (Patent Prosecution and Maintenance) and (b)&nbsp;promptly informing the other Party of any matters coming to such Party&#146;s attention that may affect the
Prosecution and Maintenance of any such Patents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <B>Infringement by Third Parties</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.1 <B>Notice</B>. Each Party shall notify the other within [***] of becoming aware of any alleged or threatened infringement by a Third
Party of any of the Program Patents or Patents within either Party&#146;s Background Technology, which infringing activity involves the using, making, importing, offering for sale or selling any (i)&nbsp;Product, any (ii)&nbsp;Biosimilar Product
with respect thereto, or (iii)&nbsp;for each Collaboration Target, otherwise involving such Collaboration Target and Gene Editing in such Collaboration Target&#146;s respective field, i.e., in the DT Field or the RT Field, as applicable, in each
case ((i) through (iii)) in the applicable DT Field or RT Field in the Territory, and any related declaratory judgment, opposition or similar action alleging the invalidity, unenforceability or
<FONT STYLE="white-space:nowrap">non-infringement</FONT> of any of the Program Patents or Patents within either Party&#146;s Background Technology (collectively &#147;<B>Infringement</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.2 <B>Generally</B>. Subject to the remainder of this Section&nbsp;8.3 (Infringement by Third Parties), each Party shall have the sole
right to bring and control any legal action in connection with any Infringement of Patents claiming inventions that such Party Controls (other than Control obtained pursuant to a grant of rights under this Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.3 <B>Patents Within Metagenomi&#146;s Background Technology</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) As between the Parties, Moderna shall have the first right to bring and control any legal action in connection with any Infringement of
any Patents within Metagenomi&#146;s Background Technology, where such Infringement relates to [***]. Moderna shall keep Metagenomi reasonably informed of the status of such enforcement efforts for such Patents. Metagenomi may, at its own expense,
be represented in any such action by counsel of its own choice with respect to the enforcement of any such Patents. If Moderna does not bring such legal action within a commercially reasonable period of time (but not less than [***]) after the
notice provided pursuant to Section&nbsp;8.3.1 (Notice), Metagenomi may bring and control any legal action in connection with such Infringement of such Patents at its own expense as it reasonably determines appropriate so long as Moderna does not
reasonably object to such action. In such case, Metagenomi shall keep Moderna reasonably informed of the status of such enforcement efforts for such Patents, and Moderna may, at its own expense, be represented in any such action by counsel of its
own choice with respect to the enforcement of such Patents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) As between the Parties, Metagenomi shall have the first right to bring
and control any legal action in connection with any Infringement of any Patents within Metagenomi&#146;s Background Technology, where such Infringement relates to [***], in each case at Metagenomi&#146;s own expense (and, for clarity, whether or not
such Infringement falls within the scope of any license granted to Metagenomi hereunder). Metagenomi shall keep Moderna reasonably informed of the status of such enforcement efforts for such Patents. Moderna may, at its own expense, be represented
in any such action by counsel of its own choice with respect to the enforcement of any such Patents. If Metagenomi does not bring such legal action within a commercially reasonable period of time (but not less than [***]) after the notice provided
pursuant to Section&nbsp;8.3.1 (Notice), Moderna may bring and control any legal action in connection with such Infringement of such Patents at its own expense as it reasonably determines appropriate so long as Metagenomi does not reasonably object
to such action. In such case, Moderna shall keep Metagenomi reasonably informed of the status of such enforcement efforts for such Patents, and Metagenomi may, at its own expense, be represented in any such action by counsel of its own choice with
respect to the enforcement of such Patents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.4 <B>Program Patents Exclusively Licensed to Moderna</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">[***] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.5 <B>Joint
Patents</B>. Subject to Section&nbsp;8.3.4 (Program Patents Exclusively Licensed to Moderna), the JPC shall determine which Party has the first right, but not the obligation, to bring and control any legal action in connection with any Infringement
of any Joint Patents, subject to either Party electing to so enforce at the enforcing Party&#146;s sole expense. The enforcing Party shall keep the other Party reasonably informed of the status of such enforcement efforts for such Joint Patents and
shall consider in good faith such other Party&#146;s comments thereon. The enforcing Party shall provide the other Party with drafts of all material papers to be filed with the court and shall in good faith incorporate all reasonable comments
thereto by such other Party before filing such papers. The other Party may, at its own expense, be represented in any such action by counsel of its own choice. If the enforcing Party does not bring such legal action within a commercially reasonable
period of time (but not less than [***]) after the notice provided pursuant to Section&nbsp;8.3.1 (Notice), the other Party may bring and control any legal action in connection with such Infringement of any such Program Patents at its own expense as
it reasonably determines appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.6 <B>Biosimilar Applications</B>. Notwithstanding the foregoing provisions of this
Section&nbsp;8.3 (Infringement by Third Parties), if either Party or any of their Affiliates receives a copy of a Biosimilar Application naming a Product as a reference product or otherwise becomes aware that such a Biosimilar Application has been
filed (such as in an instance described in Section&nbsp;351(1)(9)(C) of the PHSA), such Party shall promptly notify the other Party. If either Party receives any equivalent or similar certification or notice in the U.S. or any other jurisdiction,
either Party shall, promptly, notify and provide the other Party copies of such communication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) For all Licensed Products, Moderna,
and for all DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, the Party designated by the JSC, (in either case, the &#147;<B>Designated Party</B>&#148;) shall designate pursuant to Section&nbsp;351(l)(1)(B)(ii) of the PHSA the outside
counsel and <FONT STYLE="white-space:nowrap">in-house</FONT> counsel who shall receive confidential access to the Biosimilar Application. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The Designated Party shall have the right, after consulting with the other Party, to list any Program Patents or Patents within either
Party&#146;s Background Technology, insofar as they meet the statutory requirements pursuant to Section&nbsp;351(l)(1)(3)(A), Section&nbsp;351(l)(5)(b)(i)(II), or Section&nbsp;351(l)(7) of the PHSA, to respond to any communications with respect to
such lists from the filer of the Biosimilar Application, and to negotiate with the filer of the Biosimilar Application as to whether to utilize a different mechanism for information exchange other than that specified in Section&nbsp;351(l) of the
PHSA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Designated Party shall have the right, after consulting with the other Party, to identify Program Patents or Patents
within either Party&#146;s Background Technology to list, or respond to relevant communications under any equivalent or similar listing to those described in the preceding Section&nbsp;8.3.6(b) (Biosimilar Applications) in any other jurisdiction
outside of the U.S. If required pursuant to Applicable Law, upon the Designated Party&#146;s request, the other Party shall assist in the preparation of such list and make such response after consulting with the Primary Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The Parties recognize that procedures other than those set forth above in this
Section&nbsp;8.3.6 (Biosimilar Applications) may be applicable to Biosimilar Applications that are not governed by the PHSA. As a result, in the event that the Parties acting in good faith mutually determine that certain provisions of Applicable
Laws in the U.S. or in any other country in the Territory are applicable to actions taken by the Parties with respect to Biosimilar Applications under this Section&nbsp;8.3.6 (Biosimilar Applications) in such country, the Parties shall comply with
any such Applicable Law in such country in exercising their rights and obligations with respect to Biosimilar Applications under this Section&nbsp;8.3.6 (Biosimilar Applications). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.7 <B>Enforcement Costs for <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products</B>. Except as expressly set forth herein, all Internal
Costs and External Costs incurred by the Parties in connection with any suit or other action brought by a Party under this Section&nbsp;8.3.7 (Enforcement Costs for <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products) with respect to any
Infringement regarding a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory shall be considered &#147;<B>Shared Patent Enforcement Costs</B>&#148; that shall be shared [***] between the Parties as an Other Operating Expense in
accordance with Section&nbsp;7.4 <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.8 <B>Allocation of
Recoveries for <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products</B>. Any recoveries resulting from enforcement action relating to a claim of Infringement regarding a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory,
whether by settlement or judgment, shall be allocated as follows: [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.9 <B>Allocation of Recoveries for Licensed Products</B>. Any
recoveries resulting from enforcement action relating to a claim of Infringement regarding a Licensed Product, whether by settlement or judgment, shall [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.10 <B>Allocation of Recoveries in All Other Infringements</B>. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.11 <B>Cooperation</B>. At the request and expense of the Party bringing an action under this Section&nbsp;8.3 (Infringement by Third
Parties), the other Party shall provide reasonable assistance in connection therewith, including by executing reasonably appropriate documents, cooperating in discovery and joining as a party to the action if required by Applicable Laws to pursue
such action. In connection with any such enforcement action, the Party bringing the action shall not enter into any settlement admitting the invalidity or <FONT STYLE="white-space:nowrap">non-infringement</FONT> of, or otherwise impairing the other
Party&#146;s rights in the applicable Patents without the prior written consent of the other Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4 <B>Defense and Settlement of
Third Party Claims</B>. Each Party shall promptly notify the other in writing of (a)&nbsp;any allegation by a Third Party that the activity of either of the Parties pursuant to this Agreement infringes or may infringe the intellectual property
rights of such Third Party, including any inter partes review proceeding at the U.S. Patent and Trademark Office or foreign equivalent patent office (each a &#147;<B>Third Party Claim</B>&#148;), or (b)&nbsp;any declaratory judgment action that is
brought naming either Party as a defendant and alleging invalidity of any of the Program Patents other than in response to an Infringement action under Section&nbsp;8.3 (Infringement by Third Parties) (each a &#147;<B>Third Party Patent
Challenge</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4.1 <B>Responsibility to Defend a Third Party Claim</B>. Each Party that is named as a
defendant in a Third Party Claim proceeding shall have the right to defend itself in such proceeding. The other Party shall reasonably assist the defending Party in defending such proceeding and cooperate in any such litigation at the request and
expense of the defending Party. The defending Party shall provide the other Party with prompt written notice of the commencement of any such proceeding and shall keep the other Party apprised of the progress of such proceeding and shall promptly
furnish the other Party with a copy of each pleading, communication, or other document relating to the alleged infringement that is received by such Party and shall consider reasonable input from the other Party during the course of the proceeding.
If the defending Party is Metagenomi, then Moderna shall be entitled to attend any substantive meetings, hearings, or other proceedings related to such claim (to the extent relevant, together with its own counsel, at its own expense). If the
defending Party is Moderna, then Metagenomi shall be entitled to attend any substantive meetings, hearings, or other proceedings related to such claim (to the extent relevant, together with its own counsel, at its own expense). If both Parties are
named as defendants in any such proceeding brought by a Third Party, both Parties may defend such proceeding and the Parties shall reasonably cooperate with respect to such defense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4.2 <B>Right to Defend and Settle a Third Party Patent Challenge</B>. The prosecuting Party shall have the first right, but not the
obligation, to control the defense of any Third Party Patent Challenge relating to any Patent for which it is the prosecuting Party and to compromise, litigate, settle, or otherwise dispose of any such challenge, provided that if the prosecuting
Party notifies the <FONT STYLE="white-space:nowrap">non-prosecuting</FONT> Party that it declines to exercise such first right, then the <FONT STYLE="white-space:nowrap">non-prosecuting</FONT> Party shall have the right to control such defense and
to compromise, litigate, settle or otherwise dispose of such challenge. The Party defending the Third Party Patent Challenge shall keep the other Party timely informed of the proceedings and filings, and provide the other Party with copies of all
material communications, pertaining to each Third Party Patent Challenge. The Party defending the Third Party Patent Challenge shall not settle, stipulate to any facts, or make any admission with respect to any Third Party Patent Challenge without
the other Party&#146;s prior written consent (not to be unreasonably withheld, conditioned or delayed) if such settlement, stipulation, or admission would (a)&nbsp;adversely affect the validity, enforceability or scope, or admit infringement, of any
of the Program Patents; (b)&nbsp;give rise to liability of the other Party or its Affiliates; or (c)&nbsp;otherwise impair the other Party&#146;s or any of its Affiliates&#146; rights in the Program Patents under this Agreement. Upon the defending
Party&#146;s request, the other Party shall reasonably cooperate with the defending Party, to the extent necessary to defend the Third Party Patent Challenge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4.3 <B>Costs, Damages, and Recoveries</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Costs of Defending Patent Challenges</B>. Each Party shall bear its own Internal Costs related to any Third Party Patent Challenge,
and each Party shall be responsible for [***] of the External Costs incurred with respect to any Third Party Patent Challenge of a Patent relating to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory and such External Costs
shall be considered &#147;<B>Shared Patent Defense Costs</B>&#148; that shall be shared [***] between the Parties as an Other Operating Expense in accordance with Section&nbsp;7.4 <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and
Loss Share). The other Party shall reimburse the Party defending such Third Party Patent Challenge for its share of such External Costs pursuant to the preceding sentence either (i)&nbsp;through the Operating Profits or Losses reimbursement
procedure set forth in Section&nbsp;7.4 <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share) or (ii)&nbsp;within thirty (30)&nbsp;days of receiving the defending Party&#146;s invoice therefor, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Licensed Products</B>. Subject to Article 10 (Indemnification), with respect to any
Third Party Claim for allegedly infringing activities conducted with respect to a Licensed Product in the Territory, the Party against whom such claim was brought shall bear [***] of such cost, damages, or recovery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Products</B>. Subject to Article 10 (Indemnification), with respect to any Third Party
Claim for allegedly infringing activities conducted with respect to a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, (i)&nbsp;the Internal Costs and External Costs in defending and any damages paid by the defending Party
shall be considered &#147;<B>Shared Infringement Defense Costs</B>&#148; that will be shared [***] between the Parties as an Other Operating Expense in accordance with Section&nbsp;7.4 <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit
and Loss Share) and (ii)&nbsp;any recoveries obtained shall be considered Net Sales of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <B>Other Damages and Recoveries</B>. Subject to Article 10 (Indemnification), with respect to any Third Party Claim other than claims
described in Section&nbsp;8.4.3(b) (Licensed Products) or Section&nbsp;8.4.3(c) <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products), the Party against whom such claim was brought shall bear [***] of such cost, damages, or recovery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 <B>Patent Extension</B>. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.6 <B>Unified Patent Court</B>. In the event that Unified Patent Court Agreement enters into force during the Term of this Agreement, the JPC
shall be solely responsible for making all decisions regarding Patents, including decisions regarding the <FONT STYLE="white-space:nowrap">opting-out</FONT> or <FONT STYLE="white-space:nowrap">opting-in</FONT> of existing European Patents into the
jurisdiction of the Unified Patent Court or the registration of European Patents with Unitary Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.7 <B>Common Interest</B>. All
information exchanged between the Parties regarding the prosecution, maintenance, enforcement, and defense of Patents under this Article 8 (Intellectual Property) shall be the Confidential Information of the disclosing Party. In addition, the
Parties acknowledge and agree that, with regard to such prosecution, maintenance, enforcement, and defense the interests of the Parties as collaborators and licensor and licensee are to obtain the strongest patent protection possible, and as such,
are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patents under this Article 8 (Intellectual Property),
including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary set forth in this Agreement, to the extent a Party has a good faith believe that any information required to be
disclosed by such Party to the other Party under this Article 8 (Intellectual Property) is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party shall not be required to disclose such information and
the Parties shall in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, disclosing such information on a &#147;for counsel eyes only&#148; basis or similar procedure) under which such
information may be disclosed without waiving or breaching such privilege or immunity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.8 <B>Trademarks</B>. Moderna shall have the right
to select, and shall be free, in its sole discretion, to use and to register in any trademark office in the Territory, any Trademark for use with a Licensed Product. As between the Parties, Moderna shall own all right, title and interest in and to
any such Trademarks adopted by Moderna for use with a Licensed Product, and is responsible for the registration, filing, maintenance and enforcement thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Article 9 </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS, WARRANTIES AND COVENANTS </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <B>Mutual Representations and Warranties</B>. Each of Moderna and Metagenomi represent and warrant, as of the Effective Date, that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1.1 it is duly organized and validly existing under in the Applicable Laws of the jurisdiction of its incorporation or formation, as
applicable, has full corporate, limited liability company or other power and authority, as applicable, to enter into this Agreement and to carry out the provisions hereof, and has sufficient facilities, experienced personnel or other capabilities
(including via Affiliates or Third Parties) to enable it to perform its obligations under this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1.2 it is duly authorized to
execute and deliver this Agreement and to perform its obligations hereunder, and the individual executing this Agreement on its behalf has been duly authorized to do so by all requisite corporate, limited liability company or other action, as
applicable; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1.3 this Agreement is legally binding upon it and enforceable in accordance with its terms (except as the
enforceability thereof may be limited by bankruptcy, bank moratorium or similar laws affecting creditors&#146; rights generally and laws restricting the availability of equitable remedies and may be subject to general principles of equity whether or
not such enforceability is considered in a proceeding at law or in equity) and the execution, delivery and performance of this Agreement by it have been duly authorized by all necessary corporate action and do not and shall not: (a)&nbsp;conflict
with, or constitute a default or result in a breach under, any agreement, instrument or understanding, oral or written, to which it is a party or by which it may be bound, or violate any Applicable Law; or (b)&nbsp;require any consent or approval of
its stockholders or similar. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <B>Metagenomi Representations and Warranties</B>. Metagenomi represents and warrants to Moderna that, as
of the Effective Date: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.1 <B>No DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target or Reserved DT Targets Encumbered</B>. There
are no DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target or Reserved DT Targets that are subject to an agreement between Metagenomi or any of its Affiliates and a Third Party of any kind or Metagenomi&#146;s (or its Affiliates&#146;)
commitment to negotiate an agreement with a Third Party that would prevent, limit or conflict with the inclusion of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target or Reserved DT Targets under this Agreement on an exclusive basis or
licenses granted herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.2 <B>Metagenomi Not Developing Products Against RT Targets in the RT Field or DT Targets in the DT
Field</B>. Metagenomi itself is not (and none of its Affiliates is) developing any products Directed Against or that work through, or are based on, and has granted no rights to any Third Party with respect to, any RT Target within the RT Field or
any DT Target within the DT Field. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.3 <B>No Grants That Conflict with This Agreement</B>. Metagenomi or its Affiliates have
not granted, and shall not grant during the Term, any rights (or other encumbrances) to any Third Party to Metagenomi Licensed Collaboration Technology that would prevent, limit or conflict with the rights and licenses granted to Moderna hereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.4 <B>Control over <FONT STYLE="white-space:nowrap">Know-How</FONT> and Patents</B>. Metagenomi has Control over all <FONT
STYLE="white-space:nowrap">Know-How</FONT> and Patent rights owned by it or its Affiliates as of the Effective Date that are necessary or reasonably useful for the Research, Development, Manufacturing (including formulation), Commercialization or
other Exploitation of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products as known to be contemplated under this Agreement as of the Effective Date. To Metagenomi&#146;s knowledge, the Regents of the University of California
(&#147;<B>UC</B>&#148;) has no right and has no reason to claim any right in any such <FONT STYLE="white-space:nowrap">Know-How</FONT> or Patent rights that would prevent, limit or conflict with the rights and licenses granted to Moderna hereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.5 <B>Existing Patents</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) To Metagenomi&#146;s knowledge, all Patent rights contained in the Metagenomi Licensed Collaboration Technology existing as of the
Effective Date that are issued or subject to a pending application for issuance (the &#147;<B>Existing Patents</B>&#148;) are listed on <B>Schedule K </B>and all such Existing Patents are: (i)&nbsp;to the extent issued (unless otherwise indicated on
<B>Schedule</B><B></B><B>&nbsp;K </B>(Existing Patents)), subsisting and not invalid or unenforceable, in whole or in part; (ii)&nbsp;solely and exclusively owned by Metagenomi, free of any encumbrance, lien or claim of ownership by any Third Party;
(iii)&nbsp;to the extent subject to a pending application for issuance, being diligently prosecuted in the respective patent offices in which such applications have been filed in accordance with Applicable Laws and Metagenomi and its Affiliates have
presented all relevant references, documents and information to the relevant patent examiner at the relevant patent office; and (iv)&nbsp;filed and maintained properly and correctly, and no applicable fees applicable thereto when due and payable, as
may be or have been extended, have gone unpaid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) To Metagenomi&#146;s knowledge, neither Metagenomi nor any of its Affiliates have
taken any action that would render any invention claimed in the Existing Patents unpatentable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Existing Patents represent all
Patents in the Metagenomi Licensed Collaboration Technology that relate to the DT Targets, the Products (anticipated as of the Effective Date), or the Exploitation thereof as of the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) To Metagenomi&#146;s knowledge, other than the rights granted under this Agreement, no rights or licenses are required under any Patent
rights Covering Gene Editing to practice the Metagenomi Licensed Collaboration Technology as contemplated in the Program Plans as of the Effective Date, or to Research, Develop, Manufacture (including to formulate), Commercialize or otherwise
Exploit the Products as contemplated herein by reason of the incorporation of Metagenomi Licensed Collaboration Technology in such Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) None of the Metagenomi Licensed Collaboration Technology is subject to any existing royalty or other payment obligations to any Third
Party under any agreement or understanding entered into by Metagenomi or its Affiliates, and Metagenomi has no knowledge of any obligation to pay any royalties or other amounts to any Third Party by reason of Moderna&#146;s use thereof as
contemplated under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) Metagenomi has not given any written notice to any Third Party asserting infringement
by such Third Party of any of the Metagenomi Licensed Collaboration Technology and, to Metagenomi&#146;s knowledge, there is no unauthorized use, infringement or misappropriation of the Metagenomi Licensed Collaboration Technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.6 <B>No Third Party Agreements</B>. There are no licenses, terms of use or other agreements or arrangements with Third Parties regarding
any Metagenomi Licensed Collaboration Technology or other materials contemplated to be provided by Metagenomi to Moderna hereunder (or the Exploitation of any of the foregoing), to which Metagenomi or its Affiliate is a party or is otherwise bound,
that are inconsistent with or diminish the rights and licenses granted to Moderna under this Agreement, or Metagenomi&#146;s own right to Exploit them pursuant to this Agreement. Without limiting the generality of the foregoing, none of the
metagenomic data or sequence libraries used by Metagenomi to date is subject to any terms of use that are inconsistent with or diminish the rights and licenses granted to Moderna under this Agreement, or Metagenomi&#146;s own right to Exploit them
pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.7 <B>Litigation and Actions Relating to Intellectual Property</B>. Metagenomi or any of its Affiliates:
(a)&nbsp;have not received any written notice of any threatened claims or litigation seeking to invalidate or otherwise challenge the Metagenomi Licensed Collaboration Technology, including any Patents within the Metagenomi Licensed Collaboration
Technology, or Metagenomi&#146;s or its Affiliates&#146; rights therein; and (b)&nbsp;are not aware of any pending or threatened action, suit, proceeding or claim by a Third Party asserting that Metagenomi or any of its Affiliates is infringing or
has misappropriated or otherwise is violating any Patent right, trade secret or other proprietary right of any Third Party as would reasonably be expected to impair the ability of Metagenomi to fulfill any of its obligations under this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.8 <B>Other Material Claims and Actions</B>. There are no claims, actions or proceedings pending or, to Metagenomi&#146;s or any of
its Affiliates&#146; knowledge, threatened by any Third Party; nor, to Metagenomi&#146;s or any of its Affiliates&#146; knowledge, are there any formal inquiries initiated or written notices received that may lead to the institution of any such
legal proceedings, in each case (or in aggregate) against Metagenomi or its properties, assets or business, which if adversely decided, would, individually or in the aggregate, have a material adverse effect on, or prevent Metagenomi&#146;s ability
to conduct the Research or to grant the licenses or rights granted to Moderna under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.9 <B>No Government Funding</B>.
The inventions claimed or Covered by the Patents within the Metagenomi Licensed Collaboration Technology: (a)&nbsp;were not conceived, discovered, developed or otherwise made in connection with any research activities funded, in whole or in part, by
the federal government of the U.S. of America or any agency thereof; (b)&nbsp;are not a &#147;subject invention&#148; as that term is described in 35 U.S.C. &#167; 201(e) and (c)&nbsp;are not otherwise subject to the provisions of the Patent and
Trademark Law Amendments Act of 1980, as amended, codified at 35 U.S.C. &#167;&#167; <FONT STYLE="white-space:nowrap">200-212,</FONT> as amended, as well as any regulations promulgated pursuant thereto, including in 37 C.F.R. Part 401. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.10 <B>Regulatory Documentation</B>. To the extent that Metagenomi and its Affiliates
have generated, prepared, maintained and retained any Regulatory Documentation under this Agreement that is required to be maintained or retained pursuant to and in accordance with, to the extent applicable, good laboratory and clinical practice and
Applicable Laws, all such information is true, complete and correct in all material respects and what it purports to be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.11 <B>Data
Protection and Data Privacy</B>. Metagenomi and its Affiliates&#146; have complied with all Applicable Laws related to data protection and data privacy and has provided all legally required privacy notices to, and obtained appropriate consents,
including research informed consents, from data subjects (&#147;<B>Notices and Consents</B>&#148;), and the Notices and Consents permit the use of the data as currently and previously used and processed by Metagenomi and shall permit the licensing
and transfer of all such personal data of data subjects to Moderna as contemplated in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.12 <B>Confidentiality</B>.
Metagenomi and its Affiliates have used commercially reasonable efforts to protect the confidentiality of those parts of the Metagenomi Licensed Collaboration Technology that constitute confidential or proprietary information of Metagenomi. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <B>Moderna Representations and Warranties</B>. Moderna represents and warrants to Metagenomi that, as of the Effective Date: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.3.1 <B>No Grants That Conflict with This Agreement</B>. Moderna or its Affiliates have not granted, and shall not grant during the Term, any
rights (or other encumbrances) to any Third Party to Moderna Licensed Collaboration Technology that would prevent, limit or conflict with the rights and licenses granted to Metagenomi hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.3.2 <B>Control over <FONT STYLE="white-space:nowrap">Know-How</FONT> and Patents</B>. Moderna has Control over all <FONT
STYLE="white-space:nowrap">Know-How</FONT> and Patent rights owned by it or its Affiliates as of the Effective Date that are necessary or reasonably useful for the Research, Development, Manufacturing (including formulation), Commercialization or
other Exploitation of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products as known to be contemplated under this Agreement as of the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.3.3 <B>No Third Party Agreements</B>. There are no license or other agreements with Third Parties regarding the Exploitation of any Moderna
Licensed Collaboration Technology or other materials contemplated to be provided by Moderna to Metagenomi hereunder, to which Moderna or its Affiliate is a party that is inconsistent with or diminishes the rights and licenses granted to Metagenomi
under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.3.4 <B>Litigation and Actions Relating to Intellectual Property</B>. Moderna or any of its Affiliates:
(a)&nbsp;have not received any written notice of any threatened claims or litigation seeking to invalidate or otherwise challenge the Moderna Licensed Collaboration Technology, including any Patents within the Moderna Licensed Collaboration
Technology, or Moderna&#146;s or its Affiliates&#146; rights therein; and (b)&nbsp;are not aware of any pending or threatened action, suit, proceeding or claim by a Third Party asserting that Moderna or any of its Affiliates is infringing or has
misappropriated or otherwise is violating any Patent right, trade secret or other proprietary right of any Third Party as would reasonably be expected to impair the ability of Moderna to fulfill any of its obligations under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.3.5 <B>Other Material Claims and Actions</B>. There are no claims, actions or proceedings
pending or, to Moderna&#146;s or any of its Affiliates&#146; knowledge, threatened by any Third Party; nor, to Moderna&#146;s or any of its Affiliates&#146; knowledge, are there any formal inquiries initiated or written notices received that may
lead to the institution of any such legal proceedings, in each case (or in aggregate) against Moderna or its properties, assets or business, which if adversely decided, would, individually or in the aggregate, have a material adverse effect on, or
prevent Moderna&#146;s ability to conduct the Research or to grant the licenses or rights granted to Metagenomi under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.3.6 <B>No Government Funding</B>. The inventions claimed or Covered by the Patents within the Moderna Licensed Collaboration Technology:
(a)&nbsp;were not conceived, discovered, developed or otherwise made in connection with any research activities funded, in whole or in part, by the federal government of the U.S. of America or any agency thereof; (b)&nbsp;are not a &#147;subject
invention&#148; as that term is described in 35 U.S.C. &#167; 201(e) and (c)&nbsp;are not otherwise subject to the provisions of the Patent and Trademark Law Amendments Act of 1980, as amended, codified at 35 U.S.C. &#167;&#167; <FONT
STYLE="white-space:nowrap">200-212,</FONT> as amended, as well as any regulations promulgated pursuant thereto, including in 37 C.F.R. Part 401. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.3.7 <B>Regulatory Documentation</B>. To the extent that Moderna and its Affiliates have generated, prepared, maintained and retained any
Regulatory Documentation under this Agreement that is required to be maintained or retained pursuant to and in accordance with, to the extent applicable, good laboratory and clinical practice and Applicable Laws, all such information is true,
complete and correct in all material respects and what it purports to be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.3.8 <B>Data Protection and Data Privacy</B>. Moderna and its
Affiliates&#146; have complied with all Applicable Laws related to data protection and data privacy and has provided all legally required privacy notices to, and obtained appropriate consents, including research informed consents, from data subjects
(&#147;<B>Notices and Consents</B>&#148;), and the Notices and Consents permit the use of the data as currently and previously used and processed by Moderna and shall permit the licensing and transfer of all such personal data of data subjects to
Metagenomi as contemplated in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.3.9 <B>Confidentiality</B>. Moderna and its Affiliates have used commercially reasonable
efforts to protect the confidentiality of those parts of the Moderna Licensed Collaboration Technology that constitute confidential or proprietary information of Moderna. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.4 <B>Covenants</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.4.1
<B>Employees, Consultants and Contractors</B>. Each Party represents, warrants and covenants that it and its Affiliates have obtained from each of its and their respective former and current employees, consultants and contractors, and shall obtain
from each of its and their respective future employees, consultants and contractors, in each case who have conceived, discovered, invented or created or who may conceive, discover, invent or create any of such Party&#146;s Licensed Collaboration
Technology, written agreements containing obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> and an assignment to such Party or its applicable Affiliates of all of such Person&#146;s rights to such Licensed
Collaboration Technology such that no such employee, contractor or consultant shall retain any rights thereto that would prevent or conflict with the other Party&#146;s rights of ownership, license or use thereof or thereto, as the case may be,
contemplated under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.4.2 <B>Debarment</B>. Each Party represents, warrants and covenants to the other Party
that neither it nor its officers, employees, agents, consultants or any other person used by such Party in the performance of the respective Research and Development activities under this Agreement is: (a)&nbsp;debarred or disqualified under the
U.S. Federal Food, Drug and Cosmetic Act; (b)&nbsp;listed by any government or regulatory agencies as ineligible to participate in any government healthcare programs or government procurement or
<FONT STYLE="white-space:nowrap">non-procurement</FONT> programs (as that term is defined in 42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(f)),</FONT> or excluded, debarred, suspended or otherwise made ineligible to participate in any
such program; or (c)&nbsp;convicted of a criminal offense related to the provision of healthcare items or services, or is subject to any such pending action. Each Party shall not during the Term knowingly, employ or use, directly or indirectly,
including through Affiliates the services of any such person. In the event that either Party becomes aware of the debarment or disqualification or threatened debarment or disqualification of any person providing services to such Party, directly or
indirectly, including through Affiliates or, in the case of Moderna, Sublicensees, which directly or indirectly relate to activities contemplated under this Agreement, such Party shall promptly notify the other Party in writing and such Party shall
cease employing, contracting with, or retaining any such person to perform any such services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.4.3 <B>The Regents of the University of
California</B>. Metagenomi represents and warrants that none of the Metagenomi Licensed Collaboration Technology in existence as of the Effective Date is <FONT STYLE="white-space:nowrap">in-licensed</FONT> from UC. In the event that Metagenomi <FONT
STYLE="white-space:nowrap">in-licenses</FONT> from UC any <FONT STYLE="white-space:nowrap">Know-How</FONT> or Patent rights during the Term of this Agreement that Covers or otherwise relates to any <FONT STYLE="white-space:nowrap">Know-How</FONT>
conceived, discovered, invented or created, in each case as of the Effective Date, by any director, employee, consultant or contractor of Metagenomi as of the Effective Date in their capacity as employee, consultant, contractor or student of UC or
during their course of employment, consulting, contractor, or student relationship with UC, Metagenomi hereby covenants that it and its Affiliates shall (i)&nbsp;assume all payment obligations under such
<FONT STYLE="white-space:nowrap">in-licenses,</FONT> notwithstanding anything else herein to the contrary, (ii)&nbsp;ensure that such <FONT STYLE="white-space:nowrap">in-licenses</FONT> are fully sublicensable to Moderna, (iii)&nbsp;expressly make
Moderna an intended third-party beneficiary to such <FONT STYLE="white-space:nowrap">in-licenses,</FONT> and (iv)&nbsp;ensure that in the event of termination of such <FONT STYLE="white-space:nowrap">in-licenses,</FONT> Moderna shall become a direct
licensee of UC with respect to the <FONT STYLE="white-space:nowrap">Know-How</FONT> and Patent rights <FONT STYLE="white-space:nowrap">in-licensed</FONT> from UC to the extent Moderna has rights to such
<FONT STYLE="white-space:nowrap">Know-How</FONT> or Patent rights under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.4.4 <B>Open Source Software</B>. Metagenomi
represents, warrants and covenants that any deliverable that Metagenomi provides to Moderna and its Affiliates under this Agreement does not and will not include any open source, copyleft or community source code (including but not limited to any
libraries or code, software, technologies or other materials that are licensed or distributed under any General Public License, Lesser General Public License or similar license arrangement or other distribution model described by the Open Source
Initiative at www.opensource.org). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <B>Compliance</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.5.1 <B>Compliance with this Agreement</B>. Each of the Parties shall, and shall cause their respective Affiliates to, comply in all
material respects with the terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.5.2 <B>Compliance with Applicable Laws</B>. Each Party covenants to the other that
in the performance of its obligations under this Agreement, such Party shall comply with, and shall cause its Affiliates and its and its Affiliates&#146; employees and contractors to comply, with all Applicable Laws. No Party shall, or shall be
required to, undertake any activity under or in connection with this Agreement which violates, or which it believes, in good faith, may violate, any Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.5.3 <B>Compliance with Party-Specific Regulations</B>. In carrying out their respective obligations under this Agreement, the Parties agree
to cooperate with each other as may reasonably be required to help ensure that each is able to fully meet its obligations with respect to all judgments, decrees, orders or similar decisions issued by any Governmental Authority specific to a Party,
and all consent decrees, corporate integrity agreements, or other agreements or undertakings of any kind by a Party with any Governmental Authority, in each case as the same may be in effect from time to time and applicable to a Party&#146;s
activities contemplated under this Agreement (the &#147;<B>Party-Specific Regulations</B>&#148;). Neither Party shall be obligated to pursue any course of conduct that would result in such Party being in material breach of any Party-Specific
Regulation applicable to it; provided that in the event that a Party refuses to fulfill its obligations under this Agreement in any material respect on such basis, the other Party shall have the right to terminate this Agreement in accordance with
Section&nbsp;12.2 (Termination for Material Breach or Insolvency or Patent Challenge) however, under such circumstances, such termination shall be the sole remedy for such terminating Party and such terminating Party shall not be entitled to any
other remedy under law or equity. All Party-Specific Regulations are binding only in accordance with their terms and only upon the Party to which they relate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.5.4 <B>Compliance with Internal Compliance Codes</B>. All Internal Compliance Codes shall apply only to the Party to which they relate. The
Parties agree to cooperate with each other to help ensure that each Party is able to comply with the substance of its respective Internal Compliance Codes and, to the extent practicable, each Party shall operate in a manner consistent with its
Internal Compliance Codes applicable to its performance under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.5.5 <B>Compliance with Anti-Corruption Laws</B>. In
connection with this Agreement, the Parties shall comply with all applicable local, national, and international laws, regulations, and industry codes dealing with government procurement, conflicts of interest, corruption or bribery, including, if
applicable, the U.S. Foreign Corrupt Practices Act of 1977, as amended, and any laws enacted to implement the Organisation of Economic Cooperation and Development Convention on Combating Bribery of Foreign Officials in International Business
Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9.5.6 <B>Prohibited Conduct</B>. Without limiting the other obligations of the Parties set forth in this Section&nbsp;9.5
(Compliance), each Party covenants to the other that, as of the Effective Date and in the performance of its obligations under this Agreement through the expiration or termination of this Agreement, such Party and, to its knowledge, its Affiliates
and its and its Affiliates&#146; employees and contractors, in connection with the performance of their respective </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligations under this Agreement, have not made, offered, given, promised to give, or authorized, and shall not make, offer, give, promise to give, or authorize, any bribe, kickback, payment or
transfer of anything of value, directly or indirectly through Third Parties, to any Government Official for the purpose of: (a)&nbsp;improperly influencing any act or decision of the Person or Government Official; (b)&nbsp;inducing the Person or
Government Official to do or omit to do an act in violation of a lawful or otherwise required duty; (c)&nbsp;securing any improper advantage; or (d)&nbsp;inducing the Person or Government Official to improperly influence the act or decision of any
organization, including any government or government instrumentality, to assist any Party in obtaining or retaining business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6
<B>Disclaimer</B>. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN THIS AGREEMENT, NEITHER PARTY MAKES ANY REPRESENTATIONS OR EXTENDS ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY, QUALITY, FITNESS FOR A
PARTICULAR PURPOSE, NONINFRINGEMENT, OR VALIDITY OF PATENT CLAIMS. NOTHING IN THIS AGREEMENT SHALL BE CONSTRUED AS A REPRESENTATION MADE OR WARRANTY GIVEN BY EITHER PARTY THAT EITHER PARTY SHALL BE SUCCESSFUL IN OBTAINING ANY PATENTS OR THAT ANY
PATENTS SHALL ISSUE BASED ON A PENDING APPLICATION. WITHOUT LIMITING THE RESPECTIVE RIGHTS AND OBLIGATIONS OF THE PARTIES EXPRESSLY SET FORTH HEREIN, EACH PARTY SPECIFICALLY DISCLAIMS ANY GUARANTEE THAT THE PRODUCTS SHALL BE SUCCESSFUL, IN WHOLE OR
IN PART. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 10 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1
<B>Indemnity</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">10.1.1 <B>By Metagenomi</B>. Subject to Section&nbsp;10.1.3 (Procedure), Metagenomi shall defend, indemnify and hold
harmless Moderna and its Affiliates, and their respective directors, officers, employees and agents (each, a &#147;<B>Moderna Indemnitee</B>&#148;) from and against any and all costs, fees, expenses, losses, liabilities and damages, including
reasonable legal expenses and attorneys&#146; fees (collectively, &#147;<B>Losses</B>&#148;) to which any Moderna Indemnitee may become subject as a result of any claim, demand, action or other proceeding by any Third Party (a
&#147;<B>Claim</B>&#148;) to the extent such Losses arise out of: (a)&nbsp;the gross negligence or willful misconduct of Metagenomi or its Affiliates in connection with its activities under this Agreement; or (b)&nbsp;the breach of this Agreement by
Metagenomi or the breach of representations, warranties and covenants made hereunder by Metagenomi; except, in each case, to the extent such Losses result from (i)&nbsp;matters subject to clause (a)&nbsp;or (b) of Section&nbsp;10.1.2 (By Moderna) or
(ii)&nbsp;a Moderna Indemnitee&#146;s negligence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">10.1.2 <B>By Moderna</B>. Subject to Section&nbsp;10.1.3 (Procedure), Moderna shall
defend, indemnify and hold harmless Metagenomi, its Affiliates, and their respective directors, officers, employees and agents (each, an &#147;<B>Metagenomi Indemnitee</B>&#148;) from and against any and all Losses to which any Metagenomi Indemnitee
may become subject as a result of any Claim to the extent such Losses arise out of: (a)&nbsp;the gross negligence or willful misconduct of Moderna or its Affiliates in connection with its activities under this Agreement; or (b)&nbsp;the breach of
this Agreement by Moderna or the breach of representations, warranties and covenants made hereunder by Moderna; except, in each case, to the extent such Losses result from (i)&nbsp;matters subject to clause (a)&nbsp;or (b) of Section&nbsp;10.1.1 (By
Metagenomi) or (ii)&nbsp;an Metagenomi Indemnitee&#146;s negligence. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">10.1.3 <B>Procedure</B>. A Party that intends to claim indemnification under this Article
10 (Indemnification) (the &#147;<B>Indemnitee</B>&#148;) shall promptly notify the Indemnitor (the &#147;<B>Indemnitor</B>&#148;) in writing of any Claim in respect of which the Indemnitee intends to claim such indemnification. The failure to
deliver written notice to the Indemnitor within a reasonable time after the commencement of any action with respect to a Claim shall only relieve the Indemnitor of its indemnification obligations under this Article 10 (Indemnification) if and to the
extent the Indemnitor is actually and materially prejudiced thereby. The Indemnitor has sole control of the defense or settlement thereof. The Indemnitee shall cooperate fully with the Indemnitor and its legal representatives in the investigation of
any action with respect to a Claim covered by this indemnification. The Indemnitee may participate at its expense in the Indemnitor&#146;s defense of and settlement negotiations for any Claim with counsel of the Indemnitee&#146;s own selection. The
Indemnitor shall not settle any Claim without the prior written consent of the Indemnitee, not to be unreasonably withheld, conditioned or delayed. So long as the Indemnitor is actively defending the Claim in good faith, the Indemnitee shall not
settle or compromise any such Claim without the prior written consent of the Indemnitor. If the Indemnitor does not assume and conduct the defense of the Claim as provided above: (a)&nbsp;the Indemnitee may defend against, consent to the entry of
any judgment, or enter into any settlement with respect to such Claim in any manner the Indemnitee may deem reasonably appropriate (and the Indemnitee need not consult with, or obtain any consent from, the Indemnitor in connection therewith); and
(b)&nbsp;the Indemnitor shall remain responsible to indemnify the Indemnitee as provided in this Article 10 (Indemnification). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2
<B>Losses in the Territory</B>. All Losses arising from any Third Party Claim relating to the Exploitation of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory, including fees and disbursements to counsel, incurred by
either Party in connection with the defense of any such Third Party Claim brought in the Territory, shall be shared [***] by the Parties as an Other Operating Expense in accordance with Section&nbsp;7.4 <FONT STYLE="white-space:nowrap">(Co-Co</FONT>
Products Profit and Loss Share), provided that, such Other Operating Expenses shall not include Losses of a Party or its Affiliate to the extent such Losses are: (a)&nbsp;caused by a breach of this Agreement by such Party or Affiliate; or
(b)&nbsp;caused by the negligence or willful misconduct of such Party or its Affiliate, and any such Losses described in clause (a)&nbsp;or (b) shall not be applied to the Operating Profit or Loss as Other Operating Expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3 <B>Insurance</B>. During the Term, each Party shall maintain such types and amounts of liability insurance (including, with respect to
Moderna, self-insurance) as is normal and customary in the industry generally for similarly situated parties and adequate to cover its obligations under this Agreement, and each Party shall, upon request, provide the other Party with a certificate
of insurance in that regard, along with any amendments and revisions thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 11 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIALITY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.1
<B>Confidential Information</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">11.1.1 <B>Confidential Information</B>. In connection with this Agreement, a Party may disclose to the
other Party certain confidential information of such disclosing Party (such confidential information, &#147;<B>Confidential Information</B>&#148;). For clarity, all Results in a Program and all records of each Party&#146;s activities in a Program
constitute Confidential Information, provided, that (a)&nbsp;any confidential information initially disclosed by a Party that is to be solely owned by the other Party in accordance with this Agreement shall be the Confidential Information of such
other Party (and the owning Party shall be deemed the disclosing Party, and the initially disclosing Party shall be deemed the receiving Party, with respect thereto and regardless of the Party initially disclosing the same), (b) any confidential
information Controlled by Metagenomi or any of its Affiliates to the extent solely relating to (i)&nbsp;a DT Moderna Target in the DT Field, (ii)&nbsp;a RT Target that is selected in accordance with Section&nbsp;3.9 (RT Option) in the RT Field, or
(iii)&nbsp;an RT Candidate, a DT Moderna Candidate or a Licensed Product, or the Exploitation of any of the foregoing (i)-(iii), shall be deemed Confidential Information of Moderna (and Moderna the disclosing Party, and Metagenomi the receiving
Party, with respect thereto and regardless of the Party initially disclosing the same), and (c)&nbsp;any confidential information Controlled by either Party or any of its Affiliates to the extent solely relating to the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Target in the DT Field, a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidate or a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product or the Exploitation thereof shall be deemed Confidential
Information of both Parties. Without limiting the foregoing, the terms of this Agreement are the Confidential Information of both Parties and shall be treated confidentially by each of the Parties, subject to the exceptions set forth in
Section&nbsp;11.1.6 (Disclosure of Agreement). Information exchanged by the Parties pursuant to the Mutual Confidentiality Agreement shall be governed by such Mutual Confidentiality Agreement; provided that any such information that is subsequently
exchanged by the Parties under this Agreement shall, from that time, be governed by the terms of this Agreement. Notwithstanding anything herein to the contrary, Metagenomi shall not disclose any Results or Data Package to the extent related to the <FONT
STYLE="white-space:nowrap">mRNA-LNP</FONT> Technology without Moderna&#146;s prior written consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">11.1.2 <B>Restrictions</B>. A Party
(the &#147;<B>Receiving Party</B>&#148;) that receives Confidential Information from the other Party (the &#147;<B>Disclosing Party</B>&#148;) shall keep all the Disclosing Party&#146;s Confidential Information in confidence with the same degree of
care with which the Receiving Party holds its own confidential information (but in no event less than a commercially reasonable degree of care). A Receiving Party shall not use the Disclosing Party&#146;s Confidential Information except in
connection with the performance of its obligations and exercise of its rights under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">11.1.3 <B>Exceptions</B>. The
obligations of confidentiality and restriction on use of Confidential Information under Section&nbsp;11.1.2 (Restrictions) do not apply to any information that the Receiving Party can prove by competent written evidence: (a)&nbsp;is now, or
hereafter becomes, through no act or failure to act on the part of the Receiving Party, generally known or available to the public; (b)&nbsp;is known by the Receiving Party at the time of receiving such information, other than by previous disclosure
of the Disclosing Party, or its Affiliates, employees, agents, consultants, or contractors; (c)&nbsp;is hereafter furnished to the Receiving Party without restriction by a Third Party who has no obligation of confidentiality or limitations on use
with respect thereto, as a matter of right; or (d)&nbsp;is independently discovered or developed by the Receiving Party without the use of Confidential Information belonging to the Disclosing Party. Specific information shall not be deemed to be
within any of the foregoing exclusions merely because it is embraced by more general information falling within those exclusions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.4 <B>Permitted Disclosures</B>. The Receiving Party may disclose Confidential
Information belonging to the Disclosing Party as expressly permitted under this Agreement or if and to the extent such disclosure is reasonably necessary in the following instances: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Prosecution and Maintenance of Patents as permitted under this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Regulatory Filings for Product that such Party has a license or right to develop hereunder in a given country or jurisdiction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) prosecuting or defending litigation as permitted under this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) made in response to a valid order of a court or other Governmental Authority or to comply with Applicable Laws (including securities
laws); provided that the Receiving Party shall, to the extent permitted by Applicable Laws, first have given notice to the Disclosing Party and given the Disclosing Party a reasonable opportunity, at the Disclosing Party&#146;s expense, to quash
such order or to obtain a protective order or seek confidential treatment; and provided further that the Confidential Information disclosed in response to such court or governmental order shall be limited to that information which is legally
required to be disclosed in response to such court or governmental order or to comply with Applicable Laws; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) in response to a valid
request by a U.S., state, foreign, provincial, or local tax authority, in which case either Party may disclose, a copy of this Agreement (including any Schedules, ancillary agreements and amendments hereto); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) disclosure to its and its Affiliates&#146; employees, consultants, contractors and agents, and to Sublicensees, in each case on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis in connection with the Research, Development, making, having made, use, keeping, import, export, offering for sale, selling, or otherwise Exploiting of
Products in the RT Field or DT Field (as applicable) in the Territory, and Commercialization of the Products in accordance with the terms of this Agreement, in each case under written obligations of confidentiality and
<FONT STYLE="white-space:nowrap">non-use</FONT> at least as stringent as those herein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) to the extent otherwise necessary or
reasonably useful for a Receiving Party to exploit the licenses granted to it under this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) disclosure to <I>bona
fide</I> potential and actual investors, acquirers, and other financial partners solely for the purpose of evaluating or carrying out an actual or potential investment or acquisition, in each case under written obligations of confidentiality and <FONT
STYLE="white-space:nowrap">non-use</FONT> at least as stringent as those herein; provided that with respect to disclosure to actual or <I>bona fide </I>potential investors, such disclosure is under a written obligation of confidentiality that is
consistent with market terms, including a shorter period of time during which such information must be held confidential. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if a Party is required to make a disclosure of the other Party&#146;s
Confidential Information pursuant to Section&nbsp;11.1.4(c) or (d) (Permitted Disclosures), it shall, except where impracticable, give reasonable advance notice to the other Party of such disclosure and use efforts to secure confidential treatment
of such Confidential Information at least as diligent as such Party would use to protect its own Confidential Information, but in no event less than reasonable efforts. Any information disclosed pursuant to Section&nbsp;11.1.4(c) or (d) (Permitted
Disclosures) remains Confidential Information and subject to the restrictions set forth in this Agreement, including the foregoing provisions of this Article 11 (Confidentiality). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.5 <B>Public Domain Information and Residual Knowledge</B>. Nothing in this Agreement shall prevent a Party from using any <FONT
STYLE="white-space:nowrap">Know-How</FONT> that is in the public domain. Except to the extent a Party has granted exclusive or <FONT STYLE="white-space:nowrap">co-exclusive</FONT> rights to the other Party under this Agreement (including as and to
the extent such rights survive this Agreement), each Party grants to the other Party a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license to use, outside the scope of this Agreement and for any purpose, any
<FONT STYLE="white-space:nowrap">Know-How</FONT> or Confidential Information shared in the performance of this Agreement by such Party solely to the extent such <FONT STYLE="white-space:nowrap">Know-How</FONT> or Confidential Information has been
retained (without intentional memorization) in intangible form in the minds of such Party&#146;s employees (or its Affiliates&#146; employees) who have had access to such <FONT STYLE="white-space:nowrap">Know-How</FONT> or Confidential Information
pursuant to the terms of this Agreement and without reference to any tangible copies of such <FONT STYLE="white-space:nowrap">Know-How</FONT> or Confidential Information; provided that this provision shall not be deemed in any event to provide any
right to infringe the Patent rights of the other Party or of Third Parties that have licensed or provided materials to the other Party; provided, further, that a Party&#146;s use of such <FONT STYLE="white-space:nowrap">Know-How</FONT> or
Confidential Information is on an &#147;as is, where is&#148; basis, with all faults and all representations and warranties disclaimed and at such Party&#146;s sole risk. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.6 <B>Disclosure of Agreement</B>. Notwithstanding the foregoing, either Party or its Affiliates may disclose the relevant terms of this
Agreement: (a)&nbsp;to the extent required or advisable to comply with the rules and regulations promulgated by the U.S. Securities and Exchange Commission or any equivalent governmental agency in any country in the Territory, provided that such
Party shall submit a confidential treatment request in connection with such disclosure and shall submit with such confidential treatment request only such redacted form of this Agreement as may be mutually agreed in writing by the Parties;
(b)&nbsp;upon request from a Governmental Authority (such as a tax authority), provided the disclosing Party uses reasonable efforts to ensure the Governmental Authority maintains such terms as confidential; (c)&nbsp;to applicable licensors, solely
to the extent necessary to comply with the terms of any Third Party license agreement, the rights under which are sublicensed to the other Party under this Agreement; and (d)&nbsp;to the extent necessary to perform obligations or exercise rights
under this Agreement, to any Sublicensee, collaborator or potential Sublicensee or potential collaborator of such Party, provided that any Sublicensee, collaborator or potential Sublicensee or collaborator agree in writing to be bound by obligations
of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> no less protective of the Disclosing Party than those set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.7 <B>Survival</B>. Each Party&#146;s obligations under this Section&nbsp;11.1 (Confidential Information) apply during the Term and
continue for three (3)&nbsp;years thereafter with respect to Confidential Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.2 <B>Publicity</B>. On November&nbsp;2, 2021, the Parties shall issue a joint press
release in the form attached hereto as <B>Schedule N </B>(Joint Press Release). Except as permitted under Section&nbsp;11.1.4 (Permitted Disclosures) or Section&nbsp;11.1.6 (Disclosure of Agreement), neither Party shall issue any press release or
public statement disclosing information relating to this Agreement or the transactions contemplated hereby or the terms hereof without the prior written consent of the other Party; provided however, that neither Party shall be prevented from
complying with any duty of disclosure it may have pursuant to Applicable Laws or pursuant to the rules of any recognized stock exchange or quotation system subject to the restrictions set forth in Sections 11.1.4 (Permitted Disclosures) and 11.1.5
(Public Domain Information and Residual Knowledge). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3 <B>Publication</B>. The following restrictions shall apply with respect to
disclosure by any Party of Confidential Information in any publication or presentation with respect to the Programs, the Collaboration Targets, the Products or their testing: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.3.1 both Parties acknowledge that it is their policy for the studies and results thereof to be registered and published in accordance with
their internal guidelines; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.3.2 a Party (&#147;<B>Publishing Party</B>&#148;) shall provide the other Party with a copy of any
proposed material publication or presentation at least [***] (or [***] in the case of a manuscript) prior to submission for publication so as to provide such other Party with an opportunity to recommend any changes it reasonably believes are
necessary to continue to maintain the Confidential Information disclosed by the other Party to the Publishing Party in accordance with the requirements of this Agreement. The incorporation of such recommended changes shall not be unreasonably
refused; and if such other Party notifies (&#147;<B>Publishing Notice</B>&#148;) the Publishing Party in writing, within such [***] period (or [***] period in the case of a manuscript) after receipt of the copy of the proposed publication,
presentation, or manuscript, that such publication or presentation in its reasonable judgment (i)&nbsp;contains an invention, solely or jointly conceived or reduced to practice by the other Party, for which the other Party reasonably desires to
obtain patent protection or (ii)&nbsp;could be expected to have a material adverse effect on the commercial value of any Confidential Information disclosed by the other Party to the Publishing Party, the Publishing Party shall prevent such
publication or delay such publication for a mutually agreeable period of time. In the case of inventions, a delay shall be for a period reasonably sufficient to permit the timely preparation and filing of a patent application(s) on such invention,
and in no event less than [***] from the date of the Publishing Notice. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 12 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERM&nbsp;&amp; TERMINATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1 <B>Term</B>. This Agreement commences on the Effective Date and, unless terminated earlier as provided in this Article 12 (Term and
Termination), shall continue on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-</FONT></FONT> Program basis as follows: (a)&nbsp;with respect to the RT Technology Research Program, until the end of the RT Research
Term; (b)&nbsp;with respect to an RT Preclinical Research Program, (i)&nbsp;in the event no RT Option has been exercised within the RT Option Period for such RT Preclinical Research Program, until the expiration of the RT Option Period, or
(ii)&nbsp;in the event an RT Option has been exercised within the applicable RT Option Period for such RT Preclinical Research Program, on a Licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT>
Product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, until the expiration of the applicable RT Royalty Term; (c)&nbsp;with respect to the DT Target Evaluation Program, until the end of
the DT Moderna Research Term; (d)&nbsp;with respect to a DT Moderna Research Program, (i)&nbsp;in the event no DT Option has been exercised within the DT Option Period for such DT Moderna Research Program, until the expiration of the DT Option
Period, or (ii)&nbsp;in the event a DT Option has been exercised within the applicable DT Option Period for such DT Moderna Research </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Program, on a Licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, until the expiration of the applicable DT Moderna Royalty Term; and (e)&nbsp;with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, on a DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-DT</FONT></FONT> <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, (i)&nbsp;in the event neither Party <FONT STYLE="white-space:nowrap">Opts-Out</FONT> within the time allowed under Section&nbsp;6.8.1 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT>
Right), until neither Party (or its Affiliates, Sublicensees or assignees) continue to Commercialize such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such country; or (ii)&nbsp;in the event either Party
<FONT STYLE="white-space:nowrap">Opts-Out</FONT> within the time allowed under Section&nbsp;6.8.1 <FONT STYLE="white-space:nowrap">(Opt-Out</FONT> Right), until the expiration of the applicable <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Royalty
Term, provided that, in each case of (i)&nbsp;and (ii), in the event there is no DC Nomination in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program by the end of the Initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term,
this Agreement will expire with respect to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program at the end of the Initial DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Term, subject to the last paragraph of Section&nbsp;6.3.1
(DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan) (the &#147;<B>Term</B>&#148;). Upon the expiration of the Term with respect to (A)&nbsp;a Licensed Product in an RT Preclinical Research Program in a country in accordance with clause
(b)(ii) of the immediately preceding sentence, the licenses granted to Moderna under Section&nbsp;5.13 (License to Moderna Upon Exercise of the RT Option) with respect to such Licensed Product and such country shall survive and become perpetual,
fully- paid and royalty-free; (B)&nbsp;a Licensed Product in a DT Moderna Research Program in a country in accordance with clause (c)(ii) of the immediately preceding sentence, the licenses granted to Moderna under Section&nbsp;5.15 (License to
Moderna Upon Exercise of the DT Option) with respect to such Licensed Product in such country shall survive and become perpetual, fully-paid and royalty-free; and (C)&nbsp;a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program in a country in accordance with clause (e)(ii) of the immediately preceding sentence, the licenses granted to the Primary Party under Section&nbsp;5.5 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Program License) with respect to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such country shall survive and become perpetual, fully-paid and royalty-free. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2 <B>Termination for Material Breach or Insolvency or Patent Challenge</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.2.1 <B>Material Breach</B>. On a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis,
subject to Section&nbsp;12.2.2 (Disputes Regarding Material Breach), each Party (the &#147;<B><FONT STYLE="white-space:nowrap">Non-Breaching</FONT> Party</B>&#148;) shall have the right to terminate this Agreement with respect to such Program upon
written notice to the other Party (the &#147;<B>Breaching Party</B>&#148;) if the Breaching Party materially breaches its obligations under this Agreement with respect to [***], after receiving written notice from the
<FONT STYLE="white-space:nowrap">Non-Breaching</FONT> Party identifying such material breach by the Breaching Party in reasonable detail, fails to cure such material breach within [***] from the date of such notice (or, if such breach cannot be
cured within [***] from the date of such notice, if the Breaching Party has not commenced or is not diligently continuing in good faith efforts to cure such breach; provided that, in any event, such breach must be cured within [***] from the date of
such notice) (such [***] period, the &#147;<B>Cure Period</B>&#148;). For the avoidance of doubt, (i)&nbsp;each Party has all rights and may seek all available remedies under Applicable Laws in the event of a breach of this Agreement by the other
Party, regardless of whether such breach constitutes a material breach that could give rise to termination of this Agreement, and (ii)&nbsp;if a material breach giving rise to termination under this Section&nbsp;12.2.1 (Material Breach) is specific
to any one (1)&nbsp;or more Programs, then the <FONT STYLE="white-space:nowrap">Non-Breaching</FONT> Party&#146;s right to terminate under this Section&nbsp;12.2.1 (Material Breach) shall be limited to such affected Programs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.2.2 <B>Disputes Regarding Material Breach</B>. If the Parties reasonably and in good
faith disagree as to whether there has been a material breach, then the Breaching Party that disputes whether there has been a material breach may contest the allegation in accordance with Article 13 (Governing Law; Dispute Resolution), and the
applicable Cure Period shall be tolled upon the initiation of such dispute resolution procedures. If, as a result of such dispute resolution process, it is finally determined pursuant to Article 13 (Governing Law; Dispute Resolution) that the
Breaching Party committed a material breach of this Agreement, then the applicable Cure Period shall resume and unless such alleged breach was cured during the pendency of such Cure Period (once resumed), this Agreement shall terminate effective as
of the expiration of such Cure Period. This Agreement shall remain in full force and effect during the pendency of any such dispute resolution proceeding and all Cure Periods. Any such dispute resolution proceeding shall not suspend any obligations
of either Party hereunder and each Party shall use reasonable efforts to mitigate any damages. Any payments that are made by one Party to the other Party pursuant to this Agreement pending resolution of the dispute shall be promptly refunded if it
is determined pursuant to Article 13 (Governing Law; Dispute Resolution) that such payments are to be refunded by one Party to the other Party. If, as a result of such dispute resolution proceeding, it is determined that the Breaching Party did not
commit such material breach (or such material breach was cured in accordance with Sections 12.2.1 (Material Breach) or 12.2.2 (Disputes Regarding Material Breach)), then no termination of this Agreement shall be effective, and this Agreement shall
continue in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.2.3 <B>Termination for Insolvency</B>. To the extent permitted by Applicable Laws, either Party may
terminate this Agreement in its entirety upon providing written notice to the other Party on or after the time that such other Party files or institutes a bankruptcy, reorganization, liquidation, or receivership proceeding or upon the appointment of
a receiver or trustee over all or substantially all property of the other Party, or upon an assignment of a substantial portion of the assets of the other Party for the benefit of creditors; provided that in the case of any involuntary bankruptcy
proceeding, such right to terminate shall only become effective if the other Party consents to the involuntary bankruptcy or such proceeding is not dismissed within [***] after the filing thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.2.4 <B>Termination for Patent Challenge</B>. Metagenomi shall have the right, upon written notice to Moderna, to terminate this Agreement
on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis if Moderna directly or indirectly (whether alone, or in concert with or for the benefit of any Third Party) challenges, opposes, seeks to
invalidate or render void or unenforceable any Patent included within the Metagenomi Licensed Collaboration Technology in such Program, through a declaratory judgment, post grant review, inter partes review, or any other action or proceeding, except
to the extent required by Applicable Law, court order or bona fide judicial process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.3 <B>Moderna Option to Continue in Lieu of
Termination</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3.1 <B>Payment Reductions in Lieu of Termination</B>. For a given RT Target or DT Moderna Target (and any related
Program or Licensed Products), with respect to Metagenomi&#146;s material breach of any of its obligations under this Agreement with respect thereto as determined pursuant to Section&nbsp;12.2.1 (Material Breach) (and after completion of the process
set forth in Section&nbsp;12.2.2 (Disputes Regarding Material Breach) if invoked), Moderna shall have the right, at its option and by written notice to Metagenomi, in lieu of exercising its right to terminate this Agreement with respect to such
Collaboration Target under Section&nbsp;12.2.1 (Material Breach), to instead continue this Agreement with respect to such Collaboration Target (and related Program and Licensed Products) in accordance with its terms, and in which case: (a)&nbsp;at
Moderna&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
option, the JSC will coordinate wind-down of Metagenomi&#146;s activities with respect to such RT Program or DT Program, and (b)&nbsp;from and after such time as Moderna delivers such written
notice to Metagenomi, any and all amounts thereafter payable by Moderna for a Licensed Product applicable to such Collaboration Target hereunder (including Milestone Payments and royalties) shall be reduced by fifty percent (50%) (and for clarity,
any floors on any such Milestone Payments and royalties hereunder will also be lowered by fifty percent (50%)). Notwithstanding the foregoing, Moderna&#146;s exercise of its rights under this Section&nbsp;12.3.1 (Payment Reductions in Lieu of
Termination) with respect to a Collaboration Target shall not affect the Parties&#146; respective rights and obligations (including, without limitation, Milestone Payments and royalties) with respect to any other Collaboration Targets (or any
related Program or Licensed Products). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3.2 <B>Profit-share Reduction in Lieu of Termination</B>. For a given DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Target (and related Program and DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products), with respect to Metagenomi&#146;s material breach of any of its obligations under this Agreement with respect thereto
as determined pursuant to Section&nbsp;12.2.1 (Material Breach) (and after completion of the process set forth in Section&nbsp;12.2.2 (Disputes Regarding Material Breach) if invoked), Moderna shall have the right, at its option and by written notice
to Metagenomi, in lieu of exercising its right to terminate this Agreement with respect to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target under Section&nbsp;12.2.1 (Material Breach), to instead continue this Agreement with respect to
such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target (and related Program and DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products) in accordance with its terms, and in which case, Moderna may elect, on a one time basis, by providing a
written notice to Metagenomi, to seek to adjust the Profit and Loss Share for one or more DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target in the Territory and, to fairly
compensate Moderna for the damages arising from such material breach. Moderna will have the right to propose the adjustment, and the Parties will discuss in good faith, and if the Parties cannot mutually agree, then such adjustment shall be resolved
pursuant to Section&nbsp;13.3 (Arbitration). It is understood that such adjustment would provide Moderna with additional share of the net profits (but not more than 75% of the total net profits) for the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, to Moderna, for a period of time as may be appropriate and agreed by the Parties (or pursuant to Section&nbsp;13.3 (Arbitration), as applicable). The profit adjustment may be, with respect to
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, or for the entire Territory, and the adjustment shall not apply to the
sharing of any Development Costs. If Moderna so elects, then this Agreement shall continue to be in force with respect to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target (and related Program and DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products), provided that the foregoing shall not limit any other rights that Moderna may have under this Agreement with respect to Metagenomi&#146;s material breach, including to seek specific
performances pursuant to Section&nbsp;13.5 (Equitable Relief; Remedy for Breach of Exclusivity). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3.3
<B><FONT STYLE="white-space:nowrap">Know-How</FONT> Transfer</B>. Within thirty (30)&nbsp;days following Moderna&#146;s election not to terminate this Agreement under this Section&nbsp;12.3 (Moderna Option to Continue in Lieu of Termination),
Metagenomi shall disclose or deliver to Moderna, to the extent not previously provided, copies of all data and information in Metagenomi&#146;s (or its Affiliates&#146;) possession relating to the applicable Program which is reasonably necessary for
Moderna&#146;s Research, Development or Commercialization of the applicable Products (including for regulatory purposes and to otherwise undertake Program activities that would otherwise have been performed by Metagenomi and regardless of the stage
of any such activities). Upon Moderna&#146;s reasonable request, Metagenomi shall: (a)&nbsp;provide reasonable technical assistance to Moderna during such disclosure or delivery set forth in the preceding sentence; and (b)&nbsp;make its employees
and nonemployee consultants reasonably available at their respective places of employment to consult with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Moderna on issues arising in the course of Moderna&#146;s Research, Development or Commercialization and in connection with any request related to a Product from any Regulatory Authority,
including regulatory, scientific, technical and clinical testing issues. The <FONT STYLE="white-space:nowrap">Know-How</FONT> transfer to be undertaken under this Section&nbsp;12.3 (Moderna Option to Continue in Lieu of Termination) shall be
overseen by a Working Group established for such purposes, which Working Group may put in place a technology transfer plan expressly identifying <FONT STYLE="white-space:nowrap">Know-How</FONT> Controlled by Metagenomi or its Affiliates to be
transferred and the timing for such transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.4 <B>Termination for Convenience by Moderna</B>. Moderna may, at any time in its sole
discretion and without cause, terminate this Agreement with respect to an RT Program or a DT Program upon at least: (a)&nbsp;sixty (60) days&#146; prior written notice to Metagenomi if a First Commercial Sale has not occurred for the Products in
such Program; or (b)&nbsp;one hundred eighty (180)&nbsp;days&#146; prior written notice to Metagenomi if a First Commercial Sale of a Product in such Program has occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.5 <B>Termination for Convenience by Primary Party</B>. Subject to the remainder of this Section&nbsp;12.5 (Termination for Convenience by
Primary Party), the Primary Party may, at any time in its sole discretion and without cause, terminate this Agreement with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program upon at least [***] prior written notice to the <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Party. Upon receiving the written notice from the Primary Party, and within such [***] period, the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party may elect to opt into the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program to continue the Development and Commercialization activities in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program in the Territory by providing written notice to the Primary Party of such
election (&#147;<B><FONT STYLE="white-space:nowrap">Opt-In</FONT></B>,&#148; and such right to <FONT STYLE="white-space:nowrap">Opt-In,</FONT> the &#147;<B><FONT STYLE="white-space:nowrap">Opt-In</FONT> Right</B>&#148;). The exercise by the <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Party of its <FONT STYLE="white-space:nowrap">Opt-In</FONT> Right in accordance with the foregoing sentence shall become effective [***] after the delivery of the written notice to the Primary Party (the
&#147;<B><FONT STYLE="white-space:nowrap">Opt-In</FONT> Date</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.5.1 If the <FONT STYLE="white-space:nowrap">Opt-Out</FONT>
Party exercises its right to <FONT STYLE="white-space:nowrap">Opt-In</FONT> with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program pursuant to this Section&nbsp;12.5 (Termination for Convenience by Primary Party), then
(i)&nbsp;the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program shall not terminate, (ii)&nbsp;from and after the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Date, all rights to lead or manage any of the activities conducted by the Primary
Party as of the proposed date of termination set forth in its written notice to the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party under this Section&nbsp;12.5 (Termination for Convenience by Primary Party) shall be assumed by, and assigned
to, the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party, and (iii)&nbsp;the <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Party shall be referred to as the &#147;<B><FONT STYLE="white-space:nowrap">Opt-In</FONT> Party</B>&#148; hereafter in
this Section&nbsp;12.5 (Termination for Convenience by Primary Party). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.5.2 Subject to Section&nbsp;12.5.3 (Termination for Convenience
by Primary Party), after the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Party exercises the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Right with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program pursuant to this
Section&nbsp;12.5 (Termination for Convenience by Primary Party), (i) the license of the Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program from the <FONT
STYLE="white-space:nowrap">Opt-In</FONT> Party to the Primary Party under Section&nbsp;6.8.2 (Effects of <FONT STYLE="white-space:nowrap">Opt-Out)</FONT> shall immediately terminate as of the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Date, and
the license of the Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program from the Primary Party to the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Party
under Section&nbsp;5.5 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program License) shall immediately become effective again and immediately become exclusive (subject to applicable Antitrust Filings and related government approvals or
clearances, provided that the Parties shall reasonably cooperate with each other in connection with the Antitrust Filings); (ii) the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Party shall have sole authority and be solely responsible for all
Development and Commercialization activities and related costs in the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, provided that in any event Moderna would </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
retain the decision-making power with respect to issues related to CMC Matters, Manufacturing, and the application of Moderna&#146;s technology to any of such activities; (iii)&nbsp;the Parties
shall agree upon a written transition plan (an &#147;<B><FONT STYLE="white-space:nowrap">Opt-In</FONT> Transition Plan</B>&#148;) setting forth all of the wind-down and other activities necessary or reasonably useful to transition all Development,
Commercialization, and Medical Affairs activities, and any accompanying technology transfer activities (including the assignment of any applicable Data Packages), for clarity excluding any transfer of any consulting services with respect to the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program (collectively, the &#147;<B><FONT STYLE="white-space:nowrap">Opt-In</FONT> Transition Activities</B>&#148;); (iv) each Party shall carry out the <FONT STYLE="white-space:nowrap">Opt-In</FONT>
Transition Activities assigned to it in the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Transition Plan and be responsible for its own costs with respect to such <FONT STYLE="white-space:nowrap">Opt-In</FONT> Transition Activities; (v)&nbsp;the
Primary Party shall assign and transfer (where applicable) to the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Party all Regulatory Documentations specific to all DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program, and shall grant the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Party a right of reference to all other Regulatory Documentations with respect to such DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Products necessary for the further Development and Commercialization thereof, in each case subject to Moderna retaining <FONT STYLE="white-space:nowrap">CMC-related</FONT> components of such Regulatory
Documentations and all other Moderna&#146;s Confidential Information related to CMC Matters, as set forth in the applicable <FONT STYLE="white-space:nowrap">Opt-In</FONT> Transition Plan; and (vi)&nbsp;each Party shall submit to the applicable
Regulatory Authority any filings, letters, and other Regulatory Filings and documentation necessary to effect such assignment and transfer as soon as practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.5.3 Notwithstanding the foregoing provisions of this Section&nbsp;12.5 (Termination for Convenience by Primary Party), after Metagenomi
exercises its <FONT STYLE="white-space:nowrap">Opt-In</FONT> Right with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program pursuant to this Section&nbsp;12.5 (Termination for Convenience by Primary Party), (i) the license of the
Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program from Metagenomi to Moderna under Section&nbsp;6.8.2(b) (Effects of <FONT
STYLE="white-space:nowrap">Opt-Out)</FONT> shall become <FONT STYLE="white-space:nowrap">co-exclusive</FONT> but Moderna shall only practice its rights under the <FONT STYLE="white-space:nowrap">co-exclusively</FONT> licensed Metagenomi Licensed DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Technology to perform its obligations pursuant to Section&nbsp;5.23 (Manufacture), and (ii)&nbsp;the license of the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology with respect to
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program from Moderna to Metagenomi under Section&nbsp;5.5 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program License) shall become effective again and immediately become <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> after DC Nomination with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product nominated in such DC Nomination, provided that (A)&nbsp;Metagenomi may only keep Exploiting Moderna
Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology being Exploited by Metagenomi as of Metagenomi&#146;s prior <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Date, and the Exploitation of any other Moderna Licensed DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Technology shall be subject to Moderna&#146;s express prior written consent, and (B)&nbsp;Metagenomi may only Exploit <FONT STYLE="white-space:nowrap">mRNA-LNP</FONT> Technology of Moderna or any of its
Affiliates and not of any Third Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.5.4 Notwithstanding anything herein to the contrary, in the event Moderna exercises its <FONT
STYLE="white-space:nowrap">Opt-In</FONT> Right pursuant to this Section&nbsp;12.5 (Termination for Convenience by Primary Party), the JSC and its subcommittees, except to the extent required by the <FONT STYLE="white-space:nowrap">Opt-In</FONT>
Transition Plan to facilitate the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Transition Activities, shall immediately disband, for clarity, solely with respect to such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.5.5 Notwithstanding anything herein to the contrary, in the event Metagenomi exercises its <FONT STYLE="white-space:nowrap">Opt-In</FONT>
Right pursuant to this Section&nbsp;12.5 (Termination for Convenience by Primary Party), then Section&nbsp;6.5.1(c) (CMC Matters) and Section&nbsp;5.23 (Manufacture) shall remain in force. After Metagenomi has exercised such <FONT
STYLE="white-space:nowrap">Opt-In</FONT> Right, the Parties will use Commercially Reasonable Efforts to negotiate and enter a supply agreement and a quality agreement covering the supply of Candidates and Products for Research, Development, and
Commercialization, as applicable, for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.5.6 Notwithstanding anything herein to the contrary, in the event Metagenomi exercises
its <FONT STYLE="white-space:nowrap">Opt-In</FONT> Right pursuant to this Section&nbsp;12.5 (Termination for Convenience by Primary Party), if not previously prepared and filed, Moderna will, at Metagenomi&#146;s written request, prepare and file
with Regulatory Authorities in jurisdictions where Metagenomi is seeking Regulatory Approval of a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, a DMF containing required CMC information for such DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product&#146;s Regulatory Approval. Metagenomi and its Affiliates may refer to such DMF in any Regulatory Filing made in connection with obtaining or maintaining a Regulatory Approval for such DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product. Moderna will, on written request by Metagenomi or its Affiliate, provide to such requesting party and to any specified Regulatory Authority a letter, in the form reasonably required by such requesting
party, acknowledging that the requesting party has a right of reference to any such DMF. Notwithstanding that the foregoing provisions of this Section&nbsp;12.5.6 (Termination for Convenience by Primary Party) provide the mechanism for Regulatory
Authorities to have required access to Moderna&#146;s CMC information, in the event that the procedures set forth in the foregoing provisions of this Section&nbsp;12.5.6 (Termination for Convenience by Primary Party) are not available in a
particular country or are not sufficient to satisfy a Regulatory Authority&#146;s requirements, at Metagenomi&#146;s request, the Parties will discuss such requirements and use Commercially Reasonable Efforts to secure agreement from the Regulatory
Authority for it to receive required access to all necessary CMC information directly from Moderna in a manner that minimizes the disclosure of such CMC information and protects the confidential and proprietary nature of such CMC information.
Notwithstanding the foregoing provisions of this Section&nbsp;12.5.6 (Termination for Convenience by Primary Party), Moderna shall have no obligation to comply with Metagenomi&#146;s or its Affiliates&#146; written request that Moderna prepare and
file a DMF with, or otherwise provide CMC information to, any Regulatory Authority in any jurisdiction with respect to which Moderna has a material concern regarding the protection of its intellectual property rights in connection with any
Regulatory Filing or otherwise seeking or maintaining any Regulatory Approval in such jurisdiction, and upon written request by Moderna, Metagenomi shall, and shall cause its Affiliates and its and their Sublicensees to, refrain from preparing or
submitting any Regulatory Filing, or otherwise obtaining or maintaining any Regulatory Approval, for any DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in such jurisdictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.6 <B>Effects of Termination</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.6.1 <B>Effects of termination generally</B>. Subject to the remainder of this Section&nbsp;12.6 (Effects of Termination), upon termination
of this Agreement with respect to a Program, with respect to Products within such Program, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Product</FONT></FONT> basis: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Licenses</B>. All licenses granted hereunder with respect to such Product will terminate; provided <I>that</I> such licenses will
continue as necessary for the Parties to complete the orderly wind-down of their activities under this Agreement in accordance with Applicable Law and as otherwise required in accordance with Section&nbsp;12.6.1(b) (Wind Down). With the exception of
such wind-down activities, each Party shall immediately cease and shall cause its Affiliates, Sublicensees and contractors, each as applicable, to immediately cease, all Research, Development, Manufacturing and Commercialization activities with
respect to such Product. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Wind-Down</B>. Promptly following receipt by the applicable Party of a notice of
termination under Section&nbsp;12.2 (Termination for Material Breach or Insolvency or Patent Challenge) or Section&nbsp;12.4 (Termination for Convenience by Moderna) or Section&nbsp;12.5 (Termination for Convenience by Primary Party) if the <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Party does not exercise the <FONT STYLE="white-space:nowrap">Opt-In</FONT> Right, the Parties will begin to wind-down their respective activities under this Agreement with respect to such Product. The
Parties will establish an appropriate Working Group to coordinate such wind-down. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <B>Destruction of Confidential Information</B>.
Each Receiving Party shall destroy (at the Disclosing Party&#146;s written request) all such Confidential Information of the Receiving Party in its possession as of the effective date of expiration or termination (with the exception of one copy of
such Confidential Information, which may be retained by the legal department of the Receiving Party to confirm compliance with the <FONT STYLE="white-space:nowrap">non-use</FONT> and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> provisions
of this Agreement), and any Confidential Information of the Disclosing Party contained in its laboratory notebooks or databases, provided that each Receiving Party may retain and continue to use such Confidential Information of the Disclosing Party
to the extent necessary to exercise any surviving rights, licenses or obligations under this Agreement. Notwithstanding the foregoing, a Receiving Party shall not be required to destroy any computer files created during automatic system back up that
are subsequently stored securely by it and not readily accessible to its employees, consultants, or others who received the Disclosing Party&#146;s Confidential Information under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.6.2 <B>Reversion</B>. Upon termination of this Agreement with respect to a Program by Metagenomi under Section&nbsp;12.2.1 (Material
Breach), with respect to any Product within such Program impacted by Moderna&#146;s material breach (a &#147;<B>Reversion Product</B>&#148;), the following will occur: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) any licenses and rights granted by Metagenomi to Moderna with respect to the Reversion Product shall revert to Metagenomi, provided that
such licenses and rights will continue as necessary as otherwise required under this Section&nbsp;12.6.2 (Reversion); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) in the case
the Reversion Product is a DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product, [***]; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) effective on the effective date of
termination for such Reversion Product, Moderna hereby assigns to Metagenomi or its designee all Regulatory Filings (except DMFs), Regulatory Approvals, Pricing and Reimbursement Approvals, copies of material correspondence and conversation logs, <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> and clinical study reports, clinical study protocols, and all data (in the format in which is maintained by Moderna), in each case, that are related to the Reversion Product and Controlled by Moderna or
its Affiliates as of the effective date of termination. Moderna shall take all steps necessary to transfer to Metagenomi or its designee ownership of all such assigned Regulatory Filings (except DMFs), Regulatory Approvals and Pricing and
Reimbursement Approvals, including submitting to each applicable Regulatory Authority a letter or other necessary documentation (with a copy to Metagenomi) notifying such Regulatory Authority of the transfer of such ownership of each Regulatory
Filing, Regulatory </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Approval and Pricing and Reimbursement Approval. If it is not feasible under Applicable Laws for Moderna to transfer to Metagenomi any such Regulatory Filings, Regulatory Approvals, and Pricing
and Reimbursement Approvals, Moderna shall hold such Regulatory Filings, Regulatory Approvals, and Pricing and Reimbursement Approvals in its name for the benefit of Metagenomi and shall grant, and hereby does grant to Metagenomi an exclusive,
royalty-free license and right of reference to use such Regulatory Filings, Regulatory Approvals, and Pricing and Reimbursement Approvals in connection with Exploitation of the Reversion Product and authorize Metagenomi or its designee to conduct
regulatory activities with appliable Regulatory Authorities relating to such Regulatory Filings, Regulatory Approvals, and Pricing and Reimbursement Approvals; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Moderna shall be entitled, during the [***] following the effective date of termination of this Agreement with respect to a Reversion
Product, to finish any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">work-in-progress</FONT></FONT> and to sell any inventory of such Reversion Product and shall pay Metagenomi the amounts applicable to such sales of such
Reversion Product in accordance with the terms and conditions of this Agreement. Thereafter, Moderna shall cease selling any such Reversion Product, and Metagenomi shall have the right, in its sole discretion and upon written notification to
Moderna, to purchase from Moderna any or all of the inventory of such Reversion Product held by Moderna as of the date of such notice at a price equal to Moderna&#146;s Manufacturing Costs for such Reversion Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.6.3 <B>Conduct During Termination Notice Period</B>. Following any notice of termination permitted under this Article 12 (Term&nbsp;&amp;
Termination) other than any termination pursuant to Section&nbsp;12.2.1 (Material Breach), during any applicable termination notice period (the applicable &#147;<B>Termination Notice Period</B>&#148;), each Party shall continue to perform all of its
obligations under this Agreement then in effect in accordance with the terms and conditions of this Agreement. In such circumstances, each Party shall also continue to bear its share of all applicable costs incurred during the Termination Notice
Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.6.4 <B>Transition Agreement</B>. In connection with the termination of this Agreement, the Parties shall enter into a written
agreement (the &#147;<B>Transition Agreement</B>&#148;) that would include other reasonable terms and conditions, including terms allocating costs and expenses, describing the Parties&#146; indemnification obligations, setting forth the
Parties&#146; obligations with respect to unauthorized sales, and setting forth other coordination obligations. If, despite such efforts, the Parties are unable to agree upon such terms and conditions within [***] from the effective date of the
termination, either Party may refer the dispute for resolution by arbitration in accordance with Article 13 (Governing Law; Dispute Resolution), and the arbitrator shall have the authority to require the Parties to execute a Transition Agreement in
the form approved by the arbitrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.6.5 <B>Sublicense Survival</B>. Any permitted sublicense granted by a Party or its Affiliate to a
Third Party under the licenses granted to such Party under this Agreement shall survive the termination of this Agreement; provided that, in the case where termination of this Agreement for such Party&#146;s uncured material breach pursuant to
Section&nbsp;12.2.1 (Material Breach), such Sublicensee did not cause such uncured material breach. If permitted under such a surviving sublicense, effective upon termination of this Agreement, such sublicense shall become a direct license from
Metagenomi to such Sublicensee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.7 <B>Survival</B>. Expiration or termination of this Agreement shall not relieve the
Parties of any obligation or right accruing prior to such expiration or termination. Except as set forth below or elsewhere in this Agreement, the obligations and rights of the Parties under the following provisions of this Agreement shall survive
expiration or termination of this Agreement: Article 1 (Definitions) (to the extent the definitions are used in surviving provisions); Sections 3.7.1 (Records), 3.7.3 (Ownership; Confidentiality), 4.8.1 (Records), and 4.8.3 (Ownership;
Confidentiality); the second and third last sentences of Section&nbsp;5.18 (Collaboration Materials Transfer); Sections 5.19 (No Other Rights and Retained Rights), 5.25 (Payments); 7.6 (Accounting; Audit), 7.7 (Disputed Payments), 7.13(Method of
Payment; Foreign Exchange), 7.14 (Records and Audits), 7.15 (Default Interest), 7.16 (Taxes), 8.1 (Ownership of Intellectual Property), 8.2.1 (Generally), 8.3.2 (Generally), 8.7 (Common Interest), 8.8 (Trademarks), and 9.6 (Disclaimer); Articles 10
(Indemnification) and 11 (Confidentiality); Sections 12.6 (Effects of Termination), 12.7 (Survival), and 12.8 (Bankruptcy Code); Article 13 (Governing Law; Dispute Resolution); and Sections 14.1 (Entire Agreement; Amendment), 14.2 (Limitation of
Liability), 14.3 (Independent Contractors), 14.4 (Notices), 14.5 (Severability), 14.6 <FONT STYLE="white-space:nowrap">(Non-Use</FONT> of Names), 14.13 (Waivers), 14.15 (Interpretation), 14.18 (No Third Party Beneficiary Rights), 14.19
(Construction), 14.20 (Cumulative Remedies), 14.21 (Extension to Affiliates), and 14.22 (Other Activities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.8 <B>Bankruptcy Code</B>.
If this Agreement is rejected by a Party as a debtor under Section&nbsp;365 of the U.S. Bankruptcy Code or similar provision in the bankruptcy laws of another jurisdiction (the &#147;<B>Code</B>&#148;), then, notwithstanding anything else in this
Agreement to the contrary, all licenses and rights to licenses granted under or pursuant to this Agreement by the Party in bankruptcy to the other Party are, and shall otherwise be deemed to be, for purposes of Section&nbsp;365(n) of the Code (or
similar provision in the bankruptcy laws of the jurisdiction), licenses of rights to &#147;intellectual property&#148; as defined under Section&nbsp;101(35A) of the Code (or similar provision in the bankruptcy laws of another applicable
jurisdiction). The Parties agree that a Party that is a licensee of rights under this Agreement shall retain and may fully exercise all of its rights and elections under the Code, and that upon commencement of a bankruptcy proceeding by or against a
Party under the Code, the other Party shall be entitled to a complete duplicate of, or complete access to (as such other Party deems appropriate), any such intellectual property and all embodiments of such intellectual property, if not already in
such other Party&#146;s possession, shall be promptly delivered to such other Party: (a)&nbsp;upon any such commencement of a bankruptcy proceeding upon written request therefor by such other Party, unless the bankrupt Party elects to continue to
perform all of its obligations under this Agreement; or (b)&nbsp;if not delivered under the foregoing clause (a), upon the rejection of this Agreement by or on behalf of the bankrupt Party upon written request therefor by the other Party. The
foregoing provisions of this Section&nbsp;12.8 (Bankruptcy Code) are without prejudice to any rights a Party may have arising under the Code. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 13 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B>GOVERNING LAW; DISPUTE RESOLUTION</B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.1 <B>Governing Laws</B>. This Agreement is governed by and shall be construed in accordance with the laws of the State of New York, without
reference to its conflict of laws principles. The United Nations Convention of International Contracts on the Sale of Goods (the Vienna Convention) does not apply to this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.2 <B>Disputes</B>. The Parties recognize that controversies or claims arising out of,
relating to, or in connection with this Agreement may arise from time to time. It is the objective of the Parties to establish procedures to facilitate the resolution of disputes in an expedient manner by mutual cooperation and without resort to
litigation. To accomplish this objective, the Parties shall follow the procedures set forth in this Article 13 (Governing Law; Dispute Resolution) to resolve any dispute. If any dispute, claim or controversy of any nature arising out of or relating
to this Agreement, including any action or claim based on tort, contract or statute, or concerning the interpretation, effect, termination, validity, performance or breach of this Agreement (each, a &#147;<B>Dispute</B>&#148;), arises between the
Parties, either Party may refer the Dispute to Executive Officers of each Party for resolution within [***] of a written request by either Party to the other Party. Each Party, within [***] after a Party has received such written request from the
other Party to so refer such Dispute, shall notify the other Party in writing of the Executive Officer to whom such Dispute is referred. If, after an additional [***] after the notice of Dispute, such Executive Officers have not succeeded in
negotiating a resolution of the Dispute, and a Party wishes to pursue the matter, each such Dispute, controversy or claim that is not an &#147;Excluded Claim&#148; (defined in Section&nbsp;13.6 (Excluded Claims)) shall be submitted for binding
arbitration administered by the International Chamber of Commerce (&#147;<B>ICC</B>&#148;) pursuant to its Arbitration Rules in effect at the time such Dispute arises (the &#147;<B>ICC Arbitration Rules</B>&#148;). The option to arbitrate under this
Article 13 (Governing Law; Dispute Resolution) shall extend to any claims by or against the Parties and their respective Affiliates and any agents, principals, officers, directors, or employees of either of the Parties or their respective
Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.3 <B>Arbitration</B>. Any arbitration that the Parties decide to pursue shall be conducted by a single neutral arbitrator
experienced in the business of pharmaceuticals. If the issues in dispute involve scientific, technical or commercial matters, the arbitrator chosen hereunder may engage experts that have educational training or industry experience sufficient to
demonstrate a reasonable level of relevant scientific, medical and industry knowledge, as necessary to help resolve the dispute. The Parties shall select the arbitrator promptly following the initiation of the arbitration. If the Parties are unable
or fail to agree upon the arbitrator within [***] following the initiation of arbitration, the arbitrator shall be appointed by ICC. The arbitration shall be conducted in New York, New York, and all proceedings and communications shall be in
English. Except to the extent necessary to enforce a legal right or as may be required by law, neither a Party nor an arbitrator may disclose the existence, content, or results of an arbitration without the prior written consent of both Parties.
Each Party shall bear its own costs and expenses and attorneys&#146; fees and an equal share of the arbitrator&#146;s fees and any administrative fees of arbitration. Any arbitration findings or rulings made under this Section&nbsp;13.3
(Arbitration) shall be final and binding on the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.4 <B>Baseball Arbitration</B>. Any Disputes over any amounts invoiced under
this Agreement, Disputes over matters set forth in Sections 2.10.2 (Decision-making for DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans), 5.10.3(b) (Payments under <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT
STYLE="white-space:nowrap">In-License</FONT> Agreements), 5.10.4(b) (Payments under <FONT STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements) and 12.6.2(b) (Reversion), shall be submitted
to and finally resolved by the following provisions in this Section&nbsp;13.4 (Baseball Arbitration). The Parties shall promptly designate in writing a single mutually acceptable arbitrator experienced in the licensing, development, and
commercialization of pharmaceutical products, who is independent of each Party (i.e., not a current or former employee, consultant, officer, or director or current stockholder of either Party or their respective Affiliates and who does not otherwise
have any current or previous business relationship with either Party or their respective Affiliates). If the Parties cannot agree on an arbitrator within [***] after referral of such matter, the arbitrator shall be selected by the President of
Greater Boston Chamber of Commerce. The arbitration shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be conducted in accordance with the ICC Arbitration Rules to the extent consistent with this Section&nbsp;13.4 (Baseball Arbitration). Within [***] of the arbitrator&#146;s appointment, each
Party shall prepare and deliver to both the arbitrator and the other Party its last, best offer for the applicable unresolved terms and a memorandum in support thereof. The Parties shall also provide the arbitrator with a copy of the relevant
provisions of this Agreement. Each Party may submit to the arbitrator (with a copy to the other Party) a rebuttal to the other Party&#146;s support memorandum and shall at such time have the opportunity to amend its last such offer based on any new
information contained in the other Party&#146;s support memorandum. Within [***] after the arbitrator&#146;s appointment, the arbitrator shall select from the two (2)&nbsp;proposals provided by the Parties the proposal such arbitrator believes is
the most consistent with the intent of the Parties when this Agreement was entered into provided the arbitrator may not alter the terms of this Agreement. The decision of the arbitrator shall be final and binding on the Parties. The foregoing
&#147;baseball-style&#148; arbitration shall be the exclusive remedy of either Party if the Parties cannot agree on any Disputes over any amounts invoiced under this Agreement, or Disputes over matters set forth in Sections 2.10.2 (Decision-making
for DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Plans), 5.10.3(b) (Payments under <FONT STYLE="white-space:nowrap">Co-Co</FONT> Moderna <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements), 5.10.4(b) (Payments under <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Metagenomi <FONT STYLE="white-space:nowrap">In-License</FONT> Agreements) and 12.6.2(b) (Reversion). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.5 <B>Equitable Relief; Remedy for Breach of Exclusivity</B>. Nothing in this Article 13 (Governing Law; Dispute Resolution) shall preclude
either Party from seeking equitable relief or interim or provisional relief from a court of competent jurisdiction, including a temporary restraining order, preliminary injunction or other interim equitable relief, concerning a dispute either prior
to or during any arbitration if necessary to protect the interests of such Party or to preserve the status quo pending the arbitration proceeding. Therefore, in addition to its rights and remedies otherwise available at law, including the recovery
of damages for breach of this Agreement, such <FONT STYLE="white-space:nowrap">Non-Breaching</FONT> Party shall be entitled to seek (a)&nbsp;equitable relief, specifically including, but not limited to, both interim and permanent restraining orders
and injunctions and (b)&nbsp;such other and further equitable relief as the court may deem proper under the circumstances. Any final judgment resolving a Dispute may be enforced by either Party in any court having appropriate jurisdiction. For the
avoidance of doubt, nothing in this Section&nbsp;13.5 (Equitable Relief; Remedy for Breach of Exclusivity) shall otherwise limit a Breaching Party&#146;s opportunity to cure a material breach as permitted in accordance with Section&nbsp;12.2.1
(Material Breach). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.6 <B>Excluded Claims</B>. As used in this Article 13 (Governing Law; Dispute Resolution), the term
&#147;<B>Excluded Claim</B>&#148; means any dispute, controversy or claim that concerns: (a)&nbsp;the validity, enforceability or infringement of any patent, trademark or copyright; or (b)&nbsp;any antitrust, antimonopoly or competition law or
regulation, whether or not statutory. Any Excluded Claim may be submitted by either Party to any court of competent jurisdiction over such Excluded Claim. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 14 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.1
<B>Entire Agreement; Amendment</B>. This Agreement, including the Schedules hereto, sets forth the complete, final and exclusive agreement and all the covenants, promises, agreements, warranties, representations, conditions and understandings
between the Parties hereto along with the Convertible Note Instruments, with respect to the subject matter hereof and supersedes, as of the Effective Date, all prior and contemporaneous agreements and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
understandings between the Parties with respect to the subject matter hereof, including the Mutual Confidentiality Agreement. The Parties hereby agree to terminate the Mutual Confidentiality
Agreement as of the Effective Date, and that all confidential information that was disclosed by the Parties pursuant to the Mutual Confidentiality Agreement shall be deemed Confidential Information disclosed under, and subject to, the terms and
conditions of this Agreement. The foregoing may not be interpreted as a waiver of any remedies available to either Party as a result of any breach, prior to the Effective Date, by the other Party of its obligations under the Mutual Confidentiality
Agreement. No subsequent alteration, amendment, change or addition to this Agreement shall be binding upon the Parties unless reduced to writing and signed by an authorized officer of each Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Limitation of Liability</B>. TO THE EXTENT PERMITTED BY APPLICABLE LAW, NEITHER PARTY MAY RECOVER FROM THE
OTHER PARTY ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES; PROVIDED, HOWEVER, THAT THIS SECTION 14.2 (LIMITATION OF LIABILITY) SHALL NOT BE
CONSTRUED TO LIMIT EITHER PARTY&#146;S INDEMNIFICATION OBLIGATIONS UNDER ARTICLE 10 (INDEMNIFICATION), METAGENOMI&#146;S LIABILITY IN CONNECTION WITH A BREACH OF ITS EXCLUSIVITY OBLIGATIONS UNDER SECTIONS 5.20 (RT EXCLUSIVITY), 5.21 (DT EXCLUSIVITY)
OR 5.22 (DT <FONT STYLE="white-space:nowrap">CO-CO</FONT> TARGET EXCLUSIVITY), MODERNA&#146;S LIABILITY IN CONNECTION WITH A BREACH OF ITS EXCLUSIVITY OBLIGATIONS UNDER SECTION 5.22 (DT COCO TARGET EXCLUSIVITY), OR EITHER PARTY FROM ITS LIABILITY
FOR ANY DAMAGES BASED UPON SUCH PARTY&#146;S BREACH OF ITS OBLIGATIONS UNDER ARTICLE 11 (CONFIDENTIALITY). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Independent Contractors</B>. The relationship between Moderna and Metagenomi created under this Agreement is
solely that of independent contractors. This Agreement does not create any agency, distributorship, employee-employer, partnership, joint venture or similar business relationship between the Parties. Neither Party is a legal representative of the
other Party, and neither Party can assume or create any obligation, representation, warranty, or guarantee, express or implied, on behalf of the other Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Notice</B>. Any notice required or permitted to be given under this Agreement must be in writing, in English.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder must be in writing and shall be deemed given and effective if: (a)&nbsp;delivered by hand or by overnight courier with tracking capabilities;
(b)&nbsp;mailed postage prepaid by first class, registered, or certified mail; or (c)&nbsp;delivered by facsimile or electronic mail followed by delivery via either of the methods set forth in clauses (a)&nbsp;and (b) of this Section&nbsp;14.4
(Notice), in each case, addressed as set forth below unless changed by notice so given: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">If&nbsp;to&nbsp;Metagenomi:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1545 Park Avenue </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Emeryville, CA 94608 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attn: Jian Irish </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">E-mail:</FONT> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">with a copy (which shall not constitute notice) to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1545 Park Avenue, </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Emeryville, CA 94608 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attn: Legal Department </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">E-mail:</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">If&nbsp;to&nbsp;Moderna:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ModernaTX, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">200 Technology Square </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Cambridge, MA 02139 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attn: General Counsel </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">E-mail:</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">with a copy (which shall not constitute notice) to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ModernaTX, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">200 Technology Square </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Cambridge, MA 02139 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attn: Shaun Ryan </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="18%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">E-mail:</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Party shall also provide a copy of any notice (via <FONT STYLE="white-space:nowrap">e-mail</FONT> if available) to the other Party&#146;s
Alliance Manager. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.5 <B>Severability</B>. If, for any reason, any part of this Agreement is adjudicated invalid, unenforceable, or
illegal by a court of competent jurisdiction, such adjudication shall not, to the extent feasible, affect or impair, in whole or in part, the validity, enforceability, or legality of any remaining portions of this Agreement. All remaining portions
shall remain in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.6 <B><FONT STYLE="white-space:nowrap">Non-Use</FONT> of Names</B>. Metagenomi shall not use the
name, trademark, logo, or physical likeness of Moderna or its respective officers, directors or employees, or any adaptation of any of them, in any advertising, promotional or sales literature, without Moderna&#146;s prior written consent.
Metagenomi shall require its Affiliates to comply with the foregoing. Moderna shall not use the name, trademark, logo, or physical likeness of Metagenomi or its officers, directors or employees, or any adaptation of any of them, in any advertising,
promotional or sales literature, without Metagenomi&#146;s prior written consent. Moderna shall require its Affiliates and Sublicensees to comply with the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.7 <B>Assignment</B>. Neither Party may assign or transfer this Agreement or any rights or obligations hereunder without the prior written
consent of the other, except that a Party may make such an assignment or transfer without the other Party&#146;s consent to: (a)&nbsp;its Affiliate, provided that such Party shall remain primarily liable for any acts or omissions of such Affiliate;
or (b)&nbsp;to an Acquirer in connection with a Change of Control, subject to Section&nbsp;14.9 (Metagenomi Change of Control). Any permitted assignee shall, in writing to the <FONT STYLE="white-space:nowrap">non-assigning</FONT> Party, expressly
assume performance of such assigning Party&#146;s rights and obligations. Any permitted assignment is binding on the successors of the assigning Party. Any assignment or attempted assignment by either Party in violation of the terms of this
Section&nbsp;14.7 (Assignment) is null, void and of no legal effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.8 <B>Acquisition of Existing Competing Programs</B>. If, after the Effective Date, any
Third Party becomes an Affiliate of a Party that such Party controls (as such term is defined in the definition of &#147;Affiliate&#148;, and for clarity, excluding a New Affiliate) as a result of a merger, acquisition, consolidation, asset sale, or
other similar transaction (whether in a single transaction or series of related transactions), and, as of the closing date of such transaction, such Third Party is engaged in (a)&nbsp;the Development or Commercialization of any compound or product;
or (b)&nbsp;the licensing, conveyance, sublicensing or other grant of rights in Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> with respect to such any compound or product, in each case of (a)&nbsp;and (b) that would, if conducted by
such Party, cause such Party to breach its exclusivity obligations set forth in Section&nbsp;5.20 (RT Exclusivity), Section&nbsp;5.21 (DT Exclusivity), Section&nbsp;5.22 (DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target Exclusivity) (any such
activities in (a)&nbsp;and (b), a &#147;<B>Competing Program</B>&#148;), then continuation of the relevant Competing Program shall not be a breach of this Agreement provided that such Party provides the other Party with written notice of such
transaction promptly, but no later than [***] following the earlier of the first public announcement of such transaction or the execution of a definitive agreement relating to such transaction (if such disclosure is not prohibited under Applicable
Laws), and such Party does (or causes such Affiliate to), within [***] after the closing of such transaction, with mutual agreement with the other Party, either: (i)&nbsp;complete a Divestiture of such Competing Program; (ii)&nbsp;cease and
terminate the Competing Program, subject to any commercially reasonable wind-down provisions, including with respect to Clinical Trials; or (iii)&nbsp;offer to include the Competing Program into this Agreement; provided that the actions in clauses
(i) &#150; (iii) will not have to occur if such Third Party has <FONT STYLE="white-space:nowrap">pre-existing</FONT> license or contractual obligation that would prohibit the Third Party from taking the actions in clauses (i) &#150; (iii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.9 <B>Metagenomi Change of Control</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.9.1 <B>Notification of Change of Control</B>. If Metagenomi undergoes a Change of Control at any time before expiry of the Research Term,
Metagenomi shall provide Moderna with written notice of such Change of Control of Metagenomi promptly, but no later than [***] following the earlier of the first public announcement of such Change of Control or the execution of a definitive
agreement relating to such Change of Control (if such disclosure is not prohibited under Applicable Law or by the terms of any written agreement between Metagenomi and any Third Party), which notice shall describe in reasonable detail the nature of
the transaction and the identity of the Acquirer (a &#147;<B>Change of Control Notice</B>&#148;). If Metagenomi undergoes such a Change of Control, then Section&nbsp;14.9.2 (Effects of Change of Control) shall apply. For the avoidance of doubt, a
Change of Control of Metagenomi shall not in any way limit or alter Moderna&#146;s rights in accordance with Section&nbsp;12.3 (Moderna Option to Continue in Lieu of Termination). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.9.2 <B>Effects of Change of Control</B>. On a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis, following a Change of Control of Metagenomi at any time before expiry of the Research Term for such Program, Moderna may elect, at its sole
discretion, whether the Research Transfer Scenario (in subsection (a)&nbsp;below) or the Research Continuance Scenario (in subsection (b)&nbsp;below) shall apply to such Change of Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B>Research Transfer Scenario</B>. The &#147;<B>Research Transfer Scenario</B>&#148; means that Metagenomi shall, on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis, transfer to Moderna all ongoing Research and Development activities (including the data and results for such Program), if any, being conducted by or
on behalf of Metagenomi or any of its Affiliates, or if no Research or Development activities remain ongoing at the time of such Change of Control, the following shall apply: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) Metagenomi shall promptly disclose or deliver to Moderna, to the extent not previously
provided, copies of all data, results, and information in Metagenomi&#146;s (or its Affiliates&#146;) possession constituting <FONT STYLE="white-space:nowrap">Know-How</FONT> included in the Metagenomi Licensed Collaboration Technology, which is
reasonably necessary or useful for Moderna&#146;s Exploitation of the Candidates and the Products (including for regulatory purposes) in such Program, and upon Moderna&#146;s reasonable request and at Moderna&#146;s expense, Metagenomi will:
(A)&nbsp;provide reasonable technical assistance to Moderna during such disclosure or delivery set forth in the preceding sentence for a period not longer than [***]; and (B)&nbsp;make its employees and
<FONT STYLE="white-space:nowrap">non-employee</FONT> consultants reasonably available at their respective places of employment to consult with Moderna on issues arising in the course of Moderna&#146;s Exploitation or in connection with any request
related to a Product from any Regulatory Authority, including regulatory, scientific, technical and clinical testing issues, preparation and submission of Regulatory Filings, and assistance in responding to requests from Regulatory Authorities (the
&#147;<B><FONT STYLE="white-space:nowrap">Know-How</FONT> Transfer</B>&#148;). The <FONT STYLE="white-space:nowrap">Know-How</FONT> Transfer to be undertaken under the foregoing shall be overseen by a Working Group established for such purposes,
which Working Group may put in place a transfer plan expressly identifying <FONT STYLE="white-space:nowrap">Know-How</FONT> owned or Controlled by Metagenomi or its Affiliates to be transferred and the timing for such transfer; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) the JSC shall be immediately disbanded, and all approval rights of the JSC, or final decision making authority granted to a Party
pursuant to this Agreement, shall become approval rights of the corresponding Party (<I>i.e.</I>, mutual agreement by the Parties or final decision making authority by a Party). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B>Research Continuance Scenario</B>. The &#147;<B>Research Continuance Scenario</B>&#148; means, on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis, that Metagenomi shall continue the Research and other activities, if any, being conducted under the applicable Program Plan, and the Program and this Agreement shall continue in the
same manner as prior to the Change of Control, and in which case: (i)&nbsp;Moderna will maintain all of its rights under this Agreement; and (ii)&nbsp;Metagenomi shall continue to comply with its diligence obligations hereunder, with the same level
of diligence applied to such activities after the consummation of such Change of Control as compared to prior to the consummation of such Change of Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.10 <B>Acquirer Engaged in Competing Program</B>. On a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Program-by-Program</FONT></FONT> basis, if a Party undergoes a Change of Control at any time before expiry of the Term for such Program and, as of the closing date of such Change of
Control transaction or thereafter, the Acquirer (or any of its Affiliates) is engaged in a Competing Program, then such Party shall implement (as of the closing of such transaction or the engagement in the Competing Program, if later than the
closing of such transaction) and enforce Firewalls for the duration of the Firewall Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.11 <B>Firewalled Programs</B>. Promptly
following the first to occur of any of the following events in relation to an Acquirer of a Party during the Term: (a)&nbsp;the effective date of a Change of Control of such Party to an Acquirer with a Competing Program, or (b)&nbsp;DC Nomination
(if applicable), in either case (a)&nbsp;or (b) that results in the Acquirer&#146;s program with respect to the applicable Collaboration Target becoming a Competing Program, or (c)&nbsp;the initiation of a Competing Program by an Acquirer of such
Party (each of (a), (b), and (c), with respect to such Competing Program, the &#147;<B>Firewall Event</B>&#148;), such Party shall implement and enforce Firewalls between the applicable Program and the Competing Program for the duration of the
applicable Firewall Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.12 <B>Firewall Audits</B>. In the event a Party is obligated to implement and enforce
Firewalls under this Agreement, the other Party shall have the right, through a designated Third Party auditor reasonably acceptable to such Party, to audit such Party&#146;s (and, as applicable, its Affiliates&#146;) obligations under this
Agreement regarding implementation and enforcement of such Firewalls for purposes of confirming compliance with the Firewalls, identifying any vulnerabilities or breaches and requiring such Party (or its Affiliates) to promptly remediate any <FONT
STYLE="white-space:nowrap">non-compliance</FONT> identified by such audit. In connection with such audit, duly authorized representatives of the other Party&#146;s designated auditor may make an <FONT STYLE="white-space:nowrap">on-site</FONT> visit
to such Party (or its Affiliate) for the purpose of conducting such audit. The other Party may conduct such audits from time to time as reasonably necessary to confirm such Party&#146;s compliance with such Firewall requirements no more than [***]
or more frequently if the other Party reasonably believes at any time that such Party is not in compliance with such Firewall requirements; provided that if the auditor identifies a breach of the Firewall, the other Party will be entitled to up to
[***] additional audits within the same Calendar Year to verify that appropriate action has been taken to remedy the breach of the Firewall. Any audits described under this Section&nbsp;14.12 (Firewall Audits) shall be conducted during such
Party&#146;s regular business hours, for a duration only as reasonably necessary to confirm such Party&#146;s compliance with the applicable Firewall requirements, and shall not unreasonably interfere with or impede such Party&#146;s business
operations. The other Party shall provide such Party with written notice of such audit at least [***] prior to such requested audit (or such shorter period as may be designated by the other Party if the other Party reasonably believes at any time
that such Party is not in compliance with such Firewall requirements). All such audits shall be conducted at the other Party&#146;s cost and expense. If the auditor identifies any breach of the Firewall, the other Party or the auditor will notify
such Party, and such Party will promptly (and will use reasonable efforts to ensure its Affiliates promptly) take all action necessary to remedy such breach, and will provide the other Party with reasonable assurance that such action has been taken,
at such Party&#146;s sole expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.13 <B>Waivers</B>. The failure of a Party to insist upon strict performance of any provision of
this Agreement or to exercise any right arising out of this Agreement shall neither impair that provision or right nor constitute a waiver of that provision or right, in whole or in part, in that instance or in any other instance. Any waiver by a
Party of a particular provision or right shall be in writing, shall be as to a particular matter and, if applicable, for a particular period of time and shall be signed by such Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.14 <B>Force Majeure</B>. Neither Party shall be responsible to the other for any failure or delay in performing any of its obligations
under this Agreement or for other nonperformance hereunder (excluding, in each case, the obligation to make payments when due) if such delay or nonperformance is caused by strike, fire, flood, earthquake, accident, war, act of terrorism, pandemics,
act of God or of the government of any country or of any local government, or by any other cause unavoidable or beyond the control of any Party hereto. In such event, such affected Party shall use Commercially Reasonable Efforts to resume
performance of its obligations and shall keep the other Party informed of actions related thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.15 <B>Interpretation</B>. The captions and headings to this Agreement are for convenience
only, and are to be of no force or effect in construing or interpreting any of the provisions of this Agreement. Unless specified to the contrary, references to Articles, Sections or Schedules mean the particular Articles, Sections or Schedules to
this Agreement and references to this Agreement include all Schedules hereto. In the event of any conflict between the main body of this Agreement and any Schedule hereto, the main body of this Agreement shall prevail. Unless context otherwise
clearly requires, whenever used in this Agreement: (a)&nbsp;the words &#147;include&#148; or &#147;including&#148; shall be construed as incorporating, also, &#147;but not limited to&#148; or &#147;without limitation&#148;; (b) the word
&#147;or&#148; is used in the inclusive sense (i.e., &#147;and/or&#148;); (c) the word &#147;day&#148; or &#147;year&#148; means a calendar day or year unless otherwise specified; (d)&nbsp;the word &#147;notice&#148; means notice in writing (whether
or not specifically stated) and shall include notices, consents, approvals and other written communications contemplated under this Agreement; (e)&nbsp;the words &#147;hereof,&#148; &#147;herein,&#148; &#147;hereby&#148; and derivative or similar
words refer to this Agreement as a whole and not merely to the particular provision in which such words appear; (f)&nbsp;the words &#147;shall&#148; and &#147;will&#148; have interchangeable meanings for purposes of this Agreement;
(g)&nbsp;provisions that require that a Party, the Parties or a committee hereunder &#147;agree,&#148; &#147;consent&#148; or &#147;approve&#148; or the like shall require that such agreement, consent or approval be specific and in writing, whether
by written agreement, letter, approved minutes or otherwise; (h)&nbsp;words of any gender include the other gender; (i)&nbsp;words using the singular or plural number also include the plural or singular number, respectively; (j)&nbsp;references to
any specific law, rule or regulation, or article, section or other division thereof, shall be deemed to include the then-current amendments thereto or any replacement law, rule or regulation thereof; (k)&nbsp;the phrase <FONT
STYLE="white-space:nowrap">&#147;non-refundable,</FONT> <FONT STYLE="white-space:nowrap">non-creditable&#148;</FONT> shall not prohibit, limit or restrict either Party&#146;s right to obtain damages in connection with a breach of this Agreement; and
(l)&nbsp;neither Party shall be deemed to be acting on behalf of the other Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.16 <B>Expenses</B>. Each Party shall pay its own
costs, charges and expenses incurred in connection with the negotiation, preparation and execution of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.17 <B>Further
Assurances</B>. Moderna and Metagenomi hereby covenant and agree without the necessity of any further consideration, to execute, acknowledge and deliver any and all documents and take any action as may be reasonably necessary to carry out the intent
and purposes of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.18 <B>No Third Party Beneficiary Rights</B>. This Agreement is not intended to and shall not be
construed to give any Third Party any interest or rights (including any Third Party beneficiary rights) with respect to or in connection with any agreement or provision contained herein or contemplated hereby, except for Third-Party Indemnitees or
as otherwise expressly provided for in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.19 <B>Construction</B>. The Parties hereto acknowledge and agree that:
(a)&nbsp;each Party and its counsel reviewed and negotiated the terms and provisions of this Agreement and have contributed to its revision; (b)&nbsp;the rule of construction to the effect that any ambiguities are resolved against the drafting Party
shall not be employed in the interpretation of this Agreement; and (c)&nbsp;the terms and provisions of this Agreement shall be construed fairly as to all Parties hereto and not in a favor of or against any Party, regardless of which Party was
generally responsible for the preparation of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.20 <B>Cumulative Remedies</B>. No remedy referred to in this Agreement is intended to be
exclusive unless explicitly stated to be so, but each shall be cumulative and in addition to any other remedy referred to in this Agreement or otherwise available under law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.21 <B>Extension to Affiliates</B>. Except as expressly set forth otherwise in this Agreement, each Party shall have the right to extend the
rights and immunities granted in this Agreement to one or more of its Affiliates. All applicable terms and provisions of this Agreement, except this right to extend, shall apply to any such Affiliate to which this Agreement has been extended to the
same extent as such terms and provisions apply to the Party extending such rights and immunities. For clarity, a Party extending the rights and immunities granted hereunder shall remain primarily liable for any acts or omissions of its Affiliates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.22 <B>Other Activities</B>. Except as expressly provided in this Agreement, each Party may: (a)&nbsp;engage in research,
manufacturing, development or commercialization activities that utilize technologies similar to or involve products competitive with those contemplated under this Agreement; and (b)&nbsp;use any publicly available information and research results
(including any publicly available information of the other Party) to the same extent as Third Parties generally are legally permitted to do so. Except as expressly provided in this Agreement, nothing in this Agreement, including any obligation to
promote Products or any restriction on the use of Confidential Information, shall create: (i)&nbsp;any obligation not to research, develop, manufacture, commercialize or otherwise exploit any product; or (ii)&nbsp;any obligation to utilize a Sales
Force for Products separate from sales forces for other products. Each Party has limited resources, and as a result it is anticipated that personnel assigned to the activities contemplated under this Agreement may also participate in other
activities that may utilize technologies similar to or involve products competitive with those contemplated under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.23
<B>Counterparts; Electronic Signatures</B>. This Agreement may be executed in any number of counterparts, each of which is deemed an original, but all of which together constitute one instrument. This Agreement may be executed and delivered
electronically and upon such delivery such electronic signature shall be deemed to have the same effect as if the original signature had been delivered to the other Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the
Parties have caused this Agreement to be executed as of the Effective Date by their duly authorized representatives. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>M<SMALL>ETAGENOMI</SMALL>, I<SMALL>NC</SMALL>.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian Thomas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Brian Thomas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: CEO</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>M<SMALL>ODERNA</SMALL>TX, I<SMALL>NC</SMALL>.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen Hoge</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Stephen Hoge</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: President</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGE TO STRATEGIC COLLABORATION AND LICENSE AGREEMENT] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Target </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">PH1 </P></TD></TR></TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Manufacturing Cost </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Manufacturing
Cost</B>&#148; means [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Schedule B, &#147;<B>Direct Costs</B>&#148; equals the sum of the following as incurred for DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Candidates or DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, as applicable: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Schedule B, &#147;<B>Indirect Costs</B>&#148; equals the sum of the following as incurred for DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Candidates or DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products, as applicable: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule B-1 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Certain Technology Milestones </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule C-1 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Reserved DT Targets </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule D-1 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Approved Subcontractors </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule E-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule F </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Existing <FONT STYLE="white-space:nowrap">Co-Co</FONT> <FONT STYLE="white-space:nowrap">In-Licenses</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule G </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Existing RT <FONT STYLE="white-space:nowrap">In-Licenses</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule G-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule H </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Existing DT <FONT STYLE="white-space:nowrap">In-Licenses</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule H-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Material Transfer Record </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For clarity, defined
terms used herein and not defined herein have the meanings ascribed to such terms in the Agreement. This Material Transfer Record may be executed in one or more counterparts, including by facsimile, email or PDF exchange, each of which shall be
deemed to be an original as against any party whose signature appears thereon, but all of which together shall constitute but one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Direction of Transfer: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To Moderna, from Metagenomi </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To Metagenomi, from Moderna </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="70%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Description&nbsp;of&nbsp;Collaboration&nbsp;Material:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In signing below, the Moderna representative and the Metagenomi representative acknowledge that they understand and shall
abide by the terms and conditions under which the Collaboration Material is provided. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Moderna Representative
Signature</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Metagenomi Representative
Signature</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Moderna Representative Name</P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Metagenomi Representative
Name</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Moderna Representative
Title</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Metagenomi Representative
Title</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Date</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule I-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule J </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Profit and Loss Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This <B>Schedule J </B><FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share) covers financial planning, accounting policies and
procedures to be followed in determining the <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products Profit and Loss Share with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Products in the Territory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <B>Principles of Reporting</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 Each
Party shall provide a report of the results of its operations for the applicable period with respect to Commercialization, Medical Affairs and other related activities in the Territory for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT>
Product, which report shall include the cost categories set forth below. Following receipt of each such report from the Parties, Moderna shall generate a consolidated report, for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the
Territory, based on the foregoing financial information provided by each Party, which report shall be in the following format (the &#147;<B>P&amp;L</B>&#148;): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Cost Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Moderna</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Metagenomi</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>less</I> Cost of Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>plus</I> Licensing Income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>less</I> Eligible Medical Affairs Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>less</I> Commercialization Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>less</I> Other Operating Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">= Operating Profits or Losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <B>Standards</B>. It is the intention of the Parties to interpret each of the definitions used in the
P&amp;L in a manner that is consistent with this <B>Schedule J <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share) </B>and applicable U.S. GAAP principles; it being understood and agreed that &#147;Operating Profits or
Losses&#148; shall be calculated in accordance with applicable U.S. GAAP principles. Each Party agrees to provide reasonable supporting documentation to ensure that each Party&#146;s accounting methodologies are reasonable and consistently applied.
Reasonable methodologies may include a standard rate or some other appropriate basis for allocating costs. Notwithstanding anything herein to the contrary, in no event shall either Party be obligated to recognize revenue for its own purposes in a
manner that is contrary to the U.S. GAAP principles used by such Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule J-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3 <B>Accounting Procedures</B>. Each Party shall record and account for its Eligible
Medical Affairs Costs, Commercialization Costs or Other Operating Expenses, in each case, in a manner that allocates costs to the extent possible to a specific activity in the applicable Medical Affairs Budget, Commercialization Budget or specific
category of Other Operating Expenses. For purposes of determining Net Sales, Licensing Income, Cost of Sales, Eligible Medical Affairs Costs, Commercialization Costs, or Other Operating Expenses, any expense allocated by either Party to a particular
category under the definition of Net Sales, Licensing Income, Cost of Sales, Eligible Medical Affairs Costs, Commercialization Costs, or Other Operating Expenses shall not be allocated to any other category under the definition of Net Sales,
Licensing Income, Cost of Sales, Eligible Medical Affairs Costs, Commercialization Costs, or Other Operating Expenses, respectively. Each Party shall determine Net Sales, Licensing Income, Cost of Sales, Eligible Medical Affairs Costs,
Commercialization Costs, and Other Operating Expenses using its standard accounting procedures, consistently applied and consistent with U.S. GAAP principles, to the maximum extent practicable as if the applicable DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product were a solely-owned product of such Party (provided that the application of such procedures results, on balance, in outcomes that are fair and equitable to both Parties taking into consideration
the interests of both Parties as reflected in this Agreement). The Parties recognize that such procedures may change from time to time and that any such changes may affect the calculation of Net Sales, Licensing Income, Cost of Sales, Eligible
Medical Affairs Costs, Commercialization Costs, or Other Operating Expenses. Where the change is or would be material to the other Party, the Party proposing to make the change shall provide the other Party with an explanation of the proposed change
and an estimate of the effect of the change on the relevant cost or expense category. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4 If necessary, a Party shall make the
appropriate adjustments to the financial information it supplies under this <B>Schedule J </B><FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share) to conform with the format of reporting results of operation required for
the P&amp;L. The Parties understand that all Net Sales of each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product shall be booked in accordance with the Selling Party&#146;s U.S. GAAP principles and otherwise in accordance with
Section&nbsp;1.121 (Net Sales). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <B>Frequency of Reporting</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to prepare the consolidated P&amp;L, each Party shall submit to the other Party a financial statement of such Party&#146;s Commercialization and
Medical Affairs activities, Net Sales, Licensing Income, Cost of Sales, Eligible Medical Affairs Costs, Commercialization Costs, and Other Operating Expenses in the format of the P&amp;L within [***] after the end of [***]. Each such individual
P&amp;L shall specify in reasonable detail all categories of actual costs related to Eligible Medical Affairs Costs, Commercialization Costs and Other Operating Expenses, and, upon a Party&#146;s request the other Party shall promptly provide any
invoices or other supporting documentation for any External Costs or with respect to which documentation is otherwise reasonably requested. Within [***] after the last day of each Calendar Quarter, Moderna shall prepare a reconciliation report and
send it to Metagenomi. Within [***] after the end of each Calendar Quarter, the Parties shall agree on a consolidated P&amp;L for the applicable Calendar Quarter and for such Calendar Quarter, a consolidated reporting of the Operating Profits or
Losses, the calculation of the Operating Profits or Losses, and the applicable sharing and determination of the corresponding cash settlement in an agreed format (such report, the &#147;<B>Consolidated Report</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Within [***] after the end of each Calendar Quarter, whichever Party is owed a payment shall prepare an invoice for such payment and deliver such invoice to
the other Party. The paying Party shall pay such invoice within [***] after receipt of the invoice. For clarity, the first P&amp;L prepared with respect to each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product shall be prepared for the first
Calendar Quarter in which either Party incurs Eligible Medical Affairs Costs, Commercialization Costs, or Other Operating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule J-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Expenses (regardless of whether such Eligible Medical Affairs Costs, Commercialization Costs, or Other Operating Expenses are incurred before or after Regulatory Approval for any DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product). In addition to the above, within [***] after the last day of the [***] of every Calendar Quarter, each Party shall submit to the other Party a report, with respect to each DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Product, setting forth the P&amp;L representing for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product (if any) the actual Net Sales, Cost of Sales, Licensing Income, Eligible Medical Affairs Costs,
Commercialization Costs, and Other Operating Expenses recognized by such Party in such just-completed two month period as well as an estimate of expected Net Sales, Cost of Sales, Licensing Income, Eligible Medical Affairs Costs, Commercialization
Costs, and Other Operating Expenses to be recognized in the third month of the current Calendar Quarter for each such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product (if any). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <B>Financial Records</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Party shall keep all
financial records and reports required by this <B>Schedule J <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share) </B>in accordance with the U.S. GAAP principles to the extent applicable hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <B>Operating Profits or Loss Sharing</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 The Parties agree to share the Operating Profits or Losses with respect to Commercialization activities, Medical Affairs activities, and
the activities related to Other Operating Expenses for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product (whether such Commercialization activities, Medical Affairs activities, and the activities related to Other Operating Expenses were
conducted before or after Regulatory Approval for each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product) as set forth in Section&nbsp;7.4 <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share) of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 Each Party is entitled to [***] of the Operating Profits or Losses for a given Calendar Quarter. If, taking into account the Net Sales,
Cost of Sales, Licensing Income received, and Eligible Medical Affairs Costs, Commercialization Costs, and Other Operating Expenses incurred by the Parties as outlined in the P&amp;L for such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product,
in each case, in such Calendar Quarter, an amount is due from one Party to the other to effect the Profit and Loss Share, then at the time the applicable Consolidated Report is delivered to Moderna, Metagenomi shall make a payment to Moderna for an
amount such that Metagenomi shall be bearing [***] of the Operating Profits or Losses for the applicable Calendar Quarter. Metagenomi shall make payment in full to Moderna [***] after the date of an invoice therefor from Moderna. Likewise, if with
respect to such Calendar Quarter, a balancing payment is due from Moderna to Metagenomi to effect the Profit and Loss Share, then, [***] after the applicable Consolidated Report is delivered to Metagenomi, Moderna shall pay Metagenomi an amount such
that Metagenomi shall receive [***] of the Operating Profits or Losses for the applicable Calendar Quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 Disputes </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event any invoiced payment that is not otherwise subject to a good faith dispute is made after the date specified in Paragraph 4.2 of this <B>Schedule
J <FONT STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share)</B>, the paying Party shall pay the additional amounts or the receiving Party shall reimburse such excess payments, as applicable, with interest from the date
originally due as provided in Section&nbsp;7.15 (Default Interest) of this Agreement, and the remaining, disputed portion of any such payment shall be paid within [***] after the date on which the JSC, using good faith efforts, resolves the dispute,
or as escalated in accordance with Section&nbsp;2.10 (Decisions) with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule J-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <B>Start of Operations and Effective Accounting Date Termination</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 The Profit and Loss Share shall commence on the Effective Date. For clarity, Cost of Sales, Eligible Medical Affairs Costs,
Commercialization Costs, and Other Operating Expenses incurred prior to Regulatory Approval of each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product are chargeable to the applicable Profit and Loss Share in accordance with U.S. GAAP
principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 The Profit and Loss Share shall continue until this Agreement is terminated or expires. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <B>Audits</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The record keeping and audit provisions set
forth in Section&nbsp;7.6 (Accounting; Audit) of this Agreement shall apply with respect to all amounts payable by either Party to the other Party under the Profit and Loss Share, including with respect to the calculation of Eligible Medical Affairs
Costs, Commercialization Costs, Other Operating Expenses, Licensing Income, Cost of Sales and Net Sales with respect to the performance of Commercialization activities, Medical Affairs activities and the activities under Other Operating Expenses for
each DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule J-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule K </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Existing Patents </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule K-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule L </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RT Technology Research Plan </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule L-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule M </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Partnership Tax Matters </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1. <B>Constructive Partnership, Tax Treatment</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.1.1. Metagenomi and Moderna (the &#147;<B>Partners</B>,&#148; and each a &#147;<B>Partner</B>&#148;) acknowledge that the rights and
obligations imposed on each of them pursuant to this Agreement that relate to the allocation of Profits and Loss Share pursuant to Article 7 (Fees, Royalties, &amp; Payments), any other sharing of profits and losses from the Commercialization of the
Products within the Field in the Territory, and the collaborative relationship formed between them in connection therewith, in each case solely in connection with the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, gives rise to a
partnership for U.S. federal (and, to the extent applicable, state and local) income tax purposes (the &#147;<B>Partnership</B>&#148;), which will commence upon DC Nomination in such DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program (the
&#147;<B>Partnership Commencement Date</B>&#148;). The activities of the Partners on or after the Partnership Commencement Date with respect to the Commercialization of the Product within the Field in the Territory and the rights related thereto in
the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program (the &#147;<B>Shared Rights</B>&#148;) shall be deemed to be conducted in and held by the Partnership. The Partnership shall not, and shall not be deemed to, have any interest or rights
relating to Product outside the Field or outside the Territory (with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program) or otherwise under this Agreement other than with respect to the Shared Rights. The Partnership, and the
rights and obligations set forth in this Schedule M, shall remain in existence for so long as this Agreement remains in full force and effect (provided this Agreement has not been terminated in its entirety, in accordance with Article 12 of this
Agreement or otherwise) or until the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program is terminated pursuant to Section&nbsp;1.8 of this Schedule M, if such termination occurs prior to the termination of the Agreement in its entirety. Prior
to the commencement of the Partnership, the Parties may mutually and in good faith determine that it is desirable to affect the arrangement between Metagenomi and Moderna with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program
as two or more Partnerships for U.S. federal income tax purposes, rather than as a single Partnership, each between Metagenomi or a Metagenomi Affiliate, as one partner, and Moderna or a Moderna Affiliate, as the second partner; provided, however,
that, unless otherwise mutually agreed to by Metagenomi and Moderna, an Affiliate that is a foreign person for U.S. federal income tax purposes may only be a partner in any Partnership if the use of such foreign Affiliate shall not adversely impact
the second partner. Metagenomi and Moderna shall cooperate in a reasonably prompt manner in order to effect any amendments to this Schedule M or this Agreement required or advisable as a result of the preceding sentence. The Parties further
acknowledge that the arrangement described in this Agreement (including this Schedule M) shall be treated by the Parties as a partnership solely for U.S. federal and applicable state and local income tax purposes and is not intended to constitute a
partnership for any <FONT STYLE="white-space:nowrap">non-tax,</FONT> <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> or any other purpose. The Partners agree not to take any tax position, whether in a tax return or otherwise, that is inconsistent
with this Schedule M, other than pursuant to Section&nbsp;1.7 of this Schedule M. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.1.2. For U.S. federal income and other applicable tax
purposes, on the Partnership Commencement Date Metagenomi shall be treated as contributing to the Partnership its undivided interest in the Metagenomi Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology and its portion of the
Commercialization rights with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory (with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program) under this Agreement, and Moderna shall be treated
as contributing to the Partnership its undivided interest in the Moderna Licensed DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Technology and its portion of the Commercialization rights with respect to the DT
<FONT STYLE="white-space:nowrap">Co-Co</FONT> Product in the Territory (with respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program) under this Agreement, each as a Capital Contribution in exchange for an interest in the
Partnership. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule M-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2. <B>Definitions</B>. Capitalized terms used, but not defined, herein will have the
meanings ascribed to them in this Agreement. For purposes of this Schedule M: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B>Book</B>&#148; means the method of accounting
prescribed for compliance with the capital account maintenance rules set forth in <FONT STYLE="white-space:nowrap">Section&nbsp;1.704-1(b)(2)(iv)</FONT> of the Treasury Regulations, as distinguished from any accounting method which the Partnership
may adopt for other purposes such as financial reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B>Capital Account</B>&#148; has the meaning set forth in
Section&nbsp;1.3.1 of this Schedule M. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B>Capital Contribution</B>&#148; means, for each Partner, such Partner&#146;s cash or
property contributed (or deemed contributed) to the Partnership. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B>Code</B>&#148; means the U.S. Internal Revenue Code of
1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B>Fiscal Year</B>&#148; means the calendar year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<B>Gross Asset Value</B>&#148; means, with respect to any asset of the Partnership, the asset&#146;s adjusted basis for U.S. federal
income tax purposes, adjusted to reflect any adjustments required or permitted by Sections <FONT STYLE="white-space:nowrap">1.704-1(b)(2)(iv)(d)</FONT> through (g), (m) and (s)&nbsp;of the Treasury Regulations, as determined by the Partnership
Representative and mutually agreed upon by the Partners; provided that, in the case of any asset contributed to the Partnership, the initial Gross Asset Value of such property shall be equal to the fair market value of such asset as of the date of
contribution, as determined by the Partnership Representative and mutually agreed upon by the Partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) &#147;<B>Net Income</B>&#148;
and &#147;<B>Net Losses</B>&#148; mean the Book income, gain, loss, deductions and credits of the Partnership in the aggregate or separately stated, as appropriate, as of the close of each Taxable Year on the Partnership&#146;s tax return filed for
U.S. federal income tax purposes (or as of any other applicable time of the relevant Taxable Year). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) &#147;<B>Partnership
Representative</B>&#148; has the meaning set forth in Section&nbsp;1.6.1 of this Schedule M. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) &#147;<B>Profit Share</B>&#148; has the
meaning set forth in Section&nbsp;1.4.1 of this Schedule&nbsp;M. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) &#147;<B>Shared Rights</B>&#148; has the meaning set forth in
Section&nbsp;1.1.1 of this Schedule&nbsp;M. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) &#147;<B>Taxable Year</B>&#148; means the Partnership&#146;s Fiscal Year, or such other
year as may be required by Section&nbsp;706 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule M-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) &#147;<B>Treasury Regulations</B>&#148; means regulations (whether in final, proposed or
temporary form) promulgated by the U.S. Department of the Treasury under the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3. <B>Capital Accounts; Formation of the
Partnership</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.3.1. The Partnership shall maintain a separate capital account for each Partner according to the rules set forth in <FONT
STYLE="white-space:nowrap">Section&nbsp;1.704-1(b)(2)(iv)</FONT> of the Treasury Regulations (a &#147;<B>Capital Account</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.3.2. Each Partner&#146;s Capital Account: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) shall be increased by (A)&nbsp;the Capital Contributions by such Partner to the Partnership after the Partnership
Commencement Date, as determined by the Partnership Representative and mutually agreed upon by the Partners (net of liabilities secured by the contributed property that the Partnership is considered to assume or take subject to under
Section&nbsp;752 of the Code), and (B)&nbsp;such Partner&#146;s distributive share of Net Income and other items of income and gain allocated to such Partner after the Partnership Commencement Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) shall be decreased by (A)&nbsp;the amount of money distributed (or deemed distributed) to such Partner by the Partnership
after the Partnership Commencement Date, (B)&nbsp;the fair market value of property (as determined by the Partnership Representative and mutually agreed upon by the Partners) distributed (or deemed distributed) to such Partner by the Partnership
(net of liabilities secured by the distributed property that the Partner is considered to assume or take subject to under Section&nbsp;752 of the Code) after the Partnership Commencement Date and (C)&nbsp;such Partner&#146;s distributive share of
Net Losses and other items of loss and deduction allocated to such Partner after the Partnership Commencement Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) other adjustments shall be made to the Capital Accounts of the Partners to accord with the regulations promulgated under
Section&nbsp;704(b) of the Code as determined by the Partnership Representative and mutually agreed upon by the Partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.3.3. As of
the Partnership Commencement Date, the initial Capital Account of each Partner shall be equal to the Capital Contribution of each such Partner pursuant to Section&nbsp;1.1.2 of this Schedule M. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4. <B>Distributions</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.4.1. <B><FONT STYLE="white-space:nowrap">Non-Liquidating</FONT> Distributions</B>. In the event that assets of the Partnership are deemed to
be distributed other than in liquidation of the Partnership, such assets shall be deemed to be distributed in accordance with the payments comprising the share of Operating Profit or Losses between Metagenomi and Moderna under Section&nbsp;7.4 <FONT
STYLE="white-space:nowrap">(Co-Co</FONT> Products Profit and Loss Share) of this Agreement (the &#147;<B>Profit Share</B>&#148;), unless otherwise determined by the Partnership Representative and mutually agreed upon by the Partners. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule M-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.4.2. <B>Liquidating Distribution</B>. In the event that the Partnership is terminated
pursuant to Section&nbsp;1.8 of this Schedule M, then the assets of the Partnership shall be distributed (or deemed to be distributed) in liquidation of the Partnership in accordance with the Profit Share, and the requirements under Section&nbsp;5.6
of this Agreement shall be deemed to occur after such distribution and in exchange for payments required pursuant to Section&nbsp;7.11 of this Agreement, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.4.3. <B>Withholding for Taxes</B>. Subject to the provisions of Section&nbsp;7.16.3 of this Agreement, any Partner is authorized to withhold
from payments made to the other Partner that are treated as distributions described in Section&nbsp;1.4.1 or Section&nbsp;1.4.2 of this Schedule M to the Partners, and with respect to allocations pursuant to Section&nbsp;1.5 of this Schedule M to
the Partners, and to pay over to any federal, state or local government, any such taxes as are required to be deducted or withheld under any provision of Applicable Law. Any amounts so withheld shall be treated as distributed pursuant to
Section&nbsp;1.4.1 or Section&nbsp;1.4.2 of this Schedule M, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5. <B>Allocations, Section</B><B></B><B>&nbsp;704(c)</B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.5.1. Except as required by Section&nbsp;1.5.2 or Section&nbsp;1.5.3 of this Schedule M, the Net Income or Net Loss for any Taxable Year
shall be allocated to the Partners in such a manner so that the Capital Account of each Partner equals (as of the end of such allocation period and to the fullest extent possible) the amount that would be distributed to such Partner if all
properties of the Partnership, including cash, were sold for cash equal to their respective Gross Asset Values, all liabilities allocable to such properties were then due and were satisfied according to their terms, all minimum gain chargebacks
required by this Agreement and the Treasury Regulations were made, all obligations of Partners to contribute additional capital to the Partnership were satisfied and all remaining proceeds from such sale were distributed pursuant to the order and
priority of Section&nbsp;1.4.2 of this Schedule&nbsp;M. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.5.2. <B>Special Allocations</B>. Notwithstanding Section&nbsp;1.5.1 of this
Schedule M, the Partnership Representative may, if mutually agreed upon by the Partners, specially allocate any costs or expenses that are disproportionately borne by one Partner to such Partner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.5.3. <B>Regulatory Allocations</B>. In the event any Partner unexpectedly receives any adjustments, allocations or distributions described
in Sections <FONT STYLE="white-space:nowrap">1.704-1(b)(2)(ii)(d)(4),</FONT> <FONT STYLE="white-space:nowrap">1.704-1(b)(2)(ii)(d)(5)</FONT> or <FONT STYLE="white-space:nowrap">1.704-1(b)(2)(ii)(d)(6)</FONT> of the Treasury Regulations, items of
income (including gross income) and gain shall be specially allocated to such Partner in an amount and manner sufficient to eliminate the deficit balance in such Partner&#146;s Capital Account (in excess of (i)&nbsp;the amount such Partner is
obligated to restore upon liquidation of the Partnership or upon liquidation of such Partner&#146;s interest in the Partnership and (ii)&nbsp;such Partner&#146;s share of the Minimum Gain (as defined in
<FONT STYLE="white-space:nowrap">Section&nbsp;1.704-2</FONT> of the Treasury Regulations)) created by such adjustments, allocations or distributions as quickly as possible. Additionally, there are hereby incorporated herein such special allocation
provisions governing the allocation of income, deduction, gain, and loss for U.S. federal income tax purposes as may be necessary under, and in the manner required by, the Treasury Regulations to ensure that this Schedule M complies with all
requirements of <FONT STYLE="white-space:nowrap">Section&nbsp;1.704-2</FONT> of the Treasury Regulations relating to &#147;minimum gain&#148; and &#147;partner nonrecourse debt minimum gain&#148; and the allocation and chargeback of <FONT
STYLE="white-space:nowrap">so-called</FONT> &#147;nonrecourse deductions&#148; and &#147;partner nonrecourse deductions&#148;, including a &#147;qualified income offset&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule M-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.5.4. Except as otherwise provided in this Section&nbsp;1.5.4 and in Section&nbsp;1.5.5 of
this Schedule M, for U.S. federal income tax purposes, all items of income gain, loss, deduction and credit shall be allocated among the Partners in the same manner the corresponding Book item was allocated pursuant to Section&nbsp;1.5.1 or
Section&nbsp;1.5.2 of this Schedule M. In the case of contributed property, items of income, gain, loss, deduction and credit, as determined for U.S. federal income tax purposes, shall be allocated first in a manner consistent with the requirements
of Section&nbsp;704(c) of the Code to take into account the difference between the Gross Asset Value of such property and its adjusted tax basis at the time of contribution. If the Gross Asset Value of any asset of the Partnership is adjusted
pursuant to the terms of this Schedule M, then subsequent allocations of income, gain, loss, deduction and credit, as determined for U.S. federal income tax purposes, shall be allocated with respect to such assets so as to take into account such
adjustment in the same manner as under Section&nbsp;704(c) of the Code and the Treasury Regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.5.5.
Metagenomi and Moderna shall mutually and in good faith agree on the method under Section&nbsp;704(c) of the Code and the Treasury Regulations to be utilized by the Partnership prior to the Partnership Commencement Date. For the sake of clarity, the
allocations required by Section&nbsp;1.5.4 and this Section&nbsp;1.5.5 of this Schedule M are solely for purposes of U.S. federal and applicable state and local income taxes and will not affect the allocation of Net Income or Net Losses as between
the Partners or any Partner&#146;s Capital Account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6. <B>Tax Reports, Tax Elections and Partnership Representative</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.6.1. To the extent permitted under Applicable Law, the Partnership intends to elect out of the application of Subchapter C of Chapter 63 of
the Code (i.e., the partnership audit rules) and any applicable state or local equivalent. For any applicable Taxable Year (or portion thereof) where the Partnership is able to so elect, the Partners agree to cooperate to share information relevant
to the matters addressed by this Schedule M and agree not to take any position on any tax return applicable to the matters addressed by this Schedule M that may be materially adverse to the other Partner without the consent of the other Partner, not
to be unreasonably withheld, delayed or conditioned. To the extent required after giving effect to the first sentence of Section&nbsp;1.6 of this Schedule M, the Partnership hereby designates Moderna to act as the &#147;partnership
representative&#148; of the Partnership within the meaning of Section&nbsp;6223 of the Code (along with any state or local equivalent, the &#147;<B>Partnership Representative</B>&#148;), and the Partnership Representative shall have the authority to
appoint the &#147;designated individual&#148; within the meaning of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;301.6223-1(b)(3).</FONT> If the Partnership is unable to elect out of the partnership audit rules, the Partnership
Representative is authorized and required to represent the Partnership in connection with all examinations of the Partnership&#146;s affairs by U.S. federal (and any applicable state) income tax authorities, including resulting administrative and
judicial proceedings, to make any elections in connection therewith that are mutually agreed upon by the Partners, and to incur expenses for professional services and costs associated therewith, which shall be equally borne by each of Metagenomi and
Moderna; provided, that the Partnership Representative shall notify Metagenomi of any such administrative and judicial proceedings involving the Partnership and shall provide Metagenomi the opportunity to jointly participate in any such matters.
Metagenomi agrees to cooperate with the Partnership Representative as reasonably requested by the Partnership Representative with respect to the conduct of such proceedings. The Partnership Representative will, with mutual agreement by the Partners,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule M-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determine whether the Partnership (either on its own behalf or on behalf of the Partners) will contest or continue to contest any tax deficiencies assessed or proposed to be assessed by any
taxing authority provided, however, that the Partnership Representative shall not (i)&nbsp;agree or consent to compromise or settle such matters or (ii)&nbsp;take any action that disproportionately adversely affects Metagenomi, without the mutual
agreement of the Partners. Any deficiency for taxes imposed on any Partner (including penalties, additions to tax or interest imposed with respect to such taxes) will be paid by such Partner, and if paid by another Partner, will be recoverable from
the Partner on which such deficiency was imposed (including by offset against distributions otherwise payable to such Partner). The Partners agree to cooperate in good faith to notify each other regarding any tax notices or audits relating to the
Partnership and to provide any information or documentation reasonably requested by the Partnership Representative in connection with its duties under this Section&nbsp;1.6.1 of this Schedule M. In no event shall the Partnership Representative
require the Partners to file an amended tax return. A Partner&#146;s obligation to cooperate with the Partnership Representative and to indemnify and make payments to another Partner under this Section&nbsp;1.6.1 of this Schedule M will survive the
termination, dissolution, liquidation and winding up of the Partnership and the transfer, assignment or liquidation of a Partner&#146;s interest in the Partnership. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.6.2. The Partnership Representative shall prepare and file, or cause to be prepared and filed, all necessary U.S. federal, state or local
income tax returns for the Partnership. The Partnership Representative shall have such tax returns prepared by a &#147;big four&#148; accounting firm, which initially shall be Ernst&nbsp;&amp; Young, such accounting firm to be chosen with
Metagenomi&#146;s consent, and the cost of the preparation of such tax returns shall be equally borne by each of Metagenomi and Moderna. At least 60 days before the due date (including extensions) of any such tax return, the Partnership
Representative shall submit a copy of such tax return to Metagenomi for its review and comment. The Partners shall mutually agree on the preparation of such tax returns, making any required changes no fewer than 10 days prior to the due date of such
tax return. Within 180 days after the end of each Taxable Year, the Partnership Representative shall cause the Partnership to furnish Metagenomi with an IRS Form <FONT STYLE="white-space:nowrap">K-1</FONT> for such Taxable Year. In addition, the
Partnership shall deliver or cause to be delivered not later than the 15th day after the end of each Taxable Year to a requesting Partner all information necessary for the preparation of such Partner&#146;s U.S. federal income tax returns and any
state, local and other income tax returns that such Partner is required to file. Furthermore, the Partnership Representative shall jointly determine with Metagenomi regarding any matter for which the Partnership Representative is responsible or over
which the Partnership Representative has discretion under this Schedule M, including without limitation the preparation of any tax return or the making of any election hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.6.3. The Partners shall jointly determine whether to make or revoke any available election pursuant to the Code. Each Partner will, upon
request, use reasonable efforts to supply the information necessary to give proper effect to any such election. The Partners hereby agree to cooperate in good faith regarding any matters related to any tax elections or tax reporting positions of the
Partnership. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule M-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.7. <B>Tax Position</B>. Unless otherwise required by Applicable Law, no Partner will take
a position on such Partner&#146;s U.S. federal or other applicable income tax returns, in any claim for refund or in any administrative or legal proceedings that is inconsistent with this Agreement (including this Schedule M) or with any information
return filed by the Partnership. If any Partner believes that such a position is required by Applicable Law, such Partner must immediately notify the other Partner in writing, citing such Applicable Law or any interpretation thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.8. <B>Termination of Partnership</B>. With respect to the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, the Partnership shall
terminate upon the earlier of (i)&nbsp;the expiration or termination of the DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Program, or (ii)&nbsp;an <FONT STYLE="white-space:nowrap">Opt-Out</FONT> by either Party from the DT <FONT
STYLE="white-space:nowrap">Co-Co</FONT> Program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule M-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule N </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Joint Press Release </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Metagenomi and Moderna Establish Collaboration to Develop Next-Generation </B><B><I>In Vivo</I></B><B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Gene Editing Therapeutics </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>The collaboration will combine Metagenomi&#146;s next-generation CRISPR-based and other novel gene editing
systems with Moderna&#146;s mRNA and LNP technologies to accelerate the development of in vivo gene editing therapeutics</I> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Multi-year research collaboration funded by Moderna covering a series of undisclosed disease targets</I>
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Metagenomi to receive <FONT STYLE="white-space:nowrap">up-front</FONT> cash payment, equity investment, and
research funding, with potential for additional research, milestone and royalty payments</I> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EMERYVILLE, CA and CAMBRIDGE, MA. --
Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation gene editing tools, and Moderna Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that
the two companies have entered into a strategic research and development collaboration focused on advancing new gene editing systems for <I>in vivo</I> human therapeutic applications. The collaboration will utilize Metagenomi&#146;s novel gene
editing tools and leverage Moderna&#146;s mRNA platform, as well as lipid nanoparticle (LNP) delivery technologies, with the goal of developing curative therapies for patients with serious genetic diseases. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Metagenomi has demonstrated the power of its proprietary metagenomics approach that mines the Earth&#146;s natural environment to discover
next-generation gene editing tools and has developed discovery capabilities with the potential to address multiple diseases,&#148; said Eric Huang, PhD, General Manager&nbsp;&amp; Chief Scientific Officer, Moderna Genomics (mGx). &#147;Their
discovery platform and expertise will expand Moderna Genomics&#146; ongoing efforts to develop innovative <I>in vivo</I> gene editing therapies to address a significant unmet medical need. This collaboration represents another milestone on our
journey to create transformational genome-engineering based medicines.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Gene editing has the potential to provide a cure for millions of
patients living with genetic disease. Our partnership with Moderna is designed to accelerate the creation of genetic medicines using Metagenomi&#146;s naturally derived, compact, modular and precise gene editing systems,&#148; said Brian C. Thomas,
PhD, CEO and <FONT STYLE="white-space:nowrap">Co-Founder</FONT> of Metagenomi. &#147;This partnership will enhance our shared vision to forge transformative therapeutics for patients.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Unlocking the therapeutic potential of gene editing requires a long-term commitment to develop the best technologies for both <I>in vivo</I> delivery
and gene repair,&#148; said Jak Knowles, MD, CBO at Metagenomi. &#147;We share Moderna&#146;s goal to develop mRNA-based medicines, and we are thrilled to partner with them.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule N-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About the Collaboration </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the collaboration, Metagenomi and Moderna will advance a series of <I>in vivo </I>gene editing therapeutics against undisclosed targets.
Metagenomi will utilize its vast toolbox of gene editing systems in combination with Moderna&#146;s mRNA and LNP technologies, to deliver next-generation therapies for genetic diseases. Metagenomi will receive an upfront cash payment and is eligible
to receive certain target option exercise fees as well as development, regulatory and commercial milestone payments, plus tiered royalties on net sales of any products that are commercialized by Moderna. Moderna has also agreed to make an equity
investment in Metagenomi in the form of a convertible note. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Metagenomi </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Metagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene
editing systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. We adapt and forge these
naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific and have a decreased risk of immune response. These systems fuel our pipeline of novel medicines and can be leveraged by
partners. Our goal is to revolutionize gene editing for the benefit of patients around the world. For more information, please visit https://metagenomi.co/. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Moderna </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 10 years since its inception, Moderna
has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property
portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range
of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna&#146;s capabilities have come together to allow the
authorized use of one of the earliest and most- effective vaccines against the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moderna&#146;s
mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases,
cardiovascular diseases and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule N-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Moderna Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including
regarding: the collaboration between Moderna and Metagenomi to accelerate the development of gene editing technologies; the financial structure for that collaboration and potential for payments; and the potential development of genetic medicines
using gene editing systems. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks,
uncertainties, and other factors, many of which are beyond Moderna&#146;s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other
factors include those other risks and uncertainties described under the heading &#147;Risk Factors&#148; in Moderna&#146;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed with the U.S. Securities and Exchange
Commission (SEC) and in subsequent filings made by Moderna with the SEC, which are available on the SEC&#146;s website at <U>www.sec.gov</U>. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any
forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna&#146;s current expectations and speak only as of the date hereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Metagenomi Contacts </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simon Harnest </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CIO, SVP Strategy </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">simon@metagenomi.co </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(917)
<FONT STYLE="white-space:nowrap">403-1051</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Media: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ashlye Hodge </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sr. Marketing and Communications Specialist </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ashlye@metagenomi.co </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(510)
<FONT STYLE="white-space:nowrap">734-4409</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Moderna Contacts </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lavina Talukdar </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Vice President&nbsp;&amp; Head of Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lavina.Talukdar@modernatx.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(617) <FONT
STYLE="white-space:nowrap">209-5834</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Medias: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Colleen Hussey </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director, Corporate Communications </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Colleen.Hussey@modernatx.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(617) <FONT
STYLE="white-space:nowrap">335-1374</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule N-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule O </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DT <FONT STYLE="white-space:nowrap">Co-Co</FONT> Research Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule O-1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>3
<FILENAME>d425213dex107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.7 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT
TREATS AS PRIVATE OR CONFIDENTIAL. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>C<SMALL>OLLABORATION</SMALL> <SMALL>AND</SMALL> L<SMALL>ICENSE</SMALL> A<SMALL>GREEMENT</SMALL>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>B<SMALL>ETWEEN</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>M<SMALL>ETAGENOMI</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>I<SMALL>ONIS</SMALL> P<SMALL>HARMACEUTICALS</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>D<SMALL>ATED</SMALL> N<SMALL>OVEMBER</SMALL>&nbsp;10, 2022 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;1 Overview</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Drug Discovery Program</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Development and Commercialization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Co-Development and Co-Commercialization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exploratory Research</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;2 Collaboration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Selection of Collaboration Targets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Drug Discovery Program</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exploratory Research Program</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of Collaboration Activities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cost of Collaboration Activities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Collaboration Program Records and Reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ionis Proprietary Toolbox of Chemical Modifications</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;3 Licenses; Exclusivity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>License Grants to Ionis</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>License Grants to Metagenomi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Subcontractors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Technology Transfer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Implied Licenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exclusivity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;4 Governance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Joint Steering Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Subcommittees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Joint Research Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Alliance Managers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Additional Participants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Decision-Making</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;5 Co-Development and Co-Commercialization Options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Co-Development and Co-Commercialization Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Development and Commercialization of the Co-Co Products; Opt-Down Right</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Escalation Procedure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Metagenomi Opt-Out</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;6 Development and Commercialization of the Ionis Products</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Development</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Commercialization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;7 Regulatory Affairs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Regulatory Responsibility</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Right of Reference</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Regulatory Support</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;8 Manufacturing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Metagenomi Manufacturing Responsibilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Development Supply Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Commercial Supply Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ionis&#146; Assumption of Manufacturing Responsibilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Manufacturing After the Metagenomi Supply Term</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;9 Consideration; Financial Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Upfront Payment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Wave 2 Target Selection Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Option Exercise Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ionis Product Milestone Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ionis Products for [***] Target Populations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ionis Product Royalty Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Existing In-License Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>New In-License Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment Obligations Under Certain In-License Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Metagenomi Product Economics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Other Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Right to Offset</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Records and Audits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Currency of Payment; Non-Refundable Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Late Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Currency Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.17.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Withholding Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;10 Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ownership of Inventions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Patent Prosecution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Patent Enforcement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Defense of Claims Brought by Third Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Patent Listing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Common Ownership Legislation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Patent Term Extension</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Recording</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Unitary Patent System</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Trademarks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Common Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;11 Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidential Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Use of Name</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Residual Knowledge</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Public Announcements and Subsequent Disclosures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Publications</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;12 Representations, Warranties, and Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Mutual Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Additional Representations of Metagenomi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Covenants of Metagenomi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Additional Representations of Ionis</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Covenants of Ionis</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Warranty Disclaimer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;13 Indemnification; Limitation of Liability; Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification of Metagenomi by Ionis</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification of Ionis by Metagenomi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Losses for the Co-Co Products</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limited Liability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;14 Term and Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Term</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effects of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidential Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Surviving Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;15 Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Dispute Resolution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Designation of Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Patent Disputes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Injunctive Relief</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cumulative Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendment; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignment and Successors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rights in Bankruptcy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Force Majeure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Integration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.17.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Relationship of the Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>Schedules</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 1.114</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 1.146</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Licensed Patent Rights</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U>&nbsp;1.166</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 1.175</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Metagenomi Platform Patent Rights</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U>&nbsp;2.1.1(a)</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 2.2</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***] Drug Discovery Plan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 2.3.1</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Exploratory Research Plan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 8.2</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Development Supply Agreement Key Terms</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 11.4</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release(s)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 12.2</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Metagenomi Disclosure Schedule</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule<U> 12.4</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ionis Disclosure Schedule</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COLLABORATION AND LICENSE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This <B>C<SMALL>OLLABORATION</SMALL> A<SMALL>ND</SMALL> L<SMALL>ICENSE</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> (this
&#147;<B>Agreement</B>&#148;) is entered into as of November&nbsp;10, 2022 (the &#147;<B>Effective Date</B>&#148;), by and between Ionis Pharmaceuticals, Inc., a Delaware corporation, having its principal place of business at 2855 Gazelle Court,
Carlsbad, CA 92010 <B>(</B>&#147;<B>Ionis</B>&#148;<B></B>), and Metagenomi, Inc., a Delaware corporation, having its principal place of business at 1545 Park Avenue, Emeryville, CA 94608 (<B></B>&#147;<B>Metagenomi</B>&#148;<B></B>). Metagenomi and
Ionis are sometimes referred to herein individually as a <B>&#147;Party&#148;</B> and collectively as the <B></B>&#147;<B></B><B>Parties.</B>&#148;<B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, Metagenomi is a biopharmaceutical company that controls certain patent rights, know-how, technology, and expertise with respect to
gene editing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, Ionis is a biopharmaceutical company focused on developing and commercializing pharmaceutical and
biopharmaceutical products; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, Metagenomi and Ionis desire to enter into a collaboration to utilize Metagenomi&#146;s and
Ionis&#146; expertise and each Party&#146;s platform to perform research services and other activities focused on the (a)&nbsp;discovery and development of therapeutics, and (b)&nbsp;advancing certain gene editing technologies to enable improved
performance, novel mechanisms, and novel delivery strategies; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, Metagenomi desires to grant to Ionis, and Ionis desires to
receive from Metagenomi, an exclusive license under the Licensed Technology to Exploit Licensed Systems and Licensed Products under the terms and conditions set forth herein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, the Parties agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;1 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Overview
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Parties intend to undertake a strategic research collaboration under this Agreement, consisting of drug discovery and exploratory
research activities to advance new medicines using gene editing strategies, with the goal of discovering novel medicines for Ionis to Develop and Commercialize on its own or to co-Develop and co-Commercialize with Metagenomi. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Drug Discovery Program</B>. The Parties intend that, under this Agreement, the Parties will seek to
discover therapeutic products directed to specific genetic targets selected by Ionis under a Drug Discovery Program and pursuant to a Drug Discovery Plan for each specific genetic target, as permitted by this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Development and Commercialization</B>.<B></B> For each Drug Discovery Program, once the Parties
identify a candidate that is suitable for Development, as between the Parties, Ionis will be responsible for Development and Commercialization of products resulting from such Drug Discovery Program either on its own or, if Metagenomi exercises its
option, together with Metagenomi. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Co-Development and Co-Commercialization</B>. Metagenomi will have an exclusive option to co-Develop
and co-Commercialize products with Ionis under a limited number of Drug Discovery Programs. For any such option exercised by Metagenomi, the Parties will enter into a separate Co-Development and Co-Commercialization Agreement, as set forth herein.
Metagenomi will have a right to opt-out of such co-Development and co-Commercialization at specific times, as set forth herein. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Exploratory Research</B><B></B>. The Parties will also conduct an Exploratory Research Program under
this Agreement. The Parties intend that, under the Exploratory Research Program, the Parties will conduct collaborative research pursuant to an Exploratory Research Plan to jointly optimize Guide RNA and select delivery technologies and such other
activities as agreed upon by the Joint Research Committee in accordance with this Agreement. Any such improvements resulting from the Parties&#146; exploratory research under this Agreement will be incorporated into the Parties&#146; drug discovery
collaboration. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Governance</B><B></B>. The Parties have agreed to form (a)&nbsp;a Joint Steering Committee to
coordinate, oversee, and monitor the Parties&#146; activities under this Agreement; and (b)&nbsp;a Joint Research Committee reporting to the JSC to coordinate, oversee, and monitor the Parties&#146; research and drug discovery activities under this
Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Purpose</B>. The purpose of this<U> Article 1</U> (Overview) is to provide a high-level overview of the
roles, responsibilities, rights, and obligations of each Party under this Agreement, and therefore this<U> Article 1</U> (Overview) is qualified in its entirety by the more detailed provisions of this Agreement set forth below.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Collaboration </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Selection of Collaboration Targets</B><B>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Wave 1 Targets</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Initial Wave 1 Target</B>.<B></B> The first Collaboration Target will be [***], as set forth on <U>Schedule
2.1.1(a)</U> ([***]) (&#147;[***]&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Second Wave 1 Target</B>. Within [***] of the Effective Date, the Parties will mutually agree on the second
gene target as a Collaboration Target (the &#147;<B>Second Wave 1 Target</B>&#148;). The Second Wave 1 Target will be a target for which a Licensed Product would be delivered only to [***]. If the Parties do not agree on a Second Wave 1 Target
within such [***] period, then the Parties will mutually agree on an additional period to determine a second gene target to be the Second Wave 1 Target. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Additional Wave 1 Target Selection</B>. At any time during the period commencing on the Effective Date and
ending on the date that is [***] following the Effective Date (&#147;<B>Additional Wave 1 Target Selection Period</B>&#148;), Ionis may, in its sole discretion, but subject to <U>Section&nbsp;2.1.4</U> (Encumbrance Check), select up to two
additional gene targets as proposed Collaboration Targets by providing written notice to Metagenomi (each such notice, the &#147;<B>Additional Wave 1 Target Notice</B>&#148;), which notice will identify the proposed target (&#147;<B>Additional Wave
1 Target</B>&#148;). The Additional Wave 1 Targets will be targets for which a Licensed Product would be delivered only to [***] or only to [***]; <I>provided</I> that no more than one Additional Wave 1 Target will be a target for which a Licensed
Product would be delivered to [***]. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Wave 2 Target Options</B>. If, at any time during the Drug Discovery Term, (a)&nbsp;an IND for any Licensed
Product directed to a Wave 1 Target is filed with the applicable Regulatory Authority or (b)&nbsp;the Parties achieve [***] for a [***] under the Exploratory Research Activities (the &#147;<B>Wave 2 Target Selection Period</B>&#148;), then Ionis
may, in its sole discretion, but subject to <U>Section&nbsp;2.1.4</U> (Encumbrance Check), select up to four additional gene targets as proposed Collaboration Targets by providing written notice to Metagenomi (each such notice, a &#147;<B>Wave 2
Target Notice</B>&#148;), which notice will identify the proposed target (&#147;Wave 2 Target&#148;). Each Wave 2 Target will be a target for which a Licensed Product would be delivered only to [***] or only to [***], or any other [***] that has, at
the time of the Wave 2 Target Notice for such Wave 2 Target, achieved [***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.1.3</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Target Substitutions</B>. On a Drug Discovery Program-by-Drug Discovery Program basis, Ionis will have the
right to substitute the Collaboration Target for a Drug Discovery Program in accordance with this <U>Section&nbsp;2.1.3</U> (Target Substitutions). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Discretionary Substitutions</B>. At any time before [***] (the &#147;<B>Target Substitution
Period</B>&#148;), Ionis may, in its sole discretion, but subject to <U>Section&nbsp;2.1.4</U> (Encumbrance Check), replace the Collaboration Target for such Drug Discovery Program by providing written notice to Metagenomi, which notice will
identify the proposed replacement gene target. Ionis may substitute (i)&nbsp;up to two Wave 1 Targets other than [***] and (ii)&nbsp;up to two Wave 2 Targets that become Collaboration Targets, in each case ((i) and (ii)), for any reason. Any
Collaboration Target that is substituted out pursuant to this <U>Section&nbsp;2.1.3(a)</U> (Discretionary Substitutions) will [***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Substitutions for Technological Infeasibility</B>. If the JSC determines that it is technologically
infeasible to Develop a Development Candidate for a Collaboration Target (&#147;<B>Technological Infeasibility</B>&#148;), then Ionis may, in its sole discretion, but subject to <U>Section&nbsp;2.1.4</U> (Encumbrance Check), substitute such
Collaboration Target by providing written notice to Metagenomi, which notice will identify the proposed replacement gene target. There is no limit on the number of replacements Ionis may make pursuant to this <U>Section&nbsp;2.1.3(b)</U>
(Substitutions for Technological Infeasibility) and any substitutions that are for Technological Infeasibility will not count towards the number of substitutions Ionis can make pursuant to <U>Section&nbsp;2.1.3(a)</U> (Discretionary Substitutions).
Any Collaboration Target that is substituted out pursuant to this <U>Section&nbsp;2.1.3(b)</U> (Substitutions for Technological Infeasibility) will not be eligible to be selected as a Proposed Replacement Target except as set forth in
<U>Section&nbsp;2.1.3(c)</U> (Substitutions After Resolution of Technological Infeasibility). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Substitution After Resolution of Technological Infeasibility</B>. If a Collaboration Target is substituted
out for Technological Infeasibility pursuant to <U>Section&nbsp;2.1.3(b)</U> (Substitutions for Technological Infeasibility) and, during the Drug Discovery Term and within [***] from when such substitution occurred, Metagenomi later reasonably
believes that it can resolve the issue that led to the Technological Infeasibility, then Metagenomi will notify Ionis, which notice will include a description of the approach Metagenomi intends to take to resolve the Technological Infeasibility.
Subject to clauses (i)&nbsp;and (ii)&nbsp;of <U>Section&nbsp;2.1.4(a)</U> (Encumbered Targets), Ionis will have the right to substitute a current Collaboration Target for such previous Collaboration Target by providing written notice to Metagenomi
within [***] of receipt of notice from Metagenomi that it believes it can solve the issue that led to the Technological Infeasibility. There is no limit on the number of replacements Ionis may make pursuant to this <U>Section&nbsp;2.1.3(c)</U>
(Substitutions After Resolution of Technological Infeasibility) and any substitutions that are as a result of resolution of a Technological Infeasibility will not count towards the number of substitutions Ionis can make pursuant to
<U>Section&nbsp;2.1.3(a)</U> (Discretionary Substitutions). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Substitution Procedure</B>. Any written notice provided by Ionis to Metagenomi pursuant to
<U>Section&nbsp;2.1.3(a)</U> (Discretionary Substitutions), <U>Section&nbsp;2.1.3(b)</U> (Substitutions for Technological Infeasibility), or <U>Section&nbsp;2.1.3(c)</U> (Substitutions After Resolution of Technological Infeasibility) will be a
&#147;<B>Replacement Target Notice</B>&#148; and the proposed replacement gene target identified in any Replacement Target Notice will be a &#147;<B>Proposed Replacement Target</B>&#148;. Each Replacement Target Notice will specify which current
Collaboration Target should be removed as a result of such replacement, and, unless otherwise agreed by the Parties, each Proposed Replacement Target will be a target for which a Licensed Product would be delivered to the same tissue as the
Collaboration Target subject to the substitution. Promptly after such Proposed Replacement Target becomes a Collaboration Target pursuant to <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available), Metagenomi will re-allocate the
resources dedicated to the Drug Discovery Program for the Collaboration Target that was removed as a result of the substitution to the Drug Discovery Program for the new Collaboration Target as soon as practicable, but in any event within [***]
after such Proposed Replacement Target becomes a Collaboration Target pursuant to <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.1.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Encumbrance Check</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Encumbered Targets</B>. Metagenomi will notify Ionis within [***] after Metagenomi&#146;s receipt of an
Additional Wave 1 Target Notice, a Wave 2 Target Notice, or a Replacement Target Notice if, at the time of receipt of such notice, (i)&nbsp;Metagenomi is then engaged in <I>bona fide</I> discussions with a Third Party for an agreement, [***],
pursuant to which Metagenomi would grant to such Third Party conflicting rights to Develop or Commercialize products directed to such Proposed Target such that Metagenomi could not grant Ionis the rights or licenses granted to Ionis hereunder with
respect to such Proposed Target, (ii)&nbsp;Metagenomi is contractually obligated to grant, or has granted, to a Third Party conflicting rights to Develop or Commercialize products directed to such Proposed Target such that Metagenomi could not grant
Ionis the rights or licenses granted to Ionis hereunder with respect to such Proposed Target, as evidenced by a binding written agreement, or (iii)&nbsp;the Proposed Target is the subject of an active <I>bona fide</I> then ongoing internal research
and development program at Metagenomi, as evidenced by [***] (each of (i)&nbsp;through (iii), a &#147;<B>Pre-Existing Restriction</B>&#148; and such Proposed Target, an &#147;<B>Encumbered Target</B>&#148;). Notwithstanding the foregoing, a
Collaboration Target that has been substituted out for Technological Infeasibility but for which Ionis later selects as a Proposed Replacement Target pursuant to <U>Section&nbsp;2.1.3(c)</U> (Substitutions After Resolution of Technological
Infeasibility) will only be an Encumbered Target if the foregoing clause (i)&nbsp;or clause (ii)&nbsp;applies with respect to such Proposed Replacement Target. If Metagenomi does not notify Ionis within such [***] period that the Proposed Target is
an Encumbered Target, then Ionis may provide a second notice to Metagenomi indicating that the Proposed Target will be deemed Available if Metagenomi does not respond to such second notice within [***]. If Metagenomi (x)&nbsp;notifies Ionis that a
Proposed Target is Available or (y)&nbsp;does not provide notice that a Proposed Target is an Encumbered Target </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="23%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
within the original [***] or within [***] after Ionis&#146; second notice, then, in either case ((x) or (y)), such Proposed Target will be deemed to be Available, at which point
<U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available) will apply. If a Proposed Target is an Encumbered Target, then Ionis may select another Proposed Target (and another if such other Proposed Target is an Encumbered Target and
so on) until such time that Ionis selects a Proposed Target that is Available, at which point <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available) will apply. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Expiration of Pre-Existing Restrictions</B>. On [***], Ionis will use good faith efforts to [***], to
facilitate its activities pursuant to <U>Section&nbsp;4.1.5(b)</U> (Specific Responsibilities of the JSC), [***]. If at any time during the Additional Wave 1 Target Selection Period, the Wave 2 Target Selection Period, or the Target Substitution
Period, as applicable, any Pre-Existing Restriction that precluded Ionis from selecting a Proposed Target as a Collaboration Target later expires, terminates, or is otherwise modified such that such Proposed Target would no longer be an Encumbered
Target, and at such time (i)&nbsp;Ionis has not designated the maximum amount of Collaboration Targets as permitted under this Agreement, or (ii)&nbsp;Ionis has designated all Collaboration Targets as permitted under this Agreement, but Ionis has
not exhausted its right to substitute existing Collaboration Targets as permitted under <U>Section&nbsp;2.1.3(a)</U> (Discretionary Substitutions), <U>Section&nbsp;2.1.3(b)</U> (Substitutions for Technological Infeasibility), or
<U>Section&nbsp;2.1.3(c)</U> (Substitution After Resolution of Technological Infeasibility) (such time period prior to the occurrence of both (i)&nbsp;and (ii), the &#147;<B>Target Selection and Substitution Period</B>&#148;), then Metagenomi will
notify Ionis of such expiration, termination, or modification unless Ionis has notified the JSC that it is no longer interested in pursuing that Encumbered Target as a Collaboration Target. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Effects if a Proposed Target is Available</B>. If Ionis confirms in writing to Metagenomi that a Proposed
Target should be deemed to be a &#147;Collaboration Target&#148; under this Agreement within [***] of a Proposed Target being deemed Available pursuant to <U>Section&nbsp;2.1.4(a)</U> (Encumbered Targets), then (i)&nbsp;such Proposed Target will be
deemed a &#147;Collaboration Target&#148; as of the date of such notice, (ii)&nbsp;the Parties, through the JRC, will develop a Drug Discovery Plan for such Collaboration Target in accordance with <U>Section&nbsp;2.2.2</U> (Additional Drug Discovery
Plans), (iii)&nbsp;if the Proposed Target was a Wave 2 Target, then Ionis will pay any Wave 2 Target Selection Fee in accordance with <U>Section&nbsp;9.2</U> (Wave 2 Target Selection Fee) and, if applicable, the Drug Discovery Term will be extended
pursuant to <U>Section&nbsp;2.2.7</U> (Drug Discovery Term), and (iv)&nbsp;if the Proposed Target was a Proposed Replacement Target, then the Collaboration Target that was substituted out will no longer be a &#147;Collaboration Target&#148;. If
Ionis does not respond within [***] of a Proposed Target being deemed Available pursuant to <U>Section&nbsp;2.1.4(a)</U> (Encumbered Targets), then such Proposed Target will not be deemed a &#147;Collaboration Target&#148;. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Drug Discovery Program. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Initial Drug Discovery Plan</B>. The principal Development objectives for each Drug Discovery Program will
be set forth in a written plan that includes: (a)&nbsp;the specific activities to be performed by each Party through selection of a Development Candidate for such Drug Discovery Program, including the Gene Editing modality within the Field for such
Development Candidate, (b) the estimated timelines for the performance of such activities, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
and (c)&nbsp;the Development Candidate selection criteria (each such plan, as may be updated from time to time, a &#147;<B>Drug Discovery Plan</B>&#148; and the activities to be performed by the
Parties thereunder, the &#147;<B>Drug Discovery Activities</B>&#148;). In addition, each Drug Discovery Plan will include a written budget pursuant to which Metagenomi will perform the Drug Discovery Activities allocated to Metagenomi under such
Drug Discovery Plan, which budget will include (i)&nbsp;the number of FTEs to be dedicated by Metagenomi under such Drug Discovery Plan, and (ii)&nbsp;any Out-of-Pocket Costs expected to be incurred by Metagenomi in the performance of such Drug
Discovery Activities on a line-item basis (each such budget, a &#147;<B>Drug Discovery Budget</B>&#148;). The initial Drug Discovery Plan agreed to by the Parties for [***] is attached hereto as <U>Schedule 2.2</U> ([***] Drug Discovery Plan).
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.2.2</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Additional Drug Discovery Plans</B>. No later than [***] after (a)&nbsp;the Parties agree on the Second Wave
1 Target pursuant to <U>Section&nbsp;2.1.1(b)</U> (Second Wave 1 Target) or (b)&nbsp;a Proposed Target is deemed a Collaboration Target under this Agreement pursuant to <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available), which
period shall be appropriately extended for the Parties to undertake the process described in <U>Section&nbsp;2.2.4</U> ([***] for Additional Drug Discovery Plans), if applicable, in each case, the Parties will develop, through the JRC, a Drug
Discovery Plan for such Collaboration Target (an &#147;<B>Additional Drug Discovery Plan</B>&#148;) in accordance with this <U>Section&nbsp;2.2.2</U> (Additional Drug Discovery Plans). The JRC will submit each proposed Additional Drug Discovery Plan
to the JSC for the JSC to review, discuss, and determine whether to approve. Unless otherwise agreed by the Parties, the content of each Additional Drug Discovery Plan will be consistent in scale and scope to that set forth in the Drug Discovery
Plan for [***] attached hereto as <U>Schedule 2.2</U> ([***] Drug Discovery Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.2.3</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Amendments to the Drug Discovery Plans</B>. At least [***] during the Drug Discovery Term, or upon either
Party&#146;s request, the JRC will develop and propose updates to each Drug Discovery Plan; <I>provided</I> that in no event will those updates include [***] the applicable Collaboration Target unless such [***] pursuant to <U>Section&nbsp;2.2.5</U>
(Development of [***] for a Drug Discovery Program). Any proposed updates to a Drug Discovery Plan will be submitted to the JSC for approval. The JSC will review, discuss, and determine whether to approve any such proposed update to a Drug Discovery
Plan. Each such update to a Drug Discovery Plan will become effective and will supersede the previous Drug Discovery Plan for the applicable Drug Discovery Program upon approval thereof by the JSC. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.2.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>[***] for Additional Drug Discovery Plans</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>New</B> [***]. At each JSC meeting during the Target Selection and Substitution Period, Metagenomi will use
good faith efforts to notify Ionis if it reasonably believes that [***] (each such [***]). In addition, [***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Selection of </B>[***]<B></B>. The JSC will discuss and determine the [***] for the Second Wave 1 Target and
each Proposed Target that is deemed a Collaboration Target under this Agreement pursuant to <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available) from the [***], and, subject to <U>Section&nbsp;2.2.4(c)</U> (Incremental
Development Costs), such [***] will be set forth in the applicable Additional Drug Discovery Plan determined pursuant to <U>Section&nbsp;2.2.2</U> (Additional Drug Discovery Plans). For clarity, if the JSC selects for inclusion in an Additional Drug
Discovery Plan [***], then <U>Section&nbsp;2.2.4(c)</U> (Incremental Development Costs) is not applicable and [***] for the applicable Drug Discovery Program. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Incremental Development Costs</B>. If, in connection with the JRC&#146;s discussion and development of an
Additional Drug Discovery Plan, Ionis is considering, in good faith, selecting [***] for the applicable Drug Discovery Program and such [***], then Ionis will notify Metagenomi (an &#147;<B>Initial Interest Notice</B>&#148; and the [***] identified
in such notice, a &#147;[***]&#148;). If Metagenomi reasonably believes that the costs to progress a Drug Discovery Plan for the applicable Collaboration Target with the [***] are more than [***] of the costs to progress a Drug Discovery Plan for a
[***] (the difference between the costs to progress a Drug Discovery Plan for a [***] <I>versus</I> the costs to progress a Drug Discovery Plan for the [***], the &#147;<B>Incremental Development Costs</B>&#148;), then Metagenomi will notify Ionis
of such Incremental Development Costs (an &#147;<B>Increased Cost Notice</B>&#148;) within [***] of receipt of the Initial Interest Notice. For a period of [***] from Ionis&#146; receipt of the Increased Cost Notice, the Parties will use
Commercially Reasonable Efforts to negotiate, in good faith, economic terms that compensate Metagenomi for the Incremental Development Costs. If the Parties are unable to mutually agree on such financial compensation during such [***] period, then,
at Ionis&#146; election, (i)&nbsp;Ionis may select a different [***] and the process set forth in this <U>Section&nbsp;2.2.4(c)</U> (Incremental Development Costs) will continue to apply until (1)&nbsp;the Parties agree on financial terms to
compensate Metagenomi for the applicable Incremental Development Costs for [***], (2)&nbsp;Metagenomi does not provide an Increased Cost Notice for a [***], or (3)&nbsp;the [***], or (ii)&nbsp;Ionis may select a [***]. If the Parties mutually agree
on the economic terms [***] or if Metagenomi has not provided an Increased Cost Notice to Ionis for a [***] as set forth above, then, in either case, such [***] will be set forth in the applicable Drug Discovery Plan, [***], and such mutually agreed
economic terms will be set forth in a written agreement between the Parties. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.2.5</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Development of </B>[***]<B> for a Drug Discovery Program</B>. If either Party wishes to Develop a Licensed
Product comprising a [***] that is not already set forth in the Drug Discovery Plan for such Drug Discovery Program, then such Party may propose such additional activities to the other Party and the Parties will discuss whether to amend such Drug
Discovery Plan or create a separate Drug Discovery Program for such [***]. If the Parties agree to include the additional [***] in the Drug Discovery Program, then the Parties will enter into a mutually acceptable amended Drug Discovery Plan that
includes the additional [***]. For clarity, neither Party will have any obligation to agree to amend a Drug Discovery Plan to include any additional [***] that were not set forth in the initial Drug Discovery Plan for the applicable Drug Discovery
Program. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.2.6</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Delivery of Development Candidate; Development Candidate Report</B>. The objective of each Drug Discovery
Plan will be to identify both a lead and a backup candidate for development that each meet the development candidate criteria set forth in such Drug Discovery Plan. No later than [***] after completion by the Parties of all Drug Discovery Activities
set forth under the applicable Drug Discovery Plan with respect to each Collaboration Target, or such earlier time mutually agreed upon by the Parties, each Party will deliver to the JSC a report summarizing all results, information, and data that
were generated in connection with the performance of the Drug Discovery Activities under such Drug Discovery Plan, including information regarding any therapeutic agents that meet the development candidate criteria (each, a &#147;<B>Development
Candidate Report</B>&#148;). Following receipt of the Development Candidate Reports, and at such earlier times that the Parties have exchanged data and results regarding any therapeutic agent that meets the development candidate criteria set forth
in the applicable Drug Discovery Plan, the JSC will review and discuss such Development Candidate Reports and other data and results, and Ionis may, in its sole discretion, elect to designate one or more such therapeutic agents as Development
Candidates hereunder (regardless of whether any such therapeutic agents meet the development candidate criteria). </P></TD></TR></TABLE> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.2.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Drug Discovery Term</B>. On a Drug Discovery Program-by-Drug Discovery Program basis, the Drug Discovery
Activities for a Drug Discovery Program will be performed by or on behalf of the Parties during the period commencing on the selection of a Collaboration Target for such Drug Discovery Program and, unless this Agreement is earlier terminated with
respect to such Collaboration Target, expiring upon the earlier of (a)&nbsp;completion of all Drug Discovery Activities set forth in the Drug Discovery Plan for such Drug Discovery Program and presentation to the JSC of such Drug Discovery
Activities, (b)&nbsp;the fifth anniversary of the Effective Date, and (c)&nbsp;selection of a Development Candidate for such Drug Discovery Program (the &#147;<B>Drug Discovery Term</B>&#148;); <I>provided</I> that (x)&nbsp;if one or more Wave 2
Targets become Collaboration Targets in accordance with <U>Section&nbsp;2.1</U> (Selection of Collaboration Targets) as a result of the Parties achieving Enabled Delivery for the tissue that such Wave 2 Target is delivered to and less than two years
are remaining in the Drug Discovery Term for such Wave 2 Target, then clause (b)&nbsp;will be extended to the earlier of (i)&nbsp;the time that Metagenomi completes all of its activities under the applicable Drug Discovery Plan for such Wave 2
Target, and (ii), with Metagenomi&#146;s consent, not to be unreasonably withheld, delayed, or conditioned (taking into account whether it is substantially likely that a Development Candidate will be identified and designated for such Wave 2 Target
during any extended Drug Discovery Term and the resources that Metagenomi will need to reasonably allocate to applicable Drug Discovery Term activities), the seventh anniversary of the Effective Date. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>2.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exploratory Research Program. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.3.1</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exploratory Research Plan</B>. The principal Development objectives to enable improved Guide RNA, [***]
delivery strategies, and any other Development activities that the JRC agrees to include pursuant to any amendment under <U>Section&nbsp;2.3.2</U> (Amendments to the Exploratory Research Plan) (the &#147;<B>Exploratory Research Program</B>&#148;)
will be set forth in a written plan that includes: (a)&nbsp;the specific activities to be performed by each Party and (b)&nbsp;the estimated timelines for the performance of such activities (such plan, as may be updated from time to time, the
&#147;<B>Exploratory Research Plan</B>&#148; and the activities to be performed by the Parties thereunder, the &#147;<B>Exploratory Research Activities</B>&#148;). In addition, the Exploratory Research Plan will include a written budget pursuant to
which Metagenomi will perform the Exploratory Research Activities allocated to Metagenomi under such Exploratory Research Plan, which budget will include (i)&nbsp;the number of FTEs to be dedicated by Metagenomi under the Exploratory Research Plan,
and (ii)&nbsp;any Out-of-Pocket Costs expected to be incurred by Metagenomi in the performance of such Exploratory Research Activities on a line-item basis (the &#147;<B>Exploratory Research Budget</B>&#148;). The initial Exploratory Research Plan
is set forth on <U>Schedule 2.3.1</U> (Exploratory Research Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.3.2</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Amendments to the Exploratory Research Plan</B>. At least annually during the Exploratory Research Term no
later than [***] of each Calendar Year, or upon either Party&#146;s request, the JRC will develop and propose updates to the Exploratory Research Plan or Exploratory Research Budget for the next fiscal year, or such other period as the Parties may
mutually agree, and will submit any such proposed change to the JSC. Additionally, at any time during the Exploratory Research Term, the JRC may develop and propose <I>ad hoc</I> updates to the Exploratory Research Plan or Exploratory Research
Budget </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
based on the then-current results and data. The JSC will review, discuss, and determine whether to approve any such proposed change to the Exploratory Research Plan or Exploratory Research
Budget. Each such update to the Exploratory Research Plan or Exploratory Research Budget will become effective and will supersede the previous Exploratory Research Plan or Exploratory Research Budget upon approval thereof by the JSC.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.3.3</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exploratory Research Term</B>. The Exploratory Research Activities will be performed by or on behalf of the
Parties during the period commencing on the Effective Date and, unless this Agreement is earlier terminated with respect to the Exploratory Research Program, expiring upon the earlier of (a)&nbsp;completion of all Exploratory Research Activities set
forth in the Exploratory Research Plan, and (b)&nbsp;the fifth anniversary of the Effective Date (the &#147;<B>Exploratory Research Term</B>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>2.4</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Conduct of Collaboration Activities</B>. Each Party, directly or through its Affiliates or, subject to
<U>Section&nbsp;3.3</U> (Subcontractors), Subcontractors, will use Commercially Reasonable Efforts to conduct the Drug Discovery Activities and Exploratory Research Activities (collectively, the &#147;<B>Collaboration Activities</B>&#148;) assigned
to it under the applicable Drug Discovery Plan or Exploratory Research Plan (collectively, the &#147;<B>Collaboration Program Plans</B>&#148;) and in a professional and timely manner. Each Party will, and will require its Affiliates and
Subcontractors to, perform its obligations under the Collaboration Program Plans in compliance with Applicable Law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>2.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cost of Collaboration Activities. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.5.1</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reimbursement by Ionis</B>. Ionis will reimburse Metagenomi for all (a)&nbsp;Internal Costs and
(b)&nbsp;Out-of-Pocket Costs (provided with reasonable supporting documentation), in each case ((a) and (b)), actually incurred by Metagenomi in the performance of the Exploratory Research Activities during the Exploratory Research Term to the
extent in compliance with both the Exploratory Research Plan and the amounts budgeted therefor in the Exploratory Research Budget [***] (such amount, the &#147;<B>Metagenomi Exploratory Research Costs</B>&#148;) up to $10,000,000 in the aggregate
(the &#147;<B>Reimbursement Cap</B>&#148;). If the aggregated Metagenomi Exploratory Research Costs during the Exploratory Research Term are <I>less</I> than the Reimbursement Cap, then Ionis will also reimburse Metagenomi for all (1)&nbsp;Internal
Costs and (2)&nbsp;Out-of-Pocket Costs (provided with reasonable supporting documentation), in each case ((1) and (2)), actually incurred by Metagenomi in the performance of the Drug Discovery Activities during the Exploratory Research Term to the
extent in compliance with both the applicable Drug Discovery Plans and the amounts budgeted therefor in the applicable Drug Discovery Budgets [***] (&#147;<B>Metagenomi Drug Discovery Costs</B>&#148;) up to [***]. In each Calendar Quarter during the
Exploratory Research Term, unless and until Ionis&#146; aggregated payments under this <U>Section&nbsp;2.5.1</U> (Reimbursement by Ionis) reach the Reimbursement Cap, Ionis will pay Metagenomi $500,000 to cover the Metagenomi Exploratory Research
Costs and, if applicable, the Metagenomi Drug Discovery Costs for such Calendar Quarter (such amount, the &#147;<B>Quarterly Reimbursement Payments</B>&#148;), within [***] following receipt of an invoice from Metagenomi therefor. No later than
[***] following the conclusion of each [***] during the Exploratory Research Term, Metagenomi will provide to Ionis a written report of all Metagenomi Exploratory Research Costs and Metagenomi Drug Discovery Costs incurred by or on behalf of
Metagenomi during the applicable [***] (such reports, the &#147;<B>Metagenomi Collaboration Cost Reports</B>&#148;). If the amount set forth in the Metagenomi Collaboration Cost Report for a [***], then no further action is required by the Parties,
except that [***]. If the amount set forth in the Metagenomi Collaboration Cost Report for [***], then [***]under this <U>Section&nbsp;2.5.1</U> (Reimbursement by Ionis). For clarity, Ionis will have the right to [***]. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.5.2</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cost of Other Collaboration Activities</B>. Except with respect to amounts reimbursed by Ionis pursuant to
<U>Section&nbsp;2.5.1</U> (Reimbursement by Ionis), Metagenomi will be responsible for all costs and expenses incurred by or on behalf of Metagenomi in the performance of the Collaboration Activities allocated to Metagenomi in the applicable
Collaboration Program Plans, including in the performance of all Drug Discovery Activities after the expiration of the Exploratory Research Term. In addition, Ionis will be responsible for all costs and expenses incurred by or on behalf of Ionis in
the performance of the Collaboration Activities allocated to Ionis in the applicable Collaboration Program Plans. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>2.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Collaboration Program Records and Reports. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.6.1</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Records</B>. Each Party will maintain, or cause to be maintained, records of its Collaboration Activities in
sufficient detail and in a good scientific manner appropriate for scientific, patent, and regulatory purposes, which records will reasonably reflect the work performed by such Party under each Collaboration Program Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.6.2</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Collaboration Program Reports</B>. During the Collaboration Term, in advance of each meeting of the JSC
(unless otherwise agreed by the JSC), each Party will submit to the JSC for its review and discussion written materials that include a reasonably detailed summary of the Collaboration Activities performed by or on behalf of such Party during the
most recently completed Calendar Quarter, which summary will include an estimate of the number of personnel that are performing Collaboration Activities for such Party in such Calendar Quarter (each, a &#147;<B>Collaboration Program
Report</B>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>2.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Proprietary Toolbox of Chemical Modifications. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.7.1</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Option Grant</B>. If any Ionis Proprietary Toolbox of Chemical Modifications is necessary or reasonably
useful for Metagenomi to practice any Metagenomi Collaboration Technology or Joint Collaboration Technology (such Intellectual Property Rights, &#147;<B>Ionis Background Technology</B>&#148;), then Metagenomi will have an option to obtain the
license set forth in <U>Section&nbsp;3.2.3(a)</U> (Ionis Background Technology License Grant) to Exploit up to eight Metagenomi Products in the Field (&#147;<B>Ionis IP Option</B>&#148;). [***]. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.7.2</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Option Exercise</B>. Metagenomi may exercise an Ionis IP Option by providing written notice to Ionis
(&#147;<B>Option Exercise Notice</B>&#148;) at any time during the period commencing on [***] and ending on [***] after the expiration of the [***] of the Effective Date (the &#147;<B>Option Term</B>&#148;), which notice will identify one or more
targets that Metagenomi proposes to designate as Metagenomi Targets to which the applicable Metagenomi Product will be directed (each, a &#147;<B>Proposed Metagenomi Target</B>&#148; and such notice, a &#147;<B>Proposed Metagenomi Target
Notice</B>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.7.3</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Encumbrance Check</B>.<B></B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Encumbered Targets</B>. Ionis will notify Metagenomi within [***] after Ionis&#146; receipt of a Proposed
Metagenomi Target Notice if, at the time of receipt of such notice, (i)&nbsp;[***], (ii)&nbsp;[***], or (iii)&nbsp;[***] (each of (i)&nbsp;through (iii), a &#147;<B>Pre-Existing Ionis Restriction</B>&#148; and such Proposed Metagenomi Target, an
&#147;<B>Encumbered Proposed Metagenomi Target</B>&#148;). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B></B>(b)<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Effects if a Proposed Metagenomi Target is not an Encumbered Proposed Metagenomi Target</B>. If Ionis
does not notify Metagenomi within [***] after Ionis&#146; receipt of a Proposed Metagenomi Target Notice that the applicable Proposed Metagenomi Target is an Encumbered Proposed Metagenomi Target, then Metagenomi may provide a second notice to Ionis
indicating that the Proposed Metagenomi Target will be deemed a &#147;Metagenomi Target&#148; if Ionis does not respond to such second notice within [***]. If Ionis (i)&nbsp;notifies Metagenomi that a Proposed Metagenomi Target is not an Encumbered
Proposed Metagenomi Target or (ii)&nbsp;does not provide notice that a Proposed Metagenomi Target is an Encumbered Proposed Metagenomi Target within the original [***] period or within [***] after Metagenomi&#146;s second notice (such date, the
&#147;<B>Ionis IP Option Effective Date</B>&#148;), then, in either case, (A)&nbsp;the Proposed Metagenomi Target will automatically be deemed to be a &#147;Metagenomi Target&#148; under this Agreement with no further action by the Parties, and
(B)&nbsp;the license to Metagenomi under <U>Section&nbsp;3.2.3(a)</U> (Ionis Background Technology License Grant) will be effective with respect to Metagenomi Products for such Metagenomi Target. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.7.4</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I<B>onis Background Technology Transfer</B>. On a Metagenomi Target-by-Metagenomi Target basis, no later than
[***] after the Ionis IP Option Effective Date for each Metagenomi Target, Ionis will transfer to Metagenomi all Ionis Background Technology that is necessary or determined by Ionis in good faith to be reasonably useful, in each case, for Metagenomi
to Exploit the applicable Metagenomi Product for such Metagenomi Target in the Field. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Licenses; Exclusivity </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>3.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>License Grants to Ionis. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Collaboration Activities License</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Collaboration Activities License Grant</B>. Subject to the terms of this Agreement, Metagenomi hereby grants
to Ionis and its Affiliates a non-exclusive, royalty-free license, with the right to sublicense through multiple tiers (subject to <U>Section&nbsp;3.1.1(b)</U> (Sublicensing by Ionis)), under the Licensed Technology to perform (or have performed in
accordance with this Agreement) all Collaboration Activities allocated to Ionis under each Collaboration Program Plan during the Collaboration Term. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sublicensing by Ionis</B>. Ionis may grant sublicenses of any rights granted by Metagenomi under
<U>Section&nbsp;3.1.1(a)</U> (Collaboration Activities License Grant) through multiple tiers to any of its Affiliates or to one or more Subcontractors that are not [***]. Each such sublicense will be consistent with the terms of this Agreement and
will require such Sublicensee to comply with all applicable terms of this Agreement. Ionis will remain responsible for its Sublicensees&#146; compliance with the applicable terms of this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exclusive Exploitation License</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exclusive Exploitation License Grant</B>. Subject to the terms of this Agreement, Metagenomi hereby grants
to Ionis and its Affiliates an exclusive, royalty-bearing license, with the right to sublicense through multiple tiers (subject to <U>Section&nbsp;3.1.2(c)</U> (Sublicensing by Ionis)), under the Licensed Technology to Exploit all Licensed Systems
and Licensed Products solely in the Field in the Territory. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Limitations</B>. Notwithstanding the license granted to Ionis pursuant to <U>Section&nbsp;3.1.1(a)</U>
(Collaboration Activities License Grant) and <U>Section&nbsp;3.1.2(a)</U> (Exclusive Exploitation License Grant), subject to the terms of this Agreement, Metagenomi will retain non-exclusive rights under the Licensed Technology in the Field in the
Territory for the sole purpose of performing the Metagenomi Activities or fulfilling its obligations under this Agreement, in each case, either itself or through its Affiliates, or Subcontractors. For clarity, Metagenomi will retain all rights under
the Licensed Technology and Licensed Systems for use outside of the Field. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sublicensing by Ionis</B>. Ionis may grant sublicenses of any rights granted by Metagenomi under
<U>Section&nbsp;3.1.2(a)</U> (Exclusive Exploitation License Grant) through multiple tiers to any of its Affiliates or to one or more Sublicensees without the consent of Metagenomi; <I>provided</I> that such Sublicensees are not [***]. Each such
sublicense will be consistent with the terms of this Agreement and will require such Sublicensee to comply with all applicable terms of this Agreement. Ionis will remain responsible for its Sublicensees&#146; compliance with the applicable terms of
this Agreement. Promptly following Ionis&#146; grant of a sublicense to a Sublicensee, Ionis will notify Metagenomi of such sublicense. Upon Metagenomi&#146;s written request, Ionis will provide Metagenomi with a fully-executed copy of any agreement
reflecting any such sublicense (excluding any sublicense with an Affiliate of Ionis&#146; or any Third Party acting on Ionis&#146; behalf), which may be reasonably redacted to exclude Ionis&#146; proprietary information, other competitively
sensitive information, or any other information not necessary for Metagenomi to verify compliance with the preceding sentence, which copy will be treated as Ionis&#146; Confidential Information. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Unblocking License</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Unblocking License Grant</B>. Subject to the terms of this Agreement, including the license granted pursuant
to <U>Section&nbsp;3.1.2(a)</U> (Exclusive Exploitation License Grant), Metagenomi hereby grants to Ionis and its Affiliates a [***] non-exclusive license, with the right to sublicense through multiple tiers (subject to <U>Section&nbsp;3.1.3(b)</U>
(Sublicensing by Ionis)), under Metagenomi&#146;s interest in the Joint Collaboration Technology [***] in the Unblocking Field in the Territory. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sublicensing by Ionis</B>. Ionis may grant sublicenses of any rights granted by Metagenomi under
<U>Section&nbsp;3.1.3(a)</U> (Unblocking License Grant) through multiple tiers to any of its Affiliates or to one or more Sublicensees to which Ionis grants a license to [***]. Each such sublicense will be consistent with the terms of this Agreement
and will require such Sublicensee to comply with all applicable terms of this Agreement. Ionis will remain responsible for its Sublicensees&#146; compliance with the applicable terms of this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>3.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>License Grants to Metagenomi. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Metagenomi Activities License</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Metagenomi Activities License Grant.</B> Subject to the terms of this Agreement, Ionis hereby grants to
Metagenomi a non-exclusive, royalty-free license, with the right to sublicense through multiple tiers (subject to the provisions of <U>Section&nbsp;3.2.1(b)</U> (Sublicensing by Metagenomi)), under the Ionis Licensed Technology solely to perform the
Collaboration Activities assigned to Metagenomi under the Collaboration Program Plans ( the &#147;<B>Metagenomi Activities</B>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Sublicensing by Metagenomi</B>. Metagenomi may grant sublicenses of any rights granted by Ionis under
<U>Section&nbsp;3.2.1(a)</U> (Metagenomi Activities License Grant) through multiple tiers to any of its Affiliates or to one or more Subcontractors that are not [***]. Each such sublicense will be consistent with the terms of this Agreement and will
require such Sublicensee to comply with all applicable terms of this Agreement. Metagenomi will remain responsible for each Sublicensee&#146;s compliance with the applicable terms of this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Unblocking License</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Unblocking License Grant</B>. Subject to the terms of this Agreement, Ionis hereby grants to
Metagenomi and its Affiliates a [***] non-exclusive license, with the right to sublicense through multiple tiers (subject to <U>Section&nbsp;3.2.2(b)</U> (Sublicensing by Metagenomi)), under Ionis&#146; interest in the Joint Collaboration Technology
[***] in the Unblocking Field in the Territory. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sublicensing by Metagenomi</B>. Metagenomi may grant sublicenses of any rights granted by Ionis under
<U>Section&nbsp;3.2.2(a)</U> (Unblocking License Grant) through multiple tiers to any of its Affiliates or to one or more Sublicensees to which Metagenomi grants a license to [***]. Each such sublicense will be consistent with the terms of this
Agreement and will require such Sublicensee to comply with all applicable terms of this Agreement. Metagenomi will remain responsible for its Sublicensees&#146; compliance with the applicable terms of this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.2.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Background Technology License</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Ionis Background Technology License Grant</B>. Subject to <U>Section&nbsp;2.7</U> (Ionis Proprietary
Toolbox of Chemical Modifications), effective upon the Ionis IP Option Effective Date for a Metagenomi Target, Ionis hereby grants to Metagenomi a non-exclusive, royalty-bearing license with the right to grant sublicenses through multiple tiers
(subject to <U>Section&nbsp;3.2.3(b)</U> (Sublicensing by Metagenomi)) under the Ionis Background Technology solely to Exploit Metagenomi Products for such Metagenomi Target in the Field. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sublicensing by Metagenomi</B>.<B></B> Metagenomi may grant sublicenses of any rights granted by Ionis under
<U>Section&nbsp;3.2.3(a)</U> (Ionis Background Technology License Grant) through multiple tiers to any of its Affiliates or to one or more Sublicensees to which Metagenomi grants a license to Exploit the Metagenomi Products; <I>provided</I> that
such Sublicensees are not [***]. Each such sublicense will be consistent with the terms of this Agreement and will require such Sublicensee to comply with all applicable terms of this Agreement. Metagenomi will remain
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="23%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
responsible for its Sublicensees&#146; compliance with the applicable terms of this Agreement. Promptly following Metagenomi&#146;s grant of a sublicense to a Sublicensee, Metagenomi will notify
Ionis of such sublicense. Upon Ionis&#146; written request, Metagenomi will provide Ionis with a fully-executed copy of any agreement reflecting any such sublicense (excluding any sublicense with an Affiliate of Metagenomi), which may be reasonably
redacted to exclude Metagenomi&#146;s proprietary information, other competitively sensitive information, or any other information not necessary for Ionis to verify compliance with the preceding sentence, which copy will be treated as
Metagenomi&#146;s Confidential Information. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>3.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Subcontractors</B><B>.</B> Each Party and its Affiliates may perform any of its obligations under
this Agreement through one or more Subcontractors; <I>provided</I> that (a)&nbsp;neither Party nor its Affiliates will engage any subcontractor that has been debarred by any Regulatory Authority; (b)&nbsp;the subcontracting Party remains fully
responsible for the work allocated to, and payment to, such subcontractors to the same extent it would if it had done such work itself; (c)&nbsp;the subcontractor undertakes in writing obligations of confidentiality and non-use applicable to the
Confidential Information that are at least as stringent as those set forth in<U> Article 11</U> (Confidentiality) other than the term of any such confidentiality obligation, which will be customary for the nature of the Subcontractor;
(d)&nbsp;require such Subcontractor and its personnel to assign (or, if such Party, after using Commercially Reasonable Efforts, cannot obtain an assignment, then to grant a perpetual license) to such Party of all rights, title, and interests in and
to any Patent Rights or Know-How created, conceived, or developed in connection with the performance of subcontracted activities; <I>provided</I> that such Subcontractor and its personnel will not be required to assign its rights, title, and
interests to any of its background intellectual property or improvements thereto; (e)&nbsp;the subcontracting Party will be liable for any act or omission of any Subcontractor that is a breach of any of the subcontracting Party&#146;s obligations
under this Agreement as though the same were a breach by the subcontracting Party; (f)&nbsp;each Party will use good faith efforts to identify in writing to the other Party any Subcontractor that it engages to perform Collaboration Activities and
will only engage Subcontractors to perform the Collaboration Activities to the extent and in a manner consistent with such Party&#146;s engagement of subcontractors for other internal Development programs; (g)&nbsp;Ionis [***]; and
(h)&nbsp;Metagenomi [***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>3.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Technology Transfer. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.4.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Initial Transfers</B>. On a Collaboration Target-by-Collaboration Target basis, no later than (a)&nbsp;for
[***] after the Effective Date and (b)&nbsp;for each new Collaboration Target, [***] after the applicable target becomes a Collaboration Target pursuant to <U>Section&nbsp;2.1.1(b)</U> (Second Wave 1 Target) or <U>Section&nbsp;2.1.4(c)</U> (Effects
if a Proposed Target is Available), each Party will transfer to the other Party all Ionis Licensed Technology or Licensed Technology (as applicable), with respect to [***], as of the Effective Date, or, with respect to Collaboration Targets that
become such after the Effective Date, at the time that a target becomes a Collaboration Target, in each case, that is [***] to perform the activities allocated to the non-transferring Party under the Drug Discovery Plan for the applicable
Collaboration Target. In addition, each Party will transfer to the other Party all Ionis Licensed Technology or Licensed Technology (as applicable) that is [***] for the non-transferring Party to perform the activities allocated to the
non-transferring Party under the Exploratory Research Plan no later than [***] after the Effective Date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.4.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Additional Transfers</B>. Following the initial transfers described in <U>Section&nbsp;3.4.1</U> (Initial
Transfers), (a)&nbsp;promptly after [***] and (b)&nbsp;[***], Metagenomi will provide prompt updates to Ionis regarding any Licensed Know-How not previously transferred to Ionis that is [***] for Ionis to continue Exploiting the Licensed Systems and
Licensed Products, in each case, that relate to the Development Candidates being Exploited, or that Ionis, at such time, intends to Exploit, under this Agreement. During the Term, as reasonably requested by Ionis, Metagenomi will promptly provide
Ionis with any information specifically identified by Ionis and included in the Licensed Technology that is [***] for Ionis to Exploit the Licensed Systems or Licensed Products that relate to the Development Candidates being Exploited, or that
Ionis, at such time, intends to Exploit, and has not previously been transferred to Ionis under this Agreement. Metagenomi will provide such information to Ionis within [***] after Ionis&#146; request. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.4.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Assistance by Metagenomi Personnel</B>. To assist with the transfer of Licensed Know-How under this
<U>Section&nbsp;3.4</U> (Technology Transfer) and Ionis&#146; Exploitation thereof in accordance with the terms of this Agreement during the Term, Metagenomi will make its personnel reasonably available to Ionis during normal business hours to
transfer such Licensed Know-How to Ionis and respond to Ionis&#146; reasonable inquiries with respect thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.4.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Costs of Support</B>. On a Collaboration Program-by-Collaboration Program basis, Metagenomi will provide the
first [***] FTE hours of technology transfer, or technical or regulatory assistance under this <U>Section&nbsp;3.4</U> (Technology Transfer), <U>Section&nbsp;7.2.2</U> (Assistance; Support) and <U>Section&nbsp;7.3</U> (Regulatory Support) for a
Collaboration Program at Metagenomi&#146;s cost and expense. On a Collaboration Program-by-Collaboration Program basis, for any such assistance in excess of [***] FTE hours for a Collaboration Program, Ionis will reimburse Metagenomi for its
reasonable, documented Internal Costs with respect thereto within [***] of receipt of a reasonably detailed invoice therefor. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>3.5</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No Implied Licenses</B>. Except as expressly provided in this Agreement, neither Party will be deemed to
have granted the other Party any license or other right with respect to any Intellectual Property Rights of such Party. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>3.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exclusivity</B>. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.6.1</B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exclusivity Obligations</B>. Subject to <U>Section&nbsp;3.6.2</U> (Acquisition of Distracting Product) and
<U>Section&nbsp;3.6.3</U> (Change of Control), except in the performance of its obligations or exercise of its rights under this Agreement, neither Party nor any of its Affiliates will work independently or for or with any Third Party (including the
grant of any license to any Third Party) to: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">on a Drug Discovery Program-by-Drug Discovery Program basis, (i)&nbsp;during the Drug Discovery Term for a Drug
Discovery Program, Develop or Commercialize any product that targets the Collaboration Target in the Exclusivity Field, and (ii)&nbsp;until the earlier of the (1)&nbsp;[***] period after the expiration of the Drug Discovery Term for a Drug Discovery
Program or (2)&nbsp;[***] period after the Effective Date, clinically Develop or Commercialize any product that targets a Collaboration Target in the Exclusivity Field that is actively being Developed by Ionis under this Agreement for such Drug
Discovery Program; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">on a Co-Co Program-by-Co-Co Program basis, during the period commencing on the date [***] and expiring [***],
Develop or Commercialize any product that targets the Collaboration Target for such Co-Co Program in the Exclusivity Field. For clarity, the limitations set forth in this <U>Section&nbsp;3.6.1</U> (Exclusivity Obligations) will not apply to any
Collaboration Target that is substituted out in accordance with <U>Section&nbsp;2.1.3</U> (Target Substitutions). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.6.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Acquisition of Distracting Product</B>. Notwithstanding the provisions of <U>Section&nbsp;3.6.1</U>
(Exclusivity Obligations), if a Party or any of its Affiliates (such Party, the &#147;<B>Distracted Party</B>&#148;) acquires rights to Develop or Commercialize a product in the Field as the result of a merger, acquisition, or combination with or of
a Third Party (where such Party is not the acquired entity) other than a Change of Control (each, an &#147;<B>Acquisition Transaction</B>&#148;) and, on the date of the closing of such Acquisition Transaction, such product is being Developed or
Commercialized and such activities would, but for the provisions of this <U>Section&nbsp;3.6.2</U> (Acquisition of Distracting Product), constitute a breach of <U>Section&nbsp;3.6.1</U> (Exclusivity Obligations) (such product, a &#147;<B>Distracting
Product</B>&#148;), then the Distracted Party or such Affiliate will, within [***] after the closing of such Acquisition Transaction notify the other Party in writing of such acquisition and either: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">request that such Distracting Product be included in this Agreement on terms to be negotiated, in which case,
the Parties will discuss the matter in good faith for a period of no less than [***] and, if the Parties are unable to reach agreement on the terms on which such Distracting Product would be included hereunder within such period, then the Distracted
Party will elect to take the action specified in either <U>Section&nbsp;3.6.2(b)</U> or <U>Section&nbsp;3.6.2(c)</U> below; <I>provided</I> that the time periods specified in such clauses will be tolled for so long as the Parties are engaged in good
faith discussion under this <U>Section&nbsp;3.6.2(a)</U>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">notify the other Party in writing that the Distracted Party or its Affiliate will [***], in which case, within
[***] after the closing of the Acquisition Transaction, the Distracted Party or its Affiliate will [***]; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">notify the other Party in writing that it [***], in which case, within [***] after the other Party&#146;s
receipt of such notice, the Distracted Party and its Affiliates will [***]. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:16%; text-indent:7%; font-size:10pt; font-family:Times New Roman">During the discussion
period under <U>Section&nbsp;3.6.2(a)</U>, prior to the time of [***] to <U>Section&nbsp;3.6.2(b)</U>, or prior to the [***] pursuant to <U>Section&nbsp;3.6.2(c)</U>, as applicable, the Distracted Party and its Affiliates will segregate all
activities relating to the Distracting Product from the Exploitation of the Licensed Systems or Licensed Products under this Agreement, including ensuring that (i)&nbsp;no personnel involved in performing Development or Commercialization activities
with respect to such Distracting Product have access to non-public plans or information relating to the Development or Commercialization of Licensed Systems or Licensed Products under this Agreement (except that [***]), and (ii)&nbsp;no personnel
involved in performing Development or Commercialization activities with respect to Licensed Systems or Licensed Products under this Agreement have access to non-public plans or information relating to the Development or Commercialization of such
Distracting Product (except that [***]). The procedures set forth in clauses (i)&nbsp;and (ii)&nbsp;above will be referred to as &#147;<B>Firewall Procedures</B>&#148; for the purposes of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.6.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Change of Control</B>. If there is a Change of Control involving a Party (where such Party is the
acquired entity), then: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the obligations of <U>Section&nbsp;3.6.1</U> (Exclusivity Obligations) will not apply to any product that is
controlled by the relevant acquirer or its Affiliates and that exists prior to the closing of such Change of Control; provided that (i)&nbsp;the acquired Party and the acquirer and its Affiliates existing immediately prior to the effective date of
such Change of Control [***], (ii)&nbsp;the acquirer and its Affiliates existing immediately prior to the effective date of such Change of Control [***], and (iii)&nbsp;no personnel who were employees or consultants of the acquired Party or its
Affiliates at any time prior to or after the Change of Control will [***]; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if Ionis is the acquired entity and the acquiring entity is a [***], then Ionis will ensure that the acquiring
entity establishes and implements Firewall Procedures to segregate and protect Confidential Information related to the Licensed Systems and Licensed Products from access to or use by the acquiring party other than as permitted by this Agreement; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if Metagenomi is the acquired entity and the acquiring entity is an [***], then Metagenomi will ensure that the
acquiring entity establishes and implements Firewall Procedures to segregate and protect Confidential Information related to the Licensed Systems, Licensed Products, and Ionis Background Technology from access to or use by the acquiring party other
than as permitted by this Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;4 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Governance </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>4.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Joint Steering Committee</B><B>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Formation and Purpose of the JSC</B>. Promptly, but no later than [***] after the Effective Date, the
Parties will establish a Joint Steering Committee (&#147;<B>JSC</B>&#148;), which JSC will coordinate, oversee, and monitor the Parties&#146; activities hereunder in accordance with this <U>Section&nbsp;4.1</U> (Joint Steering Committee). The JSC
will have the responsibilities set forth herein and will have no further responsibilities (a)&nbsp;with respect to the Exploratory Research Program, upon the expiration of the Exploratory Research Term, and (b)&nbsp;with respect to any Drug
Discovery Program, upon the expiration of the Drug Discovery Term for such Drug Discovery Program. Upon the latest to occur of (a)-(b), the JSC will be dissolved. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Membership</B>. Each Party will designate [***] representatives with appropriate expertise and seniority to
serve as members of the JSC, and who have the authority to bind such Party with respect to matters within the purview of the JSC. Each Party may replace its JSC representatives at any time upon written notice to the other Party. Metagenomi will
designate one of its JSC members as one of the co-chairpersons of the JSC and Ionis will designate one of its members as the other co-chairperson of the JSC. Every [***] the co-chairpersons will alternate serving in the role of &#147;lead
co-chairperson.&#148; The lead co-chairperson or his or her designee, in collaboration with the Alliance Managers, will be responsible for calling meetings, preparing and circulating an agenda in advance of each meeting, and preparing and issuing
minutes of each meeting within [***]thereafter. Such minutes will be deemed finalized unless any JSC member objects to the accuracy of such minutes no later than [***] after receipt of such minutes. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Meetings</B>. The JSC will meet in person, by videoconference, or by teleconference at least once each
[***], unless otherwise agreed by the Parties, on such dates and at such times and places as agreed to by the members of the JSC. The Alliance Manager of each Party will attend each meeting of the JSC as a non-voting participant. Each Party will be
responsible for all of its own expenses in participating in any JSC meeting. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.1.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Meeting Agendas</B>. Each Party will disclose to the other Party the proposed agenda items at least
[***] in advance of each meeting of the JSC. Notwithstanding the foregoing, under exigent circumstances requiring JSC input, a Party may provide its agenda items to the other Party within a lesser period of time in advance of the meeting, or may
propose that there not be a specific agenda for a particular meeting, so long as such other Party consents to such later addition of such agenda items or the absence of a specific agenda for such JSC meeting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.1.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Specific Responsibilities of the JSC</B>. The responsibilities of the JSC will be to:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">oversee the overall strategic relationship between the Parties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">review, discuss, and determine whether it is technologically infeasible to Develop a Development Candidate for
a given Collaboration Target, as described in <U>Section&nbsp;2.1.3(b)</U> (Substitutions for Technological Infeasibility); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">review, discuss, and determine whether to approve each Drug Discovery Plan, and any updates thereto, pursuant
to <U>Section&nbsp;2.2.2</U> (Additional Drug Discovery Plans) and <U>Section&nbsp;2.2.3</U> (Amendments to the Drug Discovery Plans); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">discuss and determine the [***] for the Second Wave 1 Target and each Proposed Target that is deemed a
Collaboration Target under this Agreement pursuant to <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available), as described in <U>Section&nbsp;2.2.4(b) </U>(Selection of Gene Editing Modalities); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">review and discuss each Development Candidate Report and any other data or results provided by Metagenomi
regarding therapeutic agents that meet the development candidate criteria set forth in a Drug Discovery Plan, pursuant to <U>Section&nbsp;2.2.6</U> (Delivery of Development Candidate; Development Candidate Report); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">review, discuss, and determine whether to approve any updates to the Exploratory Research Plan or Exploratory
Research Budget, pursuant to <U>Section&nbsp;2.3.2</U> (Amendments to the Exploratory Research Plan); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">review and discuss each Collaboration Program Report, pursuant to <U>Section&nbsp;2.6.2</U> (Collaboration
Program Reports); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">review and discuss the Regulatory Strategy for each Licensed Product, as described in <U>Section&nbsp;7.1</U>
(Regulatory Responsibility); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">coordinate the wind-down of any Terminated Products in the Terminated Countries to the extent the JSC is still
in effect at the time of the applicable termination notice, pursuant to <U>Section&nbsp;14.3.1</U> (Wind-Down); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">perform such other functions as appropriate to further the purposes of this Agreement as determined by the
Parties. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>4.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Subcommittees</B> . From time to time, the JSC may establish and delegate duties, including any
responsibilities of the JSC set forth in <U>Section&nbsp;4.1.5</U> (Specific Responsibilities of the JSC), to operational subcommittees (each, a &#147;<B>Subcommittee</B>&#148;) on an &#147;as-needed&#148; basis to oversee particular projects or
activities, which delegations will be reflected in the minutes of the meetings of the JSC. Such Subcommittees may be established on an <I>ad hoc</I> basis for purposes of a specific project, for the life of a Licensed Product, or on such other basis
as the JSC may determine, and will be constituted and will operate as the JSC may determine; <I>provided</I> that each Subcommittee will have equal representation from each Party and decision making will be by consensus, with each Party&#146;s
representatives on the applicable Subcommittee collectively having one vote on all matters brought before the Subcommittee. Each Subcommittee and its activities will be subject to the direction, review, and approval of, and, unless otherwise
determined by the JSC, will report to, the JSC. For each Subcommittee, Ionis will designate one of its Subcommittee members to serve as the chairperson of such Subcommittee. The chairperson or his or her designee, in collaboration with the Alliance
Managers, will be responsible for calling meetings, preparing and circulating an agenda in advance of each meeting, and preparing and issuing minutes of each meeting within [***] thereafter. Such minutes will not be finalized until all Subcommittee
members have had an adequate opportunity to review and confirm the accuracy of such minutes. Each Party may replace its representatives on each such Subcommittee at any time upon written notice to the other Party. The Alliance Manager of each Party
(or his or her designee) will attend each meeting of each Subcommittee as a non-voting participant. Each Subcommittee and its activities will be subject to the oversight of, and will report to, the JSC. Any disagreement between the representatives
of the Parties on a Subcommittee will be referred to the JSC for resolution in accordance with <U>Section&nbsp;4.6</U> (Decision-Making). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>4.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Joint Research Committee</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.3.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Formation and Purpose of the JRC</B>. Promptly, but no later than [***] after the creation of the JSC, the
Parties will establish a Joint Research Committee (&#147;<B>JRC</B>&#148;), which JRC will coordinate, oversee, and monitor the Parties&#146; research activities hereunder in accordance with this <U>Section&nbsp;4.3</U> (Joint Research Committee).
The JRC will be deemed a &#147;Subcommittee&#148; as described in <U>Section&nbsp;4.2</U> (Subcommittees). The JRC will have the responsibilities set forth herein and will dissolve upon the earlier of (a)&nbsp;the dissolution of the JSC,
(b)&nbsp;the expiration of the Collaboration Term, or (c)&nbsp;by mutual agreement between the Parties. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.3.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Membership</B>. Each Party will designate [***] representatives with appropriate expertise and seniority to
serve as members of the JRC, and who have the authority to bind such Party with respect to matters within the purview of the JRC. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.3.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Specific Responsibilities of the JRC</B>. The responsibilities of the JRC will be to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">coordinate the Collaboration Activities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">develop, discuss, and submit to the JSC to further review, discuss, and determine whether to approve each Drug
Discovery Plan, and any updates thereto, pursuant to <U>Section&nbsp;2.2.2</U> (Additional Drug Discovery Plans) and <U>Section&nbsp;2.2.3</U> (Amendments to the Drug Discovery Plans); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">develop, discuss, and submit to the JSC to further review, discuss, and determine whether to approve any
updates to the Exploratory Research Plan or Exploratory Research Budget, pursuant to <U>Section&nbsp;2.3.2</U> (Amendments to the Exploratory Research Plan); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">perform such other functions as determined by the JSC. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>4.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Alliance Managers</B> . Each of the Parties will appoint a single individual to coordinate
communications regarding the activities under this Agreement (each, an &#147;<B>Alliance Manager</B>&#148;). The role of the Alliance Manager is to act as a single point of contact between the Parties to ensure a successful relationship under this
Agreement. The Alliance Managers will attend any JSC meetings. Alliance Managers will be non-voting participants in all JSC meetings that they attend; <I>provided</I>, <I>however</I>, that an Alliance Manager may bring any matter to the attention of
the JSC if such Alliance Manager reasonably believes that such matter warrants such attention. Each Party will designate its initial Alliance Manager promptly after the Effective Date and each Party may change its designated Alliance Manager at any
time upon written notice to the other Party. Any Alliance Manager may designate a substitute to temporarily perform the functions of that Alliance Manager by written notice to the other Party. Each Alliance Manager may also: (a)&nbsp;be the point of
first referral in all matters of conflict resolution; (b)&nbsp;provide a single point of communication for seeking consensus between the Parties regarding key strategy and plan issues; (c)&nbsp;identify and bring disputes to the attention of the JSC
in a timely manner; and (d)&nbsp;plan and coordinate cooperative efforts. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>4.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Additional Participants</B><B></B>. Other employees of either Party or any of its Affiliates may
attend meetings of the JSC or any Subcommittees as non-voting participants with prior written notice to the other Party (including via email notification). In addition, with the consent of each Party, consultants, representatives, or advisors may
attend meetings of the JSC or any Subcommittees as non-voting observers; <I>provided</I>, <I>however</I>, that such Third Party participants and observers are under written obligations of confidentiality and non-use applicable to the Confidential
Information of each Party that are at least as stringent as those set forth in<U> Article 11</U> (Confidentiality). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>4.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Decision-Making</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4</B><B>.6.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Committee Decisions</B>. Each Party&#146;s representatives on the JSC will, collectively, have one vote (the
&#147;<B>Party Vote</B>&#148;) on all matters brought before such committee for a decision by consensus. The JSC will make decisions as to matters within its jurisdiction by unanimous Party Vote, which Party Vote will be reflected in the minutes of
the committee meeting. No vote will be binding on either Party unless each Party has at least one representative in attendance. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.6.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Scope of Committee Authority</B>. For the avoidance of doubt, matters that are specified in this<U> Article
4</U> (Governance) only to be reviewed and discussed (as opposed to reviewed, discussed, and approved) do not require any agreement or decision by either Party and are not subject to the voting and decision-making procedures set forth in this
<U>Section&nbsp;4.6</U> (Decision-Making). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.6.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Escalation</B>. If the representatives of Metagenomi and Ionis are unable to agree on or resolve any matter
requiring the approval of the JSC after the use of good faith efforts, within [***] after the JSC first considers such matter then, at the election of either Party, such Party may refer such matter to the Party&#146;s respective Executive Officer.
The Executive Officers will use good faith efforts to resolve any such disagreement so referred to them as soon as practicable, and any final decision that the Executive Officers agree to in writing will be conclusive and binding on the Parties. If
the Executive Officers are unable to resolve any such disagreement so referred to them within [***] following such referral (or such longer period as the Executive Officers may agree upon), then: </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Final Decision-Making Authority</B>. Ionis will have the right to make the final decision regarding
[***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Resolution by Baseball Arbitration</B>. Except for those matters set forth in <U>Section&nbsp;4.6.3(a)</U>
(Ionis Final Decision-Making Authority), either Party may refer the matter for resolution pursuant to <U>Section&nbsp;15.1.3</U> (Expedited Dispute Resolution). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.6.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General Authority</B>. The JSC and any Subcommittees will have solely the powers expressly assigned to them
in this<U> Article 4</U> (Governance) and elsewhere in this Agreement. In conducting themselves on the JSC, any Subcommittees, and as Alliance Managers, and in exercising their rights under this<U> Article 4</U> (Governance), all representatives of
each Party will consider diligently, reasonably, and in good faith all input received from the other Party, and will use good faith efforts to reach unanimity, where required, on all matters before them. Notwithstanding anything to the contrary set
forth in this Agreement, the JSC, and any Subcommittees will not have the right to make any decisions: (a)&nbsp;to amend, modify, or waive compliance with any term or condition of this Agreement; (b)&nbsp;in a manner that negates any consent right
or other right specifically allocated to a Party under this Agreement; (c)&nbsp;to resolve any dispute involving the breach or alleged breach of this Agreement; (d)&nbsp;to resolve a matter if the provisions of this Agreement specify that agreement
of the Parties, including consent of each Party, is required for such matter; (e)&nbsp;in a manner that a Party reasonably believes would require it to perform any act that would cause such Party to violate any Applicable Law or the requirements of
any Regulatory Authority, or otherwise breach any of its obligations hereunder; or (f)&nbsp;that otherwise expand the rights or reduce the obligations of either Party under this Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;5 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Co-Development and Co-Commercialization Options </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>5.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Co-Development and Co-Commercialization Options</B><B></B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>5.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Option Grant</B>. Ionis hereby grants to Metagenomi the exclusive option to co-Develop and co-Commercialize
with Ionis the Licensed Products under a Drug Discovery Program (a &#147;<B>Co-Co Option</B>&#148;), which Co-Co Option may be exercised for (a)&nbsp;[***], (b)&nbsp;no more than one of the other three Drug Discovery Programs for the Wave 1 Targets,
and (c)&nbsp;no more than two Drug Discovery Programs for the Wave 2 Targets that become Collaboration Targets. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>5.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Option Period</B>. On a Drug Discovery Program-by-Drug Discovery Program basis, Metagenomi may exercise a
Co-Co Option for a Drug Discovery Program by delivering written notice to Ionis of such exercise at any time during the [***] after the selection of [***] for such Drug Discovery Program (such notice, the &#147;<B>Co-Co Option Notice</B>&#148;, and
such [***], the &#147;<B>Co-Co Option Period</B>&#148;). Notwithstanding the foregoing, Metagenomi may terminate the Co-Co Option Period for a Drug Discovery Program early by providing written notice to Ionis at any time during such [***] that
Metagenomi does not elect to exercise its Co-Co Option for such Drug Discovery Program and, upon Ionis&#146; receipt of any such written notice the Co-Co Option Period for such Drug Discovery Program, the Co-Co Option Period for such Drug Discovery
Program will be deemed to have expired </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
and Metagenomi may not thereafter exercise the Co-Co Option for such Drug Discovery Program. No more than [***] at Metagenomi&#146;s request during the Co-Co Option Period for a Drug Discovery
Program, Ionis will provide Metagenomi with [***] (&#147;<B>Option Package</B>&#148;). For clarity, Ionis will not be required to generate any additional data or information that is not in existence as of the date of Metagenomi&#146;s request for an
Option Package. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>5.1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Option Exercise</B>. If Metagenomi decides to exercise the Co-Co Option for a particular Drug Discovery
Program, then it will deliver written notice to Ionis of such determination during the applicable Co-Co Option Period, which notice will indicate the Drug Discovery Program for which Metagenomi elects to exercise the Co-Co Option, and (a)&nbsp;the
Drug Discovery Program for which Metagenomi is exercising its Co-Co Option will automatically be deemed a &#147;Co-Co Program&#148; and all Licensed Products under such Drug Discovery Program will automatically be deemed &#147;Co-Co Products,&#148;
(b)&nbsp;Metagenomi will pay Ionis the Option Exercise Fee for such Co-Co Program pursuant to <U>Section&nbsp;9.3</U> (Option Exercise Fee), and (c)&nbsp;the Parties will enter into a Co-Development and Co-Commercialization Agreement for such Co-Co
Program in accordance with <U>Section&nbsp;5.2</U> (Development and Commercialization of the Co-Co Products; Opt-Down Right). Any Drug Discovery Program for which Metagenomi does not exercise a Co-Co Option prior to the expiration of the applicable
Co-Co Option Period will automatically be deemed an &#147;Ionis Program&#148; and all Licensed Products under such Drug Discovery Program will automatically be deemed &#147;Ionis Products&#148; and Ionis will have sole control under the Development
and Commercialization of such Ionis Products in accordance with<U> Article 6</U> (Development and Commercialization of the Ionis Products). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>5.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Development and Commercialization of the Co-Co Products; Opt-Down Right</B> . On a Co-Co
Program-by-Co-Co Program basis, promptly after Metagenomi exercises a Co-Co Option for a Co-Co Program, the Parties will negotiate in good faith the terms of a worldwide, co-exclusive (with Ionis) co-Development and co-Commercialization agreement
(the &#147;<B>Co-Development and Co-Commercialization Agreement</B>&#148;), which terms and conditions will be reasonable and customary for agreements of this type and will include a requirement that the Parties share all future Development,
Commercialization, and other Exploitation costs and all future profits with respect to the applicable Co-Co Products, with the Parties bearing the share of such costs 50:50 and Ionis being responsible for booking and recording revenue and on terms
to be specified in the Co-Development and Co-Commercialization Agreement; <I>provided</I>, that [***]. Each Co-Development and Co-Commercialization Agreement will include: (i)&nbsp;the right for Metagenomi to, upon written notice to Ionis, reduce
its share of any costs borne under the applicable Co-Co Program from 50% to any percentage between 50% and 25% and Ionis&#146; share of such costs will increase accordingly (such option, the &#147;<B>Opt-Down Right</B>&#148;); <I>provided</I> that
Metagenomi will continue to bear 50% of the costs of any then-ongoing Clinical Trials through the completion of any such ongoing Clinical Trials, (ii)&nbsp;each Party will receive a share of profits equal to the percentage of costs funded by such
Party following the exercise of the Opt-Down Right based on the percentage of costs that Metagenomi commits to funding in its notice of exercise of its Opt- Down Right, and (iii)&nbsp;Metagenomi may only exercise the Opt-Down Right during the period
beginning no earlier than [***] and no later than [***] prior to the [***]. Until the Parties execute the Co-Development and Co-Commercialization Agreement, Ionis will continue to conduct and will be solely responsible for, and continue to have sole
and exclusive control over, the Development and Manufacture of the applicable Co-Co Products. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>5.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Escalation Procedure</B>. If the Parties, despite their good faith negotiations, are unable to agree
on the terms and conditions of any Co-Development and Co-Commercialization Agreement within [***] of the date of the applicable Co-Co Option Notice (or such longer time as mutually agreed by the Parties), then either Party may refer those terms and
conditions to which they have not mutually agreed to the Executive Officers, who will use reasonable efforts to reach agreement on such terms and conditions. If such Executive Officers are unable to reach consensus with respect to such terms and
conditions within [***] after such referral, then either Party may notify the other Party of its intent to invoke dispute resolution under <U>Section&nbsp;15.1.3</U> (Expedited Dispute Resolution). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>5.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Metagenomi Opt-Out</B><B></B>. On a Co-Co Program-by-Co-Co Program basis, Metagenomi will have the
right to opt-out of its rights and obligations under this Agreement to the extent related to the Exploitation of the Co-Co Products under such Co-Co Program and the applicable Co-Development and Co-Commercialization Agreement for a Co-Co Program
(each such right, an &#147;<B>Opt-Out Right</B>&#148;). Metagenomi may exercise the Opt-Out Right for a Co-Co Program by providing written notice to Ionis of such election no later than [***] after [***] (the &#147;<B>Opt-Out Period</B>&#148;). If
Metagenomi exercises the Opt-Out Right for a Co-Co Program during the applicable Opt-Out Period pursuant to this <U>Section&nbsp;5.4</U> (Metagenomi Opt-Out), then from and after the date that is the later of (a)&nbsp;[***] following the date on
which [***] or (b)&nbsp;[***] (the &#147;<B>Opt-Out Date</B>&#148;), (i)&nbsp;the applicable Co-Development and Co-Commercialization Agreement will terminate and Ionis will have sole control over, and sole decision-making authority with respect to,
at its cost and expense, the Development, Commercialization, and other Exploitation of the Licensed Products under such Drug Discovery Program, (ii)&nbsp;the Licensed Products under such Drug Discovery Program will be deemed to be &#147;Ionis
Products&#148; and such Drug Discovery Program will be deemed to be an &#147;Ionis Program&#148;, in each case, from and after the Opt-Out Date, (iii)&nbsp;Ionis will thereafter pay any Ionis Product Development Milestone Payments, Ionis Product
Regulatory Milestone Payments, Ionis Product Sales Milestone Payments, and Ionis Royalties, in each case, that accrue as a result of the Exploitation of the applicable Ionis Products from and after the Opt-Out Date (<I>provided</I> that Ionis will
not be required to pay the first Ionis Product Development Milestone Payment, Ionis Product Regulatory Milestone Payment, or Ionis Product Sales Milestone Payment, as applicable, to accrue as a result of the Exploitation of the applicable Ionis
Products after the Opt-Out Date), (iv)&nbsp;Ionis will not be responsible for any Ionis Product Development Milestone Payments, Ionis Product Regulatory Milestone Payments, or Ionis Product Sales Milestone Payments that accrued prior to the Opt-Out
Date, and (v)&nbsp;Metagenomi will continue to bear its share of the costs of any Clinical Trials for the applicable Ionis Products that are ongoing as of the Opt-Out Date through the completion of such Clinical Trials. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;6 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Development and Commercialization of the Ionis Products </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>6.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Development</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>6.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>General</B>. On an Ionis Program-by-Ionis Program basis, from and after expiration of the Drug
Discovery Term for an Ionis Product, Ionis will have sole control over, and sole decision-making authority with respect to, at its cost and expense, the Development of, and the performance of all Medical Affairs with respect to, such Ionis Product
in the Field in the Territory. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>6.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Reporting for the Ionis Products</B>. On an Ionis Program-by-Ionis Program basis, during the period
after [***], [***] per [***], Ionis will provide Metagenomi with a reasonably detailed report regarding the status of Ionis&#146; Development of the Ionis Products for such Ionis Program. At Metagenomi&#146;s reasonable request, no more than [***]
per [***], the Parties will meet to discuss the Development of the Ionis Products. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>6.1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Development Diligence for the Ionis Products</B>.<B></B> Ionis (acting directly or through one or
more Affiliates or Sublicensees) will use Commercially Reasonable Efforts to Develop and seek Regulatory Approval for at least [***] in [***]. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>6.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Commercialization. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>6.2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>General</B>.<B></B> Ionis will have sole control over, and sole decision-making authority with
respect to, at its cost and expense, the Commercialization of the Ionis Products in the Field in the Territory. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>6.2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Commercialization Diligence for the Ionis Products.</B> Following receipt by or on behalf of Ionis of
Regulatory Approval for an Ionis Product in a country, Ionis (acting directly or through one or more Affiliates or Sublicensees) will use Commercially Reasonable Efforts to Commercialize such Ionis Product in such country. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;7 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Regulatory Affairs </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>7.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Regulatory Responsibility. </B>From and after the Effective Date, as between the Parties, Ionis will be
responsible for the preparation and submission of all Regulatory Submissions (including all meetings with Regulatory Authorities in connection with the same) for all Licensed Products, but, for clarity, not including Regulatory Submissions that
relate to proprietary Metagenomi components of Licensed Products to which Ionis will have a right of reference pursuant to <U>Section&nbsp;7.2</U> (Right of Reference),<B> [***]; </B><I>provided</I><B></B> that Metagenomi will assist Ionis or any of
its Affiliates or Sublicensees in its efforts to prepare and submit any such Regulatory Submissions in accordance with this<U> Article 7</U> (Regulatory Affairs). Ionis or any of its Affiliates or Sublicensees may file all such applications in its
own name (or in the name of its designee) and will own and control all such applications. On a Drug Discovery Program-by-Drug Discovery Program basis, at Ionis&#146; request at any time after a Development Candidate is selected for a Drug Discovery
Program, the JSC will discuss a high-level regulatory strategy for such Drug Discovery Program (&#147;<B>Regulatory Strategy</B>&#148;), which strategy will leverage Metagenomi&#146;s expertise with Regulatory Submissions for products that are
similar to the Licensed Product. For clarity, the JSC will not have any approval rights with respect to the Regulatory Strategy for any Drug Discovery Program and Ionis will have sole control over, and sole decision-making authority with respect to,
the Regulatory Submissions for the Licensed Products. Notwithstanding the foregoing, if Metagenomi exercises the Co-Co Option for one or more Drug Discovery Programs in accordance with <U>Section&nbsp;5.1</U> (Co-Development and Co-Commercialization
Options), then all Regulatory Submissions with respect to any Co-Co Product will be prepared in accordance with the terms set forth in the applicable Co-Development and Co-Commercialization Agreement.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>7.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Right of Reference. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>7.2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Grant.</B> Metagenomi will grant, and hereby does grant, to Ionis and its Affiliates and Sublicensees a
&#147;Right of Reference,&#148; as that term is defined in 21 C.F.R. &#167; 314.3(b) (or any successor rule or analogous Applicable Law recognized outside of the United States), to all Regulatory Submissions (including any drug master files)
submitted by or on behalf of and Controlled by Metagenomi or any of its Affiliates that are necessary or reasonably useful to support any Regulatory Submissions for a Licensed Product to be made by Ionis, its Affiliates, or Sublicensees in the Field
in the Territory. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>7.2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Assistance; Cooperation.</B> Ionis and its Affiliates and Sublicensees may use such right of reference
solely for the purpose of seeking, obtaining, supporting, and maintaining Regulatory Approval for the Licensed Products in the Field in the Territory. Metagenomi will use Commercially Reasonable Efforts to take such actions as may be reasonably
requested by Ionis to give effect to the intent of this <U>Section&nbsp;7.2</U> (Right of Reference), including, if requested by Ionis, (a)&nbsp;providing a signed statement that Ionis may rely on, and that the applicable Regulatory Authority may
access, Metagenomi or its Affiliate&#146;s Regulatory Submissions in support of Ionis&#146; application for Regulatory Approval for any Licensed Product, and (b)&nbsp;subject to the data sharing requirements under any privacy- related Applicable
Law, providing Ionis with any underlying raw data or information submitted by Metagenomi or its Affiliates to the Regulatory Authority with respect to the applicable Regulatory Submissions. Internal Costs incurred by Metagenomi in performing any
activities requested by Ionis pursuant to this <U>Section&nbsp;7.2.2</U> (Assistance; Cooperation) will be reimbursed in accordance with <U>Section&nbsp;3.4.4</U> (Costs of Support). </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>7.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Regulatory Support. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>7.3.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Access to Data.</B> Metagenomi will use Commercially Reasonable Efforts to assist Ionis or any of its
Affiliates or Sublicensees in its efforts to prepare and submit any Regulatory Submissions to obtain, support, or maintain Regulatory Approvals for all Licensed Products in the Field in the Territory, including by providing Ionis with all data,
written reports, and other documentation generated by or on behalf of Metagenomi under the Drug Discovery Programs that is necessary or reasonably useful to support any Regulatory Submissions for a Licensed Product, as well as any necessary samples
and materials. Unless otherwise noted in the Development Supply Agreement or the Commercial Supply Agreement, the costs of Metagenomi providing such support will be reimbursed in accordance with <U>Section&nbsp;3.4.4</U> (Costs of Support).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>7.3.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Review of Regulatory Submissions.</B> Ionis may (but, for clarity, is not required to) provide drafts of any
INDs or other Regulatory Submissions for the Licensed Products to Metagenomi prior to submission to the applicable Regulatory Authority for Metagenomi to review and provide comments. Metagenomi will use Commercially Reasonable Efforts to review and
provide any such requested comments in a timely manner and the costs of such support will be reimbursed in accordance with <U>Section&nbsp;3.4.4</U> (Costs of Support). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;8 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Manufacturing </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>8.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Metagenomi Manufacturing Responsibilities. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>8.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Metagenomi Supply Term.</B> Subject to <U>Section&nbsp;8.4</U> (Ionis&#146; Assumption of Manufacturing
Responsibilities), on a Drug Discovery Program-by-Drug Discovery Program basis, commencing on [***] until [***], or such other period as mutually agreed upon by the Parties (the &#147;<B>Metagenomi Supply Term</B>&#148;), Metagenomi will Manufacture
(a)&nbsp;all applicable Licensed Systems and certain components of the applicable Licensed Products (consistent with those components that Metagenomi manufactures for its own products) (collectively, the &#147;<B>MG Manufactured
Components</B>&#148;), in each case, that are needed by Ionis for use in its Development activities pursuant to the terms of a development supply agreement (the &#147;<B>Development Supply Agreement</B>&#148;) to be entered into between the Parties
and (b)&nbsp;all MG Manufactured Components needed by Ionis for use in its Commercialization activities pursuant to the terms of a commercial supply agreement (the &#147;<B>Commercial Supply Agreement</B>&#148;) to be entered into between the
Parties. Under the Development Supply Agreement and the Commercial Supply Agreement, Metagenomi will provide the MG Manufactured Components at a cost that represents the Cost of Goods for such MG Manufactured Components <I>plus</I> 15% (the
&#147;<B>Supply Price</B>&#148;). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>8.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Requested CMO.</B> If Metagenomi is, at any point during the Metagenomi Supply Term, Manufacturing any MG
Manufactured Components without engaging a CMO, then Ionis may, upon written notice to Metagenomi, require Metagenomi to engage a CMO mutually agreeable to the Parties to conduct Manufacturing under this Agreement (such CMO, the &#147;<B>Requested
CMO</B>&#148;). Within [***] of Metagenomi&#146;s receipt of such notice requesting Metagenomi engage a Requested CMO, Metagenomi will in good faith negotiate and enter into a written agreement with such Requested CMO for the purposes of
Manufacturing the MG Manufactured Components (such agreement, the &#147;<B>Requested CMO Contract</B>&#148;) and conduct a transfer of the Manufacturing Know-How to such Requested CMO and otherwise facilitate implementation of such Manufacturing
Know-How, in each case, in a manner consistent with Metagenomi&#146;s rights and obligations with respect to the Manufacturing Technology Transfer described in <U>Section&nbsp;8.5</U> (Manufacturing After the Metagenomi Supply Term). Metagenomi will
ensure that the Requested CMO Contract is expressly and freely assignable to and assumable by Ionis without the consent of the Requested CMO. Metagenomi will provide a draft of the Requested CMO Contract to Ionis prior to executing such Requested
CMO Contract for review and comment and will incorporate Ionis&#146; reasonable comments. If Metagenomi does not engage the Requested CMO within [***] of its receipt of notice requiring the engagement of such Requested CMO, then Ionis may terminate
the Metagenomi Supply Term and assume all Manufacturing responsibilities for the MG Manufactured Components. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>8.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Development Supply Agreement. </B>At such time as directed by the JSC, the Parties will negotiate in good
faith the terms of the Development Supply Agreement, and a related quality agreement, which agreements will govern the terms and conditions of the Manufacturing of the MG Manufactured Components for Development purposes; <I>provided</I> that if
Ionis needs any MG Manufactured Components for its Development activities prior to the Parties entering into the Development Supply Agreement, then Metagenomi will supply such MG Manufactured Components on a per-batch basis and Ionis will pay
Metagenomi on a per-batch basis at the Supply Price for each such batch. The Development Supply Agreement and the related quality agreement will include terms and conditions consistent with the principles set forth on <U>Schedule 8.2</U>
(Development Supply Agreement Key Terms).<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>8.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Commercial Supply Agreement. </B>At such time as directed by the JSC, the Parties will negotiate in good
faith the terms of the Commercial Supply Agreement, and a related quality agreement, which agreements will govern the terms and conditions of the Manufacturing of the MG Manufactured Components for Commercialization purposes. The Commercial Supply
Agreement and the related quality agreement will include terms and conditions consistent with the principles set forth on <U>Schedule 8.2</U> (Development Supply Agreement Key Terms), with such modifications that are reasonable and appropriate for a
commercial supply.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>8.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis&#146; Assumption of Manufacturing Responsibilities. </B>If, (a)&nbsp;[***], or (b)&nbsp;[***], then,
in either case, [***]. For clarity, [***].<B> </B></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>8.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Manufacturing After the Metagenomi Supply Term. </B>If Ionis assumes all Manufacturing responsibilities for
the MG Manufactured Components in accordance with <U>Section&nbsp;8.1.2</U> (Requested CMO) or [***] or the Metagenomi Supply Term otherwise expires, then from and after such date, Ionis will have<B> </B>sole control over and sole decision-making
authority with respect to, at its cost and expense, all Manufacturing activities for the MG Manufactured Components; <B></B><I>provided</I><B></B> that, at Ionis&#146; request, Metagenomi will continue to Manufacture and supply MG Manufactured
Components to Ionis pursuant to the Development Supply Agreement or Commercial Supply Agreement (as applicable) until the earlier of [***] or [***]. Promptly upon Ionis&#146; request after expiration of the Metagenomi Supply Term, Metagenomi will,
if and as requested, assign the Requested CMO Contract to Ionis and effect a transfer to Ionis or its designee(s) (which designee may be an Affiliate or a Third Party manufacturer, and which Third Party manufacturer may be a primary, backup, or
second manufacturer of such MG Manufactured Component) of all Licensed Know-How that is necessary or reasonably useful to enable the Manufacture of each MG Manufactured Component (the &#147;<B>Manufacturing Know-How</B>&#148;) and to facilitate
implementation of the Manufacturing Know-How at facilities designated by Ionis (such transfer and implementation, as more fully described in this <U>Section&nbsp;8.5</U> (Manufacturing After the Metagenomi Supply Period), the &#147;<B>Manufacturing
Technology Transfer</B>&#148;). Metagenomi will provide all reasonable assistance requested by Ionis to enable Ionis (or its Affiliate or designated Third Party manufacturer, as applicable) to implement the Manufacturing Know-How at the facilities
designated by Ionis. If reasonably requested by Ionis, such assistance will include [***]. Without limiting the foregoing, in connection with the Manufacturing Technology Transfer, Metagenomi will cause all appropriate employees and representatives
of Metagenomi and its Affiliates to meet with employees or representatives of Ionis (or its Affiliate or designated Third Party manufacturer, as applicable) at the applicable manufacturing facility at mutually convenient times to assist with the
working up and use of the Manufacturing Know-How and with the training of the personnel of Ionis (or its Affiliate or designated Third Party manufacturer(s), as applicable) to the extent reasonably necessary to enable Ionis (or its Affiliate or
designated Third Party manufacturer(s), as applicable) to use and practice the Manufacturing Know-How. Each Party will be responsible for its own costs and expenses incurred in conducting the Manufacturing Technology Transfer.<B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;9 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consideration; Financial Terms </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Upfront Payment</B>. Ionis will pay Metagenomi a one-time upfront payment of $80,000,000 (the
&#147;<B>Upfront Payment</B>&#148;) no later than [***] after the Effective Date. The Upfront Payment is non- creditable and non-refundable.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Wave 2 Target Selection Fee</B>. On a Wave 2 Target-by-Wave 2 Target basis, promptly following the
designation of a Wave 2 Target as a Collaboration Target in accordance with <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available), Metagenomi will invoice Ionis for the applicable amount set forth in <U>Table 9.2</U>, which amount
will be based on the applicable scenario for selection of such Wave 2 Target (each such payment, a &#147;<B>Wave 2 Target Selection Fee</B>&#148;). Ionis will pay such Wave 2 Target Selection Fee no later than [***] after receipt of such invoice.
For clarity, each Wave 2 Target Selection Fee is only payable once for each Wave 2 Target that is designated as a Collaboration Target.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><U>Table 9.2</U> &#150; Wave 2 Target
Selection Fee</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Wave 2 Target Selection Scenario</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Wave&nbsp;2&nbsp;Target</B><br><B>Selection Fee</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Scenario 1</B>: If the Wave 2 Target is a target [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Scenario 2</B>: If the Wave 2 Target is a target [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Scenario 3</B>: If the Wave 2 Target is a target [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:11%; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order for Scenario 2 of <U>Table 9.2</U> to apply, Metagenomi must
(a)&nbsp;[***] and (b)&nbsp;[***]. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Option Exercise Fee</B>. On a Drug Discovery Program-by-Drug Discovery Program basis, if Metagenomi
exercises a Co-Co Option for a Drug Discovery Program during the applicable Co-Co Option Period in accordance with <U>Section&nbsp;5.1.3</U> (Option Exercise), then Metagenomi will reimburse Ionis in accordance with the terms set forth in this
<U>Section&nbsp;9.3</U> (Option Exercise Fee), which reimbursement will be equal to 50% of the Internal Costs and Out-of-Pocket Costs incurred by Ionis in the conduct of the Drug Discovery Activities for such Drug Discovery Program prior to the
exercise of the Co-Co Option for such Drug Discovery Program <B></B><I>minus</I><B></B> 50% of the Internal Costs and Out-of-Pocket Costs incurred by Metagenomi in the conduct of the Drug Discovery Activities for such Drug Discovery Program prior to
the exercise of the Co-Co Option for such Drug Discovery Program if such amount is a positive number (such amount, the &#147;<B>Option Exercise Fee</B>&#148; for such Drug Discovery Program). No later than [***] after the date on which Metagenomi
exercises a Co-Co Option for a Drug Discovery Program, each Party will deliver to the other Party a written report, with reasonable supporting documentation, that sets forth the Internal Costs and Out-of-Pocket Costs incurred by or on behalf of such
Party in connection with performance of the Drug Discovery Activities for such Drug Discovery Program (to the extent in accordance with the applicable Drug Discovery Plan) (each, a &#147;<B>Development Cost Share Notice</B>&#148;). Promptly after
delivery of each Development Cost Share Notice, Ionis will invoice Metagenomi for the Option Exercise Fee (if any) and Metagenomi will pay the Option Exercise Fee no later than [***] after receipt of Ionis&#146; invoice.<B>
</B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Product Milestone Payments. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.4.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Product Development Milestone Payments.</B> Subject to the terms and conditions of this Agreement,
including <U>Section&nbsp;9.5</U> (Ionis Products for [***] Target Populations), (a)&nbsp;with respect to the [***] set forth below, on an Ionis Program- by-Ionis Program basis and (b)&nbsp;with respect to the [***] set forth below, on an Ionis
Product-by-Ionis Product basis, Ionis will pay one-time milestone payments to Metagenomi of the amounts set forth in <U>Table 9.4.1</U> (each, an &#147;<B>Ionis Product Development Milestone Payment</B>&#148;) upon the first achievement by Ionis or
any of its Affiliates or Sublicensees of each of the development milestone events set forth in <U>Table 9.4.1</U> (each, an &#147;<B>Ionis Product Development Milestone Event</B>&#148;) for each Ionis Program or Ionis Product (as applicable);
<I>provided</I> that, with respect to the [***] set forth below, on an Ionis Program-by-Ionis Program basis, if more than one Ionis Product for the same Ionis Program achieve an Ionis Product Development Milestone Event, then [***]. Each Ionis
Product Development Milestone Payment is payable only once for each Ionis Program or Ionis Product (as applicable), regardless of the number of times the corresponding Ionis Product Development Milestone Event is achieved for such Ionis Program or
Ionis Product (as applicable). If Ionis or its Affiliates or Sublicensees achieve all of the Ionis Product Development Milestone Events for an Ionis Product, then the Ionis Product Development Milestone Payments payable by Ionis under this
<U>Section&nbsp;9.4.1</U> (Ionis Product Development Milestone Payments) for such Ionis Product will not exceed $29,000,000. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="44%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><U>Table 9.4.1</U> &#150; Ionis Product
Development Milestones</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Ionis Product Development</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Ionis&nbsp;Product&nbsp;Development&nbsp;Milestone&nbsp;Payment</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.4.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Product Regulatory Milestone Payments.</B> Subject to the terms and conditions of this Agreement,
including <U>Section&nbsp;9.5</U> (Ionis Products for [***] Target Populations), on an Ionis Product-by-Ionis Product basis, Ionis will pay one-time milestone payments to Metagenomi of the amounts set forth in <U>Table 9.4.2</U> (each, an
&#147;<B>Ionis Product Regulatory Milestone Payment</B>&#148;) upon the first achievement by Ionis or any its Affiliates or Sublicensees of each of the regulatory milestone events set forth in <U>Table 9.4.2</U> (each, an &#147;<B>Ionis Product
Regulatory Milestone Event</B>&#148;) by an Ionis Product. Each Ionis Product Regulatory Milestone Payment is payable only once for each Ionis Product, regardless of the number of times the corresponding Ionis Product Regulatory Milestone Event is
achieved for an Ionis Product. If Ionis or its Affiliates or Sublicensees achieve all of the Ionis Product Regulatory Milestone Events for an Ionis Product, then the Ionis Product Regulatory Milestone Payments payable by Ionis under this
<U>Section&nbsp;9.4.2</U> (Ionis Product Regulatory Milestone Payments) for such Ionis Product will not exceed $60,000,000. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="42%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><U>Table 9.4.2</U> &#150; Ionis Product
Regulatory Milestones</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Ionis Product Regulatory</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Ionis&nbsp;Product&nbsp;Regulatory&nbsp;Milestone&nbsp;Payment</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.4.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Product Sales Milestone Payments.</B> Subject to the terms and conditions of this Agreement, including
<U>Section&nbsp;9.5</U> (Ionis Products for [***] Target Populations), on an Ionis Product-by-Ionis Product basis, Ionis will pay one-time milestone payments to Metagenomi of the amounts set forth in <U>Table 9.4.3</U> (each, an &#147;<B>Ionis
Product Sales Milestone Payment</B>&#148;) upon the first achievement by Ionis or any of its Affiliates or Sublicensees of each of the sales milestone events set forth in <U>Table 9.4.3</U> (each, an &#147;<B>Ionis Product Sales Milestone
Event</B>&#148;) for an Ionis Product. Each Ionis Product Sales Milestone Payment is payable only once for each Ionis Product, regardless of the number of times the corresponding Ionis Product Sales Milestone Event is achieved for an Ionis Product.
If Ionis or its Affiliates or Sublicensees achieve all of the Ionis Product Sales Milestone Events for an Ionis Product, then the Ionis Product Sales Milestone Payments payable by Ionis under this <U>Section&nbsp;9.4.3</U> (Ionis Product Sales
Milestone Payments) for such Ionis Product will not exceed $250,000,000. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="37%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><U>Table 9.4.3</U> &#150; Ionis Product
Sales Milestones</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Ionis Product Sales Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Ionis&nbsp;Product&nbsp;Sales&nbsp;Milestone&nbsp;Payment</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">1.&#8195;&#8201;The first Calendar Year in which the aggregate Net Sales for an Ionis Product
exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">2.&#8195;&#8201;The first Calendar Year in which the aggregate Net Sales for an Ionis Product
exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">[***]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">3.&#8195;&#8201;The first Calendar Year in which the aggregate Net Sales for an Ionis Product
exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">4.&#8195;&#8201;The first Calendar Year in which the aggregate Net Sales for an Ionis Product
exceed [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">[***]</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.4.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice; Payment; Skipped Milestones.</B> Ionis will provide Metagenomi with written notice upon the
achievement of each Ionis Product Development Milestone Event, Ionis Product Regulatory Milestone Event, and Ionis Product Sales Milestone Event, such written notice to be provided (a)&nbsp;with respect to any Ionis Product Development Milestone
Event or Ionis Product Regulatory Milestone Event within [***] after such achievement and (b)&nbsp;with respect to any Ionis Product Sales Milestone Event, on or prior to the date of delivery of the Ionis Royalty Report under
<U>Section&nbsp;9.6.4</U> (Ionis Royalty Reports) for the Calendar Year in which such milestone event is first achieved. Following receipt of such written notice, Metagenomi will promptly invoice Ionis for the applicable milestone payment and Ionis
will make the appropriate milestone payment within [***] after receipt of such invoice; <I>provided</I> that with respect to the first Ionis Product Development Milestone Event (for selection of the first Development Candidate for an Ionis Program),
Metagenomi may only invoice Ionis after [***], and Ionis will have no obligation to make any payment with respect to such Ionis Product Development Milestone Event unless [***] and Metagenomi provides Ionis with an invoice for the applicable amount.
Each Ionis Product Development Milestone Event is intended to be successive. If any Ionis Product Development Milestone Event does not occur with respect to an Ionis Product for an Ionis Program, then such skipped milestone event will be deemed to
have been achieved upon the achievement of the next successive milestone event with respect to an Ionis Product for such Ionis Program. Payment for any such skipped milestone that is owed in accordance with the provisions of the foregoing sentence
will be due concurrently with the payment for the next successive Ionis Product Development Milestone Event. If more than one Ionis Product Sales Milestone Event occurs with respect to an Ionis Product in the same Calendar Year, then payments with
respect to all applicable Ionis Product Sales Milestone Events will be paid for such Calendar Year. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Products for [***] Target Populations</B>. If an Ionis Product is intended to treat target populations
with [***] (each such population, [***] &#147;[***]<B> Target Population</B>&#148;), then Ionis will notify Metagenomi and [***], in each case, for such Ionis Product, [***].<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Product Royalty Payments. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.6.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Royalty Rates.</B> Subject to the terms and conditions of this Agreement, including the provisions of
<U>Section&nbsp;9.6.2</U>. (Adjustments to Ionis Royalties), on an Ionis Product-by- Ionis Product basis, Ionis will pay Metagenomi royalties based on the aggregate Annual Net Sales of each Ionis Product at the rates set forth in <U>Table 9.6.1</U>.
On an Ionis Product- by-Ionis Product and country-by-county basis such royalties will be payable until the expiration of the applicable Royalty Term for each Ionis Product in such country. The royalty payments made pursuant to this
<U>Section&nbsp;9.6.1</U> (Ionis Royalty Rates), the &#147;<B>Ionis Royalties</B>&#148; and the rates set forth in <U>Table 9.6.1</U>, the &#147;<B>Ionis Royalty Rates</B>.&#148; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><U>Table 9.6.1</U> &#150; Royalty Rates for
Ionis Products</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>Annual Net Sales of an Ionis Product in the
Territory</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Royalty</I></B><br><B><I>Rate as a</I></B><br><B><I>Percentage</I></B><br><B><I>of Net</I></B><br><B><I>Sales</I></B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Portion of Annual Net Sales of each Ionis Product that is less than or equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Portion of Annual Net Sales of each Ionis Product that is greater than [***], and less than or
equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">[***]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Portion of Annual Net Sales for each Ionis Product that is greater than [***], and less than or
equal to [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Portion of Annual Net Sales of each Ionis Product that is greater than [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">[***]</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:15%; font-size:10pt; font-family:Times New Roman">By way of example only, if the Annual Net Sales for an Ionis Product are [***] for a given Calendar Year, then
the Ionis Royalties payable with respect to such Annual Net Sales for such Ionis Product in such Calendar Year, subject to adjustment as set forth in <U>Section&nbsp;9.6.2</U> (Adjustment to Ionis Royalties) would be: [***] + [***] + [***] + [***] =
[***]. For the avoidance of doubt, the obligation to pay Ionis Royalties will be imposed only once with respect to the same unit of an Ionis Product. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.6.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Adjustments to Ionis Royalties. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Expiration of Valid Claims.</B> Subject to <U>Section&nbsp;9.6.3</U> (Cumulative Effect of Ionis Royalty
Reductions), on an Ionis Product-by-Ionis Product and country-by-country basis in the Territory, if during the Royalty Term for an Ionis Product in a given country there is no Valid Claim of a Royalty Bearing Patent Right Covering such Ionis Product
in such country, then commencing in the first Calendar Quarter after the date on which this <U>Section&nbsp;9.6.2(a)</U> (Expiration of Valid Claims) applies and for the remainder of the Royalty Term for such Ionis Product in such country, the
Annual Net Sales for such Ionis Product in such country will be reduced by [***] for purposes of calculating the Ionis Royalties owed under <U>Section&nbsp;9.6.1</U> (Ionis Royalty Rates). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Biosimilar Product.</B> Subject to <U>Section&nbsp;9.6.3</U> (Cumulative Effect of Ionis Royalty
Reductions), if, on an Ionis Product-by-Ionis Product and country-by-country basis, a Biosimilar Product with respect to an Ionis Product is approved for sale in a country, then commencing in the Calendar Quarter in which such approval was obtained
and continuing for the remainder of the Royalty Term for such Ionis Product in such country, the Annual Net Sales for such Ionis Product in such country will be reduced by [***] for purposes of calculating the Ionis Royalties owed under
<U>Section&nbsp;9.6.1</U> (Ionis Royalty Rates). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Third Party Payments.</B> Subject to <U>Section&nbsp;9.6.3</U> (Cumulative Effect of Ionis Royalty
Reductions), Ionis will be entitled to credit against the Ionis Royalties due to Metagenomi in a given Calendar Quarter [***] of (i)&nbsp;[***] that are actually paid by Ionis or any of its Affiliates or Sublicensees to any Third Party in
consideration for rights under any Patent Right, Know-How, or other intellectual property owned or controlled by such Third Party (whether by acquisition or license) (such rights, &#147;<B>Third Party IP</B>&#148;) that is acquired or licensed by
Ionis or any of its Affiliates or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="23%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Sublicensees after the Effective Date, and [***] useful for Ionis or any of its Affiliates or Sublicensees to Exploit a Development Candidate as such Development Candidate exists as of the date
of expiration of the Drug Discovery Term for the applicable Drug Discovery Program, and (ii)&nbsp;[***] (such amount in (i)&nbsp;or (ii), the &#147;<B>Third Party Payment</B>&#148;). Notwithstanding the foregoing, Third Party Payment shall exclude
[***]. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.6.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cumulative Effect of Ionis Royalty Reductions.</B> In no event will the royalty reductions for Ionis
Products permitted under <U>Section&nbsp;9.6.2(a)</U> (Expiration of Valid Claims), <U>Section&nbsp;9.6.2(b)</U> (Biosimilar Product), or <U>Section&nbsp;9.6.2(c)</U> (Third Party Payments), alone or together, reduce the Ionis Royalties due to
Metagenomi for an Ionis Product in a given Calendar Quarter by more than [***] of the applicable Ionis Royalties that would otherwise be owed on the Annual Net Sales of such Ionis Product. If Ionis would, but for the restriction set forth in this
<U>Section&nbsp;9.6.3</U> (Cumulative Effect of Ionis Royalty Reductions), have the right to reduce the Ionis Royalties due to Metagenomi by more than [***], then [***]. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.6.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Royalty Reports.</B> Commencing on the First Commercial Sale of an Ionis Product and for so long as
Ionis Royalties are due under this Agreement, no later than (a)&nbsp;[***] prior to the start of each Calendar Year, Ionis will deliver a written good faith nonbinding estimate to Metagenomi of the projected Net Sales for the upcoming Calendar Year,
(b)&nbsp;[***] after the end of each Calendar Quarter, Ionis will deliver a written good faith non-binding estimate to Metagenomi of the Net Sales in the relevant Calendar Quarter and the Ionis Royalties payable on such Net Sales, and (c)&nbsp;[***]
after the end of each Calendar Quarter, Ionis will deliver a written report (each, an &#147;<B>Ionis Royalty Report</B>&#148;) to Metagenomi specifying on an Ionis Product-by-Ionis Product and country- by-country basis: (i)&nbsp;Net Sales in the
relevant Calendar Quarter; (ii)&nbsp;to the extent such Net Sales include sales not denoted in US Dollars, a summary of the then-current exchange rate methodology(ies) used for the calculation of Net Sales in accordance with <U>Section&nbsp;9.14</U>
(Currency of Payment; Non-Refundable Payments); (iii)&nbsp;the Ionis Royalties payable on such Net Sales; and (iv)&nbsp;if applicable, the Ionis Product Sales Milestone Payments owed to Metagenomi in the relevant Calendar Quarter. All Ionis Royalty
Reports will be the Confidential Information of Ionis. Ionis will pay the Ionis Royalties for each Calendar Quarter no later than [***] after receipt of an invoice from Metagenomi, which invoice will be provided promptly following Metagenomi&#146;s
receipt of each Ionis Royalty Report from Ionis pursuant to this <U>Section&nbsp;9.6.4</U> (Ionis Royalty Reports). For clarity, the submission by Metagenomi of an invoice to Ionis based on an Ionis Royalty Report will be without prejudice to
Metagenomi&#146;s right to dispute an Ionis Royalty Report or to audit an Ionis Royalty Report pursuant to <U>Section&nbsp;9.13</U> (Records and Audits). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Existing In-License Agreements. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.7.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Effective Date Licensed Technology; Existing Metagenomi In-License Agreements</B>. Metagenomi hereby
represents and warrants that none of the Licensed Technology Controlled by Metagenomi as of the Effective Date is in-licensed or acquired by Metagenomi under agreements with Third Party licensors or sellers. On a Collaboration
Target-by-Collaboration Target basis, if any Patent Rights or Know-How, as of the date a Proposed Target becoming a Collaboration Target pursuant to <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available), have been acquired or
in-licensed by Metagenomi and if solely owned by Metagenomi without any encumbrance or restriction on licensing, would constitute Licensed Technology as a result of such Proposed Target becoming a
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Collaboration Target pursuant to <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available) (any such agreement, an &#147;<B>Existing Potential Metagenomi In-License
Agreement</B>&#148;), then Metagenomi will, within [***] of the applicable Proposed Target becoming a Collaboration Target, provide Ionis with (a)&nbsp;notice and a copy of such Existing Potential Metagenomi In-License Agreements (which may be
redacted to exclude provisions thereof that would not be applicable to Ionis as a licensee or sublicensee (as the case may be)), and (b)&nbsp;any disclosures that would be made against the representations and warranties in <U>Section&nbsp;12.2</U>
(Additional Representations of Metagenomi) if such Existing Potential Metagenomi In-License Agreements were to become Metagenomi In-License Agreements. If Ionis provides written notice, within [***] of receipt of such information from Metagenomi,
that it would like to have any such Existing Potential Metagenomi In-License Agreement included in the licenses granted under this Agreement and be subject to the terms of such Existing Potential Metagenomi In-License Agreement that are applicable
to a licensee or sublicensee (as the case may be) thereunder, then such intellectual property rights described in such notice will automatically be deemed included in the Licensed Technology, and such Existing Potential Metagenomi In-License
Agreement will be considered a Metagenomi In-License Agreement. Except as otherwise provided in this Agreement, as between the Parties, Metagenomi will be responsible for all payments that arise under any license or other agreement to which
Metagenomi or its Affiliate is a party, including any Metagenomi In-License Agreement, in connection with this Agreement, including with respect to the Development, Manufacture, and Commercialization of Licensed Products. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.7.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Existing Potential Ionis In-License Agreements</B>. With respect to any Patent Rights or Know-How that are
the subject of an Ionis IP Option and are in-licensed or acquired by Ionis from any Third Party as of the applicable Ionis IP Option Effective Date (any such agreement, an &#147;<B>Existing Potential Ionis In-License Agreement</B>&#148;), Ionis
will, within [***] of the applicable Ionis IP Option Effective Date, provide Metagenomi with notice and a copy of each such Existing Potential Ionis In-License Agreement (which may be redacted to exclude provisions thereof that would not be
applicable to Metagenomi as a licensee or sublicensee (as the case may be)). If Metagenomi provides written notice, within [***] of receipt of such information from Ionis, that it would like to have any such Existing Potential Ionis In-License
Agreement included in the licenses granted under this Agreement and be subject to the terms of such Existing Potential Ionis In-License Agreement that are applicable to a licensee or sublicensee (as the case may be) thereunder, then such
intellectual property rights described in such notice will automatically be deemed included in the Ionis Background Technology and such Existing Potential Ionis In-License Agreement will be considered an Ionis In-License Agreement.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>New In-License Agreements. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.8.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Proposed New In-License Agreements.</B> Either Party (an &#147;<B>Acquiring Party</B>&#148;) may, during the
Term, acquire or in-license rights to additional intellectual property from a Third Party that, if solely owned by such Party, without any encumbrance or restriction on licensing, would constitute Licensed Technology (if such Acquiring Party is
Metagenomi) or Ionis Background Technology (if such Acquiring Party is Ionis) (any such agreement entered into by Metagenomi, a &#147;<B>Proposed New Metagenomi In-License Agreement</B>,&#148; any such agreement entered into by Ionis, a
&#147;<B>Proposed New Ionis In-License Agreement</B>,&#148; and any Proposed New Metagenomi In-License Agreements or Proposed New Ionis In-License Agreements, a &#147;<B>Proposed New In-License Agreement</B>&#148;). Any such Proposed New In-License
Agreement will be freely licensable or sublicensable to the non-Acquiring Party </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
to the same extent that Licensed Technology or Ionis Background Technology (as applicable) is licensed to the non-Acquiring Party hereunder (including the right to grant sublicenses through
multiple tiers) and will not (a)&nbsp;impose any material restrictions or obligations on the non-Acquiring Party as a licensee or sublicensee or (b)&nbsp;disadvantage the non-Acquiring Party, in each case ((a) and (b)), as compared to any other
potential licensee or sublicensee under such Proposed New In-License Agreement. The Acquiring Party will [***] include in any such Proposed New In-License Agreement that is an in-license a provision pursuant to which [***]. Promptly following
execution of a Proposed New In-License Agreement, the Acquiring Party will provide the non-Acquiring Party with a copy of such Proposed New In-License Agreement (which may be redacted to exclude provisions thereof that would not be applicable to the
non-Acquiring Party as a licensee or sublicensee (as the case may be)). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.8.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Acceptance of a Proposed In-License Agreement.</B> If the non-Acquiring Party provides written notice,
within [***] of receipt of a Proposed New In-License Agreement, that it would like to have such intellectual property rights included in the licenses granted under this Agreement and be subject to the terms of such Proposed New In-License Agreement
that are applicable to a licensee or sublicensee (as the case may be) thereunder, then such intellectual property rights described in such notice will automatically be deemed included in the Licensed Technology (if such Acquiring Party is
Metagenomi) or Ionis Background Technology (if such Acquiring Party is Ionis) (any such Proposed New Metagenomi In-License Agreement with respect to intellectual property rights that are included in the Licensed Technology pursuant to this sentence,
a &#147;<B>New Metagenomi In-License Agreement</B>,&#148; any such Proposed New Ionis In-License Agreement with respect to intellectual property rights that are included in the Ionis Background Technology pursuant to this sentence, a &#147;<B>New
Ionis In-License Agreement</B>&#148; and any New Metagenomi In-License Agreement or New Ionis In-License Agreement, a &#147;<B>New In-License Agreement</B>&#148;). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Payment Obligations Under Certain In-License Agreements. </B>Any payment obligations arising under the
Metagenomi In-License Agreements or the Ionis In-License Agreements that are directly a result of the Development, Manufacture, or Commercialization of a Licensed Product or Metagenomi Product (as applicable) in the Field by or on behalf of the
non-Acquiring Party or any of its Affiliates or Sublicensees, after application of all available reductions to and deductions from such payment obligations under the applicable agreement (but, for the avoidance of doubt, excluding [***] will be paid
by [***] and reimbursed by the [***] in accordance with this <U>Section&nbsp;9.9</U> (Payment Obligations Under Certain In-License Agreements), but, with respect to [***], subject to [***] pursuant to <U>Section&nbsp;9.6.2(c)</U> (Third Party
Payments). Except as set forth in the immediately preceding sentence, [***] will be responsible for [***] under such agreements (including [***]). [***] will provide the [***] with a reasonably detailed invoice for any payments made by the [***]
under a Metagenomi In-License Agreement or Ionis In-License Agreement that are [***] pursuant to this <U>Section&nbsp;9.9</U> (Payment Obligations Under Certain In-License Agreements) within [***], and [***] will pay the undisputed portion of such
invoices within [***] of receipt thereof. For clarity, the [***] and its Affiliates will be [***] under a Metagenomi In-License Agreement or Ionis In-License Agreement one time only. Notwithstanding the foregoing, the [***] may, in its sole
discretion, notify [***] that it elects to abandon its payment obligations under this <U>Section&nbsp;9.9</U> (Payment Obligations Under Certain In-License Agreements) with respect to a Metagenomi In-License Agreement or Ionis In-License Agreements,
whereupon such agreement will no longer be deemed to be a Metagenomi In-License Agreement or Ionis In-License Agreements under this Agreement (as applicable) and the [***] will no longer be responsible for such payment obligations from and after the
date of such notice.<B> </B></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Metagenomi Product Economics. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.10.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Metagenomi Product Milestone Payments.</B> If Metagenomi exercises the Ionis IP Option in accordance
with <U>Section&nbsp;2.7</U> (Ionis Proprietary Toolbox of Chemical Modifications), then, on a Metagenomi Product-by-Metagenomi Product basis, Metagenomi will pay one-time milestone payments to Ionis of the amounts set forth in <U>Table 9.10.1</U>
(each, a &#147;<B>Metagenomi Product Milestone Event</B>&#148;) upon the first achievement by Metagenomi or any of its Affiliates or Sublicensees of each of the milestone events set forth in <U>Table 9.10.1</U> (each, a &#147;<B>Metagenomi Product
Milestone Payment</B>&#148;) for a Metagenomi Product. Each Metagenomi Product Milestone Payment is payable only once for each Metagenomi Product, regardless of the number of times the corresponding Metagenomi Product Milestone Event is achieved for
a Metagenomi Product. If Metagenomi or its Affiliates or Sublicensees achieve all of the Metagenomi Product Milestone Events for a Metagenomi Product, then the Metagenomi Product Milestone Payments payable by Metagenomi under this
<U>Section&nbsp;9.10.1</U> (Metagenomi Product Milestone Payments) for such Metagenomi Product will not exceed [***]. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="69%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="39%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><U>Table 9.10.1</U> &#150; Metagenomi
Product Milestones</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Metagenomi Product Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Metagenomi&nbsp;Product&nbsp;Milestone&nbsp;Payment</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.10.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Notice; Payment; Skipped Milestones.</B> Metagenomi will provide Ionis with written notice upon the
achievement of each Metagenomi Product Milestone Event within [***] after such achievement and will pay Ionis within [***] after receipt of an invoice from Ionis. Each Metagenomi Product Milestone Event is intended to be successive. If any
Metagenomi Product Milestone Event does not occur with respect to a Metagenomi Product, then such skipped milestone event will be deemed to have been achieved upon the achievement of the next successive milestone event with respect to such
Metagenomi Product; <I>provided</I> that the [***] Metagenomi Product Milestone Event shall not be deemed to have been achieved upon the achievement of the [***] Metagenomi Product Milestone Event. Payment for any such skipped milestone that is owed
in accordance with the provisions of the foregoing sentence will be due concurrently with the payment for the next successive Metagenomi Product Milestone Event. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.10.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Metagenomi Royalties.</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Metagenomi Royalty Rates</B>. Subject to the terms and conditions of this Agreement, including the
provisions of <U>Section&nbsp;9.10.3(b)</U> (Adjustments to Metagenomi Royalties), on a Metagenomi Product-by-Metagenomi Product and country-by-country basis, Metagenomi will pay Ionis an amount equal to [***] of the Net Sales of the applicable
Metagenomi Product in a country in the Territory by Metagenomi and its Affiliates and its Sublicensees until the expiration of the applicable Metagenomi Royalty Term for such Metagenomi Product in such country. The royalty payments made pursuant to
this <U>Section&nbsp;9.10.3(a)</U> (Metagenomi Royalty Rates), the &#147;<B>Metagenomi Royalties</B>&#148; and the rate set forth in this <U>Section&nbsp;9.10.3(a)</U> (Metagenomi Royalty Rates), the &#147;<B>Metagenomi Royalty Rate</B>.&#148;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Adjustment to Metagenomi Royalties</B>. On a Metagenomi Product-by- Metagenomi Product and
country-by-country basis in the Territory, if during the Metagenomi Royalty Term for a Metagenomi Product in a given country there is no Valid Claim of a Patent Right within the Ionis Background Technology Covering such Metagenomi Product in such
country, then commencing in the first Calendar Quarter after the date on which this <U>Section&nbsp;9.10.3(b)</U> (Adjustments to Metagenomi Royalties) applies and for the remainder of the Royalty Term for such Metagenomi Product in such country,
the Net Sales for such Metagenomi Product in such country will be reduced by [***] for purposes of calculating the Metagenomi Royalties owed under <U>Section&nbsp;9.10.3(a)</U> (Metagenomi Royalty Rates). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.10.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Metagenomi Royalty Reports</B>. Commencing on the First Commercial Sale (applied <I>mutatis mutandis</I>) of
a Metagenomi Product and for so long as Metagenomi Royalties are due under this Agreement, no later than (a)&nbsp;[***] prior to the start of each Calendar Year, Metagenomi will deliver a written good faith non-binding estimate to Ionis of the
projected Net Sales for the upcoming Calendar Year, (b)&nbsp;[***] after the end of each Calendar Quarter, Metagenomi will deliver a written good faith non-binding estimate to Ionis of the Net Sales in the relevant Calendar Quarter and the
Metagenomi Royalties payable on such Net Sales, and (c)&nbsp;[***] after the end of each Calendar Quarter, Metagenomi will deliver a written report (each, a &#147;<B>Metagenomi Royalty Report</B>&#148;) to Ionis specifying on a Metagenomi
Product-by-Metagenomi Product and country-by-country basis: (i)&nbsp;Net Sales in the relevant Calendar Quarter; (ii)&nbsp;to the extent such Net Sales include sales not denoted in US Dollars, a summary of the then-current exchange rate
methodology(ies) used for the calculation of Net Sales in accordance with <U>Section&nbsp;9.14</U> (Currency of Payment; Non-Refundable Payments); and (iii)&nbsp;the Metagenomi Royalties payable on such Net Sales. All Metagenomi Royalty Reports will
be the Confidential Information of Metagenomi. Metagenomi will pay the Metagenomi Royalties for each Calendar Quarter no later than [***] after receipt of an invoice from Ionis, which invoice will be provided promptly following Ionis&#146; receipt
of each Metagenomi Royalty Report from Metagenomi pursuant to this <U>Section&nbsp;9.10.4</U> (Metagenomi Royalty Reports). For clarity, the submission by Ionis of an invoice to Metagenomi based on a Metagenomi Royalty Report will be without
prejudice to Ionis&#146; right to dispute a Metagenomi Royalty Report or to audit a Metagenomi Royalty Report pursuant to <U>Section&nbsp;9.13</U> (Records and Audits). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Other Payments.</B> With respect to any amounts owed under this Agreement by one Party to the other
for which no other invoicing and payment procedure is otherwise specified in this Agreement, a Party will provide an invoice, together with reasonable supporting documentation, to the other Party for such amounts. The owing Party will pay any
undisputed amounts within [***] of receipt of the invoice, and any disputed amounts owed by a Party will be paid within [***] of resolution of the dispute in accordance with <U>Section&nbsp;15.1</U> (Dispute Resolution). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Right to Offset.</B> Ionis will have the right to offset any amount owed by Metagenomi to Ionis that
are (a)&nbsp;[***], or (b)&nbsp;[***], in each case, against any payments owed by Ionis to Metagenomi under this Agreement. Such offsets will be in addition to any other rights or remedies available under this Agreement and Applicable Law. For
clarity, the foregoing right to offset will only apply to [***]. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Records and Audits. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.13.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Books and Records.</B> Each Party will keep (and will cause its Affiliates and Sublicensees to keep)
complete and accurate books and records pertaining to (a)&nbsp;in the case of Ionis, all Internal Costs and Out-of-Pocket Costs incurred in connection with the performance of the Drug Discovery Activities, Net Sales of Ionis Products, any amounts
paid under any Ionis In-License Agreement, and any costs shared by the Parties for the Co-Co Products pursuant to a Co-Development and Co-Commercialization Agreement (the &#147;<B>Ionis Records</B>&#148;) and (b)&nbsp;in the case of Metagenomi, all
Internal Costs and Out-of-Pocket Costs incurred in connection with the performance of the Collaboration Activities, Net Sales of the Metagenomi Products, any amounts paid under any Metagenomi In-License Agreement, and any costs shared by the Parties
for the Co-Co Products pursuant to a Co-Development and Co-Commercialization Agreement (the &#147;<B>Metagenomi Records</B>&#148;), in each case ((a) and (b)), in reasonable detail to permit the other Party to confirm the accuracy of all payments or
costs reported for at least the preceding [***]. During the Term and for a period of [***] thereafter, each Party (the &#147;<B>Auditing Party</B>&#148;) may, upon written request and subject to this <U>Section&nbsp;9.13</U> (Records and Audits),
cause a nationally-recognized independent accounting firm (the &#147;<B>Auditor</B>&#148;), that is reasonably acceptable to the other Party (the &#147;<B>Audited Party</B>&#148;) to inspect the relevant records of such Audited Party and its
Affiliates to verify the payments made and amounts reported by the Audited Party and the directly related reports, statements, and books of accounts, as applicable. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.13.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Audit Procedure.</B> Before beginning its audit, the Auditor will execute a written agreement
acceptable to the Audited Party by which the Auditor agrees to keep confidential all information reviewed during the audit, which agreement will contain terms of non-disclosure and non-use no less stringent than those set forth in this Agreement,
but otherwise will be reasonable and customary for the purposes of an audit of this nature. The Auditor will have the right to disclose to the Auditing Party only its conclusions regarding any payments owed under this Agreement. Each Party and its
Affiliates will make their records available for inspection by the Auditor during regular business hours at such place or places where such records are customarily kept, upon receipt of reasonable advance notice from the Auditing Party. The records
will be reviewed solely to verify the Audited Party&#146;s compliance with the payment obligations and financial terms of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>9.13.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Frequency; Overpayments and Underpayments.</B> Such inspection right will not be exercised more than
[***] and not more frequently than [***] with respect to records covering any specific period of time. In addition, the Auditing Party will only be entitled to audit the books and records of the Audited Party for the [***] prior to the [***] in
which the audit request is made. The Auditing Party agrees to hold in strict confidence all information received and all information learned in the course of any audit or inspection, except to the extent necessary to enforce its rights under this
Agreement or to the extent required to comply with any Applicable Law or judicial order. The Auditor will provide its audit report and basis for any determination to the Audited Party at the time such report is provided to the Auditing Party before
it is considered final. If the final result of the inspection reveals an underpayment or overpayment by either Party, then the underpaid or overpaid amount will be settled promptly plus interest due on any underpayments in accordance with
<U>Section&nbsp;9.15</U> (Late Fees). The Auditing Party will pay for such inspections, as well as its expenses associated with enforcing its rights with respect to any payments hereunder; unless such audit reveals an underpayment of amounts owed
to, or an overpayment of amounts owed by, the Auditing Party of more than [***] of the amount that was owed by the Audited Party or owed to the Audited Party, as applicable, with respect to the relevant period, in which case, the Audited Party will
reimburse the Auditing Party for the reasonable expense incurred by the Auditing Party in connection with the audit. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Currency of Payment; Non-Refundable Payments.</B> All amounts to be paid pursuant to this Agreement
will be made in United States Dollars and will be paid by wire transfer in immediately available funds to a bank account designated by the receiving Party. The rate of exchange to be used in computing the amount of currency equivalent in U.S.
Dollars owed to a Party under this Agreement will be the paying Party&#146;s then-current standard exchange rate methodology employed for the translation of foreign currency sales into U.S. Dollars in accordance with its Accounting Standards and
consistently applied during the period. Any provisions of this Agreement that describe a payment as non-refundable will be without prejudice to either Party&#146;s right to bring a claim for breach of this Agreement, misrepresentation, or any other
claim permissible under Applicable Law, including seeking recovery of payments made and damages for loss. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Late Fees.</B> If a Party does not receive payment of any undisputed sum due to it on or before the due date
set forth under this Agreement, then simple interest will thereafter accrue on the sum due to such Party from the due date until the date of payment at a per-annum rate of [***] or the maximum rate allowable under Applicable Law, whichever is lower.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Currency Restrictions.</B> If, by reason of Applicable Law in any country, it becomes impossible or
illegal for a Party to transfer, or have transferred on its behalf, payments owed to the other Party hereunder, then such Party will promptly notify the other Party of the conditions preventing such transfer and such payments will be deposited in
local currency in the relevant country to the credit of the other Party in a recognized banking institution designated by the other Party or, if none is designated by the other Party within a period of [***], in a recognized banking institution
selected by the transferring Party, as the case may be, and identified in a written notice given to the other Party. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>9.17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Withholding Taxes</B>.<B> </B>Either Party (a <B></B>&#147;<B></B><B>Withholding Party</B>&#148;) may
withhold from payments due to the other Party (a &#147;<B>Non-Withholding Party</B>&#148;) amounts for payment of any withholding tax that is required by Applicable Law to be paid to any taxing authority with respect to such payments, which will be
remitted in accordance with Applicable Law. The Withholding Party will provide to the Non-Withholding Party all relevant documents and correspondence, and will also provide to the Non-Withholding Party any other cooperation or assistance on a
reasonable basis as may be necessary to enable the Non-Withholding Party to claim exemption from such withholding taxes and to receive a refund of such withholding tax or claim a foreign tax credit. The Withholding Party will give proper evidence
from time to time as to the payment of any such tax. The Parties will cooperate with each other in seeking deductions under any double taxation or other similar treaty or agreement from time to time in force. Such cooperation may include the
Withholding Party making payments from a single source in the U.S., where possible. Notwithstanding the foregoing, [***]. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;10 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Intellectual Property </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ownership of Inventions. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Background Intellectual Property.</B> As between the Parties, and subject to the licenses granted
under this Agreement, each Party retains all rights, title, and interests in and to all Intellectual Property Rights that such Party owns or Controls as of the Effective Date or that it develops or otherwise acquires after the Effective Date outside
the performance of the activities under this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>By Inventorship.</B> For purposes of determining ownership under this <U>Section&nbsp;10.1.2</U> (By
Inventorship), inventorship will be determined in accordance with United States patent laws (regardless of where the applicable activities occurred). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Metagenomi Collaboration Technology</B>. Metagenomi will be the sole owner of any Know-How
discovered, developed, invented, or created solely by Metagenomi or its Affiliates or Third Parties acting on its or their behalf, in each case, in the performance of activities under this Agreement (&#147;<B>Metagenomi Collaboration
Know-How</B>&#148;) and any Patent Rights that Cover the Metagenomi Collaboration Know-How (&#147;<B>Metagenomi Collaboration Patent Rights</B>&#148; and together with the Metagenomi Collaboration Know-How, the &#147;<B>Metagenomi Collaboration
Technology</B>&#148;), and will retain all of its rights thereto, subject to any rights or licenses expressly granted by Metagenomi to Ionis under this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Ionis Collaboration Technology</B>. Ionis will be the sole owner of any Know-How discovered,
developed, invented, or created solely by Ionis or its Affiliates or Third Parties acting on its or their behalf, in each case, in the performance of activities under this Agreement (&#147;<B>Ionis Collaboration Know-How</B>&#148;) and any Patent
Rights that Cover the Ionis Collaboration Know-How (&#147;<B>Ionis Collaboration Patent Rights</B>&#148; and together with the Ionis Collaboration Know-How, the &#147;<B>Ionis Collaboration Technology</B>&#148;), and will retain all of its rights
thereto, subject to any rights or licenses expressly granted by Ionis to Metagenomi under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Joint Collaboration Technology</B>. Any Know-How discovered, developed, invented, or created jointly
by (i)&nbsp;Ionis, its Affiliates, or Third Parties acting on its or their behalf and (ii)&nbsp;Metagenomi, its Affiliates, or Third Parties acting on its or their behalf, in each case, in the performance of activities under this Agreement
(including in any meeting of the JSC or any Subcommittee) (such Know-How, &#147;<B>Joint Collaboration Know-How</B>&#148;), and any Patent Rights that Cover such Joint Collaboration Know-How (&#147;<B>Joint Collaboration Patent Rights</B>,&#148; and
together with the Joint Collaboration Know-How, the &#147;<B>Joint Collaboration Technology</B>&#148;), will be owned jointly by Ionis and Metagenomi on an equal and undivided basis, including all rights thereto, subject to any rights or licenses
expressly granted by one Party to the other Party under this Agreement. Except as expressly provided in this Agreement, neither Party will have any obligation to account to the other for profits with respect to, or to obtain any consent of the other
Party to license or exploit, Joint Collaboration Technology by reason of joint ownership thereof, and each Party hereby waives any right it may have under the laws of any jurisdiction to require any such consent or accounting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.1.3</B><B>.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Disclosure.</B> During the Term, (a) Ionis will promptly disclose to designated Metagenomi personnel
(including Metagenomi scientific and intellectual property personnel) in writing, and will cause its Affiliates to so disclose, the discovery, development, invention, or creation of any Ionis Collaboration Know-How or Ionis Collaboration Patent
Right and (b)&nbsp;Metagenomi will promptly disclose to designated Ionis personnel (including Ionis scientific and intellectual property personnel) in writing, and will cause its Affiliates to so disclose, the discovery, development, invention, or
creation of any Metagenomi Collaboration Know-How or Metagenomi Collaboration Patent Rights. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Patent Prosecution. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Ionis-Prosecuted Patent Rights</B>.<B></B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As between the Parties, Ionis will have the first right, but not the obligation, to control the Prosecution and
Maintenance of all Product-Specific Patent Rights, all Joint Collaboration Patent Rights, and all Ionis Collaboration Patent Rights (&#147;<B>Ionis-Prosecuted Patent Rights</B>&#148;). Ionis will be the &#147;Prosecuting Party&#148; with respect to
all Ionis-Prosecuted Patent Rights. Ionis will be responsible for and pay all future costs and expenses incurred in connection with the Prosecution and Maintenance of the Ionis-Prosecuted Patent Rights. Ionis will keep Metagenomi reasonably informed
as to material developments with respect to the Prosecution and Maintenance of the Ionis-Prosecuted Patent Rights and will provide Metagenomi a reasonable opportunity to review and comment on substantive communications from any patent authority in
the Territory regarding the Ionis- Prosecuted Patent Rights, as well as drafts of any substantive filings or responses to be made to such patent authorities in advance of submitting such filings or responses. Ionis will consider Metagenomi&#146;s
comments regarding such communications and drafts in good faith but is not required to implement such comments. In addition, Ionis will provide Metagenomi with (i)&nbsp;copies of all final substantive filings and responses made to any patent
authority with respect to the Ionis-Prosecuted Patent Rights in a timely manner following submission thereof and (ii)&nbsp;notice in advance of abandoning any such Ionis-Prosecuted Patent Rights. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If, during the Term, Ionis decides that it is no longer interested in the Prosecution and Maintenance of a
particular Product-Specific Patent Right or Joint Collaboration Patent Right, then it will promptly provide written notice to Metagenomi of such decision; provided that any such notice will be at least [***] in advance of any time based deadlines by
which an action must be taken to establish or preserve any such Patent Right. Unless Ionis decides to no longer Prosecute and Maintain a particular Product-Specific Patent Right or Joint Collaboration Patent Right for strategic reasons, Metagenomi
may, upon written notice to Ionis, assume the Prosecution and Maintenance of such Patent Right at Metagenomi&#146;s sole cost and expense. In such event Metagenomi will be responsible for 100% of the costs and expenses of the Prosecution and
Maintenance of such Patent Right, and Metagenomi will thereafter be the &#147;Prosecuting Party&#148; with respect thereto for all purposes under this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Metagenomi-Prosecuted Patent Rights.</B> As between the Parties, Metagenomi will have the sole right,
but not the obligation, to control the Prosecution and Maintenance of the Licensed Patent Rights and Metagenomi Collaboration Patent Rights, in each case, that are not Product-Specific Patent Rights (such Patent Rights, the &#147;<B>Metagenomi-
Prosecuted Patent Rights</B>&#148;) in accordance with this Agreement. Metagenomi will be the &#147;Prosecuting Party&#148; with respect to all Metagenomi-Prosecuted Patent Rights. Metagenomi will be responsible for and pay all future costs and
expenses incurred in connection with the Prosecution and Maintenance of the Metagenomi-Prosecuted Patent Rights. Metagenomi will keep Ionis reasonably informed as to material developments with respect to the Prosecution and Maintenance of the
Metagenomi-Prosecuted Patent Rights and will provide Ionis a reasonable opportunity to review and comment on substantive communications from any patent authority in the Territory regarding the Metagenomi-Prosecuted Patent Rights, as well as drafts
of any substantive filings or responses to be made to such patent authorities in advance of submitting such filings or responses. Metagenomi will consider Ionis&#146; comments regarding such communications and drafts in
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
good faith but is not required to implement such comments. In addition, Metagenomi will provide Ionis with (a)&nbsp;copies of all final substantive filings and responses made to any patent
authority with respect to the Metagenomi-Prosecuted Patent Rights in a timely manner following submission thereof and (b)&nbsp;notice in advance of abandoning any such Metagenomi-Prosecuted Patent Rights. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.2.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Cooperation.</B> The non-Prosecuting Party will (a)&nbsp;obtain and deliver to the Prosecuting Party
any necessary documents for the Prosecuting Party to exercise its rights to prepare, prosecute, defend, and maintain all Patent Rights pursuant to this <U>Section&nbsp;10.2</U> (Patent Prosecution), (b)&nbsp;render all signatures that will be
necessary in connection with all such patent filings, and (c)&nbsp;assist the Prosecuting Party in all other reasonable ways that are necessary for the issuance of those Patent Rights for which such Prosecuting Party is responsible, as well as for
the Prosecution and Maintenance of such Patent Rights. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.2.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Coordination in Prosecution.</B> Notwithstanding Metagenomi&#146;s right to Prosecute and Maintain
the Metagenomi-Prosecuted Patent Rights, the Parties will, and will cause their Affiliates to, cooperate and implement reasonable patent filing and prosecution strategies (including filing divisionals, continuations or otherwise) so that, to the
extent reasonably feasible, Product-Specific Patent Rights and other Licensed Patent Rights are pursued in mutually exclusive patent applications. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Patent Enforcement. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.3.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Notification.</B> Each Party will use reasonable efforts to promptly notify the other in the event of
any actual, likely, or suspected infringement of any Ionis-Prosecuted Patent Right or Metagenomi-Prosecuted Patent Right (an &#147;<B>Infringement</B>&#148;), including any Infringement that arises as a result of the making, using, offering to sell,
selling, or importing of a product that would be competitive with a Licensed System or Licensed Product (a &#147;<B>Competitive Infringement</B>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.3.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Competitive Infringements</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ionis will have the first right, but not the obligation, to institute, prosecute, and control a Proceeding to
enforce the Ionis-Prosecuted Patent Rights against any Competitive Infringement at its own expense. If Ionis fails to initiate a Proceeding within a period of 90 days after written notice of a Competitive Infringement is first provided by a Party
under <U>Section&nbsp;10.3.1</U> (Notification), then Metagenomi will have the right to initiate and control a Proceeding to enforce the applicable Patent Right against such Competitive Infringement by counsel of its own choice; provided that if
Ionis notifies Metagenomi during such 90-day period that it is electing in good faith not to institute any Proceeding to enforce Ionis-Prosecuted Patent Rights against such Competitive Infringement for strategic reasons, then Metagenomi will not
have the right to initiate and control any Proceeding to enforce such Patent Rights against such Competitive Infringement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi will have the first right, but not the obligation, to institute, prosecute, and control a Proceeding
to enforce the Metagenomi-Prosecuted Patent Rights against any Competitive Infringement at its own expense. If Metagenomi fails to initiate a Proceeding within a period of 90 days after written notice of a Competitive Infringement is first provided
by a Party under <U>Section&nbsp;10.3.1</U> (Notification), then Ionis will have the right to initiate and control a Proceeding to </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="23%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
enforce the applicable Patent Right against such Competitive Infringement by counsel of its own choice; provided that if Metagenomi notifies Ionis during such 90-day period that it is electing in
good faith not to institute any Proceeding to enforce Metagenomi-Prosecuted Patent Rights against such Competitive Infringement for strategic reasons, then Ionis will not have the right to initiate and control any Proceeding to enforce such Patent
Rights against such Competitive Infringement. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.3.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Proceedings for Infringements other than Competitive Infringements.</B> During the Term,
(a)&nbsp;Metagenomi will have the sole right, but not the obligation, to initiate a Proceeding against any Infringement that is not a Competitive Infringement with respect to any Licensed Patent Rights, at Metagenomi&#146;s sole discretion and at
Metagenomi&#146;s sole cost and expense and (b)&nbsp;the Parties will jointly agree upon any initiation of a Proceeding against any Infringement that is not a Competitive Infringement with respect to any Joint Collaboration Patent Right;
<I>provided</I> that neither Party will unreasonably withhold its agreement to initiate any such Proceeding with respect to any Joint Collaboration Patent Right (as applicable) upon the reasonable request of the other Party. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.3.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Collaboration.</B> Each Party will provide to the enforcing Party reasonable assistance in any Proceeding
brought under this <U>Section&nbsp;10.3</U> (Patent Enforcement), at such enforcing Party&#146;s request and expense, including to be named in such action if required by Applicable Law to pursue such action. The enforcing Party will keep the other
Party regularly informed of the status and progress of such enforcement efforts, will reasonably consider the other Party&#146;s comments on any such efforts, including determination of litigation strategy and filing of material papers to the
competent court. The non-enforcing Party will be entitled to separate representation in such matter by counsel of its own choice and at its own expense, but such Party will at all times cooperate fully with the enforcing Party. The enforcing Party
will not settle any Proceeding that it brought under <U>Section&nbsp;10.3.2</U> (Competitive Infringements) in any manner that would limit the rights of the other Party or impose any obligation on the other Party, without the prior written consent
of the other Party, which consent will not be unreasonably withheld, conditioned, or delayed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.3.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Expenses and Recoveries.</B> Any amount recovered in any Proceeding under this
<U>Section&nbsp;10.3</U> (Patent Enforcement), including any amount recovered in any settlement of such Proceeding, will first be used [***] and will thereafter be for (a)&nbsp;with respect to any Competitive Infringement, the benefit of [***];
<I>provided</I>, <I>however</I>, that to the extent any such amount is [***] then such amount will, [***] and (b)&nbsp;with respect to any Infringement that is not a Competitive Infringement, for the benefit of [***]. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Defense of Claims Brought by Third Parties.</B> If any Third Party brings a claim or otherwise
asserts that a Licensed Product or Licensed System infringes such Third Party&#146;s Patent Rights or misappropriates such Third Party&#146;s Know-How (each, a &#147;<B>Third Party Infringement Claim</B>&#148;), then the Party first having notice of
the claim or assertion will promptly notify the other Party in writing. Subject to [***], [***] will have the sole right, but not the obligation, to undertake and control the defense or settlement of any Third Party Infringement Claim using counsel
of its choice, at its cost and expense. If [***] is named as a defendant in such suit, [***] will have the right to participate in such defense and settlement with its own counsel, at its cost. [***] will not enter into any settlement of any Third
Party Infringement Claim that is instituted or threatened to be instituted against [***] without [***] prior written consent, which will not be unreasonably withheld, conditioned, or delayed; except that such consent will not be required if such
settlement includes a release of all liability in favor of [***] or an assumption of any unreleased liability by [***]. As </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
requested by [***], [***] will provide reasonable cooperation and assistance to [***] in connection with [***] control of the defense or settlement of a Third Party Infringement Claim. Such
cooperation and assistance will include executing all necessary and proper documents and taking such actions as will be appropriate to allow [***] to control the defense and settlement of such Third Party Infringement Claim. [***] will reimburse
[***]; except that [***] will have no obligation to [***] will keep [***] reasonably informed of the progress of any Third Party Infringement Claim. To the extent reasonable, both Parties will cooperate in good faith to (a)&nbsp;ensure that [***]
and (b)&nbsp;[***]. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Patent Listing.</B> Ionis will have the sole right, but not the obligation, to determine which Ionis-
Prosecuted Patent Rights will be listed in connection with the Regulatory Approval for a Licensed Product pursuant to 21 U.S.C. &#167; 355(b)(1)(G), any similar statutory or regulatory requirement enacted in the future regarding biologic products,
or any similar statutory or regulatory requirement in any non-U.S. country or other regulatory jurisdiction. The Parties will discuss and mutually agree on which Metagenomi-Prosecuted Patent Rights will be listed in connection with the Regulatory
Approval for a Licensed Product pursuant to 21 U.S.C. &#167; 355(b)(1)(G), any similar statutory or regulatory requirement enacted in the future regarding biologic products, or any similar statutory or regulatory requirement in any non-U.S. country
or other regulatory jurisdiction. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Common Ownership Legislation.</B> Notwithstanding anything to the contrary in this<U> Article 10</U>
(Intellectual Property), neither Party will have the right to make an election under the Common Ownership Legislation when exercising its rights under this<U> Article 10</U> (Intellectual Property) without the prior written consent of the other
Party, which will not be unreasonably withheld, conditioned, or delayed. With respect to any such permitted election, the Parties will use reasonable efforts to cooperate and coordinate their activities with respect to any submissions, filings, or
other activities in support thereof. The Parties acknowledge and agree that this Agreement is a &#147;joint research agreement&#148; as defined in the Common Ownership Legislation. Notwithstanding the foregoing, the other Party&#146;s consent under
this <U>Section&nbsp;10.6</U> (Common Ownership Legislation) will not be required in connection with an obviousness-type double patenting rejection in any patent application claiming a Licensed System, Licensed Product, or uses thereof.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Patent Term Extension. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.7.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Ionis-Prosecuted Patent Rights.</B> Ionis will be solely responsible for obtaining patent term
restoration for the Ionis-Prosecuted Patent Rights in any country in the Territory under any statute or regulation equivalent or similar to 35 U.S.C. &#167; 156, where applicable to a Licensed Product. Ionis will determine which relevant
Ionis-Prosecuted Patent Rights will be extended (including by filing supplementary protection certificates and any other extensions that are now or in the future become available). Metagenomi will abide by Ionis&#146; determination and cooperate, as
reasonably requested by Ionis, in connection with the foregoing (including by providing appropriate information and executing appropriate documents). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>10.7.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Metagenomi-Prosecuted Patent Rights.</B> The Parties will mutually agree on the strategy for
obtaining patent term restoration for the Metagenomi-Prosecuted Patent Rights in any country in the Territory under any statute or regulation equivalent or similar to 35 U.S.C. &#167; 156, where applicable to a Licensed Product. The Parties will
mutually agree on which relevant Metagenomi-Prosecuted Patent Rights will be extended (including by filing supplementary protection certificates and any other extensions that are now or in the future become available) and will cooperate with each
other in connection with the foregoing (including by providing appropriate information and executing appropriate documents). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Recording</B>. If Ionis deems it necessary or desirable to register or record this Agreement or
evidence of this Agreement with any patent office or other appropriate Governmental Authority in one or more jurisdictions in the Territory, then Metagenomi will reasonably cooperate to execute and deliver to Ionis any documents accurately
reflecting or evidencing this Agreement that are necessary or desirable, in Ionis&#146; reasonable judgment, to complete such registration or recordation. Ionis will [***] in complying with the provisions of this <U>Section&nbsp;10.8</U>
(Recording). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Unitary Patent System</B>. Ionis will have the exclusive right to opt-in or opt-out of the EU Unitary Patent
System for all Licensed Patent Rights and Joint Collaboration Patent Rights. For clarity, &#147;to opt-in or opt-out&#148; refers to both the right to have a European patent application or an issued European patent registered to have unitary effect
within the meaning of Regulation (EU) No 1257/2012 of December&nbsp;17, 2012 as well as the Agreement on a Unified Patent Court as of February&nbsp;19, 2013; and to the right to opt-in or opt-out from the exclusive competence of the Unified Patent
Court in accordance with Article 83(3) of that Agreement on a Unified Patent Court. Without limiting the generality of the foregoing, unless a Party or its Affiliate has expressly opted-in to the EU Unitary Patent System with respect to a given
Patent Right, the other Party will not initiate any action under the EU Unitary Patent System without such Party&#146;s prior written approval, such approval to be granted or withheld in such Party&#146;s sole discretion. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Trademarks</B><B></B>. As between the Parties, all trademarks and trade dress rights used in
connection with the Commercialization of the Licensed Products in the Field in the Territory will be owned exclusively by Ionis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>10.11</B><B>.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Common Interest</B><B></B>. All information exchanged between the Parties regarding the Prosecution
and Maintenance, and enforcement and defense, of the Patent Rights under this<U> Article 10</U> (Intellectual Property) will be deemed Confidential Information of the disclosing Party. In addition, the Parties acknowledge and agree that, with regard
to such Prosecution and Maintenance, and enforcement and defense of the Patent Rights under this<U> Article 10</U> (Intellectual Property), the interests of the Parties as collaborators and licensor and licensee are to obtain the strongest patent
protection possible, and as such, are aligned and are legal in nature. The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patent Rights under this<U>
Article 10</U> (Intellectual Property), including privilege under the common interest doctrine and similar or related doctrines. Notwithstanding anything to the contrary contained herein, to the extent a Party has a good faith belief that any
information required to be disclosed by such Party to the other Party under this <U>Article 10</U> (Intellectual Property) is protected by attorney-client privilege or any other applicable legal privilege or immunity, such Party will not be required
to disclose such information and the Parties will in good faith cooperate to agree upon a procedure (including entering into a specific common interest agreement, disclosing such information on a &#147;for counsel eyes only&#148; basis or similar
procedure) under which such information may be disclosed without waiving or breaching such privilege or immunity. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;11 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Confidentiality </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>11.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential Information</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>11.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General.</B> Each Party will maintain all Confidential Information disclosed to it or its representatives
(the &#147;<B>Receiving Party</B>&#148;) by or on behalf the other Party (the &#147;<B>Disclosing Party</B>&#148;) in strict confidence during the Term of this Agreement and for a period of [***] after the expiration or termination of this
Agreement; <I>provided</I> that any Confidential </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Information of either Party that constitutes a trade secret will continue to be subject to the terms of this<U> Article 11</U> (Confidentiality) in perpetuity, so long as such information remains
a trade secret. Each Party will use all such disclosed Confidential Information only to the extent necessary for purposes of this Agreement, including exercising the licenses and rights hereunder, and will not disclose such Confidential Information
to any Third Party without the prior written consent of the Disclosing Party, except as permitted under this Agreement. Each Party will notify the other Party promptly on discovery of any unauthorized use or disclosure by a Party of the other
Party&#146;s Confidential Information, including the other Party&#146;s trade secrets. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>11.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential Information of Each Party</B>. All information disclosed prior to the Effective Date pursuant
to the Confidentiality Agreement between the Parties dated [***] (the &#147;<B>Confidentiality Agreement</B>&#148;), by Metagenomi to Ionis will be Confidential Information of Metagenomi and by Ionis to Metagenomi will be Confidential Information of
Ionis. All Ionis Royalty Reports and reports identifying Ionis Product Development Milestone Events, Ionis Product Regulatory Milestone Events, and Ionis Product Sales Milestone Events will be considered Confidential Information of Ionis. All
Metagenomi Royalty Reports and reports identifying Metagenomi Product Milestone Events will be the Confidential Information of Metagenomi. The Product-Specific Know-How, Joint Collaboration Know-How, and the non-disclosed terms of this Agreement
will be the Confidential Information of each Party. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>11.1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exceptions to Confidentiality</B>. The following information will not be Confidential Information of the
Disclosing Party, and accordingly the obligations of each Receiving Party imposed by <U>Section&nbsp;11.1.1</U> (General) will not apply to any such information that: (a)&nbsp;was known to the Receiving Party without an obligation to keep such
information confidential prior to the Effective Date other than as a result of disclosure under any other agreement between the Parties, including the Confidentiality Agreement (as demonstrated by documentary evidence); (b)&nbsp;is or becomes
generally available to the public through means other than an unauthorized disclosure by the Receiving Party, its Affiliates, or any agents to whom it or they disclosed such information; (c)&nbsp;was or subsequently is disclosed to the Receiving
Party without restriction by a Third Party having a <I>bona fide </I>right to disclose such Confidential Information without breaching any obligation to the Disclosing Party; or (d)&nbsp;is developed independently by the Receiving Party without
benefit of or recourse to any of the Disclosing Party&#146;s Confidential Information (as demonstrated by documentary evidence). For clarity, (i)&nbsp;specific aspects or details of Confidential Information will not be deemed to be within the public
domain or in the possession of the Receiving Party merely because the Confidential Information is embraced by more general information in the public domain or in the possession of the Receiving Party; and (ii)&nbsp;any combination of Confidential
Information will not be considered in the public domain or in the possession of the Receiving Party merely because individual elements of such Confidential Information are in the public domain or in the possession of the Receiving Party unless the
combination and its principles are in the public domain or in the possession of the Receiving Party. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>11.1.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Permitted Disclosures</B>. The Receiving Party may disclose Confidential Information of the Disclosing Party
to the extent (and solely to the extent) that such disclosure is reasonably necessary in the following instances: </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(i)&nbsp;&nbsp;the prosecution and maintenance of Licensed Patent Rights and Joint Collaboration Patent Rights, in each case, in accordance with the terms of this Agreement; or (ii)&nbsp;Regulatory Submissions and other filings with
Governmental Authorities (including Regulatory Authorities), as necessary for the Exploitation of a Licensed Product;</TD></TR>
</TABLE></DIV> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">disclosure of the existence and applicable terms of this Agreement and the status and results of Exploitation
of one or more Licensed Products to actual or <I>bona fide</I> potential investors, acquirors, Sublicensees, lenders, and other financial or commercial partners (including in connection with any royalty factoring transaction), and their respective
attorneys, accountants, banks, investors, and advisors, solely for the purpose of evaluating or carrying out an actual or potential investment, acquisition, sublicense, debt transaction, or collaboration; <I>provided</I> that, in each such case,
(i)&nbsp;such Persons are bound by obligations of confidentiality, non-disclosure, and non-use provisions at least as restrictive or protective of the Parties as those set forth in this Agreement or otherwise customary for such type and scope of
disclosure, and (ii)&nbsp;that any such disclosure is limited to the maximum extent practicable for the particular context in which it is being disclosed; <I>provided</I> that in no event will a disclosure of Confidential Information under this
<U>Section&nbsp;11.1.4(b)</U> be made, with respect to Ionis as the Receiving Party, to a [***] or with respect to Metagenomi as the Receiving Party, to an [***], in each case, without the prior written consent of the other Party;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to comply with Applicable Law (whether generally or in pursuit of an application for listing of securities)
including the United States Securities and Exchange Commission or equivalent foreign agency or regulatory body, or otherwise required by judicial or administrative process; <I>provided</I> that in each such event, as promptly as reasonably
practicable and to the extent not prohibited by Applicable Law or judicial or administrative process, such Party will notify the other Party of such required disclosure and provide a draft of the disclosure to the other Party reasonably in advance
of such filing or disclosure for the other Party&#146;s review and comment. The non-disclosing Party will provide any comments as soon as practicable, and the disclosing Party will consider in good faith any timely comments provided by the
non-disclosing Party; <I>provided</I> that the disclosing Party may or may not accept such comments in its sole discretion. Confidential Information that is disclosed in order to comply with Applicable Law or by judicial or administrative process
pursuant to this <U>Section&nbsp;11.1.4(c)</U>, in each case, will remain otherwise subject to the confidentiality and non-use provisions of this<U> Article 11</U> (Confidentiality) with respect to the Party disclosing such Confidential Information,
and such Party will take all steps reasonably necessary, including seeking of confidential treatment or a protective order for a period of at least [***] (to the extent permitted by Applicable Law or Governmental Authority), to ensure the continued
confidential treatment of such Confidential Information, and each Party will be responsible for its own legal and other external costs in connection with any such filing or disclosure pursuant to this <U>Section&nbsp;11.1.4(c)</U>;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to prosecute or defend litigation so long as there is [***] prior written notice given by the Receiving Party
before filing, and to enforce Patent Rights in connection with the Receiving Party&#146;s rights and obligations pursuant to this Agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to allow the Receiving Party to exercise its rights and perform its obligations hereunder; <I>provided</I> that
such disclosure is covered by terms of confidentiality and non-use at least as restrictive as those set forth herein. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">If and whenever any Confidential Information is disclosed in accordance with this
<U>Section&nbsp;11.1.4</U> (Permitted Disclosures), such disclosure will not cause any such information to cease to be Confidential Information except to the extent that such disclosure results in a public disclosure of such information (other than
by breach of this Agreement). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>11.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No Use of Name</B>. Neither Party will use the other Party&#146;s name, logo, or Trademarks in any
promotional materials or advertising without the prior written consent of the other Party, except as provided under this Agreement or required by Applicable Law, in which case the Party disclosing such name, logo, or Trademarks will give advance
notice of such use and otherwise comply with <U>Section&nbsp;11.1.4(c)</U>. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>11.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Residual Knowledge</B>. Notwithstanding any provision to the contrary set forth in this Agreement, a
Receiving Party will not be liable for the use of any knowledge, technique, experience, or Know-How that is retained in the unaided memory of any officers, directors, agents, contractors, or employees of such Receiving Party after having access to
such Confidential Information (&#147;<B>Residual Knowledge</B>&#148;), <I>provided</I> that such officer, director, agent, contractor, or employee (a)&nbsp;has not intentionally memorized such Residual Knowledge, (b)&nbsp;is not aware at the time of
use that such Residual Knowledge is the Confidential Information of the Disclosing Party, and (c)&nbsp;has not been directed or encouraged by the Receiving Party to memorize such Residual Knowledge. Any use made by the Receiving Party of any such
Residual Knowledge is on an &#147;as is, where is&#148; basis, with all faults and all representations and warranties disclaimed and at its sole risk. For clarity, no license under any Patent Right is granted pursuant to this
<U>Section&nbsp;11.3</U> (Residual Knowledge). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>11.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Public Announcements and Subsequent Disclosures</B>. Except as may be expressly permitted under
<U>Section&nbsp;11.1.4</U> (Permitted Disclosures), neither Party will make any public announcement regarding this Agreement without the prior written approval of the other Party, except for either Party&#146;s references to the other as the
licensor or licensee (as applicable) or a collaboration partner under this Agreement. For clarity, Ionis may make scientific publications or public announcements concerning Ionis&#146; Exploitation of any Licensed Product under this Agreement
pursuant to <U>Section&nbsp;11.5.1</U> (Ionis Publications); <I>provided</I> that, except as permitted under <U>Section&nbsp;11.1.4</U> (Permitted Disclosures), Ionis will not disclose any of Metagenomi&#146;s Confidential Information in any such
publication or announcement without obtaining Metagenomi&#146;s prior written consent to do so. The Parties may each issue, or, by agreement of the Parties, may jointly issue, a press release announcing the signing of this Agreement after the
Effective Date. The press release(s) to be issued by the Parties on or after the Effective Date will be substantially in the form of the press release(s) attached hereto as <U>Schedule 11.4</U> (Press Release(s)). After the issuance of any such
press release or any other permitted public disclosure by a Party, each Party may make subsequent public disclosures reiterating such information without having to obtain the other Party&#146;s prior consent and approval so long as the information
in such press release or other public announcement remains true, correct, and the most current information with respect to the subject matters set forth therein. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>11.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Publications</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>11.5.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis Publications.</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the Collaboration Term, Ionis will submit to Metagenomi for review any proposed academic, scientific, or
medical publication or public presentation related to any Licensed System or Licensed Product or to any activities conducted pursuant to this Agreement. Metagenomi will review such publication or presentation for purposes of determining whether any
portion of the proposed </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="23%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
publication or presentation contains Metagenomi&#146;s Confidential Information. Ionis will submit written copies of such proposed publication or presentation to Metagenomi no later than [***]
before submission for publication or presentation (or [***] in advance in the case of an abstract). Metagenomi will provide its comments with respect to such publications and presentations within [***] after its receipt of such written copy (or
[***] in the case of an abstract). Metagenomi will have the right: (i)&nbsp;to require the removal of its Confidential Information from any such publication or presentation and (ii)&nbsp;to request a reasonable delay in publication or presentation
in order to protect patentable information. If Metagenomi requests such a delay, then Ionis will delay submission or presentation for a period of [***] after its provision of the copy of the proposed publication or disclosure to enable patent
applications protecting Metagenomi&#146;s rights in such information. Ionis will comply with standard academic practice regarding authorship of scientific publications and recognition of contribution of other parties in any publication.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise agreed in a Co-Development and Co-Commercialization Agreement, after the Collaboration Term,
Ionis will have the right upon at least [***] prior written notice to Metagenomi, without any required consent or review from Metagenomi but subject to this<U> Article 11</U> (Confidentiality), to publish or publicly disclose the scientific results
of any activities conducted with respect to any Licensed System or Licensed Product or any other activities conducted pursuant to this Agreement; <I>provided</I> that if Metagenomi reasonably believes that such disclosure would adversely affect the
use of any Licensed System for applications outside of the Field, then Ionis will reasonably consider any comments to such disclosure provided by Metagenomi in such [***] period. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>11.5.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Metagenomi Publications</B>. During the Term, Metagenomi will not publish or publicly disclose the
scientific results of any activities it conducts that are specific to the Licensed System or Licensed Product in the Field, or any other activities conducted pursuant to this Agreement and exclusively licensed to Ionis, in each case, without the
prior written consent of Ionis (such consent not to be unreasonably withheld, conditioned, or delayed). </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;12 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Representations, Warranties, and Covenants </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>12.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Mutual Representations and Warranties</B>. As of the Effective Date, Metagenomi and Ionis each hereby
represents and warrants to the other as follows: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is a corporation duly organized, validly existing, and in good standing under the laws of the jurisdiction
of its organization, and has all requisite power and authority, corporate or otherwise, to execute, deliver, and perform this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The execution and delivery of this Agreement and the performance by it of the transactions contemplated hereby
have been duly authorized by all necessary corporate action and will not violate (a)&nbsp;such Party&#146;s certificate of incorporation or bylaws (or equivalent charter or organizational documents), (b)&nbsp;any agreement, instrument or contractual
obligation to which such Party is bound, (c)&nbsp;any requirement of any Applicable Law, or (d)&nbsp;any order, writ, judgment, injunction, decree, determination, or award of any court or Governmental Authority presently in effect applicable to such
Party. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.1.3</B><B>.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is not under any obligation, contractual or otherwise, to any Person that conflicts with or is inconsistent
in any respect with the terms of this Agreement or that will impede the diligent and complete fulfillment of its obligations hereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.1.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">There is no action or proceeding pending or, to the knowledge of such Party, threatened that could reasonably
be expected to impair or delay the ability of such Party to perform its obligations under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.1.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All consents, approvals, and authorizations from all Governmental Authorities or other Third Parties required
to be obtained by such Party in connection with this Agreement, including the grant of any licenses, have been obtained. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>12.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Additional Representations of Metagenomi</B>. As of the Effective Date and the date on which each new target
becomes a Collaboration Target pursuant to <U>Section&nbsp;2.1.1(b)</U> (Second Wave 1 Target) or <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available) (unless otherwise noted below), Metagenomi further represents and warrants to
Ionis, that, except as set forth on <U>Schedule 12.2</U> (Metagenomi Disclosure Schedule) (which schedule may be updated each time a target becomes a Collaboration Target): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To Metagenomi&#146;s Knowledge, the practice of the Warranty Technology and the Metagenomi Platform as
contemplated by this Agreement will not (a)&nbsp;constitute misappropriation of any Know-How of any Third Party, or (b)&nbsp;infringe any Patent Rights of any Third Party. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi Controls all Patent Rights and Know-How owned or in-licensed by Metagenomi that are necessary to
Exploit licensed systems discovered using the Metagenomi Platform in the Field. For purposes of this <U>Section&nbsp;12.2.2</U>, &#147;licensed systems&#148; mean a Gene Editing protein and a Guide RNA that is designed to modulate a target.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi is the sole and exclusive owner or, if applicable, exclusive licensee, of all Warranty Technology,
all of which is free and clear of any liens, charges, restrictions, and encumbrances (other than licenses granted to Third Parties that are not inconsistent with the options, rights, and licenses granted to Ionis hereunder), and neither any
assignment, license, sublicense, or other grant of any interest in or options to the Warranty Technology granted by Metagenomi or its Affiliates to any Third Party, nor any assignment, license, sublicense, or other grant of any interest in or
options to the Warranty Technology granted by any Third Party to Metagenomi or its Affiliates conflicts with the options, rights, and licenses granted to Ionis hereunder, and Metagenomi is entitled to grant all rights and licenses under the Warranty
Technology that it purports to grant to Ionis under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U>Schedule 1.146</U> (Licensed Patent Rights) sets forth a true, correct, and complete list of all
Licensed Patent Rights as of the Effective Date. To the extent a Licensed Patent Right is omitted from <U>Schedule 1.146</U> (Licensed Patent Rights) as of the Effective Date, Metagenomi agrees and covenants to add such omitted Licensed Patent Right
to <U>Schedule 1.146</U> (Licensed Patent Rights), and that any such added Licensed Patent Right is deemed included in the licenses granted to Ionis pursuant to <U>Section&nbsp;3.1</U> (License Grants to Ionis) as of the Effective Date;
<I>provided</I> that, for clarity, any Patent Right that otherwise meets the definition of Licensed Patent Rights will be deemed a Licensed Patent Right and included in the licenses granted to Ionis pursuant to <U>Section&nbsp;3.1</U> (License
Grants to Ionis) from the time such Patent Right existed whether or not it is included on <U>Schedule 1.146</U> (Licensed Patent Rights). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All issued Patent Rights within the Warranty Technology are in full force and effect and, to Metagenomi&#146;s
Knowledge, have been Prosecuted and Maintained from the respective patent offices in accordance with Applicable Law. Metagenomi has not received any written claims from any Third Party that any such issued Patent Rights are invalid or unenforceable.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to the Patent Rights within the Warranty Technology, each patent properly identifies each and
every inventor of the claims thereof as determined in accordance with the laws of the jurisdiction in which such patent is issued or such application is pending, Metagenomi has obtained assignments from any and all inventors of all inventorship
rights relating to such Patent Rights, all such assignments of inventorship rights relating to such Patent Rights have been properly executed and recorded in the relevant U.S. and foreign patent offices, and each such inventor has complied in all
material respects with all applicable duties of candor and good faith in dealing with any patent office, including the duty to disclose to any applicable patent office all information known to be material to patentability. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To Metagenomi&#146;s Knowledge, no circumstances or grounds exist that would invalidate, reduce or eliminate,
in whole or in part, the enforceability, validity or scope of any Patent Rights within the Warranty Technology. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other than the Metagenomi In-License Agreements (if any), there is no agreement between Metagenomi or any of
its Affiliates and any Third Party pursuant to which Metagenomi or its Affiliate has acquired Control of any of the Licensed Technology, and no Third Party has any rights, title, or interests in or to, or any license under, any of the Licensed
Technology. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All Metagenomi In-License Agreements (if any) are in full force and effect. Neither Metagenomi nor its
Affiliates nor, to Metagenomi&#146;s Knowledge, the Third Party licensor in a Metagenomi In-License Agreement is in default with respect to a material obligation under such Metagenomi In-License Agreement, as applicable, and no such party has
claimed or has grounds upon which to claim that the other party is in default with respect to any obligation or permit, termination, modification, or acceleration under any Metagenomi In-License Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi and its Affiliates have taken commercially reasonable measures consistent with industry practices to
protect the secrecy, confidentiality, and value of all Warranty Technology that constitutes trade secrets under Applicable Law (including requiring all employees, consultants, and independent contractors to execute binding and enforceable agreements
requiring all such employees, consultants, and independent contractors to maintain the confidentiality of such Warranty Technology) and, to Metagenomi&#146;s Knowledge, such Warranty Technology has not been used, disclosed to, or discovered by any
Third Party except pursuant to such confidentiality agreements and to Metagenomi&#146;s Knowledge, there has not been a breach by any party to such confidentiality agreements. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Warranty Technology have not been created pursuant to, and are not subject to, any funding agreement with
any Governmental Authority or any Third Party, and are not subject to the requirements of the Bayh-Dole Act or any similar provision of any Applicable Law. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To Metagenomi&#146;s Knowledge, no Third Party has infringed, misappropriated, or otherwise violated, or is
currently infringing, misappropriating, or otherwise violating any Warranty Technology, and neither Metagenomi nor its Affiliates have brought any claim or sent any notice alleging any such infringement, misappropriation, or violation.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">There are no judgments or settlements against Metagenomi or any of its Affiliates, any pending or, to
Metagenomi&#146;s Knowledge, threatened claims or litigation in writing, or written offers for Metagenomi to acquire or license any Third Party Intellectual Property Rights, in each case, in connection with the Warranty Technology or the practice
thereof, or relating to the transactions contemplated by this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.2.14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi has not employed (and has not used a Subcontractor that has employed) any Person debarred by the FDA
(or subject to a similar sanction of EMA or foreign equivalent), or any Person that is the subject of an FDA debarment investigation or proceeding (or similar proceeding of EMA or foreign equivalent), in any capacity in connection with this
Agreement, the Warranty Technology, or the Metagenomi Platform. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>12.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Covenants of Metagenomi</B>. Metagenomi covenants to Ionis as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi and its Affiliates will maintain Control of all Licensed Technology and Licensed Systems owned by
Metagenomi or its Affiliates at any time during the Term. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi and its Affiliates will not grant or permit to be attached, any lien, security interest, or other
encumbrance with respect to any Licensed Technology which would adversely affect the rights granted to Ionis hereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Neither Metagenomi nor any of its Affiliates will effect any corporate restructuring or enter into any new
agreement or otherwise obligate itself to any Third Party, in each case, in a manner that conflicts with or otherwise adversely affects the options, rights, and licenses granted to Ionis hereunder. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi will maintain and not breach, and will cause its Affiliates to maintain and not breach, the
Metagenomi In-License Agreements, if any, or any license agreements that come into effect after the Effective Date pursuant to which Ionis receives a sublicense hereunder. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">[***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">[***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi will, and will ensure that its Affiliates, Sublicensees, and Subcontractors, obtain agreements from
any and all Persons involved in or performing any Development by or on behalf of Metagenomi that assign such Persons&#146; rights, title, and interests in and to any Licensed Technology to Metagenomi prior to any such person performing such
activities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi will, and will ensure that its Affiliates, comply with Applicable Law in connection with the
performance of its and its Affiliates&#146; activities under this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi will not, and will ensure that its Affiliates will not, take any action or enter into any agreement
with any Third Party that conflicts with or in any way relinquishes or otherwise diminishes the rights granted to Ionis under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In performing under this Agreement, Metagenomi and its Affiliates agree to comply with all applicable
anti-corruption laws, including the Foreign Corrupt Practices Act of 1977, as amended from time-to-time; the anti-corruption laws of the Territory; and all laws enacted to implement the Organization for Economic Cooperation and Development
Convention on Combating Bribery of Foreign Officials in International Business Transactions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi will not directly or indirectly offer or pay, or authorize such offer or payment of, any money, or
transfer anything of value, to improperly seek to influence: (a)&nbsp;any elected or appointed government official (e.g., a member of a ministry of health); (b)&nbsp;any employee or person acting for or on behalf of a Governmental Authority;
(c)&nbsp;any political party officer, employee, or person acting for or on behalf of a political party or candidate for public office; (d)&nbsp;an employee or person acting for or on behalf of a public international organization; or (e)&nbsp;any
person otherwise categorized as a government official under local law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Neither Metagenomi nor its Affiliates will export, transfer, or sell any Licensed Product to any country or
territory except in compliance with Applicable Law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi will not, to Metagenomi&#146;s Knowledge, engage directly or indirectly, in any capacity in
connection with this Agreement any Person who either has been debarred by the FDA, is the subject of a conviction described in Section&nbsp;306 of the FD&amp;C Act or is subject to any such similar sanction. Metagenomi will inform Ionis in writing
promptly if it or any Person engaged by Metagenomi or any of its Affiliates who is performing services under this Agreement or any ancillary agreements is debarred or is the subject of a conviction described in Section&nbsp;306 of the FD&amp;C Act,
or if any action, suit, claim, investigation or legal or administrative proceeding is pending or, to Metagenomi&#146;s Knowledge, is threatened, relating to the debarment or conviction of Metagenomi, any of its Affiliates or any such Person
performing services hereunder or thereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.3.14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi will not, and will cause its Affiliates and Sublicensees not to, use or practice the Ionis
Background Technology, including the Ionis Proprietary Toolbox of Chemical Modifications, except in accordance with this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>12.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Additional Representations of Ionis</B>. As of each Ionis IP Option Effective Date, Ionis represents and
warrants to Metagenomi that, except as set forth on <U>Schedule 12.4</U> (Ionis Disclosure Schedule) (which schedule may be updated each time a Proposed Metagenomi Target becomes a Metagenomi Target): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.4.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To Ionis&#146; Knowledge, the practice of the Ionis Background Technology as contemplated by this Agreement
will not (a)&nbsp;constitute misappropriation of any Know-How of any Third Party, or (b)&nbsp;infringe any Patent Rights of any Third Party. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.4.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ionis is the owner, or licensee, of all Ionis Background Technology, all of which is free and clear of any
liens, charges, restrictions, and encumbrances (other than licenses granted to Third Parties that are not inconsistent with the options, rights, and licenses granted to Metagenomi hereunder), and neither any assignment, license, sublicense, or other
grant of any interest in or options to the Ionis Background Technology granted by Ionis or its </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Affiliates to any Third Party, nor any assignment, license, sublicense, or other grant of any interest in or options to the Ionis Background Technology granted by any Third Party to Ionis or its
Affiliates conflicts with the options, rights, and licenses granted to Metagenomi hereunder, and Ionis is entitled to grant all rights and licenses under the Ionis Background Technology that it purports to grant to Metagenomi under this Agreement.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.4.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Ionis Background Technology have not been created pursuant to, and are not subject to, any funding
agreement with any Governmental Authority or any Third Party, and are not subject to the requirements of the Bayh-Dole Act or any similar provision of any Applicable Law. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.4.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To Ionis&#146; Knowledge, no Third Party has infringed, misappropriated, or otherwise violated, or is currently
infringing, misappropriating, or otherwise violating any Ionis Background Technology in a manner that would be reasonably likely to adversely affect Metagenomi, and neither Ionis nor its Affiliates have brought any claim or sent any notice alleging
any such infringement, misappropriation, or violation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.4.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">There are no judgments or settlements against Ionis or any of its Affiliates, any pending or, to Ionis&#146;
Knowledge, threatened claims or litigation in writing, or written offers for Ionis to acquire or license any Third Party Intellectual Property Rights, in each case, in connection with the Ionis Background Technology or the practice thereof, or
relating to the transactions contemplated by this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.4.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ionis has not employed (and has not used a Subcontractor that has employed) any Person debarred by the FDA (or
subject to a similar sanction of EMA or foreign equivalent), or any Person that is the subject of an FDA debarment investigation or proceeding (or similar proceeding of EMA or foreign equivalent), in any capacity in connection with this Agreement or
the Ionis Background Technology. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>12.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Covenants of Ionis</B>. Ionis covenants to Metagenomi as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.5.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Neither Ionis nor any of its Affiliates will effect any corporate restructuring or enter into any new agreement
or otherwise obligate itself to any Third Party, in each case, in a manner that conflicts with or otherwise adversely affects the options, rights, and licenses granted to Metagenomi hereunder. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.5.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ionis will, and will ensure that its Affiliates, comply with all Applicable Law in connection with the
performance of its and its Affiliates&#146; activities under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.5.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ionis will not, and will ensure that its Affiliates will not, take any action or enter into any agreement with
any Third Party that conflicts with or in any way relinquishes or otherwise diminishes the rights granted to Metagenomi under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.5.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In performing under this Agreement, Ionis and its Affiliates agree to comply with all applicable
anti-corruption laws, including the Foreign Corrupt Practices Act of 1977, as amended from time-to-time; the anti-corruption laws of the Territory; and all laws enacted to implement the Organization for Economic Cooperation and Development
Convention on Combating Bribery of Foreign Officials in International Business Transactions. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.5.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ionis will not directly or indirectly offer or pay, or authorize such offer or payment of, any money, or
transfer anything of value, to improperly seek to influence: (a)&nbsp;any elected or appointed government official (e.g., a member of a ministry of health); (b)&nbsp;any employee or person acting for or on behalf of a Governmental Authority;
(c)&nbsp;any political party officer, employee, or person acting for or on behalf of a political party or candidate for public office; (d)&nbsp;an employee or person acting for or on behalf of a public international organization; or (e)&nbsp;any
person otherwise categorized as a government official under local law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.5.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Neither Ionis nor its Affiliates will export, transfer, or sell any Licensed Product to any country or
territory except in compliance with Applicable Law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.5.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ionis will not, to Ionis&#146; Knowledge, engage directly or indirectly, in any capacity in connection with
this Agreement any Person who either has been debarred by the FDA, is the subject of a conviction described in Section&nbsp;306 of the FD&amp;C Act or is subject to any such similar sanction. Ionis will inform Metagenomi in writing promptly if it or
any Person engaged by Ionis or any of its Affiliates who is performing services under this Agreement or any ancillary agreements is debarred or is the subject of a conviction described in Section&nbsp;306 of the FD&amp;C Act, or if any action, suit,
claim, investigation or legal or administrative proceeding is pending or, to Ionis&#146; Knowledge, is threatened, relating to the debarment or conviction of Ionis, any of its Affiliates or any such Person performing services hereunder or
thereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>12.5.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ionis will not, and will cause its Affiliates not to, use or practice the Licensed Technology, except in
accordance with this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>12.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Warranty Disclaimer</B>. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN THIS AGREEMENT, NEITHER PARTY MAKES ANY
REPRESENTATION OR EXTENDS ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF TITLE, NON-INFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE. IN PARTICULAR, IONIS DOES NOT MAKE ANY REPRESENTATION
OR EXTEND ANY WARRANTY THAT THE LICENSED SYSTEMS OR LICENSED PRODUCTS WILL BE SUCCESSFULLY DEVELOPED OR COMMERCIALIZED HEREUNDER. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;13 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Indemnification; Limitation of Liability; Insurance </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>13.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Indemnification of Metagenomi by Ionis</B>. Subject to <U>Section&nbsp;13.4</U> (Conditions to
Indemnification), Ionis will defend, indemnify, and hold harmless Metagenomi and its Affiliates, Sublicensees, Subcontractors, and their respective employees, officers, and directors (&#147;<B>Metagenomi Indemnitees</B>&#148;) from and against any
and all liability, damage, loss, cost, or expense of any nature (including reasonable attorney&#146;s fees and litigation expenses) (&#147;<B>Losses</B>&#148;) incurred or imposed upon the Metagenomi Indemnitees in connection with any claims, suits,
actions, demands, proceedings, causes of action, or judgments resulting from a Third Party claim (&#147;<B>Third Party Claims</B>&#148;) arising out of or relating to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Exploitation of any Licensed System or Licensed Product by or on behalf of any Ionis Indemnitee other than
(a)&nbsp;claims by one or more Third Parties relating to patent infringement arising out of the practice of the Licensed Patent Rights in accordance with this Agreement, (b)&nbsp;claims by Third Parties relating to misappropriation of trade secrets
or other Intellectual Property Rights arising out of the practice of the Licensed Know-How in accordance with this Agreement, or (c)&nbsp;Losses shared pursuant to <U>Section&nbsp;13.3</U> (Losses for the Co-Co Products); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the breach by any Ionis Indemnitee of any term of this Agreement; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the negligence or willful misconduct of any Ionis Indemnitee except, in each case (<U>Section 13.1.1</U>
through <U>Section&nbsp;13.1.3</U>), to the extent that any such claim results or arises from a matter for which Metagenomi is obligated to indemnify Ionis under <U>Section&nbsp;13.2</U> (Indemnification of Ionis by Metagenomi).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>13.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Indemnification of Ionis by Metagenomi</B>. Subject to <U>Section&nbsp;13.4</U> (Conditions to
Indemnification), Metagenomi will defend, indemnify, and hold harmless Ionis and its Affiliates, Sublicensees, and Subcontractors, and their respective employees, officers, and directors (&#147;<B>Ionis Indemnitees</B>&#148;) from and against any
and all Losses incurred or imposed upon the Ionis Indemnitees or any one of them in connection with one or more Third Party Claims arising out of or relating to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any claim that the composition of matter [***] of a Gene Editing protein to edit gene targets (but not to edit
the Collaboration Targets specifically) infringes or misappropriates any issued Patent Right or other Intellectual Property Right owned or possessed by any Third Party; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Exploitation of any Licensed System that is included within a Licensed Product by any Metagenomi
Indemnitee, other than Losses shared pursuant to <U>Section&nbsp;13.3</U> (Losses for the Co-Co Products) and any amounts [***]; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.2.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Exploitation of any Licensed System or Licensed Product by or on behalf of any Metagenomi Indemnitee prior
to the Effective Date and after termination of this Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.2.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Exploitation of any Metagenomi Product by or on behalf of any Metagenomi Indemnitee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.2.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the breach by any Metagenomi Indemnitee of any term of this Agreement; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>13.2.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the negligence or willful misconduct of any Metagenomi Indemnitee except, in each case (<U>Section 13.2.1</U>
through <U>Section&nbsp;13.2.6</U>), to the extent that any such claim results or arises from a matter for which Ionis is obligated to indemnify Metagenomi under <U>Section&nbsp;13.1</U> (Indemnification of Metagenomi by Ionis).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>13.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Losses for the Co-Co Products</B>. All Losses incurred by either Party arising from any Third Party Claim
relating to the Exploitation of the Co-Co Products will be shared by the Parties pursuant to the Co-Development and Co-Commercialization Agreement; <I>provided</I> that the Parties will not share Losses of a Party or its Affiliates to the extent
such Losses are (a)&nbsp;caused by a breach of this Agreement by a Party or Affiliate or (b)&nbsp;caused by gross negligence or willful misconduct of a Party or its Affiliate. As will be further set forth in the applicable Co-Development and
Co-Commercialization Agreement, if either Party learns of any Third Party Claim with respect to Losses covered by this <U>Section&nbsp;13.3</U> (Losses for the Co-Co Products), such Party will provide the other Party with prompt written notice
thereof, and the Parties will confer with respect to how to respond to such Third Party Claim and how to handle such Third Party Claim in an efficient manner. In the absence of such an agreement, each Party will have the right to take such action as
it deems appropriate. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>13.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Conditions to Indemnification</B>. Any Person seeking indemnification under this Article 13
(Indemnification; Limitation Of Liability; Insurance) (the &#147;<B>Indemnitee</B>&#148;) will give prompt written notice of the indemnity claim to the indemnifying Party and promptly provide a copy to the indemnifying Party of any complaint,
summons, or other written or verbal notice that the Indemnitee receives in connection with any such claim. An Indemnitee&#146;s failure to deliver written notice will relieve the indemnifying Party of liability to the Indemnitee under this<U>
Article 13</U> (Indemnification; Limitation Of Liability; Insurance) only to the extent such delay is prejudicial to the indemnifying Party&#146;s ability to defend or settle such claim. The indemnifying Party will have the right to assume and
control the defense of the indemnification claim at its own expense with counsel selected by the indemnifying Party and reasonably acceptable to the Indemnitee; <I>provided</I>, <I>however</I>, that an Indemnitee will have the right to retain its
own counsel that is reasonably acceptable to the indemnifying Party, with the fees and expenses to be paid by the indemnifying Party, if representation of such Indemnitee by the counsel retained by the indemnifying Party would be inappropriate due
to actual or potential differing interests between the Indemnitee and any other party represented by such counsel in such proceedings. The indemnifying Party will act reasonably and in good faith with respect to all matters relating to such claim.
If the indemnifying Party does not assume the defense of the indemnification claim as described in this <U>Section&nbsp;13.4</U> (Conditions to Indemnification), then the Indemnitee may defend the indemnification claim but will have no obligation to
do so. The Indemnitee will not settle or compromise the indemnification claim without the prior written consent of the indemnifying Party, and the indemnifying Party will not settle or compromise the indemnification claim in any manner which would
have an adverse effect on the Indemnitee&#146;s interests (including any rights under this Agreement or the scope, validity, or enforceability of any Patent Rights, Confidential Information, or other rights licensed to Ionis by Metagenomi
hereunder), without the prior written consent of the Indemnitee, which consent, in each case (by the indemnifying Party or the Indemnitee, as the case may be), will not be unreasonably withheld, conditioned, or delayed. The Indemnitee will
reasonably cooperate with the indemnifying Party at the indemnifying Party&#146;s expense and will make available to the indemnifying Party all pertinent information under the control of the Indemnitee, which information will be subject to<U>
Article 11</U> (Confidentiality). The indemnifying Party will not be liable for any settlement or other disposition of the claims by the Indemnitee if such settlement is reached without the written consent of the indemnifying Party pursuant to this
<U>Section&nbsp;13.4</U> (Conditions to Indemnification). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>13.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Limited Liability</B>. NEITHER OF THE PARTIES NOR THEIR RESPECTIVE AFFILIATES OR SUBLICENSEES WILL BE
ENTITLED TO RECOVER FROM THE OTHER PARTY OR ITS AFFILIATES OR SUBLICENSEES ANY SPECIAL, INCIDENTAL, INDIRECT, CONSEQUENTIAL, OR PUNITIVE DAMAGES OR DAMAGES FOR LOSS OF PROFIT, LOST OPPORTUNITY, LOST DATA OR COST OF PROCUREMENT OF SUBSTITUTE GOODS OR
SERVICES IN CONNECTION WITH THIS AGREEMENT, ITS PERFORMANCE OR LACK OF PERFORMANCE HEREUNDER, WHETHER LIABILITY IS ASSERTED IN CONTRACT, TORT (INCLUDING NEGLIGENCE AND STRICT PRODUCT LIABILITY), INDEMNITY OR CONTRIBUTION, AND IRRESPECTIVE OF WHETHER
THAT PARTY OR ANY REPRESENTATIVE OF THAT PARTY HAS BEEN ADVISED OF, OR OTHERWISE MIGHT HAVE ANTICIPATED THE POSSIBILITY OF, ANY SUCH LOSS OR DAMAGE, OR ANY LICENSE GRANTED HEREUNDER, EXCEPT TO THE EXTENT THE DAMAGES RESULT FROM (A)&nbsp;A
PARTY&#146;S WILLFUL MISCONDUCT OR GROSS NEGLIGENCE UNDER THIS AGREEMENT, (B)&nbsp;A BREACH OF THE OBLIGATIONS OF A PARTY UNDER <U>ARTICLE 11</U> (CONFIDENTIALITY) OR UNDER <U>SECTION 3.6</U> (EXCLUSIVITY), OR (C)&nbsp;AMOUNTS REQUIRED TO BE PAID AS
PART OF A CLAIM FOR WHICH A PARTY PROVIDES INDEMNIFICATION UNDER <U>ARTICLE 13</U> (INDEMNIFICATION; LIMITATION OF LIABILITY; INSURANCE). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>13.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Insurance Obligations</B>. Each Party will, at its own expense, procure and maintain during the Term and for
a period of [***] thereafter, insurance policies, including product liability insurance when applicable, adequate to cover its obligations hereunder and that are consistent with normal business practices of prudent companies similarly situated. Such
insurance will not be construed to create a limit of a Party&#146;s liability with respect to its indemnification obligations under this<U> Article 13</U> (Indemnification; Limitation of Liability; Insurance). Each Party will provide the other Party
with written evidence of such insurance. Notwithstanding any provision to the contrary set forth in this Agreement, Ionis may self-insure, in whole or in part, the insurance requirements described above. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;14 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Term
and Termination </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>14.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Term</B>. This Agreement will commence on the Effective Date and, unless otherwise terminated pursuant to
<U>Section&nbsp;14.2</U> (Termination), will continue (a)&nbsp;with respect to the Ionis Programs, on an Ionis Product-by-Ionis Product and country-by-country basis until the expiration of all applicable Royalty Terms for an Ionis Product in a
country, (b)&nbsp;with respect to the Co-Co Programs for which Metagenomi has not exercised its Opt-Out Right in accordance with <U>Section&nbsp;5.4</U> (Metagenomi Opt-Out), on a Co-Co Program-by-Co-Co Program basis until the Parties cease all
Exploitation for the Co-Co Products that are the subject to such Co-Co Program, and (c)&nbsp;with respect to the Metagenomi Products, on a Metagenomi Product-by-Metagenomi Product and country-by-country basis until the expiration of the Metagenomi
Royalty Term for a Metagenomi Product in a country (the &#147;<B>Term</B>&#148;). On a Licensed Product-by-Licensed Product and country-by-country basis, effective upon the expiration of the Royalty Term for a Licensed Product in a country (but not
upon any earlier termination of this Agreement for any reason), the licenses granted to Ionis will each become fully paid-up, royalty-free, irrevocable, and perpetual in such country with respect to such Licensed Product. On a Metagenomi
Product-by-Metagenomi Product and country-by-country basis, effective upon the expiration of the Metagenomi Royalty Term for a Metagenomi Product in a country (but not upon any earlier termination of this Agreement for any reason), the licenses
granted to Metagenomi will each become fully paid-up, royalty-free, irrevocable, and perpetual in such country with respect to such Metagenomi Product. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>14.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination</B>. This Agreement may be terminated as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Termination for Convenience by Ionis</B>. Ionis may terminate this Agreement (either in its entirety
or on a Licensed Product-by-Licensed Product basis), for convenience by providing written notice of its intent to terminate to Metagenomi, in which case, such termination will be effective 90 days after Metagenomi&#146;s receipt of such written
notice. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination for Material Breach</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ionis&#146; Right to Terminate</B>. If Metagenomi is in material breach of this Agreement, then Ionis may
deliver written notice of such material breach to Metagenomi. If the breach is curable, then Metagenomi will have [***] following its receipt of such written notice to cure such breach (except to the extent such breach involves the failure to make a
payment when due, in which case such breach must be cured within [***] following Metagenomi&#146;s receipt of such written notice). If Metagenomi fails to cure such breach within such [***] or [***] period, as applicable, or the breach is not
subject to cure, then Ionis may terminate this Agreement solely with respect to those Licensed Products to which such material breach relates, or in its entirety if such material breach relates to all Licensed Products, by providing written notice
to Metagenomi, in which case, this </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="23%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Agreement will terminate on the date on which Metagenomi receives such written notice; <I>provided</I>, <I>however</I>, that if (A)&nbsp;the relevant breach does not involve Metagenomi&#146;s
failure to make a payment when due and is curable, but not reasonably curable within [***], and (B)&nbsp;Metagenomi is making a <I>bona fide</I> effort to cure such breach, then Ionis&#146; right to terminate this Agreement on account of such breach
will be suspended for up to an additional [***] so long as Metagenomi is continuing to make such <I>bona fide</I> effort to cure such breach. If such breach is successfully cured during the applicable cure period, then Ionis will no longer have the
right to terminate this Agreement on account of such breach. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Metagenomi&#146;s Right to Terminate</B>. If Ionis is in material breach of this Agreement, then Metagenomi
may deliver written notice of such material breach to Ionis. If the breach is curable, then Ionis will have [***] following its receipt of such written notice to cure such breach (except to the extent such breach involves the failure to make a
payment when due, in which case such breach must be cured within [***] following Ionis&#146; receipt of such written notice). If Ionis fails to cure such breach within the [***] or [***] period, as applicable, or the breach is not subject to cure,
then Metagenomi may terminate this Agreement in its entirety by providing written notice to Ionis, in which case this Agreement will terminate on the date on which Ionis receives such written notice; <I>provided</I>, <I>however</I>, that if
(i)&nbsp;the relevant breach does not involve Ionis&#146; failure to make a payment when due and is curable, but not reasonably curable within [***], and (ii)&nbsp;Ionis is making a <I>bona fide</I> effort to cure such breach, then Metagenomi&#146;s
right to terminate this Agreement on account of such breach will be suspended for up to an additional [***] so long as Ionis is continuing to make such <I>bona fide</I> effort to cure such breach. If such breach is successfully cured during the
applicable cure period, then Metagenomi will no longer have the right to terminate this Agreement on account of such breach. Notwithstanding the foregoing, any license granted to Ionis under this Agreement may not be terminated under this
<U>Section&nbsp;14.2.2(b)</U> (Metagenomi&#146;s Right to Terminate) if (A)&nbsp;the material breach does not involve the failure to make any material and undisputed portion of a payment due to Metagenomi under<U> Article 9</U> (Consideration;
Financial Terms) and (B)&nbsp;such license is necessary to make, have made, use or sell a Licensed Product for which a Clinical Trial has been Initiated. Termination pursuant to this <U>Section&nbsp;14.2.2(b)</U> (Metagenomi&#146;s Right to
Terminate) will not relieve Ionis from liability and damages to Metagenomi for default, and the Parties agree that if monetary damages are available to Metagenomi as a reasonable remedy for any default hereunder, then such monetary remedy will
constitute the exclusive remedy for such default in lieu of termination of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Disputes Regarding Material Breach</B>. Notwithstanding the foregoing, if the alleged breaching Party in
<U>Section&nbsp;14.2.2(a)</U> (Ionis&#146; Right to Terminate) or <U>Section&nbsp;14.2.2(b)</U> (Metagenomi&#146;s Right to Terminate) disputes in good faith the existence or materiality of any breach, or failure to cure any breach, and provides
written notice to the non-breaching Party of such dispute within the relevant cure period, then the non-breaching Party will not have the right to terminate this Agreement in accordance with <U>Section&nbsp;14.2.2(a)</U> (Ionis&#146; Right to
Terminate) or <U>Section&nbsp;14.2.2(b)</U> (Metagenomi&#146;s Right to Terminate), as applicable, unless and until the relevant dispute has been resolved in accordance with <U>Section&nbsp;15.1</U> (Dispute Resolution). During the pendency of such
dispute, all the terms of this Agreement will remain in effect and the Parties will continue to perform all of their respective obligations hereunder. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.2.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination for Insolvency</B>. If Metagenomi makes an assignment for the benefit of creditors, appoints or
suffers appointment of a receiver or trustee over all or substantially all of its property, files a petition under any bankruptcy or insolvency act, or has any such petition filed against it that is not discharged within [***] after the filing
thereof (each, an &#147;<B>Insolvency Event</B>&#148;), then Ionis may terminate this Agreement in its entirety by providing written notice of its intent to terminate this Agreement to Metagenomi, in which case, this Agreement will terminate on the
date on which Metagenomi receives such written notice. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>14.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Effects of Termination</B>. In the event of any early termination of this Agreement by a Party pursuant to
<U>Section&nbsp;14.2</U> (Termination), effective as of the effective date of termination, the following provisions will apply with respect to the Terminated Products in the Terminated Countries: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.3.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Wind-Down</B>. During the applicable termination notice period, unless otherwise agreed by the Parties, the
Parties will begin to wind-down their respective activities under this Agreement to the extent related to the Terminated Products in the Terminated Countries. The JSC will coordinate the wind-down of each Party&#146;s efforts under this Agreement
with respect to the Terminated Products in the Terminated Countries, or, if the JSC has disbanded, then the Parties will establish an appropriate committee to coordinate such wind-down. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.3.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination of Rights and Licenses</B>. Other than as expressly set forth herein, including those provisions
that this Agreement expressly provides will survive such termination and subject to <U>Section&nbsp;14.3.8</U> (Sublicense Survival), all rights and licenses granted from one Party to the other hereunder will immediately terminate with respect to
the Terminated Products in the Terminated Countries; <I>provided</I> that such licenses will continue as necessary for the Parties to complete the orderly wind-down of their activities under this Agreement in accordance with Applicable Law and as
otherwise required in accordance with <U>Section&nbsp;14.3.1</U> (Wind-Down). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.3.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination of Payment Obligations</B>. All payment obligations with respect to the Terminated Products in
the Terminated Countries hereunder will terminate, other than those that are accrued and unpaid as of the effective date of such termination. For any payment obligations that are accrued and unpaid as of the effective date of termination, an invoice
must be provided no later than [***] after the effective date of termination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.3.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sell-Off Right</B>. For a period not to exceed [***] following the effective date of termination, Ionis will
have the right to sell or otherwise dispose of the Terminated Products in the Terminated Countries on hand at the time of such termination or in the process of Manufacturing; <I>provided</I> that any revenue obtained from such disposal will be
treated as Net Sales and the provisions of<U> Article 9</U> (Consideration; Financial Terms) will apply to such Net Sales and, if such sales result in the achievement of any Ionis Product Sales Milestone Event, then the applicable Ionis Product
Sales Milestone Payment will be payable. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.3.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Assignment of Regulatory Submissions</B>. Except with respect to any termination by Ionis under
<U>Section&nbsp;14.2.2(a)</U> (Ionis&#146; Right to Terminate), Ionis will, as promptly as practicable, transfer to Metagenomi possession and ownership of all Regulatory Approvals solely relating to the Exploitation of any Terminated Product in the
Terminated Countries. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.3.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reversion for Terminated Products other than Combination Products</B>.<B></B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reversion License Grant</B>. Upon Metagenomi&#146;s written request no later than 30 days following the
effective date of termination and agreement by the Parties of the applicable royalty rate pursuant to <U>Section&nbsp;14.3.6(c)</U> (Reversion Royalties), Ionis will grant and agrees to grant to Metagenomi, an exclusive, royalty-bearing (solely as
provided in <U>Section&nbsp;14.3.6(c)</U> (Reversion Royalties)), right and license, with the right to grant sublicenses through multiple tiers, under Patent Rights and Know-How Controlled by Ionis or its Affiliates to the extent such Patent Rights
or Know-How are actually being used on the date of such termination by the Parties in the Development, Commercialization, or other Exploitation of the Terminated Products in the Terminated Countries as such Terminated Products exist as of the
effective date of termination, solely to Exploit such Terminated Products in the Terminated Countries; <I>provided</I> that, if any such Terminated Products are Combination Products, then such license will not include any license or other rights
with respect to any Other Product that is Covered by Patent Rights Controlled by Ionis or any of its Affiliates and Metagenomi will not obtain a license to any such Other Product other than pursuant to <U>Section&nbsp;14.3.7</U> (Reversion for
Certain Combination Products) (such license grant, the &#147;<B>Reversion License</B>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Third Party Reversion IP</B>. With respect to any Patent Rights or Know-How that are the subject of the
Reversion License that are in-licensed by Ionis from Third Parties, Ionis will notify Metagenomi of such Patent Rights or Know-How that are sublicensable to Metagenomi under the Reversion License (which notice will describe the terms and conditions
of any Third Party agreements that are applicable to the grant to Metagenomi of the Reversion Licenses under such Patent Rights or Know-How (any such agreement, a &#147;<B>Reversion IP In-License Agreement</B>&#148;), including applicable payment
terms). If Metagenomi elects to receive a sublicense under any Reversion IP In-License Agreement, then Metagenomi will notify Ionis in writing and Metagenomi will be responsible for (i)&nbsp;making all payments (including royalties, milestones, and
other amounts) that are payable by Ionis to the Third Parties under each Reversion IP In-License Agreement with respect to and allocable to the Patent Rights and Know-How that are the subject of the Reversion License and arising out of the
Exploitation of the Terminated Products in the Terminated Countries by making such payments directly to Ionis and, in each instance, Metagenomi will make the requisite payments to Ionis and provide the necessary reporting information to Ionis in
sufficient time to enable Ionis to comply with its obligations under each Reversion IP In-License Agreement, and (ii)&nbsp;complying with any other obligations included in each Reversion IP In-License Agreement that are applicable to the grant to
Metagenomi of the Reversion License under the applicable Patent Rights or Know-How (<I>provided</I> that Ionis has notified Metagenomi of such obligations), and the granting by Metagenomi of a sublicense under the Reversion Licenses will not relieve
Metagenomi of its obligations under subclauses (i)&nbsp;and (ii). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reversion Royalties</B>. The licenses granted to Metagenomi in <U>Section&nbsp;14.3.6(a)</U> (Reversion
License Grant) will be royalty-bearing, and Metagenomi will pay Ionis, on a Calendar Quarter basis, the royalty rates that are agreed to by the Parties at the time of Metagenomi&#146;s written request delivered pursuant to
<U>Section&nbsp;14.3.6(a)</U> (Reversion License Grant). With respect to the royalty rates to be agreed to by the Parties pursuant to this <U>Section&nbsp;14.3.6(c)</U> (Reversion Royalties), the Parties will
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="23%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
take into account, among other things, (i)&nbsp;[***], (ii)&nbsp;[***], (iii)&nbsp;[***], and (iv)&nbsp;[***], and if the Parties have not reached agreement on such financial terms within [***]
after such effective date of termination, then either Party may refer such matter for resolution pursuant to <U>Section&nbsp;15.1.3</U> (Expedited Dispute Resolution). </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.3.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reversion for Certain Combination Products</B>. If (a)&nbsp;any of the Terminated Products are Combination
Products that are required, by the approved labeling for such Terminated Product, to be promoted as a Combination Product and the Other Product for such Terminated Product is exclusively Controlled by Ionis, such that Metagenomi is not able to
otherwise acquire such Other Product, and (b)&nbsp;there is no approved label regarding the promotion of the Terminated Product that is not a Combination Product (any such Terminated Product meeting the requirements of (a)&nbsp;and (b), a
&#147;<B>Terminated Combination Products</B>&#148;), then upon Metagenomi&#146;s written request no later than [***] following the effective date of termination for such Terminated Combination Products, the Parties will enter into good faith
negotiations for up to [***] regarding the grant of a non-exclusive, royalty-bearing right and license, with the right to grant sublicenses through multiple tiers, under Patent Rights and Know-How Controlled by Ionis or its Affiliates to the extent
such Patent Rights or Know-How are actually being used on the date of such termination by the Parties in the Development, Commercialization, or other Exploitation of the Terminated Combination Products in the Terminated Countries as such Terminated
Combination Products exist as of the effective date of termination, solely to Exploit such Terminated Combination Products in the Terminated Countries. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>14.3.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sublicense Survival</B>. Any sublicense granted hereunder by Ionis will, at the Sublicensee&#146;s option,
survive such termination on the condition that the relevant Sublicensee is not in material breach of any of its obligations under such sublicense. In order to effect this provision, at the request of the Sublicensee, Metagenomi will enter into a
direct license with the Sublicensee on terms that are substantially the same terms as the applicable terms of this Agreement; <I>provided</I> that Metagenomi will not be required to undertake obligations in addition to those required by this
Agreement, and Metagenomi&#146;s rights under such direct license will be consistent with its rights under this Agreement, taking into account the scope of the license granted under such direct license. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>14.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential Information</B>. Upon the expiration or termination of this Agreement with respect to a
Terminated Product in a Terminated Country, the Receiving Party will return (or, as directed by the Disclosing Party, destroy) all Confidential Information of the Disclosing Party related to such Terminated Product in such Terminated Country to the
Disclosing Party that is in the Receiving Party&#146;s possession or control (other than any Confidential Information required to continue to exercise a Party&#146;s rights that survive such expiration or termination of this Agreement);
<I>provided</I>, <I>however</I>, copies may be retained and stored solely for the purpose of determining a Party&#146;s obligations under this Agreement, subject to the non-disclosure and non-use obligation under <U>Article 11</U> (Confidentiality).
In addition, the Receiving Party will not be required to return or destroy Confidential Information contained in any computer system back-up records made in the ordinary course of business. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>14.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Surviving Provisions</B>. Subject to the other terms and conditions regarding the termination and survival
of obligations under this Agreement in the event of expiration or termination of this Agreement, upon expiration or termination of this Agreement, all provisions of this Agreement will cease to have any effect, except that the following provisions
will survive any such expiration or termination for any reason for the period of time specified therein, or if not specified, then they will survive indefinitely: <U>Section&nbsp;2.5.1</U> (Reimbursement by Ionis) (solely with respect to obligations
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
accrued, but not yet paid, as of the effective date of termination of this Agreement); <U>Section&nbsp;3.1.3</U> (Unblocking License); <U>Section&nbsp;3.2.2</U> (Unblocking License);
<U>Section&nbsp;3.5</U> (No Implied Licenses); <U>Section&nbsp;9.4</U> (Ionis Product Milestone Payments), <U>Section&nbsp;9.6</U> (Ionis Product Royalty Payments), <U>Section&nbsp;9.9</U> (Payment Obligations Under Certain In-License Agreements),
and <U>Section&nbsp;9.10 (</U>Metagenomi Product Economics) (in each case, solely with respect to obligations accrued, but not yet paid, as of the effective date of expiration or termination of this Agreement); <U>Section&nbsp;9.11</U> (Other
Payments); <U>Section&nbsp;9.12</U> (Right to Offset); <U>Section&nbsp;9.13</U> (Records and Audits) (solely for [***] after termination or expiration of this Agreement); <U>Section&nbsp;9.14</U> (Currency of Payment; Non-Refundable Payments)
through <U>Section&nbsp;9.17</U> (Withholding Taxes); <U>Section&nbsp;10.1.1</U> (Background Intellectual Property); <U>Section&nbsp;10.1.2</U> (By Inventorship); <U>Section&nbsp;10.2</U> (Patent Prosecution) (solely with respect to Joint
Collaboration Patent Rights); <U>Section&nbsp;10.3</U> (Patent Enforcement) (solely with respect to Joint Collaboration Patent Rights); <U>Section&nbsp;11.1</U> (Confidential Information) through <U>Section&nbsp;11.4</U> (Publication Announcements
and Subsequent Disclosures); <U>Section&nbsp;12.6</U> (Warranty Disclaimer); <U>Section&nbsp;13.1</U> (Indemnification of Metagenomi by Ionis) through <U>Section&nbsp;13.5</U> (Limited Liability); <U>Section&nbsp;13.6</U> (Insurance Obligations)
(solely for [***] after expiration or termination of this Agreement); <U>Section&nbsp;14.1</U> (Term) (solely in the event of expiration and with respect to the last two sentences); <U>Section&nbsp;14.3</U> (Effects of Termination);
<U>Section&nbsp;14.4</U> (Confidential Information); this <U>Section&nbsp;14.5</U> (Surviving Provisions);<U> Article 15</U> (Miscellaneous); and <U>Appendix 1</U> (Definitions) (as applicable). Termination or expiration of this Agreement (either in
its entirety or with respect to one or more Licensed Products) will not relieve either Party of any liability that accrued hereunder prior to the effective date of such termination or expiration, preclude either Party from pursuing all rights and
remedies it may have hereunder or at law or in equity with respect to any breach of this Agreement nor prejudice any rights that will have accrued to the benefit of any Party prior to such termination or expiration. The remedies provided in this<U>
Article 14</U> (Term and Termination) are not exclusive of any other remedies a Party may have in law or equity. </TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article&nbsp;15 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Miscellaneous </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Dispute Resolution</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>15.1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Escalation</B>. In the event of any dispute, claim, controversy, or cause of action asserted by a Party
against the other Party or by the Metagenomi Indemnitees against Ionis or by the Ionis Indemnitees against Metagenomi arising out of or related to this Agreement or performance of this Agreement (other than matters within the purview of the JSC,
which will be resolved as set forth in <U>Section&nbsp;4.6</U> (Decision-Making)) (a &#147;<B>Claim</B>&#148;), including any alleged breach of this Agreement or claim for indemnification pursuant to<U> Article 13</U> (Indemnification; Limitation Of
Liability; Insurance), such Party may, by written notice to the other Party, refer such matter to the Parties&#146; respective officers designated below for attempted resolution (each, an &#147;<B>Executive Officer</B>&#148;): </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">For Ionis:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer (or such other senior executive designated by Ionis for such purpose)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">For Metagenomi:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer (or such other senior executive designated by Metagenomi for such purpose)</TD></TR>
</TABLE></DIV> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>15.1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Arbitration</B>. Except as otherwise expressly set forth in this Agreement, if such Executive Officers do
not resolve the dispute within [***] after receipt of such request, then, either Party may at any time after such [***] period submit such Claim to be finally settled by arbitration administered in accordance with the procedural rules of the
American Arbitration Association (the &#147;<B>AAA</B>&#148;) in effect at the time of submission, as modified by </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
this <U>Section&nbsp;15.1.2</U> (Arbitration) (the &#147;<B>Arbitration</B>&#148;). The Arbitration will be governed by the Applicable Law of the State of New York. The Arbitration will be heard
and determined by three arbitrators who are retired judges or attorneys with at least 20 years of relevant experience, each of whom will be impartial and independent and will not have worked for or on behalf of either Party for at least [***]. Each
Party will appoint one arbitrator and the third arbitrator will be selected by the two Party-appointed arbitrators, or, failing agreement within [***] following appointment of the second arbitrator, by the AAA. Such Arbitration will take place in
New York, NY. The Arbitration award so given will, absent an appealable error under applicable AAA procedural rules, be a final and binding determination of the Claim, will be fully enforceable in any court of competent jurisdiction, and will not
include any damages expressly prohibited by <U>Section&nbsp;13.5</U> (Limited Liability). Ionis will pay the fees, costs, and expenses for the arbitrator it chooses, Metagenomi will pay the fees, costs, and expenses for the arbitrator it chooses,
and the Parties will share payment of the fees, costs and expenses for the third arbitrator. Except in a proceeding to enforce the results of the Arbitration or as otherwise required by Applicable Law or securities exchange, neither Party nor any
arbitrator may disclose the existence, content, or results of any Arbitration hereunder without the prior written consent of both Parties. The Parties will instruct the arbitrators to complete the Arbitration within [***] after selection of the
first arbitrator by a Party and each Party will use reasonable efforts to complete such arbitration proceedings within such time period. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>15.1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Expedited Dispute Resolution</B>. If the Executive Officers fail to reach agreement on any Expedited Dispute
within [***] of submission of such Expedited Dispute to the Executive Officers, then either Party may notify the other Party of its intent to invoke dispute resolution under this <U>Section&nbsp;15.1.3</U> (Expedited Dispute Resolution) and such
Expedited Dispute will be resolved by binding arbitration in accordance with this <U>Section&nbsp;15.1.3</U> (Expedited Dispute Resolution) except that the procedures for the conduct of such arbitration will be modified as follows:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The arbitration will be conducted by a single neutral arbitrator selected by the Parties or, failing agreement
by the Parties, by the AAA in accordance with the procedural rules of the AAA. Such arbitrator will be a retired judge or attorney with at least 20 years of relevant experience, who will be impartial and independent and will not have worked for or
on behalf of either Party for at least [***]. The arbitrator will have the authority to engage one or more Third Party experts who are expert in the subject matter of the dispute to advise the arbitrator in rendering his or her decision (each, a
&#147;<B>Third Party Expert</B>&#148;), and the costs of such Third Party Expert(s) will be included in the costs of the arbitration. The arbitrator will seek to obtain the mutual agreement of the Parties regarding such Third Party Expert(s), but
absent such agreement, such Third Party Expert(s) will be selected by the arbitrator. Each Third Party Expert will be a disinterested individual who is not affiliated with either Party or its Affiliates or a Sublicensee and who has expertise and
experience with respect to the subject matter of the Expedited Dispute, as determined by the arbitrator. Neither the Third Party Expert nor any of the Third Party Expert&#146;s former employers will be or have been at any time an Affiliate,
employee, officer or director of, or a consultant for, either Party or any of its Affiliates or a Sublicensee. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Within [***] of appointment of the arbitrator (and selection of the Third Party Expert(s)) in accordance with
this <U>Section&nbsp;15.1.3</U> (Expedited Dispute Resolution), the Parties will submit their written positions regarding the Expedited Dispute to the other Party and the arbitrator. Each Party may submit a revised written position to the arbitrator
within [***] of receiving the other Party&#146;s written position. If so requested by the arbitrator, each Party will make oral or other written submissions to the arbitrator in accordance with procedures to be established by the arbitrator;
<I>provided</I> that the other Party will have the right to be present during any oral submissions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The arbitrator will render a decision in writing within [***] (or such other time period as the Parties may
agree) after receipt of the last Party&#146;s written position, which decision will be in accordance with the applicable provisions of this Agreement, and such decision will be conclusive and binding on the Parties. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything to the contrary herein, the arbitration under this <U>Section&nbsp;15.1.3</U>
(Expedited Dispute Resolution) will be conducted as a &#147;baseball arbitration&#148; type proceeding. The arbitrator will select one of the Party&#146;s position as his or her decision, based on what is most reasonable and equitable to each of the
Parties under the circumstances and in light of the terms set forth in this Agreement, and will not have the authority to render any substantive decision other than to so select one Party&#146;s position as initially submitted, or as revised in
accordance with the foregoing, as applicable. The arbitrator may fashion such detailed procedures as the arbitrator considers appropriate to implement this intent. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Parties will instruct the arbitrator to complete all arbitration proceedings within [***] after selection
of the arbitrator and each Party will use reasonable efforts to complete such arbitration proceedings within such time period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>15.1.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Tolling</B>. The Parties agree that all applicable statutes of limitation and time-based defenses (such as
estoppel and laches), as well as all time periods in which a Party must exercise rights or perform obligation hereunder, will be tolled once the dispute resolution procedures set forth in this <U>Section&nbsp;15.1</U> (Dispute Resolution) have been
initiated and for so long as they are pending, and the Parties will cooperate in taking all actions reasonably necessary to achieve such a result. In addition, during the pendency of any Claim under this Agreement initiated before the end of any
applicable cure period, including under <U>Section&nbsp;14.2.2</U> (Termination for Material Breach), (a)&nbsp;this Agreement will remain in full force and effect, (b)&nbsp;the provisions of this Agreement relating to termination for material breach
with respect to such Claim will not be effective, and (c)&nbsp;neither Party will issue a notice of termination pursuant to this Agreement based on the subject matter of the arbitration, until the arbitral tribunal has confirmed the material breach
and the existence of the facts claimed by a Party to be the basis for the asserted material breach; <I>provided</I> that if such breach can be cured by (i)&nbsp;the payment of money, the defaulting Party will have an additional [***] within its
receipt of the arbitral tribunal&#146;s decision to pay such amount (or such later date if specified in the arbitral tribunal&#146;s decision) or (ii)&nbsp;the taking of specific remedial actions, the defaulting Party will have a reasonably
necessary period to diligently undertake and complete such remedial actions within such reasonably necessary period or any specific timeframe established by such arbitral tribunal&#146;s decision before any such notice of termination can be issued.
Further, with respect to any time periods that have run during the pendency of the Claim, the applicable Party will have a reasonable period of time or any specific timeframe established by such arbitral tribunal&#146;s decision to exercise any
rights or perform any obligations affected by the running of such time periods. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Designation of Affiliates.</B> Each Party may discharge any obligations and exercise any rights under this
Agreement through delegation of its obligations or rights to any of its Affiliates; <I>provided</I> that the delegating Party will remain primarily responsible for such obligation. Each Party hereby guarantees the performance by its Affiliates of
such Party&#146;s obligations under this Agreement, and will cause its Affiliates to comply with the provisions of this Agreement in connection with such performance. Any breach by a Party&#146;s Affiliate of any of such Party&#146;s obligations
under this Agreement will be a breach by such Party, and the other Party may proceed directly against such Party without any obligation to first proceed against such Party&#146;s Affiliate. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Patent Disputes. </B>Notwithstanding <U>Section&nbsp;15.1.2</U> (Arbitration), if a dispute arises between
the Parties under this Agreement with respect to the inventorship, interpretation, scope, validity, enforceability, applicability or term of any Patent Right, then such dispute will not be resolved pursuant to <U>Section&nbsp;15.1.2</U>
(Arbitration), but instead may be brought by either Party in the federal courts in the State of New York.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Injunctive Relief. </B>Notwithstanding anything to the contrary set forth in this Agreement, the Parties
each stipulate and agree that (a)&nbsp;the other Party&#146;s Confidential Information includes highly sensitive trade secret information, (b)&nbsp;a breach of <U>Section&nbsp;3.6</U> (Exclusivity) or<U> Article 11</U> (Confidentiality), in each
case, may cause irrevocable harm for which monetary damages would not provide a sufficient remedy, and (c)&nbsp;in such case of a breach of <U>Section&nbsp;3.6</U> (Exclusivity) or <U>Article 11</U> (Confidentiality), the non-breaching Party will be
entitled to equitable relief (including temporary or permanent restraining orders, specific performance or other injunctive relief) from any court of competent jurisdiction. In addition, and notwithstanding anything to the contrary set forth in this
Agreement, in the event of any other actual or threatened breach hereunder, the aggrieved Party may seek equitable relief (including temporary or permanent restraining orders, specific performance or other injunctive relief) from any court of
competent jurisdiction without first submitting to the dispute resolution procedures set forth in <U>Section&nbsp;15.1</U> (Dispute Resolution).<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Governing Law</B><B></B>. This Agreement will be governed by and construed in accordance with the
laws of the State of New York without taking into consideration any choice of law principles that would lead to the application of the laws of another jurisdiction. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Cumulative Remedies</B>.<B></B> The rights and remedies of the Parties under this Agreement are
cumulative and not exclusive and, accordingly, are in addition to and not in lieu of any other rights and remedies of the Parties at law or in equity. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Notices.</B> Any notice or report required or permitted to be given or made under this Agreement by
either Party to the other will be in writing and delivered to the other Party at its address indicated below or to such other address as the addressee will have theretofore furnished in writing to the addressor by hand, courier or by registered or
certified airmail (postage prepaid), in writing, by registered or certified airmail (postage prepaid): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>If to Ionis:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ionis Pharmaceuticals, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2855 Gazelle
Court</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Carlsbad, CA 92010</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attention: Chief Business
Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Copy to (which copy will not constitute notice):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attention: General Counsel</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>If to Metagenomi:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Metagenomi, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1545 Park Avenue</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville CA 94608</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attention: Brian C. Thomas</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Copy to (which copy will not constitute notice):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Copy to</P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">All notices will be deemed effective: (a)&nbsp;if by courier, on the Business Day of delivery as evidenced by
the courier&#146;s receipt (or if delivered or sent on a non-Business Day, then on the next Business Day); or (b)&nbsp;if sent by registered or certified airmail, on the Business Day of receipt as evidenced on the return receipt. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Amendment; Waiver</B>. This Agreement (including all exhibits and attachments to this Agreement
except as set forth in <U>Section&nbsp;2.2.3</U> (Amendments to the Drug Discovery Plans) or <U>Section&nbsp;2.3.2</U> (Amendments to the Exploratory Research Plan)), may be amended, modified, superseded, or cancelled only by a written agreement
between the Parties, and any of the terms of this Agreement may be waived only by a written instrument executed by each Party or, in the case of waiver, by the Party or Parties waiving compliance. The delay or failure of either Party at any time or
times to require performance of any provisions will in no manner affect the rights at a later time to enforce the same. No waiver by either Party of any condition or of the breach of any term contained in this Agreement, whether by conduct, or
otherwise, in any one or more instances, will be deemed to be, or considered as, a further or continuing waiver of any such condition or of the breach of such term or any other term of this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Assignment and Successors</B>. Neither Party may assign or transfer this Agreement in whole or in
part or the licenses granted under this Agreement without the other Party&#146;s prior written consent <I>unless</I> such assignment is to (a)&nbsp;a Third Party successor or purchaser of all or substantially all of the assets or businesses to which
this Agreement relates whether pursuant to a sale of assets, merger, or other transaction, in which case the assigning Party will provide prior written notice to the other Party and need not obtain the other Party&#146;s consent or (b)&nbsp;an
Affiliate of such Party, in which case the assigning Party will provide prior written notice to the other Party and need not obtain the other Party&#146;s consent; <I>provided</I> that, in either case, the assigning Party remains fully liable for
the performance of its obligations hereunder by such assignee. Each Party will also have the right to sell, assign, and convey its rights to receive royalties from Net Sales of Licensed Product (with respect to Metagenomi) and Metagenomi Products
(with respect to Ionis) and related rights to receive royalty reports and conduct audits of the other Party, its Affiliates and Sublicensees to Third Party purchasers of royalty interests. Any other assignment of this Agreement by a Party requires
the prior written consent of the other Party. An assignment to an Affiliate will terminate, and all rights so assigned will revert to the assigning Party, if and when such Affiliate ceases to be an Affiliate of the assigning Party. For clarity, any
assignment in violation of this <U>Section&nbsp;15.9</U> (Assignment and Successors) will be null, void, and of no legal effect. This Agreement will be binding upon and inure to the benefit of the Parties and their respective legal representatives,
successors and permitted assigns. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Rights in Bankruptcy. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>15.10.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All rights and licenses now or hereafter granted by one Party to the other Party under or pursuant to this
Agreement, including, for the avoidance of doubt, the licenses granted to Ionis pursuant to <U>Section&nbsp;3.1</U> (License Grant to Ionis), are, for all purposes of Section&nbsp;365(n) of the U.S. Bankruptcy Code, licenses of rights to
&#147;intellectual property&#148; as defined in the U.S. Bankruptcy Code. Upon the occurrence of any Insolvency Event with respect to a Party granting a license (the &#147;<B>Licensing Party</B>&#148;), the Licensing Party agrees that the other
Party (the &#147;<B>Licensee</B>&#148;), as licensee of such rights under this Agreement, will retain and may fully exercise all of its rights and elections under the U.S. Bankruptcy Code. Without limiting the generality of the foregoing, the
Parties intend and agree that any sale of a Licensing Party&#146;s assets under Section&nbsp;363 of the U.S. Bankruptcy Code will be subject to Ionis&#146; rights under Section&nbsp;365(n), that the Licensee cannot be compelled to accept a money
satisfaction of its interests in the intellectual property licensed pursuant to this Agreement, and that any such sale therefore may not be made to a purchaser &#147;free and clear&#148; of the Licensee&#146;s rights under this Agreement and
Section&nbsp;365(n) without the express, contemporaneous consent of the Licensee. The Licensing Party will, during the Term, create and maintain current copies or, if not amenable to copying, detailed descriptions or other appropriate embodiments,
to the extent feasible, of all intellectual property licensed under this Agreement. Each Party acknowledges and agrees that &#147;embodiments&#148; of intellectual property within the meaning of Section&nbsp;365(n) include laboratory notes and
notebooks, cell lines, laboratory samples, product samples and inventory, research studies and data, all Regulatory Approvals (and all applications for Regulatory Approval) and rights of reference therein, marketing advertising and promotional
materials, the Licensed Technology, and all information related to the Licensed Technology. If (a)&nbsp;a case under the U.S. Bankruptcy Code is commenced by or against a Licensing Party, (b)&nbsp;this Agreement is rejected as provided in the U.S.
Bankruptcy Code, and (c)&nbsp;the Licensee elects to retain its rights hereunder as provided in Section&nbsp;365(n) of the U.S. Bankruptcy Code, the Licensing Party (in any capacity, including debtor-in-possession) and its successors and assigns
(including a trustee) will: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">provide the Licensee with all such intellectual property (including all embodiments thereof) held by the
Licensing Party and such successors and assigns, or otherwise available to them, immediately upon Ionis&#146; written request. Whenever the Licensee or any of its successors or assigns provides to Ionis any of the intellectual property licensed
hereunder (or any embodiment thereof) pursuant to this <U>Section&nbsp;15.10.1</U>, the Licensee will have the right to perform the Licensing Party&#146;s obligations hereunder with respect to such intellectual property, but neither such provision
nor such performance by the Licensee will release the Licensing Party from liability resulting from rejection of the license or the failure to perform such obligations; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not interfere with the Licensee&#146;s rights under this Agreement, or any agreement supplemental hereto, to
such intellectual property (including such embodiments), including any right to obtain such intellectual property (or such embodiments) from another entity, to the extent provided in Section&nbsp;365(n) of the U.S. Bankruptcy Code.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>15.10.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All rights, powers and remedies of the Licensee provided herein are in addition to and not in substitution for
any other rights, powers, and remedies now or hereafter existing at law or in equity (including the U.S. Bankruptcy Code) in the event of the commencement of a case under the U.S. Bankruptcy Code with respect to the Licensing Party. The Parties
intend the following rights to extend to the maximum extent permitted by Applicable Law, and to be enforceable under U.S. Bankruptcy Code Section 365(n): </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the right of access to any intellectual property rights (including all embodiments thereof) of the Licensing
Party, or any Third Party with whom the Licensing Party contracts to perform an obligation of the Licensing Party under this Agreement, and, in the case of any such Third Party, which is necessary for the Manufacture, use, sale, import, or export of
Licensed Systems and Licensed Products; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the right to contract directly with any Third Party to complete the contracted work. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Force Majeure</B>. Neither Party will be held liable or responsible to the other Party nor be deemed
to be in default under, or in breach of any provision of, this Agreement for failure or delay in fulfilling or performing any obligation (other than a payment obligation) of this Agreement to the extent such failure or delay is due to force majeure.
For purposes of this Agreement, &#147;<B>Force Majeure</B>&#148; is defined as any cause beyond the reasonable control of the affected Party and without the fault or negligence of such Party, which may include acts of God; material changes in
Applicable Law; war; civil commotion; destruction of production facilities or materials by fire, flood, earthquake, explosion or storm; labor disturbances; epidemic; pandemic; quarantine; and failure of public utilities or common carriers. The
Parties agree the effects of the COVID-19 pandemic that is ongoing as of the Effective Date (including related government orders) may be invoked as a Force Majeure for the purposes of this Agreement, even though the pandemic is ongoing, only to the
extent those effects are not reasonably foreseeable by the Parties as of the Effective Date. Notwithstanding the foregoing, a Party will not be excused from making payments owed hereunder due to any Force Majeure circumstances affecting such Party.
In the case of a Force Majeure, the Party affected by such Force Majeure will immediately notify the other Party of such inability and of the period for which such inability is expected to continue. The Party giving such notice will thereupon be
excused from such of its obligations under this Agreement as it is thereby disabled from performing for so long as it is so disabled for up to a maximum of [***], after which time the Parties will promptly meet to discuss in good faith how to best
proceed in a manner that maintains and abides by the Agreement. To the extent possible, the Party affected by such Force Majeure will use reasonable efforts to minimize the duration of any Force Majeure. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Interpretation</B>. The Parties acknowledge and agree that: (a)&nbsp;each Party and its counsel
reviewed and negotiated the terms and provisions of this Agreement and have contributed to its revision; (b)&nbsp;the rule of construction to the effect that any ambiguities are resolved against the drafting Party will not be employed in the
interpretation of this Agreement; and (c)&nbsp;the terms and provisions of this Agreement will be construed fairly as to each Party and not in a favor of or against either Party, regardless of which Party was generally responsible for the
preparation of this Agreement. In addition, except as otherwise explicitly specified to the contrary, (i)&nbsp;references to a section, schedule or exhibit means a section of, or schedule or exhibit to this Agreement, unless another agreement is
specified, (ii)&nbsp;the word &#147;including&#148; (in its various forms) means &#147;including without limitation,&#148; (iii)&nbsp;the words &#147;shall&#148; and &#147;will&#148; have the same meaning, (iv)&nbsp;references to a particular
statute or regulation include all rules and regulations thereunder and any predecessor or successor statute, rules or regulations, in each case as amended or otherwise modified from time-to-time, (v)&nbsp;words in the singular will be held to
include the plural and vice versa, and words of one gender will be held to include all genders as the context requires, (vi)&nbsp;references to a particular Person include such Person&#146;s successors and assigns to the extent not prohibited by
this Agreement, (vii)&nbsp;references to &#147;days&#148; will mean calendar days, unless otherwise specified, (viii)&nbsp;the word &#147;or&#148; will not be exclusive, unless the context otherwise requires, (ix)&nbsp;the titles and headings
contained in this Agreement are for reference purposes only and will not affect in any way the meaning or interpretation of this Agreement, (x)&nbsp;the terms &#147;hereof,&#148; &#147;hereby,&#148; &#147;hereto,&#148; and derivative or similar
words refer to this entire Agreement, including any schedules or exhibits hereto, and (xi)&nbsp;unless otherwise specified, &#147;$&#148; is in reference to United States Dollars. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Integration</B>. This Agreement, together with all exhibits and schedules attached hereto and each
Co-Development and Co-Commercialization Agreement, any Development Supply Agreement, and any Commercial Supply Agreement, sets forth the entire agreement with respect to the subject matter hereof and thereof and supersedes all other agreements and
understandings between the Parties with respect to such subject matter, including the Confidentiality Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Severability</B>. Each Party hereby agrees that it does not intend to violate any public policy,
statutory or common laws, rules, regulations, treaty, or decision of any government agency or executive body thereof of any country or community or association of countries. If one or more provisions of this Agreement be or become invalid, then the
Parties will substitute, by written agreement, valid provisions for such invalid provisions, which valid provisions in their economic effect are sufficiently similar to the invalid provisions such that it can be reasonably assumed that the Parties
would have entered into this Agreement with such valid provisions. If the Parties are unable to agree upon such alternative valid provision, then the invalidity of one or several provisions of this Agreement will not affect the validity of this
Agreement as a whole, unless the invalid provisions are of such essential importance to this Agreement such that it is to be reasonably assumed that the Parties would not have entered into this Agreement without the invalid provisions.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Further Assurances</B>. Each of Ionis and Metagenomi agrees to duly execute and deliver, or cause to
be duly executed and delivered, such further instruments and do and cause to be done such further acts and things, including, the filing of such additional assignments, agreements, documents and instruments, as the other Party may at any time and
from time-to-time reasonably request in connection with this Agreement or to carry out more effectively the provisions and purposes of, or to better assure and confirm unto such other Party its rights and remedies under, this Agreement.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Counterparts</B>. This Agreement may be executed in counterparts, all of which taken together will be
regarded as one and the same instrument. Counterparts may be delivered via electronic mail, including Adobe&#153; Portable Document Format (PDF) or any electronic signature complying with the U.S. Federal ESIGN Act of 2000, and any counterpart so
delivered will be deemed to be original signatures, will be valid and binding upon the Parties, and, upon delivery, will constitute due execution of this Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>15.17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Relationship of the Parties</B>. In entering into this Agreement and performing their respective
duties and obligations with respect to the Agreement, the Parties are acting, and intend to be treated, as independent entities, and the activities and resources of each Party will be managed by such Party, acting independently and in its individual
capacity. The relationship between the Parties is that of independent contractors, and neither Party will have the power to bind or obligate the other Party in any manner. Nothing contained in this Agreement will be construed or implied to create an
agency, partnership, joint venture, fiduciary, or employer-employee relationship between the Parties. Except as otherwise expressly provided in this Agreement, neither Party may make any representation, warranty or commitment, whether express or
implied, on behalf of or incur any charges or expenses for or in the name of the other Party. Neither Party will hold itself out, or take any action, contrary to the terms of this <U>Section&nbsp;15.17</U> (Relationship of the Parties), and neither
Party will become liable due to any such representation, warranty, commitment, act or omission made by the other Party contrary to the provisions of this <U>Section&nbsp;15.17</U> (Relationship of the Parties). Subject to the terms of this
Agreement, the activities and resources of each Party will be managed by such Party, acting independently and in its individual capacity. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Remainder of page intentionally left blank.</I>]<I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly
authorized representatives. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>METAGENOMI, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>IONIS PHARMACEUTICALS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian Thomas</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brett Monia</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Brian Thomas</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Brett Monia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page to Collaboration and License Agreement</I>]<I> </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Appendix 1 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Definitions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, whether used in the singular or plural, the following terms will have the meanings set forth
below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>AAA</B>&#148; has the meaning set forth in <U>Section&nbsp;15.1.2</U> (Arbitration).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Accounting Standards</B>&#148; means United States Generally Accepted Accounting Principles, as
generally and consistently applied throughout a Party&#146;s organization. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Acquiring Party</B>&#148; has the meaning set forth in <U>Section&nbsp;9.8.1</U> (Proposed New
In-License Agreement). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Acquisition Transaction</B>&#148; has the meaning set forth in <U>Section&nbsp;3.6.2</U>
(Acquisition of Distracting Product). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Additional Drug Discovery Plan</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.2</U>
(Additional Drug Discovery Plans). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Additional Wave 1 Target</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.1(c)</U>
(Additional Wave 1 Target Selection). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Additional Wave 1 Target Notice</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.1.1(c)</U> (Additional Wave 1 Target Selection). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Additional Wave 1 Target Selection Period</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.1.1(c)</U> (Additional Wave 1 Target Selection). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Affiliate</B>&#148; means, as of any point in time and for so long as such relationship
continues to exist with respect to any Person, any other Person that controls, is controlled by, or is under common control with such Person. For purposes of this <U>Section&nbsp;1.9</U> (Affiliate), the term &#147;control&#148; (including, with
correlative meaning, the terms &#147;controlled by&#148; and &#147;under common control with&#148;), means the possession, directly or indirectly, of more than 50% of the voting stock or other ownership interest of such Person, or the possession,
directly or indirectly, of the power to direct or cause the direction of the affairs or management and policies of such Person or the power to elect or appoint more than 50% of the members of the governing body of such Person. The Parties
acknowledge that in the case of certain entities organized under the laws of certain countries outside the United States, the maximum percentage ownership permitted by Applicable Law for a foreign investor may be less than 50%, and that in such case
such lower percentage will be substituted in the preceding sentence; <I>provided</I> that such foreign investor has the power to direct the management and policies of such entity. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Agreement</B>&#148; has the meaning set forth in the Preamble. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Alliance Manager</B>&#148; has the meaning set forth in <U>Section&nbsp;4.4</U> (Alliance
Managers). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>[***]</B>&#148; means any amount that is less than [***], on a year to date basis, set forth in
the Exploratory Research Budget or a Drug Discovery Budget (as applicable) for such Calendar Year; <I>provided</I> that such amount is not incurred as a result of any breach by Metagenomi of this Agreement. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Annual Net Sales</B>&#148; means, with respect to an Ionis Product, the aggregate Net Sales of
such Ionis Product sold by Ionis, its Affiliates, or Sublicensees in the Field in the Territory during a Calendar Year and only during the Royalty Term for such Ionis Product in the applicable country. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Applicable Law</B>&#148; means applicable (with respect to the particular activity, task, or
obligation under this Agreement to which such term applies) laws, statutes, rules, regulations, and other pronouncements having the effect of law of any Governmental Authority that may be in effect from time to time, including for clarity any
applicable rules, regulations, guidelines, or other requirements of any Regulatory Authority that may be in effect from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Arbitration</B>&#148; has the meaning set forth in <U>Section&nbsp;15.1.2</U> (Arbitration).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Audited Party</B>&#148; has the meaning set forth in <U>Section&nbsp;9.13.1</U> (Books and
Records). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Auditing Party</B>&#148; has the meaning set forth in <U>Section&nbsp;9.13.1</U> (Books and
Records). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Auditor</B>&#148; has the meaning set forth in <U>Section&nbsp;9.13.1</U> (Books and Records).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Available</B>&#148; means, with respect to a Proposed Target, that such Proposed Target is not
an Encumbered Target. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>[***]</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.4(a)</U> (New [***]).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Biosimilar Product</B>&#148; means, with respect to a particular Licensed Product in a
particular country, a product on the market in such country commercialized by any Third Party that is not a Sublicensee and that did not purchase such product in a chain of distribution that included any of Ionis or its Affiliates or Sublicensees,
that (a)&nbsp;is approved by the applicable Regulatory Authority, under any then-existing laws and regulations in the applicable country pertaining to approval of generic or biosimilar biologic products, as a &#147;generic&#148; or
&#147;biosimilar&#148; version of such Licensed Product, which approval uses such Licensed Product as a reference product and relies on or references information in the MAA for such Licensed Product, or (b)&nbsp;is otherwise recognized by the
applicable Regulatory Authority as a biosimilar or interchangeable product to such Licensed Product. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>BLA</B>&#148; means a biologics license application that is submitted to the FDA for a Licensed
Product, pursuant to 21 C.F.R. &#167; 601.2. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.23.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Business Day</B>&#148; means any day, other than Saturday, Sunday, or any day on which banking
institutions in California are authorized or required by Applicable Law to remain closed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.24.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>C.F.R.</B>&#148; means the U.S. Code of Federal Regulations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.25.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Calendar Quarter</B>&#148; means each period of three consecutive calendar months ending on
March&nbsp;30,&nbsp;June&nbsp;30,&nbsp;September&nbsp;30, or December&nbsp;31, except that the first Calendar Quarter of the Term will commence on the Effective Date, and the last Calendar Quarter of the Term will end on the effective date of the
termination or expiration of this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.26.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Calendar Year</B>&#148; means each period of 12 consecutive calendar months commencing on
January&nbsp;1 and ending on December&nbsp;31, except that the first Calendar Year of the Term will commence on the Effective Date, and the last Calendar Year of the Term will end on the effective date of the termination or expiration of this
Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.27.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Change of Control</B>&#148; means, with respect to a Party, (a)&nbsp;a merger, reorganization,
combination, or consolidation of such Party with a Third Party that results in the holders of beneficial ownership of the voting securities or other voting interests of such Party (or, if applicable, the ultimate parent of such Party) immediately
prior to such merger, reorganization, combination, or consolidation ceasing to hold beneficial ownership of more than 50% of the combined voting power of the surviving entity or the ultimate parent of the surviving entity immediately after such
merger, reorganization, combination or consolidation, (b)&nbsp;a transaction or series of related transactions in which a Third Party, together with its Affiliates, becomes the beneficial owner of 50% or more of the combined voting power of the
outstanding securities or other voting interest of such Party, (c)&nbsp;the sale, lease, exchange, contribution, or other transfer (in one transaction or a series of related transactions) to a Third Party of all or substantially all of such
Party&#146;s assets, or (d)&nbsp;a liquidation or dissolution of such Party or any direct or indirect parent of such Party. Notwithstanding the foregoing, an initial public offering, a <I>bona fide</I> venture capital financing, a SPAC transaction,
or reverse-merger transaction, in each case, of Metagenomi, will not be considered a Change of Control of Metagenomi. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.28.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Claim</B>&#148; has the meaning set forth in <U>Section&nbsp;15.1.1</U> (Escalation).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.29.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Clinical Trial</B>&#148; means any clinical trial in humans that is designed to generate data
in support or maintenance of an IND or MAA. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.30.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>CMO</B>&#148; means a contract manufacturing organization. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.31.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;[***]&#148; means [***]. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.32.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Co-Co Option</B>&#148; has the meaning set forth in <U>Section&nbsp;5.1.1</U> (Option Grant).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.33.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Co-Co Option Notice</B>&#148; has the meaning set forth in <U>Section&nbsp;5.1.2</U> (Option
Period). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.34.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Co-Co Option Period</B>&#148; has the meaning set forth in <U>Section&nbsp;5.1.2</U> (Option
Period). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.35.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Co-Co Products</B>&#148; means any Licensed Products that are the subject of a Co-Co Program.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.36.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Co-Co Program</B>&#148; means each Drug Discovery Program for which Metagenomi exercises a
Co-Co Option in accordance with <U>Section&nbsp;5.1</U> (Co-Development and Co-Commercialization Options). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.37.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Co-Development and Co-Commercialization Agreement</B>&#148; has the meaning set forth in
<U>Section&nbsp;5.2</U> (Development and Commercialization of the Co-Co Products; Opt-Down Right). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.38.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Collaboration Activities</B>&#148; has the meaning set forth in <U>Section&nbsp;2.4</U>
(Conduct of Collaboration Activities). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.39.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Collaboration Program</B>&#148; means (a)&nbsp;the Exploratory Research Program and
(b)&nbsp;each Drug Discovery Program. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.40.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Collaboration Program Plans</B>&#148; has the meaning set forth in <U>Section&nbsp;2.4</U>
(Conduct of Collaboration Activities). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.41.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Collaboration Program Report</B>&#148; has the meaning set forth in <U>Section&nbsp;2.6.2</U>
(Collaboration Program Reports). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.42.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Collaboration Target</B>&#148; means, as applicable, any of (a)&nbsp;[***], (b)&nbsp;the Second
Wave 1 Target, and (c)&nbsp;the Proposed Targets that Ionis designates in accordance with <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.43.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Collaboration Term</B>&#148; means (a)&nbsp;with respect to a Drug Discovery Program, the
applicable Drug Discovery Term for such Drug Discovery Program and (b)&nbsp;with respect to the Exploratory Research Program, the Exploratory Research Term. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.44.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Combination Product</B>&#148; has the meaning set forth in <U>Section&nbsp;1.190</U> (Net
Sales). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.45.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Commercial Supply Agreement</B>&#148; has the meaning set forth in <U>Section&nbsp;8.1.1</U>
(Metagenomi Supply Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.46.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Commercialization</B>&#148; or &#147;<B>Commercialize</B>&#148; means with respect to any
product, any and all activities directed to the marketing, promotion, patient services, distribution, pricing, reimbursement, pharmacovigilance, import, export, offering for sale, and sale of such product, including seeking and maintaining any
required Pricing Approval, but excluding any activities directed to Manufacturing, Development, or Medical Affairs. &#147;<B>Commercialize</B>,&#148; &#147;<B>Commercializing</B>,&#148; and &#147;<B>Commercialized</B>&#148; will be construed
accordingly. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.47.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Commercially Reasonable Efforts</B>&#148; means with respect to the efforts to be expended by
any Person with respect to any objective, reasonable, diligent, and good faith efforts to accomplish such objective. With respect to Ionis&#146; obligations set forth in <U>Section&nbsp;6.1.3</U> (Development Diligence for the Ionis Products) and
<U>Section&nbsp;6.2.2</U> (Commercialization Diligence for the Ionis Products), &#147;<B>Commercially Reasonable Efforts</B>&#148; means that level, caliber, and quality of efforts and resources reasonably and normally used by biopharmaceutical
companies of similar size to Ionis as to a potential or actual product with similar commercial potential and at a similar stage of product life, taking into account with respect to each applicable Licensed System or Licensed Product, (a)&nbsp;issues
of safety, efficacy, and product profile, (b)&nbsp;likelihood of receiving Regulatory Approval (including, for clarity, Pricing Approval) of the applicable Licensed Product, (c)&nbsp;regulatory structure involved, (d)&nbsp;feedback provided by any
Regulatory Authority, including relating to proposed or approved labeling, (e)&nbsp;competitiveness in the marketplace and anticipated or actual profitability of the product (including based on the Pricing Approval and the cost of goods thereof,
where applicable), (f)&nbsp;proprietary position, and (g)&nbsp;other scientific, technical, and business factors deemed relevant by Ionis. &#147;<B>Commercially Reasonable Efforts</B>&#148; will be determined on a country-by-country basis in the
relevant countries and [***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.48.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Common Ownership Legislation</B>&#148; means the legislation on conditions for patentability
and novelty, as codified at 35 U.S.C. &#167; 102(c) (Common Ownership Under Joint Research Agreements). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.49.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Competitive Infringement</B>&#148; has the meaning set forth in <U>Section&nbsp;10.3.1</U>
(Notification). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.50.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Confidential Information</B>&#148; means (a)&nbsp;the existence and terms of this Agreement,
and (b)&nbsp;with respect to each Party, Know-How, materials, and other proprietary information including data and all other scientific, pre-clinical, clinical, regulatory, Manufacturing, marketing, financial, and commercial information or data that
is disclosed, made available to, or provided by or on behalf of such Party to the other Party or to any of the Receiving Party&#146;s employees, consultants, Affiliates, or Sublicensees, whether or not specifically marked or designated by the
Disclosing Party as confidential; <I>provided</I> that, notwithstanding the foregoing, Product-Specific Know-How will be deemed the Confidential Information of Ionis during the Term and thereafter following any expiration, but not termination, of
this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.51.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Confidentiality Agreement</B>&#148; has the meaning set forth in <U>Section&nbsp;11.1.2</U>
(Confidential Information of Each Party). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.52.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Control</B>&#148; or &#147;<B>Controlled</B>&#148; means the possession by a Party (whether by
ownership, license, or otherwise other than pursuant to this Agreement) of, (a)&nbsp;with respect to any materials or other tangible Know-How, the legal authority or right to physical possession of such materials or tangible Know-How, with the right
to provide such materials or tangible Know-How to the other Party on the terms set forth herein, (b)&nbsp;with respect to Patent Rights, Regulatory Approvals, Regulatory Submissions, intangible Know-How, or other intellectual property, the legal
authority or right to grant a license, sublicense, access, or right to use (as applicable) to the other Party under such Patent Rights, Regulatory Approvals, Regulatory Submissions, intangible Know-How, or other intellectual property on the terms
set forth herein, in each case ((a) and (b)), without breaching or otherwise violating the terms of any arrangement or agreement with a Third Party in existence as of the time such Party or its Affiliates would first be required hereunder to grant
the other Party such access, right to use, license, or sublicense, and (c)&nbsp;with respect to any product, the legal authority or right to grant an exclusive license or sublicense under Patent Rights that Cover such product or Know-How that
relates to such product; <I>provided</I> that (i)&nbsp;any Know-How or Patent Rights in-licensed or acquired by Metagenomi or its Affiliates under an Existing Potential Metagenomi In-License Agreement or a Proposed New Metagenomi In-License
Agreement will not be deemed &#147;Controlled&#148; by Metagenomi unless and until such agreement becomes a Metagenomi In-License Agreement under <U>Section&nbsp;9.7.1</U> (Effective Date Licensed Technology; Existing Metagenomi In-License
Agreements) or <U>Section&nbsp;9.8.2</U> (Acceptance of a Proposed New In-License Agreement) (and only for so long as it remains a New Metagenomi In-License Agreement hereunder) and (ii)&nbsp;any Know-How or Patent Rights in-licensed or acquired by
Ionis or its Affiliates under an Existing Potential Ionis In-License Agreement or a Proposed New Ionis In-License Agreement will not be deemed &#147;Controlled&#148; by Ionis unless and until such agreement becomes an Ionis In-License Agreement
under <U>Section&nbsp;9.7.2</U> (Existing Potential Ionis In-License Agreements) or <U>Section&nbsp;9.8.2</U> (Acceptance of a Proposed New In-License Agreement) (and only for so long as it remains an Ionis In-License Agreement hereunder).
Notwithstanding the foregoing, a Party and its Affiliates will not be deemed to &#147;<B>Control</B>&#148; any of the foregoing (a)&nbsp;&#150; (c)&nbsp;that are owned or controlled by a Third Party described in the definition of &#147;Change of
Control,&#148; or such Third Party&#146;s Affiliates (other than an Affiliate of such Party prior to the Change of Control), (x)&nbsp;prior to the closing of such Change of Control, except to the extent that any such Patent Rights or Know-How were
developed by such Third Party prior to such Change of Control using or incorporating such Party&#146;s or its pre-existing Affiliate&#146;s Know-How or Patent Rights, or (y)&nbsp;after such Change of Control to the extent that such Patent Rights or
Know-How are developed or conceived by such Third Party or its Affiliates (other than such Party) after such Change of Control without using or incorporating such Party&#146;s or its pre-existing Affiliate&#146;s Know-How or Patent Rights and are
not developed or conceived by personnel who were employees or consultants of such Party or its pre-existing Affiliates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.53.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Cost of Goods</B>&#148; or &#147;<B>COGS</B>&#148; means, with respect to any Licensed Product
or Licensed System supplied by Metagenomi to Ionis pursuant to<U> Article 8</U> (Manufacturing): 100% of: (a)&nbsp;[***]; and (b)&nbsp;[***]. The Cost of Goods will exclude any amounts incurred due to gross negligence or willful misconduct of
Metagenomi, its Affiliates, or any Third Party. All components of Cost of Goods will be allocated on a basis consistent with the Metagenomi&#146;s Accounting Standards and consistent with the cost accounting policy applied by Metagenomi to other
products that it produces. For clarity, the Cost of Goods will not include any cost or expense already paid for by Ionis pursuant to this Agreement or any other agreement between the Parties or their Affiliates. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.54.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Cover</B>,&#148; &#147;<B>Covers</B>,&#148; or &#147;<B>Covered</B>&#148; means, as to a
compound or product and Patent Right, that, in the absence of a license granted under, or ownership of, such Patent Right, the making, using, keeping, selling, offering for sale, or importation of such compound or product would infringe such Patent
Right or, as to a pending claim included in such Patent Right, the making, using, keeping, selling, offering for sale, or importation of such compound or product would infringe such Patent Right if such pending claim were to issue in an issued
patent without modification. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.55.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Development</B>&#148; or &#147;<B>Develop</B>&#148; means, with respect to any product, any and
all internal and external research, development, pharmacovigilance activities, and regulatory activities regarding such product, including (a)&nbsp;research, process development, non-clinical testing, toxicology, non- clinical activities,
IND-enabling studies, and Clinical Trials, and (b)&nbsp;preparation, submission, review, and development of data or information for the purpose of submission to a Regulatory Authority to obtain authorization to conduct Clinical Trials and to obtain,
support, or maintain Regulatory Approval of such product, but excluding any activities directed to Manufacturing, Medical Affairs, or Commercialization. Development will include research, development, and regulatory activities for additional
presentations or indications for a product after receipt of Regulatory Approval of such product, including Clinical Trials initiated following receipt of Regulatory Approval or any Clinical Trial to be conducted after receipt of Regulatory Approval
that was mandated by the applicable Regulatory Authority as a condition of such Regulatory Approval with respect to an approved indication (such as post-marketing approval studies and observational studies, if required by any Regulatory Authority in
any country in the Territory to support or maintain Regulatory Approval for a product in such country, including any phase IV studies). &#147;<B>Develop</B>,&#148; &#147;<B>Developing</B>,&#148; and &#147;<B>Developed</B>&#148; will be construed
accordingly. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.56.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Development Candidate</B>&#148; means a therapeutic agent that is selected by Ionis for further
Development and Commercialization in accordance with its customary internal process and pursuant to <U>Section&nbsp;2.2.6</U> (Delivery of Development Candidate; Development Candidate Report). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.57.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Development Candidate Report</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.6</U>
(Delivery of Development Candidate; Development Candidate Report). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.58.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Development Cost Share Notice</B>&#148; has the meaning set forth in <U>Section&nbsp;9.3</U>
(Option Exercise Fee). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.59.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Development Supply Agreement</B>&#148; has the meaning set forth in <U>Section&nbsp;8.1.1</U>
(Metagenomi Supply Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.60.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Disclosing Party</B>&#148; has the meaning set forth in <U>Section&nbsp;11.1.1</U> (General).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.61.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Distracted Party</B>&#148; has the meaning set forth in <U>Section&nbsp;3.6.2</U> (Acquisition
of Distracting Product). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.62.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Distracting Product</B>&#148; has the meaning set forth in <U>Section&nbsp;3.6.2</U>
(Acquisition of Distracting Product). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.63.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;[***]&#148; means, with respect to a Distracting Product, [***]. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.64.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Drug Discovery Activities</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.1</U>
(Initial Drug Discovery Plan). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.65.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Drug Discovery Budget</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.1</U> (Initial
Drug Discovery Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.66.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Drug Discovery Plan</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.1</U> (Initial
Drug Discovery Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.67.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Drug Discovery Program</B>&#148; means, on a Collaboration Target-by-Collaboration Target
basis, the program of Development undertaken for a Collaboration Target, as set forth in the applicable Drug Discovery Plan for such Collaboration Target. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.68.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Drug Discovery Term</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.7</U> (Drug
Discovery Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.69.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Effective Date</B>&#148; has the meaning set forth in the Preamble. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.70.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>EMA</B>&#148; means the European Medicines Agency or any successor agency or authority thereto.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.71.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;[***]&#148; has the meaning set forth in Section&nbsp;3 ([***]) of the Exploratory Research Plan
attached hereto as <U>Schedule 2.3.1</U> (Exploratory Research Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.72.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B></B><B>Encumbered Proposed Metagenomi Target</B><B></B>&#148; has the meaning set forth in
<U>Section&nbsp;2.7.3(a) </U>(Encumbered Targets).<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.73.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Encumbered Target</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.4(a)</U>
(Encumbered Targets). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.74.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Encumbrance</B>&#148; means any and all liens, encumbrances, charges, mortgages, security
interests, hypothecations, easements, rights-of-way or encroachments of any nature whatsoever. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.75.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>European Union</B>&#148; or &#147;<B>EU</B>&#148; means (a)&nbsp;all countries or territories
that are officially part of the European Union, as constituted from time to time, and (b)&nbsp;the United Kingdom. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.76.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Exclusivity Field</B>&#148; means, with respect to a Drug Discovery Program, (a)&nbsp;[***] and
(b)&nbsp;any [***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.77.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Executive Officer</B>&#148; has the meaning set forth in <U>Section&nbsp;15.1.1</U>
(Escalation). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.78.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Existing Potential Ionis In-License Agreement</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.7.2</U> (Existing Potential Ionis In-License Agreements). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.79.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Existing Potential Metagenomi In-License Agreement</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.7.2</U> (Effective Date Licensed Technology; Existing Metagenomi In-License Agreements). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.80.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Expedited Dispute</B>&#148; means any dispute (a)&nbsp;that a Party elects pursuant to
<U>Section&nbsp;4.6.3(b)</U> (Resolution by Baseball Arbitration) to refer to resolution pursuant to <U>Section&nbsp;15.1.3</U> (Expedited Dispute Resolution), (b)&nbsp;regarding the determination of any final definitive terms of any Co-Development
and Co-Commercialization Agreement pursuant to <U>Section&nbsp;5.2</U> (Development and Commercialization of the Co-Co Products; Opt-Down Right), (c)&nbsp;regarding the royalty rate or royalty term for any reversion royalty pursuant to
<U>Section&nbsp;14.3.6(c)</U> (Reversion Royalties), or (d)&nbsp;regarding any other provision of this Agreement that the Parties agree to designate as an Expedited Dispute. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.81.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Exploit</B>&#148; means, with respect to any product, to Develop, have Developed, make, have
made, use, have used, perform Medical Affairs, have performed Medical Affairs, offer for sale, have offered for sale, sell, have sold, export, have exported, import, have imported, Manufacture, have Manufactured, Commercialize, have Commercialized,
or otherwise exploit such product. &#147;<B>Exploitation</B>&#148; and &#147;<B>Exploiting</B>&#148; will be construed accordingly. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.82.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Exploratory Research Activities</B>&#148; has the meaning set forth in <U>Section&nbsp;2.3.1</U>
(Exploratory Research Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.83.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Exploratory Research Budget</B>&#148; has the meaning set forth in <U>Section&nbsp;2.3.1</U>
(Exploratory Research Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.84.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Exploratory Research Plan</B>&#148; has the meaning set forth in <U>Section&nbsp;2.3.1</U>
(Exploratory Research Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.85.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Exploratory Research Program</B>&#148; has the meaning set forth in <U>Section&nbsp;2.3.1</U>
(Exploratory Research Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.86.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Exploratory Research Term</B>&#148; has the meaning set forth in <U>Section&nbsp;2.3.3</U>
(Exploratory Research Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.87.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>FDA</B>&#148; means the United States Food and Drug Administration and any successor agency or
authority thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.88.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>FD&amp;C Act</B>&#148; means the United States Food, Drug, and Cosmetic Act, as amended, and
the rules and regulations promulgated thereunder, as may be in effect from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.89.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Field</B>&#148; means, with respect to a given Drug Discovery Program, [***].
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.90.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Firewall Procedures</B>&#148; has the meaning set forth in <U>Section&nbsp;3.6.2</U>
(Acquisition of Distracting Product). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.91.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>First Commercial Sale</B>&#148; means on a Licensed Product-by-Licensed Product and
country-by-country basis, the first sale of a Licensed Product by Ionis, its Affiliate, or its Sublicensee to a Third Party resulting in a Net Sale in a particular country; <I>provided</I> that the following will not constitute a First Commercial
Sale: (a)&nbsp;any sale of a Licensed Product to a Ionis Affiliate or Sublicensee; (b)&nbsp;any sale of a Licensed Product for use in Clinical Trials, pre-clinical studies, or other Development activities at below market price; (c)&nbsp;the disposal
or transfer of a Licensed Product for a <I>bona fide</I> charitable purpose; or (d)&nbsp;compassionate use and &#147;named patient sales.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.92.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;[***]&#148; means, with respect to an Ionis Program and an Ionis Product Development Milestone
Event, [***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.93.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Force Majeure</B>&#148; has the meaning set forth in <U>Section&nbsp;15.11</U> (Force Majeure).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.94.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>FTE</B>&#148; has the meaning set forth in <U>Section&nbsp;1.95</U> (FTE Rate).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.95.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>FTE Rate</B>&#148; means an annual rate of $[***] for the time of an employee for a full-time
equivalent (&#147;<B>FTE</B>&#148;) person year (consisting of a total of 1,800 hours per annum) carrying out research, scientific, or technical work under this Agreement, prorated on a daily basis. Without limiting the foregoing, the FTE Rate will
be adjusted annually for each Calendar Year after the Calendar Year ending December&nbsp;31, 2022 to be equal to the FTE Rate for the preceding Calendar Year [***]. The FTE Rate [***]. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.96.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Gene Editing</B>&#148; means [***]. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.97.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Governmental Authority</B>&#148; means any arbitrator, court, judicial, legislative,
administrative or regulatory authority, commission, department, board, bureau, or body, or other government authority or instrumentality or any Person exercising executive, legislative, judicial, regulatory, or administrative functions of or
pertaining to government, whether foreign or domestic, whether federal, state, provincial, municipal, or other. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.98.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Guide RNA</B>&#148; means any single- or double-stranded polynucleotide (including any
analogue, variant, or mimic thereof) used for genome sequence site-specific targeting of a Gene Editing protein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.99.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Increased Cost Notice</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.4(c)</U>
(Incremental Development Costs). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.100.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Incremental Development Costs</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.2.4(c)</U> (Incremental Development Costs). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.101.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>IND</B>&#148; means an investigational new drug application filed with the FDA with respect to
a Licensed Product, or an equivalent application filed with the Regulatory Authority of a country in the Territory other than the U.S. (such as an application for a Clinical Trial authorization in the EU). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.102.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Indemnitee</B>&#148; has the meaning set forth in <U>Section&nbsp;13.4</U> (Conditions to
Indemnification). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.103.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Infringement</B>&#148; has the meaning set forth in <U>Section&nbsp;10.3.1</U> (Notification).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.104.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Initial Interest Notice</B>&#148; has the meaning set forth in <U>Section&nbsp;2.2.4(c)</U>
(Incremental Development Costs). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.105.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Initiation</B>&#148; means, with respect to any Clinical Trial, the date on which the first
subject in such trial receives his or her initial dose in such Clinical Trial. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.106.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Insolvency Event</B>&#148; has the meaning set forth in <U>Section&nbsp;14.2.3</U> (Termination
for Insolvency). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.107.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Intellectual Property Rights</B>&#148; means any Know-How, Patent Rights, Trademarks,
copyrights, trade secrets, and any other intellectual property rights however denominated throughout the world. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.108.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Internal Costs</B>&#148; means, for any period, the product obtained by multiplying
(a)&nbsp;the actual total FTEs (or portion thereof) devoted to the performance of activity under this Agreement during such period, by (b)&nbsp;the applicable FTE Rate. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.109.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis</B>&#148; has the meaning set forth in the Preamble. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.110.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Background Technology</B>&#148; has the meaning set forth in <U>Section&nbsp;2.7.1</U>
(Option Grant). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.111.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Collaboration Know-How</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(b)</U> (Ionis Collaboration Technology). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.112.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Collaboration Patent Rights</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(b)</U> (Ionis Collaboration Technology). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.113.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Collaboration Technology</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(b)</U> (Ionis Collaboration Technology). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.114.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">[***] </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.115.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Field</B>&#148; means all therapeutic, prophylactic, palliative, analgesic, and
diagnostic uses in humans utilizing oligonucleotides that bind to RNA, which such oligonucleotides are subject to a Valid Claim of a Patent Right Controlled by Ionis. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.116.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Indemnitees</B>&#148; has the meaning set forth in <U>Section&nbsp;13.2</U>
(Indemnification of Ionis by Metagenomi). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.117.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis In-License Agreement</B>&#148; means (a)&nbsp;any Existing Potential Ionis In-License
Agreement that becomes an Ionis In-License Agreement pursuant to <U>Section&nbsp;9.7.2</U> (Existing Potential Ionis In-License Agreements) and (b)&nbsp;any New Ionis In-License Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.118.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis IP Option</B>&#148; has the meaning set forth in <U>Section&nbsp;2.7.1</U> (Option
Grant). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.119.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis IP Option Effective Date</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.7.3(b)</U> (Effects if a Proposed Metagenomi Target is not an Encumbered Proposed Metagenomi Target). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.120.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis&#146; Knowledge</B>&#148; means the knowledge, after reasonable investigation (including
consultation with Ionis&#146; outside intellectual property counsel), of the following: [***] as of the applicable date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.121.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Licensed Know-How</B>&#148; means all Know-How that is Controlled by Ionis or any of its
Affiliates as of the Effective Date or during the Term (other than Joint Collaboration Know-How) that is necessary or reasonably useful to perform the Metagenomi Activities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.122.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Licensed Patent Rights</B>&#148; means any Patent Rights Controlled by Ionis or any of
its Affiliates that Cover any Ionis Licensed Know-How. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.123.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Licensed Technology</B>&#148; means Ionis Licensed Know-How and Ionis Licensed Patent
Rights. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.124.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Product Development Milestone Event</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.4.1</U> (Ionis Product Development Milestone Payments). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.125.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Product Development Milestone Payment</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.4.1 </U>(Ionis Product Development Milestone Payments). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.126.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Product Regulatory Milestone Event</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.4.2</U> (Ionis Product Regulatory Milestone Payments). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.127.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Product Regulatory Milestone Payment</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.4.2 </U>(Ionis Product Regulatory Milestone Payments). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.128.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Product Sales Milestone Event</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.4.3</U> (Ionis Product Sales Milestone Payment). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.129.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Product Sales Milestone Payment</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.4.3</U> (Ionis Product Sales Milestone Payment). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.130.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Products</B>&#148; means any Licensed Products that are the subject of an Ionis Program.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.131.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Programs</B>&#148; means each Drug Discovery Program for which Metagenomi does not
exercise its Co-Co Option prior to the expiration of the applicable Co-Co Option Period or which Metagenomi opts out in accordance with <U>Section&nbsp;5.4</U> (Metagenomi Opt-Out). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.132.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Proprietary Toolbox of Chemical Modifications</B>&#148; [***] that is Covered by an Ionis
Toolbox Patent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.133.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis-Prosecuted Patent Rights</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.2.1(a)</U>. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.134.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Records</B>&#148; has the meaning set forth in <U>Section&nbsp;9.13.1</U> (Books and
Records). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.135.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Royalties</B>&#148; has the meaning set forth in <U>Section&nbsp;9.6.1</U> (Ionis Royalty
Rates). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.136.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Royalty Rates</B>&#148; has the meaning set forth in <U>Section&nbsp;9.6.1</U> (Ionis
Royalty Rates). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.137.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Royalty Report</B>&#148; has the meaning set forth in <U>Section&nbsp;9.6.4</U> (Ionis
Royalty Reports). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.138.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Ionis Toolbox Patent</B>&#148; means any Patent Right Controlled by Ionis as of the Effective
Date or during the Collaboration Term that [***]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.139.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Joint Collaboration Know-How</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(c)</U> (Joint Collaboration Technology). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.140.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Joint Collaboration Patent Rights</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(c)</U> (Joint Collaboration Technology). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.141.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Joint Collaboration Technology</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(c)</U> (Joint Collaboration Technology). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.142.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Joint Research Committee</B>&#148; or &#147;<B>JRC</B>&#148; has the meaning set forth in
<U>Section&nbsp;4.3.1</U> (Formation and Purpose of the JRC). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.143.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Joint Steering Committee</B>&#148; or &#147;<B>JSC</B>&#148; has the meaning set forth in
<U>Section&nbsp;4.1.1</U> (Formation and Purpose of the JSC). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.144.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Know-How</B>&#148; means any information and materials, including records, discoveries,
improvements, modifications, processes, techniques, methods, assays, chemical or biological materials, designs, protocols, formulas, data (including physical data, chemical data, toxicology data, animal data, raw data, clinical data, and analytical
and quality control data), dosage regimens, control assays, product specifications, marketing, pricing and distribution costs, inventions, algorithms, technology, forecasts, profiles, strategies, plans, results in any form whatsoever, know-how and
trade secrets (in each case, patentable, copyrightable or otherwise). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.145.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Licensed Know-How</B>&#148; means any Know-How that is Controlled by Metagenomi or any of its
Affiliates as of the Effective Date or during the Term (including Metagenomi Collaboration Know-How, but excluding Joint Collaboration Know-How) that is necessary or reasonably useful to (a)&nbsp;perform the activities under any Collaboration
Program Plan or (b)&nbsp;Exploit any Licensed System or Licensed Product. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.146.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Licensed Patent Right</B>&#148; means any Patent Right Controlled by Metagenomi or any of its
Affiliates as of the Effective Date or during the Term (including Metagenomi Collaboration Patent Rights, but excluding Joint Collaboration Patent Rights) that are necessary or reasonably useful to (a)&nbsp;perform any activities under any
Collaboration Program Plan or (b)&nbsp;Exploit any Licensed System or Licensed Product. The Licensed Patent Rights as of the Effective Date are set forth on <U>Schedule 1.146</U> (Licensed Patent Rights); <I>provided</I> that any Patent Right that
otherwise meets this definition will be deemed a Licensed Patent Right even if such Patent Right is not included on <U>Schedule 1.146</U> (Licensed Patent Rights). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.147.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Licensed Product</B>&#148; means any therapeutic product, medical therapy, preparation or
substance, comprising or employing a Licensed System, in any form or formulation, and whether alone or together with one or more other therapeutically active ingredients, delivery devices, or other components. All Licensed Products comprising the
same Licensed System will be considered the same Licensed Product under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.148.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Licensed Systems</B>&#148; means, with respect to a Drug Discovery Program, (a)&nbsp;a Gene
Editing protein and a Guide RNA that (i)&nbsp;is designed to modulate the Collaboration Target for such Drug Discovery Program and (ii)&nbsp;either (A)&nbsp;was discovered or Developed by Metagenomi prior to the designation of such Collaboration
Target or (B)&nbsp;is discovered or Developed pursuant to the Drug Discovery Plan for such Drug Discovery Program, including any Development Candidate for such Drug Discovery Program or (b)&nbsp;any modification or derivative of any Gene Editing
protein or Guide RNA described in clause (a). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.149.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Licensed Technology</B>&#148; means all Licensed Know-How and Licensed Patent Rights and
Metagenomi&#146;s interest in the Joint Collaboration Technology. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.150.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Licensee</B>&#148; has the meaning set forth in <U>Section&nbsp;15.10.1</U>.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.151.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Licensing Party</B>&#148; has the meaning set forth in <U>Section&nbsp;15.10.1</U>.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.152.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Losses</B>&#148; has the meaning set forth in <U>Section&nbsp;13.1</U> (Indemnification of
Metagenomi by Ionis). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.153.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>MAA</B>&#148; means any new drug application or other marketing authorization application, in
each case, filed with the applicable Regulatory Authority in a country or other regulatory jurisdiction (and all supplements and amendments thereto), which application is required to commercially market or sell a pharmaceutical or biologic product
in such country or jurisdiction, including (a)&nbsp;all New Drug Applications and BLAs submitted to the FDA in the United States in accordance with the FD&amp;C Act with respect to a pharmaceutical product, (b)&nbsp;all MAAs submitted to
(i)&nbsp;the EMA under the centralized EMA filing procedure in the EU or (ii)&nbsp;a Regulatory Authority in any EU country if the centralized EMA filing procedure is not used to gain Regulatory Approval in such country, (c)&nbsp;all New Drug
Applications submitted to the National Medical Products Administration, or (d)&nbsp;any analogous application or submission with any Regulatory Authority in any other country or regulatory jurisdiction. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.154.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Major European Markets</B>&#148; means each of France, Germany, Spain, Italy, and the United
Kingdom. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.155.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Major Market</B>&#148; means each of Japan, the Major European Markets, and the US.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.156.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Manufacture</B>&#148; or &#147;<B>Manufacturing</B>&#148; means with respect to any product,
any and all activities directed to manufacturing, processing, packaging, labeling, filling, finishing, assembly, quality assurance, quality control, analyses, testing and release, shipping, supply, or storage of such product (or any raw materials,
components or process steps involving such product or any companion diagnostic), placebo, or comparator agent, as the case may be, including qualification, validation, and scale-up, pre-clinical, clinical, and commercial manufacture and analytic
development, product characterization, and stability testing, but excluding any activities directed to Development, Medical Affairs, or Commercialization. &#147;<B>Manufacturing</B>&#148; and &#147;<B>Manufactured</B>&#148; will be construed
accordingly. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.157.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Manufacturing Know-How</B>&#148; has the meaning set forth in <U>Section&nbsp;8.5</U>
(Manufacturing After the Metagenomi Supply Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.158.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Manufacturing Technology Transfer</B>&#148; has the meaning set forth in
<U>Section&nbsp;8.5</U> (Manufacturing After the Metagenomi Supply Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.159.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Medical Affairs</B>&#148; means any and all activities customarily conducted by the medical
affairs department of a pharmaceutical or biotechnology company commercializing products similar to the Licensed Products, including communications with key opinion leaders, medical education, symposia, advisory boards (to the extent related to
medical affairs or clinical guidance), activities performed in connection with patient registries, and other medical programs and communications, including educational grants, research grants (including conducting investigator-initiated studies),
patient advocacy, and charitable donations to the extent related to medical affairs and not related to activities that involve the promotion, marketing, sale, or other Commercialization of a product and that are not conducted by or on behalf of a
Party&#146;s or any of its Affiliates&#146; medical affairs departments. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.160.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi</B>&#148; has the meaning set forth in the Preamble. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.161.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Activities</B>&#148; has the meaning set forth in <U>Section&nbsp;3.2.1(a)</U>
(Metagenomi Activities License Grant). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.162.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>&#147;Metagenomi Collaboration Cost Reports</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.5.1 </U>(Reimbursement by Ionis). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.163.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Collaboration Know-How</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(a) </U>(Metagenomi Collaboration Technology). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.164.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Collaboration Patent Rights</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(a) </U>(Metagenomi Collaboration Technology). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.165.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Collaboration Technology</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.1.2(a) </U>(Metagenomi Collaboration Technology). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.166.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>[***]</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.167.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Drug Discovery Costs</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.5.1</U> (Reimbursement by Ionis). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.168.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>&#147;</B><B>Metagenomi Exploratory Research Costs</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.5.1</U> (Reimbursement by Ionis). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.169.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Field</B>&#148; means all therapeutic, prophylactic, palliative, analgesic, and
diagnostic uses in humans through the use of the Metagenomi Platform. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.170.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi In-License Agreements</B>&#148; means (a)&nbsp;any Existing Potential Metagenomi
In-License Agreement that becomes a Metagenomi In-License Agreement pursuant to <U>Section&nbsp;9.7.1</U> (Effective Date Licensed Technology; Existing Metagenomi In-License Agreements) and (b)&nbsp;any New Metagenomi In-License Agreement.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.171.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Indemnitees</B>&#148; has the meaning set forth in <U>Section&nbsp;13.1</U>
(Indemnification of Metagenomi by Ionis). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.172.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi&#146;s Knowledge</B>&#148; means the knowledge, after reasonable investigation
(including consultation with Metagenomi&#146;s outside intellectual property counsel), of the following: the [***] or, in each case, their functional equivalent. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.173.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Platform</B>&#148; means Metagenomi&#146;s proprietary Gene Editing proteins and
Guide RNAs specifically claimed in a Valid Claim of a Patent Right Controlled by Metagenomi. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.174.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Platform Know-How</B>&#148; means any Know-How within Metagenomi Platform as of the
Effective Date or during the Term. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.175.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Platform Patent Rights</B>&#148; means any Patent Rights Controlled by Metagenomi or
its Affiliates as of the Effective Date or during the Term that Cover any Metagenomi Platform Know-How. The Metagenomi Platform Patent Rights Controlled by Metagenomi or any of its Affiliates as of the Effective Date are listed in <U>Schedule
1.175</U> (Metagenomi Platform Patent Rights); <I>provided</I> that any Patent Right that otherwise meets this definition will be deemed a Metagenomi Platform Patent Right even if such Patent Right is not included on <U>Schedule 1.175</U>
(Metagenomi Platform Patent Rights). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.176.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Platform Technology</B>&#148; means the Metagenomi Platform Patent Rights and the
Metagenomi Platform Know-How. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.177.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Product</B>&#148; means any therapeutic product, medical therapy, preparation or
substance, comprising or employing a Metagenomi System and discovered by Metagenomi, in any form or formulation, and whether alone or together with one or more other therapeutically active ingredients, delivery devices, or other components. All
Metagenomi Products comprising the same Metagenomi System will be considered the same Metagenomi Product under this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.178.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Product Milestone Event</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.10.1</U> (Metagenomi Product Milestone Payments). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.179.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Product Milestone Payment</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.10.1</U> (Metagenomi Product Milestone Payments). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.180.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi-Prosecuted Patent Rights</B>&#148; has the meaning set forth in
<U>Section&nbsp;10.2.2</U> (Metagenomi-Prosecuted Patent Rights). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.181.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Records</B>&#148; has the meaning set forth in <U>Section&nbsp;9.13.1</U> (Books and
Records). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.182.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Royalties</B>&#148; has the meaning set forth in <U>Section&nbsp;9.10.3(a)</U>
(Metagenomi Royalty Rates) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.183.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Royalty Rate</B>&#148; has the meaning set forth in <U>Section&nbsp;9.10.3(a)</U>
(Metagenomi Royalty Rates) </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.184.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Royalty Report</B>&#148; has the meaning set forth in <U>Section&nbsp;9.10.4</U>
(Metagenomi Royalty Reports). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.185.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Royalty Term</B>&#148; means, on a Metagenomi Product-by-Metagenomi Product and
country-by-country basis, the period during the Term ending on the latest of (a)&nbsp;[***] following the First Commercial Sale (applied <I>mutatis mutandis</I>) of a Metagenomi Product in a country, (b)&nbsp;the expiration of the last Valid Claim
of a Patent Right within the Ionis Background Technology Covering such Metagenomi Product in such country, or (c)&nbsp;the expiration of any applicable Regulatory Exclusivity obtained for such Metagenomi Product in such country.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.186.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Supply Term</B>&#148; has the meaning set forth in <U>Section&nbsp;8.1.1</U>
(Metagenomi Supply Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.187.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi System</B>&#148; means a Gene Editing protein and a Guide RNA that is designed to
modulate a Metagenomi Target. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.188.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Metagenomi Target</B>&#148; means each target for which Metagenomi exercises an Ionis IP Option
pursuant to <U>Section&nbsp;2.7</U> (Ionis Proprietary Toolbox of Chemical Modifications). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.189.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>MG Manufactured Components</B>&#148; has the meaning set forth in <U>Section&nbsp;8.1.1</U>
(Metagenomi Supply Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.190.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Net Sales</B>&#148; means the gross invoiced amount for (a)&nbsp;Ionis Products sold by Ionis,
its Affiliates, or Sublicensees or (b)&nbsp;Metagenomi Products sold by Metagenomi, its Affiliates or Sublicensees, in each case ((a) and (b)&nbsp;(the &#147;<B>Selling Party</B>&#148;)), to the extent recognized in the ordinary course of business
as revenue by the Selling Party on an accrual basis in accordance with United States Generally Accepted Accounting Principles or, in the case of non-United States sales, other applicable accounting standards after deduction of the following amounts:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">normal and customary trade, quantity or prompt settlement discounts (including initial launch stocking
discounts, chargebacks, and allowances) actually allowed, <I>provided</I> that such discounts are not applied disproportionately to such Licensed Product or Metagenomi Product when compared to the other products of the Selling Party;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">amounts repaid or credited by reason of rejection, returns or recalls of goods, rebates or <I>bona fide</I>
price reductions determined by the Selling Party in good faith; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">rebates and similar payments made with respect to sales paid for by any Governmental Authority such as, by way
of illustration and not in limitation of the Parties&#146; rights hereunder, Federal or state Medicaid, Medicare or similar state program in the United States or equivalent governmental program in any other country; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">refunds or clawbacks of a portion of payments previously paid by the Selling Party for not achieving a
predetermined metric or term in an outcome-based contracts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any invoiced amounts that are not collected by the Selling Party, including bad debts, (applied to Net Sales in
the period in which such receivables are written off), provided that any such amounts subsequently collected will be included in Net Sales for the period collected; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">excise taxes, value added taxes, sales taxes, consumption taxes and other similar taxes (excluding any income,
franchise, or withholding taxes), customs duties, customs levies and import fees imposed on the sale, importation, use or distribution of the Licensed Product, including fees paid pursuant to Section&nbsp;9008 of the Patient Protection and
Affordable Care Act that the Selling Party allocate to sales of the Licensed Product or Metagenomi Product (as applicable) in accordance with such Selling Party&#146;s standard policies and procedures consistently applied across its products, as
applicable; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="15%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an allowance for transportation costs, distribution expenses, special packaging, insurance charges, and storage
and warehousing costs. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:11%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net Sales (including any deductions) will be calculated using the Selling
Party&#146;s internal audited systems used to report such sales as adjusted for any of the items above not taken into account in such systems, fairly applied and as employed on a consistent basis throughout such Selling Party&#146;s operations. To
the extent any accrued amounts used in the calculation of Net Sales are estimates, such estimates will be trued-up to actuals (including that, for any estimates of deductions that are later decreased, the difference will be added back to Net Sales).
In no event will any particular amount identified above be deducted more than once in calculating Net Sales (<I>i.e</I>., no &#147;double counting&#148; of deductions). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:11%; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of any sale or other disposal of a product between or among such Party or its Affiliates or Sublicensees for
resale, Net Sales will be calculated only on the value charged or invoiced on the first arm&#146;s-length sale thereafter to a Third Party (other than a Sublicensee). In the case of any sale that is not invoiced or is delivered before invoice, Net
Sales will be calculated at the time all the revenue recognition criteria under such Party&#146;s Accounting Standards are met. In the case of any sale or other disposal for value, such as barter or counter-trade, of any Licensed Product or
Metagenomi Product (as applicable), or part thereof, other than in an arm&#146;s-length transaction exclusively for money, Net Sales will be calculated on the value of the non-cash consideration received or the fair market price (if higher) of such
Licensed Product(s) or Metagenomi Product(s) (as applicable) in the country of sale or disposal. Notwithstanding the foregoing, the following will not be included in Net Sales: (1)&nbsp;sales between or among a Party and its Affiliates or
Sublicensees (but Net Sales will include sales to the first Third Party (other than a Sublicensee) by a Party or its Affiliates or Sublicensees); and (2)&nbsp;any named patient sales or any sale or other distribution at cost or less than cost for
use in any Clinical Trial, for <I>bona fide </I>charitable purposes, test marketing program, or for compassionate use. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:11%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Solely for purposes of calculating Net Sales, if the Selling Party sells a Licensed Product or Metagenomi Product (as
applicable) in the form of a combination product containing a Licensed System or Metagenomi System (as applicable) and one or more other therapeutically or prophylactically active ingredients or delivery devices that is not a Licensed System or
Metagenomi System (as applicable) (&#147;<B>Other Product</B>&#148;) (whether combined in a single formulation or package, as applicable, or formulated separately but packaged under a single label approved by a Regulatory Authority and sold together
for a single price) (such combination product, a &#147;<B>Combination Product</B>&#148;), Net Sales of such Combination Product for the purpose of determining the payments due to the other Party pursuant to this Agreement will be calculated by
[***]. If the gross selling price of a Licensed Product or Metagenomi Product (as applicable) containing such Licensed System or Metagenomi System (as applicable) in such country when sold separately in finished form (<I>i.e.</I>, without the other
active ingredients or delivery device) can be determined but the gross selling price of the Other Product in such country cannot be determined, then Net Sales in such country for purposes of determining royalty payments will be calculated by [***].
If such separate sales are not made in a country, then Net Sales will be calculated by [***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a license agreement or collaboration agreement that is negotiated in an
arm&#146;s length transaction with an Sublicensee includes a definition of &#147;Net Sales&#148; that differs in any material respect from the definition contained in this <U>Section&nbsp;1.190</U> (Net Sales), then the Parties will discuss such
material differences and will use reasonable efforts to negotiate in good faith any reasonable modifications to this <U>Section&nbsp;1.190</U> (Net Sales) that are necessary to avoid any ambiguity in the calculation of the royalty payment due to a
Party under this Agreement for sales of Licensed Products or Metagenomi Products by such Sublicensee. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.191.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;[***]&#148; means [***]. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.192.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>New In-License Agreement</B>&#148; has the meaning set forth in <U>Section&nbsp;9.8.2</U>
(Acceptance of a Proposed New In-License Agreement). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.193.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>New Ionis In-License Agreement</B>&#148; has the meaning set forth in <U>Section&nbsp;9.8.2
</U>(Acceptance of a Proposed New In-License Agreement). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.194.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>New Metagenomi In-License Agreement</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.8.2</U> (Acceptance of a Proposed New In-License Agreement). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.195.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Non-Withholding Party</B>&#148; has the meaning set forth in <U>Section&nbsp;9.17</U>
(Withholding Taxes). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.196.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Opt-Down Right</B>&#148; has the meaning set forth in <U>Section&nbsp;5.2</U> (Development and
Commercialization of the Co-Co Products; Opt-Down Right). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.197.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Opt-Out Date</B>&#148; has the meaning set forth in <U>Section&nbsp;5.4</U> (Metagenomi
Opt-Out). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.198.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Opt-Out Period</B>&#148; has the meaning set forth in <U>Section&nbsp;5.4</U> (Metagenomi
Opt-Out). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.199.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Opt-Out Right</B>&#148; has the meaning set forth in <U>Section&nbsp;5.4</U> (Metagenomi
Opt-Out). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.200.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Option Exercise Fee</B>&#148; has the meaning set forth in <U>Section&nbsp;9.3</U> (Option
Exercise Fee). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.201.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Option Exercise Notice</B>&#148; has the meaning set forth in <U>Section&nbsp;2.7.2</U> (Option
Exercise). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.202.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Option Package</B>&#148; has the meaning set forth in <U>Section&nbsp;5.1.2</U> (Option
Period). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.203.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Option Term</B>&#148; has the meaning set forth in <U>Section&nbsp;2.7.2</U> (Option Exercise).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.204.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Other Product</B>&#148; has the meaning set forth in <U>Section&nbsp;1.190</U> (Net Sales).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.205.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Out-of-Pocket Costs</B>&#148; means, with respect to certain activities hereunder, direct
expenses actually paid or payable by a Party or its Affiliates to Third Parties and specifically identifiable and incurred to conduct such activities, but excluding any costs that are included in the FTE Rate. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.206.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Party</B>&#148; has the meaning set forth in the Preamble. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.207.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Party Vote</B>&#148; has the meaning set forth in <U>Section&nbsp;4.6.1</U> (Committee
Decisions). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.208.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Patent Rights</B>&#148; means all rights, title, and interests in and to (a)&nbsp;all national,
regional, and international patents and patent applications filed in any country of the world including provisional patent applications and all supplementary protection certificates, (b)&nbsp;all patent applications filed either from such patents,
patent applications, or provisional applications or from an application claiming priority to any of the foregoing, including any continuation, continuation-in part, divisional, provisional, converted provisionals and continued prosecution
applications, or any substitute applications, (c)&nbsp;any patent issued with respect to or in the future issued from any such patent applications, including utility models, petty patents, design patents and certificates of invention, and
(d)&nbsp;any and all extensions or restorations by existing or future extension or restoration mechanisms, including revalidations, reissues, reexaminations and extensions (including any supplementary protection certificates and the like) of the
foregoing patents or patent applications. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.209.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Payments</B>&#148; has the meaning set forth in <U>Section&nbsp;9.17</U> (Withholding Taxes).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.210.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Person</B>&#148; means an individual, sole proprietorship, partnership, limited partnership,
limited liability partnership, corporation, limited liability company, business trust, joint stock company, trust, incorporated association, joint venture or similar entity or organization, including any Governmental Authority (or any department,
agency, or political subdivision thereof). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.211.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Phase III Clinical Trial</B>&#148; means a Clinical Trial that the FDA permits to be conducted
under an open IND and that is performed to gain evidence with statistical significance of the efficacy of such product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall
benefit-risk relationship of such product, to form the basis for approval of an MAA by a Regulatory Authority and to provide an adequate basis for physician labeling, in a manner that meets the requirements of 21 C.F.R. &#167; 312.21(c), as amended
(or its successor regulation), or, with respect to any other country or region, the equivalent of such a Clinical Trial in such other country or region. Notwithstanding anything to the contrary set forth in this Agreement, treatment of patients as
part of an expanded access program, compassionate sales or use program (including named patient program or single patient program), or an indigent program, in each case, will not be included in determining whether or not a Clinical Trial is a Phase
III Clinical Trial or whether a patient has been dosed thereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.212.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Pivotal Clinical Trial</B>&#148; means any (a)&nbsp;Phase III Clinical Trial, or (b)&nbsp;other
Clinical Trial of a product on a sufficient number of patients, the results of which, together with prior data and information concerning such product, are intended to be or otherwise are sufficient, without any additional Clinical Trial, to meet
the evidentiary standard for demonstrating the safety, purity, efficacy, and potency of such active substance of such product established by a Regulatory Authority in any particular jurisdiction, as evidenced by finalized meeting minutes or another
written statement from such Regulatory Authority, and that is intended to support, or otherwise supports, the filing of an MAA by a Regulatory Authority in such jurisdiction (including any bridging study). Notwithstanding any provision to the
contrary set forth in this Agreement, treatment of patients as part of an expanded access program, compassionate sales or use program (including named patient program or single patient program), or an indigent program, in each case, will not be
included in determining whether or not a Clinical Trial is a Pivotal Clinical Trial or whether a patient has been dosed thereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.213.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Pre-Existing Ionis Restriction</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.7.3(a)</U> (Encumbered Targets). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.214.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Pre-Existing Restriction</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.4(a)</U>
(Encumbered Targets). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.215.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Pricing Approval</B>&#148; means, in any country where a Governmental Authority authorizes
reimbursement for, or approves or determines pricing for, pharmaceutical products, receipt (or, if required to make such authorization, approval or determination effective, publication) of such reimbursement authorization or pricing approval or
determination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.216.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Proceeding</B>&#148; means any action, suit, litigation, arbitration, proceeding (including any
civil, criminal, administrative, investigative or appellate proceeding), prosecution, contest, hearing, inquiry, inquest, audit, examination or investigation that is, has been or may in the future be commenced, brought, conducted or heard at law or
in equity or before any Governmental Authority. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.217.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Product-Specific Know-How</B>&#148; means any Licensed Know-How that specifically relates to
(a)&nbsp;a Licensed System or Licensed Product, (b)&nbsp;any method of making a Licensed System or Licensed Product, or (c)&nbsp;the use of a Licensed System or Licensed Product and no other products that are not Licensed Systems or Licensed
Products. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.218.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Product-Specific Patent Right</B>&#148; means any Licensed Patent Right that specifically
claims (a)&nbsp;a Licensed System or Licensed Product, (b)&nbsp;any method of making a Licensed System or Licensed Product, or (c)&nbsp;the use of a Licensed System or Licensed Product and no other products that are not Licensed Systems or Licensed
Products. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.219.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Proposed Metagenomi Target</B>&#148; has the meaning set forth in <U>Section&nbsp;2.7.2</U>
(Option Exercise). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.220.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>&#147;</B><B>Proposed Metagenomi Target Notice</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.7.2</U> (Option Exercise). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.221.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;[***]&#148; has the meaning set forth in <U>Section&nbsp;2.2.4(c)</U> (Incremental Development
Costs). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.222.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Proposed New In-License Agreement</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.8.1</U> (Proposed New In-License Agreements). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.223.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>&#147;</B><B>Proposed New Ionis In-License Agreement</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.8.1</U> (Proposed New In-License Agreements). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.224.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>&#147;</B><B>Proposed New Metagenomi In-License Agreement</B>&#148; has the meaning set forth in
<U>Section&nbsp;9.8.1 </U>(Proposed New In-License Agreements). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.225.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Proposed Replacement Target</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.3(d)</U>
(Substitution Procedure). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.226.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Proposed Target</B>&#148; means any (a)&nbsp;Additional Wave 1 Target, (b)&nbsp;Wave 2 Target,
or (c)&nbsp;Proposed Replacement Target. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.227.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Prosecuting Party</B>&#148; means, with respect to any Patent Right, the Party that is
responsible for the Prosecution and Maintenance of such Patent Right pursuant to <U>Section&nbsp;10.2.1</U> (Ionis- Prosecuting Patent Rights) or <U>Section&nbsp;10.2.2</U> (Metagenomi-Prosecuted Patent Rights), as applicable. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.228.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Prosecution and Maintenance</B>&#148; or &#147;<B>Prosecute and Maintain</B>&#148; means, with
regard to a Patent Right, the preparing, filing, prosecuting, and maintenance of such Patent Right, as well as handling re-examinations and reissues with respect to such Patent Right, together with the conduct of interferences, derivation
proceedings, the defense of oppositions, post-grant patent proceedings (such as <I>inter partes</I> review and post grant review), and other similar proceedings with respect to the particular Patent Right. For clarity, &#147;<B>Prosecution and
Maintenance</B>&#148; or &#147;<B>Prosecute and Maintain</B>&#148; will not include any other enforcement actions taken with respect to a Patent Right. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.229.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>&#147;</B><B>Quarterly Reimbursement Payments</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.5.1</U> (Reimbursement by Ionis). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.230.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Receiving Party</B>&#148; has the meaning set forth in <U>Section&nbsp;11.1.1</U> (General).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.231.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Regulatory Approval</B>&#148; means, with respect to a particular country or other regulatory
jurisdiction in the Territory, any approval of an MAA or other approval, product, or establishment license, registration, or authorization of the applicable Regulatory Authority necessary for the commercial marketing or sale of a pharmaceutical or
biologic product in such country or other regulatory jurisdiction, including, where applicable, Pricing Approval. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.232.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Regulatory Authority</B>&#148; means, with respect to a country in the Territory, any national
(e.g., the FDA), supra-national (e.g., the European Commission, the Council of the European Union, or the EMA), regional, state or local regulatory agency, department, bureau, commission, council or other Governmental Authority involved in the
granting of Regulatory Approvals or Pricing Approvals for pharmaceutical products in such country or countries. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.233.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Regulatory Exclusivity</B>&#148; means, with respect to a Licensed Product or Metagenomi
Product (as applicable) in a country, any data exclusivity rights or other exclusive right, other than a Patent Right, granted, conferred, or afforded by any Regulatory Authority in such country or otherwise under Applicable Law with respect to such
Licensed Product or Metagenomi Product (as applicable) in such country, which either confers exclusive marketing rights with respect to a product or prevents another party from using or otherwise relying on the data supporting the approval of the
Regulatory Approval for a product without the prior written authorization of the Regulatory Approval holder, as applicable, such as new chemical entity exclusivity, exclusivity associated with new Clinical Trials necessary to approval of a change
(e.g., new indication or use), orphan drug exclusivity, non-patent-related pediatric exclusivity, or any other applicable marketing or data exclusivity, including any such periods under national implementations in the EU of Article 10 of Directive
2001/83/EC, Article 14(11) of Parliament and Council Regulation (EC) No 726/2004, Parliament and Council Regulation (EC) No 141/2000 on orphan medicines, Parliament and Council Regulation (EC) No 1901/2006 on medicinal products for pediatric use and
all international equivalents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.234.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Regulatory Strategy</B>&#148; has the meaning set forth in <U>Section&nbsp;7.1</U> (Regulatory
Responsibility). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.235.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Regulatory Submissions</B>&#148; means any regulatory application, submission, notification,
communication, correspondence, registration, Regulatory Approval, and other filing, made to, received from or otherwise conducted with a Regulatory Authority related to Developing, Manufacturing, obtaining marketing authorization, or otherwise
Commercializing a product in a particular country or jurisdiction, including all INDs, CTAs, BLAs, MAAs, and all applications for Regulatory Approval together with all supplements or amendments to any of the foregoing. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.236.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Reimbursement Cap</B>&#148; has the meaning has the meaning set forth in <U>Section&nbsp;2.5.1
</U>(Reimbursement by Ionis). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.237.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Replacement Target Notice</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.3(d)</U>
(Substitution Procedure). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.238.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Requested CMO</B>&#148; has the meaning set forth in <U>Section&nbsp;8.1.2</U> (Requested CMO).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.239.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Requested CMO Contract</B>&#148; has the meaning set forth in <U>Section&nbsp;8.1.2</U>
(Requested CMO). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.240.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Residual Knowledge</B>&#148; has the meaning set forth in <U>Section&nbsp;11.3</U> (Residual
Knowledge). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.241</B><B>.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Reversion IP In-License Agreement</B>&#148; has the meaning set forth in <U>Section&nbsp;14.3.6(b)</U>
(Third Party Reversion IP). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.242.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Reversion License</B>&#148; has the meaning set forth in <U>Section&nbsp;14.3.6(a)</U>
(Reversion License Grant). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.243.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Royalty Bearing Patent Rights</B>&#148; means, with respect to any Licensed Product, all
Licensed Patent Rights that Cover such Licensed Product and that are listed in the then-current edition of the FDA&#146;s Purple Book in connection with the Regulatory Approval of such Licensed Product, or in equivalent patent listings in any other
country within the Territory. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.244.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Royalty Term</B>&#148; means, on a Licensed Product-by-Licensed Product and country-by-country
basis, the period during the Term ending on the latest of (a)&nbsp;12 years following the First Commercial Sale of a Licensed Product in a country, (b)&nbsp;the expiration of the last Valid Claim of the Royalty Bearing Patent Rights Covering such
Licensed Product in such country, or (c)&nbsp;the expiration of any applicable Regulatory Exclusivity obtained for such Licensed Product in such country. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.245.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Second Wave 1 Target</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.1(b)</U>
(Second Wave 1 Target). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.246.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Selling Party</B>&#148; has the meaning set forth in <U>Section&nbsp;1.190</U> (Net Sales).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.247.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Subcommittee</B>&#148; has the meaning set forth in <U>Section&nbsp;4.2</U> (Subcommittees).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.248.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Subcontractor</B>&#148; means a Third Party contractor engaged by a Party to perform certain
obligations or exercise certain rights of such Party under this Agreement on a fee-for-service basis (including Third Party Distributors, contract research organizations, or contract manufacturing organizations). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.249.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Sublicensee</B>&#148; means a Third Party to whom a Party or any of its Affiliates grants a
sublicense under the licenses granted to such Party under this Agreement, as permitted herein, excluding all Subcontractors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.250.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Supply Price</B>&#148; has the meaning set forth in <U>Section&nbsp;8.1.1</U> (Metagenomi
Supply Term). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.251.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Target Selection and Substitution Period</B>&#148; has the meaning set forth in
<U>Section&nbsp;2.1.4(b) </U>(Expiration of Pre-Existing Restrictions). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.252.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Target Substitution Period</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.3(a)</U>
(Discretionary Substitutions). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.253.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Technological Infeasibility</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.3(b)</U>
(Substitutions for Technological Infeasibility). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.254.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Term</B>&#148; has the meaning set forth in <U>Section&nbsp;14.1</U> (Term).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.255.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Terminated Combination Products</B>&#148; has the meaning set forth in
<U>Section&nbsp;14.3.7</U> (Reversion for Certain Combination Products). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.256.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Terminated Country</B>&#148; means (a)&nbsp;any country in the Territory with respect to which
this Agreement is terminated or expires pursuant to<U> Article 14</U> (Term and Termination), and (b)&nbsp;in the event of termination or expiration of this Agreement in its entirety, all countries in the Territory. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.257.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Terminated Products</B>&#148; means (a)&nbsp;any Licensed Product with respect to which this
Agreement is terminated or expires pursuant to<U> Article 14</U> (Term and Termination), and (b)&nbsp;in the event of termination or expiration of this Agreement in its entirety, all Licensed Products. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.258.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Territory</B>&#148; means all countries of the world and all territories and possessions
thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.259.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Third Party</B>&#148; means any Person other than a Party or an Affiliate of a Party.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.260.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Third Party Claims</B>&#148; has the meaning set forth in <U>Section&nbsp;13.1</U>
(Indemnification of Metagenomi by Ionis). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.261.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Third Party Distributor</B>&#148; means any Third Party that distributes (but does not Develop
or Manufacture) a Licensed Product directly to customers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.262.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Third Party Expert</B>&#148; has the meaning set forth in <U>Section&nbsp;15.1.3(a)</U>.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.263.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Third Party Infringement Claim</B>&#148; has the meaning set forth in <U>Section&nbsp;10.4</U>
(Defense of Claims Brought by Third Parties). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.264.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Third Party IP</B>&#148; has the meaning set forth in <U>Section&nbsp;9.6.2(c)</U> (Third Party
Payments). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.265.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Third Party Payment</B>&#148; has the meaning set forth in <U>Section&nbsp;9.6.2(c)</U> (Third
Party Payments). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.266.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Trademarks</B>&#148; means all registered and unregistered trademarks, service marks, trade
dress, trade names, logos, insignias, symbols, designs, and all other indicia of ownership, and combinations thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.267.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;[***]&#148; has the meaning set forth in <U>Section&nbsp;2.1.1(a)</U> (Initial Wave 1 Target).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.268.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;[***] <B>Target Population</B>&#148; has the meaning set forth in <U>Section&nbsp;9.5</U> (Ionis
Products for [***] Target Populations). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.269</B><B>.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Unblocking Field</B>&#148; means [***]. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.270.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>United States</B>&#148; or &#147;<B>U.S.</B>&#148; means the United States of America and all
of its districts, territories and possessions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.271.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Upfront Payment</B>&#148; has the meaning set forth in <U>Section&nbsp;9.1</U> (Upfront
Payment). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.272.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Valid Claim</B>&#148; means, with respect to a particular country, (a)&nbsp;a claim of any
issued and unexpired patent in such country whose validity, enforceability, or patentability has not been terminated by any of the following: (i)&nbsp;irretrievable lapse, abandonment, revocation, dedication to the public, or disclaimer; or
(ii)&nbsp;a holding, finding, or decision of invalidity, unenforceability, or non-patentability, from which decision no appeal can be further taken, or (b)&nbsp;a claim within a patent application in such country that has not been pending for more
than seven years from the earliest date to which such claim or the applicable patent application is entitled to claim priority and which claim has not been revoked, cancelled, withdrawn, held invalid, or abandoned. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.273.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Warranty Technology</B>&#148; means (a)&nbsp;with respect to any representation or warranty
made as of the Effective Date, (i)&nbsp;the Metagenomi Platform Technology in the Field, and (ii)&nbsp;the Licensed Technology that is necessary or reasonably useful to Exploit Licensed Systems and Licensed Products in the Field that are directed to
[***], and (b)&nbsp;with respect to any representation or warranty made as of the date on which each new target becomes a Collaboration Target pursuant to <U>Section&nbsp;2.1.1(b)</U> (Second Wave 1 Target) or <U>Section&nbsp;2.1.4(c)</U> (Effects
if a Proposed Target is Available), the Licensed Technology that is necessary or reasonably useful to Exploit Licensed Systems and Licensed Products in the Field that are directed to such Collaboration Target. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.274.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Wave 1 Target</B>&#148; means each (a)&nbsp;[***], (b)&nbsp;the Second Wave 1 Target, and
(c)&nbsp;any Additional Wave 1 Target that Ionis designates in accordance with <U>Section&nbsp;2.1.4(c)</U> (Effects if a Proposed Target is Available). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.275.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Wave 2 Target</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.2</U> (Wave 2 Target
Options). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.276.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Wave 2 Target Notice</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.2</U> (Wave 2
Target Options). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.277.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Wave 2 Target Selection Fee</B>&#148; has the meaning set forth in <U>Section&nbsp;9.2</U>
(Wave 2 Target Selection Fee). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.278.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Wave 2 Target Selection Period</B>&#148; has the meaning set forth in <U>Section&nbsp;2.1.2</U>
(Wave 2 Target Options). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>1.279.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Withholding Party</B>&#148; has the meaning set forth in <U>Section&nbsp;9.17</U> (Withholding
Taxes). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 1.114 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 1.146 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Licensed Patent Rights </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">[***]</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 1.166 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 1.175 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Metagenomi Platform Patent Rights </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 2.1.1(a) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>[***] </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 2.2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>[***] </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 2.3.1 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exploratory Research Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attached<I>.</I> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 8.2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Development Supply Agreement Key Terms </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 11.4 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Press Release(s) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attached<I>.</I> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 12.2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Metagenomi Disclosure Schedule </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 12.4 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ionis Disclosure Schedule </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>4
<FILENAME>d425213dex108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.8 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT
TREATS AS PRIVATE OR CONFIDENTIAL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEVELOPMENT, OPTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND LICENSE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BY AND BETWEEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>METAGENOMI, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">AFFINI-T</FONT> THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>June&nbsp;14, 2022 </B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>DEFINITIONS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>GRANT OF LICENSES; EXCLUSIVITY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Grant of Licenses to <FONT STYLE="white-space:nowrap">Affini-T</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exclusivity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Grant of Licenses to Metagenomi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Potential <FONT STYLE="white-space:nowrap">Co-Development</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>GOVERNANCE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Establishment of Joint Steering Committee; Governance Term</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Membership</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Responsibilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Dispute Resolution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Alliance Managers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Project Leaders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RESEARCH ACTIVITIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Research Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of Research Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Record Keeping</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Target Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>DEVELOPMENT ACTIVITIES; REGULATORY ACTIVITIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Responsibility for Development</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Engagement of Third Party Contractors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Development Diligence</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Progress Reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Regulatory Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Know-How</FONT> Sharing; Cooperation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>COMMERCIALIZATION OF PRODUCTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Responsibility for Commercialization of Licensed Products</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Commercialization Diligence</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>MANUFACTURE AND SUPPLY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Metagenomi Reagents Supply</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Agreement Resolution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CONSIDERATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Equity Grant</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Option Exercise Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Milestone Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment of Royalties; Royalty Rates; Accounting and Records</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>TREATMENT OF CONFIDENTIAL INFORMATION; PUBLICITY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Publicity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Permitted Publication</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Use of Proprietary Materials</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>INTELLECTUAL PROPERTY RIGHTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ownership of Agreement IP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>FILING, PROSECUTION AND MAINTENANCE OF PATENT RIGHTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Patent Prosecution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Third Party Infringement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Defense of Claims</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>TERM AND TERMINATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Term</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Consequences of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Surviving Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>REPRESENTATIONS AND WARRANTIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Mutual Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Additional Representations, Warranties and Covenants of Metagenomi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Warranty Disclaimer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Warranty of Success</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>INDEMNIFICATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification of Metagenomi by <FONT STYLE="white-space:nowrap">Affini-T</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification of <FONT STYLE="white-space:nowrap">Affini-T</FONT> by Metagenomi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limited Liability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>MISCELLANEOUS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Binding Effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendment; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Purposes and Scope</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignment and Successors; Change of Control</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Force Majeure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement; Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Performance by Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Table of Schedules: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Schedule 4.1 - Research Plan for [***] </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Schedule
8.1(a) - Initial Restricted Stock Agreement </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Schedule 8.1(b) - Milestone Restricted Stock Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Schedule 9.4 - Form of Materials Transfer Record for Proprietary Materials </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Schedule 13.2.4 - Existing Patents </B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEVELOPMENT, OPTION AND </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LICENSE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
DEVELOPMENT, OPTION AND LICENSE AGREEMENT (this &#147;<B>Agreement</B>&#148;) is entered into as of June&nbsp;14, 2022 (the &#147;<B>Effective Date</B>&#148;) by and between<B> </B>Metagenomi, Inc. (&#147;<B>Metagenomi</B>&#148;), a Delaware
corporation having a place of business at 1545 Park Ave., Emeryville CA 94608, and <FONT STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics, Inc., a Delaware corporation having a place of business at 343 Arsenal St., Watertown, MA 02472
(&#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT></B>&#148;). Each of Metagenomi and <FONT STYLE="white-space:nowrap">Affini-T</FONT> is sometimes referred to individually herein as a &#147;<B>Party</B>&#148; and collectively as the
&#147;<B>Parties</B>&#148;. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Metagenomi is a gene editing company that owns or otherwise controls patent rights and
<FONT STYLE="white-space:nowrap">know-how</FONT> related to gene editing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, <FONT STYLE="white-space:nowrap">Affini-T</FONT> is a
biotech company developing immune cell receptor-based therapies, preventative treatments and diagnostics; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties previously
entered into an amended and restated side letter on May&nbsp;28, 2021 and effective as of December&nbsp;23, 2020 (the &#147;<B>A&amp;R Side Letter</B>&#148;), a Stock Issuance Notice and Restricted Stock Agreement dated December&nbsp;23, 2020
(collectively, the &#147;<B>Existing RSA</B>&#148;) and an MFN waiver letter dated August&nbsp;5, 2021 (the &#147;<B>MFN Waiver</B>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties wish to have Metagenomi identify, develop or optimize certain Metagenomi Reagents using Metagenomi&#146;s proprietary
technology to be used by <FONT STYLE="white-space:nowrap">Affini-T</FONT> to develop and commercialize gene edited <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapeutic products in the Fields in the Territory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the Parties hereto,
intending to be legally bound, hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1. <U>DEFINITIONS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever used in this Agreement with an initial capital letter, the terms defined in this Article 1 shall have the meanings specified herein
and therein.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 &#147;<B>A&amp;R Side Letter</B>&#148; is defined in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 &#147;<B>Affiliate</B>&#148; means, with respect to either Party, any Person that directly or indirectly controls, is controlled by or is
under common control with such Party; for purposes of this definition, the term &#147;control&#148; (including, with correlative meaning, the terms &#147;controlled by&#148; or &#147;under common control with&#148;) means direct or indirect
ownership of more than fifty percent (50%), including ownership by trusts with substantially the same beneficial interests, of the voting and equity rights of such Person, firm, trust, corporation, partnership or other entity or combination thereof,
or the power to direct the management of such Person, firm, trust, corporation, partnership or other entity or combination thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3 &#147;<B>Affini-T</B>&#148; is defined in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4 &#147;<B>Affini</B><B>-T Agreement IP</B>&#148; is defined in Section&nbsp;10.2.1(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5 &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148; is defined
in Section&nbsp;10.2.1(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6 &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement Patent Rights</B>&#148; is defined in
Section&nbsp;10.2.1(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.7 &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Background IP</B>&#148; means <FONT
STYLE="white-space:nowrap">(a)&nbsp;Know-How</FONT> Controlled by <FONT STYLE="white-space:nowrap">Affini-T</FONT> on or prior to the Effective Date, or that <FONT STYLE="white-space:nowrap">Affini-T</FONT> comes to Control outside of this Agreement
during the Term, that is necessary for Metagenomi to perform its obligations under this Agreement, and (b)&nbsp;Patent Rights Controlled by <FONT STYLE="white-space:nowrap">Affini-T</FONT> on or prior to the Effective Date, or that <FONT
STYLE="white-space:nowrap">Affini-T</FONT> comes to Control outside of this Agreement during the Term, that Cover the <FONT STYLE="white-space:nowrap">Know-How</FONT> described in the foregoing clause (a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.8 &#147;<B>Affini-T Clinical Target</B>&#148; means, as of the Effective Date, each of [***] and, in each case, including any modification,
translation, variation or mutation thereof; provided, that <FONT STYLE="white-space:nowrap">(i)&nbsp;Affini-T</FONT> may replace up to [***] pursuant to Section&nbsp;2.1.2(e); (ii) at any given time, the total number of <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Targets may not exceed six (6); and (iii)&nbsp;each specifically identified target (i.e., the foregoing (a)&nbsp;through (f) and any replacement target added pursuant to Section&nbsp;2.1.2(e)) will
include genetic variants thereof [***] are deemed one <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target). For the purposes of this definition: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>[***]</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of
the foregoing targets shall cease to be an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in the case of termination with respect to such target pursuant to Sections&nbsp;2.1.2(a) or 12.2 or in the case of replacement of such
target pursuant to Section&nbsp;2.1.2(e). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.9 &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnitees</B>&#148; is defined
in Section&nbsp;14.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.10 &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnity Claims</B>&#148; is defined in
Section&nbsp;14.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.11 &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> IP</B>&#148; means
<FONT STYLE="white-space:nowrap">Affini-T</FONT> Background IP and <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.12
&#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Patent Rights</B>&#148; means all <FONT STYLE="white-space:nowrap">(a)&nbsp;Affini-T</FONT> Agreement Patent Rights and (b)&nbsp;Patents Rights that are included within <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Background IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.13 &#147;<B>Agreement</B>&#148; is defined in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.14 &#147;<B>Agreement Dispute</B>&#148; is defined in Section&nbsp;15.1.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.15 &#147;<B>Agreement IP</B>&#148; means, as applicable, <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement IP or Metagenomi
Agreement IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.16 &#147;<B>Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148; means all
<FONT STYLE="white-space:nowrap">Know-How</FONT> identified, conceived, discovered, created, reduced to practice or otherwise Developed in the course of conducting activities under this Agreement (e.g., Metagenomi Research Activities). Agreement <FONT
STYLE="white-space:nowrap">Know-How</FONT> is either <FONT STYLE="white-space:nowrap">&#147;Affini-T</FONT> Agreement <FONT STYLE="white-space:nowrap">Know-How&#148;</FONT> or &#147;Metagenomi Agreement
<FONT STYLE="white-space:nowrap">Know-How&#148;.</FONT> </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.17 &#147;<B>Agreement Patent Rights</B>&#148; means Patent Rights that Cover Agreement <FONT
STYLE="white-space:nowrap">Know-How.</FONT> Agreement Patents Rights are either <FONT STYLE="white-space:nowrap">&#147;Affini-T</FONT> Agreement Patent Rights&#148; or &#147;Metagenomi Agreement Patent Rights&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.18 &#147;<B>Alliance Manager</B>&#148; is defined in Section&nbsp;3.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.19 &#147;<B>Annual Net Sales</B>&#148; means the cumulative worldwide Net Sales of an applicable Licensed Product in a given Calendar Year.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.20 &#147;<B>Applicable Laws</B>&#148; means any national, international, federal, state or local laws, treaties, statutes, ordinances,
rules and regulations, including any rules, regulations, guidance, guidelines or requirements of any Regulatory Authority, national securities exchange or securities listing organization, that are in effect from time to time during the Term and
apply to a particular activity or Party hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.21 &#147;<B>Available</B>&#148; is defined in Section&nbsp;2.1.2(e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.22 &#147;<B>Bankruptcy Code</B>&#148; means the U.S.&nbsp;Bankruptcy Code, as amended from time to time, and the rules and regulations and
guidelines promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.23 &#147;<B>BLA</B>&#148; means a Biologics License Application, as defined in the FDCA and
regulations promulgated thereunder, or any successor application or procedure required to sell a Licensed Product in the United States.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.24 &#147;<B>Business</B><B> Day</B>&#148; means any day other than: (a)&nbsp;a Saturday, Sunday, or day on which commercial banks in
(i)&nbsp;Boston, Massachusetts or (ii)&nbsp;San Francisco, California are authorized or required by Applicable Law to remain closed; or (b)&nbsp;December&nbsp;25 through January 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.25 &#147;<B>Calendar Quarter</B>&#148; means the period beginning on the Effective Date and ending on the last day of the calendar quarter
in which the Effective Date falls, and thereafter each successive period of three (3)&nbsp;consecutive calendar months ending on March&nbsp;31, June&nbsp;30, September&nbsp;30 and December 31; provided, that, the final Calendar Quarter shall end on
the last day of the Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.26 &#147;<B>Calendar Year</B>&#148; means the period beginning on the Effective Date and ending on
December&nbsp;31 of the calendar year in which the Effective Date falls, and thereafter each successive period of twelve (12)&nbsp;months commencing on January&nbsp;1 and ending on December 31; provided, that, the final Calendar Year shall end on
the last day of the Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.27 &#147;<B>Change of Control</B>&#148; means, with respect to a Party, (a)&nbsp;a merger or consolidation of
such Party with a Third Party that results in the voting securities of such Party outstanding immediately prior thereto, or any securities into which such voting securities have been converted or exchanged, ceasing to represent at least fifty
percent (50%) of the combined voting power of the surviving entity or the parent of the surviving entity immediately after such merger or consolidation, (b)&nbsp;a transaction or series of related transactions in which a Third Party, together
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with its Affiliates, becomes the beneficial owner of fifty percent (50%) or more of the combined voting power of the outstanding securities of such Party, or (c)&nbsp;the sale or other transfer
to a Third Party of all or substantially all of such Party&#146;s assets or all or substantially all of such Party&#146;s assets to which this Agreement relates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.28 &#147;<B>Claim</B>&#148; means a Metagenomi Indemnity Claim or an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnity Claim, as
applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.29 &#147;<B>Clinical</B><B> Trial</B>&#148; means human clinical trials, including Pivotal Trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.30 &#147;<B>CoC Affiliate</B>&#148; is defined in Section&nbsp;2.2.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.31 &#147;<B>Combination Product</B>&#148; means any Licensed Product sold in combination with or includes one or more Other Components. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.32 &#147;<B>Commercial License</B>&#148; means, on an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis, individually or collectively, an Exclusive License and/or a
<FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License with respect to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, as applicable (based on whether an Option for an Exclusive License and/or a <FONT
STYLE="white-space:nowrap">Non-Exclusive</FONT> License is being elected by <FONT STYLE="white-space:nowrap">Affini-T).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.33
&#147;<B>Commercialization</B>&#148; or &#147;<B>Commercialize</B>&#148; means any and all activities directed to the offering for sale and sale of a Licensed Product including activities directed to marketing, promoting, detailing, distributing,
importing, selling and offering to sell that Licensed Product, and seeking pricing approvals and reimbursement approvals (in each case, as and to the extent applicable) for that Licensed Product in the Territory, and interacting with Regulatory
Authorities regarding the foregoing. When used as a verb, &#147;to<B> Commercialize</B>&#148; and &#147;<B>Commercializing</B>&#148; means to engage in Commercialization, &#147;<B>Commercialized</B>&#148; has a corresponding meaning, and
&#147;<B>Commercial</B>&#148; means activities in connection with any of the foregoing.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.34 &#147;<B>Commercially Reasonable
Efforts</B>&#148; means the [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.35 &#147;<B>Commercial Quality Agreement</B>&#148; is defined in Section&nbsp;7.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.36 &#147;<B>Commercial Supply Agreement</B>&#148; is defined in Section&nbsp;7.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.37 &#147;<B>Competing Activities</B>&#148; is defined in Section&nbsp;1.69. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.38 &#147;<B>Competing</B><B> Business</B>&#148; is defined in Section&nbsp;4.2.1(e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.39 &#147;<B>Competing Acquiror</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.40 &#147;<B>Compulsory License</B>&#148; means, with respect to a Licensed Product, in a country or territory, a license or rights granted
to a Third Party by a Governmental Authority within such country or territory to sell or offer for sale such Licensed Product in such country or territory under any Patents Controlled by Metagenomi, <FONT STYLE="white-space:nowrap">Affini-T</FONT>
or their respective Affiliates, without direct or indirect authorization from Metagenomi, <FONT STYLE="white-space:nowrap">Affini-T</FONT> or their respective Affiliates, for example a right granted pursuant to requests under 30&nbsp;August 2003 WTO
decision. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.41 &#147;<B>Confidential Information</B>&#148; means (a)&nbsp;with respect to Metagenomi,
all information Controlled by Metagenomi and Metagenomi&#146;s Proprietary Materials; and (b)&nbsp;with respect to <FONT STYLE="white-space:nowrap">Affini-T,</FONT> all information Controlled by <FONT STYLE="white-space:nowrap">Affini-T</FONT> and <FONT
STYLE="white-space:nowrap">Affini-T&#146;s</FONT> Proprietary Materials, that are, in either case, disclosed or provided by or on behalf of a Party (the &#147;<B>Disclosing Party</B>&#148;) to the other Party (the &#147;<B>Receiving Party</B>&#148;)
or to any of the employees, directors or agents of, or consultants/service providers to, the Receiving Party; provided, that, none of the foregoing shall be deemed Confidential Information if the Receiving Party demonstrates by contemporaneous
credible written documentation that: (1)&nbsp;as of the date of disclosure, it is known to the Receiving Party or its Affiliates, other than by virtue of a prior confidential disclosure to such Receiving Party; (2)&nbsp;as of the date of disclosure
it is in the public domain, or it subsequently enters the public domain through no fault of the Receiving Party; (3)&nbsp;it is obtained by the Receiving Party from a Third Party having a lawful right to make such disclosure free from any obligation
of confidentiality to the Disclosing Party of which the Receiving Party should be reasonably aware; or (4)&nbsp;it is independently developed by or for the Receiving Party without reference to or use of any Confidential Information of the Disclosing
Party. For clarity, any combination of Confidential Information shall not be considered in the public domain or in the possession of the Receiving Party merely because individual elements of such Confidential Information are in the public domain or
in the possession of the Receiving Party unless the combination and its principles are in the public domain or in the possession of the Receiving Party. Notwithstanding anything herein to the contrary, (i)&nbsp;the terms of this Agreement shall
constitute Confidential Information of each Party, and (ii)&nbsp;Confidential Information Controlled by Metagenomi or any of its Affiliates exclusively relating to a Licensed Product or the exploitation thereof, and is not generally related to
Metagenomi&#146;s platform or have applicability beyond a Licensed Product (&#147;<B>Product Information</B>&#148;) shall be deemed to be Confidential Information of <FONT STYLE="white-space:nowrap">Affini-T</FONT> (and <FONT
STYLE="white-space:nowrap">Affini-T</FONT> the Disclosing Party, and Metagenomi the Receiving Party, with respect thereto and regardless of the Party initially disclosing the same). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.42 &#147;<B>Content</B>&#148; is defined in Section&nbsp;9.2.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.43 &#147;<B>Control</B>&#148; or &#147;<B>Controlled</B>&#148; means with respect to any Proprietary Materials, <FONT
STYLE="white-space:nowrap">Know-How,</FONT> Patent Rights, or other intellectual property rights, that a Party or any of its Affiliates has the legal authority or right (whether by ownership or license) to grant to the other Party a license,
covenant not to sue, sublicense, access, or right to use (as applicable) under, in and to such Proprietary Materials, <FONT STYLE="white-space:nowrap">Know-How,</FONT> Patent Rights, or other intellectual property rights, on the terms and conditions
set forth herein, in each case without violating any obligations of the granting Party owed to a Third Party, breaching the terms of any agreement with a Third Party or subjecting the granting Party to any fee or charge. Notwithstanding the
foregoing, any New Affiliate of a Party shall not be considered an Affiliate of such Party for the purposes of this definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.44
&#147;<B>Cover</B>&#148; or &#147;<B>Covered</B>&#148; or &#147;<B>Covering</B>&#148; means, with respect to a Licensed Product or component thereof, that the Manufacture, use, offer for sale, sale, import or export of such Licensed Product or
component thereof in a particular country by an unlicensed Person would infringe a Valid Claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.45 &#147;<B>Data</B><B>
Package</B>&#148; is defined in Section&nbsp;4.1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.46 &#147;<B>Development</B>&#148; or &#147;<B>Develop</B>&#148; means, with respect to a
Licensed Product, all <FONT STYLE="white-space:nowrap">non-clinical</FONT> and clinical drug development activities that are not Metagenomi Research Activities through and including the performance of Clinical Trials with respect to that Licensed
Product, and the preparation and filing of Regulatory Filings and all regulatory affairs related to the foregoing. When used as a verb, &#147;<B>Developing</B>&#148; means to engage in Development and &#147;<B>Developed</B>&#148; has a corresponding
meaning. For clarity, &#147;<B>Development</B>&#148; shall not include any Commercialization activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.47 &#147;<B>Development
Quality Agreement</B>&#148; is defined in Section&nbsp;7.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.48 <B>&#147;Development Supply Agreement</B>&#148; is defined in
Section&nbsp;7.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.49 &#147;<B>Disclosing Party</B>&#148; is defined in Section&nbsp;1.41. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.50 &#147;<B>Disputed Matter</B>&#148; is defined in Section&nbsp;3.5.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.51 &#147;<B>DMF</B>&#148;<B> </B>means a Drug Master File maintained with a Regulatory Authority in any country within the Territory.<B>
</B>For the purposes of this Agreement, there are two <FONT STYLE="white-space:nowrap">sub-types</FONT> of DMF: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Affini-T-Relevant</FONT></FONT> DMF</B>&#148; is defined in Section&nbsp;5.5.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>MG DMF</B>&#148; means a DMF that is both Controlled by Metagenomi and covers a Metagenomi Reagent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.52 &#147;<B>Drug Approval Application</B>&#148; means, with respect to a Licensed Product in any country in the Territory, an application
for Marketing Authorization for such Licensed Product in such country, including a BLA or a counterpart of a BLA (or the equivalent filing(s) outside of the United States) in any country in the Territory and all renewals, supplements and amendments
to any of the foregoing.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.53 &#147;<B>Effective Date</B>&#148; is defined in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.54 &#147;<B>EMA</B>&#148; means the European Medicines Agency or any successor agency or authority thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.55 &#147;<B>Escrow Agent</B>&#148;<B> </B>is defined in Section&nbsp;2.1.2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.56 &#147;<B>Escrow Materials</B>&#148; is defined in Section&nbsp;2.1.2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.57 &#147;<B>European Union</B>&#148; or &#147;<B>EU</B>&#148; means the countries of the European Union as constituted from time to time,
and any successor thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.58 &#147;<B>Exclusive Field</B>&#148; means the treatment, prevention or diagnosis of any human cancer using
products with any engineered Primary TCR alpha/beta T Cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.59 &#147;<B>Exclusive License</B>&#148; is defined in
Section&nbsp;2.1.2(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.60 &#147;<B>Exclusive Option</B>&#148; is defined in Section&nbsp;2.1.2. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.61 &#147;<B>Exclusively Licensed Product</B>&#148; means a
<FONT STYLE="white-space:nowrap">TCR-based</FONT> therapy, preventative treatment, or diagnostic for humans that (a)&nbsp;contains or comprises Primary TCR alpha/beta T Cells, (b)&nbsp;is directed to an
<FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target with respect to which an Exclusive Option has been exercised, and (c)&nbsp;is derived from <I>ex vivo</I> application of a Metagenomi Reagent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.62 &#147;<B>Executive Officers</B>&#148; means the [***], or a designee thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.63 &#147;<B>Existing RSA</B>&#148; is defined in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.64 &#147;<B>Extended Term</B>&#148; is defined in Section&nbsp;12.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.65 &#147;<B>FCPA</B>&#148; is defined in Section&nbsp;4.3.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.66 &#147;<B>FDA</B>&#148; means the United States Food and Drug Administration, or any successor agency or authority thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.67 &#147;<B>FDCA</B>&#148; means the United States Federal Food, Drug, and Cosmetic Act, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.68 &#147;<B>Field</B>&#148; means collectively or individually, as applicable, the Exclusive Field and the
<FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Field. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.69 &#147;<B>Firewalls</B>&#148; means (a)&nbsp;with respect to Metagenomi,
effective walls and screens (whether technical or physical) established between personnel working on Metagenomi Research Activities, on the one hand, and personnel performing any research, development, manufacturing or commercialization of any
therapeutic, diagnostic or preventative product directed to an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in the Exclusive Field on behalf of the CoC Affiliate or engaging in a Competing Business (&#147;<B>Competing
Activities</B>&#148;), on the other hand, to ensure that no nonpublic information, materials (such as lab notebooks, document management systems or other documented or memorialized <FONT STYLE="white-space:nowrap">Know-How)</FONT> or <FONT
STYLE="white-space:nowrap">non-personnel</FONT> resources relating to any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target or Licensed Product in the Exclusive Field, or any information, materials or
<FONT STYLE="white-space:nowrap">non-personnel</FONT> resources relating to the Commercial License, or to <FONT STYLE="white-space:nowrap">Affini-T</FONT> IP, are accessible by Metagenomi (or CoC Affiliate) personnel performing Competing Activities.
Notwithstanding the foregoing, Metagenomi personnel that manage or supervise multiple programs at Metagenomi will not be subject to the Firewall themselves; provided that, Metagenomi shall keep all laboratory notebooks, information, materials and
records of Metagenomi Research Activities separately from the other laboratory notebooks, information, materials and records of any Competing Activities and shall ensure that any such manager or supervisor personnel is obligated to segregate the
information between Metagenomi Research Activities and Competing Activities (e.g. have such information saved or located separately and cannot be viewed at the same time); and (b)&nbsp;with respect to
<FONT STYLE="white-space:nowrap">Affini-T,</FONT> effective walls and screens (whether technical or physical) established between personnel working on any Licensed Product, on the one hand, and personnel of a Competing Acquiror, on the other hand,
to ensure that no nonpublic information, materials (such as lab notebooks, document management systems or other documented or memorialized <FONT STYLE="white-space:nowrap">Know-How)</FONT> or <FONT STYLE="white-space:nowrap">non-personnel</FONT>
resources relating to any Licensed Product, or any information, materials or <FONT STYLE="white-space:nowrap">non-personnel</FONT> resources relating to the Commercial License, or to Metagenomi IP, are accessible by Competing Acquiror personnel.
Notwithstanding the foregoing, Competing Acquiror personnel that manage or supervise multiple programs at Competing Acquiror and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">Affini-T</FONT> will not be subject to the Firewall themselves; provided that, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall keep all laboratory
notebooks, information, materials and records of Licensed Products separately from the other laboratory notebooks, information, materials and records of the Competing Acquiror and shall ensure that any such manager or supervisor personnel is
obligated to segregate the information between Licensed Product and those of the Competing Acquiror (e.g. have such information saved or located separately and cannot be viewed at the same time). &#147;<B>Firewall</B>,&#148; when used as a verb,
means to implement Firewalls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.70 &#147;<B>First Commercial Sale</B>&#148; means, with respect to a Licensed Product in any country in
the Territory, the date of the first sale, transfer or disposition by <FONT STYLE="white-space:nowrap">Affini-T,</FONT> an Affiliate or Sublicensee to a Third Party in that country after Marketing Authorization for such Licensed Product has been
received in that country; provided, that, the following shall not constitute a First Commercial Sale: (a)&nbsp;any sale, transfer or disposition of a Licensed Product at no more than a de minimis charge for academic research, preclinical, clinical,
or regulatory purposes; (b)&nbsp;any sale, transfer or disposition of a Licensed Product in connection with any patient assistance programs or for a bona fide charitable purpose, including compassionate use or &#147;named patient sales&#148; or to
physicians or hospitals for promotional purposes (including free samples to a level and in an amount which is customary in the industry or which is reasonably proportional to the market for such Licensed Product); or (c)&nbsp;any sale, transfer or
disposition of a Licensed Product for use in Clinical Trials, <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies or other research or Development activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.71 &#147;<B>Force Majeure</B>&#148; means any occurrence beyond the reasonable control of a Party that prevents or substantially interferes
with the performance by such Party of any of its obligations hereunder, including by reason of any act of God, flood, fire, explosion, earthquake, casualty or accident, pandemic, epidemic or other health crisis, or war, revolution, civil commotion,
act of terrorism, blockage or embargo, or any injunction, law, order, proclamation, regulation, ordinance, demand or requirement of any government or of any subdivision, authority or representative of any such government. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.72 &#147;<B>Gene Edits</B>&#148; means <I>ex vivo</I> gene edits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.73 &#147;<B>Good Clinical Practices</B>&#148; or &#147;<B>GCP</B>&#148; means all applicable current Good Clinical Practice standards for
the design, conduct, performance, monitoring, auditing, recording, analysis and reporting of Clinical Trials, including, as applicable, (a)&nbsp;as set forth in the ICH, E6 and any other guidelines for good clinical practice for trials on medicinal
products in the Territory, (b)&nbsp;the Declaration of Helsinki (2004)&nbsp;as last amended at the 52nd World Medical Association in October 2000 and any further amendments or clarifications thereto, (c)&nbsp;U.S. Code of Federal Regulations Title
21, Parts 50, 54, 56, 312 and 314, as may be amended from time to time, and (d)&nbsp;the equivalent Applicable Laws in any relevant country, each as may be amended and applicable from time to time and in each case ((a)-(d)), that provide for, among
other things, assurance that the clinical data and reported results are credible and accurate and protect the rights, integrity, and confidentiality of trial subjects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.74 &#147;<B>Good Laboratory Practice</B>&#148;<B> </B>or<B> </B>&#147;<B>GLP</B>&#148;<B> </B>means the then-current standards for
laboratory activities for pharmaceuticals, as set forth in the FDA&#146;s Good Laboratory Practice regulations as defined in 21 C.F.R. Part 58 or the Good Laboratory Practice principles of the Organization for Economic
<FONT STYLE="white-space:nowrap">Co-Operation</FONT> and Development (&#147;<B>OECD</B>&#148;), and such standards of good laboratory practice as are required by the European Union and other organizations and governmental agencies in countries in
which a Licensed Product is intended to be sold, to the extent such standards are not less stringent than the United States Good Laboratory Practice. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.75 &#147;<B>Good Manufacturing Practice</B>&#148;<B> </B>or<B>
</B>&#147;<B>GMP</B>&#148;<B> </B>means all applicable current Good Manufacturing Practices including, as applicable: (a)&nbsp;the principles detailed in the US Current Good Manufacturing Practices, 21 C.F.R. Parts 4, 210, 211, 601, 610 and 820; (b)
European Directive 2003/94/EC and Eudralex 4; (c) the principles detailed in the WHO TRS 986 Annex 2, TRS 961 Annex 6, and TRS 957 Annex 2, and TRS 99 Annex 2; (d) ICH Q7 guidelines; and (e)&nbsp;the equivalent Applicable Laws in any relevant
country, each as may be amended and applicable from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.76 &#147;<B>Good Research Practices</B>&#148; or
&#147;<B>GRP</B>&#148; means all applicable current Good Research Practices including, as applicable, (a)&nbsp;the Research Quality Association (RQA), 2014, Quality in Research Guidelines for Working in
<FONT STYLE="white-space:nowrap">Non-Regulated</FONT> Research, (b)&nbsp;the World Health Organization (WHO) Quality Practices in Basic Biomedical Research Guidelines, and (c)&nbsp;the equivalent Applicable Laws if any, in any relevant country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.77 &#147;<B>Governance Term</B>&#148; is defined in Section&nbsp;3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.78 &#147;<B>Government Official</B>&#148; means: (a)&nbsp;any officer or employee of: (i)&nbsp;a government, or any department or agency
thereof; (ii)&nbsp;a government-owned or controlled company, institution, or other entity, including a government-owned hospital or university; or (iii)&nbsp;a public international organization (such as the United Nations, the International Monetary
Fund, the International Committee of the Red Cross, and the World Health Organization), or any department or agency thereof; (b)&nbsp;any political party or party official or candidate for public or political party office; and (c)&nbsp;any person
acting in an official capacity on behalf of any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.79 &#147;<B>Governmental Authority</B>&#148; means any
multi-national, federal, state, local, municipal, provincial or other governmental authority of any nature (including any governmental division, prefecture, subdivision, department, agency, bureau, branch, office, commission, council, court or other
tribunal). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.80 &#147;<B>[***]</B>&#148; is defined in Section&nbsp;8.3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.81 &#147;<B>ICH</B>&#148; is defined in Section&nbsp;4.3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.82 &#147;<B>IND</B>&#148; means (a)&nbsp;an Investigational New Drug Application, as defined in the FDCA and regulations promulgated
thereunder, or any successor application or procedure required to initiate clinical testing of a Licensed Product in humans in the United States; (b)&nbsp;a counterpart of an Investigational New Drug Application that is required in any other country
or region in the Territory before beginning clinical testing of any Licensed Product in humans in such country or region; and (c)&nbsp;all supplements and amendments to any of the foregoing.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.83 &#147;<B>Indemnified Party</B>&#148; is defined in Section&nbsp;14.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.84 &#147;<B>Indemnifying Party</B>&#148; is defined in Section&nbsp;14.3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.85 &#147;<B>Infringement</B>&#148; is defined in Section&nbsp;11.2.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.86 &#147;<B>Infringement Notice</B>&#148; is defined in Section&nbsp;11.2.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.87 &#147;<B>Infringement Response</B>&#148; is defined in Section&nbsp;11.2.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.88 &#147;<B>Initial Term</B>&#148; is defined in Section&nbsp;12.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.89 &#147;<B>Initial RSA</B>&#148; is defined in Section&nbsp;8.1.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.90 &#147;<B>iPSC</B>&#148; means induced pluripotent stem cells. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.91 &#147;<B>JSC</B>&#148; is defined in Section&nbsp;3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.92 &#147;<B><FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148; means, collectively, inventions, discoveries, improvements, trade
secrets and proprietary methods, whether or not patentable, including: (a)&nbsp;methods of manufacture or use of, and structural and functional information pertaining to, chemical compounds and materials and (b)&nbsp;compositions of matter, data,
formulations, processes, techniques, cell differentiation techniques and protocols, cell growth techniques and protocols, cell handling, cell assays, <FONT STYLE="white-space:nowrap">know-how</FONT> and results, including preclinical,
pharmaceutical, toxicological and clinical data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.93 &#147;<B>Letter of Authorization</B>&#148; means a written statement by the DMF
holder permitting a Regulatory Authority to refer information in the DMF in support of another party&#146;s submission, as referenced at 21 C.F.R. &#167;314.420(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.94 &#147;<B>Licensed Product</B>&#148; means an Exclusively Licensed Product or a <FONT STYLE="white-space:nowrap">Non-Exclusively</FONT>
Licensed Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.95 &#147;<B>Losses</B>&#148; is defined in Section&nbsp;14.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.96 &#147;<B>Major European Market</B>&#148;<B> </B>means each of United Kingdom, Germany, France, Spain, and Italy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.97 &#147;<B>Manufacture</B>&#148;<B> </B>or &#147;<B>Manufactured</B>&#148; or &#147;<B>Manufacturing</B>&#148; means any and all activities
related to the production, manufacture, formulation, finishing, packaging, labeling, shipping and holding of any Licensed Product, or other product or therapy, or any component, intermediary or precursor thereof, and including process development,
process qualification and validation, <FONT STYLE="white-space:nowrap">scale-up,</FONT> <FONT STYLE="white-space:nowrap">pre-clinical,</FONT> <FONT STYLE="white-space:nowrap">non-clinical,</FONT> clinical and commercial manufacture,
characterization, quality assurance and quality control, including testing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.98 &#147;<B>Marketing Authorization</B>&#148; means, with
respect to a Licensed Product, the Regulatory Approval required by Applicable Laws to sell such Licensed Product in a country or region in the Territory. For purposes of clarity, (a) &#147;<B>Marketing Authorization</B>&#148; in the United States
means final approval of a BLA permitting marketing of such Licensed Product in interstate commerce in the United States; (b) &#147;<B>Marketing Authorization</B>&#148; in the European Union means marketing authorization for such Licensed Product
granted either by an individual country or the EMA; (c) &#147;<B>Marketing Authorization</B>&#148; in the United Kingdom means marketing authorization for such Licensed Product granted by the UK Medicines and Healthcare products Regulatory Agency
and (d) &#147;<B>Marketing Authorization</B>&#148; in other countries means marketing authorization for such Licensed Product granted by the competent authority of such other country.<B> </B> </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.99 &#147;<B>Metagenomi</B>&#148; is defined in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.100 &#147;<B>Metagenomi Agreement IP</B>&#148; is defined in Section&nbsp;10.2.1(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.101 &#147;<B>Metagenomi Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148; is defined in Section&nbsp;10.2.1(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.102 &#147;<B>Metagenomi Agreement Patent Rights</B>&#148; is defined in Section&nbsp;10.2.1(a)(ii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.103 &#147;<B>Metagenomi Background IP</B>&#148; means all Patent Rights and <FONT STYLE="white-space:nowrap">Know-How</FONT> Controlled by
Metagenomi or its Affiliates on or prior to the Effective Date, or that Metagenomi comes to Control outside of this Agreement during the Term, that (a)&nbsp;Cover any Metagenomi Reagent, or Gene Edit using Metagenomi Reagents, (b)&nbsp;are otherwise
necessary or useful to make, use, sell, import or practice any Metagenomi Reagents, or Gene Edit using Metagenomi Reagents, or (c)&nbsp;are otherwise necessary to make, use, sell, import or practice, any Licensed Product; provided that in the case
of this clause (c)&nbsp;if the applicable Patent Rights or <FONT STYLE="white-space:nowrap">Know-How</FONT> are not owned by Metagenomi or its Affiliates, then such Patent Rights or <FONT STYLE="white-space:nowrap">Know-How</FONT> shall only be
included as Metagenomi Background IP in accordance with Section&nbsp;10.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.104 &#147;<B>Metagenomi Indemnitees</B>&#148; is defined in
Section&nbsp;14.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.105 &#147;<B>Metagenomi Indemnity Claims</B>&#148; is defined in Section&nbsp;14.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.106 &#147;<B>Metagenomi</B> <B><FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP</B>&#148; means Patent Rights or <FONT
STYLE="white-space:nowrap">Know-How</FONT> Metagenomi <FONT STYLE="white-space:nowrap">in-licenses</FONT> after the Effective Date that are necessary to make, use, sell import or practice any Licensed Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.107 &#147;<B>Metagenomi IP</B>&#148; means Metagenomi Background IP and Metagenomi Agreement IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.108 &#147;<B>Metagenomi Patent Rights</B>&#148; means all (a)&nbsp;Metagenomi Agreement Patent Rights and (b)&nbsp;Patents Rights that are
included within Metagenomi Background IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.109 &#147;<B>Metagenomi Reagent</B>&#148; means each of (a) [***], or (b) [***] , and (c)
[***] For clarity, Metagenomi Reagents shall include [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.110 &#147;<B>Metagenomi Reagent Improvement</B>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.111 &#147;<B>Metagenomi Research Activities</B>&#148; means activities undertaken by or on behalf of Metagenomi under a Research Plan to
identify, develop and optimize Metagenomi Reagents to implement Gene Edits for use in developing and commercializing gene edited <FONT STYLE="white-space:nowrap">TCR-based</FONT> products.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.112 &#147;<B>Milestone</B>&#148; means the earlier of the date upon which (a)&nbsp;an <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Affini-T-Relevant</FONT></FONT> DMF that has been approved by the JSC is submitted to the FDA, or (b)&nbsp;an IND that references a MG DMF is accepted by the FDA as evidenced by no
objection by the FDA within [***]after the date of submission of such IND (or any amended submission if such amendment restarted the applicable [***]period). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.113 &#147;<B>Milestone RSA</B>&#148; is defined in Section&nbsp;8.1.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.114 &#147;<B>MFN Waiver</B>&#148; is defined in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.115 &#147;<B>Net Sales</B>&#148; means [***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.116 &#147;<B>New
Affiliate</B>&#148; means a Third Party that becomes an Affiliate of a Party after the Effective Date through or after a Change of Control of such Party, other than (i)&nbsp;such Party, or (ii)&nbsp;any Affiliates of such Party immediately before
the consummation of such Change of Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.117 &#147;<B><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Field</B>&#148; means
the treatment, prevention or diagnosis of any human cancer using products with engineered Other Immune Cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.118 &#147;<B><FONT
STYLE="white-space:nowrap">Non-Exclusive</FONT> License</B>&#148; is defined in Section&nbsp;2.1.2(c). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.119 &#147;<B><FONT
STYLE="white-space:nowrap">Non-Exclusive</FONT> Option</B>&#148; is defined in Section&nbsp;2.1.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.120 &#147;<B><FONT
STYLE="white-space:nowrap">Non-Exclusively</FONT> Licensed Product</B>&#148; means a <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapy, preventative treatment, or diagnostic for humans that (a)&nbsp;contains or comprises Other Immune Cells,
(b)&nbsp;is directed to an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target with respect to which a <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Option has been exercised, and (c)&nbsp;is derived from <FONT
STYLE="white-space:nowrap">ex-vivo</FONT> application of a Metagenomi Reagent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.121 &#147;<B>OECD</B>&#148; is defined in
Section&nbsp;1.74. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.122 &#147;<B>Option</B>&#148; is defined in Section&nbsp;2.1.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.123 &#147;<B>Option Exercise Fee</B>&#148; is defined in Section&nbsp;8.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.124 &#147;<B>Option Period</B>&#148; means, with respect to a given <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in a
given Field, the time period beginning on the Effective Date and ending at the earlier of: (a)&nbsp;the end of the Initial Term, or if applicable, the Extended Term or (b)&nbsp;ninety (90) days following the date on which <FONT
STYLE="white-space:nowrap">Affini-T</FONT> files an IND for a Licensed Product directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target. For clarity, there are two (2)&nbsp;Option Periods per
<FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target: one (1)&nbsp;for the Exclusive Option and one (1)&nbsp;for the <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.125 &#147;<B>Other Components</B>&#148; means any (i) [***], or (ii) [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.126 &#147;<B>Other Immune Cells</B>&#148; means (a)&nbsp;TCR natural killer (NK) cells derived from iPSC immune cells or (b)&nbsp;TCR T
cells derived from donor-derived or iPSC immune cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.127 &#147;<B>Partial Termination</B>&#148; is defined in Section&nbsp;12.2.1 and
Section&nbsp;12.2.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.128 &#147;<B>Party</B>&#148; and &#147;<B>Parties</B>&#148; are defined in the Preamble. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.129 &#147;<B>Patent Costs</B>&#148; means the costs and expenses incurred by a Party
(including reasonable external attorneys&#146; fees) in the conduct of Patent Prosecution or Patent Defense activities, as the case may be, for which that Party is responsible in accordance with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.130 &#147;<B>Patent Defense</B>&#148; means the responsibility for defending any interference, declaratory judgment action, opposition,
derivation, <I>inter partes</I> review, post-grant review, reexamination, reissue, or other Third Party challenge or similar proceeding alleging the invalidity, unenforceability or <FONT STYLE="white-space:nowrap">non-infringement</FONT> of any
Patent Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.131 &#147;<B>Patent Prosecution</B>&#148; means the responsibility for preparing, filing and prosecuting patent
applications (of all types) for any Patent Rights, and for maintaining any Patent Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.132 &#147;<B>Patent Rights</B>&#148; means
the rights and interests in and to issued patents and pending patent applications (which, for purposes of this Agreement, include certificates of invention, applications for certificates of invention and priority rights) in any country or region,
including all provisional applications, substitutions, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisions, renewals, all letters patent granted thereon, and all reissues, <FONT
STYLE="white-space:nowrap">re-examinations</FONT> and extensions thereof, and all foreign counterparts of any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.133
&#147;<B>PDF</B>&#148; is defined in Section&nbsp;15.5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.134 &#147;<B>Person</B>&#148; means an individual, sole proprietorship,
partnership, limited partnership, limited liability partnership, corporation, limited liability company, business trust, joint stock company, trust, incorporated association, joint venture or similar entity or organization, including a government or
political subdivision, department or agency of a government. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.135 &#147;<B>Pivotal Trial</B>&#148; means, with respect to any Licensed
Product, a single randomized, placebo or active controlled human clinical trial of a Licensed Product on sufficient numbers of patients that is designed to demonstrate statistically that such Licensed Product is safe and efficacious for its intended
use, to evaluate the risk-benefit relationship of such Licensed Product, and to define warnings, precautions and adverse reactions that are associated with such Licensed Product in the dosage range to be prescribed, as described in 21 C.F.R.
&#167;312.21(c) or corresponding foreign regulations, and that is intended to support a complete application for Regulatory Approval of such Licensed Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.136 &#147;<B>Plan Budget</B>&#148; is defined in Section&nbsp;4.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.137 [***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.138
&#147;<B>Product Information</B>&#148; is defined in Section&nbsp;1.41. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.139 &#147;<B>Project Leader</B>&#148; is defined in
Section&nbsp;3.7. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.140 &#147;<B>Proprietary Materials</B>&#148;<B> </B>means<B> </B>(a)<B></B>&nbsp;any
tangible chemical, biological or physical materials that are Controlled and furnished by the Transferring Party to the Recipient Party, whether or not specifically designated as proprietary by the Transferring Party, or (b)&nbsp;any tangible
chemical, biological or physical materials that are generated, conceived or reduced to practice in the conduct of the Research Plan; provided, that &#147;Proprietary Materials&#148; does not include any Licensed Product or Metagenomi Reagents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.141 &#147;<B>Quality Agreement</B>&#148; means a document developed, approved, and updated by the Parties that sets forth the quality
expectations, responsibilities, rights (including, as applicable and agreed upon, audit requirements) and requirements relating to the Manufacture and supply of Metagenomi Reagents, as executed hereunder, or relating to supply of Metagenomi Reagents
for Clinical Trials or Commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.142 &#147;<B>Receiving Party</B>&#148; is defined in Section&nbsp;1.41. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.143 &#147;<B>Recipient Party</B>&#148; is defined in Section&nbsp;9.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.144 &#147;<B>Recovery</B>&#148; is defined in Section&nbsp;11.2.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.145 &#147;<B>Regulatory Approval</B>&#148; means, with respect to any country or region in the Territory, any approval, establishment
license, registration or authorization of any Regulatory Authority required for the Manufacture, use, storage, importation, exportation, transport or distribution of any Licensed Product for use in such country or region.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.146 &#147;<B>Regulatory Authority</B>&#148; means any national, international, regional, state or local regulatory agency, department,
bureau, commission, council or other governmental entity with authority over the distribution, importation, exportation, Manufacture, use, storage, transport, clinical testing, pricing, sale or reimbursement of any Licensed Product in the
Territory.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.147 &#147;<B>Regulatory Filing</B>&#148; means, collectively: (a)&nbsp;any IND, CTA, Drug Approval Application,
establishment license application, DMF, application for designation as an &#147;Orphan Drug&#148; under the Orphan Drug Act, for &#147;Fast Track&#148; status under Section&nbsp;506 of the FDCA (21 U.S.C. &#167; 356) or for a Special Protocol
Assessment under Section&nbsp;505(b)(4)(B) and (C)&nbsp;of the FDCA (21 U.S.C. &#167; 355(b)(4)(B)) and all other similar filings (including counterparts of any of the foregoing in any country or region in the Territory); (b) all supplements and
amendments to any of the foregoing; and (c)&nbsp;all data and other information contained in, and correspondence relating to, any of the foregoing.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.148 &#147;<B>Regulatory</B><B> Representative</B>&#148; is defined in Section&nbsp;5.5.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.149 &#147;<B>Replacement Notice Response</B>&#148; is defined in Section&nbsp;2.1.2(e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.150 &#147;<B>Replacement Notice</B>&#148; is defined in Section&nbsp;2.1.2(e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.151 &#147;<B>Replacement Right</B>&#148; is defined in Section&nbsp;2.1.2(e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.152 &#147;<B>Requesting Party</B>&#148; is defined in Section&nbsp;9.2.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.153 &#147;<B>Research Costs</B>&#148; is defined in Section&nbsp;4.2.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.154 &#147;<B>Research Plan</B>&#148; is defined in Section&nbsp;4.1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.155 &#147;<B>Research Plan Completion</B>&#148; is defined in Section&nbsp;4.2.1(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.156 &#147;<B>Retention Period</B>&#148; is defined in Section&nbsp;8.4.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.157 &#147;<B>Reviewing Party</B>&#148; is defined in Section&nbsp;9.2.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.158 &#147;<B>Royalty Term</B>&#148; means with respect to a Licensed Product, on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, the period beginning on the date of First Commercial Sale of such Licensed Product in such country and ending on the later of (a)&nbsp;date of expiration or invalidation of the last
to expire Valid Claim of a Metagenomi Patent Right in such country that Covers [***] in such country that is included within the Commercial License, (b) [***] after the date of First Commercial Sale of such Licensed Product in such country, and
(c)&nbsp;expiration of all regulatory exclusivities for such Licensed Product in such country. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.159 &#147;<B>Sublicenseable Metagenomi <FONT
STYLE="white-space:nowrap">In-Licensed</FONT> IP</B>&#148; is defined in Section&nbsp;10.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.160 &#147;<B>Sublicensee</B>&#148; means
any Third Party to which <FONT STYLE="white-space:nowrap">Affini-T</FONT> or its Affiliate grants a sublicense under the Commercial License. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.161 &#147;<B>Supply Failure</B>&#148; is defined in Section&nbsp;2.1.2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.162 &#147;<B>TCR</B>&#148; means <FONT STYLE="white-space:nowrap">T-cell</FONT> receptor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.163 &#147;<B>Term</B>&#148; is defined in Section&nbsp;12.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.164 &#147;<B>Territory</B>&#148; means every country and territory in the world. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.165 &#147;<B>Third Party</B>&#148; means a Person other than <FONT STYLE="white-space:nowrap">Affini-T</FONT> and Metagenomi and their
respective Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.166 &#147;<B>Third Party License</B>&#148; is defined in Section&nbsp;8.4.2(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.167 &#147;<B>Third Party Payments</B>&#148; is defined in Section&nbsp;8.4.2(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.168 &#147;<B>Transferring Party</B>&#148; is defined in Section&nbsp;9.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.169 &#147;<B>United States</B>&#148; or &#147;<B>U.S.</B>&#148; means the United States of America and its territories and possessions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.170 &#147;<B>Upstream Agreement</B>&#148; is defined in Section&nbsp;10.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.171 &#147;<B>Valid</B><B> Claim</B>&#148; means either (a)&nbsp;a claim of an issued and unexpired patent that has not been revoked or found
to be unpatentable, invalid or unenforceable by a court or other government agency of competent jurisdiction, or (b)&nbsp;a claim of a pending patent application, which claim was filed in good faith, has not been pending for more than [***] and has
not been abandoned or finally disallowed without the possibility of appeal or refiling of such application. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2. <U>GRANT OF LICENSES; EXCLUSIVITY</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1 <B><U>Grant of Licenses to <FONT STYLE="white-space:nowrap">Affini-T</FONT></U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1.1 <U>Research License</U>. Metagenomi hereby grants <FONT STYLE="white-space:nowrap">Affini-T</FONT> and its Affiliates a <FONT
STYLE="white-space:nowrap">non-exclusive,</FONT> fully <FONT STYLE="white-space:nowrap">paid-up,</FONT> royalty-free, worldwide license, with the right to grant sublicenses, under, in and to Metagenomi IP for
<FONT STYLE="white-space:nowrap">Affini-T</FONT> to conduct research and Development activities involving Metagenomi Reagents and Licensed Products directed to the applicable <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in each
Field prior to Option exercise and expiration of the Option Period (on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Field-by-Field</FONT></FONT> basis) for purposes of determining whether
<FONT STYLE="white-space:nowrap">Affini-T</FONT> will exercise either or both of its Options with respect to any such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1.2 <U>Commercial License</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) On an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis, Metagenomi hereby grants <FONT STYLE="white-space:nowrap">Affini-T</FONT> (i)&nbsp;an exclusive option to obtain an Exclusive License (&#147;<B>Exclusive
Option</B>&#148;) and (ii)&nbsp;a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> option to obtain a <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License (&#147;<B><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT>
Option</B>&#148;, and individually or collectively, as applicable, with the Exclusive Option, &#147;<B>Option</B>&#148;), in each case of (i)&nbsp;and (ii), with respect to each <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target. <FONT
STYLE="white-space:nowrap">Affini-T</FONT> may, at its sole discretion, exercise one or both of its Options (i.e., on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Field-by-Field</FONT></FONT> basis) with respect to an <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target by providing written notice to Metagenomi during the Option Period applicable to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target and such Field by identifying the
applicable <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target and stating whether an Exclusive License and/or a <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License is being taken with respect to such <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target. <FONT STYLE="white-space:nowrap">Affini-T</FONT> may exercise its Option for an Exclusive License or <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License with respect to a given <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target at the same time or at different times; provided, that any such Option exercise must occurring during the applicable Option Period with respect to such
<FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target and Field. During the Term, Metagenomi shall not license or otherwise dispose of any Metagenomi IP (including undertaking any such actions that would result in any given Patent Rights
and <FONT STYLE="white-space:nowrap">Know-How</FONT> no longer qualifying as Controlled by Metagenomi only as result of such actions) in any manner that is or could be inconsistent with the Option rights granted to
<FONT STYLE="white-space:nowrap">Affini-T.</FONT> Upon the expiration of the Option Period for an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, if <FONT STYLE="white-space:nowrap">Affini-T</FONT> has not exercised either Option
with respect to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, then such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target shall cease to be an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Upon <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> exercise of an Exclusive Option with respect to a given <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, Metagenomi shall grant, and hereby does grant, to <FONT STYLE="white-space:nowrap">Affini-T</FONT> and its Affiliates, without further action from either Party an exclusive (even as to
Metagenomi), royalty-bearing (as set forth in Section&nbsp;8.4), sublicensable (through multiple tiers), worldwide license under all applicable Metagenomi IP to research, Develop, Manufacture or have Manufactured (including the Manufacture of
Metagenomi Reagents, subject to Section&nbsp;2.1.2(d) and, as applicable, the Development Supply Agreement and Commercial Supply Agreement), use, Commercialize and otherwise fully exploit any <FONT STYLE="white-space:nowrap">TCR-based</FONT>
therapy, preventative treatment, or diagnostic for humans that (A)&nbsp;is directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, (B)&nbsp;contains or comprises Primary TCR alpha/beta T Cells, and (C)&nbsp;is derived from
<I>ex vivo</I> application of a Metagenomi Reagent (the &#147;<B>Exclusive License</B>&#148;). </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Upon <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> exercise of a <FONT
STYLE="white-space:nowrap">Non-Exclusive</FONT> Option with respect to a given <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, Metagenomi shall grant, and hereby does grant, to <FONT STYLE="white-space:nowrap">Affini-T</FONT> and
its Affiliates, without further action from either Party a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-bearing (as set forth in Section&nbsp;8.4), sublicensable (through multiple tiers), worldwide license under all applicable
Metagenomi IP to research, Develop, Manufacture or have Manufactured ( including the Manufacture of Metagenomi Reagents, subject to Section&nbsp;2.1.2(d) and, as applicable, the Development Supply Agreement and Commercial Supply Agreement), use,
Commercialize and otherwise fully exploit any <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapy, preventative treatment, or diagnostic for humans that (A)&nbsp;is directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical
Target, (B)&nbsp;contains or comprises Other Immune Cells, and (C)&nbsp;is derived from <I><FONT STYLE="white-space:nowrap">ex-vivo</FONT></I> application of a Metagenomi Reagent (the &#147;<B><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT>
License</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Parties acknowledge and agree that the nature of the Licensed Products is such that <FONT
STYLE="white-space:nowrap">Affini-T</FONT> may inadvertently contravene the Commercial License granted by Metagenomi to <FONT STYLE="white-space:nowrap">Affini-T</FONT> under Sections 2.1.2(b) or 2.1.2(c) by way of an
<FONT STYLE="white-space:nowrap">off-target</FONT> effect whereby a given Licensed Product or Metagenomi Reagent interacts with a target (that it was not intentionally directed against) other than an <FONT STYLE="white-space:nowrap">Affini-T</FONT>
Clinical Target and that any such unintentional contravention shall not constitute a breach of this Agreement nor give rise to any infringement claims by Metagenomi related to such Licensed Product(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Metagenomi shall supply to <FONT STYLE="white-space:nowrap">Affini-T</FONT> its requirements of Metagenomi Reagents in accordance with
the Development Supply Agreement and the Commercial Supply Agreement, as applicable; [***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) [***],
<FONT STYLE="white-space:nowrap">Affini-T</FONT> shall be entitled to [***] <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Targets with respect to which <FONT STYLE="white-space:nowrap">Affini-T</FONT> has not exercised its Option
(&#147;<B>Replacement Right</B>&#148;) by providing a written notice to Metagenomi (&#147;<B>Replacement Notice</B>&#148;). <FONT STYLE="white-space:nowrap">Affini-T</FONT> will be entitled to exercise its Replacement Right no more than [***]period.
Within[***] after receipt of a Replacement Notice, Metagenomi shall notify <FONT STYLE="white-space:nowrap">Affini-T</FONT> in writing (&#147;<B>Replacement Notice Response</B>&#148;) whether, as of the date of the Replacement Notice, the proposed
target in the Replacement Notice is Available (as defined below) for an Exclusive License or a <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License and any other limitations that would apply if
<FONT STYLE="white-space:nowrap">Affini-T</FONT> were to add such target as an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target hereunder and subsequently exercise its Option with respect to such target. If the Replacement Notice
Response provides that the proposed target is not Available for an Exclusive License or <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License, then <FONT STYLE="white-space:nowrap">Affini-T</FONT> will be free to provide a Replacement Notice
for another proposed target. If the proposed target is Available for an Exclusive License or a <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License, then <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have [***] from its receipt of
a Replacement Notice Response to determine whether it desires to have such target added as an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target hereunder, by providing a written response to Metagenomi identifying the <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target to be replaced and affirming the addition of such target as an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target; provided that if such target is only Available for a <FONT
STYLE="white-space:nowrap">Non-Exclusive</FONT> License (and not Available for an Exclusive License), then <FONT STYLE="white-space:nowrap">Affini-T</FONT> acknowledges and agrees that by affirming the addition of such target <FONT
STYLE="white-space:nowrap">Affini-T</FONT> will only be able to exercise the <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Option for such target. If such [***]period expires without a response from
<FONT STYLE="white-space:nowrap">Affini-T,</FONT> or <FONT STYLE="white-space:nowrap">Affini-T</FONT> provides a written response that it does not desire to add such target, then such target shall not become an
<FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target. As used herein &#147;<B>Available</B>&#148; means that (i)&nbsp;the proposed target [***], (ii) the proposed target [***], and (iii)&nbsp;the proposed target [***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1.3 <U>Retention of Rights</U>. Notwithstanding the license granted in Section&nbsp;2.1.1,
Metagenomi retains the rights under the Metagenomi Agreement Patent Rights as necessary to conduct its Development and Manufacturing responsibilities with respect to Licensed Products hereunder in accordance with this Agreement (including any
Metagenomi Research Activities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1.4 <U>Rights of Reference</U>. Solely for the purpose of obtaining or maintaining Regulatory Approval
for a Licensed Product, Metagenomi hereby grants <FONT STYLE="white-space:nowrap">Affini-T</FONT> the right to cross-reference Metagenomi&#146;s or its Affiliate&#146;s Regulatory Filings and Regulatory Approvals anywhere in the world to the extent
such Regulatory Filings and Regulatory Approvals relate to Licensed Products (or components thereof) and are Controlled by Metagenomi or its Affiliates, and to access any data and <FONT STYLE="white-space:nowrap">Know-How</FONT> therein and use such
data and <FONT STYLE="white-space:nowrap">Know-How</FONT> in connection with the performance of <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> obligations and exercise of <FONT STYLE="white-space:nowrap">Affini-T</FONT> rights under this
Agreement. In furtherance of the foregoing, Metagenomi shall (or shall cause an applicable Affiliate to) provide a signed statement to this effect, if requested by <FONT STYLE="white-space:nowrap">Affini-T,</FONT> in accordance with U.S. 21 C.F.R.
&#167;314.50(g)(3) or the equivalent as required in any country or region of the Territory, or otherwise provide appropriate notification of such right of <FONT STYLE="white-space:nowrap">Affini-T</FONT> to the applicable Regulatory Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2 <B><U>Exclusivity</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2.1 <U><FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Targets <FONT STYLE="white-space:nowrap">Pre-Option</FONT></U>. On an <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis, until the earlier of
(a)&nbsp;exercise of an Exclusive Option for such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target; <FONT STYLE="white-space:nowrap">(b)&nbsp;Affini-T&#146;s</FONT> written notice to Metagenomi that it does not desire to exercise its
Exclusive Option for such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target; and (c)&nbsp;expiration of the Option Period with respect to the Exclusive Option for such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target;
Metagenomi shall not, and shall ensure that none of its Affiliates, (i)&nbsp;engage in the discovery, research, Development, Manufacture, Commercialization or other exploitation of any therapeutic, diagnostic or preventative <I>ex vivo </I>gene
edited product directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in the Exclusive Field or (ii)&nbsp;work with any Third Party, including through a grant of any (sub)license to any Third Party, to discover, research,
Develop, Manufacture, Commercialize or otherwise exploit any therapeutic, diagnostic or preventative <I>ex vivo</I> gene edited product directed to or associated with such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in the
Exclusive Field. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2.2 <U><FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Targets Post-Option</U>. Upon exercise of an
Exclusive Option with respect to a given <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, except as necessary to perform its obligations hereunder, Metagenomi shall not, and shall ensure that none of its Affiliates, (i)&nbsp;engage
in the discovery, research, Development, Manufacture, Commercialization or other exploitation of any therapeutic, diagnostic or preventative <I>ex vivo </I>gene edited product directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT>
Clinical Target in the Exclusive Field or (ii)&nbsp;work with any Third Party, including through a grant of any (sub)license to any Third Party, to discover, research, Develop, Manufacture, Commercialize or otherwise exploit any therapeutic,
diagnostic or preventative <I>ex vivo</I> gene edited product directed to or associated with such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in the Exclusive Field. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2.3 <U>Change of Control</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) In the event that Metagenomi or its Affiliate acquires or is acquired by a Third Party (by merger, sale, consolidation, reorganization or
other change of control (including a Change of Control)), such acquired Party/acquiring Third Party (the &#147;<B>CoC Affiliate</B>&#148;) shall not be deemed to be in violation of Section&nbsp;2.2.1 or Section&nbsp;2.2.2 if such CoC Affiliate
(a)&nbsp;covenants in writing to <FONT STYLE="white-space:nowrap">Affini-T</FONT> that from and after the closing of such acquisition, it will not use, reference or otherwise exploit, directly or indirectly, any
<FONT STYLE="white-space:nowrap">(i)&nbsp;Affini-T</FONT> IP (or other Confidential Information of <FONT STYLE="white-space:nowrap">Affini-T,</FONT> including Product Information) that is provided by <FONT STYLE="white-space:nowrap">Affini-T</FONT>
under this Agreement for any purpose, or (ii)&nbsp;Metagenomi Agreement IP for any purpose that would result in a breach of Section&nbsp;2.2.2; (b) establishes and enforces, along with Metagenomi, Firewalls for as long as Metagenomi performs
Metagenomi Research Activities; and (c)&nbsp;independently discovers, researches, Develops, Manufactures or Commercializes any therapeutic, diagnostic or preventative product directed to an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical
Target in the Exclusive Field without any aid, use or other exploitation of any <FONT STYLE="white-space:nowrap">Affini-T</FONT> IP (or other Confidential Information of <FONT STYLE="white-space:nowrap">Affini-T,</FONT> including Product
Information) or Metagenomi Agreement IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In the event that <FONT STYLE="white-space:nowrap">Affini-T</FONT> or its Affiliate is
acquired by a Competing Acquiror (by merger, sale, consolidation, reorganization or other change of control (including a Change of Control)), <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall cause such Competing Acquiror to establish and
enforce Firewalls during the Term.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <B><U>Grant of Licenses to Metagenomi</U></B>. For so long
as any Research Plan is being performed, <FONT STYLE="white-space:nowrap">Affini-T</FONT> hereby grants Metagenomi and its Affiliates a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> fully <FONT STYLE="white-space:nowrap">paid-up,</FONT>
royalty-free, worldwide license, with the right to grant sublicenses, under, in and to <FONT STYLE="white-space:nowrap">Affini-T</FONT> IP solely for Metagenomi to perform its Development obligations under, and in accordance with, each Research
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <B><U>Potential <FONT STYLE="white-space:nowrap">Co-Development</FONT></U></B>. The Parties will discuss the
potential for <FONT STYLE="white-space:nowrap">co-development</FONT> and <FONT STYLE="white-space:nowrap">co-commercialization</FONT> of one or more <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapeutic products that embody <I>ex vivo</I>
engineered TCR immune cells made using Metagenomi Reagents based Gene Edits and (a)&nbsp;are directed to targets other than the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Targets<U> </U>in the Exclusive Field or (b)&nbsp;are directed
to any targets, including <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Targets, in the <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Field. Any such <FONT STYLE="white-space:nowrap">co-development</FONT> and <FONT
STYLE="white-space:nowrap">co-commercialization</FONT> relationship would be governed by a separate <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">co-development/co-commercialization</FONT></FONT> agreement to be negotiated and
agreed to by the Parties in each Party&#146;s sole and absolute discretion. For clarity, neither Party is obligated to <FONT STYLE="white-space:nowrap">co-develop</FONT> such other products or enter into any such further agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>3. <U>GOVERNANCE</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <B><U>Establishment of Joint Steering Committee</U></B><B><U>; Governance Term</U></B>. Within [***] after the Effective
Date, Metagenomi and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall establish a joint steering committee (the &#147;<B>JSC</B>&#148;). The JSC shall have and perform the responsibilities set forth in this Article 3; provided, that, the JSC
shall conduct its activities in good faith and shall not have any authority to amend this Agreement without the mutual written agreement of both Parties. Unless otherwise agreed by the Parties, the term for the JSC shall commence as of the date upon
which it is established and continue until the earlier of (a) [***] or (b) [***] (&#147;<B>Governance Term</B>&#148;); provided that, the Governance Term with respect to any given Licensed Product will end upon the initiation of a Pivotal Trial with
respect to such Licensed Product. From and after the expiration of the Governance Term, this Article 3 shall have no further force or effect, including on a Licensed
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product basis in accordance with the proviso in the foregoing sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <B><U>Membership</U></B>. Each Party shall designate in writing, in its sole discretion, three (3)&nbsp;representatives to
represent it on the JSC. The JSC may change its size from time to time by mutual written consent of the Parties (which consent may be withheld by either Party at its sole discretion) and each Party may replace its representatives at any time upon
written notice to the other Party. Each Party shall appoint one or more of its representatives to serve as a <FONT STYLE="white-space:nowrap">co-chairperson</FONT> of the JSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <B><U>Meetings</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3.1 <U>Schedule of Meetings; Agenda</U>. [***], without limitation, the planning needs for each Research Plan and the responsibilities of
the JSC. Special meetings of the JSC may be convened by any member upon [***] written notice to the other members; provided, that (a)&nbsp;notice of any special meeting may be waived at any time, either before or after the special meeting and
(b)&nbsp;attendance of any member at a special meeting shall constitute a valid waiver of notice of such member. Meetings of the JSC may be held in person or by teleconference or videoconference; provided, that, any meetings held in person shall
alternate between the respective offices of the Parties or be held at other locations as may be mutually agreeable to the JSC members. Each Party may invite representatives, presenters or experts of such Party or of its Affiliates as it determines
is appropriate, subject to the other Party consenting to such attendance, which consent will not be unreasonably withheld, conditioned or delayed; provided, that any such guest attendees (i)&nbsp;shall not vote or otherwise participate in the
decision-making process of the JSC and (ii)&nbsp;are bound by obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> consistent with Article 9. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3.2 <U>Voting; Decisions</U>. At each JSC meeting, the representatives of a Party shall have one (1)&nbsp;collective vote on all matters
before the JSC at such meeting. All decisions of the JSC shall be made by unanimous vote, subject to Section&nbsp;3.5. The JSC may also act by written consent signed by at least [***]<B> </B>designated by each Party. Whenever any action by the JSC
is called for hereunder during a time period in which the JSC is not scheduled to meet, the Parties may call a special meeting or circulate a written consent to the JSC in order to enable the JSC to address, and if agreed, take, the action in the
requested time period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3.3 <U>Meeting Minutes</U>. With the sole exception of specific items of any JSC meeting
minutes to which the JSC cannot agree and which are escalated as provided in Section&nbsp;3.5, definitive minutes of all meetings of the JSC shall be finalized [***] after the meeting to which the minutes pertain, as follows: (a)&nbsp;within [***]
after each JSC meeting, <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> Alliance Manager shall prepare and distribute to all members of the JSC draft minutes of the meeting; (b)&nbsp;the JSC members shall then [***] after receiving such
draft minutes to provide comments thereon to the JSC <FONT STYLE="white-space:nowrap">co-chairpersons;</FONT> (c)&nbsp;upon the expiration of such [***] period, the <FONT STYLE="white-space:nowrap">co-chairpersons</FONT> shall have an [***] to
finalize the minutes; (d)&nbsp;if no comments are received by the JSC <FONT STYLE="white-space:nowrap">co-chairpersons</FONT> within the [***], the minutes shall be deemed final; and (e)&nbsp;the JSC members shall each sign and date the final
minutes. The signature of the JSC members upon the final minutes shall indicate each Party&#146;s assent to the minutes. If at any time during the preparation and finalization of JSC meeting minutes, the Parties do not agree on any issue with
respect to the minutes, such issue shall be resolved by the Executive Officers pursuant to Section&nbsp;3.5. The decision resulting from this escalation process shall be recorded by the <FONT STYLE="white-space:nowrap">co-chairpersons</FONT> in
amended finalized minutes for said meeting and if no resolution can be reached than the disagreement shall be reflected in the minutes accordingly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3.4 <U>Expenses</U>. Metagenomi and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall each bear all expenses of their respective JSC
representatives related to their participation on the JSC and attendance at JSC meetings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4 <B><U>Responsibilities</U></B>. The JSC
responsibilities will include: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4.1 overseeing initiation of, progress of, reviewing, approving, amending and updating (as appropriate),
each Research Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4.2 discussing Metagenomi&#146;s performance of the Metagenomi Research Activities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4.3 reviewing and discussing Metagenomi&#146;s supply abilities with respect to each Metagenomi Reagent to be utilized in a Licensed
Product; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4.4 approving each <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Affini-T-Relevant</FONT></FONT> DMF for
submission; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4.5 establishing or abolishing other such working groups or subcommittees, as needed to further the purposes of this
Agreement, as mutually agreed by the Parties in writing at the JSC; provided that each such working group or subcommittee shall report to the JSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.5 <B><U>Dispute Resolution</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.5.1 <U>Generally</U>. The JSC members shall use reasonable efforts in good faith to reach agreement on any and all matters within its
responsibility. If, despite such reasonable efforts, agreement on a particular matter that is within the responsibility of the JSC cannot be reached by the JSC within[***] after the JSC first meets to consider such matter or such later date as may
be mutually acceptable to the Parties (each such matter, a &#147;<B>Disputed Matter</B>&#148;), the Parties shall refer such Disputed Matter to the Executive Officers of the Parties who shall promptly initiate discussions in good faith to resolve
such Disputed Matter, and if not resolved by the Executive Officers within [***] from the date the Disputed Matter is first referred to the Executive Officers, then, subject to the limitations set forth in Section&nbsp;3.5.2, the Executive Officer
of <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right to make the final decision on such Disputed Matter, but shall only exercise such right in good faith after full consideration of the positions of both Parties. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.5.2 <U>Limitations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <FONT STYLE="white-space:nowrap">Affini-T</FONT> cannot exercise its final decision making authority to (i) [***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) If any Disputed Matter involves a matter outside of the decision making authority of the JSC, then such Disputed Matter shall be resolved
in accordance with Section&nbsp;15.1 except as otherwise expressly set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 <B><U>Alliance Managers</U></B>.
Each Party will appoint an individual designated as the alliance manager (&#147;<B>Alliance Manager</B>&#148;). The Alliance Managers will attend each JSC meeting but will not be a member of the JSC and will be the main point of contact for each
Party to exchange information and facilitate communication for general matters concerning this Agreement or Research Plans, to provide support to the JSC and such other committees and working groups as the JSC may establish and to coordinate the
communication and feedback from each Alliance Manager&#146;s organization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7 <B><U>Project Leaders</U></B>. Each Party
will appoint a project leader for each Research Plan (each a &#147;<B>Project Leader</B>&#148;). The Project Leaders will be responsible for the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> exchange of
information and communication in connection with its assigned Research Plan(s) and will be the first contact person for the other Party for operational and scientific matters with regard to such Research Plan. The Project Leaders will routinely
report on the progress of its assigned Research Plan(s) to the JSC. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4. <U>RESEARCH ACTIVITIES</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1 <B><U>Research Plan</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1.1 <U>Initial Research Plan</U>. <B></B>From time to time during the Term, <FONT STYLE="white-space:nowrap">Affini-T</FONT> may draft and
propose to the JSC and the JSC shall promptly ([***]) upon receipt of such proposal, consider and subject to Section&nbsp;3.5, approve research plan(s) for Gene Edits describing the applicable Metagenomi Research Activities (each, a
&#147;<B>Research Plan</B>&#148;). As of the Effective Date, the Parties have agreed to the Research Plan for [***] attached hereto as Schedule 4.1. Each Research Plan will include a description of all Metagenomi Research Activities to be performed
thereunder, a budget for the conduct of such Metagenomi Research Activities (&#147;<B>Plan Budget</B>&#148;), a timeline for Metagenomi&#146;s performance, key milestones and progress/data/discovery reporting requirements, deliverables, one or more
success criteria with respect to such Research Plan and the required contents of the final report and data package to be delivered to <FONT STYLE="white-space:nowrap">Affini-T</FONT> upon completion of the Research Plan (the &#147;<B>Data
Package</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1.2 <U>Quarterly Review of Research Plan</U>. During each Calendar Quarter JSC meeting, the JSC shall review the
contents of each Research Plan, progress under each Research Plan and discuss and mutually agree on any amendment or update (as appropriate) for such Research Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2 <B><U>Conduct of Research Plan</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2.1 <U>Metagenomi Responsibilities</U>. <B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Metagenomi shall use Commercially Reasonable Efforts to perform the Metagenomi Research Activities and deliver to <FONT
STYLE="white-space:nowrap">Affini-T</FONT> the Metagenomi Reagents (including, as and to the extent applicable, [***] in the quality and amounts provided in the applicable Research Plan and the Data Package in accordance with the timelines set forth
in the applicable Research Plan, and to commit such resources (including employees, agents, consultants, facilities, equipment and materials) as are necessary to comply with such diligence obligation. Metagenomi shall use Commercially Reasonable
Efforts to perform its obligations under each Research Plan until such Research Plan has been completed or terminated in accordance with the terms of the Agreement.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Without limiting Metagenomi&#146;s supply and transfer obligations under Section&nbsp;4.2.1(a) and the Development Supply Agreement and
Quality Agreement, upon Metagenomi&#146;s completion of its obligations, including delivery of all deliverables, and achievement of all success criteria (or all success criteria are achieved except for those expressly waived by <FONT
STYLE="white-space:nowrap">Affini-T</FONT> in writing or those that Metagenomi demonstrates to <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> satisfaction that Metagenomi has used Commercially Reasonable Efforts to achieve without success),
set forth in a given Research Plan, Metagenomi shall notify <FONT STYLE="white-space:nowrap">Affini-T</FONT> in writing of such completion and submit to <FONT STYLE="white-space:nowrap">Affini-T</FONT> the Data Package for such Research Plan (the
&#147;<B>Research Plan Completion</B>&#148;). <FONT STYLE="white-space:nowrap">Affini-T</FONT> acknowledges and agrees that Metagenomi is not providing any guarantee that all success criteria in a Research Plan will be met, and Research Plan
Completion will be achieved when all work under the Research Plan has been completed and all success criteria has been achieved, except for those success criteria expressly waived by <FONT STYLE="white-space:nowrap">Affini-T</FONT> in writing or
those that are demonstrated to <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> satisfaction have been the subject of Metagenomi&#146;s Commercially Reasonable Efforts to achieve without success. Within [***] after <FONT
STYLE="white-space:nowrap">Affini-T&#146;s</FONT> receipt of such notice and Data Package, the JSC shall meet to discuss the Data Package. If <FONT STYLE="white-space:nowrap">Affini-T</FONT> does not believe Research Plan Completion has been
achieved, it shall so notify Metagenomi and the Parties will discuss in good faith the status of the activities under the Research Plan. <FONT STYLE="white-space:nowrap">Affini-T</FONT> may request any reasonable updates or additional information
with respect to the Data Package that are reasonably necessary for <FONT STYLE="white-space:nowrap">Affini-T</FONT> to exercise its rights under this Agreement with respect to the applicable Metagenomi Reagents. If
<FONT STYLE="white-space:nowrap">Affini-T</FONT> notifies Metagenomi that such Data Package contains inaccuracies or lacks necessary information generated under the Research Plan or is otherwise not complete, the Parties shall confer in good faith
with respect to any changes or additions recommended by <FONT STYLE="white-space:nowrap">Affini-T,</FONT> including the performance by Metagenomi of reasonable additional Metagenomi Research Activities that will be reflected in an updated Research
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Metagenomi shall assign such scientific and technical personnel and allocate such other resources as are reasonably necessary
for performing the activities as are assigned to it in each Research Plan and shall perform such activities in accordance with all Applicable Laws (including GRPs and GLPs) in each case to the extent applicable to performance of the relevant
Research Plan activities by Metagenomi, the terms and conditions of this Agreement, and within generally accepted professional standards. Metagenomi shall be solely responsible for the safety and health of its employees and consultants, and for
compliance with all Applicable Laws related to health, safety and the environment, including providing its employees </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and consultants with all required information and training concerning any potential hazards involved in performing such activities and any precautionary measures to protect its employees and
consultants from any such hazards. Metagenomi shall reasonably train its personnel assigned to perform activities under this Agreement to ensure compliance with each Research Plan and shall ensure that any personnel so assigned shall be capable of
professionally and competently performing the activities assigned to Metagenomi in each Research Plan. <B></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth
below in Article 7, in performing the Metagenomi Research Activities, Metagenomi shall not have the right to subcontract any of such activities without the prior written consent of <FONT STYLE="white-space:nowrap">Affini-T;</FONT> provided that
Metagenomi shall cause its subcontractors to comply with the provisions of this Agreement in connection with such performance.&nbsp;Metagenomi shall execute a formal written agreement with any such permitted subcontractor governing the provision of
services by such subcontractor. Each such subcontractor agreement shall (i)&nbsp;require such subcontractor to comply with the terms and conditions of this Agreement (including those provisions governing intellectual property, confidentiality and
audit rights) and (ii)&nbsp;prohibit such subcontractor from further subcontracting. Metagenomi&#146;s execution of such a subcontractor agreement shall not relieve Metagenomi of any of its obligations under this Agreement. Metagenomi shall remain
jointly and severally liable to <FONT STYLE="white-space:nowrap">Affini-T</FONT> for any performance or <FONT STYLE="white-space:nowrap">non-performance</FONT> of any such subcontractor, and Metagenomi hereby expressly waives any requirement that <FONT
STYLE="white-space:nowrap">Affini-T</FONT> exhaust all right, power or remedy, or proceed against any such subcontractor, prior to proceeding directly against Metagenomi. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) In the event that Metagenomi or its Affiliate is conducting any discovery, research, development, manufacture, commercialization or other
exploitation of any therapeutic, diagnostic or preventative <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapy directed to an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target other than under this Agreement (&#147;<B>Competing
Business</B>&#148;), Metagenomi shall establish and enforce Firewalls between such activities and personnel (subject to the terms of Section&nbsp;1.69) performing Metagenomi Research Activities under this Agreement for so long as Metagenomi performs
Metagenomi Research Activities. For clarity, Metagenomi and its Affiliates shall not reference, use or otherwise exploit any <FONT STYLE="white-space:nowrap">Affini-T</FONT> IP (or other Confidential Information of
<FONT STYLE="white-space:nowrap">Affini-T,</FONT> including Product Information) in conducting or pursuing the Competing Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2.2
<U><FONT STYLE="white-space:nowrap">Affini-T</FONT> Responsibilities</U>. In support of Metagenomi&#146;s activities under each Research Plan, <FONT STYLE="white-space:nowrap">Affini-T</FONT> will provide Metagenomi, subject to Article 9, with
access to <FONT STYLE="white-space:nowrap">Know-How</FONT> (including data and other information) that is Controlled by <FONT STYLE="white-space:nowrap">Affini-T</FONT> that is necessary or reasonably useful for the performance of such Metagenomi
Research Activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2.3 <U>Research Plan Costs</U>. <FONT STYLE="white-space:nowrap">Affini-T</FONT> will pay all reasonable costs
actually incurred by Metagenomi for the performance of Metagenomi Research Activities under each Research Plan (&#147;<B>Research Costs</B>&#148;); provided that, <FONT STYLE="white-space:nowrap">Affini-T</FONT> is not obligated to pay any costs and
expenses that exceed the Plan Budget set forth in the applicable Research Plan and Metagenomi shall not be obligated to provide any services or materials for which it will not be paid under the applicable Plan Budget; provided, further, that in the
case it appears that the Plan Budget will be exceeded, the Party identifying such issue shall promptly notify the other Party and the Parties shall discuss in good faith any reasonable adjustments to the Plan Budget. [***] Metagenomi will submit to <FONT
STYLE="white-space:nowrap">Affini-T</FONT> a detailed invoice, including the Metagenomi Research Activities completed and the actual Research Costs incurred in connection with each such Metagenomi Research
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Activity pursuant to the Plan Budget as well as appropriate receipts for passthrough costs for the Research Costs that Metagenomi [***] and <FONT STYLE="white-space:nowrap">Affini-T</FONT> will
pay all undisputed invoices (or portions thereof) within[***] of receipt of such invoice pursuant to Section&nbsp;8.4.5(c); provided that <FONT STYLE="white-space:nowrap">(i)&nbsp;Affini-T</FONT> may reasonably request Metagenomi to provide
additional details, documents or support in connection with any invoice and <FONT STYLE="white-space:nowrap">(ii)&nbsp;Affini-T</FONT> shall pay all disputed invoices within[***] following resolution of a dispute by the Parties regarding any
invoice. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right to audit Metagenomi&#146;s Research Costs by way of Section&nbsp;8.4.4 applied <I>mutatis mutandis</I> (with appropriate substitution/replacement of relevant Party and
subject matter references). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3 <B><U>Compliance</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3.1 <U>Applicable Laws</U>. Metagenomi shall perform the Metagenomi Research Activities in compliance with all Applicable Laws. For clarity,
with respect to each activity performed under the Research Plan that will or would reasonably be expected to generate any results, data, or analyses to be submitted to a Regulatory Authority in support of an IND, each Party shall comply with the
regulations and guidance of the FDA that constitute GRP, GLP or GMP (or, if and as appropriate under the circumstances, International Conference on Harmonization (&#147;<B>ICH</B>&#148;) guidance or other comparable regulation and guidance of any
Regulatory Authority in any country or region in the Territory). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3.2 <U>Compliance with Anti-Corruption Laws</U>. In connection with
this Agreement, each Party will comply with all applicable local, national, and international laws, regulations, and industry codes dealing with government procurement, conflicts of interest, corruption or bribery, including, if applicable, the U.S.
Foreign Corrupt Practices Act of 1977, as amended (&#147;<B>FCPA</B>&#148;), and any laws enacted to implement the OECD Convention on Combating Bribery of Foreign Officials in International Business Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3.3 <U>Prohibited Conduct</U>. In connection with this Agreement, neither Party has made, offered, given, promised to give, or authorized,
and neither Party will not make, offer, give, promise to give, or authorize, any bribe, kickback, payment or transfer of anything of value, directly or indirectly, to any person or to any Government Official for the purpose of: (a)&nbsp;improperly
influencing any act or decision of the Person or Government Official; (b)&nbsp;inducing the Person or Government Official to do or omit to do an act in violation of a lawful or otherwise required duty; (c)&nbsp;securing any improper advantage; or
(d)&nbsp;inducing the Person or Government Official to improperly influence the act or decision of any organization, including any government or government instrumentality, to assist Metagenomi or <FONT STYLE="white-space:nowrap">Affini-T</FONT> in
obtaining or retaining business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3.4 <U>Certain Standards Applicable to Metagenomi Work</U>. All research done by Metagenomi for <FONT
STYLE="white-space:nowrap">non-regulated</FONT> work under this Agreement will be conducted in accordance with the Research Plan, GRP, and all applicable data privacy and security laws and regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3.5 <U>Compliance Audits</U>. Without limiting Section&nbsp;8.4.4 (which is specific to financial audits) and other Sections
cross-referencing to Section&nbsp;8.4.4, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right to audit Metagenomi and the facility(ies) where Metagenomi is performing activities under any Research Plan, including reviewing such
documents and records, as is reasonably necessary for assessing Metagenomi&#146;s performance of the Research Program. Such audit and document review shall be conducted during business hours no more than [***] and only upon [***]advance notice
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by <FONT STYLE="white-space:nowrap">Affini-T</FONT> and the mutual agreement of the Parties as to the specific date and time for such audit; provided, however, that in the case of audits for
cause, the [***] audit limit shall not apply and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall request such audit upon at least [***] advance written notice. It is understood that <FONT STYLE="white-space:nowrap">Affini-T</FONT> undertakes
no obligation to inspect, audit or qualify the facility(ies) and any inspection conducted hereunder is for <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> sole interest without undertaking any obligation or liability to Metagenomi or any
other person or entity. Any audit under this Section&nbsp;4.3.5 conducted by or on behalf of <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall not relieve Metagenomi from any of its obligations or liabilities under this Agreement. <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall not have the right in connection with any such audit to obtain access to information or materials that are (a)&nbsp;solely related to Metagenomi&#146;s collaboration with Third Parties, or
(b)&nbsp;related to Metagenomi Background IP that is not licensed to or expected to be licensed to <FONT STYLE="white-space:nowrap">Affini-T</FONT> under this Agreement (e.g. nuclease systems that are not currently utilized under a Research Plan).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <B><U>Record Keeping</U></B>. For so long as any Research Plan is being performed and for [***] thereafter, each
Party shall maintain complete and accurate records (paper or electronic as applicable) of its research and Development activities under the Research Plans in sufficient detail, including in sufficient detail for purposes of making patent filings, in
good scientific manner, or otherwise in a manner that reflects all work done and results achieved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <B><U>Target
Termination</U></B>. At any time during the Term, if <FONT STYLE="white-space:nowrap">Affini-T</FONT> conclusively determines in good faith that it will not be Developing or Commercializing any Licensed Products with respect to a particular <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, then <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall promptly notify Metagenomi of such conclusive determination and such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical
Target shall cease to be an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target under this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5. <U>DEVELOPMENT
ACTIVITIES; REGULATORY ACTIVITIES</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <B><U>Responsibility for Development</U></B>. As between the Parties, <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall have the sole right and responsibility, at its sole cost and expense, for the conduct of all Development activities applicable to any Licensed Product in the Territory, including the Manufacture and
supply of such Licensed Product in such quantities as required for such Development activities pursuant to this Agreement (subject to Metagenomi&#146;s Manufacturing rights and obligations under Article 7). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <B><U>Engagement of Third Party Contractors</U></B>. <FONT STYLE="white-space:nowrap">Affini-T,</FONT> and its Affiliates
and Sublicensees, shall have the right to engage Third Party contractors to perform any of its Development activities. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall cause its contractors to comply with the provisions of this Agreement in
connection with such <FONT STYLE="white-space:nowrap">performance.&nbsp;Affini-T</FONT> shall execute a formal written agreement with its contractor governing the provision of services by such contractor. Each such contractor agreement shall require
such contractor to comply with the applicable terms and conditions of this Agreement (including those provisions governing intellectual property, confidentiality and audit rights). <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> execution of
such a contractor agreement shall not relieve <FONT STYLE="white-space:nowrap">Affini-T</FONT> of any of its obligations under this Agreement. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall remain jointly and severally liable to Metagenomi
for any performance or <FONT STYLE="white-space:nowrap">non-performance</FONT> of any such contractor, and <FONT STYLE="white-space:nowrap">Affini-T</FONT> hereby expressly waives any requirement that Metagenomi exhaust all right, power or remedy,
or proceed against any such contractor, prior to proceeding directly against <FONT STYLE="white-space:nowrap">Affini-T.</FONT> </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <B><U>Development Diligence</U></B>.<B> </B>Upon <FONT
STYLE="white-space:nowrap">Affini-T&#146;s</FONT> exercise of its Exclusive Option or <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Option with respect to a given <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, <FONT
STYLE="white-space:nowrap">Affini-T</FONT> will use Commercially Reasonable Efforts during the Term to Develop, including seeking Regulatory Approval for, at least one (1)&nbsp;Exclusive Licensed Product or Nonexclusive Licensed Product, as
applicable, directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <B><U>Progress
Reports</U></B>. From the date of the Option exercise until [***], <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall provide Metagenomi an annual written update on the progress of its efforts to Develop Licensed Product(s) with respect to such <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, including a high-level summary of material (a)&nbsp;Clinical Trials completed, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(b)&nbsp;work-in-progress,</FONT></FONT>
(c)&nbsp;current schedules or anticipated events or milestones, and (d)&nbsp;transaction(s) involving Licensed Products, which summaries shall include relevant activities conducted and being conducted by
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> Affiliates or Sublicensees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <B><U>Regulatory Matters</U></B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.5.1 <U>Regulatory Filings Generally</U>. As between the Parties, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the sole
right and responsibility for (i)&nbsp;preparing, filing and maintaining all Regulatory Filings for Licensed Products in the Territory and (ii)&nbsp;reporting to Regulatory Authorities all adverse, including serious, events occurring in any Clinical
Trial conducted by or on behalf of <FONT STYLE="white-space:nowrap">Affini-T</FONT> related to Licensed Products, to the extent required by Applicable Laws. Metagenomi shall prepare and file with the FDA a MG DMF (or an amendment to a <FONT
STYLE="white-space:nowrap">pre-existing</FONT> MG DMF) containing pertinent chemistry manufacturing control (CMC) information regarding the Metagenomi Reagents required for <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> IND submissions
(each such MG DMF, an &#147;<B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Affini-T-Relevant</FONT></FONT> DMF</B>&#148;); provided that <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall notify Metagenomi at [***] to <FONT
STYLE="white-space:nowrap">Affini-T&#146;s</FONT> first anticipated IND filing (or foreign equivalent) for a Licensed Product, including through an update at the JSC, and Metagenomi shall file such an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Affini-T-Relevant</FONT></FONT> DMF at [***]to the date of such anticipated IND filing, subject to JSC approval to so file. Metagenomi hereby grants <FONT STYLE="white-space:nowrap">Affini-T</FONT> or its designee a right
of reference to all MG DMFs in any Regulatory Filing related to the use of the Metagenomi Reagents for a Licensed Product. Metagenomi shall provide <FONT STYLE="white-space:nowrap">Affini-T</FONT> a copy of any MG DMF submission that also qualifies
as an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Affini-T-Relevant</FONT></FONT> DMF at [***] prior to the date of such anticipated IND filing; provided that <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall not have the
right to download copies of such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Relevant DMF. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right, but not the obligation, to provide comments and feedback with respect to such
proposed DMF submission. Metagenomi shall consider <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> comments and feedback in good faith, including amending a <FONT STYLE="white-space:nowrap">pre-existing</FONT> DMF as appropriate, and shall
provide subsequent iterations of each such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Affini-T-Relevant</FONT></FONT> DMF until <FONT STYLE="white-space:nowrap">Affini-T</FONT> has no further comments or feedback and then the <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Relevant DMF shall be submitted to the JSC for approval. After Metagenomi or its Affiliate submits an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Affini-T-Relevant</FONT></FONT> DMF to
a Regulatory Authority (following JSC approval to so submit), and upon <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> written request [***] prior to an anticipated IND filing (or foreign equivalent) for such Licensed Product, Metagenomi
shall provide to such Regulatory Authority a Letter of Authorization (letter of access or other foreign equivalent) advising such Regulatory Authority that <FONT STYLE="white-space:nowrap">Affini-T</FONT> has a right of reference with respect to,
and permitting such Regulatory Agent the right to reference, the applicable DMF. Upon <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> request, Metagenomi shall update such Letter of Authorization (letter of access or other foreign
equivalent) to grant such right of reference to <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> successor or permitted assign. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.5.2 <U>Licensed Product-Related Regulatory Interactions</U>. <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall be solely responsible for any communications with any Regulatory Authorities regarding the Licensed Products. In the event that Metagenomi receives any communication from a Regulatory Authority
regarding a Licensed Product, Metagenomi shall refer such Regulatory Authority to <FONT STYLE="white-space:nowrap">Affini-T</FONT> and shall not otherwise communicate with such Regulatory Authority without
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> prior written consent. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right to require that Metagenomi make available (at Metagenomi&#146;s cost and expense) an appropriate
representative to be present, as a silent observer (except as <FONT STYLE="white-space:nowrap">Affini-T</FONT> may expressly authorize otherwise), during a meeting or substantive telephone conference call with any Regulatory Authorities relating to
Metagenomi Reagents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.5.3 <U>Regulatory Consultation</U>. Each Party will appoint a representative to discuss regulatory matters related
to Metagenomi Reagents and Licensed Products with the other Party on a Calendar Quarter basis (each, &#147;<B>Regulatory Representative</B>&#148;), until such time as the Parties agree (each at its own discretion) in writing that such meetings will
no longer be held. Such meetings may take place in person or by tele-/video-conference as the Regulatory Representatives may agree between themselves. The Regulatory Representatives shall discuss interactions and filings with Regulatory Authorities
relating to: (a)&nbsp;with respect to Metagenomi and Metagenomi Reagents, for so long as there are outstanding Research Plans, all Metagenomi Reagents that are subject of any such Research Plans, and thereafter, all Metagenomi Reagents that are
incorporated into one or more Licensed Products; or (b)&nbsp;with respect to <FONT STYLE="white-space:nowrap">Affini-T,</FONT> Metagenomi Reagents for using Gene Edits to Manufacture Licensed Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <B><U><FONT STYLE="white-space:nowrap">Know-How</FONT> Sharing; Cooperation</U></B>. Promptly after the Effective Date
(and in no event longer than [***]after the Effective Date), and from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time</FONT></FONT> thereafter, Metagenomi shall disclose or deliver to
<FONT STYLE="white-space:nowrap">Affini-T</FONT> copies of all <FONT STYLE="white-space:nowrap">Know-How</FONT> in Metagenomi&#146;s or its Affiliate&#146;s possession (and will use reasonable efforts to obtain all data and information in
Metagenomi&#146;s contract researcher&#146;s possession) relating to the Development and Commercialization of Licensed Products to the extent necessary or useful for <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> performance or exercise of
its rights under this Agreement, including [***]. Metagenomi shall promptly notify <FONT STYLE="white-space:nowrap">Affini-T</FONT> regarding [***].<B> </B>Upon <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> reasonable request, Metagenomi
will provide technical assistance to <FONT STYLE="white-space:nowrap">Affini-T</FONT> during such disclosure or delivery set forth in the preceding sentences. Metagenomi shall, [***] reasonably cooperate with
<FONT STYLE="white-space:nowrap">Affini-T</FONT> in the Development of any Licensed Products, including making its employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> consultants reasonably available to consult with <FONT
STYLE="white-space:nowrap">Affini-T</FONT> on issues arising during <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> Development and in connection with any request related to a Licensed Product or its Development from any Regulatory
Authority, including regulatory, scientific, technical and clinical testing issues. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6. <U>COMMERCIALIZATION OF PRODUCTS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <B><U>Responsibility for Commercialization of Licensed Products</U></B>. As between the Parties, <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall be responsible for the Commercialization of Licensed Products in the Territory,<B> </B>including (a)&nbsp;the conduct of all <FONT STYLE="white-space:nowrap">pre-marketing,</FONT> marketing,
promotion, sales, distribution, import and export activities (including securing reimbursement, sales and marketing and conducting any post-marketing trials or databases and post-marketing safety surveillance); (b) reporting of all adverse,
including serious, events to Regulatory Authorities if and to the extent required by Applicable Laws; (c)&nbsp;the timing for the launch of Licensed Products and for submitting applications for reimbursement with respect to Licensed Products in any
country in the Territory; and (d)&nbsp;booking all sales of Licensed Products in the Territory. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2
<B><U>Commercialization Diligence</U></B>. Upon <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> exercise of its Exclusive Option or <FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Option with respect to a given <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target and subject to obtaining Regulatory Approval for an Exclusive Licensed Product or Nonexclusive Licensed Product, as applicable, directed to such
<FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall use Commercially Reasonable Efforts during the Term to Commercialize at least one (1)&nbsp;Exclusive Licensed Product or
Nonexclusive Licensed Product, as applicable, directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <B><U>Compliance</U></B>. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall perform its Commercialization activities
in compliance in all material respects with all Applicable Laws. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7. <U>MANUFACTURE AND SUPPLY</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <B><U>Metagenomi Reagents </U></B><B><U>Supply</U></B>. Metagenomi shall define, subject to the terms and conditions of
this Agreement, and the Development Supply Agreement and Development Quality Agreement, or the Commercial Supply Agreement and Commercial Quality Agreement, as applicable, the strategy and plans to manufacture Metagenomi Reagents supplied by
Metagenomi and shall keep <FONT STYLE="white-space:nowrap">Affini-T</FONT> informed on the progress therefor. Subject to Section&nbsp;2.1.2(d), Metagenomi will supply, and <FONT STYLE="white-space:nowrap">Affini-T</FONT> will purchase from
Metagenomi, all of the Metagenomi Reagents ordered by <FONT STYLE="white-space:nowrap">Affini-T</FONT> to be used for Gene Edits in the manufacture of Licensed Products for <FONT STYLE="white-space:nowrap">pre-clinical</FONT> research use pursuant
to one or more Research Plans and clinical Development use pursuant to the Development Supply Agreement and Quality Agreement. The Parties will enter into a supply agreement (the &#147;<B>Development Supply Agreement</B>&#148;) and a Quality
Agreement for Development purposes (the &#147;<B>Development Quality Agreement</B>&#148;) within[***] after <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> exercise of its first Option unless mutually extended by the Parties in writing. Upon
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> request, to be made at a logical time based on JSC discussions with respect thereto (but, in any event, prior to filing for Drug Approval Application) for a Licensed Product, the Parties shall
amend the Development Supply Agreement (the &#147;<B>Commercial Supply Agreement</B>&#148;) and Development Quality Agreement (the &#147;<B>Commercial Quality Agreement</B>&#148;) to cover the supply of Metagenomi Reagents for Commercial purposes
within [***] of such request. The Development Supply Agreement and Development Quality Agreement will include supply amount, cost (for development supply, to be set at Metagenomi&#146;s manufacturing costs therefor (as will be further defined) plus
a reasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">mark-up</FONT> to be set forth in the Development Supply Agreement, and for commercial supply, the Parties will agree on reasonable fixed tier pricing to be set
forth in the Commercial Supply Agreement), quality requirements, appropriate supply contingency plans, define supply defaults and remedies therefor, and certain manufacturing and scale up matters and other terms and conditions typically contained in
a contract manufacturing services agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <B><U>Agreement Resolution</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2.1 <U>Development Supply Agreement Finalization</U>. If the Parties have not entered into a Development Supply Agreement within [***] after
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> exercise of its first Option or such later date as mutually extended by the Parties in writing, the finalization of such Development Supply Agreement shall be finally resolved by binding
arbitration. [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2.2 <U>Development Quality Agreement Finalization</U>. If the Parties have not entered into a Development Quality
Agreement within [***] after <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> exercise of its first Option or such later date as mutually extended by the Parties in writing, the finalization of such Development Quality Agreement shall be
finally resolved by binding arbitration. [***] </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>8. <U>CONSIDERATION</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <B><U>Equity Grant</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1.1 <U>Initial Equity Grant</U>. In partial consideration of Metagenomi entering into this Agreement,
<FONT STYLE="white-space:nowrap">Affini-T</FONT> will, promptly following the Effective Date, issue 719,920 shares of <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> common stock to Metagenomi or its Affiliate in accordance with the terms of
that certain restricted stock agreement, in substantially the form attached hereto as <U>Schedule 8.1(a)</U> (the &#147;<B>Initial RSA</B>&#148;), to be executed by the Parties contemporaneously with the execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1.2 <U>Milestone Equity Grant</U>. In partial consideration of Metagenomi entering into this Agreement,
<FONT STYLE="white-space:nowrap">Affini-T</FONT> will issue an additional 933,650 shares of <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> common stock to Metagenomi or its Affiliate in accordance with the terms of that certain restricted
stock agreement, in substantially the form attached hereto as <U>Schedule 8.1(b)</U> (the &#147;<B>Milestone RSA</B>&#148;), to be executed by the Parties promptly following the achievement of the Milestone. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <B><U>Option Exercise Payments</U></B>. Within [***] after providing a written notice identifying an <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target(s) with respect to which <FONT STYLE="white-space:nowrap">Affini-T</FONT> wishes to exercise its Option for either an Exclusive License, a Non-Exclusive License or both, Metagenomi shall
submit an invoice to <FONT STYLE="white-space:nowrap">Affini-T</FONT> pursuant to Section&nbsp;8.4.5(c) and <FONT STYLE="white-space:nowrap">Affini-T</FONT><B> </B>shall, within [***] of receipt of such invoice, make the following up to <FONT
STYLE="white-space:nowrap">two-times</FONT> (once for each Field), on an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis (and corresponding to whether an Exclusive License, a
<FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License or both is/are taken with respect to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target), payments to Metagenomi (&#147;<B>Option Exercise Fee</B>&#148;): <B></B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Option for Commercial License in a Field</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option&nbsp;Exercise<BR>Fee&nbsp;for&nbsp;Exclusive<BR>License</B><br><B>($ US Dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option&nbsp;Exercise<BR><FONT STYLE="white-space:nowrap">Fee&nbsp;for&nbsp;Non-</FONT></B><br><B>Exclusive&nbsp;License</B><br><B>($ US Dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of First Option in a Field</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of Second Option in a Field</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of Third Option in a Field</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of Fourth Option in a Field</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of Fifth Option in a Field</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of Sixth Option in a Field</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3 <B><U>Milestone Payments</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.1 <U>Development Milestones</U>. <FONT STYLE="white-space:nowrap">Affini-T</FONT><B> </B>shall notify Metagenomi within [***] after the
first achievement of each of the following Development milestone events with respect to each <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target once for each Field. Metagenomi shall submit an invoice to
<FONT STYLE="white-space:nowrap">Affini-T</FONT> for the applicable payment pursuant to Section&nbsp;8.4.5(c) and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall, within [***] of receipt of such invoice, make the following payments once for
each Field, on an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis (and
corresponding to whether the Licensed Product achieving the relevant milestone is an Exclusively Licensed Product or a <FONT STYLE="white-space:nowrap">Non-Exclusively</FONT> Licensed Product). Each Development milestone shall be payable only once
for each <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in each Field once for each Field regardless of the number of Exclusively Licensed Products or <FONT STYLE="white-space:nowrap">Non-Exclusively</FONT> Licensed Products
associated with such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target that achieve such milestone event. In the event a Licensed Product is directed to more than one <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target,
such Licensed Product shall only trigger payment of applicable Development milestone amounts for a single <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target. <B></B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Development Milestone Event in a Field</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exclusively&nbsp;Licensed<BR>Product Milestone<BR>Payment</B><br><B>($ US Dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Exclusively</FONT><BR>Licensed&nbsp;Product<BR>Milestone<BR>Payment</B><br><B>($ US Dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Development Milestone Event in a Field</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exclusively Licensed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Product Milestone</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Payment</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>($ US
Dollars)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Exclusively</FONT><BR>Licensed&nbsp;Product<BR>Milestone<BR>Payment</B><br><B>($ US Dollars)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Maximum Total Development Milestone Payments</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">$18,750,000 for each <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target if all Development Milestones were achieved by an Exclusively Licensed Product and a
<FONT STYLE="white-space:nowrap">Non-Exclusively</FONT> Licensed Product both directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target [***]</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purposes of this Section&nbsp;8.3.1, &#147;<B>[***]</B>&#148; means the earlier of (a) [***], (b)
[***], or (c) [***]. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.2 <U>Regulatory Approval Milestones</U>. <FONT STYLE="white-space:nowrap">Affini-T</FONT><B>
</B>shall notify to Metagenomi within [***] after the first achievement of each of the following Regulatory Approval milestone events with respect to each <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target once for each Field.
Metagenomi shall submit an invoice for the applicable payment to <FONT STYLE="white-space:nowrap">Affini-T</FONT> pursuant to Section&nbsp;8.4.5(c) and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall, within [***] of receipt of such invoice,
make the following payments once for each Field, on an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis (and corresponding to whether the Licensed Product achieving the relevant milestone is
an Exclusively Licensed Product or a <FONT STYLE="white-space:nowrap">Non-Exclusively</FONT> Licensed Product). Each Regulatory Approval milestone shall be payable only once for each <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target
in each Field regardless of the number of Exclusively Licensed Products or Non-Exclusively Licensed Products associated with such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target that achieve such milestone event. In the event a
Licensed Product is directed to more than one <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target, such Licensed Product shall only trigger payment of applicable Regulatory Approval milestone amounts for a single <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target.&nbsp;&nbsp;&nbsp;&nbsp;<B> </B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Regulatory Approval Milestone Event in a Field</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exclusively<BR>Licensed&nbsp;Product<BR>Milestone<BR>Payment</B><br><B>($ US Dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Exclusively</FONT><BR>Licensed&nbsp;Product<BR>Milestone<BR>Payment</B><br><B>($ US Dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Regulatory Approval Milestone Event in a Field</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exclusively</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Licensed Product</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Milestone</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Payment</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>($ US Dollars)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Exclusively</FONT><BR>Licensed&nbsp;Product<BR>Milestone<BR>Payment</B><br><B>($ US Dollars)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Maximum Total Regulatory Approval Milestone Payments</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">$40,625,000 for each <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target if all Regulatory Approval Milestones were achieved by an Exclusively Licensed Product and a
<FONT STYLE="white-space:nowrap">Non-Exclusively</FONT> Licensed Product both directed to such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target [***]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.3 <U>Commercial Sales Milestones</U>. On a <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis, <FONT STYLE="white-space:nowrap">Affini-T</FONT><B> </B>shall notify and pay to Metagenomi
within [***] after the first achievement of each of the following Commercial sales milestone events as determined by aggregating Net Sales of all Licensed Products directed to a given <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target
(i.e., all Exclusively Licensed Products and <FONT STYLE="white-space:nowrap">Non-Exclusively</FONT> Licensed Products directed to a given <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target). Metagenomi shall submit an invoice to <FONT
STYLE="white-space:nowrap">Affini-T</FONT> for the applicable payment pursuant to Section&nbsp;8.4.5(c) and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall, within [***] of receipt of such invoice, make the following <FONT
STYLE="white-space:nowrap">one-time</FONT> payments. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Commercial Sales Milestone Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Milestone&nbsp;Payment</B><br><B>($ US Dollars)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">[***]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Maximum Total Commercial Sales Milestone Payments</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">$250,000,000&nbsp;for&nbsp;each<BR><FONT STYLE="white-space:nowrap">Affini-T&nbsp;Clinical&nbsp;Target</FONT><BR>[***]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event [***] or more Commercial sales milestone events are achieved in the same Calendar Year, <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall pay to Metagenomi each Commercial sales milestone payment corresponding to the respective Commercial sales milestone event. For the avoidance of doubt, each Commercial sales milestone payment shall be
payable one time upon the first achievement of the corresponding Commercial sales milestone event, regardless of the number of times such Commercial sales milestone event may be achieved.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once the Royalty Term with respect to a given Licensed Product and country has expired, the Net Sales of such Licensed Product in such country
shall not count towards cumulative Net Sales for purposes of this Section&nbsp;8.3.3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3.4 <U>Notice of Missing Payment</U>. If Metagenomi believes any of the foregoing
milestone event (Development, Regulatory Approval or Commercial sale) has occurred and it has not received payment of same from <FONT STYLE="white-space:nowrap">Affini-T,</FONT> it shall so notify <FONT STYLE="white-space:nowrap">Affini-T</FONT><B>
</B>in writing and shall provide to <FONT STYLE="white-space:nowrap">Affini-T</FONT><B> </B>documentation or other information that supports its belief. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4 <B><U>Payment of Royalties; Royalty Rates; Accounting and Records</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4.1 <U>Payment of Royalties</U>.<B> </B>On a Licensed
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, during the applicable Royalty
Term for such Licensed Product and country, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall pay Metagenomi tiered royalties on the worldwide Annual Net Sales of such Licensed Product at the royalty rates set forth below. No more than one
royalty payment shall be due per Licensed Product per Calendar Quarter during the Royalty Term for such Licensed Product. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Annual Net Sales Thresholds</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>(Determined on an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-</FONT></FONT></B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target basis)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exclusively<BR>Licensed&nbsp;Product</B><br><B>Royalty Rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Exclusively</FONT><BR>Licensed&nbsp;Product<BR>Royalty Rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Net Sales of all Licensed Products directed to a given [***] is less than [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Net Sales of all Licensed Products directed to a given [***]is equal to or greater than
[***]but less than [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Net Sales of all Licensed Products directed to a given [***]is equal to or greater than
[***]but less than [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Net Sales of all Licensed Products directed to a given [***]Target is equal to or greater
than [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[</TD>
<TD NOWRAP VALIGN="bottom">***]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Once the Royalty Term with respect to a given Licensed Product and country has expired, the Net Sales of such
Licensed Product in such country shall not count towards cumulative Net Sales for purposes of establishing Net Sales tiers pursuant to this Section&nbsp;8.4.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4.2 <U>Adjustments to Royalty Payments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding anything to the contrary in Section&nbsp;8.4.1, if any Licensed Product is sold in a country and [***], then the
royalties shall be [***], continuing until [***] with respect to such Licensed Product and such country at issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) If <FONT STYLE="white-space:nowrap">Affini-T,</FONT> or any of its Affiliates or
Sublicensees, is a party to a (sub)license from one or more Third Parties, including any Third Party license to Patent Rights which Cover, or <FONT STYLE="white-space:nowrap">Know-How</FONT> which relates to a given Licensed Product (or its use or
manufacture), because it is necessary or useful for <FONT STYLE="white-space:nowrap">Affini-T,</FONT> its Affiliate or Sublicensee to avoid infringement of such Patent Right or misappropriation of such
<FONT STYLE="white-space:nowrap">Know-How</FONT> in the Development, Manufacture, Commercialize or other exploitation of a Licensed Product in a given country (each such Third Party license is referred to herein as a &#147;<B>Third Party
License</B>&#148;), then, [***] of any payments owed by <FONT STYLE="white-space:nowrap">Affini-T</FONT> or any of its Affiliates or Sublicensees to any such Third Party for such a Third Party License (collectively, the &#147;<B>Third Party
Payments</B>&#148;) shall be creditable against royalties payable to Metagenomi under Section&nbsp;8.4.1; provided, that in no event will such credit reduce the royalties payable to Metagenomi for a given Calendar Quarter by [***]; provided,
further, that if additional reductions would be possible but for the foregoing [***], then such amounts may be rolled forward to reduce future royalty payments. Notwithstanding the foregoing, if the Third Party License is necessary or useful for <FONT
STYLE="white-space:nowrap">Affini-T,</FONT> its Affiliate or Sublicensee to avoid infringement of one or more Patent Rights or misappropriation of <FONT STYLE="white-space:nowrap">Know-How</FONT> as a result of exploitation of Metagenomi IP or the
Metagenomi Reagents in accordance with the terms of this Agreement, then [***] of any Third Party Payments in connection with such Third Party License shall be creditable against payments to Metagenomi under Sections 8.3 and 8.4.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) If <FONT STYLE="white-space:nowrap">Affini-T</FONT> is required to grant a Compulsory License to a Third Party with respect to a Licensed
Product, as applicable in any country, and such Third Party actually sells such Licensed Product in such country under such Compulsory License, with a royalty rate lower than the applicable royalty rate provided by this Section&nbsp;8.4, then the
Parties shall share all amounts actually received by <FONT STYLE="white-space:nowrap">Affini-T</FONT> or its Affiliates or Sublicensees from any Compulsory License in consideration of the sale of a Licensed Product less any withholding tax or other
taxes as may be required under Applicable Law and actually withheld from such payment due to <FONT STYLE="white-space:nowrap">Affini-T,</FONT> its Affiliate or Sublicensee, as applicable, [***] with
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> share included in the royalty payments and reports made pursuant to Section&nbsp;8.4.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4.3 <U>Payment Dates and Reports</U>. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall provide a report showing the Net Sales of each
Licensed Product and calculation of the amount of royalty due to Metagenomi within [***] after the end of each Calendar Quarter in which a sale of such Licensed Product occurs, commencing with the Calendar Quarter in which [***]. Metagenomi shall
submit an invoice to <FONT STYLE="white-space:nowrap">Affini-T</FONT> based on such royalty report pursuant to Section&nbsp;8.4.5(c) and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall pay such royalty payments within [***] after receipt of
invoice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4.4 <U>Records; Audit Rights</U>. <FONT STYLE="white-space:nowrap">Affini-T</FONT> and its Affiliates and Sublicensees
involved in booking sales of the Licensed Product shall keep and maintain for [***] from the end of the Calendar Year in which Net Sales occurred (the &#147;<B>Retention Period</B>&#148;) complete and accurate records of gross sales and Net Sales
by, as applicable, <FONT STYLE="white-space:nowrap">Affini-T</FONT> and its Affiliates and Sublicensees of each Licensed Product, in sufficient detail to allow royalties to be determined accurately. Metagenomi shall have the right during the
applicable Retention Period to appoint at its expense a nationally recognized independent certified public accountant reasonably acceptable to <FONT STYLE="white-space:nowrap">Affini-T</FONT> to audit the relevant records of <FONT
STYLE="white-space:nowrap">Affini-T</FONT> and its Affiliates and Sublicensees to verify that the amount of such payment was correctly determined. <FONT STYLE="white-space:nowrap">Affini-T</FONT> and its Affiliates and Sublicensees shall each make
its records available for audit by such nationally recognized independent certified public accountant during regular business hours at such place or places where such records are customarily kept, upon [***]written notice from Metagenomi. Such audit
right shall not be exercised by Metagenomi more than once in any Calendar Year or more than once with respect to sales of a particular Licensed Product in a particular period and such audit shall not unreasonably
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interfere with or impede <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> or its Affiliate&#146;s or sublicensee&#146;s business operations. All records made available for audit shall be
deemed to be Confidential Information of <FONT STYLE="white-space:nowrap">Affini-T.</FONT> The results of each audit, if any, shall be provided to and are binding on both Parties absent manifest error; provided, that,
<FONT STYLE="white-space:nowrap">Affini-T</FONT> shall be provided an opportunity to discuss the findings of any such audit with the auditor prior to disclosure of the results thereof to Metagenomi. In the event there was an underpayment by <FONT
STYLE="white-space:nowrap">Affini-T</FONT> hereunder, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall promptly (but in any event no later than [***] after <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> receipt of the report so
concluding) make payment to Metagenomi of any shortfall. Metagenomi shall bear the full cost of such audit unless such audit discloses an underreporting by <FONT STYLE="white-space:nowrap">Affini-T</FONT> of [***] or at least [***] of the aggregate
amount of royalties payable in any Calendar Year, in which case <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall reimburse Metagenomi for [***]. In the event there was an overpayment by <FONT STYLE="white-space:nowrap">Affini-T</FONT>
hereunder, <FONT STYLE="white-space:nowrap">Affini-T</FONT> may, at its discretion, credit such overpayment in the next royalty payment or request Metagenomi to and Metagenomi shall promptly (but in any event no later than [***] after
Metagenomi&#146;s receipt of the report so concluding) make repayment to <FONT STYLE="white-space:nowrap">Affini-T</FONT> of any such overage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4.5 <U>Payments; Withholding Tax</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) All payments made by <FONT STYLE="white-space:nowrap">Affini-T</FONT> under this Article 8 shall be made by wire transfer from a banking
institution in US Dollars in accordance with instructions given in writing from time to time by Metagenomi; provided however that <FONT STYLE="white-space:nowrap">Affini-T</FONT> will, or its vendor on behalf of
<FONT STYLE="white-space:nowrap">Affini-T,</FONT> will disburse payments only to Metagenomi&#146;s jurisdiction of incorporation or to a jurisdiction in which Metagenomi has a significant business presence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) If Applicable Laws require withholding of income or other taxes imposed upon any payments made by
<FONT STYLE="white-space:nowrap">Affini-T</FONT> to Metagenomi under this Agreement, including any value added tax or sales tax, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall (i)&nbsp;make such withholding payments as may be required,
(ii)&nbsp;subtract such withholding payments from such payments, (iii)&nbsp;submit appropriate proof of payment of the withholding taxes to Metagenomi within a reasonable period of time, and (iv)&nbsp;promptly provide Metagenomi with all official
receipts with respect thereto. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall render Metagenomi reasonable assistance in order to allow Metagenomi to obtain the benefit of any present or future treaty against double taxation which may apply
to such payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) All invoices required to be submitted to <FONT STYLE="white-space:nowrap">Affini-T</FONT> under this Agreement
shall be submitted by Metagenomi to Bill.com or such other vendor designated by <FONT STYLE="white-space:nowrap">Affini-T</FONT> in writing from time to time. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9. <U>TREATMENT OF CONFIDENTIAL INFORMATION; PUBLICITY.</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1 <B><U>Confidentiality</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1.1 <U>Confidentiality Obligations</U>. Metagenomi and <FONT STYLE="white-space:nowrap">Affini-T</FONT> each recognizes that the other
Party&#146;s Confidential Information and Proprietary Materials constitute highly valuable assets of such other Party. Metagenomi and <FONT STYLE="white-space:nowrap">Affini-T</FONT> each agrees that, during the Term and for an additional [***]
after termination or expiration of this Agreement, (a)&nbsp;subject to Section&nbsp;9.1.2, it will not disclose, and will cause its Affiliates not to disclose, any Confidential Information or Proprietary Materials of the other Party, (b)&nbsp;it
will not use, and will cause its Affiliates not to use, any Confidential Information or Proprietary Materials of the other Party, except as expressly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
permitted in this Agreement, (c)&nbsp;it shall not attempt to reverse engineer, deconstruct or in any way determine the structure or composition of any of the other Party&#146;s Proprietary
Materials, and (d)&nbsp;it will use the same efforts to protect the other Party&#146;s Confidential Information as it does to protect its own similar Confidential Information (but, in any event, no less efforts than a reasonable Person in the
industry would use to protect similar information). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1.2 <U>Limited Disclosure</U>. Each Disclosing Party agrees that disclosure of its
Confidential Information or any transfer of its Proprietary Materials may be made by the Receiving Party to any employee, director or agent of, or consultant to, such Receiving Party or to other Third Parties to enable such other Party to exercise
its rights (including <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> right to fully exploit any Commercial License granted to it) or to carry out its responsibilities under this Agreement; provided, that, any such disclosure or transfer
shall only be made to Persons who are bound by written obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> at least as strict as those described in Article 9. In addition, each Disclosing Party agrees that the
Receiving Party may disclose Confidential Information of the Disclosing Party (a)&nbsp;on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis to such Receiving Party&#146;s professional, legal and
financial advisors, (b)&nbsp;as reasonably necessary in connection with an actual or potential (i)&nbsp;permitted license or sublicense of such Receiving Party&#146;s rights hereunder, (ii)&nbsp;financing of such Receiving Party in a public or
private offering, or (iii)&nbsp;merger, acquisition, consolidation, share exchange or other similar transaction involving such Receiving Party and any Third Party, (c)&nbsp;to any Third Party that is or may be engaged by a Receiving Party to perform
services in connection with the Research Plan (or perform services in connection with carrying out Development or Commercialization activities) as necessary to enable such Third Party to perform such services, (d)&nbsp;as reasonably necessary to
file, prosecute or maintain Patent Rights, or to file, prosecute or defend litigation related to Patent Rights, in accordance with this Agreement, (e)&nbsp;as reasonably necessary for Regulatory Filings or interactions with Regulatory Authorities,
in each case relating to the Licensed Products, or (f)&nbsp;as required by Applicable Laws (including securities laws or regulations and the applicable rules of any public stock exchange in the case of any initial public offering or subsequent
public offering or in response to rules or guidance of the United States Internal Revenue Service or other taxing authority, or in other legal processes, including by the rules or regulations of the United States Securities and Exchange Commission
or similar regulatory agency in a country other than the United States or of any stock exchange or other securities trading institution); provided, that, in each case of clauses (a) &#150; (c) any such disclosure or transfer shall only be made to
Persons who are bound by written obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> consistent with those described in Article 9 (or industry standards in the case of a disclosure pursuant to clause (b)(ii)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1.3 <U>Requirement to Cooperate to Enable Accurate Public Disclosure</U>. To the extent either Party discloses to the other Party any
Confidential Information which is a fact, result or event relating to the Metagenomi Research Activities or the Development, Manufacture or Commercialization of any Licensed Product that the Receiving Party in good faith reasonably believes is
insufficient to allow the Receiving Party to fully understand the materiality of such Confidential Information for purposes of determining whether the Receiving Party is required to disclose, to any Governmental Authority or publicly, any such
Confidential Information in order to comply with Applicable Laws (including securities laws or regulations and the applicable rules of any public stock exchange), the Disclosing Party agrees to discuss such Confidential Information with the
Receiving Party and provide any additional information reasonably necessary to enable the Receiving Party to assess the materiality, and the accuracy and completeness, of such information for such public disclosure purposes as the case may be, which
additional information shall be treated as the Disclosing Party&#146;s additional Confidential Information and shall be treated in accordance with the terms hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <B><U>Publicity</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.1 <U>Press Releases</U>. The Parties shall, upon such timing as the Parties jointly agree, issue a joint press release with respect to
this Agreement, and each Party may make subsequent public disclosure of the contents of such press release without further approval of the other Party. Subject to the foregoing, except as otherwise permitted under this Article 9, neither Party shall
issue a press or news release or make any similar public announcement related to the Research Plan or the terms and conditions of this Agreement without the prior written consent of the other Party.&nbsp;If a Party determines the need to make an
announcement related to this Agreement (as distinct from a publication related to a Licensed Product, which is subject to Section&nbsp;9.2.2) is required by Applicable Laws, it shall, to the extent reasonably practicable and permitted, give the
other Party at least [***] advance notice of the text of the announcement so that the other Party will have an opportunity to comment upon the announcement. With respect to any such public disclosure, except for the initial press release described
above, the requesting Party (the &#147;<B>Requesting Party</B>&#148;) shall provide the other Party (the &#147;<B>Reviewing Party</B>&#148;) with a draft of the Content (as defined in the next sentence) of the draft press release or public
disclosure for review, at least [***] (if practicable under the circumstances, or if not practicable, such shorter time) in advance of the issuance of the press release or filing. The word &#147;<B>Content</B>&#148; in this Section&nbsp;9.2.1 means
any information relating to the activities contemplated by this Agreement and does not include any other business information of the Requesting Party or information pertaining to the &#147;safe harbor&#148; provisions of the U.S. Private Securities
Litigation Reform Act of 1995 relating to &#147;forward-looking statements.&#148; The Reviewing Party may notify the Requesting Party of any reasonable objections or suggestions that the Reviewing Party may have regarding the Content in the proposed
public disclosure provided for review, and the Requesting Party shall reasonably consider any such objections or suggestions that are provided in a timely manner. The Requesting Party shall use diligent and good faith efforts to adopt the reasonable
requests of the Reviewing Party with respect to its Confidential Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2.2 <U>Right to Publish/Present</U>.
<B></B>Notwithstanding the foregoing or anything to the contrary in this Agreement, except as set forth in the last sentence of this Section&nbsp;9.2.2, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the sole right to publish or
publicly present all results or any and all milestone events achieved with respect to the research (including arising from or relating to the Metagenomi Research Activities), Development, Manufacture or Commercialization of any Licensed Product;
provided, that, to the extent such publication contains Metagenomi&#146;s Confidential Information, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall submit a draft of any proposed press release, manuscript, abstract or speech to Metagenomi at
least [***] prior to any such submission for publication and at least [***] prior to any such oral presentation and Metagenomi shall have the right to notify <FONT STYLE="white-space:nowrap">Affini-T</FONT> in writing within such [***]or [***], as
applicable, period if it reasonably determines that such draft contains Confidential Information of Metagenomi, in which case <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall remove such Confidential Information from the proposed press
release, manuscript, abstract or speech. Subject to the foregoing portion of this Section&nbsp;9.2.2, Metagenomi shall have the right to publish or present without the prior written consent of <FONT STYLE="white-space:nowrap">Affini-T</FONT> so long
as no Confidential Information of <FONT STYLE="white-space:nowrap">Affini-T</FONT> is included in any such publication or presentation (including no Product Information). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <B><U>Permitted Publication</U></B>. Notwithstanding Section&nbsp;9.2,
either Party may include in a public disclosure, without prior delivery to or approval by the other Party, any information which has previously been included in a public disclosure pursuant to Section&nbsp;9.2. A Party relying on this
Section&nbsp;9.3 shall bear the burden of establishing that information has previously been included in a public disclosure that has been approved pursuant to Section&nbsp;9.2 or published or publicly disclosed by the other Party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <B><U>Use of Proprietary Materials</U></B>. From time to time during the Term, either Party (the &#147;<B>Transferring
Party</B>&#148;) may supply the other Party (the &#147;<B>Recipient Party</B>&#148;) with Proprietary Materials of the Transferring Party for use in connection with this Agreement. Any Proprietary Materials being provided to Recipient Party shall be
accompanied by a Materials Transfer Record substantially in the form of <U>Schedule 9.4</U>, which shall be signed by an official representative of both Parties. In connection with the receipt of any Proprietary Materials from the Transferring
Party, each Recipient Party hereby agrees that (a)&nbsp;it shall not use such Proprietary Materials for any purpose other than exercising its rights or performing its obligations hereunder; (b)&nbsp;it shall use such Proprietary Materials only in
compliance with all Applicable Laws; (c)&nbsp;it shall not transfer any such Proprietary Materials to any Third Party without the prior written consent of the Transferring Party; (d)&nbsp;the Recipient Party shall not acquire any rights of
ownership, or title in or to, such Proprietary Materials as a result of such supply by the Transferring Party; and (e)&nbsp;upon the expiration or termination of this Agreement, the Recipient Party shall, if and as instructed by the Transferring
Party, either destroy or return any such Proprietary Materials that are not the subject of the grant of a continuing license hereunder; provided, that each Recipient Party may retain the Proprietary Materials of the Transferring Party for the sole
purpose of fulfilling regulatory requirements or industry best practices, including archived encapsulated cells from nonclinical GLP and clinical studies. EACH PARTY ACKNOWLEDGES THAT THE PROPRIETARY MATERIALS ARE BEING SUPPLIED WITH NO WARRANTIES,
EXPRESS OR IMPLIED, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE PROPRIETARY MATERIALS WILL NOT INFRINGE ANY PATENT OR PROPRIETARY RIGHTS OF ANY THIRD PARTY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>10. <U>INTELLECTUAL PROPERTY RIGHTS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1 <B><U>Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP</U></B>. If Metagenomi knows or should have
knowledge of any Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP that Metagenomi has a right to sublicense (&#147;<B>Sublicenseable Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP</B>&#148;), or <FONT
STYLE="white-space:nowrap">Affini-T</FONT> becomes aware of any Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP, then Metagenomi or <FONT STYLE="white-space:nowrap">Affini-T,</FONT> as applicable, shall promptly notify the other
Party in writing of any such Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP (i.e., Sublicenseable Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP in the case of Metagenomi, and Metagenomi <FONT
STYLE="white-space:nowrap">In-Licensed</FONT> IP in the case of <FONT STYLE="white-space:nowrap">Affini-T),</FONT> including, in the case of Metagenomi providing a general description of the relevant Sublicenseable Metagenomi <FONT
STYLE="white-space:nowrap">In-Licensed</FONT> IP and any applicable financial terms (if <FONT STYLE="white-space:nowrap">Affini-T</FONT> initiates this process, then Metagenomi shall promptly respond to
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> initial notice advising whether such Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP is Sublicenseable Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP and,
if it is, with such information). Upon receipt of any such notice from Metagenomi (including a subsequent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
notice if Metagenomi is to provide information following an initial notice from <FONT STYLE="white-space:nowrap">Affini-T),</FONT> <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the
right to request, and Metagenomi shall provide, a copy of the license agreement and any amendments thereto with respect to such Sublicenseable Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP (the &#147;<B>Upstream
Agreement</B>&#148;) and answer any reasonable questions with respect to such Upstream Agreement and Sublicenseable Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP. Following such discussions,
<FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right to include such Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP as Metagenomi Background IP hereunder upon written notice to Metagenomi subject to <FONT
STYLE="white-space:nowrap">Affini-T</FONT> agreeing to be subject to any pass-through obligations or limitations applicable to <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> exercise of such rights, including responsibility for payment
obligations to the extent solely attributable to the rights granted to <FONT STYLE="white-space:nowrap">Affini-T.</FONT> To the extent Sublicenseable Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP is included as Metagenomi
Background IP, Metagenomi shall comply with all terms and conditions of, and shall maintain in full force and effect each relevant Upstream Agreement related to such Sublicenseable Metagenomi <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP
and shall not terminate or amend any such Upstream Agreement in a way that could have an adverse effect on <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> rights without <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> prior written
consent, such consent not to be unreasonably withheld or delayed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.2 <B><U>Ownership of Agreement IP</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.2.1 <U>General</U>. As between the Parties, all right, title and interest in any Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT>
and Agreement Patent Rights, shall be owned as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Metagenomi shall solely own all (i)&nbsp;Agreement <FONT
STYLE="white-space:nowrap">Know-How</FONT> that solely (1)&nbsp;relates to the identification, characterization, composition of matter, and manufacture of Metagenomi Reagents, or (2)&nbsp;constitutes an improvement to Metagenomi Background IP
(collectively (1)&nbsp;and (2), &#147;<B>Metagenomi Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148;), and (ii)&nbsp;Patent Rights that Cover Metagenomi Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT>
(&#147;<B>Metagenomi Agreement Patent Rights</B>&#148;) (collectively (i)&nbsp;and (ii), &#147;<B>Metagenomi Agreement IP</B>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall solely own all (i)&nbsp;Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT>
that is not Metagenomi Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT> (&#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT></B>&#148;), including all Agreement <FONT
STYLE="white-space:nowrap">Know-How</FONT> that constitutes an improvement to <FONT STYLE="white-space:nowrap">Affini-T</FONT> Background IP, and (ii)&nbsp;Patent Rights that Cover <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement <FONT
STYLE="white-space:nowrap">Know-How</FONT> (&#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement Patent Rights</B>&#148;) (collectively (i)&nbsp;and (ii), &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement
IP</B>&#148;).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.2.2 Notice, Assignments, Assistance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Each Party shall (i)&nbsp;promptly notify the other Party of any Agreement <FONT STYLE="white-space:nowrap">Know-How</FONT> made by or on
behalf of itself and that is to be owned by the other Party, and (ii)&nbsp;hereby assigns, transfers and conveys to the other Party, or its designee, all of such Party&#146;s worldwide right, title and interest in and to any and all Agreement IP
that is to be owned by such other Party in accordance with Section&nbsp;10.2.1, including any and all moral rights and intellectual property rights inherent therein and appurtenant thereto, including all Patent Rights, copyrights, trademarks, <FONT
STYLE="white-space:nowrap">Know-How</FONT> and trade secrets and the rights to apply for the same. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Upon the request and at the reasonable expense of the other Party, each Party shall
execute and deliver any and all instruments and documents and take such other acts as may be necessary or desirable to document the assignment and transfer described in Section&nbsp;10.2.2(a) or to enable such other Party to secure its rights in the
applicable Agreement IP, including providing any necessary powers of attorney for such purpose.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.2.3 <U>CREATE Act</U>. Notwithstanding
anything to the contrary in this Article 10, neither Party shall have the right to make an election under the Cooperative Research and Technology Enhancement Act of 2004, 35 U.S.C. 103(c)(2)-(c)(3) (the &#147;<B>CREATE Act</B>&#148;) when exercising
its rights under this Article 10 without the prior written consent of the other Party. With respect to any such permitted election, the Parties shall coordinate their activities with respect to any submissions, filings, or other activities in
support thereof. The Parties acknowledge and agree that this Agreement is a &#147;joint research agreement&#148; as defined in the CREATE Act. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>11. <U>FILING, PROSECUTION AND MAINTENANCE OF PATENT RIGHTS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1 <B><U>Patent Prosecution</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.1 <U>Metagenomi </U><U>Patent </U><U>Prosecution Rights</U>. Subject to the last sentence of this Section&nbsp;11.1.1, Metagenomi shall
be solely responsible (but not obligated) for the Patent Prosecution of the Metagenomi Agreement Patent Rights. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall cooperate with and reasonably assist Metagenomi in connection with
Metagenomi&#146;s Patent Prosecution of the Metagenomi Agreement Patent Rights (including review and providing comments for responses to office actions or official actions from worldwide patent offices), including by obtaining assignments to reflect
chain of title consistent with the terms of this Agreement. All Patent Costs incurred by Metagenomi in connection with the Patent Prosecution of such Patent Rights shall be the sole responsibility of Metagenomi. If Metagenomi decides to cease
prosecution of or to allow to lapse any Metagenomi Agreement Patent Right, it shall inform <FONT STYLE="white-space:nowrap">Affini-T</FONT> of such decision promptly and, in any event, so as to provide
<FONT STYLE="white-space:nowrap">Affini-T</FONT> a reasonable amount of time to meet any applicable deadline to establish or preserve such Patent Rights. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right, but not the obligation,
to assume sole responsibility for continuing the prosecution of such Patent Rights and paying any required Patent Costs to maintain such Patent Rights or defend such Patent Rights. If <FONT STYLE="white-space:nowrap">Affini-T</FONT> notifies
Metagenomi that it desires to assume responsibility for any such Metagenomi Agreement Patent Right, then <FONT STYLE="white-space:nowrap">Affini-T</FONT> will have the right to undertake the Patent Prosecution with respect to such Patent Right in
Metagenomi&#146;s name and such Patent Right shall cease to be a Metagenomi Patent Right for purposes of determining the Royalty Term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.2 <U>Metagenomi&#146;s Patent Defense Rights</U>. Metagenomi will notify <FONT STYLE="white-space:nowrap">Affini-T</FONT> within [***] of
becoming aware of any declaratory judgment, opposition, or similar action alleging the invalidity, unenforceability or <FONT STYLE="white-space:nowrap">non-infringement</FONT> of any of the Metagenomi Agreement Patent Rights in the Territory.
Metagenomi shall only be primarily responsible (but not obligated) for the Patent Defense of Metagenomi Agreement Patent Rights. At Metagenomi&#146;s reasonable expense, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall cooperate with and
assist Metagenomi in all reasonable respects, in connection with Metagenomi&#146;s Patent Defense activities. All Patent Costs incurred by Metagenomi in connection with the Patent Defense of such Patent Rights shall be the sole responsibility of
Metagenomi. If Metagenomi decides to cease such Patent Defense with respect to any such Patent Right, it shall inform <FONT STYLE="white-space:nowrap">Affini-T</FONT> of such decision promptly and, in any event, so as to provide <FONT
STYLE="white-space:nowrap">Affini-T</FONT> a reasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amount of time to meet any applicable deadline to defend or preserve such Patent Rights. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right, but not the obligation, to assume
sole responsibility for continuing such Patent Defense (and thereafter the prosecution of such Patent Rights). If <FONT STYLE="white-space:nowrap">Affini-T</FONT> notifies Metagenomi that it desires to assume responsibility for any such Patent
Defense, then <FONT STYLE="white-space:nowrap">Affini-T</FONT> will have the right to undertake the Patent Defense with respect to such Patent Right in Metagenomi&#146;s name. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.3 <U><FONT STYLE="white-space:nowrap">Affini-T</FONT> Prosecution Rights</U>. As between the Parties,
<FONT STYLE="white-space:nowrap">Affini-T,</FONT> at its sole expense, shall be solely responsible for the Patent Prosecution of all <FONT STYLE="white-space:nowrap">Affini-T</FONT> Patent Rights. Metagenomi shall cooperate with and assist <FONT
STYLE="white-space:nowrap">Affini-T</FONT> in all reasonable respects in connection with <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> Patent Prosecution of such Patent Rights, including by obtaining assignments to reflect chain of title
consistent with the terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.4 <U><FONT STYLE="white-space:nowrap">Affini-T</FONT></U><U>&#146;</U><U>s Patent
Defense Rights</U>. <FONT STYLE="white-space:nowrap">Affini-T</FONT> will notify Metagenomi within [***] of becoming aware of any declaratory judgment, opposition, or similar action alleging the invalidity, unenforceability or <FONT
STYLE="white-space:nowrap">non-infringement</FONT> of any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Patent Rights in the Territory. <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall be responsible for the Patent Defense of such <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Patent Rights. Metagenomi shall cooperate with and assist <FONT STYLE="white-space:nowrap">Affini-T,</FONT> at <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> reasonable expense, in all reasonable
respects in connection with <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> Patent Defense activities. All Patent Costs incurred by <FONT STYLE="white-space:nowrap">Affini-T</FONT> in connection with the Patent Defense of such <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Patent Rights shall be, as between the Parties, the sole responsibility of <FONT STYLE="white-space:nowrap">Affini-T.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1.5 <U>I</U><U>nformation and Cooperation</U>. Metagenomi shall (a)&nbsp;promptly provide <FONT STYLE="white-space:nowrap">Affini-T</FONT>
with copies of all patent applications with respect to Metagenomi Agreement Patent Rights to be filed pursuant to Section&nbsp;11.1.1 and other material submissions and correspondence with the applicable patent offices, at least [***] (unless the
circumstances require otherwise) prior to undertaking any filing for review and comment by <FONT STYLE="white-space:nowrap">Affini-T</FONT> and (b)&nbsp;provide <FONT STYLE="white-space:nowrap">Affini-T</FONT> and its patent counsel with an
opportunity to consult with Metagenomi and its patent counsel regarding the filing and contents of any such application, amendment, submission or response, during such review period and as may otherwise be agreed by the Parties. The advice and
suggestions of <FONT STYLE="white-space:nowrap">Affini-T</FONT> and its patent counsel shall be taken into consideration in good faith by Metagenomi and its patent counsel in connection with such filing; provided, that, if <FONT
STYLE="white-space:nowrap">Affini-T</FONT> fails to timely provide any comment before the proposed filing or response date, Metagenomi&#146;s obligations under this Section&nbsp;11.1.4 shall be deemed to have been fulfilled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.2 <B><U>Third Party Infringement</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.2.1 If (a)&nbsp;Metagenomi becomes aware of any suspected infringement of any Metagenomi Patent Rights or misappropriation of any Agreement
<FONT STYLE="white-space:nowrap">Know-How,</FONT> in each case with respect to the use by a Third Party of the Metagenomi Reagents to make Gene Edits directed to an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in the Exclusive
Field (&#147;<B>Infringement</B>&#148;); or <FONT STYLE="white-space:nowrap">(b)&nbsp;Affini-T</FONT> becomes aware of an Infringement, then that Party shall promptly notify the other Party of such Infringement of which it is aware (each, an
&#147;<B>Infringement Notice</B>&#148;). The Parties shall promptly meet to discuss any Infringement and the strategy for patent enforcement with respect to that Infringement; provided, that, at the request of either Party, the Parties shall first
execute a common interest agreement before any such meetings or exchange of detailed information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.2.2 Metagenomi shall have the first right, but not the obligation, to address any such
Infringement in the Territory with respect to the Metagenomi Agreement IP, taking reasonable steps, which may include the institution of legal proceedings or other action, and to compromise or settle such Infringement (each, an &#147;<B>Infringement
Response</B>&#148;); provided, that: (A)&nbsp;Metagenomi shall keep <FONT STYLE="white-space:nowrap">Affini-T</FONT> reasonably informed about any such Infringement Response and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall provide all
reasonable cooperation to Metagenomi in connection with such Infringement Response; (B)&nbsp;Metagenomi shall not take any position with respect to, or compromise or settle, any such Infringement that relates to any Metagenomi Agreement IP in any
way that is reasonably likely to adversely affect the scope, validity or enforceability of any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Agreement IP, the Commercial License or any Licensed Product, without the prior consent of <FONT
STYLE="white-space:nowrap">Affini-T,</FONT> which consent shall not be unreasonably withheld, conditioned or delayed; and (C)&nbsp;if Metagenomi does not intend to or does not take any action to prosecute or defend an Infringement of Metagenomi
Agreement IP within [***] after the date of the Infringement Notice, or ceases to diligently pursue an Infringement Response with respect to such an Infringement of Metagenomi Patent Rights, it shall promptly inform
<FONT STYLE="white-space:nowrap">Affini-T</FONT> in such a manner that such Infringement Response will not be prejudiced and <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right, but not the obligation, to assume sole responsibility
to prosecute or defend an Infringement of such Patent Rights and paying all future costs associated with such Infringement Costs.<B> </B>All costs, including attorneys&#146; fees, relating to an Infringement Response from Metagenomi shall be borne
solely by Metagenomi. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.2.3 Each Party shall have the right to participate and be represented by counsel that it selects, in any
Infringement Response instituted or continued under Section&nbsp;11.2.2 by the other Party. If a Party with the right to initiate an Infringement Response under Section&nbsp;11.2.2 to eliminate an Infringement lacks standing to do so and the other
Party has standing to initiate such action, then the Party with the right to initiate an action under Section&nbsp;11.2.2 may name the other Party as plaintiff in such action or may require the Party with standing to initiate such Infringement
Response at the expense of the other Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.2.4 In any Infringement Response instituted under this Section&nbsp;11.2, the Parties
shall cooperate with and reasonably assist each other in all reasonable respects. Upon the reasonable request of the Party instituting that Infringement Response, the other Party shall join such Infringement Response and shall be represented using
counsel of its own choice, at the requesting Party&#146;s expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.2.5 Any settlements, damages or monetary awards
(&#147;<B>Recovery</B>&#148;) recovered by either Party pursuant to any Infringement Response shall, after reimbursing the Parties for their reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses), be [***]or[***] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3 <B><U>Defense of Claims</U></B>. If any action, suit or proceeding is brought against either Party or any Affiliate of
either Party alleging the misappropriation or infringement of the <FONT STYLE="white-space:nowrap">Know-How</FONT> or Patent Rights of a Third Party by reason of the research, Development, Manufacture or Commercialization of any Licensed Product or
component thereof, including receipt of any notices of infringement under 35 U.S.C. &#167; 271(e)(2), 42 U.S.C. &#167; 262(1), or 42 U.S.C. &#167; 262(1)(9)(C), such Party shall notify the other Party within [***] of the earlier of (a)&nbsp;receipt
of service of process in such action, suit or proceeding, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
or (b)&nbsp;the date such Party becomes aware that such action, suit or proceeding has been instituted. To the extent such action, suit or proceeding does not relate to Metagenomi Reagents, <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall have the sole right but not the obligation to control and defend such action, suit or proceeding at its sole expense. To the extent such action, suit or proceeding relates to Metagenomi Reagents, the
Parties shall meet as soon as possible to discuss the overall strategy for defense of such matter and except as unanimously agreed by the Parties, <FONT STYLE="white-space:nowrap">(i)&nbsp;Affini-T</FONT> shall have the right but not the obligation
to control and defend such action, suit or proceeding at its sole expense; (ii)&nbsp;Metagenomi shall have the right to engage separate counsel at its own expense in any such action, suit or proceeding; and (iii)&nbsp;the Parties shall cooperate
with each other in all reasonable respects in any such action, suit or proceeding. Each Party shall promptly furnish the other Party with a copy of each communication relating to the alleged infringement or misappropriation and a Metagenomi Reagent
that is received by such Party including all documents filed in any litigation </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.4 <B><U>Patent Term Extension</U></B>.
The Parties shall cooperate with each other in obtaining patent term extensions or supplemental protection certificates or their equivalents in any country in the Territory where applicable to any Patent Right Covering a Licensed Product. Such
cooperation shall include diligently and timely conferring and coordinating with respect to such matters to ensure compliance with applicable filing deadlines and agreeing on procedures to be followed by the Parties to ensure such compliance. In the
event that elections with respect to obtaining such patent term extension are to be made or the Parties otherwise disagree, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right to make the election or decision solely with respect to
any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Patent Rights, and Metagenomi shall retain the right with respect to an election or decision with respect to the Metagenomi Patent Rights; provided that, Metagenomi shall consider any input from <FONT
STYLE="white-space:nowrap">Affini-T</FONT> with respect to the decision to extend Metagenomi Patent Rights in good faith. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>12. <U>TERM
AND TERMINATION</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1 <B><U>Term</U></B>. This Agreement shall commence on the Effective Date and shall continue
in full force and effect, unless otherwise terminated pursuant to Section&nbsp;12.2, until the fifth year anniversary of the Effective Date (the &#147;<B>Initial Term</B>&#148;); provided that, if <FONT STYLE="white-space:nowrap">Affini-T</FONT>
exercises an Exclusive Option<B> </B>with respect to any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target during the Initial Term, then the Initial Term shall be extended by five (5)&nbsp;years (the &#147;<B>Extended Term</B>&#148;)
to allow <FONT STYLE="white-space:nowrap">Affini-T</FONT> to exercise its Option with respect to other <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Targets. Following the expiration of the Extended Term, if any, this Agreement shall
survive, on an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis, with respect
to each <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target for which <FONT STYLE="white-space:nowrap">Affini-T</FONT> has exercised its Option during the Initial Term or Extended Term until the earlier of (i)&nbsp;termination of such <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target in its entirety under Section&nbsp;12.2 and (ii)&nbsp;the last day of the Royalty Term for the last Licensed Product associated with such <FONT STYLE="white-space:nowrap">Affini-T</FONT>
Clinical Target (collectively, the Initial Term, Extended Term (if any) and foregoing survival, the &#147;<B>Term</B>&#148;). Upon the expiration of the Royalty Term with respect to a given Licensed Product, country, and Field, the Commercial
License granted to <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall be retained as fully <FONT STYLE="white-space:nowrap">paid-up,</FONT> irrevocable and perpetual licenses with respect to such Licensed Product, country, and Field. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2 <B><U>Termination</U></B>. This Agreement, a given <FONT
STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target or a Licensed Product may be terminated as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.2.1 <U>Unilateral Right
to Terminate</U>. <FONT STYLE="white-space:nowrap">Affini-T</FONT> may terminate this Agreement (a)&nbsp;in its entirety, or (b)&nbsp;on (i) a Research <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Plan-by-Research</FONT></FONT>
Plan basis, (ii)&nbsp;an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis, or
(iii)&nbsp;a Licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product basis (terminations under this subclause (b), a &#147;<B>Partial Termination</B>&#148;), effective at any time by
providing not less than sixty (60)&nbsp;days&#146; prior written notice to Metagenomi. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.2.2 <U>Termination for Breach</U>. If a Party
materially breaches this Agreement, then the <FONT STYLE="white-space:nowrap">non-breaching</FONT> Party may provide the breaching Party with a written notice specifying the nature of the breach, and stating its intention to terminate this Agreement
if such breach is not cured; provided, that, this Agreement may only be terminated in its entirety pursuant to this Section&nbsp;12.2.2 if the material breach materially and adversely impacts this Agreement as a whole, otherwise such termination
must be specific to the impacted Research Plan, <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target or Licensed Product, as such specifically impacted subject matter(s) are noted in the notice of breach (also, a &#147;<B>Partial
Termination</B>&#148;). If the material breach is not cured by the allegedly breaching Party within [***] after the receipt of such notice or if such other breach is curable but cannot be cured within the [***]period, the allegedly breaching Party
fails to commence actions during such [***]period to cure such breach and thereafter fails to use Commercially Reasonable Efforts to promptly cure such breach, then, in each case, the <FONT STYLE="white-space:nowrap">non-breaching</FONT> Party shall
be entitled, without prejudice to any of its other rights under this Agreement, and in addition to any other remedies available to it by law or in equity, to terminate this Agreement by providing written notice to the other Party. If the allegedly
breaching Party in good faith disputes such material breach or the failure to cure or remedy such material breach, such Party shall, within [***] of receipt of written notice from the other Party of termination (a)&nbsp;provide written notice of
that dispute putting forward in reasonable detail the rationale for disputing the alleged breach to the notifying Party and (b)&nbsp;initiate a proceeding in accordance with Section&nbsp;15.1, in which case, such termination shall not be effective
until [***] after the proceeding has concluded; provided that the breaching Party shall have [***] after such proceeding to cure the breach and during the pendency of any such proceeding the Parties shall continue performing their respective
obligations, and exercising their respective rights, under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.2.3 <U>Termination for Insolvency</U>. Either Party shall
have the right to terminate this Agreement in its entirety upon immediate written notice if the other Party (i)&nbsp;applies for or consents to the appointment of, or the taking of possession by, a receiver, custodian, trustee or liquidator of
itself or of all of a substantial part of its property, (ii)&nbsp;makes a general assignment for the benefit of its creditors, (iii)&nbsp;commences a voluntary case under the Bankruptcy Code of any country, (iv)&nbsp;files a petition seeking to take
advantage of any Applicable Laws relating to bankruptcy, insolvency, reorganization, <FONT STYLE="white-space:nowrap">winding-up,</FONT> or composition or readjustment of debts, (v)&nbsp;fails to controvert in a timely and appropriate manner, or
acquiesce in writing to, any petition filed against it in any involuntary case under the Bankruptcy Code of any country, (vi)&nbsp;takes any corporate action for the purpose of effecting any of the foregoing, (vii)&nbsp;has a proceeding or case
commenced against it in any court of competent jurisdiction, seeking (A)&nbsp;its liquidation, reorganization, dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> or the composition or readjustment of its debts, (B)&nbsp;the
appointment of a trustee, receiver, custodian, liquidator or the like of all or any substantial part of its assets, or (C)&nbsp;similar relief under the Bankruptcy Code of any country, or an order, judgment or decree approving any of the foregoing
is entered and continues unstayed for a period of [***], or (viii)&nbsp;has an order for relief against it entered in an involuntary case under the Bankruptcy Code of any country and, in any of (i)&nbsp;through (vii) above, the application,
assignment, commencement, filing, or corporate action continues unstayed for, or is not otherwise discharged or withdrawn on or before, a period of [***]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3 <B><U>Consequences of Termination</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3.1 If this Agreement is terminated in its entirety or subject to a Partial Termination by <FONT STYLE="white-space:nowrap">Affini-T</FONT>
pursuant to Section&nbsp;12.2.2 or Section&nbsp;12.2.3 or by Metagenomi pursuant to Section&nbsp;12.2.3, Metagenomi shall cease performing all applicable Metagenomi Research Activities. Upon <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT>
written request, Metagenomi will discuss in good faith (a)&nbsp;granting to <FONT STYLE="white-space:nowrap">Affini-T</FONT> a research use license with respect to any applicable Metagenomi Background IP, and/or (b)&nbsp;a transfer of all complete
or incomplete deliverables, reports and data with respect to the terminated Research Plan(s), <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target(s) or Licensed Product(s), in each case of (a)&nbsp;and (b), on commercially reasonable
terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3.2 If this Agreement is terminated in its entirety or subject to a Partial Termination by
<FONT STYLE="white-space:nowrap">Affini-T</FONT> pursuant to Section&nbsp;12.2.1, or by Metagenomi pursuant to Section&nbsp;12.2.2, Metagenomi shall cease performing all applicable Metagenomi Research Activities.
<FONT STYLE="white-space:nowrap">Affini-T</FONT> shall be responsible for any <FONT STYLE="white-space:nowrap">non-cancellable</FONT> costs incurred in accordance with an applicable Research Plan (and the subject of which costs cannot be reasonably
allocable to other activities being conducted by Metagenomi). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3.3 Subject to the foregoing Section&nbsp;12.3.1 and
Section&nbsp;12.3.2, all rights and licenses granted by one Party to the other under Article 2 will terminate with respect to the terminated subject matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.3.4 Notwithstanding the foregoing, with respect to a Licensed Product on a Licensed <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Product-by-Licensed</FONT></FONT> Product basis or with respect to all Licensed Products directed to such an <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target on an
<FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Target-by-Affini-T</FONT></FONT></FONT> Clinical Target basis, in the event that <FONT
STYLE="white-space:nowrap">Affini-T</FONT> has the right to terminate this Agreement in accordance with Section&nbsp;12.2.2 as a result of a breach under Section&nbsp;2.1.2 (Commercial License), 2.2
<FONT STYLE="white-space:nowrap">(Non-Compete),</FONT> 4.2.1 (Metagenomi Responsibilities), 4.3 (Compliance), 9.1 (Confidentiality), 13.2.1 (No Claims), 13.2.3 (Ownership), 13.2.4 (Completeness) or 14.2 (Indemnification), and such breach resulted in
a material adverse effect on the potential or actual development or commercialization of such Licensed Product(s) or such <FONT STYLE="white-space:nowrap">Affini-T</FONT> Clinical Target(s), then, in lieu of exercising such termination right, <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall have the right, by way of written notice to Metagenomi, to continue this Agreement in accordance with its terms subject to [***] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.4 <B><U>Surviving Provisions</U></B>. Termination or expiration of this Agreement for any reason shall be without prejudice
to: (a)&nbsp;the survival of rights specifically stated in this Agreement to survive, including as set forth in this Section&nbsp;12.4; (b) the rights and obligations of the Parties provided in Sections 2.1.4 (only for expiration and not
termination), 4.4 (for the period set forth therein), 5.5.2 (first two sentences only and only for expiration and not termination), 8.4.4 (for the period set forth therein), 8.4.5, 10.2.2(b), 12.3 (as applicable) and 12.4<B> </B>and Articles 1, 9
(for the period set forth in 9.1.1), 14 and 15 (excluding Section&nbsp;15.8) (including all other Sections or Articles referenced in any such Section or Article), all of which shall survive such termination except as provided in this Article 12; and
(c)&nbsp;any other rights or remedies provided at law or equity which either Party may otherwise have. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>13. <U>REPRESENTATIONS AND WARRANTIES</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.1 <B><U>Mutual Representations and Warranties</U></B>. Metagenomi and <FONT STYLE="white-space:nowrap">Affini-T</FONT> each
represents and warrants to the other, as of the Effective Date, as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.1.1 <U>Organization</U>. It is a corporation or company
duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, and has all requisite power and authority, corporate or otherwise, to execute, deliver and perform this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.1.2 <U>Authorization</U>. The execution and delivery of this Agreement and the performance by it of the transactions contemplated hereby
have been duly authorized by all necessary corporate action and will not violate (a)&nbsp;such Party&#146;s certificate of incorporation or bylaws, (b)&nbsp;any agreement, instrument or contractual obligation to which such Party is bound in any
material respect, (c)&nbsp;any requirement of any Applicable Laws, or (d)&nbsp;any order, writ, judgment, injunction, decree, determination or award of any court or Governmental Authority presently in effect applicable to such Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.1.3 <U>Binding Agreement</U>. This Agreement is a legal, valid and binding obligation of such Party, enforceable against it in accordance
with its terms and conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.1.4 <U>No Inconsistent Obligation</U>. It is not under, and will not become subject to, any obligation,
contractual or otherwise, to any Person that conflicts with or is inconsistent in any respect with the terms of this Agreement or that would impede the diligent and complete fulfillment of its obligations hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.2 <B><U>Additional Representations, Warranties and Covenants of Metagenomi</U></B>. Metagenomi further represents and
warrants to <FONT STYLE="white-space:nowrap">Affini-T,</FONT> as of the Effective Date, as follows:</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.1 <U>No Claims</U>.<B> </B>There
are no claims, judgments or settlements against Metagenomi pending, or threatened that invalidate or seek to invalidate Metagenomi&#146;s rights in any Metagenomi Background IP. To Metagenomi&#146;s knowledge, the exploitation of the Metagenomi
Reagents and Metagenomi Background IP and use of Metagenomi Reagents by <FONT STYLE="white-space:nowrap">Affini-T</FONT> in accordance with the terms of this Agreement, including as used in connection with
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> further research, Development, Manufacturing or Commercialization of Licensed Products, will not infringe on the rights of any Third Party, including any Third Party intellectual property
rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.2 <U>No Conflict</U>. Metagenomi has not granted any right, license or interest in or to the Metagenomi Patent Rights that
is inconsistent with the licenses and rights granted to <FONT STYLE="white-space:nowrap">Affini-T</FONT> under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.3 <U>Ownership</U>. Metagenomi is the sole and exclusive owner of the Metagenomi
Reagents, Metagenomi Background IP, and Metagenomi Patent Rights, and, in each case, has the ability to grant to <FONT STYLE="white-space:nowrap">Affini-T</FONT> the rights granted to <FONT STYLE="white-space:nowrap">Affini-T</FONT> under this
Agreement, and such ownership is free and clear of all encumbrances, security interests, options and licenses. None of the Metagenomi Reagents or Metagenomi Patent Rights is subject to any existing royalty or other payment obligations to any Third
Party under any agreement or understanding entered into by Metagenomi or its Affiliates, and to Metagenomi&#146;s knowledge of any obligation to pay any royalties or other amounts to any Third Party by reason of
<FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> use thereof as contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.4 <U>Completeness</U>. The
intellectual property licensed to <FONT STYLE="white-space:nowrap">Affini-T</FONT> hereunder represents all of the intellectual property rights that are being used by Metagenomi or its Affiliates, or that are necessary or useful, for the
exploitation of the Metagenomi Reagents internally referred to by Metagenomi, as of the Effective Date, as [***]. The Patent Rights set forth in Schedule 13.2.4 represents all patents that, as of the Effective Date, Metagenomi or its Affiliates
Control, and that (a)&nbsp;Cover the Metagenomi Reagents internally referred to by Metagenomi, as of the Effective Date, as [***], Gene Edit using such Metagenomi Reagents or, to Metagenomi&#146;s knowledge, Licensed Products made using such
Metagenomi Reagents, or (b)&nbsp;are otherwise necessary or useful to make, use, sell, import or practice such Metagenomi Reagent, Gene Edit using such Metagenomi Reagents, or, to Metagenomi&#146;s knowledge, Licensed Products incorporating such
Metagenomi Reagents, such schedule shall be updated from time to time by Metagenomi on and after the Effective Date. For each Metagenomi Reagent (other than the Metagenomi Reagents internally referred to by Metagenomi, as of the Effective Date, as
[***]), simultaneously with providing the Data Package in connection with such Research Plan, Metagenomi shall provide to <FONT STYLE="white-space:nowrap">Affini-T</FONT> a written statement that represents and warrants that, except as disclosed in
such written statement, the representations and warranties of Metagenomi set forth in this Section&nbsp;13.2.4 are true and correct with respect to such Metagenomi Reagent as of the date of such written statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.5 <U>No Interference</U>. The Metagenomi Patent Rights are not the subject of any interference proceeding and there is no pending or
threatened action, suit, proceeding or claim by a Third Party challenging Metagenomi&#146;s ownership rights in, or the validity or scope of, such Patent Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.6 <U>No Litigation</U>. There is no claim, action, suit, proceeding, complaint or investigation pending before any court or
administrative office or agency or, except with respect to disclosures provided in a letter from Simren Delaney at Metagenomi to Head of Legal at <FONT STYLE="white-space:nowrap">Affini-T</FONT> of even date herewith, to Metagenomi&#146;s knowledge,
currently threatened against, Metagenomi or any of its Affiliates, with respect to any of the Metagenomi Background IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.7 <U>No
Third Party Infringement</U>. Metagenomi has not initiated or been involved in any proceedings or claims in which it alleges that any Third Party is or was infringing or misappropriating any Metagenomi Background IP nor have any such proceedings
been threatened by Metagenomi. To Metagenomi&#146;s knowledge, no Person is infringing or threatening to infringe or misappropriating or threatening to misappropriate any of the Metagenomi Background IP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.8 <U>Assignment by Employees, Agents and Consultants</U>. All employees and agents of,
and consultants to, Metagenomi are obligated to assign to Metagenomi their rights in and to any inventions arising out of their work at Metagenomi either pursuant to written agreement or by operation of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.9 <U>No Government Funding</U>. The inventions and <FONT STYLE="white-space:nowrap">Know-How</FONT> included within Metagenomi Background
IP (a)&nbsp;were not conceived, discovered, developed, or otherwise made in connection with any research activities funded, in whole or in part, by the federal government of the U.S. or any agency thereof, (b)&nbsp;are not a &#147;subject
invention&#148; as that term is described in 35 U.S.C. Section&nbsp;201(f), and (c)&nbsp;are not otherwise subject to the provisions of the Bayh-Dole Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.10 <U>Absence of Debarment</U>. None of Metagenomi, its officers, employees, agents, consultants or any other person Metagenomi intends
to use in the performance of the Metagenomi Research Activities has been or is (a)&nbsp;debarred, convicted, or is subject to a pending debarment or conviction, pursuant to section 306 of the United States Food Drug and Cosmetic Act, 21 U.S.C.
&#167; 335a, (b)&nbsp;listed by any government or regulatory agencies as ineligible to participate in any government healthcare programs or government procurement or <FONT STYLE="white-space:nowrap">non-procurement</FONT> programs (as that term is
defined in 42 U.S.C. <FONT STYLE="white-space:nowrap">1320a-7b(f)),</FONT> or excluded, debarred, suspended or otherwise made ineligible to participate in any such program, or (c)&nbsp;convicted of a criminal offense related to the provision of
healthcare items or services, or is subject to any such pending action. Metagenomi agrees to inform <FONT STYLE="white-space:nowrap">Affini-T</FONT> in writing promptly if Metagenomi or any person who is performing Metagenomi Research Activities is
subject to the foregoing, or if any action, suit, claim, investigation, or proceeding relating to the foregoing is pending, or to the best of Metagenomi&#146;s knowledge, is threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.11 <U>Disclosure</U>. Metagenomi has made available to <FONT STYLE="white-space:nowrap">Affini-T</FONT> all toxicology studies, clinical
data, process and analytical development information, material filings and material correspondence with Regulatory Authorities, and all other material information in its possession or control relating to the Metagenomi Reagents internally referred
to by Metagenomi, as of the Effective Date, as [***], and, to Metagenomi&#146;s knowledge, all such information is complete and accurate in all material respects. For each Metagenomi Reagent (other than the Metagenomi Reagents internally referred to
by Metagenomi, as of the Effective Date, as [***]), simultaneously with providing the Data Package in connection with such Research Plan, Metagenomi shall provide to <FONT STYLE="white-space:nowrap">Affini-T</FONT> a written statement that
represents and warrants that, except as disclosed in such written statement, the representations and warranties of Metagenomi set forth in this Section&nbsp;13.2.11 are true and correct with respect to such Metagenomi Reagent as of the date of such
written statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2.12 <U>No Human Materials</U>. If pursuant to this Agreement Metagenomi provides to
<FONT STYLE="white-space:nowrap">Affini-T</FONT> any biological materials that consists of human tissues, cells or blood products or was directly obtained from human tissues, cells or blood products, then Metagenomi shall ensure that it has obtained
and maintained the informed consent required under state and federal law from the donor of the tissue for the research and development, information disclosure, handling, storage and any other use associated with the human tissue, cells or blood
products to be conducted under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.3 <B><U>Warranty Disclaimer</U></B>. EXCEPT AS OTHERWISE EXPRESSLY
PROVIDED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY WITH RESPECT TO ANY <FONT STYLE="white-space:nowrap">KNOW-HOW,</FONT> RIGHTS OR OTHER SUBJECT MATTER OF THIS AGREEMENT AND EACH PARTY HEREBY DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED,
INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.4 <B><U>No Warranty of
Success</U></B>. Nothing contained in this Agreement shall be construed as a warranty, either express or implied, on the part of either Party that (a)&nbsp;the Metagenomi Research Activities, or development of Metagenomi Reagents on behalf of <FONT
STYLE="white-space:nowrap">Affini-T</FONT> will be successful, (b)&nbsp;the Development or Commercialization of any Licensed Product will be successful, or (c)&nbsp;any Licensed Product will be commercially exploitable in any respect. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>14. <U>INDEMNIFICATION</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.1 <B><U>Indemnification of Metagenomi by <FONT STYLE="white-space:nowrap">Affini-T</FONT></U></B>. <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall indemnify, defend and hold harmless Metagenomi, its Affiliates, their respective employees, directors, agents, officers and consultants (collectively, the &#147;<B>Metagenomi Indemnitees</B>&#148;),
against all liabilities, damages, losses and expenses (including reasonable attorneys&#146; fees and expenses of litigation) (collectively, &#147;<B>Losses</B>&#148;) incurred by or imposed upon the Metagenomi Indemnitees, or any of them, as a
direct result of claims, suits, actions, demands or judgments of Third Parties, including personal injury and Licensed Product liability claims (collectively, &#147;<B>Metagenomi Indemnity Claims</B>&#148;), arising out of (a)&nbsp;any breach of
this Agreement (including any representation or warranty hereunder) by <FONT STYLE="white-space:nowrap">Affini-T</FONT> or any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnitee or Sublicensee,<B> </B>(b)&nbsp;the gross negligence or
willful misconduct of <FONT STYLE="white-space:nowrap">Affini-T</FONT> or any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnitee or Sublicensee, or (c)&nbsp;the Development or Commercialization of a Licensed Product by <FONT
STYLE="white-space:nowrap">Affini-T</FONT> or any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnitee or Sublicensee (expressly excluding any such activities conducted by or on behalf of Metagenomi or liabilities for which Metagenomi is
liable as the manufacturer under the Development Supply Agreement or Commercial Supply Agreement); provided, that (i)&nbsp;any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnity Claims or Losses for which Metagenomi has an obligation to
indemnify <FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnitees pursuant to Section&nbsp;14.2 shall be excluded and with respect to which claim or Losses each Party shall indemnify the other to the extent of their respective liability for
such Losses, <FONT STYLE="white-space:nowrap">(ii)&nbsp;Affini-T</FONT> has no obligation to indemnify with respect to Losses arising out of the infringement or misappropriation of Third Party&#146;s intellectual property rights as a result of the
exploitation of Metagenomi IP or the Metagenomi Reagents, in each case provided such exploitation is within the scope of the licenses granted to <FONT STYLE="white-space:nowrap">Affini-T</FONT> hereunder, and
<FONT STYLE="white-space:nowrap">(iii)&nbsp;Affini-T&#146;s</FONT> indemnification obligations shall be limited to the extent that it is increased by Metagenomi&#146;s or any Metagenomi Indemnitee&#146;s negligence. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.2 <B><U>Indemnification of
<FONT STYLE="white-space:nowrap">Affini-T</FONT> by Metagenomi</U></B>. Metagenomi shall indemnify, defend and hold harmless <FONT STYLE="white-space:nowrap">Affini-T,</FONT> its Affiliates, their respective employees, directors, agents, officers
and consultants (collectively, the &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnitees</B>&#148;), against all Losses incurred by or imposed upon the <FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnitees, or any of them, as
a direct result of claims, suits, actions, demands or judgments of Third Parties, including personal injury and Licensed Product liability claims (collectively, &#147;<B><FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnity Claims</B>&#148;)
arising out of (a)&nbsp;any breach of this Agreement (including any representation or warranty hereunder) by Metagenomi or any Metagenomi Indemnitee, or (b)&nbsp;the gross negligence or willful misconduct of Metagenomi or any Metagenomi Indemnitee;
provided, that (i)&nbsp;any Metagenomi Indemnity Claim or Losses for which <FONT STYLE="white-space:nowrap">Affini-T</FONT> has an obligation to indemnify any Metagenomi Indemnitees pursuant to Section&nbsp;14.1 shall be excluded and with respect to
which claims or Losses each Party shall indemnify the other to the extent of their respective liability for such Losses, and (ii)&nbsp;Metagenomi&#146;s indemnification obligations shall be limited to the extent that it is increased by <FONT
STYLE="white-space:nowrap">Affini-T</FONT> or any <FONT STYLE="white-space:nowrap">Affini-T</FONT> Indemnitees negligence. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.3 <B><U>Conditions to Indemnification</U></B>. A Person seeking recovery under this Article 14 (the &#147;<B>Indemnified
Party</B>&#148;) in respect of a Claim shall give prompt notice of such Claim to the Party from whom indemnification is sought (the &#147;<B>Indemnifying Party</B>&#148;); provided, that the Indemnifying Party is not contesting its obligation under
this Article 14, shall permit the Indemnifying Party to control any litigation relating to such Claim (including selecting counsel) and the disposition of such Claim; and further provided, that the Indemnifying Party shall (a)&nbsp;act reasonably
and in good faith with respect to all matters relating to the settlement or disposition of such Claim as the settlement or disposition relates to such Indemnified Party and (b)&nbsp;not settle or otherwise resolve such claim without the prior
written consent of such Indemnified Party (which consent shall not be unreasonably withheld, conditioned or delayed) unless such settlement fully releases the Indemnified Party without any liability, loss, cost or obligation incurred by the
Indemnified Party (in which case prior consent shall not be required). Each Indemnified Party shall cooperate with the Indemnifying Party in its defense of any such Claim in all reasonable respects and shall have the right to be present in person or
through counsel at all legal proceedings with respect to such Claim (with any such counsel being at its own sole cost and expense). If the Indemnifying Party does not assume and conduct the defense of the Claim as provided above, (i)&nbsp;the
Indemnified Party may defend against, consent to the entry of any judgment, or enter into any settlement with respect to such Claim in any manner the Indemnified Party may deem reasonably appropriate (and the Indemnified Party need not consult with,
or obtain any consent from, the Indemnifying Party in connection therewith), and (ii)&nbsp;the Indemnifying Party shall remain responsible to indemnify the Indemnified Party as provided in this Article&nbsp;14. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.4 <B><U>Limited Liability</U></B>. EXCEPT IN CONNECTION WITH A PARTY&#146;S GROSS NEGLIGENCE OR WILLFUL MISCONDUCT, NEITHER
PARTY SHALL BE LIABLE TO THE OTHER PARTY OR ANY OF ITS AFFILIATES FOR ANY SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, INCLUDING LOST PROFITS OR LOST REVENUES, REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES.
NOTWITHSTANDING THE FOREGOING, NOTHING IN THIS SECTION&nbsp;14.4 IS INTENDED TO OR SHALL LIMIT OR RESTRICT THE INDEMNIFICATION RIGHTS OR OBLIGATIONS OF ANY PARTY UNDER SECTION&nbsp;14.1 OR&nbsp;14.2. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>15. <U>MISCELLANEOUS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.1 <B><U>Governing Law</U></B><B><U> </U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.1.1 <U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the State of New York (U.S.A.),
without regard to the application of principles of conflicts of law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.1.2 <U>Jurisdiction and Venue</U>. Subject to Section&nbsp;15.1.3
and 15.1.4, any legal suit, action, or proceeding arising under, out of or in connection with this Agreement (including any subsequent amendment) or the matters contemplated hereunder, including any dispute, controversy or claim with respect to the
validity, enforceability, construction, performance or breach hereof, shall be instituted exclusively in the United States District Court for the Southern District of New York or the courts of the State of New York located in the city of New York
and County of New York, and each Party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action, or proceeding and waives any objection based on improper venue or forum <I>non conveniens</I>. Service of process,
summons, notice, or other document by mail to such Party&#146;s address set forth in Section&nbsp;15.2 shall be effective service of process for any suit, action, or other proceeding brought in connection with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.1.3 <U>Equitable Relief</U>. Notwithstanding anything to the contrary, each of the Parties hereby acknowledges that a breach or threatened
breach of their respective obligations under this Agreement may cause irreparable harm and that the remedy or remedies at law for any such breach may be inadequate. Each of the Parties hereby agrees that, in the event of any such breach or
threatened breach, in addition to all other available remedies hereunder, the <FONT STYLE="white-space:nowrap">non-breaching</FONT> Party shall have the right, through any court of competent jurisdiction, to seek equitable relief to enforce the
provisions of this Agreement, and each Party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action, or proceeding and waives any objection based on improper venue or forum non conveniens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.1.4 <U>Agreement Dispute</U>. It is the desire of the Parties to establish procedures to facilitate the resolution of any dispute,
controversy, or claim between the Parties that may arise from time to time pursuant to, arising out of or in connection with this Agreement (excluding such matters as are the subject of the JSC&#146;s responsibilities under Article 3), including any
Party&#146;s rights or obligations hereunder or any questions regarding the formation, existence, validity, enforceability, performance, interpretation, tort, breach or termination hereof (each, an &#147;<B>Agreement Dispute</B>&#148;), in an
expedient manner by mutual cooperation and without resorting to litigation. To accomplish this objective, the Parties shall use reasonable efforts in good faith to resolve any Agreement Disputes. If, despite such reasonable efforts, agreement on a
particular Agreement Dispute cannot be reached by the Parties within [***] after the Parties first consider such Agreement Dispute, the Parties shall refer such Agreement Dispute to the Executive Officers of the Parties who shall promptly initiate
discussions in good faith to resolve such Agreement Dispute, and if not resolved by the Executive Officers within [***] from the date the Agreement Dispute is first referred to the Executive Officers, then each Party is free to pursue any remedy at
law or in equity available to such Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.2 <B><U>Notices</U></B>. All notices and communications shall be in
writing and delivered personally or by internationally-recognized overnight express courier providing evidence of delivery or mailed via certified mail, return receipt requested, addressed as follows below, or by email or facsimile confirmed
thereafter by any of the foregoing, or to such other address as may be designated from time to time by written notice given in accordance with this Section&nbsp;15.2. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left"><FONT STYLE="white-space:nowrap">If&nbsp;to&nbsp;Affini-T:</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">87 Greendale Ave. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Needham, MA 02494 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attention: CEO </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With an electronic copy by email to: </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With a copy to </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(that shall not
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">constitute notice): </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Affini-T</FONT> Therapeutics, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">2940 11th Ave. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Los Angeles, CA 90018 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attention: Head of Legal </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With an electronic copy by email to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With a copy to </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(that shall not
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">constitute notice): </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Morgan Lewis Bockius LLP </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">110 North Wacker Drive </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Chicago, IL 60606-1511 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attention: Benjamin H. Pensak </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With an electronic copy by email to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">If&nbsp;to&nbsp;Metagenomi:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1545 Park Avenue </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Emeryville CA 94608 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attention: CEO </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With an electronic copy by email to: </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With a copy to </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(that shall not
</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">constitute&nbsp;notice):</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1545 Park Avenue </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Emeryville CA 94608 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attention: VP of Legal, Chief of Staff </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With an electronic copy by email to: </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With a copy to </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(that shall not
</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">constitute&nbsp;notice):</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fenwick&nbsp;&amp; West LLP </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">555 California Street, 12<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">San Francisco, CA 94104 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attention: Jake Handy </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With an electronic copy by email to: </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise expressly provided in this Agreement or mutually agreed by the Parties
in writing, any notice, communication or document (excluding payment) required to be given or made shall be deemed given or made and effective upon actual receipt or, if earlier, (a) [***]after deposit with an internationally-recognized overnight
express courier with charges prepaid, or (b) [***]after mailed by certified, registered or regular mail, postage prepaid, in each case addressed to a Party at its address stated above or to such other address as such Party may designate by written
notice given in accordance with this Section&nbsp;15.2. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.3 <B><U>Binding Effect</U></B>. This Agreement shall be binding
upon and inure to the benefit of the Parties and their respective legal representatives, successors and permitted assigns. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.4 <B><U>Headings</U></B>. Article, section and subsection headings are inserted for convenience of reference only and do not
form a part of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.5 <B><U>Counterparts</U></B>. This Agreement may be executed simultaneously in two or
more counterparts, each of which shall be deemed an original and both of which, together, shall constitute a single agreement. Each Party may execute this Agreement by facsimile transmission or in Portable Document Format
(&#147;<B>PDF</B>&#148;)&nbsp;sent by electronic mail. In addition, facsimile or PDF signatures of authorized signatories of any Party will be deemed to be original signatures and will be valid and binding, and delivery of a facsimile or PDF
signature by any Party will constitute due execution and delivery of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.6 <B><U>Amendment; Waiver</U></B>.
This Agreement may be amended, modified, superseded or canceled, and any of the terms of this Agreement may be waived, only by a written instrument executed by each Party or, in the case of waiver, by the Party or Parties waiving compliance. The
delay or failure of either Party at any time or times to require performance or to exercise any right arising out of any provisions shall in no manner affect the rights at a later time to enforce the same. Any waiver by a Party of a particular
provision or right shall be in writing, shall be as to a particular matter and, if applicable, for a particular period of time and shall be signed by such Party. No single or partial exercise of any right, power or privilege will preclude any other
or further exercise of such right, power or privilege or the exercise of any other right, power or privilege. No waiver by either Party of any condition or of the breach of any term contained in this Agreement, whether by conduct, or otherwise, in
any one or more instances, shall be deemed to be, or considered as, a further or continuing waiver of any such condition or of the breach of such term or any other term of this Agreement. Except as expressly set forth in this Agreement, all rights
and remedies available to a Party, whether under this Agreement or afforded by Applicable Law or otherwise, will be cumulative and not in the alternative to any other rights or remedies that may be available to such Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.7 <B><U>Purposes and Scope</U></B>. The Parties hereto understand and
agree that the relationship between the Parties described in this Agreement is limited to the activities, rights and obligations as set forth in this Agreement. Nothing in this Agreement shall be construed (a)&nbsp;to create or imply a general
partnership between the Parties, (b)&nbsp;to make either Party the agent of the other for any purpose, (c)&nbsp;to alter, amend, supersede or vitiate any other arrangements between the Parties with respect to any subject matter not covered
hereunder, (d)&nbsp;to give either Party the right to bind the other, (e)&nbsp;to create any duties or obligations between the Parties except as set forth herein, or (f)&nbsp;to grant any direct or implied licenses or any other rights other than as
set forth herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.8 <B><U>Assignment and Successors; Change of Control</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.8.1 <U>Generally</U>. Neither this Agreement nor any obligation of a Party hereunder may be assigned by either Party without the written
consent of the other Party, which consent shall not be unreasonably withheld, conditioned or delayed, except that each Party may assign this Agreement and the rights, obligations and interests of such Party without such consent (a)&nbsp;in whole or
in part, to any of its Affiliates, or (b)&nbsp;in whole, but not in part, in connection with a Change of Control of such Party (whether this Agreement is actually assigned or is assumed by the acquiring party by operation of law (e.g., in the
context of a reverse triangular merger). Subject to the terms and conditions hereof, no right of a Party shall be diminished and no obligation of a Party increased as a result of an assignment by the other Party hereunder, including as a result of a
Change of Control of the other Party. This Agreement is intended for the benefit of the Parties and their respective successors and permitted assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person,
other than the Parties and their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.8.2 <U>Metagenomi Change of Control</U>. In the event of
a Change of Control of Metagenomi prior to delivery of all Data Packages for each Research Plan, Metagenomi shall provide notice to <FONT STYLE="white-space:nowrap">Affini-T</FONT> of such Change of Control within [***] after the date upon which the
Change of Control closes or otherwise becomes public, and, if the merger partner for such Change of Control has a Competing Business, then following such Change of Control, <FONT STYLE="white-space:nowrap">Affini-T</FONT> shall have the right to
limit the information or reports otherwise required to be provided to Metagenomi or the JSC hereunder to only that which is essential to ensure <FONT STYLE="white-space:nowrap">Affini-T&#146;s</FONT> compliance with its obligations hereunder and <FONT
STYLE="white-space:nowrap">Affini-T</FONT> shall have the right to refrain from including in such information or reports commercially sensitive information of <FONT STYLE="white-space:nowrap">Affini-T</FONT> (as
<FONT STYLE="white-space:nowrap">Affini-T</FONT> may determine at its sole discretion). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.9 <B><U>Force Majeure</U></B>.
Neither <FONT STYLE="white-space:nowrap">Affini-T</FONT> nor Metagenomi shall be liable for failure of or delay in performing obligations set forth in this Agreement, and neither shall be deemed in breach of its obligations, if such failure or delay
is due to a Force Majeure. In the event of such Force Majeure, the Party affected shall use Commercially Reasonable Efforts to cure or overcome the same and resume performance of its obligations hereunder. Notice of a Party&#146;s failure or delay
in performance due to Force Majeure must be given to the other Party within [***] after its occurrence. All delivery dates under this Agreement that have been affected by Force Majeure shall be tolled for the duration of such Force Majeure. If a
Force Majeure persists for more than [***], then the Parties will discuss in good faith the modification of the Parties&#146; obligations under this Agreement in order to mitigate the delays caused by such Force Majeure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.10 <B><U>Interpretation</U></B>. The Parties hereto acknowledge and agree
that: (a)&nbsp;each Party and its counsel reviewed and negotiated the terms and provisions of this Agreement and have contributed to its revision; (b)&nbsp;the rules of construction to the effect that any ambiguities are resolved against the
drafting Party shall not be employed in the interpretation of this Agreement; and (c)&nbsp;the terms and provisions of this Agreement shall be construed fairly as to each Party and not in a favor of or against either Party, regardless of which Party
was generally responsible for the preparation of this Agreement. In addition, unless a context otherwise requires, wherever used, the singular shall include the plural, the plural the singular, the use of any gender shall be applicable to all
genders, the word &#147;or&#148; is used in the inclusive sense (and/or) and the word &#147;including&#148; is used without limitation and means &#147;including without limitation&#148;. Unless otherwise specified, references in this Agreement to
any Article shall include all Sections, subsections and paragraphs in such Article, references to any Section shall include all subsections and paragraphs in such Section, and references in this Agreement to any subsection shall include all
paragraphs in such subsection. The words &#147;herein,&#148; &#147;hereof&#148; and &#147;hereunder&#148; and other words of similar import refer to this Agreement as a whole and not to any particular Section or other subdivision. The phrase <FONT
STYLE="white-space:nowrap">&#147;non-refundable,</FONT> <FONT STYLE="white-space:nowrap">non-creditable&#148;</FONT> is not intended to limit either Party&#146;s rights to pursue or obtain damages arising from a breach of this Agreement. All
references to days in this Agreement shall mean calendar days, unless otherwise specified. Unless the context requires otherwise, (i)&nbsp;any definition of or reference to any agreement, instrument or other document herein will be construed as
referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein or therein), (ii)&nbsp;any
reference to any Applicable Laws herein will be construed as referring to such Applicable Laws as from time to time enacted, repealed or amended, (iii)&nbsp;any reference herein to any person will be construed to include the Person&#146;s successors
and permitted assigns, (iv)&nbsp;any reference herein to the words &#147;mutually agree&#148; or &#147;mutual written agreement&#148; will not impose any obligation on either Party to agree to any terms relating thereto or to engage in discussions
relating to such terms except as such Party may determine in such Party&#146;s sole discretion, (v)&nbsp;all references herein to Sections or Schedules will be construed to refer to Sections and Schedules to this Agreement, (vi)&nbsp;except as
otherwise expressly provided herein all references to &#147;$&#148; or &#147;dollars&#148; refer to the lawful money of the U.S., and (vii)&nbsp;the words &#147;copy&#148; and &#147;copies&#148; and words of similar import when used in this
Agreement include, to the extent available, electronic copies, files or databases containing the information, files, items, documents or materials to which such words apply. This Agreement has been prepared in the English language and the English
language shall control its interpretation. In addition, all notices required or permitted to be given hereunder, and all written, electronic, oral or other communications between the Parties regarding this Agreement shall be in the English language.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.11 <B><U>Entire Agreement; Severability</U></B>. This Agreement, the
Existing RSA, the A&amp;R Side Letter, MFN Waiver and the Initial RSA and Milestone RSA executed in accordance with Section&nbsp;8.1 set forth the entire agreement with respect to the subject matter hereof and thereof and supersede all other
agreements and understandings between the Parties with respect to such subject matter. There are no covenants, promises, agreements, warranties, representations, conditions or understandings, either oral or written, between the Parties with respect
to the subject matter of this Agreement other than as are set forth in this Agreement and any other documents delivered pursuant hereto or thereto. If any provision of this Agreement is or becomes invalid or is ruled invalid by any court of
competent jurisdiction or is deemed unenforceable, it is the intention of the Parties that the remainder of the Agreement shall not be affected. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.12 <B><U>Further Assurances</U></B>. Each of Metagenomi and <FONT STYLE="white-space:nowrap">Affini-T,</FONT> upon the
request of the other Party and without further consideration, will do, execute, acknowledge, and deliver or cause to be done, executed, acknowledged or delivered all such further acts, deeds, documents, assignments, transfers, conveyances, powers of
attorney, instruments and assurances as may be reasonably necessary to effect complete consummation of the transactions contemplated by this Agreement, and to do all such other acts, as may be necessary or appropriate in order to carry out the
purposes and intent of this Agreement. The Parties agree to execute and deliver such other documents, certificates, agreements and other writings and to take such other actions as may be reasonably necessary in order to consummate or implement
expeditiously the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.13 <B><U>Expenses</U></B>. Each of the Parties will bear
its own direct and indirect expenses incurred in connection with the negotiation and preparation of this Agreement and, except as set forth in this Agreement, the performance of the obligations contemplated hereby and thereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.14 <B><U>Intellectual Property</U></B>. The Parties acknowledge and agree that the licenses granted by the Parties and all
other rights granted under or pursuant to this Agreement are and shall otherwise be deemed to be, for purposes of Section&nbsp;365(n) of the Bankruptcy Code (or analogous provisions of the bankruptcy laws of any Governmental Authority), licenses of
rights to &#147;intellectual property&#148; as defined under Section&nbsp;101(35A) of the Bankruptcy Code (or analogous foreign provisions), and that this Agreement is an executory contract governed by Section&nbsp;365(n) of the Bankruptcy Code (or
analogous foreign provisions) in the event that a bankruptcy proceeding is commenced involving either Party. <FONT STYLE="white-space:nowrap">Affini-T,</FONT> as the licensee of such rights under Article 2, shall retain and may fully exercise all of
its rights and elections under the Bankruptcy Code. The foregoing provisions of this Section&nbsp;15.14 are without prejudice to any rights the Parties may have arising under the Bankruptcy Code or other Applicable Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.15 <B><U>Performance by Affiliates</U></B>. Subject to Section&nbsp;2.2.3 and Section&nbsp;4.2.1(e), as applicable, either
Party may discharge any obligation and exercise any right hereunder through any of its Affiliates. Each Party shall remain jointly and severally liable to the other Party for any performance or non-performance of any such Affiliate, and each Party
hereby expressly waives any requirement that the other Party exhaust all right, power or remedy, or proceed against any such Affiliate, prior to proceeding directly against such Party<U>.</U></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[SIGNATURE PAGE FOLLOWS] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly
authorized representatives. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><FONT STYLE="white-space:nowrap">AFFINI-T</FONT> THERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jak Knowles</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Jack Knowles</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CFO</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">June&nbsp;14, 2022</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>METAGENOMI, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian C. Thomas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Brian C. Thomas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CEO</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">June&nbsp;14, 2022</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGE TO DEVELOPMENT OPTION AND LICENSE AGREEMENT] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>5
<FILENAME>d425213dex109.htm
<DESCRIPTION>EX-10.9
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.9 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#149; 1545 PARK AVENUE &#149; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#149; EMERYVILLE, CALIFORNIA &#149; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#149; <B>NET LEASE </B>&#149; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BASIC LEASE INFORMATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Date of Lease:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">January&nbsp;22, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Landlord:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">EPL HALLECK INVESTORS LLC, a California limited liability company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Landlord&#146;s Notice Address:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EPL Halleck Investors LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Ellis Partners
LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">111 Sutter Street, Suite 800</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94104</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: James F. Ellis</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Telephone:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">METAGENOMI, INC.,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant&#146;s Notice Address:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the Rent Commencement Date (as defined herein):</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 Horton Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Brian Thomas</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After the Rent Commencement Date:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1545 Park Avenue</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, California 94608</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Brian Thomas</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone:</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with a copy to (except for notices to access the Leased Premises):</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dalsin Law</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1630 N. Main Street, No.&nbsp;221</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Walnut Creek, CA 94596</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Ann Dalsin</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Telephone:</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Building:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The building whose address is 1545 Park Avenue, Emeryville, California.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Leased Premises:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approximately 23,851 rentable square feet consisting of the entire Building (as defined herein). The Leased Premises (as defined herein) contains the following: (i)&nbsp;approximately 22,519 rentable square feet of office and
R&amp;D space (the &#147;<B>Office Premises</B>&#148;) and (ii)&nbsp;approximately 1,332 rentable square feet of a roof deck (the &#147;<B>Roof Deck Premises</B>&#148;), all as approximately shown on the floor plan attached hereto as <B><U>Exhibit <FONT
STYLE="white-space:nowrap">A-1</FONT></U></B>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Rentable Area:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Leased Premises:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approximately 23,851 rentable square feet.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Building:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approximately 23,851 rentable square feet.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Term Commencement Date (and Rent Commencement Date):</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The later of (i)&nbsp;February&nbsp;1, 2021, or (ii)&nbsp;the earlier of (x)&nbsp;the date that the punchlist items set forth in <U>Schedule 2.20</U> are substantially complete, or (y)&nbsp;the date that a temporary or permanent
certificate of occupancy or its equivalent has been obtained from the City of Emeryville.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Term Expiration Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The last day of the one hundred twentieth (120<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) full calendar month after the Term Commencement Date (meaning if the Term Commencement Date shall occur on a date other than the
first day of a calendar month, the Term shall be one hundred twenty (120)&nbsp;full calendar months plus a partial month).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Option to Extend:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Number of Extension Periods</B>: One (1)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Years per Extension Period</B>: Five (5)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Base Rent:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rent Commencement Date through the last day of the 12th full calendar month after the Rent Commencement Date&nbsp;=&nbsp;$149,068.75 per month.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Notwithstanding the foregoing, provided that no event of default beyond any applicable cure period is occurring, Base Rent shall be abated for the first fifty-seven (57)&nbsp;days after the Rent Commencement Date (the &#147;<B>Base
Rent Abatement Period</B>&#148;) (the collective Base Rent abatement during the Base Rent Abatement Period is equivalent to $279,350.75).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 13 through Month 24 = $153,540.81 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 25 through Month 36 = $158,147.04 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 37 through Month 48 = $162,891.45 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 49 through Month 60 = $167,778.19 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 61 through Month 72 = $172,811.54 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 73 through Month 84 = $177,995.88 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 85 through Month 96 = $183,335.76 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 97 through Month 108 = $188,835.83 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Month 109 through the Term Expiration Date = $194,500.91 per month.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant&#146;s Proportionate Share:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">100% of the Building.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Landlord estimates that Tenant&#146;s Proportionate Share of Basic Operating Costs will be approximately $1.57 per rentable square foot per month for the initial year of the Term.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The foregoing amount does not include HVAC Maintenance [as defined in Section&nbsp;5.4(b)], Elevator Maintenance [as defined in Section&nbsp;5.4(c)], and fire/life safety monitoring of the Building, which costs shall be paid by
Tenant to Landlord as set forth in the Lease.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Landlord does not represent, warrant or guarantee to Tenant that Tenant&#146;s Proportionate Share of Operating Costs will be the above-stated amount during the term of the Lease. Landlord&#146;s estimate is merely intended to be
Landlord&#146;s reasonable estimate, based upon information presently available to Landlord. Tenant acknowledges and agrees to the foregoing limitation with respect to Landlord&#146;s estimate.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Utilities, Janitorial, and Refuse Removal:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">In addition to payment of Tenant&#146;s Proportionate Share of Basic Operating Costs, HVAC Maintenance, Elevator Maintenance, and fire/life safety monitoring of the Building and other expenses, Tenant shall be responsible for, among
other things, the payment of all separately- metered utilities for the Leased Premises, janitorial services for the Leased Premises, and refuse removal for the Leased Premises.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Parking Spaces:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tenant shall have the use of all parking spaces on the Project at no cost for the initial Term and the Option Term (as defined in <U>Section&nbsp;8.1</U>).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Security Deposit:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$3,300,000.00, which shall be provided in the form of a letter of credit (amount is subject to reduction; see <U>Section&nbsp;5.14</U>).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Guarantor:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Landlord&#146;s Broker:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant&#146;s Broker:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Kidder Matthews</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXHIBITS: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit <FONT STYLE="white-space:nowrap">A-1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Floor Plan of the Leased Premises</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit <FONT STYLE="white-space:nowrap">A-2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Legal Description of Project</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Landlord Improvements and Tenant&#146;s Work</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit <FONT STYLE="white-space:nowrap">B-1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Base Building Upgrades</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Confirmation of Term of Lease</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit D</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Building Rules and Regulations</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit E</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Asbestos Notification</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hazardous Materials Questionnaire</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SCHEDULES </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule 1.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Letter of Credit</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule 2.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">List of Punchlist Items</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing BASIC LEASE INFORMATION is incorporated herein and made a part of the LEASE to which it is
attached. If there is any conflict between the BASIC LEASE INFORMATION and the LEASE, the BASIC LEASE INFORMATION shall control. </P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NET LEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS NET LEASE (this &#147;<B>Lease</B>&#148;) is made as of the date specified in the BASIC LEASE INFORMATION sheet, by and between the
landlord specified in the BASIC LEASE INFORMATION sheet (&#147;<B>Landlord</B>&#148;) and the tenant specified in the BASIC LEASE INFORMATION sheet (&#147;<B>Tenant</B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article I </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Definitions
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.1 Definitions</B>: Terms used herein shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.2 </B>&#147;<B>Additional Rent</B>&#148;<B> </B>shall mean all monetary obligations of Tenant under this Lease other than the obligation
for payment of Net Rent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.3 </B>Intentionally deleted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.4 </B>&#147;<B>Base Rent</B>&#148;<B> </B>shall mean the minimum monthly rental amounts set forth in the Basic Lease Information due from
time to time as rental for the Leased Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.5 </B>Intentionally deleted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.6 </B>&#147;<B>Basic Operating Costs</B>&#148;<B> </B>shall have the meaning given in <U>Section&nbsp;3.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.7 </B>&#147;<B>Building</B>&#148;<B> </B>shall mean the building and other improvements associated therewith identified on the Basic
Lease Information sheet. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.8 </B>&#147;<B>Building Standard Improvements</B>&#148;<B> </B>shall mean the standard materials ordinarily
used by Landlord in the improvement of the Building and leased premises within the Building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.9 </B>Intentionally Omitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.10 </B>&#147;<B>Computation Year</B>&#148;<B> </B>shall mean a fiscal year consisting of the calendar year commencing January 1st of each
year during the Term and continuing through the Term with a short or stub fiscal year in (i)&nbsp;the period between the Rent Commencement Date and December&nbsp;31 of such year and (ii)&nbsp;any partial year in which the Lease expires or is
terminated for the period between January&nbsp;1 of such year and the date of lease termination or expiration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.11 </B>Intentionally
deleted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.12 </B>&#147;<B>Landlord&#146;s Broker</B>&#148;<B> </B>shall mean the individual or corporate broker identified on the
Basic Lease Information sheet as the broker for Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.13 </B>Intentionally deleted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.14 </B>&#147;<B>Leased Premises</B>&#148;<B> </B>shall mean the floor area more particularly shown on the floor plan attached hereto as
<B><U>Exhibit <FONT STYLE="white-space:nowrap">A-1</FONT></U></B>, containing the Rentable Area (as such term is defined in <U>Section&nbsp;1.19</U> below) specified on the Basic Lease Information sheet. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.15 </B>&#147;<B>Net Rent</B>&#148;<B> </B>shall mean the total of Base Rent and
Tenant&#146;s Proportionate Share of Basic Operating Costs calculated in accordance with <U>Section&nbsp;3.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.16
</B>&#147;<B>Permitted Use</B>&#148;<B> </B>for the Office Premises shall mean general office and administrative use, and other ancillary uses, all legally permitted functions of a life science or research and development company, including, without
limitation, chemistry labs, biology labs, protein production, pilot plant, and related or ancillary uses, and warehouse use, and ancillary uses. Except as set forth above or approved by Landlord, the Leased Premises shall not be used for any other
purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.17 </B>&#147;<B>Project</B>&#148;<B> </B>shall mean the Building, adjoining parking areas, and the real property on which
the Building and the parking are located. The Project is located on a legal parcel of land described on <B><U>Exhibit <FONT STYLE="white-space:nowrap">A-2</FONT></U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.18 </B>&#147;<B>Rent</B>&#148;<B> </B>shall mean Net Rent plus Additional Rent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.19 </B>&#147;<B>Rentable Area</B>&#148;<B> </B>shall mean the area or areas of space in the Building/Leased Premises as calculated in
accordance with BOMA 2017 office standard measurement methods. The Rentable Area of the Building/Leased Premises shall not be subject to <FONT STYLE="white-space:nowrap">re-measurement</FONT> or modification during the Term of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.20 </B>&#147;<B>Security Deposit</B>&#148;<B> </B>shall mean the amount specified on the Basic Lease Information sheet to be delivered by
Tenant to Landlord in the form of a clean and irrevocable letter of credit, substantially in the form attached hereto as <B><U>Schedule 1.20</U> </B>and held and applied pursuant to <U>Section&nbsp;5.14</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.21 </B>Intentionally deleted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.22 </B>Intentionally deleted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.23 </B>Intentionally deleted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.24 </B>&#147;<B>Tenant&#146;s Broker</B>&#148;<B> </B>shall mean the individual or corporate broker identified on the Basic Lease
Information sheet as the broker for Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.25 </B>Intentionally deleted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.26 </B>&#147;<B>Tenant&#146;s Proportionate Share</B>&#148;<B> </B>is specified on the Basic Lease Information sheet and is based on the
percentage which the Rentable Area of the Leased Premises bears to the total Rentable Area of the Building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.27
</B>&#147;<B>Term</B>&#148;<B> </B>shall mean the period commencing with the Term Commencement Date and ending at midnight on the Term Expiration Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.28 </B>&#147;<B>Term Commencement Date</B>&#148;<B> </B>shall be the date set forth on the Basic Lease Information sheet. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.29 </B>&#147;<B>Term Expiration Date</B>&#148;<B> </B>shall be the date set forth on
the Basic Lease Information sheet, unless sooner terminated pursuant to the terms of this Lease or unless extended pursuant to the provisions of <U>Section&nbsp;8.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.30 Other Terms</B>. Other terms used in this Lease and on the Basic Lease Information sheet shall have the meanings given to them herein
and thereon. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Leased Premises </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.1
Lease</B>. Landlord hereby leases to Tenant and Tenant hereby leases from Landlord the Leased Premises upon all of the terms, covenants and conditions set forth in this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.2 Current Tenant; Acceptance of Leased Premises</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Tenant acknowledges that (i)&nbsp;Perfect Day, Inc., a Delaware corporation, is the current tenant of the Leased Premises (the
&#147;<B>Current Tenant</B>&#148;) under that certain Net Lease Agreement dated as of June&nbsp;26, 2019, between Current and Landlord, as amended by that certain First Amendment to Net Lease dated as of August&nbsp;1, 2019 (the &#147;<B>First
Amendment</B>&#148;), by that certain Second Amendment to Net Lease dated as of February&nbsp;24, 2020 (the &#147;<B>Second Amendment</B>&#148;), and by that certain Third Amendment to Net Lease dated as of September&nbsp;21, 2020 (the
&#147;<B>Third Amendment</B>&#148;) (as so amended, the &#147;<B>PD Lease</B>&#148;). Current Tenant performed substantial improvements to the Building (the &#147;<B>PD Tenant Improvements</B>&#148;), and (ii)&nbsp;concurrently with Current
Tenant&#146;s performance of the PD Tenant Improvements, Landlord performed numerous upgrades to the Building (the &#147;<B>Base Building Upgrades</B>&#148;) as set forth in <B><U>Exhibit <FONT STYLE="white-space:nowrap">B-1</FONT></U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Tenant acknowledges that (a)&nbsp;it has satisfied itself with respect to the condition of the Leased Premises (including, without
limitation, the PD Tenant Improvements, the Base Building Upgrades, HVAC, electrical, plumbing and other mechanical installations, fire sprinkler systems, security, environmental aspects, and compliance with applicable laws, ordinances, rules and
regulations) and the present and future suitability of the Leased Premises for Tenant&#146;s intended use; (b)&nbsp;Tenant has made such inspection and investigation as it deems necessary with reference to such matters and assumes all responsibility
therefor as the same relate to Tenant&#146;s occupancy of the Leased Premises for the Term of this Lease; and (c)&nbsp;neither Landlord nor any of Landlord&#146;s agents has made any oral or written representations or warranties with respect to the
condition, suitability or fitness of the Leased Premises other than as may be specifically set forth in this Lease. Tenant accepts the Leased Premises in its AS IS condition existing on the date Tenant executes this Lease, subject to all matters of
record and applicable laws, ordinances, rules and regulations. Tenant acknowledges that neither Landlord nor any of Landlord&#146;s agents has agreed to undertake any alterations or additions or to perform any maintenance or repair of the Leased
Premises except for the routine maintenance specified herein and except as may be expressly set forth herein and in <B><U>Exhibit B</U></B>. If Landlord, for any reason whatsoever, cannot deliver possession of the Leased Premises to Tenant on the
Term Commencement Date in the condition specified in this Section&nbsp;2.2, Landlord shall neither be subject to any liability nor shall the validity of this Lease be affected; provided, the Term and the obligation to pay Net Rent shall commence on
the date possession is actually tendered to Tenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and the Term Expiration Date shall be extended commensurately and Tenant shall not have any obligation to perform the covenants or observe the conditions herein contained until the Leased
Premises have been so delivered. When the Term Commencement Date, the Rent Commencement Date, and the Term Expiration Date have been ascertained, the parties shall promptly execute a Confirmation of Term of Lease substantially in the form attached
as <B><U>Exhibit C</U></B>. Tenant shall execute and return such Confirmation of Term of Lease to Landlord within fifteen (15)&nbsp;days after Tenant&#146;s receipt thereof. If Tenant fails to execute and return (or reasonably object in writing to)
the Confirmation of Term of Lease within fifteen (15)&nbsp;days after receiving it, Tenant shall be deemed to have executed and returned it without exception. Notwithstanding anything to the contrary set forth herein, except to the extent caused by
Tenant and excluding the PD Tenant Improvements, the base Building electrical, heating, ventilation and air conditioning systems, mechanical systems, plumbing systems, and fire sprinkler, fire alarm monitoring and smoke detector systems and the
Building roof, curtain wall, and envelope shall be in good working order and leak-free as of the Rent Commencement Date. If the foregoing are not in good and working order as provide above, Landlord shall be responsible for repairing or restoring
same at its sole cost and expense promptly, provided that Tenant has delivered written notice thereof to Landlord. In addition, Landlord represents and warrants to Tenant that the Base Building Upgrades were performed substantially in accordance
with the plans submitted to and the permit issued by the City of Emeryville. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Landlord shall use good faith and diligent efforts to
cause the contractor that constructed and performed the PD Tenant Improvements to assign to Landlord and/or Tenant all warranties, rights and remedies provided to the Current Tenant under the construction contract between the contractor and the
Current Tenant relating to construction defects and similar claims, and Landlord shall use good faith and diligent efforts to enforce any such warranties, rights and remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.3 </B>Intentionally Omitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.4 Reservation of Rights</B>. Landlord reserves the right from time to time, to install, use, maintain, repair, relocate and/or replace
pipes, conduits, wires and equipment within and around the Building and the Project and to do and perform such other acts and make such other changes, additions, improvements, repairs and/or alterations in, to or with respect to the Building and the
Project (including without limitation with respect to the driveways, parking areas, walkways and entrances to the Project) as Landlord may, in the exercise of sound business judgment, deem to be appropriate (&#147;<B>Landlord Alterations</B>&#148;);
provided, however that Landlord shall give Tenant written notice at least ten (10)&nbsp;business days prior to the commencement of any Landlord Alterations and Landlord shall not unreasonably interfere with Tenant&#146;s access, use and enjoyment of
the Leased Premises, Building or Top Roof Deck. Notwithstanding the foregoing, any Landlord Alterations that would materially impact Tenant&#146;s access, use and enjoyment of the Leased Premises, the Building or the Building Top Roof Deck shall
require Tenant&#146;s written approval, in its sole and absolute discretion; however, any Landlord Alterations that are necessitated to comply with laws or to maintain or repair the Building or the Project as required of Landlord under this Lease
shall not require Tenant&#146;s consent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.5 Roof Deck Premises</B>. Tenant shall have exclusive access and use of the Building
Top Roof Deck, subject to Landlord&#146;s right of entry as set forth in <U>Section&nbsp;5.11</U> below. Tenant&#146;s planned uses of the Building Top Roof Deck are subject to Tenant obtaining all necessary governmental approvals and permits, if
any, as well as Landlord&#146;s prior written approval, which approval shall not be unreasonably withheld. Tenant shall maintain the Building Top Roof Deck in a clean, attractive and orderly condition and Tenant shall not commit any waste in or upon
the Building Top Roof Deck. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Term, Use and Rent </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.1 Term</B>. Except as otherwise provided in this Lease, the Term shall commence upon the Term Commencement Date, and unless sooner
terminated, shall end on the Term Expiration Date. Subject to Landlord&#146;s reasonable security precautions and factors beyond the reasonable control of Landlord, Tenant shall have access to the Leased Premises twenty-four (24)&nbsp;hours per day,
seven (7)&nbsp;days per week, and <FONT STYLE="white-space:nowrap">fifty-two</FONT> (52)&nbsp;weeks per year. Any entry and possession of the Leased Premises by Tenant prior to the Term Commencement Date shall be on all terms and conditions of the
Lease, except that the obligation to pay Base Rent and Tenant&#146;s Proportionate Share of Basic Operating Costs shall commence on the Rent Commencement Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.2 Use of the Office Premises</B>. Tenant shall use the Office Premises solely for the Permitted Use and for no other use or purpose.
Tenant shall not commit waste, overload the Building&#146;s structure or the Building&#146;s systems or subject the Leased Premises to any use that would materially damage the Leased Premises, normal wear and tear excepted. Tenant shall maintain a
ratio of not more than one Occupant (defined as employees and contractors of Tenant working at the Office Premises) for each two hundred fifty (250)&nbsp;rentable square feet of the Office Premises. Tenant acknowledges that increased numbers of
Occupants causes additional wear and tear on the Office Premises and the Building systems. Tenant&#146;s failure to comply with the requirements of this <U>Section&nbsp;3.2</U> shall constitute an event of default under <U>Section&nbsp;7.8</U> and
Landlord shall have the right, in addition to any other remedies it may have at law or equity, to specifically enforce Tenant&#146;s obligations under this <U>Section&nbsp;3.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.3 Base Rent</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Tenant shall pay the Base Rent to Landlord in accordance with the schedule set forth on the Basic Lease Information sheet and in the manner described below. Tenant shall prepay <B>$149,068.75 </B>of Base Rent (for the first (1st) month of the Term
that Base Rent is payable after the Base Rent Abatement Period expires) upon execution of this Lease (the &#147;<B>Prepaid Rent</B>&#148;). Tenant shall pay the Net Rent (consisting of Base Rent plus, when applicable in accordance with
<U>Section&nbsp;3.4</U> below, Tenant&#146;s Proportionate Share of Basic Operating Costs) in monthly installments on or before the first day of each calendar month during the Term and any extensions or renewals thereof, in advance without demand
and, except as set forth herein, without any reduction, abatement, counterclaim or setoff, in lawful money of the United States at Landlord&#146;s address specified on the Basic Lease Information sheet or at such other address as may be designated
by Landlord in the manner provided for giving notice under <U>Section&nbsp;9.11</U> hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Term commences on other than the first day of a month, then the Base Rent
provided for such partial month shall be prorated based upon a thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> month. If the Term terminates on other than the last day of a calendar month, then the Net Rent provided for such partial month
shall be prorated based upon a thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> month and the prorated installment shall be paid on the first day of the calendar month in which the date of termination occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.4 Tenant&#146;s Proportionate Share of Basic Operating Costs</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Commencing on the Rent Commencement Date and continuing through the remainder of the Term, Tenant shall pay to Landlord Tenant&#146;s
Proportionate Share of Basic Operating Costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) During the first Computation Year, on or before the first day of each month during such
Computation Year, Tenant shall pay to Landlord <FONT STYLE="white-space:nowrap">one-twelfth</FONT> (1/12th) of Landlord&#146;s estimate of the amount payable by Tenant under <U>Section&nbsp;3.4(a)</U> as set forth in Landlord&#146;s written notice
to Tenant delivered prior to the Rent Commencement Date. During the last month of each Computation Year (or as soon thereafter as practicable), Landlord shall give Tenant notice of Landlord&#146;s estimate of the amount payable by Tenant under
<U>Section&nbsp;3.4(a)</U> for the following Computation Year. On or before the first day of each month during the following Computation Year, Tenant shall pay to Landlord <FONT STYLE="white-space:nowrap">one-twelfth</FONT> (1/12) of such estimated
amount, provided that if Landlord fails to give such notice in the last month of the prior year, then Tenant shall continue to pay on the basis of the prior year&#146;s estimate until the first day of the calendar month next succeeding the date such
notice is given by Landlord; and from the first day of the calendar month following the date such notice is given, Tenant&#146;s payments shall be adjusted so that the estimated amount for that Computation Year will be fully paid by the end of that
Computation Year. If at any time or times Landlord reasonably determines that the amount payable under <U>Section&nbsp;3.4(a)</U> for the current Computation Year will vary from its estimate given to Tenant, Landlord, by notice to Tenant, may revise
its estimate for such Computation Year, and subsequent payments by Tenant for such Computation Year shall be based upon such revised estimate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Following the end of each Computation Year, Landlord shall deliver to Tenant a statement of amounts payable under
<U>Section&nbsp;3.4(a)</U> for such Computation Year. If such statement shows an amount owing by Tenant that is less than the payments for such Computation Year previously made by Tenant, and if no event of default (as defined below) is outstanding
at the time such statement is delivered, Landlord shall credit such amount to the next payment(s) of Net Rent falling due under this Lease. If such statement shows an amount owing by Tenant that is more than the estimated payments for such
Computation Year previously made by Tenant, Tenant shall pay the deficiency to Landlord within thirty (30)&nbsp;days after delivery of such statement. The respective obligations of Landlord and Tenant under this <U>Section&nbsp;3.4(c)</U> shall
survive the Term Expiration Date, and, if the Term Expiration Date is a day other than the last day of a Computation Year, the adjustment in Tenant&#146;s Proportionate Share of Basic Operating Costs pursuant to this <U>Section&nbsp;3.4(c)</U> for
the Computation Year in which the Term Expiration Date occurs shall be prorated in the proportion that the number of days in such Computation Year preceding the Term Expiration Date bears to three hundred sixty-five (365). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) If, within ninety (90)&nbsp;days of Tenant&#146;s receipt of Landlord&#146;s statement,
Tenant notifies Landlord that Tenant desires to audit or review Landlord&#146;s statement, Landlord shall cooperate with Tenant to permit such audit or review during normal business hours. Landlord shall make available in the San Francisco Bay Area
at Landlord&#146;s, or at Landlord&#146;s election at Landlord&#146;s property manager&#146;s, place of business, such books and records as are reasonably necessary for Tenant to conduct and complete such audit. Tenant shall have the right to
examine and make copies of such books and records at Tenant&#146;s sole cost and expense. Tenant shall bear all other costs and expenses associated with Tenant&#146;s audit (including fees of Tenant&#146;s auditor), unless such audit shall conclude
that Tenant was overcharged by an amount in excess of three percent (3%) of the amount charged to Tenant hereunder as Tenant&#146;s Proportionate Share of Basic Operating Costs, in which event Landlord shall bear the reasonable <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs of the audit up to a maximum amount of $5,000.00. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) Within ten (10)&nbsp;business days of completion of the audit, if Tenant desires to challenge Landlord&#146;s statement, then Tenant
shall provide Landlord with a copy of Tenant&#146;s auditor&#146;s report. Within twenty (20)&nbsp;days of Landlord&#146;s receipt of Tenant&#146;s auditor&#146;s report, Landlord shall notify Tenant as to whether Landlord agrees or disagrees with
the conclusions reached in Tenant&#146;s auditor&#146;s report. Landlord&#146;s failure to respond (where such failure continues for three (3)&nbsp;business days after Landlord&#146;s receipt of a notice that Landlord failed to respond within such
twenty (20)&nbsp;day period) shall be deemed to constitute an agreement with the Tenant&#146;s auditor&#146;s report. After Landlord&#146;s notice, Landlord and Tenant shall endeavor to resolve any disagreements regarding Tenant&#146;s
auditor&#146;s report. If Landlord and Tenant are unable to resolve such disagreement regarding Tenant&#146;s auditor&#146;s report within twenty (20)&nbsp;business days of the completion of such audit, then Landlord and Tenant shall submit the
matter to an independent audit conducted by an independent nationally recognized accounting firm or a nationally recognized real estate management or consulting firm that has been mutually selected by Tenant and Landlord. If Landlord and Tenant fail
to agree upon and appoint such auditor/arbitrator, then the appointment shall be made by Judicial Arbitration and Mediation Services (&#147;<B>JAMS</B>&#148;). The results of such independent audit shall be conclusive and binding upon Landlord and
Tenant. In the event Tenant&#146;s audit reveals a discrepancy in Tenant&#146;s favor, and Landlord agrees with the conclusions of Tenant&#146;s auditor, or in the event that the independent audit determines a discrepancy in Tenant&#146;s favor,
then Landlord shall credit the amount of such discrepancy to the next payment(s) of Net Rent falling due under this Lease. In the event such audit reveals a discrepancy in Landlord&#146;s favor, Tenant shall pay the amount of the discrepancy to
Landlord within ten (10)&nbsp;business days of completion of the audit. Any such audit may only be conducted by an independent nationally recognized accounting firm or a nationally recognized real estate management or consulting firm that is not
being compensated by Tenant on a contingency fee basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) The failure of Tenant to notify Landlord that Tenant desires an audit within
ninety (90)&nbsp;days of Tenant&#146;s receipt of Landlord&#146;s statement under this <U>Section&nbsp;3.4(c)</U> shall constitute an acceptance by Tenant of Landlord&#146;s statement and a waiver by Tenant of its right to audit for such Computation
Year. If Tenant commences an audit in accordance with this <U>Section&nbsp;3.4(c)</U>, then such audit and the Tenant&#146;s auditor&#146;s report must be completed within forty-five (45)&nbsp;days of Landlord&#146;s books and records reasonably
requested by Tenant&#146;s auditor being made available by Landlord. Failure of Tenant to complete the audit within such forty-five (45)&nbsp;day period shall constitute an acceptance by Tenant of Landlord&#146;s statement for such Computation Year
unless such failure was caused by the failure of Landlord to make its books and records available to Tenant as required under this <U>Section&nbsp;3.4</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Landlord shall have the same remedies for a default in the payment of Tenant&#146;s
Proportionate Share of Basic Operating Costs as for a default in the payment of Base Rent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.5 Basic Operating Costs</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Basic Operating Costs shall mean all expenses and costs (but not specific costs which are separately billed to and paid by particular
tenants of the Project) of every kind and nature which Landlord shall pay or become obligated to pay because of or in connection with the management, ownership, maintenance, repair, replacement, preservation and operation of the Leased Premises, the
Building, the Project and its supporting facilities directly servicing the Building and/or the Project (determined in accordance with generally accepted accounting principles, consistently applied) including, but not limited to, the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) Fair market wages, salaries and related expenses and benefits of all employees and personnel engaged in the operation, maintenance,
repair and security of the Project (prorated based on the percentage of time spent working for the Project) that are normally incurred by owners of Comparable Buildings (as defined in <U>Section&nbsp;8.1</U>) providing comparable services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) Intentionally Omitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) All supplies, materials, equipment and equipment rental to the extent specifically used in the operation, maintenance, repair,
replacement and preservation of the Project. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(4) Intentionally Omitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(5) All maintenance and service agreements for the Project, including, without limitation, HVAC Maintenance and Elevator Maintenance (as such
terms are defined in <U>Section&nbsp;5.4</U> below, however only to the extent Landlord, and not Tenant, is maintaining), exterior window cleaning, landscaping, pest control, and roof maintenance (provided, however, that Tenant shall employ
(i)&nbsp;its own bonded and reputable janitorial service, subject to Landlord&#146;s reasonable prior written approval, to clean the Leased Premises, at Tenant&#146;s sole cost and expense), and (ii)&nbsp;its own refuse collection [the foregoing
janitorial expenses and refuse collection for the Leased Premises shall be paid by Tenant separately and shall not be part of Basic Operating Costs]). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(6) A property management fee in an amount not to exceed three percent&nbsp;(3%) of all gross revenues derived from the Project. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(7) Legal and accounting services for the Project, including the costs of audits by certified public accountants; provided, however, that
legal expenses shall not include the cost of lease negotiations, termination of leases, extension of leases or legal costs incurred in proceedings by or against any specific tenant, or for the defense of Landlord&#146;s legal title to the Project.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(8) All insurance premiums and costs, including, but not limited to, the cost of property
and liability coverage and rental income and earthquake and flood insurance applicable to the Project and Landlord&#146;s personal property used in connection therewith, as well as deductible amounts applicable to such insurance; provided, however,
that Landlord may, but shall not be obligated to, carry earthquake or flood insurance. Landlord may elect to self-insure for the coverages required herein; provided, however, Landlord may not self-insure unless it has a net worth of at least
$500,000,000.00. Any undertaking by Landlord to self-insure with respect to some or all the insurance coverage otherwise required to be maintained by Landlord under this Lease will not adversely affect Tenant, and Tenant will be protected against
loss or damage in the same manner as if Landlord had obtained separate insurance as provided herein (including the equivalent of any benefits Tenant would have received from additional insured status under a third-party insurance policy). A <FONT
STYLE="white-space:nowrap">non-Affiliate</FONT> assignee of Landlord may not self-insure without the prior written approval of Tenant, which approval will not be unreasonably withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(9) Repairs, replacements and general maintenance (except to the extent paid by proceeds of insurance or by Tenant or other tenants of the
Project or third parties). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(10) All real estate or personal property taxes, possessory interest taxes, business or license taxes or
fees, service payments in lieu of such taxes or fees, annual or periodic license or use fees, excises, transit charges, housing fund assessments, open space charges, assessments, bonds, levies, fees or charges, general and special, ordinary and
extraordinary, unforeseen as well as foreseen, of any kind which are assessed, levied, charged, confirmed or imposed by any public authority upon the Project (or any portion or component thereof), its operations, this Lease, or the Rent due
hereunder (or any portion or component thereof) (collectively &#147;Project Taxes&#148;), except: (i)&nbsp;inheritance or estate taxes imposed upon or assessed against the Project, or any part thereof or interest therein, and
(ii)&nbsp;Landlord&#146;s personal or corporate income, gift or franchise taxes. Project Taxes shall not be subject to the property management fee set forth in Section&nbsp;3.5(a)(6)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(11) Amortized costs (together with reasonable financing charges) of capital improvements made to the Project subsequent to the Term
Commencement Date which are primarily designed to achieve energy or carbon reduction or to reduce current or future Basic Operating Costs or otherwise improve the operating efficiency of the Building (and approved by Tenant in writing, in
Tenant&#146;s reasonable discretion), or which may be required by governmental authorities, including, but not limited to, those improvements required for the benefit of individuals with disabilities (capital improvements made to the Project
subsequent to the Term Commencement Date which may be required by governmental authorities shall not be subject to Tenant&#146;s approval), such amortization to be taken in accordance with generally accepted accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event any of the Basic Operating Costs are not provided on a uniform basis, Landlord shall make an appropriate and equitable
adjustment, in Landlord&#146;s discretion reasonably exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding any other provision of this Lease to the contrary, in
the event that the Building is not fully occupied during any year of the Term, an adjustment shall be made in computing Basic Operating Costs for such year so that Basic Operating Costs shall be computed as though the Building had been 95% occupied
during such year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The following items shall be excluded from Basic Operating Costs: (i)&nbsp;depreciation
on the Building and the Project; (ii)&nbsp;debt service or interest on debt or amortization payments on any mortgages or deeds of trust; (iii)&nbsp;rental under any ground or underlying lease; (iv)&nbsp;attorneys&#146; fees and expenses incurred in
connection with lease negotiations with prospective Building tenants or enforcement of leases; (v)&nbsp;the cost of any improvements or equipment which would be properly classified as capital expenditures (except for any capital expenditures
expressly included in <U>Section&nbsp;3.5(a)</U>, including, without limitation, <U>Section&nbsp;3.5(a)(11))</U>; (vi) the cost of decorating, improving for tenant occupancy, painting or redecorating portions of the Building to be demised to
tenants; (vii)&nbsp;advertising and publicity expenditures; (viii)&nbsp;real estate brokers&#146; or other leasing commissions and other similar payments; (ix)&nbsp;costs of restoration to the extent of net insurance proceeds received by Landlord
with respect thereto; (x)&nbsp;repairs or other work occasioned by fire, windstorm or other casualty or damage to the extent Landlord is reimbursed by insurance; (xi)&nbsp;Landlords&#146; reserve accounts; (xii)&nbsp;costs of correcting construction
or latent defects in the Building; (xiii)&nbsp;costs of cleaning up or removing asbestos or hazardous materials not directly attributable to the activities of Tenant, its agents, employees or contractors; (xiv)&nbsp;costs incurred by Landlord due to
the violation by Landlord of the terms and conditions of any lease of space in the Project; (xv)&nbsp;costs incurred in connection with upgrading the Building to comply with disability, life, fire and safety codes in effect prior to the Rent
Commencement Date (unless such compliance is triggered by Tenant&#146;s Work or alterations or improvements performed by or for Tenant, in which case such compliance shall be Tenant&#146;s responsibility); (xvi) Landlord&#146;s general corporate
overhead and general administrative expenses not related to the operation of the Building; (xvii)&nbsp;all compensation to executives, officers or partners of Landlord or to any other person at or above the level of property manager (or the person
fulfilling the function of property manager, notwithstanding his or her actual title); (xviii) salaries of service personnel to the extent that such service personnel perform services not attributable to the management, repair or operation of the
Building; (xix)&nbsp;the cost of any political or charitable donations or contributions; (xx)&nbsp;costs of purchasing, installing and replacing art work or decorative features; and (xxi)&nbsp;costs incurred by Landlord to appeal the amount of
Project Taxes payable for the Project to the extent that Landlord does not receive a refund produced by such appeal. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article IV
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Landlord&#146;s Covenants </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.1 Basic Services</B>. Tenant acknowledges that this Lease is a net lease, it being understood that Landlord shall receive the Base Rent
specified in the Basic Lease Information sheet free and clear of any and all expenses, costs, impositions, taxes, assessments, liens or charges of any nature whatsoever, which shall be payable by Tenant unless otherwise set forth in this Lease.
Accordingly, Tenant shall be solely responsible for and promptly pay the appropriate utility company directly for all water, gas, HVAC, light, power, telephone, and other utilities and services supplied to the Leased Premises for which there is a
separate meter or submeter to the Leased Premises [if separate metering is available, Tenant shall pay for such separate metering] and Tenant shall pay Landlord for Tenant&#146;s share, as reasonably determined by Landlord, of all utilities and
services furnished to the Leased Premises for which there is no separate meter or submeter, within thirty (30)&nbsp;days after billing by Landlord [the foregoing utility and service expenses for the Leased Premises shall be paid by Tenant separately
and shall not be part of Tenant&#146;s Proportionate Share of Basic Operating Costs]). With respect to janitorial, Tenant shall employ its own bonded </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and reputable janitorial service, subject to Landlord&#146;s reasonable prior written approval, to clean the Leased Premises on all business days (including, without limitation, cleaning and
providing supplies for the restrooms and break rooms), at Tenant&#146;s sole cost and expense; and with respect to refuse collection, Tenant shall employ its own reputable refuse collection service, subject to Landlord&#146;s reasonable prior
written approval, to collect refuse from the Leased Premises on all business days, at Tenant&#146;s sole cost and expense (the foregoing janitorial expenses and refuse collection for the Leased Premises shall be paid by Tenant separately and shall
not be part of Tenant&#146;s Proportionate Share of Basic Operating Costs). Tenant shall also be responsible for fire/life safety monitoring of the Building and the applicable fees and costs; notwithstanding the foregoing, Tenant has requested that
Landlord undertake the foregoing on behalf of Tenant and Tenant shall pay Landlord for the actual costs related to the fire/life safety monitoring of the Building and the applicable fees and costs within ten (10)&nbsp;days after billing by Landlord.
Subject to inclusion in Basic Operating Costs, Landlord agrees to furnish Tenant only with the following services: maintenance, repair and replacement of all Building systems (including without limitation, fire/life safety systems, mechanical,
electrical, and plumbing systems), structural portions of the Building, including the structural walls, exterior walls, foundation and roof of the Building (not including the Roof Deck Premises), exterior window cleaning, landscaping, parking lot
lighting, and sidewalk and parking lot cleaning and sweeping, all of the foregoing in the manner and to the extent reasonably determined by Landlord to be consistent with those standards of Comparable Buildings (as defined below). Notwithstanding
anything in this Lease to the contrary, Tenant&#146;s use of electrical service shall not exceed, either in voltage, rated capacity, or overall load, its <FONT STYLE="white-space:nowrap">pro-rata</FONT> share of the Building capacity. Except as
specifically set forth in this Lease or to the extent caused by any negligence, willful misconduct or breach of this Lease by Landlord, Landlord shall not be liable for damages to either person or property, nor shall Landlord be deemed to have
evicted Tenant, nor shall there be any abatement of Rent, nor shall Tenant be relieved from performance of any covenant on its part to be performed under this Lease by reason of any (i)&nbsp;deficiency in the provision of basic services;
(ii)&nbsp;breakdown of equipment or machinery utilized in supplying services; or (iii)&nbsp;curtailment or cessation of services due to causes or circumstances beyond the reasonable control of Landlord or by the making of the necessary repairs or
improvements. Landlord shall use reasonable diligence to make such repairs as may be required to machinery or equipment within the Project to provide restoration of services and, where the cessation or interruption of service has occurred due to
circumstances or conditions beyond Project boundaries, to cause the same to be restored, by diligent application or request to the provider thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing or anything in this Lease to the contrary, if any such deficiency, breakdown, or curtailment described above is
within the reasonable control of Landlord to correct and continues for five (5)&nbsp;or more consecutive business days after Landlord becomes aware thereof, whether by Tenant&#146;s written notice to Landlord thereof or otherwise, and Tenant is
unable to reasonably conduct and does not conduct any business in a material portion of the Leased Premises as a result thereof including interference to Tenant&#146;s business, then Tenant shall be entitled to an abatement of Base Rent, which
abatement shall commence as of the first day after the expiration of such five (5)&nbsp;business day period and terminate upon the cessation of such deficiency, breakdown, curtailment or interference and which abatement shall be based on the portion
of the Leased Premises rendered unusable for Tenant&#146;s business by such deficiency, breakdown, curtailment or interference. The rental abatement rights set forth above shall be inapplicable to any interruption, failure or inability described in
this grammatical paragraph that is caused by (i)&nbsp;damage from fire or other casualty (it being acknowledged that such situation shall be governed by Section&nbsp;7.7 below), or (ii)&nbsp;to any deficiency, breakdown, or curtailment caused by the
negligence or willful misconduct of Tenant or its agents, employees or contractors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.2 Extra Services</B>. The cost chargeable to Tenant for all extra services requested by
Tenant in writing and provided by Landlord, if any, shall constitute Additional Rent and shall include a management fee payable to Landlord of five percent (5%) (extra services shall not be subject to an additional property management fee set forth
in Section&nbsp;3.5(a)(6)). Additional Rent shall be paid monthly by Tenant to Landlord concurrently with the payment of Base Rent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.3 Window Coverings</B>. All window coverings for the Office Premises shall be those approved by Landlord, in its reasonable discretion
not to be reasonably withheld, conditioned or delayed. Tenant shall not place or maintain any window coverings, blinds, curtains or drapes other than those approved by Landlord on any exterior window without Landlord&#146;s prior written approval,
which Landlord shall have the right to grant or withhold in its reasonable discretion not to be reasonably withheld, conditioned or delayed. Notwithstanding anything to the contrary herein, Landlord hereby conceptually approves Tenant&#146;s right
to install window coverings to block visual monitoring of the Leased Premises and/or control the temperature and sunlight entering the Leased Premises through the windows. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.4 Graphics and Signage</B>. All signs, notices, advertisements and graphics of every kind or character, visible in or from the exterior
of the Leased Premises shall be subject to Landlord&#146;s prior written reasonable approval, which Landlord approval shall not be unreasonably withheld, conditioned or delayed. Landlord may remove, upon reasonable prior written notice to Tenant and
at the expense of Tenant, any sign, notice, advertisement or graphic of any kind inscribed, displayed or affixed in violation of the foregoing requirement. All approved signs, notices, advertisements or graphics shall be printed, affixed or
inscribed at Tenant&#146;s expense by a sign company selected by or approved by Landlord. Landlord shall be entitled to revise the Project graphics and signage standards at any time. The location, design, content and size of any signage shall be
subject to Landlord&#146;s reasonable approval as well as the approval of the City of Emeryville. Tenant shall remove Tenant&#146;s signs and repair any damage caused by the installation or removal of such signage and shall restore the area of such
signage to the condition existing prior to installation of the signs at the expiration or earlier termination of this Lease. Installation, fabrication, maintenance and removal of Tenant&#146;s signs shall be at Tenant&#146;s sole cost and expense.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.5 </B>Intentionally deleted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.6 Repair Obligation</B>. Landlord&#146;s obligation under this Lease with respect to maintenance, repair, and replacement shall be
limited to the items set forth in <U>Section&nbsp;4.1</U> above. However, Landlord shall not have any obligation to repair actual damage directly caused by Tenant, its agents, employees, contractors, invitees or licensees, unless otherwise excepted
under this Lease. Landlord shall have the right, but not the obligation, to undertake work of repair which Tenant is required to perform under this Lease or which Landlord deems necessary, in Landlord&#146;s reasonable discretion, including, but not
limited to, the painting and refinishing of the exterior areas of the Building and Project, so as to impede, to the extent possible, deterioration by ordinary wear and tear and to keep the same in attractive condition, and which Tenant fails or
refuses to perform in a timely and efficient manner after Tenant&#146;s receipt of written notice. Tenant shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reimburse Landlord upon demand, as Additional Rent, for all costs incurred by Landlord in performing any such repair for the account of Tenant, together with an amount equal to five
percent&nbsp;(5%) of such costs to reimburse Landlord for its administration and managerial effort (the foregoing costs incurred by Landlord in performing any such repair for the account of Tenant shall not be subject to an additional property
management fee set forth in <U>Section&nbsp;3.5(a)(6))</U>. Except as specifically set forth in this Lease, Landlord shall have no obligation whatsoever to maintain or repair the Leased Premises or the Project. The parties intend that the terms of
this Lease govern their respective maintenance and repair obligations. Tenant expressly waives the benefit of any statute now or hereafter in effect to the extent it is inconsistent with the terms of this Lease with respect to such obligations or
which affords Tenant the right to make repairs at the expense of Landlord or terminate this Lease by reason of the condition of the Leased Premises or any needed repairs. All costs in performing the work described in this <U>Section&nbsp;4.6</U>
shall be included in Basic Operating Costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.7 Peaceful Enjoyment</B>. Landlord covenants with Tenant that upon Tenant paying the
Rent and all other charges required under this Lease and performing all of Tenant&#146;s covenants and agreements herein contained, Tenant shall peacefully have, hold and enjoy the Leased Premises subject to all of the terms of this Lease and to any
deed of trust, mortgage, ground lease or other agreement to which this Lease may be subordinate. This covenant and the other covenants of Landlord contained in this Lease shall be binding upon Landlord and its successors only with respect to
breaches occurring during its or their respective ownerships of Landlord&#146;s interest hereunder. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Tenant&#146;s Covenants </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1 Payments by Tenant</B>. Tenant shall pay Rent at the times and in the manner provided in this Lease. All obligations of Tenant
hereunder to make payments to Landlord shall constitute Rent and failure to pay the same when due shall give rise to the rights and remedies provided for in Section&nbsp;7.8. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2 Tenant&#146;s Work</B>. Tenant&#146;s Work, if any, shall be installed and constructed pursuant to <B><U>Exhibit B</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.3 Taxes on Personal Property</B>. In addition to, and wholly apart from its obligation to pay Tenant&#146;s Proportionate Share of Basic
Operating Costs, Tenant shall be responsible for, and shall pay prior to delinquency, all taxes or governmental service fees, possessory interest taxes, fees or charges in lieu of any such taxes, capital levies, and any other charges imposed upon,
levied with respect to, or assessed against Tenant&#146;s personal property, and on its interest pursuant to this Lease. To the extent that any such taxes are not separately assessed or billed to Tenant, Tenant shall pay the amount thereof as
invoiced to Tenant by Landlord. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.4 Repairs by Tenant</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall be obligated to maintain and repair, at Tenant&#146;s sole cost and expense, the Leased Premises (except the items that are
Landlord&#146;s responsibility to maintain and repair) and Tenant&#146;s personal property, trade fixtures and any improvements or alterations installed by or on behalf of Tenant), to keep the same at all times in good order, condition and repair,
and, upon expiration of the Term, to surrender the same to Landlord in the same condition as on the Term Commencement Date, reasonable wear and tear, taking by condemnation, and damage by casualty not caused by Tenant, its agents, employees,
contractors, invitees and licensees excepted. Tenant&#146;s obligations shall include, without limitation, the obligation to maintain and repair all walls, floors, ceilings and fixtures and to repair all damage caused by Tenant, its agents,
employees, contractors, invitees and others using the Leased Premises with Tenant&#146;s expressed or implied permission. At the request of Tenant, but without obligation to do so, Landlord may perform the work of maintenance and repair constituting
Tenant&#146;s obligation under this <U>Section&nbsp;5.4</U> at Tenant&#146;s sole cost and expense and as an extra service to be rendered pursuant to <U>Section&nbsp;4.2</U>. Any work of repair and maintenance performed by or for the account of
Tenant by persons other than Landlord shall be performed by contractors approved by Landlord and in accordance with procedures Landlord shall from time to time reasonably establish. Tenant shall give Landlord prompt notice of any damage to or
defective condition in any part of the mechanical, electrical, plumbing, fire/life safety or other system servicing or located in the Leased Premises. As set forth in Section&nbsp;4.1, Landlord shall be responsible for the repair and maintenance of
the structural parts of the Building, including structural walls, exterior walls, structural portions of the floors of the Building, foundation and roof of the Building (except for structural improvements performed by or for Tenant). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything in this Lease to the contrary, Tenant shall enter into and continue in force throughout the term of this Lease a
regularly scheduled (at least once every three (3)&nbsp;months) preventive maintenance/service contract, with a maintenance contractor approved by Landlord, for servicing all HVAC units serving the Leased Premises (&#147;<B>HVAC
Maintenance</B>&#148;), and Tenant shall promptly provide Landlord a copy of the contract and all quarterly service reports and other service reports. The service contract must include, at a minimum, all services suggested by the equipment
manufacturer. Tenant shall be responsible for any repair, replacement and maintenance of the HVAC units serving the Leased Premises and shall surrender the HVAC units on the Term Expiration Date (or earlier termination of this Lease) in good working
order with no deferred maintenance. Notwithstanding the foregoing, Tenant has requested that Landlord undertake the HVAC Maintenance on behalf of Tenant and Tenant shall pay Landlord for the actual costs related to the HVAC Maintenance, including
without limitation the repair or replacement of parts and equipment within ten (10)&nbsp;days after billing by Landlord; Landlord has agreed to undertake the HVAC Maintenance on behalf of Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything in this Lease to the contrary, Tenant shall enter into and continue in force throughout the term of this Lease a
regularly scheduled preventive maintenance/service contract, with a maintenance contractor approved by Landlord, for servicing the Building elevator system (&#147;<B>Elevator Maintenance</B>&#148;). The service contract shall include, at a minimum,
all services suggested by the equipment manufacturer. Since Tenant is the sole user of the Building elevator system, Tenant shall pay for all costs related to Elevator Maintenance, including without limitation the repair or replacement of parts and
equipment. Notwithstanding the foregoing, Tenant has requested that Landlord undertake the Elevator Maintenance on behalf of Tenant and Tenant shall pay Landlord for the actual costs related to the Elevator Maintenance, including without limitation
the repair or replacement of parts and equipment within ten (10)&nbsp;days after billing by Landlord; Landlord has agreed to undertake the Elevator Maintenance on behalf of Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything to the contrary set forth in this Lease, in the event that the
originally named Tenant in this Lease develops the capacity and facilities management expertise necessary to perform facilities management of the Leased Premises in accordance with prevailing industry standards and can provide reasonable evidence to
Landlord of such capacity, the originally named Tenant in this Lease may elect (on any January&nbsp;1 during the Term of this Lease by providing Landlord at least sixty (60)&nbsp;days prior written notice of such election) to assume the obligations
of Landlord under service contracts for HVAC Maintenance, Elevator Maintenance and fire/life safety monitoring and pay such costs directly to the providers of those services. During all periods following any such election by Tenant, Tenant shall
maintain records of its performance of its maintenance obligations under this Lease and shall provide reasonable access to Landlord to inspect such maintenance records, and, with respect to Tenant&#146;s payment obligations under this Lease,
Landlord shall adjust Basic Operating Costs and/or Additional Rent payable by Tenant accordingly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.5 Waste</B>. Tenant shall not
commit or allow any waste or damage to be committed in any portion of the Leased Premises or the Project. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.6 Assignment or
Sublease</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall not voluntarily or by operation of law assign, transfer or encumber (collectively
&#147;<B>Assign</B>&#148;) or sublet all or any part of Tenant&#146;s interest in this Lease or in the Leased Premises, or allow any third party to use any portion of the Leased Premises (which for purposes of the balance of this
<U>Section&nbsp;5.6</U> shall be deemed to be a &#147;sublet&#148; or &#147;sublease&#148; of the Leased Premises), without Landlord&#146;s prior written consent given under and subject to the terms of this <U>Section&nbsp;5.6</U>. Tenant may not
sublease the Roof Deck Premises separately from the Office Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If Tenant desires to Assign this Lease or any interest herein or
sublet the Leased Premises or any part thereof, Tenant shall give Landlord a request for consent to such transaction, in writing. Tenant&#146;s written request for consent shall specify the date the proposed assignment or sublease would be effective
and be accompanied by information pertinent to Landlord&#146;s determination as to the financial and operational responsibility and appropriateness of the proposed assignee or subtenant, including, without limitation, its name, business and
financial condition, financial details of the proposed transfer, the intended use (including any modification) of the Leased Premises, and exact copies of all of the proposed agreement(s) between Tenant and the proposed assignee or subtenant. Tenant
shall promptly provide Landlord with (i)&nbsp;such other or additional information or documents reasonably requested (within ten (10)&nbsp;days after receiving Tenant&#146;s consent request) by Landlord, and (ii)&nbsp;an opportunity to meet and
interview the proposed assignee or subtenant, if requested by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Landlord shall have until the later of (x)&nbsp;ten (10)
business days following such interview and receipt of all such additional information and (y)&nbsp;thirty (30) days from the date of Tenant&#146;s original notice if Landlord does not request additional information or an interview, within which to
notify Tenant in writing that Landlord elects either (i)&nbsp;to terminate this Lease as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to the space so affected as of the effective date of the proposed assignment or sublease specified by Tenant, in which event Tenant will be relieved of all further obligations hereunder as to
such space as of such date, other than those obligations which survive termination of the Lease, or (ii)&nbsp;to consent to or withhold consent to Tenant&#146;s request to Assign this Lease or sublet such space, such consent not to be withheld so
long as the proposed assignee or sublessee is approved by Landlord and is of sound financial condition as determined by Landlord in its absolute and sole discretion, the use of the Leased Premises by such proposed assignee or sublessee would be a
Permitted Use, the proposed assignee or sublessee executes such reasonable assumption documentation as Landlord shall require, and the proposed assignee or sublessee is not (x)&nbsp;already a tenant in the Building or (y)&nbsp;a party with whom
Landlord has been discussing the leasing of space in the Building. Failure by Landlord to approve a proposed subtenant or assignee shall not cause a termination of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event Tenant shall request the consent of Landlord to any assignment or subletting hereunder, Tenant shall pay Landlord a
processing fee of $2,500.00 and such fee shall be deemed Additional Rent under this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Any rent or other consideration realized
by Tenant under any such sublease or assignment in excess of (i)&nbsp;the proportionate Rent payable for the applicable subleased space, (ii)&nbsp;any reasonable tenant improvement allowance or other economic concession (e.g., space planning
allowance, moving expenses, free or reduced rent periods, etc.), and (iii)&nbsp;any advertising costs and brokerage commissions associated with such assignment or sublease (&#147;<B>Profit</B>&#148;), shall be divided and paid as follows: fifty
percent (50%) to Tenant and fifty percent (50%) to Landlord; provided, however, that if Tenant is in default hereunder beyond any applicable cure period, Landlord shall be entitled to all such Profit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) In any subletting undertaken by Tenant, Tenant shall use commercially reasonable efforts to obtain not less than fair market rent for the
space to be sublet. In any assignment of this Lease in whole or in part, Tenant shall seek to obtain from the assignee consideration reflecting a value of not less than fair market rent for the space subject to such assignment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The consent of Landlord to any assignment or subletting shall not constitute a consent to any subsequent assignment or subletting by
Tenant or to any subsequent or successive assignment or subletting by the assignee or subtenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) No assignment or subletting by
Tenant shall relieve Tenant of any obligation under this Lease. In the event of default by an assignee or subtenant of Tenant or any successor of Tenant in the performance of any of the terms hereof, Landlord may proceed directly against Tenant
without the necessity of exhausting remedies against such assignee, subtenant or successor. Any assignment or subletting made without Landlord&#146;s consent or which conflicts with the provisions hereof shall be void and, at Landlord&#146;s option,
shall constitute a default under this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything to the contrary contained in this Lease, Tenant may (with ten
(10)&nbsp;business days&#146; prior written notice to Landlord) assign this Lease or sublet the Leased Premises, without Landlord&#146;s consent (or sharing of Profit, or recapture right by Landlord), to any entity controlling, controlled by, or
under common control with Tenant, or to a successor of Tenant resulting from a merger or consolidation of Tenant, or to the purchaser of all or substantially all of Tenant&#146;s assets or stock (each, a &#147;<B>Permitted Transfer</B>&#148;);
provided, however, that (i)&nbsp;no such assignment, sublease, or change of control shall relieve Tenant from any liability under this Lease, whether accrued to the date of such assignment, sublease, or change of control, or thereafter accruing
(unless Tenant is a &#147;disappearing&#148; entity in a transaction otherwise allowed hereunder, except if such transaction(s) is/are entered into to evade Tenant&#146;s obligations hereunder), (ii) if an assignment or sublease, such assignee or
sublessee expressly assumes, in writing, all of Tenant&#146;s obligations under this Lease, in form and content reasonably acceptable to Landlord (except, as between a sublessee and Tenant, for the specific business deal between Tenant and such
sublessee), and (iii)&nbsp;no series of one or more of such transactions shall be used by Tenant to &#147;spin off&#148; this Lease to independent third parties if such transactions are entered into to evade Tenant&#146;s obligations hereunder, and
(iv)&nbsp;Tenant shall give Landlord ten (10)&nbsp;business days&#146; prior written notice of any such transaction not requiring Landlord&#146;s consent (or if Tenant is unable to disclose an impending transaction due to legal requirements, then
Tenant shall notify Landlord in writing within five (5)&nbsp;days after the transaction). In addition, any change in the controlling interest in the stock of Tenant as a result of an initial public offering of Tenant&#146;s stock, and any transfer
of the capital stock of Tenant by persons or parties through the &#147;over the counter market&#148; or through any recognized stock exchange, shall not be deemed to be an assignment or transfer requiring Landlord&#146;s consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.7 Alterations, Additions and Improvements</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in <B><U>Exhibits B</U> </B>and <B><U><FONT STYLE="white-space:nowrap">B-1</FONT></U></B>, Tenant shall not make or
allow to be made any alterations, additions or improvements in or to the Leased Premises without first obtaining the written consent of Landlord, provided that Tenant shall be permitted, without Landlord&#146;s consent, to make <FONT
STYLE="white-space:nowrap">non-structural</FONT> alterations or additions to the Leased Premises that do not affect any of the Building systems, cost less than $25,000.00 in the aggregate per project, or $50,000.00 in the aggregate per calendar
year, do not require a building permit, and are of a cosmetic nature (e.g., painting, carpeting, etc.; any such alteration complying with all of the foregoing constituting a &#147;<B>Cosmetic Alteration</B>&#148;). Landlord&#146;s consent will not
be unreasonably withheld, conditioned or delayed with respect to proposed alterations, additions or improvements which (i)&nbsp;comply with all applicable laws, ordinances, rules and regulations; (ii)&nbsp;are compatible with and do not adversely
affect the Building and its mechanical, telecommunication, electrical, HVAC and fire/life safety systems; (iii)&nbsp;will not affect the structural or exterior portions of the Building; and (iv)&nbsp;will not trigger any material costs to Landlord.
Specifically, but without limiting the generality of the foregoing, Landlord&#146;s right of consent shall encompass plans and specifications for the proposed alterations, additions or improvements, construction means and methods, the identity of
any contractor or subcontractor to be employed on the work of alterations, additions or improvements, and the time for performance of such work. Tenant shall supply to Landlord any additional documents and information requested by Landlord in
connection with Tenant&#146;s request for consent hereunder. If Tenant performs any alterations or additions permitted under this <U>Section&nbsp;5.7</U>, Tenant shall, in addition to complying with the provisions of this <U>Section&nbsp;5.7</U>,
perform such alterations or additions in a manner that avoids disturbing any asbestos containing materials present in the Building. If asbestos containing materials are likely to be disturbed in the course of such work, Tenant shall encapsulate or
remove the asbestos containing materials in accordance with an asbestos-removal plan approved by Landlord and otherwise in accordance with all applicable laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Any consent given by Landlord under this <U>Section&nbsp;5.7</U> shall be deemed
conditioned upon: (i)&nbsp;Tenant&#146;s acquiring all applicable permits required by governmental authorities; (ii)&nbsp;Tenant&#146;s furnishing to Landlord copies of such permits, together with copies of the approved plans and specifications,
prior to commencement of the work thereon; and (iii)&nbsp;the compliance by Tenant with the conditions of all applicable permits and approvals in a prompt and expeditious manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Tenant shall provide Landlord with not less than fifteen (15)&nbsp;days prior written notice of commencement of the work so as to enable
Landlord to post and record appropriate notices of <FONT STYLE="white-space:nowrap">non-responsibility.</FONT> Except as set forth in <B><U>Exhibits B</U> </B>and <B><U><FONT STYLE="white-space:nowrap">B-1</FONT></U></B>, all alterations, additions
and improvements permitted hereunder shall be made and performed by Tenant without cost or expense to Landlord and in strict accordance with plans and specifications approved by Landlord. Tenant shall pay the contractors and suppliers all amounts
due to them when due and keep the Leased Premises and the Project free from any and all mechanics&#146;, materialmen&#146;s and other liens and claims arising out of any work performed, materials furnished or obligations incurred by or for Tenant.
Landlord may require, at its sole option, that Tenant provide to Landlord, at Tenant&#146;s expense, a lien and completion bond in an amount equal to the total estimated cost of any alterations, additions or improvements to be made in or to the
Leased Premises, to protect Landlord against any liability for mechanics&#146;, materialmen&#146;s and other liens and claims, and to ensure timely completion of the work. In the event any alterations, additions or improvements to the Leased
Premises are performed by Landlord hereunder, whether by prearrangement or otherwise, Landlord shall be entitled to charge Tenant a five percent (5%) administration fee in addition to the actual costs of labor and materials provided. Such costs and
fees shall be deemed Additional Rent under this Lease, and may be charged and payable prior to commencement of the work. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Any and all
alterations, additions or improvements made to the Leased Premises by Tenant shall become the property of Landlord upon installation and shall be surrendered to Landlord without compensation to Tenant upon the termination of this Lease by lapse of
time or otherwise unless (i)&nbsp;Landlord conditioned its approval of such alterations, additions or improvements on Tenant&#146;s agreement to remove them, or (ii)&nbsp;if Tenant did not provide a Removal Determination Request (as defined below),
Landlord notifies Tenant prior to (or promptly after) the Term Expiration Date that the alterations, additions and/or improvements must be removed, in which case Tenant shall, by the Term Expiration Date, remove such alterations, additions and
improvements (which includes, without limitation, Tenant&#146;s Work), repair any damage resulting from such removal and restore the Leased Premises to their condition existing prior to the date of installation of such alterations, additions and
improvements, ordinary wear and tear excepted. Prior to making any alterations, additions or improvements to the Leased Premises, Tenant may make a written request that Landlord determine in advance whether or not Tenant must remove such
alterations, additions or improvements on or prior to the Term Expiration Date or any earlier termination of this Lease (&#147;<B>Removal Determination Request</B>&#148;). Notwithstanding anything to the contrary set forth above, this clause shall
not apply to movable equipment or furniture owned by Tenant. Tenant shall repair, at its sole cost and expense, all damage caused to the Leased Premises and the Project by removal of Tenant&#146;s movable equipment or furniture and such other
alterations, additions and improvements as Tenant shall be required or allowed by Landlord to remove from the Leased Premises. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) All alterations, additions and improvements permitted under this <U>Section&nbsp;5.7</U>
shall be constructed diligently, in a good and workmanlike manner with new, good and sufficient materials and in compliance with all applicable laws, ordinances, rules and regulations (including, without limitation, building codes and those related
to accessibility and use by individuals with disabilities). Tenant shall, promptly upon completion of the work, furnish Landlord with &#147;as built&#148; drawings for any alterations, additions or improvements performed under this
<U>Section&nbsp;5.7</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding anything in this Lease to the contrary, Tenant shall construct all alterations, additions
and improvements and perform all repairs and maintenance under this Lease (all contractors to be approved in writing in advance by Landlord or, at Landlord&#146;s option, designated by Landlord) in conformance with any and all applicable laws,
including, without limitation, pursuant to a valid building permit issued by the applicable municipality, in conformance with Landlord&#146;s construction rules and regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) All alterations, additions and improvements permitted under this <U>Section&nbsp;5.7</U> shall be completed using Building standards and
all vendors (including, without limitation, Tenant&#146;s cabling contractors and subcontractors) accessing areas above the ceiling grid shall be certified to work in an asbestos containing setting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Tenant shall have the right to install a wireless intranet, internet, and communications network (also known as &#147;<B><FONT
STYLE="white-space:nowrap">Wi-Fi</FONT></B>&#148;) within the Leased Premises for the use of Tenant and its employees (the &#147;<B>Network</B>&#148;) subject to this subsection and all the other clauses of this Lease as are applicable. Tenant shall
not solicit, suffer, or permit other tenants or occupants of the Building to use the Network or any other communications service, including, without limitation, any wired or wireless internet service that passes through, is transmitted through, or
emanates from the Leased Premises. Tenant agrees that Tenant&#146;s communications equipment and the communications equipment of Tenant&#146;s service providers located in or about the Leased Premises, including, without limitation, any antennas,
switches, or other equipment (collectively, &#147;<B>Tenant&#146;s Communications Equipment</B>&#148;) shall be of a type and, if applicable, a frequency that will not cause material radio frequency, electromagnetic, or other interference to any
other party or any equipment of Landlord at the Building. In the event that Tenant&#146;s Communications Equipment causes or is believed to cause any such material interference, upon receipt of notice from Landlord of such interference, Tenant will
take commercially reasonable steps necessary, at Tenant&#146;s sole cost and expense, to mitigate the interference. If the interference is not mitigated within forty-eight (48)&nbsp;hours (or a shorter period if Landlord believes a shorter period to
be appropriate) then, upon request from Landlord, Tenant shall shut down the Tenant&#146;s Communications Equipment pending resolution of the material interference, with the exception of intermittent testing upon prior notice to and with the
approval of Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.8 Compliance With Laws and Insurance Standards</B>. Tenant shall not occupy or use, or permit any portion of
the Leased Premises to be occupied or used in a manner that violates any applicable law, ordinance, rule, regulation, order, permit, covenant, easement or restriction of record, or the recommendations of Landlord&#146;s engineers or consultants,
relating in any manner to the Project, or for any business or purpose which is disreputable, objectionable or productive of fire hazard. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall not do or permit anything to be done which would result in the cancellation, or
in any way increase the cost, of the property insurance coverage on the Project and/or its contents. If Tenant does or permits anything to be done which increases the cost of any insurance covering or affecting the Project, then Tenant shall
reimburse Landlord, upon demand, as Additional Rent, for such additional costs. Landlord shall deliver to Tenant a written statement setting forth the amount of any such insurance cost increase and showing in reasonable detail the manner in which it
has been computed. Tenant shall, at Tenant&#146;s sole cost and expense, comply with all laws, ordinances, rules, regulations and orders (state, federal, municipal or promulgated by other agencies or bodies having or claiming jurisdiction) related
to the use, condition or occupancy of the Leased Premises now in effect or which may hereafter come into effect including, but not limited to, (a)&nbsp;accessibility and use by individuals with disabilities, and (b)&nbsp;environmental conditions in,
on or about the Leased Premises. If anything done by Tenant in its specific and unique use or operation of the Leased Premises (as opposed to general office use or general research and development use as contemplated herein) after the Rent
Commencement Date or alterations performed by or for Tenant shall create, require or cause imposition of any requirement by any public authority for structural or other upgrading of or alteration or improvement to the Project, Tenant shall, at
Landlord&#146;s option, either perform the upgrade, alteration or improvement at Tenant&#146;s sole cost and expense or reimburse Landlord upon demand, as Additional Rent, for the cost to Landlord of performing such work. The judgment of any court
of competent jurisdiction or the admission by Tenant in any action against Tenant, whether Landlord is a party thereto or not, that Tenant has violated any law, ordinance, rule, regulation, order, permit, covenant, easement or restriction shall be
conclusive of that fact as between Landlord and Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.9 No Nuisance; No Overloading</B>. Tenant shall use and occupy the Leased
Premises, and control its agents, employees, contractors, invitees and visitors in such manner so as not to create any nuisance, or interfere with, annoy or disturb (whether by noise, odor, vibration or otherwise) any other tenant or occupant of the
Project or Landlord in its operation of the Project. Tenant shall not place or permit to be placed any loads upon the floors, walls or ceilings in excess of the maximum designed load specified by Landlord or which might damage the Leased Premises,
the Building, or any portion thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.10 Furnishing of Financial Statements; Tenant&#146;s Representations</B>. In order to induce
Landlord to enter into this Lease, Tenant agrees that it shall promptly furnish Landlord, from time to time, within ten (10)&nbsp;days of receipt of Landlord&#146;s written request therefor (but no more than once each calendar year, unless requested
by Landlord because of a bona fide financing or sale of the Building or a bona fide request by Landlord&#146;s financial partners or lender, in which case Tenant shall be required to furnish more than one time per calendar year), with financial
statements in form and substance reasonably satisfactory to Landlord reflecting Tenant&#146;s current financial condition. Tenant represents and warrants that all financial statements, records and information furnished by Tenant to Landlord in
connection with this Lease are true, correct and complete in all material respects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.11 Entry by Landlord</B>. Landlord, its employees, agents and consultants, shall have
the right to enter the Leased Premises at any time, in cases of an emergency, and otherwise at reasonable times after at least twenty-four (24)&nbsp;hours advance written notice to Tenant (which written notice may be via email) to inspect the same,
to clean, to perform such work as may be permitted or required under this Lease, to make repairs to or alterations of the Leased Premises or other portions of the Project or other tenant spaces therein, to deal with emergencies, to post such notices
as may be permitted or required by law to prevent the perfection of liens against Landlord&#146;s interest in the Project or to show the Leased Premises to prospective tenants, purchasers, encumbrancers or others, or for any other purpose as
Landlord may deem reasonably necessary or desirable; provided, however that Landlord shall not unreasonably interfere with Tenant&#146;s access, use and enjoyment of the Leased Premises or Building Top Roof Deck. Tenant shall not be entitled to any
abatement of Rent or damages by reason of the exercise of any such right of entry or performance of any such work by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.12
Nondisturbance and Attornment</B>. This Lease and the rights of Tenant hereunder shall be subject and subordinate to the lien of any deed of trust, mortgage, ground lease or other hypothecation or security instrument (collectively, &#147;<B>Security
Device</B>&#148;) now or hereafter placed upon, affecting or encumbering the Project or any part thereof or interest therein, and to any and all advances made thereunder, interest thereon or costs incurred and any modifications, renewals,
supplements, consolidations, replacements and extensions thereof. Without the consent of Tenant, the holder of any such Security Device or the beneficiary thereunder shall have the right to elect to be subject and subordinate to this Lease, such
subordination to be effective upon such terms and conditions as such holder or beneficiary may direct which are not inconsistent with the provisions hereof. Tenant agrees to attorn to and recognize as the Landlord under this Lease the holder or
beneficiary under a Security Device or any other party that acquires ownership of the Leased Premises by reason of a foreclosure or sale under any Security Device (or deed in lieu thereof). Tenant covenants and agrees to execute (and acknowledge if
required by Landlord, any lender or ground lessor) and deliver, within ten (10)&nbsp;days of a written demand or request by Landlord and in the form reasonably requested by Landlord, ground lessor, mortgagee or beneficiary, any additional documents
evidencing the priority or subordination of this Lease with respect to any such ground leases or underlying leases or the lien of any such mortgage or deed of trust. Landlord shall use diligent and good faith efforts to obtain a nondisturbance
agreement in a commercially reasonable form from the current lender within thirty (30)&nbsp;days after the Rent Commencement Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.13 Estoppel Certificate</B>. Within fifteen (15)&nbsp;days following Landlord&#146;s request, Tenant shall execute, acknowledge and
deliver written estoppel certificates addressed to (i)&nbsp;any mortgagee or prospective mortgagee of Landlord, or (ii)&nbsp;any purchaser or prospective purchaser of all or any portion of, or interest in, the Project, on a form specified by
Landlord, certifying as to such facts (if true) and agreeing to such notice provisions and other matters as such mortgagee(s) or purchaser(s) may reasonably require, including, without limitation, the following: (a)&nbsp;that this Lease is
unmodified and in full force and effect (or in full force and effect as modified, and stating the modifications); (b) the amount of, and date to which Rent and other charges have been paid in advance; (c)&nbsp;the amount of the Security Deposit; and
(d)&nbsp;acknowledging, to Tenant&#146;s knowledge, that Landlord is not in default under this Lease (or, if Landlord is claimed to be in default, stating the nature of the alleged default). Any such estoppel certificate may be relied upon by any
such mortgagee or purchaser. Failure by Tenant to execute and deliver any such estoppel certificate within three (3)&nbsp;business days following a second (2nd) written notice from Landlord shall be conclusive upon Tenant that (1)&nbsp;this Lease is
in full force and effect and has not been modified except as represented by Landlord; (2)&nbsp;not more than one month&#146;s Rent has been paid in advance; and (3)&nbsp;Landlord is not in default under this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.14 Security Deposit</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Instead of a cash deposit, Tenant shall deliver the Security Deposit to Landlord in the form of a clean and irrevocable letter of credit
(the &#147;<B>Letter of Credit</B>&#148;) issued by and drawable upon (said issuer being referred to as the &#147;<B>Issuing Bank</B>&#148;) a financial institution which is reasonably approved by Landlord within five (5)&nbsp;business days after
the execution of this Lease. Such Letter of Credit shall (a)&nbsp;name Landlord as beneficiary, (b)&nbsp;be in the amount of the Security Deposit, (c)&nbsp;have a term of not less than one year, (d)&nbsp;permit multiple drawings, (e)&nbsp;be fully
transferable by Landlord, and (f)&nbsp;otherwise be in form and content reasonably satisfactory to Landlord. If upon any transfer of the Letter of Credit, any fees or charges shall be so imposed, then such fees or charges shall be payable solely by
Tenant and the Letter of Credit shall so specify and if the Issuing Bank will not agree to the transfer (or if it imposes unreasonable requirements for the transfer), Tenant shall promptly replace such Letter of Credit. The Letter of Credit shall
provide that it shall be deemed automatically renewed, without amendment, for consecutive periods of one year each thereafter during the Term unless the Issuing Bank sends a notice (the &#147;<B><FONT STYLE="white-space:nowrap">Non-Renewal</FONT>
Notice</B>&#148;) to Landlord by certified mail, return receipt requested, not less than forty-five (45)&nbsp;days next preceding the then expiration date of the Letter of Credit stating that the Issuing Bank has elected not to renew the Letter of
Credit. Landlord shall have the right, upon receipt of the <FONT STYLE="white-space:nowrap">Non-Renewal</FONT> Notice, to draw the full amount of the Letter of Credit, by sight draft on the Issuing Bank, and shall thereafter hold or apply the cash
proceeds of the Letter of Credit pursuant to the terms of this <U>Section&nbsp;5.14</U>. The Issuing Bank shall agree with all drawers, endorsers and bona fide holders that drafts drawn under and in compliance with the terms of the Letter of Credit
will be duly honored upon presentation to the Issuing Bank at an office location in the San Francisco Bay Area. Notwithstanding the foregoing, Landlord hereby approves Silicon Valley Bank as an Issuing Bank. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If at any time during the Term, Tenant shall be in default in the payment of Rent or in material default for any other reason, Landlord
may use or apply all or part of the Security Deposit for payment of any amount due Landlord or to cure such default or to reimburse or compensate Landlord for any liability, loss, cost, expense or damage (including attorneys&#146; fees) which
Landlord may suffer or incur by reason of Tenant&#146;s default. If Landlord uses or applies all or any part of the Security Deposit, Tenant shall, on demand, restore the Letter of Credit to the full amount required by this Lease. Within thirty
(30)&nbsp;days after the expiration of the Term or earlier termination of this Lease and after Tenant has vacated the Leased Premises, Landlord shall or shall cause the Issuing Bank to return the Letter of Credit to Tenant, reduced by such amounts
as may be required by Landlord to remedy defaults on the part of Tenant in the payment of Rent, to repair damages to the Leased Premises caused by Tenant and to clean the Leased Premises. The portion of the Letter of Credit not so required shall be
returned to Tenant (or, at Landlord&#146;s option, to the last assignee of Tenant&#146;s interest in this Lease) within thirty (30)&nbsp;days after expiration of the Term or earlier termination hereof. No part of the Security Deposit shall be
considered to be held in trust, or to be prepayment of any monies to be paid by Tenant under this Lease. Tenant hereby waives (i)&nbsp;the protections of Section&nbsp;1950.7 of the California Civil Code, as it may hereafter be amended and any and
all other laws, rules and regulations applicable to security deposits in the commercial context (&#147;<B>Security Deposit Laws</B>&#148;), and (ii)&nbsp;any and all rights, duties and obligations either party may now or, in the future, will have
relating to or arising from the Security Deposit Laws. Notwithstanding anything to the contrary herein, the Security Deposit may be applied by Landlord (a)&nbsp;to offset Rent which is unpaid either before or after termination of this Lease, and
(b)&nbsp;against other damages suffered by Landlord before or after termination of this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything in this <U>Section&nbsp;5.14</U> to the contrary, provided that
there has been no previous material monetary default by Tenant under the Lease, (i)&nbsp;on the last day of the twenty-fourth (24th) full calendar month after the Rent Commencement Date, the amount of the Security Deposit and Letter of Credit shall
be reduced to seventy-five percent (75%) of the original Security Deposit amount, (ii)&nbsp;on the last day of the forty-eighth (48th) full calendar month after the Rent Commencement Date, the amount of the Security Deposit and Letter of Credit
shall be reduced to fifty percent (50%) of the original Security Deposit amount, and (iii)&nbsp;on the last day of the seventy- second (72nd) full calendar month after the Rent Commencement Date, the amount of the Security Deposit and Letter of
Credit shall be reduced to twenty-five percent (25%) of the original Security Deposit. Except as set forth in the following sentence, in no event shall the Security Deposit and Letter of Credit be less than $825,000.00. Provided that there has been
no previous material monetary default by Tenant under the Lease, Tenant has a minimum net worth of $1,000,000,000.00 on the last day of the ninety-sixth (96th) full calendar month after the Rent Commencement Date, and Tenant has produced an EBITDA
profit for the immediately preceding four (4)&nbsp;consecutive quarters, the amount of the Security Deposit and Letter of Credit shall be reduced to $500,000.00. Subject to the foregoing, Tenant shall have the right to reduce the Letter of Credit
amount via the delivery to Landlord of either (i)&nbsp;an amendment to the existing Letter of Credit (in form and content reasonably acceptable to Landlord) reducing the Letter of Credit amount to the amount set forth above, or (ii)&nbsp;an entirely
new Letter of Credit (in the form and content required by this <U>Section&nbsp;5.14</U>) in the Letter of Credit amount then required as set forth above. If applicable, Landlord shall cooperate with Tenant in executing such authorizations as the
Issuing Bank may require to accomplish any such reduction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.15 Surrender</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the provisions of <U>Section&nbsp;5.7</U> hereof, on the Term Expiration Date (or earlier termination of this Lease), Tenant
shall quit and surrender possession of the Leased Premises to Landlord in broom clean condition and as good order and condition as they were in on the Term Commencement Date, reasonable wear and tear, casualty damage, taking by condemnation and
damage by casualty not caused by Tenant, its agents, employees, contractors, invitees and licensees excepted. Reasonable wear and tear shall not include any damage or deterioration that would have been prevented by good maintenance practice or by
Tenant performing all of its obligations under this Lease. Tenant shall, without cost to Landlord, remove all furniture, equipment, trade fixtures, debris and articles of personal property owned by Tenant in the Leased Premises, and shall repair any
damage to the Project resulting from such removal. Any such property not removed by Tenant by the Term Expiration Date (or earlier termination of this Lease) shall be considered abandoned, and Landlord may remove any or all of such items and dispose
of same in any lawful manner or store same in a public warehouse or elsewhere for the account and at the expense and risk of Tenant. If Tenant shall fail to pay the cost of storing any such property after storage for thirty (30)&nbsp;days or more,
Landlord may sell any or all of such property at public or private sale, in such manner and at such times and places as Landlord may deem proper, without notice to or demand upon Tenant. Landlord shall apply the proceeds of any such sale as follows:
first, to the costs of such sale; second, to the costs of storing any such property; third, to the payment of any other sums of money which may then or thereafter be due to Landlord from Tenant under any of the terms of this Lease; and fourth, the
balance, if any, to Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition, on the Term Expiration Date (or earlier termination of this Lease), Tenant
shall remove, at its sole cost and expense, all of Tenant&#146;s telecommunications lines and cabling installed by Tenant or Current Tenant, including, without limitation, any such lines and cabling installed in the plenum or risers of the Building
in compliance with the National Electrical Code (collectively, &#147;<B>Wires</B>&#148;) and repair all damage caused thereby and restore the Leased Premises or the Building, as the case may be, to their condition existing prior to the installation
of the Wires (&#147;<B>Wire Restoration Work</B>&#148;). Landlord, at its option, may perform such Wire Restoration Work at Tenant&#146;s sole cost and expense. In the event that Tenant fails to perform the Wire Restoration Work or refuses to pay
all costs of the Wire Restoration Work (if performed by Landlord) within ten (10)&nbsp;days of Tenant&#146;s receipt of Landlord&#146;s notice requesting Tenant&#146;s reimbursement for or payment of such costs or otherwise fails to comply with the
provisions of this <U>Section&nbsp;5.15(b)</U>, Landlord may apply all or any portion of the Security Deposit toward the payment of any costs or expenses relative to the Wire Restoration Work or Tenant&#146;s obligations under this
<U>Section&nbsp;5.15(b)</U>. The retention or application of such Security Deposit (if any) by Landlord pursuant to this <U>Section&nbsp;5.15(b)</U> does not constitute a limitation on or waiver of Landlord&#146;s right to seek further remedy under
law or equity. The provisions of this <U>Section&nbsp;5.15(b)</U> shall survive the expiration or sooner termination of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.16 Tenant&#146;s Remedies</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Landlord shall not be deemed in breach of this Lease unless Landlord fails within a reasonable time to perform an obligation required to
be performed by Landlord. For purposes of this <U>Section&nbsp;5.16</U>, a reasonable time shall in no event be less than fifteen (15)&nbsp;days after receipt by Landlord, and by the holders of any ground lease, deed of trust or mortgage covering
the Leased Premises whose name and address shall have been furnished Tenant in writing for such purpose, of written notice specifying wherein such obligation of Landlord has not been performed; provided, however, that if the nature of
Landlord&#146;s obligation is such that more than fifteen (15)&nbsp;days after such notice are reasonably required for its performance, then Landlord shall not be in breach of this Lease if performance is commenced within said fifteen <FONT
STYLE="white-space:nowrap">(15)-day</FONT> period and thereafter diligently pursued to completion. If Landlord fails to cure such default within the time provided for in this Lease, the holder of any such ground lease, deed of trust or mortgage
shall have an additional period of time as described in <U>Section&nbsp;9.26</U> below. The liability of Landlord to Tenant for any default by Landlord under the terms of this Lease shall be limited to the actual interest of Landlord and its present
or future partners or members in the Building, and Tenant agrees to look solely to Landlord&#146;s interest in the Building for satisfaction of any liability and shall not look to other assets of Landlord nor seek any recourse against the assets of
the individual partners, members, directors, officers, shareholders, agents or employees of Landlord, including without limitation, any property management or asset management company of Landlord (collectively, the &#147;<B>Landlord
Parties</B>&#148;). It is the parties&#146; intention that Landlord and the Landlord Parties shall not in any event or circumstance be personally liable, in any manner whatsoever, for any judgment or deficiency hereunder or with respect to this
Lease. Landlord shall not be liable for any loss, injury or damage arising from any act or omission of any other tenant or occupant of the Building, nor shall Landlord be liable under any circumstances for damage or inconvenience to Tenant&#146;s
business or for any loss of income or profit therefrom or for other consequential </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
damages. The liability of Landlord under this Lease is limited to its actual period of ownership of title to the Building. Any lien obtained to enforce any such judgment and any levy of execution
thereon shall be subject and subordinate to any lien, deed of trust or mortgage to which <U>Section&nbsp;5.12</U> applies or may apply. Tenant&#146;s obligation to provide written notice to Landlord of a default by Landlord is limited to those
instances where knowledge of Landlord&#146;s default is within the actual knowledge of Tenant. Tenant shall not have the right to terminate this Lease or withhold, reduce or offset any amount against any payments of Rent due and payable under this
Lease by reason of a breach of this Lease by Landlord (except as otherwise provided in this Lease); provided, however, that nothing herein shall be deemed to preclude Tenant from bringing legal action to terminate this Lease or to seek actual
damages from Landlord in the event of a material breach by Landlord of its obligations under this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event
(i)&nbsp;Landlord fails to perform any affirmative duty or obligation of Landlord under this Lease and the failure continues beyond the applicable cure period set forth in this <U>Section&nbsp;5.16</U>, and (ii)&nbsp;Tenant delivers an additional
notice to Landlord specifying that Tenant will have the right to perform such duty or obligation on Landlord&#146;s behalf and Landlord does not, within five (5)&nbsp;days after receipt of the additional notice notify Tenant that a good faith, bona
fide dispute exists as to whether or not Landlord has failed to perform such duty or obligation, then Tenant may (but shall not be obligated to) perform such duty or obligation on Landlord&#146;s behalf without waiving any of Tenant&#146;s other
rights or remedies in connection therewith or releasing Landlord from any of its obligations for such default and Tenant shall be entitled to reimbursement (within thirty (30)&nbsp;days of Landlord&#146;s receipt of a written request for payment
accompanied by written invoices and other reasonably satisfactory written evidence showing the costs incurred) by Landlord of Tenant&#146;s reasonable direct
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses in performing such duty or obligation on Landlord&#146;s behalf, and Landlord shall indemnify, defend and hold Tenant harmless from and
against any claims, liability or damage caused by Landlord failure to perform any affirmative duty or obligation of Landlord under this Lease (excluding special, punitive, speculative or consequential damages). In the event Tenant performs such duty
or obligation on Landlord&#146;s behalf, such work, if applicable, must be performed in a first-class manner and in compliance with all applicable laws; and, if such work will affect the Building&#146;s systems and equipment or the structural
integrity of the Building, Tenant shall use only those contractors used by Landlord in the Building for work on such systems and equipment (or structural components) (and Landlord shall cause such contractors to charge Tenant competitive rates for
such work) unless such contractors are unwilling or unable to perform, or timely perform, such work, in which event Tenant may utilize the services of any other qualified union contractor which normally and regularly performs similar work in
Comparable Buildings (as defined in <U>Section&nbsp;8.1</U>). If Landlord fails to make any required reimbursement within the <FONT STYLE="white-space:nowrap">30-day</FONT> period referred to above, Tenant shall have the right to offset the amount
set forth in such invoice (other than any portion thereof with respect to which there exists a good faith, bona fide dispute) against the next payment(s) of Rent due under the Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.17 Rules and Regulations</B>. Tenant shall comply with the rules and regulations for the Project attached as <B><U>Exhibit D</U> </B>and
such reasonable amendments thereto as Landlord may adopt from time to time with prior notice to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.18 Water Leak Monitoring
Plan</B>. Tenant shall, at Tenant&#146;s sole cost and expense, maintain a water leak monitoring plan to detect water leaks occurring in the Leased Premises in order to, among other things, minimize potential damage to the Leased Premises and
Tenant&#146;s furniture, trade fixtures and equipment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Environmental Matters </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.1 Hazardous Materials Prohibited</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall not cause or permit any Hazardous Material (as defined in <U>Section&nbsp;6.1(c)</U> below) to be brought, kept, used,
generated, released or disposed in, on, under or about the Leased Premises or the Project by Tenant, its agents, employees, contractors, licensees or invitees (collectively, &#147;<B>Tenant&#146;s Representatives</B>&#148;); provided, however, that
Tenant may use, store and dispose of, in accordance with applicable Governmental Requirements (as defined in <U>Section&nbsp;6.1(b)</U>, limited quantities of standard office and janitorial supplies, but only to the extent reasonably necessary for
Tenant&#146;s operations in the Leased Premises, and Hazardous Materials which may be used in a Laboratory (as defined in California Building Code Section&nbsp;201) or Business Group B occupancies (as defined in California Building Code
Section&nbsp;304), but only to the extent reasonably necessary for Tenant&#146;s operations in the Leased Premises. Within fifteen (15)&nbsp;days following Landlord&#146;s request, Tenant shall provide Landlord with copies of or access to
Tenant&#146;s reports provided to governmental authorities with respect to Hazardous Materials, including, without limitation, reports in the California Environmental Reporting System. In addition, with at least fifteen (15)&nbsp;days prior written
notice (however, no more than once per year), Tenant shall allow Landlord&#146;s environmental consultant, at Landlord&#146;s sole cost, to perform an environmental audit of Tenant&#146;s use, handling and disposal of Hazardous Materials. Tenant
hereby indemnifies Landlord from and against (i)&nbsp;any breach by Tenant of the obligations stated in the preceding sentence, (ii)&nbsp;any breach of the obligations stated in <U>Section&nbsp;6.1(b)</U> below, or (iii)&nbsp;any claims or liability
resulting from Tenant&#146;s use of Hazardous Materials. Tenant hereby agrees to defend and hold Landlord harmless from and against any and all claims, liability, losses, damages, actual costs and/or expenses which arise during or after the Term as
a direct result of any breach of the obligations stated in <U>Sections 6.1(a)</U> or <U>6.1(b)</U> or otherwise resulting from Tenant&#146;s use of Hazardous Materials. This indemnification of Landlord by Tenant includes, without limitation, death
of or injury to person, damage to any property or the environment and costs incurred in connection with any investigation of site conditions or any cleanup, remedial, removal, or restoration work required by any federal, state or local governmental
agency or political subdivision because of any Hazardous Material present in, on, under or about the Leased Premises or the Project (including soil and ground water contamination) which results from such a breach. Without limiting the foregoing, if
the presence of any Hazardous Material in, on, under or about the Leased Premises or the Project caused or permitted by Tenant results in any contamination of the Leased Premises or the Project, Tenant shall promptly take all actions, at
Tenant&#146;s sole expense, to remediate such contamination as required by applicable law or by the applicable governmental agencies; provided that Landlord&#146;s approval of such actions, and the contractors to be used by Tenant in connection
therewith, shall first be obtained. This indemnification of Landlord by Tenant shall survive the expiration or sooner termination of this Lease. Within fifteen (15)&nbsp;days following Landlord&#146;s request (the frequency of such requests by
Landlord shall be reasonable), Tenant shall complete, execute, and deliver to Landlord a Hazardous Materials Questionnaire substantially in the form attached to this Lease as <B><U>Exhibit F</U></B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Tenant covenants and agrees that Tenant shall at all times be responsible and liable
for, and be in material compliance with, all federal, state, local and regional laws, ordinances, rules, codes and regulations, as amended from time to time (&#147;<B>Governmental Requirements</B>&#148;), relating to health and safety and
environmental matters, arising, directly, out of the use of Hazardous Materials (as defined in <U>Section&nbsp;6.1(c)</U> below) in the Project, including the specific laws, ordinances and regulations referred to in <U>Section&nbsp;6.1(c)</U> below.
Health and safety and environmental matters for which Tenant is responsible under this paragraph include, without limitation (i)&nbsp;notification and reporting to governmental agencies, (ii)&nbsp;the provision of warnings of potential exposure to
Hazardous Materials to Landlord and Tenant&#146;s agents, employees, licensees, contractors and others, (iii)&nbsp;the payment of taxes and fees, (iv)&nbsp;the proper <FONT STYLE="white-space:nowrap">off-site</FONT> transportation and disposal of
Hazardous Materials, and (v)&nbsp;all requirements, including training, relating to the use of equipment. Immediately upon discovery of a release of Hazardous Materials, Tenant shall give written notice to Landlord, whether or not such release is
subject to reporting under Governmental Requirements. The notice shall include information on the nature and conditions of the release and Tenant&#146;s planned response. Tenant shall be liable for the cost of any
<FONT STYLE="white-space:nowrap">clean-up</FONT> of the release of any Hazardous Materials by Tenant or Tenant&#146;s Representatives on the Project. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As used in this Lease, the term &#147;<B>Hazardous Material</B>&#148; means any hazardous or toxic substance, material or waste which is
or becomes regulated by any local governmental authority, the State of California or the United States Government. The term &#147;Hazardous Material&#148; includes, without limitation, any substance, material or waste which is (i)&nbsp;defined as a
&#147;hazardous waste&#148; or similar term under the laws of the jurisdiction where the Project is located; (ii)&nbsp;designated as a &#147;hazardous substance&#148; pursuant to Section&nbsp;311 of the Federal Water Pollution Control Act (33 U.S.C.
&#167; 1317); (iii) defined as a &#147;hazardous waste&#148; pursuant to Section&nbsp;1004 of the Federal Resource, Conservation and Recovery Act, 42 U.S.C. &#167; 6901 et seq. (42 U.S.C. &#167; 6903); (iv) defined as a &#147;hazardous
substance&#148; pursuant to Section&nbsp;101 of the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. &#167; 9601 et seq. (42 U.S.C. &#167; 9601); (v) hydrocarbons, petroleum, gasoline, crude oil or any products, <FONT
STYLE="white-space:nowrap">by-products</FONT> or fractions thereof; or (vi)&nbsp;asbestos in any form or condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In connection
with Landlord&#146;s recent acquisition of the Project, Landlord commissioned an environmental site assessment for the Project and the findings are set forth in an environmental report (&#147;<B>Environmental Report</B>&#148;). In addition, a
summary with respect to the activities associated with the investigation and content removal of an Underground Storage Tank was prepared by Roux Associates, Inc. on August&nbsp;5, 2020 (the &#147;<B>Tank Report</B>&#148;). A true and correct copy of
the Environmental Report and the Tank Report was delivered to Tenant on January&nbsp;13, 2021. Notwithstanding anything to the contrary herein, to the best of Landlord&#146;s actual knowledge, except for suspected asbestos material and lead paint in
the Building and any materials that may be set forth in the Environmental Report and the Tank Report, there are no Hazardous Materials in the Building or on or under the Project. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2 Limitations on Assignment and Subletting</B>. In addition to the provisions of <U>Section&nbsp;5.6</U> above, it shall not be
unreasonable for Landlord to withhold its consent to any proposed assignment or subletting of the Leased Premises if (i)&nbsp;the proposed transferee&#146;s anticipated use of the Leased Premises involves the generation, storage, use, treatment, or
disposal of Hazardous Material (excluding standard office and janitorial supplies; in limited quantities as hereinabove provided) in violation of Governmental Requirements; (ii)&nbsp;the proposed transferee has been
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required by any prior landlord, lender or governmental authority to take remedial action in connection with Hazardous Material contaminating a real property if the contamination resulted from
such transferee&#146;s actions or use of the property in question; or (iii)&nbsp;the proposed transferee is subject to an enforcement order issued by any governmental authority in connection with the generation, storage, use, treatment or disposal
of a Hazardous Material. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.3 Right of Entry</B>. In addition to the provisions of <U>Section&nbsp;5.11</U> above, Landlord, its
employees, agents and consultants, shall have the right to enter the Leased Premises at any time, in case of an emergency, and otherwise during reasonable hours and upon reasonable prior written notice to Tenant, in order to conduct periodic
environmental inspections and tests to determine whether any Hazardous Materials are present. The costs and expenses of such inspections shall be paid by Landlord unless a default or breach of this Lease, violation of Governmental Requirements or
contamination caused or permitted by Tenant is found to exist. In such event, Tenant shall reimburse Landlord upon demand, as Additional Rent, for the costs and expenses of such inspections. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.4 Notice to Landlord</B>. Tenant shall promptly notify Landlord in writing of: (i)&nbsp;any enforcement,
<FONT STYLE="white-space:nowrap">clean-up,</FONT> removal or other governmental or regulatory action instituted or threatened regarding the Leased Premises or the Project pursuant to any Governmental Requirements; (ii)&nbsp;any claim made or in
writing threatened by any person against Tenant or the Leased Premises relating to damage, contribution, cost recovery, compensation, loss or injury resulting from or claimed to result from any Hazardous Material; and (iii)&nbsp;any reports made to
or received from any governmental agency arising out of or in connection with any Hazardous Material in or removed from the Leased Premises or the Project, including any complaints, notices, warnings or asserted violations in connection therewith.
Tenant shall also supply to Landlord as promptly as possible, and in any event within three (3)&nbsp;business days after Tenant first receives or sends the same, copies of all claims, reports, complaints, notices, warnings, asserted violations or
other communications relating in any way to the Leased Premises or Tenant&#146;s use thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.5 Disclosure as to Hazardous
Materials</B>. Landlord hereby discloses to Tenant that previous occupants or others possessed and used or may have possessed and used office supplies, cleaning products, construction and decorating materials and other substances in or about the
Leased Premises or portions thereof and which may contain or may have contained Hazardous Materials for which Tenant shall have no liability. In addition: (i)&nbsp;portions of the Project (including, without limitation, the equipment rooms) contain
Hazardous Materials of the kind ordinarily employed in such areas; and (ii)&nbsp;automobiles and other vehicles operated or parked in the parking and loading areas emit substances which may contain Hazardous Materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.6 Asbestos Notice</B><I>.</I> Tenant acknowledges that Tenant has received the asbestos notification letter attached hereto as
<B><U>Exhibit E</U> </B>pursuant to California Health and Safety Code Sections 25915 et seq. (as amended from time to time, the &#147;<B>Connelly Act</B>&#148;), disclosing the existence of asbestos in the Building. Tenant hereby agrees to comply
with the Connelly Act, including providing copies of Landlord&#146;s asbestos notification letter to all of Tenant&#146;s &#147;employees&#148; and &#147;owners,&#148; as those terms are defined in the Connelly Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Insurance, Indemnity, Condemnation, Damage and Default </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.1 Landlord&#146;s Insurance</B>. Landlord shall secure and maintain policies of insurance for the estimated full replacement cost of the
Project covering loss of or damage to the Project, including the Base Building Upgrades and the PD Tenant Improvements, but excluding all subsequent alterations, additions and improvements to the Leased Premises, with loss payable to Landlord and to
the holders of any deeds of trust, mortgages or ground leases on the Project. Landlord shall not be obligated to obtain insurance for Tenant&#146;s trade fixtures, equipment, furnishings, machinery or other property (regardless of whether such items
may be a component of the PD Tenant Improvements). Such policies shall provide protection against fire and extended coverage perils and such additional perils as Landlord deems suitable, and with such deductible(s) as Landlord shall deem reasonably
appropriate. Landlord shall further secure and maintain commercial general liability insurance with respect to the Project in such amount as Landlord shall determine, such insurance to be in addition to, and not in lieu of, the liability insurance
required to be maintained by Tenant. Landlord may also secure and maintain earthquake insurance with respect to the Project subject to the terms and provisions set forth in Section&nbsp;3.5(a)(8). Landlord may elect to self-insure for the coverages
required under this <U>Section&nbsp;7.1</U>. Tenant shall not be named as an additional insured on any policy of insurance maintained by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.2 Tenant&#146;s Liability Insurance</B>. Tenant (with respect to both the Leased Premises and the Project) shall secure and maintain, at
its own expense, at all times during the Term (including any early access period), a policy or policies of commercial general liability insurance with the premiums thereon fully paid in advance, protecting Tenant and naming Landlord, the holders of
any deeds of trust, mortgages or ground leases on the Project, and Landlord&#146;s representatives (which term, whenever used in this <U>Article 7</U>, shall be deemed to include Landlord&#146;s partners, trustees, ancillary trustees, officers,
directors, shareholders, beneficiaries, agents, employees and independent contractors) as additional insureds against claims for bodily injury, personal injury, advertising injury and property damage (including attorneys&#146; fees) based upon,
involving or arising out of Tenant&#146;s operations, assumed liabilities or Tenant&#146;s use, occupancy or maintenance of the Leased Premises and the Project. Such insurance shall provide for a minimum amount of Two Million Dollars ($2,000,000.00)
for property damage or injury, bodily injury, or death of one or more than one person in any one accident or occurrence, with an annual aggregate limit of at least Five Million Dollars ($5,000,000.00). The coverage required to be carried shall
include fire legal liability, blanket contractual liability, personal injury liability (libel, slander, false arrest and wrongful eviction), property damage, medical payments, products liability and completed operations coverage (as well as owned, <FONT
STYLE="white-space:nowrap">non-owned</FONT> and hired automobile liability if an exposure exists) and the policy shall contain an exception to any pollution exclusion which insures damage or injury arising out of heat, smoke or fumes from a hostile
fire; notwithstanding the foregoing, completed operations coverage shall not be required provided Tenant is engaged only in research and development activities and does not have any sponsored human clinical trials and is not engaged in the
production, manufacturing, marketing and/or sale of any products for human trials or use (collectively, &#147;Production Activities&#148;), however, prior to commencing any Production Activities, Tenant shall notify Landlord in writing and shall add
completed operations liability insurance to its coverages. Such insurance shall be written on an occurrence basis and contain a separation of insureds provision or cross-liability endorsement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acceptable to Landlord. Tenant shall provide Landlord with a certificate evidencing such insurance coverage. The certificate shall indicate that the insurance provided specifically recognizes the
liability assumed by Tenant under this Lease and that Tenant&#146;s insurance is primary to and not contributory (and Tenant shall provide Landlord with evidence of a primary and <FONT STYLE="white-space:nowrap">non-contributory</FONT> endorsement)
with any other insurance maintained by Landlord, whose insurance shall be considered excess insurance only. Not more frequently than every two (2)&nbsp;years, if, in the opinion of any mortgagee of Landlord or of the insurance broker retained by
Landlord, the amount of liability insurance coverage at that time is not adequate, then Tenant shall increase its liability insurance coverage as required by either any mortgagee of Landlord or Landlord&#146;s insurance broker. Whenever, in
Landlord&#146;s reasonable judgment, good business practice or change in conditions indicate a need for additional or different types of insurance, Tenant shall, within fifteen&nbsp;(15) days of receipt of Landlord&#146;s request therefor, obtain
the insurance at its own expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.3 Tenant&#146;s Additional Insurance Requirements</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall secure and maintain, at Tenant&#146;s expense, at all times during the Term (including any early access period), a commercial
property policy, covering risks of direct physical loss (known as Special Form coverage) including a replacement cost provision, on all of Tenant&#146;s fixtures, furnishings, equipment, machinery, merchandise and personal property in the Leased
Premises and on any alterations, additions or improvements made by or for Tenant upon the Leased Premises, all for the full replacement cost thereof without deduction for depreciation of the covered items and in amounts that meet any <FONT
STYLE="white-space:nowrap">co-insurance</FONT> clauses of the policies of insurance. Such insurance shall insure against those risks customarily covered in an &#147;all risk&#148; policy of insurance covering physical loss or damage. Tenant shall
use the proceeds from such insurance for the replacement of fixtures, furnishings, equipment and personal property and for the restoration of any alterations, additions or improvements to the Leased Premises. In addition, Tenant shall secure and
maintain, at all times during the Term, loss of income, business interruption and extra expense insurance in such amounts as will reimburse Tenant for direct or indirect loss of earnings and incurred costs for a minimum period of twelve
(12)&nbsp;months attributable to all perils commonly insured against by prudent tenants or attributable to prevention of access to the Leased Premises or to the Building as a result of such perils; such insurance shall be maintained with
Tenant&#146;s property insurance carrier. Further, Tenant shall secure and maintain at all times during the Term workers&#146; compensation insurance in such amounts as are required by law, employer&#146;s liability insurance in the amount of One
Million Dollars ($1,000,000.00) per occurrence, and all such other insurance as may be required by applicable law or as may be reasonably required by Landlord. In addition, Tenant shall maintain environmental or pollution legal liability insurance
applicable to bodily injury, property damage including loss of use of damaged property or of property that has not been physically injured or destroyed, cleanup costs and defense, including costs incurred in the investigation, defense or settlement
of claims; all in connection with any loss arising from the Leased Premises in an amount not less than Five Million Dollars ($5,000,000.00) each incident and in the annual aggregate; if such insurance coverage is written on a claims-made basis,
Tenant warrants that continuous coverage will be maintained or an extended discovery period will be exercised for a period of five (5)&nbsp;years after the expiration of the Term of this Lease with such cost incurred by Tenant (the parties agree
that the foregoing environmental or pollution legal liability insurance shall only cover claims, costs or losses caused by Tenant&#146;s Representatives and shall not cover, among other things, <FONT STYLE="white-space:nowrap">pre-existing</FONT>
conditions, claims caused by future tenants that occupy the Project after the expiration of the Term of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Lease, or claims caused by Landlord&#146;s Representatives). In the event Tenant makes any alterations, additions or improvements to the Leased Premises, prior to commencing any work in the
Leased Premises, Tenant shall secure &#147;builder&#146;s all risk&#148; insurance which shall be maintained throughout the course of construction, such policy being an all risk builder&#146;s risk completed value form, in an amount approved by
Landlord, but not less than the total contract price for the construction of such alterations, additions or improvements and covering the construction of such alterations, additions or improvements, and such other insurance as Landlord may
reasonably require, it being understood and agreed that all of such alterations, additions or improvements shall be insured by Tenant pursuant to this <U>Section&nbsp;7.3</U> immediately upon completion thereof. Tenant shall provide Landlord with
certificates of all such insurance. The property insurance certificate shall confirm that the waiver of subrogation required to be obtained pursuant to <U>Section&nbsp;7.5</U> is permitted by the insurer. Tenant shall, at least thirty (30)&nbsp;days
prior to the expiration of any policy of insurance required to be maintained by Tenant under this Lease, furnish Landlord with an &#147;insurance binder&#148; or other satisfactory evidence of renewal thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All policies required to be carried by Tenant under this Lease shall be issued by and binding upon a reputable insurance company of good
financial standing licensed to do business in the State of California with a rating of at least <FONT STYLE="white-space:nowrap">A-IX</FONT> or such other rating as may be required by a lender having a lien on the Project, as set forth in the most
current issue of &#147;Best&#146;s Insurance Reports.&#148; Tenant shall not do or permit anything to be done that would invalidate the insurance policies referred to in this <U>Article 7</U>. All policies required to be carried by Tenant under this
<U>Article 7</U> shall contain a waiver of subrogation endorsement and shall contain an endorsement or endorsements providing that (i)&nbsp;Landlord and its affiliated entities, the property manager for the Building, the asset manager for the
Building, and any lender with a deed of trust encumbering the Project or any part thereof, of whom Landlord has notified Tenant, are included as additional insureds, (ii)&nbsp;the insurer agrees not to cancel or alter the policy without at least
thirty (30)&nbsp;days&#146; prior written notice to Landlord and all named and additional insureds, and (iii)&nbsp;all such insurance maintained by Tenant is primary, with any other insurance available to Landlord or any other named or additional
insured being excess and noncontributing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Tenant shall provide evidence of each of the policies of insurance which Tenant is required
to obtain and maintain pursuant to this Lease on or before the Term Commencement Date (or any early access period, if applicable) and at least thirty (30)&nbsp;days prior to the expiration of any policy, which evidence shall be binding upon the
insurance carrier, shall be accompanied by a copy of the ISO Additional Insured Endorsement CG 2037 or CG 2026 (or their equivalent), as applicable, and, as to property insurance, shall be in the form of an &#147;ACORD 28 (10/2003)&#148; evidence of
insurance or other form reasonably acceptable to Landlord. In the event that Tenant fails to provide evidence of insurance required to be provided by Tenant under this Lease, prior to commencement of the Term, and thereafter during the Term, within
ten (10)&nbsp;days following Landlord&#146;s written request therefor, and thirty (30)&nbsp;days prior to the expiration date of any such coverage, Landlord shall be authorized (but not required) to procure such coverage in the amounts stated with
all costs thereof (plus a fifteen percent (15%) administrative fee) to be chargeable to Tenant and payable upon written invoice therefor, which amounts shall be deemed Additional Rent hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The minimum limits of insurance required by this Lease, or as carried by Tenant, shall not limit the liability of Tenant nor relieve
Tenant of any obligation hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.4 Indemnity and Exoneration</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To the extent not prohibited by law, Landlord and Landlord&#146;s representatives, partners, members, agents, employees, directors,
officers, successors and assigns (&#147;<B>Landlord&#146;s Representatives</B>&#148;) shall not be liable for any loss, injury or damage to person or property of Tenant, Tenant&#146;s agents, employees, contractors, invitees or any other person,
whether caused by theft, fire, act of God, acts of the public enemy, riot, strike, insurrection, war, court order, requisition or order of governmental body or authority or which may arise through repair, alteration or maintenance of any part of the
Project or failure to make any such repair or from any other cause whatsoever, except as expressly otherwise provided in <U>Sections 7.6</U> and <U>7.7</U>. Landlord shall not be liable for any loss, injury or damage arising from any act or omission
of any other tenant or occupant of the Project, nor shall Landlord be liable under any circumstances for damage or inconvenience to Tenant&#146;s business or for any loss of income or profit therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except to the extent such damage is caused by any negligence, willful misconduct or breach of this Lease of or by any Landlord&#146;s
Representatives, Tenant shall indemnify, protect, defend and hold the Project, Landlord and Landlord&#146;s Representatives, harmless of and from any and all claims, liability, costs, penalties, fines, damages, injury, judgments, forfeiture, actual
losses or expenses (including without limitation attorneys&#146; fees, consultant fees, testing and investigation fees, expert fees and court costs) arising out of or in any way related to or resulting directly from (i)&nbsp;the use or occupancy of
the Leased Premises, (ii)&nbsp;the activities of Tenant or Tenant&#146;s Representatives in or about the Leased Premises or the Project, (iii)&nbsp;any failure to comply with any applicable law, and (iv)&nbsp;any default or breach by Tenant in the
performance of any obligation of Tenant under this Lease; provided, however, that the foregoing indemnity shall not be applicable to claims arising by reason of the active gross negligence or willful misconduct of Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except to the extent such damage is caused by any negligence, willful misconduct or breach of this Lease of or by any Landlord&#146;s
Representatives, Tenant shall indemnify, protect, defend and hold the Project, Landlord and its representatives, harmless of and from any and all claims, liability, costs, penalties, fines, damages, injury, judgments, forfeiture, actual losses or
expenses (including without limitation attorneys&#146; fees, consultant fees, testing and investigation fees, expert fees and court costs) arising out of or in any way related to or resulting directly or indirectly from work or labor performed,
materials or supplies furnished to or at the request of Tenant or in connection with obligations incurred by or performance of any work done for the account of Tenant in the Leased Premises or the Project. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything to the contrary herein, except with respect to a Tenant hold over as set forth in <U>Section&nbsp;9.5</U> below,
Landlord and Tenant hereby acknowledge and agree that each party hereunder waives any right to special, punitive, speculative or consequential damages as a result of the default of the other party hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The provisions of this <U>Section&nbsp;7.4</U> shall survive the expiration or sooner termination of this Lease. TENANT AND LANDLORD
ACKNOWLEDGE THAT THE PARTIES HAVE READ AND UNDERSTAND THE MEANING AND RAMIFICATIONS OF THE PROVISIONS SET FORTH IN THIS <U>SECTION 7.4</U> AND FURTHER ACKNOWLEDGES THAT SUCH PROVISIONS WERE SPECIFICALLY NEGOTIATED. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.5 Waiver of Subrogation</B>. Anything in this Lease to the contrary notwithstanding,
Landlord and Tenant each waives all rights of recovery, claim, action or cause of action against the other, its agents (including partners, both general and limited), trustees, officers, directors, and employees, for any loss or damage that may
occur to the Leased Premises, or any improvements thereto, or the Project or any personal property of such party therein, by reason of any cause required to be insured against under this Lease to the extent of the coverage required, regardless of
cause or origin, including negligence of the other party hereto, provided that such party&#146;s insurance is not invalidated thereby; and each party covenants that, to the fullest extent permitted by law, no insurer shall hold any right of
subrogation against such other party. Tenant shall advise its insurers of the foregoing and such waiver shall be a part of each policy maintained by Tenant which applies to the Leased Premises, any part of the Project or Tenant&#146;s use and
occupancy of any part thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.6 Condemnation</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the Leased Premises are taken under the power of eminent domain or sold under the threat of the exercise of such power (all of which
are referred to herein as &#147;<B>Condemnation</B>&#148;), this Lease shall terminate as to the part so taken as of the date the condemning authority takes title or possession, whichever first occurs (the &#147;<B>Date of Taking</B>&#148;). If the
Leased Premises or any portion of the Project is taken by Condemnation to such an extent as to render the Leased Premises untenantable as reasonably determined by Landlord, this Lease shall, at the option of either party to be exercised in writing
within thirty (30)&nbsp;days after receipt of written notice of such taking, forthwith cease and terminate as of the Date of Taking. All proceeds from any Condemnation of the Leased Premises shall belong and be paid to Landlord, subject to the
rights of any mortgagee of Landlord&#146;s interest in the Project or the beneficiary of any deed of trust which constitutes an encumbrance thereon; provided that Tenant shall be entitled to any compensation separately awarded to Tenant for
Tenant&#146;s relocation expenses, loss of Tenant&#146;s trade fixtures, or Tenant&#146;s use of the Leased Premises. If this Lease continues in effect after the Date of Taking pursuant to the provisions of this <U>Section&nbsp;7.6(a)</U>, Landlord
shall proceed with reasonable diligence to repair, at its expense, the remaining parts of the Project and the Leased Premises to substantially their former condition to the extent that the same is feasible (subject to reasonable changes which
Landlord shall deem desirable) and so as to constitute a complete and tenantable Project and Leased Premises and Rent shall be abated for the period of such Taking. Following a Condemnation, Net Rent shall thereafter be equitably adjusted according
to the remaining Rentable Area of the Leased Premises and the Building. Except as hereinafter provided, in the event of any Condemnation, Landlord shall have the right to all compensation, damages, income, rent or awards made with respect thereto
(collectively an &#147;<B>Award</B>&#148;), including any award for the value of the leasehold estate created by this Lease. No award to Landlord shall be apportioned and, subject to Tenant&#146;s rights hereinafter specified, Tenant hereby assigns
to Landlord any right of Tenant in any award made for any Condemnation. So long as such claim will not reduce any award otherwise payable to Landlord under this <U>Section&nbsp;7.6</U>, Tenant may seek to recover, at its cost and expense, as a
separate claim, any damages or awards payable on a taking of the Leased Premises to compensate for the unamortized cost paid by Tenant for the alterations, additions or improvements, if any, made by Tenant during the initial improvement of the
Leased Premises and for any alterations, or for Tenant&#146;s personal property taken, or for interference with or interruption of Tenant&#146;s business (including goodwill), or for Tenant&#146;s removal and relocation expenses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event of a temporary Condemnation of all or a portion of the Leased Premises,
Rent shall be abated for the period of such temporary Condemnation and in proportion to the percentage of the rentable square footage of the Leased Premises, if any, that is subject to, or rendered inaccessible or untenantable by, such Condemnation
and not occupied by Tenant. In the event of the a temporary Condemnation, Tenant shall remain fully obligated for performance of all of the covenants and obligations on its part to be performed pursuant to the terms of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.7 Damage or Destruction</B>. In the event of a fire or other casualty in the Leased Premises, Tenant shall immediately give notice
thereof to Landlord. The following provisions shall then apply: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the damage is limited solely to the Leased Premises and the Leased
Premises can, in Landlord&#146;s reasonable opinion, be made tenantable with all damage repaired (excluding Tenant&#146;s personal property, trade fixtures, equipment and any improvements or alterations installed by or on behalf of Tenant) within
six (6)&nbsp;months from the date of damage, then Landlord shall be obligated to rebuild the same to substantially their former condition to the extent that the same is feasible (subject to reasonable changes which Landlord shall deem desirable and
such changes as may be required by applicable law) and shall proceed with reasonable diligence to do so and this Lease shall remain in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If portions of the Project outside the boundaries of the Leased Premises are damaged or destroyed (whether or not the Leased Premises are
also damaged or destroyed) and the Leased Premises and the Project can, in Landlord&#146;s opinion, both be made tenantable with all damage repaired (excluding Tenant&#146;s personal property, trade fixtures, equipment and any improvements or
alterations installed by or on behalf of Tenant, except for the PD Tenant Improvements and Base Building Upgrades set forth in <B><U>Exhibits B</U> </B>and <B><U><FONT STYLE="white-space:nowrap">B-1</FONT></U></B>) within six (6)&nbsp;months from
the date of damage or destruction, then Landlord shall be obligated to rebuild the same to substantially their former condition to the extent that the same is feasible (subject to reasonable changes which Landlord shall deem desirable and such
changes as may be required by applicable law) and shall proceed with reasonable diligence to do so and this Lease shall remain in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary contained in <U>Sections 7.7(a)</U> or <U>7.7(b)</U> above, Landlord shall not have any
obligation whatsoever to repair, reconstruct or restore the Leased Premises if (i)&nbsp;the cost to repair and restore the Building is fifty percent (50%) or more of the replacement cost of the entire Building prior to such damage or destruction,
(ii)&nbsp;the holder of any mortgage or beneficiary of any deed of trust requires that Landlord&#146;s insurance proceeds be paid to it, or (iii)&nbsp;when any damage thereto or to the Building occurs during the last eighteen (18)&nbsp;months of the
Term. Under such circumstances, Landlord shall notify Tenant of its decision not to rebuild within thirty (30)&nbsp;days of such damage, whereupon the Lease shall terminate as of the date of such notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If neither <U>Section&nbsp;7.7(a)</U> nor <U>7.7(b)</U> above applies, Landlord shall so notify Tenant within thirty (30)&nbsp;days after
the date of the damage or destruction and Landlord may terminate this Lease within thirty (30)&nbsp;days after the date of such notice, such termination notice to be immediately effective; provided, however, that if Landlord elects to reconstruct
the Project </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and the Leased Premises, such election to be made at Landlord&#146;s sole option, in which event (i)&nbsp;Landlord shall notify Tenant of such election within said thirty (30)&nbsp;day period,
and (ii)&nbsp;Landlord shall proceed with reasonable diligence to rebuild the Project and the Leased Premises to substantially their former condition to the extent that the same is feasible (subject to reasonable changes which Landlord shall deem
desirable and such changes as may be required by applicable law) but excluding Tenant&#146;s personal property, trade fixtures, equipment and any improvements or alterations installed by or on behalf of Tenant, except for the PD Tenant Improvements
and Base Building Upgrades set forth in <B><U>Exhibit <FONT STYLE="white-space:nowrap">B-1</FONT></U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) During any period when
Tenant&#146;s use of the Leased Premises is significantly impaired by damage or destruction, Base Rent shall abate in proportion to the degree to which Tenant&#146;s use of the Leased Premises is impaired and Tenant does not actually use the Leased
Premises until such time as the Leased Premises are made tenantable as reasonably determined by Landlord and Tenant; provided that no such rental abatement shall be permitted if the casualty is the result of the negligence or willful misconduct of
Tenant or Tenant&#146;s Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The proceeds from any insurance paid by reason of damage to or destruction of the Project or
any part thereof insured by Landlord shall belong to and be paid to Landlord, subject to the rights of any mortgagee of Landlord&#146;s interest in the Project or the beneficiary of any deed of trust which constitutes an encumbrance thereon. Tenant
shall be responsible at its sole cost and expense for the repair, restoration and replacement of (i)&nbsp;its fixtures, furnishings, equipment, machinery, merchandise and personal property in the Leased Premises, and (ii)&nbsp;its alteration,
additions and improvements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Landlord&#146;s repair and restoration obligations under this <U>Section&nbsp;7.7</U> shall not impair or
otherwise affect the rights and obligations of the parties set forth elsewhere in this Lease. Subject to <U>Section&nbsp;7.7(e)</U>, Landlord shall not be liable for any inconvenience or annoyance to Tenant, its employees, agents, contractors or
invitees, or injury to Tenant&#146;s business resulting in any way from such damage or the repair thereof. Landlord and Tenant agree that the terms of this Lease shall govern the effect of any damage to or destruction of the Leased Premises or the
Project with respect to the termination of this Lease and hereby waive the provisions of any present or future statute or law to the extent inconsistent therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Tenant shall promptly replace or repair, at Tenant&#146;s cost and expense, Tenant&#146;s movable furniture, equipment, trade fixtures and
other personal property in the Leased Premises which Tenant shall be responsible for insuring during the Term of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The
respective rights and obligations of Landlord and Tenant in the event of any damage to or destruction of the Leased Premises, or any other portion of the Building or the Project, are governed exclusively by this Lease. Accordingly, Tenant hereby
waives the provisions of any law to the contrary, including California Civil Code Sections 1932(2), 1933(4), 1941 and 1942 and any similar or successor laws and any other laws providing for the termination of a lease upon destruction of the leased
property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.8 Default by Tenant</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <B>Events of Default</B>. The occurrence of any of the following shall constitute an event of default on the part of Tenant: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) Intentionally Omitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) <B>Nonpayment of Rent</B>. Failure to pay any installment of Rent due and payable hereunder on the date when payment is due, which
failure is not cured within three (3)&nbsp;business days following receipt of written notice from Landlord that such payment is past due; furthermore, if Tenant shall be served with a demand for the payment of past due Rent, any payment(s) tendered
thereafter to cure any default by Tenant shall be made only by cashier&#146;s check, wire-transfer or direct deposit of immediately available funds; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) <B>Other Obligations</B>. Failure to perform any obligation, agreement or covenant under this Lease other than those matters specified in
<U>subsections 7.8(a)(1)</U>, <U>7.8(a)(2)</U> or <U>7.8(a)(12)</U>, such failure continuing for a period of fifteen (15)&nbsp;days after written notice of such failure (or such longer period as is reasonably necessary to remedy such default (not to
exceed sixty (60)&nbsp;days), provided that Tenant commences the remedy within such fifteen <FONT STYLE="white-space:nowrap">(15)-day</FONT> period and continuously and diligently pursues such remedy at all times until such default is cured); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(4) <B>General Assignment</B>. Any general arrangement or assignment by Tenant for the benefit of creditors; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(5) <B>Bankruptcy</B>. The filing of any voluntary petition in bankruptcy by Tenant, or the filing of an involuntary petition against Tenant,
which involuntary petition remains undischarged for a period of sixty (60)&nbsp;days. In the event that under applicable law the trustee in bankruptcy or Tenant has the right to affirm this Lease and continue to perform the obligations of Tenant
hereunder, such trustee or Tenant shall, within such time period as may be permitted by the bankruptcy court having jurisdiction, cure all defaults of Tenant hereunder outstanding as of the date of the affirmance of this Lease and provide to
Landlord such adequate assurances as may be necessary to ensure Landlord of the continued performance of Tenant&#146;s obligations under this Lease; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(6) <B>Receivership</B>. The appointment of a trustee or receiver to take possession of all or substantially all of Tenant&#146;s assets or
the Leased Premises, where possession is not restored to Tenant within ten (10)&nbsp;business days; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(7) <B>Attachment</B>. The
attachment, execution or other judicial seizure of all or substantially all of Tenant&#146;s assets or the Leased Premises, if such attachment or other seizure remains undismissed or undischarged for a period of thirty (30)&nbsp;business days after
the levy thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(8) <B>Insolvency</B>. The admission by Tenant in writing of its inability to pay its debts as they become due; the
filing by Tenant of a petition seeking any reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar relief under any present or future statute, law or regulation; the filing by Tenant of an answer admitting or
failing timely to contest a material allegation of a petition filed against Tenant in any such proceeding; or, if within sixty (60)&nbsp;days after the commencement of any proceeding against Tenant seeking any reorganization, arrangement,
composition, readjustment, liquidation, dissolution or similar relief under any present or future statute, law or regulation, such proceeding shall not have been dismissed; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(9) Intentionally Omitted; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(10) <B>Partner</B>. If Tenant is a partnership or consists of more than one (1)&nbsp;person or entity, if any general partner or managing
member of Tenant is involved in any of the events or acts described in <U>subsections 7.8(a)(4)</U> through <U>(8)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(11)
<B>Misrepresentation</B>. The discovery by Landlord that any representation, warranty or financial statement given to Landlord by Tenant under this Lease was materially false or misleading; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(12) <B>Estoppel/SNDA</B>. Failure to deliver the documents required to be delivered by Tenant under <U>Sections 5.12</U> and/or <U>5.13</U>
within the applicable time period set forth in such sections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <B>Remedies Upon Default</B>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) <B>Termination</B>. If an event of default occurs, Landlord shall have the right, with or without notice or demand, immediately (after
expiration of any applicable grace period specified herein) to terminate this Lease, and at any time thereafter recover possession of the Leased Premises or any part thereof and expel and remove therefrom Tenant and any other person occupying the
same, by any lawful means, and again repossess and enjoy the Leased Premises without prejudice to any of the remedies that Landlord may have under this Lease, or at law or in equity by reason of Tenant&#146;s default or of such termination. In
addition to the foregoing, if at any time, Tenant is in default of any term, condition or provision of this Lease, to the fullest extent permitted by law, any express or implicit waiver by Landlord of Tenant&#146;s requirement to pay Base Rent shall
be null and void and Tenant shall immediately pay to Landlord all Base Rent so expressly or implicitly waived by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2)
<B>Continuation After Default</B>. Even though Tenant has breached this Lease and/or abandoned the Leased Premises, this Lease shall continue in effect for so long as Landlord does not terminate Tenant&#146;s right to possession under <U>subsection
7.8(b)(1)</U> hereof in writing, and Landlord may enforce all of its rights and remedies under this Lease, including (but without limitation) the right to recover Rent as it becomes due, and Landlord, without terminating this Lease, may exercise all
of the rights and remedies of a landlord under Section&nbsp;1951.4 of the Civil Code of the State of California or any amended or successor code section. Acts of maintenance or preservation, efforts to relet the Leased Premises or the appointment of
a receiver upon application of Landlord to protect Landlord&#146;s interest under this Lease shall not constitute an election to terminate Tenant&#146;s right to possession. If Landlord elects to relet the Leased Premises for the account of Tenant,
the rent received by Landlord from such reletting shall be applied as follows: first, to the payment of any indebtedness other than Rent due hereunder from Tenant to Landlord; second, to the payment of any costs of such reletting; third, to the
payment of the cost of any alterations or repairs to the Leased Premises; fourth, to the payment of Rent due and unpaid </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hereunder; and the balance, if any, shall be held by Landlord and applied in payment of future Rent as it becomes due. If that portion of rent received from the reletting which is applied against
the Rent due hereunder is less than the amount of the Rent due, Tenant shall pay the deficiency to Landlord promptly upon demand by Landlord. Such deficiency shall be calculated and paid monthly. Tenant shall also pay to Landlord, as soon as
determined, any costs and expenses incurred by Landlord in connection with such reletting or in making alterations and repairs to the Leased Premises, which are not covered by the rent received from the reletting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <B>Damages Upon Termination</B>. Should Landlord terminate this Lease pursuant to the provisions of subsection <U>7.8(b)(1)</U> hereof,
Landlord shall have all the rights and remedies of a landlord provided by Section&nbsp;1951.2 of the Civil Code of the State of California. Upon such termination, in addition to any other rights and remedies to which Landlord may be entitled under
applicable law, Landlord shall be entitled to recover from Tenant: (i)&nbsp;the worth at the time of award of the unpaid Rent and other amounts which had been earned at the time of termination; (ii)&nbsp;the worth at the time of award of the amount
by which the unpaid Rent which would have been earned after termination until the time of award exceeds the amount of such Rent loss that Tenant proves could have been reasonably avoided; (iii)&nbsp;the worth at the time of award of the amount by
which the unpaid Rent for the balance of the Term after the time of award exceeds the amount of such Rent loss that Tenant proves could be reasonably avoided; and (iv)&nbsp;any other amount necessary to compensate Landlord for all the detriment
proximately caused by Tenant&#146;s failure to perform its obligations under this Lease or which, in the ordinary course of things, would be likely to result therefrom. The &#147;worth at the time of award&#148; of the amounts referred to in clauses
(i)&nbsp;and (ii) shall be computed with interest at the lesser of ten percent (10%) per annum or the maximum rate then allowed by law. The &#147;worth at the time of award&#148; of the amount referred to in clause (iii)&nbsp;shall be computed by
discounting such amount at the discount rate of the Federal Reserve Bank of San Francisco at the time of the award plus one percent (1%). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <B>Computation of Rent for Purposes of Default</B>. For purposes of computing unpaid Rent which would have accrued and become payable
under this Lease pursuant to the provisions of <U>Section&nbsp;7.8(c)</U>, unpaid Rent shall consist of the sum of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) the total Base
Rent for the balance of the Term, plus </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) a computation of Tenant&#146;s Proportionate Share of Basic Operating Costs for the balance
of the Term, the assumed amount for the Computation Year of the default and each future Computation Year in the Term to be equal to Tenant&#146;s Proportionate Share of Basic Operating Costs for the Computation Year immediately prior to the year in
which default occurs, compounded at a per annum rate equal to the mean average rate of inflation for the preceding five (5)&nbsp;calendar years as determined by the United States Department of Labor, Bureau of Labor Statistics Consumer Price Index
(All Urban Consumers, all items <FONT STYLE="white-space:nowrap">(1982-84=100))</FONT> for the Metropolitan Area or Region in which the Project is located. If such Index is discontinued or revised, the average rate of inflation shall be determined
by reference to the index designated as the successor or substitute index by the government of the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <B>Late Charge</B>. If any payment required to be made by Tenant under this Lease is not
received by Landlord on or before the date the same is due, Tenant shall pay to Landlord an amount equal to ten percent (10%) of the delinquent amount. The parties agree that Landlord would incur costs not contemplated by this Lease by virtue of
such delinquencies, including without limitation administrative, collection, processing and accounting expenses, the amount of which would be extremely difficult to compute, and the amount stated herein represents a reasonable estimate thereof.
Acceptance of such late charge by Landlord shall in no event constitute a waiver of Tenant&#146;s breach or default with respect to such delinquency, or prevent Landlord from exercising any of Landlord&#146;s other rights and remedies.
Notwithstanding the foregoing, in the first instance in any calendar year wherein Tenant is late in making a payment to Landlord of any sums payable by Tenant hereunder, the foregoing late charge shall not be assessed unless such payment is more
than five (5)&nbsp;days past due after written notice from Landlord. After Landlord has given written notice of one (1)&nbsp;late payment in any calendar year, no other notices will be required during the remainder of the applicable calendar year
for a late charge to be assessed to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <B>Interest on <FONT STYLE="white-space:nowrap">Past-Due</FONT> Obligations</B>. Except
as expressly otherwise provided in this Lease, any Rent due Landlord hereunder, other than late charges, which is not received by Landlord on the date on which it was due, shall bear interest from the day after it was due at the lesser of ten
percent (10%) per annum or the maximum rate then allowed by law, in addition to the late charge provided for in <U>Section&nbsp;7.8(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <B>Landlord&#146;s Right to Perform</B>. Notwithstanding anything to the contrary set forth elsewhere in this Lease, in the event Tenant
fails to perform any affirmative duty or obligation of Tenant under this Lease, then Landlord may (but shall not be obligated to) perform such duty or obligation on Tenant&#146;s behalf without waiving any of Landlord&#146;s rights in connection
therewith or releasing Tenant from any of its obligations or such default, including, without limitation, the obtaining of insurance policies or governmental licenses, permits or approvals. Tenant shall reimburse Landlord upon demand for the costs
and expenses of any such performance (including penalties, interest and attorneys&#146; fees incurred in connection therewith). Such costs and expenses incurred by Landlord shall be deemed Additional Rent hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <B>Remedies Cumulative</B>. All rights, privileges and elections or remedies of Landlord are cumulative and not alternative with all other
rights and remedies at law or in equity to the fullest extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <B>Waiver</B>. Tenant waives any right of redemption
or relief from forfeiture under California Code of Civil Procedure Sections 1174 and 1179 and California Civil Code Section&nbsp;3275, or under any other present or future law in the event Tenant is evicted and Landlord takes possession of the
Leased Premises by reason of a default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article VIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Tenant Options </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.1
Option to Renew</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Landlord hereby grants to Tenant one (1)&nbsp;option (the &#147;<B>Option</B>&#148;) to extend the term of this
Lease for an additional period of five (5)&nbsp;years (the &#147;<B>Option Term</B>&#148;), all on the following terms and conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) The Option must be exercised, if at all, by written notice irrevocably exercising the Option (&#147;<B>Option Notice</B>&#148;) delivered
by Tenant to Landlord not earlier than fifteen (15)&nbsp;months and not later than twelve (12)&nbsp;months prior to the Term Expiration Date. Further, at Landlord&#146;s option, the Option shall not be deemed to be properly exercised if, as of the
date of the Option Notice or at the Term Expiration Date, (i)&nbsp;Tenant is in material default under this Lease, or (ii)&nbsp;Tenant has assigned this Lease or sublet any portion of the Leased Premises (other than with respect to a Permitted
Transfer). Provided Tenant has properly and timely exercised the Option, the term of this Lease shall be extended for the period of the Option Term, and all terms, covenants and conditions of this Lease shall remain unmodified and in full force and
effect, except that (i)&nbsp;the Landlord Improvements set forth in <B><U>Exhibit B</U> </B>and the Base Building Upgrades set forth in <B><U>Exhibit <FONT STYLE="white-space:nowrap">B-1</FONT></U> </B>shall not apply to the Option Term (Tenant
shall accept the Leased Premises in its AS IS condition existing prior to the Option Term), and (ii)&nbsp;the Base Rent shall be modified as set forth in <U>subsection 8.1(a)(2)</U> below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) The Base Rent payable for the initial year of the Option Term shall be the greater of (i)&nbsp;the Base Rent payable on the Term
Expiration Date, or (ii)&nbsp;the then-current rental rate per rentable square foot (as further defined below, &#147;<B>FMRR</B>&#148;) being agreed to (with annual market increases) in renewal leases by the Landlord and other landlords of buildings
in the Emeryville, California area which are comparable in quality, location and prestige to the Building (&#147;<B>Comparable Buildings</B>&#148;) and tenants leasing space in the Building or Comparable Buildings. As used herein, &#147;FMRR&#148;
shall mean the rental rate per rentable square foot for which Landlord and/or other landlords are entering into renewal leases with tenants leasing space from Landlord and other landlords in the Building and/or Comparable Buildings
(&#147;<B>Comparative Transactions</B>&#148;), taking into consideration fair market annual increases, and the value of existing tenant improvements in the Leased Premises. To the extent such other Comparable Buildings have historically received
lower or higher rents from the rents in the Building, then for the purpose of arriving at the FMRR, such rates when used to establish the FMRR in the Building shall be increased or decreased as appropriate to reflect such historical differences.
Landlord shall provide its determination of the FMRR to Tenant within twenty (20)&nbsp;days after Landlord receives the Option Notice. Tenant shall have ten (10)&nbsp;days (&#147;<B>Tenant&#146;s Review Period</B>&#148;) after receipt of
Landlord&#146;s notice of the FMRR within which to accept such FMRR or to reasonably object thereto in writing. In the event Tenant objects to the FMRR submitted by Landlord, Landlord and Tenant shall attempt to agree upon such FMRR. If Landlord and
Tenant fail to reach agreement on such FMRR within ten (10)&nbsp;days following Tenant&#146;s Review Period (the &#147;<B>Outside Agreement Date</B>&#148;), then each party shall place in a separate sealed envelope its final proposal as to FMRR and
such determination shall be submitted to arbitration in accordance with <U>subparagraph 8.1(b)</U> below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Landlord and Tenant shall
meet with each other within three (3)&nbsp;business days of the Outside Agreement Date and exchange the sealed envelopes and then open such envelopes in each other&#146;s presence. If Landlord and Tenant do not mutually agree upon the FMRR within
one (1)&nbsp;business day of the exchange and opening of envelopes, then, within ten (10)&nbsp;business days of the exchange and opening of envelopes, Landlord and Tenant shall agree upon and jointly appoint one arbitrator who shall be by profession
be a real estate broker who shall have been active over the ten (10)&nbsp;year period ending on the date of such appointment in the leasing of comparable commercial properties in the vicinity of the Building. Neither Landlord nor Tenant shall
consult with such broker as to his or her opinion as to FMRR prior to the appointment. The determination of the arbitrator shall be limited solely to the issue of whether Landlord&#146;s or Tenant&#146;s
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
submitted FMRR for the Leased Premises is the closer to the actual rental rate per rentable square foot for renewal leases for Comparative Transactions. Such arbitrator may hold such hearings and
require such briefs as the arbitrator, in his or her sole discretion, determines is necessary. In addition, Landlord or Tenant may submit to the arbitrator with a copy to the other party within two (2)&nbsp;business days after the appointment of the
arbitrator any data and additional information that such party deems relevant to the determination by the arbitrator (&#147;<B>Data</B>&#148;) and the other party may submit a reply in writing within two (2)&nbsp;business days after receipt of such
Data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) The arbitrator shall, within thirty (30)&nbsp;days of his or her appointment, reach a decision as to whether the parties shall
use Landlord&#146;s or Tenant&#146;s submitted FMRR, and shall notify Landlord and Tenant of such determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) The decision of the
arbitrator shall be binding upon Landlord and Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) If Landlord and Tenant fail to agree upon and appoint such arbitrator, then
the appointment of the arbitrator shall be made by the American Arbitration Association. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(4) The cost of arbitration shall be paid by
Landlord and Tenant equally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(5) The arbitration proceeding and all evidence given or discovered pursuant thereto shall be maintained in
confidence by all parties. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article IX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Miscellaneous Matters </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.1 Parking</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Landlord agrees to provide Tenant for use by the employees, agents, customers and invitees of Tenant the number of parking spaces designated on the Basic Lease Information sheet on an unreserved and unassigned basis on those portions of the Project
designated by Landlord for parking. Landlord shall have no obligation to monitor the use of the parking area. If Tenant is not the sole occupant of the Building and if a parking density problem occurs during the Term, Landlord may address the
problem, in its reasonable discretion, which solution may include initiating a parking permit system or a reserved parking system and any costs associated therewith (including, without limitation, costs of patrolling the parking lot for compliance
with the parking system) shall constitute a Basic Operating Costs. All parking shall be subject to any and all rules and regulations adopted by Landlord in its reasonable discretion from time to time, which rules and regulations shall be consistent
with the prevailing market conditions, provided they have been delivered in writing to Tenant at least thirty (30)&nbsp;days prior to Landlord&#146;s adoptions of such rules and regulations. Only automobiles no larger than full size passenger
automobiles or <FONT STYLE="white-space:nowrap">pick-up</FONT> trucks or standard business use vehicles (which do not require parking spaces larger than full size passenger automobiles) may be parked in the Project parking area. Tenant shall not
permit or allow any vehicles that belong to or are controlled by Tenant or Tenant&#146;s employees, agents, customers or invitees to be loaded, unloaded or parked in areas other than those designated by Landlord for such activities. A failure by
Tenant or any of its employees, agents, customers or invitees to comply with the foregoing provisions shall afford Landlord the right, but not the obligation, without notice, in addition to any other rights and remedies available under this Lease,
to remove and to tow away the vehicles involved and to charge the cost to Tenant, which cost shall be immediately due and payable upon demand by Landlord. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Landlord reserves the right to charge a <FONT STYLE="white-space:nowrap">per-car</FONT>
parking fee during the Term if such parking fees are mandated or otherwise imposed by applicable law. Except for the foregoing, Landlord shall not charge Tenant parking fees during the initial Term or Option Term of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.2 Brokers</B>. Tenant has been represented in this transaction by Tenant&#146;s Broker. Upon full execution of this Lease by both
parties, Landlord shall pay to Tenant&#146;s Broker a fee for brokerage services rendered by it in this transaction provided for in separate written agreements between Landlord and Tenant&#146;s Broker. Tenant represents and warrants to Landlord
that the brokers named in the Basic Lease Information sheet are the only agents, brokers, finders or other similar parties with whom Tenant has had any dealings in connection with the negotiation of this Lease and the consummation of the transaction
contemplated hereby. Tenant hereby agrees to indemnify, defend and hold Landlord free and harmless from and against liability for compensation or charges which may be claimed by any agent, broker, finder or other similar party by reason of any
dealings with or actions of Tenant in connection with the negotiation of this Lease and the consummation of this transaction, including any costs, expenses and attorneys&#146; fees incurred with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.3 No Waiver</B>. No waiver by either party of the default or breach of any term, covenant or condition of this Lease by the other shall
be deemed a waiver of any other term, covenant or condition hereof, or of any subsequent default or breach by the other of the same or of any other term, covenant or condition hereof. Landlord&#146;s consent to, or approval of, any act shall not be
deemed to render unnecessary the obtaining of Landlord&#146;s consent to, or approval of, any subsequent or similar act by Tenant, or be construed as the basis of an estoppel to enforce the provision or provisions of this Lease requiring such
consent. Regardless of Landlord&#146;s knowledge of a default or breach at the time of accepting Rent, the acceptance of Rent by Landlord shall not be a waiver of any preceding default or breach by Tenant of any provision hereof, other than the
failure of Tenant to pay the particular Rent so accepted. Any payment given Landlord by Tenant may be accepted by Landlord on account of monies or damages due Landlord, notwithstanding any qualifying statements or conditions made by Tenant in
connection therewith, which statements and/or conditions shall be of no force or effect whatsoever unless specifically agreed to in writing by Landlord at or before the time of deposit of such payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.4 Recording</B>. Neither this Lease nor a memorandum thereof shall be recorded without the prior written consent of Landlord, which
consent may be withheld in Landlord&#146;s sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.5 Holding Over</B>. If Tenant fails to surrender possession of the
Leased Premises in the condition required under this Lease or holds over after expiration or termination of this Lease without the written consent of Landlord, Tenant shall pay for each month of hold-over tenancy one hundred fifty percent (150%)
times the Gross Rent which Tenant was obligated to pay for the month immediately preceding the end of the Term for each month or any part thereof of any such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hold-over period, together with such other amounts as may become due hereunder. No holding over by Tenant after the Term shall operate to extend the Term. In the event of any unauthorized holding
over, Tenant shall indemnify, defend and hold Landlord harmless from and against all claims, demands, liabilities, losses, costs, expenses (including attorneys&#146; fees), injury and damages including any lost profits incurred by Landlord as a
result of Tenant&#146;s delay in vacating the Leased Premises, provided Landlord gives Tenant thirty (30)&nbsp;days prior written notice notifying Tenant that it may suffer consequential damages if it holds over because the Leased Premises will be
needed for, among other things, a replacement tenant or for improvements scheduled to be made to the Leased Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.6 Transfers by
Landlord</B>. The term &#147;Landlord&#148; as used in this Lease shall mean the owner(s) at the time in question of the fee title to the Leased Premises or, if this is a sublease, of the Tenant&#146;s interest in the master lease. If Landlord
transfers, in whole or in part, its rights and obligations under this Lease or in the Project, upon its transferee&#146;s assumption of Landlord&#146;s obligations hereunder and delivery to such transferee of any unused Security Deposit then held by
Landlord, no further liability or obligations shall thereafter accrue against the transferring or assigning person as Landlord hereunder. Subject to the foregoing, the obligations and/or covenants in this Lease to be performed by Landlord shall be
binding only upon Landlord as defined in this <U>Section&nbsp;9.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.7 Attorneys&#146; Fees</B>. In the event either party places
the enforcement of this Lease (including, without limitation, a constructive eviction action by Tenant), or any part of it, or the collection of any Rent due, or to become due, hereunder, or recovery of the possession of the Leased Premises, in the
hands of an attorney, or files suit upon the same, the prevailing party shall recover its reasonable attorneys&#146; fees, costs and expenses as a cost of suit incurred and not as damages, including those which may be incurred on appeal. Such fees
may be awarded in the same suit or recovered in a separate suit, whether or not suit is filed or any suit that may be filed is pursued to decision or judgment. The term &#147;prevailing party&#148; shall include, without limitation, a party who
substantially obtains or defeats the relief sought, as the case may be, whether by compromise, settlement, judgment, or the abandonment by the other party of its claim or defense. The attorneys&#146; fee award shall not be computed in accordance
with any court fee schedule, but shall be such as to fully reimburse all attorneys&#146; fees reasonably incurred. In addition to the foregoing, in the event Tenant requires Landlord&#146;s consent or signature with respect to an agreement or other
matter not provided for in this Lease (e.g., an agreement requested by Tenant&#146;s lender), Tenant shall reimburse Landlord for its reasonable attorneys&#146; fees or other consultant fees incurred in connection with the review and/or negotiation
of such agreement or matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.8 Termination; Merger</B>. No act or conduct of Landlord, including, without limitation, the acceptance
of keys to the Leased Premises, shall constitute an acceptance of the surrender of the Leased Premises by Tenant before the scheduled Term Expiration Date. Only a written notice from Landlord to Tenant shall constitute acceptance of the surrender of
the Leased Premises and accomplish a termination of this Lease. Unless specifically stated otherwise in writing by Landlord, the voluntary or other surrender of this Lease by Tenant, the mutual termination or cancellation hereof, or a termination
hereof by Landlord for default by Tenant, shall automatically terminate any sublease or lesser estate in the Leased Premises; provided, however, Landlord shall, in the event of any such surrender, termination or cancellation, have the option to
continue any one or all of any existing subtenancies. Landlord&#146;s failure within thirty (30)&nbsp;days following any such event to make any written election to the contrary by written notice to the holder of any such lesser interest, shall
constitute Landlord&#146;s election to have such event constitute the termination of such interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.9 Amendments; Interpretation</B>. This Lease may not be altered, changed or amended,
except by an instrument in writing signed by the parties in interest at the time of the modification. The captions of this Lease are for convenience only and shall not be used to define or limit any of its provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.10 Severability</B>. If any term or provision of this Lease, or the application thereof to any person or circumstances, shall to any
extent be invalid or unenforceable, the remainder of this Lease, or the application of such provision to persons or circumstances other than those as to which it is invalid or unenforceable, shall not be affected thereby, and each provision of this
Lease shall be valid and shall be enforceable to the fullest extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.11 Notices</B>. Except as otherwise expressly
provided herein, all notices, demands, consents and approvals which are required or permitted by this Lease to be given by either party to the other shall be in writing and shall be deemed to have been fully given by personal delivery or by
recognized same day or overnight courier service or when deposited in the United States mail, certified or registered, with postage prepaid, and addressed to the party to be notified at the address for such party specified on the Basic Lease
Information sheet, or to such other place as the party to be notified may from time to time designate by at least fifteen (15)&nbsp;days&#146; notice to the notifying party given in accordance with this <U>Section&nbsp;9.11</U>, except that upon
Tenant&#146;s taking possession of the Leased Premises, the Leased Premises shall constitute Tenant&#146;s address for notice purposes. A copy of all notices given to Landlord under this Lease shall be concurrently transmitted to such party or
parties at such addresses as Landlord may from time to time hereafter designate by notice to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice sent by registered or
certified mail, return receipt requested, shall be deemed given on the date of delivery shown on the receipt card, or if no delivery date is shown, the postmark thereon. Notices delivered by recognized overnight courier shall be deemed given on the
next business day after the business day upon which delivery of the same was made to the courier. If notice is received on a Saturday, Sunday or legal holiday, it shall be deemed received on the next business day. Tenant hereby appoints as its agent
to receive the service of all default notices and notice of commencement of unlawful detainer proceedings the person in charge of or apparently in charge of or occupying the Leased Premises at the time, and, if there is no such person, then such
service may be made by attaching the same on the main entrance of the Leased Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.12 Force Majeure</B>. Any prevention, delay
or stoppage of work to be performed by Landlord or Tenant which is due to strikes, labor disputes, inability to obtain labor, materials, equipment or reasonable substitutes therefor, acts of God, governmental restrictions or regulations or controls,
judicial orders, enemy or hostile government actions, terrorism, civil commotion, or other causes beyond the reasonable control of the party obligated to perform hereunder, shall excuse performance of the work by that party for a period equal to the
duration of that prevention, delay or stoppage. Nothing in this <U>Section&nbsp;9.12</U> shall excuse or delay Tenant&#146;s obligation to pay Rent or other charges due under this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.13 </B>Intentionally Omitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.14 Successors and Assigns</B>. This Lease shall be binding upon and inure to the benefit of Landlord, its successors and assigns (subject
to the provisions hereof, including, without limitation, <U>Section&nbsp;5.15</U>), and shall be binding upon and inure to the benefit of Tenant, its successors, and to the extent assignment or subletting, may be approved by Landlord hereunder,
Tenant&#146;s assigns or subtenants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.15 Further Assurances</B>. Landlord and Tenant each agree to promptly sign all documents
reasonably requested to give effect to the provisions of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.16 Incorporation of Prior Agreements</B>. This Lease, including
the exhibits and addenda attached to it, contains all agreements of Landlord and Tenant with respect to any matter referred to herein. No prior agreement or understanding pertaining to such matters shall be effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.17 Applicable Law</B>. This Lease shall be governed by, construed and enforced in accordance with the laws of the State of California.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.18 Time of the Essence</B>. Time is of the essence of each and every covenant of this Lease. Each and every covenant, agreement or
other provision of this Lease on Tenant&#146;s part to be performed shall be deemed and construed as a separate and independent covenant of Tenant, not dependent on any other provision of this Lease or on any other covenant or agreement set forth
herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.19 No Joint Venture</B>. This Lease shall not be deemed or construed to create or establish any relationship of partnership
or joint venture or similar relationship or arrangement between Landlord and Tenant hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.20 Authority</B>. If Tenant is a
corporation, limited liability company, trust or general or limited partnership, each individual executing this Lease on behalf of Tenant represents and warrants that he or she is duly authorized to execute and deliver this Lease on Tenant&#146;s
behalf and that this Lease is binding upon Tenant in accordance with its terms. If Tenant is a corporation, limited liability company, trust or partnership, Tenant shall, upon request by Landlord, deliver to Landlord evidence satisfactory to
Landlord of such authority. If Landlord is a corporation, limited liability company, trust or general or limited partnership, each individual executing this Lease on behalf of Landlord represents and warrants that he or she is duly authorized to
execute and deliver this Lease on Landlord&#146;s behalf and that this Lease is binding upon Landlord in accordance with its terms. If Landlord is a corporation, limited liability company, trust or partnership, Landlord shall, upon request by
Tenant, deliver to Tenant evidence satisfactory to Tenant of such authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.21 Landlord Renovations</B>. Except as set forth
herein, it is specifically understood and agreed that Landlord has no additional obligation and has made no additional promises to alter, remodel, improve, renovate, repair or decorate the Leased Premises, Building, Project, or any part thereof and
that no representations or warranties respecting the condition of the Leased Premises, the Building or the Project have been made by Landlord to Tenant, except as specifically set forth in this Lease. However, Tenant acknowledges that Landlord may
from time to time, at Landlord&#146;s sole option, renovate, improve, alter, or modify (collectively, the &#147;<B>Renovations</B>&#148;) the Building, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Leased Premises, and/or Project, systems and equipment, roof, and structural portions of the same and in connection with such Renovations, Landlord may, among other things, erect scaffolding or
other necessary structures in the Building, limit or eliminate access to portions of the Project, or perform work in the Building, which work may create noise, dust or leave debris in the Building; provided, however that Landlord shall not
unreasonably interfere with Tenant&#146;s access, use and enjoyment of the Leased Premises or Building Top Roof Deck. Tenant hereby agrees that such Renovations and Landlord&#146;s actions in connection with such Renovations shall in no way
constitute a constructive eviction of Tenant nor entitle Tenant to any abatement of Rent. Landlord shall have no responsibility or for any reason be liable to Tenant for any direct or indirect injury to or interference with Tenant&#146;s business
arising from the Renovations, nor shall Tenant be entitled to any compensation or damages from Landlord for loss of the use of the whole or any part of the Leased Premises or of Tenant&#146;s personal property or improvements resulting from the
Renovations or Landlord&#146;s actions in connection with such Renovations, or for any inconvenience or annoyance occasioned by such Renovations or Landlord&#146;s actions in connection with such Renovations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.22 Security</B>. Landlord shall not be required to provide, operate or maintain alarm or surveillance systems or services for the Leased
Premises or the Project. Tenant shall provide such security services and shall install within the Leased Premises such security equipment, systems and procedures that Tenant, in its sole discretion, determines is reasonably required for the
protection of its employees, invitees, and property, provided that Tenant shall coordinate such services and equipment with Landlord, if necessary. The determination of the extent to which such security equipment, systems and procedures are
reasonably required shall be made in the sole judgment, and shall be the sole responsibility, of Tenant. Tenant acknowledges that it has neither received nor relied upon any representation or warranty made by or on behalf of Landlord with respect to
the safety or security of the Leased Premises or the Project or any part thereof, and further acknowledges that Tenant has made its own independent determinations with respect to all such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.23 Offer</B>. Preparation of this Lease by Landlord or Landlord&#146;s agent and submission of same to Tenant shall not be deemed an
offer to lease to Tenant. This Lease is not intended to be binding and shall not be effective until fully executed by both Landlord and Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.24 No Easement For Light, Air and View</B>. This Lease conveys to Tenant no rights for any light, air or view. No diminution of light,
air or view, or any impairment of the visibility of the Leased Premises from inside or outside the Building, by any structure or other object that may hereafter be erected (whether or not by Landlord) shall entitle Tenant to any reduction of Rent
under this Lease, constitute an actual or constructive eviction of Tenant, result in any liability of Landlord to Tenant, or in any other way affect this Lease or Tenant&#146;s obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.25 OFAC Compliance</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Tenant represents and warrants that (i)&nbsp;Tenant and, to Tenant&#146;s actual knowledge, each person or entity owning an interest in
Tenant is (A)&nbsp;not currently identified on the Specially Designated Nationals and Blocked Persons List maintained by the Office of Foreign Assets Control, Department of the Treasury (&#147;<B>OFAC</B>&#148;) and/or on any other similar list
maintained by OFAC pursuant to any authorizing statute, executive order or regulation (collectively, the &#147;<B>List</B>&#148;), and (B)&nbsp;not a person or entity with whom a citizen of the United States is prohibited to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
engage in transactions by any trade embargo, economic sanction, or other prohibition of United States law, regulation, or Executive Order of the President of the United States, (ii)&nbsp;none of
the funds or other assets of Tenant constitute property of, or are beneficially owned, directly or indirectly, by any Embargoed Person (as hereinafter defined), (iii) no Embargoed Person has any interest of any nature whatsoever in Tenant (whether
directly or indirectly), (iv) none of the funds of Tenant have been derived from any unlawful activity with the result that the investment in Tenant is prohibited by law or that the Lease is in violation of law, and (v)&nbsp;Tenant has implemented
procedures, and will consistently apply those procedures, to ensure the foregoing representations and warranties remain true and correct at all times. The term &#147;Embargoed Person&#148; means any person, entity or government subject to trade
restrictions under U.S. law, including but not limited to, the International Emergency Economic Powers Act, 50 U.S.C. &#167;1701 et seq., The Trading with the Enemy Act, 50 U.S.C. App. 1 et seq., and any Executive Orders or regulations promulgated
thereunder with the result that the investment in Tenant is prohibited by law or Tenant is in violation of law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Tenant covenants and
agrees (i)&nbsp;to comply with all requirements of law relating to money laundering, anti-terrorism, trade embargos and economic sanctions, now or hereafter in effect, (ii)&nbsp;to immediately notify Landlord in writing if any of the
representations, warranties or covenants set forth in this paragraph or the preceding paragraph are no longer true or have been breached or if Tenant has a reasonable basis to believe that they may no longer be true or have been breached,
(iii)&nbsp;not to use funds from any &#147;Prohibited Person&#148; (as such term is defined in the September&nbsp;24, 2001 Executive Order Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support
Terrorism) to make any payment due to Landlord under the Lease and (iv)&nbsp;at the request of Landlord, to provide such information as may be requested by Landlord to determine Tenant&#146;s compliance with the terms hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Tenant hereby acknowledges and agrees that Tenant&#146;s inclusion on the List at any time during the Term shall be a material default of
the Lease. Notwithstanding anything herein to the contrary, Tenant shall not permit the Leased Premises or any portion thereof to be used or occupied by any person or entity on the List or by any Embargoed Person (on a permanent, temporary or
transient basis), and any such use or occupancy of the Leased Premises by any such person or entity shall be a material default of the Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Simultaneously with the execution of the Lease, Tenant will provide to Landlord the names of the persons holding an ownership interest in
Tenant, if required to comply with Presidential Executive Order 13224 (issued September&nbsp;24, 2001). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.26 Mortgagee Protection</B>.
Upon any default on the part of Landlord, Tenant will give written notice by registered or certified mail to any beneficiary of a deed of trust or mortgagee of a mortgage covering the Leased Premises who has provided Tenant with notice of their
interest together with an address for receiving notice, and shall offer such beneficiary or mortgagee a reasonable opportunity to cure the default, including time to obtain possession of the Leased Premises by power of sale or a judicial
foreclosure, if such should prove necessary to effect a cure. If such default cannot be cured within such time period, then such additional time as may be necessary will be given to such beneficiary or mortgagee to effect such cure so long as such
beneficiary or mortgagee has commenced the cure within the original time period and thereafter </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
diligently pursues such cure to completion, in which event this Lease shall not be terminated while such cure is being diligently pursued. Tenant agrees that each lender to whom this Lease has
been assigned by Landlord is an express third party beneficiary hereof. Tenant shall not make any prepayment of Rent more than one (1)&nbsp;month in advance without the prior written consent of each such lender. Tenant agrees to make all payments
under this Lease to the lender with the most senior encumbrance upon receiving a direction, in writing, to pay said amounts to such lender. Tenant shall comply with such written direction to pay without determining whether an event of default exists
under such lender&#146;s loan to Landlord. If, in connection with obtaining financing for the Leased Premises or any other portion of the Project, Landlord&#146;s lender shall request reasonable modification(s) to this Lease as a condition to such
financing, Tenant shall not unreasonably withhold, delay or defer its consent thereto, provided such modifications do not materially and adversely affect Tenant&#146;s rights hereunder, including Tenant&#146;s use, occupancy or quiet enjoyment of
the Leased Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.27 Confidentiality</B>. Landlord and Tenant each agree that the terms of this Lease are confidential and
constitute proprietary information of the parties hereto. Disclosure of the terms hereof could adversely affect the ability of Landlord to negotiate with other tenants. Each of the parties hereto agrees that such party, and its respective partners,
officers, directors, employees, agents, real estate brokers and sales persons and attorneys, shall not disclose the terms and conditions of this Lease to any other person without the prior written consent of the other party hereto except pursuant to
an order of a court of competent jurisdiction. Provided, however, that Tenant may disclose the terms hereof to prospective investors in subsequent rounds of financing (under confidentiality obligations to not disclose the terms and conditions of
this Lease to any other person) and disclosures required of publicly traded companies (in the event that Tenant undergoes an initial public offering), that Landlord may disclose the terms hereof to any lender now or hereafter having a lien on
Landlord&#146;s interest in the Project or any portion thereof, and either party may disclose the terms hereof to its respective independent accountants who review its respective financial statements or prepare its respective tax returns, to any
prospective transferee of all or any portions of their respective interests hereunder, to any lender or prospective lender to such party, to any governmental entity, agency or person to whom disclosure is required by applicable law, regulation or
duty of diligent inquiry and in connection with any action brought to enforce the terms of this Lease, on account of the breach or alleged breach hereof or to seek a judicial determination of the rights or obligations of the parties hereunder.
Tenant acknowledges that any breach by Tenant of the agreements set forth in this <U>Section&nbsp;9.26</U> shall cause Landlord irreparable harm. The terms and provisions of this <U>Section&nbsp;9.26</U> shall survive the termination of the Lease
(whether by lapse of time or otherwise). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.28 Waiver of Jury Trial</B>. To the extent permitted by applicable law, Landlord and Tenant
each hereby waive trial by jury in any action, proceeding or counterclaim brought by either party against the other on any matter whatsoever arising out of or in any way connected with this Lease, the relationship of Landlord and Tenant created
hereby, Tenant&#146;s use or occupancy of the Leased Premises or any claim or injury or damage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.29 Counterparts; Signatures</B>.
This Lease may be executed in counterparts. All executed counterparts shall constitute one agreement, and each counterpart shall be deemed an original. The parties hereby acknowledge and agree that facsimile signatures or signatures transmitted by
electronic mail in <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;pdf&#148; format shall be legal and binding and shall have the same full force and effect as if an original of this Lease had been delivered. Landlord and Tenant
(i)&nbsp;intend to be bound by the signatures on any document sent by facsimile or electronic mail, (ii)&nbsp;are aware that the other party will rely on such signatures, and (iii)&nbsp;hereby waive any defenses to the enforcement of the terms of
this Lease based on the foregoing forms of signature. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.30 Accessibility Inspection Disclosure</B>. Landlord and Tenant acknowledge and agree
that the Leased Premises has not been inspected by a Certified Access Specialist (&#147;<B>CASp</B>&#148;) pursuant to Section&nbsp;1938 of the Civil Code (&#147;<B>Code</B>&#148;). The parties further agree, pursuant to subdivision (e)&nbsp;of
Section&nbsp;55.53 of the Code the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) a CASp can inspect the Leased Premises and determine whether the Leased Premises
complies with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp inspection of the Leased Premises, Landlord may not prohibit Tenant from obtaining a CASp inspection of the
Leased Premises for the occupancy or potential occupancy of Tenant, if requested by the Tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and
the cost of making any repairs necessary to correct violations of the construction- related accessibility standards within the Leased Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) pursuant to the paragraph above, the parties expressly agree that, if Tenant elects to obtain a CASp inspection of the Leased Premises,
Tenant shall be solely responsible for scheduling the inspection and that such inspection shall not unreasonably interfere with the operations of the Leased Premises and/or the Building or disturb any other tenant or occupant. Tenant shall be solely
responsible for any and all costs to perform the CASp inspection, including any ancillary costs relating thereto. If the results of the inspection determine that modifications or alterations are required to meet all applicable construction-related
accessibility standards, Tenant agrees to perform such work, in its sole cost and expense and provided approvals from Landlord are obtained under the Lease, as required. Tenant agrees that all work shall be performed in a first class manner in
compliance with all laws and using best efforts to minimize any disruption to the Building and other tenants or occupants, if applicable. Furthermore, Tenant agrees that any report that is generated as a result of an inspection pursuant to this
<U>Section&nbsp;9.30</U> and all information contained therein, shall remain confidential, except as necessary for Tenant to complete repairs and/or correct violations, as agreed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.31 Tax Status of Beneficial Owner</B>. Tenant recognizes and acknowledges that Landlord and/or certain beneficial owners of Landlord may
from time to time qualify as real estate investment trusts pursuant to Sections 856 et seq. of the Internal Revenue Code and that avoiding (a)&nbsp;the loss of such status, (b)&nbsp;the receipt of any income derived under any provision of this Lease
that does not constitute &#147;rents from real property&#148; (in the case of real estate investment trusts), and (c)&nbsp;the imposition of income, penalty or similar taxes (each an &#147;<B>Adverse Event</B>&#148;) is of material concern to
Landlord and such beneficial owners. In the event that this Lease or any document contemplated hereby could, in the opinion of counsel to Landlord, result in or cause an Adverse Event, Tenant agrees to cooperate with Landlord in negotiating an
amendment or modification thereof and shall at the request of Landlord execute and deliver such documents reasonably required to effect such amendment or modification. Any amendment or modification pursuant to this <U>Section&nbsp;9.31</U> shall be
structured so that the economic results to Landlord and Tenant shall be substantially similar to those set forth in this Lease without regard to such amendment or modification. Without limiting any of Landlord&#146;s other rights under this
<U>Section&nbsp;9.31</U>, Landlord may waive the receipt of any amount payable to Landlord hereunder and such waiver shall constitute an amendment or modification of this Lease with respect to such payment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.32 Landlord&#146;s Reservations</B>. In addition to the other rights of Landlord under
this Lease, Landlord reserves the right to change the street address and/or name of the Building without being deemed to be guilty of an eviction, actual or constructive, or a disturbance or interruption of the business of Tenant or Tenant&#146;s
use or occupancy of the Leased Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.33 Electric Charging Stations</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall have the right to install and operate, at Tenant&#146;s sole cost and expense, electric charging stations and associated
equipment (collectively, the &#147;<B>Electric Charging Stations</B>&#148;) in the parking area designated by Landlord, provided that Landlord has, in its reasonable discretion, approved in writing the design, size and weight of the equipment. The
location, design, size and weight of such Electric Charging Stations may also be subject to the approval of the City of Emeryville and other applicable governmental authorities. The Electric Charging Stations shall at all times, during the Term of
the Lease, remain the property of Tenant. Tenant acknowledges that installation of the Electric Charging Stations may cause a loss of a limited number of parking spaces on the Project. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In installing the Electric Charging Stations, Tenant shall adhere to industry standards for installation and workmanship, all work to be
completed to Landlord&#146;s reasonable satisfaction. Upon termination of the Lease, Tenant shall leave the Electric Charging Stations at the Project in good working order, or, if so requested by Landlord, remove the Electric Charging Stations and
shall repair, to Landlord&#146;s reasonable satisfaction, any damage caused by the installation or removal of the Electric Charging Stations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Tenant shall, at its sole cost, immediately repair and restore to its prior condition, reasonable wear and tear, any damage to the Project
caused by the installation, operation or maintenance of the Electric Charging Stations. If Tenant fails to repair and restore damage caused to the Project within a reasonable time, Landlord shall have the right to repair and restore such damage and
receive reimbursement from Tenant of all reasonable costs incurred by Landlord. All costs incurred by Landlord as a result of the existence of the Electric Charging Stations shall be considered an extra service as set forth in Section&nbsp;4.2 and
shall be reimbursed by Tenant. The Electric Charging Stations shall be used solely for Tenant&#146;s employees and guests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All
aspects and phases of Tenant&#146;s installation of the Electric Charging Stations shall at all times be subject to supervision and approval by Landlord (solely to protect Landlord&#146;s interests; Landlord shall have no obligation to Tenant to
exercise any such power of supervision or approval). Tenant shall be responsible for procuring all consents, approvals, licenses or permits required for the installation, use, operation and removal of Tenant&#146;s equipment. Landlord makes no
warranties or representations as to the permissibility of any such installation by Tenant. All costs and expenses incurred in connection with any such installation or proposed installation by Tenant, including, without limitation, any cost or
expenses incurred by Landlord in connection with review or supervision or obtaining approvals, shall be borne by Tenant. Tenant shall at all times and at Tenant&#146;s sole expense be responsible for proper maintenance, repair and replacement of the
Electric Charging Stations and all governmental permits and approvals required in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.34 Equipment Financing</B>. Landlord acknowledges that Tenant may lease from or finance
with a third party (&#147;Tenant&#146;s Creditor&#148;) Tenant&#146;s trade fixtures, equipment, inventory, and personal property utilized for Tenant&#146;s business operations in the Leased Premises (the &#147;<B>Financed Equipment</B>&#148;).
Subject to Tenant reimbursing Landlord for its reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (e.g., legal fees), Landlord will execute and promptly deliver any commercially
reasonable waiver, acknowledgments, or consents that may be required by Tenant&#146;s Creditor in connection with the leasing or financing of the Financed Equipment, which will include, without limitation, the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The agreement of Landlord that, as between Landlord and Tenant&#146;s Creditor, Tenant&#146;s Creditor will have the right, at reasonable
times and with advance written notice to Landlord, to remove any or all of the Financed Equipment at any time or times before the Term Expiration Date, however, (i)&nbsp;in no event may Tenant&#146;s Creditor conduct a sale of the Financed Equipment
on or around the Project, (ii)&nbsp;if such removal causes any damage to the Leased Premises, the Building, or the Common Areas, Tenant&#146;s Creditor shall either promptly repair such damage or reimburse Landlord promptly for the cost of repair,
and (iii)&nbsp;if Tenant is no longer in lawful possession of the Leased Premises and Tenant&#146;s Creditor takes possession of the Leased Premises at any time in order to remove any or all of the Financed Equipment (which period of time shall not
exceed ten (10)&nbsp;days), Tenant&#146;s Creditor agrees to pay Landlord, during the period while Tenant&#146;s Creditor is in possession of the Leased Premises, a license fee equivalent to the <FONT STYLE="white-space:nowrap">pro-rated</FONT>
monthly rental payments provided for in the Lease (however, only to the extent that Tenant has not paid rent for the applicable time period); &#147;possession&#148; shall commence on the date Tenant&#146;s Creditor is provided possession of the
Leased Premises by Landlord and ends on Tenant&#146;s Creditor final departure from the Leased Premises. In no event may Tenant&#146;s Creditor possession of the Leased Premises exceed ten (10)&nbsp;days; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Financed Equipment shall in no event include any and all existing or hereafter installed structural, electrical, mechanical, HVAC,
plumbing and fire/life safety systems and related equipment and components, any fixtures or improvements which are necessary for the operation of the Building and/or the Leased Premises as a laboratory or life-science use (as opposed to the special
purpose nature of Tenant&#146;s business in the Leased Premises), and any <FONT STYLE="white-space:nowrap">built-in</FONT> furniture, <FONT STYLE="white-space:nowrap">built-in</FONT> cabinetry, and <FONT STYLE="white-space:nowrap">built-in</FONT>
appliances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.35 Lease Contingency; Early Access</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The effectiveness of this Lease is subject to Landlord&#146;s terminating the PD Lease. Landlord shall have a period expiring on
February&nbsp;28, 2021 to terminate the PD Lease (the &#147;PD Lease Termination Expiration Date&#148;) and deliver the Leased Premises to Tenant pursuant to this Lease (the &#147;<B>Delivery Date</B>&#148;). If Landlord has not obtained such
termination and has not delivered the Leased Premises to Tenant on or before the PD Lease Termination Expiration Date, Landlord or Tenant may elect to terminate this Lease upon written notice to the other party delivered at any time following the PD
Lease Termination Expiration Date but prior to the Delivery Date, in which case this Lease shall be terminated and of no further force and effect, and Tenant shall be refunded all funds deposited or paid to Landlord and the Letter of Credit shall be
returned to Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Provided that the PD Lease has been terminated, Tenant shall have delivered the Security
Deposit (letter of credit) and the <FONT STYLE="white-space:nowrap">pre-paid</FONT> Base Rent to Landlord (pursuant to Section&nbsp;3.3(a) of the Lease), and Tenant shall have procured all required insurance (and shall have delivered to Landlord all
required insurance certificates), and to the extent allowed by applicable laws and allowed by applicable governmental authorities, Tenant shall be given access to the Leased Premises prior to the Term Commencement Date in order for Tenant to install
Tenant&#146;s furniture, trade fixtures, equipment, telephone networks and computer networks. From the date Tenant is given early access to the Leased Premises as set forth above through the Term Commencement Date, Tenant shall be subject to all of
the covenants in the Lease, except that Tenant&#146;s obligation to pay Rent shall commence in accordance with the Basic Lease Information sheet of the Lease; provided, however, (i)&nbsp;Tenant shall not enter the Leased Premises unless accompanied
by a person designated by Landlord, if required by Landlord, and Tenant shall provide to Landlord at least 24 hours prior written notice prior to such entry, (ii)&nbsp;Tenant shall exercise such right of access in a manner that comports with the
requirements of all relevant insurance policies, (iii)&nbsp;Tenant (and Tenant&#146;s contractors, vendors, agents, and employees) shall not disrupt or delay the performance of the Landlord Improvements or other improvements occurring in the Leased
Premises, and (iv)&nbsp;Tenant (and Tenant&#146;s contractors, vendors, agents, and employees) shall in no event give directions to (or otherwise interfere with) the contractor or others performing the Landlord Improvements or other improvements
occurring in the Leased Premises. In the event that the PD Lease has not yet been terminated, Tenant has delivered the Security Deposit and the <FONT STYLE="white-space:nowrap">pre-paid</FONT> Base Rent to Landlord, and Tenant has procured all
required insurance (and shall have delivered to Landlord all required insurance certificates), Landlord shall use good faith and diligent efforts to facilitate Tenant&#146;s early access rights to the Leased Premises with the Current Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.36 Exhibits; Addenda</B>. The following Exhibits and addenda are attached to, incorporated in and made a part of this Lease:
<B><U>Exhibit <FONT STYLE="white-space:nowrap">A-1</FONT></U> </B>Floor Plan of the Leased Premises; <B><U>Exhibit <FONT STYLE="white-space:nowrap">A-2</FONT></U> </B>Legal Description of Project <B><U>Exhibit B</U> </B>Landlord Improvements and
Tenant&#146;s Work; <B><U>Exhibit <FONT STYLE="white-space:nowrap">B-1</FONT></U> </B>Base Building Upgrades; <B><U>Exhibit C</U> </B>Confirmation of Term of Lease; <B><U>Exhibit D</U> </B>Building Rules and Regulations; <B><U>Exhibit E</U>
</B>Asbestos Notification; and <B><U>Exhibit F</U> </B>Hazardous Materials Questionnaire. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Lease as of the day and year first
written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>&#147;LANDLORD&#148;:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EPL HALLECK INVESTORS LLC, a California limited liability company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Ellis Partners LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a California limited liability company</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">its Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James F. Ellis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Printed Name: James F. Ellis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: Managing Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>&#147;TENANT&#148;:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">METAGENOMI, INC.,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian Thomas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Printed Name: Brian Thomas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Title: CEO</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT <FONT STYLE="white-space:nowrap">A-1</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLOOR PLAN OF THE LEASED PREMISES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
parties acknowledge that the following plans were prepared by the Current Tenant&#146;s architect, the purpose of the following plans are solely to show the approximate general layout of the Leased Premises, and that Landlord makes no warranty and
expressly disclaims all warranties as to the accuracy of the information included in the following plans as such information has been provided by others. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp059.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT <FONT STYLE="white-space:nowrap">A-1</FONT> CONTINUED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties acknowledge that the following plans were prepared by the Current Tenant&#146;s architect, the purpose of the following plans are solely to show
the approximate general layout of the Leased Premises, and that Landlord makes no warranty and expressly disclaims all warranties as to the accuracy of the information included in the following plans as such information has been provided by others.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp060.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT <FONT STYLE="white-space:nowrap">A-2</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LEGAL DESCRIPTION OF PROJECT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Real
property in the City of Emeryville, County of Alameda, State of California, described as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARCEL ONE: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PORTION OF BLOCK 27, MAP OF PART OF PLOT 6 KELLERSBERGER&#146;S SURVEY OF VICENTE&nbsp;&amp; DOMINGO PERALTA RANCHO, PROPERTY OF J. S. EMERY, FILED MARCH 01,
1889, IN BOOK 19, PAGE 68, OF MAPS, DESCRIBED AS FOLLOWS: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BEGINNING AT A POINT ON THE SOUTHERN LINE OF PARK AVENUE, DISTANT THEREON WESTERLY 76.50 FEET
FROM THE WESTERN LINE OF HUBBARD STREET, AS SAID AVENUE AND STREET ARE SHOWN ON SAID MAP; RUNNING THENCE SOUTHERLY, PARALLEL WITH SAID WESTERN LINE OF HUBBARD STREET, 54.50 FEET; THENCE EASTERLY, PARALLEL WITH SAID SOUTHERN LINE OF PARK AVENUE, 19
FEET; THENCE SOUTHERLY, PARALLEL WITH SAID LINE OF HUBBARD STREET, 70.47 FEET; THENCE WESTERLY, PARALLEL WITH SAID LINE OF PARK AVENUE, 79.85 FEET; THENCE SOUTHERLY, PARALLEL WITH SAID LINE OF HUBBARD STREET, 4.925 FEET; THENCE WESTERLY, PARALLEL
WITH SAID LINE OF PARK AVENUE, 128.65 FEET TO A POINT ON THE EASTERN LINE OF HALLECK STREET, AS SAID STREET IS SHOWN ON SAID MAP, DISTANT THEREON SOUTH 129.895 FEET FROM SAID SOUTHERN LINE OF PARK AVENUE; THENCE ALONG THE LAST MENTIONED LINE,
NORTHERLY 129.895 FEET TO SAID SOUTHERN LINE OF PARK AVENUE; THENCE ALONG THE LAST MENTIONED LINE, EASTERLY 189.50 FEET TO THE POINT OF BEGINNING. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARCEL
TWO: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AN EASEMENT FOR INGRESS AND EGRESS OF ALL PEDESTRIAN AND VEHICULAR TRAFFIC, APPURTENANT TO AND FOR THE BENEFIT OF PARCEL ONE, ABOVE DESCRIBED, OVER,
ALONG AND ACROSS THE PARCEL OF LAND DESCRIBED AS FOLLOWS: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PORTION OF BLOCK 27, MAP OF PART OF PLOT 6 KELLERSBERGER&#146;S SURVEY OF VICENTE&nbsp;&amp;
DOMINGO PERALTA RANCHO, PROPERTY OF J.S. EMERY, FILED MARCH 01, 1889, IN BOOK 19, PAGE 68, OF MAPS, DESCRIBED AS FOLLOWS: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BEGINNING AT A POINT ON THE
EASTERN LINE OF HALLECK STREET, DISTANT THEREON 129.895 FEET SOUTHERLY FROM THE SOUTHERN LINE OF PARK AVENUE, AS SAID STREET AND AVENUE ARE SHOWN ON SAID MAP; RUNNING THENCE EASTERLY, PARALLEL WITH SAID LINE OF PARK AVENUE, 128.65 FEET; THENCE
SOUTHERLY, PARALLEL WITH SAID LINE OF HALLECK STREET, 4.925 FEET; THENCE WESTERLY, PARALLEL WITH SAID LINE OF PARK AVENUE, 128.65 FEET TO SAID </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit <FONT
STYLE="white-space:nowrap">A-2,</FONT> Page 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EASTERN LINE OF HALLECK STREET; THENCE ALONG THE LAST MENTIONED LINE, NORTHERLY 4.925 FEET TO THE POINT OF
BEGINNING. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">APN: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">049-0617-005-06</FONT></FONT></FONT>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit <FONT
STYLE="white-space:nowrap">A-2,</FONT> Page 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LANDLORD IMPROVEMENTS AND TENANT&#146;S WORK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Landlord Improvements</U>. Landlord, at Landlord&#146;s sole cost, shall remove the steam generator located in the Leased Premises and
repair any damage caused by such removal (collectively, the &#147;Landlord Improvements&#148;). Landlord shall use good faith and diligent efforts to perform the Landlord Improvements within sixty (60)&nbsp;days of the date that the PD Lease is
terminated. Notwithstanding the foregoing, the parties agree that any improvement or installation that is not referenced above shall be Tenant&#146;s responsibility and shall be part of Tenant&#146;s Work (as defined below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Tenant&#146;s Occupation of the Leased Premises During Performance of the Landlord Improvements</U>. Tenant will likely be in occupation
of the Leased Premises during the construction or performance of the Landlord Improvements. Tenant, at its sole cost, shall be responsible for moving, if applicable, any of its furniture, fixtures, and equipment required with respect to the
performance of the Landlord Improvements, and Tenant shall cooperate with Landlord in order to make the completion of the performance of the Landlord Improvements as efficient as reasonably possible. Landlord shall use commercially reasonable
efforts to minimize interference with Tenant&#146;s use and occupation of the Leased Premises during performance of the Landlord Improvements; however, Tenant understands that some noise and dust will be unavoidable, and Tenant also understands that
some portions or all of the Leased Premises must be cordoned off and cannot be used by Tenant during construction or performance of the Landlord Improvements. Landlord shall not be deemed to have evicted Tenant, nor shall there be any abatement of
Rent, nor shall Tenant be relieved from performance of any covenant on its part to be performed under the Lease by reason of the performance of the Landlord Improvements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Requirements for Work Performed by Tenant</U>. All work performed at the Building by Tenant or Tenant&#146;s contractor or
subcontractors prior to Tenant&#146;s commencing business operations (&#147;Tenant&#146;s Work&#148;) shall be subject to the following additional requirements: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such work shall not proceed until Landlord has approved in writing (which approval shall not be unreasonably
withheld, conditioned or delayed): (i) Tenant&#146;s contractor and the amount and coverage of public liability and property damage insurance, with Landlord named as an additional insured, on such liability coverage carried by Tenant&#146;s
contractor, (ii)&nbsp;complete and detailed plans and specifications for such work (among other things, Landlord may condition its approval of any improvements on Tenant&#146;s agreement to remove them prior to the Term Expiration Date, repair any
damage resulting from such removal and restore the Leased Premises to their condition existing prior to the date of the installation of such improvements), and (iii)&nbsp;a schedule for the work. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All work shall be done in conformity with a valid permit when required, a copy of which shall be furnished to
Landlord before such work is commenced. In any case, all such work shall be performed in accordance with all applicable laws. Notwithstanding any failure by Landlord to object to any such work, Landlord shall have no responsibility for Tenant&#146;s
failure to comply with applicable laws. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant shall be responsible for cleaning the Leased Premises, the Building and the Project and removing all
debris in connection with its work, except for work performed by the Landlord&#146;s contractor. All completed work shall be subject to inspection and acceptance by Landlord. Tenant shall reimburse Landlord for the actual <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost for all extra expense incurred by Landlord by reason of faulty work done by Tenant or Tenant&#146;s contractor or by reason of inadequate cleanup by Tenant
or Tenant&#146;s contractor. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tenant (and Tenant&#146;s contractors, vendors, agents, and employees) performing Tenant&#146;s Work shall not
disrupt or delay the performance of the Landlord Improvements. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT <FONT STYLE="white-space:nowrap">B-1</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BASE BUILDING UPGRADES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(previously performed by Landlord under the PD Lease; items in <I>italics</I> below were the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">responsibility of the Current Tenant and not the responsibility of Landlord.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electrical: </B><I>Tenant responsible for installing entire electrical system of 1200A at 277/480</I> (revised per Second Amendment to PD Lease). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gas: </B>1,620 MBH service serving roof top mechanical units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Plumbing: </B>Existing <FONT STYLE="white-space:nowrap">1-1/2&#148;</FONT> water service connected to bathrooms and stubbed into the Tenant space with a <FONT
STYLE="white-space:nowrap">shut-off</FONT> valve for Tenant point of connection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HVAC: </B><I>Tenant responsible for entire HVAC system</I> (revised
per First Amendment to PD Lease). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fire Sprinkler: </B>Coverage throughout the building in a standard grid<I>. Tenant shall be responsible, at its sole
cost and expense, for modifications required for Tenant Improvements</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fire Alarm: </B>Modern FACP with devices distributed throughout the space to
provide minimum coverage for warm shell turn over. <I>Tenant shall be responsible, at its sole cost and expense, for modifications required for Tenant Improvements</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bathrooms: </B>New accessible men&#146;s and women&#146;s restrooms will be provided. The new 1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>
floor Men&#146;s restroom will have 2 water closets and 2 urinals while the women&#146;s will have 3 water closets. The new 2<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP> floor restroom will be a single stall ADA restroom. All restrooms
will receive standard commercial fixtures and finishes at Landlord&#146;s discretion, which will be commensurate with the Tenant&#146;s intended use. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interior Lighting: </B>Landlord shall provide lighting inside of bathrooms, utility closets and stairs. <I>Tenant shall be responsible, at its sole cost
and expense, for all other interior lighting to suit Tenant&#146;s program</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Parking: </B>Parking lots will be resurfaced and striped. <I>Tenant
shall be responsible, at its sole cost and expense, for additional parking equipment, if desired by Tenant, in Tenant&#146;s sole and absolute discretion</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Elevator: </B>Landlord shall provide a passenger elevator and machine room adjacent to the existing stairs which will provide access to the new mezzanine
and the existing 2<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP> floor office space. The elevator specifications are as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Capacity: 3500 lbs. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Clear Car
Inside Dimensions: 6 ft. 5 9/16 inches wide x 5 ft. 6 1/8 inches deep </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cab Height: 93 inches </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Door Opening: 42 inches wide x 84 inches high </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The cab interior finishes will be at Landlord&#146;s discretion and will be commensurate with the Tenant&#146;s intended use. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit B, Page 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Floor Drains: </B>Landlord shall provide under slab waste lines in general conformance with Plumbing 1<SUP
STYLE="font-size:75%; vertical-align:top">st</SUP> Floor Plan P2.1 dated 12/20/2018. Exact location will be coordinated with Tenant but will be limited to areas that can reasonably be reached via code minimum waste line slopes. <I>Tenant shall be
responsible, at its sole cost and expense, for ejector pumps, if desired by Tenant, in Tenant&#146;s sole and absolute discretion</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mezzanine:
</B>Landlord will provide new 2<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP> Floor, aka the &#147;Mezzanine,&#148; with a steel post and cable guardrail and in the configuration shown on <B><U>Exhibit A</U></B>. The floor structure will be
designed to support a minimum of 80 lbs per square foot live load. A new enclosed stair will be added in the southeast corner of the new 2<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP> floor as shown on Tenant&#146;s Plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Roll Up Door: </B>At the east side entrance from the parking lot a new glass panel style rollup door with a separate man door will be provided. The roll up
will be approximately 6&#146; wide and the man door will be approximately 3&#146; wide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Roof Decks: </B>Landlord shall provide one fully improved roof
deck on the west side roof, consisting of approximately 1,200 rentable square feet. <I>Tenant shall be responsible, at its sole cost and expense, for furniture, planting, irrigation, and accent lighting on the roof deck, if desired by Tenant, in
Tenant&#146;s sole and absolute discretion</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Painting: </B>Landlord shall prime paint all newly constructed walls. Landlord shall remove any loose
and peeling lead paint and spot prime in those locations. <I>Tenant shall be responsible, at its sole cost and expense, for finish painting of all surfaces, if desired by Tenant, in Tenant&#146;s sole and absolute discretion</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Existing Concrete Floors: </B>Landlord shall grout patch any major spalls and trip hazards. <I>Tenant shall be responsible, at its sole cost and expense,
for floor finish, if desired by Tenant, in Tenant&#146;s sole and absolute discretion</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Concrete Floors</B>: Landlord shall provide poured in
place concrete surface with a color admixture<I>. Tenant shall be responsible, at its sole cost and expense, for floor finish, if desired by Tenant, in Tenant&#146;s sole and absolute discretion</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Existing Carpeted Floors: </B>Landlord shall remove existing carpet and underlayment. <I>Tenant shall be responsible, at its sole cost and expense, for
floor finish, if desired by Tenant, in Tenant&#146;s sole and absolute discretion</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit B, Page 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIRMATION OF TERM OF LEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Confirmation of Term of Lease is made by and between EPL HALLECK INVESTORS LLC, a California limited liability company, as Landlord, and
_______, a _____________, as Tenant, who agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Landlord and Tenant entered into a Net Lease dated _______, _______(the
&#147;<B>Lease</B>&#148;), in which Landlord leased to Tenant and Tenant leased from Landlord the Leased Premises described in the Basic Lease Information sheet of the Lease (the &#147;<B>Leased Premises</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Pursuant to Section&nbsp;3.1 of the Lease, Landlord and Tenant hereby confirm as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. The Leased Premises contains the following: (i)&nbsp;approximately [______] rentable square feet of office and R&amp;D space and
(ii)&nbsp;approximately [______] rentable square feet of a roof deck, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. _____, ______ is the Term Commencement Date (_____, ______ is
the Rent Commencement Date); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. _____, ______ is the Term Expiration Date; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. _____, ______ is the commencement date of Rent under the Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. Tenant hereby confirms that the Lease is in full force and effect and: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. It has accepted possession of the Leased Premises as provided in the Lease; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. The improvements and space required to be furnished by Landlord under the Lease have been furnished; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. Landlord has fulfilled all of its duties of an inducement nature, except as follows: _________________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. The Lease has not been modified, altered or amended, except as follows: ________________________________________________________ and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. There are no setoffs or credits against Rent and no security deposit has been paid except as expressly provided by the Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The provisions of this Confirmation of Term of Lease shall inure to the benefit of, or bind, as the case may require, the parties and their
respective successors, subject to the restrictions on assignment and subleasing contained in the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>///signature page follows///
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit C, Page 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>///continued from previous page/// </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DATED: __________________, _______ </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>&#147;LANDLORD&#148;:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EPL HALLECK INVESTORS LLC, a California limited liability company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Ellis Partners LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">a California limited liability company its Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Printed
Name:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>&#147;TENANT&#148;:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">_________________________,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">a&#8201;________________________</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Printed
Name:&#8201;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title:&#8201;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit C, Page 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BUILDING RULES AND REGULATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following rules and regulations shall apply to the Leased Premises and the Project: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Intentionally Omitted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.
Tenant, at its expense, shall be responsible for providing all door locks in the Leased Premises and shall provide to Landlord, at Tenant&#146;s expense, contemporaneously with the installation of such devices, a master key, card keys, access codes
or other means to allow Landlord immediate access to all areas within the Leased Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Landlord may prescribe weight limitations
and determine the locations for safes and other heavy equipment or items, which shall in all cases be placed in the Building so as to distribute weight in a manner reasonably acceptable to Landlord which may include the use of such supporting
devices as Landlord may require, in Landlord&#146;s commercially reasonable discretion. All damage to the Building caused by the installation or removal of any property of Tenant, or done by Tenant&#146;s property while in the Building, shall be
repaired at the expense of Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Plumbing (including outside drains and sump pumps), fixtures and appliances shall be used only for
the purposes for which designed, and no sweepings, rubbish, rags or other unsuitable material shall be thrown or deposited therein. Damage resulting to any such fixtures or appliances from misuse by Tenant or its agents, employees or invitees, shall
be paid by Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. Sidewalks, doorways, hallways, loading areas and associated overhead doors, and other similar areas shall not be
obstructed by Tenant or used by any tenant for purposes other than ingress and egress to and from their respective leased premises and for going from one to another part of the Building. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. No birds or animals (other than service animals) shall be brought into or kept in, on or about the Leased Premises. No portion of the
Leased Premises shall at any time be used or occupied as sleeping or lodging quarters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. Tenant shall not introduce, disturb or release
asbestos or PCB&#146;s into or from the Leased Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. Except for limited quantities of standard office and janitorial supplies, but
only to the extent reasonably necessary for Tenant&#146;s operations in the Leased Premises, and Hazardous Materials which may be used in a Laboratory (as defined in California Building Code Section&nbsp;201) or Business Group B occupancies (as
defined in California Building Code Section&nbsp;304), Tenant shall not (i)&nbsp;keep in the Leased Premises any flammable or explosive fluid or substance and (ii)&nbsp;install or operate any steam or gas engine or boiler, or other mechanical
apparatus in the Leased Premises without the prior written consent of Landlord. Except as set forth above, the use of oil, gas or inflammable liquids for heating, lighting or any other purpose is expressly prohibited. Explosives or other articles
deemed extra hazardous shall not be brought into the Project. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit D, Page 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. Landlord will not be responsible for lost or stolen personal property, money or jewelry
from the Leased Premises or the Project regardless of whether such loss occurs when the area is locked against entry or not. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. Tenant
shall not conduct any activity on or about the Leased Premises or the Project which will draw pickets, demonstrators, or the like. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.
All vehicles are to be currently licensed, in good operating condition, parked for business purposes having to do with Tenant&#146;s business operated in the Leased Premises, parked within designated parking spaces, one vehicle to each space. No
vehicle shall be parked as a &#147;billboard&#148; vehicle in the parking lot. Any vehicle parked improperly may be towed away. Tenant, Tenant&#146;s agents, employees, vendors and customers who do not operate or park their vehicles as required
shall subject the vehicle to being towed at the expense of the owner or driver. Tenant shall indemnify, hold and save harmless Landlord of and from any liability arising from the towing of any vehicles belonging to a party related to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. Tenant shall not park or operate any semi-trucks or semi-trailers in the parking areas associated with the Leased Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. No party shall wash and/or detail automobiles or perform automobile repair work (except in the event of an emergency) at the Project. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. Canvassing, soliciting or peddling in or about the Leased Premises or the Project is prohibited and Tenant shall cooperate to prevent
same. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. Tenant shall not permit storage outside the Leased Premises, including outside storage of trucks and other vehicles, or dumping
of waste or refuse or permit any harmful materials to be placed in any drainage system or sanitary system in or about the Leased Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. [intentionally deleted]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. Tenant shall not install or operate on the Leased Premises any machinery or mechanical devices of a nature not directly related to
Tenant&#146;s ordinary use of the Leased Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. Tenant will not permit any party related to Tenant to bring onto the Project any
handgun, firearm or other weapons of any kind or illegal drugs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. Tenant shall not permit its employees, invitees or guests to smoke in
the Building, or permit its employees, invitees or guests to loiter at the Building entrances for the purposes of smoking. Landlord may, but shall not be required to, designate an area for smoking outside the Building. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. Other than bicycles, Tenant shall not bring into (or permit to be brought into) the Building any type of vehicle. In no event may a
hoverboard or similar type of motorized device be charged in the Leased Premises or in the Project. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit D, Page 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. Tenant shall comply with all health, safety, fire protection and evacuation procedures
and regulations established by Landlord or any governmental agency, and shall take reasonable measures to assure that Tenant&#146;s employees comply with such procedures and regulations. Health procedures and regulations include, but are not limited
to, any protection measures in response to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic or other public health-related condition. Such compliance shall include promptly informing Landlord if any employee or visitor to the Leased
Premises has tested positive for <FONT STYLE="white-space:nowrap">COVID-19</FONT> or is reasonably believed to be or have been positive for <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and the date(s) of such presence at the Building and the
area(s) of the Leased Premises visited. However, Tenant shall not be required to identify such person or otherwise breach any confidentiality rights of such person. Tenant shall comply with requests by Landlord concerning the informing of their
employees of items of importance to the Landlord, including but not limited to promptly informing employees of any measure employees will be required to comply with in connection with health, safety, fire protection and evacuation procedures and
regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. Landlord reserves the right to rescind any of these rules and regulations and to make future rules and regulations
required for the safety, protection and maintenance of the Project, the operation and preservation of the good order thereof. Such rules and regulations, when made and written notice thereof given to Tenant, shall be binding as if originally
included herein. Landlord reserves the right to exclude or expel from the Project any person who, in Landlord&#146;s judgment, is under the influence of liquor or drugs, or who shall in any manner do any act in violation of any of these rules and
regulations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit D, Page 3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASBESTOS NOTIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Asbestos-containing materials (&#147;<B>ACMs</B>&#148;) were historically commonly used in the construction of commercial buildings across the
country. ACMs were commonly used because of their beneficial qualities; ACMs are fire-resistant and provide good noise and temperature insulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some common types of ACMs include surfacing materials (such as <FONT STYLE="white-space:nowrap">spray-on</FONT> fireproofing, stucco, plaster
and textured paint), flooring materials (such as vinyl floor tile and vinyl floor sheeting) and their associated mastics, carpet mastic, thermal system insulation (such as pipe or duct wrap, boiler wrap and cooling tower insulation), roofing
materials, drywall, drywall joint tape and drywall joint compound, acoustic ceiling tiles, transite board, base cove and associated mastic, caulking, window glazing and fire doors. These materials are not required under law to be removed from any
building (except prior to demolition and certain renovation projects). Moreover, ACMs generally are not thought to present a threat to human health unless they cause a release of asbestos fibers into the air, which does not typically occur unless
(1)&nbsp;the ACMs are in a deteriorated condition, or (2)&nbsp;the ACMs have been significantly disturbed (such as through abrasive cleaning, or maintenance or renovation activities). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is possible that some of the various types of ACMs noted above (or other types) are present at various locations in the Building. Anyone
who finds any such materials in the Building should assume them to contain asbestos unless those materials are properly tested and found to be otherwise. In addition, under applicable law, certain of these materials are required to be presumed to
contain asbestos in the Building because the Building was built prior to 1981 (these materials are typically referred to as &#147;<B>Presumed Asbestos Containing Materials</B>&#148; or &#147;<B>PACM</B>&#148;). PACM consists of thermal system
insulation and surfacing material found in buildings constructed prior to 1981, and asphalt or vinyl flooring installed prior to 1981. If any thermal system insulation, asphalt or vinyl flooring or surfacing materials are found to be present in the
Building, such materials must be considered PACM unless properly tested and found otherwise. In addition, Landlord has identified the presence of certain ACMs in the Building. For information about the specific types and locations of these
identified ACMs, please contact the Building manager. The Building manager maintains or can obtain records of the Building&#146;s asbestos information including any Building asbestos surveys, sampling and abatement reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the presence of ACM in the Building, we are also providing the following warning, which is commonly known as a California
Proposition 65 warning: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WARNING: This Building contains asbestos, a chemical known to the State of California to cause cancer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please contact Landlord with any questions regarding the contents of this <B><U>Exhibit E</U></B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit E, Page 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT F </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>HAZARDOUS MATERIALS QUESTIONNAIRE </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Landlord:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">EPL HALLECK INVESTORS LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tenant:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">METAGENOMI, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Leased&nbsp;Premises:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approximately 23,851 rentable square feet consisting of the entire building located at 1545 Park Avenue, Emeryville, California</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Lease:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">________________, 2021</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact Person for Hazardous Waste Materials Management and Manifests and Telephone Number(s) and Email Address(es): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">&#8195;&#8195;&#8195;&#8195;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Length of initial Term: Ten (10)&nbsp;years </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any and all capitalized terms used herein, which are not otherwise defined herein, shall have the same respective meanings ascribed to such terms in
Tenant&#146;s lease for the Leased Premises. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General Information:</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Describe the operations to take place in, on or about the Leased Premises, including, without limitation, principal products processed,
manufactured or assembled services and activities to be provided or otherwise conducted. If this Questionnaire is an update delivered by an existing tenant, tenant should describe any proposed changes to
<FONT STYLE="white-space:nowrap">on-going</FONT> operations. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">&#8195;&#8195;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">&#8195;&#8195;&#8195;&#8195;</FONT></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Use, Storage and Disposal of Hazardous Materials</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">2.1 Will any Hazardous Materials be used, generated, stored or disposed of in, on or about the Leased Premises? Existing tenants should
describe any Hazardous Materials which continue to be used, generated, stored or disposed of in, on or about the Leased Premises. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Wastes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Yes &#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No &#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chemical Products</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Yes &#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No &#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Yes &#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No &#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit F, Page 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If Yes is marked, please
explain:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">2.2 If Yes is marked in Section&nbsp;2.1, attach a list of any Hazardous Materials to be used, generated,
stored or disposed of in, on or about the Leased Premises, including the applicable hazard class and an estimate of the quantities of such Hazardous Materials at any given time; estimated annual throughput; the proposed location(s) and method of
storage (excluding nominal amounts of ordinary household cleaners and janitorial supplies which are not regulated by any Environmental Laws); and the proposed location(s) and method of disposal for each Hazardous Material, including, the estimated
frequency, and the proposed contractors or subcontractors. Existing tenants should attach a list setting forth the information requested above and such list should include actual data from <FONT STYLE="white-space:nowrap">on-going</FONT> operations
and the identification of any variations in such information from the prior year&#146;s certificate. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Storage Tanks and Sumps </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">3.1 Is any above or below ground storage of gasoline, diesel, petroleum, or other Hazardous Materials in tanks or sumps proposed in, on or
about the Leased Premises? Existing tenants should describe any such actual or proposed activities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No
&#9744; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If Yes, please
explain:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Waste Management </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">4.1 Has your company been issued an EPA Hazardous Waste Generator I.D. Number? Existing tenants should describe any additional identification
numbers issued since the previous certificate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No &#9744; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If Yes, provide the
number(s):<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">4.2 Has your company filed a biennial or quarterly reports as a hazardous waste generator? Existing tenants
should describe any new reports filed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No &#9744; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If Yes, attach a copy of the most recent report filed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit F, Page 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>5<B>.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Wastewater Treatment and Discharge </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">5.1 Will your company discharge wastewater or other wastes to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">________ storm drain?</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">________ sewer?</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">________ surface water?</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">________ no wastewater or other wastes discharged.</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Existing tenants should indicate any actual discharges. If so, describe the nature of any proposed or actual
discharge(s). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">5.2 Will any such wastewater or waste be treated before discharge? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No &#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If Yes, describe the type of treatment proposed to be conducted. Existing tenants should describe the actual treatment conducted. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Air Discharges </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">6.1 Do you plan for any air filtration systems or stacks to be used in your company&#146;s operations in, on or about the Leased Premises that
will discharge into the air; and will such air emissions be monitored? Existing tenants should indicate whether or not there are any such air filtration systems or stacks in use in, on or about the Leased Premises which discharge into the air and
whether such air emissions are being monitored. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No &#9744; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If Yes, please describe
:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">6.2 Do you propose to operate any of the following types of equipment, or any other equipment requiring an air
emissions permit? Existing tenants should specify any such equipment being operated in, on or about the Leased Premises. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">______ Spray booth(s)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">________ Incinerator(s)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">______ Dip tank(s)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">________ Other (please describe)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">______ Drying oven(s)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">________ No equipment requiring air permits</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If Yes, please describe
:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit F, Page 3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Hazardous Materials Disclosures </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">7.1 Has your company prepared or will it be required to prepare a Hazardous Materials management plan (&#147;Management Plan&#148;) pursuant to
Fire Department or other governmental or regulatory agencies&#146; requirements? Existing tenants should indicate whether or not a Management Plan is required and has been prepared. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No &#9744; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If Yes, attach a copy of the Management Plan. Existing tenants should attach a copy of any required updates to
the Management Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">7.2 Are any of the Hazardous Materials, and in particular chemicals, proposed to be used in your operations, in on or
about the Leased Premises regulated under Proposition 65? Existing tenants should indicate whether or not there are any new Hazardous Materials being so used which are regulated under Proposition 65. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No &#9744; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8194;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If Yes, please
explain:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Enforcement Actions and Complaints </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">8.1 With respect to Hazardous Materials or Environmental Laws, has your company ever been subject to any agency enforcement actions,
administrative orders, or consent decrees or has your company received requests for information, notice or demand letters, or any other inquiries regarding its operations? Existing tenants should indicate whether or not any such actions, orders or
decrees have been, or are in the process of being, undertaken or if any such requests have been received. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744;
&#8195;&#8195;&#8195;No &#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If Yes, describe the actions, orders or decrees and any continuing compliance obligations imposed as a
result of these actions, orders or decrees and also describe any requests, notices or demands, and attach a copy of all such documents. Existing tenants should describe and attach a copy of any new actions, orders, decrees, requests, notices or
demands not already delivered to Landlord. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit F, Page 4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">8.2 Have there ever been, or are there now pending, any lawsuits against your company
regarding any environmental or health and safety concerns? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No &#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If Yes, describe any such lawsuits and attach copies of the complaint(s), cross-complaint(s), pleadings and all other documents related thereto
as requested by Landlord. Existing tenants should describe and attach a copy of any new complaint(s), cross-complaint(s), pleadings and other related documents not already delivered to Landlord. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">8.3 Have there been any problems or complaints from adjacent tenants, owners or other neighbors at your
company&#146;s current facility(ies) with regard to environmental or health and safety concerns? Existing tenants should indicate whether or not there have been any such problems or complaints from adjacent tenants, owners or other neighbors at,
about or near the Leased Premises. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Yes &#9744; &#8195;&#8195;&#8195;No &#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If Yes, please describe. Existing tenants should describe any such problems or complaints not already disclosed to Landlord under the
provisions of the Lease. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Permits and Licenses</B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">9.1 Attach copies of all Hazardous Materials permits and licenses including a Transporter Permit number issued to your company with respect to
its proposed operations in, on or about the Leased Premises, including, without limitation, any wastewater discharge permits, air emissions permits, and use permits or approvals. Existing tenants should attach copies of any new permits and licenses
as well as any renewals of permits or licenses previously issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[SIGNATURE PAGE FOLLOWS] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit F, Page 5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned hereby acknowledges and agrees that (A)&nbsp;this Hazardous Materials Questionnaire is being
delivered to Landlord in accordance with, and as required by, the provisions of Section&nbsp;6.1(a) of the Lease and (B)&nbsp;that Tenant shall have and retain full and complete responsibility and liability with respect to any of the Hazardous
Materials disclosed in this Questionnaire notwithstanding Landlord&#146;s/Tenant&#146;s receipt and/or approval of this Questionnaire. Tenant further agrees that none of the following described acts or events shall be construed or otherwise
interpreted as either (a)&nbsp;excusing, diminishing or otherwise limiting Tenant from the requirement to fully and faithfully perform its obligations under the Lease with respect to Hazardous Materials, including, without limitation, as set forth
in this Lease, Tenant&#146;s indemnification of Landlord and compliance with all Governmental Requirements, or (b)&nbsp;imposing upon Landlord any duty or liability with respect to any such Hazardous Materials, including, without limitation, any
duty on Landlord to investigate or otherwise verify the accuracy of the representations and statements made therein or to ensure that Tenant is in compliance with all Governmental Requirements: (i)&nbsp;the delivery of such Questionnaire to Landlord
and/or Landlord&#146;s acceptance of such Questionnaire, (ii)&nbsp;Landlord&#146;s review and approval of such Questionnaire, (iii)&nbsp;Landlord&#146;s failure to obtain such Questionnaire from Tenant at any time, or (iv)&nbsp;Landlord&#146;s
actual or constructive knowledge of the types and quantities of Hazardous Materials being used, stored, generated, disposed of or transported on or about the Leased Premises by Tenant or Tenant&#146;s representatives. Notwithstanding the foregoing
or anything to the contrary contained herein, the undersigned acknowledges and agrees that Landlord and its partners, lenders, agents and representatives may, and will, rely upon the statements, representations, warranties and certifications made
herein and the truthfulness thereof in entering into the Lease and the continuance thereof throughout the Term of the Lease, and any renewals thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I,
(<I>print name</I>) _________________________, acting with full authority to bind Tenant and on behalf of Tenant, hereby certify, represent and warrant that the information contained in this Questionnaire is true and correct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tenant: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">METAGENOMI, INC., </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a Delaware corporation </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="70%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Printed&nbsp;Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U>, 20___</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit F, Page 6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 1.20 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FORM OF LETTER OF CREDIT </U></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.20, Page 1
</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>L/C DRAFT LANGUAGE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IRREVOCABLE STANDBY LETTER OF CREDIT NUMBER ____________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISSUE
DATE: __________________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISSUING BANK: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SILICON VALLEY BANK
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3003 TASMAN DRIVE </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2ND FLOOR, MAIL SORT HF210 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SANTA CLARA, CALIFORNIA 95054 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BENEFICIARY: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EPL HALLECK INVESTORS LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C/O ELLIS PARTNERS LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">111 SUTTER STREET, SUITE 800 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SAN FRANCISCO CA 94104 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ATTN: JAMES F. ELLIS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EMAIL: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PHONE: &#8195;&#8195;&#8195;&#8195;&#8195;&#8195;APPLICANT: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">APPLICANT: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">METAGENOMI, INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 HORTON STREET SUITE 600 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EMERYVILLE CA 94608 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AMOUNT:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">US$3,300,000.00 (THREE MILLION THREE HUNDRED THOUSAND AND 00/100 U.S. DOLLARS)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXPIRATION DATE:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">SVB WILL PUT A SPECIFIC DATE HERE THAT&#146;S 1 YEAR ISSUANCE HERE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PLACE OF EXPIRATION:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">ISSUING BANK&#146;S COUNTERS AT ITS ABOVE ADDRESS</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DEAR SIR/MADAM: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AT THE REQUEST
AND FOR THE ACCOUNT OF METAGENOMI, INC. (&#147;APPLICANT&#148;), WE HEREBY ESTABLISH OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVBSF IN YOUR FAVOR AVAILABLE BY PAYMENT AGAINST YOUR PRESENTATION TO US OF THE FOLLOWING DOCUMENT: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF
CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATURE</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DATE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. BENEFICIARY&#146;S SIGNED AND DATED STATEMENT STATING AS FOLLOWS: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;AN EVENT OF DEFAULT (AS DEFINED IN THE LEASE) HAS OCCURRED UNDER THAT CERTAIN LEASE AGREEMENT BETWEEN METAGENOMI, INC., AS TENANT, AND EPL HALLECK
INVESTORS LLC, AS LANDLORD, AS AMENDED, SUPPLEMENTED OR OTHERWISE MODIFIED TO DATE. THE UNDERSIGNED HEREBY CERTIFIES THAT: (I)&nbsp;THE UNDERSIGNED IS AN AUTHORIZED REPRESENTATIVE OF LANDLORD; (II)&nbsp;LANDLORD IS THE BENEFICIARY OF LETTER OF
CREDIT NO. SVBSF _____________ ISSUED BY SILICON VALLEY BANK; (III)&nbsp;LANDLORD HAS GIVEN WRITTEN NOTICE TO TENANT (IF REQUIRED UNDER THE LEASE) TO CURE THE DEFAULT PURSUANT TO THE TERMS OF THE LEASE; (IV)&nbsp;SUCH DEFAULT HAS NOT BEEN CURED UP
TO THIS DATE OF DRAWING UNDER THE LETTER OF CREDIT; (V)&nbsp;LANDLORD IS AUTHORIZED TO DRAW DOWN ON THE LETTER OF CREDIT; AND (VI)&nbsp;LANDLORD WILL HOLD THE FUNDS DRAWN UNDER THE LETTER OF CREDIT AS SECURITY DEPOSIT FOR TENANT OR APPLY SAID FUNDS
TO TENANT&#146;S OBLIGATION UNDER THE LEASE. THE AMOUNT HEREBY DRAWN UNDER THE LETTER OF CREDIT IS US$ ______________, WITH PAYMENT TO BE MADE TO THE FOLLOWING ACCOUNT: [INSERT WIRE INSTRUCTIONS (TO INCLUDE NAME AND ACCOUNT NUMBER OF THE
BENEFICIARY)].&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARTIAL DRAWS AND MULTIPLE PRESENTATIONS ARE ALLOWED. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS LETTER OF CREDIT SHALL BE AUTOMATICALLY EXTENDED FOR ADDITIONAL PERIODS OF ONE YEAR, WITHOUT AMENDMENT, FROM THE PRESENT OR EACH FUTURE EXPIRATION DATE
UNLESS AT LEAST SIXTY (60)&nbsp;DAYS PRIOR TO THE THEN CURRENT EXPIRATION DATE WE SEND TO YOU A NOTICE BY REGISTERED OR CERTIFIED MAIL OR OVERNIGHT COURIER SERVICE AT THE ABOVE ADDRESS (OR ANY OTHER ADDRESS INDICATED BY YOU, IN A WRITTEN NOTICE TO
US THE RECEIPT OF WHICH WE HAVE ACKNOWLEDGED, AS THE ADDRESS TO WHICH WE SHOULD SEND SUCH NOTICE) THAT THIS LETTER OF CREDIT WILL NOT BE EXTENDED BEYOND THE THEN CURRENT EXPIRATION DATE. IN NO EVENT SHALL THIS LETTER OF CREDIT BE AUTOMATICALLY
EXTENDED BEYOND MARCH&nbsp;31, 2031. IN THE EVENT WE SEND SUCH NOTICE OF <FONT STYLE="white-space:nowrap">NON-EXTENSION,</FONT> YOU MAY DRAW HEREUNDER BY YOUR PRESENTATION TO US OF YOUR SIGNED AND DATED STATEMENT STATING THAT YOU HAVE RECEIVED A <FONT
STYLE="white-space:nowrap">NON-EXTENSION</FONT> NOTICE FROM SILICON VALLEY BANK IN RESPECT OF LETTER OF CREDIT NO. SVBSF ______________, YOU ARE DRAWING ON SUCH LETTER OF CREDIT FOR US$ _____________, AND YOU HAVE NOT RECEIVED A REPLACEMENT LETTER
OF CREDIT ACCEPTABLE TO YOU. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL DEMANDS FOR PAYMENT SHALL BE MADE BY PRESENTATION OF THE REQUIRED DOCUMENTS ON A BUSINESS DAY AT OUR OFFICE (THE
&#147;BANK&#146;S OFFICE&#148;) AT: SILICON VALLEY BANK, 3003 TASMAN DRIVE, MAIL SORT HF 210, SANTA CLARA, CA 95054, ATTENTION: GLOBAL TRADE FINANCE. AS USED IN THIS LETTER OF CREDIT, &#147;BUSINESS DAY&#148; SHALL MEAN ANY DAY OTHER THAN A
SATURDAY, SUNDAY OR A DAY ON WHICH BANKING INSTITUTIONS IN THE STATE OF CALIFORNIA ARE AUTHORIZED OR REQUIRED BY LAW TO CLOSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL THE DETAILS SET FORTH
HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL
PREVAIL. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATURE</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DATE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FACSIMILE PRESENTATIONS ARE ALSO PERMITTED. EACH FACSIMILE TRANSMISSION SHALL BE MADE AT: (408) <FONT
STYLE="white-space:nowrap">496-2418</FONT> OR (408) <FONT STYLE="white-space:nowrap">969-6510;</FONT> AND UNDER CONTEMPORANEOUS TELEPHONE ADVICE TO: (408) <FONT STYLE="white-space:nowrap">450-5001</FONT> OR (408)
<FONT STYLE="white-space:nowrap">654-7176,</FONT> ATTENTION: GLOBAL TRADE FINANCE. ABSENCE OF THE AFORESAID TELEPHONE ADVICE SHALL NOT AFFECT OUR OBLIGATION TO HONOR ANY DRAW REQUEST. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS LETTER OF CREDIT IS TRANSFERABLE IN WHOLE BUT NOT IN PART ONE OR MORE TIMES, BUT IN EACH INSTANCE ONLY TO A SINGLE BENEFICIARY AS TRANSFEREE AND FOR THE
THEN AVAILABLE AMOUNT, ASSUMING SUCH TRANSFER TO SUCH TRANSFEREE WOULD BE IN COMPLIANCE WITH THEN APPLICABLE LAW AND REGULATION, INCLUDING BUT NOT LIMITED TO THE REGULATIONS OF THE U.S. DEPARTMENT OF TREASURY AND U.S. DEPARTMENT OF COMMERCE. AT THE
TIME OF TRANSFER, THE ORIGINAL LETTER OF CREDIT AND ORIGINALS OR COPIES OF ALL AMENDMENTS, IF ANY, TO THIS LETTER OF CREDIT MUST BE SURRENDERED TO US AT OUR ADDRESS INDICATED IN THIS LETTER OF CREDIT TOGETHER WITH OUR TRANSFER FORM ATTACHED HERETO
AS EXHIBIT A DULY EXECUTED. APPLICANT SHALL PAY OUR TRANSFER FEE OF <SUP STYLE="vertical-align:top">1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">4</SUB> OF 1% OF THE TRANSFER AMOUNT (MINIMUM US$250.00) UNDER THIS LETTER OF CREDIT. EACH TRANSFER
SHALL BE EVIDENCED BY EITHER (1)&nbsp;OUR ENDORSEMENT ON THE REVERSE OF THE LETTER OF CREDIT AND WE SHALL FORWARD THE ORIGINAL OF THE LETTER OF CREDIT SO ENDORSED TO THE TRANSFEREE OR (2)&nbsp;OUR ISSUING A REPLACEMENT LETTER OF CREDIT TO THE
TRANSFEREE ON SUBSTANTIALLY THE SAME TERMS AND CONDITIONS AS THE TRANSFERRED LETTER OF CREDIT (IN WHICH EVENT THE TRANSFERRED LETTER OF CREDIT SHALL HAVE NO FURTHER EFFECT). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IF ANY INSTRUCTIONS ACCOMPANYING A DRAWING UNDER THIS LETTER OF CREDIT REQUEST THAT PAYMENT IS TO BE MADE BY TRANSFER TO YOUR ACCOUNT WITH ANOTHER BANK, WE
WILL ONLY EFFECT SUCH PAYMENT BY FED WIRE TO A U.S. REGULATED BANK, AND WE AND/OR SUCH OTHER BANK MAY RELY ON AN ACCOUNT NUMBER SPECIFIED IN SUCH INSTRUCTIONS EVEN IF THE NUMBER IDENTIFIES A PERSON OR ENTITY DIFFERENT FROM THE INTENDED PAYEE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS LETTER OF CREDIT IS SUBJECT TO THE INTERNATIONAL STANDBY PRACTICES (ISP98), INTERNATIONAL CHAMBER OF COMMERCE, PUBLICATION NO. 590. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF
CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATURE</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DATE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AUTHORIZED
SIGNATURE</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AUTHORIZED&nbsp;SIGNATURE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN
THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATURE</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DATE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IRREVOCABLE STANDBY LETTER OF CREDIT NUMBER ____________________ </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF
TRANSFER FORM </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATE:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="67%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TO: SILICON VALLEY BANK</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3003 TASMAN DRIVE</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SANTA CLARA, CA 95054</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ATTN: GLOBAL TRADE FINANCE</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">STANDBY LETTERS OF CREDIT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RE: IRREVOCABLE STANDBY LETTER OF CREDIT</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NO.
____________ ISSUED BY</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SILICON VALLEY BANK, SANTA CLARA</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">L/C
AMOUNT: _________________</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GENTLEMEN: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED,
THE UNDERSIGNED BENEFICIARY HEREBY IRREVOCABLY TRANSFERS TO: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(NAME OF TRANSFEREE) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ADDRESS) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY TO DRAW UNDER THE ABOVE LETTER OF CREDIT UP TO ITS AVAILABLE AMOUNT AS SHOWN ABOVE AS OF THE DATE OF THIS TRANSFER.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BY THIS TRANSFER, ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY IN SUCH LETTER OF CREDIT ARE TRANSFERRED TO THE TRANSFEREE. TRANSFEREE SHALL HAVE THE SOLE
RIGHTS AS BENEFICIARY THEREOF, INCLUDING SOLE RIGHTS RELATING TO ANY AMENDMENTS, WHETHER INCREASES OR EXTENSIONS OR OTHER AMENDMENTS, AND WHETHER NOW EXISTING OR HEREAFTER MADE. ALL AMENDMENTS ARE TO BE ADVISED DIRECTLY TO THE TRANSFEREE WITHOUT
NECESSITY OF ANY CONSENT OF OR NOTICE TO THE UNDERSIGNED BENEFICIARY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY
APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATURE</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DATE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE ORIGINAL OF SUCH LETTER OF CREDIT IS RETURNED HEREWITH, AND WE ASK YOU TO EITHER (1)&nbsp;ENDORSE THE
TRANSFER ON THE REVERSE THEREOF, AND FORWARD IT DIRECTLY TO THE TRANSFEREE WITH YOUR CUSTOMARY NOTICE OF TRANSFER, OR (2)&nbsp;ISSUE A REPLACEMENT LETTER OF CREDIT TO THE TRANSFEREE ON SUBSTANTIALLY THE SAME TERMS AND CONDITIONS AS THE TRANSFERRED
LETTER OF CREDIT (IN WHICH EVENT THE TRANSFERRED LETTER OF CREDIT SHALL HAVE NO FURTHER EFFECT). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SINCERELY,</P> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(BENEFICIARY&#146;S NAME)</P> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(SIGNATURE OF BENEFICIARY)</P> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(NAME AND TITLE)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE AUTHENTICATED</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The name(s), title(s), and signature(s) conform to that/those on file with us for the company and the signature(s) is/are authorized to execute this
instrument.</P> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Name of Bank)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Address of Bank)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(City, State, ZIP Code)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Authorized Name and Title)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Authorized Signature)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Telephone number)</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN
THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">AUTHORIZED SIGNATURE</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DATE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 2.20 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>LIST OF PUNCHLIST ITEMS </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(to be completed by the Current Tenant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1545 Park - Perfect Day Punch List 12/16/2020 Completion Due Date ASAP </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Item</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Floor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Location</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Action Required</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Responsible</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Complete</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Notes</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Future <I>Analytics Robotics room</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial and final clean up</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Bike Storage rm. #2</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Adjust sprinkler heads</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lyons</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Bike Storage rm. 109</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Final janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">31</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>IT Closet/MPOE 111</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">37</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>IT Cioset/MPOE 111</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Patch/paint penetrations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rossi/Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">40</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Electrical Room 112</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Final janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">48</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Main Corridor 101</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">53</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Main Restrooms</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint touch up</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Proforma nee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">57</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Stairwell ill</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rework black base at second floor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">East Bay Floor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">In progress</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">58</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Stairwell ill</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Install rubber base</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">East Bay Floor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">61</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Hallway 108 (adjacent to main restrooms)</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">73</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Lobby 105</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">82</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Hallway (elevator)</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">85</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Cold Room/Pre Fab Components 130</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">91</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Powder Lab 133</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">97</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Gel Lab 1.132</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">104</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Spray Dry Lab 131</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">108</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Future Storage 134A</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">112</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Warehouse</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">117</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Shop </I>134B<I></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">124</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Pallet Storage 134</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">128</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Ramp 121</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">131</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>HPLC139</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">139</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>FPLCLabl41</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">141</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>FPLCLabl41</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Installdoorand hardware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Pacifc Door</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">yes -</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hardware - needs lock GRE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">143</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Analytics Equipment room 140</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint touch up</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Proforma nee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">144</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Analytics Equipment room 140</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Door hardware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Pacifc Door</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">yes -</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Needs lock GRE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">145</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Analytics Equipment room 140</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">150</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Analytics Lab 141</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">158</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Ferm Wet Lab 137</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">168</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Ferm&nbsp;&amp; DSP Equipment room 143</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">171</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>DSP</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Complete all MEP installs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><STRIKE>Western Allied/Mclure</STRIKE>/Bellanti</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">yes-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">sink stainer&#151;Bellanti 12/16</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">173</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>DSP</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">178</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>DSP Lab</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">183</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Ferm Equipment room 028</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">188</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Ferm Tank Lab 136</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">191</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Stairwell#2</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NIC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 2.20, Page 1
</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Item</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Floor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Location</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Action Required</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Responsible</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Complete</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Notes</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">194</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Future Pilot Plant 135</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">209</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Trash Room 122</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">217</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I></I>Multi-Purpose room 203<I></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Open box above door: to blank</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">JCI</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">In progress</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">228</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Break room 205</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Stain column/door jamb</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><STRIKE>Proformance</STRIKE> Rossi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">236</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Kitchen</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Trim sink/ disposal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bellanti</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Disposal after inspection final</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">285</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>IT room 219</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">288</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Open Staging</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Base</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">East Bay Floor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">yes-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Needs paint</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">291</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Engineering 210 and hallway to roof</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint touch up</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Proformance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">306</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Equipment room 211</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint touch up at duct work</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Proforma nee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">X</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">312</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Equipment room 211</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><STRIKE>Emergency signag</STRIKE>e <STRIKE>above door</STRIKE></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><STRIKE>JP Digital</STRIKE></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">314</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Incubation room 212</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Janitorial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">316</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Incubation room 212</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint touch up - steel beam</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Proformance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">318</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Incubation room 212</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><STRIKE>Exit sign</STRIKE>a<STRIKE>ge above door</STRIKE></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><STRIKE>JP Digital</STRIKE></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">319</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Incubation room 212</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Open Penetration at wall (East elevation)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Giampolini</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">yes-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Needs paint</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">323</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Incubation room 212</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Damage at demising wall</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Core</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Core?</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">324</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Incubation room 212</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint touch up at trusses where seismic wires were removed by landlord</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Proformance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">330</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>BSC Lab 213</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint sprinkler</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">| Proforma nee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">BSC-Lab-213</FONT></FONT></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><STRIKE>Exit sign</STRIKE></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">341</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>GELS Lab 214</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint touch up</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">| Proforma nee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">357</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Future Robotics Area 217</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paint touch up at walls and celling</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">|Proformance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">359</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Future Robotics Area 217</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Missing bolts at truss system</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Proformance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 2.20, Page 2
</P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>6
<FILENAME>d425213dex1010.htm
<DESCRIPTION>EX-10.10
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.10</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.10 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SUBLEASE </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BASIC
SUBLEASE INFORMATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Effective Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">November&nbsp;11, 2022</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Sublandlord:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zymergen Inc.,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Sublandlord&#146;s Address For Notice:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zymergen Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5300 Chiron Way</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: Chief Financial Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>With a Copy To:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zymergen Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5300 Chiron Way</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: Chief Legal Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Sublandlord&#146;s Address For Payment of Rent:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>ACH / EFT Payments</U>:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bank Name: Silicon
Valley Bank</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address: 3003 Tasman Drive, Santa Clara, CA 95054</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Account Name: Zymergen Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Account Number: 3300931746</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SWIFT: SVBKUS6S</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">ABA: 121140399</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Subtenant:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Metagenomi, Inc.,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Subtenant&#146;s Address For Notice and Tenant&#146;s Representative:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1545 Park Avenue</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: VP of Legal</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone:</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Fax:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Project:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Emeryville Station West</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Master Landlord:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EmeryStation West, LLC,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a California limited
liability company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Building:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The building within the Project with a common address of 5959 Horton Street, Emeryville, California 94608</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Building Address:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Street:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5959 Horton Street</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>City and State:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Emeryville, California 94608</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Master Tenant:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Dynavax Technologies Corporation, a Delaware corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Subleased Premises:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approximately seventy-five thousand six hundred <FONT STYLE="white-space:nowrap">sixty-two</FONT> (75,662) rentable square feet located within the Building, comprising the entirety of the 6<B><SUP
STYLE="font-size:75%; vertical-align:top">th</SUP></B><B> </B>and 7<B><SUP STYLE="font-size:75%; vertical-align:top">th</SUP></B><B> </B>floors of the Building, as generally shown in <B>Exhibit A</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Subleased Premises Address:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Street:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5959 Horton Street</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>City and State:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, California 94608</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">6<B><SUP
STYLE="font-size:75%; vertical-align:top">th</SUP></B><B> </B>and 7<B><SUP STYLE="font-size:75%; vertical-align:top">th</SUP></B><B> </B>Floor</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Commencement Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The later to occur of: (a)&nbsp;January&nbsp;1, 2023, and (b)&nbsp;the date that the Sublease Contingency is satisfied, subject to Section&nbsp;2 below.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Expiration Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March&nbsp;31, 2031</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Sublease Term:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A period of approximately ninety-nine (99)&nbsp;months beginning on the Commencement Date and ending on the Expiration Date.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Base Rent:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">From:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">To:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Base Rent (per month)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 1st Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$238,335.30</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1st Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 19 Month Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$246,677.04</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">19 Month Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 2<B><SUP STYLE="font-size:75%; vertical-align:top">nd </SUP></B>Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$493,354.07</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2nd Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 3rd Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$510,621.46</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3rd Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 4th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$528,493.21</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 5th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$546,990.47</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 6th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$566,135.14</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 7th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$585,949.87</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">7th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Day Prior to 8th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$606,458.12</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">8th Anniversary of Commencement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Expiration Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$627,684.15</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Base Rent Abatement:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">One half (50%) of the Base Rent for the first full eighteen (18)&nbsp;months following the Commencement Date shall be abated as reflected in the above table.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Subtenant&#146;s Share:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">Building: 28.94%</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Letter of Credit:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">One Million Nine Hundred Seventy-Three Thousand Four Hundred Sixteen and 28/100 Dollars ($1,973,416.28).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Sublandlord&#146;s Broker:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bill Benton, Newmark</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Subtenant&#146;s Broker:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Timothy Mason of Kidder Mathews and Eric Bluestein of Newmark</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Permitted Use:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Office, research and development and laboratory use, in each case, to the extent permitted and subject to Section&nbsp;5 below.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EXHIBITS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">A.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Outline of Subleased Premises</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">B.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Master Lease (Zymergen Sublease and Original Master Lease)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">C.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Sublease Commencement Memorandum</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Zymergen FF&amp;E</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">E.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Environmental Questionnaire</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">F.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Removable Dynavax FF&amp;E</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">G.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Letter of Credit</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Master Landlord, as landlord, and Master Tenant, as tenant, are parties to that certain Office/Laboratory Lease dated as of
September&nbsp;17, 2018 (the &#147;<B>Original Master Lease</B>&#148;), pursuant to which Master Landlord leases to Master Tenant the Subleased Premises. A copy of the Original Master Lease is attached to this Sublease as <B>Exhibit B</B>, attached
as Exhibit E to the Zymergen Sublease, as defined below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Master Tenant, as sublandlord, and Sublandlord, as subtenant,
are parties to that certain Sublease dated as of July&nbsp;12, 2019 (the &#147;<B>Zymergen Sublease</B>&#148;), pursuant to which Master Tenant subleases to Sublandlord the Subleased Premises. A copy of the Zymergen Sublease is attached to this
Sublease as <B>Exhibit B</B>. The Zymergen Sublease, collectively with the Original Master Lease, the &#147;<B>Master Lease</B>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the parties hereto desire that Sublandlord sublet to Subtenant, and Subtenant sublet from Sublandlord the Subleased Premises
on all of the terms and conditions of this Sublease. Capitalized terms used herein shall have the meanings given such terms in the Master Lease, unless otherwise defined herein or within the Basic Sublease Information. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW,
THEREFORE</B>, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.
<B>Sublease</B>. Sublandlord does hereby sublet to Subtenant and Subtenant does hereby sublet from Sublandlord the Subleased Premises, subject to the terms, provisions, and conditions of this Sublease. Subtenant hereby acknowledges the rentable
square footage of the Subleased Premises set forth above in the Basic Sublease Information, and Subtenant accepts and agrees that, for all purposes in this Sublease, such amount is not approximate and agrees to be bound by such figure.
Notwithstanding the foregoing, in the event the Master Lease provides the right to Master Landlord to remeasure and/or otherwise modify the rentable square footage of the Subleased Premises, the parties agree that the rentable square footage of the
Subleased Premises may be modified to reflect such adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <B>Sublease Contingency; Sublease Term</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <B>Sublease Contingency</B>. Sublandlord and Subtenant expressly acknowledge and agree that this Sublease is subject to the following
contingency (the &#147;<B>Sublease Contingency</B>&#148;): Master Landlord&#146;s and Master Tenant&#146;s prior written consents to this Sublease, in forms provided by Master Landlord and Master Tenant and reasonably acceptable to Sublandlord and
Subtenant (collectively, the &#147;<B>Master Landlord&#146;s Consent</B>&#148;). Subtenant agrees to cooperate in all reasonable respects in connection with obtaining the Master Landlord&#146;s Consent. If Sublandlord, despite the parties&#146; good
faith efforts, fails to obtain the Master Landlord&#146;s Consent within forty-five&nbsp;(45) days after the Effective Date, then either Sublandlord or Subtenant may terminate this Sublease by giving written notice thereof to the other at any time
prior to receipt of the Master Landlord&#146;s Consent. If either party terminates this Sublease pursuant to the immediately preceding sentence, then notwithstanding anything to the contrary set forth herein, this Sublease shall be null and void, of
no force or effect, and Sublandlord shall within thirty (30)&nbsp;days after notice of termination is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
given, return to Subtenant the Prepayment (defined in Section&nbsp;4 below), and/or Letter of Credit (defined in Section&nbsp;19 below) to the extent actually delivered by Subtenant to
Sublandlord. The return of such sums paid by Subtenant shall be Subtenant&#146;s sole and exclusive remedy in the event of a termination pursuant to this Section&nbsp;2(a). Furthermore, neither party shall have any liability to the other for any
termination or cancellation of this Sublease if Master Landlord&#146;s Consent is not obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <B>Sublease Term</B>. The Sublease
Term shall commence on the Commencement Date and shall continue in full force and effect for the period of time specified as the Sublease Term in the Basic Sublease Information; provided, however, that in no event shall the Sublease Term extend
beyond the term of the Master Lease. Sublandlord and Subtenant shall complete and execute a &#147;<B>Sublease Commencement Memorandum</B>&#148; substantially in the form attached hereto as <B>Exhibit C</B>, confirming, among other things, the
Commencement Date for the Sublease. Failure to execute and deliver such Sublease Commencement Memorandum, however, shall not affect the Commencement Date or Subtenant&#146;s liability hereunder. Subtenant shall have no right whatsoever pursuant to
this Sublease to extend the Sublease Term for any portion of the Subleased Premises, and Subtenant acknowledges and agrees that this Sublease does not incorporate by reference or include any right of Sublandlord in the Master Lease to extend the
term of the Master Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <B>Early Access</B>. Following forty-eight (48)&nbsp;hours&#146; notice to Sublandlord (via email
to&#8195;&#8195;&#8195;&#8195;), Sublandlord shall permit Subtenant and its agents to enter the portions of the Premises not designated as &#147;Laboratory&#148; on Exhibit A (&#147;<B>Office Premises</B>&#148;) beginning on December&nbsp;12, 2022
(&#147;<B>Early Access Period</B>&#148;) for the purpose of touring working groups, space planning, delivery and storage of equipment/instruments, and related purposes; provided, however, that (i)&nbsp;in no event shall such early access, regardless
of when provided, extend or otherwise affect the Commencement Date; and (ii)&nbsp;Subtenant&#146;s access does not unreasonably interfere with any of Sublandlord&#146;s activities within the Premises. Subtenant shall be liable for any damages caused
by Subtenant&#146;s activities at the Premises. The entry shall be deemed to be under all of the provisions of this Sublease except as expressly set forth in this subsection 2(c). During the Early Access Period, Tenant shall have no obligation to
pay Rent. The parties acknowledge that the laboratory portion of the Premises are scheduled to be decommissioned on or about December&nbsp;31, 2022. To the extent such decommissioning occurs prior to such time, Sublandlord shall provide Subtenant
early access to the laboratory portion of the Premises under the same conditions as the Office Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <B>Delivery and Condition</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <B><FONT STYLE="white-space:nowrap">As-Is</FONT></B>. Subtenant shall sublet the Subleased Premises in its &#147;AS IS, WHERE IS, WITH ALL
FAULTS&#148; condition; subject to any express representations and warranties herein, and provided, however, the Subleased Premises shall be in broom clean condition with Sublandlord&#146;s furniture, fixtures and equipment (&#147;<B>Zymergen
FF&amp;E</B>&#148;) remaining. Such Zymergen FF&amp;E is generally described on <B>Exhibit D</B>, attached hereto and incorporated by reference, which the parties acknowledge is not an itemized or absolute description and will be used by the parties
only as a guide. Any such Zymergen FF&amp;E shall be sold to Subtenant by Sublandlord in its &#147;AS IS, WHERE IS, WITH ALL FAULTS&#148; condition upon the Commencement Date for a purchase price of $1.00, pursuant to a bill of sale to be signed by
both parties. Prior to the Commencement Date, all laboratories and associated equipment of Sublandlord shall be decommissioned with an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
associated Exit Survey (as defined in Section&nbsp;17(b)) provided to Subtenant. Upon the expiration of the Sublease, Subtenant shall have the right but not the obligation to purchase the
additional furniture, fixtures and equipment generally described on <B>Exhibit A</B>, which the parties acknowledge is not an itemized or absolute description and will be used by the parties only as a guide, but specifically including nine biosafety
cabinets and two lab freezers located on the 6th&nbsp;Floor Premises and not included as part of the Zymergen FF&amp;E (the &#147;<B>Dynavax FF&amp;E</B>&#148;) for the same value that Sublandlord is obligated to purchase such Dynavax FF&amp;E from
Master Tenant under the Zymergen Sublease. Subtenant acknowledges that except as expressly set forth in this Sublease (i)&nbsp;Sublandlord has made no representations of any kind in favor of Subtenant, including, without limitation, in connection
with improvements or physical conditions on, or bearing on, the use of the Zymergen FF&amp;E, the Dynavax FF&amp;E, the Subleased Premises, the Building, and/or the Project, and Subtenant waives any implied warranty with respect to such matters and
otherwise; and (ii)&nbsp;Sublandlord shall have no obligation to perform any improvements, alterations, or other work to the Subleased Premises, or provide Subtenant with any improvement allowance with respect to the Subleased Premises. By taking
possession of the Subleased Premises, Subtenant accepts the Subleased Premises in the condition provided for in this Section and waives all claims of defect in or relating to the Subleased Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <B>Delivery</B>. Notwithstanding anything to the contrary contained in this Sublease or otherwise, Sublandlord shall have no obligation to
deliver possession of the Subleased Premises to Subtenant unless and until (i)&nbsp;the Sublease Contingency has been met; (ii)&nbsp;the Commencement Date has occurred; and (iii)&nbsp;Subtenant has delivered all of the following to Sublandlord as of
the Effective Date: (w)&nbsp;the Prepayment; (x)&nbsp;the Insurance Certificate (defined in Section&nbsp;12 below); and (y)&nbsp;the Letter of Credit. Subtenant agrees that in the event that Sublandlord fails to deliver possession of the Subleased
Premises on the anticipated Commencement Date for any reason, it will not be a default and Sublandlord shall not be liable for any damage resulting therefrom. If Sublandlord permits Subtenant, or any agent, employee or contractor of Subtenant, to
enter, use or occupy the Subleased Premises prior to the Commencement Date, such entry, use or occupancy shall be subject to all the provisions of this Sublease, including, without limitation, Subtenant&#146;s compliance with the insurance
requirements of Section&nbsp;12 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <B>Rent</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <B>Terms of Payment</B>. Subtenant shall pay to Sublandlord, at Sublandlord&#146;s Address for Payment of Rent designated in the Basic
Sublease Information, or as otherwise directed by Sublandlord, Base Rent, and Additional Rent, without notice, demand, offset or deduction, in advance, on the first day of each calendar month, except as otherwise expressly set forth in this
Sublease. All payments required to be paid by Subtenant to Sublandlord shall be made in federal funds by electronic fund transfer (EFT) or Automated Clearing House (ACH) (or to such other party or at such location as Sublandlord may otherwise from
time to time specify in writing) before 11:00 am. Pacific Time. If the Sublease Term commences (or ends) on a date other than the first (or last) day of a month, Base Rent shall be prorated on the basis of a thirty (30)&nbsp;day month. Subtenant
shall have no right at any time to abate, reduce, or <FONT STYLE="white-space:nowrap">set-off</FONT> any rent due hereunder except as may be expressly provided in this Sublease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <B>Additional Rent</B>. All sums due from Subtenant to Sublandlord or to any third party
under the terms of this Sublease (other than Base Rent and the Letter of Credit) shall be additional rent (&#147;<B>Additional Rent</B>&#148;). Additional Rent shall include, without limitation, (i)&nbsp;Subtenant&#146;s Share of all amounts other
than base rent payable by Sublandlord to either Master Tenant or Master Landlord, as applicable, under the Master Lease with respect to the Subleased Premises, including without limitation amounts payable as Rent Adjustment, as defined in the Master
Lease; (ii)&nbsp;taxes on personal property, equipment and fixtures located in or about the Subleased Premises; (iii)&nbsp;amounts recoverable due to a failure of performance by Subtenant under this Sublease; and (iv)&nbsp;any other costs or
expenses due from Sublessee to Sublessor under this Sublease. &#147;<B>Subtenant&#146;s Share</B>&#148; shall be the percentage set forth in the Basic Sublease Information as Subtenant&#146;s Share of the Project and Subtenant&#146;s Share of the
Building, as applicable. However, Subtenant&#146;s Share may be reasonably adjusted by Sublandlord in the future for changes in the physical size of the Project made by Sublandlord and/or Master Landlord. Sublandlord may equitably increase
Subtenant&#146;s Share for any item of expense or cost reimbursable by Subtenant that relates to an item of maintenance, repair, replacement, or service that benefits only the Subleased Premises. All Additional Rent that is payable to Sublandlord
shall be paid at the time, place, and manner as Base Rent pursuant to Section&nbsp;4(a) above, unless this Sublease expressly provides otherwise. Sublandlord will have the same remedies for a default in the payment of any Additional Rent as for a
default in the payment of Base Rent. Together, Base Rent, Additional Rent and any other sums due hereunder from Subtenant are sometimes referred to in this Sublease as &#147;<B>Rent</B>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <B>Rent Due Upon Execution</B>. On or before the Effective Date, Subtenant shall pay to Sublandlord in cash, the sum of Four Hundred
Thirty Eight Thousand Nine Hundred Thirteen and 07/100 Dollars ($438,913.07) (the &#147;<B>Prepayment</B>&#148;), which shall be applied as a credit against the first installment of Base Rent and Subtenant&#146;s Share of Rent Adjustment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <B>Late Charge; Interest</B>. Subject to other provisions of this Sublease, if Subtenant fails to pay any Rent within two
(2)&nbsp;business days after notice of late payment (with notice to be given by noon on such first business day), Subtenant shall pay to Sublandlord on demand a late charge equal to ten percent (10%) of such delinquent sum. In addition to such late
charges, if Sublandlord is charged interest by Master Tenant in accordance with Section&nbsp;7.2 of the Zymergen Sublease, then Subtenant shall be responsible for reimbursing Sublandlord for such amount. The provision for such late charge shall be
in addition to all of Sublandlord&#146;s other rights and remedies hereunder or at law and shall not be construed as a penalty. No endorsement or statement on a check or letter accompanying a check or payment shall be considered an accord and
satisfaction of past due Rent. Subtenant&#146;s covenant to pay Rent is independent of every other covenant in this Sublease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <B>Use; Compliance with
Laws; Hazardous Materials</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Subleased Premises shall be used for the Permitted Use to the extent permitted by the Master Lease,
in accordance with this Sublease, and for no other purpose. Subtenant shall use the Subleased Premises in compliance with all statutes, codes, ordinances, orders, rules and regulations of any municipal or governmental entity, including, without
limitation, all applicable federal, state and local laws or regulations governing protection of, damage to the environment, or the treatment, storage or disposal of hazardous materials, and any covenants, conditions and restrictions encumbering the
Subleased Premises, the Building and/or the Project (collectively referred to as &#147;<B>Laws</B>&#148;). Subtenant shall be responsible for obtaining any permit, business license, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or other permits or licenses required by any governmental agency permitting Subtenant&#146;s use or occupancy of the Subleased Premises. Sublandlord represents and warrants to Subtenant that as
of the Commencement Date, to the best of its knowledge, the Premises are in compliance with all local and state codes including the Americans with Disabilities Act of 1990, as amended. For purposes of this Sublease, Sublandlord&#146;s
&#147;knowledge&#148; means actual knowledge (as opposed to imputed, inquiry or constructive knowledge) of Enakshi Singh, without any duty to investigate or inquire. Sublandlord makes no warranty or representation as to whether or not the Subleased
Premises comply with Law and, notwithstanding anything to the contrary contained herein, Sublandlord shall have no obligation to bring the Subleased Premises into compliance with Law, nor any such obligation with respect to the Building or the
Project. In the event that Subtenant&#146;s use of the Subleased Premises requires modifications or additions to the Subleased Premises, the Building, or the Project in order to be in compliance with Law, Subtenant agrees to make any such necessary
modifications and/or additions at its sole cost and expense and in accordance with the terms of Section&nbsp;8 herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Subtenant
shall not use, store, transport or dispose of any Hazardous Materials (as defined in the Master Lease) in, under or about the Subleased Premises, Building or the Project, except that Subtenant may keep, store and use in the Subleased Premises those
Hazardous Materials, and their respective quantities, specifically listed on the &#147;<B>Environmental Questionnaire</B>&#148; attached to this Sublease as <B>Exhibit E</B>, in each case, to the extent approved in writing by Sublandlord and (if
applicable) Master Landlord, and as otherwise permitted pursuant to the terms and conditions of Section&nbsp;7.1(g) of the Original Master Lease incorporated herein. The Environmental Questionnaire may be reasonably updated by written notice by
Subtenant to Sublandlord from time to time. Subtenant shall update such Environmental Questionnaire upon reasonable notice from Sublandlord. Any such updates shall be subject to the review and approval of Sublandlord and (if applicable) Master
Landlord. Subtenant hereby represents and warrants to Sublandlord that (i)&nbsp;neither Subtenant nor any of its legal predecessors has been required by any prior landlord, sublandlord, lender or governmental authority at any time to take remedial
action in connection with Hazardous Materials contaminating a property which contamination was permitted by Subtenant or such predecessor, or resulted from Subtenant&#146;s or such predecessor&#146;s action or use of the property in question; and
(ii)&nbsp;Subtenant is not subject to any enforcement order issued by any governmental authority in connection with the use, storage, handling, treatment, generation, release or disposal of Hazardous Materials (including, without limitation, any
order related to the failure to make a required reporting to any governmental authority). If Sublandlord determines that this representation and warranty was not true as of the date of this Sublease, Sublandlord shall have the right to terminate
this Sublease in Sublandlords&#146; sole and absolute discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <B>Utilities and Services</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subtenant shall be solely responsible for and shall pay when due all (i)&nbsp;water, sewer, gas, electricity, other utilities and
utility-type services used on or provided to the Subleased Premises, (ii)&nbsp;environmental health and safety services and hazardous waste management furnished to the Subleased Premises, and (iii)&nbsp;information technology services and support,
administrative support, janitorial services, business services, office supplies, food and beverage, and other similar items and services with respect to the Subleased Premises. Subtenant shall contract directly for such services. Sublandlord shall
not be liable to Subtenant for interruption in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or curtailment of any such utility or service, nor shall any such interruption or curtailment constitute constructive eviction or grounds for rental abatement. In the event the Subleased Premises
is not separately metered for a utility service, Subtenant shall have the option, subject to Sublandlord&#146;s and Master Landlord&#146;s prior written consent and the terms of this Sublease, to cause the Subleased Premises to be separately metered
at Subtenant&#146;s sole cost and expense. If Subtenant does not elect to cause the Subleased Premises to be separately metered, Subtenant shall pay, upon demand, a reasonable proration of utilities, as determined by Sublandlord. Subtenant hereby
waives the provisions of any applicable existing or future Laws permitting the termination of this Sublease due to an interruption, failure or inability to provide any services or utilities (including, without limitation, the provisions of
California Civil Code Section&nbsp;1932(1)). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) To allow for compliance with building performance benchmarking and disclosure laws and
regulations (including, but not limited to, compliance with California Public Resources Code &#167;25402.10), Subtenant, promptly upon request, shall deliver to Sublandlord (or, at Sublandlord&#146;s option, execute and deliver to Sublandlord an
instrument enabling Sublandlord to obtain from such provider) any data about Subtenant&#146;s utility consumption. Further, Subtenant authorizes Sublandlord and Master Landlord to disclose such information and data regarding the Subleased Premises
as may be requested or required from time to time to comply with Laws and/or energy regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <B>Maintenance and Repairs</B>. Subtenant
acknowledges and agrees that Master Landlord shall be responsible for the maintenance and repair obligations of the &#147;Landlord&#148; under the Master Lease. Subtenant shall look solely to Master Landlord for performance thereof. Subtenant hereby
recognizes and agrees that all acknowledgements, reservations of rights, limitations on and waivers of liability, and rights to notice in favor of &#147;Landlord&#148; are incorporated into this Sublease in favor of Master Landlord and Sublandlord,
as if the same were restated in this Sublease by Subtenant. In no event shall Sublandlord be obligated to undertake any maintenance, repair or replacement obligations that are otherwise the responsibility of Master Landlord or Subtenant, whether
hereunder or under the Master Lease. Notwithstanding anything to the contrary contained herein, if any maintenance, repairs, or replacements are required to be made to the Subleased Premises, the Master Premises, the Building, or the Project due to
the acts, omissions or negligence of Subtenant or any Subtenant Party (defined in Section&nbsp;11 below), then such maintenance, repairs, or replacements shall be at Subtenant&#146;s sole cost and expense; provided, further, Subtenant shall be
responsible for keeping and maintaining the Subleased Premises in good condition at its sole cost and expense except as explicitly set forth in the Master Lease or herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <B>Alterations</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Any alterations,
additions or improvements to the Subleased Premises by or for Subtenant (collectively referred to as &#147;<B>Alterations</B>&#148;) shall require the prior written consent of Sublandlord, Master Tenant and Master Landlord. Alterations shall be
subject to and made in accordance with Section&nbsp;19 of the Zymergen Sublease, which is incorporated herein by this reference (provided, however, that all references therein to &#147;Subtenant&#148; and &#147;Subleased Premises&#148; shall mean
&#147;Subtenant&#148; and the &#147;Subleased Premises&#148;, respectively, and all references therein to &#147;Master Landlord&#148; shall mean &#147;Sublandlord&#148;, &#147;Master Tenant&#148; and &#147;Master Landlord&#148;). Upon the expiration
or earlier termination of this Sublease, Subtenant shall remove any or all Alterations made or installed by, or on behalf of, Subtenant and restore the Subleased Premises to the condition </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required pursuant to Section&nbsp;17 below; provided, however, (a)&nbsp;rights in favor of Master Landlord or Master Tenant to retain, preserve, and/or leave in place all or any portion of such
Alterations are incorporated into this Sublease in favor of Master Landlord, Master Tenant and Sublandlord, as if the same were restated in this Sublease by Subtenant; and (b)&nbsp;in the event of the exercise of such right, such items shall be and
become the property of (as applicable) Sublandlord, Master Tenant or Master Landlord upon the expiration or earlier termination of this Sublease. Subtenant shall be solely responsible for the planning, permitting, construction and completion of any
Alterations at Subtenant&#146;s sole cost and expense. Subtenant shall make all payments for Alterations in a timely manner so as not to permit any mechanic&#146;s or other liens to be placed upon the Subleased Premises in connection with any
Alterations. Subtenant shall fully discharge any such lien within fifteen&nbsp;(15) days after the date of filing, and if Subtenant fails to do so, Sublandlord may take such action as may be necessary to remove such lien and Subtenant shall promptly
pay Sublandlord such amounts expended by Sublandlord in connection therewith. Subtenant shall not damage or deface the furnishings, walls, floors, ceilings or other portions of the Subleased Premises. Any damage to the Subleased Premises, the
Building and/or the Project caused by Subtenant or a Subtenant Party shall be promptly repaired by Subtenant, to Sublandlord&#146;s and (if applicable) to Master Landlord&#146;s and Master Tenant&#146;s satisfaction, all at Subtenant&#146;s sole
cost and expense. Any provision which permits Master Landlord and/or Master Tenant to recover costs incurred in connection with reviewing and coordination of Alterations shall be construed as requiring Subtenant to pay such costs of Master Landlord,
Master Tenant and Sublandlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It is hereby acknowledged and agreed that it is Subtenant&#146;s intention to convert all or a portion
of the 7th floor of the Premises to laboratory space (the &#147;<B>Laboratory Conversion Work</B>&#148;). Subtenant shall have the right, but not the obligation, to undertake the Laboratory Conversion Work at its own cost and expense. Provided
Subtenant complies with Article 9 of the Master Lease, Sublandlord consents to Subtenant performing the Laboratory Conversion Work. Notwithstanding anything in this Sublease or Master Lease to the contrary, the Security Deposit and Rent Adjustment
shall not be increased due to any Laboratory Conversion Work, nor shall Subtenant nor Sublandlord have any obligation to remove the Laboratory Conversion Work or restore the Sublease Premises to its condition prior to the Laboratory Conversion Work
at the end of the Sublease Term. This paragraph and Sublandlord&#146;s consent hereto, shall be subject to Sublandlord&#146;s and Subtenant&#146;s receipt of consent to the same from Master Landlord and Master Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In connection with the Laboratory Conversion Work, certain of the Dynavax FF&amp;E located on the 7th floor Premises and highlighted on
<B>Exhibit F </B>(&#147;<B>Removable Dynavax FF&amp;E</B>&#148;) may be required to be removed. With written approval from Master Tenant and Sublandlord, Subtenant may remove and dispose of the Removable Dynavax FF&amp;E; provided, however, in the
event such consent of disposal is not obtained within 30 days of request, then upon at least 60 days&#146; notice (&#147;<B>Removal Notice</B>&#148;) from Subtenant to Sublandlord, subject to the terms of the Zymergen Sublease, Sublandlord shall
coordinate with Master Tenant to have the Removable Dynavax FF&amp;E designated in the Removal Notice removed from the Premises and stored during the Sublease Term; provided, further, that only one (1)&nbsp;Removal Notice may be given to Sublandlord
during such Sublease Term. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. <B>Entry by Sublandlord or Master Landlord</B>. Sublandlord, Master Tenant or Master Landlord may enter
the Subleased Premises at any time during the Sublease Term and/or undertake the following all without abatement of Rent or liability to Sublandlord, Master Tenant and/or Master Landlord: inspect the Subleased Premises; to make and operate repairs,
alterations, improvements, or additions to the Subleased Premises; show the Subleased Premises to prospective purchasers and investors and existing and prospective lenders; and (if applicable), during the last nine (9)&nbsp;months of the Subleased
Term, place signs for the rental of, and show the Subleased Premises to prospective tenants and/or subtenants. Subtenant acknowledges that any prior notice of entry into the Subleased Premises may be given orally; however, no notice shall be
required in case of an emergency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. <B>Assignment and Subletting</B>. Subtenant shall not assign, sublease, or transfer any interest in this Sublease
or allow any third party to use any portion of the Subleased Premises (collectively or individually, a &#147;<B>Transfer</B>&#148;), without the prior written consent of Sublandlord, Master Tenant and Master Landlord. Each Transfer (including a
proposed Transfer) shall be subject to Section&nbsp;16 of the Zymergen Sublease. Any Transfer without the prior written consent of Sublandlord, Master Tenant and Master Landlord shall be an incurable default by Subtenant and, in addition to any
other rights and remedies, shall entitle Sublandlord to terminate this Sublease immediately. Subtenant shall not be released from any of its obligations under this Sublease or those provisions of Master Lease incorporated herein, and shall continue
to be liable as a principal, not as a guarantor or surety, and to the same extent as though no Transfer had been made. Subject to all of the foregoing, no permitted Transfer shall be effective until there has been delivered to Sublandlord a
counterpart of the Transfer instrument in which the transferee agrees to be and remain jointly and severally liable with Subtenant for the payment of Rent pertaining to the Subleased Premises and for the performance of all of the terms and
provisions of this Sublease and those provisions of Master Lease incorporated herein. Notwithstanding anything to the contrary herein or otherwise, Subtenant shall not collaterally assign, mortgage, pledge, hypothecate or otherwise encumber the
Subleased Premises, this Sublease, the Master Lease, or any of Subtenant&#146;s rights hereunder without the prior written consent of Sublandlord, Master Tenant and Master Landlord, which consent Sublandlord, Master Tenant and/or Master Landlord may
withhold in its/their sole discretion. Subtenant hereby waives (for itself and all persons claiming under Subtenant) the provisions of California Civil Code Section&nbsp;1995.310. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. <B>Indemnity and Waiver of Claims</B>. Subtenant shall indemnify, defend (by counsel acceptable to Sublandlord) and hold Sublandlord and all of
Sublandlord&#146;s affiliates, and each of their respective, owners, investors, partners, principals, members, trustees, officers, directors, shareholders, agents, contractors, employees and lenders (&#147;<B>Sublandlord Parties</B>&#148;) harmless
from and against all liabilities, damages, claims, and expenses, including, without limitation, reasonable attorneys&#146; fees (if and to the extent permitted by Law), which may be imposed upon, incurred by or asserted against Sublandlord or any of
the Sublandlord Parties, arising directly or indirectly out of (a)&nbsp;the use or occupancy of the Subleased Premises, the conduct of Subtenant&#146;s business or any activity, work or things done, permitted or suffered by Subtenant or any of
Subtenant&#146;s affiliates, or their respective employees, agents, customers, visitors, invitees, licensees, contractors, assignees (individually, a &#147;<B>Subtenant Party</B>&#148;, and collectively, the &#147;<B>Subtenant Parties</B>&#148;), or
(b)&nbsp;a breach or default in the performance of any obligation on Subtenant&#146;s part to be performed hereunder, except to the extent caused by Sublandlord&#146;s gross negligence or willful misconduct. Subtenant hereby waives all claims
against Sublandlord and the Sublandlord Parties for (i)&nbsp;any injury or damage to person or property (or resulting from the loss of use thereof) in or about the Subleased Premises or the Building by or from any cause whatsoever (including,
without limiting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the foregoing, rain or water leakage of any character from the roof, windows, walls, basement, pipes, plumbing works or appliances, the Project, the Building and/or the Subleased Premises not
being in good condition or repair, gas, fire, oil, or electricity), except to the extent caused by Sublandlord&#146;s gross negligence or willful misconduct, and (ii)&nbsp;any failure to prevent or control any criminal or otherwise wrongful conduct
by any third party or to apprehend any third party who has engaged in such conduct. Notwithstanding any provision in this Sublease to the contrary, neither Sublandlord nor any Sublandlord Parties, nor Master Tenant or Master Landlord nor any of
their owners, partners, principals, members, trustees, officers, directors, shareholders, agents, employees and lenders, shall be liable for (and Subtenant hereby waives any claims for) any injury or damage to, or interference with, Subtenant&#146;s
business, including consequential damage, loss of profits, loss of rents or other revenues, loss of business opportunity, loss of goodwill or loss of use, or for any form of punitive damage. Subtenant and Subtenant parties shall only be liable to
Sublandlord, Sublandlord Parties, Master Landlord and Master Tenant for any consequential damage, compensation or claims for inconvenience or loss of business, rents or profits as a result of any injury or damage (a)&nbsp;(i) caused directly by an
act or omission of Subtenant or any of Subtenant&#146;s invitees, agents or employees, and (ii)&nbsp;Master Landlord or Master Tenant has brought an action against Sublandlord for same; or (b)&nbsp;to the extent resulting from a holdover (which is
governed by Section&nbsp;18 of this Sublease). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. <B>Insurance</B>. The provisions of Section&nbsp;27 of the Zymergen Sublease and Article 16 of the
Original Master Lease pertaining to insurance shall be incorporated into this Sublease, subject to the following terms. For purposes of this Sublease, (i)&nbsp;the term &#147;Tenant&#148; in Article 16 of the Original Master Lease shall be deemed to
mean Subtenant; (ii)&nbsp;the term &#147;Landlord&#148; in Section&nbsp;16.3 of the Original Master Lease shall be deemed to mean Master Landlord; (iii)&nbsp;the term &#147;Landlord&#148; in Sections 16.1, 16.2, 16.4 and 16.5 of the Original Master
Lease shall be deemed to mean Master Landlord, Master Tenant and Sublandlord (it being understood that Sublandlord and Sublandlord Parties shall be named, as applicable, as additional insureds and loss payees, that Sublandlord shall be entitled to
all applicable notices related to such insurance and to evidence of all such insurance, and that the release and waiver of subrogation in Section&nbsp;16.4 of the Original Master Lease shall also apply as between Sublandlord and Subtenant; and
(iv)&nbsp;the term &#147;Premises&#148; shall mean the &#147;Subleased Premises.&#148; The insurance certificate to be provided by Subtenant shall be subject to approval by Sublandlord and Master Landlord (the &#147;<B>Insurance
Certificate</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. <B>Damage or Destruction and Condemnation</B>. The provisions of Section&nbsp;19 of the Zymergen Sublease and Article 13 of
the Original Master Lease pertaining to damage or destruction and condemnation, respectively, shall be incorporated into this Sublease, subject to the following terms. For purposes of this Sublease, the term &#147;Tenant&#148; in Article 13 of the
Master Lease shall be deemed to mean Subtenant and the term &#147;Landlord&#148; therein shall be deemed to mean Master Landlord and the term &#147;Premises&#148; shall mean the &#147;Subleased Premises&#148;, except that (a)&nbsp;in no event shall
Sublandlord have any obligation to Subtenant to restore the Subleased Premises if damaged, destroyed or condemned as described in Article 13 of the Master Lease; and (b)&nbsp;Subtenant shall have no right to (i)&nbsp;terminate this Sublease due to
casualty damage to or condemnation of all or any portion of the Subleased Premises unless Sublandlord has such right under the Master Lease, or (ii)&nbsp;any insurance proceeds or condemnation awards received by Sublandlord under the Master Lease,
all of which shall be deemed to be the property of Sublandlord. Subtenant hereby (A)&nbsp;waives (I) any and all provisions of applicable Laws that provide alternative rights for the parties in the event of damage or destruction (including, without
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
limitation, the provisions of California Civil Code Section&nbsp;1932, Subsection 2, and Section&nbsp;1933, Subsection 4, and any successor statute or laws of a similar nature), and (II)&nbsp;any
rights it may have pursuant to any applicable Laws in the event of a condemnation (including, without limitation, Section&nbsp;1265.130 of the California Code of Civil Procedure and any successor statutes); and (B)&nbsp;agrees that the provisions of
this Section&nbsp;13 shall govern the parties&#146; rights in the event of any casualty and/or condemnation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. <B>Events of Default</B>. The occurrence
of any of the following shall constitute a material breach of this Sublease and a default by Subtenant (&#147;<B>Default</B>&#148;): (i) Subtenant&#146;s failure to pay Rent within three (3)&nbsp;days of the date due; provided, however that
Sublandlord will give Subtenant notice and an opportunity to cure any failure to pay Rent within three (3)&nbsp;days of any such notice not more than twice in any twelve (12)&nbsp;month period; provided, further, that any such notice shall be in
lieu of, and not in addition to, any notice required under California Code of Civil Procedure Section&nbsp;1161; (ii) all those items of default set forth in the Master Lease where the obligation is incorporated in this Sublease, including, without
limitation, the Defaults listed in Section&nbsp;22 of the Zymergen Sublease and Article 11 of the Original Master Lease, which remain uncured after the cure period provided in the Master Lease; (iii)&nbsp;Subtenant shall attempt or there shall occur
any Transfer in contravention of this Sublease or the Master Lease; or (iv)&nbsp;Subtenant&#146;s failure to perform any other term, provision or covenant of this Sublease, which failure remains uncured after fifteen&nbsp;(15) days written notice
thereof; provided that, subject to Section&nbsp;16(b) below, if the failure is of a nature that reasonably requires more than fifteen (15)&nbsp;days, to cure, the cure period shall be extended so long as the cure is commenced within such period and
diligently prosecuted to completion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. <B>Remedies</B>. Upon any Default by Subtenant under the terms of this Sublease, beyond any applicable notice
and cure period, Sublandlord shall have the remedies set forth in Section&nbsp;22 of the Zymergen Sublease and Article 11 of the Original Master Lease (which rights are hereby incorporated by reference into the terms of this Sublease) as if
Sublandlord were Master Landlord or Master Tenant, as applicable, including, without limitation, the right to terminate this Sublease, in which case Subtenant shall immediately surrender the Subleased Premises to Sublandlord. If Subtenant fails to
surrender the Subleased Premises, Sublandlord may, in compliance with applicable Laws and without prejudice to any other right or remedy, enter upon and take possession of the Subleased Premises. In addition to the right to terminate this Sublease
and collect damages, Sublandlord shall have the right to pursue any other remedy provided under the Master Lease or that is now or hereafter available at law or in equity. No right or remedy conferred upon or reserved to Sublandlord is intended to
be exclusive of any other right or remedy, and each and every right and remedy shall be cumulative and in addition to any other right or remedy given hereunder or now or hereafter existing by agreement, Laws, or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. <B>Sublandlord Representations, Warranties and Covenants; Master Lease</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Sublandlord represents and warrants the following is true and correct as of the Effective Date and Commencement Date: (i)&nbsp;Sublandlord is the tenant
under the Zymergen Sublease and has the capacity to enter into this Sublease with Subtenant subject to the Sublease Contingency, (ii)&nbsp;the Master Lease attached as <B>Exhibit B</B>, is a true, correct, and complete copy of the Master Lease, is
in full force and effect, and has not been further modified, amended, or supplemented except as expressly set out herein, (iii)&nbsp;Sublandlord has not received any notice, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has no actual knowledge of any default by Sublandlord under the Master Lease, including without limitation as to any covenants related to Hazardous Materials, (iv)&nbsp;Sublandlord has no actual
knowledge, of any default by Master Landlord or Master Tenant under the Master Lease. Sublandlord covenants that it will maintain the Master Lease during the entire Sublease Term, subject, however, to any earlier termination of the Master Lease
without the fault of Sublandlord. Sublandlord hereby covenants not to enter into any amendment or other agreement with respect to the Master Lease without the prior written consent of the Subtenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Subtenant takes possession of the Subleased Premises, and enters into this Sublease, subject and subordinate to all of the terms,
covenants, conditions, and restrictions of the Master Lease, except as otherwise expressly provided for herein. Subtenant&#146;s use of the Subleased Premises, the Building, and the Project shall be subject and subordinate to all of the terms,
covenants, conditions, and restrictions of the Sublease and the Master Lease, except as otherwise expressly provided for herein. Subtenant shall not, and shall not permit Subtenant Parties to, by act or omission cause a breach of any of the terms,
covenants, conditions, and restrictions contained in this Sublease or the Master Lease. Except as specifically set forth herein, with respect to any obligation of Subtenant to be performed under this Sublease, wherever the Master Lease grants to
Sublandlord a specified number of days after notice or other time condition to perform its corresponding obligation under the Master Lease (excluding the payment of Rent), Subtenant shall have <FONT STYLE="white-space:nowrap">one-fourth</FONT> fewer
days (rounded to the nearest whole day) to perform the obligation, including without limitation curing any defaults. Any default notice or other notice of any obligations (including any billing or invoice for any Rent or any other expense or charge
due under the Master Lease) from Master Landlord or Master Tenant which is received by Subtenant (whether directly or as a result of being forwarded by Sublandlord) shall constitute such notice from Sublandlord to Subtenant under this Sublease
without the need for any additional notice from Sublandlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It is expressly understood, acknowledged and agreed by Subtenant that
all of the other terms, conditions and covenants of this Sublease shall be those stated in the Master Lease except as excluded or modified below in this Section&nbsp;16(b). Except as otherwise set forth in this Sublease, Subtenant shall be subject
to, bound by and comply with all of said Sections of the Master Lease with respect to the Subleased Premises and shall satisfy all applicable terms and conditions of the Master Lease for the benefit of Sublandlord, Master Tenant and Master Landlord,
it being understood and agreed (except as otherwise expressly set forth in this Sublease), however, that (i)&nbsp;wherever in the Master Lease the word &#147;Tenant&#148; appears, for the purposes of this Sublease, the word &#147;Subtenant&#148;
shall be substituted, wherever the word &#147;Landlord&#148; appears, for the purposes of this Sublease, the word &#147;Sublandlord&#148; shall be substituted, wherever the word &#147;Lease&#148; appears, for purposes of this Sublease, the word
&#147;Sublease&#148; shall be substituted, and wherever the word &#147;Premises&#148; appears, for the purposes of this Sublease, the word &#147;Subleased Premises&#148; shall be substituted, and wherever the word &#147;Term&#148; appears, for
purposes of this Sublease, the words &#147;Sublease Term&#148; shall be substituted; (ii)&nbsp;Sublandlord shall have no liability to Subtenant with respect to (w)&nbsp;representations and warranties made by Master Landlord or Master Tenant under
the Master Lease, (x)&nbsp;any indemnification obligations of Master Landlord or Master Tenant under the Master Lease, (y)&nbsp;obligations or liabilities of Master Landlord or Master Tenant under the Master Lease with respect to compliance with
laws, condition of the Subleased Premises or Hazardous Materials, or (z)&nbsp;obligations under the Master Lease to repair, maintain, restore, or insure all or any portion of the Subleased Premises, regardless of whether the incorporation of one or
more provisions of the Master Lease might otherwise operate to make Sublandlord liable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
therefor; (iii)&nbsp;in any case where &#147;Tenant&#148; is to indemnify, release or waive claims against &#147;Landlord&#148;, such indemnity, release or waiver shall be deemed to run from
Subtenant to Master Landlord, Master Tenant and Sublandlord; (iv)&nbsp;whenever the provisions of the Master Lease incorporated as provisions of this Sublease require the written consent of Master Landlord, said provisions shall be construed to
require the written consent of Master Landlord or Master Tenant and Sublandlord; (v)&nbsp;whenever the provisions of the Master Lease incorporated as provisions of this Sublease require the written consent of Tenant, said provisions shall be
construed to require the written consent of Subtenant; and (vi)&nbsp;in any case where Master Landlord or Master Tenant is to indemnify, release or waive claims against &#147;Tenant&#148;, such indemnity, release or waiver shall be deemed to run
from Master Landlord, Master Tenant and Sublandlord to Subtenant. In the event of any conflict between this Sublease, on the one hand, and the Master Lease, on the other hand, the terms of this Sublease shall control as between Sublandlord and
Subtenant. Subtenant hereby acknowledges that it has read and is familiar with all the terms of the Master Lease. In addition to any other provisions contained in this Sublease which specifically state that certain provisions of the Master Lease are
not incorporated into this Sublease or are otherwise modified as described in such other provisions, the terms and provisions of the following Sections and portions of the Master Lease are not incorporated into this Sublease or are modified as
provided for below: (A)&nbsp;the following provisions of the Master Lease are expressly <U>not</U> incorporated herein by reference: the definition of &#147;Base Rent,&#148; &#147;Applicable Monthly Base Rent,&#148; &#147;Security Deposit,&#148;
&#147;Sublease Term,&#148; and &#147;Commencement Date,&#148; as the same appear in the Zymergen Sublease, are not a part of this Sublease; the definition of &#147;Monthly Base Rent,&#148; &#147;Security Deposit,&#148; &#147;Lease Term&#148; and
&#147;Commencement Date,&#148; as the same appear in the Original Master Lease, are not part of this Sublease; Section&nbsp;3, Section&nbsp;4, Section&nbsp;6, Section&nbsp;8, Section&nbsp;13.2, the second grammatical sentence of Section&nbsp;15,
Section&nbsp;20, Section&nbsp;21, and Section&nbsp;35 of the Zymergen Sublease are not part of (and not incorporated into) this Sublease; Section&nbsp;2.1, Section&nbsp;2.2, Section&nbsp;2.3, Section&nbsp;2.6, Section&nbsp;2.7, Section&nbsp;2.8,
Article 3, Article 5, Article 22 and Section&nbsp;24(b), all of the Original Master Lease, are not part of (and not incorporated into) this Sublease; the references to &#147;Landlord&#148; in Section&nbsp;8.1, Section&nbsp;16.3, Article 14 and
Article 15 of the Original Master Lease shall be deemed to mean &#147;Master Landlord,&#148; the references to &#147;Master Landlord&#148; in Section&nbsp;2, Section&nbsp;23 and Section&nbsp;26 in the Zymergen Sublease shall be deemed to mean
&#147;Master Landlord,&#148; &#147;Master Tenant&#148; and &#147;Sublandlord&#148;; and Exhibit B to the Zymergen Sublease and Exhibits B, <FONT STYLE="white-space:nowrap">B-1</FONT> and <FONT STYLE="white-space:nowrap">B-2</FONT> to the Original
Master Lease are not part of (and are not incorporated into) this Sublease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Sublandlord shall have no liability to Subtenant on
account of any failure of Master Landlord or Master Tenant to observe or perform any of the terms, covenants or conditions of the Master Lease required to be observed or performed by Master Landlord or Master Tenant, as applicable. Sublandlord, upon
Subtenant&#146;s written request, shall use commercially reasonable efforts to cause the Master Landlord and/or Master Tenant, as the case may be, to perform its obligations under the Master Lease (including without limitation by notifying Master
Landlord or Master Tenant, as applicable, of Master Landlord&#146;s or Master Tenant&#146;s failure to perform its obligations under the Master Lease if Master Landlord or Master Tenant, as applicable, fails to perform same within thirty
(30)&nbsp;days after Master Landlord or Master Tenant, as applicable, has been requested to do so in writing by Subtenant) and shall use commercially reasonable efforts to cooperate with Subtenant in its efforts to obtain such performance at no cost
to Sublandlord. In no event shall Sublandlord be required to initiate any legal proceedings or to incur any expense or liability in connection with such efforts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If (i)&nbsp;Subtenant shall fail to perform any of its obligations hereunder and such
failure shall continue beyond any cure period provided for herein, or (ii)&nbsp;Master Landlord or Master Tenant, as applicable, shall give any notice of failure or default under the Master Lease arising out of any failure by Subtenant to perform
any of its obligations hereunder, then, in any such case, Sublandlord shall have the right (but not the obligation) to enter the Subleased Premises and perform or endeavor to perform such obligation, at Subtenant&#146;s expense. Subtenant shall,
within ten (10)&nbsp;days of Sublandlord&#146;s demand, reimburse Sublandlord for all such costs and expenses incurred by Sublandlord in doing so (plus a sum for overhead to Sublandlord equal to five percent (5%) of such costs and expenses) as Rent.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Subtenant shall promptly execute, acknowledge and deliver to Sublandlord, any certificate or other document evidencing the status of
the Sublease or subordination of this Sublease to the Master Lease, that Sublandlord, Master Tenant or Master Landlord may reasonably request, in accordance with the Master Lease or this Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17. <B>Surrender of Subleased Premises</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
Subtenant shall remove from the Subleased Premises on or before the expiration or earlier termination of this Sublease (i)&nbsp;any Alterations that are required to be removed pursuant to Section&nbsp;8 of this Sublease, other than the Laboratory
Conversion Work, (ii)&nbsp;any other improvements, alterations or fixtures in the Subleased Premises that were performed by or on behalf of Subtenant and that are required to be removed at the expiration of the term of the Master Lease pursuant to
the terms therein, and (iii)&nbsp;Subtenant&#146;s personal property, including, without limitation, any property that would be considered &#147;Required Removables&#148; pursuant to the terms of the Master Lease. In addition, Subtenant shall quit
and surrender the Subleased Premises to Sublandlord on or before the expiration or earlier termination of this Sublease, broom clean, and in at least the same order, condition and repair as on the date received, ordinary wear and tear excepted and
in accordance with the terms of the Master Lease. Conditions existing because of Subtenant&#146;s failure to perform maintenance, repairs or replacements shall not be deemed &#147;ordinary wear and tear.&#148; If Subtenant fails to timely remove any
Alterations, improvements or fixtures that are required to be removed, or any of Subtenant&#146;s personal property, Sublandlord, at Subtenant&#146;s sole cost and expense, shall be entitled (but not obligated) to remove such Alterations,
improvements and/or fixtures and/or remove, store or dispose of Subtenant&#146;s personal property. Sublandlord shall not be responsible for the value, preservation or safekeeping of Subtenant&#146;s personal or other property. On the basis of the
foregoing, Subtenant waives and releases its rights under Sections 1980 et. seq. and 1993 et. seq. of the California Civil Code, or any similar Laws now or hereafter in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) At least thirty (30)&nbsp;days prior to Subtenant&#146;s surrender of possession of any part of the Subleased Premises, Subtenant shall
provide Sublandlord with a facility decommissioning and Hazardous Materials closure plan for the Subleased Premises (&#147;<B>Exit Survey</B>&#148;) prepared by an independent third-party, state-certified professional with appropriate expertise,
which Exit Survey must be reasonably acceptable to Sublandlord. The Exit Survey shall comply with the American National Standards Institute&#146;s Laboratory Decommissioning guidelines (ANSI/AIHA <FONT STYLE="white-space:nowrap">Z9.11-2008)</FONT>
or any successor standards published by ANSI or any successor organization (or, if ANSI and its successors no longer exist, a similar entity publishing similar standards). In addition, at least ten (10)&nbsp;days prior to Subtenant&#146;s surrender
of possession of any part of the Subleased Premises, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subtenant shall (i)&nbsp;provide Sublandlord with written evidence of all appropriate governmental releases obtained by Subtenant in accordance with Laws, including laws pertaining to the
surrender of the Subleased Premises, (ii)&nbsp;place laboratory equipment decontamination forms on all decommissioned equipment to assure safe occupancy by future users, and (iii)&nbsp;conduct a site inspection with Sublandlord. In addition,
Subtenant agrees to remain responsible after the surrender of the Subleased Premises for the remediation of any recognized environmental conditions, including those set forth in the Exit Survey and comply with any recommendations set forth in the
Exit Survey. Subtenant&#146;s obligations under this Addendum shall survive the expiration or earlier termination of the Sublease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) On
the Expiration Date, Sublandlord shall purchase the FF&amp;E from Master Tenant pursuant to Section&nbsp;10 of the Zymergen Sublease, and Sublandlord shall sell to Subtenant the FF&amp;E on the same terms and conditions; provided, however, in the
event Sublandlord is unable to consummate the contemplated transaction with Master Tenant, Sublandlord shall be released of its obligation to sell the FF&amp;E to Subtenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18. <B>Holding Over</B>. Subtenant shall have no right to holdover in the Subleased Premises beyond the expiration or earlier termination of this Sublease. If
Subtenant does not surrender and vacate the Subleased Premises as and when provided for herein, Subtenant shall be deemed to be holding over as a tenant at sufferance, and the parties agree that the Rent during such holdover period shall be one
hundred seventy five percent (175%) of the Rent in effect immediately prior to such holding over. No holding over by Subtenant shall operate to extend the Sublease Term. Notwithstanding the foregoing, and in addition to all other rights and remedies
on the part of Sublandlord, if Subtenant fails to surrender the Subleased Premises upon the expiration or earlier termination of this Sublease, in addition to any other liabilities to Sublandlord accruing therefrom, Subtenant shall be liable to
Sublandlord for any obligations imposed by Master Tenant or Master Landlord pursuant to the Master Lease (including without limitation, Section&nbsp;24 of the Zymergen Sublease) as a result of such holding over, and Subtenant shall be responsible
for all damages suffered by Sublandlord resulting from or occasioned by such holding over, including, without limitation, consequential damages (notwithstanding any limitations thereon under the Master Lease). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">19. <B>Letter of Credit</B>. Concurrent with Subtenant&#146;s execution of this Sublease, Subtenant shall deliver to Sublandlord, at Subtenant&#146;s sole
cost and expense, an unconditional, irrevocable, standby letter of credit (the &#147;<B>Letter of Credit</B>&#148;) with an initial expiration date no earlier than one (1)&nbsp;year after the Effective Date of this Sublease in the amount set forth
in the Basic Lease Information (the &#147;<B>Letter of Credit Amount</B>&#148;), in the form attached hereto as <B>Exhibit G </B>or in other such form as is reasonably acceptable to Sublandlord. The Letter of Credit shall secure the full and
faithful performance of each provision of this Sublease to be performed by Subtenant pursuant to the following terms and conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
The Letter of Credit shall state on its face that, notwithstanding the stated expiration date, the term of the Letter of Credit shall be automatically renewed for successive, additional one&nbsp;(1) year periods during the Sublease Term through the
date that is at least ninety (90)&nbsp;days after the last day of the Sublease Term, unless, at least ninety (90)&nbsp;days prior to any such date of expiration, the issuing bank shall have given written notice to Sublandlord, by certified mail,
return receipt requested at the Sublandlord&#146;s Address For Notice stated in the Basic Sublease Information or such other address as Sublandlord shall have given to the issuing bank, that the Letter of Credit will not be renewed. The failure of
Subtenant to cause the Letter of Credit to be renewed or reissued at least sixty (60)&nbsp;days prior to the expiration thereof shall constitute Default under this Sublease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Letter of Credit shall be issued by a financial institution reasonably acceptable to
Sublandlord, which financial institution shall be a bank that accepts deposits, maintains accounts, will negotiate letters of credit, and whose deposits are insured by the FDIC. The Letter of Credit must be presentable in Emeryville, California or
such other United States location reasonably acceptable to Sublandlord. If the financial institution that issues the Letter of Credit makes a general assignment for the benefit of creditors, or commences any case, proceeding or other action seeking
to have an order for relief entered on its behalf as a debtor or to adjudicate it as bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, liquidation, dissolution or composition of it or its debts or seeking appointment of a
receiver, trustee, custodian or other similar official for it or for all or of any substantial part of its property, or loses or has its charter revoked, goes into receivership, or is otherwise taken over by any regulatory agency which oversees such
issuer, then Subtenant shall, promptly, but in no event later than ten (10)&nbsp;days after the occurrence of such event, deliver a replacement Letter of Credit to Sublandlord in the full Letter of Credit Amount and otherwise in accordance with the
requirements set forth in this Section&nbsp;19, and promptly upon Sublandlord&#146;s receipt of the replacement Letter of Credit, Sublandlord shall return to Subtenant the Letter of Credit being replaced. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If Subtenant fails to perform fully and timely all or any of Subtenant&#146;s covenants and obligations set forth in this Sublease,
including, without limitation, Subtenant&#146;s failure to renew the Letter of Credit at least ninety&nbsp;(90) days prior to the expiration thereof, or if Subtenant has filed a voluntary petition under the federal bankruptcy code or an involuntary
petition has been filed against Subtenant under the federal bankruptcy code, Sublandlord may, without notice to Subtenant, execute one or more drafts on the Letter of Credit and apply all or any portion of the Letter of Credit toward fulfillment of
Subtenant&#146;s unperformed covenants and/or obligations, including any Rent payable by Subtenant that is not paid when due; provided, however, that a failure of Subtenant to renew the Letter of Credit in accordance with this Section&nbsp;19 shall
entitle Sublandlord to execute a draft for the entire amount of the Letter of Credit and such proceeds shall be deemed the property of Sublandlord until such time as Subtenant delivers a replacement Letter of Credit to Sublandlord in the full Letter
of Credit Amount and otherwise in accordance with the requirements set forth in this Section&nbsp;19, and promptly upon Sublandlord&#146;s receipt of the replacement Letter of Credit, Sublandlord shall apply the amount of proceeds drawn from the
issuing bank upon Subtenant&#146;s failure to renew the Letter of Credit against the next due installment(s) of Base Rent under this Sublease. Any proceeds drawn shall constitute the property of Sublandlord and need not be segregated from
Sublandlord&#146;s other assets. If, as a result of any application or use by Sublandlord of all or any part of the Letter of Credit, the amount of the Letter of Credit shall be less than the Letter of Credit Amount, Subtenant shall, within ten
(10)&nbsp;days thereafter, provide Sublandlord with additional letter(s) of credit in an amount equal to the deficiency, and any such additional (or replacement) letter of credit shall comply with all of the provisions of this section and if
Subtenant fails to comply with the foregoing, notwithstanding anything to the contrary contained in the Sublease, the same shall constitute an immediate Default by Subtenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Ninety (90)&nbsp;days after Subtenant vacates the Subleased Premises, upon the
expiration or sooner termination of this Sublease, if Subtenant is not then in default, Sublandlord shall return to Subtenant the Letter of Credit (and any unapplied cash balance of the Letter of Credit that had been previously drawn upon); provided
that Sublandlord may retain the Letter of Credit (or previously drawn proceeds therefrom) until such time as any Rent (including Additional Rent) due from Subtenant for known defaults in accordance with this Sublease has been determined and paid in
full by Subtenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) In no event or circumstance shall the Letter of Credit or any renewal thereof or any proceeds thereof be deemed to
be or treated, or intended to serve as a &#147;security deposit&#148; within the meaning of any applicable law or statute. Subtenant hereby waives the provisions of any Laws which establishes the time frame by which Sublandlord must refund
collateral or security for performance of a subtenant&#146;s obligations under a sublease. Subtenant agrees and acknowledges that Subtenant has no property interest whatsoever in the Letter of Credit or the proceeds thereof and that, in the event
Subtenant becomes a debtor under any chapter of the Federal Bankruptcy Code, neither Subtenant, any trustee, nor Subtenant&#146;s bankruptcy estate shall have any right to restrict or limit Sublandlord&#146;s claim and/or rights to the Letter of
Credit and/or the proceeds thereof by application of Section&nbsp;502(b)(6) of the federal bankruptcy code or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Should the
Permitted Use be amended to accommodate a change in the business of Subtenant or to accommodate a <FONT STYLE="white-space:nowrap">sub-subtenant</FONT> or assignee, Sublandlord shall have the right to increase the Letter of Credit to the extent
necessary, in Sublandlord&#146;s reasonable judgment, to account for any increased risk to the Subleased Premises or increased wear and tear that the Subleased Premises may suffer as a result thereof. If a change in control of Subtenant occurs
during the Sublease and following such change the financial condition of Subtenant is, in Sublandlord&#146;s reasonable judgment, materially reduced, Subtenant shall deposit such additional monies with Sublandlord as shall be sufficient to cause the
Letter of Credit to be at a commercially reasonable level based on said change in financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Subtenant acknowledges that
Sublandlord has the right to transfer its interests in this Sublease. Subtenant agrees that in the event of any such transfer, Sublandlord shall have the right to transfer, assign and/or endorse the Letter of Credit to Sublandlord&#146;s master
lessors, or other transferees or assignees. Subtenant shall look solely to such parties for the return of the Letter of Credit in accordance with the terms of this Sublease. Subtenant agrees further that, upon Sublandlord&#146;s written request, it
shall have the Letter of Credit issued, at Subtenant&#146;s sole cost and expense, in favor of Sublandlord&#146;s master lessor or other transferee or assignee to be held by any such party in accordance with the terms of this Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">20. <B>Parking; Signage</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
<B>Parking</B>. Subtenant shall have Subtenant&#146;s proportionate share of such parking rights as Sublandlord may have in connection with the Subleased Premises, as set forth in the Master Lease. Sublandlord shall have the right to pass through to
Subtenant any charges payable to Master Landlord under the Master Lease for such parking rights. Subtenant shall pay as Additional Rent all such amounts at the same time and in the same manner as Subtenant pays Base Rent pursuant to Section&nbsp;4
above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <B>Signage</B>. Subtenant shall not, without the prior written consent of Sublandlord
(which consent may be granted or withheld in its sole and absolute discretion), Master Tenant and Master Landlord, post, project, affix, exhibit or display any signs, notices, window or door lettering, placards, decorations, or advertising media of
any type which can be viewed from the exterior of the Subleased Premises. Subtenant shall have the right to display, at Subtenant&#146;s sole cost and expense, signs bearing Subtenant&#146;s name and/or logo at specific locations within the
Subleased Premises, subject to the prior written consent of Sublandlord (which consent shall not be unreasonably withheld, conditioned or delayed). Subtenant shall be entitled to Subtenant&#146;s signage rights and proportionate share of any
Building standard identification signage allowed to the &#147;Tenant&#148; under the Original Master Lease and &#147;Subtenant&#148; under the Zymergen Sublease, at Subtenant&#146;s sole cost and expense, and subject to Laws and Sublandlord&#146;s,
Master Tenant&#146;s and Master Landlord&#146;s prior written approval, of the design and location of such signage. Upon the expiration or earlier termination of this Sublease, Subtenant shall be responsible for removing any signage described above,
repairing any damage caused by such removal, and restoring the area to its prior condition. Subtenant shall in no event be entitled to any exterior Building signage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">21. <B>Limitation of Liability</B>. None of the Sublandlord Parties shall have any personal liability for any obligation of Sublandlord under this Sublease or
arising in connection herewith or with the operation, management, leasing, subleasing, repair, renovation, alteration or any other matter relating to the Project, the Building or the Subleased Premises, and Subtenant hereby expressly waives and
releases such personal liability on behalf of itself and all persons claiming by, through or under Subtenant. Whenever Sublandlord transfers its interest, Sublandlord shall be automatically released from further performance under this Sublease and
from all further liabilities and expenses hereunder subject to assumption by the transferee of Sublandlord&#146;s interest of all liabilities and obligations of Sublandlord hereunder from the date of such transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">22. <B>Miscellaneous</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All demands,
approvals, consents or notices shall be in writing and delivered by hand or sent by registered or certified mail with return receipt requested, or sent by overnight or same day courier service at the party&#146;s respective Address(es) for Notice
set forth above in the Basic Sublease Information. Each notice shall be deemed to have been received or given on the earlier to occur of (i)&nbsp;actual delivery or the date on which delivery is refused, (ii)&nbsp;three (3)&nbsp;business days after
notice is deposited in the U.S. mail, one (1)&nbsp;business day after notice is deposited with an overnight or same day courier service in the manner described above or the date on which delivery is refused. Any party may, at any time, change its
notice address (other than to a post office box address) by giving the other parties written notice of the new address. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Either
party&#146;s failure to declare a default immediately upon its occurrence or delay in taking action for a default shall not constitute a waiver of the default, nor shall it constitute an estoppel. If either party institutes a suit against the other
for violation of or to enforce any covenant, term or condition of this Sublease, the prevailing party shall be entitled to all of its costs and expenses, including, without limitation, reasonable attorneys&#146; fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) This Sublease shall be interpreted and enforced in accordance with the Laws of the state in which the Subleased Premises is located. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Subtenant represents and warrants to Sublandlord that it has not dealt with any broker
in connection with this Sublease, other than Subtenant&#146;s Broker (if any) identified in the Basic Sublease Information. Subtenant agrees to indemnify, defend and hold Sublandlord and Sublandlord Parties party harmless from any commissions due to
any broker claiming by, through or under Subtenant. Sublandlord shall pay a commission equal to Two Dollars&nbsp;($2.00) per rentable square foot of the Subleased Premises for each year of the Sublease Term to Subtenant&#146;s Broker. Any partial
years shall be prorated. Notwithstanding the foregoing, no such commission shall exceed Eighteen Dollars ($18.00) per rentable square foot of the Subleased Premises. All commission payable to Subtenant&#146;s Broker shall be deducted from any
amounts owed to Sublandlord&#146;s Broker under its separate agreement with Sublandlord. Commission shall be payable to Subtenant&#146;s Broker on the earlier to occur of (i)&nbsp;Sublandlord&#146;s receipt of the Prepayment and the Letter of Credit
and (ii)&nbsp;the Commencement Date. No broker shall be deemed to be, or may make a claim as, a third party beneficiary of the terms of this Sublease, including, without limitation, this subsection (d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Basic Sublease Information set forth above and any Addenda, Exhibits and Schedules attached hereto are incorporated into and made a
part of the Sublease. Each reference in this Sublease to any of the Basic Sublease Information shall mean the respective information above. In the event of any conflict between the Basic Sublease Information and the provisions of the Sublease, the
provisions of the Sublease shall control. This Sublease constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings related to the Subleased Premises. This
Sublease may be modified only by a written agreement signed by Sublandlord and Subtenant and consented to by Master Tenant and Master Landlord, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Subtenant represents and warrants that the execution, delivery, and performance by Subtenant of its obligations under this Sublease have
been duly authorized and will not violate any provision of Laws, any order of any court or other agency of government, or any indenture, agreement or other instrument to which it is a party or by which it is bound. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) This Sublease may be executed in multiple counterparts, and by each party on separate counterparts, each of which shall be deemed to be an
original but all of which shall together constitute one agreement. Signature pages may be detached from the counterparts and attached to a single copy of this document to physically form one document. This Sublease may be executed in <FONT
STYLE="white-space:nowrap">so-called</FONT> &#147;pdf&#148; format and each party has the right to rely upon a pdf counterpart of this Sublease signed by the other party to the same extent as if such party had received an original counterpart. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Subtenant represents and warrants that neither it, nor any Subtenant Party, (i)&nbsp;is directly or indirectly owned or controlled by any
individual or entity included on the List of Specially Designated Nationals and Blocked Persons or the Foreign Sanctions Evaders List maintained by the Office of Foreign Assets Control, Department of the Treasury (&#147;<B>OFAC</B>&#148;) or any
other governmental entity imposing economic sanctions and trade embargoes, (ii)&nbsp;is directly or indirectly owned or controlled by any individual or entity who is located, organized, or resident in a country or territory that is, or whose
government is, the target of sanctions imposed by OFAC or any other governmental entity (&#147;<B>Sanctioned Territory</B>&#148;); and (iii)&nbsp;shall provide any technology or technical information shared between the parties to any Sanctioned
Territory or entity or individual that is a citizen of a Sanctioned Territory; Subtenant shall notify Sublandlord promptly upon knowledge of a violation of the foregoing (i)&nbsp;through (iii). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">23. <B>California Civil Code Section</B><B></B><B>&nbsp;1938 Statement</B>. To Sublandlord&#146;s actual
knowledge, the Subleased Premises has not undergone an inspection by a certified access specialist. For purposes of the preceding sentence, Sublandlord&#146;s actual knowledge shall mean and be limited to the actual knowledge of the person who is
Sublandlord&#146;s Chief Financial Officer (not any other person) on the Effective Date, without any duty of inquiry or investigation, and such Chief Financial Officer shall have no personal liability if such representation is untrue. California
Civil Code Section&nbsp;1938 provides in relevant part as follows: &#147;A Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related
accessibility standards under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject
premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp
inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises.&#148; Nothing in this paragraph or California Civil Code Section&nbsp;1938 shall relieve or modify
Subtenant&#146;s obligations with respect to (a)&nbsp;compliance with Laws, including without limitation any construction-related accessibility standards, as set forth elsewhere in this Sublease, including, without limitation, Section&nbsp;5(a) and
Section&nbsp;8 above, or (b)&nbsp;payment of Additional Rent as set forth in Section&nbsp;4 above. Subtenant hereby agrees that any Subtenant-initiated CASp inspection (x)&nbsp;shall be at Subtenant&#146;s sole cost and expense, and (y)&nbsp;shall
take place during normal business hours following reasonable prior written notice to Sublandlord, Master Tenant and Master Landlord. Any information contained in a CASp report shall be maintained as confidential. Subtenant, at its sole cost and
expense, shall be responsible for making any improvements, alterations, modifications and/or repairs to or within the Subleased Premises to correct violations of construction-related accessibility standards, including, without limitation, any
violations disclosed by such CASp inspection; and if such CASp inspection identifies any improvements, alterations, modifications and/or repairs necessary to correct violations of construction-related accessibility standards relating to those items
of the Building and/or the Project located outside the Subleased Premises then, at the Master Landlord&#146;s election, either Subtenant or the Master Landlord shall perform such improvements, alterations, modifications and/or repairs as and to the
extent required by applicable laws to correct such violations, in either instance at Subtenant&#146;s sole cost and expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">24. <B>Anti-Corruption</B>.
Neither Subtenant nor any of its directors, officers, employees, or any agent, representative, subcontractor or other third party acting for or on Subtenant&#146;s behalf (collectively, &#147;<B>Representatives</B>&#148;), shall, directly or
indirectly, offer, pay, promise to pay, or authorize such offer, promise or payment, of anything of value, to any person, governmental agency, or other entity for the purposes of obtaining any improper advantage in connection with this Sublease. Not
by way of limitation of Section&nbsp;5 of this Sublease, neither Subtenant nor any of its directors, officers or employees shall violate any applicable laws, rules and regulations concerning or relating to public or commercial bribery or corruption
(&#147;<B>Anti-Corruption Laws</B>&#148;). Within five (5)&nbsp;business days of Sublandlord&#146;s written request, Subtenant shall execute and deliver a compliance certification (which certification may be limited to Subtenant&#146;s knowledge)
with respect to Subtenant&#146;s compliance with Anti-Corruption Laws and this Section&nbsp;24. If Subtenant shall breach the foregoing at any time during the Sublease Term, a Default will be deemed to have occurred, without the necessity of notice
to Subtenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">25. <B>Confidential Information</B>. During the Sublease Term, Sublandlord and Subtenant may each receive,
obtain, or be given access to, whether directly or indirectly, including through audio or visual observation, information that relates to their respective business, finances, and/or technology (collectively, &#147;<B>Proprietary
Information</B>&#148;), which such Proprietary Information shall include, without limitation, the existence and contents of this Sublease, the Master Lease, the Subleased Premises, the Building and the Project. Sublandlord and Subtenant shall each
(i)&nbsp;not use the Proprietary Information for any purpose, except as is necessary to perform its obligations hereunder, (ii)&nbsp;not disclose any Proprietary Information, or component thereof, to any third party, (iii)&nbsp;within their
respective organization, only disclose Proprietary Information to those Sublandlord Parties and Subtenant Parties, as applicable, who need such Proprietary Information for the purposes of performing the obligations hereunder and who are bound by
obligations of confidentiality with respect to such Proprietary Information at least as protective as those contained herein, and (iv)&nbsp;use best efforts to protect the confidentiality of the Proprietary Information. Sublandlord and Subtenant
shall each notify the other of any unauthorized use or disclosure of Proprietary Information and to take all actions reasonably necessary to prevent further unauthorized use or disclosure thereof. Sublandlord and Subtenant each also recognizes and
agrees that they have no expectation of privacy with respect to Sublandlord&#146;s or Subtenant&#146;s, as applicable, telecommunications, networking or information processing systems (including, without limitation, stored computer files, email
messages and voice messages) and that their respective activity, and any files or messages, on or using any of those systems may be monitored at any time without notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26. <B>No Publicity</B>. Sublandlord and Subtenant each hereby acknowledges and agrees that it shall not use, without the other&#146;s prior written approval,
which may be withheld in such party&#146;s sole discretion, the name of the other party, its affiliates, trade names, trademarks or trade dress, products, or any signs, markings, or symbols from which a connection to such party may be reasonably
inferred or implied, in any manner whatsoever, including, without limitation, press releases, marketing materials, or advertisements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Signature Page Follows] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Sublandlord and Subtenant have executed this Sublease effective as of
Effective Date above written, on the dates set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>SUBLANDLORD:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>SUBTENANT:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ZYMERGEN INC.,</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>METAGENOMI, INC.,</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: <U>/s/ Celeste Ferber&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By: <U>/s/ Brian Thomas&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Celeste Ferber</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Brian Thomas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: 11/11/2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date: 11/11/2022</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OUTLINE OF SUBLEASED PREMISES </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp113.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT A </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OUTLINE OF SUBLEASED PREMISES </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp114.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT A </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MASTER LEASE </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[to
be attached] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT B </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBLEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">T<SMALL>HIS</SMALL> S<SMALL>UBLEASE</SMALL> (this &#147;<B><I>Sublease</I></B>&#148;) is entered into as of July&nbsp;12, 2019 (the
&#147;<B><I>Effective Date</I></B>&#148;), by and between DYNAVAX TECHNOLOGIES CORPORATION, a Delaware corporation (&#147;<B><I>Sublandlord</I></B>&#148;), and ZYMERGEN INC., a Delaware corporation (&#147;<B><I>Subtenant</I></B>&#148;). Sublandlord
and Subtenant may each be referred to herein as a &#147;<B><I>Party</I></B>&#148;, and collectively, the &#147;<B><I>Parties</I></B>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RECITALS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Sublease
is made with reference to the following recitals of essential facts: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Sublandlord, as tenant, and Emery Station West, LLC, a California
limited liability company (&#147;<B><I>Master Landlord</I></B>&#148;), as landlord, are parties to that certain Office/Laboratory Lease, dated as of September&nbsp;17, 2018 (as may be amended from time to time, the &#147;<B><I>Master
Lease</I></B>&#148;), for certain space located on the sixth (6<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) and seventh&nbsp;(7<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) floors of the building commonly known as 5959 Horton
Street, Emeryville, CA (the &#147;<B><I>Building</I></B>&#148;), containing approximately 75,662 rentable square feet, as more particularly described in the Master Lease (the &#147;<B><I>Master Premises</I></B>&#148;). Capitalized terms used, but
not defined, herein have the meanings set forth in the Master Lease, a copy of which has been previously provided to Subtenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B.
Subject to the terms and conditions of this Sublease, Sublandlord desires to sublease to Subtenant, and Subtenant desires to sublease from Sublandlord, all of the Master Premises, as depicted in <B><U>Exhibit A</U></B><B> </B>attached hereto (the
&#147;<B><I>Subleased Premises</I></B>&#148;) until the Expiration Date (as defined in <U>Section</U><U></U><U>&nbsp;3</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>AGREEMENT </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
<U>R<SMALL>ECITALS</SMALL></U><SMALL></SMALL>. The foregoing recitals are hereby incorporated into this Sublease by this reference as if fully set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>S<SMALL>UBLEASED</SMALL> P<SMALL>REMISES</SMALL></U><SMALL></SMALL>. Sublandlord hereby subleases to Subtenant, and Subtenant hereby
subleases from Sublandlord, the Subleased Premises. Additionally, Subtenant is hereby granted the nonexclusive right to use the common areas of the Building to the extent of Sublandlord&#146;s rights to use of the same pursuant to the Master Lease,
in common with other tenants in the Building (collectively, the &#147;<B><I>Common Areas</I></B>&#148;), each throughout the Sublease Term (as defined in <U>Section</U><U></U><U>&nbsp;3</U>). Subtenant covenants that its use of the Subleased
Premises and Common Areas shall at all times comply with all of the terms, conditions and provisions of the Master Lease and with all the rules and regulations established by Master Landlord from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>S<SMALL>UBLEASE</SMALL> T<SMALL>ERM</SMALL></U><SMALL></SMALL>. The term of this Sublease (the &#147;<B><I>Sublease Term</I></B>&#148;)
shall commence upon the latest to occur of: (a)&nbsp;Sublandlord&#146;s receipt of the Landlord Consent (as defined in <U>Section</U><U></U><U>&nbsp;35</U>), (b) Sublandlord&#146;s receipt of a Certificate of Occupancy, and (c)&nbsp;July&nbsp;15,
2019 (the &#147;<B><I>Commencement Date</I></B>&#148;). Unless earlier terminated under any provision of the Master Lease or this Sublease, the Sublease Term shall continue until March&nbsp;31, 2031 (the &#147;<B><I>Expiration Date</I></B>&#148;).
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sublandlord shall deliver possession of the Subleased Premises to Subtenant upon the occurrence of all of
the following: (a)&nbsp;Sublandlord&#146;s receipt of the Landlord Consent, (b)&nbsp;Sublandlord&#146;s receipt of the first full month&#146;s Base Rent (as defined in <U>Section</U><U></U><U>&nbsp;4</U>) and the Security Deposit (as defined in
<U>Section</U><U></U><U>&nbsp;8</U>), and (c)&nbsp;Sublandlord&#146;s receipt of evidence that Subtenant carries the insurance required by the Master Lease and this Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>B<SMALL>ASE</SMALL> R<SMALL>ENT</SMALL></U><SMALL></SMALL>. Beginning on the Commencement Date, Subtenant shall pay base rent to
Sublandlord in an amount determined by multiplying rentable square feet of the Subleased Premises by the Applicable Monthly Base Rate (as hereinafter defined) (each payment, a monthly installment of &#147;<B><I>Base Rent</I></B>&#148;). As used
herein, &#147;<B><I>Applicable Monthly Base Rate</I></B>&#148; shall be an amount equal to Five Dollars and Fifty Cents ($5.50) for the twelve (12)&nbsp;month period following the Commencement Date, which amount shall increase by a compounded three
percent (3%) on each annual anniversary of the Commencement Date. Notwithstanding the foregoing, the Base Rent for the first five (5)&nbsp;full calendar months of the Sublease Term shall be abated; however, if Subtenant defaults resulting in an
Event of Default under this Sublease during the Sublease Term, Subtenant shall not be entitled to any further Base Rent abatement, and if the Event of Default results in termination of the Sublease, then Subtenant shall pay to Sublandlord the
unamortized portion of the abated Base Rent as of the termination date within thirty (30)&nbsp;days of receipt of an invoice therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.
<U>A<SMALL>DDITIONAL</SMALL> R<SMALL>ENT</SMALL></U><SMALL></SMALL>. In addition to paying Base Rent, beginning on the Commencement Date, Subtenant shall pay to Sublandlord, as additional rent, Subtenant&#146;s Share of Rent Adjustment on a monthly
basis throughout the Sublease Term in accordance with Section&nbsp;4.1 of the Master Lease. As used in this Sublease, &#147;<B><I>Subtenant&#146;s Share of Rent Adjustment</I></B>&#148; means an amount which equals the ratio that the rentable square
footage of the Subleased Premises bears to the rentable square footage of the Master Premises, multiplied by Rent Adjustment attributable to the Master Premises payable by Sublandlord to Master Landlord pursuant to Article 4 of the Master Lease.
Sublandlord shall promptly forward to Subtenant all Landlord&#146;s Statements for the Master Premises that Sublandlord receives from Master Landlord. If Sublandlord receives a credit for overpayment of Rent Adjustment attributable to the Master
Premises (&#147;<B><I>Direct Expense Credit</I></B>&#148;) pursuant to Section&nbsp;4.2 of the Master Lease, Subtenant shall receive a credit against the next installment of Rent due under this Sublease in an amount equal to the ratio that the
rentable square footage of the Subleased Premises bears to the rentable square footage of the Master Premises at the time that the overpayment was made multiplied by the total Direct Expense Credit or, if the Sublease Term has ended, Sublandlord
shall pay such amount to Subtenant within thirty&nbsp;(30) days of Sublandlord&#146;s receipt of the Direct Expense Credit. If Sublandlord needs to make a payment to Master Landlord due to an underpayment of Rent Adjustment attributable to the
Master Premises (&#147;<B><I>Direct Expense Shortfall</I></B>&#148;) pursuant to Section&nbsp;4.2 of the Master Lease, Sublandlord shall submit to Subtenant an invoice therefor and Subtenant shall pay Sublandlord an amount equal to the ratio that
the rentable square footage of the Subleased Premises bears to the rentable square footage of the Master Premises at the time the underpayment was made multiplied by the total Direct Expense Shortfall together with the next installment of Rent due
or, if the Sublease Term has ended, Subtenant shall pay such amount to Sublandlord within thirty (30)&nbsp;days of Subtenant&#146;s receipt of an invoice therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Sublease to the contrary, Subtenant shall pay to
Sublandlord, together with its payment of Subtenant&#146;s Share of Rent Adjustment, 100% of the cost of: (a)&nbsp;any charges that apply solely to the Subleased Premises (e.g., real estate taxes on leasehold improvements therein), (b) late fees or
penalties assessed against Sublandlord or Master Landlord as a result of Subtenant&#146;s acts or omissions, (c)&nbsp;charges incurred as a result of excess or additional services requested by Subtenant for the Subleased Premises, and (d)&nbsp;the
cost of utilities and janitorial services consumed by Subtenant in accordance with Section&nbsp;6.2 of the Master Lease. Sublandlord shall pass through to Subtenant all abatements, credits, <FONT STYLE="white-space:nowrap">set-offs,</FONT> offsets,
and refunds received by Sublandlord under the Master Lease to the extent such abatements, credits, <FONT STYLE="white-space:nowrap">set-offs,</FONT> and offsets directly relate to the Subleased Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>P<SMALL>AYMENT</SMALL> <SMALL>OF</SMALL> R<SMALL>ENT</SMALL></U><SMALL></SMALL>. Base Rent, Rent Adjustment and any other amounts
payable by Subtenant in connection with this Sublease are referred to in this Sublease as &#147;<B><I>Rent</I></B>&#148;. Except as explicitly provided in this Sublease or the Master Lease, Rent shall be due and payable to Sublandlord without prior
written notice or demand, in advance, without deduction or offset, in lawful money of the United States of America, on or before the first day of each calendar month during the Sublease Term. Rent shall be payable at Sublandlord&#146;s address set
forth herein, or at such other place as Sublandlord may designate in writing to Subtenant. Rent for any period during this Sublease Term that is less than one (1)&nbsp;month shall be prorated based on a thirty (30)&nbsp;day month. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>D<SMALL>ELINQUENT</SMALL> P<SMALL>AYMENTS</SMALL></U><SMALL></SMALL>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.1. <U>Late Fee</U>. Subtenant acknowledges that Subtenant&#146;s late payment of Rent will cause Sublandlord to incur costs not contemplated
by this Sublease, the exact amount of such costs being difficult and impractical to fix. Such other costs include, without limitation, processing, administrative and accounting charges and late charges that may be imposed on Sublandlord.
Accordingly, if Sublandlord does not receive any Rent within five (5)&nbsp;days of its due date, Subtenant shall pay to Sublandlord an additional sum of five percent (5%) of the delinquent amount as a late charge. The Parties agree that this late
charge represents a fair and reasonable estimate of the costs that Sublandlord will incur due to Subtenant&#146;s late payment of Rent. Sublandlord&#146;s acceptance of a late charge will not constitute a waiver of Subtenant&#146;s default with
respect to the delinquent amount or prevent Sublandlord from exercising any of the other rights and remedies available to Sublandlord under this Sublease or under Applicable Laws (as defined in <U>Section</U><U></U><U>&nbsp;12</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2. <U>Interest</U>. In addition to the late charges referred to above, if Sublandlord is charged interest by Master Landlord in accordance
with Article III of the Master Lease, then Subtenant shall be responsible for reimbursing Sublandlord for such amount. Sublandlord&#146;s acceptance of interest payments will not constitute a waiver of Subtenant&#146;s default with respect to the
delinquent amount or prevent Sublandlord from exercising any of the other rights and remedies available to Sublandlord under this Sublease or under Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>S<SMALL>ECURITY</SMALL> D<SMALL>EPOSIT</SMALL></U><SMALL></SMALL>. Subtenant shall deposit with Sublandlord on or before the Effective
Date the sum of One Million Six Hundred Sixty-Four Thousand Five Hundred Sixty-Four Dollars ($1,664,564) (the &#147;<B><I>Security Deposit</I></B>&#148;), which Sublandlord will hold as security for Subtenant&#146;s faithful performance of all of
the terms, covenants and conditions of this Sublease to be kept and performed by Subtenant during the period commencing on the Effective Date and ending upon the expiration or earlier termination of Subtenant&#146;s obligations under this Sublease.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Sublandlord reserves the right to increase the amount of the Security Deposit (by the amount required to restore such Tenant Alteration) in the event that Subtenant desires to construct any
Tenant Alterations in accordance with the Master Lease, and Subtenant shall restore such Tenant Alteration as required under the Master Lease, with such increase serving as security for Subtenant&#146;s faithful performance of such restoration
obligation. Notwithstanding the foregoing, the Security Deposit shall not be increased, nor shall Subtenant have restoration obligations, with respect to the Subtenant Alterations pursuant to <U>Section</U><U></U><U>&nbsp;9</U>, so long as Master
Landlord does not seek restoration for such Subtenant Alterations. If an Event of Default occurs with respect to any provision of this Sublease, including any provision relating to the payment of Rent, then Sublandlord may, but is not required to,
use, apply or retain all or any part of the Security Deposit for the payment of any Rent or any other sum in default, or to compensate Sublandlord for any other loss or damage that Sublandlord may suffer by reason of Subtenant&#146;s Event of
Default. If Sublandlord so uses or applies any portion of the Security Deposit, then Subtenant shall, within ten (10)&nbsp;days following demand therefor, deposit cash with Sublandlord in an amount sufficient to restore the Security Deposit to its
original amount, and Subtenant&#146;s failure to do so shall be an Event of Default under this Lease. Sublandlord shall return to Subtenant the Security Deposit, less any portion thereof which Sublandlord may have used, applied, or retained as
permitted by this <U>Section</U><U></U><U>&nbsp;8</U> (provided that Sublandlord provides Subtenant with an accounting of the amounts so retained and how they were used or applied), within sixty (60)&nbsp;days after the expiration of the Sublease
Term by lapse of time or termination of the Master Lease. Subtenant shall not be entitled to any interest on the Security Deposit, and Sublandlord shall have the right to commingle the Security Deposit with Sublandlord&#146;s other funds. The
provisions of this <U>Section</U><U></U><U>&nbsp;8</U> shall survive the expiration or earlier termination of this Sublease. SUBTENANT HEREBY WAIVES THE REQUIREMENTS OF SECTION 1950.7 OF THE CALIFORNIA CIVIL CODE, AS THE SAME MAY BE AMENDED FROM
TIME TO TIME. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In lieu of the cash Security Deposit described above, the Security Deposit may be in the form of an irrevocable letter of
credit (the &#147;<B><I>Letter of Credit</I></B>&#148;) in an amount equal to the foregoing amount issued to Sublandlord, as beneficiary, in form and substance reasonably satisfactory to Sublandlord, by a bank reasonably approved by Sublandlord, in
which case, the Letter of Credit shall serve as the Security Deposit under this Sublease. Subtenant shall deliver to Sublandlord the proposed form of Letter of Credit for Sublandlord&#146;s reasonable approval prior to issuance of such Letter of
Credit. Subtenant shall maintain the Letter of Credit for the entire Sublease Term, provided that Subtenant may at any time substitute a cash Security Deposit for the Letter of Credit, and upon such substitution, Sublandlord shall return the Letter
of Credit to Subtenant. Subtenant shall pay all expenses, points and/or fees incurred by Subtenant in obtaining and maintaining the Letter of Credit. The Letter of Credit shall secure Subtenant&#146;s full and faithful performance and observance of
the terms, covenants and conditions of this Sublease. The Letter of Credit shall provide that it will be automatically renewed until at least sixty (60)&nbsp;days after the Expiration Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, as of the sixth (6<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) anniversary of the Commencement Date, all of the following are
true: a) all Rent due has been paid, b) Subtenant is not in an Event of Default hereunder, c)&nbsp;Subtenant&#146;s net worth and liquidity, as calculated pursuant to GAAP, are each not materially less than they were as of the Commencement Date,
Sublandlord agrees that the Security Deposit amount shall be reduced by fifty percent (50%), and the amount by which the Security Deposit is reduced shall be returned to Subtenant within thirty (30)&nbsp;days following the sixth (6<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) anniversary of the Commencement Date. Failure of any of the above to be true at the end of the sixth (6th) anniversary of the Commencement Date shall mean the Security Deposit shall remain
unchanged in amount for the balance of the Sublease Term. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>C<SMALL>ONDITION</SMALL> <SMALL>OF</SMALL> S<SMALL>UBLEASED</SMALL>
P<SMALL>REMISES</SMALL>; S<SMALL>UBTENANT</SMALL> A<SMALL>LTERATIONS</SMALL></U><SMALL></SMALL>. Sublandlord represents and warrants to Subtenant that (i)&nbsp;Sublandlord has completed the Tenant Work prior to the Commencement Date and in
accordance with the Master Lease (including Exhibit B of the Master Lease) and all other work required of Sublandlord by Master Landlord for occupancy of the Master Premises (e.g., installation of the Meter), (ii) as of the Commencement Date, to the
best of its knowledge, the Building Systems serving the Premises are in good working condition and repair, and (iii)&nbsp;as of the Commencement Date, to the best of its knowledge, the Premises are in compliance with all local and state codes
including Americans With Disabilities Act of 1990, 42&nbsp;U.S.C. &#167;12101, <U>et seq</U>. (as amended). Provided the foregoing representations and warranties are true, Subtenant accepts the Subleased Premises in their current &#147;AS IS, WHERE
IS&#148; condition with all faults. Except as expressly set forth in this Sublease, Subtenant hereby waives all warranties, whether express or implied (including warranties of merchantability or fitness for a particular purpose), with respect to the
Subleased Premises or any furniture, fixtures and equipment located therein, including, without limitation, the FF&amp;E (as defined in <U>Section</U><U></U><U>&nbsp;10</U>). Except as expressly set forth in this Sublease, Sublandlord makes no
representation or warranty of any kind with respect to the Subleased Premises, and Subtenant shall have full responsibility for making any desired repairs, installations, alterations or additions to the Subleased Premises. Any installations,
alterations or additions which Subtenant desires to make to the Subleased Premises shall be subject to the prior written approval of both Master Landlord and Sublandlord and shall otherwise be constructed in accordance with all of the terms and
conditions of the Master Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provided that Subtenant complies with the provisions of Article 9 of the Master Lease, Sublandlord
consents to Subtenant performing the alterations (the &#147;<B><I>Subtenant Alterations</I></B>&#148;) described in <B><U>Exhibit B</U></B><B> </B>attached hereto. Notwithstanding anything in this Sublease or the Master Lease to the contrary, the
Security Deposit shall not be increased due to the Subtenant Alterations, nor shall Subtenant have any obligation to remove the Subtenant Alterations, or restore the Subleased Premises to its condition prior to the Subtenant Alterations, at the end
of the Sublease Term. This paragraph, and Subtenant&#146;s consent hereto, shall be subject to Subtenant&#146;s receipt of consent to same from the Master Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>FF&amp;E</U>. Provided no Event of Default (as defined in <U>Section</U><U></U><U>&nbsp;22</U>) has occurred and is continuing,
Subtenant may utilize all the furniture, fixtures and equipment owned by Sublandlord and located in the Subleased Premises as of the Commencement Date (collectively, the &#147;<B><I>FF&amp;E</I></B>&#148;) during the Sublease Term, which such
FF&amp;E are itemized in <B><U>Exhibit C</U></B><B> </B>attached hereto. Sublandlord represents and warrants as of the Commencement Date that (i)&nbsp;Sublandlord is the rightful owner of the FF&amp;E, (ii)&nbsp;the FF&amp;E has not otherwise been
sold or assigned to any other person or entity, (iii)&nbsp;the FF&amp;E is free and clear of all liens, encumbrances, claims and demands, and (iv)&nbsp;to the best of Sublandlord&#146;s knowledge, the FF&amp;E is in good operating condition and free
of any defects. Except as provided in the immediately preceding sentence, Subtenant shall accept the FF&amp;E in its <FONT STYLE="white-space:nowrap">&#147;AS-IS,</FONT> <FONT STYLE="white-space:nowrap">WHERE-IS,</FONT> WITH ALL FAULTS&#148;
condition as of the Commencement Date, and Sublandlord shall have no liability to Subtenant of any kind under any circumstances arising out of or in connection with the FF&amp;E arising from and after the Commencement Date of such FF&amp;E or
Subtenant&#146;s use thereof. Subtenant hereby releases Sublandlord from and against any and all claims, damages, costs, expenses and liabilities arising out of or in connection with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
FF&amp;E, and/or Subtenant&#146;s use thereof, from and after the Commencement Date, including, without limitation, any taxes with respect to the FF&amp;E and/or Subtenant&#146;s use thereof, and
any related interest and penalties resulting from late payment by Subtenant thereof (collectively, &#147;<B>FF&amp;E Claims</B>&#148;), and Subtenant shall indemnify, defend and hold Sublandlord harmless from and against any and all FF&amp;E Claims
accruing on and after the Commencement Date. Notwithstanding the foregoing, Sublandlord shall inform Subtenant of the terms and conditions of any manufacturer&#146;s warranties or guarantees (&#147;<B><I>Manufacturer&#146;s Warranties</I></B>&#148;)
with respect to the FF&amp;E in effect as of the Commencement Date, and in the event of any FF&amp;E defect in design, material, or workmanship covered by such Manufacturer&#146;s Warranties, Sublandlord shall assert such applicable
Manufacturer&#146;s Warranties using commercially reasonable efforts after Subtenant notifies Sublandlord of the defect. Subtenant shall maintain the FF&amp;E in good condition and repair, reasonable wear and tear excepted, and shall be responsible
for any loss or damage to the FF&amp;E occurring from the Commencement Date through the Expiration Date. Subtenant may freely move, and/or remove any of the FF&amp;E from the Subleased Premises without replacement thereof or notification to
Sublandlord. On the Expiration Date, Subtenant shall purchase the FF&amp;E from Sublandlord for the sum of One Dollar ($1.00) pursuant to a bill of sale in form and content substantially identical to the form of Bill and Sale attached hereto as
<B><U>Exhibit D</U></B>, in its &#147;AS IS, WHERE IS&#148; condition, without representation or warranty whatsoever, except that Sublandlord is the rightful owner of the FF&amp;E, that the FF&amp;E has not otherwise been sold or assigned to any
other person or entity, and that the FF&amp;E is free and clear of all liens, encumbrances, claims and demand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.
<U>U<SMALL>SE</SMALL></U><SMALL></SMALL>. Subtenant may use the Subleased Premises solely for the Permitted Use, and for no other use. Subtenant&#146;s use of the Subleased Premises must at all times comply with the requirements of the Master Lease,
and Subtenant shall not use the Subleased Premises in a manner that is in any way inconsistent with the Master Lease or that might cause Sublandlord to be in breach of the Master Lease. Subtenant shall not commit or allow to be committed any waste
upon the Building or Subleased Premises, or any public or private nuisance or act which is unlawful. Subtenant shall not commit any act that will increase the then existing rate of insurance on the Building or the Master Premises. Subtenant shall
promptly pay upon demand the amount of any such increase in insurance rates caused by any act of Subtenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.
<U>C<SMALL>OMPLIANCE</SMALL> <SMALL>WITH</SMALL> L<SMALL>AWS</SMALL></U><SMALL></SMALL>. Subtenant shall, at its sole cost and expense, promptly comply with all laws, ordinances and regulations with respect to Subtenant&#146;s use, occupancy or
improvement of the Subleased Premises, including, without limitation, the Americans With Disabilities Act of 1990, 42 U.S.C. &#167;12101, <U>et seq</U>. (as amended, together with the regulations promulgated pursuant thereto) (collectively,
&#147;<B><I>Applicable Laws</I></B>&#148;). Additionally, Subtenant shall be responsible, at its sole cost and expense, to reimburse Sublandlord for any legal compliance costs incurred by Sublandlord with respect to the Subleased Premises as a
result of Subtenant&#146;s (a)&nbsp;specific use and occupancy of the Subleased Premises (as opposed to general office use), (b)&nbsp;obtaining any permit or license with respect to the Subleased Premises, or (c)&nbsp;making any installations,
additions or alterations to the Subleased Premises. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>C<SMALL>OMPLIANCE</SMALL> <SMALL>WITH</SMALL> M<SMALL>ASTER</SMALL>
L<SMALL>EASE</SMALL></U><SMALL></SMALL>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.1. <U>Subtenant Representations, Warranties, and Covenants</U>. Subtenant represents and
warrants that it will occupy the Subleased Premises in accordance with all of the terms and conditions of the Master Lease as they apply to the Subleased Premises and will not suffer to be done or omit to do any act which may result in a violation
of or a default under any of the terms and conditions of the Master Lease, or render Sublandlord liable for any damage, charge or expense thereunder. Subtenant further covenants and agrees that it will indemnify Sublandlord against and hold
Sublandlord harmless from any claim, demand, action, proceeding, suit, liability, loss, judgment, expense (including reasonable attorneys&#146; fees) and damages of any kind or nature whatsoever (&#147;<B><I>Claims</I></B>&#148;) arising out of, by
reason of, or resulting from, Subtenant&#146;s failure to perform or observe any of the terms and conditions of the Master Lease applicable to the Subleased Premises or this Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2. <U>Sublandlord Representations, Warranties, and Covenants</U>. Sublandlord represents and warrants the following is true and correct as
of the Effective Date and Commencement Date: (i)&nbsp;Sublandlord is the tenant under the Master Lease and has the capacity to enter into this Sublease with Subtenant, subject to Master Landlord&#146;s consent, (ii)&nbsp;the Master Lease attached
hereto as <B><U>Exhibit E</U></B><B> </B>is a true, correct, and complete copy of the Master Lease, is in full force and effect, and has not been further modified, amended, or supplemented except as expressly set out herein, (iii)&nbsp;Sublandlord
has not received any notice, and has no actual knowledge, of any default by Sublandlord under the Master Lease, and (iv)&nbsp;Sublandlord has no actual knowledge of any default by Master Landlord under the Master Lease. Sublandlord covenants that it
will maintain the Master Lease during the entire Sublease Term, subject, however, to any earlier termination of the Master Lease without the fault of Sublandlord. Sublandlord shall use commercially reasonable efforts to cause the Master Landlord to
perform its obligations under the Master Lease (including without limitation by making written demands to Master Landlord to perform its obligations under the Master Lease with respect to the Subleased Premises) and shall use commercially reasonable
efforts to cooperate with Subtenant in its efforts to obtain such performance. Sublandlord hereby covenants not to enter into any amendment or other agreement with respect to the Master Lease without the prior written consent of the Subtenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.3. <U>Subordination of Sublease</U>. This Sublease is subject and subordinate to the Master Lease in all respects. If the Master Lease is
terminated for any reason whatsoever, then this Sublease shall automatically terminate as if it expired by its terms (unless assumed by Master Landlord), and in such event neither Sublandlord nor Master Landlord shall have any liability whatsoever
to Subtenant as a result of such termination, except that Sublandlord shall be liable to Subtenant for any such termination arising as a result of Sublandlord&#146;s default under the Master Lease (to the extent not caused by Subtenant&#146;s acts
or omissions). Except as expressly provided in <U>Section</U><U></U><U>&nbsp;13.2</U>, under no circumstance shall Sublandlord be obligated to, or be responsible or liable in any way for, Master Landlord&#146;s failure to (a)&nbsp;perform any acts
required to be completed by Master Landlord under the Master Lease, (b)&nbsp;supply any item, including, but not limited to, any utility or service to the Subleased Premises required to be supplied by Master Landlord under the Master Lease, or
(c)&nbsp;complete any work or maintenance in the Subleased Premises, the Building or the Master Premises required to be completed by Master Landlord under the Master Lease; and no such failure will in any way excuse Subtenant&#146;s performance
under this Sublease or entitle Subtenant to any abatement of Rent, unless Sublandlord has so received an abatement of Rent from Master Landlord, in which case such abatement shall be passed through to Subtenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.4. <U>Incorporation of Terms</U>. Except as expressly provided in this
<U>Section</U><U></U><U>&nbsp;13.4</U> or as otherwise stated in this Sublease, Subtenant hereby assumes and agrees to perform, and shall inure to the benefit of, each and every covenant, term, condition, and obligation binding on or inuring to the
benefit of Sublandlord under the Master Lease with respect to the Subleased Premises (and Sublandlord shall have the right to elect to require Subtenant to perform its obligations under the Master Lease directly to Master Landlord on prior written
notice and Master Landlord&#146;s consent to the same). Whenever the term &#147;Landlord,&#148; &#147;Tenant,&#148; or &#147;Premises&#148; appears in the Master Lease, the word &#147;Sublandlord,&#148; &#147;Subtenant&#148; or &#147;Subleased
Premises&#148; shall be substituted therefore. Notwithstanding the foregoing, (i)&nbsp;to the extent of any inconsistencies between the express terms of this Sublease and the terms of the Master Lease incorporated herein by reference, the express
terms of this Sublease shall control, (ii)&nbsp;Subtenant shall have no renewal or extension rights (including the Renewal Option), other options under the Master Lease (including the Right of First Offer and Special ROFO) or rights to terminate the
Master Lease, whether following a casualty or condemnation event, or otherwise, without prior written consent of Sublandlord and Master Landlord, which may be withheld or conditioned at their sole discretion, (iii)&nbsp;with respect to any
obligation of Subtenant to be performed under this Sublease, except as provided in this Sublease, wherever the Master Lease grants to Sublandlord a specified number of days after notice or other time condition to perform its corresponding obligation
under the Master Lease (excluding the payment of Rent), Subtenant shall have <FONT STYLE="white-space:nowrap">one-third</FONT> fewer days (rounded to the nearest whole day) to perform the obligation (by way of example only, Subtenant shall have 10
fewer days to perform an obligation to be performed in 30 days, and shall have 2 fewer days to perform an obligation to be performed in 5 days), including, without limitation, curing any defaults. Any default notice or other notice of any
obligations (including any billing or invoice for any Rent or any other expense or charge due under the Master Lease) from Master Landlord which is received by Subtenant (whether directly or as a result of being forwarded by Sublandlord) shall
constitute such notice from Sublandlord to Subtenant under this Sublease without the need for any additional notice from Sublandlord, and (iv)&nbsp;Sublandlord shall be solely responsible for any obligations and liability arising under the Master
Lease prior to the Commencement Date. Whenever the provisions of the Master Lease require the written consent of Master Landlord, said provisions shall be construed to require the written consent of both Master Landlord and Sublandlord. For any act
requiring Master Landlord consent, upon request from Subtenant and subject to Subtenant&#146;s full cooperation, Sublandlord shall promptly make such consent request on behalf of Subtenant and Subtenant shall promptly provide any information or
documentation that Master Landlord may request. Wherever the provisions of the Master Lease require the indemnification of Master Landlord, said provisions shall be construed to require the indemnification of both Master Landlord and Sublandlord
(and their respective owners, partners, principals, members, trustees, officers, directors, shareholders, agents, employees and lenders). Subtenant hereby acknowledges that it has read and is familiar with all the terms of the Master Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.5. <U>Survival</U>. The provisions of this <U>Section</U><U></U><U>&nbsp;13</U> shall survive the expiration or earlier termination of this
Sublease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>U<SMALL>TILITIES</SMALL>; S<SMALL>ERVICES</SMALL></U><SMALL></SMALL>. Sublandlord shall have no obligation to provide to
the Subleased Premises any services or utilities (including, without limitation, telephone or internet services) of any kind and shall have no liability for any interruption in utilities or services to the Subleased Premises; provided, however, that
to the extent Sublandlord provides any services or utilities to the Subleased Premises, Subtenant shall pay to Sublandlord (upon receipt of invoice) the amounts necessary to reimburse Sublandlord for the actual costs of providing such services.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Sublandlord shall not be responsible or liable in any way for any failure or interruption, for any reason whatsoever, of the services, utilities or facilities that may or should be appurtenant or
supplied to the Subleased Premises, and no such failure will in any way excuse Subtenant&#146;s performance under this Sublease or entitle Subtenant to any abatement of Rent, unless Sublandlord receives such an abatement from Master Landlord, in
which case such abatement shall be passed through to Subtenant, or such failure is a result of Sublandlord&#146;s gross negligence or willful misconduct, or Sublandlord&#146;s default under the Master Lease, in which event Subtenant may contract
directly with Master Landlord to restore such interrupted utilities and services. Subtenant shall pay to Sublandlord as Rent hereunder any and all sums which Sublandlord may be required to pay to Master Landlord or any service provider arising out
of excess consumption by Subtenant or a request by Subtenant for additional building services (e.g., charges associated with after-hours HVAC usage and over-standard electrical charges). Notwithstanding anything to the contrary in this Sublease or
the Master Lease, Subtenant agrees that Sublandlord shall not be required to perform any of the covenants, agreements or obligations of Master Landlord under the Master Lease and, insofar as any of the covenants, agreements and obligations of
Sublandlord hereunder are required to be performed under the Master Lease by Master Landlord thereunder, Subtenant acknowledges and agrees that Subtenant will look solely to Master Landlord for such performance, subject to Section&nbsp;13.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>M<SMALL>AINTENANCE</SMALL>; &#147;T<SMALL>ENANT</SMALL> W<SMALL>ORK</SMALL>&#148;</U>. Subtenant shall perform all maintenance and
repairs in the Subleased Premises which Sublandlord is required to perform under the Master Lease; <U>provided</U>, <U>however</U>, that, at Sublandlord&#146;s option, or if Subtenant fails to make such repairs, Sublandlord may, but need not, make
such repairs and replacements, and Subtenant shall pay Sublandlord&#146;s costs or expenses, arising from Sublandlord&#146;s involvement with such repairs and replacements upon being billed for same. Notwithstanding the foregoing, with respect to
the Tenant Work performed by Sublandlord pursuant to the Master Lease, Sublandlord shall be solely responsible for completing any &#147;punch list&#148; items and correcting any defects, deviations, or disapprovals identified by Master Landlord
pursuant to Master Landlord&#146;s inspection under Exhibit B of the Master Lease. For the avoidance of doubt, in no event shall Sublandlord be obligated to undertake any maintenance and repair obligations that are the responsibility of Master
Landlord under the Master Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>A<SMALL>SSIGNMENT</SMALL> <SMALL>AND</SMALL> S<SMALL>UBLETTING</SMALL></U><SMALL></SMALL>.
Subtenant shall not assign, mortgage, hypothecate, encumber or otherwise transfer this Sublease or <FONT STYLE="white-space:nowrap">sub-sublease</FONT> (which term shall be deemed to include the granting of concessions and licenses and the like) the
whole or any part of the Subleased Premises, including by operation of law (any of the foregoing, an &#147;<B><I>Assignment</I></B>&#148;), without in each case first obtaining the prior written consent of Sublandlord, not to be unreasonably
withheld; it being agreed that it shall be deemed reasonable for Sublandlord to withhold its consent to an Assignment, if Master Landlord has withheld its consent to the same. No Assignment shall relieve Subtenant of any liability under this
Sublease. Consent to any such Assignment shall not operate as a waiver of the necessity for consent to any subsequent Assignment. In connection with each request for an Assignment, Subtenant shall pay up to $2,500 Sublandlord&#146;s reasonable costs
of processing such Assignment, including reasonable attorneys&#146; fees, and any fees or costs payable under the Master Lease, upon demand of Sublandlord. Any assignee or subtenant shall assume all of Subtenant&#146;s obligations under this
Sublease and be jointly and severally liable with Subtenant hereunder. Any Assignment hereunder must comply with terms and conditions in Article 10 of the Master Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>I<SMALL>NDEMNITY</SMALL></U><SMALL></SMALL>. Without in any way limiting the
applicability or terms of any indemnities found in the Master Lease, Subtenant shall, except to the extent caused by Sublandlord&#146;s negligence or willful misconduct, indemnify, protect, defend and hold harmless Master Landlord and Sublandlord or
any of its owners, partners, principals, members, trustees, officers, directors, shareholders, agents, employees and lenders (&#147;<B><I>Sublandlord Related Parties</I></B>&#148;), from and against any and all Claims occurring within the Subleased
Premises on or after the Commencement Date or arising out of, involving, or in connection with, (a)&nbsp;the use or occupancy of the Subleased Premises by Subtenant, (b)&nbsp;the acts or omissions of Subtenant or any of Subtenant&#146;s invitees,
agents or employees, (c)&nbsp;any breach of this Sublease by Subtenant, and (d)&nbsp;any violation of Applicable Laws caused by Subtenant. If any action or proceeding is brought against Master Landlord or Sublandlord by reason of any of the
foregoing matters, Subtenant shall upon notice defend the same at Subtenant&#146;s expense by counsel reasonably satisfactory to Master Landlord and Sublandlord. Sublandlord shall, except to the extent caused by Subtenant&#146;s negligence or
willful misconduct, indemnify, protect, defend, and hold harmless Subtenant and any of its owners, partners, principals, members, trustees, directors, officers, shareholders, agents, employees, and lenders (&#147;<B><I>Subtenant Related
Parties</I></B>&#148;), from and against any and all Claims occurring within the Subleased Premises prior to the Commencement Date or arising out of, involving, or in connection with (a)&nbsp;the use or occupancy of the Subleased Premises by
Sublandlord prior to the Commencement Date, or (b)&nbsp;breach of this Sublease by Sublandlord. If any action or proceeding is brought against Subtenant by reason of any of the foregoing matters, Sublandlord shall upon notice defend the same at
Sublandlord&#146;s expense by counsel reasonably satisfactory to Subtenant. This <U>Section</U><U></U><U>&nbsp;17</U> shall survive the expiration or earlier termination of this Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>E<SMALL>XEMPTION</SMALL> <SMALL>OF</SMALL> S<SMALL>UBLANDLORD</SMALL> <SMALL>FROM</SMALL> L<SMALL>IABILITY</SMALL></U><SMALL></SMALL>.
Unless caused by Sublandlord&#146;s gross negligence or willful misconduct, Sublandlord shall not be liable for injury or damage to the person or goods, wares, merchandise, or other property of Subtenant, Subtenant&#146;s employees, contractors,
invitees, customers, or any other person in or about the Master Premises, whether such damage or injury is caused by or results from fire, steam, electricity, gas, water or rain, or from the breakage, leakage, obstruction or other defects of pipes,
fire sprinklers, wires, appliances, plumbing, air conditioning or lighting fixtures, or from any other cause, whether said injury or damage results from conditions arising from the Master Premises or from any other source or place, and regardless of
whether the cause of damage or injury or the means of repairing the same is accessible. Notwithstanding any provision in this Sublease to the contrary, neither Sublandlord nor any Sublandlord Related Parties, Master Landlord, any holder of any
mortgage, deed of trust, or other security instrument encumbering the Building, the Building ground lessor, the Building property manager, the Building leasing manager, nor their respective partners, members, officers, directors, agents, or
employees (collectively, the &#147;Indemnitees&#148;), shall be liable for (and Subtenant hereby waives any claims for) any consequential damages, compensation or claims for inconvenience or loss of business, rents or profits as a result of any
injury or damage, whether or not caused by the willful and wrongful act of any of the foregoing Indemnitees. Subtenant and its respective partners, members, officers, directors, agents, and employees shall only be liable to Sublandlord and
Sublandlord&#146;s Related Parties for any consequential damages, compensation or claims for inconvenience or loss of business, rents or profits as a result of any injury or damage to the extent; (a)&nbsp;(i) caused directly by an act or omission of
Subtenant or any of Subtenant&#146;s invitees, agents or employees and (ii)&nbsp;Master Landlord has brought an action or proceeding against Sublandlord for same; or (b)&nbsp;to the extent resulting from a holdover (which is governed by
Section&nbsp;24 of this Sublease). Without limiting Subtenant&#146;s indemnity obligations under Section&nbsp;17, Subtenant shall indemnify Sublandlord in accordance with Section&nbsp;17 for any Claims brought by Master Landlord against Sublandlord
pursuant to item (a)(ii) above, provided that (a)(i) is satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>D<SMALL>AMAGE</SMALL> <SMALL>AND</SMALL> D<SMALL>ESTRUCTION</SMALL>;
C<SMALL>ONDEMNATION</SMALL></U><SMALL></SMALL>. In no event shall Sublandlord have any obligation to Subtenant to restore the Subleased Premises or the Master Premises if damaged, destroyed or condemned as described in Article 14 or Article 15 of
the Master Lease. To the extent any damage, destruction or casualty loss occurs in the Master Premises or Subleased Premises which entitles Sublandlord to terminate the Master Lease, Sublandlord shall so notify Subtenant, and Sublandlord may
terminate the Master Lease, in which event this Sublease shall automatically terminate without liability to Subtenant. With respect to damage, destruction or condemnation (as described in Articles 14 and 15 of the Master Lease), Subtenant shall be
entitled to any abatement, credits, allowances, awards, insurance proceeds, or other compensation for loss or relocation, in each case as received by Sublandlord and only to the extent pertaining to the Subleased Premises, any Tenant Additions made
by Subtenant, or any Subtenant personal property, trade fixtures, and equipment, or any interruption of Subtenant&#146;s business, and only to the extent provided under the Master Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>B<SMALL>ROKERS</SMALL></U><SMALL></SMALL>. Sublandlord and Subtenant hereby represent and warrant to each other that they have had no
dealings with any real estate broker or agent in connection with the negotiation of this Sublease, and that they know of no other real estate broker or agent who is entitled to a commission in connection with this Sublease, other than:
(a)&nbsp;Cresa, representing Sublandlord, and (b)&nbsp;Savills, representing Subtenant (collectively, the &#147;<B><I>Brokers</I></B>&#148;). Each Party agrees to indemnify and defend the other Party against and hold the other Party harmless for,
from and against any and all Claims with respect to any leasing commission or equivalent compensation alleged to be owing on account of the indemnifying Party&#146;s dealings with any real estate broker or agent other than the Brokers. The
indemnities in this <U>Section</U><U></U><U>&nbsp;20</U> shall survive the expiration or termination of this Sublease. Sublandlord shall pay the Brokers applicable commissions per a separate agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>N<SMALL>OTICES</SMALL></U><SMALL></SMALL>. Any notice, demand or request required or desired to be given under this Sublease to
Sublandlord or Subtenant shall be in writing via (a)&nbsp;personal delivery, (b)&nbsp;First Class&nbsp;U.S. Mail, return receipt requested, (c)&nbsp;FedEx or other reputable overnight carrier, or (d)&nbsp;email (but only if a hard copy is sent
within one (1)&nbsp;business day thereafter by one of the methods in the foregoing sections (a)&nbsp;through (c)), and shall be addressed to the address of the Party to be served, as set forth in this <U>Section</U><U></U><U>&nbsp;21</U>. Either
Party may from time to time, by written notice to the other Party in accordance with this <U>Section</U><U></U><U>&nbsp;21</U>, designate a different address than that set forth below for the purpose of notice. Upon receipt of any notice from Master
Landlord, Subtenant shall promptly deliver a copy of such notice to Sublandlord in accordance with the terms and conditions of this <U>Section</U><U></U><U>&nbsp;21</U>. Upon receipt of any notice from Master Landlord, Sublandlord shall promptly
deliver a copy of such notice to Subtenant in accordance with the terms and conditions of this <U>Section</U><U></U><U>&nbsp;20</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Sublandlord:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Subtenant:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dynavax Technologies Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Chief
Financial Officer</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2929 7th Street, Suite 100</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Berkeley, CA
94710</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zymergen Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: VP Real Estate&nbsp;&amp;
Facilities</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 Horton St., Suite 105</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA
94608</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>With a copy to:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>With a copy to:</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dynavax Technologies Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: General
Counsel</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2929 7th Street, Suite 100</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Berkeley, CA
94710</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zymergen Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: General Counsel</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 Horton St., Suite 105</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email:</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>D<SMALL>EFAULT</SMALL></U><SMALL></SMALL>. The occurrence of any of the following events (each, an
&#147;<B><I>Event of Default</I></B>&#148;) shall constitute a material default and breach of this Sublease by Subtenant: (a)&nbsp;Subtenant&#146;s failure to pay Rent, where such failure shall continue for a period of four (4)&nbsp;days following
Subtenant&#146;s receipt of written notice thereof from Sublandlord; provided, however, that any such notice shall be in lieu of, and not in addition to, any notice required under California Code of Civil Procedure, Section&nbsp;1161, (b) the
occurrence of any of the events described in Article&nbsp;11 of the Master Lease due to Subtenant&#146;s acts or omissions, which remain uncured after the cure period provided in the Master Lease as such cure period is adjusted pursuant to this
Sublease. Upon any Subtenant Event of Default under this Sublease, Sublandlord shall have all of the remedies available to Master Landlord pursuant to the Master Lease, including, without limitation, the remedies enumerated in Section&nbsp;11.2 of
the Master Lease. All of Sublandlord&#146;s rights and remedies herein enumerated or incorporated by reference above are cumulative, and none will exclude any other right or remedy allowed by law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following events (each, an &#147;<B><I>Event of Default</I></B>&#148;) shall constitute a material default and breach of this Sublease by
Sublandlord: the occurrence of any of the events described in Article&nbsp;11 of the Master Lease due to Sublandlord&#146;s acts or omissions, which remain uncured after the cure period provided in the Master Lease. Upon any Sublandlord Event of
Default under this Sublease, Subtenant shall have all rights or remedies allowed by law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.
<U>S<SMALL>URRENDER</SMALL></U><SMALL></SMALL>. On the expiration or earlier termination of this Sublease, Subtenant shall, at its sole cost and expense, surrender and deliver up the Subleased Premises to Sublandlord, in a broom-clean, good and
tenantable condition, excepting ordinary wear and tear, repair and maintenance for which Master Landlord is responsible under the Master Lease and casualty damage, and otherwise in accordance with the requirements of the Master Lease, including,
without limitation, removal of Required Removables in accordance with Section&nbsp;12.1 of the Master Lease. Subtenant acknowledges that, pursuant to Section&nbsp;12.1 of the Master Lease, all permanent improvements, including the Subtenant
Alterations, shall remain upon the Subleased Premises at the end of the Sublease Term without compensation to Subtenant, except for the Required Removables. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>H<SMALL>OLDOVER</SMALL></U><SMALL></SMALL>. If Subtenant fails to surrender the
Subleased Premises in accordance with the terms and conditions of this Sublease on or before the Expiration Date or earlier termination of this Sublease, such tenancy shall be from
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">month-to-month</FONT></FONT> only, at a rental rate that is 150% of the monthly Rent payable under this Sublease immediately prior to termination or expiration of this Sublease, and
shall not constitute a renewal or extension of this Sublease. Notwithstanding any provision to the contrary contained in this Sublease, (i)&nbsp;Sublandlord expressly reserves the right to require Subtenant to surrender possession of the Subleased
Premises upon the expiration of the Sublease Term or upon the earlier termination hereof and the right to assert any remedy at law or in equity to evict Subtenant or collect damages in connection with any such holding over, and (ii)&nbsp;Subtenant
shall indemnify, defend and hold Sublandlord harmless from and against any and all Claims incurred or suffered by Sublandlord by reason of Subtenant&#146;s failure to surrender the Subleased Premises on the expiration or earlier termination of this
Sublease in accordance with the provisions of this Sublease, including without limitation one hundred percent (100%) of all holdover rent and other costs chargeable to Sublandlord pursuant to the Master Lease as a result of Subtenant&#146;s
holdover. The provisions of this <U>Section</U><U></U><U>&nbsp;24</U> shall survive the expiration or earlier termination of this Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <U>P<SMALL>ARKING</SMALL></U><SMALL></SMALL>. During the Sublease Term, Subtenant shall have the right to park at the Garage or at such
other location(s) in the vicinity of the Project designated by Master Landlord or Master Landlord&#146;s parking operator from time to time, on an unreserved basis, up to 151 cars (two&nbsp;(2) unreserved parking spaces for each (1,000) rentable
square feet of the Subleased Premises), in accordance with Section&nbsp;2.5 of the Master Lease. Subtenant&#146;s right to use the parking space is expressly conditioned upon Subtenant&#146;s compliance with terms and conditions of the Master Lease
and all reasonable rules and regulations respecting parking established from time to time by Master Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.
<U>S<SMALL>IGNAGE</SMALL></U><SMALL></SMALL>. Subtenant&#146;s signage rights under Section&nbsp;6.7 of the Master Lease are conditioned on Master Landlord&#146;s prior written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27. <U>I<SMALL>NSURANCE</SMALL></U><SMALL></SMALL>. The provisions of Article 16 of the Master Lease pertaining to insurance shall be
incorporated into this Sublease, subject to the following terms. For purposes of this Sublease, the term &#147;Tenant&#148; in Article 16 of the Master Lease Agreement shall be deemed to mean Subtenant, and the term &#147;Landlord&#148; shall be
deemed to mean Master Landlord (except that the release and waiver of subrogation shall also apply as between Sublandlord and Subtenant, as well as between Sublandlord and Subtenant) and the term &#147;Premises&#148; shall mean the &#147;Subleased
Premises&#148;, except that all policies of liability insurance required to be maintained by Subtenant hereunder and thereunder shall name Sublandlord and Master Landlord as additional named insureds and all notices related to such insurance and all
evidence of such policies shall be delivered to Sublandlord and Master Landlord. The form of insurance certificate to be provided by Sublandlord shall be subject to approval by Sublandlord and Master Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">28. <U>L<SMALL>IMITATION</SMALL> <SMALL>OF</SMALL> L<SMALL>IABILITY</SMALL></U><SMALL></SMALL>. None of the Sublandlord Related Parties shall
have any personal liability for any default by Sublandlord under this Sublease or arising in connection herewith or with the operation, management, leasing, repair, renovation, alteration or any other matter relating to the Project or the Subleased
Premises, and Subtenant hereby expressly waives and releases such personal liability on behalf of itself and all persons claiming by, through or under Subtenant. The terms of this <U>Section</U><U></U><U>&nbsp;28</U> shall inure to the benefit of
Sublandlord&#146;s and the Sublandlord Related Parties&#146; present and future partners, beneficiaries, officers, directors, trustees, shareholders, agents and employees, and their respective partners, heirs, successors and assigns. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29. <U>E<SMALL>STOPPEL</SMALL></U><SMALL></SMALL>. Within ten (10)&nbsp;business days after
request therefor by Sublandlord, Subtenant agrees to execute an Estoppel Certificate in accordance with Article 21 of the Master Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30. <U>G<SMALL>OVERNING</SMALL> L<SMALL>AW</SMALL></U><SMALL></SMALL>. The terms and provisions of this Sublease shall be construed in
accordance with and governed by the laws of the State of California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">31. <U>P<SMALL>ARTIAL</SMALL>
I<SMALL>NVALIDITY</SMALL></U><SMALL></SMALL>. If any term, provision or condition contained in this Sublease shall, to any extent, be invalid or unenforceable, the remainder of this Sublease, or the application of such term, provision or condition
to persons or circumstances other than those with respect to which it is invalid or unenforceable, shall not be affected thereby, and each and every other term, provision and condition of this Sublease shall be valid and enforceable to the fullest
extent possible permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">32. <U>A<SMALL>TTORNEYS</SMALL>&#146; F<SMALL>EES</SMALL></U><SMALL></SMALL>. If any Party commences
litigation against another in connection with this Sublease, for damages for the breach hereof or otherwise for enforcement of any remedy hereunder, the prevailing Party shall be entitled to recover from the other Party such costs and reasonable
attorneys&#146; fees as may have been incurred, including any and all costs incurred in enforcing, perfecting and executing such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">33. <U>C<SMALL>OUNTERPARTS</SMALL> <SMALL>AND</SMALL> E<SMALL>LECTRONIC</SMALL> S<SMALL>IGNATURES</SMALL></U><SMALL></SMALL>. This Sublease
may be executed in counterparts, each of which shall be deemed an original, but such counterparts, when taken together, shall constitute one agreement. This Sublease may be executed by a Party&#146;s signature transmitted by email, and copies of
this Sublease executed and delivered by means of emailed signatures shall have the same force and effect as copies hereof executed and delivered with original signatures. All Parties hereto may rely upon emailed signatures (including signatures in
Portable Document Format) as if such signatures were originals. All Parties hereto agree that an emailed signature page may be introduced into evidence in any proceeding arising out of or related to this Sublease as if it were an original signature
page. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">34. <U>E<SMALL>NTIRE</SMALL> A<SMALL>GREEMENT</SMALL></U><SMALL></SMALL>. This Sublease, together with the Master Lease as
incorporated or referenced herein, constitutes the entire agreement and complete understanding of the Parties with respect to the matters set forth herein and merges and supersedes all prior, oral and written, agreements and understandings, and all
contemporaneous oral agreements and understandings, of any nature whatsoever with respect to such subject matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">35.
<U>M<SMALL>ASTER</SMALL> L<SMALL>ANDLORD</SMALL>&#146;<SMALL>S</SMALL> C<SMALL>ONSENT</SMALL></U><SMALL></SMALL>. This Sublease is subject to and contingent upon and shall be of no force or effect until Master Landlord&#146;s execution of a written
consent to this Sublease in a form reasonably acceptable to the Parties hereto (the &#147;<B><I>Landlord Consent</I></B>&#148;). In the event Master Landlord does not so execute the Landlord Consent within thirty (30)&nbsp;days of the Effective
Date, either Party may terminate this Sublease upon written notice to the other Party after the expiration of such thirty (30)&nbsp;day period, but before Master Landlord delivers the Landlord Consent. If this Sublease is so terminated, Sublandlord
shall promptly return to Subtenant any prepaid Rent and the Security Deposit previously paid to Sublandlord. Neither Party shall have any liability to the other for any termination or cancellation of this Sublease as a result of Master
Landlord&#146;s failure or refusal to consent to this Sublease despite such efforts by the Parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>]
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL>,</B> Sublandlord and
Subtenant have executed this Sublease as of the date and year set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SUBLANDLORD:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>SUBTENANT:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DYNAVAX TECHNOLOGIES CORPORATION,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware corporation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ZYMERGEN INC.,</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ryan Spencer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Enakshi Singh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Ryan Spencer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Enakshi Singh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: <FONT STYLE="white-space:nowrap">Co-President</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Title: VP, Finance</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>E<SMALL>XHIBIT</SMALL> A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Subleased Premises </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6th Floor </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp132.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>E<SMALL>XHIBIT</SMALL> A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Subleased Premises </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7th Floor </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp133.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>E<SMALL>XHIBIT</SMALL> B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Subtenant Alterations </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6th Floor </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp134.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>E<SMALL>XHIBIT</SMALL> B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Subtenant Alterations </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7th Floor </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp135.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>E<SMALL>XHIBIT</SMALL> C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FF&amp;E </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5959 Horton FF&amp;E </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(216) 6x8 workstations with height adjustable work surface and various storage configurations
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assorted conference/huddle/focus room furniture including tables, chairs and credenzas </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">100 black desk chairs </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Breakroom and open collaboration area furniture on
6<B><SUP STYLE="font-size:75%; vertical-align:top">th</SUP></B><B> </B>floor </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6 leatherette chairs&nbsp;&amp; 3 tables on 7<B><SUP STYLE="font-size:75%; vertical-align:top">th</SUP></B><B>
</B>floor </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All centralized waste containers </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Small tables located in private offices </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Security hardware including card readers, security cameras, and AiPhone stations in freight elevators
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">TAB file system </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Breakroom and coffee bar accessories: refrigerators, microwaves, and dishwashers </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2 lab freezers </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1 lab deli case </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9 biosafety cabinets </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Televisions in conference and huddle rooms </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>E<SMALL>XHIBIT</SMALL> D </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BILL OF SALE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This BILL OF SALE
(&#147;<B>Agreement</B>&#148;) is made and entered into as of __________, from _________________ (&#147;<B>Seller</B>&#148;) to _________________ (&#147;<B>Buyer</B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>RECITALS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A. Seller has subleased
to Buyer, and Buyer has subleased from Seller, certain space located at _________________ in that certain Sublease dated _________________ (the &#147;<B>Premises</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B. Seller is the owner of certain furniture, fixtures and equipment (the &#147;<B>FF&amp;E</B>&#148;) as listed on Exhibit C of the Sublease and made a part
hereof, which is currently located in the Sublease Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C. Seller has agreed to sell, transfer and convey to Buyer all of Seller&#146;s right, title
and interest in and to the FF&amp;E upon the terms and conditions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are acknowledged, Seller and Buyer agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERMS AND CONDITIONS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Consideration</U>. As consideration for the sale of the FF&amp;E by Seller to Buyer, Buyer hereby agrees to pay to Seller the amount of One Dollar
($1.00) (the &#147;<B>Purchase Price</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Transfer and Assignment</U>. Subject to the terms and provisions contained herein, as of the date
of this Agreement, Seller transfers and conveys to Buyer all of Seller&#146;s right, title and interest in and to the FF&amp;E, and under any manufacturer&#146;s warranties or guarantees (the &#147;<B>Manufacturer&#146;s Warranties</B>&#148;)
related to the FF&amp;E, free and clear of all liens, encumbrances and security interests created by Seller. Buyer accepts the transfer and conveyance of the right, title and interest of Seller in and to the FF&amp;E and the Manufacturer&#146;s
Warranties, subject to the provisions contained herein. Buyer accepts the FF&amp;E in its currently existing &#147;<B><FONT STYLE="white-space:nowrap">AS-IS</FONT></B>&#148;, &#147;<B><FONT STYLE="white-space:nowrap">WHERE-IS</FONT></B>&#148;<B>
</B>condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Inspection of the FF&amp;E</U>. Buyer has inspected the FF&amp;E and determined that it is acceptable to Buyer. Seller has not made,
and shall not be bound by, any statements, agreement, or representations regarding the FF&amp;E not specifically set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>NO WARRANTY FOR
MERCHANTABILITY AND FITNESS</U>. BUYER AGREES THAT SELLER MAKES NO WARRANTIES, EXPRESSED OR IMPLIED AND ALL WARRANTIES OF ANY KIND, INCLUDING ANY EXPRESSED OR IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR PURPOSE OR CONDITION OF SAME, ARE
HEREBY EXCLUDED BOTH AS TO THE FF&amp;E AND AS TO MAINTENANCE OR REPAIR WORK PERFORMED BY SELLER, IF ANY, ON THE FF&amp;E. BUYER HEREBY ACCEPTS THE FF&amp;E ON AN &#147;<B><FONT STYLE="white-space:nowrap">AS-IS</FONT></B>&#148; &#147;<B><FONT
STYLE="white-space:nowrap">WHERE-IS</FONT></B>&#148; BASIS WITH ALL FAULTS. IT IS EXPRESSLY AGREED THAT SELLER SHALL HAVE NO RESPONSIBILITY TO REPAIR, MAINTAIN, REPLACE, OR OTHERWISE CARE FOR THE FF&amp;E ON AND AFTER THE DATE HEREOF.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
SELLER AND BUYER AGREE THAT THE DISCLAIMERS OF WARRANTIES AS CONTAINED IN THIS PARAGRAPH ARE CONSPICUOUS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>Entire Agreement</U>. This Agreement constitutes the entire agreement between Seller and Buyer regarding the subject matter hereof and supersedes all
oral statements and prior writings relating thereto. Except to the extent expressly set forth in this Agreement, no representations, warranties, or agreements have been made by Seller or Buyer with respect to this Agreement or the obligations of
Seller or Buyer in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U>Severability</U>. If any provisions of this Agreement shall be held to be invalid, void or unenforceable,
the remaining provisions hereof shall not be affected or impaired, and such remaining provisions shall remain in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <U>Voluntary
Agreement</U>. The parties hereto, and each of them, further represent and declare that they have carefully read this Agreement and know the contents thereof and that they sign the same freely and voluntarily. This Agreement and each provision of
this Agreement was negotiated by the parties and therefore, neither this Agreement nor any provision of this Agreement shall be interpreted for or against any party on the basis that such party or its attorney drafted the Agreement or provision in
question. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <U>Successor and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
heirs, representatives, successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. <U>Counterparts</U>. This Agreement may be executed in counterparts, all of which executed
counterparts shall together constitute a single document. Signature pages may be detached from the counterparts and attached to a single copy of this document to physically form one document. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[</B><B><I>Signatures follow on next page</I></B><B>] </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Seller and Buyer have executed this Agreement as of the date first set forth above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#147;<B>SELLER</B>&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#147;<B>BUYER</B>&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>E<SMALL>XHIBIT</SMALL> E </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>M<SMALL>ASTER</SMALL> L<SMALL>EASE</SMALL> </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICE/LABORATORY LEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMERY STATION
WEST, LLC (LANDLORD) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DYNAVAX TECHNOLOGIES CORPORATION (TENANT) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EmeryStation West </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7Emeryville, California </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>BASIC LEASE PROVISIONS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.1 <U>BASIC
LEASE PROVISIONS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any conflict between these Basic Lease Provisions and any other provisions in the Lease (as
hereinafter defined), such other Lease provision shall control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) BUILDING AND ADDRESS: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">5959 Horton Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Emeryville,
California 94608 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) LANDLORD AND ADDRESS: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Emery Station West, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1120 Nye
Street, Suite 400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San Rafael, California 94901 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Notices to Landlord shall be addressed: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Emery Station West, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">c/o
Wareham Property Group </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1120 Nye Street, Suite 400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San Rafael, California 94901 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With a copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Shartsis Friese
LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">One Maritime Plaza, 18th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San Francisco, California 94901 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: David H. Kremer, Esq. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) TENANT AND CURRENT ADDRESS: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Name: Dynavax Technologies Corporation, a Delaware corporation </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Federal Tax Identification Number: <FONT STYLE="white-space:nowrap">33-0728374</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tenant shall promptly notify Landlord of any change in the foregoing items. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Notices to Tenant shall be addressed: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><I>Prior to the Commencement Date: </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">2929 Seventh Street, Suite 100 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Berkeley, California 94710 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
Attention: Michael Ostrach, Senior Vice President, Chief Financial Officer and Chief Business Officer </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><I>On and after the Commencement Date: </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">At the Premises </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Michael Ostrach, Senior Vice President, Chief Financial Officer and Chief Business Officer </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) DATE OF LEASE: September&nbsp;17,2018 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) LEASE TERM: Commencing on the Rent Commencement Date and continuing through the last day of the one hundred forty-fourth (144th) full
calendar month following the Rent Commencement Date; subject to the options set forth in Section&nbsp;2.6 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) COMMENCEMENT DATE:
The date which Landlord delivers possession of the Premises to Tenant with the Landlord Work Substantially Complete to allow Tenant to commence construction of the Tenant Work. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) PROJECTED COMMENCEMENT DATE: September&nbsp;20, 2018 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) RENT COMMENCEMENT DATE: The earlier to occur of: a) Tenant&#146;s commencement of its business operations at the Premises, and b)
April&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) EXPIRATION DATE: The last day of the one hundred forty-fourth (144th) full calendar month following the Rent
Commencement Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) MONTHLY BASE RENT: An amount determined by multiplying the Rentable Area of the Premises (as the same may exist
from time) by the Applicable Monthly Base Rate. As used herein, the &#147;Applicable Monthly Base Rate&#148; shall be an amount equal to Four Dollars and Seventy-Five Cents ($4.75) for the twelve (12)&nbsp;month period following the Rent
Commencement Date (which twelve (12)&nbsp;month period shall include any partial calendar month following the Commencement Date if the Commencement Date is other than the first (1st) day of a calendar month), which amount shall increase by a
compounded three percent (3%) on each annual anniversary thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) RENTABLE AREA: 75,662 square feet. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) TENANT IMPROVEMENT ALLOWANCE: Notwithstanding anything in this Lease to the contrary. Landlord shall provide Tenant a tenant improvement
allowance to be utilized to pay for Tenant Improvement Costs (as such are defined in the work letter attached to this Lease as Exhibit B (the &#147;Workletter&#148;)), in the amount of up to $8,322,820.00, calculated to be equal to one <FONT
STYLE="white-space:nowrap">hundred-ten</FONT> dollars ($ 110.00) per rentable square foot of Premises (the &#147;Tenant Improvement Allowance&#148;). Provided that no Default under the Lease has occurred and is continuing with respect to Tenant, the
Tenant Improvement Allowance shall be drawn down pursuant to the terms of the Workletter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) SECURITY DEPOSIT: $1,437,578.00, subject to reduction at the end of the sixth&nbsp;(6<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) full year of the Lease Term, as more specifically defined in Article 5 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)
PREMISES: The leasable area located on the sixth (6th) and seventh (7<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) floors of the Building, as outlined on Exhibit A hereto (such portion of the Building collectively hereafter the
&#147;Premises&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) TENANT&#146;S USE OF PREMISES: Office, laboratory, biotechnology research and development, ancillary uses
thereto and other related legal uses, subject to any and all applicable government approvals (the &#147;Permitted Use&#148;). Any other uses shall be subject to Landlord&#146;s approval which shall not be unreasonably withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) PARKING: Rights to park at the parking garage located at 6100 Horton Street (the &#147;Garage&#148;) or at such other location(s) in the
vicinity of the Project designated by Landlord or Landlord&#146;s parking operator from time to time, on an unreserved basis, up to one hundred <FONT STYLE="white-space:nowrap">fifty-one</FONT> (151)&nbsp;cars, calculated using a ratio of two
(2)&nbsp;unreserved parking rights for each 1,000 square feet of Rentable Area of the Premises. The current parking charge is $145. In addition, Tenant shall have the right to use, on an unreserved basis in common with other tenants and Building
users, the secured bicycle parking area and charging stations for electric cars inside the Garage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) BROKERS: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord&#146;s Broker: Kidder Mathews </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Tenant&#146;s Broker: Scott Stone (CRESA Partners) and Mark Moser (Savills Studley) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.2 <U>ENUMERATION OF EXHIBITS, SCHEDULES AND RIDER</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exhibits, schedules and rider set forth below and attached to this Lease are incorporated in this Lease by this reference: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Outline of the Premises</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Workletter Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT <FONT STYLE="white-space:nowrap">B-1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Applicable Green Building Standards</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT <FONT STYLE="white-space:nowrap">B-2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Landlord Work / Warm Shell Description</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT <FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Laboratory Rules and Regulations</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT <FONT STYLE="white-space:nowrap">C-2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rules and Regulations</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">RIDER 1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rent Commencement Date Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SCHEDULE 1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Superior Rights</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SCHEDULE 2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Special Superior Rights</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.3 <U>DEFINITIONS</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes hereof, in addition to terms defined elsewhere in this Lease, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">AFFILIATE: Any corporation or other business entity that is currently owned or controlled by, owns or controls, or is under common ownership
or control with Tenant or Landlord, as the case may be. The term &#147;control&#148; means (i)&nbsp;ownership or voting control, directly or indirectly, of 50% or more of the beneficial ownership interest of the entity in question, or (ii)&nbsp;the
possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such entity, whether through the ability to exercise voting power by contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BUILDING: The building located at the address specified in Section&nbsp;1.1(1). The Building may include office, laboratory, medical, retail
and other uses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CABLE: As defined in Section&nbsp;8.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">COMMENCEMENT DATE: The date specified in Section&nbsp;1.1(6). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">COMMON AREAS: All areas of the Project made available by Landlord from time to time for the general common use or benefit of the tenants of
the Building, and their employees and invitees, or the public, as such areas currently exist and as they may be changed from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DECORATION: Tenant Alterations which do not require a building permit, are not visible from outside of the Premises, and which do not involve
any changes to the structural elements of the Building, or any of the Building&#146;s systems, including its electrical, mechanical, plumbing, security, heating, ventilating, <FONT STYLE="white-space:nowrap">air-conditioning,</FONT> communication,
and fire and life safety systems. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DEFAULT: As defined in Section&nbsp;11.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DEFAULT RATE: Two (2)&nbsp;percentage points above the rate then most recently announced by Bank of America N.T. &amp; S.A. at its San
Francisco main office as its base lending reference rate, from time to time announced, but in no event higher than the maximum rate permitted by Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EXPIRATION DATE: The date specified in Section&nbsp;1.1(9), as may be extended in accordance with Section&nbsp;2.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FORCE MAJEURE: Any accident, casualty, act of God, war or civil commotion, strike or labor troubles, or any cause whatsoever beyond the
reasonable control of Landlord or Tenant, including water shortages, energy shortages or governmental preemption in connection with an act of God, a national emergency, or by reason of Law, or by reason of the conditions of supply and demand which
have been or are affected by act of God, war or other emergency; in no event, however, shall any Force Majeure event excuse or delay Tenant&#146;s obligation to timely pay all Rent owing under this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">GREEN BUILDING STANDARDS: One or more of the following: the U.S. EPA&#146;s Energy Star<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Portfolio Manager, the Green Building Initiative&#146;s Green Globes<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> building rating system, the U.S. Green Building Council&#146;s
Leadership in Energy and Environmental Design (LEED<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>) building rating system, the ASHRAE Building Energy Quotient (BEQ), the Global Real Estate Sustainability Benchmark (GRESB), or other
standard for high performance buildings adopted by Landlord with respect to the Building or the Project, as the same may be revised from time to time. The Green Building Standards applicable to the Tenant Improvements are set forth on Exhibit <FONT
STYLE="white-space:nowrap">B-l</FONT> to this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">INDEMNITEES: Collectively, Landlord, any Mortgagee or ground lessor of the Property,
the property manager and the leasing manager for the Property and their respective partners, members, directors, officers, agents and employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LAND: The parcel(s) of real estate on which the Building and Project are located. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LANDLORD WORK: The construction or installation of the improvements to the Premises, to be furnished by Landlord, as specifically described in
the Workletter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LAWS OR LAW: All laws, ordinances, rules, regulations, other requirements, orders, rulings or decisions adopted or made
by any governmental body, agency, department or judicial authority having jurisdiction over the Property, the Premises or Tenant&#146;s activities at the Premises and any covenants, conditions or restrictions of record which affect the Property.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LEASE: This instrument and all exhibits, schedules and any riders attached hereto, as may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LEASE YEAR: The twelve month period beginning on the first day of the first month following the Commencement Date (unless the Commencement
Date is the first day of a calendar month in which case beginning on the Commencement Date), and each subsequent twelve month, or shorter, period until the Expiration Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LEASEHOLD IMPROVEMENTS: As defined in Section&nbsp;12.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MONTHLY BASE RENT: The monthly rent specified in Section&nbsp;1.1(10). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MORTGAGEE: Any holder of a mortgage, deed of trust or other security instrument encumbering the Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NATIONAL HOLIDAYS: New Year&#146;s Day, Memorial Day, Independence Day, Labor Day, Thanksgiving Day and Christmas Day and other holidays
reasonably recognized by the Landlord and the janitorial and other unions servicing the Building in accordance with their contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">OPERATING EXPENSES: All costs, expenses and disbursements of every kind and nature which Landlord shall pay or become obligated to pay in
connection with the ownership, management, operation, maintenance, replacement and repair of the Property, including, without limitation, property management fees not to exceed 3.5% of gross revenues; costs and expenses of capital repairs,
replacements and improvements which shall be amortized over a period reasonably determined by Landlord pursuant to sound accounting principles consistently applied together with interest thereon at a rate reasonably determined by Landlord (not to
exceed the Default Rate) which, in the case of capital improvements, are (A)&nbsp;reasonably expected by Landlord to produce </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an actual net reduction in operating charges or energy consumption or effect other economies in the operation or maintenance of the Project (except in the case of capital replacements, which
shall not require this test), or (B)&nbsp;required under any governmental law or regulation not in effect as of the Commencement Date (such capital repairs, replacements and improvements collectively, &#147;Permitted Capital Expenditures&#148;); an
equitable allocation of management office expenses (including, without limitation, market office rent, supplies, equipment, salaries, wages, bonuses and other compensation relating to employees of Landlord or its agents engaged in the management,
operation, repair, or maintenance of the EmeryStation Campus); and, if applicable, the cost of operating any shared campus amenities, including but not limited to a fitness center and/or conference center, that are available for use by Tenant (which
amenities may be located in the Building or in other buildings in the EmeryStation Campus owned by Landlord or affiliates of Landlord), as reasonably determined by Landlord. Operating Expenses shall not include, (i)&nbsp;costs of alterations of the
premises of tenants of the Project, including all costs relating to preparing rental space for tenants, (ii)&nbsp;costs of goods or services to the extent billed directly to other tenants of the Project (other than as reimbursement of general
operating expenses), (iii) depreciation charges, (iv)&nbsp;interest, fees and principal payments on loans (except for interest charges for Permitted Capital Expenditures as provided for above, which Landlord may include in Operating Expenses), (v)
ground rental payments, (vi)&nbsp;real estate brokerage and leasing commissions, (vii)&nbsp;advertising and marketing expenses, (viii)&nbsp;costs to the extent Landlord has been reimbursed for the same by insurance proceeds, condemnation awards,
third party warranties or other third parties (other than tenant&#146;s reimbursement of general operating expenses), (ix) expenses incurred in negotiating leases of tenants in the Project or enforcing lease obligations of tenants in the Project,
(x)&nbsp;Landlord&#146;s general corporate overhead, (xi)&nbsp;costs directly incurred in connection with a sale, financing, refinancing or transfer of all or any portion of the Project, (xii)&nbsp;costs incurred to comply with Laws relating to the
removal and remediation of any Hazardous Material which were (A)&nbsp;in existence at the Project as of the Commencement Date or (B)&nbsp;not brought on to the Premises by Tenant or (C)&nbsp;migrated thereto through air, water or soil through no
fault of Tenant; provided, however, that any costs incurred in the cleanup or remediation of <I>de minimis</I> amounts of Hazardous Materials customarily used in office buildings or used to operate motor vehicles and customarily found in parking
facilities shall be included as Operating Expenses, (xiii)&nbsp;original construction costs or original capital expenditures for expansion of the Project, (xiv)&nbsp;costs for employees not dedicated full time to the Project unless such costs are
reasonably prorated to reflect time spent on the Project, (xv)&nbsp;legal costs for disputes with tenants, (xvi)&nbsp;capital improvements, capital replacements, capital repairs, capital equipment and tools that are not Permitted Capital
Expenditures, (xvii)&nbsp;reserves, (xviii) expenses for any item or service which is not provided to Tenant but is provided for the sole use or benefit of another tenant, (xix)&nbsp;interest or penalties attributable to late payment by Landlord
(provided that such late payment is not caused by Tenant), (xx) cost of correcting any building code or curing violations of other applicable law which existed prior to the Commencement Date, and (xxi)&nbsp;any item that, if included, in Operating
Expenses, would involve a double collection for such item by Landlord. In the event there exists a conflict as to an expense that is specified to be included in Operating Expenses and is also specified to be excluded from Operating Expenses within
the above list, the exclusions listed above shall prevail and the expenses shall be deemed excluded. If any Operating Expense, though paid in one year, relates to more than one calendar year, at the option of Landlord such expense may be
proportionately allocated among such related calendar years; provided that only those periods falling within the Term of the Lease shall be allocated to Tenant. Landlord agrees that Landlord </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
will not collect or be entitled to collect Operating Expenses from Tenant in an amount in excess of Tenant&#146;s Share of one hundred percent (100%) of the Operating Expenses attributable to the
Project. In addition, Operating Expenses shall be reduced by all cash discounts, trade discounts or quantity discounts received by Landlord or Landlord&#146;s managing agent in the purchase of any goods, utilities or services in connection with the
prudent operation of the Building. Operating Expenses for the Building that are not, in Landlord&#146;s reasonable discretion, allocable solely to either the office, laboratory, or retail portion of the Building shall be equitably allocated by
Landlord between/amongst such uses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PREMISES: The space located in the Building described in Section&nbsp;1.1(14) and as outlined on
<U>Exhibit A</U> attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PROJECT or PROPERTY: The Project consists of the <FONT STYLE="white-space:nowrap">mixed-use</FONT>
building located at the street address specified in Section&nbsp;1.1(1) in Emeryville, California, and associated surface and garage parking as designated by Landlord from time to time, landscaping and improvements, together with the Land, any
associated interests in real property, and the personal property, fixtures, machinery, equipment, systems and apparatus located in or used in conjunction with any of the foregoing. A portion of the parking garage located at 6100 Horton Street shall
be designated by Landlord as part of the Project. The Project may also be referred to as the Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PROJECT&#146;S SUSTAINABILITY
PRACTICES: The operations and maintenance practices for the Building, whether incorporated into the Building&#146;s Rules and Regulations, construction rules and regulations, separate written sustainability policies or otherwise reasonably
implemented by Landlord with respect to the Building or the Project, as the same may be revised from time to time, addressing, among other things: energy efficiency; energy measurement and reporting; water usage; recycling, composting, and waste
management; indoor air quality; and chemical use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PROJECTED COMMENCEMENT DATE: The date specified in Section&nbsp;1.1(7). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">REAL PROPERTY: The Property excluding any personal property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RENT: Collectively, Monthly Base Rent, Rent Adjustments and Rent Adjustment Deposits, and all other charges, payments, late fees or other
amounts required to be paid by Tenant under this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RENT ADJUSTMENT: Any amounts owed by Tenant for payment of Operating Expenses
and/or Taxes. The Rent Adjustments shall be determined and paid as provided in Article 4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RENT ADJUSTMENT DEPOSIT: An amount equal to
Landlord&#146;s estimate of the Rent Adjustment attributable to each month of the applicable calendar year (or partial calendar year) during the Term. On or before the Commencement Date and with each Landlord&#146;s Statement (defined in Article 4),
Landlord may estimate and notify Tenant in writing of its estimate of Tenant&#146;s Share of the Operating Expenses and of Taxes for such calendar year (or partial calendar year). Prior to the first determination by Landlord of the amount of
Operating Expenses and of Taxes for the first calendar year (or partial calendar year), Landlord may estimate such amounts in the foregoing calculation. Landlord shall have the right from time to time during any calendar year to provide a new or
revised estimate of Operating Expenses and/or Taxes and to notify Tenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in writing thereof, of corresponding adjustments in Tenant&#146;s Rent Adjustment Deposit payable over the remainder of such year, and of the amount or revised amount due allocable to months
preceding such change. The last estimate by Landlord shall remain in effect as the applicable Rent Adjustment Deposit unless and until Landlord notifies Tenant in writing of a change, which notice may be given by Landlord from time to time during
each year throughout the Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RENTABLE AREA OF THE PREMISES: The amount of square footage stipulated and/or determined, from time to
time, pursuant to Section&nbsp;1.1(11). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">STANDARD OPERATING HOURS: Monday through Friday from 8:00 A.M. to 6:00&nbsp;P.M. and Saturdays
from 9:00 A.M. to 1:00 P.M., excluding National Holidays. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUBSTANTIALLY COMPLETE or SUBSTANTIAL COMPLETION: The completion of the
Landlord Work in good and workmanlike manner, in material compliance with all applicable Laws and the plans and specifications, except for minor insubstantial details of construction, decoration or mechanical adjustments which remain to be done
which do not materially and substantially interfere with Tenant&#146;s construction of the Tenant Work in the Premises. Substantial Completion shall be deemed to have occurred notwithstanding a requirement to complete &#147;punchlist&#148; or
similar minor corrective work. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TAXES: All federal, state and local governmental taxes, assessments, license fees and charges of every
kind or nature, whether general, special, ordinary or extraordinary, which Landlord shall pay or become obligated to pay because of or in connection with the ownership, leasing, management, control, sale, transfer or operation of the Property or any
of its components (including any personal property used in connection therewith) or Landlord&#146;s business of owning and operating the Property, which may also include any rental, revenue, general gross receipts or similar taxes levied in lieu of
or in addition to general real and/or personal property taxes. For purposes hereof, Taxes for any year shall be Taxes which are assessed for any period of such year, whether or not such Taxes are billed and payable in a subsequent calendar year.
There shall be included in Taxes for any year the amount of all fees, costs and expenses (including reasonable attorneys&#146; fees) paid by Landlord during such year in seeking or obtaining any refund or reduction of Taxes. Taxes for any year shall
be reduced by the net amount of any tax refund received by Landlord attributable to such year. If a special assessment payable in installments is levied against any part of the Property, Taxes for any year shall include only the installment of such
assessment and any interest payable or paid during such year. Taxes shall not include any federal or state inheritance, general income, transfer, gift or estate taxes, except that if a change occurs in the method of taxation resulting in whole or in
part in the substitution of any such taxes, or any other assessment, for any Taxes as above defined, such substituted taxes or assessments shall be included in the Taxes. Tenant and Landlord acknowledge that Proposition 13 was adopted by the voters
of the State of California in the June, 1978 election and that assessments, taxes, fees, levies and charges may be imposed by governmental agencies for such purposes as fire protection, street, sidewalk, road, utility construction and maintenance,
refuse removal and for other governmental services which may formerly have been provided without charge to property owners or occupants. It is the intention of the parties that all new and increased assessments, taxes, fees, levies and charges due
to any cause whatsoever are to be included within the definition of real property taxes for purposes of this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TENANT ADDITIONS: Collectively, Tenant Work and Tenant Alterations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TENANT ALTERATIONS: Any alterations, improvements, additions, installations or construction in or to the Premises or any Building Systems
serving the Premises (excluding Landlord Work and Tenant Work); and any supplementary <FONT STYLE="white-space:nowrap">air-conditioning</FONT> systems installed by Landlord or by Tenant at Landlord&#146;s request pursuant to Section&nbsp;6.1(b).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TENANT WORK: All work installed or furnished to the Premises by Tenant in accordance with the Workletter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TENANT&#146;S SHARE: The percentage that represents the ratio of the Rentable Area of the Premises to the Rentable Area of the Building, as
determined by Landlord from time to time, and which as of the Date of Lease is 28.94%. Tenant acknowledges that the Rentable Area of the Premises or Building may change from <FONT STYLE="white-space:nowrap">re-measurement</FONT> or otherwise during
the Term, or as a result of Tenant leasing additional space within the Building or a physical change to the size of the Premises or Building (provided, however, that, the Base Rent payable hereunder shall not be changed as a consequence of a <FONT
STYLE="white-space:nowrap">re-measurement</FONT> of the Building and/or the Premises unless the Premises are physically expanded). Notwithstanding anything herein to the contrary. Landlord may equitably adjust Tenant&#146;s Share for all or part of
any item of expense or cost reimbursable by Tenant that relates to a repair, replacement, or service that benefits only the Premises or only a portion of the Building and/or the Project or that varies with the occupancy of the Building and/or the
Project, provided such adjustment is done in accordance with sound real estate accounting and management principles, consistently applied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TERM: The initial term of this Lease commencing on the Commencement Date and expiring on the Expiration Date, including the Renewal Term, if
Tenant properly exercises the Renewal Option in accordance with Section&nbsp;2.6. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TERMINATION DATE: The Expiration Date or such earlier
date as this Lease terminates or Tenant&#146;s right to possession of the Premises terminates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WORKLETTER: The Agreement regarding the
manner of completion of Landlord Work and Tenant Work set forth on Exhibit B attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 2 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>PREMISES, TERM, FAILURE TO GIVE POSSESSION, AND PARKING </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.1 <U>LEASE OF PREMISES</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Landlord
hereby leases to Tenant, and Tenant hereby leases from Landlord, the Premises for the Term and upon the terms, covenants and conditions provided in this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The parties acknowledge and agree that the Rentable Area set forth in this Lease has been conclusively determined and is deemed final for
the purposes of this Lease and that prior to the Date of Lease, Tenant had the right to cause its Architect to verify and confirm the Rentable Area of the Premises. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.2 <U>TERM</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Commencement Date shall be the date which Landlord delivers possession of the Premises to Tenant with the Landlord Work Substantially
Complete to allow Tenant to commence construction of the Tenant Work. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Within thirty (30)&nbsp;days following the Rent Commencement
Date, Landlord and Tenant shall enter into an agreement (the form of which is attached hereto as <U>Rider 1</U>) confirming the Rent Commencement Date and the Expiration Date. If Tenant fails to enter into such agreement, then the Rent Commencement
Date and the Expiration Date shall be the date designated by Landlord in such agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.3 <U>DELIVERY OF POSSESSION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall use commercially reasonable efforts to tender possession of the Premises to Tenant by the later of the Date of Lease or the
Projected Commencement Date with the Landlord Work Substantially Complete. Tenant agrees that if Landlord shall be unable to tender possession of the Premises with the Landlord Work Substantially Complete by the Projected Commencement Date for any
reason, then this Lease shall not be void or voidable, nor shall Landlord be subject to any liability therefor. Landlord and Tenant hereby acknowledge and agree that Tenant&#146;s access/entry to the Premises prior to Rent Commencement Date shall be
subject to all the provisions of this Lease (including payment of any utilities used in the Premises) other than the payment of Monthly Base Rent and Tenant&#146;s Share of Operating Expenses, including, without limitation. Tenant&#146;s compliance
with the insurance and indemnity requirements of this Lease. In connection with any such early entry, Tenant agrees that it shall not in any way unreasonably interfere with the progress of any other work being conducted in the Building, either by
Landlord and/or Landlord&#146;s tenants. Should such early entry unreasonably interfere with the progress of other work, in Landlord&#146;s reasonable judgment, then Landlord may demand that Tenant forthwith cease the activities that are causing
such interference or vacate the Premises as necessary until such interference would not occur, and Tenant shall immediately comply with such demand. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.4
<U>CONDITION OF PREMISES</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord represents and warrants that, as of the Commencement Date, the Building&#146;s structural components
and electrical and plumbing systems, including, without limitation, heating, ventilation and <FONT STYLE="white-space:nowrap">air-conditioning</FONT> (collectively, &#147;Building Systems&#148;), are in good condition and repair. No later than one
hundred twenty (120)&nbsp;days after the Commencement Date, Tenant shall notify Landlord in writing of any defects in the Landlord Work and/or the Building Systems (other than defects caused by Tenant after the Commencement Date) that are claimed by
Tenant or in the materials or workmanship furnished by Landlord in completing the Landlord Work. Except for defects stated in such notices, Tenant shall be conclusively deemed to have accepted the Premises &#147;AS IS&#148; in the condition existing
on the Commencement Date. Landlord shall proceed diligently to correct the defects stated in such notices unless Landlord disputes in good faith the existence of any such defects. In the event of any dispute as to the existence of any such defects,
the reasonable and good faith decision of Landlord&#146;s architect shall be final and binding on the parties. No agreement of Landlord to alter, remodel, decorate, clean or improve the Premises or the Real Property and no representation regarding
the condition of the Premises or the Real Property has been made by or on behalf of Landlord to Tenant, except as may be specifically stated in this Lease or in the Workletter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.5 <U>PARKING</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the Term, Tenant shall have the right to park up to one hundred <FONT STYLE="white-space:nowrap">fifty-one</FONT> (151)&nbsp;cars of
Tenant and its employees (&#147;Tenant&#146;s Parking&#148;), such quantity calculated to be two (2)&nbsp;vehicle rights for every one thousand (1,000) rentable square feet of Premises. Subject to the aforementioned maximum. Tenant shall have the
right to set the number of Tenant&#146;s Parking as of the Commencement Date and thereafter to adjust the amount of Tenant&#146;s Parking not more often than monthly upon thirty (30)&nbsp;days&#146; advance written notice to Landlord. Initially,
Tenant&#146;s Parking shall be located in the Garage owned by Landlord and located at 6100 Horton Street and shall be leased by Tenant at then quoted rates. In the event Tenant fails at any time to pay the full amount of any such parking charges
beyond all applicable notice and cure periods, then Tenant&#146;s parking rights shall be reduced to the extent of Tenant&#146;s failure to pay for any such parking, and Tenant shall be in Default hereunder. The locations and type of parking shall
be designated by Landlord or Landlord&#146;s parking operator from time to time; provided, however, that any portion of Tenant&#146;s Parking that is not provided in the garage shall be located at other location(s) in the vicinity of the Project.
Tenant acknowledges and agrees that the parking stalls serving the Project may include valet parking and a mixture of stalls for compact vehicles as well as <FONT STYLE="white-space:nowrap">full-size</FONT> passenger automobiles, and that Tenant
shall not use parking stalls for vehicles larger than the striped size of the parking stalls nor shall Tenant park cars overnight. All vehicles utilizing Tenant&#146;s parking privileges shall prominently display identification stickers or other
markers, and/or have passes or keycards for ingress and egress, as may be required and provided by Landlord or its parking operator from time to time. To the extent provided to Tenant in writing, Tenant shall comply with any and all <FONT
STYLE="white-space:nowrap">non-discriminatory</FONT> parking rules and regulations from time to time established by Landlord or Landlord&#146;s parking operator, including a requirement that Tenant pay to Landlord or Landlord&#146;s parking operator
a charge for loss and replacement of passes, keycards, identification stickers or markers, and for any and all loss or other damage caused by persons or vehicles related to use of Tenant&#146;s parking privileges. Tenant shall not allow any vehicles
using Tenant&#146;s parking privileges to be parked, loaded or unloaded except in accordance with this Section, including in the areas and in the manner reasonably designated by Landlord or its parking operator for such activities. If any vehicle is
using the parking or loading areas contrary to any provision of this Section, Landlord or its parking operator shall have the right, in addition to all other rights and remedies of Landlord under this Lease, to remove or tow away the vehicle without
prior notice to Tenant, and the cost thereof shall be paid to Landlord within ten (10)&nbsp;days after notice from Landlord to Tenant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.6 <U>RENEWAL
OPTIONS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall have the option to renew this Lease (&#147;Renewal Option&#148;) with respect to the entirety of the Premises
for two (2)&nbsp;consecutive additional terms of five (5)&nbsp;years each (each a &#147;Renewal Term&#148;), commencing upon expiration of the initial Term or the first Renewal Term, as applicable. Each Renewal Option must be exercised, if at all,
by written notice given by Tenant to Landlord not earlier than eighteen (18)&nbsp;months and not later than twelve (12)&nbsp;months prior to commencement of the Renewal Term. If Tenant properly exercises a Renewal Option, then references in this
Lease to the Term shall be deemed to include the Renewal Term. Tenant&#146;s rights </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under this Section&nbsp;2.6 shall, at the option of Landlord, be null and void and Tenant shall have no right to renew this Lease if on the date Tenant exercises a Renewal Option or on the date
immediately preceding the commencement date of a Renewal Term a Default beyond the applicable notice and cure period shall have occurred and be continuing hereunder; provided, however, if Tenant cures such Default within the applicable periods
provided under this Lease, then the Renewal Option shall be reinstated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If Tenant properly exercises a Renewal Option, then during
such Renewal Term all of the terms and conditions set forth in this Lease as applicable to the Premises during the initial Term shall apply during the Renewal Term, including, without limitation, the obligation to pay Rent Adjustments, except that
(i)&nbsp;Tenant shall accept the Premises in their then <FONT STYLE="white-space:nowrap">&#147;as-is&#148;</FONT> state and condition, and Landlord shall have no obligation to make or pay for any improvements to the Premises, and (ii)&nbsp;during
the Renewal Term the Monthly Base Rent payable by Tenant shall be the Fair Market Value during the Renewal Term as hereinafter set forth, except that in no event shall Monthly Base Rent during a Renewal Term be less than one hundred percent (100%)
of the Monthly Base Rent in effect during the month immediately preceding the Renewal Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) For purposes of this Section, the term
&#147;Fair Market Value&#148; shall mean the base rental rate, including periodic rent adjustment, for space comparable in size, location and quality of the Premises under primary lease (and not sublease) to new or renewing tenants, for a comparable
term with base rent adjusted for the relative tenant improvement allowance, if applicable, and taking into consideration such amenities as existing improvements and <FONT STYLE="white-space:nowrap">non-removable</FONT> fixtures in place at the time
of such renewal (but not including the value of any Tenant Alterations made to the Premises following the Rent Commencement Date and the completion of Tenant&#146;s initial <FONT STYLE="white-space:nowrap">build-out),</FONT> view, floor on which the
Premises is situated and the like, situated in comparable science/laboratory buildings in Emeryville and Berkeley. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) If Tenant properly
exercises a Renewal Option, then Landlord, by notice to Tenant not later than six (6)&nbsp;months prior to commencement of the Renewal Term, shall indicate Landlord&#146;s determination of the Fair Market Value. Tenant, within fifteen (15)&nbsp;days
after the date on which Landlord provides such notice of the Fair Market Value shall either (i)&nbsp;give Landlord final binding written notice (&#147;Binding Notice&#148;) of Tenant&#146;s acceptance of Landlord&#146;s determination of the Fair
Market Value, or (ii)&nbsp;if Tenant disagrees with Landlords&#146; determination, provide Landlord with written notice of Tenant&#146;s election to submit the Fair Market Value to binding arbitration (the &#147;Arbitration Notice&#148;). If Tenant
fails to provide Landlord with either a Binding Notice or Arbitration Notice within such fifteen (15)&nbsp;day period, Landlord shall send Tenant a second written notice specifying the Fair Market Rent (&#147;Second FMV Notice&#148;), and such
Second FMV Notice shall include the following: <B>&#147;FAILURE TO ACCEPT SAID FAIR MARKET RENT AMOUNT IN WRITING OR DISPUTE SUCH AMOUNT BY SUBMITTING TO ARBITRATION IN ACCORDANCE WITH SECTION 2.6(d) OF THIS LEASE WITHIN TEN
(10)</B><B></B><B>&nbsp;DAYS SHALL BE DEEMED TENANT&#146;S AGREEMENT TO PAY SUCH AMOUNT DURING THE RENEWAL TERM.&#148; </B>If Tenant fails to provide Landlord with either a Binding Notice or Arbitration Notice within ten (10)&nbsp;days after
receiving the Second FMV Notice, Tenant shall have been deemed to have given the Binding Notice. If Tenant provides or is deemed to have provided Landlord with a Binding Notice, Landlord and Tenant shall enter into the Renewal Amendment (as defined
below) upon the terms and conditions set forth herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If the parties are unable to agree upon the Fair Market Value for the Premises within
ten (10)&nbsp;business days after Landlord&#146;s receipt of the Arbitration Notice, Fair Market Value as of commencement of the Renewal Term shall be determined as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) Within thirty (30)&nbsp;days after the date Tenant delivers the Arbitration Notice, Tenant, at its sole expense, shall obtain and deliver
in writing to Landlord a determination of the Fair Market Value for the Premises for a term equal to the Renewal Term from an independent broker or appraiser (&#147;Tenant&#146;s broker&#148;) licensed in the State of California and engaged in the
science/laboratory markets in Emeryville and Berkeley, California, for at least the immediately preceding five (5)&nbsp;years who has not been engaged by either Landlord or Tenant in the last five (5)&nbsp;years. If Landlord accepts such
determination, Landlord shall provide written notice thereof within ten (10)&nbsp;days after Landlord&#146;s receipt of such determination and the Base Rent for the Renewal Term shall be adjusted to an amount equal to the Fair Market Value
determined by Tenant&#146;s broker. Landlord shall be deemed to have rejected Tenant&#146;s determination if Landlord fails to respond within the ten (10)&nbsp;day period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) If Landlord provides notice that it rejects, or is deemed to have rejected, such determination, within twenty (20)&nbsp;days after receipt
of the determination of Tenant&#146;s broker, Landlord shall designate a broker or appraiser (&#147;Landlord&#146;s broker&#148;) licensed in the State of California and possessing the qualifications set forth in (1)&nbsp;above. Landlord&#146;s
broker and Tenant&#146;s broker shall name a third broker, similarly qualified, within five (5)&nbsp;days after the appointment of Landlord&#146;s broker (&#147;Neutral Broker&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) The Neutral Broker shall determine the Fair Market Value for the Premises as of the commencement of the Renewal Term within fifteen
(15)&nbsp;days after the appointment of such Neutral Broker by choosing the determination of the Landlord&#146;s broker that was set forth in the initial notice delivered by Landlord pursuant to Section&nbsp;2.6(d) or the Tenant&#146;s broker that
was delivered pursuant to Section&nbsp;2.6(e)(1) which is closest to its own determination of Fair Market Value. The decision of the Neutral Broker shall be binding on Landlord and Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Landlord shall pay the costs and fees of Landlord&#146;s broker in connection with any determination hereunder, and Tenant shall pay the
costs and fees of Tenant&#146;s broker in connection with such determination. The costs and fees of the Neutral Broker shall be paid <FONT STYLE="white-space:nowrap">one-half</FONT> by Landlord and <FONT STYLE="white-space:nowrap">one-half</FONT> by
Tenant. Landlord shall have no obligation to pay a fee or commission to any broker retained by Tenant in connection with Tenant&#146;s exercise of a Renewal Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) If the amount of the Fair Market Value has not been determined pursuant to this Section&nbsp;2.6 as of the commencement of the Renewal
Term, then Tenant shall continue to pay the Base Rent in effect during the last month of the initial Term until the amount of the Fair Market Value is determined. When such determination is made, Tenant shall pay any deficiency to Landlord upon
demand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) If Tenant is entitled to and properly exercises its Renewal Option, upon determination of Fair Market Value pursuant to this
Section&nbsp;2,6, Landlord shall prepare an amendment (the &#147;Renewal Amendment&#148;) to reflect changes in the Base Rent, Term, Expiration Date and other appropriate terms. The Renewal Amendment shall be sent to Tenant within a reasonable time
after determination of Fair Market Value and, provided the same is accurate, Tenant shall execute and return the Renewal Amendment to Landlord within ten (10)&nbsp;days after Tenant&#146;s receipt of same, but an otherwise valid exercise of the
Renewal Option shall be fully effective whether or not the Renewal Amendment is executed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.7 <U>RIGHT OF FIRST OFFER: ADJACENT FLOOR</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of other parties existing as of the Date of Lease (&#147;Superior Rights&#148;) as set forth in <U>Schedule 1</U>
attached hereto, commencing upon the Rent Commencement Date and continuing throughout the Term (including the Renewal Term), Tenant shall have the right of first offer (&#147;Right of First Offer&#148;, or &#147;ROFO&#148;) with respect to no more
than one (1)&nbsp;adjacent full floor in the Building which becomes Available for Lease (described below) (the &#147;Offering Space&#148;). Landlord represents and warrants that all Superior Rights are set forth in <U>Schedule 1</U> attached hereto
and incorporated herein. For the avoidance of doubt, Landlord shall have the right to lease any space in the Building at any time prior to the Rent Commencement Date on such terms as Landlord may determine in its sole and absolute discretion
regardless of whether such space would otherwise qualify as Special Offering Space if it were Available for Lease as of the Rent Commencement Date. Offering Space shall be deemed to be &#147;Available for Lease&#148; as follows: (i)&nbsp;with
respect to any Offering Space that has been leased to a third party tenant prior to the Rent Commencement Date hereunder or that at any time and from time to time thereafter is under lease to a third party tenant, such Offering Space shall be deemed
to be Available for Lease when Landlord has determined that such third party will not extend or renew the term of its lease for the Offering Space (whether or not pursuant to the terms of a renewal option provided for in its lease), no occupant has
a Superior Right which is subject to exercise and Landlord is ready to market such space for lease, or (ii)&nbsp;with respect to any Offering Space that is not under lease, such Offering Space shall be deemed to be Available for Lease when Landlord
has determined that no occupant has a Superior Right which is subject to exercise and Landlord is ready to market such space for lease. After Landlord has determined that any portion of Offering Space is Available for Lease, Landlord shall advise
Tenant (the &#147;ROFO Notice&#148;) of the terms under which Landlord is prepared to lease such portion of the Offering Space to Tenant, including, without limitation, description of the space so offered to Tenant and material economic terms and
conditions applicable to Tenant&#146;s lease of such space (collectively, &#147;First Offer Economic Terms&#148;). Tenant may lease such Offering Space in its entirety only, under such First Offer Economic Terms, by delivering written notice of
exercise to Landlord (&#147;ROFO Notice of Exercise&#148;) within fifteen (15)&nbsp;days after the date of delivery of the ROFO Notice, except that Tenant shall have no such Right of First Offer and Landlord need not provide Tenant with a ROFO
Notice, if: (i)&nbsp;Tenant is in Default under this Lease at the time Landlord would otherwise deliver the ROFO Notice; or (ii)&nbsp;the Premises, or any portion thereof, is sublet (other than pursuant to a Permitted Transfer) at the time Landlord
would otherwise deliver the ROFO Notice; or (iii)&nbsp;this Lease has been assigned (other than pursuant to a Permitted Transfer) prior to the date Landlord would otherwise deliver the ROFO Notice; or (iv)&nbsp;either Tenant or Permitted Transferee
is not occupying at least fifty percent (50%) of the Premises on the date Landlord would otherwise deliver the ROFO Notice. If Tenant does not accept a ROFO Notice from Landlord pursuant to the above, then Landlord shall have the right to lease all
or any portion of the Offering Space to any third party or parties upon such terms as Landlord and such tenant(s) may approve, in their respective sole and absolute discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Terms</U>. The term for the Offering Space shall commence upon the commencement date stated in the ROFO Notice and thereupon such
Offering Space shall be considered a part of the Premises, provided that all of the First Offer Economic Terms stated in the ROFO Notice shall govern Tenant&#146;s leasing of the Offering Space and only to the extent that they do not conflict with
the ROFO Notice, the terms and conditions of this Lease shall apply to the Offering Space. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Limitation on Right of First Offer</U>. The rights of Tenant hereunder with respect
to any portion of the Offering Space shall terminate on the earlier to occur of: (i)&nbsp;with respect to any portion of the Offering Space that is the subject of a ROFO Notice, Tenant&#146;s failure to exercise its Right of First Offer within the
fifteen (15)&nbsp;day period provided in Section&nbsp;2.7(a) above, and (ii)&nbsp;with respect to any portion of the Offering Space which would otherwise have been the subject of a ROFO Notice, the date Landlord would have provided Tenant a ROFO
Notice if Tenant had not been in violation of one or more of the conditions set forth in clauses (i)&nbsp;through (iv) of Section&nbsp;2.7(a) above. In addition, at any time that Tenant has expanded its Premises beyond 150% of the size set forth in
Section&nbsp;1.1(11) hereof pursuant to the above ROFO process or otherwise, Tenant shall have no further ROFO rights hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
<U>Offering Amendment</U>. If Tenant exercises its Right of First Offer, Landlord shall prepare an amendment (the &#147;Offering Amendment&#148;) adding the Offering Space to the Premises on the First Offer Economic Terms and reflecting the changes
in the Monthly Base Rent, Rentable Area of the Premises, Tenant&#146;s Share, Rent Adjustments and other appropriate terms. A copy of the Offering Amendment shall be (i)&nbsp;sent to Tenant within a reasonable time after receipt of the ROFO Notice
of Exercise executed by Tenant, and (ii)&nbsp;executed by Tenant and returned to Landlord within fifteen (15)&nbsp;days thereafter, but an otherwise valid exercise of the Right of First Offer shall be fully effective whether or not the Offering
Amendment is signed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.8 <U>SPECIAL RIGHT OF FIRST OFFER</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>In the Building</U>: Subject to the superior rights of other parties existing as of the date of this Lease (&#147;Special Superior
Rights&#148;) as set forth in <U>Schedule 2</U> attached hereto, for the period commencing January&nbsp;1, 2020 and ending March&nbsp;31, 2021 (the &#147;Special ROFO Period&#148;), Tenant shall have the right of first offer (the &#147;Special
ROFO&#148;) with respect to any suite in the Building measuring no less than twelve thousand (12,000) rentable square feet nor more than twenty-thousand (20,000) rentable square feet that becomes Available for Lease (described below) (the
&#147;Special Offering Space&#148;). Landlord represents and warrants that all Special Superior Rights are set forth in <U>Schedule 2</U> attached hereto and incorporated herein. For the avoidance of doubt. Landlord shall have the right to lease any
space in the Building at any time prior to the commencement of the Special ROFO Period Special on such terms as Landlord may determine in its sole and absolute discretion regardless of whether such space might otherwise qualify as Special Offering
Space if it were Available for Lease as of the first day of the Special ROFO Period. Special Offering Space shall be deemed to be &#147;Available for Lease&#148; as follows: (i)&nbsp;with respect to any Special Offering Space that has been leased to
a third party tenant prior to the commencement of the Special ROFO Period (or if Landlord has entered into a letter of intent with a prospective third party for the lease of any such space prior to the commencement of the Special ROFO Period), such
Special Offering Space shall be deemed to be Available for Lease when Landlord has determined that such third party (i.e., one who has entered into a lease prior to the Special ROFO Period or who has entered into a lease that was the subject of a
letter of intent entered into prior to the commencement of the Special ROFO Period) will not extend or renew the term of its lease for the Special Offering Space (whether or not pursuant to the terms of a renewal option provided for
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in its lease), no occupant has a Special Superior Right which is subject to exercise and Landlord is ready to market such space for lease, or (ii)&nbsp;with respect to any Special Offering Space
that is not under lease prior to the commencement of the Special ROFO Period, such Special Offering Space shall be deemed to be Available for Lease when Landlord has determined that no occupant has a Special Superior Right which is subject to
exercise and Landlord is ready to market such space for lease. If during the Special ROFO Period, Landlord has determined that any Special Offering Space is Available for Lease, Landlord shall advise Tenant (the &#147;Special ROFO Notice&#148;) of
the terms under which Landlord is prepared to lease such Special Offering Space to Tenant, including, without limitation, description of the space so offered to Tenant and material economic terms and conditions applicable to Tenant&#146;s lease of
such space (collectively, &#147;Special ROFO Economic Terms&#148;). Tenant may lease such Special Offering Space in its entirety only, under such Special ROFO Economic Terms, by delivering written notice of exercise to Landlord (&#147;Special ROFO
Notice of Exercise&#148;) within fifteen (15)&nbsp;days after the date of delivery of the Special ROFO Notice, except that Tenant shall have no such Special Right of First Offer and Landlord need not provide Tenant with a Special ROFO Notice, if:
(i)&nbsp;Tenant is in Default under this Lease at the time Landlord would otherwise deliver the Special ROFO Notice; or (ii)&nbsp;the Premises, or any portion thereof, is sublet (other than pursuant to a Permitted Transfer) at the time Landlord
would otherwise deliver the Special ROFO Notice; or (iii)&nbsp;this Lease has been assigned (other than pursuant to a Permitted Transfer) prior to the date Landlord would otherwise deliver the Special ROFO Notice; or (iv)&nbsp;either Tenant or
Permitted Transferee is not occupying all of the Premises on the date Landlord would otherwise deliver the Special ROFO Notice. If Tenant does not accept a Special ROFO Notice from Landlord pursuant to the above, then Landlord shall have the right
to lease all or any portion of the Special Offering Space to any third party or parties upon such terms as Landlord and such tenant(s) may approve, in their respective sole and absolute discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Terms</U>. The term for the Special Offering Space shall commence upon the commencement date stated in the Special ROFO Notice and
thereupon such Special Offering Space shall be considered a part of the Premises, provided that all of the Special ROFO Economic Terms stated in the Special ROFO Notice shall govern Tenant&#146;s leasing of the Special Offering Space and only to the
extent that they do not conflict with the Special ROFO Notice, the terms and conditions of this Lease shall apply to the Special Offering Space. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Limitation on Special Right of First Offer</U>, The rights of Tenant hereunder with respect to any Special Offering Space shall
terminate on the earlier to occur of: (i)&nbsp;with respect to any Special Offering Space that is the subject of a Special ROFO Notice, Tenant&#146;s failure to exercise its Special Right of First Offer within the fifteen (15)&nbsp;day period
provided in Section&nbsp;2.8(a) above, (ii)&nbsp;with respect to any Special Offering Space which would otherwise have been the subject of a Special ROFO Notice, the date Landlord would have provided Tenant a Special ROFO Notice if Tenant had not
been in violation of one or more of the conditions set forth in clauses (i)&nbsp;and (iv) of Section&nbsp;2.8(a) above, or (iii)&nbsp;the expiration of the Special ROFO Period. In addition, at any time that Tenant has expanded its Premises beyond
the 150% of the size set forth in Section&nbsp;1.1(11) hereof, or to an additional floor, pursuant to the above ROFO process outlined in Section&nbsp;2.7 above or otherwise, Tenant shall have no further Special ROFO rights hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) <U>Offering Amendment</U>. If Tenant exercises its Special Right of First Offer,
Landlord shall prepare an amendment (the &#147;Offering Amendment&#148;) adding the Special Offering Space to the Premises on the Special ROFO Economic Terms and reflecting the changes in the Monthly Base Rent, Rentable Area of the Premises,
Tenant&#146;s Share, Rent Adjustments and other appropriate terms. A copy of the Offering Amendment shall be (i)&nbsp;sent to Tenant within a reasonable time after receipt of the Special ROFO Notice of Exercise executed by Tenant, and
(ii)&nbsp;executed by Tenant and returned to Landlord within fifteen (15)&nbsp;days thereafter, but an otherwise valid exercise of the Special Right of First Offer shall be fully effective whether or not the Offering Amendment is signed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>In Property Owned By Landlord Affiliates</U>: During the Special ROFO Period, but only if (i)&nbsp;Landlord has not previously offered
Offering Space to Tenant pursuant to Section&nbsp;2.7, or Special Offering Space to Tenant pursuant to Section&nbsp;2.8(a), or (ii)&nbsp;a Landlord Affiliate has not previously offered Affiliate Offering Space to Tenant pursuant to this
Section&nbsp;2.8(b), Tenant may request in writing (a &#147;Tenant Affiliate Offering Space Request&#148;) that Landlord use commercially-reasonable efforts to cause a Landlord Affiliate that owns office and/or lab property in Emeryville, California
(if any, an &#147;Emeryville Affiliate to provide Tenant with an offer (&#147;Affiliate Offer Right&#148;) to lease to Tenant any space owned by such an Emeryville Affiliate which measures no less than twelve thousand (12,000) rentable square feet
nor more than twenty-thousand (20,000) rentable square feet and is then Available for Lease (described below) (the &#147;Affiliate Offering Space&#148;). Tenant&#146;s rights hereunder shall be subject to the superior rights of other parties (an
&#147;Affiliate Offer Superior Rights&#148;) in any respective Emeryville Affiliate&#146;s property or properties, which superior right(s) may be granted by any Emeryville Affiliate at any time and from time to time. For the avoidance of doubt, any
Emeryville Affiliate shall have the right shall have the right to lease any space in a property it owns at any time on such terms as such Emeryville Affiliate may determine in its sole and absolute discretion regardless of whether such space might
otherwise qualify as Affiliate Offering Space if it were Available for Lease at the time that Tenant delivers a Tenant Affiliate Offering Space Request. An Affiliate Offering Space shall be deemed to be &#147;Available for Lease&#148; if, at the
time that Tenant delivers a Tenant Affiliate Offering Space Request, (i)&nbsp;such space is not then under lease to a third party and the Emeryville Affiliate in question is not then in negotiations with a third party for the lease thereof,
(ii)&nbsp;no third party has an Affiliate Offer Superior Right which is subject to exercise, and (iii)&nbsp;the respective Emeryville Affiliate is ready to market such space for lease. If at the time Tenant delivers a Tenant Affiliate Offering Space
Request, Landlord determines that an Emeryville Affiliate has Affiliate Offering Space that is Available for Lease, said Emeryville Affiliate may advise Tenant (the &#147;Affiliate Offer Notice&#148;) of the terms under which said Emeryville
Affiliate may be prepared to lease such Affiliate Offering Space to Tenant, including, without limitation, description of the space so offered to Tenant and proposed material economic terms and conditions applicable to Tenant&#146;s lease of such
space (collectively, &#147;Affiliate Offer Economic Terms&#148;). Tenant may lease such Affiliate Offering Space in its entirety only, under such Affiliate Offer Economic Terms, by delivering written notice of exercise to the appropriate Emeryville
Affiliate (&#147;Affiliate Offer Notice of Exercise&#148;) within fifteen (15)&nbsp;days after the date of delivery of the Affiliate Offer Notice, except that Tenant shall have no such Affiliate Offer Right and an Emeryville Affiliate need not
provide Tenant with an Affiliate Offer Notice, if: (i)&nbsp;Tenant is in Default under this Lease at the time the Emeryville Affiliate would otherwise deliver the Affiliate Offer Notice; or (ii)&nbsp;the Premises, or any portion thereof, is sublet
(other than pursuant to a Permitted Transfer) at the time the Emeryville Affiliate would otherwise deliver the Affiliate Offer Notice; (iii)&nbsp;this Lease has been assigned (other than pursuant to a Permitted Transfer) prior to the date the
Emeryville Affiliate would otherwise deliver the Affiliate Offer Notice; or (iv)&nbsp;either Tenant or Permitted Transferee is not occupying all of the Premises on the date the Emeryville Affiliate would otherwise deliver the Affiliate Offer Notice.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Terms</U>. The term for any Affiliate Offering Space shall commence upon the
commencement date stated in the Affiliate Offer Notice. Tenant understands and acknowledges that the terms of any accepted Affiliate Offer Notice would require documentation in a new lease between said Emeryville Affiliate and Tenant, the terms of
which lease, other than the Affiliate Offer Economic Terms, must be approved by both the Emeryville Affiliate and Tenant in their respective sole and absolute discretions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Limitation on Affiliate Offer Right</U>. The Affiliate Offer Right is a <FONT STYLE="white-space:nowrap">one-time</FONT> only right;
and if Tenant does not accept an Affiliate Offer Notice from an Emeryville Affiliate within the fifteen (15)&nbsp;day period provided in Section&nbsp;2.8(b) above, such right shall terminate. Further, the Affiliate Offer Right shall terminate if and
at such time as Landlord is able to offer either Offering Space or Special Offering Space to Tenant pursuant to process outlined in Section&nbsp;2.7 or 2.8(a) above prior to the expiration of the Special ROFO Period, whether or not Tenant accepts
any such offer from Landlord. The Affiliate Offer Right shall also terminate upon the expiration of the Special ROFO Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant
specifically understands and agrees that, while Landlord has agreed to use its commercially-reasonable efforts to cause an Emeryville Affiliate to follow the Affiliate Offer process outlined above. Landlord&#146;s inability or failure to do so shall
not constitute a Default under this Lease, and that Tenant shall have no remedy nor cause of action either against Landlord or against any Emeryville Affiliate for such failure or inability on the part of Landlord nor for the failure of any
Emeryville Affiliate to make any Affiliate Offer Notice to Tenant or of any Emeryville Affiliate to conclude a lease with Tenant pursuant to terms contained in any Affiliate Offer Notice that Tenant may have accepted via Affiliate Offer Notice of
Exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 3 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RENT
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall pay to Landlord at the address specified in Section&nbsp;1.1(2), or to such other persons, or at such other places
designated by Landlord or by electronic funds transfer pursuant to Landlord&#146;s written instructions, without any prior demand therefor in immediately available funds and without any deduction or offset whatsoever, Rent, including Monthly Base
Rent and Rent Adjustments in accordance with Article 4, during the Term. Monthly Base Rent shall be paid monthly in advance on the first day of each month of the Term, except that the first installment of Monthly Base Rent shall be paid by Tenant to
Landlord concurrently with execution of this Lease. Monthly Base Rent shall be prorated for partial months within the Term. Unpaid Rent shall bear interest at the Default Rate from the date Tenant receives a notice of such default due until paid.
Tenant&#146;s covenant to pay Rent shall be independent of every other covenant in this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 4 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RENT ADJUSTMENTS AND PAYMENTS </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.1
<U>RENT ADJUSTMENTS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the Commencement Date, Tenant shall pay to Landlord Rent Adjustments with respect to each calendar
year (or partial calendar year in the case of the year in which the Commencement Date and the Termination Date occur) as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The
Rent Adjustment Deposit representing Tenants Share of Operating Expenses for the applicable calendar year (or partial calendar year), monthly during the Term with the payment of Monthly Base Rent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Rent Adjustment Deposit representing Tenant&#146;s Share of Taxes for the applicable calendar year (or partial calendar year), monthly
during the Term with the payment of Monthly Base Rent; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Any Rent Adjustments due in excess of the Rent Adjustment Deposits in
accordance with Section&nbsp;4.2. Rent Adjustments due from Tenant to Landlord for any Lease Year shall be Tenant&#146;s Share of Operating Expenses for such Lease Year and Tenant&#146;s Share of Taxes for such Lease Year; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) For purposes of determining Rent Adjustments, if the Building or Property is not fully occupied during all or a portion of any calendar
year (or partial calendar year). Landlord shall make appropriate adjustments to the variable components of Operating Expenses for such calendar year (or partial calendar year), employing sound accounting and management principles consistently
applied, to determine the amount of Operating Expenses that would have been paid or incurred by Landlord had the Building or Property been fully occupied, and the amount so determined shall be deemed to have been the amount of Operating Expenses for
such calendar year (or partial calendar year). In the event that the Property is not fully assessed for all or a portion of any calendar year (or partial calendar year) during the Term, then Taxes shall be adjusted to an amount which would have been
payable in such calendar year (or partial calendar year) if the Property had been fully assessed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.2 <U>STATEMENT OF LANDLORD</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or before April&nbsp;1 of each calendar year (or as soon thereafter as practical). Landlord will furnish to Tenant a statement
(&#147;Landlord&#146;s Statement&#148;) respecting the prior calendar year showing the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Operating Expenses and Taxes for
such calendar year; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The amount of Rent Adjustments due Landlord for the last calendar year, less credit for Rent Adjustment Deposits
paid, if any; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Any change in the Rent Adjustment Deposit due monthly in the current calendar year,
including the amount or revised amount due for months preceding any such change pursuant to Landlord&#146;s Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall pay
to Landlord within thirty (30)&nbsp;days after receipt of each Landlord&#146;s Statement any amounts for Rent Adjustments then due in accordance with such Landlord&#146;s Statement. Any amounts due from Landlord to Tenant pursuant to this Section
shall be credited to the Rent Adjustment Deposit next coming due or refunded to Tenant if the Term has expired, provided Tenant is not in Default hereunder. No interest or penalties shall accrue on any amounts that Landlord is obligated to credit or
refund to Tenant by reason of this Section&nbsp;4.2. Landlord&#146;s failure to deliver Landlord&#146;s Statement or to compute the amount of the Rent Adjustments shall not constitute a waiver by Landlord of its right to deliver such items nor
constitute a waiver or release of Tenant&#146;s obligations to pay such amounts. The Rent Adjustment Deposit shall be credited against Rent Adjustments due for the applicable calendar year (or partial calendar year). During the last complete
calendar year (or partial calendar year) or during any partial calendar year in which this Lease terminates. Landlord may include in the Rent Adjustment Deposit its estimate of Rent Adjustments which may not be finally determined until after the
termination of this Lease. Tenant&#146;s obligation to pay Rent Adjustments and Landlord&#146;s obligation to refund any Rent Adjustment Deposit to Tenant shall survive the expiration or termination of this Lease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.3 <U>BOOKS AND RECORDS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall
maintain books and records showing Operating Expenses and Taxes in accordance with sound accounting and management practices, consistently applied. Tenant or its representative (which representative shall be a certified public accountant licensed to
do business in the state in which the Property is located and whose primary business is certified public accounting and who shall not be paid on a contingency basis) shall have the right, for a period of ninety (90)&nbsp;days following the date upon
which Landlord&#146;s Statement is delivered to Tenant, to examine the Landlord&#146;s books and records with respect to the items in the foregoing statement of Operating Expenses and Taxes during normal business hours, upon written notice,
delivered at least three (3)&nbsp;business days in advance, Tenant shall pay for all costs of such examination, provided, however, if such examination results in a discrepancy of more than five percent (5%) in the actual Operating Expenses and Taxes
from those shown on the Landlord&#146;s Statement, such costs shall be reimbursed by Landlord. If Tenant does not object in writing to Landlord&#146;s Statement within ninety (90)&nbsp;days of Tenant&#146;s receipt thereof, specifying the nature of
the item in dispute and the reasons therefor, then Landlord&#146;s Statement shall be considered final and accepted by Tenant and Tenant shall be deemed to have waived its right to dispute Landlord&#146;s Statement. If Tenant does dispute any item
in the Landlord&#146;s Statement, Tenant shall give notice of such dispute to Landlord and deliver a copy of any such audit to Landlord at the time of notification of the dispute. If Tenant does not provide such notice of dispute and a copy of such
audit to Landlord within such ninety (90)&nbsp;day period, it shall be deemed to have waived such right to dispute Landlord&#146;s Statement. Any amount due to Landlord as shown on Landlord&#146;s Statement, whether or not disputed by Tenant as
provided herein shall be paid by Tenant when due as provided above, without prejudice to any such written exception. In no event shall Tenant be permitted to examine Landlord&#146;s records or to dispute any statement of Operating Expenses and Taxes
while Tenant is in Default under this Lease. Upon resolution of any dispute with respect to Operating Expenses and/or Taxes, Tenant shall either pay Landlord any shortfall or Landlord shall credit Tenant with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to any overages paid by Tenant (or promptly pay such amount directly to Tenant, if there are not sufficient months left in the Term to credit such amount to). The records obtained by
Tenant shall be treated as confidential and neither Tenant nor any of its representatives or agents (including without limitation any financial or legal consultants) shall disclose or discuss the information set forth in the audit to or with any
other person or entity except (a)&nbsp;to Tenant&#146;s lawyers and accountants, or (b)&nbsp;as required by applicable law (&#147;Confidentiality Requirement&#148;). Tenant shall indemnify and hold Landlord harmless for any losses or damages arising
out of the breach of the Confidentiality Requirement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.4 <U>TENANT OR LEASE SPECIFIC TAXES</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to Monthly Base Rent, Rent Adjustments, Rent Adjustment Deposits and other charges to be paid by Tenant, Tenant shall pay to
Landlord, within thirty (30)&nbsp;days following receipt of written demand, any and all taxes payable by Landlord (other than federal or state inheritance, franchise, general income, gift or estate taxes) whether or not now customary or within the
contemplation of the parties hereto: (a)&nbsp;upon, allocable to, or measured by the Rent payable hereunder, including any gross receipts tax or excise tax levied by any governmental or taxing body with respect to the receipt of such rent; or
(b)&nbsp;upon or with respect to the possession, leasing, operation, management, maintenance, alteration, repair, use or occupancy by Tenant of the Premises or any portion thereof; or (c)&nbsp;upon the measured value of Tenant&#146;s personal
property located in the Premises or in any storeroom or any other place in the Premises or the Property, or the areas used in connection with the operation of the Property, it being the intention of Landlord and Tenant that, to the extent possible,
such personal property taxes shall be billed to and paid directly by Tenant; (d)&nbsp;resulting from any Landlord Work, Tenant Work, Tenant Alterations, or any other improvements to the Premises, whether title thereto is in Landlord or Tenant; or
(e)&nbsp;upon this transaction; provided, however, Tenant shall not have any obligation to pay such taxes to the extent they are already included in the calculation of the Operating Expenses for the Project. Taxes paid by Tenant pursuant to this
Section&nbsp;4.4 shall not be included in any computation of Taxes payable pursuant to Sections 4.1 and 4.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 5 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SECURITY DEPOSIT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of this Lease, Tenant shall pay to Landlord the Security Deposit, in immediately available funds. The Security
Deposit may be applied by Landlord to cure, in whole or part, any Default of Tenant under this Lease, and upon notice by Landlord of such application, Tenant shall replenish the Security Deposit in full by paying to Landlord within ten&nbsp;(10)
days following receipt of written demand from Landlord the amount so applied. Landlord&#146;s application of the Security Deposit shall not constitute a waiver of Tenant&#146;s default to the extent that the Security Deposit does not fully
compensate Landlord for all losses, damages, costs and expenses incurred by Landlord in connection with such default and shall not prejudice any other rights or remedies available to Landlord under this Lease or by Law. Landlord shall not pay any
interest on the Security Deposit. Landlord shall not be required to keep the Security Deposit separate from its general accounts. The Security Deposit shall not be deemed an advance payment of Rent or a measure of damages for any default by Tenant
under this Lease, nor shall it be a bar or defense of any action that Landlord may at any time commence against Tenant. In the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
absence of evidence satisfactory to Landlord of an assignment of the right to receive the Security Deposit or the remaining balance thereof, Landlord may return the Security Deposit to the
original Tenant, regardless of one or more assignments of this Lease. Upon the transfer of Landlord&#146;s interest under this Lease, Landlord&#146;s obligation to Tenant with respect to the Security Deposit shall terminate upon the date Landlord
transfers to the transferee of the Security Deposit, or any balance thereof, and such transferee assumes all of Landlord&#146;s obligations under this Lease in writing, including, without limitation, those relating to the Security Deposit. If Tenant
shall fully and faithfully comply with all the terms, provisions, covenants, and conditions of this Lease, the Security Deposit, or any balance thereof, shall be returned to Tenant within thirty (30)&nbsp;days after Landlord recovers possession of
the Premises, Tenant hereby waives any and all rights of Tenant under the provisions of Section&nbsp;1950.7 of the California Civil Code or other Law regarding the uses to which security deposits may be applied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, upon the expiration of the sixth (6<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) Lease Year, all of the following are true: a)
all Rent due has been paid, b) Tenant is not in Default hereunder, c) Tenant&#146;s net worth and liquidity, as calculated pursuant to GAAP, are each not materially less than they were as of the Date of Lease, Landlord agrees that the Security
Deposit amount shall be reduced by fifty percent (50%), to become a revised total of $718,789.00, and the difference of $718,789.00 shall be returned to Tenant within ten (10)&nbsp;days following the expiration of the sixth (6<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) Lease Year. Failure of any of the above to be true at the end of the sixth (6<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) Lease Year shall mean the Security Deposit shall remain
unchanged in amount for the balance of the Lease Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 6 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SERVICES </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.1 <U>LANDLORD&#146;S GENERAL
SERVICES</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) So long as this Lease is in full force and effect, Landlord shall furnish the following services the cost of which
services shall be included in Operating Expenses or paid directly by Tenant to utility or service provider: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) heat, ventilation and <FONT
STYLE="white-space:nowrap">air-conditioning</FONT> (&#147;HVAC&#148;) in the Premises during Standard Operating Hours as necessary in Landlord&#146;s reasonable judgment for the comfortable occupancy of the Premises under normal business office and
laboratory operations, and (ii)&nbsp;outside of Tenant&#146;s Standard Operating Hours to minimum safe setback levels for laboratory operations (&#147;After-Hours Setback&#148;), subject to compliance with all applicable mandatory regulations and
Laws; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) tempered and cold water for normal and customary use in the Premises and in lavatories in common with other tenants from the
regular supply of the Building; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) customary cleaning and janitorial services in the Common Areas five (5)&nbsp;days per week, excluding
National Holidays; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) washing of the outside windows in the Premises weather permitting at intervals determined by Landlord; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(5) automatic passenger elevator service in common with other tenants of the Building and
freight elevator service subject to reasonable scheduling by Landlord. Tenant shall have access to the Premises seven (7)&nbsp;days per week, twenty-four (24)&nbsp;hours per day, subject to such reasonable measures and systems for access control
and/or tenant identification as exist from time to time at the Building, including, for example only, keys or card-keys for entry which shall be provided to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Landlord shall provide a security program for the Building (but not individually for Tenant or the Premises) and Tenant&#146;s Parking
generally consistent with the standards of comparable office/laboratory buildings in Emeryville. The cost of the security program shall be an Operating Expense. Landlord shall not be liable in any manner to Tenant or any other Tenant Parties for any
acts (including criminal acts) of others, or for any direct, indirect, or consequential damages, or any injury or damage to, or interference with, Tenant&#146;s business, including, but not limited to, loss of profits, loss of rents or other
revenues, loss of business opportunity, loss of goodwill or loss of use, or other loss or damage, bodily injury or death, related to any malfunction, circumvention or other failure of any security program, or for the failure of any security program
to prevent bodily injury, death, or property damage, or loss, or to apprehend any person suspected of causing such injury, death, damage or loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Upon the Rent Commencement Date, Landlord agrees that in the event of an interruption of power to the Building, Tenant will connect Tenant
loads to the emergency generator serving the Building (the &#147;Emergency Generator&#148;) on the following conditions: (i)&nbsp;Tenant loads to the Emergency Generator shall in no event exceed Tenant&#146;s Share of the kVA capacity of the
Emergency Generator Landlord elects to make available for shared use by tenants of the Building; (ii)&nbsp;any use of the Emergency Generator, including the duration of use, shall be subject to the requirements and limitations (if any) imposed by
applicable Law; and (iii)&nbsp;in the event of an emergency causing an interruption of power to any portion of the Building, Landlord may, in its reasonable discretion, immediately shed or shut down Tenant loads (an &#147;Emergency Shut Down&#148;)
to the extent reasonably necessary to redirect the power from the Emergency Generator (&#147;Emergency Generator Power&#148;) to the Building&#146;s emergency/life-safety systems (e.g., elevators, fire-life safety and emergency lighting). To the
extent Landlord&#146;s load shedding equipment accommodates shedding Tenant loads in stages, then Landlord shall use commercially reasonable good-faith efforts to shed Tenant loads in a priority which Tenant has delivered to Landlord in writing. As
a condition to Tenant&#146;s right to connect Tenant loads to the Emergency Generator: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Tenant shall install and maintain, at
Tenant&#146;s sole cost and expense (the cost of which may be deducted from Tenant Improvement Allowance), a meter (the &#147;Meter&#148;), which shall be designed and configured to capture all Tenant loads connected to the Emergency Generator. Any
and all reasonable out of pocket costs and expenses incurred by Landlord in connection with the Emergency Generator, including, without limitation, provisions for load-shedding and shunt trips, fuel and maintenance/repair/replacement costs, shall be
an Operating Expense; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Landlord shall have the right to require Tenant to install and maintain a shunt trip device (&#147;Shunt
Trip Device&#148;) designed and configured to automatically shut down Tenant&#146;s connection to the Emergency Generator and use of Emergency Generator Power in the event that the generator load for the Building exceeds eighty percent (80%) of the
Emergency Generator rating. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Tenant shall provide Landlord and Landlord&#146;s building management staff (the
&#147;Building Management Staff&#148;) with access to the Meter installed on the Emergency Generator (&#147;EG Meter&#148;) during normal business hours with at least 48 hours&#146; advance notice for the purpose of inspection. In the event that
Tenant fails to repair the EG Meter within thirty (30)&nbsp;days following receipt of written notice from Landlord thereof, Landlord shall have the right to perform necessary maintenance or repairs thereto, and Tenant shall reimburse Landlord for
Landlord&#146;s reasonable and customary <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses in connection therewith within thirty (30)&nbsp;days after Tenant&#146;s receipt of
Landlord&#146;s written demand therefor (which demand shall be accompanied by documentation of the costs and expenses which are the subject of such demand). Landlord shall have the right at any time during the Lease Term to install and maintain
additional or separate transfer switches, meters, control devices and shunt trip devices in order to monitor and control Tenant&#146;s connection to the Emergency Generator and use of the Emergency Generator Power. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Notwithstanding anything to the contrary herein, Tenant acknowledges that the Emergency Generator and any transfer switch may be
exercised on a periodic basis, such exercise to be conducted by Landlord or the Building Management Staff at Landlord&#146;s reasonable discretion. Tenant further acknowledges that annual maintenance procedures require that the Emergency Generator
be taken <FONT STYLE="white-space:nowrap">off-line</FONT> and that an annual full load test be performed on an annual basis, which test shall be conducted by Landlord or the Building Management Staff at Landlord&#146;s reasonable discretion;
provided, however, Landlord shall give Tenant not less than five (5)&nbsp;business days&#146; prior written notice thereof. Landlord shall not be liable to Tenant, and Tenant shall not be entitled to any abatement of rent or other recourse in the
event that Emergency Generator Power is not available for any reason. Landlord&#146;s actual <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-</FONT></FONT> pocket cost of such exercise and testing shall be included in the
maintenance costs, of which Tenant shall pay its proportionate share as set forth above in Paragraph 5(f). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) Upon the expiration or
earlier termination of the Lease Term, Tenant shall surrender and assign to Landlord the Meter with the Premises. In no event shall Tenant be entitled to any reimbursement from Landlord for costs incurred by Tenant in connection with Tenant&#146;s
installation and maintenance of the Meter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) The rights granted to Tenant under this Section&nbsp;6.1(c) are personal to the named
Tenant hereunder (and any assignee pursuant to a Permitted Transfer) (each an &#147;Approved User&#148;), and shall only be exercisable by an Approved User so long only one connection exists from the Premises to the Emergency Generator at a time.
Any attempt by an Approved User or any of its subtenants or other transferees to make any additional connection from the Premises to the Emergency Generator shall constitute a material breach and default, and Tenant shall reimburse Landlord for all
reasonable and customary <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred by Landlord in connection with curing any such default within ten (10)&nbsp;business days following
Tenant&#146;s receipt of Landlord&#146;s demand therefor accompanied by documentation of such costs and expenses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) So long as this Lease is in full force and effect. Landlord shall furnish to the
Premises replacement lamps, bulbs, ballasts and starters used in any normal Building lighting installed in the Premises, except that if the replacement or repair of such items is a result of negligence of Tenant, its employees, agents, servants,
licensees, subtenants, contractors or invitees, such cost shall be paid by Tenant within ten (10)&nbsp;days after notice from Landlord and shall not be included as part of Operating Expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If Tenant uses heat generating machines or equipment in the Premises to an extent which materially and adversely affects the temperature
otherwise maintained by the <FONT STYLE="white-space:nowrap">air-cooling</FONT> system or whenever the occupancy or electrical load materially and adversely affects the temperature otherwise maintained by the
<FONT STYLE="white-space:nowrap">air-cooling</FONT> system, and if Tenant fails to eliminate such impact within thirty (30)&nbsp;days following written notice from Landlord, Landlord reserves the right to install or to require Tenant to install
supplementary <FONT STYLE="white-space:nowrap">air-conditioning</FONT> units to service the Premises. Tenant shall bear all reasonable costs and expenses related to the installation, maintenance and operation of such units. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.2 <U>UTILITIES AND JANITORIAL SERVICES</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All utility services used in the production of heating and cooling and air supply and exhaust from the central HVAC systems serving the
Building and Premises, including, without limitation, electricity and gas, as well as water and sewer services, shall constitute Operating Expenses. If Landlord so elects, any or all utility services used by Tenant within the Premises, including,
without limitation, electricity and gas, shall be paid for by Tenant by separate charge and shall not be included as part of Operating Expenses. Such charges shall be based upon Tenant&#146;s usage as measured by a separate meter or <FONT
STYLE="white-space:nowrap">sub-meter</FONT> for the Premises installed by Tenant at Tenant&#146;s sole cost and expense (the cost of which may be deducted from Tenant Improvement Allowance), a meter, or as reasonably estimated by Landlord and shall
be payable by Tenant to Landlord within 30 days after billing by Landlord. In addition, Tenant shall provide its own janitorial services to the Premises, using a janitorial service reasonably acceptable to Landlord or shall make arrangements with
Landlord for Landlord, through Landlord&#146;s vendors, to perform such Premises cleaning services, and shall pay the costs thereof directly to Landlord. Notwithstanding any provision of this Lease to the contrary, Tenant shall not make any
alterations or additions to the electric equipment or systems, in each instance, without the prior written approval of Landlord, which approval shall not be unreasonably withheld, conditioned or delayed so long as such alterations or additions
(i)&nbsp;do not exceed the capacity of the wiring, feeders and risers and (ii)&nbsp;are in compliance with the City&#146;s building code. Tenant&#146;s use of electric current shall at no time exceed the capacity of the wiring, feeders and risers
providing electric current to the Premises or the Building. The consent of Landlord to the installation of electric equipment shall not relieve Tenant from the obligation to limit usage of electricity to no more than such capacity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.3 <U>ADDITIONAL AND AFTER HOUR SERVICES</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At Tenant&#146;s written request, Landlord shall furnish additional quantities of any of the services or utilities specified in
Section&nbsp;6.1, if Landlord can reasonably do so, on the terms set forth herein. For services or utilities requested by Tenant and furnished by Landlord, Tenant shall pay to Landlord as a charge therefor Landlord&#146;s prevailing rates charged
from time to time for such services and utilities, including, without limitation, HVAC service outside of Standard Operating Hours and beyond After-Hours Setback levels. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.4 <U>TELEPHONE SERVICES</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All telephone, and communication connections which Tenant may desire shall be subject to Landlord&#146;s prior written approval, in
Landlord&#146;s reasonable discretion, and the location of all wires and the work in connection therewith shall be performed by contractors reasonably approved by Landlord, and shall be subject to the direction of Landlord and in compliance with
Landlord&#146;s then current Building Standards for voice, data and wiring installation. Notwithstanding the foregoing, such approval is not required for Tenant&#146;s telephone equipment (including cabling) within the Premises and from the Premises
in a route reasonably designated by Landlord to any telephone cabinet or panel provided on Tenant&#146;s floor for Tenant&#146;s connection to the telephone cable serving the Building so long as Tenant&#146;s equipment does not require connections
different from or additional to those to the telephone cabinet or panel provided. Tenant shall be responsible for and shall pay all costs incurred in connection with the installation of telephone cables and communication wiring in the Premises,
including any hook up, access and maintenance fees related to the installation of such wires and cables in the Premises and the commencement of service therein, and the maintenance thereafter of such wire and cables; and there shall be included in
Operating Expenses for the Building all installation, removal, hook up or maintenance costs incurred by Landlord in connection with telephone cables and communication wiring serving the Building which are not allocable to any individual users of
such service but are allocable to the Building generally. If Tenant fails to maintain all telephone cables and communication wiring in the Premises, and such failure adversely affects or interferes with the operation or maintenance of any other
telephone cables or communication wiring serving the Building, Landlord or any vendor hired by Landlord may enter into and upon the Premises forthwith and perform such repairs, restorations or alterations as Landlord deems reasonably necessary in
order to eliminate any such interference (and Landlord may recover from Tenant all of Landlord&#146;s reasonable costs in connection therewith). Tenant agrees that neither Landlord nor any of its agents or employees shall be liable to Tenant, or any
of Tenant&#146;s employees, agents, customers or invitees or anyone claiming through, by or under Tenant, for any damages, injuries, losses, expenses, claims or causes of action because of any interruption, diminution, delay or discontinuance at any
time for any reason in the furnishing of any telephone or other communication service to the Premises and the Building. Notwithstanding the foregoing to the contrary, to the extent such interruption, diminution, delay or discontinuance is caused by
the gross negligence or willful misconduct by Landlord, the property manager, the leasing manager for the Property and their respective partners, members, directors, officers, agents and employees, then Tenant shall be entitled, as its sole remedy,
to pursue an action for actual damages (but not punitive, consequential, exemplary, treble or special damages) against Landlord. In no event shall Tenant be entitled to any abatement of Rent or the right to terminate this Lease due to any such
interruption, diminution, delay or discontinuance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.5 <U>DELAYS IN FURNISHING SERVICES</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant agrees that Landlord shall not be in breach of this Lease nor be liable to Tenant for damages or otherwise, for any failure to furnish,
or a delay in furnishing, or a change in the quantity or character of any service when such failure, delay or change is occasioned, in whole or in part, by repairs, improvements or mechanical breakdowns, by the act or default of Tenant or other
parties or by an event of Force Majeure. No such failure, delay or change shall be deemed to be an eviction or disturbance of Tenant&#146;s use and possession of the Premises, or relieve Tenant from paying Rent or from performing any other
obligations of Tenant under this Lease, without any deduction or offset; provided, however, in the case of any such failure or delay is caused by the gross negligence or willful misconduct of Landlord and the same materially interferes with
Tenant&#146;s ability to conduct business in the Premises, then unless Landlord is diligently pursuing a remedy. Rent shall be abated commencing on the fifth (5th) consecutive business day following such failure or delay and shall continue until
such time as the failure or delay that materially interferes with Tenant&#146;s ability to conduct business in the Premises is cured. Failure to any extent to make available, or any slowdown, stoppage, or interruption of, the specified utility
services resulting from any cause, including changes in service provider or Landlord&#146;s compliance with any voluntary or similar governmental or business guidelines now or hereafter published or any requirements now or hereafter established by
any governmental agency, board, or bureau having jurisdiction over the operation of the Property shall not render Landlord liable in any respect for damages to either persons, property, or business, nor be construed as an eviction of Tenant or work
an abatement of Rent, nor relieve Tenant of Tenant&#146;s obligations for fulfillment of any covenant or agreement hereof. Notwithstanding the foregoing, Landlord shall make commercially reasonable efforts to provide Tenant with at least three
(3)&nbsp;business days&#146; notice of any known, planned interruption in utilities or services. Should any equipment or machinery furnished by Landlord break down or for any cause cease to function properly, Landlord shall use reasonable diligence
to repair same promptly, but Tenant shall have no claim for abatement of Rent or damages on account of any interruption of service occasioned thereby or resulting therefrom. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.6 <U>CHOICE OF SERVICE PROVIDER</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant
acknowledges that Landlord may, at Landlord&#146;s sole option, to the extent permitted by applicable law, elect to change, from time to time, the company or companies which provide services (including electrical service, gas service, water,
telephone and technical services) to the Building, the Premises and/or its occupants. Notwithstanding anything to the contrary set forth in this Lease, Tenant acknowledges that Landlord has not and does not make any representations or warranties
concerning the identity or identities of the company or companies which provide services to the Building and the Premises or its occupants and Tenant acknowledges that the choice of service providers and matters concerning the engagement and
termination thereof shall be solely that of Landlord. The foregoing provision is not intended to modify, amend, change or otherwise derogate any provision of this Lease concerning the nature or type of service to be provided or any specific
information concerning the amount thereof to be provided. Tenant agrees to cooperate with Landlord and each of its service providers in connection with any change in service or provider. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.7 <U>SIGNAGE</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Initial Building
standard signage for Tenant will be installed by Landlord in the directory in the main lobby of the Building and, in the case of any multi-tenant floor, in the listing of tenants in the elevator lobby for the floor on which the Premises is located,
at Landlord&#146;s sole cost and expense. In the event Tenant occupies an entire floor of the Building, Tenant may install its own signage in the elevator lobby of such floor, at Tenant&#146;s sole cost and expense, and otherwise in accordance with
the provisions of Article 9 below. Any change in such initial signage shall be only with Landlord&#146;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed), shall conform to Building standard signage and shall
be at Tenant&#146;s sole cost and expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Landlord hereby agrees not to offer exterior,
<FONT STYLE="white-space:nowrap">non-exclusive,</FONT> top of building signage to any other tenant of the Building who has leased two (2)&nbsp;full floors or less without first offering such signage rights to Tenant. Landlord and Tenant hereby agree
and acknowledge that if such exterior signage rights are offered by Landlord and accepted by Tenant, Tenant shall pay Landlord the prevailing market rate for such rights, and Landlord and Tenant also agree that the cost to design, secure approvals
and permits for, fabricate, install, maintain, repair, remove and restore any such exterior signage shall be at Tenant&#146;s sole cost and expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 7 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>POSSESSION, USE AND
CONDITION OF PREMISES </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.1 <U>POSSESSION AND USE OF PREMISES</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall occupy and use the Premises only for the uses specified in Section&nbsp;1.1(15) to conduct Tenant&#146;s business. Tenant
shall not occupy or use the Premises (or permit the use or occupancy of the Premises) for any purpose or in any manner which: (1)&nbsp;is unlawful or in violation of any applicable Law or Environmental Law; (2)&nbsp;may be dangerous to persons or
property or which may increase the cost of, or invalidate, any policy of insurance carried on the Building or covering its operations; (3)&nbsp;is contrary to or prohibited by the terms and conditions of this Lease or the rules of the Building set
forth in Article 18; (4) creates a nuisance, or (5)&nbsp;in any manner that will cause the Building or any part thereof not to conform with the Project&#146;s Sustainability Practices or the certification of the Building pursuant to the applicable
Green Building Standards; provided, however, that in no event shall such practices or certification requirements have the effect of preventing Tenant from conducting its business at the Premises in a manner consistent with the Permitted Use. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Upon Commencement Date, Landlord shall provide Tenant with 250 Access Card Keys the cost of which shall be paid by Tenant within ten
(10)&nbsp;days of Landlord&#146;s demand therefor (or at Tenant&#146;s election, the cost thereof may be deducted from Tenant Improvement Allowance), and Tenant shall place a deposit for such cards with Landlord to cover lost cards or cards which
are not returned at the end of the Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Landlord and Tenant acknowledge that the Americans With Disabilities Act of 1990 (42 U.S.C.
&#167;12101 et seq.) and regulations and guidelines promulgated thereunder, as all of the same may be amended and supplemented from time to time (collectively referred to herein as the &#147;ADA&#148;) establish requirements for business operations,
accessibility and barrier removal, and that such requirements may or may not apply to the Premises, the Building and the Project depending on, among other things: (1)&nbsp;whether Tenant&#146;s business is deemed a &#147;public accommodation&#148;
or &#147;commercial facility&#148;, (2) whether such requirements are &#147;readily achievable&#148;, and (3)&nbsp;whether a given alteration affects a &#147;primary function area&#148; or triggers &#147;path of travel&#148; requirements. The
parties hereby agree that, as between Landlord and Tenant, compliance with any accessibility requirement relating to the Common Area and Landlord Work, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on an unoccupied basis, promulgated under the ADA shall be responsibility of Landlord (and not Tenant), except to the extent that any specific compliance is triggered by Tenant&#146;s Use in the
Premises or any Tenant Alterations, and more specifically, (A)&nbsp;Landlord shall be responsible for ADA Title III compliance in the Common Areas, except as provided below; (B)&nbsp;Tenant shall be responsible for ADA Title III compliance in the
Premises, subject to Landlord&#146;s obligation to construct all of the Landlord Work in compliance with all applicable Laws (including ADA), on an unoccupied basis and without regard to Tenant&#146;s specific use of the Premises, the cost of which
compliance shall be a Tenant Improvement Allowance Item (as defined in the Workletter); provided, however, Landlord shall make commercially reasonable efforts to cause such ADA Title&nbsp;III compliance to be at the cost of the Architect, Building
Consultants, and/or Contractor (all as defined in the Workletter), to the extent such <FONT STYLE="white-space:nowrap">non-compliance</FONT> was due to any negligent act or omission on any of their parts; (C)&nbsp;Landlord may perform, or require
that Tenant perform, and Tenant shall be responsible for the cost of, ADA Title III &#147;path of travel&#148; requirements triggered by Tenant Additions in the Premises, and (D)&nbsp;Landlord may perform, or require Tenant to perform, and Tenant
shall be responsible for the cost of, ADA Title III compliance in the Common Areas necessitated by the Building being deemed to be a &#147;public accommodation&#148; instead of a &#147;commercial facility&#148; as a result of Tenant&#146;s use of
the Premises. Tenant shall be solely responsible for requirements under Title I of the ADA relating to Tenant&#146;s employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Civil
Code Section&nbsp;1938. TENANT HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, THE PROTECTIONS OF CALIFORNIA CIVIL CODE SECTION 1938. IF SUCH WAIVER IS NOT ENFORCEABLE UNDER CALIFORNIA LAW, THEN THE FOLLOWING PROVISIONS SHALL APPLY. The
Premises have not been issued a disability access inspection certificate or undergone inspection by a Certified Access Specialist (&#147;CASp&#148;). The following notice is given pursuant to California Civil Code Section&nbsp;1938: &#147;A
Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp
inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested
by the lessee or tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of
construction-related accessibility standards within the premises.&#148; Landlord and Tenant hereby agree that if Tenant elects to perform a CASp inspection of the Premises, Tenant will provide written notice to Landlord, and Landlord may elect, in
Landlord&#146;s sole discretion, to retain a CASp to perform the inspection. If Landlord does not so elect, the time and manner of the CASp inspection is subject to the prior written approval of Landlord. In either event, the payment of the fee for
the CASp inspection shall be borne by Tenant. The cost of making any repairs necessary to correct violations of construction-related accessibility standards within the Premises shall be allocated as provided in this Article. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Tenant agrees to cooperate and use commercially reasonable efforts to participate in traffic management programs provided to Tenant in
writing by Landlord, and Tenant shall encourage and support van, shuttle service, and carpooling by, and staggered and flexible working hours for, its office workers and service employees to the extent reasonably permitted by the requirements of
Tenant&#146;s business. Neither this Section or any other provision of this Lease is intended to or shall create any rights or benefits in any other person, firm, company, governmental entity or the public. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Tenant agrees to cooperate with Landlord and to comply with any and all reasonable
guidelines or controls concerning energy management and usage disclosure imposed upon Landlord by federal or state governmental organizations or by any energy conservation association to which Landlord is a party or which is applicable to the
Building, including, without limitation, the requirements of California&#146;s Nonresidential Building Energy Use Disclosure Program, as more particularly specified in California Public Resources Code Sections 25402,10 <I>et seq.</I> and regulations
adopted pursuant thereto. Further, Tenant hereby authorizes (and agrees that Landlord shall have the authority to authorize) any electric or gas utility company providing service to the Building to disclose from time to time so much of the data
collected and maintained by it regarding Tenant&#146;s energy consumption data as may be necessary to cause the Building to participate in the ENERGY STAR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Portfolio Manager system and similar
programs; and Tenant further authorizes Landlord to disclose information concerning energy use by Tenant, either individually or in combination with the energy use of other tenants, as applicable as Landlord determines to be necessary to comply with
applicable Laws pertaining to the Building or Landlord&#146;s ownership thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Hazardous Materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) <U>Definitions</U>. The following terms shall have the following meanings for purposes of this Lease: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) &#147;Biohazardous Materials&#148; means any and all substances and materials defined or referred to as
<FONT STYLE="white-space:nowrap">&#147;a-medical</FONT> waste,&#148; &#147;biological waste,&#148; &#147;biohazardous waste,&#148; &#147;biohazardous material&#148; or any other term of similar import under any Hazardous Materials Laws, including
(but not limited to) California Health&nbsp;&amp; Safety Code Sections 25105 <I>et seq.,</I> and any regulations promulgated thereunder, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) &#147;Environmental Condition&#148; means the Release of any Hazardous Materials in, over, on, under, through, from or about the Project
(including, but not limited to, the Premises). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) &#147;Environmental Damages&#148; means all claims, suits, judgments, damages,
losses, penalties, fines, liabilities, encumbrances, liens, costs and expenses of whatever kind or nature, contingent or otherwise, matured or unmatured, foreseeable or unforeseeable, arising out of or in connection with any Environmental Condition,
including, to the extent arising out of an Environmental Condition, without limitation: (A)&nbsp;damages for personal injury, or for injury or damage to the Project or natural resources occurring on or off the Project, including without limitation
(1)&nbsp;any claims brought by or on behalf of any person, (2)&nbsp;any loss of, lost use of, damage to or diminution in value of any Project or natural resource, and (3)&nbsp;costs of any investigation, remediation, removal, abatement, containment,
closure, restoration or monitoring work required by any federal, state or local governmental agency or political subdivision, or otherwise reasonably necessary to protect the public health or safety, whether on or off the Project;
(B)&nbsp;reasonable fees incurred for the services of attorneys, consultants, contractors, experts and laboratories in connection with the preparation of any feasibility studies, investigations or reports
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or the performance of any work described above: (C)&nbsp;any liability to any third person or governmental agency to indemnify such person or agency for costs expended or liabilities incurred in
connection with any items described in clause (A)&nbsp;or (B) above; (D)&nbsp;any fair market or fair market rental value of the Project; and (E)&nbsp;the amount of any penalties, damages or costs a party is required to pay or incur in excess of
that which the party otherwise would reasonably have expected to pay or incur absent the existence of the applicable Environmental Condition, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) &#147;Handling&#148; or &#147;Handles&#148;, when used with reference to any substance or material, includes (but is not limited to) any
receipt, storage, use, generation, Release, transportation, treatment or disposal of such substance or material. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) &#147;Hazardous
Materials&#148; means any and all chemical, explosive, biohazardous, radioactive or otherwise toxic or hazardous materials or hazardous wastes, including without limitation any asbestos-containing materials, PCB&#146;s, CFCs, petroleum and
derivatives thereof, Radioactive Materials, Biohazardous Materials, Hazardous Wastes, any other substances defined or listed as or meeting the characteristics of a hazardous substance, hazardous material, Hazardous Waste, toxic substance, toxic
waste, biohazardous material, biohazardous waste, biological waste, medical waste, radiation, radioactive substance, radioactive waste, or other similar term, as applicable, under any law, statute, ordinance, code, rule, regulation, directive,
order, condition or other written requirement enacted, promulgated or issued by any public officer or governmental or quasi-governmental authority, whether now in force or hereafter in force at any time or from time to time to protect the
environment or human health, and/or any mixed materials, substances or wastes containing more than one of the foregoing categories of materials, substances or wastes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) &#147;Hazardous Materials Laws&#148; means, collectively, (A)&nbsp;the Comprehensive Environmental Response, Compensation and Liability
Act of 1980, 42 U.S.C. Sections 9601-9657, (B) the Hazardous Materials Transportation Act of 1975, 49 U.S.C. Sections&nbsp;1801-1812, (C) the Resource Conservation and Recovery Act of 1976, 42 U.S.C. Sections&nbsp;6901-6987 (together with any
amendments thereto, any regulations thereunder and any amendments to any such regulations as in effect from time to time, &#147;RCRA&#148;), (D) the California Carpenter-Presley-Tanner Hazardous Substance Account Act, California Health&nbsp;&amp;
Safety Code Sections&nbsp;25300 et seq., (E) the Hazardous Materials Release Response Plans and Inventory Act, California Health&nbsp;&amp; Safety Code Sections 25500 et seq., (F) the California Hazardous Waste Control Law, California
Health&nbsp;&amp; Safety Code Sections 25100 et seq. (together with any amendments thereto, any regulations thereunder and any amendments to any such regulations as in effect from time to time, the &#147;CHWCL&#148;), (G) California
Health&nbsp;&amp; Safety Code Sections 25015-25027.8, (H) any amendments to or successor statutes to any of the foregoing, as adopted or enacted from time to time, (I)&nbsp;any regulations or amendments thereto promulgated pursuant to any of the
foregoing from time to time, (J)&nbsp;any Laws relating to Biohazardous Materials, including (but not limited to) any regulations or requirements with respect to the shipping, use, decontamination and disposal thereof, and (K)&nbsp;any other Law now
or at any time hereafter in effect regulating, relating to or imposing liability or standards of conduct concerning any Hazardous Materials, including (but not limited to) any requirements or conditions imposed pursuant to the terms of any orders,
permits, licenses, registrations or operating plans issued or approved by any governmental or quasi-governmental authority from time to time either on a Project-wide basis or in connection with any Handling of Hazardous Materials in, on or about the
Premises or the Project. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) &#147;Hazardous Wastes&#148; means (A)&nbsp;any waste listed as or meeting the
identified characteristics of a &#147;hazardous waste&#148; or terms of similar import under RCRA, (B)&nbsp;any waste meeting the identified characteristics of a &#147;hazardous waste&#148;, &#147;extremely hazardous waste&#148; or &#147;restricted
hazardous waste&#148; under the CHWCL, and/or (C)&nbsp;any and all other substances and materials defined or referred to as a &#147;hazardous waste&#148; or other term of similar import under any Hazardous Materials Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) &#147;Radioactive Materials&#148; means (A)&nbsp;any and all substances and materials the Handling of which requires an approval,
consent, permit or license from the Nuclear Regulatory Commission, (B)&nbsp;any and all substances and materials the Handling of which requires a Radioactive Material License or other similar approval, consent, permit or license from the State of
California, and (C)&nbsp;any and all other substances and materials defined or referred to as &#147;radiation,&#148; a &#147;radioactive material&#148; or &#147;radioactive waste,&#148; or any other term of similar import under any Hazardous
Materials Laws, including (but not limited to) Title 26, California Code of Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;17-30100,</FONT> and any statutes, regulations or other laws administered, enforced or promulgated by the Nuclear
Regulatory Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) &#147;Release&#148; means any accidental or intentional spilling, leaking, pumping, pouring, emitting,
discharging, injecting, escaping, leaching, migrating, dumping or disposing into the air, land, surface water, groundwater or the environment (including without limitation the abandonment or discarding of receptacles containing any Hazardous
Materials). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) &#147;Tenant&#146;s Contamination&#148; means any Hazardous Material Release on or about the Property caused by Tenant
and/or any agents, employees, contractors, vendors, suppliers, licensees, subtenants, and invitees of Tenant (individually a &#147;Tenant Party&#148; and collectively, &#147;Tenant Parties&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) &#147;Landlord&#146;s Contamination&#148; means any Hazardous Materials which exist in, on, under or in the vicinity of the Project as
of the Commencement Date or which migrate onto or beneath the Project from <FONT STYLE="white-space:nowrap">off-site</FONT> sources during the Term or after termination of this Lease or which are brought onto the Project during the Term by Landlord
and/or any agents, employees, contractors, vendors or licensees of Landlord (collectively with Landlord, &#147;Landlord Parties&#148;). Tenant shall not be required to pay any costs with respect to the remediation or abatement of Landlord&#146;s
Contamination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) <U>Handling of Hazardous Materials</U>. The parties acknowledge that Tenant wishes and intends to use all or a portion
of the Premises as a <FONT STYLE="white-space:nowrap">bio-pharmaceutical</FONT> laboratory, research and development and otherwise for the conduct by Tenant of its business in accordance with the use specified in Section&nbsp;1.1(14), that such use,
as conducted or proposed to be conducted by Tenant, would customarily include the Handling of Hazardous Materials, and that Tenant shall therefore be permitted to engage in the Handling in the Premises of necessary and reasonable quantities of
Hazardous Materials customarily used in or incidental to the operation of a bio pharmaceutical research, development, preparation and dispensing facility and the other business operations of Tenant in the manner conducted or proposed to be conducted
by Tenant hereunder (&#147;Permitted Hazardous Materials&#148;), provided that the Handling of such Permitted Hazardous Materials by all Tenant Parties shall at all times comply with and be subject to all provisions of this Lease and all applicable
Laws, including all Hazardous Materials Laws as well as be in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compliance with Landlord&#146;s Chemical Control Area Plan for the Building. Without limiting the generality of the foregoing, Tenant shall comply at all times with all Hazardous Materials Laws
applicable to any aspect of Tenant&#146;s use of the Premises and the Project and of Tenant&#146;s operations and activities in, on and about the Premises and the Project, and shall ensure at all times that Tenant&#146;s Handling of Hazardous
Materials in, on and about the Premises does not violate (x)&nbsp;the terms of any governmental licenses or permits applicable to the Building (including, but not limited to, the Building Discharge Permit as defined below) or Premises or to
Tenant&#146;s Handling of any Hazardous Materials therein, or (y)&nbsp;any applicable requirements or restrictions relating to the occupancy classification of the Building and the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) <U>Disposition or Emission of Hazardous Materials</U>. Tenant shall not Release or dispose of any Hazardous Materials, except to the
extent authorized by permit, at the Premises or on the Project, but instead shall arrange for <FONT STYLE="white-space:nowrap">off-site</FONT> disposal, under Tenant&#146;s own name and EPA waste generator number (or other similar identifying
information issued or prescribed by any other governmental authority with respect to Radioactive Materials, Biohazardous Materials or any other Hazardous Materials) and at Tenant&#146;s sole expense, in compliance with all applicable Hazardous
Materials Laws, with the Laboratory Rules and Regulations (defined below) and with all other applicable Laws and regulatory requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) <U>Information Regarding Tenant&#146;s Hazardous Materials</U>. Tenant shall maintain and make available to Landlord the following
information and/or documentation within thirty (30)&nbsp;days following written demand: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) An inventory of all Hazardous Materials that
Tenant receives, uses, handles, generates, transports, stores, treats or disposes of from time to time, or at the time of preparation of such inventory proposes or expects to use, handle, generate, transport, store, treat or dispose of from time to
time, in connection with its operations at the Premises. Such inventory shall include, but shall separately identify, any Hazardous Wastes, Biohazardous Materials and Radioactive Materials covered by the foregoing description. If such inventory
includes any Biohazardous Materials, Tenant shall also disclose in writing to Landlord the Biosafety Level designation associated with the use of such materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Copies of all then existing permits, licenses, registrations and other similar documents issued by any governmental or
quasi-governmental authority that authorize any Handling of Hazardous Materials in, on or about the Premises or the Project by any Tenant Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) All Material Safety Data Sheets (&#147;MSDSs&#148;), if any, required to be completed with respect to operations of Tenant at the
Premises from time to time in accordance with Title 26, California Code of Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;8-5194</FONT> or 42 U.S.C. Section&nbsp;11021, or any amendments thereto, and any Hazardous Materials Inventory
Sheets that detail the MSDSs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) All hazardous waste manifests (as defined in Title 26, California Code of Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;22-66481),</FONT> if any, that Tenant is required to complete from time to time in connection with its operations at the Premises. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) A copy of any &#147;Hazardous Materials Business Plan&#148; required from time to time
with respect to Tenant&#146;s operations at the Premises pursuant to California Health&nbsp;&amp; Safety Code Sections 25500 et seq., and any regulations promulgated thereunder, as amended from time to time, or in connection with Tenant&#146;s
application for a business license from the City of Emeryville. If applicable law does not require Tenant to prepare a Hazardous Materials Business Plan, Tenant shall furnish to Landlord at the times and in the manner set forth above the information
that would customarily be contained in a Hazardous Materials Business Plan, including (but not limited to) information regarding Tenant&#146;s Hazardous Materials inventories. The parties acknowledge that a Hazardous Materials Business Plan would
ordinarily include an emergency response plan, and that regardless of whether applicable Law requires Tenant or other tenants in the Building to prepare Hazardous Materials Business Plans, Landlord in its discretion may elect to prepare a
coordinated emergency response plan for the entire Building and/or for multiple Buildings on the Project. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) Any &#147;Contingency
Plans and Emergency Procedures&#148; required of Tenant from time to time, in connection with its operations at the Premises, pursuant to applicable Law, Title 26, California Code of Regulations Sections
<FONT STYLE="white-space:nowrap">22-67140</FONT> et seq., and any amendments thereto, and any &#147;Training Programs and Records&#148; required under Title 26, California Code of Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;22-66493,</FONT> and any amendments thereto from time to time. Landlord in its discretion may elect to prepare a Contingency Plan and Emergency Procedures for the entire Building and/or for multiple
Buildings on the Project, in which event, if applicable law does not require Tenant to prepare a Contingency Plan and Emergency Procedures for its operations at the Premises, Tenant shall furnish to Landlord at the times and in the manner set forth
above the information that would customarily be contained in a Contingency Plan and Emergency Procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) Copies of any biennial
or other periodic reports furnished or required to be furnished to the California Department of Health Services from time to time, under applicable law, pursuant to Title 26, California Code of Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;22-66493</FONT> and any amendments thereto, relating to any Hazardous Materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii)
Copies of any industrial wastewater discharge permits issued to or held by Tenant from time to time in connection with its operations at the Premises (the parties presently anticipate, however, that because of the existence of the Building Discharge
Permit in Landlord&#146;s name as described above. Tenant will not be required to maintain a separate, individual discharge permit). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) Copies of any other lists, reports, studies, or inventories of Hazardous Materials or of any subcategories of materials included in
Hazardous Materials that Tenant is otherwise required to prepare and file from time to time with any governmental or quasi-governmental authority in connection with Tenant&#146;s operations at the Premises, including (but not limited to) reports
filed by Tenant with the federal Food&nbsp;&amp; Drug Administration or any other regulatory authorities primarily in connection with the presence (or lack thereof) of any &#147;select agents&#148; or other Biohazardous Materials on the Premises,
together with proof of filing thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) Any other information reasonably requested by Landlord in writing from time to time in
connection with (A)&nbsp;Landlord&#146;s monitoring (in Landlord&#146;s reasonable discretion) and enforcement of Tenant&#146;s obligations under this Section and of compliance with applicable Laws in connection with any Handling or Release of
Hazardous Materials in the Premises or Building or on or about the Project by any Tenant Party, (B)&nbsp;any inspections or enforcement actions by any governmental authority pursuant to any Hazardous Materials Laws or any other Laws relating to the
presence or Handling of Hazardous Materials in the Premises or Building or on or about the Project by any Tenant Party, and/or (C)&nbsp;Landlord&#146;s preparation (in Landlord&#146;s discretion) and enforcement of any reasonable rules and
procedures relating to the presence or Handling by Tenant or any Tenant Party of Hazardous Materials in the Premises or Building or on or about the Project, including (but not limited to) any contingency plans or emergency response plans as
described above. Except as otherwise required by applicable Law, Landlord shall keep confidential any information supplied to Landlord by Tenant pursuant to the foregoing, provided, however, that the foregoing shall not apply to any information
filed with any governmental authority or available to the public at large. Landlord may provide such information to its lenders, consultants or investors provided such entities agree to keep such information confidential. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(5) <U>Indemnification; Notice of Release</U>. Tenant shall be responsible for and shall indemnify, defend and hold Landlord harmless from and
against all Environmental Damages to the extent arising out of or otherwise relating to, (i)&nbsp;any Handling of Hazardous Materials by any Tenant Party in, on or about the Premises or the Project in violation of this Section, (ii)&nbsp;any breach
of Tenant&#146;s obligations under this Section or of any Hazardous Materials Laws by any Tenant Party, or (iii)&nbsp;the existence of any Tenant Contamination in, on or about the Premises or the Project to the extent caused by any Tenant Party,
including without limitation any removal, cleanup, restoration or remediation work and materials necessary to return the Project or any improvements of whatever nature located on the Project to the condition existing prior to the Handling of
Hazardous Materials in, on or about the Premises or the Project by any Tenant Party and as required by applicable Laws. In the event of any Tenant Contamination in, on or about the Premises or any other portion of the Project or any adjacent lands,
Tenant shall promptly remedy the problem in accordance with all applicable Hazardous Materials Laws and other applicable Laws, shall give Landlord oral notice of any such <FONT STYLE="white-space:nowrap">non-standard</FONT> or <FONT
STYLE="white-space:nowrap">non-customary</FONT> Release promptly after Tenant becomes aware of such Release, followed by written notice to Landlord within five (5)&nbsp;days after Tenant becomes aware of such Release, and shall furnish Landlord with
concurrent copies of any and all notices, reports and other written materials filed by any Tenant Party with any governmental authority in connection with such Release. Tenant shall have no obligation to remedy any Hazardous Materials contamination
which was not caused or released by a Tenant Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(6) <U>Governmental Notices</U>. Tenant shall promptly provide Landlord with copies
of all notices received by Tenant relating to any actual or alleged presence or Handling by any Tenant Party of Hazardous Materials in, on or about the Premises or any other portion of the Project, including, without limitation, any notice of
violation, notice of responsibility or demand for action from any federal, state or local governmental authority or official in connection with any actual or alleged presence or Handling by any Tenant Party of Hazardous Materials in or about the
Premises or any other portion of the Project. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(7) <U>Inspection by Landlord</U>. In addition to, and not in limitation of,
Landlord&#146;s rights under this Lease, upon reasonable prior request by Landlord (of no less than one (1)&nbsp;business day&#146;s notice), Tenant shall grant Landlord and its consultants, as well as any governmental authorities having
jurisdiction over the Premises or over any aspect of Tenant&#146;s use thereof, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reasonable access to the Premises at reasonable times to inspect Tenant&#146;s Handling of Hazardous Materials in, on and about the Premises, and Landlord shall not thereby incur any liability to
Tenant or be deemed guilty of any disturbance of Tenant&#146;s use or possession of the Premises by reason of such entry; provided, however, that Landlord shall use reasonable efforts to minimize interference with Tenant&#146;s use of the Premises
caused by such entry. Landlord shall comply with any safety and security precaution reasonably imposed by Tenant during any entry onto the Premises (which may include, without limitation, requiring escort by a Tenant representative at all times
except during an emergency) and shall minimize to the extent reasonably possible any interference with Tenant&#146;s use of the Premises caused by such entry. Notwithstanding Landlord&#146;s rights of inspection and review of documents, materials
and physical conditions under this Section with respect to Tenant&#146;s Handling of Hazardous Materials, Landlord shall have no duty or obligation to perform any such inspection or reviewer to monitor in any way any documents, materials, physical
conditions or compliance with applicable Laws in connection with Tenant&#146;s Handling of Hazardous Materials, and no third party shall be entitled to rely on Landlord to conduct any such inspection, review or monitoring by reason of the provisions
of this Section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(8) <U>Monitoring by Landlord</U>. Landlord reserves the right to monitor, in Landlord&#146;s reasonable discretion and
at Landlord&#146;s cost (the reasonable cost of which shall be recoverable as an Operating Expense (except in the case of a breach of any of Tenant&#146;s obligations under this Section, in which event such monitoring costs may be charged back
entirely to Tenant and shall be reimbursed by Tenant to Landlord within ten (10)&nbsp;business days after written demand by Landlord from time to time, accompanied by supporting documentation reasonably evidencing the costs for which such
reimbursement is claimed), at such times and from time to time as Landlord in its reasonable discretion may determine, through consultants engaged by Landlord or otherwise as Landlord in its reasonable discretion may determine, (x)&nbsp;all aqueous
and atmospheric discharges and emissions from the Premises during the Term by a Tenant Party, (y)&nbsp;Tenant&#146;s compliance and the collective compliance of all tenants in the Building with requirements and restrictions relating to the occupancy
classification of the Building (including, but not limited to, Hazardous Materials inventory levels of Tenant and all other tenants in the Building), and (z)&nbsp;Tenant&#146;s compliance with all other requirements of this Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(9) <U>Discovery of Discharge</U>. If Landlord, Tenant or any governmental or quasi-governmental authority discovers any Release from the
Premises during the Term caused by a Tenant Party in violation of this Section that, in Landlord&#146;s reasonable determination, jeopardizes the ability of the Building or the Project to meet applicable Laws or otherwise adversely affects the
Building&#146;s or the Project&#146;s compliance with applicable discharge or emission standards, or if Landlord discovers any other breach of Tenant&#146;s obligations under this Section, then upon receipt of written notice from Landlord or at such
earlier time as Tenant obtains actual knowledge of the applicable discharge, emission or breach, Tenant at its sole expense shall within a reasonable time (x)&nbsp;in the case of a Release caused by a Tenant Party in violation of this Lease, cease
the applicable discharge or emission and remediate any continuing effects of the discharge or emission until such time, if any, as Tenant demonstrates to Landlord&#146;s reasonable satisfaction that the applicable discharge or emission is in
compliance with all applicable Laws and any other applicable regulatory commitments and obligations to the satisfaction of the appropriate governmental agency with jurisdiction over the Release, and (y)&nbsp;in the case of any other breach of
Tenant&#146;s obligations under this Section, take such corrective measures as Landlord may reasonably request in writing in order to cure or eliminate the breach as promptly as practicable and to remediate any continuing effects of the breach. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(10) <U>Post-Occupancy Study</U>. No later than thirty (30)&nbsp;days prior to the
Termination Date, Tenant at its sole cost and expense, shall obtain and deliver to Landlord an environmental study, performed by an expert reasonably satisfactory to Landlord, evaluating, the presence or absence of any Tenant Contamination in, on
and about the Premises and the Project. Such study shall be based on a reasonable and prudent level of tests and investigations of the Premises and surrounding portions of the Project (if appropriate) and, if applicable, as required by governing
regulatory agencies or bodies for such closure, which tests shall be conducted no earlier than thirty (30)&nbsp;days prior to the Termination Date. Liability for any remedial actions required or recommended on the basis of such study shall be
allocated in accordance with the applicable provisions of this Lease. To the extent any such remedial actions are the responsibility of Tenant, Tenant at its sole expense shall promptly commence and diligently pursue to completion the required
remedial actions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(11) <U>Emergency Response Plans</U>. If Landlord in its reasonable discretion adopts any emergency response plan
and/or any Contingency Plan and Emergency Procedures for the Building or for multiple Buildings on the Project as contemplated above, Landlord shall provide copies of any such plans and procedures to Tenant and, so long as such plans and procedures
are reasonable, comply with applicable Laws, do not unreasonably interfere with Tenant&#146;s use of or access to the Premises or materially increase the cost incurred by Tenant with respect to the Premises. Tenant shall comply with all of the
requirements of such plans and procedures to the extent applicable to Tenant and/or the Premises. If Landlord elects to adopt or materially modify any such plans or procedures that apply to the Building during the Term, Landlord shall consult with
Tenant, and Tenant shall cooperate, in the preparation of such plans, procedures or modifications in efforts to accurately reflect and maintain consistency with Tenant&#146;s operations in the Premises, but Landlord alone shall determine, in its
good faith reasonable discretion, the appropriate scope of such consultation and nothing in this paragraph shall be construed to give Tenant any right of approval or disapproval over Landlord&#146;s adoption or modification of any such plans or
procedures so long as such plans and procedures are reasonable, do not unreasonably interfere with Tenant&#146;s use of or access to the Premises or materially increase the cost incurred by Tenant with respect to the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(12) <U>Radioactive Materials</U>. Without limiting any other applicable provisions of this Section, if Tenant Handles or proposes to Handle
any Radioactive Materials in or about the Premises, Tenant shall provide Landlord with copies of Tenant&#146;s licenses or permits for such Radioactive Materials and with copies of all radiation protection programs and procedures required under
applicable Laws or otherwise adopted by Tenant from time to time in connection with Tenant&#146;s Handling of such Radioactive Materials. In addition, Tenant shall comply with any and all rules and procedures issued by Landlord in its good faith
discretion from time to time with respect to the Handling of Radioactive Materials on the Project (such as, by way of example but not limitation, rules implementing a label defacement program for decayed waste destined for common trash and/or rules
relating to transportation and storage of Radioactive Materials on the Project), provided that such rules and procedures shall be reasonable and not in conflict with any applicable Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(13) <U>Deemed Holdover Occupancy</U>. Notwithstanding any other provisions of this Lease,
Tenant expressly agrees as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) If Tenant Handles any Radioactive Materials in or about the Premises or the Project during the
Term, then for so long as any license or permit relating to such Radioactive Materials remains open following the Termination Date, and another entity handling Radioactive Materials which is a prospective tenant of Landlord is legally prohibited
from occupying a portion of the Premises for a use similar to Tenant&#146;s use, then Tenant shall be deemed to be occupying that portion of the Premises on a holdover basis without Landlord&#146;s consent (notwithstanding such otherwise applicable
termination or expiration of the Term) and shall be required to continue to pay Rent and other charges in accordance with Article 13 solely for that portion of the Premises effected by the radioactive materials license, until such time as all such
Radioactive Materials licenses and permits have been fully closed out in accordance with the requirements of this Lease and with all applicable Hazardous Materials Laws and other Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) If Tenant Handles any Hazardous Materials in or about the Premises or the Project during the Term and, on or before the Termination
Date, has failed to remove from the Premises or the Project all known Hazardous Materials Handled by a Tenant Party or has failed to complete any remediation or removal of Tenant&#146;s Contamination and/or to have fully remediated in compliance
with the requirements of this Lease and with all applicable Hazardous Materials Laws and any other applicable Laws, the Tenant&#146;s Handling and/or Release (if applicable) of any such Hazardous Materials during the Term, then for so long as such
circumstances continue to exist, Tenant shall be deemed to be occupying the Premises on a holdover basis without Landlord&#146;s consent (notwithstanding such otherwise applicable termination or expiration of the Term) and shall be required to
continue to pay Rent and other charges in accordance with Article 13 until such time as all such circumstances have been fully resolved in accordance with the requirements of this Lease and with all applicable Hazardous Materials Laws and other
Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(14) <U>Survival of Obligations</U>. Each party&#146;s obligations under this Section shall survive the Termination Date and shall
survive any conveyance by Landlord of its interest in the Premises. The provisions of this Section and any exercise by either party of any of the rights and remedies contained herein shall be without prejudice to any other rights and remedies that
such party may have under this Lease or under applicable Law with respect to any Environmental Conditions and/or any Hazardous Materials. Either party&#146;s exercise or failure to exercise, at any time or from time to time, any or all of the rights
granted in this Section shall not in any way impose any liability on such party or shift from the other party to such party any responsibility or obligation imposed upon the other party under this Lease or under Hazardous Materials Laws,
Environmental Conditions and/or compliance with applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(15) <U>Laboratory Rules and Regulations</U>. Tenant agrees for itself
and for its subtenants, employees, agents, and invitees to comply with the laboratory rules and regulations (&#147;Laboratory Rules and Regulations&#148;) attached to this Lease as <U>Exhibit <FONT STYLE="white-space:nowrap">C-l</FONT></U> and with
all reasonable modifications and additions thereto which Landlord may make from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.2 <U>LANDLORD ACCESS TO PREMISES; APPROVALS</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall permit Landlord to erect, use and maintain pipes, ducts, wiring and conduits in and through the Premises, so long as
Tenant&#146;s use, layout or design of the Premises is not materially affected or altered. Landlord or Landlord&#146;s agents shall have the right to enter upon the Premises (i)&nbsp;to perform scheduled janitorial and other routine services or
(ii)&nbsp;in the event of an emergency, or (ii)&nbsp;upon not less than 48 hours&#146; prior notice, to inspect the Premises, to conduct safety and other testing in the Premises, and to make such repairs, alterations, improvements or additions to
the Premises or the Building or other parts of the Property as Landlord may deem necessary or desirable (including all alterations, improvements and additions in connection with a change in service provider or providers) during reasonable times, in
all cases, subject to the terms and conditions set forth in this Lease. Janitorial and cleaning services shall be performed after Standard Operating Hours. Any entry or work by Landlord may be during Standard Operating Hours and Landlord shall use
reasonable efforts to ensure that any entry or work shall not materially interfere with Tenant&#146;s access to, use and occupancy of the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Advance notice shall not be required for entry to perform routine janitorial and cleaning services or for entry in the event of an
emergency or urgent situation, as reasonably determined by Landlord, but any other entry or work by Landlord shall be upon at least two (2)&nbsp;business day&#146;s prior notice to Tenant, which notice may be delivered orally or by <FONT
STYLE="white-space:nowrap">e-mail</FONT> to Tenant&#146;s <FONT STYLE="white-space:nowrap">on-site</FONT> manager at the Premises. If Tenant shall not be personally present to permit an entry into the Premises when for any reason an entry therein
shall be necessary or permissible, Landlord (or Landlord&#146;s agents), after notifying Tenant (unless Landlord believes an emergency situation exists), may enter the Premises without rendering Landlord or its agents liable therefor, and without
relieving Tenant of any obligations under this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Subject to the entry requirements set forth in this Section&nbsp;7.1(g)(7),
Landlord may enter the Premises for the purpose of conducting such inspections, tests and studies as Landlord may deem reasonably desirable or necessary to confirm Tenant&#146;s compliance with all Laws and Hazardous Materials Laws or for other
purposes necessary in Landlord&#146;s reasonable judgment to ensure the sound condition of the Property and the systems serving the Property. Landlord&#146;s rights under this Section&nbsp;7.2(c) are for Landlord&#146;s own protection only, and
Landlord has not, and shall not be deemed to have assumed, any responsibility to Tenant or any other party as a result of the exercise or <FONT STYLE="white-space:nowrap">non-exercise</FONT> of such rights, for compliance with Laws or Hazardous
Materials Laws or for the accuracy or sufficiency of any item or the quality or suitability of any item for its intended use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)
Landlord may do any of the foregoing, or undertake any of the inspection or work described in the preceding paragraphs without such action constituting an actual or constructive eviction of Tenant, in whole or in part, or giving rise to an abatement
of Rent by reason of loss or interruption of business of Tenant, or otherwise; provided that such activities are conducted in accordance with the requirements under this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The review, approval or consent of Landlord with respect to any item required or permitted under this Lease is for Landlord&#146;s own
protection only, and Landlord has not, and shall not be deemed to have assumed, any responsibility to Tenant or any other party, as a result of the exercise or <FONT STYLE="white-space:nowrap">non-exercise</FONT> of such rights, for compliance with
Laws or Hazardous Materials Laws or for the accuracy or sufficiency of any item or the quality or suitability of any item for its intended use. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.3 <U>QUIET ENJOYMENT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord covenants, in lieu of any implied covenant of quiet possession or quiet enjoyment, that so long as Tenant is in compliance with the
covenants and conditions set forth in this Lease, Tenant shall have the right to quiet enjoyment of the Premises without hindrance or interference from Landlord or those claiming through Landlord, and subject to the covenants and conditions set
forth in this Lease and to the rights of any Mortgagee or ground lessor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.4 <U>TENANT ACKNOWLEDGMENTS REGARDING PROPERTY</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Property is situated in the City of Emeryville (&#147;City&#148;) in a <FONT STYLE="white-space:nowrap">mixed-use</FONT> area that
includes, among other possible uses permitted by the City, residential, commercial, manufacturing, industrial and laboratory/research uses. In recognition of such <FONT STYLE="white-space:nowrap">mixed-use</FONT> character of area in which the
Property is located, as a condition of the approval of the development of the Building on the Property, the City has required that Landlord disclose to tenants of the Building that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) industrial and laboratory/research uses located in nearby buildings have the potential to emit noise at levels and during hours of the day
that persons may find disturbing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) nearby manufacturing, industrial and laboratory/research uses may generate odor; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) at times there may be substantial truck traffic in the area; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) there is a mainline railroad in the vicinity of the Property that operates 24&nbsp;hours per day, seven days per week, with associated
train horns and other sounds and vibration; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(5) future development in the vicinity of the Property may block views from the Building; and
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(6) the site on which the Building is built formerly contained hazardous materials; under the direction of the Environmental Protection
Agency and the State Department of Toxic Substances Control (the &#147;Agencies&#148;), remediation and abatement measures have been undertaken to address potential health risks associated with such hazardous materials; and the documents relating to
the remediation and abatement measures at the Property are on file at Landlord&#146;s property management office and at the offices of the Agencies (the parties acknowledge that this clause (6)&nbsp;constitutes the notice required by Cal. Health and
Safety Code Section&nbsp;25359.7). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant acknowledges the foregoing disclosures required to be made by Landlord regarding the <FONT
STYLE="white-space:nowrap">mixed-use</FONT> character of the area in which the Property is located. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(7) As required by the terms of that
certain Covenant and Restriction referenced hereinbelow, the following notice regarding the land upon which the 6100 Horton Street parking garage is situated is provided: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;The land described herein [i.e., the land upon which the Parking
Garage is located] contains polychlorinated biphenyls (PCBs) in soil and volatile organic compounds in groundwater under the Burdened Property referred to as &#147;Emery Station West Parking Garage&#148;, and is subject to a deed restriction dated
as of August&nbsp;11, 2016, and recorded on August&nbsp;19, 2016, in the Official Records of Alameda County, California, as Document No, 2016210925, which Covenant and Restriction imposes certain covenants, conditions, and restrictions on usage of
the property described herein. This statement is not a declaration that a hazard exists.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(8) During the Lease Term, Landlord shall
provide Tenant and its employees reasonable access to any shared lockers and showers serving the Building and other properties owned by Landlord or Landlord&#146;s Affiliates, such access to be free of charge other that for charges customarily
charged to all tenants and employees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.5 <U>TRANSPORTATION DEMAND MANAGEMENT PROGRAM</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord may elect or may be required to develop and implement a Transportation Demand Management (&#147;TDM&#148;) program for the Building in
order to reduce the traffic-related impacts resulting from development of the Property. One element of any such TDM program will require tenants of the Building to adopt programs and offer incentives to their employees to reduce auto use and support
the increase of alternative modes of transit. The following are examples of such programs and incentives: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Alternative commute subsidies and/or parking <FONT STYLE="white-space:nowrap">cash-out,</FONT> where employees
are provided with a subsidy if they use transit or commute by alternative modes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Opportunities to purchase commuter checks which allow employees to purchase transit tickets at discounted rates
from their <FONT STYLE="white-space:nowrap">before-tax</FONT> income; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Compressed work weeks and flex time where employees adjust their work schedules to reduce peak hour trips
to/from the Building. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to support any such TDM program for the Building, Tenant agrees that it shall use
commercially reasonable efforts to adopt programs and offer incentives to its employees in order to reduce auto use and support the increase of alternative modes of transit. The specifics of Tenant&#146;s programs and incentives shall be tailored to
the needs of Tenant&#146;s workforce and shall be determined by Tenant in its good faith efforts to meet the goals of the TDM program. Upon request by Landlord from time to time, but not more often than once per calendar year, Tenant shall provide
to Landlord a written report summarizing the programs and incentives being offered by Tenant to achieve the goals of the TDM program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 8 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MAINTENANCE </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.1 <U>LANDLORD&#146;S
MAINTENANCE</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of Articles 4 and 14, Landlord shall, as an Operating Expense, maintain and make necessary
repairs to the foundations, roofs, exterior walls, and the structural elements of the Building, the electrical, plumbing, heating, ventilating, <FONT STYLE="white-space:nowrap">air-conditioning,</FONT> mechanical, communication, security and the
fire and life safety systems of the Building and those corridors, washrooms and lobbies which are Common Areas of the Building, except that: (a)&nbsp;Landlord shall not be responsible for the maintenance or repair of any floor or wall coverings in
the Premises or any of such systems which are located within the Premises and are supplemental or special to the Building&#146;s standard systems; and (b)&nbsp;the cost of performing any of said maintenance or repairs whether to the Premises or to
the Building caused by the negligence of Tenant, its employees, agents, servants, licensees, subtenants, contractors or invitees, shall be paid by Tenant, subject to the waivers set forth in Section&nbsp;16.4. Landlord shall not be liable to Tenant
for any expense, injury, loss or damage resulting from work done in or upon, or in connection with the use of, any adjacent or nearby building, land, street or alley. Notwithstanding the foregoing to the contrary, to the extent such expense, injury,
loss or damage is caused by the gross negligence or willful misconduct by Landlord, the property manager, the leasing manager for the Property and their respective partners, members, directors, officers, agents and employees, then Tenant shall be
entitled, as its sole remedy, to pursue an action for actual damages (but not punitive, consequential, exemplary, treble or special damages) against Landlord. In no event shall Tenant be entitled to any abatement of Rent or the right to terminate
this Lease due to any such expense, injury, loss or damage. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.2 <U>TENANT&#146;S MAINTENANCE</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall periodically inspect the Premises to identify any conditions that are dangerous or in need of maintenance or repair. Tenant shall
promptly provide Landlord with notice of any such conditions. Tenant shall, at its sole cost and expense, perform all maintenance and repairs to the Premises that are not Landlord&#146;s express responsibility under this Lease, and keep the Premises
in good condition and repair, reasonable wear and tear and damages from casualty excepted. Tenant&#146;s repair and maintenance obligations include, without limitation, repairs to: (a)&nbsp;floor covering; (b)&nbsp;interior partitions;
(c)&nbsp;doors; (d) the interior side of demising walls; (e)&nbsp;electronic, phone and data cabling, wiring and related equipment that is installed by or for the exclusive benefit of Tenant (collectively, &#147;Cable&#148;); (f) supplemental air
conditioning units, kitchens, including hot water heaters, plumbing, and similar facilities exclusively serving Tenant; and (g)&nbsp;Tenant Alterations. To the extent Landlord is not reimbursed by insurance proceeds, Tenant shall reimburse Landlord
for the cost of repairing damage to the Building caused by the acts of Tenant, Tenant Parties and their respective contractors and vendors. All maintenance and repairs, including, but not limited to, janitorial and cleaning services, pest control
and waste management and recycling performed by or on behalf of Tenant must comply with the Project&#146;s Sustainability Practices and the applicable Green Building Standards. If Tenant fails to make any repairs to the Premises for more than thirty
(30)&nbsp;days after notice from Landlord (although notice shall not be required in an emergency), Landlord may make the repairs, and Tenant shall pay the reasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cost of the repairs, together with an administrative charge in an amount equal to 10% of the cost of the repairs. Tenant hereby waives all right to make repairs at the expense of Landlord or in
lieu thereof to vacate the Premises and its other similar rights as provided in California Civil Code Sections 1932(1), 1941 and 1942 or any other Laws (whether now or hereafter in effect). In addition to the foregoing, Tenant shall be responsible
for repairing all special tenant fixtures and improvements, including garbage disposals, showers, plumbing, and appliances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 9 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ALTERATIONS AND IMPROVEMENTS </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.1
<U>TENANT ALTERATIONS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The following provisions shall apply to the completion of any Tenant Alterations: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) Tenant shall not, except as provided herein, without the prior written consent of Landlord, which consent shall not be unreasonably
withheld, conditioned or delayed, make or cause to be made any Tenant Alterations in or to the Premises or any Building Systems serving the Premises. Prior to making any Tenant Alterations, Tenant shall give Landlord ten (10)&nbsp;days&#146; prior
written notice (or such earlier notice as would be necessary pursuant to applicable Law) to permit Landlord sufficient time to post appropriate notices of <FONT STYLE="white-space:nowrap">non-responsibility.</FONT> Subject to all other requirements
of this Article 9, Tenant may undertake Decoration work without Landlord&#146;s prior written consent. Tenant shall furnish Landlord with the names and addresses of all contractors and subcontractors and copies of all contracts. All Tenant
Alterations shall be completed at such time and in such manner as Landlord may from time to time designate, and only by contractors or mechanics approved by Landlord, which approval shall not be unreasonably withheld, conditioned or delayed;
provided, however, that Landlord may, in its sole discretion, specify the engineers and contractors to perform all work relating to the Building&#146;s Systems (including the mechanical, heating, plumbing, security, ventilating, <FONT
STYLE="white-space:nowrap">air-conditioning,</FONT> electrical, communication and the fire and life safety systems in the Building). The contractors, mechanics and engineers who may be used are further limited to those whose work will not cause or
threaten to cause disharmony or unreasonable interference with Landlord or other tenants in the Building and their respective agents and contractors performing work in or about the Building. Landlord may further condition its consent upon Tenant
furnishing to Landlord and Landlord approving prior to the commencement of any work or delivery of materials to the Premises related to the Tenant Alterations such of the following as specified by Landlord (only to the extent applicable and
applicable to the type of Tenant Alterations proposed by Tenant): architectural plans and specifications, opinions from Landlord&#146;s engineers stating that the Tenant Alterations will not in any way adversely affect the Building&#146;s systems,
necessary permits and licenses, certificates of Insurance, and such other documents in such form reasonably requested by Landlord. Landlord may, in the exercise of reasonable judgment, request that Tenant provide Landlord with appropriate evidence
of Tenant&#146;s ability to complete and pay for the completion of the Tenant Alterations such as a performance bond or letter of credit for any Tenant Alterations which are expected to cost more than Five Hundred Thousand Dollars ($500,000). Upon
completion of the Tenant Alterations, Tenant shall deliver to Landlord an <FONT STYLE="white-space:nowrap">as-built</FONT> mylar and digitized (if available) set of plans and specifications for the Tenant Alterations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) Tenant shall pay the cost of all Tenant Alterations and the cost of decorating the
Premises and any work to the Property occasioned thereby. Upon completion of Tenant Alterations, Tenant shall furnish Landlord with contractors&#146; affidavits and full and final waivers of lien and receipted bills covering all labor and materials
expended and used in connection therewith and such other documentation reasonably requested by Landlord or Mortgagee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) Tenant agrees
to complete all Tenant Alterations (i)&nbsp;in accordance with all Laws, Hazardous Materials Laws, all requirements of applicable insurance companies and in accordance with Landlord&#146;s standard construction rules and regulations, (ii)&nbsp;in a
good and workmanlike manner with the use of good grades of materials, and (iii)&nbsp;in accordance with the requirements of the Project&#146;s Sustainability Practices and comply with the applicable Green Building Standards. Tenant shall notify
Landlord immediately if Tenant receives any notice of violation of any Law in connection with completion of any Tenant Alterations and shall immediately take such steps as are necessary to remedy such violation. In no event shall such supervision or
right to supervise by Landlord nor shall any approvals given by Landlord under this Lease constitute any warranty by Landlord to Tenant of the adequacy of the design, workmanship or quality of such work or materials for Tenant&#146;s intended use or
of compliance with the requirements of Section&nbsp;9.1 (a)(3)(i) and (ii)&nbsp;above or impose any liability upon Landlord in connection with the performance of such work. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All Tenant Additions, whether installed by Landlord or Tenant, shall without compensation or credit to Tenant, become part of the Premises
and the property of Tenant at the time of their installation and shall remain in the Premises, unless pursuant to Article 12, Tenant may remove them or is required to remove them at Landlord&#146;s request. Any remaining Tenant Additions and
Landlord Work shall become the property of Landlord at the expiration or termination of this Lease, For the avoidance of doubt, Tenant shall retain the right to depreciation deductions of all Tenant Alterations made at Tenant&#146;s expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.2 <U>LIENS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall not permit any
lien or claim for lien of any mechanic, laborer or supplier or any other lien to be filed against the Building, the Land, the Premises, or any other part of the Property arising out of work performed, or alleged to have been performed by, or at the
direction of, or on behalf of Tenant; provided that Tenant shall have no obligation for liens or encumbrances caused by Landlord even if such liens or encumbrances arise out of work done on behalf of or for the benefit of Tenant. If any such lien or
claim for lien is filed, Tenant shall within twenty (20)&nbsp;days of receiving notice of such lien or claim (a)&nbsp;have such lien or claim for lien released of record or (b)&nbsp;deliver to Landlord a bond in form, content, amount, and issued by
surety, reasonably satisfactory to Landlord, indemnifying, protecting, defending and holding harmless the Indemnitees against all costs and liabilities resulting from such lien or claim for lien and the foreclosure or attempted foreclosure thereof.
If Tenant fails to take any of the above actions, Landlord, in addition to its rights and remedies under Article 11, without investigating the validity of such lien or claim for lien, may pay or discharge the same and Tenant shall, as payment of
additional Rent hereunder, reimburse Landlord upon demand for the amount so paid by Landlord, including Landlord&#146;s expenses and reasonable attorneys&#146; fees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 10 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ASSIGNMENT AND SUBLETTING </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.1
<U>ASSIGNMENT AND SUBLETTING</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to Landlord&#146;s recapture right set forth in Section&nbsp;10.2, without the prior written
consent of Landlord, which consent of Landlord shall not be unreasonably withheld, conditioned or delayed, Tenant may not sublease, assign, mortgage, pledge, hypothecate or otherwise transfer or permit the transfer of this Lease or the encumbering
of Tenant&#146;s interest therein in whole or in part, by operation of Law or otherwise or permit the use or occupancy of the Premises, or any part thereof, by anyone other than Tenant. Tenant agrees that the provisions governing sublease and
assignment set forth in this Article 10 shall be deemed to be reasonable. If Tenant desires to enter into any sublease of the Premises or assignment of this Lease, Tenant shall deliver written notice thereof to Landlord (&#147;Tenant&#146;s
Notice&#148;), together with the identity of the proposed subtenant or assignee and the proposed principal terms thereof and financial and other information sufficient for Landlord to make an informed judgment with respect to such proposed subtenant
or assignee at least thirty (30)&nbsp;days prior to the commencement date of the term of the proposed sublease or assignment. If Tenant proposes to sublease a portion of the Premises containing more than 3,000 rentable square feet, the space
proposed to be sublet and the space retained by Tenant must each be a marketable unit as reasonably determined by Landlord and otherwise in compliance with all Laws. Landlord shall notify Tenant in writing of its approval or disapproval of the
proposed sublease or assignment or its decision to exercise its rights under Section&nbsp;10.2 within ten (10)&nbsp;business days after receipt of Tenant&#146;s Notice (and all required information). In the event Landlord fails to respond to
Tenant&#146;s Notice within such ten (10)&nbsp;day period, then Tenant may deliver to Landlord a second (2nd) written request, which must contain the following inscription, in bold faced lettering: &#147;SECOND NOTICE DELIVERED PURSUANT TO SECTION
10.1 OF THE LEASE &#151; FAILURE TO TIMELY RESPOND WITHIN THREE&nbsp;(3) BUSINESS DAYS SHALL RESULT IN DEEMED APPROVAL OF PROPOSED TRANSFER.&#148; If Landlord fails to respond within such three (3)&nbsp;business day period, then Landlord shall be
deemed to have approved the proposed transfer that was the subject of such Tenant Notice. Tenant shall submit for Landlord&#146;s approval (which approval shall not be unreasonably withheld, conditioned or delayed) any advertising which Tenant or
its agents intend to use with respect to the space proposed to be sublet. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) With respect to Landlord&#146;s consent to an assignment or
sublease, Landlord may take into consideration any factors that Landlord may deem relevant in its commercially reasonable judgment, and the reasons for which Landlord&#146;s denial shall be deemed to be reasonable shall include, without limitation,
the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the business reputation or creditworthiness of any proposed subtenant or assignee is not acceptable to Landlord; or
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) in Landlord&#146;s reasonable judgment the proposed assignee or sublessee would diminish the value or reputation of the Project or
Landlord; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any proposed assignee&#146;s or sublessee&#146;s use of the Premises would violate
Section&nbsp;7.1 of this Lease or would violate the provisions of any other leases of tenants in the Project; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) the proposed
sublessee or assignee is a bona fide prospective tenant of Landlord in the Project as demonstrated by a written proposal dated within six (6)&nbsp;months prior to the date of Tenant&#146;s request and Landlord has vacancy in the Project of a similar
size and finish as the space subject to such proposed sublease or assignment; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) the proposed sublessee or assignee would materially
increase the estimated pedestrian and vehicular traffic to and from the Premises and the Project above that deemed typical by Landlord for office/lab use in the Project; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) a Default by Tenant under this Lease shall be continuing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Any sublease or assignment shall be expressly subject to the terms and conditions of this Lease. Any subtenant or assignee shall execute
such commercially reasonable and customary documents as Landlord may reasonably require to evidence such subtenant or assignee&#146;s assumption of the obligations and liabilities of Tenant under this Lease. Tenant shall deliver to Landlord a copy
of all agreements executed by Tenant and the proposed subtenant and assignee with respect to the Premises. Landlord&#146;s approval of a sublease, assignment, hypothecation, transfer or third party use or occupancy shall not constitute a waiver of
Tenant&#146;s obligation to obtain Landlord&#146;s consent to further assignments or subleases, hypothecations, transfers or third party use or occupancy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) For purposes of this Article 10, an assignment shall be deemed to include a change in the majority control of Tenant, resulting from any
transfer, sale or assignment of shares of stock of Tenant occurring by operation of Law or otherwise if Tenant is a corporation whose shares of stock are not traded publicly. If Tenant is a partnership, any change in the partners of Tenant shall be
deemed to be an assignment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) For purposes of this Lease, a &#147;Permitted Transferee&#148; shall mean any Person which: (i)&nbsp;is
an Affiliate; or (ii)&nbsp;is the corporation or other entity (the &#147;Successor&#148;) resulting from a merger, consolidation or <FONT STYLE="white-space:nowrap">non-bankruptcy</FONT> reorganization with Tenant; or (iii)&nbsp;is otherwise a
deemed assignee due to a change of control under Section&nbsp;10.1(d) above; or (iv)&nbsp;purchases substantially all of the assets of Tenant as a going concern (the &#147;Purchaser&#148;). Notwithstanding anything to the contrary in Sections
10.1(a) and (b)&nbsp;and 10.3, provided there is no uncured Default under this Lease, Tenant shall have the right, without the prior written consent of Landlord, to assign this Lease to a Permitted Transferee or to sublease the Premises or any part
thereof to a Permitted Transferee provided that: (1)&nbsp;Landlord receives ten (10)&nbsp;days&#146; prior written notice of an assignment or sublease (including a proposed transaction described in subparts (i), (ii), (iii) or (iv)&nbsp;of this
Section&nbsp;10.1 (e), to the extent such prior notice is permitted under applicable Laws); (2) with respect to an assignment of this Lease or a sublease of more than half the Premises to an entity described in subparts (ii)&nbsp;or (iv) of this
Section&nbsp;10.1(e), the Permitted Transferee&#146;s net worth and liquidity are each not less than Tenant&#146;s net worth immediately prior to such assignment or subletting; (3)&nbsp;with respect to an assignment of this Lease or a sublease of
more than half the Premises to an entity described in subparts (i)&nbsp;or (iii) of this Section&nbsp;10.1 (e), Tenant (as the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assignor or sublandlord) continues in existence with a net worth not less than Tenant&#146;s net worth immediately prior to such assignment or subletting; (4)&nbsp;the Permitted Transferee
expressly assumes (except a Permitted Transferee which is a deemed assignee under subpart (iii)&nbsp;of this Section&nbsp;10.1(e) or which is a sublessee in the event of a sublease under this Section&nbsp;10.1(e)) in writing reasonably satisfactory
to Landlord all of the obligations of Tenant under this Lease and delivers such assumption to Landlord no later than fifteen (15)&nbsp;days following the effective date of the assignment; (5)&nbsp;Landlord receives no later than five (5)&nbsp;days
following the effective date a fully executed copy of the applicable assignment or sublease agreement between Tenant and the Permitted Transferee; (6)&nbsp;promptly after Landlord&#146;s written request, Tenant and the Permitted Transferee provide
such reasonable documents and information which Landlord reasonably requests for the purpose of substantiating whether or not the assignment or sublease is to a Permitted Transferee; and (7)&nbsp;such transfer is not being entered into for the
primary purpose of avoiding the requirement for Landlord&#146;s prior consent or the provisions of Sections 10.2 or 10.3. All determinations of net worth and liquidity for purposes of this Subsection shall exclude any value attributable to goodwill
or going concern value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) With respect to any sublease hereunder, subject to Section&nbsp;10.3 below, Tenant hereby irrevocably assigns
to Landlord, effective upon any such sublease, all rent and other payments due from subtenant under the sublease, provided however, that Tenant shall have a license to collect such rent and other payments until the occurrence of a Default by Tenant
under any of the provisions of this Lease. At any time after such Default, at Landlord&#146;s option. Landlord shall have the right to give notice to the subtenant of such assignment. Landlord shall credit Tenant with any rent received by Landlord
under such assignment, but the acceptance of any payment on account of rent from the subtenant as the result of any such default shall in no manner whatsoever serve to release Tenant from any liability under the terms, covenants, conditions,
provisions or agreement under this Lease. No such payment of rent or any other payment by the subtenant directly to Landlord and/or acceptance of such payment(s) by Landlord, regardless of the circumstances or reasons therefor, shall in any manner
whatsoever be deemed an attornment by the subtenant to Landlord in the absence of a specific written agreement signed by Landlord to such an effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.2
<U>RECAPTURE</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Excluding any assignment or sublease contemplated in Section&nbsp;10.1(e), if Tenant requests an assignment of this Lease
or a sublease of the entire Premises for any period or a sublease for at least seventy-five (75%) of the Premises for the remainder of the then-current Term, Landlord shall have the option to exclude from the Premises covered by this Lease
(&#147;recapture&#148;) the space proposed to be sublet or subject to assignment, effective as of the proposed commencement date of such sublease or proposed effective date of such assignment. If Landlord elects to recapture, Tenant shall have the
right to revoke the request to so sublet or assign by providing Landlord written notice thereof no later than five (5)&nbsp;days following Landlord&#146;s recapture notice to Tenant in which case, the Premises shall not be transferred, and this
Lease will remain in full force and effect with respect to the entirety of the Premises then-existing as of the date of such request or consent by Tenant. If Landlord elects to recapture and Tenant has not revoked its request for consent, Tenant
shall surrender possession of the space proposed to be subleased or subject to the assignment to Landlord on the effective date of recapture of such space from the Premises, such date being the Termination Date for such space. Effective as of the
date of recapture of any portion of the Premises pursuant to this section, the Monthly Base Rent, Rentable Area of the Premises and Tenant&#146;s Share shall be adjusted accordingly. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.3 <U>EXCESS RENT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except in connection with any assignment or sublease contemplated in Section&nbsp;10.1(e), Tenant shall pay Landlord on the first day of each
month during the term of the sublease or assignment, fifty percent (50%) of the amount by which the sum of all rent and other consideration (direct or indirect) due from the subtenant or assignee for such month exceeds: a) that portion of the
Monthly Base Rent and Rent Adjustments due under this Lease for said month which is allocable to the space sublet or assigned, and b) the following costs and expenses for the subletting or assignment of such space: (i)&nbsp;brokerage commissions and
attorneys&#146; fees and expenses, (ii)&nbsp;the actual costs paid in making any improvements or substitutions in the Premises required by any sublease or assignment; and (iii) &#147;free rent&#148; periods, costs of any inducements or concessions
given to subtenant or assignee, moving costs, and other amounts in respect of such subtenant&#146;s or assignee&#146;s other leases or occupancy arrangements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.4 <U>TENANT LIABILITY</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of
any sublease or assignment, whether or not with Landlord&#146;s consent, Tenant shall not be released or discharged from any liability, whether past, present or future, under this Lease, including any liability arising from the exercise of any
renewal or expansion option, to the extent such exercise is expressly permitted by Landlord. Tenant&#146;s liability shall remain primary, and in the event of default by any subtenant, assignee or successor of Tenant in performance or observance of
any of the covenants or conditions of this Lease, Landlord may proceed directly against Tenant without the necessity of exhausting remedies against said subtenant, assignee or successor. In addition, if Tenant has any options to extend the Term or
to add other space to the Premises, such options shall not be available to any subtenant or assignee (other than Permitted Transferees), directly or indirectly without Landlord&#146;s express written consent, which may be withheld in Landlord&#146;s
sole discretion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.5 <U>ASSUMPTION AND ATTORNMENT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Tenant shall assign this Lease as permitted herein, the assignee shall expressly assume all of the obligations of Tenant hereunder in a
written instrument satisfactory to Landlord and furnished to Landlord not later than fifteen (15)&nbsp;days prior to the effective date of the assignment. If Tenant shall sublease the Premises as permitted herein. Tenant shall, at Landlord&#146;s
option, within fifteen (15)&nbsp;days following any request by Landlord, obtain and furnish to Landlord the written agreement of such subtenant to the effect that the subtenant will attorn to Landlord and will pay all sublease rent directly to
Landlord. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.6 <U>PROCESSING EXPENSES</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall pay to Landlord, as Landlord&#146;s cost of processing each proposed assignment or subletting (whether or not the same is
ultimately approved by Landlord or consummated by Tenant) except in connection with Permitted Transfers, an amount equal to the sum of (i)&nbsp;Landlord&#146;s reasonable attorneys&#146; and other professional fees, not to exceed $2,000, plus
(ii)&nbsp;the sum of $1,500.00 for the cost of Landlord&#146;s administrative, accounting and clerical time </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(collectively, &#147;Processing Costs&#148;). Notwithstanding anything to the contrary herein, Landlord shall not be required to process any request for Landlord&#146;s consent to an assignment
or subletting until Tenant has paid to Landlord the amount of Landlord&#146;s estimate of the Processing Costs. When the actual amount of the Processing Costs is determined, it shall be reconciled with Landlord&#146;s estimate, and any payments or
refunds required as a result thereof shall promptly thereafter be made by the parties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.7 <U>EFFECT OF IMPERMISSIBLE TRANSFER</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any assignment or sublease effected without Landlord&#146;s consent in violation of this Article&nbsp;10 shall, at Landlord&#146;s option, be a
<FONT STYLE="white-space:nowrap">non-curable</FONT> Default under Section&nbsp;11.1 without the necessity of any notice and grace period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 11 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DEFAULT AND
REMEDIES </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.1 <U>EVENTS OF DEFAULT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The occurrence or existence of any one or more of the following shall constitute a &#147;Default&#148; by Tenant under this Lease: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Tenant fails to pay any installment or other payment of Rent including Rent Adjustment Deposits or Rent Adjustments when due, where such
failure shall continue for a period of five (5)&nbsp;days after Tenant&#146;s receipt of written notice thereof from Landlord; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)
Tenant fails to observe or perform any of the other covenants, conditions or provisions of this Lease or the Workletter and fails to cure such default within thirty&nbsp;(30) days after written notice thereof to Tenant, unless the default involves a
hazardous condition, which shall be cured forthwith or unless the failure to perform is a Default for which this Lease specifies there is no cure or grace period. Notwithstanding the foregoing, if any such cure cannot be reasonably completed within
such thirty (30)&nbsp;day period, Tenant shall have such longer period as needed to complete such cure (up to ninety (90)&nbsp;days, subject to extension due to Force Majeure) so long as the cure is commenced within such thirty (30)&nbsp;day period
and Tenant diligently pursues to completion; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Tenant fails to maintain any insurance policy required hereunder, and fails to cure
such default within five (5)&nbsp;business days after written notice thereof to Tenant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Tenant abandons the Premises for a period
of ten (10)&nbsp;consecutive days or any abandonment of the Premises by Tenant which would cause any insurance policy to be invalidated or otherwise lapse, in each of forgoing cases if Tenant is then in monetary default under this Lease; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) an assignment or sublease, or attempted assignment or sublease, of this Lease or the Premises by Tenant contrary to the provisions of
Article 10, unless such assignment or sublease is expressly conditioned upon Tenant having received Landlord&#146;s consent thereto; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) the interest of Tenant in this Lease is levied upon under execution or other legal
process; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) a petition is filed by or against Tenant to declare Tenant bankrupt or seeking a plan of reorganization or arrangement
under any Chapter of the Bankruptcy Act, or any amendment, replacement or substitution therefor, or to delay payment of, reduce or modify Tenant&#146;s debts, which in the case of an involuntary action is not discharged within sixty (60)&nbsp;days;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) Tenant is declared insolvent by Law or any assignment of Tenant&#146;s property is made for the benefit of creditors; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) a receiver is appointed for Tenant or Tenant&#146;s property, which appointment is not discharged within thirty (30)&nbsp;days; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) any action taken by or against Tenant to reorganize or modify Tenant&#146;s capital structure in a materially adverse way which in the
case of an involuntary action is not discharged within thirty (30)&nbsp;days; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) upon the dissolution of Tenant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.2 <U>LANDLORD&#146;S REMEDIES</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) A
Default shall constitute a breach of this Lease for which Landlord shall have the rights and remedies set forth in this Section&nbsp;11.2 and all other rights and remedies set forth in this Lease or now or hereafter allowed by Law, whether legal or
equitable, and all rights and remedies of Landlord shall be cumulative and none shall exclude any other right or remedy now or hereafter allowed by applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) With respect to a Default, at any time Landlord may terminate Tenant&#146;s right to possession by written notice to Tenant stating such
election. Any written notice required pursuant to Section&nbsp;11.1 shall constitute notice of unlawful detainer pursuant to California Code of Civil Procedure Section&nbsp;1161 if, at Landlord&#146;s sole discretion, it states Landlord&#146;s
election that Tenant&#146;s right to possession is terminated after expiration of any period required by Law or any longer period required by Section&nbsp;11.1. Upon the expiration of the period stated in Landlord&#146;s written notice of
termination (and unless such notice provides an option to cure within such period and Tenant cures the Default within such period), Tenant&#146;s right to possession shall terminate and this Lease shall terminate, and Tenant shall remain liable as
hereinafter provided. Upon such termination in writing of Tenant&#146;s right to possession, Landlord shall have the right, subject to applicable Law, to <FONT STYLE="white-space:nowrap">re-enter</FONT> the Premises and dispossess Tenant and the
legal representatives of Tenant and all other occupants of the Premises by unlawful detainer or other summary proceedings, or as otherwise permitted by Law, regain possession of the Premises and remove their property (including their trade fixtures,
personal property and Required Removables pursuant to Article 12), but Landlord shall not be obligated to effect such removal, and such property may, at Landlord&#146;s option, be stored elsewhere, sold or otherwise dealt with as permitted by Law,
at the risk of, expense of and for the account of Tenant, and the proceeds of any sale shall be applied pursuant to Law. Landlord shall in no event be responsible for the value, preservation or safekeeping of any such property. Tenant hereby waives
all claims for damages that may be caused by Landlord&#146;s removing or storing Tenant&#146;s personal property pursuant to this Section or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;12.1, and Tenant hereby indemnifies, and agrees to defend, protect and hold harmless, the Indemnitees from any and all loss, claims, demands, actions, expenses, liability and cost
(including attorneys&#146; fees and expenses) arising out of or in any way related to such removal or storage. Upon such written termination of Tenant&#146;s right to possession and this Lease, Landlord shall have the right to recover damages for
Tenant&#146;s Default as provided herein or by Law, including the following damages provided by California Civil Code Section&nbsp;1951.2: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) the worth at the time of award of the unpaid Rent which had been earned at the time of termination; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) the worth at the time of award of the amount by which the unpaid Rent which would have been earned after termination until the time of
award exceeds the amount of such Rent loss that Tenant proves could reasonably have been avoided; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) the worth at the time of award of
the amount by which the unpaid Rent for the balance of the Term of this Lease after the time of award exceeds the amount of such Rent loss that Tenant proves could be reasonably avoided; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) any other amount necessary to compensate Landlord for all the detriment proximately caused by Tenant&#146;s failure to perform its
obligations under this Lease or which in the ordinary course of things would be likely to result therefrom, including, without limitation, Landlord&#146;s unamortized costs of tenant improvements, leasing commissions and legal fees incurred in
connection with entering into this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The word &#147;rent&#148; as used in this Section&nbsp;11.2 shall have the same meaning as the
defined term Rent in this Lease. The &#147;worth at the time of award&#148; of the amount referred to in clauses (1)&nbsp;and (2) above is computed by allowing interest at the Default Rate. The worth at the time of award of the amount referred to in
clause (3)&nbsp;above is computed by discounting such amount at the discount rate of the Federal Reserve Bank of San Francisco at the time of award plus one percent&nbsp;(1%). For the purpose of determining unpaid Rent under clause (3)&nbsp;above,
the monthly Rent reserved in this Lease shall be deemed to be the sum of the Monthly Base Rent, monthly storage space rent, if any, and the amounts last payable by Tenant as Rent Adjustments for the calendar year in which Landlord terminated this
Lease as provided hereinabove. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Even if Tenant is in Default and/or has abandoned the Premises, this Lease shall continue in effect
for so long as Landlord does not terminate Tenant&#146;s right to possession by written notice as provided in Section&nbsp;11.2(b) above, and Landlord may enforce all its rights and remedies under this Lease, including the right to recover Rent as
it becomes due under this Lease. In such event. Landlord shall have all of the rights and remedies of a landlord under California Civil Code Section&nbsp;1951.4 (Landlord may continue Lease in effect after Tenant&#146;s Default and abandonment and
recover Rent as it becomes due, if Tenant has the right to sublet or assign, subject only to reasonable limitations), or any successor statute. During such time as Tenant is in Default, if Landlord has not terminated this Lease by written notice and
if Tenant requests Landlord&#146;s consent to an assignment of this Lease or a sublease of the Premises, subject to Landlord&#146;s option to recapture pursuant to Section&nbsp;10.2, Landlord shall not unreasonably withhold, condition or delay its
consent to such assignment or sublease. Tenant acknowledges and agrees that in the absence of written notice pursuant to Section&nbsp;11.2(b) above terminating Tenant&#146;s right to possession, no other
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
act of Landlord shall constitute a termination of Tenant&#146;s right to possession or an acceptance of Tenant&#146;s surrender of the Premises, including acts of maintenance or preservation or
efforts to <FONT STYLE="white-space:nowrap">re-let</FONT> the Premises or the appointment of a receiver upon initiative of Landlord to protect Landlord&#146;s interest under this Lease or the withholding of consent to a subletting or assignment, or
terminating a subletting or assignment, if in accordance with other provisions of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) in the event that Landlord seeks an
injunction with respect to a breach or threatened breach by Tenant of any of the covenants, conditions or provisions of this Lease, Tenant agrees to pay the premium for any bond required in connection with such injunction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Tenant hereby waives any and all rights to relief from forfeiture, redemption or reinstatement granted by Law (including California Civil
Code of Procedure Sections 1174 and 1179) in the event of Tenant being evicted or dispossessed for any cause or in the event of Landlord obtaining possession of the Premises by reason of Tenant&#146;s Default or otherwise; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding any other provision of this Lease, a notice to Tenant given under this Article and Article 24 of this Lease or given
pursuant to California Code of Civil Procedure Section&nbsp;1161, and any notice served by mail, shall be deemed served, and the requisite waiting period deemed to begin under said Code of Civil Procedure Section upon mailing (except as may be
required under Code of Civil Procedure Section&nbsp;1161 et seq.), without any additional waiting requirement under Code of Civil Procedure Section&nbsp;1011 et seq. or by other Law. For purposes of Code of Civil Procedure Section&nbsp;1162,
Tenant&#146;s &#147;place of residence&#148;, &#147;usual place of business&#148;, &#147;the property&#148; and &#147;the place where the property is situated&#148; shall mean and be the Premises, whether or not Tenant has vacated same at the time
of service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The voluntary or other surrender or termination of this Lease, or a mutual termination or cancellation thereof, shall not
work a merger and shall terminate all or any existing assignments, subleases, subtenancies or occupancies permitted by Tenant, except if and as otherwise specified in writing by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) No delay or omission in the exercise of any right or remedy of Landlord upon any default by Tenant, and no exercise by Landlord of its
rights pursuant to Section&nbsp;26.16 to perform any duty which Tenant fails timely to perform, shall impair any right or remedy or be construed as a waiver. No provision of this Lease shall be deemed waived by Landlord unless such waiver is in
writing signed by Landlord. The waiver by Landlord of any breach of any provision of this Lease shall not be deemed a waiver of any subsequent breach of the same or any other provision of this Lease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.3 <U>ATTORNEY&#146;S FEES</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event
any party brings any suit or other proceeding with respect to the subject matter or enforcement of this Lease, the prevailing party (as determined by the court, agency or other authority before which such suit or proceeding is commenced) shall, in
addition to such other relief as may be awarded, be entitled to recover reasonable attorneys&#146; fees, expenses and costs of investigation as actually incurred, including court costs, expert witness fees, costs and expenses of investigation, and
all reasonable attorneys&#146; fees, costs and expenses in any such suit or proceeding (including in any action or participation in or in connection with any case or proceeding under the Bankruptcy Code, 11 United States Code Sections 101 et seq.,
or any successor statutes, in establishing or enforcing the right to indemnification, in appellate proceedings, or in connection with the enforcement or collection of any judgment obtained in any such suit or proceeding). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.4 <U>BANKRUPTCY</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following provisions shall apply in the event of the bankruptcy or insolvency of Tenant: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In connection with any proceeding under Chapter 7 of the Bankruptcy Code where the trustee of Tenant elects to assume this Lease for the
purposes of assigning it, such election or assignment, may only be made upon compliance with the provisions of subclauses (b)&nbsp;and (c) below, which conditions Landlord and Tenant acknowledge to be commercially reasonable. In the event the
trustee elects to reject this Lease then Landlord shall immediately be entitled to possession of the Premises without further obligation to Tenant or the trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Any election to assume this Lease under Chapter 11 or 13 of the Bankruptcy Code by Tenant as <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">debtor-in-possession</FONT></FONT> or by Tenant&#146;s trustee (the &#147;Electing Party&#148;) must provide for the Electing Party to cure or provide to Landlord adequate assurance that it will cure all monetary defaults
under this Lease within fifteen (15)&nbsp;days from the date of assumption and that it will cure all nonmonetary defaults under this Lease within thirty (30)&nbsp;days from the date of assumption. Landlord and Tenant acknowledge such condition to be
commercially reasonable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If the Electing Party has assumed this Lease or elects to assign Tenant&#146;s interest under this Lease to
any other person, such interest may be assigned only if the intended assignee has provided adequate assurance of future performance (as herein defined), of all of the obligations imposed on Tenant under this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) For the purposes hereof, &#147;adequate assurance of future performance&#148; means that Landlord has ascertained that each of the
following conditions has been satisfied: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The assignee has submitted a current financial statement, certified by its chief financial
officer, which shows a net worth and working capital in amounts sufficient to assure the future performance by the assignee of Tenant&#146;s obligations under this Lease; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Landlord has obtained consents or waivers from any third parties that may be required under a lease, mortgage, financing arrangement, or
other agreement by which Landlord is bound, to enable Landlord to permit such assignment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Landlord&#146;s acceptance of rent or any
other payment from any trustee, receiver, assignee, person, or other entity will not be deemed to have waived, or waive, the requirement of Landlord&#146;s consent. Landlord&#146;s right to terminate this Lease for any transfer of Tenant&#146;s
interest under this Lease without such consent, or Landlord&#146;s claim for any amount of Rent due from Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.5 <U>LANDLORD&#146;S DEFAULT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall be in default hereunder in the event Landlord has not commenced and pursued with reasonable diligence the cure of any failure of
Landlord to meet its obligations hereunder within thirty (30)&nbsp;days after the receipt by Landlord of written notice from Tenant of the alleged failure to perform. Failure to provide the requisite notice and cure period by Tenant under this
paragraph shall be an absolute defense by Landlord against any claims for failure to perform any of its obligations. In no event shall Tenant have the right to terminate or rescind this Lease as a result of Landlord&#146;s default as to any covenant
or agreement contained in this Lease. Tenant hereby waives such remedies of termination and rescission and hereby agrees that Tenant&#146;s remedies for default hereunder and for breach of any promise or inducement shall be limited to a suit for
damages and/or injunction. In addition, Tenant hereby covenants that, prior to the exercise of any such remedies, it will give the Mortgagee notice and a reasonable time to cure any default by Landlord, provided that Tenant has received written
notice of the address of such Mortgagee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 12 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SURRENDER OF PREMISES </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.1 <U>IN
GENERAL</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Termination Date, Tenant shall surrender and vacate the Premises immediately and deliver possession thereof to
Landlord in a broom-clean, good and tenantable condition, excepting ordinary wear and tear, repairs and maintenance for which Landlord is responsible under this Lease and damage caused by casualty and/or Landlord. Tenant shall deliver to Landlord
all keys to the Premises. All permanent improvements in and to the Premises (other than Tenant&#146;s trade fixtures, equipment and personal property), including any Tenant Alterations (collectively, &#147;Leasehold Improvements&#148;) shall remain
upon the Premises at the end of the Term without compensation to Tenant. Landlord, however, by written notice to Tenant at least 90 days prior to the Termination Date, may require Tenant, at its expense, to remove (a)&nbsp;any Cable, and
(b)&nbsp;any Tenant Additions that, in Landlord&#146;s reasonable judgment, are of a nature that would require removal and repair costs that are materially in excess of the removal and repair costs associated with standard laboratory and office
improvements, as applicable, only to the extent Landlord notified Tenant of such required removal at the time Landlord approved such Tenant Addition (collectively referred to as &#147;Required Removables&#148;). Required Removables shall include,
without limitation, raised floors, personal baths and showers, vaults, rolling file systems and structural alterations and modifications. The designated Required Removables shall be removed by Tenant before the Termination Date. Tenant&#146;s
removal and disposal of items pursuant to this Paragraph&nbsp;12 must comply with the Project&#146;s Sustainability Practices and the applicable Green Building Standards. Tenant shall repair damage caused by the installation or removal of Required
Removables. If Tenant fails to perform its obligations in a timely manner, Landlord may perform such work at Tenant&#146;s expense. Tenant, at the time it requests approval for a proposed Tenant Alteration, may request in writing that Landlord
advise Tenant whether the proposed Tenant Alteration or any portion of the proposed Tenant Alteration is a Required Removable. Within 10&nbsp;days after receipt of Tenant&#146;s request. Landlord shall advise Tenant in writing as to which portions
of the proposed Tenant Alterations are Required Removables. If any of the Tenant Additions which were installed by Tenant involved the lowering of ceilings, raising of floors or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the installation of specialized wall or floor coverings or lights, unless otherwise approved by Landlord, then Tenant shall also be obligated to return such surfaces to their condition prior to
the commencement of this Lease. Tenant shall also be required to close any staircases or other openings between floors. In the event possession of the Premises is not delivered to Landlord when required hereunder, or if Tenant shall fail to remove
those items described above, Landlord may (but shall not be obligated to), at Tenant&#146;s expense, remove any of such property and store, sell or otherwise deal with such property, and undertake, at Tenant&#146;s expense, such restoration work as
Landlord deems necessary or advisable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.2 <U>LANDLORD&#146;S RIGHTS</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All property which remains in the Premises after the Termination Date (including any of Tenant&#146;s trade fixtures, equipment and personal
property) shall be conclusively presumed to have been abandoned by Tenant, and Landlord may deal with such property as provided in Section&nbsp;11.2(b), including the waiver and indemnity obligations provided in that Section. Tenant shall also
reimburse Landlord for all costs and expenses incurred by Landlord in removing any Required Removables Tenant failed to remove prior to the Termination Date and in restoring the Premises to the condition required by this Lease. For the period prior
to the Termination Date, Landlord hereby waives any lien rights which it may otherwise have concerning Tenant&#146;s furniture, fixtures, equipment and/or supplies at the Premises, and Tenant shall have the right to remove the same at any time
without Landlord&#146;s consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 13 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>HOLDING OVER </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the
event that Tenant holds over in possession of the Premises after the Termination Date, for each month or partial month Tenant holds over possession of the Premises, Tenant shall pay Landlord 150% of the monthly Base Rent payable for the month
immediately preceding the holding over, as well as Rent Adjustments during the period of such holding over, as the same may be reasonably estimated by Landlord). Tenant shall also pay all damages, but not including consequential damages, sustained
by Landlord by reason of such holding over. The provisions of this Article 13 shall not constitute a waiver by Landlord of any <FONT STYLE="white-space:nowrap">re-entry</FONT> rights of Landlord, and Tenant&#146;s continued occupancy of the Premises
shall be as a tenancy in sufferance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 14 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DAMAGE BY FIRE OR OTHER CASUALTY </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14.1
<U>SUBSTANTIAL UNTENANTABILITY</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If any fire or other casualty (whether insured or uninsured) renders all or a substantial portion
of the Premises or the Building untenantable, Landlord shall, with reasonable promptness after the occurrence of such damage, cause a licensed and qualified architect or contractor to estimate the length of time that will be required to
substantially complete the repair and restoration and shall, by notice advise Tenant of such estimate (&#147;Landlord&#146;s Notice&#148;). If Landlord&#146;s Notice indicates that the amount of time required to substantially complete such repair
and restoration will exceed one hundred eighty (180)&nbsp;days from the date such damage occurred, then Landlord, or Tenant if all or a substantial portion of the Premises is rendered untenantable, shall have the right to terminate this Lease as of
the date of such damage by delivering written notice to the other at any time within thirty (30)&nbsp;days after delivery of Landlord&#146;s Notice, provided that if Landlord so chooses, Landlord&#146;s Notice may also constitute such notice of
termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Unless this Lease is terminated as provided in the preceding subparagraph, Landlord
shall proceed with reasonable promptness to repair and restore the Premises to its condition as existed prior to such casualty, subject to reasonable delays for insurance adjustments and Force Majeure delays, and also subject to zoning Laws and
building codes then in effect. Landlord shall have no liability to Tenant, and Tenant shall not be entitled to terminate this Lease if such repairs and restoration are not in fact completed within the time period estimated by Landlord so long as
Landlord shall proceed with reasonable diligence to complete such repairs and restoration. Notwithstanding the foregoing, if Landlord is obligated to repair or restore the Premises pursuant to this Section&nbsp;14.1 (b) and does not Commence (as
defined below in this Section&nbsp;14.1(b)) such repair or restoration within ninety (90)&nbsp;days after such obligation shall accrue (the &#147;Outside Start Date&#148;), which Outside Start Date shall be subject to extension due to Force Majeure,
Tenant shall have the right, as its sole remedy, to terminate this Lease effective as of the date that is thirty (30)&nbsp;days after the Outside Start Date (the &#147;Casualty Lease Termination Date&#148;) by giving written notice thereof to
Landlord (&#147;Tenant&#146;s Termination Notice&#148;) within fifteen (15)&nbsp;days after the Outside Start Date; provided, however, that if Landlord does Commence the repair or restoration on or before the Casualty Lease Termination Date,
Tenant&#146;s election to termination shall be null and void and this Lease shall continue in full force and effect. &#147;Commence&#148; shall mean either the unconditional authorization of the preparation of the required plans necessary for such
repair or restoration, or the beginning of the actual work to repair or restore the Premises, whichever first occurs. In order for Tenant to have the termination right provided for in this Section&nbsp;14.1(b), Tenant&#146;s Termination Notice must
(i)&nbsp;be concurrently sent to any Mortgagee whose address has been provided to Tenant, and (ii)&nbsp;state Tenant&#146;s intention to terminate this Lease as of the Casualty Lease Termination Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Tenant acknowledges that Landlord shall be entitled to the full proceeds of any insurance coverage, whether carried by Landlord or Tenant,
for damages to the Premises, except for (i)&nbsp;those proceeds of Tenant&#146;s insurance of its own personal property, trade fixtures and equipment which would be removable by Tenant at the Termination Date, and (ii)&nbsp;proceeds of any business
interruption insurance maintained by Tenant. All such insurance proceeds shall be payable to Landlord whether or not the Premises are to be repaired and restored, provided, however, if this Lease is not terminated and the parties proceed to repair
and restore Tenant Additions at Tenant&#146;s cost, to the extent Landlord received proceeds of Tenant&#146;s insurance covering Tenant Additions, such proceeds shall be applied to reimburse Tenant for its cost of repairing and restoring Tenant
Additions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything to the contrary herein set forth: (i)&nbsp;Landlord shall have no duty pursuant to this Section
to repair or restore any portion of any Tenant Additions or to expend for any repair or restoration of the Premises or Building in amounts in excess of insurance proceeds paid to Landlord and available for repair or restoration; and (ii)&nbsp;Tenant
shall not have the right to terminate this Lease pursuant to this Section if any damage or destruction was caused by the act or neglect of Tenant, its agent or employees. Whether or not this Lease is terminated pursuant to this Article 14, in no
event shall Tenant be entitled to any compensation or damages for loss of the use of the whole or any part of the Premises or for any inconvenience or annoyance occasioned by any such damage, destruction, rebuilding or restoration of the Premises or
the Building or access thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Any repair or restoration of the Premises performed by Tenant shall be in accordance
with the provisions of Article 9 hereof. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14.2 <U>INSUBSTANTIAL UNTENANTABILITY</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Premises or the Building is damaged by a casualty but neither is rendered substantially untenantable for the Permitted Use, and
Landlord&#146;s Notice indicates that the time to substantially complete the repair or restoration will not exceed one hundred eighty (180)&nbsp;days from the date such damage occurred, then Landlord shall proceed to repair and restore the Building
and/or the Premises other than Tenant Additions, with reasonable promptness, unless such damage is to the Premises and occurs during the last twelve (12)&nbsp;months of the Term (regardless of the estimated repair time), in which event either Tenant
or Landlord shall have the right to terminate this Lease as of the date of such casualty by giving written notice thereof to the other within thirty&nbsp;(30) days after the date of such casualty. Notwithstanding the aforesaid, Landlord&#146;s
obligation to repair shall be limited in accordance with the provisions of Section&nbsp;14.1 above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14.3 <U>RENT ABATEMENT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for the negligence or willful act of Tenant or its agents, employees, contractors or invitees, if all or any part of the Premises are
rendered untenantable by fire or other casualty and this Lease is not terminated, Monthly Base Rent and Rent Adjustments shall abate for that part of the Premises which is untenantable on a per diem basis from the date of the casualty until Landlord
has Substantially Completed the repair and restoration work in the Premises which it is required to perform, provided, that as a result of such casualty. Tenant does not occupy the portion of the Premises which is untenantable during such period.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14.4 <U>WAIVER OF STATUTORY REMEDIES</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of this Lease, including this Article 14, constitute an express agreement between Landlord and Tenant with respect to any and
all damage to, or destruction of, the Premises or the Property or any part of either, and any Law, including Sections 1932(2), 1933(4), 1941 and 1942 of the California Civil Code, with respect to any rights or obligations concerning damage or
destruction shall have no application to this Lease or to any damage to or destruction of all or any part of the Premises or the Property or any part of either, and are hereby waived. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 15 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EMINENT DOMAIN
</U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15.1 <U>TAKING OF WHOLE OR SUBSTANTIAL PART</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event the whole or any substantial part of the Building or of the Premises is taken or condemned by any competent authority for any
public use or purpose (including a deed given in lieu of condemnation) and is thereby rendered untenantable or such taking could reasonably </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expected to have a material adverse effect on Tenant&#146;s ability to operate its business at the Premises in substantially the same manner operated by Tenant prior to such taking, this Lease
shall terminate as of the date title vests in such authority, and Monthly Base Rent and Rent Adjustments shall be apportioned as of the Termination Date. Notwithstanding anything to the contrary herein set forth, in the event the taking is temporary
(for less than the remaining Term of this Lease), Landlord may elect either (i)&nbsp;to terminate this Lease, or (ii)&nbsp;permit Tenant to receive the entire award attributable to the Premises in which case Tenant shall continue to pay Rent and
this Lease shall not terminate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15.2 <U>TAKING OF PART</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event a part of the Building or the Premises is taken or condemned by any competent authority (or a deed is delivered in lieu of
condemnation) and this Lease is not terminated, this Lease shall be amended to reduce or increase, as the case may be, the Monthly Base Rent and Tenant&#146;s Share to reflect the Rentable Area of the Premises or Building, as the case may be,
remaining after any such taking or condemnation. Landlord, upon receipt and to the extent of the award in condemnation (or proceeds of sale) shall make necessary repairs and restorations to the Premises (exclusive of Tenant Additions) and to the
Building to the extent necessary to constitute the portion of the Building not so taken or condemned as a complete architectural and economically efficient unit. Notwithstanding the foregoing, if as a result of any taking, or a governmental order
that the grade of any street or alley adjacent to the Building is to be changed and such taking or change of grade makes it necessary or desirable to substantially remodel or restore the Building or prevents the economical operation of the Building,
Landlord shall have the right to terminate this Lease upon ninety (90)&nbsp;days&#146; prior written notice to Tenant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15.3 <U>COMPENSATION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall be entitled to receive the entire award (or sale proceeds) from any such taking, condemnation or sale without any payment to
Tenant, and Tenant hereby assigns to Landlord, Tenant&#146;s interest, if any, in such award; provided, however, Tenant shall have the right separately to pursue against the condemning authority a separate award in respect of the loss, if any, to
Tenant Additions paid for by Tenant and relocation costs without any credit or allowance from Landlord so long as there is no diminution of Landlord&#146;s award as a result. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 16 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>INSURANCE </U></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16.1 <U>TENANT&#146;S INSURANCE</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant, at
Tenant&#146;s expense, agrees to maintain in force, with a company or companies acceptable to Landlord, during the Term: (a)&nbsp;Commercial General Liability Insurance on a primary basis and without any right of contribution from any insurance
carried by Landlord covering the Premises on an occurrence basis against all claims for personal injury, bodily injury, death and property damage, including contractual liability covering the indemnification provisions in this Lease, and such
insurance shall be for such limits that are reasonably required by Landlord from time to time but not less than a combined single limit (each occurrence and in the aggregate) of Five Million and No/100 Dollars ($5,000,000.00) (which limit may be
achieved through use of umbrella coverage); (b) Workers&#146; Compensation and Employers&#146; Liability Insurance to the extent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required by and in accordance with the Laws of the State of California; (c) &#147;All Risks&#148; property insurance in an amount adequate to cover the full replacement cost of all Tenant
Additions, equipment, installations, fixtures and contents of the Premises (including coverage in the event of loss from earthquake, water damage, and earthquake sprinkler leakage, up to a maximum coverage amount of Five Million and No/100 Dollars
(35,000,000.00)); (d) in the event a motor vehicle is to be used by Tenant in connection with its business operation from the Premises, Comprehensive Automobile Liability Insurance coverage with limits of not less than One Million and No/100 Dollars
(31,000,000.00) combined single limit coverage against bodily injury liability and property damage liability arising out of the use by or on behalf of Tenant, its agents and employees in connection with this Lease, of any owned, <FONT
STYLE="white-space:nowrap">non-owned</FONT> or hired motor vehicles; (e)&nbsp;environmental liability (also known as &#147;Pollution Legal Liability&#148;) coverage with limits of not less than One Million and No/100 Dollars (31,000,000.00) to cover
Tenant&#146;s indemnity obligations pursuant to Section&nbsp;7.1 (f)(5) above; and (f)&nbsp;such other insurance or coverages as Landlord reasonably requires, so long as such coverages are then required for all comparable tenants of the Project.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16.2 <U>FORM OF POLICIES</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each policy
referred to in Section&nbsp;16.1 shall satisfy the following requirements. Each policy shall (i)&nbsp;name Landlord and the Indemnitees as additional insureds (except Workers&#146; Compensation and Employers&#146; Liability Insurance), (ii) be
issued by one or more responsible insurance companies licensed to do business in the State of California reasonably satisfactory to Landlord, (iii)&nbsp;where applicable, provide for deductible amounts satisfactory to Landlord and not permit <FONT
STYLE="white-space:nowrap">co-insurance,</FONT> and (iv)&nbsp;each policy of <FONT STYLE="white-space:nowrap">&#147;All-Risks&#148;</FONT> property insurance shall provide that the policy shall not be invalidated should the insured waive in writing
prior to a loss, any or all rights of recovery against any other party for losses covered by such policies. Tenant shall deliver to Landlord, certificates of insurance (and at Landlord&#146;s request, copies of all policies and renewals thereof to
be maintained by Tenant hereunder), prior to Tenant&#146;s entry into the Premises and prior to the expiration date of each policy. Additionally, Tenant shall provide Landlord written notice of any cancelation or amendment of any such insurance
within two (2)&nbsp;business days following Tenant&#146;s knowledge of the same. If Tenant fails to carry the insurance required under this Article 16 or fails to provide certificates of renewal as and when required hereunder, Landlord may, but
shall not be obligated to acquire such insurance on Tenant&#146;s behalf or Tenant&#146;s sole cost and expense. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16.3 <U>LANDLORD&#146;S INSURANCE</U>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord agrees to purchase and keep in full force and effect during the Term hereof, including any extensions or renewals thereof,
insurance under policies issued by insurers of recognized responsibility, qualified to do business in the State of California on the Building in amounts sufficient to cover the replacement cost thereof, insuring against fire and such other risks as
may be included in standard forms of all risk coverage insurance reasonably available from time to time. Landlord agrees to maintain in force during the Term, Commercial General Liability Insurance covering the Building on an occurrence basis
against all claims for personal injury, bodily injury, death, and property damage. Such insurance shall be for a combined single limit (each occurrence and in the aggregate) of not less than Five Million and No/100 Dollars (35,000,000.00) (which
limit may be achieved through use of umbrella coverage). Neither Landlord&#146;s obligation to carry such insurance nor the carrying of such insurance shall be deemed to be an indemnity by Landlord with respect to any claim, liability, loss, cost or
expense due, in whole or in part, to Tenant&#146;s negligent acts or omissions or willful misconduct. Without obligation to do so, Landlord may, in its sole discretion from time to time, carry insurance in amounts greater and/or for coverage
additional to the coverage and amounts set forth above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16.4 <U>WAIVER OF SUBROGATION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> </B>Landlord agrees that, if obtainable at no, or minimal, additional cost, and so long as the same is permitted under the laws of the
State of California, it will include in its &#147;All Risks&#148; policies appropriate clauses pursuant to which the insurance companies (i)&nbsp;waive all right of subrogation against Tenant with respect to losses payable under such policies and/or
(ii)&nbsp;agree that such policies shall not be invalidated should the insured waive in writing prior to a loss any or all right of recovery against any party for losses covered by such policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Tenant agrees to include, if obtainable at no, or minimal, additional cost, and so long as the same is permitted under the laws of the
State of California, in its &#147;All Risks&#148; insurance policy or policies on Tenant Additions, whether or not removable, and on Tenant&#146;s furniture, furnishings, fixtures and other property removable by Tenant under the provisions of this
Lease, appropriate clauses pursuant to which the insurance company or companies (i)&nbsp;waive the right of subrogation against Landlord and/or any tenant of space in the Building with respect to losses payable under such policy or policies and/or
(ii)&nbsp;agree that such policy or policies shall not be invalidated should the insured waive in writing prior to a loss any or all right of recovery against any party for losses covered by such policy or policies. If Tenant is unable to obtain in
such policy or policies either of the clauses described in the preceding sentence, Tenant shall, if legally possible and without necessitating a change in insurance carriers, have Landlord named in such policy or policies as an additional insured.
If Landlord shall be named as an additional insured in accordance with the foregoing, Landlord agrees to endorse promptly to the order of Tenant, without recourse, any check, draft, or order for the payment of money representing the proceeds of any
such policy or representing any other payment growing out of or connected with said policies, and Landlord does hereby irrevocably waive any and all rights in and to such proceeds and payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Provided that Landlord&#146;s right of full recovery under its policy or policies aforesaid is not adversely affected or prejudiced
thereby, Landlord hereby waives any and all right of recovery which it might otherwise have against Tenant, its servants, agents and employees, for loss or damage occurring to the Real Property and the fixtures, appurtenances and equipment therein,
to the extent the same is covered by Landlord&#146;s insurance, notwithstanding that such loss or damage may result from the negligence or fault of Tenant, its servants, agents or employees. Provided that Tenant&#146;s right of full recovery under
its aforesaid policy or policies is not adversely affected or prejudiced thereby, Tenant hereby waives any and all right of recovery which it might otherwise have against Landlord, its servants, and employees and against every other tenant of the
Real Property who shall have executed a similar waiver as set forth in this Section&nbsp;16.4 (c) for loss or damage to Tenant Additions, whether or not removable, and to Tenant&#146;s furniture, furnishings, fixtures and other property removable by
Tenant under the provisions hereof to the extent the same is coverable by Tenant&#146;s insurance required under this Lease, notwithstanding that such loss or damage may result from the negligence or fault of Landlord, its servants, agents or
employees, or such other tenant and the servants, agents or employees thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B> </B>Landlord and Tenant hereby agree to advise the other promptly if the clauses to
be included in their respective insurance policies pursuant to subparagraphs (a)&nbsp;and (b) above cannot be obtained on the terms hereinbefore provided. Landlord and Tenant hereby also agree to notify the other promptly of any cancellation or
change of the terms of any such policy that would affect such clauses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16.5 <U>NOTICE OF CASUALTY</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall give Landlord notice in case of a fire or accident in the Premises promptly after Tenant is aware of such event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 17 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>WAIVER OF CLAIMS
AND INDEMNITY </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17.1 <U>WAIVER OF CLAIMS</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent permitted by Law, Tenant hereby releases the Indemnitees from, and waives all claims for, damage to person or property sustained
by Tenant or any occupant of the Premises or the Property resulting directly or indirectly from any existing or future condition, defect, matter or thing in and about the Premises or the Property or any part of either or any equipment or
appurtenance therein, or resulting from any accident in or about the Premises or the Property, or resulting directly or indirectly from any act or neglect of any tenant or occupant of the Property or of any other person, including Landlord&#146;s
agents and servants, except to the extent caused by the gross negligence or willful and wrongful act of any of the Indemnitees. To the extent permitted by Law, Tenant hereby waives any consequential damages, compensation or claims for inconvenience
or loss of business, rents, or profits as a result of such injury or damage, whether or not caused by the gross negligence or willful and wrongful act of any of the Indemnitees. If any such damage, whether to the Premises or the Property or any part
of either, or whether to Landlord or to other tenants in the Property, results from any act or negligence of Tenant, its employees, servants, agents, contractors, invitees or customers. Tenant shall be liable therefor and Landlord may, at
Landlord&#146;s option, repair such damage and Tenant shall, upon demand by Landlord, as payment of additional Rent hereunder, reimburse Landlord within thirty (30)&nbsp;days of demand for the total cost of such repairs, in excess of amounts, if
any, paid to Landlord under insurance covering such damages. Tenant shall not be liable for any such damage caused by its acts or negligence if Landlord or a tenant has recovered the full amount of the damage from proceeds of insurance policies and
the insurance company has waived its right of subrogation against Tenant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17.2 <U>INDEMNITY BY TENANT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent permitted by Law, and except to the extent indemnified by Landlord under Section&nbsp;17.3, Tenant hereby indemnifies, and agrees
to protect, defend and hold the Indemnitees harmless, against any and all actions, claims, demands, liability, costs and expenses, including reasonable attorneys&#146; fees and expenses for the defense thereof, arising from Tenant&#146;s occupancy
of the Premises, from the undertaking of any Tenant Additions or repairs to the Premises by Tenant, from the conduct of Tenant&#146;s business on the Premises, or from any breach or default on the part of Tenant in the performance of any covenant or
agreement on the part of Tenant to be performed pursuant to the terms of this Lease, or from any willful act or negligence of Tenant, its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agents, contractors, servants, employees, customers or invitees, in or about the Premises or the Property or any part of either. In case of any action or proceeding brought against the
Indemnitees by reason of any such claim, upon notice from Landlord, Tenant covenants to defend such action or proceeding by counsel reasonably acceptable to Landlord. Landlord reserves the right to settle, compromise or dispose of any and all
actions, claims and demands related to the foregoing indemnity. The foregoing indemnity shall not operate to relieve Indemnitees of liability to the extent such liability is caused by the willful and wrongful act of Indemnitees. Further, the
foregoing indemnity is subject to and shall not diminish any waivers in effect in accordance with Section&nbsp;16.4 by Landlord or its insurers to the extent of amounts, if any, paid to Landlord under its
<FONT STYLE="white-space:nowrap">&#147;All-Risks&#148;</FONT> property insurance. This Article 17 shall survive the expiration or earlier termination of this Lease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17.3 <U>INDEMNITY BY LANDLORD</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent
permitted by Law, Landlord hereby indemnifies, and agrees to protect, defend and hold Tenant, its partners, members, directors, officers, agents and employees (the &#147;Tenant Indemnitees&#148;) harmless, against any and all actions, claims,
demands, liability, costs and expenses, including reasonable attorneys* fees and expenses for the defense thereof, arising from any willful act or the gross negligence of Landlord, in or about the Premises or the Property or any part of either. In
case of any action or proceeding brought against the Tenant Indemnitees by reason of any such claim, upon notice from Tenant, Landlord covenants to defend such action or proceeding by counsel chosen by Landlord. The foregoing indemnity shall not
operate to relieve Tenant Indemnitees of liability to the extent such liability is caused by the willful and wrongful act of the Tenant Indemnitees. Further, the foregoing indemnity is subject to and shall not diminish any waivers in effect in
accordance with Section&nbsp;16.4 by Tenant or its insurers to the extent of amounts, if any, paid to Tenant under its <FONT STYLE="white-space:nowrap">&#147;All-Risks&#148;</FONT> property insurance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17.4 <U>WAIVER OF CONSEQUENTIAL DAMAGES</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To
the extent permitted by law, Tenant hereby waives and releases the Indemnitees from any consequential damages, compensation or claims for inconvenience or loss of business, rents or profits as a result of any injury or damage, whether or not caused
by the willful and wrongful act of any of the Indemnitees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 18 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RULES AND REGULATIONS </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18.1 <U>RULES</U>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant agrees for itself and for its subtenants, employees, agents, and invitees to comply with the rules and regulations listed on
<U>Exhibit <FONT STYLE="white-space:nowrap">C-2</FONT></U> attached hereto and with all reasonable modifications and additions thereto which Landlord may make from time to time and provided to Tenant in writing, provided that such modifications and
additions apply to all tenants generally and <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> manner. In the event of any conflict between such rules and regulations and any provision in this Lease, such provision of this Lease shall
control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18.2 <U>ENFORCEMENT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Lease shall be construed to impose upon Landlord any duty or obligation to enforce the rules and regulations as set forth on
<U>Exhibit <FONT STYLE="white-space:nowrap">C-2</FONT></U> or as hereafter adopted, or the terms, covenants or conditions of any other lease as against any other tenant, and Landlord shall not be liable to Tenant for violation of the same by any
other tenant, its servants, employees, agents, visitors or licensees. Landlord shall use reasonable efforts to enforce the rules and regulations of the Project in a uniform and <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 19 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>LANDLORD&#146;S
RESERVED RIGHTS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall have the following rights exercisable without notice to Tenant and without liability to Tenant for
damage or injury to persons, property or business and without being deemed an eviction or disturbance of Tenant&#146;s use or possession of the Premises or giving rise to any claim for offset or abatement of Rent: (1)&nbsp;to change the
Building&#146;s name or street address upon thirty (30)&nbsp;days&#146; prior written notice to Tenant; (2)&nbsp;to install, affix and maintain all signs on the exterior and/or interior of the Building; (3)&nbsp;to designate and/or approve prior to
installation, all types of signs, window shades, blinds, drapes, awnings or other similar items, and all internal lighting that may be visible from the exterior of the Premises; (4)&nbsp;upon reasonable written notice to Tenant, to display the
Premises to prospective purchasers and lenders at reasonable hours at any time during the Term and to prospective tenants at reasonable hours during the last twelve (12)&nbsp;months of the Term, subject to Tenant&#146;s reasonable security and
safety rules and procedures (which may include, without limitation, requiring a Tenant representative to escort visitors at all times); (5) to grant to any party the exclusive right to conduct any business or render any service in or to the
Building, provided such exclusive right shall not operate to unreasonably interfere with Tenant&#146;s use of the Premises for the purpose permitted hereunder; (6)&nbsp;to change the arrangement and/or location of entrances or passageways, doors and
doorways, corridors, elevators, stairs, washrooms or public portions of the Building, and to close entrances, doors, corridors, elevators or other facilities, provided that such action shall not materially and adversely interfere with Tenant&#146;s
access to the Premises or the Building or unreasonably interfere with Tenant&#146;s use of the Preemies for the purposes permitted hereunder; (7)&nbsp;to have access for Landlord and other tenants of the Building to any mail chutes and boxes located
in or on the Premises as required by any applicable rules of the United States Post Office; and (8)&nbsp;to close the Building after Standard Operating Hours, except that Tenant and its employees and invitees shall be entitled to admission at all
times, under such reasonable regulations as Landlord prescribes for the Building for security purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 20 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RELOCATION OF TENANT </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At
any time during the Term, Landlord may substitute for the Premises, other premises in the Building, in which event the New Premises shall be deemed to be the Premises for all purposes under this Lease, provided that (i)&nbsp;the New Premises shall
be located on higher floors in the Building than the Premises and shall be substantially similar to the Premises in area, configuration and functionality; (ii)&nbsp;if Tenant is then occupying the Premises, Landlord shall pay the actual and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reasonable expenses of physically moving Tenant, its property and equipment to the New Premises; (iii)&nbsp;Landlord shall give Tenant not less than ninety (90)&nbsp;days&#146; prior written
notice of such substitution; and (iv)&nbsp;Landlord, at its expense, shall improve the New Premises with improvements substantially similar to those in the Premises at the time of such substitution, if the Premises are then improved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 21 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ESTOPPEL
CERTIFICATE </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">21.1 <U>TENANT ESTOPPEL</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within ten (10)&nbsp;business days after request therefor by Landlord, Mortgagee or any prospective mortgagee or owner, Tenant agrees as
directed in such request to execute an Estoppel Certificate in recordable form, binding upon Tenant, certifying (i)&nbsp;that this Lease is unmodified and in full force and effect (or if there have been modifications, a description of such
modifications and that this Lease as modified is in full force and effect); (ii) the dates to which Rent has been paid; (iii)&nbsp;that Tenant is in the possession of the Premises, if that is the case; (iv)&nbsp;that to the best knowledge of Tenant
without any duty to investigate, Landlord is not in default under this Lease (or if Tenant believes Landlord is in default, the nature thereof in detail); (v) that to the best knowledge of Tenant without any duty to investigate, Tenant has no
offsets or defenses to the performance of its obligations under this Lease (or if Tenant believes there are any offsets or defenses, a full and complete explanation thereof); (vi) that the Premises have been completed in accordance with the terms
and provisions hereof or the Workletter, that Tenant has accepted the Premises and the condition thereof and of all improvements thereto and has no claims against Landlord or any other party with respect thereto (or stating such exceptions thereto
as applicable); (vii) that if an assignment of rents or leases has been served upon the Tenant by a Mortgagee, Tenant will acknowledge receipt thereof and agree to be bound by the reasonable provisions thereof; (viii)&nbsp;that Tenant will give to
the Mortgagee copies of all notices required or permitted to be given by Tenant to Landlord, provided that the Mortgagee&#146;s address is provided to Tenant in writing; and (ix)&nbsp;to any other factual information reasonably and customarily
requested. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">21.2 <U>ENFORCEMENT</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the
event that Tenant fails to deliver an Estoppel Certificate within three (3)&nbsp;days of its receipt of a second written notice from Landlord to Tenant after the expiration of the initial ten (10)&nbsp;day period, then such failure shall be a
Default for which there shall be no cure or grace period. In addition to any other remedy available to Landlord, Tenant shall be deemed to have irrevocably appointed Landlord as Tenant&#146;s <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> to execute and deliver such Estoppel Certificate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">21.3 <U>LANDLORD ESTOPPEL</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within ten (10)&nbsp;business days after request therefor by Tenant, Landlord shall also certify that (i)&nbsp;that this Lease is unmodified
and in full force and effect (or if there have been modifications, a description of such modifications and that this Lease as modified is in full force and effect); (ii) the dates to which Rent has been paid; (iii)&nbsp;whether or not to the best
knowledge of Landlord without any duty to investigate, Tenant is in default in the performance of any covenant, agreement or condition contained in this Lease and, if so, specifying each such default of which Landlord may have knowledge. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 22 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>REAL ESTATE BROKERS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant represents that, except for the broker(s) listed in Section&nbsp;1.1(17), Tenant has not dealt with any real estate broker, sales
person, or finder in connection with this Lease, and no such person initiated or participated in the negotiation of this Lease, or showed the Premises to Tenant. Landlord represents that, except for the broker(s) listed in Section&nbsp;1.1(17),
Landlord has not dealt with any real estate broker, sales person, or finder in connection with this Lease, and no such person initiated or participated in the negotiation of this Lease, or showed the Premises on behalf of Landlord. Tenant hereby
agrees to indemnify, protect, defend and hold Landlord and the Indemnitees, harmless from and against any and all liabilities and claims for commissions and fees arising out of a breach of the foregoing representation as well as from any claim or
claims for any commission or fee by any broker or other party claiming to represent Tenant in connection with any future extensions or renewals hereof. Landlord hereby agrees to indemnify, protect, defend and hold Tenant and the Tenant Indemnitees,
harmless from and against any and all liabilities and claims for commissions and fees arising out of a breach of the foregoing representation by Landlord as well as from any claim or claims for any commission or fee by any broker or other party
claiming to represent Landlord in connection with any future extensions or renewals hereof. Landlord agrees to pay any commission to which the brokers listed in Section&nbsp;1.1(17) are entitled in connection with this Lease pursuant to
Landlord&#146;s written agreement with such broker. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 23 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MORTGAGEE PROTECTION </U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">23.1
<U>SUBORDINATION AND ATTORNMENT</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Lease is and shall be expressly subject and subordinate at all times to (i)&nbsp;any ground or
underlying lease of the Real Property, now or hereafter existing, and all amendments, extensions, renewals and modifications to any such lease, and (ii)&nbsp;the lien of any mortgage or trust deed now or hereafter encumbering fee title to the Real
Property and/or the leasehold estate under any such lease, and all amendments, extensions, renewals, replacements and modifications of such mortgage or trust deed and/or the obligation secured thereby, unless such ground lease or ground lessor, or
mortgage, trust deed or Mortgagee, expressly provides or elects that this Lease shall be superior to such lease or mortgage or trust deed. If any such mortgage or trust deed is foreclosed (including any sale of the Real Property pursuant to a power
of sale), or if any such lease is terminated, upon request of the Mortgagee or ground lessor, as the case may be, Tenant shall, provided that such Mortgagee or ground lessor agrees not to disturb Tenant&#146;s rights under this Lease if Tenant is
not in Default hereunder, attorn to the purchaser at the foreclosure sale or to the ground lessor under such lease, as the case may be, provided, however, that such purchaser or ground lessor shall not be (i)&nbsp;bound by any payment of Rent for
more than one month in advance except payments in the nature of security for the performance by Tenant of its obligations under this Lease; (ii)&nbsp;subject to any offset, defense or damages arising out of a default of any obligations
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of any preceding Landlord; (iii)&nbsp;bound by any amendment or modification of this Lease made without the written consent of the Mortgagee or ground lessor, or (iv)&nbsp;liable for any security
deposits not actually received in cash by such purchaser or ground lessor. This subordination shall be self-operative and no further certificate or instrument of subordination need be required by any such Mortgagee or ground lessor. In confirmation
of such subordination, however, Tenant shall execute promptly any commercially reasonable certificate or instrument that Landlord, Mortgagee or ground lessor may request. Tenant hereby constitutes Landlord as Tenant&#146;s <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> to execute such certificate or instrument for and on behalf of Tenant upon Tenant&#146;s failure to do so within fifteen (15)&nbsp;days of a request to do so.
Upon request by such successor in interest, Tenant shall execute and deliver reasonable instruments confirming the attornment provided for herein. The terms of this paragraph shall survive any termination of this Lease by reason of foreclosure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the thirty (30)&nbsp;day period following the Date of this Lease, Landlord shall use commercially reasonable efforts to obtain a
subordination, <FONT STYLE="white-space:nowrap">non-disturbance</FONT> and attornment agreement (a &#147;SNDA&#148;) from the current Mortgagee in a form reasonably acceptable to Tenant; provided, however, in no event shall Landlord be in default of
this Lease if, despite Landlord&#146;s exercise of commercially reasonable efforts, Landlord is unable to obtain a SNDA for Tenant from any such Mortgagee. Additionally, notwithstanding anything herein to the contrary, Tenant&#146;s obligation to
subordinate this Lease to any future ground lease or mortgage as provided above is conditioned upon Landlord providing a SNDA from such future Mortgagee on the standard form provided by such Mortgagee (with such commercially reasonable modifications
as may be requested by Tenant and approved by such Mortgagee). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">23.2 <U>MORTGAGEE PROTECTION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant agrees to give any Mortgagee or ground lessor, by registered or certified mail, a copy of any notice of default served upon Landlord by
Tenant, provided that prior to such notice Tenant has received written notice (by way of service on Tenant of a copy of an assignment of rents and leases, or otherwise) of the address of such Mortgagee or ground lessor. Tenant further agrees that if
Landlord shall have failed to cure such default within the time provided for in this Lease, then the Mortgagee or ground lessor shall have an additional thirty (30)&nbsp;days after receipt of notice thereof within which to cure such default or if
such default cannot be cured within that time, then such additional notice time as may be necessary, if, within such thirty (30)&nbsp;days, any Mortgagee or ground lessor has commenced and is diligently pursuing the remedies necessary to cure such
default (including the commencement of foreclosure proceedings or other proceedings to acquire possession of the Real Property, if necessary to effect such cure). Such period of time shall be extended by any period within which such Mortgagee or
ground lessor is prevented from commencing or pursuing such foreclosure proceedings or other proceedings to acquire possession of the Real Property by reason of Landlord&#146;s bankruptcy. Until the time allowed as aforesaid for Mortgagee or ground
lessor to cure such defaults has expired without cure, Tenant shall have no right to, and shall not, terminate this Lease on account of default. This Lease may not be modified or amended so as to reduce the Rent or shorten the Term, or so as to
adversely affect in any other respect to any material extent the rights of Landlord, nor shall this Lease be canceled or surrendered, without the prior written consent, in each instance, of the ground lessor or the Mortgagee. Landlord agrees to
diligently use reasonable efforts to obtain such Mortgagee consents as may be required and shall promptly inform Tenant in writing upon obtaining such consents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 24 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NOTICES </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All notices,
demands or requests provided for or permitted to be given pursuant to this Lease must be in writing and shall be personally delivered, sent by Federal Express or other reputable overnight courier service, or mailed by first class, registered or
certified United States mail, return receipt requested, postage prepaid, or sent by electronic mail, provided that the sender also sends a hard copy of the notice within one (1)&nbsp;business day by one of the other methods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All notices, demands or requests to be sent pursuant to this Lease shall be deemed to have been properly given or served by delivering or
sending the same in accordance with this Section, addressed to the parties hereto at their respective addresses listed in Section&nbsp;1.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notices, demands or requests sent by mail or overnight courier service as described above shall be effective upon deposit in the mail or
with such courier service. However, except with respect to a notice given under Code of Civil Procedure Section&nbsp;1161 et seq., the time period in which a response to any such notice, demand or request must be given shall commence to run from
(i)&nbsp;in the case of delivery by mail, the date of receipt on the return receipt of the notice, demand or request by the addressee thereof, or (ii)&nbsp;in the case of delivery by Federal Express or other overnight courier service, the date of
acceptance of delivery by an employee, officer, director or partner of Landlord or Tenant. Rejection or other refusal to accept or the inability to deliver because of changed address of which no notice was given, as indicated by advice from Federal
Express or other overnight courier service or by mail return receipt, shall be deemed to be receipt of notice, demand or request sent. Notices may also be served by personal service upon any officer, director or partner of Landlord or Tenant, and
shall be effective upon such service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) By giving to the other party at least thirty (30)&nbsp;days&#146; written notice thereof,
either party shall have the right from time to time during the term of this Lease to change their respective addresses for notices, statements, demands and requests, provided such new address shall be within the United States of America. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 25 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OFAC </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord advises Tenant hereby that the purpose of this Article is to provide to the Landlord information and assurances to enable Landlord to
comply with the law relating to OFAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant hereby represents, warrants and covenants to Landlord, either that (i)&nbsp;Tenant is
regulated by the SEC, FINRA or the Federal Reserve (a &#147;Regulated Entity&#148;) or (ii)&nbsp;neither Tenant nor any person or entity that directly or indirectly (a)&nbsp;controls Tenant or (b)&nbsp;has an ownership interest in Tenant of
twenty-five percent (25%) or more, appears on the list of Specially Designated Nationals and Blocked Persons (&#147;OFAC List&#148;) published by the Office of Foreign Assets Control (&#147;OFAC&#148;) of the U.S. Department of the Treasury. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, in connection with this Lease, there is one or more Guarantors of Tenant&#146;s
obligations under this Lease, then Tenant further represents, warrants and covenants either that (i)&nbsp;any such Guarantor is a Regulated Entity or (ii)&nbsp;neither Guarantor nor any person or entity that directly or indirectly (a)&nbsp;controls
such Guarantor or (b)&nbsp;has an ownership interest in such Guarantor of twenty- five percent (25%) or more, appears on the OFAC List. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant covenants that during the term of this Lease to provide to Landlord information reasonably requested by Landlord including without
limitation, organizational structural charts and organizational documents which Landlord may deem to be necessary (&#147;Tenant OFAC Information&#148;) in order for Landlord to confirm Tenant&#146;s continuing compliance with the provisions of this
Article. Tenant represents and warrants that the Tenant OFAC Information it has provided or to be provided to Landlord or Landlord&#146;s Broker in connection with the execution of this Lease is true and complete. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 26 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MISCELLANEOUS
</U></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.1 <U>LATE CHARGES</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All
payments required hereunder (other than the Monthly Base Rent, Rent Adjustments, and Rent Adjustment Deposits, which shall be due as hereinbefore provided) to Landlord shall be paid within ten (10)&nbsp;days after Landlord&#146;s demand therefor if
not otherwise set forth in this Lease. All such amounts (including Monthly Base Rent, Rent Adjustments, and Rent Adjustment Deposits) not paid when due shall bear interest from the date due until the date paid at the Default Rate in effect on the
date such payment was due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event Tenant is more than five (5)&nbsp;days late in paying any installment of Rent due under this
Lease, Tenant shall pay Landlord a late charge equal to five percent (5%) of the delinquent installment of Rent. The parties agree that (i)&nbsp;such delinquency will cause Landlord to incur costs and expenses not contemplated herein, the exact
amount of which will be difficult to calculate, including the cost and expense that will be incurred by Landlord in processing each delinquent payment of rent by Tenant, (b)&nbsp;the amount of such late charge represents a reasonable estimate of
such costs and expenses and that such late charge shall be paid to Landlord for each delinquent payment in addition to all Rent otherwise due hereunder. The parties further agree that the payment of late charges and the payment of interest provided
for in subparagraph (a)&nbsp;above are distinct and separate from one another in that the payment of interest is to compensate Landlord for its inability to use the money improperly withheld by Tenant, while the payment of late charges is to
compensate Landlord for its additional administrative expenses in handling and processing delinquent payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment of interest at
the Default Rate and/or of late charges shall not excuse or cure any default by Tenant under this Lease, nor shall the foregoing provisions of this Article or any such payments prevent Landlord from exercising any right or remedy available to
Landlord upon Tenant&#146;s failure to pay Rent when due, including the right to terminate this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.2 <U>NO JURY TRIAL; VENUE; JURISDICTION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the fullest extent permitted by law, including laws enacted after the Commencement Date, each party hereto (which includes any assignee,
successor, heir or personal representative of a party) shall not seek a jury trial, hereby waives trial by jury, and hereby further waives any objection to venue in the County in which the Project is located, and agrees and consents to personal
jurisdiction of the courts of the State of California, in any action or proceeding or counterclaim brought by any party hereto against the other on any matter whatsoever arising out of or in any way connected with this Lease, the relationship of
Landlord and Tenant, Tenant&#146;s use or occupancy of the Premises, or any claim of injury or damage, or the enforcement of any remedy under any statute, emergency or otherwise, whether any of the foregoing is based on this Lease or on tort law. No
party will seek to consolidate any such action in which a jury has been waived with any other action in which a jury trial cannot or has not been waived. It is the intention of the parties that these provisions shall be subject to no exceptions. The
provisions of this Section shall survive the expiration or earlier termination of this Lease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.3 <U>NO DISCRIMINATION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant agrees for Tenant and Tenant&#146;s heirs, executors, administrators, successors and assigns and all persons claiming under or through
Tenant, and this Lease is made and accepted upon and subject to the following conditions: that there shall be no discrimination against or segregation of any person or group of persons on account of race, color, creed, religion, sex, marital status,
national origin or ancestry (whether in the leasing, subleasing, transferring, use, occupancy, tenure or enjoyment of the Premises or otherwise) nor shall Tenant or any person claiming under or through Tenant establish or permit any such practice or
practices of discrimination or segregation with reference to the use or occupancy of the Premises by Tenant or any person claiming through or under Tenant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.4 <U>FINANCIAL STATEMENTS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within ten
(10)&nbsp;days after written request from Landlord from time to time during the Term (not more than once per any <FONT STYLE="white-space:nowrap">12-month</FONT> period), Tenant shall provide Landlord with current financial statements setting forth
Tenant&#146;s financial condition and net worth for the most recent quarter, including balance sheets and statements of profits and losses. Such statements shall be prepared by an independent accountant and certified by Tenant&#146;s president,
chief executive officer or chief financial officer. Landlord shall keep such financial information confidential and shall only disclose such information to Landlord&#146;s lenders, consultants, purchasers or investors, or other agents (who shall be
subject to the same confidentiality obligations) on a need to know basis <B>in </B>connection with the administration of this Lease. Notwithstanding the foregoing, Tenant shall have no obligation to deliver any financial statements so long as Tenant
is a publicly traded entity and its financial statements are publicly available. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.5 <U>OPTION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Lease shall not become effective as a lease or otherwise until executed and delivered by both Landlord and Tenant. The submission of this
Lease to Tenant does not constitute a reservation of or option for the Premises, but when executed by Tenant and delivered to Landlord, this Lease shall constitute an irrevocable offer by Tenant in effect for fifteen (15)&nbsp;days to lease the
Premises on the terms and conditions herein contained. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.6 <U>TENANT AUTHORITY</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant represents and warrants to Landlord that it has full authority and power to enter into and perform its obligations under this Lease,
that the person executing this Lease is fully empowered to do so, and that no consent or authorization is necessary from any third party. Landlord may request that Tenant provide Landlord evidence of Tenant&#146;s authority. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.7 <U>LANDLORD AUTHORITY</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord
represents and warrants to Tenant that it has full authority and power to enter into and perform its obligations under this Lease, that the person executing this Lease is fully empowered to do so, and that no consent or authorization is necessary
from any third party (or, if required, such consent has been obtained by Landlord). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.8 <U>ENTIRE AGREEMENT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Lease, the exhibits, schedules, and riders attached hereto contain the entire agreement between Landlord and Tenant concerning the
Premises and there are no other agreements, either oral or written, and no other representations or statements, either oral or written, on which Tenant has relied. This Lease shall not be modified except by a writing executed by Landlord and Tenant.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.9 <U>MODIFICATION OF LEASE FOR BENEFIT OF MORTGAGEE</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Mortgagee of Landlord requires a modification of this Lease which shall not result in any increased cost or expense to Tenant or in any
other substantial and adverse change in the rights and obligations of Tenant hereunder, then Tenant agrees that this Lease may be so modified. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.10
<U>EXCULPATION</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant agrees, on its behalf and on behalf of its successors and assigns, that any liability or obligation under this
Lease shall only be enforced against Landlord&#146;s equity interest in the Property up to a maximum of Twenty Million Dollars ($20,000,000.00) and in no event against any other assets of Landlord, or Landlord&#146;s members, officers or directors
or partners, and that any liability of Landlord with respect to this Lease shall be so limited and Tenant shall not be entitled to any judgment in excess of such amount. Notwithstanding anything to the contrary contained herein, in no event shall
Landlord be liable to Tenant for consequential, punitive or special damages with respect to this Lease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.11 <U>ACCORD AND SATISFACTION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No payment by Tenant or receipt by Landlord of a lesser amount than any installment or payment of Rent due shall be deemed to be other than on
account of the amount due, and no endorsement or statement on any check or any letter accompanying any check or payment of Rent shall be deemed an accord and satisfaction, and Landlord may accept such check or payment without prejudice to
Landlord&#146;s right to recover the balance of such installment or payment of Rent or pursue any other remedies available to Landlord. No receipt of money by Landlord from Tenant after the termination of this Lease or Tenant&#146;s right of
possession of the Premises shall reinstate, continue or extend the Term. Receipt or acceptance of payment from anyone other than Tenant, including an assignee of Tenant, is not a waiver of any breach of Article 10, and Landlord may accept such
payment on account of the amount due without prejudice to Landlord&#146;s right to pursue any remedies available to Landlord. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.12 <U>LANDLORD&#146;S OBLIGATIONS ON SALE OF BUILDING</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any sale or other transfer of the Building, subject to purchaser&#146;s assumption of Landlord&#146;s obligations under this
Lease accruing or to be performed after the date of such sale or transfer, Landlord shall be entirely freed and relieved of all agreements and obligations of Landlord hereunder accruing or to be performed after the date of such sale or transfer, and
any remaining liability of Landlord with respect to this Lease shall be limited to the dollar amount specified in Section&nbsp;26.10 and Tenant shall not be entitled to any judgment in excess of such amount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.13 <U>BINDING EFFECT</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the
provisions of Article 10, this Lease shall be binding upon and inure to the benefit of Landlord and Tenant and their respective heirs, legal representatives, successors and permitted assigns. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.14 <U>CAPTIONS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Article and Section
captions in this Lease are inserted only as a matter of convenience and in no way define, limit, construe, or describe the scope or intent of such Articles and Sections. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.15 <U>TIME; APPLICABLE LAW; CONSTRUCTION</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Time is of the essence of this Lease and each and all of its provisions. This Lease shall be construed in accordance with the Laws of the State
of California. If any term, covenant or condition of this Lease or the application thereof to any person or circumstance shall, to any extent, be invalid or unenforceable, the remainder of this Lease, or the application of such term, covenant or
condition to persons or circumstances other than those as to which it is held invalid or unenforceable, shall not be affected thereby and each item, covenant or condition of this Lease shall be valid and be enforced to the fullest extent permitted
by Law, Wherever the term &#147;including&#148; or &#147;includes&#148; is used in this Lease, it shall have the same meaning as if followed by the phrase &#147;but not limited to&#148;. The language in all parts of this Lease shall be construed
according to its normal and usual meaning and not strictly for or against either Landlord or Tenant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.16 <U>ABANDONMENT</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event Tenant abandons the Premises but is otherwise in compliance with all the terms, covenants and conditions of this Lease, Landlord
shall (i)&nbsp;have the right to enter into the Premises in order to show the space to prospective tenants, (ii)&nbsp;have the right to reduce the services provided to Tenant pursuant to the terms of this Lease to such levels as Landlord reasonably
determines to be adequate services for an unoccupied premises, and (iii)&nbsp;during the last six (6)&nbsp;months of the Term, have the right to prepare the Premises for occupancy by another tenant upon the end of the Term. Tenant expressly
acknowledges that in the absence of written notice pursuant to Section&nbsp;11.2(b) or pursuant to California Civil Code Section&nbsp;1951.3 terminating Tenant&#146;s right defenses to the enforcement of the terms of this Lease based on such
telecopied or <FONT STYLE="white-space:nowrap">e-mailed</FONT> signatures. Promptly following request by either party, the other party shall provide the requesting party with original signatures on this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">26.23 <U>EXHIBITS, SCHEDULES AND RIDERS</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All exhibits, schedules, riders and/or addenda referred to in this Lease as an exhibit, schedule, rider, or addenda hereto, or attached hereto,
are hereby incorporated into and made a part of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures on Following Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, this Lease has been executed as of the date set forth in
Section&nbsp;1.1(4) hereof. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TENANT:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">LANDLORD:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dynavax Technologies Corporation,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a
Delaware corporation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emery Station West, LLC,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a
California limited liability company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eddie Gray</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">ES West Associates, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Print Name: Eddie Gray</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Its: Chief
Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a California limited liability company,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">its
Managing Member</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Ostrach</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Wareham-NZL,</FONT> LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Print Name: Michael Ostrach</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Its:
Senior Vice President, Chief Financial Officer and Chief Business Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a California limited liability company,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">its
Member</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard K. Robbins</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richard K. Robbins</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Manager</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OUTLINE OF PREMISES </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp215.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp216.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>WORKLETTER </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS
WORKLETTER (this &#147;<B>Workletter</B>&#148;) is attached to and made a part of that certain Lease (the &#147;<B>Lease</B>&#148;) between EMERY STATION WEST, LLC, a California limited liability company (&#147;<B>Landlord</B>&#148;), and DYNAVAX
TECHNOLOGIES CORPORATION, a Delaware corporation (&#147;<B>Tenant</B>&#148;). All capitalized terms used but not defined herein shall have the respective meanings given such terms in the Lease. This Workletter sets forth the terms and conditions
relating to the construction of Tenant Improvements (defined below) in the Premises. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SECTION 1 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ALLOWANCE; TENANT IMPROVEMENTS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Allowance</U>. Tenant shall be entitled to an allowance (the &#147;<B>Tenant Improvement Allowance</B>&#148;) in an amount not to
exceed $110.00 per square foot of Rentable Area of the Premises for the costs relating to the design, permitting and construction of Tenant&#146;s improvements which will be permanently affixed to the Premises in accordance with this Workletter (the
&#147;<B>Tenant Improvements</B>&#148;). In no event will Landlord be obligated to make disbursements pursuant to this Workletter in a total amount which exceeds the Tenant Improvement Allowance. Tenant agrees that it shall commence the Tenant
Improvements promptly following the Commencement Date and diligently proceed to complete the same. Tenant must submit Payment Request Supporting Documentation (defined below) for such work in accordance with this Workletter no later than
April&nbsp;1, 2020, after which date Landlord&#146;s obligation to fund such costs shall expire. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Disbursement of the Tenant
Improvement Allowance.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Tenant Improvement Allowance Items</U>. Except as otherwise set forth in this Workletter, the Tenant
Improvement Allowance shall be disbursed by Landlord only for the following items and costs (collectively the &#147;<B>Tenant Improvement Allowance Items</B>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Payment of the fees of the Architect and the Building Consultants (as those terms are defined below) and payment of fees and costs
reasonably incurred by Landlord for the review of the Construction Drawings (defined below) by Landlord or by Landlord&#146;s third party consultants; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The payment of plan check, permit and license fees relating to the Tenant Improvements, including, without limitation, taxes, fees,
charges and levies by governmental agencies; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The cost of construction of the Tenant Improvements, including, without limitation,
costs and expenses for labor, materials, equipment and fixtures, after hours charges, testing and inspection costs, freight elevator usage, trash removal costs, any other services provided by third parties unaffiliated with Tenant in connection with
the construction and contractors&#146; fees and general conditions; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The cost of any changes to the Building when such changes are required by the
Construction Drawings, such cost to include all direct architectural and/or engineering fees and expenses incurred in connection therewith; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) The cost of any changes to the Construction Drawings (defined below) or Tenant Improvements required by applicable laws, including,
without limitation, building codes (collectively, &#147;<B>Code</B>&#148;);<B> </B>and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) The Coordination Fee (defined below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Disbursement of Tenant Improvement Allowance</U>. During the design and construction of the Tenant Improvements, Landlord shall make
periodic disbursements (no more often than once per month) of the Tenant Improvement Allowance to reimburse Tenant for Tenant Improvement Allowance Items and shall authorize the release of funds as follows. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) To request a periodic disbursement, Tenant shall deliver to Landlord: (A)&nbsp;a request for payment from Contractor (defined below)
approved by Tenant, in a reasonable form to be provided or approved in advance by Landlord, including a schedule of values and showing the percentage of completion, by trade, of the Tenant Improvements, which details the portion of the work
completed and the portion not completed; (B)&nbsp;invoices from all of Tenant&#146;s Agents (defined below) for labor rendered and materials delivered to the Premises; (C)&nbsp;executed conditional mechanic&#146;s lien releases from all of
Tenant&#146;s Agents who have lien rights with respect to the subject request for payment (along with unconditional mechanics&#146; lien releases with respect to payments made pursuant to Tenant&#146;s prior submission hereunder) in compliance with
all applicable laws; (D)&nbsp;if not already supplied to Landlord, a copy of the construction permits referenced in Section&nbsp;3.2(a) below; and (E)&nbsp;all other information reasonably requested by Landlord (collectively, the &#147;<B>Payment
Request Supporting Documentation</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Within forty (40)&nbsp;days after Tenant&#146;s delivery to Landlord of all Payment
Request Supporting Documentation, Landlord shall deliver to Tenant payment in an amount equal to the lesser of: (x)&nbsp;the amount so requested by Tenant, as set forth in Section<B>&nbsp;1 </B>-2(b)(i) above, less (i)&nbsp;the applicable
Over-Tenant Improvement Allowance Amount (defined in Section&nbsp;3.2(a) below and (ii)&nbsp;a ten percent (10%) retention (the aggregate amount of such retentions to be known as the &#147;<B>Final Retention</B>&#148;),<B> </B>and (y)&nbsp;the
balance of any remaining available portion of the Tenant Improvement Allowance (not including the Final Retention), provided that if Landlord, in good faith, disputes any item in a request for payment based on
<FONT STYLE="white-space:nowrap">non-compliance</FONT> of any work with the Approved Working Drawings (defined below) or due to any substandard work (reasonably determined by Landlord) and delivers a written objection to such item setting forth with
reasonable particularity Landlord&#146;s reasons for its dispute (a &#147;<B>Draw Dispute Notice</B>&#148;) within ten (10)&nbsp;days following Tenant&#146;s submission of its Payment Request Supporting Documentation, Landlord may deduct the amount
of such disputed item from the payment. Landlord and Tenant shall, in good faith, endeavor to diligently resolve any such dispute. Landlord&#146;s payment of such amounts shall not be deemed Landlord&#146;s approval or acceptance of the work
furnished or materials supplied as set forth in Tenant&#146;s payment request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Subject to the provisions of this Work Agreement, following the final completion of
construction of the Tenant Improvements, Landlord shall deliver to Tenant a check made payable to Tenant, or a check or checks made payable to another party or parties as reasonably requested by Tenant, in the amount of the Final Retention, provided
that (A)&nbsp;Tenant delivers to Landlord properly executed unconditional mechanics&#146; lien releases from all of Tenant&#146;s Agents in compliance with all applicable laws, as reasonably determined by Landlord; (B)&nbsp;Landlord has determined
in good faith that no substandard work exists which adversely affects die mechanical, electrical, plumbing, heating, ventilating and air conditioning, life-safety or other systems of the Building, the curtain wall of the Building, the structure or
exterior appearance of the Building; (C)&nbsp;Architect delivers to Landlord a certificate, in a form reasonably acceptable to Landlord, certifying that the construction of the Tenant Improvements has been finally completed; (D)&nbsp;Tenant supplies
Landlord with evidence that all governmental approvals required for an occupant to legally occupy the Premises has been obtained; and (E)&nbsp;Tenant has fulfilled its Completion Obligations (defined below) and has otherwise complied with
Landlord&#146;s standard <FONT STYLE="white-space:nowrap">&#147;close-out&#148;</FONT> requirements regarding city approvals, closeout tasks, closeout documentation regarding the general contractor, financial
<FONT STYLE="white-space:nowrap">close-out</FONT> matters, and Tenant&#146;s vendors. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SECTION 2 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>CONSTRUCTION DRAWINGS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Selection of Architect; Construction Drawings</U>. Tenant shall retain DGA Architects (the &#147;<B>Architect</B>&#148;) to prepare the
Construction Drawings. Such approval shall be granted or denied within three (3)&nbsp;business days upon request, and Landlords* failure to respond within such three&nbsp;(3) business day period shall be deemed approval by Landlord. Tenant shall
retain engineering consultants approved in writing, in advance by Landlord, such approval not to be unreasonably withheld (the &#147;<B>Building Consultants</B>&#148;) to prepare all plans and engineering working drawings and perform all work
relating to mechanical, electrical and plumbing (&#147;<B>MEP</B>&#148;), HVAC/Air Balancing, life-safety, structural, sprinkler and riser work. Landlord acknowledges its <FONT STYLE="white-space:nowrap">pre-approval</FONT> of the following Building
Consultants: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="94%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MEP:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Interface</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Structural:&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rutherford&nbsp;&amp; Chekene.</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The plans and drawings to be prepared by Architect and the Building Consultants hereunder (i.e., both
the Space Plan and the Working Drawings, as each term is defined below) shall be known collectively as the &#147;<B>Construction Drawings</B>.&#148; All Construction Drawings shall comply with the drawing format and specifications reasonably
determined or approved by Landlord and shall be subject to Landlord&#146;s prior written approval, not to be unreasonably withheld, conditioned or delayed. Such approval shall be granted or denied within ten (10)&nbsp;business days after delivery to
Landlord, and Landlord&#146;s failure to respond within such ten (10)&nbsp;business day period, if such failure continues following a second, five (5)&nbsp;business day notice, shall be deemed approval by Landlord. Any disapproval of the
Construction Drawings shall accompany Landlord&#146;s detailed reasons for such disapproval. All MEP drawings must be fully engineered and cannot be prepared on a &#147;design-build&#148; basis. Landlord&#146;s review of the Construction Drawings
shall be for its sole purpose and shall not obligate Landlord to review the same, for quality, design, Code compliance or other like matters. Accordingly, notwithstanding that any Construction Drawings are reviewed by Landlord or its space planner,
architect, engineers and consultants, and notwithstanding any advice or assistance which may be rendered to Tenant by Landlord or Landlord&#146;s space planner, architect, engineers, and consultants, Landlord shall have no liability whatsoever in
connection therewith and shall not be responsible for any omissions or errors contained in<B> </B>the Construction Drawings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Space Plan</U>. Tenant shall supply Landlord for Landlord&#146;s review and approval
with four (4)&nbsp;copies signed by Tenant of its space plan for the Premises (the &#147;<B>Space Plan</B>&#148;) before any architectural working drawings or engineering drawings have been commenced. The Space Plan shall include a layout and
designation of all laboratory facilities, offices, rooms and other partitioning, their intended use, and equipment to be contained therein. Landlord may request clarification or more specific drawings for special use items not included in the Space
Plan. Landlord shall advise Tenant within five (5)&nbsp;business days after Landlord&#146;s receipt of the Space Plan (or, if applicable, such additional information reasonably requested by Landlord pursuant to the provisions of the immediately
preceding sentence) if the same is approved or is unsatisfactory or incomplete in any respect, and any disapproval of the Space Plan shall accompany Landlord&#146;s detailed reasons for such disapproval. Upon any disapproval by Landlord, Tenant
shall promptly cause the Space Plan to be revised to correct any deficiencies or other matters Landlord may reasonably require and deliver such revised Space Plan to Landlord. Landlord&#146;s failure to respond within five (5)&nbsp;business days
thereafter, if such failure continues following a second, three (3)&nbsp;business day notice, shall be deemed approval by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3
<U>Working Drawings</U>. After the Space Plan has been approved by Landlord, Tenant shall cause the Architect and the Engineers to promptly complete the architectural and engineering drawings, and Architect shall compile a fully coordinated set of
drawings, including but not limited to architectural, structural, mechanical, electrical, plumbing, fire sprinkler and life safety in a form which is complete to allow subcontractors to bid on the work and to obtain all applicable permits
(collectively, the &#147;<B>Working Drawings</B>&#148;) and shall submit the same to Landlord for Landlord&#146;s review and approval (such approved Working Drawings, &#147;<B>Approved Working Drawings</B>&#148;). Tenant shall supply Landlord with
four (4)&nbsp;copies signed by Tenant of the Working Drawings. Landlord shall advise Tenant within ten (10)&nbsp;business days after Landlord&#146;s receipt of the Working Drawings if Landlord, in good faith, determines that the same are approved or
are unsatisfactory or incomplete, and any disapproval of the Working Drawings shall accompany Landlord&#146;s detailed reasons for such disapproval. If Tenant is so advised. Tenant shall promptly revise the Working Drawings to correct any
deficiencies or other matters Landlord may reasonably require and deliver such revised Working Drawing to Landlord. Landlord&#146;s failure to respond within five (5)&nbsp;business days thereafter, if such failure continues following a second, three
(3)&nbsp;business day notice, shall be deemed approval by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <U>Landlord&#146;s Approval</U>. Tenant acknowledges that it
shall be deemed reasonable for Landlord to disapprove the Space Plan and any subsequent Working Drawings unless, at a minimum, the same are prepared on the basis that they will only utilize the appropriate
<FONT STYLE="white-space:nowrap">pro-rated</FONT> share of building systems capacity made available by Landlord for tenant usage in the building (including, but not limited to, the HVAC equipment, electrical power, fire sprinkler, emergency
electrical power), (b) the Tenant Improvements as specified and designed comply with the requirements of the Project&#146;s Sustainability Practices and the applicable Green Building Standards set forth in Exhibit
<FONT STYLE="white-space:nowrap">B-l</FONT> attached hereto, and (c)&nbsp;the sprinkler systems shall be designed in compliance with the specifications provided by FM Global. Additionally, Landlord&#146;s approval of any matter under this Workletter
may be withheld if Landlord reasonably determines that the same would violate any provision of the Lease or this Workletter or would adversely affect the mechanical, electrical, plumbing, heating, ventilating and air conditioning, life-safety or
other systems of the Building, the curtain wall of the Building, the structure or exterior appearance of the Building. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <U>Changes to the Working Drawings</U>. Any changes to the Approved Working Drawings
(each, a &#147;<B>Change</B>&#148;) shall be requested and instituted in accordance with the provisions of this Section&nbsp;2.5 and shall be subject to the written approval of the <FONT STYLE="white-space:nowrap">non-requesting</FONT> party in
accordance with this Workletter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Either Landlord or Tenant may request Changes after Landlord approves the Working Drawings by
notifying the other party thereof in writing in substantially the same form as the AIA standard change order form (a &#147;<B>Change Request</B>&#148;), which Change Request shall detail the nature and extent of any requested Changes, including
(i)&nbsp;the Change, and (ii)&nbsp;any modification of the Approved Working Drawings, as applicable, necessitated by the Change. If the nature of a Change requires revisions to the Approved Working Drawings, then Tenant shall be solely responsible
for the cost and expense of such revisions and any increases in the cost of the Tenant Improvements as a result of such Change. Change Requests shall be signed by the requesting party&#146;s representative. Landlord shall only request a Change if it
reasonably believes that such Change is necessary to comply with applicable Laws, to prevent a material adverse impact on the Building&#146;s systems or to address a material Building structural issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All Change Requests shall be subject to the other party&#146;s prior written approval, which approval shall not be unreasonably withheld,
conditioned or delayed. The <FONT STYLE="white-space:nowrap">non-requesting</FONT> party shall have three (3)&nbsp;business days after receipt of a Change Request to notify the requesting party in writing of the
<FONT STYLE="white-space:nowrap">non-requesting</FONT> party&#146;s decision either to approve or object to the Change Request. The <FONT STYLE="white-space:nowrap">non-requesting</FONT> party&#146;s failure to respond within such three
(3)&nbsp;business day period shall be deemed approval by the <FONT STYLE="white-space:nowrap">non-requesting</FONT> party. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SECTION 3
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>CONSTRUCTION OF THE TENANT IMPROVEMENTS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Tenant&#146;s Selection of Contractors.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>The Contractor</U>. Tenant will retain Dome Construction as a general contractor to construct the Tenant Improvements
(&#147;<B>Contractor</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Tenant&#146;s Agents</U>. A list of all subcontractors, laborers, materialmen, and suppliers used
by Tenant (such subcontractors, laborers, materialmen, and suppliers, and the Contractor to be known collectively as &#147;<B>Tenant&#146;s Agents</B>&#148;) must be provided to Landlord, provided that Landlord will require Tenant to retain the
Building Consultants. Tenant shall contract with Landlord&#146;s base building subcontractors for any mechanical, electrical, plumbing, life safety, structural or HVAC work in the Premises. All of Tenant&#146;s Agents shall be licensed in the State
of California, capable of being bonded and union-affiliated in compliance with all then existing master labor agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Construction of Tenant Improvements by Tenant&#146;s Agents.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Construction Contract</U>. Prior to Tenant&#146;s execution of the construction contract and general conditions with Contractor (the
&#147;<B>Contract</B>&#148;), Tenant shall submit the Contract to Landlord for its approval, which approval shall not be unreasonably withheld, conditioned or delayed. Landlord shall have three (3)&nbsp;business days upon receipt of the Contract to
either grant or deny its approval, and Landlord&#146;s failure to respond within such three (3)&nbsp;business day period shall be deemed approval by Landlord. Prior to the commencement of the construction of the Tenant Improvements, Tenant shall
provide Landlord with a schedule of values consisting of a detailed breakdown, by trade, of the final costs to be incurred or which have been incurred, for all Tenant Improvement Allowance Items in connection with the design and construction of the
Tenant Improvements, which costs form the basis for the amount of the Contract (&#147;<B>Final Costs</B>&#148;). Prior to the commencement of construction of the Tenant Improvements, Landlord and Tenant shall identify the amount equal to the
difference between the amount of the Final Costs and the amount of the Tenant Improvement Allowance (less any portion thereof already disbursed by Landlord, or in the process of being disbursed by Landlord, on or before the commencement of
construction of the Tenant Improvements), the &#147;<B>Over-Allowance Amount</B>&#148;, and Landlord will reimburse Tenant on a monthly basis, as described in Section&nbsp;1.2(b)(ii) above, for a percentage of each amount requested by the Contractor
or otherwise to be disbursed under this Workletter, which percentage shall be equal to the Tenant Improvement Allowance divided by the amount of the Final Costs (after deducting from the Final Costs any amounts expended in connection with the
preparation of the Construction Drawings, and the cost of all other Tenant Improvement Allowance Items incurred prior to the commencement of construction of the Tenant Improvements), and Tenant shall be solely responsible for any Over-Allowance
Amount. If, after the Final Costs have been initially determined, the costs relating to the design and construction of the Tenant Improvements shall change, any additional costs for such design and construction in excess of the Final Costs shall be
added to the Over-Allowance Amount and the Final Costs, and Landlord&#146;s reimbursement percentage, shall be recalculated in accordance with the terms of the immediately preceding sentence. Notwithstanding anything set forth herein to the
contrary, construction of the Tenant Improvements shall not commence until Tenant has procured and delivered to Landlord a copy of all permits necessary for commencement of construction of the Tenant Improvements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Construction Requirements.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Landlord&#146;s General Conditions for Tenant&#146;s Agents and Tenant Improvement Work</U>. Construction of the Tenant Improvements
shall comply with the following: (A)&nbsp;the Tenant Improvements shall be constructed in strict accordance with the Approved Working Drawings and Landlord&#146;s then-current published construction guidelines; (B)&nbsp;Tenant&#146;s Agents shall
submit schedules of all work relating to the Tenant Improvements to Landlord and Landlord shall, within five (5)&nbsp;business days of receipt thereof, inform Tenant&#146;s Agents of any changes which are necessary thereto, and Tenant&#146;s Agents
shall adhere to such corrected schedule; and (C)&nbsp;Tenant shall abide by all reasonable and <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> rules made and provided to Tenant in writing by Landlord&#146;s Building manager with respect
to the use of contractor parking, materials delivery, freight, loading dock and service elevators, any required shutdown of utilities (including life-safety systems), storage of materials, coordination of work with the contractors of Landlord, and
any other matter in connection with this Workletter, including, without limitation, the construction of the Tenant Improvements, provided that such rules shall not include additional charge for the use of freight, loading dock and service elevators
or storage of materials. Tenant shall pay an oversight and supervisory fee (the &#147;<B>Coordination Fee</B>&#148;) to Landlord in an amount equal to one percent (1.0%) of the Final Costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Indemnity</U>. Tenant&#146;s indemnity of Landlord as set forth in the Lease shall
also apply with respect to any and all costs, losses, damages, injuries and liabilities related in any way to any act or omission of Tenant or Tenant&#146;s Agents, or anyone directly or indirectly employed by any of them, or in connection with
Tenant&#146;s <FONT STYLE="white-space:nowrap">non-payment</FONT> of any amount arising out of the Tenant Improvements and/or Tenant&#146;s disapproval of all or any portion of any request for payment. Such indemnity by Tenant, as set forth in the
Lease, shall also apply with respect to any and all costs, losses, damages, injuries and liabilities related in any way to Landlord&#146;s performance of any ministerial acts reasonably necessary (A)&nbsp;to permit Tenant to complete the Tenant
Improvements, and (B)&nbsp;to enable Tenant to obtain any related building permit or certificate of occupancy; provided, however, nothing contained in this Workletter shall be deemed to indemnify Landlord from or against liability caused solely by
Landlord&#146;s negligence or willful misconduct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) <U>Requirements of Tenant&#146;s Agents</U>. Each of Tenant&#146;s Agents shall
guarantee to Tenant and for the benefit of Landlord that the portion of the Tenant Improvements for which it is responsible shall be free from any defects in workmanship and materials for a period of not less than one (1)&nbsp;year from the date of
completion thereof. Each of Tenant&#146;s Agents shall be responsible for the replacement or repair, without additional charge, of all work done or furnished in accordance with its contract that shall become defective within one (1)&nbsp;year after
the completion of the work performed by such contractor or subcontractor. The correction of such work shall include, without additional charge, all additional expenses and damages incurred in connection with the removal or replacement of all or any
part of the Tenant Improvements, and/or the Building and/or common areas that are damaged or disturbed thereby. All such warranties or guarantees as to materials or workmanship of or with respect to the Tenant Improvements shall be contained in the
Contract or subcontract and shall be written such that such guarantees or warranties shall inure to the benefit of both Landlord and Tenant, as their respective interests may appear, and can be directly enforced by either. Tenant covenants to give
to Landlord any assignment or other assurances as may be necessary to effect such right of direct enforcement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Insurance
Requirements</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>General Coverages</U>. All of Tenant&#146;s Agents shall cany employer&#146;s liability and worker&#146;s
compensation insurance covering all of their respective employees, and shall also carry commercial general liability insurance, including personal and bodily injury, property damage and completed operations liability, all with limits, in form and
with companies as are required to be carried by Tenant as set forth in the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Special Coverages</U>. Tenant or Contractor
shall carry &#147;Builder&#146;s All Risk&#148; insurance in an amount approved by Landlord covering the construction of the Tenant Improvements, and such other insurance as Landlord may require, it being understood and agreed that the Tenant
Improvements shall be insured by Tenant pursuant to the Lease immediately upon completion thereof. Such insurance shall be in amounts and shall include such extended coverage endorsements as may be reasonably required by Landlord, and shall be in
form and with companies as are required to be carried by Tenant as set forth in the Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) <U>General Terms</U>. Certificates for all of the foregoing insurance coverage shall
be delivered to Landlord before the commencement of construction of the Tenant Improvements and before the Contractor&#146;s equipment is moved onto the site. All such policies of insurance must contain a provision that the company writing said
policy will endeavor to give Landlord thirty (30)&nbsp;days&#146; prior written notice of any cancellation of such insurance. In the event that the Tenant Improvements are damaged by any cause during the course of the construction thereof, Tenant
shall immediately repair the same at Tenant&#146;s sole cost and expense. Tenant&#146;s Agents shall maintain all of the foregoing insurance coverage in force until the Tenant Improvements are fully completed and accepted by Landlord, except for any
Products and Completed Operations Coverage insurance required by Landlord, which is to be maintained for one (1)&nbsp;year following completion of the work and acceptance by Landlord and Tenant. All policies carried hereunder shall insure Landlord,
Wareham Property Group as Landlord&#146;s manager, and Tenant, as their interests may appear, as well as Tenant&#146;s Agents. All insurance, except Workers&#146; Compensation, maintained by Tenant&#146;s Agents shall preclude subrogation claims by
the insurer against anyone insured thereunder. Such insurance shall provide that it is primary insurance as respects Landlord and Tenant and that any other insurance maintained by Landlord or Tenant is excess and noncontributing with the insurance
required hereunder. The requirements for the foregoing insurance shall not derogate from the provisions for indemnification of Landlord by Tenant under the Lease and/or this Workletter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Governmental Compliance</U>. The Tenant Improvements shall comply in all respects with the following: (i)&nbsp;the Code and other
applicable federal, state, city and/or quasi- governmental laws, codes, ordinances and regulations, as each may apply according to the rulings of the controlling public official, agent or other person or entity; (ii)&nbsp;applicable standards of the
American Insurance Association (formerly, the National Board of Fire Underwriters) and the National Electrical Code; (iii)&nbsp;building material manufacturer&#146;s specifications, and (iv)&nbsp;the Project&#146;s Sustainability Practices and the
applicable Green Building Standards as set forth in Exhibit <FONT STYLE="white-space:nowrap">B-l.</FONT> Landlord Work shall comply with all respects with the following: (i)&nbsp;the Code and other applicable federal, state, city and/or
quasi-governmental laws, codes, ordinances and regulations, as each may apply according to the rulings of the controlling public official, agent or other person or entity; (ii)&nbsp;applicable standards of the American Insurance Association
(formerly, the National Board of Fire Underwriters) and the National Electrical Code; and (iii)&nbsp;building material manufacturer&#146;s specifications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Inspection by Landlord</U>. Landlord shall have the right to inspect the Tenant Improvements during normal business hours upon no less
than 48 hours&#146; advance notice, provided however, that Landlord&#146;s failure to inspect the Tenant Improvements shall in no event constitute a waiver of any of Landlord&#146;s rights hereunder nor shall Landlord&#146;s inspection of the Tenant
Improvements constitute Landlord&#146;s approval of the same. Should Landlord disapprove any portion of the Tenant Improvements, Landlord shall notify Tenant in writing of such disapproval and shall specify the items disapproved and the reasons
therefor. Any defects or deviations in, and/or disapproval by Landlord of, the Tenant Improvements shall be rectified by Tenant at no expense to Landlord, provided however, that in the event Landlord determines that a defect or deviation exists or
disapproves of any matter in connection with any portion of the Tenant Improvements and such defect, deviation or matter might adversely affect the mechanical, electrical, plumbing, heating, ventilating and air conditioning or life-safety systems of
the Building, the structure or exterior appearance of the Building or any other tenant&#146;s use of such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other tenant&#146;s leased premises, and Tenant fails to commence to remedy the same within thirty (30)&nbsp;days after Landlord&#146;s written notice thereof or Tenant fails to diligently
execute the same to completion, Landlord may take such action as Landlord deems necessary, at Tenant&#146;s expense and without incurring any liability on Landlord&#146;s part, to correct any such defect, deviation and/or matter, including, without
limitation, causing the cessation of performance of the construction of the Tenant Improvements until such time as the defect, deviation and/or matter is corrected to Landlord&#146;s reasonable satisfaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Meetings</U>. Tenant shall hold periodic meetings at a reasonable time with the Architect and the Contractor regarding the progress of
the preparation of the Construction Drawings and the construction of the Tenant Improvements, which meetings shall be held at the Premises (unless otherwise notified by Tenant to Landlord), and Landlord and/or its agents shall receive prior written
notice of, and shall have the right to attend, all such meetings. Upon Landlord&#146;s reasonable request, certain of Tenant&#146;s Agents shall attend such meetings. In addition, minutes shall be taken at all such meetings, and Landlord will be
included in the distribution list for such minutes. One such meeting each month shall include the review of Contractor&#146;s current request for payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Notice of Completion; Copy of Record Set of Plans</U>. Following completion of construction of the Tenant Improvements, Landlord shall
cause a Notice of Completion to be recorded in the office of the Recorder of Alameda County and shall furnish a copy thereof to Tenant. Within thirty (30)&nbsp;days following the completion of construction, (i)&nbsp;Tenant shall cause the Architect
and Contractor (A)&nbsp;to update the Approved Working Drawings as necessary to reflect all changes made to the Approved Working Drawings during the course of construction, (B)&nbsp;to certify to the best of their knowledge that the updated drawings
are true and correct, which certification shall survive the expiration or termination of the Lease, and (C)&nbsp;to deliver to Landlord such updated drawings in accordance with Landlord&#146;s then-current CAD Requirements within ninety
(90)&nbsp;days following issuance of a certificate of occupancy for the Premises, and (ii)&nbsp;Tenant shall deliver to Landlord a copy of all warranties, guaranties, and operating manuals and information relating to the improvements, equipment, and
systems in the Premises. Tenant&#146;s obligations set forth <B>in </B>this Section are collectively referred to as the &#147;<B>Completion Obligations</B>.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SECTION 4 </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>LANDLORD
WORK </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall deliver the Premises in &#147;warm shell&#148; condition and in conformance with the base building standards as
set forth on Exhibit <FONT STYLE="white-space:nowrap">B-2</FONT> hereto (the &#147;Landlord Work&#148;). The Landlord Work shall be performed in a good workmanlike manner and comply in all respects with the Code and other federal, state, city and/or
quasi-governmental laws, codes, ordinances and regulations, as each may apply according to the rulings of the controlling public official, agent or other person or entity; the applicable standards of the American Insurance Association (formerly, the
National Board of Fire Underwriters), and the National Electrical Code. Subject to the foregoing and the terms of the Lease, Tenant shall accept the Premises in its then existing, <FONT STYLE="white-space:nowrap">&#147;AS-IS&#148;</FONT> condition.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SECTION 5 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MISCELLANEOUS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1
<U>Tenant&#146;s Representative</U>. Tenant has designated Dave Johnson as its sole representative with respect to the matters set forth in this Workletter, until further notice to Landlord, who shall have full authority and responsibility to act on
behalf of Tenant as required in this Workletter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Landlord&#146;s Representative</U>. Landlord has designated Geoffrey Sears as its
sole representative with respect to the matters set forth in this Workletter, who, until further notice to Tenant, shall have full authority and responsibility to act on behalf of Landlord as required in this Workletter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Tenant&#146;s Default</U>, Notwithstanding any provision to the contrary contained in the Lease, if a Default by Tenant under the Lease
(including, without limitation, this Workletter) has occurred and is continuing at any time on or before the substantial completion of the Tenant Improvements, then in addition to all other rights and remedies granted to Landlord pursuant to the
Lease, Landlord shall have the right to withhold payment of all or any portion of the Tenant Improvement Allowance until such time as such Default is cured pursuant to the terms of the Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT <FONT STYLE="white-space:nowrap">B-1</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>APPLICABLE GREEN BUILDING STANDARDS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant shall cause the Architect, Engineers and General Contractor (the Tenant&#146;s &#147;Tl Project Team&#148;) to rate the proposed Tenant
Improvements on a &#147;LEED&#148; scorecard with a goal of achieving at least a &#147;Gold&#148; level as set forth by the USGBC, and shall provide that information, attested to by Tl Project Team as part of the Space Plan and Working Drawings
approval process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tenant agrees to direct the Architect and Engineers to design the Tenant improvements such that they meet the following
standards: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Under the LEED 2009 Core&nbsp;&amp; Shell Haling System, achieving certain credits is dependent open integrating the ci edit
requirements Into a binding tenant lease or sales agreement In these cases, the technical requirements mist be clearly Identified as part of the tenants&#146; scope, and enforced through the tenant lease agreement. The tot lowing sample text can be
referenced to that end. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>TENANT&#146;S WORK </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tenant agrees that Tenant&#146;s Work shall Include the following </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>SUSTAINABLE DESIGN </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Please
refer to the LECO Reference Guide for Green But ding Design and Construction 2009 lor detailed information on the specific credits and goals described below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>WATER EFFICIENCY </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>WEc3
- Water Use Reduction (reduce by 40%)</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tenant Installed plumbing fixtures must comply with the following applicable maximum fixture
flush and flowrates. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Water closet: 1.1 gpf </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Urinals: 0.125 gpf </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lavatory faucets 0.35 gpm </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kitchen faucets: 1.5 gpm </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Showerheads: 1.5 gpm </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>ENERGY&nbsp;&amp; ATMOSPHERE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>EAo3 - Fundamental Refrigerant Management and EAc4 &#150; Enhanced Refrigerant Management</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tenant Installed heating, ventilating, air conditioning and refrigeration (HVAC&amp;R) systems must contain two chlorofluorocarbon (CFO based
refrigerants and either eliminate IM use of chemical refrigerants or select refrigerants that minimize or eliminate the emission of compounds that contribute to atone depletion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Refer to LEED 2009 EAc4 Enhanced Refrigerant Management for details on calculating maximum thresholds lor refrigerant contributions to ozone
depletion and global warming potential. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U>EAcl &#150; Optimize Energy Performance</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tenant Installed regulated building energy consuming systems demonstrate a minimum 20% Improvement when measured by energy cost than a baseline
building determined according to Appendix G of ASHRAE Standard <FONT STYLE="white-space:nowrap">90.1-</FONT> 2007. Regulated energy includes lighting; HVAC; and service water heating for domestic or space heating purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Refer to LEED 2009 EAp2 Minimum Energy Performance and EAc1 Optimize Energy Performance for details on calculating baseline and proposed
building performance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>INDOOR ENVIRONMENTAL QUALITY </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U>IEQp2 &#150; Minimum Indoor Air Quality Performance &#150; Prerequisite</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Mechanical ventilation systems must be designed using the ventilation rate procedure as defined by AS HR At
<FONT STYLE="white-space:nowrap">62.1-</FONT> 2007, or the applicable local code, whichever is more stringent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U>IEQp2 &#150;
Environmental Tobacco smoke (ETS) Control &#150; Prerequisite</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Prohibit smoking inside the building and within 25 feet of all
building entrances, outdoor air intakes, and operable windows </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U>IEQcl - Outdoor Air Delivery Monitoring</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tenant installed ventilation systems must provide permanent monitoring system that monitor CO2 concentrations within all mechanically
ventilated densely occupied spaces and provide direct outdoor air flow measurement devices in air handling units where more then 20% of the design supply air flow serves <FONT STYLE="white-space:nowrap">non-densely</FONT> occupied spaces. All
naturally ventilated spaces must monitor CO2 concentrations and all CO2 monitors must be placed between 3 and 6 feet above the floor. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Refer to LEED 2009 lEQc1 Outdoor Air Delivery Monitoring for details on monitoring accuracy and integration into building automation system.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U>IEQc2 &#150; Increased Ventilation</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tenant installed ventilation systems must increase breathing zone outdoor air ventilation rates by at lent 30% above the minimum rates
prescribed by ASHRAE <FONT STYLE="white-space:nowrap">62.1-2007.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U>IEQc3.1 &#150; Construction Indoor Air Quality Management
Plan</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tenant construction must develop an Indoor Air Quality (IAQ) management plan that meets or exceeds the recommended control
measures of the Sheet Metal and Air Conditioning National Contractors Association (SMACNA) IAQ Guidelines for Occupied Buildings under Construction, 2nd edition, 2007, ANS l/S MACHA <FONT STYLE="white-space:nowrap">008-2008,</FONT> Chapter 3 In
addition, the plan should address </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Protection of absorptive materials stored <FONT STYLE="white-space:nowrap">on-site</FONT> and Installed Iran
moisture damage. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Permanently installed <FONT STYLE="white-space:nowrap">air-handling</FONT> equipment is not operated during
construction unless filtration media with a minimum efficiency reporting value (MERV) of 8 are installed at each return air grille and return. Immediately before occupancy, replace all Iteration media with the final design filtration media.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Refer to LEED 2009 IEQc3.l - Construction Indoor Air Quality Management Plan - During Construction for details on IAQ
plan requirements and reporting </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U><FONT STYLE="white-space:nowrap">IEQc4.l-4.4</FONT>
<FONT STYLE="white-space:nowrap">Low-Emitting</FONT> Materials</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">All adhesives and sealants used on the interior of the Tenant
construction must comply to the VOC limits established by the South Coast Air Quality Management District (SCAQMO) Rule #1168. All paints and coatings used must not exceed the VOC limits established by Green Seal Standard <FONT
STYLE="white-space:nowrap">GS-11,</FONT> Groen Seal Standard <FONT STYLE="white-space:nowrap">GC-03,</FONT> and SCAQMD Rule #1113. All installed flooring must meet the requirements of <U>IEQc4.3 <FONT STYLE="white-space:nowrap">Low-Emitting</FONT>
Materials - Flooring </U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
<U>Systems</U>. Carpet must meet the requirements of the Carpet and Rug Institute Green Label Plus program. Carpet adhesive must meet the requirements of <U>IEQc4.1</U> <FONT
STYLE="white-space:nowrap">Low-emitting</FONT><U> Materials-Adhesives and Sealants</U> Hard surface flooring must be FloorScore Standard certified. All flooring sealers, stains and finish must meet the SCAQMD Rule #1113 and tile setting adhesives
must meet Rule # 1168. All composite wood and agrifiber products used must comply with the <FONT STYLE="white-space:nowrap">no-</FONT> added urea formaldehyde requirements of 1EQC4.4 <FONT STYLE="white-space:nowrap">Low-Emitting</FONT> Mate<U>rials
Composite</U> and Agrifiber Products. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Refer to LEED 2009 IEQc4.1 to 4.4 <FONT STYLE="white-space:nowrap">Low-Emitting</FONT> Materials for
further details on VOC limits arid third-party certification requirements, </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U>IEPc5- Indoor chemical and pollutant source control</U>
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Sufficiently exhaust each space where hazardous gases or chemicals may be pre sent or used [e.g., garages, housekeeping and laundry
areas, copying end printing rooms] to create negative pressure with respect to adjacent spaces when the doors to the room are closed. For each of these spaces, provide self-closing doors end <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">deck-to-deck</FONT></FONT> partitions or a <FONT STYLE="white-space:nowrap">hard-lid</FONT> ceiling. The exhaust rate must be at least 0.50 cubic feet per minute (cfm) per square foot (0.15 cubic meters per minute per
square motor) with no air recirculation. The pressure differential with the surrounding spaces must be at least 5 Pascals (Pa) (0.02 Inches of water gauge) on average and 1 Pa (0.004 inches of water) at a minimum when the doors to the rooms are
closed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In mechanically ventilated buildings, each ventilation system that supplies outdoor air shall provide MERV 13 air filtration. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT <FONT STYLE="white-space:nowrap">B-2</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>LANDLORD WORK / WARM-SHELL DESCRIPTION </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>OCCUPANCY </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Tower designed to accommodate &#147;B&#148; and &#147;L&#148; occupancies. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>SITEWORK / PARKING </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Exterior hardscape and landscape including site lighting, curbs, sidewalks and drive aisles, miscellaneous site
furnishings and stormwater <FONT STYLE="white-space:nowrap">bio-filtration</FONT> system. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Hardscape and landscaping on podium rooftop (tower&#146;s base), accessible from tower. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Connection from podium roof terrace to pedestrian bridge. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Landlord-provided Generac emergency generator with enclosure for life-safety and tenant purpose <FONT
STYLE="white-space:nowrap">back-up</FONT> power (1600kW / 2000 kVA/60Hz). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Immediate connection to area commuter trains, buses and free EmeryGoRound shuttle. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ample visitor/transient parking in podium with tenant employee parking in adjacent 6100&nbsp;Horton St Garage
structure, including provisions for electric vehicle charging. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Outdoor bike racks and large indoor, secured bike storage. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Significant <FONT STYLE="white-space:nowrap">on-site</FONT> public art. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>STRUCTURE </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Structural slab on grade supported by auger piles, pile caps and grade beams. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Steel superstructure for podium and commercial tower above. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lateral system using moment frames and buckling-restrained brace frames (BRB&#146;s). Seismic importance of 1.0.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Floors of concrete slab on metal deck. Floor load of 100 lbs/SF, reducible. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Structural roof (100 lbs per SF, reducible), and central mechanical penthouse. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Floor-to-floor</FONT></FONT> height of
14&#146;10&#148; with top (9<SUP STYLE="font-size:75%; vertical-align:top">lh</SUP>) floor at 15&#146;0&#148;. Designed to allow robust lab MEP above a minimum finished ceiling height of 10&#146;0&#148;. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Floor vibration: 3<SUP STYLE="font-size:75%; vertical-align:top">rd</SUP> floor 14,000 micro-inches/second,
Floors <FONT STYLE="white-space:nowrap">4-9</FONT> 18,000 micro- inches/second. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>EXTERIOR SKIN </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Glass (curtainwall, storefront and ribbon window systems), metal panels and precast panels.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Head of ribbon windows at <FONT STYLE="white-space:nowrap">9&#146;-0&#148;</FONT> above finished floor, sills at <FONT
STYLE="white-space:nowrap">3&#146;-0.&#148;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Metal panels for penthouse and screened mechanical area. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Accessible private exterior terraces on Floors <FONT STYLE="white-space:nowrap">4-6.</FONT>
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>COMMON AREAS / FACILITIES </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Double-height ground floor lobby, complete with main greeting/security desk, and all interior finishes, FF&amp;E
and art. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ground floor main electrical room, and fire control room with main fire alarm panel. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Covered loading dock with roll-down door, <FONT STYLE="white-space:nowrap">at-grade</FONT> area for
shipping/receiving, and hydraulic scissor lift. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Trash room. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">750 GPM Patterson fire pump and 60,000 gallon fire water storage tank. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Telecom main point of entry (MPOE) room. At grade with pathway to stacked tower riser closets on every floor.
Open access to main telco providers (AT&amp;T, Comcast and Paxio Fiber). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">One service/freight elevator with capacity of 5,000 lbs. (sized to accommodate an 8 ft. chemical fume hood). This
elevator is accessible from loading dock and services all floors plus roof and penthouse. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Three destination dispatch passenger elevators serving the commercial tower with capacity of 3,500 lbs. Fourth
pit for potential future elevator. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Two exit stair towers completed including drywall enclosure finished and painted on interior, stair treads,
handrails, lighting, and stairway pressurization/smoke evacuation. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>FULL FLOOR TENANT AREAS: </U></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Central, fully finished men&#146;s and women&#146;s restrooms on each floor. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Janitor closet on every floor. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Electrical closet with access to main bus duct riser on every floor. Closets have been sized to allow some amount
of future tenant transformers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IDF riser closet on every floor. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Tenant and employee access to nearby shared campus conference facility and workout room. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Exterior cladding and framing ready for tenant insulation and drywall. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>MECHANICAL </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Floor heights and structural beam depths allow for 22&#148; duct height while still maintaining a 10&#146;0&#148;
finished ceiling, with higher ceilings possible. Indicative duct layout drawings can be shared upon request. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stand-alone split system serves the main lobby and ground floor back of house areas. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Completed vertical shafts sized to accommodate supply air mains, exhaust duct mains, and chilled and heating
water risers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">74&#148;x24&#148; supply air duct <FONT STYLE="white-space:nowrap">stub-out</FONT> at each shaft (typ. x3) per
floor </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">66&#148;x24&#148; general lab exhaust <FONT STYLE="white-space:nowrap">sub-duct</FONT> <FONT
STYLE="white-space:nowrap">stub-out</FONT> at each shaft (typ. x3) per floor </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4&#148; process condenser water <FONT STYLE="white-space:nowrap">stub-out</FONT> at each floor
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4&#148; heat hot water <FONT STYLE="white-space:nowrap">stub-out</FONT> at each floor </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Central equipment (air handlers, exhaust fans, chillers, boilers, pumps, cooling tower, and associated equipment)
designed to supply 100% outside air of 1.6 CFM per square foot of tenant area. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(3) 100,000 CFM GovernAir custom air handling units </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(4) 60,000 CFM Lorin Cook lab exhaust fans </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(2) 750 ton Trane water cooled chillers </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(1) 400 ton heat exchanger for process cooling </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(1) 1875 GPM B AC cool Ing tower </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(4) 5,600 MBH Aereo output boilers. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Central Building Management System (BMS) to control core HVAC, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">Pre-identified</FONT> future louver area on each floor allows for potential
additional <FONT STYLE="white-space:nowrap">on-floor</FONT> air handler for greater capacities, if necessary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">High-rise smoke evacuation system as required by code for base building shell. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Core restrooms on every floor served by dedicated bathroom exhaust riser with rooftop exhaust fan. <FONT
STYLE="white-space:nowrap">Transfer/make-up</FONT> air will be provided as part of Tenant Improvement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>ELECTRICAL </U></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">PG&amp;E transformer at 100kVA, 480Y/277V. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Transformer serves installed main switchboard rated at 4,000 amp, 480Y/277V. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3000 amp, 277/480V 3P, 4W bus duct runs from main electrical room up to penthouse and connecting all <FONT
STYLE="white-space:nowrap">on-floor</FONT> tenant electrical rooms. Tenants have their <FONT STYLE="white-space:nowrap">pro-rata</FONT> share of access to this electrical riser. Assuming a typical 60/40 lab to office mix for any tenant, this
electrical system allows for power and lighting at 5.2W/sq. ft. in office areas and of 6.2W/sq. ft. in lab areas. Please note that the Mechanical system electrical needs have been accommodated outside/on top of these amounts. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each tenant electrical room has a 200 amp 277/480V panel, a 45 kVA step down transformer, and a 100 amp 120/2087
panel. If Tenants&#146; electrical allowance (above) permits, they can add taps to the 480V bus duct to access more power. The electrical room on each floor has been sized to allow for the siting of transformers(s) tenants will likely employ.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Landlord-provided 1.5 MW 60Hz 480V diesel standby emergency generator at grade at building exterior. Generator is
sized for 2400A. Two Automatic Transfer Switches (ATS) divide life safety loads from tenant discretionary loads. 800A is allocated for life safety purposes and 1600 A for tenant discretionary loads. Off this riser each floor has a 200A emergency
panel (rated 277/480V, <FONT STYLE="white-space:nowrap">3-phase,</FONT> 4 wire) to which tenants have their <FONT STYLE="white-space:nowrap">pro-rata</FONT> access. There is an 800A emergency panel on the roof. 400A was used to support certain AHU
and EF HVAC equipment, and the 400A balance is available for future loads. The opportunity to serve greater tenant loads would be through separate standby power equipment on ground floor. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>PLUMBING: </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Building storm and overflow drainage system, including <FONT STYLE="white-space:nowrap">bio-retention</FONT>
system to biologically treat/filter all site-generated storm water. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Backflow prevention device at main water entry point. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Cold and hot water provided to all restrooms in core and shell, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Two 2&#148; Cold water stub outs on every floor. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4&#148; Waste and 3&#148; vent stub on every floor, located at risers in each quadrant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Tenant domestic hot water to be via electric hot water heaters as part of Tenant Improvements,
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Natural gas riser to serve core and shell domestic hot water needs and building penthouse HVAC heat boilers.
Tenant natural gas available at each floor with <FONT STYLE="white-space:nowrap">1-1/4&#148;</FONT> <FONT STYLE="white-space:nowrap">stub-out</FONT> at 2psi. Tenant to provide pressure reducing valves and
<FONT STYLE="white-space:nowrap">sub-meters.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">No provisions for acid waste. Neutralization, if and as required, to be performed by tenants in tenant spaces.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>FIRE/LIFE SAFETY: </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Existing <FONT STYLE="white-space:nowrap">2-hour</FONT> separation between floors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Base building sprinkler system with shell configuration heads on every floor as part of base building.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Fire pump with 60,000 gallon emergency fire water tank at ground floor. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Main fire alarm closet with main fire alarm panel at ground level (Notifier by Honeywell). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Code fire alarm devices for core areas at every floor, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">2-hour</FONT> fire rating at north facade met with addition of tenant-supplied
interior drywall. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>SECURITY / TELECOM: </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Main MPOE room at grade, with central risers up commercial tower connecting tenant IDF rooms on every floor.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Card access at all exterior points of entry and at parking garage. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Manned security station in main lobby with 24/7 manned campus security. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT <FONT STYLE="white-space:nowrap">C-l</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>LABORATORY RULES AND REGULATIONS </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any laboratory equipment (glass and cage washers, sterilizers, centrifuges, etc,) being used during normal
business hours must be properly insulated for noise to prevent interruption of other tenants&#146; business. Landlord reserves the right to request all equipment be reasonably insulated prior to occupancy. Should other tenants complain of noise.
Tenant will be responsible for abating any noise issues, at Tenant&#146;s sole cost. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any damages to property due to leaks from laboratory equipment of Tenant will be the sole responsibility of
Tenant, Should damage occur in other tenant spaces, any and all damages and <FONT STYLE="white-space:nowrap">clean-up</FONT> will be the responsibility of Tenant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Animal activities are a recognized and necessary process in the biotech industry. It can only be conducted by
laboratory tenants pursuant to all the requirements of their respective lease (including any &#147;Use&#148; clause) and requires specific, written approval by Landlord in advance, which shall not be unreasonably withheld, conditioned or delayed.
Any animal operations shall be conducted pursuant to all regulations, standards and best industry practices relating to them. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Project may be a <FONT STYLE="white-space:nowrap">mixed-use</FONT> facility in which laboratory tenants
share space with office tenants. To reduce the potential interaction with office tenants and their employees and visitors with any biotech animal operations, any animal testing, delivery and removal of animals and/or any equipment, foods, cleaners,
etc. associated with animal activities must be coordinated through the loading dock and freight elevator after hours and with the cooperation and approval of building management and security personnel. No cartons, containers or cardboard boxes
bearing the nature of contents may be stored or left in common area spaces, to include any garage/freight areas. Feed bags, animal carriers, and any and all containers must be disposed of properly and with discretion. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All exterior signage relating to laboratory operations (i.e. visible to common areas including corridors) must
be kept to the minimum required by law. All signs must have Landlord&#146;s approval prior to installation. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT <FONT STYLE="white-space:nowrap">C-2</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RULES AND REGULATIONS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
No sidewalks, entrance, passages, courts, elevators, vestibules, stairways, corridors or halls shall be obstructed or encumbered by Tenant or used for any purpose other than ingress and egress to and from the Premises and if the Premises are
situated on the ground floor of the Project, Tenant shall further, at Tenant&#146;s own expense, keep the sidewalks and curb directly in front of the Premises clean and free from rubbish. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. No awning or other projection shall be attached to the outside walls or windows of the Project without the prior written consent of
Landlord. No curtains, blinds, shades, drapes or screens shall be attached to or hung in, or used in connection with any window or door of the Premises, without the prior written consent of Landlord which shall not be unreasonably withheld,
conditioned or delayed. Such awnings, projections, curtains, blinds, shades, drapes, screens and other fixtures must be of a quality, type, design, color, material and general appearance approved by Landlord, and shall be attached in the manner
reasonably approved by Landlord. All lighting fixtures hung in offices or spaces which can be seen from the outside the Premises must be of a quality, type, design, bulb color, size and general appearance reasonably approved by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. No sign, advertisement, notice, lettering, decoration or other thing shall be exhibited, inscribed, painted or affixed by Tenant on any
part of the outside of the Premises or of the Project, without the prior written consent of Landlord. In the event of the violation of the foregoing by Tenant, Landlord may remove same without any liability, and may charge the expense incurred by
such removal to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The sashes, sash doors, skylights, windows and doors that reflect or admit light or air into the halls,
passageways or other public places in the Project shall not be covered or obstructed by Tenant, nor shall any bottles, parcels or other articles be placed on the window sills that can be seem from the outside of the Premises or in the public
portions of the Project. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. No showcases or other articles shall be put in front of or affixed to any part of the exterior of the
Project, nor placed in public portions thereof without the prior written consent of Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. The water and wash closets and other
plumbing fixtures shall not be used for any purposes other than those for which they were constructed, and no sweepings, rubbish, rags or other substances shall be thrown therein. All damages resulting from any misuse of the fixtures shall be borne
by Tenant to the extent that Tenant or Tenant&#146;s agents, servants, employees, contractors, visitors or licensees shall have caused the same. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. Tenant shall not mark, paint, drill into or in any way deface any part of the Premises or the Project other than Decoration which is
permitted under the Lease. No boring, cutting or stringing of wires belonging to Landlord shall be permitted, except with the prior written consent of Landlord, and as Landlord may direct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. No animal or bird of any kind shall be brought into or kept in or about the Premises or the Project, except registered service animals.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. Tenant shall cooperate with Landlord&#146;s efforts to implement the Project&#146;s
Sustainability Practices and the applicable Green Building Standards, including, but not limited to, complying with Landlord&#146;s then-current energy saving efforts and participating in any recycling programs and occupant satisfaction and
transportation surveys. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. Tenant shall not make, or permit to be made, any unseemly or unreasonably disturbing noises or disturb or
unreasonably interfere with occupants of the Project, or neighboring buildings or premises, or those having business with them. Tenant shall not throw anything out of the doors, windows or skylights or down the passageways. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. Tenant shall regularly conduct cleaning and janitorial activities, especially in bathrooms, kitchens and janitorial spaces, to remove
mildew and prevent moist conditions and shall comply with the Project&#146;s Sustainability Practices and the applicable Green Building Standards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. No additional locks, bolts or mail slots of any kind shall be placed upon any of the doors or windows by Tenant, nor shall any change be
made in existing locks or the mechanism thereof. Tenant must, upon the termination of the tenancy, restore to Landlord all keys of stores, offices and toilet rooms, either furnished to, or otherwise procured by Tenant, and in the event of the loss
of any keys so furnished. Tenant shall pay to Landlord the cost thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. All removals, or the carrying in or out of any safes,
freight, furniture, construction material, bulky matter or heavy equipment of any description must take place during the hours which Landlord or its agent may reasonably determine from time to time. Landlord reserves the right to prescribe the
weight and position of all safes, which must be placed upon <FONT STYLE="white-space:nowrap">two-inch</FONT> thick plank strips to distribute the weight. The moving of safes, freight, furniture, fixtures, bulky matter or heavy equipment of any kind
must be made upon previous notice to the Building Manager and in a manner and at times prescribed by him, and the persons employed by Tenant for such work are subject to Landlord&#146;s prior approval. Landlord reserves the right to inspect all
safes, freight or other bulky articles to be brought into the Project and to exclude from the Project all safes, freight or other bulky articles which violate any of these Rules and Regulations or the Lease of which these Rules and Regulations are a
part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. Tenant shall not purchase janitorial or maintenance or other like service from any company or persons not approved by Landlord.
Landlord shall approve a sufficient number of sources of such services to provide Tenant with a reasonable selection, but only in such instances and to such extent as Landlord in its judgment shall consider consistent with security and proper
operation of the Project. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. Landlord shall have the right to prohibit any advertising conducted by Tenant referring to the Project
which, in Landlord&#146;s reasonable opinion, tends to impair the reputation of the Project or its desirability as a first class building for offices and/or commercial services and upon notice from Landlord, Tenant shall refrain from or discontinue
such advertising. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. Landlord reserves the right to exclude from the Project between the hours of 6:00&nbsp;p.m. and 8:00 a.m. Monday
through Friday, after 1:00 p.m. on Saturdays and at all hours Sundays and legal holidays, all persons who do not present a pass to the Project issued by Landlord. Landlord may furnish passes to Tenant so that Tenant may validate and issue same.
Tenant shall safeguard said passes and shall be responsible for all acts of persons in or about the Project who possess a pass issued to Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. Tenant&#146;s vendors and contractors shall, while in the Premises or elsewhere in the
Project, be subject to and under the control and direction of the Building Manager (but not as agent or servant of said Building Manager or of Landlord) and shall be required to maintain such insurance coverage as reasonably approved by Landlord
with liability policies naming Landlord and the Indemnitees as additional insureds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. If the Premises is or becomes infested with
vermin as a result of the use or any misuse or neglect of the Premises by Tenant, its agents, servants, employees, contractors, visitors or licensees, Tenant shall forthwith at Tenant&#146;s expense cause the same to be exterminated from time to
time to the satisfaction of Landlord and shall employ such licensed exterminators as shall be approved in writing in advance by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. The requirements of Tenant will be attended to only upon application at the office of the Project. Project personnel shall not perform any
work or do anything outside of their regular duties unless under special instructions from the office of the Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. Canvassing,
soliciting and peddling in the Project are prohibited and Tenant shall cooperate to prevent the same. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. No water cooler, air
conditioning unit or system or other apparatus shall be installed or used by Tenant without the written consent of Landlord which shall not be unreasonably withheld, conditioned or delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. There shall not be used in any premises, or in the public halls, plaza areas, lobbies, or elsewhere in the Project, either by Tenant or by
jobbers or others, in the delivery or receipt of merchandise, any hand trucks or dollies, except those equipped with rubber tires and sideguards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. Tenant, Tenant&#146;s agents, servants, employees, contractors, licensees, or visitors shall not park any vehicles in any driveways,
service entrances, or areas posted &#147;No Parking&#148; and shall comply with any other parking restrictions imposed by Landlord from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. Tenant shall install and maintain, at Tenant&#146;s sole cost and expense, an adequate visibly marked (at all times properly operational)
fire extinguisher next to any duplicating or photocopying machine or similar heat producing equipment, which may or may not contain combustible material, in the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. Tenant shall make reasonable efforts to close the window coverings of any areas of the Premises that remain fully lighted after 10:00 pm.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. Tenant shall not use the name of the Project for any purpose other than as the address of the business to be conducted by Tenant in
the Premises, nor shall Tenant use any picture of the Project in its advertising, stationery or in any other manner without the prior written permission of Landlord. Landlord expressly reserves the right at any time to change said name without in
any manner being liable to Tenant therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27. Tenant shall not conduct any restaurant, catering operations, or similar activities at
the Premises; provided, however. Tenant may cook and/or prepare food and beverage solely for <FONT STYLE="white-space:nowrap">in-Premises</FONT> consumption by its employees provided that no odors of cooking or other processes emanate from the
Premises. Tenant shall not install or permit the installation or use of any vending machine or permit the delivery of any food or beverage to the Premises except by such persons and in such manner as are approved in advance in writing by Landlord.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">28. The Premises shall not be used as an employment agency, a public stenographer or typist, a labor union office, a physician&#146;s or
dentist&#146;s office, a dance or music studio, a school, a beauty salon, or barber shop, the business of photographic, multilith or multigraph reproductions or offset printing (not precluding using any part of the Premises for photographic,
multilith or multigraph reproductions solely in connection with Tenant&#146;s own business and/or activities), a restaurant or bar, an establishment for the sale of confectionery, soda, beverages, sandwiches, ice cream or baked goods, an
establishment for preparing, dispensing or consumption of food or beverages of any kind in any manner whatsoever, or news or cigar stand, or a radio, television or recording studio, theatre or exhibition hall, or manufacturing, or the storage or
sale of merchandise, goods, services or property of any kind at wholesale, retail or auction, or for lodging, sleeping or for any immoral purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29. Business machines and mechanical equipment shall be placed and maintained by Tenant at Tenant&#146;s expense in settings sufficient in
Landlord&#146;s judgment to absorb and prevent vibration, noise and annoyance. Tenant shall not install any machine or equipment which causes noise, heat, cold or vibration to be transmitted to the structure of the building in which the Premises are
located without Landlord&#146;s prior written consent, which consent may be conditioned on such terms as Landlord may require. Tenant shall not place a load upon any floor of the Premises exceeding the floor load per square foot that such floor was
designed to carry and which is allowed by Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30. Tenant shall not store any vehicle within the parking area. Tenant&#146;s parking
rights are limited to the use of parking spaces for short-term parking, of up to twenty-four (24)&nbsp;hours, of vehicles utilized in the normal and regular daily travel to and from the Project. Tenants who wish to park a vehicle for longer than a <FONT
STYLE="white-space:nowrap">24-hour</FONT> period shall notify the Building Manager for the Project and consent to such long-term parking may be granted for periods up to two (2)&nbsp;weeks. Any motor vehicles parked without the prior written consent
of the Building Manager for the Project for longer than a <FONT STYLE="white-space:nowrap">24-hour</FONT> period shall be deemed stored in violation of this rule and regulation and shall be towed away and stored at the owner&#146;s expense or
disposed of as provided by Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">31. Smoking is prohibited in the Premises, the Building and all enclosed Common Areas of the Project,
including all lobbies, all hallways, all elevators and all lavatories. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RIDER 1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RENT COMMENCEMENT DATE AGREEMENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emery Station West, LLC, a California limited liability company (&#147;<B>Landlord</B>&#148;), and ___________ a ____________ corporation
(&#147;<B>Tenant</B>&#148;), have entered into a certain Office/Laboratory Lease dated as of ____________ 2018 (the &#147;Lease&#148;). Unless otherwise defined herein, all capitalized terms shall have the same meaning ascribed to them in the Lease.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Landlord and Tenant wish to confirm and memorialize the Rent Commencement Date and Expiration Date of the Lease as provided for
in Section&nbsp;2.2(b) of the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the mutual covenants contained herein and in
the Lease, Landlord and Tenant agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The Rent Commencement Date is acknowledged to be ________________. The Expiration
Date is acknowledged to be ________________. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Tenant hereby confirms that it has accepted possession of the Premises pursuant to the
terms of the Lease and that the Lease is in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Except as expressly modified hereby, all terms and provisions of
the Lease are hereby ratified and confirmed and shall remain in full force and effect and binding on the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The Lease and
this Rent Commencement Date Agreement contain all of the terms, covenants, conditions and agreements between the Landlord and the Tenant relating to the subject matter herein. No prior other agreements or understandings pertaining to such matters
are valid or of any force and effect. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">TENANT:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">LANDLORD:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Emery Station West, LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">a <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U>corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">a California limited liability company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">By:&#8194;ES West Associates, LLC</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">a California limited liability company,</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">its Managing Member</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">By:&#8194;Wareham-NZL,</FONT> LLC</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">a California limited liability company,</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">its Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">By:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#8195;&#8194;&#8201;Richard K. Robbins</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">&#8195;&#8194;&#8201;Manager</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Rider 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE 1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SUPERIOR RIGHTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The rights of Stanford Health
Care. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE 2 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SPECIAL SUPERIOR RIGHTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The rights of Stanford
Health Care. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SUBLEASE COMMENCEMENT MEMORANDUM </U></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U>, 2022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zymergen Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 Horton Street, Suite 105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Chief Legal Officer </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sublease Commencement Memorandum (this &#147;<B>Memorandum</B>&#148;) with respect to that certain Sublease
dated as of , 2022 (&#147;<B>Sublease</B>&#148;), by and between ZYMERGEN INC., a Delaware corporation (&#147;<B>Sublandlord</B>&#148;), and Metagenomi, Inc., a Delaware Corporation (&#147;<B>Subtenant</B>&#148;), relating to approximately 75,662
rentable square feet of space within the building located at 5959 Horton Street, Emeryville, California. Capitalized terms not defined herein shall have the meanings set forth in the Sublease. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms and conditions of the Sublease, Sublandlord and Subtenant hereby execute this Memorandum to confirm the
Commencement Date, the Expiration Date and other matters under the Sublease as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Commencement Date is <U></U>, 20__ </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Expiration Date is <U></U>, 20__ </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The schedule of Base Rent set forth in the Sublease is deleted in its entirety, and the following is
substituted therefor: </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<B>Insert revised base rent schedule.</B>] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>.] </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT C </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Memorandum to be executed as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>SUBLANDLORD</B>:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>SUBTENANT</B>:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ZYMERGEN INC</B>.,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>METAGENOMI, INC</B>.,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8201;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8201;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;</U></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT C </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>6TH FLOOR ZYMERGEN FF&amp;E </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>TOTAL&nbsp;NUMBER</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Asset CategoTask</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Furniture Tag</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Asset Tag</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Table</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">262 <FONT STYLE="white-space:nowrap">TA-57</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3052</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Training Table, GOW x 24D x 29H, <FONT STYLE="white-space:nowrap">Y-Leg,</FONT> Casters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Table</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">265 <FONT STYLE="white-space:nowrap">TA-59</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3071</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Sage Coffee Table, 32.5Wx 15H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chair</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">211 <FONT STYLE="white-space:nowrap">CH-04</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2992</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lily Lounge Chair, 27x27x34</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bench</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">212 <FONT STYLE="white-space:nowrap">BE-04</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2997</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Together; Bench, Right corner with back, 11/2 offset</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Stool</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">214 <FONT STYLE="white-space:nowrap">ST-14</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2998</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Naughtone, Polly Barstool with <FONT STYLE="white-space:nowrap">4-Leg</FONT> Base, 22.5W x 21D x 43.5H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Table</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">215 <FONT STYLE="white-space:nowrap">T-60</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3074</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Flex; Work table. Standing height, 70W x 23D x 41.5H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bench</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">216 <FONT STYLE="white-space:nowrap">BE-06</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3072</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">B-Free;</FONT> Beam, Aluminum, 1200MML, 47W x 15D x 28H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tethered Sp</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">185 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">T-SPE-04</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2920</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Steelcase Ology, <FONT STYLE="white-space:nowrap">6-Pack,</FONT> No Gallery Panel, Boundary Screen, 58W x 230 Surfaces</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tethered Sp</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">185 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">T-SPE-03</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2921</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Steelcase Ology, <FONT STYLE="white-space:nowrap">8-Pack,</FONT> No Gallery Panel, Boundary Screen, 58W x 230 Surfaces</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tethered Sp</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">187 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">T-SPE-03</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2923</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Steelcase Ology, <FONT STYLE="white-space:nowrap">7-Pack,</FONT> No Gallery Panel, Boundary Screen, 58W x 23D Surfaces</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chair</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">263 <FONT STYLE="white-space:nowrap">CH-05</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3063</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Dot Side Chair, 18W x 200 x 31H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Table</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">201 <FONT STYLE="white-space:nowrap">TA-55</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2949</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lagunitas Square Table, <FONT STYLE="white-space:nowrap">1-1/4</FONT> x 36W x 360 x 26H, Rounded Square Table, Disc Base, Square Column</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lounge Cha</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">205 <FONT STYLE="white-space:nowrap">CH-47</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2957</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hem, Hai Chair, 34.20 x 34.6W x 39 4H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Table</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">207 <FONT STYLE="white-space:nowrap">TA-56</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2963</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Finn Side Table, 11_7W x 23 5D &laquo; 18H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">165</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Mobile Ped</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">180 <FONT STYLE="white-space:nowrap">MP-02</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2541</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">S-Series</FONT> Mobile Pedestal w/Top, Box/File, 15W x 23D x 21H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">33</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Conference</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">181 <FONT STYLE="white-space:nowrap">CH-45</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2697</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Wit Mid Back Task Chair w/ Adjustable Lumbar, Swivel Tilt, Fixed, Mesh, Grade 1, Carpet Casters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Conference</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">182 <FONT STYLE="white-space:nowrap">CT-21</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2754</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">HPL Trapezoid Shaped Conference Table, 78W x 480 x 360 x 29H, Fawn Cypress, Looped Leg, Silver Powdercoat Finish</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">155</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Task Chair</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">183 <FONT STYLE="white-space:nowrap">CH-22</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2763</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">AmiaTask Chair, <FONT STYLE="white-space:nowrap">3-0</FONT> Knit Back, Height/Width/Pivot/Depth Adjustable arms</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tethered Sp</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">193 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">T-SPE-09</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2929</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Steekcase, Ology <FONT STYLE="white-space:nowrap">S-Pack,</FONT> (1) 66W x 48H Gallery Panel, Boundary Screen, S8W x 23D Surface</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT D </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Phone Boo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">202 <FONT STYLE="white-space:nowrap">PH-01</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2952</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Comfort Booth, 84.5&#148; H x 45.5* W x 41* D, Double Pane Insulated Glass Door, Two Electrical Outlets, Fast Charging USB Outlets</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Stool</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">203 <FONT STYLE="white-space:nowrap">ST-13</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2953</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Donatello Bar Stool, 15W x 16D x 31H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Table</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">204 <FONT STYLE="white-space:nowrap">TA-65</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2955</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Round Side Table, 22W x 18H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Table</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">210 <FONT STYLE="white-space:nowrap">TA-56</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2987</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Finn Side Table, 11.7W x 23 5D x 18H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chair</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">211 <FONT STYLE="white-space:nowrap">CH-04</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF2994</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lily Lounge Chair, 27x27x34</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bench</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">213 <FONT STYLE="white-space:nowrap">BE-05</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3070</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Coalesse, Together, Bench-Straight, Back, 11/2 offset, 96W x 27D x 31H</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lockers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">217 <FONT STYLE="white-space:nowrap">LK-19</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3108</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">HPL Lockers, 129W x 36D x 44.5H, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L5959-601-628</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">27</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Conference</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">261 <FONT STYLE="white-space:nowrap">CH-02</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3030</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Wit Mid Back Task Chair w/Adjustable Lumbar, Swivel Tilt, Fixed, Mesh, Grade 1, Carpet Casters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tethered SpTBD</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">T-SPE-09</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">TBD</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Steelcase, Ology <FONT STYLE="white-space:nowrap">5-Pack,</FONT> (1) 66W x 48H Gallery Panel, Boundary Screen, 58W x 23D Surface</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Task Chair</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">CH-22</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OF3O82</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">AmiaTask Chair, <FONT STYLE="white-space:nowrap">3-D</FONT> Knit Back, Height/Width/Pivot/Depth Adjustable arms</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT D </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ENVIRONMENTAL QUESTIONNAIRE FORM </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of this form is to obtain information regarding the use of &#147;Hazardous Materials&#148; (as such term is defined in the Master
Lease, as incorporated into the Sublease) in the Subleased Premises. Prospective subtenants and contractors should answer the questions in light of their proposed activities on the Subleased Premises. Existing subtenants and contractors should
answer the questions as they relate to ongoing activities on the Subleased Premises and should update any information previously submitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If additional space is needed to answer the questions, you may attach separate sheets of paper to this form. When completed, the form should
be sent to the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Zymergen Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">5980 Horton Street, Suite 105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn:
Director, Global Facilities, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Real Estate, and Capital Projects </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>GENERAL INFORMATION</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Name of Responding Company: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Check all that apply:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subtenant</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Contractor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prospective</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Existing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Mailing
Address:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U>
</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Contact person&nbsp;&amp;
Title:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Telephone Number: ( )&#8201;<U>&#8195;</U><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>Current Subtenant(s):</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Address of Subleased
Premises:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;<U><I>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</I></U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Length of Sublease or Contract
Term:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Prospe<U>ctive Subtenant(s)</U><U>:</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Address of Subleased
Premises:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Address of Current
Operations:&#8201;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;&#8195;</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Describe the proposed operations to take place on the property, including principal products manufactured or services to be conducted. Existing
Subtenants and contractors should describe any proposed changes to ongoing operations. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>HAZARDOUS MATERIALS</U>. For the purposes of
this Environmental Questionnaire Form, the term &#147;Hazardous Materials&#148; includes any raw material, product or agent considered hazardous under any state or federal law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.1 Will any Hazardous Materials be used or stored on site? </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chemical Products</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">Yes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Biological Hazards/</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">Yes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Infectious Wastes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">Yes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Radioactive Materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">Yes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Petroleum Products</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">Yes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">&#9744;</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.2 List any Hazardous Materials to be used or stored, the quantities that will be
<FONT STYLE="white-space:nowrap">on-site</FONT> at any given time, and the location and method of storage (e.g., bottles in storage closet on the premises). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Hazardous Materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Location and Method of Storage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Quantity</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.3 Is any underground storage of Hazardous Materials proposed or currently conducted on the Subleased Premises?
Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If yes, describe the materials to be stored, and the size and construction of the tank. Attach
copies of any permits obtained for the underground storage of such substances. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>HAZARDOUS WASTE</U>. For the purposes of this Environmental Questionnaire Form, the term
&#147;hazardous waste&#148; means any waste (including biological, infectious or radioactive waste) considered hazardous under any state or federal law, and which is intended to be discarded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.1 List any hazardous waste generated or to be generated on the premises, and indicate the quantity generated on a monthly basis. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Hazardous Materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Location and Method of Storage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Quantity</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.2 Describe the method(s) of disposal (including recycling) for each waste. Indicate where and how often disposal will take
place. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Hazardous Materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Location and Method of Storage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Quantity</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.3 Is any treatment or processing of hazardous, infectious or radioactive wastes currently conducted or proposed to be
conducted on the Subleased Premises? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If yes, please describe any existing or proposed treatment methods. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.4 Attach copies of any hazardous waste permits or licenses issued to your company with respect to its operations on the Subleased Premises. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>SPILLS</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.1 During the past year, have any spills or
releases of Hazardous Materials occurred on the Subleased Premises? Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If so, please describe the
spill and attach the results of any testing conducted to determine the extent of such spills. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.2 Were any agencies notified in connection with such spills? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If so, attach copies of any spill reports or other correspondence with regulatory agencies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.3 Were any <FONT STYLE="white-space:nowrap">clean-up</FONT> actions undertaken in connection with the spills? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If so, briefly describe the actions taken. Attach copies of any clearance letters obtained from any regulatory agencies involved and the
results of any final soil or groundwater sampling done upon completion of the <FONT STYLE="white-space:nowrap">clean-up</FONT> work. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>WASTEWATER
TREATMENT/DISCHARGE</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.1 Do you discharge industrial wastewater to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U></U><U>&#8195;&#8195;&#8195;</U>storm drain? <U></U><U>&#8195;&#8195;&#8195;&#8195;</U>Sewer? </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U></U><U>&#8195;&#8195;&#8195;</U>surface water? <U></U><U>&#8195;&#8195;&#8195;</U>no industrial discharge </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.2 Is your industrial wastewater treated before discharge? Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If yes, describe the type of treatment conducted. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.3 Attach copies of any wastewater discharge permits issued to your company with respect to its operations on the Subleased Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U>AIR DISCHARGES</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.1 Do you have any air filtration
systems or stacks that discharge into the air? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.2 Do you operate any equipment that requires air emissions permits? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.3
Attach copies of any air emission permits pertaining to these operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <U>HAZARDOUS SUBSTANCES DISCLOSURES</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.1 Does your company handle an aggregate of at least 500 pounds, 55 gallons or 200 cubic feet of Hazardous Materials at any given
time?&#8195;Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.2 Has your company prepared a Hazardous Materials Disclosure &#150; Chemical Inventory and
Business Emergency Plan or similar disclosure document pursuant to state or county requirements? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes&#8194;&#9744;&#8195;No&#8194;&#9744;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If so, attach a copy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.3 Are any of the
chemicals used in your operations regulated under Proposition 65? </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If so, describe the procedures followed to comply with these
requirements. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.4 Is your company subject to OSHA Hazard
Communication Standard Requirements? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If so, describe the procedures followed to comply with these requirements. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <U>ANIMAL TESTING</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.1 Does your company bring or intend to bring live animals onto the Subleased Premises for research or development
purposes?&#8195;Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If so, describe the activity. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.2 Does your company bring or intend to bring animal
body parts or bodily fluids onto the Subleased Premises for research or development purposes?&#8195;Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If so, describe the activity. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. <U>ENFORCEMENT ACTIONS, COMPLAINTS</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.1 Has your company ever been subject to any agency enforcement actions, administrative orders, lawsuits, or consent orders/decrees regarding environmental
compliance or health and safety?&#8195;Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If so, describe the actions and any continuing
obligations imposed as a result of these actions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.2 Has your company ever received any request for information, notice of violation or demand letter,
complaint, or inquiry regarding environmental compliance or health and safety? </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.3 Has an environmental audit ever been conducted which concerned operations or activities on premises occupied by
you?&#8195;Yes&#8194;&#9744;&#8195;No&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.4 If you answered &#147;yes&#148; to any questions in this section, describe the environmental
action or complaint and any continuing compliance obligation imposed as a result of the same. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned hereby acknowledges and agrees that
this Environmental Questionnaire Form will be updated from time to time in accordance with Section&nbsp;7.1(g) of the Original Master Lease, as incorporated into the Sublease. The undersigned further acknowledges and agrees that Sublandlord and its
partners, lenders and representatives may, and will, rely upon the statements, representations, warranties, and certifications made herein and the truthfulness thereof in entering into the Sublease and the continuance thereof throughout the Sublease
Term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I [print name] <U></U><U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>, acting with full authority to bind the
(proposed) Subtenant and on behalf of the (proposed) Subtenant, certify, represent and warrant that the information contained in this certificate is true and correct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Metagenomi, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a Delaware corporation </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT F </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REMOVABLE DYNAVAX FF&amp;E </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425213dsp255.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT F </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT G </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FORM OF LETTER OF CREDIT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IRREVOCABLE STANDBY LETTER OF CREDIT NUMBER<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISSUE DATE:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISSUING BANK: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SILICON VALLEY BANK </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3003 TASMAN DRIVE </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2ND FLOOR, MAIL SORT HF210 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SANTA CLARA, CALIFORNIA 95054 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BENEFICIARY: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ZYMERGEN INC. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 HORTON STREET, SUITE 105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EMERYVILLE, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ATTN: FINANCE DEPT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EMAIL:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PHONE:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CC: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ZYMERGEN INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 HORTON STREET, SUITE 105 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EMERYVILLE, CA 94608 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ATTN: CHIEF FINANCIAL OFFICER </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EMAIL:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PHONE:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">APPLICANT: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">METAGENOMI, INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 HORTON STREET SUITE 600 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EMERYVILLE CA 94608 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AMOUNT:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">US $1,973,416.28 (ONE MILLION NINE HUNDRED SEVENTY-THREE THOUSAND FOUR HUNDRED SIXTEEN AND 28/100 DOLLARS).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXPIRATION DATE:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">SVB WILL PUT A SPECIFIC DATE HERE THAT&#146;S 1 YEAR ISSUANCE HERE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PLACE&nbsp;OF&nbsp;EXPIRATION:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">ISSUING BANK&#146;S COUNTERS AT ITS ABOVE ADDRESS</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT G </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DEAR SIR/MADAM: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AT THE REQUEST AND FOR THE ACCOUNT OF METAGENOMI, INC. (&#147;APPLICANT&#148;), WE HEREBY ESTABLISH OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVBSF<U>
_____________</U> IN YOUR FAVOR AVAILABLE BY PAYMENT AGAINST YOUR PRESENTATION TO US OF THE FOLLOWING DOCUMENT: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.BENEFICIARY&#146;S SIGNED AND DATED
STATEMENT STATING AS FOLLOWS: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;FUNDS ARE DUE AND OWING TO BENEFICIARY PURSUANT TO THE TERMS OF THAT CERTAIN SUBLEASE AGREEMENT BETWEEN METAGENOMI,
INC., AS SUBTENANT, AND ZYMERGEN INC., AS SUBLANDLORD, AS AMENDED, SUPPLEMENTED OR OTHERWISE MODIFIED TO DATE. THE UNDERSIGNED HEREBY CERTIFIES THAT: (I)&nbsp;THE UNDERSIGNED IS AN AUTHORIZED REPRESENTATIVE OF SUBLANDLORD; (II)&nbsp;SUBLANDLORD IS
THE BENEFICIARY OF LETTER OF CREDIT NO. SVBSF <U>_____________</U> ISSUED BY SILICON VALLEY BANK; (III)&nbsp;SUBLANDLORD HAS GIVEN WRITTEN NOTICE TO SUBTENANT (IF REQUIRED UNDER THE SUBLEASE) TO CURE THE DEFAULT PURSUANT TO THE TERMS OF THE
SUBLEASE; (IV)&nbsp;SUCH DEFAULT HAS NOT BEEN CURED UP TO THIS DATE OF DRAWING UNDER THE LETTER OF CREDIT; (V)&nbsp;SUBLANDLORD IS AUTHORIZED TO DRAW DOWN ON THE LETTER OF CREDIT; AND (VI)&nbsp;SUBLANDLORD WILL HOLD THE FUNDS DRAWN UNDER THE LETTER
OF CREDIT AS SECURITY DEPOSIT FOR SUBTENANT OR APPLY SAID FUNDS TO SUBTENANT&#146;S OBLIGATION UNDER THE SUBLEASE. THE AMOUNT HEREBY DRAWN UNDER THE LETTER OF CREDIT IS US$<U>_____________</U>, WITH PAYMENT TO BE MADE TO THE FOLLOWING ACCOUNT:
[INSERT WIRE INSTRUCTIONS (TO INCLUDE NAME AND ACCOUNT NUMBER OF THE BENEFICIARY)].&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARTIAL DRAWS AND MULTIPLE PRESENTATIONS ARE ALLOWED. WE
FURTHER ACKNOWLEDGE AND AGREE THAT, UPON RECEIPT OF THE DOCUMENTATION REQUIRED HEREIN, WE WILL HONOR YOUR DRAWS AGAINST THIS IRREVOCABLE STANDBY LETTER OF CREDIT WITHOUT INQUIRY INTO THE ACCURACY OF THE BENEFICIARY&#146;S SIGNED STATEMENT AND
REGARDLESS OF WHETHER APPLICANT DISPUTES THE CONTENT OF SUCH STATEMENT. PRESENTATION MADE UNDER AND IN COMPLIANCE WITH THE TERMS OF THIS IRREVOCABLE STANDBY LETTER OF CREDIT RECEIVED AT OUR OFFICE PRIOR TO 10:00 AM PACIFIC TIME ON A BANKING DAY WILL
BE DULY HONORED ON THE NEXT BANKING DAY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS LETTER OF CREDIT SHALL BE AUTOMATICALLY EXTENDED FOR ADDITIONAL PERIODS OF ONE YEAR, WITHOUT AMENDMENT,
FROM THE PRESENT OR EACH FUTURE EXPIRATION DATE UNLESS AT LEAST NINETY (90)&nbsp;DAYS PRIOR TO THE THEN CURRENT EXPIRATION DATE WE SEND TO YOU A NOTICE BY REGISTERED OR CERTIFIED MAIL OR OVERNIGHT COURIER SERVICE AT THE ABOVE ADDRESS (OR ANY OTHER
ADDRESS INDICATED BY YOU, IN A WRITTEN NOTICE TO US, AS THE ADDRESS TO WHICH WE SHOULD SEND SUCH NOTICE) THAT THIS LETTER OF CREDIT WILL NOT BE EXTENDED BEYOND THE THEN CURRENT EXPIRATION DATE. IN NO EVENT SHALL THIS LETTER OF CREDIT BE
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT G </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
AUTOMATICALLY EXTENDED BEYOND FEBRUARY&nbsp;28, 2031. IN THE EVENT WE SEND SUCH NOTICE OF <FONT STYLE="white-space:nowrap">NON-EXTENSION,</FONT> YOU MAY DRAW HEREUNDER BY YOUR PRESENTATION TO US
OF YOUR SIGNED AND DATED STATEMENT STATING THAT YOU HAVE RECEIVED A <FONT STYLE="white-space:nowrap">NON-EXTENSION</FONT> NOTICE FROM SILICON VALLEY BANK IN RESPECT OF LETTER OF CREDIT NO. SVBSF <U>_____________</U>, YOU ARE DRAWING ON SUCH LETTER
OF CREDIT FOR US$<U>_____________</U>, AND YOU HAVE NOT RECEIVED A REPLACEMENT LETTER OF CREDIT ACCEPTABLE TO YOU. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL DEMANDS FOR PAYMENT SHALL BE MADE
BY PRESENTATION OF THE REQUIRED DOCUMENTS ON A BUSINESS DAY AT OUR OFFICE (THE &#147;BANK&#146;S OFFICE&#148;) AT: SILICON VALLEY BANK, 3003 TASMAN DRIVE, MAIL SORT HF 210, SANTA CLARA, CA 95054, ATTENTION: GLOBAL TRADE FINANCE. AS USED IN THIS
LETTER OF CREDIT, &#147;BUSINESS DAY&#148; SHALL MEAN ANY DAY OTHER THAN A SATURDAY, SUNDAY OR A DAY ON WHICH BANKING INSTITUTIONS IN THE STATE OF CALIFORNIA ARE AUTHORIZED OR REQUIRED BY LAW TO CLOSE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FACSIMILE PRESENTATIONS ARE ALSO PERMITTED. EACH FACSIMILE TRANSMISSION SHALL BE MADE AT: (408) <FONT STYLE="white-space:nowrap">496-2418</FONT> OR (408) <FONT
STYLE="white-space:nowrap">969-6510;</FONT> AND UNDER CONTEMPORANEOUS TELEPHONE ADVICE TO: (408) <FONT STYLE="white-space:nowrap">450-5001</FONT> OR (408) <FONT STYLE="white-space:nowrap">654-7176,</FONT> ATTENTION: GLOBAL TRADE FINANCE. ABSENCE OF
THE AFORESAID TELEPHONE ADVICE SHALL NOT AFFECT OUR OBLIGATION TO HONOR ANY DRAW REQUEST. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS LETTER OF CREDIT IS TRANSFERABLE IN WHOLE BUT NOT IN PART
WITHOUT OUR APPROVAL OR CHARGE ONE OR MORE TIMES, BUT IN EACH INSTANCE ONLY TO A SINGLE BENEFICIARY AS TRANSFEREE AND FOR THE THEN AVAILABLE AMOUNT, ASSUMING SUCH TRANSFER TO SUCH TRANSFEREE WOULD BE IN COMPLIANCE WITH THEN APPLICABLE LAW AND
REGULATION, INCLUDING BUT NOT LIMITED TO THE REGULATIONS OF THE U.S. DEPARTMENT OF TREASURY AND U.S. DEPARTMENT OF COMMERCE. AT THE TIME OF TRANSFER, THE ORIGINAL LETTER OF CREDIT AND ORIGINALS OR COPIES OF ALL AMENDMENTS, IF ANY, TO THIS LETTER OF
CREDIT MUST BE SURRENDERED TO US AT OUR ADDRESS INDICATED IN THIS LETTER OF CREDIT TOGETHER WITH OUR TRANSFER FORM ATTACHED HERETO AS EXHIBIT A DULY EXECUTED. ALL CHARGES AND FEES ASSOCIATED WITH THIS IRREVOCABLE STANDBY LETTER OF CREDIT, INCLUDING
UPON ANY TRANSFER OF THE IRREVOCABLE STANDBY LETTER OF CREDIT, SHALL BE FOR THE ACCOUNT OF APPLICANT. EACH TRANSFER SHALL BE EVIDENCED BY EITHER (1)&nbsp;OUR ENDORSEMENT ON THE REVERSE OF THE LETTER OF CREDIT AND WE SHALL FORWARD THE ORIGINAL OF THE
LETTER OF CREDIT SO ENDORSED TO THE TRANSFEREE OR (2)&nbsp;OUR ISSUING A REPLACEMENT LETTER OF CREDIT TO THE TRANSFEREE ON SUBSTANTIALLY THE SAME TERMS AND CONDITIONS AS THE TRANSFERRED LETTER OF CREDIT (IN WHICH EVENT THE TRANSFERRED LETTER OF
CREDIT SHALL HAVE NO FURTHER EFFECT). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT G </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IF ANY INSTRUCTIONS ACCOMPANYING A DRAWING UNDER THIS LETTER OF CREDIT REQUEST THAT PAYMENT IS TO BE MADE BY
TRANSFER TO YOUR ACCOUNT WITH ANOTHER BANK, WE WILL ONLY EFFECT SUCH PAYMENT BY FED WIRE TO A U.S. REGULATED BANK, AND WE AND/OR SUCH OTHER BANK MAY RELY ON AN ACCOUNT NUMBER SPECIFIED IN SUCH INSTRUCTIONS EVEN IF THE NUMBER IDENTIFIES A PERSON OR
ENTITY DIFFERENT FROM THE INTENDED PAYEE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS LETTER OF CREDIT IS SUBJECT TO THE INTERNATIONAL STANDBY PRACTICES (ISP98), INTERNATIONAL CHAMBER OF
COMMERCE, PUBLICATION NO. 590. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AUTHORIZED SIGNATURE</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">AUTHORIZED SIGNATURE</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT G </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A TO EXHIBIT E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TRANSFER FORM </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATE:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TO: SILICON VALLEY BANK</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3003 TASMAN DRIVE</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SANTA CLARA, CA 95054</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ATTN: GLOBAL TRADE FINANCE</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">STANDBY LETTERS OF CREDIT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RE: IRREVOCABLE STANDBY LETTER OF CREDIT</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NO.<U>&#8195;&#8195;&#8195;&#8195;</U>ISSUED BY</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SILICON VALLEY
BANK, SANTA CLARA</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">L/C AMOUNT:____________________</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LADIES AND GENTLEMEN: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR
VALUE RECEIVED, THE UNDERSIGNED BENEFICIARY HEREBY IRREVOCABLY TRANSFERS TO: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">_________________________________________________________________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(NAME OF TRANSFEREE) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">_________________________________________________________________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ADDRESS) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY TO DRAW
UNDER THE ABOVE LETTER OF CREDIT UP TO ITS AVAILABLE AMOUNT AS SHOWN ABOVE AS OF THE DATE OF THIS TRANSFER. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BY THIS TRANSFER, ALL RIGHTS OF THE
UNDERSIGNED BENEFICIARY IN SUCH LETTER OF CREDIT ARE TRANSFERRED TO THE TRANSFEREE. TRANSFEREE SHALL HAVE THE SOLE RIGHTS AS BENEFICIARY THEREOF, INCLUDING SOLE RIGHTS RELATING TO ANY AMENDMENTS, WHETHER INCREASES OR EXTENSIONS OR OTHER AMENDMENTS,
AND WHETHER NOW EXISTING OR HEREAFTER MADE. ALL AMENDMENTS ARE TO BE ADVISED DIRECTLY TO THE TRANSFEREE WITHOUT NECESSITY OF ANY CONSENT OF OR NOTICE TO THE UNDERSIGNED BENEFICIARY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF
CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">APPLICANT&#146;S SIGNATURE(s)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DATE</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT A TO EXHIBIT G
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE ORIGINAL OF SUCH LETTER OF CREDIT IS RETURNED HEREWITH, AND WE ASK YOU TO EITHER (1)&nbsp;ENDORSE THE
TRANSFER ON THE REVERSE THEREOF, AND FORWARD IT DIRECTLY TO THE TRANSFEREE WITH YOUR CUSTOMARY NOTICE OF TRANSFER, OR (2)&nbsp;ISSUE A REPLACEMENT LETTER OF CREDIT TO THE TRANSFEREE ON SUBSTANTIALLY THE SAME TERMS AND CONDITIONS AS THE TRANSFERRED
LETTER OF CREDIT (IN WHICH EVENT THE TRANSFERRED LETTER OF CREDIT SHALL HAVE NO FURTHER EFFECT). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SINCERELY,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">SIGNATURE AUTHENTICATED</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(BENEFICIARY&#146;S NAME)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The name(s), title(s), and signature(s) conform to that/those on file
with us for the company and the signature(s) is/are authorized to execute this instrument.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(SIGNATURE OF BENEFICIARY)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(NAME AND TITLE)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Name of Bank)</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Address of Bank)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(City, State, ZIP Code)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Authorized Name and Title)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Authorized Signature)</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Telephone number)</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN
THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">APPLICANT&#146;S SIGNATURE(s)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DATE</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT A TO EXHIBIT G
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>7
<FILENAME>d425213dex1011.htm
<DESCRIPTION>EX-10.11
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.11</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.11 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LEASE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>By and Between
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PARK AVENUE BUILDING LLC, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>a California limited liability company </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#147;Landlord&#148; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>And </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>METAGENOMI, INC.,
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>a Delaware corporation, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#147;Tenant&#148; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated: September&nbsp;29, 2021 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Basic Lease Information </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Lease Date</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">September&nbsp;24, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Landlord</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Park Avenue Building, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Landlord&#146;s Address</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o David Bruck Property Mgt.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1105 La Grande
Ave.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Napa, CA 94558</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Metagenomi, Inc., a Delaware corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant&#146;s Address</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">After Commencement Date:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1485 Park Avenue</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA
94608</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prior to Commencement Date:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1545 Park Avenue</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, California
94608</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: VP of Legal</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All notices to Tenant regarding any default</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">shall be copied via email and U.S. mail to:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dalsin Law</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1630 N. California Street, #221</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Walnut Creek, CA 94596</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: Ann M. Dalsin</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Guarantor</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Premises</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The entire Building (defined below) and</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">other
areas of the Property, including any</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">parking spaces.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Building</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">That certain office building containing approximately 23,155 rentable square feet located on the Property.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Property</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A parcel of real property commonly known</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">as
1485 Park Avenue, Emeryville, CA 94608</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Term</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">One hundred eleven (111)&nbsp;months</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Commencement Date</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">November&nbsp;1, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Rent Commencement Date</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">January&nbsp;1, 2022</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="50%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Termination Date</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">January&nbsp;31, 2031</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="11"><B>Base Rent (</B><B>&#167;</B><B>4)</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/21 &#150; 12/31/21:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$0.00 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">01/1/22 &#150; 10/31/22:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$31,259.25 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11/1/22 &#150; 10/31/23:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$93,777.75 per month</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/23 &#150; 10/31/24:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$96,591.08 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/24 &#150; 10/31/25:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$99,488.82 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/25 &#150; 10/31/26:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$102,473.48 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/26 &#150; 10/31/27:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$105,547.68 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/27 &#150; 10/31/28:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$108,714.11 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/28 &#150; 10/31/29:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$111,975.54 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/29 &#150; 10/31/30:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$115,334.80 per month</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">11/1/30 &#150; 01/31/31:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$118,794.85 per month</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Security Deposit (</B><B>&#167;</B><B>6)</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Two Hundred Thirty-Seven Thousand Five Hundred Eighty-Nine Dollars and Seventy Cents ($237,589.70) plus a Letter of Credit in the amount of Eight Hundred Thousand Dollars ($800,000.00) (the &#147;Letter of
Credit&#148;).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Prepaid Rent</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Base Rent for the Month of January, 2022 of the Term ($31,259.25) shall be paid upon execution of the Lease.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Base Year</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">The calendar year of 2022.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant&#146;s Share of Operating Expenses (</B><B>&#167;</B><B>5.1)</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">100% of the Building</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant&#146;s Share of Tax Expenses (</B><B>&#167;</B><B>5.2)</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">100% of the Building</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tenant Improvement Allowance</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Two Hundred <FONT STYLE="white-space:nowrap">Thirty-One</FONT> Thousand Five Hundred Fifty Dollars ($231,550.00)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Permitted Uses (</B><B>&#167;</B><B>9)</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">General office use, ancillary kitchen and other legally permitted uses that are compatible with the Building, subject to all applicable laws, including zoning.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Broker (</B><B>&#167;</B><B>34)</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cushman&nbsp;&amp; Wakefield for Landlord</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Kidder Matthews and Newmark for Tenant</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Exhibits</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exhibit A</I> - <I>Premises and Building</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exhibit B</I> - <I>Commencement Date Amendment</I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exhibit
C</I> - <I>Tenant Improvements</I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exhibit D</I> - <I>Rules and Regulations</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Exhibit E</I> - <I>Consent to Sublease/Assignment</I></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TABLE OF CONTENTS </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>1.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>PREMISES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TERM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>3.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INTENTIONALLY DELETED</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RENT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ADDITIONAL RENT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>6.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SECURITY DEPOSIT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>7.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>LATE CHARGES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>8.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>UTILITIES AND SERVICES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>9.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>USE OF PREMISES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>10.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>CONDITION OF PREMISES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>11.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ALTERATIONS; AND SURRENDER OF PREMISES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>12.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SERVICES AND MAINTENANCE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>15</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>13.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INSURANCE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>16</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>14.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INDEMNITY AND LIMITATION OF LIABILITY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>17</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>15.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ASSIGNMENT AND SUBLEASING</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>18</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>16.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>INTENTIONALLY DELETED</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>17.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SUBORDINATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>18.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>RIGHT OF ENTRY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>19.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ESTOPPEL CERTIFICATE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>23</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>20.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TENANT&#146;S DEFAULT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>23</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>21.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>REMEDIES FOR TENANT&#146;S DEFAULT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>24</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>22.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>HOLDING OVER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>26</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>23.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>LANDLORD&#146;S DEFAULT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>26</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>24.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ARBITRATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>26</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>25.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>TRANSFER OF LANDLORD&#146;S INTEREST</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>27</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>26.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>WAIVER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>27</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>27.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>CASUALTY DAMAGE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>27</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>28.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>CONDEMNATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>29</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>29.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>ENVIRONMENTAL MATTERS/HAZARDOUS MATERIALS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>30</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>30.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>FINANCIAL STATEMENTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>31</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>31.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>SIGNS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>31</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>32.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>COMMUNICATIONS AND COMPUTER LINES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>31</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>33.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MORTGAGE OF TENANT&#146;S LEASEHOLD INTEREST</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>31</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>34.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>MORTGAGEE PROTECTION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>32</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>35.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>WARRANTIES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>32</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>36.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>BROKERAGE COMMISSION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>33</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>37.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>QUIET ENJOYMENT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>33</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>38.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>GENERAL PROVISIONS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>33</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iv- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>L<SMALL>EASE</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Basic Lease Information set forth on Pages (i)&nbsp;and (ii) and this Lease are and shall be construed as a single instrument. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. P<SMALL>REMISES</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord hereby leases the
Premises to Tenant upon the terms and conditions contained herein. Landlord and Tenant hereby agree that for purposes of this Lease, as of the Lease Date, the rentable square footage area of each of the Premises and the Building shall be deemed to
be the number of rentable square feet as set forth in the Basic Lease Information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. T<SMALL>ERM</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Term of this Lease will begin on the Commencement Date and shall expire on the Termination Date. On the day that Tenant executes this Lease, Tenant will
deliver to Landlord the original executed Lease, the Prepaid Rent, and the Security Deposit. Within ten (10)&nbsp;days of the date Tenant executes this Lease, Tenant will deliver to Landlord the Letter of Credit. Prior to the Commencement Date,
Tenant shall also deliver insurance certificates evidencing the insurance required to be obtained by Tenant under <U>Section</U><U></U><U>&nbsp;13</U> and <U>Exhibit C</U> if any of this Lease. If Landlord, for any reason whatsoever, cannot deliver
possession of the Premises to Tenant on the Commencement Date in the condition specified in <U>Section</U><U></U><U>&nbsp;10</U> hereof, then Landlord will not be subject to any liability nor shall the validity of the Lease be affected; however, the
Rent Commencement Date of this Lease will be extended on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-for-day</FONT></FONT> basis and the Termination Date shall be extended commensurately. Notwithstanding anything to the
contrary herein, in the event Landlord cannot deliver possession of the Premises to Tenant by March&nbsp;31, 2022, Tenant shall have the right upon seven (7)&nbsp;days written notice to terminate this Lease without liability and Landlord shall
return the Security Deposit and Letter of Credit within 30 days of such termination. In order to confirm the Commencement Date, the Rent Commencement Date and/or the Termination Date of this Lease, on or before the date that Tenant takes possession
of the Premises, Landlord and Tenant will execute a written amendment to this Lease, in the form of <U>Exhibit B</U> hereto, which will specify the actual Commencement Date, Termination Date and the Rent Commencement Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. I<SMALL>NTENTIONALLY</SMALL> D<SMALL>ELETED</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. R<SMALL>ENT</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant agrees to pay Landlord the
Base Rent, without prior notice or demand, abatement, offset, deduction, or claim, in advance at Landlord&#146;s Address on the Rent Commencement Date and thereafter on the first (1st) day of each month throughout the balance of the Term of the
Lease. In addition to the Base Rent, commencing on January&nbsp;1, 2023, Tenant shall pay Landlord in advance and thereafter on the first (1st) day of each month throughout the balance of the Term of this Lease, without prior notice or demand,
abatement, offset, deduction or claim, as Additional Rent (as defined below), Tenant&#146;s Share of Operating Expenses and Tax Expenses (collectively, the &#147;Expenses&#148;) for the amounts, if any, in excess of the Base Year. The term
&#147;Rent&#148; whenever used herein refers to the aggregate of Base Rent and Additional Rent. The Rent for any fractional part of a calendar month at the commencement, expiration or termination of the Lease Term shall be a prorated amount of the
Rent for a full calendar month based upon a thirty (30)&nbsp;day month. The first months Base Rent will be paid upon execution of the Lease and any prorated Rent for the final calendar month hereof shall be paid on the first day of the calendar
month in which the Termination Date occurs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. A<SMALL>DDITIONAL</SMALL> R<SMALL>ENT</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is intended by Landlord and Tenant that this Lease be a modified gross lease, wherein Base Rent includes for Operating Expenses and Tax Expenses in the
amount of the Base Year, except for janitorial and the Utility Expenses (as defined in <U>Section</U><U></U><U>&nbsp;8.1</U> below), which Tenant shall pay in full as of the Commencement Date. For Operating Expenses and Tax Expenses in excess of the
Base Year Expenses, Tenant will pay all Operating Expenses and Tax Expenses with respect to such excess. The costs and expenses described in this <U>Section</U><U></U><U>&nbsp;5</U> and all other sums, charges, costs, and expenses specified in this
Lease, other than Base Rent, are to be paid by Tenant to Landlord as additional rent (&#147;Additional Rent&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1 </B>Operating
Expenses: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>5.1.1 Definition of Operating Expenses</B>: Tenant shall pay to Landlord Tenant&#146;s Share of all Operating Expenses in
excess of the Operating Expenses for the Base Year, if any, as Additional Rent. The term &#147;Operating Expenses&#148; as used herein shall mean the total amounts paid or payable by Landlord in connection with the ownership, management,
maintenance, repair, and operation of the Premises, the Building, and the Property. These Operating Expenses may include, but are not limited to, Landlord&#146;s cost of: (i)&nbsp;repairs to, and maintenance of, all wall and floor coverings, ceiling
tiles and fixtures in the Building, the roof membrane, the <FONT STYLE="white-space:nowrap">non-structural</FONT> portions of the roof and the <FONT STYLE="white-space:nowrap">non-structural</FONT> elements of the perimeter and exterior walls of the
Building, sidewalks and curbs, exterior windows, foundation and basement areas and any landscaping on the Property; (ii)&nbsp;annual insurance premium(s) insuring against personal injury and property damage (including, if Landlord elects, &#147;all
risk&#148; or &#147;special purpose&#148; coverage) and all other insurance, including, but not limited to, earthquake and flood for the Property, rental value insurance against loss of Rent for a period of at least twelve (12)&nbsp;months
commencing on the date of loss, and any deductible; (iii)&nbsp;the costs of supplying all utilities, the cost of operating, repairing, maintaining, and renovating the utilities, including without limitation, telephone, electricity, gas, sanitation,
storm drainage, and elevator systems that are not paid directly by Tenant, if any; (iv)&nbsp;(a) modifications and/or new improvements to any portion of the Building occasioned by any rules, laws or regulations effective subsequent to the Lease
Date; (b)&nbsp;reasonably necessary replacement improvements to any portion of the Building after the Commencement Date; and (c)&nbsp;new improvements to the Building that reduce operating costs or improve life/safety conditions, all of the
foregoing as reasonably determined by Landlord, in its sole but reasonable discretion (if such costs are of a capital nature, then such costs or allocable portions thereof will be amortized on a straight-line basis over the estimated useful life of
the capital item or fifteen (15)&nbsp;years whichever is shorter, together with reasonable interest on the amortized balance); (v) preventative maintenance and repair contracts including, but not limited to, contracts for elevator systems and
heating, ventilation and air conditioning systems; (vi)&nbsp;security and fire protection services for the Building, if and to the extent, in Landlord&#146;s sole discretion, such services are provided; (vii)&nbsp;supplies, materials, equipment and
other similar items used in the operation and/or maintenance of the Building and any reasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reserves established for replacement or repair of any improvements or equipment; (viii)&nbsp;any and all levies, charges, fees and/or assessments imposed on Landlord by any federal, state or
local governmental agency or body or to any applicable owner&#146;s association or similar body; (ix)&nbsp;the service and maintenance items set forth in <U>Section</U><U></U><U>&nbsp;12</U> below; (x)&nbsp;costs incurred in connection with the
areas servicing the Building; (xi)&nbsp;fees and other costs, including management fees, consulting fees, legal fees and accounting fees, and the fees of all contractors and consultants in connection with the management, operation, maintenance and
repair of the Building; (xii)&nbsp;payments under any equipment lease agreements; and (xiii)&nbsp;wages, salaries and other compensation and benefits, including taxes levied thereon, of all persons engaged in the operation, maintenance and security
of the Building. As of the Lease Date, Landlord does not carry earthquake insurance. In the event that Landlord obtains earthquake insurance during the Term, the amount of such earthquake insurance shall be included in Operating Expenses for the
Base Year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>5.1.2 Operating Expense Exclusions</B>: Notwithstanding anything to the contrary contained herein, for purposes of this
Lease, the term &#147;Operating Expenses&#148; shall not include the following: (i)&nbsp;legal and auditing fees (other than those fees reasonably incurred in connection with the maintenance and operation of all or any portion the Building or
Property), leasing commissions, advertising expenses, and other costs incurred in connection with the original leasing of the Building or future <FONT STYLE="white-space:nowrap">re-leasing</FONT> of any portion of the Building;
(ii)&nbsp;depreciation of the Building or any other improvements situated on the Property; (iii)&nbsp;any items for which Landlord is actually reimbursed by insurance; (iv)&nbsp;costs of repairs or other work necessitated by fire, windstorm or other
casualty (excluding any deductibles) and/or costs of repair or other work necessitated by the exercise of the right of eminent domain to the extent insurance proceeds or a condemnation award, as applicable, is actually received by Landlord for such
purposes; provided, such costs of repairs or other work shall be paid by the parties in accordance with the provisions of <U>Sections 27</U> and <U>28</U>, below; (v)&nbsp;any interest or payments on any financing for the Building or the Property;
(vi)&nbsp;any interest or penalties incurred as a result of Landlord&#146;s late payment of any invoice (provided that Tenant pays Tenant&#146;s Share of Operating Expenses and Tax Expenses to Landlord when due as set forth herein), and any bad debt
loss, rent loss or reserves for same; (vii)&nbsp;advertising and promotional expenditures, including the cost of signage identifying the Building owners; (viii)&nbsp;overhead and profit increment paid to Landlord or to subsidiaries or affiliates of
Landlord for goods and/or services in the Building to the extent the same exceeds the costs of such by unaffiliated third parties on a competitive basis; or any costs included in Operating Expenses representing an amount paid to a person, firm,
corporation or other entity related to Landlord that are in excess of the amount that would have been paid in the absence of such relationship; (ix)&nbsp;any payments under a ground lease or master lease; (x)&nbsp;any expense related to the repair
and maintenance of any structural element of the Building or the foundation; (xi)&nbsp;costs arising from the negligence or fault of Landlord or its agents, vendors or providers of materials; (xii)&nbsp;Landlord&#146;s charitable or political
contributions; (xiii)&nbsp;costs arising in the base, shell or core of the Building or improvements installed by Landlord; (xiv)&nbsp;any expense due to the acquisition of any sculpture, painting or other objects of art; (xv)&nbsp;costs of operation
of the business of the partnership or entity which constitutes Landlord that are not directly attributable to the operation of the Building, including partnership accounting and legal matters and the cost of defending any lawsuit that is unrelated
to the operation of the Building; (xvi)&nbsp;the expenses incurred by Landlord in connection with any environmental <FONT STYLE="white-space:nowrap">clean-up,</FONT> response action or remediation on, in, under or about the Premises or the Building
to the extent not caused, directly or indirectly by Tenant, but excluding the costs of monitoring; and (xvii) <FONT STYLE="white-space:nowrap">&#147;in-house&#148;</FONT> legal and/or accounting fees (other than the management fees). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2 Tax Expenses</B>: Tenant shall pay to Landlord Tenant&#146;s Share of all real
property taxes applicable to the Property in excess of real property taxes due for the Base Year, in accordance with <U>Section</U><U></U><U>&nbsp;5.3</U> below. The term &#147;Tax Expenses&#148; shall mean and include, without limitation, any form
of tax and assessment (general, special, supplemental, ordinary or extraordinary), commercial rental tax, payments under any improvement bond or bonds, license fees, license tax, business license fee, rental tax, transaction tax or levy imposed by
any authority having the direct or indirect power of tax (including any city, county, state or federal government, or any school, agricultural, lighting, drainage or other improvement district thereof) as against any legal or equitable interest of
Landlord in the Premises or any other portion of the Property or any other tax, fee, or excise, however described. The term &#147;Tax Expenses&#148; shall only exclude any franchise, estate, inheritance, net income, or excess profits tax imposed
upon Landlord, or a penalty fee imposed as a result of Landlord&#146;s failure to pay Tax Expenses when due. Tenant will pay Landlord, as Additional Rent, irrespective of the Base Year, within ten (10)&nbsp;days after demand therefore, one hundred
percent (100%) of (i)&nbsp;any increase in real property taxes attributable to any and all Alterations (defined below in <U>Section</U><U></U><U>&nbsp;11</U>), Tenant Improvements, fixtures, equipment or other improvements of any kind whatsoever
placed in, on or about the Premises for the benefit of, at the request of, or by Tenant, and (ii)&nbsp;taxes and assessments levied or assessed upon or with respect to the possession, operation, use or occupancy by Tenant of the Premises or any
other portion of the Property. Prior to delinquency, Tenant shall pay any and all taxes and assessments levied upon Tenant&#146;s Property (defined below in <U>Section</U><U></U><U>&nbsp;11.2</U>) located or installed in or about the Premises by, or
on behalf of Tenant. To the extent any such taxes or assessments are not separately assessed or billed to Tenant, then Tenant shall pay, as Additional Rent, the amount thereof as invoiced by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.3 Payment of Expenses</B>. Following the Base Year, Landlord will invoice Tenant for its share of increases in Operating Expenses and Tax
Expenses at the end of each calendar year. Tenant will have thirty (30)&nbsp;days from receipt of invoice to pay Tenant&#146;s Share of said increases for the preceding year. Alternatively, Landlord may, in its sole and absolute discretion, invoice
Tenant for said increases in advance based on an estimate to be paid by Tenant monthly. Should Landlord elect to collect increases in advance, Landlord will notify Tenant in writing. Beginning on January&nbsp;1, 2023, Tenant will pay <FONT
STYLE="white-space:nowrap">one-twelfth</FONT> (1/12th) of the estimated amount of the Expenses in an amount that Landlord reasonably expects the Expenses for that calendar year to exceed the Expenses for the Base Year, as Additional Rent, and
thereafter on the first (1st) day of each month throughout the remaining months of such calendar year. Thereafter, within the first ninety (90)&nbsp;days of any subsequent calendar year, Landlord will provide Tenant with an estimate of Operating
Expenses and Tax Expenses for the calendar year, Tenant will pay the amount of the revised estimate on the first day of the next preceding calendar month. Until the Landlord delivers the estimate for the then current calendar year, Tenant&#146;s
payments will be based upon the estimate from the previous year. At any point during any Lease Year (other than the Base Year), Landlord may revise its estimate for that calendar year if Landlord has a reasonable basis for the belief that the
ultimate Operating Expenses and Tax Expenses for that year will be more than five percent (5%) above the current estimate, Landlord may deliver written notice to Tenant increasing the estimated payments for the remainder of that calendar year.
Tenant will pay the increased amount beginning on the first day of the month following Landlord&#146;s delivery of said notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.4 Annual Reconciliation</B>: By June 30th of each calendar year in which Tenant is
obligated for Tenant&#146;s Share of Expenses, or as soon thereafter as reasonably possible, Landlord shall furnish Tenant with an accounting of actual and accrued Operating Expenses and Tax Expenses for the prior calendar year. Within thirty
(30)&nbsp;days of Landlord&#146;s delivery of such accounting, Tenant shall pay to Landlord the amount of any underpayment. Notwithstanding the foregoing, failure by Landlord to give such accounting by such date shall not constitute a waiver by
Landlord of its right to collect any underpayment by Tenant at any time. Landlord may, at its option and in its sole and absolute discretion, either credit the amount of any overpayment by Tenant toward the next estimated monthly installment(s)
falling due, or refund the amount of overpayment to Tenant within thirty (30)&nbsp;days thereafter. If the Term of the Lease expires prior to the annual reconciliation of Expenses Landlord shall have the right to reasonably estimate Tenant&#146;s
Share of such Expenses, and (a)&nbsp;if Landlord determines that there has been an underpayment, Landlord may deduct such underpayment from Tenant&#146;s Security Deposit, and (b)&nbsp;if Landlord determines that there has been an overpayment,
Landlord shall refund the amount of the overpayment to Tenant within thirty (30)&nbsp;days after the expirations of the Term. Failure by Landlord to accurately estimate Tenant&#146;s Share of such Expenses or to otherwise perform such reconciliation
of expenses shall not constitute a waiver of Landlord&#146;s right to collect any of Tenant&#146;s underpayment at any time during the Term of the Lease or at any time after the expiration or earlier termination of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.5 Audit</B>: After delivery to Landlord of at least thirty (30)&nbsp;days prior written notice, Tenant, at its sole cost and expense
through any reputable accountant designated by it, shall have the right to examine and/or audit the books and records evidencing such costs and expenses for the previous one (1)&nbsp;calendar year, during Landlord&#146;s reasonable business hours
but not more frequently than once during any calendar year. Any such accounting firm designated by Tenant may not be compensated on a contingency fee basis. The results of any such audit (and any negotiations between the parties related thereto)
shall be maintained strictly confidential by Tenant and its accounting firm and shall not be disclosed, published, or otherwise disseminated to any other party other than to Landlord and its authorized agents. Landlord and Tenant each shall use its
best efforts to cooperate in such negotiations and to promptly resolve any discrepancies between Landlord and Tenant in the accounting of the Expenses. In no event will any discrepancies be deemed a material breach of the Lease by Landlord. Once all
of the discrepancies, if any, have been resolved, should the audit reveals that Landlord overstated Tenant&#146;s Share of Operating Expenses and Tenant&#146;s Share of Tax Expenses by more than five percent (5%), then Landlord will reimburse Tenant
for the actual cost of the audit. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. S<SMALL>ECURITY</SMALL> D<SMALL>EPOSIT</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.1 Cash Security Deposit</B>: Simultaneously with Tenant&#146;s execution and delivery of this Lease, Tenant shall deliver to Landlord, the
cash portion of Security Deposit for the faithful performance by Tenant of its obligations under this Lease. If Tenant is in default hereunder, Landlord may, but is not required to, use all or any portion of the Security Deposit to cure the default
or to compensate Landlord for all damages sustained in connection therewith, including without limitation, Reletting Costs (as defined in <U>Section</U><U></U><U>&nbsp;21.1</U>). Tenant will, immediately on
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
demand, pay to Landlord the sum required to replenish and restore the Security Deposit to its full amount. At any time after Tenant has defaulted hereunder, Landlord may require an increase in
the amount of the Security Deposit required hereunder for the then balance of the Term and Tenant shall, immediately on demand, pay to Landlord such additional sums. As soon as practicable after the expiration or termination of this Lease, Landlord
will return the cash portion of the Security Deposit to Tenant, less any amounts that are reasonably necessary, as determined by Landlord in its reasonable discretion, to remedy Tenant&#146;s default(s) hereunder or to otherwise restore the Premises
to a clean and safe condition, reasonable wear and tear excepted. If the cost to restore the Premises exceeds the amount of the Security Deposit, Tenant will immediately deliver to Landlord any excess sums. Landlord is not required to keep the
Security Deposit separate from other funds, and, unless otherwise required by law, Tenant is not entitled to interest on the Security Deposit. Tenant hereby waives the provisions of Section&nbsp;1950.7 of the California Civil Code, and all other
provisions of law, now or hereafter in effect that provide that limit the types of damages to which a security deposit may be applied, it being agreed that Landlord may claim those sums reasonably necessary to compensate Landlord for any loss or
damage, foreseeable or unforeseeable, caused by the act or omission of Tenant or any officer, employee, agent or invitee of Tenant. In no event or circumstance shall Tenant have the right to any use or application of the Security Deposit and,
specifically, Tenant may not use the Security Deposit as the last month&#146;s Rent, as a credit or to otherwise offset any payments required hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2 Letter of Credit</B>: In addition to the cash Security Deposit, Tenant will deliver to Landlord within ten (10)&nbsp;days following
Tenant&#146;s execution and delivery of this Lease an irrevocable letter of credit payable in the San Francisco Bay Area, California issued for the benefit of the Landlord by a bank reasonably satisfactory to Landlord, in the amount of Eight Hundred
Thousand Dollars ($800,000.00) (the &#147;Letter of Credit&#148;). The Letter of Credit will be irrevocable for the term thereof and will provide that it is automatically renewable for a period ending not earlier than sixty (60)&nbsp;days after the
expiration of the Term without any action whatsoever on the part of Landlord. However, the issuing bank will have the right not to renew said Letter of Credit on written notice to Landlord given not less than sixty (60)&nbsp;days before the
expiration of the Term (it being understood, however, that the privilege of the issuing bank not to renew said letter of credit will not, in any event, diminish the obligation of Tenant to maintain such irrevocable Letter of Credit with Landlord
through the date which is sixty (60)&nbsp;days after the expiration of the Term). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Letter of Credit must be issued by a bank
reasonably satisfactory to Landlord, in a form reasonably acceptable to Landlord, and must provide, among other things, in effect that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(i) Landlord, or its then managing agent, will have the right to draw down an amount up to the face amount of the Letter of Credit upon the
presentation to the issuing bank of Landlord&#146;s (or Landlord&#146;s then managing agent&#146;s) statement that the drawer is entitled to draw upon the Letter of Credit pursuant to this Lease, it being understood that if Landlord or its managing
agent is a corporation, limited liability company, partnership or other entity, then such statement will be signed by an officer or member (if a corporation or limited liability company), a general partner (if a partnership), or any authorized party
(if another entity); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) The Letter of Credit will be honored by the issuing bank without inquiry as to the
accuracy thereof and regardless of whether the Tenant disputes the content of such statement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(iii) In the event of a transfer of
Landlord&#146;s interest in the Property, Landlord will have the right to transfer the Letter of Credit to the transferee at no cost to Landlord or transferee, and thereupon, Landlord will, without any further agreement between the parties, be
released by Tenant from all liability therefor, and it is agreed that the provisions hereof shall apply to every transfer or assignment of said Letter of Credit to a new landlord; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(iv) Tenant further covenants that it will not assign or encumber said Letter of Credit or any part thereof and that neither Landlord nor its
successors or assigns will be bound by any such assignment, encumbrance, attempted assignment or attempted encumbrance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without
limiting the generality of the foregoing, if the Letter of Credit expires earlier than sixty (60)&nbsp;days after the expiration of the Term, or the issuing bank notifies Landlord that it will not renew the Letter of Credit, Landlord will accept a
renewal thereof or substitute Letter of Credit (such renewal or substitute letter of credit to be in effect not later than thirty (30)&nbsp;days prior to the expiration thereof), irrevocable and automatically renewable as above provided to sixty
(60)&nbsp;days after the end of the Term upon the same terms as the expiring letter of credit or such other terms as may be acceptable to Landlord. However, (i)&nbsp;if the Letter of Credit is not timely renewed or a substitute Letter of Credit is
not timely received, or (ii)&nbsp;if Tenant fails to maintain the Letter of Credit in the amount and terms set forth in this <U>Section</U><U></U><U>&nbsp;6.2</U>, Tenant, at least thirty (30)&nbsp;days before the expiration of the Letter of Credit,
or immediately upon its failure to comply with each and every term of this <U>Section</U><U></U><U>&nbsp;6.2</U>, must deposit with Landlord cash security in the amounts required by, and to be held subject to and in accordance with, all of the terms
and conditions set forth in this <U>Section</U><U></U><U>&nbsp;6.2</U> hereof, failing which the Landlord may present such letter of credit to the bank, in accordance with the terms of this <U>Section</U><U></U><U>&nbsp;6.2</U>, and the entire sum
secured thereby will be paid to Landlord, to be held by Landlord as provided in this Section&nbsp;6.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Subject to the terms of this
<U>Section</U><U></U><U>&nbsp;6.1</U>, and further provided Tenant has paid all Rent due under this Lease when due or after notice and within the applicable cure period, during each <FONT STYLE="white-space:nowrap">12-month</FONT> period immediately
preceding the effective date of any reduction in the Letter of Credit, Tenant shall have the right to reduce the amount of the Letter of Credit on each anniversary of the Commencement Date through the Lease Term by the amount of Eighty Thousand
Dollars ($80,000.00) per annum. If Tenant is not entitled to reduce the Letter of Credit as of a particular anniversary of the Commencement Date due to Tenant&#146;s failure to timely pay all Rent beyond all applicable notice and cure periods during
the 12 months prior in time, then the right to all subsequent reduction(s) shall terminate. Notwithstanding anything to the contrary contained in this <U>Section</U><U></U><U>&nbsp;6.1(c)</U>, the occurrence of any material default under this Lease
that has not been cured after notice and within the applicable cure period, shall extinguish all further right to reduce the amount of the Letter of Credit as described herein. Any reduction in the Letter of Credit shall be accomplished by Tenant
providing Landlord with a substitute letter of credit in the reduced amount and otherwise in compliance with all terms of this Section. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. L<SMALL>ATE</SMALL> C<SMALL>HARGES</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any and all sums or charges set forth in this <U>Section</U><U></U><U>&nbsp;7</U> will be paid as Additional Rent. Tenant acknowledges that late payment (the
fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day of each month or any time thereafter) by Tenant to Landlord of Rent and all other sums due hereunder, will cause Landlord to incur costs not contemplated by this Lease. Such costs
may include, without limitation, processing and accounting charges, and late charges that may be imposed on Landlord by the terms of any note secured by any encumbrance against the Premises, and late charges and penalties due to the late payment of
real property taxes on the Premises. Therefore, if any installment of Rent or any other sum payable by Tenant is not received by Landlord within five (5)&nbsp;days from the date due (provided, however, that with respect to Tenant&#146;s first
failure during each Lease year to pay any installment of Rent or any other sum payable by Tenant, Landlord shall provide written notice to Tenant of such failure and Tenant shall have five (5)&nbsp;days following the date of such notice to pay such
past due amount), Tenant shall promptly pay to Landlord a late charge, as liquidated damages, in an amount equal to ten percent (10%) of such delinquent amount plus interest on such delinquent amount at the maximum legal rate. In addition to the
late charge described above, any Rent or other amounts owing hereunder that are not paid within ten (10)&nbsp;days the date that they are due (provided, however, that with respect to Tenant&#146;s first failure during each Lease year to pay any
installment of Rent or any amounts owing hereunder, Landlord shall provide written notice to Tenant of such failure and Tenant shall have five (5)&nbsp;days following the date of such notice to pay such past due amount) will bear interest from the
date when due until paid at a rate that is the higher of (i)&nbsp;ten percent (10%) per annum or (ii)&nbsp;the highest rate permitted by applicable law. The parties agree that this late charge and the other charges referenced above represent a fair
and reasonable estimate of the costs that Landlord will incur by reason of such late payment by Tenant, excluding attorneys&#146; fees and costs. Acceptance of any late charge or other charges shall not constitute a waiver by Landlord of
Tenant&#146;s default with respect to the delinquent amount, nor prevent Landlord from exercising any of the other rights and remedies available to Landlord for any other breach of Tenant under this Lease. If a late charge becomes payable for three
(3)&nbsp;installments of Rent, then Landlord, at Landlord&#146;s sole option, can either require the Rent be paid quarterly in advance or be paid monthly in advance by cashier&#146;s check or by electronic funds transfer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. U<SMALL>TILITIES</SMALL> <SMALL>AND</SMALL> S<SMALL>ERVICES</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.1 Utility Expenses</B>: Tenant shall arrange for and pay for all water, gas, heat, light, power, telephone, and other utilities and
services supplied to the Premises, together with any taxes thereon, directly to the utility providers. Tenant shall also provide for its own garbage and janitorial service, at its sole cost and expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.2 Interruption of Use</B>: Tenant agrees that Landlord is not liable for damage, by
abatement of Rent or otherwise, for failure to furnish or delay in furnishing any service (including electricity, telephone and telecommunications services), or for any diminution in the quality or quantity thereof, when such failure or delay or
diminution is occasioned, in whole or in part, by breakage, repairs, replacements, shortages, outages, brown-outs, black-outs, or improvements, by any strike, lockout, or other labor trouble, by inability to secure electricity, gas, water, or other
fuel at the Property after reasonable effort to do so, by any riot or other dangerous condition, emergency, accident, casualty whatsoever, by act or default of Tenant or any of Tenant&#146;s agents, employees, contractors or service-providers, or by
any other cause (other than arising from or in connection with the negligence or willful misconduct of Landlord); and such failure, delay or diminution will never be deemed to constitute an eviction, interruption, cessation or disturbance of
Tenant&#146;s use and possession of the Premises or relieve Tenant from paying Rent or performing any of its obligations under the Lease. Furthermore, Landlord shall not be liable under any circumstances for any loss of, or injury to, property or
for injury to, or interference with, Tenant&#146;s business, including, without limitation, loss of profits, however occurring, through or in connection with or incidental to a failure to furnish any of the services or utilities set forth in
<U>Section</U><U></U><U>&nbsp;8 (other than arising due to or in connection with the negligence of willful misconduct of Landlord)</U>. Tenant acknowledges that the Premises may become subject to the rationing or partial or intermittent
&#147;blackouts&#148; of utility services or restrictions on utility use as required by a public utility company, governmental agency or other similar entity having jurisdiction thereof. Tenant agrees that its tenancy and occupancy hereunder shall
be subject to such rationing restrictions as may be imposed upon Landlord, Tenant, the Premises, or other portions of the Building, and Tenant shall in no event be excused or relieved from any covenant or obligation to be kept or performed by Tenant
by reason of any such rationing or restrictions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. U<SMALL>SE</SMALL> <SMALL>OF</SMALL> P<SMALL>REMISES</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.1 Approved Use</B>: The Premises are to be used solely for the purposes and uses specified in the Basic Lease Information and for no other
uses or purposes without Landlord&#146;s prior written consent, which may be withheld in Landlord&#146;s reasonable discretion. Tenant&#146;s use of the Premises will be in accordance with the rules and regulations for the Building, as set forth in
<U>Exhibit D</U> hereto, and any other reasonable rules and regulations promulgated by Landlord now or hereafter enacted relating the operation of the Premises and/or any other part of the Building (collectively, the &#147;Rules and
Regulations&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.2 Prohibition on Use</B>: Tenant shall not use the Premises or permit anything to be done in or about the
Premises nor keep or bring anything therein that will in any way increase the existing rate of or affect any policy of fire or other insurance upon the Building or any of its contents, or cause a violation or cancellation of any insurance policy. No
auctions may be held or otherwise conducted in, on or about any portion of the Premises or the Building without Landlord&#146;s prior written consent thereto, in its sole and absolute discretion. Tenant shall not do or permit anything to be done in
or about the Premises that will in any way obstruct or interfere with the rights of Landlord or other tenants or occupants of any portion of the Building. The Premises shall not be used for any unlawful purpose. Tenant will not cause, maintain, or
permit any private or public nuisance in, on or about any portion of the Premises or the Building, including, but not limited to, any offensive odors, noises, fumes, or vibrations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. C<SMALL>ONDITION</SMALL> <SMALL>OF</SMALL> P<SMALL>REMISES</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord shall deliver the Premises with the Covered Items (as defined in Section&nbsp;12.1 below) in good order and operating condition. Tenant agrees to
accept the Premises on the Commencement Date as then being suitable for Tenant&#146;s intended use and in good operating order, condition, and repair in its then existing &#147;AS IS&#148; condition, except as otherwise set forth in <U>Exhibit C</U>
hereto. The Tenant Improvements (defined in <U>Exhibit C</U>) shall be installed in accordance with the terms, conditions, criteria, and provisions set forth in <U>Exhibit C</U>. Landlord shall advance the Tenant Improvement Allowance to Tenant for
the purposes of constructing the Tenant Improvements in accordance with the procedures described in <U>Exhibit C</U>. By taking possession of the Premises, Tenant shall be deemed to have accepted the Premises in good condition and state of repair
and in full compliance with the Delivery Condition set forth in <U>Exhibit C</U>, punchlist items excepted. Tenant expressly acknowledges and agrees that neither Landlord nor any of Landlord&#146;s agents, representatives or employees has made any
representations as to the suitability, fitness, or condition of the Premises for the conduct of Tenant&#146;s business or for any other purpose, including without limitation, any storage incidental thereto. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. A<SMALL>LTERATIONS</SMALL>; <SMALL>AND</SMALL> S<SMALL>URRENDER</SMALL> <SMALL>OF</SMALL> P<SMALL>REMISES</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.1 Alterations</B>: Tenant will not install any signs, fixtures, improvements, nor make or permit any other alterations or additions
(individually, an &#147;Alteration&#148;, and collectively, the &#147;Alterations&#148;) to the Premises without the prior written consent of Landlord, which consent shall not be unreasonably withheld so long as any such Alteration is in compliance
with <U>Section</U><U></U><U>&nbsp;11</U> of this Lease and does not affect the Building systems or the structural integrity of the Premises or the Building. It is hereby acknowledged and agreed that the Tenant Improvement shall not constitute
&#147;Alternations&#148; and shall be governed by <U>Exhibit C</U>. Any Alteration affecting the structure of the Building or Building systems is subject to the sole and absolute discretion of Landlord. If any such Alteration is expressly permitted
by Landlord in writing, Tenant shall deliver at least twenty (20)&nbsp;days prior notice to Landlord, from the date Tenant intends to commence construction, sufficient to enable Landlord to post a Notice of
<FONT STYLE="white-space:nowrap">Non-Responsibility.</FONT> In all events, Tenant shall obtain all permits or other governmental approvals prior to commencing any of such work and deliver copies to Landlord. All Alterations shall be at Tenant&#146;s
sole cost and expense, and shall be installed by a licensed contractor (reasonably approved by Landlord) in compliance with all applicable Laws (including, but not limited to, the ADA). Tenant shall keep the Premises and the Property free from any
liens arising out of any work performed, materials furnished or obligations incurred by or on behalf of Tenant. Tenant shall, prior to construction of any and all Alterations, cause its contractor(s) and subcontractor(s) to provide insurance as
reasonably required by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.2 Surrender of Premises: </B>At the expiration of the Term or earlier termination of this Lease,
Tenant shall surrender the Premises to Landlord in good condition and repair (damage by acts of God, casualty, and normal wear and tear excepted), but with all interior walls cleaned, any carpets cleaned, all floors cleaned. On or before the
expiration or earlier termination of this Lease, Tenant shall remove all of Tenant&#146;s Property (as hereinafter defined) from the Premises. Tenant shall repair any damage caused by such removal of the Tenant&#146;s Property. For purposes hereof,
the term &#147;Tenant&#146;s Property&#148; shall mean and refer to all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equipment, trade fixtures, computer wiring and cabling, furnishings, inventories, goods, and personal property of Tenant. Any of Tenant&#146;s Property not so removed by Tenant as required herein
shall be deemed abandoned and may be removed, and disposed of by Landlord at Tenant&#146;s expense, and Tenant waives all claims against Landlord for any damages resulting from Landlord&#146;s retention and disposition of such property; provided,
however, Tenant shall remain liable to Landlord for all costs incurred in disposing of such abandoned property of Tenant. All Tenant Improvements and Alterations, except those that Landlord requires Tenant to remove, will remain in the Premises as
the property of Landlord. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. S<SMALL>ERVICES</SMALL> <SMALL>AND</SMALL> M<SMALL>AINTENANCE</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.1 </B><B>Maintenance by Landlord</B>: Landlord shall maintain the structural portions of the Building, including the roof, foundation,
parking lot, and building systems and utilities to the point where they enter the Building structure itself (collectively, &#147;Covered Items&#148;), in reasonably good order and condition except for damage occasioned by the negligence or willful
misconduct of Tenant, which damages shall be repaired by the Landlord at Tenant&#146;s expense. Tenant acknowledges that Landlord does not assume any responsibility for the security of persons or property in, upon or about the Premises or the
Building. Tenant expressly releases Landlord from any liability for theft, burglary, or damage or injury to persons or property caused by the persons gaining access to the Building or the Premises, except as occasioned by the active negligence or
willful misconduct of Landlord or its authorized representatives (&#147;Covered Claims&#148;). Tenant shall indemnify and defend Landlord from and against all such Covered Claims by Tenant&#146;s agents, contractors, employees, subtenants,
licensees, invitees, and visitors. Te </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.2 Services by Landlord</B>: Tenant shall be entitled to use the parking spaces on a <FONT
STYLE="white-space:nowrap">non-reserved</FONT> basis; however Tenant acknowledges that Landlord does not monitor the parking on the Property. Tenant will pay the utility costs associated with all Landlord services provided to the Premises in
accordance with <U>Section</U><U></U><U>&nbsp;8.1</U> above. Tenant will provide for its own janitorial service for the Premises, at Tenant&#146;s own cost and expense. Tenant agrees to cooperate with Landlord and to abide by all rules and
restrictions that Landlord may prescribe for the proper functioning and protection of heating, ventilating and air conditioning systems. Tenant acknowledges that the controls for the HVAC service to the Premises are located within the Premises and
Tenant shall cause the HVAC to be turned on in the morning and off every evening. Landlord shall not be in default hereunder or be liable for any damages directly or indirectly resulting from, nor shall it constitute a constructive eviction of the
Tenant, nor shall the Rent be reserved or abated by reason of (a)&nbsp;the installation, use or interruption of use of any equipment in connection with furnishing any of the foregoing services, or (b)&nbsp;the failure to furnish or delay in
furnishing any such service when such failure or delay is caused by accident or any condition beyond the reasonable control of Landlord or by the making of necessary repairs or improvements to the Premises or the Building, unless occasioned by the
negligence or willful misconduct of Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.3 Common Area</B>: Intentionally Deleted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.4 Security</B>: Tenant may install its own security system for the Premises, at its
sole cost and expense. Installation of the security system shall be in accordance with <U>Section</U><U></U><U>&nbsp;11</U> of this Lease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13.
INSURANCE. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.1 Types of Insurance</B>: Tenant shall maintain in full force and effect at all times during the Term of this Lease,
at Tenant&#146;s sole cost and expense, for the protection of Tenant and Landlord, the following policies of insurance: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.1.1
</B>Commercial General Liability Insurance (or its equivalent approved by Landlord in its reasonable discretion, if such policy form is no longer issued) insuring, among other liabilities, claims arising out of bodily injury, personal injury and
property damage arising out of Tenant&#146;s operations and contractual liabilities, including a Broad Form endorsement covering the insuring provisions of this Lease and the performance by Tenant of the indemnity set forth in
<U>Section</U><U></U><U>&nbsp;14</U> of this Lease, in limits not less than Three Million Dollars ($3,000,000) combined single limit for each occurrence for bodily injury, personal injury and property damage liability. Such insurance shall insure,
on an occurrence basis, against all liability of Tenant, its employees, and agents arising out of or in connection with Tenant&#146;s use of the Premises; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.1.2 </B>Worker&#146;s Compensation and Employer&#146;s Liability Insurance, as required by law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.1.3 </B>&#147;All Risk&#148; or &#147;Special Purpose&#148; Property Insurance for Tenant&#146;s personal property, including without
limitation, sprinkler leakage, and if the property of any of Tenant&#146;s invitees, vendors or customers is to be kept in the Premises, warehouser&#146;s legal liability or bailee&#146;s customer insurance. All insurance under this
<U>Section</U><U></U><U>&nbsp;13.1.3</U> will be written on a replacement cost basis (without deduction for depreciation) in an amount equal to One Hundred Percent (100%) of the full replacement value of any property damaged; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.1.4 </B>Such other insurance or higher limits of liability as is then customarily required for similar types of buildings within the
general vicinity of the Building as may be required by any of Landlord&#146;s lenders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.2 Insurance Policies</B>: Insurance required
to be maintained by Tenant shall be written by companies (i)&nbsp;licensed to do business in the State of California, (ii)&nbsp;domiciled in the United States of America, and (iii)&nbsp;having a &#147;General Policyholders Rating&#148; of at least
A:X (or such higher rating as may be required by a lender having a lien on the Premises) as set forth in the most current issue of &#147;A.M. Best&#146;s Rating Guides.&#148; Any deductible amounts under any of the insurance policies required
hereunder shall not exceed Five Thousand Dollars ($5,000). Tenant shall deliver to Landlord certificates of insurance and true and complete copies of any and all endorsements required herein for all insurance required to be maintained by Tenant
hereunder at the time of execution of this Lease by Tenant. Tenant shall, at least fifteen (15)&nbsp;days prior to expiration of each policy, furnish Landlord with certificates of renewal or &#147;binders&#148; thereof. Each certificate shall
expressly provide that such policies shall not be cancelable or otherwise subject to material modification except after thirty (30)&nbsp;days prior written notice to the parties named as additional insureds as required in this Lease (except for
cancellation for nonpayment of premium, in which event cancellation shall not take effect until at least ten (10)&nbsp;days&#146; notice has been given to Landlord). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.3 Additional Insureds and Coverage</B>: Each of Landlord, Landlord&#146;s property
management company or agent, and Landlord&#146;s lender(s) having a lien against the Premises or any other portion of the Property shall be named as additional insureds or loss payees (as applicable) under all of the policies required in
<U>Section</U><U></U><U>&nbsp;13</U>. Additionally, all of such policies shall provide for severability of interest. All insurance to be maintained by Tenant shall, except for workers&#146; compensation and employer&#146;s liability insurance, be
primary, without right of contribution from insurance maintained by Landlord. Any umbrella/excess liability policy (which shall be in &#147;following form&#148;) shall provide that if the underlying aggregate is exhausted, the excess coverage will
drop down as primary insurance. The limits of insurance maintained by Tenant shall not limit Tenant&#146;s liability under this Lease. It is the parties&#146; intention that the insurance to be procured and maintained by Tenant as required herein
shall provide coverage for any and all damage or injury arising from or related to Tenant&#146;s operations of its business and/or Tenant&#146;s or Tenant&#146;s officers, directors, agents, employees, invitees and contractors&#146; (collectively,
the &#147;Tenant&#146;s Representatives&#148;) use of the Premises and any of the areas within the Building. Notwithstanding anything to the contrary contained herein, to the extent Landlord&#146;s cost of maintaining insurance with respect to the
Building is increased as a result of Tenant&#146;s acts, omissions, Alterations, improvements, use or occupancy of the Premises, Tenant shall pay one hundred percent (100%) of, and for, each such increase as Additional Rent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.4 Failure of Tenant to Purchase and Maintain Insurance</B>: If Tenant fails to obtain and maintain the insurance required herein
throughout the Term of this Lease, Landlord may, but without obligation to do so, purchase the necessary insurance and pay the premiums therefore. If Landlord so elects to purchase such insurance, Tenant shall promptly pay to Landlord as Additional
Rent, the amount so paid by Landlord, upon Landlord&#146;s demand therefore. In addition, Landlord may recover from Tenant and Tenant agrees to pay, as Additional Rent, any and all losses, damages, expenses and costs which Landlord may sustain or
incur by reason of Tenant&#146;s failure to obtain and maintain such insurance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.5 Waiver of Subrogation</B>: Landlord and Tenant
hereby mutually waive their respective rights of recovery against each other for any loss of, or damage to, either parties&#146; property to the extent that such loss or damage is insured by an insurance policy required to be in effect at the time
of such loss or damage. Each party shall obtain any special endorsements, if required by its insurer, whereby the insurer waives its rights of subrogation against the other party. This provision is intended to waive fully, and for the benefit of the
parties hereto, any rights and/or claims which might give rise to a right of subrogation in favor of any insurance carrier. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14.
I<SMALL>NDEMNITY</SMALL> <SMALL>AND</SMALL> L<SMALL>IMITATION</SMALL> <SMALL>OF</SMALL> L<SMALL>IABILITY</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.1
Indemnity</B>: Except to the extent of damage resulting from the sole gross negligence or willful misconduct of Landlord or its authorized representatives, Tenant agrees to indemnify and defend (with counsel reasonably acceptable to Landlord)
Landlord and Landlord&#146;s lenders, partners, members, agents, directors, officers, employees, representatives, contractors, successors and assigns (collectively, the &#147;Indemnitees&#148;) from and against all
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liabilities, damages, demands, penalties, costs, claims, losses, judgments, charges and expenses (including reasonable attorneys&#146; fees, costs and expenses) (collectively, &#147;Claims&#148;)
arising from or in any way related to, directly or indirectly, (i)&nbsp;Tenant&#146;s or Tenant&#146;s Representatives&#146; use or occupancy of the Premises and other portions of the Building, (ii)&nbsp;the conduct of Tenant&#146;s business, or
(iii)&nbsp;Tenant&#146;s failure to perform any covenant or obligation of Tenant under this Lease. Tenant agrees that the obligations of Tenant herein shall survive the expiration or earlier termination of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.2 Limitation of Liability</B>: Except to the extent of damage resulting from the sole gross negligence or willful misconduct of Landlord
or its authorized representatives, to the fullest extent permitted by law, Tenant agrees that neither Landlord nor any of the Indemnitees shall at any time or to any extent whatsoever be liable, responsible or in any way accountable for any loss,
liability, injury, death or damage to persons or property which at any time may be suffered or sustained by Tenant or by any person(s) whomsoever who may at any time be using, occupying or visiting the Premises or any other portion of the Building,
including, but not limited to, any acts, errors or omissions of any other tenants or occupants of the Building. Tenant shall not, in any event or circumstance, be permitted to offset, avoid, mitigate, diminish, or otherwise credit against any
payments of Rent required herein for matters for which Landlord may be liable hereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. A<SMALL>SSIGNMENT</SMALL> <SMALL>AND</SMALL>
S<SMALL>UBLEASING</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.1 Prohibition</B>: Except for Permitted Transfers (as defined below), Tenant shall not, without the
prior written consent of Landlord (which consent shall not be unreasonably withheld, conditioned or delayed), assign, sublease, grant any license or concession or otherwise transfer this Lease or any interest herein, permit any assignment or other
such transfer of this Lease or any interest hereunder by operation of law, sublet the Premises or any part thereof, or permit the use of the Premises by any persons other than Tenant and Tenant&#146;s Representatives (all of the foregoing are
sometimes referred to collectively as &#147;Transfers&#148; and any person to whom any Transfer is made or sought to be made is sometimes referred to as a &#147;Transferee&#148;). No consent to any Transfer shall constitute a waiver of the
provisions of this <U>Section</U><U></U><U>&nbsp;15</U>, and all subsequent Transfers may be made only with the prior written consent of Landlord, which consent shall not be unreasonably withheld, but which consent shall be subject to the provisions
of this <U>Section</U><U></U><U>&nbsp;15</U>. Landlord&#146;s consent shall not be required for any Transfer to an affiliate, subsidiary of Tenant in which Tenant owns no less than fifty percent (50%) of the ownership interest or an entity that has
purchased all or substantially all of Tenant&#146;s assets. Any Transfer to an affiliated entity shall not be effective until the Transferee assumes all of the obligations under this Lease in writing to Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.2 Request for Consent</B>: If Tenant seeks to make a Transfer, Tenant shall notify Landlord, in writing, and deliver to Landlord at
least thirty (30)&nbsp;days (but not more than one hundred eighty (180)&nbsp;days) prior to the proposed commencement date of the Transfer (the &#147;Proposed Effective Date&#148;) the following information and documents (the &#147;Tenant&#146;s
Notice&#148;): (i) a description of the portion of the Premises to be transferred (the &#147;Subject Space&#148;); (ii) all of the terms of the proposed Transfer including without limitation, the Proposed Effective Date, the name and address of the
proposed Transferee, and a copy of the existing or proposed assignment, sublease or other agreement governing the proposed Transfer; (iii)&nbsp;current financial statements of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the proposed Transferee certified by an officer, member, partner or owner thereof, and any such other information as Landlord may then reasonably require, including without limitation, audited
financial statements for the previous three (3)&nbsp;most recent consecutive fiscal years; (iv)&nbsp;the Plans and Specifications (defined below), if any; and (v)&nbsp;such other information as Landlord may then reasonably require. Tenant shall give
Landlord the Tenant&#146;s Notice by registered or certified mail addressed to Landlord at Landlord&#146;s Address specified in the Basic Lease Information. Within fifteen (15)&nbsp;days after Landlord&#146;s receipt of the Tenant&#146;s Notice (the
&#147;Landlord Response Period&#148;) Landlord shall notify Tenant, in writing, of its determination with respect to such requested proposed Transfer and the election to recapture the Subject Space. If Landlord elects to recapture the Subject Space,
Tenant may withdraw its request for consent within twenty (20)&nbsp;days thereafter (&#147;Tenant&#146;s Request Withdrawal&#148;) and this Lease will continue in full force and effect. If Landlord does not elect to recapture pursuant to the
provisions of <U>Section</U><U></U><U>&nbsp;15.5</U> hereof and Landlord does consent to the requested proposed Transfer, Tenant may thereafter assign its interests in and to this Lease or sublease all or a portion of the Premises to the same party
and on the same terms as set forth in the Tenant&#146;s Notice. If Landlord fails to respond to Tenant&#146;s Notice within Landlord&#146;s Response Period, then, the proposed Transfer shall then be deemed disapproved by Landlord. As Additional Rent
hereunder, Tenant shall upon the Transfer pay to Landlord, a transfer fee in the amount of one thousand dollars ($1,000) (&#147;Transfer Fee&#148;), <U>plus </U>Tenant shall promptly reimburse Landlord for actual and reasonable legal and other
expenses incurred by Landlord in connection with any actual or proposed Transfer. This Transfer Fee is due at the time that any request for Transfer is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.3 </B><B>Criteria for Consent</B>: Tenant acknowledges and agrees that, among other circumstances for which Landlord could reasonably
withhold consent to a proposed Transfer, it shall be reasonable for Landlord to withhold its consent where (i)&nbsp;Tenant is or has been in default of its obligations under this Lease beyond applicable notice and cure periods; (ii) ) the use to be
made of the Premises by the proposed Transferee is prohibited under this Lease or differs from the uses permitted under this Lease, (iii)&nbsp;the proposed Transferee or its business is subject to compliance with additional requirements of the ADA
beyond those requirements which are applicable to Tenant, unless the proposed Transferee shall (a)&nbsp;first deliver plans and specifications for complying with such additional requirements (the &#147;Plans and Specifications&#148;) and obtain
Landlord&#146;s written consent thereto, and (b)&nbsp;comply with all Landlord&#146;s conditions contained in such consent, (iv)&nbsp;the proposed Transferee does not intend to occupy a substantial portion of the Premises assigned or sublet to it,
(v)&nbsp;Landlord reasonably disapproves of the proposed Transferee&#146;s business operating ability or history or creditworthiness of the business to be conducted by the proposed Transferee at the Premises, (vi)&nbsp;the proposed Transfer would
cause Landlord to violate another agreement or obligation to which Landlord is a party or otherwise subject, or (vii)&nbsp;Landlord otherwise reasonably determines that the proposed Transfer would have the effect of decreasing the value of the
Building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.4 Effectiveness of Transfer and Continuing Obligations</B>: Prior to the date on which any permitted Transfer becomes
effective, Tenant shall deliver to Landlord (i)&nbsp;a counterpart of the fully executed Transfer document, and (ii)&nbsp;Landlord&#146;s standard form of Consent to Assignment or Consent to Sublease attached hereto as <U>Exhibit E</U>, as
applicable, executed by Tenant and the Transferee in which each of Tenant and the Transferee confirms its obligations pursuant to this Lease. Failure or refusal of a Transferee to execute any such consent instrument shall not release or discharge
the Transferee from its obligation to do so or from any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liability as provided herein. The voluntary, involuntary, or other surrender of this Lease by Tenant, or a mutual cancellation by Landlord and Tenant, shall not work a merger, and any such
surrender or cancellation shall, at the option of Landlord, either terminate all or any existing subleases or operate as an assignment to Landlord of any or all of such subleases. Each permitted Transferee shall assume and be deemed to assume this
Lease and shall be and remain liable jointly and severally with Tenant for payment of Rent and for the due performance of, and compliance with all the terms, covenants, conditions, and agreements herein contained on Tenant&#146;s part to be
performed or complied with, for the Term of this Lease. No Transfer shall affect the continuing primary liability of Tenant (which, following assignment, shall be joint and several with the assignee) to perform any of the terms, covenants, and
conditions of this Lease. For purposes hereof, if Tenant is a business entity, direct or indirect transfer of fifty percent (50%) or more of the ownership interest of the entity (whether in a single transaction or in the aggregate through more than
one transaction) shall be deemed a change in Control and shall be subject to the provisions of Section&nbsp;15.8 hereof. Any and all options, first rights of refusal, tenant improvement allowances and other similar rights granted to Tenant in this
Lease, if any, shall not be assignable by Tenant unless expressly authorized in writing by Landlord. Any transfer made without Landlord&#146;s prior written consent, shall, at Landlord&#146;s option, be null, void and of no effect, and shall, at
Landlord&#146;s option, constitute a material default by Tenant of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.5 Recapture</B>: Landlord shall have the right, to
be exercised by giving written notice to Tenant within fifteen (15)&nbsp;days from receipt of Tenant&#146;s Notice, to recapture the Subject Space described in the Tenant&#146;s Notice, subject to Tenant&#146;s Request Withdrawal. If such recapture
notice is given, it shall serve to terminate this Lease with respect to the proposed Subject Space, or, if the proposed Subject Space covers all the Premises, it shall serve to terminate the entire Term of this Lease, in either case, as of the
Proposed Effective Date. If this Lease is terminated pursuant to the foregoing provisions with respect to less than the entire Premises, the Rent shall be adjusted on the basis of the proportion of rentable square feet retained by Tenant to the
rentable square feet originally demised and this Lease as so amended shall continue thereafter in full force and effect. Notwithstanding the foregoing, Landlord shall not recapture for the purposes of entering into a direct lease with Tenant&#146;s
proposed transferee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.6 Transfer Premium</B>: If Landlord consents to a Transfer, as a condition thereto which the Tenant hereby
agrees is reasonable, Tenant shall pay to Landlord, as Additional Rent, fifty percent (50%) any &#147;Transfer Premium&#148; received by Tenant from any Transferee. The term &#147;Transfer Premium&#148; shall mean all rent, additional rent, and
other consideration payable by such Transferee that either initially or over the term of the Transfer exceeds the Rent or pro rata portion of the Rent, as the case may be, for such space reserved in the Lease, less the &#147;Reasonable Costs of the
Transfer&#148;. &#147;Reasonable Costs of the Transfer&#148; means the actual costs incurred by Tenant in effectuating the Transfer, including the cost of constructing any tenant improvements as required by the Transfer to the extent attributable to
the Subject Space, leasing commissions, professional fees associated with space planning and any improvements, and legal fees. If less than all of the Premises is sublet or assigned, then the Transfer Premium shall be determined <FONT
STYLE="white-space:nowrap">pro-ratably</FONT> on a <FONT STYLE="white-space:nowrap">per-square-foot</FONT> basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.7 Waiver</B>: Notwithstanding any Transfer, or any indulgences, waivers or extensions
of time granted by Landlord to any Transferee, or failure by Landlord to take action against any Transferee, Tenant agrees that Landlord may, at its option, proceed against Tenant without having taken action against or joined such Transferee, except
that Tenant shall have the benefit of any indulgences, waivers and extensions of time granted to any such Transferee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.8
</B><B>Permitted Transfer</B>: Notwithstanding the foregoing, Tenant may Transfer all or part of its interest in this Lease or all or part of the Premises (a &#147;Permitted Transfer&#148;) to the following types of entities (a &#147;Permitted
Transferee&#148;) without the written consent of Landlord or fulfilling the requirements of the foregoing subsections: (a)&nbsp;any parent, subsidiary or affiliate corporation which Controls (as defined below), is Controlled by or is under common
Control with Tenant (collectively, an &#147;Affiliate&#148;); (b) any corporation, limited partnership, limited liability partnership, limited liability company or other business entity in which or with which Tenant, an Affiliate of Tenant, or their
respective corporate successors or assigns, is merged or consolidated, in accordance with applicable statutory provisions governing merger and consolidation of business entities, so long as in both cases (a)&nbsp;and (b), (i) Tenant&#146;s
obligations hereunder are assumed by the Permitted Transferee; and (ii)&nbsp;the Permitted Transferee satisfies the Net Worth Threshold as of the effective date of the Permitted Transfer; or (c)&nbsp;any corporation, limited partnership, limited
liability partnership, limited liability company or other business entity which acquires all or substantially all of Tenant&#146;s assets and/or ownership interests, if the Transferee satisfies the Net Worth Threshold as of the effective date of the
Transfer; provided, that no such Permitted Transfer is a subterfuge by Tenant to avoid its obligations under this Lease. Tenant shall remain liable for the performance of all of the obligations of Tenant hereunder, or if Tenant no longer exists
because of a merger, consolidation, or acquisition, the surviving or acquiring entity shall expressly assume in writing, the obligations of Tenant hereunder. Additionally, the Permitted Transferee shall comply with all of the terms and conditions of
this Lease, whether accruing prior to and/or from and after the consummation of the Transfer. No later than ten (10)&nbsp;days prior to the effective date of any Permitted Transfer, Tenant shall (1)&nbsp;notify Landlord in writing of such Permitted
Transfer, and (2)&nbsp;furnish Landlord with copies of (A)&nbsp;the instrument effecting any of the foregoing Permitted Transfers, (B)&nbsp;documentation establishing Tenant&#146;s satisfaction of the requirements set forth above applicable to any
such Permitted Transfer, and (3)&nbsp;evidence of insurance as required under this Lease with respect to the Permitted Transferee (collectively, the &#147;Permitted Transferee Information&#148;). Landlord hereby acknowledges that the prospective
transaction effecting a Permitted Transfer (&#147;M&amp;A Activity&#148;) may be <FONT STYLE="white-space:nowrap">non-public</FONT> and highly confidential. Landlord shall maintain all information on the M&amp;A Activity, including the Permitted
Transferee Information strictly confidential. The occurrence of a Permitted Transfer shall not waive Landlord&#146;s rights as to any subsequent Transfers. As used herein, the term &#147;Net Worth Threshold&#148; shall mean the proposed Permitted
Transferee has a tangible net worth equal to or greater than that of the originally named Tenant as of December&nbsp;31 of the year prior to the Commencement Date (determined in accordance with generally accepted accounting principles consistently
applied and excluding from the determination of total assets all assets which would be classified as intangible assets under generally accepted accounting principles, including, without limitation, goodwill, licenses, trademarks, trade names,
copyrights and franchises The term &#147;Control&#148; shall mean the possession of the power to direct or cause the direction of the management and policy of such corporation, partnership, limited liability company or other entity, whether through
the ownership of voting securities, by statute or by contract, and whether directly or indirectly through Affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. I<SMALL>NTENTIONALLY</SMALL> D<SMALL>ELETED</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. S<SMALL>UBORDINATION</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the fullest extent
permitted by law, this Lease, the rights of Tenant under this Lease and Tenant&#146;s leasehold interest shall be automatically subject and subordinate at all times to: (i)&nbsp;all ground leases or underlying leases which may now exist or hereafter
be executed affecting the Building or the Property, and (ii)&nbsp;the lien of any mortgage or deed of trust that may now or hereafter exist for which the Building, ground leases or underlying leases or Landlord&#146;s interest or estate in any of
said items is specified as security. Notwithstanding the foregoing, Landlord or any such ground lessor, mortgagee, or any beneficiary shall have the right to require this Lease be superior to any such ground leases or underlying leases or any such
liens, mortgage, or deed of trust. If any ground lease or underlying lease terminates for any reason or any mortgage or deed of trust is foreclosed or a conveyance in lieu of foreclosure is made for any reason, Tenant shall attorn to and become the
Tenant of the successor in interest to Landlord, provided such successor in interest does not disturb Tenant&#146;s use, occupancy or quiet enjoyment of the Premises so long as Tenant is not in material default of the terms and provisions of this
Lease. The successor in interest to Landlord following foreclosure, sale or deed in lieu thereof shall not be: (a)&nbsp;liable for any act or omission of any prior lessor or with respect to events occurring prior to acquisition of ownership;
(b)&nbsp;subject to any offsets or defenses that Tenant might have against any prior lessor; (c)&nbsp;bound by prepayment of more than one (1)&nbsp;month&#146;s Rent, except in those instances when Tenant pays Rent quarterly in advance pursuant to
<U>Section</U><U></U><U>&nbsp;7</U> hereof, then not more than three months&#146; Rent; or (d)&nbsp;liable to Tenant for any Security Deposit not actually received by such successor in interest to the extent any portion or all of such Security
Deposit has not already been forfeited by, or refunded to, Tenant. Landlord shall be liable to Tenant for all or any portion of the Security Deposit not forfeited by, or refunded to Tenant, until and unless Landlord transfers such Security Deposit
to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successor-in-interest.</FONT></FONT> Tenant covenants and agrees to execute (and acknowledge if required by Landlord, any lender or ground lessor) and deliver, within five
(5)&nbsp;days of a demand or request by Landlord and in the form reasonably requested by Landlord, ground lessor, mortgagee or beneficiary, any additional documents evidencing the priority or subordination of this Lease with respect to any such
ground leases or underlying leases or the lien of any such mortgage or deed of trust. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18. R<SMALL>IGHT</SMALL> <SMALL>OF</SMALL> E<SMALL>NTRY</SMALL>.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord and its agents shall have the right to enter the Premises at all reasonable times, upon reasonable prior notice, for purposes of inspection,
exhibition, posting of notices, investigation, replacements, repair, maintenance and alteration. It is further agreed that Landlord shall have the right to use any and all means Landlord deems necessary to enter the Premises in an emergency.
Landlord shall also have the right to place &#147;for sale&#148; signs on the outside of the Building. Tenant hereby waives any Claim from damages or for any injury or inconvenience to or interference with Tenant&#146;s business, or any other loss
occasioned thereby except for any Claim for any of the foregoing arising out of the sole active gross negligence or willful misconduct of Landlord or its authorized representatives. Notwithstanding the foregoing, Tenant may designate in writing
certain secured areas within the Premises which Landlord will not enter except in an emergency situation or upon no less that twenty-four hours prior written notice for the purpose of inspection. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19. E<SMALL>STOPPEL</SMALL> C<SMALL>ERTIFICATE</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant shall execute (and acknowledge if required by any lender or ground lessor) and deliver to Landlord, within ten (10)&nbsp;days after Landlord provides
such to Tenant, a statement in writing certifying that this Lease is unmodified and in full force and effect (or, if modified, stating the nature of such modification), the date to which the Rent and other charges are paid in advance, if any,
acknowledging that there are not, to Tenant&#146;s knowledge, any uncured defaults on the part of Landlord hereunder or specifying such defaults as are claimed, and such other matters as Landlord may reasonably require. Any such statement may be
conclusively relied upon by Landlord and any prospective purchaser or encumbrancer of the Building or other portions of the Property. Tenant&#146;s failure to deliver such statement within such time shall be conclusive upon the Tenant that
(a)&nbsp;this Lease is in full force and effect, without modification except as may be represented by Landlord; (b)&nbsp;there are no uncured defaults in Landlord&#146;s performance; and (c)&nbsp;not more than one month&#146;s Rent has been paid in
advance, except in those instances when Tenant pays Rent quarterly in advance pursuant to <U>Section</U><U></U><U>&nbsp;7</U> hereof, then not more than three months&#146; Rent has been paid in advance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20. T<SMALL>ENANT</SMALL>&#146;<SMALL>S</SMALL> D<SMALL>EFAULT</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The occurrence of any one or more of the following events shall, at Landlord&#146;s option, constitute a material default by Tenant of the provisions of this
Lease: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20.1 </B>The abandonment of the Premises by Tenant or the vacation of the Premises by Tenant which would cause any insurance
policy to be invalidated or otherwise lapse; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20.2 </B>The occurrence of two (2)&nbsp;or more
<FONT STYLE="white-space:nowrap">non-material</FONT> defaults during any one calendar year, or four (4)&nbsp;or more material defaults during the Term; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20.3 </B>The failure by Tenant to make any payment of Rent, Additional Rent or any other payment required hereunder within five
(5)&nbsp;days for written notice (such notice being in lieu of any notice required by California Code of Civil Procedure Section&nbsp;1161). Landlord may, by written notice to Tenant, require Tenant to pay any late Rent with a cashier&#146;s check
or by wire transfer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20.4 </B>The failure by Tenant to observe, perform or comply with any of the conditions, covenants or provisions
of this Lease (except failure to make any payment of Rent and/or Additional Rent) and such failure is not cured within (i)&nbsp;thirty (30) days from the date that Landlord delivers written notice of such failure to Tenant for all failures other
than with respect to the timely delivery by Tenant of a subordination, <FONT STYLE="white-space:nowrap">non-disturbance</FONT> and attornment agreement (an &#147;SNDA&#148;), a counterpart of a fully executed Transfer document and a consent thereto
(collectively, the &#147;Transfer Documents&#148;), an estoppel certificate or insurance certificates, and (ii)&nbsp;the time period, if any, specified in the applicable sections of this Lease with respect to subordination, assignment and sublease,
estoppel certificates and insurance. However, Tenant shall not be in default of its obligations hereunder if such failure (other than any failure of Tenant to timely deliver an SNDA, the Transfer Documents, an estoppel certificate or insurance
certificates, for which no additional cure period shall be given to Tenant) cannot reasonably be cured within such thirty (30)&nbsp;or ten (10)&nbsp;day period, as applicable, and Tenant promptly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commences, and thereafter diligently proceeds with same to completion, all actions necessary to cure such failure as soon as is reasonably possible, but in no event shall the completion of such
cure be later than sixty (60)&nbsp;days after the date on which Landlord delivers to Tenant written notice of such failure, unless Landlord, acting reasonably and in good faith, otherwise expressly agrees in writing to a longer period of time based
upon the circumstances relating to such failure as well as the nature of the failure and the nature of the actions necessary to cure such failure; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20.5 </B>The making of a general assignment by Tenant for the benefit of creditors, the filing of a voluntary petition by Tenant or the
filing of an involuntary petition by any of Tenant&#146;s creditors seeking the rehabilitation, liquidation, or reorganization of Tenant under any law relating to bankruptcy, insolvency or other relief of debtors and, in the case of an involuntary
action, the failure to remove or discharge the same within sixty (60)&nbsp;days of such filing, the appointment of a receiver or other custodian to take possession of substantially all of Tenant&#146;s assets or this leasehold, Tenant&#146;s
insolvency or inability to pay Tenant&#146;s debts or failure generally to pay Tenant&#146;s debts when due, any court entering a decree or order directing the winding up or liquidation of Tenant or of substantially all of Tenant&#146;s assets,
Tenant taking any action toward the dissolution or winding up of Tenant&#146;s affairs, the cessation or suspension of Tenant&#146;s use of the Premises, or the attachment, execution or other judicial seizure of substantially all of Tenant&#146;s
assets or this leasehold. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>21. R<SMALL>EMEDIES</SMALL> <SMALL>FOR</SMALL> T<SMALL>ENANT</SMALL>&#146;<SMALL>S</SMALL> D<SMALL>EFAULT</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>21.1 Landlord&#146;s Rights</B>: In the event of Tenant&#146;s material default under this Lease, and in addition to all other rights and
remedies available at law or in equity, Landlord may terminate Tenant&#146;s right to possession of the Premises by any lawful means in which case upon delivery of written notice by Landlord this Lease shall terminate on the date specified by
Landlord in such notice and Tenant shall immediately surrender possession of the Premises to Landlord. In addition, the Landlord shall have the immediate right of <FONT STYLE="white-space:nowrap">re-entry</FONT> whether or not this Lease is
terminated, and if this right of <FONT STYLE="white-space:nowrap">re-entry</FONT> is exercised following abandonment of the Premises by Tenant, Landlord may consider any of Tenant&#146;s Property left on the Premises to also have been abandoned. No <FONT
STYLE="white-space:nowrap">re-entry</FONT> or taking possession of the Premises by Landlord pursuant to this <U>Section</U><U></U><U>&nbsp;21.1</U> shall be construed as an election to terminate this Lease unless a written notice of such intention
is given to Tenant. If Landlord relets the Premises or any portion thereof, Tenant shall be liable immediately to Landlord for all costs Landlord incurs in reletting the Premises or any part thereof, including, without limitation, unamortized
broker&#146;s commissions, reasonable expenses of cleaning, redecorating, and further improving the Premises and other similar costs (collectively, the &#147;Reletting Costs&#148;). Any and all of the Reletting Costs shall be fully chargeable to
Tenant and shall not be prorated or otherwise amortized in relation to any new lease for the Premises or any portion thereof. Reletting may be for a period shorter or longer than the remaining term of this Lease. In no event shall Tenant be entitled
to any excess rent received by Landlord. No act by Landlord other than giving written notice to Tenant shall terminate this Lease. Acts of maintenance, efforts to relet the Premises or the appointment of a receiver on Landlord&#146;s initiative to
protect Landlord&#146;s interest under this Lease shall not constitute a termination of Tenant&#146;s right to possession. So long as this Lease is not terminated, Landlord shall have the right to remedy any default of Tenant, to maintain or improve
the Premises, to cause a receiver to be appointed to administer the Premises and new or existing subleases and to add to the Rent payable hereunder all of Landlord&#146;s reasonable costs in so doing, with interest at the maximum rate permitted by
law from the date of such expenditure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>21.2 Damages Recoverable</B>: If Tenant breaches this Lease and abandons the Premises
before the end of the Term, or if Tenant&#146;s right to possession is terminated by Landlord because of a breach or default under this Lease, then in either such case, Landlord may recover from Tenant all damages suffered by Landlord as a result of
Tenant&#146;s failure to perform its obligations hereunder, including without limitation, the unamortized cost of any Tenant Improvements constructed by or on behalf of Tenant pursuant to <U>Exhibit C</U> hereto to the extent Landlord has paid for
such improvements, the unamortized portion of any broker&#146;s or leasing agent&#146;s commission incurred with respect to the leasing of the Premises to Tenant for the balance of the Term of the Lease remaining after the date on which Tenant is in
default of its obligations hereunder, and all Reletting Costs, and the worth at the time of the award (computed in accordance with paragraph (3)&nbsp;of Subdivision (a)&nbsp;of Section&nbsp;1951.2 of the California Civil Code) of the amount by which
the Rent then unpaid hereunder for the balance of the Lease Term exceeds the amount of such loss of Rent for the same period which Tenant proves could be reasonably avoided by Landlord and in such case, Landlord prior to the award, may relet the
Premises for the purpose of mitigating damages suffered by Landlord because of Tenant&#146;s failure to perform its obligations hereunder; provided, however, that even though Tenant has abandoned the Premises following such breach, this Lease shall
nevertheless continue in full force and effect for as long as Landlord does not terminate Tenant&#146;s right of possession, and until such termination, Landlord shall have the remedy described in Section&nbsp;1951.4 of the California Civil Code
(Landlord may continue this Lease in effect after Tenant&#146;s breach and abandonment and recover Rent as it becomes due, if Tenant has the right to sublet or assign, subject only to reasonable limitations) and may enforce all its rights and
remedies under this Lease, including the right to recover the Rent from Tenant as it becomes due hereunder. The &#147;worth at the time of the award&#148; within the meaning of Subparagraphs (a)(1) and (a)(2) of Section&nbsp;1951.2 of the California
Civil Code shall be computed by allowing interest at the rate of ten percent (10%) per annum. Tenant waives redemption or relief from forfeiture under California Code of Civil Procedure Sections 1174 and 1179 (or any successor or substitute
statute), or under any other present or future law, in the event Tenant is evicted or Landlord takes possession of the Premises by reason of any default of Tenant hereunder. Tenant hereby waives for Tenant and for all those claiming under Tenant all
rights now or hereafter existing to redeem by order or judgment of any court or by any legal process or writ, Tenant&#146;s right of occupancy of the Premises after any termination of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>21.3 Rights and Remedies Cumulative</B>: The foregoing rights and remedies of Landlord are not exclusive; they are cumulative in addition
to any rights and remedies now or hereafter existing at law, in equity by statute or otherwise, or to any equitable remedies Landlord may have, and to any remedies Landlord may have under bankruptcy laws or laws affecting creditors&#146; rights
generally. In addition to all remedies set forth above, if Tenant materially defaults under this Lease, all options granted to Tenant hereunder shall automatically terminate, unless otherwise expressly agreed to in writing by Landlord. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>22. H<SMALL>OLDING</SMALL> O<SMALL>VER</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Tenant holds over after the expiration of the Lease Term hereof, with or without the express or implied consent of Landlord, such tenancy shall be from <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">month-to-month</FONT></FONT> only, and shall not constitute a renewal hereof or an extension for any further term, and in such case Base Rent shall be payable at a monthly rate equal to one
hundred fifty percent (150%) of the Base Rent applicable during the last rental period of the Lease Term under this Lease. Such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">month-to-</FONT></FONT> month tenancy shall be subject
to every other term, covenant and agreement contained herein. Landlord hereby expressly reserves the right to require Tenant to surrender possession of the Premises to Landlord as provided in this Lease upon the expiration or other termination of
this Lease. The provisions of this <U>Section</U><U></U><U>&nbsp;22</U> shall not be deemed to limit or constitute a waiver of any other rights or remedies of Landlord provided herein or at law. If Tenant fails to surrender the Premises upon the
termination or expiration of this Lease, and Landlord has provided Tenant with notice of a pending tenancy, then in addition to any other liabilities to Landlord accruing therefrom, Tenant shall protect, defend, indemnify, and hold Landlord harmless
from all Claims resulting from such failure. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>23. L<SMALL>ANDLORD</SMALL>&#146;<SMALL>S</SMALL> D<SMALL>EFAULT</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord shall not be considered in default of this Lease unless Landlord fails within a reasonable time to perform an obligation required to be performed by
Landlord hereunder. For purposes hereof, a reasonable time shall not be less than thirty (30)&nbsp;days after receipt by Landlord of written notice specifying the nature of the obligation Landlord has not performed; provided, however, that if the
nature of Landlord&#146;s obligation is such that more than thirty (30)&nbsp;days, after receipt of written notice, is reasonably necessary for its performance, then Landlord shall not be in default of this Lease if performance of such obligation is
commenced within such thirty (30)&nbsp;day period and thereafter diligently pursued to completion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>24. A<SMALL>RBITRATION</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties agree that any and all <FONT STYLE="white-space:nowrap">non-monetary</FONT> disputes, claims or controversies arising out of or relating to this
Lease that are not resolved by mutual agreement shall be submitted to mediation before JAMS, Inc. or its successor (&#147;JAMS&#148;). The parties agree to mediate any claims or disputes for a period of fifteen (15)&nbsp;days from the date that the
matter is submitted for mediation. If the parties are unable to reach an agreement through mediation, then either party may submit the matter to JAMS for final, binding arbitration, pursuant to the United States Arbitration Act, 9 U.S.C. Sec. 1
<U>et seq</U>. Either party may commence the mediation/arbitration process called for in this Lease by filling a written demand for mediation with JAMS, with a copy to the other party. The arbitration will be conducted in accordance with the
provisions of JAMS Streamline Arbitration Rules and Procedures in effect at the time of filing the demand for arbitration. In the event of any conflict between the United States Arbitration Act and the JAMS Streamline Arbitration Rules, the JAMS
rules shall prevail. The parties will cooperate with JAMS and with one another in selecting a mediator and an arbitrator from JAMS&#146;s panel of neutrals, and in scheduling the mediation and arbitration proceedings. The mediator and the arbitrator
shall not be the same neutral. The parties covenant that they will participate in the mediation and arbitration in good faith. The costs of the mediation will be borne equally by both parties; the costs of the arbitration shall be borne by the
losing party. The provisions of this Section may be enforced by any court of competent jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>25. T<SMALL>RANSFER</SMALL> <SMALL>OF</SMALL> L<SMALL>ANDLORD</SMALL>&#146;<SMALL>S</SMALL>
I<SMALL>NTEREST</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If there is any sale or other transfer of the Premises or any other portion of the Property by Landlord or any of
Landlord&#146;s interest therein, Landlord will automatically be entirely released from all liability under this Lease upon transfer of Security Deposit to the new transferee and Tenant agrees to look solely to such transferee for the performance of
Landlord&#146;s obligations hereunder after the date of such transfer. A ground lease or similar long-term lease by Landlord of the entire Building, of which the Premises are a part, shall be deemed a sale within the meaning of this
<U>Section</U><U></U><U>&nbsp;25</U>. Tenant agrees to attorn to such new owner provided such new owner does not disturb Tenant&#146;s use, occupancy, or quiet enjoyment of the Premises so long as Tenant is not in material default of any of the
provisions of this Lease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>26. W<SMALL>AIVER</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No delay or omission in the exercise of any right or remedy of either party on any default by the other party shall impair such a right or remedy or be
construed as a waiver. The subsequent acceptance of Rent by Landlord after default by Tenant of this Lease will not be deemed a waiver of such default, other than a waiver of timely payment for the particular Rent payment involved, and does not
prevent Landlord from maintaining an unlawful detainer or other action based on such breach. No payment by Tenant or receipt by Landlord of a lesser amount than the monthly Rent and other sums due hereunder shall be deemed to be other than on
account of the earliest Rent or other sums due, nor shall any endorsement or statement on any check or accompanying any check or payment be deemed an accord and satisfaction; and Landlord may accept such check or payment without prejudice to
Landlord&#146;s right to recover the balance of such Rent or other sum or pursue any other remedy provided in this Lease. No failure, partial exercise, or delay on the part of the Landlord in exercising any right, power or privilege hereunder shall
operate as a waiver thereof. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>27. C<SMALL>ASUALTY</SMALL> D<SMALL>AMAGE</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>27.1 Casualty</B>: If the Premises or any part thereof [excluding any of Tenant&#146;s Property, any Tenant Improvements and any Alterations
installed by or for the benefit of Tenant (collectively, the &#147;Tenant&#146;s FF&amp;E&#148;)] shall be damaged or destroyed by fire or other casualty, Tenant shall give immediate written notice thereof to Landlord. Within sixty (60)&nbsp;days
after receipt by Landlord of such notice, Landlord shall notify Tenant, in writing, whether the necessary repairs can reasonably be made, as reasonably determined by Landlord: (a)&nbsp;within one hundred eighty (180)&nbsp;days; or (b)&nbsp;in more
than one hundred eighty (180)&nbsp;days, from the date of such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>27.1.1 Minor Insured Damage</B>: If the Premises (other than
the Tenant&#146;s FF&amp;E) are damaged only to such extent that repairs, rebuilding and/or restoration can be reasonably completed one hundred eighty (180)&nbsp;days, this Lease shall not terminate and, provided that insurance proceeds are
available and paid to Landlord to fully repair the damage and/or Tenant otherwise voluntarily contributes any shortfall thereof to Landlord, Landlord shall repair the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Premises to substantially the same condition that existed prior to the occurrence of such casualty, except Landlord shall not be required to rebuild, repair, or replace any of Tenant&#146;s
FF&amp;E. The Rent payable hereunder shall be abated proportionately from the date and to the extent Tenant vacates the affected portions of the Premises until any and all repairs required herein to be made by Landlord are substantially completed
but such abatement shall only be to the extent (i)&nbsp;of the portion of the Premises which is actually rendered unusable and unfit for occupancy and only during the time Tenant is not actually using same, and (ii)&nbsp;Landlord receives rental
abatement insurance proceeds therefore. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>27.1.2 Major Insured Damage</B>: If the Premises (other than the Tenant&#146;s FF&amp;E) are
damaged to such extent that repairs, rebuilding and/or restoration cannot be reasonably completed, as reasonably determined by Landlord, within two hundred seventy (270)&nbsp;days, then either Landlord or Tenant may terminate this Lease by giving
written notice within twenty (20)&nbsp;days after notice from Landlord regarding the time period of repair. If either party notifies the other of its intention to so terminate the Lease, then this Lease will terminate and the Rent will be abated
from the date of the occurrence of such damage, provided Tenant diligently proceeds to and expeditiously vacates the Premises (but, in all events Tenant must vacate and surrender the Premises to Landlord by no later than ten (10)&nbsp;business days
thereafter or there shall not be any abatement of Rent until Tenant so vacates the Premises). If neither party elects to terminate this Lease, Landlord shall promptly commence and diligently prosecute to completion the repairs to the Premises,
provided insurance proceeds are available and paid to Landlord to fully repair the damage or Tenant voluntarily contributes any shortfall thereof to Landlord (except that Landlord shall not be required to rebuild, repair, or replace any of
Tenant&#146;s FF&amp;E). During the time when Landlord is prosecuting such repairs to substantial completion, the Rent payable hereunder shall be abated proportionately from the date and to the extent Tenant actually vacates the affected portions of
the Premises until any and all repairs required herein to be made by Landlord are substantially completed but such abatement shall only be to the extent (i)&nbsp;of the portion of the Premises which is actually rendered unusable and unfit for
occupancy and only during the time Tenant is not actually using same, and (ii)&nbsp;Landlord receives rental abatement insurance proceeds therefore. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>27.1.3 Damage Near End of Term</B>: Notwithstanding anything to the contrary contained in this Lease except for the provisions of
<U>Section</U><U></U><U>&nbsp;27.3</U> below, if the Premises are substantially damaged or destroyed during the last year of then applicable term of this Lease and, at the time of the damage or casualty, no notice regarding the exercise of any
Option has been delivered by Tenant, then either Landlord or Tenant may, at their option, cancel and terminate this Lease by giving written notice to the other party of its election to do so within thirty (30)&nbsp;days after receipt by Landlord of
notice from Tenant of the occurrence of such casualty. If either party so elects to terminate this Lease, all rights of Tenant hereunder shall cease and terminate ten (10)&nbsp;days after Tenant&#146;s receipt or delivery of such notice, as
applicable, and Tenant shall immediately vacate the Premises and surrender possession thereof to Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>27.2 Uninsured
Casualty</B>: If any portion of the Premises is damaged and is not fully covered by the aggregate of insurance proceeds received by Landlord and any applicable deductible, and Tenant does not voluntarily contribute any shortfall thereof to Landlord,
or if the holder of any indebtedness secured by the Premises requires that the insurance proceeds be applied to such indebtedness, then Landlord shall have the right to terminate this Lease by delivering written notice of termination to Tenant
within thirty (30)&nbsp;days after the date of notice to Tenant of any such event, whereupon all rights and obligations of Tenant shall cease and terminate hereunder, except for those obligations expressly provided for in this Lease to survive such
termination of the Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>27.3 Tenant&#146;s Fault and Lender&#146;s Rights</B>: Notwithstanding anything to the
contrary contained herein, if the Premises (other than Tenant&#146;s FF&amp;E) or any other portion of the Building be damaged by fire or other casualty conclusively determined to have been resulting from the intentional or sole gross negligent acts
or omissions of Tenant or any of Tenant&#146;s Representatives, (i)&nbsp;the Rent shall not be diminished during the repair of such damage, (ii)&nbsp;Tenant shall not have any right to terminate this Lease due to the occurrence of such casualty or
damage, and (iii)&nbsp;Tenant shall be liable to Landlord for the cost and expense of the repair and restoration of all or any portion of the Building caused thereby (including, without limitation, any deductible) to the extent such cost and expense
is not covered by insurance proceeds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>27.4 Tenant&#146;s Waiver</B>: So long as Landlord is using commercially reasonable efforts to
complete the repairs and renovations needed as a result of a casualty event, Landlord shall not be liable for any inconvenience or annoyance to Tenant, injury to the business of Tenant, loss of use of any part of the Premises by Tenant or loss of
Tenant&#146;s Property, resulting in any way from such damage, destruction or the repair thereof, except that, Landlord shall allow Tenant a fair diminution of Rent during the time and to the extent the Premises are actually unusable and unfit for
occupancy and Tenant is not using or otherwise occupying same as specifically provided above in this <U>Section</U><U></U><U>&nbsp;27</U>. With respect to any damage or destruction which Landlord is obligated to repair or may elect to repair, Tenant
hereby waives all rights to terminate this Lease or offset any amounts against Rent pursuant to rights accorded Tenant by any law currently existing or hereafter enacted, including but not limited to, all rights pursuant to the provisions of
Sections 1932(2.), 1933(4.), 1941 and 1942 of the California Civil Code, as the same may be amended or supplemented from time to time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>28.
C<SMALL>ONDEMNATION</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If fifty percent (50%) or more of the Premises is condemned by eminent domain, inversely condemned or sold in lieu of
condemnation for any public or quasi-public use or purpose (&#147;Condemned&#148;), then either Tenant or Landlord may terminate this Lease by written notice as of the date when physical possession of the Premises is taken and title vests in such
condemning authority, and Rent shall be adjusted to the date of termination. Tenant shall not because of such condemnation assert any claim against Landlord or the condemning authority for any compensation because of such condemnation, and Landlord
shall be entitled to receive the entire amount of any award without deduction for any estate of interest or other interest of Tenant; provided, however, the foregoing provisions shall not preclude Tenant, at Tenant&#146;s sole cost and expense, from
obtaining any separate award to Tenant for loss of or damage to Tenant&#146;s Property or for damages for cessation or interruption of Tenant&#146;s business provided such award is separate from Landlord&#146;s award and provided further such
separate award does not diminish nor otherwise impair the award otherwise payable to Landlord. In addition to the foregoing, Tenant shall be entitled to seek compensation for the relocation costs recoverable by Tenant pursuant to the provisions of
California Government Code Section&nbsp;7262. If neither party elects to terminate this Lease, Landlord shall, if necessary, promptly proceed to restore the Premises or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Building, as applicable, to substantially its same condition prior to such partial condemnation, allowing for the reasonable effects of such partial condemnation, and a proportionate allowance
shall be made to Tenant, as solely determined by Landlord, for the Rent corresponding to the time during that, and to the part of the Premises of that, Tenant is deprived on account of the partial condemnation and restoration. Landlord is not
required to spend funds for restoration in excess of the amount received by Landlord as compensation awarded. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>29. E<SMALL>NVIRONMENTAL</SMALL>
M<SMALL>ATTERS</SMALL>/H<SMALL>AZARDOUS</SMALL> M<SMALL>ATERIALS</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant must strictly comply with all statutes, laws, ordinances, rules,
regulations, and precautions now or hereafter mandated or advised by any federal, state, local or other governmental agency (collectively, &#147;Environmental Laws&#148;) with respect to the use, generation, storage, or disposal of hazardous, toxic,
or radioactive materials (collectively, &#147;Hazardous Materials&#148;). As herein used, Hazardous Materials shall include, but not be limited to, those materials identified in Sections 66680 through 66685 of Title 22 of the California Code of
Regulations, Division 4, Chapter 30, as amended from time to time, and those substances defined as &#147;hazardous substances,&#148; &#147;hazardous materials, &#147;hazardous wastes,&#148; &#147;chemicals known to cause cancer or reproductive
toxicity,&#148; &#147;radioactive materials,&#148; or other similar designations in the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, 42 U.S.C. Section&nbsp;9601 <U>et seq</U>., the Resource Conservation
and Recovery Act, 42 U.S.C. Section&nbsp;6901 <U>et seq</U>., the Hazardous Materials Transportation Act, 49 U.S.C. Section&nbsp;1801 <U>et seq</U>., 33 U.S.C. Section&nbsp;1251 <U>et seq</U>., 42 U.S.C. Section&nbsp;300(f) <U>et seq</U>., 42 U.S.C.
7401 <U>et seq</U>., California Health and Safety Code Section&nbsp;25249.5 <U>et seq</U>., California Water Code Section&nbsp;13000 <U>et seq</U>., California Health and Safety Code Section&nbsp;39000 <U>et seq</U>. and any other Environmental Laws
now or hereafter in effect. Tenant shall not cause, or allow anyone else to cause, any Hazardous Materials to be used, generated, stored, or disposed of on or about the Premises, the Building, or the Property other than reasonable quantities of
office and cleaning supplies in their retail containers. Tenant shall defend (with counsel approved by Landlord), indemnify and hold Landlord, its trustees, employees and agents, any entity having a security interest in the Premises, the Building,
or the Property, and its and their employees and agents (collectively, &#147;Indemnitees&#148;) harmless from and against, and shall reimburse the Indemnitees for, all liabilities, claims, costs, damages, and depreciation of property value,
including all foreseeable and unforeseeable consequential damages, directly or indirectly arising out of the use, generation, storage, or disposal of Hazardous Materials by Tenant or any person claiming under Tenant, including, without limitation,
the cost of any required or necessary investigation, monitoring, repair, cleanup, or detoxification and the preparation of any closure or other required plans, whether such action is required or necessary prior to or following the termination of
this Lease, as well as penalties, fines and claims for contribution to the full extent that such action is attributable, directly or indirectly, to the use, generation, storage, or disposal of Hazardous Materials by Tenant or any person claiming
under Tenant. Neither the consent by Landlord to the use, generation, storage, or disposal of Hazardous Materials nor the strict compliance by Tenant with all statutes, laws, ordinances, rules, regulations, and precautions pertaining to Hazardous
Materials shall excuse Tenant from Tenant&#146;s obligation of indemnification set forth above. Tenant&#146;s obligations under this <U>Section</U><U></U><U>&nbsp;29</U> shall survive the expiration or termination of this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>30. F<SMALL>INANCIAL</SMALL> S<SMALL>TATEMENTS</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant and any permitted Transferee, within twenty (20)&nbsp;days after Landlord&#146;s request therefore, but not more often than once annually so long as
Tenant is not in material default of this Lease, shall deliver to Landlord the then current audited financial statements of Tenant (including interim periods following the end of the last fiscal year for which annual statements are available. If
audited financial statements have not been prepared, Tenant and any permitted Transferee shall provide Landlord with certified, unaudited financial statements and such other information, the type and form of which are acceptable to Landlord in
Landlord&#146;s reasonable discretion, which reflects the financial condition of Tenant and any permitted Transferee. Landlord shall maintain the confidentiality of the financial statements provided by Tenant hereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>31. S<SMALL>IGNS</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All signs and graphics of
every kind visible in or from public view or corridors or the exterior of the Premises shall be subject to Landlord&#146;s prior written approval and shall be subject to and in compliance with all applicable Laws and the Rules and Regulations.
Tenant shall have the right to install a sign on the ground floor entry door, subject to the requirements of this Section. Tenant shall also have the right to listing on the directory board in the lobby area. The lobby directory will be maintained
at Landlord&#146;s sole cost and expense. In addition, Tenant, at its sole cost and expense, shall have the right to install &#147;eyebrow&#148; signs on the Building that are facing the street, provided that Landlord shall have the right to
reasonably approve the signage and Tenant must obtain all applicable approvals and permits for the City of Emeryville. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>32.
C<SMALL>OMMUNICATIONS</SMALL> <SMALL>AND</SMALL> C<SMALL>OMPUTER</SMALL> L<SMALL>INES</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant may install, maintain, replace or remove any
communications or computer wires and cables (collectively, the &#147;Lines&#148;) to serve the Premises, provided that (i)&nbsp;Tenant has obtained Landlord&#146;s prior written consent, in Landlord&#146;s reasonable discretion; (ii)&nbsp;Tenant
uses an experienced and qualified contractor, approved in writing by Landlord, in Landlord&#146;s reasonable discretion; (iii)&nbsp;Landlord complies with all other provisions of <U>Sections 10</U> and <U>11</U> of this Lease; (iv)&nbsp;the Lines
must be appropriately insulated to prevent excess electromagnetic fields or radiation and shall be surrounded by a protective conduit; and (v)&nbsp;Tenant shall pay all costs in connection therewith. As a condition precedent to the installation of
new Lines, Landlord may require that Tenant remove the Lines upon the expiration of the Lease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>33. M<SMALL>ORTGAGE</SMALL> <SMALL>OF</SMALL>
T<SMALL>ENANT</SMALL>&#146;<SMALL>S</SMALL> L<SMALL>EASEHOLD</SMALL> I<SMALL>NTEREST</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding any provision in this Lease to the
contrary, Tenant may not, without the prior consent of Landlord, which consent may be withheld in its sole and absolute discretion, mortgage, pledge, hypothecate or encumber the leasehold interest granted under this Lease, whether voluntary of by
operation of law. Any mortgage effected without the approval of Landlord shall constitute a material default under the Lease. Landlord&#146;s approval will not be construed to require Landlord to provide any leasehold mortgagee with any notice of
default or otherwise under this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>34. M<SMALL>ORTGAGEE</SMALL> P<SMALL>ROTECTION</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon any default on the part of Landlord, Tenant will give written Notice by registered or certified mail to any beneficiary of a deed of trust or mortgagee of
a mortgage covering the Premises who has provided Tenant with notice of their interest and an address for receiving Notice, and shall offer such beneficiary or mortgagee a reasonable opportunity to cure the default, including time to obtain
possession of the Premises by power of sale or a judicial foreclosure, if such should prove necessary to effect a cure. If such default cannot be cured within such time period, then such additional time as may be necessary will be given to such
beneficiary or mortgagee to effect such cure so long as such beneficiary or mortgagee has commenced the cure within the original time period and thereafter diligently pursues such cure to completion, in which event this Lease shall not be terminated
while such cure is being diligently pursued. Tenant agrees that each lender to whom this Lease has been assigned by Landlord is an express third party beneficiary hereof. Tenant shall not make any prepayment of Rent more than one (1)&nbsp;month in
advance without the prior written consent of each such lender, except if Tenant is required to make quarterly payments of Rent in advance pursuant to the provisions of <U>Section</U><U></U><U>&nbsp;7</U> above. Tenant waives the collection of any
deposit from such lender(s) or any purchaser at a foreclosure sale of such lender(s)&#146; deed of trust unless the lender(s) or such purchaser shall have actually received and not refunded the deposit. Tenant agrees to make all payments under this
Lease to the lender with the most senior encumbrance upon receiving a direction, in writing, to pay said amounts to such lender. Tenant shall comply with such written direction to pay without determining whether an event of default exists under such
lender&#146;s loan to Landlord. If, in connection with obtaining financing for the Premises or any other portion of the Property, Landlord&#146;s lender shall request reasonable modification(s) to this Lease as a condition to such financing, Tenant
shall not unreasonably withhold, delay or defer its consent thereto, provided such modifications do not materially and adversely affect Tenant&#146;s rights hereunder, the Rent, Term or the use, occupancy or quiet enjoyment of Tenant hereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>35. W<SMALL>ARRANTIES</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant hereby warrants
and represents to Landlord, for the express benefit of Landlord, that Tenant has undertaken a complete and independent evaluation of the risks inherent in the execution of this Lease and the operation of the Premises for the use permitted hereby,
and that, based upon said independent evaluation, Tenant has elected to enter into this Lease and hereby assumes all risks with respect thereto. Tenant hereby further warrants and represents to Landlord, for the express benefit of Landlord, that in
entering into this Lease, Tenant has not relied upon any statement, fact, promise or representation (whether express or implied, written or oral) not specifically set forth herein in writing and that any statement, fact, promise or representation
(whether express or implied, written or oral) made at any time to Tenant, which is not expressly incorporated herein in writing, is hereby waived by Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>36. B<SMALL>ROKERAGE</SMALL> C<SMALL>OMMISSION</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord and Tenant each represents and warrants for the benefit of the other that it has had no dealings with any real estate broker, agent or finder in
connection with the Premises and/or the negotiation of this Lease, except for the Broker(s) specified in the Basic Lease Information, and that it knows of no other real estate broker, agent or finder who is or might be entitled to a real estate
brokerage commission or finder&#146;s fee in connection with this Lease or otherwise based upon contacts between the claimant and Tenant. Each party shall indemnify and hold harmless the other from and against any and all liabilities or expenses
arising out of claims made for a fee or commission by any real estate broker, agent or finder in connection with the Premises and this Lease other than Broker(s), if any, resulting from the actions of the indemnifying party. Unless expressly agreed
to in writing by Landlord and Broker(s), no real estate brokerage commission or finder&#146;s fee shall be owed to, or otherwise payable to, the Broker(s) for any renewals or other extensions of the initial Term of this Lease or for any additional
space leased by Tenant other than the Premises as same exists as of the Lease Date. Tenant further represents and warrants to Landlord that Tenant will not receive (i)&nbsp;any portion of any brokerage commission or finder&#146;s fee payable to the
Broker(s) in connection with this Lease or (ii)&nbsp;any other form of compensation or incentive from the Broker(s) with respect to this Lease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>37.
Q<SMALL>UIET</SMALL> E<SMALL>NJOYMENT</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord covenants with Tenant, upon the paying of Rent and observing and keeping the covenants,
agreements and conditions of this Lease on its part to be kept, and during the periods that Tenant is not otherwise in default of any of the terms or provisions of this Lease, and subject to the rights of any of Landlord&#146;s lenders,
(i)&nbsp;that Tenant shall and may peaceably and quietly have, hold, occupy and enjoy the Premises during the Term of this Lease, and (ii)&nbsp;neither Landlord, nor any successor or assign of Landlord, shall disturb Tenant&#146;s occupancy or
enjoyment of the Premises. The foregoing covenant is in lieu of any other covenant express or implied. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>38. G<SMALL>ENERAL</SMALL>
P<SMALL>ROVISIONS</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.1 Time</B>. Time is of the essence in this Lease and with respect to each and all of its provisions
in which performance is a factor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.2 Successors and Assigns</B>. The covenants and conditions herein contained, subject to the
provisions as to assignment, apply to and bind the heirs, successors, executors, administrators and assigns of the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.3 Recordation</B>. Tenant shall not record this Lease or a short form memorandum hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.4 Landlord Exculpation</B>. The liability of Landlord to Tenant for any default by Landlord under the terms of this Lease, except for a
failure of Landlord to transfer the Security Deposit to any successor to Landlord, shall be limited to the actual interest of Landlord and its present or future partners or members in the Building, and Tenant agrees to look solely to Landlord&#146;s
interest in the Building for satisfaction of any liability and shall not look to other assets of Landlord nor seek any recourse against the assets of the individual partners, members, directors, officers, shareholders, agents or employees of
Landlord, including without limitation, any property management company of Landlord (collectively, the &#147;Landlord Parties&#148;). It is the parties&#146; intention that Landlord and the Landlord Parties shall not in any event or circumstance be
personally liable, in any manner whatsoever, for any judgment or deficiency hereunder or with respect to this Lease. The liability of Landlord under this Lease is limited to its actual period of ownership of title to the Building. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.5 Severability and Governing Law</B>. Any provisions of this Lease which shall prove
to be invalid, void, or illegal shall in no way affect, impair, or invalidate any other provisions hereof and such other provision shall remain in full force and effect. This Lease shall be governed by, and construed in accordance with, the laws of
the State of California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.6 Attorneys&#146; Fees</B>. In the event any dispute between the parties arises, regardless of whether
such disputes results in litigation or other proceeding, the prevailing party shall be reimbursed by the party not prevailing for all reasonable costs and expenses, including, without limitation, reasonable attorneys&#146; and experts&#146; fees and
costs incurred by the prevailing party in connection with such litigation or other proceeding, and any appeal thereof. Such costs, expenses and fees shall be included in and made a part of the judgment recovered by the prevailing party, if any. The
prevailing party is also entitled to any and all costs incurred in the collection of any judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.7 Entire Agreement</B>. It is
understood and acknowledged that there are no oral agreements between the parties hereto affecting this Lease and this Lease supersedes and cancels any and all previous negotiations, arrangements, brochures, agreements and understandings, if any,
between the parties hereto or displayed by Landlord to Tenant with respect to the subject matter thereof, and none thereof shall be used to interpret or construe this Lease. This Lease and any side letter or separate agreement executed by Landlord
and Tenant in connection with this Lease and dated of even date herewith contain all of the terms, covenants, conditions, warranties and agreements of the parties relating in any manner to the rental, use and occupancy of the Premises, shall be
considered to be the only agreement between the parties hereto and their representatives and agents, and none of the terms, covenants, conditions or provisions of this Lease can be modified, deleted or added to except in writing signed by the
parties hereto. All negotiations and oral agreements acceptable to both parties have been merged into and are included herein. There are no other representations or warranties between the parties, and all reliance with respect to representations is
based totally upon the representations and agreements contained in this Lease. The parties acknowledge that (i)&nbsp;each party and/or its counsel have reviewed and revised this Lease, and (ii)&nbsp;no rule of construction to the effect that any
ambiguities are to be resolved against the drafting party shall be employed in the interpretation or enforcement of this Lease or any amendments or exhibits to this Lease or any document executed and delivered by either party in connection with this
Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.8 Notices</B>. All notices, demands, consents, requests or other communications required to or permitted to be given
pursuant to this Lease (the &#147;Notices&#148;) shall be in writing, shall be given only in accordance with the provisions of this Section, shall be addressed to the parties in the manner set forth below, and shall be conclusively deemed to have
been properly delivered: (a)&nbsp;upon receipt when hand delivered during normal business hours; (b)&nbsp;upon the day of delivery if the notice has been deposited in a authorized receptacle of the United States Postal Service as first-class,
registered or certified mail, postage prepaid, with a return receipt requested; or (c)&nbsp;one (1) business day after the notice has been deposited with either FedEx or United Parcel Service to be delivered by overnight delivery. All notices shall
be delivered (i)&nbsp;to Tenant at the Tenant&#146;s Address set forth in the Basic Lease Information, or to such other place as Tenant may from time to time designate in a Notice to Landlord; or (ii)&nbsp;to Landlord at Landlord&#146;s Address set
forth in the Basic Lease Information, or to such other firm or to such other place as Landlord may from time to time designate in a Notice to Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.9 Joint and Several; Covenants and Conditions</B>. If Tenant consists of more than one
person or entity, the obligations of all such persons or entities shall be joint and several. Each provision to be performed by Tenant hereunder shall be deemed to be both a covenant and a condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.10 Authority</B>. If either Tenant or Landlord is a corporation, trust or partnership, each individual executing the Lease on behalf of
Tenant or Landlord, as applicable, hereby represents and warrants that Tenant or Landlord is a duly formed and validly existing entity qualifies to do business in California and that Tenant or Landlord has the full right and authority to execute and
deliver this Lease and that each person signing on behalf of Tenant or Landlord is authorized to do so. In such event, Tenant shall, within ten (10)&nbsp;business days after execution of this Lease, deliver to Landlord satisfactory evidence of such
authority and, if a corporation, upon demand by Landlord, also deliver to Landlord satisfactory evidence of (i)&nbsp;good standing in Tenant&#146;s state of incorporation and (ii)&nbsp;qualification to do business in California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.11 Confidentiality</B>. Tenant acknowledges that the content of this Lease and any related documents are confidential information.
Landlord acknowledges that the business plans and financial information of Tenant is confidential information. Each of the parties agrees it shall keep and maintain such confidential information strictly confidential and shall not disclose such
confidential information to any person or entity other than the other party&#146;s financial, legal and space planning consultants. Tenant shall notify all parties that have knowledge of the terms of this Lease, including all relevant employees, in
writing as to the existence of this confidentiality covenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.12 Landlord Renovations</B>. Tenant acknowledges that Landlord may
from time to time, at Landlord&#146;s sole option, renovate, improve, develop, alter, or modify (collectively, the &#147;Renovations&#148;) portions of the Building, Premises, and the Property, including without limitation, the systems, equipment,
roof, the Building and structural portions of the same, which Renovations may include, without limitation, (i)&nbsp;modifying any portion of the Building, including the Premises to comply applicable Laws, including regulations relating to the
physically disabled, seismic conditions, and safety and security; or (ii)&nbsp;creating additional parking areas or occupied space on the Property. The Renovations may also include any improvement or renovation done to increase the safety or
security of the Building in excess of the requirements required by the Laws, as Landlord determines to be necessary in its sole and absolute discretion. In connection with the Renovations, Landlord may, among other things, erect scaffolding or other
necessary structures in the Building, limit or eliminate access to portions of the Building, or perform work in the Building, which work may create noise, dust, or leave debris in the Building. Similarly, other properties in the vicinity of the
Building may undergo substantial construction or renovation during the Term, which may cause substantial disturbance to traffic and parking, and may cause dust, noise and vibration which may affect the Premises. Landlord shall use commercially
reasonable efforts to minimize disruption to Tenant&#146;s business. Tenant hereby agrees that such Renovations and Landlord&#146;s actions in connection with such Renovations shall in no way constitute a constructive eviction of Tenant
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nor entitle Tenant to any abatement of Rent. Landlord shall have no responsibility, or for any reason be liable to Tenant, for any direct or indirect injury to or interference with Tenant&#146;s
business arising from the Renovations, nor shall Tenant be entitled to any compensation or damages from Landlord for loss of the use of the whole or any part of the Premises or of Tenant&#146;s Property, Alterations or improvements resulting from
the Renovations or Landlord&#146;s actions in connection with such Renovations, or for any inconvenience or annoyance occasioned by such Renovations or Landlord&#146;s actions in connection with such Renovations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.13 Joint and Several</B>. The obligations of Tenant shall be joint and several between all entities names as &#147;Tenant&#148;
hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.14 Submission of Lease</B>. Submission of this instrument for examination or signature by Tenant does not constitute a
reservation of or an option for lease, and it is not effective as a lease or otherwise until execution and delivery by both Landlord and Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.15 Accessibility</B>. As of the Effective Date, there has been no inspection of the Property by a Certified Access Specialist
(&#147;CASp&#148;), as referenced in Section&nbsp;1938 of the California Civil Code. A CASp can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards
under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy
or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of fees for the CASp inspection, and the cost of
making any repairs necessary to correct violations of the construction- related accessibility standards within the Premises. Tenant is hereby advised that any CASp inspection shall be at Tenant&#146;s sole cost and expense and that any violation
within the Premises or on the Property shall be the responsibility of Tenant to correct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>38.16 OFAC Representation</B>. For purposes
hereof, &#147;List&#148; shall mean the Specially Designated Nationals and Blocked Persons List maintained by OFAC and/or on any other similar list maintained by OFAC pursuant to any authorizing statute, executive order, or regulation, and
&#147;OFAC&#148; shall mean the Office of Foreign Assets Control, Department of the Treasury. Each party represents and warrants to the other that (i)&nbsp;each Person owning a ten percent (10%) or greater interest in such party is (A)&nbsp;not
currently identified on the List, and (B)&nbsp;is not a person with whom a citizen of the United States is prohibited to engage in transactions by any trade embargo, economic sanction, or other prohibition of United States law, regulation, or
Executive Order of the President of the United States and (ii)&nbsp;each party has implemented procedures, and will consistently apply those procedures, to ensure the foregoing representations and warranties remain true and correct at all times.
Each party shall comply with all requirements of law relating to money laundering, anti-terrorism, trade embargos and economic sanctions, now or hereafter in effect and shall use reasonable efforts to notify the other in writing if any of the
forgoing representations, warranties or covenants are no longer true or have been breached or if such party has a reasonable basis to believe that they may no longer be true or have been breached. In addition, at the request of a party, the other
party shall provide such information as may be requested by the requesting to determine the other party&#146;s compliance with the terms hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of page intentionally left blank. Signatures on following page.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, this Lease is executed by the parties as of the Lease Date
referenced on Page i of this Lease. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>LANDLORD:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>TENANT:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PARK AVENUE BUILDING, LLC, a California limited liability company</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>METAGENOMI, INC.,</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>a
Delaware corporation</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>By:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Bruck</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>By</B>:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian C Thomas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>David Bruck,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Name</B>: Brian C. Thomas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Manager</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Title</B>: CEO</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PREMISES DESCRIPTION </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All that
certain real property situated in the City of Emeryville, County of Alameda, State of California, described as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARCEL ONE: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beginning at a point on the eastern line of Hubbard Street, distant thereon southerly 125 feet from the intersection thereof with the southern line of Park
Avenue, as said street and avenue are shown on the map hereinafter referred to; running thence southerly along said line of Hubbard Street, 50 feet; thence at right angles easterly 133 feet; thence at right angles northerly 50 feet; and thence at
right angles westerly 133 feet to the point of beginning. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Being a portion of Block 24 as said block is shown on the &#147;Map of art of Plot 6,
Kellersberger&#146;s Survey of Vicente&nbsp;&amp; Domingo Peralta Rancho, Property of J. S. Emery&#148;, etc., filed March&nbsp;1,1889 in Book 19 of Maps at Page 68 in the office of the County Recorder of Alameda County. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARCEL TWO: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beginning at the point of intersection of the
southern line of park Avenue with the eastern line of Hubbard Street, as said avenue and street are shown on the map hereinafter referred to; running thence southerly along said line of Hubbard Street, 125 feet, thence at right angles easterly 106
feet, 6 inches; thence at right angles northerly 125 feet to sard line of Park Avenue; and thence westerly along said line of Park Avenue, 106 feet, 6 inches to the point of beginning. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Being Lots 17 and 18 in Block 24 as said lots and block are shown on the &#147;Map of Part of Plot 6, Kellersberger&#146;s Survey of Vicente&nbsp;&amp;
Domingo Peralta Rancho, property of J. S. Emery&#148;, etc., filed March I, 1889 in Book 19 of Maps at Page 68 in the office of the County Recorder of Alameda County. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARCEL THREE: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The western 26.50 feet, front and rear
measurement, of Lot 19 in Block 24, as said lot and block are shown on the &#147;Map of part of Plot 6 Kellersberger&#146;s Survey of Vincente&nbsp;&amp; Domingo Peralta Rancho&#148;, filed March&nbsp;1, 1889 in Book 19 of Maps at Page 68 in the
office of the County Recorder of Alameda County. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>APN:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">049-0617-007-01</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ARB: None
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-A 1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMENCEMENT DATE AMENDMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1485 PARK AVENUE </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Lease, dated September&nbsp;29, 2021, between PARK AVENUE BUILDING, LLC, a California limited liability company
(&#147;Landlord&#148;), and METAGENOMI, INC., a Delaware corporation (&#147;Tenant&#148;), and for Premises known as 1485 Park Avenue, Emeryville, California. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant hereby verifies that the dates stated below are correct and further acknowledges and accepts possession of the Premises. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Commencement Date: <U></U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Rent Commencement Date: <U></U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Termination Date: <U></U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LANDLORD:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">TENANT:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PARK AVENUE BUILDING, LLC,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a
California limited liability company</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">METAGE NOMI, INC.,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Delaware
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Bruck</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Manager</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8195;</U></P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TENANT WORK LETTER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This &#147;Tenant Work Letter&#148; will set forth the terms and conditions of the Work (as defined below) to be performed by Tenant. The term
&#147;Work&#148; means the preparation and installation of the Tenant Improvements (as defined below), as more particularly described in this Tenant Work Letter. All terms not defined herein will have the meaning attributed to them in the Lease.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Condition of the Premises. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord will deliver
the Premises in its <FONT STYLE="white-space:nowrap">&#147;as-is&#148;</FONT> condition, broom-clean with the roof, foundation, parking lot and existing Building systems in good working order and condition. Landlord will, at its sole cost and
expense, ensure that all utilities are accessible and operable prior to the installation of the Tenant Improvements. All Work performed inside the exterior perimeter of the Premises, including the surfaces of any floors or ceilings, will be
performed by Tenant at the expense of Tenant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Tenant Improvements. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The &#147;Tenant Improvements&#148; consist of improvements constructed in the Premises pursuant to the plans and specifications mutually approved by Landlord
and Tenant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Tenant Improvement Allowance. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant
is entitled to a <FONT STYLE="white-space:nowrap">one-time</FONT> tenant improvement allowance (the &#147;Tenant Improvement Allowance&#148;) in the amount of up to Two Hundred <FONT STYLE="white-space:nowrap">Thirty-One</FONT> Thousand Five Hundred
Fifty Dollars ($231,550.00) for the design and construction of the Tenant Improvements. The Tenant Improvement Allowance may be used for all actual costs incurred performing the Work, including without limitation architecture, design, engineering,
and permitting (collectively, &#147;Soft Costs&#148;); provided, however, that in no event shall the amount of Soft Costs exceed ten percent (10%) of the Tenant Improvement Allowance. In no event will Landlord be obligated for any costs in excess of
the Tenant Improvement Allowance. No credit will be given for any unused portion of the Tenant Improvement Allowance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Provided that Tenant is not in
default hereunder beyond any applicable grace period, the Tenant Improvement Allowance shall be disbursed to Tenant, or as designated by Tenant, to Tenant&#146;s architect and/or General Contractor, on a monthly basis for costs theretofore incurred
by Tenant for which the Tenant Improvement Allowance is applicable within thirty (30)&nbsp;days after Tenant has provided Landlord with a written request for such payment, together with (i)&nbsp;copies of all government approvals theretofore
required, (ii)&nbsp;confirmation of the portion of the Work theretofore completed, certified by Tenant&#146;s architect and/or General Contractor, as appropriate, on standard AIA forms and (iii)&nbsp;partial lien waivers (conditioned solely on
payment of the payment amount requested) and progress payment affidavits from General Contractor and from all subcontractors. Landlord shall be permitted to hold a retainage equal to the greater of 10% of any payment or the retainage amount
specified in the contract with General Contractor. Landlord shall not be required to make final payment of the Allowance until thirty (30)&nbsp;days after Tenant has taken occupancy of the Premises and Landlord has received, in addition to the items
required under clauses (i)&nbsp;and (ii) above, final lien waivers and affidavits from General Contractor and all subcontractors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-C 1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Plans and Specifications. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant, through its architect (the &#147;Architect&#148;) and its engineers (the &#147;Engineers&#148;), (the Architect and the Engineers to be selected by
Tenant subject to reasonable agreement of Landlord will prepare the architectural, mechanical, and electrical plans (&#147;Construction Plans&#148;) required for the installation of the Tenant Improvements, if any. Tenant will consult with Landlord,
Architect, and the Engineers in the preparation of the Construction Plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Landlord&#146;s Review of Construction Plans.</U> The
Construction Plans are subject to the written approval of Landlord, which will be provided within ten (10)&nbsp;business days of receipt by Landlord and will not be unreasonably withheld, conditioned, or delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Changes to the Construction Plans.</U> If Landlord reasonably disapproves of the Construction Plans, it shall do so in writing
providing reasonably detailed specificity as to the reason for the disapproval, and Tenant will cause Architect and the Engineers to modify the Construction Plans, where appropriate. Landlord will then have an additional five (5)&nbsp;business days
to review the revised Construction Plans. Failure of Landlord to approve or disapprove of the Construction Plans within said <FONT STYLE="white-space:nowrap">5-day</FONT> period will constitute disapproval of the Construction Plans. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Permits. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant will submit the final Construction
Plans to all appropriate municipal authorities in order to secure the permits needed for the Work (the &#147;Permits&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Contractor. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the reasonable approval of Landlord, Tenant will retain a contractor to construct the Tenant Improvements in accordance with this Tenant Work Letter
(the &#147;Contractor&#148;). Tenant shall, prior to construction of the Tenant Improvements, cause the Contractor and any subcontractor(s) to provide insurance as reasonably required by Landlord. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Representatives. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 Tenant hereby
designates Arthur Salmon and Michael Charney (Spectrum Project Management Group) or their designee as its sole representative with respect to the matters set forth in this Tenant Work Letter, who, until further notice to Landlord, has full authority
and responsibility to act on behalf of Tenant as required in this Tenant Work Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 Landlord hereby designates David Bruck as its
sole representative with respect to the matters set forth in this Tenant Work Letter, who, until further notice to Tenant, has full authority and responsibility to act on behalf of Landlord as required in this Tenant Work Letter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-C 2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Landlord Supervision Fee. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant will pay to Landlord a construction supervision and management fee (&#147;Landlord Supervision Fee&#148;) equal to three percent (3%) of the total cost
of the Tenant Improvements, including any costs in excess of the Tenant Improvement Allowance, which fee may be paid with funds from the Tenant Improvement Allowance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Ownership of Tenant Improvements. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon termination of
the Lease, all Tenant Improvements that are permanently affixed to the Premises, or that are paid for with the Tenant Improvement Allowance, will become the property of Landlord. Depreciation of the Tenant Improvements will be allocable to the
parties <FONT STYLE="white-space:nowrap">pro-rata</FONT> in proportion to their payment of the Tenant Improvements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Work Free from Liens. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant will keep the property and the Premises free and clear of liens, claims, security interests or other encumbrances arising out of the Work. Tenant will
bond or otherwise remove any filed lien within ten (10)&nbsp;days after notice of the existence of the lien. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-C 3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>RULES AND REGULATIONS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The sidewalks, halls, passages, exits, entrances, elevators, escalators, and stairways of the Building shall not be obstructed by Tenants
or used by them for any purpose other than for ingress to and egress from their respective premises. The halls, passages, exits, entrances, elevators, escalators and stairways are not for the general public, and Landlord shall in all cases retain
the right to control and prevent access thereto of all persons whose presence in the judgment of Landlord would be prejudicial to the safety, character, reputation and interests of the Building and its Tenants, provided that nothing herein contained
shall be construed to prevent such access to persons with whom any Tenant normally deals in the ordinary course of its business, unless such persons are engaged in illegal activities. No Tenant and no agent, contractor, employee, subtenant,
licensee, invitee, or visitor of any Tenant shall go upon the roof of the Building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. No sign, placard, picture, name, advertisement, or
notice visible from the exterior of any Tenant&#146;s premises shall be inscribed, painted, affixed, or otherwise displayed by any Tenant on any part of the Building without the prior written consent of Landlord. Landlord will adopt and furnish to
Tenant general guidelines relating to signs inside the Building on the office floors. Tenant agrees to conform to such guidelines but may request approval of Landlord for modifications, which approval will not be unreasonably withheld. All approved
signs or lettering on doors shall be printed, painted, affixed, or inscribed at the expense of the Tenant by a person approved by Landlord, which approval will not be unreasonably withheld. Material visible from outside the Building will not be
permitted. Landlord may remove any sign or material that does not conform to the foregoing requirements without any liability to Tenant, and Landlord may charge Tenant for the cost of any such removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The premises shall not be used for the storage of merchandise held for sale to the general public (except for customary amounts of
inventory held in the usual course of business) or for lodging. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Tenant shall maintain the portions of its premises that are visible
from the outside of the Building, from the hallways, or any other public areas of the Building in a neat, clean, and orderly condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. No Tenant shall employ any person or persons other than a janitorial service approved by Landlord for the purpose of cleaning the premises,
unless otherwise agreed to by Landlord in writing. Except with the written consent of Landlord, no person, or persons other than those approved by Landlord shall be permitted to enter the Building for the purpose of cleaning the same. No Tenant
shall cause any unnecessary labor by reason of such Tenant&#146;s carelessness or indifference in the preservation of good order and cleanliness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. No Tenant shall alter any lock or install a new or additional lock or any bolt on any door of its premises without providing Landlord with
keys or access cards for those locks immediately upon alteration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-D 1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. No furniture, freight, or equipment of any kind shall be brought into the Building
without the prior written consent of Landlord. The persons employed to move such equipment in or out of the Building must be acceptable to Landlord and provide Liability Insurance and Workman&#146;s Compensation coverage naming the Landlord and
Management Company as additional insureds. Landlord shall have the right to prescribe the weight, size and position of all equipment, materials, furniture or other property brought into the Building. Heavy objects shall, if considered necessary by
Landlord, stand on wood strips of such thickness as is necessary to properly distribute the weight. Landlord will not be responsible for loss of or damage to any such property from any cause, and all damage done to the Building by moving or
maintaining such property shall be repaired at the expense of Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. No Tenant shall place any items whatsoever on the roof of the
Building without the prior written consent of Landlord, which may be withheld in Landlord&#146;s sole and absolute discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. No
Tenant shall use or keep in the premises or the Building any kerosene, gasoline or inflammable or combustible fluid or material other than limited quantities thereof reasonably necessary for the operation or maintenance of customary office
equipment. Without Landlord&#146;s prior written approval, no Tenant shall use any method of heating or <FONT STYLE="white-space:nowrap">air-conditioning</FONT> other than that supplied by Landlord. No Tenant shall use or keep or permit to be used
or kept any foul or noxious gas or substance in the premises, or permit the premises to be occupied or used in a manner offensive or objectionable to Landlord or other occupants of the Building by reason of noise, odors or vibrations, or interfere
in any way with other Tenants or those having business therein. Each Tenant, at its sole cost and expense, shall install and maintain in good working order a fire extinguisher next to any duplicating or photocopying machine or similar heat
generating equipment in its premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. Landlord shall have the right, upon 90 days&#146; prior notice and without liability to any
Tenant, to change the name and street address of the Building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. Handicap lift is to be used only by individuals needing access
assistance. The handicap lift is not to be used to move furniture, supplies or any other items. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. No curtains, draperies, blinds,
shutters, shades, screens or other coverings, hangings or decorations shall be attached to, hung, or placed in, or used in connection with any window or the Building without the prior written consent of Landlord. In any event, with the prior written
consent of Landlord, such items shall be installed on the office side of Landlord&#146;s standard window covering and shall in no way be visible from the exterior of the Building. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. No Tenant shall obtain for use in the premises ice, drinking water, food, beverage, towel, or other similar services, except at such
reasonable regulations as may be fixed by Landlord. Landlord agrees to allow tenant to maintain bottled water service, coffee and tea service, and a soda vending machine in the premises, subject to Landlord&#146;s reasonable regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. Each Tenant shall ensure the doors of its premises are closed and locked and that all water faucets, water apparatus and utilities are
shut off before Tenant or Tenant&#146;s employees leave the premises, so as to prevent waste or damage. For any default or carelessness in this regard Tenant shall make good all injuries sustained by other tenants or occupants of the Building or
Landlord. On multiple-tenancy floors, all Tenants shall keep the doors to the Building corridors closed at all times except for ingress and egress. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-D 2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. The toilet rooms, toilets, urinals, wash bowls and other apparatus shall not be used for
any purpose other than that for which they were constructed. No foreign substance of any kind whatsoever shall be thrown therein and the expense of any breakage, stoppage or damage resulting from the violation of this rule shall be borne by the
Tenant who, or whose agents, contractors, employees, subtenants, licensees, invitees, or visitors shall have caused it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. No Tenant
shall use or permit the use of any premises for a physician&#146;s or dentist&#146;s office, a dance or music studio, a school, a beauty salon or barber shop, a theater or exhibition hall, or for any business that would tend to generate a large
amount of foot traffic in or about the Building. No Tenant shall sell, or permit the sale at retail, or newspapers, magazines, periodicals, theater tickets or any other goods or merchandise to the general public in or on the premises. No Tenant
shall carry on, or permit or allow any employee or other person to carry on, the business of stenography, typewriting, copying, printing or any similar business in or from the premises of any Tenant be used for manufacturing of any kind or for the
storage of merchandise or for the sale of merchandise, goods or property of any kind at auction, or for any business or activity other than that specifically provided for in such Tenant&#146;s lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. No Tenant shall install any radio or television antenna, loudspeaker or other device on the roof or exterior walls of the Building. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. No Tenant shall bring into or keep within the Building, or within its premises, animals, or birds. If its premises become infested with
vermin, as a result of the use or any misuse or neglect of the premises by Tenant, its agents, contractors, employees, subtenants, licensees, invitees or visitors, Tenant shall at its sole cost and expense promptly cause the same to be exterminated
from time to time to Landlord&#146;s satisfaction, and Tenant shall employ such licensed exterminator therefore as shall be approved in writing in advance by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. There shall not be used in any space, or in the public halls of the Building, either by any Tenant or others, any hand trucks except those
equipped with rubber tires and side guards or such other material handling equipment as Landlord may approve. No other vehicles of any kind shall be brought by any Tenant into the Building or kept in or about its premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. Each Tenant shall store all its trash and garbage within its premises. No material shall be placed in the trash boxes or receptacles if
such material is of such nature that it may not be disposed of in the ordinary and customary manner of removing and disposing of trash and garbage in the City of Emeryville without being in violation of any law or ordinance governing such disposal.
All garbage and refuse disposal shall only be made through entryways and elevators provided for such purpose and at such times as Landlord shall designate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. Canvassing, peddling, soliciting, and distribution of handbills or any other written materials in or about the Building are prohibited,
and each Tenant shall cooperate to prevent the same. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-D 3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. The requirements of the Tenants will be attended to only upon application by telephone
or in writing. Employees or Landlord shall not perform any work of do anything outside of their regular duties unless under special instructions from Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. While in the Building, Tenant&#146;s contractors shall be subject to and under the control and direction of the manager of the Building.
Tenant&#146;s contractors shall employ labor that is harmonious and compatible with other labor working in the Building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. Landlord may
waive any one or more of these Rules and Regulations for the benefit of any particular Tenant or Tenants, but no such waiver by Landlord shall be construed as a waiver of such Rules and Regulations in favor of any other Tenant or Tenants, nor
prevent Landlord from thereafter enforcing any such Rules and Regulations against any or all of the Tenant of the Building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. These
Rules and Regulations are in addition to, and shall not be construed to in any way modify or amend, in whole or in part, the terms, covenants, agreements and conditions of any lease of premises in the Building. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. Landlord reserves the right to make such other and reasonable rules and regulations as in its judgment may from time to time be needed for
the safety, care, and cleanliness of the Building and for the preservation of good order therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-D 4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONSENT TO SUBLEASE/ASSIGNMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This CONSENT TO (SUBLEASE/ASSIGNMENT) (the &#147;Consent&#148;) is entered into by and between PARK AVENUE BUILDING, LLC, a California limited
liability company (&#147;Landlord&#148;), METAGENOMI, INC., a Delaware corporation (&#147;Tenant&#148;) and<U>&#8195;&#8195;&#8195;&#8195;&#8195;</U><U></U>(&#147;Assignee/Subtenant&#148;), effective as of
<U></U><U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>,20<U>&#8195;&#8195;&#8195;</U>. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Tenant currently leases that certain premises located at 1485 Park Avenue, Emeryville, California (the &#147;Premises&#148;) pursuant to
that certain Lease (the &#147;Lease&#148;), dated September&nbsp;29, 2021, by and between Landlord and Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. Tenant and
Assignee/Subtenant have entered into that certain Assignment/ Sublease (the &#147;Assignment/Sublease&#148;), dated as of <U></U><U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>,20<U>&#8195;</U><U>&#8195;&#8195;</U>, a copy of which is attached hereto as
<U>Exhibit A</U>, for (a portion of) the Premises (the &#147;(Subleased) Premises&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. <U>Section</U><U></U><U>&nbsp;15</U> of the
Lease requires Landlord&#146;s consent for any assignment or sublease. Pursuant to the terms of the Lease and this Consent, Landlord hereby consents to the Assignment/Sublease. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Consent
to Assignment/Sublease.</U> Landlord hereby consents to the Assignment/Sublease. This consent shall apply only to the Assignment/Sublease and shall not be deemed to be a consent to any further sublease or to any assignment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Acknowledgment and Agreement by Assignee/Subtenant</U>. Assignee/Subtenant acknowledges and agrees as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1 Assignee/Subtenant hereby assumes the obligations under the Lease to the extent of the Assignment/Sublease. Assignee/Subtenant
acknowledges that, to the extent of the Assignment/Sublease, he is liable jointly and severally with Tenant for payment of Rent and for the due performance of, and compliance with all the terms, covenants, conditions, and agreements of the Lease.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2 (For a Sublease) From and after the date of this Consent, in the event of any act or omission of Tenant that would give Subtenant the
right, either immediately or after the giving of notice and passage of time, to terminate the Sublease or to claim a partial or total eviction, Subtenant will not exercise any such right, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.2.1 Until Subtenant has given written notice of such act or omission to Landlord; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-E 1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.2.2 Until the same period of time as is given to Tenant under the Sublease to cure such
act or omission, but in all events no less than fifteen (15)&nbsp;days, shall have elapsed following the delivery of such notice to Landlord, without the cure of such act omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.3 (For a Sublease) In the event that Landlord notifies Subtenant of an Event of Default under the Lease and demands that Subtenant pay its
rent and all other sums due under the Sublease to Landlord, Subtenant shall honor such demand and pay its rent and all other sums due under the Sublease directly to Landlord or as otherwise required pursuant to such notice. Notwithstanding the
foregoing, nothing in this <U>Section</U><U></U><U>&nbsp;2.3</U> shall be construed to obligate Landlord to provide Subtenant with notice of any default under the Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4 Assignee/Subtenant will send a copy of any notice or statement under the Assignment/Sublease to Landlord at the same time such notice or
statement is sent to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.5 The Assignment/Sublease terminates no later than the Term Expiration Date. Should the Lease terminate
prior to the Term Expiration Date for any reason whatsoever, the Assignment/Sublease will terminate immediately upon the termination of the Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.6 Assignee/Subtenant agrees to comply with all the provisions of the Lease, which are hereby incorporated into the Assignment/Sublease. To
the extent of any inconsistency, the terms of the Assignment/Sublease will control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.7 Assignee/Subtenant agrees to indemnify Landlord
to the full extent of the indemnity required by Tenant, as Tenant, under <U>Section</U><U></U><U>&nbsp;13</U> of the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.8 Any
insurance required by Assignee/Subtenant in accordance with the Lease and the Assignment/Sublease shall name Landlord as &#147;Additional-Insured&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Acknowledgment and Agreement by Tenant</U>. Tenant, as tenant under the Lease and assignor/lessor under the Assignment/Sublease,
acknowledges and agrees for itself and its successors and assigns, that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.1 This Consent does not: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) constitute a waiver or amendment by Landlord of any of its rights under the Lease; and/or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) in any way release Tenant from its obligations to comply with the terms, provisions, conditions, covenants, agreements, and clauses of
the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.2 The provisions of the Lease remain in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3 (For a Sublease) In the event of an Event of Default by Tenant under the Lease, Subtenant may, and shall upon demand of Landlord, pay all
rent and all other sums due under the Sublease to Landlord as provided under this Consent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-E 2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>No Obligation of Landlord</U>. Landlord shall have no obligation or incur any
liability with respect to the erection or completion of any improvements in the (Subleased) Premises for Assignee&#146;s/Subtenant&#146;s use or for the erection or completion of any improvements for Assignee&#146;s/Subtenant&#146;s use in
connection with a relocation pursuant to the Lease, if any, of any portion of the premises leased to Tenant that may constitute all or a portion of the (Subleased) Premises. The foregoing shall not affect any obligations of Landlord to Tenant under
the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Miscellaneous.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.1 All notices required or permitted under this Consent to be given to Assignee/Subtenant and Tenant will be given as provided in the
Assignment/Sublease. All notices required or permitted under this Consent to be given to Landlord will be given as provided in the Lease to Landlord at the following address: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Park Avenue Building, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1105
La Grande Ave. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Napa, CA 94558 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: David Bruck </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2 All
exhibits and recitals attached to this Assignment/Sublease are hereby incorporated as though fully set forth herein. Any capitalized term that is not defined herein shall have the meaning attributed to it in the Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.3 This Consent supersedes any inconsistent provision of the Lease or the Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4 During the term of the Assignment/Sublease, Landlord has no obligation or any liability to Assignee/Subtenant with respect to any
warranties of any nature whatsoever, whether pursuant to the Lease, the Assignment/Sublease or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.5 This Consent shall inure to
the benefit of the parties hereto, their respective successors and permitted assigns; provided, however, that in the event of the assignment or transfer of the interest of Landlord, all obligations and liabilities of Landlord under this Consent will
terminate and shall become the responsibility of Landlord&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successor-in-</FONT></FONT> interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.6 This Consent shall be governed by and construed in accordance with the laws of the State of California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.7 This Consent may be executed in counterparts, each of which shall constitute an original, but all of which together shall constitute one
(1)&nbsp;and the same instrument. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-E 3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Consent is effective as of the date first written above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>LANDLORD:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>TENANT:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PARK AVENUE BUILDING, LLC,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>a California limited liability company</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>METAGENOMI, INC.,</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>a
Delaware corporation</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>By</B>:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>/s/ David Bruck</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>By</B>:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>David Bruck</B>,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Manager</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Name</B>:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Title</B>:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ASSIGNEE: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-E 4- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>8
<FILENAME>d425213dex1012.htm
<DESCRIPTION>EX-10.12
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.12</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;10.12 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE EMPLOYMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Executive Employment Agreement (the &#147;<U>Agreement</U>&#148;) is entered into as of the 20th day of March, 2023 (the
&#147;<U>Effective Date</U>&#148;) by and among Brian C. Thomas (the &#147;<U>Executive</U>&#148;), Metagenomi Inc. (the &#147;<U>Company</U>&#148;) and Metagenomi Technologies, LLC, the parent of the Company (the &#147;<U>Parent</U>,&#148; and
together with the Company, &#147;<U>Metagenomi</U>&#148;). The Executive and the Company are collectively referred to as the &#147;<U>Parties</U>&#148;). This Agreement shall be effective as of the Effective Date. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>,
the Company desires to continue to employ the Executive and the Executive desires to continue to be employed by the Company under the terms and conditions contained herein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Employment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Term</U>. The Company hereby employs the Executive, and the Executive hereby accepts such employment, on the terms set forth herein
commencing as of the Effective Date and continuing until this Agreement is terminated in accordance with the provisions of Section&nbsp;3 hereof (the &#147;<U>Term</U>&#148;). The Executive&#146;s employment with the Company shall be <FONT
STYLE="white-space:nowrap">&#147;at-will,&#148;</FONT> meaning that the Executive&#146;s employment may be terminated by the Company or Executive at any time and for any reason, subject to the terms of this Agreement, including but not limited to,
Sections 3 and 4. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Position and Duties</U>. During the Term, the Executive shall serve as the Chief Executive Officer of the Company
and of the Parent and shall have such powers and duties as may from time to time be prescribed by the Board of Directors of the Parent (the &#147;<U>Board</U>&#148;). The Executive shall devote the Executive&#146;s full working time and efforts to
the business and affairs of Metagenomi. Notwithstanding the foregoing, the Executive may engage in appropriate civic, religious, charitable or other community activities and service on approved boards of directors as long as such services and
activities are approved in advance by the Board in writing, and do not (i)&nbsp;create a conflict of interest or (ii)&nbsp;materially interfere with the Executive&#146;s obligations or performance of the Executive&#146;s duties to Metagenomi. The
Executive&#146;s current outside activities are disclosed on <U>Exhibit&nbsp;A</U>, to be updated from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Compensation
and Related Matters</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Base Salary</U>. During the Term, the Executive&#146;s initial annual base salary shall be five hundred
thousand dollars ($500,000), subject to applicable withholdings and deductions. The base salary shall be evaluated periodically by the Board or the Compensation Committee of the Board (the &#147;<U>Compensation Committee</U>&#148;). The base salary
in effect at any given time is referred to herein as &#147;<U>Base Salary</U>&#148;. The Base Salary shall be payable in a manner that is consistent with the Company&#146;s usual payroll practices for senior executives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Incentive Compensation</U>. During the Term, the Executive shall be eligible to
receive an annual cash bonus as determined by the Board or the Compensation Committee from time to time. The Executive&#146;s target annual bonus shall be fifty percent&nbsp;(50%) of Executive&#146;s Base Salary (the &#147;<U>Target
Bonus</U>&#148;). The actual amount of the annual bonus, if any, shall be determined in the sole discretion of the Board or the Compensation Committee, subject to the performance of the Executive and the Company in accordance with performance goals
established by the Parent and the terms of any applicable incentive compensation plan that may be in effect from time to time. The Executive must be employed by the Company on the day such bonus is paid in order to earn or receive any annual bonus.
The annual bonus, if any, shall be paid within thirty&nbsp;(30) days following the completion of the Company&#146;s annual financial audit for the fiscal year to which such bonus relates and the Company&#146;s receipt of an unqualified audit opinion
for such audit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Equity</U>. The Executive will be eligible to receive awards of stock options, restricted stock, profits interests
units or other equity awards (each, an &#147;<U>Award</U>&#148;) pursuant to any plans or arrangements the Parent (or if and as applicable, the Company) may have in effect from time to time. The Board or Compensation Committee, as applicable, will
determine in its discretion whether Executive will be granted an Award and the terms of such Award. Any Award will be subject to the terms and conditions of an agreement to be provided to the Executive, the Parent&#146;s (or if and as applicable,
the Company&#146;s) applicable equity incentive plan or arrangement as in effect and amended from time to time (each, an &#147;<U>Equity Incentive Plan</U>&#148;), and the Parent&#146;s Amended and Restated Limited Liability Company Agreement, as
amended from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Anti-Dilution</U>. During the period from the Effective Date until the earliest of (i)&nbsp;the date of
the Parent&#146;s (or the Company&#146;s) first public offering of its common units (or equivalent common securities) registered under the Securities Act of 1933, as amended, including (A)&nbsp;an initial public offering of the Parent&#146;s (or
Company&#146;s) common units (or equivalent common securities) (the &#147;<U>Initial Public Offering</U>&#148;), (B)&nbsp;a direct listing of the Parent (or the Company), or (C)&nbsp;a de-spac transaction, and (ii)&nbsp;a Change in Control, subject
to Executive&#146;s continuous service as Chief Executive Officer of the Company and Metagenomi, if, immediately following the final closing of any private placement preferred equity financing transaction (such financing an &#147;<U>Equity
Financing</U>&#148; and such closing, a &#147;<U>Final Equity Financing Closing</U>&#148;), the percentage of equity securities held by the Executive is less than six percent&nbsp;(6%) of the Fully Diluted Capitalization (as defined below) as of the
date of such Final Equity Financing Closing, then the Company will recommend to the Board that the Executive be granted an additional Award (an &#147; <U>Additional Equity Award</U>&#148;), the size of which will be such that, following the grant of
such Additional Equity Award, the percentage of equity securities of the Parent held by Executive (inclusive of the Additional Equity Award) shall equal six percent&nbsp;(6%) of the Fully Diluted Capitalization as of the date of such grant. Unless
otherwise determined by the Board or Compensation Committee, the terms of each Additional Equity Award with respect to vesting and acceleration will be identical to the vesting and acceleration terms of that certain Notice of Profits Interest Grant
and Profits Interest Grant Agreement, in each case between Parent and Executive dated March&nbsp;13, 2019; <U>provided</U> that the time-based vesting period of such Additional Equity Award will commence on the date of grant of such Additional
Equity Award, and to the extent that the Additional Equity Award is granted as an option or profits interest, as applicable, the exercise price or threshold amount, as applicable, for the Additional Equity Award shall be no less than the fair market
value as determined by the Board on the date of such grant. &#147; <U>Fully Diluted Capitalization</U>&#148; means the sum of the number of (i)&nbsp;the Parent&#146;s outstanding common units or shares (including all common units or shares issuable
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or issued upon conversion of preferred units or shares or upon the exercise of outstanding warrants, options or any other convertible securities), (ii)&nbsp;units or shares that are reserved
under any Equity Incentive Plan and that are not yet issued or subject to an outstanding Award and (iii)&nbsp;units or shares necessary to be added to any Equity Incentive Plan reserve of units or shares in order to grant the applicable Additional
Equity Award. Notwithstanding the foregoing, in the event of an Equity Financing requiring certain milestones to be achieved in connection with the receipt of funds in such Equity Financing, the Fully Diluted Capitalization will include the units or
shares issuable solely in the event the milestone-based units or shares in such Equity Financing are issued; <U>provided, however</U>, that (x)&nbsp;the applicable Additional Equity Award shall not vest under any circumstances unless the applicable
milestone occurs and the milestone-based units or shares are issued and (y)&nbsp;any portion of such Additional Equity Award that is unvested due to an applicable milestone not being met shall terminate upon the earlier of (A)&nbsp;such time as the
applicable milestone can no longer be met pursuant to the terms of the applicable agreement and (B)&nbsp;the occurrence of the Initial Public Offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Employee Benefits</U>. During the Term, the Executive will be eligible to participate in the Company&#146;s employee benefit plans and
programs in effect from time to time for senior executives of the Company, subject to the terms and eligibility requirements of such plans and programs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Expenses</U>. The Executive shall be eligible to receive reimbursement for all reasonable and documented business expenses incurred by
the Executive during the Term in performing services hereunder, in accordance with the policies and procedures then in effect and established by the Company. In addition, the Company will reimburse the Executive for any documented attorney&#146;s
fees incurred in connection with the negotiation of this Agreement (and any term sheet leading up to this Agreement) up to an amount not to exceed $20,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Paid Time Off</U>. During the Term, the Executive shall be entitled to paid time off in accordance with Company policy as in effect from
time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Termination</U>. During the Term, the Executive&#146;s employment hereunder may be terminated without any breach of
this Agreement under the following circumstances: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Death</U>. The Executive&#146;s employment hereunder shall terminate upon the
Executive&#146;s death, and the Executive or the Executive&#146;s estate will be eligible to receive death benefits in accordance with the Company&#146;s plans, programs, and practices as may be in effect at such time (if any). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Disability</U>. The Company may terminate the Executive&#146;s employment if the Executive is disabled and unable to perform or expected
to be unable to perform the essential functions of the Executive&#146;s then-existing position or positions under this Agreement with or without reasonable accommodation for a period of one hundred eighty&nbsp;(180) days (which need not be
consecutive) in any twelve&nbsp;(12)-month period. Upon such termination, the Executive will be eligible to receive disability benefits in accordance with the Company&#146;s plans, programs, and practices as may be in effect at such time (if any).
If any question shall arise as to whether during any period the Executive is disabled so as to be unable to perform the essential functions of the Executive&#146;s then existing position or positions with or without reasonable accommodation, the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Executive may, and at the request of the Company shall, submit to the Company a certification in reasonable detail by a physician selected by the Company to whom the Executive or the
Executive&#146;s guardian has no reasonable objection as to whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the purposes of this Agreement be conclusive of the issue. The
Executive shall cooperate with any reasonable request of the physician in connection with such certification. If such question shall arise and the Executive shall fail to submit such certification, the Company&#146;s determination of such issue
shall be binding on the Executive. Nothing in this Section&nbsp;3(b) shall be construed to waive the Executive&#146;s rights, if any, under existing law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. &#167;2601 et
seq. and the Americans with Disabilities Act, 42 U.S.C. &#167;12101 et seq. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Termination by Company for Cause</U>. The Company may
terminate the Executive&#146;s employment hereunder for Cause. For purposes of this Agreement, &#147;<U>Cause</U>&#148; shall mean any of the following: (i)&nbsp;Executive&#146;s commission of any act of fraud, embezzlement, dishonesty or other act
involving moral turpitude, (ii)&nbsp;Executive&#146;s commission of a felony under the laws of the United States or any state thereof or any foreign jurisdiction, (iii)&nbsp;Executive&#146;s continued failure to perform lawfully assigned duties for
thirty&nbsp;(30) days after receiving written notification from the Board, (iv)&nbsp;Executive&#146;s unauthorized use or disclosure of confidential information or trade secrets of Metagenomi or any of its affiliates or other violation of any
material Metagenomi written policy or breach of any of Executive&#146;s written agreements with the Company or any of its affiliates relating to employment, <FONT STYLE="white-space:nowrap">non-competition,</FONT>
<FONT STYLE="white-space:nowrap">non-solicitation,</FONT> nondisclosure, and/or assignment of inventions, (v)&nbsp;Executive&#146;s failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement
authorities, after being instructed by the Company to cooperate, or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or the inducement of others to fail to cooperate or to produce
documents or other materials in connection with such investigation, or (vi)&nbsp;any other misconduct or gross negligence by Executive that adversely affects the business of Metagenomi in a material manner. Cause shall be determined by the Board in
its discretion, and such determination shall be conclusive and binding. If the Board determines Cause exists and the Executive resigns before a termination for Cause is effectuated, the Board may treat such termination as by the Company for Cause.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Termination by Company Without Cause</U>. The Company may terminate the Executive&#146;s employment hereunder at any time without
Cause. Any termination by the Company of the Executive&#146;s employment under this Agreement which does not constitute a termination for Cause under Section&nbsp;3(c) and does not result from the death or disability of the Executive under
Section&nbsp;3(a) or (b)&nbsp;shall be deemed a termination without Cause. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Termination by the Executive</U>. The Executive may
terminate the Executive&#146;s employment hereunder at any time for any reason, including but not limited to, for Good Reason. &#147; <U>Good Reason</U>&#148; means that the Executive resigns from employment within ninety&nbsp;(90) days after any of
the following is undertaken by the Company (or its acquirer) without the Executive&#146;s consent: (i)&nbsp;a reduction in Executive&#146;s title, (ii)&nbsp;a material reduction of Executive&#146;s duties, authority or responsibilities,
(iii)&nbsp;any material reduction of Executive&#146;s Base Salary (other than a proportionate reduction in Executive&#146;s Base Salary that affects all senior management of the Company); or (iv)&nbsp;a material change in the geographic location at
which Executive must </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
perform services; <U>provided</U> that in no instance will the relocation of Executive to a facility or location of thirty-five&nbsp;(35) miles or less from Executive&#146;s then current office
location be deemed material for purposes of this Agreement; <U>provided, however</U>, that Good Reason shall not exist unless Executive has provided written notice to the Board of the purported grounds for the Good Reason within sixty&nbsp;(60) days
of its initial existence and the Company has not remedied the condition after having been provided at least thirty&nbsp;(30) days to remedy the condition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Notice of Termination</U>. Except for termination due to the Executive&#146;s death as specified in Section&nbsp;3(a), any termination
of the Executive&#146;s employment by the Company or any such termination by the Executive shall be communicated by written Notice of Termination to the other party hereto. If Executive terminates employment with the | Company without Good Reason,
Executive shall provide thirty&nbsp;(30) days&#146; notice to the Company, and the Company shall have the option to accelerate the notice period and pay Executive in lieu of the remainder of the
<FONT STYLE="white-space:nowrap">thirty&nbsp;(30)-day</FONT> notice period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Date of Termination</U>. For the purposes of this
Agreement, &#147; <U>Date of Termination</U>&#148; shall mean: (i)&nbsp;if the Executive&#146;s employment is terminated by death, the date of Executive&#146;s death; (ii)&nbsp;if the Executive&#146;s employment is terminated for any reason other
than death, the date that the Executive&#146;s employment with the Company terminates. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Resignation of All Other Positions</U>. Upon
termination of employment for any reason, unless otherwise agreed in writing, the Executive shall be deemed to have resigned from all officer and board member positions (if applicable) that the Executive holds with the Company or any of its
subsidiaries and affiliates. The Executive shall execute any documents in reasonable form as may be requested to confirm or effectuate any such resignations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Compensation Upon Termination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Accrued Obligations</U>. If the Executive&#146;s employment with the Company is terminated for any reason, the Company shall pay or
provide to the Executive (or to the Executive&#146;s authorized representative or estate) (i)&nbsp;any Base Salary earned through the Date of Termination; (ii)&nbsp;unpaid expense reimbursements (subject to, and in accordance with, Section&nbsp;2(f)
of this Agreement); (iii)&nbsp;any accrued but unused vacation, and (iv)&nbsp;any vested benefits the Executive may have under any employee benefit plan of the Company through the Date of Termination, which vested benefits shall be paid and/or
provided in accordance with the terms of such employee benefit plans (collectively, the &#147;<U>Accrued Obligations</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
Severance Upon Termination by the Company without Cause or by the Executive for Good Reason Outside of the Change in Control Period. During the Term, if the Executive&#146;s employment is terminated by the Company without Cause or the Executive
terminates employment for Good Reason, in each case outside of the Change in Control Period, then in addition to the Accrued Obligations, subject to the Executive (i)&nbsp;resigning from all positions, (ii)&nbsp;signing a separation and general
release agreement (including a <FONT STYLE="white-space:nowrap">re-affirmation</FONT> of any continuing obligations and restrictive covenants) in a form and manner satisfactory to the Company (the &#147;Separation and General Release
Agreement&#148;), (iii)&nbsp;the Separation and General Release Agreement becoming irrevocable and fully effective, all within sixty&nbsp;(60) days after the Date of Termination, and (iv)&nbsp;the Executive not breaching any of the post-employment
covenants and contractual obligations to the Company, the Company shall provide the Executive the following payments and benefits (the &#147;Severance Benefits): </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">A. the Company shall pay the Executive a lump sum amount equal to
nine&nbsp;(9) months of the Executive&#146;s then current Base Salary (the &#147;<U>Severance Pay</U>&#148;), payable within sixty&nbsp;(60) days following the Date of Termination; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">B. the Company shall pay the Executive a <FONT STYLE="white-space:nowrap">pro-rated</FONT> Target Bonus <FONT
STYLE="white-space:nowrap">(pro-rated</FONT> based on the number of days that the Executive was employed in such year, divided by 365) for the year in which the termination occurs (the &#147;<U><FONT STYLE="white-space:nowrap">Pro-rated</FONT>
Bonus</U>&#148;), in a lump sum amount payable within sixty&nbsp;(60) days following the Date of Termination; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">C. if
the Executive and Executive&#146;s eligible dependents were participating in the Company&#146;s group health plan immediately prior to the Date of Termination and timely elects continued group health coverage pursuant to the Consolidated Omnibus
Budget Reconciliation Act of 1985, as amended (&#147;<U>COBRA</U>&#148;), then the Company shall pay to the Executive a monthly cash payment for nine&nbsp;(9) months in an amount equal to Executive&#146;s and Executive&#146;s eligible dependents
monthly COBRA premium, subject to <FONT STYLE="white-space:nowrap">tax-related</FONT> deductions and withholdings and payable in accordance with the Company&#146;s regular payroll schedule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Severance Upon Termination by the Company without Cause or by the Executive for Good Reason during the Change in Control Period</U>.
During the Term, if the Executive&#146;s employment is terminated by the Company without Cause or the Executive terminates employment for Good Reason, in each case during the Change in Control Period, then in addition to the Accrued Obligations,
subject to the Executive (i)&nbsp;resigning from all positions, (ii)&nbsp;signing the Separation and General Release Agreement, (iii)&nbsp;the Separation and General Release Agreement becoming irrevocable and fully effective, all within
sixty&nbsp;(60) days after the Date of Termination, and (iv)&nbsp;the Executive not breaching any of the post-employment covenants and contractual obligations to the Company, the Company shall provide the Executive the following payments and
benefits (the &#147;<U>Change in Control Severance Benefits</U>): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">A. the Company shall pay the Executive a lump sum amount
equal to twelve&nbsp;(12) months of the Executive&#146;s then current Base Salary (the &#147;<U>Enhanced Severance Pay</U>&#148;), payable within sixty&nbsp;(60) days following the Date of Termination; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">B. the Company shall pay the Executive the Pro-rated Bonus, in a lump sum amount payable within sixty&nbsp;(60) days following
the Date of Termination; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">C. if the Executive and Executive&#146;s eligible dependents were participating in the
Company&#146;s group health plan immediately prior to the Date of Termination and timely elects continued group health coverage pursuant to COBRA, then the Company shall pay to the Executive a monthly cash payment for twelve&nbsp;(12) months in an
amount equal to Executive&#146;s and Executive&#146;s eligible dependents monthly COBRA premium, subject to <FONT STYLE="white-space:nowrap">tax-related</FONT> deductions and withholdings and payable in accordance with the Company&#146;s regular
payroll schedule; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">D. notwithstanding anything to the contrary in any applicable Award
agreement or Equity Incentive Plan, one hundred percent&nbsp;(100%) of Executive&#146;s <FONT STYLE="white-space:nowrap">then-outstanding</FONT> and unvested Awards shall immediately vest on the Date of Termination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) For the avoidance of doubt, in no case will the Executive be * eligible for benefits under both Section&nbsp;4(b) and Section&nbsp;4(c).
The Company shall provide the applicable severance benefits under Section&nbsp;4(b) or Section&nbsp;4(c) starting within sixty&nbsp;(60) days after the Date of Termination; <U>provided, however</U>, that if the
<FONT STYLE="white-space:nowrap">sixty&nbsp;(60)-day</FONT> period begins in one calendar year and ends in a second calendar year, such severance benefits, shall begin to be paid in the second calendar year by the last day of such <FONT
STYLE="white-space:nowrap">sixty&nbsp;(60)-day</FONT> period. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2).</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The amounts payable and benefits provided to Executive on or
following the Date of Termination pursuant to this Section&nbsp;4 shall be in full and complete satisfaction of Executive&#146;s rights under this Agreement and any other claims for additional compensation that Executive may have in respect of
Executive&#146;s employment with the Company or any of its subsidiaries. The receipt of any severance payments or benefits pursuant to Section&nbsp;4 shall be subject to Executive not violating any of Executive&#146;s post-employment contractual
obligations, including Executive&#146;s <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> obligations referenced in this
Agreement or in any other agreement between the Parties. In the event Executive breaches any of Executive&#146;s post-employment obligations, in addition to all other legal and equitable remedies, the Company shall have the right to terminate or
suspend all continuing payments and benefits to which the Executive may otherwise be entitled pursuant to Section&nbsp;4 and shall be permitted to recover any severance payments or benefits provided, without affecting the Executive&#146;s release or
Executive&#146;s obligations under the Separation and General Release Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) For purposes of this Agreement, &#147;<U>Change in
Control</U>&#148; means the occurrence of any of the following events: (i)&nbsp;any &#147;person&#148; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the &#147;beneficial owner&#148; (as
defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under said Act), directly or indirectly, of securities of the Company representing fifty percent&nbsp;(50%) or more of the total voting power represented by the Company&#146;s then
outstanding voting securities; (ii)&nbsp;the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately
prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent&nbsp;(50%) of the total voting power represented by the voting securities of the
Company or such surviving entity outstanding immediately after such merger or consolidation; or (iii)&nbsp;the consummation of the sale, lease or other disposition by the Company of all or substantially all the Company&#146;s assets. &#147;<U>Change
in Control Period</U>&#148; means the period beginning on the date two&nbsp;(2) months prior to, and ending on the date that is twelve&nbsp;(12) months following, a Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Section 409A</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive&#146;s separation from service within the
meaning of Section&nbsp;409A of the Code, the Company determines that the Executive is a &#147;specified employee&#148; within the meaning of Section&nbsp;409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Executive
becomes entitled to under this Agreement or otherwise on account of the Executive&#146;s separation from service would be considered deferred compensation otherwise subject to the twenty percent&nbsp;(20%) additional tax imposed pursuant to
Section&nbsp;409A(a) of the Code as a result of the application of Section&nbsp;409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A)&nbsp;six&nbsp;(6) months
and one&nbsp;(1) day after the Executive&#146;s separation from service, or (B)&nbsp;the Executive&#146;s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a <FONT
STYLE="white-space:nowrap">catch-up</FONT> payment covering amounts that would otherwise have been paid during the six (6)-month period but for the application of this provision, and the balance of the installments shall be payable in accordance
with their original schedule. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided and expenses eligible for
reimbursement under this Agreement shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any
reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided or reimbursable expenses incurred in one
taxable year shall not affect the <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to
medical expenses). Such right to reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits is not subject to liquidation or exchange for another benefit. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent that any payment or benefit described in this Agreement constitutes
<FONT STYLE="white-space:nowrap">&#147;non-qualified</FONT> deferred compensation&#148; under Section&nbsp;409A of the Code, and to the extent that such payment or benefit is payable upon the Executive&#146;s termination of employment, then such
payments or benefits shall be payable only upon the Executive&#146;s &#147;separation from service.&#148; The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in
Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h).</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Parties intend that this Agreement will be
administered in accordance with Section&nbsp;409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section&nbsp;409A of the Code, the provision shall be read in such a manner so that all payments
hereunder comply with Section&nbsp;409A of the Code. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2).</FONT> The
Parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section&nbsp;409A of the Code and all related rules and regulations in order to preserve the payments and
benefits provided hereunder without additional cost to either party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company makes no representation or warranty and shall have no
liability to the Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section&nbsp;409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Restrictive Covenants</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Executive hereby <FONT STYLE="white-space:nowrap">re-affirms</FONT> the Employee Invention Assignment and Confidentiality Agreement
that the Executive signed on September&nbsp;16, 2016 and that is attached hereto as <U>Exhibit&nbsp;B</U> (the &#147;<U>Restrictive Covenant Agreement</U>&#148;), and the Restrictive Covenant Agreement is hereby incorporated as a material term of
this Section and this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Protected Disclosures</U>. For the avoidance of doubt, the Executive understands that pursuant to
the federal Defend Trade Secrets Act of 2016, the Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A)&nbsp;is made (i)&nbsp;in confidence to a federal,
state, or local government official, either directly or indirectly, or to an attorney; and (ii)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is made in a complaint or other document filed in a
lawsuit or other proceeding, if such filing is made under seal. The Executive further understands that nothing contained in this Agreement or the Restrictive Covenant Agreement limits the Executive&#146;s ability to (A)&nbsp;communicate with any
federal, state or local governmental agency or commission, including to provide documents or other information, without notice to the Company, (B)&nbsp;share compensation information concerning the Executive or others, except that this does not
permit the Executive to disclose compensation information concerning others that the Executive has obtained because the Executive&#146;s job responsibilities require or allow access to such information, or (C)&nbsp;discuss or disclose information
about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that the Executive has reason to believe is unlawful. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Litigation and Regulatory Cooperation</U>, During and after the Executive&#146;s employment, the Executive shall cooperate fully with
the Company in the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events or occurrences that transpired while the Executive was employed by
the Company. The Executive&#146;s full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the
Company at mutually convenient times. During and after the Executive&#146;s employment, the Executive also shall cooperate fully with the Company in connection with any investigation or review of any federal, state or local regulatory authority as
any such investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company shall reimburse the Executive for any reasonable <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with the Executive&#146;s performance of obligations pursuant to this Section. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Third-Party Agreements and Rights</U>. The Executive represents to the Company that the Executive&#146;s execution of this Agreement, the
Executive&#146;s employment with the Company and the performance of the Executive&#146;s duties for the Company as contemplated under this Agreement will not violate any obligations the Executive may have to any other party. In the Executive&#146;s
work for the Company, the Executive will not disclose or make use of any information in violation of any agreements with or rights of any such other party, and the Executive will not bring to the premises of the Company any copies or other tangible
embodiments of <FONT STYLE="white-space:nowrap">non-public</FONT> information belonging to or obtained from any such other party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Severability</U>. If any provision of this Agreement, or any part thereof, is held by
a court, arbitrator or other authority of competent jurisdiction to be invalid or unenforceable, the parties agree that the court, arbitrator or authority making such determination will have the power to and shall, reduce the duration or scope of
such provision or to delete specific words or phrases as necessary (but only to the minimum extent necessary) to cause such provision or part and the remainder of this Agreement to be valid and enforceable to the fullest extent permitted by
applicable law. If such court, arbitrator or authority does not have I the legal authority to take the actions described in the preceding sentence, the parties agree to negotiate in good faith a modified provision that would, in so far as possible,
reflect the original intent of this Agreement without violating applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Remedies</U>. The Executive acknowledges that the
restrictions contained in this Agreement are reasonable and necessary to protect the Company&#146;s legitimate business interests and that any violation of the provisions contained herein would result in irreparable injury to the Company and that
monetary damages may not be sufficient to compensate the Company for any economic loss which may be incurred by reason of breach of the restrictions contained herein. In the event of a breach or a threatened breach by the Executive of any provision
contained herein, the Company shall be entitled to a temporary restraining order and injunctive relief restraining the Executive from the commission of any breach, shall not be required to provide any bond or other security in connection with
obtaining any such equitable remedy and shall be entitled to recover the Company&#146;s reasonable attorneys&#146; fees, costs and expenses related to the breach or threatened breach. Nothing contained in this Section shall be construed as
prohibiting the Company from pursuing any other remedies available to it for any breach or threatened breach, including, without limitation, the recovery of money damages. In the event of a breach by Executive of any covenants contained herein, the
term of such covenant shall be tolled until such breach has been duly cured. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Withholding</U>. All payments made by the Company to
the Executive under this Agreement shall be net of any tax or other amounts required to be withheld or deducted by the Company under applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Survival</U>. The provisions of this Agreement and any other confidentiality, invention assignment, or other post-termination
restrictive covenant obligations of the Executive to the Company shall survive the termination of this Agreement and/or the termination of the Executive&#146;s employment to the extent necessary to effectuate the terms contained herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Waiver</U>. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of
any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any
subsequent breach. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Notices</U>. Any notices, requests, demands and other communications provided for by this Agreement shall be
sufficient if in writing and (a)&nbsp;delivered in person, (b)&nbsp;sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, or (c)&nbsp;sent by electronic mail, to the
Executive at the last mailing address or <FONT STYLE="white-space:nowrap">e-mail</FONT> address, as applicable, the Executive has filed in writing with the Company or, in the case of the Company, at its main offices, attention of the Board, with a
copy to legal@metagenomi.co. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Amendment</U>. This Agreement may be amended or modified only by a written instrument
signed by the Executive and by a duly authorized representative of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Governing Law</U>. This Agreement shall be
construed under and be governed in all respects by the laws of the State of California, without giving effect to the conflict of laws principles of such state. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Assignment; Successor to Company</U>. Neither the Company nor the Executive may make any assignment of this Agreement or any interest
herein, by operation of law or otherwise, without the prior written consent of the other party. Notwithstanding the foregoing, the Company may assign its rights under this Agreement, without any consent of the Executive, to any of the Company&#146;s
affiliates or successors (including if the Company or any of Metagenomi effects a reorganization, consolidates with or merges into any other corporation, limited liability company, partnership, organization or other entity, or transfers all or
substantially all of its properties or assets to any other corporation, limited liability company, partnership, organization or other entity), in which case all references to the &#147;<U>Company</U>&#148; shall be deemed to mean the assignee or a
designated affiliate of the assignee. This Agreement shall inure to the benefit of and be binding upon the Company and the Executive, and their respective successors, executors, administrators, heirs and permitted assigns. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>No Third-Party Beneficiaries</U>. This Agreement is intended solely for the benefit of the parties and the Company&#146;s respective
successors and permitted assigns and shall not confer upon any other person any remedy, claim, liability, reimbursement, or other right. The Agreement is not intended and shall not be construed to create any third party beneficiaries or to provide
to any third parties with any remedy, claim, liability, reimbursement, cause of action, or other right or privilege. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.
<U>Integration</U>. This Agreement and the Restrictive Covenant Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior written or oral agreements (including any previous term
sheets) between the Parties concerning such subject matter, but does not in any way merge with or supersede any other confidentiality, assignment of inventions or other restrictive covenant agreement or obligation entered into between the Parties,
which agreements and obligations shall supplement, and shall not limit or be limited by, this Agreement and the Restrictive Covenant Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Counterparts</U>. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be
taken to be an original; but such counterparts shall together constitute one and the same document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of Page Left
Intentionally Blank] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Agreement effective on the Effective
Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>METAGENOMI, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: 3/20/2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Simren Delaney</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Simren Delaney</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President, Legal</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>METAGENOMI TECHNOLOGIES, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: 3/20/2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sebastian Bernales</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Sebastian Bernales</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Manager; Member of Compensation Committee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: 3/20/2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian C. Thomas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Brian C. Thomas</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit&nbsp;A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Outside Activities </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board member for Haya Therapeutics, Inc. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit&nbsp;B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Restrictive Covenant Agreement </U></B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>9
<FILENAME>d425213dex1013.htm
<DESCRIPTION>EX-10.13
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.13</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.13 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19&nbsp;January 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jian Irish </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Offer of Employment by Metagenomi, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Jian: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are very pleased to confirm our
offer to you of employment with Metagenomi, Inc. (the &#147;<B><I>Company</I></B>&#148;). The terms of our offer and the benefits currently provided by the Company are as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><U>Position and Start Date</U></B>. You are being offered the position of Chief Operations Officer reporting to the Chief Executive
Officer. This is an exempt position to be based partly in our Emeryville office or partly working remotely, subject to such periodic travel as may be required from time to time. Your anticipated start date will be 14&nbsp;January 2021. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><U>Responsibilities</U></B>. You will have the duties and responsibilities commensurate with the duties and responsibilities customarily
associated with the position of Chief Operations Officer and such other duties and responsibilities as may be prescribed by the Chief Executive Officer or as determined by the Board (as defined below). These duties may include the responsibilities
outlined in <U>Appendix&nbsp;A</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will be expected to devote all of your business time and attention to this position, but as an
exempt employee, you must work such hours as may be required by the nature of your work and will not be eligible for overtime pay. You shall devote all of your business time, attention and energy to the Company and shall not, during the term of your
employment, be actively engaged in any managerial or employment capacity in any other business activity for gain, profit or other pecuniary advantage without the written consent of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, we acknowledge the consulting agreement to be executed between yourself and Affini-T Therapeutics, Inc. (the
&#147;<B><I>Affini-T Consulting Agreement</I></B>&#148;) and deem that the services and obligations thereunder will not be in conflict with your duties and responsibilities to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B><U>Expenses</U></B>. The Company will reimburse you for any reasonable <FONT STYLE="white-space:nowrap">pre-approved</FONT> expenses
incurred in the course of your employment. Requests for reimbursement will be in a form acceptable to the Company and shall include appropriate documentation substantiating the expenses. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B><U>Base Salary</U></B>. Your starting salary will be $375,000 per year, payable in accordance with the Company&#146;s standard payroll
schedule, and will be subject to periodic review by the Compensation Committee of the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B><U>Annual Incentive Bonus</U></B>. You will be eligible for an incentive bonus of 35%
of your base salary, based on the achievement of performance objectives as determined by the Compensation Committee of the Board in its sole discretion. This Annual Incentive Bonus will be <FONT STYLE="white-space:nowrap">pro-rated</FONT> for the
initial year of participation based on the period of time you are employed by the Company. Any Annual Incentive Bonus for a fiscal year will be paid within 2<SUP STYLE="vertical-align:top">1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">2</SUB>
months after the close of that fiscal year, but only if you are still employed by the Company at the time of payment. The determinations of the Board with respect to your Annual Incentive Bonus will be final and binding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><U>Benefits</U></B><I>. </I>In addition, you will be eligible to participate in regular health insurance, retirement plan, and other
employee benefit plans established by the Company for its employees from time to time. The Company reserves the right to change or otherwise modify, in its sole discretion, the preceding terms of employment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><U>Equity</U></B>. We will recommend to the Board of Managers (the &#147;<B><I>Board</I></B>&#148;) of Metagenomi Technologies, LLC, the
parent entity of the Company (the &#147;<B><I>Parent</I></B>&#148;), that you be granted 480,605 Common Units of the Parent (the &#147;<B><I>Equity Grant</I></B>&#148;) in the form of profits interests pursuant to the terms of the Parent&#146;s 2019
Equity Incentive Plan (the &#147;<B><I>Plan</I></B>&#148;). The Equity Grant will vest over a period of four years, with 25% of the Equity Grant vesting on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of your start date, and the
remainder vesting in 36 equal monthly installments thereafter, so long as you continue to provide services to the Company or the Parent. The grant of such Equity Grant by the Parent is subject to the Board&#146;s approval and this promise to
recommend such approval is not a promise of compensation and is not intended to create any obligation on the part of the Company. Further details on the Plan and your Equity Grant will be provided upon approval of such grant by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of a Change of Control (as defined below), the vesting of any remaining Common Units in the Equity Grant shall be
accelerated and all such Common Units shall be deemed fully vested. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this agreement, the term &#147;<B><I>Change of
Control</I></B>&#148; means either: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(1) </B>the acquisition of the Company by another entity by means of any transaction or series of
related transactions (including, without limitation, any reorganization, merger or consolidation or stock transfer, but excluding any such transaction effected primarily for the purpose of changing the domicile of the Company), unless the
Company&#146;s stockholders of record immediately prior to such transaction or series of related transactions hold, immediately after such transaction or series of related transactions, at least 50% of the voting ower of the surviving or acquiring
entity (provided that the sale by the Company of its securities for the purposes of raising additional funds shall not constitute a Change of Control hereunder); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(2) </B>a sale of all or substantially all of the assets of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><U>Termination of Consulting Agreement</U></B>. A consulting agreement was executed
between yourself and the Company on 1&nbsp;September 2020 (&#147;<B><I>the Metagenomi Consulting Agreement</I></B>&#148;). With your signature acknowledging and agreeing to this offer of employment, you hereby also consent to the termination of the
Metagenomi Consulting Agreement and as such, will not receive any compensation under the Metagenomi Consulting Agreement. To the extent there is a conflict between your obligations under the Metagenomi Consulting Agreement and this letter agreement,
the terms of this letter agreement will prevail. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><U>Equity Award under Consulting Agreement</U></B>. Pursuant to the Metagenomi
Consulting Agreement, the Parent was to grant you a total of 36,000 Common Units subject to the vesting provisions and other terms and conditions of the Plan. If such grant had occurred on 1&nbsp;September 2020, you would currently have 5,000 Common
Units vested and 31,000 Common Units unvested. With the termination of the Metagenomi Consulting Agreement in accordance with paragraph 8 herein, you agree that in lieu of any Common Units owed under the Metagenomi Consulting Agreement, the Company
will grant you 5,000 Common Units in recognition of services rendered from 1&nbsp;September 2020 to 13&nbsp;January 2021. For the avoidance of doubt, this grant of 5,000 Common Units will be in addition to the Equity Grant outlined in paragraph 7
herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B>Severance</B>. If you are terminated not for Cause, or resign for Good Reason, you will receive 6 months Base Salary and
pro rated Annual Incentive Bonus, and 6 months vesting acceleration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this agreement, the terms of &#145;Cause&#146; and &#145;Good
Reason&#146; is defined below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Cause&#148; means a termination of your employment by the Company due to: (i)&nbsp;your conviction of a felony or
your entering a plea of nolo contendere to a felony; (ii)&nbsp;your recklessness, dishonesty, willful malfeasance, or gross misconduct in connection with your employment duties hereunder that result in material harm to the Company; or
(iii)&nbsp;your willful failure to perform the duties assigned to you pursuant to the terms hereof and your failure to correct within thirty&nbsp;(30) days of written notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Good Reason&#148; means the occurrence of any of the following without your written consent: (i)&nbsp;the Company&#146;s material breach of any
provision of this Agreement; (ii)&nbsp;any material adverse change in your compensation, position, authority, duties or responsibilities, or any other action by the Company or (iii)&nbsp;relocation of your primary work location by more than
thirty&nbsp;(30) miles; provided, however, that none of the above shall constitute Good Reason unless you have provided the Company with written notice of the Company&#146;s alleged actions constituting Good Reason within thirty&nbsp;(30) days after
the initial existence of any such alleged actions and the Company has not cured any such alleged actions constituting Good Reason within thirty&nbsp;(30) days of the Company&#146;s receipt of such written notice; provided further, that a termination
by you for Good Reason shall not be deemed to have occurred unless the termination occurs within six&nbsp;(6) months after the initial existence of any of the conditions specified above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <B><U>Protection of Confidential and Proprietary Information</U></B>. As an employee of the Company, you will have access to certain
confidential information of the Company and you may, during the course of your employment, develop certain information or inventions that will be the property of the Company. To protect the Company&#146;s interests, as a condition of employment, you
must sign and abide by the Company&#146;s standard &#147;Employee Invention Assignment and Confidentiality Agreement.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <B><U>No Breach of Obligations to Prior Employers</U></B>. We wish to impress upon you
that we do not want you to, and we hereby direct you not to, bring with you any confidential or proprietary material of any former employer or violate any other obligations you may have to any former employer. You represent that your signing of this
offer letter, agreement(s) concerning profits interests granted to you, if any, under the Plan and the Company&#146;s Employee Invention Assignment and Confidentiality Agreement and your commencement of employment with the Company will not violate
any agreement currently in place between yourself and current or past employers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <B><U>No Competition During Employment</U></B>.
During the period that you render services to the Company, you agree to not engage in any employment, business or activity that is in any way competitive with the business or proposed business of the Company. You will disclose to the Company in
writing any other gainful employment, business or activity that you are currently associated with or participate in that competes with the Company. You will not assist any other person or organization in competing with the Company or in preparing to
engage in competition with the business or proposed business of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <B><U>At Will Employment</U></B>. Employment with the
Company is for no specific period of time. Should you accept our offer, you will be an <FONT STYLE="white-space:nowrap">at-will</FONT> employee of the Company, which means the employment relationship can be terminated by either of us for any reason,
at any time, with or without prior notice and with or without cause. Any statements or representations to the contrary (and, indeed, any statements contradicting any provision in this letter) are superseded by this agreement. Further, your
participation in any benefit program is not to be regarded as assuring you of continuing employment for any particular period of time. Although your job duties, title, compensation and benefits, as well as the Company&#146;s personnel policies and
practices, may change from time to time, the <FONT STYLE="white-space:nowrap">&#147;at-will&#148;</FONT> nature of your employment may be changed only in an express, written employment agreement signed by you and a duly authorized officer of the
Company (other than you). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <B><U>Tax Matters</U></B>. All forms of compensation referred to in this agreement are subject to reduction
to reflect applicable withholding and payroll taxes and other deductions required by law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <B><U>Authorization to Work</U></B>. Please
note that because of employer regulations adopted in the Immigration Reform and Control Act of 1986, within three&nbsp;(3) business days of starting your new position you will need to present documentation demonstrating that you have authorization
to work in the United States. If you have questions about this requirement, which applies to U.S. citizens and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> citizens alike, please let me know. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <B><U>Arbitration and Class</U><U>&nbsp;Action Waiver</U></B>. You and the Company agree to submit to mandatory binding arbitration any and
all claims arising out of or related to your employment with the Company and the termination thereof, including, but not limited to, claims for unpaid wages, wrongful termination, torts, stock or stock options or other ownership interest in the
Company, and/or discrimination (including harassment) based upon any federal, state or local ordinance, statute, regulation or constitutional provision except that each party may, at its, his or her option, seek injunctive relief in court related to
the improper use, disclosure or misappropriation of a party&#146;s private, proprietary, confidential or trade secret information </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(collectively, &#147;<B><I>Arbitrable Claims</I></B>&#148;). Further, to the fullest extent permitted by law, you and the Company agree that no class or collective actions can be asserted in
arbitration or otherwise. All claims, whether in arbitration or otherwise, must be brought solely in your or the Company&#146;s individual capacity, and not as a plaintiff or class member in any purported class or collective proceeding. Nothing in
this Arbitration and Class&nbsp;Action Waiver section, however, restricts your right, if any, to file in court a representative action under applicable law, including California Labor Code Sections 2698, <I>et seq.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUBJECT TO THE ABOVE PROVISO, THE PARTIES HEREBY WAIVE ANY RIGHTS THEY MAY HAVE TO TRIAL BY JURY IN REGARD TO ARBITRABLE CLAIMS. THE PARTIES
FURTHER WAIVE ANY RIGHTS THEY MAY HAVE TO PURSUE OR PARTICIPATE IN A CLASS OR COLLECTIVE ACTION PERTAINING TO ANY CLAIMS BETWEEN YOU AND THE COMPANY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This agreement to arbitrate does not restrict your right to file administrative claims you may bring before any government agency where, as a
matter of law, the parties may not restrict the employee&#146;s ability to file such claims (including, but not limited to, the National Labor Relations Board, the Equal Employment Opportunity Commission and the Department of Labor). However, the
parties agree that, to the fullest extent permitted by law, arbitration shall be the exclusive remedy for the subject matter of such administrative claims. The arbitration shall be conducted in San Francisco, CA through JAMS before a single neutral
arbitrator, in accordance with the JAMS employment arbitration rules then in effect. The JAMS rules may be found and reviewed at <U>http://www.jamsadr.com/rules-employment-arbitration</U>. If you are unable to access these rules, please let me know
and I will provide you with a hardcopy. The arbitrator shall issue a written decision that contains the essential findings and conclusions on which the decision is based. If, for any reason, any term of this Arbitration and Class&nbsp;Action Waiver
provision is held to be invalid or unenforceable, all other valid terms and conditions herein shall be severable in nature, and remain fully enforceable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <B><U>Background Check</U></B>. This offer is contingent upon a satisfactory verification of criminal, education, driving and/or employment
background. This offer can be rescinded based upon data received in the verification. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <B><U>Entire Agreement</U></B>. This offer, once
accepted, constitutes the entire agreement between you and the Company with respect to the subject matter hereof and supersedes all prior offers, negotiations and agreements, if any, whether written or oral, relating to such subject matter. You
acknowledge that neither the Company nor its agents have made any promise, representation or warranty whatsoever, either express or implied, written or oral, which is not contained in this agreement for the purpose of inducing you to execute the
agreement, and you acknowledge that you have executed this agreement in reliance only upon such promises, representations and warranties as are contained herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <B><U>Acceptance</U></B>. This offer will remain open until 22&nbsp;January 2021. If you decide to accept our offer, and we hope you will,
please sign the enclosed copy of this letter in the space indicated and return it to me. Your signature will acknowledge that you have read and understood and agreed to the terms and conditions of this offer letter and the attached documents, if
any. Should you have anything else that you wish to discuss, please do not hesitate to call us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We look forward to the opportunity to welcome you to the Company. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian C. Thomas, CEO</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Brian C. Thomas, CEO</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Metagenomi, Inc.</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I have read and understood this offer letter and hereby acknowledge, accept and agree to the terms as set forth above
and further acknowledge that no other commitments were made to me as part of my employment offer except as specifically set forth herein. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jian Irish</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">1/19/2021</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jian Irish</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Date signed</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>APPENDIX&nbsp;A</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Responsibilities of Chief Operations Officer include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Work with CEO to develop an operations plan </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Work with CEO and other C-suite executives to guide the growth of the company </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Support BD discussions with potential partners </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Oversee the production of high quality reagents </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Oversee MTAs to ensure Metagenomi is a successful collaborator </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Support partnerships as they come online </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Support Team building/recruitment/hiring for both ex vivo and in vivo teams </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Oversee restructuring of existing lab teams to scale production ability </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Support strategic and planning discussions for growth and for spinout creation with MG assets
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lead all operations staff </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Oversee the design and building of 1545 Park Ave into a functioning, high-quality lab </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Oversee the design and building of a GMP suite in 1545 park Ave </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Support CMC scaleup for IND-ready materials </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Key goal: Have clinical-ready reagents by year end, 2021 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>10
<FILENAME>d425213dex1014.htm
<DESCRIPTION>EX-10.14
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.14</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.14 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sarah Noonberg </P>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sarah: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I am very pleased to confirm our offer to you of
employment with Metagenomi, Inc. (the &#147;<B><I>Company</I></B>&#148;). The terms of our offer and the benefits currently provided by the Company are as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Position and Start Date</B>. You are being offered the position of Chief Medical Officer, reporting to Brian Thomas. This is an exempt position based in
our Emeryville office. Your anticipated start date will be January&nbsp;30, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Responsibilities. </B>You will have the duties and
responsibilities commensurate with the duties and responsibilities customarily associated with the position of Chief Medical Officer, and such other duties and responsibilities as may be prescribed by the Chief Executive Officer or as determined by
the Board (as defined below). These duties may include the responsibilities outlined in Appendix&nbsp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be expected to devote all of your
business time and attention to this position, but as an exempt employee, you must work such hours as may be required by the nature of your work and will not be eligible for overtime pay. You shall devote all of your business time, attention and
energy to the Company and shall not, during the term of your employment, be actively engaged in any managerial or employment capacity in any other business activity for gain, profit or other pecuniary advantage without the written consent of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Base Salary</B>. Your starting salary will be $420,000.00 per year, payable in accordance with the Company&#146;s standard payroll
schedule, and will be subject to periodic review pursuant to the Company&#146;s employee compensation policies in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Annual
Incentive Bonus. </B>You will be eligible for an incentive bonus based on the achievement of performance objectives as determined by the Board (as defined below) in its sole discretion. Your discretionary bonus target will be 40% of your annual base
salary. Any bonus for a fiscal year will be paid within 2<SUP STYLE="vertical-align:top">1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">2</SUB> months after the close of that fiscal year, but only if you are still employed by the Company at the
time of payment. The determinations of the Board with respect to your bonus will be final and binding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Benefits. </B>In addition, you will be
eligible to participate in regular health insurance, retirement plan, and other employee benefit plans established by the Company for its employees from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company reserves the right to change or otherwise modify, in its sole discretion, the preceding terms of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Equity. </B>We will recommend to the Board of Managers (the &#147;<B><I>Board</I></B>&#148;) of Metagenomi Technologies, LLC, the parent entity of the
Company (the &#147;<B><I>Parent</I></B>&#148;), that you be granted 200,000 Common Units of the Parent (the &#147;<B><I>Equity Grant</I></B>&#148;) in the form of profits interests pursuant to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 1 of 4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">terms of Parent&#146;s 2019 Equity Incentive Plan (the &#147;<B><I>Plan</I></B>&#148;). The Equity Grant
will vest over a period of four years, with 25% of the Equity Grant vesting on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of your start date, and the remainder vesting in 36 equal monthly installments thereafter, so long as you
continue to provide services to the Company or Parent. The grant of such Equity Grant by the Parent is subject to the Board&#146;s approval and this promise to recommend such approval is not a promise of compensation and is not intended to create
any obligation on the part of the Company. Further details on the Plan and your Equity Grant will be provided upon approval of such grant by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Protection of Confidential and Proprietary Information</B>. As an employee of the Company, you will have access to certain confidential information of
the Company and you may, during the course of your employment, develop certain information or inventions that will be the property of the Company. To protect the Company&#146;s interests, as a condition of employment, you must sign and abide by the
Company&#146;s standard Employee Invention Assignment and Confidentiality Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. No Breach of Obligations to Prior Employers</B>. We wish to
impress upon you that we do not want you to, and we hereby direct you not to, bring with you any confidential or proprietary material of any former employer or violate any other obligations you may have to any former employer. You represent that
your signing of this offer letter, agreement(s) concerning profits interests granted to you, if any, under the Plan and the Company&#146;s Employee Invention Assignment and Confidentiality Agreement and your commencement of employment with the
Company will not violate any agreement currently in place between yourself and current or past employers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. No Competition During Employment</B>.
During the period that you render services to the Company, you agree to not engage in any employment, business or activity that is in any way competitive with the business or proposed business of the Company. You will disclose to the Company in
writing any other gainful employment, business or activity that you are currently associated with or participate in that competes with the Company. You will not assist any other person or organization in competing with the Company or in preparing to
engage in competition with the business or proposed business of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. At Will Employment</B>. Employment with the Company is for no
specific period of time. Should you accept our offer, you will be an <FONT STYLE="white-space:nowrap">at-will</FONT> employee of the Company, which means the employment relationship can be terminated by either of us for any reason, at any time, with
or without prior notice and with or without cause. Any statements or representations to the contrary (and, indeed, any statements contradicting any provision in this letter) are superseded by this agreement. Further, your participation in any stock
option or benefit program is not to be regarded as assuring you of continuing employment for any particular period of time. Although your job duties, title, compensation and benefits, as well as the Company&#146;s personnel policies and practices,
may change from time to time, the <FONT STYLE="white-space:nowrap">&#147;at-will&#148;</FONT> nature of your employment may be changed only in an express, written employment agreement signed by you and a duly authorized officer of the Company (other
than you). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Tax Matters</B>. All forms of compensation referred to in this agreement are subject to reduction to reflect applicable withholding and
payroll taxes and other deductions required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Authorization to Work</B>. Please note that because of employer regulations adopted in the
Immigration Reform and Control Act of 1986, within three&nbsp;(3) business days of starting your new position you will need to present documentation demonstrating that you have authorization to work in the United States. If you have questions about
this requirement, which applies to U.S. citizens and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> citizens alike, you may contact our personnel office. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 2 of 4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Arbitration and Class</B><B></B><B>&nbsp;Action Waiver</B>. You and the Company agree to submit to
mandatory binding arbitration any and all claims arising out of or related to your employment with the Company and the termination thereof, including, but not limited to, claims for unpaid wages, wrongful termination, torts, stock or stock options
or other ownership interest in the Company, and/or discrimination (including harassment) based upon any federal, state or local ordinance, statute, regulation or constitutional provision except that each party may, at its, his or her option, seek
injunctive relief in court related to the improper use, disclosure or misappropriation of a party&#146;s private, proprietary, confidential or trade secret information (collectively, &#147;Arbitrable Claims&#148;). Further, to the fullest extent
permitted by law, you and the Company agree that no class or collective actions can be asserted in arbitration or otherwise. All claims, whether in arbitration or otherwise, must be brought solely in your or the Company&#146;s individual capacity,
and not as a plaintiff or class member in any purported class or collective proceeding. Nothing in this Arbitration and Class<U></U>&nbsp;Action Waiver section, however, restricts your right, if any, to file in court a representative action under
applicable law, including California Labor Code Sections 2698, et seq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUBJECT TO THE ABOVE PROVISO, THE PARTIES HEREBY WAIVE ANY RIGHTS
THEY MAY HAVE TO TRIAL BY JURY IN REGARD TO ARBITRABLE CLAIMS. THE PARTIES FURTHER WAIVE ANY RIGHTS THEY MAY HAVE TO PURSUE OR PARTICIPATE IN A CLASS OR COLLECTIVE ACTION PERTAINING TO ANY CLAIMS BETWEEN YOU AND THE COMPANY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This agreement to arbitrate does not restrict your right to file administrative claims you may bring before any government agency where, as a
matter of law, the parties may not restrict the employee&#146;s ability to file such claims (including, but not limited to, the National Labor Relations Board, the Equal Employment Opportunity Commission and the Department of Labor). However, the
parties agree that, to the fullest extent permitted by law, arbitration shall be the exclusive remedy for the subject matter of such administrative claims. The arbitration shall be conducted in San Francisco, CA through JAMS before a single neutral
arbitrator, in accordance with the JAMS employment arbitration rules then in effect. The JAMS rules may be found and reviewed at http://www.jamsadr.com/rules-employment-arbitration. If you are unable to access these rules, please let me know and I
will provide you with a hardcopy. The arbitrator shall issue a written decision that contains the essential findings and conclusions on which the decision is based. If, for any reason, any term of this Arbitration and Class&nbsp;Action Waiver
provision is held to be invalid or unenforceable, all other valid terms and conditions herein shall be severable in nature, and remain fully enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Background Check</B>. This offer is contingent upon a satisfactory verification of criminal, education, driving and/or employment background. This
offer can be rescinded based upon data received in the verification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Entire Agreement</B>. This offer, once accepted, constitutes the entire
agreement between you and the Company with respect to the subject matter hereof and supersedes all prior offers, negotiations and agreements, if any, whether written or oral, relating to such subject matter. You acknowledge that neither the Company
nor its agents have made any promise, representation or warranty whatsoever, either express or implied, written or oral, which is not contained in this agreement for the purpose of inducing you to execute the agreement, and you acknowledge that you
have executed this agreement in reliance only upon such promises, representations and warranties as are contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Acceptance</B>. This
offer will remain open until January&nbsp;23, 2023. If you decide to accept our offer, and I hope you will, please sign the enclosed copy of this letter in the space indicated and return it to me. Your signature will acknowledge that you have read
and understood and agreed to the terms and conditions of this offer letter and the attached documents, if any. Should you have anything else that you wish to discuss, please do not hesitate to call me. We look forward to the opportunity to welcome
you to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 3 of 4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brian C. Thomas, CEO </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I have read and understood this offer
letter and hereby acknowledge, accept and agree to the terms as set forth above and further acknowledge that no other commitments were made to me as part of my employment offer except as specifically set forth herein. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #7f7f7f">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Offer Letter Acceptance </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I have read and accept this
offer of employment: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sarah Noonberg</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">23&nbsp;January 2023</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sarah Noonberg</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Date</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 4 of 4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>11
<FILENAME>d425213dex1015.htm
<DESCRIPTION>EX-10.15
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.15</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.15 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIALITY, <FONT STYLE="white-space:nowrap">NON-INTERFERENCE,</FONT> AND ASSIGNMENT OF INVENTIONS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIS</SMALL> C<SMALL>ONFIDENTIALITY</SMALL>, <SMALL>NON</SMALL><FONT STYLE="white-space:nowrap">-</FONT><SMALL>INTERFERENCE</SMALL>,
<SMALL>AND</SMALL> <SMALL>ASSIGNMENT</SMALL> <SMALL>OF</SMALL> <SMALL>INVENTIONS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> (this &#147;<B><I>Agreement</I></B>&#148;) is made and entered into as of the date of the last signature below
(&#147;<B><I>Effective Date</I></B>&#148;), by and between <B>M<SMALL>ETAGENOMI</SMALL>, I<SMALL>NC</SMALL>.</B> (&#147;<B><I>Company</I></B>&#148;), having a principal place of business at 5959 Horton Avenue, Emeryville, CA 94608, and
___________(or &#147;<B><I>Employee</I></B>&#148;), having a residence at the address listed in the signature block below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
<U>Consideration</U><B>.</B> As a condition of their employment with Metagenomi Inc., its subsidiaries, affiliates, successors or assigns (together, the &#147;Company&#148;), and in consideration of Employee&#146;s receipt of the compensation now
and hereinafter paid to them by the Company, Employee agrees to the terms set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U><FONT
STYLE="white-space:nowrap">At-Will</FONT> Employment</U><B>.</B> EMPLOYEE UNDERSTANDS AND ACKNOWLEDGES THAT THEIR EMPLOYMENT WITH THE COMPANY IS FOR AN UNSPECIFIED DURATION AND CONSTITUTES &#147;AT WILL&#148; EMPLOYMENT. EMPLOYEE ALSO UNDERSTANDS
THAT ANY REPRESENTATION TO THE CONTRARY IS UNAUTHORIZED AND NOT VALID UNLESS IN WRITING AND SIGNED BY THE CEO OR PRESIDENT AND COO OF THE COMPANY. ACCORDINGLY, EMPLOYEE ACKNOWLEDGES THAT THEIR EMPLOYMENT RELATIONSHIP MAY BE TERMINATED AT ANY TIME,
WITH OR WITHOUT GOOD CAUSE OR FOR ANY OR NO CAUSE, AT EMPLOYEE&#146;S OPTION OR THE OPTION OF THE COMPANY, WITH OR WITHOUT NOTICE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.
<U>Confidentia</U><U>l Information</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Company Confidential Information</U>. Employee acknowledges that during the course of
their employment, Employee will have access to information about Metagenomi, Inc., and its subsidiaries and affiliates, including the Company (collectively, the &#147;Company Group&#148;), and that their employment with the Company will bring
Employee into close contact with confidential and proprietary information of the Company Group. In recognition of the foregoing, Employee agrees, that at all times during the term of their employment with the Company and thereafter, to hold in
confidence and not to use, except for the benefit of the Company Group, or to disclose to any person without written authorization of the Company, any Confidential Information that Employee obtains or creates. Confidential Information includes any
information that has been or may be disclosed to Employee by or on behalf of Company in writing, orally, electronically, or by inspection of facilities or tangible objects, including, without limitation, documents, prototypes, compounds, protein
sequences, chemical structures, samples, formulations, technical data, trade secrets, know how, research, product plans, services, customers, markets, software, assays, discoveries, inventions, ideas, techniques, assays, processes, designs,
drawings, marketing plans, statements of financial condition, or equipment, as well as any information created using the foregoing information. Notwithstanding the foregoing, Confidential Information shall not include any information that Employee
can establish (i)&nbsp;was publicly known or generally available to the public prior to disclosure under this Agreement; (ii)&nbsp;becomes publicly known or generally available to the public after disclosure to Employee hereunder through no action
or inaction of Employee; (iii)&nbsp;was, at the time of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
disclosure to Employee hereunder, already in the possession of Employee, without confidentiality restrictions, as shown by Employee&#146;s contemporaneous written records; (iv)&nbsp;is
independently developed by Employee without use of or reference to Confidential Information; or (v)&nbsp;is obtained without confidentiality restrictions by the Employee from a third party (not acting on behalf of Company) without a breach of any
obligations of confidentiality. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Returning Company Documents</U>. Employee agrees that, at the time of leaving the employ of the
Company, Employee will deliver to the Company (and will not keep in their possession, recreate or deliver to anyone else) any and all devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings blueprints,
sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items developed by Employee pursuant to their employment with the Company or otherwise belonging to the Company, its successors or assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Former Employers</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Former Employer Information</U>. Employee represents that their performance of all of the terms of this Agreement as an employee of the
Company has not breached and will not reach any agreement to keep in confidence proprietary information, knowledge, or data acquired by Employee in confidence or trust prior or subsequent to the commencement of Employee&#146;s employment with the
Company, and Employee will not disclose to any member of the Company Group, or induced any member of the Company Group to use, any developments, or confidential or proprietary information or material Employee may have obtained in connection with
employment with any prior employer in violation of a confidentiality agreement, <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement, or similar agreement. Employee further represents and agrees that if they have a signed confidentiality
agreement with any former employer or entity, they will comply with the terms of any such agreement to the extent such terms are lawful under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Indemnification</U>. Employee represents that they have retuned all property and confidential information belonging to all prior
employers. In the event that the Company or ay of its directors, officers, shareholders or agents (collectively, &#147;Indemnitees&#148;) is sued based on any obligation or agreement to which Employee is a party or is bound, Employee agrees to fully
indemnify the Indemnitees for all verdicts, judgments, settlement and other losses incurred by the Indemnitee in the event that it is the subject of any legal action resulting from any breach of Employee&#146;s obligations under this Agreement, as
well as any reasonable attorneys&#146; fees and costs if the plaintiff is the prevailing party in such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Third-Party
Information</U>. Employee recognizes that the Company may have received and, in the future, may receive from third parties associated with the Company their confidential or proprietary information, such as their habits and practices, their
technology requirements and information related to the business conducted between the Company and such parties. Employee agrees at all times during their employment with the Company and thereafter, to hold in the strictest confidence, and not to
disclose or use any such confidential information, except as necessary in carrying out their work for the Company consistent with the Company&#146;s agreement with such parties. Employee understands that their unauthorized use or disclosure of such
third party confidential information during their employment will lead to disciplinary action, up to and including termination and legal action by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Inventions</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1 <U>Inventions Retained and Licensed</U>. Employee has attached hereto, as <B><U>Schedule 1</U></B>, a list describing all inventions,
original works of authorship, developments, improvements, and trade secrets which were made by Employee prior to their employment with the Company (collectively referred to as &#147;Prior Inventions&#148;), which belong to Employee, which relate to
the Company&#146;s business, products or research and development, and which are not assigned to the Company hereunder; or, if no such list is attached, Employee represents that there are no such Prior Inventions. If in the course of their
employment with the Company, Employee incorporates into a Company product, process or service a Prior Invention owned by Employee or in which they have an interest, Employee hereby grants to the Company a nonexclusive, royalty-free, fully <FONT
STYLE="white-space:nowrap">paid-up,</FONT> irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or service, and to practice any method related
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2 <U>Assignment of Inventions</U>. Employee will assign and does hereby irrevocably assign to the Company, or its designee,
all their right, title, and interest in and to any and all copyrights, inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether or not patentable or registrable
under copyright or similar laws, which Employee may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the period of time Employee is in the employ of the Company
(collectively referred to as &#147;Inventions&#148;), except as provided in Section&nbsp;4.4 below. Employee agrees to promptly make full written disclosure to the Company of any Inventions. Employee further acknowledges that all original works of
authorship which are made by them (solely or jointly with others) within the scope of and during the period of their employment with the Company and which are protectable by copyright are &#147;works made for hire,&#148; as that term is defined in
the United States Copyright Act. Employee understands that no royalty will be due Employee as a result of the Company&#146;s efforts to commercialize or market any such invention. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3 <U>Patent and Copyright Registrations</U>. Employee agrees to assist the Company, or its designee, at the Company&#146;s expense, in every
proper way to secure the Company&#146;s rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent
information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and
convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. Employee
further agrees that their obligation to execute or cause to be executed, when it is in their power to do so, any such instrument or papers shall continue after the termination of this Agreement. If the Company is unable because of Employee&#146;s
mental or physical incapacity or for any other reason to secure Employee&#146;s signature to apply for or to pursue any application for any United States or foreign patents or copyright </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
registrations covering Inventions or original works of authorship assigned to the Company as above, then Employee hereby irrevocably designates and appoints the Company and its duly authorized
officers and agents as Employee&#146;s agent and attorney in fact, to act for and on Employee&#146;s behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of
letters patent or copyright registrations thereon with the same legal force and effect as if executed by Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.4 <U>Exception to
Assignments</U>. Employee understands that the provisions of this Agreement requiring assignment of Inventions to the Company do not apply to any invention which qualifies fully under the provisions of California Labor Code Section&nbsp;2870
(attached hereto as <B><U>Schedule 2</U></B>). Employee will advise the Company promptly in writing of any inventions that Employee believes meet the criteria in California Labor Code Section&nbsp;2870 and are not otherwise disclosed on
<B><U>Schedule 1</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.<U> Restrictive Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.1 <U><FONT STYLE="white-space:nowrap">Non-Competition.</FONT></U> During of their employment with the Company, Employee shall not, directly
or indirectly, as an employee, sole proprietor, partner, stockholder, director, officer principal or executive engage in any business activities in which the Company is engaged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2 <U><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> of Employees</U>. Employee agrees that for a period of twelve (12)&nbsp;months
immediately following the termination of their employment relationship with the Company for any reason, whether with or without cause, Employee shall not either directly or indirectly solicit, induce, recruit or encourage any of the Company&#146;s
employees to leave their employment, or take away such employees, or attempt to solicit, induce, recruit, encourage or take away employees of the Company, either for Employee or for any other person or entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.3 <U><FONT STYLE="white-space:nowrap">Non-Disparagement</FONT></U>. Other than in connection with filing a charge or participating in any
investigation or proceeding conducted by the Equal Employment Opportunity Commission, the National Labor Relations Board, or other comparable federal, state, or local governmental agency or commission, under a valid subpoena or court order to do so,
or when constituting protected activity described in Section&nbsp;5.4 below, Employee agrees that during the term of their employment and at all times thereafter, they will not make any disparaging or defamatory comments regarding any member of the
Company Group or their respective current or former officers, directors, shareholders or employees. Notwithstanding the foregoing, Employee shall not be restrained from making any disclosures mandated by applicable law, regulation or order of a
court of government agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4 <U>Protected Activity.</U> Nothing in this Agreement shall be construed to prohibit Employee from
engaging in any protected or concerted activity, or filing a complaint or charge with, or participating in any investigation or proceeding conducted by, or providing information to or otherwise assisting the Equal Opportunity Employment Commission,
Department of Fair Employment and Housing, National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state, or local governmental agency or commission
(&#147;Government Agencies&#148;). By signing this Agreement, Employee agrees to waive their right to recover individual relief based </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on any claims asserted in such a complaint or charge; provided, however, that nothing in this Agreement limits Employee&#146;s right to receive an award for information they provide to any
Government Agencies that are authorized to provide monetary or other awards to eligible individuals who come forward with information that leads to an agency enforcement action. Employee further understand that this Agreement does not limit their
ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any of the Government Agencies, including providing documents or other information, without notice to the
Company. Should any charge or action be filed on Employee&#146;s behalf involving claims released by this Agreement, Employee agrees to promptly inform the relevant agency, court, or arbitral forum that any individual claims they might otherwise
have had have been released. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Disclosure and Notification</U>. For so long as this Agreement is in effect, Employee agrees that they
will disclose the existence of this Agreement to any prospective employer, partner, <FONT STYLE="white-space:nowrap">co-venturer,</FONT> investor or lender prior to entering into an employment, partnership or other business relationship with such
person or entity. In the event that Employee leaves the Company, Employee hereby grants consent to notification by the Company to Employee&#146;s new employer about Employee&#146;s obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>General Provisions.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>Severability; Blue Pencil</U>. Each of the rights set forth in this Agreement shall be independent of the others and shall be in
addition to, and not in lieu of any other rights and remedies available to any member of the Company Group at law or in equity. If any of the provisions of this Agreement or any part of any of them is hereinafter construed or adjudicated to be
invalid or unenforceable, the same shall not affect the remainder of this Agreement, which shall be given full effect without regard to the invalid portions. If any of the covenants contained herein are held to be invalid or unenforceable because of
the duration of such provisions or the area or scope covered thereby, Employee agrees that the court making such determination shall have the power to reduce the duration, scope, and/or area of such provision to the maximum and/or broadest duration
or scope permissible by law, and in its reduced form said provision shall then be enforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Injunctive Relief</U>. Employee
expressly acknowledges that any breach or threatened breach of any of the terms or conditions set forth in this Agreement may result in substantial, continuing and irreparable injury to members of the Company Group. Therefore, Employee agrees that
in addition to any other remedy that may be available, the Company shall be entitled to injunctive relief, specific performance, or other equitable relief by a court of competent jurisdiction in the event of any breach or threaten to breach of this
Agreement without the necessity of proving irreparable harm or injury as a result of such a breach or threatened breach. Notwithstanding any other provision to the contrary, Employee acknowledges and agrees that the
<FONT STYLE="white-space:nowrap">non-competition</FONT> or <FONT STYLE="white-space:nowrap">non-interference</FONT> periods, as applicable, shall be tolled during any period of violation of any of such covenants and during any other period required
for litigation during which the Company seeks to enforce such covenants against Employee if it is ultimately determined that Employee was in breach of such covenants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Cooperation</U>. Employee agrees that, following any termination of their employment,
Employee will continue to provide reasonable cooperation to the Company and its counsel in connection with any investigation, administrative proceeding, or litigation relating to any matter that occurred during Employee&#146;s employment and which
they were involved in or of which they had knowledge. As a condition of such cooperation, the Company shall reimburse Employee for reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses
incurred at the request of the Company with respect to such compliance. Employee also agrees that, in the event that Employee is subpoenaed by any person or entity to give testimony or provide documents that in anyway related to Employee&#146;s
employment by the Company, they will give prompt notice of such request to the Company and will make no disclosure until Company has had reasonable opportunity to contest the right of the request in person or entity to such disclosure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U>Dispute Resolution; Governing Law</U>. Any dispute regarding the interpretation or enforcement of this Agreement shall be subject to
the governing law and arbitration agreement and/or dispute resolution provisions set forth in Employee&#146;s employment offer letter agreement in which this Agreement is incorporated by reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <U>Successors and Assigns</U>. This Agreement will be binding upon Employee&#146;s heirs, executors, administrators, and other legal
representatives and will be for the benefit of the Company, its successors, and its assigns. Employee expressly acknowledges and agrees that this Agreement may be assigned by the Company without Employee&#146;s consent to any other member of the
Company Group as well as any purchaser of all or substantially all of the assets or stock of the Company, whether by purchase, merger, or other similar corporate transaction </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6 <U>Survival</U>. The provisions of this Agreement shall survive the termination of Employee&#146;s employment with the Company, or the
assignment of this Agreement by the Company to any successor in interest or other assignee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Employee has executed this Agreement on the date set forth
below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;Date: _________________</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Signature</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Name of Employee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Employee Address:____________________</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acknowledged and agreed: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Metagenomi, Inc. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signature</P>
<P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 1 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LIST OF PRIOR INVENTIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND ORIGINAL WORKS OF AUTHORSHIP </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Title</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Identifying Number or Brief</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Description</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">___&nbsp;No
inventions or improvements </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">___&nbsp;Additional Sheets Attached </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signature of Employee: <U></U>________________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Print Name of
Employee: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: <U></U>_______________________________ </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALIFORNIA LABOR CODE SECTION 2870 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVENTION ON OWN TIME-EXEMPTION FROM AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;(a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention
to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer&#146;s equipment, supplies, facilities, or trade secret information except for those inventions that
either: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) Relate at the time of conception or reduction to practice of the invention to the employer&#146;s business, or actual or
demonstrably anticipated research or development of the employer; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) Result from any work performed by the employee for the employer.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to
be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>12
<FILENAME>d425213dex1017.htm
<DESCRIPTION>EX-10.17
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.17</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.17 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">August&nbsp;19, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Willard Dere </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Independent Manager Offer Letter </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Willard, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>Metagenomi
Technologies, LLC, a Delaware Limited Liability Company (the &#147;<B><I>Company</I></B>&#148; or &#147;<B><I>we</I></B>&#148; or &#147;<B><I>our</I></B>&#148;), is pleased to offer you a position as a member of its Board of Managers (the
&#147;<B><I>Board</I></B>&#148;). We believe your background and experience will be a significant asset to the Company and we look forward to your participation on the Board. Should you choose to accept this position as a member of the Board, this
letter agreement (the &#147;<B><I>Agreement</I></B>&#148;) shall constitute an agreement between you and the Company and contains all the terms and conditions relating to the services you agree to provide to the Company. The terms of our offer are
as follows:<B><I> </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Term</B>. This Agreement is effective as of August&nbsp;19, 2021. Your term as independent manager shall
continue for a period of three&nbsp;(3) years subject to the provisions in Paragraph&nbsp;9 below.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Services</B>. You shall render services (a)&nbsp;as a member of the Board; and (b)&nbsp;a member of the
committees of the Board to which you are elected (hereinafter, your &#147;<B></B><B><I>Duties</I></B><B></B>&#148;). During the term of this Agreement, you shall attend and participate in such number of meetings of the Board and of the Committee of
which you may become a member as regularly or specially called. You may attend and participate at each such meeting, via teleconference, video conference or in person. You shall consult with the other members of the Board and committee (if any)
regularly and as necessary via telephone, electronic mail or other forms of correspondence.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Services for others</B>. You shall be free to represent or perform services for other persons during the
term of this Agreement. You agree, however, that you do not presently perform and do not intend to perform, during the term of this Agreement, similar Duties, consulting, or other services for companies whose businesses are or would be, in any way,
competitive with the Company (except for companies previously disclosed by you to the Company in writing). Should you propose to perform similar Duties, consulting, or other services for any such company, you agree to notify the Company in writing
in advance (specifying the name of the organization for whom you propose to perform such services) and to provide information to the Company sufficient to allow it to determine if the performance of such services would conflict with areas of
interest to the Company.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Compensation</B>.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>a.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>As compensation for your services to the Company, you will receive upon execution of this Agreement cash
compensation of $30,000 for each calendar year of service under this Agreement on a pro-rated basis.<B> </B></P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>b.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>We will also recommend to the Board that you be granted 94,856 Common Units of the Company (the
&#147;<B><I>Equity Grant</I></B>&#148;) in the form of profits interests pursuant to the terms of the Company&#146;s 2019 Equity Incentive Plan (the &#147;<B><I>Plan</I></B>&#148;). The Equity Grant will vest over a period of three years in 36 equal
monthly installments so long as you continue to provide services to the Company or its affiliates. The grant of such Equity Grant by the Company is subject to the Board&#146;s approval and this promise to recommend such approval is not a promise of
compensation and is not intended to create any obligation on the part of the Company. Further details on the Plan and your Equity Grant will be provided upon approval of such grant by the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>c.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>You shall be reimbursed for reasonable expenses incurred by you in connection with the performance of
your Duties (including travel expenses for in-person meetings).<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>D&amp;O Insurance Policy</B>. During the term under this Agreement, the Company shall include you as an
insured under its officers and directors insurance policy.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No Assignment</B>. Because of the personal nature of the services to be rendered by you, this Agreement may
not be assigned by you without the prior written consent of the Company.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential Information; Non-Disclosure</B>. In consideration of your access to certain Confidential
Information (as defined below) of the Company and in connection with your business relationship with the Company, you hereby represent and agree as follows:<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>a.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Definition. </B>Confidential Information as used in this Agreement shall mean any and all information of the
Company, whether in writing or not, including but not limited to, all data, compilations, summaries, programs, devices, strategies, or methods concerning or related to: (a)&nbsp;the Company&#146;s finances, financial condition, results of
operations, employee relations, and any other data or information relating to internal affairs and policies of the Company; (b)&nbsp;the Company&#146;s marketing and business plans, future plans, concepts, competitive strategies, pricing, margins,
designs, models, apparatus; (c)&nbsp;customer and suppliers lists and the identities and business preferences of the Company&#146;s actual and prospective customers and suppliers; (d)&nbsp;the terms and conditions of purchases, sales and offers
regarding potential or actual projects contemplated or evaluated hereunder; (e)&nbsp;the terms, conditions, and current status of the Company&#146;s agreements and relationships with any customer, supplier, or business associate, affiliate or
partner whether or not in writing; (f)&nbsp;the Company&#146;s trade secrets as defined by state and federal law, and/or as defined by the jurisdictions, whether foreign or domestic, in which the Company operates; (g)&nbsp;the Company&#146;s pricing
structure, including its costs, margins and mark-ups; (h)&nbsp;any other information and knowledge with respect to all projects or plans of the Company in any stage of development or evaluation by the Company; (i)&nbsp;any communication between the
Company and its officers, directors, employees, consultants and attorneys; and (j)&nbsp;any other matter or thing, whether or not recorded on any medium by Company, from which Company may derive actual or potential economic value by virtue of it not
being generally known to other persons or entities who might obtain any value from its disclosure or use or that gives Company an opportunity to obtain an advantage over its competitors who do not know of or use the same.<B>
</B></P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>b.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exclusions</B>. Confidential Information does not include information that: (1)&nbsp;is or becomes part of
the public domain other than as a result of disclosure by you; (2)&nbsp;becomes available to you on a non-confidential basis from a source other than the Company, provided that the source is not bound with respect to that information by a
confidentiality agreement with the Company or otherwise prohibited from transmitting that information by a contractual, legal or other obligation; (3)&nbsp;is compelled to be disclosed by a public authority; or (4)&nbsp;can be proven by you to have
been in your possession prior to disclosure of the same by the Company. You shall have the burden of proving the applicability of any of the above exceptions.<B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>c.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Documents</B>. You agree that, without the express written consent of the Company, you will not remove from
the Company&#146;s premises, any notes, formulae, programs, data, records, machines or any other documents or items which in any manner contain or constitute Confidential Information, nor will you make reproductions or copies of the same. You shall
promptly return any such documents or items, along with any reproductions or copies to the Company upon the Company&#146;s demand, upon termination of this Agreement, or upon your termination or Resignation (as defined in Paragraph&nbsp;9
herein).<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>d.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidentiality</B>. You agree that you will hold in trust and confidence all Confidential Information and
will not disclose to others, directly or indirectly, any Confidential Information or anything relating to such information without the prior written consent of the Company, except as may be necessary in the course of your business relationship with
the Company. You further agree that you will not use any Confidential Information without the prior written consent of the Company, except as may be necessary in the course of your business relationship with the Company, and that the provisions of
this paragraph&nbsp;(d) shall survive termination of this Agreement. Notwithstanding the foregoing, you may disclose Confidential Information to your legal counsel and accounting advisors who have a need to know such information for accounting or
tax purposes and who agree to be bound by the provisions of this paragraph&nbsp;(d).<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>e.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Ownership. </B>You agree that the Company shall own all right, title and interest (including patent rights,
copyrights, trade secret rights, mask work rights, trademark rights, and all other intellectual and industrial property rights of any sort throughout the world) relating to any and all inventions (whether or not patentable), works of authorship,
mask works, designations, designs, know-how, ideas and information made or conceived or reduced to practice, in whole or in part, by you during the term of this Agreement and that arise out of your Duties (collectively,
&#147;<B><I>Inventions</I></B>&#148;) and you will promptly disclose and provide all Inventions to the Company. You agree to assist the Company, at its expense, to further evidence, record and perfect such assignments, and to perfect, obtain,
maintain, enforce, and defend any rights assigned.<B> </B></P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Non-Solicitation</B>. During the term of your appointment, you shall not solicit for employment any employee
of the Company with whom you have had contact due to your appointment.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination and Resignation</B>. Your membership on the Board may be terminated for any or no reason by a
vote of the members holding a majority of the Company&#146;s preferred units. You may also terminate your membership on the Board or on a committee for any or no reason by delivering your written notice of resignation to the Company
(&#147;<B></B><B><I>Resignation</I></B><B></B>&#148;), and such Resignation shall be effective upon the time specified therein or, if no time is specified, upon receipt of the notice of resignation by the Company. Upon the effective date of the
termination or Resignation, your right to compensation hereunder will terminate subject to the Company&#146;s obligations to pay you any compensation that you have already earned and to reimburse you for approved expenses already incurred in
connection with your performance of your Duties as of the effective date of such termination or Resignation.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Governing Law</B>. This Agreement and all matters relating to the meaning, validity or enforceability
thereof and the performance of services hereunder shall be governed by the laws of the State of California.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Entire Agreement; Amendment; Waiver; Counterparts. </B>This Agreement expresses the entire understanding
with respect to the subject matter hereof and supersedes and terminates any prior oral or written agreements with respect to the subject matter hereof. Any term of this Agreement may be amended and observance of any term of this Agreement may be
waived only with the written consent of the parties hereto. Waiver of any term or condition of this Agreement by any party shall not be construed as a waiver of any subsequent breach or failure of the same term or condition or waiver of any other
term or condition of this Agreement. The failure of any party at any time to require performance by any other party of any provision of this Agreement shall not affect the right of any such party to require future performance of such provision or
any other provision of this Agreement. This Agreement may be executed in separate counterparts each of which will be an original and all of which taken together will constitute one and the same agreement, and may be executed using facsimiles of
signatures, and a facsimile of a signature shall be deemed to be the same, and equally enforceable, as an original of such signature.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Indemnification</B>. The Company shall, to the maximum extent provided under applicable law, indemnify and
hold you harmless from and against any expenses, including reasonable attorney&#146;s fees, judgments, fines, settlements and other legally permissible amounts (&#147;<B></B><B><I>Losses</I></B><B>&#148;), </B>incurred in connection with any
proceeding arising out of, or related to, your performance of your Duties, other than any such Losses incurred as a result of your negligence or misconduct. The Company shall advance to you any expenses, including reasonable attorneys&#146; fees and
costs of settlement, incurred in defending any such proceeding to the maximum extent permitted by applicable law. Such costs and expenses incurred by you in defense of any such proceeding shall be paid by the Company in advance of the final
disposition of such proceeding promptly upon receipt by the Company of (a)&nbsp;written request for payment; (b)&nbsp;appropriate documentation evidencing the incurrence, amount and nature of the costs and expenses for which payment is being sought;
and (c)&nbsp;an undertaking adequate under applicable law made by or on your behalf to repay the amounts so advanced if it shall ultimately be determined pursuant to any non-appealable judgment or settlement that you are not entitled to be
indemnified by the Company.<B> </B></P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Not an employment agreement</B>. This Agreement is not an employment agreement and shall not be construed or
interpreted to create any right for you to continue employment with the Company.<B> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Acknowledgement</B>. You accept this Agreement subject to all the terms and provisions of this Agreement.
You agree to accept as binding, conclusive, and final all decisions or interpretations of the Board of Managers of the Company of any questions arising under this Agreement.<B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We look forward to the opportunity to welcome you to the Company. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian C. Thomas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian C. Thomas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Metagenomi Technologies, LLC</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I have read and understood this offer letter and hereby acknowledge, accept and agree to the terms as set
forth above and further acknowledge that no other commitments were made to me as part of my offer except as specifically set forth herein. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Willard Dere</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">8/20/2021</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Willard Dere</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date signed:</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>13
<FILENAME>d425213dex161.htm
<DESCRIPTION>EX-16.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-16.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="right">Exhibit 16.1 </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top">


<IMG SRC="g425213g12s76.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:20pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial">KPMG LLP</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial">Suite 1400</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial">55 Second Street</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial">San Francisco, CA 94105</P></TD></TR></TABLE>
<P STYLE="margin-top:30pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial">August&nbsp;3, 2023 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Securities and Exchange
Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Washington, D.C. 20549 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Ladies and Gentlemen: </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We were previously engaged as principal accountants to audit the consolidated financial statements of Metagenomi Technologies, LLC., (the &#147;Company&#148;) as of and
for the year ended December&nbsp;31, 2020. Since the date of our appointment, we never issued an audit report on the Company&#146;s consolidated financial statements. On April&nbsp;28, 2022, we were dismissed. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have read the statements made by the Company under the heading &#147;Changes in independent registered public accounting firm&#148; included in its <FONT
STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> dated August&nbsp;3, 2023, and we agree with such statements, except that we are not in a position to agree or disagree with the Company&#146;s statement in the third paragraph relating that the Audit
Committee of the board of directors dismissed us, or any of the Company&#146;s statements in the seventh and eight paragraphs relating to the engagement of PricewaterhouseCoopers LLP and any consultation with them during the Company&#146;s most
recent two fiscal years and subsequent interim period. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Very truly yours, </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:arial">/s/
KPMG LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>14
<FILENAME>d425213dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the use in this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> of Metagenomi Technologies, LLC of our report
dated August&nbsp;3, 2023<SUP STYLE="font-size:75%; vertical-align:top"> </SUP>relating to the financial statements of Metagenomi Technologies, LLC, which appears in this Registration Statement. We also consent to the reference to us under the
heading &#147;Experts&#148; in such Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ PricewaterhouseCoopers LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Jose, California </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;5, 2024 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>15
<FILENAME>d425213dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML><HEAD>
<TITLE>EX-FILING FEES</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 107 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Calculation of Filing Fee Tables </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form <FONT STYLE="white-space:nowrap">S-1</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Metagenomi
Technologies, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Table 1: Newly Registered Securities </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Security<BR>Type</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Security<BR>Class&nbsp;Title</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Fee<BR>Calculation<BR>or Carry<BR>Forward<BR>Rule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Amount<BR>Registered</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Proposed<BR>Maximum<BR>Offering<BR>Price Per<BR>Unit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Proposed<BR>Maximum<BR>Aggregate<BR>Offering<BR>Price(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Fee Rate</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount of<BR>Registration<BR>Fee</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="22" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Newly Registered Securities</P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Fees to</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">be&nbsp;Paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Common&nbsp;Stock,<BR>$0.0001 par<BR>value per<BR>share(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Rule 457(o)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">100,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.00014760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,760.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Fees</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Previously</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="22" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Carry Forward Securities</P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Carry</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Forward</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Offering Amounts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">100,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.00014760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,760.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="7" VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees Previously Paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees Offsets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="7" VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="7"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Fee Due</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,760.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="7" VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the
Securities Act of 1933, as amended. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Metagenomi Technologies, LLC, the registrant whose name appears on the cover of the registration statement on
Form <FONT STYLE="white-space:nowrap">S-1</FONT> of which this exhibit forms a part, is a Delaware limited liability company. Prior to the effectiveness of the registration statement, Metagenomi Technologies, LLC will complete a series of
transactions pursuant to which Metagenomi Technologies, LLC will merge with and into its wholly-owned subsidiary, Metagenomi, Inc., a Delaware corporation, with Metagenomi, Inc. continuing as the surviving corporation. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g425213dsp059.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp059.jpg
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M-G:65[>"LD8G>/#1DJ+"4U49.46EU88HX?%$5,56ID>'$0$  @(!!0$
M         1$A P(Q05%A@3+_V@ , P$  A$#$0 _ /OXT'111-(AU53E333*
M8YSG,!2$(4!,8QC"( !2@&XCH,**EHR<C6,Q#2#*5B9-JB]CI*/<HNV+YFX(
M"B#IHZ0.=%P@LF/<4Y1$I@ZAH,T%$Q,)0.43%^\&X;A^4/9H.1.4H"83%
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M1 I!EFRC!!8=]NU%1<I4S;[=-AT"H2627(51%1-5,P 8ITSE.0P#X"!BB("
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M0_<HJ<J9A  ZCVCH'8$P  CW%#;;J(AMU]_Y0T"&MS%=^:IE;%./RVZ0<@X
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MYH2T56G+4RY$QV,4IQ$H]!ZZ!/VW+5)"DU#(K"A7M6*3O<.B+)KBNVIV]H0
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MCGH$,(@':8&R@]WO';;V:"/O'\B)\<X-6-%N':H4N5*A,)@=-O&@*B?G(+I
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M_P#UYOH$QD8C1/*N&U&1SJ+KY\6)(IJ=W8@!,*W42F0 0  $Q@#?;WCH)9:
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M,K*-DDBF44,4H&56.!2AOU,( '70*M,0.1,X^TH&#?\ N@#K^SH/30&@- :
MT&IG?T-*?S>\_DRN@9GC:43\=\+E*8"#^KNGG[A*)@[4XUNH8.FVPF*78!'V
MZ"JY*/RZZ^MOCN<;T^^5C [/C'EZ*?NWKKNI%@RDM8*FX),-VQ-B'E%X@IR)
MJ=?A3.&@N_.82).3 /4!$0^T00 0#]D= D 6*M<9R*,DFDF6GQCP5Q$ V4>R
M$XBH)O:!0\H1$1T#'<<VA6-VY!-$W";I%M;Z @@X14*JBH1/$]1'=-0@B0P
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MPVV\=]_#;;0'<4"]PF "[;]VX=NWOW\-M!QWD#<!,4!* &$.X.@#X"/7H Z
M,)=A^("AL/7< VV\1W^S0(>XOCL(Z.7002<G7M%98 @<2^2D+N>;('=%#80\
MY$AQ/[P$- V>1[&]:4;*;R/,>/>P]@8MD72 _G%!,G!@)]RAW (@J(?DT#H6
MGM-1;#NIYH!4Y<PF.(#YAC1AU?- W@8 $?$.@:!(X!,4F%,3E.8I3?J^J@[&
M$"CL,4B4!V'8>HCM^70/$4Y#  E.0P&W[1*8! =A !VV'KL(]=!VT!H(_<D
MWQ+/;]?\]T3_ %ZA- ^[;_%FW^#0_@B:#*T!H#0&@-!J9W]#2G\WO/Y,KH&6
MXX?[NV&! P@8N.*L<A05.@50Q89,0(JJ4! J8^WN 2_9H*B*99>2-C^M;5PL
MOXQ;X"@<"YO@V+,TB+^B?CA&T5=9@"0H(-VI)Q&)65,4I@%4J*F_@;J%]A!,
M'G=I0,/>'PB.P#^:+H$,5!4F0+ ]52$S-2BP: ' IA(HH26L)SI%/MVF.)%
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MH.F"N/?U!Z/ELEJS3SDK68,6BVL2:F-X_!$%3WQGK\ZGR1R%D:/W#@2PZ0E
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MZ]0F@?=M_BS;_!H?P1-!E: T!H#0&@U,[^AI3^;WG\F5T#+<<"$/QWPL"AB
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MMAWT$U<,YIPRG5<!J.\L8S;KM*;:"KE-;ZTB++SP9BBBX*K*)+('!(HD IB
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MPKR#2#K;]RW;H%^(YE *0I>HCMH/./Y,<,8_T<98;3BF!G"1Z+AS%SM3-6I
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M !NW?;N[=]^W?IOH.V@-!J9W]#2G\WO/Y,KH&5XXE$>.V%M@WVQY4.[=0R8
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M&M5X5LV:R2"RD4 (=_<19/?[NX;:#6X)^FO4.6&#.'G)+/G+S($]D>,P>DG
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MP[[AN&V@2EYL$C%-8:R5&==SD4Q42B%8V.<*3HS*CA0J!G":#5,X/%4 '<P
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M_$"O.,;V")K$]EF3>%8-4(VM+9"=+13U-J^;KK1RC)TW!JNW=-@.0Y#_  G
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M;-^XZX& IBCX .PAMH$K.UBM-)RK&2K%8*>7FG+:3$L!%&=+G/%.I%8CLZJ
M"Z$SMND8-Q$0$H#UVZ!@P%=KKRGSCU:FUEZNB_N!&3=>K0JQ%SLI*2%HEY7I
MQ!<5%D@*4N_Q&Z:"#?".QYCOSW)S[->-VL0Q3@8>5J-:GL70E,9DEWLS9DIW
MT[@C=P"R2Y6K;S#&+W@0P&[1Z:!:\2<\I\B;!DUO;,+1D(-4R'::E&OS4Z)/
M%NHF',4C!\TEW23>1D0E4BF%0RC1(@=I0 P[AH%SSRP"^S%PUY$8IQ%4JU'9
M#O6+[%6ZBOZ"*@BM)*3;@EYI9)NDD=D!D.\!,!@ P;E'H(Z"&.+J55:OR9N&
M.;)%U2/<R&,,=02L$\)'HIV)ZPHE:83$# Q:1DQ?S"SJ/54%SVF$$S@;?P'0
M+SGY9XG"4+AZOTJ1@L6.KWD_&N*V;HCB$KHLHZ;;V--1^K(NP+YD=$*+D]2B
M&YC;@;W#H&^R9CVF9U6XR\<7.:HG(=]@\+9-;W&[8NML*ZE!D(5Q2C,I0TP9
MV]%!H679JE4;F*?<#C\)0$# %J>.:538:,;ECX)JN\,DDSFW<K%QQ9-Y*1Z2
MC%^]>%2;E**CD[<#"H G!0#;[> Z!D>6C^=I&'N3-LQO!,5+M4^+U]L5)0C:
M\SE9 ;9$15H?0QV42#%4\@N5^B3L1*4QU#  % 3"&@4W#Z7EKUQ6X[VS(K)C
M)7*PX@Q].V-PZA6T?Y]CDX!D\F'!8H6I31*OKU# HF)";&#80#8=!AY<Q#,W
M#).-):LWEW1V$8N196M1,*V/$SQFA9$\N234!),")N&;QJ ;A]Y - [2>,)-
M,H%_$9#' @ <2Q;,HG$ VW 3(B7<1]^^@Q%<5RQUTSM[.FBF0WYY,\)&',IT
MV[05(U*<HB( .X:#U_5;)%^(]D(8A0$3A\H9&$2 'Q% #MQ+N)>@:!L,D8DF
M9D]7$F2WL00MABDXU$L)'.UG4H"X+LTWCTK3=1J5BW53[!^$O=H)*D@88-O\
MRQ#@#;J*?YJ8)]Z8%#RC'W:AN<# ([>(:"G7ZQE#MV1.*UPQSCBOJR]ED\B8
M//#0T4E#Q9E5SV8T@\(HJHV(4Y09,E!'?KTZ==M!+?Z?D/BQYQ2Q2ZQ\T(^B
M%$9<9 9AB[%ZG9491\C/M7!YM@D\.$:\(8J73RA /@$0VT&VM-.P-9J3F%]=
M&MAIM3HN8):\7:492;ROK?-Z@PB'4E.(NX%(CQW6W#=5(#-?B*KV#TZ:!!<>
M3\3'T)QW<X$]1<Z2_M66DZ%:?72DS&LYEQ77DI:OF[RPH>O<%<,U11: ;\VD
ML(%+[M!Z?4XA<<(<$.4)[VW)'0:6)[88CV,C5$I,D[\J<#")M303%9V!)%]V
M$5,(=I2"/<(!UT&)]-&'K2_TZ^)+*I-VY2.\!5-:/E)J,+(*-I=1B@G+.%6D
MDU2<+IDFS*D*!]N]%(@]0V'01IR3QGM.2YW->=\@R)KO<\%6*4IU0K./ZV$6
M^M$178VOVNMM8Z(:NVS9U8FTC,]J!C"!1/[0\=!&F%X;OI;'>6^3K:E6C!MY
MJ,D:UL8FXE5=*RMDJLF\5E'4C! ^5:KQHOCD7)N8R:@^ CH+LI!LOC_%\6[R
M+8*I)/$9NLIR]G95EG"MUX)Q+QR;QF$<W1<+J 9BJ<.XG<([Z"FWAS)XSD\T
M9@5(+>P4%NAEMQ6BM40:3)X!QE&/3(=PC),TG[1T215!,!$I3 4P#[=!?]*Q
M44ZA7RKV(8+G^4N1[W+=JX=@DFW R)5'!VYCB<I=N@CH-9CZ*C$ZC45R1;!H
MY_#C A5&S9H"AD1;- $/,3;D-N?8 VWZ:"OCD3QJR3?.>? ?,E3C(G]6>%D<
MXCD1J[DDHI<QK?56$9#IC641*QGU"N [BKF(<Z!OBW#06-3=4KLA#2J3NN0#
ME%PP=][20A8URV*H5LIVBLDHV,"Q0,&_7]C0,EQ)@*S"\<,.)0L+'1K%2GLI
MALV08H))-UYLRDA(F:)%0#TR9G#LP]I0+T';09').'ADL23RH0T88P3E%'U)
MF3,RIP6OD(!A/_%3&V+W".P[[[Z!^FL5%E9 BE$1A4'B+<54$VK5%!QLF7XE
M4RMRE-L'0 , ]-!Z*1,8MV >(C7HH")$_4,VG\5#;;RT.]L( 0 #]SL&@0EG
MA[ @@5E4HS^('%14AV;Z+B31:JFX+G:E6CEE"=P&$0$O7?PT"D@$)H&J+J8:
MF9R8D;M%FI),99'T[<0 KL%TD6A0<N0#=0>T?'0+30&@U,[^AI3^;WG\F5T#
M)\<D@5X[X4,!^Q1#'E462[A.*8F"&3(/F)DZK%(0PF O]L #[-!4'!5;&#CZ
MR3C#4-BJC2V.Y3 -SRY<7\UCN,5D&N8F%[AT4G,19P8"NBB1J\,J"9E0 ZBA
MAVW+H+TK/"0]@K,W7YR-9R,+,QJ["4BY1+U4<\8NT3MQ9KHAT.@<-@$H> :#
MY);7D(;K)Y.K#_"M;K1<&Q&-F\-+P,DI+?K!AXA_D26<V2:1JE<*U0G(V+DF
MJD4RD_,</)#9$I]A. A89]).CY:G<)V^S1V3[#B4MCL-7FE*\\I%/G)!)9?'
ML !UI?\ %#(TS%S@QZ:(2*#@3&(\*H(&VT%KI<;YM./:3E/-',"::HE)BS%9
MA!)4=DE=BL!'RU1#8IO P^&@;1[/N(\ZZ4ES]I3<S1R+1\U>P^!&YT5R'%-9
MJY(HLFHV73$![BF[3%[1WT$?)?&F.;KF?'=WC>8N/GM_1DI&<9V>N06!C3[N
M5CXEE"13&1.T666?%.W=F(BD8! XCVAOH%3R]XG90S-CR(8NLT.;O9*.:US\
M;67E;JM0-;SS4 [A6,"9>OIM6C9)1T'=YRH& !)UT$OZ!8JSBO&^-(/(MLJE
M#D&-*KD,O&V.SPL4V"2AH-FRD&,>XDGC5-V9FND83BAN40^(?'0*,>0&!5OS
M26;<1*J"Z.R!,F2*:H<7J7Q*- 3+-"8726VYD_O@ =0T#:Y1Q#@KD97&\LY_
M!EH)&KQB4?=X.48/A9)U^Q-)T(E&=C5G" )?.2 *K<%-Q,8 $-Q#0/)'H,6T
MY9Y5&0CW:DRO"HHMF;H".!/#-#LO2N=Q4\PY"KB8Q=MP]NV@;W(&:Z/3[3$T
M*0@K;;;'-U9[9&T76H'YPZ7KS&6)#N%U%5WK!N55.25#<@G XEZE =!"B8Y"
M<F;UGV=H>$B5BE4JIUAM(R$?E*';0\D?=+S/4@\57D2HHHD*(CVF @@ CX (
MZ!0XIR=RNG8^<R;9XC$UFKS<DY4HXD186R;>2/'/Q5]4S=,VHD=(N"$$2 F8
M2J:!C/J1XZQC8,-47)XUR'@<B!E#CS-0UPCSA$S#,LM:8IO+*I2J!NQH^!L8
MB0+*$%1--(3 &Q1V"%-(GXR'HG%SD+;(B^GD8CGA9*FFDE'S\VO-5[S322TI
M#UM4HKRIYZ32(H,FAW$=$#N*&V@NC0YU8>67<%3JV<^YG+NH5P?]3UP(U,X2
M([="<BIF92*M!3CA3\T![.XQ2^)@T#%6[ZGW&-BSIEQD$,T1]?2L)#DD9'#E
MQ(DLZDG;JG-HE WIA,M-_B)<K<&Q.Y8!W#MT&\J7U$N.3 ]D@VS;+\L_K5D<
M,[,I%XCN"[>"F)ILG8F[-P'IS)LCILY<#*%4$IB*#L( .@6:GU(>/*<6WEUH
MO-2<8YCI&6]8OAZVF39M(U,PJI2 BW_BB[P$]VZ9^TRPB';OH-)&\[.-U>=V
MH\'0LR(R23R*6LB\9A2W]):4@8^6CB.C-F8K)H*QXD,KN  F;H;00WYQ_4#Q
M'GWAIG'&6!DLQ3&4,E8OO9<;,8?&-L;R[I*K.F#.4G&C@?3&28L)!P!4W"2F
MY_NI=R@E*(-M4,Q\<\E,LA/I"!S'5L\XJ98P:M+[%XOM#VVUEZ&)Z(@C" Y3
M1</G+5TY.=V?SA(\2(<%=NT '0.-.Y0J',:JR^+\K8=R9.Y&Q[)M73%_ 4]1
MLU96J#=NU*W-/E'+MFY9DERR GV^)%X!$U@\LJ@$ (P-*?FR BL98M8X R"Y
MRQ,8<RBRBOQE1J_CAE)/&=VI\Y(J?B&NR[R2=F)!MSB45!*8YC$*8-C]0^B_
M%;=XE!-$W*"T:X9^0@]B%5S+(L'1V"9W*394@F!P4JVX=QAWZ#H&9Y<W:U8T
MPUR@R)1E0;W.B<6,BV^K.!:^N*WG:[#6J6C'!F6QA=E0=-2F%, $3@&P=1T&
M\X;35CL_%3CO8[4\!Y9+#ANC2LVHBT29$7F)&OMGDD[%N78Z"+MPX[R)" "G
MOML&@?J4?"UGZLU(W(N5ZM*)J+J"&[4Q&R1Q!/I]X1#;;W:!7=Y![MC%'L^_
M\0?#N&_Q=?AZ=>OLT !BB.P&*([;[ (".WAOT]F^@[#^UH$-:'H,#5;M;)N
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M3.0:F5@O:J-Q>OMNKS61CD9I@O,0$99Y.,2DH58IR2L:J\;$*NW$IO.2$Q
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M9!)A5V*LS56+>EHVF)*Y(,FN:2ZHF$AQ1\0T%FLE^CG_ /D3K^ 4T#%\7?\
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M8L/\E<RYTO<HW?*VO'LC:"Q,.F=9]'P+"^Q$2K#O'B)$6Y7+A94.T>T2$#J
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M\K+J[Q2!;/S1K=>;/C1WRDL>_F.2\_',I!![''4=E<,72G>!";"H8.T1#?<
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MRU465_%YZ:]N8K2EWO.0HF>:2MZM2SMVU%TQ;5V#<F+$%=%\AR=4R1]B'3
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MLI7'N<+<U2C$W:L9%O'LMA2FH/G,I%I[,YE-,JA_(.H B0X ("!@T$H&W&#
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M70;]ACD5)W@<1  T#_8*X3Q<G!3$L\S_ ,PHVW6^&Q_)9">GS;\NDI.X%J$
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MM:#<6"=BKT38%&ZI!,9LG,-3*F:D4 -]TUR=1#\ONT%?_)B\Y]@OJ#?3\J-
M6MA,+6]CG93-2$-%J.ZVH$=7XE6F'L$CY8IL-I(PB3O,4P]>W<>F@LSDOT<_
M_P B=?P"F@8OB[_N]85_V>5_^2):#SY*F,7$%B,5,5C%EZ.)4BAN*I@O$*()
M@&Y=Q./3Q#00A^HK(HLVF%DBU25OA$W%E.ICQLSL;N)GV!PK42G)R;^K+(S:
M#V DWZ!$$^\ ,#U3KL&^@F/Q1F8^:P;1E8FOI4I-JW=1R]63;2Q3PKUFZ,F[
M9&3L*RTLF8# /[Z81VZZ"3F@- : T&IG?T-*?S>\_DRN@97CB?R^.^%3]HG$
M,=U/8@;=RFT.D)B%W$"B8Q0VT%;F,LN04!]6>S8"E<)5<]VL&%+WE.-SJ[<K
MA>D*D>WP;!M3&S0Z7IAK;Y=<5#*$./YQL4.H^ 7$S"0.(]0ATNXX)+*$*3N$
M4S@V<=IB)@=,%C>SM$=NN_LT'Q'V1(V>LM\F:AB2VU%=W17-#5N+UNX9GLL*
MZ8B6KI5NHN6?R>:_%)YEJ5/TR2IVY6L6)U%0["[A>+]+7!U=J6#\_8_RJI$S
M=7L.1:7)-VTO)QKM=U$DQU4'L>:7^7N5F;>=-(M!.Y;D.8Z2Y1(81$N@N78.
MX268$/$KHJL"$!)'R#JI+#Z,A"'2.4X$.D5%)$FW3<2AL'0=!\$W)NKYYO$H
M%7K%FN;A-5[DMP5XP1EI B-7>VB3>+5Z,80*B0)0RC1MYZSAR?S&*")S"F8#
M@40>O"E;S+5ICCY5;)#/)T:?FHZ*D>TR =.SU*CL).EOT+ O%R;9=&_,;*Q>
M(K.%Q617<*G\CL[T3;!].'-Z=S=+5BNH8#5D <MI^."W-R-TB2C5=:?@%6C*
M0C1,G*D2;,RJF3,@"A"[F[M!7[]6UKD-9_QG78V=["2S:B9I+8PBQ.C(%8O8
M)F K2S%7S)62KZ!B'.X210,OYGE')L)=P"E['G'3-4/?;':9B:O$V\2N,2TM
M=MOB@PE(BZ>[I7F55.6B7/>5E%/U4DV@3,>198-TUSE$QC!H+X/I[X?E,T_2
M\NF*<J56P5R4O&4,A)6>!@K(UE;(CY%^@)ULZ3F$T&B(NG*,>FKL":9P;"'=
ML8=!CYP;XYXVYBY(,8' ]%E&.7(_'U4:3#YK74)F,D'N*;&:4LL(C(QKU1S+
M+R9$S>5W%\]<!'8=!"_A32:+#YMLLED#'++(-,A\9P;QY$IUN%*ZA9EPV8-0
MD+4P62B&R*KF8V,4J1OC';H.X!H,_#N3(O'O*+'62:GBR0R!!2$KF+Y-1JTS
M@J\[EVJ]5E&8RD4VEG*4>4T;Y9B*AYG>)"_#H+G^*\]3LPX)SK-RE#=0E&N6
M6,G.Y3'TJ:+<.VS D/ HR+!\K$/%FRRR[QL;X"J@8H]-^F@J?^KK8Y&F4BAO
MZ(^@L3(R^!;S-5MX=*-5FGTM56<'.5XSY-2.7,L^6/&IM42C^=1$.XQA - X
MO/3)CNQ?3QX"Y/R4WLEJD[R.&;-<TJR,6-GEY:W8I1=3*L<L[\N*<OW3V3 Z
M1%=DE Z&$"AN ;&<Y79%JK7BF#+$%\Q]5,"Y%=1=N9SE]Q[!.,NL(C$4RD2'
M:1\6Z,VD'C5,S1X8%0],H;L\@YCB0!"3_'CFJXOV0J%0[=4;FZ8SEZM"\7E:
MR2]1CXTC^2A;38H;'S2%8D"2D3P5?9JIBH4FP]@@(^X)9XTQ]5[+GP<LN:[=
MX>\8ZK%RH2$C/-CQD%,U^]65I9C'AF9BJ@Y(DO&$[C@8NPA[?#029=2DG,OU
MXN$52;-6:P(R4HL@FZ*DH0W<*"2"ATTE3','8;KN7Q\=!3!;LE9RY!T[*^#X
M^"6RM=8WE?+S]<42F:]78V+QKQ_R1BFPNHI4),@B9RX&3\I$"@<P*&#<0#0+
M3ZB7)7FY1>)N9K5QYPQ%TBY0./)"75E97)E:D[C5)0KUD8DE6H!HW=%L,L2/
M*H#=J4#>8J(!V^S0-QAG.WU?DJS49NP\4^-EC>6>"JLM87;?.IPF'BI6A4MX
MM!E'&;NCR<$S,X%54P"5TN<AOA(&@P\<QLA)_4>RY<,GXO4+(YAA\3T^1I$T
M+"8#&(XN;)VR%E&MAK\@V+(I3KVP"XV.4XIJ-R"8OLT#D7;%O(JH6F]0>-]S
M7ZV2?(BRXQ^3VYE'RB=2EI+$1HQ89-5JHU:N$"IN"'1,3O[=R[[CH).\_"R1
M."N3TI)%16:"LT!.7*X4*HLDJ6V5LCH%G(@4KPXO2J#N0 $>[?PT"XY%V&/Q
M]QQSKDR?J45>:O3.)%FF9>E3AU$8:WM(&J3TT]JTFJF&Y&,VT0],K[B*]>F@
M6G#*P-;5Q:X\V=C7&=09V7$-$G&M6AE07AZVSE8%M),H-DJ/Q':1;5R5NF/M
M(F&W30/7-&8DLE7!V@Y,X.K. S6(8!11.*20&%=,1V4(8@[ 'VZ"O?AUG#(D
MSEV5P@XJ-1;8TK.,&=S;W$EA*%U=V*7M,NV7BG]2[@39QK=!'N!=,-@';?QT
M"SYN@T7R#Q$;.E">2\RO-->SS2)G7%6$: **/<8/,5,7?8H;B.V@FA3J%6<?
M,)-C569V#>5DW$L\#JKNZ6[?-,)1[1V,7</[.@J;N7U!;4PR-S(QH_Q"U8RO
M%B6Q[,48ZJDX5*\,K+-HPT3-2LH_2+$*LO)>K&*DT/YG<0-QV =!+3'=^Y07
M%IQ]M9*-44ZC;&+?]:S1O-QBKZMF<24FCZ^/5(Y64>I-HM!N?L0,<.]02B("
M Z"+?U)JVYY/\;+I2L12E6DW]RRMB^@L)N:=/R02%BK=F4DYEFKZ8H*IK1Z\
M:"8*%^Z<WCXZ!H_IVYLK.4<\V^]56(N#.N86XF1V+<D3,]2[) 0C;(E<R5(S
M-CC(N3EVC8UE;LV#%PJ@NB*A#$$-AZZ!S[I]7'@GBILO=7+W)ME93#"0?5A*
MC8<R!:7C\8!7TLLV T9#N6R#\%) 3$35.03)[CX:!E(;F_E;-U#E^;/'B6S3
M)<=U)Q^E6,:RN-B1"<XK$&:5I!*1F7BWJ*[ $GC'%SW$ Y!#J&@F7.RG**=R
MI&W)A,9FJ^.TI^K3<CBF)QC#&%.-BF;EM8:\M:%G9EW\?+21P5,*9"J"0 $-
M!'/(G(O/TY+VK/L8&;,?X?Q;;U8N2QPWI<>L_N,?34U32YWDD[7[HMG/R;EJ
M"ABB)R))]VWAN$YHVEJ<@<82,S''?8W?VR-9M9II+0<1+/HIVHFV=N)"';JJ
M 2-=3#=4H.$U!3$Y3 (]! =!"GZLF,G3O#6*+'+95KL$^89WI9W]HN$,@9G\
MH09.6J-?A8EKYQ$7KZ7(13O*)@#<3#T#?06Z6%JY>P==30W<>59*2\<+)_F_
M4-FLE$JKOT2!N)&Y$R"82[= #043\1[<SEN9'(JOG:W6D+(2F<7C*X2U8?PU
M<E4H[*<7$F&$L*YC,Y8P"J)0\OQ'IT'07VVPG;1K$4%17[:M* 90X!W.-HI4
M//,&WWC>(_;H$=@+;]1^*>[[OZO:MW#U#8ORA+<=PZAH(3<E\EYSK'U ?I]4
M*C.K&EAZ_-<])9E;14(K)5]0D'78AY2S3DJ"9T(HYY/HF)SE,8=^W<=!9A)?
MHY__ )$Z_@%- Q?%W_=ZPK_L\K_\D2T!R0,D3$D\=8!,B6:HIE2E 1$4PO,*
M)P  Z[B70.,\KL#/.HEQ,0D=*N8I@*;1Z]:@<S<CQ1NJZ*0#$$/B7BD#C]I
M'0*&)B8R(;';0\<Q8-%%SNBH-$00(HX6-W.'!BE* =YS#OOXCH-UH#0&@-!J
M9W]#2G\WO/Y,KH&7XW@8>.V& *82]V.*F7<I0.?<T0D!1(40$HG*;J&_3IH(
M)P>4Z@Q^J^AA6<Q_4;;D]]QNN%XK^<V3[RK14L?M+I%L/U./8<H^29FG(.0?
M MXE.;;H(CH+5Y'O] N;L+YAD#D$@G[ *4Y#E4,!@WW,1(QAV^S043\/*%2>
M0N2LY1MRPU4X2)QW2Z=C:0DUJ[7)1>Y24U*6&V.+2"Q&H2;*2?H2K<HN0-W$
M*00]N@<[.%K8<=Z+A2J83B*/!W2Z6:GXX95)*,AGHLYNT5VZ^B&3@5%DBB:2
M<UYN<'CH"'(!>AMC:"QC#"-Z2@H=#)KA@I>R4>JIW=".13;,VMM\I4'ZB"+,
MZK,&IB@F&Z:A@V#81T%5%&X@8YS7CGFJ^JF"ZE3LS1^;,X4S%5@1-9X,0,51
M%K$V(JBDFBS,$FD0@BN5,4QVZ#H)34C@3QJJ\UAV9E<'5-SDAC7E5KM90=3B
MRKRYUJ)A5B2KKOD3$?)$G"*J%,4H%$P@/:/0- XW)_E%6\ V"B05BH$Y8'%R
M@+3-H6.'<M(XM?6K;N!;J-#.WYD7/8_).@" ;"4!(.X:!"XDJG'+G]CN'R[D
M3$Q[8[@+=D2K5]W>%Y$\[!HQ<@I7I-NUF(MQ%'1;/&R0@)  2J$]^V@=V2X#
M\/Y>&)6Y3!]?D(0BC%4D2YFK:JV%=@B5!@84S6'L,+=JF4"[]  - YE=Q-C7
M#5"G*QCV*2H%,>2R\ZX:0R;U<A)N9DV"KV1(9PNLX,J_,V(D?<X^.@@[:IMY
M8L[<R*H[P9D*_N#5K%Z=3=KU1LO78V7)CFQ-HR3CI-PH4[5VZ=..JR7YQ Q0
M'H.@AM#\2<IR-<FV<IBG(U=D;E0Z.M,)?*4K$BQN-2L[*64@1?+/ =/F,DU8
MEW5./YG?IH&Q?<(N1D^^QS-)XK;P4IC9G*$+"RM)E7],DPF&TXU2>M20\HA)
MLYJ+&4\TW8/8J<-C (:"9W#3C=GC&<5>:Q>T%ZS1R05^L#'Y1&R4%$O[';9J
M!=JHJP4H?S%/\U0BX"J(F,3U0^W02^DY[$>;6-FP*ZCJ?/94B<*.H\C-\TBI
MN3KC:UU!9JS5*RDFIWK4#K*!N).T.GCH*@,MX_YD6_$_&[B=,\?,=V%3CW5:
M7-P442W6N$?Y&8XVIR5'<,SCZ,H1C=5=1-0[ANH<J0!X"'002L/@GF+G"&%%
M7&=(BXAO(,J_.V-)I.SYE*]26+>KKXW0$Z;4Y9)9L119M-(E0<(N/)[^J!"B
M#RX[XZ\E<66S'4^%14FW-<EG@1$%98^_2A%DVD98&L;%@X5(8&3QBTL!SG?I
MB8[HI!(8>T1T$SJ[+<L+LC U=]0$(R)ELKUB3M=KB5KG#2$/ P-X/)SD8B]D
MTR-A9I,VQDSD,8 5(8Q-A$0T$L'6=*GC;+./, 3,DT>VRY-)"28O3+ W=R*A
M5W#AT5)F7N!82I]H&.;8!+OL.^@@75\7\HL&9WR_9,>8_@[1"360<FV.GS3]
MC8U =PN5QQ]8)?U"T>D8B:T?*UOR2AMUVT"$YXY<YK1'$O-ME98?9)VR I#^
M3@)F)B+Y*O8V4;*)*-%XZ./#+$6<D6V[ +N8!$.WKMH.M%Y0\M<:U^K,HKBU
M?I]9]2Z1+R*5,Q[DVT1$.[6KD4W=1S@$4&[1N8GR]544P$H]ZXAXZ#142J\@
M,Z9[D<N36"\PTR78)Q4Q9&KF%AL1&=*G:QS!FE7762OF$ZW6,A72IKG:=NZ9
MQ VQ1WT$Z&M]RTTY38)K\_QZD:E79"@9=;IS9,B5.TNV;DSJE.%GL^2+,HJJ
MV<G3 "]AS&!10!$ #0++ZDHE_J5YM[C^6'RRK"8P"'YD!NU:W4*(]!$@!N'Y
M-!N.0]IK5'XOYHNMFB&V0H.G<6+?9K!C"66.WAKK6X:COI&3C9)8H"*:<XV:
MJ-##XB!Q#0*GAW-P<_QAX_3U:A$*Q7;#B&CRM>K;9;S6<+$2, VD6\6T4. *
MJ)0Z+LC4H[;]I T#RV AQM=-$"&$ &= P]G<!1%LWVWW#M[A]@#XCH&+XSTF
MHJX\KEW0KL,-M>14Q .+4G&-V]C<1'S^1$[!Y()D%51 I@Z%W'X@#05A\D>6
MV-L^9!X+/\6M9X&$'SC1QE8U;+".XE,9I2M22JYX5POYJ<B0IH\?SA>TH[[;
MZ"^-8PE*J8"@<2E.(%$1 NX'$0$PEW-VE'J.W7;041<D^)&=HT><&3_Q/795
MMFT:PUQ3'OT'J\K!-F=J3L9FLPJ"*P+1T:*(ILT>P01 VP  :# Q_P I<Q<;
M>-7#V@UNLQ-JMUEQ&VD)9B]829G[F;1R>>(FQ;L2(I.&Z!&CPROFG3 I  !'
M8-AT$BLB0.(,/0\)C&NW]Y"6ZQ9SBLFRU8D5G$I(0!Y5[-.9M\U(NF)4HIT[
M5[$3J%*B)AZ&$0T$#\9)YYKN8L;8U>WB]2U,L>.LFW.)@VUF!S7!J<JUG CV
M+HL@W9NYR;%,5!(@4#(I"8-S;:"0?!G*TK5?I^LI6*M!22".:I#&TS8+545'
M+BAMEW;./FPE*ZT8MUI)Y M" !W!NY%8J@&[Q - S' LL^G]'7*+]MD1K$$/
ME#.,LE9%Z]&J1D9&DS.Z.\;+,)%PT;@HY3$3@=4Q?* ? =!=U%'R#,2T%,4R
M_,9^FD@H]NZ3<5]BU82[LR"H%GBR?J!F"'<F#]X2341'8/B !T%>I*V[OF,N
M7F,U,_51W;CY)LJ3F9E6M;AF]0 J,(Y1APAU9(&(^M*8"K+G,18 V[@#NT&!
M@W+N0J%R=<8L+D>OY2IV1\UWN.D;"2HJ-565CIF-\>B\;,Y*ON'$2#ET@4Q3
M)KB5!(H=Q1$=!-7EIQ1K',"OX\K%OGY& @*)D:+OZ:+%BV4--.X=-^T3BUC'
M73.DS<@J(&.4IAV$!VT$FYX&96<6DYDEX8H3E;*FJVW\Q1<TBT38Q(& H@",
MBHD5-3V !NN@H9P0AE>8Y&YOKTSE)O<J:R#.J-9H32BQ\&[I+J1S-$RQTPGV
MTH]<R_F"ENH'D$'Q$=M!?/; $*/8P$>Y1*JRR)S>P3?*S]^_VB.@1V @$V#\
M4@7Q''M6 .NWC$)>WV:"$G);,>:Z7]0;Z?N)J*O+H8DRJQSP?+[9C7%I2(,G
M5Z[$2-3-+3!43MX<RTGT2,H<AC"/P[CTT%F4E^CG_P#D3K^ 4T#%\7?]WK"O
M^SRO_P D2T!R0_HEGOY[HG^O4)H'W;?XLV_P:'\$3096@- : T!H-3._H:4_
MF]Y_)E= S7&PW9QXPP8  QBXXJ8@4?;M$H[]H?=$W;X;]-!7E3,G8'#ZM3W%
M4/A1,F9G/'NZVR1SJ]DSA(IQ+2Z135W2&T1N*7H)%=X1QYP!ONV OMT%N4CN
M+,W=L<2)J"KL80^$J"PCU(4W;U\?#IH*A_I^MYFI6+.:UGD:\[8Y4@J#D''C
M&M_-GCHE: L[26C63\YLV<G=A(UI50WEF$H$'?NV\08SD)35Z5=,G\F8W\(9
M&E)FP\?)*LH1C5<)6M77&AGE;?$=2B7FL)0[="R& R912!+P5-OH+A\/66>N
MGKYZ>9>D>(LV,8X3.1- ZCA),72O8BW.LT,B8[G[Q3F\- \Z:""13%*EZ,%5
M2G,1(P$,<0Z=QNT.@"(AOMH-/(-WJUB@EDEFI6*#:81>IG/V.E5E"M?2&2V'
MO.FGV&[MN@;]=!&_E3QHK/(&H*IK-&Q+;&M!CZQ,/G+@S5FUE9F&>RP&;I$6
M.8RORPFW3IMH%?QEPV_P7CHE$?2<?+*IV&RSJCN-]2FW,I.R(N^SRET$MC)^
M _;H)&:!O\I (T2<  $1WB^@=1_3,=H.T&8"WB^]V^QOPD!?9U^5.=Q#W@'M
MT',]D.K0$]$UJ5DA;2DVL5!@@ @!U3FZ@! ^\8H!]X0 >T/'IH%L3<XE,!M@
M3$Q!V'<#[E#8?M\=!AS)7!XM\FT%L#L[98K7UA>YH+@4S>4#HO@* G#XM^FV
M@9&J8-I=>R%)YB3C(Q/(=CKD1%ST^C_C#D&[<2 W,Z('6+((CY! '8NP#H%^
MM0ZRYN4?D!:,VM$1"2-<CI1-T;X8&7=(OW:)TS"!=EW*(;CXET'-%H]9H+-[
M%5:-)%L'LK,3;ANDY6<E4DIQT#]^Z/YYA.0RRP;^X-]@T'-G PRV/@V-N%C.
M(AUW  A7X;C]@"/]G0=<?B8M>==##_I+:=R@3O,)1L#X1 "=-^XH_M#OH-5*
M8NHDQD&&R)*U]BZMT$P/&1LVHC'E=L&:IQ5!--3R!>)^8;X=BG#H.VVV@<XA
MME/+[@$YS&5';KNF)1 @]/?V_P!C01#^H%DS(6'.&?(;)V)W!FV1J;CN5F:B
MJFP5E%0F&YT 0(BP0(JLX6.!C 4"E$0$=_9H-CB3(LD^@(N6FHN7>2MM@:+,
M/GY6A&<2B\EZ3"O%$'Q#@4S;U$BJL00, =IS;#UT&/A3/D3>\R99Q*)5S6^@
M*-7UG.8ABM&X/! D;'L5C%!-RB@@/Q&((@!@Z]= QW.^W9=HTI2K/@]%^XR3
M'8ORX\C$8JN(VQ\9-.=Q.$B=*O+N&J;X$XL%C&'O 4BE$X 82@ @TW*WDWC?
M,O$_E'C^MS$I*7+#T91(;*#IS6G+2-;3CNV5D'*#)1PH5)TN<R2@]B9>T! =
MA';?0;'DQR^P]1^.6<[Q><99$O.-8#B[/L[.S>4^7CZ3:V",=+13JN3%A04
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M;=G9XV3L$!7J?- M 1*%:+'1$S(V^.=HV1\[3D)4XO0,V4:MB+%\L! PE\-
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M=V#15V6JW(442"'<!S 1IW%.)! >WH.V@:[-WU,;1AV*.IE'CC=(JKNY&,B
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MC.O(&KBH.CHKR!'B@I]JHB(#W!ON.^@VUKD<YYD?UUWC[+C?+<%3\M8DM,9
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M:FW=)NE_S8'8E,4H%,.VV@9OZ0S&R2/TV^(;UG=% ;KXU7,!CPB"^ZQ+O/\
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MN@9?C@!3<=L+E,4XB;'=1*F) 4,!5#Q2)2&4!(0'R@,;KOTVT%?-(R%@.?\
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M[>W05S\K,>W1S?+EE>.!I%U>K\3LI5EQ:?4':2[&T-Y)2TQJ4:LB *D47*R
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M-I*+I;MVX<%M+<A&(,I".549JHNTS'0 3=@""RX;P=A:<H>%;B=@7R*M5O\
M3::WJ==J'R&C451FO:0?S0SUF.TM[FPRH"BWEFR@N&GKR!Z8YB]P@%E%TK'(
M]+G&%N-CO)1<12^4KZDFZ3D=HQJ5LY@U&DK(D1F4$21C@Y!*U%?= .\1,40T
M#!YF,\>\@^:<FX89!K3BOY,/*NI]-S5&U5B&3V&B(\C C\KUNX"Z3+A7TL>L
MJL=,6H'(F7N';06]?3CE):$X,<<&D75IF?02I\T"[P\C#(KD.C=K0DD1\HN[
M04,\W$#'.0HE'J(#H*?L^<<,L81KCFQ72.8$K;NQ9DBO-JRT$NY825M4EK"Q
M2FYIPZ462>G"4*1+M*8HG#0;'@;6KYGO#%@C+UGOEC%3E3QG8K'"Q">8*\T9
MSD/!(DB6$*I7G=*%4(1(A2@)S."D,GT 1T$ELM<-<W<E9C!&2XFND94NJ8XP
MW-J04A9( [VR2U9H\K'))$51<^C!)R>8**W>!.\N^P:"!&/.+65>,%]O,'GG
M&(!!3KZGY4Q?8(#*]=JDA:+35GKJ08XO-&H/OXPDX=3#U(#"&P"8-!-'CC**
MY=GLQU!U07.%*CD;C>UKM(3=7ZGR<U!X^5=5UK7[6Z.^F6/GO7#=T!NP%.\H
MIATT%@6"RRT3=GT PA'\VVJLE1H$+ G,5==K+GKV.'[)N91:*EG9?-=J%*<V
MZ@E(<P ?H.V@8VUP>*<09!RMD1U22TNR91Q)=*K+.E)J!3<24ZK;73>,*15X
M^)&+.7KNT@1(4NP ,.YAZ:"BF>JTKFRWXNJ,S )M;SQG88SN%HD(2P,Y=S6G
MM+;V6DUZ%GU7ZJ3&2@I$JA%G+A)%->*(+5% 15664T&V^E-:+1-\X\=VZSM[
M<DC<[O.U6),I-B\K<]<<1X>O5<GGU?5D'3B<;5!2("-4,T4.H4D@[,7L $ $
M >[GWGK*&$>;F9LEEPG 6RGU&G6D7<;>XC'$Y7;9)HX-1>!!2M@=,%;+&1:0
M$!90$%U!4*42G2 AA'02;RS.S66<Q9$9-J4I!V)YQ8XW7:/@&LW$,JA"5A\]
MNB<O>!>1\LP8E&D)2!@B45N\3JD(D*9.X#@$5/H8X]O7ZX>?-3/DO-"IZ%D>
MOPT<XJ%LI95G#6TJ2]L<2DZ[L$1)?,G\I)OG)UEA\TB+@BI"*B!@T%Q5[X^R
M4]R+PLO/N<V34B2H9.LP/G]KPPI*)6"'-CQA'+H+*U$@^8@T4'8W< %_L:".
MWU<\3Y <?3UY'2,G>>1(MJ[7HFV)MYRZXH=1ZTG!6>$D8LIBP\ WDTTVSYL1
M0H)' 1,4-QVWT$AK[EO'#GBC>OUM,YBTT9QPH=H95;5F_41W<9FD*4B25O;J
M+;H3!G99E6.>*%*/D]Y#& 1 - PO"#@MAF(XBK59/"4EE7#7(S&=.D35K(LS
M457$147,(D%?J,2H+PIVJ,2U,5<!W*8'ISGZ:!O@^@W]+=9Y#-QX63*+@%Y%
MBLU/E&072,LDBF8[6478VHB3%9,INY,Q=P$I>WP';04[\ZN#G%[C;R ;XVQ9
M]/=3%]2"AWN5#--@M\I=8:UKDJ;11*+8P#M[(QD0[24)N5??O,(>&@^M/%5S
MQW#5BBV-I5*8E;'V.<<Q\]8RV_&D?+N4HRGQ:,<S=KO)M.1!!DC\!4^W<FVV
MP:![6.8&<J[;L(N+BI-\Y5*F@RCLAX^>O%MAW4!%JWFU%EA(F41$I0$1 !#0
M?,M;:!GW$O'OZA".3*A8:9%Y0S[6Y:L62^-(FGU!X1"T*6-9=M(HH%DUZTM$
M1)4#*.!50.LH4 *.X:"Y*HY^O<A#8XLMAI>*(-V[AJV2*EXC+-,DI-G 2K%B
M_=IMII^W278+.F?EE^5B1-%0!'<X&  T%*7 /(]JML%R+Q63'\](1\M]0+($
M@]N$ L<&$8$_;GC0T9%O7 .88\EY:_F$4(02=X .@^A!UAR[%QXC2(ZP9Z7:
M*4HM51^97''3CTR9*\Z@4CR#1Q#E<NDG(N %X0IRF.!0V$-M!236OIH?5WHV
M-(?"5.YO5ECB&KMG,?5*!)8PQO,Q\= (N7#V.3<*.6GEKO4)9R)NX0';Q#01
MBSA]/[ZU-9/@ZIP67K?EN)PA<F^4\=SU&A<*UJ)K=WBE3*QZIH&??Q;U7TXR
MCL>KE1(0'][V'0.1C3!GUY)*7G&=DY)S^"#*.&MH?/);%>"WK.URTA+1T9\Q
M$U0>/5591J0.X3.-P-MN.^V@;W*58^O[2LAL,:92YXXDKN*,C-K.RC[?:X:K
M1<M(PC9@HD^1)%0M;>BF*J2W:(F4(  ;[P:"(\3QZ^J!=?(@:_\ 5(P=-K0-
M,BSV$K=1H@RAZXU;3=$\P@JU02#&LX1863%052*+G,(&V#KH,I[QW^JU%6J4
MO;#G3@7*=F<X_DLGVB35J4/D!5H:/=0]9LQ&H/*FHJ4$:\9D*;E$WG.CD[#$
M3#XM!=9A2MYJP;QVXVI8;IB>4;M?,LU:;SIDA!G4ZL,_%RME;S4A/0\-'E;N
MV[M9L1D5$%RKD#U!NX2[#L#'9<Y%OY;.AXB:X]-*FOF/F5-U"!S!%6"N3]K@
MY''$1 52:9*PPE1W)(M(HIQ IR@/K3!W!L.@O?DJIG.OQ\L2*RB]3CXN%D9:
M.D1IM:3CC*(MRKI1SDOSLRXK',3M[^SPZZ!>8GOUMMF/<?V:4I,JZD9RKP<H
M^E"2D&P:OW<A&(+K.TF9)$1,)A3W @AT ?MT$*,_\E)JC\Y^".'EL&5"=D<T
M)YO50M%D<U]QD*C-*I5&+_U]#>%7=H,6T[^\NB^>D;L\0T$^KW9+W#UB8=5K
M&LW9YA6(7,V9DG:LU,DZ!!;RB.SO))BF=(J@!W]AC#MX!H(K8*RIDYCPRHUJ
M:8+L#*UP>,O.C:ZXM--4%5["-G"(NB+_ #SRCL14 5  Q@W3'8/9H%!9[]:[
MQQ$876U4*3KD[)ML9OWE9>2,4LY=/75QK9#J)/(A\Z;-VAC#ON8P;$ZCTZZ!
MH9OE7^I+DA8J?,8CO$VKF2\TFN1KNOO81^T8/F^.*Z"'J5E) @H-"J*?&J.Q
M2EW,(AMH)89002LU>(6UL'M.-\[8QK;U+9A:'#<BD>NH=<I8MR\3V(8=]S#M
MN'7QT#D8X8,HRNUYC%NTWC$L2Q= Y+'EB%'AP%1N#E5L3;L44 H")#== ZV@
M- :#4SOZ&E/YO>?R970,OQO!0>.^%_*4*0_ZN:H  <O<5030Z12$,8.J9?,$
M!W#KTVT%<&+C<>G?U8K,\EY^]..53;#-]C(.#<+G=T-'#*-K@O,<(*'W%O+I
M3A"@FG["'/H+BWY3"Q7[A %"(&.<_F"F!>U,X@81 IP$I1#J @/P[Z#XY\MJ
MGR1E/DE*O:O>:_"2YL290Q<O;;<KBF MYZ;;&K%I<:)9K(94Z\E!NV+WY<@9
MD,:=(ZPG Q@3(8+#OI2S=JX]XMS4W+@6=;5:V92KUYAS1V1<>K1I&=FQM6Y1
M%NDI9[4QDG4NNT3!VY J8@8Z@]OQ ;8'=YRTF<R!6GG+>/>EIM8=<<8:HJHG
M7<2EZAUY+,51L*2C*!;,%JS((( H<%#^K,=0 ["E$IQ, ?/[.9B:5:B<9WUQ
MCG,1:XB\5R"EF<]'J6ZX4R^0N1+U*2-HN=32.E5GD"[CY=)0BQ'C62*R(B"1
M-SF( 6P\+8E97ZOEHM+!RFK59#"V2X:,,_:N8>=>27SVNSDJH:!>LVKYE'M5
M7_EB"PJBW5'R"'.0@"(7/<P<96')5?Q2YKXP8IX[S#!9"FTYOU>QX: @[(B]
M+%%:M7??,B5\ ( H4$2_$8Q@V#0?'9-S-AM]MD+#5(B8$]:N]/RM6:7<KO&O
M(:YP=;M+Z M):%#-H=U78"S,CNB.$&#A\8BSM(A5/* !$ E;@**ND]S"Q_&,
MKM9*+C>3Y/,8:J(1\HE8I>2E8&;G#S3J5F[C2UFT=D*.D5S*JI,E5F_<H<0W
MV+H+T.)')U_F:ZYJI=8L&4)MI7@:OJ_/98&KN%XE>(LB]8L\.V=5V.B6JJBC
M]L9=J0Z:I?3F#=7?X=!5'RLL]2A>17+!Y:7#V46B9RY1R;)Q3+5-4JDUI,U=
MN$G9;05A&S]>L*:RQ-C+.&GFQ)A Z2J8[CH+>OI?9!B7/ S"\L_*>&B(FFV"
M0!:343$JM8"X695G.-E"JKJN(]9(0.05"I"1(0#M >F@:7G3;(C,>$Z)-XLL
M,1(T;(^082)DG;ENW.<KM\Z>0<;8(L7FY3-%I!N9-X*0"<4@#MZZ!7X/XB9A
MX^TJ69C^JNYVTV.YS'\M?96V78D^K5'JJKQNQ6]77Y%%)I&$;E],@00()@V$
M0#KH+ <=&;U3$U$92#IJD2#HE3AG*QU 2*H>,K<<U_BIC>69P7S!W+OV&$/8
M&@K[Y#N:WR%S#;L7UK(..H>=PKB)2S3[6^TF>=S=2N=HD/6XWNT%.)^DCE8%
M)" ??Q5)RHLJML':.@AQQ[PABNT9.M4ER/D*CFVH8WP0UEJ9;ZM'VRL&_5\9
MS6UHAT_AVDP4SQZU9B4KHP@(@L)##X:":N)LE<<N,MRNM$AK3 XVJ$S*UB]M
M:Q/OY=)0M<ML5%1!91@M)++'\UW87C4#!W;COH$QR#I:W*E!%U4\AQ#5JABZ
M>N4+-C$%DHJ19U6_1YVZ+A8QB"IU:[>7N7N-T$0\0#YV<Y\C\S,,59"FZ=5[
M_5SP;.UTVBV:R4:O0UB;RU>7EKV6YP$^RMBQW%8D):OHJ,V:A5RG5?E(L4A!
M,(!9GPLDY6PYXXSOY>R1#U\\S78KDE(S59C*19;:XL/&N;/:V["J0DBY28R#
M2Y*NUY9R\!%=XH*:J*)FYDS@&EYT\C+3A+EARB;V/!C'-&,D*!*7A=C?8IXV
MHK9_&X89-7$;&2A8%ZRG0FP#TRY'#ID"0*"("80 HAMN7]VGTN1M?GV-9IHQ
MN3.'N-(F%9_QL]>KZ;E>SVE&%N#2':O94*B:39.$VYTFJP(+II'[# &P@H/H
MF2:,5R-YW/+59Z^67RO=J#+4V,;KD21EH^MQ$K6GQJZFNIYB4>U4BMDF8&4\
ME,.\HB!Q'07F6G_>5PA_LUS5_8?8NWT$6_K&JK-_ID\Q'#<ZJ;EOB=XNW40
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M>TEA<K*W83CRTUULHQ;)0\; O*6V7"*>I(LQ6>KHEL!E595N(D0.<-MMM@$
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M6D<6YJ9X^?4N+?/9UI=%;O6;S<2EF[:>+:UJ%FKF0CI9<IR.",S*=ATVK<5
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M)0]"KF,(FHL&M^GF<7 0JYYJ:")@FT>SBE6<4WE%5Q;,A(8C?O';?NWT%A_
MF$3@(C*S4DA/R)'$]CUV1S99!Q(R!O.Q34O@!R[,+@R90)T[NN@=WF=7XVU\
M=[A69@S@L5.3F.(V1,T>N(UT1LYR742F,A(-?S[)0#;;*!X:!MGGT^^-+U\_
M?GKEG]4Z"/*Z$+C:HT'LA&)/FK*:=/HY^V=/9!HA(K>6J8X["/4-!4YSYX_5
M7C]FKBK(X,MM@H=DO"V4FUFL<Y=I>2E;@UKM+<R\-!23^6FB.) Y7JQ2LV0
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M!HD%?:YAF/FC2)4&O([$+Y!W#R3B+?,A5FU$!<-W37=3X"FW[>H&VZZ!A''
M"D.+SD6P7A.4MV/E&<7*T>OS5TL3WY78HHKR0DYN3:$4(199Q)I)*)?GER]Q
M>J9- Y&8Z/FBYK\;I+&$C$L6,3+5^5R?Z]L]]=+USY:T46,A+,%!12%9VD1R
M8JP=Q^P \= X61N'^",L7E_D&\55*4MTQ#PL0^DTY&0;"XAX 9 L<U*LD8"F
M3(>5.(!^Z$?<&@8^$XK8GI'(-E"5!*U5B+D<.S,BZ1K]KGVAU5@ME>;D."K5
M4BA2D,("8=_#QT$F(3#U!H;IL@W1FI=W:K*5[)GFWSFV>MED(%XS\QZO+><L
MV:H,!$1-X!T#05A6+C_C*(R=DEU)7VSXXBY'#E\8*PD)<0I-2L3N6M2+1O%-
M!,9,".GJRX$[$_C,8VP>.@=*B?2BX/V:JU:9M6)%)VQ2>(\=4R7=6:R6"9<'
MKU1:LS5EB@YD'95B$;*,/, 4C$#NV$=P'0(*^?3[XN\6T\8R&!J"]JLBC+YD
M8L%"3TO-"D2UX.O1)(&B;UZ\12[S0Q.T/+, #[O8%2$3>*'0,?6VR9;JK3*<
M+A6@SHO\9V%*PQREOBW. *>X>Q$S--VB3-LW7;&,8JA1$X;;E 1T%HN7^$[[
M/ECA\T4O/#?"1YRC8Q".H"E'D[DG%)P56(:LPU0G/U@5M$JC4DR\[7R39%Z
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MJ+2M5Z#(T6CF\8K7V/D7 A5=R;$V =!;)B+AK1LT<<,:N''*+E]$U_*&(8%
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MVR-5NM9BL-Q&+,EU"<C(\TM:I#):5;<UR4D9M%IY:\6^CE$UVQ8(_J3&(!E
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M[["! '0,6]Y2<=DN3M?26S%1S$=89L3%JHC*(%2063M$"Z<G6,8ZI$TE$R"
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M4M+:)0924HT91LDHW9N9$I06<),S&'8IA'KU\!  #/M1##Q$JX 4PF^5XOZ
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M78.7G[=R.-)RL+%RZQ2R=@.@)Y&):23E/N<THQ.PJCL=BBHH7W#H$O&?2O\
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M@<P.;E$K&I"6%P$1!]\=A^0;%<2AR]J8HKNF_<'Q&[=AT'#&<RIG_DP9>2R
MYPA&5[C'>FCC&=8BIYO?[PNYO,$8UO']:N)85,]4B.WT2H-"G$7CLO4  -!.
M_C5#6&!QA6XRQW!"YOVZ6Q)9DWCD4RL2MVQ&L;)#&QD:@$NR =EP\L!$V@BY
M]3*%EY[&F+XZ&EGM>5_6[#O)&QQLHPB']<@XZ.>OI><9N))H^9N',>T;B8C8
M4C&<FV3+U'05U_2EQQ*XPY$RZCJZ1]E2R#A/*F7X6/EHM!&_0J62,OU:3DI6
MR2<:Y<L5'4X[BTBNHXS=J,8JV3( =QU-!):5YH6N_P"/\\3DZS?8W;5>5NE0
MI<@T,\+(IV-BO,03-!-5NHC( +LT9YZ8^D2(7N#\Z<.@AM.+F(J,RY8YEG&E
MANDLA&6*QO&[VPW2>%DXFUHO')4BRT3(RYF;T4W3Y4$ ,W'8_:(;" :"KN>Y
M69&B*W5\'Q1J:A3I#ZD</7'Y',94GTRJTFN4&2)X091;HQHMZ<TM#IB<ZNS@
M@ *B7YT T'TD981(7(G&E8$DB*FRU,"LL"8E PEQ#?T>T0'91 1 =BE'<I1Z
M>(Z"!OU=\=-;?Q^L%\N40$GA&@8VR0OEUA$^0%Y=P$U&QHE;515RX:HM'J[I
ML0#K"?=(@B;8VW:(5(W;C/B+!UELS*MVC)CF)L_'%E:HFQ1,DQ1N$&&3++=[
M@TQO)^5'N5GE-*HZ02.Z(5(5S"V2$Q@$0T$IN!%KD6'*'E#9(NHRTL_P=AS%
MU8F&QESRQF+UW45)V$BW,@C+-E':KJ!*T.)TXZ1.@.Z15B"(DT$LN+?)W)^>
M^3&.G5VQT]@&;*HYABV2C#RTV$:D9CBE[YSY.3696$#+G*("*S1,O<;H(Z!
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M*@8Y3^<78?9T$!Z:!73M$Q_:WC64L=:J\\^31,U2>S48S=N#$$2B!$A7#M.
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MZ@=5XO52K(7VY<LL<L;A%FF(AS69EI&R$B:UNHGYXD\BHI4[$B1U%%$5"@J
M@'40'061U#Z0G'!RK$2&2Y>U7 HUW%WS"DO[##?ANL6K'9'<E'O(96-:Q[P#
M%DY1P'Q!Y8A[-MM!/&4KU;H5,N]1K)VK2"KV,&D1!LC2I%SHL63=1/8Q#*&.
M)@Z=1\=!"OCUE)]B'@[DR_P$8YLDG6LJ9!=-X"'70"5E#A(1I1:1_>5<OGG$
MPCU(;H ]- XW(:^I73"G$VZ61J>)?VS/N!'AXUXH[%]#2\A.*F1%WZ19LU 4
M=MC><D*8;]0\- _?.EVU'B!R+ 'C94?U564.BZ'=OY)?W('_ '.^@=_!SQF&
M%<.@+MJ AC"@]!<(@/\ U6B?[OKH$E:GC(O(W%QS/&A2A0KV(F%R@4/\:B.H
M[G#VZ"!'TW\(Y#PIGOGQ)Y"461B\H9BC+E25G;J3,W6A7:]H$X- D%19%)^=
M((@AL'4-!8)>G+/\2.XIL[8D>R%.DY]JJHNW,D5:IMG"*!5R'!9,4E5I@HG
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M)I9Z\G'1;>#6GZ\"X0,J0XD=M2O _==0  T%D>-W38<P\A-G37<97'.P^J1
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MI9$RYR@A;-2\61T%A[(<-6:PJSC42S$DU)6FTQ(/6JYY'N%=!-?<#>0AM[M
M[F6,KUJ@RF-,L.WN+H.)MUMAJ$X<V608MY9[6I-%YZ(A9118Q$Y BC4PHMP
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MGF_]7/EUC6ZX^#']^O#>UTUOE*#99(FJK!R-:9PUF/ +-W:L4GCN6<+D@P8
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MN A5\-S1H"%&G6B$?PCTS<A)1!^TEUY!Z[.X5,8WJDE$VXCU*0 VT%H&#KE
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M6Q+;9MNG'- 4()@?.<H."N%BN3"8IQ.8W3VAH*Y 89]AOJA6YLM=N.\.!N-
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MYXJDW\W/WK&M'@KK#OG+%"J4>/J>+YRM,95D5!1%<K%_87A16'S' BF7[GM
M) X[P5E/&6=N"%>M,"XDW6*>.5NAKE8H2(6?U!K86\L\E) HR8&_BR\F#@OH
M_P!T8.X!\=!$VP_4#M:BO(J @)R3:_(\CY-L4Y32P[&1D8.%8#$JG>QMF")4
MA7*;P$^ST95R+L0./>(CH'&KW+;$7+K/E1P?FGB-!6F";8\G[JRM5O%>Q-Y%
ME4H2.:. CVZT.HDWD8T[T._RE0W 1V'0/=R*PIQVP-?>.^0<&85QU3ITEL:2
M#8]#KD+"2L@^21,LTC%2-FXO'Z[@VR?:/:(F,&XZ![^+ULR5E[DH7*MWQM.4
M-N?"!X<AY6,%LJ$JE:VY7L'+JAL!9%DD *)^\HZ"2_.]0J/#?DBH<X)%)B:U
M"90P"8I ]$("(@ "(@ #H%9C*Y56D<<,4V>Q3L5!5N.Q30!=S+]8$V;0IZU$
MD,JN<P@!$P./7<>@CH,::=M)//V(9*.=(/63K'=T=-5D3 9JNU65B#D=H'+W
M <!(8!#KX#H'=KQ@D).7FMR^4JL6*C]O_P"78[BOMTZ=RO\ P:!9"(% 1$=@
M#J(C[- T=V791<Q#O)-JH[CIN4KT8@U3[0,A.MIQN>)?&W^$025, ]?=H/F.
M^H*[-)\YZU#VFU71@WJ_)R%D\7UQ+&C5M5+'/RE"QJC<'*V3?G1"N%X^)'<6
M81_>(@(=^_70?4S:?^I%@_[(2O\ T4;0)# 0;X0Q2&V^^/:L&WO_ ,T)=.O3
M00RY'07'5WSSX%RV2+E;(7/<2WS,3 U;B" I7[:V<5>/)=C6LQHUP"1V46(B
M@ *ICW==]!9')_HV0]G\1=]1 3!_BZGB4-A-^3VZ"LG@S5\VL+<\LUB<SRN"
M)O"^+$L7HR-I)+124J@P)^(/15HI05B5#J]>X>FP[Z"8/)+IB.P?SS1?]>87
M08N-/Z8^07\[XW_\O8#02-_XM : T!H#0:F=_0TI_-[S^3*Z!E^-YB%X[X8$
M^X@&.*J8 V$2")8=,WYTH=3)[!U#05KXMP)?9CZN%MY/C-0Q\<P>%KSB (1:
MQF"Q)SZ]K@IILY:543"'R<K=NJ4[K8  XE+[=!<=+N%D(]5PW;&=&\LXG234
M337\HJ*ISF;^<4R)UMB[ 4PE 0]H:"G;Z?,)DV)Y!<J\DY-<T>-JF9,>8CR7
MCQ2M3$H\E&-0%Q<:V0UM2?1[.,92I583H#51<FV_Q:"VJCNHI:K0#N/D4'K1
M>.;'3?%43-ZXOE 0BIC (B(B4/[&@C\A=J;4>1F3#7&TUFL>OHM#38'E95M%
M"OV.)8WE%>.UD43J")=^P#"(AOTVT#D.N0&!&:Q$GN9\;LG!D4W!6[B]P29N
MQ0PD(<2C)%W3[@^S0:$N;,%R=D@G3/-F/73EBWF6H-(^\0J[%7U1&WQN4DY0
MVZZ()_ ([[;]-M!K\J63CCE&J*U2_P"3J*Y@P7^<J RR$W@SI*Q:*Y2KJ/HJ
M9;N?)0*Y-WD$_8??J [!H&@H^1\#0V>6X5O*5!/48'CM U%B]0NL6[;(J-,@
MR:B+-:6<R"BZKL2_= RIC&#??<= AOJ+YRPLXX/<K8I#*F/W4O)X!R(#*&_'
M,4#IZ*\"\23!$C=XLL;N.&P=I1Z_9H$%].+XOI_P::BA/-"1C2E(Y6(^["FB
MJ()4TEBB'>F)!#8?<.@D1E/"?';D;?+9#90905JD:E(5"38LPM[B->1$A$ 9
M^S<E;QZR2J3A!1,3;#N!MMA#0>C7A5P^=0T;"35#JUL*FR,S.O/R!Y9Y)12\
MNZF$6$@"SPZT@T%T\$"D.4Y1  #;;0,U2H3CE6<Q!?JIA!_1G6.$KL,!<BRT
M#%TYR5!H6JNX>'CT;"#*).N!P3)ZM!#N\.N^@8G'C7#?);G;GRPY6Q="_,\8
M8L)3F;>_IUZQ.:U+1TK'.EYRN2;+S",6SZ/F $XMEA#^VZ^ 6JTI'&>*Z-!5
M^O.JY6:]%1;$R46P6CVR:QG+=N<7Y4#+>?YL@)M@$PB([AUT'M6,LUV?N=NI
MF_RI_38RI2"XRCADU.\:6Q"658JM136-W);0X[[?9H''^>0QA$@2L<93;X4_
MFR(&,8/ NPG#QT# YBS1BS&KBKS=SN=4@XN.EU)-RN]F2"NG'R#0\6QE&R+<
M%G"J[R77(T2*4H@)S[:"F[D%F'CQR-GX.M5#-]19R$.HXNC*3FH*U.(V6)6<
MD%FYJ&4=1,65X91!@R.+H"[E!(![NF@G?G?*7%'D)78VG/LD)1<S&RU2M[:<
M88^LCRR^DH%EK]N4:1J;B%]8:">+PQ"N1(/PF$@CT#02'0YJ\:EC.4FF0G+H
MT6@V=2@MZK;W ,D'!2$0,Y43A13:@<VP=OO';;00\YT<R>!60.(&?JGE+/CN
MK8VL%+=UVWVJL5>SN9F";R[ENQ04C4EX0459=1XH1-N4?O+" :"LNXW;'^2,
MW90E<433NZ,J[Q@QK2HZYRC%Q3652BTJ[;%TY)TA.)+LI*ZQ#6,;F:MO2J&5
M%RIY8 H!3 &_^@93V>(\G_4%A'*\F (2.!)(ZCYFZB7[P9ZAJ.0E#14JT82;
M9_)"H"@&\OR3E .SH&@L.YJX5G^5%@QQBJL6]O#R[['V8%8:7G2JG4:.6$SB
M65*WGF[-1-;T#T&8H[EZAW[]=MM!7WR+Q!$05$6KUMRB\KY[[<L@4.O5UB,P
MZA33=8S U6L4P^=I.6?R\K49LRK4!5**B)!+OU#05>VO&W,K)$3><;-,U8\9
MJVO"&0&$-:2XVM;-N]KS3'+FV2\#-6-OD AR \A91&,%T**A4A)WF*)2B&@M
M P=R5?<7^(6!,%RW#-CF$]5Q56X\).OY:@[E(.&]A(:)E[-"M75:<H##KMX@
MZI6*+D7'\6].*6Y1-H&-XG\WK%AK-5]M]JQ!D*(D,@V*!:0V.;K=Y>(JX5R8
MC/1N+57ZQ'4MV;S:HR9)DDC"0X,F:R!-MS[Z!;XLGZ3C2O9)J-@QWC.UTS(.
M(T:#8IROY0M_RYE)2V0KE4D+"S:#C616J\JTC) S(7)&[<QU&NW<(B&@;(M9
MLV$ZY!QU$J=-D93#N36[^[TISD]K,V#(<9%XR=N&$1"-7==<3SV'8(,40D@=
M)>3WK$V7[ *0H3OXQY=RMB6:@,GHXD)(U/*V$(+(3R'LG)]NWK..*D-@>$<*
M0=4G:RW9(/#+IK)%;D4, @CMYQ=!+6 ^HK5LMY;B,'0F',KHW-*R322#A=]1
M647-_A-HFXDVC69;V511W&2K>43,D<B1!$ #IH$DAQJX\QV7;9'1W#V]P-]N
MM(LEEL[R$R)')C,0=NDOPI*'<G1GA,D=90FXF( &#V[Z"N!BTFN.G.W(V6;#
MB&PPM3I..LDP-0@G=CI8S!(&1K,0NTAHUJ6Z,W<\]>-X@YNTS0#FV$>_02[L
MO*G&_)>[X R-%X7GXQGB++<2T,I;B5UH[6EU85@\,#%-I)OEE%OE4D42@ B(
M#H+ML866)MM1C[#%1'R!B]%50&"HI^854#!WJ',7;J80WZ]= LII&(?1,@TF
M21KF*<LUR/D)0C=>.7:=@BL5VBX'R%6_8'Q ;X=O'05/U4].RM(<AZ)F2;QF
MKB_U\2E2XAMD*$+'3-<;'[G<-(PZ#@JD>V4,F4# 4-P -@T$JY%W!Q&0L.+5
M;T)8-IB6VHU_R)$K@A45%8=LT:M@[A]0R33Z ;?P -!*V":-HJ+:,2K(B+8G
M8J/FD$/4''S3COW=1W/H-R8Z8EZJ$ !Z (G  '[-]] SV8?3DK43(*K)D"*O
M%+D#CN4PE3;6=F)]R=W</0? /$-!\U_U)KW6Y7FAA6C1LLF_LE<Y>.)F;B",
ME#A7HB7Q;C4C*6.Y OE!\X=#Y(#W;]P^&@^H&T_]2;+_ -E)3_H<V@2& N[]
M1^*A* F,&/:OVE >T3&^4); !OW(C[]!"7DI4L#2'U . =BO^1;%7LUUEEG!
M'"-+:QAY"$NR4E7HA&YK3[T""#)>.C>K<VX!N(CTVT%E<VY;LX>5=.UTFS9O
M'/5EW"YRII(I)ME3G44.<0*4A"@(B(CX:!C.+*B+KCIA%9!P5=-;'5<50=-A
M*9%5+T:)NXA@W+VJ%$ _((Z#OR3_ *([!_/-&_UYA=!B8VW_ %Q<@]N@C+8X
M[1^W]7L!L/[>@6&3;T_H\6I,QD:SD4FS@Q'WG'.54IB(B<P)%*/[YTZ>\= H
M:'87=@@XF0DVGHG4A'ED$4S"._D+FW#<!'H( (:!>Z T!H-3._H:4_F]Y_)E
M= S'&XQ2<=L,F.'YHN.*F=4^_P"]D3B45._M !$X;E -OMT$$X7 69GOU9&_
M)A_$5JNX?C>-5NQ4P1:V3MG[#/.+I&3#6:7J0'#=MZ1%0IW8EW*)BEWZZ"U*
M6^*-=")P2\UJX2/N0Q]_.;+)D -NI/SAP'<>G304R<6\H8RRQD,_'^2WL#:0
MXA4.#LI8V=CFSEHI7[ED )9J!8Q5*78$[G1-ENXH$-MU 1T$_,/4[$$%BJJQ
M,;5#(Q5>AF,44%X2R2#PGIBCZ;S'[U [N8'RR" KE\TN_B;J&X*]Y(85E')(
M=>MM))[! U?(1AZ!)/'D,=T!E$5RE=1)B$,X$@B03>'L\=!LY2F88E74>_F,
M;UMV^F4!6:O'% 3?." ">Q#O%BQ1P:J%[=@3.(#]F@1#^"PW6,@58\?CV&CC
M#'6MN_6C<=*BH]\YI$AV[M(<YC)B #OTV]^@6R5;PR^9.6:% B%6;5-5^LW<
MT)RDH*@;F\U+U<0F518!-T*&XC[M!@FI.$&3-G)&Q=7DR/3)F R-#[US*$,
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M_IBTZ$QQE>O(WY[:,EV"U5*_KW"98&;_ "9%LM6?G42R5 2E.,W^&0,4!WV
M1Z;Z"ZB+,0K*-(8=S'9-R!T  5$C9(XK 'C\0:#;Z T!H#0=# 40$1*!N@^S
M<?:&W3K[=!!3"&'LJ5+E/R6R+:R1/ZO[P]JX8^<M':BCD(MM%F&=;N&YSB1
M?FY  1  W#02UMH,"L(T9+SR)?BBL*) W*!2*/RS[4(\#B0HF$AUBD _0?A
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M&X@(^ C[0+OH(,9]O-WJ7(_C@G6L9R5_C',?F B@PKYJRD&\NI7HDKLXK/#
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MJ;[@ @/30-5Q9<TZK9(Q#%L*8^>.;SQ1H"J<[$"^F:[ (,+5D5\SF9*4*J9
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MGV$I-!6]F3$>><E83I>#TY>@6R'S7Q.S;^I>7E*LA1)'#S=!G20A2VZ['>N
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M !X^/[>@YT!MH.#!N'@ C[-] @[PY6;QT2JV%0IW-QIS)8R2@IJ%06LC1!8
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MCU(V_0S5O'S2]_O+.)=(IJ2R:ZQ2IN!.0AC=>OCH(<<K<'V^<P_B/BQQKRM
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M_B'DE!6-Q$IS$1GVQ/XA07RKIF[IUA8,).-4;1H/GKJ.2 >XJ9%P1$H;]I-
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M^XR;0#@V*&P]-BAMH%UH#0:F=_0TI_-[S^3*Z!F>-Q2GX[89*?82FQQ4@VV
M1$PQ2'9V".X$.4^P@/L$-!$:8Y#SS/ZK=%XPA5:.:N3/$*RY9-;U(5);(K>1
M97UK!I0[>RB@*J%:6(=511J53L.J4IMM!*_E>Q7DN-F<HYDD+A_)XKO$<R:
M<I3.7#NMR:!$DTQZJJ[*B(%+\0B'305I\<WTY^&,0?AVJO)5* XN<:4WZ2-=
M6DW34(BS7Z->D;0QU6[D'31RF4Y%P$03[1Z==!):(CK-=&U&R%7I_-]8N47&
M!&+2$QC1M:H1TSM+5OYC]A6IA^V;-TFKF$)YSE-0W88P <!$P; Z&+;&ICV*
MFF$G7LSWB5L%ND;#+6']4!8ALM*VM87:Z[9C'2B[-!D@IL)Q*(E+N&_700=P
M!%RZL#S,B6L1+C.!(I$)!&KYFCM K>:7>MTD8AFL<OFJ([CVAL(B&@G&3D9
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M$H"=6<'913<K(J??V&* B ;==!& _P!0?&X@(G4YQE H";N);U#*!L&^Q _
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M[M Z^36K9GBZ[MVC=!J@WIDRW;H-TDT$4&Z$6N1%!%-(I2)(HD#8I2@!2AT
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M9U4KX. J!C*5Z'"D$MYB@9!(_P R-^8 ^PG$1VT%H&@-!'[DA_1+/?SW1/\
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MA3B&X#\.W;^70(6E)')R#R#YHB10F.\?I"D4.X@G*F\[_P Y_<CX>_021T'
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MB/$W/Z!S=DIIG7DUC')MB=4VCM*5+4?"XTUM5)PKJ92B[#.HNI9V:?CV2RA
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MFVVQ#1Q)N$7;UP1I7ZH057:R!$B H?N =A*&PZ"3DUYGRJ0!%4B"PLW((N%
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M(/5<6U)E4()U).IAQ%QWK%VII"054<N7@J/'*P(*KK*&,8$]@$P[[== [Y@
M2B AN&P]!ZZ"%%U@HBTYVME<L#%"4A)J-QC'R<<Z$_IWC1TI+I+MU13,10"*
MD-L/:(#UT#_8PQ'CW#%=+5,<U=M5H SMT^7BV2SZ0%1^Z, JNU'S]XZ= )BE
M -A'P  V#;0;F:6D"K60$X1-VBG#MC-3"@F<[Y0#DW;G$Q1%4" (B!1W -M
MR;6OP]KS%EZMST2UDX2=QA1F,S#O@5]*\:K(NP.Q<E2,53R3%^$Q0$-PZ:!U
M<<XJH&(8I>N8XK#:MPSR5<S;I@U4=.&P24@1)-VNDX?.7"A02(W( )@.Q2D
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M#<PN>NWMT#@=H= V#8.H!L'3;W>[0<'*!R&(.^QRB4=A$H[&#8=C!U =A\=
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MR8P'4*Q0)*ZYJQ=4BV^JQ<] *V"Y0,*WL<2=JUWEX<'+Q$KABJJ;8IB;E !
M T&ZLO)+C[3HZL3UIS1C&LQ%O8*2%0DI^\0D=&66-2, >O@G;EV1*1;@KL!C
MIB;8-!S8N27'RG0E:L=KS7C&O05S8+OZE+3=WAF$/8F21@!=U"OW+Q-&1025
M$ ,=,3=H:#0SO(/CW'5^G9%L^8<4PU6L*SIUCVR2]UA&%=FY!%)5DY/$2*KI
M)"2!-OW 82"82A]F@\HC/W'NF4.&N$UG'&#"EW:<LKFKV>3N\$R@IP0E7OKT
MH*36>IMY#TR_<!^PP]NV@4C[DQQ\C*A"WZ0S9BUG1[#(JQ$#;GMU@VU<F))$
MAS'CHB64>@T?.T?+W.!#F$I0$=!U>\E<!,:3%Y">YLQ:RHLQ)JPT5<5+O EJ
MDI,(%5.M#LIHSP&B[TB:1A,0IA.&P]-]!V5Y'\?6=(;9&/F7%J-$>S!JXA=%
M+E"C5G,^*)ECQ*,Z+OTBKTI"=QB=_<!0Z^&@2L'G_CTRKMHR>&<\6*4"8LS&
M&=6LMU@!J+";;0<>E^'@G!>D:'DUVY15 O?W]GY- J6_)' *M)=Y$+F;%JF/
MVDJ6!?W5*[P@U)I-&*4Z4,,YZP&@2)T#=WE]_=^WH!CR5P$_I<CD9GFG%[RA
M1LN6#D[NWND(I5HR</Y8LHA[*E>@T1>*IG*/88Y1-^SH(_<:N16"'&),EWQ'
M,..S4.$SMEQG,6A.VPYX&-<2=[E9&,2?29G0-FX2L>\052 P_$50-O'0,7RZ
MS?BOD'A3D3@OC+F?#^6,]Y=XZW_&]#QM"WN'D'\FG*QKV*F'K@6+Q9?:+:32
MRI1]Y.T?$=!.SC!CR4Q3QXPACB=,V>6#'>*Z73IETU[!1"3@(!C&O6J) Z%*
MBLAVB8 Z]N@<V5?.6]EJK,GD';OG,SZDJA0,<#(HIG1,GW>!TS".P^S<= MN
MPH#W 4H#N([[!ON/B.^V^X[:#MH.IC 4.X? -O[(@'_".@0=K>N6*M2.0C<P
MO[A"Q[DBI"F.0BQ'X^:F)@$05*! V'Q /#0+M02@0PF^Z!1$?9T#K_Q:!'S#
M,).NS)E%RLOF*/E^>L;\TV1(J0"''?8 +\/]G0*1DGY+9F@13S2I-TB^?XE5
M I"AN4? >[;?\F@S3_<-_>F_X!T$<U?]ZZ$_^'FR?^9=7T$C (0! 0*4! -@
M$"AN >X!VZ!TT';0&@3-S$4ZA;%"$**A:U.G* E,8#&"+<B & GQF 1*&X!U
M'V:"F7&]@K[SB\\3G+E38^10S'@MR^;PLDP.(K-:MC+TC3N?#YITUA[?../[
MT &ZAL.@LFXP,FB.+:DX3<,U',C 4V768-R%%U&&<4N#;%82+DXB#AVD@4#[
M@._EB !TT$F>TO\ :AU'?P#Q]_Y=!P!2@(B!2@(^(@  (] #J/B/0 _:T';0
M&@-!U[2[[]I=^H;[!O\ %U-_](?'WZ#G8/<'_P NG_!H.= : T!H#00?Y_I4
MUU@YA'7B+83,))Y%I3)2,?1<1+B]\R1,==HS0EI&)]*^=-"*)INFZY'+43>:
M0#"7M$*Y>'UY@4^3.,*3*U%C8Y!GB6H/J9>7E\<1L_36CVA1"4A7HVC3YTFL
MY#)1R[10SR.\U0CA90AR]!'07D6*J5VZ0,G5;=!1=EK4VV59S<#88YK*1<ZR
M6*D*R+V*=$5163,8H;E.4"B/78?'01PH_ SACC2XL<A8YXR8AI-YC'"[F*L]
M>HD3#2T<[<MSME7#1ZR:HKM3*(*&3,8@@/8(AX#H&[0XP<.,=9LL=]K?&[$\
M'EB#C8S(SG(\52V!+$C,7.?F(1Q)HO6C<KU61<G14%10# 8X#L(Z Q/PVX91
M\Y4LCL..F*F>51>NK!'9!2Q^R96A[-M#F/(3P/U&I7C9X!W8=RPG XB/CH'-
M1X0<0VV1QR^GQRQ(&5E;"6SJ9 )18H]C&Q)]QDYKYN+8799 HCOZCO[P'KOH
M.\KPJXAKY&<YOD^.^(G&53SK>U/<CO*9&+6DT\QW63G23"C51XK*I>7N543=
M_3QT#-7?BQPZF\VUC-\_QYQO-Y%G)AU81MS^B1DI:I>>?*-DHNRK2"#$SH%X
MI1H(IJK'[T^X-AT#KSG#GAWDO(Q\P6KCEBNS912ET%QNT]28I[9$YF" @LY
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MPCN(;^.PCUT';0&P>[0<   (B   CMN( &X[>&X^W;0<Z#H8I>W;8.T! >T
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M*Q3%"[C$+KYCBW'3E9R+H5Z765#G.AY'F'&&8FW,0? 0-U#??;0.=H#0&@-
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M0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
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MH+"- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
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MGJ.F[A<\=9)7M5A:C*1LT61L@5\^.HL&SATF@DFHOZL?(*(%+T'024IA3_\
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MP:"QS(?%[A)C?"UP/7Z7!15?C6!9=K%8VEHA2=9NA>^;'#4XUY)$B'+U60=
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M>P-CZF9<=0D?>'RJ=IQ[/U))S%/8E)M7B,9AC=S52274>/07,15$9% H.#
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MRSY82#1:/B,T77!]*P^@[9BQ<!A+%=[A&=?L9FRA2J()WZRRLE)(I[!V-7"
M#X:#Z,H7]%QW^1M?X -!MM : T$!N7_3+OT^Q#H)N6!RCMTW#]1^71V'WAN&
M@GP8=BF'KT*(_#][P]GVZ"KOF]"1EIREQNAY5:2,BQNAI%>,@'BT%)E*K*,6
MT:^;7-L9)TU4;.# 8[,NY% #8?'0)]W746OU)(R=]$[6=_A^%AVDRZQ^5\F:
M,;51+SFB>055?4Q[@%R[J)B3M5'IOW]^@MET!H/)<1!%82F.0P)G$#D("AR"
M!1V,1,0$#F*/@ AL.@K0^HGEODWQSQ6XY&X.O= -$XZ5@F-PQ+DFO(JUV\)S
MUJAH0KLMZC%496DO6B+TQS*&!1J0G<)B[@&@UO#[ZE-?Y*Y:F^/\UC^0@<IU
M&L?B2?L&/YQ'*^#'+<RK!,K2,RU"MVD*2=$T@';&JE%T)"'-OL0V@M ()@$I
M#CW&V/N(?=V[@V[O[H T'=3[H_E+_P"L&@KOY+"(<T_I_P"WMD<\@/Y/P?6M
M!8,<PIM2B7;X4Q'L\._8H_  ]IA*(^_8=!6GSM;8]8VC#MNSG,98KN$H9A<X
MNWV?'$M;(^,B9VQNJTQJ"5M:TT59!=D=8RR1%3M54TQ5^(0[@'0.=A"L<8J9
MQYOD?C&VKV_#+Z'LS^Y*KW=[>'T>Q&!73L4,LYD%C2K)<T6!@!H8J:I3&$.T
MN@B!BN+Y#L\H87E<]&N"O&>3N<6AQXK+BR4*3D:W:'L5)N<?N[^:&JD9:YE
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M98%/AT%K&@-!T5$034$ W$"&$ $_E[B #_RFP]GY?9H*$/K9DP:RQYBZ>O\
M9*G:;P\R;B2DTS F6LI25=PI;V=SRA6(.?MV0*#"2<8>THUN(>JK%=N#'3:D
M 5!(/;T"3'TZ>:7%?,2D]QWQ=!XTQ'E_%D<V<6K"E#6@GT*K7T2(M6]_H5BK
MQ?EUQHKYVL*:3L1!RB<0(LF0VPF"U9,A2;]NP;B83?:81\1^W0<J?='\I?\
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M*8>_?<0T#]9-Q63(+N'=L;58:A(LQ=(JOJO*&AG4@VV WHY$[8".GK=!40,
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M69I!%DJ[V&"0DBKG#R%=]DQ'<= U&(L*YIJU0X50\M$2:4SC9>?4R>B6PD]
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MB8.O;TT&0E66Z*Q%OFD^J)%P7 BTPZ53';?\R8AAZMAWZD\!T'@G4FZ9P/\
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M8O>)=C>\O30>YJPD91-3YW9@%-4BH$+.O 3.) V\M0@#L=(WM*/01T"E -@
M.H[!MN/41V]X^T=!SH#0<; '@&WC_9ZCH.= : VW\>N@\CH(G[>](AA+V]HB
M4!,7L'<O:;Q#;?0>7HFOYK9!,/)$HI=H=O9V%[2@7MV^$H> >&@]?(1[N\$R
M ?<1[@#8=Q*!1$=MMQ$H '[&@"H(E(1,$R@1,O80NVX%*.W0 '?W!H./3H^8
M14$R@HGYO88-P[?/$HJ]-]OC$@;_ )-!ZB " @(;@(" A[P'H(:#J"9 VV*
M;#W!X^(AMO\ M:#OH#0&@- : 'KT'P'0>8I)&Z&3*8-@#8Q0'PVV$=_$0V\?
M'0=1;H"<5!3+WF  ,;J F "B4 $0'KL4=@T'H!"@8Q@#XC;=P]>NWA^UH.1
M! 0'P'0>9$4B;B4@ ([;CU'[HF,'B(^ F'0>N@- :#KV%$0-VAN!A, _W0E$
MF_Y>T=M =A-^[M#?N[]]NO=V]G=^7MZ:#MH#0 @ @(#U >@A]@Z#S!%(#BH!
M  XCW"8-P$1[0)N/LW[2@&@]- : T!H#0&@- : T!H#0&@- : T!H#0&@- :
M T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#
20&@- : T!H#0&@- : T!H/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g425213dsp060.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp060.jpg
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MY:A%.PPD/V'*;L.'B4W:(]I@^@>N@154S'.F50ACI[=Y"G*)R;^'>4!W+O\
M7H.^@6@6@6@6@6@Z'433 #*'(F43 4!.8I $QAV*4!,( )C#X![=!U.LBF4Q
MCJI$*3\,QU"E*3P_"$1 "^/MT'H @( (" @(;@(=0$!\! ?: Z#G0+0+0+0+
M0+0>15T3AW%62,7O\O<JA!#S/[C<!$._ZO'0<D614.<B:J9SI#VJ$(<IC)C]
M!R@(B4?NZ#TT"T"T"T"T"T'D==%(2E4533,<Y4R%.<I1,<^_80H"(")C;#L'
MMVT"4711 !5532 3%( J'*0!.<=BE 3"&YC#X![=!ZZ!:!:!:!:!:!:#R*NB
M<QR$62,=,_EG*50IC$/MOV&* B)3;>P>N@Y\U(3F2\PGF$*!SI]Y>\I3="F,
M7?<"CMT'0>F@6@6@6@6@6@6@6@6@$GGH #PPY. ( (#AF\;@/4/\3N-%:=HR
M)&I_DQ7/X#B/WDAJ[--ZSR<(K) )@%0H"4 $VX@&P"/: C]0CTU#%Z:!:#72
M(?N=,PE,8J:Z*BG:7N$J9!W.82[#T*&@BN(K<]%7"7G9&YGEH9XV4$E?/VF#
M9WYHLP22Z[  )B!=O'M'02E''*FU9HJ*%*J9 %"IF$H'!/<.G:(]WN@<H#]
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MV$V 0V[ [ #LV^K096@X$Q2["80 !$ #<=NH^ :#S,LB3M[E4R]X;D[CE#N
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M2R2@=@NE2@ &-U$0+]6@>T978R.,D9N@83HLU8_S *  *"SH) X;;!L'G;=
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MY&X(\]\8<LTLZAW)BF2++HB*/E% O:<H=2"/U[;Z#9?UC<%?\ZE-_P!UD?\
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M(S+0XB)U!*7?V &^X[Z#&K.>\),W5P,YRS254Y.W2$@V\N70W:IEC(I$4UA
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M@@8-^\HZ##R#G+"+NE3S5M"SBSMTQ.5)(<-78.\$5T%5.[S:BFF!2D*(AW"
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MF'$O^\\0'8G7IOOH !D.5W(]UE>+B:_@*AML7.,@HQ,Q9['0KR2::8[)-V@
ML3:+CX@!^*N8J/9J%*MV%$ZVWE;[@ 'Z7/6"NTNT?,A[H!LIAZ[)J= _;D&G
M@)#?4/AH.WY^L%?[0EO^B"Z_^R&@7Y^L%?[0EO\ H@NO_LAH!+Y"Y]X[$Q]/
M'+6Y=N\9Y+I"Y3I8:M@/7BHV6'4*"1U*H! 4.4_NE$0,(;]/'06;04G&2\7'
MRL61="-D&8+M$7#%Q&K)(*")A,JR=(H+M!WZ=IBE^K0;\/ -O#;IH.= M M
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M6@$+G]^I1RB_0K>OXF<:*T[QD3%3_)BN?P'$?O)#5V:;UGE"O_6V;_Y.3O\
MI-9ZAB(_0+0+05Z9W_OO-'_)\QY_:R!H#ZCO]B-O_-&?_<:#8Z#@P[ ([;_5
MH&(^>NFMUJC'W03E65C7=!OW>6I'-HP$2)"( (%.#CN-]8:!^:!:!: >.27Y
M+4/],^*_Y4-M!VPQ^7/(']):/\0,- 0N@6@U<W_B>5_@U_\ O-;00UQ>_5VP
MG^C"F_Q,WT$\Z!: >N1/^*<7_IMQY^^)#0>6#?RMY _I<??Q1': BM M M S
M7T@[)=X6,(KVLW$%*NW"7: ^8HW<-2)CW>(; H.@=Y!W^G;8NQ?84-O9H.^@
M6@'CDK^1M1_2[BK^649H.,)_EYR8_30S_HJQOH)-R*]6C:E/R#80\]K&"8A3
M=2"4SIN4XB&VW<4!Z?3H'PGV@7W=]M]Q$?$1$ $1_LZ#OH%H-=(%.=%3M]T"
M)G4$X&V-YB0IJI$VV'<AS%V-]6@TE$?KRE-K4DY H+OH=FZ5 @ !2G62!02E
M .FQ>[;[V@B/DO\ D15OTO8@_E]#:#QP/_C_ )$_Y0D]_(?'F@(PGX(??_MC
MH.V@6@6@6@6@6@KRO/\ BCD)^GO&W[_K>@L-T"T"T"T"T"T"T"T"T"T A<_O
MU*.47Z%;U_$SC16G>,B8J?Y,5S^ XC]Y(:NS3>L\H5_ZVS?_ "<G?])K/4,1
M'Z!:!:"O3._]]YH_Y/F//[60- ?4=_L1M_YHS_[C0;'0=3_@F'J.P;[!U$=N
MNP![1Z:!F2,>L[N=5E"'1(A&LK*DLFJIV.%3/V\45,6Z0 /F%2% ?,'<.W</
M'?0/70+0+0#QR2_):A_IGQ7_ "H;:#MAC\N>0/Z2T?X@8: A= M!JYO_ !/*
M_P &O_WFMH(:XO?J[83_ $84W^)F^@GG0+0#UR)_Q3B_]-N//WQ(:#RP;^5O
M(']+C[^*([0$5H%H%H&@]CEU+I$2A3H^0U@95JHD*FSDRCAPU.0R:0AL9, (
M("._0=M ["!L'7Q[2]/:&P>W0=] M /')7\C:C^EW%7\LHS0<83_ "\Y,?IH
M9_T58WT$H9!CUI6J3L>@=)$[R-,@1=R?RFJ1O/15[EU0*;RR=J8AOL/40T#S
M1W[-Q 0W'P';<-@ O781#KMO]S0>N@6@PW8[IK)  ]QTQ !Z 7W_ '>IA$ #
MM[!$?H#0:&C1ZT33ZU&+J(*K,8=BV54;*>:W.=)$I3&14$I>],1#H.P;AH(A
MY+_D15OTO8@_E]#:#QP/_C_D3_E"3W\A\>: C"?@A]_^V.@[:!:!:!:!:!:"
MO*\_XHY"?I[QM^_ZWH+#= M M M M M M M M M (7/[]2CE%^A6]?Q,XT5I
MWC(F*G^3%<_@.(_>2&KLTWK/*%?^MLW_ ,G)W_2:SU#$1 ."[;F(H0>PQ^TP
M !MBF$HAMW#N8 #?8-^F@ /.?S3>!'&Z]NL7YEY'4NHY$8*M$)&G=DM-348N
M^*4[-O*(P,=)(QSEPF8#%36.0^P^&@Z9X^:;P2XS3T'6,VYXBZ3.6.L1-QAF
M2]8NLJ+VN3B9%HN2(O"5R2;$3=)J (%,<IR[^\ : 'N8GS&N&6&I+/<?DO-<
M36'F;>+&+;9C1NM!V=^O9(*3-?2,G::45#/3,3J^8 ]CGRC 'CUZ: V,I_-$
MX+X J^++-EG.\14X++]0;7#',@K7[9)$LU9321$TNW1B(*0<M6_>L!.UP1)0
M# .Y=!L<H?-#X-X9H.)<H9+SC'5>C9RAG=@QA.N*U<7B5FBF0[.'*;6-@'KY
MCV;?@N$DC#[ T&+>_FG<$\:8HQ9FZZYWBX3&6:6DD^QO9SUNXO4; VBN_P!8
MIZ*.@'<DP!/RQV!PBD([=- V[9\S3@95,;8JY/V3/3:.Q+D"0ME;H-M3KEO>
M1L](M 9&E4%(ME N)MF* @7RS+-B%,&_4- Z9'YI/!B(P/6N3,GG*-980M]J
MD:37+RK6[>+63LT6HLF\C$HM.!/.)J$%N<0.=L4@E#??0>IOFA\&2\?S\I#9
MVB"X();0H_V^& M?I#682@;X>2)"#&?-VB/:*GI?+ ?;MUT'FP^:3P5D\!SW
M)YCG>)7P;6;4A2IV]_9VX)LX^QN03%%@K&JP!)HPJ>:78Y6QB=?'00YD_P"8
MUPVRKQJ7Y$T/,L=.X>Q7FW%B%ZN!8"TQZ,*H%B;+]HQTK"L95YW)#N'D(J;Z
M#'XX_,HX5W6M<N\[U7-<=,XNQK<XR=NUE2KUK;$A(R0AV+=HX,P?0C:2> JJ
M40 J"2AOJT$X8R^:%P:S%C[*N4\<YTB['1,*132;R7.IURX,$ZY%/5$T6[T[
M64@&3U^D=14 V;)K&#?J&@Q,2?--X+9T@<G6?%^<8^RP6&:PE<<F/PK5NC J
ME;74622DW;:6@F+MVFH='8"MDUCCW!L'70>&(_F>\(>3,9D]MA'-C&\.L;X[
MG+]<FS>LV^)4B*M'L%5'4B8T] Q:3GRRF#\6B910=PZ:"+>!?S*.%>:\:U#&
M.+\V1EKNF,<&,+A>(AK 6EH,%6JFU:1<Y++.7\*U:N$6C\_E=B)U%3F_!*(:
M"5L'_-4X'<CKN[QSAO/43<;@QK]@M#F)2KEPBQ)!U5)56?>E<S4!'-5/AQ43
M=Q"G%0PA[I3:#KA7YJO WD-DQ/#V(<\1EMR,HTFWWV;2K-SCERMZ\@LYEC&>
M2U>8QQCMD&YS=A5C&, >Z Z" [A\TS@AG')N(L XQSS&67+4CGNJ1K*I)56\
ML5EGT"O,&E6XR,E6F<0D+4K4^XF7 IMO=$=] N/WS2> \EG?-&(4>1].:9!L
M&:'\;#0,RVG($924[D( (R.>S$6R8OGYI9DHD"::AC;@!MNT0$0N'*<#>'AM
MX[E$-^NY>@CU#;[F@[:!:!IO$6)[A$K'<.B2*4-)>G0)V^E5;&7;>>97<VXJ
MD-V]H;> CUT#K#P#[@??^[H.= M /')7\C:C^EW%7\LHS0<83_+SDQ^FAG_1
M5C?02S>B,SU2<))*+)QRC$Y'AFVPN2I&.0-VY1,0HG$XAXF#IH'2@D"1! !$
M>XW<.YN[;8I2  #T_:D#[^@]M M!@OD0<(K)J")$_(5 3D,(*;'3435V]G1,
M^X?7H-+2?0_9&N_#%'*T?\(9^C4>=OJCM_*+Y0N.TQR^;V^.PCH(?Y+_ )$5
M;]+V(/Y?0V@\<#_X_P"1/^4)/?R'QYH",)^"'W_[8Z#MH%H%H%H%H%H*\KS_
M (HY"?I[QM^_ZWH+#= M M M M M M M M M (7/[]2CE%^A6]?Q,XT5IWC(
MF*G^3%<_@.(_>2&KLTWK/*%#!W<M4"[[;\<7@;_1ODQF&^H8H<^9+F&ZX(X"
M\J<Q8XDS0UXI&*)^5JDV":BCF&E'*S6+;2:*2:#E07+ '@JI[$/^,*&X;;Z!
M[8 PU2E\48WMUTIM&N&3+KCO'<ED#(TQ2Z\M8+W/+U1@[=S,^L$>11P\,NH;
M8YMA#ZM 0DICNES2C=:;J-7G%&B1F[4\S!Q<F=FUZ]K=LH\9+*E;D#\%+<"%
M]F@ OD#1Z=*O.7*DE5:Y(J1/'7'S6'7?P$2Y>P[8!OQB(QSQPV6.S0(?W@33
M I2B'30'$7&U+F&$&G-U"JR*45&H-HI%_7HIX$:F=J@FX2B_4-E"QK-<J75%
M("EZ[^(Z#:O\?4R7:,XZ7J%6DXZ*)Y,2P>P<6NT8H&V$Z31NHQ,FS2,/B1,.
MTWM#0>*^.:4ZC&D-(4ZIR4/&;%BHEW 1:L9&E.!RJECX]1DHU8E.4^Q@2*'?
MUWT#"EZ)2UK1C^#-4JZ>$3C;NNPAO@<42%8K*IQ6YDHGT2C%)<2B8OF@4#;;
MZ!]&QK2U(]"%5IU25@6K@7#> 7@8Q>$;*G5<**.6D4=F#%J^4\X>Y8I.XP"(
M#].@R/S>4PD,-?3J%3^!"X4<C!EKT8A$&5,!P*<&";;TJ:_O !E0()C!TT'1
M+'-)28+PY*?520KER5VZATX&*)%/G!-O+<NXTK(&JKE$H 4%! 1$H==_#00#
MR)H]4C:#58AE6JRQAW^:<7*OXQ. BC1;_NL[8#*2$<1FF@Z4[![ [@, %T'K
MA.AU!K:>1<(UJM=;P;_(K5-U$IP<6G&+ID@VAO*68IM"-G:/<;H50H@0>H:"
M?(_'U-C6;Z-84^J1\7*%$LI&,H&*19R0=XF C]!-@FD[1V[?<.4P (=- H['
M5(B"/B1-0JL8$FU(RDP8P$6V)*-$NX4FTF1NT1*_;HB<>U-0#%#??;0:M?'=
M,@8"PI0=3K,3ZZ%E&3[X= Q#7U[!9NIYK1Z"+%/U#=4FY13-W%V'8-!$7%;'
M]2AL!X?=1%7K4<\>XMJK:0?Q\%$Q[J00=1C99VB].V9!YZ3E4?-.0VY3'$=_
MK";8S&])A'(O8FGU2.?'3635>1L#&QJYB*@8JB29FK4OEI.4SB54 $.\!Z[Z
M#R98ZHL(_P#B,+2JG$22IC[/XB"B(V2$ZQ#%75(];,V[A,03$2F #&\P@["&
M@J@YX<XN _%2[T6E9(F(.(R]#9'H=UD8:GXQF9^XL(18TFHI,N'-0KSE=F5=
M+<1$50%8-PV'?H$=8]Y>?+RL&'\\<O9Z CI/&\7R$1A(>[DX^S3RX0]QE(-J
MXB)*+JRM8D+.Q<M%4Q5]6")$^\.XX@(Z!I?+#^:[1;1\O:^\C.2F0[C8@Q#G
MS)F,K9<CTBQR<Z]:.+E(/L>(? (2)5=.':E3?-0."*1@0[>U02F 0T!XTOYK
MO#._X<REGBMVZ]+8YPX_C(V\/WN*,A1TJT>2_F^B2CH![ (S$N!O)-W&;HG*
M3;J(;AN'OC3YJ?#O+F+\OYAI%JO;^BX,C&$OD-\\Q1D**D6#"2*H=FM&0DA
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M;&T&2M\V;A<AGU7C,I<;O^=]&[ACM:$+BK()HA*UBJFCZ)2U! C7"-^Y0-G
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ML[/RO5H%JPPP3I6J *[BL9$$S  ]HCH JL7S%>+4YQJS[R98VFU_FE<<E:'
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M!6Q??@NYV("M)(U,]2EPLJC%,@"=9T2,.IY92AN8P!].@AG@:UQ)&<*N,S/
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M+NB,GG(9W/QC!E(O$FR&0SH,V#T509J/W8VE)-J+@B(]NW<(B/AH!97R%E'
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MT[%Q $/(3A7==<.FKPR2;-5)%/\ PBBW7()C&ZD "=H[CN(Z"O/Y6]YK.3L
MWJP<?,:U?"=,:<@\Y5Z2J<B:<G32%R@KW)QEMM1%TY!FBFA89=NHNFEVF,F
M[&,(Z"SDS"Y)A'J-I6#*ON8)A-=E)K,UDP[?*^&(_$2F9'V[N[N$X#T^C0='
MC2_>L/\ #)*IHQH)D!%![$RKAT53J*ASK)RB29BB8>@ 4-M STD;F3(\+\;D
MJ\N3[+SHMTXR+>-]E?4M (HNHZ>N5!*41#H02[A^SH ^^8;G;)W&CC59<I5U
M>AREMK16SQM'SQ9^.KTL1W,,&*2;XS!5=TW3: Z[NY=4C,QAV, ;: -KESTR
M?$+6-M!XBQS)FC.1&$J&_*<DPIZ:GWAA%DGY^2<M)U!B^68R;I3X:#,/2$3
M!5W4W#0%KPDS7?\ -*MJDY5:J,1K^2LC5B1CHR*DFQ5X:.=-5*Z"NZC9(\H5
MB[(*RW88J@@.WLT#XY!)7;[3M/\ "-4,DK;L)-D&[J$EW")DG-[%-N51=.2(
MJDN@L83"<@E$Q1VZ;:"1Y:[6.BOK1#S,(I;9+(.0?L]!H4:#(Z^%N!J#68=2
M=C^)S<>1K$L6#!0P',J90RFQ0 =PV ,;SR9O4'5\EC<<5W2-DJM82QL6V<T\
M45+'6WB=;9I6-56N6J7!0T4^F1*Y( J% J13[@.X !H5?*5TL,'7W[EDPCV5
MAA(Z4/%&KDPC)ECI&/;O#)(*N'8'<BD@N J*B7<#"(;=-!'U;R#99C*60:S-
M0K(E9H1Z,,8[BHJ44DY4+!#O)**"337=*L"L8\R@D,)$BG6Z"(]-!,X6_("2
M3<I$ZZF1=!0@%)6YQ!9!PV5%,QU#EDO>%=$A0#;;VZ :LV9CO6."P$BQ@HI_
M*6V2L*C\20DWO''802'F.ZT+IVH)I%VV(*9BJ&.D0.I2@;KH'_Q>RK;,U\;J
ME>(&)9TR.;Q-@K*L+=6,HK-E<4]Y*5]S*BLVD6A4V4WZ$'*)52F,5(X;B;QT
M$.T6$R"&/>/\8_-4'%7FW4(:<EO22<?,5YPG+-E5$HE52268I&FG >5WJ)&(
M9,H!L&_=H'+E3E#6^-1I"+FFS2TRMPRG8*S482K1;UQ\!5@JBPL2SBTQ[9PH
MHP;%CFY")NB$+WK#N!MC &@W_&_EHOGF4O-=C?LM4)ZDNH-DM%V2-D6LE/DE
MX]R]8R$,V4FDA=L6J#4Y%#D*/</7H/00RL4#:G?*KEDQ;2M>4E&[?!"\FW=Q
M<B>)5(K0#"@NP(D_*[17(9/;<53)B02AMH*M/F-5F^I<EK!-GC8!2NRC>CLH
M^P/:Q+KL$'\90K\NY%\^!VU0>2+02@4I&_F&(W5'NZ#H+(^)Q+0YL]6<R<O5
MY)N/$' XC)LX9^Q?'.YGKV5LJDBL]7*U+Y(="E#M W7;KH-3F+C-,Y3Y4TFX
MW:7Q^:+CL7*QD:W24G(F8-.P5ZK]G@E6[=J_0%XBWE(](PIBL.^PAV@ Z ZT
MFV2 !4Y)&F%$5@,956!G =[F*"9#J@65.D=3M#M Q?= GX0".@KMY$9VR9@W
MD#&/*?#U6RK7N5PE3;<G,PUK?MHB*?NIA"0E(5:$<MTV"X (B!G?FIAL&X;:
M"$/FCT^QV7#5AC):*J=G8+9"5E4VYH<BRK1W'.ZTL21:)S;\\7ZI",,?S ,0
M_G[[!MH"7XS0->FOE<T^"L\TM6:=)\:+G"V&<013 :]6WL7:64S(HMB>XH,?
M'',IY(B*8 38-@T$>P="6KGRG:#3^*F8ZY:*#3^-01]5R9;X)ZX;7NE0E>=H
MLU%(Z)=L46!YMIW(JF[5.FP_2.@+C&F(DL>XZEEIE^@M)Y%81MCM(L%5RQK6
M=>0,4RDHVHH2;@%6L<[!KN0K@ZARB;J/3031CUA&QE?@XR C9B)C8E!RW,A/
M2:4D\!N@?L*FY>%>/UUA4,/<41/T#Q#02T)1V'8VWU]>GU]3;: +)P#%M/.8
M2B &#%-+'?80[A+B^[ 7N$H@(>]]&WAH"&Q.F)\3XS(!S)B./*6<QB['$>ZL
MQ91V.IW'*/=U 0'</NZ!Z'B#DW.R?+M5S" J+&_=1UQ /P517$WNC]6QOKT&
M8U8$;*++@<QW#CL\Y0^X@(EVW[2[^Z _1H,_0"%S^_4HY1?H5O7\3.-%:=XR
M)BI_DQ7/X#B/WDAJ[--ZSRA0W=_6U1[=N[^KB\[=_#N_.8SVW^K?4,45?,1G
ML6U;A+R+LF;ZE(7_  W#8XDG>0J1#KBUE;' >OBR*QK!SY2QDS&=[&[NT1[0
MZ== 3&,5H9;'V/W%;8JQ=:7H=,5@8Y8#F58PJL"T/$1ZBRHG]2Z9QQDTSCL
M^YO]6@87)G^;V)_3!@O^EJE:"$\#IE5KV=$S/!CRGL&22B] O<+4!S%E@/.
MH&*(B3Q\0T!VH?WM%,P]PE2*8!$=Q/V]@ J(@/3N'KM]>@R= M!'4[VGO5)
MY5 (G&W %.PHFZ';PQ^T>T!'W@#;;8=]!0+S"M6/F=]^8@>I(3:5UIN(:,A<
M8X]XG'K*>F)6VP7V:M9&AH5P\JLI5!. L?*54;@H0! IB@80!O?+Y?1T%SFP
MY5A:QMBD9WB3#3ZLL:[23ZT5IW'13:%<NIJHQ:S. 0&PM&"!E'K]LL^64, E
M4*7IH/I@T#5MQ>YE&"$@:.$EAA#@J4G>*W8\*/HQ#N+L#K\'?KMOX#H/. 2$
MDW:C_$%'@*/VAO3'Z%C1]'U0)[QNX#^/LT#NT"T %?- )W\".3(;["7'CA0
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M>)^333E5"\1\PMZ ZJ2-_L^6F8U]\]CK(C"+U"'E(UR+J79(-D3MWJC?S$U
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MU!H)$T"T '?,Z$X<#^28I;>:7'[@4N[H7S D&&W?X^Z(;[Z J<1&7'&6.Q=
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MG*B0$A7ACB"+8?4G Q0$H@3<=A\!#IH*$N,47*95X4XXJ,JWB<?2^06?+^M
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M6.-^4XW*2V(F\7"95D;G"6#MH.(8Z03ECN8)JM!1YXJ-.'G^;OYIPWV*&XZ
ME,7YH^;7F*LQ%BJ^+. !!L29K&+#[1Y?5.WF?2K,G[X9GT)H4JR$<ON@0#&3
M4V#81 =]!+5"RME?C?P]KF6>7K>BREMH3.-IM?K^,DK*YQ]7HA[%F(TM4P28
M21=/IIX"1RF%#S4T53$%,  1V"(8N_\ S"4L=4=WQMK7%E?$-L+CZU,D,KN\
MGM;Q#V-\M&?&8B11B8KT"[5":#HL7WC%,([^W0;6N9U^<4GD%[36N/\ @J:5
MLRD_;!E5[%EE6.2"+<U>!=MBMTF .&:K0S],$S+=HJ"8>[H :!CI\K/G9MX*
MS/(?$?"*_P ]7L@OZ6O7T;?D]!Z4S<Q DW R+:,5C&$8DHH $,<QENT>H^S0
M:SY>W,/.KOF!GUSS&QOCZH98RS=L<8/^"X4FY^RPM4D<?5N92;.9X\U$(.TR
MR:+<PIB50=Q#W2COH#LLO#N!L/-^I\ZGF4&[>(ICA!E'THE,GUWRB@PDA#F.
M[=>2+PBO=)KJ%$J D YQ#NVT TY.B,OFRI<XNC766Q8\B\CXZO;&:@)=@D6^
M56YY<S3/-(63;SA($T4D=M(%1=I%4=."&(7M3$/$"NNE0SW9>7N%,^!3GT03
M&V-KS5T\=M,N1)8;(/VI(F(/9EP:M"V8?#BH)NB%,/F>80I1WT$CY9R?EC(M
M#MU#+B*/A26*.-%FFE<CI2B;/RG+%==="):T\KIX=)$QCE$AP*<Q ]@Z")H6
MR8GPMROOV2[#F3*9(R]0U J3>M3+ZPS-6E+5-%E_*(6NJ0""T,C&%3_<YRB5
M,0-UWT#(YTI8]R@6%I-WJR%LIDC:;/8SJVJ*?? 5%XRBJ"TBB%*U<*@]\_M5
M1'M G< ;[:!T\87,3/\ RMZ#BZ'DFT58+)Q;ME-A2/491.+C7D["VB$:.)*5
M38D9-XY)<Z95%-P\LNXAMMH-QA&DR.#OE@U/ 5UEHN4O.,.)2E?LKRN&DY.N
M.7\14W;A9U$SY4#M'K!=,WN*E.8Y]AW^C0'A4<QX\D*Y'*,+*TDTF#&/8/5H
MEI*2B;1^FQ0\Z/<&CV3H"/6W^N)B(&+N&X:!ZC?JT$*G8/7+?"E7'HR.OA4Q
MY@NMNI!C_0?$"D_T0I@7Z] I/(%7B!3*_?KI&5;E=D D3,KAZ8^W:<3-8]P4
M!V'J'CH*J.1/+FM8<R5G*!"FV^Y$SI%4G'C"3@HQZDTJ#U7$EW>HR]E!XR(<
ML4LF'NF3'?06+XHN,$EBFAK"\4%&)Q_2V[\0C);O!4*[%@!D" S%1=(1]I"G
M#Z] ]&N3:B\<MVB#YT99TNDW1*,+8$P,JL<J9 $ZL01,@"8P=3& H>T0#02!
MH%H!"Y_?J4<HOT*WK^)G&BM.\9$Q4_R8KG\!Q'[R0U=FF]9Y0H/ZVJ'^3B\\
M?#^<UGXZABBOYA%4H&1^$O)*DY>R,WPSCJT8X?QESR2\)ZE&AQ*SM@899TD4
M#^>45$R%*!2] 4ZZ FL8-&D9CK'K*'DDYR(94FI,(V92$"$FHQK ,&S"? @'
MV!M)LVZ:I"[ 8OF=?HT$?\FSF+CF+[![1#+F#B#N<2@8I\M4ON QAW  $!VT
M%.N&WO*C+&2^>-:H^>*KCK'>+LJ6F#1BY3'!+!("UE;A>YYXH21;OF/G%%P_
M.4-P$!*4-_:.@L :X8Y\%2(='EUCO8Y#*($<X:4,0C?<GD_BAL!0,)2[;[]!
MW\- /N'WW/O+&1N0M%<<FL=1!L$Y%B:*I(EQ"L1*P)RE783Z;Q- )T"$%)5X
M9,0 =M@#V]=!(\!4.?T[?<DTT.5^-T/L$:E@#\,,G\URG:8!>74\U$9\R!?(
M72[2F  ]S?NZ]=!M)'#?/Q6VTXQN6&.U3!'VCM=HX:_$MQ.UB2J>H )LO:"P
MDW2V$!WWWWVT#H7POSZ325./+G'"H)D$R20X>4 14* B!?,&QF,85!Z!N [;
MZ" >,;OGWR'Q87(P\FL;5L5;KDFJ(Q"F(5'/EDQ]?[!3?4N -/%!87I(8BIR
M[@7N4$/#8- ^LE<1><&38)2'?\RZG77GJ&;MK9ZGBM>'M;%9H]3?"@VFD+%Z
ML(MR=/L59B(H&2,8O;L.@BKF(VYW<>^.F1<X2G*/'4X3&;2*L:<8RPH9%:35
M)-0[!LS<&+8P,JB"JWF',&R@COUT$Q4G%?.V8&5E6/+:@(*ROPQ\^2<86-V)
MK2,6W?D!J8+ 7M0!%?M 1][N ?9H'X;"O/TP%*/+W&X%)T#LPVH0PAX"!SA9
M-S[Z##:0W,;&61\+#DOD/2<@42Y9*2I<W683%R%>D'*#NH6R:1.$RM*R!DT4
M7,&3O*4@'-N&Q@]H;OYFS90_ KDJ)%#G6#'2Q>I2&,MY4@SV  $/=.?NZB7Z
M- 5F%D#I8IQH"A#HF2Q[3FX%4V,J8B=?CC=QSFW,(@8PAM[-!M<HO&<?CRZN
MY)N5U&MZG8EWY%4VZK8&K>(=KJ^I3<)K(F2,5/80,FH7KU+MH/F=P[Q&R)S4
MXUU#.= EZMCY[#$Y$0E7J+%"'@8V4"RJ%;P)I):M PC$_B@-R?CCH@NBOL<=
MMM!=WQ,QQ8L0<.>+&*LHR!U[G0*;CVLV609//BJ;BSQ#=5FY 9%P8ZKXJCPA
M@.KML;Q#0%/%EBO56@6*KPJOQ,3R2)A4522?)MT3F.W[=C))$)U,4!]\!$ T
M &?*PQKAW%N [[7\'YC8YNI\ER%S=:'MKCHPD6C%6FPW>1D++4%D>Q,RCFMR
M:AT!.8H")0#<1'06%VY91&ORXH^8*H14HHGY8*$4!1-BN*7E.4@W:*BL)0!4
M $Q-^X-MMP"KWY0<OD>>P/D9[E674F+4?+LL"BRCIPZ6)')P,"C& Z77?R)G
M#U5FD0[A83$4<.#'453(J8X:"R>0('YQJ_L =P5B;V.( 8P%]6S]T!'P =^N
M@>YD06#WA#H0"DW*4P%!0H H E-N4X'+T$! >F@\"Q;,F^R"(B*?EAW((F*0
M@;B4J9!3[2$ W78-@$>HZ "/F"M,Y-L7U=7 1SFGR76.6D&:BZJ351@4S<%B
M""2"P(H(L@<K%*4H *Q"[]-PT$#\H.0]_P 5UNIX^AJ;DV;RSD6G87C8NZTZ
ML+6BNP,^\M9T73QX^*=&,;O!*S5$J:YDB=W:(]!T$"T+E3GC!.1\@,>0L-FZ
MR45%4)8DY9X6I,)EI8I]>HTVL-*_#LK"1NNBT6G2N54R&[A.8O;[0T#1BN75
MZP9CB;RGR)N?(?(5$OM9LY:?"R-(KT*Z24H<E)KW"1E$&DX]?M"-6K8J2/<4
M.XI0[M]] \9KD#RZG7V9^0#4^;(+#U?NDU5:CC*O0M3(_1AWE7KT77)1R]E9
MT$8Y^VLMA*Y6!5+M\L"" ;[Z#98Y2S_?;1;\<9--F_(]GPG?*Q)V*P/7-48
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M,]PU#%%/S%:/3LG<)N2F/<A9$AL/4BSXV?Q=GRC86))."HD>H[C5"S$E'*&
MLD@"B92 7P()M 3V+V#:+QSC^-8R+>881E$J<9'3K9($6LVR9P3!LWE&2!#&
M*DTDVR)%TT]Q$A5-O9H(\Y-% V.XHI@W <OX+ 0^D!RU2NF@K$X5!YN4/FIG
M4,'XK-4DF0?*2'RTRR-M/_<")OP/;OH+LDQ$R"!BJ H(H(G*8"E*4$=DN[P#
M??<=] !7$^%E(WD%SX6?-)%L:9SK6I"-2?D7!LXBQQ]#IMWS50RITQ:/5D5
M*(%#WB;: @,>1\LTSAR(DGC)=*+EU<0I1#U5,R+:1]!2W3>2,P6, ^I*U='
MA]O =PT$HR8KM[G3VZ#LZ;5RRLYGC83B;U1F[:+!L8P&W 10%0P_?T#P7)^)
M5#N'JF<.G:4=S%$ V,!=P-UZ?7H 2^714[!3>.2<)9Z[-U:4-F#D!+EB9Q!T
MV?(,9K,-NE8Y=0CM10ZB,DQ>$<)#^"8AP$ #0'EV?6(_>)_F%T%?_P T>KSM
MQX+9VK%8AY.PS\O$0#>+@H9@XDI25<EM<&L#)DT:%,JHLHFF8=]A*4 $1Z:
MF<0D619O6KI)9JZ2;0"!F;DA$W35-G7HU+R%$U!%8H(*B8AMR]#AMH)G[/\
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MC0/<0Q>VLS@ 8P%*)Q!ZT*8P$ QC%+N7IOXAH)"3\/\ L2?]SH,9ZX4;D[R
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M.Z$@'(^&4.0&ZFP=IMA$-!TP+"Y3KWRHZ/!9R0MC7,$=Q2<M,F-,A.%7MO\
MM.C5'A;",^X=*N574@&XF.<%  X[" !X %EM<V^ST#V_@_!HOM^YZ%#;^QH-
MSH%H LGORHYS_HHIG]&-VT!$XD_FKQG^CFD_R<B]!)6@6@6@$+G]^I1RB_0K
M>OXF<:*T[QD3%3_)BN?P'$?O)#5V:;UGE"9Q .6B(CN(!QP>B( &X[!DQIX!
M[1U#%%_S#L+R/(/A;R(PK!SE;KLODC'CF!CK#<7Y8FNQ4AZYDLD[EI4ZJ)&2
M:94>T!,8-A'0$MCR*5KN/\?UMXJV=JP%0J4$#IH?SFCI]%0#-BNY;*)AL9D<
M6AS(J[]IRG^@0T$?\F>F/(H?_P#;^"_Z6J5H*U.![9!]EWYI;9VX*T;K9XDT
M5G)OP4$O76T14'ZB[Z"Z7P0["E[SD0("9!$VRJ9?)#S/<'<-^G3050\*(6"B
M.0GS 5&:TM#OI^\42?GJG+W2+NJK!:2KUM[+HF\CTTDX1"UQ\<8$V)RBJ@FU
M !$1#J X3.+;D7E"ME"D8NL*6!D>,=S;0]UE)-,R+"5"G3$0NR4CUU0;/GRL
MD!R@Y[RN 1.5,J8@/=H/A;R%0^;?&GYNETY6XFXWY]G6L#FN<M43(US']K!*
MVTJ;KS-E+JM'X,5&;MLX8/E2F$HF+T =N@:#]+S O*/#3+#N+6<_;30T\%%@
M5Y2$>5NVD?Q#I>.;.7D>] *^8HNX]9P"2VPAN<!'02\KRHP HF<A[^B)#%,!
MMZ[;]MA#KX0 #H**OGBXMPYS+X<V/#F$)2.3R)F',N(S6NUQ]2N"C]K6XFT1
M:DW.R1RP1U9%*#AT#J%2.(I^[T* ]=!EAQ4^5G&?+;;?+=:KNVF+92/CVLO;
ME\:7(L](7XAP];DI"35JOJ?M(G*D[FIQW'R@\HH"70<?(,K])X'\0+_QQO5\
M!5>H\@<IN:Y.N*];"#9*;(+,UZQ9E&QZ^0[<7K("E41 -P4 1T%B5KOE6R5R
MOP]:J9++3D U:4NO+R1(6:CV9)LMFND@HW%>4C6&QQ;* )2 '7069-UA I3*
M;D]P^Z0DZI&3'<_<H(]1, @(!TT%>GS-[.U><%^2K6.3>.%$J,KW.TF1E6S9
M5"4CU2@IW"4%0[DO /'?0175,'9#M?+WC5R&(SKC>J5S!4$29>%702L2S%S0
MY.-:L$F7I 42CTY::[^SS1V$-!; U3$AU!+T2$3B4-MA'O$J@&-N'<8>XYNH
MCT#IMH(0Y3FMZ?'#.*N/OB_V\1Q7>EJ9\ (!YTUG3KD@,*2%*/4)8[[L! 0W
M$%-A#005PZ3R+(\+.**F<'U@C\JC1,;N+RYN('^U/VO](K\1:S15!#RY=50>
MP_<&^XCH(RY<\4\"7.NY.RM(UF##*B,TP81=R:@:-E&,[;W=7J;1M*KMB]LF
MF7N;D 5RG!(@;@'CH-;\JOCY+\-N+DMC2_WS']DD7F<LNVX\G2YYO-0K).YW
M)]+,H1Q()B5(9QBV6(1V3H)5M]P#?;06"Y9BXZP8VN\7)^8M#R]3FF+[TA!.
MJI&O60IN 05*<HIJG1$>PP=0'80\-!2=DW"<]1>87'M-[&O#8AK-(XYTF)FG
MC,[IC.6V#F+*;RT%_,4\MT)'!!5./4X"7?P#07:+D[,C09?PMJS. )S'*=3<
M7S504SB4I0V1\S8O^AT$BI^'_8D_[G01#G3)=.Q;CV9G;S-)P,-)H*UI!^HF
MJ<1EIQLNTCVZ8I (E45.(]OUAH*N<50-:SWPCJ&*X9%G-*L<6PMD)+I2:C?)
M#9)>Y)3(N(1VX8.5&K%\[A034'MV,0!)]>@]\^6ZT37(7 #MG66[Q)M4&:39
M!O/QCET+EAD['!O2RBID4_0/7"B9$B>88 **X#V_2 P?,_;V:T79HP/4;?#+
M+6=EZ23A;O6&*;2?&)C58-T^<JH+F=L&[T$2H(%,EV.U$A$=@$=!8_R&RW"1
ME*H6.[I5;DPO=QBU7N.);T)IPOVKJ\2G)"1U-0IR'=KOVQ/+.CL N4A,8P"G
MW  53\F7UY:X4>7I_BJ;K=\7I.4:+<IX<<Q,R^5C)"Q/7HL2W:#D48N0BV[?
MSS%%1N*R7?Y0_CRF 0(>AW3#]L<PW(M6S0RU.X_3^,X6XQ+I=S)R;MA/8]BZ
ME862%?CGZA)99M.237=%RDNF!.XP  )[ $-8REY6\7;DKDEA?DJ=37],G&[1
M\\G(%I/P,7$7*PQ1%F0/WD:XC(6:*ELB@T X F)0V =!$&$*<HAR,XGX$CLK
M?9]6$XV<@:A8Y+'LDTCFEAE:]D*0<>BF4TP?I'*^;NO/-Z@P H8=P = 8&9*
M3=<9\8H9]6\LY":7++192 B<<QUDAV4?:Y,<:SKBO-HT7K1D>+?NW<&F^15\
MU($U"'$H&*8- /O&/ $I(<@K),VV$R'3,-.$,EBS?KV^4:DD;8_R_5_6"H,<
M\%F^6?(-W2Q3 !B&.(' !VT$ZY/XRXYS;RV&F53&T/)NXB(OCN0L60&$LM78
MJV-<;PL+CYW)F92;24?NFQ405$A=DUC%(([;: =L+8SY7DY?*XFK^?:5CB8L
M.*[I&&NU<QLW3N$.M5%(TKIO'QTF95I9HM5XB*A067!9(!W 0WT&X^3?0+HA
MR@^=%C#)&25<CWEEGJ/J%DR@:&;P#NR2;^@D9JVQQ!,UU&#:0%J[(4?+$?[R
M'7??<)0N^,G^!>)?.G%($)\%QO6<'5N*N:K*1:O+\Q:FJZLM-O9-1)99>5.Z
M<+-&I$>\"&3( CL&^@%'CM>>0%?H6+I;")+/7F-K&ENKA&P4"UCMZV_SQ?B%
M='8QP33F&0/#D6$4$NXR)NJFW4- 3''=&R7"M<EZ;;9 &;^S\PH-M+B_"-D5
M0>2N78E@U?GAW)#&>MNQ7N,0YDRG-^U+X: ^.$]50HN,T:A6L:P5DD<8WNU8
M\?V>MRT9&P3->,>28NYF+K,FZ=%K,@X$K47S%KLH*[@RX "0[:"=86;Y%W1P
MT=Y(PRE6V,=.(R#6NUK)E1DO*.S>.%&+V0F1!,[D&Z*:9EFZ9-A,KL [!H*T
MOF<6I.\XWG<;W:C#5W(*LKX4)27AK;&K.#V*"C$RKH,DOW":.6 4A'<0$%NH
M=- 7O&U*Q,OE6U1.A Z;6]GQAO 4M*O=BDFG8F\-:OLXA!@  )WAGQ2%:@4/
M</ML&@QL GR>[^5#1!S9]J4\MK\3E?SCMKJ)SVQ.S+5IV:3-8U%A%<9,A3"*
MY#" J!]&@LMKH %?@@#;8(:, -@V#8&2 !L'L#0;G0+0!9/?E1SG_113/Z,;
MMH")Q)_-7C/]'-)_DY%Z"2M M M (7/[]2CE%^A6]?Q,XT5IWC(F*G^3%<_@
M.(_>2&KLTWK/*%!_6U0W$0#^KB\W$/$/^4UGU#ZPU#%$/S%\/V_/O"7D=AFC
M.H-K=,@8\>PE:>V&6&#KS23,]9.R/9.9*='X>!BD[?,$Y>H[: H,:P\A7,>X
M[K\F#8\C#46G0#Y1HN+EN>2BX-BS>E;N-A,JR36:G.DKN/F ;QZZ"/N3:J88
MZB3&.D1/\[V#MU#''<3%RW2@[ (4-Q,;P#;0?/?B?EY4L \L.>E3L][HU?K=
MOSK-NY./F'"?QR818R]B2DB *IMF48W-((I'.W*JY[3"8I1'07YX^YE\8\I6
M*)IN.LRT^UVR535"/@XI=]ZQ=)DW(Y>^05TR;G%$I V P[#TZ: <>(N*;GC+
ME-SK<Y#N4#:6^5[1B.RU=9*.CX-XK%*5BRMT:^BB4XKNV-?9'(D4FPAYJBA_
M%0= 91>/.&D:I/THE%CB5.ROCRT]""_F%&#]\)5!,NHC\0[T4Q%0PF20,DD8
M1'<N@A]WQ?P4A=Z2BC06;1DVCK,U202M=D;I'271BPBR-$#6HJXE,1HI[B:8
ME* :"0E.+&"/<'[!)]B0 FB!K1;^PACF'?N +$7O[C'Z[[B/W@T'B7C/Q\46
M,V)1FHKD GF-PLMH.L0%.X2 9,MF P"JFF8Q>G4H;]=AT'O_ %5,"E3]['R*
M8$[R%*G9[BF )"._4Q;"78PCXCUT#4M7&CCO%-XQ57'Z)S)6"O(HB>W6](K5
MTY>"FQ7 5+(! !)4W< ?MA]@CH,:K<;..<V^LYF-":N 93"3)XY2N-N7!9^S
M;I N<AT[$/E"14A0$H;=0ZZ"3(; .%J5-M;G$T]G&SD.555G,.YR=D19"8A@
M45*G,3#IF0X)B;8XE[B;CVB&@]<R7N<IN,K):JC2K/EF9CQ9I(4K'Y6+BT39
M#OV[62)$D>OV3,JS5L8YP,HH!0[>OCH*</F'\E\NWOA3G#'$;Q%Y4XN2G:L2
M--?)^HT5W#QC-W(L4"O)L[>W.W379<Y3'531.)2E'V#H+8>/U72IN.J$:?MY
MK#9R4"GP\DYEIZ.<$2^'0S("GCT$"I(-D%3;B)-MQ'8?KT$_$GH@FX'EXH%#
M$]TZLDR QC%W$I12*J4W;U]G7003RBM,W%\;LZ25(GA;7F.Q+D![5%JRY36G
M$[$A6)!2#4AD"G66/*%D@3\D (;W]!!W#F]62>X9\3)_-CB2DLFSE&QR>[%M
M;YNPLR5S<1RAY&5LS1SZ<Y9))= QSD$A1 /JT#SY&6&-<X?R,C$F@W3]K>L:
M$,@@]:"YDG[?(],,JJY(N84TTQ3#<5 _ 3*(Z"E_B;Q/Y21W%^X8QN<A&T65
M_K89RR'5SUB;0D'3UM<[U(S3)*132=B*\.B*(B"YQ $T5"D*&Q0T'T2P1V[.
M@0T'89*.4?(UF/BI,YWK4[11^I%D9N$Q5%?=0AES"81']K[=!$;M]7Y#%&/#
MS#Z(=J5>T5'S3J+,WJC9>KS:,7)/T067W+V%;*&\SQ(!M]!)[^<A2Y"@71)J
M&3;A7IH%-WJ!SN5#O&B8)H*$6],50VW>;O'NV+T]N@?OQZ'+L0)R)[A+L _$
M&.X 4!-YHE]1MV@F'LT$$\C,;XTSGCD*U>%$)2-A)AA>8ILWFB,P<V*K%6>0
MJ#DC-QZEXT=K+=ID2_A@(:"F_@Q,FQ):\IW""J"LX\K-7CJ"C%Q]D(Y&#KM:
MCTK%\$/6G7=+M!";GU1,X,IW'*';VB ;@$E<DV4->@J?*(]BD<.S]#M&+8Z9
MADK"\K=0DV#_ ".T/)FE6T>V>.UGBZL$W43.)#@?RRE[C>.@$/FJ^HG(9WFA
ME2^158AB52TO9Z MN4(>]6AH#5"H5EZZKT4VA8V/.<!>K+>C!;;R=P, ] V#
M89"Y6V]])<87>1XBGTJ'Q558PE,R],S]GGF-P3L>)/*?V52"KSE4Y'[]\V].
MW:N2 X357W$>NV@QLF\@HG('&:[5\M]8(SR+_-D?#0Y(S*4%*R;1\JG)Q;IC
M6$6'PU1I(L9=PE^Z3 "0H"H ]QA'0-V,:XOSE<(NOXRO%/IM6<6/'$3FR5J@
MR-+6C%86I(22=H<5][!%;RQ7<S'$1<*E5[7)#FW$-]]!/T]BCBI@7C#F$KRS
M4>PY0DV#EO%V2+)(OH12&D,DQD\1LRCG[9Z1M+IKO%?-2*!P4 >TI0#0=3%X
M6+<T\2VVN7UQ2*S4>.]OF%+52%)RO/?SAV>ZM7,J>=/\ 4<*'>D*X*8BB0%
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M4,4/?,C897G>"W):,P*VM[K,K[&KYO0$,>NQ8W,)T[Z/41-6WH' [-ZHV2.
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MIH(-Y:Y9XHW'C]D^L96S= 5>DV.NN6\Q.PSM0;)'-4#IN"2=<3:B60/*,CI
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M6^*O)LCB,@W3,S7'\4SWV(;H!@#VZ!G\A?\ 8&*/\HS#/\J6^@CJ>_*CG/\
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M8E(4WP?P)W= ]H:#;&K;A:/91ZMLLR:K+<RK]!^V3=._>_!>G-'^6H42]/=
MG70509-Y&R'&6<(\+%W.RQ.8>;%XQC,(P=F9QA*HO*(U5E%3"3EU$NT>U51P
M!G"9C";?H AOMH*SZY9LFTC+W/*ZUR[6VC66NW!W#K7^=EXXH/8O[0+-SV6
MBD(=5"4AX]!H5H[;H)J]ZABJ$5W Y0"\3B.FXMC7+,JO?++,N)^:Q3/.[FBY
M(TE9MVOABF@NJBFK%$(A%+&'<J8I ;<.HZ O/L6J;W27Z_B8>@?X48^(^WK#
M  [>.@VZT&LN\CGA+)8BECO)058H.$!9R(H"!E#221F8**J+ &QC$,0.OAH
MHY?QM0AS4%]<F62+F>1G;4G&(PLDP"/KQ/LNZ4GQ4:BP%;>2A>]LB 'Z'$-N
MHZ BL60Y?03K=E.6WT@(QS!D1^^8@Z9-#Q+!=FNW$C(H)/DT3 F/< @ EZAH
M/'/< JK@C*21[#:D0C<4Y!\U5I(M"O)#>IRO^,#>@4!100\.TI-!"_!VH**\
M1N.CQ*YWEND&+ZPJ1D>59^2!$T3?BE"FB?,%,0'80WWVVT!>*1"IGCJ3+/S1
MT3LU6Y(]1=%2)(!VQR&<J-Q:)JE5*/7N\S;ZM ,T!CA1#(F.DRY"N@>GP[86
MI$(^S%3;JH*SE5\M=K'JQ*C J#<" 0IQ$5"[@'@([A%EMJ9FO+3&K(]PLASR
M$DU].]<3"*TVW])B'*@*@U$8X&;<%A$.X2I#W;#N(!H*?_F.V9_BKE;C.S1K
M\DT*<YFZ8EX25>>I;3,;7*Q#2Q&*GQ!D3R',F^:D3=IHD59*MC&#N[A[= #=
MZG<Y9RL%-O\ 0JY;HQE8,#\0,H2F/J&]J<3C-5S=*7.4"<92\U--6L?5B5!!
M\5.)39)%=JG,<=_=W$+&^ =;Q_5,N\W*=3X"_4VV06 ;LWLMJL,FJ$D^?DR1
M<4G9RN%@<*QLHE-MEE ,(&!5LHF8@B [@ Q<6(GD;D[Y.=!4Y 9!RF6\6;DE
MD. @U;NN1TF%!))79*L*&:2#0CE>*;1;<@IB)S@NCN0A!$P;!C8?X]T"4SX_
MCWDJ^L,7!Y5@+Y6JG:7-3CU*JXG(R?HUN>Q;1K%/#6MFZ-%D1%N^,!$U!%5-
M$@J (!9[C+!T5CNQ87Y SN7GU(HDGA:ATB/J[:8AH*$4DI:EQL)'M#$38J+M
M9 'Q045!;\69/?<NQ>@-'']!A[OACDM:IPN/K<SC)O*$)BV?3JU)?LT*3$RM
M8C()\63C:ZT76DF\PB[_ !JPF(<Y0$QA#?0419 JMGJ6,LB6'),:WAXIO6LQ
M41RA.L*!4K#1I2+"X6B(O;R<B4/32S6\*2P,VC-J4RG8</P1 -@^B=Y&Y=+0
M\(1A).^EPB;B[QHF'$F$^U3AVM]^TM#:MXAHP/"J+J*IPXD4,;SA[MNO7?01
MM\T;D=R$PA:,;3N#+J\A1C9<M&!1RSC9\]A6[C2MIDED#H&\HR3)IZ910"E
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M@.(AMH&/Q)<I?U><-O" U\A2LF:/'AW1 ,W+Z]0443&$^WXTWB'30%,$A%@
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M/+5 #?@CQQ>;[_1^<QGO_8U#%#_S',I7K"'!_DMF/&?8UR-C[&LC.U10\/\
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MJMES&"-/A79\@U)%FTAH<B[ES8HT&;!91B0P,G,B#@K0S@@%V[#&\WIU#<=
M]/SC491Q#MPMT$DZL*'GP#3XFW%_--0-L9Q'L#'\UP@(AT4*4P;:#5/\HXX1
M6?,W=]K'?&.TD)9(TVR,G$N=^Y-%\NV6*DV..P"*:QB_7H&N;(5*E;[06\=<
MZE(.%(*VO4FS.=: X<MS)QI0?,6H*IB[9@/0QTP. >/LT#P2RCCT[5=^>_TT
M&C9THT?J)6-D9!D[0$45F[I<ZX"V,4P@ E.5/8WMT&/^>3%8MVCH^0ZHFRD1
M5+'O#SK))E(F;"*2Z<6].J5&14*IT$J9CF^C0;0MVJJ[L(5.W00S?I$I3X8C
M+-%)!M%F*)TWRC103N")J$VV,L4I3#X#[= $W+7)F%73;'AYW,L?7/166T(-
M5(&2:NTU)PU.=I.U)QT5X5C&?9]LH+H$1%0YSE "@4>N@)#&>1,=JQ;T(RT0
MKAVR80CB1>FED1>2S0D"R$ME>,3'%TV9+IB!Q5 @I@ [CTT&HSGDV@+8)R8_
M)?ZL,=+8WOD;%2:-DACHR$BXJTFBFR;"*IVCE918X$[# 53?\$-] '?$SF7A
M/'G'#"&/K+(7(EFKN.J[%2J;#'MOE$$9%-OWJMROHZ(,P5 "*%$H$/X#H"4-
MSBP2^)+M4%\B+JLH]==TDEBR\]R;<$A[U1 (@VY $P ([!X[:"$L.\E</Y)S
MKCAM7YI^J6"XXVU*?=3=9GH)JU%[:Z,HRC73J59MVZ3CRDSB5,1$W:!NFV@Q
M.2>:X"BYGP!'5XUK1BGLCE:>3NT?5I::HL#.?F?M36+C4IE!BO&^J<OC$.HB
M)P*DF G. E 0T TX^^854'?"FV3?,N&M$Q>76,,A)W6#B<86:&+>:@QCEF_<
MRDFC!1BT2GX=?\6IW)D,=<1)V@40 *98"O8AL->;V/B74;[1L57JM5JRT2EV
MC%5@R+*U>3R!C52 ER8[?1[AB+5[3W$9Y)CJ"*)EE"*@MN)A*%E_RBGM(K&;
M\RL&U\R!/2M)PJE"6-/)T6YK;\I#YPMBYK4_CI&2>GA#/9!95%)L ]YTD0,(
M!N7<(1R9RKNO*OY5.8['8&U,0R0WY&Y_QS4JO2*Z:%)-QM/7OE?K+L\ Y34"
M27F&K<JCE<P"1<3]P: <>%ME?8XEN,%GRMC?(^/I($*-6[##+XO?"=VKCM\^
M,V/ FBW*P3<:5%ZDB0I4T@:I[%* @;8 NJS1R/@CXNRQ*X5K6,,?NF%@?5!E
M.V>5_-K-SL<@UK$DX;)$=PI%_M K)SYCILUE"(N$6QQ4.': : -.6')VT98R
MEBQ[C^I(E"G1_)[#K5Y6)%ZZG&LLUIL04DXQB@J[@6CIHH55=(RI21YR$ X*
MJ$W#0#>QK!+.E .;<AF2QUZ"=7B8BG<59HA1SD6?A$BFM,K+*J WBUWL?ZM&
M249;)(JJ$W32\= 967.6N9*I@&K7D[M+(V)G+2K3<=%TQ:MR.0I0M3F8%XM'
MS=<+'LE(I1)*)4\XS9595,P"';H)85RO2Z1P^=7JTXQR)1W6=8J4RV%,:0U@
MO[V!NF2GZLQ(&G&C"(3FHR/(F5(P%6 H$5#H @ #H*V.4N5<,DS[R$>.E<GT
MREW3A;68N+3;XLMD:I;,A?$;TA;WA$U(!J^]4PB!:+EE%O/22\HJ?=N(Z -9
M?'>);[$1Q*7"7*?N.+6<63&L;%XO/48C&T.E8*BWL%LDF=380X7&S6](Q'R#
MEUYOHDVK@OEE.?NT%DM<D8>@Y*NMLN68\AW^$L/&J0IQK(XQQ9UW=KL,/DCX
MLG#RS5]&J"D(13]-,KGU!S'40'N3[B"8P6?_ "ZT:!/?+^PA1+PRBBJRIK](
M$J-@(0',<,[EV\SL"H_9+%372,1I(HJB @40*(=/#0-_(/(G&''VTU3CNRQA
M8*M!V>AV>TM;'CJ*D)1Y6C)RTK#2!K>DDW/Z-O*) ==N(JN%#IF /**'O %&
M-ZQHL2D40CG(UOSG+-,,Y$I4R2S5RSUV892,S8G4[6*M)-3*R"3Z(9EE6R9E
M4%%G:C1-3N)Y  GH&)6YJ=HN11S$AA=-FP=DQ"J2V5BC25>FV*T2A!1#K$RU
M8KD0UKYS(3L60[F2,D@X<&3*HB4YOQ10LMR)E&N<B^*^?%\<U.;=9?J69,!W
M"OU^9I4G"R$9)1D'BEA88R'=VE@U4<[1L<]4.1$0,LR #" E$= +F8LGP>1G
M56P[<J=?Z7;L#WV]TI&>QQ%DMU992=@R;1;-#W9B+%P@,HN%0>/Q,S:G]4W>
M;E(<I^W8!(XOY[N_'CF:OGJD\=;[FIY T><H5D-78F7:66R/D6UL9(6V>%XF
MZ=%3?-44U1[3.#D3$  HB&V@^C$_/_/Y*T-A-Q[J:+A*DIW$(!U.Y=">\U1L
MLX-!II'PTVCS2J)2 ':*YC=W[4 ]X0A=A\X3D&XC(J3;?++Y*2$;+F*G'R3,
M4S-'Q^T.]5L*T8"OD** /9W  [>( /30![Q,I^<<V\\<_P"<+M4+UQ4:7BD.
M9-!ED5C>X<Q7\ED:=?%K?K*Q9J&A* E#R2:VXJ+ 8P@(#] &CS2X_P!VE>)'
M)IA6L^,[E,M<*WIRWJ48IE]](RY8Z"DGB#(S20S),-!%V<IR&,X;+H&+MW%$
M VT%B?#.SP+?BMA<RDRT:HM:C%-%B/%&H+MED3^2LBZ,CY:(+IJ 8IMBEZ^
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M ]OAN'U:!C<C.3G'XB6$XT<N4T7DOR'P\HP($R4B;@Z-K13,0SA-$Q$5C*"
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M&3.L9<._N$.[N'?QT#=XB*J+\;\4+JE[55J^"JA Z=ISOG)C%#Z@$= &'([
M&;;KSCQ?D&HHPY,0EQQ,,;:^/))LIHUKAX:U(5ML!DTC.6L9YDV8ZANA3F*
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MMQ9N!4:/&RAE@'8Q1*8.NV@P.*,O07''3G-79>)N50PM7)7)?KH0(48J7J%
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M)=OUG3BZ1>7M>?MG5DA:G89&+C4%22"QY=C$NW4>B6/2'S'9CO$B *8=1T#
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MW41*.@A3DH'_ ,/N>!VZ_FMNP?7L-7>[A]P= V>'P;\:<1 /_JVD&P^SM>N
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M5%G_ (&QFAD[EDE5J^L5D6CGZL:2VR2,<9RT:1<JU:K)LTBE.FD*:13 /:4
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M_&V[62;CZ?"1<2TE*?&SJSZ(E):;=*M[)8&Q)!,CUZR4<"+T%R)"4$]A//\
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M)3 (]J^^Y?P/'0&'B?&M<Q)18NA59MZ&O0PNT635%HS8D1(Y,"A")M(M%L1
M"@'@!"CH&]R.'?CQG0?>#_DLNNP&[P,'^]9[T$#^^ _=ZZ!E\4%0)Q@Q+N9L
M4RM>12 '@B*9MY)4NPE#J8NP^ ?5H"K1*!$DB !  J9"@"8=J8;% -B!["![
M/JT&GE6R;]B\140*Y/VF,FU$1*"CIK^/;^^&PAN8 ^H=] %_)EFC8.-G*!M+
MQ[)\A]D+*X7:O""LF5PQJB[DY"IIM'_F&2. @ @@N;</[T<>F@@#B+6ZQ)_+
M<NM1DI-E2*E+U#,L&_L+=AY4?3H>7KKY@]GBI&;M14&$1=G7W!-/O[!W*7P
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M)UFK5"H<Y?[!)UZ(&J0+U]%V:P)+##P;YY&"T8KK"@7U9(Y1T!/.!,0.*0B
M==M'=>T9?"MR;^57\PC)&4KSFI_\P7"-4=9@NM[N#ZHXYN^5*;2(F:-1("4F
M9&'K_J4W30+15UVY2 8I504 3*B8HAIE[/?]80=:/DW\\X)98K[YEU.D$&UB
MD(M9^7,&6%E/.;$J */!2]8/=\1"8;I#O[&>_LT&'._)[YVHW"=@W'S):@[D
M8M6_-9:0-E/*R)7CNL72(J\DCYPNP, 6"8>$<?2($W]FND?PSO\ \#AS\.YN
M7;\S&FI.(6>KJ$LY+F+*H_%U9O,<C3$'X=[L2&^'V5F66 ?'8_<'TZY-4?9,
M?ZS%UNGRD> 7*GC;D+,I\D?,$KTJZR;QS4@\;V*%N,M?GV.9->\+@6T-(K*#
M@T:Y=12S%400$P$.1R/LT>59GR582T/\F3D3%S=I&\2L3C[+3*2NCML@R6L[
M]MD&91>6@S.',$>U>3RQ_/\ ()NDAW]Q=]@T 3\>*C&L^1%IG,O69<*++T\[
MS&@U*X1DT^8%8UZ*-<ZO,L"QY9=D_,S 5&1_-*F5QT'?PT'TJ8U;QY&[EW%/
M2.F#Q&.,@4W^S42EBF MTY4=Q[Y/T?:*AOVPCH)2T"T&*]$H,W)S=2IH*J=/
M_L9#'#P^LN@;5$D0DJA678]!=0$8ZV\-O-0V'Z^@ET#OW#Z?'PT$"\HJS&W3
MCKF^H2]I84>+M&*K[7I"Z2I.Z,J;28K4@P<S\@?_ %MG&(KBJI[1*4= ''&7
M%#_$W#+CY7\69+J>4Z_5*%1D(N77<.8^GWEY&1QF+&:KUB0:NWL3'RWE#MLB
M8!,;;<-]]!\]_&[&]+B:QDEBDX>V>4EZIFI2_8^7D(V-:ML@-<@VZ7DYBIS,
MD\CEV,+!V!\8K2+W$A&#8%NTIUP*<+\?E"V'C;:.*DJIQCK5LK- 99DRI&S\
M9<GK66E7-_:SJZ%ZETE$3'!K#6*<,J[9)G'<J"@ )2_@@ I?.,@[%BOCU0$L
M?QS&=9,,N2,DE19BHQ5KABDD*1<?73[F)CCLW:B$,=V#D0 PKB8H"G^, NC?
MZ;RI0L]?E)\KNQW?)F/&MIK,OE=^:QS%IE\:/(-C++XK8-8IY0E7[)['1KA)
M515D0J:P><8Y"F(BGN5+==O\O"-0HF1LN5)L#B:B6$+4V\>XD7UID%CP_J+6
MYK;IE(W!!M)NW8Q[KHL4%4E"@4WG'.)P*>?[:PG_ )Q</;GF5U1,KTR)@[C-
M5&-A8+[)3YW\?/2+!]>X.:<2)K2S?-4H\(!)F*XI"!_5$+Y8B!1T8J7.4U?<
MW!U=J7 &E8:4NF*LIEA[-4ZU75;@5U V%[+7BQUIT$FFK/G9PZ2S11HHX*Y:
MH+ F1,0/OH/+".')F%0@)VX5MX:-*6G,L?UV7%_)3L/%R>+J<]-:H&T-EG1[
M0NLHD;U<6\6\M)F(GV*+8AA"T3*5JHCSDIR2A<DSET^%0%&Q46/) QOFHLX&
M7H2KFU)L90ZCI?8L;YRK/\2D!5%#;=V_<(3/S=9HN(O'+,)5PT .02,HS=F^
M +H-FL/@]R\;/94+,Z;QQD 9)D.YV%-8/>\K=02Z#YL9]^-*M3N-R @\MU 7
MN-\2H[U];ZLZM5G:V[-,!+JN,B2HB%:MD G(N02BW7J.[?SDP,)BI  ?43\J
MW(D%EG#F0,AUAG=65=L66)P84EW/'J/%XV)81$&S>P)HHZK M/>MXPJL80AU
M!3:F*0YC'*81"QBTD[X*Q)^ZF)X&7[1./F%4[XQR05>T1W1!#N]G;W[]1]N@
M^,&^V:T52Z2=/98ZI\*1'(KV'?R,YC?[)Q,G%6K%-D:M;P\L-?L,DP&T)NR"
MA'F=D*= !!X)0,N(: B:;A^1Q]GZC7"4H].:.9K-%.KJEDJ1%)M-FTDY:G2]
M.C;!(#!D+VN(Y1XY2FS@V.@LN5F)CB9(V@O QM>;(;F17Z -D(%5?<2*W:#4
M]1HJA)/YA"XR;=.QE70C08E611 2"4793& -P2'\+0!Y\WJDR]\N?'Z,:0U@
MF(B ;#D"9D(2(KLFG"LZ7DW'=@.O+M):1BW[UF^79D:$18"9T+MPG[HD$PE"
MDS ./9G-G+3'N*,85J1B9*NVJ8R(G$7>/B%7<%7(6]S,_/PUDGXMRM#OI]H5
MT<B8@L"H)E*!^\X&,(?<JW 01)N8QQ'N'N.8IS;&.80#N(4A1 H#L&P> :"M
MOYAO*ZS<9J"J^I3! UGF6CLK2:ED&JD# H^K;0Z#DAUA3-)32DC) *;!,PK&
M O< ;;;A-G$;/,OFV@JJVJ(DF%LJAXZ+G'SV$=5]O/N5F**B4NA$/MG<:*A1
M$3H*>^G[=M]M!(W)$0/Q[SL)1[@-BV[;" #U_P!Z[WP#QT#"XCF\WCKA= QV
M91^SQES).R&.[,"$@L(&:C^"0/K'ZM 691[BE-L(;E =C?A!N&^P_6&@[:"N
MKE)59:R<:>3E:@'%=AWC9>1=-TK/.VB!K<G&1P)R[ME+V&IK)6)FE.QA'"!P
M9B0Y0-XZ"*N)-<0L7RY\FU>=<U;';&QP>?("36A9*Q3=)I,9+P\K& [:O+0J
MO8%X&!8+E6/WF\PP%$=]QT#OPKCZ Q3\J^E8VK=_@\I5VC\3U*Y!9!J;84(:
MXMF=6>,V]DAT# )B1L@!]Q*8/ !'Z]!+W#/CY-<>*QD2*E;!&69KD7)3[)D.
MXCH@D(Z9-+-%08*,)5@B(MU%FRB0@)@\0Z^W0&X!BCML(#N(@&P@.XE'80#Z
MP$.N@'+D+_L#%'^49AG^5+?01U/?E1SG_113/Z,;MH")Q)_-7C/]'-)_DY%Z
M"2M M] M (?/S]2GE#^A:]?Q,XT5IWC(DJC^3-9_@&(_>:.NV;;4GRR%ECD2
MY8$44$"D3XVOSG,81 I2$R6T,81$.H  ![.NN/.A7Y@$[Q[D.$?(IQGN3L X
M+^PKACDB2I#1=Q8V];4?M#'1CP52\Q0Y'/:8!#<-NN@)"E6*CQ5 QL2.F%D*
MTM0*BO60EDUROU:\G!QY(QZ^%),2JOEF!T 5#;W1W';;0-[,6;82G8PM]EK;
MZ'FY]C#*_"(Z5=/F+!:0>B+)H5P\19"X00!=0.\R8"8 WVT%=V(IK&7#2'S%
M2\LY?93<3:$Z3)MIVSPS:N!*Y!R*XN!E:A$)03$&KH'9H-9VBL8GGN3.A,H/
M<.@,G,^6^,^0L/W2CW:T0UFKUG@'$<]K3LTFR+-NG"1#1]?*^7BQ;M!DG:9$
M"G-T*8X#X:*TGUM$_P OGB=9XY%Y_;R+BC?*D168X^ON2<<S]D?WO'RB:$S'
MTBN5*.K:KQ1D=ZY>UR-5;*BL<!(8@[;]!T>KW$35SDFS\G6IV:E@^6-0*@$U
M8'TO'I2^6<4Q19OXVA56Y8AMZ]DV(\<,DJNLL1-/N./J1V#0Y^7G+3_*:SW:
M3EF/RQJ,FA.J9.EF#4<JXN J;*U6JOVN.6*!6 %\R&;L#HE  Z&4V#KH[$Q^
M6+*9*SU4W]M3M?R[,-5QQ;YJMR;"*G,ZX4B))K%P&9G^06QF$?(E;.G3)_"K
MC'>:F04Q*GMN.F&?V3_S/R=..^6>0L;OF<W._+VP+(IL:>E47 ON0^"D8[U:
ML_*S;M=1TN"C<IT".T6Y0'J/AH\R0N77+WF/F3A%E;$]>^6Z:FX\R3CB1CT+
MG4LQTB:JU:A%GC99S/M@KZ)6[IHD@B<Y3(B)#;>(AH+&V2^/*1B'!5KI>*<?
MV6R62/686R:2JL>VF57'V<=R$+'NYKT23IPE+SC0J:_:<P*$\>GB!.X<Y88.
MM[^WP=>F05GZ^[%"R1;"+6;ECW4$R8M'I \X$/-!JN84B[".X%#;?03DYS=C
M]@V:OG+YXV;R!14;K'9 (*@4=O?*#DQDS?0!@ =!AAR!QH82E+,.U#G$H)D(
MP$ICB8P ';NN "'70;9;+=,4=.X=LZ<G?E9F6\CL0(F<BR)@ HJG<&3[A$X>
MZ/7?0-"LY?HE:IM1:3,PX1<G@8X3)GC_ ,8D4R F\H_:)"E+N&P=1W /KT&8
M^Y)X>BX\[^8MC"%;$4,1(DNZC(ERN!#E3.=JW?2+=9R0JARE-V /:(AOH(>Y
M$96Q)D[ N9,?,,B5^)&ZXIMT"K8EG+&5AZZWLU=D&:,O.ECI!SZ=JBD<RHE5
M[1,0AA#< '0#]QXR3A#CGQ(XOXKF<G0=X/CVB4RO1EN@&#T(*V!$1QT/CL.@
MAY[9:,4(L4" J'8([["'CH/FBI>>ZS08]Q+6?$K=LSOMQS71G69D$4 <71>>
MEIE>MLY&,EGIU($\^R<^H,NCN!UFY0  .4H:"Y7Y+EDP1%8/SNUPG<9R)I,Q
MR8R#*Q!;Z=Z=W-.FK*)CK8ZD3$1(K'G<V)LX%,@ !D]_#;;03?\ -%+3[3A/
M ;&;:%<UVU9_:P*1'<A,H+1$B:CW!PVL3)^S;.'Z[9B]026,"A3(II *ABF
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MQS(!),#1\55TX]8P@[.NV<+/CK'(N)B"8?>V#</$>OAH"8'(-+ "B>QI$[P
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M]!U#$,35,7N+4PG:-7CUHY;##-U$:S&UF%13?32[EJ*#-W\/4;CV(@)#F,8
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M?T+7K^)G&BM.\9$E4?R9K/\  ,1^\T==LVVI/ED,FW'EJ@!1V-_5Q>=HB&X
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MAS&4]CV09W?)K=G\6-CV*(\CU/BR4<1,RDJ)UBE*)" )BB;;;?;0!DX<X[Y
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M)!)H9N+\.TQE#"?RS!H,)HR^:S&7>6D,LVGA$7CPV5F%G*-$K66&>5R0AGI
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M*@E!6'A87E E<G0WEY(P&54\,.<?"V-Z5.M-6KQ6S%M"+L2[>J$$!+OX>T/
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MB(3KH&5(LA-=H:0*J@7R8.3:G34<%*J<BSIHH(IM!'N7 !3\0_!'0,'&&?\
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M].U9-1%$DO38-N#Y)NHF*9W#(ZO>3NZ"8 Z;:"*N.G%9'BEQC2PXUFT\FRD
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M)*BQ9 HNV2%<J+5(J;LQT2;J/"" ^I4$1ZF,(B.@[%K,#VE_P%"%Z![I8>/
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M12;&9+QDM(O(IF5)PG(*HG[W,>N7W=Q 4AWVW 1!\_$?F$?_ ,)Q=_\ H?\
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M'@G(%?$[.XPD0]H^ :"+/ET]>#?&@0W !QI%B #X@'Q)[L _6 :"9N2_ZO\
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MX]0*/:/[7I[/NZ#OH%H&5>&+A^PB4VQ2F,WLU>>*]YRIE!!O)H&5$#&$ ,<
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MV,8.NVX@ CL7Z]!Z@(&Z@("&^VX" ]0\0Z>T-!AO#E!!P7?WO*-TV$?$I=O
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M'-*W\PHI[?[VXPP[]X!MV@4=]_#0;F7M;"*3*X?R#"):F=%:H.)-VBT0>*&
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MT6OMDOEZ<P7Y7<R*L;QVR"V3)\9=%16*G"O$Q!=(0,FH<W=U4$-^N_LT$/\
M'6-SL7C3C-5AC*#?MOZM>&3M72V9I=N:61+42^2BHP+7CI(B8H;"43=O7;?0
M&&P:\A&K-TT#&]5%.02.#DBV:9M<Z*AS)]J;%0U9[F9P*/0Q=Q#09"S7D0LQ
M:1ZF.:WY#4!,F=MFN=;.@4#\ #N JYC+ &_MT&"G$<@"J)G4QU%KD(HFH**N
M>9TZ9_+.4X <@U/8Y=R[[#T'PT&FEW7(?\XU5=_FVIR+N1@[0V,),M28H 1J
MWBMP21+6"^0L G*/F% 1'V[:#=?!.0(% HT&$4[%A7*8N;[ CN<1[MA(6LB&
MV^@S?2<AO1&C/S<5KTAU1<BK^>F=]8550??(5Q]F/,!(H#X;[#H&_>4N0CFK
M6)=[CFNMTVM5G6IABLT3;=0698AX J*$^S!2KK"'M'KUT W8TMN=86C<6ZHR
MQ6SE%[50:%)QBDGFN4<I(M86MQ;YR=VP5K?:D"22Y>IMQ*(#TW#0;!?*O(BS
MT_)L_7L$5Q2"G)J4;JRI<ROV"Z:D2_4BUS%*C6EA23]4S-X#MVB'T[:![1TU
MRF%"/%7CZQ<B5FV40-_6*EP1=D]*F4%3$^RABE43(.^P_3H'$:T<JQ:,67]7
M6'\B,7!PU$,^R +*J"/<8KE;[)=ZJ1?[D1$!T&--VCE=*"Z=+\=HE!8[<S8I
MF?("2:HE0,D=,YU$$JD4IC% =_KT&BH5GY31D'65F& 8B1;(P39-HNXS])G(
MHBJW1!83M5*JHGYQ5D]@-ON!?#QT#D7MO+)1B9G_ %=8M,BC@[@YV?(219J%
M,<1 2F7)41.*/:8?=\-]!%R>7N03G*#C$A>/IG4^QHY;Z(J\B9=9@G&DGD((
MP><>IE_=0O%P]SM'<G7?V:"0IRZ\K7#J!=+\;ZZK\/E6/I&Y\Z/#HG<D!4&Y
ME^ZI%*(%$!W$0'?0,ZO27+*,EK[(/,+HA]H+$E-)%3SS*,RL3BS:H':(@A4E
M043!00 I1V]W<0^C0")\M7*OS"K#@C(#K,&*+3>9\<]9D@XU]E+*\O6K(VJ$
M9<9!*":1[5S4U#'@V;<PHLG)!_=#8A#B ;[: ]U[/RQ4:-&"7'N.;MV1EC)'
M:\A9-NX5%<2B8'2Q*D)W!2"7W.[\'<=O'08Z4YRN*8ISX#;',0P')YW(J76V
M,7J&V]3   1\0Z[Z#5*W#E<C?X>2' ,,=^:N2S8K-?/$@L@HW%RW$ZQ>^J"!
M#IC]!?;OH-@,WRN$3&2X_-42',*G[GY%2J ',<=S=Q2U(?P1Z!]6@V2%KY9)
ML'$:KQXBW+=RL58ZSGD')+O"&(3L B+H]2\Q)$0ZB4.@CUT'D\L_+-T#9,./
MK!LFT1\A(K+D-*->\G<)N]QY=1_'+;CMW#UVZ:#02LWRH3)%NG''2+?>FG(A
M;S'F?I*041%.39&3'L5JQ"BD4W78=P\=!LXBY<KB25Q.7CC7 -*315) J&<7
MK<GFFBV!>Y'_ 'JJ=11 H=P;#TV]F@:UXEN30U&?06P Q9LO0[K&_K$RX=IU
M'2 %$.VJE_#-_:T#Y+:N5QF#2,4X[0ZC1DX4415'/TD#PP>8/:"RYJF*BA-@
M_!$=@WT'20M7+:1<>>?C\P;=J2:!$V/(>49H^6D':0QD4ZCV"L8/PC>)AT'#
M6S<LV8E52P Q56#N+^Z>0TJM[IM^@F-4Q =O9TZ:#A>U\KBQSN-)Q[A?+< \
M=J+JY\?G7!1=L=!P!5#U05/)13< 8H;[ (= Z:!GTJ5Y0EIM;0:X$8.&7PIB
M9%?^L'+D%9,B8>4?8E6V]X"@(]=AT#AL%RY5]L.Y?<<*VX2:24:DDBKG%^N9
M=R,HS](LN<U7#O,F;VB ] T&K8S_ "K7=6)P;CQ%MU'TZ]=.&Z.?I5F11R1K
M&D[FQ4ZP8!2$I0V'IU = YXJS<L(7U@M^.D(NH\2,DOZKD%).P#O,81%!5:H
MB9(W:;Q .@Z#NI9^5*C%M&CQRAP:LU3.$%"Y_D"NCJJ;]Y%EPJ0'43 3=-]!
M _(&5Y/-L2V51U@EJV9BYK(N54\_2[I<I4[3#':H))#6$R"F)AV-U#8- 0#:
M[<KTUV\JGQQKAGYHMLR.8V=7_I%&P()]H@T^R8D*Y$  14\>[0:8\[RQ,<QB
MX"22*8PB":?)"6*0@"._80I:B!0*7P  Z:#/2LW*M)@[C XZQ!V\B8JKM9;/
M\@J]*JGMV^0Z-4?,3 XAN;;;??0=GUIY5R14 <<<X=/TZ9$B>GS_ ""1C$3*
M4I?,,2I!WF$ ZB(;B.@9K]KRCLM0R$4N'((D@8TC$L(F7S3)R>QU8LS7SE3%
M@$/6)@JX#M*;;W?N:"7N%F&[)BKB[AVA7L\Q'7F#QVPA;7&-Y]VLU9/ROWJJ
MR<:?W2(IIF7$"'(!!$FW3?0/#-G&&"S1CNST.1MU]B33L)*Q3&4872=2-&N'
M[,S=&15;IN"D>K-SB [&Z;!H-+#\.<?QD6>+-:<L*D>GCW$ZK^<ZR)#.R,=&
MIL4Y9X1!5( =*@G[WLVT&]B.*./H,JWPJR978'<=554LH6@Z@?445')@#?ZM
MM!L1XSU#8?\ ?IF3_I:N'_W[H(GDN"U&DGV67Y\@YH2+EJKQM;FF:64[&4B8
M1D-(0S9Z"_F>:=9)!]N7?<-PZ].F@F['F!H7'E)J],;6S($^C6(6/AV\C8KC
M+2+]5./9HLTSJ*=Y ,84T0]@:#?R='K\G'L(>QQSB3:PSM$\:=9VNX64107*
MZ2.X.<0,=7SR  E'?<OMT#LK,0VAVS1C'-Q;1T<P0CVB1C#W B0553F,7K[P
M*'  Z^&@=F@$/GY^I3RA_0M>OXF<:*T[QD251_)FL_P#$?O-'7;-MJ3Y9#)O
MUM$>HA_\.#SJ'B'_ "F,^H?6&N/.B#YC=\R?BCA'R1R-AQR\993JF.G4G1G;
M"%"Q.T)P'K!N9%K" 4XOEEFXF$0[1#0%)C![(RN/L=R<^HHM/2-#ILG,^8B+
M,3S+R!8+OWAFI0 &RZSM=4#)@'N[;: 2OFD;?_@Y^:7=U+^8'(V^P"/3X6YW
MZ% 3#T^@-]!Z\>72@<3J&W!\KVH\5,,*M3M^GDD^Q@;K-S")1]XX[AOMX: [
M&I3;-A ^Q?2E[B" #YAA!$05.;8![]M!GZ#@P[ /L';IO]/L_LZ!C214"WFJ
M"N10S@[.RBR,4 %-(A&D25T"H]P"7OW+V[ (".@?6@6@'+EW*VR%XS9JD:(_
M:Q=O2H<RG7Y%\ZC&;)E(.DRM4W#MS,&+')-TRK")Q5W#M]@CH!%Q,^N*<?PE
M86^6;/+BP@Y>'GGL0,*M%OF4>_&(249.8ML1H5LX8E;]HM3% Y!V,'00T&%&
MY+<8HX3YPO+)J5Z[@++??A$<Y.46CB07O,LV8-7"RIBIM6KAX<I3G,.Q 'VC
MMH#6XR9(E\O8+Q?DJ=C6$).6ZHQ\I-0L:Z,Z8,9,.]HX2:+J$*H=$IFX["!>
MT?8(Z"?-S_W)?^V'_4:#'=F,5JX$2@( BIW !AW$O:/?M[H>]V[[?7H&U1DV
MJ52KA&"*J;(D*Q](#DP@X!)5,#B"Q0[BE.(@ ^(Z!TJ]W88=@W* B&QS?<Z^
MZ&X;#H!Z*F7^MAYH$3 QN/RY1,"8 H/_ "A1X[&4#WA*'T>S02=?CKE:5WR%
M3H'-;H,G<F80[B"9P)R&V#<2F*40T&)77+U9[<3%.HY%M8EFS5,RA"G(D#1N
M!CE,=,X!Y F$Q2[AW> Z #_E2Y=SOFCCQ>K3R$?24A=HSD9G:I1:DI74:PH6
ME5F]R,;4A29(,60.$E8E,AP7$@BKOOW#H+-MS_W)?^V'_4:!;G_N2_\ ;#_J
M- T7@,_MI#&41<#(A"RA6ZA-A:D;BNV\\%3"(&!4QMNT  >F^@=H;[!V@ EV
MZ")A_P!2.@YW/_<E_P"V'_4:!;G_ +DO_;#_ *C0,2_KN6\=$';KG044LU=;
MB0@^XL5:7:=Q%1V 0()2#[!\= J@=89K(93JF5*2W)%2*H8=D2#6H _E$Z#L
M0#&$?NCH/;(";-6ISB<BBJHR,Q!1SZ4V[C9%R@9/RBF$A3"!QW'<0Z:!YD,H
M)0$2E 1WW#N'IU';]K]&@[;G_N2_]L/^HT"W/_<E_P"V'_4:# ?)B9)0Y4RG
M4*D=,Q3*"!?(6$@.>H!OW@B&Y?I-^SH-'1@8EIU:+$IKDC2PS$K$KO8CD&Q4
M2@D"Y2^84%.P WV,/70:S(*ZK>'9J%,8IS6:LI%[##T\V8:%#V!H%47*J[N]
MD6755(WNSY!(3B "V2"'A#E11VW_ !?<81]G4PZ!_>\'0"EV_P!,/^IT&.=T
M5+N\PHE @^^.X#VE$=BGV#J)3#X>WZM /'*&;AVN'+2V>R+)HNLO6# BX>HH
M&  M4()A,)C@4H  ?3H)SAIF-D6+4\8\:R*8-T"B=BX3=%*<$2"!5#(B<$]_
M8(B :#=%,<Q2F$@%$0 1*)]Q+N'@/:42[A]0CH.VY_[DO_;#_J- MS_W)?\
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M79E4X_MMR.68% O3_1:!ZI[ 4"AOL !X_6&^@[Z!:!E7AH#QA%@9P@T3:V.
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MX;@.P% =ON?YN@[Z!:!DWE1HDPC3.VIG95;! MD$O..DF5RK*MA175 H^^5
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M'_&+-UU%A%2BU9Q]/2[..FV#"3BGC]JU,9D@]8RFS!P@HX[0,"@E+MUW#QT
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M >X"<K<6F,4_[4A@%B0 $WW= OZV\P8QR_93#)4R$W,J'*[%XB1;H((J%!@
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M>E$R%=Z_PR<4C'$K=U8*6B'=J48QA7A8^NKG@$G19!<0[08=_OG3)VJB<A3
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MZ!T /=#?;[^@[Z!:#%<@8$7 B("0451V'P 03 "A_P!MUT#-Q?W_ )NZ9Y@
M!_L]&]X &P=WIR]W3V==!FW%=VW8,56:2*ROQZ!2[5O[V":DHU*H80_NRD'<
M!#PT'G7"OP<6TC_RG")K.]-' F8!.# 6,8((*[=04(X\P>O[7;0/$@[E ?N^
MP0\!$ Z#UT';0>1D^\??,/: ^Z ;>T/VP" @(A[-!T\D2]H$$-@Z")NX3#]!
M_8'F?7H/< V  W$=@ -Q\1V#Q'ZQT'.@6@BY8TPNA:RM))#=.T-2HE$2!Y#0
M%68N&QM_%53KM]W02CH%H%H%H%H%H%H%H%H%H!#Y^?J4\H?T+7K^)G&BM.\9
M$C4P U7K91Z ,!$@(_0 LD0UVS;:D^65F<V,CY#Q_ERMSN*EY)M838D9,7BB
M,:#U-O!OLIL8UTZ=+'63;-%"'4W2.H(E[@W$-@'7'G$33Z&PY(<.XS&N?TYB
MX0N7<:RU0R2TL;((.>FF<FXD63MXJWCUG ,I Z)$S(K$5$I.PBH;;AH!!NEM
M^9IQKG(C$G&KB#AS.?'.I,ZU4<=SDOGF5@,B0M6@H-E'HA:"3<>Z0?NO,;;B
MH541[![1 1T#VY7Y*Y^B9MC_ !7P-Q5R'QY<:!'AD4+KFMK4X=M8)! "3M23
MB'<0\4E8YJ!S)BN!RE6 / -] $W)C!^4**HQ)A'Y5/&K)<:_PA4IJ_!*Y#BZ
MNIC.Z+_&V\E5X=N$2H$TWCV92E(X)Y9C 3PT$G9LP?E:J5+$#C"?RF.,F6++
M9J<66RO#6#(<+566/+2BDB1*NQCY:&<C-><F?N%8H$#IU 1ZZ#VS'@[*=<QE
MAJ=Q+\I[C/DS(UH@G;[,=&F<@0]=C\:3R _N*+C)D\0X)9P6#;\80B8%#V>W
M0>.0,*9>AL.X=MM$^4QQGNN9K$G(&S!CJ0R9"0L?CE9MW_"QBYX(91"P?$2[
M=2ID%,-]]]!KK=A3*D3AG$MSK?RF^-4YR'LTU<V=XQ&?(<7'5>CP+0S$S&9;
M6]>)59S:TMW )DBH)]G4 $=!L9G!^4V?':FWF+^4QQFE.1,O;I!I<L+#D2(:
M5VNU1L99)K8F=L5B%&L@N]]W=N5$HE WB.V@RBX)R>/&[[=F^4_QD'D@6Z_!
ME<'_ )PX@D :D#[X69*\DAP:"J!1$H-/(W[@ZCH/.)P=E9SQSM5UF/E0<98_
MD5&VYO%U7"Z&1()S$3=,461*O9%[H6'!!DJT(<W:W,D81,7QT&JC,+Y>1P;;
M<J3?RQ>/V.^2%5OU>:8PQE5LIH WND \?I_$W<G<X=@P;QY2)G$OD'1/YHAL
M(Z!V4"(Y:Y&XC<HL2Y%X-43&$LP,RC\984I6>?*9W(LB5O*2K8;NTC"FKYE'
M8G.8X%-W=PA]>@F/C)=N=U2P%D&#M_"JFXWL>(ZE!Q>!<=,,YEM;;)#Y(Q2N
M&$K9#QB1(,&A5Q$[DQ%/-[1[@Z[@#KPEG?YCESKN6W6;>$^/L6SM:J?Q7%D'
M#9R;61'(%D%14OV>?/48=N6!*<4@$5S]Y??#IH/; F>/F)WAMDXG(#A=0<+I
M5_'LG,X^+!YI;W0UVNA$!&/J+H&\4U^&HN2 <%' ]X%-MTT&FXJ9V^8+<Y*P
M1F;N$E P;2(S&TG-4"5CLS(6M_8[NU,Q/$5618DBFP0\?(-W!^YR/=Y9T? 0
M'0+"'(GYD%HM=G:\CN%..,,8UA*7;YU&[PV;4KJ_<2T*Q=/8:,4A&<6R-Y4N
M#<"G5*;\0)MQ =M!@<9.3'S'LIWFNDS#PHQ[BK"T]6G4ZADB*S<VL\P=!6(]
M=5T/LXE$-G +3"JJ13_C/Q('$1WT&FJV=OF36S,M/JN7^%>/\7824R*FE(92
MALZ-9^<;QS)9Z$(_&JMH9LZ.>9V(54@J[)E-L.^@:U-S)\UJT9;L]21X=8.H
MF*QR>=G-Y L&:'TC,FH!GHM7DG!5^&B$54[%(0A142*LH!&QSE$>[J&@L>XS
M<;L9\4L71^',1QC^+I43+6&>;$DY%65D7TO;YM[9;!)R4@N(*O7[R7D53&4,
M #V=H> : @] M TWBJ);C$)"Q547-#29DY # "+4A5VP&14+MN(K"/0=PVVT
M#I(/<'=L'7;80'<!_L=-!WT"T# R&H9.-AP+T%:U5IN80$0]Q27;&$!V\2B!
M!W#0<4P?\-Y&*!CB!;@EL!C;E+W5BO&$J8?M2]PCT\-]]!L+XHFG4YTRK47B
M96 F.@4X$%4 71]P#"!@ 0'K][0.Q(#@F7O_  NN_P!6XB(!_P!B'30>F@6@
MPGI#*-U@#P H&$-]M^P0.8/^R+TT#?H:A%J9654D!;)J0S(Y&XF XI%,B40(
M)B@4#" >W8-!I\DB8L1&G*HH3:TU4@@F;M[N^;9_A?5MH.U,(<7M_P!S'[#7
MI]N(F,)RA\&@M@2$>A2@;KMX=1T$AA]W?0+0+0+0+0+0+00)*JD30NXAN02W
MJ&*90A# .ZSAB D$0.'=W>(CX==!/>@6@6@6@6@6@6@6@6@6@$3GT43\*^4!
M0\387O(!]WX,XT5IVC(DJJ7:K5T=_P & BOIZ[,41]G7]C5>OAKM/KW"L+G!
M(045F"F2MM9LW54@\=QDC-I6!&5?5<C-;(I6WK9YA!M7DK*L$E%  C<P)%!0
M0,)@VU+ 9W%@47G'K$2K8BS5-Q5_4()K.W#Y1)JL^>*-3>L50:*G2.T.3RTU
M2%'RNT@@/;N($>#4HD[3G.H;IN8P$Z[#X]A2@F41#IT -!U,V$WX8D4W-N('
M+T H=2D3V$.WWMMQ'??00Y;$(U8F3O/=.#%7IT:#T$VAE5D"(*S*2ZC< $OG
M&.7H4@=0V\1WT$L-2 J@U6*<QB+MDCH@L0=S@HBF<5'! [!\WRP -O9H,\Z0
MF* %$NX;=3EW .FPB':)![@+T#KTT'F=LGY0IB &*)!(<3AW'.':)"]Q^@B)
M2F'QT#%ES.$KW2FA5Q].K%VP/3B4/(\QLWB#-U#E#8Q_+!40\0T#\*@(%$IS
M 8#E #% ON ;IW]@"(B"9_:41'0(K?M H#V#V]2E\O8A3!MV=@;B8I2_1N/C
MH.$6I$0$I>I0$_8)@[CE(H83G2[Q][L[AW#Z- U+@UB081/Q-R5BV0L<$9N<
MJ1C=[@CTAFC0P@;<I5G @ F\/JT'C6$&A9>V$2."BXS!%'A/(.F5%06H 'EK
M&$?/%0HAN(;=NVV@>OE"("'>)=PZ]@!MN'[8.[N$!$-M_IVT'06X;  "4H#U
M.(%ZF, @8@@(B/: &#<0]HZ#&=IBFV74[@[B-W(E$H;#WF14.<X[B(;F.4!\
M.F@:>/CN'=,JBZZWG+J5N)5.LL0#G4463$SGO'<-RJ]H= VVVT'MD-(P4*]#
MW 4 IUG(F5,!* )C!/NA@$3 8P&#<!  T#2P W5#".'E%EQ4..*J 5,2E[=D
MS5.&$#* (F*HX[B"(GV#??;;0.NXM6GEP1W*ID"?:>&-YJ*7<LHN!E@*50>H
M=JH[ ([>Z&@XKC1@:1LXLWAU7!IOS)84P50 71FJ90(02*@!RE1 H /AN&@?
M!2=OU[ !0$=Q-VE\ ,81$3#N(Z#OH%H&*_66#(,"@54Y43UV9542 0[%#$<L
MP)W (#^#W:![)[[;"!0#8!*!0$-@,&_7J/70>F@6@9=V(R,PCSOW)6J*4_7U
M4C]@JG4<DEFWD(E3#80!10X )]_= =]AT'2I^F^+WSR%#G5^U*7K""D9,B+G
M[.P7XM)0VWJ""EVF[P  [A$/9H,?)KA1O2;*JF( 9.*.<!$-^OJFY?;T\!T#
M[2,)B!OU$-@$?I'8!W_LZ#TT"T&*[$P-W E';\6IO_V@!T^OKH&EC4YCT"H'
M..YCP$<81^Z@40_8#0>%_(W6BF)7"XMT26:LJ&5*D98052F&ADTA3+L.RH[!
MW;]-!Z5=1HF[NR;=P9RJ6VN5GQ 1,3T:ZT7%=B!1$1]0'EI%-W!MU-MMTT#W
M3_ +X]0WZAL/7KU#V;;Z#OH%H%H%H%H%H(:?!!"C;Q?%D&B1K;&D654 WEK2
M9'#,6IVP 'O-^@ ([[!H)ET"T"T"T"T$7HYDQTXR2XQ$A9XI?(K2)"<>5=!P
M*L@UC#I&52=*E*EVE*H!=MM^[?V:#UB\NX_F[]/8NB[&Q=WVKL6<E/UPGG@[
MCV+X %!<YC( D<1W#<H#N'MVT#,N7(JB5:)LTL@[))I4JSUZM6T3G5CF\(>?
MD&[$C]5XY;F;K-&7G^8L)1]TA1ZZ!VXZS#2,K1II:C2"\HR1>"Q>E=1\C$2#
M!R J=I7L7*-&C]H1=(I54#J$(FX1.!TS& 0W"4= )7//]3'DW^AF\?Q.XT5I
MWC(CJL.U6KP@ F$(&*$"@( )MF*([ (B  (_2(]-79IO656//W'<QE/(<?68
MN8?P<:XP_'KW19C)0\:NO5$<GM55H](\W+0\5*@X="5)=N9R!3IF'<#;[##$
M<W%^'EZU@'#E=F!C#RL-4FC!8T$6*/%'09JN$4$69X=5Q"HI%8^5_L=8Q ,4
M2AX: C]!P/@/W!_M:"(;)/N8M7(KENBW,M#4^&D4153 Q%5%E)I0J:I!Z&(3
MRMA^G?02DUW$$SB/O+HIJJ@&_;W^6F ]A1$>POO>'709N@Z*;@0P@&X@&X!]
M(^P/OCH&=(M6Z]RJKQ1X1)TT960K=B!>XSI-RA%)N5._<!3]*9$/8/=W>S;0
M/30+0+0,ZZO#,X^*,1!LN+BR0+,2NT073(5R^(F94I!$/QJ8=2COT'0=Z_)*
M/Y>TM5$DDRQ,JF@B=(O898J[4J@F7V#WSE\ $= [M M!BO2][98FX%[T5B]P
M_@E[D5 $3#[  .N@;5$:ILZI7FR2Y7*;:%CFJ2Y=@!=-% OXX"@)M@,)]MMQ
MVVT'3(OY 7C_ ('V?^(W^@:^!/YCL-?HIQY_).*T#MMT@M'(P1T2(G,XLL4S
M-YQ.\I4U_4=YB!TV4 "^Z/L'0>55?'>OK44R+=$K*<,Q1\A(J9C)(MTC 98P
M=5%!,<>HZ!Y:!:!:!INV"2EQBI$79"+-X.3;%9B =ZQ%W#4QEBCW .R0D !#
M;VZ!SI=0W#82"4G:/4!'8-AW ?#KH/70+0,N[/!8,8M8B*"RJ]A@F!!7)YA4
M2NY-L514I/:H4I?='IL/70>U;D5GLG<FRB:!$XJQ),6PI)@0YT30,,\$RY@Z
MJJ^:Z,'</[4 #V:#'R"S2?U.=:JN"M4W$>9%1P8 ,5 HK(J%.8HF+OW&)MXA
MXZ!Y)!L40]H#U\=MP  Z"(!N AH/30+083H=TURF$I""D;=0PB  ':)E/9^T
M(7?0:.D-&[&H5MFU= ^;-H=DB@\ GE@Y2(B4I%NSN-V>84-]MQVT&+=I L;'
M,' MR..ZR5QMV''8/W3*M4N_P-[R?=N'W-!XU>14>/+H I((EC;8YCR^2F!%
M'!4XN+7\UPH ^^IW.=@';H!0#0/@I>T #<P[>TP[B/W1]N@YT"T"T"T"T"T$
M/R4^]*WMA54VK@D?;HN/:$60 Y4T';AD"@F+OL=0O?N4P^&@F#0+0+0(= S+
M[<&]%I5LN;QN#AG5*[+3SQ$5R-@4+%LCO#M_/4#RT?-*3;O-L4N^X]-!44S^
M;+AMK2R9CFL03\<29PB_RTX>QDY39YX[K5<DU8MS&Q[Z.DE2KJ-DQ*L&XE Y
M!$1   1T#UR9\T/%6.9V^1[#%C^5ME6QKCG)CI4TY2(MT]KM_8@[C$I9YZY5
MPT61*8I2)GW\TP[$VZ:##R;R1A^0E*S[C:HU=G$36,+9BM!^HUE(658O9"XG
MC': 348U2]8DLU.\ BA52J$'8!W'PT#R^5?$3+#!UO/+SCFU,QRM,EKE@?,!
M:R$E'L6$7$/O7"BS8$?F8S;)R@DJ=,PII$* #MH+3= )///]3#DW^AF\?Q.X
MT5IVC(D*KM]EZ[W;=OP*)[M_#M]"CW;_ %;:NS3>L\JS.9AF:V:*O7Y0D:2*
MM.*XV"63-'1+M=WOE5J^:HQZL\Y:04*F3TH'4<N5$R*![@=1U#$:'&9.IA@[
M&:&/?6#3&L,JE%JR;48Q\H"<B],Y \>0!01$LF9<! H=AB=IDQ$@@.@(G0<&
MW[1V#<=AV#Z>GW]!"MMAY-Z.3B-6IU1EJ5!L8TI1#N771^-@<@AO[@@*H?LZ
M"7FXB ($$!(<J!2]I]@$2D!(IA#81WZATT&;H.#=W:/;MW;#MOX;^S?0,F24
M8)W2HI+-/,D'3*RBT=@<Q?2D;(QQW2?8 "50'7GAXB';V^W0/?0+0+0,R\,G
MKZ/BBLD!<*-K- /5B@(!V-6K]-1PL81$/=23W$=!Q68]XSF+@Y=-SHDD9A%=
MJH.WE+H$:E(51$=^XWT&W -AT#TT"T&(^[?3+%4+WHF17*L7J'<D*"G<'< @
M)=]MM] W*2HS4J5?<,4@09'B&)FJ B)@;MS)$#R04$.Y3M$OB( (Z##R0Z10
MH-Y%THDV1"GV8067712((? WXB(BJ<@$[0]H]- T./K])U@[#AVWE+M@Q;04
MRNT';1RW$4ZI% 'OMU5 ]X?HWT#SN;5T^1@4VB(J*-[3#.3@(]I?(3%P"IRF
M\! A3;Z#TJL>[8/[8+E/L(]GC/6QM^JB"S5$ ,(>S8Q1T#RT"T"T#1?+Q9+A
M#)+(*FECQ$D9DL0P^61L"[8'"9R![HB<PE'<?#;0.X/ - M M RKNR<2#.+1
M:IBJHWL, _,4HAN"364;F5.<!VV3(F(B(AN/3PT'>KL7;25N[AP@=)&2LR3Q
MDH;;M<-BU^$:BLF(".Y/.;'+]THZ#B_&8I5.<6D4?4,BLMW;?N$GJ""JF1,@
MJ@ F3$JA@$! - [D>A.T V(0>Q,.O][*4H%_"$1'[HZ#UT"T&&\(!T5RJ@!D
M104W+UW-[ABJ%$?9WIF$/JT#>H:[-U3:VYCVWHV2\0T5;->\5/3I*)@8J(',
M!3& F^P#L'3085]9JOXN/;(!W*A9:TX /9VMYAHH<!'_ $H:#RJK)RR<WA1T
MB=)*0N3Y\V4Z"51J,5#-RJ!UW]Y9 X?>T#^#PZ[?>ZA]7]C0<Z!:!:!:!:!:
M"')& DE&UN/Y&X/;C%/FP$,!C':M5V0JJ"7<-MNP>F@F/0+0+0(?J\=!!'))
M,Y^/F;2$("AS8TN9_+[/,W5""<B ^7W)^9V]N_;N7N\-P\=!\H&-8A*RX'JA
MK?7E+-C%#A39?6(_'F%(=GF0L#U*47+%3#R7L3"(6CT^PRB:)FQU #L.)MA
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M_:_6],F/JT!'Q2$O3?Z0T#JT"T"T#"D#F_.)7T^X?+^SDTKV;CVB<KIF!3"
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M5FP>,T5DQ51011Z=H"4!#J(>W068Z!:!:!: 1>?*@I<*^3ZA0 QB87O)@ ?
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MY3);+$$QM]P'IH""X*F2/Q%P(= QE$3T)@9)0^W><@N'7O& .@"([Z LM M
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MT5;%314W#RS'[]@'?VZ"B/&N$[SQY1^6+BN[QQXF2A>4^='X1ZRL8X(WB9R
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MZ0:*H->XQV:;MHDFJ3O$=@Z:"R%43%(8Q0 Q@V$ $1#?J'M IAWV\.F@J/\
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M;63RS)#[QO,[0-M[=!JX;"V/7[0Z\CQ>LT.X+'+.@15O$FX.JZ 1VCR@A<1
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M.4 8KK@0@[?MMA^K0/;0+0+08[DAE$3I%[@\TITQ,3;O)W$,'>'=T';_ #=
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CH%H%H%H%H%H%H%H%H%H%H%H%H%H%H%H%H%H%H%H%H%H/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g425213dsp113.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp113.jpg
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M9*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!J'AH%Q0=')##:2IQQ*$CF5$
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MHU^&@Z?_ *'X[R.?*JHS'IGOQWMS\+>_V=56&_X;P5B>UOI&MD_PNX?[7?\
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M,':?Z+8C\$9^+1-:UNXOTTVGV^=.^0JQ-O:3@BX)X7X^Q6:ZY\(]M=Y@SL^
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MRE3*DEOO0JW(@HM:JQBF+Q4S';\;3+R<G)ES&.%"Y6BZ!WR+Z-(3SI6HF1
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MAXKFN^CYG=[?2 Y5U<2@4"@4"@4"@JOUFO[G,U]<Q\JFA4,]7O\ 1C(_A_\
M^ W7F[/;Z7]?^*R,7_-E_=7?CFL/0])T5J7#>BO7#3Z"A92;* /@-$J/JV*3
MW>C<&6;0WQ[L/CB!V<44RC.Q6UHN.R*\AZ7+FRRT6$N2G.\TH40HA/!/:*N5
MPW/9QJ*T;&U6HS:68N1FLL))+;270 FYN0 4GM-7++WC[?::EL2G9DF2N.2I
ME+[@4E*E#238)'93*MIV\.794PK4G;<7OWWF)$J-Z2LNNI9=TI+B@ 5 6/.U
M7+/&L,[+96;/9?)/-DW4RM^Z"+\CYO*IDXU(4   #X(X<>VU&FJR^W&,G-:F
M^F2H<AILL]Y$<[O4@JU:3<'M%&<->-CJ*7$N9_+.)7>Z3(2+!7"P\RKDK>8G
M%Q<5C8V-B!0C1$!IH*.I5AX2>9J-:^(XR.,8G!K6MQIQA14TZTK0I)4+&W/L
MID8OYO\ _P"XSC_EO^;5RSBLO&XYJ PIII:W M:G%..**EJ4KF2:ABN<ECVL
MA#<B.J6A*[$+:5I6E23<$&AQK5M;3[I>KYXR;O"VE;XM?V$U<K(SX&(8AON2
M$NO2'G4I;*WEZ[)2;\. [:F5C/-K'P$$'V:)A&/S';2WW+&9RL=L$E*&Y  3
M<WTI\T\*N2LF%M"-&R,;(.Y"=,>B:BPB2\%H2I:=)58)'93*8;Q0%K]I%K<K
MU%D\*V@2ME/Y%]O*PVDMXUQ;11Z*HJ<>!NMQPA'$"]A5RYW6(ATSV=A\]N7<
MZ)0?CLQ'4^C)84N. EQ:E < +BW&MY<->KRGLCI?@<<A,^(]-$F$XB2VE4E9
M02TH*.H=O &I7HFC<[\G+.Q\K+ANE)<C_:WF^>EP@>:H=ME5@:AOI'M1Z$RA
M]R:ZA32-27)"E@W2">"@:LMB727V]T])]LI2$ID3PE(LD"2L  =@IFK-)'/Z
MJMM_ZQD/Z4NF5XP'2G;8%O29X'X4Y3)Q=5])MKK24KD3U)/ I,E9!%,TXO,]
M'=H$DA<T7Y@2%I' 6Y"U.53A#]3NTOXR=_2G*9IPA^IW:7\9._I3E,U/G'5S
MHSLYUM3;BIBVUBRD*DK((\8-,T^<>C'2+:L=E++#TYIE'P6T25I2/(!3-7YQ
MW/2C;9_TB?\ TIRF:32.4]*-M:A_*,AS%P)2[FF4NKG84EC&[4E"3(6J/ G3
M([*WE:W"VVZ0A(OQ4>P5%F<,7<1FY.%C,+E&Y,961G(4Z6"H?: HK2GO4?!L
M+7HOEDJZ4;:-P7YQ!Y@R5F]7)=<S#%5T4V0X%A291#ERX._58WY\+4Y4FDB;
M0(,>!"8A1P0S&0EML$DG2D6'$^*HW)AC9S"0LWC'<;,[P,/%)465EMP%!U#2
MI/'F*,[3*).=%-E.OM/O*GN26+]R\J8Z5HN+'22;BKECYRI)MO:F,V\T\S!6
M^X'U!3JY+JWE73P%BJ]1U;=UM+C2VU@E"TE*K<[*%C:A8TL+:;$.*U%9R$T,
ML)T-#OKV">R^GLHDCW9V[&;G,37)$B2]&"@R'G-03K%B0+#F*&&U(HK5/;?9
M7*?DMR9,<R%!;J6G-*-0&FX%CV43$='-LQW4A+\V6\T%!1;6[YI*3<7X#MHM
MC;WN3<F_;X*$<T"@4&+-@HF,!E:UM@*"TN-JTJ"AX*##.WP!^,9OW[_FT,,G
M&XIB!WRD+<==D$*>>=5J4K2+#VA19&:>1([.VC-0 *2>LZTA0*C"20 1?^#/
M&M?ARD\IZXTAQM3;@"D*!"AX0:YUTK6-;8P;3G>)C>?K2Y=2E*&M'%)L3V=E
M:7C&U-#"H]C--GUC4K*1J&/D6/LFN^CYG=[?2 Y5U<2@4"@4"@4"@JGUFPY^
MIS-:%:?.8OPO_C4T*AWJ\_HOD?P__P# ;KS=GM]/^O\ Q61B_P";+^ZN_'-8
M=LLNC4*+@HAPH%%P42E$RZ.K0VVIUQ8;:1Q4I1  %%Y,:-E<=(>2RQ(2ZZM!
M<0E-_.;!L2#R-C0Y,RA@H8.'M\Z+AR 3R%[49MCA7FI*E< D$D^  7-$S&B:
MWSM%Y&MG*-.(O:Z0LV/L)HS]'E-ZA[)@-]]-R[+#=_A+UB_9]33!>R/1G?&T
M'FPXSE&G6SQ"D!9'MZ:8/HX7OS9S;S3*\LRAY]24-(5J!4I7!/--%FTJ0%*Q
MS%O<HUEP010S"A+"C6#C[GT*)6BD/MX+(.R7EA.+GKU.J4;!E\#F?"E8%'.B
M=Y;-,@-(RT-,AVQTJ6A"U]@X<":IRD9;FX]OMJTNY".A8^E6M(]L$U";R^&L
MD8'"YO#RX..R"DP92BE\1UI6@*)"BE-[A/*C21M-I;:0VGX*$A*?(D6%Z-2.
MU%P4,%#!0P4,%#!0P4,%#!0P D<N'(W\%J,V-1 VKA8,A3[#)*U.N/@+45(2
MXZK4M00>%R31)&WHN"C6"B4HSF%&H<*+@HR4#2HFP'A(MSH9:+(;XVACIRX$
M_,1HLUNVN.XLA8U"XX4PG*/$]1=BI^%G(W'D=2O>H<HZKZE; :/VS/1$']LL
MIOY+BF$Y1(6G&W4(<;(6VI(4A0-P4JX@BBYCTX47)0**43)0.%%.%%C7YUV.
M,8^P\AQX2$*;]'8_A5ZA8Z.7$>&]&-D?V)L?'8-LS58UN-DUCNP^75O/EOEY
MREE02;<[&M,ZSRF%<ZZV!K3+5S-S[<@R%1YN4C1WT6ULN.I2H7XBX/*KA,Q6
M^P'6G?6&;=:4%MN8^0I"AQ!!/,5VT?,[O;Z03RKJXE H% H% H%!5?K-?W.9
MKRL?*IJ4B!] <C C;:R*)+Z&G#.N$J-C;N&Z\^SZ'5M,>5A8[.X9N,KO)K*+
MNN6U+"?IB>VLX=YOI&6G/850)3.86 ;$I6"+^Q3"_2?AR,YASRF->+SA3!]
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M$[<D/<-#:@#Y#%;->??V^AU>DOV$8YVAC#'L6>Z\Q2> /G*O6*[1OZS&RJ%
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MTZ'_ (#P''_0FO<J5TZOXI'46%%*!0*#JI6E*E=H!MPOV7H5 &]]Y9,I3#Z
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MK0/]UT;S%T*7K<81=(Y7='G'Q4&#ZKF4BY+9,]^-?NTS0@ZN!NEAL'Z-!<U
MH% H% H% H% H%!7'K#W'2/.V^H;^431=?;B'$1+P$%I2EM*$=E33K9TJ2L(
M%E ^*]>7;V^OUZ^$9E=,V\OGUY/<$TRU(C)C1EQM49T><2HKT\""#Q JS?#G
MMIFY<_J9V.?\5)OV_P H5[U/HU.H'1C8P_Q4G^D*K/T/D]!T@V>  DS0!R E
M. "K.Q?GAS^J/:7U4[^ENU>9P<?JBVC]5._I;M.9P<_JCVE]5._I;M.9P/U0
M[1'-<[^EN4YM?-Q^J+:'"YFV'+^5.&W9PIR.#HKH_M%3C:BN>I*!YS2I3A2O
MP:KTRET2F/A,1&E.2FHR/27-)<<(-U%*0BYO^U%JF5FF&HS.V,E*A.P8<U*(
M+KC2TL/H*NZ#;J7#H4DA1"M/(T8L8^2VQM1[.2',WBF7%S"E;4YU(L3R[I:N
MQ5^53+$TU;;&;/VIC6"S Q,5IE2BI0#2%74>VY!IEUFFK+^9<(>6/C?>6_>I
MDX:L7*;2VYDX#D&5 92P[;4II"6W 4FX*5)'"I],)>N7TT*>D&ST@)3Z:D)X
M!(E. #Q"M3?)P9^UL1C-O.9>)&6X(33C;RE/N*<*2MKSSJ5V<*E,LO;4[(.R
M9B,@2!(>,C&I78*]%-@!;Q$?1J1FWP@6QNG^&W!C9.;RDB:Y,DS):70B2MMN
M[;ZDI(0.7FBU;YIKJD?ZHMH_53OZ6[3FZ70_5%M'ZJ=_2W??IS3@UV6Z,8I]
M;*L=/F1$-A7?)5(=7KO\&W'LIS9O56%^I #_ +XD7^[O>_3FGRKG]2(_+$G[
M^][].9\JX/0]!M?+R#;E=YT^Z:<DO1:]8'36)MO,P,W)RK[C<)Q3RD+4ZZ%6
M018@ZOJN%,I\L,W'NP\8P]#GY C'RY;\[3':=#CB)"N\2VXHC@+'C;C5PU*D
M6/\ S4S$@/0XX4]CRA;2BVIO0H#2D@^;JL*Q:W(UV<Z5[2SN37D)R9)=62IQ
M+;Q0@D@"^GLXBGT2Z9:]GH9L%MO26I3AO<J6^J_'V*L[&)TW+O\ J1Z?]L>1
M]_75YM_ _4?T_O<,2?)WZO>IS3XT/0[I^3_-Y _RZJ<SXT_4AT^_U>1]_53F
MOP/U(]/O]7D_?U^]3F? 1T0Z>H4%)C2 H<CWQ]ZGT3XLR)TIVG$<96V)1#"T
MNMM+DN*1J2K4+I)MSK-VRWKIA+GF67D:'6TJ1<*T$7 (Y>U47#!S^!QN=QJ\
M=DD+7'4M*P6U%M86@ZDE*D^"AO,H_P#JJVGRUSOZ6[[]$G5XR?JIVH>2YW]+
M=]^KS3@Y'2C:H(\^<1V@RW??IR2Z.AZ2;*,=J.['=>98<[Y"'7EJ <O?4+TR
MLZ<I=&C1XS0;CMI;0.-DBW&UKGQUG+7'#5;AVC@=PQO1LG'*DE27-3:BVO4G
MC?4GG24NN6H_51M+OS(O-[\H#9<$IT*T)XA/D%=.;/SP[_JNVQ_&SOZ6[[]2
M[G$_5?MC^-G?TMWWZG,X-1NGIKCV,,\]B9,IF6DI =>D/.H0DGBLI!%P.VK-
MV+JT2>B^[I!0'=S(;CE22XY&[_O%('$Z2I6D:A5YF$J'2/;@ !GY0]FHS%@D
MCML*SS;X.?U2;;!'\ORG],6:LVREZ\H7TKP<7$>L"F/'<=<0F!( +ZRXKGX3
M7?1\_MUQ7T\GE6W%S0*!0*!0*!05]UWVGFMU]-<E@\*R)&1DJ:+3:EAL>:X"
M;J/#E0?+\'U>O6"QS19@1O1FCYQ0S-" 5>&R5#C0;SHWC.HVW.NV+V_NB7(#
MP8<>>CF2MY!0MM123YRAS%!]AH-[T':@4"@4"@4"@4"@UFYL5C<KA)4#),-R
M83R+.LNVT&W$7OXZFS6GM7BTXW!LMNP9-X;;B$.Q2^'$A"SHND$D^;PL*\V^
MKZNF\PD>DV'#R5B3#6N,.NA5^1JM>'.DD<J'AQH5X#1+9#2KP4RG.&A7@-,G
M.&A7U)IDYPT*^I-,G.&A7@-,DVE<A)[13+7@J6GAS:IDQ'FY':?2IMUM+B%6
M^UJ2"GVJLK-D:&7"VY&DK7&FM8_(H!2&Q("$ZCR"V]6FWEK;G<1LL+DDY/&M
M2DJ2I9)2[W9U)[Q!LK2H<Q6<MS:,[0H]AHMLK6;A<E-L0PRZM@NRVFEN(^%H
M-[BF6<1KTX>"C<-IY<DNR %0UK4="RV+*0M .E12.5Z&(W4_$Q9[01):)"3Y
MCB2I*TV[$J3Q3?P"F5Q'E@\% PF/3CX#2FXR5+< 62HZG%%2KDW/,T7$;"Q/
M94M7$-)\%3*8AH5X#3*XCKI5?X)X<Z&([6/@HO@TGP58EP6M:XX'AR\-7*8B
M)O;!9=G.R_3E N+=7W2F6U =Y?M)XZ=7"M9<[IY22'$3$BLQPK6&TA&LBQ5I
M%KFF7;61D:%> VK)X-*O :'@TJ\!ID\&E7@-,G@*5> T/ 4JM>U#PZ@&X\=#
MPY*5<.!H>'6Q\%2TQ'8<O)SJ9,0]RF4Q"U,DD+47$<VIDQ'%J9,1S3)B.#X.
MWP53$< &_*JSB!J4Q #AQJ97$%H0M"DJ&I"A922+@@_"!!K4J61#=[RY^U-L
MKR.(D*3W3[+:(SWVUH(>="5  \1:_#C1C$3(&X!-@2 >'+E66\1R 21IYWK4
MF5\/F3I1N'"X'K_D,CG9Z8D4":A+SZB4ZE.&R17HT?)[IY?3'ZZ.EPX?G)#_
M 'RO>KHYN&^MG2IS4$;EADI-E64>?M4'*NM72Q().Y(8 Y^<?>H">M72U2$K
M3N2'I4+@ZE>]02K#9G&9G&LY+%R42X$E.IB0T;H4.5P:#-H% H% H/DWK'E\
MYB?6*,O"241,BG',AJ0Z@.)2.[<4;I/ W H+PZ+;BW-G-NR)&XIC4Z:AU&EY
MEM+2=+C27--DW' JH+"H% H% H% H% H()UPC"3TQS3)<6UK0V"MLE*@"ZD&
MQ'EI3*'Q_5?V$&V7DRIR'+(6%![DJP-QP\-3#4[-FS/1_;PO?=N5&G@K^6\C
MRXU.$:^VS*3T.QRDA2=R9E0/$$2SQIPA]ME+=0]GY>-UFP6Q<;N?*1XF692M
M<EQ];BD*.L\!<?4TX0^VR:?\,&Z/_4/)_P#*^SIQB?78_P"&#<__ *AY/_E?
M9TXP^E1GJ%T2WAM';SF7C[TR&2+:TI7&7(,?S5&UTJ)5J/BIPA]-E3[3SJ)T
MN?&W1OK)801"$QEM+<DAU6I05<I4+6 %.$/ILDO>; _]7,M]Y>^RIPA]-CO.
MGY__ .N9;[R]]E3A#Z[-#NW,X[&,17=L]0LGFY2WTH>CN!UD);/TVHJX\>RG
M"+]MGV_B<3#=QD-Q:"5K8:4HW/$E )J<(L[]F7\R0?XOZ)I\XOWV4QZU"Y.'
MV'CW<5*=@/O9)IE3S"U)5I4E1L;$>"DTB7NV1MKU/US4)FN[NDK=E(0XXM35
MU$J 5\(J)[:UQC%[-FRA^JGG(; 8B[]R##"22EIL%*03SX!=3C%G9L\LOZMV
MZX&-DRV=_9%YUAM3B6EN%I*BD7L5E1"?+3A%^NRNNBCV:F]:<?@\SE)DEI@O
MK7$=?+S=VF2I)U7L>/BIPA]MGTSU Z?X_-XUJ0)4B [BB[,:<C+TJ40T4Z%>
M*G"'VV?-VU<[O"8U+_JK/9_NG0E$S'O:&P%(2K000>(O3A#[;-Z9>\CRV;NS
M^E#WJ<(U]]G!E;SMQV9NP7_[2GWJETA]]CTK>=OT,W9;M_E*?>I\X??9SZ9O
M!*?T,W98\OY2GWJ?.'WV9O33'YO=N_,OALHYE\!%@0VGVX4EX^D:UG3K418:
M3Y*?.)]MEGS>D.(@QERINZ,A&C-"[CSKX0A(\:E$"GSB?;9JOS-V$$W&_G./
M$?RYJW#]U3A%^VRJ-Q[IQBL;D'-JYK(NRH#B$.N/O$@+[];5TZ3I6E:4W\57
MA%^^R_L(EZ'M_$9&>HS84J.SZ4X$_;&E.)!UJ(/% ^FJ<(?>L'?WIBMEYG+8
MV0(D5IDB&ZUQ=6=025ZSR![+4X1?OLHWI1MG<'4/<66BS-SY.$F$@N!;3ZSJ
M\_1:UP!5X1C[;+3_ .&Z5_OOF?OROLJ<(?;8_P"&Z5_OOF?OROLJ<(?;9!MR
M],<MA^I.V]IHW=EW8^;0XMR1WZPMLMA1\T7MQM3A#[;/#=_3C+X#J'MO:K6[
MLJ]'SJ5J<D*?6%ME*@/- 5;PTX0^VRPHO1&5MK)0,TK=F4GQX<EM<F*^XHM*
M:4=*M0OR%[TX0^VR0=;4?-W3',R\:XJ++*&VVI*%$*1WCB4ZDD>(TX0^VSYS
MVQGLS(V0^MZ3+<R!9FNLY)65""CT?L,=0*N?+CQIPA]ME]N2P]T2A9)<DC*.
MP(JUOH<TNZU%(6;WO?C4ND6=^R13VF-MQ8TM];LO%.)2VX75%QUMU8\PZCS0
MH\+4^<7[[--O;&R,:]M22[-=2]*S,9B4A*^[9[I:5E22GE[=/G#[[)\86#^K
M;\7VP>_3YQ/OLX]"PGU;?WP>_3YQ?OLX]#P@X]XW;P]X/?I\X??9ZMXC&N)"
MVTA:#R4E5Q[8I\X??9V^98/\7]$T^</OLTDZ(S)RR<1"/<Z&^^G/H/GH2H^8
ME!XV4L\?)3A#[[*3ZI9Z5M;J(YB&,GE6\<YBER4-1%=ZYZ4E*BE:M059!(XU
M>$3[[+ Z(Y&1F.F\?+9Y\S):7GPN2[8%2$&Z=1'#A>U2Z0^^S9Q>FDN2T)#V
MY\HVN0I3O=MN)"$A9*DI2"GD :?.+]]GL.EKO^].7^^H^QJ\(??9#>K&P7,7
ML]<MS.Y&<VW+B:HLAQ);5JD)'G!*1RIPC'UV6^C$0"E!+7-([3X!4^<:^VRF
M.M_SS#S,=.&R*L>VS$0I;?>*0A9=D):N+$<1JJS21-N[9Y[$Z(]-)6,8S&66
MXYGR\_Z5-;DK2%N!U0*DI-Q8U<,9M]IA^J3IN>)F2;_A9]ZK$5ING =-]F;G
MRD./ R,N/*Q2\@E<1;CP]+"RBZR+Z=0MQY4$OV=TSZ?9?9>,>R;CKKLR*DRT
MJD%-]0X@@4&'U!Z8[ Q&S%)PY=26W(["&4/J59I3R4E-NT6-!.>A\1B)TQPT
M=A)2TVEU*4GF+/+%!.Z!0>,J4W&CNR'+]VRA3B[<[(&HV]B@B>#ZGXK-P!/Q
M^/FKC*4I*5J2RBY2;'@IT&@]L?U%QV0C&1&Q\Q306MLDAD><V=*N!=\-!174
M3;&-W!UPB9;=3*\=M')141?2GI#3"N^8:4HBZ%K(^%06UL:9T@V3BEXO!YZ(
MB&IPN6>EI=.KE;4302=CJ%L:0\AEC.P77G5!#;:'T%2E$V  !H) .5 H% H%
M H% H('UNDML=.,EWA(#JX[22!?SE/HM036*/Y*S?^+2#^]%!7>7Z:Y%_(S%
M0D,-09*RYH*E7N>VWUW&@L/',.1X$=ARW>--(0O3RNE(!M0?.G5R*XWZQVT\
M@75(90RVE?=*TK2D:]2DGQ7H+X1MM"N(R>0(/&_?\/8\V@Y.VA^4Y_W_ /YM
M!7N^X6;3GVL7"EJF1'V$I5%GJ#B ZM5@X%%/FD"@J7U8]G87+[PWBUN''1,B
M8Q0$I?;2XE"N^<2K2%#]K07:]M_HPS)?CJVS$4Y'66W2C'%:0H<P%)010=4X
M+HNIQ"/S9BI+BDH258U0%U&PN2B@JGUJ-B;:Q>)VT[@\9$Q;SD]2'E1VDME0
M" 0#I O:@^E<,",1!![([0_Y H,R@I+ULX)E=.8JDJ*51LBRZD#F2$J%A[=!
M8.W<2WD,' EIR,]'>L-E2 _\%02 I/P>PT&S_-H?E.?]_P#^;01/J'"RF-QK
M"\;E)1<+A+Z)#@<0MI()4G24VXT'SMBYZ-A=34[[S"'IB_2'8KD%BSCFE^&E
MQ*]=D@V[SP4%D9/UN=H.P),4X:<VX\RMM&M32>*TD \3XZ#+]609:9M'(R84
MKT:,].);"V@L*(:2E5C?PB@N3T'<GY3:_HX^RH.?0=Q_E-K[P/LJ#CT'<E_Q
MFU;\''V5!SZ#N/\ *;?]''V5! <UT<W'/WG)W5$WC)Q<R7';BOMQ6$!*D-#S
M?A$]O&@U6:Z#;VS>-=QF7ZC9";CG[=_$=CM%"PE04$JL0;<*#7S>AFR8.4QV
M)D1,>N7D-0C.)QKA;^U"ZN\6'K)) [:"';^Z0HQV\L!MK&2V,=%S82F4(D8-
MI44N'0I:5*7?0>(H/I:#@6H^W&<(XLN--Q1#6Y:Q4G1H)MV7H,7<&TV,KM"3
MMMMTQF'HXCM/) )0$@!)MXK4% ='-LN;>ZO[BVX_DGE-M([HS63W*G'20X 0
M+CE>@^@QMH?E.?\ ?_\ FT'"MM ?]YS_ +__ ,V@^?\ =CF7?ZV[?;;D2'NX
M=?,$K<^V]RALE24+MPUV-!D[FD)E];]AS(\AZ3#>2X&3(5K6%(<LX.0M95T^
MQ0?1SS#;S2V7 %-N I6D]H/.@@>_]CY+*;*R>%9R&J&M <;[]-UMI9/>:-8^
M$/-MQH*-Z,= MN;YV0C/3YKT>0Y(D,*;:0@ILA=N9X\>V@L:'ZKFW8TJ(Y\]
M3'(\5U#ABJ #:PV;A!&KE07!.Q,&=%$66TEV."E0;5>P+9"D<O 10:#J1T]Q
MV^MN?,L^2[$;2\W(;D,6UI6V>%KT'R?OS;&3AYIU.(<2QCL?C(+L]R0^M-W7
MBI&L J4=2U)[*#1(V[NY<J#'1*BJ.0;4ZP[Z79I*4<PXHJ&@^(B@P]PX[<>&
M"V9F0A=\IKO$MM2RZ5)OQ"=)MJ\5!?OJ^;#Q&Y.F./R.0R>4$Q2WDN(9GOM)
M"4K(3YB5<.%!97ZFMM?E',__ ,E)^RH-YM?8^'VRJ6Y <DO.S2@R'9;ZY"SW
M8(2 IPFP%Z"N=W;9Q><Z[P8$IQYI$C!OF1Z.LMK4 O38K'997*@FVVNF&W]O
M8\8Z*Y(>QS;JGH\-YS4VA:C>]A:_'PT&#G(1V]#=,?,R9.0D IC09,A [S6N
MY#:3I42D7TVH-7A,?N;(3TQYJLC#:"]1>#JD"PXCM(M0<]6\0K%],Y+)EO3-
M4V&>\D*UKMZ0CA>@LYH>:CZT>X*"$]0>C^UM]2HTG-*D!45!;0AEPH21JU<;
M>.@W^U=K8W;6"BX6$%.18B2EI;Q"UD$D^<HCCSH-L6F1_BD_O101/<W3?&9[
M)'(+FSH+RX_HKJ83O<I6U<G2L <;ZJ#>8+ 8_#8F'BXJ+QX;:6FBY92[)':;
M<Z"-]8\A&Q6PY<DL=ZM3T=III 2%*<<>2E !/ 7/;0:?8VY7MI=.XS&:Q,IA
M[&M/.2D(5'<"4A:G+A27>/ T$JZ>=0<-OS;PSN'0ZW$+SC&E](2O4WSX GAQ
MH)/>@U.ZFUN;;RR$)*UJAOI0@?3$MFPH/F/H,E68R>ZI"<2E[0$A$:0VEQ+*
MD#0>[\I!O071TYVW@W8,II[%Q0RTX.[1W:7$A2@2O2Z1YPOV?2T$N5LS:"R-
M>%A+T\4E3#:@+^(B@@.:5"QV7?A*VSA;!1]%'=-E3B>S5P&D^&@\MU;&5F\7
MM3)8?!PXLQO(,29QB(;0$LCB3J %P*"WQRH% H% H% H%!".L&(=S.S_ )L;
M*DF5-AH4M"2HH2'TDJL/!:@F;+>AM"+W*$A)/AL+7H/2U [*"ANHL9N5ZPFU
M(SGP'V%(5Y%-N"@N?;XTXQAK67"PGN"M7%1+1*>/CX4&>\ZEIM3BB E *E$\
M+ <304?U*S.Y($%G<6W82LIE)!7*C1"A3GVGO4H3YJ>-@GC05_ZL.X'8&[=U
MO364MR9*$+D,J46]#G>K*D^<#VF@NU74B%B,'E<FXP'4Q')#Y:2Z-2@GB4BX
MYT&+A^K\#=6SFLS&AF,U*(TLNNI#@TK -]((H*V]9W<2,C$VLRVE"=,YQ2M*
M]9L$ #L%!]'8C\50ON#7Q!09=!3_ *T']W;9Y6G,&_LT%A;7T,)>@I5P;#;R
M$<+A+R H\/!JO0;X\J"N][/3<A$S+D=LNMPPB)"2 3K>4-2R!Y;)H*@Z*.[A
MG;Y@+W3$]'ROILI#T9QL(LEJ A+=T']J*"^<MM_&C*JE2,'%R,=YM*"LL-..
MMJ2?VP^#IH-MMV3A)&/0O#H;;A)4MH-M(#:4K;.E:=  M8B@VE H% H.I5;W
M!0<D\+&@TV2R<HS?FW'(2N=H#CCK@/=LH5P"C]43;@!041E,[F<AU\QV/R3Z
M9"<1/9CQEI;#9T.)+BK@?MCPH/I&@4% [690YUJZAN*%S%+,E)[4EM23<>Q>
M@OMEQ+B$.(-T+2%)/A!XT&#G\DC'8MZ2H@*"=#(/:ZOS6T^RHB@^>=^J?QO6
MG;2&W R\VV4.2"0D-E;)"W!J(3<!1[>=!TW/,Q,7K7L9J(ZTWBHR%E+RGFE)
M"EJ!7J4E1 N?.-^=Z#Z(9W)M]]]##&4B.ON'2AI#[:E*/@"0HF@[Y]YEC!Y!
MUY:6FD1W2I:R$I'F'F305;ZJA!Z3,D<09TO21X.\H+AH% /(T'R5EGY*>MF
MBWO$DC$)D-VOJ(<<*=8[10?59QV/)/\ )FN//S$^]0?.?K:XB,[*V>W&4TP]
M*DKB *;&A(=*0'%$6^#06MTSP4+;^%P^$AS&)[F+B%F?,CCS5F_F<K\>-!8
MY4"@K+(!/_$%B+?"^8I)/WY(H-_NW=N8Q^7@X;"8]F=D933DE7I+_H[:&62
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MLU0;?=!O#B_AD?Y04%);DVCAMV=8G\+EPZ83L]QQ89<+2[MXY!%EIXB@EO\
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M")=(]][>W!FMQ8K&XYV-,Q+Q3.F/!L%]16M(*>['*Z>V@M+LH-1E,N\ET8^
MA+V2< .DWTMH5>SJ_%PY=M!0'K!S,^(*\;E)J);<:9CWF AH-!*G4NA8',D'
M3VT'T7B?Q5#^X-_$%!ET%/\ K0?W=M_AK/NT%B9"6VSMYEL_#DMLQVD=JE.@
M)L/':YH//<L-Y.%2Y"\V3CBV^R4CZ5K@M/[I%Q0=L^^A_&0GD? =E15I/A"E
M@T%8Q/[_ )7X8_\ _P!<B@NR@I[<!_\ N8VO_9$SW*"X%<O'V4%<87%R9V^L
MH_I>;C1V%M,RAJ2@2"^I5AQLHZ;7X4&GV#M_<<O=VY\AF(K\&0KNDP9JKI07
M$:@5H2#8W%B;B@E72J+F8^ F*RT542:_D9;RFUBUPITV4/$H<:"83;>AOWY=
MVOXIH/EOIEJ^8MB'3SW=)N?(TJ@^J >)!\M *N/*_CH.P-Q0*"E.FW]_G4'L
M\UOW4T%K1U,2,Y*6D!3D1M#.OZDK\]21]"@\X,9$+-S6VQI:FH3)T#D'$G0X
M?9\V@H#K U(>Z[[91&0E;OI3*DI7<).FQ() 4?H4$WG;<SKV[H)R#R'6GVWE
M/8]!>3&6E%M"2CN[FQX^.@C&R8TL=>M]M-QV=:(D(%K[:$@:4VM9%_;%!*Y$
M;(?F;GSZ.Q;1-XW>X>8K_HZ"J?5<W1F&<]B\ G'DXJ2Q(<5D%)5P6A1.D*^#
MS-!'\4X[&RN^GX\-V4N7D)T.0A"[)2R5 E;@)TE*:#ZA;S#6V8L:(^5>A2&&
M_FR]U6<TI3W![0+FX-!J^HT&5 Z9YN4\53LHMIMQXC@5$.I*6D#D/ *"E,Y'
M>G9:24.O1I\S'X2*QB^^2VAQR3KOWUPJ_=\>(H,V%TCZ@9=6.RJ673$:9?9[
MOT](*D.>9]J/=^:@Z?!00[J-&SV(B,,Y>/(4X\R_$"US$.+:5'/G V;3YMB+
M)H+U]61,F'TMP\"2R4!U"Y<:2""AQ#KA/#M!3VWH+@'*@4%.;^)_6PX+</S3
MR7'V:";=)?[M]O?@;?N4$MH% H.%*TI)H/'TV,"07$7'$C4.'T:#CYPA V+[
M8/@UI]^@]4/-N)NVM*QX4D'W*#O0*!01OJ0"=@[A -C\WR;'_)F@KSU3DN)Z
M56<4%J]/DW4.'U-!<WO4&OW"I*<'D5*-DB,Z3V< @WYT'S/ZL&1S49C<Z<6F
M)=<@NK5,=4A%DE7!(0.=!]%[>SC&>QJ^\;T2&QW4^*>*0M2>(!^F01R-!%YG
M2KO)DP,9(LXV=)1)6UI67VRC3YC3VL</-[1P[*# SF,R^,RSL7'+R1@+\YON
M3J;8"K>:UY".1H).]ME69V=!QL]YP2$EA\O2 %NA;2PNQ_;&U!+4\A0<T"@4
M"@4"@4%?==Y2X_3>?I />O1FC?CP6^@<*"=14_R9H=FA-O)I%!&\OL6+DLD9
MRY[S2M14&4);*/.%C?4DD^W02/'PVX4%B(VHK0PVEM*E?"(2+7-J"E-]?^X_
M9_B;-O90X*"U\*@RLKDLBX@#[9Z)&7V]TS\*WB+EZ#)W"E:<2^\TG4[' ?0G
MG<M>=:WCM0:163B/;HP^04XAJ._CGG-2R$@:U(-B21VT'R_L'>^[-K[VW@YM
MG'HR2IDQ8D(4VXL(0A]S0H%LVXWH)UA.OO6'-S)</%[=CRI,'^=-(:>NBYL
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M,4$6A8F-AYD?*.XN<A$-Q;B%$,A*"\.[42$<2+&@L=M04 1PN+^W05;U+/\
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MU#D(?4W(DJ7HN>!:(H+B'M4"@K79&6QD7J'OJ))E--27)L=QMI:@%%'<)3<
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MCN74N*+*70I03]+<KY&@GL:.S&CML,H#;+0"6T)Y!(Y 4'I08F54GYLE\?\
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M]83I:VM2%Y)T*02E0]&?X$<#])0<?\1'2K\IN_T9_P"PH'_$1TJ_*;O]&?\
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MEA:4K;#<EQ!"C=(*N"4%(''PT$UV\UDA$2].E^DK>2E03I"0CAQ (YT&UH%
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MQVU]N8T$8_&18@4;J[EEM%SX["@SPPR!P0D>0 4'?3X^5!S:@XM0<VH% H%
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>@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g425213dsp114.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp114.jpg
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M:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E
M   0_.$?B<BWR7@O-&(T!UAWZ__N  Y!9&]B90!DP     '_VP"$  8$! 0%
M! 8%!08)!@4&"0L(!@8("PP*"@L*"@P0# P,# P,$ P.#Q /#@P3$Q04$Q,<
M&QL;'!\?'Q\?'Q\?'Q\!!P<'#0P-&! 0&!H5$14:'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'__  !$( =0"7P,!
M$0 "$0$#$0'_Q "C   " P$! 0$             !@0%!P," 0@! 0
M               0  $# P($ @0"$PP$"P<#!0(! P0 $042!B$Q$P=!(E$R
M% AA%7&!D;'10E*RTB-SLW24518V%S>A8G*2,U.3)#0U=5;35+0EP8*BPD-C
M@Z-D)ACQ1)5V)U<XX82D1</CU$81 0                    #_V@ , P$
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MJ_N4'N@YK*C(JHKH(J<T4DH/GM<7^>;_ (R?1H#VN+_/!_&3Z- >UQ?YYO\
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MND>C4O%$0[:5H"!N[#3Y#;$8G2-U; JM&@\K\55+)07- 4!0% 4$6/E($I9
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M.'A0-6U"SC*2<;F)H9&3"5M!FBVC1&)C?S@BJ-T^"@OZ H"@* H"@* H"@*
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M=3@!Y;DJ"MQ4?3X4%/O+O%V[GY#9SD*:01\?F!-Q%8=%$9!AP$,;#Q'S):U
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M;M[(AD<5#-F4T!-MD3[S@B))9403,AY?!0-5 CR^R_;R7(=??Q[A..N*\?\
M69"#K)=2J@HY9./HH%#,;0[/8O('C0QLI455;DSV'Y)1H\ES@V#YBYY3-?\
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M!^IGMEQ_W"QQY\7/LJ#[^IKMG^06/FN?94'Q.S7;-.6!8^:Y]E0'ZFNV:_\
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MGV]R<&..3E2([D0Q<=6-&*4T)/(3("IJ"AYK^7X:"3L?>&U6IDJ)A7)$V1'
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MDU;9*8IHR-@(U(NFBDOJ\J!1R$7=^Y\)D]N9MN$Q+CN,B4V&\X :U07FB$'
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MTIQ"D-O,D#2N(0JJISM9>-!=[A@Y0,G@HV"?8@FT,D45]HG@Z: 'E04,%O\
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M;LX/F5>5N/&@M5Y+08WVRV!M?<VP)#.8BD^V_DIBN"+K@75N22BJ:22UK>%
MR_J,[>)%2*,1\64E%.0?:7EM((="G<B7Z7A;E0)F?WP[VIS$7:6#QZ/X-B,T
M\V,AP55$<>7J(WTQZFJUUN?"@;,5W4R&1BL2FL6@A*;ZT<55RY-^*WT?2^-
M;8=5[O'N)Y405<Q&/-11;HFJZ\Z#1J!=R>=S^/%U^1 9"&!:1?1U25=2H(>1
M!O<B5$H*Z)O?*SIGL\#'MNHIJV)F9MIJ$=1"JD/!>"T#1BW\@]%USXXQ9&HD
MZ0'U$THOE75PYT$N@S+O[*8B;;PLI]5%EC.XYQPD15L(O75;)0.>W-X[>W&+
MQ8B3U^@2"Z) ;9(JHB\C05M9:"ZH"@S'9G[1-TKX^W/)_P#QV:![VS_<4/\
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MJ:]IE@KL5G6.MP!2ZD WN2)?PH(.ZLK/Q6*.=$1I>DJ(XCNKCJ5!%!T^*DM
MM[9WSF<ME683C<8$)5ZBIKNJ"ER0>*^;Y- ^4!09P6S-W8C=&:W#!G-/0\@Z
MKP00:0G@U-@!6U60E\G*] [;<%L,)$!M[VA!"RNJ.A5*ZZKA]*J+X4$V3&CR
M6#CR&Q=8<32XV:(0DB^"HM!EDK:O_G9(K6R]3*RP<3<'4:2,,32BDWTKZM7T
MNG3\N@U*+%C16 CQFA98;2P- B"*)SX(E!UH,N[C;<SF-V'DI+&6!8^(:D36
MV"CBJF/F-6B+5POJMJH%;W5=R3=QAO'+RFFV5DSF#%ENZH.ILB5+KSYT&]4!
M0% 4!0%!PFP(,YA8\V.W*85456G@%P+IR722*E! _-+:J?\ ]&@_BS7V-!C.
MYMP;.[?=Y).<FPQBQ @-,J41@=2:P)?5"W!;<:#6]C;YPF]<&F:PRN+"5TF4
M5X% M0(BKP7P\U PT%?*W%@HD@X\F>PR^W97&C<%"&Z72Z*O"Z4$\#!P!,"0
M@)$(23BBHO%%2@\@\R9F &)&VJ(X**BJ*JET1?1PH.<W(08+2/3'PCM*NE#<
M)!157PXT'.!E\7D>I[#*:E=%4%WI&AZ55+HA6Y<*#I-R$&"TCLQ]N.TJH*&X
M2"BJOAQH(\7<&#E*0QI\=TA5!(1<%515Y(J7\:"?01LG)E1L=)D1(RS)+39&
MS%%4%7#%+H"*O!+T"&&^.ZI )+L(A541=*SF+I?TT'MO>O=%7!1S8A"VM]1)
M.8)4^50>$WOW5MQV$J?_ +]B@7MW]Z=_;:]C3(;/:A^VDH,F_,0T(D41011D
M3+4JFGA01/UW=S/\EI\V7_H* _7?W,_R6GS9?^@H/+G?/N0V!&YLT0 4N1DL
MM!1$\556:"NC>\INN5DOBV+MZ(_.TZO96WI)NZ;7OI1GE06GZ[>YO^2D^;+_
M -!0'Z[>YO\ DI/FR_\ 04'*3WV[BQ8[LF3L\&8[(J;SIE+01%.*DJJSR2@[
M[4[^[MW'BUR./V<LF.#CS1OMRP%M2CHA'IUH)>JJ+RH-JBND]&9>(.F3@"9!
M>^E22]K_  4%?NC-+@]N9+,(UUU@1W)",WTZE;%5TW\+T&+8GWA=^9:"$W'[
M39DQSNB.LG*,;IS'4+-KIXT$S]=_<S_):?-E_P"@H#]=_<S_ "6GS9?^@H*K
M)^\IN_'H:2-N0V70545IU^0!*J)?3Q:]:@TGMAFMR[B<R69W)@RPDT";C0V2
M)3$F-".*0:D'F1<:#+9O<O=6Q.Z>[L'"P#>1/,S0R,5QUXFM0+' 50?*J+;1
MZ:"W_7QW+_R6Q^-K]C0'Z^.Y?^2V/QM?L: _7QW+_P EL?C:_8T!^OCN7_DM
MC\;7[&@B93WCM]XN.$B=M".RTXX#($LHENXXMA%$0%YK07'ZW>\O_P!NU_IG
M/L* _6[WE_\ MVO],Y]A0<9O>GNY"B/2Y/;_ *4>.!..N&^X@B(I=57R<D2@
MTWMUNUW=NSX&>>C#$=EH?48 E,14#4%TDJ)=%T^B@9*!*[M]PG=A[63,M10E
MN'(;80'35ML4.]R(A0EX6\$H$%KOGW(=:!UO9HFVX*$!BLM45%2Z*GVB@]?K
MO[F?Y+3YLO\ T%!Y=[Y]R&FC=<V:(-MBI&9++1$$4NJK]H\*"+C?>%WQDHY2
M,?M>/-8%=)/1W)3@(J)=4U(SSLM!\Q?O$[TRS3CN,VNQ-:9/INFPY*-!-$OI
M549YT&F=L=Z9W=6+FR<SB%P\B))6.#5S5'!04+6G4$"3UK<J!<[B]['-H[]Q
M6V0A,R&)H-')D..DV8=5U05 32H+I'S+=4H'%>X.W%WA"VHT\LC)3XSLMDV=
M)LH#*V)",5X%\% 3-US6MVE@8V.64#4,9K[XN")().*WI$%]9>'IH+(\_"]E
M9>:0WG)!$VS&%/MI&%]0J*VMIMYK\J!;E]R#QK.X7<KC#97 ^RJK3+@NFZDM
M/);@B(MZ"G/*YC/Y#VW<F"FP<! 1)$3'KI47EY*Y+L6E=/,&^7BM!#97&Y%K
M(8Z4,E^64LEPDV"H>T18XV5E6BO<=*J5T]'.@Z[D[H97:^$<:W9MQ^1I,8[>
M0% *'(,[=$B154A4OITMP7E0.>)<@Q9K3,K&L0)KZ?U9]@45MQ%&ZHAV11+@
MOE6@8J H,:W/WG[@0<[D8N$V8N1Q4*8F.;R!OZ.I(54'2@HB\R6R4'7;&^^Y
M45[(OY;M]/:66Z+K3$1ULP%4%!-?.HV4E2]!8Y7O+F<3'23D]D96)'(Q:%UP
MF+*X:V$>!+Q5:";^LO=O^0,O_&8^SH#]9>[?\@9C^,Q]G0'ZS-V\?_I_F/@\
MS'V=!GW<_OU&<PF6V=/V[.QV:RD1V,RP\K:JA.@J(I:%+AQO0*?9S8_?3:F(
M=D8B. 0<R#4GIB;*K=!L)7/5S%:!\?=]Y==2,--"BBJ)K6.JH7IX(E JAO3W
MA<9!EM9*9'*9C9<:#(11:4R<E"I!:R66Z>-^% QY-SWF7H3C4)GH22MTW5.*
MJ)945>2>B@[.3O>-:CDX<7BV"D2ZXMO*EU^EH&C9FXM[SNS&0S.1>:<W0W%R
M11W!LC:/,=1&47A;@0)?A0:90% 4'Y][GX+<&:[L2(F 8CR<B,-HA9E.=)O0
M3#@$JK8N6KAPH-0[58#<.%VZ\QGV&(V0?E&\3,4^HT@JV #8E0?J*!RH,W8?
MFIN?>K$7',S54F2(G'@;,46(B>JHDMOAH&G8F.<Q6U,7BWY2294>.'5+5=?-
MYK<>-DO9+T$7:GZ4;M_"X_\ LP4$7=N,FR=S;?S, QFA!<?CO8PG$%LB=:*Q
MWL0H0Z?%*"%VZ<<=WEO8W6 C.>U0T)ELQ<%%2,B>L*"E_E4'?>N)FRMT;9S4
M!P)@8Y]YE_&DX@@:O-*B'?S"A!;Q2@6F7'7\CW#D) 8:R3"0AC,(0.HCH,^5
M$-$'F7.@UJ,KJQFE=32ZH"KB)X%;C^[05&]L\]M_:F3S3(@;D!E7A%U50."I
M?4J>%!;QWA?CM/"J$+H"8D*W14)+W1:#I0%!B7O(O(S,V:\O)O(@2W6R<'V/
M'PH-<6=E[_W9?X>L'T*#Y[?F/R9_WP?0H*3=^Y7,?B2:R$%66I^J*+MVWT!3
M EU&VNG4*6X\:#\G[5V]-R?=/%8# 9U[&/'%5M,K';1IU!!LS451LK%>W.]!
MM_ZB>Y/_ -SLG_ROLZ _43W(_P#N=D_^5]G04&_>S_<#$;+S62D]P\C.CQ8C
MCCL-S4@.BB<0+SKP5*"H]W5QI=J2!2<>OK9-?BVR=-$Z(?;+VO?Y=!^GH?\
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M#,=HXK*[TW3\;0I\,7V\P.4>8"5(1O2)<2:C.@".C9.!T&V[CD[]B.0V<,Y
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MO="LMJ#;.QF9W_E=G.O[Y F\T$MP$$VP;+HZ1(/*'#Z:@T2@*#/>]7Z/X_\
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M+T%IA<@N0Q<:62:7' ^V@J647!\II;^$BT&+^\#^R_#_ (>/_/H-O@_V*/\
M<P^M2@S'WE_V53/PF-]\H+7M!@V V+MG(*XYK7'LN>SZKMHXXT@DXG"]U%/3
M0=.X\]Z!D,4_T/:X[C<F,<85TDIO]-L3U_2B*$MZ!6WG+3%[@P4$X!R7)!26
M9C;YV)PY0ML@[U!2W3$>:HET6U!9N-RHW<G;, F]+:C.>F%(-#>-TF1$""WE
M5K0-N7.@T7XI@>ULRA:0#9;<: 11$#2\HJ=Q3@OJ)08KW9VSA<WW8V]A,A'U
M8V3$9%YAI5:NB/O$EE#2J<4\*!C]VYOI=L&V04E%J=,;;UDI6$'E04NMU\*#
M0MOKGUQ@+GQCCD]1]1(:FK.C6O3MKL5]%K_#06- 4&+^]A^S ?PUKYQ4&HX6
M2U%VE DO%I:9@LF:_ +2+00!AECL) FB%WVGQE2E7G:0MGOF(Y^Y0=>XGZ"9
M_P# 7_O:T'YK["3\;#V]GCDDTKRS!Z+)(A.FJ1QX /5:^=0=.Z,ER;V;EO-M
MM,PT1G2KR ,PR1WBBMB\: *?P>- _8-N#^9VWKK%U:(5[J%^2<_ZPGSDH,Z[
MWMQ/S^VD@*SH5MW6K*BB(G4'FHNN_P#!0,'>./@878QX,"\,C'MYJ*0$#W7'
M4@BI"AW+Q\*#0=H90G<SC<^[#1IB?A!=R,9'.J,<D?$.HVEO56USM\F@TF?E
MV(T5MUE/:79-DB,M*BJZJI=-/[U$XJO@E!AO=&$]&WNP<IWK39./0Y!^"+HE
M)H!/ 1Y)0*V*[F9;#Q,+(@8W)03D8*+"<%Z*R:/=$51MQA2<'R*I\Z";@.]F
MYU>8D.0YR)'5W'FC$2.2* *BMWU.CY]2+J\/109//SLUGNI@MP,FZDZ1DT<7
MVEEL  GGUU:4 SO_ "B\Z#]UXZ W!C=$#)Q5(C<=<6YF9K<B5:"30% C;:_2
M-_\ Q#)?.;H&G _W:/W5_P"_'089[SZVW1V__"WOGM4&]/8S&ON*Z]$9=<6U
MS-L2);<N*I0(_>UR%"[=R4-M 81P&P0 %4 CU")H*^7RDNJ@8-J/,NJXK4P)
MZ!&B <P"$D<,6U0BN'ENJ\>% G[XDL-]W=J@<\<::,JZ3Y=-!<; G$*.I.<N
MIJ3E0/.TN.!CJG)2<^^%09;@IL-[<.\0:EBV09&(T6.5&Q4W EW*0-EUEP73
M>@U;=+C;6VLJXZFIL(CQ&/.Z(VJJG&@2>UTF.]BML(U,&6HPI"J@J%VD,T(6
MB$/5T)PXT&E4!0?G+N?_ /D_M'C;^IM_7N>-!IVZMB9:=NU[/00A36YF.^*W
M(\[4GLZ:R/KLJ(GYO-Q3ARYT'F!OV5!QP@Y$8/&8QYO%RLN4H1;Z[:(V5Q4=
M?K\*!63%Q7L[BI*RL;'"+D2R;NXVWTZSHN$1+!%+(2HJ$B+==-O"@=][XQ9&
MZ-EY$3\L+(.HH(E]2/QC&]_"VF@<Z#-&\;)R&[=Y,A-GPV@1D]4=0%@E6/91
M550EU_\ !076S=U;5%B#M_&H;###(LPW3!0CO&VB=0&'"X.$*\[4'K:[[+&?
MWD\^8M,MSFB<<-401%(K=U55H*R9E-N;OS.*&,Y)Q^6ANF<20H*R\49QLT)Q
MDB14-H]*4'/MN7LNY-\%*>?46);'4?G**.:0C^L2I9--DNGP4!DLAMK=^:Q!
M1BDP<M!?(X4M05ETH[H$)N,$2*)MGILM N,38[1[]P\B?):R$F5&8C/2T4GE
M70("=VQTZ?$?@H-F8 @8; BU$(HBEZ51+7H%GNEE9.)[>Y[)QG38?AQ#>!UI
M;&.BRKI7TVH&#&RAEXZ+*&^F0RVZ.KG8Q0N/S:!;S6])^+R#D5R"T2"0J!=9
M;],U5$,D0%T\EX4%OMW,2\K'>??C#'%MU6V])Z]2#S545!4?D+08S[Q?Z:[(
M_" _VQB@V3,LG,R6,AH5F@<66^/I%FVA/XY(ORJ"5G8!3\3)C 6ATAU,FG-'
M 74"_P 9*"IR\KVK&821XNS(Q%\GC=/FT&59'<#&,]Z(_C'))#QR8L/*^]TV
M-2M<.!*@W6@UK]8&QOR_C_QEK[*@C/[FP.?F1\+B,Q'?-[4[+2*Z#A^SM^L/
ME5=.M50;T&9>\JD''Q-I@G3C16W,DV"< !-6/<$4^6JT"=[N@8_\U7S2.][?
MU<FBRM)]%6^B'EU7T:OE4'Z@A_V-C[F'UJ4"]W/_ &>;B_ '_K%H$7W>,@UC
M^R3$USB+#DHD'DI%U%013X2*R4&JX>+[+C(S"I8Q!%<_AEYC7^,JT$;$*K,[
M(P5%! '4?9MX@^EU^8:+08_[P/[+\/\ AX_\^@V^#_8H_P!S#ZU*#,?>7_95
M,_"8WWR@<NW++;.P=NM-I8!QT;2G_9#00MPQ,7GMRX:(KI/M15?=D"P:HB$(
MBH"X0^&I/5O06F=V;@\YDL?D<@V9RL8JE%('"!/,0DJ$@K8DN"<Z#O+VWB96
M>A9YYI2R6/;<9BNH2HB ]ZZ**<%Y>-!:4&%]Y<R]@.Z6!S?Q?)GL18;:JU&;
M(R*S[J$B*B***FI%XT%!V=[OCMG"P=M9#;F31Z9DG!26C2BT'MC_ )%)21/5
MU<:#;.XN_<=L7;1Y[(,.R6!=;8%EFVLC=6R<^%!*V/NZ)N[;,3/16'(S,O7I
M8>LIBH&H+?3=.8T%[08O[V/[,!_#6?G%0/X W*VM@<89?VUJ*)AXJVVV+A_6
MI0,4V*,F$_&7@CK9-_(U):@4]QRI$GM;ERE<)3>/D-2?3U&P4"7Y=KT&%^[?
M'8/#9XS-D#]M;2[G3U61@?JVW%M\N@G=YV&1[+S2%UDBLQP!6]7\K^]:$O\
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M^"%H)>*72@9F=C[-5D%7"0;J*?\ N[?H^10(>X]B8W!3EDQ(@36I/4<6,Y&
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M+<9&Y(ME%.-UX(M!IF(V;M3#2EE8K$Q84E14%>9:$#TKS2Z)RH+B@* H"@*
MH"@* H"@I=[?H=F_P&3]Z*@[;7(4VSB.*?V*/]Z&@YY7:FV\M*25D(@OR$%
MZFLQ6PJJCZI)RO03<;CL=C8R183:,L(2EIU*7F);JJJ2JJT&?=V%ON[MU9;_
M .^5Y?<Z#2G"46R).:(JI\I*"AQT'*S(+$IS)6-X$,D1AJUU^2E!-V](E/P"
M]J<1YUIYUKJ(*!=&S44X)PY4&0^\R8 YM926R*[+%/&ZDV"(GRU6@TS/.,8G
M'1MP(B-'"%L99KP18QJB.(=OJ?63T4'%SN=VW=:)MS.PC:<11,"-%$A5+*BH
MJ<EH .Z';@ 0 ST(0!$010T1$1.2(EJ C]UNVTB2W%8W) <D.FC;;(O"I*9+
M9!1/2JT#70%!PGP(L^&[#E!KCO)I<&ZI=.?-*"KQ^S<' F#,8!Q7Q)313=,T
MU*.G595M>RT%W08=W0A]R,GM+<&X(TW&Q,0]CGF)$16G''CCLF:I8U5!$UNO
MP4#9VQQ47*]N3Q\DC%A]]Q#5HU;-$0A+@8\4Y4$OO.*#VWR(CR$HR)?X'PH'
M=C^0;_@I\Z@J#3*2\O,89G+&8CBUH 6P*ZF*JJJI4'6&F1CY9(TB8LIHXY.(
MA (*A"8CS'X"H(?<3] ]P6_U"1][6@]=OOT&P'^'QOO0T'15RDS,3F&IRQF(
MJ-( "V!74PU*JJ5 0W,G'W$D"1,65'.&3Z(38@J&+HAS'X"H+>3_ &=W^ 7S
MJ!.[,_LUPOW-S[Z= ZT"IW(VOD]Q8:'&QS@ _%GQ9A ZND' 8<U$*JB*J+Z*
M"ZB9=7)BPI<<HDK3K;0E0@<%.?3-.:IXI04&YMG9+*Y9)K+S* "!TA=5U%'2
MEB1-*V2_IYT#!@($J!BF(DIU'WV[ZC125.)*J(BE<N"<.- E;A7_ .M>UT],
M"9\Y:#1:"#F\4&4Q[D,C1O6HKK4$<3RDA642X*G"@H<!V_8Q&3;G)*1WI]2S
M8L-M?RB(G$AXV2W!*!LH"@* H"@*#-^^7]R[?_Q_&_?TH-(H"@* H"@* H"@
M*"IW=^BF8_ I'WHJ!(]WV7&E['>?C.B\R4Y[2X"W1;""+0:;0% 4!0% 4&6^
M\G^RZ3^%QOKZ"_[37_-1+_SY_6C0.= 4"!W!SD_&[LVNU(?.)MJ24D<A(:4D
MN\+5V0-115LO-*"7VZS#>2F[D]FFN38$><+<0G"(M ]$5(1U(BVU4'+?>;>Q
MVYMO-3))P]OR5D)+?;(Q57Q!%:;)015LO%4H/?;K,-Y+([F]FFN3<?'G-MPR
M<(BT#[.!$(ZK+;4JK0?=\YF?CL_@ D.+&VU(-X<C+;4D-'D;560+3Q02X_+H
M.';K-#DMQ[L"-.=FXR-(BA"ZA$2!J80C0=2(O$J#[W!S64QVX]M XX<;;$AU
MX<K+;4D)'$;560)1NJ"1>CQH*"-GV77][9&#DI4N!AAB.0@%X["O2UNBB$GT
MRIXT&K1GNM&:>M;J )V7FFI+T$?,_%JXF6.4,6\<;1-RC<+2*-FFDKEX<Z!'
M;[$[%%L ;=R2-B*"")/D6042R(GF]%!Z_47LG^>R?_Q"1]E0'ZC-D_SV3_\
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MW<@>2?D9#* $)YIJ8QH!(6I-33:(BJBC:RI=4XT#SM+?/;?&X^));;F^W.,
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M69%EM=:*Z+S5U36"HJ73FG#QH*_=WZ*YC\"D?>BH$[L/^ALC\.>^M"@T>@*
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MHCYDNJ"B\+K0:M#:ESLFF1EQUCL1A((#9K]L7J(FMPT3U>5D2@5^_7[)L_\
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MA,I\6-P%@QVFW9#+9--2&D:) ,=?F)25RZ7]5/%:"/#W+!');ZQ\<9A>U2U
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A0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g425213dsp132.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp132.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0    \
M  #_X0.C:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 Y+C$M8S P,2 W.2XQ-#8R.#DY-S<W+" R,#(S+S V
M+S(U+3(S.C4W.C$T(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT
M=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7 ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B('AM;&YS.F1C/2)H='1P.B\O<'5R
M;"YO<F<O9&,O96QE;65N=',O,2XQ+R(@>&UL;G,Z>&UP34T](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(B!X;7 Z
M0W)E871O<E1O;VP](DUI8W)O<V]F=,*N($]F9FEC92!7;W)D(#(P,#<B('AM
M<$U-.DEN<W1A;F-E240](GAM<"YI:60Z140W1D,W0S V,38T,3%%14(S1D9&
M14,P-3<U-C,S0T(B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z140W1D,W
M0S$V,38T,3%%14(S1D9&14,P-3<U-C,S0T(B/B \9&,Z8W)E871O<CX@/')D
M9CI397$^(#QR9&8Z;&D^1V]O9'=I;CPO<F1F.FQI/B \+W)D9CI397$^(#PO
M9&,Z8W)E871O<CX@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E
M240](GAM<"YI:60Z140W1D,W0D4V,38T,3%%14(S1D9&14,P-3<U-C,S0T(B
M('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z140W1D,W0D8V,38T,3%%14(S
M1D9&14,P-3<U-C,S0T(B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$
M1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[0!(4&AO=&]S
M:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E
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M@J+"@X0EE59V\&/#11CA\>*C1-0FXV3$9;8G$0$! 0 " @$# P(& @,
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MW%2A1F*NQ4;[#C^SRV&@BS=SR!0\=8>4PY+*9.8X^.^T*RG;0=(<GF)@KK6
MB8;APC,#[NC&-OUM!";.96QE'QL"3+/'&9'=80D>RD @/*2I(Y#IH!*G<P\M
M;$SLTCD*PDVXCJ=W$4?';V>.@FSX>^:SA;/*4(>&YE!+CJ-RLB]-]!7TL)E;
M/S;9<0UUCF9:Q0+.)( H(D;S>7$[D@CZ-]!VJ8?'PM(TF0V4D"(Q.D7P; [,
M% 'VM_#V:#J,-C1E1/\ .\HO*\EJ)<'E(&Y"7EOSY;=-!:/C,<4XR1@H.NSL
MQ'ZYT$>U@.W[%66O)3@$<Z&-RJ*K<6&QV8#<=-!)HU*=.E!3BV\FO&L47,\F
MXH J[L>IZ#0=2U==O#KX #?]C0<I30>>%I(@TT9)@<QDE3ML>+;?#T.@]26T
M2>*%DD+S<N!"$J.(W/)AT7\N@ZD[C;B=CX]- *_LX$ =/#IX>S0<:]BS(C,]
M5HB&*A6922 >C=">AT'0/*?&(C_RAH,+S&"]8NQ52WV[;QQQU_)+)E*>_FR2
M>9L&EC:Q&GE_<Q=4YMU^S[M!N'#(_P#6P_\ 9M^_T!PR/_6P_P#9M^_T 5R/
M_6P_]FW[_09IVC=BN^KU^U&6(FQLQ/)#&>DU<?9);IT]^@T+(_TMBO[Y-_$M
MH++05B?[QR#V?)IT_P#6OH%OU!<)F.W'/4)<#[?4-_\ DT"U5]1O56GVY4RM
MGLJDF(6M#.TZY=6D%=E4\Q%\N-R%._'?0:PWG@?#Q8_3NO[&^@Y%\B(Y&\F(
MN 3&@D/Q$#H"2O3?0?#)86!9I8HTEXKY@+_9WVY#F1[- JY;N_NNI;ECIX&.
M] #]S*EN->:\MO!AT;3KS<JNX[H[K_&4K_@ _"3(B/D?FH]PC#JZQ@?%Q;H>
MND\\_K_RS;P9TLJXY(K,OL8;$'ZB#HKZ)3_U;_J#_GT'UI55>3!@.GL)\?JW
MT'SS(#[/U5/_ #:!<P<]1<M9#21C@LP8$J.)-V=@#[NAWT'?NCMK%]Q8J6FL
MZU)I&C<7JX0RH8Y%DV!]S<>)^@Z#IB>V8*&1R=H3F2#(21R0UANBP!(PC(G%
MNJL1R\/$Z#EG>V)KD^/FQ]EJAJVDEN(6<K8@ (>%AN?'?<:"7-VU3D_Z:=-@
M0@#@J-_[%@1H(5GMF6O3F>A(KVDC8P(T4:AG )4,T80]3TWT'3%T,G)0IR6R
M*UR6)7LU]Y&X2$;NH/FL-E8[>.@^VL1G]F%6Z0W3C(TK#;KU^ I(/U]!Z@/<
ML9 DY./:6$+ ?VO!C^IH)#7,T"-H VV^_P ! ^CJ7_Y-!&/<-]'XR4PQWVV4
MRIM]9>,)_P"=H.\7<4)Y":!X64[; H^_T[JQT'5^X<9&I:5G0 <B1&[[#_U8
M?02$RF.< K83KX G8_J'8Z#M'8KR':.5'/N5@?V-!TT!H#0&@- : T!H#0&@
M- : T!H#0&@- : T")ZE>L/;_I_\L,O4MSFV>$!KHC ML6V)9EVZ#02*_>N;
MM&I_[LCH?B"EJ(G>65Y-D,FP6*/;?@"?M:#E=?U*R.\=3AC8V&S2F.,,/W/)
MY#^MH+C'19:[69K/FUI%=XV21V!8(Q <;#8JPZC;;0>OT6B>7S)95+>\)R/Y
M3*TJ_P#FZ#W!@;<.6,JV]\48 GR?'BPG#[^:&7B-BO0KMH)9P6'#<WKJYWY'
MS"6&Y.^^S';0=&H8\)Q5%BB*LKQQ@(K!QL>07;?0><7C\=C\9!C:"%*-:,0P
MQ L_&-1L%Y-N>@^G023(% 558CPV ]GY=M <Y?S8NGTD _\ +H/6\FW@/U]!
M\VG)^TJCV="?^4:"J[CFOP8N8P5I,@TGW;UH]E)1P0=NA/T:E-97#C:E<S_,
M=F2UI/A8Q27=VF63?=U5MMMO [['5O"=;_=;P87MVE!6RV-[:L7LM&5;Y;SF
ME>%N7Q,[;D=..^_M]FIVMG$.LEG+2*\$=S'H+E41_,1#YBK)\7$NOQ(=_=OM
MK7:26R)TMLEO"7'#%&H2- JJ   -N@Z#4:<;V1IT8Q+:E6&,G8,WAOX^S02%
MV(WT'*Y;KU*[3V)!%"I 9V\!R(4?JDZ#J!H/#6*Z,5:5%8>*E@#UT'SYNKMO
MYR;?NA_SZ#J"" 0=P? Z T&2^M>1[1S7:BPWI;1KXW/UJLWD1F-Q=C1G1=Y@
MJO'NZ\F3<>XZ#6AH#0?&.PWT&6]OPX+&^KMI:*UZ5-\7,ZJG&)"YL0\B!T&Y
MVZZ![MW*D^8Q2PSQRL'F)5'5CMY+==@=!<:"L7_>.3;_ ")/XU]!A>,[R]3<
MMW!3I^H6*K8286U_ X8U,;V5"2F<@-+*6X*JGIMH-#N -Z*"0G=_P2LNW7X0
M((^G70:)H.<UFM  9I4B!\.;!=_U=!!R4.%S%"2E9FCEK2%2X24 [HP8=5/O
M&F++A&S7IWV!B:HNU\>;$PXHL0M."5Y#X@"W4KM[--2^97;&=N]ARX.CC+.]
M1)05AQHMR.R<Y4;AN&+?#*J['PW\-:[=KOG?_A,XIXPV(HX?&P8VBA2I77C$
MC,6(&^_VFW)\=2W3'>U;KU51IW"*[B-"?:S> U%=O9H#;04>6P79]NQYV4K4
MWG ZO-P5MOI.XT$G"8?"T(9#BZT->O.0Q\D#B_$;!CX@Z"Q\F+]HOZ@T'GY:
M'ERX]?#Q.@]>6/>WZIT'PQGV.P_4/[.^@BU;E62Y)5%I)K=8;31= Z\]F&X'
MT:";H(T61I36GJQ3I)8B :2-2"5!.W7;Z1H).V@-!\9%8;$ @^(.@B/AL4^Q
M-6-2/:@X']5=M #$U%7BO-5_:AV'_+H*^UVG3FD$BR%64DJ&1&'7QW("R'^V
MT'2+$7H5XQV-Q[-FD0?J;N?_ #M!'>#N>!F\N9IEY;@_=N.)]@1@C=/W>@[K
MD<U'"QDJ\W7P'!E9OJ"&1?\ SM!]&=LI*(YJ+<O=&ZEO[5^'[.@D1YRBYXGS
M%8#DRE&/$#WE01^OH.L&5QUC?R;,;<?$<MB/R';02D='4,C!E/@0=QH/N@-
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MZQJ;SBR/SCC<GD8HJYR[9')9U3;C-J&6=[/E+,.22BO;)4+\'PDG;WZJ-O\
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M?[O'_P ;%H+T:#/_ %56I)\A!;$;UYRB213;&-T^>J%U93\+#@#T/30*7<&
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MCMMG9HJ5RW5L5X(?B^\=9ZZJL0(Y/\(!WV^G0:CD/Z7Q7]\F_B6T%EH*Q/\
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M[%'S84@:OR2"7RH74V$7[^,=)0O(; _7[- ]1PSQY&+S)O-4QR<%XA>/5-_
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MH<O\SQ?[,^@G]A$_B$'^Q\%_H]O0:)H%[+=,C9V_:XS_ $U]!F?;Y/XAG/\
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M#9CY(11CE^'6>73'R0GX>'[<[:#6NR,DE[$\A7LU6A\J%XKD+UY.4<$8.R2
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MOX6K_??_ +V^@0?4'_?'%CV?AUC_ $ZEH&C!7HZG9N,EZ/+'CH'2'<!G(A!
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ML&S"ZD&9H6K$MOR/W+M(R#KT!8Z"9F>\L%AK@J9"5XY602+M&[J021XJ#[M
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M'[IQ(J[@#KR4=?UM3.95=^])C=[.SN/QU2W8L7<?:KUZ_P K,I:66%D79F0
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MR_+@HW*8^40N\7V@6_)HD:3EK $*B&2+SUFCXK(VR[\OSMNNBN/SF;_;8_\
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MY5IEQEMX-_/6&1HMEYGF$)7X?SNOLT&+Y7#Y1%F:N;LST(FNX^P<;%Y;VX8
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M$\^F^V@3[&7[=I>HV&MR7JE>"8Q22V&FC1&84;J%BQ;;?J@_4T&@_ISV5_\
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M,P08-[#?++ !%-+DZJL&\AY1OP11]K3$UKG:?^ZV'_F5?^*715KH#0&@- :
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MS'C\+,?BY<ORCW:DNPVM/CBCCC2-?LH J@]>@&P\=6W;J29,>^@U%&XT!N-
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MK,Q\B2$!2\T@  DWV"DG8:!G&1[<(_@&_P TF_P>@BY23M^]C+=)$>%K4$D
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M"S>WX/>WB\[[B3[GQY_ ?AZ>_P - F=KO!?E3&S8H4*->0L<?(FRB?XF#*&
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M$?VCSZ'05&?M=S6NR,U)/&&Q_P"#7T%V1H^<P2NP28+#R3C,OQ>(_<ZA2]Z
M_B__  AQGX8B/)\V_F*Y*C@2G([@-U ZC3V-![J[F^3I#'5WJSYB>:G4>O8#
M^4!>G$.[A=B?A+'B#OTU0ES8+N*>Z^)7-XM<U%&($G6E/YL4Q D,ZDGR^;(
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MB:(\W\Q^C2$^>Y\SJ?;HKAZ/(H],.VME _D,7L]^^@9<MBJN3I-5G4;;AXI
M 6CE0\HY4W_.1@&7Z= KW.T+BD7[.:EI18\/(Y7@8I4"J6>P&7HHX,>*;=23
MH$F?N# 30_B2]\U(LI'7DCCQ"W8OE'8\BG*QP\U6)(^,?9\-M!\P^8[:H(EJ
M3ONI8M3-'YU*2S&L$*F;G(8V0<F(1B"&.S[>S0=X\SVC HIIW_#8AL"9K&4E
MM0"U"S\2@B14\M_!N)8;I].@8NVJ5/,R1/B>Y3D:F,>!I<A6DBDGGD1F9H;
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M:*OQ0A I=N>V_327.W/@LX.]>"AW;BZ%G)JUYFR-EK$&/L2QQS;2EQ')&TL
M\_DVZCB1L#I?)#S@>P^W>SLI2JX&26K!=FFL6JUBS-8::0JO5?-9S\/VCL=
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M%>;9PV[!5W(/3Z- VU.V\#V9V75_$&CR'Z.I)9BR%M4C?SB7/F;J"$9C*5W
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M':*7P\M$_7T#%H#0?') )]W708U'_6B[5GDG6GVUW'=CKRO \]6BDL9>-N+
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M=SU]^@B^F6.N4NP.WH(Q ODX^"/;9MAL@W V.WCH).;J31&221EV:.%%C0$
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M, L?(LQZ !?$G52E[&>IGIWD[\-#']PT+-VRW"M!'.A>1MM]HQO\1^K1#,[
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MM'QK-/D@4@;@2N['<Q'?XD*?![1H++TEQ$%#-]TP5ZXAIPV!'5'%5 XV[I8
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MSTE)D6&I4_% K6[@C5FL3!(Y:XA25XVB9=]I%ZZ#1^WNT:]3M7MG%Y"[RO\
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ML(D<TM&5*ZF39ASF/W:]#UW/3P\= ZZ T$',8/%YFLE;)0>?#&XE1>3H0X!
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M\E0Q83'8[]- R]OX7N/%2WI'KXYS:D3R1"TD7EP1H%2)V\HF3BW(AC[#M[-
MMU^VN[,C<R>2%7%^:V7L.BS.TOFU5@BKF(,(BT),E=6Y>.P\.NE'"YWCENR\
M%9%BC5+8:S2@R+568)/)DGC>>6*ND2DLOF,50-XZ$EM:I'(KJ&7?8@$;C8]=
M$E4/<F'7)9; -(CM#2N-:9D.P5XXF,9?Z.>W315_MT^G0)U[TC[!O7[5^WB:
M\UNY*T]B66&"5F=_M'E)&[;?1OH/N:AH=C=DYN]B:[#@KVC&K!2961(0R[+Q
M7BJ+T"^S0(5G,Y:3UP[5H1WLE%CKF NSS59PJ6.0D._PE=QR-=#M] U.UR;Y
MX7.<./8-]>]_3N>'-12316)K^-MK,=I)8H;,D&[[!=BR+U&JCM'Z.>GT>YAQ
M4$#E67G#!7C<!P5;BZ1*R[@^(.@=(84BB2)!LD:A4'CL%&PT%5C<5'5[BS%Y
M%<?B*57E=CNK21*\7P^[9%7?05GJMF,GAO3O.Y+&3_*WZ]8FO:V4^4S,%\S9
MNAX!N6I:L970R./3*XNOE?5B/+6ZLG&PU6S\JVTRMN[".5Z_P[ ?&A ^@G6L
M0NR=V=R'NKN/M2UF<OWEAI&@2ID<5=J4EAK6D)D#D M+Y?,*SJVW3KMOJ#&7
M]/NS8<UFJ;6\G9I4<C=HX^Y4A2>.:.O6DE@)=5*EVD1>6WYFYT636A=N7)O3
MGL=Q@Z^9.2RU!\A)=@R-5*D<P5XX6$#K]XHX;CB-W'0;[:G7M;'3YNDZ]N+L
MIQA[DB>CV_'G/4QC;^3&4N9-IVBA6R[J(ZIAJ21 -&K$.LA.^WV1JQRI^](\
MYF9^ZNX\59[H7NS&PP4[E#(0B/RH?F&E#5P\;/R*B,'XFWU<35[ZSYC,8KLE
MI<3D/PFW9NTJ9RNR,*L=BPD<DQ$GPD(K==9:D9Q'E:$><Q_F>J$>2L.S8^W/
M5MF(1*89)!89/-EK?PJ*#NGMV!&K+J4JX7N+.=U-E.Q.XLAE^Y*\^2EQ<V?Q
M]VG6K_+%U2.9JH!?@3U\>+> )TP9QEO2/MZK8R%6M<R;6JOZ0&"9HE>NWX,0
M4Y2HHVYIS\W]J2H]NEW.&NEZ[SX.LV6R?IWV35P7;,^9IRVH:%N/-R7:K4XY
M<AY4LP6DZ\_@5V7BO[L^_278EF5HF4R&)IV\;\QZIK\Y6J 3Y":T?)FG<\'*
MP02QPKOMRXMR(]FIJ&CT3SF=MS]RXC*=P?I7%B;<(I=P(D:0RQSP+(8E,192
M8V\>I\1K6)[7?K%G,OA/3S+Y#$SFK>18HXKB\3Y FF2-IMF^$^6K<NNL=K=C
M49FV4HULMC99_4Z/+VHIX:5L5;;0D13,JRS%5FDKCCORW9#MX#;6HE*5;N3N
M_+YG,=AY?)9+NS$6KR8UNY*%^M1CCJ64C#2&LL<AE6,R$L>?%OLZ8;C(^]/3
M;$8#.7L; <C(:L=^1)6C617%2&*6)RR*H"MS;S/V@XZ+,]M/R<N?]*^TY<?V
MK#F6%RG!DILR^1@6&M;M("8C2:%N;*%WV!#,.OLTEV+\G7\>V;O^I\M7L=6&
M+?(^JJOD*5;S9L@]EDAEEF9@RBO6ECB'%57H_+WC;1)--GH_F<W+F^Y\1D.Z
M%[NJTODYZ.3B2-8T6RDA:'E&SAN/ >+;Z6,M3&BC0&@-M : T!H#0&@X7:HL
MUWAW*\O:#MH/E2LT*$,Q9F.YZ[CH-O\ \^A$AO Z#,[N<[2Q'JS"]S,4:]IJ
M-WYJ.1TA>,NU,QK(S'J6"DCV[:N_[<9SG57W#W"\!LV\9Z@5;,EJ;C4H1S50
M(E=B>C23(OPKOU8[?1K/II38[U#S&5DQF-BSDT5Q95J7+<<M&7S'MV!%'*L*
M3,Q$;-MTW^'KK5^L\<?K^4E]>S79I7<// _<'<-G+R)E:EJK&*;;0QE?),0*
MJ^X+MRW!Y:>I]M_G?[+[:$EZ26J]B*(\5#%0[!=^!(/AOMU&H/%BS:,,4T+H
MD<G%NJDMQ.Q/C[>._LT'N:40LWFNY3@"-O$G?8@ :#E512+2\2R[\XC)NS<7
M4';KOT#;C09!!%W+V_ZB]W9$=HY/.8K+F@:%FD*97:M6$;\OF)$8;,=N@]F@
M;.P&REONW+Y:UV]>[?J/1K5T3(?*@R2I+,[E/EGDZ!77?EH',Y#'07I%:>,2
M/Q' $%B?S>@Z]=SH(5K,8J#?S.7GGFB ; ]-P#\17V'0>7R\\R",49>4/ELH
MV9BQ(\5(7CTVZ]=!YL1=QY6M- \:TX)590'X[D'PWV,A'ZV@5Z.4[\[=K#"3
M8^K*E6,QXZPCNYDC7HLDD:[E1OT\1J9X6N SO>V1O>5?K4XZ*+ TQ3S5E :=
M=RH?H1S4*/K^C6N,/34=1!H#0&@- : T!H#09;Z^_P! 5-O'R\G_ -U6M!G_
M *(UL9>AQ^'CM1QXV_5A>U4K2!))YX:J%^6QZHOYZJ/M'KJ\>?:;9^QISO9V
M)Q5^ZE*QD$CM6#:N4ILF\,5B\)(O(M33F0O'R,:JFR^(&HIH;T9P,[T6NY3+
MWX*%V/)04[EPS1>=$K*H967J-F^OZ=7:F0SOV=VRTGG-CXS-N#YC%BVX\#RW
MWZ:SBL;SG8G8$G>W=&=SF1R&&M0VJ]".&C<,1DK_ "M>19#XOT9BVP;V>&^V
MLR_6-639E+/>&#7]!L-)V]D<Q:-O,M0LXVY>NI'/BI)94C:TKAI(%9$CW<*-
MN6^VNE9Q4]R=D/VUV[1S&%DR';>4_%J^%?"XK+2VXOEK3AF:)[*1E7E(!7KP
M.P/OU(56^G-3N/NFM;F[JSF9DH18HY2I!/DFJUK4B63 L4LJ!W2-V7A\/Q;_
M )-3+[;[?C9,_G?]/L:?3GM5Y<[W8N4O93MZK36*Q4P=3(V6KO9LU>4G*PP6
M6:0,JD\2-F^$[[:M8E?.X.V?3ZK0JY3"7\YD,OB,IBK\6.O67/S4YL)$4$-@
M"0.JGB"P7Q&Q(U2>7ZAB)90Q4J6 )4^(W]FHDI7]0>X,UAZ^&CPP@^;RV3AQ
M_*PAD55E21BP4/'U^[]IT572W?4:*TM23)XN.TZ\T@:MLY7<C<#YKP^$Z#*_
M47U6]0<)W,^.D&0E-)X*KS8JDIJR3VT$T,9)L,3(5Z!?;I/)4C)>M'>GX7&?
M(@N8Z]7^&R/E*\A63E$P:.>]#+')N#N./31<*=F_FCWUB9I3:/=38R=L?OD(
M"ZUN9Y1F?Y_RE<\6*KSZ@]>NB+?'^K_=M;M>W1H5_DL=C*MB::WYE)K$:Q%G
MD92<A)(\C-X?"=R=*KYV5Z_]W7LY3[?1+ALWYZ\"V,E27C$UI#)"7(LJ0)$!
M9?>/#51L:V_4=K)JKD\6UD#D816^/;QWV^:U!9]G9?N&U?S6-SA@>QC)8$22
MO&8@RS0K+\2EY>HY>PZ"_P EC:&3HS4,A MFG87C-!(-U9=]]B/R:#A4P&!I
M69;=+'5:UN??S[$,,<<C[GD>;JH9MSUZZ!"[RH9>LF7/DV+26UL05+K)#**Z
MS1></M;JM>,IQ^-">7Y#H/RU@O4;!8:BE.7YF5:UW*RK4>JH3G?H&"&8/SW5
ME<]4V^G?4NYPWTDMY\-M],9I\HDRU*EJQ=6RMB62:.(B.00F0JL\<A/EN)@(
M3\2 []!XZIW[3>/'IIM3TZI3U8!>8O68)8EH68()6^8D;S)VE)#Q,TAZ-\/0
M[E3[=&#/CL!@\=8DL8^C!4FECCAD,"+&#'#R,:<5V "\VVZ>W0=\EC,=DH%K
MWX$L0I)'.L<@W DA<21M]:LH(T'*A@<%CGEDQ^.JTWG.\[5X8XBY!W^(HHY>
M/MT&9=[85,!V_D\C?5ACHY4FL6@Z377AK6/,CC$A59)#)R.REO@'0'3SX(Q#
M,>IN,H1Y+!10V?Q$0=RU91.J,%&06(1EW$A'+:%N77H??K.=IGU=NLZ6W=SG
M/]&E>C?;UO*=C0>17DL06#+(EVV\:3P!-JWDQMLTT3%%+(X/0?J:W;KE:W&S
M@L-=I14\A3@OUX>/!+4:3CDJ\0VT@;XMO;J(]XW"XC&O.V.J153:97G$*A Q
MCC6)#L.GPHBJ/H&@[7:%*]6>M<A2Q7DV\R&0!D;B0PW!]Q&^F#A3PF#HSSST
MJ%:K/9.]F6&&.-Y#N3N[* 6ZD^.@@=[38ZIVIE;%V)9*\5660Q\ Y8QH7 53
MXMNOP_3J6:/Q=WOW[C4R4]:O'8#IC\E1<3JK.!<J5XDY\9).++Y9Y G=?;J7
M73K^-MW_ "_R?I[T$CI_HU?"B9IHKWDL]U5%D^55@!YD%]P'9N/Q'IX:LG"=
M^VVM%OXG$Y"N:U^G!<KDAC!/&DJ$CP/%P1N-5A]JXO&U)9)JM:*"298TE:-
MI9805C4[>Q%.P]V@E: T"7WOW!W0F=Q/;G:=O&0YF['8M6$R22S!:T 4!ECA
M>-QR=]MSTT"SV7WWW_-7P><[NR?;]3 9B22NL,,=B"SYWQI$JO-,R'E*@&VW
MMVT#_5[E-C,SXP4IU,#E'M?"T0V ()(.XWWZ:DI5WJ@T'QF5?$@?7H/!GCW(
M#<B/$*-R-_?MH.<^0IP(K3RB/F"44_:;;QV'B=!"7N.E)=@IQJYDL<C&7' ;
M(-SN&V?Z/LZ"8TEGF0S)&@&X/5CMOMU^SH.1HUIYQ8=5>>$/'#-Q4NJR!2X5
MMNG+B-_JT$"2A1R.)DCN1>8T$A+%B0?,B.XV((/T:".W;?;RVHV;&HJU[,4L
M3DN?O4.\3[$^(DVVT%M)Q&2C20<ED4F+<;@..O3Z=EWT'%5@CL.C6541RLQB
M)'42 -QVW]F@AY/-XRIC4\R79UV\M%4G?XN(7?[(W'3KH.\F:AD5)#79SL5:
M+^$?XAU!6,/[0-!PKV^XK%MFCHBK5\M0K. &)4GH 6!7H?:N@]_AF>8>5'96
MM!R+<B2\G7J?L",>/]EH.E7MUDIK7M7I[3;$/*_$%MR3[B?H\=!WA[<Q,<2Q
M^2756#CFS'9AU!\=!,@H4:[%H*\<;'Q95 )^L^.@[G;0'0:!=[CPF.RW(6+\
MU='B\IXZQ3=U#A^GPNVX/[704YQ$%&N_DV+%A%2&&/YGRR1_*UD^$HJD[ECH
M'K0&@- : T!H#0&@-!DW]8:X*N!Q[-%)(LC7X?NUY%3)C+"!F'[4;[L?8-2U
M>O77Y]]&8._<'DZ/<%FOCY>W,(NTZ6;M>DB?B,"-%R<;D.XXLNZ^_?51M-?U
MJO9M<U<Q_84>0BQTD=";*);BLUY[!D188(G2%FF^\G4A5]^^@O<#ZP]U-E\)
MBNZ.R[>&7*RBHV5+L*RVC&SH@66.-OCX';KOJ^QJOB.NH.:00QO))&BH\Q#2
MLHV+L%"@M[SQ4#0*W<]7*#)K<B@MW*<:1L]:/@Z>9')NIB7DKB3<AF/V=E]^
M@P[^L+W'CZ65PT63CL6,SA[V-R%JU!&B0O"C!98]BZDMR&ZC;C](U)UYU=XP
ME^FW<]2]7[<BI)9CR.+@@Q4<IC1XA/<RR2<F4N.<9A)7;;?<[;;==:_+-3T_
M4_;57)SY&+)SQVJ5;R).-20B,/)/(&9IX>3?>+Q^$^&S'VZ@9K-2M9C$=F)9
MHPRN$D 8<D8,K;'VJP!&@ZZ!(]3?\:[,_P#J.I_$S:"SSC97](: K"#Y;RG\
MTS'Q'-=]E Y;\N&Q!]^^@PSU'[LK5NX,M8K(\UBAW9VY.5*-P+05^+*7 _;*
M?IUKK-L^Z5(M=NX/OPIEK]S(8HID+BWTKO6540RN3)&T4+R2J"P7:1N74ZG:
M27@EWBK"Q_5QP8[QQ\'Z1YAK;X^W-%?,L7F1K#-701J/+VXD3OOJ*A5O3/MK
MMF'/6JF5R5^J*DD FD^4E8LA<3'R[%?X%C?Q*G<^S2A,K=RX'],(\U<4P7F[
M@[=+='+?)5\.R[A3MXNP/A[=2;N%Q^E\58R4O<CNYKFA)!SK^6?O-V"ES(".
M6_V/ \=:J2Z\]M-OWIW@/:)J)_5IIJ*]^IV<RF"[!S>5Q15<E6KDU'=>2K(S
M!%9A[EY;ZEJR,WQN%]5/G,/!W-W?87(B01SRXZQ7$7*=6*M\LU%%D7BO@[G8
M]1JXA1SF9]2HNZ.XNSLSW?G+M:%ZU:O<PN-H,@3(1%U6R[&)XR 0-T/7KX:G
MV:G2W<],-E])8ZV6RV/M9I(CB[]O'"5:TD@E:K7DG5P$)XB0Q<.OAON>FKB-
M)[)K]V]F=D393%9SN&&WEJ4V7=*>-J6*"_+Q$!K$D[2L@'$<V1?L_5I+L:^3
MI^-XNQID-;U%NTNW1<[QNV,G;HIF9)*\M?'UE!*!(RJ5;#2_POQ*_P /32>7
M.TU>EF4[^C[L[D[=[OR"9)JD=2]C)8PC>77LF51&\L<-8,_W6Y^#ZM,PU=>L
M.;[BQ/9C/VY*M?-7;E.A3LNH9(WMV$BYOR5P%^+J>)V]VIK6$B/%^H\.=QD>
M5[KNPW;C'',]:U6E@2;R7GYFJU&%&&\6W+?D =674L(=FUWYW3!F.SNXNZ\S
M/Y^3L8/SZ.,I'&.89%0>=-]U.O[9PI\/?J<6XU.MLW.&6W/23(0V+<TO<>]V
M!<\037EYN<*H\T<PY %E7;8D]/;XZL9I]HCOOTX[(KX_!]PYR-Y(Z=U)$QM2
M3"Q#)R1?]/,TDR[>?L0%ZO[.N@UK*=O^H=+(8^)^]+MW)0U?,LRB6M2K,[MY
M;<:ZT[(8;^'/[.H+KT;SO?$\W<?;W>MJ._FL';C NUTVA:"S$)8T\P)"KNG7
M?X!MTUO.-3?2Z]6NX,M@>P<KD,3(8,D!%!4LK&)?*>Q*D(E*-T(3GOUUSMY5
MGUWMWU3Q^8Q=C)>H4L[M9AQ\L5:!8019=4,@B9&@9EY [LI^@ZU"TGV,YWCD
M[G<7IYW/W9E[^0EMG$16L92HQTQ%8AC(>U_!S*@,I\S@?L@^_19+Y8!W)V.^
M-RMRE-D);4] 7(W?Y63BWX?&AV5E+CB0QZG[(&[;;Z&36S5WS_I+V+;JT.X,
MW^)VJJY>*6&K4;&1R64!2.8V6EE63X3RX^/0^S275[]?QN--N]L>IRV,89O4
M:89&K5%BP_RZK!*T[,OPUX$V8*J#^$Y=>HU-3-B[["[ISN#S?<';???<U7)6
M: K6J5]XHZ>\5A'+H0-E/E\5Z_3JWQK)XC[S[4DF6%,O4>1U#HBS(25;P(V/
MMVTQ72+NOMR8\8<E6D.Q.RR*?#??;;ZM BY>SVO:]3^W>Y*#G)WAC+\?EP,I
M7Y6,QR"9%<IO\3;<@WMTW%G7\KA9[<K]J]P]B]J8W-H\,.*R?+YT-$C+81Y+
M4,:[EY-I&" CCU\-<OA^;K\DWJ]?_=_Z/R_];M^'R3GRT7 T,B^6MY+'V<8:
MMBR?G!!59)V ZE9)2PW<>\KKKUXCQ]I[GDXCPT!H(]N>.%H6<$AY!&-MNA?H
M/'0=$9>9''BYZG<>/Y=!3Y[$39#Y26LQ6>G,S=':,%6'Q*60ANO3PT$6?#^7
M=@R-AX()H$9(T7?<\V5MF8^/QHO@-!/NY;&>6LDDN\#@AF3<$;$$;$;>W0<!
MF*=?E9@BEEB,801H 3\!V7B-_I.^@YU;&7G>P4I-%%/U;F#R^SQW7GY0\- 6
M:?=%HK6#QPU%4;SLWWQ=2-FXJK >_P"UXZ"4N!D9!YUIGD&Y\PCFRD^/$R%]
MOU-!YQO:>+H\SRFLN[M(S3R%NKG<C8<5V'LZ:"Q&,QP._P M&2/ E 3^OH).
MV@- : T$=[]1?&523]D*>1.WNV\=!'?,1#HD;$^]]D4?02? _1MH./SV1GW"
M)Q!Z JI)_P#.V _7T'D8Z_*^\S]/:'8M^LNP_)X?1H)$>'@!!9V/T+L@^H!?
M#\F@EQU*T>W"-5(]NW70== : T!H#0&@- : T&7>OA(P-3;_ *O)_P#=5K09
MMZ/]MXW+XVMVW,D4F R$52UD*S%)OOXJBRK&J/R\L,=Y"?'?PU<]I=.3=B]L
M]O/8QF'FR4>'GLM:O4ZUAH)FR$#Q,C5X1"$<#RU/PLHZ#QU%7\'H]8-S&V+_
M '5D\Q7Q^1CR<5/)>5)&#''(B@&-8FY#S 0Q)\/#KJSM6;TEF7PT@]%U&F0Y
MMUR'=7<-C+=U6>WZ./MPT:U,6I( 0U:!UE412*.+O*Q)*_60!K,[-7KA!]0[
M^6I=HXK)=I]U9.Q?M9M\7)#'DVE\Z!9)HTEB:3FD:N(E;DP8=?'6F2+WUZ8Y
M?*X7']T=QY')?BMC+5L$]2[/#>E6"9^DBR1)"/;NB\>OCOH*GTU])HLG&F9J
MY6W4NT,4V=KI%PKLUF"V\,<<<T@9%W,0V?8[-[/>O!.6F>ET_=67RG<T/=?<
MN7HQX>**2M2FR7WS&6$R@>?"(HVZ^(X;CP\=!?YS)08>I!D^WN];F6R%"YCF
MM8U+<UDSPV;"HT,8D<QNS*2OMV]NQVTPG+] 1OS4'8KN =CXCZ]$E*/?=.U:
MRO:D=:/S#'EDGDZ@<8X49W;K[@-%,EG$8RS:CNSU8Y+<2\8K#*/,5>OPA_$#
MXCTT'YK[Z[%];9>\\U8PW;\%_%39VMF:5F6P$++20+#%P66,!/R<OIT&I>G_
M &D<9BLEELS1GPTWXM/F12CFY;AJZ!A)P9Q(O/GLI;W:"7=[XQ:^J>$QC5KB
MY"SA[LD,!AZLCS5W#;\MO"N__P!CH/7=^(K]X=AYS(8))I\CDJ$L6.@E;@JV
MH/,2(A&/%'$OB?H&@P&MZ5^M]ONY,MD>W4J5F:K(ZP6%<QO1J-7A*<Y6;XB0
MQW/U;#0?JS&X6A7\JV:L29$PQQS6 B^8>*[<>7CQ&YZ>&@AX?&FKW9W#:\SF
MN06E,%X[<.$30[;[]?X+?\N@M,OB,;F,98QF3@6U0MIY=BN^_%T/78[$:!?C
M]+O3NL\MB/MVB78$D-"K+OOOT5]U7\@U*2:S>]V)%B9<UEHL1#%=MB9<5:2G
M&8H T?FQQNB%%,2!""[CQZ?7F3?+T]OEG29U_P 63]O^I?:%/$-%=O-\R<IG
MK$SF*4DC(8QH:Y)*_G2ML ?#6IX>>YK3>V:>)S\>0H34QF6@L*/*FA+&$HKR
M>2WQ!3&%G'E;J4WW!UOMVWQX9DOMI6,]+.Q6P5.M=P52>588UDGEK0Q6&( /
MWAB"[-[P.F^LJN\!V9VOV])/)A,=#0>RL:6#""O-8M^'+KXCD>OCH)6;P6(S
ME$T,M52Y29TD:O*"4+1,'0D>W9@#MH%^3TS]/J$$T];MJA++]H))$C_%[-O,
MY!?'V:G:\-=)+9*S*7M.EV?C<CE[%1:=F202V,FM-4"P0S@R!4C/!2ZMQB*C
MDVW(C69U=>_R^IXGZY(MKOGMJG%E<-9NN^22GW;782HP9I+:1")F9O R&%]]
MS^SK<W'&YO'@V>G.*A[I["A@N4ERSN2]&X:G)H8H$6J&8RGRY9D=-U$B]5'A
ML-7MGKPQUGU\M@D]+^P;%:.*U@*#LH'*1($B9F V))C"'K[O#4:6N [5[>[>
MCL1X2A%CXK3B6Q'".*NZHL88C?;?B@&@DYC#XS,XV?&92NMJA9 6>N^_%P"&
MV.Q'M&@7)?37L"E%8L5^VJ$LS#EP>%'4MON-@_(+U/YNIVW.&NDEN5G1[&@[
M5IY7)-01+.TLDN5-:->*(PL2<5C95X>6GEQ\1R)'74G7C'7Y/EGB>/UY8IWA
MWCV\,G;A%R69UQ.7K&62-P[2VZ5>.'GN/%BA!;]75G$<;YX;%V94;,X7(8^S
M5?-\6->%Y8"Y KTHHY_,:0\'D62;[I7&Q V7IOJSQ"^;3_E>P_3[#=F3W,G@
MJUY,31-BW,*\,5B?Y6(NS$QB,!WXD[;@;Z(0L[7PR8UKU;L:Q@J=E(C9L(<5
M(DD9 2(M')+(/LMMN%Z[]=3.5TZ5/32'("MD8<@:L+UXD2E\I3/!50 KR5/'
MENWPG8'PT9L7=7LG%8SMZQ7M&*U.D<K'(O7B60;J=FV0*-UU;RK.,J;=GNOM
M7C,_GQXF\M<5Z%FC(\(\@<@R222<-]O@V^G2B[_EUJKC)14CJ1ULE"]5GHSO
M8E:*.5ASCF:)G8^Q]]P>NGXR>FNW?M>+;</':+2.F0DF8FP]G>9#6:KQ(10!
MP9I.73KRWT97[,%4L? #<_4-!7-W#C )").1CZ,FVS;[ _9/Q>!]V@@W,S;M
M4R]6C(Z*\;;LK*=ED4MT8#P4'02KDV4GKN:BQPE?B2Q*>@V_L%Y'P]AT'*/'
M9.>0S?B#1 @AHQ&-M]P0VQ.P/'0=ZW;]6)B\LLMB0^+.W'K] 0+H.T&#Q$#!
MHZD7,$D.R\FW)W\6W.@G!0HV V \ - : T!H#0>'GB3[;JOUD#01VRE, [,7
MX^/$$_J=.OY-!'ES!Y!8XO$[#D>I^G8;_K[:#PUC)SK\ *^(/!2!]'Q-U_4&
M@^+CKDP(G;ITZR$M^4(#QT'>'#PH26=COX@;+O\ 7MU.@DQTJL9!2)01X';<
M_KZ#OH#0&@- : T!H#0&@- : T!H,G_K!78HL=@J9#-8RMFUCJ:* =Y[E">O
M$"21LO.5=S[!H/SWZ&)W+A.[>W!7PC9&2=;[53!(D$DG! LGESRQQJ$C(^\'
M-N1TS5U^CLI8S^2,]F]Z<SVFD6,.AR-7K\N_FQ\5Y@!E<;@C4M+#'V_W/W?D
MKD$>1[1L8>I*I:2U-;K2F,A20&CB9FW)Z=-5#5XKH*ZUVW@KGG?.8ZM:%F19
MIUGB24/*D8B5R'##<1H%^K0+W<V1MX[)(@>6##Q10.P@AD58RLO$*)(P1)R^
M$&/;HNY/308SZ_9R%,CAI[5><7L;E,9:R1IHSUR%(W@Y$KRF!&ZJR[[>W3KU
MN_KZEPD^G.?J7JW;D=2&6>QAZU>G/5GBWK/+9S".C3 ,?N?+8@,4/Q> ]NFK
M?'[OT_VIE;F8O17ZMF5\(\,KE98FVDD>;9"&E"/%Y?%AY?'P(^C1%W:[5[:M
M3///BZKSRR1RRS^4@D=X762-F< ,W%T4C<^S06NPT%?DY<37GI3Y":*&7SC%
M1:5@N\TB,.*[D;L4!Z:#QE.YNW<36%G)9*M4KE@GFRRHJ\CX#J= LY#UJ].*
M=B*$9>&SYBEO-KNDB+L=MF/(;'2'IR[D[H['[Q[<O=NX_N&H;N3@:."..6-I
M"X',+Q+#K\.WCH0J6\7D!ZV=LYM8)VQU' W*\\DMB%Y^9DZ_$9>NQL+M\7[&
MI9JZG]A=X=B=F]G24[O<%6:VMJ[=FJI-'),&LV9)O*&S'DRA]O'QU4D,N.]8
M_3B[$9#FJU;;8<;$B1L=_<.1U;$U,SGJ3VWB#0!^8R R43SU6Q\1M;QQ\-V/
MEDGKYH(U%1>W?5#"9O./AH:=ZM:"+)'\U7:'E&VXYD/L1\2E?;H+/O\ [CM=
MM]FY7.4X%LVZ</.M#(2$:1F")S*]>/)AO]&I:LC.X[O]82;)8R+*3X''HTOE
MVHJZM81C(I*<XWD678<=_A8?E&JFD[N7UB]2*6<S79'<D]''W@8JU>WC,98O
M(RW$WC=BUA5C;BR]"I]ONT'Y]M^F"T<SE<3D,]3J3XJ[:I,9!)]Y\K#)()5
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M>3;QV7C^N_$:".<G"FP2#??XB"57;<^/7Q_\G?0>3>OR;B!!M^:45FV'T\N
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M*-S( /$'8[?L:BH=ON7%U"/.<@,0%;8!23T W)&@^1YZ.4_=PLPV^V#S7_S
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M"P*$_:=2OZA.V@]Q8ZA"=XJT49WWW5%!W_(-!( VT!H#0&@- : T!H#0&@-
M: T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H
M#0&@- : T!H : T - : T!H#0&@- : T!H#0&@- : T!H#0&@- '0&@- : T
M!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&
'@- : T'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g425213dsp133.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp133.jpg
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M:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E
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M8Y,TE>&BPH.CXV34M28G\$2$I$48\</$Y&6%1C@1 0$! 0 " P !! (" P$
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MC7;O1Y5?8V8P5#!^FX.WAH+A*4JUULR=LU($!$5$67M7H6)VZ[;;Z"KO<_\
M;_%5'L36YP8R.U?1E1NYE)5?N#M[]NA.@_>-R5.3YO*EIK<$5.&@5J+8*F)[
M$+3.K^F2&.Q70>.$8^G%GN90=-H<HFTDV\C$?1P?>9O'J?CH&RW9PE'%MD[<
M<44$:AI)%C#$;D+T"@GQ.@4K'.N$?5M'/<9[-EU7'[12*0S;;1JO;L.W<$D_
M Z"?F*]N3G_"IVC+"O#DA:D4=RHSP1@!F'AN1TT#N?#0*N=LPTN586W;N1UJ
MA6PG;-*L:,_IDC[VV_34@MEY1QK;;\WI;_\ .(O[K5'[_.GC.^WYO2W_ .<1
M?W6@/YT<9_ZWI?XQ%_=: _G1QG_K>E_C$7]UH%S(W^//S'"Y%,K19QZM?L$\
M1<AHW;<;'Y_;\= Z=Z[;CKH(-CD&!K2M#9R56"9/OQ23QHP^/568'0>/YT\8
M_P"MZ7^,1?W6@/YT<9/_ .MZ7^,1?W6@/YT\8_ZWI?XQ%_=: _G1QG_K>EU\
M/Y1%_=:#K4SF&N3>C4OUK$NQ/IPS1NVP^/:I)T$TL!XG05S<FXXI(;*TP0=B
M#8B!!_X6@_/YT\9_ZWI?XQ%_=: _G1QG_K>E_C$7]UH#^=/&?^MZ7^,1?W6@
M/YT<9\/S>EO_ ,XB_NM!*J9+'W5+4K,5I%.SM"ZR 'QV)4G02= :!-]REVCX
M\P5F9<Q78=@W?[K[]OV[;Z"5=3T(+&1@ADCIK2ED9Y1YE98S(CB)O,6^>^QZ
M:!'?/\DK5E-O(()'IBT))ZE= $,?J>K\NBCPWT%[<KT\WQK(9)99!#+A([,0
MA8Q(3-!*Y8QKT\VPW&A$:IC,5C^#P9R>:VAC,;R"*29ALUA4($4?COW> &@M
MKN<PL=.S9QE>?)?1S-5MQK)V&)U0.5WF^\=F'W=!&Q>7KY'*Q4HL?/6]16=K
M,PAD2/M!Z,-O'R_/01ZN#R3>Y.1CCF9:,>*JF.1A((C*T\A/:J.B!E4#?;X:
M!K_*\PB@)9!V;<@.Z@CY=>[^OH/,D/(U/<C$_P"Y21-M_M]13H/R.QR2)2TR
M"7;P01C?;^R5^O\ P=!^SY^W #ZU1@VWE15D/=^L*0-!Z@Y-#(0'A[6/[JNI
M;I\P>TC023GZ:L%9)-V&X"+ZAV'V(6.@Z19S%2'M$X5_X,@*-^Q@-!*2U7?[
MLJ-^A@=!UWT!N-!^=PT2U^@@Z*- : T!H#0&@- : T!H#0&@- : T$/+W9Z>
M/GL5ZYM3Q+W1UP>TN=]MM^N@SCAONIR/E5G*018B+'''2/$-V:PSM'/+ 0?X
ME%\T!^)T%X8_<B[*I2>.E6.W<=HN[]6WK=/]]H+2MQK(]LOUM][#R-W L\A"
M[ #HJE%V^S;02H.,P1C9I 01LRK&J@C[?O:"0,'4'[TFWQ <J#^D)VC0=(<+
MBX00E=.OS'=_;;Z"2M>%/N(J_H4#0=-M : VT!MH*KDW'JO(,)9Q%MV2O9[.
M]DV[AV.L@VW^U= '&QU9S.I.S*P*@[)W,.C%.HW^&^@06Q><NQXRKD7N=S1Q
MMF%$,7J^LB[GTV6,J59_$'X>&I-%7A<%Q6+*V8>;75KY-*=$D6;0JLQ990W2
M,Q*W:-E\.GAJCS#G[E&7E-W"A+>&&9@-BQ"X8O66G )%CD!/F[!T;X^&@NLQ
ME\S*U*;B,4\O'[:HTDZJ/34EB&[%E4EMUV/CX]>N@@<BNW\>TZRY%JT=B MC
M%M)6@<RJ5W[F=%!4?,'0:/CN2\9ORF#'9.G:E4;^E#-&[;?/923MH+1)4<[*
M0?T$'IH,P]T>)V<OR_CN1FPL^>Q>-K72:M:186BM.8A%+W&2'<E=QV[_  U(
M%;-\6H?S0SJY_@QJ8RRL?TCV+\+LED!HXY&[IC)&6E=1V*S;ZH5+G%9J/ME^
M5<QJ4YLU'!3K8))J=7U:KQ68H9]Y8?49DDW&SMXCQZG;0&!X9A8/<[*C,8C%
M28VK8M5XJL5)"3-Z:>@(8F[P$0CRCN_3H+/"\1S<_N)%D\UBH^068L78APTL
M$=2I%#:BE*NW8K(CA%D[=Y!W;^"^!T$O/>W>1O\ &9\<W!;29NO%$]'(B\EB
M(6X^W^4[>NH)ZD]@31EOU995JPK,W=,J*)&'0%@!N=OTZ+&0P8.QA^3Y_-7>
M&SY:6QE)[ R(^E/K4C$$AB1)I =U=R?N^ T4QU\I8M6BE7V[ J5Y&BM33OCH
MB-E!5X%[F$J$G;N[AH*GW'P^-RW"LO6O<%C6..M+8BE$U%/3FBC9HY-X90Y[
M3U('B.FQT"%@.,18ULY'2J8G%\D^K]6"Q5HQ31P4H@1:C03*O1G'E_5X:"1Q
M'@F<AP><C;BHR6:L9YK.4N">K3:>JK"1:_<C[Q]'\(QV[GQT#3QWAC1^X''<
M]2XC:P<E86H<I>LSK/W0M"?2B $\I [SOOMH-:RT5B7&7(:[%+$D$J0N!N5=
MD(4['[=*,+XWP*[C>/8K'5^ 6_S&**%[EB6_'%%ZY/?-( 9W4D]?(4&Y\3H*
MO(<)S'^M7*9OC>*AP5*>J*^7]1:5V-;.XGD]6-G=(@\2CJGQ^&V@7^7\7XY:
M?D-[C6(Q<6,_-Z%6&%JBJ4WH%Y$W7M[8C(.XA0>YMCX:"[R7$K;\!AQ?%H*-
M2U:Q]BMF%KTJH^KN!7!*RR*A4(JMW,O7^"#H+[%<,>O@\&<;P6:;#U\?&H@B
MNQ1/]1*YDEL]JS*\I8G[KL-OLT*:_:OC$^"Y!R:Q%B7P&(R+5)JU&Q*LKM.(
MB)Y?4628=6Z$;Z,M/C967<'<?,'?1J/6@K\OAH,F:32NR&C92W%V[=7C! !W
M^'FT'NS7CGBEI6D#PV(VC8#<!E<=KKX[CH?AH$G-^W& N58Z>/\ J&EA98B)
M+]WR0;%)%CWD8=W8>T?#0=*6"3"<;Y%25?388L%XEEDF1>V&9%"&3P7L4=
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MQ12F%(K5:Q#6!B;<#OB9N^0G?KT&@S:I[S9Q>4Y#*RY44CE";#QQ58GC+SA
MR_B%V1&7?KW;KMOH/K+CUKCL$M>]+GZ;+]/$$0W$>7NV/<)9"^T@V( \N^I)
M35[1YKPZ^TB4\W0L/%*:[JEB(D2J0.S;NZGK\-47AT"_R7)\2^FFK9G*5:JU
M2L\@>RD+QF/SJS#N5MAX['QT&?<LQF$O>VF2HX3D5?(9;+I2[[BVX(O42&9'
M+11&5(X]X^X]H(W^.@SG*XC ?E>0MXURTN+68V%];'$;I"^\9"3*Q^\/#?\
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ME^JIXO-5:>25'2-VA<=K['9PA5/4"GKT.JA'K9?CG(L=DJ+7Y<M)<#1W17C
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M37HJ\(BL322QQNI1W,:!]F('PT'3EU_V[Y3#B9LEFL/!9PTM=;,8M/:2Q"C
MRPU]_3$:,JC<L.IZ;ZQ;77\IHX7_ $A./5>.0\2AQBT:-.Y*:]MKL5>(1/::
M6-2K*Y*!7V?[/#6]<^IE6O(Y/;7W 6.._FL-1RE'TP)UL/<B]%+'K210C9.U
M&B':[[;DG;P&LWIKGC?3W[/8ZM<XYG<WC;N0QF#MY^1Z&%@"MCE@6>,!)6:-
M_*00#LR]-7J^&,NX^@\+7P\<UR:FE=;\S1G)FN=R9%0!.[?KT7[N_P -5-7
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M*PS12R7W,J>J0#Y0-COX@;:"DYUB/<3(VZ?'\%4AKIC+'YSZ5F45DL&E.#O
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MQ^-R5C&'*Y^"E8FK2RPDQ2HRD,8FC8K\?O:"$OLMRF3SQ<AR+1DGL;\QR W
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MG^GI<DQUF<J6$45F)V[1XG8-OMH(?,<%.9,GR"J(6?\ )+5&99"RMV]9592
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MS!?TG;0?GJ1_PA^W0)_N-=AJ#CUF7O:&'+P22>DCRD(D<A)[4#-T_1H%7/\
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M]!5\F_S'9_WG]\70+'M%!Z&*S*>I)+_TK.>^5NYNL<9\= ]Z T!H#0&@- :
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MVZ"!D\#A<LL:Y2A6O+"2T(LQ)+V$C8E>\-VD_9H%[.\5X+BL99O_ ,WL5O$
MW;)7@B1G8A5[G*=-]_'08/[X<-Q>2E5*''*5&6G1FLUXJ2I68^O:KUHY9@8T
M$A#LP";]-]]]09[AO97-S\BN8JW35[&/[HGE6:+TXY*:H[=Q907';OML//\
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MJ4!7J/#<D7UPS223,CEYD#R2=B-\MAN>NJBHX1C(KG$[DSLZM2Y!]1&%VV+
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MBKQH9&X*UT*KFM)982=K[]I[1UV/:=!2S<%X':L3+0Y#718H1::$$R,L+2!
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M=]MO<[&\RLY6I2DDFEQ/HBPTD$E<J\O?Y&258V[AZ?7II0V8'!T,+0-*BK+
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M>5=+E.BE>U7NCT3(R0HK)&_:_P!PJ3^CXZ*??J<Y_P A@_QEO\%H/WZG._\
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MW\P4.C%T4(O[W0GY:#YWY3QD93W4L7+-*W+MR)W:2O%!('K)C(I1'&'8'O\
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M)VEK\EM6I+,M9)*\9)B59)#&4*'NC<#8=_3N^>@=L-Z(QE5:[&2 1*(W(V)
M&W7[=!-/AH%?E[9VO6GN8^T88HHON)'ZLGJ$]J]L>WG.Y'3<:B6$6MROF+6%
MADR%E/Q$K2RRX_L6.:9A#'W[%NT>JRZTSAUY$##C,+'D[LBV5MP*TT"_QTP!
M\K ?=1CXZC1K*AD8'P;<'14:!R\BJ.JQCS'Y-X;?U- O>YQVXU$0W81D<<0Y
M\%_ED77]6@@X&U':Q5P7!#: N3.Y[W[9"H'F\J;$-MOUT$C.\\.&X_7R4-%)
MA*8E2L)&CV$B[CS&/;R[;:"Q_G#D6] &K6WF&_\ 'R]/+W?^9T%!%>NV_<NL
M)ZR]D54&*:.5W2,L).X%61/O].OV:#0- : T"-[JO13&5&N/8C7UF$9K;;E^
MWH'W_<^>@M<''6RF/_,I:\8M3HCA]@6 [ 57NV!T%E%CL=([.:R;=H0KL".O
M5AMH$;A?'Y$Y;F+,:PQ4J-IZ\L2@ F4PH0ZC;Y-\]!H\1/I@_'P'VZ"DO\ZX
MM0G^GMY".*;J0A#$[*-SX ^&B7K%Q2NP7*T=FNW?!* T;[$;J? [$ Z$JAP
M*V8MC]^K*[CYL+!&Y^W;12;_ #FSD?,>*X^K>D-R[4L293 /VK"JQH#&V_IL
MR^)Z]YWV\- @^ZW_ /T+7_T/C/\ [KQZ#Z%P(_Z$H_\ $1_VHT& 5NY>=^Y1
M%1).ZO%'(9]W3T7RM@22%%\S* .L:]6VU*-!RYC&&Y>D9*K'3VCD)'XX:)6+
M =N_;$?(.I(^.K?$"[PM=Z.%@EKI4K"?/R+9/=)-ZIN.K(C#HC=NQ]1^A'36
M=$OW *S>U-<M#V&:-7DI!MA!O)"3%X)T3XC;KJRB7D7[+V9D-6-9SF:U?Z2$
M=I6$I'&MF1V!23TX]I5"#R>!ZZHL\J)%]Q<?8KTC?L0Q7FKNTJJK2"I6V3KN
MJLWCW[=/#01N*E?S/'Q]AC3\J,S65(5!*693452"P!'XAZ]=M]!RK0>GB++I
M1$)L93'_ %%J9_5)01UV60+NS=C-T5/!?';0<K;]_ ^4EH369;:QB$L&+HEE
M0E@[*O69?-XG02N"C_\  A>_YOEO[[/H-/\ GHC",IC<9<]R[$N1:9*T5BZ]
MBQ&'\B1P @EE'3M"']6^N5Z_Y/5^?//^.V7RZPX#C7)VBCK0WI<>)0R7XBL\
M9A=-XI )%?\ C%.X[1I_DNM7_7X^OV^_._W3Z?LOQBQD9JPFO)''&C+,\$"
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MT$Q462!GV_C"7!^/3[O];01<\X?C628>#4YS_P#1-H%K(M5'$^*>O$TI+T!
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M';NUMYV0^[!5/Z0==G(51A\9N?A_G>/0;CB,+6B^DR$KLLZQ1H\;,=@ZIV[
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M*?.<?E</B!E<95203>I<AKNQGABB+[.A8NOH_,*=]!9\>XCD:DN-L66$#UH
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MT.)=G"A=_P 0]OET#AH#0&@-!\Z>ZT_'$L78LQ22]*\X-> Q),P[;,K.X#^
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M;;?6K$=?<N.S9YMAJ=:O)/+/74@H 501VD<ER2-N@.H-#S.17'4S=->>UZ9
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MJ= @)@<A0L\<GFP8PT<#8?'S,#6/K6([0+,!79R1L/%M!LPT"5[N?^'O(?\
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M3,O>$;UDV8IN.[8_#?06V)6PN.JI8D$LRPH)9 O8&8*.Y@NYVW/PT$O0&@-
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M_-:/O;<FS#Y0.@_'CZ:"_P"%6[,W%*%N5N\LLA==OE*XW7;[-!7^XV$I99<
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MC68T%@!D(<*5[DZ[@>.B.OY)SO\ [SP_^[D_PN@\3<>YQ-#)"_)XNR12C?\
M1R>##8_^5T'O!<7Y'CJE:E/GQ8ITX4AKK'3CBD C4(N[EI >@_@Z"-S/@F1Y
M)BA1&<EK,LB2"5Z\,H\CJ^W:!%\5'QT$_"\5MXK$UL=%EYV2NI'?Z4 W)8LQ
MV*';JQ^.@@Y7B'*KT]=EY&D4%.RMJK&:,;LKHK* S>HO=]\_ :"1^1\[_P"\
M\/\ [NC_ ,+H.5OC7-K5:2O+R>(QRJ5;;')X'_YW0,6*HM1Q]>HTGJM"@5I
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M4>15^.1\C;$RX"ED((,:L@2=540Q]\NZQ;HYW<*?#Y:FCS[*X['_ ,P9</\
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M+E@Q5R\]V:Y$8XNQX_5  4[C<$#02^:_]FK?Z8?[\F@MJ1!JP_V"_P!;0=M
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MB59X]N]"9D'<O<"-Q\-QH+;%0-#CJL;2O.R0HK32;=SE5 +-L -SXG02] :
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M$<T<,;D>(#V(U.W[=27PIAH8"Q2H5Z<&5M"&M$D,0*P$A8U"C?\ #^0U0O\
M)JN43D''EJ6%NW)&N"$W2$A0"#=SM @9CMX=>F@HN1\H]R\)++/:P6)_+5)1
ML@UET5F9@B(L9!=FE[SL/VZ+\*R3W+Y+-'#]/0Q$MJT1&*TLLT6\IDVB0NRE
M.XD*5._3<?'4G1ZGF&/&0<VNTV!CQ5:Q.0[1+//(\0'9WQ1R(#Y#Z?G ^.^J
M89\1R2"4K2O6:L>5:Q-56O"Y(9X%[F"AO-N$/<0?AHC,_</)Y+&^]V(R./6J
M\];C5R0B]*88.Q; []Y #L=O#05>:Y/8Y/G[N*RT.'AN8F".Q'=@R,PBF5NU
MT2!U"^93+W'[0- ]^U,,5<VJ\=B"=1#"^T%N6VR>9TVD]1F[6/;OT\=!3XF'
M?V9O2!$E[)[TIADC:52R7Y-F*(58@>.V@H*E;!ID1%#EXI/HY5LU0*5A8YIX
MW'IH-INA;]&V@M/=+'2I[K\ R/189[JQ!>YOOI+&Q/9]T=&\?'0;/H$[W@&_
MMIR ?.MX?[]=!\W<6]Q<%6XF<;G);\EL02Q-W9NO66'T@Z10)2[HY$1>XCM?
M=OVZ!2S/(\10P,7Y#:*9(PUX1-%:25B"06B]);,S=>XC?LW&KH^U+]:M%Q5B
MT(D6G4]6%')V#11;KN00?A\]095P3/QY#FM/!VJ?U,=FI);N3M7EC@2Q"YD5
M49V*]>\,H\W0;[Z!;]_KD&.R=J\+"5K*97'P^AV/'++6D@#RO]2\BQJO<Q4[
M;>'CHNE[BO/."XT3"S-8AE[I"4IYRO#'(LX!D$@-A]SW#Q#:(HI<MC>3^Y.!
MQ>)>6+&S6%D;'V;\.3ACGGMQ&619(N]E]4[EE8GKUT'U?S.C7GX?EXY5[DAI
MRR(/,1W11ED.RD,=BHZ:4?'O'.58&3%8^3+3>K;6))+$OYA%'*65@Q\ILJ4;
M=1MY.FWAH&_F/N/Q:Y6,V)N9"'.($A@R39NM<=UF=$EADK!W+I(J@-VC^H-!
MO?LWACC>)>H?3)R%B>UO&.WHTK =W3JW3QT&&>]V7JT_>;(5<@@3'C&P2P*T
MXK+)+)_&2!Y)80S;#MV4_JT$+!\TX#0H9"A::>]6OR":2JF;KU8MYHBDFX^H
MD[B1T/7]F@K^*\AL9Z?+4I9*E^G%DQDEFS5A9'D2M%' E<SPJ8Y 4D*LVW4#
M0;;QC-\GP?#J%C"<9QL. ,<<S-%9"!4D8>M*=E4,!U(Z;MTU9!"Y'[H96YAK
M]9X*1=9XEIF)I6]4"Q'VMLZC8%=R=]MM8OM8F):Y++AN&IGZ\4%B//TQ7:)@
MXDB].3S-L>A[M_U;:TRT/D&(J28V[-7H1SWWB8)Z:1B9RPV*AV[>K#IU;12?
M%A2+GK1<4M0V'D3TK++34Q#U5))9+#-LL8V/0[Z!PY!6JP\8S?H1)%WT[+-V
M +N6B<DG;0>>"C_[U,?]J'^V.@OB.FV@HLWQ2IF+23S6)H62O+481=@#13/&
M[;]RMU[HEVVT-(_+\=EN-9;CRX/+V89;HGQ\DDD$5QE@C1K7DC[4+-WK\_#0
M7/ \SR*QR3,8O+9!LA%3K5)J[R54J.IFDG1^Z-2QZ^D-MSH'MO#K\-!BTW\X
M8<7_ "\PV;R\Y+5EC/:&'>YB5CL /)V#?;0;+"7>"-I4$<K*#(@.X5B.HW^P
MZ#%XO>7F&(YS>P.;Q@R\<U6:[A:N'KN)Q%%9:(&>2:3MV"IYF5=M]9ZZR-?G
M/M<2L9-F+MN*U2XS.E1KR79T>&$R"+;O=/5:TH^H]?J'VZ)TVTYZV-?K^=XN
M)^=YC!E/</B.%>A:H7Z>0EFE2QZ)4J:4G0-#)+UVE4['YZTYM4T!H#0)O-/^
MV'!_](6O\@FT%%#SFU@N05L;9@8TGH;-7<0UIEG@]+S>I:F@1E*S$;+\M!=#
MW2Q?_(I/\<Q?_P!N:"NX-F!E^?<BOQ#TZ\B0HD!:&1@Z0P]S&2"2:,@[CIOT
MT&>X7W.RO%^4<NQ=?'QVH)N52D]ZV?5?ZN6.)FC9(VB[8PN[=S#0?0Z@ :!?
M]P;<%/A^0M3DK! (Y)6 +$*LR$[*H)/ZAH+;$V8K..JV(B6AFACDC)4J2K*"
M#L>HZ'02] : T!H#0&@- $[:!6YV5VP9/A^:U=_^%J6R$8O%_2!AR\T'&JN)
MGAA@NFG9G]>%7F=)R $5CUB.VTG3][1<=^9KPK-QUK>9&.QMNE) 98[_ .('
MB@:0M7K%HY5V<2J&(.S'ITVWTB%#VR]ZH?YO8SBM?#218^O>GD,_K0Q*4LVF
M>&/M8CM53,%/V[;'5L#+RU>'Y:3'WLW-4Q=_'E18J7Y.^*=$&TL=-&25!ZBA
M0=CYONGKUU!1<#]^,78PU+B./PTE6DM^5M_5@A0Q6++RPP^F3T3\0*^W3[=,
M%GS;!8;D<N+R&1>M1L8RQ66]7O,TM=TCE#21U5[9%'J+VJVS;-]TZ.G.?*MX
MC[XT&QU3AV.Q$L-2CD9]RDT$*21RV7:*+TFV/8/4'<!\NFC/4GPO^88KBO):
M439B:GB<HIJUF?(=\U;OCLQR2)6';*(_5CC[3V-UWV.KL)S:7N$>\%"O7R'&
M\3A9J^*L\AM6(7AEKP(L4TX9*HC;IV@;!@/AX:,V&OE>-XIR*.&YEWHXN_5^
MEAD:^3+ %BN+*T5;=9E4RQ[(S*>NX4Z0</;;)8>;CE"W"BT\58YI9;&XSTHP
M%C>1^P)VCR]A91L.FIW/"RUM/ *CU>,U(71D=?5+*Y).YE8GQ \=_EK59^5?
M[Q_^&V9_17_RJ+6>?2FK)5K5BE/#6F->:1"L<X 8H2/'9NFJ,XXQ0OU+/ A?
MQPQUF"I;@L12,IF[TK@'N[-UV;M[OO;]= ]YW%MEH((4D>NU:Q#:BG"J?/ _
M<H[6\0?CI3"K#[6V$R]JW+G;5FG>E@GLT954Q]U:59D"#P4%EV/3?8ZQ.7HO
M[R\YARK8;&5'$M2G%!(H(#1H$.Q\0-A\=;<-*ECCUW)2O)!.:/TN5FG>S68>
MN57^"#&1W/\ <8D_<T0D\PHG.>[6#FNUY8<=8PUVL6'8K&:"TKA#WK)L-BK>
M'@= ^\7X=QS /)4[$M6+_P".994C??TQV[ +&JJ%'[=!>3I'3Q]JU2ABJE(V
M=0D:KW% 2.[8#0*GM!8L2<8:$,%2.:RZ#;]Z2[8[M_C^[H'2:^(^R(["Q(WI
MHC$A2VV_WOT:!)YRI>?C7U2QRW*G(*"Q60H![)6);M\>W?M 8?9H-#7PT"A[
MO?\ AMGO^(']\704>;IXNHE]UXDEQZ\U>..2&I$_JB<(2Z@IY@O>0YWZ'07^
M-XQQN6W81N/584A$9CDDK1;EGW/E(4?=VZ_;H&HQJT91@"K#M*GJ"#TVVT"O
MQ&A3CO9(QQ(A@F,<.P'D3U)/*OR'V:!@R&.Q^0@%>_6BMP=P;T9T61.X>![6
M!&XT"+DL7AX85>MQ&.>1[3P2(E6'I&CE3( 5Z @;KH*>U@L/-S[B\1P*8Y:N
M0MB)O32,SF"I',DR-&%+1K+]W?XCPT&LA1V%3U!Z=?#K^G0(_(,5QK'Y**O%
MQ>&VLM6Q99J]2/8& @E&;L([Y VT:_$Z"OAQ>'M8&O9;C$-::S#+)(\E6)/1
M"1LR,ZE59&)V"_;H'3B->&MQVG#"O9&BL%4?#=V/QT'/DN)Q-FI/=MXN#)6*
M\1](20I+(5'F[$[@3U^ ^>@4K5'"0YIZ,7#UFC%1K"NE6$ NG7TU<IV][^"@
MGQ^S00,#0Q39+,*^%C@]:?$2?3&O&!7::"%I$<;>5COLVWQT&A18R&?!QTHM
MJ\78JQF)5 3L;N7M7;;IMX:"GRO WR44\<^6G1;6PG")&H8>HLIW 'B2NV_R
MT"NTM:GQ_C.3RE"&G.;\0+'M!F[HGV^![69NFQT1=MGZUN:&2GCV]&,N)FC5
M9=RRCM'12/VZ*]R9M(2\DU&58MU"L8%&VY[>OD^).BXB93D56GB9Y+]5Z\;*
MT33/"JH&DW5.O9\2P&B%:.'C]BQ'W82WD;44TC1V*^3D17\[,/3B$JE!\=@H
MT!%B#8JSQ97CF6M$VY9J[')V&"0M)O''LTOBJ>7_ &=!U:I5OI:CEXWEI:LI
M"UU_,[#B-HQVMT:7;HX.FBHD3C,^;K06L#;DIUJ(>M0FRLH=)#*4]= TP[05
M!3H?U:!LXW;I8"2>UA>'7(GNK&)YOJ_7,BQ[E!W2O)T7O/AH+MO</++(L1XQ
M;$C@LB>K%N0NVY'Z-] I\DY#2R'(>.TIL,N)R;Y>K;,LLD7JR*C%#Y4\Q)[A
MXZ#7YY$BA:0[]J*6.PW.P&_0#4M'SS[@X'C_ "K/09?&5(X4CB",;E*QZ9*F
M7OV>!XCYFDW^]MN-/ML)[2L=[*\CR.&KRP3X?Z&W$KI Z9,?AL 0&3ZKIT^&
MJ;?E[P?M=D.'<VXE9LS4REC)652"DLZHI>D3_P"7:1O_ "'\+XZ#?= : T&=
M^ZUO(5,OP^SC^PW([]@Q"2*29232E!!2(JYZ'X'0+5;(9W(\^L'(I )JZ6H(
M7%.8)+"HID2"*9;##<L>OV:!J$5OQ[:O^(O_ /:N@5L9D^04.?7:^.6NBVW*
MV[#4[$D<2I4@=/PX17([F\NY&@Y^U<MZ[2Y-(].L<Q8Y)DI#9LPR"",Q^CL!
M$3ZFY)W"]V@U>EETDOG&SCT[ZPBP4V/8R=W:Q1FVW[25[OEN-!PYH=N-6CX>
M:'^_)H+:F0:L/S[%_K:#MH#0&@- : T!H ^!T"1[FY)\?!@['TLMF%,G \WI
M;%E6,%MPIZL21V@#6>N_JUQQ][G\OB? 7D@]PI+\E:U*D>9,K58E@+;-+(?3
M(L!HRY^'<.T;==675ZY^OAM=W/Y'**),5Q;.-3K)(;X.-PTW<DD3!.R5(0$&
M_4L-]_AUU6(P3VXE@K9^A?DK6;/TMV!Y(ZX@;RD..WMLAHV9CX=PV&W7X::-
MVR?(,AF(%EPG&,Q)5J>LV19L=AIP4:)U'IR10KZ9#]2W7IO\=!@WMO-7J\BQ
M]QZUBT]>Y"YCKBNV\?:X9>VR&C9B2-NX;#KO\-!]!'D&0R]RD^&XKF[%:I,6
MR"C'86=FC*D!8G2$*K=WB3W#;[=!@G%)ZE?DQM3UK32P9..3T(E@)[1(^\;I
M,/3+DG8=.T;=1J-3TW:;/S\@G@BP_%\S:JUIN[)PC'8:<O$RD!8VCA4(W=^]
MU&KXIYC N(RUJO-*]J6&P_TUSN-6)(3)L).B$3;Q!OAL5VT2^7T'+R#)Y>>J
M^#XOFY8*LPDOC\MPMCOAV9>V)TA54;N_>\P\?CHFO/L6<HW"<&MKZ084\G?T
MX) ZVTG#,0&V/I_>[?ATTIKZ"X3'8CX_72Q5EIRAI>Z"<@R#>1CN2/GXZ(J?
M>4[>VV8_17_RJ+13K\-!4<DH)8Q[2BE'=LU_/7CD?TMB=@_;)L>T]N_Z=#2/
MC[J9"*[DJW'CM2+0RUFL2"0>EWEMX=N_N7R]/%OW=]!)L17D@CM_S: BM,B0
M1_42%U]8K]] O<A/4=>B_O;:"*,)DC9?&V>.LCY!A8::.]*ZH8S%]V8(JQ@=
MOF3Q._3?KH-"6EZ%(PT56 ]2JCPW/4_/J=!GO(<;G+',>)U8+,=&])6R?=.T
M8F"IO!ZFR'M!9EZ#?PT##0X?RBI,LAY+ZJ[CU%-&+=E^*ANXE1^C0,UNG]31
MEJE^SU8VC+@=1W+MN!H%CVXX;F.+TK=3(WX;ZR2%JS11&(JA>21N_<MNS-*3
MTZ#0=N98+F>2:$<>RM3'1!3]0EJL;!9@=T9"&7MVT"]!P+W&GO8PYC/T+>/H
MWX+\D,51XI7:!N[[_>>I\.N@TL:"CYQ@9N0<4R6&@F6O-=B]-)I%+*I#!MV"
MD$CIH)BBW%0CC66.6U&B*TL@*JS  ,W:G4;_ &:DI2Y<Q/N//>>6MR2G4INP
M*UUIB4HOQ =W&_Z]4B0,'S4]!RS_ /0(/[K06'&N/W<3%:^LR!R-FU*96F,2
MP@ DGM"J2-MV.@AYK&<]MO$<7EZ>,5 PE!K-8[]_ [NR]NV@6>4U?=+&T\::
M/*:SW;=Z"I*)J""("4D;CM;NZ$:"9A.%^X$O(\=E^5Y^G>CQ/K-3KTJA@[GG
MC]-_49G;H%\-M X9.'-R1R)CI8(69"(YI59V20@@-V@A6 ^1T"]5X[[D[GZO
ME</;T[?1Q\>^_P =^Y]!TM<5YI9K25Y.5[QRJ4?_ */@WV(V/[V@O:6.M4,3
M#4@E6:Q H42R@JKG?=F8+X;[_#04%[!^Y-B\\M;D52G3=@4K"D)2B]-P'9P6
M^?70=_YN\WVV_G7_ /H$']UH*.7@G/4OW[$&>KS?7RP32S/#Z+EJZ*J JJR+
MLI3?IX_'0/6)K6JN-KU[4HGLQQA9I5&P9_B0/TZ"#RW(SX[!S6Z[I'.C1B-I
M#VKNTBKL3VO\_EJ?*QC/N?+#+[=\>R%?'&K<_/<:FUT'TY>Z4$D@=^\;;]K>
M7Y]-5F#AO)LABN=WB,#N\N-2!#BEECH*XN3L9)EE6,= /XQ=V[=@!J6^5Y]-
M<Q.0FY#C+$%RO+1EB:..1U([78*DOJ0EM]U[NGF&M$)W+N(YRCQ?E%_+\JGR
ME1H);E2G)7K5TBFA_$B_$0=S[=JKMTWUG1B52_D%RV&WI0V(XN1S)#+7$BWN
MQ;U4E"RIMVKOT\QW4L#MOJT?2F*YK)?O58FQEJ".ZJD*Z@25V[68_4@,0@.R
M@=I/4]=7!SR7$N06,K3MXOE%C&8^O(99L<M:O.LI=RTGXLB]Z]P8CX[>.I@Q
M/G-BT/<;D-*-:60JXS&15J[7U+M''ZM>5O3])&[I#)(V^^W0[:!T]KN:92MA
M+51<#:A=<I>EE=^_Z8H]F3\*IW!7_=\BE>U1\=!HU^E;Y'@X+5.U9P5ZQ6;T
M9#''))!]0%+"2)PRL5[=O'097R+CT^*Y=Q0WK8RF3CS%*F^4E6"*62,0^I_%
M1H"NQ4=>_P#KZ:N>&Z[C;[-+&96=93C&3JSQVE0!7G[9E-D]DB22D@]K*>T@
M-\-17[!)?].OA[KS6<+&PCLW849U97A[D 95.\:,"'<_$CKJZ*W(9M9.:<4P
MUF0)=K9BQ/4K2-O.U TYXXYW78;*\@8+H-8T!H#0)O,_^V'!O](6O\@FT"OS
MGZX>X=?Z,V._Z.?N^F^L[^W^3>/T1$FV_P#"Z:#A_P#?)\\I^W/_ .WH+'VP
M^K_G9GOJC-ZNZ=WU'U/?MZ$&W_M?XNWZ>GRT'/V^I6YUYK/3F2&Y7Y7DC$TJ
MEXR"L/<KA?-UV'4>&@><)<J79K$HC8W:LKT[$[QA.YH@I<)L3LA)\-!QY^;0
MXAD#45'M 1^@LI*QE_53M#%>H&_CMH+;$_4''56LA!8,*>LL9)0/VCN[2>I&
M_AH)>@- : T!H#0&@- K<[4$8/\ TK5_MM!3Y3COU6 Q\U/'0VY"S+;5UCV:
M%Q(K%PP\Z[D;J/'I\M%TG<SX]SO*0XV/!8*/NHO7OFI)/#2DK10M($I]D<<L
M<JOMX_N_#4'?VLX^]SVAQ\RXP098Y&W-:KJL0D!-^3U(I6=3WH%V#KXD#8:J
M*KF&#YW>NX:A@L)"GY=ZEYZ'?%2+"E.%[X]EF#16#+Y4;J/'QT#%[<8HY7VH
MJW5Q@I96>];L3U8TB$H)OOZD+NZ]1VCM;XD#;1"Q[@8'G66S.+QW',/'&F)E
M_,GIN5H=_P!%9!;TBG?ZD<_J[*#ML>NVBKOB$L+>T%6\_'Y6R^0L7)6J5(5>
M=)6O.71Y>WIY1VL3\- J\VPG,<W<^@XSQPTIZL2W)ED9<?ZR5[44_?$JAC(D
MOW.QO!NNLXZ?Y+9E6/ +UVSQS*"WQZ2KE;G(;=Z>&,USZ9ED64U7=QOMVMVM
ML/LUIS>^48_F^=L4L1@<%%7DBCAO/4>Q#1]+Z6ZLG<GIK-ZD<PW7L?[I\WCH
M8A>W]V[?H^ED< :,\7+[.2O?B)O78S=YA'E#$KWK\NX:#Z+0#Q'Q^7AH%KW(
MP>1SW#<CA\:$-VT(1%ZA[5\DR2$D_H0Z"MN'WFAK2R5Y,#9G1=XZXAM1ES_!
M[VF[1^O0+-[E'](:MT?C6+F!&_X+-)^H[3Z#W7S/OA4GA%K#X6A!<EV>8>K,
MRDJ6W]**5G;8+\-!VQ_,O<"Y=OU3;PU=L?;CHO)-2OK&\LR(R;'U/+W&4* ^
MQWU!XM9W^D)6!*8##SIW%08G8DCKLVQF!VU1XI<D_I#6H#*O',3$ Q7LG=D8
M[?'8S^&@8*&"YY8Y;ALWGIL:\&/@M0^C12:-U-I4W+&5Y VQB Z?/?0/F@-!
M&M9&G5EBBGF6-YV[(E;Q+;%OZRGQT$AG4*6)V &Y)\-M!&I9&K<$AKRK*(G,
M<G;\'4[,#^L:#W;N5ZL1FL2+%$/%V.PWT'I6CG0]0\;;@[>!^!U,"^WMWPQ;
M!LKC569F+%A)*!N1MT'?L/U:2%CA:XWP"&5UM+"LR@]\<EEPVQ'Q4OJD3N/4
MN*49)H\+Z"23]K31PR]['L&RGM+$C8'07V@- F<^QQER?%[HV_DV7@!'7<^K
MN.G[- Y@Z T' VX0W;W$D[[; D>7QZ@:#JCAP&4[J1N"/ Z#UH#0?G<-!^Z
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M]VWD8*&<[[^(0?LT$*+(K9O^K&#.D3;A5&\O=MLI;LW':.N@GP6\Y9#-]/\
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M_5&@N<#G<)F?J)<18AMUX6"/8K,KQEB.[8,OQ7XZ"VT!H#01,IBZ&4IR4LA
MEFI, LL$@W5MB&&X_2-]!3Y3AO$KL JW<5!=1R.V"8&1-QX-VN2.F@4N14_;
M"(QUXJF"B"R>C;5X*Z. O20=$W! TC2#Q_BO%+-RW5XCQ_CUS&U8:[M=MHTO
MJ-.'8]FT;[!>SXG?596'#H<7%8Y;2Y!6I=DV6A@-1(O4K,PIP=D<:.O4#8;
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M].W0:U)E*56I%8OS1TUD"@F>1(P'(W[-V.V_Z#H.]6[4MHSUIDF1':-VC8,
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M6<^8ZIALG*5:Q>V96#;1ACN!\#W'8C_>ZK-CL^!CD_C+$GVA.U=_T]#H.M?
MXR'<B+O+>)D9I/[8G;]6@DI1J(=TA12/CVC?0=NT:#]VT3!HHT!H#0&@- :
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M_)&@XQYC.N6 QC@*W:"1MN/GYBN@ZFUR!E)2L5;X*X3I^R0Z#LASA&[JF_\
MN6"_U"&_KZ#FT7(6GW62,0E-BC;$]^_CW!?#;[-!YDQ^=E\;21$?%"Y_J#M&
M@@XGBF1HR67FR\MI;+=_INO1#\>PEF(!UGZ^6[WO.+-L*C =UB4@$'8]I&X^
MPC6F),?@X]1#A@90?]RY3^HNV@[QX;'1DD0^9CN6)8G?].^@Z'%XTG=JL3'Y
ML@8_U=]!(2*)!LB*H'P4 ?UM!ZT 1TT'D ::GAZ&BC0&@- : T!H#0&@- :
MT!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0
M&@- : T!MH#0&V@-M : T!H/PJ#\-!Y2*-0=D4;DD[ #<GXZ".XB?R2JC*3N
M%8 []IWWV/RU+USK,OSKNC#QZ[?/5OM99?+T74>)T4=Z_;H/WN&@_= : T!H
M#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
M : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!
MH#0&@- FXWVUJ4>1/FERV0EE?OWAEF[D'>=R!T^[T'37EY_ULZ^VU]3]?_ZG
M7?YS\[SQ_?$B'@%>.PD_YQE'DC(*=]G=0!\.WMV(_3KUOER8D#AD?K+*V6R+
MLI.X]<!2#OY2%4=.NH.<O!8)'1OS?)J$VV06/+\?@5^.^B8FXSC*4+OU2Y"[
M..SL]":7OB_LNW8>;15SH#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
A: T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g425213dsp134.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp134.jpg
M_]C_X3$S17AI9@  24DJ  @    -   ! P !    .@(   $! P !    O@$
M  (! P #    J@    8! P !     @   !(! P !     0   !4! P !
M P   !H!!0 !    L    !L!!0 !    N    "@! P !     @   #$! @ >
M    P    #(! @ 4    W@   #L! @ (    \@   &F'!  !    _    #0!
M   (  @ " " _ H $"<  (#\"@ 0)P  061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD ,C R,SHQ,#HP,R P,CHQ-SHS. !';V]D=VEN    !   D <
M!    # R,C !H ,  0   /__   "H 0  0   $("   #H 0  0   *D!
M       &  ,! P !    !@   !H!!0 !    @@$  !L!!0 !    B@$  "@!
M P !     @    $"!  !    D@$   ("!  !    F2\       !(     0
M $@    !    _]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R
M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M         0  ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
M;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$ Q@#+ -  U0#;
M .  Y0#K /  ]@#[ 0$!!P$- 1,!&0$? 24!*P$R 3@!/@%% 4P!4@%9 6 !
M9P%N 74!? &# 8L!D@&: :$!J0&Q ;D!P0') =$!V0'A >D!\@'Z @,"# (4
M AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+! LL"U0+@ NL"
M]0,  PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#QP/3 ^ #[ /Y
M! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P!/X%#04<!2L%
M.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&609J!GL&C :=
M!J\&P ;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?"#((
M1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)^PH1
M"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X +F NP"\@+X0OY#!(,
M*@Q##%P,=0R.#*<,P S9#/,-#0TF#4 -6@UT#8X-J0W##=X-^ X3#BX.20YD
M#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[! )$"800Q!A$'X0FQ"Y$-<0
M]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D
M$\43Y10&%"<4211J%(L4K13.%/ 5$A4T%585>!6;%;T5X!8#%B86219L%H\6
MLA;6%OH7'1=!%V47B1>N%](7]Q@;&$ 891B*&*\8U1CZ&2 911EK&9$9MQG=
M&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC',P<]1T>'4<=
M<!V9'<,=[!X6'D >:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@;""8(,0@\"$<
M(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_ D'R1-)'PDJR3:)0DE
M."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$HHBC4*08I."EK
M*9TIT"H"*C4J:"J;*L\K BLV*VDKG2O1+ 4L.2QN+*(LURT,+4$M=BVK+>$N
M%BY,+H(NMR[N+R0O6B^1+\<O_C U,&PPI##;,1(Q2C&",;HQ\C(J,F,RFS+4
M,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I-R0W8#><-]<X
M%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\93RD/.,](CUA
M/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9 YT$I06I!K$'N0C!"<D*U0O=#
M.D-]0\!$ T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(!4A+2)%(UTD=
M26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\ 3TE/
MDT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755PE8/
M5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R&7-9=
M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$
M A$#$0 _ /3G;G9/I[B&A@= TU)4_2_EO^]0']-/_%#_ *HHZ2D?I?RW_>EZ
M7\M_WJKU>S.932W!L95=;<RLOL:7C8?YS;#F[;-GT/YS_OZP7=2Q[>GT9IZU
ME9&-E7G%I=6:*FNM<7[6;Z\?'N]NSTOT5OO_ -$DIZCTOY;_ +TO2_EO^]<Q
M=^Q&GJ55]N5<>EM:<HV9N0!#P2USA]IV8_L=N^A_PJKX_3^C/S,?%M]+(MSF
MC/H;9CXSIH'Z047;ZW/L_P##%7I^_P!%)3U5MN+3_.Y(K_K6!O\ U2"[J/26
M:.ZA4TG43<P:?YRYSIW4NC7X&-FLZ3AT-R,[[$QL5M (#JF7-FICGV/V[?3V
M[_1_XM%QW=+LR^M%N+BU&JYN/1NV!AN#',W7/;O;7O\ 39ZOL]E;/?7ZJ2G=
M'4^D$P.H4DZF/79P.?SE)N?TMWT<ZH]M+FG7_.6#Z%V3]4\-K#57>]E&RRH@
MM(-F/75^EV[V6/K<SU;J?TE%_P#,;TV=-W5+.G"JJL8>(,OU]XWOVZ6XU_J5
MOL]"WU/9D?Z3?^AN24]-7Z-HFJXO'BU\_D4_2_EO^]<?D7=,OZ7TS*MZ-CML
MZGD>BRIS*W>D-SP[=ZE%GT\>NSVOKKK99^CM]/Z:L9/3>C8?[2%6/^DPFC)<
M[7&:&N_2,H^TX88_T?9^Y[-GZ7UTE/4>E_+?]Z7I?RW_ 'KFL=^%9?T[%;9E
M57]1I-S'U9M[VM#1O KKR;;/5;M_PGH(-_5\ZGIS\[%ZA9869)QA5<<:YD[?
M6]QQ*:;6V5M]OI67^I^^DIZOTOY;_O2]+^6_[UDYF9UWIOHV6C&S:+;ZJ'EC
M7XSJ_7M9C5V>^S.];:ZYG^C6TDI'Z7\M_P!Z54C>TDG:Z!/P!1%0RKWTW,+;
M36TO=O:&!^X!K.^YFQ)3SW7OK5US"ZN[%Z>,&S'IRJ,>]MI/JL;=4,ESW 9%
M?N>SU/0_0;/T7^D78+*]3%=<;"&>L_Z=OHM+B&CV[MKG6.V_FJW7D$Y0H+R3
M$QMCLT_O;OSOW$E/_]#TX?TT_P#%#_JBCH _II_XH?\ 5%'24X^=EY#^OX?3
M@&#'#/M+R0=Y<WU0QE;Q8UK?H?Z*S_"+"PND]4_8&%2VO(9=CYCGWL<&,LV#
M<US7 !E-E/\ X7_2/_P*U.I59+_K$;<:VJA^/@AQLM!(#76N;;NVEGL;1ZS_
M *?\_P#9_P#!>JK3KLD/+#U+&WLL%+F%I!]5XWTXY_3>RU[7,]GTTE.?E]/S
MVV=>M97<1EMK^SEC*G'V ,>ZAMCVML>WZ6S*_P"M^I6IX^#F?M'I>7LM]''Z
M>*K)8UHWN:?;8TG[0RUNS^;8SV(N7E9>+B8F99?ZSI!ROL^Y[2:FV.N^SUNL
M;^B9^D]7>[U/T/\ I51R*^KYV1?D8W7&8V,7;J:F["6L %NU^K7>IIO].S_!
MV?I?T?Z!)32Z=T?JF!T3IM=^+<ZRGJS<FT,:SU&5/+F^JYM%EVYK77?IO2]1
M_H[_ %O\*KF*Q]?5.KMR\9S0;'9&/E;7!K0/5&^K9ZKGY&SW_H?Y_P!-_P#A
MU:QZ^MXV%5;DY_K_ &HM$6U@/K:YEEKH>QS-EF[Z6_UO3V(F5=E?M*^HMKS,
M+TV/%-#-SVOLLM_39#++VU64-;BL^A_AO\"DISZK RO"I#,NSTL;'JMQK<7)
M=C!S34RVS]'7[<FJIMCF5[/0WL_TJL79O3&YEF:,;J1MR,6REU=>);M:&^FW
MT_YC>W(MV_J^YWI>RQ6<C%MS^E6,R*@VNRL/];'VUN(@7L?C[BY['?X/]/\
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MWXU6/G.;5NE[!>\DEQ+:[1;=](N]OI_H6L_X5<JW)Z4W,R7YF>VK)K>;3?\
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M6UU;V.J^S^]G_@BSLO+>R_':Z@!V4_"LJ-U;-X]6UE.30[VNM?>RAEC[+/\
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M+V@S.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  2     $  @!(     0 ".$))300F       .
M             #^    X0DE-! T       0    >.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         "
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -!    !@
M           !J0   D(    & &0 <P!P #$ ,P T     0
M           !              )"   !J0                     !
M                     !     !        ;G5L;     (    &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG   !J0    !29VAT;&]N9P   D(    &
M<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC
M94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T
M   ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T
M   *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   :D     4F=H=&QO;F<   )"     W5R;%1%6%0    !
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M3001       ! 0 X0DE-!!0       0    !.$))300,     "^U     0
M *    !V   !X   W4   "^9 !@  ?_8_^(,6$E#0U]04D]&24Q%  $!   ,
M2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0
M245#('-21T(               $  /;6  $     TRU(4" @
M                                                   18W!R=
M 5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA9
M6@   A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P
M9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@
M   4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P
M!#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@
M2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#
M-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                         %A9
M6B        #S40 !     1;,6%E:(                     !865H@
M    ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@
M   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                        9&5S8P         N245#
M(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M           N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A
M8V4@+2!S4D="                             &1E<V,         +%)E
M9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y
M-C8M,BXQ                                  !V:65W       3I/X
M%%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE
M87,          0                        */     G-I9R      0U)4
M(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!*
M $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +<
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MCPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W KS"PL+(@LY"U$+:0N
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MSN)^,?W*O@,N%8?;O:X;@&/+#(F6OBAC*_\ -5M)3__1].']-/\ Q0_ZHHZ
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M5[&5/]-K6^K^E_3+F'ORK,W,C=]G.1?6V[:YX:+,W%=LWFI]=7^%?Z7J^_\
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M^T5EP<UN7B?SF+9_X9_TJYW*^I?4:J6LNLKI>ZBZNJISFUML--S'T8C:VO\
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M]NW<W^LO$$DE/__9 #A"24T$(0      50    $!    #P!! &0 ;P!B &4
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __
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M6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@ , P$
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M_P">KE_]!O=G_P!8O?NO=>_V8/J+_GJY?_0;W9_]8O?NO=>_V8/J+_GJY?\
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M_P">KE_]!O=G_P!8O?NO=>_V8/J+_GJY?_0;W9_]8O?NO=>_V8/J+_GJY?\
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M )*/OW7NO:!_JG_Y*/OW7NO:!_JG_P"2C[]U[KV@?ZI_^2C[]U[KV@?ZI_\
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M)+>Z]T<WI?L3:F_*#>=/M7:&4V/+L/>#[+W/MO*87"8+)XW/Q;7VUN\P2TN
MK<A02Q-A-VT3ADD_6[+P5(]^Z]T%?</S#V_TSO;(;+J^FOD9V1D\5MK;^X:F
MLZKZW_OA@Y6W+FZ_"XG;6+KGS&*_BN^*J2@EG&,IU>?[*-IA=8WM[KW16-X;
M:ZU_F!O-4;/ZASG5V\MG9+9V\MQ;N[DZDH]J9+LO9>\NN=^8S9T&U=]8S^/9
M>N79>YJ^DR4L4D4B4>4Q HZB$@S+[]U[I.]0=,;%^#&5.'[/VS/\@]W5FT9^
MT=BU&"V#M3<F[-F8GJBKP6+[%WW39C/TNSUQV?W#N#?^(J'H\1##H:G,J(+.
MWOW7NC"8S=OQY^=-/A]J=E?'#-YG;_W&:W%A</\ (#K;"04U'N/8E2VWLFT6
M*JLKDZW'YO&0YAQ%KA$9IZAFC8B9B?=>Z#CY7T]%\6,=\:=A_&S [PV'4;TW
MQN/K7977W1&V>O\ (S2438G,]I;PH]M['[0RN,ZEBKVVY@<[7)+7JLCU $,#
M"25![]U[JE7J?^:OVA\FN_>O/C+NG?7>E=L'<GRGRWQ-^14&^>D^E]B8:@KL
MGM_L-\7M#;._^KZZ3/T79,F0P>.JC]C+-"*6.KD(,(N/=>ZV8_EYV-M[HWXP
M=G]F[DRF4P^T^N=N8K.;@R&+J/'G(]N8O.X1,Q#BIA54#OF*_%>6"G"S1/)/
M*JJP8@CW7NJ1.C_YE>U.WLY\JNOY_CE\T,9O+JBNBW7U72[;VYW5%E\5T7OK
M;?\ $>H^U>RZ/=?9M/2T";@JJ>MJ"D:5-*V/QLLEB;K[]U[J^SM/N#:717QX
MWOWOV16UZ[(ZHZLRG:&]\AAJ&7,9,;<VAMMMR;@K,9CJ=H9,E6_844KQ1*1Y
M7L/S[]U[K3B[=^7.POE%\I_Y<6<PO36[]I]>]L_S >R_D[T7VI\D=K5FP-B]
MH[#WOMWJ?";<S70]?MS<]?F,SW3C*['2&AQ^:H:?$LLA\CR:HP/=>ZWA4;QT
MX:P4JINM]7J%[K_6Y;\<$?2WX]^Z]UK)_P ^W?V\-I; [3S6P>E.]]U;GV'M
M3K+===W7UC1BOV;TCU9O#_21L+NK-[UQ#YBFAW3]SU;/DJ<TOV-<<9][#6WC
M*@^_=>Z)K\+,AWG3=^=/;>VCFOYB3?R[WWCVK)W'44FP.M/]!\?9O]^Z*HV3
M%M[<NRMMUW8TNW*SL(NN>>IF$:4E@Q2(NP]U[K<S)(0:K7^Y3_6#%UX%PU[D
MV'^)]^Z]UK[?,78L&ZOY.O8V7CSNYJ3<6S.YMT;LV[G=BYJKV[N:?)X?Y\Y6
M:# 4V<CIY*\T66:H-+)2N1332!/(&13[]U[H*OY;6W?D;LKI/X48'L#I'>F
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M<DQ2'QU IR:V,ZBBOK!(TJJL&4DD7'TL?\+^_=>ZHZ^62;,7^3MWU#7A*G:
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M'DR5#&".(IV:6,<,;@^_=>Z5WOW7NO_6W^/?NO=%!^8W_'O]!?\ BWWQD_\
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M[GI<KEO[OPTT6)R.UZ&LBF#R!9()2IN&]^Z]U:'\\L2VY?Y5O<& QE/7U?\
M>/X];5PE#387+/@<I-_&:7:M#3PXK.115,N&KY14*M/5)'(:>5EDTD*??NO=
M:BO57QN^1M?WK\=_[_\ S:[L[[Q/<U/VK!LKKG$['W;T[_HSH>IL7U%DIL%B
M-]2RU]3U+N#%X*AHCNVH@Q_AF? FE@EJ#DHY4]U[K?%EJ5@Z(6L9(IXX>IQ4
MRPM&6CGABV:T\D(C8-Q-&I4@WX/OW7NM"W"?'3L*3=.'W'M3N#=G4G2F*[!^
M)>V=Z_#=^A<7OWKK<=;\DMH=D-@J*?=>W<7@=L[@W)CJ6BEBP==D,56)MO\
MC=/75C-'.Z^_=>ZW)/Y8FV(]F_ GH[9PQ/\  EVK1]A[<&$3)4V9.%7!]N;^
MQG\-3+T%!C:/*OC/M?&*F&E@CF,>M(D!"CW7NM;K^8[BOF!NCYC=TT_5GR3H
M>J=G=+[K[=[KI<5US\><;V'O'=5'2[:^-$N4Z@W=4-N6AGWEC]YY++T=;-AI
MTIEFAA:5203I]U[J^+^4;D.P\ATGW+E^V-X]>;\W[N#Y"39G/[DZHVQ0[/V=
M6SUW1?0\L*)@<9DLEC\;N*@IPE+F4BG=#EJ6J^A] ]U[JN;^<3M_Y>=G_*W8
M_0_QQ[RVETKA.X\#U_!NS?.T>OJS<'R%Z>@V7!V-NRG[/VWN'$[APV9I*7-5
MF+AV]C(HO"LU1DJJ)I06 'NO=#E_(5W-\@]W=3;WS7R&W1U=GLU%MSJC [2P
M.S>O)NOMZ;6V7A)-\4V&/<./JZZIKUWIN6A:#*30U :2EFJ)X]<H.OW[KW4O
M^=O7]W4NY.G*3H+?6Q]E[RW%T3\C=IU\>Y>K8NW]V;@VWNC?OQIPV9HNKMHR
MY;%$;IQE%5R5M95IY7I,/#53 *8PX]U[HIG\AK87?G4?:6>Z5['[PV]V=L/I
M7&=X[)V33[LZ>GZ^[]SU<F^=N-ENP-Q;BRFYLOG=U;-S.3I*M*6KF,BU\1H9
MED1-,8]U[H]/\\.LW90[2^)$NR<[LS;NXI.Y>WJ2DK]\X:3<.+EIZWXF=\4>
M1QV#Q$.0Q<M9O[(4$\D6VE2>,_QTTEOZ>_=>ZTMOY3=1N;:'SH^*N*V;V/VE
MV=UCO_Y&_%O"=ES]M['R^%R.U>Q-ETU7O'#[0Q$^9WKO)<12[?JZZICQ\T,D
M4F3IYY1]K##$K)[KW7TF/E;DVP_0._\ +IF:C;K8N';V1&?HZ&BRE7A!1[NV
M_.<M2XS(PU%!DZC'!/,E--&\50R"-@0Q'OW7NM0O^7D>T^V/FS\_]VUG=??V
MW<]DOC?\8]VUL?9?Q:Z@VSF\_M[<'7G=N;QRY&.FQ]1%M'$U>#K=<==01PUU
M3+E:J.J05%'?W[KW6SA_,>KSB_Y7?S*RRQ12'$_#/N'*K!,VF"0X[JK,5PBF
MD969('^WTNP&I5N1R![]U[K5"W!\H]@]Y?(?^2KNG!]9]T;*Q?9>^*'=M3O_
M .0'QEP\&P^]>T,O0;9HUWAT)D*'?.XZG;&7KQEY*.3<4X\N-H<=0,4;QA3[
MKW6]ZL=/I",RF1=094E*DNVLN-",NIFY^HN??NO=4V?S-,+V=NSK+Y:;,^.=
M?TYMWO++]/=;4E=V'V5E=HTV4Z?Z7G/8M5V!V3A<1N/;>YFW(E-C<1/1P8^2
M.DI*BJG+&HCDBO[]U[I+?RUZ3 3_ ,L[.4=7B::MPV2[A[FH,_B<BM)7T>6_
MBG=4]!74T\%=A:RB-!7P5"1FFE@K%>,LID.H%/=>Z+!_,)^)NX<K\FMN8WI'
M 9WK#:VX,1L?8V9R_5^T.E\=M/8='50U,<O9>6Q>[.E]X93-Q45/HI9H<745
M=4L5%&/MX;#7[KW0];1^8'7?2?QBV?O7=GQFZWZ ZS[5R60Z4H=^Y#L'K?9^
MX-Y[RPV5WKM.ORV<VOM;8>%J&R>X-V;3J:I*1IEFDDK[1H'+1^_=>ZM"^.7<
MO6^_=G]?XC;N32EJLOM!\MCMK5^)W#B\C#34DX^]IYH\]B<:)JC&-4 5"*-<
M<A(**%N?=>Z0WSU^+FYOEGTYC.M-I93K;&9+'=@[9WI+%VYL[(;\V!GL;B<;
MN#!Y7 9W;N,R^%KJG[G'[B>2FE6I3[>JA232VFQ]U[HC'1?\M?Y%=;=[];]P
M[K[/Z!W!3[5EZXVQNB*BZWW]4;GS6P>H]M4^VMI9'!9G<FY,@NWNV*^#'4T&
M6S4(2ER&+@@I8Z6%(%DD]U[JSKY/=5[A[GZ%[-ZNVCN;"[2W1N[;L=/M?<>X
M\=5YC!87<-)E\;F\37Y;&4%=CZVOQJU^/C66*.2*5E)"N/?NO=4T8C^4O\C]
MN]L[M[GH-[_$:KW1N[<VZNQLGBLQUIW1N+!1]C=F46T,=V%F,5C<MVA+38?!
MQIM^6LP&-I/MQCJ^>.:IEK5IHD7W7NM@;:V(;;^WL'A&F^Y;#X7$8IJH*Z"I
M..Q\%&9PLC2.OF:$OI)9@6Y)/OW7NJ:/YA'1&*[5SG4^Y=Z[J[$AVCO7Y?=<
M]>YK9NP.WYMOT24V#P78VVL?NK;U!@]K0[EI.SEH#4PK%19F-X6,;Z6DC<#W
M7NC6_$;=N/W[WIWWO'%[=WOM'&YWI/XC2T&V>R\-4;=[ P5)20=YX^'';MP%
M9+-5XO+K]J9'25F9Q*'O9P![KW2Q^9^_^N^M\!U9F^R]T=>[2V]D.Y<'B?XE
MV?N6GVELV7(U6TMVR8ZDK\]45E!'03R_9O)#JD"O+$ 3:X]^Z]UKJ_R#OD!\
M=\OU1L?JW;VZNA\/V/\ \.(?,QJ39^U=YY+([ZW!19C/5.[L5GL;@\OD*HU>
MW,OM6FC*5M-&*4T&(H2K"=JEG]U[J^K^:7%FYO@MWG#MO'P93-S-U7#A<?)2
MT60%9D9NZ>N!14YQV4I*[&5C"J,;+3S03Q3D^-TL]_?NO=4/[56IR78W5&3V
M-N'(]H9#M2GPVXDV?O3IO:6T]C[%P?6.\>NMO]F;@Z]HLWL62GZMW/69*G_B
M6X<;1PTU3/N"*F6*H83Q5$7NO=;//R7+-\9_D8['A^D^X2EB?\T-A;@6,CU/
MJ#JMP00#?Z#Z>_=>ZU6Z?=^_*?L;9&ZLGN?=&*[(Z^W;TST=C^H:'8.W)^H8
M=];S^'OR9R>U4P"0;.7;&_-XK0STD5)EXJ2-:"*<I/)Y581^Z]UM2?%6+)P_
M';IZ/-4=/C<PFQL,F6QU&(!1T&4$3?Q"DHC!!2Q/24]676(K%$ACL51 =(]U
M[JAON;XH=I?)\]R[2P';.Y.L,3D/E'\F#M^78.QS7C*9BK[LW+@9<3VMFZ'
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M,LIWOM18V1OJKAV%B.;^_=>ZI]^+.\:K']2?RP]H8'?&X<319WN_X9-N7J+
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M=>Z'*3XS?%]0*6;XX="&DAEDEAC_ -#W7SHL\VE)C]J=N#QSS>)-3  N +\
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MD_\ ?G8GW[KW1NT^G^Q_X@>_=>ZY^_=>Z][]U[KWOW7NO>_=>Z][]U[JKO\
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M%["V%NS:?Q\R&TJC*8/>U-NCMK)X/=6/[,BR-7BMNPXNEK(9^<]54JJIB8R
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M2.EK,S4SO-%(FA_=>Z1W;'PO^<> WO\ (K"]8?$W;6_>NMA8+&Y#XY[@R/\
M* V?A\CVOEJG*XBARU/D<:^QJ:HPC8[;^Y]P3&-EI&UTT,2S2?<!T]U[I)Y+
MX=?S#O[TBBQGPQVC7[:/QLHM[-FI_P"4OLO%2?[,3_=VBR=5U"J1];5D_P#
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M/C)4]4XWN';=!]]18'=N0V/!M',XW#96OQ\=1#M?=&VH6V[557V*3-A)0OB
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M5RW9^>J]R[3W9D<H=V[;GDDPE+2P*<=5XO6TD1F##W7NA&_G(= =,[%^2_\
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MX?AG\*-H"2;'9:AJ),QC>P/DQFJJ18<OCZ*22%*#,P!G36NH\\BP]U[JD?\
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M(MRX"M@W+M1ZS*X"'$E*FOQE53M&TM(Z30,R$,A X]U[KZ-M&%62I52-(=;
M-?2!J5 1_9LJV ^E@/S?W[KW4[W[KW7O?NO=?__0W^/?NO=%!^8W_'O]!?\
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M')#AF8T#1F61:,$EU]U[JA7<6P-];SPFS-J[Y^:?R0[QV;LC.4^&V]\]=O\
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MHQ6:W+FL_2QYF;&=_4./GKH8,HJ2O%#'$[JS(B @#W7NB$?SE.Q^O*;^4?\
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MS^&RN_\ ^7EG-R5.V,9]OCL_4_RX?G]5[KI,#15%'B=@4.)H<5OC:N$;-XW
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M>GQB^0^].Q][]?;HV]GOD3U]V5V=4=<X'J*EHI>OFVK7U6[ML5>V:O!UR,'
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MO1[AVC@9ZBFF\>;QE9@(J>GFA;6RYK!/7TLJP>1I03"J1S _3Z-[]U[JZ/\
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M5G3[UVT.Q*H2;<SZ[PW%4;EV?34V3K8Y4DQ\F.;(I4TJK'4&&1U3W7NK?O\
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M[KW7BMQ_CQ_QO^GOW7NL9B8MJ\C6T:=/]GDDL; KZOI;GBWOW7NLB@J ";V
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MO7_:]/ME*S:M4HS>WLSN'.]BC'X7=]'A)GRG\,;7,:>"4AS3P5%1%[KW6?\
ME.;FV5\T=H]W?,W<]$]/#G!\E>S\3V'BNOMP8G%[4["R6^]R46X=WXC%Y"?-
MT=9N;9]#0(<?AILSE):"1/N*<Z*A)W]U[JM[^0'\6<A\Q/Y;OSUZ?V1V]N[K
MC=,GRQZM[$ZV^06W=K4D.[EWILC%8O>>!WS)AMUP9$?<[CRV-CBRIC#HU/4S
M"'6H9&]U[H#,!MJN[9_X4ITVT=Z?+?NCK_M'<75D766YM_X[8^Q%[.S6_?\
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M?G\VF]E'S.#M(7'(*K\Z)"50"]B IM^38>_=>ZM$V-2QT6S=KTD6'S>WXJ;
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MCJ&LD2:"%?M:H'UJP M[KW58/;G_  G!KNX*O=.4WE\N\#-)N*BP%'31[?\
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MC\.NF/\ O!'IS_T,L9_A^/[O^_=>Z]_LG73'_>"/3G_H9XO_ .Q_W[KW7O\
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MDSO2_P#-P[G_ )?>8^2AQYW!VK6;TQFS=U]$4>+P_;62H.@^JTK,-U]O6E[
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MO#YS3-5B,-ICUZ;V7Z>_=>Z(G_+5^9V]/F#D.Y=S;ZZBZEZNS-'44(BJNO\
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M>*;W7NAK^&G\Z#Y!?(?Y@;JZD[6WO0[\^)63[AINN.@=\87HU,/NW?>Y]O\
MR#ZCP6P<SNG,X*JCFPM!5[=W%Y,Q6SXRFHXLC+# 1#YM*>Z]UN<1NKZM/]FP
M(/!!M>W^(%_];CW[KW6LG\A\!T WR@[QRWR]S7=&Y.I8-[;6W;UKUEU/U_OC
M?&/Q6[-D[P[4P6\-R[WCQ6V]R;8GPV<HMXTT$M+"(LE]O3NS$QZ?;9BB8U:)
M#7C4#_-UXYI45IT7CY;_ ,EWX"?+;J[L?^8UUIW9VI\>HI]A]D9[ T6\*G;W
M7'3.+;&XU\328?<VV\_LBJW+MG92[TP:ULZ0229"MEDTH7*PCWI[6.:WG@T*
MJNM#04!QY@#/Y]&NS[H^TW:SJ 3Y>1'K0]48?RO.O,]LO^8?OKY(=2?)^DW=
M42_&#^8!N?+;0P>)WMB.P]KT>U,!M/;VS:/)XB/;]+-_"]X;LW[B<QA*F*B\
M'AP4TC0QR1H%+=EV*WL4D18$5*< ,<*<*?,U]>EW-W,UUO#P/X\C:2O%F)XC
MYGJTG=?PDWS_ #>(]A='][?S!_DEM'=O]QZWL3<?6FY.@]Z4NT,/D=OY/!2)
MG,7N?=><P.&84D])23T\;0ZYV>8BSHP0T$:**)&% IP _P!7SZ*+::0,09&H
M*>9_R_LZI>[*Z?V52?,[>W4>TN]-M]M]4_'BHZCV#_%\ANRDR==\A:/_ $EX
M/8V8J-EXC#[:Q-!GJS;VX,]51Y&ACRLQQU,\P2LJ%N(P_;6+P<RW5Z@THX2I
M%0,*!P!R<4-1Z<>/4@7.^!N2K3:6;]1#(:>8U,3^7V];<WQF_ER[SZ>^4ZU_
M6\=3\:=FXW=FXNZ\%L#!U=7F,,V&RF8H<%N2AQ4KYW+U6X-R5F"E.*JCF?%2
M14F32:F$DL+H19<R+(RD4)IDT _P =1;&*%M66J:$Y-/MZLU_F&_';9GR!^*
M'<5!O<9;'5FRNM.QMX[5SNV<B<9FL#F<5L?-U+1TLE1#64TU+E*:,TU0)89/
M)%(S+XY CJFZ>ZK5PV[.P^HMS?"3(X;XQU6%SN9[/Z'VQMCK:C[TP6:QN?;<
M7P^^5.._O+#G:Z%\)L2DI*.A5ZBC2&26J"W12S:A[KW2%_X3Y]:];;,7Y-;H
MV'O'+[ARW8E=B\OO_!54G=E7M_"[PI>[/D/592?8U5V?L/:&R5V_297)5.*J
M8-GU&4Q4F5Q-34/,#.J^_=>Z=_EG\-MX=P?,#(T>T/DY\C>EY]V=_1[EQ6 Z
M_P!W=]R[#U8WJ#9BYA/OMJ[4W%L3K+*UV5W-4U'DRM9+BZI*EU3'HZO(_NO=
M'WZ,_EX?%K>W5G5F9[WZ.ZV[L[HV+M9>O-P]R;YQU3NS?NZ,OL"OR6QJG<M3
MO#,S+G*J7-PX)9&E9_++"R1.=$:*ONO='7[/V=6X+I\T'7^!H5/65'M7<&SM
MF44513T>0I.KZO'YO$[+HH<51UU53QY.BP$6/IDIZ>1TUJJHW'OW7NB*T/?L
M&%W?N;N_#_$7L"#M_<.W*?$[BW'3_&WY9Q;CSE%AL3#/1;<KLJ>D3%)'!54<
M5/'P\8"!B>+>_=>Z1==V+NG=.WZ_KCO?XK=DY&/8/<F6WQL^7:?7ORPS^&R,
MV1K)-]8#=6-W-U=UBV/KX\=4;OJ,=-03U<B?<T4@J(5:RK[KW1M_C?5[U[/[
MP[3[YW-M'/;%QE3UGUIT_@L/N39O8.RLEF'VEN3L7>N7ST6*[*VILW/1T<=3
MOY*-"M&\#M"665N??NO=%Z^.BU3_ ,WC^949UB2%.COA M$8)6:22([?[)DD
M:I5X5$4K50=+*[ Q(IX)('NO=%5I>?\ A277G@?\X"4' _'^YJ8V_P!A[]U[
MK88]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T$.$_YG9V8!]3UWU4!_
MK_QGM3W[KW1;?DUT-NCNK1B]O9;KWKV6CS>)S7]\*'-/BM]YB+&E3)BL\[;'
MRL,^/JC$8F3SN# YN#Q[]U[HGW\PK+X["YKHC:N6E["VRNY-LUF#7,=1;:S&
M?V9M"MJ\M2XV"LKLCB-N5E1A:2DJZP2P5!IXTC6!9&3]L!O=>ZJ4V?G:3=--
MENQ\/OK^8!!0;@.X,_18?-=:YRDDV9)M3#[IB%/!@\CUU,^,Q>>GI@:#%5PJ
M)<Q604BP>1*A1[]U[I^P78%#@=S8K;D$?\P+=>7?%;4['2ORW3.XZW#Y""/:
ML;K@Z7+R]>4.VX*WRO(,WBG5A_$Z66!8GD4E_=>ZV$^LI<QV%LK [LAZ#Z#V
MI3Y:G;P8C?17$[FA2E9J9I,ECJ+8^3CHY)I8B50RE](NP6XO[KW2_.SLU_SZ
MGXIC_P B-7_KG_FFW]/?NO=.U3M?,2[1H: ]<_'?SPYRMJY,7+6U/]TJ976(
MQUN.F_N.9'S588E%2#30C0H];?3W[KW5$N^:2';?<.&:LWA\@8O[TU?<D<&T
M]O[5K\MLB@7&;#KHJB;-H.L:F;$8R@I@M7MNI*P>;.O&D+JS!6]U[J^#X>U$
M57\5_CY509;L3.PS]2;(DBS/;F.FQ/9^11L'2%:K?N,J*/'ST.Z91S61/!"R
MS7!13Q[]U[HR'OW7NO_3W^/?NO=%!^8W_'O]!?\ BWWQD_\ ?G8GW[KW1NT^
MG^Q_X@>_=>ZY^_=>Z][]U[KWOW7NO>_=>Z][]U[JK'^='!@ZO^7)WY1;MR6^
M\3L:MFZSH>P:SK3#3[@WJFPJ[M79E)NW^"8BDP>XZZLF&'FD8K!13R@"X6P/
MOW7NJKOC3_/6^(GQ^^,/1'3.XZG=>9R_5/4O7G7&5S<O3WR8Q%#F<IMO;^*V
MW]S'+D/CK3X^B.8K(V$2/(J*\H75S?W[ &I\+UJ0-X0\(!ICY5IU93NGY\_R
MW/B)/!(VY.I-H]A[QHZ.?<VP>DMDX?<_9V,9J2/+_P#&0\)UCBJC/XVBQM15
M%*BIR0B@6L;3PYY2R[CMD U37( 'KTOAV?>7@%U)MDC6Q(4: 223]M,?/H1N
MAOEU_+Z^:FZ]O;OZLW'TMO7N6FAK:C%X/>6"VOB/D+M6DVW5U)1Y-J[EID['
MV]3T,B-4TWHAB6!Q,+AP?;=GN-I?3>%#)QX?/I+?6NY[6OB[GL=Y%;>1,=,?
M:2!7HQO?W8/0VWZ78FR^^8-HY/&]I[[Q&R=EX#>."QNY<?G=W5(,V,6HQV6H
MJRE@I:34%FK9 L5&]1&&=3+&67^OV]-*=0#4X^O$?E_AZ8\G\D_B=T=V7UE\
M6LKVCU!U1VIV)2Y&IZKZ2;(X+:V3R^/QTZS.VWMMTT=)1T:UE74LE*K"!ZZH
M#BG622-T776^DUDNWO@]\=^[MG=3Y'<WQ^Z>^0/?464DVCLU*/9>R>Q.S4HY
MJK(5<SKCZ+&UDT5?51S"D>N>)JZK#1TYEGN/?NO=$V[OSOP:7L3Y)TWSERO0
MG7"[P[OZPZLZXW7NVKQNQ=_[E6/JSK/+T&,QV_:B"FWM'4TF9R1^XJL;4Q4-
M' RAY$+.3[KW2GV%\F/Y?GQ6VG\HZSI#L'#5,.P]P_Z1^R=NOO'(5>.W1OW/
MT>'V#B9]A9'.&3!5=)E\OCL?B)I<,?MA7,SR"22[/[KW2-K?DQLKY _*O^4I
MG\-+14.X-Q;I^:,>9VSC,Q1;B@VUN39OQNJ8=Z;?K<SB*BIII&IY]QTD](7\
M4L]+/'(T::BB*8&7P+FOH/VUZ]JIBG'K2@_F@?#3Y%_&G:/<_87R&V)N[9FP
M-_?-+Y.97;%'G*#8='A\MB=\Y+&;OVYF=J[AV]629S+R[RVU@YR]/4ZH,::-
M%0P2RRZR3<(GGE2.)*ZR!3UKBGYUX^70NY=EAL=4@8-)Q%3P^WY=3_Y876G0
MGRO^9OQKZ-^3G6NS\WTYB>E>Z,V_9]!W'DNA:K&TM1E'GPVY*;<U%O7%56XZ
MV'-U<N$FQE*:>1(W5U5TAE>4CY9V"9+?F3=]PMEC$4BJJ%NV0_":U],9X8)/
M'!U[D[^\>X<N;-;7C$SIK8J!V=FH!:"E/MR>'''0_P#RB^).U.B>NOY;WR Z
M$^+.5[/['[[WC\L</OK?&1WIV'V1_%\KMO=?9&.VWLG'=44NYJ1L-B5VY0O7
MSY6@$%% L32S:&+.YA-LFS7^P;GM;6RH]P(IM2\0RK50#P/'-:TIQST&H^8=
MPGW2V\*\D-HDN@,]-0TG2=0&!D&G^#HH_P 1NA>WOE)M[Y,]2]'TF<[+[QPG
MQI@EWE5=78/9.9J=QX?>.Q-M8/KC:E)M_/Y"+%4F*QVW\OCMN9/*1Q"NHJBF
MEGC(T/,H<Y/CN8;[<)3 !;RH  26*&-Y PX"FMFU4H:"F>/0Q]PY[>5+/P[L
MO(=.* "FG!!KY9'6[M\=NM]U=1=C?R9.K]_XZHP^_.NO@Q\B=D[PQ-8*!*C!
M[BV[LKXSX[,8R6+%RRXUACJVG>%7A:2)T34K/?49"/'J*^CP_-;XU57=NT<3
MN_96Y^X-D=R=90Y)=A;AZ/WE@=B;WK\+NG([:DWULJ3-;KV[NK;<>!W=2;>I
MONON*(R1K2@1,FI@VNO=::'\Q'X:?*+XMY[IWM[I/^7QFNN/C%T)LS<O8.\W
MJ=[]=]S5NW]_0[T+YG?/9.Y=QP"IWUCJW:U;5_8;>K*&OQ\K53PB)C/H7W7N
MJ2MS[PE^0_RJI]WTO0&W<KVI6=/=:]3;YV3LJFP75>S=U]C5F/P^V,1FMD;<
MV_L_;NSNMI,M5XM5%114U+%%5JKC]UW<^Z]U?%\/OY+7>F7Z"S&]>W/@+W7T
MU\R!N_?7^BOY"=3_ ";H^D>V<)LO-8!8\90]B82EKL]M_)2U>56:FJ:F%*+(
M-C:U4#>6"227W7NC@]8=J[I^!.ZZ'I[#_#CH39_:O6^)W)L/-9;+_(;Y<]RX
M&JPN[]OP=J]WUVXZ?$;*W#A-S[@BIZJERF5JJ*EE6ECK:EBL,2/[]U[I9P?R
M^_D[V-USD9NY.@^UNVNR=E[-[*J/@)A=W]Q;![A^+'QC7,=38/;NPX*?;N1Q
MF+J]UXO/R8J.DBCS1R"T-'' \L*2M))[]U[K5W[WZ9^2WQIZ[VU\9_EQ\7>@
M.M,)F.\>FMW[LZ[?(_&C$]V9JOWKV!MV*N7![\P$-/V!BMB[XFPV9$\5%5+B
M,51Y"F$L,$*,[^Z]T>?XN_$O^8I\H?DGM?N787PE^*/:6V=HU^/Z)[?W]MRC
M^-VV.D\_A]J;2VUD-V[1H:CK"""EQ68JJG.K54>XL-1+5RR3KKJ9H(S"ONO=
M;<'\LG^71NGXY8K;F[NVG[!V;_H]GW3@N@OBW7]O4?;_ $M\;]K9P5-#E,AU
M?N&JV[C]U)EMUT.0E2?^)5<TD232 7U67W7NC7_/[I*'L+J_$[[P.Z?DALGL
MSJBNJ3L?>GQ.;!'N7'8[>=;AL=O'#XJBW%CLKA,IA<U28RF&02:#]F*'R@^@
M@^Z]UJ:_S#?Y97>.5VW\7NZ/@Y\(LI/U7AI>V>\^_E^4S=7CNG:W?E/O'(;B
MR79W:.5W_J;/;7R-%-DLE)BJ)_[OU$LY I##XH5]U[JJ"AW/O[*[M^1N6VC\
M?OAYEN\.\-O]%[#W=+1Y'XE9_8M9%O' ;BVOCMN]4]=T2MA=C[EW#N#-XJOR
M53M&GI\CBJ2F<U<D;'5[]U[JT#H?^1]W%\B?AYO'X]?,SX$;EZ<[5QVZ\SE?
MBYV=UON?KC;-)U/M>6+$T-)B>S4VE/E8NPYFS\];-]ODQ6O_  <G35BIBCD?
MW7NK)?AMU/\ '3^6%G>D?A%NI=L5_>%!FL'M^FW73[ER&5CZ]A[B[[ZMWYA^
MK8$K0F.RV4W;D]MTN5K<F8J:IAEK<?!&C0K*\?NO=;6\E6].C.(?))-*%$:J
M"[,=80.58)Y&5%2U[!OJ;&_OW7NM?_X^=5;J^1<7<'<G8>.[]RFS>TOD9O/N
M7IK%;@ZTV[61[8V-D\O20X'99_A?85!'5XW;>:VG53MJTQ5]-E1'4),5U^_=
M>Z(S\M_CI_,9[0[^DV#UGB_EG!\-<;U_B\;MO"5&UMEX' [<W\*+?6$WG-0]
M=4U5G8\MC\VNYH*F@K*WSM2$,(_'$B^ZLI)!#$4Z]CS'1F/Y5_P9QG4V+J]L
M8?JWM_:&!INF^T]F;@[/[6V7MY]S;AWV_=.Q(7Q4N=?)ODNP*NNHNLZELC)/
M3X^CDIG2D"LJF639!-.\]64@$$K7H(/G!\3/F!MX; V9\&=K?*;%8K=NZ=\#
MY"Y?#[?Q&VTKMH;]QCRTT29K*=C[GKL]@=M;L$58^WJ:*FIO&A2/R(SQ-L>7
M5HY/#(;34CHK6TOY8OR%V/L#Y&;CH^COD3VS\E^\NP>J-QI4;EVQL#;FVZ;#
M[+^1^WNWLU08/=V5R>VZ'8M$-K8;P?9PT_ARF5>2HEEC#!%<\0% GAC5Z_;_
M )NO2RR2R%V;MH*#R'5MO?.X>T_FAVI)LO))VI\!,GT!U;0]U;SB[&W?UJB[
MDZZK]]WH]_U6X.M-P[R7"8?K_);$K,C'#4UT5)6-"ZU44:".=&@*>?3.GNU5
M\J4Z.9O3YE_#OL3H7?W6>W_FI\;MRY+<_4>Z]FQ[RR/;^R6BJZW<>VY]H1;I
MS'\'KI(DIIL_FH&J?MHRJO.%479-6^K=)'J?%=0=[9+JG>.U]L?&'OOM+XLX
MC86WX]V['^1&>S<O7.X<?M2NQ6,KJG$839O\.QE?D<)69&6AEKJ8U'\/JIT2
M\<C@^Z]TC/Y6?P5[*^&--VH-^8G9>&K][I'*T6S.U=^]D4&7S%1VSW)V#7YR
MEQN\ML;=QO6]%58OLF@IWQ&'22CDR$%75M(\TSNWNO=)#Y'_ !$_F$]A]\;P
MWOT7W_0=4]<;K[0P^;K<-B.].V]MU59LG&]>X/:]='#M?#;9JMN8_=N3S^#$
MRRQR^$TQ178R7/OW7NK,?BOLC?'5W0?5NP>R<I0;F["VYM&@IM_;KQN7RV<H
M-R[PFEJJW<>Z!F<[2TF5KY=QY6IDKI7G17$D[_BP]^Z]T_\ 9WR+Z0Z:A#]K
M=M=;=?*]?BL4!NO>.$Q50V1SQJ$P="F/J*I<@]7F7I9/M4$5YUB?3<K;W[KW
M2#P?R[^.^[Z'=%1UOVMM?LNKV9_==MP8+K_)T.XMRXU-XYV';FU34X&*:EE@
MAR^;G$$+OXXV^I<@-[]U[H*\A\WZBC[:W+TZO366V=D-O;>H-P46Z.YM_P"R
M>M\!NE,A039(8?;=-35FZ]R9#<$-/ [O2FB1S$#(I8++X_=>Z*Y\OOGI\J/C
MEU=0=C;'ZCZ=WQG>Q>JJ[>_3W65/4=H;BW!DLYMQ=KYW/;>S-?MO%P295Y=G
M9F6HITQV,6HCJ(@KK*.#[KW2?^ 6_=T=A_S&/G5O+>V'QV#W-G?CC\':S)TV
M)%?!@ZJJ.)[4I'K\)2YEOX]1XFNFBU4\=:HJ/&06)!!/NO=!52_]Q)5=_P"*
M!T'_ +NIO?NO=;#'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@?PU_]
M-?9A!TL.N^JBI-P W\7[5L3;\#W[KW13/D+2]DR]@4,_5_QHZWW_ (_RT<N\
M-V]@[ .3S62TQ2JZ[?R=-/+'D8C3/3)JJ5C*!90-5E'MMS(/[-03U[KKO3)=
MK9C'[(BZ1^-^W\C'BFK*//4G;W7%.\&+VX[8^.FH-FIA<K4I35*1FJ9HFC\#
MD1C@7MY?&(.I5#=>Z "IH?E_69"I1/C1T'C,5'M^>IH9ZKJ.ORN3J=V0TTL5
M'AJL#)4./I]L5M8*?35!9*R"G616A9F%O'Q?(+_/KW0P=/4?8+9;=4?>7Q1V
M1'@C#CFV>_7G5U'496>J0RG*KN1,Y44F-2!;QFF^W92P6SKJ3WL>+G5I_GU[
MH?EH>J@Q8_%3.,ILP5^H=D$J_(UZCDRQ=@>?\?;?BOFD9ZW3K)]IU3_WBAFC
M_P"4@V1_L/\ EY?3VXC%AW*0?LZV%J./7=0.O9<0N%;XS[M;$4]7/D*;%R=5
M;/J,;35U0-$]338]\O\ ;0S2H &95!-K^[FOD1UXBGGT6GM3'=JU&ZHEZB^+
MNPX-DK@6\U5OGJ.@GW+3[JIDROV\F-I,/7+2OB)JV+'>8S3JZTRRK"I>Q]T_
M4Q4#JO5@W52;F3K382[TQF&PV\!M' ?WIQ&W*>:DP&,W <93'+T.$I:@)44^
M)I:\R)3I(-:Q!0W-[V%<UIU[H0/>^O=?_]3?X]^Z]T4'YC?\>_T%_P"+??&3
M_P!^=B??NO=&[3Z?['_B![]U[KG[]U[KWOW7NO>_=>Z][]U[KWOW7NL4D8=D
M8FQ0W!'YX^A^G''OW7NJWOYM^ZLUU_\ R[/EEV3A(J.JKNL.MZ?M*FQ^3J:F
MFH,HW6.Y\!OLXN2II:>LFHSE%P+4XD6%[&0$CT^_.JR)H)XCK>MHR)$!+#RZ
M^=IV]C]\[B7&;B^5G=FR8NW>QJ#;%3O2CVYW7FMFU'3N\MV[1P%;10=UX+8'
MP\W1)'%D:[<D$R)%EJZD@@UPFI=D$Y(;CE6RNPQ:=0>.2<_+ ^?0_P!J]R-_
MLK:.UV]8X'C(-9%!! (P..3]GKU;)_+F^-?R@^%_9_46ZMS]8?,FK^8.W_DS
MC\=6=28;K3;F^NE-T?"#<69VML#L;LC$]H979.,STU7E:#-Y+*4$)R])-1TE
M-$DE+#+I\M=MV&WVVXUPB@&*Y-?S/^H]:YH]U>?^<+$;3>SV@M12A*T (SBB
MGSI3YY\NMAW^9?!B.ZNC^QMP[OZ2^0_6NY.M-[=<]?\ 5?9M)M+%9/(Y#;W9
M'9W7.W]T;\Z^P4N*W,N$W9'0YNHQ^+BJ8*+)35L:6LAA/L0FE30= #/!C5AQ
M_P!7V]4K_/Y_A1V?_,+Z S>V<AW36=^]3[NZKVKV9)W/M#L/&]C[6K^H*;:W
M:M!/N6MS>.Q$SP'JG(1U&/?%_<5-5F:U34 PO4:==>Z$+YZ=A_R5N[-WU_9.
MZ^T>^MP_-?JR$1]5;U[+Q_9E;-MW>G0=&O<"I7C;6(H,9DI-O;;W *J"*I=\
M35RF"-A*T<R^_=>Z8NV]W_RMODWTOUYVQ_-?W?WUOSNO^[O:65V-E,52;UQR
MT^R<UAL)+24E7ANN(:C!TN\8]H4&&DKY:*-8XJP$T<ATR/[]U[JP?^1/MOMK
M<]/\I=F?+?XT[-Z?WWM_-=31#J_=FVJ^;>%+L3);=R@VQ4R[=WON'?-/CNO<
MQ!AO+2+25A2HR^/JZF:-:ASJ]U[HZ7\RKXY].#!=8[TCS/7?3N4V5BNTMI;"
MHL%N2FZ9W;/EN[=Q])X+LC=_7>1P&Z=@&MW+M;I;:F?:IIHYS4UD4Z1J0I8-
ML2%*@'CUZF"?(=:^V^]C?$7=6W-[[>^8_P W-D=2;%Z_HZ3*QUF.[WJ?D!E*
M*OVQV1@<1L9,=U]V+O;,;J;,]C;4S<]3FDHL=,*&E@M+/XY#:ITB:%G<++J&
MFOK44Z<62ZDADCMV:A0Y%,"G'R(I_DZL"^2C_"/M[X@?&CK[XD]J_"?LP[2[
M$V-O#L;#[(I/CSL3=&[]B0;6WIBZS-5O6V)R.*J=HI+N_*4%354C+ T+D/I;
M1I:._=&PYA/(^\[=R[-++OTTP(6,]V9 33*\ #GJ0_:6^V6P]Q]ION=8EFV&
MWMFK)(*KJ\/2M2P)\J4]?LZUQ>N?DMV1\,.D=[;DWENSK?9$^^_DKN_&=.X[
M/Y_H_?.XZ;J'%8;LNCR,>/VCEZK,Y#9V+HM]59@JQ-38Z?*T\QA#&*.,$3[!
MM+[;96L>YW7^,_00!B2:Z_#74I]"K54_,5Z+.=MRBWS<;J[Y8V5H[0WLY$:K
MIHOB-1J"F&&?V?/J_*/NW^7K\@_B1U-NSXE9#XS]$]SX]<GB<SUUU_W!MCH;
M>VX-T83#T:+M7>%3U/N? [QSG7F2S556U],)!E<>DT$$FAI0"AMMEIX%A.YA
MTNTE0?XN.?Y=!2_DN)+B 7$I\18Z$&M1PQQ\N'5B'P%P'6.(SW2,%9VGMSLK
MO#;VX^YY\>M3VS+V1N[;^R-T=/; &]Z/%+FMTYG=,VQEWOM6C@2LJHHO+-!&
MP6+SMK4=)NA,_FM]8[KSF%ZI[BFZWK>Z>I.HZ7?U%V+U-2]ZYCH*22I[#KM@
MX/ =D3;GQ&YMI)GX]F8VFRD0Q\^1C19*Y9$22[Z?=>ZT7>_/X1\6ZCK7XU]I
M?+2D[CV_V[AX\AN;);$>I[9Z@ZXV2=[U.WL3M#;&Y=]=N[-?=/8^V:>>BDJT
MJ*>GQM/71)))5#QDM[KW17#MGXH;%[&S&>B^2]+DX-P=6]9]E]0RUW6.QZ^6
MKSN)V<M)EMF=_P"-P_=LIV;+#NBL6LK8<-+EZJIKE%8:>)P(C[KW5OG\OCI+
MY!?,BEVY\X^OZ_>7RPZGZO['['ZL[(^'N9[GW'\>LWO#LJ@Z]I*#;6=ZQW'1
M=M?89O9]!/O"CRE=?(0Y*2K2*-*>21)8Q[KW6W=\4OY=NQ]I?&[9F)^0W4'4
M6\_D1B\;V?K[!W3M_'=I;EVYC][9;<,&U-L5V^MQ4LFX=VS[3ZYK,3@:^IEJ
M':OI\:86DEB"L?=>ZUE_E%U--CJRDZDCGW)\5M[_  XV;N[(_+7>>'^5V]NU
M>R?D[3[$Z>VIVO5[DZ#ZG_O75T>,RKU.WLA5S4>6_@,(P62DBB8R7C@]U[J@
M;Y/;C^.WREVMC<]UGVM6S=X9S??7& V3/V'@-OT&V*;#9C=FU/X9G]U]JTG8
M6<S&VMU;>BWE'%DJ:DI*VFI*>GJ?%,P5UA]U[H?.@]_]#?P/K#X^["^0W8_3
MF\>W8>N98MRT])2;:Q^'[RWLM+GA1;PJ=J]@SQKT8:2;&8<YVEAR&4APRR_<
MTE+'$GD]U[K;$_DF=3;U:38.:I8FS^5^.^)WOU/\A_E7@ODONSO#K;Y8;[W#
M34^7AP>R-H;OSD-;M*#K>MK*7R5]5A:"<K"L*(\<S,ONO=6)_P T[K?>>;V;
MUMV3#US'W;U;U1D=XUO872M7WOD_CR-S9#>)VUM_:>XE[ IMV[)H*F':*SY!
MA0UN0AIGEJD8!V0:/=>ZTUOD[U_AO@[1X7K7Y,=W[MR\7RCJ>R-Z=:=:X+M!
M>^^GNO\ HK&;]GQU/UJ-Z9G>."BRW9^&I,\,>^(@ER.,D./C66N^V4U1]U[J
MH=\=\=.M/EEGYJK?V<WK\?*CKO9'8>V\S-@-FT>[ZS=5'M[<%+M/";PZ[BW[
MD\;CX*C+X2;^.5&,J<C6T]J>;Q$R>(>Z]U<I\-.K?D!\YMP4GR/Z&SL7R%V[
MT'OO<. W_P#$G=_R!W;UQE=_;OH^LA'M6?JE-N=G8.?>.!IJC=S97-3R9O"5
M---B(XECEFCFAD]U[K:5ZY^.'=OQL^&)SG;DG26-[*P';O\ ?W9M)V#M/)]M
M[JV5M/(=WX[=^P>M)^W:_>M9O#/YC9VTPM###229%Z84ZTE)-50Q1N_NO='[
M^+GS2^/?SXZCWKV/\5^U<ANK8V&S61V!4]@XO;.<Q/\ "-ZIM?&9FKBPN,W1
MC:.IR61VS2YJG=P(9H_NT>G)9@P]^Z]U7_T1_-*^&OQ%^ G2V8[L[6W+2Y7"
M;.S&--+7=6]E8K/[PW#CLIGZZO2@.9VCAMOKDZN,-/5L]7%2TAD)=T07][((
MR>M@$UH.'1W_ (.?S*?B/_,$V'NG>WQKWQ5;EDV'C\#FNP=GY+"5V.W5LN;<
M6+J\GBZ')0R1OB,DU5'C9O#/CZVLI9GBTB3W0,K5TD'K71C_ (Q[AQF].F<)
MO#'4U73XW<^?[(S=%3Y2B%!DJ>BR/9&[:F*FR5"'E^UK8%;3*FIK2 \^[=>Z
M'IY*0660P@R6 #J+.3=P%N+/]+FU[>_=>Z"+NKLW&=2;&R>_*ZFJ<C%138G"
M8S#TCI239S<6?S%-@<#AX:RHB^VH%J<MD(EFJ9@:>EIQ)-(52)M7NO=5^Y6#
M>NT_D1L3MO<76^3^4E?\G-N;8^)'9^,Z'QFV,KTY\;^ML-FMZ;_FW?VAD]S9
M^LR^Z-OUN1WE4XVKE-)2+-"J@48%S)[KW5?O\P#X"="#Y#[3W#LJA^.75^U-
MK;-PFY=\=3XW9G?^-J]W;#V[1U\F5Q>XL5T!B7P>U=L5T.!609-/M,C,])9Y
M'\$5O=>ZL;^.79/5O7VT^F-M_'_X\SYR3O#:F&D;M7:N#V9U5LKL?/[0VG]W
M59/+YG<V:I=_[DR%-A8*J>"27&UN06G@D\A#)(![KW47M?YA?)/"[!V]VSLC
MI7:?]P(NW]S]2=BXZBS.X-^=L[<.S\SO3:VX,]MO:&*Q.V\)N]TW!LX04E!]
MW!55:UL/A?6UC[KW29_TO]R]Z;2[KWOT]W]N&II=A["VUO[K7"[4ZJP_7M!O
MBCSF/R]564.Y3OG%;E[#V]N3$Y;:&5H<A0-/0O2,\/DA60@'W7N@T^36#BZ\
M[NKM^9#<V=[BZYW#TQM2?>O6G<GR!K-GT>UMAY_*;JPVY.[.K=MY-HMG[KWA
MM9:R@@JL/44B2UD10TTHJ_&DONO=5$?(?MG^73V!T9_+'AB^='770?<_4VY\
M3N3(]K]<;4E[-[5R-1UI@\KB,32;^H-BY+"9[&C=&>P%/)D)YZI*RGG8%(U$
MC.ONO=*_#_,#I_&[][^;H#&?,7YB=O\ >W5VW>G,=FNE_C%V_M_9NS]T["W;
MF-S[?WEEM[=[]Q]E5F3KY,IEXA3RT$AH9H,>L:W=5T^Z]T;#M[<?\Q?Y7]F9
MT;5_E%[<QNT-W;:ZYPF=WG\K^Z=HX+'X/<G6^X]TYK97:&R,!A@=Y8G<>V&W
MKD4II!0QY&$M=EFA?0WNO=/.TO@/_.8W-6_'W&[R^9/QVZ4V=\=UR4>T\IUW
MUKD^PNV<A'G\3E<'N23/YG<D.-P-15UV'RIHS#324=,8HDD18I5NONO=.N__
M (D?,'X3;LWY\I=F?.G?7<787;<.$H.S\1OWIWK)*K=>'ZHVQG\ELW86TLG4
M5](,)#-1?Q"FH8IYJBOK,A50JU0H-S[KW0%?![?>[-]_SB]H93MK,YG<W=64
M^'FX-S9[,9;";"PN0P^Q\W)ADVEL'/4>Q\ADH:/<6V,G19&2HCDD8-'61MJO
MZ5]U[K:J6^E;WOI%[_UM_O?OW7NN_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW00X/_F=W9/_ (C[JCC^H_C/:EQ[]U[I8[OW+A]F[;S&Z,S*U-A<!CZK*Y2I
MBADG>&CI4+32"GBBEDG"C^RJD_T'LAW_ 'V+E_;[S<YV"VENFJ1CP1?4_P"Q
M7K9HM2QH.@JP7?\ UIN&I@H*2?-TE978J?-XN'+[2W!AI,SCZ6F_B#S80Y/&
MP)F*A:<++XH2S,O*CCV06_/^V26<%Y<7BHKQAQ6N8W 9'% :AE-1TUXT)X2
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M6X*A;G=A[?;VJ>[J7&V/$DTA%J=)_L#K) Q0#*CTK2O2<W>Q3ZK<W2QN1Q)
M(X<#\R3^SI(5'6F[-F97K"MV=%19?;4-7A]X;OVA39;&TT^W-XX':U0M;6T*
M3U"1B#<54!!,$8JE4VMM*7;V%K#VLYLVW<O;V[LU81)("W$@?#GRI6O2&Y$"
MN#9;J/#!!*ZJBHQZC&3Y] 'B>A=^;0V7TYWRU'29'Y*'N7,]G=Q8&GR^&AK,
MSLONBI3#[^Z]AJ9*MZ7(T>V]FKC9*,-*Z,<./&X+>\_-QYB2XN-SL+"P9M@6
MU1+3#8EC4488H&,@-2!DTKPZA/;N3UVZTVK=-RW!1O\ N\[+>DD O$S%0K9J
M0$(P:'/I7K'UKT3VKL;N7.T61H\-E>AOC@G8N[/BNL>9QE2,[N#MPS9*DPM1
M!+41I0-UI05%;14,LBB\%>S(WI!)+[C[RJ>U=U><K1/_ *Y=UV3I0CX 5K32
M#DL"P)SIX=>V#EB\L.;WV^XW&G*5@Y2V%<:& >G&G:[,?+SIT8G8?6_8O5VX
MMC[L3.;:W4]'3Y7;^[L)MV&*CST]/NBJDS%14UM5D,D\66K,;NAT5;JA,,AL
M?P<&MA]M.>.4]QVSF:*W=[JYUM=@ U;6K5U8J>XC.>'4YRQ[58RV<FSWM88Z
MAE!!U5]:'/YYZ4O6.P>PMF]GU'9^3VK3R?Z6)J^GW;@<<M)]QUXJ57FV]4K*
MK*N0IZJD0+D?&?(:A@X%@1[WRELV^;;SN^\WNSLI=Z\,C/J1_@Z.K2W$7^.'
M3W^7F.CT0@+%&%M8(J@CFX M]3R?>3X<OWD4KGI26U'4//K+[WUKK__6W^/?
MNO=%!^8W_'O]!?\ BWWQD_\ ?G8GW[KW1NT^G^Q_X@>_=>ZY^_=>Z][]U[KW
MOW7NO>_=>Z][]U[J)6*3&/2K@-=@XNFD E@WXTD<<\>_=>ZUY/GQM&>C_E]?
MSMMR=DXW;.0W)3T'9_\ =+<$V*VI'G\3LE^F]C#:5(V:HL'CJV&HCBR,K0_<
M/-4-YC^X^LD^Z]UI4_R_/C1N;Y3X_K78W5?\Q3XW]!87KK;O57<&XD[/W3O3
MJ6KZKW)EJV/;V]</UK49.9=NYKL-Z39]&<D](:/'Y43K,7G\<@7W7NMU#9.R
M/AQF_P"8MUSNKJSIOX*;JI*>KF.#[@Z]^4>SWWSE]Z+L_&Y*;?L?QMVUNB/;
M.=[(3=]/4TT62.*KLM]HAJ!*@4'W[KW1D?D._??RBZ5^=VQY.S]G=3[-Z_[<
MQ^SL-C=\8B3:^/R6P]A0=;[UW/0;I[/Q^Y*2OV[MCLE5K:09)*83TU!7 6!#
M'W[KW6G;\X/AYV[\>>N=V_S"M^]P8;K/J_LCMC9/7>&^/7PX[HK>U>ONCNS,
MOM"FQ.7F[*[%W?DLW@AMZOJ\&U=!#1O5U25=?I$VMRP]U[JEW>^U/CGE]M=>
M=L;.[\RVY.P,3VS_ '>[?ZWWR.M,1FLG@M[8#'9/,;OZ0K\+G\EEGH:]:FHI
MP^8BI3395UDF)=YB/=>ZL[^'GQ1Q_P ^.PNW?A_\8^]^T=G9+K;;VX=\;+WY
MN/LN+&_'S;O2^'W7@L!C-B]@P]<T-;7KO+(0UX2DR%+7G"UE5%4FF!A"/-[K
MW6\=_*Q^.W:?34?<.^-Y['Z[Z1VWVA7[-Q> ^/\ U1W3G>^]C;2K^MI-V8#)
M]B4F^]P/+4P9;LO#9#%-48R&1HZ1*2-G F:95]U[H1?F[U3N?/?(_P"+7>VS
MLO)@]P_&OI/YW[NVS5MA://X]]Y;VZSZYV%ML97$UF1Q@JZ&A?+SUIC\J)*U
M((W9%?4/4!()Z]I9C@X\^M3[Y9[+^5?\PSK/N'978VW-\[]BZQW_ $N5RFV-
MB?&WJ'I3M/?W9N-IMI["W1D<%N7K?<6ZZ[>/7TF-SF0K:;,24M;2R4P\)JM<
M:,:2QK,M'6OV_P"K/1C;31VB,ZU6:AR#FOE_Q?1B>M.MMS?RW_C'\3NXNM?@
M'VM1_(7+9;/?'ZH[_P"Q.X\;BMYTN-W97[BWAG,=EMMX_'[9S^,P>?.%<XNI
MR$$TE%14HIY)"3&/89YQW%.5=FBGM@JM\1H*5R*@\22:X],]'/+>WS<V[I"+
MVYU2FE2W'_(,4H?MZ*#_ "R?CQF*OMGL'N[#9+N'MK=6X-X[SZ?J.GNANKNG
M*?;5/1]N[QW'NS<5+\D]Y=K]<]A[-W3AS5;;26DDRJQ4L-12@+-YJ>-&+^3=
MUCWS=;JZELRL?A(:M6E0HX#@/BR<UZ%/N7M-KL%E8;5&%:[IJ)!\F)H/3 X>
M@-,]7)=W]Z_/;X98/X_]-==S=J[%VYB-O8O:HVOD>K/B[W;DLE6;DJMY4. E
MRFX=D;KZ]VKL?KO:62BH:1A3XJ.EHJ#',)IW6H0>QU';.8Y;QGQKT@>5,_YN
MHOECAA>&.):52IX_+R/V]&U^ GQP^%W367^+G=.R\+\=L+\K>T<3V72=T[SZ
MMRNU<17[WW/O# 5F:W32X_;.%W9FL;28.HW)MR!L?08UFHH@BM  'NVNJ='<
M^?\ W'UGU[UK2; W"M2G879J9:MZODI?C9N;Y7TV(RG7LVW]P9;=>5ZKVS@,
MW/4X[!TM9$@J9A!'%431D2JVDGW7NM.S^8VOQ#^>6VX_EO6_,SOGMOY/=$=8
M3;<PVWNE_BAN[8G7?86 I-YU.[]IXO)4^Y\164>R#AXXIDK*M"8ZF" $P3-J
M5_=>ZIKVG5]+]H=Y46S,S3_.' [.VSM'I?KGI;+8RAZ]SNZ>OMKYO%TV1S%%
M_#\;U9M]<QF*C95++F-M&BEQT<M+#)'/5,T\A/NO=;*OQIW7\1OB9T=0? 'X
MB_,[L3=V[-_=G;Z[$[,V_P!U_P OW>O=6Y>S-QY_:NWLO1XW%=64VRLG0XNF
MVUM#9<E3XJ:E>T$GW#AEBLONO=;;/QV[?ZY[KZ+Z_P"U.M<[!FME93;CT]+E
M8=KUNS1'4[5J)<#N:C?9]?2XZMVK5XG.8>IIY<=+"DE&86A90R,OOW7NM;7N
M;Y]?RVN\>Q/D5UC'_,KZ4Z_^-OR3Z_W5LO=_6'4OQ+W5CNP-PU6YMLP]593,
M;C[>H^J),IN6KI-WULD],Z3*!4K#2F=HQ)&_NO=:L?SR^/72_P (LGALCT1W
M#\K^_L-U[N_X[U<'R RVT-H]9;2AIZ'=4%37[5Q&!R6PFR,^YMHXK8N'CH:N
M>4P_Q%Q++#*I8/[KW1N/@CUC_+7J:S!?(WL#^99W?\0ZSH_O=*[I38NZ-@8+
M?DRY7:&U-F[;V5V+D=];2ZYH*#-M1[MQ\E)58MJ1:*LJJ$+()O+)/)[KW6Z!
M_+M[U^-_8M&VY=D=[U'R)WIWM4[DWGMKN7._&?(='Y'?.S=IU%-@*FAQ6\DV
M!MO;O9%'@LE4/+'41Y"IK9(ZAQH$43%?=>Z%7^85G\>>O>ONN*;L;:FPMP;[
M[!CJXZ;<7QJS/RJ3>.S=E4$^9WM@\5UIB]H;S^RSU/15M)-3Y6>F6"AG2-;N
M&"-[KW6I-_,3R/\ +5_F4[K?Y$]T?S&=[[<[$^,FQ]Q;,Z[^+_6W2E=_>.*F
MVODJR3^[VY<9G-FTF$V/V'O/=6(D1Z1(R<2B".5Y'A\:>Z]U0;U]5] =N?*7
M"=98;,_)^BQ&\-J_&SIO:>^I-R]79G^[>8W7V#'C*RJS=;2=;X:CQFT*7;>]
MZ@8A=5#+2Y&,FMK2G$/NO=;FDO\ *[^3_P#*Q^%_S3R'07RMG[_VUE$RW=60
MZL[)^._6V\LIOW>%'LB#;53BHL5FL5N+;<,\M30X^7'T<%.],W@(FCD9K^_=
M>Z;>I.V>XOECW1U%T!F_EWV-@ND,+@X>W,EF-X_'WIGJ27KOMCJ'=&S-S=18
M+%4^7Z V)MC*8ZKK:>I62EHZM@[4YTW0-[]U[JY+N/L#=VT?E+U)O>?%UW8?
M5U/UQ2/M3%=6X:'=78^X-UY*KWG0;@R#4'W>,PM7MEZ2JQTT$E-+JC<2L!H9
M??O]7^K!Z]UI5_(K)=B0?SJ/E+V-O/8':VPMH]@[EWI7];4?:?Q_S>4RJO%L
MG:4%744"[DRF/V9DL?!2K.&I:+*&2-*B*=E]!C]P/]XC;!NW*'+<9T$R;S;Q
M2:G,>N+O_2U &H+4[*#52E1QZR&^[-<&SYCW%GJ(V9^ J<^?[.FC/ONW?WS@
M^-$?65 (,AMCY!?&')]E_>_'_<V0K:M<;VAM5\AN>2?8;9VBV5M'">"JGS,&
M2R%-39%61 9#"U@3]T^&_M^5-\BOMP2XI<C05D\4*E9*)JT)E?\ 2]&OWD#;
M2[CLUQ;P:2S2@FE*T$?V^=>MS'YR_(/YN;+^3'QI^-7Q!CZ(Q$GR V[V?E*G
M?_>N(W3G<!MK+; HERD>&2CVIE\?E*RMSN,\DM$L:-%"**<S,=42ME=UC)U3
MY_,/Z\_G(="4?QN[+W1\KMT_)3>>0[U\&'VA\>/C]A=M;>ZSK,E@Z_;5+6K6
M46&R^=J*VJP.\LC3T4M3&E/+D(:45&NG\T,ONO=&9I_Y3/Q:[Q[ZH]W=][M^
M8'R-H]P[XS^%WQM'Y![_ -T;(A;M[;FVZ%Z;N)=H[6R'6>SY]M46,QE'A<1E
M-L82J\V4R">:K"TY2/W7NK=>FOY:GP$Z!QDV)ZP^)'1NWJ>HG>IJ:O);(Q6Z
MLO65$CN\DU3F]XIG\O-+-+,SO>8*TLA;3=B??NO='3PN"P.W:&/$;=Q&*P.,
MI_3#C,)0TV*H(!I"_M45!'!31$+&%]*CA;?06]^Z]TF=[=C=;];X_P#B78>^
M]F;!Q[1R.M?O+<^$VS3/'3*7E,-1G*ZBBD$:L02I.D&W^'OW7NJZNX/YS_\
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MP(47YM[]U[KL5$;*&4MI/]JU@.2&OJ _3;W[KW7(2H3IOZK!F4\,H/TO_K7
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M4ZY?"]1_PKH.KR6,VA)C<MN_'X<86HEH->A)J"HFEE#J6F]U[H$.M*K^56V
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M/6-]Q!,+Q'GW7NCAY#^:_P#%#&T-#DJANY325U3%3K*G0W:5J<RRB&.6J/\
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MB_)+:-)A:C:..K]LY*J_F:=T/F\GOF5,8U3#F1'52T<NRZFH:O>E-,U1-:.
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MXK"8'#02)2P9+<FY,G2X+;M%E,K/%-18'#5.9R$"5=?4#P4=.7E:^G2?=>Z
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MG^).=I((*6E^77RWIJ6GBCIX*>#>'5$$%/!"JI%!3T\73"0PPQ1J%5%5550
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==>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g425213dsp135.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp135.jpg
M_]C_X2:D17AI9@  24DJ  @    -   ! P !    .@(   $! P !    OP$
M  (! P #    J@    8! P !     @   !(! P !     0   !4! P !
M P   !H!!0 !    L    !L!!0 !    N    "@! P !     @   #$! @ >
M    P    #(! @ 4    W@   #L! @ (    \@   &F'!  !    _    #0!
M   (  @ " " _ H $"<  (#\"@ 0)P  061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD ,C R,SHQ,#HP,R P,CHQ-SHP,P!';V]D=VEN    !   D <
M!    # R,C !H ,  0   /__   "H 0  0   #@"   #H 0  0   *<!
M       &  ,! P !    !@   !H!!0 !    @@$  !L!!0 !    B@$  "@!
M P !     @    $"!  !    D@$   ("!  !    "B4       !(     0
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M8R_%ZMTG*QG9)RFY&#=E7EYCTVL#195;738_U<NG*_2UNM_P-O[]7J7=S@-
MQ:GQ[K&,<\R3)VM;W_JI*;"IYSBT.BKUB?3&R8[O\VJXJ6=LUW!KOYO:'@N$
MR_\ -8DICCTBX$OJ%;F.^BX%PT/[S;-O]E'.*UQ9(9%9!: TB(.[2'JGTSTS
M8_T/3$1O+6/,C]QMCW^W]Y:B2G__T?46 $V@\;O^^L4,:MPQZ0+"0&-UANL
M?R5.OZ5O];_OK%D]7ZGU#IW0WY>-16+JVU"L6OFN;'U4?I?3VNV-]7=O:DIX
M3)Z7UCJU.;U'%SJ[*F7_ &1E/L+S36_U*O;_ #?HXD5Y3L*_TV9OZ;*S?3]/
MWK_FY];"]I%K[@7Y@=8 =7QNN>S);^EV=0JW,Q\_^E?]YG]$_2+=WY.5U"WJ
MMV1NOKQ'6T-P['X];FTLN=C9.5B767,R:KKK;OL62_\ 0VUT?I/\)CK#_P"=
MWUI^R81?396'8MMC;ANBYK6-H_:'I;O4?155^M>A4_UOM'Z]ZGV-)3T'0,'J
M3_JGT_&=T[TC540:MWI21<RQWK4PS<S(=5ZMU/\ -9.-;9^G_?DSH'5:,K$&
M+B8]-3LFNS-LHK%0].JRO(:UU;[=]ONIK]';_,^_U/41+.H9-_1NC/Q=N>ZS
M&'VFIMM32]QJILUL>YC/4<[V?N?I56Z9]OM^K^=D=0 9U(Y.0"T:BL!_IVUT
MOWV6L;CM8_T-EWZ+]$E>M*K2W5ZIT#JF1U-F5AYUF/0"W]'4 WTP-N]K&!S*
M\CU?TCW?:?YC?^K_ )ZS7X'UJKZMU#)9AM?AW,-6+2+*WNK)J%8OH?=92VIC
MGN=Z_P#-VV?];KM?E9_6?19C65F[!?1<T7Y5EKKF!IQS:^U]#8]7^<:^JIGO
M^T?X&Q;W5F.KZ5U*TN<;@ZS99.VP5!H;ZGJ-VW5V-V.V/8^OTWH<.^IUUW3Q
M'30::;.%=B?6NKI&!B9&-]JR'9!-@KN%8M)JL:,._-IRZ<FW)JL&Q]NST?\
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MGU-VP_H/9_I%=Z;ZC<.MMQ<'Z[1:0; V?T0N]SOTNS;ZB2G_TO4:_I6_UO\
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MWW?S#O6V>G7^KK2P\0="OOS7U.LIR*<=MMM3:V18++&.W8U5>-L9^M;WW/\
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M:W;6[_K=7\YE>F3H>!G4]7PLFVBQN/CY9-]AD,K:W$90YUI.VBKTK_T6W?\
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M/K-'U/\ K930:;.J8.19K^G?G9S;"20YN]M5C:]K6->QGILI_P",>I8?U/\
MK8SJ^%F_MG%^S4Y%+[</'RLDM<QMC'V,9]I=;ZCG,]OZ2Q>2))*?_]G_[2XR
M4&AO=&]S:&]P(#,N,  X0DE-! 0      ",< 5H  QLE1QP!6@ #&R5'' (
M  (  AP"4  '1V]O9'=I;@ X0DE-!"4      !#_$I&\Y[7?=RI4GZE"+V@S
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%(            *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      !  2     $  @!(     0 ".$))300F       .
M         #^    X0DE-! T       0    >.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         ".$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!!X       0     .$))300:      -!    !@
M       !IP   C@    & &0 <P!P #$ ,P U     0
M       !              (X   !IP                     !
M                 !     !        ;G5L;     (    &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   !IP    !29VAT;&]N9P   C@    &<VQI
M8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$
M;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,
M15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *
M15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   :<     4F=H=&QO;F<   (X     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    !.$))300,     "4F     0   *
M  !W   !X   WR   "4* !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" !W * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M0W(_HES_ +-57;53_P!JKZ_22M:=_I]GU?H./TO#R+"#LRJFP;!8TV-?7?\
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M '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
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MR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:  P# 0 "$0,1 #\
MWXLCG<)AVACR^8Q>+>I$C4ZY'(4E"TXB*>4PK4S1&41F1=6F]M0O]??NO=-_
M]]=F_P#/6[9_\_V*_P#JKW[KW7O[Z[-_YZW;/_G^Q7_U5[]U[KW]]=F_\];M
MG_S_ &*_^JO?NO=>_OKLW_GK=L_^?[%?_57OW7NO?WUV;_SUNV?_ #_8K_ZJ
M]^Z]U[^^NS?^>MVS_P"?[%?_ %5[]U[KW]]=F_\ /6[9_P#/]BO_ *J]^Z]U
M[^^NS?\ GK=L_P#G^Q7_ -5>_=>Z]_?79O\ SUNV?_/]BO\ ZJ]^Z]U[^^NS
M?^>MVS_Y_L5_]5>_=>Z]_?79O_/6[9_\_P!BO_JKW[KW7O[Z[-_YZW;/_G^Q
M7_U5[]U[KW]]=F_\];MG_P _V*_^JO?NO=>_OKLW_GK=L_\ G^Q7_P!5>_=>
MZ]_?79O_ #UNV?\ S_8K_P"JO?NO=>_OKLW_ )ZW;/\ Y_L5_P#57OW7NO?W
MUV;_ ,];MG_S_8K_ .JO?NO=>_OKLW_GK=L_^?[%?_57OW7NO?WUV;_SUNV?
M_/\ 8K_ZJ]^Z]UU_?79M[?WMVQ>U[?Q[%7L/J?\ @7]!?W[KW7:[UV:]]&[=
MLO:U].>Q36O]+VJS:_OW7NN7]\MH?\]5MO\ \_F,_P#JKW[KW71WGL\?7=>V
MA_KYW%C_ ..O?NO=>&\]GGD;KVT1_AG<6?\ XZ]^Z]UW_?+:'_/5;;_\_F,_
M^JO?NO=>_OEM#_GJMM_^?S&?_57OW7NO?WRVA_SU6V__ #^8S_ZJ]^Z]UP_O
MKLWC_?W;9]1LO^Y[%<FU[#_*^3;GW[KW7(;SV>0"-U[:((N",[BR"/P0?NN1
M[]U[KO\ OEM#_GJMM_\ G\QG_P!5>_=>Z]_?+:'_ #U6V_\ S^8S_P"JO?NO
M=='>FSE%VW9MI1<"YSN+ N?H+FJ^I]^Z]UX;SV>1<;KVT0?R,[BR/_<KW[KW
M7?\ ?+:'_/5;;_\ /YC/_JKW[KW7O[Y;0_YZK;?_ )_,9_\ 57OW7NN+;UV<
MBL[[LVRB*"69L]BPJ@7N6)J@ +>_=>ZXKO?9;@E=W[7<*Q4E<_BF 8?53:K-
MF'Y'U]^Z]UR_OKLW_GK=L_\ G^Q7_P!5>_=>Z]_?79O_ #UNV?\ S_8K_P"J
MO?NO=>7>FSV8(FZ]M,[LJHJYW%LS,Q"JJ@51)9F-@/R??NO=*6X_J/\ ;CW[
MKW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_;CW[KW7KC^H_P!N/?NO=>N/ZC_;
MCW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>N/ZC_ &X]^Z]UZX_J/]N/?NO=>N/Z
MC_;CW[KW7KC^H_VX]^Z]UZX_J/\ ;CW[KW7KC^H_VX]^Z]UZX_J/]N/?NO=>
MN/ZC_;CW[KW7KC^H_P!N/?NO=>N/ZC_;CW[KW7KC^H_VX]^Z]UZX_J/]N/?N
MO==:EN!J%S>PN+FWUM_M_?NO=<O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7__0W\)HGE(TR-& KJ2C,K>HKR+&Q(4$ GZ$W'OW7NB]
M;&SW>6^MJ8?=E)F>J\92YN*HJJ?'U6TMW5U320+6U-/##/6P;YH8JJ98H5+.
ML,09B;*/?NO=*W[#OO\ YZ?J/_T"-Y__ &PO?NO=>^P[[_YZ?J/_ - C>?\
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M%DKJ/9:]R3;MK\6V1:RU4-%)3R1?O*[0G7[]U[HZ/Q(^3GQY_F#XW8VZL?\
M"7=F ZT[/ZWKNT.L.T>[^J^EZG:V_MM8W+8_$E<"F.W)NS/TF3:;-I4)%6T5
M,@IM1!!(!]U[HZT?P\^*U*I..^-O1&*E)9M>'ZJV9@R'D8L\JOA\/221RNQN
MS W)Y]^Z]U3_ /SW/AW\<L1_*D^9V[MK](]8XKLC$]<X8;/WE_ *./,;=S>5
M[$V;BX:_&YRJ$U7AR@KBK2QLHCC9O[-Q[]U[JF#H_P#D@_%[8>]L=#\A:[XJ
M8/"[EV5TMENR\?GN_<UN;M#K+?>V,I%E.V,_A*[:>'H-E9_;_>-#/58".G^_
MHX:"!(JU?WXC3-[KW0F="="_R'_F7W;VS\;/B#TCB:#(=24>^<AV-O+N^CWG
M5;$WA1[3R>*PL3[ KMT[O>;+&HS-;57^ZCB<4<:5$<9C:ZW*$*K>1ZN8V"*Y
M^$]$1^(G\L3^51V_\1>C>TOD/OS =1[UW7O?MNFSVV,%V=O6FW/MW9VU.S>X
M\-B=S8/9HK:NDR$(78L!A@IZ!A(K%;.]@6@ZN=(XCIE9$9F4'N'1^]K?\)SO
MY;.PHZWL/9?STWW2S"DA:D--DL-C-PX9<A$E9A**#'[?>;=]/N9C*K00Q4\.
M4D>RJFH@>[=7Z3G6G\B?YQ9_?G;,O0'\S;YD=0X+:U/LZ7"47=6<["P^;W_7
MY:+<=8&RTL/8NY-T8[;U%104_P!K-4005+"5P],C*1[]U[H?MG?RR?\ A1=T
MU39FLV=_-5EWEGTDB&V\/N[<,_9FUJ;'(6:6GEH^TMO4D-$DU_$)GHZ^:.VI
M2#<^_=>Z:=P9G_A6QTM42)%_LN7>U-*M.N*EPFT=A[A@CC)\<B[A%(_7.4>J
MC8Z@],$C5;:F8W'OW7ND-WG_ #*_YY_6>?\ CQ4=]_RRMJ=B2;![:H=X[8W'
MU?3[[PW]_=Z?Z)>SMOUFUZ^ 97<F+VZ]!MS<F4RA$!K&DCQA(L+W]U[H7]B?
M\*@=]8YLW)\@/Y6'R2V5@-LK!!F=U==;@3=T=+D*JH2(+6X#=6T=D+AL=3I<
MSRS9)Y4L;1L>/?NO=#SL7_A5Y_+(W'E*;&[JV[\F^N*RNK4Q"2Y[IR7+8R.M
MC?36I/D-MYS(I#!2?J:1D]:*2H/T]^ZJS!!J;AU8'LO^?!_**WS'CWQ/SOZ4
MQO\ $XQ-1_WRJ=Q=?H\%RKU#3[WP."IDI(9%,;SF3P!U(UW]^Z\KAN'5@NPO
MDM\=^T\109[K7O3J'?N(RE/'4XZOVEV/M#.P5L$]O"\!Q^8G+"6XTW O?W[J
MW4C /_QG#LN71)XSL#J<*VDV<ME>T& 3^ME!)_P'^M[]U[H8C+&@]3!/IPWI
M/-OH#8GZ^_=>ZYA@?H?]\?I[]U[H&.D_^+3OK_Q,W;__ +W.7]^Z]T-'OW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z!WY ?\R6[/\ _#+S/_N.
MWOW7NAB]^Z]U[W[KW7O?NO=:LG_"B7^8?!_+I[J_EW=C[NZ;ZX[ZZ9WAN/M[
M;?<G6O86Q-I[OFR&U8(-B3Q9O9&1W+B\D^W-Y[9J*@U=*T6B*L*^">Z,&3W7
MNAQ^<>YOAQVO_++QGRI^'.TNC)MN=H]G?$JCQ78/7W6W7N,R.3VQN?Y/]4X+
M=NR,Y-!MZ.III_LZJHHLKBZP!E;RHZ$"_OW7NJ%:[.5&*VEUMG\/0[9QF=@[
M>RT1S%!LK8N-R4-/CODA\0L7CS#6P[9AGAFAPVYLA30M$1)315SZ2+&WNO=?
M0/BOHY^NIA_MF/\ B3_M^?Z^_=>ZR^_=>Z][]U[K_]/?X]^Z]T#GQ^_YDYL/
M_M53_P#NRKO?NO=#'[]U[KWOW7NO>_=>Z][]U[KWOW7NN+KK%KD<@W%K\&_Y
M!'OW7NOG2_SH_BY_"_YNNZ.DMC;I[RWC+WSULW?V]LEN/*=D=B[=ZOPVXL]O
MW)9I-L[6V!M_<F9P.+_O)C,1CL='28\M%"VEI&%C[]U[J^CXI?R)/Y5^W/C9
MU1WYW3\?ZYMW;SZ:VKVUW#7=U;ZW774F$W#GMC8_/;W@W%2;F-+)@5VZ\M1$
M\A@I:R-*?0]F 'OW7NK!?BC\5?Y26>P]92?&GXX] ;BHMNT>,RLU9DNJ,ID<
MW14.52>3"UN.SG:V DSM9B\@D,A@FI)VA(0Z?H![]U[I=[?[>^%W7ORFWQT9
M29#J3;N^)Z3I/8N)V9A-D1".@WUFXM]Y#%;:R&3PNUYMKXC<V7QE3324]-5U
MD-5(NFRDD >Z]T.7R=[EZPZ=I^DLKV;NBCVECJ_NK T6 @>DS&2R&6JZ3:>\
M*F:EP>"V]C\KF<F]%16>814Q2(7U%; ^_=>Z"7IG^9Q\0OD/O3([-Z:W/V+V
M3EL54[@I:3)X#I/MV':FXI=J3K1;KCVAN_+;/Q^V]U3[:K7%/D(:*JEJ*:9'
M$J#2UO=>Z.9MWM#!Y[-IMV+%[PPV5GQE9EZ6FW7M/,;96KHL?/04E9+0R96F
MI8Y_MJC)P*ZI<CRCW[KW0D2@RTS70DO'<QDNA)TWT'3ZA<\>_=>ZU=?D7_,F
MP'5O97=O7&U/@C\D=X=U]+?(WLN?8'?NTNM*>LVC)GYMQ19"OF_C^)HQG\QL
MO/8NJ?'YB&-99ZF R(BF18V3W7NK#>R_GQ\#NS]H5V(W!7=RX_/RXF2CPF[X
MOAE\@\QN;8^38I4T^3VS7YSHO(P138RMC5XP0T$FCU*RL?=6^%J\*=;"^(=
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MW5YGOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z!WY ?\R6[/\
M_#+S/_N.WOW7NAB]^Z]U[W[KW7O?NO=5G?S%?Y2_P[_FDT76%!\LL#OO-T_4
M%9N2MV8-E;ZR>RGIYMUP8VGS KGQT4IKDFCQ,&D-;05/]3[]U[HOO0/\@CX%
M?&CKC?O3W5<GR#HNJNR=R]<[SW1U[F^]-T9[:4N\.J][87?^SMT8W"U\;TN'
MSU+G<#3I45-,(Y*RC!@F+IIT^Z]T,E9_)T^%F0H,/BZG!=B&AP6X:O<]!!_I
M#RK:<I7;TZ\W]4F1WA>1H&W'UCBWT@@^(3)>TS^_=>ZM,C3QH$U,UK^IC=B2
M222?R;GW[KW7/W[KW7O?NO=?_]3?X]^Z]T#GQ^_YDYL/_M53_P#NRKO?NO=#
M'[]U[K ]1#&X5W"L1]+,;#CEB 0@.H?6WOW7NL_OW7NO>_=>Z][]U[KWOW7N
MM=ZD<I_PIWW"S$B./^5!C9#^I@H'>,EVTKR?I^.3[]U[H4OYR_\ ,5^)_P 8
M.N\#\5OD=L+M'M*3YJ[+[(V#2[1ZVPE#D:F@VD])387/;LS-579C$2P4F'K\
MK U/%2":LJ90L<,;RZ5/NO=5M_R??YEW:#=1?/\ ^1GS'[(GWWU5\,MD]6]=
M[*DZXZ\V]@FKNL]I5N_L5B<ACL5B/MLE4;CS66QYI4BK*I4&L2'2#Q[KW1%?
MC;\VJKYH?S+X=U?#*EW1TK\;_DC\COBYWW\C]C;KPO7;]AT7;^Q=R;4V9C]T
M#,R5^[\?4XG=BY+')4X[$2134L[3&HLT;(/=>Z,U_-F_FP;=WQ\HNJ>H?AKL
M7>2?,?X._*J78FV.X-\;6V@>LZ[=F_(7Z=[2ZIVM!N7-+79&NK:7<$#192JQ
MZXF*6F60R*[11R>Z]T#&4^1_RZZ$^#?P+['^$FV\3W?\J]M=R_+_ &)W[M"D
MZR';&8VAO1>XMP)NJOR'\,KZ;&=?X><.V+K<UC:(T;05(C2:+477W7NMMSIO
MLVE[5W=T[FZS*[/K-]TO3>[T[0P.S-TT.[\5L;?N3_T/Y+<.SQDJ2:8J,37S
M/$BRA)6CC4LOY]^Z]T<HJAC",JE" I7C3]0 +?3Z^_=>ZU7>A/YRE'O''UOQ
MXP&X-YXCY&4?RF^7>UMZ[PW%AMK;)ZVR4NRNQNX<AM#:NVM];PP5;M/+;MW'
MA=K8ZDIJ"GIP[2U!O*TD<B>_=>ZM=^-_S'P<_47<>[^]>[<(\G3NU8.Q]^9!
M\CMC)9386Q:K;*9/*5>=CZ^Q5/BGFP,U-4+*M/'6:)P560Z19)>.;>%I-1S_
M *L=7@'C2^$HR".M-7X5]/[=WCD_D]BNE?E#N#=FS-S[T^/V[XN^HL7NG:^_
MUQU?V1O+=U!5;7I-[[5PR5V97;&#%3%/#+34*UC_ +%80LC>X3W[8-VWO?-C
M:WNI5CAO#(R:Y A6A6C!6%:5RIQZCJ=.7^;=JY8V7=FO=M@FEELVB4ND;%6-
M"&&I30XP1GCUM1_*3^:3L38-3M;;&W^V,7U#O"KV)_I.P^TNUM_]'=;;@[9V
MOELIBMM[<AV14[]SFY,?F*BJJLA/5Q(C40K$HI5CF8J?<^P6UO!/9V4MP-84
M U)X\,_;\^H$$4^X6MU?152-F[:5  ^5,#KCW?\ (OL&M^/GQVSF[VJ,ENZM
M_F@_'CJ?;VXWBQTV'S^&QG;&/K6W31OCL/MVBJ-O97;U/54M-+##(&J&7]QQ
MZ@T11F'SZ<ZN^E2)UF\H9ETOY3)=R(2S\:#_ +JTMRO!_P!B.-=>ZUS?F10_
MR8ND>@?E!\C.M/C=\*N^.[NF=C;TK,=U; VU\?G-\[@Q53055?CXZ6>1JC.4
ME-7YA*K(5^/IZEA!K"S FX]U[K23^8&8VC\E8:3ONN^!6)Z?V_OO=_Q_V4<O
M\8]_T.#Z%ECVAF&;>.W<+4;@V;FDCWON;^]U'C#E8Z^2GAJJ4MXZFG\9;W7N
MK-?Y=_=GQKZG^07QK^)W9/\ +(Z8Q76_R5[?I]Q;J[)^4^[J+='R$V=MKM':
M_P#>[:^;%'4[:V+B*/8NV<32K#4&:C,5&5D:5E1J<O[KW6ZO\,NOOY7^P]_[
MNQGP?VS\;L)V'AMMI#NNIZ9@Q4F7FVEN+(TF8M_&Z%JA<W@*G)TU.\C4]140
M0SK&K%&TK[]U[I:?.7M;X#]4[?V37?.N7I>FV_NW/Q[%V55=N[0H-W0KE=S_
M .15$-&M3A\K+M_'31@"KR+FGI(%*^:501[]U[K5)_F>?*';^8[\J?@K\*/@
MC\3NQNCM]]7=:3XGY ;0Z[QU;+V-7U&?I\GEL;U9V!U3B,Y0F#:-+0&GK($2
MLR-6]+7H:.6-4U>Z]UKO;-V1VGU_W[O_ +!Q7Q$PN]-T[1R/17R9W/LG<F0[
M$W[M[IVLH:[;>['V%V_12[!HJD97,X_<D])/#F)<5#34U#50)*XNK>Z]UN3_
M  5^:O\ +D[,^&>V/DY_,#^/7PJ^,?;6+WQOC"CKV/IG!T.9R&VYMRC:V!WU
MMOJRJVSD.PJ[;VXXV=)*EZ"6CBD@ED618EU^_=>ZV5>J:WJRLZ[V?6]/R[1/
M5U3M_'-L0;'I\?1;,7;,T7EQL>W*7%10XZGQ:Q7T)$BHA!6P*D#W7NJ(/E5\
MF_Y5&U>D/EEV1\:.G/AE\A/DM\=MI[HQ^(Z:/5^UX,OOW=LJTF5R&$V]0?W8
MIZ_L.F6"9ZZIJ\$F0<1T[VD"W]^Z]UIM_)_&=J?,_;O8?R>[+^&W1?2&TMQP
M=.X*IS&QLCN_IOKR*79>\]D[:I,#C\?0]>YB@_O7NJK[4"?;RU-#7(N,JJZ.
MB9KJ_NO=6\_RM_YA?R?^$'?'0G\O7(?$O:?5WQLWSW-EZC?^>S=;VGD-P; Q
M.^3D\YENR1G-XX#:E%0;*HCC8WERM;1P4U8Q=_([!M/NO=;C_2WS:^*/R&[4
MWWTOTGW?L;L_L+KC;^&W1N[#[1KWR]#!M_.LJ4&8Q^>IH9-N[CI/O'$4LM#4
M3K#,2CZ7# >Z]T;8*%O;ZGZD\D_ZY^I]^Z]U0E_/:ZAW37_%[L#Y$4N[Z/";
M:Z:V_P!<U%3@H<-/5;GK:W_9@.N*VHK\1DXZZDIJ-#BI&B,<BRDLNI2I9O>P
MVDAO3JDL;2QM&C48CCTW_);9/9_PAZ,GWGN#OWIG8.WI]U;7P4N]ZW)[DZ<G
MW!G,EB<Y @[+W=5]CTN"R,.72F-+1T>+AQH2HJ/+)',$(]OF. KXKR%0/]1Z
M3V\LT4BP*NMOV_X>JE_D/US\G_D?T7T-WMTGV)7=NYYNPTPVWLIT#O+=':XW
MQNR?![@VE4[#K#C^SZ'8^[>NL#FZML-N;,5X=<5%EYK&&E^ZNU;;BDPN+98_
MT@"%8CC\P?SZ7W$9A99)(P)&I44R/M'0(_\ "?'Y#=._%_L;N+:_=OR.V+@>
M\>V,;W9@Z+JG,-O"F_NEVCMOL[>FY=Q["QN_=V8C']:9;RU6"K3!)35=0N0R
M6L ,6",#=MM;F/FC<KF29S;M;A54FJBC*:TK@_SH>C_<(-.RV=P(Q1I:5Q_"
M?SZOOVG\@:7MS;.^Z#NOM[:6\?C&8<K3=AYSK??'7.;I:RCVIMO*[KS6Y*#)
M=,[:H]SX:>BSE)CZ5Z97CS/\2A@IX86:HTL+^@YT8S^7A\COCYW_ +[[:J/B
M[D<5-U+1]<]-5DN)DV_5;1W]MW>=/4;_ -KYO$]B;8R5+C\]@-S?;[>AEJ(,
MC E5*[^>Y62Y]U[JS3<5(E?B\SB$E,$V4PV2I8Y/&TFB2NI)J,U $?JEEC5[
MZ/J]N/H3[]U[K46^6W\@+LG=E1U5VMC/E)\1OAAM3X_] /L#L+?77O2C[8QW
M:4256"J-Q[][@K-W9ZHVY/ELIC<3:HRTOE>GEE=P!J*^_=>ZUC_F'U3\A.JJ
MO:OQPZ$^=.(^1OQCV=\D^C,EUC)U[WAUMCNLD[?W/0U^^L9O_%44NZ(:O!9'
M 9*2IQIJK''XFL@,E54PL\<!]U[HZ&WOB%F_D)C^S^W/E7_-OZVZQ^3E9DY.
MKLAM+>>Z.N>_.\NPMAIX?[J4NV\'M7<=:LG]Y3F_X;2MC*@^ 1253U2QPL%U
MTP3W'K;[_E>?R^-]_$S8/0:;[VW\3L5N38?2N-V-N;>/2O6N3PO;/9=12;8P
M^!Q&0[.[ FR512;NJ10T_P!W6-'"R&NDNLLH E??5HR1JHQZLZ[Z[=QG0_6>
MZ.S<S@MP[HQ6UJ7#Q4^ VPB56X<_G<_GL;M7;&W\7!55E-3FJSFYLQ0T:RR,
ML49G:5SH1P?=795:FI0?M%>M4O\ F@_SW>S9MH[0ZQ^"W:&*^*GR6ZI[/Q</
MS+ZQ^0L'6.VM_P#6VWLSM_[_ !^$VS3=MY"GVYV F,R<<C90[>CKZ^.)84\%
MZ@!O=6ZUP]FN[_*';6X.Q*GX)?(/>M-U?D^S=N_P_<GQ_CZDW!M?<?:^$[*[
MKW/VO-G=_;?PD^_\5@LCEZ'$X*JJJ;*48:(I&M/32/'[KW5Y/\N?^6]VW\\>
MQNP(?F3\.:'XS?'S:NT\)V#T-W+L/8_4.T][U_9V=WC@=VX^DZPW?28S=$F8
MZF?;%%%(HA5HGIE6*"M;R%S[KW6R=M[^5YU%G^X^OODG\A-Q97Y%?)[K;=>Q
M=S[?[\W+L?K#9N[:7_1]-75&SL3CQL;:F+DP>!QR9BI2IHZ:I\=<9Y7G#>4J
M/=>Z)O\ \)RV>K^.7SG2K=JG[#^;+\W8*3[@F04T-)G]HI30TR2-)]O%3H;(
MJFR#@<>_=>ZV&_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T#O
MR _YDMV?_P"&7F?_ '';W[KW77?<'<E3U7N.+H*JP5'VJ9,.^VY]R&!<3XHL
MWCGS4<S5-+5TRS3X):E(3)&R"9E)X'OW7NJ_1MO^;^]50T\N\?BZD-'F=H9;
M-YF*+/,,YBL<*R;=&T]OX-L"K86'<$?VD$U=4U4LT,RU$E.JH8A[]U[H\>Z:
MWOP[MJ8=F[>VR=JPY+ T\=?G,H8:N6@K:1GW!D8((!)++_"7F98HWT/+,B6'
MC+'W[KW27R61^4V+IX*C^[^P<XTU5B:.>DP576)6PQ5>Z_#DLFL63J:2C%-C
M=F>HJ6>5ZP>D6]^Z]TILBW?TV3:+$T6W*?"#'[:>GR555B;+R92I71G_ #8V
M2IAHZ2DQ@)8@M.\IL(Q<>_=>Z:J:H^3T4M?%D,+L*HI8VC?'U6*KBM=(9<CD
M!/":6OFI:411XI:>SM*'\TC\$*/?NO=*#&3=YFJJI=P8S:E'C*BF5J&GPU7+
M5Y"@J%S\$"TM=-.T4-6LNVR\CR1Z1'+< L0"?=>Z2V:?Y609NHBP-+UU68&6
MDHI*>HR-15T]335)K,I]_2LL+SSR.*)J3Q2?YO6)-0M;W[KW2\V3)W6V4H?[
M]X_:4.*GARC5;X.MFDJ<>U/-3)B*>2.="M9-D8C*\[1%(H"JA=6IK>Z]U__5
MW^/?NO= Y\?O^9.;#_[54_\ [LJ[W[KW0Q^_=>Z+)\AMX]\;3FZZCZ/PO4V;
MJ]S;_P =M3<$/:V=WA@:.EH,CB<G6TU1A:G:.#ST[5HGQ["4S1: C(%5B6M[
MKW277*_/LGG9/Q M:]QV;W7_ ,3U /?NO=<_XI\^?^>*^(/_ *,WNG_[4/OW
M7NO?Q3Y\_P#/%?$'_P!&;W3_ /:A]^Z]U[^*?/G_ )XKX@_^C-[I_P#M0^_=
M>ZU]]PY7Y:TO_"A'L+(PXKX[XKM*#^5'4>J+=?:N1V;B]MP]IU=3%FJ>>'KF
M3<.2W+1Y!=8HAC_MI85TB4RG3[]U[K3V?N+YC]P5GQL[&[(ZDW+\D=UXKMGN
M*78V[^Q.\MT[XJ=_4%*W5.4?%Q;<W)D\Y)L^EQU;5T]6E7'30QY"IS8C"AZ=
M%3W7N@#W'W-\A(.X/ECM&EZXW3UICM[2?)6?LOH/;_==3@-F[+3!;>['W#3X
M.NV[MB;;]!GFZ8K)*NNI(ZR":7)248IP"CQH/=>Z=VSGS*^/6X-L=A;?Z;K^
MG-H=E[;H9,'@=E;^H^M:S?%+U+N[#;DJY:/<N-J,=NW^,;9W_5T,@-$U/DU
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M^;V["QFX-D8ZAS&"J.U]O4*],;#[%GI:#(1R4,\T-9/EZFHHZJHEBJJ>)HF
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M3[*R._XMNT%3UMLZAV?F^MNQJ$8++UDE6]15K'33?<Q00JY$A4^Z]T*'Q_\
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MV_08?']78[%9/&TV$WSC85J\A)5RM*\5#3O*D;^$J?=6ZHQ^/G\K/8>)V_\
MP+I?^:=TCVQVMTSA]KKL'M[;W6W>52_0F8&SCL+$1[$WEU9\C:7:5+F\/C<5
M75D=/44E360U%06J(8Z:H2/W[KW5.U=BNZ^A/YAOS3ZRW7\N.M,_U=V-W9T7
MLGY1]C]@=E;YZ_VKVIUYO_;<^TX-[;[ZRJN\<'VOV5B-GINK[W*4"561D@R)
M0P3?P][M[KW6QC\4OY6=?OC>O2_S1^*'SW^,G<?6&R=I;[ZOV-%D?COOSMCK
M';NWJC%[>VO6[6P.'WM\B]SY%9\#F-NR3S055=!)C*FIG]04HD?NO=;'OQ?Z
M=KN@>A^M^FLQN6AWAE^O]L+M[*;JPN 7:.-SM=)7Y+*5M=C=L_Q+-#;]!]QD
MF$%(:NH6"-0 Q !]^Z]UKU_*G^3AV]/@NG^R>Q_G[\?OC_U9\/-B[QFD[0V_
M\9Z[K7<3;5R3;<H,I!VON_%]Y8^;-8NNV;M]<;65_P!W0S%9Y#''Y'4I[KW6
MK7\[:"?-[%W?T+\)OD#\=NS/AWM?.=%[QHL1U[VAN3IC:>Y.VMX]D5+5>6;J
M;OSY&;ESLV:V?5XJ*&JR5/$]!3XG(1U >&WE7W5'!(QQZMK^*G53?+K,8G:G
M<?\ ,O\ C?U%\X-\Y/=?2'7M!B-Y]A]Z]Y9SK#;&?DS>/V[@-PXGY72[%GV]
MEZ/S4U#CG@J9A0JQ+?<ZK>Z;6)O.G6R=_+2_E\=L_!S!]8[+WSW'TMV9L[J+
MJ'.],;)EV%\?9>M=_P"7Q\^Z<5F,?G-^=A5>^MQ5>Z*R.CPI22B^U2.*IF>1
M)6%[^Z?ZLF[EZ*Z?^0VUJ?9'=G6FT.T]HT.:Q^XZ3;>^<)2YS#TVX<9#5PXW
M-0TE;'+ N2QT.0F6&4 F,R-8@GW[KW16<Q_+G^)&V,#V'E^IOBYTOL_L'<G7
M>[MH46?VIMK;FT]R&'<%'+YL9CMUS;?S";<CKJQ8W6H6DG2FE_=$+&X;VIE[
MD^,<.MBE<\.JSZ'X_?S2*[?.#S&[.F*C<NU*/<^S=\YK:NY_Y@NS*O YW='5
MF7P.Y>L:S(P[<^&NW\M]M@\E@$AFQ]+44E/4G1*\]H]#)K9KL7%;E5\#Y&O\
MNDUP)R*04X>9IU8CWUO_ .65-\2<%N->N*/KKY!Y[=.T-N[XVQUG!OCY(TO6
MF!S>X(Z7/[FV[%L"@V%O3>[8;#K'+(U'3T[4XF=F5DC)+MTLWCL]I-"8JU D
MA5C]AJU#]M.G86,<,584,X&3\^J@NX=\?)+,_"N27O6O[TQ&4'<.$%5DLUL#
MNOI_ I&^U\AG8*7<=5O&JR6ZLAD\3NJ.C_N2V)5,76[MDHJ2JBELP-9Y[GPH
M1))"IK0^%"L9_,J34?;\NG!-<254V\=?+_53'1K.L:_^77B^]-D_)5_GCOZO
M[JW$^+GJMK;Y[;V=D<WF<O3;8Q..SO7NXMGXO8S9?50T>8I4R&'HZP1TE4Z%
M0 ![U'MZ2_J)(Y?[:?Y>JW<K0*HO;= GRR?\'5Q6P_D3TWV=5&AV'O:DW'6
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MP[@[!IM^;>W]F=S;HV7N;<O7&6P&S\CCNQ.DMB8S&S[?QO75%D),_CT-974
MDCE"I+!3>_=>ZL+^.F*KMV5.VOF?\8?@7OO>O8O5>ZES_6$W565[NW;M_$=L
M[=:JP4/9-3D]P_&9\9FZ%GR'\1_@U570T,*0M''_ )PP1^Z]U<EUK\I_YH.S
M\%\>=_;:VY\R.S?DKW#MC-+\S>M?E'LL]*?&OJK*8/;F;R.W:_HG<<W3>7VU
MLBMRFZ&IZ>6AH(LJE?#(% B.EE]U[K:;^.NYM[;QZ0ZJW1V31ICNP,_L#:F6
MWOC8Q&(<;NZMP]+/N''PF*&F22.CR4DD:L(H]:J&TC58>Z]T#?\ ,$[GWM\?
M?B)W%V[U[D,7A]U[-I=ES8_,YK%PYK%X:DS/8^SMN9S,U^-J98*:HI\3@,Q5
M5!\CHB>+66 4GW[KW5,V]_YJ6]]D[UWOC]G?S!OAIVAL+!=93]BTV[LOU)D-
M@9&NW29]]._5N!HJ/?F>H<S)04> Q CJ9W@FC3,"21IQ';W[KW5>OR4_G"=H
MXK?E?NS ]Y_&3N.JJ.B,7CMF[DVS4=M5?2NRM\S=I9"NR^V=]8#JG=5)DZW?
M>4V?341%;--2QXV.22&)*T\OL DT''K1( J>'00?\.^][;QPV-IHZGH2@JZ#
M/].Y3 [QV54?)_\ @LN\L/W1MG<.<W/D:[L'+_W(3JK%[+QE12Y?'UDBU,P$
MKQ3#2(C98/%.DK@=,S2B/P6#8+=!)\T/FQVC1_-+XG[YV3G_ (4[LQ$79&TQ
MN[N3JS$5+8KJ""D[+VE'5[ZGIJ7=>P):'(UN W/62UTZQU-3E5QT=*SHJ*P:
M>;Z=Z>?2V[MQ<6ZEOD>K"/DO\\]T[T^0>Z/[L_S2Y*O:&.V/MO"]6Q=#[FQ_
MQMZEWKN3<NU^Q*G<>?W9D<CMSOBI&=ZTW!@L5)"DE9C:/,I6K1R2P>F;W;IG
MHZ?P5[NR7?/6WP_W-O+^83U+N3Y+[,V;OC94&V]X[NV)+V[G]Q;LR"[1SV6W
M1M./:\>7J<IG*79<-;21QPF%4<&.66("5_=>Z-I!\L.R88-Q4N6[TR$VY=FK
MM63>&W]C=&[U[&J,33;YK]QQ[5K8)]J=3Y&'(05V*VY)4SF,L*53ZR05O[KW
M02?);Y:[@QG1';U-GN[TW [;&V/@MW==Y+IW?>WLK'BOD+D(NO\ $8?<=4_3
MS2;5J\G2Y:ID"RVFAB16:VH'W[KW2V^#6YNGOA+G)_B)CLKN7;_4T5=G<OUJ
MF5ZI[4P6&J^R]R[ES.YMV[1V+N+,;"Q:;RH?X+,M=###/5S0:64$A21[KW0[
M_P J[YM;D^;W6_=.Z]SXFH@K.L^[LWUS2[@H\)4XO:>=H%VYMO<L./VW6U-)
M0R9:JV949V;$Y4R1"6FR-+)$6< ,?=>ZM+/T-K$V^A_XGW[KW50?\TCY4?+_
M .,NWNO]R_%7IA.WI,E0]D-NS%K7Y7'S1Y/;^&QF0V=04%1B>L.T:JLK<W4?
M=TPHVI:%&=0?N5("O[KW1<^S?E/NO=_76-S&[OE!N#9'6R/3TG9.3VOL[<^R
M=^X#LC![9Q?:D_2&5VOD^I\-V'(N[-B&=XY\=3Q&MT+!YX/,CGW7NJX>N?E3
MM^MQ.V]S[L^07S!V]@TWMN[;>Y.O.U^WQ3;4_O/0YO 5FV=E9R@RF.P^4W7@
MJG#;KQU3@:;&D1U7W?V[O4SPLOOW7NCC4VT.ZO[M457UMV3_ #&VRN?S^Z_X
M[AME8'=-5N?#[*RF2GI<)3C+]B;>BVYB-E5=%3TM9MML;5G*TU'*SNT4@E1/
M=>Z#/^9[T3W'O#H3X.9+Y?=N[MZAI\5\M.M<1O+M7JW?V/V_W+T-L7,8'=.$
MW3O"+MK;NP<=329?);0H*89H1":D^[J&TK4A%U>Z]U/_ .$UW7D]'\3?D%@M
MF]][VDP^W_E7N2@I32UG7F\4EQM-L/8M-A,G+65^U,O]K79/'0*TJP2*KL@=
MT5BWOW7NMA3X]]+Y?I/#;_Q66WS7;\J-[]S]E]KKDLEBL3B:O&1=CYR3.'"3
MQ86DH<?6OCZJ5@9HXHU=C=55;*/=>Z,5[]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z!WY ?\ ,ENS_P#PR\S_ .X[>_=>Z5W8&S:;L#:69VE5Y/.8:GS5(:.7
M*;;R9P^=H%=E?[G%Y T]6E/5(R"Q>*1"+@J??NO=!+B.D!MW:&&VKD.PMY[I
MJ:"KB4[LW2NT,CN:OH%I!3-A*J:+:=%C(\=73@U$Y@I8IFG)8. =/M%<V]Q,
M^J(XITQ(VD_/I K\3*VFHZN.G[_[BIJJ61*F+++#U;-DL?.M#+CYIZ1ZCKB6
ME,TM-*Q5Y8I&@E9Y(C&SN63BVG3N>2JCCU30_P 6K/2_Z=Z#BZVP^2H=P=A;
MX[HK<IN>KW5!NGMA=FY3<F)EJZ6"FI\7BZO;>T]M4L.*Q<<)-*'BDGB,C#RE
M; &D!THI/IUI$-:E<=&&1T0K"/U <):QTW/KXL-/NQ-37I4!11Z=9_>NM]>]
M^Z]U[W[KW7O?NO=?_]/?X]^Z]T#GQ^_YDYL/_M53_P#NRKO?NO=#'[]U[HF?
M?<D8^4GP4B+H)9-\=\LD98"1TB^/N]!(ZI?44C,JAC] 6%_J/?NO=',]^Z]U
M[W[KW71^G^Q'^]CW[KW52.*IZ>/^;;FIXZ>!*B?J.CCJ*A(8DGGCI]NY8T\<
M\RJ)9DIS/)XPQ(36UK:C?W7NAS^8]#Y\_P!1UF7ZMJNU^OH(N],=V5MNEV!E
M.P:^MVSFNI,A2"BQ&)Q6.R93*9K(P144$<J1Q59E,9EC+7'NJ2 M&ZCB1T1W
MJKX[5:?R<NA\7N[XE;2[B^0'2WQ1ES74/2G:?7F%@W/M_M'#8/)5VQ]OT^.W
M#2O7;2S.%K/LDEABDCD6> (#Y-#I[IF+]$*#7A_E)Z!G^2Y_+DW;\/HOE!C^
MW=\Q=[8OY0[4ZK[$['H-X?'G.]70T.^:Z#>(W?L3-8;>>3W%C=YP4]+D_P!Q
MH%B@:7]4(U'W[I3K$G>.!Z*YN;^7/VS3_P QK9?<G2G7.VOC+TK\8?E=TCL'
MHOHK;OQSRF9Z_P!X]89X["W+V]\B\#V=LK<.(VGLI<U6TLE-)29"AK9$:@(<
M1RN&7W5'K04]>CF_S=_Y:^(^4N5ZFINENO\ 9?3.]>V]]U\/R.^5^TNCZ?LO
M>4?76S\/_??$=>;\VMMFKVYN_>&U.S=ZXJABKJJ'(1R)]HH=_P!T,-=-9IPS
MTH/AE\.WPW\GC9'3_P @?CWM3Y$;[ZKP7R W1UUT_P!H=88_;T4&\<?V1V7F
MNN\%M_:^\/O<ILJ+.U%/2-0K-42U4<%7&DE1)[WTHZU/^L?@=\X>F?F)T1N?
MHK8>[_EKV#N#<OQL[4^7M%D^H]]]+T/Q&[#@W%M7(8KIO?V1R^X:S;^\UIL%
M1)'/7+23T])3TRU<D( ;W[KW6Y5L+^8IO7:&X.L=@?+WJV@ZNWWV;O#*T,!Q
MM?7T-#BMIUDTE'@<C4[?RM)_&(:.BS?W..FK*J2"FKH,?/7TP8*(_?N&1QZ]
MT5;YD?$[:&,W9WGF=A?-/Y;;;WUNC-[H[-HNN=I8O9FZNG^L=R=H9^/';B09
M ]3[JW#M?%SYS)R5F3HHJXY%(7D:R*P?W[R(\CUHBN3DCHOF!_DC_P G7;^P
M=YYK 9+Y'8_;0V'B]P=KU>W8:23#X[;N-QB;[H8.QJG;O2N3HL&V/I*-<E-2
M5DJS4D(#R#Z IGL[.5X7DM(F>,DH2BDJ2*$J2*J2"02*$@D'HQAW7<+>*:WA
MOI5MY5I(H=@KBM0' 8!@.(# CJD>H^(G3T78/>'6M/O;8^7Z'V%\'-F_-7';
MCILKN^/ [EV=#MO!U%-ULM9%E96K:.MH]WQ8^@DJ$FQ]#- O@QX\I 2R[5M(
M"M^Z[;4'+ ^$F&8U9AVX9CDMQ)R37IU-WW+28H]PG6.@P)' H!0"@:E , >0
MP.KOM]_R3?Y2DVVMM;OS^X?DEBLE0;-8]2[C[!HI?L:,-!5;GP\>!?*=(156
M:H\?D\Q]_)3TC._@D)*Z"![K#:65L&%K9Q1*QJ=**M3ZF@%3\^JR7=]<+X5Q
M=22+Z,S,/V$T_P!GHT'Q%^(?2^[-W=)[\S?S?^2/96YNN-Z[4[73I+>V8ZXP
MNR<CVGAJ#+4.)J!'0=1=?9[=<F DJ*L11P2"801Z741@@FO19U;9V3OS 8WY
M#?&GKZO-6-P[JH^Z=QX.U)-5T4E!M/9E)29GSY%?\GIJV-=Q0F$/S/&)+<CW
M[KW5%7SF_GCY# _'KL/K_8?4WR ^)7R)[]Z[WAE?@IVSVC2]-U&PNRJ+!U.U
MHV[#ARU7V!E</LFAE&XZ:.EI<[ D\CUB$1LX=$]U[K4%[^SG:W>/465^3ORS
M^5_7&]>T)^R=@=90[%[$V=TYNKN^6DVUO'%8[;&6R. W-@MQUTW6.%RF?S3U
M>1HLK/BJG'PT\4E//&[A_=>Z/M\4_F/\K/Y?GRFZ"V4/F#UYOWX<;1R^V^RO
MD5@/C_-T>O2&4I=PX5/]+V(VSDL/C^L\1F][4'8\3T&,H*2%*W[:*%I9+ +-
M[KW6Y'\7OF_M;^9+A7QB_%3O39?QW[5ZZ'8G4O;/:\FQ<;M#O+9 K<319!L5
MB]H;TS>\-KY"EDR<)^WR$$$KQ:M6G]+>Z]T0;Y#]-]R_'3(9W*R_''KOMGJ3
M:&![M[:RO7FQ*;KS!5.-Z[VCN_'3[7W)!7[WWU@ZTMMOK<PC+Q1*]5)7J[4R
M%&"GW7NJ!_EM\YMR_-SLS9>;^//S SWQF_EY;DV3LC$9CHV7(;JR*[$S%1F!
MOW?FZ?DYA\/LO?\ M+&4N8HI&EI/XK75L"0BDE$#.)(Q[KW1%L17U63PW;,_
M57\PO;I[QVSVSC-Z;BCV_M9:#=7;7:^RNN^DMTX+L'XR5&R>EDW.]'C<K2[J
M\2)+B)_!0T3F AIW?W7NMD7^5A_-D[QINM]F_!C?TF\_Y@/SLR--V%OW'YZ#
ML7#[(BI.M/XGB:FDVOV5OOM'%;;S>([.VA@L^E2**IPPD:C:(^1G5_;-PK/!
M(JUU$=>ZM(^-G\OKXZ;]P6TODWUGNOY*=6;CWSB:S/FHHNRL#39^CR=8<WA,
M]+D*R@VU6TM5EX:O[E5G4FG=O&X0@E3>QU0(=>2?7/7NB3_.[^;EO?8'QI7K
MJAVGO+XD;Z^677^<P7P<^36].S-B[DVID*JGP&V*^DWMV"=N+5Y[KS,RKES3
M140Q];4-DW1%3ZE7Y2#(S8R?+'7NM2KNKLG>F$ZD[&[5^47S]WMV3V]N/<G4
MNUH^NMV;9DRW=&X<9LCL/9DNV-YU[]L]0T-?7=<[3J:[=%1'+%5PPR3&DI8X
M)Z<&25OKW1\_C-\M?DS\8/EAU?V*?YD*;U^%VP=Z0]@]O8N@3.[2Z2W]M#.1
MUD&\MJ0/C.H]J=?CM_\ O-%!2/0U'V1%5(B+/(/&5]U[K:!Z]SFPOYOD?4N[
M-_\ 0/<'7/0&X^K/].'QQ[,J^XMA-4]D4&2SV,I\E1;FZ^Q%#G<YM+,;>R-#
M0U4$=3+-$8Y+2%CI0>Z]U9S\>/BSA/C71MAME=@]N;AVT:!*&#:V_MYP;FP.
M.F%=69&JRN(I1B<>^,RF0JJQC/(C"*50H$26]^Z]U!^<7R%C^)_QB['^057!
M'68[K6;KZMSD4E!)DV;;6:[,V7M;=$M/00U%,]17P[?SE5)3+Y%45"H6NH(-
MD8*=1%1U5UUJ4]>D+\VNT-P]/]9X7<&RI^NL6F?W1#M+*1=@TFV(,/7T&5V[
MGLC'202;JS^U]LS5]6V%:*.FFJ M6L@0:KV]L+9K-<>--,5C'SZN]PT</A1Q
MZFZHU[3[GWQ\D-B=4_%[96T>O-O[XW_VKTQWIB:KKS;^Q-I]:;IVACLCN#"Y
MG8F\I]K9+=.*H^QTS&'CJWHYY)4IZ:.G,\H##2&/<389N8N6;SE[:+R1+^Z)
MTM&Y1@* 5U"A !K4@@]"CVZYEM^7?<3EN?>=O$EG]*SLKH'4T#DT5J@X&!3C
M\^D3_+KZBZOK,K_+AZ2W!T!O?!9#=G7GS+R79O;N%W7NK"=;=EY#$9O?FV\S
MUADI]M9Z@I\YG=O5E%2U3K+#%''3*OA!U2 '&RV$UEM>UK).S2P6ZP/W$U90
M*DU)J<'NJ2:]).9KFVW/?M\W*VC1;9[MM(   !R**  !3T Z'_,?R]E^0_=?
M86+W)V7V5L?H+_9L^]<))%MCMC(U.9K-W;7PN+S&WZ3/X_=N$R31[/QN+P-2
M(TILFMZF5:B1TEAB]F; -\6>B&II34:='MV]+'\&<7V#6=?;*7NW8VT,;\<=
MB;GS55V554F>H:2+%9?;,>X(L1FH<[MBFQF+GJ8GJJ7'5,4D<CR2"!B6/O?G
MTS;U)Z!/Y'=O=7?(&NW7M:LV%6=5=Q[8W7LS9<W8'5G:V*V?VQ_=?-Y#;V4W
M-M$[T384U%!#N&FIFH9:69,E3/#<!X6<$>Z<NETNH'"E>JUOC73_ #OZDHOG
M54[A[0^0DT77_0?7G8'57;W7M1U-B.M8DVS2=D02=5[BJMR=.3TV9S/7D\Q<
M1$4];4TLZ2223-+IC;EJ$8KQZ8C8Z@#TILN_S5[9[J_F$=-[[W]\K)>J-D=2
M+F-H=P;ESO1NRMB4F9V#N3-[BP/7^>WI)TVN%S=9MRMC1ZJ2:*CFKU68Q%H>
M7<M>[3KZ4]6][_\ DMBM];6V3C>RMY?$7<FSJO#;"@[$V;-N/>N_JG>^<[8P
M]#3=?0[$J\7L)9HJVNW!7(T4E%2U-4L8(+4X]?NS@!V 'GU[H5_Y<>,Q^UMN
M_)?;.+V/A>L]K[<^5.[\#M+9F#&?I<?AL-C^J>F8(Z9,9N3;VV<QCX[T_E05
M%*LC"4L>6N:]>ZLB1UE0.AU*U[&Q%[&W%P#]1[]U[HI/>7>VZ=B]O='=";$V
MK@\KO?Y!87N'(8/<6ZLQ7XW:NV3U+MS"9FNER]'AJ"KSF8?*-GZ=(HXI:8D1
MM>6.X8>Z]U31_,<^%.Y=E383YM=P_*ZBVGU[T(U)VGV/CL-T]4YGLWL3LFJR
MF-&?EZ]S>.WYAZK;-=D]LX7';<V_CZ=:EZ+%X^.*>:=/(S^Z]TS1_P O+H#Y
MB]4U&S.G-@T\=1L'L2BWMO"I^7N.EAWH-X[WZTSNW*O8>^^N=A[/PN(@;8FW
M\LF3Q#T]7X*3.2K7A9W+LWNO=+?=':75']T>J/@?A=V_);JOY ?'_"]L=)_&
MJ#9N]=V[1ZS[U[<^./4N*JL5UCG^Z<WA=LX+?VYMW8>JHZL896CET$N\T,H4
M>_=>Z'OX^]2?(?LGL7:%%W3'\V=N[:P54N2R65[$W/U9MG![@HMOXQ*W"MF:
MCK#<U=F*C*Y+<.BFJ,:]//2ST/D>2HUA1[]U[H"/^$VRU'^RS?*<2)2_:I\T
M.QQ12Q-_E$A_N?L,U)J:<1)%2,DSD1A"P:,AC9BP]^Z]UL7V'TMQ_3W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0.?(+_F2G:/_ (96:_\ <9O?NO=/
MG;&-SV8Z^W'C-LPU-1G:RA\6.@I-T5.RJF6H\L958MUT=#DZO!-Q?SQP2-QI
ML-5Q[I/<$A,=$1EZJ^1&1JJ6ERI['I<1_$S22Y/'?*<5&7IJ662:F&X!19/K
M!*6KJ\-!*L]*AD>3RJ-:L$4%!.7$ZC41VCSZOMO:IG?/<1G/35C^N/D[DMSY
M.FW-0=F4&TL5M/:&+I\KC/E:DZ[DRF$3+Q35<N/BV-2&EKJB.EHDR\WCIFR,
ML[3&R:H_:MJF#)\ATU=5GNEGCQ&M<# ST(/6W26_\[-F<;V?N+N';\VW<3#@
M]J[NP7>E56_WFH=PR4F3R=5C*7$XC#UNUZS;-7M^GI(DG68R1RS"0S([($JD
MGMU&G6E\]?\ /H7,5\:J_'Y7%9^F[Z[]JZRCJ<95/3YG?D&8Q-?3T=;15E=C
MLA228:G>6@SHQZQU,<;QJJR,(U4$CVM7X1THC^!?LZ-6@*JJGDJ M_ZV %_\
M+^]]7ZY>_=>Z][]U[KWOW7NO_]3?X]^Z]T#GQ^_YDYL/_M53_P#NRKO?NO=#
M'[]U[H@_R&VDM7\V/Y?6]3DZF)L)E/E#MI<0D49HZM=T]&U&0?(32E@ZU./.
MTE2,:2&6I?D6LWNO='X]^Z]U[W[KW6*9F2-F1=;"VE>;$W'UMS8>_=>ZJ!V]
MDZVJ_F[;HHJK!Y#&PT'46(DI<I438^2@S'WNV,R]1%CUIZR:N5\5)"$G:>&!
M&:1?$9%#,/=>ZL5[#[EZXZSSNV<!O?>&(V[FMY2YX[2P<JY"NS>Y8-N4M/D,
M]/B\+AZ/(9.N@P]/-Y*B3QB*$%26N1[]UX&AKU6/DNCLIO3;N[/E?M_^9EOS
M$?'?>L%3W'C-P/2Y*GV5M7KV(U55Y,3E,AOC%T]!@J"@U(TDE)&Y*HQ0NJ^_
M=,SQ"84U:>CI?%'-.VWJK Q_(&J[\Q=!MS9N4VG79CK[,;3SV.VM58UXJ+.9
M?<F7JILCOZ7=D]*]1][)IDYT^L78^ZM#'X4:QZJT\^B__*WY2Y;!S9?%_'CY
M"=44&]MG[SVQU+N38FZ,3#68?']I[^FH9\#M[>'8]70Y7;_7<D>(R:5;PS+/
M,[&.+1%<D^ZLPU"G0&]#_,;O7>V_:"A[?[(ZTZ:H*_,4+[8Z\QJX[M'<78%/
M0291-WX'#S8':&%W)C:RAI,')5R54=-64RT]5='"PKKU3JNCY]6D[6[KZDWU
MU&W=>V>PL)E>ITQNY<VW84E148_;])0;-R>:PNZ:_(UV:BHIJ.# 9' 5<52[
MI%IDII;\6][Z<Z)3\</F-\?]T]Y?(2EG[VHJNCWG'U)OCJ&I[$Q ZIQ>\^L<
M[MFLI\+-T]F-T+B8>WMETV=J)(8\K0K)*:RH-/(EDC9_=>ZL@K-J[;KDGRN4
MQ&,R$\D7GEJ<AC*.MJ8XHE$T<$4U1!+410T\H+JJ$6=BP]1O[]U[K5(^26$S
ME;WGDHJ&@Z@JL?O+YD_).DPF;[$Z:VQV9-A\]USO+<VZ\IC-U97(_(?K&KVS
ML3<%)EGIGI)Z"=,O-2P2(\::0?=>Z'+J7XU_);8_2V].I:;J3,=V[BW]TW_"
ML!OC;&[^N^L:+;^%W=U1D^OL-D*KJ*C^15(,Q18_#YVG:09G^*13R1ZHYE)0
M)[IIH@VHUX]$ZQ/PS^5.]>S^SGJOAQV=AL;VE_+Y@^$>/VSO+9'5.VMH8FMV
MCLO:FW*?L3&Y/(_(,4F6KH\QM-LU1X@0K(T8\JN&B+BK+JIU:)3&VK57'0^?
M)SOS?.V._?BI\3\KM7._&[Y0]L-M3;FU\CN/-0=F;-WG1C"C;&.QM9MW;7R8
MPM'UVFZZK;TL$=1AZK'5DTL9BD9E:S4\(4I7'3ZR%22!T[?PWM_J'LW^7KM/
MO[?>#R%9VA\Y]@XCJBA_@VY\9NO/UW5M;V#'OYZVIW3WYW+7UJXZE='\Q^V_
MR)HD)D:6T;O3?6P;V?UYMW-?(/XS;\K8JL[CV>G<FWL)-%5RQTE-C=X;%@?-
MQR4*G[>6>;^ 4X24!7C4,%/J]^Z]UJ7?//\ E9?+$_.+:&[>HOCSE=Z_'K:F
M6W7MSI:AK/D%N2?K;9NQJC:V$S])2YL;C3/R]638OMS T>1QRU$QII:NEI$I
MHU%-$R[ J0.JLP12QX#JI3J/^7'\LM\[IS^9^4?=.1^6. V:O6N4Q^X\SV!W
M=EL_U^V)W*.P\MMW*[:KUDPM7M.N_NY4AUK,A29O$U5/!5BA221*>1&;JD_@
MZ?/C7I2$A,'C>,>'"G1X_CW_ "__ )J=H=!8NHVML;8&^^OY.S=V]LY?XY5O
M<OR@J=W;TZ[SF,R4M-/5;F[%AH>DJ[%2[[KTS\. PV&;*+E((ZB"KE=V"K&%
M"1TF1@Z*Z_">KGOY"/P1^6/Q?HH=P_(_![AV1M'"_&?KGJGJOK[=O;NY=[YW
M$[F?>F[=X=K[M;KZK@I]N]8TFY8:O!8Z&@025,,6% 61HG+-KJW5X_R#^(GQ
MR^5=%B\7\A^IMJ=K8S!TF5H\/1[GAKV7&P9ZG2DSB4TN/R%!*JY.FBC5P2;>
M,$$'W[KW148_Y,/\KZ#;59L^G^%_3-)MO)4>/QV3Q=!B\UCHLI18N&."BI\I
M)C\Y2S9*.&"%(_\ *&E+QKH<L"??NO==M_)@_E;ZJ>2#X3])8ZII<Q%GZ>LP
MV%RN#K(LM#&($JDK<3F:.L ^W'A,?D\;0$QE2IM[]U[J?4?R=/Y9=5G*+=$_
MPWZ=.YJ!\E+3YZ+&9FGR;R9:"*FKC75D&<CJLGYJ>GC0?</*8T0!"H]^Z]T?
M'K[K/9?5.R=M=<=<X''[/V+LW#4NW]J[8PD'VV+P6'H;_:8^AC9Y)%I8-3#2
M6)8$ZBQY]^Z]UI-?-G^1_P!Z4_S#&>ZS^%'4G</2&X?EY/V7LR.@W]400-T]
MD^K<1CX.E-ST&0PE9)U#BL3V9C:S-MEA+)0S/5Q1)9H[CW7NBR]D?R7\_@,[
MB^K^V?C=L&ISJ=%[?@[0[_VEG>X^\LN>V\O*,G24>V=K[CR>,P.T<=AA-3"J
M?;ZST\TB.J+&3J]^Z]T8+-?R%>QLKL>??74WQP^.W9N&V_V_NBKGV10=J]\;
M!F[.ZMEV9N'%8^GRG2/8N%;JS:NZ=M;FR..R4@I*>JJ,ID*42PR%F(]^Z]U:
M%_PGL_E\]N?$VGW5V)W3\9,!T5E,_P!/;,V#LVMFSDTF_P"JBH]PY7-;TH]T
M;1:-6VXM;5PXTH\ZI+-]B&0%9#;W7NMGKW[KW1*OYB^SML[Z^#/RIV]N_#TN
M>P4O2^\<I-BZQ)&@?(;9H3NC!5G[4L,@FQ>=P]-51$-9985)! (+,TGA1-)2
MM/\ /UZI&5%6ZTXOYM_R?[=^6O0'R?Z3[WFWR.LMA?S3\=U1M+/9'KG8^)Z?
MH]A[ [+&S,/0[<W?@9(=V[LWW@<%N6>3/P95UBT"!X2JAS[*^;)KW;>7;S<[
M!2]PMN[*O"K!:J*YI4XK_(\.C_DZ*VO=ZMX=QC"Q%A6N?SI\NBO?RT^Q:/XM
M_)KXLS=J_*3JOH?X7X? ]AT5=UIN#=>ZJ,5V"S>T]NRYO-8':^RLE09W"=H;
M^[&IWJ8\L895.&)O421B6$A_D/F(W1M=VO9-&XQPRQZ<,H.N0*S%L$T(:FGS
MH:T'0L]QMDF@YBV*^V>S0006^A2,:PP-7I2E:DXR"1D]7Q_RP,FB=J_RXJ/:
MK=V;CZQWGMSYL=G[5WSG]WYS/]%3PYK</8*XO =?4.2AECH\[+@:^'(R>65)
MHZ6H( DUR^$7V]Q$TU]#'*9%>0R:BH6E<%12M1FOET [NPEVXR13L#+*_B'A
M45'PX\L_+H\/4/<.[*GYF;O^.E7TUN&IZTK_ )8_)S?N2[GR%#5'9=5EUV+6
M8W_1W0RFEJL979.:DR4DU4LLU-)%'$OCCGU.T:OI!U'^8>^MW=+;B[ Z3Z#Z
M Q]7C.RZ;J_-U6\%P]9A>J]D9W%3RYM:?=E7MS'UGV>9W+-3A8VEBB637J^Y
M\EHF<MT$T;2%Z?+HNN;EK!U2./6:^>.@.SOQ%^6M5FTSFW(:+#=.8F+(5E%6
M5>Z=UUNY<GL&'8VV\IC<M5;J_P!F6VM65=1NC.39 5KUV(I7Q,-) T$<\MP[
M",7+#T-.E2R/=JLLD>AJ4IQ^=>K#]JR?!'=NW,[UW0;BKM_4N-H*7979&$;*
M=S[HDEDAH!C*G$;\IZ$&D>IJDI&CT5,2^?2\@5V9F.V74K#UZ<5 I4CRZ!'O
M7+_"S=>*PVV=B9/;6Z$K.\NE:CN[;DF7[PJ:A]@9#?6/CR>3K:'!AY:O,5-=
M4T8A:O003(SDMK8$[B!B&.K]*[Y;=W]?YOJ6?9OQ5GZYW%\C,1DL#GNNMMUN
MR]R4,5&,?55F$.Y*O^&[9CK\;AL+53M"*U T5+5(%:[*0:^+KD8>=>MI1BPU
M4ITR?#3-[VH=N=H9;,]FS56\1\I=@X#?VTY,=AZC'9O*YGKWXY[&WUGRV?P4
M&_\ [>IS\]7XJDU$<;21+86-B^R:55O7I,DPDGD@\U%>KCXH_&I%RQ9BQ) !
M)//-N"?;?2CJLGY3Y?*X7^8-_+FJ\3M7,;LJ1M#YIA\9AJK"4E6D?^CSKAC,
M9<]E,1C](D54T^8.2_I#6M[]U[HJ'\\_N?=]'_+J[]VAE>LML[2PG8^QMP;5
MS63[@[2ZVVO6QXYZ Y)EZHPU%F=RU^]^T":5108^* .D^E@ZVN?=>ZJX_ER_
MS=NBOC%UIV/T_@.F^^MV;?V=W]U'T]@MX]CY+K_";LI-O;B&Q]J2YGM[(/GJ
M:MK=Q;3J=P5<M96P4E3/.DM#'4QP:S*/=>Z20W_OFN_GI[?W7U)L/(]N9>G[
M8^1&X*/KSL'LCK7&?'&@P6Z.FMET']]NF]VXS>^XL?-\NJ.JA>GR^&%"]9%@
M6<DJ2SP^Z]UM;[I[T[.VILV+-K\<-XY'.?Q'9^%_A(WKUA0T$F3W1N3!;;8'
M)G=]9-3T=//F3(LAIY'9$%T#$J/=>ZJ!_P"$W<<T?Q>^3_EB>+5\T>T" RFV
MI=J;!1U5OHWC9;&WY]^Z]UL2^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z!WY \]*]H#_LR\U_O-,WOW7NI_<^=J-L=9[NSM*LCU&)PU55PF'<.#VI/
M&P7Q&>#<FYC_ '>PL],DAD2>M(IU9 &//OW3<B:Q2M.B'[8R>Z&VYLZMPW:/
M=6[]OT.,HC1[YS'97QGW1'O;<%5_$JRIVQN=Z<TU!'FJ6%:=HWQ$A2IHY%=7
M1@P9'/'JE5]7 =:#F"V:U&:L3J\\^7\ND'E^V8 N#GI?D!OG%5V*RB9')U^3
M[A^,F-V_5[>KI%R]35S1U\^4QVX\=M_,4Z8=8EDH*XT=;*XD=2DGMP2:QX9X
M=)XCX:,C9J>/2FZCWSW'/VAN7L;9=3V-\AMH;BWR_7>X]IP?(CXW97IOIO%0
MU29*7?NV,;LS 4^YYL@,2(S48FMKILDL<[WB8LLK6$(7\76U9A\QU:E3-J@B
M8@K= ;-P0/P#_K#VZ!0 =*QP'6?WOK?7O?NO=>]^Z]U[W[KW7__5W^/?NO=
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MT))D<7LRBCS2PUM!%DIOMC6034<$Y$TD1ET3]"M\X_E+\D>F]G=R[>Q_S/\
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M=M-E_P#0[3; ;"1Y3JC.;FQ;[LW%F]F;6P5)@,#N#;M-M[(FHG^\DEK(323
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MV46NR*@*OVMJ8D56NHG&:'@0,GU*).6^3(-CCO(.9OJMR+$%%%* 5.JND<<
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MX'MJ.1)!VL*]7GU0-H9"3\LCJJ+YE=^?-/!;\ZQ[9V?M[8<&R>B,EO7K_O\
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MKZ??NO=7=J+*HYX '-K\?UM^??NO=<O?NO=>]^Z]U[W[KW0._(#_ )DMV?\
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M\W3B-JTN9K*;:F[*ZK@QU5G*NCIJEJ2EB+S$-IB!765+J&]U[I0_[.;\/O\
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M#/,:F9%EI6CB(C0*ONG^K#/?NO=>]^Z]U__3W^/?NO= Y\?O^9.;#_[54_\
M[LJ[W[KW0Q^_=>Z+[WEMC;N>K^FSGL'A\ZM-W9M:JHTS6*QV5CH:N+;^ZPM7
M0I7TTXI*O2=/E2TFG@$>_=>Z%3_1_L/_ )XG:/\ Z#>&_P#J+W[KW7O]'^P_
M^>)VC_Z#>&_^HO?NO=:CW\Q+#=>[?_X4Z?RSVW!]MLO8>)^#O=^[-W9/ A,!
M%C,-MS!_)_.Y;+U+XNE#M%0T.'+SE4=Y((]&D@6/NO=/&ZOGI\8/E#T'40?
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M7NV</L_M'^51M+ 02T>$VU\Q*7!8>"-GE:'&83XG]_X^A@DD%O0M)2(C$V!
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M,O7[HW#D<!M](\)A:"IDCJ9/M* PS222B;W7NG#X>X7M?<OR<_G)93%UG9.
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M7U=DNU-QUV*W;NC#Y!EA?%-H@FU.T4/J+5IO=C>3;79!E%_$65VKEC4FI4X
M (&!0_;TKEY)W80[INX8_N8) R+0475.D;9IJ.KN!!. <4-.AQP>W<SGOFWT
MYWYL7>7R<W%TO\B_D_TWVMUUV]\@.K9\ME=R[;;K[#8N7J^FK]\;&VU0;5Q/
MGI6^RSF&R5961XZCA6" JTQC [\E[M;^[EUSM<7:MM[;2]L% (JS2QR!CFF
MA44 QU(&X\^;9N'M/M_)%M;JEY!O$DS%104C\:*F:G&H<37USUM2](4T>^.\
M_DGW-48"JI4I]U8CX][0R5;)-(V6VGU!%45.YZW%4Y"T=/AY^T]V9:F)T&6:
M;&R,SLJQ!9$ZBOJOCN>>KVKF_CST=D*S$RR]2_S:.EZ_:M%BT-/-3=7=KXCL
M?LC9"U])+8F2AGSV2Q_G0+$YQ[)&OH('NO=%)^'G\P7X7_$C;_R9Z'[-J-PX
M3*=A?S".Z-N9BDP^?'9^"J,]W5#BJRCKMTYZ#^!T'4.'SU)0S^>AR,L=#MF4
MBEGKQ*ZW]U[H=NO=Y_#_ .4_<O1FP/CUU[W]MG)9S(;^[7W1O'>NW^\-@T.,
MZVV9CMR;"W92468S^3GH*#<N]\YN48F&&I:&OJ,%6UU90@JR5 ]U[JJ[^<QM
MF+ISYW=1;/V7U;NS#[6W5LSK#<FT\5L/%XW;G66:P^R=\=9;6R.,WUO"CCCR
M&$JJ'.P04]*M%50Y-ZR:G9V>"6_OW7NMK7XD%)>KYV>..$-F\6R0QI4P11*V
MP-AR1Q0PUDTU7'"OITI*[R6MK9FN3[KW15/GA4[5@^6/\KM-PIM5\I4_)+>\
M&SCN':5=N3*)GSUSD)9VV=E:3;V9@V7GOX&E29,A45&,BDH1/3"H9YE@E]U[
MHR_QLKL=V-/W9W)244_\*W]VQG=L8.IJ:>2D_C.S^I*.#K+'Y&D1C9Z&JS6&
MRTD$R$QU,#)*EP]S[KW5<.?EJL%OO^7YTGE<[49O-?'G^93O?K-ZC)P24^1?
M9TWQG^0F]NJY98U189%/7.YL=!%)'>,BG9"=:,/?NO=)/^1IV7UMUY\(^X=Q
MYK<&V<%ME_G1\A<'-E<?@J_;V(_O'+6[9@KXZJFGPN*FDR;Y:"=:ZN:%HJVL
M$DZ33I(LTGNO=*SN3"];?*#^9[\).T=A[QSQ/6/4/R-VO0]E]?=JXK;N5VSN
M;>.U))I]KKU?N3:.:BWPV2VS5-4RY6$A,!-2PQRI(U4JK[KW2?\ F[\<]I?(
M.L^.?3.X^P?F?WQMW87S ZUJ]_U^%SFP5P>.KZ?K_>#G%9W/4&S=FT4U9AJG
M"T]9714_F2B>OJ(IVBFF@A7W7NC6;XVK\0>O^_>U^P.TLGNOK+LSYK]-X;I_
M=>V]T9NA@P6YMI[4J<YB/O-LX##IF/X#N;'C?&K(5YE>GE%7"7$DNHCW7NAU
MZA^#'Q\ZEZ2Z>^/>SL;O9^M.B-N4.WNMJ3(=G;XFRF&HZ T;455_%\=GZ)I:
MV(T2,A0)%3LTBPK&DC*?=>ZJW[^^/7S=ZW^9OR;[,Z ^,T7>G7_=&_?@%VU@
M\YG>^<'M9J/*?$;)K7[FVE-3;GI\UG*>3=:96I^WG9_LJ9J- L8\WOW7NCU;
MF^?>[NK_ (,]W_*[O+HZOZO['Z$J<]AM]=$4VZ\?O.II=STNX<-@MI4-%O''
MT-!25>!WE%N7&5J9 4MH:.L9Q&QBL?=>Z-]\7^ZZ?Y(_';I+OZBQ3X.A[FZO
MV7V918:2K@R#8NEWC@Z/-4]"U=3I'#5&"*K U!1_B+^_=>Z(_P#SNI\+2_RL
MOF14[C;$I@8>O]N2Y=L]A:K<>$&/3LK9#57\5P-#B\W69B@,2GRTT5'5/,EU
M$3DZ3[KW4_XSTE#V;V%\:IGPE3)@?C#\*^J:^@R[M-'0P]E]];(V[0-0T5*@
MA5<I@>L-FDRF128X,]'I5&N??NO=%>_FJT,_7/4G\Q;$TF$CI-I?)3X/[A[$
MDST$W[E1VOTK)C]D[GI6HB6C.0R77.Y\%*)"%$G\+"VNK$^Z]UKH_&[I/JCM
M#X_]D=K;EP='-O,_/[9FSGR72'9V)SO7B81^U.B**:EVSE]U;#WANF7,^*I=
M<B6ROVU)F-2) T<(C/NO=./Q]^*>%I_DE_-E;=.SN_,)M=.^/C\O769DW)1X
M6#=&$;%T%/F:M=Q5/5<^+WM)3UKJIJ<;'2PP$A9$)*^_=>ZMR^"6R,+UG_.!
MJMJ[+@[UAVSDOB^<W5G<^:V-N?K1<K3UNXZ"#^+9C&[3VONE-\2T\I-#311I
MCQ0K5-,TDWA*^Z]T2O)?'[>L/S)^??RFV/E.N=KY')_-WJ;X];*J^I-V[Y[,
M[$RO9\]1NO/;ZQO9G6E54;@V]M_=NZ=E9G'XK[!:2>FQ=-4K71P17J)9/=>Z
MV#^J-M=T].=\]1;P[X;;&&V1N_K#-[,R,^ BVOE\;M?N?.S[(GQ6V\]N/#=:
M["FHJ'+Q8O+/%6LTM%59>KDB"TX> 2>Z]UI'_"KMW,]B]C;!^ D^P-J;\ZV[
M$[L[-[IW;A<-U)6[$WEN#*[0[,^5V(@Q69W=OC-8[9W<%-MS&SR9'^]5&RTF
M*$45'(#+CG)]U[K8O^:?Q]^*L?1?;,^R?B#L+XYXV#I_Y)&I[+Q><ZQRM!0[
MIW%UYD\1M?<^5Q6T][R;DQ&Z\?VK#M^ICSJP3U--7K'%.-4Y,?NO=#=_([V/
MM#J7I7X^=?=:YVCEW3G.D1W'\DL-M;)[YJ=@39GLG"[2J=E9:M'9&7S68R_;
M4N1I)7R5;CIFHDIIYED$4+X^%/=>ZV*86+QAKJ22UBOZ;7.FU^?TV^O/OW7N
MBB_('XI[*^0^^>F=_;ER&0I=S]%97*;AV!70T*5='C<_7Y3:687)U5$]714U
M;]I7;-I"M/4>:F<\M&;#W[KW2+^15%-U3\<>RL3/-)V+O;L[,U^ V>N2I8,*
MF8[:[.RE#AMATE8,)/0TVW,!B=V244L^0>HBCHX(V=G#?7W7NM.;;WQ(WM\C
MDGV1@,Y6Y3Y"]/\ PERFX]@TN=WGCZ./>^=V_P#/+N^D['R9P-;)CMN[FWD^
MT\169+'.&IIJ>LB1&J$B,BO[KW2L_FM]7[F[Q_ET=B]D]GY#<W7.Z>AMV;<S
M&&VSTKOO*Y7H3=N5W1O;IO:>Z<UN"EDEK,=75&3R^=K<G6XVAK*NCV_NMZV.
M.JJ;/(WNO=!9U-TKEN__ .5E\[>OMZ-\?.LJ#8&[X>Q\=E/@)%L'";@W#/U7
M\/L]O&EPW=46T<ON 5>"W!4Q0#(%ZF2>J>:MCA$9U%/=>Z SXF[3W#O'8_SB
MZ/S];\?J+;V[/C%T5L"KW[U3C<-MWY1STFX/G=MW;/\ >C>N4?(YW>LG9*C(
M/4U?\9:"6-(Z!YX"P#-[KW0I_!#K/*?''^:/T]\>\!+\==[;5V)O_P"6^RH^
MQN\<7MS'?*?,8';FP:7%_>'=66RV3WF^\J)HDFVP(*:AI)BU2U%J@<B/W7NB
M[[SZ#R/Q(^;(ZVZ[R'3G:<$'R[^,&X*#<GSII=M;SW_+7;PQD/8M?C*;<F\L
MI XV[+59R:GJ*J@H%4SP41JYTJD_=]U[KZ$WP<WIG>P_C!UAO?<VUZG8^>W3
M%N_,9;9]:DZ5&V\E4[^W6:S$-]W#3U3K22H0I=0Q6Q/OW7NM?/\ D37'\X'_
M (49:@1?Y6[+(N+7#;T[]*D?X,IN/ZCW[KW6V%[]U[KWOW7NO>_=>Z!WY ?\
MR6[/_P##+S/_ +CM[]U[H8O?NO=8WB1^64$W4_ZQ4^EA_M2WX/X]^Z]U\\WY
MG[@?N'Y0?)?LNNHJ6BPF]^TLW55."H<I/N!=IY79;8K;-'D_-74])$:N<;6^
MYGIEI@$>?2OD,1O[KW1<*)8Z UL=5M^@K*AZ&854$6/A2AW?20#73U>+3Q&!
MLC#J#+3(P(<EU/I(]^Z]TFO[S4VZLI50T.S=S82CPM+39+;V],\,32M'6M+4
MRMB,I05$TE4S?MK&H+E@AL5M=_?NO=*M(?LZF2LJ]K4->I$4>Z]MK@S4?Y2M
M8\E+N;%JD*K,M50,KR1LPTZ=2@ %5]U[I6Y:EH*]H<GAMTY?;$-5%#28O=6V
M=T5VWI\$TQ:C1:V/'9"@2E@@2H#)/+Y(&*^)]0#:?=>ZVXNH_CAN+Y7_ !7^
M//8&1W=C\7NC.]<Q;<WS6;CI]Q]M8E\90Y/^%5>5Z\@S^]S!M3=$XP_HJ8I:
MB@E9R98'5(T7W7NKC-IXB+;^ QF"IYZJJIL/1TF+IJFM+/63T]!24]-'-53,
MJ?<5,@CO(X507)%N/?NO=?_7W^/?NO= Y\?O^9.;#_[54_\ [LJ[W[KW0Q^_
M=>Z*9\I\!VMG*?IZ#JCL+:W7F97O#:<T^1W5UY+V-05-&N W6*JF7%P[MV=+
M3S/=621:FX*$<:KCW7NHZ=:?-%0 ?E;T\UAS_P XF9)0?]8#Y(<>_=>ZY_Z-
MOF?_ -Y5=._^DFY3_P"Z1]^Z]UK,?S1OY8_S0^2'\R;I;Y Y3M'<^1P?4_Q/
MR.T,)V?T_P#%;L>MPN4W-NC=/:>-R/7&6V]U[W7+N2C%/A-RK65U7-DX8:FC
MK!3"%B&!]U[H+]A? GY\]9;ZZY[+VCNO!4F\.LH<2^WY\Q_+0^4N]*.MS.V=
MK8G:.Q]R;FI-U_(++4V?W#USCJ"J? 54J^3&/EJP0:(S"D/NO=6,=<_+O^:/
MN+Y&8+XFYOM+X^3]N9+I_*]S+MW-? 7NCJK/U&P\/GO[K2;O%5V/\H<3MBKH
MJG<P-(\5.\<T<C I&1]/=>Z&/9?\M_YV=F+VIG^_?Y@/9NTLKOKMC.;VQNS>
MOHNQ,%M?;^ JL=AJ;#XG;^.VK\E=&VL5BZBFJ(HZ**LG5]/ED<M(P'NO=:Q_
M\QCK;YW=(_S;\%TUTMO;;?S#STG7W7N:JMO=\UN1K,9GZN+X^]ZTGFSFPMQ=
M@YW^)OL_K>ES$V*R%3625%1EF@I$29IA#)[KW5.T_8ORGV3UGM6BV:=@878>
M4[VK=T46+_OYN/X];KK]U;=K<)78[);CZBQ.\NN\7C(6=*:KH*N/#T\\U3KD
M,@<+;W5)%+"@Z%CNO)?-Q-Z;TW3!M3:^*SN,J>J^QNV\WUK02U.QLUL5*+H^
MJIJZ'Y79"AWCD<MGJC=&;P4CR?QVMK*.KGDGC0V8-[IZ%A$,YQTT[#[/[5S6
MV>G*[M+J7(]N;!PWS)[EJ,#08'MFL[=W369/*[!W-FI-O4^U\AL[LNB3;29V
MI?+5.XZ7;]-_$70SD02/]VGNJ=6L=<9;=_8'S-^3LWS)V#L7XV9["]F?%3!3
M]9[-[:GW_A]D8_.?S'\=DMP8#:DV!BI\-LF*AR#20Z)H7BJ:9/NT5==O?NO=
M?1#DDM3M!K;S>(JI2R,S@6LBLI*M;G]/ Y]U<$J0./6U(!!/#K2/_F)_,_X_
M[4[0ZHZEP7R#7KGL/J;^8/\ .G,]CX7;'56U>PZC9^,W[G,IBMN4N\L-OVFH
M\5@*/=$F5U))$KNT$IG<"/\ =&I5+P-&OQ$?EUN)A',DK?"#^?6K<F_>M-Y]
MAY#9[[IJ:>"M^/1VH-XXG.5^T<;AMS4L7:>'R;UF=DIJ:FR\T%)NY+8\/]KE
M(ZAD,F@EEBV]M]QV*ZW#=5M7F'U#Z1&*M1UCH=."0-+5(!IPSUD)RQO>Q;EL
M%QRY>W2QSOMZRJ7H% @N3(P)R0Q56TC@216G5^GQQ_F1[TR'07Q@Z;W%D^G'
MV#\1=_\ 1N\.H]J=%;GRO4^]6PNW*;L_8\F#W/@\[V5O4=_Y3,9C^&U VI0+
M3R9"?)1R%'6,$"#D[?K[=X+A+VWDB96P)/B(' @%5-*'S%>H<WO9K3;;>UO;
M9]:WDUQ*C+E1&TI*@G^+.0*C''K>K^-_7<?4W2'7.P?+5U>1PFWX)MR5U=5_
MQ"NR&\,W)-G]Y5];6FS5%56;IRE7(S-R=7]+>QKT'.JN/YCVVMP[8^77\M+L
M#;^VHZ[;?9/S!ZEZP[2S<"!:O$Y#9='O[>W5N1J5#)][13_Q#.4/E8,U*TB(
MI/D-O=>ZU+?Y@U$B=1_-67 ;^;*==]I]X_(''?(G^[O6&:ZEVUL3=G5.^]O8
MWX_]<[@K(FQN$?,=N9/-9O&9/=^1@JHL[5X:&O+E_$P]U[K:7VUW;V]MG!;
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MC43[![7[URE#N()2N7QF_P#JKH7OF/;66K*\MI5-Q[8WS/1I$P:1Y<=JN%0
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M7)C96L1[KW52?77RPR74O1>Q]L47QY_FKY')]<]'='X\[2V#W+MVDHZS=$N
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M_P!78I\M7OE,NU'UYM2B.3RM1%#%-75OBP\?W5=-'$JEVN[!;?CW[KW0@87
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M<I-G8?;F3W?N/*59%5LG:N&R.Z*VMD29:QLQ@8MI1U\PIHIU7S:=/VNJZL
M??NO=;>72/RDD^)WQ+Z'V1N[J;LRFS&W.M\ME<IA]R8/+;5SS4F,W174D-+A
MZ:IQ-=59[+2P5L,I9_MX$EFB$]0KU"L/=>ZN;V_4&LQ%%7:)$6N@AK8XY5:.
M:..IACEC6:%V8TLVEKO%<^-B5N;7/NO=?__2W^/?NO= Y\?O^9.;#_[54_\
M[LJ[W[KW0Q^_=>Z!3M^%7R/3\C$W7N;;)6Q*VT[?W4;$J1J4M8D'CCW[KW0U
M^_=>Z][]U[K@XU*1_4@<BX^H_!X/OW7NJD<9!I_FP9>))90LG5,;O?0R._\
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MXOCIF?CA/\H.T.S,=\*M]==]<2;.Q6XL4<-UW\<NY*7>N8K<Q5[RV+D]N5.
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MN#"5E1!N/M'*T&T-T;GIL9L"HSLFU:6AVY+MB"H1]W)D:G^(RQ-&X3'8R97
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MO?NO='F]^Z]U[W[KW7"1@BEB";6X N3S]/?NO=4J[WQN]=S?S/\ .X3K/?\
MC>N]VGK#$UJ;GK]H4._Z>DH8\#FUJ:*?;%9F,%'*,BL#(LWW*Z+$K<@V]U[H
M[-1U1\RJ>FDJG^9>S$IZ:!YY%3XHX)G\4*&1E4?Z63=@BFP ]^Z]T6JCW;W'
MN'I/'?,!/YB^U\%\>J3KK,=F5FX<K\3-J8K;3;,HZ.MJZK<F?@R>_P!MRTCT
M%/2R:%BE@9S& $8D7]U[I>];YWY$=LS21[,^9V)JJ9MK[9WI1UN:^%=1MN@R
MNV=X1U<N#R.(J<_V1BADZ>HCHI2?$K%56YN""?=>Z*+V/W)VWLG<O?61V?\
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MZK^VS6X]O;+W14]TX+L##[D>KPM;LR@IDRV0Q>.>LG@@N(B8RS>Z]U6+W?\
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M<6NXW/M+S'<V2P[G?7=[(X50*'P5 \O0#_#Y];9'\G5=/1?>@/U'RP[.!_\
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M4G;E+MS&[EW!_>2IPV&Q5:U2L5<@IZMJ>2H\2'5[]U[H#-]?SN_YE_3TN_\
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M\[D]HID>Z<=@L=B=KY? T_>/6]3C-F4>^O!492IW-M?)4$F0_A<7VL42U:U
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MN-CEF\3P7TE!2E *K73CYGC0CH;7^[<K06NG;MFMHMTIW3*9-;M_$1K*UQY
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M( )X'OG=>_<4]P]P5DD]R)@K"AK)-4CT-.(^7#K->W^^'R;&5=N00K#T6/\
M;Q/3[C_CO\Z<7-]_VI\5:+I_96*I*ROS?8F?^0W3^Y<-@::-)JB:IR>-VKD<
MKGZR'QTJJB45)/4F60 )SY C;[@ON1;0;/$/<&PNK*WGF(B*OXJJT:BK,8NX
MEA3XO+RX=&EO]\?D6>;<3=\LW<*R6\2C2J4)5W+*.\4H"#PR3Z#JW/\ E<=;
M]E]7=/=J47:FWL=M;*[Q^1/9N]MNT.,W-@-W4F0VA5TVU]MX+.T^9VW45% :
M?.?W7EJ8(6T5$5+)%YE60D#H?[*<C7GM[[8<K<L;E*3N%LD@=:FBZII'&#BM
M&&1Y=84>\'-VQ<[>Y',6_P#+^VS1;?-X)61PH#TAC5J48FNI2"" ,8ZLX1UD
M4.C!E-[,/H;&QM_A<>Y3ZC;HF'\QD--\ OFHD2M(Y^+O>8"HK,21UQN*X%@;
MGCD#D>_=>ZIO^1OQ[P'?_P PNG*/=^5VC@MO;)_ED=4YZ?)[UW?3;+QD!J^T
M<E2RRQ9&NQV0II?$L'[NH1B-2+DDA??NO=4]_*3 _%+JCJ/9?<)[ZZ6K<K3?
M++H'>6!V+MKLS$[KWMLOJ?:/;VW*C+;EW3M;;&W6S&&Q*;9Q-1GI\AEVIH(X
M)!XU4 !O=>Z'>E^1_P#+0^9G\W[MC?Z[VWWO_.]^[W^)'Q^^..\^HNQ.T>E]
MTXJN;K?=&U>R\M!58G%8F@W9L?(PUJ?Y7'6Z9HZ258>&5G]U[K;DZZZ.Z[^-
MOQEQW1/4V-K\3UQUGUIF=K[0QN5S.1W%D*7$4^.R<\:5V<R]569/*5#S5+L\
MT\KR,6Y/OW7NJ@O^$T-;!7_RTJ::G^XT1_(#N&B9JFFEI9'EQLNWL?,0DRJ[
MQI)3%%?D,%X)%O?NO=;!'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@
M=^0'_,ENS_\ PR\S_P"X[>_=>Z5/86,K,QM'*8VAQ<.:J:M(H4Q,^X<EM2+(
M:IT!IGW!B(:C(XP.#_G(D)_'T/MM0?# \Z=>ZJA^-&TY*+Y,_,!%SV]ZY\2U
M-#7[/S&^M\Y;:'3ZU&!RT'VO729?"TM)NX;FD%ZJJ+&>GDB4PJ2I!1S6MP>7
M6C\'N^J8TQ6E%^?#I!;LL6_M-(U(S HK\]1Q]O54&_ZK;/7FU*2.H^2_S"Q>
M5Q&Z]N;KR>\,;O/N'>FXLCC</DZ"DEVED-O8?:T>)3:.2ES,2U-.M,)8*1W4
M"U+Y8O12)<2;;! =4JJ:@>5%/2R.WF0;E,8R(F8$'UST-G3W?/4W3N?W9N[?
MN]ODQWCF=P4510S;9W+V'W\NS,3%A:G%5$V3Z^V3M?953AHHS'GZ""HEIZB=
MO*\I+ W3V:"-F.@+W=)NY6]:]64=']H[#[_S^Z]M]?\ 3=;+FME5#4>>@W%W
M7W=ML(8(\<\LU#6Y':8Q^5HF;-1H):>:8&59T-GA90VP*LR'!'2A'4JHU9IT
M9G_1%F]6K_0=@=7'/^S/]IWX! Y_NG?@$C_6]^Z<ZDXKJS.8_.X:N'3.#Q*T
MF1I)Y,ROR'[%W ^,C@DUM618+([?HZ',F%3<4TTL:2D6;@#W[KW16/E[UOF*
M;'X?=L^'K]B8K']D19'(;DVSVWOC(_WFAK(<FL.+W%@3M\T>"VYD8SYZXT]0
M!1DE8W)5""N[5GN%D1:H*9Z9G1G32JU/1<_@7NC;^5[IZ8F3MKMK-5^=H>\,
M=@\-74&]L=MO<D&R*7!XO+T&],/N3:JT]'+MF0?=87)?>TK9*&HUK]RK!RH=
M"]S%(BU0**GJEHC)&RO4-4]?_]/?X]^Z]T#GQ^_YDYL/_M53_P#NRKO?NO=#
M'[]U[HF_?7_94'P6_P##Z[W_ /@?-[^_=>Z.1[]U[KWOW7NN+"XL#8_4'_$?
MU ()'OW7NBR]G?"_XE=U[JEWSW#\:^CNT-YST5%C)=T[]ZQVENG//C<?')%1
M4+Y3,8RLK'IZ.*9UB4O9 QM[]U[JJ_XU=8="_'[^=U\I^MNF^H]A=5PY'^73
MT+O"#$]=;,P.S\(]-2=T[YP^6>:GPE'0T[UM;65%"78B\BP@M<J#[]U[H,_Y
MIG\PKLSX9]M=I8K<6^=_[0V1O_XK5,_Q7K^I=I;6R>.Q/R>QK[I7)P=V[LWF
MR[:PZ9%#AVQ-%(XDK:-)S%&7C8'W7NCO?,'O'N39WPMVCVWU/O*@@WIM3(_&
MS<_=M/B<33;Q[$J>K\UD=G9#MW%;$VCC)5IW[&R^WLJ\E!$R:)(&E,>EO$Z^
MZ]TF_P"4]\SI_FOU/\A^YZ'=F^-T=7X[Y1[]VWTWN/LW&[8Q.<HNM,9M#9.0
MH\1E:':[4T,+;?SU?6I,*AC5EUTLY6VGW7NB2?!7^8]V+VM\O<+\/^U>R][[
MK^0G7'?OR]V[\A\+2X;8>$Z4FZ^VXG8>:Z<JNNZAJI-X9["8'!4V'5JVG22'
MSZHIYI).7]U[I*_SFOD?MSJ'Y7]0[>[H[)[\VGUI%\<NTM^?&RD^.&YIMA97
M;WS!Q(SVW9<[W-V#'N7:V-P.QJOKC<45)B:;)5<5)4RO5!%<NP;W7NB39#^8
MU\P?Y3GPXZD[AJ-C[@^9F9^0M+\;,U4GL?Y#]H]S5%;G>U.LZG=F1S6-S4VQ
MXY=C;NWUF)/M$P=*CXI:U=5.]7*&3W[KW6X[LK<=?O/K'9^[\KMW);2RFZMD
M;<W)DMJ9;U9?;%?G,)192KP&1U1(/XEA*BI:GE+(H$L1+ "X]^Z]UJ![G^,?
M:66_FF[C[.[.Z+J]Y?''$_++M#<O\;RD?4>1K*7"5^[VW)N#-TF'W?@_])E+
MA]PU&TMNC"2X/+TU#S7L*=(ZRJFG]U[HIOR1ZP_F(=P?./MGOBK^,NR>Q:#"
M;J&+Z1[.[4INJ<[GJCK3:_8^_LUUS35>#HV$E%683:^Z88XFKQ41VIXQ,)'
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M<KGVMNFGW'!M:7L:6:+:HS%+F$G>H@IIFDGI8V(:S#W[KW7OY=/\ASX]]/\
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M0>$VAV759C>6;VELW'4E'CZV?*YND>7("D<U'B63]P@JPTO]TM89(F9U:7#
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MZ00IY/'OW7NNPZD BY!Y!"L0?]X]^Z]UWJ']&_Y(?_HWW[KW7M0_HW_)#_\
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M& )2U2@2R31F/39E]^Z9=S'-&Y-4 R.A)Z3^0FX>KJ?=^[QVE+N[ [K7(4N
MA[2WMWQV5F*',[=QK5L$<&U\KLS#U.U</7G*TY>6GC9JI6?QAR@M[K=S<K*T
M9AC*J#GY_LZ';#?/?-UM!E9\N.MJ?*8G%Y"=*2EVWW:9ZBMIBA6GK:*LV5%5
M8NFQJ:6K0OWD\0D%U0#4?4ZKXX_AZ=JOYN;SQ^U),M44W7TE?45M!2XW[/!=
MRU&,CD2*JJ]QQ2T=-M+(9FN5:$1R8ZHA7[>8:F)464>Z=5@RZNGR.'Y)]B_(
M[9'>O66X\C!T1@\/C]HY;K/-0Y#9]'NRBRGCJ=X;GRV!W/C:3/Q9_$U=0O\
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M8%Z,32XZ2N61#+9HM1N=CI-/Q7H-I?D^(,;M7![C^"W74&R\WE,ADQ25N_\
M"5^/H:O%+6I@,WB:7)81*++BIJX\HRS1M ((3KC:0R7/O+JJ_P!H/MZ351\D
M-N[Q2OEE^#'3=5D,5M6KDPXD[+H9H3A)<UD:/,4-774NW*:/"8YQ1K)XDU5$
MC,;Q!;O[UTKZ.WTK\Y<'+CIJ3N[9^'Z#HZ+ X7);+I<;F<UV+2[@P$\]1B8Z
MB*?;>W)?X3##4XM8XHYU:6H5AXR5&H^Z]T:%_E5TA_!<+N2/L"-L#N%:B3%9
M.GVMNZ>EE%(46H@G:';DSXVIC>5%*58B9F(4"Y]^Z]TV'YC?'VGHS7U?851%
M"DL@JX3L3L)ZS')$SHQRE)#M)JW$Q,5NLE5%"&'(M]![KW6:+Y@_'B;*08Z#
MLR"6HEDQ414;9WD:&-]P(9,**O*-MQ,=CEKT6Z-/,B@#U$$CW[KW0B[/[LZX
M["P>XMQ[-W;19+![5K<A0;AR]1093$T>&GQ$+U62-1_'*3%O+3P4D;2?<('I
M] U!R+7]U[H!MO?,#9V9R-'7;@Q61V/L#=)K/]%?9>=:%,#V M%@Y<W6FNIA
M3-D-DUE=CJ.HK<-2Y%8ILSC8C40#4RP^_=>Z(;\A.SO@-NONF?<N[<!W[O'=
M.Y=I;'KFW7UQUAV7O#9S8#(8RES&U,JC8_9>;QU'6QP!(V:().DC2PRJ)5D5
M?=>Z!%^X_P"7K+AI-M4_4_S!DH,8N3AI(L=\>.U)8YXYZZMW?6QX2G7KZ2C=
MLCD?+(D*10NS+(9+J"??NDT@[FX]#7U1\J_B1MS?VR\?L:#YZ.T%7@<'B=OY
M;J?O1>N8**LIX,+29+<V-K]GT6&HL+%%4&2JJZIXX(RGEU7M[]UN(9U=7/1;
MGVDC4\#[HV\LV2.J@B_CN-\M? T6N,TBFH62I5H6U#Q@\<_X^_=*.GBDKL+7
MFLH<?7T%:](_V]?3T==%434DKQZA#5+!*\M-*T?(#:6MR/?NO=3H:>&!-$*Z
M5]-R&8L=( 74Q)9K 6Y/T]^Z]UZIN*:;1&TK+$Q6*/3KD*K<1IK95U,187(]
M^Z]U67L;Y1]IYWMC:LN2PE&=D=A[HEZ]Q?3]%@A3]D]95N*J\S!D=S9[)K7S
MOE<YC8*-:S=&*GI::AP>-JZ*2FJZJ1W\WNO= C\W=V]<XSNJ@VMV!U!5=AQU
MFQ,;DZ3/P=P[ V;]K+1U]17(<;M?=5,V6IJB" 2-)5T\C12A532"@;W[JLS&
MWB65>)_U>701;H[=ZC@VZN0VC\9,UOC;F>S$^YY::L[IZBV[MZ+*9';N.HZ^
MGHJOQY2BG@HYI)E80QJL+I]S3R6D(5/<_"M.%>E5J-<?C\"<?/UZ"_#YKIS3
M1H/BIN_#1X2F+G,Q?)7J.JK\=5TM4M4!D<LF*7+Z/O:I*":L:03K2.D:HZ6]
MK[3]F.D%SD#[>C2=+X/X<[PP\^XNT9Z;I?-XG)X>:AQ._NX=@9N#<6"DQ]#4
M[>KA7BF@Q><P$,-;+0TU/+$5A@F9;:)U 8Z?Z.)TOF?AMT3C]TU'7G=W79Q^
M:R$-?F9\CV-L^KIL<WVE/%34E**::A@Q6-9-,B0HJH7>_P"0/?NO=&"/R&Z,
MCRLV$D[@ZVAS<,5+//C)]Y[<2O@IZL*:*:>$5]XX:R-P\+M97'(N/?NO=+K9
M6_\ 9?8..J<ILG=FW]W8^CJY*&JR&WLOCLQ1T]9$2)*26IQL\].L\=N5U7]^
MZ]T6_P"3O8V\=H2X#:VS)Z[:.0W>,C4+V.V#Q>X*6CJ-OP15M/LS;6(SF4Q6
M!R6^]T-+JIHJZ>"$T5+6,C/,L:>_=>Z+OA/FWU]V;UWVKLG<> CWAV'L'9L^
M1W;L##9 8O;O9>"AJXJ&7<6Q=T96IH9Q@LO1UE-D9(:CPU%'15<;.TL16:3W
M7NBA0?)/HBDP[X2J^"VQ\=CLY456=KL?C>\.KI((*G$T2T,$M1JR&.J&:;[N
M>*HGI@8/!=W\Q/C'NO=+'!]G_&7<6]]@X'+?$'9FW\9N3?4M/7;\S_<.PDQ^
MU&H#2U.(W/04<&;GR62:LQTT-1%CZ01>'BX#"_OW7NCE+UU_+RH<Q]RD?04.
M>:+'99PV[\3)/#%5Y,)B\A14\^;G2D,N5ITCBDC0.9$" WX]^Z]U/K-I_P O
M/&[IGW'65/1^,WFF4%?5Y*3>5'0YI\O%"U(9*O5FXYIYQ!="DH<, -0.D6]U
M5OA/2[ZRZE^&V\\I2;CZPP/6F[LIUKD:&"AR.W\V^XY-GY"FB9,9"@&4K8L9
M44\%,5@6P"HEDX'OW3%%/X>C.;DW!MS9>W<GN+<F5H,#@<%0561R&2R,RP4-
M'31([RS3'EGU'@(H9Y'8*H9V /NGU^$=([8NZ^N.W]DQ;AVME\;NW9NZ\;50
MM5TWWD%/71UHJL;EJ"OHJV.EKZ+)0M'+2U=-.D=33RQO#,B21E1[JW09X[X8
M_%7"O(V-Z3V;2:Z'^%2I'25S0OC3425:XYXGJWA-$L\[,L5M U?2WO1(''KW
M67-?#GXO;BD\N:Z9V?D)EAHJ9)JB@JO)'38^E6AQ]+'(D\;"GHJ%%ABCN42)
M0H%O>^O=2Z;XD_&ZD$2P]3[;22"@R&+IY0N6>HI<5F(YHLIC*2>6ODJ*/'Y!
M)W$L,3)&^HW7W[KW6&K^(?QGR-8E;/U+M4U4:4T4AB&3HS5+2),M.<BE-D*<
M9-U%0YU5(F9F-R21?W[KW1B*'%T6-HJ7'4,$5)CZ"GAI*2BI@(J6GIJ=/'%
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MIC1]?Y2D[&W+MFLAP>]A-*:Z2GBJ)EA@14$;,6]^Z]U8?C9JW.;3QE1G<1_
M:_,8"@FS6!;(09#^#UF0H(7R6&;)T16GKA033/ 9X2$ETZDX(]^Z]U5YL3KO
MJ]?D)1]&#L[$U>T.JZW$[SZ^ZVH<1G*'(56Y]KUV4S])L_+]AOIVON%.L'S:
M5AQN-T9^>"KA&9:6. "3W7ND)\T=FU^X^Z\=4#;F]LA34.R,!4RY+:FV,_E%
MJG_BM=4&E-30]*;ZI:NKC;5X4?+*\+2,5A2Y<^Z]T6W<VP=U[8P?V#=>U63J
M9EIZZ@GH^KMV[BSN1K-PG&28ZFW-GL1\>99*'"45#)4Q55H/O::K<KJ9)"5]
MU[K-N#KS>5/1[>Q^-ZUDIJK>=%.]5#7[)WLN#Q.6GRU=54LVW<CCOCQDJZGD
MH,)!X)7R:+XY9S!H*>&0>Z]TO<+U]UMF,54X?LC9_?VSYZBB@FQIZLZ7SF?I
MR,&IQF0K\M-O'I=!#FJPXT%V:-_,K^1%0NI/NO=+JKZL^,U%CWIYZ#Y>-]]0
MXFJQV2A^.-/5U](GW,I5:*7_ $/U#0R%/V:FF= L:H"$4G4?=>Z'+IWIWJ3=
MNZ=P;GZNR?R&ZFW#A<5CZ%<AE^K=N]94T-*QJ*6LKL1_&^LZ*.O7->(&N5FD
M 6&-U"$"_NO=&J^+>ZMH;PV5G\OLGMK>W<&'AWON+#3Y[?=915N2Q^4PT\=+
M5XS'2T.*Q$3X)HS'44DGB(F@G616*M[]U[I4=U=*;;[=Q%*,CN#<NQ=QX*K^
M^VMV-LJMQN+WAM"H=#!7G%Y#+4&3Q;T64I':*:FK*:II78K(8_+'&Z>Z]T'W
M<6QMH=7?&+?FWMJ;;PD&#P.R\H]+CLS5Q4]#7U.D2U==N#,5V9PYGKLI4GRU
M5?4Y".>21C(9=7MB>1XU4IQKU[JL?-5%)OG:TF<K=F]#XZDDCP&9QK_QK:3'
M)[BVM)CL/78>AK]N]SXV+/-,E8CQU3U1^U($<\4\DT=TOU-Q_"O^K\^O8ZA;
M#V7VIF\[N&?ICK_H_<RX/)X;8^>W!MW(S[C;;<AR>%WW4RUM-0=SY)L?2RZE
M2""\%4)8B75:9B/9CU[H2=H_'KMC;NY<'79_X\;5JMGY3+[QPFZ8=K9'+8;<
MU)BLG!-2MD8,QN#LW*3G;N>HZHF!)*:2JB2)HY(8-4;CW7NCD; W#NO96,I=
MO[9^'F\\#2[>Q3S87[K>/5U3&*M\E%#-BJ',29ZHJWT4L\DZS"R:%* AG ]^
MZ]T%':^(^<':O;O4_8O5./VSUCL7K#+Y Y?K;LS>N2Q^3[%&0D:ASL^<IMG8
MG-8N/'MA1'_#//458B)DF$*5'A=?=>ZL)W+O#;^P]H9#<^Z\K28/!X3&M/79
M2NF44\:Q*D$,:$L7JJNMG*QT\,8>6>1E1 S,+^Z]TE=K[RV5WGUY-F]I9N2O
MVKN?#9?&C(T])48S(XQZJGJ,=D:&OQ^5I5J<+N##S%UJ*.LA2HHYUTSQ@BQ;
M>,2!:DBGIU[HH4/PFZ<P,9J*?M;>\.)JDA2BH:^NZKKL?!'C14SAJ:7([$EF
MJWH*)92LS3/)%!$0I 'M^)S$-(4'[>O=.&=^*?3V7S%'G6[CW-AJBF-!-B)L
M3F>J:>NII,=1)31UE#E)-G/D@TE>Z53E)F66=S8!796IU[J+_LJ'2(J)JK,]
MQYG+5\T&6Q;5V5R74D=9329.&6GJH2U-LZD26MI)9 \7E+%3&@8,@T^_=>ZE
MY#XI].9&KQT]#W'N/&&CH\93PIA\WU4WECQ\]7'35T9GV?6STT[5U3,$^WDC
MB6=6TZ6)'OW7NC8X#I/J7#U\>=HNN]FC<"*FK<;;<PS9RID&HO53Y-*,5!JI
MY6:20AA=W)_/OW7NA1-' 0 5.D,6TABJEB2;V6UCS^+<<?3CW[KW7?C2&Q15
MN2[$V%R67D\  7TCWJO<H]>M,Q6-V'$#H@'SDK4I:3K+R4VT*Q'WI2334^YM
MPC;V2N)L:D<VVZO^]>T-57 S%C :DK.5 M<7]HX8TN]V:SEKX(4MCC4"H]?\
M'17ND8CVM;\,?&U+CRR:'_57JC+"3[IJ\YE<;B\+\7LCG\90#:NV<?#V]3-4
M9O,;HS=1G4P^-J*KY*1UN&R%9>2G#/")JFH=!#*8%L%NW'ZJ#Q)<-\NFKN=X
M9]"J-'1_?C!UE\\=HY3.XK!;"ZFZ*Q69V;M?(R9CL+:^X=]4,V?QDR8>KP*4
M<'>.9S=/52TQDF,JE$,:J)=4FD^[-VD@<.EXMDD*RLQU4ZN=W+'D%Z]RL=?5
M8V?*#:&02NK&B6BP\]<,),*J=X:F>5*3&3U 8E7E(CB:Q?C5[17PK:S ^=/\
M(Z6H0N&^'K5TWCF=T462P=!3X[XQ&MK(-V9C(YV/LA,G234U%O?<M/3XS!X?
M)?)C#5=/44\$U74.XIXL?35GJ<QI'XD,;>)?H?/AT@O)K.I[C3[>K$^JMF_R
M[-\[-Q.;W/O?8VW]V9;:$\>YMLP_*C[B;'8^AKI%KL@T6WNQZO'XA/N:XL:B
MGF,U,DR0F=N2S--("^0ZI'H**4^'RZL9^.6Y_CG0;;Q74/078VSMXXW9.&2H
MAQ6![+I>R<QC<-754LT-9E,K)G<WFJFGFJI61*BID:[>@-Q;W[I3#@LO2W[_
M #?I7L\_UV7F2/\ 6^W:W^\>_=/]#'[]U[HKGREV9\@M^;9V3@_CQVA1=29^
M+LS:&6WKNFLQU-E7EZXQ[5\VY,+CZ"JI*I*FORK""(+^UI1F;7< %%+-,LZQ
MHHT$=.*$TL6KJ\NJR]P='?SE,IV329/!_)GJ?:>PJ/8N=VG/MN.''YRJK-YS
M[7Q^+Q/9,D]7UY L41S\<^5;&LS1Q*?M@2IN#E8X&@8LS!Z?E_@Z*IX&U5!.
MCJ3/U'_."I9J:;)_)GI 9*JS^\$Q]+1Q1XS:];C:C;6>BVM4OA:[9E3F_O,/
MEX:*JDQ\-:$6-IE,Y$*NP3W1)4-(L_;TOM44#N8Y'4?=>SOYK]1B\AE=H_,S
MXQ8F<9VO@>JR^/H:C9U?C:[=&#K85H]$%5DL)D\!MFCKC% :NH^X$WAD<$+/
M&NM$W+Z:$Z5/:/G_ )>FY'MP\BLQ!KZ@=.&QNN/YGN*3+R;B^3W6^4H]R]+]
MO;0V3+F-W;2KD7O7,4-0G5&[\5)ANK]M)F:&ES<CL^--X\;2111H)Y4J&E6*
M+E@RW*JM1@K@_P"7JT;0MJ$;5^W/2AQ'6'\W;86T$V+2=S=/=N;GI>T.N]W4
M7<N_:^+:M=F^M,)M';[=@]43[!VSL&>*CR&Y-Y4M>D>5^Y?Q4<\<@5)+A-06
MXA+%9&)/J>G200V!P/0\?$S9W\Q+8]!DXODSV;TEVGE:W<?7T=!D,309S"G'
M[*%#F:CL7738[%T5+5;T&0J**"@G73CJJGI6EDCBEU!E-&/ET3QF>)J!0?MZ
MLEIGD>/]TKY 2&"@ #@&Q 9P"+_U]Z((.>C*!W= S_%7K__0WE>W.Q*KKL=?
MSTVQMR;Y_O?V/M7851'MH8U)=L4NZ*LTD^\,O/DIZ:.' 8!$,E7XW$[(P6,,
MQ"FI90ZQEN]N'5)72&)IY&I$I%3]O#''KC\?W0].;"LP(.)EMI^AOD:Y1I('
MTN/;A4@D$9'7ED1T65&K&W ]#+[KU?KWOW7NHE8LC1*(IC"?*FIPBN-/-U8,
M5LI-KD&X_'/OW7NJB_\ 3%W+/W344TM=DX>WTS-3M6I^-,N:<[$/7<>52&FW
M'$T^(O5;<R.VYCN,]D))I2O_ -^\U(2F@>Z]T=3MS9W>VX=TXO\ N/M#XU;I
MV,,9219=^W8]VS[IEJDJ:IY8<?#BL!F<,<9]C/HC\[-()69C=20?=>Z:>K.N
MN[FSF=H.Z^M?B52]=U--*^(QW5F)W16YR6MAJ8&QZ;AI]V[>H,%40QT\6HO"
MH*2J-*VL1[KW1@4ZLZS41D=<;#$D4D4RM_=';NI)X(Y(H)D9<:NF6&&5E1@
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M9&/R&X\/ANQ.J^O8<A-29K+;@K\]NWHB&::HQC4U9#)2XV2FJ,A1U%=6U5'
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MP5M=V%NFJJX,;GH*J#(TT,TV1-BQJWDCF8/4PR!2D@"V][ )X=,R<?RZ[E^
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MZF_YY#Y._P#I'WRD_P#M1^_=>Z]_LZ74W_/(?)W_ -(^^4G_ -J/W[KW7O\
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M/_M1^_=>Z]_LZ74W_/(?)W_TC[Y2?_:C]^Z]U[_9TNIO^>0^3O\ Z1]\I/\
M[4?OW7NNC\T>I3]=H?)W_P!(^^4G_P!J/W[K14'B.O?[.CU+_P \?\G/_2/?
ME'_]J+W[K051P'7?^SI=3?\ /(?)W_TC[Y2?_:C]^ZMU[_9TNIO^>0^3O_I'
MWRD_^U'[]U[KW^SI=3?\\A\G?_2/OE)_]J/W[KW6)OF9U QNVS/DTQ_!;X>?
M*)B/]:_41M[T@$9)3!/571)!210P^?7E^9?3ZFZ;+^3*D#2"/AY\HQQ>]O\
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M]J?&CK72>MCM^'!Z,M\BMU?\*#?E=\>.KNGNYO@AW=N.3JGL;%]I;0[RV_\
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KG?\ MRN[-CZHI8&EV=+E^OL5N:JGQFW6I' H<A_#(1-3 *LKH![]U[K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g425213dsp215.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp215.jpg
M_]C_X0"B17AI9@  24DJ  @    # #$! @ =    ,@   #(! @ :    4
M &F'!  !    :@        !-:6-R;W-O9G3"KB!/9F9I8V4@5V]R9" R,# W
M   R,#(S+3$P+3 S5# R.C U.C4V+3$X.C,P  ,  ) '  0    P,C(P J $
M  $   "! 0   Z $  $   #X 0       /@!     /_L !%$=6-K>0 !  0
M  !D  #_X02.:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K
M970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_
M/B \>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K
M/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O
M,#8M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<#TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z<&1F/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!D9B\Q+C,O(B!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G
M+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UP.D-R96%T
M941A=&4](C(P,C,M,3 M,#-4,#$Z-3@Z,30K,#4Z,S B('AM<#I#<F5A=&]R
M5&]O;#TB36EC<F]S;V9TPJX@3V9F:6-E(%=O<F0@,C P-R(@>&UP.DUO9&EF
M>41A=&4](C(P,C,M,3 M,#-4,#(Z,#4Z-38M,3@Z,S B('AM<#I-971A9&%T
M841A=&4](C(P,C,M,3 M,#-4,#(Z,#4Z-38M,3@Z,S B('!D9CI0<F]D=6-E
M<CTB36EC<F]S;V9TPJX@3V9F:6-E(%=O<F0@,C P-R(@9&,Z9F]R;6%T/2)I
M;6%G92]J<&5G(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.C0Y03=$.#A"
M-C$V,S$Q144X-S8R1C5%03<V,D4X13(T(B!X;7!-33I$;V-U;65N=$E$/2)X
M;7 N9&ED.C0Y03=$.#A#-C$V,S$Q144X-S8R1C5%03<V,D4X13(T(CX@/&1C
M.F-R96%T;W(^(#QR9&8Z4V5Q/B \<F1F.FQI/D=O;V1W:6X\+W)D9CIL:3X@
M/"]R9&8Z4V5Q/B \+V1C.F-R96%T;W(^(#QX;7!-33I$97)I=F5D1G)O;2!S
M=%)E9CII;G-T86YC94E$/2)X;7 N:6ED.C0Y03=$.#@Y-C$V,S$Q144X-S8R
M1C5%03<V,D4X13(T(B!S=%)E9CID;V-U;65N=$E$/2)X;7 N9&ED.C0Y03=$
M.#A!-C$V,S$Q144X-S8R1C5%03<V,D4X13(T(B\^(#PO<F1F.D1E<V-R:7!T
M:6]N/B \+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R
M(C\^_^T 5%!H;W1O<VAO<" S+C  .$))300$       ;' %:  ,;)4<< @
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M%\'10U,T)9)CX?%R@L+2&!F35#9STT1DE#55)C@1 0
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M"IZZ&]$J^2G)S]#(:G7^2V\=R'6RX3<2 [6PV6F[I94/7V$<QEK?>3L%MA(
MZ:#$X-E1)W%>&2H<FDEQW*MX,R,;181Z%YKU4P-/U,>R)?6R\D=R@5'M.X^
MT#?6--_U5E#Z45 ]1%QU)<A-J:MEF.U+;WMG2"ET-'_TB!XME>@= =^OSZ]1
MM_=\- @<E5LJTP/-JVO;K')\_%LBBPDW:'7*-=@]5R$Q4W+;*DO?I7>1YJ@H
M$)WZC087$35G&XGXZ9MS3.7,3!\8A6*\?4LTZ)42KA1WA5%TJ<56MN-D,=Q*
MO+ WW.^@LS^._P!?G]?XZ T!H,20/-0ZQN 7&5- *;4['W7OMW]FQ"NOST%8
M<1PG:W :BLEMXQ'DPGK_ -4SB 7_ $T/.O+1U@Q7G%*)=4T0I_KTEE8T%LI\
M!^;P'YOS>'^+_F^>@K;*(4%W*\!L7HM4JQJK:Y57S9Y<%E#_ %>E>@26J%:5
M)9=DRHV[;_>%=C!)'7062.H3T'@#L#W =/\ "?B!\#H.=O\ ;_;\= C8U65E
M5(R5-76P(JK7);.VL4P5!U$ZVG(A-2IUHH$^3;]D=L/)Z;-A'30//]_U'QT"
M#R!55=OBMY66=?36,*P8\N=#R%/=2/H3)CR BT<2M);9\YI!3UZN]@T#RS]S
M+)4V&R66R6]MNS="=T;'J GPV^6@[-A\A\M J1"V<FMNSTGJ/05_F%IQ2K$M
M^:YTDM=W:AC;P(T#6.@ Z= /#P\/A]-!SH#0&@0Y%+7/Y]7Y$4L+M8>.6%="
M6N:6W$,3IS#[X%?XOC=CH2- ]IZ)2"=R .NW;OT\>WX?AH%7*HD>QHK:'*+B
M(;D%X+6U+?K' HN)&[<^/_K8*A_YB1LGQ&@8*HH3!AL-E2D,Q([2%.2')CBD
M-LH0DKF.?S)2B!U<5]RS]QZG09A\3^)T%;9575UI:XJY.C]ZJ?+(TN(^9JX#
MZ+",DF&5D*'KV#YAW:ZA7RZ:"Q_KT)\=]AU)\3_'0(&<4U3>0JI%O6-6+=9E
M-'<UR'9"8B&KFGE>?63H[@/W.17UE>Q^*=!W7L>,NYP^R<3',V%93T5ZI,Q3
M8+EM 7#DB,A)[9+R(@*@"#LKJ.O70.K?V)Z$_;VC<^.P/Q^>_P =!6N.5$:A
MQ^FIH4=Y$:-?N2H\=RV>F*;\RUGV,M9F2 &W$EV2I7E _:#V_ :"S^BNHV()
MW!_W'^S0&@- :"!OVFI-/:Q'HJ9;$F!)BN0_,2QZY#\=W>.EYQ)3$[B3]ZAM
MOUT'U0,MQJFICM,&*U&K8+348NI?,9+<1M 9+Z $O*:">TK'19&_QT$YH#0&
M@- : T -!5T>"N-39U&7*:5(GV63/Q)"G]FH_JZH,ID2UJ'; 8CGQ4>@ WT%
M4^T"JN:+VY\945]<45Y95L"^3,M,:M'[NGL4.9+=*B.UUPYV,R@&U /)3T2L
M* Z#07+62X"<XR2"W95CMBY7T$URG:DI;L8D-MB9#;ERX.Y68JGW/L5\=!8*
M>[8=^Q7L.XIZ JV^[8'KMOH(B\2V[2W,=Q3:6G:JR94XLCTX#L)]*O,)(^T
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MX#_L\/X:"#R6,[*HKB/%;:??D1'&TH>/:@E2=NNVQV!T&?2-J9JJYEQ(2XU
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MK$I$?X#O\@[=3X$'01V-)DHH:U$K_/1"0A6VW^%?:3\_AH& ^)_$_P"_0<:
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MV5Q%<B6-E409$Z*\TJ.ZV\J(TXZZY'7][#BG"2I!ZI)V^&@:?]/_ .8?]O\
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MH?&\F^R.GQB.YRUA$>&]<SDPDV=DY.=3'JHZE%(-B^OHR-_$Z#8%(V2D$$$
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MWTM='5(DL(^&W>R4@_+IH%; *Z368O6U<YOMEQO-4ZHGN[VW9<AP?<=^H0=
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MV^N@7>0?<APEB;]WB>69@BFM7*AYJ3$>I[YX-1YL-[RW3-9K7&>TMJWW[B-
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M.ER!C$K7CWGFOR*0BND0*JPP:%!M+6+=M-R:E^LA3;I+TZ+91GD+;6V.U25
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M;&\&]PN18M:&='J\GI.'<ILJ>RD5LE(F-5ULRPMF0N.-B4IZ;*Z:"5L_W.N
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M5&L+6KQ>+,R-^-'C*6H>GCJ+SG;M^70:SV'N4Y,Q"1P;CW/WMUR-+E!Q//\
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MGS.,S*QZS;=09;*T-K,9)'>VIN1'^Y77<KW'70.P   2-@.@'R \!_ :!=R
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M@,KL%/%_&0?5N29[SBI9)GC?R2K^.@TZYVQ_+Z?-IF0YM;-6<$U=&UC&:O\
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M@5GFDG*XCQ>C)<%>Z$QW #+6!T!:._AOH&B-N4$D$'?J#X@]=P?KH.I?^/\
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MQ+R1_J/(D'<(Z @;:# 3BW)BH56R[R,TF=$;?1:26,9AI5:*<)#+W89H2SY
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M:4(6Y7PG%H;_ ,M*EQFU*2W_ ,B2=A]-!(:"M[\PHV=X*%0H[LZS1DD54Y3
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MW=Z&BP5 UP5Y('>5",^5=X.WWCXZ!A/7K\"?'_;IOH(JY#0K;%3I:"3!>_\
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M.G4:"M,,Y@Y+R>^CU-Y[=>1L*KG(LF4S>V]OADNO:4TSL(DIN#>S)27Y*O\
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MJ465<ZAA$U]M+CO;L5K\2= N\4\2\2X_BYI<:XJX_P 3IX=UD;<*JQO%Z6%
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MMK#_ .E4;4Z I$2(AQ?F%*-DCKTT#_4\:\?XS54M#2X=B]-18] D5%-65M+
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M@3<O@N3QCK;*F N)E=+8.J4=@I$%QUWMWW&YV5^.@<HXV21\B!].G3I]- :
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M8VDFM9E)G64@HEP'([R43GG''6R4GXDZ"7:XVQ6/9&T:@2VY34MY\.*MKF0
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M+*7T"0WO\M!'X;AU=4>XCFS,8=E=/VV58IQ-7V5/*I'X=/7L8O"OD5ZJC(I
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M/ _/0+=--8E6%ZPWVE4*<A"BE];Y[G& 3NV3_+/7PT#&.@'_ ';?W?#0&@-
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M"^1+_$\*B463X-B>&\95%;CE?-@YMEE;E, Y+D,6[ERULS15F2'(P(0T5_<
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M>VPU54W#TS,%LO*RN^.3F\5F#UQ2NSFH,2H<;="$1@_W+.P;A^T7GQZ\;PC
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MT'.@- :!1&(8F,A5E",8Q\Y.M)2YD2J6N;O0TC[4H<LW6S/+8'AVJ'TT#:/
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M&8>1.2E*)R'FD!8= "5[]VPWT%J?[?+0&@- : T!H#0&@- : T!H#0&@- :
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M^/30<Z T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
M: T!H#0&@- : T!H#0&@- : T!H#0?GHY&JY,7]R*TO4XO8(SU7+V&0L)XHA
MU%K:\7<I8=+K(XON9LXOD72\<ILXQ'L5Z7U4-M<5UIO_ #.\%(?H40OO0A9\
M5H2LCIT*@"1]I4GH3MT)&@^] : T!H#0&@- : T!H#0&@- : T!H#0&@- :
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5N22= T'Z>'TT!H#0&@- : T!H/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g425213dsp216.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp216.jpg
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M 0,1 ?_$ )0   (" @,! 0             &!P@!!0($"0,* 0$
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M)_,_[]!C0&@-!$W*7+V/\3U=38WE9D=V[?W\7&*>GQ*FE7MO96\WN4VS&B1
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M\>Z>OXZ#8@;>'3KOT^>VV_Y[:#1/,1W+EB0XISU#=>\VVM*#V!I3X4I"MO\
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MF0\:X&ORZ^;(5&H,RL'IBK41SZ**PFUJH++;=@M/82=O+2-SXZ#;6>7\PM9
MF#6<;4:L;?J8[C=K<9;'CVB;=271(@JKH[+B5LLD)V6%)"M^GCH(KPV[YOY%
MAY7#YCX&PFN34-LSJFNL,JILMJYN0QYTAMB"A#4*8N&EVK9CS$+=9[F5R"T5
MGMT#M15N2V\N-=99P=@E794=99(QJTB6%+96;#T\.*FUE=+>K_/K(=JXLA[R
MU)2[W$J!W.@J_P A^U;BRUY*K+"R]JF+W=5GU?)O>0;5W+H+;)R=-?(0:9&,
M65B&W%K>EEQ<B$RTA3J MSN(&@@CD']H3VE9I1TH1P5/Q*RQR1'RR#,PG*ZK
M';]V]VG--XW)GPDUB1"/J5%+R%]%)"@=P#H(%H_VS.1:JZN;O#I7/G#;</'7
MYF+5-!S_ "K%[^YX4A7HH\&<YFM@TRJ0YVE?K:^3%<;2ON\4@A\L&PK]S^MR
M+-./JW,?<52C'+2<O$<E5=\'<IX;.Q2/+>12V5A:9NQ@&:2K?(G%.!Z(Z@+C
MLI\QDE!Z!]K7W%_OA\3RH;&6<#\.<KU+L1::^=B5#>Q+AXQI4N$F-DUE76EI
M24-RZS%;E//N-H@!MSZ5;D)T$LM_NIY-Q3D4U/NE]LF:\>9I6\<P,SS+'./,
MCP[D9C'<71:3H4G.E.Q)T/(F,+6KR6O,D, %\+("0$]X69XJ]X+_ #+G<G,N
M,L%Y#SKC;(^(<&R;'JV+58W7W%3-N9]WZF1?IF6*+B MQ$/L;;6GRG$?6GQ&
MX6XSOD*91\?6&3O8E>PY,;'T6BZV5%9FN1'2\TAVLDEIUR.])"7NA2I22H;@
MD;:#42>6$GDG&\<;X_S8.S<3R*T;NG:!CT$-%:8#YK'Y+C@EB5,#H#8;/:3_
M %:"0K#D,U:8BY6(YG(7+BLRO+K:&59KA^>T'3&E-5_G*1(9[NU8VZ*&@2.5
M\P0YPYGEHU5V9"L&R.W5%NJR= 8<;AQE-.1)T5#K%@PZX1L$I4A2C\M]!]^+
M.2:^SP3#&8V.9E 4G!\?FA"\,R"%7LM"HBJ<9@R9;+Q?'B&4E2U%.W4G0.,S
MDNMKDM%ZBS(L2(S,AB0SB]FZL>:V%A+R0UW!X;[*!'0]- C9+R(P<EXY9AUE
MPI%Y+F2794FEL&I$%N(R26W8WD?2Z\!T!Z[^&@^/)_,#N-8?=V=!56,V^;C-
MQJ:/;5TRNKI%M.E-QX34V7](AQTI>"UN*[>T(V/CH(YXFY)SFSS:#37.2LY9
M3I?OJ*_EV6%6/'TZIS2I2F6\W11YSSO]T4 A-O)1)1]#A[5C;?06_P!W/_:S
M_P#AU?\ 7H.]VI!W"4@]W=OL-^XCM*M_^+MZ;_+00[/X-XOM\I>RJPQR1)M)
M<A,QUI%[D;>.NS67$+$V3CK5BWCC\_S64**W(RU%202>F@3.=J.MM\P]O+\^
MNL;1^GY:18U:H$^)$:@34XW:MHDV/G>6J1#2T3NAH%PJ/3Z=]!.&2O>1CN2R
M%H:D*CT-VXY$D$.,N]M=(=0Q*[$A7IW4MD%*3U!.@\H/<=E*V,?]OF;MT>-O
M>5[9,_MVL<N(CJL/+,S$L6E"',A_HR55$?S A"$*W[ !W;]-!Z_) 7%3W)1]
M49M1  *0HMHZ@=1T^&@5,0=\RG:>,/T;BY\]M+047&UH:M);7GCQ#:G4C<^&
MV^@<@2/PW\=CO_M^.@B?D&JH;'(>,'[6DK;B75YF_,H9,SM2_1V:J::P;&"X
ML=PE!IQ2"4;$I41X'02J$[H"'.U9"0%]!V*(VW(2>FQ5U&@Y; ;    [C\#\
MQ\CH I"ALH CPV(!'4[^!_'0!2D@@I202"00""1X$@^)&@A?G2X@4''5Q=V3
M$EV/!E4[@$2>]5S%NFT9CI493 +GI@7OK'4*3T/CH)CCA/IX_:E"4^0UVI0=
MT!);2=DD@$I_WZ#Z%""H**$E0)4%%([@HI[20=MP2GI^6@C:NN&'.2\BH68\
MMI^%0U<M3KCKAKU)=><[DQF=_*:>5L.Y20"=!)("2!LD %.VQ&^R5=2D_/<^
M/S.@U5S(;CU%E(>0H-M1UCM1]+A2$J'TD'IW Z#C3+;=@07FT[)>AQ71W#Z]
MEQT$=Y\2H)V!W^6@W':D^(!\/@/AX?R^&@67I$4Y-70"G<2*JS4$;'L'E/Q
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MT\'.YLI(!^H CPT%HFCO&BGHDJ:9)["2!NE']*CL2!OT/RT"YB<I^?2MR7V
MPLV5NV4)'8D)AW$UEEP)&P'G(0"?F3OH&5)) *NA(!(^1/C_ ".@B[*JN@L<
MJP67<44&WMJ2VN;'%Y,I2O4T-D]5/UC[T,[J;=>DUTMQ )ZH#F_3MWT$I
M #8#H!TZ > Z;#0&@- :!3RR2(=6N2IM<A/J(; 0VZMIQ*G9 3NXM)"O+Z^!
MZ;:!K3N$@=4]!N-R=OPW^/YZ#.@46948Y;.@);<3.13Q)+BE.+<CF.9+O;VM
M$J0EP#X[ Z!L2=TI/CND'?PWW&^@U5VM#-18+<"ULM,K=<"'5-.; %2@AQ)"
M@?EH/O3.(>KX#K84$.0HJT!:BM82MA*DA2R25* /4_'0;$^)_,_[] L.RXR<
MCBU:T2E/R*Z0^EQ)'EI0EX%05M\>G^[0,W\_X^/\?QT'6D+V8D+^+*'5;_\
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MY5!L*+A''[BQGXE6_?K!_DF)!AP;7U2Q,QZ"PN(MUYB#'2'T2E('G%93OTV
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M/47)=M)JXV#-SX./\<93<%:K)B:&G:^1 @OLWT=OU(]2N.%>E[?K[=M!,/\
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M.1&I<=E*Y*V6[)E3,MH?<)*G>]M8"B'2=T?@1H'P'N 5UZ@'KT/4;]?QT&=
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MN- YH4E2$*1N4*2E22=]^T@%.^_7?;0<M!%U/,L'^3<\K9+K?VV/38H_$\M
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M&E,->-I!D38,N/*=<-AW!MI: T4[K!T$] @@%)[DD I5TZC;H>@ ZC0?0_\
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M3CRU@-;I0I/U>.@L4U.A+.[,J*\M2>\I:DLN^<C_ +QK9\[(:W^H@:#[&3'
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MF2F*:HCJ<7<+2EABMDN,@A\$)4D@[Z"YD5/:Q%3X]C#"=SL3]+:!ON  ?#Q
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M.'\JY R^^RNLN>6\"J,WY+M+C#54&2OT<V3D(JZI3^,MR%[B.TME'4%M:4J
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MV#<?N8K=3Y^"X=8+AP'$,JD8]5+<94ZXD$-N+AJ+?5?4I(.^@8!Q3QBKR?\
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M9RE(;5].Y.ROXZ!Y2D]J=D[     [#8> _+0?-2^[Z0D@@[= 02?E^?30?0
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MML[@#?8HWZJ'C_4?YZ#GVC;;8;?+8;?RT%?XEI4.^XC(:=/W]5NUQ353'O\
MWD?[736+OY+8]/"W*D7?GCZG -_+Z;[:"?TC8 D *V&^W796P!^H>/3IO\M
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M#[#TW)$LK:=<C7IC2V64I95WKB0'4N/E&RG'0UT[CU[1H&O<%GN VW3N-_$
M^&YZG?;0*5MY2)U$ER1"2\[/6M@/-!:]@R4K3%*M_*=4DD$C8G?0-2>J01X;
M#;Q^(Z>/709T"C":*<EO'$" 0XS5^:B,.VR)2)829JW1V*:._P!(3U T#</
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M9W]N4_J44L*0N+!I4N^D[TU4%"0&6/\ E-I [4@:"".><=5(S_BO$:'!J?\
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MM*D"2E7B=RG?IL=!I+W!<+2YB,!ZIJPS%\FLKV91G][<:/%##+$5QAX-^8A
MV[E=5?$G0,3.!8PU,ESFJ]U$V55HHG'!-GJCN0&E!:-F%22VQ(3MV%X .'YZ
M#30>(<"BW"<C@T3L2X](]"+[=Q=MH4S()2^EZ(F<EDNIZAMSM[OB#H-!<\8X
M#EF0V+-E'GS)%;74D%Q-5EV55EBEB.U+;BIL_M-I#5(0A)^E2BI>^YWWT&X=
MXHQ%^"*I42Z$)%,*)B*SEV71U+K.Y,KTR+!O(6Y29K3\<*]45A\(/EE6VXT$
M56/%G"_&4ZZN)?K*ZK@<>9-,R29;<CYY)N&\?#C*[)R Y99.XJ##6A"BX^TX
MTXT^6^Q041H*]^WK@?"<V,K/<YK($C+.7J#^_9<VDY"Y"H,VD83)?:@<<Q+F
M-3WD%U^+!PGT2=WEN.)E+<43WJ42%J[_ (EQ&'BJHD<7+#%'A]KBE5.GYQE[
MPBP9SH=4FSE3[20U9.!6Q:G2DO2FE@("]M!]H'$>+U63XQ*=NLIMI\&KL(+
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M5+11.<0Y@Y(;0I_[,;Q.68HB*[,;2H1E6*JY3@0M0\P-A8!V)&@FT    ;
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MJ ="BI25,J!2QOOV.*22"1\]!OXO:0DI3V@I20/D"GH.O7H-!]CXG\S_ +]
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M2D%I"=^J%+^HI\-]!,! '0> Z#\AH#0&@-! ?N*A3)W&%LS"K7;:4FWQY^/
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M*=!,\*='L8L>3#DQYD9Q.[3\>4Q):D=@V4J/)BN*9<+1!W3O\-!L@.@&Y5T
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M*&5GTS%D/P!E$;&8EI)CA)^]"CE37&FUE:D!@1E2FMMA]6^@VN6[*QB_,E*
MVN*Z2B0-T[=K?0A&_0:#M/QXZ[JDD^EANN-1'TLRU**7V&RD ICI\2A0&Q^>
M@8AU /S_  V_V?#0&@- :!4R2L8L7:%Q]HNK@7462SW2O3^0H>8/-;V4GU"]
MMOHZZ!J2=TI)))*022-B=QXD? G09T!H#09'0@_(Z!$P;!:/CFA:Q7&F'HU0
MW;Y#<L-//*?<,W)\BM,IO75.+)[&W+2U=*!T[0K8:"!?<'Q3?9Y88YDM1&BY
M(QCM3E5#<X%);JHCF1UN50V8KKV/Y':J>&-Y/3>67F9*4I2\@*:<4$.$$(3?
MXQYF>G2KFTP%2,;LJ#&,+BT."YM447,]%!PZ0NVI;BSSY1KJV:WD$M?IYU;&
M[66@G=/<D[ &8\+<E?Z/W*#3X=_J%;\N0N8W./IBD(Q1F-72ZCS<)D6T5J6T
M_=SJJD3(<GH:2U]U?6Z-T J4'4]L7"N9X5EB[W*<(@8-#IJG,$UDK[M7RLBR
M"7G61LY!:(N6JBVR&$JFIG4%+2ES&UN22' PV#V@/0- V0D;J.R4C=125'8#
MJHI 25?/;IH//+DWA3,I/(>=9$SBV793&D9(QR%C#^)YW1XW1Y'8+Q^+CK7'
MO)]5<%F;>8S4280EM1FG4LO)E.@]0-!<SBK'K3$N-\,QR_?AR+FIQFLC6IJC
M(%8W.9BL-R&:I$I]^2W5LNA28Z5N*4EH $G;?02&?_#?0&@-!YV>\?BG(,P?
MF2*F)E33][7XM!J<YP_#:?D>[P1..Y$BTNJ!C$KA"F6:_D:"ZIJ5.: ,<1TE
M7=X:"=_;CBF48?0YLU>8NG$(=SGUI<XKAZ[*LE2ZC'EU=%6M.2HU*MZFJ)5E
M+KY$T1(R@VTF5LX$.=R0%A;2--DU=@U62A%GRJZ9&A32%!$*<Y$>1"D%H>*6
M7G$J/Y:#QIE<.\K'+;RFP3 [#C[E9ZJQ.#2\O?:,I53UN5T605UCEN?Y%92:
MM_#Y2KEAN6Z'(MH[)G,241'8J@G9(>U#"7D,,(DN(>DI9:3(>:;\IMU]+:0\
MZVUNKRT.. D)W.P.V@I![N\4SO);/BZ7 BVEKQ;CMEF;O(U)3TARYQQVRQ*=
M!PW(K3"FUM.YG44>3/MK?KAWI"-W5@!&X#M>UVD<@7&3S<=J+S'>.EXKQ_%1
M'ML8L<%@W^>5T6XC9'D^-X78>4SC]#:%+#NT4&,^I:"D[(45!=EO?M;W5W'9
M.ZM]^X[#=6^PWW_(:#PZY/HJD\LYM1ESF5/N$ML/SQS"'*V:N7D-)D4O+9MC
MBUQBE68$6DL*R14P([PE.6OH&HD);+S*'.X+#V>P=&1-X5A[>7R&I>6-XO0(
MR>4SY?DR<@15Q4W#[?D@,]CL\.*'9].QZ=-! WNL>?B<=P+&7/M*[$*_)ZR;
MGTJF7/1)C8A'6I4V1,=JY$:P13-/)0JP##J7EP@XE'4[:"O'LVOK6WR>9_;.
M<8-R'@43%+2+DV1\7Q<AK^,SF3=Q6.XO#QJOO9%BB%91L?>G"S3%>#;BU-J*
M2YOH/29&_8G<;'M3N#N-CL.FQ (V_'0<M :").;K^QQCBSD&\I[>33V5/B=C
M:1K6-6.W+]4J.D*>LX]?''?-?@QRMQ+'7O[-]B =P\XN%<FR;%N;\+I,;GRW
M(N=9A<26(%=S%_JZQS%Q)88XY8/<VY?'7%><XSN:><8:8["51F9(6& U]2=@
M]=T_TCH!T'0;@#IX $ [#0>1W-F0<J9A[EE0).?95QGCG&&:N;1J>0]75#>!
MHPMB[J\PO$RF40)+.4Y(9,9J4M<AI)K2P&=W%* >A/ &3Y5F7"_'.4Y>IJ3?
M7N/19L^R:;]*W9L.R%H@W*(O:WZ86U6EJ5V=J>WS=MAX:!US>\D8[C&274)I
MZ1.IZ:VGQ&6V53'5R8<"0^U_E6G$EU+ 'FJ'BM".T==!Y.W$3,LHQK$;R)G^
M4\KQN=,QX6Q>\R^/9XF[Q_GE%(OF).1E&$0*M%[1XO0P9LJ,PE]]3P6E7J00
MG0>PLQ::^+(EI3(>3&A..^2V2ZIUJ$RM];"1U3YK_9V @;Z#Q-F>YGE3COE>
M\Y&R._M<HJH''<GE6=%IZ9BMA3\0:RYZEK^ *:E%:Y%D9]'+B$(LI-JT\N4Z
M-HP;![@ZU;[EL]B>XZUS638)LYL/C#"+*?7,V42-76=5GV:-Q&^(H^/)J7FC
MR-AG>([LM%HH&<TI*F$ASH%PO>-S5R7A#C>(8&EVLBUW&V4<IYC<)*FY4VCH
MK"HHD8U0W,RML*^DE^JN$39$YYF5Z>/'7^DH'<!73BGW'<U<@4<W/:GD:_SF
M)%6;*AM<5XU9D\5X?3XX(TS+,$Y=R%_R)L[D>>I2XS$N(8C3<(QY28ZU/%"0
M]=,2OCE.*8SDYAOUQR*@J+PU\I"FY,$VL!B:8<A"PE:'HQ>[% @$$== PZ T
M!H-!<T[%LY5.K.RJNS3*;'4;K0WW;#\=SH-ZR2L[J^/78_#<$[;:#F?$_F=!
MC0&@- ;;[@]01L?Q!\0?PT''M3U^E/4 'H.H'@#\P-!CRV]^[L1W=Q5OVC?N
M4GM4K?;?N*1L3\M!R[4C;Z4]-]N@Z=V_=M^>_70<0A 3VA" GI](2 GIMMTV
MVZ;#^6@YZ#B4(.^Z4GN[2=T@[]AW1OTZ]I/3Y:#E_P!(V/XCY?EH#0&@-  ;
M'<=#\QT/\_X:#CVI!*@E(4K?N.PW.^V^Y\3OL/Y:#.P^0^6@R>IW/4CP)ZGQ
M!_WC0&@QV@[[@'<=IZ#J/D?F-!A24K&RDI4".W9201VG;=.Q&W;T\-!RT' M
MME2EEMLK6D(4LH05J0G?M2I6W<4CN.P)VZZ#GH.*D(6%A:$+#B2A:5I2H+00
M04+"@0I)"CT/3KH.C6U%3311!IZNMJ825J6(=9!C08H6M16M8CQ6FFN]2U$D
M[;DG?0;#0&@-!Q6A#B%-N(0XVL*2XVM(6VM*P4K2M"@4J2I)V(/B- F8UQMQ
MUADZQM,0P+#,5L[?;[K8X[C%-2SK()*%)$Z770X[\H MI("U*_I'RT#J!MT'
M0#H /AH(]RGB[CG.)D*7F>#XIE<J$T['9DY!1U=JH1U/^H1"4B=&>\R.B24.
M)0=TAQ(5MN- ^LM-LLM,M--LM-M(:;9:;2TTVVA(2AIMM("4-H2D ) V &V@
MRIEE86%M-K#B"VX%(2H.-D$*;6"/K00H@@].N@BJEX2XHQJX^_T7'^+U=HVZ
MN1 ?BU+)C5#[I=\Y['8.PAT,B3YJB^Y$;:4LJ/<3N=!+"=^U._R'0'IO\=OX
MZ#S\]P>1<3>VO)JG-:_VY7F<Y'<2)5Z+.CM\=Q'CJEMUSX["9M_<YWDM!QQC
MN26,YY"XSKJ4RG%A;J%;I4K0*OMQS[@WGC/K%IK@3)N.\[@)5F0@SKZHS/CM
M;C%LRPY>UUMQ[EE]QDC(T63RG" V)ZEI4Z=]M]!57EO]T/@#-;B\XWS+VO\
M/^54.,U&>YE+S*B<HX+$+!>.N29_$F69LFUJ,GK+VII%935/,.LH4VMYLC=!
M[MM!ZD4/M@X3HX2V*3$9<2#+D5]O90$99EST2YG18["(LRVKG[]Z'</R8S+;
M3[DH.K?0RE+A4$C06*CLMQH[$=I#;34=EIEIII"6VFVVD)0AMIM)*4-H2G9(
M'0#0?;0&@-!C8?(>._A\?G^>@R.GAT_+IH#0&@- : T!H#0&@- : T!H#0&@
M- : T!H#0&@- : T!H#0&@- : T!H#0&@-!@I22"0"0=P2!N""""#\""-!G0
M&@-A\O#<#\ ?$?QT&       -@!T  \ !\ -!0/]Q'%N3,S]M&?8SQ%Q5P;S
M'GUC-HD8SB_N,E5;'$\"4]/0',AO8=L]%B6B*%M"GTL*>96^[VI0H=3H/,G]
MG3@Q[VV<Y<EXERM[5,!X,]Q7*W&QY(R#D/$>:\/Y*?S2EAY;4UES18[A.'-H
MJN-N/ZFYFQUP8H;<_32D+>=4"LA5[DOE3&&[>VJL7X:XOR2]@4GNHH>2*6!?
M9S7R<2X5R3W)IBX_PG(57N26\BY?YPSPR[^K?F]C<-#I;:9"$!PA^LV,.V-'
M 0IO_+, H605I :2 AQ20 I2-]C\-]!]@      -@!T  \ !\ -!G0&@- :
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M@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- :
MT!H#0&@- : T!H#0&@QVC?NV'=MV]VPWVWWVW\=MQH,A(!&R1T)\!_Q'ZMMO
M^+?0?GV]T7/W[NW O-7(\;'IW!&6<*8UQ_-YGHI57[?.1+.RLZ%')])A\'AY
M-U!R0Q9&>?9+U,IR;Y:8[*6W'5M]FV@_0''45QXZR22MAE9)VW)6VE1)VV&Y
M)T'VT!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T
M!H#0&@- : T!H#0&@- : T!H#0:*V>FL5]B]!:1+L8]?8.08#TOTD218".\J
M'%?G=BEPD27>U"G"E8;"RH#IH/S)>V/%?]0?>?A-%FV1\GR.4!E^=Y?[HN"H
MF6<[P,5]L*J>)D]Y@TRNSM7,$S&,GJ,HR-B'":856*C6<5Y3B&F$HVT'ZB4G
M=*3L1]*>A.Y'0="1ON1H,Z T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#
M0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H-!9152HLF*9,V&[,C
MO1VY\)QL6<$R/-C+F05AF0AJ9#:?"F5%I:$D#N"NN@_,_P"SCV]\H\+_ +D^
M-1>2.(HV 8XQ?<\1N+?<#"Q7(#R%[G9\RMOI[U5SKELB6:*2JJHW7[B*4-->
MJEPVO)0VC9L!^GU&_8C?;?M3OMOMOL-]MP#MH.6@- : T!H#0&@- : T!H#0
M&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- :
M#'8CJ"E.RE=RAL.IZ;J(VZG8:#QXYK]['O!X&R:VQ_E/VA(C8_DO(M;C7#G.
MG%]N[RA@RHMMDWVB([RMCB6*_)<!M9&/.MDNAMZ"'R1YVP T'L,@$(;W2$GL
M1ND;;)/:-TC;IL#H.6@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#
M0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T&M_^S3_ /K?_P XC0;,
5^)_,_P"_08T!H#0&@- : T!H/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g425213dsp255.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213dsp255.jpg
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M]-/#"TAG,%46N1>.++.Y+>6:1EX#(MI@$TE+8_>MU4C.D&B#8L@@J*(%1[P
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M:/D16:/D'2(BL'>3J!NO7SU:RS1]FM,R[A9YLQ2CV-U@V8KIMY$IC1A^U/U
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M^T=#F/T>EP1B^?Y_WM?)_P!:>O\ %YG#]1QKO18W-KX,D"Z9D>T"]Y'7<*H
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MKJAVEVW$PB/GH:P\\51_W/9&$/E[LKVXP@'3J99#??;SVU8M)L[11E_KC?\
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M*[M)XX'"1R%>T!!ANBJ1,91R0IMS^!Q+XB&B&GDU_(XSR$DHWG+:T8.JXB6
M20:OIQQ;9%(P(%KPO$$SH0:3(A>\QS"  0.N@\5F9,[;R>QP=4JX3ZV K"LZ
M28OW#9>04.5-5%H\=D*7M3%X/8)P'8P?AH,SA>YR*EG1ISI>8<(M&4RE:VKB
M&D&<177K9)RY)5XQ9WN,HL9)+U%%2_I%W$.@Z:@SCQ44PQJSML:>62B&.6)I
M1X^8'D7B$"S(].<DBPB&Q1,JY!;PV#?RWT-KRV*<;6RF.7,_]6LHK:Z.WK+R
M8:G0FOIUW_5V'J@!FZCXH@<A3_,GOMY:=X=-KFI3'V3G\<W/82.UU(-.O194
MI22+86*BB?U\A-3)"F9QY&&X@0IAV  T-;)-%(T_(C/YFI$A5#%-#4ES$*)Q
M!==VH=/<Y  #@83>/@;QTV UV7^ETO+^(H=/_D2::A#F0<>6:RW&I6JG79&J
MS]=B9N.*FO&HRQ7C28]+O J2QB!N'I#TTKI+6+&I9^'</Y98T"B._::EL^GP
MW#O$-PU:;1V)5//I12 N9XHNZG4 HS7J._\ " %-A'4U@8\%US+*^1N2 0V3
M64<Y:9-$L^\7K[==.1=FC8X$5T$BB;TBICXE\O#2OM!,FJN?>X=\T09A V_=
M^QC'J._Z0;CN&^LCS25%SP_CY&.4S7%*)OXY9B;LI#?<&S@@E7'<J@;]G<.M
M"5L>5DU0I-;JZ3\DH,.P0C@E")@DF\."ZSAZ8J1?E2$QQ-\O\$.F@\F09"Q,
MX9D6FR$+#STK)_;$)6R$="QCTB)_4"BH!5"D$5@_1$>O700/88N>R.XJ,K+6
M?'C6>A$K"R/&&5.ZCYAHHD#)X[(BNJH0AP5 3$';N)OTVT$79N@*U5J1BB%1
ME:]*2K?/&.)"0426:'])J^<F1*03G5%0R0%:;!OOTTV%J7LAXQ:7!]8).KVV
MD1#>6:'B'<A*E:.58QHT 5'Q6B0+[(N3E 0*<NQO#KI,0.UO8;_$I,&-:M&.
M$ZC2(N&9RI#K.'LE;4%6I!04:/U' F:+ BD'<!2CVCTU(.X3"CM06(O2)E*H
M*1W@(E'O( $:@?L*8P;F /B/4=6P"%)6Z[E>M6UFR;09.E9+C[ P-!&:M&3J
MG-&S9SWF.[;OA65='(EUWV'?RT#HH-:JM/<5J<L.2JC-MXMFP@*^Z1^RH.SL
M%E"$;MWR +E,HFW3V #G 3=-Q'?5##HC:@VJ RG2I*SU]BM+9>M;YB!Y*+3;
M.4F;A$  RH+;@F< WVWVZZE YV:;['Y+6_A\H8]>66:3KS#UEB-"M(-H0!AX
M)=HT9/"M7@MFBAN_<0[Q)N(:*EG%LU87[2>AK+88.X2E>703<V2$;M&;24^H
MV](Z23-=4J?H /4.NVEB/+E::M;-%C%U*ZUZD/U6$G)/YRP((2#9V2(1.[+!
MQZ;DZ93?6%)L<0ZEWT[U[D'P2Q\QH0ESE<@T*#GI*I+PMEBCJM"M)"%<NNY%
M1L#ET<C=515J( )>H;[:3I1DK&>CUUSAR&C[+779("WR/W)<92*<$22&,5$4
MC"FJ)A3((= $=*#MN-%J%E-99Z#R=4HF"M2J+J9%RJS</7#1DY070;%$CCU&
MK7ZEF(%$HATT[E=U<O\ >9.S/W;3(%$_8RKS+>N)U1FTCW<C.$=H-TP=).E'
M7U8 B []"CL.G6@MS!VF$O3Y1$.GAT';I^&C;C0+017F1GEM>G.CX7E8!E>F
MYFAXUC;$3+P4HB=;9^9XLCL9!9!ON*9=PWVU6*I%@0D@@H@LR9N:8!DQ++&9
M[_1FD@02!^+0#?-]*+KN]/?KV[:S-JRR _I"/F CMJM.- M M!\"9,1[3 (^
MD@L+A5<-D2)" []!V 2]O[NC"*UKYCETTM9JP:GVJ:IJ*Z[VNQZ\29Z=X5L(
MI(F(!A.103!L(#YZ >*A9;]D>QQ3N)0QXF51E(O!6+!.$V\:@X;G1DX9V@/Z
MP\@S<%(F*H[D[]Q+T'2@C3#U?OE;Q#]YCV=5>Q+;*-LD2,'+)R>8,Z1FW#9Q
M]2^5,9!&%!<@CZ)OF,7]'2EX(W%^4X><:6]6\HTEK&4M8AUK<V:HPT(^,Z;
MHX9IINB 9;[88PIF$-]^W4$_5B4K<Y",9FJOHB2A)$AE&[N&<-G")Q(7H<"M
M@#H)?#?KMJAM997=I4.6,U"7$5RM$7Z4"B=674C3J@#@S0B?ZQ,XE$>I=AT
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M'X+N6>%L?-THVL8J>U5[?;A#OHR=>ST>^=RB]D=.C+"5<H"+)J<X@500W$@
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M')L%8?&[F+<#W+L*0_05.*AEA%3[<L01]8^YU>O\(1$1\=34&O@4H)X9H)2
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M%=:?UT+2)JDG1XF2ED%(>!0?E?IE(DB N50],1*D!A 1$"[!H/+E6O.+ I$
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M:B._I))*"0H&[?AHS:@<<9<VA$1_NEJ &_7;^38 V_#;U>FIH9JX_DRYM?\
M:7Q__P VX?Z+IHNE2_DRYM?]I?'_ /S;A_HNFBX<_P F/-K_ +2U _YM@_T7
M30E2'%W-H=]N2E"W'S_DW_\ VFE-JUD6M.8V.,J\2SN4RQL5A:LRDFY6.:&8
MHR+PR@%2<(I&'M1(4W42AX!TU1V6\DBI7+$WAU5BS*\1*ILEFHD+_9%W'.6S
M8HBH E']:(#T\]!3G&XOR)1$&;7(KG+<H[) KNW3HT_(/58YDJL9:320^C<
MDUARF[1W$/U91T+3[B,7Y7$LC:WSK*KVH&C4)2OL!LZRT9%LDT2+ ];.2NO4
M/LGL8"B/339J#'/B;(,\W^U8[2RU!/HA![,+%BYQTV?-/VG155AI!LDLY[%V
MLD\,<YS[;==-8RK>G6E<D="R1<I.K.F<D2TE9*<=BWD+DP0**9$'Q'7TX29#
M H*9/,0T!@\,J'E:B1F46&3G-E>)O[=$NZDO;'Z3^7/&%CEUUBD73$VWI/\
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M;L97Q+Y:=PZT;01NV:FK&:XV.K=*:0?V.O-VT:*-@:*MR(E9J)+ 9RJH!40
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M1OT^'Z@G3\VOKO"_98?R1W0]?P_R1U?!DM=N+(<Q:H6@6@C#+']I[[_/D?\
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M:8L<7<[;3XQU$%;*D-6X])ZD)%B%,7UC"<P@;;;<!\]+$2@2N9/[DO\ ?(:
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M3K[F!TP=IVV*<J*)[B":2AW4BJ4ZR9>@C\?#334%@%TIP"&UOJP  ]-[%#=
MW\]I( _<VTH!)XZW&J(Y.Y4JJ6FM()N,LHF8**S\6W*H0L-&?4& ZC@0, "
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MT2D#;8>FB'&V5;N)]]$*/[<E] @_*5TI9U@?)J,43.5EW#<Z&Y&KU(OI)F$
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MF, ;!N.@)S??J([B/7?X_C^?1L.UZ8'/R#PM,)")6Z,'=FBO:(E >]) # 8
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M7NCU#)R!?U(J>'R^'CKCQ?=[OKA>&T[SM;#,7_K8P'8 'Z-L.P> ?J$^@#\
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MQK"':]BA%7TR%'< 'PZZ ILA./I:+;UA63,5.ORNQN@D^5(@;AO_  =OZ&J
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M4XSR=QE,>TOY(L>?\7E:_P#L38?Z%I3C/)/N,KO-KY#$=!2Z_P GM:\1$/\
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M0H[^6KX^,\GNA<KC[4\5?'D-3/6&'BETE7*+-!_(*)K+*K)L2%39I$$XF,F
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MEH+.O4#X&_=/_2T'=H&K9;96:;&*2]HFV$#%%<I-OKI-RF@A]4N<"I-0,?\
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MZ" >0=VJU(YW\:G5IGX.LQ4GCK*<0I*V"9CX%@T,ZC.T56J\HH@FHN #X;Z
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M$^T0 -]!)/%S,2.::I?[4V)("C$YAO\ 36R<GVBN1.IOVD4L9(A0W*W];<2
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MLP*8P'$TV[3(L8H@(" @U*;?0 %[F;0(WB9S'8)?*1AP=O#)/M^4"D;KMVX
M';L !V)@'3IMH!,_FNI2C[./'$!* _V5O0]0 >H6%YL/7S#;0'/8LS5J@^Y
MSQE,L7H2V7L/0C:M3#<J!F<:O7W3]Z\1D ,8/2(9L43%-Y==!*..^<6.\@W+
M/%/2K]A@%L$Q[N:E9.2%JHTLD8BM]*5Y "0XBLF[7#TTPZ[B(;==!\1_-&I/
ML"2&<R4FU(LVDJG"%I2B[)&PO7QS_*DQ[E!;"4C=0%E!,("0/';;0-_-ON X
MUP93<*W:U5JUR+?-LS&Q49$P_P!$NZKQ)$-D'DVL4XI*MBK#V#V#UWZ:#*9,
MMU8R9F^L8P?1$NYAZ11)O*-CL$=(J-THI&6COL\0S:-8Y4LA)2C=VZ(N %*<
M$A#KH-%3G@KR9R?SWYZQZ/*_.^/(3 DA@II3(2JW238-YJ!R#88BIJ2CYL#M
M(C5ZWBY'U.WL*(G#<0WT&XO[8?MDK\"8[(\O.\DLO<C7N98RN+/7.5IAS)JP
M;5FR[U6;8ZAUS]J@N!* [@(AH,9P)]HJD<#.2W(;D=3<KV^X+9Z//*'IU@*0
MT742S]H"T+-HPY1]0Z)%R 0@#L.P:"Y@! 0 0\! !#<-N@_AY:#3X]_8=O=G
M]E\?ADV2#\WW9H(A^01#0;1-*=HUS+60Z.X.H09P[6]0*8!\HH/R TF0( ;
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M4E?%\9T;E77("8M\E+MWDA<;-'3\>2S_ +2%=D.[,FI+R)5#*%.3<=Q  \-
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MWBXNVM>1%6U?JU9CYM-:5A$)J64D3R3E55^VD+""0("DF(@5,HB&@SW$>?\
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M=)O](0:T5,47K981/ZO<;XZ"0O<)(Y#$F'$Y 2*O S?BT'QBANF=V5V .#E
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M<7;;S$1T&M!S4QI'8<_G#OM68^AK+?K6Q0?(SB<A?[9+6AX@:4)((B5LX<'
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M$B"F*0D3.W3,0OI#U2$"B =O\'PT%;^1'MC9>Z+Q]2;*N6E9F^.^5&4BD!B
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M83?#03=A-2K_ ,GL,UK5Z@<B,D?J!5L=??1DFP>/9)ZXD%^U:-5732!15<1
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M.@J0Y%WJOU+G%$L'UPK%2>3F I:/?M+.Z! UJ8JNU 8PE214$I5IDDB)51[
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M>PA:ZA6YE^[QU,7V+D9A-L^=E;,91",=-HY!4AQ^G447 5=@Z#H)9+AW$Y0
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M?0-;W76[I_[<?,QFQ:JO5G."K:5!NDB=<S@YD455%"I$#OV;I)B)@_#0:VG
MWWB>"O'3BAB/#F2X'.2MVI=<3:6 U5,5.%74D'2KU)TR*G,) "J13!N7M*8-
MNN@+W^_Z>VT/7['R=-OU[A/L)M_,?[-=-_AH*R/<S]S_ (B<I\6-:EQW@LK1
M-_DI9@A/2UXCHMRU<55$X"2.+*2<JZ%@HW?[*]R(&.4!\- 7?LN\^<:AB?"_
MMLP:EJ3RO-7J\2MGL< Q3E:NK5EUCRJ[8\XR=?5Q3QPV_P U[0V'KTT%:_\
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M"I2#(QC%W.(B7;J.@MB1RT[6>.V#?DIA)=]'BF#R/:HQHG:IG$ *8P?<Q-T
M>F^_30!9[?%VC+)RYYWP1+A7K3+P]EJ*SP\$N3Z;Z=PV.H"GT13'$ 4#KN7H
M.@N5]5+XC_X)7^EH/3H%H ']S/DC>^(W!GDAR-QHE#N[SBFAO+'7D+ B=S#'
MD&RB1 3<MDQ[U">FKN(!XZ#2LQ?_ #A/^<%YKJK&\X@X<U[)]*D=@86VI8CD
M7L4Y.0 %PW*N1WV'%,^X;_*.@V$_85M/,'.M$Y(9<Y^8-<8VRA:\K$DH1E::
M4R@DQ@"LDBE2BX]=-5X@1NN&Q5-]AVWT&QL0H$(0A2@4"E*4"E_1*     >'
M0-!7_P D^++[,F<L7Y.6K=3NE>HU.O$ ^J]H?+QR9WUG;@V;/45FY3F4!'MZ
ME'<-!./%[$]JPSA.L8YN%E"S3T"$JD$@01]%DQ=23Y]#PK(X@!E6L"R=D;)F
M'J)$@T'?QYQ',8@IUCK<U(L7[J;R%;K>DY8)"02(61^1X5)<3"("H4$P[O -
MPT %W;@3:[0XGE'L?3;5;)#DC$9FC\NS4BZ0GF-:CY..?DK2L*4ITC*Q+=@*
M"1@[0/W@.@-3ESAJU<@<"7#%5-N3BC35C08(EETBF*1^R9.VCY_"OE"B!VK"
M810% YBB!B@/304K\F_9VN&;,N*9!J>.\)4UF[Q/!T7TGL_/N7:%BBI)LNYM
MZA&GHD=JD;IB!$E%! 1\>N@ORPEBUCAS%5(QM'K%7"KP#*)<.@[RIO7Z:29Y
M!XF10QSE36< 8Q $1$"B >6@"_)U>,A[GO&.S L46ZW'?,,$+(J9@$I@G8=T
M"QA =C% 3>?GH)3YJV#/E6QS'SV!K/\ 8)UA,BI+QR5+:6MU-PY4Q.$>T*Z2
M<$8.'*NQ2J&#;KH&GP1R-R$R15;#.9Z"5:/UU(EW!PDK5F=:?PK-T9^W?L'B
MS1NV3>*-7#1-7IN;M5 /#003R7Z^[;[=Q1V$!Q-R/$2[?)N,4P$1 H[[;B'Y
M= 4?,7%LQ<JU'6FM9-N] LM854+$,:W;RUF'F17,'J%F&ZQBM9!<@ /ID$0$
M?#0"WQ2Q?E"]SM^7Y)Y"F[($C7Y6M-Z:PN/U5;F*J_(2.]61@D5Q72D3,Q$R
MIP^7U!$0T D\_>$/'GB%B3%^4,/5^TP\M1LI0(0[$]RFI..90KZ5+)343'QD
MJNZ:-T7QTS_,)-D]^FV@M[PAR68929U-"8I,]0GUG@64O6#2()/X:9:K@)B(
M1TFB0$?JP3(&X?'03/;;M)5>6IS!E3IN?3MEC-!OW<41OZ-::_2"Z">EC'$.
MQB90/2[OZK02: (CV'$$P,!>@[E$Q=^H@4_CMO\ #IH.X #Q  ^._P".VV^_
MQVT'AD(YC*,G<?),FLC'OD3MW;)ZDDX:.4% $JB*Z"Q%$E45 Z&*8! ?,-!4
M%R-P#<\4,I[)4$QPU.5Q*5]:-H<)QPI3]\VATRKK%8IR01;Q^[?N##Z?J%)\
MQQWVT&!XJ88NF67K"]W&)P]&TUJ:,EGU =\;*9$3KMI--US!!FF7,.Q>).F8
MH#WB!-P,;0'-DW!''Z(-1%E,/8@CTC7J(!1RO2JHS)L85!/Z@FCR@?O'J;?H
M.@!7VXZSB2A6'F;?$*?3(9&O9NGC(6"%K<6$DSBA25%<C!>*:BY1;"7P @E
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M'BCD-],>\&CQ1G"K13'U?I@9'.;^+#OXCOUZZ"X3,C*/D;3A9F_9MWK)>ZR
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M!C"/0OQ\QT%U0    ;!MMY>&@6P? -!SM_1\= M M M M !'N8].%6;?_-3
M?_RJQ']_09[@<.^"XHP]3=[?YA\?]()>?CH#8#P#\@:"N3EMR3H[(N1N/\CC
M>P9+9K8^<*Y6!@O'($JE2M)%V$<_"/DA(\GR/' ;[H%,5+T] "^,TI#$ON$<
M5:FO8K!+8UBN%5VN$8I,.2.E(UNUBV*2K1N@GU22:1Z8%* > %VT!"KY=KO+
M7,6(D8^G7O&LQ%1F1;/C#)3%W!+EM52>03J+=LF,HP6?J00/W!-Q2<% QM_
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M37 ##TT$PY_Q,UP%Q$J]:F*<>1E);.U(F*E7&K926+47Y9M$X,VTD45$XE(
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M'KH+4:%7QJ-+K%;$XJ# P4?%]PJG7[@9()MRCZRHBHK\J?0QNHAXZ >N=_\
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M@8\C,(X=Y3\B8#*.4*I1IB3BJ1,QT389)-H^=1;*(>B[?L$QV%1FB!=U!\M
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M9+8H"HLINHL?;Q,/4P]1\=!GG;MLR357=JD011]5<QU#%(3L33[A$1$0\-M
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M8QW'S^J1W'X=>[0<_<6'_P!&LO\ \:1_[K0?)'[,Y_32=MUCCU[0=)B(?XT
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M19#+QK<'+U\V26(@U;.'(-R&!@D+E<-S'V#0%1@8!#!N& $P'$,68] 3@;O
MX_LG$[F _P#" WCOYZ"6]!X'CI!N4H+F[2JG*1,0\SB8 [?W=!KWNP3_ +W-
MS\ PF$H\@LE@OZWR@"?[9P^_:(;#MMH)TK)JZ%;KP +?8(*( /\ =$@3PCFW
M\ 6PB3\GEH,9Q%.R-S]RG] )3$_D9@-S?6@^'<#//T=O+]_0$I@G#4%E7'[]
MU*R,A&.(;,&2@3&-*F .V+R:V69.RKE."0K>D( <NP@ ]!T%CT>S1CF#)@V*
M8C9BT;-&Y#&[S$0;(D12(8XB/<8J9 #?ST%-' ^<D9#GM[C46XK,C%L&ENK
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MDL*B\88P&(0?E$0\-!4NPX;\UY*H)05<X_G-8DHN2AFDH;);5A"1TPQ6(E(
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MMS?;O7%R4NP?AMH(<XZY&K5"YZ95?WNSHL6+7"T 0LJ_5(5N8YQ>"9$>UVY
M1)U#J7?03IP+YU\=[MD6U\5H*RR+G+RERR-<48TT4]3C5Z^5X=X1TQDQ(")A
M.T 3!^ Z"X8O0I0Z]"AX]1\/,?CH*;>"5D@93GA[B\&SEX]U*Q%PJWW*,04[
ME69E&9/1.</X'=TWV\]!<H'X^.@6@6@6@6@6@6@'_D?Q^QYRIPUD# 66V+V6
MQYDF(7@++'Q[Y>,=.HM4Z:H)(OVP&,D/J)]1\=!4F?\ FZOMG1D2W;M\<VYJ
ME"Q1&[(I+O+JG]..;G.0#G$=SF*0@;^8Z!]>QSBC'&*^+>18G',.R:,7>?\
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M%UGC3-1.1\IDA?,SY3##FO-(]AB D8U!LUF$S'(YD5G@_K@*J;YM]] 4(!L
M '@  ']#\-!SH%H&Q-TRHV-5%Q8*U!32S<!!!65C&;XZ(".XE2.Z15,F41\0
M+MOH.8:IUBM=YH&O0L+ZFP*?:HQLR[P+OV@;Z5%+O OEOX>6@<V@0  > ;?D
MT'&P=>@=?'H'7;PW^.V@9=GO]&IJ!G5LMU<KK9(AUCGF9>/CR%!+J8PBNL40
M -!K\<(N6.#([W,>9M92RL:<'-MKJ<?C%F@F#^#=S4:T,:5;01T"FW3 A1]1
M01[1VW#IH-CP     Z '0 _ - M M M M M M M!CY'O^B?=H$$P-'(H]X[
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M\5,S0EPP7ERIL<KX^J;:X<\,G(2CVQ2*,3.0T@]E!7)8G#5:='[E4A=F33$
M$0$G7J.@M,XIQN$\8,<E/LT9?XP/IS(QX!":J-1L5;-1DDH.+/#FE&S67DE
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M(/M7"GB3=R*IVWCKB&P 9PF[4+(4J'4W<I[&15-V-B"8^X;[^/QT$(6/VJ^
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5!:!:!:!:!:!:!:!:!:!:!:!:#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g425213g00a13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g00a13.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[29T4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )EB^F!8X0DE-! 0      &4< 5H  QLE1QP!6@ #&R5'' (   )_]QP"
M4  (4E(Q,3<U-S(< @4 /$UI8W)O<V]F="!0;W=E<E!O:6YT("T@1W)A<&AI
M8W,@9F]R($)U<VEN97-S(%-E8W1I;VX@7S4N<'!T>  X0DE-!"4      !"'
M+D4\@(IX%U#:&E%_6<'..$))300Z      #E    $     $       MP<FEN
M=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M    0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M
M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'8Z9F
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M_P  .$))300-       $    'CA"24T$&0      !    !XX0DE- _,
M  D           $ .$))32<0       *  $          CA"24T#]0
M2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M    !@       0 U     0 M    !@       3A"24T#^       <   ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@     ____________
M_________________P/H   X0DE-! @      !     !   "0    D
M.$))300>       $     #A"24T$&@     #-0    8              ?@
M  .5          $                          0             #E0
M ?@                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M ?@     4F=H=&QO;F<   .5    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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MU@ !     -,M2% @(
M                    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0
M  'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)8
M65H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
MAG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P
M    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0
M    0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0              $G-2
M1T(@245#-C$Y-C8M,BXQ
M                          !865H@        \U$  0    $6S%A96B
M                    6%E:(        &^B   X]0   Y!865H@
M8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#
M(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N
M:65C+F-H
M         &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M          !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M            =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !
M6%E:(       3 E6 %    !7'^=M96%S          $
M       "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4
M !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($
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M 7YB?L)_(W\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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MA'9Q=>S]=S>_OM@"1V #WX , & #3R^D< & #OWTP FO7Z>C7JXZX 7 "<-
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MB+15:D1K55$6Y52M%/I'-=X+D=O*B\QL&_?Z=_9C\#(;]^_J]> #H[@'OTP
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MJ#A\FT( 0\[QI[<2OBDT1;<J_*4[F7<@[J(<W;B?CU?H(:<BO]Y5_5SAU#B
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M="TRM%&F%O/2TDF-S0WH:DZ4L#/QH0^J?O)T?80R[ZB/7\=LRNGI ?5@!_L
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M\E-0/P;%XTP,*+7Q=I9FY$62E* ;.- /U3UXZA =!LEEYII$0'0:J9KF3YP
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MWEJ$-/\ ;'A@#<< & # !W[]_P H!W[[8 , '?OW]NP!W[^OZ0P 8 , & #
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g425213g00a14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g00a14.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1OL4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &]"^<2 X0DE-! 0      &T< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M @   G_W' )0  A24C$Q-S4W,AP"!0 \36EC<F]S;V9T(%!O=V5R4&]I;G0@
M+2!'<F%P:&EC<R!F;W(@0G5S:6YE<W,@4V5C=&EO;B!?-2YP<'1X #A"24T$
M)0      $'EN*7^M@RK?P'K6#4FQUSPX0DE-!#H      .4    0     0
M    "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M    26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R
M:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M# !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0
M  !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$
M.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P
M  !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#
M8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;
M    16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M  !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M          !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q
M=)S @         IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0
M<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&
M(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R;W!7
M:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M#&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M      MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ !
M [_^-0 "  $X0DE-!"8       X             /X   #A"24T$#0
M!    !XX0DE-!!D       0    >.$))30/S       )           ! #A"
M24TG$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F  8
M      $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0
M  $ +0    8       $X0DE- _@      '   /______________________
M______\#Z     #_____________________________ ^@     ________
M_____________________P/H     /____________________________\#
MZ   .$))300(       0     0   D    )      #A"24T$'@      !
M   X0DE-!!H      S4    &              (#   #M@         !
M                      $              [8   (#
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   (#     %)G:'1L;VYG
M   #M@    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   " P    !29VAT;&]N9P   [8    #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!$       $! #A"24T$%       !     \X0DE-! P
M$4,    !    H    %<   '@  "C(   $2< &  !_]C_[0 ,061O8F5?0TT
M O_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,#/_  !$( %< H ,!(@ "$0$#$0'_W0 $  K_Q $_
M   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MQ:'L8]K&WMN?Z@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0 !!0$! 0             ' 00%!@@" PG_Q !6$0 ! P(# @4/!@@+" ,
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M=EY2GSNV"+ZNV/\ JX^7[]OU<(M?#$BQ\DI+@C8,*4<G-DS,F)#CQWRQ%D=
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M&$"E=7AD/XO?,Z7J@T\Q&<26 CXL/U%SFR\FJ^]%4TL\CA 92X,N>,:&C+F
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M@+G2Y WK-\&>#XKAV+5\M?AM;1128<8V255-- QTG5-.[(UTC&@NRM<[*-;
MG<$DNKYKJ;K^XM);;Z>ZY:M@1-7ZUW?)M.J(%A>!4_:9.VVG1-3KU:L2WYC0
M9HZ!%$K?L>JE9T.3-C-T8^('O16#Y'#\4\O1KZ=+?;]JFL6L;\X\V_\ =??X
M+V408FMNHB@:RG@=QQ^H'<!H2#WJ)U+8H2MXW&#*VQCJAWB:18MB5C3NQZ9?
M8D786L)NHOW$;B^:B5C4X(<9C##U*8>C#["^-WW>K[572XMT>S7>+<][Z%/I
MUFT#J@V&0T&:UQ\,JS&!:9V#-VW&I!K8;9X <-7[I@9?ET#%/V;3AIS;M,J2
M-KG]<P;RW? -A2#L%=?!$%'W/=%=?CX]7K5!;PZCHTUOKS>CU+Z;3IF=3ZYU
M7O*";UF>_NZ18S4!".<ZA-P#J[5%]/\ J29"L*];U+<-9N-FH\;;R;Q$F#ZO
M-7*BVZ>DJ1C1P0::5#4Y_#IR\WVW\'@5=--V[7<#H3RVWV]*G[I-NV-::U*U
M?()H9>&M9T1NY#;(=B6BQ0+4W5Q2+!#/V6 Q%@V$U&+8ELE3<.+'BE9R'YT=
MAIE]#::JAWGP^!.=PJ*IWK M$XMM\1L37=NCP6NG/7G4< VN.QLJ\Z@L$?(:
MN=/&Z2LP00#Z$W>$N@\'2Y8N9)&3!X>7@D<@HK1:1+C6& @BM7@/)DP84A&<
MJ2_$CO)5G*E94EUE#F,Y4I#:E9SC.,YRIMM6<^.4)S^]P1?5V]F,8[?%\GY.
M$7QQ1H^$^0DPH,.)(+3$$"K\:,RP\2G-P88MN;/=:0A<R6@:.'CT29"G'DP8
M,.(E>(\5AMLB^S&,>S&.WK\.WK^/A$P6\<?QYT]9QV[?N^!<?EU[LK..WW]O
M"*N;J1\J3;-$[NV!J:!J*NV*'3"4&"P9F6DE DSD3 @PMEQV(P)D-,J;604S
MA*'EX4EI*\YPI6<8(M_UG]1&PRG0?J+=]+-&M7VB^V>D3YF:<?(09$.&7K]J
ME21*"D;,*7)A*>BQG%I<0A+CC#2U-]VTYP1,)Y*G>6Y-G;VO 38NT+W>!$/5
M),I$&6BSEC<&,1;ME1BMSF8T^4^TU)1&ERF$/(3AQ+4AUO"L)<7C)%?EG&.V
M>^/#QS^W'R\(N>6S]4G4'#M%BA1MK6AF)$/EHL9A+T3S&H[!&0RRTC&8F<^:
MVVA*,=\YSC&,=\YSR?Z;9?9]]+3R.PNF+W4\3W.M)JYT;7$D!]KDDDZ:E8A\
M\P>XB0@!QL--U]P%M;;BI9^4L6IT=HYQQ2EN+C7)Q:L^.5*4Q4%+5GY<JSW]
MF/'/-5X-@!+C@&X.H@!S &K%E<5VHC\+R>4CL=?!O2@\F/V]X=O=N_\ .]/]
M?_Y.P>KY.?#A*_3X3\U6?M4_K^PA5HK6DM?>W?\ ]6[?HK*+79P]*J]CN-BD
M+A@*H"+60W+:CO2W(H@' D$R4A$6,V[)DJ9AQ7G$L1VG'WLIPVRVMQ24YCBE
MIIJRIIZ2G:'SU4\-- PN:P.FGD;%&TO<0UH<]S07.(:V]R0 2KQ[@QKGN-FL
M:7.-B;!H))L+DZ#<!<\B@G1O*E]%NQ[G5*!4MDFB%INMB#U6N07M>WN"U,-G
MI[ P9%<FS0#$.(A^9)9;5)E/,QV4JRX\XA"5*QNU;P9[8X?1U=?5X;%'345/
M-55#Q7T+RR&"-TDC@QE0Y[B&-)#6M+G;@"2 K%F*44CV1LE<7O<UC08I1=SB
M !<L %R1J2 J3O+/W6X@.L"!! VRS!(*M/TN1F&)/%1L7+[IJW)<>S'ARV6<
MNK2VC"W/,\]24(2I6<)3VF;@=HJ.?9)[YZ2GFD.+UK<\M/#*X 0TA#<SV.-M
M387M>Y N23A\8>]M6,KWM'$LT:X@=D_F(5NWD?#!8[T5U@@;*$3,]=YV"VN:
M5G2B,Q3;1SS6D*DS'7GLH;1VPVC*_-0GP3C&/#D4<+444&V-1'#%'"P4- <D
M4;8V F$EQ#6 -!OO-KW&MRLKA))HFDN+CQDFI-SV6[S*S8L7& A\@J8G1AHZ
M+AO,F;+=2S'9PZ\VPWEQU><)1Y[SK;2>^<=UK2G'CG'(YIZ:>KF93TT,D\\F
M81Q1-+WORM<]V5HU-FM<X\P!/(KNJJZ:A@DJJR>*FIHLIDGF>&1LSO;&W,]Q
M &9[VM%][G ;RDZ)V%1[!.0,"6@*4(O(=6U#A3F'Y"T-(RXZI+;:LYREM&,K
M7G'_ "4XSG/JY>U6#8M11&>KPZKIX&EK72RPN9&'/.5H+B-"XD 7T)-E84>/
MX)B$[::BQ2AJJAS7.;#!41R2.:P9G$-:22&M!)YAJJW=SNNIVE=L(==2G!ES
M&$X<5C&,>@8\.V,]L?'X=N3GLJUIV>PDEK2>I1J0/UW]"YQVTD>-J<: >X 5
MAL XC^;CON/.K$]3YSG6E&RK/?.:P'SG.<]\YSF$SXYS\?Q]_'X^0EM$ ,>Q
M< 6 Q"JL-UOE7;AS<W)S:+H;94D[-X$2;DX51$D[R>(9J4F-W;]UWT^ !%EV
M1+*0Q9LQ[QP7!0M\J\J?[AE$/-=98SA337N:&_GTN?WOGX2CUJQRYV;V7Q;:
MJJGH\'CADGIJ?JF433L@:(N,9%<.?H3GD8+#6QNK?:C:[!MCZ2GK<:DJ(X*J
MIZEB-/ ZH<9N*?-9S6D%K<D;CFYP!O*3&C^JO474,3.B-;3SDR978$4B3P5!
MRA+;<:9(<C,9:<D*SAY:G6UXRA&.Z4X\[.>V<<O-I=B,?V3AI9\8BIXHZR1\
M4!AJ63ESXV![KAFK0 X:G0G0*RV6V^V=VQGJZ?!):J22BBCFG%12OIP&2O+&
MEI<3F.8&X&X:KE[+>%[*_P!KIN?;_IASV^OU\[3IM<,@^A1^J 67"=3W5GO_
M ,0EZ-!4.^Q=A[&,>@9\/^:;_P!Q/. ']F[QG>TK]'F=@WQ6^P+U^3Z>>5Z1
MPBHXZP>M#J$U+U#WR@T:WCQ58!HK61T!ZL5LDZSDC50A27E4P@,D2W<.39LA
MQ.'7E8;2O#:,)0A*<=)\'_!SLGCNRF&8KB=!+/6U1K..E;75D+7<375,$=HX
M9F1MM'$QNC021<W)7+?"/PF[8[.[8XKA.%8E%!0THH3#"^@H9RWC\/I9Y+R3
M0/D=>61[AF)L#8$  )VO)_=4^ZM[[-N%;V99X9P0(HSAN!'C  0E;))-@"P,
M.Y?%#X;KJ?<LU]&6G%J;\Y6%^;YR4YY@>%38?9O9C!\.K,&HI*:HJ,3%-*]]
M755 =%U+4RY<L\LC0<\;3F !L"+V)"V'@AV]VGVLQS$J+&ZZ.JIZ;"G543&T
M=)3%LPJZ:(.S4\4;CUDKP6N<6Z@VN!:0/5+U=2^F#<.DX]KB@X_3_8:'N:U;
MMN4B"5EV*A(JAS3M3UV=&9@S\1W@A.Z[.@U*P0%A"4YR19 1:+-%P0I9!"";
MZVZ"?1;[UT);0^$>PW]BCE1>L/J=V)03A$LSK+45YUQ3]N[$O=>QK<ULDP<A
M4OJ3W;IV#4J?69NZ-;-/.:TKNIX$S<M@^%4I9(Q; F:V-JK16!%<7W]&OMZ.
MCXY:D#2VX\_)H#KZ4X_5QU>;<U2:Z?6]+"ZP;%;;UU;+D]FTT686BS3.+[TY
M477 @Q8U[?UO!U)5+&5W<Y L5Z)P=B*KDIP*\FM3T,2HT][-;GX^-%0 :[^3
M=T^WP:72/VAU==0.AJ!U6VN]673MS*ZNV4WI;4<('IK8--"JMQ#1&O-Y-W/9
M9?.Y-@J^"M?#6RQ,30<%BLR;'(K@L.*LX\]:AT%L+ZZCFW<MK\^OJY56P-K
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MFI+-FX\U.<$P7_3$ORDEFN7+DZU5ZF@S9LAS%F2^>3L0T,M;/;L; &U]+WN
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MS$Q+CPR$O,:?B5$3AE24,)0^^EWAB;'<4D=59ZEI%7&()[4U(.,A8)&M:,L
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M'4#Y0&RNHJ&EI'2-:;M;(ZGBC+P"20'$@$DC4J/6H-"=%6Q;U:J)9.F"FA;
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M'A!;?#)/L"B\<^&G [+:*:?"FHL6:/01#6BEFJ]9A$AX83*")V1A>)@B%*E
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M250[M=1UMA^8%1.NL"Y; 'R7[@>C6=4!D8S,%UX%.N[6O*0Q>X0IJM;;EQJ
M8D[(I$TQ7"^67R:S#)$H]R],>M]NZSKVN$#H]'1KT@)L&HC-1AMB'=76BN#Y
M@NO%:Q!%N#6(L.&,GS@LH3#=@-R01"= B21LE<4A#(MOHC157TA6,C127YYX
MJ\1)6*P%"1.Q%Y$X]8S]V,B8UGLL@G<B%6CW6WW \!@6D^?(CG[(56Z2D/S)
M#KA$^G"(QXXQGX^$7Y\_'CZ_#]?;X^$7ZX1'"(X18QG&?5\7Z\?9PBSZL?-C
7\W"(X18SGMC.<_?U8X19X1'"(X1?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g425213g00a20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g00a20.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1D04&AO=&]S:&]P(#,N,  X0DE-! 0
M    &/2^8X@X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE-! T
M  0   !:.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!$0      !
M   "   "0    D      .$))300>       $     #A"24T$&@     #00
M  8              T,   =0    !@!G #  , !A #( ,     $
M                 0             '4    T,
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   T,     4F=H=&QO;F<   =0
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   -#     %)G:'1L;VYG   '4     -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $    !CA"24T$#      .8@
M  $   "?    1P   >   (4@   .1@ 8  '_V/_M  Q!9&]B95]#30 "_^X
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M-C?T:@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M&24F,S4V57BA)T)%<W6%M+?!\"@R0U)WN-'_Q  = 0$  @,! 0$!
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MD8J\XE:+#S$Y8O%EANH1L4M%>J(.2_5HQ^82N25?]#U+DY*K_P!99%8?"PW
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M2G&$I3CRPG&,8QCRQSFWN222222226))]R68DDGYDDD_,SI(          4
M#P     !X    \  3]N),<1'$1Q$<1'$1Q$<1(V;-^L3UD_@V[/ZJ .(DD^(
MCB(XB.(CB(XB.(CB(XB.(CB(XB1;[;Z.F[OU=,A"-@[ZH9ZG,F[=76.O^WCF
MFK'<3T.NE&!52-6,%^O2@A.:^RCV.3_DS,_$2>K]7%1Q$\W>KMC:;?UUTW*:
MI\4ONEOCO&:W%UA:OW4<YV5O!$]8#);9=,8[#:XV=HAZ'BUZRIVKZF]L D7G
MW*5&@A8%,CM7&P6V#/E-GI^7U_/^D?7$]='(B.(F.MN2@T#6=XG6*W%Z$"A5
MHO++7,#*]A,UH?'A/.RBXR=["2]CEPV4K=:DX@RELJQZQMK+F$9PB08I^X=A
MW'PNM=;3@M1-EWXUU4K.=FRK=-N  H_;<:L;$;.FR852UM?+#*M@^\,E6" 5
MJIQ(?M;9)Z21&1(>7%HD]=9_>XH'Y%5;^@X/X_SYXD < #\!Q+WXDQQ$<1'$
M1Q$<1'$1Q$<1'$1Q$<1'$2-/87?#^L8X*CT, B_;UV4N4-U9KY,M<2-+?BI;
MR5N5R(,(=<KFM:6T^R1MMA<1EQ2%1009F?82XN _OM'I5V39&7G9#:[1:U4M
MVNT[ QK6QN*L/!1QV96US>&3"Q03Y6S(O]/&ILL%8ZCZ@;4C&P-=BC9]0[0O
M7I]4MG8+60<W9V=8I[L34X *V9V6W'AJ\;'%N5?54>WU[T.QJ$6</V,\[?MQ
M;'EQS^W-GD8B(A"V'VF,,1!XV$EQYNO4:K1O2$4BH0G/80(A/I.9EF)Q8F0_
M&\W1VUM%./CKK]/KD;'U.KK<NF)02"]MS]Q&3L,MU]?.S6'J7W,>!76J5K].
MG>GUTM61D960VRWFTL7)W6WM3LLS,@*173160#B:W#0FC7X*!4QZ>6</DVWW
M62+YI)8XXB.(CB(XB.(CB(XB<*^C/XL_FXB15Z/?5+T-^0 O])[B)&'NS?-Q
MG^P&F>KU-W)IOKC0=C:LVCLFP;-VWJ^M[=?NMCH5@H8<;J>F5BZ6JM4V-.2)
MM92['YA9HT5DAPV4 ![3,$Z0A(DK.JU;V'5:*5$;#[(5'LM+8.^B$LM,UE2M
M6":L%0+'MM53 &C'3PJ0MB2B023,>D1Y.&2#<7$9+$=EQ:))WB(XB.(D'@PY
MN-XB%Q()'(C.$NJP3#A!-:'C%DL0]C,-)PNQQWUD+/B%A?JD((L,)"87F)#R
MZT^M6$2</$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1(7=]^WU9Z5=<;MN RJ%)L*1Q
M )K8%/P[['9-ARPQ:;7QA!QIQCV<0VH:^0,R/:H[ONV')CP%/%) ^))M/1?2
MV3UEU%A:2@]F.Y6_9Y"D>IBZU+Z:LFVM62Q&NXN6NE'4J;70NOHK:R8N;EC"
MQK,C@NZAO2K'O9:%9E3GP!SV^_X _/CG31U:(]AO&FT6_4.T[%9J.H]?;/S9
M5[+U^"0*MUPM4:KNHJ58KX8VR;K(>-4V[&7(6JPJ:GR2,.;6@D*'"FNERK74
MNL,/IO[*=R7Z2S,Y^H+]<^*F*^07HTM>0?2OS;LBGTK;\C(H15PL-CZ>+:'S
M+>[LQJUYM7?F_:!;9KF!KZ2P[_3W&?2+L:SJ#)0_YVAPG#^I3AXSFRO<["HU
MO:ZC78EH<9=B>@C06D:7UQU!1]*Z]1.34J&,?'C'2;L=XE,=G$IQDH2GKB1H
M4+$PH7)3R,EN#"A06GI2VH4.+%0S';X9EY>7GY-^;G9%V7F95C79.3>[6W7V
ML>6>RQR6=C[<D^P ' \3I]-5=%5=%*)5536E55==:55I6BA41*ZE2M%50 JH
MBJ .  )F#F//I'$1Q$<1'$1Q$<1'$1Q$C9LWZQ/63^#;L_JH XB23XB.(CB(
MXB.(CB(XB.(CB(XB.(CB);-U,$Z]3K6?""5'S(2N&RXD$A]N*LT3'#9,R )3
M)=_6HZB4IEJ'A]SR0SE[UB\X2G.>(FF?J9_OC=RB-(=DSOB2]>DDMKC->W6[
M:LUMUBTX-:?C%W1Q0]I@==+#<RFU6E#EN3:*[//.NVP<78E29 R"69R,C3QX
M]C^ORX'O\OZR.1SQR/T^?Y?.;ON1)CB(XB1W[;C4%^LF]!SHW!=$C6EH](<J
MLBKAB1ZH<Z_CSKAMZ.+(^IRUA_\ RIY&(GJO;F?2D16DJ1,HZS^]QK_\BJM^
M'S_]!P?P_A_'Q$O?B(XB.(CB(XB.(CB(XB.(CB(XB.(F .P&]AFE@ MF&#G7
MK95[GJK.I]7@I##%@V!;W&')"(#$A_/LP0 )BM.F+?;B?JP]6 1I1&:XX_F'
M"F;G2::W<7V\W)@Z[!J^+VNVO5CB:W#4\>I9VJQMON?BG"PTYMS,AEJ4!/4L
M2O=1=04Z+%J[<>S8[3/M^#TVGQF1<O:9S+W"FLN0M&/4G-^=G6]N/@XJ67VO
MR$1[=Z]:))T%\]M+:)R)>.P>R6HRMA7&*S(;"AAL1;CHC66MXDW*I8+6514\
MZD3"=]$B?)NSK79')!LFYB-]]YN:L]<;6ZNA\'I_6,_^'8=C*V3?:X*7;3:6
MU%4R=IF (;G*=F-6J8F,J45()\.G=!=KFRMMM\BO8=2[54.SSJT9,;'I0EZ-
M1J:[0;,;4X+,XI0GU<NUK,S+:RZP%)0\K\M$<1'$1Q$<1'$1Q$<1'$3A7T9_
M%G\W$2*O1[ZI>AOR %_I/<1-??<71O9#L=LV9\=^%+X>W:JD4,@=#:BO?8#L
M(ZJW9J)&7%D+DN5@IU=NC%/DF%P8<DF&'V(I'1(C,><Z3EI#F)''XD?H/^1'
M\/Q'U^LEOX?.DR^C=8W.NF>F763I,^6O;IIG7W5JWL7&G6IE5?"0?C$_.CZL
MU.B)97%PUA%P\A2*L"Q(Y_WHK#N(D:#^_P"OT8D^.(CB(XB0N'9<_P"$"L'I
M +*/;QU6@>@=)FH4VMV#.=F1LK16 S-H*30C@CY1CBYM9JR2<MZ._%<.MLKF
M1T2:/$1Q$<1'$1Q$<1'$1Q$<1'$1Q$B%WTVMMS2/4K=6TM%5Y-FVE4*S%G5H
M>H3(L&(C<@^''G;#@#%5A\RJJUR67LJ!R4N(DJ$X0^R]&R\RY8^D-3K-YU/I
MM3N,PX.NS<HU9&0+4I8]M3VU8ZW6 I2V9=77AK:1_EF_N'D"8V9;93BWVU+W
M65IW*."W'D!F*CW"*2Y'/D#P">)X[=L=M^\?BK4#477&!0)&P=E:V(VG8A&1
M3Z^+'O77*<C*C5KM;PJTB!%3CU%FX$0TS#4\77RLL]',DX0^#!PV[ZVU/2/1
M?V29FQZDR-H,;$SZL778QV#V7MBJRV9>5B4W4\ME69=F'1D5L:#96N.:4#&W
MN'*<[:;7K2YM%KD>O78=EO\ C6PHL%=F0>/276XCHX./:RV YV0C$T8]P%3#
M(\T>T;J9I%GKAUQU%I1J8Z1?H-.'#"L]U[,CVVPRL+*662RZK&'%0WC\\DN
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MFP6$$$CLV,_ $-(;ALFS[OK2Q567&\3);TV6\Z1)*<)D%R2#KDE?,]QU+O\
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M4DM8I[3R$57[AY+.H0%2>1IY[6[][O=G>W54U9=[=?AUML>[ L33]7.#)]%
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MD^K!'6\-H:F-343%06!.C^(A<IKRI68,[JN$Q 0[&.M1$9B[&8;E^R2)UL+
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M%H;2M]Y"5.+0A.<K4G&?K11D9=]6+B47965>2M./CU67W6L 3PE=2L['@$\
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M5B1EF/&:$"X+$&)AF0RU'A#H\6+&PAMA"-JB48N.RUIZ=*L2*ZZ^Y>ZVPEB
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M_8_VCXNKW[/5_J1#_9>(Y'Y_L?[3CXOKW[/7_J)'_9.),?%]>_9Z_P#42/\
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M:0MY?ZMQ6,K5\\YY2[KK,BZ[(N8O=D76Y%SG@%[K[&MM<@>!W6.S<#[HYX4
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M8+UH@7=(CB$R4%E*.82+;KTV+[*ZV0]*/<^B>N=IT+LK,[ 2F_&R?038X=X
M7*QZ79PJ7=C-C7*6?T[E6P+W$-6P/$P=A@4[''./=W+R25L0D.A9>P\ >&#*
M>"IX'S]Q/* 9L.AC%O'ZH"[5*!QH(%#=>O=OK14,"CMBWGZV!N9&L@'K>51'
MF 8@R8ZU@>3M/M+[*6APV&ZP[']6].];G/R?A[]795U#F4/LZ>GE[K\U-1DA
M<A6RLRS'Q<'!OR++3;5B9&50*:+,<7,V3::1R+-QVZDNNHP[2G2FOL.'E;8>
M*-UL</NK;"PZ49GNUF*:Q5GYZ>M5F7)9ATKZ0R.[&NL=B:I$HO@3:U9V):J
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M)K>LWCQT8U?"%DJ]CLS-GULAN6JST&&Y4KWKNPUI=Q5[ (+64/86B\2L.GX
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MW9;K5A<N#(<(*3*1+G4,S+9PG"?3%OBYV/-$Y*4(_7C^')_H/K^/%VF-G=A
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MZE/3J;.U^*TWJK9E&;$58L(MPB5:K/LBIV,7:K#+MYL7:FW9E';*B) JLT_
MN(0]V2V"[["BDA$DMQ$<1'EC[/WO\WV<1.@43/6-GI%284,HN')0,F$H3Y(?
M%(+96F'(G#XTX9)G0V9.6G),..3'/R64K9:G1%K3(;1-.UC[V;_KVEJS>5,:
MLF6^LZK[A;CV)F/2+'&%;)A]4>P=8U%&US0 KNPY<^EFMBA;([+8+D;!?%U\
M^D2VV).1),F.XD#]/KD_^_XS<LG]4E.<^6?-.,^?X,^>//SXDSZXB/+'V?O?
MYOLXB1I[3[%V'JJB4NXZ]GTZ,M6^.N](M\"WU@M8O?-'VSO"@:CL4.N2!5NJ
MN*U9H<>](-#+"1CVH:PH6Y DUB7D@B</1(3WWNAO*MW,W %/:FP'N&S;WIVA
MC)M3L4H]JXC2^T'7/K0UL784QF\PF+E7)J=TF=ESPD.#1<PP[5($1SCC9 H<
M?2/Q_L?H_P!9/;K=L2S[-U?D]<W0$NS!-C;IUH5*U>!,% #[VG]QWO5+=E&B
MIQ,U)$MV1BFM''Q"C)9L5+GR!S!.>Q%;E.I,SQQ$<1'$1Q$<1'$1Q$<1'$1Q
M$<1'$1Q$I1L$#LPJ:"L@858 9)G,<B&-CXA440CJSC*F)HZ>S(ARV59QC.6G
MV7$9SC&<I\\8XB4DC0Z.8B/0"U,JA2#(]SYD0B-=$38C^:\YZT!EZ-)ANLN^
MXW?UP/Z:%>['/U<+U"OGQ$P+V7DPJ=569]6I>KI=\W!=]9:0>L&PJ4S9JY[I
MNUJB!7G+N*'DJT8N8,.*E%7!-07: \8N;?'BE%!4>?(FLHD9AO8V[L=<^K;>
MGJ1I77-SW<?OU1F0258*2M+5,AKC6^Y-@W.>"J]7L-.)3@5V/ZKG1:L[[_BN
M1 =HS;"23\@2\'+I'X?+Y_\ $I6G^ZNY=W6 ;BHUS6M1JNR1=QKNKA%AKUO+
M66FWBH:9U/M=-AV/.&VH...TDDN_' 35> AJH1C-B:O/:N,U=N<A DGZ_K)O
M=7MI&=Y=:NO>Z;) %BK'MS2.JMF'Q81$ML,--7NC K23@"6Y\J=.;&1)I5YB
M B;-F2DQ4-8D2I#V%NK1,Z^6/L^GZ?W^(G5FR$PH<N9EIQU,2*_(4VRWEUYQ
M##:G5-M-)_5..+PC.$-I^:UYPG'SSCB)K&UMW:V#/Z[;YW%M*I4([,U[U"HG
M<JNUZA13@83.I&T=5[$V$*U,9FV0O9G#-LK;^M2XDQ=8<8&*L8XV$+LT2M*]
MH&N(EPU[LQON):@%(LR-+%)=1[>"NLVU357K%Q##[0+N77ZE[TJMCUT'G; L
M+E+FA&[Q&KEABV4Q>&2R@CI,:T(;-LQ0Z)LAQY9^>/+/GCY9Q^''X_LXB<^6
M/L^GZ?W^(G'EC/TXQ]'E]&/H^S\7[W$2 KO:&[/]HW]4R 5)7J3.]$]8)$25
M *YO[UV?ZBN]N'=B9,K/*KCE$R"PC72J8Y3\EG"^7[3FY^Q-?#2T3.6O]CWX
MMV#WOJBU(IKE9HU0TS>J!-K@TU!-X#;-(;<"3Q5OD$C1(>5)P)^K<SHDX*.
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M((,KC3Q98409D02(^;'<<8EPY;#T>0RM;3K:T*RG*)B<QUAZXV&H/Z_/:'U
M:HDFL5^DR:85UQ4)]5D4VIF9=BJ]4?K\H.Z)=KE=/SYQL(%7$4.%EIDHC"CL
MS)#KRT2X=:6+4#;EDT[JB=3H?W W*Q0+'KRG,P1\75^9=/!V>I51X".9CPP#
M"Z29 % PV.PU';"S8*H[:&LI3A$RGQ$Q;==R4#7U\U!K6T%GH%NWK8;/5M:C
MFQI.8V;-4^DG=B'XK\Z'#D01*8=2K1@BB06D0H\IR,F#&==FOL,.(G[7K<.N
M-:V?5--NUFC@K)NZYSM>ZO&/0BDERUW ;3K+?YH6,_ @RXL%YBHT^QF<R"SX
M^$MH8Y';E+F/1HSZ)^4/1^FAVTRN\A^J==0MSG [=>-;8B4RO1]CEP++,*,R
M%)W5D<BQSA34<:/9:'R2+L1MJ#$0EG"8[.$(GQNG<^O^OVN3.UMHEWP5( $*
ML+*%8XPF8=CS;G;05'KK21P>'/(O8FV6R!X"W&8KC<5$E4R4IF)'?>;1,J8^
MCZ/+][[/WN/>)C"I[AH=VV+M?55=*O3+KI233(FQ!C@TE%:#/W^M-V^K(8(2
MHC(\K@@!=1,<4+DS$PEY]EF98E8RSA$Q:<[8]:U;LQU6/7B'(V@>>15Y%5EU
M:US*O)/&*5.OK.NREXS77M;Q[V8UU#GW*-K<E9V;@2IK:S[ !\.\U*<1+9U!
MJ#I#88!ZFZ>T9HYFNZ#WD2;>$U[3-<!52F;[""JX1.G:GC-5'@I%S"-2P@TU
M;JDN:^+L V569Y9BQ5DH,&(^OKZ_I)C_ $?1Q$<1'$3&.UM*:=WL A53=FJ]
M=[=JXXO&L$"N;+IM>NX.$=A,R8T,U%%60>2@QRL2/,EL1I[3")3#4J0AMU*7
M5X4B4Z1U^T5,(7<M+TYK"44V97HU2V,2DT.KOSK[5HD)@9&KERENBEOV8$P.
MBQ8#0HRY,@MPXL:,AC#,=E"$3(%6JM9H]=#U&F5\+5*K7H$<6!K=<%P@H(*,
MB(PW%'BA(UB-!'PH[>,(9BQ6&F6DX\D(QCB)7^(CB(XB.(CB(XB.(CB(XB.(
MCB(XB.(CB(XB6E>*)3]E5J=3KY7AEHK))X=)EART=,B*N6')1#(><WY^3D8@
M',0(!<20BN,S1A6##(P9$>9%8>0B8Q-]6^N]CJT.CFM-Z^G4\<-JP<;6EUD8
MV&&"J2'+UVK#AD%F.VR.AAJ[8#U>BQH26&<@#9<(ZAP43G1'T3O3NM^B2)^W
MVJ3JNF8L=^J\NEW W&"Q81(]5YXT&&(")DR$B._A@@&J]6$3W6%M29@NK5F!
M)?<BUX,U"1+OUAJW7NEZ.!UIJNIAZ+0:O'<AURI@(^8@4)#<?=DYA#8F5K3%
MAH=><RS&:SAB.C.&6$-LH0VE$O[B(SCSQG'V\1,$5[K/UZI<)V+7=0Z^!#$G
M2=K=A0JT+9'X,$J<5H$^8J'B/F-AC-#,EZ@S ]5[NA5F?)"PXC ]?L^$2-,J
MM^'&]UIUUO=\7IO'6.NE FU]<[%:;<CTV":NY</7 %Y'$8_JI$@D;*3 00>5
MEX?DY0N! 2MN&VAI")L,3CR2G&/P8QCZ?/Z,?;^'\?$2@0[;5B-D.4Z!8@DV
MVUD>$*V.LQ"D*0> C+*HHBND3 EIY<X;".J!F4B)4MAEDBH41Q$6[F'(PVB7
M!Q$PU9^O.D;G:#UUM.L*<<M=GJ!2A6 Z0"PWR!>HFA,H"5"3GEMYR^Q/ SIH
M.0^K'MBPLN0)]IP.=7&RB49W6O7?3-XLG8&<'H^O;M=6:GK^R[*+D& CYY!4
MX'KE(J<PD2FLPGG)]DEAPM9%IPEZ09)M01K2YA1QN2CQ]?7Z3/V,^>//'T9^
M>.(G&<^6,Y^GRQG/$3'>J-L4#=]%%[*U?86+5234ZQC19V-%(0F9<RI64Q3K
M"RF,5AP)S>1ME &!3BG8J$/.PEO1EO17&7W$2T/7:%[?ZAL KUM5W-INUE+7
M1K)#2M9"MFB5!N)*I7"MD48RQF1D%<:P4!F(2_-G,T9*B/)>9]-*T>\RM5JP
M!I5<!U&KCF0]<K8R&&""XZG5,#QD!E$>'$94\XZ\IMAE"&T9<<6O.$X])6<_
M/B):M1VYKV]W3:6O*K8F"UQTL;KE=V:%;B$6':L9MM2$WJO09,B7#8A35DJF
M=$F&W!<F<PTU,0Q)=9F-O1VT3[VOMC7^D*,3V3M"Q,56DAR%:%$CLF(0FLQ9
M]PM :EUN.J,*B3IRU%+/80PEI345;;+LY#TE;,5MY]M$[6R]G4#3E&/[+VA:
MQ%)HU7BL2SMD.R/9H$!$N9&'0F<^BEQ^3-(DID,6+'0V9! H4F0QHZ+*G2H\
M=Q$C48L?2O<;.B>T90C0KPMRZB*3H39"%$9I%F_V2S2*HQ5ZS$BIP0C63%DB
M$A-B%RAC<\!D2=39VAD((85"1)":RTUJO3 XL)U50:O01IPHDP6A5@3%%1YL
M]H?"$Q5N-QFT)2P/$C1XD5";PB$)%088P9'B0(K$=M$R9Q$<1'$2->>GO6;.
M=CJSIRGY<V[9Q]VV0\J(^X_;+B(>P^*M)!YR0MUL^-4EMJ"5A+BS8T1F/!9>
M1#CL,-HE[A-!Z8K5T'[#KVLZ:#N@FLPJ<*/B0(\?,&5D:-BA1XF F(PU'AL0
M@D&""BKCLMOL H40(VZD5&9B(1,N\1'$1Q$<1'$1Q$<1'$1Q$<1-5?:DP)IG
MB:^&9;K62A5ZLF*)W;U@..EI+,$4_?;/4=0VBNU94^0MN.T7.A*+:Y8B(ZM+
MA'(66Q%P[(0EI2)KH[(7&Q$KEXQ%XTEM"Q4MTIV-\([2 S<&KCB8Y*NVU%XT
MQ6-CB0AN(I^!,*@ 6RH$"RA929HQ]HN_7;#"E19)$<N?[_V_M_O(/CD\^./;
M^O/REH>('KAC4M'\6OJY6KUN\]IMWPM*;VF@UZ_[ZW-LHL!VY"OV\ZW83(FX
MWB[G[I'KER'4&K2KS2G["_2+ H7.:(@%C#)J%,  \?KQX]^/'\_Z2"2!P!YX
M\?N![?QDR-B:"J)WMAT;ZU4;>G9!GKG;-$]R]F[$ @.VW8$\4VM* 'NL3%;$
M6';L[:);:" @>;:5EA38"\C)$*)[?784F/5[/:!)F)^I#"LC.WNY#?8_9&O;
M+'K6\-%=S[[K*B7#8WB(;>H52T[KC2VUXE;H6IKMU0:UT=U=;ZEM#3@@45L)
MZYD[%;=J.[%=OT:VCB#P5@'/]OZ?E^?]C\XGX=XM]W$19NP/:S1[A/7\WKEW
M(UOHI^^WWO[V 'V&T7>MW?5(&XZ\I'1T77K%H GJJVA3I(5( 60G7CUA"KL6
MTV<"G&1AA\/) _'_ &^7X_Q^O,$\ G\!S,I/UA&EMW>//V(T_/V68[,:4DR=
MFZ1HSN\=Q%:X?MAOP_:'<(D@OI*1?WJ)L>%#M<XLW3A=BJ!J-68 D;4:-@$)
MK( <(B3/C1@[MCJZM4WL?I4Z+LH2P]2-Y6^T,VWQ#]I=P"?:J_,:7F7_ %#>
MJ=J_8&M*[6ZA=FMBA8K9A.L)=9KL>EV@_7W:PN(+"-#$?7U^DH^E*AJT/V#\
M#+8M3[*;2W+?]]@=P[3V0SL#>MOVU%V%8BO2^^DS^VH-8M!\V&UK*%6*PSZF
MH-KD92ZQB&58 3P,B15!>1B0/]_WX^OQ^<V3]^_K4^$1_P!^*_?_ -*.TO$F
M:V-;#KS6=)]8NXC^^>Q=DW+:/%E):*)9L>\]DE=?.Z(O?B$;0Z]$=0/ZIEV)
MW6I"K#Z6ZR0"DR-5EW,38!XE\?:8PH*'$#WU]?7])'L/Q('[S#7:]FO[)ZC=
MI.Q>T^PVTX78^)XE#>C,:Q?W1<H= !4O7W>2IT?7&@HW7]VP9UL^.GZ;!U_<
MZ+ BF*O,\S.<V$U:\BO6,YG_ '\?T\_A[?7,'V/X\&97VNCMIV1W?XC4FGV;
M-4VYUZW%F@]=[<;[];/ZUU?KA6PNJ->6_7-U,];:SK>PZXVO3MB&SA*TW:S;
M/DV*/? 4\K0HF:_!K+&6H'CC\/Z?7XQ\_KY_^OTFT_J(LHYW>\25PWB$DRY.
MZ:K+)&N..CDDU=:Q:IZ8#KJ4.N0DRLNXBK<2EQ3'JU+QA6<XXDR.?<_K?:M9
M;2B[1U3MIB1<>P':VC[/TYH(Q0XL_)?N9$Z\R-! M@F-C-6%J=%T%JO3]6?W
MKM"@,U!T\3=U>42'OT2(>132")6/#QWY: %KUOUE9JE+9TS8!G<J%K VP=L!
M;?&;+U![&B].;6OW8IT@CW$:MW8.\VPYM@D5 L!\U^R%900DFS22V#,5$W2<
M1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1
MQ$ZA!I;T"<RTGTG'8<EIM/GC'I+<96E"?-6<)QYJSC'GG.,8\_GG&.(GEM;(
MP)O^YD- 5.)-CR;+/HG4_4,$(VZC)2;L\=VDUC49U$C0_/USUGB6,62$R12$
MJDL28,O+B4LQW74O]Y!\@C\00/VF6>T$W>YF)XW.]A/:OL71)G169$N76>C4
M+8DFMZ_JEDI'1+1F^"2;36(\1R)L.J6ZT$7XIBB7%1:H-QREE(0 \0\>?+M!
MY('XQS[_ )?VYF>=):O8NGB7]M]QR=J;M!'(?6;I!M)NE -L6 =0"4NUUWL9
M#>!GJ<VOV,Y3@KX=N8!"S4JAC#1,X095[45D^:3('U>U]HZWT(\,/9B>P7:_
M<.U_$4-:$I>ZCZ=\AZ<3@54EI#8FWQ-*T\4N3HG7FG+Q>"=2KM#,;.80Q?K;
M%E'5-V&1?3E?G1)]B?XCZ_\ ?[R/?]///\C\OU_;\#)3.V3LWI73.Q-3[V%=
MK88S='9_2VK^E]4:[<4$AV4D3[]59QZU:TN_:,*6/DZUK8<5H5KL<.Y'"\[:
M.:L9DU$,2,$8P.*['UYD_7UY^OPD-=AD]N[+ZT=ONO6Z=@[:!M]7_$D\.,15
M&$]F".X[Y206V]J=:I9>B6G?C=9J1O8,2F%[<6NM3E6V#-LU)L[@!B>=)RZ0
M,>;?7U_Q\OSB3"WZSV"E=Q8?2B@&.Y>R-9:<ZE4O;8-S6?;NIZ7W)=[MLW:V
MU0)B_P"P=L7DY7[?LL3KB-4ZZ!KU4A2YE3&2S6%WT,9CS*U&:?+Z^OG\Q\OU
MB5O6F>V&_P#>'7OJMV[WEM?25HUQT+>WE>'^O^T0>OK!MK=J=VG=2.VNSW37
MV9(H_ H-1KE:MAZB DXUV]<]EJ^)@<\-!%@FD26_@LR%2_#6Z]RUV!BVKE%]
M^R5VN*Q%BQ;.M_LIN%U5BC1H.,0HT<XI>2;$>'C$5EJ4EN/^M)1Q$U?=:L[$
MM.K?#TTG4=R[/T[3]T^(3XM87:TK5%C<JEEM=1J6T.XEWBUMH^PT]*"^TFP<
M#*3@M+)\,VI^=6B(4^V--CD2_!.U]W3OAGI22[%[G#T"3XOVU^FI3?;UXDIW
MX[HNH=62?9^F:R7N1V/\1,6JUW1P=K"+?TR4; E5",V.C'56&6HQQ$P!8=@;
M;ZS%_$KH6E]L;.V(7N/B5=$NM)+;SMVJ&-S52@;%T-J*$6"M;8OT=FH0-@#F
M51-&U_9M\3/GAB9D0>LT\I=H4HD\_#Z_'Z\?W$3+>_*KVPH74WN+6-NUW<H#
M04RR]$;#J 7V*[#4GLAMNNWM[MWKP;LX3'OE=L%FLTO712!!I!NO1;P8GSQ-
MC>M\,1)0$>A#ATC^C?R,E>>?/X'Y_D?R$WQ]K-&&>P>IFZ95[8-I-TK6R-/;
MAH5B.@95JK,2^:.VK3]NU"-;:Q!-UN<?J94[3(0JQCH%@"D5"ILJ0+)PB3$2
M0W^5]A^@_E(FCN@3]NT7>M$9K G7O8*S,]I>UU;U60LI SH_0YCMS=1&W-[]
MM]PA<0AFX;3#J6EZM"G=2-01,-V$_*N9;>YJRF%1DJF\F/K\9OFZT;O$=ENO
M.D>PH$*1K@?=>K:/L\?7BSK,@D"CW2NP#R0\V3'2B/+?&YFYAKF1T(CS/4^U
M,(0TZA.$3-_$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1,9;;TMJ'?E,G:YW
M?K"A;=H1)Z/)G4[8]4"7*MR)<->7(4U8<_"G0<3H3F<N0IR&4RX;F<N1GFEY
M]+B)0*QUKZ\TG6 _2=/T=J>KZ>$E11T;JX#K^KBJ#".@[% MP8W'JD(8R$;,
M#+6*&6:"4Q"]OC6 ?",-2$D(S,A")>1#5^MRUA.6TK0:<2M-GI;&N++8I]<$
M3#=AU[&F%B$>C&RDB(Y-*U!F<>.3$5R<\^'Q),%'O8_63Y2G42R=:=9>N6F,
M@,ZAT-I_5WPJU;F*QC7VN*C3TUUB_P L'/O+(-( 1 2):N,VLUR79VX.&$'9
M($.^3Q)<&PU,HEN7GIKU)V=M$1N[8W6?1%ZW"!6,=#[.MNJZ58+T/>!NI?!R
M&+,4#2BV) -Y*70DA4I3P=S'IC7(RLYSE$_*S],.HEVV,:V_<NL6A;7M2R0(
M8NP;$L>J*0:N1N .Q$3!CE;"1"R"D],1H? 887)DN.-QH,*,E>(\5AIM$OLG
MU_T4:VN!WP7TUJXGN^K"Y02M;AGT2L2]G@ TV%/&2Q(>^/C%V@<-DCBI2 ]"
MB%&HSD,C/C*;RS+D(<1+)UKTVZDZ9V":VQJ3K-HC6>SK$DB@WL"BZJI-6N!!
MLP][28:>L 4+#)X9+R?\J*LMR4-$I6529J'WU9<RB<T+IOU+U9<Y.Q=:]:-$
MT&_R[*1N,BZ4_5=*KMI7:BXPP%*GTG10:*2:*D1-BL(Z;+:DH=DQ#YQEY2T%
MR&)*)F>P42DVPM3C]IJ-:L9S7AV39Z$8.!!Q4G2[),!E:S+/U6=-C/R0!F37
M#AH"^2%N19CH<L2'+>5$FR67$2W6M*Z?9K86G,ZMU\U4JY>&=FU^LHJ !($'
ML:/<9.PV+X)$X@8@CK@S?9LRZM6.(PT7;M4J0?3+P4><E*1,<VKIKU)O6QB^
MW[KUFT1;MJ'X(L8<V)9=54DW<R\$))@3 \<E8B0624F)%R!0MP>I^2XY#]VP
M$,+;;AQT-HGUMKIQU,WY;P6P-W]:=%;=O%9C,0@%MV3JREW2PBX,22N;$@12
MUA#$)B1\2:XN=%@J>5$C35*F,LHDYR[Q$S2(I-.KY^SVL%5J^'L]V6&<N5A&
M"(,(U:W*Z,0% .6(G'8;F&5A!#;8L2L@](4/'H3#B9:CXPWQ$$*342MKKMY)
MUL.0N-0@'Q=6LLR"Q(,5T?:L"\62*&FNH4\.;.(""6RGLJFE3&H$9EY2VD>A
ME$LJH: T;K_8EXVY1M0:UJ&T]F8;QL/8M;I=?#76[X:=;?3\4V4? 8+F_2D-
M-27?>$M_U\EIJ2]ZQ]M#B43+O$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'
M$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$@^ ?T,A@,\/CI,(W4WV,&=9=2PMT9L[
MUY1=V*RPB0Q?)KCRYM]B!_3^'85\F.R)#\JZQ!#-HD27WI+Q9;[BW%),S27T
M!I<^)WB ,ZVJQ(-V1;EL[W&RA^'(NTVIU"#:NEMV]OT\8))D:\ !J@YA64>D
M$&Q8GT-XSF/F?T']?[1+:/\ 5#K=;-ET;<UATQ0BFV-7!(E7H.Q'@C+=NK5:
MA-SDPJ]#-L9:FO X.2Q1R$)FNR8$-\E.D1H[3\I]Q<Q.\:ZN]=[%H<3UC/Z;
MH)KK^#KM>J874Q4!$(4T0 J:(F*M!%C)27<0%5Q4""\"F17&IXF3#BRX$IB2
MPTZE$Q9 \/GI<.U+:M&1^NVO7-7W6R"[C:Z].AD"<H]<028> 5O(68D0EVQV
MU@4P(:0=EP=2;#)C,I&3HJ48QQ$KE9Z0=0ZIK;8&G0'734\#5NU6!L?9=$S4
MATNN7SW.RPV-E6P?.;DMG2<9;:)OO<AZ\J\43[W?F.E<YF91*%;?#YZ7WBD:
MYUS:.N] )5+4K!J'K2(B,2'E*0/L<YXG8A5=LXPC"M \/8)S[D@Z':,X%F%>
MK21B26V6D(1*A>^AG3?9-)U=KFZ]<=6&Z1IF#+':MKF:XP/'TD.0CHBEP 7
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%1'$3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g425213g00a22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g00a22.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1T84&AO=&]S:&]P(#,N,  X0DE-! 0
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M;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0
M   !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "
M4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,
M8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M 0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B
M;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M  !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L("!D
M;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD(%5N
M=$8C4FQT                4G-L=%5N=$8C4'AL0%>            *=F5C
M=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,
M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L
M;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14
M;W!L;VYG       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F
M       .             #^    X0DE-! T       0   !X.$))3009
M   $    'CA"24T#\P      "0           0 X0DE-)Q        H  0
M       !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9
MF@ &       ! #(    ! %H    &       ! #4    ! "T    &       !
M.$))30/X      !P  #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@  #A"24T$"
M$     $   )    "0      X0DE-!!X       0     .$))300:      ,U
M    !@              S0   2           0
M   !              $@    S0                     !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    S0    !29VAT;&]N9P   2     &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   ,T     4F=H=&QO;F<   $@     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    %.$))300,     !)]     0   *    !R
M   !X   U<   !)A !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1" !R * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M     P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0
M  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!
M8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&
M)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(!
M @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R
M@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6T
ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
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M4T@AC;2=23+G;GO=[RYWN>Y=PC"7$#YIQ0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0'_P  1" #1 28# 1$  A$! Q$!_\0 '@   @$$ P$
M  D( 0('"@0%!@/_Q !M$  ! @4" P0$!@81#0T%"0 ! @,$!08'$0 A"!(Q
M$T%180DB<8$4%18RD? 8(S>AL<$7)"4F)R@U-D)6<G:5T=3A\1DS-#A&4E=F
M<Y*6LK1%5%5B971U@H64I+760T13HL1'9(.$AI.8I<7_Q  < 0$  @(# 0
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M.K*"]SX2$^TLTJD=ZSY1G%9P\7)J66T30UY:)J.K9VW%JE$DDDW8BIE,7)=
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MG<E)P"4D8.V0=;):>O%=.G.$PO@<L&N F+LG(<'86N"$[Y(&.@ Z) SN$@8
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M@_M)EV<G?/QK.3GV@D;GO\QJO^M4K9Q?JT:<CSV4D* \JWUFSQ\W#[T^SYJ
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MP0_9*;)]8Y3^,^< DKI8.#GBV<L*24S6RGLT\OJ@>K@)(P1U3@Y(W\_?HG)
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MQ [! *<>*321G'MW/>,;[>\=?HZZJ)B88!?.7)G>J!A#&\ZK@83J\ZWX]Q$
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MH-_\TYS[CC1%QTN-KPM*FU(V!=&RBKFR$C8['E&<GPQTT4.*..S&GA\)+D)
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MI%Q*9+\6+>:44.Q,;'RY+3:"^')<8I3R8>(;2?F%AID5I"18VIA!B!8$X%F
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M/$]P1))Y<UY>524D'*BGA^N6GJ"4\I22H=^P.W3122TZBM)@,9UY'%3&T4I
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M,T,Q7&>^CW-*>(>;$+N:BA^(ICBUX,EW8G-IIK3KE97E,N30<BJN3S*'CG+
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M>UM>Y_:K.>NV_P !>Z^&_P!'CWZZ[HWZ[H?Y]C[P67F2UIB-@#_\)H$?]0#
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MN!W^V:MSD?\ O,_Q_HK._=G<^>.N>NMOZE_7K)O^X7_T1[+I_&BW+R6ANL$
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71$:(C1$:(C1$:(C1$:(C1$:(C1%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g425213g00b06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g00b06.jpg
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M,D)A8F-TH;/2X0<7(U-4<7*!E9?!U-8T=K&U\!8S)$."_]H # ,!  (1 Q$
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M!W"F3VGO-.J-/)F_U*?HTP.P=PID]I[S6![/V'KO3, E&S]E%AT7@\.'7*2
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M8&J9;J42CBFJ26GJ0L8_9#<3@;)_YL'8O_L9\WFSD_O[*]-SR;&X[2>1R"0
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MFMV[8N@F2RQ%CKC[=9^E_A#_  <6?!EIIEW:Z@]ZMY*]K/'<0Q12"9(NEZ:
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MH-&G4"+DGDZ#%(\9%PF2IR</'PH,])4X>^9FET1D5BN;\Y-M7NK:UC+7*2W
MN[\S*\48 CM[Y(C!(S3HT;K#()4CC1Y!"RN0D,1:2Y+^$WB'0N'K&6?B"UO]
M;7B7C5]2M[W3K!(4L-$XQM;"31KF>35[2XLKNWTF^&H6MG:6=Y?+IDL5U(MM
MIVG&:\^Q[FGO1D;VCFV-0I,5%9R8BBK#,?$F"T;C3/DJUU6[V"+3.S)F4)1R
M)Z]4'+R^4[!P@L6CT]DS$B[Q(PC-MXKV36;Y9+K$D&R*9XMI$*F*)=2%J;A0
M\X=HXH-O32W'011W$JL0T. )WOX5>+XKOB QW6DK;Z=J]SISPF'387L+"+CR
M/AV36K9;S5(KB>QTW1&@?4]1UL:1IUEK-_%-()=),>V0 7*+D8ZD,*N\Q@)@
M9BOQ['FQ,2%(G6,XRW&EMYH^+ 9L)DY0,Q;H6@D<,CL161H<@Y,NF2Y1^PQ;
MJ9YTU/4#)!GV.REM/5TB42";V9[+5GCG25T5<01NFW>H+D%V7%;JS_"#QS)>
MZ5THT6Y@#\$PW=MIMLMY#J__ ,H'$L4US9ZM;:A<6L*(-(L;N#V-[+@1[F2)
M[B:$(QQ2'<N>0DT!1)J*D$'>/Y:;U6S,R\9 'CAC I+.M ;YV1L343D)G*,\
M;RK4<JUO#&+O(T]1+CTI6F,E(M5]:V"F*+5M0FCB"20,TKVH>9;=BL$L]A?W
M-Q:%.E/Y6TDMX%.\AUZ7;*A;D==I?X2N-M5M-,CMKS2)9M2O.'(KO4[?1I9(
M=&OM8X-XPUW7.&I+0Z@0-0X:U#0]*AE-W*ES"NHK!J%NTV <DU'O[<NQ)MQT
M:[#Q$OLI%.]4R;-R""R6(H!A^U>$FYMI% *S)I)W#(TA'Y2';#&J\E3)M\DW
MN:BPU$TW#OAV:SO[NXGT];@HW23VLFY$DA"K=:+>W31[1*5<)*BJIDWCRN:A
MPC+>X9XSXIUS5>"(];%M*;[6.'+\O:6M_IJ6L/$?X)N*>(;BS:*/4'BNELM1
MM4MXGOUN$*S$O MVEM-#M5KIZ_1-*4I2E*4I2E*4KY(N$'..>;==%?!-99OG
MDBI@KC@NV5S0<(9Y8996Q6063S163O>V:2N&:>>..>-[6\!!ZB#S(Y<^8."/
MU@@@]A&*BKHX)1U<!F0E6# .C%'0D$X9&!5E/-6!! ((KZU[4J4I2E*I?S.T
M!M3?X/6XK4\P&:\,QDON!8C-W$CD@4W'VFR>+^]M$ARL78  I%$X9C$OVO&]
MA-VQ4D 135@Z*3,DW?O$'C*:,%SD9SMY>;DRMSY]@(_?6OU"UGNEA6"00LC7
M!:0LZLHFLKJV4H%4AF22=)0&91^2Y')!%#SWL;.^CN!5-A(=.PD8?2.XQ:*1
MZ2S%Y'^,@UV:V 1.0K2=[ZV"V.Q?>PN5BXUMY1<=K;LD6P6ZB'FR2+-G4Q(H
M\Q.,9) !; &"W,\UQD=>3@Y!R:UK:3<L& :WC#A@B(\A2S4M*6CM_P DI9+D
M.JS\H0 #A)!@5+?'OB_S)UQO>"K3+:A5WI/786-.FPZ^]]G3<*]8.K<OPQ_6
M3:/2=N@]GCQ&\RXY3-W-=EL1><*;1 1"=;NSX\00S'^,R%3@#)^*!@^1SSYN
MIARZ\DD"L]I9W\-S'TDQ-O"D>![)FD4@^SE>((X'2'R[20O*!T0C6.(L <;9
M:Q5NZ4I2E*4I2E*4I4$[2XZ:ZW";82"8/]GM2 X4F&;80C=6WM:C<F:;MV]Q
MS=!M>S:,B7KZZ[U>V9-XR7(J-\6[7-UDV:MDDJ-SI\%VZR2M=*RH$ @O;NV7
M +-S2WFC1FRQ\H@L1@9P !R'$/ ^A\3W<-[J<W$$<T%N+6-=)XKXFT&W,2RR
M2@R6NBZM86TLV^5P;B6)YV0)&9#''&JQG^@UH[SQR"_BOY-_W9JO[2V?YS4/
MXKJ7]U6@_%'PC^D\:?S&X^_R2GZ#6CO/'(+^*_DW_=FGM+9_G-0_BNI?W5/Q
M1\(_I/&G\QN/O\DI^@UH[SQR"_BOY-_W9I[2V?YS4/XKJ7]U3\4?"/Z3QI_,
M;C[_ "2GZ#6CO/'(+^*_DW_=FGM+9_G-0_BNI?W5/Q1\(_I/&G\QN/O\DI^@
MUH[SQR"_BOY-_P!V:>TMG^<U#^*ZE_=4_%'PC^D\:?S&X^_R2GZ#6CO/'(+^
M*_DW_=FGM+9_G-0_BNI?W5/Q1\(_I/&G\QN/O\DI^@UH[SQR"_BOY-_W9I[2
MV?YS4/XKJ7]U3\4?"/Z3QI_,;C[_ "2GZ#6CO/'(+^*_DW_=FGM+9_G-0_BN
MI?W5/Q1\(_I/&G\QN/O\DK-=>\6=6ZQE3"91@CMYP9&I/46R4LW_ +PG8/+
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:*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g425213g00k01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g00k01.jpg
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M  (1 0,1 ?_$ !X  0 " P$! 0$!           &!P0%" ,) 0(*_\0 7A
M 04  @$"! ($!PH'"@L)! $" P4&  <1$A,(%!4A%C$7(B,R05%55I?5U@DD
M)3-789.4E=<F)S1"=):8-38W4G%R=Y&SM$-%5&*!H;:WT]3P4V1V>)*QM;C1
M_\0 ' $!  (# 0$!              (# 00%!@<(_\0 6Q$  @$# P(#! ,*
M"0<("0,% 0(#  01!1(A$S$&05$4(C)A4G&!!Q4C0I&3H='3\#-38G*2E+'!
MTD-456-S@N$6)#0U=:*RLP@7E;2UPM35\24F=(.VP\3B_]H # ,!  (1 Q$
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MUS44K:QRQS,;+#(R6-Z>621O;(QR(JHJM>U5:Y/**GE%7[HJ<4K5V!LT)U8
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M5I&A^]FF6$5PMG96EE8,@A@#O%UG>:7HK/6M]<"5$][E2\S8J' ?8BNLJZU
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MA$@6=T([$C8XDHDTAR(JJKIS#9B"R97*JN?,1/+-(Y5<][G*J\O50JA1DA0
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M^SGQ$?$WWC1:$.7LSX=^K>K*KK#$;#5:L; F8;7Y[::C=33X?/W=4+>7.EM
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MHDFQT*HOGK;6M5%\(BF954<GIC7RBMT*JB>7N;]T1?,3U\>E8U>I4P^H)_\
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M+ZBI;.L\:HU\+(5OTEDD1SFM1C&.<YSV(U%5[45]ZQ_I+2_ZTW[&F_\ D/\
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M69NT)]H@MH[6R-Q-+<>T% AOUM555MH+B5G,ES$ !'M"[B6&.:0VUI."V90
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M_P#"Z%__ #0S?_Z52_\ Z^_.S9_]!U3_ +&C_P#[AT[O^_;%4#^$;_;_ /\
MK"K^QYCSZ:,N0A27S/8Y\JDP%O\ 7\J*CXY)1XH8TDB>CHGQ.:Z:%S%BG>Z9
MCUYQJOJN=YW;0YF=E+1$5-OI_JEH"8!9$W%>#5C9_.VVIOCRR*VBNSRV UM0
M\9L%16V,[[(T(5S6*]_I^.>-?NPZ)X=G31]%GTS5/$9U'4K.ZLM0GU:QL]-M
M]#T#4_$NM7MU/I^BZQ>W26=AI;VZP:5I]_,^HW=I;LJ$R%?>^'O >HZK&U_J
M$5Y9:3[+:7$-S:Q65S/=RZEJEGI&GV\,=UJ-A;P-/=7JRF2]NK6-;2WN)@6
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MX->R>&D?8VQ,D!"A4M%6PT\Q]U=.1K'!5M4%86=C+ L0X,[Y?;221NY(0,Q
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M'$CVU*2K#$Z1S$G+M$C*N-J80%>S; %+_P"^07_WJC'N* MG+98@^6XDA?\
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MD]QWHIJ?GW[>7ZZT&\[<ZTZP)H!.P-G29*?3NM4I$N2'#1F,I!&&VL[Y_;=
M&(''.)#(:=*,(ZPL*NKCF?9VM<(5K3WEK:M$MQ/'"TQ81!VP7*+N8+]0Q]I
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M"JI8@'X=_$IVI<;2JU/Q ]?:/XF^K;[3?#?;TE-U[#H>QA3\KM[GO+)= B:
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M5"%[SR/E63JB2?+I/)),V)7*QLDCWM1'/<J[MMJ-]9HT5K=301N^]DC<A2^
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MMK@8&#! 5X(L<0H808T40XHHT4< \$;(HHV1L:U,5< % 50%50 J@   #
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M 7BH,I1';.9'PH;L SD*@4<[55F!QR3R3DDFM7B]_P!@%8W'E9/J/)A98Z@
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MJ/4=Q,GLK%B0"0I8_1! )^0+$#/ID@9[D=ZFBJS -(L8.??<.5'';$:.W/\
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M+,2Q  S@ #*H%R<EF/Q,>Y]!Z #R   [XR237&KP]KMK"[-MBX?E+E1<<%!
M#H'-I>IC903MV.)YI8Y9]AV4H24%N9$37#4% E+/2EOM:$V;3V),L84*#E<R
M$D#WIAD1D\_!$"648.YMVX;6&R#QLY))&#A1WXC."X''Q28P3QA<8.1[W/\
MJNLMIH?B9S';I>=M9,AE1;D $!E87)<_)DG=)VU(- .D" QPTEWUEJ[$1KSH
M$B_'UDC4E<KN6I<HEJ\(#[W*DG"[<XG5SG.X;EE0'CGIC.*@T#-.LI*[5!
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MZU5=W\5/2E3DKJXSNYSF^NZ7/W%D!BL;<"W6HOS*:.2&*KKZRO4LN-UK8QQ
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MS0RQD/'( 4="&5BI!K56M#4:_-V=#;1J556_SL;WC$2#D1+\_*0'8UAXSV$
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MJ.TJ9J[(&VX!88W8]X#D$*?Q=P.&(P2/=SM+ Q*AL;N<<X_%)X()'G@C(!R
M><9 (M2%]TV&)I ]9*0V*-)Y83"H(I9D8B2R10/ (?#&]_J<R)Q$[HVJC'32
MJU7NA4JB.SU5I5U@%9GA12-QJ3B*/,!3I,97AE0K,MCI;A(E"E7-Y<&*6XM/
M5-7NLI6 9H R*]OZ:(BR- Q+.2(T&YR.Y]$7@^^Y]U>#CER-JMB#L0 %&68[
M5XR ?-F_DJ.3VSPH.6%1HL%N- PO5N4GD)MM);%6%U:VL8QYY.>K+""_[-V%
MY&L$0IECJ+"S&SY!,$$,8NFWU;90 I7A2C1SSU#)*X]U5 51D ,05BC4\D!
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M)GF(DA'BDN8P0SJ N<D2"NUM30&'%?1&W()^(V',;G$<F,GOL<9V28Y^')#
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MW1R\2 1OCB15]TG_ %B*./F\8!X),;L21C:R?!EE^@Q]X#CX&/ISA7X)( =
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ME735044QUI:&"5X4$Q1,,3Y(C.P51DGU.  !DDD\!5 )8G@ $G@5%F"*68X
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MQBQB'W-W/@A) JGDNFLG\$</_%,1D_[-^ ^?)"%DY"J)#EJCN9/X3!7^,4<
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MK"P*&! !&G,-.,GB%$#$%B=.2443.YD(XP\+'S3SS/9%%$QTDCFL:JI> 20
M"22  !DDG@  <DD]A59( ))  &23P !W)/D!559D,SL"[![$OA"0\]5NFDZP
MS=A!*.5'$4/,'/V)? $,9*#?7M>20)F:HJ)ECF<J:0ZT8!H-/>4-!<Y$:F)2
M"QQU7!R.,$1*1P54@%V'#N!C*(K-!07(=A@#X%/<>1=AY,1PHQE5SDY8J+>Y
M15E41<]'K;.U(K.P].+G=?='WUKDR,WU;HJ%QEI#% ?&D.KZ_O"YQ)VQ>5&-
M+*C:CWM;^JOCG5;4+::"&&\TFPO.C;K;;YI+]3)$A8JLB0WL<)(#$$B,9\QF
MHJ&1MR2R(=VX%=H*G.<@["PY[<U'Z_X; *EL;:O<V5:V$<$2) >MNA1?0+6^
M$!@:L'4S%2(9J(R-GGT^VC8W(K$1J:D?WCAGDNH?"^BPW,L?2DN(OO@D\D0*
M$1/*M\)'C!CC(1F*YC3CW%QLR7E_-"EM+J%[+;Q2/+'!).SPQRR9$DB1,"B.
MX)#NJAG!(8D$U7^3^'FGO+C7ROT(\8^0WUT!F+(7J?H!)II;7)9Z786GOOZF
MD1+0K0W&HSMJ4*T92!@' D,D<TB2>Y3HUJ%Z'AK2(3*K2RB)M1CR\DC,2VR^
M7<7"QR,6R68AB<XQ1-/=7EQ%<W=U<7-Q9+%!9W-Q)UI[:&"%(HHK>:57DACA
M0=&)(F1(XD6-%"J!4XHOAAI\NR./-[(S/Q1 5E7%%2]9=!U<4==3HC:L*.,+
MJ6!C!@F-CBAB:U&)#%#"J+%#$QE[:C9N[2/HMB\C_$[76KL[<D^\QU$L>23R
M3R2:PQE=BSSS,S,S,S%6)9PJNQ)0DLX50['E@JAB0HQ:F2Z[)SFBL-1;;?2[
M*U.HJ[.1.O <?7#5]57''6,40@V3S&<C<]Y-A,LDA2$.2-L<<?MM1?--U?I/
M;QVL-E;6<,<TEP1 ]W(SR2)'&2S75S<8 6-<!-O.2<U@+@DEF8D <[>P)/XJ
MKZU9?.=4J<4IQ2J?)_XR]BE>W]K@.N[D<BSD3]8;6]C54T18%2QSOV1-)UV4
MP>UM'PLFC(WS*FN8:&;A=)5&7C\$F?\ *2J0/5(CP6^32C(7/:(LV")$85?P
MC8_$0\]L,X/;ZD."?5\#.48'0]^:4.L&ZSSBPD%V>G[BZF=!"*D;EKZNC[,Q
MQME>GM>]CV5(QTU)0R$1-E<RWTM) YB,*=)'T-&0F>[;( 32M8SGS+:5> */
MY1 9L?11CY4E8#8O<LZ=O(!U)8_+.%SZL/6K6J?3:RW$\SC&>Q<FA1MAL+J"
M+VPG-&1T<;YH(4]3HW+(H;7B^[[B-D69)FMY%6>OR/\ <*T6MH,(QL=CI(JI
MU@1"ZIJI;^_( 4XA4F,&J8#2C%>BRS1OF;'"R:2+TRD,A<L;N<[4=6TO2$@D
MU/4M/TX74ZVEH=0O;>Q2ZNW1WCM8'N)$$L[K&[+%&'D*([A"$;&]8V%U?RE+
M>VN[A(E$UTUG:RW;VUJ'1)+AXHL>Y'O R[QHSE4,BE@:YQ^&KM:IUHP-9O<-
ME.E>UMG=]LB9[ 9;LN\WLNGS/1NM#PFMTC[]V8QC(_I^NLBQ(*L@%TSZV0:U
M$G(:19#5>MH^J3W\ :^M8+"Z>XOHHK:&[:\#QV$_LLTO5-M;;?PZR*$*$E K
MACN94]9]U70?!O@3QIIWA+PUXPO?%0U'POI'B6*ZU3PZOAB[9=5TS3]:]GBT
MZ/6M?1X[72]:T626X:^C=KJZN;=+8I9//+U7=CL&K;9L<A3FR9^[5S9S3"FJ
MK((D8Y&DSS-:Y$>]/4U$7PY4553G?@_AX?\ :Q_^-:\*W8_4?[*I/,_X&SOP
MQZ[]V#\(TO7MP1+_ ,E"J-YCZ(RO(>J?="S-YD,-G@7+Y8KKZ:)6^9FO9T-1
M][4-73S]NNI5 [DQW,H(^H1O(Y_F9JKMT6^6P_(.H(^TNJ*/KJU=1%GJXT!D
MHR"6^YNPJ8<^!2QH2KBJI+JU 6V) EB?%YJ:NP!&(F1S3)DK::=TK)01EYH#
M,IQR(U+8SV!95./7E@2!V&6]35A*J1Y%SM^L@$C/EV!Y^H>E>NL@[&/H#!L9
M897-:1_R[P+:Z"L-/6#N@/&E(@*IQYL[,5'85S"0VRQ6HCP)YV&-:7['R\VK
M<1231-''=36CDH1/;I;M*NQU<J!=P74!255,4F82_3=C$\4NR5+$8JV=D+\$
M8G2:6,%@5W%(+FRE8IG?&!<(O4"F0/&&C?E</J#<&]D:=T^^R::M.V>N^]K<
M4G$7, UC'3=25W4H+Z;VM:V-:DY^6E>>GO3'5MP.7'+!%7GT\D_,CT,QN;F2
M[ENFDO[.^+O'##(;FSL(M/?JF%>DXGAC28B*WMD29G,8Z9$4?O/_ %BZG]Z;
M+1(['38H-/\ !6K>"(V$=X[-I>M>+M0\8SW0WWAVW<-_J$UI;EGEC6SCB$T<
ML^Z>2WNG^O.T.K<[3Y$S1X32T8$FQLC)!LW?Y^U,NM/JK34-<*3+J+\0&LA(
MNC8D$E L"FP1#,=8/E26:3<L[-[.-((IE]G1KAS')$9)F>XN)+@D7*RPHJ*T
MK*$-HQ*A?P@)->?\1^(;SQ1J<^LZG%;)J$]MI-HWL"2V]FL.D:3::1"1;W$U
M[.99;>QMY)'-YL$QF*QA'1(KV0..<&8*P@&*A+84PT66-I D\1KY7$#21S,]
M) [V3/A>V6/TS1JJ/C1'*WF\"1@@X(YR..?4>E<'OWJIOD;OJ7]>D%L]/U='
M^M+FQ(B;74]>#IX]Q^2'C2>PU&,&;YF9C8FDZ3.0-F"Q;;JH;18JEORL_P 1
M"3'\<\)*?Y?DDA[&3A'/,FUM\C5<Q=@6C'XHY9!_) Y91]$>\H&%W#"B;VYP
M6IP=N=FS!;X&]RMG+3&5)$1XMI$=5D('( 0,^2$J,E9&)"^%[VR*Y/2J^>9M
M_P '=0&3W-EQ$7W<;0LBEMV>V,'.>U3R&7*G((R".<Y'&*HK+]DPT%#DF1XK
MM*2S!Q6;SUL*5U?VT-$*57!C13.@:-UW9C$.&E]_W)FD*V=C42%'(C5EZE_I
M<\UW=RPW6E,DUS.Z/]^-,4[))797 :X/.T@A67OP1WJ*.H"[@_"@$=*0Y( X
MX ..,'!^JJ#S5YW>_L;$[O?-.M8Z"OM1-&#G.D^]JXV]2&NNALP,"9-UXP2N
M@"-O;,RW;\@L>C4\>0J.J_#E,*_Y9']R&\/BS1_%^I>-'UC5=(@2U$OM?A?1
MX;^UM[35K:UM[RTLY+@!$DUS4[VX%E<V4=]<3VHO(I8M(TQ(>T/%>M+8S:'#
M8>'K;0;UIYKR%+'7)]0BNKB6SFZVG75UJ\L,71&F6%L!>VU_(T'M+6TNGR7-
MU[72.]ZD[?L.S]%V#U;V+O.N8X^XQ.Z.NZPKX<^Q=>/E=3K<!/U5W'):K9]6
M"&Z,#39(ZQLL[3SV(@><TTL%BZ6V&@%K /OEAK5Q%;'3]5T3PWJEHVE1:-++
M'XOCT^[N+.UO5U.P+[))X(9K2]1%=X8@US9CH$QR,\[^+;3[EKN:=+\P1>TB
M[M8UL&E:&5K9K:X$K.Z"9+A6)3'3]F8[\7& @[VH>_)K$@BIT&,UHUG7DP%6
M U'UQW/83@UDA;UIRI0R^L@Y56Y;7FRP*^2"&-()H$EFG&F1/#6VBZLJ?\\O
M-!E8NP22VU.PMTV*JCF.74;DERV6.)0%5E3WBI=O022VS'\"EPF%7*R9F.XY
M)]Y88=J@^XON,7VF0[-W220]?T NQQW9 &@IKZOI=MNMH6.-<U=OEKQ:JR>*
MP.S'%LAJ^ZIS8Y8?G*H[V130RQQSPWQS10RIN:HPBGLE26&5[:PM(G:"6*XB
M$J!BR=2)GB<#(# ,PY*GS%4J RN"" S'N"IQ@#/.".V0>".]2?(EOV&6T&(W
MD(EI?TGSN'W8Q 8WR.A'*KVH+?MKG1R _2=OG#A+M:Z)# JLBPL<Q/.0;1V+
M&<R0;'62,D*V)(SDY4@\KGONC<%<\%L!P &%%.Y2C@$C*.#C# CXL=L.ISCR
MR5/(-4S)U%G-1<C=8=N&W6KGS]1;2=>7-J2(^;5==%$T*'U=B:@+#2=5D;.N
MSPFD+D)F+N!5SVG<<XC07512^:\2>#_#_BR..36;.XN!%#<VBFVU35=,DMDO
M3"]RL3Z5>V3*+@VD++)DRQ"*2W1UADG6XZ&GZI<:<7BBBL)0YB<>W:9IVI*X
M@9FCRNH6UTON,YWQXZ4C"&=E,T4+0[F]^$GJK3#V(=Y-LC@KB$&"TKDUUP'4
M&,"TLFO<JTP$XM2.\K1336I$@@4$DI<LCI'R1N]I*M,\)Z1I-L+2U%\]L!,.
MC<ZE>W,0,]V]\Y6*69HX]MS)(\2QHB1(W1C5852-9WE\E_*\MYI/A^Y>0L91
M<^']'NEFWQI&1<+=6<RW(4HMQ'[0)3#>[]0B*7TLMS).NNNC\AU3^)$PI-O3
M-V&HL=CJ/VP!DEYH;5K_ )ZT.F,KYY)#R9%CD(,]2$%>Q"TI\WH1W.Y#9VUL
M9#;1&#K2&68+-<2"25@ TC=>6;:S$;F";%+$G;C '/6.VBW>SV&FV74)>8Z?
MIMCIQN)F;<]U=^PV]O[9>2$_A;V[Z]W*,=29]JXMP0=PT#(73RE/:KW/(G2%
MLLKY'ND>][1XH(6JKG*B)'$QJ-1$\*OER[(_+]=9K\(-#$=$PHL49\_K]EA!
M$4+IO:1JR^TV1[5D]M'M5_H1?0CFJ[QZD\J52UW0A8GYS2];WP6<DE(D,M,4
MHQUSA=&41*X@B5*&B@-L\?<'SO)D(TV0$;#,<<1=:O-;,F$:!EPD# +,"P P
M)!CJJ/+DX$BCC".> -J/&"3590KEHR%)Y*G.P^IQ^(3SEE[DY96-;_,=L4=Y
M65Y%H#<9JW+GD#)ICZFW(48J(UP*3QG05J0NJ37-:=7''1UA/TN>$BWKJ8N,
MZO!K8 ,0K!QY-@C(//((X([$#(SG#,,$R!)'O#:?0D'L<9!!Y!\NQP1D \58
MOU.M7\K '_6Q_P#\3D:E6=Q2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2H77V(5,7=P6UF"-(AA1<;);%
M)'M#F+)-:JPR#C*/[<9\"R00J6QB2QS.)]<SHHL$@=S^_P!E21&=L*,DX&20
M!GGNS$ #CSP/GS5(YCM_=+W5VI1;.NSH73X4.4@ZJOJD?0E:,NP=6UGXE74L
M;735CQ;FYN)HLU+6$>@('-6#[1SIS4:'YJT\02SZ[J>E2Z5K$-O9I&]OJ$FD
M7PL+KW;;JFWO4BDAF!DN>F@RC9M;D@,D;,*$TWQ#!=7=W>OH+Z'<+ ND1V.I
M)/K4,L44K7WWVLL8C65T=K9H&D6*&.(7!$UY%&ORC^*7L/XE>^[S,;#,=!:+
M-18G&?%GUH*):R7X]K;"]S==66 S%E'75^?LV(S/:(6A3<S%65;%725BWF37
M4TYT+QZ]874GGA!MAE8M0A'LDJW:%;F-[<;YK1Y8HWC8(7S*F2G5A9XF5J^1
M^,]"^Z)K#Q:C!X:MK=-,TO7[+I#Q!I,]W<0>,-&DMM)DAL[*ZN9KA[>5;8ZQ
M%&>IIDD0=T974+]3O@]L3@^BNG<!IQ(*G<]>]<@X_1T@$5I)4@KD)1\H++2V
MEA7@-M*(T:I@+H;!L<;K*HF$.2"-DJM9V=,=A:6\$D<D<L,(C96AF2,"(],!
M))%V., ;=KL2O/.#CZ%X4LM0L/#&B6>IVRVEY86,6G3P(^](WT\&T A+!9'M
MV2!7@E:-.I"T;X&\"NL.=&N_3BE.*4XI3BE4Q)_QN7<@Z?K=5Y:T=&6J?>/L
MG6TY:M>%ZOW9,'D;(=6GM;ZEV&K$6OE</F<Y8"[:_P#@5S_EG&1_JD8=_P#:
M.#Q_%H<\NX,=1_"'_5J>?Y; ]OYBD<_288/N@[KGY15M.*4XI3BE5?TS^WZX
MH+I/LS93W_8D,2_O"C]DZ6XWPP+U_P"=)7CZ.(&1Z?9SQW.1?"IRZ?\ A67^
M+"Q?68D6(G[2F<>6<57%_!J?I[G^KJ,7Q]F[%6ARFK*<4K\54:BN<J(U$555
M51$1$3RJJJ_9$1/NJK]D3BE8"6U4Y$<VSKU:J(J*AHRHJ*GE%14D\*BI]T5/
MLJ<4JINQ>S*\$#Z!FM%7A:.XL8:)]V_V)QL<(2PIUCJ)X"(YHK$FM$$(CHZV
M(8^*QTA%*+9Q#4,UK: 61[-V9.54%MO.7(QA 1V#$^\V1A0Q&6P#%]V,+W)Q
MGCW0>[8/? ' P<L0#QDB;9"3&5&:J*O+G@,H@!5% 5QZS3S)%+(TDHPHZ5QQ
M]@86A!=C9G23&V9TQ%@80023+/)%F+L68Y).3Y#Z@!P !P ,     "LJH50H
M[ 8'F?K)/))[DGDG)/-4MM,WIM!%H-U#0%WUJ'V+U>/E\Y6&TDEC#U[UOV7G
MM!<E!O/MA*:&WU1HE[I)&I<!.L<Z+AJ^T@&N*9XT76TR:"*XZ<LZ01R6.I0M
M-(LIC6>\T^YMXMXBCDEV*TD:$B-MK&1AE3DU%6)9BO.] HR,[$=6)Y. 6(8]
M^5" \BO>T[1U.3@LK/\ 1/V+75!5A&]$/K\-:$?6+RP"KP!84@[H]R5;2W.8
M,.$"(Q4*)@B&'D?.Y&P&EQ.P":WI'8D@KJGD"Q.[[WJ   2<CR[U8751ET?&
M1R&0#!.,8Y)))&#Y<\'(Q6G;X?<?:$.4'KLQOL?'F=O3Z8I1<-UW9RZ2A"@F
MBM<=:S2?$0$\>GOGSL6Q?7J.8^,$6. H:1SIX_+^)/ .B>*HK2'6-5T:>.RN
M?:;?9]_K>0%HVCEADFM88))+:=2!/;EA%*8XF=2T4;+9]\==L>@_A[59]%E]
MH@DOG]DL-1CO[>$LXM&ANTVVZ.Y4M<0GVQ%#)!/$)9-U$9?IS2TW?&7[*@I^
MVK/7=75>XM8,K]!R%=GT;W#L^[-(LQ(L'Q"/IIH+*Q[!T0Y+BP+B\ AQ>0^G
MGUL2W;]3OV'A6*T5)I_$.CW$ZSWCQ31PZS;Q@74T]S-&;<P3J^);R0B1FSTU
MA1<-'(\MOBR33O&'BVS\9WUGJ5MKFF:%X:\/V45KJH72(]/\/>'%\,J]QI[V
MS&YO-0LX+>XGN#<IT+FW4V\44+O"_9\NY['*9<1V'4G8!<!-0:#6P T_7=7/
M$09"QCY#2R.[K>.>+W(T]#80AW,;)^LYZQ_M.Q!IT<<R/)KNC-&K(P5(=61Q
MM8%B6:R<,"!P JX\V-4,R% %AE5\>\S2Q,C9!^%0JLO..6=OJ]-W/C[^7H*I
MRL(;8MK0=?96:E#EG@6,3L#%5M5<9ILT\<D@LL0.OI*U\RI+(+/'"]JO?!(J
MK7=3Q2:G=SHVZ":]N7#8(W03329(# ,-T3G (##/(!XJME)BVX]X*"!_+7!7
MMZ,!VJ37PHO:G6D9.;.8.[1TM%KL3<%0R^W7W8SJ_6X>\*$14?+%6W8E/9D@
M2(K"HH) B(Y(99(W:BDPRX<9VLR2*.Y4Y210?(E2R@CD9R""*,!)'[I[@,C>
MC##(V/D0#CS'!XJ0XW30;'+TFD@&E =:!,D-JR7L>926T#GBW5!8^W^JRTH+
M> VFM(?"+!8 DPN:UT:M2,B&-V0D'!X8=F4\JP_DLI#*?,$5)6W*&QC(Y'F#
MV*GYJ00?F#6CW^<L["*LU.5CA7<XV0H[/QS3-$@O@"VP)H,19F+_ ,GJ-8*(
M-$A$J3"T^BK\UJ9@;&3.0!3RB902C_P<F W&2I'PR*/I(2>W+*73(#DUAU)P
MR_&N2OD"#\2'Y,,?4P5L';BI+F='6:VBKM#3OF<#90O>D14+ACP2AYI1+&IM
M0I/VU=<T]B.557-62C"ZNU#,KRXXR1I8VP="C%6[CTY!!&00?-6!!4C@@@C@
MUE6#*&'8^O!'D01Y$'((\B"*WO(U*G%*JBUR5SE;,[6=;10/DL"IK#5]>D$1
MA4>MGG>LIMQ1D2>!\MNY'N>2MCX90:R9TP6NA'-,"V>:N#AP$E/8 ))C+( ,
M!6\WC[#'Q(,%. 8WK*%26C\SED_%;U*_1?SSV8\-R0RS'*ZVFV-=*?42SLD#
M+DK;BIL!W@W>?N((H9B*:^JY_!-;90PD#DMBE:L1@!05I73&51X!Q,'1D.&\
MQN5ARK*20&4^8)!'R(*D!@0)*P8$@]C@@\%2.X([@_VC!&00:DW(5*G%*JBY
M('R_:U%>%3P@U6WQ]GE;4XN5C!_KF)()UV0#CDD<UHJ.S]OVI8F3/5(98ZP9
MLDD;X86RWHK2Q&-0S.DBLBJ"21+B-^ "22X@50.<L< YXK/NR ^3J5)/JF64
M#[#(3]0]*F/XUQO\[<S_ +>JO_S?,^R7?^;7'YF3_#4\CU'Y154;G7Y/+7]/
MV>!J,Z\82 ?+]A##W5;(\S$$FR3 7SHHR6NF(Z\NS9[KW9I5A!Q]SV"Z 4RS
M*KXVW1VEVZM";:XR27B_ R<2 <K\/:51MP!DR+%R%!JMR%82 C ]V09[IS@_
M6A.?YI?N<"I1MB<7K:B(<?=9NFOJDV&\R>BBMZHDC.Z0.*>$.R9!]0'<4).,
M494WE9\R-'>YRSN*$J=@=F0O(1V]TC9-I<,I!5UZ,H#*<9&=AP00&4X.UPK8
M)%2<*P^( @[E;@[6'8]QGN01D94E>QIBNVLMIJB22TNLY1Z*H-FH]32.T-<1
M%6WP44$I#:\V209;.EL!B1+C/VBCBRV-%8UQ105<;(37"9DL;I",6]PRL R-
MT).5.>XVG# @JZY.&! )&"2.&'. P.&&0<,.^#Y@@@J< E2"0#D"SAB1C((B
M@R("AIV)) 2-+'/!-&[]U\4T3G1R,7^!S'*U?X%YJ,K(Q5E*LIP58$,#Z$'!
M!^1J=>_,4J+%SS?BNK&]QR0?)2S+$I$C&.E6,]GK:,@SXIG-:B(Z1Y4#HD<W
MTQS>O]12I ::'7!EV%@6,   -.:<<;/$*&$&+$^<DLLF=\<(XP\+'S3SS/9%
M#$Q\DCVL:JI)$>1TCC1I))&5$1%+.[L0JHBJ"S,S$!5 ))( !)K!( ))  !)
M).  .223P !R2>U?'KXJ.[];?]J['-9[XJ">H^N:VX^$3KQM3A;7  F7V.^(
M'M2>B[-[4KMN> =IZJVI:P5,SG-!F;<2IQSJN^M[(0F<E"Z_ZYX7T2U@TNTN
M;CPNNK:A)#XLU RWL5_(D%YH&EB?3=*DLHWCMI8II']JN;>YB>6\$MO%&RA-
MDGF]0NI7N)HTU!K:%6TR';"85+Q7MULGN!,RM(K*BF..1&5(BKLP8D%>Y>H_
MB'Z9U5-987.=F1:*?KN>LZO?IMKLL;+IMQI0A#Z<0V0.*]9I["TU:T)EW575
MEEZ,#L $ANKPZWV;.'LG?,]8B%K<]6XDTZWGOIGE.GV;LJ6$LY$XL"I4PQ30
MB7I-8)<37-D\;VMXD-Q$\8])-#/IMMITVHV]Y86VHA(])O-5B>S36>-JR:?+
M<+$+\2[=Z26ZLDZD2PEXF5CU3SFUFG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ
M2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2OQ6M7\T1?LK?NB+^J[Q
MZD^_\"^$\I^2^$\_EQ2GI:OYM1?W?X$_YJ^IO_\ 2JJK?XE^Z>%XI7XC6I^3
M6I^\OV1$^[U]3U_+_G.^[O\ QE^Z^5XI7ZC6M\>EJ)X1&IX1$\-;Y]+4\?P)
MY7PGY)Y7QQ2OWBE.*4XI49CF;8WMB'(L\;*YC(/[VL;,=)'.&KC6NE@A6 5C
MV(?(Q)(I9996>E)VL;%!Y4JKK[3]6W'<53T3=,N3=Z3UK<]IA0_4;EE>-E =
M/394E9;""XAEAL3K8R%X(?L.^9%JK,EDS/D)&NUS<Q"Z6SR>LT#7 &..FL@C
MY.?B+'@8Y"L?Q37*;6+)=:CT L_WPETR75U7:.D+2&ZBLR6DW9$KS2_@TVG>
MD<K _@R*UG6EQU)J-]VMC<?4WP&CZ.T])F-%,796\(!!FGQ=7JA3\Z]M\5\[
M5,#OBJ H@@4&2'04U]7QCOB!B+G17,<\MS"A)>U=(Y20,%GC60;3DYP&*G(!
M#*1R,$XL-8L]1OM8T^W$PGT.ZM[2[,B*L<CW-E!>I);,'8R1*LQMW=E0K<P7
M$04A [7NHD8Q ;XI#%5Q#V.;+8'D1N:HA3O#HB"98W>',:Y%5BJUS45%14YL
M5UJV?%*<4JO^UK0ZGZTW1U3.X:\3+7(F=DC_ ,<[36(4M=FAQT7[*47>EUXH
MK5^SB)HFJJ>?/+(0&EC##*[U+<X]P$%R3Y *"2?2H2$B-R.^TA?YQ&%'VD@5
M,*FK!HZJLI:N!@M;45X=77"Q_N# UXT8@D#/_F0CPQQM_P S4Y!B68L3DL22
M?4DY)_+4@ H '    ^0&!6PYBLTXI6JO2'AT=R7')[3Q:JQ(9*CHF+&^ 2:5
MLGKG:^%GH5J.]4S71-\>9&JQ%15*AUOV+B\%29:78Z,"E^NB(-3O+E:]+8RO
MHI[PX8*40=@I)$-/7V-L]D$<+%K:^PL(XHP02GP:UQ=V]J8A/*L9F9DA#9S(
MZ(TC(G&"XC1Y-N<[$=_A1B.C9Z1J=_8ZSJ5E9RW-EX>T\ZKK5S'MZ>FZ:LJ0
M&]NB[J8[?VB6&VZIROM-Q;6^>M<0I)\SZK^ZSX!.OA]A>Y3/_4&_#NWNPNLI
MNSLY*-/?.[[E^'YN(KSB(/84%^G;$>NQFF^FQ R^'"N]N25O%7Q#$(1))$H;
MV/VDJLJX+^UFTZ()S^, ^\^[M.>P)'PJ'[L&G?>Y;VXM+;JCPT-=>*#5;9D:
MX/B%O#OL$4C+MZ?M85_;6;I!&Y3W21]9JFT O*NMNJHF,VKN*\.TK3(558BP
M+ :,L,F)51%6.<>:.5BJB*K7I]DYZ%65U5U.5=0RGU5@"#]H(-?8(98[B**>
M%Q)%-&DL3K\+QR*'1Q\F5@1\C7L/_CCO^E,_]R#Y*K*KCL#_  OH.M<<WQ+%
M9:Q-?=BI^K*F?ZZ'_$ =A')]O0P/L>3K>"=C55\\)SX5:L+YG-NB]U99/1.F
MI\M\OND'ZXNJ1Y9'U"JWY:-?5MQ_FH-P/V2=,'OWJT>4U958XU?FMWV^>[]\
M/19;,-7^'Y>NP.;TL:?^:D^R*5$_)%5R_FJ\NDXC@'JCO^61T_\ \=5KR\I]
M&5?R(K?_ #59W*:LK3V)Q$)U6 *K62GO+<^24*4N%D D+7/];XC!/EWNEF@;
M&YZ3-D17L1K'>'HI6H@S)5;0"YS.VL6:!KX1AJUU961DR5P8LT<C A([HJU$
M8'[#%!C@>,]H@+TA ^46$9\&68L2S'))R3ZGU/S]?6L !0 !@#L/3Y#Y>@\O
M*M#38.]H7SI7;L^(0NYLKTRO_#^<00DZXL76EH_TQ@L>,AQ<A$Q*@O%6<@TX
M^;W;,N4Y18MC)R0 H)[X48 SYX& ,]@ !P *  9P,9)/VDY)^T\GYDGN34YG
M6SAAFF4H!_M122^GZ>0WU>VQ7^GU?5'>GSX\>?2[QY\^%_+F*S59V/\ Q;[+
MZ\S]GA>P;0$#2Q)]X<SOC7#U=%IF-7Q[%3LW-!S&A;$YT0VF;E[B(")+K9W;
M;Q^%CV_Y2,$I_+C&2R'U9.63U3>N?=C6JC^#?/XCD!O17/ /U/PI]&VG'+&K
M@Y15M?BJB(JK]D1%55_S)]UXI6EKK(RS#A.&%"<.1[BPO4XQGN1LEDC9)Z)J
MB*1B2-8DB->QJHCD3[I^LJE5Y<XG7&;0#:T]EDZ0\*"2N)=%57DAE_2>T1\I
M2:4J"\#!N0*P\LBTJGD4R'4Y<Q3:4RLBM;QEK,.P0IP5)R >=K?27S4D<-CA
MAC<"54B)4;@W9L8)'XP\@WJ >1Y@YP1DYG-0W8PQRI?39FQE56>R^H&M*:-B
M(CO=66(TJ]=(LCE:K$9-$D2-<URS*Y',A4JW0\Q#Y9H2(88G1QPR-6$AY"/2
M9T[51WK&&5BM6'RGCUHY'?\ -]/W4J@OBFS#=-TSH%9/&*=0&TN@!+DA2=(X
MQK* &_#]IR^AR7V1L=%FI72(YL4%U+,C5?&Q4[/A]RFKV6.S2%3SCG8S(0?(
MHZHX^:BJIEW1GG!4A@?J."/]Y2RGY&I<-U]@#[N^$;CL>/'5K60-A'S^6F=Z
MR1%+?-*/)0NE$]QLL;&->1,DR0K*U(D56KI??'4/\^O/ZS/_ (ZGL3Z*_P!$
M?J_?[:UI70/41UB2=-F*YQIL43YHX&CC#^U&R"".0>M$BA!%8J#QHZ006%))
M%FD>YTI)#Y8#5;SJ=(:E<]79U.F+R7J=/.W?LZF[9NXW8VYXSFL](%=XC&S.
MW?L]W=C.W=C&<<XSG'/:N6/A:PB]L0]@=@[3KWKNHZYD[(T];T2RALM):Z\O
M*X+<ZO$&6':$&@4FDDM;H_(AZ2M'I?=KTIKU*>T@D* (E+]5XE6'1WTZQL=5
MUR;44T^TFUPW-P%LUO+VSM+Y(].Z3B8PPI=-;3&Y&]I8#*AZ<@5>=82S70GF
MFBMT@,\J6@C#&4Q0RRPEI]WN;G,8D4)P%<*1N7<W9OZ,,!!.*JX[*3-DF?&^
M.;*9CT*WY4B1%\Q4\3T5'QL5%1Z?DJ*BHJISS'WQU#_/KS^LS_XZZ&Q/HK_1
M'ZJTW0T,0_5>;@@BC@@@)TT,,,+&QQ0Q1ZV]9'%%&Q&LCCC8U&,8QJ-8U$:U
M$1$3FUKA+:I<LQ+,RVQ9B222;6 DDGDDGDD\DT3X1^_F:M_G)J58!];!8MB2
M:0V)T+G.B>%8&@O:YR(USE42>%)%]**Q/>;(C6OD1B-21_J4!QS_ &@']!XJ
M)WO6^5TSQ77L-Q8QAR%/A&FT^E016&CM&*@G%CMF0$CRQM3U1D,D1$=+"U6C
M3SP2426\4CQNW4WQ,'C9)YHRC@@AE,<BX.0.?3([$@SW J5>&UE!&!UK.UG9
M0<9,;30NT98##-&59E)5B5)!I0SX)OA8L08JX[I;'EBP8>XZX@CG%(E4?&:
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M0/>Y@^\" N,W(,)M\F4^XR9I<DD A!"Q+#99JXFAB(D3.:L!9*BW\BG+7R2
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M6-K$-3GC9-/CU.7[W6<ERZL+9KF[N-B0V;R;2UPI8-%N: 2OL5N =?\ %?\
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ML;ZI[?V4WKB]<4LT3U8JLD7[HBE0?;936ZJ:DE".R]0_/7U9HJ@R8&X/M@+
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M945G=@JJ"S,Q"JJJ,EF)P   222  ,FHLRHK.[!54%F9CA551EF)/   R3P
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M<Z)&HD:M1.;H4#./,Y))).3W.22?7\I]:T'DDD(:1WD8 *&=BQVCL,L2< <
M=@.!6\YFH4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
?3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g425213g00s01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g00s01.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1@44&AO=&]S:&]P(#,N,  X0DE-! 0
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M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q <L            IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ "4S,P  0 ! )3,S  !  $X0DE-
M!"8       X             /X   #A"24T$#0      !    %HX0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$1       $     (   )    "0
M   X0DE-!!X       0     .$))300:      -!    !@             !
M$    K     & &< ,  P ', ,  Q     0                         !
M              *P   !$                      !
M         !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG   !$     !29VAT;&]N9P   K     &<VQI8V5S5FQ,
M<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P
M       '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E
M3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E
M5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M 1      4F=H=&QO;F<   *P     W5R;%1%6%0    !        ;G5L;%1%
M6%0    !        37-G951%6%0    !       &86QT5&%G5$585     $
M      YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $
M      EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A
M=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E
M9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E
M     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO
M;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T
M;&]N9P      .$))300H       ,     C_P        .$))3004       $
M    !#A"24T$#      -7     $   "?    /P   >   '8@   -0  8  '_
MV/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)
M#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ /P"? P$B  (1
M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
M 04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!
M  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]522224I))))2DDDDE*2
M2224I))))2DDD'-RZ<+#OS+R13C5ONL(U.UC38^!_5:DI,J=76>DWY]G3:<N
MFS.I$V8S7@V-'>63^;^?^XL3ZH_7K%^LU^1C-QGXE]#1:UCG!X?43LW[V!NR
MQKOIU?\ @EBX'ZK#_P!>77_X=SO^IRTEID-*ULTWOKM]9NO87UU?3B9MM-&(
M<<5T,,5$/;7;9Z]7T;][K'?SB[WZQ_6WI'U;;2>H&QUF03Z=5+=[]K8]2TZM
M:VMFYOYW_%KR[_&#_P"+C-_K8O\ Y[I6S_C?_P"4^F_\1;_U=:*WB(XSV+Z9
MB96/FXM67BO%F/D,;0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            _^+__TE#0U]04D]&24Q%  $)OLS^_AX
M"(!P041"10(0  !P<G1R0TU92TQA8B 'T  ' !H !0 I #5A8W-P05!03
M  !!1$)%                     0  ]M8  0    #3+4%$0D4
M                                                      ID97-C
M    _    '1C<')T   !<    "MW='!T   !G    !1!,D(P   !L   H@9!
M,D(R   !L   H@9!,D(Q  "CN   H@9",D$P  %%P  ".+1",D$Q  -^=  "
M.+1",D$R  6W*  ".+1G86UT  ?OW   D)%D97-C         !I5+E,N(%=E
M8B!#;V%T960@*%-73U I('8R
M
M         '1E>'0     0V]P>7)I9VAT(#(P,# @061O8F4@4WES=&5M<RP@
M26YC+@  6%E:(        +5:  "\9P  DC!M9G0R      0#"0   0
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M_H;MA]N(RHFXBJ:+E8R#C7&.8(].D#V1+)(;DPJ3^I3IE=F6R9>ZF*>9DYJ
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MN7U2DHL9/'W&CO#UA7JJNEW=67J?M$C$IWJSKHNK?'KPJ3V1XGM,I$YWLGO
MG[I<BWP]FX\^TWR\F'88%WS;D$GT.'HOQG+<#7H;OSO#8GHGN'.J37IDLC:0
MWWK)K'%VTGM$IQ!;KGO HC ^#'P[GP\7''P'CZ#S'7G1TLC:\7FTRF'"27FX
MPHVI/WGPNV&/YWI9M,YV!GK=KL9;!GM>J8<]8WO0I-,627M2CQ'R*GF,WX39
M_7EFU=/!57E@S.ZH5GF4Q.*/$WG^O9)U2WJ&MP=::7L,L=P\VGMZJ245GGK(
MCIWM[8D3?BO6?H@ ?;&^S8<%?5>FM88P?3..&H6$?4ATT(3\?8Q::X2;?>@]
MCH2??HL8BX9Z@ 'KR8>NB0C5 (:CAWV]C86YAB&E?H3XA0.,T(1DA"IS?8/T
M@XA9#X.H@P<\.8.X@N 6^85WA /I^X9PD_C34X5WD76\$(2<CQFD%(/UC1.+
MB8-UBU9R58,7B=57_X+8B'P[+(+KAY05B(1[AZCH4H5SGOC1LH2#FX&Z?X.R
MF#NBH8,.E3J*.(*@DJ%Q*8)0D$-6]X(;CAPZ-((NC)84.(.)BLGFR(2JJAC0
M,H.[I:VY!H+QH8*A/X)5G:2([H'CFA)P"X&CEN=6 H%UD_\Y4X&&D@P3%8*:
MC.?E8X0,M6+.UH,=L .WM8)2JNJ@!8&YIBZ'U8%.H<9N_8$)G;Q5'X#CFC,X
MB8#SF#@2'X&\C$'D+X.+P-K-K(*<NH*VDH'.M'J>]($VKM^&Z(#3J;!N,8"3
MI.U47(!EH-@WW8!TGE@15($#B[?C*8,DS)7,KX(VQ3NUF(%EOD.> X#*M\N&
M"8!IL=UM=X SK(U3QH (J%8W38 *HUP0KH!LBT?B3H+0V+O+VH'FT$ZTQ($3
MR&&=-8!TP12%3H 2NGILU7_?M,U3/'^ZL$@VT7^\I1 0*G_TBN[=/))A?)C'
M:Y!Z?$.Q5HZR?!":QXT:?!&#EXNW?$EKGHJ"?+%2=8F(?3(VCHDG?@$1,HO6
M?][;1I$MALO&!8]"A82P*HV#A&^9LHO\@Y""@XJM@O)JC(F-@HA17HBC@D U
M>HA)@F 0!(J8@X;9LY  D23$G8XBCNVN_8QCC-^8@(KQBR:!58FSB;)I:HBF
MB'Q02H?+AW8T=H=YAP4.^HE6AKO81X\(FY+#+HTRF'NM@8N&E9>7'HH3DOV
M%XCHD+YH4X?FCKQ/6X<3C/\SG8;"C!T.%(@HB836Z8Y*IA7!T8QXHB:L)(K4
MGG.5THEHFPI^YH@RE^IG2X<^E2U.?89ODLPRV88<D<$-3H<EB/_5IXVQL,?
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MDW1@"[&[D95.Z*S6D"8\PZB2CVDHUZ5CD!L0!*7ABM0  (Q>@ "/Q\%0H&*
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M<'S#>HIWNWT[>Q9<]GW#>ZH_UGYX?%P;%G_1?0_P7'F0A._9.GH'@^C!<7J
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MFAM0.'WYEPLT7GXRE5\.>WZ B<K8\WWSN>K#R'V.M(&MVGT^KS&7/'T8JB"
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M?W<;?:Z2?ZL$EZQ)@'4  (,A@ ![<,?HB11M?<)SAYY?%[T1AF=0);?4A85
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MG-,<>*C@DT &AZ7KA&H  (,<@ !ZW,2=KSYM/K[AJY-?";DXJ%M0*K/,IC-
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MKGU0"G2.JDDT8W3]HR@.]'2?BAS6%7\.<;;!Y7\0<LJL]'\=<\^7'W\U=-&
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MM*"D=X5ZPYW!=^EIY)L1>%Y7_)B;>.=$W9:">7HOZI4J>>T5II;4>=P  (4
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M!:6*I+UKYZ'DH<Y;^)YBGR-+2ILYG3DYBIB9G*PE\Y;+F7(-2I<YB/P  (
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M!;)Q@[!BQJX]@O%3RJHX@F9#R::6@A0R<J.D@? >I*)B@A8&MJ%_@>0  (
M@ !^3+6_C#API+%RBN%B6ZT^B;!35:DWB*U#=*6&A_ R,:*3AYX>D*$TB"L&
M\9_ZA+$  (  @ !]\+3^E 9P3["MDD!B"*QQD)=3 JABCR9#):2JCA(Q_J&=
MC;4>@: CC> '(9ZCA-(  (  @ !]G[1IF^9P"[ 2F;9AQJO)EYE2OJ>OE<1"
MXJ/VE((QTJ#>E'H>?I\NDJ<'3IUXA/$  (  @ !]:K/IH^5OV*^.H5!AD*L]
MGLU2AJ<;G*E"K*-<FW QG*!*FN(>9IY\E(T'>9QVA0X  (  @ !]-K.;K$=O
MT*\KJ59AA*K!IEU29*:"H^M"D**MHL,QE)^/G_,>=IW)E)D'H)O%A2@  (
M@ !RK\5(;-YEI<"L;;18';PY;I])T[?L;Y4Z=;0!<($I4[$T<2T4EK'I<+@
M *LI='L  (  @ !RHL1W='!EP[^Q=(M8.KL$=-5)\;:&=4 ZEK)V=;\IC:]_
M=B$5%:_$=;L #ZGI>.<  (  @ !RH\,Z>[AEJKYR>T58)KFU>OU)UK4D>O<Z
MB+$#>Q(IGJWR>S@5;JW>>P0 HZ?3?2X  (  @ !RE<'M@MIE@+TF@?A7Y[AJ
M@4))J+/2@,PZ9J^M@)8IG*R*@) 5KZPP@,P!(:7X@,0  (  @ !R=L#2B@ME
M7[P'B,A7P+=%A[9)=;*HAMHZ4:YSAE$IGJM'ADD5[:JOAI !D:15@0\  (
M@ !R4;_YD6AE2KL?C\M7LK9.CE1)9[&HC2(Z0:ULC%XIJ*HAC(46)ZE8BX,!
M\:+J@5   (  @ !R,+]0F--E/[IBEN!7KK5_E0I)8[#/DXTZ/ZR0DL(IMJDX
MDP<68*@MCR$"1Z&T@8H  (  @ !R$[[3H&!E/;G,GAI7L;35F^Y)9+ 6FCHZ
M.JO2F;8IMZA]F'D6A:=-CSH"C:"S@;H  (  @ !Q_KYVJ#9E0[E0I:)7N[1#
MHRA):Z]WH6LZ1:LIH%$IT*?*G$46J*:/CU("NI_S@=@  (  @ #9M7&!;*K%
M#G+7;C>OOW0;;[>9FW5)<2V"K'9K<J-JZW>*=!M2!7B@=8(V>GF@=L 2 GIY
M=JW7MV]7=][#<'#<>$>N27)!>+>82W./>32!='32>;YIQW8.>E%0ZW<T>M8U
M:'@A>SX0SGC">JW5XFV$@QW!I&\;@F>LM7"9@<*6S'( @4F ''->@.IHDW2R
M@)Q/V77E@$HT;':\?^\/P'=!?R+4&6OJCDJ_U6V.C)"J[F\9BO"5.G"7B75^
ML'(.B#%G5W-VAP1.S'2TA>(S@'5RA-L.UG7S@S#2>FJ4F6^^.VQ ELRI5&W6
ME#^3KF]>D=5]4G#BCY1F)7)>C9%-SG.DBZ@RI71'BA@.#G34AJC1)FF*I)V\
MZVLXH2.H FS/G:J286Y<FE%\'&_HERIE"G%HE#],XW*VD:8QX',_C\X-97/C
MB0[0%6BYK]2[W6IGJXJFZVOYIRN126V%HN=[&&\8GN9D)G"?FS-,&7'HE^\Q
M.G):EA0,V7,;B+#/1V@?NQ6[$&G+M@&F#&M3L,.07FS6JYAZ+VYJIL9C5V_X
MHFU+<'%#GL@PJG&7FY ,9W)YB&+.N6>\QF"Z@&EAP'VE86K:NF./G&Q-M&!Y
M;6W:KL]BIV]HJ>]*SG"NIE P&G#KG^X,#''WB"7*6GGD:XNW?7ID;4NCP7KF
M;NN/ GMH<'1Y57ON<?IBM7Q\<W]*TGT5=.XOX7W0=AX+.7]D=C?(Z7?H=CRV
M5WB1=N2BI'DM=X.-['G$>")X0GI=>,IAKWK_>7I)V7NB>AHN]7Q)>I *:WVQ
M>JC'978J@.2TKG;F@(>A''>5@"R,<WA#?^AV\GCU?[E@A7FM?YA(SWI:?W,N
M!WKE?T )MGPS?M;%TW2EBWJS"W5KBC.?>'8GB/*+ W;DA\1UHG>NAK]?7WAX
MA=!'U7DMA.\M,'F<A#0)&7KH@G?$6W-=EA.QEW0JD_:>!'3PD=F)EW6WC\UT
M97:)C>%>2'=FC"U&[7@@BITL;'ARB8H(DWG,A9/#)');H,*P8G,LG=><SG/R
MFMZ(:'2^E_1S2G67E3-=2W9TDJY&&W<TD(LKO7=KCWH((GC=A8#"*W&/JWZO
M9G)AI\R;S7,CH_F':'/NH#-R773/G*Q<?76QF79%:G9IEM$K+':'E5<'Q'@7
MA4#!;G#XMDVNI'''L=F:^G*!K3&&CG-$J)-QAW0FI$U;O741H(Q$SG7)G< J
MKG7'FB,'>'=VA0W \'"4P3:N%W%>O .:4G()MHF%UG*^L1YPU7.9K"M;'G2$
MJ A$.W4[I1 J*G4CG(('.W;VA.2[;H*4:IRJ,8(X;'B7ZX'Y;BJ$>8'1;[]O
M_(&Y<4U:<(&X<ME#@('==$<I!(*!=5,%/(.[=HVZ3("]=+.I$("-=8V6LX!E
M=E:#3X!+=Q=NY8!"=]U9<(!0>*9"DX!X>5HH+H#\><@$R((,>M*Y''\.?LVG
MPG[Y?K>5F'[??IR")'[8?H9MSW[<?H-8>7[X?HU!NG\G?I(G;G^.?GP$8H"1
M?I*WO'V4B-6F7'V&A^Z4#GU\AOZ R7V!AA5LD'V?A4Q787W,A)A S'W_@_8F
MJ'Y$@X0$"7](@=2V;7Q9DN&E"WQ0D3B2OWQ0CW]_A'Q=C<AK=WR C"U6:'R^
MBL<__GSTB9 E_WT8B08#OGXO@HBU57MBG0RC\WM>FJ.1J'M>F!Y^=7MNE9MJ
M>7N5DSQ5BGO/D1X_1GP)CW4E:'P/CP #?GU!@ERT=7J>ITFC#7J=I":0O'J9
MH-5]BGJGG8AIH'K4FG54SGL2E[\^K'L^E<8D['LJE" #27Q]@CFSS'H+L:"B
M6'H,K<:/^'G_J:]\PGH$I9EHW'HQH=U4&GIYGKH^&7JCG.0D?WIJF%(#'GO=
M@ARS7'FGO""ATGFGMYB/5GF-LKY\%'F#K>EH.7FHJ9=3C'GNID$]EWH:HWPD
M"WG-F%\"_'M>@@2LV(N]:=J<^8J :[N+_8E^;7!YP(BI;PAF:8?Q<)A1[(=B
M<B0[Z(<@<X4AL8?U=$X  (>!=R2K\XH"<V6<!XCX=%6*[H@,=3)XN8<_=@AE
M<8:-=N)1!X8&=[P[$87 >'@@]H9J>,<  (65>Q6J\(AJ?-N:U8=[?/F)V8:8
M?0MWG87:?2%D<84T?490*82X?74Z481R?9D@583T?9   (/F?HJIT8;VAEJ9
MI(8/A;>(D(4^A0!VBX2&A%-C>8/M@\-/7(-Y@TDYIH,X@N,?QH.8@K@  ()O
M@ "HI87#C]N8F(3@CHJ'@X07C2)U8H-GB[9B;X+6BF1.:X)UB4HXX8(RB&X?
M,H)FB'L  ($N@ "GJX37F7Z7EH/ZEWZ&@8,PE5QT;X* DS-AC('QD3!-JH&&
MCW@X18%%CE(>M8%8C=T  ( @@ "FXH0<HS*6R(-%H(B%K8)VG:QSF8'"FLI@
MQ($WF"9- (#-E?(WQX!VE+H>48!LDE<  (  @ "F2H./K0B6(X*^J;J$^('G
MIB9RX8$FHHQ@$H"7GU9,4X YG-DW-W_?F[4=^'^GE$0  (  @ "EXX,MMQJ5
MI()@LS.$7H%\KNMR/("IJJ!??( 0IN]+UW^OI'HVS7]8H7D=GG\-E <  (
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M (WBC!![^(Q>BNEK"(KVB;]9+8FUB+)&'(B^A]PQ68@7AU 7L(C&AU@  (
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MUYQ,:HUSWYH";#1CQ)?O;<52AY8+;TD_[)2&<+$K2I/H<;,0;);><2\  (
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M%Y9XD<MP 90\D$!@"I(?CKI/,Y SC6 ])8Z?C&HI(HVVC%T/BX[ B9$  (
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MWJ36<4=GK:'G<BQ8@9\G<Q9(,)RK<_XV9YK#=,LB*YI'=1X(@)MT=3$  (
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M]Y^9ELYDN)RHE0)5G9G:DTU%II=1D?(T=Y4\D5LA%90>D.@(XI,.A@(  (
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M8*W8=QM< JI'=V!-H*;K=\,^**/L>"TM$*''>(08[J'I>%0"7IWY>E@  (
M@ !UK+ =?EUHZ:Q]?A9;=ZCS?=U--*64?<,]QZ*9?<8LT*!J?=$8YZ!:?;P"
MK)OZ?J\  (  @ !U1*[TA>%H?ZM8A2Y;!:?/A(=,MZ1M@_,]<J%D@X\LD)\R
M@VL8V9[W@[\"[9H[@?L  (  @ !TY*X3C8IH**IUC'):KZ;CBUA,7Z-YBE@]
M'J!HB9HL7YX8B6@8TIVVB8,#(YBV@A\  (  @ !TE*UEE3UGYJG!D\I:;J8C
MDD-,&**MD-X\U)^:C^XL,)T[D <8VIR5CED#5I=J@D(  (  @ !T7:S7G0)G
ML:DMFSM:,J6&F59+V*(&EZ,\E)[LEK4KZYR3EG88NYO&D+D#B993@F0  (
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M8;=F?!Y0A[-=>^E"\J]W>]XT+:P4>_ CDZGR>_@/9ZKB>]@  )MH?Z$  (
M@ !I>KHQ@W]=-;8C@MI05K(5@DM"M*XK@=<T%*JW@9HCE*B%@9X/J:DP@:X
M )IL@    (  @ !I3KD\BKM='K4<B<E01+$ B-Q"GJT-B! S_*F1AY(CG:<Z
MA\ /YJ>KAK@  )F0@    (  @ !I*;A_D?Y=%+1'D,A0/[ 8CX)"E*P;CFPS
M\:B;C>$CIZ8RCD40(J99BND  )C?@    (  @ !I#;?SF5E=%[.>E^901*]9
MEE5"DJM-E0@SY*?'E+8CG*5>D\P0/Z59BOP  )A(@    (  @ !H^K>/H.M=
M([,3GTE04:ZUG7Q"EJJ;G"4SZ:<+FVXCL:24F"(05J2#BPP  )>R@    (
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M9H&(=XN!78$[>"MP$H$#>,!=P(#>>55*.(#7>>0U!8#S>D\;-X&:>BP  (
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MMGO<HU5\CGNGH&MK=WMYG7)9B7MQFLE&CWN#F,,R'WMME_D9('K$D/T  (
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M"XBR?B1T\H?!?C5DZH;B?CM3J88N?D=!+H6I?E4LRX5V?E02N8:@?@8  (
M@ "1,(A,ALR##X=3AE=S_(9KA<-C]862A1U2]839A(% G(1<A PL6X0@@[\2
M=X3H@X8  (  @ "05X<[C[Z"5(9*CK)S0X5@C7=C(H2%C"=2)(/,BO _\H-$
MB@ KTH+]B9X2'X-GB#H  (  @ "/J(9BF+6!FH5XEQ=RA82)E3EB9X.IDT91
M;8+RD8H_58)ED$(K;X'[D!T1Y8(>C!D  (  @ "/((6\H;Z!"839GY9QZ8/A
MG1MAS(+TFHM0U8(WF%H^N8&REO0J\($ZED81LH$1B_<  (  @ ".OH5%JO>
MEX1EJ%=Q8X-BI45A/X)BHB%06(&7GY@^5H$*GF4JFX".FS41<8!%B\L  (
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M*I"QA =H^(\8@Z%9QHV:@S%)J(Q!@LDX!8M1@H<D.(K^@F<*[8KQ@>X  (
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M$Z F9)5@JYWN9J!2()OG:(I"6)H>:DXPXIC^:\,<@9G!;#\#WYBA;+X  (
M?]!Y_*%!:GMMH)[,:^)@-)Q_;4%1N9I=;I5" 9B ;](PHY=*<-0<9I?/<0<$
M()80<=(  (  @ !Y:Y^B<EAL[IU"<R%?G9KT<^91(9C1=*Q!@I;R=6@P1)6Q
M=?X<-I8%=?L$4I/%=TT  (  @ !XQ)X0>AUL,IN[>F%>S9EX>IQ0?)=8>MQ
M[)6!>QTOTY0\>T\;]Y1G>S$$=)' ?$P  (  @ !X&YR_@>]KB)IR@;E>'I@U
M@79/R)83@2U :)0T@/@O9)+O@-P;M9+U@-@$CH_]@)T  (  @ !WAINZB=]J
M^IESB3A=DY<PB'5/.I4)AZT_XI,BAP<O&9&YAK$;CY&=AQ8$J(YV@R8  (
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MNJD;:H]4_:9&:^%'0*.@;2HX-Z%@;E,G/Z Q;QL2<:(M;HH  )<M<VD  (
M@ !M%ZJ!<+-A.:>3<7-4F*2T<C=&WJ(#<P$W[9^Y<[HG&YYR="X2DJ 3<Y@
M )6@>#   (  @ !LH:CJ> A@KZ8#>%-3_:,L>)Q&:J!Z>.\WB9XS>4$FW9S<
M>6P2EYXR>/4  )0P?&,  (  @ !L**>0?VQ@.*2O?U!3@:'9?RM%XY\F?P0W
M,9S0?O0FG9MP?O(2DIR&?N,  )+H@    (  @ !KO::'AO)?V:.EAG=3):#'
MA>1%A9X+A5 VV)NKA.4F;YHHA-42DIL#A+@  )'&@    (  @ !K9*6WCGU?
MD:+2C:]2WY_GC+)%.IT>B[LVAIJ\BQLF.YDEBTH2I9FHB:$  )#;@    (
M@ !K)*4/EA!?5*(FE/52G)\SDY]$\YQ?DEDV0)GTD;,EZ9AAD;P2@IBMC(,
M ) G@    (  @ !J\*2AG>-?5J&DG*A2F9Z8FO=$V)NBF58V,YD7F,\E_)=J
MEN<2JI>IC)X "X^*@ @  (  @ !AL[A\8(E5]+5\8E))H;*09!@\8:_#9<,M
MNZV,9R4<DJU$9[@(7*ZD9VL  )-8<M@  (  @ !A,+>19]M5Q[1/:0))DK$5
M:C@\;ZX+:V8MY:N?;&0<\*L*;+H(\:P);&D  )(7=VX  (  @ !@ZK8+;NQ5
M=[*_;Y))7:]R<$4\0ZQ1<0<MUJG.<:<=%*D%<<D)7*FE<9T  )#A>X   (
M@ !@JK1D==A5);$:=AE(_:W0=F$\!*JK=KHMJJ@@=PL=%Z<R=P8)J*=Z=S@
M (^_?Q8  (  @ !@:++U?-)4Z:^L?+](OJQ=?*T[N:DT?)PMCJ:5?*(=&:6.
M?)D)ZJ6(?1D  ([!@    (  @ !@+K':@_%4QZZ!@Y=(HZLD@RH[FZ?Q@L$M
M;Z5(@H,=):00@J *)Z/,@CD  (WC@    (  @ !?_;#\BQ14M:V-BGU(F*H?
MB;P[BZ;AB0@M7:0QB+8=*Z+>B2 *9:)*AH@  (TS@    (  @ !?V;!7DD94
MLJS+D7Y(F*E(D'8[A:7YCXDM2Z-!CV4=&*'LCKP*?*$?AQ<  (R<@    (
M@ !?P:_=F:!4NZPLF+U(HZB1EX$[AZ4TEH0M4J)MEBT=,Z$!DTX*DJ BAR8
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M>G>O8;J&-'A<9'1TIWD49OMA\'G3:6=.!GJ;:[<XBWMF;;\>RWP[;M,  (
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M(&WOCCY_^&\3C/=NS7 LBYU<O7%%BE5)C7),B38TVW+RB&,;[W'+B$L  (
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M1GTY::1Z 7UD:X=ID7V<;4U7[7WC;OY$^WY!<(\P.7Z]<<D6-G^S<;L  (
M>F>6.7K7<+Z( 7L@<@%XY7MB<R=H>'NP=#=6^GP(=3I$+WQP=BDOEWS;=M@5
MQ7U(=H4  (  ??.5!7C$>>>&O'DJ>G)WEWF%>MMG>7GA>SE6$'I.>XY#<7K
M>]PO"7L;? H59GL=>Z8  (  @ "3TW<'@PZ%KG=_@O-VA'?J@K!F37A2@E)5
M'WC'@?M"EGE(@;0N5WF2@784Z7E-@5,  (  @ "2U'6DC$N$J78FBX=UA':7
MBI%E6'<&B8-4.G=^B(-!X'?VAZXMQG@PART4@7?&AJ8  (  @ "2!W2"E8F#
MVW4,E"-TMW5]DGQDD77ND,%3?79LCRE!07;BC>$M6G;\C5,4.79^BQ8  (
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M'8.D<*-M[8-"<=M>=X+S<OI-WX*[= L[V(*Q=/HGLX+W=8<-GH/G=.\  (
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MYWS[F41IL'RWEU]:>7QOE6)*27Q&D[(XTWPTDK$E@GOFDDH,RWPGB*8  (
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M1(KN=JIAWHGY=U13A8D3=_%#UXA=>'LRHX?V>.<>W8A&>.T&?(>2>;\  (
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M4H6^G<M>ZH2XF\90@H.EF:)!-H+"F"4PAH(FE[8=@8&OD_,&?8$4A&,  (
M@ !QKYO87+)E\9GW7T)9.YA@8;1+3I;\8_L\"I7:9@<JXI5]9YX6+I>%9\<
M ),-:;\  (  ?TIP]YH.9(QE9YA'9F]8M):B:$!*X94C:?@[MI/J:X,JKY-N
M;*L6,)47;)0 +Y"^;K8  (  @ !P3Y@3;$)DHI9J;8Y8#I3+;LQ*/Y--;_L[
M-)(1<0DJ5I&"<<H6%9+<<84 <XYP=#,  (  @ !ODY8Q<^-CT926=*U7*Y,'
M=65)C9&/=A(ZF9!;=J@IY8_!=PD5WI#9=JT HHQK>40  (  @ !NUY2;>Y!C
M%Y,,>^)6<9&"?!U(T) )?$,Z$H[/?&<I=8XQ?'P5G(\.?#H PXJJ?:8  (
M@ !N,I-;@UIB?)'6@SY5W)!(@OM(.X[*@J$YA(V&@E8I,(R^@C<5=HUD@F@
MX(DG@)<  (  @ !MK))/BR=A]9#5BJ%55(]%B>1'LXV_B14Y!HQVB'8HSXN=
MB%$5=8OCB 0! X??@*\  (  @ !M0I&+DPIAL9 7DC55$HYYD0%':8S3C[$X
MO(MTCM,H<(J>CP05&8K'C* !&H;1@+X  (  @ !L[Y#XFPYA7X]]F?A4N8W4
MF%]'$(P@EK$X<HJQE=$H.8G%E2<4_(G)CC !)X8#@,@  (  @ !E8J976[!:
M$J0?7A5-\*(C8&5 JZ!;8HTQ\I\%9&@@YY\398H+^Z&[91H  (V4;=(  (
M@ !DLZ3,8R=9IJ*.9/%-DZ!M9K! ;)Y[:%8QTIS_:;\@\YS5:HH,3Y[Z:?T
M (O[<LP  (  @ !D*Z+H:G59#*"X:[A-&9Z4;/$_^)R:;AXQ?YL1;QH@T)K!
M;Y4,?9QL;P8  (I[=Z(  (  @ !CG:$'<:M8:Y[B<GI,:)S)<SP_=9K1<_4Q
M$9E(=(T@D)C>=,,,CIH9=%4  (D4>^4  (  @ !C#I]N>/!7X9U3>5A+WIL[
M>:T^XYD_>>PPM)>I>B<@39<M>C$,CI@!>BH  (?1?YP  (  @ !BD)XL@%97
M<9P6@&%+=9GX@$@^?)?S@!HP599.?_H@)96B?_@,E98>@!$  (:T@    (
M@ !B)ITMA[]7&9L8AWE+))CPAO@^*);<AF8O^I4RA@X?YI1MAD0,K)1TA0T
M (7.@    (  @ !AU9Q>CRM6S)I*CIM*TY@<C;X]V)7]C-LOKI1$C'8?BY-^
MC*\,B9,EB'H  (4A@    (  @ !AE9O+ELU6OYFNEB1*Q9=LE.\]O94HDZPO
MJY-*DV<?L9);D>\,OY'LB)\  (2<@    (  @ !9([&M6F1.&J]27(U"9*T9
M7JHUG*L88)XG+*GC8B,5DZMA8F@#1:FV8UH  (CG<?T  (  @ !8<+!G87U-
MNJWB8QM"(ZMJ9+DU?ZDN9CHG.J>]9V 5ZJC/9W #TJ:_:%$  (>@=K(  (
M@ !8"*Z2:&A-2JP+:9!!T*F):K0U.*<X:\XG&*6L;)H6"J9S;'P$.:/S;7@
M (9G>MT  (  @ !7KJRG;SI,WZHF;_U!5Z>H<+DTYZ55<6TFWZ.\<>P6"J1.
M<:L$A*%<<OP  (5!?HH  (  @ !74JK]=AQ,BJB"=HI!!*7_=NHTBJ.F=S,F
MNJ'U=VT6":)==RD$PI\&>.$  (0^@    (  @ !6_ZFM?2-,4*<J?4I U:2=
M?4XT7J(W?3\FDJ!T?3,6&Z"7?18$_YSO?A8  (->@    (  @ !6NJB@A"U,
M*:82A!9 N:-U@\<T0:$"@VPF=)\T@T<6'9\M@X<%/ILA@GH  (*M@    (
M@ !6A:?2BT-,$Z4RBOU JJ*#BF<T,I_^B<\F79XAB<H5_YX1B38%39FK@Y8
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M9V>F?SQX,VE>?T9G^&KY?SE6QFR(?RQ$.6WM?R@P&FZ>?QX74FX&?O   (
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M)WE27 ERMWGA7RAB_GJ$8A-2 7LQ9-0_G7OO9UXK/'S%:5L0WGY0:6   (
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M1VWCA7IM#F[_A0Q=QW )A()-?W$'@_\[XW';@YDH6W'_@V4/6G.A@OH  (
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M:'[*8U]FU'[M9;58%W\>9^=("W]@:?(V<'_*:[DB9X"$;,D(WX'I;)H  (
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M9G40BMYB#'6)BA!3I77QB2A$-'98B%TS7':@A]D@2G8[B \(<GC8A54  (
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MK(4^:;-;"X3I:V9-(X2A;/D]^(1X;F0M!X2A;WT9 (69;Z "3H43<38  (
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MUWTOCW)717T CF=)JGRUC3PZ]7Q\C& JI'Q1C#P7D'NTBUL"GWUJ@<8  (
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M7HR>;O]/8HO)<"I"98L%<3PS[(J <B C;XJ8<IT/-XO/<@X  (*\>)H  (
M@ !EKXM]=4Q:EHJ\=A5.FXGQ=L)!GHDN=U S9HB?=\@C XBB=_T/#(E3=Y0
M (%.?.4  (  @ !D]XGB?/!9[HDP?4M. (AG?7M!"8>??8TRWH<$?9DBV8;,
M?:,/"X<2?;4  ( ;@    (  @ !D6HB(A(M94H?FA'=-:(<@A"] =H94@] R
M6H6P@XHB@(58@XD/,X4A@T<  (  @    (  @ !CWH> C$59#8;OB^5-+X8?
MBR1 /X4LBCLR+X1GB; B-H0&B@$.Y8.@A_(  (  @    (  @ !C?(:QE!E8
MK88ADWQ,RX5-DE,_X81/D08QXX-SD&XB H+MD"H.VX)=B@L  (  @    (
M@ !<X)[Q5=]20IU96)]&P)P(6T4Y^9K[7;@KB9I]7[X:29O-8+@&A)Q*800
M (.C;4D  (  @ !<!IS=71U1K)M97U5&-YGT87DYE9C 8W(K49@490P:4)D1
M9;0&WYC=9>,  ((0<C$  (  @ !;7YJ%9$-0]9D;9?Q%GY>]9Z(Y!9:$:28J
MZI7%:E8:)I:':K4'%Y6<:N0  ("7=Q0  (  @ !:MIA :UI0.);G;)Y$T967
M;<XX:I1A;N,J:I.?;[$9W90S;\X'+I*Q<",  (  >V4  (  @ !:#)9,<H%/
MDI4$<UM$,).W=!PWQI)\=+<J I&K=2T9E)(<=2$',9 J==X  (  ?RX  (
M@ !9<Y2W><A/!I-]>D-#L9(N>I4W49#I>L,IF) $>M\9<9 M>LP'.XWX>]$
M (  @    (  @ !8\)-K@1-.EI(^@3M#3)#J@2,V[8^7@.PI+HZE@,X9((ZI
M@.L'4(P<@.   (  @    (  @ !8B))<B&!.+Y$ZB#M"YX_FA\0VD(Z&AS8H
MW(U^AP88MXUSAT<'*XJCA-D  (  @    (  @ !8-Y&.C^5."9!RCZ-"PX\5
MCLXV;XV0C=LHXHQ7C<(8^8P(C*$'<HE4A0D  (  @    (  @ !0IJIA5$U&
M8JB85M([3:<-63TN[*7D6VD@AJ797/<.EZBC70@  * (8'P  (  <2X  (
M@ !/QJB46RI%Q*;,73<ZOZ4>7S(NA:/!8/<@6Z-M8BL.QZ6R8@<  )UL914
M (  =?@  (  @ !//:938>]%+:268XXZ0:+K91@N$:%^9GD@$Z$'9U8.T:+A
M9PH  )K>:>X  (  >CP  (  @ !.QZ0+:*=$HZ)9:=XYI*"V:P$MH9]);  ?
MP)Z_;)$.QJ _;"@  )AW;RL  (  ??\  (  @ !.2Z(+;W%$*Z!K<$XY,Y[%
M<1$M*YU,<:0?C)RE<?8.P)W9<8X -98 =0D  (  @    (  @ !-UZ!J=F!#
MRI[3=O XY)TH=U4LZYN>=Y$?6)K7=YP.V)NI=UX <9/:>E0  (  @    (
M@ !-<Y\3?55#?YV#?:(XJYO/?; LMYHW?9X?)IE=?8P.T9GE?;4 L)()?LX
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MGEU#:69\3U_U:UQKS&)^;3Q:/&3B;PE'=V;[<+PS*V@M<BX:NF>1<L\  (
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M>U%MED1VB%3%E$EFD5?;DE)5G5JWD)-#C%SZCRTP+%UXCGP8N5\YC.T  (
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M4V%H<-=P_F.K<B5AH67&<UA0_F?#='@_&VEC=8 K<6GK=D42DFQ'=@P  (
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MJE>]FY]L@EIGF59=7ES2EPA-15\#E18[^F"/D],I"5_ODV@1)&7OBY<  (
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M2&9S=V-EW&@^>")78&G=>,%'SVM:>50VI&QX>=,C;6PY>A4+"G&;>F4  (
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M!'IB5H]@#7L 6?91UWNP72E"1WQH8!\P_WU!8JX<XGYL9",$A(#I9.T  (
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M;VR/?1-:VFW/?5I-,F[B?7X^:F_.?9PN '!2?;T:X6^(?<($F'@\?H(  (
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MD'_!72%49H '7]!'$(!58E,X0X"Y9) G=(%K9D02UX+[9E\  ($):F(  (
M?S9JA'Q38B-?;WS+9%Y3=GTR9GQ&+GV0:&XWBWWX:B<FZGZ*:V<2E'^):S\
M (  ;WH  (  @ !I;7EF:?A>3GH$:Z%247J%;2U%2WKW;I@VOWMH;\XF3'O;
M<*$2.7R/<$@  (  =/X  (  @ !H8W;5<=-=5'>0<O5177@E<_5$47BB=-$V
M(WD+=8TER'E@=@,1]7GX=9X  (  >>(  (  @ !G<W2@><5<<'5X>F)0B'8>
M>M5#FG:=>R4U?W;_>V0E?7<?>Y(1UW>Y>V   (  ?@D  (  @ !FKG+(@;-;
MRW.]@=M/]G1K@<5#"W3C@8PTZ74Y@6,D]W4O@601J77:@8D  (  @    (
M@ !F$G%)B9I;-')-B55/8G,!B+U"@G-TB 4T9W.[AXLD<G.)AYL12W1JAL$
M (  @    (  @ !EF' 6D89:OG$HD.I.ZW'@C]M"$W)+CK,T"W)^C@(D+W(A
MCC81$7,_BO   (  @    (  @ !@IHQO49A6!XOM5-Q*=XNI5_T]G(N56N0O
M&HO7764>"(TI7OH)@(YJ7RD  (  :6D  (  ?G!?CXE26/Y5*XD16[M)JHC>
M7E4\]8C$8+PNH8CN8L8=R8GY8_@)I(JH8_T  (  ;BD  (  @ !>GX9!8&-4
M+88Q8IA(UX879*\\+X8$9I8N!88D:"D=8H;U:/T)HX=1:.L  (  <V0  (
M@ !=L(-H9\E3,H-W:7I'U8-Q:PT[9X-J;'HM58.);9P<XX0D;A@)AH1G;@P
M (  >%L  (  @ !<QH#H;SU23H$2<'%&]($<<84ZBX$5<F\LP($G<RT<9X&.
M<V,)88'C<XH  (  ?*P  (  @ !;]'['=L11B'\*=X5&/7\?>!PYW7\7>(XL
M(W\4>.(<)7\H>/$)6G^T>9D  (  @    (  @ !;/'SP?CU0UWU/?I)%F7UO
M?K0Y1WUD?K<KFWU/?KH;T7TD?L0)C7W2?S,  (  @    (  @ !:K'MYA<M0
M='OYA<Y%1GP;A7@Y!GOQA/TK;WNVA,,;C7M:A1L)4GQ<@]\  (  @    (
M@ !:.WI*C6Q0!7K7C2M$V7K_C&TXIWK-BY(K)WIUBT@;8GG9BS()3'LJADD
M (  @    (  @ !4I9;<4#U*C)7Q4U4_B95/5DHS)I4"6/HDSY5W6Q82[YA2
M6Z@!@I2E78T  (  ;10  (  @ !3GI/]5S])O)-$6> ^Q9*G7%TRB))$7ILD
M9Y*(8$\2V)3G8)D!U)$*8FD  (  <?@  (  @ !2RY$,7C](W)!Y8&<^"H_L
M8FTQV(^'9#DCY(^O98<2FY&D98X"!HW+9V<  (  =N0  (  @ !2 (Y"94!(
M!HW(9O$]*(U+:($Q+XSI:>$C5(T!:M 22HZ3:IT"'XKP;*0  (  >SP  (
M@ !1.8O(;%5'1(MI;98\:XKW;K4P=(J/;YXBXXJ*<#T1_HN^;^8"+8AX<EH
M (  ?P8  (  @ !0@HFK<X!&F8EG=%P[THC]=0TOZHB,=8\B:8AH==<1XHD?
M=8@"1895>$H  (  @    (  @ !/XH?B>JE&#(>X>RT[6(=4>W4O@(;5>Y<B
M!(:3>Z81J(;E>XL"<(2"?5<  (  @    (  @ !/8(9C@<1%B(92@? ZV(7V
M@=<O#(5P@:<AFX41@:81+X48@<,"88,1@74  (  @    (  @ !.^(4TB3-%
M6H5&B4 ZN83SB+TO$(0XB!0A[8.#B!H1Y(,=AR0"UX&T@>P  (  @    (
M@ !(6*)Q3E\^WZ$\44(T::!G4_8H6: H5DX9PZ%S5[\(HZ,;6&4  )&47^0
M (  <'H  (  @ !'1Y_F5/X]^)[L5W<S>)X:6<4GCYVO6[P919ZA7-@(IY]S
M75D  ([<9'X  (  =5$  (  @ !&FYT-6YT]-)PM7:PRPIMO7XXFVYKY8208
MPYN]8>H(EYO.8E   (Q#:5$  (  >:D  (  @ !&!YH\8CH\A)EO8]PQ]IB\
M958F0)A'9HL81YCM9P8(@)A,9U\  (G>;GP  (  ?8   (  @ !%9)>X:.@[
MW9<,:BDQ7I98:T EJ)72; H7^Y9,;$L(=94/;*\  (?&="\  (  @    (
M@ !$Q963;[X[2I4*<*<PY)1;<5\E3).^<=,7N)0 <= (DI(I<F0  (80>6<
M (  @    (  @ !$.Y/"=IPZSY-:=SDP@I*N=Y8D^)(!=[P7:)(>=YD(@H_2
M>)L  (2R?<H  (  @    (  @ !#R9)!?9 Z;9'V?>TP,I%/??@DPY"(?=H7
M0I!S?<@(4HWP?G@  (-%@    (  @    (  @ !#@)$$A,8Z)9#.A/0O\9 R
MA+,DF8]9A&472H\%A(<(A8Q9@U@  ()Q@    (  @    (  @ ">^U/53=6/
MR%<(4AV !%HB5E!O7%TL6F-=I6 97E%*OV*U8A$V<61C98$>7V.69_0!>WV
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MU5B[6OYU+5NV7DIE?UZ-8794HV$Q9'A"@&-J9THNN61=:;<63F9@:MH  (
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M?D<&APUNETM$AFU?GD\>A<U/E%)^A4,^6%34A-\KFU1,A,0455VBA/H  (
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MM%M;8M]J+5X<96-;7&"C9\5+:6+H:@,Z"V2A; TFN622;9D.$VN';<4  (
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MTDP*C,-DJD^VB[)6=U+XBIQ')U6JB;@VA%<*B2LD-U;"B6(-)6G(AS8  (
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MFE[::;Y>Y&%$:Y=1.V-R;5A"%V5+;NLQ;69E<$4>6&7><0$'#G03<<X  (
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M+5'MD:):L%3UD$M-+U>"CN(^F%EAC=(NBEF4C7D<0%N>C1D&G733A'D  (
M@ !PT7%S3>)E!G*34:18>'/-555*T74&6-X[S78M7" JYW=#7MD6G7@P8!8
MIW[F8EH  (  >-IO#VSK5=QCNVYJ61-77V_<7"Y)Z7$V7R$[#7)J8= J4G-:
M9 ,60W0)9-< SGZD9R$  (  ?(1MEFBG7?=B4FIX8)%6-FPC8Q%(V&V=96DZ
M)F[=9X@IFF^?:3<5QW!]::T X'Z&;"H  (  ?[QL-62T9A=@^&;$:!)4XFB<
M:?='WFHV:[TY1FN$;4TH\&P1;H(576UN;JD \WYE<98  (  @ !JXV$C;D9?
MN&-F;Z13NV5D<.U&RF<7<A8XHVAN<R(H;6C#<^<5&VK)<]H!$WXN=QX  (
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MW'JX4/A.!WN(5()! WQD5]TR='U,6MLAE'Z 70T,S("@77@  (  99T  (
M>[1C177"5-]8J';!6 ),_7>Z6P5 *GBD7=@QR'F"8%,A''IG8A$,M'RL8CT
M (  :D@  (  ?O1A\7&G7(-777+N7Q=+[G0289 _+W4/8]<P^G7F9= @@79X
M9QX,?'E!9QH  (  ;U8  (  @ !@L&W59#)6&V]19C1*L'"7:!T^-W&L:=\P
M'G)^:UD?U7*S;#\,,'98;"   (  =-$  (  @ !?A&I<:^A5 VP$;5])I&UI
M;KP]+&Z+;_,O>&]/</D?2V\=<8@+_G/0<6X  (  >;(  (  @ !>=F=&<[)4
M!FD9=*1(OFJ<=70\:FO'=B(NSVQT=K ? VO;=OT+]'&9=Q\  (  ?=,  (
M@ !=F&23>WA32V:5>_-(&V@S?#H[TFE??&(N,VGH?(L>>FD=?*P+UV_"?3T
M (  @    (  @ !<YV)*@S)2I&1M@T%'?68A@P<[0V=,@K,MJV>S@HH=[&;J
M@K<+BFY<@GL  (  @    (  @ !<8F!MBNQ2)F*JBJ5&_V1NB?4ZS&65B2TM
M2V78B,P=J&4FB2H+66T^AJH  (  @    (  @ !8\X-<3&!.JX.63]U#A(0$
M4SXW"H2:5F$HO(6 60(75H>)6EP$<8?56Z(  (  :34  (  ?AI7>'].4WQ-
MA'_55HI">8!@67$V+(#Q7!LH$X&Q7DD6\8,S7T,$C80(8&X  (  ;?$  (
M@ !62'M:6K-,5'P?74!!>WS)7ZHU/GU?8=<G4WX"8Y$6:W[[9"\$BH"V958
M (  <R0  (  @ !5*W>B8?5+,7B28_U 5GE59>0T6'GW9YHFB'I_:.85TWKX
M:2\$<WW<:F\  (  >"   (  @ !4&G0Y:4=**752:LX_578O;#8S8G;0;6PE
MXG<W;E@51W>$;EX$6GMI;^,  (  ?'(  (  @ !3)G$L<*M)0W)O<;L^A'-D
M<J8RH70&<V<E-W0]<^L5!72'<],$8GE#==\  (  @    (  @ !246YW> I(
M<V_G>*D]Q'#V>1HQ]7&6>6LDH7&;>9\4HG(F>8 $D'A*>W,  (  @    (
M@ !1IFPG?W1'[VW,?[@]6&[W?[$QJ&^)?XTD96]2?XD40G Z?[ $7'BB@"<
M (  @    (  @ !1)6H_AO)';VP!AND\W&U!AG@Q.6W.A?,D$6UDA=L4$&ZD
MA;@$47BU@NL  (  @    (  @ !,[XV@2M=#8(UJ3C8XU8V#46DLO8W_5$0>
M58]?5E<,@)'=5O8  (F*7#0  (  ;*T  (  @ !+DXG+491".(GF5(LWM8H7
M5U KQ8I_6;X=F8N86VP,.8T56]8  (9.8-\  (  <8X  (  @ !*A87Z6&=!
M'(9+6NDVO(:473PJUX;S7SL<W(?48(0+Y(B>8+\  (-49;H  (  =H@  (
M@ !)C8)47T= %X+(84\UJX,C8RLJ 8.!9+\<((0Q9:L+B(2W9<(  ("J:MX
M (  >NL  (  @ !(FW[Q9CP_)W^/9\XTPG_^:3<I'H!/:E<;E8#!:O@+.X%@
M:OT  (  <'D  (  ?KX  (  @ !'NGOB;4P^37RP;G S_GTV;V@H<7U]<"(:
M^WVF<&P+$WZ&<(<  (  =E4  (  @    (  @ !&^'DQ=%T]E7HM=1TS7'K+
M=:<GYGL%=@,:<GKG=A,*U'PV=FP  (  >T<  (  @    (  @ !&3W;0>VP\
MZW@#>] RO7B\>_@G77CM?  9^GB$>_L*;7IO?*T  (  ?W@  (  @    (
M@ !%TW3;@KP\AW9$@N R;W<@@I\G.G<Y@DL:)'9R@EL*SGBU@@8  (  @
M (  @    (  @ ! F9E%2*LWLIBM2^4MHYB43M0AJIE143L2>9PR4E,#4IF^
M5&   (2R7XH  (  < T  (  @  _-Y6\3P0V5)6.4=DL+)695&(@2Y9 5F81
M;IBA5R\#"94563\  (&N9$   (  =0$  (  @  ^09(657@U.I(95^$K'I(^
M6@(?.I+76Z 0H)3#7!\"TI#/7BX  (  :2,  (  >70  (  @  ];XY]6_TT
M4(Z?7?8J&([57ZD>9X]D8.@/_Y#782H"JHT&8SH  (  ;E8  (  ?5@  (
M@  \FHL48IHS=(MI9"8I1(NM970=F8PB9DL/IXT09F<"F8G%:(<  (  = 0
M (  @    (  @  [RX?R:5TRIHB':H$HD(CE:VL=!HE":_$//XFD:]8"IH<#
M;C   (  >3L  (  @    (  @  [%84I<"DQ](7^<.\G^(9W<7D<C8:_<;0.
MYX:N<88"EH3%=%,  (  ?9@  (  @    (  @  Z?(*[=PHQ78//=WPG=H1E
M=ZX<+H27=Z@.HX1)=Y(";H,">BL  (  @    (  @    (  @  Z#8"J?B<P
MYX'V?D\G"X*L?C$;XX+,?@$.D8)<?BX"B8&(?O\  (  @    (  @    (
M@    /__  #__P  __\  &UF=#(     ! ,)   !
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MA\1]PL"?AL-]<*F,A>9]59)2A2I]=7L'A(9]QF/$@_%^-4R/@WA^Z362@RB
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MD!%]_RG0BQQ_Q*]<K5*"9I[4J-F!@HX&I(2 T'S^H%" 6FN_G#* (EI]F ^
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M@>)\[#-\@@1^=>#A@HZ"J<Q<@A>!YK<2@;.!/Z$H@66 P8KI@2N :W2@@0F
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MDH-^V)Z$D&U^DXNVCGI^<GB%C*)^>64UBME^I5(4B0]^YS\[AT=_6RTKA72
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MDR-^5R1NC&1_GHR$NFZ"LG\NM/^!QW&IKX2!#&/IJ@* FE8FI&. 74B4GIR
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M"5L-KH&-PDZ@I]:+F$*4H/R)@S=*F>:'=2T'DHR%>R1HBQ:#JH"]P/F;8G1
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M=&F(&KB%=7^&Q*)]=I6%J(PK=[.$KW6_>.*#RU]D>B:"XDDT>Y6!]3-P?4R
MY.$H<?R4C<PS<R.2"+;4=$:/I:#]=7&-:XK8=JR+:G2@=_>)<UY]>5>':4B
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MA75]B"M^A$-^LK=ZC?F"RZ<$C&."/Y7[BN&!MH0LB86!2W(+B#N ^5_-AP2
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M?:6'A9?F?:2&BH7W?;2%D7.=?>&$KV$P?B6#U$[_?GN"]#T:?OJ"!"P9?Z*
M\KB2?'^1_*?V?'^0.9:K?(N.8(3,?*J,>W*B?.2*G&!>?46(R$YB?;6&WCRV
M?D^$S"OR?Q&"=K>&>Y.;@:;L>YJ8ZI6F>ZF6)X/2>]"33W'!?!:0<U^C?("-
MDDW8?0J*FSQ=?;R'8RO2?I6#T+:O>MBD[J82>N2A?Y3)>O*=S8+[>QN9]W$
M>VZ6'5\&>^:2,4UE?'B.'CP5?4")PBNW?BV$_K8,>DNN.*5F>EJI[901>F2E
M1()#>HB@9G!3>N&;@EYP>VN6BDSV? J18#O6?-N+X"N@?=>& ;6A>>RW5Z3F
M>?RR*I-Z>?JL?8&D>A2FC&_">FN@E%WY>ON:B$R6>ZJ41CN3?(N-L2N/?9.&
MUZ]FBSMJLJ!.B?1LJ)!9B.!N?G^#A^YP1VXIAP=R(UR@ABET(TM7A5%V23I
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MB*]]WR60A@I^T)+[F3J"%X7$EJZ!M7@-E"V!4VGKD;6 _UMPCTJ P$T#C-V
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ML$*"<%M1JR^!X%!TI=N!9T7!H%.!&#M0FJ: Z#&CE,: PRCCCL2 MR&CB-Z
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MALB%TGI'A=*%*VP"A.6$;EU\A R#L4[;@U:# T">@JN"4#+@@A^!DR9N@::
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M.7R]F!V6E7&7E9Z4J&7;DN^23EG&D"J/M4VZC7V-(D'NBNV*F#;8B%6(%2R
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M<'B$XH8Q<<6$4W:)<QN#KF:4=):#"U9R=D6"<D:[>!2!UC=T>B&!,"E9?&F
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M-YKZ?4=HOXW3?6MJZ7^_?9]L^G#S?>)O!6&F?CAQ'E(W?J5S5$,C?RIUJS2
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M=>E]'RJ%>:Q^*:2_7X&!:9938EJ!1X<_91F!#W>59]V RV>>:L^ CE=T;?Z
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M=W&"D6L >!F"4UZI>,F!]5(F>9R!F$6I>IV!1CFJ>\. ^2Y0?1N JB1??HV
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M@&Q[;4!5@&Q\+S5R@'A\_BM&@*=]X2*&@.Y^S'=&?YM_]&S=?X^ 'F'[?W"
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M?<M^TE*R?@%^^TEM?B%_$4 D?E!_,#<H?IA_7R[0?O1_GR<$?XE_W""=@"N
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MA/V!@4J/A&B!5$)<@Z*!$CHT@MV Y3)0@C> RBL_@9. Q"3;@3* L!^7@0R
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MC*"#?4+TBSV# #OEB6N":S3]AW^!_"Y1A;R!J2A4A!N!:2+]@M&!(!ZY@=>
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M3Y=^<78X5(-^FFCH67Y^O5M*7K5^Y4V:9#A_'4!=:?]_8C/$<!!_MRB>=B&
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M?O]_EA[A?_V  U+@=W&"'DO,>/:"%T2@>A^!OSUQ>NV!6#95>Z.!&B]H?'R
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M@)Z &QX%@,2 5   __\  /__  #__P  ;69T,0     #!"$   $
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MYN?HZ.GIZNOK[.SM[N[O[_#P\?+R\_/T]/7V]O?W^/CY^?K[^_S\_?W^_O\
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M,O^F0$O_L#E8^;TQ8N?.+6G0X"1_N<\WEZ?"4JF>NF:UFK5SNYBS?;Z7LH/
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M_Z(W(O^?1#?_H4A(_Z=&5?RL16+TLD9N[+A(>N:_3(/AQU.*W,UBCL[(;)O
MOW&JM+=WM:FQ?+Z?K('%EZ>&RI"DC,Z*HI71AJ*ATH2;I="%FJ7/A9JESX6:
MI<^%FJ7/A9JESX6:I<^%FJ7/A9JESX6:I<^%FJ7/A9JESX6:I<^%FJ7/_Z(V
M(O^?0S?_HD9'_ZA$5/VN0V'UM41L[KQ&=^G$2W_CSU2$V=1EB,C+:YJZPG"I
MKKIWM*.T?+V:KX'#DJR%R(NIBLR$IY+/@*:<T("CI<^ H:;.@*&FSH"AILZ
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MK,9]GJS&?9ZLQGV>K,9]GJS&?9ZLQGV>K,9]GJS&_Z U&O^=0B[_HD(\_ZI
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MDE$W_Y=31?^95U/]F5M@]9AA;>V5:'GEDG*$WX]\CMJ,A9;5AXN<T8.0H<^
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MY4ACK.)-<I_?5'^3V5V*B=)GDX/-<)I]R7>?>,9]I'3$@Z=PPHBI;L&.JVS
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M8O=S@VCT;XQN\6R3<N]JFG7M9Z!X[&6E>NMDJGSJ8J]]Z6&U?NA@NW_H7\.
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MM%0_W;-;2="L8EG&I&IFO)UQ<K27=WRLD7Z%IHR&C*"(C9&:A966EH*>FI*
MIYV/?[*>C8#!GHR R9Z+@,J=BH#+FXJ RYN*@,N;BH#+FXJ RYN*@,N;BH#+
MFXJ RYN*@,N;_W\B!O^%, __E386_Y\['?^E/23_JT$J];!%+^RU3#3CNE0Y
MV+=92,NO85C!J&AFMZ%O<J^;=7RGE7R$H)&#BYJ-BY&4BI.6CX>;FHN%I9V(
MA+"?AH2^GX6%R9Z%A,F=A83*G(6$RYN%A,N;A83+FX6$RYN%A,N;A83+FX6$
MRYN%A,N;_X B!O^'+P__ES46_Z Z'/^G/"+^K3\G\[-$+.FZ2S#AOU(UT[I8
M1\>S7U>\K&9ELJ5M<:F?<WNAFGJ$FI:!BY22B)&.CY"6B8R9FH2*HIV!BJV?
M?XJ[GWZ*R)Y_B<F=@(C*G("(RYN B,N;@(C+FX"(RYN B,N;@(C+FX"(RYN
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M=>ACJ7CF8;)ZY&"[>^)?QWS@7]I]U&+A?<ICX'[#9.!_O6;?@+=GWX"W9]^
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M@EBOW8)8K]V"6*_=@EBOW8)8K]V"_X07 O^9' +_JA\#];D5 M[-# #0WQ(
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MB# P_X\P+O^6,2W_GC(M_YXR+?^>,BW_GC(M_YXR+?^>,BW_GC(M_YXRI,(
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MID<\^[%(._N^23K\STDY_.-).?SC23G\XTDY_.-).?SC23G\XTDY_.-)QZT
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M)2;_H28E_Z<F)?^G)B7_IR8E_Z<F)?^G)B7_IR8E_Z<FG\   )'-  "#VP
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M@Q@E_XX9)/^8&B/_H!HB_ZH;(?^M&R'_K1LA_ZT;(?^M&R'_K1LA_ZT;FKX
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M!_]C.P[_9486_V50'?]A623_760K_UIP,/]6?#7_4X<Y_U"1//].FC__3:)
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M8V2,]&-DC/1C9(ST8V2,]&-DC/1C_W$0 ?^"#P#_D0T WI\) -.J"0#,LPD
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MH2TY\JXN./*^+S?ST"\W\^<O-O'S+S;Q\R\V\?,O-O'S+S;Q\R\V\?,ON:<
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M$![_H! >_Z@1'?^Q$1W_L1$=_[$1'?^Q$1W_L1$=_[$1E;P  (;'  !YTP
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M6')Z_%AR>OQ8<GK\6')Z_%AR>OQ8_V<1 ?]U#P#_@PX ](X- -N9"@#4H0L
MS*05 ,*D)P.XHC8*L)Y"%:>:3!^@EU0IF9-<,9.08SB-C6H_B(IQ1(.(>$E^
MAG]->H2(47:"D55S@9M8;X"F6FU_M%QK?\5<:X#?7&N \EIK@/M9;'[\6&U^
M_%AM?OQ8;7[\6&U^_%AM?OQ8_VD0 ?]X#@#_A0P XI(( -6;"0#.HPD QZ@2
M +VH)0*TIC0)JZ) $Z.?2AZ;FU(GE)A:,(Z583>(DF@]@I!O0WZ.=DAYC'U,
M=8J%4'&(CE1MAYE7:H:D66>%L5MEA<);987<6V6%\%IFA?M99X/\6&>#_%=G
M@_Q79X/\5V>#_%=G@_Q7_VP. /][# #RB0D V94& ,^>" #)I@@ P:L0 +BK
M(@*OJC((IJ<^$IZD2!R6H5$ECYY8+HB;7S6"F68\?99M07B4=$9SDGM+;Y"#
M3VN/C%)GCI959(VB6&&,KUE?C,!:7XS965^,[EE?C/M888K]5V&)_5=AB?U7
M88G]5V&)_5=AB?U7_V\, /]_"0#?C0, TI@& ,JB!@#"J08 NJ\. +*P( &I
MKB\&H:P\$)BI1AJ1IT\CB:16+(.B73-]GV0Y=YUK/W*;<41NFGE(:9B!3&67
MBE!AE9137I6@55N4K5=:E+U869345UF4[%=9D_E66Y'^55N0_E5;D/Y56Y#^
M55N0_E5;D/Y5_W,) /6$! #8D0, S)P% ,.E!0"[K00 L[,, *NU' &CM"P%
MF[(Y#I*P1!>*K4T@@ZM4*7VI7#!WIV(V<:5I/&RD;T%HHG=%9*%_25^?B$Q<
MGI)/6)Z>4E:=JU-4G;Q44YW15%.=ZU-3G/A35)K_4U29_U-4F?]35)G_4U29
M_U-4F?]3_W@& .&)  #0E@( QJ$# +RI P"SL $ J[@( *2Z& "<NBD#E+DV
M"XRW012$M4H=?+-2)7:Q6BQPKV R:ZYG.&:M;CQBJW5 7JI]1%JIADA6J)%*
M4ZB=35&GJDY/J+I/3JC/3TZGZ4]-IO=/3:7_3TZD_T].I/]/3J3_3TZD_T].
MI/]/^G\  -B.  #)FP$ OJ4" +2M 0"KM0  H;\$ )O!% "4P24"C, S"(2_
M/A%\O4@9=;Q0(6^Z6"=JN5\M9;AE,F"W;#9<MG0Z6+5\/E6TA4%1M)!$3K.<
M1DRSJ4A*L[E(2;3.2$FSZ4A(L?9)2+#_2DBP_TI(L/]*2+#_2DBP_TI(L/]*
MXH8  ,Z4  #"H0  MJD  *NQ  "AN@$ F,,% )#)$ "*R2 !@\DO!7O(.PUT
MQT44;L9.&VC%5B%CQ%TG7L-D*UK":R]6P7(S4\%[-D_ A#E,P(\\2L";/D?
MJ#]&P+A 1<#-0$7 Z#]$OO9!0[W_0D.\_T-#O/]#0[S_0T.\_T-#O/]#UHT
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M(S7NSR,T[N8C-.OU(S3K^",TZ_@C-.OX(S3K^",TZ_@CLZ4  *:M  "9MP
MC<$  (#+  !UU0$ :>$& &3S$0!>\QP!6?0F E3T, 1/]3@&2_5 "$?V1PI$
M]DX,0?=5#C_W7 \\]V,1.OAJ$S?X<Q0U^'T6,_F(%S'YE!@O^J$9+OJO&BW[
MOAHL^\\;*_OG&RO[ZQLK^^L;*_OK&RO[ZQLK^^L;J*H  )JT  "-OP  @,D
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M2W]K_TM_:_]+?VO_2W]K_TM_:_]+_UX0 ?]K#@#_=@X ^X - .J(#0#;CPP
MT)(5 ,>2)P*^CS8(MHQ"$:Z(31JHA%8BHH!>*IQ]93"7>FPUDW=S.H]U>SZ,
M<X)"B'*+1H5PDTF";YU,?VZH3GUNM4][;<90>F[@4'EO\DYY;_Y->6__3'EO
M_TMY;_]+>6__2WEO_TMY;_]+_V / /]M#0#_>0P [H,+ -N+"0#4D0H S)43
M ,*5)0*YDS0'L8]!$*J,2QFCB%0AG81<*9>!8R^2?FHUCGQQ.8IZ>#V&>(!"
M@W:(17]UD4E\<YM,>7*F3G9RLU!U<L-0<W+=4'1S\$]T<_U-='/_3'1S_TQT
M<_],='/_3'1S_TQT<_],_V(. /]O# #\>PH WH8& -6." #/E D QY@1 +Z8
M(P&UEC(&K9,_#Z:021B?C%(@F(E:*).&82Z.@V@TB8%O.85_=CV!?7Y!?7N&
M17IYCTEV>)E,<W>D3G%WL5!O=L%0;G?94&YW[T]N=_Q.;G?_36]W_TQO=_],
M;W?_3&]W_TQO=_],_V0- /]R"@#P?@8 VH@% -"0!P#*EP@ PIL0 +F;(0&Q
MFC &J9<]#J&41Q>:D5 ?E(U8)XZ+7RV)B&8SA(9M.("$=#U[@GM!>("$171_
MC4AQ?9=+;7RB3FM\KT]I>[Y0:'S54&A\[4]I?/M.:7S_36I[_TQJ>_],:GO_
M3&I[_TQJ>_],_V8* /]U" #A@0( U(L% ,N3!@#$F@8 O9X. +6?'P&LGBX%
MI)L[#)V81166E4X>CY-6)8F072R$CF0R?XMK-WJ*<CQVB'E <H:!1&^%BD=K
M@Y5*:(*@366!K$YC@;Q/8H'13V*!ZTYC@?E-8X'_3&2 _TMD@/]+9(#_2V2
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MIT=2F;9(49G*2%&8YDA1E_5(49?_1U&6_T=1EO]'49;_1U&6_T=1EO]']G<
M -B%  #)D0  OYL! +2B  "KJ   H;   )JR$0"4LR(!C;(P!86Q/ Q^KT84
M>*Y.&W*L5B%MJUPG:*EC+&2H:C!@IW$T7*9Y.%BE@CM5I(P^4:.80$^CI4)-
MH[1#3*/(0TRCY$-+H?1#2Z#_1$N@_T1+H/]$2Z#_1$N@_T1+H/]$XWT  ,^+
M  #"E@  MY\  *VF  "CK0  F;4  )"Y#@"+NAX!A+HM WVY.0EWN$,0<;9,
M%VNU4QUFM%HB8K-A)EZR:"M:L6\N5K!W,E.P@35/KXLX3*^7.DJNI#Q(KK,]
M1Z['/4>NXSQ&K?,]1JO^/D6K_S]%J_\_1:O_/T6K_S]%J_\_VH,  ,>1  "[
MG   KZ0  *6K  ":L@  D+H! (;!"0"!PA@ >\(H G7"-09OP4 ,:<!)$F2_
M41=?OE@<6[Y?(%>]9B14O&XG4;QV*DV[?RU*NXHP2+N6,D6[HS1#N[(T0KO%
M-4.[XC1"N?,U0;C]-T"W_S= M_\W0+?_-T"W_S= M_\WSHL  +^8  "RH0
MIZD  )RP  "1N   AL " 'O(!P!TRQ( <,PB 6O+, -FRSP'8<M%#%S*3A%8
MRE855,I=&5')9!Q.R6P?2\ET(DC(?B1%R(@G0\B5*$'(HBH_R+$K/LG$*S[)
MX2H^Q_(K/<;\+3S%_RX\Q?\N/,7_+CS%_RX\Q?\NQ),  +:?  "II@  G:X
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M$2?U\1$G]?$1)_7Q$2?U\1$G]?$1HZ@  ):R  "(NP  >\4  &_.  !BUP
M5MX  $[P!P!*^A  1OL9 $+[(@$__"H!._TR CC].0(U_C\#,OY& S#_3 0N
M_U,%*_]:!2G_8@8G_VL&)/]V!R/_@@@A_Y ((/^="1__JPD>_[H)'?_)"1S_
MW0D<_]T)'/_="1S_W0D<_]T)F+   (JZ  !\Q   ;\T  &+8  !5W@  2>0
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M-/\A_S@J O\_)P+_0R8"_T8I O]),@/_23P%_TA'!_]&4PO_1%\/_T)J$O]
M=A7_/H 8_SR*&?\\DAO_.YH<_3J@'?PZIQW[.:T>^CFT'_DYO!_X.<8?]CG3
M'_(YY!_O.? ?[#KZ'^HY_R'I.?\CZ#G_).<Y_R3G.?\EYSG_)><Y_R7G.?\E
M_SPG O]#(P+_2"("_TPF O]/+P/_4#D%_TY#!_],3PO_2EL/_TAF$_]%<1;\
M0WP9^D*&&_A!CASV0)8>]3^='_,_HR#R/JH@\3ZQ(? ^N2'N/L,A[3[/(>H^
MXB'F/^\AXS[Y(^$]_R7?/?\GWCW_*-P]_RC</?\HW#W_*-P]_RC</?\H_S\C
M ?]'( '_3!X!_U$D O]5+ /_5C4$_U4_!O]32@K^4%8/^DYB$_9+;1?S27<:
M\$>!'.Y&BA[L19(@ZT29(>E#H"+H0Z<CYD.N(^5"MB3D0L DXD/,)-]#X"3;
M0^TEUD+X*--"_RK10O\KST'_*\Y!_RS.0?\LSD'_+,Y!_RS.0?\L_T,@ ?]*
M' '_4!L!_U<A ?];* +_7#(#_UL[!OQ91@GV5E$.\51=$^U1:!?I3W(:YDU\
M'>1+A2#B2HXAX$F5(]Y(G"3<1Z,FVD>K)]A&LRC51KPHTT;(*=%&W"K-1^PJ
MR4;W+,=&_R[$1O\OPT;_+\)&_R_!1O\OP4;_+\%&_R_!1O\O_T8= ?].& '_
M5A@!_UP> ?]@)0+_8BT#_&(W!?1@00CN74P-Z%I8$N-88Q??56X;VU)W']A0
M@"+43XDDT4V0)\],ERC-3)XJRTNF*\E*K2S'2K<MQDK"+L1*T2_!2^<OO4KT
M,;M*_S*X2O\RMTO_,[9+_S.V2_\SMDO_,[9+_S.V2_\S_TH: ?]2%0'_6A8!
M_V$; ?]F(0'^:"D"]&@R ^QG/ ;E9$@+WV%4$-E>7A?26VD<SEAR(,M6>R3(
M5(,GQ5*+*L-1DBS!4)DNOT^A+[U/J#&[3K$RN4Z\,[=.RC2U3N$TLD[Q-:]/
M_3:M3_\VK$__-JM/_S:K3_\VJT__-JM/_S:K3_\V_TT7 ?]5$@'_7Q0 _V88
M /]K'0'X;20![6XL N5M-@3=:T,(U&=/$,UD6A?(8&0=Q%UM(L%;=B:]67XI
MNU>%++A6C2^V590QM%2<,[)3I#2P4JTVK5*W-ZQ2Q3BJ4MHXIU+M.:53^CFC
M4_\YHE/_.:%4_SBA5/\XH53_.*%4_SBA5/\X_T\4 ?]9$ #_8Q( _VH4 /]O
M&0#R<A\ YG0F =UT,0+3<3\(RVU+#\5I5A? 9F =NV-I(K=@<2>T7GDKL5R
M+JY;B#&L68\SJEB7-:=7GS>E5Z@YHU:S.J%6P#N?5M(\G5;I/)M7^#R:5_\\
MF5C_.YA8_SN86/\ZF%C_.IA8_SJ86/\Z_U(2 ?]<#@#_9A  _VT1 /IS% #K
M=Q@ X'D? -1Y+0++=CP'Q')(#KYO4Q:X:UP=LVAE(J]E;2>L8W4KJ6%\+Z9?
MA#*C7HLUH5V3-YY<FSF<6Z0[F5JO/9=:NSZ66LP_E%KE/Y);]3Z16_\^D%S_
M/9!<_SR/7/\\CUS_/(]<_SR/7/\\_U41 /]?#0#_:0X _W$. /5W$ #F>Q$
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M06AXJD-F>+A$97C,165XYT1E>/=#9GC_0F9X_T%F>/] 9GC_0&9X_T!F>/]
M_V0# .YQ  #8?   RX4" ,., P"[D0, LY0) *R6& "EEB@"G90V!Y:200Z0
MCTH5BHU2'(2+6B)_B6 G>X=G+'>%;C!S@W4T;X)]-VR!ACMI?Y ^9GZ;06-^
MJ$-A?;9$8'W)1%]]Y4-@??9"8'W_06%]_T!A??] 87W_0&%]_T!A??] _V<
M .-T  #2?P  QX@! +Z/ @"VE0$ KI@& *::%0"?FB8"F)DS!I&7/PR+E4@4
MA9-0&G^16"!ZCU\E=HUE*G*+;"YNBG,R:HA[-F:'A#ECAHX\8(69/UV$ID%;
MA+1"6H3'0UJ$XT):@_1!6X/_0%N#_T!;@_\_6X/_/UN#_S];@_\__VH  -YX
M  #-@P  PHP  +F3  "PF   IYT" *"?$@"9GR,!DYXQ!8R=/ N%FT82?YE.
M&'J75AYUEETC<)1C*&R2:BQHD7$P99!Y-&&.@C=>C8PZ6HR7/5B,I#]6B[)
M5(O%0%2+X4!4BO,_58K^/U6)_SY5B?\^58G_/E6)_SY5B?\^[V\  -9\  #(
MAP  O9$  +28  "JG   H*(  )FD$ "3I2 !C*0N X6C.0E_HD,/>:!,%G2?
M4QMOG5H@:IQA)6:::"ECF6\M7YAW,%N7@#18EHHW5965.5*5HCM0E+ ]3Y3#
M/4^4WSQ/D_(\3Y+]/$^2_SQ/D?\\3Y'_/$^1_SQ/D?\\Y'0  ,^!  #"C
MN)8  *V<  "CH0  F*@  )"J#0"+JQL A:LJ GZJ-@9XJ4$,<JA)$FVG41AI
MIE@<9*1?(6"C9B5=HFTI6:%U+%:A?B]3H(@R3Y^3-4V?H#=+GJ\X2I[!.$F>
MW3A)G? X29S\.$F;_SE)F_\Y29O_.4F;_SE)F_\YVWH  ,B'  "\D@  L9H
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M(CB__R0XO_\D.+__)#B__R0XO_\DO9$  +";  "DH@  F*H  (RQ  " N0
M=;\  &K&! !>S @ 6<\2 %?0(0!5T"X!4= Y D[00P1+T$P&2=!3"$;06PM#
MT&,-0=!K#S[0=1$\T8 3.M&,%#C1FA8VT:D7-=&[%S32TA<UT.P6-,_W&#/.
M_QHSSO\:,\[_&C/._QHSSO\:LYD  *:A  ":J0  CK$  (&Y  !UP   :L<
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M!!;_Y 06_^0$DZX  (6W  !XP   :LD  %W2  !0V0  1-\  #KD   U]P,
M,O\, "[_$@ K_QH */\A ";_)P C_RT (/\S ![_.0$<_S\!&?]% 1?_30$5
M_U4!$_]? 1'_:@(0_W@"#O^' @[_E@(-_Z0"#/^P @S_O@(,_\("#/_" @S_
MP@(,_\("A[8  'F_  !KR0  7M,  %#;  !#X   ..4  "_P   K_P  )_\(
M "3_#@ A_Q, 'O\9 !O_'@ 8_R, %?\H !/_+0 1_S( $/\X  [_/P ,_T8!
M"O]/ 0?_60$$_V4! ?]R 0#_@0$ _X\! /^; 0#_IP$ _ZD! /^I 0#_J0$
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MVD.1&=A"F1K50I\;TT&F'-%!KAW/0;<>SD'!'LQ!T!_)0N4?Q4+S(<)!_B/
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M*Z=+_RNG2_\KITO_*Z=+_RNG2_\K_TD2 /]0#@#_61  _U\2 /]C%@#R91T
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MJ#AN:K<Z;6K).FQJY#IM:_4X;6O_-VUK_S9M:_\V;6O_-FUK_S9M:_\V_UL
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M.5QYW3E=>?$X77C^-UYX_S9>>/\U7GC_-5YX_S5>>/\U]60  -QP  #*>@
MP(,  +:)  "NC0  I(\  )V1$ "7DB  D9$N XJ0.0>$CD,,?XU,$GJ+4Q=U
MB5H;<8AA(&Z&:"-JA6\G9X1W*V.#?RY@@HDQ78&4,UN H399?Z\W5W_ .%=_
MVC=7?_ W6'[]-EA^_S58?O\U6'[_-5A^_S58?O\UZ6@  -1T  #&?@  NX<
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M+D:6_RY&EO\N1I;_+D:6_RY&EO\NT7<  ,&$  "VC@  JI4  *";  "5GP
MBJ0  'VI  !WJQ  <ZL> &^L+ %JJS<$9:M!!V&J20M=J5$/6JE8$U>H7Q93
MIV894*=N'$VF=A]*I8$A2*6,)$6EF29#I*@G0J2X*$&DSB=!H^HG0*+X*$"A
M_RE H/\I0*#_*4"@_RE H/\IR7X  +J+  "OE   HYH  )B@  "-I0  @JH
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M$B['_Q(NQ_\2KI<  *&>  "5I0  B:T  'RT  !PNP  9,$  %G&  !.RP,
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M8@ )_V\ "/]_ 0?_D $%_Z !!/^N 03_O $#_\<! __' 0/_QP$#_\<!@[0
M '6]  !GQ@  6L\  $O5   _W   ,^$  "GE   A[   'OT  !K_!0 7_PP
M%?\0 !+_%  0_QD #O\>  W_(P +_R@ "/\N  ;_-0 #_ST  /]&  #_40
M_UT  /]K  #_>P  _XL  /^9  #_I0  _ZP  /^L  #_K   _ZP _R<L ?\J
M*@'_*RH!_RHN ?\F- +_)3\"_R-+ _\A6 /_(&0$_QYP!/\=>P3_'84%_QV.
M!?\=E@7_'9P&_QVB!O\<J ;_'*X'_QRT!_\<NP?_',,'_QS.!_\=WP?_'>L'
M_!WU!_D=_@;W'O\']QW_"/8=_PGV'?\)]AW_"?8=_PGV'?\)_RDJ ?\L)P'_
M+B<!_RTJ ?\L,@'_*ST"_RE) _\G50/_)6$$_R-M!/\B> 7_(H(%_R&+!O\A
MDP;_(9H'_R&@!_\AI0?_(:L(_R&Q"/\AN C_(<$(_R'+"/PAW CY(>D(]B'T
M"/,B_0?R(O\)\2+_"O$A_POP(?\+\"'_"_ A_POP(?\+_RPF ?\P) '_,2,!
M_S$F ?\R+P'_,3H"_R]& _\M4@/_*UX$_REI!?\H=07_)W\&_R>(!_\FD ?_
M)I8(_R:="/XFHPG])JD)_":O"?LFM@GZ)KX)^";("?8FV0GR)N@)[R?S">TG
M_0KK)O\+ZB;_#>DF_PWH)O\.Z";_#N@F_P[H)O\._R\C ?\S( '_-1\!_S<C
M ?\X+ '_.#<"_S9" O\T3@/_,EH$_S!E!?\N< ;^+7L'_"V$"/HLC GX+),)
M]RR9"O8KH KT*Z8*\RNL"_(KLPOQ*[L+[RO&"^XLU OJ+.8+YBSR"^0L_ WB
M+/\/X2S_$. L_Q#?+/\1WRS_$=\L_Q'?+/\1_S,? ?\W&P'_.AH!_ST@ ?\_
M* '_/S(!_ST^ O\[20/_.54$^S=A!O<U; ?U-'8(\C-_"? RAPKO,H\+[3*6
M"^PQG SJ,:(,Z3&I#.@QL WF,;D-Y3'##>,RT0W?,N4,W#+Q#]@Q_!'5,?\2
MTC'_$]$Q_Q30,?\4T#'_%- Q_Q30,?\4_S<; ?\[%P#_/Q8 _T,< /]&) '_
M1BX!_T0Y OQ"1 /V/U $\3U<!NT\9P?J.W$)Z#IZ"N4Y@POC.(L,XCB2#> W
MF0W?-Y\.W3>F#MLWK0_9-K80US;!$-4VSA#1-^,1S3?Q$\HW^Q7(-_\6QC?_
M%\4W_QC$-_\8Q#?_&,0W_QC$-_\8_SL7 /] $P#_11, _TD8 /],( #_3"D!
M^DLS ?)(/@+L1DH$YT16!N-#8@C?06P*W$!U#-D_?@W5/H8/TSV-$-$]E!'/
M/)L2S3RB$\P\J13*.[$4R#N[%<<[R!;%/-P6P3SM%[X\^1F[//\:NCS_&[D\
M_QNX//\;N#S_&[@\_QNX//\;_SX4 /]$$ #_2A$ _T\4 /]1&P#[4B, \5$M
M >E/. 'B344#W$M1!=9)7 C11V8+SD9P#LM%>!#(1( 2QD.'%,1"CA7#0I46
MP4&<%[]!I!B]0*P9O$"V&KI PAJX0-(;M4'H&[)!]AVP0?\>KD'_'JU!_QZL
M0?\>K$'_'JQ!_QZL0?\>_T(1 /]'#0#_3PX _U,1 /]6%0#S5QP Z%8E .!5
M,0'74S\"SU),!<I05PG&3F$-PTQJ$,!*<A*]27H5NTB"%KE'B1BW1Y 9M4:7
M&[-&GQRQ1:<=L$6Q'JY%O!^L1<P?JD7C(*=&\R&E1O\AHT;_(J)&_R&B1O\A
MHD;_(:)&_R&B1O\A_T4. /]+"@#_4PP _U<- /E:$ #K6Q0 WUH< -1:*P#,
M6CL"QEA(!<%64PF\5%P-N5)E$;50;12S3W47L$Y\&:Y-A!JL3(L<JDN2'JA*
MFA^F2J,AI$FL(J-)N".A2<8DGTK>))U*\"2;2OTEF4O_))E+_R282_\DF$O_
M))A+_R282_\D_T@, /]/" #_5@@ ]5L) .E>"@#D7@T U5\5 ,M@)P#$7S8"
MOEY#!;A;3@FT65@.L%=A$JQ5:16J5' 8IU-X&J52?QRB488>H%".()Y/EB*<
M3I\CFDZH)9A.LR:73L(GE4[6)Y-.[">13_LGD$__)Y!0_R:/4/\FCU#_)H]0
M_R:/4/\F_TH) /]3!0#X6@0 XE\# -IB!@#48PD S6,2 ,1E(P"\93("MF-
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MJBQ]6K<M?%K)+GI:XRYZ6_4M>ES_+'E<_RMZ7/\J>ES_*GI<_RIZ7/\J_U$
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M,&EFVS!I9_ O:6?]+6EG_RQJ9_\K:F?_*VIG_RMJ9_\K_E@  .%C  #/;
MQ',  +MX  "S>@  JWH$ *1[$@">?"( F'PO I)Z.P6,>$4*AW=-#H-U51)_
M<UP6>W)B&GAP:1UU;W @<FYX(V]M@29M;(LI:FR6*VAKH2YF:Z\O9&J_,&-K
MV#!C:^\O9&O\+61K_RUE:_\L96O_+&5K_RQE:_\L]%L  -UF  #+;P  P'8
M +=[  "O?@  IGX! )]_$ "9@!\ DX M HU_.06(?4,)@WM+#7YZ4Q)Z>%H6
M=G=A&7-U9QQP=&X?;7-V(FIR?R9H<8DH97"4*V)PH"U@;ZTO7V^]+UYOU"]>
M;^TO7V_[+5]O_RQ@;_\L8&__+&!O_RQ@;_\LZUX  -AI  #'<@  O'D  +-_
M  "K@@  H8(  )F##@"4A!T CH0K 8B#-@2#@D (?H!)#'E_41!U?5@4<GQ?
M&&Y[91MK>FP>:'ET(F5X?25B=X<G8':2*EUUGBQ;=:LN6G2[+UEUT2]9=.PN
M673Z+5IT_RQ:=/\K6G3_*UIT_RM:=/\KYF$  -%M  ##=@  N7T  *^#  "F
MA@  G(8  )2(# ".B1D B8DH 8.)- -^ASX'>89'"W2%3P]PA%83;8)=%VF!
M8QIF@&H=8W]R(&!^>B-=?80F6GR/*5A[G"M6>ZDL5'NY+5-[SBU4>NHM5'KY
M+%1Y_RM5>?\J57G_*E5Y_RI5>?\JX64  ,QQ  "_>@  M((  *N'  "AB@
ME8L  (V-"0"'CA8 @H\D 7V/,0)XCCL%<XU$"6^,3 UKBE019XE:%62(81AA
MAV@;7H9P'EN%>"%8A((D582-)E*#FBE0@J<J3X*W*TZ"S"M.@N@K3H'X*D^
M_RI/@/\I3X#_*4^ _RE/@/\IVVH  ,=U  "Z?P  L(<  *:,  "<CP  CY$
M (:3!0" E!( >Y4A '>5+0%RE3@$;91"!VF32@MEDE$.8I%8$EZ07Q5;CV88
M6(YM&U6.=AY2C8 A3XR+(TV+F"5+BZ4G28NU*$B+RBA(BN<G28GW*$F(_R=)
MA_\G28?_)TF'_R=)A_\GT6\  ,%[  "UA   JXP  *"0  "5E   B9<  'Z:
M  !WFPX <YP< &^=*0%KG#4"9IP_!6*;1PA?FD\+7)I6#UB97!)5F&,54YAK
M%U"7<QI-EGT=2I6)'T>5E2%%E:0C1)2S(T.4R"-#E.4C0Y+U)$.1_R1#D/\D
M0Y#_)$.0_R1#D/\DRG4  +N!  "PBP  I)$  )J5  "/F0  @YT  '2B  !N
MHPL :J07 &:E)0!CI3$!7Z0[ UND1 58I$L(5:-3"U*C6@U/HF$03:)H$TJA
M<15'H'L81*"&&D*?DQQ GZ(=/I^R'CV?QAX]G^,=/9WT'CV<_Q\\F_\?/)O_
M(#R;_R \F_\@PGP  +6(  "ID   GI8  ).;  "'GP  >Z0  &^H  !CK 0
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MA (DU)0"(M2F B'5N0(AU=("(-/K B#2]@,?T?\$']'_!!_1_P0?T?\$GYL
M )2B  "'J0  >;$  &VX  !@O@  5,,  $G'   ^RP  -= ! "W5!@ EVPL
M)-X2 "/>'  BWR4 (> N "#@-P ?X4  'N%* !WB4P <XUX &^-J !KD>  8
MY(@!%^6: 1;FK $5YL !%.?= 1/E[P$3X_H!$^/Z 1/C^@$3X_H!EJ(  (FI
M  ![L0  ;KD  &'   !4Q@  2,H  #W/   STP  *MD  "+> @ >ZPH '.P0
M !OM%P 9[1\ %^XF !7N+0 4[S4 $_ ] !'P1@ 0\5  #_);  [R:0 -\W@
M#/2*  OUG  *]:X "?;"  GVV0 (]>T "/7M  CU[0 (]>T BZD  'VR  !O
MN@  8L(  %7)  !'S@  .](  #'8   GW0  '^$  !GH   6^ 8 %/H- !+[
M$@ 0_!< #OP=  W](P ,_2D "OXP  C_.  &_T$  _],  #_6   _V8  /]W
M  #_B0  _YL  /^K  #_NP  _\X  /_/  #_SP  _\\ ?[(  '&Z  !CPP
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MKAV22;L>D$G,'HY*Y1Z-2O8>BTO_'HM+_QV*2_\=BDO_'8I+_QV*2_\=_T4
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M)'96VB1U5^\D=5?](W58_R)U6/\A=5C_(758_R%U6/\A_TT  .57  #37P
MR&0  +]G  "W:   L6<' *EH% "C:20 GF@R 9EG/02494<'D&1/"HQB5PV(
M85X0A5]E$X->;!: 77,8?5UZ&GM<@QUY6XP?=EN7(71:HB-R6J\D<5J_)7!:
MU25O6^TE;UO\(V];_R)O6_\B;UO_(6];_R%O6_\A^D\  .%:  #/8@  Q&<
M +MK  "S;   K&H$ *1K$@">;"$ F6PO 91K.@./:40&BFA-"89F50V#95P0
M@&1B$WUB:15Z8G 8>&%X&G5@@!US7XH?<%^4(6Y>H"-L7JTE:UZ\)FI>T29I
M7NPE:E_[)&I?_R-J7_\B:E__(FI?_R)J7_\B\%(  -U=  #+90  P&L  +=N
M  "O;P  IVX! *!O$ ":<!\ E' L 8]O. .*;4(&AFQ+"8)J4@Q^:5D/>VA@
M$G=F9A1U9FX7<F5U&G!D?AUM8X@?:V.2(FEBGB1G8JLE96*Z)F1BSR9D8NHF
M96+Z)&5C_R-E8_\B96/_(F5C_R)E8_\BZU4  -A@  #(:   O&X  +-Q  "K
M<P  HG$  )MR#@"5<QP D'0J 8IS-@*%<D %@7!("'UO4 MY;5<.=FQ>$7-K
M9!1P:FP7;6ES&FMI?!QH:(8?9F>0(61GG"-B9JDE8&:Y)E]FS29?9N@F8&;Y
M)&!F_R-@9O\C86;_(F%F_R)A9O\BZ%@  --C  #$:P  N7$  +!U  "G=P
MGG4  )9V#0"0=QD BW@G (9W,P*!=CT$?'5&!WAS3@MU<E4.<7%<$6YP8Q1K
M;VH6:6YQ&69N>AQC;8,>86R.(5]KFB-=:Z<E6VNW)EIKRB9::^<E6VOW)%MJ
M_R-<:O\B7&K_(EQJ_R)<:O\BXUL  ,YF  # ;@  MG0  *QY  "C>P  F'D
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MA1  >88> '6'*P%QAS8";88_!&F%1P=EA$\*8H-6#5^#7 ]<@F,26H%K%5>
M<QA4?WT:47^('$]^E!]-?J(@2WVQ(4I]Q")*?>$A2WST(4M[_R!+>_\@2WO_
M($M[_R!+>_\@T&<  ,!R  "T>P  JH(  *"&  "5B   AX@  'R*  !VC X
M<HT: &Z.)P!JCC(!9HT\ V.-1 5@C$P(7(M3"EJ+6@U7BF$05(EH$E&(<15/
MB'H73(>%&DJ&DAQ(AJ =1H:O'D6%PAY%A=\>183R'D6#_AY%@O\>18+_'D6"
M_QY%@O\>RFT  +IX  "O@0  I8<  )J+  "/C0  @8X  '21  !NDPH :905
M &:5(@!CE2X!8)4X ER50019E$D&5I10"%235PI1DUX,3I)F#TR2;A%)D7@4
M1I"#%D20D!A"CYX90(^M&C^/P!H_C]P:/XWQ&C^,_1L_B_\;/XO_&S^+_QL_
MB_\;PG,  +5^  "JAP  GXP  )20  "(DP  >Y4  &R9  !EFP0 8)P0 %V=
M'0!;GBD 6)XT 56>/0)2G44#4)U-!4V=5 =+G%L)2)QC"T:<:PU#FW4/09N
M$3Z:C1,\FIL4.IJK%3F:O14YFMD5.9CO%CF7_!8XEO\7.)7_%SB5_Q<XE?\7
MNWH  *^%  "DC   F)$  (V5  "!F@  =9T  &B@  !;I   5J4, %.F%P!1
MIR, 3Z<O $RG. %*IT$!2*=) D:G4 1#IU@%0:=?!C^F: @]IG(*.J9]"SBF
MB@TVI9D.-*6I#S.ENP\SI=0/,Z3N#S*B^Q RH?\1,J'_$3*A_Q$RH?\1M((
M *B,  "=D@  DI<  (:<  !YH0  ;:4  &&I  !5K   2Z\% $>P$ !%L!P
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M !G.K@$8SL4 &,WD !C,] $8ROP!&,K_ AC*_P(8RO\"FYD  (^?  ""I@
M=:T  &BS  !<N0  4+T  $3!   YQ   ,,@  "C, 0 @T 8 &=4+ !;7$  5
MV!D %=DB !39*P 3VC0 $]H] !+;2  1W%, $=U? !#=;0 0WGX #M^1  [@
MI  -X+@ #.#2  O?[0 ,WO< #-W[  S=^P ,W?L DI\  (6G  !WK@  :K4
M %V\  !0P0  1,4  #C)   NS0  )=$  ![5   6V@$ $=X& !#G#0 .YQ(
M#>@9  SH(0 +Z2D "NHQ  GJ.P 'ZT4 !>M1  3K7@ #ZVX  >N   #JE
MZJ<  .N\  #KT@  Z^D  .SO  #L[P  [.\ AZ<  'FO  !KMP  7KX  %'%
M  !#R0  -\T  "W1   CU@  &]L  !/?   .XP  #.X"  KV"@ ']@X !?82
M  /V&   ]1X  /4E  #U+@  ]3<  /9"  #V3@  ]ET  /9N  #V@0  ]I4
M />G  #WMP  ^,<  /C0  #XT   ^-  >Z\  &VX  !@P   4L@  $3-   W
MT0  *]<  "'<   8X   $>0   SG   '[P  !/H   '_ P  _P@  /\-  #^
M$   _A0  /\:  #_(0  _RD  /\S  #_/@  _TL  /];  #_;   _X   /^2
M  #_H0  _ZT  /^S  #_LP  _[, _QPF /\<) #_&B4 _Q4G /\1+@#_$#H
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M.[P/H#O-#YX[YA";//41FCS_$9D\_Q&8//\1F#S_$9@\_Q&8//\1_SH! /]
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M%HI%W!:(1O 6AD;]%H9&_Q:%1_\5A4?_%85'_Q6%1_\5_S\  .Q(  #=3P
MSU,  ,95  # 4P, NU$, +-2&0"M4RD J%,V :-20@*?44L$G%!4!IE/7 B6
M3F,*E$UJ#)%,<0Z/2W@/C4M_$8M*AQ*)2I 4ATF:%85)I1>#2;$8@DG &(%*
MUAE_2NT8?DO\&'Y+_Q=]2_\7?4O_%GU+_Q9]2_\6_T,  .9,  #64P  R5@
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M&VI7_QIJ5_\9:U?_&6M7_QEK5_\9ZTP  -A6  #(7@  O&(  +-E  "K90
MHV(  )QB#@"68QP D60I (QC-0&(8C\#A&%(!8!@4 =]7U<)>EY="W==9 UU
M7&L0<UQR$G!;>Q1N6X07;%J/&&I:FAIH6J<<9EJV'65:R!UE6N0=95KV'&5:
M_QME6O\:95K_&65:_QEE6O\9Z$\  --9  #$80  N68  +!H  "G:0  GF4
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M&E=F_QI79O\:VUD  ,=B  "Z:@  KW   *9S  ":<P  CW   (=Q!0"!<A$
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MC!-$@9H50H"I%D& NA9 @-(607_M%D%^^Q9!??\607W_%D%]_Q9!??\6PFH
M +5U  "J?0  GX(  )*#  "%A   >84  &J)  !DB@, 8(P0 %V-&P!;CB<
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M""Z@LP@NH,D(+I_G""V=]PDMG/\*+9O_"BV;_PHMF_\*KX   *.)  "7C@
MC9,  '^5  !RF   9IP  %N@  !/I   1:<  #ZI#  \JA0 .JH? #FJ*0 X
MJS( -ZL[ #6K0P TK$L ,JQ3 3&L7 $OK&8"+:QQ BNL?P,JK(X#**R>!">L
ML 0FK,4$)JOD R6I]00EJ/\%):?_!26G_P4EI_\%IXD  )N/  "1E   A)D
M 'B>  !KH@  7Z8  %.J  !(K0  /;   #2S P OM0X +;46 "RU(  KMBD
M*K8R "FW.@ HMT, )[=, ":X50 DN%\ ([AK "*X> $@N(@!'[B9 1VYJP$<
MN< !'+C? 1RV\@$;M?P"&[3_ ANT_P(;M/\"GX\  )25  "(FP  >Z$  &ZF
M  !BJP  5K   $JS   _M@  -;D  "R\   DOP8 '\(- !W"%  <PAX &\,F
M !K#+P 9Q#@ &,1! !?$2@ 6Q54 %<5A !3&;P 3QG\ $L:1 !''I  0Q[D
M#\?4 !#&[@ 0Q/H $,/_ !##_P 0P_\ EY8  (N<  !^H@  <:D  &2O  !8
MM   2[@  $"[   UO@  *\$  "/%   ;R0$ %,P& !#0"P .T1$ #=$9  W1
M(0 ,T2H #-$T  O2/@ *TDD "=-5  G38@ (TW( !M2$  74F  $U*L  ]7
M  '5W  !U>T  =7V  '5]@ !U?8 CIT  ("D  !SJP  9K$  %FX  !,O0
M/\   #3#   JQP  (<H  !G.   2T@  #=8!  G;!0 &W T !-P1  /=&  !
MWB   -XH  #?,0  X#P  .%'  #B5   XV,  .-T  #DB   Y)L  .6N  #E
MP0  Y=4  .;G  #FYP  YN< @Z0  '6L  !HLP  6KL  $W!  ! Q   ,\@
M "C,   ?T   %]0  !#9   +W0  !>$   #D    Y0<  .8-  #G$0  Z!8
M .D=  #J)0  ZRX  .TY  #O10  \%,  /%D  #Q=@  \HH  /.<  #SK0
M]+L  /3(  #TR   ],@ =ZT  &JU  !<O0  3\0  $#)   SS0  )]$  !W6
M   4W   #N    CC   !Y@   .H   #N    [@   .\$  #P"@  \0X  /,2
M  #T&   ]B   /@J  #Z-0  _4,  /Y2  #_8P  _W8  /^)  #_F@  _Z8
M /^P  #_L   _[  _Q8C /\5(0#_$2$ _PTD /\)*P#_!C< _P-$ /\ 40#_
M %T _P!H /\ <@#_ 'L _P"# /\ B@#_ )$ _P"6 /\ G #_ *$ _0"F /L
MK #Y +, ]P"[ /4 Q0#S -$ \@#D /$ \0#O /H [@#_ .X _P#M /\ [0#_
M .T _P#M /\ _QD@ /\8'0#_%1T _Q ? /\.*0#_##0 _PI! /\'30#_!5D
M_P1D /\$;@#_ W< _P.  /\#AP#_ XT _0*3 /L"F0#Y IX ]P*D /4"J@#S
M ;  \0&X .\!P@#M <\ ZP'C .H![P#H OL YP3_ .8%_P#F!O\ Y@;_ .8&
M_P#F!O\ _QP; /\;&0#_%Q@ _Q4= /\3)0#_$3  _Q ] /\.20#_#%4 _PM@
M /\+:@#]"W, ^PM\ /D*@P#W"HH ]0J0 /0*E@#S"IL \0JA .\)IP#M":X
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M /\E"P#_* P _RD0 /\H%@#^)B  ]"0K .PA. #F($0 X1]0 -T?6P#9'F4
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M!J0PX@:A,/,'GS#_")XQ_PB=,?\(G#'_")PQ_PB<,?\(_S   /\U  #O.
MXCH  -LY! #6-0D SC03 ,8V(@"_.#$ NC@_ +8X2@&S.%0!L#== JTW9 *K
M-FP#J39S!*@V>02F-8 %I#6'!:,UCP:A-9<'GS6@!YXUJ@B<-;8(FS7%"9DU
MW0F6-N\*E#;]"I,W_PJ2-_\*DC?_"I(W_PJ2-_\*_S,  /8Z  #D/P  V$(
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M$7A&_Q!X1O\0>$;_#WA&_P]X1O\/\#\  -])  #-3P  P5,  +A4  "Q4@
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M$F%6_Q)A5O\2X$T  ,M6  "]70  LF$  *AC  "=80  E5T  (U>"0"'7A,
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MC1%/9YH23F>I%$UGN11,9\\43&;K%$UF^Q--9O\23F7_$DYE_Q).9?\2S%H
M +QC  "P:@  I6\  )AN  ",;0  @&P  '=M  !Q;@L ;6\4 &EP(0!F<2P
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M#CQ[LPX\>\@./'KF#CQY]PX\>/\./'C_#CUW_PX]=_\.O&@  *]R  "D>0
MEGH  (AZ  !\>@  <'P  &-_  !<@@  5X0+ %.%% !1AB  3X8J $Z'- !,
MASP!2H=$ 4B'2P)&AU,"1(9: T*&8@1 AFP&/H5V!SN%@P@YA9$*.(2@"S:$
ML0LVA,8+-H/D"S:"]@LV@?\,-H#_##: _PPV@/\,MF\  *IX  "??P  D'X
M (-_  !W@   :X(  %Z'  !5B@  3HP& $J.$ !(CQH 1X\E $60+P!$D#@
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M 1ZD[P$>HOL"'J'_ AZA_P(>H?\"HH8  )>,  "+CP  ?9$  &^4  !CF
M5YT  $VA  !#I0  .*@  #"K   HK@< )*\0 ".O%P AKR$ (+ I !^P,0 >
ML#H ';%" !RQ3  ;L58 &K%A !FR;P 8LGX %K*0 !6RH@ 4LK8 $[+. !.Q
MZP 3K_D $Z[_ 1.N_P$3KO\!FHT  )"2  "$EP  =9H  &B?  !;HP  4*@
M $6L   [L   ,;(  ">U   @N   &+H' !2\#@ 3O!4 $KP> !&])@ 1O2X
M$+TW !"^00 .ODP #KY7  V^90 ,OW0 "[^&  J^F0 (OJP ![["  >^WP (
MOO  "+WZ  B]_  (O?P DY0  (>9  !ZGP  ;*4  &"J  !3KP  1[,  #RV
M   QN   )[L  !^^   7P0  $<0!  S("  (R0X !\D4  ;)'  %R20 !,HL
M  /*-@ "RD   ,M,  #+60  RV@  ,MY  #,C   RY\  ,NS  #+R   S.(
M ,SO  #,\0  S/$ BIH  'RA  !OIP  8JT  %6S  !(N   .[L  #"^   F
MP0  '<0  !7(   /RP  "LX   32 @  TPH  -,/  #4%   U1H  -8B  #7
M*@  V30  -H_  #<2P  W%H  -UJ  #=?0  W9$  -VD  #>M@  WL@  -[>
M  #>X@  WN( ?Z(  '&I  !DL   5K<  $F\   \P   +\0  "3'   ;RP
M$\\   W2   'U@   -L   #>    WP,  . )  #A#@  XA(  .,7  #E'@
MYB<  .@Q  #J/0  [$L  .Q:  #M;   [H   .Z4  #NI0  [K0  .["  #N
MQ@  [L8 =*H  &:R  !8N0  2\   #W%   OR0  ),T  !G1   1U@  "]L
M  />    X0   .4   #H    Z0   .H   #K!@  [0L  .\/  #P$P  \AH
M /0C  #W+@  ^3L  /M*  #\6P  _6T  /V   #^DP  _J(  /ZM  #^KP
M_J\ _Q ? /\.'0#_"AT _P$@ /\ * #_ #4 _P!! /\ 3@#_ %H _P!E /\
M;@#_ '< _P!_ /X A@#\ (P ^P"2 /D EP#X )P ]P"B /8 IP#U *T \P"U
M /( O0#Q ,D [P#< .X ZP#M /< [ #_ .L _P#J /\ Z@#_ .H _P#J /\
M_Q,< /\1&0#_#1D _P8< /\#)0#_ #$ _P ^ /\ 2@#_ %8 _P!A /\ :P#]
M ', ^@![ /< @P#U (D ] "/ /( E #Q )D \ "? .X I #M *L [ "R .H
MN@#H ,8 YP#6 .4 Z #D /4 XP#^ .( _P#A /\ X0#_ .$ _P#A /\ _Q48
M /\3% #_#Q0 _PT9 /\+(@#_""T _P0Y /\!1@#_ %$ _@!< /H 9@#V &\
M\@!W .\ ?@#M (4 ZP"+ .H D0#H )8 YP"< .8 H0#D *@ XP"O .$ N #?
M ,, W0#1 -L Y@#9 /, UP#] -4"_P#4 O\ U /_ -0#_P#4 _\ _Q@3 /\5
M$ #_$@\ _Q(5 /\1'0#_#B@ _PPT /\*00#Y"$P ]097 /$&80#M!FH Z05R
M .8%>@#D!8$ X@6' . &C0#?!I( W0:8 -L&G@#9!J4 UP:M -0&M0#2!L
MT ?/ ,X(Y0#,"?0 R@O_ ,@,_P#'#/\ QPS_ ,8,_P#&#/\ _QL. /\9# #_
M& T _Q@1 /\7& #_%"( ^Q$N /,0.@#M#D8 Z U2 .4-7 #A#64 W@UM -L-
M=0#8#7P U0V" -,-B0#1#8\ T V5 ,X-G #-#J, RPZK ,D.M #(#L  Q@[/
M ,,0Y@# $?4 O1+_ +P2_P"[$O\ NA+_ ;H2_P&Z$O\!_Q\* /\<! #_'P@
M_Q\- /\=$@#X&AL [A8F .84,P#@$S\ VA-+ -035@#0$U\ SA1H ,L4;P#)
M%'< QQ5] ,85A #$%8H PQ61 ,$6F # %I\ OA:G +P7L "[%[P N1?+ +<8
MX@"S&?(!L1K_ :\;_P&N&_\!KAO_ :T;_P&M&_\!_R($ /\B  #_)0( _"0'
M /<A# #L'1( X1H< -@:*@#0&S@ RQU% ,<=4 ##'EH P!YB +X>:@"\'W$
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M!8TQ_P6-,?\%C#'_!8PQ_P6,,?\%_RT  .HU  #<.@  SCT  ,8\  # -P(
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M"FM&_PIK1O\*Y4   ,])  #!3P  M5(  *M2  "A3P  FTH  )1*# "/2Q<
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MC0M95)H-6%2G#E95N ]65<P/5E7I#E95^0U65?\-5U3_#%=4_PQ75/\,T4T
M ,!6  "S7   IUX  )I=  "/7   AE@  ']9  !Y6@T =%L7 '%;(P!N6RX
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M#$ABL@U'8L<-1V+D#4AA]@Q(8?\,2&#_"TE@_PM)8/\+Q%@  +5@  "J9@
MFV8  (UF  ""90  =F0  &YE  !H9@4 8V<0 &!H&@!=:24 6VHO %EJ. !7
M:D !56I' 5-J3@)1:E4#3VE=!$UI9 5+:6T&26AX!T=HA E&:)(*1&>A"T-G
ML0Q"9\4,0F?B#$)F]0Q#9O\+0V7_"T-E_PM#9?\+OUP  +%D  "F:@  EFD
M (EI  !]:0  <6D  &=J  !B; $ 76T- %EN%@!7;R$ 57 K %-P-0!1<#T
M4'!% 4YP3 %,<%,"2G!: TAP8@1&;VL%1&]U!D)O@@= ;H\)/VZ>"CUNKPH]
M;L(*/&[@"CUM] H];/\*/6O_"CYK_PH^:_\*NF   *UI  "@;@  D6T  (1M
M  !X;0  ;&X  &%P  !;<@  5G0* %)U$@!0=AT 3G<G $QW,0!+>#D 27A!
M $AX20%&>% !1'=7 D)W7P- =V@#/G=S!#QV?P8Z=HT'.7:<"#=UK0@W=< (
M-G7>"#=T\@@W<_X(-W+_"#=R_P@W<O\(M68  *EO  ":<0  BW$  'YQ  !S
M<@  :',  %QV  !4>0  3GL% $I]#P!(?A@ 1G\C $5_+ !#@#4 0H ] $&
M10 _@$P!/8!4 3R 7 (Z?V4".']O S9_? 0T?XH$,G^:!3%^J@8P?KT&,'[:
M!C!]\ 8P>_T&,'O_!C!Z_P8P>O\&L&P  *1U  "4=0  AG4  'EV  !N=P
M8WD  %=]  !/@0  1X0  $*&#  _AQ, /8@= #R()P [B3  .HDX #B)0  W
MB4@ -HE/ #2)6 $SB6$!,8EL 2^)> (MB8<"+(F7 RJ(IP,IB+H#*8C4 RF&
M[@,IA?P$*83_!"F$_P0IA/\$JG0  )Y[  ".>@  @'H  '1[  !H?@  78$
M %*%  !)B0  08P  #F0!0 UD0\ ,Y(7 #*2(0 QDBD ,),R "Z3.@ MDT$
M+)-* "N44@ JE%P *)1G ">4<P$EE((!))23 2*3I $AD[<!()// 2&2[ $@
MD/H"((__ B"/_P(@C_\"I'P  )>   "'?P  >X   &Z"  !BA0  5XD  $V.
M  !"D@  .I8  #*9   JG D *)T1 ":=&0 EG2( ))XJ ".>,@ BGCH (9Y"
M "">2P ?GU4 'I]@ !R?;0 ;GWP &I^- !B?GP 7G[( %I_) !:>Z  6G/<
M%IO_ 1>;_P$7F_\!G8,  (^&  ""A@  =(<  &>+  !;CP  4),  $:8   \
MG   ,Z   "NC   CI@  '*@+ !JI$0 8J1@ %ZDA !:J*0 5JC$ %*HY !.J
M0P 3JTT $JM8 !&K90 0JW0 #JN&  ZKF0 -JZP #*O!  RJWP ,J?( #:C\
M  VH_P -J/\ EHH  (F,  !ZC0  ;)$  &"5  !4F@  29\  #^C   UIP
M*ZH  ".N   ;L   %+,!  ^U"@ -MA  #+86  NV'P *MB< ";8O  BV.0 '
MMT, !K=/  2W6P #MVH  K=[  "WC@  MZ$  +:T  "VRP  MN4  +7Q  "U
M]P  M?< CY$  (&4  !REP  99P  %BA  !,I@  0:L  #>O   LL@  ([4
M !JX   3NP  #KT   G !0 #P0T  ,$1  #!%P  PAX  ,(F  #"+P  PSD
M ,1$  #$4   Q%X  ,5O  #%@0  Q94  ,6H  #%O   Q-$  ,3F  #$[@
MQ.X AI@  'F>  !KHP  7:D  %"N  !$LP  -[8  "RY   BO   &;\  !'"
M   ,Q0  !L@   #+    S <  ,P-  #-$0  S18  ,X=  #/)   T"T  -(X
M  #41   U%(  -5A  #5<P  UH<  -:;  #6K0  U[\  -C.  #8W0  V-T
M>Z   &ZF  !@K0  4[,  $6X   XO   *[\  "'"   7Q@  $,D   K,   "
MT    -0   #7    V    -H%  #;"P  W X  -X3  #?&0  X2$  .,J  #E
M-@  YT,  .=3  #H9   Z7<  .F,  #JGP  ZJX  .JZ  #JPP  ZL, <*@
M &*O  !5M@  1[P  #G    LQ   (,@  !;,   .T   !]0   #9    W0
M .$   #C    Y    .8   #G 0  Z0<  .L,  #L$   [A4  / =  #S)P
M]C,  /=#  #X5   ^68  /EZ  #ZC@  ^IX  /NI  #[L   ^[  _PL; /\'
M&0#_ !D _P < /\ )0#_ #( _P _ /\ 2P#_ %< _P!B /\ :P#_ ', _0![
M /L @@#Z (@ ^ "- /< D@#V )@ ]0"= /0 H@#S *D \0"P .\ N #N ,,
M[ #1 .L Y@#I /, Z #^ .@ _P#H /\ Z #_ .@ _P#H /\ _PX8 /\*%0#_
M 10 _P 8 /\ (@#_ "X _P [ /\ 1P#_ %, _0!> /H 9P#W &\ ]0!W /,
M?@#R (0 \ ") .\ CP#N )0 [ ": .L GP#I *4 Z "L .8 M #D +\ XP#,
M .$ X@#? /  W@#[ -X _P#= /\ W0#_ -P _P#< /\ _Q 3 /\-$0#_!A
M_P(5 /\ '@#_ "D _P V /\ 0@#Z $X ] !9 /$ 8@#N &L [ !R .H >0#H
M '\ YP"% .4 BP#D )  X@"6 .$ G #? *( W0"I -H L0#8 +L U0#( -(
MW0#1 .T T #Y ,\ _P#. /\ S0#_ ,T _P#- /\ _Q$/ /\.#0#_# T _PL2
M /\'&0#_ B0 _P P /8 / #O $D Z@!3 .< 70#D &8 X0!M -\ = #= 'L
MVP"! -D A@#6 (P U "2 -( F #0 )X S@"F ,P K@#* +@ R #$ ,8 UP#%
M .H PP#W ,( _P#! ?\ P +_ , "_P#  O\ _Q0+ /\0!@#_$ D _Q . /\.
M% #_"AX ]08I .L$-@#C T( WP-. -L$5P#6!&  TP1H - $;P#.!78 S 5\
M ,H%@@#)!8@ QP6. ,8%E #$!9L P@6C , &JP"^!K4 O0;" +L(U "Z">D
MMPOX +4,_P"T#/\ M S_ +0,_P"T#/\ _Q<$ /\4  #_%@, _Q0) /\1#@#R
M#A4 Z PA -X*+@#6"SL T Q' ,P,40#)#%H Q@UB ,0-:@#"#7$ P UW +\-
M?0"]#H, O Z* +H.D0"Y#I@ MPZ@ +8.J0"T#[0 L@_! +$0U "N$>L JQ+Z
M *D2_P"H$_\ IQ/_ *<3_P"G$_\ _QH  /\;  #Y&P  ZQD  .44!@#E$ X
MV0X7 ,\1)@#($C0 Q!-  +\42P"\%%0 N15= +<59 "U%6L M!5Q +(5> "Q
M%GX KQ:% *X6C "L%I0 JQ>< *D7I@"G&+  IAB] *08SP"B&N< GQKW )T;
M_P&<&_\!G!O_ 9L;_P&;&_\!_QT  /<A  #H)   W24  -0A 0#/&P@ RA<1
M ,(:( "\'"T MQTZ +,>10"P'D\ K1Y7 *L>7P"I'V8 J!]L *8?<P"E'WD
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M WPQ_P-\,?\#[2\  -LW  #)/0  OCX  +,\  "L.   IS,$ *(R$0"=-!T
MF34J )4U-0"2-4  CS5) (TU4 "+-5< B35> 8<U9 &%-&L!A#1R H(T>0*
M-(("?C2+ WTTE@-[-:$$>36N!'@UO@5W-M0%=C;M!70W_ 5T-_\$=#?_!'0W
M_P1T-_\$YS4  -(]  ##0@  N$0  *Q"  "D/@  GSD  )HX#@"4.AD D#HF
M (T[,0"*.SL ASM$ (0[3 "".U,!@#I: 7XZ8 %].F<">SIN GDZ=0)W.GX#
M=CJ(!'0ZDP1R.IX%<3JK!6\[NP9N.\\&;3OJ!FT\^@9L//\%;#S_!6P\_P5L
M//\%XCD  ,Q"  "^1P  L4@  *5&  "=0P  ES\  )(^"P"-/Q4 B3\A (5
M+0""0#< ?T!  'U 2 ![0$\!>4!6 7<_70%U/V,"<S]J G$_<@-P/WH#;C^$
M!&P_D 5K/YP&:3^I!F@_N =G0,P'9D#H!V9 ^09E0/\&94#_!F5 _P5E0/\%
MW#X  ,=&  "Y2P  K$P  *!*  "71P  D4,  (M#" "&0Q( @D0> 'Y$*0![
M130 >44] '9%10!T1$P!<D13 7!$60%N1& ";$-G FM#;P-I0W<$9T.!!69#
MC09D0YD&8D.G!V%$M@A@1,H(8$3F"%]%^ =?1?\'8$7_!F!$_P9@1/\&UD$
M ,-)  "V3@  IT\  )M-  "22P  C$<  (5'! " 1Q  ?$@: 'A()@!U23
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M"%%0L0E04,0)4%#A"5!0] A14/\'44__!U%/_P913_\&R4L  +E3  "K5P
MG%8  (]5  "%5   ?%   '51  !P4@D :U,2 &A4'0!E5"< 8E0Q &!4.0!>
M5$$ 7%1( 5I43P%95%8!5U1= E9490-45&X$4E1X!5%4A 9/5)$'3E2@"$Q4
MKPA,5,()2U3?"4Q4\PA,4_\'3%/_!TU3_P9-4_\&Q4X  +96  "G6@  F%D
M (M8  "!5P  =U0  '!5  !J5@8 9E<0 &)7&@!@6"0 75@N %M9-P!963\
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M!SUA[P8]8?T&/F#_!CY@_P8^8/\&N5D  *MA  ":80  BV$  ']A  !T80
M:6$  %]B  !99   5&8) %%G$0!.9QH 3&@D $MI+0!):38 2&D^ $9J10!%
M:DP 0VI4 4)J7 % :64"/FEO CQI>P,[:8D$.6F8!3AHJ 4W:+H%-VG3!3=H
M[@4W9_P%.&;_!3AF_P4X9O\%M%X  *=E  "590  AF0  'IE  !O90  9&8
M %EH  !2:@  36P$ $EN#@!';A8 16\@ $1P*0!"<#( 07 Z $!Q0@ _<4D
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M B)]_P(B??\"I7$  )-Q  "#<0  =G$  &QR  !@=0  5G@  $Q\  !#@
M.X,  #.&   MB0H *HH1 "F+&0 GBR( )HLJ "6,,0 DC#D (XQ" "*-2@ A
MC50 ((U> !^-:P =C7D '(V* !N-G  9C:X &(S$ !B,XP 9BO4 &8G_ 1F(
M_P$9B/\!G7<  (QV  !]=@  <G<  &5Y  !:?   4(   $:$   \B0  -(P
M "V0   EDP( 'Y4, !V6$@ <EAH &Y<B !J7*@ 9ES( &)@Z !>80P 6F$T
M%9A8 !289  3F', $9B$ !"8E@ 0F*D #IB_  Z7W0 /EO( $)7\ !"4_P 0
ME/\ E7T  (5\  !X?   :WX  %^!  !4A@  2HH  $"/   VDP  +9<  "::
M   >G0  %Z # !*B#  0HQ( $*,9  ^C(0 .I"D #J0Q  VD.@ ,I$4 "Z10
M  JD7  )I&H !Z1[  :CC@ $HZ$  J.T  .BRP #HN8  Z'S  .A^P #H?L
MC8,  '^"  !QA   9(<  %B,  !-D0  0I8  #B:   OG@  )J(  !ZE   7
MJ   $:L   RN!P 'KPT  Z\2  *O&0 !KR$  *\I  "P,@  L#P  +!'  "P
M4P  L&$  +!Q  "P@P  KY<  *^J  "OOP  KMD  *[K  "N]   KO0 AXD
M 'B*  !JC@  79,  %&8  !%G0  .Z(  #"F   GJ@  'JX  !:Q   0M
M"[8   6Y P  N@H  +H.  "Z$P  NQD  +LA  "\*   O#$  +T\  "^2
MOE8  +YE  "^=P  OHP  +Z?  "]LP  OL<  +[>  "]ZP  O>L ?Y(  '"5
M  !BF@  59\  $FE   ]JP  ,J\  "BT   >M@  %;D   Z\   )OP   L(
M  #$    Q00  ,8*  #&#@  QQ(  ,@8  #)'P  RB<  ,PP  #./   SDD
M ,]9  #/:@  SWX  ,^3  #/I@  S[@  ,_(  #/VP  S]L =YP  &BA  !;
MIP  3JX  $&T   TMP  *+H  !V]   3P   #<0   ;'    R@   ,X   #0
M    T0   -("  #3"   U0P  -80  #9%0  VQP  -TD  #@+P  XCP  .-+
M  #D7   Y&\  .6#  #EF   Y:D  .6V  #EPP  Y<, ;*4  %^L  !1L@
M1+D  #6\   HP   ',0  !+(   ,RP   \\   #3    V    -P   #?
MWP   .$   #C    Y ,  .8(  #H#0  Z1$  .P8  #N(@  \2X  /,\  #T
M30  ]5\  /9S  #WAP  ]YD  /BE  #XL   ^+  _P,7 /\ %0#_ !4 _P 8
M /\ (P#_ "\ _P \ /\ 2 #_ %0 _P!> /\ 9P#] &\ ^P!V /D ?0#X (,
M]@"( /4 C@#T ), \@"8 /$ G@#P *0 [@"K .T LP#K +T Z@#+ .@ X0#G
M /$ Y@#] .4 _P#D /\ Y #_ .0 _P#D /\ _P<3 /\ $0#_ !$ _P 5 /\
M'P#_ "L _P W /\ 1 #^ $\ ^@!: /< 8P#T &L \@!R /  >0#O '\ [0"$
M .L B@#J (\ Z "4 .< F@#E *  Y "G .( KP#@ +D W@#& -P V@#: .P
MV #Y -8 _P#6 /\ UP#_ -@ _P#8 /\ _PH0 /\##@#_  T _P 2 /\ &@#_
M "8 _  R /< /P#T $H \0!5 .T 7@#J &8 Z !N .4 = #C 'H X@"  .
MA0#> (L W "0 -L E@#8 )P U0"C -, JP#1 +4 S@#! ,P T0#+ .< R0#U
M ,@ _P#( /\ R #_ ,@ _P#( /\ _PP, /\&" #_ @H _P / /\ %0#\ "
M\0 L .P .0#I $4 Y0!/ .$ 60#> &$ VP!H -< ;P#4 '4 T@![ -  @ #.
M (8 S ", ,L D@#) )@ QP"@ ,4 J ## +$ P0"\ +\ RP"] ., O #R +L
M_0"[ /\ N@#_ +H _P"Z /\ _PX% /\)  #_"04 _P8+ /\!$ #P !D Y@ E
M .$ ,@#< #\ U@!) -$ 4P#. %L RP!C ,@ :@#& '  Q0!V ,, >P#! ($
MP "' +X C@"\ )0 NP"< +D I "W *X M0"Y +, R "Q -\ L 'O *\!^P"N
M O\ K0/_ *T#_P"M _\ _Q   /\.  #_#0  ]@L# /('"@#B 1$ VP(= -(#
M*P#, S< R 1# ,0$30#!!%8 O@5= +P%9 "Z!6L N 5Q +<%=@"U!7P LP:#
M +(&B0"P!I$ KP>9 *T'H0"K!ZL J0BW *@)Q@"F"MT I0OP *,,_0"B#?\
MH0W_ *$-_P"@#?\ _Q$  /P2  #L$P  XA,  -L/ P#6"0L S@@4 ,8*(@#
M##  O T\ +@-1@"U#4\ L@Y7 + .7P"N#F4 K0YK *L.<0"J#G@ J Y^ *</
MA0"E#XT I ^6 *(0GP"@$*D GQ"U )T1Q0";$=X F1+Q )<3_P"6%/\ E13_
M )44_P"4%/\ _Q4  .T;  #@'P  TA\  ,D;  #$% 4 P1 . +H2&P"T$RD
ML!0U *P50 "I%4D IA52 *0660"B%F  H19F )\6; ">%G( G!9Y )L7@ "9
M%X@ F!>1 )88FP"4&*8 DQFR )$9P0"0&M@ C1ON (L<_0"*'/\ BAS_ (D<
M_P")'/\ ]!T  .0E  #3*0  QRH  +PF  "V(   M!D+ *X:%0"H'", I!TO
M *$>.@">'D0 FQY, )D>5 "7'UL E1]A )0?9P"2'VT D1]T (\@? ".((0
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MCP%T+YL!<R^H G$OM@)P,,D";S#E FXQ]P)M,?\";3'_ FTQ_P)M,?\"WS(
M ,DY  "[/@  K#T  *$Z  ":-P  E3,  ) Q"@",,10 AS(@ (0S*P"!,S4
M?S,^ 'TS1@![,TT >3-4 '<S6@!V,V$ =#-G 7(T;P%Q-'<!;S2! 6XTC )L
M-)@":C6E FDULP-H-<8#9S;B V8V]0-F-O\"9C;_ F8V_P)F-O\"V#<  ,0^
M  "U0@  ID$  )L_  "3/   C3@  (@V!P"$-Q$ @#<< 'PX)P!Z.#$ =SDZ
M '4Y0@!S.4D <3E0 ' Y5P!N.5T ;#ED 6LY:P%I.70!:#E^ F8YB0)D.94#
M8SJB V(ZL0-A.L,#8#O@!%\[\P-?._\#7SO_ U\[_P)?._\"T3L  ,!"  "P
M10  H40  )5#  "-0   AST  (([ @!].PX >3P8 '4](P!S/2T <#TV &X]
M/P!L/48 :SU- &D]4P!G/5H 9CUA 60]: %C/7$!83Y[ E\^A@)>/I,#7#Z@
M UL_KP1:/\$$6C_=!%D_\@19/_\#63__ UD__P-9/_\#S#\  +Q&  "K2
MG$<  )%&  "(1   @D   'P_  !W0 P <T 5 &]!( !L02H :D$S &A!.P!F
M0D, 9$)* &-!4 !A05< 8$)> 5Y"90%=0FX"6T)X EI"A -80I #5T*>!%9#
MK0150[\$5$/:!%1#\0140_X#5$/_ U1#_P-40_\#R$(  +A)  "G2P  F$H
M (U)  "#1P  ?4,  '9#  !Q1 H ;402 &I%'0!G12< 9$4P &)%. !@13\
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M!$9/[01&3OP$1D[_ T=._P-'3O\#O4P  *Y2  "<40  C5$  (%1  !W4
M;DP  &=.  !B3P  75 - %I0% !741X 55$G %-1, !14C@ 4%(_ $Y21@!-
M4DT 3%-5 $I370%)4V4!2%-O D93>P)%4XD#0U.7 T)3IP1!4[@$05//!$%3
M[ 1!4OL#0E+_ T)2_P-"4?\#ND\  *I4  "85   B50  'U3  !S4P  :5$
M &)2  !<4P  6%0* %15$@!251L 3U8D $Y6+0!,5S4 2U<\ $I71 !(5TL
M1UA2 $986@%$6&,!0UAM 4%8>0) 6(8"/EB5 SU8I0,\6+<$/%C-!#Q7Z@,\
M5_H#/5;_ SU6_P,]5O\#ME,  *57  "45P  A58  'E6  !O5@  954  %Q6
M  !76   4ED' $Y:$ !,6A@ 2ELA $A<*@!'7#( 15PZ $1=00!#74@ 0EU0
M $!=6  _76$!/5UK 3Q==@(Z780".5V3 CA=HP,W7;4#-EW+ S9<Z ,W7/D#
M-UO_ SA;_P,X6O\#LE<  *!:  "/60  @5D  '59  !K60  8%H  %9;  !1
M70  3%X" $A@#0!%8!0 1&$> $)B)@! 8BX /V(V #YC/@ ]8T4 /&-- #MC
M50 Y8UX .&-H 39C= $U8X$!,V.1 C)CH0(Q8[,",6/( C%BYP(Q8?@",6'_
M C)@_P(R8/\"KEP  )M=  "*70  ?%T  '!=  !F70  7%X  %)@  !,8@
M164  $%F"@ ^9Q$ /&@: #MH(@ Y:2L .&DR #=J.@ V:D$ -6I) #1J4@ S
M:EL ,6IE #!J< $N:GX!+6J. 2QJGP$K:K !*FK& 2IIY0$J:/8"*V?_ BMG
M_P(K9_\"J6$  )5@  "$8   =V   &QA  !B80  6&,  $YF  !':   0&L
M #IN!0 V;PX -' 5 #-P'@ R<28 ,'$N "]Q-0 N<CT +7)% "QR30 K<E<
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M8P 5AG$ %(:! !*&DP 1AJ8 $86[ !"%U@ 1@^\ $8+[ !*"_P 2@?\ D6X
M (%M  !T;@  :6X  %UP  !3<P  27<  $!\   W@   +X,  ">'   AB@
M&HT& !6/#0 3D!, $I : !*0(@ 1D"H $)$R !"1.P /D40 #I%/  V17  ,
MD6H "Y%Z  J1C0 (D)\ !Y"S  >/R0 'C^8 !X[T  B-_  (C?\ B7,  'MS
M  !O<P  8W4  %=X  !-?0  0X$  #F&   PB@  *(X  "&1   :E0  $Y<
M  Z:"  +G X "9P3  B<&@ 'G"( !IPJ  2<,P #G#T  IU(  "=5   G6(
M )QR  "<A   G)<  )NJ  ";OP  FML  )KL  ":]0  F?@ @GD  '9Y  !H
M>@  7'X  %&"  !&AP  /(P  #*1   IE0  (9D  !F=   2H   #J,   FF
M!0 #IPP  *<0  "G%0  J!P  *@C  "H*P  J30  *D_  "I2P  J5D  *EH
M  "I>@  J8X  *FA  "HM0  J,L  *?D  "G[P  I_, ?8   &^!  !AA
M58D  $F.   ^E   -)D  "J>   AH@  &:8  !*I   -K   !Z\   "R
MLP<  +,,  "S$   M!4  +0;  "U(@  MBL  +<U  "W0   N$X  +A=  "X
M;@  N((  +B7  "XJ@  M[X  +?2  "WY@  M^H =H@  &>+  !:D   3I8
M $*<   WH@  +*<  "*K   9KP  $;,   NV   $N0   +P   "^    O@
M +\&  # "P  P0\  ,(3  ##&0  Q"   ,4I  #'-   R$(  ,E1  #)8@
MR74  ,F*  #)GP  RK$  ,K!  #)T0  R=D ;I,  &"8  !3G@  1J0  #JK
M   OL   )+4  !FX   0O   "K\   '!    Q    ,@   #*    R@   ,P
M  #- P  S@@  - -  #1$   TQ8  -8>  #:*   W30  -Y#  #?5   WV<
M .!\  #@D0  X*0  ."R  #@O@  X,, 9I\  %FF  !,K0  /[0  #*X   D
MO   &+\  !##   (QP   ,H   #-    T0   -4   #8    V0   -L   #=
M    WP   .$$  #C"@  Y0X  .<3  #J'   [2<  / U  #Q1@  \E@  /-K
M  #S@   ])0  /2C  #TK@  ]+( _P 3 /\ $0#_ !$ _P 5 /\ 'P#_ "P
M_P Y /\ 10#_ %  _P!: /X 8P#[ &L ^0!R /< > #U 'X ] "$ /( B0#Q
M (X \ "3 .X F0#M )\ [ "F .H K@#H +@ Y@#% .4 VP#C .T X@#[ .(
M_P#A /\ X0#_ .$ _P#A /\ _P 0 /\ #@#_  T _P 2 /\ &P#_ "@ _P T
M /X 00#[ $P ]P!6 /0 7P#Q &8 [P!M .P = #J 'H Z0!_ .< A0#F (H
MY0"/ ., E0#A )L X "B -X J@#; +0 V0#  -8 T #3 .@ T@#W -$ _P#1
M /\ T #_ -  _P#0 /\ _P - /\ "0#_  H _P / /\ %@#[ "( ]P O /0
M.P#P $< [0!1 .D 6@#E &( X@!I .  ;P#> '4 W !Z -H @ #8 (4 U0"+
M -, D0#1 )< SP"> ,T I@#+ *\ R0"Z ,< R0#% .( Q #R ,, _@#" /\
MP0#_ ,( _P#" /\ _P,& /\  0#_  8 _P , /D $0#Q !T ZP I .< -@#C
M $$ WP!+ -L 5 #5 %P T@!C ,\ :@#- '  RP!U ,D >P#( (  Q@"& ,4
MC ## ), P0": +\ H@"] *L NP"V +D Q "W -H M@#M +0 ^@"T /\ M #_
M +0 _P"T /\ _P0  /\   #_    _P & .P #0#E !8 W@ B -< +P#1 #L
MS0!% ,H 3@#& %< Q !> ,$ 9 "_ &H O0!P +P =0"Z 'L N0"! +< AP"U
M (X LP"5 +( G@"P *< K@"R *P OP"J -$ J #H *@ ]P"G /\ IP#_ *8
M_P"F /\ _P8  /\%  #Q P  Z    .$ !P#5 !  S0 ; ,< )P## #, OP ^
M +P 2 "Y %$ M@!8 +0 7P"R &4 L !J *\ < "M '8 K !\ *H @@"I (D
MIP"1 *4 F@"C *0 H0"N *  NP"> <T G0+F )P$] ";!/\ F@7_ )H%_P"9
M!?\ _PH  /$.  #D$   V0\  ,X+  #( PL P@ 3 +P"'P"W RP LP0W + %
M0@"M!DH J@92 *@'60"F!U\ I0=E *,':P"B"'$ H AW )\(?@"="(4 FPF.
M )H)EP"8"J$ E@JL )4+N@"3"\P D@SE ) -]@"/#O\ C@[_ (X._P"-#O\
M]A$  .87  #6&P  QQD  +X5  "Y$   MPH- +$+%P"L#20 J XP *4..P"B
M#D0 GP], )T/4P";#UH F@]@ )@09@"7$&P E1!R ),0>0"2$($ D!"* (\1
ME "-$9\ BQ&J (H2N "($LL AA/F (44]P"#%?\ @Q7_ ((5_P""%?\ [1H
M -PA  #*)0  NR(  +$?  "K&@  J10& *42$0"@%!X G!4J )D5-0"6%CX
ME!9' )(63@"0%E4 CA=; (P780"+%V< B1=M (@7= "&&'P A1B& (,9D "!
M&9L @!JG 'X:M0!]&\< ?!SB 'H=]0!Y'?\ >!W_ '@=_P!X'?\ Y2(  - I
M  "_+   L"H  *<G  "@(P  G1\  )H:#@"5'!@ D1TD (X>+P",'CD B1Y!
M (<?20"%'U  @Q]6 ((?7 " 'V( ?Q]I 'T@< !\('@ >B"! 'DAC !W(9<
M=2*D '0BL@!S(\, <B/? ' D\P!O)/\ ;R3_ &XD_P!N)/\ W2D  ,@P  "W
M,@  J#   )XN  "7*@  DR<  ) C"@",(Q, B"0? (0E*@"")30 @"8] 'TF
M1 !\)DL >B92 '@F6 !W)EX =29E '0G; !R)W0 <2=] &\HB !N*)0 ;"BA
M &LIKP%J*< !:2K; 6<J\0%G*_\!9BO_ 68J_P%F*O\!U"\  ,(V  "O-@
MH34  )8T  "0,   BBT  (<J!@"#*1  ?RH: 'PK)0!Y*R\ =RPX '4L0 !S
M+$< <2Q- ' L5 !N+%H ;2QA &LM: !J+7  :"UZ &<NA0!E+I$!9"Z> 6(O
MK %A+[T!83#5 6 P[P%?,/T!7S#_ 5\P_P%?,/\!S30  +P[  "I.@  FSH
M ) X  ")-0  @S(  '\P 0![+PX =S 6 '0P(0!Q,2L ;S$T &TQ/ !K,4,
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M DX^Z0)-/OH"3C[_ 4X]_P%./?\!P#\  *Y#  "<0P  CD,  ()"  !Z0
M<ST  &T\  !H/04 9#T. &$^%P!>/B$ 7#XI %H^,0!8/CD 5SY  %4_1@!4
M/TT 4S]5 %) 7 !00&4 3T!O 4Y!>@%-08<!2T&6 4I!I0))0K4"24++ DE"
MZ ))0OD"24'_ DE!_P%)0?\!O4,  *I%  "810  BD4  ']%  !V0P  ;T
M &A   !C00$ 7T$- %Q!% !90AT 5T(F %5"+@!30C8 44(] $]"0P!/0TL
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M 3M,_P$\3/\!LTT  )Y,  "-3   ?TP  '1,  !J3   8$H  %E+  !43
M4$T% $Q.#@!)3Q4 1T\> $5/)@!$4"X 0E U $%0/0! 440 /U%+ #Y14P ]
M4EP /%)F #I2<@ Y4G\!.%*. 3=2G@$V4J\!-5+$ 352X@$V4O4!-E'_ 390
M_P$W4/\!KD\  )E/  ")3P  >T\  '!/  !F3P  7$X  %1/  !/40  2E(!
M $93# !#5!( 050; $!5(P ^52L /58R #Q6.@ [5D$ .E9) #E740 X5UH
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M:0 G9'8 )F2& "5DEP D9*D (V2] ")DV@ C8_$ (V+] 21A_P$D8?\!G%@
M (E8  !Z60  ;ED  &-9  !:6@  4%P  $A>  !!8   .F,  #1F   O: H
M+&D0 "II%P I:A\ *&HF "=J+@ F:S4 )6L] "1K1@ C:T\ (FQ9 "!L90 ?
M;'( 'FR" !ULE  <;*8 &VNZ !IKU  ;:NX '&G\ !QH_P <:/\ E5P  (-<
M  !U7   :5T  %]=  !67@  3&$  $-D   \9P  -6H  "]M   H< 0 (W(-
M "%R$@ @<QH 'W,A !YS*  ==#  ''0X !MT0  :=$H &714 !=U8  6=6X
M%75^ !1UD  3=*( $G2V !%TSP 2<^P $G+Z !-Q_P 3<?\ CF   'U@  !O
M80  96$  %MB  !19   2&<  #YK   W;@  ,'$  "EU   B>   ''L' !=]
M#@ 6?1, %7T; !1^(@ 3?BH $GXQ !%^.@ 1?D0 $'].  ]_6@ .?V@ #7]X
M  Q_B@ +?IT "GZP  E]Q@ *?>0 "GST  M[_0 +>O\ AF4  '=E  !J90
M868  %9H  !,:P  0F\  #ES   Q=P  *GH  "-^   <@0  %80  !"'"  -
MB0X #(D4  R)&P +B2, "HDK  F),P (B3T !HE(  6)5  $B6$  HEQ  &)
M@P  B98  (BI  "'O@  A]H  (;L  "&]0  AOH ?FH  '%J  !G:P  6VP
M %!P  !&=   /'@  #-]   J@0  (X4  !R(   5C   $(\   R2!@ &DPP
M I,1  "4%@  E!T  )0D  "5+   E34  )5   "53   EED  )9I  "5>@
ME8X  )2A  "4M0  D\P  )+F  "2\@  DO< >'   &UP  !@<@  5'4  $EY
M   _?@  -8,  "R(   CC0  &Y$  !24   /EP  "IH   2= P  G@D  )\.
M  "?$@  H!<  * =  "A)0  HBT  *(W  "C0P  HU   *-?  "C<0  HX0
M **9  "BK0  H<(  *'<  "AZP  H/( <W8  &9W  !9>P  38   $*%   X
MBP  +I   "25   ;F@  %)X   ZA   )I    J<   "J    JP0  *L*  "L
M#0  K1$  *T6  "N'   KR0  + M  "Q.0  L48  +)5  "R9@  LGD  +*.
M  "QHP  LK<  +'*  "QX   L>D ;'X  %^"  !2AP  1HT  #N3   PF0
M)IX  !RC   3IP  #:L   >N    L@   +4   "W    N    +D"  "Y"
MN@P  +L0  "\%   O1L  +\C  #!+0  PCH  ,))  ##6@  PVP  ,2"  #$
MEP  Q*L  ,2\  #$RP  Q-H 98D  %B.  !+E0  /YL  #.B   HJ   ':T
M !2Q   -M@  !KD   "\    OP   ,,   #$    Q0   ,8   #'    R00
M ,H)  #+#0  S1$  ,\8  #2(0  U2T  -8\  #830  V5\  -IS  #:B@
MVYX  -NN  #;N@  W,, 7I8  %&<  !$HP  .*H  "RQ   @MP  %;L   V^
M   $P@   ,4   #)    S0   -    #2    T@   -4   #6    V0   -L
M  #>!0  X H  .(/  #E%@  Z"   .PM  #M/@  [5$  .YE  #O>@  [X\
M /"?  #PJP  \+, _P 0 /\ #@#_  X _P 2 /\ '0#_ "D _P U /\ 00#_
M $T _@!6 /L 7P#X &8 ]@!M /0 = #R 'D \0!_ /  A #N (D [0"/ .L
ME0#J )L Z "B .8 J@#E +, XP#  .$ T@#@ .H WP#Y -T _P#= /\ W0#_
M -X _P#> /\ _P - /\ "@#_  D _P / /\ & #_ "0 _@ Q /L /0#X $@
M] !2 /  6@#M &( ZP!I .D ;P#G '4 Y0!Z ., ?P#B (4 X "* -X D #<
M )8 V@"= -@ I0#5 *\ T@"Z -  R@#. ., S0#T ,L _P#+ /\ RP#_ ,L
M_P#+ /\ _P ( /\  P#_  4 _P , /P % #W !\ \@ K .\ -P#K $( YP!,
M .0 50#@ %T W0!D -H :@#8 '  U0!U -( >@#0 (  SP"% ,T BP#+ )(
MR0"9 ,< H0#% *H PP"U ,$ PP"_ -H O@#N +T _ "\ /\ O #_ +P _P"\
M /\ _P   /\   #_    ^0 ' /$ $ #J !H Y  E -\ ,0#; #P UP!' -(
M4 #. %< RP!> ,D 90#& &H Q0!P ,, =0#! 'H P "  +X A@"\ (T N@"4
M +D G "W *4 M0"P +, O0"Q ,\ KP#H *X ^ "N /\ K0#_ *T _P"M /\
M_P   /\   #]    [@ ! ., # #: !0 T0 ? ,P *P#( #8 Q0!  ,( 2@"_
M %( O !9 +H 7P"X &4 M@!J +0 ;P"S '4 L0!Z +  @0"N (@ K0"/ *L
MF "I *$ IP"K *4 N "C ,@ H@#B *$ \P"@ /X H #_ *  _P"@ /\ _P
M /8   #J    X    -, !@#)  \ P@ 8 +T ) "Y "\ M@ Z +0 0P"Q $P
MK@!3 *P 60"J %\ J0!D *< :@"F &\ I !U *, >P"A (( H "* )X DP"<
M )T F@"G )@ M "6 ,, E0#< )0 [P"3 /L DP#_ ), _P"2 /\ ^04  .H+
M  #<#0  RPH  ,(%  "\  H M@ 1 +$ ' "N "@ J@ S *< /0"D $4 H@!-
M *  4P"> %D G !? )L 9 ": &H F !P )< =@"5 'X DP"& )(!CP"0 9D
MC@*D (P"L0"+ \  B076 (@&[0"(!_H APC_ (8(_P"&"/\ [P\  -X4  #*
M%0  O!(  +,0  "N#   JP8- *<#%0"B!2  GP<L )P(-@"9"#\ EPE' )4)
M3@"3"50 D0I: ) *7P"."F4 C0IK (L*<@"*"WD B N" (<+C "%#)< @PRB
M ($-L " #<  ?PW8 'T.[P!\#_T >P__ 'L0_P![$/\ YA<  -$>  "]'0
MKQP  *89  "A%0  GA $ )T-#P"8#AD E XE )$/+P"/$#D C!!! (H02 "(
M$$\ AQ!5 (406P"$$6$ @A%G ( 1;@!_$74 ?1%^ 'P2B !Z$I0 >!*@ '<3
MK@!U$[X =!35 ',5[@!Q%OT <1;_ '$6_P!P%O\ W!\  ,8E  "S)0  I2,
M )PA  "6'@  DAD  )$4"P"-%!0 B14? (86*0"#%C, @1<\ ( 70P!^%TH
M?!=0 'H75@!Y&%P =QAB '88:0!T&'$ <QEZ '$9A !O&I  ;AJ= &P;JP!K
M'+L :AS0 &D=[ !H'OL :![_ &<>_P!G'O\ T28  +TJ  "K*@  G2H  ),H
M  "-)0  B"(  (8=!@"#&Q  ?QP: 'P=) !Z'2X =QXV '8>/@!T'D4 <A]+
M '$?40!O'U@ ;A]> &P?90!K(&T :2!V &@A@0!F(8T 92*: &,BJ !B([@
M82/- & DZ0!@)/H 7R3_ %\D_P!?)/\ RBP  +8O  "D+P  EB\  (PM  "%
M*@  @"@  'TD  !Z(@T =B,5 ',C( !Q)"D ;R0R &TD.@!K)4$ :B5' &@E
M30!F)50 925: &0F80!B)FD 829R %\G?0!>)XH 72B7 %LII0!:*;4 6BK*
M %DJYP!8*O@ 6"K_ %@J_P!8*O\ Q3$  *\S  ">,P  D#,  (8R  !_+P
M>2T  '4J  !R* H ;R@2 &LI&P!I*24 9RHM &4J-0!C*CT 8BI# & J2@!?
M*U  7BM7 %PK7@!;+&8 62QO %@M>@!7+8< 5BZ5 %0NHP!3+[, 4R_' %(O
MY0!2+_< 4B__ %(O_P!2+_\ P38  *HV  "9-@  BS8  ($U  !Y,P  <S$
M &\O  !K+@8 :"T0 &0N& !B+B$ 8"\J %XO,0!<+SD 6R]  %DO1@!8+TT
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M 4(\_P%"._\!LST  )X^  "-/@  ?SX  '4^  !L/0  9CH  & Y  !;.@
M5SH( %,[$ !1.Q@ 3CL@ $P[* !+.R\ 23PV $<\/0!'/$0 1CU+ $4]4P!$
M/EP 0SYF $(_<0!!/WX 0#^- #] G  ^0*T!/4#  3U W0$]0/(!/4#_ 3X_
M_P$^/_\!KD   )I   ")00  ?$$  '%!  !H0   83P  %L]  !6/@  4CX%
M $X_#@!,/Q4 23\= $= )0!&0"P 1$ S $- .@!"04( 04%) $!!40 _0EH
M/D)C #U#;P \0WP .T.+ #I$FP Y1*L!.42^ 3A$VP$Y1/$!.4/^ 3E#_P$Y
M0_\!JD(  )9#  "&0P  >$,  &Y#  !E0P  74   %9   !10@  34(" $E#
M# !&0Q( 1$0: $)$(@!!1"H /T4Q #Y%.  ]13\ /$9' #M&3P Z1E< .4=A
M #A';  W1WH -DB) #5(F0 T2*H -$B] #-(V0 T2/  -$?] #1'_P U1O\
MID0  ))%  ""1@  =48  &I&  !A10  640  %%$  !,1@  2$<  $1'"@!!
M2!  /TD8 #U)(  \22< .DHN #E*-@ X2CT -TM$ #9+3  U2U4 -$Q? #-,
M:@ R3'< ,4R& #!,EP O3:@ +DV[ "Y-U0 N3.\ +TS] "]+_P P2_\ H4<
M (Y(  !^2   <4@  &9)  !=2   54@  $Q)  !'2@  0DL  #],!@ [30X
M.4X5 #=.'0 V3R0 -4\K #-/,P R4#H ,5!" #!02@ O45( +E%< "U19P L
M474 *U&$ "I2E0 I4J8 *5*Y "A2T@ I4>X *5#\ "I0_P J3_\ G$H  (E*
M  !Z2P  ;4L  &-,  !:3   44P  $A-  !#3P  /5   #E2 @ U4PP ,U02
M #%4&0 P52$ +E4H "U5+P L5C< *U8^ "I61@ I5D\ *%=9 "=79  F5W(
M)5>! "17D@ C5Z0 (E>W ")7SP B5^P (U;Z "-5_P D5?\ EDT  (1.  !U
M3@  :4X  %]/  !63P  35   $52   _4P  .58  #-8   O6@@ *UL/ "I;
M%0 H7!T )UPD "9<*P E7#, )%TZ "-=0P B74P (5U6 "!>80 ?7FX 'EY^
M !U>CP <7J$ &UZT !I=S  ;7>D &USY !Q;_P <6_\ D%$  'Y1  !P40
M9%(  %M2  !24P  2E0  $%7   [60  -5L  "Y>   H8 , )&(, ")C$0 A
M8Q@ 'V0@ !YD)P =9"X '&0V !ME/@ :94< &651 !AE70 796H %F5Z !5E
MBP 499X $V6Q !)ER  29.< $V/W !1B_P 48O\ B50  'A5  !K50  8%8
M %=6  !/5P  1ED  #U<   V7P  ,&(  "ED   C9P  '6H' !EL#@ 8;!,
M%FT: !5M(0 4;2D %&TP !-M.0 2;D( $6Y, !!N6  /;F4 #FYU  UNAP -
M;IH #&VM  MMP@ +;.  #&OS  UK_0 -:O\ @ED  ')9  !F60  7%H  %1:
M  !*7   05\  #EC   Q9@  *FD  "1L   =;P  %W(  !)U"0 /=P\ #G<4
M  YW&P -=R, #'<J  MW,P *=SP "7='  AW4@ '=U\ !7=O  1W@  #=Y0
M 7:G  !VNP !==4  73K  )T]@ "=/P >UT  &U=  !B7@  65X  $Y@  !%
M8P  /&<  #-K   K;@  )'(  !YU   7>0  $GP   U_!@ )@0P !8$1  .!
M%@ "@1T  8$D  "!+0  @C8  ()   ""3   @ED  ()H  "">0  @HT  (&@
M  " M   @,L  '_G  !^\@  ?OD =&(  &AB  !>8@  4V0  $EG   _:P
M-G   "UT   E>   'GP  !>    1@P  #88   B)!  "BPH  (L.  "+$P
MC!@  (P?  "-)@  C2\  (XY  ".1   CE$  (Y@  ".<0  CH4  (Z9  "-
MK0  C,,  (S?  "+[@  B_8 ;F@  &1G  !8:0  36P  $)Q   X=@  +WL
M "9_   >A   %H@  !",   ,CP  !I(   "5    E@<  )<,  "7#P  F!,
M )D8  ":'P  FR8  )LP  "<.P  G$@  )Q7  "<:   G'L  )R0  ";I0
MF[H  )K0  ":YP  FO$ :FT  %YO  !1<@  1G<  #M\   Q@@  )X<  !Z,
M   6D0  $)4   J9   $G    *    "B    HP$  *,&  "D"P  I0X  *82
M  "G%P  J!X  *HF  "K,0  JSX  *Q-  "L70  K'   *R%  "LFP  JZ\
M *O#  "KV0  JN@ 9'4  %=Y  !+?@  /X0  #2*   ID   'Y8  !:;   0
MGP  ":,   &G    J@   *X   "P    L    +$   "R P  M @  +4-  "V
M$   MQ4  +D=  "[)@  O#,  +U!  "]4@  O60  +YY  "^D   O:0  +VW
M  "]Q@  O=< 7'\  %"%  !$BP  .)(  "R9   AGP  %Z0  !"I   )K@
M +(   "V    N0   +T   "_    OP   ,    #!    PP   ,0%  #&"@
MQPX  ,D3  #+'   SB8  - U  #110  TE<  -)K  #3@@  TY<  -.I  #2
MN   TL0 58P  $F3   ]F@  ,*(  "6H   :K@  $;0   FY    O0   ,$
M  #$    R    ,L   #-    S0   ,\   #0    T@   -0   #8    V@8
M -T,  #@$0  XQH  .8G  #G.   Z$H  .E=  #J<@  ZX@  .N;  #LJ
M[+( _P - /\ "P#_  L _P 0 /\ &@#_ "8 _P R /\ /0#_ $@ ^P!2 /@
M6@#V &( \P!I /$ ;P#P '4 [@!Z .P ?P#K (0 Z0"* .@ D #F )8 Y "=
M .( I0#A *\ WP"[ -T RP#; .8 V0#W -@ _P#8 /\ UP#_ -< _P#4 /\
M_P ( /\ ! #_  0 _P - /\ %0#^ "$ ^@ L /< . #T $, \ !- .T 50#J
M %T YP!D .0 :@#B '  X !U -X >@#= '\ VP"% -D BP#5 )$ TP"9 -$
MH #/ *H S0"U ,L Q #) -T R #Q ,< _P#& /\ Q@#_ ,8 _P#' /\ _P
M /\   #_    _P * /@ $0#Q !P [  G .D ,@#F #T X@!' -T 4 #9 %@
MU0!? -( 90#0 &H S@!P ,P =0#* 'H R0!_ ,< A0#% (P PP"4 ,$ G "_
M *4 O0"P +L O0"Z -  N #K +< ^P"V /\ M@#_ +8 _P"V /\ _P   /\
M  #]    \P % .D #@#A !8 VP A -4 +0#1 #< S@!! ,H 2@#' %( Q !9
M ,( 7P#  &4 O@!J +P ;P"[ '0 N0!Z +< @ "V (< M ". +( EP"P *
MK@"J *T MP"K ,@ J0#C *@ ]0"G /\ IP#_ *< _P"F /\ _P   /X   #Q
M    Y0   -< "@#- !$ QP < ,( )@"_ #$ O  [ +H 1 "W $P M !3 +(
M60"Q %\ KP!D *T :0"L &\ J@!T *D >@"G ($ I@") *0 D0"B )L H "E
M )X L@"= ,$ FP#: )H [P"9 /T F #_ )@ _P"8 /\ _0   /    #A
MT0   ,8 ! "]  T MP 5 +, ( "P "L K0 U *L /@"H $8 I@!- *0 5 "C
M %D H0!? *  9 "> &D G0!N )L =0": 'L F "# )8 C "5 )8 DP"A )$
MK0"/ +L C0#/ (P Z0"+ /@ C #_ (P _P", /\ \P(  .('  #,!P  OP0
M +<   "Q  @ JP 0 *< &0"D "0 H  N )X -P"< $  F@!' )@ 3@"6 %0
ME0!9 ), 7@"2 &0 D !I (\ ;P"- '8 BP!^ (H B "( )( A@"= (4 J0"#
M +@ @0#* (  Y0"  /4 ?P#_ '\ _P!_ /\ Z T  - 0  "^$   L0X  *@-
M  "C"   H (, )P $P"8 !T E0 G )( ,0"0 #D C@%! (P!2 "* DX B0)4
M (<"60"& E\ A -D (,#:P"! W( @ 1Z 'X$A !]!8X >P6: 'D&IP!X!K4
M=@?( '4(XP!U"?0 = K_ ',*_P!S"O\ W14  ,07  "Q%P  I18  )P3  "6
M$0  E T$ ),(#0".!Q4 BPD@ (@)*@"%"C, @PL[ ($+0@" "TD ?@M/ 'T,
M5 ![#%H >@Q@ '@,9P!W#&X =0UV '0-@ !R#8P < V9 &\.I@!M#K4 ; [)
M &L/Y@!J$/< :1#_ &D0_P!I$/\ T!T  +D>  "H'@  FQT  )(;  "+&0
MB!4  (<1!P"%#A  @0\: 'X0) ![$"T >1 V '<1/0!V$40 =!%* ',14 !Q
M$58 <!%< &X28@!M$FH :Q)S &D3?0!H$XD 9A.6 &44HP!C%;, 8A7& &(6
MXP!A%O8 8!?_ & 7_P!@%_\ QR(  + C  "?)   DB,  (DB  ""(   ?AT
M 'P9  !Z%0T =Q45 '06'P!Q%B@ ;Q<P &X7. !L%S\ :Q=% &D82P!H&%$
M9AA8 &487@!C&68 8AEO & 9>0!?&H4 71N2 %P;H0!;'+  6AS# %D=X !8
M'O0 6![_ %@>_P!8'O\ OR<  *DH  "9*   BR@  ((G  ![)0  =B,  ',@
M  !Q' D ;AP1 &L<&@!I'2, 9QTL &4=,P!C'CH 8AY! & >1P!?'DT 7AY4
M %P?6P!;'V( 62!K %@@=@!6(8( 52&0 %0BG@!3(JX 4B/  %$CW0!1)/(
M423_ %$D_P!1(_\ N2L  *,L  "3+   ABT  'PL  !T*@  ;R@  &LE  !I
M(@4 9B$. &,B%@!A(A\ 7R,G %TC+P!<(S8 6B,] %DD0P!7)$H 5B10 %4D
M5P!3)5\ 4B5H %$F<P!/)G\ 3B>- $THG !,**P 2RF^ $LIV@!**?$ 2BG_
M $LI_P!+*?\ LRX  )XO  ".,   @3   '<O  !O+@  :BL  &4J  !C)P$
M7R<, %PG$P!:)QL 6"@D %8H*P!5*#( 4R@Y %(I0 !0*48 3RE- $XI5 !-
M*EP 3"IE $HK< !)*WP 2"R+ $<MF@!&+:H 12Z\ $4NU@!%+N\ 12[^ $4N
M_P!%+?\ KC$  )HR  "),P  ?#,  '(S  !K,0  92\  & M  !=+   62P)
M %8L$ !4+!@ 4BP@ % L* !.+2\ 32TV $PM/ !*+4, 22U* $@N40!'+ED
M1B]C $4P;0!#,'H 0C&) $$QF !!,J@ 0#*[ #\RTP _,NX 0#+] $ R_P!
M,O\ JC,  )8U  "&-0  >38  &XU  !F-0  83(  %PP  !7,   5# & %$P
M#@!.,!4 3#$= $HQ)0!(,2P 1S$R $8Q.0!$,4  0S)' $(R3P!!,U< 0#-@
M #\T:P ^-7@ /36' #PVE@ [-J< .S:Y #HVT0 Z-NT .S;\ #LV_P [-O\
MIC8  )(W  "".   =3@  &LX  !C-P  738  %<S  !3-   3S0# $LT# !)
M-!( 1C4: $4U(@!#-2D 034O $ U-@ _-CT /C9$ #TW3  \-U4 .SA> #HX
M:0 Y.78 .#F% #<ZE0 W.J4 -CJX #4ZSP V.NP -CK[ #8Y_P W.?\ HC@
M (XY  !^.@  <CL  &@[  !?.@  63D  %,V  !.-P  2C@  $8X"@!$.1
M03D7 #\Y'P ^.28 /#DM #LZ-  Z.CL .3M" #@[2@ W.U, -CQ< #4\9P T
M/70 ,SV# #,^DP R/J0 ,3ZV #$^S0 Q/NH ,3[Z #(]_P R/?\ GCL  (L\
M  ![/   ;CT  &0]  !</0  53P  $XZ  !).P  13P  $$]!P ^/0X /#T5
M #H^'  Y/B, -SXJ #8_,0 U/S@ -#]  #- 2  R0%  ,4!: #!!90 O07(
M+D*! "U"D0 M0J( +$*U "M"RP L0ND +$+Y "U!_P M0?\ F3T  (<^  !W
M/P  :S\  &%   !9/P  4C\  $D^  !$/P  0$   #Q!!  Y0@T -T(2 #5#
M&0 S0R$ ,D,H #%$+P P1#8 +T0] "Y%10 M14X +$58 "M&8P J1F\ *49^
M "A&CP G1Z$ )D>S "9'R0 F1N< )T;X "A%_P H1?\ E4   ()!  !S0@
M9T(  %Y"  !50@  3D(  $5"   _1   .T4  #=&   T1PH ,4@0 "](%@ N
M21X +$DE "M)+  J23, *4HZ "A*0@ G2DL )DM5 "5+8  D2VT (TM\ ")+
MC0 A3)\ (4RQ "!,QP @2^8 (4OW ")*_P B2O\ D$,  'Y$  !O1   9$4
M %I%  !210  2D8  $%'   \2   -TD  #)+   N30< *TX. "E.$P G3QH
M)D\A "5/*  D3S  (U W ")0/P A4$@ (%!2 !]170 >46H '5%Y !Q1B@ ;
M49P &E&O !E1Q0 94>0 &E#V !M/_P <3_\ BD8  'E'  !K1P  8$@  %9(
M  !.2   1TD  #Y+   Y3   ,TX  "Y0   H4P( )%0+ ")5$  @518 'U8>
M !Y6)  =5BP '%8S !M7.P :5T0 &5=. !A760 76&8 %5AU !18AP 46)H
M$U>L !)7P@ 25^$ $U;T !15_P 45?\ A$D  '1*  !F2P  7$L  %-+  !+
M3   1$T  #Q/   U40  +U0  "E6   D60  'EL' !I=#0 871( %UT9 !9>
M(  57B< %%XN !->-P 27D  $5]* !%?50 07V( #U]Q  Y?@P -7Y8 #5^I
M  Q>O@ ,7MH #5WP  U<_  .7/\ ?DT  &Y.  !B3@  6$\  $]/  !(4
M0%(  #A4   P5P  *EH  "1=   ?7P  &6(! !-E"0 19@\ $&84  ]F&P .
M9R( #6<I  UG,@ ,9SL "V=%  IG4  )9UT !V=L  9G?0 %9Y  !&:C  )F
MMP #9<\ !&7I  1D]0 $9/P =U$  &E2  !=4@  5%(  $Q3  !#50  .U@
M #-;   K7@  )6$  !]D   99P  $VH   ]M!@ +< P "' 1  =P%@ %<!T
M!' D  -P+  "<#4  ' _  !P2@  <%<  '!E  !P=@  <(H  &^>  !OL@
M;L@  &WE  !M\@  ;?D <%8  &-6  !95@  _^+__TE#0U]04D]&24Q%  0)
M45<  $=8   ^6P  -E\  "YB   F9@  'VH  !EM   3<   #G,   MV!  %
M> L  7@/  !Y$P  >1D  'D?  !Z)@  >B\  'HY  !Z1   >E   'I?  !Z
M<   >H,  'J8  !ZK   ><(  'C?  !X[P  =_< :EL  %];  !66P  3%P
M $)@   Y8P  ,&@  "AL   @<   &70  !-W   .>P  "7X   2! @  @@@
M (,-  "#$   A!0  (49  "&(   AB@  (<Q  "'/   ATD  (=7  "':
MAWL  (>0  "&I0  A;H  (73  "$Z@  A/0 96   %Q@  !180  1F0  #QI
M   R;0  *7(  "%W   9>P  $H    V#   (AP   HH   "-    C@0  (X)
M  "/#0  D!   )$4  "2&0  DR   )0I  "5,P  E4   )9.  "67P  E7(
M )6(  "5G0  E+(  )3(  "3X@  D^X 864  %9F  !*:@  /VX  #5T   K
M>0  (7\  !F$   1B0  #(T   :1    E    )@   ":    FP   )P"  "=
M!P  G@L  )\.  "A$@  HA@  *,@  "E*0  IC8  *9$  "F50  IF@  *9]
M  "FE   I:D  *2]  "DT0  I.0 6VP  $]P  !#=0  .'L  "V!   CAP
M&8T  !&2   +EP  !)P   "@    HP   *8   "H    J0   *H   "L
MK00  *X)  "P#0  L1$  +,7  "U(   MBL  +<Z  "W2P  N%P  +AQ  "X
MB   N)T  +BQ  "WP@  M]  5'8  $A\   \@@  ,8D  ":0   ;EP  $IT
M  RB   #IP   *L   "N    L@   +8   "X    N    +H   "[    O0
M +X   # !0  P0L  ,,0  #&%@  R2   ,HN  #+/@  S%   ,QD  #->@
MS9$  ,VD  #-M   S<  38,  $&*   UD0  *9D  !Z@   3I@  #*P   .Q
M    M@   +H   "^    P@   ,8   #(    R    ,H   #+    S0   ,X
M  #0    T@$  -4(  #9#@  W14  .$A  #B,0  Y$,  .56  #F:P  YH(
M .>6  #GI0  YK  _P ) /\ !0#_  8 _P . /\ %@#_ "$ _P M /\ . #]
M $, ^0!- /4 50#R %T \ !C .X :0#L &\ Z@!T .D >@#G '\ Y@"% .0
MBP#C )$ X0"9 -\ H0#< *H V@"V -< Q@#5 .$ TP#T -( _P#1 /\ T0#_
M ,\ _P#* /\ _P ! /\   #_  $ _P , /\ $@#Z !T ]@ H /, ,P#P #X
M[ !( .@ 4 #E %@ X@!> -\ 9 #= &H VP!O -D = #6 'H U !_ -( A0#0
M (P S@"3 ,P G #) *4 QP"P ,8 O@#$ -0 P@#N ,$ _@#  /\ P #_ +\
M_P"^ /\ _P   /\   #_    ^@ ' /$ #P#K !@ Y@ C .( +@#@ #@ VP!"
M -4 2P#1 %( S@!9 ,L 7P#) &4 QP!J ,8 ;P#$ '0 P@!Z ,$ @ "_ (8
MO0". +L E@"Y *  MP"J +8 MP"T ,H L@#F +$ ^ "P /\ KP#_ *\ _P"P
M /\ _P   /\   #W    Z@ " .$ # #7 !, T  = ,P * #) #( Q@ \ ,(
M10"_ $T O !3 +H 60"X %\ MP!D +4 :0"T &X L@!T +$ >@"O (  K0"(
M *P D0"J )H J "E *8 L0"D ,$ HP#< *$ \@"A /\ H #_ *  _P"A /\
M_P   /<   #H    V0   ,L " ## !  O0 8 +D (@"V "P M  V +( /P"O
M $< K !- *L 5 "I %D IP!> *8 8P"E &@ HP!N *( = "@ 'H G@"" )P
MBP"; )4 F0"? )@ K "6 +H E #/ ), ZP"2 /L D@#_ )( _P"1 /\ ]P
M .<   #3    Q@   +L  @"S  P K0 2 *H ' "G "8 I  P *, . "@ $
MG@!' )P 3@": %, F0!8 )< 70"6 &, E0!H ), ;@"2 '0 D !\ (\ A0"-
M (\ BP": (H IP"( +4 A@#' (4 Y "$ /4 A #_ (, _P"# /\ [    -,
M  #! 0  M    *P   "F  < H  . )T %@": "  EP I )4 ,@"3 #H D0!!
M (\ 2 "- $T C !3 (L 6 ") %T B !C (< :0"% &\ @P!W (( @ "  (H
M?@"6 'T HP![ +  >@#" 'D W0!X /$ =P#] '@ _P!X /\ W@H  ,0+  "R
M#   I@L  )T(  "9!   E0 * )$ $0". !D BP C (D + "' #0 A0 [ (,
M0@"" $@ @ !. '\ 4P!] %@ ? !> 'L 9 !Y &H > !R '8 >P!T (8 <P"2
M '$ GP!P *T ;@"^ &T!U@!M NT ; /Z &P#_P!L _\ SA   +<1  "F$@
MFA$  )$0  "+#@  B0L# (<%# "$ 1, @0$< 'X")0!\ RX >@,V '@$/ !W
M!$, =05( '0%3@!S!50 <059 ' &7P!N!F8 ;09N &L'> !J!X, : B0 &<)
MG0!E":P 9 F\ &,*U !C"^P 8@SZ &(,_P!B#/\ PQ8  *T7  "=&   D!@
M (<6  "!%   ?1$  'P.!@!\"@X > H6 '4+'P!R"R@ < PP &\,-P!M##X
M; Q$ &L-2@!I#4\ : U5 &<-7 !E#6, 8PYK &(.=0!@#H$ 7PZ. %T/G !<
M$*L 6Q"] %H0U@!9$?  61'] %D1_P!9$?\ N1L  *4=  "4'@  B!X  'X=
M  !X&P  =!@  '$5  !Q$0D ;Q 1 &P0&0!I$"( 9Q$J &81,@!D$3D 8Q$_
M &(110!@$DL 7Q)1 %T26 !<$E\ 6A-H %D3<@!7%'T 5A2+ %05F0!3%:D
M4A:Z %$6T@!1%^T 41?] %$7_P!1%_\ LB   )XB  ".(@  @2,  '<B  !P
M(0  ;!X  &D;  !G& 0 9A4. &,6%0!A%AX 7Q8F %T6+0!<%S0 6A<[ %D7
M00!8&$< 5AA- %485 !3&%P 4AED %$9;@!/&GH 3AN( $T;EP!+'*8 2ARX
M $H=SP!)'>L 21W[ $D=_P!*'?\ K"0  )@E  "()@  >R<  '$F  !J)0
M9B,  &(A  !@'@  7AP+ %L;$@!9'!H 5QPB %4<*0!4'#  4QTW %$=/0!0
M'4, 3QU* $T>40!,'E@ 2Q]A $D?:P!(('< 1R"% $8AE !$(J0 1"*V $,B
MS !#(^D 0R/Z $,C_P!#(O\ IB<  ),I  "#*@  =BH  &TJ  !E*0  8"<
M %PE  !9(P  5R$' %4A#P!2(18 4"$> $XA)0!-(BP 3"(S $HB.0!)(D
M2")& $<C30!%(U4 1"1> $,D:0!")74 0":# #\FD@ ^)Z, /B>T #TGR@ ]
M*.@ /2CY #TG_P ^)_\ HBH  (XK  !_+0  <BT  &@M  !A+   7"L  %@H
M  !4)@  428$ $XE#0!,)1, 2B8: $@F(@!')BD 128O $0F-@!#)SP 02=#
M $ G2P _*%, /BE< #TI9@ \*G( .RJ! #HKD  Y*Z$ ."RR #<LR  W+.8
M."SX #@L_P X+/\ G2P  (HN  ![+P  ;S   &4P  !=+P  6"X  %,K  !0
M*@  3"H  $DJ"P!&*A$ 1"H7 $(J'P!!*B4 /RHL #XK,P ]*SD /"M  #LL
M2  Z+%  .2U9 #@N9  W+G  -B]_ #4OCP T,)\ ,S"Q #(PQP R,.4 ,S#W
M #,P_P T+_\ F2\  (<Q  !W,@  :S(  &(R  !:,@  5#$  $\O  !++0
M1RX  $0N" !!+@X /RX4 #TN'  [+B( .2\I #@O+P W+S8 -C ^ #4P1@ U
M,4X -#%7 #,R8@ R,FX ,3-] # SC0 O-)X +C2P "TTQ0 M-., +C3V "\S
M_P O,_\ E3$  (,S  !T-   :#4  %XU  !7-   430  $LR  !&,0  0C(
M #\R!0 \,@T .3,2 #@S&0 V,R  -#,F #,S+0 R-#0 ,30[ # U0P P-4P
M+S95 "XV8  M-VP +#=[ "LWBP J.)P *3BN "@XPP H..( *3CU "HW_P J
M-_\ DC0  '\U  !Q-@  93<  %LW  !4-P  338  $<V  !"-0  /38  #HV
M @ W-PL -#<0 #(W%@ Q.!T +S@D "XX*P M.3( +#DY "LY00 J.DD *CI3
M "D[7@ H.VH )SMY "8\B0 E/)L )#RM ",\P@ C/.  )#ST "4[_P E._\
MC38  'PX  !M.0  8CD  %@Z  !1.0  2CD  $0Y   ].0  .3H  #4[   R
M.P@ +SP. "T]%  L/1H *CTA "D]*  H/B\ )SXV "8^/@ E/T< )#]0 "-
M6P B0&@ (4!V "! AP ?09D 'T&K !Y!P  >0=X 'T#S !] _@ @/_\ B3D
M '@Z  !I.P  7CP  %4\  !-/   1SP  $ \   X/0  -#X  #!    M004
M*D(, "="$0 F0Q@ )$,> "-#)0 B0RP (40S "!$.P ?1$0 'D5. !U%60 <
M164 &T5T !I%A0 91I< &4:I !A&O@ 71=P &$7Q !E$_0 :1/\ A#P  ',]
M  !F/@  6S\  %(_  !*/P  1#\  #U    V00  ,4,  "Q$   G1@$ )$<*
M "%(#P @210 'DD; !U)(@ <22D &THP !I*.  92D$ &$I+ !=+50 62V(
M%4MQ !1+@@ 32Y0 $DNG !)+O  12]D $DKP !-*_  42?\ ?S\  &]   !A
M00  5T(  $Y"  !'0@  04(  #I#   R10  +4<  "A)   C2P  'DT& !M/
M#0 84!$ %U 7 !90'@ 54"4 %% L !-1-  243T $5%' !%14@ 045\ #U)M
M  Y2?@ -49$ #5&D  Q1N  ,4=$ #5#L  U0^@ .3_\ >4,  &I$  !=1
M4T4  $M%  !$10  /D8  #9(   O2@  *4P  "1/   ?40  &E,  !16"0 1
M5PX $%@3 !!8&0 /6"  #E@H  U8,  -6#D #%A#  M83@ *6%H "%AH  =8
M>0 &6(P !5B?  18LP $5\H !5?F  57\P &5OP <T8  &1'  !92   4$@
M $A(  !!20  .DH  #)-   K4   )5(  "!5   :6   %5H  !!=!@ ,8 P
M"F 0  E@%0 (8!P !V C  5@*P $8#0  V ]  %@20  8%4  &!C  !@<P
M8(8  %^:  !?K@  7\0  %[B  !>\   7O@ ;$H  %]+  !52P  3$P  $5,
M   ]3@  -5   "Y3   G5@  (%D  !I<   57P  $&(   UE!  (9PL  V<.
M  !H$P  :!@  &@?  !I)@  :2X  &DX  !I0P  :4\  &E=  !I;0  :8
M &F4  !HJ0  :+\  &?<  !F[@  9O< 9D\  %I/  !13P  2D\  $%1   X
M5   ,%<  "A;   A7@  &F(  !1E   0:   #&L   =N P !< D  ' -  !Q
M$   <10  '(:  !S(0  <R@  ',Q  !S/   =$@  '-6  !S9@  <WD  '..
M  !SHP  <KD  ''2  !QZP  </0 85,  %93  !/4P  154  #M8   R7
M*F   ")D   ;:   %&P   ]O   +<@  !G8   !Y    >@8  'H*  ![#@
M?!$  'T5  !^&P  ?R(  ( J  " -0  @$$  (!/  " 7P  @'$  ("&  "
MG0  ?[(  '[*  !^Y0  ??$ 7%@  %18  !)6@  /UT  #5A   L90  (VH
M !MO   4<P  #G<   E[   #?P   ((   "$    A@$  (8&  "("@  B0T
M (H0  "+%0  C!L  (XB  "/+   CS@  (]&  "/5@  CV@  (]^  "/E0
MCJL  (W!  "-W   C.L 65T  $Y?  !#8@  .&8  "YL   D<0  ''<  !1\
M   .@0  "(4   ")    C0   )    "2    DP   )0   "6 P  EP@  )@,
M  ":#P  FQ,  )T:  "?(P  H"X  * \  "@3   H%X  *!T  "?C   GZ(
M )^W  ">RP  GN  4V0  $=H   \;0  ,7,  "=Y   =?P  %(4   V+   &
MD    )0   "8    G    )\   "A    H@   *0   "E    IP   *@$  "J
M"0  K T  *T2  "P&0  LB,  +(Q  "R0@  LE0  +)I  "R@   LI@  +&L
M  "ROP  L<X 3&X  $!S   U>@  *H$  !^(   5C@  #I4   ::    GP
M *0   "H    K    *\   "Q    L0   +,   "U    M@   +@   "Z
MO 8  +X,  # $0  PQD  ,4F  #%-P  QDD  ,9=  #'<@  QXH  ,B?  #(
MKP  R+P 1GH  #F!   NB0  (I   !>8   /GP  !Z4   "J    KP   +,
M  "W    O    +\   #!    P@   ,0   #%    QP   ,D   #+    S0
M ,\#  #2"@  UA   -P:  #=*@  WCP  -]0  #@90  X7L  .&1  #BH@
MXJT _P " /\   #_  , _P , /\ $P#_ !T _P H /X ,P#[ #X ]P!( /,
M4 #P %< [0!> .L 9 #H &D YP!O .4 = #C 'D X@!_ .  A0#> (P W "3
M -D G #6 *8 TP"Q -$ P #/ -H S@#Q ,P _P#+ /\ RP#_ ,8 _P#! /\
M_P   /\   #_    _P ( /L $ #V !D \@ D .\ +@#M #D Z !" ., 2P#@
M %( W0!9 -D 7P#6 &0 TP!I -$ ;@#/ '0 S@!Y ,P ?P#* (8 R ". ,8
ME@#$ *  P@"K ,  N0"^ ,T O #J +L _ "Z /\ N@#_ +H _P"V /\ _P
M /\   #^    ]  $ .L #0#D !0 WP ? -L *0#8 #, TP ] ,X 10#* $T
MQP!3 ,4 60## %\ P0!D +\ :0"] &X NP!S +H >0"X (  M@"( +0 D "R
M )H L0"E *\ L@"M ,0 K #A *L ]@"J /\ J@#_ *H _P"J /\ _P   /T
M  #N    X@   -4 "@#- !$ QP 9 ,0 (P#! "T OP W +L /P"W $< M0!.
M +( 4P"P %D KP!> *T 8P"L &@ JP!M *D <P"H 'H I@"! *0 B@"C )0
MH0"? )\ K "> +L G #2 )L [@": /\ F@#_ )D _P"9 /\ _@   .X   #>
M    RP   ,$ !0"Y  T M  4 +$ '@"N "< JP P *H .0"G $$ I !( *(
M30"A %, GP!8 )X 70"= &( FP!G )H ;0"8 ', EP![ )4 A "4 (X D@"9
M )  I@". +0 C0#( (P Y@"+ /D B@#_ (H _P"+ /\ \    -L   #'
MN@   +    "H  H I  0 *  & "= "$ FP J )H ,P"8 #L E@!! )0 2 "2
M $T D0!2 (\ 5P". %P C !A (L 9P"* &X B !U (< ?@"% (@ @P"4 ((
MH "  *\ ?P#  'X W0!] /( ?0#_ 'T _P!] /\ X    ,8   "U    J@
M *(   ";  4 E0 - )( $P"0 !P C0 D (L +0"* #0 B  [ (8 0@"% $<
M@P!- (( 4@"! %< ?P!< 'X 8@!] &@ >P!P 'H >0!X (, =@"/ '4 G !T
M *H <@"Z '$ T0!P .P < #[ '  _P!P /\ S00  +<&  "G!P  FP8  ),$
M  ".    B@ ( (8 #P"$ !8 @0 > '\ )P!] "X ?  V 'H / !Y $( =P!'
M '8 3 !U %( <P!7 '( 70!Q &, ;P!K &X = !L 'X :P"* &D F !H *8
M9P"V &8 RP!E .< 90#W &4 _P!E /\ P P  *L-  ";#@  CPX  (8-  "!
M"P  ?@<! 'P!"P!Y !$ =P 8 '4 (0!S "D <0 P &\ -@!N #P ; !" &L
M1P!J $T :0!2 &@ 6 !F %\ 90!G &, < !B 7H 8 &' %\"E0!> J, 7 .S
M %P#QP!;!.0 6P7T %L&_@!;!O\ M1   *$2  "1$P  A1,  'P2  !V$0
M<PX  '(,! !Q!PT ;@02 &P$&P!I!2, 9P4J &8&,0!D!C< 8P8] &('0P!A
M!TD 7P=. %X(50!="%P 6PEC %H);0!8"G@ 5PJ% %8+DP!4"Z( 4PNS %(,
MQP!2#.0 40WU %$-_P!1#?\ K14  )D7  ")&   ?1D  '08  !M%P  :A0
M &<1  !G#@< 9@P. &,,%0!A#!T 7PPE %T-+ !<#3, 6PTY %H-/P!8#44
M5PU+ %8.40!5#ED 4PYA %(.:P!0#W8 3A"# $T0D@!,$*( 2Q"R $H1R !)
M$>4 21'W $D2_P!)$?\ I1D  )(<  "#'0  =AX  &T=  !F'   8AH  %\7
M  !>% $ 7A$* %L0$0!9$1@ 5Q$@ %41)P!4$2X 4Q$T %$1.P!0$D$ 3Q)'
M $X23@!,$E4 2Q-> $D39P!(%', 1A2  $45CP!$%9\ 0Q:P $(6Q0!"%^,
M0A?V $(7_P!"%_\ GQT  (P@  !](0  <2(  &@B  !A(0  7!\  %D<  !7
M&0  518& %05#@!1%10 3Q8< $X6(P!,%BH 2Q8P $H6-P!)%ST 1Q=# $87
M2@!%&%( 0QA: $(99 !!&7  /QI] #X;C0 ]&YT /!RN #L<PP ['.$ .QWU
M #L<_P \'/\ FB$  (<C  !X)   ;"4  &,E  !<)   5R,  %,@  !1'@
M3QP" $T;# !+&A$ 2!L8 $<;( !%&R8 1!LM $,<,P!"'#D 0!Q  #\=1P ^
M'4\ /1Y8 #P>8@ Z'VT .1][ #@@BP W(9L -B&M #4AP0 U(=\ -2'S #8A
M_P V(?\ EB,  (,F  !T)P  :"@  %\H  !8)P  4R8  $\D  !,(@  22
M $<@"0!$'P\ 0A\5 $ @'  _(", /B I #P@+P [(38 .B$] #DA1  X(DP
M-R)5 #8C7P T(VL ,R1Y #(EB0 Q)9H ,"6K # FOP O)MP ,";R # F_P Q
M)?\ D28  '\H  !Q*@  92H  %PJ  !5*@  3RD  $LH  !()0  1"0  $$D
M!0 _) T /202 #LD&0 Y)!\ -R0F #8D+  U)3, -"4Z #,F00 R)DH ,2=3
M # G70 O*&D +BEW "TIAP L*9@ *RJJ "HJO0 J*MH *RKQ "LJ_@ L*?\
MC2@  'PJ  !M+   8BT  %DM  !1+0  3"P  $<K  !#*   /R@  #PH @ Y
M* L -R@0 #4H%@ S*!P ,B@C # H*0 O*3  +RHW "XJ/P M*T< +"M1 "LL
M6P J+&< *2UU "@MA0 G+9< )BZH "4NO  E+M@ )B[P "8N_0 G+?\ BBL
M '@M  !J+@  7R\  %8O  !.+P  2"X  $,M   _+   .RP  #<L   T+ D
M,BP. # M$P N+1H +2T@ "LM)P J+BT *BXU "DO/0 H+T4 )S!. "8P60 E
M,64 )#%S ",Q@P B,I4 (3*G "$RNP @,M0 (3+O "(Q_  B,?\ ABT  '4O
M  !G,   7#$  %,Q  !+,0  13$  $ P   [,   -C   #,P   P,08 +3$-
M "LQ$0 I,A< *#(> "<R)  E,RL )3,R "0S.@ C-$, (C1, "$U5P @-6,
M'S5Q !XV@0 =-I, '#:E !LVN0 ;-M( '#;M !TV^P =-?\ @C   '$R  !C
M,P  630  % T  !)-   0C,  #TS   W,P  ,30  "XU   K-0( *#8+ "4W
M$  D-Q4 (C<; "$X(@ @."@ 'S@P !XX-P =.4  '#E) !LZ5  :.F  &3IN
M !@Z?P 7.Y$ %SND !8[MP 5.]  %CKL !<Z^@ 8.?\ ?3(  &TT  !@-0
M538  $TV  !&-@  0#8  #HV   T-@  +C@  "HY   F.@  (SL( " \#@ >
M/1( '3T8 !P]'P ;/B4 &CXM !D^-  7/CT %C]' !4_40 4/UX %#]L !-
M?  20(\ $4"B !% M@ 00,X $3_K !(_^0 2/O\ >34  &DW  !<.   4CD
M $HY  !#.0  /3D  #<Y   Q.@  *SP  "<]   B/P  'D$$ !I""P 80Q
M%T,5 !5$&P 41"( $T0I !-$,0 21#H $45# !!%3@ 015L #D5I  Y%>0 -
M18P #46?  Q%L@ +1<D #$7E  U$]@ -1/\ =#D  &4Z  !8.P  3SL  $<\
M  ! /   .CP  #0\   N/@  *$   "-"   ?1   &D8  !5("  22@T $4H2
M !!*&  /2QX #DLE  U++0 -2S8 #$M   M+2@ *2U8 "4MD  A+=  '2X<
M!4N:  1+K@ $2L0 !4K@  5*\  &2?H ;CP  & ]  !4/@  2SX  $0^   ]
M/@  -S\  #%    J0@  )$4  !]'   :20  %4P  !%.!0 .40L "U$0  I1
M%  )41L "%$B  =1*0 %43( !%([  -21@ !4E(  %)?  !2;P  4H$  %&6
M  !1J0  4;\  %#<  !0[@  4/< :$   %M!  !000  2$$  $%!   [0@
M-$,  "U%   F2   ($L  !M-   64   $5,   Y5!  *6 H !E@.  )8$@
M61<  %D=  !9)0  62T  %DV  !900  64T  %I:  !::0  67P  %F0  !9
MI0  6+H  %C5  !7[   5_8 8T0  %9%  !-10  144  #]%   W1P  +TD
M "A,   B3P  &U(  !95   16   #5H   E= P $7PD  & -  !@$   810
M &$9  !B(   8B<  &(Q  !B.P  8D<  &)5  !C9   8G8  &*+  !BH
M8;8  &'/  !@Z@  8/4 74@  %))  !*2   0T@  #I*   R30  *E   "-3
M   <5P  %EH  !%=   -8   "&,   -F 0  9P8  &@+  !I#@  :A$  &L5
M  !L&P  ;2(  &TJ  !M-   ;4   &U.  !M70  ;6\  &V$  !LF@  ;+
M &O(  !KY@  :O, 6$T  $Y-  !(3   /DX  #51   L5   )%@  !U<   6
M8   $&0   QG   ':P   6X   !P    <@,  '('  !S"P  =0X  '81  !W
M%@  >!P  'DC  !Z+0  >CD  'I'  !Z5@  >6@  'I\  !YE   >*H  'C!
M  !WWP  =^\ 5%$  $Q1  !"4@  .%4  "]9   F7@  'F(  !9G   0:P
M"V\   5S    =P   'H   !\    ?@   '\"  " !@  @0H  (,-  "$$0
MAA4  (@<  "))0  BC   (H^  ")30  B5\  (ES  "(BP  B*(  (>Y  "'
MT0  AN@ 4E8  $=7   \6@  ,E\  "AD   ?:0  %F\  !!T   *>0   GT
M  "!    A0   (@   "*    C    (T   "/    D 0  )((  "3#   E1
M )<5  "9'0  FR<  )LT  ";1   FE8  )IJ  "9@@  FIH  )BP  "8QP
ME]X 2UP  $!@   U90  *VH  "%Q   7=P  $'T   F#   !B    (P   "1
M    E0   )@   ":    FP   )T   "?    H    *(   "D!0  I@H  *@.
M  "J%   K1T  *TJ  "M.0  K4L  *U?  "M=P  K)   *NG  "KN@  J\L
M168  #EK   N<0  (W@  !E_   0A@  "8T   "3    F    )T   "A
MI0   *@   "K    JP   *X   "O    L0   +,   "U    MP$  +D'  "\
M#0  OQ,  ,(?  #"+@  PD   ,)4  #!:P  P8,  ,";  #!K0  P;P /G(
M #)X   G@   '(@  !*0   *EP   )T   "C    J    *T   "R    M@
M +D   "[    O    +X   #     P@   ,0   #&    R    ,L   #.!0
MT0T  -84  #7(P  V#4  -E)  #:7@  VW4  -N,  #<GP  W*L _P   /\
M  #_    _P ) /\ $ #_ !D _@ D /P +P#Y #D ] !# /  2P#M %( Z@!9
M .< 7P#D &0 X@!I .  ;@#> ', W !Y -H ?P#7 (8 U ". -$ E@#/ *$
MS "L ,H NP#( -( Q@#N ,8 _P#% /\ Q0#_ +\ _P"Z /\ _P   /\   #_
M    _@ % /< #@#R !4 [@ ? .L *@#I #0 XP ] -X 10#9 $T U !3 -$
M60#. %X S !C ,H : #) &T QP!S ,4 >0## (  P0"( +\ D "] )L NP"F
M +D M "W ,@ M@#F +4 ^P"T /\ M #_ +, _P"N /\ _P   /\   #X
M[0   .4 "P#= !$ UP : -( ) #/ "X RP W ,< 0 ## $< P !. +X 4P"\
M %D N@!> +@ 8P"V &@ M0!M +, <P"Q 'D KP"! *T B@"K )0 J0"@ *@
MK0"F +X I0#; *0 ] "D /\ HP#_ *, _P"B /\ _P   /8   #F    UP
M ,L !@#$  X O@ 5 +L 'P"Y "@ MP Q +0 .@"P $$ K0!( *L 3@"I %,
MIP!8 *8 7 "D &$ HP!G *$ ; "@ ', G@!Z )T @P"; (X F0"9 )< I@"6
M +8 E0#, )0 ZP"3 /T DP#_ ), _P"3 /\ ]P   .0   #0    P0   +<
M @"O  L JP 1 *< &0"E "( HP K *( ,P"? #L G !" )L 2 "9 $T EP!2
M )8 5P"5 %L DP!A )( 9@"0 &T CP!T (T ?0", (< B@"3 (@ H "' *\
MA0#" (4 X@"$ /< A #_ (0 _P"$ /\ Y0   ,T   "\    KP   *8   ">
M  < F@ . )8 % "4 !T D@ E )$ +0"0 #4 C0 \ (P 0@"* $< B !, (<
M40"& %8 A !; (, 8 "! &< @ !N 'X =P!] ($ >P"- 'H F@!X *D =P"Z
M '8 TP!V .\ =@#^ '4 _P!U /\ T    +L   "K    GP   )<   "0  (
MBP + (@ $ "& !< A  @ (( )P"! "\ ?P U 'T / !\ $$ >P!& 'D 2P!X
M %  =P!5 '8 6P!T &$ <P!I '$ <0!P 'L ;@"' &T E0!K *, :@"T &H
MR0!I .@ :0#Y &D _P!I /\ P    *P   "< @  D (  (@   "#    ?P &
M 'L #0!Y !( =P : '8 (@!T "D <P P '$ -@!P #P ;P!! &T 1@!L $L
M:P!0 &H 5@!H %P 9P!D &4 ; !D '8 8P"" &$ D !@ )\ 7P"O %X PP!>
M .$ 7@#T %T _P!= /\ M <  * )  "0"P  A L  'P*  !W!P  = 0  '$
M"0!O  \ ;0 5 &L ' !I ", :  J &< ,0!E #8 9  \ &, 00!B $8 8 !,
M %\ 4@!> %@ 70!? %L : !: '( 6 !^ %< C !6 )L 50"K %0 O@!4 -H
M4P#O %0 ^P!4 /\ J0T  )8.  "'$   >A   '(0  !L#@  :0P  &<) P!F
M! L 9  0 &( %P!@ !X 7@ E %T *P!< #$ 6@ W %D / !8 $( 5P%' %8!
M3@!5 E0 4P)< %(#90!1 V\ 3P1[ $X$B@!-!9D 3 6I $L%O !*!M0 2@?M
M $H'^0!*!_\ H1   (X2  !^%   <Q0  &H4  !D$P  8!$  %X/  !=#04
M70D- %H&$@!8!QD 5@<@ %4')P!3!RT 4@@S %$(. !0"#X 3PE$ $X)2@!,
M"5$ 2PI9 $H*8@!("VT 1PMZ $8,B !$#)@ 0PRI $(-O !"#=4 0@WN $(-
M^P!"#?\ FA0  (<6  !X&   ;!D  &,9  !=&   618  %83  !4$0  5 X(
M %,-#@!1#10 3PT; $T-(@!,#2@ 2PTN $H-- !)#3H 1PY! $8.1P!%#D\
M1 Y7 $(/80!!$&P /Q!Y #X0B  ]$9@ .Q&I #L1O  Z$=8 .A'P #H2_0 [
M$?\ DQ@  ($:  !S'   9QT  %X=  !8'   4QL  % 8  !.%@  3!,# $P1
M"P!*$!  2!$7 $81'@!%$20 1!$J $(1, !!$3< 0!(] #\21  ]$DP /!-4
M #L37@ Y%&D .!1V #<5A0 V%98 -!:G #06N@ S%M, ,Q;N #06_  T%O\
MCAL  'P=  !N'P  8R   %H@  !3(   3AX  $H=  !(&@  1A@  $46!P!#
M%0X 0143 #\5&@ ^%2  /14G #L5+0 Z%C, .18Z #@600 W%TD -1=1 #08
M6P S&68 ,AES # :@P O&I0 +ANE "T;N  M&]  +1OL "X;^P N&_\ BAX
M '@@  !J(@  7R,  %8C  !/(@  2B$  $8@  !#'@  01L  #\: P ]&@P
M.QD1 #D9%@ W&AT -AHC #4:*0 T&C  ,QLV #$;/@ P'$8 +QQ/ "X=60 M
M'60 +!YQ "L?@0 J'Y( *1^D "@@MP G(,X )R#K "@@^@ I'_\ AB   '0C
M  !G)   7"4  %,E  !,)0  1R0  $(C   _(0  /1\  #H>   W'@D -1X.
M #,>$P Q'AH ,!X@ "\>)@ N'RT +1\S "P@.P K($, *B%, "DA5@ H(F(
M)B)O "4C?P D(Y  (R.B "(DM0 B),P (B3I ",D^0 D(_\ @B,  '$E  !C
M)@  62<  % H  !))P  0R<  #\F   [)   ."(  #4B   R(@8 ,"(- "XB
M$0 L(A< *B(= "DB(P H(RH )R,Q "8D.  E)4$ )"5* ",F5  B)F  (2=M
M " G?0 ?)X\ 'BBA !XHM  =*,H '2CH !XH^  ?)_\ ?B4  &XG  !@*0
M5BD  $TJ  !&*@  02D  #PH   W)P  -"8  # F   M)@, *R<+ "@G$  G
M)Q0 )2<: "0G(0 C*"< (B@N "$I-@ @*3X 'RI( !XJ4@ =*UX '"MK !LK
M>P :+(T &2R? !@LL@ 8+,D &"SG !DK]P :*_\ >B<  &HJ  !=*P  4RP
M $HL  !#+   /BL  #DK   T*@  ,"H  "LJ   I*P  )BL( ",L#@ B+!(
M("P8 !\L'@ >+24 '2TL !PM,P ;+CP &BY% !DO4  8+UP %R]I !8P>0 5
M,(L %#"> !0PL0 3,,< $S#E !0P]@ 5+_\ =BH  &<L  !:+0  4"X  $@N
M  !!+@  .RX  #8M   Q+0  +"T  "<O   D+P  (3 % !\Q#  <,1  &S(5
M !HR'  9,B( &#(I !<S,0 6,SD %3-# !0T30 3-%D $C1G !$U=P 1-8D
M$#6< ! UL  .-<8 #S3D ! T]0 0-/\ <BP  &,N  !7,   33   $4P   ^
M,   .#   #,P   O,   *3$  "0R   A,P  '34" !HV"0 7-PX %3<3 !0X
M&0 3.!\ $C@F !(X+@ 1.38 $#E  ! Y2P ..5< #CID  TZ=  ,.H8 ##J9
M  LYK  *.<$ "CG>  LY\0 ,./P ;B\  %\Q  !3,@  2C,  $(S   [,P
M-C,  #$R   L,P  )S0  "$V   =.   &3D  !4[!@ 2/0P $#X0 ! ^%0 .
M/AP #CXC  T^*@ ,/C, ##X\  L_1P */U( "#]@  <_;P &/X$ !3^4  0_
MJ  #/KP !#[7  4^[  %/O< :3,  %LT  !0-0  1S4  #\U   Y-0  -#4
M "XU   I-P  (S@  !X[   :/   %C\  !)!!  .0PH #$0.  I$$P )1!D
M"$0@  =$)P &1"\ !40X  -%0@ "14X  $5;  !%:@  17P  $60  !$I
M1+D  $31  !$Z@  0_4 9#8  %<W  !,.   0S@  #PX   W.   ,3@  "LY
M   E.P  (#T  !I    60@  $D0   Y'!  +20D !TH-  1+$0 !2Q8  $L<
M  !+(P  2RL  $LT  !+/@  3$D  $Q7  !,9@  3'<  $N,  !+H0  2[4
M $K.  !*Z0  2O4 7SH  %([  !(.P  0#L  #H[   T.P  +CP  "<^   B
M00  '$,  !9&   220  #DL   M. P '4 @  E$,  !1$   4A,  %,8  !3
M'P  4R8  %,O  !3.0  4T4  %-2  !380  4W(  %.'  !2G   4K$  %'*
M  !1YP  4?0 63X  $X^  !%/@  /CX  #@^   P0   *4(  "-$   =1P
M%TH  !)-   .4   "U,   95 @  5P<  %@+  !9#@  6A$  %H5  !;&@
M7"$  %PJ  !<-   7#\  %Q-  !<6P  7&P  %R!  !;EP  6ZT  %K%  !:
MY   6?, 5$(  $I"  !"0@  /$(  #1#   L1@  )4D  !Y,   73P  $E,
M  Y6   *60  !5L   !>    8 0  &$(  !B#   8PX  &01  !E%@  9AP
M &<C  !G+0  9SD  &=&  !G50  9V8  &=Z  !FD0  9:@  &7   !DW@
M9/  3T8  $=&  ! 10  -T<  "]*   F30  'U$  !A5   260  #5P   A@
M   "8P   &8   !H    :@   &L$  !L"   ;0P  &\.  !P$@  <A<  ',=
M  !T)@  =#(  '0_  !T3@  <U\  '1R  !SB@  <J$  '&X  !QU   <.P
M3$H  $5*   [2P  ,DX  "E2   @5@  &%L  !)?   -9   !V@   !K
M;P   '(   !U    =@   '<   !Y @  >@8  'P*  !^#@  @!$  ((6  "$
M'@  A"D  (0V  "$10  A%8  (-J  "#@0  @ID  (&Q  " R0  @.4 2DX
M #]0   U4P  *U<  ")<   98@  $F<   QL   %<0   '4   !Y    ?0
M ($   "#    A0   (8   "(    B0   (L$  "-"   CPT  )(0  "4%@
MEB   )8L  "6.P  EDP  )5@  "5=@  E)   ).G  "2O0  DM4 1%4  #E9
M   O70  )&,  !II   2;P  #'4   1[    @    (4   ")    C0   )$
M  "3    E    )8   "8    F@   )P   ">    H 8  *(+  "E$   J!<
M *DC  "I,0  J4,  *E6  "H;0  IH<  *>>  "FLP  I<< /EX  #)C   G
M:@  '7   !-X   ,?P   X4   "+    D0   )8   ";    GP   *(   "D
M    I0   *<   "I    JP   *T   "P    L@   +4"  "W"0  NQ   +X8
M  "^)@  OC@  +Y+  "]80  O'H  +N4  "ZJ0  NKD -VH  "MP   @>
M%H    V(   %CP   )8   "<    H@   *<   "L    L    +,   "V
MMP   +D   "[    O0   +\   #"    Q0   ,@   #*    S@@  -(0  #5
M&P  U2P  -1   #45P  TVX  -2&  #4FP  TZL _P   /\   #_    _P %
M /\ #@#_ !4 _  @ /D *@#V #0 \0 ] .T 1@#I $T Y@!3 .0 60#A %X
MW@!C -P : #9 &X U0!S -, >0#0 (  S@"( ,L D0#) )P Q@"G ,0 MP#"
M ,P P #L +\ _P"^ /\ O0#_ +< _P"R /\ _P   /\   #_    ^@ ! /,
M"P#M !( Z  ; .4 )0#D "X WP X -@ 0 #2 $< S@!. ,L 5 #( %D Q@!>
M ,0 8P#" &< P !M +\ <P"] 'H NP"! +D BP"V )4 M "A +( KP"P ,(
MK@#C *X ^@"L /\ K0#_ *D _P"F /\ _P   /\   #R    Y@   -T !P#2
M  X S0 6 ,H ( #( "D Q0 R ,  .@"\ $( N0!( +< 3@"U %, LP!8 +$
M70"P &( K@!G *P ; "J ', J0![ *< A "E (X HP": *$ J "? +D G@#2
M )T \@"< /\ G0#_ )P _P"9 /\ _    .X   #=    S    ,$  @"Z  P
MM@ 2 +( &@"P ", KP L *T - "I #P I@!" *0 2 "B $T H !2 )X 5P"=
M %L G !@ )H 9@"9 &P EP!T )4 ?0"3 (< D0"3 )  H0". +$ C0#& (P
MZ "+ /T C #_ (P _P", /\ [0   -@   #%    MP   *P   "F  @ H0 .
M )\ %0"= !X FP F )H +@"7 #4 E0 \ ), 0@"1 $< D !, (X 40"- %4
MBP!: (H 8 ") &8 AP!M (4 =@"$ (  @@", (  F@!_ *D ?0"\ 'P W !\
M /4 ? #_ 'P _P!\ /\ V0   ,$   "Q    I    )P   "4  , D  , (T
M$0"+ !@ B0 @ (D * "' "\ A0 V (, / "" $$ @ !& '\ 2P!] $\ ? !4
M 'L 6@!Y &  > !G '8 < !U 'H <P"& '$ DP!P *( ;P"T &X S !N .T
M;@#^ &X _P!N /\ Q    *\   "@    E    (P   "&    @0 ( 'X #@!\
M !0 >P ; 'D (@!X "D =P P '4 -@!T #L <@!  '$ 10!P $H ;P!/ &T
M5 !L %L :P!B &D :@!H '0 9@"  &4 C@!C )T 8@"M &$ P@!A .0 80#X
M &$ _P!A /\ M    *    "1    A@   'X   !Y    =0 # '$ "P!O !
M;0 6 &P '0!K "0 :P J &D , !H #8 9@ [ &4 0 !D $4 8P!* &$ 3P!@
M %8 7P!= %T 90!< &\ 6@!Z %D B !8 )@ 5P"H %8 NP!6 -@ 5@#Q %8
M_P!6 /\ J $  )0%  "%!P  >@<  '(&  !L!   :0$  &< !P!D  T 8P 1
M &$ & !@ !\ 7P E %X *P!= #  6P V %H .P!9 $  6 !% %< 2P!6 %$
M50!8 %, 80!2 &H 4 !V $\ A !. ), 30"D $P M@!, ,T 3 #K $P ^@!,
M /\ G0D  (L+  !\#0  < T  &@-  !B#   7PH  %T& 0!< 0D 6@ . %@
M$P!7 !D 5@ @ %4 )@!3 "L 4@ Q %$ -@!0 #L 3P!! $X 1P!- $T 2P!5
M $H 70!) &< 1P!S $8 @ !% )  1 "A $, L@!# ,@ 0P#F $, ]0!# /\
ME0T  (,/  !T$   :1$  & 1  !:$   5@X  %0-  !3"@0 4P8+ %$#$ !/
M 14 3@$; $P!(0!+ 2< 2@(L $D",@!( C< 1P,] $4#0P!$ TH 0P11 $($
M6@! !60 /P5P #X&?@ ]!HX / >? #L'L0 Z!\8 .@?C #H'\P Z"/P CA
M 'P2  !N%   8A4  %H5  !4%   4!,  $T1  !+#@  2PT& $H*# !)"!$
M1P@6 $4('0!$"", 0@@H $$)+@! "3, /PDY #X*0  ]"D< / I/ #H+6  Y
M"V, . QO #8,?@ U#(X - V? #,-L0 R#<< ,@WC #(-]  R#?X B!,  '<5
M  !I%P  7A@  %48  !/&   2A8  $<5  !%$P  0Q " $,." !"#0X 0 T2
M #\-&  ]#1\ / TD #L-*@ Y#3  . XW #<./0 V#D4 -0Y- #,/5P R#V(
M,1!N "\0?0 N$(X +1&@ "P1L@ K$<@ *Q'F "L1]@ L$?\ @Q8  '(9  !D
M&@  61L  %$;  !+&P  1AH  $(8   _%P  /A0  #P2!  [$0H .A 0 #@0
M%0 W$!L -1$A #01)P S$2T ,A$S # 1.@ O$D( +A)+ "T35  K$U\ *A1L
M "D4>P H%(P )Q6> "85L  E%<8 )17D "45]@ F%?\ ?AD  &X;  !@'0
M5AX  $T>  !''@  0AT  #X<   Z&@  .!@  #<6   U%0< -!0- #(4$@ P
M%!< +Q0= "T4(P L%2H *Q4P "H5-P I%C\ *!9( "<74@ F&%T )!AJ ",9
M>0 B&8H (1F< " 9KP ?&<0 'QGB " 9]  @&?\ >AL  &H>  !='P  4R
M $H@  !$(   /A\  #H>   W'0  -!P  #(9   P&00 +A@+ "P8$  J&!0
M*1@: "<8(  F&28 )1DM "0:-0 C&CT (AM& "$;4  @'%L 'QUH !X==P =
M'8@ '!Z; !L>K0 :'L, &A[@ !H=\P ;'?\ =QT  &<@  !:(0  4"(  $@B
M  !!(@  .R(  #<A   S(   ,!\  "T=   K'0  *!T( "8=#@ E'1( (QT7
M "$='0 A'20 (!XJ !\>,@ >'SH '1]# !P@30 ;(5D &B%F !DA=0 8(H<
M%R*9 !8BK  5(L$ %2+? !4A\@ 6(?X <R   &0B  !7(P  320  $4E   ^
M)   .20  #0C   P(@  +"(  "DA   F(0  )"$& "(A#  @(1  'B$5 !TB
M&P ;(B$ &R(H !HC+P 9(S@ &"1! !<D2P 6)5< %25D !0F<P 3)H4 $B:8
M !$FJP 1)L  $";= !$E\0 2)?T <"(  &$D  !4)@  2B8  $(G   \)@
M-B8  #$E   M)0  *20  "8D   B)0  'R4# !TF"@ ;)@X &2<2 !@G&  7
M)Q\ %B<E !4H+0 4*#4 $RD^ !(I20 1*54 $2IB ! J<0 /*H, #BJ6  XJ
MJ0 -*KT #2K7  TJ[@ .*?L ;"0  %TF  !1*   2"@  $ I   Y*   -"@
M "\H   K)P  )R<  "(H   >*0  &RH  !@K!P 6*PT %"P1 !,L%@ 2+!P
M$2TC ! M*@ 0+3( #RX\  XN1@ -+E( #2Y?  PO;@ ++W\ "B^2  DOI0 )
M+KD ""[0  DNZ0 *+O< :"<  %HI  !.*@  12L  #TK   W*P  ,2H  "TJ
M   I*@  )"H  " K   ;+0  &"X  !4O!  2,0H $#(.  \R$P .,AD #3(@
M  TR)P ,,B\ "S,X  HS0@ ),TX "#-;  8T:@ %-'L !#..  ,SH@ ",[8
M C/-  ,SYP $,O, 9"H  %8L  !++0  0BT  #HM   T+0  +RP  "LL   F
M+   (BT  !TO   9,0  %3(  !(T P /-@D ##@-  HX$0 ).!8 "#@=  <X
M)  &."P !#@T  ,X/@ ".4H  #E7   Y90  .7<  #F+   XGP  .+,  #C*
M   XY@  -_( 7RT  %(N  !(+P  /S   #@O   R+P  +2\  "DO   D,
M'S$  !HS   5-0  $C<   \Y P ,.P@ "#T-  4^$  #/A0  #X:   ^(0
M/B@  #XQ   _.P  /T8  #]3   _80  /W,  #^'   ^G   /K   #W'   ]
MY   /?( 6C   $XR  !$,@  /#(  #4R   P,0  *S$  "8R   @-   &S8
M !8X   2.P  #ST   P_ P (00@ !$,,  !##@  1!(  $46  !%'0  120
M $4M  !&-@  1D(  $9.  !&70  1FX  $6"  !%F   1*T  $3$  !#XP
M0_( 530  $HU  !!-0  .34  #,T   N-   *#4  "(W   =.@  %SP  !(_
M   /00  #$0   A& 0 #2 8  $D*  !*#0  2Q   $P4  !-&0  3B   $XH
M  !.,@  33T  $Y*  !.6   36D  $U]  !,E   3*H  $O!  !+X0  2O(
M4#@  $8X   ].   -S@  #$W   J.0  )#L  !X]   80   $T,   ]&   +
M20  !TL   ).    4 0  %$(  !2"P  4PX  %01  !5%0  5AL  %<C  !7
M+   5S@  %=$  !74@  5F,  %9W  !6C@  5:4  %2]  !3W0  4_  2SP
M $(\   [.P  -3L  "T\   F/P  'T(  !E%   32   #DL   M/   %40
M %0   !7    6 $  %H%  !;"   7 P  %T.  !?$0  8!8  &(=  !B)@
M8C$  &(^  !A3   85T  &%P  !@B   8*   %^W  !>U   7>X 1T   #\_
M   Z/P  ,4   "E#   A1@  &DH  !-.   .40  "E4   18    6P   %X
M  !A    8P   &0!  !E!   9P@  &@+  !J#@  ;!(  &X7  !O(   ;RH
M &\V  !N10  ;E4  &YH  !M?P  ;9@  &RP  !KR@  :N@ 1$0  #Y#   U
M1   *T<  "-+   ;3P  $U0   Y8   (7    F    !D    9P   &L   !M
M    ;P   '    !R    = (  '4&  !W"@  >0X  'P2  !^&   ?R(  '\N
M  !_/0  ?DT  'UA  !]=P  ?)   'NH  !ZP   >=\ 0T<  #E)   O3
M)5   !Q5   46P  #F    =E    :@   &X   !R    =@   'D   !\
M?@   '\   "!    @P   (4   "' P  B@@  (P-  "/$0  DAD  )(E  "2
M,P  DD0  )%7  "0;0  CX8  (Z?  "-M0  C,T /4X  #)1   H5@  'EP
M !5B   .:   !VX   !T    >0   'X   ""    A@   (D   ",    C@
M )    "2    E    )8   "8    FP   )X&  "A#   I!$  *8;  "F*0
MICH  *5-  "E8@  I'L  *.4  "AJP  H;\ -E<  "Q<   A8@  %VD   ]P
M   '=P   'X   "$    B@   (\   "4    F    )L   ">    GP   *(
M  "D    I@   *@   "K    K0   +    "S!   MPP  +L2  "['P  NS
M +M#  "Z6   N7   +>+  "WH0  M[, ,&(  "5I   :<   $'@   F
MB    (\   "6    FP   *$   "F    J@   *X   "P    L0   +0   "V
M    N    +L   "]    P    ,,   #'    RP,  ,\,  #3%0  TB4  -(X
M  #13@  T&4  ,]^  #-E@  S*D _P   /\   #_    _P # /\ "P#\ !$
M^0 ; /< )0#S "\ [@ X .D 0 #F $@ X@!. -\ 5 #< %D V0!> -4 8P#3
M &@ T !M ,X <P#+ 'H R "" ,8 C ## )< P "C +X L@"\ ,@ N@#J +D
M_P"X /\ L0#_ *H _P"G /\ _P   /\   #[    ]@   .T !P#G  \ X@ 6
M -\ ( #> "D V0 S -$ .P#, $( R !( ,4 3@#" %, P !8 +X 70"\ &(
MN@!G +D ;0"W '0 M0![ +( A0"P )  K@"< *P J@"I +T IP#> *8 ^0"E
M /\ HP#_ )T _P"; /\ _0   /8   #K    WP   -$  P#*  P Q0 2 ,,
M&P#  "0 O@ L +D -0"V #P LP!# +  2 "N $X K !2 *L 5P"I %P IP!A
M *8 9P"D &T H@!T *  ?0"> (@ G "5 )H HP"8 +0 E@#- )4 \0"4 /\
ME0#_ )  _P". /\ \P   .8   #1    P@   +@   "Q  @ K0 / *H %@"H
M !X J  G *8 +P"B #8 GP \ )T 0@"; $< F0!, )< 40"6 %4 E !: ),
M8 "1 &8 D !N (X =@", ($ B@"- (@ FP"& *P A0#! (0 Y@"# /T A #_
M (, _P"! /\ Y    ,L   "Z    K    *(   "<  0 F  , )8 $0"4 !D
MDP A )( * "/ #  C0 V (L / ") $$ B !& (8 2P"% $\ A !4 (( 6@"!
M &  ?P!G 'X ;P!\ 'H >@"& '@ E !W *0 =0"W '0 U !S /0 = #_ '0
M_P!T /\ RP   +8   "F    F@   )(   "*    A@ ( (, #@"! !0 @0 ;
M (  (P!_ "H ?0 P 'L -@!Z #L > !  '< 10!U $D = !. ', 5 !Q %H
M< !A &X :0!M ', :P!_ &D C0!H )T 9P"N &8 QP!E .H 9@#_ &8 _P!G
M /\ N    *0   "5    B@   ($   !\    =@ $ '0 # !R !  <0 6 '
M'0!P "0 ;@ J &T , !K #4 :@ Z &D /P!H $0 9P!) &4 3@!D %0 8P!;
M &$ 8P!@ &T 7@!Y %T AP!; )8 6@"H %D O0!9 -\ 60#X %H _P!: /\
MJ    )4   "'    >P   ',   !N    :@ ! &< " !E  X 9  2 &, & !C
M !\ 8@ E &$ *@!? #  7@ U %T .@!< #X 6P!$ %D 20!8 $\ 5P!6 %8
M7@!4 &@ 4P!S %$ @0!0 )$ 3P"B $X M0!. -  3@#P $X _P!/ /\ G
M (D   ![ P  < ,  &@#  !B 0  7P   %T ! !;  L 60 / %@ % !7 !D
M5P @ %8 )0!5 "H 4P P %( - !1 #D 4  _ $\ 1 !. $L 30!2 $L 6@!*
M &, 20!O $< ? !& (P 10"= $4 L !$ ,< 1 #H $0 ^@!% /\ D@0  ( '
M  !Q"@  9@H  %X*  !9"0  50<  %0$  !2  < 4  , $\ $ !. !4 30 ;
M $P ( !+ "8 2@ K $D , !( #4 1P Z $8 0 !% $8 0P!. $( 5@!! %\
M0 !K #X >  ] (@ / "9 #P JP \ ,$ .P#@ #L ]  [ /\ B0H  '@,  !J
M#@  7PX  %<.  !1#@  30P  $L+  !*" ( 200) $@ #0!& !$ 10 6 $0
M' !# "$ 0@ F $$ *P _ #$ /@ V #T /  \ $, .P!* #H 4@ Y %P . !H
M #8 =0 U (4 - "6 #0 J  S +P ,P#8 #, [P S /L @@T  '$/  !D$
M61$  %$1  !+$0  1Q   $0.  !"#0  00L% $$'"P _!0X /@,2 #P"&  [
M AT .@,B #D#*  X RT -P,R #8$.0 U!#\ - 5' #,%4  Q!EH , 9F "\'
M<P N!X, +0>5 "P'IP K![H *P?2 "L'ZP K!_< ?1   &P1  !?$P  5!0
M $P4  !&%   0A,  #X2   \$   .@X! #H-!@ Z"@P . D0 #8(%  U"!D
M- D? #())  Q"2D , DO "\*-@ N"CT +0I% "P+3@ K"UD *0QE "@,<P G
M#(, )@V5 "4-IP D#;L (PW2 ",-ZP C#?< >!(  &@4  !;%@  41<  $@7
M  !"%@  /18  #D5   W$P  -1$  #,0 P S#@@ ,@T- # -$0 O#18 +0T;
M "P-(0 K#2< *@TM "D.-  H#CL )PY$ "4.3@ D#UD (Q!E "$0<P @$(0
M'Q"6 !X0J0 =$+T '!#8 !T0[@ =$/D <Q0  &06  !7&   31D  $49   _
M&0  .A@  #47   R%@  ,!4  "X3   M$00 +! * "L0#@ I$!( *! 8 "80
M'@ E$"0 )! J ",1,0 B$3D (1%" " 22P >$E8 '1-C !P3<0 :$X( &125
M !@4IP 7%+L %Q/4 !<3[@ 8$_H <!8  & 9  !4&@  2AL  $(<   \&P
M-AL  #(:   O&0  +!@  "H6   H% $ )A,' "43#  C$Q  (A,5 " 3&@ ?
M$R$ 'A0G !T4+@ <%38 &Q4_ !H620 9%E0 &!=A !87<  5&($ %!B3 !,8
MI@ 2&+H $A?2 !(7[  3%_H ;!D  %T;  !1'0  1QT  #\>   Y'0  -!T
M "\<   K&P  *!H  "89   D&   (A<$ " 7"@ >%PX '!<2 !H7%P 9&!X
M&1@D !@9+  7&30 %AH] !4:1P 4&U( $QM? !(<;@ 1''\ $!R2 ! <I0 /
M'+D #AS0  X;Z@ /&_@ :1L  %H=  !.'P  11\  #T@   V'P  ,1\  "T>
M   I'0  )1T  ",<   @&P  '1L! !L;!P 9' T %QP0 !8<%0 5'!L %!TB
M !,=*0 2'C$ $1XZ !$?10 0'U  #R!=  X@;  -('P #2"/  P@H@ +(+4
M"R#*  L@Y0 ,'_0 91T  %<?  !,(0  0B$  #HA   T(0  +R$  "H@   F
M'P  (Q\  " >   ='@  &2   !8@!  4( L $B$. !$A$P 1(AD $"(?  \B
M)@ .(R\ #B,W  TC00 ,)$T "R19  HD9P ))'@ ""2+  <DG@ ')+$ !B3'
M  8CXP '(_$ 8A\  %0A  !)(P  0",  #@C   R(P  +",  "@B   D(0
M(2$  !XA   :(0  %B,  !,D P 1)0@ #R8-  XG$0 -)Q8 #"<=  LG(P *
M)RL "2@T  @H/@ '*$D !BA5  4I9  $*70  RF'  (IFP !**\  "C%  $H
MX0 !)_  7B(  %$D  !&)0  /24  #4E   O)0  *B0  "8D   B(P  'R,
M !LD   8)0  %"8  !$H P /*0@ #"P,  HL$  (+!0 !RP:  8L(0 %+"@
M RTP  (M.@ !+44  "U2   N8   +G$  "V$   MF0  +:T  "S"   LX
M+/  6B0  $TF  !#)P  .B<  #,G   M)P  *"8  "0F   A)@  '28  !DG
M   5*0  $2L   \L P -+@< "3 ,  8Q#@ #,1(  3(7   R'@  ,B4  #(M
M   R-@  ,T(  #-.   S70  ,VT  #.!   RE@  ,JL  #'!   QWP  ,?
M5B<  $HI   _*@  -RH  # J   K*0  )R@  ",H   >*0  &BH  !8L   2
M+@  #S    TQ @ *- < !34+  (V#@  -Q   #@4   X&@  ."(  #@J   Y
M,P  .3X  #E*   Y60  .6D  #E]   XDP  .*@  #>_   WW@  -O  42L
M $8L   \+   -"P  "XL   J*P  )2L  " L   ;+0  %R\  !,Q   0,P
M#34   DW @ %.@8  3L*   \#0  /0\  #X2   _%P  0!X  $ E  ! +P
M0#H  $!&  ! 5   0&4  #]X   _CP  /J8  #Z]   ]W   /?  32X  $(O
M   Y+P  ,B\  "TN   H+@  (B\  !TP   8,@  $S4  ! W   ,.@  "3P
M  4^    000  $((  !#"P  1 T  $80  !'%   2!D  $@A  !(*@  2#4
M $A!  !(3P  2&   $=S  !'B@  1J(  $6Y  !%V0  1/  2#(  #XR   V
M,@  ,#$  "LQ   E,@  'S0  !DV   3.0  $#P   P_   (0@   T0   !&
M    2 (  $H%  !+"   3 L  $X.  !/$0  414  %(<  !2)0  4C   %(\
M  !12@  45H  %%M  !0A   3YT  $ZU  !-T@  3>X 0S8  #LV   T-0
M+S0  "<U   A.   &CL  !0^   000  #$0   ='   "2@   $T   !/
M40   %,"  !4!0  50@  %<+  !9#@  6Q$  %T7  !='P  72H  %TV  !<
M1   7%0  %MG  !;?@  6I<  %FO  !8RP  5^H /SD  #@Y   S.   *SD
M ",\   </P  %4,  !!'   +2@  !4X   !1    5    %<   !:    7
M %T   !?    8 0  &('  !D"P  9@X  &@2  !K&0  :R,  &HN  !J/
M:DT  &E?  !H=0  9X\  &:H  !EP@  9., /3T  #<\   N/0  )4   !U$
M   620  $$T   I1   $50   %H   !=    8    &,   !F    :    &H
M  !K    ;0   &\"  !Q!@  = H  '8.  !Y$P  >QL  'LG  !Z-0  >44
M 'A9  !X;0  =X8  ':?  !UMP  =-( /$$  #)"   H10  ($H  !=.   0
M5   "ED   )>    8P   &<   !K    ;P   '(   !U    =P   'D   ![
M    ?0   '\   ""    A ,  (<)  "*#@  CA,  (\>  ".*P  CCL  (U.
M  "+8P  BGP  (J5  "(K0  A\4 -D<  "Q+   B3P  &54  !!;   *80
M 6<   !M    <@   '<   ![    ?P   (,   "&    B    (H   "-
MCP   )$   "4    EP   )H!  "=!P  H0T  *44  "D(0  I#$  *-$  "B
M60  H'   )^+  "=H@  G;< ,%   "55   ;6P  $F(   MI   !<    '<
M  !]    @P   (@   "-    D0   )4   "8    F@   )P   "?    H0
M *,   "F    J0   *P   "P    M <  +@.  "Z&   NB<  +DY  "X3@
MMV4  +9^  "UE@  LZL *5L  !YB   4:0  #'$   )Y    @0   (D   "/
M    E@   )L   "@    I    *@   "K    K    *\   "R    M    +8
M  "Y    O    ,    #$    R    ,T'  #2$   TAT  -$O  #01   SUL
M ,US  #+C0  RJ$ _P   /\   #[    ^@   /P " #X  \ ]0 7 /0 ( #Q
M "H ZP S .8 .P#B $, W@!) -H 3P#6 %0 TP!9 -  7@#. &, RP!H ,D
M;@#& '4 PP!] ,$ A@"^ )( NP"> +D K@"V ,, M #H +, _P"O /\ I0#_
M )X _P"; /\ _0   /<   #R    \    .<  P#A  P W  2 -@ &P#6 "0
MT@ M ,P -@#& #T P@!# +\ 20"\ $X N@!3 +@ 6 "V %T M0!B +, 9P"Q
M &X KP!V *P ?P"J (H J "7 *4 I@"C +D H0#9 *  ^0"> /\ F #_ )(
M_P"/ /\ \P   .P   #C    TP   ,@   #!  D O0 / +L %@"Y !\ MP G
M +, +P"O #< K  ] *H 0P"H $@ I@!- *0 4@"C %8 H0!; )\ 80"> &<
MG !O )H > "7 (, E0"0 ), G@"1 +  D #( (X \ "- /\ B@#_ (4 _P""
M /\ YP   -T   #&    N    *X   "H  0 I0 , *$ $@"A !D H  B )\
M*0"; #  F  W )8 /0"3 $( D@!' )  2P"/ %  C0!5 (P 6@"* &$ B !H
M (< < "% 'L @P"( ($ E@!_ *< ?0"\ 'P XP!\ /T ? #_ '@ _P!V /\
MU@   ,    "O    HP   )D   "3    CP ) (T #@"+ !0 B@ < (H (P"(
M "H A0 P (, -@"" #L @ !  '\ 10!^ $H ? !/ 'L 5 !Z %H > !A '8
M:0!U ', <P"  '$ C@!O )\ ;@"R &T SP!L /0 ; #_ &L _P!I /\ P
M *L   ";    CP   (<   "     ?  $ 'H # !X !$ >  7 '@ '@!W "0
M=0 J ', , !Q #4 <  Z &X /P!M $0 ; !) &L 3@!J %0 : !; &< 8P!E
M &T 9 !X &( AP!@ )< 7P"J %X P@!> .D 7@#_ %X _P!= /\ K    )D
M  "*    ?P   '<   !Q    ;0   &H " !I  X :  2 &< & !G !\ 9P E
M &4 *@!C "\ 8@ T &$ .0!@ #X 7P!# %X 2 != $X 6P!5 %H 70!8 &<
M5P!R %4 @0!4 )$ 4P"C %( N !1 -P 40#Y %( _P!2 /\ G0   (L   !\
M    <0   &D   !D    8    %X !0!<  L 6P / %L % !: !D 6@ ? %D
M)0!7 "H 5@ O %4 - !4 #@ 4P ] %( 0P!0 $D 3P!0 $X 6 !- &( 2P!M
M $H >@!) (L 2 "= $< L0!' ,P 1@#P $< _P!' /\ D    'X   !P
M9@   %X   !9    5@   %,  0!2  @ 4  - $\ $ !/ !4 3@ : $X ( !-
M "4 3  J $H +@!) #, 2  X $< /@!& $0 10!+ $0 4P!# %T 00!H $
M=0 _ (4 /@"7 #T JP ] ,, /0#F #T ^P ^ /\ AP   '4#  !H!@  70<
M %4&  !0!@  3 0  $H!  !)  0 1P * $8 #@!% !$ 10 6 $0 &P!# "
M0@ E $$ *@!  "\ /P T #X .@ ] $  .P!' #H 3P Y %D . !D #< <0 V
M ($ -0"3 #0 I@ T +L - #= #0 ]0 U /\ ?@8  &T)  !@"P  5@P  $X,
M  !("P  1 H  $((  ! !0$ /P$' #X "P ]  X /  2 #L %P [ !P .@ A
M #D )0 W "H -@ P #4 -0 T #P ,P!# #( 3  Q %4 , !@ "\ ;0 N 'T
M+0"/ "P H@ L +8 + #0 "P [@ L /P =PH  &<,  !:#@  4 X  $D.  !#
M#@  /@T  #L,   Y"P  . D# #<%"  V @T -0$0 #0 $P S !@ ,@ = #$
M(@ P "< +P L "X ,@ M #@ + !  "L 20 J %( *0!= "@ :P G 7H )@&,
M "4 GP E +( )0#* "4 Z  E /< <@T  &(.  !6$   3!$  $01   ^$0
M.1   #8/   S#@  ,0T! # +!0 P" H +P8- "X%$0 L!!0 *P,9 "H#'@ I
M R, * 0I "<$+P F!34 )04] "0%1@ C!E  (@9< "$':0 @!WD 'P>+ !X'
MG0 >![  '0;& !T&XP =!?, ;0X  %X1  !2$@  2!,  $ 3   Z$P  -1(
M #$1   N$   + \  "H. P J#0< *0L+ "@)#@ G"1$ )0@6 "0(&P C"2
M(@DF "$)+  @"C, 'PH[ !X+1  ="T\ ' Q; !L,:0 :#'D & R+ !@,G@ 7
M#+  %@S% !8,X0 6"_  :1   %H2  !.%   114  #T5   W%0  ,10  "T3
M   J$@  *!$  "80 0 D$ 0 (PX( ",-#  B# \ ( P3 !\,&  >#1T '0TC
M !P-*@ ;#3( &@XZ !@.1  7#E  %@]< !4/:@ 3$'L $A"- !$0H  1$+,
M$ _) ! /Y  1#_( 91(  %<4  !+%@  0A<  #H7   T%P  +Q8  "H5   G
M%   )!,  "(3   @$@, 'A$& !T0"0 <$ T &P\0 !D0%0 8$!L %Q A !80
M*  5$3  %!$Y !,10P 2$DX $1): ! 2:0 0$WD #A.,  X3G@ -$[$ #1+%
M  P2X0 -$O$ 8A0  %06  !)&   /QD  #<9   Q&0  +!@  "@7   D%@
M(18  !\5   <% ( &A,$ !D2!@ 7$@L %1(. !02$@ 3$Q@ $A,? !$3)@ 1
M%"T $!0V  \500 .%4P #A97  T690 ,%W4 "Q>'  H7F@ )%JT "!;!  @6
MW0 )%>X 7Q8  %$8  !&&@  /1H  #4;   O&@  *AH  "49   B&   'Q@
M !P7   9%@$ %Q8# !46!  3%@D $18- ! 7$0 /%Q8 #A<<  X8(P -&"H
M#!DS  P9/  +&D< "AI3  D:80 '&W$ !AN#  4;EP $&JH  QJ_  ,9V@ $
M&>P 7!@  $X:  !#'   .AP  #,<   L'   )QP  ",;   @&@  '1D  !H9
M   7& $ %1@" !(9!  0&P< #AL,  T<$  ,'!, "QP9  H<'P )'2< "!TO
M  <>.0 &'D, !!Y0  ,?7@ "'VX  1^    ?E0  'JD  !Z]   =V   '>P
M6!H  $L<  !!'@  .!X  # >   J'@  )1T  "$<   >'   &QL  !@;   6
M&P$ $QL" !$<!  .'@< #!\+  H@#@ ((!( !B$7  4A'0 $(20  B(L  $B
M-0  (D   "--   C6@  (VL  "-^   CDP  (J<  "*\   AUP  (>T 51T
M $@?   ^(   -2   "X@   H(   (Q\  " >   ='0  &AT  !8=   3'@
M$1\"  X@!  -(@< "B0+  8E#0 $)1   B84   F&@  )B$  "<I   G,@
M)ST  "=)   H5P  *&<  "=[   GD   )Z4  ":[   FU@  )>T 42   $4A
M   [(@  ,B(  "PB   F(0  (B$  !X@   ;'P  &"   !0@   1(@  #R,
M  TE P *)@8 !B@*  ,I#0  *P\  "P2   L%P  +!X  "PF   M+P  +3D
M "U&   M5   +60  "UW   LC0  +*0  "NZ   KU@  *NX 32(  $$D   X
M)   ,"0  "DD   D(P  (2(  !TB   9(@  %2,  !(D   /)@  #2@   HJ
M @ &+ 4  BX)   O"P  , X  #(0   S%0  ,QL  #,B   S*P  ,S8  #-"
M   S4   ,V   #-S   RB@  ,J$  #&X   PU@  ,.\ 224  #XF   T)P
M+2<  "@F   C)0  'R0  !LE   6)@  $B@  ! J   -+   "BX   8P 0 "
M,@0  #0'   U"@  -PP  #@.   Z$@  .A<  #H?   Z)P  .C(  #H^   Z
M3   .EP  #IO   YA@  .)X  #BV   WU   -N\ 1"D  #HI   Q*0  *RD
M "8H   B)P  '2@  !@I   3*P  $"X   TP   ),@  !34   $W    .0(
M #L%   \"   /@L  #\-  !!$   0Q0  $,;  !#(P  0RX  $,Y  !#1P
M0E<  $)J  !!@0  0)H  #^R   ^SP  /N\ /RP  #8L   O+   *BL  "4J
M   ?*P  &2T  !0O   0,@  #34   @X   $.@   #P    _    00   $,"
M  !%!0  1@@  $@+  !*#@  3!$  $T6  !-'@  32@  $TT  !,0@  3%$
M $MD  !+>P  2I0  $FM  !(R@  1^P .S   #,O   M+P  *"T  "(O   ;
M,0  %30  ! W   -.@  "#T   )     0P   $8   !(    2@   $P   !.
M 0  3P0  %$'  !3"P  50X  %@2  !9&0  6"(  %@N  !7/   5TL  %9>
M  !6<P  58T  %2G  !2P@  4N8 .#,  #$R   L,0  )3(  !TU   6.
M$3P   Q    '1    $<   !*    30   %    !3    50   %<   !9
M6@   %P#  !>!P  80L  &0.  !F$P  9QP  &8G  !F-   940  &17  !D
M:P  8H4  &&?  !@N0  7MP -3<  # U   H-P  (#H  !@]   10@  #$8
M  9*    3P   %,   !6    60   %P   !?    80   &0   !E    9P
M &D   !L 0  ;@8  '$+  !T#P  =Q4  '<@  !V+0  =CT  '5/  !T8P
M<WL  '*5  !PKP  ;\D -3H  "L[   B/P  &D,  !)(   ,30  !5(   !7
M    7    &    !D    :    &L   !N    <0   ',   !U    =P   'H
M  !\    ?P   (($  "&"@  B@\  (P7  "+)   BC,  (E%  "'6P  AG(
M (6+  "#I0  @KP +T   "5$   <20  $TX   U4   $6@   &$   !F
M:P   &\   !T    >0   'T   "     @P   (4   "'    B@   (P   "/
M    D@   )8   "9 @  G@D  *(0  "B&@  H2D  * [  "?4   G6<  )J!
M  ":F0  F:\ *4D  !].   55   #EL   5B    :0   '    !W    ?0
M ((   "&    BP   (\   "3    E0   )<   ":    G0   *    "C
MI@   *H   "N    L@   +<*  "[$0  NA\  +DP  "W10  M5P  +1T  "Q
MC@  KZ0 (E0  !A;   08@  !VH   !S    >P   ((   ")    D    )4
M  ":    GP   *,   "F    J    *L   "N    L    +,   "V    N@
M +T   #"    QP   ,P!  #3"P  U!4  -,F  #1.@  T%$  ,UH  #+@0
MRI8 _    /8   #R    \0   /, !0#T  P \@ 3 /  ' #M "4 Z  N .(
M-@#> #X V0!$ -0 2@#1 $\ S@!4 ,L 60#) %X Q@!C ,0 :0#! '  O@!X
M +P @0"Y (T M@": +, JP"Q ,  KP#F *X _P"E /\ F@#_ )0 _P"/ /\
M]    .P   #H    YP   -\   #9  D T@ 0 ,\ %P#/ "  S  H ,8 , #
M #< O  ^ +D 1 "W $D M0!. +, 4P"Q %< KP!= *T 8@"K &D J0!Q *<
M>@"E (4 H@"3 *  H@"= +8 FP#4 )D ^0"6 /\ C0#_ (@ _P"$ /\ Z
M -\   #9    R0   +\   "X  0 M0 - +, $@"Q !H L  B *T *@"I #$
MI@ X *0 /0"B $, H !( )X 3 "< %$ FP!6 )D 7 "7 &( E0!I ), <@"1
M 'T CP"+ (T F@"+ *P B0#% (@ [@"& /\ ?P#_ 'H _P!X /\ V0   ,T
M  "[    K@   *4   "?    G  ) )D #P"9 !4 F0 = )@ ) "4 "L D0 Q
M (X -P", #P BP!! (D 1@"( $L A@!0 (4 50"# %L @@!B (  :P!^ '4
M? "" 'H D@!X *, =P"Y '8 X !U /\ <@#_ &X _P!L /\ QP   +4   "E
M    F0   (\   ")    A0 $ (0 # "" !$ @@ 7 (( '@"  "4 ?@ K 'P
M,0!Z #8 >0 [ '< 0 !V $0 =0!) ', 3P!R %4 < !< &\ 9 !M &X ; !Z
M &H B@!H )L 9P"O &8 S !E /4 9 #_ &$ _P!@ /\ M    *    "0
MA0   'T   !W    <P   '  " !O  X ;P 2 &\ & !O !\ ;0 E &L *@!I
M #  :  T &< .0!F #X 90!# &, 2 !B $X 80!5 %\ 7@!> &< 7 !S %L
M@@!9 ), 6 "F %< OP!7 .H 5P#_ %8 _P!4 /\ H0   (X   !_    =0
M &P   !H    9    &$ ! !@  L 7P / %\ $P!? !D 7P ? %T )0!< "H
M6P O %D ,P!8 #@ 5P ] %8 0P!5 $D 4P!0 %( 6 !1 &$ 4 !M $X >P!-
M (P 3 "? $L M0!* -P 2@#Z $H _P!* /\ D@   (    !R    9P   %\
M  !:    5P   %4  0!3  < 4@ , %( $ !2 !0 4@ : %$ 'P!/ "0 3@ I
M $T +@!, #, 2P X $H /0!) $, 2 !* $8 4@!% %P 1 !G $, =0!" (8
M00"8 $  K@!  ,L /P#R $  _P!  /\ A0   '0   !G    70   %4   !/
M    3    $H   !(  0 1P * $< #0!& !$ 1@ 5 $8 &@!% !\ 1  D $,
M*0!" "T 00 S #\ .  ^ #X /0!% #P 3@ [ %< .@!B #D ;P X (  -P"3
M #8 IP V ,  -@#H #8 _@ V /\ ?    &L   !> @  5 ,  $T#  !' P
M0P$  $$    _  $ /@ ' #T "P ]  X /  1 #P %@ \ !H .@ ? #D )  X
M "D -P N #8 ,P U #H - !! #, 20 R %, ,0!> #  :P O 'L +@". "T
MH@ M +@ +0#= "T ^  N /\ <P$  &0%  !7!P  30@  $8(  ! "   .P<
M #@%   W P  -@ $ #4 "  T  P -  / #0 $@ S !8 ,@ ; #$ (  P "0
M+P I "X +P M #8 +  ] "L 10 J $\ *0!: "@ 9P G '< )@") "8 G0 E
M +, )0#/ "4 \  F /\ ;08  %X)  !2"P  2 P  $ ,   Z"P  -@L  #(*
M   P"   +@8" "X#!@ M  H +  - "P $  K !, *@ 7 "D '  H "  )P E
M "8 *P E #( )  Y ", 0@ B $L (@!7 "$ 9  @ ', 'P"% !\ F0 > *X
M'@#' !X Z0 ? /H : D  %D,  !-#0  0PX  #P.   V#@  ,0T  "T-   J
M#   * L  "<)!  F!@@ )@0+ "4##@ D 1  ) $4 "(!&  A 1T (0 B "
M*  ? "X '@$V !T!/P < 4D &P%4 !H!80 : 7  &0&" !@ E@ 8 *H & #!
M !@ X0 8 /0 8PP  %4.  !)#P  0!   #@0   R$   +0\  "D.   F#@
M(PT  "(, P @"P8 ( D) !\'#  >!@X '@41 !P%%0 ;!1H &@4? !H%)0 9
M!2L & 4S !<&/  6!D8 %@92 !4'7P 4!VX $P>  !('E  2!J< $@6\ !($
MV0 2 ^\ 7PX  %$/  !&$   /!$  #41   O$0  *A$  "80   B$   ( \
M !T. @ <#04 &@T' !H+"@ 9"@T & D0 !<)$@ 6"1< %0D< !0)(@ 4"BD
M$PHQ !(*.@ 2"T4 $0M1 ! ,7P /#&X #@R   X,E  -"Z< #0NZ  T*T@ -
M"NH 7 \  $X1  !#$@  .A,  #(3   L$P  )Q(  ",1   ?$0  '!   !H0
M @ 8#P0 %@X' !4."0 4#0L $PP- !(,$  2#!0 $0P: !$-(  0#2@ #PTP
M  X..P -#D8 #0Y1  P/7@ +#VT "@]_  D/DP )#Z8 " ZY  @.T  '#N@
M6!$  $L2  ! $P  -Q0  # 4   I%   )10  "$3   =$@  &A(  !<1 @ 5
M$04 $Q ' !(0"0 1#PH $ X,  X.#@ .#Q( #1 8  T0'@ ,$"4 #! M  L1
M-@ *$4$ "1%-  @26@ '$FH !A)\  42D  $$J0  Q&X  ,1SP "$>@ 51(
M $D4   ^%0  -18  "T6   G%@  (A4  !X4   ;%   &!,  !42 P 3$@4
M$A$' ! 1"0 /$0H #1$+  P2#@ +$A$ "A(5  D3&P )$R( "!,J  <4,P %
M%#X !!5*  ,56  "%6<  15Z   5C@  %:,  !2W   4SP  $^D 4A0  $86
M   [%P  ,A<  "L7   E%P  (18  !P6   9%0  %A0! !03!  2$P8 $1((
M  \2"  .$PD #!0*  H5#0 (%A  !A83  46&0 $%Q\  Q<G  (8,  !&#L
M !E'   950  &60  !EW   9C   &*(  !BW   7SP  %^H 3Q8  $,8   Y
M&0  ,!D  "D9   C&0  'Q@  !L7   8%@  %14" !,5!0 1% 8 $!0&  X5
M!P ,%@@ "A<*  <9#  $&@X  AL2  $;%@  &QT  !PD   <+0  '#@  !U$
M   =4@  '6(  !UU   =B@  '*   !RV   ;T   &NL 3!@  $ :   V&P
M+1L  "8;   A&@  '1D  !D9   7&   %!<# !(6!  0%P0 #A<$  P9!0 *
M&@< !QP)  ,="P  'PT  " 0   @%   (1H  "$B   A*@  (34  ")!   B
M3P  (E\  ")R   AB   (9\  ""V   ?T0  '^T 2!H  #T<   S'0  *QT
M "0=   @'   '!L  !@:   6&0$ $QD! !$9 0 .&@$ #!P"  H= P ''P4
M R$(   B"@  ) P  "8.   F$@  )A@  "<?   G)P  )S(  "<^   G2P
M)UP  "=N   FA0  )IT  "6T   DT0  (^X 1!T  #D?   P'P  *!\  ",>
M   >'0  &QP  !@;   4'   $1P   X=   -'P  "B$   8B 0 #) 0  "8&
M   H"   *@L  "L-   M$   +14  "T<   M)   +BX  "XZ   N2   +5@
M "UJ   M@0  +)H  "NR   JT   *>\ 0"   #8A   M(0  )B$  "$@   =
M'P  &AX  !8>   2'P  #R$   TB   *)   !B8   (H    *P(  "T$   O
M!@  , D  #(,   T#@  -1(  #48   U(   -2H  #4V   U0P  -5,  #1F
M   T?   ,Y8  #*O   QS0  ,.\ /",  #(D   J)   )",  " B   <(0
M%R$  !,C   0)0  #2<   DI   %*P   2X    P    ,@   #0!   V!
M. 8  #H)   \#0  /A   #X4   ^'   /B8  #XQ   ^/P  /4X  #UA   \
M=P  .Y$  #JK   YR0  ..T -R<  "\G   H)@  (R4  !\D   9)0  %"8
M ! H   -*P  "2X   4P    ,P   #4    X    .@   #P    ^ 0  0 ,
M $('  !$"@  1@T  $D1  !)%P  2"$  $@L  !'.@  1TD  $9;  !%<0
M1(L  $.E  !"PP  0>@ -"H  "PJ   G*   (B<  !PH   6*@  $2T   TP
M   ),P   S8    Y    /    #X   !!    0P   $8   !(    2@   $P#
M  !.!@  4 H  %,.  !4$P  5!P  %,G  !3-   4T,  %)5  !1:@  4(,
M $^>  !-N0  3.  ,"T  "LL   F*P  'RP  !@N   2,@  #34   @Y   "
M/0   $    !#    1@   $D   !,    3@   %$   !3    50   %<   !9
M 0  7 8  %\*  !B#@  8Q4  &,?  !B+   83P  &!.  !?8@  7GL  %R6
M  !;L   6<\ +S   "HO   B,   &C,  !,W   ..P  "#\   %$    2
M $P   !/    4@   %4   !8    6P   %T   !@    8@   &0   !F
M:0   &T%  !P"P  =!   '08  !S)0  <C0  ')%  !P60  ;W$  &V+  !K
MI@  :L  +C,  "4U   =.   %#P   Y!   '1P   $P   !1    50   %D
M  !=    80   &4   !H    :P   &T   !O    <@   '0   !W    >@
M 'X   ""!   A@L  (H1  ")'   B"L  (8]  "$4@  @V<  (&!  !_FP
M?K( *3H  " ]   60@  #T@   A.    5    %H   !@    9    &D   !N
M    <@   '8   !Z    ?0   (    ""    A0   (@   "+    C@   )(
M  "6    FP,  * ,  "B$P  H"$  )\S  "=1P  FEX  )AW  "7CP  E:<
M(T,  !E(   13@  "54   !<    8P   &H   !Q    =@   'L   "
MA@   (H   ".    D0   ),   "6    F0   )P   "@    HP   *<   "K
M    L    +8$  "\#0  NA<  +DH  "W/   M%(  +)J  "OA0  K9P '$X
M !-4   +7    60   !L    =    'P   "#    B0   (\   "4    F@
M )\   "B    I    *<   "J    K@   +$   "T    N    +P   #!
MQP   ,T   #4!0  V!   -4>  #3,0  T$@  ,U?  #+=@  R(X
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MY.7FY^CIZNOL[>[O\/'R\_3U]O?X^?K[_/W^_VUF=#$      P0A   !
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MA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VO?
M$!7XP!8Q^;T@4^JW*'S,J$2JQJ5=M,*C<+J^HG^_O*"(P[F;B,:WF(C*M96)
MS;.2BM"QCXO2L(R-U*^*D-:NB)/8K8:8V:R%G=JLA9W:K(6=VJR%G=JLA9W:
MK(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VO? $!7X
MP!8Q^;T@4^JW*'S,J$2JQJ5=M,*C<+J^HG^_O*"(P[F;B,:WF(C*M96)S;.2
MBM"QCXO2L(R-U*^*D-:NB)/8K8:8V:R%G=JLA9W:K(6=VJR%G=JLA9W:K(6=
MVJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VO? $!7XP!8Q
M^;T@4^JW*'S,J$2JQJ5=M,*C<+J^HG^_O*"(P[F;B,:WF(C*M96)S;.2BM"Q
MCXO2L(R-U*^*D-:NB)/8K8:8V:R%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%
MG=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VO? #Q7XP!8P^;T@
M4^JX)WS,J$2KQJ5=M,*D<+J^HG^_O*"(P[F;B,>WF(C*M96)SK.2BM"QCXO3
ML(V-U:^*C]>MB)/9K8:8VJN&G=JKAIW:JX:=VJN&G=JKAIW:JX:=VJN&G=JK
MAIW:JX:=VJN&G=JKAIW:JX:=VJN&G=JKAIW:JX:=VO?!#Q7WP18P^+X?4^JX
M)GS+J4.KQJ9<M,*D;[J^HGZ_NZ"(P[F=A\BVFH?,LY>(S[&4B=*PDHK5KH^,
MUZV-CMFLBI+<JXF9W:>(G-NGB)S;IXB<VZ>(G-NGB)S;IXB<VZ>(G-NGB)S;
MIXB<VZ>(G-NGB)S;IXB<VZ>(G-NGB)S;IXB<V_;!#A3WP14P^+\>4^JY)7S+
MJ4*KQJ=;L\*E;KJ^HWZ_NZ&(Q+B>A\FUG(?-LIF'T;"6B-2NE(G7K9*+VJN0
MC=RIC9+?J(V:WZ.+G-RCBYS<HXN<W*.+G-RCBYS<HXN<W*.+G-RCBYS<HXN<
MW*.+G-RCBYS<HXN<W*.+G-RCBYS<HXN<W/;!#A3VPA4P][\>4^JZ)'S+J4&L
MQJ=:L\*E;;J^HWV_NZ.(Q+>@A\FTG8?.L9N'TZ^9B-:MEXG:JY6*W*F3C=^G
MDI'BI)&9X*".G-R@CIS<H(Z<W*".G-R@CIS<H(Z<W*".G-R@CIS<H(Z<W*".
MG-R@CIS<H(Z<W*".G-R@CIS<H(Z<W/7"#A3UPA0P]L =4^JZ(WS+JD&LQJA9
ML\*F;;J^I'V_NJ2'Q;>AA\JSGX?/L)V'U*Z;B-BKF8G<J9B+WZ>8CN*EEY+F
MH):9X)R3F]V<DYO=G).;W9R3F]V<DYO=G).;W9R3F]V<DYO=G).;W9R3F]V<
MDYO=G).;W9R3F]V<DYO=G).;W?3"#13UPQ0P]L <4^J[(GS*JD"LQJA8L\*F
M;+J^I'R_NJ6%Q;:CA\NSH8?0L)^'U:V=B-JJG8K=IYN,X*2:CN*?F(_CG9J8
MX9F7F]V9EYO=F9>;W9F7F]V9EYO=F9>;W9F7F]V9EYO=F9>;W9F7F]V9EYO=
MF9>;W9F7F]V9EYO=F9>;W?+##13TPQ,P]<$;4^J\(7S*JS^MQJE7L\*G:[J^
MI7N_NJ:$Q;:EA\NRHX?1KZ&'UJN?B-JGG8G=I)R*WZ";B^";FHWBEYJ3X9><
MF]Z7G)O>EYR;WI><F]Z7G)O>EYR;WI><F]Z7G)O>EYR;WI><F]Z7G)O>EYR;
MWI><F]Z7G)O>EYR;WO###13TQ!,O]<(:4NJ]('S*JSZLQJI6L\*H:[J^IWF_
MNJB#Q;:GA\RRI8?1K**'UJB@A]FDGHC<H9V(W9R<B=Z7FXO@DYN/X)*=E]Z2
MG9?>DIV7WI*=E]Z2G9?>DIV7WI*=E]Z2G9?>DIV7WI*=E]Z2G9?>DIV7WI*=
ME]Z2G9?>DIV7WNW$#!/SQ1(O],(94NJ]'WS*K#RLQJM5L\*H:KF^J7>_NJJ
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MFW^YP)N(O;Z9B<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+.
MG=&R?Z/1L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZD
MT;!^I-&P?J31L'ZDT?^X% [_N!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^Y
MP)N(O;Z9B<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R
M?Z/1L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^
MI-&P?J31L'ZDT?^X% [_N!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(
MO;Z9B<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1
ML'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P
M?J31L'ZDT?^X% [_N!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(O;Z9
MB<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1L'ZD
MT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31
ML'ZDT?^X% [_N!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(O;Z9B<"\
ME8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1L'ZDT;!^
MI-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZD
MT?^X% [_N!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(O;Z9B<"\E8K#
MNI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1L'ZDT;!^I-&P
M?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT?^X
M% [_N!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(O;Z9B<"\E8K#NI&+
MQKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1L'ZDT;!^I-&P?J31
ML'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT?^X% [_
MN!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(O;Z9B<"\E8K#NI&+QKB-
MC<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1L'ZDT;!^I-&P?J31L'ZD
MT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT?^X% [_N!XG
M_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(O;Z9B<"\E8K#NI&+QKB-C<BW
MBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1L'ZDT;!^I-&P?J31L'ZDT;!^
MI-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT?^X% [_N!XG_[0J
M1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(O;Z9B<"\E8K#NI&+QKB-C<BWBH_*
MMHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1L'ZDT;!^I-&P?J31L'ZDT;!^I-&P
M?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT?^X% [_N!TG_[4I1O>P
M-6G>J$&0QYQAL<2<<;;"FWZYOYV&O;V:B<&[EXG$N9.*Q[>/C,JUC([,M(F0
MSK.'DM"RA)72L8*9T[&!GM2N@*+4K("CTJR H]*L@*/2K("CTJR H]*L@*/2
MK("CTJR H]*L@*/2K("CTJR H]*L@*/2K("CTO^Y$P[_N1PG_[8H1O>P-&K=
MJ$"0QYU@L<2<<;;"G'RZOYZ%OKR<B,*ZF8C%N)6)R;:1BLRTCHS/LHN.T;&(
MD=.PAI35KX29UJ^#G]>J@J'5IX*BTZ>"HM.G@J+3IX*BTZ>"HM.G@J+3IX*B
MTZ>"HM.G@J+3IX*BTZ>"HM.G@J+3IX*BT_^Y$P[_N1PG_[8H1O>Q,VK=J3^1
MQYU@L<2=<+;"GGNZOY^#OKR>B,*YFXC'MY>(RK64B<ZSD(O1L8V-TZ^*D-:N
MB)/8K8:9V:J%GMFEA*'5I(2BU*2$HM2DA*+4I(2BU*2$HM2DA*+4I(2BU*2$
MHM2DA*+4I(2BU*2$HM2DA*+4I(2BU/^Z$@[_NALG_[<G1O>Q,FK=J3Z1QYY?
ML<2=;[;!GWFZOJ""O[N@B,.XG(?(MIF(S+.6B-"QDHK3KX^,UJZ,CMBLBI/;
MJXF9W*:'G=JBAJ#6H(:BU*"&HM2@AJ+4H(:BU*"&HM2@AJ+4H(:BU*"&HM2@
MAJ+4H(:BU*"&HM2@AJ+4H(:BU/^Z$@[_NALF_[<F1O:R,6K=JCV1QYY>L<2=
M;[;!H'BZOJ&!O[NAB,2XGH?)M9N'S;*8B-&PE8G5KI*+V*R/C=NJC9+>J(R:
MWZ**G=J>B:#6G(FAU)R)H=2<B:'4G(FAU)R)H=2<B:'4G(FAU)R)H=2<B:'4
MG(FAU)R)H=2<B:'4G(FAU/ZZ$0[_NQHF_[@F1O:R,&K=JCR1QYY=L<2>;K;!
MH7:ZOJ)_O[NCB,2WH(?*M)V'S[&:A].NF(C7K)6*VZJ3C=ZHD9+BI)"9X)Z-
MG=N:C*#7F8NAU9F+H=69BZ'5F8NAU9F+H=69BZ'5F8NAU9F+H=69BZ'5F8NA
MU9F+H=69BZ'5F8NAU?Z[$0[^NQHF_[@E1O:S,&K<JSN2QY]=L<2?;+;!HG2Z
MOJ1^O[JDA\6WHH?*LY^'T+"<A]6MFHC9JIF*WJB8CN*EEY/FGY69X)J1G-N7
MCY_7EHZAU9:.H=66CJ'5EHZAU9:.H=66CJ'5EHZAU9:.H=66CJ'5EHZAU9:.
MH=66CJ'5EHZAU?V[$0[^NQHF_[DE1O:S+VK<JSJ2QY]<L<2@:K;!HW.ZOJ5\
MP+JEA<6VHX?+LZ&'T:^?A]:LGHG;J)R+WZ2:C>&?F8_CG)J8X9>6G-R4DY_8
MDY*@UI.2H-:3DJ#6DY*@UI.2H-:3DJ#6DY*@UI.2H-:3DJ#6DY*@UI.2H-:3
MDJ#6DY*@UOV[$0W]O!DF_KDD1O:T+FK<JSJ2QZ!<L<2A:+;!I7&ZOJ=ZP+JG
MA,6VIH?,LJ2'T:ZBA]>IGXC;I)V)WJ";BN":FHSAEIN3X96;F]V2EY[8D96@
MUY&5H->1E:#7D96@UY&5H->1E:#7D96@UY&5H->1E:#7D96@UY&5H->1E:#7
MD96@U_R\$ W]O!DF_KHC1O:T+6K<K#F2QZ!;L<2C9K7!IFZZOJEXP+JI@L6V
MJ(C,L*6'TJJBA]>FGX?:H9Z'W)N=B-Z6G(K?D9N0WY&=F=V/FY[9CYF?UX^9
MG]>/F9_7CYF?UX^9G]>/F9_7CYF?UX^9G]>/F9_7CYF?UX^9G]>/F9_7CYF?
MU_R\$ W\O!@F_;HB1?:U+&K<K3>3QZ%:L<6E8[7"J6NZOJQUO[JM?\6SJ8?,
MK:6&TJ>BAM:BH8;8G9^&VIB>A]N2G8G=CIV-W8R>E-R-H)[9C)Z?UXR>G]>,
MGI_7C)Z?UXR>G]>,GI_7C)Z?UXR>G]>,GI_7C)Z?UXR>G]>,GI_7C)Z?U_N]
M$ W[O1<E_;LB1?:V*VK;K3:3QZ)9L<6G7[7"K6:YO[%POK>M?L:PJ8?-JJ:&
MT:2DA=2>HH76F:&%V)2@AMF/GX?:BY^+VXB?D-N(H)C8B*&=UXBAG=>(H9W7
MB*&=UXBAG=>(H9W7B*&=UXBAG=>(H9W7B*&=UXBAG=>(H9W7B*&=U_J]#@WZ
MOA8E_+P@1?:W*FK;KS24R*15L<:K6+3#LU^WN[)NO[*M?L>LJ8;,IJ>%T*"E
MA-*;I(34EJ.$U9&BA=:-H8;7B:&)V(:AC=B$H9/7A**7UH2BE]:$HI?6A**7
MUH2BE]:$HI?6A**7UH2BE]:$HI?6A**7UH2BE]:$HI?6A**7UOF^#@SYOQ4E
M^KT?1?:X)VK;L#&4R*A-K\>R3K+!N%BXM+%PP:VM?\>IJH7+HJB$SIVG@]"7
MIH/1DJ6$THZDA=.+HX;4B*.(U82CB]6"HY#5@:.3U8&CD]6!HY/5@:.3U8&C
MD]6!HY/5@:.3U8&CD]6!HY/5@:.3U8&CD]6!HY/5@:.3U?3 #0SWP!,D^;\=
M1/:Z)6K:LBZ5RJ] K<B]/:^WMEVZKK%RPJFM?\:EJX7)GZJ#RYFI@\V4J(/.
MD*>$SXRFA=")IH;1AJ6'TH2EBM*!I8W2@*6/TH"EC]* I8_2@*6/TH"EC]*
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MGH&KQO^M& 7_K2(6_ZLQ+_^G/TOXH4QGYYY3@=F=69?*FV6LQ9QOM,.=>+C
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MJ:G,<:VJS'"RJ\MPMJO+;[RKR'# J\1QP*K$<<"JQ'' JL1QP*K$<<"JQ''
MJL1QP*K$<<"JQ'' JO^2$@'_EB<*_Y8['/^42S#_D%E#_X]C5/J.:63QC7!R
MZ8MZ?N*)@HG<A8F2V(*.F=1_DY[1?9>BSWN;ILUYGJC,=Z*JRW:EK,ITJ:W)
M<ZVNR7*RK\EQMZ_(<;ROPG.]KKYTO:^^=+VOOG2]K[YTO:^^=+VOOG2]K[YT
MO:^^=+VOOG2]K_^3$@'_ER<*_Y@['/^52S#_D5E$_Y%@5?J09F3PCVUSZ(UW
M@.&,@(O;B(>4U86-G-*"D:'/?Y:FS'V9J<M[G:S)>:&NR'>EL,=VJ;'&=:VR
MQG2RL\9SN;/"=;JSO'6ZL[AVNK.X=KJSN':ZL[AVNK.X=KJSN':ZL[AVNK.X
M=KJSN':ZL_^4$0'_F"<*_YD['/^62S#_DEE$_Y)>5?J29&7PD6ITYX]S@>".
M?8S9BX66U(B+GM"%D*3-@I2IRG^8K<A]G+#'>Z"RQGFDM,5XJ+7$=JZVQ'6T
MML%VM[:\=[>VMW>WMK-XM[:S>+>VLWBWMK-XM[:S>+>VLWBWMK-XM[:S>+>V
MLWBWMO^5$0'_F2<*_YD['/^72C#_DUA$_Y1<5?J4867PDV=TYY%P@M^/>H[8
MC8.8THN*H,Z'CZ?+A).LR(&7L,9_F[/$?9^UPWNDM\)YJ;G"=Z^YPG:UN;QX
MMKBX>+:XLWBVM[!YM[>P>;>WL'FWM[!YM[>P>;>WL'FWM[!YM[>P>;>WL'FW
MM_^6$0'_FB<*_YH['/^72C'_E%5$_Y995?J67F7PE61TYY-L@MZ1=H[8CW^9
MT8V(HLV*CJG)AY*NQH26L\2!FK;"?I^YPGNDNL%YJKK!=[&ZO7BUNK=XM;FS
M>;6YKWFVN*QZMK>L>K:WK'JVMZQZMK>L>K:WK'JVMZQZMK>L>K:WK'JVM_^7
M$0'_FR8*_YL['/^823'_EE-$_YA75?J86V7PEV%TYY9H@MZ3<H_6D7N:T(^$
MH\N-C*O'BI&QQ(:5ML.#F;C!?YZZP7NDN\!YJ[R_=[.\N'BSN[)YM+NN>;6Z
MJWJUN:A[MKBH>[:XJ'NVN*A[MKBH>[:XJ'NVN*A[MKBH>[:XJ'NVN/^7$0'_
MFR8*_YPZ'/^823'_F%%$_YI45/J;6&3PFEUTYYAC@MZ6;8_6DW>:T)& I,J/
MB:S&C8^SPXF4M\*$F+K ?YZ\OWNEOK]YKKZY>+*^LGFRO:UZL[RI>[2ZIGNU
MN:1\MKBD?+:XI'RVN*1\MKBD?+:XI'RVN*1\MKBD?+:XI'RVN/^8$0'_G"8*
M_YPY'/^92#'_F4]$_YQ25/N=56/QG5ISYYM?@=Z9:8_6EG*:SY-\I<J1A:W%
MD(VTPXN2N,&%EKN_@)V^O7NEP;MYK\&R>K# K'NQOJA[L[VE?+2[HGVUN:!]
MMKB@?;:XH'VVN*!]MKB@?;:XH'VVN*!]MKB@?;:XH'VVN/^9$0'_G28*_YTY
M'/^91S'_FTU#_YY/4_N?4F/QH%9RZ)];@-^=9([7FFV:T)=WI,J4@:W%DHJU
MPHZ0N;^'E;V]@)S!NWNGQ+-ZK<2K>Z_"IGRQOZ-]LKV@?K2[GG^UN9Q_MKB<
M?[:XG'^VN)Q_MKB<?[:XG'^VN)Q_MKB<?[:XG'^VN/^9$0'_GB8*_YTX'/^:
M1S'_G$M"_Z!-4ORB4&+RHU-QZ:-7?^"A7HS8GF>8T)MQH\J8>ZW%E86TPI*-
MNKZ*DK^Z@9O%MWRIR:M\J\>D?:[#H'ZPP)U_LKV;@+.[F8&UNIB!MKB8@;:X
MF(&VN)B!MKB8@;:XF(&VN)B!MKB8@;:XF(&VN/^:$0'_GB8*_YXX'/^:1C+_
MGDE"_Z)*4?VD36#SIE!OZJ=4?>&F6(K:I&*6TJ%KH<N==:O&FH"SPIB*NKR.
MC\*V@YG+K'VFSJ)_JLF=@*W$FH&PP)B"LKZ7@[.\E8.UNI2#MKB4@[:XE(.V
MN)2#MKB4@[:XE(.VN)2#MKB4@[:XE(.VN/^:$0'_GR8*_YXW'/^;1C+_GT=!
M_Z1(4/ZG2E_TJ4QMZZM0>^.L5(?<JUR3U*EEG<ZF;Z?(HWJPPY^$N+N6B\2P
MC)G.H(.DT9F$J<J6A:W%E(6OP9.%L;Z2A;.\D86TNI&%M;F1A;6YD86UN9&%
MM;F1A;6YD86UN9&%M;F1A;6YD86UN?^;$0'_GR8*_Y\W'/^;13+_H45 _Z9&
M3_^J1UWVK4EK[;!,>.:S3X/?M%6.V;5?E].U::#.M7:GP:M\MK"?A<2AE9+.
ME(ZCTI"+J,N/BJS&CHJOPHZ)L;^.B;*]CHBTNXZ(M;F.B+6YCHBUN8Z(M;F.
MB+6YCHBUN8Z(M;F.B+6YCHBUN?^;$0'_H"8*_Y\V'/^<1#'_HT,__ZA#3O^M
M1%OXL45H\+9(=.F[3'[CP%&'W\9;CM;(:Y3&O7&FM;-XM:6H@<.4GXW-B9RB
MTH>4I\R(D:O'B8^NPXF.L,")C;*^BHRSO(J+M+J*B[2ZBHNTNHJ+M+J*B[2Z
MBHNTNHJ+M+J*B[2ZBHNTNO^<$ '_H28*_Z V'/^>0C'_I4 ^_ZM 3/^Q0%GZ
MMT%D\[U$;^[%27?ESE)\W=9B?\S.:)*\Q6ZDJ[MVM)JQ?\&*JHK+?Z>=SX"?
MJ,R"F:O'@Y6MQ(23K\&%D;&_AH^SO8>.M+N'CK2[AXZTNX>.M+N'CK2[AXZT
MNX>.M+N'CK2[AXZTN_^=$ '_HB8*_Z U'/^@/S#_IST]_ZX\2O^U/%7ZO3U@
M\,9"9^;12FS>WDYVS=I7A[[08I:NQ6ZEH;QYLI6T@[V&K8C&>ZJ4RGBKJ,E[
MHJO'?IRMQ("9K\*!EK# @I2ROH.2L[R#DK.\@Y*SO(.2L[R#DK.\@Y*SO(.2
ML[R#DK.\@Y*SO/^>$ '_HB8*_Z$T'/^B/"[_JCH[_[(X1_R[-U'RQ3I8YM%!
M7-O>0FG-XD9\OM=1C*[,7YNAPVVHF+QYLI&UA+N%L8G"?*Z1Q7BNG\5UK:S%
M>*6NQ'J@K\)\G+# ?IFQOG^6LKU_EK*]?Y:RO7^6LKU_EK*]?Y:RO7^6LKU_
MEK*]?Y:RO?^>$ '_HR4)_Z(T'/^E.2W_KC4X_[@S0O3#,TKGT#A.V=XY6LOF
M/6Z^X$* KM10D*'+7YV8PVVHD;UYL8NX@[B#M(B]?;&0P7FQFL%UL:7!<J^O
MPG6HK\%WH[# >9^QOWN<LKU[G+*]>YRRO7N<LKU[G+*]>YRRO7N<LKU[G+*]
M>YRRO?^@$ '_I"0)_Z,R'/^H-"O_LR\T^;\M/.G-+T#9WB]*RN<T7[WJ.G.O
MWD&#H=-1D9?+8)V0Q&ZFC+]ZK8:[@;-_N(>X>K:-NW>UE;QUM9^\<K2HO6ZS
MLKYQK+*^=*>ROG:CLKUVH[*]=J.RO7:CLKUVH[*]=J.RO7:CLKUVH[*]=J.R
MO?^A$ '_I2,)_Z0Q'/^M+B?_N2DO[L@F,]K<)C?*YRQ/O?(R8Z_H.76AW4*$
MEM13D(_-8IJ*QW"BAL-ZJ("_@*U[O86Q=KN+M'.YDK5QN9JV<+FCM6VYJ[9J
MN+2X:[*VN&ZLMKANK+:X;JRVN&ZLMKANK+:X;JRVN&ZLMKANK+:X;JRVN/^C
M$ '_IR()_Z4O&_^S)R+TPB$FW=@=),OG(SR]\BI3K_,R9J'G.W:5WD:#C=96
MC8?09):$RW&<?\AXH7K%?J5VPH.I<L&)JV^_CZULOY:N:[Z=KFJ_IJYHOZZN
M9;VXL&6YN[!EN;NP9;F[L&6YN[!EN;NP9;F[L&6YN[!EN;NP9;F[L/^E$ '_
MJ" (_ZPF%_R['1KCT1,9S.49*;WR(D&O_2I5H?,T9I;I/W2,X4M_A=M9B(#5
M9H]\T6^4=\YVF7/+?)QPR8&?;<B'H6K'C*-HQI*D9L69I63%H*5DQ:BE8\:R
MI&#$NZ9@Q+NF8,2[IF#$NZ9@Q+NF8,2[IF#$NZ9@Q+NF8,2[IO^H$ #_JAX(
M_[,=$>S)#@_.XPX5OO(8+:_^(D.A_RU5EO0Y9(SL16^$Y5%Y?N!<@'G<9X9T
MV6Z*<-9TCFS3>9%ITG^39]"$E63/BI=BSH^88,V5F5_-G)I>S:*;7<VKFUS-
MM)I<S;2:7,VTFES-M)I<S;2:7,VTFES-M)I<S;2:7,VTFO^K#P#_K1H'\L -
M",[3"@:^\ X:K_X9,*'_)$.5_S)2B_@_7H/Q2VA][%9P=^A?=G'D97ILX6Q^
M:=]R@6;=>(1CW'V&8=N"B%_:AXE=V8R+6]B2C%G7F(U8UIZ-5]:ECE;5K(Y6
MU:R.5M6LCE;5K(Y6U:R.5M6LCE;5K(Y6U:R.5M6LCO^O#0#_MPX#S<D( ;[8
M"0FN_1 <H?\<+Y7_*3^+_S=,@OY%5GSY4%YU]%ED;O%?:6CN9&UDZVIP8>IP
M<U_H=75=YWIW6^9_>%GEA'E8Y(E[5N..?%7BDWU4XIA^4N&>?E'AI7]1X:5_
M4>&E?U'AI7]1X:5_4>&E?U'AI7]1X:5_4>&E?_&T" #.P 8 O<X' :[@!PN@
M_Q(<E/\@*XK_+SB!_SU#>O])2W/_4E%L_E=79?M=6V'Y8UY>]VA@6_5M8ECT
M<F16\W=F5?)[9U/Q@&A1\(1I4/"):D_OCFM.[I-L3.Z9;4OMGVY+[9]N2^V?
M;DOMGVY+[9]N2^V?;DOMGVY+[9]N2^V?;M&Y P"\Q04 K=8# 9_X"PN3_Q88
MB?\D)(#_-"]Y_T$W</](/FC_3T-B_U5'7?]:2UG_8$U6_V504_]J45'_;E-/
M_W)43O]V54S^>U9+_7]72?V$6$C\B%E'^XU:1ON36T7ZF%Q%^IA<1?J87$7Z
MF%Q%^IA<1?J87$7ZF%Q%^IA<1?J87+V] P"MS0$ GM\  9+_#0B'_QD2?O\I
M&W7_-2-L_SPJ9/]#+U[_2C18_U W5/]6.E'_6SQ._V ^2_]D0$K_:$%(_VQ"
M1O]P0T7_=$1$_WA%0O]]1D'_@4= _X9(/_^,23W_D4H]_Y%*/?^12CW_D4H]
M_Y%*/?^12CW_D4H]_Y%*/?^12J[%  ">UP  C_4  8;_#P1\_QL+<?\D$6?_
M+!=?_S4<6?\](53_129/_TLI3/]2+$C_5R]&_UTP1/]A,D+_9C- _VHU/_]N
M-CW_<S<\_W<X._]\.3K_@3HX_X8Z-_^,.S;_DCPV_Y(\-O^2/#;_DCPV_Y(\
M-O^2/#;_DCPV_Y(\-O^2//^#$P'_A"(&_X4U%/^#1B3_?U4T_X%>0O^!9E#_
M?VY<^7QW9O-Z@&_N=XAWZG6/?>=RE8+D<)J%XVZ>B.%LHHO@:Z>-WVFKCMYH
MKY#=9[21W6:ZD=QEP9+<9<F2VV70DM)GTI'.:-*1SFC2D<YHTI'.:-*1SFC2
MD<YHTI'.:-*1SFC2D?^#$P'_A"(&_X4U%/^#1B3_?U4T_X%>0O^!9E#_?VY<
M^7QW9O-Z@&_N=XAWZG6/?>=RE8+D<)J%XVZ>B.%LHHO@:Z>-WVFKCMYHKY#=
M9[21W6:ZD=QEP9+<9<F2VV70DM)GTI'.:-*1SFC2D<YHTI'.:-*1SFC2D<YH
MTI'.:-*1SFC2D?^#$P'_A"(&_X4U%/^#1B3_?U4T_X%>0O^!9E#_?VY<^7QW
M9O-Z@&_N=XAWZG6/?>=RE8+D<)J%XVZ>B.%LHHO@:Z>-WVFKCMYHKY#=9[21
MW6:ZD=QEP9+<9<F2VV70DM)GTI'.:-*1SFC2D<YHTI'.:-*1SFC2D<YHTI'.
M:-*1SFC2D?^$$P'_A2(&_X8U%/^$1B3_@%4T_X1=0_^%95#_@VU=^(!U:/)]
M?G'L>H9YZ'>-?^5UDX7B<IB)X'"=C-]NHH[=;*:0W&NKDMMIKY3::+65VF>[
ME=IFPY;:9LR6TVC/ELQISY7(:L^6R&K/ELAJSY;(:L^6R&K/ELAJSY;(:L^6
MR&K/EO^%$@'_AR(&_X<U%/^%1B3_A%0U_XA<0_^(9%'^AVM>]X-R:?& ?'/K
M?85[YWJ,@N-WDH?@=)>,WG*<C]QPH9+;;J:4V6RJEMEJL)C8:;:9UVB]F==H
MQIK3:,R:S&K,F<9KS)K";,R:PFS,FL)LS)K";,R:PFS,FL)LS)K";,R:PFS,
MFO^&$@'_B"$&_X@U%/^&1B7_AU,U_XM;0_^,8E'^BFI>]H=Q:O"$>G3J@(-]
MY7V*A.)ZD(K>=I:/W'2;DMIQH)78;Z68UFVKFM5KL)O5:K><U&F_G=1IR9W,
M:\J=QFS)G<!MR9V];LF=O6[)G;UNR9V];LF=O6[)G;UNR9V];LF=O6[)G?^'
M$@'_B2$&_XHU%/^(1B7_BE(U_XY:0_^/85'^CFA>]HMO:N^'>'7IA(%^Y("(
MAN!\CXS=>921VG::E=ASGYG5<*6;U&ZJGM-ML9_2:[B@TFO"H<ULQZ'&;L>A
MP&['H;MOQZ&X<,>AN'#'H;APQZ&X<,>AN'#'H;APQZ&X<,>AN'#'H?^($0'_
MBB$&_XLU%/^)1B7_C5$U_Y)80_^27E'^D&5>]HYL:^^+=7;HAWZ XX2&B-Y_
MC8_;>Y.4V'B9F=5UGIS3<J2?T7"JHM!NLJ/0;;JDSFS$I<9OQ*2_<,2ENG'$
MI;5QQ*6R<L2DLG+$I+)RQ*2R<L2DLG+$I+)RQ*2R<L2DLG+$I/^)$0'_BR$&
M_XPT%/^*1B7_D$\T_Y160_^46U'^DV%>]I%H:^Z.<';HBWN XH>#B=V#BI'9
M?I&7U7J7G--WG:#0=*2CSW&JILYOLZ?-;KVHQW#"J+YQP:FX<L&IM'/!J:]T
MPJBM=,*GK73"IZUTPJ>M=,*GK73"IZUTPJ>M=,*GK73"I_^*$0'_C"$&_XTT
M%/^+1B;_DTXT_Y930O^76%#^EEY>]I1D:NZ2;';GCW:!X8R BMR'B)+8@H^9
MTWV5G]!YG*/.=:.GS'*KJLMPM*O(<+^LOW.^K+=TOJVR=;ZLKG:_K*IVOZNH
M=\"JJ'? JJAWP*JH=\"JJ'? JJAWP*JH=\"JJ'? JO^+$0'_C2 &_XXT%/^-
M12;_EDTS_YE00?^:54__FEI=]YA@:>^5:'7HDG" X8][BMR+A)/6AHR:TH"3
MH<Y[FJ;,=Z*JRG2KKLARN*_ =+ROMW6\L+!VO+"K=[ROJ'B]KZ5YOJVC>;ZM
MHWF^K:-YOJVC>;ZMHWF^K:-YOJVC>;ZMHWF^K?^+$ '_CB &_X\T%/^/1"7_
MF$HS_YM-0/^=44[_G5=;^)Q<:/":8W3HEVI_XI-UBMR/@)/6BHF;T820H\U^
MF*G)>:*NQW6ML<1TNK.W=KFSKWBYLZIYNK.F>KJRHWN[L:![O+"??+VNGWR]
MKI]\O:Z??+VNGWR]KI]\O:Z??+VNGWR]KO^,$ '_CR &_Y T%/^20R7_FD@R
M_YU*/_^?3DW_H%-:^:!89O&?7W+JG&5]XYAOB-R3>I+6CX2;T(B-H\N!EJO'
M>Z&QQ7:PM;IWM[:O>;>VJ'JXMJ-\N+2@?+FSGGVZLIQ^N[&;?KRPFWZ\L)M^
MO+";?KRPFWZ\L)M^O+";?KRPFWZ\L/^-$ '_CR &_Y$T%/^40R3_FT8Q_Z!(
M/O^B2TO_I%!8^J159/.D6G#KHF%[Y)]IA=Z:<Y#7E7Z9T(Z(H\J%DZS$?:#_
MXO__24-#7U!23T9)3$4 !0FTO7BPN:]YM;FF>[:XH7VWMIU^N+6;?[FTF7^Z
MLYB NK*7@+NQEX"[L9> N[&7@+NQEX"[L9> N[&7@+NQEX"[L?^-$ '_D" &
M_Y$T%/^70B3_G4,P_Z)%/?^E2$G_J$Q5_*E18?6J5VSNJ5UWYZAC@>&D;8O6
MGGF6RY6#HL"+CJVV@YJVKGZJNZ1\L[R>?K6ZFH"WMYB!N+66@;FTE8*ZLY2"
MNK*3@KNQDX*[L9."N[&3@KNQDX*[L9."N[&3@KNQDX*[L?^.$ '_D2 &_Y(T
M%/^902/_GT$O_Z1"._^H14?_K$E3_JY.7O6P4VCLLEIRY+-A>]NO;H3,IG:4
MP)Q^HK22B*ZIBI2WH(6DO9F"L;Z5@[2[DX2VN)*$N+:1A+FTD(2YLY"$NK*0
MA+JRD(2ZLI"$NK*0A+JRD(2ZLI"$NK*0A+JRD(2ZLO^/#P'_DB &_Y,T%/^:
M/R+_H3\N_Z= .O^L0D7_L$90^;-+6O"W4F/HNUEKW[UD<M&V;(+$K'.3MJ-Z
MH:J9@ZZ>DI"WE(V?OHZ+L;^,B;.\C(FUN8R(M[:,B+BUC(>YM(R'NK.,A[JR
MC(>ZLHR'NK*,A[JRC(>ZLHR'NK*,A[JRC(>ZLO^/#P'_DA\&_Y0T%/^</2'_
MHSPM_ZH]./^O0$+_M$1,];I)5>R_45SDQEIAV,5B;\F\:8&[LG"2K:IWH*"A
M@*V3FXNWB9:;O8.5K[^$D;.\AHZUN8>-MK>'C+>VB(NXM8F*N;2)BKJRB8JZ
MLHF*NK*)BKJRB8JZLHF*NK*)BKJRB8JZLO^0#P'_DQ\&_Y4T%?^>.R#_I3DK
M_ZPZ-?^S/3_[ND)'\<%(3NC)45+?T5M9S\I@;<'"9X"RN6V0I+%TGY>J?:N*
MI(BU?Z"7NWB?K+Y\FK.\?Y6TNH&2MKB#D+>WA(^XM82-N;.%C;JRA8VZLH6-
MNK*%C;JRA8VZLH6-NK*%C;JRA8VZLO^1#@'_E!\&_Y8S%?^@.!__J#8I_[ X
M,O^X.COVP#]![,I'1>/65$76V5=8Q]!>:[C(9'ZJP6N.G+IRG(ZT>JB KH6R
M=JN4N&^KJ;IRI;6Z=YVUN7J9MK=]EK>V?I.YM'^1NK* D+NQ@)"[L8"0N[&
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M:TCOL&Q'[K=L1^ZW;$?NMVQ'[K=L1^ZW;$?NMVQ'[K=L1^ZW;-VO  #%O 0
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M?%'.X']2QMZ!4\3>@5/$WH%3Q-Z!4\3>@5/$WH%3Q-Z!4\3>@?^2# #_H T
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M_YE '?^<1B?_G4PQ_)U2._2<647MF6!/YI1H6=^.<V/5AGUNS7^'>,9XD8#
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M@[*9@X3+F(2#SI:$@]"4A(+2DH2!TY"$@=2.A(#6C(2 UHR$@-:,A(#6C(2
MUHR$@-:,A(#6C/]W$@'_=!L#_X(>!/^4)PC_H#(-_Z<T$_JN.!COM3T<YKQ&
M(=R_3"S.N50_P[%=4+>J95^MI&QLHYUT=YF8?(&1DX:*B8^2D8*,GY9]BJ^8
M>HO'F'R)SI9]B-"4?H;2DG^%TY!_A-2.@(/6C("#UHR @]:,@(/6C("#UHR
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M_YH1 /^M% #:O@H T<T* ,OD$ '!Y"4'M^,U$ZWA0"&CWDDOE]M2/HO764N
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M8TG2\F-)TO)C2=+R8TG2\F-)TO)C2=+R8_Z5  #4J0  PK4# +7! P"JSP4
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M4_]=&P+_628#_U,Q!O]4.0C_74(0_V)+&O]B52/_8%\L_U]K-/]<=SO_68)
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M2R30IE0UQI]>1+R99E*TDF]=K(QW9Z2'@&^>@HIWF'Z4?9)[H(&->JV$BGG
MA8AZW(2'>MV"AGK?@(9ZX'Z%>N)\A7GC>H5YY'F%>>1YA7GD>85YY'F%>>1Y
MA7GD>?]J%0'_:QL"_WL7 O^*' +_F"8%_Z(P"/6H,PSKKCD0XK-!%-:Q1R/*
MJU(TP*1<0[:>9%&MF&Q<I9)T9IV-?6^6B(9VCX61?8J"G(*%@*J%@7^\AH"
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M<%FCZW!9H^MP6:/K<%FCZW!9H^MP6:/K</]W#P'_C0@ WJ " ,^N!0#$N04
MN\4& +73"@"NX18!IN$I!IW@-Q&3WD(=B=Q,*7_:5#5UUUP_;=5D2&73;$]?
MTG946=*!6531CEU0T9U@3=*P8DO3R6)*TNUB2\CR9DV_\6A/N/!I4;+P:5*O
M[VE2K^]I4J_O:5*O[VE2K^]I4J_O:?]_"@#ME@  TJ8! ,2R P"YO , L,D&
M *G8"@"AYQD"F><J"9#G-Q2'YD(??>5**73D43-KXUDZ9.)A05[B:T=8XG5+
M4^& 3T_BC5-+XIM52>.L5T?DQ%=&X^E71MWV64?0]UQ)R/=>2L'V8$N]]F!+
MO?9@2[WV8$N]]F!+O?9@2[WV8/^)  #9G@  QZP! +FV @"NP0, I<X& )SD
M# "5[QT#C>\L"X7O.15\[T$><^]))VKN4"]B[E<U7.Y?.E;N:#]2[G%"3>]\
M1DGOB4E&\)9+0_"F34#QN4X_\MM//O#W3D+F^T]#W?M11-3\4T7/_%1%S_Q4
M1<_\5$7/_%1%S_Q41<_\5.&5  #+I@  N[   *Z[ 0"BR ( F-4% )#X#P&)
M^" $@O@N"WGY-Q-P^3\;:/E&(F#Z32A:^E0M5/I<,4_[935+^VTX1_QW.T/\
M@ST__9 _//V?03K^KT,X_\9$-__J13;\_44[\O]$/NK_1#[F_T8^YO]&/N;_
M1C[F_T8^YO]&/N;_1M"?  "]K   KK4  *+"  "5SP  BMT# (3_$@%[_QX#
M=/\J"6S_,P]D_SL67?]#&U?_2B!1_U$D3/]8)TC_8"I$_V@L0/]Q+CS_>S$Y
M_X@R-?^6-#/_I#8Q_[8W+__0."[_[SDM__\Y,?__.3/\_SDS_/\Y,_S_.3/\
M_SDS_/\Y,_S_.<&H  "OL0  HKT  )3*  "'V   ??,' ';_$@%M_QH#9?\D
M!5[_+0I8_S8/4O\]$TS_119(_TP90_]3&S__6AX\_V$@./]I(37_<B,Q_WTE
M+O^*)BO_F2@I_Z<I)_^Y*R;_TBPE_^\L)/__+23__RTD__\M)/__+23__RTD
M__\M)/__+;&N  "CN0  E,8  (;3  !YX0  <?\( &?_#P%?_Q4"5_\> U'_
M)@5+_RX'1O\V"D'_/0P]_T0..?]+$#;_41(R_U@3+_]?%2S_9Q8I_W$7)O]\
M&"/_B1H@_Y@;'_^F'!W_MQT<_\H>'/_F'QO_\!\;__ ?&__P'QO_\!\;__ ?
M&__P'Z2U  "5P@  AL\  '?>  !K]   8O\# %G_"P%1_Q$!2O\7 D3_'P,_
M_R8$.O\M!3;_- 8R_SH'+O] ""O_1@@H_TP))?]2"2+_60H@_V(+'?]K#!K_
M=@T7_X0.%?^2#Q3_H! 3_ZT1$_^Z$1/_PQ(3_\,2$__#$A/_PQ(3_\,2$__#
M$I>^  "&S   =]L  &GG  !<_0  5/\  $O_!0!#_PP!/?\1 C?_%P(R_QX#
M+O\D RK_*@0E_R\$(O\U!1__.@4=_S\%&O]%!AC_2P86_U(&%/]:!Q+_8@<0
M_VP'#_]W" W_A @,_Y (#/^<" S_H@@,_Z((#/^B" S_H@@,_Z((#/^B"/]0
M( +_2RH#_T0V!?]'.@;_2C\(_TY)#_]/5!?_3V >_TUL)/]*>2K_2(4N_T:0
M,O]$FC3_0Z(W_T*J./]!L3K_0+D[_T#!//\_RSW_/MP^_S[H/O\]\S[_/?L_
M_S[_/O] _S[Z0_\]]$3_/NY&_S_N1O\_[D;_/^Y&_S_N1O\_[D;_/_]0( +_
M2RH#_T4U!?]*. ;_33T(_U%(#_]24A?_45X>_T]J)?]-=RO_2H,O_TB.,_]&
MF#;_1*$X_T.I.O]"L#S_0K@]_T'!/O] RS__0-Q _S_I0/\_]$#_/OU!_T#_
M0/U"_T#V1?] \$;_0>E(_T'I2/]!Z4C_0>E(_T'I2/]!Z4C_0?]1'P+_3"D#
M_T<T!?]--@;_43L(_U5&$/]64!C_55P?_U)H)O]0="S_38 Q_TJ,-?](ESC_
M1J [_T6H//]$L#[_0[@__T/!0?]"S$'_0=Y"_T'K0_] ]4/_0/U#_T/_0_A&
M_T+P2/]#ZDG_1.-*_T7C2O]%XTK_1>-*_T7C2O]%XTK_1?]2'P+_32D#_THR
M!/]0,P;_53D(_UE#$/]:31C_65@@_U9D)_]3<2W_4'TS_TV)-_]+E#K_29X]
M_T>F/_]&KD'_1;="_T3!1/]$S$7_0]]%_T+M1O]"]T;_0_U&^4;_1O!)_T;I
M2_]'XDS_2-M-_TC;3?](VTW_2-M-_TC;3?](VTW_2/]3'@+_3B@#_TXO!/]4
M, ;_6C8(_UY $/]@2AC_7E4@_UM@*/]8;2__5'DT_U&%.?].D3W_3)M _TJD
M0O])K43_2+9&_T?!1_]&S4C_1>%)_T3O2O]%^$K[1_U*\4K_2>A-_TO?3O],
MUT__3,]1_TS/4?],SU'_3,]1_TS/4?],SU'_3/]4'0+_4"<#_U(L!/]9+07_
M7S((_V0\$/]F1QC_9%(@_V%<*/]=:##_6G4V_U:!._]2C3__3YA#_TVB1?],
MJTC_2K5)_TF_2_](S$S_2.%-_TCN3?Q(^4[R2_Q-YT[]3]U0_5#24OY0S%/_
M4<94_U'&5/]1QE3_4<94_U'&5/]1QE3_4?]5'0+_42<#_U8I!/]>*@7_9"\(
M_VHZ#_]L11?_;$\@_VA9*/]D8S#_8' W_UQ\/?]8B$+_59-&_U.=2?]1IDO_
M3[!-_TZZ3_U-QE#Z3=E1]DSJ4?)-]U'G4/I2VU+[5,Y4_%7'5OU5P5?^5;Q8
M_E6\6/Y5O%C^5;Q8_E6\6/Y5O%C^5?]7' +_4B8#_UHF!/]B)@3_:BP'_W$W
M#O]S0A;_<TP?_W!6*/]K8##_9FLX_V-W/OY?@T3[6XY(^5B83/=6H4_U5:M1
M\U.U4_%2P53O4=!5ZU'G5>92]E;:5/E8S%;Z6<-8^UJ\6OM:MUO[6;-<^UFS
M7/M9LUS[6;-<^UFS7/M9LUS[6?]8&P+_4R4#_UXC _]G(P3_<"H&_W<U#?]Z
M0!7_>DH=_WA3)O]S7"_\;F8W^&ER/_1E?D7Q88E*[EZ33NM<G5+H6:95YEBP
M5^17O%CB5LQ9WE;D6=A6]%O*6/==P%KX7KA<^%ZS7?A>KE[X7:M?^5RK7_E<
MJU_Y7*M?^5RK7_E<JU_Y7/]9&P+_5B,#_V(@ _]L( /_=2@%_WTS"_^ /1/_
M@4<;_W]0)/E[62WT=F(V[G%M/NIL>47F:(1+XF2.4=YAF%7;7J)9UERL6]-;
MN%[06L9?S5K?8,A:\F&^7/5BM5[T8JY@]6*J8?5AIF+V8:-C]U^C8_=?HV/W
M7Z-C]U^C8_=?HV/W7_]:&@+_62$"_V8= O]P'@/_>B8$_X(Q"?^&.Q#_B$09
M^89-(?*#5BOK?EXTY7EI/>!T=$7:;W],TVJ)4\]FDEC+8YQ=QV&F8,1?L6/!
M7K]DOE[29;I?[&:R8/)FJV+R9J5D\F6A9?-DGV7T8YQF]6*<9O5BG&;U8IQF
M]6*<9O5BG&;U8O];&@+_7!\"_VD; O]U' +_?B0#_X<N"/^,. [[CD(6\HY*
M'NN+4B?DAULPW8%F.M-Z<$7-=7I.R'"#5<-LC5N^:99@NF:@9+=DJV>T8[AI
ML6+*:JYCYFJH9.]JHF;O:9UG\&B::/%GF&GR9I9I\V26:?-DEFGS9)9I\V26
M:?-DEFGS9/];&0+_7QP"_VP8 O]Y&P+_@R$#_XPL!O^1-@OUE#\2[)5'&>23
M3R+<CE@MTH=B.LJ!;$7#>W5.OG9_5KARB%VT;I%BKVN;9JMIIFJH9[-LI6?#
M;J)GX&Z>:>UMF6KN;)9K[VJ3;/!IDFSQ9Y!L\F:0;/)FD&SR9I!L\F:0;/)F
MD&SR9O]<&0'_8AH"_W 6 O]\&0+_AA\"_Y I!/J6,PGPFCP.YYM$%=^:2QW3
ME%4LRHU?.<*':46[@7%/M7Q[5Z]XA%ZJ=(UCI7&7:*%NHFR=;*YOFFR^<)AL
MV7&5;>MOD6[L;H]O[6R-;^]JC&_P:8MO\6>+;_%GBV_Q9XMO\6>+;_%GBV_Q
M9_]=&0'_9!D"_W(4 ?]_& '_BAT!_Y0F _:;, ;KGS@*XJ(_$-B?1QS-F5(K
MQ))=.;N,9D2TAVY.K8)W5Z=]@%ZB>8EDG7:3:9ASGFV4<:IQD'&Z<HYQT7.,
M<NIQBG/K;XAS[6V'<^YKAW/O:H9R\&B&<O!HAG+P:(9R\&B&<O!HAG+P:/]>
M& '_9Q<!_W43 ?^#%@'_CAH!_I@C O&?+ 3GI3,'W:@Y#-&C11O'G5 JOI=:
M.+628T2MC&Q.IH=T5Z"#?%Z:?X9DE7R/:I!YFFZ+=Z9RB':V=(5VS'2$=^ER
M@W?J<()W[&Z"=NUL@G;O:H%V\&F!=O!I@7;P:8%V\&F!=O!I@7;P:?]>& '_
M:14!_W@2 ?^&% '_D1@!^IP? >VD)P+BJBP$UJPT"\NG0QK!HDXIN)Q8-J^7
M84.GD6E-H(UQ5IF(>5Z3A8)DC8&,:HA_EV^#?:1R?WRS='U\R'5\?>AS?'SJ
M<7Q[[&]]>NUM?7GN:WUY\&E]>?!I?7GP:7UY\&E]>?!I?7GP:?]?& '_:Q,!
M_WL1 ?^)$P#_E14 ]: : >BI( '=L"0!T+ R"L:L01B\IDPGLZ%6-:J<7T&B
MEV=,FI)O59..=UV,BX!DAHB*:8&%E6Y\@Z%R=X*P='6"Q75T@^=S=8'J<79_
MZV]W?NUM>'WN:WA\\&EX?/!I>'SP:7A\\&EX?/!I>'SP:?]@%P'_;A(!_WX0
M /^,$0#_F1$ \:03 ..N%@#6MAP!R[0P",&P/Q>WJTLEK:94,Z2A74"<G65*
ME)AL4XR5=%N&D7UB?XZ':'F,DFUTBIYQ<(BM=&V(P71MB>1S;X?J<7"$[&]R
M@^UM<X'N:W2 \&ET@/!I=(#P:72 \&ET@/!I=(#P:?]A%P'_<1 !_X(. /^0
M#@#UG0T XZD, -FU# #/N1H Q;@N![NT/16QL$DCIZM2,9ZG6SZ6HV-(CI]J
M48:;<EE_F'I@>)6$9G*3CVQMD9QO:9"J<F:0OG-ED>%R:([K<&J*[&YLB.UL
M;8;O:VZ$\&ENA/!I;H3P:6Z$\&ENA/!I;H3P:?]C%0'_=0X!_X8- /B4"P#<
MH@@ U*T) ,^X"@#)O1< O[PK!K6Y.Q.KMD<AH;%0+YBM63N/JF%&AZ9H3W^C
M<%=XH'A><IZ!9&N;C&EFFIEM8IFH;U^9O'!>F=]O8);L;F.1[6UFCNYK9XOO
M:FF)\&AIB?!H:8GP:&F)\&AIB?!H:8GP:/]G$@'_>0P _XH* -^:! #3I@<
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M6DZM^EI.K?I:3JWZ6O]_  #<DP  RJ(  +RL 0"QM0  J, # )_+!@"6V0L
MD> ; 8K?+ :"WSD.>=Y#%W'=32!JW%8H8]M?+UW:9S58V7$Z4]E[/D_9B$)+
MV99%2-FF1T;:NDA%V]M'1-CT24+3_TU$R?]/1<+_4$>[_U)'N_]21[O_4D>[
M_U)'N_]21[O_4N:*  #/FP  OZ<  +*P  "GNP  G,8# )/1!@"+Z@X A>@?
M G[H+09VZ#@.;NA!%F;G2AU?YU(C6>=;*57G9"U0YVTQ3.=X-4GGA#A&Z)$Z
M0^B@/$#ILCX_ZLL^/NCO/CWF_S\]X/]"/]?_1$#._T9 SO]&0,[_1D#._T9
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M" __G @._ZP)#O^["0W_TPD-_],)#?_3"0W_TPD-_],)#?_3"9&\  "!R0
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M7Q0!_VP1 ?]X$P'_@1<!_X@= ?*/)0+GDR\$WI4X"=.0117*BU$BPH5;+KN
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M /]^$ #_B!$ ]9$4 .B8&0#=GB !T9XQ!\>:0!.^E4P@MI!6+*Z+8#>GAFA
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M7'1Y^EMU>?M:=7G[6G5Y^UIU>?M:=7G[6O]=$P'_; T _WL+ /:("0#<DP8
MU9T) -&E"@#*JA4 P:DJ!+>F.@^NHD8;IIY0*)Z:63.6EF$\CY-I1(F/<4R#
MC7E2?8J#5WB(C5QSAIE@;X2F8VR$MV1JA,]D:H3P8FR"]F!M@/=>;W_Y7&]]
M^EMP?/M:<'S[6G!\^UIP?/M:<'S[6O]?$0'_;PH _WX( .., P#6EP4 SZ '
M ,JH" #$KA, NZTG [*K-PVIIT09H*1.)IB@5S&1G%\ZBIEG0X.6;TI]DW=0
M=Y& 5G*/BEIMC99>:(NC866+M&-CB\QC8XON866)]U]GAOA>:83Y7&J"^EIK
M@?M::X'[6FN!^UIK@?M::X'[6O]B$ #_<@< ^((# -N/ @#/F@4 R:,& ,.L
M!@"]LA  M;(D JRP-0NCK4(7FZI,(Y*F52Z*HUTX@Z!E0'V=;$=VFW1-<)E]
M4VN6B%AFE91<8I2A7U^3LF!=D\E@79/M7UZ0^%YAC/E<8XKZ6V2'^UIEAOM9
M98;[666&^UEEAOM998;[6?]F#0#_=P, XX<  -.3 0#*G@0 PJ<$ +NO! "U
MM@T KK<A J6V,@F=LS\5E+!*((RM4RN$JELT?:AC/':E:D-PHW)*:J%[3V6@
MAE1@GI%86YV?6UB=L%U6G<==5IWK7%>:^EM:E?I:7)'[65Z._%A?C?Q77XW\
M5U^-_%=?C?Q77XW\5_]J"@#_?   W(P  ,V8  ##HP, NJH" +.S 0"LO H
MIKT= 9Z\+P:6NCP1C;A''(6U4"=]LUDP=K%@.&^O:#]IK7!%8ZMY2EZJA$]:
MJ9!25:B>55*GKU=1J,974*?J5U"E_%=3G_U759K]5E>6_E98E?Y56)7^55B5
M_E58E?Y56)7^5?]O! #F@@  TI$  ,:=  "[I@$ LJX  *JW 0"BP@4 G,08
M )7#*@2-PCD-A<!$&'V^3B%UO%8J;KI>,FBY9CABMVX^7;9X0UBU@D=4M(]+
M4+2=3DVSKE!+M,502[/J4$JQ_U%,J_]23J7_4E"A_U)1GO]149[_45&>_U%1
MGO]149[_4?]V  #=B0  RI<  +ZB  "SJ@  J;,  *"\ @"8Q@8 D<P2 (O,
M)0*$RS0)?,E $G7(2AMMQU,C9\5<*F'$9#!<PVTV5\)V.E/"@3]/P8Y"2\&=
M14C!KD9'P<5&1\'J1D2^_TE%N?]*1[/_2TFM_TQ*J_],2JO_3$JK_TQ*J_],
M2JO_3.E_  #1D   PIX  +6G  "JKP  H+@  );! @",RP< A-4- (#5'@%Y
MU2X%<M0\#&S31Q1ETE ;7]%9(5K18B=5T&LL4=!U,$W/@31)SXXW1L^=.430
MKCM"T,8[0]#J.D#-_3X^R_] 0,/_0D&]_T-"N?]$0KG_1$*Y_T1"N?]$0KG_
M1-V(  #'F   N*,  *NK  "@M   E;X  (O( P" T0< >.$- '3A'0%NX2L#
M:. W"&'@0@Y<X$T45^!6&5/@7QU/X&DB2^!S)4?@?BA$X(LK0N":+3_AJR\^
MXL$O/N+E+SS?^C$YWO\T.=G_-CK0_S@[S/\Y.\S_.3O,_SD[S/\Y.\S_.<V2
M  "\H   K:@  *&Q  "5NP  B<4  '[/ @!TV@8 ;NL1 &CK'@%BZRH#7>PU
M!E?L/PM2[$@/3>Q1$TKM6A9&[6,90^UM'$#M>!X][H4A.NZ3(SCOHR0V\+8F
M-?'2)C3O\R8T[/\F,NO_*#+G_RLSY/\L,^3_+#/D_RPSY/\L,^3_+,&<  "P
MI@  HZX  ):X  ")PP  ?<T  ''8  !GY@8 8O81 %SW'0%7]R<"4O<Q!$WX
M.@9(^4()1/E+"T'Z5 X^^EP0._ME$CC[;Q0U^WL6,OR)&##]F!DN_:H;+/Z_
M'"O_XQTJ_/H=*OK_'2KW_QPJ]_\=*O?_'2KW_QTJ]_\=*O?_';.C  "DJP
ME[8  (G!  ![RP  ;]8  &/?  !;]08 5?\0 %#_&0%+_R,"1O\L T+_- 0^
M_SP%.O]#!C?_2P<T_U,(,?];"2[_9 HK_V\,*/]\#2;_BPXD_YP0(O^N$2'_
MQ1(@_^D3'__\$Q[__Q,>__\3'O__$Q[__Q,>__\3'O__$Z:I  "8LP  BK\
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M2 ?_.U4+_SEB#_\W;Q/_-7T7_S.*&?\RE1O_,9X=_S"G'O\PKQ__,+<@_R_
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M38!K_TR :_]*@&O_2H!K_TJ :_]*@&O_2O]4$@'_80P _VX* /UX"0#H@@@
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M3&QY_TQL>?],;'G_3/]># #_; $ YGH  -:&  #+CP( Q)<$ +Z=! "XH@X
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M+S_']3 ]Q/\S.\/_-3R^_S8]N/\W/;C_-SVX_S<]N/\W/;C_-]&&  # E0
MLI\  *6G  ":KP  CK<  (._  !XQP, ;L\' &77#0!CV!T 8-@M EO8.@17
MV$8)4]A0#4_861%+UV(51]=L&$37=QM!UX0>/MB3(#S8HR$[V;<B.MK5(CK6
M\B,WU/\G-M+_*331_RLVRO\M-LK_+3;*_RTVRO\M-LK_+<60  "VG0  J*4
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M"1K__PD9__\)&?__"1G__PD9__\)&?__":*G  "3L0  A;L  ';&  !IT
M6]H  $[@  !#Y0  /OL! #K_#  V_Q, ,O\; "__(P K_RH!*/\Q 23_-P$A
M_S\"'_]& AS_3@(9_U@#%O]C Q/_< ,2_X$$$?^3!!#_IP0/_[T%#O_@!0[_
M]@4.__\%#O__!0[__P4.__\%#O__!96O  "&N@  =\4  &C0  !:VP  3.$
M $#G   W\P  ,O\  "[_!P J_PX )O\3 "/_&@ ?_R  &_\F !C_*P$5_S(!
M$O\X 1#_0 $._T@!#/]2 0G_70(&_VL"!/]] @+_D (!_Z," /^V @#_S0,
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M/)%;_SN/6_\ZCUO_.H];_SJ/6_\ZCUO_.O],$@#_5@T _V ) /]H"@#Z;PP
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M8_\]@F/_/()C_SR"8_\\@F/_//]0#P#_6P< _V8# .QO @#<=@, U'P' -&
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M/G=J_SYW:O\^=VK_/O]4# #_7P  \FP  -UV  #0?0( R8,$ ,2'!@"_BA
MMXPC ;"*- 6IB$$.HH5,%YR!51^6?UXFD7QF+8QY;C*(=W8WA'5_.X!TB#]\
M<I)#>'&>1G5PK$AS;[U)<7#927%P]$=Q<?]$<G#_0G)O_T%R;O\_<F[_/G)N
M_SYR;O\^<F[_/O]6"@#_8@  YF\  -=Y  #,@0$ Q8<# +^+! "YC@X LI @
M :N/,06DC#\-G8I*%I:'4QZ1A%PEBX%D+(9_:S&"?7,V?GM\.WIYAC]V=Y!"
M<G:<16]UJ4AL=;I):W7426MU\D=K=?]%;'7_0VUS_T%M<O\_;7+_/VUR_S]M
M<O\_;7+_/_]9!P#_90  XG(  -%\  #'A   P(H" +F/ @"SD@P K)0= *:3
M+P2>D3P+F(](%)&,41R+B5HDAH=B*H&%:3!\@G$U>(%Z.G1_@SYP?8Y";'R:
M16E[IT=F>KA(9'O02&1[\$=E>_]$9GK_0V=X_T%H=O\_:';_/VAV_S]H=O\_
M:';_/_];! #W:0  W78  ,V   ##B   NXX  +23 0"MEPD IY@: *"8+ .9
MECH*DI1%$HR23QJ&CU<B@(U?*'N+9RYVB6\S<H=W.&V%@3QIA(M 9H*70V*!
MI49@@;9'7H'-1UZ![T9?@?]$8'__0F%]_T%B>_\_8WK_/V-Z_S]C>O\_8WK_
M/_]>  #I;0  UGD  ,B$  "^C   MI,  *Z7  "FFP0 H)T7 )J=*0*3G#<(
MC)I#$(:831B EE4?>I1=)G6292QPD&PQ;(YU-F>-?CICBXD^7XJ505R)HT1:
MB;1%6(G+15B([418B/]#68;_05N#_T!=@?\^78#_/EV _SY=@/\^78#_/O]B
M  #D<0  SWX  ,.(  "YD0  L)<  *>;  ">H0  F*,3 ).C)0&-HC0&AJ%
M#8"?2A5YG5,<=)M:(V^98BAJF&HN9I9R,F&5?#==E(8Z69*3/E:2H4!3D;)!
M4I+)0E*1ZT%2D/] 4H__/U6+_SY6B/\]5X?_/5>'_SU7A_\]5X?_/?EG  #=
M=@  R8,  +V-  "SE0  J9L  *"@  "6IP  CZD/ (NJ(0&%J3 $?Z@\"GBG
M1Q)SI5 8;:-8'FBB8"1DH6<I7Z!P+EN>>3)7G80V4YR1.5"<GSM.F[ ]3)S'
M/4R;ZCQ,F?\\3)C_/$V5_SQ/D?\[4(__.U"/_SM0C_\[4(__.^MM  #3?
MPXD  +>3  "LF@  HI\  )FE  ".JP  A; + (&Q&P!\L2L"=[ X!W&O0PUK
MKDT49JU5&6&L71Y=JV4C6:IN)U6I=RM1J((O3:>/,DJGGC5(IZ\V1Z?&-D:F
MZ39%I/XW1:/_-T:@_S=(G/\W29K_-TF:_S=)FO\W29K_-^)T  #*@P  O(\
M +"8  "EG@  FZ0  )"K  "%L0  >K@$ ':Y% !RN24!;;DS!&BX/PACN$D.
M7K=2$UJV6AA6MF(<4K5K($ZT=21+M( G2+..*D6SG2Q"LZXM0;/%+D&SZ2U
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M'3'*_Q\PR?\A+\C_(2_(_R$OR/\A+\C_(;Z/  "OF@  HJ$  ):I  "*L
M?;@  '&_  !FQ@  6\P" %#2!P!'V@P 1MP8 $7<)P!$W34!0=U  C_>2P,]
MWE4$.M]?!CC?:0<UWW8),^"$"S'@E POX:8-+N&\#BWBX XMWO@/*]W_$BK<
M_Q0IVO\6*-K_%BC:_Q8HVO\6*-K_%K.8  "EH   F:<  (NP  !^N   <<
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M @?__P('__\"!___ I&M  ""N   <\(  &3,  !6U0  2-T  #OB   PYP
M)^X  "/_   @_P0 '/\, !G_$0 6_Q8 $_\; !'_(0 ._R< #?\N  K_-@ '
M_SX !/](  #_5   _V(! /]S 0#_AP$ _YT! /^R 0#_R@$ _^H! /_S 0#_
M\P$ __,! /_S 82W  !TP0  9<P  %;8  !'WP  .>4  "WJ   C[@  '/T
M !C_   5_P  $?\$  __"P -_PX "?\1  ;_%0 #_QH  /\@  #_)@  _RX
M /\W  #_00  _TT  /]<  #_;0  _X(  /^6  #_J   _[H  /_#  #_PP
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M)ZY&_R>J1_\FITC_)J=(_R:G2/\FITC_)O] % #_2 X _TX+ /]5#@#_61$
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M+X5;_R^%6_\OA5O_+_]+# #_5   ^UX  .)E  #8:P$ SVX% ,QP" #&<A(
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M.UM\XSI;?/HX7'O_-UU[_S5>>?\T7W?_,U]W_S-?=_\S7W?_,_Y<  #A:@
MS74  ,!^  "VA@  KHL  *6.  ";D0  E9,1 )"4(@&+DS$#A9(]"7^12 ]Z
MCU$6=8U9&W&,8"!LBF@E:(EP*62'>2UAAH,Q786/-%J$G#97@ZPX58._.56#
MX3A5@ODW5H+_-5:!_S18?_\S67W_,EE]_S)9??\R67W_,N]@  #;;@  QWH
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M*T*<_RQ"F_\L1)?_*T27_RM$E_\K1)?_*]=R  ##@   MHP  *J4  "?F0
ME)X  (FC  !^J   <*X  &JP#@!HL1T 9;$L 6&Q. -=L$,&6;!,"E6O5 Y2
MKUT13JYE%4NN;QA(K7D;1:V&'D*LE2 _K*4B/JVY(SVMV"(]J_4C/*G_)3NG
M_R8[IO\F.Z3_)CND_R8[I/\F.Z3_)LQZ  "[B   KI(  **9  "7G@  C*0
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M#2/0_PTCT/\-(]#_#:Z6  "@G0  E*0  (:L  !YM   ;+L  &#"  !4Q@
M2,L  #[0   UU00 +=T* "SA$P KXA\ *>,J "CD-0 GY#\ )N5* "3F50 C
MYF$!(>=N 2#G?@(>Z) "'>FD AOIO (:ZN("&N;\ AGE_P,9Y/\$&./_!1CC
M_P48X_\%&./_!:.=  "6I   B*P  'JU  !LO0  7\0  %/*  !'S@  /-,
M #+:   JWP  )>X) "/P$0 A\1D '_$B !WR*P ;\S0 &?0^ !?T2  5]5(
M$_9? !+V;@$1]X !$/B4 0_YJ@$.^<8!#OGM 0WV_P$-]/\!#?/_ 0WS_P$-
M\_\!#?/_ 9FC  "+K   ?+4  &V^  !?Q@  4LT  $72   YV   +]X  ";B
M   ?Z@  '/L& !G_#@ 7_Q, %/\: !+_(0 0_R@ #O\P  W_.0 +_T, "?].
M  ;_7  $_VP  O^   '_E@  _ZT  /_*  #_\   __\  /__  #__P  __\
M /__ (VK  !]M0  ;K\  &#(  !2T   0]<  #?=   KX@  (N8  !GJ   5
M^0  $O\  !#_"  ._PX #/\1  G_%@ &_QP  _\B  #_*@  _S,  /\]  #_
M20  _U<  /]I  #_?@  _Y4  /^L  #_QP  _^@  /_Z  #_^@  __H  /_Z
M ("U  !POP  8<D  %+3  !#VP  ->$  "GF   >Z@  %>X  !#X   ._P
M"_\   C_   $_P8  /\*  #_#@  _Q$  /\5  #_&P  _R,  /\K  #_-@
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M#](L_Q#1+/\0SRS_$,XM_Q#.+?\0SBW_$/\R&0#_-Q0 _SH1 /\\$@#_/QD
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M'II'_QZ:1_\>FD?_'O] #0#_1@0 _TP  /A2 @#H500 X54( .)5#0#551D
MS%<L ,57/ *_5DH&NE55"K937PZR4F@2KU!Q%:Q/>1BJ3H$:J$V*':5,DA^C
M3)P@H4NF(I]+L2.=2\ DFTO8)9E+\"663/\DE4S_))1,_R.33/\BD4W_(9%-
M_R&13?\AD4W_(?]""@#_20  _U$  .97  #=6P$ U5P% -);"0#+7!0 PUXH
M +Q>. *V748&L5M1"JU96P^I6&03IE9L%Z-5=!J@5'T=GE.%'YM2CB*949<D
MEU"A)I50K2>24+PHD5#0*(Y0["B-4?XGBU'_)HM1_R6*4O\DB5+_(XA2_R.(
M4O\CB%+_(_]%!P#_2P  \%4  -];  #38   S&$# ,AA!@##81$ NV0D +5D
M- *O8T(%JF%."J5?5P^A76 4GEQH&)M;<!N867@>E5B!(9-7BB205I,FCE6>
M*(M5J2J)5+<KAU3+*X55Z2N$5?PJ@U;_*(-6_R>"5O\E@5;_)(%6_R2!5O\D
M@5;_)/]' P#_3P  YU@  -E@  #-9   QF8! ,%F! "[9@X M&D@ *YI,0*H
M:#\%HV9*"I]E5 ^:8UT4EV%E&)-@;1R07G4?CEU](HM<AB6(6Y HA5J:*H-9
MIBR 6;0M?UG'+GU9YBU\6OHL>UK_*GM;_RA[6_\G>UK_)GI:_R5Z6O\E>EK_
M)?])  #[4@  XUP  -)C  #':   P&L  +IK @"U:PT KFT= *AN+@&C;3P%
MG6M("IEJ40^4:%H4D&9B&(UE:AR*8W(@AV)Z(X1A@R:!8(PI?E^7*WM>HRUY
M7K$O=UW$+W5>XB]U7ODM=5__*W5?_REU7_\H=5[_)G5>_R9U7O\F=5[_)O]+
M  #P50  WE\  ,UG  ##;   NV\  +5P  "O;PH J'$: *-R*P&=<CD$F'!%
M"9-N3PZ/;5@4BVM@&(=I9QR$:&\@@6=W(WUF@"9Z9(HI=V.4+'5CH2YR8J\O
M<&+!,&]BWS!N8_<N;V/_+&]C_RIO8_\H;V+_)V]B_R=O8O\G;V+_)_]-  #K
M6   V6,  ,EJ  "_<   MW,  +!T  "I= < HW87 )YW* &8=C<$DW5""(YS
M3 Z)<543A7!=&(%N91Q^;6P?>VQT(WAJ?29T:8<I<6B2+&YGGBYL9ZPP:F>^
M,6EGW#!I9_4N:6?_+&EG_RIJ9_\I:F;_*&IF_R=J9O\G:F;_)_]0  #G6P
MTV8  ,5N  "[<P  LW<  *MY  "D> , G7H4 )A[)0&3>S0#CGI !XEX2@V$
M=E,2@'5;%WQS8AMX<FH?=7%R(G)O>R9O;H4I;&V0+&ELG"YF;*HP9&R\,6-L
MV3!C;/0O8VS_+61L_RMD:_\I96K_*&5J_RAE:O\H96K_*/U3  #C7P  SFD
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M*U)\_RE3>_\H5'K_)U1Z_R=4>O\G5'K_)^A>  #0:P  P'8  +1^  "KA0
MH8D  )>+  ")C0  @X\( 'Z0%P![D2<!=I$T W*0/P9MCTD+:8Y1#V6-61-B
MC& 77HMH&UN*<1Y7B7LA5(B&)%&'E"=/AJ(I38:T*DN&S"I+A>XI3(3_*4R#
M_RA,@_\G38'_)DZ!_R9.@?\F3H'_)N%C  #)<   NWL  +"$  "FB@  FXX
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M'#>?_QPWG_\<-Y__',1X  "UA0  J8\  )V5  "2F@  AI\  'JC  !NJ
M8JP  %6P  !0L@X 3K(; $VS* !+LS4 2;,_ 4:S20)$LU($0;-;!C^S9 @\
MLV\*.K-[##>SB@XULIH/,[.M$#*SQ1 RLND0,;#^$C"N_Q0OK?\5+ZS_%B^L
M_Q8OK/\6+ZS_%KN!  "NC@  H94  )::  ")H   ?:8  '&K  !EKP  6;0
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M IZ:  "2H0  A*D  ':Q  !HN   6[\  $[$  !"R   -\P  "W0   DU0
M'-L  !7?!0 4Z0X $NH4 !'K'0 0ZR8 #NPP  [M.@ -[D8 "^Y3  KO8@ )
M\'0 "/&)  ?RH  %\KH !/'D  +Q_0 "[_\  ^W_  /M_P #[?\  ^W_ )6A
M  "&J0  >+(  &FZ  !;P@  3<@  $#,   TT0  *M8  "';   9X   $N0
M  _P 0 -^0H "_H/  G[%0 '^QP !/PD  '\+   _#<  /Q"  #\4   _&$
M /UU  #\C   _*0  /S!  #\ZP  _/\  /W_  #]_P  _?\  /W_ (FI  !Y
ML@  :KL  %S$  !.S   /]$  #+7   GW0  '>$  !7E   .Z   "O$   C]
M   %_P,  ?\)  #_#@  _Q(  /\7  #_'P  _R<  /\Q  #_/@  _TT  /]?
M  #_=0  _XT  /^F  #_P@  _^<  /_\  #__P  __\  /__ 'RS  !LO
M7<8  $[/   _U@  ,=T  "7B   :Y@  $>H   SN   %\@   /\   #_
M_P   /\   #_!0  _PH  /\.  #_$@  _Q@  /\A  #_*P  _SD  /]*  #_
M70  _W,  /^,  #_I   _[D  /_4  #_W@  _]X  /_> /\8+ #_&2D _QDH
M /\5*P#_$#  _PLX ?\#1 '_ %$!_P!> ?\ ; '_ '@!_P"" ?\ C '_ )0!
M_P"< /\ H@#_ *@ _P"O /\ M@#_ +X _P#( /\ UP#_ .< _P#S /\ _0#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\;*0#_'28 _QPE /\9
M)P#_$RP _PXT /\+0 '_"$X!_P5; ?\#: '_ G0!_P)_ ?\"B '_ I$!_P*8
M ?\"GP'_ :4 _P&L /\!L@#_ ;H _P'$ /\!T0#_ .0 _P#Q /\ _ #\ ?\
M_ +_ /P#_P#\!/\!_ 7_ ?P%_P'\!?\!_ 7_ ?\?)@#_(2( _R A /\>(P#_
M&"< _Q,P /\1/ '_#DH!_PU7 ?\+8P'_"F\!_PIZ ?\*A '_"HT!_PJ4 ?\*
MFP'_"J(!_PJH ?\*KP'_"K<!_PK  /\*S #_"N  ^PKO /<*^@#U"_\!]0S_
M ?0-_P'T#?\"] W_ O0-_P+T#?\"] W_ O\B(@#_)!T _R0< /\B'0#_'B(
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M#+LL_PR[+/\,NRS_#/\Q$0#_-0P _S8' /\Z"P#_/!  _SL5 /@Y'P#O-RL
MYS8Y .$U1P#<-50!U35@ M$U:@/.-',$S#1\!<HTA0;(-(T'QC.4",0SG G"
M,Z4)P3.N"K\SN0N],\@+NS3A"[<T\PVT-/\/L33_#[ T_Q"O-/\0KC3_#ZXT
M_P^N-/\/KC3_#_\U#@#_. < _SP" /] !@#_00L ^D$/ .T_%@#C/"( VCTQ
M -(^00#,/D\"R#Y: \0]9 7!/6X'OSQV"+P\?@JZ.X<+N#N/#+<[EPVU.I\.
MLSJI#[$ZM!"O.L(1KCK9$:H[[Q*G._\3I3O_%*0[_Q.C._\3HCO_$Z([_Q*B
M._\2HCO_$O\X"@#_/   _T$  /5%  #F1@( X44' .-"#0#50QD S$4L ,9'
M/ '!1TD"O$95!+E%7P:U1&@)LT-Q"[!#>0VN0H$/K$*)$*I!D1*H09H3IT"D
M%*5 KQ6C0+P6H4#0%IY!ZA><0?P7FD'_%YA!_Q>80?\6ET'_%9=!_Q670?\5
MET'_%?\[!@#_/P  ^48  .5+  #<3@  TTT$ -%*"0#*2A0 PDTG +Q.-P&W
M3D4"LDU0!:],6@BK2V,*J$IL#:9)= ^D27P1H4B$$Y]'C!6=1Y47FT:?&)E&
MJAF71K@:ED;*&Y-&YAN11_D;CT?_&HY'_QF.1_\8C4?_&(U'_Q>-1_\7C4?_
M%_\^ @#_0P  ZTL  -U1  #15   RE0! ,92!0#!41$ N5,B +-5,P&N5$$"
MJE1,!:935@BB45\,GU!G#YU/;Q&:3G<4F$Y_%I9-B!B33)$9D4R;&X]+IAV-
M2[,>BTO%'HE+XAZ'3/<>ADS_'85,_QR%3?\:A4S_&85,_QF%3/\9A4S_&?]
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M(WA5UR-W5?(B=E;_('96_Q]V5O\==E;_''96_QMV5O\;=E;_&_]%  #L3@
MVE@  ,E>  "_8@  MV0  +%C  "K80@ I&,7 )]D* ":93<"EF1#!9%C30B.
M854,BF!=$(=?91.$7FP6@5UT&7Y<?1Q\6X8>>5J1('=:G2)T6:HD<EFZ)7%9
MTB5P6O C;UK_(F]:_R!P6O\><%K_'7!:_QQP6O\<<%K_'/](  #G4@  TUL
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M(U]G_R%?9O\?8&;_'F!F_QY@9O\>8&;_'N]/  #:7   QF4  +IM  "P<@
MIW4  )UT  "4<P  C70- (EV' "%=RL!@7<X WQV0P9X=4P)='14#7%S6Q%N
M<F,4:W%K%VAP<QIE;WP=8FZ'(%]ME")=;*(D6FRR)5ELQR58;.@E66S](UEK
M_R%::_\?6VO_'EMJ_QY;:O\>6VK_'NM3  #38   PFD  +9Q  "L=@  HWD
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M3W7_'4]U_QU/=?\=3W7_'=]<  #(:   N7(  *YZ  "E@   FH(  (Z"  "
M@P  >84" '2&$0!QB"  ;H@N 6J(.0)GAT,%8X=,"&"&4PM=A5L.6H1C$5>$
M:Q14@W4748* &DZ!C1Q+@9L>28&L'TB P2!'@.,?1W_Z'DA^_QY(??\=27S_
M'$E\_QQ)?/\<27S_'-9A  #";@  M'@  *J   "?A0  E(<  (B'  ![B0
M<(P  &N.#0!HCQH 9H\I &*0-0%?CS\#7(](!5F.4 A6CE@+4XU@#E",:!!-
MC'(32HM]%DB*BAA%BID:0XJJ&T**OQM!BN$;08CY&T&&_QM!A?\;0H7_&D*$
M_QI"A/\:0H3_&LUG  "\=   KWX  *6&  ":B@  CHP  (*-  !UD   9Y0
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M#;6   "HBP  G)$  )&6  "%G   >*   &NE  !?J   4ZP  $BO   ]L@
M-K4+ #2U%0 SMB$ ,K8L #&W-P PMT$ +[A+ "ZX50 LN& !*KAM 2FY>P(G
MN8T");F? R2YM ,CN=(#([?T!"*U_P4AM/\&(;/_!R&R_P<ALO\'(;+_!ZV*
M  "@D0  E9<  (B=  ![HP  ;J@  &&M  !5L0  2K0  #^W   TNP  *[X#
M "3"#  BPA0 (L,? "'#*@ @Q#0 '\0_ ![%2@ =QE8 ',9C !O'<P :QX4
M&<>9 !C(K@ 7R,L %\;Q 1?$_P$6P_\"%L'_ Q;!_P,6P?\#%L'_ Z.1  "8
MF   BYX  'VE  !PJP  8K$  %:V  !*N0  /KT  #3    JQ   (L@  !G,
M!  3T H $=(1 !#2&@ 0TR4 #],P  [4/  .U$@ #=56  W590 ,UG@ #-:-
M  O8I  *V+X "=GF  K6_@ +U/\ "]+_  O2_P$+TO\!"]+_ 9J8  ".GP
M@*8  '*M  !DM   5[H  $F_   ]P@  ,L8  "C)   ?S0  %]$  !'6   ,
MVP4 "-X+  ;?$0 %WQH !. D  +A+@ !XCH  .-'  #D5@  Y&<  .5[  #F
MD@  YJH  .?(  #G\   Z/\  .C_  #H_P  Z/\  .C_ )&?  ""IP  =*\
M &6W  !7O@  2<,  #S'   PRP  )<\  !S4   4V0  #MT   GA   "Y0
M .D&  #I#0  Z1$  .H8  #K(0  [2L  .\W  #Q10  \E8  /-H  #S?@
M])<  /6P  #VT   ]_,  /?_  #W_P  ]_\  /?_ (6G  !VL   9K@  %C!
M  !*R   .\P  "[1   CU@  &=P  !'@   ,XP  !.<   #J    ]0   /0
M  #U!0  ]0L  /8/  #V%   ^!T  /HG  #\-   _T,  /]5  #_:0  _X$
M /^:  #_L@  _\\  /_M  #_^0  __D  /_Y 'BP  !HN@  6<,  $O+   [
MT0  +=@  "'=   6X@  #N8   CJ    [0   /    #X    _P   /\   #_
M    _P   /\&  #_#   _Q   /\8  #_(@  _S   /]   #_4P  _VD  /^!
M  #_F0  _Z\  /_#  #_U0  _]4  /_5 /\3* #_$R4 _Q$E /\-)P#_!BT
M_P U /\ 00#_ $\ _P!< /\ :0#_ '0 _P!^ /\ B #_ )  _P"7 /\ G0#_
M *0 _P"J /\ L #_ +< _P#  /\ S #_ -\ _P#L /\ ^ #_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\6)0#_%B( _Q0A /\0(P#_"B@ _P P
M /\ /0#_ $L _P!8 /\ 9 #_ '  _P!Z /\ A #_ (P _P"3 /\ F@#_ *
M_P"F /\ K0#_ +0 _P"\ /X R #] -D ^P#I /H ]@#Y /\ ^ #_ /@ _P#X
M /\ ^ #_ /D _P#Y /\ ^0#_ /\:(@#_&AX _Q@= /\3'@#_#B( _PHL /\'
M.0#_ T8 _P!3 /\ 8 #_ &L _P!V /\ ?P#_ (@ _P"/ /\ E@#_ )T _P"C
M /X J0#\ +  ^@"Y /< Q #U -( \P#F /( ] #Q /\ \ #_ .\ _P#O /\
M[P#_ /  _P#P /\ \ #_ /\>'0#_'AD _QP7 /\7& #_$QX _Q$H /\.- #_
M#$$ _PI. /\(6P#_!V8 _P9Q /\&>@#_!H, _@:+ /P&D@#Z!ID ^ :? /8&
MI@#T!JT \@:U / %P #M!<X ZP7D .D&\P#F"/\ Y0K_ .0+_P#D"_\!Y O_
M >0+_P'D"_\!Y O_ ?\A& #_(1, _R 1 /\;$@#_'!H _QHD /\6+P#_$SP
M_Q%) /\050#\#F$ ^0YK /8.=0#T#GX \@Z& / .C@#N#I4 [0Z; .L.H@#J
M#JH Z ZS .8/O0#E#\P X0_C -T0\P#9$?\!UA+_ =03_P'3$_\"TA/_ M(3
M_P+2$_\"TA/_ O\E$P#_)1  _R0- /\C#@#_(Q0 _R(> /\?*0#_'#4 ^1E#
M /083P#O%UL [!=F .D7< #F%WD Y!>! .(7B0#@%Y$ WQ>8 -T7GP#;%Z<
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M"/\O" #_,0  _S4  /8W  #J-@( YS,( .0O#P#9+AL SS$L ,DS/ #$-$D
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M50.D1%X%H41F!Y]#;@B=0W8*FT)^"YE"A@V708\.E4&9#Y-!I!&10; 2D$'
M$HY!V1*+0?$2B4+_$HA"_Q&(0O\0AT+_$(="_P^'0O\/AT+_#_\X  #S/0
MXT<  -),  #(3@  P$T  +M* @"V1PX L$D= *M++0"F3#L!HDQ' IY+402;
M2UH&F4IB")9):@J427$,DDAY#H](@@^-1XL1BT>5$HE&H!2'1JP5A4:[%H1&
MT1:"1^X6@$?_%7]'_Q1_1_\2?T?_$7]'_Q%_1_\1?T?_$?\[  #N0P  W$P
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M&6I5_Q=J5?\6:E7_%6M5_Q1K5?\4:U7_%/)#  #?3P  RU@  +U=  "S80
MJV(  *)@  ";7   E5X0 )!@'P",82X B&$Z H1@102!8$X&?E]6"7M>70MX
M764.=EQL$'-<=!-P6WT5;EJ(%VM:E!EI6:$;9UFP'&59PQQD6>,<9%GZ&F19
M_QAD6?\795G_%659_Q1E6?\495G_%.]&  #:4@  QEL  +IA  "P90  IF8
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M%E9E_Q569?\55F7_%>)1  #*70  NV8  *]L  "F<0  F7   (YO  "#;@
M?7 % 'AR$@!U<R$ <G,O 6]S.@)L<T0$:7),!F9R5 AC<5L+8'!C#5UP:Q!;
M;W036&Y_%55NBQ=3;9D946VH&D]MNQM.;=D:3FST&4]K_QA/:_\74&K_%E!J
M_Q50:O\54&K_%=U5  #%80  MVH  *QQ  "B=0  E'0  (ET  !\<P  =G4
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M$<5F  "U<0  JGL  )^"  "2@@  A8(  'F#  !MA@  7XH  %B- 0!4C@\
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M R>EK00FI<8#)J3K!"6B_P4EH/\&))__!B2>_P<DGO\'))[_!Z]^  "CB
MEXX  (V3  !^E0  <)@  &.;  !7GP  3*(  $*F   XJ0  +ZP# "JN#@ I
MKA@ **\C ">O+0 FL#< );!! "2P2P CL58 (K%C "&Q<0 ?L8( 'K*4 1RR
MJ0$;LL$!&['G 1NO_@(:K?\"&JS_ QJK_P,:J_\#&JO_ ZB(  ";CP  D90
M (2:  !VGP  :*(  %NE  !/J0  1*T  #FP   OLP  )K8  !ZY!0 8NPX
M%[L6 !>\(  6O"H %;TU !2]0  3ODL $KY8 !*^9P 1OW@ $+^, !# H@ .
MP+H #L#A  ^]^P /O/\ $+K_ 1"Z_P$0NO\!$+K_ 9^/  "4E0  AYL  'FA
M  !KIP  7JP  %*Q  !%M   .K8  "^Y   EO   ';\  !7#   /Q@4 "\H-
M  G*%  (RAT !\HG  ?*,@ &RSX !<M+  3,6@ #S&H  LQ^  ',E   S*L
M ,W(  #,[0  S/\  ,O_  '*_P !RO\  <K_ )>6  "*G   ?*,  &ZJ  !@
ML   4K8  $6Y   YO   +K\  "/#   ;Q@  $\H   W-   (T0   =0)  #4
M#@  U14  -8>  #8)P  V3$  -L^  #<2P  W5L  -YN  #>A   WYL  -^T
M  #>V0  W_<  -__  #?_P  W_\  -__ (V=  !_I0  <*P  &&S  !3N@
M1;\  #C"   LQ@  (<D  !C-   0T0  "]4   3:    W@   . !  #A"0
MX@X  .03  #E&P  YR0  .DO  #K/   [4L  .Y=  #N<0  [XD  /"B  #P
MO   \.,  ._Y  #P_P  \/\  /#_ (&E  !RK0  8[4  %2]  !&Q   -\@
M "K,   ?T   %=4   [:   'W@   .(   #F    Z0   .H   #L    [@4
M .\,  #Q$   \Q<  /4@  #X*P  ^SD  /U*  #^7@  _W0  /^-  #_I@
M_\   /_A  #_]0  __4  /_U '2N  !EMP  5L   $?(   XS0  *M(  !W8
M   3W0  #.(   /F    Z0   .P   #P    \P   /0   #V    ^    /H
M  #]!P  _PT  /\2  #_&P  _R@  /\W  #_2@  _UX  /]V  #_CP  _Z8
M /^Z  #_T0  _]$  /_1 /\/) #_#B( _PLA /\#) #_ "D _P R /\ /@#_
M $P _P!9 /\ 90#_ '  _P!Z /\ A #_ (P _P"2 /\ F0#_ )\ _P"E /\
MJP#_ +( _P"Z /\ Q0#_ -, _P#G /\ ] #_ /\ _@#_ /\ _P#^ /\ _@#_
M /X _P#^ /\ _@#_ /\1(0#_$!X _PT= /\''P#_ ", _P M /\ .@#_ $@
M_P!5 /\ 80#_ &P _P!V /\ ?P#_ (< _P". /\ E0#_ )L _P"A /\ IP#^
M *X _0"V /P P #[ ,T ^0#B /@ \ #W /P ]@#_ /4 _P#U /\ ]0#_ /4
M_P#U /\ ]0#_ /\5'0#_$QH _Q 9 /\+&0#_ !T _P I /\ -@#_ $, _P!0
M /\ 7 #_ &< _P!Q /\ >@#^ (, _ "* /H D0#Y )< ^ "= /< HP#U *H
M] "R /( NP#Q ,@ [P#< .X [ #M /H ZP#_ .H _P#J /\ Z@#_ .H _P#J
M /\ Z@#_ /\8&0#_%A4 _Q,3 /\.$P#_"QH _P<D /\", #_ #X _P!+ /\
M5P#_ &( _ !L /@ =0#U 'X \@"% /$ C #O ), [@"9 .P H #K *8 Z0"N
M .< MP#F ,, Y #4 .( Z0#A /< WP#_ -T _P#= /\ W0#_ -T _P#= /\
MW0#_ /\;$P#_&A  _Q8. /\2#@#_$A4 _P\? /\,*P#_"3@ _P9% /L#40#W
M EP \@)F .X"< #J G@ YP*  .8#AP#D XX X@.5 .$#G #?!*, W02K -L$
MM #8!<  U@70 -,&YP#0"/@ S@K_ ,P+_P#+#/\ RPS_ ,L+_P#+"_\ RPO_
M /\?$ #_'@L _QH' /\9"P#_&!$ _Q89 /\2) #Z$#  \PX^ .X-2@#I#%8
MY0QA .(,:@#>#7, VPU[ -D-@P#6#8H U V1 -(-F0#0#J  SPZI ,T.LP#+
M#K\ R@_0 ,81Z0#"$OD OQ/_ +T3_P&\$_\!O!/_ ;P3_P&[$_\!NQ/_ ?\B
M# #_(00 _R   /\A!0#_'PP _QP1 /88' #L%2@ Y1,V -\20P#9$T\ TQ1:
M - 59 #-%FT RQ9U ,D7?0#'%X4 Q1B, ,08E #"&9P P!FE +X9KP"]&KL
MNQK+ +@;Y0&T'/8!LAW_ K =_P*O'?\"KAW_ JX=_P*N'?\"KAW_ O\F!@#_
M)0  _R8  /LG  #Q)0, \"$+ .@<$@#>&1T U!LM ,T=/ #('TD Q2!5 ,$A
M7P"_(F@ O")P +HC> "Y(W\!MR.' ;4CCP&T))<!LB2@ ;$DJ@*O)+8"K27&
M JLEWP*H)O,#I2;_ Z,F_P.B)O\$H2;_ Z$F_P.A)O\#H2;_ _\I  #_*
M]BT  .<P  #?+P  V2L$ -8B"@#.(Q8 QB8G , H-@"[*D0 N"M/ +4L60"R
M+&(!L"QJ :XM<@&L+7H"JBV! JDMB@*G+9(#I2V; Z0MI02B+;$$H"W !)\M
MV 2<+N\%F2[_!I<O_P:6+_\&E2[_!94N_P65+O\%E2[_!?\L  #_+@  ZC4
M -TY  #1.0  RC8  ,<O!@#!+1$ NC A +0R,0"P-#X K#5* *DU5 &G-5T!
MI#5E J(U;0*@-70#GS5\!)TUA 2;-8T%FC27!I@TH0:6-*T'E#6["),UT B0
M->P(CC;^"(PV_PB+-O\(BS;_!XHU_P>*-?\'BC7_!_\O  #R-   XCP  -)!
M  #'0@  P$   +LZ 0"V-@X L#D< *H[+ "F/#H HSU& )\]4 &=/5D"FCUA
M Y@]: 26/' %E#QW!I(\@ >1/(@'CSN2"(T[G0F+.ZD*B3NW"X@[R@N%/.@+
M@SS["X(\_PJ!//\*@3S_"8$\_PB!//\(@3S_"/\S  #L.@  VD,  ,I'  "_
M20  MT<  +%"  "M/@H ID 7 *)")P">0S4 FD1" 9=$3 &41%4"D4-= X]#
M9 6-0VL&BT)S!XE">PB'0H0*A4&."X-!F0R!0:4-?T&S#GY!Q@Y\0>0.>D+Y
M#7E"_PQX0O\+>$+_"WA"_PIX0?\*>$'_"O8V  #F0   T4@  ,--  "Y3@
ML4T  *E)  "D108 GT83 )I((P"623( DDH^ 8]*2 *,2E$#BDE9!(=)8 6%
M26@'@TAO"(%(=PI_1X +?4>*#7I'E0YX1J(/=D:P$'5&PA!S1N 0<D?W#W%'
M_PYQ1_\-<4?_#'%'_PMQ1O\+<4;_"_,Y  #@1   S$P  +Y1  "T4P  JE(
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M#E]3_PU?4_\-7U/_#>=$  #/4   OU@  +-=  "H7P  G%T  ));  "+6
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M#=%4  "^7@  L6<  *9M  "7;   BFL  ']K  !S:P  ;6T  &AN# !E<!<
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M"CE^K LW?L,+-WWF"S=[_ LW>O\+-WG_"CAX_PHX>/\*.'C_"KYD  "P;P
MI7@  )9Y  "'>0  >WD  '!Z  !D?   6(   %"#  !+A0H 2(84 $>'( !%
MB"L 1(@U $.(/@!!B4<!0(E/ 3Z(6 (\B&$#.HAL!#>(> 4UB(<&,XB8!S*'
MJ@<PB, ',(?D!S"%^P@P@_\(,(+_"#"!_P@P@?\(,('_"+=K  "J=@  H'\
M )!^  ""?@  =G\  &J   !>@P  4X<  $J+  !!C@( /9 . #N0&  ZD2,
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M !*H]0 3I_\!$Z7_ 1.E_P$3I/\!$Z3_ :.&  "7C   C9$  'V2  !ME0
M8)@  %2<  !(H   /J0  #2G   JJP  (:X  !FQ   2LP< #[40  ZU%P .
MM2$ #;4K  VU-@ ,MD$ "[9.  JV7  )MFP "+9_  >VE  &MJH !;;%  :V
MZ@ 'M?\ "+3_  BS_P )LO\ ";+_ )J-  "0DP  A)@  '2<  !EH   5Z0
M $NH  ! K   -;   "JS   AM0  &+@  !&[   ,O@( !L +  + $0 !P1D
M ,$B  #"*P  PC8  ,-"  ##4   Q%\  ,1Q  #$AP  Q)T  ,2U  #$V@
MQ/8  ,/_  ##_P  P_\  ,/_ ).4  "'F@  >*   &JF  !<K   3[$  $&U
M   UMP  *;H  !^]   6P   $,,   K&   #R@   ,P%  #,#   S1$  ,X8
M  #.(0  T"H  -$U  #30P  U%(  -1C  #5>   U8\  -6G  #6P@  UND
M -;]  #6_P  UO\  -;_ (J;  ![H@  ;*D  %ZP  !0M@  0KH  #2]   H
MP0  '<0  !3'   -RP  !LX   #2    UP   -D   #:!0  W L  -T0  #?
M%0  X1T  .,G  #E,P  YT(  .A4  #H9P  Z7X  .F7  #JKP  ZLX  .OO
M  #K_@  Z_\  .O_ 'VC  !NJP  7[(  %&Z  !"P   -,,  "?'   ;RP
M$L\   O3   "V    -T   #A    Y    .4   #G    Z0   .L'  #M#0
M[Q$  /$9  #T)   ]S$  /E!  #Z50  ^FH  /N$  #[G0  _+8  /S2  #]
M[0  _?0  /WT '&L  !AM0  4KT  $3$   TR0  )LT  !K2   0V   "-T
M  #A    Y0   .@   #L    [P   /$   #S    ]0   /<   #Y 0  ^P@
M /X.  #_%0  _R$  /\O  #_00  _U8  /]M  #_AP  _Z   /^V  #_R@
M_]0  /_4 /\+( #_!QX _P = /\ ( #_ "4 _P N /\ .P#_ $D _P!6 /\
M8@#_ &T _P!V /\ ?P#_ (< _P". /\ E #_ )H _P"@ /\ I@#_ *T _P"U
M /\ O@#_ ,L _P#A /\ \ #^ /T _0#_ /T _P#] /\ _0#_ /P _P#Y /\
M^0#_ /\-'0#_"QH _P09 /\ &@#_ !\ _P J /\ -P#_ $4 _P!1 /\ 7@#_
M &@ _P!R /\ >@#_ (( _P") /\ D #_ )8 _P"< /X H@#\ *D ^P"P /D
MN0#X ,8 ]@#9 /4 ZP#T /D \P#_ /( _P#S /\ \P#_ /, _P#S /\ \P#_
M /\0&0#_#A4 _P@4 /\ % #_ !D _P E /\ ,@#_ $  _P!, /\ 60#_ &,
M_@!M /P =0#Z 'T ^0"$ /< BP#V )$ ] "7 /, G@#R *0 \ "L .X M #M
M ,  ZP#/ .D Y@#H /4 Y@#_ .< _P#F /\ Y0#_ .4 _P#E /\ Y0#_ /\2
M% #_$!  _PP/ /\#$ #_ !4 _P @ /\ + #_ #H _P!' /H 4P#W %X ] !G
M /$ < #O '@ [0!_ .L A@#J (P Z "3 .< F0#E *  XP"G .$ L #? +H
MW0#) -L X #8 /  UP#^ -4 _P#4 /\ TP#_ -, _P#3 /\ TP#_ /\5$ #_
M$@P _PX) /\+# #_"1( _P,: /\ )@#] #, ] !  .\ 30#K %@ Z !A .4
M:@#B '( X !Z -X @ #< (< V@". -@ E0#4 )P T@"C -  K #. +8 S #$
M ,H V0#( .T QP#[ ,4 _P#$ ?\ PP'_ ,0!_P#$ ?\ Q '_ /\8"P#_%04
M_Q   /\0!@#_#PT _PP4 /P''P#Q RL YP Y .( 1@#> 5$ V@); -4"9 #2
M VP SP-T ,T$>P#+!(( R@2) ,@%D #&!9@ Q 6@ ,(&J0#!!K0 OP;! +T(
MU0"[">P N O] +8,_P"U#?\ M W_ +0-_P"T#?\ M W_ /\;!0#_&   _Q<
M /\6  #[$P8 ^A . .X,%@#C"2( V@DP -,*/@#."TH R@Q5 ,<-7@#%#6<
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M I H_P*/*/\"CB?_ HXG_P*.)_\"CB?_ O\F  #R*0  XS$  -(T  #(-
MP#   +LI @"X(PX L28< *PH*P"H*C@ I"M$ *$L3@"?+5< G2U? )LM9P&9
M+6X!F"YU 98N?0*4+H8"DRZ0 I$NF@./+J8#C2ZS XPNQ0.*+^$$AR_V!(4O
M_P2$+_\#A"__ X,O_P.#+_\#@R__ _LI  #K,0  V3@  ,D\  "_/   MCD
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M!FI!_P9J0?\%:D'_!>TW  #60@  Q$D  +=-  "K30  H$H  )A'  "30@
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M!]I&  ##4   M5@  *A;  "96@  C5@  (17  ![5   =E8! '%7#P!N61L
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M"D9BJ@M$8K\+1&+A"T1A^0I$8/\)1&#_"$5?_P=%7_\'15__!\A2  "X7
MJV0  )MD  ",8P  @&,  '9C  !J8@  8V0  %]F!@!;9Q$ 66@= %=I*0!6
M:C, 5&H\ %)J10%0:DP!3FI4 DQJ7 -*:F4$2&EO!49I>@=$:8@(0FB8"4!H
MJ0H_:+T*/FC>"3YG]PD^9O\(/V7_!S]E_P<_9/\'/V3_!\-7  "S80  IVD
M )9H  "'9P  >V<  '%G  !E:   7&H  %AL 0!4;@X 4F\8 %!O) !.<"X
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M<   <G   &=Q  !<<P  47<  $IZ  !"?0, /WX. #U_&  \?R, .X M #J
M-@ Y@3\ .(%( #:!4  U@5H!,X%D 3&!< $O@7\"+8&/ RR!H0,J@;8#*8'2
M RE_\P,I??\#*7S_ RE[_P,I>_\#*7O_ [%J  "E=   E78  (5U  !X=0
M;74  &%W  !7>@  3'X  $.!   [A0  -8@) #*)$0 QB1L ,(DE "^*+P N
MBC@ +8M! "R+2@ JBU0 *8M? "B+:P FBWH!)(N+ 2.+G@$BB[,!(8S. 2&*
M\0$@B/\"((;_ B"%_P(AA?\"(87_ JMR  "A?   CWL  (!Z  !S>@  9GP
M %M_  !0@@  1H8  #R*   TC0  +)$  ":3#  DE!, (Y0< "*5)@ AE2\
M()4X !^60@ >EDP '998 !R69  :EW0 &9>& !B7F0 7EZX %9?) !:5[@ 6
MD_\!%I+_ 1:1_P$6D/\!%I#_ :5[  "9@P  B8$  'N   !L@@  7X0  %2(
M  !)BP  /Y   #64   MEP  )9H  !V> 0 6H P %*$2 !2A&P 3H24 $J$N
M !&B.  1HD, $*)/  ^B7  .HVL #:-]  VCD@ ,HZ< "J+   NBY@ ,H/X
M#9__  V>_P -G?\ #9W_ )Z$  "2B0  @X@  '.(  !EBP  6(X  $R2  !!
MEP  -YL  "Z>   DH@  '*4  !6H   /JP0 "JX,  >M$@ &K1L !:TD  2N
M+@ "KCD  :Y%  "N4@  KF$  *YS  "NAP  KIT  *ZT  "NU0  K?0  *W_
M  "L_P  J_\  *O_ ):+  ",D   >Y   &N2  !=E@  4)H  $2?   YHP
M+Z<  "6K   <K@  %+$   ZT   )MP   ;@)  "X#@  N10  +D<  "Z)0
MNB\  +LZ  "\1P  O%8  +QG  "\>P  O)$  +RI  "\Q   O.L  +O^  "[
M_P  N_\  +O_ )"2  "#F   <YL  &.?  !5HP  1Z@  #NM   PL0  );0
M !NW   2N@  #+T   6_    PP   ,0"  #%"@  Q0X  ,84  #'&P  R"0
M ,HN  #,.@  S4D  ,U9  #-;   SH,  ,Z;  #-M0  SMH  ,[V  #-_P
MS?\  ,W_ (:9  !WH   ::8  %JL  !,L@  /K8  #"Y   DO   &;\  !'"
M   *Q0   LD   #,    T    -$   #2 0  TP@  -4-  #7$0  VA@  -PA
M  #?+   X3H  .)*  #C70  Y'(  .2+  #EI0  Y<   .7F  #E^   Y?\
M .7_ 'JA  !KJ0  7*\  $VV   _O   ,+\  "/#   7QP  #\H   ?.
MT0   -8   #<    WP   .    #B    Y    .8#  #H"0  Z0X  .P5  #N
M'@  \2L  /0Z  #U30  ]F$  /=Y  #XDP  ^*T  /G&  #YY   ^?,  /GS
M &VJ  !>L@  3[H  $#!   QQ0  (LD  !;.   -T@  !-@   #=    X0
M .0   #H    ZP   .T   #O    \0   /,   #V    ^ ,  /H+  #]$0
M_QL  /\I  #_.P  _T\  /]F  #_?P  _YD  /^O  #_PP  _]8  /_6 /\$
M' #_ !D _P 9 /\ ' #_ "( _P K /\ . #_ $8 _P!3 /\ 7@#_ &D _P!R
M /\ >@#_ (( _P") /\ CP#_ )4 _P"; /\ H0#_ *@ _P"O /\ N0#_ ,4
M_P#9 /X [ #] /L ^P#_ /L _P#[ /\ ^@#_ /0 _P#P /\ \ #_ /\'& #_
M 14 _P 4 /\ %@#_ !L _P F /\ - #_ $( _P!. /\ 6@#_ &0 _P!M /\
M=0#_ 'T _P"$ /\ B@#] )  _ "6 /H G0#Y *, ^ "K /< M #U +\ ] #.
M /, Y@#Q /8 \ #_ .\ _P#O /\ [@#_ .X _P#J /\ Z@#_ /\+% #_!A$
M_P 0 /\ $ #_ !8 _P B /\ +@#_ #P _P!) /\ 5 #^ %\ ^P!H /D < #W
M '@ ]0!_ /, A0#R (L \ "2 .\ F #M )\ [ "F .H K@#H +D YP#' .4
MW@#C /  X@#^ .  _P#@ /\ X0#_ .$ _P#A /\ X0#_ /\-$ #_"0T _P$,
M /\ # #_ !( _P < /\ * #\ #8 ^0!# /8 3@#R %D [P!B .P :P#J '(
MZ !Y .8 @ #D (8 X@", .$ DP#? )H W0"A -L J@#8 +0 U0#  -( TP#0
M .H S@#Z ,T _P#- /\ S0#_ ,P _P#, /\ S #_ /\0# #_# < _P," /\
M" #_  X _P 6 /8 (@#P "\ [  \ .D 2 #E %, X0!< -X 90#; &P UP!S
M -0 >@#2 (  T "' ,X C@#, )4 R@"= ,@ I0#& *\ Q "[ ,( RP#  .4
MO@#U +T _P"\ /\ O #_ +P _P"\ /\ O #_ /\1!0#_#@  _PH  /\( 0#_
M! H ^  0 .D &@#C "@ W@ U -D 00#3 $P SP!6 ,L 7P#) &8 Q@!N ,0
M= #" 'L P0"" +\ B0"] )  O "8 +H H0"X *L M@"W +0 QP"R .  L0'R
M *\"_P"N _\ K03_ *T$_P"M!/\ K03_ /\4  #_$   _P\  /(-  #J"@
MZ0,) -T $@#4 !\ S0$M ,@".@#$ T4 P -0 +T$60"[!6$ N05H +<&;P"U
M!G8 M =] +('A "Q"(P KPB5 *T)G@"K":@ J@JU *@*Q0"F"]\ I WT *(.
M_P"@#O\ GP[_ )\._P"?#O\ GP[_ /\7  #_$P  [Q@  .09  #;%@  TA "
M ,\)"P#("!8 P0HD +P,,@"W#3X M Y) +$.4P"O$%L K1!C *L0:@"I$7$
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M 7PH_P%\*/\!?"C_ ?4D  #C+@  SS4  ,$X  "T-@  JS$  *4L  "B)@8
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M ]\Y  #(0P  N4H  *E+  ";20  D$<  (A$  "#00  ?D$& 'I"$0!V0QX
M=$4J '%%-0!O1C\ ;49' &M&3P%J1E8!:$9= F9&90)D1FT#8D9V!&!&@@1>
M1HX%7$6<!EM%K 991K\'6$;?!EA&]P571?\$5T7_!%=$_P-81/\#6$3_ ]H]
M  #$1P  M4X  *1.  "63   BTL  (-)  !]10  >$8" '1'$ !P2!L ;DDG
M &M*,@!J2SP :$M$ &9+3 %D2U,!8DM: F!+8@)?2VH#74MT!%M*?P592HP%
M5TJ:!E5*J@=42KT'4TK<!U)*]@922O\%4DG_!%))_P-22/\#4TC_ ]1!  #
M2P  LE$  *!0  "23P  ATX  'Y,  !X2   <DH  &Y+#0!K31@ :$XD &9.
M+P!D3SD 8D]" &%020%?4%$!75!8 EM/8 )93V@#5T]R!%5/?0533XH%4DZ8
M!E!.J =.3KL'34[9!TU.]09-3O\%34W_!$U-_P1.3/\#3DS_ \Y$  "\3@
MKE0  )Q3  ".4@  @U$  'I0  !R30  ;$\  &A0"P!E414 8U(A &%3+ !?
M4S8 750_ %M41P!:5$X!6%16 59470)45&8#4E-O U!3>P1.4X@%3%.7!DM3
MIP=)4[H'2%/5!TA2\P9(4O\%2%'_!$E1_P1)4/\#25#_ \I(  "Y4@  JE<
M )A6  "*50  ?U0  '93  !L40  9U,  &)4" !?5A( 75<> %M7*0!96#,
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M!3AB[P0X8?\$.&#_ SA?_P,Y7O\#.5[_ [Q5  "M7P  G&   (M?  !]7P
M<E\  &A?  !=8   56(  $]D  !+9@H 26<2 $=H'0!%:"< 1&DQ $-I.0!"
M:D( 0&I* #]J4@ ]:EL!/&IE 3IJ< (X:GX"-FF- S1IGP,S:;(#,6G+ S%H
M[0,Q9_\#,6;_ S)E_P,R9/\#,F3_ [=;  "I9   EF0  (9C  !X8P  ;6,
M &1D  !990  4&@  $EK  !#;00 0&X. #YO&  ];R( /' K #IP-  Y<3T
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M 1E__P$9?O\!&7[_ :9P  "5<P  A'(  '9Q  !K<0  7G,  %1V  !)>0
M/WT  #>!   OA   )X@  ""+!0 ;C0X &HT5 !F-'@ 8CB< %XXP !:..0 5
MCD, %(]/ !./6P 2CVH $8][ !"/CP /CZ0 #H^[  V/X  .C?H #XO_ !"*
M_P 0B?\ $(G_ *%Z  ".>0  ?G<  ')W  !D>   6'L  $U^  !"@@  .88
M "^*   GC@  ()$  !B5   2F 4 #IH.  V:%  ,FAT "YHF  N:,  *FCL
M"9I&  B:4P &FV$ !9IR  2:A@ "FIL  )JQ  &9SP "F?   IC_  27_P %
MEO\ !9;_ )F!  "'?P  >GX  &M^  !=@0  4(4  $6)   [C0  ,9(  "B6
M   ?F0  &)T  !&@   ,HP( !J4*  &E$   I18  *8?  "F*   IC(  *<]
M  "G2@  IU@  *=H  "G?   IY$  *:H  "FPP  I>D  *7\  "E_P  I/\
M *3_ )&'  ""A@  <H8  &.(  !5C   29$  #V6   RF@  *)X  !^B   7
MI@  $*D   NL   $KP   +$&  "Q#   LA$  +(7  "S'P  LR@  +0R  "U
M/P  M4T  +5=  "U<   M88  +6=  "UM@  M=P  +3W  "T_P  M/\  +3_
M (N/  !ZC@  :I$  %N5  !-F@  0)\  #6D   JJ   (*P  !:P   /M
M";<   &Y    O0   +X   "^!@  OPP  , 0  #!%@  PAT  ,,G  #%,@
MQD   ,91  #'8P  QW@  ,>1  #'J0  Q\<  ,?L  #'_@  Q_\  ,?_ (.7
M  !QF@  89X  %*C  !%J0  .*X  "RS   @MP  %KH   Z]   &P    ,,
M  #'    R0   ,H   #,    S0,  ,X)  #0#@  TA,  -0;  #8)0  VS(
M -U"  #=5   WFD  -Z!  #>G   W[4  -_9  #?\P  W_\  -__ '>?  !H
MI@  6:T  $JS   [N   +;L  !^_   4P@  #,8   /)    S    -    #5
M    V0   -H   #<    W@   .    #B!0  Y L  .<0  #J&   [20  / R
M  #Q1   \E@  /-O  #TB@  ]*0  /2_  #TWP  ]/,  /3T &JH  !;KP
M3+<  #V]   MP0  '\8  !/*   +S@   -(   #7    W    .    #E
MYP   .D   #K    [0   .\   #Q    \P   /8'  #Y#@  _!8  /\B  #_
M,P  _T<  /]=  #_=@  _Y$  /^I  #_O@  _]@  /_; /\ & #_ !8 _P 5
M /\ & #_ !X _P G /\ -@#_ $, _P!/ /\ 6@#_ &0 _P!M /\ =0#_ 'T
M_P"$ /\ B@#_ )  _P"6 /\ G #_ *, _P"K /\ M #^ +\ _0#/ /L YP#Z
M /@ ^0#_ /D _P#Y /\ ]0#_ .X _P#I /\ YP#_ /\ % #_ !$ _P 1 /\
M$@#_ !< _P C /\ ,0#_ #X _P!* /\ 5@#_ &  _P!H /\ < #_ '@ _0!^
M /P A0#Z (L ^0"1 /@ F #W )X ]0"F /0 K@#R +D \0#' .\ X #N /(
M[ #_ .P _P#L /\ ZP#_ .4 _P#@ /\ W@#_ /\#$ #_  X _P - /\ #0#_
M !, _P > /\ *P#_ #@ _P!% /X 4 #[ %H ^ !C /4 :P#S '( \0!Y .\
M?P#N (8 [ ", .H D@#I )D YP"@ .8 J0#D +, X0#  .  TP#> .L W #[
M -L _P#: /\ V@#_ -D _P#4 /\ T@#_ /\'#0#_  D _P & /\ "0#_  \
M_P 8 /L )0#X #( ]0 _ /( 2@#M %0 Z@!= .< 90#D &P X@!S .  >@#>
M (  W "& -H C0#7 )0 U "; -( I #/ *T S0"Y ,L R0#) .0 R #V ,8
M_P#% /\ Q@#_ ,< _P#' /\ QP#_ /\*!@#_ 0  _P   /\ ! #_  L ]  2
M .\ 'P#J "P Y0 X .( 0P#= $X V0!7 -0 7P#1 &< S@!M ,P = #* 'H
MR "  ,8 AP#% (X PP"6 ,$ G@"_ *@ O0"S +H P@"Y -L MP#P +4 _P"V
M /\ M0#_ +4 _P"U /\ M0#_ /\,  #_!   _P   /X   #V  , Z  - .
M%P#9 "0 T0 Q ,T / #* $< Q@!1 ,, 60#  &  O@!G +P ;@"Z '0 N0![
M +< @@"U (D LP"1 +( F@"P *0 K@"O *P O0"J -  J #K *< ^P"F /\
MI@#_ *4 _P"E /\ I0#_ /\-  #_!P  ] D  .H)  #B!   V@ ' ,\ $0#(
M !P P@ I +X -0"[ $  MP!* +0 4P"R %L L !B *X : "L &\ JP!U *D
M?0"H (0 I@"- *0 E@"C *  H0"K )\!N0"= \P G 3H )H&^0"9!_\ F C_
M )<(_P"7"/\ EPC_ /\0  #W$   Z!0  -P5  #.$0  Q@T  ,($"P"\ !0
MMP$A +(#+@"N!3H JP9$ *@(30"F"%4 I E< *(*8P"@"FH GPMQ )T+> "<
M"X  F@R) )D,DP"7#)X E0VJ )0-N "2#<P D [J (X0_ ",$/\ BQ#_ (L0
M_P"+$/\ BA#_ /L3  #M&@  W2   ,PA  "_'0  MQ<  +,1  "R"PT JPT9
M *<.)@"C#S, GQ ^ )T11P":$5  F!)7 )827@"5$V4 DQ-L )(3<P"0%'P
MCQ2% (T5CP"+%9H BA6G (@6M0"&%LD A!?G ((8^P" &?\ ?QG_ '\9_P!_
M&/\ ?QC_ /4:  #D(P  SRD  , J  "S)@  JB(  *4<  "D%0@ H!03 )L6
M(0"7&"T E!DX )$:0@"/&TL C1Q2 (L<60")'6  B!UG (8>;P"%'G< @Q^
M ((?BP" 'Y< ?B"C 'T@L@![(,4 >2'D '<B^0!V(O\ =2+_ '0A_P!T(?\
M="'_ .\A  #;*P  QS$  +8Q  "I+@  H"H  )LF  "8(0$ E1X0 ) @&P"-
M(2@ B2,S (<D/0"%)$8 @R5. ($F50!_)EP ?B9C 'PG:P![)W, >2=\ '@H
MAP!V*), ="B@ 7(HKP%Q*<$!;RG@ 6TI]P%L*?\!:RG_ 6LI_P%K*/\!:RC_
M >@H  #0,@  P#@  *XW  "A-0  F#(  )(M  ".*0  BR<, (<H%P"#*B,
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M EL[IP)9.[@#6#O2 U<[\0)6._\"5CO_ E8Z_P%6.O\!5CG_ =0W  # 00
MKT0  )U#  "00@  A4   'X^  !Y.P  =#H  '$Z#@!M/!@ :STD &D^+P!G
M/S@ 93]  &1 2 !B0$\ 84!7 %] 7@%=0&8!7$!O 5I >@)80(<"5D"5 E1
MI -30+8#4D#/ U% [P-00/_B__])0T-?4%)/1DE,10 &"?\"4#__ E __P)1
M/O\!43[_ <\[  "]10  JD<  )E&  "+10  @40  'E"  !T/@  ;S\  &M
M# !G014 94(A &-#*P!A0S4 7T0^ %Y$10!=14T 6T54 %E%7 %8160!5D5M
M 51%> )2184"4423 T]$HP--1;0#3$7, TM%[0-+1/\"2T3_ DM#_P),0O\"
M3$+_ LH_  "Y2   IDH  )5)  "'2   ?4<  '5%  !N0@  :4,  &5$"0!B
M11, 7T8> %U'* !<2#( 6D@[ %E)0P!724H 5DE2 %1)60%326$!44EK 4])
M=@)-28("2TF1 TI)H0-(2;,#1TG* T9)[ -&2/\"1DC_ D='_P)'1O\"1T;_
M L9#  "V3   HDP  )%,  "$2P  >4H  '!)  !I1@  9$<  %])!@!<2A
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M CI7FP(X5ZT"-U?$ C=7YP(W5OT"-U7_ C=4_P(W4_\".%/_ KI/  "I5@
ME54  (54  !X5   ;50  &14  !85   4E8  $Y7  !*60D 1UH1 $9:&P!$
M6R4 0ULN $)<-@!!7#X /UQ& #Y=3P ]75< .UUA #I=; $X77D!-EV( 31=
MF0(S7:L",5W" C%<Y0(Q6_P",5K_ C%9_P(R6?\!,EC_ ;94  "D60  D%@
M (!8  !S5P  :5<  &!8  !460  3EL  $A=  !#7P0 0& . #YA%P ]82
M.V(I #IB,@ Y8CH .&-" #=C2P V8U0 -&-= #-C:  Q8W8!+V.% 2YCE@$L
M8ZD!*V._ 2ICXP$J8OL!*F#_ 2M?_P$K7_\!*U[_ ;%9  ">7   BUP  'M;
M  !O6P  95L  %Q<  !17@  26   $-B   \90  .&<* #5H$@ T:!L ,VDD
M #)I+0 Q:34 +VH] "YJ1@ M:D\ +&I9 "MK90 I:W( *&N" "9KDP D:Z<
M(VN] ")JX  C:?D!(V?_ 2-F_P$C9O\!)&7_ :Q@  "88   A6   '9?  !J
M7P  86   %=@  !-8P  1&8  #UH   V:P  ,&X$ "QP#@ J<14 *7$> "AQ
M)@ G<B\ )G(W "5R0  D<DH (G)4 "%S8  @<VT 'G-] !USD  ;<Z, &G.Y
M !ESW  :<?< &G#_ !MO_P ;;O\!&VW_ :9F  "190  ?V0  '%D  !F9
M760  %)F  !(:0  /VP  #=O   P<P  *78  ")Y"  ?>Q  'GL7 !Q['P ;
M>R@ &GLP !E\.0 8?$, %WQ. !9\6@ 5?&< %'UX !)]BP 1?9\ $'VU  ]]
MU0 0>_4 $7G_ !%X_P 2=_\ $G?_ )YK  "*:@  >FD  &UI  !B:0  5VH
M $QM  !#<   .70  #%X   I>P  (G\  !N"   4A0D $880 !&&%P 0AQ\
M$(<H  Z',0 .ASL #8=&  R'4P +AV$ "H=Q  F'A  'AY@ !H:N  6&R0 &
MA>P !X3_  B#_P )@O\ "8+_ )5Q  "#;P  =&X  &EN  !<;P  4'(  $9U
M   \>0  ,GT  "J!   BA0  &XD  !2,   /CP, "I(+  :2$0 $DA@  I(@
M  &2*0  DC,  ),^  "32P  DUD  )-I  "3>P  DI   )*F  "1OP  D>4
M )#Z  "/_P  C_\  (__ (UW  !]=0  <'0  &)U  !5>   27P  #^    T
MA   *XD  "*-   :D0  $Y0   Z7   )FP   9T(  "=#@  G1,  )X:  ">
M(@  GRL  )\U  "@0@  H%   *!?  "@<0  H(<  )^=  "?M0  GMH  )WV
M  "=_P  G/\  )S_ (9]  !X?   :7P  %M_  !.@P  08@  #:,   LD0
M(Y8  !J:   2G@  #:$   :D    IP   *D#  "I"@  J@X  *L3  "L&0
MK2(  *XK  "O-P  KT4  *]4  "O9@  KWL  *Z4  "NJP  KLD  *[O  "M
M_P  K?\  *W_ (&$  !QA   88<  %.+  !&D   .98  "Z;   CH   &J0
M !*H   ,K   !*\   "R    M@   +<   "W @  N @  +D-  "Z$@  NQ@
M +TA  "^*P  P#@  ,!(  # 6@  P6X  ,&&  #!H   P;H  ,'C  # ^0
MP/\  ,#_ 'F-  !HD   690  $N:   ]H   ,:4  "6K   :KP  $;,   NX
M   "NP   +X   #!    Q    ,4   #&    QP   ,@%  #*"P  S \  ,X5
M  #0'P  TRL  -4Z  #53   UF   -AW  #8D@  V*P  -G)  #9[   V?L
M -C_ '"9  !@G@  4:0  $.J   UL   *+8  !RZ   1O@  "<$   #%
MR    ,L   #/    T@   -,   #6    V    -L   #=    WP<  .(-  #E
M$P  Z!T  .PJ  #M/   [5$  .YG  #O@0  [YP  /"W  #PTP  \.P  /#T
M &>F  !8K0  2;0  #JZ   JO@  ',(  !#&   'R@   ,X   #2    U@
M -P   #@    XP   .0   #F    Z    .L   #M    [P   /("  #U"@
M^!$  /P<  #_+   _S\  /]5  #_;@  _XH  /^D  #_N@  _]$  /_A /\
M% #_ !( _P 2 /\ % #_ !D _P E /\ ,@#_ #\ _P!+ /\ 5@#_ &  _P!H
M /\ < #_ '@ _P!_ /\ A0#_ (L _P"1 /\ F #_ )X _@"F /T K@#\ +D
M^@#( /D X@#X /0 ]P#_ /8 _P#V /\ [P#_ .< _P#B /\ W@#_ /\ $0#_
M  X _P . /\ #P#_ !0 _P @ /\ +0#_ #H _P!& /\ 40#_ %L _P!C /X
M:P#\ ', ^@!Y /D @ #W (8 ]@", /4 D@#S )D \@"@ /  J0#N +, [0#!
M .L U@#J .X Z0#^ .< _P#G /\ Y0#_ -T _P#5 /\ T0#_ /\ #0#_  H
M_P ( /\ "0#_ !  _P ; /\ * #_ #4 _P!  /H 2P#V %4 \P!> /$ 9@#N
M &T [ !T .L >@#I (  YP"& .8 C0#D ), X@"; .  HP#> *T W "Y -H
MR@#7 .8 U #X -( _P#2 /\ T@#_ ,X _P#) /\ Q@#_ /\ " #_  , _P
M /\  P#_  T _  6 /< (@#S "X [P Z .P 10#H $\ Y !8 .$ 8 #> &<
MVP!M -D = #5 'H TP"  -$ AP#/ (X S0"5 ,L G@#) *< QP"S ,4 P@##
M -P P0#Q +\ _P"_ /\ O@#_ +X _P"] /\ NP#_ /\   #_    _P   /\
M  #V  @ [@ 1 .< &P#A "< W0 S -D /@#3 $D SP!2 ,L 60#( &$ Q@!G
M ,0 ;0#" ', P !Z +\ @ "] (@ NP"0 +D F "X *( M0"M +, NP"Q ,X
ML #J *\ _ "M /\ K0#_ *X _P"N /\ K@#_ /\"  #_    _0   /(   #H
M    W@ , -, %0#, "$ R  L ,0 . #! $( O0!+ +H 4P"X %H M@!A +0
M9P"R &T L !T *\ >@"M (( K "* *H DP"H )T I@"H *0 M0"B ,8 H0#C
M )\ ]@"> /\ G@#_ )X _P"> /\ G@#_ /\&  #[    [@4  .($  #5
MRP & ,, #P"] !D N  E +0 ,0"Q #L K@!% *P 30"I %4 IP!; *4 8@"D
M &@ H@!N *$ =0"? 'P G@"% )P C@": )@ F "D )8 L "5 ,$ DP#< )(
M\@"1 /\ D #_ )  _P"/ /\ CP#_ /T*  #P#@  X1$  ,X0  #"#0  NP<
M +< "@"Q !( K  > *@ *0"E #0 H@ ^ )\ 1P"= $\ FP!6 )D!7 "7 6,
ME@)I )0"< "3 W@ D0.  ) $B@".!)4 C 6A (H%K@")!KX APC8 (8)\ "$
M"O\ @PO_ (,+_P"#"_\ @PO_ /80  #F%P  TAP  , :  "S%@  K!(  *@-
M  "F!PT H@46 )T'(@"9"2X E@HX )0+00"2#$H D Q1 (X-6 ",#5X BPUE
M (D-; "(#G0 A@Y] (4.AP"##I, @0^? ( 0K0!^$+X ?1#; 'H1] !X$O\
M=Q+_ '<2_P!W$O\ =Q+_ .\7  #;(0  QB0  +0C  "H(   H!P  )L7  "9
M$00 F X0 ),0&P"/$2< C!(R (D3/ "'$T0 A11, (,44P"!%5H @!5@ 'X6
M: !]%F\ >Q9X 'D7@P!X%X\ =AB< '08J@!S&;L <AG4 &\:\0!N&_\ ;1O_
M &T:_P!M&O\ ;1K_ .<@  #0*0  O"L  *LJ  ">*   EB0  ) @  "-'
MC!<, (@8%@"$&B( @1LM 'X<-P!\'4  >AU( 'D>3P!W'E4 =A]< '0?8P!S
M'VL <2!T ' @?P!N(8L ;"&8 &LAIP!I(K@ :"+/ &8B[@!E(_\ 9"/_ &0B
M_P!D(O\ 9"'_ . F  #(+P  M#$  *,P  "6+@  C2L  (<H  "$)   @B (
M 'X@$@![(AX >",I '4D,P!S)3P <25# ' F2P!N)E( ;2=9 &LG8 !J)V@
M:2AQ &<H>P!E*(@ 9"F5 &(II !@*;4 7RG+ %XJ[ !<*O\ 7"G_ %PI_P!<
M*?\ 7"C_ -@L  ##-0  K34  )TT  "0,P  AC$  ( M  !\*P  >2@# '8G
M$ !R*1H <"HE &TK+P!K+#@ :BQ  &@M1P!G+4X 92Y5 &0N70!C+F4 82]N
M %\O> !>+X0 7"^2 %HOH0%9+[(!6##( 58PZ0%5,/X!52__ %4O_P!5+O\
M52[_ - Q  "].@  J#D  )<X  "*-P  @#8  'HR  !U,   <BX  &XN#0!K
M+Q8 :3 A &8Q*P!D,C0 8S(] &$S1 !@,TL 7S12 %TT6@!<-&( 6C1K %DU
M=0!7-8( 5360 50UGP%2-; !437& 5 UYP%/-?T!3S7_ 4\T_P%/-/\!3S/_
M <LV  "X/0  HSP  )(\  "%.P  >SH  '0W  !O-0  ;#,  &@T"@!E-1,
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M0P  FD(  (I"  !]00  <T   &L_  !E/   8#P  %P^! !9/@\ 5S\8 %5
M(@!302L 4D$T %!"/ !/0D, 3D)+ $U#4@!+0UH 2D-D $A#;@!'0WL!14.)
M 4-#F0%"0ZL!0$/  3]#X0$_0_D!/T+_ 3]!_P% 0?\!0$#_ ;]!  "J10
MED4  (9%  !Y1   ;T0  &="  !@/P  6T$  %="  !40PT 4405 $]%'P!.
M12@ 3$8Q $M&.0!*1T$ 24=( $A'4 !&1U@ 14=A $-(; !"2'@!0$B' 3Y(
MEP$\2*D!.TB^ 3I(WP$Z1_@!.D;_ 3I%_P$[1?\!.T3_ ;M%  "F2   DD<
M ()'  !V1P  :T<  &-&  !;0P  5D4  %)'  !.2 H 3$D2 $I)' !(2B4
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M "E7U@ I5O4 *57_ "I4_P$J4_\!*E+_ :]1  "840  A5$  '90  !J4
M8%   %A1  !.4@  1U,  $%5   [6   .%D* #5:$0 T6AH ,ULB #);*P Q
M6S, +UP[ "Y<0P M7$P +%Q6 "M=8  I76T *%U\ "9=C@ D7:$ (UVU ")=
MT@ B7/, (EO_ "-:_P C6?\ )%C_ *A5  "25   @%0  '%4  !F5   7%0
M %15  !*5@  0U@  #Q;   V70  ,& % "UA#@ K814 *F(= "EB)0 H8BX
M)V,V "9C/@ E8T< (V-1 ")D7  A9&D 'V1Y !YDB@ <9)X &V2S !EDS@ :
M8_$ &V'_ !M@_P <8/\ '%__ *%9  ",6   >U@  &U8  !B6   65@  %!9
M  !'6P  /EX  #=@   Q8P  *F8  "1I"0 A:A  (&H7 !]J(  >:R@ '6LP
M !QK.0 ;:T( &FQ, !EL6  7;&4 %FQT !1LA@ 3;)H $FRO !%LR@ 1:^\
M$FG_ !-H_P 3:/\ $V?_ )E=  "%70  =5P  &A<  !>7   55P  $M>  !"
M80  .60  #)G   K:@  )&T  !YP 0 7<PL %701 !1T&  3="$ $G4I !%U
M,@ 1=3L $'5&  ]U4@ .=5\ #75N  QU@0 +=94 "G6J  ATPP )=.< "G/]
M  MQ_P ,<?\ #'#_ )%B  !_80  <&$  &1A  !:80  3V(  $5E   \:
M,VP  "MO   D<@  '78  !=Y   1? 0 #7\,  M_$@ *?QD "7\B  A_*@ &
M?S0 !7\_  1_2P "?U@  7]G  !_>0  ?XX  '^C  !^NP  ?>   'WW  !\
M_P  >_\  'O_ (EG  !X9P  :V8  &%F  !49P  26D  #]M   U<0  +'4
M "1Y   =?   %H   !"#   ,A@( !HD*  &)#P  B10  (H;  "*(P  BRP
M (LW  "+0P  BU   (M?  "+<0  BX8  (N<  "*LP  B=,  (CS  "(_P
MA_\  (?_ ()M  !S;   :&P  %IM  !.;P  0G,  #AW   N>P  )8   !V$
M   5B   $(P   N/   $D@   )0&  "5#   E1   )85  "7'   F"0  )@N
M  "9.0  F4<  )E6  "9:   F7T  )F4  "8JP  E\@  );N  "6_P  E?\
M )7_ 'MT  !O<P  87,  %-V  !&>@  .W\  #"$   FB   '8T  !22   .
ME@  "9D   &<    H    *$   "B!@  H@P  *00  "E%   I1P  *<D  "H
M+P  J#T  *E,  "I7@  J7(  *B)  "HH@  J+P  *?E  "F^P  IO\  *7_
M '=[  !H>P  67X  $N"   ^AP  ,HT  ">2   =EP  %)P   Z@   'I
M *@   "K    K@   *\   "P    L00  +,*  "T#@  M1,  +8;  "X)
MNC$  +I   "Z4@  NV4  +M]  "ZEP  NK$  +K2  "Z\P  N?\  +G_ &^#
M  !?A@  48L  $.0   VEP  *IT  !^B   5IP  #:P   6P    M    +<
M  "[    O@   +\   #     P0   ,,!  #$!P  Q0T  ,<1  #*&0  S20
M ,XS  #/1   T%@  -!N  #1B   T*0  -#!  #1Y@  T?@  -'_ &>/  !7
ME   29H  #NA   NIP  (:T  !:S   .N   !KP   #     PP   ,8   #+
M    S0   ,X   #0    T0   -0   #6    V@(  -P)  #?#P  XQ<  .8D
M  #G-@  Z$D  .E?  #J>   ZY0  .NO  #KS   [.@  .SV %^>  !0I
M0JL  #2R   FN0  &;X   ["   $Q0   ,H   #-    T0   -@   #;
MWP   .    #B    Y    .8   #I    ZP   .X   #Q!0  ]0T  /D6  #\
M)0  _3D  /Y/  #_9P  _X(  /^=  #_M0  _\L  /_D /\ $0#_  \ _P /
M /\ $0#_ !8 _P B /\ +P#_ #L _P!' /\ 4@#_ %L _P!D /\ ; #_ ',
M_P!Z /\ @ #_ (8 _P", /X DP#] )D ^P"A /H J0#X +0 ]P#" /8 V@#U
M /$ ] #_ /, _P#S /\ Z0#_ .  _P#8 /\ TP#_ /\ #@#_  L _P * /\
M"P#_ !$ _P = /\ *@#_ #8 _P!! /\ 3 #_ %8 _@!? /L 9@#Y &T ]P!T
M /4 >@#T (  \@"& /  C0#O )0 [0"; .P I #J *X Z0"Z .< S0#E .D
MY #[ ., _P#B /\ W@#_ -$ _P#, /\ R #_ /\ "0#_  0 _P ! /\ ! #_
M  X _P 8 /\ ) #] #  ^P [ /< 1@#S %  [P!9 .P 8 #J &< YP!N .8
M= #D 'H X@"  .  AP#> (X W "5 -H G@#6 *@ U "S -$ PP#/ -\ S@#T
M ,P _P#+ /\ RP#_ ,4 _P"_ /\ O #_ /\  @#_    _P   /\   #]  L
M]P 3 /$ '@#M "H Z@ U .< 0 #B $H W0!2 -D 6@#5 &$ T@!G -  ;0#.
M ', S !Z ,H @ #( (< Q@"/ ,0 F #" *$ P "M +X NP"\ -  N@#M +D
M_@"X /\ N #_ +< _P"S /\ L #_ /\   #_    _P   /D   #N  4 Y0 .
M -X & #8 ", T@ N ,\ .0#+ $, QP!, ,0 5 #! %L OP!A +P 9P"[ &T
MN0!S +< >@"U ($ M ") +( D@"P )L KP"G *P M "K ,8 J0#D *< ^ "F
M /\ I@#_ *4 _P"E /\ I #_ /\   #_    ]0   .H   #>    T  * ,@
M$@#" !T O@ H +L ,P"Y #T M0!& +( 30"P %4 K0!; *P 80"J &< J !M
M *< <P"E 'H I "" *( C "@ )8 GP"A )T K@"; +X F0#8 )< \0"6 /\
ME@#_ )< _P"7 /\ EP#_ /\   #U    YP$  -0   #)    P  $ +@ #@"S
M !8 KP A *L + "H #8 I@ _ *, 1P"A $\ GP!5 )T 6P"; &$ F@!G )@
M;@"7 '4 E0!] )0 A@"2 )$ D "< (X J0", +@ BP#- (D ZP"( /T B #_
M (@ _P"( /\ B #_ /D&  #I#   U X  ,,,  "W"0  L (  *L "0"F !
MH@ : )X )0"; #  F  Y )8 00"4 $D D@!0 )  5@". %P C0!B (L :0"*
M '  B !X (< @0"% (P A "8 (( I0"  +0 ?@#( 'T!YP!\ OD >P/_ 'L$
M_P![!/\ >P3_ /$.  #>%0  Q14  +04  "I$0  H0X  )X*  "; PP EP 3
M ), '@"0 2D C0(S (H#/ "(!$, A@5+ (4&40"#!E< @@=> ( '9 !_"&P
M?0AT 'P(?@!Z"8D > F6 '<*HP!U"K, <PO' '(,Y@!P#?L < W_ &\-_P!O
M#?\ ;PW_ .@6  #0'@  N1T  *D<  "=&@  E18  ) 3  "/#@, C@H. (D+
M%P"&#", @PTM ( --@!^#CX ? Y& 'L.30!Y#U, >!!: '8080!U$&@ <Q!Q
M '$1>P!P$8< ;A&4 &P1H@!K$K( :1+' &@3YP!F$_T 913_ &44_P!E$_\
M91/_ -\>  #&)   L"0  * C  "4(0  BQ\  (8;  "#%P  @A(( '\1$@!\
M$AT >10H '84,0!T%3H <A9! '$62 !O%T\ ;A=6 &P770!K&&0 :1AM &@9
M=P!F&8, 9!F0 &,:GP!A&J\ 8!K$ %X;Y !='/L 7!S_ %P;_P!<&_\ 7!O_
M -4E  "]*@  J"D  )@I  ",*   @R4  'TB  !Y'P  >!L# '89#P!R&A@
M;QPC &T=+0!K'34 :1X] &@>1 !F'TL 91]2 &,@60!B(&$ 82!I %\A<P!=
M(7\ 7"&- %HBG !9(JP 5R+  %8CX0!5(_D 5"/_ %0B_P!4(O\ 5"+_ ,TK
M  "V+@  HBX  )(N  "%+0  ?"L  '8H  !R)@  ;R,  &TA# !J(A4 9R,?
M &4D*0!C)#$ 8B4Y & F00!?)D@ 729/ %PG5@!;)UT 62=F %@H< !6*'P
M5"B* %,IF0!1*:H 4"F^ $\IW@!.*?< 32G_ $TI_P!-*/\ 3BC_ ,@P  "P
M,@  G#(  (PR  " ,0  =C   ' M  !K*P  :"D  &8H"0!C*!$ 8"D< %XJ
M)0!<*RX 6RLV %DL/0!8+$0 5RU, %4M4P!4+5L 4RUC %$N;@!0+GH 3BZ(
M $POEP!++Z@ 22^[ $@OVP!(+_8 1R__ $<N_P!'+?\ 2"W_ ,0T  "K-0
MES4  (<U  ![-0  <C0  &LR  !F+P  8BX  %\M!0!<+A  6B\8 %@P(@!6
M,"L 53$S %,Q.@!2,D( 43)) % R4 !.,U@ 33-A $LS:P!*,W< 2#2% $<T
ME0!%-*8 0S2Y $(TU@!"-/0 0C3_ $(S_P!",O\ 0C+_ , X  "G.   DS@
M (,X  !W.   ;3<  &8V  !A,P  73(  %DR @!7,PT 5#05 %(U'P!1-2@
M3S8P $XV. !,-S\ 2S=& $HW3@!).%8 1SA? $8X:0!$.'4 0SB# $$YDP!
M.:0 /CFX #TYTP \.?, /#C_ #TW_P ]-_\ /3;_ +L[  "B.P  CSL  '\[
M  !S.P  :CH  &(Y  !=-P  6#8  %0W  !1. L 3SD3 $TY' !+.B4 2CHM
M $@[-0!'.SP 1CQ$ $4\2P!$/%, 0CQ< $$]9P _/7, /CV! #P]D0 Z/:,
M.3VV #@]T0 W/?( -SS_ #@[_P X._\ .#K_ +8]  ">/@  BSX  'P^  !O
M/@  9CT  %X]  !8.P  4SH  $\[  !,/ @ 23T1 $<^&0!&/R( 1#\J $,_
M,@!"0#H 04!! $! 20 ^05$ /4%: #Q!9  Z07  .$%_ #=!CP U0J$ -$*T
M #)"S@ R0?  ,D#_ #- _P S/_\ -#[_ +%   ":0   AT   'A!  !L00
M8D   %M   !4/P  3C\  $I   !&004 1$(. $)#%@! 0Q\ /T0G #Y$+P \
M1#< .T4^ #I%1@ Y14X .$98 #9&8@ U1FX ,T9\ #%&C0 P1I\ +D:S "U&
MS  M1N\ +47_ "Y$_P N0_\ +D/_ *Q#  "60P  @T,  '1#  !H0P  7T,
M %=#  !00P  2$,  $1%  !!1@$ /D<, #Q($P Z2!P .4DD #A)+  V230
M-4H[ #1*0P S2DP ,DI5 #!+7P O2VL +4MZ "Q+BP J2YT *$NQ "=+R@ G
M2^T )TK_ "A)_P H2/\ *4?_ *=&  "11@  ?T8  '!&  !E1@  6T8  %1&
M  !,1P  1$@  #]*   [2P  -TP) #5-$  S3A@ ,DX@ #%/*  P3S  +T\X
M "Y/0  L4$@ *U!2 "I07  H4&@ )U!W "50B  D4)L (E"O "%0R  @4.L
M(4__ ")._P B3?\ (TW_ *%)  ",20  >DD  &Q*  !A2@  6$H  %!*  !)
M2P  0$P  #M.   U4   ,5($ "U3#0 L5!0 *E0< "E5)  H52P )U4S "95
M/  E5D4 )%9. ")660 A5F4 'U9T !Y6A0 <5I@ &U:L !E6Q0 95ND &E7_
M !M4_P ;4_\ '%+_ )M-  "&30  =4T  &A-  !=30  5$T  $U.  !%3P
M/%$  #93   Q50  *U@  "9:"0 C6Q  (EL7 "%<'P @7"< 'UPN !U<-P <
M74  &UU* !I=50 876$ %UUP !5=@0 4794 $UVJ !%=P@ 17>< $EO^ !-:
M_P 36O\ %%G_ )11  " 40  <%$  &11  !940  45$  $E2  !!4P  .%8
M #)9   K6P  )5X  !]A P :8PP &&01 !=D&0 69"$ %60I !1E,0 393H
M$F5$ !%E4  095T #V5K  YE?0 -99$ #&6E  IDO  *9.  "V/Y  QB_P -
M8?\ #6'_ (U5  !Z50  :U4  %]5  !650  3E4  $17   \60  -%P  "Q?
M   F8@  'V4  !EH   3:P4 $&T-  YN$@ -;AH #&XB  QN*P +;C0 "FX^
M  AN2@ ';E< !FYE  1N=@ ";HH  &V?  !MM@  ;-8  &SS  %K_P ":O\
M VK_ (5:  !T6@  9EH  %Q9  !360  2%H  #]=   V8   +F,  "9G   ?
M:@  &6T  !-Q   .= , "G<*  5W$  !=Q4  '<<  !W)   >"T  '@W  !X
M0P  >%   'A>  !X;P  >(0  'B9  !WL   =LT  '7P  !U_P  =/\  '3_
M 'Y?  !N7P  8EX  %E>  !-7P  0F(  #EE   P:   )VP  !]P   8=
M$G<   U[   (?@   H (  "!#0  @1$  ((7  "#'@  @R8  (0P  "$.P
MA$@  (17  "$:   A'P  (23  "#J@  @L4  ('K  "!_@  @/\  (#_ '=E
M  !I9   7V,  %)D  !'9P  /&L  #%O   H<P  ('<  !A\   1?P  #(,
M  :'    B@   (P#  ","0  C0X  (X1  "/%P  D!X  )$G  "2,@  DC\
M )).  "27P  DG,  )*+  "1H@  D;P  )#E  "/_   CO\  ([_ '%K  !F
M:@  6&L  $MM   _<0  -'8  "I[   @@   %X4  !")   +C0  !)$   "5
M    F    )D   ": P  FP@  )P-  ">$0  GQ8  * >  "B*   HC4  *-$
M  "C50  HVD  **   "BF@  H;,  *#8  "@]@  G_\  )__ &YQ  !?<@
M474  $1Y   W?@  +(0  "&*   7CP  $)0   J9   !G0   *    "D
MIP   *@   "I    J@   *P&  "M"P  KQ   + 5  "R'@  M"D  +0Y  "T
M2@  M5T  +5S  "UC@  M:@  +3&  "S[0  LO\  ++_ &9Z  !7?0  28(
M #R'   OC@  (Y0  !B:   0GP  ":0   "I    K0   +    "T    MP
M +@   "Y    NP   +P   "^ @  P @  ,(.  #$%   QQX  ,@L  #)/0
MRE   ,IF  #*?P  RIL  ,JX  #*W0  RO4  ,K_ %Z&  !/BP  09$  #.8
M   GGP  &Z4  !&K   )L    +4   "Y    O0   ,$   #&    R    ,D
M  #+    S    ,X   #0    T@   -0%  #9#   W1(  .$>  #B+@  XT(
M .17  #E;P  YHP  .:H  #EQ0  Y><  .;V %:4  !(FP  .J(  "RI   ?
ML   $[8   N\    P0   ,4   #)    S0   -(   #6    V@   -L   #>
M    X    .(   #D    YP   .D   #M    \ H  /01  #X'P  ^3(  /I(
M  #[7P  _'H  /V7  #]KP  _<<  /WD /\ #@#_  T _P , /\ #@#_ !,
M_P > /\ *@#_ #8 _P!" /\ 30#_ %< _P!? /\ 9P#_ &X _P!T /\ >@#_
M ($ _0"' /P C0#Z )0 ^0"< /< I0#U *\ ] "\ /, SP#Q .P \ #^ .\
M_P#O /\ XP#_ -< _P#. /\ R@#_ /\ "@#_  8 _P $ /\ " #_ !  _P 9
M /\ )0#_ #$ _P ] /\ 1P#^ %$ ^P!9 /D 80#V &@ ] !N /, = #Q 'H
M[P"! .X AP#L (X Z@"6 .@ GP#F *D XP"U .( Q@#@ ., WP#X -T _P#=
M /\ U #_ ,D _P#" /\ O@#_ /\  P#_    _P   /\  0#_  T _P 4 /T
M( #Z "L ]P V /, 00#O $L [ !4 .@ 6P#F &( XP!H .$ ;@#? '0 W !Z
M -H @0#8 (@ U "0 -( F #/ *( S0"N ,L O #) -, QP#P ,8 _P#$ /\
MQ #_ +L _P"V /\ LP#_ /\   #_    _P   /\   #W  @ \  0 .L &@#G
M "4 Y  P .$ .P#< $4 U0!- -$ 50#. %L RP!B ,D 9P#' &T Q0!S ,,
M>@#! ($ OP") +T D@"[ )P N0"G +< M0"U ,@ LP#F +( ^P"Q /\ L #_
M *X _P"J /\ IP#_ /\   #_    _@   /$   #E  ( W  - -, % #- !\
MR@ J ,< - #$ #X P !' +P 3@"Z %4 MP!; +4 80"S &< L@!M +  <P"N
M 'H K "" *H BP"H )4 IP"@ *4 K0"C +X H0#; *  ] "? /\ G@#_ )\
M_P"= /\ FP#_ /\   #\    [@   .    #0    Q0 ( +X $ "Y !D M0 C
M +, +@"P #< K0!  *H 2 "H $\ I0!5 *, 6P"B &  H !F )\ ; "= ',
MFP![ )H A "8 (X E@": )4 IP"3 +< D0#, )  [ "/ /\ C@#_ (X _P".
M /\ CP#_ /P   #O    VP   ,D   "]    M0 " *X # "I !, I0 = *(
M)P"@ #$ G0 Z )H 0@"8 $D E@!/ )0 50"3 %L D0!@ )  9P". &T C0!U
M (L ?@") (D B "5 (8 H@"% +$ @P#$ ($ Y "  /D ?P#_ (  _P"  /\
M@ #_ /0"  #@"0  QP@  +<'  "L P  I@   *  !P";  \ F  7 )4 (0"2
M "H CP S (T / "+ $, B0!) (< 4 "& %4 A !; (, 80"! &@ @ !P 'X
M>0!\ (0 >P"0 'D G0!X *P =@"^ '4 W0!S /0 <P#_ ', _P!S /\ <P#_
M .D-  #/$   N1   *D0  ">#@  EPL  ),&  "0  L C  1 (D &@"& "0
M@P N ($ -@!_ #X ?0!$ 'P 2P!Z %$ >0!7 '< 70!V &0 = !L ',!=0!Q
M 8  ;P*- &X"F@!L ZH :P.[ &D$U@!H!O$ : ?_ &<'_P!G!_\ 9P?_ -\4
M  ##%P  KA<  )X6  "3%0  BQ(  (80  "$# ( @P8- ( #% !\!1X >0<H
M '<(, !U"#@ <PE  '()1@!P"DP ;PI3 &T+60!L"V$ :@MI &D,<@!G#'X
M9@R+ &0-F0!B#:D 80V[ & -V !>#O, 70[_ %T._P!=#O\ 70[_ -0<  "Y
M'0  I!X  )4=  ")'   @1H  'L7  !X$P  >! & '<-#P!S#A@ < XB &X/
M*P!L$#, :A [ &D00@!G$4D 9A%/ &015@!C$ET 81)F & 2;P!>$GL 7!.(
M %L3EP!9$Z< 5Q2Z %84U0!5%?, 5!7_ %05_P!4%?\ 5!3_ ,HB  "P(@
MG2,  (TC  "!(@  >2$  ',>  !O&P  ;A<  &T3# !J%!0 9Q4> &46)P!C
M%B\ 81<W & 7/@!>&$4 71A+ %P94@!:&5H 61EB %<:; !6&G< 5!J% %(;
ME !1&Z0 3QNW $X;T !-'/$ 3!S_ $P<_P!-'/\ 31O_ ,,F  "J)P  EB<
M (<H  ![)P  <B8  &PD  !H(0  9AX  &0;" !B&Q$ 7QP: %T=(P!;'BL
M6AXS %@?.@!7'T$ 5B!( %0@3P!3(%< 42%? % A:0!.(70 32&" $LBD0!)
M(J( 2"*T $<BS0!&(^\ 12/_ $4B_P!&(O\ 1B'_ +PJ  "D*P  D2L  ((L
M  !V*P  ;2H  &8I  !B)@  7R0  %TB! !;(0X 6"(6 %8C'P!4)"@ 4R0P
M %(E-P!0)3X 3R9% $XF3 !,)E0 2R=< $DG9@!()W$ 1B=_ $4HCP!#**
M02BR $ HRP _*.T /RC_ #\H_P! )_\ 0"?_ +<M  "?+@  C"\  'TO  !Q
M+P  :"X  &$M  !=*P  6B@  %<G  !4)PP 4B@3 % I' !.*24 32HL $LJ
M- !**SL 22M" $@L20!&+%$ 12Q: $0L9 !"+6\ 0"U] #\MC0 ]+9X /"VP
M #HMR  Z+>L .BW_ #HM_P Z+/\ .BS_ +(P  ";,0  B#(  'DR  !M,@
M9#(  %TQ  !8+P  52P  %$L  !/+0D 3"T1 $HN&0!)+R( 1R\J $8P,0!%
M,#@ 0S _ $(Q1P!!,4\ 0#%7 #XQ80 ],FT .S)[ #DRBP X,IP -C*O #4R
MQP T,ND -#+_ #4Q_P U,?\ -3#_ *TS  "6-   A#4  '4U  !I-0  8#4
M %DT  !4,P  4#   $PQ  !),08 1S(/ $4S%@!#,Q\ 0C0G $ T+@ _-38
M/C4] #TU1  \-DP .C95 #DV7P W-FL -C9X #0WB0 R-YH ,3>M "\WQ0 O
M-^@ +S;^ # U_P P-?\ ,#3_ *DV  "2-@  @#<  '(X  !F.   73<  %8W
M  !0-@  2S0  $<U  !$-@, 03<- #\X%  ^.!P /#DD #LY+  Z.3, .3HZ
M #@Z0@ V.DH -3I3 #0[70 R.V@ ,#MV "\[AP M.YD +#NL "H[PP I.^8
M*CK] "HZ_P K.?\ +#C_ *0X  "..0  ?#H  &XZ  !C.@  6CH  %,Z  !-
M.@  1C@  $(Z   _.P  /#P+ #H\$0 X/1D -STA #8^*0 T/C  ,SXW #(_
M/P Q/T< ,#]0 "X_6@ M0&8 *T!T "E A  H0)< )D"J "5 P0 D0.4 )#_\
M "4^_P F/?\ )CW_ )\[  "*/   >#T  &H]  !?/0  5CT  $\]  !)/0
M0CT  #P^   Y/P  -D$( #1!#P R0A8 ,4(> "]#)0 N0RT +4,T "Q$/  K
M1$0 *D1- "A$6  G16, )45Q "-%@@ B194 ($6H !]%OP >1., 'T3[ !]#
M_P @0O\ (4'_ )H^  "%/P  =$   &=   !<0   4T   $Q   !&0   /D$
M #A#   T10  ,$8# "U'#0 K2!( *D@: "E((@ H22D )TDQ "5).0 D24$
M(TI* ")*50 @2F$ 'TIO !U*?P ;2I( &DJF !A*O0 72N  &$GZ !E(_P :
M1_\ &D?_ )5"  " 0@  <$,  &-#  !80P  4$,  $E#  !"1   .T4  #5'
M   P20  *TL  "9-"0 D3A  (DX6 "%/'0 @3R4 'T\L !Y/-0 =3ST '%!'
M !I040 94%T %U!K !90?  44(\ $U"D !%0N@ 14-X $4_X !)._P 33?\
M%$W_ (]%  ![1@  :T8  %]'  !51P  34<  $9'   _1P  -TH  #%,   K
M3@  )E   "!3 P <50P &E81 !E6&  75B  %E8G !56,  45CD $U=" !)7
M30 15UD $%=H  ]7>0 .5XP #5>@  M7M@ +5M0 "U;T  Q5_P -5/\ #E/_
M (A)  !V2@  9TH  %M*  !12@  2DH  $-*   [3   ,TX  "Q1   F5
M(58  !M9   57 < $5X- !!>$P 07AH #EXB  Y>*@ -7C, #%X]  M>2  *
M7E0 "%YB  =><P %7H8  UZ;  )>L0 "7<P  EWN  -<_P $6_\ !5O_ (%.
M  !P3@  8DX  %=.  !.3@  1TX  #Y/   V40  +E0  "=7   A6@  &UT
M !5@   08P, #&8+  AG$  &9Q4 !6<<  1G)  "9RT  6<W  !G0@  9TX
M &=<  !G;0  9X   &:5  !FK   9<<  &7K  !D_   9/\  &/_ 'I2  !J
M4P  75(  %12  !+4@  0E,  #E5   P6   *%L  "%?   :8@  %&4  !!H
M   ,:P$ !FX)  !O#@  ;Q(  &\8  !P'P  <"<  '$P  !Q.P  <4@  '%6
M  !Q9@  <7D  '&/  !PIP  ;\$  &_G  !N_   ;?\  &W_ '-8  !E5P
M6E<  %%6  !&5P  /%H  #)=   J80  (F0  !IH   4;   #F\   IR   $
M=@   '@%  !X"P  >0X  'H3  ![&0  ?"   'TI  !],P  ?4   'U.  !]
M7@  ?7(  'V(  !\H0  ?+H  'OB  !Z^@  >?\  'C_ &U=  !@7   5UP
M $M=  ! 7P  -6,  "MG   C:P  &F\  !-S   .=P  "'L   )^    @@
M (,!  "$!@  A0L  (8/  "($P  B1D  (HA  "+*P  BS<  (Q&  "+5@
MBVD  (N   "+F0  BK,  (G8  "(]P  B/\  (?_ &AC  !>8@  46(  $1E
M   X:0  +FX  "1S   :>   $WT   V!   &A0   (D   "-    D    )(
M  "2    E 4  )4*  "7#@  F!(  )H8  ";(0  G"T  )T\  "=3   G%\
M )QV  ";D0  FZL  )K)  ":\   F?\  )C_ &5I  !7:0  26P  #UQ   P
M=@  )7P  !N!   2AP  #(P   21    E0   )D   "=    H    *$   "B
M    I    *4!  "G!P  J0P  *H1  "M&   KR(  *\P  "O00  KU0  *]K
M  "NA0  KJ$  *Z^  "MY@  K/P  *S_ %YQ  !/=   0GD  #5_   HA0
M'8P  !.2   ,F    YT   "B    I@   *H   "N    L    +$   "S
MM    +8   "X    N@0  +P*  "^$   P1<  ,,D  ##-0  Q$D  ,1>  #%
M=P  Q9,  ,6O  #%T0  P_(  ,/_ %9\  !'@@  .H@  "R/   @E@  %)T
M  VC   #J0   *X   "R    MP   +L   "_    P@   ,(   #%    Q@
M ,@   #*    S0   ,\   #2"   U0X  -L8  #=)P  WCH  -]0  #@:
MX(0  .&A  #AO0  X>(  .#T $Z+  ! D@  ,ID  "6A   8J   #J\   6U
M    N@   +\   #$    R    ,X   #1    U    -4   #8    V@   -T
M  #?    X@   .0   #G    ZP4  .\.  #T&0  ]2L  /9!  #W6   ^'(
M /F0  #YJP  ^,0  /CA /\ "P#_  @ _P ) /\ # #_ !( _P : /\ )@#_
M #( _P ^ /\ 2 #_ %( _P!: /\ 8@#_ &D _P!O /\ =0#^ 'L _ "! /L
MB #Y (\ ]P"7 /4 H #S *H \@"W .\ R0#M .8 [ #[ .L _P#K /\ W0#_
M ,X _P#& /\ P@#_ /\ ! #_    _P   /\ !0#_  T _P 5 /\ (0#_ "P
M_P X /\ 0P#] $P ^0!4 /< 7 #T &, \@!I /  ;P#N '4 [ ![ .H @@#H
M (D YP"1 .0 F@#B *0 X "P -T P #: -P V #T -4 _P#3 /\ RP#_ ,$
M_P"[ /\ MP#_ /\   #_    _P   /\   #_  H _0 1 /D &P#V "< ]  R
M /  / #L $8 Z !. .0 5@#A %P W@!C -P : #9 &X U0!T -( >P#0 ((
MS0"* ,L DP#( )T Q@"H ,0 MP#! ,P P #K +X _P"] /\ O0#_ +0 _P"N
M /\ JP#_ /\   #_    _P   /H   #R  4 Z@ . .4 %@#@ "$ W0 K -L
M-@#3 #\ S@!( ,H 3P#' %8 Q !< ,( 80#  &< O@!M +P <P"Z 'H N ""
M +8 BP"T )8 L@"A +  KP"N ,$ K0#@ *L ]P"J /\ J0#_ *8 _P"A /\
MGP#_ /\   #_    ]P   .@   #<    T  * ,H $0#% !L P@ E +\ +P"\
M #@ N !! +4 2 "R $\ L !5 *X 6P"L &$ J@!F *@ ; "G ', I0![ *,
MA "A (X GP": )T IP"; +@ F@#0 )D [P"8 /\ EP#_ )8 _P"4 /\ D@#_
M /\   #V    Y    -(   #%    NP % +4 #@"P !4 K  ? *H *0"H #(
MI0 Z *( 0@"@ $D G@!/ )P 50": %H F !@ )8 9@"5 &P DP!T )( ?0"0
M (< C@"3 (P H0"+ +  B@#% (@ Y@"' /L A@#_ (< _P"' /\ A@#_ /@
M  #E    S0   +T   "S    J@   *, "@"? !$ FP 9 )D (P"7 "P E0 T
M )( / "0 $, C@!) (P 3P"* %0 B0!: (< 8 "& &8 A !N (, =P"! ($
M?P"- 'X FP!\ *H >P"\ 'H VP!X /4 > #_ '@ _P!X /\ > #_ .T   #1
M @  NP(  *P!  "B    FP   )8 !0"1  T C0 4 (L '0"( "8 A@ N (0
M-@"" #T @ !# 'X 20!] $\ ? !5 'H 6P!Y &$ =P!I '4 <0!T 'P <@"(
M '$ E@!O *4 ;@"V &T S@!L .X :P#_ &L _P!K /\ :P#_ -\+  #"#
MK@P  )X,  "3"P  C <  (@"  "%  D @0 0 '\ %P!\ "  >@ H '@ , !V
M #@ =  ^ ', 1 !Q $H < !0 &X 5@!M %T ; !D &H ;0!H '< 9P"$ &4
MD@!D *$ 8P"R &$ R0!@ .D 8 #\ &  _P!@ /\ 8 #_ - 0  "V$0  HA(
M ),2  "($0  @ \  'P-  !Y"0$ > ,+ '4 $0!S !H <  C &X!*P!L 3,
M:@(Y &D#0 !G T8 9@1, &4$4@!C!5D 8@5A & %:@!?!G0 70:! %P'CP!:
M!Y\ 60>P %<'Q@!6">< 5@K[ %4*_P!5"O\ 5@K_ ,85  "M%P  F1@  (H8
M  !_%P  =A8  '$3  !N$   ;0T% &T)#0!J"10 9PH= &4*)@!C"RX 8@PU
M & ,/ !?#$( 7@U( %P-3P!;#58 60U> %@.: !6#G, 50Z  %,.CP!1#I\
M4 ZQ $X.R !-$.H 31#] $T0_P!-$/\ 31#_ +P;  "E'   DAT  (,>  !W
M'0  ;QP  &D:  !F%P  9!0  &00" !B#Q  7Q 8 %T0(0!;$2D 6A$Q %@2
M. !7$CX 5A)% %023 !3$U, 41-; % 390!.%'  3!1] $L4C !)%)P 1Q6N
M $85Q0!%%>@ 11;^ $46_P!%%?\ 117_ +4?  ">(0  BR(  'PB  !Q(@
M:"$  &(?  !?'0  7!H  %L7 @!:%0T 5Q84 %46'0!4%R4 4A@M %$8- !/
M&#L 3AE" $T92 !+&E  2AI8 $@:8@!'&FT 11MZ $,;B0!"&YH 0!NL #\;
MP@ ^'.4 /1S\ #X<_P ^&_\ /AO_ *\C  "8)   AB4  '<F  !L)@  8R4
M %TD  !9(@  5A\  %0=  !3' L 41P2 $X=&@!-'2( 2QXI $H>,0!)'S<
M1Q\^ $8@10!%($T 0R!5 $(@7P! (6H /R%W #TAAP [(9@ .2&J #@BP  W
M(N, -R+[ #<B_P X(?\ ."'_ *HF  "4)P  @2D  ',I  !G*0  7RD  %@H
M  !4)@  42,  $\B  !,(@< 2B(0 $@B%P!'(Q\ 120F $0D+@!")#0 024[
M $ E0P _)4H /293 #PF7  Z)F< .29U #<GA  U)Y8 -">H #(GO@ Q)^$
M,2?Y #(F_P R)O\ ,R7_ *4I  "/*@  ?2P  &\L  !D+0  6RP  %4K  !0
M*@  3"@  $HF  !')P0 1"<- $(H% !!*!P /RDC #XI*P ]*3( /"HY #LJ
M0  Y*D@ ."M0 #8K6@ U*V4 ,RMR #$K@@ P+)0 +BRG "PLO  K+-X +"SX
M "PK_P M*O\ +2K_ *$L  "++0  >2X  &LO  !@+P  6"\  %$N  !,+@
M2"P  $4K  !!*P  /RP+ #TL$0 [+1D .BXA #DN*  W+B\ -B\V #4O/@ T
M+T4 ,R]. #$P6  P,&, +C!P "PP@  J,)( *3"E "<PN@ F,-P )C#W "<O
M_P H+_\ *"[_ )PN  "',   =C$  &@R  !=,@  53(  $XQ  !(,0  1#
M $ O   \,   .C$) #<Q$  V,A8 -3(> #,S)0 R,RP ,3,S # T.P O-$,
M+31, "PT5@ J-6$ *35N "<U?@ E-9  (S6C "(UN0 A-=D (33V "(T_P C
M,_\ (S+_ )@Q  "#,P  <C0  &4T  !:-0  434  $LT  !%-   0#0  #HS
M   W-   -#4& #(V#@ P-Q, +S<; "XW(@ M."D *S@Q "HX.  I.4  *#E)
M "8Y4P E.5\ (SEL "$Z?  @.HX 'CJB !PZMP ;.=4 '#GU !TX_P =./\
M'C?_ ),T  !_-@  ;C<  &$W  !7-P  3C<  $@W  !"-P  /#<  #4X   R
M.0  +SH" "P["P J/!$ *3P8 "@]'P F/28 )3TN "0]-0 C/CT (CY& " ^
M4  ?/EP '3]I !L_>0 :/XP &#^@ !8_M0 5/M( %C[S !<]_P 8//\ &#S_
M (XW  !Z.   :CD  %XZ  !3.@  2SH  $4Z   _.@  .3H  #(\   N/@
M*4   "9!"  D0@X (D(4 "%"&P @0R, 'T,J !Y#,@ <0SH &T1# !I$30 8
M1%D %T1G !5$=P 31(H $D2> !%$LP 01-  $$/R !%"_P 20O\ $T'_ (D[
M  !V/   9CT  %H]  !0/0  2#T  $(]   \/0  -CX  "]    J0@  )40
M "%& P =2 P &TD1 !E)%P 821X %TDF !9)+@ 52C8 %$I  !-*2@ 12E8
M$$ID  ]*=  .2H< #4J;  Q*L  *2LH "TGL  Q(_P -1_\ #4?_ (,^  !Q
M/P  8D   %9   !-0   14   #]    Y00  ,D(  "M%   F1P  (4D  !Q+
M   63@< $U . !)0$P 14!D $% A  ]0*0 .4#$ #5 [  U11@ +45$ "E%?
M  E1;P '4($ !5"6  -0JP "4,4  T_H  -/^P %3O\ !DW_ 'U"  !K0P
M740  %)$  !*1   0T,  #Q$   U10  +D<  "=*   A3   '$\  !=1   2
M5 , #E<*  M8$  *6!4 "%@<  =8)  &6"P !5@V  -80  !6$P  %A:  !8
M:0  6'P  %B1  !7IP  5\   %;E  !6^0  5?\  %7_ '9'  !F1P  64@
M $]'  !'1P  0$<  #A(   P2@  *4T  ")0   <4P  %E4  !%8   -6P(
M"5X)  1?#@  7Q(  %\8  !@'P  8"<  & P  !@.P  8$<  &!4  !@8P
M8'8  &"+  !?H@  7[L  %_B  !>^0  7?\  %W_ &]+  !A3   54P  $Q+
M  !$2P  .TP  #).   K40  (U0  !Q7   66P  $5X   U@   (8P   F8'
M  !G#   9P\  &@3  !I&0  :B$  &HI  !J-   :D   &I-  !J70  :F\
M &J%  !JG0  :;8  &C=  !H]P  9_\  &;_ &E1  !<4   4E   $I/   _
M4   -5,  "U6   D60  '5T  !9@   09   #&<   9J    ;@   &\#  !P
M"   <0T  '(0  !T%   =1L  '8C  !W+   =S@  '9&  !V5@  =F@  '9^
M  !VEP  =;$  '33  !S]0  <_\  '+_ &-6  !850  4%0  $15   Y6
M+UL  "9?   =8P  %6<  !!L   *<   !',   !V    >@   'P   !\ P
M?@@  '\,  "!$   @A0  (0;  "%)   AB\  (8]  "&30  A5\  (5U  "%
MCP  A*D  (/)  ""\0  @?\  (#_ %];  !66@  25L  #U>   R80  )V8
M !YK   5<   #G4   EY   !?@   ($   "%    B    (H   "+    C0$
M (X&  "0"P  D0\  ),4  "5&P  ER8  )<T  "71   EU8  )9L  "5A@
ME:(  )3!  "3Z@  DO\  )+_ %UA  !/80  0F0  #9I   J;@  'W0  !5Y
M   .?P  !X0   ")    C@   )(   "6    F    )H   ";    G0   )\
M  "A P  HP@  *4-  "G$P  J1P  *HH  "J.0  JDL  *IA  "I>@  J)D
M *BU  "GW0  I_@  *;_ %9H  !(;   .G   "YV   B?0  %X0   Z*   '
MD    )8   ":    GP   *,   "G    J@   *L   "M    KP   +$   "S
M    M0   +@%  "Z#   O1(  , <  # +0  P$   +]5  "_;@  OHL  +ZH
M  "^R0  O>\  +S^ $YT  ! >0  ,G\  "6'   9C@  $)4   ><    H@
M *<   "L    L    +4   "Y    O    +T   "_    P0   ,,   #&
MR    ,H   #- @  T L  -42  #6(0  US0  -A)  #98   VGP  -J:  #;
MM0  V]D  -OR $:"   XB0  *Y   !V8   2H   "J<   "N    M    +D
M  "^    P@   ,@   #+    S@   ,\   #2    U    -8   #:    W0
M -\   #B    Y@   .H*  #O$P  \"4  /(Z  #S40  ]&L  /2)  #UI0
M];\  /7= /\ !@#_  , _P % /\ "P#_ !  _P 7 /\ (@#_ "T _P Y /\
M1 #_ $T _P!5 /\ 70#_ &0 _P!J /\ < #] '8 ^P!\ /D @P#W (H ]0"2
M /, FP#P *8 [@"S .L Q #I .0 YP#Y .8 _P#E /\ TP#_ ,< _P"_ /\
MNP#_ /\   #_    _P   /\  @#_  L _P 2 /\ '0#_ "@ _P S /\ /@#\
M $< ^ !/ /0 5P#Q %T [@!C .P :0#J &\ Z !U .8 ? #D (, X@"+ -\
ME0#< )\ V0"K -4 NP#2 -0 SP#R ,T _P#, /\ Q0#_ +H _P"T /\ L #_
M /\   #_    _P   /\   #_  8 ^0 / /4 %P#S "( \0 M .T -P#G $
MX@!) -\ 4 #; %< UP!= -0 8P#1 &@ SP!N ,P =0#* 'P R "$ ,4 C0#"
M )@ P "D +T L@"[ ,8 N0#H +@ _0"W /\ M@#_ *T _P"G /\ HP#_ /\
M  #_    _P   /4   #K  $ Y  , -X $P#9 !P TP F -$ , #, #H R !"
M ,0 2@#  %  O0!6 +L 7 "Y &$ MP!G +4 ;0"S '0 L0!\ *\ A0"M )
MJ@"< *@ J@"F +L I0#: *, ]0"C /\ H@#_ )X _P": /\ EP#_ /\   #^
M    [P   -\   #0    QP ' ,$ #P"\ !< N0 @ +< *@"U #, L  [ *T
M0P"K $D J !/ *8 50"D %H HP!@ *$ 9@"? &T G0!T )P ?0": (@ F "4
M )8 H@"4 +( D@#) )$ ZP"1 /\ D #_ )  _P", /\ B@#_ /P   #L
MV0   ,<   "Z    L0 " *L # "G !( I  ; *$ ) "@ "P G@ U )L / "8
M $, E@!) )0 3P"2 %0 D !: (\ 7P"- &8 BP!M (D =@"( (  A@", (0
MF@"" *H @0"^ (  X "  /D ?P#_ '\ _P!_ /\ ?@#_ /$   #8    P@
M +,   "H    H    )D !P"5  X D@ 5 )  '@". "8 C0 N (H -@"' #T
MA0!# (0 20"" $X @0!4 '\ 60!^ &  ? !G 'H ;P!Y 'H =P"& '4 E !T
M *, <@"U '( SP!Q /$ < #_ '  _P!P /\ <0#_ .$   #$    L    *(
M  "7    D0   (L  @"&  L @P 1 ($ & !_ "$ ?0 I 'P , !Y #< >  ]
M '8 0P!T $D <P!. '( 5 !P %H ;P!B &T :@!K '0 :@"  &@ C@!G )T
M90"O &4 Q@!D .@ 9 #] &, _P!C /\ 9 #_ ,\%  "V!P  HP@  )0(  ")
M!P  @@,  'X   ![  8 =P . '4 $P!R !L <0 C &\ *P!M #( ;  X &H
M/@!I $0 9P!) &8 3P!E %8 8P!= &( 90!@ &\ 7P![ %T B0!< )D 6P"J
M %D OP!9 .$ 6 #X %@ _P!8 /\ 60#_ ,(,  "J#0  EPX  (D.  !]#@
M=@T  '$*  !O!@  ;0 * &L $ !I !8 9P > &4 )@!C "T 80 S &  .0!?
M #\ 70!% %P 2P!; %( 6@!9 %@ 8@!7 &P 50!X %, A@!2 )8 40"G %
MNP!/ =L 3@+T $X#_P!.!/\ 3@/_ +@0  "A$@  CA,  '\3  !T$P  ;!(
M &<0  !E#@  8PL# &,&# !A!!$ 7@,9 %P$(0!;!2@ 608O %@&-0!6!SL
M50=" %0'2 !3"$\ 40A6 % )7P!."6D 30EV $L*A !)"I0 2 JF $<*N@!&
M"M@ 10OS $4,_P!%#/\ 10S_ + 4  "9%@  AQ@  '@9  !M&   91<  %\6
M  !<$P  6A$  %H.!@!:# T 5PP4 %4,' !3#20 4@TK % -,0!/#C@ 3@X^
M $T.10!+#DT 2@Y5 $@/7@!'#V@ 10]U $,0A !!$)4 0!"F #X0NP ]$-P
M/1'V #T1_P ]$/\ /A#_ *D9  "2&P  @1P  '(=  !G'0  7QP  %D;  !5
M&0  4Q8  %(3  !2$0H 4! 0 $X1& !,$2  2A(G $D2+@!($S0 1Q,[ $43
M0@!$$TD 0Q12 $$46P _%&4 /A5R #P5@0 Z%9( .!6D #<5N0 U%=@ -1;U
M #86_P V%O\ -Q7_ *,<  "-'@  >R   &TA  !B(0  6B$  %0?  !0'@
M31L  $P9  !+%@8 218. $<7%0!%%QP 1!@D $(8*@!!&#$ 0!DX #\9/P ]
M&48 /!I/ #H:6  Y&F, -QMO #4;?@ S&Y  ,ANB # ;MP O&], +QSS "\;
M_P P&_\ ,!O_ )T?  "((@  =R,  &DD  !>)   5B0  % C  !+(@  2"
M $8=  !%' ( 0QP, $$<$@ _'1D /ATA #P>)P ['BX .A\U #D?/  W'T0
M-A], #0@5@ S(&  ,2!M "\@?  M(8X +"&@ "HAM0 I(=  *2'R "DA_P J
M(/\ *R#_ )DB  "$)0  <R8  &4G  !;)P  4R<  $PF  !')0  1"0  $(A
M   _(0  /2$) #LA$  Y(A8 ."(> #8C)0 U(RL -"0R #,D.0 R)$$ ,"1*
M "\E4P M)5X *R5K "HE>@ H)8P )B6? "0ELP C)<X (R7P "0E_P E)/\
M)23_ )0E  " )P  ;RD  &(J  !7*@  3RH  $DI  !$*   0"<  #TF   Z
M)0  -R8& #4F#@ T)Q0 ,B<; #$H(@ P*"D +R@P "TI-P L*3\ *RE' "DI
M40 H*EP )BII "0J>  C*HH (2J= !\JL@ >*LP 'BKO !\I_P @*?\ (2C_
M ) H  !\*@  ;"L  %\L  !4+   3"P  $8L  !!*P  /"L  #@J   U*@
M,BL# # K#  N+!$ +2P8 "PL'P J+28 *2TM "@M-  G+CP )BY% "0N3P C
M+EH (2]G !\O=@ =+X@ '"^; !HOL  8+\H &"[M !DN_P ;+?\ &RW_ (PK
M  !X+0  :"X  %LO  !1+P  22\  $,O   ^+@  .2X  #0N   P+@  +2\
M "LP"@ I,1  )S$5 "8Q'  E,B, )#(J ",R,0 A,SD (#-" !\S3  =,U<
M&S-D !HT=  8-(8 %C2: !0SK@ 3,\@ $S/L !0S_P 5,O\ %C'_ (<N  !T
M+P  93$  %@Q  !.,@  1C(  $ Q   [,0  -C$  #$Q   K,P  *#0  "4U
M!@ C-@T (382 " W&0 ?-R  'C<G !TX+@ ;.#8 &C@_ !DX20 7.54 %3EB
M !0Y<0 2.80 $3F8 ! YK0 ..,< #CCK ! X_P 0-_\ $3;_ (,Q  !P,@
M830  %4T  !+-   1#0  #TT   X-   ,S0  "TU   H-P  )#D  " Z @ =
M.PL &SP0 !D]%0 8/1P %STC !8]*P 5/C, %#X\ !(^1@ 1/E( $#Y?  \^
M;P ./H$ ##Z5  L^J0 */L$ "CWD  L]^P ,//\ #3O_ 'TT  !K-@  73<
M %$W  !(-P  03<  #LW   U-P  ,#<  "HY   E.P  (#T  !P_   7008
M%$,- !)#$@ 10Q@ $4,? !!$)P /1"\ #D0Y  U$0P ,1$X "T1;  E$:@ '
M1'P !D20  1#I0 "0[T  T/@  -#]@ $0O\ !D'_ '@X  !G.0  63H  $XZ
M  !%.@  /CH  #@Z   S.@  +3L  "<]   A0   '$(  !=$   31@, #TD*
M  U*#P ,2A0 "TH;  E*(P (2BL !THT  5*/@ $2DD  DI6  !*90  2G<
M $J+  !*H0  2;D  $G=  !)]0  2/\  $C_ '(\  !B/0  53X  $H^  !"
M/0  /#T  #8]   O/@  *4   "-"   =10  %T<  !-*   /3 ( "T\)  =0
M#0 #41$  %$7  !1'@  428  %$O  !1.0  440  %)1  !28   47(  %&'
M  !1G0  4;4  %#8  !0]0  3_\  $__ &Q   !=00  44$  $=!  ! 0
M.4   #)!   J0P  )$8  !Y(   72P  $DX   Y1   +4P$ !E8'  !7#
M6!   %@3  !9&0  6B$  %HI  !:,P  6C\  %I,  !:6@  6FP  %J!  !9
MF0  6;$  %C1  !8]   5_\  %?_ &5%  !810  344  $5$   ^1   -44
M "U'   E2@  'DT  !A0   24P  #E8   I9   $7    %X$  !?"0  8 T
M &$0  !B%0  8QL  &0C  !D+0  9#@  &1%  !D5   9&8  &1[  !CDP
M8ZT  &+,  !A\@  8?\  &#_ %]*  !32@  2DD  $-(   Y20  +TP  "=/
M   ?4@  &%4  !)9   -70  "&    )C    9@   &@!  !I!0  :@H  &L-
M  !M$0  ;A8  ' =  !Q)@  <3$  ' ^  !P3@  <%\  '!S  !OC0  ;Z<
M &[&  !M[P  ;/\  &S_ %I/  !03@  2$T  #U.   S40  *50  "!8   8
M7   $6    QD   &:    &L   !O    <@   '0   !U    =P0  '@)  !Z
M#0  ?!   'T6  !_'@  @"@  ( U  " 10  ?U8  ']K  !_A   ?J   'V^
M  !\Z0  >_\  'K_ %94  !.4P  0E0  #=6   L6@  (E\  !AC   1:
M"VT   -R    =@   'H   !]    @    (,   "$    A@   (<"  ")!P
MBPP  (T0  "0%@  DA\  )(L  "2.P  DDT  )%B  "1>@  CY<  (^T  ".
MX0  C/L  (S_ %59  !(6@  .UT  "]A   D9@  &6P  !%R   *=P   GT
M  ""    A@   (L   ".    D0   ),   "5    EP   )D   ";    G00
M )\*  "B#P  I!8  *8A  "F,0  ID,  *57  "D<   HXX  *.K  "AT
MH/4  )__ $YA  ! 9   ,VD  "=N   ;=0  $7P   N#    B0   (X   "3
M    F    )T   "A    I    *4   "G    J0   *L   "M    L    +(
M  "U"   N X  +P6  "\)0  O#<  +M,  "Z9   N8$  +>B  "WP   M^H
M +?\ $9K   Y<   *W<  !]_   3A@  "XX   &5    FP   *$   "F
MJP   +    "S    MP   +<   "Z    O    +\   #!    Q    ,<   #*
M    S04  -$.  #4&0  U"L  -1   #36   TW0  -.2  #2L   TM,  -+R
M #YY   Q@   (X@  !>1   -F0   Z    "G    K@   +,   "X    O0
M ,(   #&    R@   ,H   #-    SP   -(   #5    V0   -T   #?
MXP   .<%  #K#P  [!\  .TS  #N2P  [V0  .^"  #PGP  \;D  /'8 /\
M  #_    _P $ /\ "0#_  X _P 5 /\ '@#_ "D _P T /\ /P#_ $@ _P!0
M /\ 6 #_ %X _P!E /T :P#[ '$ ^0!W /@ ?@#V (4 \P"- /$ EP#N *(
MZP"O .@ P #F .  XP#X .( _P#; /\ RP#_ ,$ _P"Y /\ M #_ /\   #_
M    _P   /\   #_  D _P 0 /\ &0#_ ", _P N /T .0#Y $( ]0!* /(
M4@#N %@ ZP!> .D 9 #F &H Y !P .( =@#? 'T W0"& -D CP#5 )H T0"G
M ,X M@#+ ,X R0#P ,< _P#% /\ NP#_ +0 _P"M /\ J0#_ /\   #_
M_P   /\   #[  ( ]@ - /$ $P#M !X [  H .D ,@#C #L W0!$ -@ 2P#3
M %$ T !8 ,T 70#+ &, R0!H ,8 ;P#$ '8 P@!^ +\ AP"\ )( N@"? +<
MK0"U ,$ L@#D +$ _0"O /\ K #_ *4 _P"@ /\ G #_ /\   #_    ^P
M .X   #D    W  ( -, $ #/ !@ RP B ,D *P#& #0 P0 ] +T 1 "Z $L
MMP!1 +4 5@"R %P L !A *X 9P"L &X J@!V *@ ?P"F (H HP"6 *$ I0"?
M +8 G0#1 )P \P"; /\ G #_ )8 _P"3 /\ D #_ /\   #V    YP   -,
M  #&    O0 # +@ #0"S !, L0 < *\ )0"N "X J0 V *8 /0"C $0 H0!*
M )\ 3P"= %4 FP!: )H 8 "8 &8 E@!N )0 =P"2 ($ D ". (X G ", *T
MB@## (D Z "( /\ B0#_ (< _P"% /\ @@#_ /,   #C    S    +P   "P
M    IP   *$ " ">  \ FP 6 )D 'P"8 "< E@ O ), -P"1 #T C@!# (P
M20"+ $X B0!4 (< 60"% &  A !G (( ;P"  'H ?@"& 'P E !Z *0 >0"X
M '@ V !W /< > #_ '@ _P!W /\ =0#_ .8   #+    MP   *@   ">
ME@   (\ ! "+  P B  2 (< &0"% "$ A  I (( , !_ #< ?0 ] 'P 0P!Z
M $@ >0!- '< 4P!V %D = !A '( :0!Q ', ;P!_ &T C0!L )T :@"O &D
MR !H .T :0#_ &D _P!I /\ :0#_ -(   "X    I0   )<   "-    A@
M ($   !\  @ >0 . '< % !V !P =  C ', *P!Q #$ ;P W &X /0!L $,
M:P!( &H 3@!H %0 9P!; &4 8P!C &T 8@!X &  AP!? )8 70"H %T O@!<
M .0 7 #[ %P _P!< /\ 7 #_ ,(   "J 0  F ,  (D$  !_ @  >    '0
M  !P  0 ;0 , &L $0!I !< :  > &8 )0!E "P 8P R &( . !@ #T 7P!#
M %X 20!< $\ 6P!6 %H 7@!8 &@ 5P!S %4 @0!4 )$ 4@"C %$ MP!1 -8
M40#U %$ _P!1 /\ 4@#_ +8'  "?"0  C0L  'X,  !S"P  ; H  &@'  !E
M P  8P ' &$ #0!? !, 70 : %P (0!; "< 60 M %@ ,P!6 #D 50 _ %0
M10!3 $L 40!2 %  6@!/ &0 30!O $P ?0!* (T 20"? $@ L@!' ,P 1P#O
M $8 _P!' /\ 1P#_ *P,  "5#@  @Q   '40  !K$   8P\  %X.  !;#
M6@D" %D$"@!7  \ 50 5 %, ' !2 ", 40 I $\ +P!. #4 30$[ $P!00!*
M D@ 20)/ $@"5P!& V$ 10-M $,#>@!" XL 0 .< #\#KP ^ \@ /03J #T%
M_  ]!O\ /@;_ *00  ".$@  ?!,  &X4  !D%   7!,  %82  !3$0  40X
M % ,!0!0"0P 3P<1 $T'%P!+"!\ 20@E $@)*P!'"3$ 1@DX $0*/@!#"D4
M0@I- $ +50 _"U\ /0MK #P+>0 Z#(H . R< #<,KP U#,< -0SI #4-_0 U
M#?\ -@S_ )T3  "'%0  =A<  &D8  !>&   5A@  % 7  !-%0  2A,  $D1
M  !)#@< 2 T. $8-$P!$#1H 0PXA $(.* ! #BX /PXU #X//  ]#T, .Q!+
M #H05  X$%X -A!K #00>0 R$(H ,1"< "\0L  M$,D +1'L "T1_P N$?\
M+Q#_ )<6  ""&0  <1L  &0<  !9'   41P  $P;  !'&@  1!@  $,5  !"
M$P( 01(+ $ 1$  ^$A< /!(> #L3)0 Z$RL .!,R #<3.0 V%$  -!1( #,4
M40 Q%%P ,!5H "X5=P L%8@ *A6: "@5K@ G%<< )A7J "<5_P H%?\ *17_
M )$:  !]'   ;1X  & ?  !6'P  3A\  $@>  !#'0  0!P  #X:   ]&
M.Q<' #D6#@ X%Q0 -A<; #48(@ S&"@ ,A@O #$9-@ P&3T +AE& "T:3P K
M&ED *AIF "@:=  F&H8 )!J9 "(:K0 A&L4 (!KH "$:_@ B&O\ (QK_ (T=
M  !Y'P  :2$  %PB  !2(@  2B(  $0A   _(0  /"   #D>   X&P  -1P$
M #0<#0 R'!( ,!T8 "\='P N'24 +1XL "L>,P J'CL *1]# "<?30 F'U<
M)!]D "(?<@ @'X0 'Q^7 !T?JP ;'\, &Q_G !L?_0 ='_\ 'A[_ (D@  !U
M(@  92,  %DD  !/)0  1R4  $$D   \(P  .",  #4B   S(   ," ! "XA
M"@ L(1  *R$5 "HB'  H(B, )R(I "8C,  E(S@ (R-! "(D2@ A)%4 'R1A
M !TD<  ;)(( &225 !<DJ@ 6),$ %23E !8D_  7(_\ &2/_ (4B  !Q)
M8B8  %8G  !,)P  1"<  #XG   Y)@  -28  #$E   N)   *R4  "DE!P G
M)@X )283 "0G&0 C)R  (B<G "$H+@ @*#8 'B@^ !TH2  ;*5, &2E? !@I
M;@ 6*8  %"F4 !(IJ  1*<  $2CD !$H^P 3*/\ %"?_ ( E  !N)P  7R@
M %,I  !)*@  0BD  #LI   V*0  ,B@  "XH   J*   )BD  "0J!  B*PP
M("L1 !\L%@ =+!T '"PD !LM*P :+3, &"T\ !<M10 6+E  %"Y= !(N;  1
M+GX $"Z2  XNIP -+;T #2W?  TM^0 .+/\ $"S_ 'PH  !J*@  6RL  % L
M  !&+   /RP  #DL   T*P  +RL  "LK   F+   (BX  !\O   <, D &C$.
M !DQ$P 7,1H %C(A !4R*  4,C  $S(Y !(S0P 1,TX $#-;  XS:0 -,WH
M##..  HSH@ (,KD "#+9  @R]  *,?\ "S'_ '<K  !F+0  6"X  $TO  !#
M+P  /"X  #8N   Q+@  +2X  "DN   C,   'S(  !LS   7-04 %#8, !(W
M$0 1-Q8 $3<= ! X)  /."P #C@U  TX/P ,.$H "SA7  DX90 '.'8 !3B*
M  ,XGP !-[4  3?3  (W\0 #-O\ !3;_ ',N  !B,   5#$  $DQ  !!,0
M.3$  #0Q   O,   *S   "4R   @,P  &S8  !<X   3.@( $#P)  T]#@ ,
M/1, "ST9  H](0 )/2D "#TQ  8^.P %/D8  SY2  $^80  /G(  #Z&   ]
MG   /;(  #W0   \\   //\  #S_ &TR  !=,P  4#0  $8T   ^-   -S0
M #(S   M,P  )S0  "(V   =.   &#H  !0]   0/P( #4$(  E##0 &1!$
M T06  )$'0  1"0  $0M  !$-@  1$$  $1.  !$7   1&T  $2!  !$F
M0Z\  $/-  !"\   0O\  $+_ &@V  !8-P  3#@  $,X   [-P  -38  # V
M   I-P  (SD  !X[   8/0  $T   !!"   -10$ "$<'  -)#   20\  $H3
M  !+&0  2R   $LH  !+,@  2ST  $Q)  !,5P  2V@  $M]  !+E   2JP
M $K*  !)[P  2?\  $G_ &(Z  !4.P  23L  $ [   Y.@  ,SD  "PZ   E
M/   'S\  !E!   31   $$<   Q)   (3    D\%  !0"@  4 T  %$0  !2
M%0  5!L  %0C  !4+   5#<  %1$  !44@  5&,  %1W  !4CP  4Z@  %+&
M  !2[0  4?\  %'_ %P_  !//P  13\  #X^   W/0  +SX  "=    @0P
M&48  !-)   /3   "T\   92    5    %<"  !8!P  60L  %H.  !;$0
M718  %X=  !?)@  7S$  %X]  !>3   7ET  %YQ  !=B0  7:,  %S!  !;
MZP  6O\  %K_ %9$  !+0P  0T(  #Q!   R0@  *44  "%(   :2P  $TX
M  Y2   *50   UD   !;    7@   &    !B @  8P8  &4*  !F#@  :!$
M &H7  !K'P  :RD  &LV  !K10  :U8  &IJ  !J@@  :9T  &B[  !GYP
M9O\  &7_ %%(  !(2   048  #='   L2@  (TT  !M1   350  #ED   A=
M   !80   &0   !G    :@   &P   !N    <    '(%  !S"0  =0T  '<1
M  !Z&   >R$  'LN  !Z/0  >DX  'EB  !Y>0  >)8  '>S  !UX   =/P
M '/_ $Y-  !'3   .TT  #!/   F4P  '%@  !-<   -80  !F8   !J
M;P   '(   !V    >0   'P   !]    ?P   ($   "# @  A@<  (@,  "+
M$0  CA@  (XD  ".,P  C40  (Q8  "+;P  BHP  (FJ  "(SP  AO<  (7_
M $U1  !!4P  -%4  "E:   >7P  %&4   UJ   %<    '8   ![    ?P
M (,   "'    B@   (T   ".    D0   ),   "5    F    )H%  "=#
MH!$  *,:  "C*   HCH  *%.  "@90  H($  )Z@  "=P0  F^X  )K_ $99
M   Y7   +6$  "%G   6;@  #G4   5[    @0   (<   "-    D@   )8
M  ":    G0   )\   "A    I    *8   "H    JP   *X   "Q P  M L
M +@1  "Y'@  N2\  +A#  "W6@  M78  +27  "TM0  L>(  +#\ #]D   Q
M:0  )6\  !AW   /?P  !H<   ".    E    )H   "@    I0   *H   "N
M    L0   +(   "U    MP   +H   "\    OP   ,,   #&    R0   ,X*
M  #2$P  TB,  -$W  #03P  SFH  ,V*  #*JP  R\L  ,OO #=Q   I>
M'8   !&)   (D0   )H   "A    IP   *T   "S    N0   +X   #"
MQ0   ,8   #)    S    ,X   #2    U0   -H   #>    X0   .4   #J
M"P  ZQ<  .HK  #J0P  ZEX  .IZ  #KF0  Z[4  .O5 /\   #_    _P !
M /\ !P#_  T _P 2 /\ &P#_ "4 _P O /\ .@#_ $, _P!+ /\ 4P#_ %H
M_0!@ /L 9@#Z &L ^ !R /8 > #T (  \0") .\ D@#L )T Z0"J .8 O #C
M -P WP#W -T _P#, /\ O@#_ +4 _P"P /\ K0#_ /\   #_    _P   /\
M  #_  8 _P - /\ % #_ !\ _P I /L ,P#W #T \P!% .\ 30#L %, Z !9
M .4 7P#C &4 X !J -T <0#: '@ U@"  -( B@#/ )4 S "B ,@ L@#% ,D
MP@#M ,  _P"[ /\ L #_ *@ _P"D /\ H0#_ /\   #_    _0   /H   #X
M    \  ) .P $0#H !D YP C .4 +0#> #8 U@ ^ -$ 1@#- $P R@!2 ,@
M6 #% %T PP!C ,  :0"^ '  O !X +D @0"W (T M ": +$ J0"N +P K #A
M *H _ "H /\ H #_ )D _P"6 /\ E #_ /\   #Y    \@   .<   #;
MT0 $ ,H #0#' !0 Q  = ,( )@"_ "\ NP W +< /P"T $4 L0!+ *X 40"L
M %8 J@!< *@ 80"F &@ HP!P *$ >0"? (0 G0"1 )H H "8 +$ E@#, )4
M\0"4 /\ D0#_ (L _P"( /\ A@#_ /<   #L    W@   ,D   "\    M
M *\ "@"K !  J0 7 *@ ( "G "@ H@ P )\ . "< #X F@!$ )@ 2@"6 $\
ME !5 ), 6@"1 &$ CP!H (T <0"+ 'L B0"( (< EP"% *@ @P"^ ($ Y "
M /\ @ #_ 'P _P![ /\ >0#_ .D   #7    P0   +$   "F    G0   )<
M!0"4  T D@ 2 )  &@"/ "( C@ J (L ,0") #@ AP ^ (4 0P"# $@ @0!.
M '\ 5 !^ %H ? !A 'H :0!X ', =@!_ '4 C@!S )\ <0"S '  T !O /8
M;P#_ &\ _P!M /\ ; #_ -H   "_    K    )X   "3    C    (4   ""
M  D ?P / 'X %0!] !P ?  D 'H *P!W #$ =0 W '0 /0!R $( <0!( &\
M30!N %, ; !: &L 8@!I &P 9P!X &8 A@!D )< 8@"J &$ P@!@ .L 80#_
M &$ _P!A /\ 8 #_ ,4   "M    FP   (T   "#    ?    '<   !R  4
M<  , &X $0!L !< ;  > &L )0!I "P 9P Q &8 -P!D #T 8P!" &( 2 !@
M $X 7P!5 %T 70!< &8 6@!R %D @ !7 )  5@"C %4 N0!4 -X 5 #[ %0
M_P!5 /\ 50#_ +8   "?    C0   '\   !U    ;@   &D   !F  $ 8P )
M &$ #@!@ !, 7P 9 %X ( != "8 6P L %H ,@!8 #< 5P ] %8 0P!5 $D
M4P!0 %( 6 !1 &$ 3P!L $X >@!, (H 2P"< $H L0!) ,X 20#S $D _P!)
M /\ 2@#_ *H!  "4!0  @@<  '0(  !J"   8P8  %X$  !;    60 % %<
M# !6 !  5  5 %, &P!2 "( 40 H %  +0!. #, 30 X $P /@!+ $4 2@!,
M $@ 5 !' %T 1@!H $0 =0!# (4 00"8 $  JP!  ,4 /P#J #\ _P!  /\
M0 #_ * (  "*"P  >0T  &P-  !A#0  6@T  %4+  !2"0  4 8  $\"" !.
M  T 3  2 $L %P!* !X 20 C $< *0!& "\ 10 T $0 .@!" $$ 00!( $
M4  ^ %H /0!D #P <@ Z (( .0"4 #@ IP W +X -@#C #8 ^0 V /\ -P#_
M )@-  "##@  <A   &41  !;$0  4Q   $X0  !*#@  2 T  $<* P!'!PH
M100. $0"$P!" AH 00(@ $ #)0 ^ RL /00Q #P$-P [!#X .@5% #D%3@ W
M!5< -@5B #0&<  R!H  ,0:2 # &I0 O!;L +@7= "X&]0 M!_\ +@?_ )$0
M  !]$0  ;!,  %\4  !5%   3A0  $@3  !$$@  01   $ .  ! #08 0 H,
M #X)$  \"18 .PH< #D*(@ X"B@ -PLN #8+-0 U"SL ,PM# #(,3  P#%8
M+PQA "T,;P K#'\ *@R2 "@,I0 G#+L )0S= "4-]0 F#?\ )PW_ (L2  !W
M%   9Q8  %L7  !1&   21<  $,7   _%0  /!0  #H2   Y$0$ .0\( #@.
M#0 W#A( -0X8 #0.'P R#B4 ,0\L # /,@ O$#H +1!" "P02P J$%4 *!!A
M "80;P D$(  (Q"3 "$0IP ?$+T 'A#@ !X1]P ?$/\ (!#_ (84  !S%P
M8QD  %<:  !-&P  11H  $ :   [&0  .!@  #46   T%   ,Q($ #(2"P Q
M$A  +Q(5 "T2'  L$R( *Q,I "H3,  H$S< )Q0_ "842  D%%, (A1? " 5
M;0 ?%7X '161 !L5I0 9%;L &!7> !@5^  9%/\ &A3_ ((7  !O&@  7QP
M %,=  !*'0  0AT  #P=   W'   -!L  #$:   O&0  +A8  "P7"  K%@X
M*1<3 "@7&0 G&"  )1@F "08+0 C&#0 (AD] " 91@ >&5$ '1E= !L::P 9
M&GP %QJ/ !4:HP 4&;H $AG; !,9]@ 4&?\ %1C_ 'T:  !K'0  7!\  % @
M  !'(   /R   #D?   T'P  ,1X  "T=   K'   *1L  "<;!0 E&PP )!P1
M "(<%@ A'!T (!TC !\=*@ >'3( '!XZ !L>1  9'DX %QY; !8>:0 4'WH
M$AZ- !$>H@ 0'K@ #A[8  \>]0 0'?\ $1W_ 'H=  !G'P  62$  $TB  !$
M(@  /"(  #8B   R(0  +B$  "H@   G(   )!\  "(@ @ @( H 'B$/ !TA
M%  <(1H &R(A !DB)P 8(B\ %R(X !4C00 4(TP $B-8 !$C9P 0(W@ #B.+
M  TCGP ,([0 "R/0  LB\  ,(O\ #2'_ '8?  !D(@  5B,  $LD  !!)
M.B0  #0D   O(P  *R,  "@C   D(P  (",  !TD   ;)0< &28- !<F$0 6
M)A< %2<> !0G)0 3)RP $B<U !$H/P 0*$H #BA6  TH9  ,*'0 "BB'  DH
MFP ')[$ !2?,  8G[  ')OX "";_ '$B  !@)   4R8  $@G   _)P  -R8
M #$F   M)@  *24  "4E   B)0  '2<  !DH   6*@0 %"L+ !(L$  1+!0
M$"P; ! L(@ .+"D #BTR  TM.P ++48 "BU2  @M8  &+7  !"V#  (MF
M+*X  "S)   LZP !*_P  BO_ &TE  !=)P  3R@  $4I   \*0  -2D  "\H
M   K*   )R<  ",G   ?*   &RH  !<L   3+@( $# (  XQ#0 -,1( ##$7
M  LQ'@ *,28 "#(N  <R-P %,D(  S).  $R7   ,FP  #)_   RE0  ,:P
M #''   PZ@  ,/P  ##_ &@I  !8*@  3"L  $$L   Y+   ,BL  "TK   I
M*@  )2H  " K   <+   %RX  !,P   0,@( #C0'  HW#  '-Q  !3<4  ,W
M&P "-R(  #<J   X,P  .#X  #A*   X6   .&@  #A\   WD@  -ZD  #;%
M   VZ@  -OT  #7_ &,L  !4+@  2"\  #XO   V+@  ,"X  "LM   G+0
M(BT  !TO   8,0  %#,  ! U   .-P$ "CH'  8["P "/ X  #T2   ^%P
M/AX  #XF   ^+P  /CH  #Y&   ^5   /F0  #YW   ^CP  /:<  #W#   \
MZ0  //T  #O_ %XP  !0,0  1#(  #LR   T,0  +C   "DO   D,   'C(
M !DT   4-@  $#D   T[   */0  !4 %  !!"@  0@T  $,0  !$%   11H
M $8B  !&*P  1C4  $9!  !&3P  1E\  $9S  !%B@  1:0  $3   !#Z
M0_X  $+_ %@T  !+-0  034  #DU   R-   +3,  "8T   @-0  &C@  !0Z
M   0/0  #4    E"   $10   $<#  !(!P  2@L  $L.  !,$0  3A4  $\<
M  !/)0  3R\  $\\  !/2@  3UH  $YM  !.A0  3:   $R\  !+YP  2_X
M $K_ %,Y  !'.0  /CD  #<X   Q-P  *3<  "$Y   ;/   %3\  !!"   ,
M10  !T@   )*    30   $\   !1!   4@<  %0+  !5#@  5Q$  %D7  !:
M'P  62D  %DV  !91   650  %AG  !8?P  5YH  %:W  !5XP  5/T  %3_
M $X]  !#/0  /#P  #4[   L/   )#X  !Q!   51   $$@   M+   %3@
M %$   !4    5P   %D   !;    70(  %X&  !@"P  8@X  &02  !G&
M9R(  &8N  !F/   9DT  &5@  !E=P  9),  &.Q  !AW0  8/P  %__ $E"
M  !!00  .C\  #!    F0P  'D8  !5*   03@  "E(   -6    6@   %T
M  !@    8P   &4   !G    :0   &L!  !M!0  ;PH  '(.  !U$@  =QL
M '8F  !V-0  =48  '19  !T;P  <XL  '*I  !PS0  ;_<  &[_ $9&  !
M10  -48  "I(   @3   %U$  !!6   )6@   5\   !C    :    &L   !O
M    <@   '4   !W    >0   'L   !]    @ ,  (,(  "&#0  B1,  (H=
M  "**P  B3P  (A/  "&9@  A8$  (2@  ""P@  @?   '__ $9+   Z3
M+D\  "-3   86   $%X   ED    :0   &\   !T    >    'P   "!
MA    (<   "(    BP   (X   "0    DP   )8   "9!P  G0T  *$4  "@
M(0  H#$  )Y$  "=6P  G'8  )F6  "9M0  EN4  )7^ #]2   R50  )EH
M !M@   19P  "6T   !T    >P   ($   "&    BP   )    "4    EP
M )D   "<    GP   *$   "D    IP   *H   "M    L08  +4-  "X%@
MMR8  +8Y  "U4   M&H  +*)  "PJ@  KL\  *WU #=<   K80  'F@  !-P
M   +>    (    "'    C@   )4   ":    GP   *0   "H    K    *T
M  "P    LP   +4   "X    NP   +\   ##    QP   ,L%  #1#@  T1L
M - N  #/10  S5\  ,M^  #)G@  R+X  ,7I "]I   C<   %GD   V!   !
MBP   ),   ";    H@   *@   "N    M    +@   "]    P    ,(   #%
M    R    ,L   #.    T0   -8   #;    WP   .0   #H!@  ZQ$  .HC
M  #J.@  Z50  .=R  #EDP  X[,  ./4 /\   #_    _P   /\ ! #_  L
M_P 0 /\ %P#_ "$ _P K /\ -0#_ #X _P!' /\ 3@#_ %4 _ !; /H 80#X
M &8 ]@!M /0 <P#R 'L [P"$ .T C@#J )D Y@"G ., N0#? -4 VP#W -8
M_P#  /\ L@#_ *H _P"E /\ H@#_ /\   #_    _@   /P   #\  , _@ +
M /\ $0#_ !H _0 D /D +@#T #@ \ !  .P 2 #I $X Y@!4 .( 6@#? %\
MW !E -@ :P#4 '( T ![ ,T A0#* )$ QP"> ,, K@#  ,4 O0#K +L _P"P
M /\ I #_ )P _P"8 /\ E0#_ /\   #Z    ]    /$   #R    Z@ % .<
M#@#B !4 X0 > .$ * #8 #$ T  Y ,L 0 #( $< Q0!- ,( 4P"_ %@ O0!>
M +L 9 "Y &L M@!S +0 ? "Q (@ K@"5 *L I "H +@ I@#< *, ^P"? /\
ME0#_ (\ _P"+ /\ B0#_ /D   #O    YP   -\   #/    R    ,$ "@"_
M !$ O  8 +L (0"Y "H M  R +$ .@"N $  JP!& *@ 3 "F %$ HP!6 *$
M7 "? &, G0!J )L <P"9 'X E@", )0 FP"2 *T D #' (X \ "- /\ A@#_
M (  _P!] /\ ? #_ .T   #@    T0   +\   "S    J@   *8 !0"B  T
MH0 3 *  &P"? ", FP K )@ ,@"5 #D DP _ )$ 1 "/ $H C@!/ (P 50"*
M %L B !C (8 :P"$ '8 @@"" (  D@!^ *, ? "Z 'H X0!Y /\ =P#_ '(
M_P!P /\ ;P#_ -T   #+    M@   *<   "=    E    (X  0"+  H B0 0
M (@ %0"' !T AP E (0 + "" #( ?P X 'T /0![ $, >0!( '@ 3@!V %0
M=0!; ', 8P!Q &X ;P!Z &T B0!L )H :@"N &D S !H /8 9P#_ &4 _P!D
M /\ 8P#_ ,H   "T    H0   ),   ")    @@   'L   !X  4 =@ , '4
M$0!T !@ <P ? '( )0!P "P ;@ R &P -P!J #P :0!" &@ 2 !F $X 90!5
M &, 70!B &8 8 !R %X @ != )( 6P"E %H O@!9 .D 60#_ %D _P!8 /\
M6 #_ +D   "B    D    (,   !Y    <0   &T   !I  $ 9@ ) &4 #@!D
M !, 8P 9 &, ( !A "8 8  L %X ,0!< #< 6P \ %H 0@!8 $@ 5P!/ %8
M5P!4 &  4P!L %$ >0!0 (H 3P"> $X M !- -H 30#[ $T _P!- /\ 30#_
M *H   "4    @@   '4   !K    9    &    !=    6@ % %@ # !7 !
M5@ 5 %8 &P!5 "$ 4P G %( + !1 #$ 3P W $X /0!- $, 3 !* $H 4@!)
M %L 2 !F $8 <P!% (0 1 "7 $, K !" ,D 0@#Q $( _P!# /\ 0P#_ )X
M  ")    > ,  &H$  !A!   6@,  %4!  !2    4  " $X "0!-  T 3  1
M $L %P!* !P 20 B $@ )P!' "T 10 R $0 . !# #X 0@!% $$ 30 _ %8
M/@!A #T ;@ [ 'X .@"1 #D I@ X +\ . #H #@ _P Y /\ .0#_ )4#  "
M!P  ;PD  &(*  !8"P  40H  $P(  !)!@  1P,  $8 !@!$  L 0P / $(
M$P!! !@ 00 > #\ (P ^ "D /0 N #L -  Z #H .0!! #@ 20 W %( -@!=
M #0 :@ S 'H ,@", #$ H0 P +@ +P#> "\ ^0 O /\ , #_ (P)  !X#
M: T  %P.  !2#@  2PX  $4-  !!#   /PH  #X( @ ]! @ / $- #L $  Z
M !4 .0 : #@ (  V "4 -0 K #0 ,  S #< ,@ ^ #$ 1@ O %  +@!: "T
M9P K '< *@") "D G0 H +, )P#1 "< \@ G /\ )P#_ (8,  !R#@  8Q
M %81  !-$0  11$  $ 0   \#P  .0X  #<-   V"P0 -@@* #4&#@ T!1(
M,@07 #$%'  P!2( +P4H "X&+@ M!C0 *P8\ "H&1  I!TX )P=9 "8'90 D
M!W4 (P>' "('FP @!K  ( ;+ !\%[0 ?!OX 'P?_ ( .  !M$0  7A(  %(3
M  !($P  01,  #L3   W$@  -!$  #(0   P#P$ , T& # +"P O"A  +0H4
M "P+&0 J"Q\ *0LE "@,*P G##( )@PZ "0,0P C#$T (0U8 " -90 >#74
M' V( !H-G  9#;$ & S* !<,ZP 7#?P & S_ 'L1  !I$P  6A4  $X6  !%
M%@  /18  #@5   S%0  ,!0  "T3   K$@  *A # "H/"  I#@T * X1 "8.
M%@ E#QT ) \C ",/*0 A$#$ (! Y !X00@ =$$P &Q!8 !D09@ 7$'8 %1")
M !00G@ 2$+, $1#. !$0[@ 2$/X $A#_ '<3  !E%0  5Q<  $L8  !"&0
M.AD  #08   P%P  +!<  "D6   G%0  )A0! "42!  C$@L (A(/ "$2%  @
M$AH 'A,@ !T3)P <$RX &A,V !D40  7%$H %A16 !049  2%'0 $12' ! 4
MG  .%+$ #13*  T4ZP .$_X #A/_ ',5  !A&   4QH  $@;   _&P  -QL
M #(:   M&@  *1D  "88   D&   (A<  " 6 0 >%@@ '18- !L7$@ :%Q<
M&1<= !@8)  6&"L %1@T !08/0 2&4@ $1E4 ! 98@ .&7( #1F$  P9F  *
M&:T "1C&  D8YP )&/H "A?_ &\8  !>&@  4!P  $4=   \'0  -1T  "\=
M   J'   )AL  ",;   A&@  'AH  !P:   :&P4 &!L, !8<$  5'!4 %!P;
M !,<(@ 2'2D $1TQ ! =.P .'44 #1Y1  P>7@ *'FT "1Z   <>E  %':H
M QW"  ,=Y@ $'/@ !1S_ &L:  !;'0  31X  $(?   Z'P  ,A\  "T?   H
M'@  )!X  "$=   >'0  '!T  !@>   5'P( $R ) !(A#@ 0(1( $"$8  XA
M'P .(B8 #2(N  PB-P *(D$ "2)-  <B6@ %(FD  R)\  $BD0  (J@  "'
M   AY0  (/@  "#_ &<=  !7'P  2B$  $ A   W(@  ,"$  "HA   F(
M(B   !\?   <'P  &2   !8A   2(P( $"0'  XF#  ,)A  "R85  HF'  )
M)B( ""8J  8G,P $)ST  R=)  $G5@  )V8  "=Y   GCP  )J8  ":_   E
MY   )?D  "3_ &,@  !4(@  1R,  #TD   T)   +B,  "@C   D(@  (2(
M !XA   :(@  %R,  !,D   0)@( #B@'  LJ"P (*PX !BL3  0K&  "*Q\
M 2PG   L,   +#H  "Q%   L4P  +&,  "QV   LC   *Z0  "N^   JY
M*OH  "G_ %\C  !0)0  1"8  #HF   R)@  *R8  "8E   C)   'R0  !LD
M   7)0  %"<  !$I   .*P( "RT&  <O"P $, X  # 1   Q%0  ,1P  #$C
M   R+   ,C8  #)"   R3P  ,E\  #)R   QB0  ,:(  #"\   PY   +_L
M "__ %HG  !,*   0"D  #<I   O*0  *2@  "4G   A)@  '"<  !@H   4
M*@  $2P   XN   +, $ !S(%  ,T"0  -0P  #8/   W$@  .!@  #@@   X
M*   .#(  #D]   Y2P  .5L  #AN   XA0  -Y\  #>Z   VY   -?P  #7_
M %4J  !(+   /2P  #0L   M*P  *"H  "0I   >*@  &2L  !0M   1+P
M#3$   HT   '-@   C@$   Z!P  .PH  #T-   ^$   0!0  $ ;  ! )
M0"X  $ Y  ! 1P  0%8  $!I  ! @   /YL  #ZW   ]XP  //P  #S_ % O
M  !#+P  .2\  #(O   L+0  )RP  " M   :+P  %3$  !$S   --@  "3@
M  4[    /0   $ !  !!!   0P<  $4+  !&#@  2!$  $H6  !*'@  2B@
M $HT  !)0@  25$  $ED  !(>P  2)<  $>T  !&X   1?P  $3_ $HS   _
M,P  -C,  # Q   J,   (S$  !PS   6-0  $3@   T[   (/@   T$   !#
M    1@   $@   !*    3 0  $X'  !/"P  40X  %02  !5&0  52(  %0N
M  !4/   5$L  %->  !3=   4I   %&N  !0UP  3_L  $[_ $4W   \-P
M-38  "\T   F-0  'C<  !<Z   1/0  #$$   =$    2    $H   !-
M4    %,   !5    5P   %@"  !;!@  70L  %\.  !B$P  8AL  &(G  !B
M-   844  &!7  !@;0  7XD  %VG  !<S   6O@  %G_ $$\   Z.P  -#D
M "HZ   A/   &$   !%#   ,1P  !DL   !/    4P   %8   !9    7
M %\   !A    8P   &4   !G 0  :@4  &T*  !P#@  <Q4  '(@  !R+0
M<3T  '!/  !O90  ;H   &V?  !KP0  :?$  &C_ #]    Y/@  +C\  "1"
M   :1@  $DH   Q/   $5    %@   !=    80   &4   !H    :P   &X
M  !Q    <P   '4   !X    >P   'X#  "!"@  A0\  (<7  "&)   A30
M (1&  ""70  @78  '^6  !^M@  ?.<  'K_ #]$   S10  *$@  !U,   3
M4@  #%<   -=    8P   &@   !M    <0   '8   !Z    ?@   ($   "#
M    A@   (D   "+    C@   )(   "5 0  F0D  )X0  ">&@  G2D  )P\
M  ":4@  F&P  ):+  "4J@  DM0  )#Z #A+   L3@  (%,  !59   -8
M V<   !N    =    'H   "     A    (H   ".    D@   )4   "7
MF@   )T   "@    HP   *<   "K    KP   +0)  "X$   MQX  +4P  "S
M1@  L6   *]^  "LH   J\$  *GN #%5   D6P  &&$   YI   %<0   'D
M  "!    B    (\   "4    F@   )\   "D    J    *D   "L    KP
M +,   "U    N0   +T   #!    Q@   ,L   #1"@  TQ0  -$E  #0.P
MS50  ,IQ  #(D@  Q;,  ,/> "EB   <:0  $7$   =[    A    (T   "5
M    G0   *,   "I    KP   +0   "Y    O    +X   #"    Q0   ,@
M  #,    T    -0   #:    WP   .0   #J    [@P  .T:  #L+P  ZDD
M .AE  #FA@  Y*4  .+& /\   #_    _P   /P  0#\  @ _@ . /\ % #_
M !T _P F /\ , #_ #H _P!" /\ 20#^ %  ^P!6 /D 7 #V &( ] !H /(
M;P#P '8 [0!_ .H B0#G )4 Y "C .  M0#; -  U0#V ,H _P"V /\ J #_
M )\ _P": /\ E@#_ /\   #[    ]@   /,   #S    ]@ ) /H #@#] !8
M^P @ /< *@#R #, [0 [ .D 0P#F $D X@!/ -X 50#; %L U@!@ -( 9P#/
M &X S !V ,D @ #& (P P@": +\ J@"[ ,$ N #I +8 _P"G /\ F@#_ )(
M_P"- /\ B@#_ /H   #Q    Z@   .<   #G    Y  ! .  "P#; !$ V@ :
M -L (P#1 "P R@ T ,8 .P#" $( OP!( +P 3@"Z %, N !9 +8 7P"S &8
ML0!N *X =P"L (, J0"1 *8 H0"C +4 H #8 )X ^P"5 /\ BP#_ (4 _P"
M /\ ?@#_ .\   #C    V@   -,   #&    OP   +D !@"W  X M  4 +0
M'0"S "4 K@ M *L - "G #L I !! *$ 1@"? $P G0!1 )L 5P"9 %X EP!E
M )4 ;@"3 'D D "' (X EP", *D B0#$ (@ [P"% /\ ? #_ '8 _P!S /\
M<@#_ .    #0    Q@   +8   "I    H0   )T  0"9  H F  0 )@ %@"7
M !X E  F )$ +0"/ #0 C  Z (H /P"( $4 AP!* (4 4 "# %8 @0!> (
M9@!^ '$ ? !] 'D C0!W *  =0"V ', WP!R /\ ;@#_ &D _P!G /\ 90#_
M ,P   "^    JP   )T   "3    B@   (4   ""  4 @  - '\ $0!_ !@
M@  @ 'T )@!Z "T =P S '4 . !T #X <@!# '  20!O $\ ;0!6 &P 7@!J
M &@ : !U &< A !E )8 9 "K &( R0!A /8 8 #_ %P _P!; /\ 6@#_ +T
M  "I    EP   (D   !^    >    ',   !O  $ ;0 ) &P #@!K !, :P 9
M &H ( !H "8 9@ L &4 ,@!C #< 8@ \ &  0@!? $@ 70!/ %P 5P!: &$
M60!M %< >P!6 (X 50"B %, NP!2 .D 4@#_ %  _P!/ /\ 3P#_ *T   "8
M    A@   '@   !N    9P   &,   !@    70 % %P "P!; !  6P 5 %L
M&P!: "$ 6  F %8 + !4 #$ 4P V %( / !1 $( 3P!) $X 40!- %L 2P!F
M $H = !) (4 2 "9 $< L0!& -@ 1@#\ $4 _P!% /\ 10#_ )\   ")
M>    &P   !B    6P   %8   !3    40 " $\ " !/  T 3@ 1 $X %@!-
M !P 3  A $H )@!) "P 2  Q $< -P!% #T 1 !$ $, 3 !" %4 0 !@ #\
M;@ ^ 'X /0"2 #P J0 [ ,< .P#S #L _P [ /\ / #_ ),   !^    ;@
M &$   !8    40   $P   !)    1P   $4 !0!$  L 0P . $, $@!# !<
M0@ = $  (@ _ "< /@ L #T ,@ [ #@ .@ _ #D 1P X %  -P!; #4 :  T
M '@ ,P", #( H@ Q +P ,0#G #$ _P R /\ ,P#_ (D   !V P  9@4  %D'
M  !0!P  208  $,%  !  P  /@$  #P  P [  @ .@ - #H $  Y !0 .0 9
M #< '@ V ", -0 H #0 +@ S #0 ,@ [ #  0P O $P +@!7 "T 9  L ',
M*P"' "H G  I +4 *0#< "D ^P I /\ *@#_ ($$  !N"   7PH  %,+  !*
M"P  0@L  #T*   Y"0  -@@  #4%   T @8 ,P * #( #@ Q !$ ,0 5 #
M&@ O !\ +@ D "P *@ K #  *@ W "D /P H $D )P!4 "8 8  D &\ (P""
M "( EP A *X (0#, "$ \P A /\ (@#_ 'L)  !H#   6@T  $X.  !%#@
M/0X  #@-   S#0  , P  "X+   M"0, +08( "P$#  K @\ *@$2 "D!%P H
M 1P )P A "8 )P E "T )  T ",!/0 B 48 (0%1 !\!70 > 6P ' %_ !L
ME  : *H &@#% !H ZP 9 /\ &@#_ '4,  !D#@  50\  $H0  ! $   .1
M #,0   O#P  + X  "D.   G#0$ )PP% "<*"@ F" T )0<0 "0&%  B!AD
M(08? " ')  ?!RL '@<R !T'.@ <"$0 &@A/ !D(7  7"&L %@A] !4'D0 4
M!Z< $P:_ !(%Y  2!?H $@7_ '$.  !?$   41$  $82   ]$@  -A(  # 2
M   K$0  *!$  "40   C$   (@X$ "$-!P A# L ( L. !\+$@ ="Q< ' P<
M !L,(@ :#"D &0PQ !@,.0 6#4, %0U/ !,-7  2#6L $ U^  \-D@ .#:<
M#0R^  T,X  -#/4 #0S_ &T0  !<$0  3A,  $,4   Z%   ,A0  "T4   H
M$P  )1,  "(2   @$0  'A$# !P0!0 <#P@ &P\, !H.$  9#Q0 %P\: !8/
M(0 5$"@ %! P !(0.0 1$$0 $!!0  X070 -$&L #!!\  L0D  )$*4 "!"\
M  <0WP '$/0 !P__ &D1  !8%   2Q4  $ 6   W%@  ,!8  "H6   F%0
M(A4  !\4   =$P  &A," !D2!  7$@8 %A(* !42#@ 4$A( $A(8 !$3'@ 1
M$R4 $!,N  X3-P -%$  #!1+  L46  )%&< !Q1X  84C0 $%*,  Q.[  (3
MW0 !$O0  A+_ &43  !5%@  2!<  #T8   T&   +1@  "@8   C%P  (!<
M !T6   :%0  &!4" !85!  4%04 $A8( !$6#0 0%Q  #A<5  X7&P -%R(
M#!<I  L8,@ )&#P !QA'  485  $&&,  AAU  $8BP  %Z$  !>Y   7W0
M%O4  !;_ &$6  !2&   11H  #L:   R&@  *QH  "4:   A&0  'A@  !L8
M   8%P  %A<" !07 P 2& 4 $!D'  X;"P ,&P\ "QL3  H;&  ('!\ !QPF
M  4<+P $'#@  AQ$   =40  '6   !UR   <B   '*   !NY   ;W@  &O8
M !K_ %X8  !/&@  0AP  #@<   O'0  *1P  ",<   ?&P  '!H  !D9   7
M&0$ %!D" !(: P 0&P0 #AT'  P>"P )'PX !B 1  4@%@ #(!P  2$C   A
M*P  (34  "%    A3@  (5T  "%O   AA@  ()X  ""X   ?W@  'O@  ![_
M %H;  !+'0  /QX  #4?   M'P  )QX  "(=   >'0  &QP  !@;   5&P
M$AP  ! = @ .'P0 #"$&  DB"@ %(PT  B00   E$P  )1D  "8@   F*
M)C(  "8]   F2@  )EH  "9L   F@P  )9P  "6W   DWP  (_D  "/_ %4>
M  !'(   /"$  #(A   K(0  )2   " ?   ='@  &AT  !8>   3'@  $"
M  XA   ,(P( ""4%  4G"0  * L  "H.   K$0  +!8  "P=   L)0  +"X
M "PZ   L1P  +%8  "QI   L@   *YH  "JU   IWP  *?L  "C_ %$B  !$
M(P  ."0  "\D   H(P  (R(  !\A   <(   %R   !,A   0(P  #B0   LF
M   (*   !"H$   L!P  +@D  # ,   Q#P  ,Q,  #,9   S(0  ,RH  #,U
M   S0P  ,U(  #-E   R>P  ,I<  #&S   PW@  +_L  "[_ $PE   _)@
M-2<  "TF   G)0  (B0  !XC   9(P  %"0  !$F   .*   "RH   <L   #
M+P   #$"   S!   -0<  #<*   Y#0  .A   #L5   ['0  .R8  #LQ   [
M/@  .TX  #M@   Z=P  .9(  #BP   WVP  -OP  #7_ $<I   [*@  ,BH
M "LI   E)P  (28  !LG   5*   $2H   XL   *+P  !C$   $T    -@
M #@    [ 0  /00  #\'  !!"@  0PX  $41  !%&   12$  $4L  !$.0
M1$@  $1;  !#<0  0HT  $&K  ! T@  /_H  #[_ $(M   X+@  +RT  "DK
M   D*@  '2H  !<L   1+@  #3$   DT   $-P   #H    \    /P   $$
M  !$    1@   $@#  !*!P  3 L  $X.  !0$P  4!P  % G  !/-   3T,
M $]5  !.:@  388  $RD  !*R@  2?@  $C_ #XR   U,0  +B\  "DN   @
M+@  &3$  !(S   .-P  "3H   (]    0    $0   !'    20   $P   !/
M    40   %,   !5 0  6 8  %H+  !=#@  7Q4  %X@  !>+   73P  %Q.
M  !;8P  6GX  %B=  !7P   5?(  %3_ #HV   S-   +3(  "0S   ;-@
M$SD   X]   (00   $4   !)    3    %    !3    5@   %D   !;
M70   &    !B    90   &@%  !K"P  ;Q   &\8  !N)0  ;30  &U&  !K
M6P  :G4  &B4  !FM@  9.D  &+_ #@Y   R-P  *#D  !X[   5/P  #D0
M  =)    30   %(   !6    6@   %X   !B    90   &@   !K    ;0
M '    !S    =@   'D   !]!   @0L  (41  "$'0  @BP  ( ^  !^5
M?FL  'N*  !ZJ@  =]8  '7] #@]   L/@  (D$  !=&   /2P  !U$   !7
M    7    &(   !F    :P   &\   !T    >    'L   !^    @    (,
M  "&    B@   (T   "1    E@,  )L,  "=$P  FR$  )HS  "720  E&(
M )-_  "0H   CL4  (SS #%$   E2   &DT  !!3   (6@   &$   !H
M;@   '0   !Y    ?P   (0   ")    C0   )$   "3    E@   )D   "=
M    H    *0   "H    K    +(#  "W#0  MQ<  +4H  "R/@  L%8  *QS
M  "JE   J;0  *7E "I/   >5   $EL   IB    :@   ',   ![    @@
M (D   ".    E    )H   "?    I    *8   "I    K0   +    "S
MMP   +L   #     Q0   ,L   #1!   U0X  -,=  #0,@  S4L  ,IF  #&
MAP  PJD  ,'+ ");   68@  #&L   %T    ?0   (<   "0    EP   )X
M  "D    JP   +$   "V    N@   +P   #     Q    ,@   #+    SP
M -0   #:    X    .8   #K    \08  / 3  #N)P  [#\  .I;  #G>@
MY)L  ."[ /\   #[    ]@   /,   #T  4 ]@ , /H $0#_ !D _P B /\
M+ #_ #4 _P ] /\ 10#\ $P ^@!2 /< 6 #U %X \P!D /$ :@#N '( [ !Z
M .D A0#E )$ X0"@ -T L@#8 ,X T@#V ,$ _P"M /\ G@#_ )8 _P"0 /\
MC #_ /H   #R    [    .D   #I    [  % /( # #X !( ]P ; /4 )0#P
M "X ZP W .8 /@#B $4 W0!+ -@ 4 #3 %8 T !< ,T 8@#* &H R !R ,4
M? #" (@ O@"6 +H J "W +\ M #H *X _P"= /\ D #_ (@ _P"# /\ @ #_
M /    #E    W@   -H   #;    W    -@ !P#1  X T0 5 -( '@#+ "<
MQ0 O ,  -P"] #T N@!$ +< 20"U $\ L@!5 +  6P"N &$ K !I *D <P"G
M '\ I "- *$ G@"> +( FP#5 )D _ ", /\ @@#_ 'L _P!V /\ = #_ .(
M  #3    R@   ,<   "\    M@   +   0"O  L K  1 *T & "M "  J  H
M *0 +P"@ #8 G0 \ )L 0@"9 $< EP!- )4 4P"3 %D D0!A (\ :@", '4
MB@"# (@ E "& *< @P#" (( \ !\ /\ <P#_ &T _P!J /\ : #_ ,\   #!
M    N0   *T   "@    F    )0   "1  8 D  - )  $@"/ !D C@ A (L
M* "( "\ A@ U (0 .@"" $  @ !% 'X 2P!\ %( >@!9 '@ 8@!V &P = !Y
M '( B0!Q )T ;P"T &T WP!L /\ 90#_ &  _P!> /\ 7 #_ +X   "Q
MH    )(   ")    @@   'P   !Z  $ >  ) '< #@!X !0 =P : '0 (0!R
M "< <  M &X ,P!L #@ :P ^ &D 1 !H $H 9@!1 &0 6@!C &0 80!P %\
M?P!> ), 70"I %P R !; /< 5P#_ %0 _P!2 /\ 40#_ +    "?    C0
M '\   !T    ;@   &H   !F    90 $ &, "P!C !  8P 5 &, &P!A "$
M7P G %T + !< #( 6@ W %D /0!7 $, 5@!+ %4 4P!3 %P 4@!H %  =P!/
M (D 3@"? $T N@!, .D 2P#_ $D _P!' /\ 1P#_ *(   "-    ?    &X
M  !E    7@   %D   !7    50 ! %0 !P!3  T 4P 1 %0 %@!2 !L 40 A
M $\ )@!. "L 3  Q $L -P!* #T 20!$ $< 3 !& %8 1 !A $, < !" ($
M00"7 $  KP _ -< /P#_ #X _P ] /\ /@#_ )0   !_    ;P   &,   !9
M    40   $T   !*    2    $< ! !'  H 1@ . $8 $0!' !8 10 < $0
M(0!" "8 00 K $  ,0 ^ #< /0 ^ #P 1P Z %  .0!; #@ :0 W 'H -@"/
M #4 IP U ,8 - #U #0 _P T /\ -0#_ (@   !T    90   %@   !/
M2    $,    _    /0   #P  @ \  < .P , #L #P [ !( .@ 7 #D '  W
M "$ -@ F #4 +  T #( ,P Y #$ 00 P $L +P!6 "X 8P M ', + "( "P
MH  K +L *P#J "L _P K /\ + #_ '\   !L    70$  %$"  !( P  0 ,
M #L"   W    -    #,    R  4 ,@ ) #( #0 Q !  ,0 3 #  &  O !T
M+0 B "P *  K "X *@ U "D /0 H $8 )P!1 "8 7@ E &X ) "" ", F0 C
M +, (@#> "( _P C /\ ) #_ '<   !E!   5@8  $L'  !""   .@@  #4'
M   P!@  +04  "P#   K  , *@ ' "D "P I  X *0 1 "@ %0 G !D )@ >
M "4 )  D "H (P Q "( .0 A $, ( !. !\ 6@ > &D '0!\ !P DP ; *P
M&P#- !L ]@ ; /\ ' #_ ' %  !?"   40H  $8+   ]"P  -0L  # +   K
M"@  * D  "4(   D!P( (P0& ",""0 B 0P (@ / "$ $@ @ !8 'P ; !X
M(  = "8 '  N !L -@ : #\ &0!* !@ 5P 7 &8 %@!X !4 CP 5 *8 % ##
M !0 [@ 4 /\ %0#_ &L(  !;"P  30P  $(-   Y#0  ,0T  "P-   G#0
M(PP  "$,   ?"P$ '@H% !T("  =!@L ' 4- !P$$  ;!!0 &008 !D$'@ 8
M!", %P0K !8$,P 5!#P % 1' !,#5  2 V, $0-U ! "B@ 0 :( #P"\  \
MY0 / /X $ #_ &<+  !7#0  20X  #X/   U#P  +@\  "@/   D#@  ( X
M !T.   ;#0$ &0T$ !@,!P 8"PD %PD, !<)#@ 6"1( %0D6 !0)&P 3"2$
M$@DH !(),  1"3H $ E%  \)4@ ."6$ #0ES  P(B  +")\ "@>W  H&VP *
M!?8 "@3_ &,-  !3#@  1A   #L1   R$0  *Q$  "40   A$   '1   !H/
M   8#P$ %@X$ !4.!P 4#0D $PT+ !,,#0 2#!  $0P4 ! ,&0 0#!\ #PPG
M  X-+P -#3D # U%  L-40 )#6  " UQ  8-A@ %#9T ! RT  ,,T@ "#/$
M @O_ %\.  !0$   0Q$  #@2   O$@  *!(  ",2   >$0  &Q$  !@1   5
M$ ( %! % !(0!P 1#PD $ \* ! .#  .#@X #@\2  T/%P ,$!T #! D  H0
M+  )$#8 "!!!  803@ %$%T  Q!O  $0A   $)P   ^T   .U   #O,   [_
M %P0  !-$@  0!,  #84   M%   )A0  "$3   <$P  &1(  !82   4$0,
M$A$& !$1"  0$ H #A +  T1"P ,$0T "Q(1  H2%0 )$AH "!(A  83*0 %
M$S,  Q,^  (32P  $UH  !-L   3@@  $IL  !*T   1UP  $?4  !'_ %@2
M  !)%   /14  #,6   K%@  )!4  !\5   :%   %Q0  !03 0 3$@0 $1('
M ! 2"0 .$@D #1()  L3"@ )% T !Q4/  86$P $%A@  Q8?  (6)P  %S
M !<[   72   %U@  !=J   6@   %ID  !6T   5V0  %/<  !/_ %44  !&
M%@  .A<  # 8   H&   (A<  !T6   9%@  %A4  !,4 P 2$P8 $!,'  \3
M!P -% < "Q4(  D6"0 && P  QH.  $:$0  &A8  !L<   ;)   &RT  !LX
M   ;1@  '%4  !MG   ;?0  &Y<  !JS   9VP  &/D  !?_ %$6  !#&
M-QD  "X:   F&@  (!D  !L8   8%P  %18! !,5!0 1%00 #Q4$  T6!  +
M%P4 "1D&  8:"  "' H  !X-   @$   (!,  " 9   @(0  (2H  "$U   A
M0@  (5(  "!D   @>@  'Y4  !^Q   >VP  '?H  !S_ $T9   _&P  -!P
M "L<   D'   'AL  !H:   7&   %!<" !(7 @ 0& $ #1D!  L: @ (' ,
M!1T$  (?!@  (0@  ",+   E#@  )A$  "86   F'@  )R<  "<R   G/P
M)DX  "9@   F=P  )9(  "2O   CV@  (OL  "'_ $@=   \'@  ,1\  "@>
M   B'@  '1P  !D;   6&@  $AH  ! ;   -'   "QT   @?   $(0   2,"
M   E!   )P8  "D)   L#   +@\  "X3   N&@  +B,  "XN   N.P  +DH
M "U<   M<@  +(X  "NL   JU   *?L  "C_ $0@   X(0  +B$  "8A   @
M(   '!X  !@=   4'0  $!X   X?   +(0  !R,   ,E    )P   "D    L
M 0  +@,  # &   S"@  -0T  #81   V%P  -A\  #8I   V-@  -D4  #57
M   U;0  -(D  #*H   QSP  ,/H  "__ #\D   T)   *R0  "0C   ?(0
M&R   !8@   1(0  #B,   HE   &*    BH    M    +P   #(    T
M-P   #D#   [!@  /@H  $ .  !!$@  01H  $ E  ! ,0  0$   #]2   ^
M9P  /8(  #RB   ZQP  .?@  #C_ #HH   P*   *2<  ",E   ?(P  &"0
M !(E   .*   "BH   4M    ,    #,    V    .    #L    ^    0
M $(   !% @  1P8  $H*  !-#@  314  $P?  !,*P  2SH  $I,  !)80
M2'P  $>;  !%OP  0_,  $+_ #8L   M*P  )RD  ",G   ;*   %"H   XM
M   *,   !#,    W    .@   #T   !     0P   $8   !(    2P   $T
M  !0    4P$  %8&  !9"P  6Q   %L9  !:)0  630  %A&  !76@  570
M %23  !2M0  4.H  $__ #,P   L+@  )RP  !XM   6+P  $#(   HV   #
M.@   #\   !"    1@   $D   !,    3P   %(   !5    6    %H   !=
M    8    &,   !G!@  :PP  &P2  !K'@  :RP  &D]  !G4@  9FH  &2)
M  !AJP  7]P  %W_ #$S   L,0  (C(  !DU   1.0  "CT   )"    1P
M $P   !0    5    %@   !;    7P   &(   !E    :    &L   !N
M<0   '4   !Y    ?08  ((-  ""%@  @"0  'XU  !\20  >V$  'A_  !V
MGP  <\8  '#W #$V   F.   '#L  !)    +10   DL   !1    5@   %L
M  !@    90   &D   !N    <@   '8   !Y    ?    'X   ""    A0
M (D   ".    DP   )@&  "<#@  FQH  )@K  "60   DED  )%S  "-E0
MB[4  (CH "L^   @00  %4<   U-   "5    %L   !A    :    &X   !S
M    >0   'X   "#    B    (P   "/    D@   )4   "9    G0   *$
M  "E    J@   +    "W!P  N!$  +4A  "R-0  KTT  *II  "HB   IJ@
M *+1 "-(   83@  #E0   1<    9    &T   !U    ?    (,   ")
MCP   )4   ";    H    *,   "F    J0   *T   "Q    M0   +D   "^
M    Q    ,H   #2    V@H  -86  #2*0  SD$  ,I<  #%?   PIT  ,&]
M !Q5   17   !V4   !N    =P   '\   "(    D    )@   "?    I0
M *T   "S    N    +H   "^    P@   ,8   #*    S@   -,   #:
MX    .<   #M    \P   /0.  #R'@  [S8  .Q1  #H;@  Y)   -^Q
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M______________________________________\
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MX.'BX^3EYN?HZ>KK[.WN[_#Q\O/T]?;W^/GZ^_S]_O]M9G0Q      ,$(0
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M_ZUE5_BI;VCMHWAYXYM_A]N2A934BXR>SX61ILN E:S'?)FQQ7F>M<)VH[G
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MM38/^<$_%^[.1B/DW$PRW>=/2<_H5E[ Y%URLMYD@J/4:9&5RVV<B<5PI7_
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M;47_BWA/_X:$6?R"CF'W?99H]'B=;O%THW/N<:EW[&ZN>NILLWWI:KE_YVC
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M ]#C,@S%[$ =NO%'+[#O2S^E[5%.FNM:6H_J8F6%Z&IN?>=R=77C>'MOX'Z
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M%/^50QS_FDPG_YE8,_^68S__DFY,_XYZ5_R)A6+UA(]K\'Z7<^QYGGKH=*6
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MW()1V=R"4=G<@E'9W(+_CQ,"_Z03 ?ZX$@#6S L S.01 <#O)@>U]3@5JO1
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M)3S_F24[_YXF._^>)CO_GB8[_YXF._^>)CO_GB8[_YXF._^>)CO_GB:KP0
MG=   (_A  "&_PX">O\5 V[_' 9D_R,)7/\K#%7_,P]/_SL12?]"$T;_211"
M_T\60/]5%C[_6A<\_U\8._]D&#G_:!DX_VT9-_]R&C;_=QHU_WP:-/^!&S/_
MB!LR_XT;,O^-&S+_C1LR_XT;,O^-&S+_C1LR_XT;,O^-&S+_C1O_<!X#_VPI
M!O]I,PG_<C<-_WD^$O]]1QG_@%$A_WY?*?]\;3+_>7LY_W:(0/]SDT7_<)U*
M_VZF3O]KK5'_:;13_VB[5?]FPU?_8\=9^V',6_=?TUSS7MU=\%SC7NM;Z5_G
M6>]@Y5GQ7^59\5_E6?%?Y5GQ7^59\5_E6?%?Y5GQ7^59\5__<!X#_VPI!O]I
M,PG_<C<-_WD^$O]]1QG_@%$A_WY?*?]\;3+_>7LY_W:(0/]SDT7_<)U*_VZF
M3O]KK5'_:;13_VB[5?]FPU?_8\=9^V',6_=?TUSS7MU=\%SC7NM;Z5_G6>]@
MY5GQ7^59\5_E6?%?Y5GQ7^59\5_E6?%?Y5GQ7^59\5__<!X#_VPI!O]I,PG_
M<C<-_WD^$O]]1QG_@%$A_WY?*?]\;3+_>7LY_W:(0/]SDT7_<)U*_VZF3O]K
MK5'_:;13_VB[5?]FPU?_8\=9^V',6_=?TUSS7MU=\%SC7NM;Z5_G6>]@Y5GQ
M7^59\5_E6?%?Y5GQ7^59\5_E6?%?Y5GQ7^59\5__<!X#_VPH!O]K,0G_=38-
M_WL\$O]_1AG_@U A_X%>*O]^:S/_>W@[_WB&0O]UDDC_<IM-_W"D4?]MK%3_
M:[)7_VFY6O]GP5S\9<=>^&+,7_5@TV'P7MUB[%SD8^A;Z63B6N]DX%KP8N!:
M\&+@6O!BX%KP8N!:\&+@6O!BX%KP8N!:\&+_<1T#_VTH!O]N, G_>#0,_W\[
M$O^#1!G_ATXA_X9;*_^#:#3_?W4]_WR"1?]YCDS_=IE2_W*A5O]OJ5K^;;!>
M_&JW8?MHOF/Y9L9E]&/,9_!ATVGK7]YKYEWE;.!;Z6W97.YHUESO9]9<[V?6
M7.]GUESO9]9<[V?67.]GUESO9]9<[V?_<AT#_VXH!O]Q+@G_>S(,_X,Z$?^'
M0QC_BDPA_XI9*_^'937_@W(__W]^2/]\BU#_>996_W6?7/URIF#Z;JUD^&RT
M:/9IO&OT9\5M\&3,<.MATW+E7]]SWESE=-9<Z''/7NULS5[N:\U>[FO-7NYK
MS5[N:\U>[FO-7NYKS5[N:\U>[FO_<QP#_V\G!O]T+0C_?C$,_X8Y$?^+0AC_
MCDLA_XY6*_^+8S;_AV]!_X-[2_]_AU/^?));_'B<8?ETI&?V<*MK\VVR;_%J
MNG/O:,-VZV7,>.9BU7K>7]]\TUWC>\U?YG;'8.IPQF#L;L9@[&[&8.QNQF#L
M;L9@[&[&8.QNQF#L;L9@[&[_=!P#_W G!O]V*PC_@2\+_XDX$/^.0!C_DDDA
M_Y-4+/^08#?_C&Q#_X=W3?N#@U?X?XY@]GJ79_-VH&[P<JAS[6ZO>.MKN'SH
M:,)_YF;-@M]BV(317]R%RF#@?\5AXWJ_8^ATOF/I<KYCZ7*^8^EROF/I<KYC
MZ7*^8^EROF/I<KYCZ7+_=!P#_W F!O]Y*@C_A2X+_XTW$/^2/Q?_ED@@_Y=2
M+/^57CC^D6E$^HQT4/6'?UOR@HEE[GV3;NIWFW7G<J-\Y&ZK@>%JLX;>9[V*
MVF7*C=)BU([(8MB*PF/<A+QEX'ZW9N5XMF;F=K9FYG:V9N9VMF;F=K9FYG:V
M9N9VMF;F=K9FYG;_=1L#_W$F!O]\* ?_B"T*_Y V#_^6/A;_FD<@_YQ0*_^:
M6SCYEV9%]))P4N^,>U_JA85JY7Z-=.!XE7W;<IV%U&VDB]!JK8[-:+>0RVC#
MD<AGT9*_9=2/N6?9B;1HW8*P:>)\KFKD>:YJY'FN:N1YKFKD>:YJY'FN:N1Y
MKFKD>:YJY'G_=AL#_W(F!?]_)P?_BBP*_Y,U#O^9/1;_GD8?_Z%.*_N@63CU
MG&-&[YAM5.B0=V+BB']OVH"'>])ZCX/-=9>)R7&?C<5NJ)'";+&3OVN\E;UK
MRY6V:="4L6O5C:QLVX:H;>!_IVWB?*=MXGRG;>)\IVWB?*=MXGRG;>)\IVWB
M?*=MXGS_=AL#_W,E!?^!)@?_C2P)_Y8T#O^=/!7_H40>_J5,*O>E5SCPHF%'
MZ9QJ5N&4<F78C'MSSX6#?,E_BX3#>I.*OW:;C[ISHY.W<*R6M&^WE[%OQ)BL
M;<V8J6_3D*5PV(FA<=Z"H''@?Z!QX'^@<>!_H''@?Z!QX'^@<>!_H''@?Z!Q
MX'__=QL#_W0E!?^#)0;_D"L)_YDS#?^@.Q3_I4,=^ZE+*?.J5#CLJ%Y'XZ%G
M5]J9;V?/D7ASQXJ ?<&$B(6[?X^+M7J7D+%WGY2M=*B7JG.RF:=ROYJD<LN:
MH7/0DYYTUHR;==R$FG7>@9IUWH&:==Z!FG7>@9IUWH&:==Z!FG7>@9IUWH'_
M>!H#_W8D!?^&(P;_DBH(_YLR#/^C.A/_J$(<^*U**/"O4C?GK%Q'WJ5D6-&=
M;6;(E75SP(Y\?;F)A(6S@XR,K7^3D:E[FY6E>:29H7>NFYYVNIR==\J<F7?/
MEI=XU(Z5>-N&E'C=@Y1XW8.4>-V#E'C=@Y1XW8.4>-V#E'C=@Y1XW8/_>!H#
M_W@C!?^((P;_E"H(_YXQ"_^F.A+^JT(;];!))^RU4#;CL%I&V*EC5\RA:V;"
MFG)RNI-Z?+.-@86LB(F,IH20D:& F):=?:&:F7NJG)9[MIV4>\:>DGO-F)%\
MTY"/?-F(CWS<A8]\W(6/?-R%CWS<A8]\W(6/?-R%CWS<A8]\W(7_>1H#_WHB
M!?^*(@7_EBD'_Z Q"_^H.1'[KT$:\K1()NFY3S3?M%E%TJUA5L>E:66]GG!R
MM)=W?*V1?H6FC(:,H(B-D9J%E9:6@IZ:DH"GG8]_LYZ-@,*>BX#,FHN!TI**
M@-B)B8#;AHF VX:)@-N&B8#;AHF VX:)@-N&B8#;AHF VX;_>1H"_WLA!/^+
M(@7_F"@'_Z,P"O^K.!#YLD 8[[A').:]3C/;N%=$S;!@5L*I9V2XHFYQKYMU
M>Z>6?(2@D8.+FHV+D92*DY:/AYN:BX6EG8B$L)^%A+^?A87+FX6%T9.%A=B*
MA(3:AX2$VH>$A-J'A(3:AX2$VH>$A-J'A(3:AX2$VH?_>AD"_WT@!/^-(07_
MFR@&_Z4O"?^N-P[VMC\7[+Q&(N/!3C#5O%9#R+1>5;VL9F.SIFQPJI]S>Z&:
M>H2:EH&+E)*(D8Z/D):)C)F:A(JCG8&*KI]^BKR??HK*G'^*T)1_B=:+?XC9
MB'^(V8A_B-F(?XC9B'^(V8A_B-F(?XC9B'^(V8C_>AD"_W\>!/^0(03_G2<%
M_Z@N"/ZR-@WSNCX5Z<%%']_%3"_0OU1"Q+==4[BP9&*NJFIOI*1Q>IR?=X.4
MFWZ*CIB&D(>5CI6"DI>9?9"@G'J/JYYXC[F?=Y'*G7F0SY5YCM:,>8W8B7F-
MV(EYC=B)>8W8B7F-V(EYC=B)>8W8B7F-V(G_>QD"_X$=!/^2( 3_H"8%_ZLM
M!_NU-0OPOCT2YL=$'-K)22[+PU-!OKQ;4K.U8F&HKVENGZIO>):E=8&.H7R)
MAYZ#CX&;BY1[F928=Y>>FW.6J9UQEK:><)?(G7*6SY5SE-6,=)/8B723V(ET
MD]B)=)/8B723V(ETD]B)=)/8B723V(G_?!@"_X0< _^5'P/_HR4$_Z\L!O>Z
M,PGLQ#L/XLY"&-/.2"S&QU) N<!:4:VZ85^CM&=LF;!M=Y"K=("(J'J'@:6!
MC7JBB9)UH)*6<)Z;F6R>IYMJGK2<:9_%FVR>T)1MFM:,;9G8B6V9V(EMF=B)
M;9G8B6V9V(EMF=B);9G8B6V9V(G_?1@"_X<: _^8'@/_IB,#_[,I!// ,0?G
MRS@+W=@Z%LW21BK S% ^L\983Z? 7UV<NV5JDK=K=(FS<7V!KWB$>JU_BG2J
MAX]NJ8^3::>:EF:GI9ACI[*98JC#F&6GT9-FH]:+9Z'9B6>AV8EGH=F)9Z'9
MB6>AV8EGH=F)9Z'9B6>AV8G_?A<"_XL8 O^<' +_JR$"^[DF ^W'+ 3?U3$&
MT]XY%,;81"BYT4X[K,Q63*#'75J5PF-GB[]I<8*[;WEZN': <[9]AFVTA8MH
MLXZ/8[*8DF"QI)->LK&47++"E%ZRTY!?K-F)8*K:AF"JVH9@JMJ&8*K:AF"J
MVH9@JMJ&8*K:AF"JVH;_?Q<"_Y 6 O^A&@'_L1T!], @ >/1( '3WRP&R>([
M%+[?1"6RV4PXI=-429G/6U>.RV%CA,AH;'O%;G5SPW5[;,%\@6? A(5BOXZ)
M7KZ8BUJ^I(U8OK&.5[_"C5B_UXM9N-R%6;;=@UFVW8-9MMV#6;;=@UFVW8-9
MMMV#6;;=@UFVW8/_@18"_Y44 ?^G%@']N!< Z<L1 -/?%@'(YRP'ON8[%K/D
M1"6HX4LUG-U21)'965*&U6!=?--F9G31;6YLSW1T9LY\>6'-A7U<S(Z 6<R9
M@U;,I814S+.%4\W$A5/-W8-3QN!^5,/A?53#X7U4P^%]5,/A?53#X7U4P^%]
M5,/A?53#X7W_AQ,!_YP2 ?^N$0#:P@H T-(* ,?H& &\["P*LNL\%ZCJ0R6=
MZ$@SDN900(CD64M^XF!4=N%H7&_@;V)HWW=H8]Y_;%[>B'!:WI%S5]Z;=53>
MIW=2W[1X4-_$>$_@WGA/UN5U3]/G=$_3YW1/T^=T3]/G=$_3YW1/T^=T3]/G
M=$_3YW3_CP\!_Z0. -NX" #-Q0D Q=4* +KQ&@.P\BT,IO$[&)OP0221[T<O
MA^Y..G[N6$-W[6%*<.UI4&KL<55E['E98>R!7%WLBE]:[)-A5^V=8U7MIV52
M[;-F4>[ 9T_OU&A.Z^9H3>CH:$WHZ&A-Z.AH3>CH:$WHZ&A-Z.AH3>CH:$WH
MZ&C_F0L W:X$ ,R\!@#!R0< N-L* *WX' 2D^"\-F?@Y%X_X/R&%^$8J?/A-
M,G7W5SEN]V _:?=I0V3X<4=A^'E*7?B!3%KXB4]8^))15OF;4E/YI511^J]5
M4/J[5D[ZRE=-^^-73/OI5TS[Z5=,^^E73/OI5TS[Z5=,^^E73/OI5TS[Z5?E
MI0  SK0$ +^_!0"TS@8 JNL- :#_'P:7_R\-C/\V%8+_/1UX_T0D</],*FK_
M5"]E_UXS8?]G-UW_;SE:_W8\6/]^/E;_AC]3_XY!4?^70E#_H$-._ZE%3?^S
M14O_OD9*_]!'2?_<1TG_W$=)_]Q'2?_<1TG_W$=)_]Q'2?_<1TG_W$?1K@
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M117_=4\<_W9=(_]S;"K_<'HQ_VV'-O]KE#O_:9\__VBH0O]FL$7_9+A'_V/
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M;4S;W&Q-V.QJ3L_P9T[/\&=.S_!G3L_P9T[/\&=.S_!G3L_P9T[/\&?_CPL
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M,#[_S3 ^_\TP/O_-,#[_S3 ^_\TP/O_-,#[_S3"[L0  K+P  )_)  "3V0
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MJ#4+Z:T]$]^O1A[2J5$OQZ):/[Z;8TRUE6I7KH]R8*>+>6BAAX%NG(.(=)>
MD'B2?9E\CGRB@(MZK8*(>KN#AWK-@X=\XGR'?.=UAGSL;H9\\&F&?/!IAGSP
M:89\\&F&?/!IAGSP:89\\&G_9QP"_W49 O^%&0+_DA\"_YPE _NE+ 7PK#0)
MYK([$-NS1!W-K4\NPZ99/KF?84NPF6A6J)1P7Z&/=V>;BWYNEHB&<Y"%CGB,
M@I9\B("@@(1_JX*!?[B#?W_*A(&!X7V!@>9V@8#K;X" [VJ @.]J@(#O:H"
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M=HCM;':([6S_:QH"_WT4 O^-%@'_FAH!_Z8> ?"Q(P+DNRD#V<(P"<N]/QG
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M44CA_$](X?Q/2.'\3TCA_$](X?Q/2.'\3TCA_$_AF0  S:D  +ZS @"SO@,
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M_S3_5",#_U M!/]9+07_7S '_V,V"O]F0 [_9DH3_V55&?]C91[_87,C_UZ
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M7U6N^EM6K?M:5JW[6E:M^UI6K?M:5JW[6E:M^UK_?@D \I$" -:A @#*K04
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M3]):IU'/6;!3S5BZ5,M8QE7)5]I6Q5?L5<-;^4_"7O]*P%__1KU@_T*Z8/]
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M7&>2_5=GD?]29Y'_4F>1_U)GD?]29Y'_4F>1_U+_;@X _W\) /&.!0#9FP4
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M24ZY_TE.N?])3KG_24ZY_TGOA0  U)4  ,>C  "ZK $ L+0  *>_ P">R08
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M"1?_APD6_Y0)%?^?"A3_J@H4_[,*%/^S"A3_LPH4_[,*%/^S"A3_LPJ3NP
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M47> _TQW@/]'=X#_1G> _T9W@/]&=X#_1G> _T;_9 \ _W() /]_" #EC 4
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M1F"6_T9@EO]&8);_1F"6_T;_< , ZX$  -:/  #*F@$ P:,# +FJ @"QL@$
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M&3/TL1DR]<4:,?7B&C'T\1DQ\?X9,?'_&3'Q_QDQ\?\9,?'_&3'Q_QFRI
MI:L  )BV  "+P   ?LH  ''5  !EW@  7O4* %G\$P!3_!X!3OPG DK], -%
M_3D%0?U !C[^2 <[_D\)./]7"C;_7@LS_V<,,?]P#2[_? XL_XD/*_^6$"G_
MI! H_[01)__'$2?_X1$F__(1)O_V$2;_]A$F__81)O_V$2;_]A&GJ0  F;,
M (N^  !^R0  <-,  &3>  !8YP  4O\) $W_$0!'_QD!0_\B 3[_*@(Z_S(#
M-_\Y S/_/P0P_T8%+?]-!2O_5 8H_UL')O]C!R/_;0@A_WD)'_^'"1[_E0H=
M_Z,*'/^Q"AO_P L:_]8+&O_?"QK_WPL:_]\+&O_?"QK_WPN;L0  C;P  '['
M  !PT@  8]X  %7D  !+]0  1O\% $#_#@ [_Q0 -_\; 3/_(P$O_RD"*_\P
M BC_-0(E_SL#(O]! Q__1P,=_TX#&O]5!!C_7@05_V@%$_]T!1'_@@40_Y &
M$/^=!@__J08._[4&#O^Z!@[_N@8._[H&#O^Z!@[_N@:.N@  ?\4  '#1  !B
MW@  5.4  $;K   __@  .?\  #3_"0 O_PX *_\4 "?_&@$C_R$!'_\E 1S_
M*@$9_R\!%O\T A3_.@(1_T "$/]& @[_3@(,_U8""?]@ P?_; ,$_W@# _^&
M P+_D0,!_YT# ?^A P'_H0,!_Z$# ?^A P'_H0/_-BT"_SDN O\^+@/_0#(#
M_T X!/\^00;_/$P(_SI:"O\X: S_-G8._S6##_\TCQ#_,YD1_S.A$?\SJ1+_
M,K 2_S*W$O\ROQ+_,L@3_S+3$_\RXQ/_,NT3_S+V$O\S_A+_,_\2_S/_$O\S
M_Q'_,_\1_S/_$/\S_Q#_,_\0_S/_$/\S_Q#_-BT"_SLL O] + /_0R\#_T,U
M!/]"/@;_0$H(_SY7"_\\90W_.G,/_SB $/\WC!'_-Y82_S:?$_\VIQ/_-JX4
M_S:U%/\VO!3_-<45_S70%?\UX!7_-NL5_S;T%?\V_13_-O\4_S;_%/XW_Q/^
M-O\3_3;_$OTV_Q+]-O\2_3;_$OTV_Q+_-RP"_SXJ O]#*@+_1BT#_T<R!/]&
M/ ;_14@(_T-5"_]!8@W_/W 0_SU]$?\\B1/_.Y,4_SN<%?\ZI!;_.JL6_SJR
M%_\ZN1?_.<(7_SG,%_\YW1C_.>D8_SGS&/\Z^QC\.O\7^CK_%_DZ_Q;X.O\6
M^#K_%?@Z_Q7X.O\5^#K_%?@Z_Q7_.2L"_T$G O]&)P+_2BD#_TLO!/],.0;_
M2T4(_TA1"_]&7@[_1&P1_T)Y$_]!A17_0(\7_T"8&/\_H!C_/Z<9_SZN&O\^
MMAK_/KX;_S[(&_\]UAS^/>8<^S[Q'/@^^ASU/O\<\S[_&O(__QGQ/_\9\3__
M&/$__QCQ/_\8\3__&/$__QC_/2@"_T4D O]*(P+_3B4#_U$L!/]2-@;_44$(
M_T]-#/],6@__2F<2_TAT%?]'@!?_1HL9_T64&_]$G!S_0Z0=_D.K'OU"LA_\
M0KH@^D+$(/E"T"'V0>(A\D+N(N]"^2+M0O\@ZT/_'^I#_QWI1/\<Z$3_&^A$
M_QOH1/\;Z$3_&^A$_QO_0"4"_T@A O]/( +_4R$"_U<I _]9,P7_6#X(_U9)
M#/]251#_46,4_T]O%_Y->QK[2X8=^4J/'_=)F"'V2)\B]$>F)/-'KB7Q1K8F
M\$:_)^]%RRCL1=XIZ$7L*>5&^"CB1_\FX4C_)-])_R+>2?\@W4G_']U)_Q_=
M2?\?W4G_']U)_Q__0R("_TP> ?]3' +_61X"_UTF _]?, 3_7SH'_UU%"_]:
M4!#]6%X5^%5J&?53=AWR48 A[T^*).U-DR;K3)HIZ4NB*^=*J2SE2;$NY$B[
M+^)(QS'@2-DQW$CJ,=A)]B[42_\KTDS_*=!-_R;/3O\ESD[_(\Y._R/.3O\C
MSD[_(\Y._R/_1Q\!_U : ?]7& '_7AP!_V,C O]F+ 3_9C8&_V1!"OIB3 _T
M7UD5[UQE&^M9<"#G5GLEY%2$*>%1C2W>4)4PW$^=,ME.I3/63:TUTTVW-M%,
MPC?/3-$XS$SF.,E-]#7'3_\QQ5'_+L12_RO#4_\IPE/_)\)3_R?"4_\GPE/_
M)\)3_R?_2AP!_U07 ?]<%0'_8QD!_VD@ O]L*0/_;3(%^6P]"?)I1P[K9E05
MY6-@'.!?:R+;7'4HUEE_+=)7B##/59 SS%28-LI3H#C'4J<ZQ5&P.\-0NSS!
M4,D]OU#?/;Q1\#NZ4_PWN57_,[A7_R^W6/\MMUC_*[=8_RNW6/\KMUC_*[=8
M_RO_31H!_U<4 ?]@$@'_:!<!_VX= ?]R)0+[<RX#\G,X!^EQ0PWB;E 4VVE<
M'--E9B3.8G JR5]Z+\9<@C/#6XHVP%F2.;U8FCN[5J(^N%6K/[95M4&T5,)"
MLE340K!5ZD&N5_D\KEG_-ZU;_S.M7/\PK5W_+JU=_RZM7?\NK5W_+JU=_R[_
M4!<!_UH2 ?]D$ #_;10 _W,: ?]W(0'T>2D"ZGHS!>)X/PK9=$P3SW!8',EK
M8B3$:&PKOV5U,+MB?36X8(4XM5Z-/+)<E3ZO6YU!K5JF0ZM9KT2I6;Q%IUC,
M1J18Y4:D6_9 HU[_.Z-?_S>C8/\SHV'_,:-A_S&C8?\QHV'_,:-A_S'_4Q4!
M_UT0 /]H#P#_<!( _W<6 /M\' 'N?R0!Y( M ]I_.PC/>DD2QW54&\%Q7R2[
M;6@KMFIP,;)G>3:O98 ZJV.(/:AAD$"F8)A#HUZA1:!>JT>>7;=(G%W&29I<
MWTF:7_)$FF+_/IIC_SF;9?\VFV7_,YME_S.;9?\SFV7_,YME_S/_51,!_V .
M /]K#@#_=!  _WL2 /6!%P#HA!X WH<G =&$-P?(?T81P'M1&[EV6R.T<F4K
MKV]M,:IL=3:G:GPZHVB$/J!FC$&=9)1$FF.=1Y=BITF58;)+DV'!3)%AV$R1
M8^]'DF7]09)G_SR3:?\XDVK_-9-J_S63:O\UDVK_-9-J_S7_5Q$!_V,- /]N
M# #_=PX _W\/ /"%$0#CB18 UHLC <N(-0;"A$,0NH!/&K-[62.M=V(JJ'1J
M,:-Q<3:?;GD[G&R!/YAJB$*5:9%%DF>:2(]FHTJ-9:],BF6]38EET4Z)9^Q*
MBFG[0XMK_SZ,;?\ZC&[_-XQN_S>,;O\WC&[_-XQN_S?_61  _V4+ /]Q"P#_
M>@L \8(, .B)#0#=C@X SX\@ <:-,@:]B4$/M81-&:Z 5B*G?%\JHGAG,)UU
M;S:9<W8ZE7%]/Y)OA4*.;8Y&BVR628AJH$N%:JQ-@VFZ3X%IS$^!:NA,@VWY
M181O_S^%</\[AG'_.(9Q_SB&<?\XAG'_.(9Q_SC_6P\ _V<( /]S" #S?0@
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M/&^!_SQO@?\\;X'_/&^!_SS_9 @ _W(  .%_  #3B0$ RI(# ,.8! "]G@0
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M,4&_NC%!P-(Q0;[N,$&]_2]!O/\N0;S_+4&\_RU!O/\M0;S_+4&\_RW.B@
MOY@  +&@  "FJ   F[   )"X  "%OP  >L<$ &_/"0!KT14 9]$F 6/1- 1>
MT$ (6=!*#%7/4Q!1SUL43L]C&$O.:QM(SG4>1<Y_($+.C") SIDD/LZH)CS.
MNB8\S]0F/,WO)3O,^R4[R_\E.\K_)3O*_R4[RO\E.\K_)3O*_R7#DP  M9X
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M"R'_X LA_?(*(/S\"B#\_ H@_/P*(/S\"B#\_ JBIP  E;$  (>[  !YQ@
M;,\  %_9  !2WP  2.@  $/_"  __Q  ._\9 #?_(0 T_RD!,/\P 2W_-P(J
M_SX")_]$ B7_2P,B_U,#(/]< QW_9@0;_W($&?^ !1?_CP46_Y\&%?^O!A3_
MP 84_]8&$__I!A/_Z083_^D&$__I!A/_Z0:7KP  B+H  'K%  !LSP  7MH
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M-99>_S&67_\MEF#_*I9@_RJ68/\JEF#_*I9@_RK_4@\ _UP* /]F"0#_;@H
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M9_\QAVC_+H=I_RV':?\MAVG_+8=I_RW_5PP _V$$ /YL P#D=0$ VWL% -.
M" #0@PH QX4: +Z$+0.V@3P)KWU($JAY4AFB=EL@G7-C)IEP:RN5;G(OD6UY
M,XYK@3:+:8DZB&B2/(5GG#^"9J=!@&:T0WYFQ41\9N%#?FCU/']J_S> :_\S
M@6S_+X%L_R^!;/\O@6S_+X%L_R__60L _V,! /1O  #?>   U'\$ ,Z#!@#*
MAP@ PH@8 +F'*P*QA3H(JH%&$:-^4!B=>ED?F'=A)9-U:"J/<V\OBW%W,XAO
M?C:%;H8Z@FR//7]KF4!\:J5">6JQ1'=JPD1V:MU$>&SS/GEN_SAZ;_\T>W#_
M,'QP_S!\</\P?'#_,'QP_S#_6P@ _V8  .=R  #:>P  SX(# ,F'!0#$B@8
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MEC$%EY,^#)"02!2*CE$;A(M9(7^)8"=[AV<K=X5N,'.$=31O@GTW:X&'.VB
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M.T^6M#Q.ELD\3I;H.D^6^391EO\S4I;_,%*6_S!2EO\P4I;_,%*6_S#F<@
MT(   ,*,  "XE@  K9P  *.A  "9I@  CJT  (BN$0"#KB(!?:TQ!'>L/0IR
MJD<0;*E/%F>H5QMCIUX?7Z9E)%ND;2=8I'4K5*-_+E&BB3%.H98T2Z&D-DFA
MM#9(H<@W2*#G-4F@^3)*G_\P2Y__+DN?_RU+G_\M2Y__+4N?_RW=>0  R88
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M'#?'^1PWQ?\<-L3_'#;$_QPVQ/\<-L3_'#;$_QR^D0  L)L  *2C  "8J@
MC+(  ("Y  !TP   :,<  %W-!0!3TPH 3]<2 $W8(@!+V#  2=@\ D;81@-$
MV4\$0=E8!C_980@\V6L*.MEV##?9@@XUVI /--J@$#+:L1$QV\<1,=KG$3#8
M]A(PUO\3+]3_$R_4_Q,OU/\3+]3_$R_4_Q.SF@  IJ$  )JI  "-L0  @+H
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M P[_\ ,.__ ##O_P P[_\ .3K@  A+@  ';"  !GS   6M4  $S<   _X0
M->8  "WT   J_P( )O\+ "/_$0 @_Q< '?\= !G_(P 6_RD %/\O !+_-0 0
M_ST #O]% 0S_3@$*_U@!!_]E 07_= $#_X4! O^6 0'_I@$ _[4! /_& 0#_
MR@$ _\H! /_* 0#_R@&&MP  =\$  &C,  !:UP  2]X  #[D   RZ0  )^T
M "/_   ?_P  &_\% !?_#  4_Q  $?\4  __&  -_QT "_\B  C_*  %_RX
M O\U  #_/0  _T<  /]2  #_7@  _VT  /]^ 0#_C@$ _YL! /^I 0#_JP$
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M(JY+_Q^N3/\=K4S_&ZU-_QJM3?\:K4W_&JU-_QK_1Q$ _T\- /]6# #_7 X
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M# #A;!  TVT> ,EL,0+":D 'NV=,#;5D5Q.P86 9K%]I':A=<2&E7'@DHEJ
M)Z!9ARJ=6) LFU>8+IE6HC"65:PRE%6Y,Y-5RC.15>4SD5?W+9%9_RF16O\E
MD5O_(Y%;_R&16_\AD5O_(9%;_R'_3PL _U<" /]A @#J: $ WFT$ -AP" #5
M< L RW(; ,)Q+@*Z;ST&M&Q)#:YI5!.I9UT9I&1E':%B;2&=870EFE]\*)A>
M@RN578LMDEN4,)!;GC*-6J@TBUFU-8I9QC:(6>$VB%ST,(A=_RN)7O\HB5__
M)8E?_R.)7_\CB5__(XE?_R/_40D _UH  /5D  #@;   UW$# -!T!@#-=0D
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M-UUZLSA<>L<Y7'KE-UY[^#)?>_\N8'S_*V%\_REA?/\I87S_*6%\_RGU8@
MWF\  ,QZ  # @P  MXD  *^.  "FD0  G9(& )>3%P"1DR@!BY(V!86000M_
MCDH1>HQ2%G6*6AMQB&$?;8=H(VJ&;R=FA'<K8X. +F""BC%=@98T6H&C-EB
MLC=6@,4W5H#C-EB!]S%9@?\M6X+_*EN"_RE;@O\I6X+_*5N"_RGL9@  V',
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M*T6;]"E&FO\G1YK_)4>:_R1'FO\D1YK_)$>:_R34=P  PH0  +:/  "KE@
MH9P  ):@  "+I0  ?ZH  '2N!0!OKQ0 ;*\D &BO,@)DKCT%7ZU&"5NL3PU8
MK%815*M>%%&J9A=.JFX:2ZEX'4BI@R!%J(\B0ZB=)$&HK25 J, E/ZC?)3^F
M]"- I?\B0*7_(4"D_R! I/\@0*3_($"D_R#*?@  NXL  *^5  "DFP  F:$
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M#"G-_PTIS?\-*<W_#2G-_PVNF   HI\  ):F  ")K@  ?+8  &^]  !CPP
M5\@  $S-  !"T@, .=D) #7?$  TWQL ,N G #'A,@ PX3T +N)' "WB4 $K
MXEH!*N-E BCC<0(FY'\#)>2/ R/EH00BY;0$(>7-!"#D[ 0@XOL$'^'_!1_@
M_P4?X/\%'^#_!1_@_P6DG@  F*4  (NN  !]M@  <+X  &/&  !6RP  2]
M $#5   VW   +^4' "WM$  K[A@ *>XB "?O*P E[S0 (_ \ "'P10 ?\4X
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M  #_U@""M0  <[\  &3)  !6TP  1]L  #K@   NY0  (^D  !KM   5_0
M$O\  !#_ @ ._PD "_\-  C_$  $_Q,  ?\8  #_'@  _R0  /\K  #_,P
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M#= S_PS.,_\,S33_"\PT_PO,-/\+S#3_"\PT_PO_.18 _SX2 /]!$ #_11,
M_T@; /]() #_1R\!_D0[ O="1P/Q/U0%[#Y@!N@\:PCE.W8)XCM_"^ ZB S=
M.9 -VSF7#MDXG@_6.*80U#BN$=(XMQ'0.,,2SCC3$LHXZ!+'.?<2Q#G_$<(Z
M_Q#!.O\/P#K_#K\Z_PZ_.O\.OSK_#K\Z_P[_/1, _T(/ /]&#0#_2Q  _TX6
M /]/'P#]3BD!]$PT >Q(00+F1TX$X$5;!MM$9@G60G ,TD%Y#L] @A#-0(H1
MRC^1$\D_F13'/J 5Q3ZH%L,^L1?!/KP7P#[+&+T^XABZ/O(7MS__%K5 _Q2T
M0/\3LT'_$;-!_Q"S0?\0LT'_$+-!_Q#_0!  _T8, /]+"@#_40T _U,1 /]4
M& #S5"( Z5(M >%0.P':3TD#TDU5!\Q+8 O(26H.Q4AS$<)'>Q._1H,5O46+
M%[M%DQBY1)H9MT.B&K5#JQNT0[8<LD/$';!#V1ZM0^T=JT7\&JE%_QBH1O\6
MJ$;_%:='_Q.G1_\3IT?_$Z='_Q/_1 X _TH( /]0!@#_50H _U@- /=9$0#J
M6!@ WU<D -17-0',540$QE10",%26PR]4&40N4YM$[9-=A:T3'T8L4N%&J]*
MC1NM294=JTF='JE(IB"G2+ AI4B](J1(SR*A2.@BH$GX'I]+_QN>2_\9G4S_
M%YU,_Q:=3/\6G4S_%IU,_Q;_1PL _TT" /]4 @#W6@0 ZUT' .=="P#A7!
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M+FIFLR]I9L8P:&;D+VIH]REK:?\E;&G_(FQJ_R!L:O\@;&K_(&QJ_R#_5P
MY&(  -)L  #&<P  O7@  +5[  "M?   I7P* )]]&@"9?"H!DWLX!(UY0PF(
M=TP.@W54$G]S6Q9[<F(9>'!I'75O<"!R;G@C;VV!)FQLBREJ;)<L9VNC+F5K
MLB]D:\0P8FOA+V1L]BIF;?\F9FW_(V=N_R!G;O\@9V[_(&=N_R#V60  X&4
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M+5-\\BE5?/\E5GS_(E=\_R!7?/\@5WS_(%=\_R#E9   SW   ,%Z  "V@P
MK8D  *.,  "9C@  C8\  (:0#@"!D1T ?9 L 7B/. 1SCD((;HU+#&J,4Q!G
MBEH48XEA%V"(:!M=AW >6H9Y(5:%@R14A8\F482<*$^$JBI-A+PJ3837*DV#
M\2=/@_\D4(/_(E"#_Q]0@_\?4(/_'U"#_Q_>:0  R74  +R   "RB   J(T
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M&3R?_Q@\G_\8/)__&#R?_QC$?   MHD  *J2  "?EP  E9P  (FA  !]I@
M<:H  &2N  !:L0@ 5[$4 %6R(P!3LC !4+([ DVR1 -+L4T%2+%5!T6Q70E#
ML64+0+!O#3ZP>@\[L(<1.:^6$S>OIA0VK[@4-;#1%#6N[Q0TK?X4-*S_%#2K
M_Q0TJ_\4-*O_%#2K_Q2[A0  KY   *.7  "8G0  C*,  ("H  !TK0  :+(
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M A?:_P*@G   E*,  (>K  !YLP  ;+H  %_!  !2Q@  1LH  #O.   QTP
M*=D  "'>!0 >Z X '>@5 !OI'@ 9Z2< &.HP !;J.0 5ZT, %.Q. !+L6@ 1
M[6< $.YW !#NB@ .[YX #O"S  WPS0 ,[^P #.W\  SK_P ,Z_\ #.O_  SK
M_P"7HP  B:L  'NT  !MO   7\0  %+*  !%S@  .=,  "_8   EW0  '>$
M !CL @ 6]PL %/<1 !'X%P 0^!X #ODE  WY+0 +^C4 "?L_  ?[2@ $_%<
M _UF  +^=P  _8L  /V?  #\M0  _-$  /SM  #\_   _/T  /S]  #\_0"+
MJP  ?;0  &Z]  !@Q@  4LT  $32   WV   +-T  "+A   9Y0  $^H  !#Z
M   ._P8 #?\,  K_$  '_Q0 !/\:  '_(   _R<  /\P  #_.@  _T4  /]3
M  #_8@  _W4  /^*  #_GP  _[,  /_'  #_Y0  _^4  /_E  #_Y0!_M
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M ?(3_P'Q$_\"\!3_ O 4_P+P%/\"\!3_ O 4_P+_*A\ _RP< /\L&P#_*QT
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M";HS_PFZ,_\)NC/_";HS_PG_.1  _ST+ /] "0#_1 T _T81 /]%&0#W1",
M[D$O .8_/ '@/DH!VCU7 M,\8@3/.VP&S#IU!\DZ?0G'.84*Q3F,"\,XE S!
M.)L-P#BC#;XXK Z\.+8/NCC##[DXUQ"U..P0LCG[#[ Z_PZO.O\-KCK_#*TZ
M_PNM.O\+K3K_"ZTZ_PO_/ T _T & /]%! #_20D _TL- /E*$0#M21H XT8F
M -I&-@#11D4!RT51 \9$7 7"0F8(OT)O"KQ!=PNZ0'\-N#^&#K8_CA"T/I41
MLCZ=$K ^IA.O/K 4K3Z]%*L^S16I/N85IC_W$Z1 _Q*C0/\0HD#_#Z) _PZB
M0?\.HD'_#J)!_P[_/PD _T0  /]*  #W3@( [% & .I/"P#C3!  UDP> ,U-
M, #&33\!P$Q,!+M+5P:W26$)M$AI#+%'<0ZN1GD0K$: $:I%B!.H1) 4ID28
M%J1#H1>B0ZL8H$.W&9]#QQF=0^ :FT3S%YE%_Q681O\3F$;_$9A&_Q"71O\0
MET;_$)=&_Q#_0@4 _T<  /=/  #E4P  W54! -=5!@#54@L RU,9 ,-4*P"\
M5#L!ME)(!+%14@>M4%P*J4YD#:9-; ^D3'01H4M[$Y]*@A6=2HH7FTF3&)E)
MG!J72*8;E4BR')1(P1V22-@=D$GO&X]*_AB/2_\6CDO_%(Y,_Q*.3/\2CDS_
M$HY,_Q+_10  _TL  .E3  #>6   TUL  ,U;! #*6 < PE@5 +I:)P"S6C<!
MKEA$!*E73P>D55@*H51@#9Y3:!";46\3F%!V%990?A>43X89DDZ.&H].F!R-
M3:(=BTVN'XI-O""(3= @ATWK'X9/_!N&4/\8AE#_%H90_Q2&4?\4AE'_%(91
M_Q3_1P  ^$\  .17  #570  S&   ,5@ @#!7@4 NET1 +-?(P"L7S,!IEY
M Z%<2P>=6E0*F5E<#I989!&35FL3D%5R%HY4>AB+5((:B5.*'(=2E!Z%4IX?
M@U&J(8%1N")_4<LB?E+G(7Y3^1U^5/\:?E7_%WY5_Q9^5?\5?E7_%7Y5_Q7_
M2@  [E(  -Y;  #/80  QF0  +]E  "Z8P( LV(/ *QC( "F8S !H&(] YMA
M2 :67U$*DEY9#8]<81&,6V@3B5IO%H99=AB$6'X:@E>''']7D!]]5ILA>U:G
M(GE6M2-W5L<D=E;D)'97]Q]W6/\;=UG_&7=9_Q=W6?\6=UG_%G=9_Q;_3
MZ58  -E?  #+90  P6@  +II  "T:   K6<- *9H' "@:"T!FF<Z Y5E10:0
M8TX*C&)7#8EA7A"&7V43@UYL%H!=<QA^7'L:>UR#'7E;C1]V6I@A=%JD(W):
MLB1Q6L0E;UKA)7!;]B!Q7/\<<5W_&G%=_QAQ7?\7<5W_%W%=_Q?]3P  Y5D
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M)E]G\2)@:/\>86C_'&)H_QIB:/\98FC_&6)H_QGL5P  V6(  ,=K  "\<@
MLW<  *IY  "A>0  EW<! )!X$0"+>"$ AG@O 8%W.P1\=44'>'1-"G1R50YQ
M<5P1;G!C%&MO:A9H;G$99FYZ'&-MA!Y@;(\A7FR<(UQKJB5::[LF66S3)EIL
M[R-;;/\?7&W_'%UM_QI=;?\976W_&5UM_QGH6@  TF8  ,-O  "X=@  KWL
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M&DM^_QE,?O\83'[_&$Q^_QC59P  PW,  +9\  "LA   HHD  )B+  "-C0
M?(T  '6.! !OCQ( ;9 A &F0+@%ECSD"8HY"!%Z.2P=;C5(*6(Q9#%:+80]3
MBV@24(IQ%$V)>Q=*B8<92(B5&T:(HQU$B+0=0XC*'4.'ZAQ$AOL:1(;_&$6&
M_Q=%A?\7187_%T6%_Q?-;0  O7@  +&"  "GB@  G(X  )*0  "&DP  >94
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M#2^E_PVVA   JHX  )Z4  "4F0  AYX  'NC  !OJ   8ZP  %>O  !+L@
M0;4& #ZV$0 ]MAX .[8I #JW-  YMSX -[=' #:W4 $TMUH!,K=D C"W;P,N
MMWP$++>+!2JWG 4IMZX&*+C%!2BWY@4GM?D')K/_!R:R_P@FLO\()K+_"":R
M_PBOC0  HI0  )>:  "+H   ?J8  '&K  !EL   6;0  $VW  !"NP  .+X!
M "_""0 MPQ( +,,> "O#*0 JQ#, *<0] "C%1P GQ5$ )L5< "7&:  CQG8!
M(L:& 2#&F $?QJL!'L?! 1[&Y $=Q/@"',+_ QS!_P,<P?\$','_!!S!_P2E
ME   FIH  (ZA  "!IP  <ZX  &>T  !:N0  3KT  $+    XPP  +\<  ";+
M!  >T H &]$1 !K2&@ 9TB4 &-,O !C3.@ 7U$0 %M10 !7570 4U6L $]9\
M !+7CP 1V*0 $-F[ !#9W@ 0U?, $-/_ !#2_P$0T?\!$-'_ 1#1_P&<F@
MD:$  (.H  !UL   :+<  %N]  !.P0  0L4  #?(   MS   )-   !S5   5
MV@4 $.(+ !#C$0 .Y!H #N0C  WE+0 ,Y3< "^9"  KF3P )YUT ".=M  ;F
M@  %YI4 !.:K  +FQ  !YN8  .?Y  #G_P  YO\  .;_  #F_P"3H0  A:D
M '>Q  !IN0  6\   $[&  !!R@  -<X  "K2   AU@  &=L  !+?   -XP
M"_$(  GS#@ '\Q, !/(:  +R(@  \BH  /(T  #R/P  \DP  /)<  #R;0
M\H(  /*8  #SK0  \\8  /3E  #T]@  ]/L  /3[  #T^P"'J0  >;(  &JZ
M  !<P@  3LD  $#.   STP  *-@  ![=   5X0  #^0   KH   %\P   _T!
M  #\"   ^PT  /L1  #[%@  _!X  /PF  #\,   _3P  /Y)  #^6@  _FT
M /^"  #_F   _ZP  /_   #_V   _^0  /_D  #_Y ![L@  ;+L  %W$  !/
MS0  0-(  #+9   FW@  &^(  !+F   ,Z@  !>T   #T    _P   /\   #_
M    _P0  /\)  #_#@  _Q(  /\8  #_(0  _RL  /\W  #_1@  _U@  /]K
M  #_@   _Y4  /^F  #_LP  _[L  /^[  #_NP#_&R8 _QPD /\:) #_%2<
M_Q M /\*-@#_!4, _P%0 ?\ 7@'_ &L!_P!V ?\ @0#_ (H _P"2 /\ F@#_
M *  _P"F /\ K #_ +( _P"Y /\ P@#_ ,T _P#? /\ [ #_ /@ _P#_ /T
M_P#] /\ _0#_ /T _P#] /\ _0#_ /T _P#_'R, _Q\A /\>(0#_&2, _Q,I
M /\.,@#_#$  _PE- ?\'6@'_!&<!_P-S ?\#?0'_ X<!_P./ /\"E@#_ IP
M_P*B /\"J #_ J\ _P&V /\!O@#_ <D _P'; /\ Z@#\ /8 ^ #_ /<"_P#W
M _\ ]@3_ /8$_P#V!?\ ]@7_ /8%_P#_(A\ _R(< /\A' #_'A\ _Q@D /\5
M+P#_$CP _Q!) /\.5@'_#&(!_PMN ?\+>0'_"X(!_PN+ ?\+D@'_"ID!_PJ?
M /\*I0#_"JL _PJR /\*NP#]"L8 ^PK4 /<*YP#S"O0 \ K_ .\+_P#N#/\
M[0S_ >T,_P'M#/\![0S_ >T,_P'_)1L _R88 /\E%P#_(1@ _R A /\>*P#_
M&C< _Q=% /\440'_$EX!_Q%I ?\1= '_$7T!_Q"& ?T0C@'\$)4!^A"; ?D0
MH0'W$*@!]A"O ?00MP#S$,( \1#0 .T0Y0#H$?( YA'^ >02_P'C$O\!XA+_
M >(2_P'A$O\!X1+_ >$2_P'_*18 _RH3 /\I$@#_)Q, _R@< /\G)P#_(S,
M_R _ /\=3 #_&U@!_!ED ?@9;@'V&'@!\QB! ?$8B0'O&) ![AB7 >P8G@'J
M&*0!Z1BL ><8M 'F&+\!Y!C- > 9XP'<&O$!V!K^ M0;_P+2&_\"T1O_ M ;
M_P+0&_\"T!O_ M ;_P+_+1( _RX/ /\N#0#_+Q  _R\7 /\N(0#_+"T _RDY
M /DF1@#T)%,![R)> >LB:0'H(7,!YB%\ >,AA 'A(8P!X"&3 =XAF@'<(:$!
MVB&I =@AL0+5(;P"TR+) M BWP+,(_ #R"/] \8D_P/$)/\#PR3_ \(D_P/!
M)/\#P23_ \$D_P/_, \ _S(+ /\S" #_-@T _S82 /\U&@#],B4 ]# R .TM
M/P#G+$P XBM8 =TK8P'9*FT!U2IV M(J?P+0*H8"SBJ. \PJE0/**IP#R2JC
M!,<JK 3%*K8$PRK#!<(JU06^*^L%NBOY!K@L_P:V+/\%M2S_!;0L_P6T+/\%
MM"S_!;0L_P7_- P _S8% /\Y P#_/ @ _SP- /T[$P#Q.!T Z#4I . T-P#9
M,T8 T312 <TS70'),V<"QC-P \0R> 3!,H $OS*'!;XRCP:\,I8&NC&>![@Q
MI@>W,; (M3*\"+,RS FQ,N4)K3/U":LS_PFJ,_\(J#/_!Z@S_P>G,_\'IS/_
M!Z<S_P?_-P< _SH  /\^  #Z00$ \4$& /$_#0#F/!( VSH? - [,0#*/$
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M%(]#NA6-0\T5BT3H%8I%^A*)1O\0B4;_#HA&_PV(1O\-B$;_#8A&_PW_0
M\D<  .-/  #44P  RU4  ,14  # 4 0 N4\1 +)0(@"L43( IU$_ J)02@.>
M3U,%FTY<")A-8PJ53&H,DTMQ#9%*>0^.2H 1C$F)$HI)DA2(2)P5ADBH%H5(
MM1>#2,<8@4CD&(%*]Q6 2O\2@$O_$(!+_P^ 2_\.@$O_#H!+_P[_0P  [$L
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M'6M6\!IK5_\7:UC_%&Q8_Q)L6/\1;%C_$6Q8_Q'Q2P  WU8  ,Q>  # 9
MMV<  *YH  "G9@  GV(& )AC% "29"0 C6,R 8EB/0*$84<$@6!/!WU?5@EZ
M7ET+=UUD#75<:Q!S7',2<%M[%&Y;A1=L6I 9:EJ<&VA9JAQF6KH=95K1'65:
M[AME6_X79EO_%69<_Q-G7/\29US_$F=<_Q+M3@  VED  ,AA  "\9P  LVH
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M%E=H_Q189_\36&?_$UAG_Q/A6   RV,  +UK  "R<@  J78  *!X  "6=P
MB',  (%S"P!\=!< >'0F '1T,@%P<ST";7-&!&IR3@=G<54)9'!<"V%P8PY?
M;VH07&YS$EIN?!57;8@756R4&5-LHQM1;+,<4&S('$]LYQM1;/H846S_%5)L
M_Q12;/\34FS_$U)L_Q/<7   QV<  +EO  "O=@  I7L  )Q\  "1?   @G@
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M$$" _Q#&:P  MW8  *Q_  "BA0  EXD  (R+  "!C0  <XX  &6/  !=CPD
M6I 4 %B0(0!6D2T 4Y X 5&000).D$D#3)!0!$J/6 5'CV '18YI"4*.<PM
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M!2VDEP8LI*D&*Z2]!BJDW@8JHO4'*:'_!RF@_P@IG_\(*9__""F?_PBQ@@
MI8L  )J1  "0E@  @YH  ':?  !JH@  7J8  %*I  !&JP  /*T  #6O#  S
ML!4 ,K A #&P*P OL#4 +K$^ "VQ2  LL5$ *[%; "FQ9P$GL70!)K&# 22Q
ME (CL:8"(K*[ B&RVP(AK_,#(*[_ R"M_P0?K/\$'ZS_!!^L_P2JBP  G9$
M ).7  "'G   >J(  &VG  !@JP  5:\  $FQ   ^M   ,[<  "JZ P DO T
M(KT5 "&](  AO2H (+TS !^^/0 >OD< ';Y2 !R_7@ :OVP &;]\ !B_C@ 7
MP*$ %L"V !3 TP 5OO$ %;S_ 16[_P$4NO\"%+K_ A2Z_P*AD@  EI@  (J>
M  !]I   ;ZH  &*O  !6M   2K<  #ZZ   SO0  *L   "'$   9QP4 $\L+
M !',$@ 1S!L $,PE  _-+P .S3H #LU&  W-4@ -SF  #,YP  O.@P *SI<
M"<ZL  C.Q@ (SN@ ",W[  G+_P )R_\ "<O_  G+_P"8F   C9X  '^E  !Q
MK   9+,  %>Y  !*O0  /L   #+#   HQ@  '\H  !?-   1T0  #-8%  C9
M#  &V1( !=H;  3:)  #VRX  =LY  #<10  W5(  -YB  #><P  WH@  -^=
M  #?LP  W\X  .#N  #?^@  W_\  -__  #?_P"/GP  @:8  '.N  !EM0
M6+T  $K"   ]Q0  ,<D  ";,   =T   %-0   [9   )W0   ^$   #C!P
MXPT  .02  #E&0  YB(  .<K  #I-@  ZT,  .Q2  #L8@  [78  .Z,  #N
MH0  [[<  ._1  #OZP  \/8  /#V  #P]@"$IP  =:\  &>W  !9OP  2\8
M #S*   OS@  )-(  !K8   2W   #.    7C    YP   .L   #K    [04
M .X+  #P$   \14  /,>  #T)P  ]S,  /E   #Z40  ^V,  /QW  #]C0
M_:,  /ZV  #^R0  _]\  /_?  #_WP!WL   :+D  %K!  !,R@  /,\  "[4
M   BV@  %]X  !#B   )Y@   .D   #L    \    /8   #V    ]P   /@
M  #Z!P  ^PT  /T1  #_&0  _R,  /\O  #_/@  _T\  /]B  #_=P  _XT
M /^?  #_K@  _[H  /^Z  #_N@#_%B, _Q4A /\2(0#_#B0 _P8J /\ ,P#_
M $$ _P!. /\ 7 #_ &@ _P!T /\ ?@#_ (< _P"/ /\ E@#_ )P _P"B /\
MJ #_ *X _P"U /\ O0#_ ,< _P#6 /\ YP#^ /, _@#^ /T _P#\ /\ ^P#_
M /L _P#[ /\ ^P#_ /L _P#_&B  _QD> /\6'@#_$"  _PHE /\$, #_ #T
M_P!+ /\ 6 #_ &0 _P!P /\ >@#_ (, _P"+ /\ D@#_ )@ _P"> /\ I #_
M *H _P"Q /T N0#[ ,, ^@#0 /@ XP#W /$ ]@#\ /0 _P#T /\ \P#_ /,
M_P#S /\ \P#_ /, _P#_'1P _QP9 /\9&0#_%!L _PXA /\,+ #_"3D _P5&
M /\"4P#_ %\ _P!K /\ =0#_ 'X _P"& /\ C@#_ )0 _@"; /P H0#Z *<
M^ "N /4 M0#S +\ \0#+ /  WP#N .X [ #Y .L _P#J /\ Z@'_ .D!_P#I
M ?\ Z0'_ .D!_P#_(!< _Q\4 /\<$P#_%Q4 _Q8= /\3* #_$#0 _PU! /\,
M3@#_"5H _PAF /\(< #^!WD _ >! /H'B0#X!Y  ]@:6 /,&G0#Q!J, [P:J
M .T&L@#_XO__24-#7U!23T9)3$4 " GJ!KL Z ;( .8&W #D!NP X@CZ . *
M_P#>"_\ W0O_ -T,_P#<#/\ W S_ -P,_P#_(Q( _R,0 /\A#@#_'A  _QX8
M /\<(P#_&"\ _Q0[ /\220#\$%4 ^ ]@ /0/:@#Q#W0 [PY\ .T.A #K#HL
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M Z\D_P.N)/\#KB3_ ZXD_P/_+P8 _R\  /\R  #_,P( ^3(( /<O#@#K*Q8
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M"()!_PC_/   ZT,  -Q*  #,3P  PU   +Q.  "W20$ L48. *I(' "D22P
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M$F]-J1-N3;D4;$W.%&Q-ZQ-L3OT0;$__#FQ/_PQL3_\+;$__"VQ/_PON10
MW%   ,E7  "]7   M%X  *Q>  "D6P  G%8$ )56$@"05R$ BU@O (=7.P&#
M5D0"?U9- WQ55 5Z5%L&=U1B"'53: ES4W +<5)X#6]2@@]M48T1:U&9$FE1
MIA1G4;859E'+%652Z11E4OL19E/_#V93_PUF4_\,9E/_#&93_PSJ20  U5,
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M%E5>XQ567O<25E[_$%=>_PY77O\-5U[_#5=>_PW>4P  R%T  +MD  "P:@
MIFT  )UN  "3;0  A6<  'YG"0!X9Q4 =&<C '%H+P!N9SD!:V=" FAF2@-E
M9E(%8V58!F!E7PA>9&<*7&1O#%IC>0Y88X0056*1$E-BGQ-28JX546+"%5!B
MX1518O8246+_$%)B_PY28O\-4F+_#5)B_PW95@  Q&   +=H  "L;@  HW$
M )IS  "/<0  ?VL  'AK!0!R:Q( ;FP? &ML+ !H;#<!9FQ  F-K2 -@:T\$
M7FI6!EQJ70=9:64)5VEM"U5I=PU3:((/4&B/$4YGG1--9ZP42VC %$MHWA1+
M9_423&?_#TQG_PY-9_\-36?_#4UG_PW26@  P&0  +-L  "I<@  H'8  )9W
M  "*=@  >7$  '%Q  !K<0\ :'$< &9R* !C<C0 8'(] 5YR10);<4T#67%4
M!5=P6P94<&,(4F]K"E!O= Q-;H .2VZ-$$ENFQ%';:L21FZ^$T5NW!)&;?01
M1FW_#T=M_PY';/\-1VS_#4=L_PW,7P  O&D  +!Q  "E=P  G'L  )%\  "&
M>P  =7@  &MW  !E=PP 87@7 %]X) !=>3  6GDZ 5AY0@)6>$H"4WA1!%%W
M6 5/=V '3'9H"$IV<@I(=7T,176*#D-UF0]"=:D00'6\$$!UV1! =/,/0'3_
M#D%S_PU!<_\,07/_#$%S_PS&9   MVX  *MV  "B?   EW\  (R!  "!@0
M<H   &5_  !=?P@ 67\3 %> ( !5@"L 4X$V %& /@%/@$8"38!. DM_50-)
M?UT%1G]F!D1^< A"?GL)/WZ("SU]EPP\?:<-.GVZ#CI^U@TZ?/$-.GO_##I[
M_PLZ>O\+.GK_"SIZ_PO :0  LG0  *=\  "=@0  DH0  (>&  ![AP  ;H<
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M!"*9_P2L@0  H(@  )6.  "+D@  ?Y8  '*:  !EG0  6:   $ZC  !"I
M-Z8  "ZH!0 IJ0\ **D8 ">J(@ FJBP ):HU "2J/P CJD@ (JM3 "&K7@ @
MJVH 'JMY !VKBP ;JYT &JNQ !FKR@ 9JNP!&:C] 1BG_P(8IO\"&*;_ ABF
M_P*EB0  F8\  (^4  "#F0  =9X  &BB  !<I@  4*D  $2L   YK@  +[
M ":S   >M08 &;</ !BW%P 7MR$ %K<J !6W-  4N#X $[A) !*X5  2N6(
M$;EQ !"Y@P /N9< #KFL  VYQ  -N.< #K;[  ZU_P .M/\ #K3_  ZT_P"<
MD   DI4  (:;  !YH   :Z8  %ZK  !2KP  1K(  #JU   OMP  );H  !V]
M   5P   $,,&  O&#@ *Q14 "<4>  C%*  'Q3( !L8]  7&20 %QE<  \9F
M  +&=P !QHL  ,:@  #%M@  QM(  ,7O  #%_   Q?\  ,7_  #%_P"5E@
MB9P  'NC  !MJ0  8*\  %.T  !&N   .KL  "Z^   DP0  &\0  !/'   .
MR@  ",X!  '0"@  T!   - 6  #1'@  TB<  -,Q  #4/   U4D  -98  #6
M:0  UGP  -:2  #6IP  UK\  -;@  #6\P  UOX  -;_  #6_P",G0  ?J0
M &^K  !AL@  5+D  $:]   YP0  +<0  "+'   9RP  $<X   S2   %U0
M -L   #< P  W0H  -X/  #?%   X1P  .(D  #D+@  YCH  .=)  #H60
MZ&L  .F!  #IF   Z:T  .G%  #IX@  Z?(  .GU  #I]0" I0  <:T  &.U
M  !5O   1\(  #G&   LR@  (,X  !;2   /U@  "-L   #?    XP   .4
M  #G    Z $  .H'  #K#0  [1$  .\8  #Q(0  \RL  /8X  #W2   ^%H
M /EM  #ZA   ^IL  /JO  #ZP@  ^MH  /K?  #ZWP!TK@  9;8  %:^  !(
MQ@  .<L  "O0   ?U   %-H   W?   %XP   .8   #I    [0   .\   #Q
M    \P   /4   #V @  ^ D  /H.  #]$P  _QP  /\H  #_-@  _T<  /]:
M  #_;@  _X4  /^:  #_JP  _[D  /^\  #_O #_$2  _Q > /\,'@#_!"$
M_P G /\ , #_ #X _P!, /\ 60#_ &4 _P!P /\ >@#_ (, _P"+ /\ D@#_
M )@ _P"> /\ I #_ *H _P"P /\ N #_ ,( _P#. /\ X@#^ /  _0#[ /L
M_P#[ /\ ^P#_ /H _P#Z /\ ^@#_ /H _P#_%!P _Q(: /\.&@#_"!P _P A
M /\ +0#_ #H _P!( /\ 50#_ &$ _P!L /\ =@#_ '\ _P"' /\ C@#_ )0
M_P": /X H #] *8 _ "L /L M #Y +T ^ #) /< W #U .P \P#X /, _P#R
M /\ \0#_ /  _P#P /\ \ #_ /  _P#_%Q@ _Q46 /\1%0#_#!< _P4= /\
M* #_ #8 _P!# /\ 4 #_ %P _P!G /\ <0#_ 'H _ "" /H B0#X )  ]P"6
M /4 G #T *( \P"H /$ L #P +@ [@## .P TP#J .< Z0#U .< _P#F /\
MY0#_ .4 _P#E /\ Y0#_ .4 _P#_&A, _Q@1 /\4$ #_#Q$ _PT9 /\*) #_
M!3  _P$^ /\ 2P#_ %< _@!B /H ; #U '4 \@!] /  A #N (L [ "1 .L
MEP#I )X YP"D .8 K #D +0 X@"_ .  S0#> ., W #R -H _0#8 /\ U@#_
M -4!_P#5 ?\ U0+_ -4"_P#_'A  _QP- /\7"P#_%0X _Q05 /\1'P#_#BH
M_PLX /T(10#X!E$ ] 1< .X$9@#J!&\ Y@-W .0$?P#B!(8 X 2, -X$DP#=
M!9H VP6@ -@%J #5!;$ T@6[ - &R0#.!^  S CQ ,D*_P#'"_\ Q@S_ ,4,
M_P#%#/\ Q0S_ ,4,_P#_(0P _R & /\< P#_'0H _QL0 /\8& #_%", ]A$P
M .\./@#J#DH Y0U6 .$-8 #=#6D V0UQ -4->0#3#8$ T0V( ,\-CP#-#I8
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M ILE_P+_+   _RT  .TR  #B-   VC,  -,N P#2)0H R247 ,$G)P"[*38
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M!X,YK0>".;P(@3G3"'\Z[@A].OX'?#O_!GP[_P5\._\%?#O_!7P[_P7T-P
MY4   -)'  #%2@  O$L  +5)  "O0P  J3X+ *(_%P"=0"8 F$$T )1!/P"1
M04D!CD%1 8M 60*)0& #AT!G X4_;02#/W4%@3]]!G\^AP=]/I$(>SZ<"7H^
MJ0EX/K@*=S_-"G4_Z@IT0/P(=$#_!W1 _P9S0/\&<T#_!G- _P;Q.P  WT4
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M#F!-X0Y@3?8,8$[_"F!._PE@3O\(8$[_"&!._PCC1P  S5   +Y7  "S6P
MJET  *%=  "86@  C5,  (92# " 4Q@ ?%,E 'E4,0!U5#P <U-$ 7!33 )M
M4E,":U)9 VE28 1G46@&95%P!V-1>0AA480*8%"1#%Y0G@U<4*T.6U' #EI1
MW@]:4?4,6E+_"EM2_PE;4?\(6U'_"%M1_PC?2@  R5,  +M:  "P7P  IF$
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M"TQ=_PI,7?\)3%W_"$Q=_PC/5   OEX  +%E  "G:@  G6T  )1M  ");
M>&4  &]D  !I9 X 9609 &)D)0!@93  7F4Z %QE0@%:94H"6&11 E9D6 -4
M9%\$4F1G!5!C<0=.8WL)3&.("DICEPM(8Z8,1V.X#49CT0U&8^\,1F+_"D=B
M_PE'8O\)1V+_"$=B_PC*6   NF(  *YI  "C;@  FG$  )!R  "$<0  =&L
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M!C5T_P:Y:   K7$  *)Y  "8?@  C8   (*!  !V@@  :8$  %N!  !1@0
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M ""8AP ?F)D!'9BL 1R8PP$<E^4!')7Z 1N4_P$;D_\"&Y/_ AN3_P*G?P
MG(8  )&+  "'CP  >I(  &V5  !AF   59L  $F=   ]G@  ,Y\  "JA   A
MHPH 'Z,1 !ZC&@ =I"0 '*0M !ND-@ :I#\ &:1* !BD50 6I6$ %:5P !2E
M@0 3I90 $J6H !&EOP 0I.( $:+X !&A_P 1H/\!$:#_ 1&@_P&@A@  E8P
M (R1  !_E0  <9H  &2>  !8H0  3*0  $"F   UIP  *JD  "*L   9K@
M$K ) !"Q$  0L1@ #K$B  ZQ*P -L34 #;%   RQ2P +L5@ "K%G  BQ>  '
ML8L !;&@  2PM0 $L-  !+#O  6O_@ &KO\ !J[_  :N_P"8C@  CY,  (*8
M  !UG0  9Z(  %JG  !.JP  0:T  #6O   KL0  (;0  !BV   1N0  #;P#
M  >^#  #O1(  ;T9  "^(@  OBL  +XV  "^00  OTX  +]<  "_;0  OX
M +Z5  "^J@  OL(  +WD  "]]@  O?\  +W_  "]_P"2E   A9H  'B@  !J
MI@  7*L  $^P  !"LP  -;8  "JX   @NP  %[X  !#!   +Q   !,<   #)
M!P  R0T  ,D2  #*&0  RR(  ,LK  #--0  SD$  ,Y0  #/8   SW(  ,^'
M  #/G0  S[,  ,_.  #/ZP  SO@  ,[^  #._@"(FP  >J(  &RH  !>KP
M4+4  $*Y   UO   *;\  !["   5Q@  #LD   C,    T    -,   #5
MU@8  -@,  #9$0  VQ8  -P?  #>*   X#0  .)!  #B40  XV,  .-W  #D
MC@  Y*0  .2Z  #EU   Y>H  .7S  #E\P!\HP  ;JH  &"R  !1N0  0[X
M #7"   HQ@  ',D  !/-   ,T0  !-4   #:    W@   .$   #B    Y
M .4#  #G"0  Z0X  .L2  #M&@  [R0  /(Q  #T00  ]%,  /5F  #U?
M]I,  /:I  #WO   ]\X  /??  #WWP!PK   8;0  %.[  !%PP  -L<  "?,
M   ;T   $=4   K;    WP   .(   #E    Z0   .P   #M    \    /$
M  #S    ]00  /<*  #Z$   _!8  /\A  #_+@  _T   /]3  #_:   _X
M /^6  #_J   _[8  /^_  #_OP#_#1P _PH; /\"&P#_ !X _P D /\ +@#_
M #P _P!* /\ 5@#_ &, _P!M /\ =P#_ '\ _P"' /\ C@#_ )0 _P": /\
MH #_ *8 _P"L /\ M #_ +T _P#) /X W0#] .T _ #Z /L _P#Z /\ ^0#_
M /H _P#Z /\ ^@#_ /H _P#_$!D _PT7 /\&%@#_ !@ _P > /\ *@#_ #<
M_P!% /\ 4@#_ %X _P!I /\ <@#_ 'L _P"" /\ B0#_ )  _@"6 /T G #\
M *$ ^P"H /D KP#X +@ ]@## /0 T@#S .< \@#V /  _P#O /\ \ #_ .\
M_P#O /\ [@#_ .X _P#_$A0 _P\2 /\+$@#_ !( _P : /\ )0#_ #, _P!
M /\ 30#_ %D _P!D /T ;0#[ '8 ^0!] /< A #U (L ] "1 /, EP#Q )T
M\ "C .X J@#L +, Z@"] .@ RP#G .$ Y0#Q ., _0#C /\ X@#_ .$ _P#A
M /\ X #_ .  _P#_%!  _Q$. /\-#0#_!P\ _P(5 /\ ( #_ "T _P Z /\
M1P#Y %, ]0!> /( : #P '  [0!X .L ?P#I (4 Z ", .8 D@#E )@ XP"?
M .$ I@#? *X W "X -H Q0#6 -D U #L -( ^0#1 /\ SP#_ ,X _P#. /\
MS@#_ ,X _P#_%PP _Q0( /\/!0#_#@L _PP1 /\'&@#_ 28 _  T /0 00#M
M $T Z0!8 .8 8@#C &H X !R -X >0#; (  V0"& -8 C0#3 ), T0": ,\
MH0#- *H RP"S ,D OP#& -  Q0#H ,, ]@#! /\ P +_ +\#_P"_ _\ OP/_
M +\#_P#_&P8 _Q<  /\4  #_$P4 _Q$- /\.% #Y"A\ \ 8L .8#.0#@ T8
MW -1 -8$6P#2!&0 SP5L ,P%<P#*!7H R 6! ,8%AP#%!HX PP:6 ,$&G0"_
M!J8 O0:P +L'O "Y",T N KE +4+]P"S#?\ L0W_ + -_P"P#O\ KP[_ *\.
M_P#_'@  _QL  /\;  #Z&@  ]18% /81#0#K#A4 X@LB -@+,0#0##X RPU*
M ,<-50#$#EX P0YF +\.;0"]#G0 NP][ +D/@@"W$(H MA"1 +00F@"R$*,
ML!&M *\1N@"M$<H JA+E *<4]P"E%?\ HQ7_ *(5_P"B%?\ HA7_ *(5_P#_
M(@  _R   / C  #F)   X"$  -P9!0#;$ P T!$9 ,@3*0#"%3< O19$ +D7
M3@"U%U< LQA@ + 89P"N&&X K!EU *L9? "I&80 J!J, *8:E "D&IX HQNH
M *$;M "?',4 GAS? )H=\P&8'O\!EQ[_ 98?_P&5'_\!E1__ 94?_P'_)@
M]"<  .8M  #:+P  SRT  ,HG  #''P@ P1P3 +H>(@"T'S$ KR ] *LA2 "H
M(E( IB): *,C8@"A(VD H"-O )XC=P"<(WX FR.& )DDCP&7))D!EB2C 90D
ML &2);\!D276 8XF[P&,)_\"BR?_ HHG_P*))_\"B2?_ 8DG_P'Z*0  [#
M -TV  #-.   Q#<  +XR  "Z*P( M24. *XG'0"H*2L I"HX * J0P"=*TP
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M!F\ZX@9N.O<%;CO_!&T[_P1M._\#;3K_ VTZ_P/J.0  U4(  ,1(  "Y2P
MKTL  *=)  "?1   F#X! )$\$ ",/1T B#XJ (0_-0"!/S\ ?C]( 'P_3P%Z
M/U8!>#]= 78^9 )T/FL"<CYS W ^? -O/H<$;3Z3!6L^H 9J/JX&:3_ !V<_
MW@=G/_4&9D#_!69 _P1F0/\$9C__!&8__P3E/0  ST8  +],  "T3P  JE
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M!E5,_P953/\%54S_!55,_P752   PE$  +57  "J6P  H%P  )=<  "-60
M@5,  '=/! !Q3Q  ;E < &I0* !H4#( 95 [ &-00P!A4$H!7U!1 5U06 )<
M4%\"6E!G UA0<0174'L%55"(!E-0E@=24*4(4%"W"5!0S@E/4.T(4%#_!U!0
M_P904/\%4%#_!5!0_P702P  OU0  +):  "G7@  G6   )1@  ")70  ?%<
M ')4  !L4PX :%09 &54) !B5"\ 8%0X %Y40 !<5$@!6E1/ 5E45@%75%T"
M551E U14;@125'D%4%2&!DY4E =-5*0(2U2U"$M4S E*5.L(2U3^!TM4_P9+
M5/\%2U3_!4M4_P7,3@  NU<  *Y>  "D8@  FF0  )%D  "&8@  =UL  &U8
M  !F6 P 8E@6 %]8(@!=62P 6UDV %E9/@!7648 5EE- 5195 %265L"45EC
M T]9; --67<$2UB$!4E8D@=(6*('1UFS"$99R@A%6>H(1EG]!D98_P9&6/\%
M1UC_!4=8_P7'4@  N%L  *MA  "A9@  F&@  (YI  "#9P  <F   &A>  !A
M70D 7%T3 %I='@!772D 5EXS %1>.P!27D, 45Y* 4]>4@%.7ED"3%YA DI>
M:@-(7G4$1EZ"!41=D 9#7J '05ZQ!T!>R = 7N@'0%W\!D%=_P5!7?\%05S_
M!4%<_P7#5@  M%\  *AF  ">:@  E6T  (IM  !_;   ;V<  &1D  !;8@4
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M C-RB0,Q<IH#+W*L RYRP0,N<N,#+G'X RYP_P,N;_\#+F__ RYO_P.S9@
MIV\  )UV  "3>@  B'P  'Y]  !R?0  9'P  %=[  !,>@  0GD# #QY#@ Z
M>A< .7HA #AZ*@ W>S, -GL[ #1[1  S>TP ,GM5 #![7P O>VH!+7MW 2M[
MAP$J>Y@"*'NJ B=[OP(F>^$")GKW B9X_P(F>/\")W?_ B=W_P*N;   HW8
M )E\  ".?P  A((  'B#  !LA   7X0  %&$  !'A   /(0  #.$"0 PA!$
M+X0: "V$)  LA2T *X4U "J%/@ IA4< *(90 ">&6@ FAF8 )(9S ".&@P A
MAI4 ((:G 1Z&O $>AMX 'H3U 1Z"_P$>@O\!'H'_ 1Z!_P&H=   GGT  )."
M  ")A0  ?H@  '&*  !EBP  6(P  $R-  ! C@  -HX  "R/   ED P (Y 3
M "*0'  AD"4 ()$N !^1-@ >D4  '9%) !R15  :D6  &9%N !B1?@ 6DI
M%9*D !21N0 3D=@ $X_T !2._P 4C?\ %(S_ 12,_P&C?0  F(,  (Z(  "$
MC   =X\  &F1  !=DP  4)4  $67   YF   +ID  "6:   =FP( %IT, !6=
M$P 4G1L $YTD !*=+0 1GC< $9Y! !">3  /GE@ #IYG  V>=P ,GHH "YV>
M  J=L@ )G<P "9SL  J;_@ +FO\ "YG_  N9_P"<A   D8H  (B.  ![D@
M;98  &"9  !4G   2)\  #R@   PH0  )J,  !VE   5IP  $*D%  NK#0 (
MJA, !ZH;  :J)  %JBX !*HX  *J1  !JE   *I>  "J;@  JH$  *J5  "I
MJ@  J<$  *CD  "H]@  I_\  *?_  "G_P"5BP  C)   '^5  !QF@  8YX
M %:B  !*I@  /:@  #&J   FJP  ':T  !2P   .L@  ";4!  *V"@  M@\
M +85  "W'0  MR4  +<O  "X.0  N$8  +A4  "X9   N'8  +B+  "WH
MM[8  +?3  "V[P  MOP  +;_  "V_P"/D@  @I<  '2=  !FH@  6*<  $NL
M   ^KP  ,;$  ":S   <M@  $[@   V[   &O@   ,$   #"!   P@L  ,,0
M  #$%0  Q!P  ,4D  #&+@  R#H  ,E'  #)5P  R6D  ,E]  #)E   R*H
M ,C#  #(Y   R/0  ,C]  #(_0"%F0  =Y\  &BF  !:JP  3;$  #^U   Q
MN   );H  !J]   1P   "\,   /'    R@   ,T   #.    SP,  - )  #1
M#@  TQ(  -49  #7(@  VBT  -TY  #>20  WEH  -]N  #?A0  WYP  -^R
M  #>RP  WN8  -_T  #?] !YH0  :Z@  %RO  !.M0  0+L  #&^   DP0
M&<4  !#(   )S    ,\   #3    V0   -P   #=    WP   .$   #B!0
MY L  .80  #H%@  ZB   .TK  #P.@  \4L  /%>  #R<P  \XL  /.B  #S
MM@  \\D  //A  #SX0!MJ@  7K$  %"Y  !!OP  ,L0  "3(   7S   #M
M  ;5    V@   -X   #B    Y@   .D   #J    [    .X   #P    \@
M /0&  #V#   ^1(  /P<  #_*0  _SH  /]-  #_8@  _W@  /^0  #_HP
M_[,  /_!  #_P0#_!QD _P$7 /\ %P#_ !H _P A /\ *P#_ #D _P!' /\
M5 #_ %\ _P!J /\ <P#_ 'L _P"# /\ B@#_ )  _P"6 /\ FP#_ *$ _P"H
M /\ KP#_ +@ _P#$ /X U0#\ .H ^P#X /H _P#Y /\ ^ #_ /@ _P#V /\
M\P#_ /$ _P#_"Q4 _P43 /\ $P#_ !0 _P : /\ )P#_ #0 _P!" /\ 3P#_
M %L _P!E /\ ;@#_ '8 _P!^ /\ A0#^ (L _0"1 /L EP#Z )T ^ "C /<
MJP#V +, ] "^ /, S #Q ., [P#S .X _P#M /\ [ #_ .L _P#L /\ [ #_
M .L _P#_#1$ _PD0 /\ #P#_ !  _P 6 /\ (@#_ "\ _P ] /\ 2@#_ %4
M_0!@ /H :0#X '$ ]@!Y /0 ?P#S (8 \0", .\ D@#N )@ [ "? .L I@#I
M *X YP"X .4 Q0#C -H X0#M -\ ^P#> /\ W0#_ -T _P#= /\ W0#_ -T
M_P#_#PT _PP+ /\#"0#_  P _P 2 /\ '0#_ "D ^P W /@ 1 #U %  \@!:
M .X 8P#L &L Z0!S .< >@#E (  XP"& .$ C #? ), W0"9 -L H0#9 *D
MU0"R -( O@#0 ,X S@#F ,P ]@#* /\ R@#_ ,D _P#( /\ R #_ ,@ _P#_
M$0@ _PT" /\'  #_!0@ _P . /\ %@#W "( [P P .L /0#H $D Y !4 .
M70#= &4 V0!M -4 <P#2 'H T "  ,X AP#, (T R@"4 ,@ FP#& *0 Q "M
M ,( N #  ,< O0#? +P \0"[ /X N0#_ +@ _P"X /\ N #_ +@ _P#_%
M_P\  /\-  #_#   _P<) /@!$ #H !H XP H -T -@#8 $( T@!- ,X 5P#*
M %\ QP!F ,4 ;0## '0 P0!Z +\ @0"] (@ NP"/ +D EP"W )\ M0"H +,
MLP"Q ,( KP#8 *X"[0"L _L JP7_ *H&_P"I!O\ J0;_ *D&_P#_%@  _Q(
M /<2  #L$0  Y@X  .4&" #= Q( U ,@ ,T$+0#(!#H PP5& +\%4 "\!E@
MN09@ +<'9P"U!VX LP=U +$(>P"O"(( K@F* *P)D@"J"9L J JE *8*L "E
M"[\ HPS4 *$-[0"?#OX G0[_ )P/_P";#_\ FP__ )L/_P#_&@  ]QD  .H>
M  #?'@  U1H  - 3 @#.# L QPL6 , -)0"Z#C( M@X_ +(/20"O$%( K!!:
M *H080"H$6@ IA%O *01=@"B$7T H1&% )\2C@"=$I< G!*B )H3K0"8$[P
MEQ30 )05[ "2%OT D!?_ (\7_P".%_\ CA?_ (X7_P#Z'0  [B,  -\H  #0
M*@  QR<  ,$A  "]&04 N1(0 +(5'@"M%BP J!<X *080P"A&4P GQE4 )P:
M7 ":&F( F1II )<;< "5&W< E!M_ )(<B "0')( CQR= (T=J0"+';< BA[*
M (@?YP"&(/H A"#_ 8,@_P&#(/\!@B#_ 8(@_P'U)   Y2P  -,Q  #&,P
MO#$  +8M  "P)0  K!T, *8>& "A("8 G"$R )DB/0"5(D< DR-/ )$C5@"/
M(UT C21D (LD:P"))'( B"1Z (8D@P"$)8T @R68 8$EI & )K(!?B;% 7TG
MX@%[)_<!>2C_ 7@H_P%X*/\!>"C_ 7@H_P'O*P  W3,  ,HY  "^.P  M#H
M *TV  "F+P  H2@' )LG$P"6*"  D2DM (XJ. "+*T( B"M* (8K4@"$*U@
M@BQ? ( L9@!_+&T ?2QU 'LL?@%Z+(@!>"R4 78MH %U+:X"="W  G(NW0)Q
M+O0"<"__ F\O_P)O+_\!;B__ 6XO_P'H,0  TSH  ,,_  "W00  KD$  *8^
M  ">.   ES$! )$N$ ",+QP B# H (0Q,P"!,CT ?S)& 'TR30![,E0 >3);
M '<R80!U,FD!=#)P 7(R>0%P,X0!;S.0 FTSG0)L,ZL":C2\ FDTU0-H-?$"
M9S7_ F<U_P)F-?\"9C7_ F8T_P+B-@  S#\  +U$  "R1P  J$<  *!$  "8
M/P  D#D  (@T#0"#-1< ?S8D 'PW+P!Y-SD =SA" '0X20!R.%  <3A7 &\X
M7@!M.&4!;#AM 6HX=0%H.( "9SB, F4XF0-D.:@#8CFY V$ZT -@.NX#8#K_
M U\Z_P)?.O\"7SK_ E\Z_P+=.P  QT,  +E)  "N2P  I$P  )M*  "210
MB3\  ($Z"0![.A0 =SL@ '0\*P!R/#4 ;ST^ &T]1@!K/4T :3U3 &@]6@!F
M/6$!9#UI 6,]<@%A/7T"8#V) EX]E@-=/J4#6SZV!%H^S 1:/^P$63_^ UD_
M_P-9/_\"63__ ED^_P+6/P  PT<  +5,  "J4   H%   )=/  ".2P  A$4
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M TI+_P/(20  N%$  *Q7  "A6P  F%P  (Y<  "#60  =E,  &M.  !D30H
M7TP3 %Q-'@!:32@ 6$TQ %9-.@!434$ 4TY( %).3P!03E<!3TY? 4U.: %,
M3G,"2D]_ DE/C0-'3YT$1D^N!$5/PP1$4.0$1$_Y!$5/_P-%3_\#14[_ T5.
M_P/$3   M54  *E;  "?7@  E6   (M@  " 7@  <E<  &=3  !>40< 65$1
M %=1&P!4424 4E(O %%2-P!/4C\ 3E)& $U330!,4U4 2E-= 4E39@%'4W "
M15-] D13BP-"4YL#052L!$!4P00_5.($/U3X T!3_P- 4_\#0%/_ T!2_P/
M4   LE@  *9>  "<8@  DF4  (AE  !]8@  ;EP  &-9  !95@, 5%8. %%6
M& !/5B( 35<L $Q7- !*5SP 25A$ $A82P!'6%, 15A; 4189 %"6&X!0%A[
M C]8B0(]6)D#/%BJ SM9OP,Z6> #.ECW SI8_P,[5_\#.U?_ SM7_P.\5
MKEP  *-C  "99P  D&D  (5I  !Y9P  :V(  &!@  !570  3EL, $M;% !)
M7!\ 1UPH $9=,0!%73D 0UU! $)=2 !!7E  0%Y8 #Y>80$\7FP!.UYX CE>
MAP(W7I<"-EZI S5>O0,T7]T#-%[U S5=_P(U7?\"-5S_ C5<_P*X60  JF$
M *!G  "6;   C&X  (%N  !V;   9VD  %QF  !19   2&() $1B$0!"8AL
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M "!UMP ?==( 'W3Q !]S_P$?<O\!(''_ 2!Q_P&I:P  GG,  )1Y  "*?
M@'X  '1_  !G?P  6G\  $U^  !#?@  .'T  "]] @ H?0T )GT4 "1]'  C
M?B4 (GXM "%^-@ A?C\ 'W]( !Y_4@ =?UX '']K !I_>@ 9?XP %W^? !9_
MLP 5?\X %7[O !9\_P 6>_\ %GO_ !=[_P"D<@  FGH  (]_  "%@@  >X0
M &V&  !@AP  5(<  $B(   \B   ,H@  "B(   @B 4 &HD. !F)%0 8B1T
M%XHF !:*+@ 5BC< %(I! !.*3  2BU@ $8ME !"+=0 /BX< #HJ;  V*KP ,
MBL@ #(GJ  V'_  .A_\ #H;_  Z&_P"?>P  E($  (J%  " B   <XL  &6-
M  !9CP  3)   $&2   TD@  *I(  "&3   9E   $I8&  Z7#@ -EQ4 #)<=
M  R7)@ +ER\ "I<Y  F71  (EU  !I=>  67;@ #EH   9:4  "5J   E;X
M )3@  "4]   D_\  9+_  &2_P"8@@  CH@  (6,  !WCP  :I(  %V5  !0
MF   1)H  #B;   LG   (IT  !F>   2H   #:("  >C"P !HQ   *,7  "C
M'P  HR<  *,Q  "D/   I$@  *16  "D90  HW<  *.+  "CH   HK8  *'2
M  "A\   H/L  *#_  "@_P"1B@  B8X  'N2  !MEP  8)L  %.>  !&H0
M.:,  "VD   CI@  &:@  !&J   ,K   !:X   "O!P  KPT  *\1  "P&
ML"   +$H  "Q,@  LCX  +),  "R6P  LFP  +*!  "QEP  L:P  +#&  "P
MZ   K_<  *__  "O_P",D   ?Y4  '&:  !CGP  5:0  $>H   ZJ@  +:P
M "*N   8L   $+,   JU   "N    +L   "[    O <  +P-  "]$0  OA8
M +\>  # )P  P3(  ,)   ##3P  PV   ,-T  ##BP  PZ$  ,.X  #"UP
MPN\  ,+Z  #!_@"!EP  <YT  &6C  !7J   2:T  #NQ   MLP  (;8  !:Y
M   .NP  ![X   #!    Q0   ,<   #(    R0   ,H%  #+"P  S0\  ,X4
M  #0'   TR8  -8R  #800  V%,  -EF  #9?   V90  -FK  #9PP  V>$
M -GP  #9] !VGP  9Z8  %FL  !+L@  /+<  "ZZ   AO0  %<    W$   %
MQP   ,H   #.    T@   -4   #6    V0   -L   #=    WP<  .$,  #C
M$0  YAD  .DD  #L,@  [4,  .Y6  #O:P  [X0  .^<  #OL@  [\8  ._=
M  #OY !JJ   6Z\  $RV   ^O   +\   "#$   4R   #,P   +0    U
M -D   #>    X@   .4   #F    Z    .D   #L    [@   / "  #R"0
M]0\  /@7  #\(P  _S,  /]&  #_6@  _W$  /^)  #_GP  _[$  /_   #_
MQ@#_ !4 _P 4 /\ % #_ !< _P = /\ * #_ #< _P!$ /\ 40#_ %P _P!F
M /\ ;P#_ '< _P!^ /\ A0#_ (L _P"1 /\ EP#_ )T _P"D /\ JP#_ +0
M_@"_ /T S@#[ .8 ^0#V /@ _P#W /\ ]P#_ /< _P#P /\ [ #_ .D _P#_
M Q( _P 0 /\ $ #_ !$ _P 7 /\ ) #_ #( _P _ /\ 3 #_ %< _P!A /\
M:@#_ '( _P!Y /T @ #\ (8 ^@", /D D@#X )@ ]@"? /4 I@#T *X \@"Y
M /  Q@#N -X [0#P .L _@#J /\ Z0#_ .D _P#G /\ XP#_ .  _P#_!PX
M_P - /\ "P#_  P _P 3 /\ 'P#_ "P _P Z /\ 1@#^ %( ^P!< /@ 90#U
M &P \P!T /$ >@#O ($ [@"' .P C0#J ), Z0": .< H0#F *D XP"S .$
MOP#? -  W0#I -H ^0#9 /\ UP#_ -4 _P#5 /\ U0#_ -0 _P#_"0H _P$%
M /\  P#_  D _P 0 /\ &0#[ "8 ]P T /0 0 #R $P [@!6 .H 7P#G &<
MY !N .( = #@ 'L W@"! -P AP#: (T U@"4 -0 FP#1 *, SP"M ,P N #*
M ,< R #@ ,8 \P#% /\ PP#_ ,, _P## /\ PP#_ ,, _P#_"P$ _P,  /\
M  #_  , _P + /, $@#N !\ Z@ M .8 .@#B $4 W@!/ -D 6 #4 &  T0!H
M ,X ;@#, '0 R@![ ,@ @0#& (< Q ". ,( E@#  )X O@"G +L L@"Y ,
MMP#4 +4 [ "S /L LP#_ +( _P"R /\ L0#_ +$ _P#_#0  _P8  /\#  #W
M    ]  # .< #0#@ !@ V@ E -, ,@#. #X R@!) ,8 4@## %H P !A +X
M: "\ &X N@!T +@ >P"V ($ M "( +( D "P )D K@"B *P K0"J +H J #+
M *8 Y@"E /< I #_ *, _P"B /\ H@#_ *( _P#_$   ^PP  .\.  #F#0
MWPD  -H !@#0 !$ R0 = ,0 *@"_ #< NP!" +< 2P"T %0 L@!; *\ 8@"M
M &@ JP!N *D =0"H 'L I@"# *0 BP"B )0 H "> )X!J "< K4 FP/& )D%
MX@"8!O0 E@C_ )4)_P"4"?\ E G_ )0)_P#\$0  \14  .,9  #6&0  S!4
M ,<0  #$!PH O0,4 +<$(0"R!BX K@@Z *H)1 "G"4T I I5 *(*7 "@"F(
MG@MI )P+;P";"W8 F0Q^ )<,A@"6#)  E R: )(-I@"1#;, CPW% (T.X@"+
M$/8 B1#_ (@1_P"'$?\ AQ'_ (<1_P#V&0  YR   -8D  #()0  OR(  +D<
M  "T% $ L0T. *H.&0"E#R< H1 S )T1/@":$4< F!)/ )425@"3$EP D1)C
M ) 3:0".$W  C!-X (L3@0")%(L AQ26 (85H@"$%;  @Q;! ($7W0!_&/0
M?1G_ 'P9_P!\&?\ >QG_ 'L9_P#O(0  W2D  ,HM  "^+P  M2P  *XG  "H
M(   HQ<( )X6$P"9%R$ E!DM )$:. ".&D$ BQM) (D;4 "'&U< A1Q> (0<
M9 ""'&L @!QS '\=? !]'88 ?!Z1 'H>G@!X'ZL =Q^\ '8@U !T(?  <B'_
M '$B_P!Q(?\ <2'_ '$A_P#H*   TC   ,(U  "W-P  K34  *4Q  ">*P
MF"," )(>$ "-(!L B2$G (8B,@"#(SP @2-$ 'XC2P!\)%( >R19 'DD7P!W
M)&8 =B5N '0E=P!S)8$ <2:- &\FF0!N)J< ;2>X &PGS@%J*.T!:2G_ 6@I
M_P%H*?\!:"C_ 6@H_P'A+@  RS8  +P[  "Q/0  IST  )\Y  "7,P  CRT
M (@G# "#)Q8 ?R@B 'PI+0!Y*C< =RH_ '4J1P!S*TX <2M4 ' K6P!N*V(
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M 5,Y_P'-/   O$0  *])  "D3   FDP  )%+  "'1@  ?4   ',[  !L. T
M:#D7 &4Y(@!C.BL 8#HT %XZ/ !=.D, 6SI* %H[4 !8.U@ 5SM@ %8[: !5
M/',!4SQ_ 5(\C0%0/9P!3SVL DX^P0)-/N$"33[X DT^_P%-/O\!33W_ 4T]
M_P')0   N$@  *Q-  "A4   EU$  (Y/  "$2P  >44  &Y   !F/0L 8CT4
M %\]'@!</B@ 6CXQ %@^. !7/D  53]& %0_30!3/U4 4D!= %! 9@!/0' !
M3D!\ 4Q!B@%+09H"2D&K DE"O@)(0MX"2$+V DA"_P)(0O\!2$'_ 4A!_P'%
M1   M4L  *E0  ">5   E50  (M3  " 4   =4H  &I&  !A0@@ 7$$1 %E"
M&P!70B4 54(N %-"-0!10CT 3T)# $]#2P!.0U( 341: $M$8P!*1&X!245Z
M 4=%B %&19@"14:I D1&O0)#1MP"0T;U D-&_P)#1O\!0T7_ 4-%_P'!1P
MLD\  *94  "<5P  DE@  (A8  !^50  <4\  &9*  !<1@4 5T8/ %1&& !1
M1B( 3T8K $Y&,P!,1SH 2T=! $I'20!)2%  2$A8 $=(80!%26P 1$EX 4))
MA@%!298!0$JG C]*NP(^2]@"/DKS CY*_P(^2?\!/TG_ 3])_P&]2@  KU(
M *-8  "96P  D%T  (9<  ![60  ;5,  &)/  !73 $ 44H- $Y*%0!,2Q\
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M 2Y9M0$M6<\!+5GO 2Y8_P$N5_\!+E?_ 2Y6_P&R5P  I5\  )ME  "1:0
MAVH  'QJ  !Q:   8V4  %AB  !-7P  0UT" #Q;#0 Z7!0 .%P= #=<)@ U
M72X -%TV #-=/@ R748 ,5Y. #!>5P O7F( +5YN "Q??0 J7XX *5^@ "A?
MLP$G7\P )U_M 2=>_P$G7?\!*%W_ 2A<_P&M7   HF0  )AJ  ".;@  @V\
M 'EO  !N;@  8&L  %1I  !)9P  /V4  #5C"0 R8Q$ ,&,9 "]D(0 N9"D
M+60Q "QD.0 K94( *F5* "AE5  G95\ )F9K "1F>@ C9HL (F:= "!FL0 ?
M9LD 'V;K "!E_@ @9/\ (&/_ 2%C_P&I8@  GFH  )5P  "*<P  @'4  '5U
M  !I=   7'(  $]Q  !$;P  .FX  #!M P I; T )VP4 "9L'  E;20 )&TL
M "-M-  B;3T (6Y& "!N4  >;EL '6YG !QN=@ :;H< &6^: !AOK@ 6;\8
M%F[I !=M_  8;/\ &&O_ !AK_P"D:0  FG$  )!V  "&>0  ?'L  '%[  !D
M>P  5WH  $IY   _>   -7@  "MW   B=@< '78/ !QW%@ ;=QX &G<F !EW
M+@ 8=S< %WA  !5X2@ 4>%8 $WAC !)X<@ 1>(, $'B7  ]XJP .>,, #G?F
M  YV^@ /=?\ $'7_ !!T_P"?<0  E7@  (M\  ""?P  =X$  &J"  !=@@
M4((  $2"   X@@  +H(  "2"   <@@  %(() !&#$  0@Q8 $(,>  Z#)P .
M@S  #8,Y  V#1  ,@U  "X-=  F#;  (@WX !H.1  6"I0 #@KL !(';  2!
M\@ %@/\ !G__  9__P":>0  D'X  (:#  !]A0  ;X<  &*)  !5B@  28L
M #V,   QC   )HP  !V-   5C@  #X\#  J0#  &D!$ !(\8  ./(  !CRD
M (\R  "0/0  D$D  (]6  "/90  CW8  (^*  ".GP  CK0  (W/  ",[@
MC/L  (O_  "+_P"4@   BX4  (*)  !TC   9H\  %F1  !,DP  0)4  #26
M   HE@  'I<  !68   /F@  "IL   *<"0  G X  )P3  "<&@  G"(  )TK
M  "=-0  G4   )U.  "=7   G6X  )R!  "<EP  G*P  )O&  ":Z   F?D
M )G_  "8_P".B   AHP  'B0  !JE   7)<  $^:  !"G0  -IX  "F?   ?
MH0  %:(   ZD   (I@   *@   "I!   J0H  *D.  "I$P  JAH  *HB  "K
M*P  K#8  *Q$  "L4P  K&,  *QW  "KC@  JZ0  *N\  "JW@  J?0  *G]
M  "I_P")C@  >Y,  &V7  !?G   4:   $2D   VI@  *J@  !ZI   4JP
M#:X   :P    L@   +4   "U    M0,  +8)  "W#@  N!(  +@9  "Z(0
MNRL  +PX  "]1P  O5@  +UK  "]@0  O9D  +VP  "]S   O.H  +SW  "[
M_@!^E0  <)L  &*@  !3I0  1JH  #BM   JKP  'K$  !.T   ,MP   [D
M  "\    OP   ,(   #"    PP   ,0   #&!@  QPP  ,@0  #*%@  S"
M ,\K  #0.@  T4L  -%>  #2<P  THL  -*D  #3NP  T]@  -/M  #3]@!S
MG0  9*,  %:I  !'KP  .;,  "JV   =N0  $KP   J_    PP   ,8   #)
M    S0   ,\   #0    T@   -0   #6    V0(  -L(  #>#@  X1,  .0=
M  #H*@  Z#P  .E/  #I9   ZGP  .N5  #KK   Z\(  .S5  #LY0!FI@
M6*P  $FS   [N0  *[P  !W    1Q   "<@   #,    SP   -,   #9
MW0   .    #A    XP   .4   #G    Z@   .P   #N!   \0L  /42  #X
M'   ^RL  /T^  #^4P  _FH  /^#  #_FP  _ZX  /^^  #_R@#_ !( _P 0
M /\ $0#_ !, _P 9 /\ )@#_ #0 _P!! /\ 30#_ %@ _P!B /\ :P#_ ',
M_P!Z /\ @0#_ (< _P"- /\ DP#_ )D _P"@ /\ IP#^ *\ _ "Z /H R0#Y
M .$ ^ #S /< _P#V /\ ]0#_ /$ _P#I /\ Y #_ .$ _P#_  \ _P - /\
M#0#_  X _P 4 /\ (0#_ "X _P \ /\ 2 #_ %, _P!= /\ 9@#^ &T _ !U
M /L >P#Y (( ^ "( /< C@#V )0 ] "; /, H@#Q *H [P"T .T P0#K -4
MZ@#L .@ _ #G /\ Y0#_ .8 _P#@ /\ V0#_ -0 _P#_  L _P ( /\ !@#_
M  D _P 0 /\ ' #_ "D _P V /\ 0@#[ $X ]P!7 /0 8 #R &@ [P!O .T
M=@#L 'P Z@"" .@ B #G (X Y0"5 ., G #A *0 WP"N -T N0#: ,H UP#D
M -0 ]@#1 /\ T #_ -  _P#/ /\ RP#_ ,< _P#_  , _P   /\   #_  0
M_P - /H %@#V ", \P P /  / #M $< Z0!1 .4 6@#B &( WP!I -T ;P#:
M '8 V !\ -0 @@#2 (@ T "/ ,T E@#+ )X R0"H ,< LP#% ,$ P@#8 ,
M[P"_ /X O@#_ +T _P"\ /\ O #_ +P _P#_ @  _P   /\   #_    ]  '
M .T $0#H !P XP I -\ -0#; $$ U@!+ -$ 5 #- %P R@!C ,@ :0#& &\
MPP!U ,$ >P"_ (( O@"( +P D "Z )@ N "B +4 K "S +D L0#+ *\ YP"N
M /@ K #_ *L _P"L /\ K #_ *L _P#_!   _P   /8   #N    YP   -\
M# #6 !4 SP B ,H +@#' #H PP!$ ,  30"\ %4 N0!< +< 8P"U &D LP!O
M +$ =0"O 'L K0"" *L B@"I )( IP"< *4 I@"C +, H0## )\ W@"> /(
MG0#_ )P _P"< /\ FP#_ )L _P#_!P  ]@D  .D+  #?"@  U00  ,X !0#&
M !  P  : +L )P"W #( LP ] +  1@"M $\ J@!6 *@ 7 "F &, I !H *(
M;P"A '4 GP!\ )T A "; (T F0"7 )< H@"5 *X DP"] )$ TP"0 .T CP#\
M (X _P"- ?\ C0'_ (T!_P#Y#@  ZA(  -P5  #-%0  Q!$  +X,  "Z @H
MM  2 *X '@"J "H I@ U *( /P"@ $@ G0%0 )L"5@"9 EP EP-C )4#:0"3
M V\ D01V ) $?P".!8@ C 62 (H&G@"(!JH A@>Z (4(SP"$"NL @@O\ ($,
M_P" #/\ @ S_ ( ,_P#Q%0  X!T  ,T@  #!(0  N!T  +$7  "L$   J D-
M *('%@"="2, F0HN )4+. "3#$$ D Q) (X-4 ",#5< B@U= (@-8P"'#6H
MA0YQ (,.>@""#H0 @ Z/ 'X/FP!\#Z@ >Q"X 'H0S@!X$>P =A+_ '42_P!T
M$_\ =!/_ '03_P#H'@  TR8  ,,J  "X*@  KB@  *<C  "@'   FQ,# )8/
M$ "0$!L C!$G (D2,@"&$SL A!-# ((42P" %%$ ?A17 'P47@![%64 >15L
M '<5= !V%GX =!:* '(7E@!Q%Z0 ;QBT &X8R0!M&>@ :QK\ &H;_P!J&_\
M:AO_ &H;_P#@)@  RBT  +PQ  "P,P  IS$  )\L  "7)@  D!\  (H7# "%
M&!8 @1DB 'X:+ ![&S8 >1L^ '<<10!U'$P <QQ3 '$=60!P'6  ;AUG &T>
M< !K'GH :AZ% &@?D@!G'Z  92"P &0AQ0!C(>0 8B+Z &$B_P!A(O\ 82+_
M &$B_P#7+   PS0  +8X  "J.0  H3@  )@U  "0+P  B"@  ( A" ![(!(
M=R$= '0B)P!Q(C$ ;R,Y &TC00!K(T@ :2-. &@D50!F)%L 921C &,E:P!B
M)74 826! %\FC@!>)IT 72>M %LHP0!;*.  6BGW %DI_P!9*?\ 62G_ %DH
M_P#/,@  OCD  +$]  "F/P  G#\  ),\  "*-@  @3   'DJ P!R)@\ ;B<9
M &LH(P!I*"P 9BDU &4I/ !C*4, 82I* & J40!>*E< 72I? %PK: !:*W(
M62Q] %@LBP!6+9H 52VJ %0NO0!3+MP 4B_U %(O_P!2+O\ 4B[_ %(N_P#*
M-@  NCT  *U"  "B1   F$0  (]!  "%/   >S<  '(Q  !K+ P 9RT5 &0M
M'P!A+B@ 7RXQ %TN.0!<+T  6B]& %@O30!7+U0 5C!< %4P9 !3,6X 4C%Z
M %$QB !0,I< 3C*H $TSNP!---@ 3#3S $PT_P!,-/\ 3#/_ $PS_P#&.@
MMD(  *E&  ">20  E4D  (M'  "!0@  =ST  &TW  !D,@D 8#(2 %TR' !:
M,B4 6#,M %8S-0!5,SP 4S1# %(T2@!1-%$ 4#19 $\U80!--6P 3#9W $LV
MA0!*-Y4 2#>F $<XN %'.-,!1CCQ 48X_P%&./\ 1CC_ $8W_P#!/@  LD4
M *9*  "<30  DDT  (A+  !^1P  <T(  &D]  !?-P8 6C80 %<W& !4-R(
M4C<J % W,@!/.#D 33A  $PX1P!+.$X 2CE6 $DY7P!(.FD 1SIU $4[@P!$
M.Y, 0SRD 4(\M@%!/= !03WP 4$]_P%!//\!03S_ 4$\_P"^0@  KTD  *-.
M  "94   CU$  (50  ![3   ;T8  &5"  !:/0( 5#L. %$[%0!/.Q\ 33LG
M $L[+P!)/#8 1SP] $<\1 !&/4L 13U4 $0^7 !#/F< 0C]S $ _@0 _/Y$
M/D"B #U M0$\0<X!/$'N 3Q!_P$\0/\!/$#_ 3T__P&Z10  K$P  *%1  "7
M5   C54  (-4  !X40  ;$L  &%'  !60@  3T , $P_$P!)0!P 1T D $9
M+ !$0#, 0T Z $)!0@!!04D 0$)1 #]"6@ ^0V4 /4-Q #M#?P Z1(\ .42@
M #A%LP$W1<L!-T7L 3=%_P$W1/\!.$3_ 3A#_P"W20  J5   )Y5  "46
MBUD  (!8  !V5@  :%   %U,  !32   2D4) $9$$0!$1!D 0D0B $%%*0 _
M13$ /D4X #U%/P \1D< .T9/ #I'6  Y1V( .$AN #9(?  U2(T -$F> #-)
ML0 R2<D ,4GK #))_@ R2/\ ,DC_ #-(_P"T3   IU0  )Q9  "27   B%T
M 'Y=  !S6@  954  %M2  !03@  1DH% $!)#@ ^218 /4D> #M*)@ Z2BX
M.4HU #A+/0 W2T0 -DM- #1,5@ S3&  ,DQL #%->@ P38L +DV< "U.KP L
M3L< +$[I "Q-_0 M3?\ +4S_ "U,_P"P4   I%@  )E=  "/80  AF(  'MA
M  !P7P  8EL  %A8  !.50  0U$! #M/#  X3Q, -D\; #5/(P T4"L ,U R
M #)0.@ Q4$( ,%%* "Y14P M4ET +%)I "M2>  I4H@ *%.: "=3K0 F4\4
M)E/G "93_  G4O\ )U'_ "=1_P"L50  H%P  )9B  "-9@  @V<  'AF  !M
M90  8&$  %5>  !*6P  /U@  #56"  Q51  ,%87 "Y6'P M5B< +%8O "M7
M-@ J5SX *5=' "A74  F6%H )5AG "18=0 C688 (5F8 "!9JP ?6<( 'UGE
M !]8^@ @6/\ (%?_ "%7_P"H6@  G6(  )-G  "*:P  ?VP  '5L  !J:P
M76@  %%E  !&8P  .V   #%> P J70T *%T3 "9=&P E7B, )%XJ "->,@ B
M7CH (5Y# "!?3  ?7U< 'E]C !Q@<0 ;8(( &6"5 !A@J0 78,  %F#B !=?
M^0 87O\ &5[_ !E=_P"D8   F6@  )!N  "&<   ?'(  ')R  !F<0  6&X
M $QL  !!:P  -FD  "UG   C9@@ 'V8/ !UF%0 <9AT &V8E !IF+0 99S4
M&&<^ !=G2  69U, %6A? !-H;@ 2:'\ $6B2 !!HI@ /:+T #FC@ !!G]P 0
M9O\ $67_ !%E_P"?9P  EF\  (QS  ""=@  >'@  &UX  !@=P  4W8  $9T
M   [<P  ,7(  "=Q   ><0  %G * !-P$  3<!< $G ? !%Q)P 0<2\ $'$X
M  YQ0@ .<4X #7%;  QQ:0 +<7H "G&-  AQH0 &<;8 !G#2  =P[P (;_\
M"6[_  EN_P";;P  D74  (=Y  !^?   ='X  &9^  !9?@  37X  $!]   U
M?0  *GP  "%\   8?   $7P$  Q\#  *?!$ "7P9  A\(0 '?"D !GPR  1\
M/0 #?$@  7Q5  !\8P  ?'0  'R'  ![G   >[$  'K+  !YZP  >?H  'G_
M  !X_P"6=P  C'P  (.   !Y@P  ;(0  %Z%  !1A@  18<  #F'   MAP
M(X<  !J'   2AP  #8@!  :)"@ !B0\  (D4  "(&P  B",  (DL  ")-@
MB4(  (A.  "(70  B&T  (B!  "'E0  AZL  (;$  "%Y@  A/@  (3_  "$
M_P"0?@  AX,  'Z'  !QB0  8XL  %:-  !)CP  /)$  #"1   DD0  &I(
M !*3   -E   !I4   "6!@  E@P  )40  "6%0  EAT  )8D  "6+@  ECD
M )9&  "650  EF4  )9X  "5C@  E:0  )2\  "3WP  D_4  )+_  "2_P"+
MA@  @XH  '6-  !GD   690  $R7   _F0  ,IH  ":;   ;G   $IT   R?
M   $H    *(   "C 0  HP<  *,,  "C$   I!4  *0<  "E)0  IB\  *8\
M  "F2P  IEL  *9N  "EA   I9L  *2S  "CT   H^\  *+\  "B_P"&C0
M>)$  &J5  !<F0  3IT  $&@   SH@  )J,  !NE   1IP  "JD   &K
MK0   *\   "P    L    + %  "Q"P  L@\  +,4  "T&P  M20  +<P  "W
M/P  MU   +=B  "W>   MY   +:I  "VP@  MN0  +;U  "U_@![DP  ;9@
M %^=  !0H@  0J8  #2I   FJP  &JT  !"O   )L@   +0   "W    N@
M +P   "]    O@   +X   #  @  P0@  ,(-  #$$@  QAD  ,DD  #*,@
MRT,  ,M5  #,:@  S(,  ,R<  #+M0  S,X  ,SI  #,]@!PFP  8:$  %*F
M  !$JP  -K   ">R   :M0  $+@   >[    O@   ,$   #$    R    ,L
M  #+    S0   ,X   #0    T@   -4#  #8"@  VQ   -X8  #B)   XS4
M .1(  #E7   YG,  .:-  #FI0  YKP  .;3  #GYP!CI   5:H  $:P   X
MM0  *+D  !J\   /P   !<0   #'    RP   ,\   #4    V    -P   #=
M    WP   .$   #C    Y0   .@   #J    [08  /$.  #U%@  ^"4  /DX
M  #Y30  ^F,  /M\  #\E0  _*H  /R[  #]RP#_  \ _P . /\ #@#_ !
M_P 6 /\ (P#_ #  _P ] /\ 20#_ %0 _P!> /\ 9@#_ &X _P!V /\ ? #_
M (( _P") /\ CP#_ )4 _@"; /T HP#[ *L ^@"U /D PP#W -L ]@#P /0
M_P#S /\ \@#_ .P _P#B /\ W #_ -8 _P#_  P _P ) /\ " #_  H _P 2
M /\ '@#_ "L _P X /\ 1 #_ $\ _P!9 /X 80#\ &D ^@!P /@ =P#W 'T
M]@"# /0 B0#R (\ \0"6 .\ G0#M *4 [ "O .H O #H ,T Y@#H .0 ^@#C
M /\ X@#_ .  _P#5 /\ S@#_ ,L _P#_  8 _P ! /\   #_  0 _P . /\
M&0#_ "4 _0 R /L /@#W $D \P!3 /  7 #N &, [ !J .H <0#H '< Y@!]
M .0 @P#B (D X "0 -X EP#< )\ V0"I -8 M #3 ,0 T #> ,X \P#, /\
MRP#_ ,H _P#( /\ P@#_ +X _P#_    _P   /\   #_    ^P + /8 $P#Q
M "  [0 L .H . #G $, XP!- .  5@#< %T V0!D -4 :P#2 '$ T !V ,X
M? #, (, R@") ,@ D0#& )D Q "C ,$ K0"_ +L O0#/ +L ZP"Y /P MP#_
M +< _P"V /\ M #_ +$ _P#_    _P   /\   #V    [@ % .< #P#A !D
MVP E -4 ,0#2 #P S@!& ,H 3P#' %< Q !> ,$ 9 "_ &H O0!P +L =@"Y
M 'P N "# +8 B@"S ), L0"< *\ IP"M +, JP#% *D X0"G /4 I@#_ *4
M_P"D /\ I #_ *0 _P#_    _    /$   #H    X    -0 "P#, !, QP ?
M ,( *@"_ #4 O  _ +@ 2 "U %  LP!7 +  7@"N &0 K !I *L ;P"I '4
MIP!\ *4 A "C (P H0"6 )\ H0"= *T F@"\ )@ T@"7 .X E0#^ )0 _P"5
M /\ E0#_ )4 _P#\ 0  \ 4  .,'  #5!0  S    ,4 ! "^  X N  7 +,
M(P"O "X JP X *D 00"F $H HP!1 *$ 5P"? %T G0!C )L :0": &\ F !V
M )8 ?0"4 (8 D@"0 )  FP". *< C "V (H R0"( .< AP#Y (< _P"& /\
MA@#_ (8 _P#T#   Y!   -$2  #%$0  O0X  +8(  "Q  @ JP 1 *8 &P"A
M "8 G@ Q )H .@"8 $, E0!* ), 40"1 %< CP!= (X 8P", &D B@!P (@
M=P"& (  A "+ (( E@"  *, ?@"Q 'T Q ![ N$ >@/U 'H%_P!Y!?\ > ;_
M '@&_P#J$P  UAH  ,8=  "Z'   L1D  *H3  "D#0  GP4, )D % "5 !\
MD0(I (T#,P"+!#P B 5$ (8&2P"$!E$ @@=7 ($'70!_!V, ?0AJ 'L(<@!Z
M"'P > F& '8)D@!T"J  <PJO '$+P0!P#-\ ;PWV &X._P!M#O\ ;0[_ &T.
M_P#A'   RR,  +PF  "Q)@  J"0  * >  "9&   DQ " (X+#@"("Q< A PB
M ($-+ !^#34 ? X] 'H.10!X#DL =PY1 '4/6 !S#UX <1!E ' 0;@!N$'<
M;!"" &L0CP!I$9T :!&M &82P !E$M\ 9!/V &,4_P!C%/\ 8A3_ &(4_P#6
M)   PRH  +4N  "J+P  H"T  )@H  "0(@  B1L  ((3" !]$1( >1(< '83
M)P!S%#  <10X &\5/P!M%48 ;!5, &H64P!H%ED 9Q9A &46:0!D%W( 8A=^
M &$8BP!?&)D 7AFI %P9O !<&M@ 6AOS %H<_P!9'/\ 61S_ %D<_P#-*@
MO3$  *\U  "D-@  FS0  )(Q  ")*P  @24  'D= P!S& X ;QD8 &P:(@!I
M&RL 9QLS &4<.P!D'$$ 8AU( & =3@!?'54 71U< %P>9 !;'FX 61]Y %@?
MAP!6()8 52"F %0AN !3(=( 4B+Q %(C_P!2(_\ 4B+_ %(B_P#(+P  N#8
M *LZ  "@/   ECL  (TX  "#,@  >BT  '(F  !J( P 9B 3 &,A'0!A(28
M7R(O %TB-@!;(CT 6B-$ %@C2@!7(U$ 52-8 %0D80!3)&H 425V % E@P!/
M)I, 3B>C $PGM0!,*,X 2RCN $LI_P!+*/\ 2RC_ $LH_P##-   LSL  *<_
M  "<00  DD   (D^  !_.0  =3,  &PM  !C)P@ 7B81 %PF&0!9)R( 5R<K
M %4H,@!4*#D 4BA  %$H1@!0*4T 3BE5 $TI70!,*F< 2RIS $DK@ !(*Y
M1RRA $8MLP!%+<L 12[L $0N_P!$+O\ 12W_ $4M_P"^.   L#\  *1#  "9
M10  CT4  (5#  ![/@  <3D  &<T  !>+@0 6"L. %4K%@!2+!\ 4"PG $\L
M+P!-+38 3"T\ $HM0P!)+4H 2"Y2 $<N6@!&+V0 12]P $,P?@!",(T 03&>
M $ RL0 _,L@ /S/J #\S_@ _,O\ /S+_ #\R_P"[/   K4,  *%'  "620
MC$D  (-(  !X1   ;3X  &,Y  !:-   4C , $\P$P!,,!P 2C D $DQ*P!'
M,3( 1C$Y $0Q0 !#,D< 0C)/ $$S6 ! ,V( /S1M #XT>P ]-8L /#:< #LV
MKP Z-\8 .3?H #DW_  Z-_\ .C;_ #HV_P"W0   JD8  )Y+  "430  BDX
M (!,  !U2   :D,  & ^  !6.0  334) $DT$0!'-1D 134A $,U* !!-2\
M0#4V #\V/0 ^-D4 /3=- #PW50 [.&  .CAK #DY>0 X.8D -SJ; #4ZK0 U
M.\0 -#OF #0[^P U._\ -3K_ #4Z_P"T0P  ITH  )Q.  "240  B%(  'Y0
M  !S30  9T@  %Q$  !2/P  2#H& $0Y#P!!.18 /SD> #XY)@ \.2T .SHT
M #HZ.P Y.T( .#M* #<\4P V/%T -3UI #0]=P S/H< ,3Z9 # _JP O/\(
M+S_D "\_^@ P/_\ ,#[_ # ^_P"Q1P  I$T  )E2  "/50  AE8  'Q5  !Q
M4@  9$P  %E)  !/10  14 # #\^#0 \/A, .CX; #D^(P W/BH -C\Q #4_
M.  T/T  ,T!( #) 40 Q05L ,$%G "Y"=0 M0H4 +$.7 "M#J@ J0\  *43B
M "I#^0 J0_\ *T+_ "M"_P"N2@  H5$  )=6  "-60  @UH  'E:  !N5P
M85(  %=.  !-2P  0T<  #I#"@ V0Q$ -$,8 #-#(  R1"< ,40O #!$-@ O
M13T +45& "Q%3P K1ED *D9D "E'<@ H1X, )D>5 "5(J  D2+X (TC@ "1(
M]P E1_\ )4?_ "9'_P"J3P  GU4  )1:  "+7@  @5\  '=>  !K7   7U@
M %55  !+40  0$T  #5*!P P20X +DD5 "U)'0 L220 *THK "I*,P H2CL
M)TM# "9+3  E2U8 )$QB "-,<  A3(  ($V3 !]-I@ >3;L '4[= !Y-]@ >
M3/\ 'TS_ "!+_P"G4P  G%H  ))?  "(8P  ?F0  '1C  !I80  7%X  %);
M  !'6   /%4  #)2 @ J4 P )T\2 "90&0 E4"  )% H "-0+P B43< (5%
M "!120 >4E, '5)? !Q2;0 :4WT &5.0 !A3I  64[D %5/9 !93]  74O\
M&%'_ !E1_P"C60  F&   (]E  "%:   >VD  '%I  !F9P  660  $UA  !"
M7P  .%P  "Y:   E6 @ (%<. !Y7%  =5QP '%@C !M8*P :6#, &5@\ !A8
M10 665  %5E; !19:0 36GH $EJ- !%:H0 06K< #EK5 !!9\P 06?\ $5C_
M !%8_P"?7P  E68  (QK  "";0  >&X  &YO  !B;0  56H  $AH   ^9@
M,V4  "EC   @80$ && + !5@$  48!< $V > !)@)@ 28"X $6$W !!A0  /
M84L #F%8  UA9@ ,8G8 "V*)  IAG0 )8;( "&'+  AAZP )8/T "E__  M?
M_P";9@  DFT  (AQ  !^<P  =74  &IT  !<<P  3W(  $-P   X;P  +6X
M "1L   ;:P  $VL$  YJ#  -:A( #&H9  MJ(0 *:BD "6HR  AJ/  ':T<
M!6M3  1K80 ":W$  &J$  !JF   :JT  &G&  !IYP  :?@  &C_  !H_P"7
M;0  C7,  (1W  ![>@  <'L  &-[  !6>@  27H  #UY   Q>   )W<  !UV
M   5=@  #W8"  EV"@ $=@\  '85  !V'   =B0  '4L  !U-@  =4$  '5.
M  !U7   =6P  '5^  !TDP  =*@  '/   !SXP  <O<  '+_  !Q_P"2=0
MB7H  (!^  !V@   :8$  %N"  !.@@  08(  #6#   I@@  'X$  !:!   0
M@@  "H(   *#!P  @@T  ((1  ""%P  @AX  ((F  ""+P  @CL  ()'  ""
M50  @64  (%X  "!C0  @*(  '^Z  !_W0  ?O0  'W_  !]_P"-?   A($
M 'N$  !NA@  8(@  %**  !%BP  .8P  "R,   AC   %XP  !"-   )C@
M H\   "0 P  CPD  (\.  "/$@  D!@  ) ?  "0*   D#(  ) _  "030
MD%T  (]P  "/A0  CIP  (ZS  "-T   C/   (O^  "+_P"(A   @(@  '*+
M  !DC0  5I   $B3   [E0  +I8  "*6   7EP  #Y@   B9    FP   )T
M  "=    G0,  )T)  "=#0  GA$  )X7  "?'P  GRD  * U  "@0P  H%0
M *!F  "?>P  GI,  )ZK  "=Q@  G>D  )SY  "<_P"#BP  =8X  &>2  !9
ME@  2YD  #V<   PG@  (Y\  !>@   .H@  !Z0   "F    J    *H   "J
M    J@   *L!  "K!P  K P  *T0  "N%@  KQX  +$I  "Q.   L4@  +%:
M  "Q;P  L8@  +&@  "PN@  K]T  *_R  "O_0!XD0  :I8  %R:  !-GP
M/Z,  #&F   CIP  %ZD   ZK   %K@   +    "R    M0   +<   "W
MN    +D   "Z    O ,  +T)  "^#@  P!0  ,,>  #%*P  Q3P  ,9.  #&
M8@  QGH  ,:4  #&K0  QL@  ,7E  #%\P!LF0  7IX  $^D  !!J   ,JP
M "2O   6L0  #;0   .W    N@   +T   #     Q    ,8   #&    R
M ,D   #+    S    ,X   #0!@  TPT  -@3  #<'@  WBT  -]   #@5
MX6L  .&%  #AGP  X;<  .'/  #AY@!@H0  4J<  $.M   TL@  );4  !>Y
M   -O    ;\   ##    QP   ,H   #/    TP   -8   #7    V@   -P
M  #?    X0   .,   #F    Z0$  .P+  #P$@  \Q\  /0Q  #V1@  ]UP
M /AT  #XCP  ^:8  /FX  #XR0#_  T _P + /\ "P#_  X _P 3 /\ 'P#_
M "P _P Y /\ 10#_ %  _P!9 /\ 8@#_ &H _P!Q /\ =P#_ 'X _P"$ /X
MB@#] )  _ "7 /H G@#Y *< ]P"Q /8 O@#U -( \P#L /$ _@#P /\ \ #_
M .8 _P#< /\ T@#_ ,T _P#_  < _P $ /\  @#_  8 _P 0 /\ &P#_ "<
M_P S /\ /P#_ $H _@!4 /L 70#Y &0 ]P!K /4 <@#S '@ \@!^ /  A #O
M (H [0"1 .P F0#J *$ Z "K .8 M@#D ,< X@#C .  ]P#> /\ W0#_ -D
M_P#, /\ Q0#_ ,$ _P#_    _P   /\   #_  $ _P - /\ %@#\ "( ^0 N
M /8 .0#S $4 [P!. .P 5P#I %X Y@!E .0 ; #B '( X !W -\ ?@#= (0
MVP"+ -@ D@#5 )L T@"D ,\ KP#- +X RP#5 ,D [P#' /\ Q0#_ ,0 _P"^
M /\ N #_ +4 _P#_    _P   /\   #^    ]P ) /$ $0#K !P YP H .0
M,P#A #X W0!( -@ 40#3 %@ T !? ,X 90#, &L R@!Q ,@ =P#& 'T Q "$
M ,( C #  )0 O@"> +L J "Y +8 MP#( +4 Y@"S /H L0#_ +  _P"P /\
MK #_ *D _P#_    _P   /H   #Q    Z  # .  #0#8 !8 T0 B ,T +0#*
M #< Q@!! ,( 2@"_ %( O0!9 +H 7P"X &4 MP!J +4 < "S '8 L0!] *\
MA0"M (T JP"7 *D H0"G *X I0"^ *( V "@ /( GP#_ )X _P"> /\ G@#_
M )P _P#_    ]P   .L   #A    U@   ,L "0#% !$ OP ; +L )@"W #$
MM  Z +$ 0P"N $L JP!2 *D 6 "G %X I@!D *0 :0"B '  H !V )X ?@"<
M (8 F@"0 )@ FP"6 *< E "V )( R@"0 .D CP#\ (X _P"- /\ C #_ (T
M_P#X    Z0(  -L#  #, 0  Q    +T  @"V  T L  5 *L ( "G "H I  T
M *$ / "> $0 G !+ )H 4@"8 %@ E@!= )4 8P"3 &D D0!P (\ =P"- (
MBP"* (D E0"' *$ A0"O (, P0"! .  @ #U '\ _P!_ /\ ?P#_ '\ _P#N
M"@  W X  ,H0  "^#@  M0L  *\#  "I  < HP 0 )X & "9 ", E@ L ),
M-0"0 #X C@!% (P 2P"* %$ B !7 (8 70"% &, @P!J ($ <0!_ 'H ?0"$
M 'L CP!Y )P =P"J '4 NP!T -0 <@#P '( _P!R /\ <0#_ '$ _P#C$0
MS1<  +\9  "S&0  JA4  *,0  "="@  EP$* )$ $@"- !L B0 E (4 +P"#
M #< @  ^ 'X 10!] $L >P!1 'D 5P!X %T =@!D '0!:P!R 70 < )_ &X"
MBP!L Y@ :P.F &D$MP!H!<X 9P?L &8(_0!F"?\ 90G_ &4)_P#6&@  Q"
M +8C  "K(P  H2   )D;  "2%   C X! (8'#0" !!0 ? 8> 'D'* !V"#
M= @X '()/P!P"44 ;PI, &T*4@!L"E@ :@M? &@+9P!G"W  90QZ &,,AP!B
M#)4 8 VD %\-M@!>#<X 7 [M %P/_P!;$/\ 6Q#_ %L0_P#-(0  O"@  *\K
M  "D*P  FBD  )(D  ")'P  @A@  'L1!0!U#0\ <0T7 &X.(0!K#BH :0\R
M &<0.0!E$$  9!!& &,030!A$%, 7Q%: %X18@!<$6L 6Q%V %D2@P!8$I(
M5A.B %43M !4$\L 4Q3L %(5_P!2%O\ 4A7_ %(5_P#&*   MBX  *DR  "?
M,@  E3$  (PM  "#)P  >B$  '(:  !K$PL 9Q,3 &04' !A%"4 7Q4M %T5
M- !<%3L 6Q9" %D62 !8%D\ 5A=6 %477@!3%V< 4AAR % 8?P!/&8X 3AJ?
M $P:L !+&\< 2QOI $H<_0!*'/\ 2AS_ $H<_P#!+0  L30  *4W  ":.
MD#<  (<T  !]+P  ="D  &PC  !D' < 7AD0 %L:& !9&R$ 5QLI %4;, !4
M'#< 4AP] %$<1 !/'4L 3AU2 $T=6@!+'F, 2AYN $D?? !''XL 1B"< $4A
MK@!$(<0 0R+F $,B_ !#(O\ 0R+_ $,B_P"\,@  K3@  *$\  "7/@  C3T
M (,Z  !Y-0  ;S   &8J  !>) ( 5R - %0@% !1(!T 3R$E $XA+ !,(3,
M2R(Z $DB0 !((D< 1R). $8C5P!$(V  0R1K $(D>0!!)8@ /R:9 #XFJP ]
M)\$ /2?C #TH^@ ]*/\ /2?_ #TG_P"X-@  JCT  )Y   "40@  BD(  ( _
M  !V.P  ;#8  &(P  !9*@  424+ $TE$0!+)1D 224A $<F* !%)B\ 1"8V
M $,F/0!")T0 02=+ #\H5  ^*%T /2EI #PI=@ [*H8 .2N7 #@KJ0 W++\
M-RS@ #<L^  W+/\ -RS_ #@L_P"U.@  IT   )Q$  "11@  AT8  'U$  !S
M0   :#L  %\V  !5,0  3"L' $<I#P!%*A8 0RH> $$J)0 _*BP /BLS #TK
M.0 \*T$ .RQ( #HL40 Y+5L ."YF #8N<P U+X, -"^5 #,PIP R,+T ,3'>
M #$Q]P R,?\ ,C#_ #,P_P"Q/@  I$0  )E(  "/2@  A4H  'M)  !P10
M94   %L[  !2-@  2#$$ $(N#0 _+A, /2X; #LN(@ Y+RD ."\O #<O-@ V
M,#X -3!& #0Q3P S,5D ,C)D #$R<0 P,X$ +S23 "XTI@ L-;L +#7; "PU
M]0 M-?\ +33_ "XT_P"N00  HD@  )=,  "-3@  @TX  'E-  !N2@  8D4
M %A   !./   13<  #TS"P Y,Q$ -S,8 #8S'P T,R8 ,S,M #(T-  Q-#P
M,#5$ "\U3  N-E8 +39B "PW;P K-W\ *CB1 "@XI  G.;D )CG8 "<Y]  H
M.?\ *#C_ "DX_P"K10  GTL  )1/  "+4@  @5,  '=2  !L3P  7TD  %9&
M  !,0@  0CT  #@X"  T. \ ,C@5 #$X'0 O."0 +C@K "TY,@ L.3D *SI!
M "HZ2@ I.U0 *#M? "<\;0 E/'T )#V/ ",]H@ B/;< (3[4 "$^\P B/?\
M(SW_ ",\_P"H20  G4\  ))3  ")5@  ?U<  '56  !J4P  74\  %-,  !*
M2   0$0  #9 !0 O/0T +3T3 "L]&@ J/B$ *3XH "@^+P G/C< )C\_ "0_
M2  C0%( (D!= "%!:@ @07H 'D&- !U"H  <0K4 &T+1 !M"\0 <0O\ '4'_
M !Y!_P"E30  FE,  )!8  "&6P  ?5P  ');  !G6   6U0  %%2  !(3@
M/4H  #-'   J0PL )D,0 "5#%@ D0QX (T0E ")$+  A1#0 ($4\ !Y%10 =
M14\ '$9: !M&:  91G@ &$>* !='G@ 61[, %$C. !5'[P 61_\ %T;_ !=&
M_P"B4@  EU@  (U=  "$8   >F$  '!@  !E7@  65H  $]8  !$5   .5$
M "].   F2P8 ($H. !Y*$P =2AH '$HA !M+*  :2S  &4LX !=+0@ 63$P
M%4Q7 !1,90 3374 $DV( !%-G  03;$ #D[,  ]-[@ 03?\ $4S_ !%,_P">
M5P  E%T  (MB  "!90  =V8  &UF  !C9   5F$  $I>   _6P  -5@  "M6
M   B5 $ &E(* !92$  54A8 %%(= !-2)  24BP $5(T !%2/@ 04T@ #U-4
M  Y38@ -5'( #%2$  M4F  )5*T "%3%  E4YP *4_L "U+_  M2_P";70
MD60  (AH  !^:P  =&P  &ML  !?:@  4F<  $5D   Z8@  ,&   "9>   =
M70  %5L% !!:#  .6A$ #EH8  U;(  ,6R< "ULP  I;.@ )6T4 !UM1  9;
M7@ $6VT  UN   %;E   6Z@  %O   !:X@  6O8  5K_  )9_P"79   CFL
M (1N  ![<   <G(  &=Q  !9<   3&X  $!L   U:P  *FD  "%G   89@
M$68!  QE"@ '90\ !&44  -D&P "9",  &0L  !D-0  9$   &1,  !D6@
M9&D  &1[  !DCP  8Z0  &.[  !BW0  8O0  &+_  !A_P"3;   B7$  (!U
M  !X=P  ;7@  &!W  !2=@  1G4  #ET   N=   (W(  !IQ   2<0  #7$
M  9Q"   < T  ' 2  !P%P  ;Q\  &\F  !O,   ;SL  &]'  !O5   ;V0
M &]U  !NB@  ;:   &VV  !LU@  :_(  &O_  !K_P".<P  A7@  'U[  !S
M?0  97X  %A^  !+?@  /GX  #)^   F?0  ''P  !-\   -?   !GT   !]
M!0  ? L  'P/  !\$P  ?!D  'PA  !\*0  ?#0  'M   ![3@  >UX  'MO
M  !ZA   >IH  'FQ  !XS@  =^\  ';^  !V_P")>@  @7\  'B"  !K@P
M784  $^&  !"AP  -8@  "F'   =AP  %(<   V(   &B0   (H   "*
MB08  (D,  ")#P  B1,  (D:  "*(@  BBP  (HX  "*1@  B58  (EH  ")
M?   B)0  (>K  "&Q@  A>H  (7[  "$_P"%@@  ?88  &^(  !ABP  4XT
M $6/   XD0  *Y$  !^2   4D@  #9,   24    E@   )<   "8    EP
M )<%  "7"P  F X  )@3  "9&@  F2(  )HN  ":/0  F4T  )E>  "9<P
MF(L  )BC  "7O   EN(  );W  "5_P" B0  <HP  &2/  !6DP  2)8  #J9
M   LF@  'YL  !2<   ,G@   Y\   "A    HP   *4   "E    I0   *4
M  "F @  IP@  *<-  "H$0  J1D  *LC  "K,0  JT$  *Q3  "L9P  JX
M *J:  "JLP  JM   *GO  "I^P!UCP  9Y0  %F8  !*G   /)\  "VB   @
MHP  $Z4   NG   !J0   *L   "N    L0   +(   "R    LP   +0   "U
M    M@   +@$  "Y"P  NQ   +T8  "_)   OS4  ,!'  # 6P  P'(  ,"-
M  #!I@  P,$  +_C  "^\P!JEP  6YP  $VA   ^I0  +ZD  "&K   3K0
M"[    "S    M0   +@   "\    OP   ,$   #!    PP   ,0   #&
MQP   ,D   #+    S@@  -$/  #5&   V"<  -DY  #:30  VV0  -M^  #<
MF0  W+   -S)  #<XP!=GP  3Z4  $"J   RKP  (K(  !2U   *N    +L
M  "_    PP   ,8   #+    S@   -$   #1    U    -8   #9    VP
M -X   #@    Y    .<&  #K#@  [QD  / J  #R/P  \U4  /1M  #TB
M]*$  /2V  #TQP#_  D _P & /\ !P#_  P _P 1 /\ ' #_ "@ _P T /\
M00#_ $P _P!5 /\ 70#_ &4 _P!L /\ <@#^ '@ _ !^ /L A #Z (L ^0"2
M /< F0#V *( ] "L /, N0#Q ,L \ #H .X ^P#M /\ [ #_ .$ _P#2 /\
MR0#_ ,0 _P#_  $ _P   /\   #_  0 _P . /\ %P#_ ", _P O /\ .P#]
M $8 ^@!0 /< 6 #T %\ \@!F /  ; #O '( [0!X .P ?@#J (4 Z0", .<
MDP#E )P XP"F .$ L0#? ,$ W0#= -L ] #9 /\ U@#_ ,\ _P#$ /\ O0#_
M +D _P#_    _P   /\   #_    _P + /P $P#W !X ]  J /( -0#N $
MZ0!* .8 4@#C %D X !@ -X 9@#< &P V@!R -< > #4 'X T@"% -  C0#.
M )4 S "? ,D J@#' +@ Q0#- ,, ZP#  /X OP#_ +X _P"V /\ L #_ *T
M_P#_    _P   /\   #Y    \@ & .L #P#F !D X0 D -X +P#: #D TP!#
M ,\ 3 #, %, R0!: ,< 8 #% &8 PP!K ,$ <0"_ '< O0!^ +L A@"Y (X
MMP"8 +4 HP"S +  L0#" *X X "L /< JP#_ *H _P"H /\ HP#_ *  _P#_
M    _P   /4   #K    X0   -8 # #/ !, R@ > ,8 *0#" #, OP ] +L
M10"X $T M@!4 +, 6@"Q %\ L !E *X :@"L '  JP!W *D ?P"G (< I0"1
M *, G "@ *D G@"X )P S@": .X F0#_ )< _P"6 /\ E@#_ ), _P#]
M\0   .4   #9    S0   ,0 !@"]  \ MP 8 +, (@"P "P K0 V *D /@"G
M $8 I !- *( 4P"@ %D GP!> )T 9 "; &H F@!P )@ =P"6 (  E "* )$
ME0"/ *( C0"P (L PP") ., B #Y (8 _P"& /\ A@#_ (8 _P#S    XP
M -$   #%    O0   +8   "N  L J  2 *0 ' "@ "8 G  O )H -P"7 #\
ME0!& )( 3 "1 %( CP!8 (T 70"+ &, B@!J (@ <0"& 'D A "# (( CP!_
M )L ?@"I 'P NP!Z -4 > #R '@ _P!W /\ =P#_ '< _P#G!P  T0P  ,,-
M  "X#   K@@  *@   "B  4 FP . )8 %0"2 !\ C@ H (L ,0"( #D A@!
M (0 1@"" $P @ !2 '\ 5P!] %T >P!C 'H :P!X ', =@!] '0 B !Q )4
M< "D &X M !L ,H :P#J &H _ !J /\ :@#_ &H _P#:$   QA0  +@6  "M
M%0  I!(  )P.  "6!P  D  ) (H $ "% !@ @0 A 'X *@![ #( >0 Y '<
M0 !U $8 <P!, '( 40!P %< ;@!> &T 90!K &X :0!W &< @P!E )$ 8P"?
M &( KP!@ ,0 7P#D %\!^ !> O\ 7@+_ %X"_P#.&   O1T  + @  "E'P
MFQP  ),7  "+$0  A P  'X$"P!Y !( =0 ; '( (P!O "L ;0$S &L!.@!I
M D  9P-& &8#3 !D!%( 8P19 &$$8 !?!6D 7@5S %P&?P!:!HT 60>< %<(
MK0!6",$ 50GA %0+]@!4"_\ 5 O_ %0+_P#&'P  MB4  *DH  ">*   E"4
M (LA  "#&P  >Q0  '0. P!N"0T :0@4 &8)'0!D"B4 8@HM & +- !>"SH
M70M  %L,1P!:#$T 6 Q4 %<-7 !5#60 5 UO %(->P!0#HH 3PZ: $X.K !,
M#\( 3!#C $L0^0!+$/\ 2Q'_ $L0_P"_)@  L"L  *0O  "9+P  CRT  (8I
M  !])   =!X  &P7  !E$0< 7PX0 %P/%P!:$!\ 6! G %80+@!4$#4 4Q [
M %(10@!0$4@ 3Q%0 $X15P!,$F  2Q)K $D2> !($X< 1A.7 $44J0!$%+X
M0Q7? $,6^ !#%O\ 0Q;_ $,6_P"Z*P  JS$  * T  "5-0  BS0  ($Q  !X
M*P  ;R8  &8@  !>&0$ 5Q0- %04$P!1%!L 3Q4C $X5*@!,%3$ 2Q8W $D6
M/@!(%D0 1Q=, $475 !$%UT 0QAG $$8= ! &8, /QJ4 #T:I@ \&[L .QO;
M #L<]@ \'/\ /!S_ #P<_P"U,   J#8  )PY  "1.P  ASH  'XW  !S,@
M:BT  &$G  !9(0  41L) $P9$ !*&A< 2!H? $8:)@!%&RT 0QLS $(;.@!!
M'$$ 0!Q( #X<4  ]'5D /!YD #L><0 Y'X  .!^2 #<@I  V(+@ -2'6 #4A
M]  U(O\ -2'_ #8A_P"R-   I#H  )D^  "//P  A3\  'L\  !P.   9S(
M %TM  !4*   3"(% $8?#@!#'Q0 01\; #\?(@ ^("D /2 P #L@-@ Z(3T
M.2%% #@B30 W(E< -B-B #0C;@ S)'X ,B2/ #$EH@ O);8 +R;2 "\F\@ O
M)O\ ,";_ # F_P"O.   HCX  )9"  ",0P  @D,  'A!  !N/0  8S@  %HS
M  !1+@  2"@! $ D#  ](Q$ .R08 #DD'P X)"8 -B0L #4E,P T)3H ,R9"
M #(F2@ Q)U0 ,"=? "\H;  N*'L +"F- "LJH  J*K0 *2K/ "DK\  J*_\
M*BK_ "LJ_P"L/   GT(  )1&  "*1P  @$<  '9%  !L0@  83T  %<X  !.
M,P  1"X  #PI"0 W*!  -2@5 #,H'  R*", ,"@I "\I,  O*C< +BH_ "TK
M2  L*U( *RQ= "HL:@ H+7D )RV+ "8NG@ E+K, )"_- "0O[@ E+_\ )2__
M "8N_P"I/P  G44  )))  "(2P  ?DP  '1*  !J1P  7D(  %0]  !+.0
M030  #@O!@ R+0T ,"T3 "XM&0 M+2  *RTG "HN+@ I+C4 *2\] "@O1@ G
M,$\ )3!; "0Q:  C,7< (C*) "$RG0 ?,[$ 'C/+ !XS[0 ?,_\ (#/_ "$R
M_P"F0P  FDD  )!-  "&3P  ?%   '-/  !H3   7$8  %)#  !)/P  /SL
M #8V @ N,@P *S(1 "DR%P H,AX )C(D "4S*P D,S( (S0Z "(T0P A-4T
M(#58 !\V90 >-G4 '#>' !LWFP :-Z\ &3C( !DXZP :./\ &S?_ !LW_P"C
M1P  F$T  (Y1  "$4P  >U0  '%3  !F4   6DP  %!)  !'10  /4$  #,]
M   J.0D )3<. ",W%  B.!L (3@B " X*  ?.#  'CDX !TY00 <.DL &CI6
M !D[8P 8.W( %CN% !4\F0 4/*T $SW& !,]Z0 4//T %3S_ !8[_P"@2P
ME5$  (M5  ""6   >5D  &Y8  !D5@  6%$  $Y/  !%2P  .D<  #!#   G
M0 4 (#X- !T^$0 </A< &SX> !H^)0 9/BT &#\U !8_/@ 5/T@ %$!3 !-
M8  207  $4&" !!!EP /0:P #D+$  Y"YP /0?P $$'_ !! _P"=4   DU8
M (E:  " 70  =EX  &Q=  !B6P  5E<  $Q5  !!40  -DX  "Q+   C2
M&T4) !=$#P 51!0 %$4; !-%(@ 212D $44Q !%%.P 01D4 #T90  Y'7@ -
M1VT #$=_  M'DP )1Z< "$>^  A'X  )1_8 "D;_  M&_P":50  D%L  (=@
M  !]8@  <V,  &IB  !@80  4UX  $=:   \5P  ,E4  "A2   ?4   %TX$
M !%,#  /3!$ #DP7  Y,'@ -324 #$TN  M--P *34( "4U-  =.6@ &3FD
M!$Y[  ).CP !3J0  $VZ  !-VP !3?(  4W_  ),_P"66P  C6(  (1F  !Z
M:   <6D  &AI  !<9P  3V0  $)A   W7P  +5P  "-:   :6   $E<!  U6
M"0 )50X !U43  95&@ $52(  U4J  )5-   53X  %5*  !65P  5F4  %5W
M  !5BP  5:   %6V  !4U   5/$  %/]  !3_P"38@  BF@  (!L  !W;@
M;V\  &-N  !6;   26H  #UH   R9@  )V4  !UC   58@  #F$   E@"  #
M8 T  %\1  !?%P  7QX  %\F  !?+P  7SH  %]%  !?4P  7V$  %YR  !>
MAP  79P  %VR  !<SP  7.\  %O]  !;_P"0:@  AF\  'UR  !U=   :G4
M %UT  !/<P  0G(  #9P   K;P  (&X  !=M   0;   "FP   )K!@  :PL
M &H/  !J%   :AH  &HA  !I*@  :30  &E   !I3@  :5P  &EM  !H@@
M:)@  &>N  !FR@  9>T  &7\  !D_P"+<0  @G8  'IY  !P>P  8GL  %5[
M  !(>@  .WH  "]Z   C>0  &7@  !%W   *=P   W<   !W @  =P@  '8-
M  !V$   =A4  '8;  !V(P  =BX  '4Z  !U1P  =58  '5H  !T?   =)(
M '.J  !RQ   <>D  '#[  !P_P"&>0  ?WT  '9_  !H@0  6H(  $R"   _
M@P  ,H0  "6#   :@P  $8,   J#   "@P   (0   "%    A ,  (,(  "#
M#0  @Q   (,5  "$'   A"8  (0R  "$/P  @T\  (-@  ""=0  @HP  (&D
M  " O0  ?^,  '[Y  !^_P""@   >H0  &R&  !>B   4(H  $*+   UC0
M)XT  !N-   1C@  "HX   "/    D0   )(   "2    D@   )(!  "2!P
MD@P  )(0  "3%0  DQT  )0H  "4-@  E$4  )-7  "3:P  DX(  )*<  "1
MM@  D-@  (_S  "/_P!^AP  <(H  &&-  !3D   19,  #>5   IE@  ')<
M !&8   )F0   )L   "<    G@   *    "@    H    *    "A    H00
M *()  "C#@  I!0  *4=  "F*@  ICH  *9,  "E8   I7@  *62  "DK
MI,D  */K  "B^@!SC@  9)$  %:5  !'F0  .9P  "J>   =H   $:$   BC
M    I0   *<   "I    K    *X   "N    K@   *\   "P    L0   +(
M  "S!@  M0T  +<3  "Y'@  N2X  +I   "Z5   NVH  +J%  "YH0  N;L
M +K>  "Y\@!GE0  6)D  $J>   [H@  +*8  !VH   1J@  !ZP   "O
ML0   +0   "X    NP   +P   "\    O@   +\   #     P@   ,0   #&
M    R ,  ,L+  #/$@  T2   -$R  #21@  TUT  -1V  #4D@  U:L  -7$
M  #4X@!;G0  3*(  #VG   OK   'Z\  !&Q   'M0   +@   "[    O@
M ,(   #'    R@   ,P   #,    S@   -    #2    U0   -@   #;
MWP   .(   #F"P  ZQ,  .PD  #M.   [DX  .]G  #P@@  \)P  /"R  #Q
MQ0#_  , _P ! /\ ! #_  D _P / /\ & #_ "0 _P P /\ / #_ $< _P!1
M /\ 60#_ &  _0!G /P ;0#Z ', ^0!Y /@ ?P#V (4 ]0", /, E #R )T
M\ "G .X LP#L ,0 ZP#A .H ^ #I /\ YP#_ -D _P#+ /\ P@#_ +T _P#_
M    _P   /\   #_    _P , /\ % #_ "  _P K /X -P#Z $( ]@!+ /(
M4P#P %L [@!A .P 9P#J &T Z !S .< >0#E '\ XP"& .$ C@#? )8 W0"@
M -L K #8 +L U #1 -, \ #0 /\ S@#_ ,@ _P"] /\ M@#_ +( _P#_
M_P   /\   #_    _0 ( /< $ #S !H [P F .T ,0#H #L XP!% .  30#<
M %4 V0!; -8 80#3 &< T0!L ,\ <@#- '@ RP!_ ,D AP#' )  Q0": ,,
MI0#  +( O@#% +P Y0"Z /L N #_ +< _P"P /\ J0#_ *4 _P#_    _P
M /X   #U    [  # .4 #0#? !4 V@ @ -0 *@#0 #4 RP ^ ,@ 1P#% $X
MP@!5 ,  6P"^ &$ O !F +H ; "X '( M@!X +4 @ "S (@ L0"2 *X G@"L
M *H J0"[ *@ U0"F /, I #_ *, _P"A /\ FP#_ )@ _P#_    ^P   /
M  #E    V    ,X "0#' !$ P@ : +X ) "[ "X MP X +0 0 "Q $@ K@!.
M *P 5 "J %H J0!? *< 90"E &L I !Q *( > "@ ($ G@"+ )P E@"9 *,
MEP"R )8 QP"3 .@ D@#^ )$ _P"0 /\ C0#_ (L _P#Y    ZP   -T   #/
M    Q@   +P ! "U  T L  5 *P '@"H "@ I0 Q *( .0"? $$ G0!( )L
M3@"9 %, EP!9 )8 7@"4 &0 D@!J )  <0". 'H C "# (H CP"( )P A@"J
M (0 O "" -P @0#V (  _P!_ /\ ?P#_ 'X _P#L    V@   ,D   "^
MM@   *X   "G  D H0 0 )P & "8 "( E0 J )( ,@"0 #H C0!! (L 1P")
M $T AP!2 (8 6 "$ %T @@!D ($ :P!_ ', ?0!] 'L B !X )4 =@"C '4
MM !S ,P <0#M '  _P!P /\ < #_ '  _P#?!0  R@H  +P+  "Q"0  J 0
M *$   ";  , E  , (\ $P"* !L AP D (0 + "! #, ?P Z 'T 00![ $<
M>0!, '< 4@!V %< = != '( 9 !P &T ;P!V &P @@!J (\ :0"= &< K@!E
M ,, 9 #D &, ^@!C /\ 8@#_ &, _P#0#@  OQ(  +(3  "G$@  G1   )4+
M  "/ P  B0 ' (( #@!^ !4 >@ > '8 )0!T "T <0 T &\ .@!N $  ; !&
M &H 3 !I %( 9P!8 &8 7P!D &< 8@!Q &  ? !> (D 7 "8 %L J0!9 +P
M6 #< %@ ] !8 /\ 5P#_ %< _P#&%@  MAH  *H=  "?'   E1D  (T4  "%
M#P  ?@D  '<!"@!R !  ;@ 7 &H 'P!H "< 90 N &0 - !B #L 8 !  %\
M1@!= $P 7 !3 %H 6@!8 &( 5P!L %4 =P!3 (4 4@"4 % !I0!/ ;@ 3@+2
M $T$\ !-!?\ 307_ $T%_P"_'0  L"(  *,E  "9)0  CR(  (4=  !]&
M=1(  &X- @!G!@P 8P,1 %\"&0!= R$ 6P0H %D$+P!7!34 5@4[ %0&00!3
M!D< 409. % '50!.!UX 30AG $L(<P!)"8$ 2 F2 $<*HP!%"K8 1 O0 $0,
M[P!##?\ 0PW_ $0-_P"Y)   JBD  )XL  "4+   BBH  ( F  !W(0  ;AL
M &84  !?#P4 60L- %4*$P!3"QL 40LB $\,*0!-#"\ 3 PV $L-/ !)#4(
M2 U) $8-40!%#EH 1 YD $(.< ! #G\ /P^0 #X0H@ \$+8 .Q#1 #L1\0 [
M$?\ .Q'_ #P1_P"T*0  IB\  )HR  "0,@  AC$  'PM  !R*   :2,  &$=
M  !9%@  41$( $P/$ !*$!8 2! = $80) !%$"L 0Q$Q $(1-P!!$3X 0!%%
M #X230 ]$E8 /!)A #H3;0 Y$WP -Q2- #84GP U%;, -!7- #,6[@ T%O\
M-!;_ #06_P"O+@  HC0  )<W  ",.   @C8  '@T  !N+@  92H  %PD  !4
M'@  3!@$ $84#0!"%!( 0!09 #\4(  ]%2< /!4M #L5-  Y%CH .!9" #<6
M2@ V%U, -1=> #,8:@ R&7D ,!F* "\:G0 N&K$ +1O* "T;[  M'/\ +AO_
M "X;_P"L,@  GS@  )0[  "*/   @#P  '8Y  !K-   8B\  %DJ  !0)0
M1Q\  $ :"@ \&1  .AD6 #@9'0 V&B, -1HI #0:,  S&C< ,AL^ #$;1P O
M'%  +AU; "T=9P L'G8 *AZ( "D?FP H'ZX )R#' "8@Z@ G(/X *"#_ "@@
M_P"I-@  G3P  )(_  "'00  ?4   '0^  !I.@  7S4  %8P  !-*P  1"4
M #L@!P V'@X ,QX3 #(>&0 P'B  +QXF "X?+0 M'S0 +" [ "L@1  J(4X
M*2%8 "<B90 F(G0 )2.% ",CF0 B)*T (23% "$EZ  B)?T (B3_ ",D_P"F
M.@  FC\  (]#  "%10  >T0  ')#  !G/P  73H  %,V  !*,0  02P  #@F
M P Q(PP +B(1 "PB%@ J(AT *2(C "@C*@ G(S$ )B0Y "4E00 D)4L (R96
M "(F8P A)W( 'R># !XHEP =**L &RG# !LIY@ <*?L '2G_ !XH_P"C/@
MF$,  (U'  "#20  >DD  '!'  !F1   6C\  %$[  !'-P  /C(  #4M   L
M* D *"</ "<G%  E)QH )"<A ",H)P B*"X (2DV " I/P ?*DD 'BI4 !TK
M8  ;*V\ &BR! !DLE0 7+:D %BW! !8MY  7+?H &"W_ !DM_P"A00  E4<
M (M+  ""30  >$T  &Y,  !D20  6$0  $]   !&/0  /3@  #,T   J+P8
M)"P- "$L$@ @+!@ 'RT> !XM)0 =+2P '"XT !LN/  :+T8 &"]1 !<P7@ 6
M,&T %3%_ !,QDP 2,:@ $3*_ !$RX@ 2,OD $S'_ !,Q_P">10  DTL  (E/
M  " 40  =E(  &U0  !B3@  5DD  $U&  !$0P  .S\  #$Z   G-@, 'S(+
M !PR$  ;,A4 &3(; !@R(@ 7,RD %C,Q !4T.@ 4-$0 $S1/ !(U7  1-6L
M$#9]  \VD0 .-J8 #3>\  TWW0 --O8 #C;_  \V_P";20  D4\  (=3  !^
M5@  =58  &I5  !@4P  54\  $Q,  !"20  .$4  "Y!   D/0  '#H( !8X
M#@ 5.!( %#@8 !,Y'P 2.28 $3DN ! Y-P /.D$ #CI,  T[60 -.V@ "SMZ
M  H[C0 )/*( !SRX  <\U0 (//  "3O_  H[_P"83@  CE0  (58  !\6P
M<EL  &A:  !>6   4U4  $E2   ^3@  -$L  "I'   A1   &$(# !) "P 0
M/Q  #C\5  X_'  -0", #$ K  M -  *0#X "4%*  =!5@ &064 !$%V  -!
MB@ !09\  $&T  !!T  !0>X  4'\  ) _P"55   C%D  (->  !Y8   <&
M &9@  !=7@  45L  $57   Z5   +U$  "5/   <3   %$H   Y("  +1PX
M"$<2  ='&0 &1R  !4@H  -(,0 "2#L  $A'  !(4P  2&(  $AS  !(A@
M2)L  $BQ  !'S   1^T  $?[  !'_P"26@  B6   (!C  !W90  ;F8  &5F
M  !99   3&   $!=   U6P  *ED  "!7   750  $%,   M2!P %40T  5 1
M  !0%@  4!T  % E  !0+@  4#@  %!#  !04   4%X  %!O  !0@P  3Y@
M $^N  !.R0  3NL  $W[  !-_P"/80  AF8  'UI  !T;   ;&T  &%K  !3
M:0  1F<  #ID   O8P  )&$  !I?   27@  #%P   9<!@  6PL  %H/  !:
M$P  6AD  %DA  !9*0  63,  %D_  !93   65H  %EK  !8?@  6)0  %>K
M  !7Q0  5ND  %7[  !5_P",:   @FT  'IP  !R<@  9W(  %IQ  !,<
M/VX  #-M   H:P  '6H  !1H   -9P  !V<   !F P  9@D  &4-  !E$0
M9!4  &0<  !D)   9"X  &0Z  !C1P  8U4  &-F  !C>@  8I   &&G  !@
MP0  7^8  %_Z  !>_P"';P  ?W0  'AW  !N>   8'@  %)W  !%=P  .'8
M "MV   @=   %G,   YS   '<@   '(   !R    <04  '$*  !Q#@  <!$
M ' 7  !P'@  <"<  ' S  !O0   ;U   &]@  !N=   ;HL  &VB  !LO
M:^(  &KX  !I_P"#=P  ?'L  '-]  !E?@  5W\  $E_   \?P  +X   ")_
M   7?@  #WX   =^    ?P   '\   !_    ?@   'X%  !^"@  ?@T  'X1
M  !^%P  ?B   'XK  !].0  ?4@  'U9  !\;0  ?(0  'N<  !ZM@  >=H
M 'CU  !W_P" ?P  =X(  &F#  !;A0  388  #^(   RB0  )(D  !B)   /
MB0  !XH   "+    C    (T   "-    C    (P   ", P  C @  (T-  "-
M$0  C1<  (XB  ".+P  CC\  (U0  "-9   C'L  (R5  "+K@  BLT  (GO
M  ")_P![A0  ;8@  %Z*  !0C0  0H\  #21   FD@  &9,   Z4   &E0
M )8   "8    F@   )L   ";    FP   )L   ";    G    )T%  "="P
MGA   )\7  "@)   H#0  *!&  "@60  GW   )^*  ">I0  GL(  )WH  "<
M^0!PC   88\  %.2  !$E@  -ID  ">;   9G   #YT   6?    H0   *,
M  "E    J    *D   "I    J0   *H   "K    K    *T   "N 0  L D
M +(/  "S&   M"<  +0Y  "U30  M&0  +1^  "SF@  L[0  +/5  "S\ !D
MDP  59<  $>;   XGP  *:(  !JD   .I@  !*@   "K    K0   +    "T
M    M@   +@   "X    N0   +H   "\    O0   +\   #     PP   ,4'
M  #)#P  RAH  ,LL  #,0   S58  ,YO  #-BP  S*@  ,S"  #,X@!8FP
M2:   #JE   LJ0  '*L   ^N   $L0   +0   "W    N@   +X   ##
MQ@   ,@   #(    R@   ,L   #-    SP   -(   #5    V0   -T   #A
M!0  Y@\  .<>  #H,@  Z4@  .I@  #K>P  ZY<  .RN  #LP@#_    _P
M /\   #_  8 _P - /\ %0#_ "$ _P L /\ . #_ $, _P!, /X 5 #[ %L
M^@!B /@ : #V &X ]0!T /0 >@#R (  \0"' .\ CP#M )< ZP"A .D K0#G
M +T Y0#8 .0 \P#B /\ X #_ -  _P#$ /\ O #_ +8 _P#_    _P   /\
M  #_    _P ) /\ $0#_ !P _0 G /D ,@#U #T \0!& .T 3P#K %8 Z !<
M .8 8@#D &@ XP!N .$ <P#? 'D W0"  -H B #8 )$ U "; -( I@#/ +0
MS #) ,D Z0#( /\ QP#_ ,$ _P"W /\ KP#_ *L _P#_    _P   /\   #_
M    ^  % /( #@#N !< Z@ B .8 + #A #< W0!  -@ 20#3 %  T !6 ,X
M7 #, &( R@!G ,@ ;0#& ', Q !Y ,( @0#  (H O@"4 +P GP"Y *P M@"^
M +0 W0"S /< L0#_ +  _P"H /\ H@#_ )X _P#_    _P   /D   #O
MY@   -\ "P#6 !( T  < ,P )@#( #  Q  Z ,  0@"] $H NP!0 +@ 5@"V
M %L M0!A +, 9@"Q &P L !R *X >@"L (( J0", *< F "E *4 HP"T *
MRP"? .X G0#_ )P _P"9 /\ E #_ )$ _P#_    ]@   .H   #=    SP
M ,< !@#   \ NP 7 +< ( "S "H L  S *T .P"J $, IP!) *4 3P"C %4
MH@!: *  7P"> &4 G0!K )L <@"9 'L EP"% )0 D "2 )T D "L (X OP",
M .( BP#Z (D _P") /\ A@#_ (, _P#T    Y    -0   #(    OP   +4
M 0"N  L J0 2 *4 &P"A ", G@ L )L - "8 #P E@!# )0 20"2 $X D !3
M (X 60"- %X BP!D (D :P"' ', A0!] (, B "! )4 ?P"D 'T M0![ ,\
M>0#Q '@ _P!W /\ =P#_ '4 _P#E    T0   ,,   "X    KP   *@   "@
M  8 F@ . )4 %0"1 !X C@ F (L +0"( #4 A@ \ (0 0@"" $< @ !- '\
M4@!] %@ >P!> 'D 90!X &T =@!V ', @0!Q (X ;P"= &T K@!L ,0 :@#G
M &D _0!H /\ : #_ &D _P#5 P  PP<  +8(  "K!@  H@   )L   "4
MC0 * (@ $ "# !@ ?P @ 'P )P!Z "X =P U '4 .P!T $$ <@!' '  3 !O
M %( ;0!8 &L 7P!I &8 9P!P &4 >P!C (@ 8@"7 &  IP!> +L 70#< %P
M]@!< /\ 6P#_ %L _P#)#0  N1   *P1  "A$   EPT  (\(  "(    @@ %
M 'L #0!W !( <P : &\ (0!L "@ :@ O &@ -0!G #L 90!! &, 1@!B $P
M8 !2 %\ 60!= &$ 6P!J %D =0!7 (( 50"1 %0 H@!3 +4 40#/ %  [P!0
M /\ 4 #_ %  _P"_%   L!@  *0:  "9&0  CQ8  (<1  !_#0  =P8  '$
M" !K  X 9P 4 &0 &P!A "( 7@ I %T +P!; #4 60 [ %@ 00!6 $8 50!-
M %, 5 !2 %P 4 !E $X < !, 'T 2P"- $D G@!( +  1P#' $8 Z0!& /L
M1@#_ $4 _P"X&P  JB   )XB  "3(@  B1\  ( :  !W%0  ;Q   &@+  !A
M! H 70 0 %D %@!6 !T 5  C %( *@!0 #  3P U $X .P!, $$ 2P!( $D
M3P!' 5< 1@%A $0"; !# GD 00.) $ #F@ ^!*T /03$ #P%Y0 \!_@ / ?_
M #P'_P"R(@  I2<  )DI  ".*0  A"<  'LC  !Q'@  :1@  &$2  !:#0,
M4P@, $\%$0!,!1< 2@8> $@&) !'!BH 10<P $0'-@!#"#T 00A# $ (2P ^
M"5, /0E= #L*:  Z"G8 . N' #<+F0 U"ZP - S" #,,Y  S#?D ,PW_ #0-
M_P"M)P  H"P  )4O  "++P  @"X  '<J  !M)0  9"   %P:  !4%   3 \&
M $8,#0!##!( 00P8 #\,'P ^#"4 / TK #L-,@ Z#3@ . T_ #<.1P V#E
M- Y: #,.9@ Q#W0 , ^% "X0F  M$*L +!## "L1Y0 L$?H +!'_ "T1_P"J
M+   G3$  )(T  "'-0  ?30  '0Q  !J*P  8"<  %@A  !/&P  1Q8  $ 1
M"0 [$ \ .1 4 #<0&P V$"$ -! G #,1+0 R$30 ,1$[ # 10P N$DT +1)7
M "P28P J$W$ *1." "<4E0 F%*D )17  "05XP E%OH )A;_ "85_P"F,0
MFC8  (\Y  "%.@  >SD  '$V  !G,0  72T  %0H  !,(@  0QT  #L7!0 U
M% T ,A,1 #$4%P O%!T +A0D "P4*@ K%3$ *A4X "D60  H%DH )Q=4 "87
M8  D&&\ (QB  "$9DP @&:< 'QF^ !X:X  ?&O@ (!K_ " :_P"C-   F#H
M (T]  "#/@  >3T  &\[  !E-P  6S(  %(M  !)*   0",  #@> 0 P&0H
M+!@/ "H8%  I&!H )Q@@ "89)P E&2T )!HU ",:/@ B&T< (1M2 " <7@ ?
M'6P '1U^ !P=D0 :'J4 &1Z\ !@?W0 9'_8 &A__ !L>_P"A.   E3T  (M!
M  "!0@  =T(  &U   !C/   63<  $\S  !&+@  /2D  #4D   M( < )QT-
M "4=$@ C'1< (1T= "$=)  @'BL 'QXR !X?.P ='T4 '"!/ !HA7  9(6H
M&")[ !8BCP 5(J, %".Z !,CV@ 4(_4 %2/_ !8C_P">/   DT$  (E$  !_
M1@  =48  &Q$  !B00  5SP  $TX  !$-   /#   #,K   J)@, (R(+ " A
M$  >(14 '"(; !LB(0 :(B@ &B,P !DC.  8)$( %B5- !4E60 4)F@ $R9Y
M !(FC0 1)Z( $">X  XGU@ 0*/0 $2?_ !$G_P"<0   D44  (=(  !]2@
M=$H  &I)  !@1@  54$  $P^  !#.@  .C8  #$R   H+0  ("D) !LG#@ 9
M)Q( &"<8 !8G'P 5*"4 %"@M !,H-@ 2*4  $BE+ !$J5P 0*F8 #BMW  XK
MBP -+)\ #"RU  LLSP ,+.\ #2S_  TK_P"91   CTD  (5,  !\3@  <T\
M &E.  !>2P  4T<  $I$  !"0   .3T  "\X   E-   '3 % !8M#  4+!
M$RT5 !(M'  1+2, $"TJ  \N,P .+CT #2](  TO50 ,,&, "C!T  DPB  (
M,9P !C&Q  8QRP &,>L !S#\  @P_P"72   C4T  (-1  !Z4P  <50  &=2
M  !=4   4DP  $E*  ! 1@  -4(  "L^   B.@  &C<! !(T"0 /,PX #C,3
M  TS&0 -,R  ##0H  LT,0 *-3L "#5&  <U4@ %-F  !#9Q  (VA   -ID
M #:O   VR   -N@  #;Y  $U_P"430  BE(  (%6  !X6   ;UD  &58  !;
M50  45(  $=/   \3   ,4@  "=$   >00  %C\  ! \!P +.@T "3H1  @[
M%P &.QX !3LF  0[+@ ".S@  3Q#   \3P  /%X  #QN   \@0  /)<  #RL
M   [Q0  .^<  #OX   [_P"14@  B%@  ']<  !V70  ;5X  &-=  !:7
M3E@  $)4   W40  +4X  "-+   :20  $D8   U$!@ '0PP  T,0  !#%0
M0QL  $,C  !#*P  0S4  $-   !#30  0UL  $-K  !#?@  0Y0  $*J  !"
MPP  0>8  $'Y  !!_P".6   AEX  'UA  !S8P  :V0  &)C  !780  25T
M #U:   R6   )U4  !Y3   540  #D\   E-!0 "30L  $P.  !,$P  2Q@
M $L?  !+*   2S(  $L]  !+20  2U<  $MG  !*>P  2I   $FG  !)P
M2.0  $CX  !'_P"+7P  @V0  'IG  !Q:0  :6H  %YI  !09@  0V0  #=A
M   L7P  (5T  !A;   060  "E@   -7 P  5PD  %8-  !5$   514  %0;
M  !4(P  5"T  %0Y  !410  5%,  %1D  !3=P  4XT  %*D  !1O0  4.(
M %#X  !/_P"(9P  ?VL  '=N  !O<   97   %=N  !*;   /6L  #!I   E
M:   &F8  !%D   +8P  !&(   !B 0  808  & +  !@#@  7Q(  %\7  !?
M'@  7B@  %XS  !>0   7D\  %Y?  !=<@  78@  %R@  !;N0  6M\  %GW
M  !8_P"$;@  ?'(  '5U  !K=@  774  $]T  !"<P  -7,  "AR   =<
M$V\   QN   $;@   &X   !N    ; (  &P'  !K"P  :PX  &L2  !J&0
M:B(  &HM  !J.@  :4D  &E:  !I;   :(,  &>;  !FM0  9=@  &3U  !D
M_P" =0  >GD  '![  !B>P  5'P  $9\   Y?   +'P  !][   4>@  #7H
M  1Z    >@   'H   !Z    >0   'D!  !X!@  > L  '@.  !X$P  >!H
M '@E  !X,@  =T$  '=2  !W90  =GP  '65  !TKP  <\X  '+Q  !Q_P!^
M?0  =8   &>!  !8@@  2H,  #R$   NA0  (84  !6%   -A0   X4   "&
M    AP   (@   "(    AP   (<   "'    AP0  (<)  "'#@  B!,  (@<
M  "(*0  B#@  (=*  "'70  AG,  (:-  "%IP  A,4  (/L  ""_@!XA
M:H8  %R(  !-B@  /XP  #&.   CCP  %H\   V0   "D0   )(   "3
ME0   )8   "6    E@   )8   "6    EP   )<   "7!P  F T  )D3  ":
M'P  FBT  )H_  ":4@  FF@  )F#  "9GP  F+H  )?B  "6^ !MB@  7XT
M %"0  !!DP  ,Y8  "27   6F   #9D   &;    G0   )\   "A    I
M *4   "D    I0   *4   "F    IP   *@   "I    J@0  *P,  "N$P
MKB$  *XS  "N1P  KET  *YV  "NDP  KJX  *W-  "L[P!AD0  4Y4  $28
M   UG   )I\  !>A   -HP   *4   "G    J@   *P   "P    L@   +0
M  "S    M    +4   "W    N    +D   "[    O0   +\!  ##"P  Q14
M ,4E  #&.0  QT\  ,=H  #&A0  QJ(  ,:\  #&W@!5F0  1YT  #BB   I
MI@  &:@   VK    K0   +$   "T    MP   +H   "_    P0   ,0   ##
M    Q0   ,8   #(    R@   ,T   #/    T@   -8   #;    X P  .$8
M  #C*P  Y$$  .5:  #F=   YI$  .6L  #EQ #_    _P   /\   #_  $
M_P * /\ $@#_ !T _P H /\ - #_ #X _0!( /H 4 #W %< ]0!= /0 8P#R
M &D \ !O .\ = #M 'L ZP"! .D B0#H )( Y@"< .0 J #B +< WP#- -P
M[@#9 /\ V0#_ ,H _P"^ /\ M0#_ +  _P#_    _P   /\   #_    _P &
M /\ #P#\ !@ ^  C /0 +@#P #@ ZP!" .@ 2@#E %$ X@!8 .  70#> &,
MW !H -D ;@#6 '0 U ![ -$ @@#/ (L S0"5 ,H H0#( *\ Q0#! ,( XP#
M /L P #_ +L _P"P /\ J #_ *0 _P#_    _P   /\   #[    \P ! .T
M# #H !, XP > .  * #: #( TP \ ,\ 1 #, $L R0!1 ,8 5P#$ %T P@!B
M ,$ 9P"_ &T O0!T +L >P"Y (0 MP". +0 F0"R *< KP"W *T T "K /(
MJ@#_ *D _P"A /\ FP#_ )< _P#_    _P   /0   #I    X    -4 " #.
M !  R0 8 ,4 (@#! "L O  U +D /0"V $4 LP!+ +$ 40"O %8 K@!; *P
M80"J &8 J0!M *8 = "D 'P H@"& *  D@"> )\ G "N )D PP"7 .< E@#_
M )4 _P"2 /\ C0#_ (H _P#\    \    .,   #4    R    +\  P"Y  T
MLP 3 *\ ' "L "4 J0 N *4 -@"C #X H !$ )X 2@"= %  FP!5 )D 6@"7
M %\ E@!F )0 ; "2 '4 D !^ (X B@"+ )< B0"F (< N "% -8 A #V ((
M_P"! /\ ?@#_ 'P _P#M    W0   ,P   #!    N    *X   "G  D H@ 0
M )X %P": !\ EP G )0 +P"1 #< CP ] (T 0P"+ $D B0!. (@ 4P"& %D
MA !? (( 90"  &T ?@!W 'P @@!Z (\ > "> '4 KP!S ,< <@#L '$ _P!P
M /\ < #_ &X _P#=    R0   +P   "Q    J0   *$   "9  , DP , (X
M$@"* !D AP A (0 *0"! #  ?P W 'T /0![ $( >0!( '@ 30!V %( = !8
M '( 7P!Q &< ;P!P &P >P!J (@ : "7 &8 J !E +P 8P#A &( ^@!A /\
M80#_ &$ _P#- 0  O 4  *\%  "E @  G    )0   "-    A@ ( ($ #@!\
M !0 >  ; '4 (P!R "D <  P &X -@!M #P :P!! &D 1P!H $P 9@!2 &0
M60!C &  80!I %\ = != ($ 6P"0 %D H0!7 +0 5@#0 %4 \@!5 /\ 5 #_
M %4 _P#!#   L@X  *8/  ";#@  D@L  (D%  ""    >P " '4 "P!P !
M;  6 &@ '0!F ", 8P J &$ , !@ #8 7@ [ %T 00!; $8 6@!, %@ 4P!6
M %L 5 !D %( ;@!1 'L 3P"* $T FP!, *X 2P#& $H Z@!) /X 20#_ $D
M_P"Y$@  JA8  )X7  "4%@  BA,  ($0  !Y"P  <0,  &L !@!E  T 80 1
M %T & !: !X 6  D %8 *@!4 #  4P V %$ .P!0 $$ 3@!' $T 3@!+ %8
M20!? $< :0!& '8 1 "% $, EP!! *D 0 "_ #\ X@ _ /@ /@#_ #\ _P"R
M&0  I!X  )@?  ".'P  A!P  'H8  !R$@  :@X  &((  !< 0@ 5P . %,
M$P!0 !D 3@ ? $P )0!* "L 2  P $< -@!& #P 1 !" $, 20!! %$ /P!:
M #X 90 \ '( .@"! #D DP X *4 -@"Z #8 VP U /0 -0#_ #4 _P"L(
MGR0  )0F  "))@  ?R0  '4@  !L&P  9!4  %P0  !4# $ 3@8* $H"#P!'
M !0 1  : $( ( !  "4 /P K #X!,0 \ 3< .P(^ #D"10 X TT -@-6 #4$
M80 S!&X ,05^ # %D  O!:, +0:X "P&U  L!_  + C_ "P(_P"H)0  FRH
M ) L  "&+0  >RL  '(G  !H(@  7QT  %<7  !/$@  2 X$ $$*"P ^!Q
M.P85 #D'&P X!R$ -@@F #4(+  S"#( ,@DY #$)00 O"4D +@I3 "P*7@ K
M"VP *0M\ "@,CP F#*( )0RW "0,TP C#?  ) W_ "4-_P"D*@  F"\  (TR
M  "#,@  >3$  &\N  !E*0  7"0  %,?  !+&0  0Q,  #P0!@ U#0P ,PP1
M #$,%@ O#!P +@TB "T-*  K#2X *@TU "D-/0 G#D8 )@Y0 "0.7  C#VH
M(@][ " 0C@ ?$*( '1"W !P0U  =$?( '1'_ !X1_P"A+P  E3,  (HV  "
M-P  =C8  &TS  !C+P  62H  % E  !((   /QH  #@5   P$0@ +! . "H0
M$@ H$!@ )Q > "40)  D$"H (Q$R "(1.@ A$4, (!). !X26@ =$V@ &Q-X
M !H3BP 8%*  %Q2U !84T0 6%?$ %Q7_ !@4_P">,P  DS<  (@Z  !^.P
M=#L  &LX  !A-   5R\  $XK  !%)@  /2$  #0<   M%P4 )A,, ",3$  B
M$Q4 (!,: !\3(0 >%"< '10O !P5-P ;%4$ &A9+ !D65P 7%V4 %A=V !08
MB0 3&)X $ABS !$9S@ 1&>\ $AG_ !,9_P"<-@  D3L  (8^  !\/P  <S\
M &D]  !?.0  534  $PP  !#+   .B<  #(B   J'@$ (AD) !X7#@ <%Q(
M&A<7 !D8'@ 9&"0 &!DL !<9-  6&CX %1I) !,;50 2&V, $1QT ! <AP /
M'9P #AVQ  T=RP -'>P #AW_  \=_P"9.@  CS\  (1"  ![1   <4,  &A"
M  !>/@  4SH  $HV  !!,@  .2T  #$I   H)0  (" & !H=#  7'!  %1P5
M !0=&P 4'2( $QTI !(>,@ 1'SP $!]& ! @4P .(&$ #2%Q  PAA0 +(ID
M"B*N  DBQP )(N< "B+[  LA_P"7/@  C$,  (-&  !Y2   <$@  &=&  !<
M1   4C\  $D[  ! .   .#0  "\P   G+   'B<# !8C"@ 2(0X $2$3 ! B
M&0 0(B  #R(G  XC+P -)#D #"1$  LE4  *)5X "29O  <F@@ &)I8 !":L
M  ,FQ  $)N4 !";W  8F_P"50@  BD<  (%*  !X3   ;TP  &5+  !;2
M4$0  $=!   _/@  -SL  "TV   D,0  &RT  !,J!P /* T #2<1  TH%@ ,
M*!T "R@E  HI+0 )*3< !RI"  8J3@ $*UP  RML  $K?P  *Y0  "NI   K
MP0  *^,  "OV   J_P"21@  B$L  ']/  !V40  ;5$  &-0  !:30  3TH
M $='   ^1   ,T   "D\   @.   %S0  !$Q!0 ,+PP "2X0  <N%0 &+QL
M!2\C  ,O*P ",#4  # _   P3   ,5D  #%I   Q?   ,9$  #&G   POP
M,.$  ##U   O_P"02P  AE   'U4  !U5@  :U8  &)5  !84P  3E   $5-
M   Z20  +T4  "5"   </@  %#L   XY!0 )-PL !#8/  $V$P  -AD  #8@
M   V*0  -C(  #<]   W20  -U<  #=G   W>0  -X\  #:E   VO0  -N
M #7U   U_P"-4   A%8  'Q:  !R6P  :5L  &!;  !760  3%8  $!2   U
M3@  *DL  "!(   71@  $$,   M!!  $0 H  #\.   ^$0  /A8  #X=   ^
M)@  /B\  #XZ   ^1@  /E0  #YD   ^=@  /8P  #VC   \NP  /-X  #OU
M   [_P"*5P  @EP  'E?  !P80  :&$  %]A  !47@  1UL  #I7   O50
M)5(  !M0   230  #$L   9* P  20D  $@-  !'$   1Q0  $8:  !&(@
M1BP  $8W  !&0P  1E$  $9@  !%<P  18D  $2@  !$N   0]P  $+U  !"
M_P"(70  ?V(  '=E  !N9P  9V@  %MF  !.8P  06$  #1>   I7   'UH
M !57   .5@  !U0   !3 0  4@8  %$+  !1#@  4!$  $\6  !/'@  3R<
M $\R  !//P  3TT  $Y=  !.;P  3H4  $V=  !,M0  2]@  $KU  !*_P"%
M90  ?&D  '1L  !M;@  8FT  %1K  !':0  .F<  "UE   B9   &&(  !!@
M   )7P   %X   !>    70,  %P(  !;#   6@\  %H3  !9&0  62(  %DM
M  !9.@  64@  %A8  !8:P  5X$  %>9  !6L@  5=(  %3T  !3_P"!;
M>7   '-S  !H<P  6G(  $QQ   _<   ,F\  "5N   :;   $6L   EJ
M:@   &D   !I    :    &<#  !F"   9@P  &8/  !E%   91P  &4G  !D
M-   9$,  &13  !D90  8WL  &*4  !AK0  8,T  %_Q  !>_P!]=   =W<
M &YY  !?>0  47D  $-Y   V>   *7@  !QW   1=@  "G4   !U    =0
M '8   !U    =    '0   !S @  <P<  ',,  !R$   <A4  '(@  !R+
M<CL  '%,  !Q7P  <70  '".  !OJ   ;L8  &SM  !K_P![>P  <GX  &1^
M  !5?P  1X   #F!   K@@  'H$  !*!   *@0   ($   ""    @P   (,
M  "#    @@   ((   ""    @@   ((%  """@  @@\  ((7  ""(P  @C(
M ()#  "!5@  @6P  ("&  !_H0  ?KT  'WF  !\_ !V@@  :(,  %F%  !+
MAP  /(D  "Z*   @BP  $XL   J+    C    (T   "/    D0   )(   "1
M    D0   )$   "1    D0   )(   "2 @  DPD  )0/  "4&0  E"<  )0X
M  "43   DV(  )-\  "3F   DK,  )'8  "0]@!JB   7(H  $V-   _D
M,)(  "&4   4E0  "I8   "7    F0   )L   "=    GP   *    "@
MH    *    "A    H@   *,   "D    I0   *8'  "H$   J!P  *@M  "I
M0   J58  *EO  "IBP  J*@  *?'  "F[ !?CP  4)(  $&6   SF0  (YP
M !2=   *GP   *$   "C    I@   *@   "L    K@   *\   "O    L
M +    "R    LP   +0   "V    MP   +H   "]!P  OQ   +\?  # ,P
MP$D  ,!B  # ?@  P)L  ,"W  "_V !3EP  1)L  #6?   FHP  %J4   NG
M    J@   *T   "P    LP   +8   "[    O0   ,    "_    P0   ,(
M  #$    Q@   ,@   #*    S    ,\   #3    V@<  -L3  #=)0  WCL
M -]3  #@;@  WXP  -VI  #=P@#_    _P   /\   #_    _P ' /\ $ #_
M !D _P D /\ +P#\ #H ^0!# /4 2P#S %( \0!9 .\ 7@#M &0 ZP!I .D
M;P#G '4 Y@!\ .0 A #B (T X "7 -T H@#: +$ U0#% -( Z #0 /\ SP#_
M ,0 _P"X /\ KP#_ *D _P#_    _P   /\   #_    _P " /L #0#W !4
M\P ? .\ *0#J #0 Y@ ] .( 10#> $P VP!3 -@ 6 #4 %X T@!C -  :0#.
M &X S !U ,H ?0#( (4 Q@"0 ,( FP#  *D O@"Z +L V0"Y /< N #_ +0
M_P"I /\ H@#_ )T _P#_    _P   /\   #V    [@   .< "@#A !$ W  :
M -< (P#0 "X RP W ,< /P#$ $8 P0!- +\ 4@"] %@ NP!= +D 8@"X &@
MM@!N +0 =0"Q 'X KP"( *T DP"J *$ J "Q *8 R "D .T H@#_ *( _P";
M /\ E0#_ )$ _P#_    _    .X   #C    V    ,T !0#&  X P0 5 +T
M'@"Y "< M0 P +( . "O $  K !& *H 3 "H %$ IP!6 *4 6P"C &$ H0!G
M )\ ;@"> '8 FP"  )D C "7 )D E "H )( O "0 -\ C@#[ (X _P"+ /\
MA@#_ (, _P#X    Z0   -P   #,    P0   +@   "R  H K  1 *@ & "E
M "$ H@ I )X ,@"< #D F0 _ )< 10"5 $H E !0 )( 50"0 %H CP!@ (T
M9P"+ &\ B0!X (8 A "$ )$ @@"@ (  L@!] ,P ? #Q 'L _P!Z /\ =P#_
M '4 _P#F    TP   ,8   "[    L0   *<   "A  4 FP - )< $P"3 !L
MD  C (P *P"* #( B  X (8 /@"$ $0 @@!) ($ 3@!_ %, ?0!9 'L 8 !Y
M &@ =P!Q '4 ? !S (D < "8 &\ J0!M +\ :P#F &H _P!I /\ :0#_ &<
M_P#3    PP   +4   "K    HP   )L   "2    C  * (< $ "# !8 ?P =
M 'T ) !Z "L >  R '8 . !T #T <@!" '$ 2 !O $T ;0!3 &P 60!J &$
M: !J &8 = !D ($ 80"1 %\ H@!> +8 7 #5 %L ]P!; /\ 6@#_ %H _P#%
M    M@(  *D"  "?    E@   (X   "'    @  % 'H # !U !$ <0 8 &X
M'@!K "4 :0 K &< ,0!F #< 9  \ &, 00!A $< 7P!- %X 4P!< %L 6@!D
M %@ ;@!6 'L 5 "* %( FP!1 *X 4 #( $\ [@!. /\ 3@#_ $T _P"["@
MK T  * -  "5#   C @  (,"  !\    =0   &X " !I  X 90 3 &( &0!?
M !\ 70 E %L *P!9 #$ 6  V %8 .P!5 $$ 4P!' %$ 3@!0 %4 3@!> $P
M: !* '4 2 "$ $< E0!% *@ 1 "_ $, Y !" /P 0@#_ $( _P"R$0  I10
M )D5  ".$P  A!$  'L-  !S"   ;    &4  P!?  L 6P / %< % !4 !H
M40 ? $\ )0!. "L 3  P $L -@!) #P 2 !" $8 2 !% %  0P!9 $$ 8P _
M &\ /@!^ #P D  [ *, .@"X #D V0 X /4 . #_ #@ _P"L%P  GQL  ),=
M  ")'   ?QD  '45  !L$   9 P  %T&  !6  8 40 , $T $ !* !4 1P :
M $4 ( !$ "8 0@ K $$ ,0 _ #8 /@ ] #P 1  [ $L .0!4 #< 7P V &L
M- !Z #( C  Q )X , "S "\ S@ O .\ +@#_ "X _P"G'@  FB(  (\D  "$
M)   >B$  '$=  !G&   7Q,  %<.  !0"@  20,( $4 #0!! !$ /@ 6 #P
M&P Z "$ .0 F #< +  V #( -  X #, /P Q $< , !0 "X 6P M &< *P!V
M "H B  H )P )P"P "8 R0 E .H )0'[ "4!_P"B(P  EB@  (LJ  "!*@
M=R@  &TE  !D(   6QL  %(5  !+$   0PP" #T'"0 Y PX -@$2 #,!%P Q
M 1P , $B "\")P M BT + ,T "H#.P I!$, * 1- "8%6  E!64 (P9T "(&
MA@ @!IH 'P>N !X'Q@ =!^< '0CX !T)_P"?*   DRT  (@O  !^+P  ="X
M &HK  !A)@  6"$  $\<  !'%P  /Q(  #@.!  Q"PH +@@. "L'$@ I!Q<
M* @= "<((P E""D ) DP ",)-P A"D  ( I* !\+50 ="V( &PQR !H,A0 8
M#)D %PRM !8,Q@ 5#>8 %0WY !8-_P"<+0  D#$  (8T  !\-   <C,  &@Q
M  !?+   52<  $PC  !$'0  /!@  #03   M$ 8 )@T+ "0,#P B#!, (0P9
M !\,'P >#24 '0TL !L--  :#CT &0Y' !<.4P 6#F$ % ]Q !,0A  2$)@
M$1"N ! 0Q@ 0$.@ $!#[ !$0_P"9,0  CC4  (0X  !Z.0  <#@  &<V  !=
M,@  4RT  $HH  !")   .1\  #$:   J%0$ (Q$' !T0#0 ;#Q  &0\5 !@0
M&P 7$"$ %A I !40,0 4$3H $Q%% !(240 1$E\ $!)O  X3@@ .$Y8 #1.K
M  L3P@ +%., #!3Z  T3_P"7-0  C#D  ((\  !X/0  ;ST  &4Z  !;-P
M4C(  $DN  ! *@  -R4  "\A   H'   (!@# !D4"@ 5$@X %!(2 !,3&  2
M$Q\ $10F !$4+@ 0%#@ #Q5"  X63P -%EP #!=L  L7?P )&), "!BH  88
MOP '&.  !QCU  D8_P"5.   BCT  (!   !W00  ;4$  &0_  !:/   4#@
M $<S   ^,   -BL  "XG   G(P  'Q\  !<:"  2%PT $!<1  \7%@ .&!P
M#A@C  T9+  ,&C4 "QI   H;3  )&UH !QQI  4<?  $'9$  AVF  $=O  "
M'-T  ASR  ,<_P"3/   B$$  ']$  !U10  ;$4  &-$  !900  3ST  $8Y
M   ^-@  -3(  "XN   E*@  '24  !0A!  /'0L #1T0  P=%  +'1H "AXB
M  @>*@ ''S, !B ^  0@2@ #(5<  2%G   A>0  (8X  "&D   AN@  (=L
M "'R   @_@"00   AD4  'U(  !T2@  :TH  &))  !81@  3D(  $4_   ]
M/   -3D  "LT   B+P  &2L  !(H!  -) H "2,.  8C$@ %(QD !"0@  (D
M*  !)3$  "4\   E2   )E4  "9E   F=P  )HP  ":B   FN0  )MD  "7R
M   E_@".10  A$D  'M-  !S3P  :D\  &!.  !72P  34@  $1%   \0@
M,3T  "<Y   >-0  %3(   \N P *+ H !2L.  $J$0  *A8  "H>   J)@
M*R\  "LY   K10  +%,  "QB   L=0  +(H  "N@   KMP  *]8  "KR   J
M_P",20  @DX  'I2  !Q5   :%0  %]3  !640  3$X  $-+   W1P  +4,
M ",_   :/   $C@   PV P &,PD  #(-   R$   ,10  #$;   Q(P  ,2P
M #(W   R0P  ,E   #)@   R<@  ,H<  #&>   QM0  ,-0  ##R   O_P")
M3P  @%0  'A7  !O60  9ED  %Y9  !55P  25,  #Y/   R3   *$@  !Y%
M   50@  #D    @] @ !/ @  #L,   Z#P  .1(  #D8   Y(   .2D  #DT
M   Y0   .4X  #E=   Y;P  .(4  #B<   WLP  -](  #;R   U_P"'50
M?UH  '9=  !M7P  95\  %U?  !27   1%@  #A5   M4@  (D\  !A,   0
M2@  "D@   -& 0  108  $0*  !##0  0A   $$5  !!'0  028  $$Q  !!
M/0  04H  $%:  !!;   0($  #^9   _L0  /M   #WR   \_P"$7   ?&
M '-C  !L90  9&8  %ED  !+80  /EX  #);   F60  '%8  !)4   ,4@
M!%$   !/    3@,  $T(  !,#   2PX  $L2  !*&0  2B(  $HL  !*.0
M2D<  $I6  !):   27X  $B6  !'KP  1LT  $7Q  !$_P"!8P  >6<  ')J
M  !K;   8&L  %)I  !$9@  -V0  "IB   ?8   %5X   U=   &6P   %H
M  !9    6    %<$  !6"   5@P  %40  !4%   5!T  %0G  !4-   5$(
M %-2  !39   4GD  %*2  !1JP  4,H  $_O  !._P!^:@  =VX  '!Q  !F
M<0  6'   $IO   \;0  +VP  ")J   7:0  #F<   9F    90   &4   !E
M    8P   &(   !B!   80@  &$-  !@$   8!<  & A  !?+@  7SP  %]-
M  !>7@  7G0  %V-  !<IP  6\4  %KM  !9_P![<@  =78  &MW  !==@
M3W8  $%U   S=0  )G0  !ES   0<@  !W$   !Q    <0   '$   !Q
M;P   &\   !N    ;@(  &X(  !M#   ;1$  &T:  !M)@  ;#4  &Q&  !K
M6   :VT  &J&  !IH0  :+X  &?H  !F_@!Y>@  <'P  &%\  !3?0  1'T
M #9^   H?@  &WT  !!]   '?0   'T   !]    ?@   '\   !^    ?0
M 'T   !\    ?    'P   !\!@  ? P  'P2  !\'0  ?"P  'P\  !\3P
M>V4  'M^  !ZF@  >;8  'C?  !W^@!S@   98$  %:#  !(A   .88  "N'
M   =AP  $8<   >(    B    (D   "*    C    (T   "-    C    (P
M  ",    C    (P   "-    C00  (X,  ".$P  CR$  (XR  ".1@  CEL
M (UT  "-D   C*T  (O.  "*\P!HA@  6H@  $N+   \C0  +8\  !Z0   1
MD0  !Y(   "3    E0   )<   "9    FP   )P   ";    FP   )P   "<
M    G0   )X   ">    GP   *$#  "B#   HA8  *,F  "C.@  HT\  *-H
M  "BA@  HJ(  *+   "AZ !<C0  39   #^3   PE@  (9D  !*:   'FP
M )T   "@    H@   *0   "H    J@   *L   "J    JP   *P   "M
MK@   *\   "Q    L@   +0   "W 0  N0T  +D:  "Z+0  ND,  +I;  "Z
M=P  NY0  +NQ  "YT@!0E0  09@  #*<   CH   $Z(   BD    IP   *H
M  "L    KP   +(   "W    N0   +L   "Z    O    +T   "_    P
M ,(   #$    Q@   ,D   #-    T@$  -0/  #5'P  US4  -A-  #8:0
MUX8  ->C  #6O0#_    _P   /\   #_    _P # /\ #0#_ !4 _P @ /P
M*P#X #4 ]  _ /  1P#N $X ZP!4 .D 6@#G %\ Y0!D ., :@#A '  WP!V
M -T ?@#; (< V "1 -, G0#/ *L S0"] ,L X #) /L QP#_ +T _P"Q /\
MJ0#_ *, _P#_    _P   /\   #_    _    /8 "P#Q !$ [0 ; .D )0#D
M #  WP Y -H 00#5 $@ T0!. ,\ 5 #- %D RP!> ,D 8P#' &D Q0!O ,,
M=P#  '\ O@"* +L E0"X *, M@"T +0 S0"R /( L #_ *P _P"C /\ G #_
M )< _P#_    _P   /H   #Q    Z    .  !@#9  X T@ 6 ,X 'P#( "D
MQ  R ,  .@"] $$ N@!( +@ 30"V %, M !8 +( 70"P &( K@!I *P ;P"J
M '@ J "" *8 C@"D )L H0"K )\ P "= .8 FP#_ )H _P"4 /\ C@#_ (H
M_P#_    ]@   .@   #<    S@   ,8  0"_  L N@ 1 +8 &@"R "( K@ K
M *H - "H #L I0!! *, 1P"A $P GP!1 )X 5@"< %P F@!B )D : "7 '
ME0!Z )( A@"0 ), C0"B (L M0") -, AP#W (8 _P"$ /\ ?P#_ 'P _P#R
M    XP   -(   #%    N@   +$   "K  < I0 . *$ % "> !P F@ E )<
M+0"4 #0 D@ Z )  0 ". $4 C0!* (L 4 ") %4 B !; (8 80"$ &D @@!R
M '\ ?0!] (L >P": '@ JP!V ,0 = #K ', _P!S /\ < #_ &X _P#?
MS    +\   "T    JP   *$   ":  ( E  + )  $ ", !< B  > (4 )@"#
M "T @0 S '\ .0!] #\ >P!$ 'D 20!X $X =@!4 '0 6@!S &( < !K &X
M=0!L (, :@"2 &@ HP!F +@ 9 #> &, ^P!B /\ 8@#_ &  _P#,    O
M *\   "E    G0   )0   ",    A@ ' ($ #0!\ !( >  9 '4 'P!S "8
M<0 M &\ ,@!M #@ :P ] &H 0@!H $@ 9P!. &4 5 !C %L 80!D %\ ;@!=
M 'L 6P"* %D FP!7 *\ 5@#+ %4 \@!4 /\ 5 #_ %0 _P"^    L    *0
M  "9    D    (@   "!    >0 " ', "@!O  \ :P 4 &< &@!E "  8P F
M &$ + !? #( 7@ W %P / !; $( 60!' %< 3@!6 %4 5 !> %( : !0 '0
M3@"# $P E0!* *@ 20#  $@ Z !' /\ 1P#_ $< _P"T"0  I@L  )L,  "0
M"@  A@4  'X   !V    ;P   &@ !0!C  P 7P 0 %L %0!8 !H 5@ A %0
M)@!3 "P 40 Q %  -@!. #P 30!" $L 2 !) %  2 !8 $8 8@!$ &X 0@!]
M $  C@ _ *( /0"X #T W0 \ /@ / #_ #P _P"L$   GQ(  )02  ")$0
M?P\  '8,  !N!0  9@   &   0!9  @ 50 - %$ $0!. !8 2P ; $D (0!(
M "8 1@ K $4 ,0!# #8 0@ \ $  0P ^ $L /0!3 #L 70 Y &D -P!X #8
MB0 T )P ,P"Q #( S@ R /$ ,0#_ #$ _P"F%@  FAD  (X:  "$&@  >A8
M ' 2  !H#@  7PH  %@#  !1  0 3  * $@ #@!$ !( 00 6 #\ &P ] "$
M/  F #H +  Y #$ -P W #8 /@ T $8 ,P!/ #$ 60 O &4 +@!S "P A0 K
M )@ *@"M "D Q@ H .H * #^ "@ _P"A'   E2   (HA  !_(0  =1\  &P:
M  !C%@  6A$  %(-  !+!P  1  & $  "P \  \ .  2 #8 %P T !P ,P A
M #$ )P P "P +@ S "T .@ K $( *@!+ "@ 50 F &$ )0!P "0 @0 B )4
M(0"I "  P0 @ .0 'P#Y !\ _P"=(@  D28  (8H  !\)P  <B4  &DB  !?
M'0  5Q@  $X3  !&#@  /PL  #@%!P T  P ,0 0 "X $P L !@ *@ = "D
M(@ G "@ )@ N "0 -@ C #X (@!' "  4@ ? %X '0!M !P ?@ : )( &0"G
M !@ O0 7 -\ %P'U !<"_P":)P  CBL  (0M  !Y+0  <"L  &8H  !=)
M5!\  $L:  !#%   .Q   #0- @ M"0D *04- "8#$  D 1, (@(9 "$"'@ @
M B0 '@,J !T#,@ ;!#H &@5$ !D%3P 7!EP %@9J !0'?  3!Y  $@>E !$'
MNP 0!]L $ CR ! )_P"7*P  C"\  ($Q  !W,@  ;C$  &0N  !;*@  424
M $D@  ! &P  .!8  #$2   I#@0 (PP) !\)#0 =!Q  &P<5 !D(&@ 8""
M%PDG !8)+@ 5"C< $PI! !(+30 1"UH $ MI  X,>P .#)  #0RE  P-NP +
M#=D "PWQ  P-_P"5+P  BC,  '\V  !V-@  ;#4  &,S  !9+P  4"L  $<F
M   ^(0  -AT  "X8   G$P  (! % !D."@ 5# X % P1 !,,%@ 2#!P $0TC
M ! -*P /#30 #@X_  T.2@ ,#U@ "P]G  H0>0 ($(T !Q"B  80N  %$-0
M!1#O  80_P"2,P  B#<  'XZ  !T.P  :SH  &$X  !8-0  3C   $4L   ]
M)P  -2,  "T?   F&@  'A8! !<3!@ 1$ L #@X.  X/$P -$!D #1 @  P0
M*  +$3( "A$\  @22  '$E4 !A-E  03=@ #$XL  12@   3M@  $]$  !/N
M   3^P"0-@  ACL  'P^  !S/P  :C\  & ]  !7.0  338  $0Q   \+@
M-"H  "PF   E(@  'AX  !8: @ 0%0D #!,.  H3$@ )%!< "!0?  <5)@ &
M%2\ !!8Z  ,61@ !%U,  !=B   8=   &(D  !B?   8M0  %]   !?M   7
M^P"..@  A#\  'M"  !R0P  :$,  %]"  !6/P  3#L  $,W   [-   ,S
M "PL   D*0  &R0  !,? @ -&PD "1D-  89$0 $&18  AD=  $:)   &BT
M !LX   ;1   '%$  !Q@   =<@  '8<  !R=   <LP  ',X  !OM   ;_ ",
M/@  @D,  'E&  !P2   :$@  %Y&  !51   2T   $,]   [.@  ,S<  "HR
M   @+0  %RD  ! E @ +(@D !2 -  $?$   'Q0  !\;   @(@  ("L  "$V
M   A00  (4\  "%>   B<   (H4  "&;   AL@  (<T  "#M   ?_ "*0P
M@$@  'A+  !O3   9DT  %U+  !420  2D8  $)#   Z0   +SL  "4W   <
M,P  $R\   TL @ '*0@  2<,   F#@  )1(  "89   F(0  )BD  "8S   G
M/P  )TT  "=<   G;0  )X(  ">9   FL   )<P  "7N   D_0"(2   ?TP
M '90  !N40  95(  %Q1  !33P  2DP  $%)   U1   *T   "$\   7.0
M$#8   HR 0 #, <  "\+   N#@  +1$  "T6   M'@  +2<  "TQ   M/0
M+4H  "U9   M:P  +8   "R7   LKP  *\L  "KN   J_@"%30  ?5(  '55
M  !L5P  8U<  %M6  !350  1U$  #M-   P20  )48  !Q#   3/P  #3T
M  8Z    . 4  #<)   V#0  -0\  #04   T&P  -"0  #0N   T.@  -$<
M #17   T:   -'T  #.5   RK0  ,<H  #'N   P_P"#4P  >U@  '-;  !J
M70  8ET  %M=  !/6@  0E8  #92   J3P  ($P  !9)   .1P  "$0   !"
M    00,  #\'   ^"P  /0X  #T1   \&   /"$  #PK   \-P  /$0  #Q3
M   \90  .WH  #J2   ZJP  .<@  #CM   W_P"!6@  >5X  '%A  !I8P
M8F0  %=B  !)7@  /%L  "]8   D50  &5,  !!1   *3P   4T   !,
M2@   $D$  !("   1PP  $8/  !&%   11P  $4G  !%,P  14   $50  !$
M80  1'8  $./  !"J   0<8  $#L   __P!^80  =F4  &]H  !H:@  76D
M $]F  !"9   -&$  "A?   =70  $EL   M9   "6    %8   !6    5
M %,   !2!   40D  % -  !0$   3Q@  $\B  !/+@  3SP  $]+  !.70
M3G(  $V+  !,I0  2\(  $GJ  !(_P![:0  =&P  &YO  !D;P  56T  $=L
M   Y:@  +&D  "!G   490  #60   -B    8@   &$   !@    7P   %X
M  !=    7 0  %P)  !;#0  6Q(  %L<  !:*   6C8  %I&  !96   66T
M %B%  !7H   5KT  %7H  !3_@!Y<   <W0  &EU  !;=   3',  #YS   P
M<@  (W$  !9O   -;@  !&T   !M    ;0   &T   !L    :P   &H   !I
M    :0   &D#  !H"0  : X  &@5  !G(0  9R\  &<_  !F4@  9F8  &5_
M  !DF@  8[<  &+A  !A_ !W>   ;7H  %]Z  !0>@  0GH  #-[   E>P
M&'H   YY   $>0   'D   !Y    >@   'H   !Z    >    '@   !W
M=P   '<   !W 0  =P@  '<.  !W&   =R8  '8V  !V20  =5\  '5W  !T
MDP  <Z\  '+3  !Q]P!Q?@  8W\  %2   !%@@  -H,  "B$   :A   #H,
M  2$    A    (4   "&    B    (D   "(    AP   (<   "'    AP
M (<   "(    B    (@'  ")$   B1P  (DL  "(/P  B%4  (AM  "'B0
MAJ<  (7'  "$[P!FA   5X8  $B(   YB@  *HP  !N-   /C0  !(X   "0
M    D0   ),   "5    EP   )@   "6    EP   )<   "7    F    )@
M  "9    F@   )L   "=!P  G1$  )TA  "=,P  G4D  )QB  "<?P  G)P
M )RY  ";X@!:BP  2XX  #R1   MDP  'I4  !"6   $F    )H   "<
MG@   *$   "D    I@   *<   "F    IP   *<   "H    J0   *H   "L
M    K0   *\   "Q    LPD  +,5  "T)P  M#T  +55  "U<   M(X  +2L
M  "TS !-D@  /Y8  "^:   @G0  $9\   6A    HP   *8   "I    K
M *\   "S    M0   +<   "V    MP   +@   "Z    NP   +T   "_
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M____________________________________________
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M1TE*2TU.3U!24U155UA96UQ=7F!A8F-E9F=I:FML;F]P<7-T=7=X>7I\?7Z
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M________J#4          %S3____________________________?0T
M     %36___________________________N?44          $34________
M___________________\JF0O @  !"(W25C.________________________
M____Z:1K02@_8W^5I[K:_______________________________5LJRRS.3Z
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________ENY=W8LC_________________
M________________VYYG-@H  HS________________________________(
M?S\%     %[/_____________________________]F!.0       #RJ____
M_________________________YY,         ".0____________________
M________W&\:         !!]^?__________________________KT@
M      !O[O__________________________A!,           !DYO______
M___________________L40            !7WO______________________
M__^X%0            !(UO________________________]T%
M   XS_________________________FB6A,            CQ?__________
M_______________?FUPL           -NO__________________________
M[[%]53DB$0<! A$BLO______________________________W[^EF9B:H*R]
MVO__________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____X[Z=@'S[________________________________\K>$5S . !VL____
M___________________________2BDP5      !R\___________________
M_________]9_-@        !+R?__________________________^I$^
M       OJ___________________________P%H            :E?______
M____________________C20            (A/______________________
M___G7@              =_________________________^T)0
M    :O________________________]]                6_3_________
M______________TK                3.O______________________Z4
M                /.'______________________S ,
M+=G_____________________F8IA)P              )]?_____________
M_________^V^B54G            )=S__________________________LJ=
M=EU*/#(M+# Y1][_______________________________WFW=;2T-/9Y/__
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________OU+O6____________________
M_____________^>XCVI++Q5O_______________________________DH6<T
M!P     \R?___________________________]:".P         2E_______
M____________________[84Q            ;_______________________
M____ID(             4.'________________________L:0
M    -\G_______________________^S+P              (K;_________
M______________]Y                $*?_______________________(T
M                 )G______________________ZD
M (S______________________T8                  '______________
M________WP                   '3_____________________EP
M             &K_____________________S@                   &/_
M_____________________RDB 0               &'_________________
M_____[FC@%<W%P           &C___________________________K3KI2&
M?'5Q<')W@93_________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________V[J=@FEIT_______
M________________________R)-E/1D    =GO______________________
M_____]N.3!,         ;O__________________________VWPL
M    1=?_________________________BRH             (K3_________
M_______________"1                Y?_______________________]]
M 0               '_______________________^<V
M &K______________________YT                  %C_____________
M_________T8                  $?X____________________Z0
M             #7I____________________E@                   "7;
M____________________O                    !C.________________
M____ZP                    _"_____________________P
M          JY_____________________R<                   JU____
M_________________W                    VY____________________
M_^"<C'!50C,F&Q0/#0X2&B:_____________________________^>38TL[,
MR\S/UN#\____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________Z].\X________________________________]*IA65(
M+!(!A?____________________________&K<3P/        3^#_________
M________________U7\U            '[+________________________C
M=1T              (G_______________________^0(P
M &?______________________]5#                 $CV____________
M_________XH                  "[=_____________________S@
M             !?(____________________O@                    2V
M____________________G                     "E________________
M____N@                    "3____________________W
M          ""_____________________P                    !T____
M_________________Q,                   !H____________________
M_T(                   !@_____________________WH
M      !=_____________________]$                   !A________
M______________\D                  !F_______________________)
MK)F)?79Q;&EG9F=K<'J,________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________XL6JD7EA=___________________________
M___=IG=0+ P     ,<3_________________________X)).$P
M (_________________________2<!T              &#_____________
M_________^YO#P               #?B_____________________Y8<
M             !3 _____________________T                    "C
M____________________K@                    ")________________
M____G@                    !R____________________O
M          !?____________________V@                    !-____
M________________^@                     [____________________
M_PX                    J^?___________________S,
M       ;Z?___________________UX                    /V_______
M_____________X\                    &T/___________________]
M                    RO____________________\K
M    R/____________________^                     R___________
M___________W%@$%!0,!       !!@T8R________________________.OA
MV,_,S<_0TM37W.+J____________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________________________':
MQO______________________________\<:CA&A-,A@ %:O_____________
M_____________[E\1A@          ''________________________7?"\
M             #OC_____________________]]D"0                RU
M_____________________W0#                  "-________________
M____Q14                   !J____________________F0
M          !+____________________M@                     P_?__
M________________UP                     9Y___________________
M]@                     %T____________________PX
M        P?___________________R\                     K_______
M_____________U(                     GO___________________WD
M                    CO___________________Z4
M    @/___________________]@                     =/__________
M__________\V                    ;?____________________]\
M                :?_____________________7#0
M:/______________________<                   8?______________
M_________U \1DY465UA9&AL<'9^B?______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____[]6[HXMS6I7___________________________B_CF1!(04      %+\
M_______________________WG588             !?!________________
M_____^5L%@                "-_____________________V,
M          !>____________________G0                     U_/__
M________________H0                     1V?__________________
MR@                      N___________________[@
M        H?___________________PP                     BO______
M_____________RT                     =O___________________TT
M                    9/___________________V\
M    4O___________________Y0                     0/__________
M_________[P                     ,/___________________^H.
M                (O____________________]$
M%?____________________^!                    "_7_____________
M_______("P                   NS_____________________7@
M             .7_____________________R1P                  -K_
M_____________________YT!              <.%\7_________________
M_______5N;S!Q\[5V^'F[?3[____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________XW\__________________
M____________[,:EB&U4.R$' #+>________________________UY)9*0
M          "@______________________^)-@                !G____
M_________________V8                    R]O__________________
ME0                     #R/__________________IP
M        H/__________________UP                      ?/______
M_____________P                      7O___________________R4
M                    0____________________T@
M    +/___________________VH                     &/__________
M_________XL                     !?/__________________Z\
M                 .'__________________]4
M ,____________________\D                     +[_____________
M______]4                     *[___________________^+
M             )_____________________+#@                   )+_
M____________________5P                   (;_________________
M____J@H                  'G______________________VT
M         &;_______________________=5                 $7_____
M____________________:B,K-3]*56!J=7Z'D9S_____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________________^C/MIV#:4ZY____
M_____________________^RR@UPZ'0(       ![____________________
M___%;2D               ! _____________________X,;
M       'R___________________D@                      F/______
M____________I                       :O__________________W0
M                    0?___________________PX
M    '?___________________SD                      .C_________
M_________V                       ,[__________________X4
M                 +?__________________Z@
M */__________________\L                      )#_____________
M_____^\6                     'W___________________\^
M             &S___________________]I                     %K_
M__________________^9                     $G_________________
M___2%@                   #G_____________________6
M         "G_____________________H@                   !G_____
M________________]58                   3_____________________
M_[LO                  #X______________________^K*0
M      #/________________________R4<     !Q,@+CY2:(3M________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________]-7)____________________________^M*PDG==
M0B@,  !*________________________Q7U%%P             1V/______
M_____________\10                    G___________________H@P
M                    :/__________________E
M    -O__________________V@                      !^S_________
M_________Q4                      ,3__________________T@
M                 *+__________________W4
M (/__________________YT                      &G_____________
M_____\,                      %+__________________^</
M             #[___________________\S                     "O_
M__________________]8                     !C_________________
M__^!                      7___________________^L
M          #____________________>(@                    #R____
M________________7                     #?____________________
MGP                    #,____________________Z$H
M      "W_____________________Z 6                  "<________
M______________]Z @                !W________________________
M>@L               5,_________________________Z)7:'2 C9RKO-#G
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________^WC________________________
M___2HWI8.BDC'!8.!@  G_____________________^L4@X
M    :?__________________Y$,                     -/__________
M________>0                       ./_________________S0
M                 ++__________________Q,
M (7__________________T\                      %W_____________
M_____X,                      #K__________________[(
M             !S__________________]L#                      +_
M__________________\J                      #[________________
M__]/                      #G__________________]T
M          #4__________________^;                      # ____
M_______________$!P                    "M___________________P
M,P                    ":____________________9P
M      "&____________________HP                    !R________
M____________XT0                   !<_____________________Y$&
M                  !!_____________________^M?
M   =_______________________*2P                  ____________
M____________RU<   P8)#$_3F!TBZ?'___________________________7
MY_+_________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________KU,W'PKZZM[.PK:FHI?___________________]U^4S\P
M(QD1"0(          -O_________________=@
M *?_________________N@                       '7_____________
M_____P<                      $;__________________TX
M             !K__________________XP                       #]
M_________________\$                       #;________________
M__$9                      "^__________________]$
M          "D__________________]K                      "-____
M______________^1                      !Y__________________^W
M                      !F___________________>(0
M      !3____________________2@                     _________
M____________=P                     K____________________K H
M                   6____________________YT4
M    _____________________XH                     ____________
M_________]9-                    _?____________________^G+@
M                U?______________________F"H           88+45@
MX/_______________________ZAC=(&/G*N[S>+Z____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______GR[>IG96.B82 ?'AT<&QH99#_________________O&I(+1D*
M             #'__________________P                        /_
M_________________T(                       #<________________
M_XX                       "R_________________\X
M          "-__________________\I                      !K____
M______________]:                      !.__________________^&
M                       T__________________^N
M       >___________________4%P                     *________
M___________Z/0                      ____________________90
M                    ____________________C@
M    ____________________O!D                     [___________
M________\4X                     V/___________________XL
M                O____________________\Q#
MH?____________________^1&0                  >O______________
M_______R= H                17_______________________Z'03'RPX
M15-B<H6;M-+U___________________________7Z/3_________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________OW\_'N[.OK[/'_________________
M_]FRF8=Y;61=5E%+1D$\.#(M*"/$_________________TLE"P
M          "2_________________X@                       !F____
M_____________]<                        ]__________________\S
M                       8__________________]L
M        __________________^=                        ________
M___________)#                       ]O_________________Q-0
M                    W___________________6P
M    R___________________@@                      M___________
M________J08                     H___________________TR\
M                C?___________________UX
M=____________________Y,'                    7O______________
M_____\U#                    0/____________________^'$
M            '/_____________________87@                   /__
M____________________OTX       X<+#Y2:H:ER/__________________
M_____\)\C)JGML76Z/W_________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________^[AU\_)P[ZZMK&MJ:>FIJ>N_________________[Z&
M;5M,0#<O*"(<%A +!      4_________________]<%
M        __________________\T                        ]O______
M__________]V                        TO________________^P
M                    LO_________________A)
M    EO__________________40                      ?/__________
M________>0                      9O__________________H
M                4?__________________QR,
M//__________________[DL                     )_______________
M_____W0                     $/___________________Z,6
M             /___________________]A,                     /__
M__________________^(#P                   /__________________
M___+4P                   /______________________I3@
M  D=-$YKC/_______________________YDY0U%?;GV.H+7+Y?__________
M___________________K^?______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________KS+FLH9F1BX:!?'AT<&MH9F9H\?________________]A13(C
M& X&                GO________________]^
M    =?_________________#                        4O__________
M_______[-P                      ,O__________________:@
M                %O__________________E@
M /__________________OQL                      /______________
M____YD(                      /___________________VD
M             /___________________Y "                     /__
M_________________[DL                     /3_________________
M_^A<                     -G___________________^1&
M         +S____________________*4P                   )W_____
M________________F"X             $"E&9L3_____________________
M[G\=#!HH-T97:7Z5K\SN_________________________^>@JKG(V.G\____
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________?7PZ^;BW]O8U-+1T-+7X/__________
M_______.GHI\<6EA6U913$A#/CHV,B\N,?_________________2)1$#
M                 /__________________0@
M /__________________?0                       /______________
M____L L                      /;_________________W3D
M             -S__________________V(                      ,7_
M_________________XD                      *__________________
M_Z\B                     )G__________________]9(
M         (+___________________]R                     &G_____
M______________^A*                    $[____________________3
M7                    #/_____________________EBX
M !4R4G?_____________________X'(3   !#Q\O0EAPBZC([/__________
M_____________\IO;GZ.GK##V.__________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________^>#2R,"ZM;"LJ*6BGYV;FYR@I_______________
M____@F162T,\-C K)R(=&!,."00  -3_________________D@
M             *W_________________S!X                      (O_
M________________^U(                      &W_________________
M_X                       %'__________________ZD;
M         #K__________________]!"                     "/_____
M______________5H                      S___________________^/
M%                     #___________________^X/@
M      #____________________E;0,                   #_________
M____________GS<              ! O4'3_____________________W7(4
M      87*D%:=92VVO_______________________[Q81%1D=8::K\CC____
M___________________________2S>'Q____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________\^_K[_?______
M________________[KFHG9:/BH:"?WMX=G1R<W5X?Y#_________________
MZT\Z,"@A&Q40"P<"         "/__________________VD
M          #__________________YL*                      #_____
M_____________\@Y                      #___________________!C
M                      #___________________^*#@
M      #___________________^P-                     #_________
M___________56P                    #_____________________A1H
M                  /L____________________L4D              !@Y
M78'_____________________Y7L>       ,(3A2;X^SV?______________
M_________[M8*3E)6FR E[#-[?____________________________^SGK3%
MU^O_________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________Z[^?AW-G6U-+0T-#1T]G@Z_?_____
M_____________[B*?G=Q;&AD85Y;65A75UE>97'__________________[\Q
M'Q80"@4               #__________________^U6
M      #H__________________^"!                     #,________
M__________^K+P                    "S___________________25P
M                  ";___________________W?!
M  "%____________________HC<                 !2N4____________
M________RV$"            #"Q0=I[1____________________]8TP
M   -(SM7=IF^Y?_______________________\-C&"H[3%]TC:?&Y_______
M______________________^H?Y:HN]#G____________________________
M_________?__________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________=SL6_O+FVM+.QLK*UN<#)U>/_________
M__________^7;&1>65513TQ*2$=&2$M066:A__________________^G)@X'
M @                !6___________________.4
M   Z___________________T>0L                    A____________
M________GS(                    .____________________Q%@
M           (,5J$____________________Z7\?           &)TMQFL+I
M_____________________Z=)      (7+TIHBJ[5_/__________________
M_____]-U'B8X2EYUCZO+[_____________________________^N<H68K,+;
M]O__________________________________W^______________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________O[*JIJ.AH)^?H:.FK+3 S=WL____________
M________BEI33TM(1D1#0D%"0T=.66E]____________________GBX&
M                ____________________PU8                  !5!
M____________________YWL:              DT8(NT________________
M_____Y\_          0E2G&9PNO______________________\9F#P   !,J
M1&*#I\WU_________________________^N.-2L^46B!G;S>____________
M__________________^^=G^4J<'<^?______________________________
M____TMCS____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________V\O#O[^_Q\_C]________
M____________________^+"?FI>6EI:8FY^DK+;"T>'N________________
M_____HY02D=%1$1$149'2U%::(.I_____________________Z9! 0
M    !S9CC[KA_____________________\9E"@      !"=,<YS$[/______
M_________________^6(+P  $RI$8H*FS/3_________________________
M__^K4#9*87N6M-;Z_______________________________2AWR8L<OI____
M________________________________U,[M________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________MY>/CY.;H[?'Y____________
M__________________VQE)*2E9F=HZFRO-#M________________________
M__^=4T=)35%68'.*K];\__________________________^R5@ :-5!MBZ[2
M]______________________________-;SY?>YFWU_G_________________
M_______________NGX.FPN'_____________________________________
MX\[K________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________________
M
M
M                                              #_____________
M____________________________________________________________
M____________________________________________________________
M_____________________________________P    #_X4&W:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60]
M(E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS
M.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 W
M+C(M8S P," W.2XQ8C8U83<Y+" R,#(R+S V+S$S+3$W.C0V.C$T(" @(" @
M(" B/@H@(" \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G
M+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS
M.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(*(" @(" @(" @
M(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O
M(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*
M(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B"B @(" @(" @(" @('AM;&YS
M.G1I9F8](FAT=' Z+R]N<RYA9&]B92YC;VTO=&EF9B\Q+C O(@H@(" @(" @
M(" @("!X;6QN<SIE>&EF/2)H='1P.B\O;G,N861O8F4N8V]M+V5X:68O,2XP
M+R(*(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O
M8F4N8V]M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'AM<#I#<F5A=&5$
M871E/C(P,C,M,#8M,C=4,3,Z,3$Z-#@K,#4Z,S \+WAM<#I#<F5A=&5$871E
M/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/E!38W)I<'0U+F1L;"!697)S
M:6]N(#4N,BXR/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z36]D
M:69Y1&%T93XR,#(S+3 V+3(W5#$S.C,T.C$Q*S U.C,P/"]X;7 Z36]D:69Y
M1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,RTP-BTR-U0Q
M,SHS-#HQ,2LP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'!D
M9CI0<F]D=6-E<CY!8W)O8F%T($1I<W1I;&QE<B Q,"XP+C @*%=I;F1O=W,I
M/"]P9&8Z4')O9'5C97(^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @
M(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<]
M(G@M9&5F875L="(^36EC<F]S;V9T(%=O<F0@+2!0<F]J96-T(%1O($MA;&]N
M("T@1%)3($9O<FT@4RTQ(%-H96QL(%]'4"!$<F%F=" V+C(V+C(S7W-E;G0@
M=&\@<')I;G1E<B!V,CPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^
M"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @(" @(#QD8SIC<F5A=&]R/@H@
M(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3YR
M<C4P,#<S-#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @
M(" @(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E
M<'-F/"]D8SIF;W)M870^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM
M<"YI:60Z,6)B-S,S960M86$S-"TP-S0V+6(T,SDM.#=A96,T,#$T-S4V/"]X
M;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YA
M9&]B93ID;V-I9#IP:&]T;W-H;W Z-F4Q-V$R96(M93DT-BUA9C0W+3@W.60M
M-60T.3DW.&(R-3%C/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP
M34TZ3W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z,65E-#!C,F0M,S,S."TT
M8S1E+6)C-3<M8CEC9&4Y-3)E.34S/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT
M240^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F
M.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V
M960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN
M<W1A;F-E240^>&UP+FEI9#HQ964T,&,R9"TS,S,X+31C-&4M8F,U-RUB.6-D
M93DU,F4Y-3,\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IW:&5N/C(P,C,M,#8M,C=4,3,Z,S,Z-#DK,#4Z,S \+W-T179T
M.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT
M/D%D;V)E(%!H;W1O<VAO<" R,RXU("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A
M<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO
M<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA
M8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM
M<"YI:60Z-S4P.#8X8S8M9&5A9BTW8S0U+6(P-C,M-&(Y,#4V.&-D,V8S/"]S
M=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE
M;CXR,#(S+3 V+3(W5#$S.C,T.C$Q*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T
M;W-H;W @,C,N-2 H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG
M960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L
M:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T
M179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V
M=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S
M/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H
M;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z,6)B-S,S960M86$S-"TP-S0V
M+6(T,SDM.#=A96,T,#$T-S4V/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3 V+3(W5#$S.C,T.C$Q*S U
M.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F
M='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @,C,N-2 H5VEN9&]W<RD\+W-T
M179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC
M:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ
M2&ES=&]R>3X*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E
M240^>&UP+FEI9#HW-3 X-CAC-BUD96%F+3=C-#4M8C V,RTT8CDP-38X8V0S
M9C,\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U
M;65N=$E$/GAM<"YD:60Z,65E-#!C,F0M,S,S."TT8S1E+6)C-3<M8CEC9&4Y
M-3)E.34S/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z
M;W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z,65E-#!C,F0M,S,S."TT8S1E
M+6)C-3<M8CEC9&4Y-3)E.34S/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^
M"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(" @(#QT:69F
M.D]R:65N=&%T:6]N/C$\+W1I9F8Z3W)I96YT871I;VX^"B @(" @(" @(#QT
M:69F.EA297-O;'5T:6]N/C,P,# P,# O,3 P,# \+W1I9F8Z6%)E<V]L=71I
M;VX^"B @(" @(" @(#QT:69F.EE297-O;'5T:6]N/C,P,# P,# O,3 P,# \
M+W1I9F8Z65)E<V]L=71I;VX^"B @(" @(" @(#QT:69F.E)E<V]L=71I;VY5
M;FET/C(\+W1I9F8Z4F5S;VQU=&EO;E5N:70^"B @(" @(" @(#QE>&EF.D-O
M;&]R4W!A8V4^-C4U,S4\+V5X:68Z0V]L;W)3<&%C93X*(" @(" @(" @/&5X
M:68Z4&EX96Q81&EM96YS:6]N/C8X.#PO97AI9CI0:7AE;%A$:6UE;G-I;VX^
M"B @(" @(" @(#QE>&EF.E!I>&5L641I;65N<VEO;CXR-S(\+V5X:68Z4&EX
M96Q91&EM96YS:6]N/@H@(" @(" @(" \<&AO=&]S:&]P.D-O;&]R36]D93XT
M/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @(" @(" \<&AO=&]S:&]P.DE#
M0U!R;V9I;&4^52Y3+B!796(@0V]A=&5D("A35T]0*2!V,CPO<&AO=&]S:&]P
M.DE#0U!R;V9I;&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D
M9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ 5P#< P$1  (1
M 0,1 ?_$ !X  0 " 04! 0             )"@@#!08'"P0"_\0 1!   00"
M @$# P %!P8/    ! (#!08!!P ("0H1$A,4%187(3%1(SE!87>1MB(W5VAT
M@20I,S0U1DAQL;.WP>'P\?_$ !L! 0 !!0$                $ 0(#!08'
M_\0 1A$  @$# P(#! 8&!@@'     0(#  01!1(A,4$&$U$B87&!%#*1H;'!
M%2,S<M'P%C5#<X+Q)4)25'2RPN$T-D1BDI.T_]H # ,!  (1 Q$ /P"_QQ2G
M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2HXO+=VAV-TU\>
M?8_L3J-<<QLFD0-5CZA(2H@\B'"RUYV#4Z"W/JCC&"09$B!9L[LN$">.\ 4:
M$.R<TZ*MYM62)0\BJ>ASGWX!/N]/\^AU&NWLVGZ5=W<&/.C6-8R0&"M++'%N
MVG@E=^0"""0,@C-5H_3U^7+N]V4[LR'7'LIM^1W32+YK6YVB)(L\/71IJGV>
MF,ARK)$-)P,7#NXBI2-5( R,4:@X;#^(\H) 3C12B9$\2*FY1M((& 3C!X[Y
M)^VN1\*Z[J-YJ+6EY.;B*6&1U+J@:.2/#>RR*OLE205.0.",8YNA7_9FM]40
M.;3M+8-(UK6,%, YL=_M<#3H+!I6<I&#S+V(^.C_ +HE6,I8'^X^L\K&<-H5
MG&>1 ">@)^ S7H,LT4"[YI8X4R!OE=8UR> -SD#)/09YKE4;)1TQ'A2T0>%*
MQ4D*P='2<:4P='GA%-I>&,",%<=&*%(96AU@AAQQIUM25MK4E6,YI5X8, RD
M,I (8'((/0@C@@^XU]O%5IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2G%*<4IQ2O-F[X>:OR+T3R3[VE*/V$M-3I^A]^["UQ2M2PKN!
M]6%T_7MY*KK$=:J>Y]:/M)5C%KS+\]+3*2Y3[D\_$07%"K8&'GQPQF,97VF'
M)ZD'W>E>1:GXAU6/5[HQW<D:6UU-%' I_4%(9&4*\8P&+A?;=LL23@JO MC^
M?&;=LWA/[&V0AA K]@J_7J;>&:4IQL=V6W=J$]QAM:L84M#*R%-H4K&%*2G&
M<XQG.>1H/VRXZ>UC_P"+5W/B9B_AZZ<\%ULV..Q:YMSQGTSWJI#Z8K^=<H7]
MC^Y_\+H_?R7<_LC\1^-<-X-_KJ+_ (>Y[_\ M'V?/T^S++U;E[MQ?<KKQK5^
M?DG*+!=;0+K%U?[ES$0-:K/LO8T).3V \*PRN2-B:K  +*6A3J!8]#+:D(6Y
MA=EJ/98]]V/NJ9XYED.HVL6\^6EFLBKDX#R2S*S8'<K$HS[O0FINO2S7NW7/
MQF2<7:)Z1FPM=]CMD4>FM2)+I68&IIJ6MK8U! K>6M34</.VN=,%%3E+0WW[
MC3*$-82G&&Y $G QE03[SDC/3W>_X]AT?@N6232&5V+"&[ECCSGV4\N*3:,]
M@TC8QP!C&.E61.1ZZZG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%
M*<4IQ2G%*<4JG5ZI'OKV4T#8^N?771&T+IIZ"NU/L>S[W8]=V20J=ILSHMA3
M7:[ +GX184['0\0J.E)$H8"488F"I$3[]ES$4-C,NVC5@S, <' !'3C[\YY[
M5P/C/4[RU>TM;6:2W62-YI'B9D=\/L5=ZX90N"2 1DD9Z '/STV7</?';OH_
M=">P-UDMCVG3NZ)364#=["0LZUS%3Q3:?:8YBSRSN,DS<C%E3YX3,P>X_)%
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M*;E7) CQD9)'&>>.O'YG@\XZ5Q?@R"5M6695S#%!.'=2"%9E0*&YRA;<-FX
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M3N*FQ%NW%TX\%Z6B9HH^NP:H0V :(0389&2KT';]'"DF1PJYPIR,MWY&>/\
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M:CZ--XGBL(AIEG!):,TC)(RV^YV\Q@Y8O<Q.6#*5!90< =0 3R$#H1YOM_\
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5E.*4XI3BE.*4XI3BE.*4XI3BE?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g425213g01a13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a13.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[18^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %B*^5F8X0DE-! 0      $8< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(< @4 %U!O=V5R4&]I;G0@4')E<V5N=&%T:6]N
M.$))300E       0].*/ANZ7F;2^;:-=8O[/"CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!HX           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 )3,
MS  !  $ E,S,  $  3A"24T$)@      #@             _@   .$))300-
M       $    6CA"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))301$
M   0     @   D    )      #A"24T$'@      !      X0DE-!!H
M T$    &              $6   #,0    8 9P P #$ 80 Q #,    !
M                      $              S$   $6
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   $6     %)G:'1L;VYG
M   #,0    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   !%@    !29VAT;&]N9P   S$    #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!$       $! #A"24T$%       !     HX0DE-! P
M"X<    !    GP   #8   '@  !E0   "VL &  !_]C_[0 ,061O8F5?0TT
M O_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,#/_  !$( #8 GP,!(@ "$0$#$0'_W0 $  K_Q $_
M   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MWTLB
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M /_A02]H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B
M96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX
M.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D
M;V)E(%A-4"!#;W)E(#DN,2UC,# Q(#<Y+F$X9#0W-3,L(#(P,C,O,#,O,C,M
M,#@Z-38Z,S<@(" @(" @("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*(" @
M(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q
M+C,O(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C
M+V5L96UE;G1S+S$N,2\B"B @(" @(" @(" @('AM;&YS.G!H;W1O<VAO<#TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP+R(*(" @(" @(" @
M(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M
M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @
M('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y
M<&4O4F5S;W5R8V52968C(@H@(" @(" @(" @("!X;6QN<SIT:69F/2)H='1P
M.B\O;G,N861O8F4N8V]M+W1I9F8O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z
M97AI9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]E>&EF+S$N,"\B/@H@(" @(" @
M(" \>&UP.D-R96%T941A=&4^,C R,RTQ,BTP.%0P,#HU,SHQ-BLP-3HS,#PO
M>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^36EC
M<F]S;V9TPJX@4&]W97)0;VEN=,*N(#(P,38\+WAM<#I#<F5A=&]R5&]O;#X*
M(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C,M,3(M,#A4,# Z-3DZ,C4K
M,#4Z,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A
M1&%T93XR,#(S+3$R+3 X5# P.C4Y.C(U*S U.C,P/"]X;7 Z365T861A=&%$
M871E/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/DUI8W)O<V]F=,*N(%!O=V5R
M4&]I;G3"KB R,#$V/"]P9&8Z4')O9'5C97(^"B @(" @(" @(#QD8SIC<F5A
M=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:3Y086YN965R<V5L=F%M(%1H:6QA:V%R/"]R9&8Z;&D^"B @(" @(" @
M(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]D8SIC<F5A=&]R/@H@(" @(" @
M(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @
M(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/E!O=V5R4&]I;G0@
M4')E<V5N=&%T:6]N/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*
M(" @(" @(" @/"]D8SIT:71L93X*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G
M92]E<'-F/"]D8SIF;W)M870^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-
M;V1E/C0\+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(" @(#QX;7!-33I)
M;G-T86YC94E$/GAM<"YI:60Z,C%E,V(V,S$M.3DV,RTT,#1A+6$Q-C M-#AD
M-SAF-SAA,65E/"]X;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ
M1&]C=6UE;G1)1#YA9&]B93ID;V-I9#IP:&]T;W-H;W Z9C$S.3AE9#DM.#EA
M.2TV,#1A+6%F-3 M,3$X,S%E,S(Q8F0Y/"]X;7!-33I$;V-U;65N=$E$/@H@
M(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z93%B
M8V$Y9#4M,&%F8RTY.30V+6)D-3<M8SDX-S1E.#@S83$S/"]X;7!-33I/<FEG
M:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @
M(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#IE,6)C83ED-2TP869C+3DY
M-#8M8F0U-RUC.3@W-&4X.#-A,3,\+W-T179T.FEN<W1A;F-E240^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C,M,3(M,#A4,# Z-3DZ,3DK
M,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS
M;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<" R-"XV("A7:6YD;W=S*3PO
M<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A
M=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II
M;G-T86YC94E$/GAM<"YI:60Z93@S.#,V,34M8S(U8BTS.30P+3AF938M864V
M931A-34W.3<W/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z=VAE;CXR,#(S+3$R+3 X5# P.C4Y.C(U*S U.C,P/"]S=$5V
M=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N
M=#Y!9&]B92!0:&]T;W-H;W @,C0N-B H5VEN9&]W<RD\+W-T179T.G-O9G1W
M87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\
M+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E
M<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM
M86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYD
M97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T:6]N+W9N9"YA
M9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R
M<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z,C%E,V(V
M,S$M.3DV,RTT,#1A+6$Q-C M-#AD-SAF-SAA,65E/"]S=$5V=#II;G-T86YC
M94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3$R+3 X
M5# P.C4Y.C(U*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @,C0N-B H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @
M(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-.D1E<FEV961&
M<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T
M4F5F.FEN<W1A;F-E240^>&UP+FEI9#IE.#,X,S8Q-2UC,C5B+3,Y-# M.&9E
M-BUA939E-&$U-3<Y-S<\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @
M(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z93%B8V$Y9#4M,&%F8RTY.30V
M+6)D-3<M8SDX-S1E.#@S83$S/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @
M(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z93%B8V$Y
M9#4M,&%F8RTY.30V+6)D-3<M8SDX-S1E.#@S83$S/"]S=%)E9CIO<FEG:6YA
M;$1O8W5M96YT240^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @
M(" @(" @(#QT:69F.D]R:65N=&%T:6]N/C$\+W1I9F8Z3W)I96YT871I;VX^
M"B @(" @(" @(#QT:69F.EA297-O;'5T:6]N/C$Y.3 P,# O,3 P,# \+W1I
M9F8Z6%)E<V]L=71I;VX^"B @(" @(" @(#QT:69F.EE297-O;'5T:6]N/C$Y
M.3 P,# O,3 P,# \+W1I9F8Z65)E<V]L=71I;VX^"B @(" @(" @(#QT:69F
M.E)E<V]L=71I;VY5;FET/C(\+W1I9F8Z4F5S;VQU=&EO;E5N:70^"B @(" @
M(" @(#QE>&EF.D-O;&]R4W!A8V4^-C4U,S4\+V5X:68Z0V]L;W)3<&%C93X*
M(" @(" @(" @/&5X:68Z4&EX96Q81&EM96YS:6]N/C@Q-SPO97AI9CI0:7AE
M;%A$:6UE;G-I;VX^"B @(" @(" @(#QE>&EF.E!I>&5L641I;65N<VEO;CXR
M-S@\+V5X:68Z4&EX96Q91&EM96YS:6]N/@H@(" @(" \+W)D9CI$97-C<FEP
M=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( (8!B@,!$0 "$0$#$0'_Q  >  $   <! 0$              @,$!08'
M" D!"O_$ %X0   % P$$! 8-!0D-!P4   $" P0%  8'$0@)$B$3,9;5%!89
M(E:3%1<:,D%15%576)?2UQ@C87&S)"8U0G)TD96Q)313=8&2E*6TT=/4U@HG
M*$99H;(V1%)B<__$ !X! 0 " P$! 0$!           ! @,$!08'" D*_\0
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M#2YVE,4\&U\B=A.P 7N!;9\^O)\\=S-I!PY;-W)5W %<()+E 5%BB!54RJ
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M'(3D2G2D.(<A.0IITPE*;K* F,( ( )A'G7SGOL]TI7A#<[P\@'4(54*JI2
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MOL]TRV7N>X<M<'_3JK?81MRW^J]M-D.]<P[>_9?$.RWMJ?\ 8/FB]AO/KE
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M)=V5/<%3SRG^3=]3&+ON< _([$?E*5]HB-/=,;;@G %9_&Z9-#:F)<,BH8!
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M10MQ>^GLA1Y]_?5;YE59\-Y4)RMI.92LZ7RVE*0TTO0&ZPN^O%X+B1;3DO\
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MKPLD"X403FPV+BR5'0'9]$:DY69>10')E#*$F^6R'U$V*4V 2X>-:1K8:[;
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M4- 'B(19-<H (AJ4042(.I1 1 ! >0B%04A122-4**D_,2E2+_/X*E#7EOM
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MI"%(0I"%(0I"%(0I"%(0I"%(0I"%(1,664<*J+K'%154YE%#CH G.8=3&'0
M#41$1'0 YU"4I0D)2+)2  .0#0#6++6IQ2EK)4I1*E*.TDZDQ+J8K&16C_\
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M6J4@V5/2X-@=%$Z$7&H!&P\NG''T=Q_N-RD(H.PSBP"*&.4AO9#(>AC)\(G
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M[D3TA#.GE_0?1'22=[PBJA$R^%\2ARD+JW  XCF H:CTG(-1#4:@RCP!)";
M$^VY(9DGC_0?1&7UK1:%(12D]X7^27^P*A.P?0/V0BGCO?/OY\X_:&JC?N_[
M17[HLKW/]4?OBY5DBL*0A2$*0A2$*0A2$*0A2$*0C!<@?P0U_P 8)_[.YK<D
M?Z57]F?]Y$47L'T_N,:&FG2R!"$2,!06;R/'YI1$>B9**$$!$!$.$X /+KZA
MU#E7I9!EMQ2UK%RVY+93<@>&\E*@1L-P;?-Q6,<2JONLMA+:\H<8GBK07.]2
MJUI()%QE6 ;BW(8U@5T=N9BL@H)5D$S#J CJ!A<KFX3?&!R&#B+U&*;0>0UZ
MDM)<#Z'$W0XH:'C&]MBX^<*2;':"+C9'SI,TMA4D\PX4NL-JN4D@A1F'U%*N
M4+0H9AJ"E5CH;12*'%0YSB&@G.8X@'4 F$1T_P FM94C*E*1L2 /$+1JN++B
MUK(L5K4L@; 5$FWU7B"IBD*0B:590J2B("'1JF3,<- U$R7%P" ]8:<9M0 =
M!UY]054H25)61X20H WXE6OI\^4>*,J7G$M.,I-FW5-J6+#4MYLAOM%LZMFW
MCB#C/Q"?B-Q& P&-J/$(' 2F 1ZQ Q1$!^,!$!Y#4V%@+"PM86%A8W%ALT(!
M'(1<13.O,59E9E!0*KFY"P4J!.TA224D<8)!TB&IBL*0A2$*0A2$3S.5C'0.
M)@XFY$TTAX0\TJ1A,0!#30=!$>8\Q^&J!M "T@:.%2E:G4K%E?1?D$9U3+RE
ML+*AFET-MM'*/!0V2I (M8V)-R=3QQ+*<Q .!1T!0G ;D ZEXRGTY]7G$*.H
M<^6G4(U8BY!.T&X^D@C]A,8DK4@+"38.(R*T!NG,E5M=FJ1J-8KI!P9P#$#%
M*7H6""(:"(Z@03\QUZA'X@K PV&R^02<[ZUF_$56T'S<D;L\^7A) @#>I%EH
M6-[A&87/(=-1%NK8C0A2$1BH<4R)"(B0ACG(7X ,H! .(?KZ,O\ 1490%%5M
M2 ">4)*B/%F/CBY6LH2V5$H0I:DIX@5A(61].1-_HB)-91(#E(<2@?@$P /6
M*9P.0?T"4P:@(<PU$/A&H4E*K9@#:]K\5P4GZB"01L\0B4.N-I6E"BE+F3,!
MQE"PM!^8I4+@C47(XXN02ZXKO'!R@*CP@%,(',44Q*42E$@CQ"  (]0_!R ?
MAK7X(WD90+A+*K@6!S G4*T%[\9%M3>W%'1%6>WZ<>4F[DVE*5*"U ME((!0
M3<V!(L"= + WUBW^$+"8QS',H8Q%""*@F,.BI.C,.HCKQ<.@ /Z U =*SY$V
M  "0"D@) 'M3<#9LO^TQH<(>*E+4LK4M+B25DJ-G49%G4[2FPO\ ,--(N1)I
M=)!9!,H%367.N<HCJ!A.*?FB.@#H4$QTT$.9M1U#D.N9-M3B'5$E3: @&UK
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MH6&9.9;E];@*TT%HG*W.JNV<%)H54&Y@,42 ">I@;E.( /$(AQ=,4NIP,'&
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MD0#_ .53OROA5=,^F&\4;X&F>3E?1$T)6[B@!2R5QE*4-  'DF   =0  *:
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M%- '](O*MOBO?GI'TQ PWAHZ"@T,GD%+D#_Z$1!D7((  !?5X@ <@ +GFP
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MZ" AUA4\"DSME);R#74BPQ/B4&XQ#7 1J"*M/W!Y?](B5[6>-_H^LCLI _\
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M(.V-Y>+EO?,4-_5;'_@5GX7-\YF/+.=:,7!Y?X!GR2.K#Q<M[YBAOZK8_P#
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M528ADR'LO(<U#VF@P-%8PE+/EX^;N.70C]%U(0I"(2@)0$!__(X_Y#'$P?\
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4AB,P09@#8H="4" A&\:0A2$?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g425213g01a14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a14.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[12:4&AO=&]S:&]P(#,N,  X0DE-! 0
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M;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0
M   !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "
M4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,
M8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M 0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B
M;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M  !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L("!D
M;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD(%5N
M=$8C4FQT                4G-L=%5N=$8C4'AL0%@E+P         *=F5C
M=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,
M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L
M;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14
M;W!L;VYG       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F
M       .             #^    X0DE-! T       0   !X.$))3009
M   $    'CA"24T#\P      "0           0 X0DE-)Q        H  0
M       !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9
MF@ &       ! #(    ! %H    &       ! #4    ! "T    &       !
M.$))30/X      !P  #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@  #A"24T$"
M$     $   )    "0      X0DE-!!X       0     .$))300:      ,U
M    !@              X    F$          0
M   !              )A    X                      !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    X     !29VAT;&]N9P   F$    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   .      4F=H=&QO;F<   )A     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    '.$))300,      G_     0   *     [
M   !X   ;J    GC !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1"  [ * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M     P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0
M  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!
M8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&
M)Y2DA;25Q-3D]*6UQ=7E]59F
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                         /_A00IH='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB
M5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z
M>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N
M,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @
M(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q
M.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z
M+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O
M<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIC<F5A
M=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:3YR<C$P.3(Q.3PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^
M"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C.G1I=&QE/@H@
M(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X
M;6PZ;&%N9STB>"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9" M(%1O($MA;&]N
M("T@4RTQ("A'4"!$<F%F=" Q,BXQ+C(S*2YD;V-X/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT:71L93X*(" @(" @
M/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+R(^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR
M,#(S+3$R+3 R5#(P.C4Q.C$Q*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @
M(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!9&]B92!0:&]T;W-H;W @0U,V("A7
M:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF
M>41A=&4^,C R,RTQ,BTP,E0R,CHU,CHQ-"LP-3HS,#PO>&UP.DUO9&EF>41A
M=&4^"B @(" @(" @(#QX;7 Z365T861A=&%$871E/C(P,C,M,3(M,#)4,C(Z
M-3(Z,30K,#4Z,S \+WAM<#I-971A9&%T841A=&4^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO
M<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%C<F]B870@1&ES
M=&EL;&5R(#(S+C @*%=I;F1O=W,I/"]P9&8Z4')O9'5C97(^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V
M96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@H@(" @(" @(" \
M>&UP34TZ1&]C=6UE;G1)1#YU=6ED.C)C,S1C.68S+3DS-V(M-#,X,RUA,&)C
M+3(X,CEE9#AB8C@R9#PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM
M<$U-.DEN<W1A;F-E240^>&UP+FEI9#I$1D5#.4(P.#,W.3%%13$Q.$0S0C@P
M.#<U,3=#,T0T03PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-
M.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO
M;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A
M<'!L:6-A=&EO;B]P9&8@=&\@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O
M<VAO<#PO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z1$-%0SE",#@S-SDQ144Q,3A$,T(X,#@W-3$W0S-$
M-$$\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C,M,3(M,#)4,C(Z-3$Z,S<K,#4Z,S \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I$
M145#.4(P.#,W.3%%13$Q.$0S0C@P.#<U,3=#,T0T03PO<W1%=G0Z:6YS=&%N
M8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTQ,BTP
M,E0R,CHU,CHQ-"LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N
M861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E
M<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F
M<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O
M97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z1$9%0SE",#@S-SDQ144Q,3A$,T(X,#@W-3$W0S-$
M-$$\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C,M,3(M,#)4,C(Z-3(Z,30K,#4Z,S \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @
M(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I9#HR8S,T8SEF,RTY,S=B
M+30S.#,M83!B8RTR.#(Y960X8F(X,F0\+WAM<$U-.D]R:6=I;F%L1&]C=6UE
M;G1)1#X*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^
M>&UP+FEI9#I$145#.4(P.#,W.3%%13$Q.$0S0C@P.#<U,3=#,T0T03PO<W12
M968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^
M=75I9#HR8S,T8SEF,RTY,S=B+30S.#,M83!B8RTR.#(Y960X8F(X,F0\+W-T
M4F5F.F1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O
M8W5M96YT240^=75I9#HR8S,T8SEF,RTY,S=B+30S.#,M83!B8RTR.#(Y960X
M8F(X,F0\+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/"]X
M;7!-33I$97)I=F5D1G)O;3X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H
M;W O,2XP+R(^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-;V1E/C0\+W!H
M;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@
M(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ WP)=
M P$1  (1 0,1 ?_$ !X  0 !! ,! 0             '! 4&" (#"0$*_\0
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MA;IR>F)FU6&R[CJ4>>H,!K$;%NJ0Y=:@=V".FI&33?2$%88D4H\3%4<'B=_
MQ\@?WJ/7HQ!]=0M>Y/Q3WE,Z:.G_ &:+S4VS=D7-)V]V?4(^>DXR4CXN+L*\
M5,'C$J_&3D#7))@W.T4%K;9:/75-R1G&OU%1!*T?N/\ ?\=_OF4SC;.,R.4]
M"?EG<&%27GQ1]Q59O27:6J=-($V=L/:5-UZRD-E3YY6<+JZ_RE$78NT7%>A(
MZ)F[*HT0DX]^\E2U.)336924VH[>,BEA#CIM.3[Q\M]^O(J1:#XA.U]L:(ZK
M=F,]70U 5TW'VP:%-'EPL*$A(U6V3]0>L;) NR,'S60*Y@!EBD(F5B9I(%9
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M]W!86ND-DS.L+78Y&J+5AE"-(5:>K4ZHB$?8Y-RU8_!7#@HGDUT(\AP0,$$
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M9:0UZ^KE/@(>>UU#2MBG)B#V$M&S[ RVR8)FU:T:3LLL#\[PCB.3)%R/D03
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M$$0 !$1   .1$?8  /F(C] #"+@FHFL0JB2A%4SAR11,Y3D,'(AR4Y1$I@Y
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M?7K*WB^8,4YF-@-MQ&W(]A.ST<U;IK+LW"*+2&F85 \X]XG/G&/E^,()F>4
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M7O\ 2ULV09MT&C9(B#9LBF@@BF4"II(I$ B:9"AP!2D(4"@ ?( SZ" &@-:
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M#RQC;X2X;!Q&X),R-CSG8^LJW>G5#W%-0 X'NY*(<!P/XA\OY>/Q'YYE+FS
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MC3WM&#&R^%?E+]F;_B#K2ZL>'7=>]I]HVY=3!JT7T_LO:-1UU29@ANK08=L
MI@UMX;6Q;=1'5YLMOJ55?*P;N8K]2-),7M@DG16OGQS1Q^G,TC1>@*C82.#^
MI04.D84O<>W@T/9CB%2CVM2G4I.+"YM/LGN>3@AI[@:)'=/,3M!7/X)^1WBM
MQ9.O^)7%O:U76M5U"P:&U:SWO87TZ;WGN434PTYUL<08@*$T.@[J56.PD2TN
M+(D^=)$!)Y9:^9=IY)NX59%CZT%T&_:7[PG+W+!PF \F !U'>SO%H#_H-: 7
M'0&DOEH)  @_6( @^1PO-T?R4^V8N+>L[A=+LG502'7=NXTPQVIKJM+621($
MB#J+8YY]=H:IN4X2'K/I=E"2/9';A"+V&=0@&RIXZ+:H,S/%)M)NX8-'2LNX
M*5RJJT4*V;I'3%$P%-K.I<8<WL*?!..ZB'EM%]*Z91:2V@&-[74VGH8]U9V3
MH)IC[+E]ZH\$/8TK5U'C.AK8[$U[QENPFG1:&!WTAK74VO-5VESG4]+0PMTF
M#N+HJ'<45B^8OEJ35ZXOV*1M:CIN/=O6;A/]#Y[E9H<D<456A&X+@W.JHX=%
M6=KG%5<PYZG@/#N,V[:WTVT9;4'Z31M:;75*M,@D:JCV#LI-/0':2XN>'/<9
M<5[#@E@[AU%]$4*%I;$@TK:FYKG,<!#G.+ *8+FANK27%SPY[B7.)6P/VCKW
M_CZ&_G1C_7YZ+L*_^AJ__P ;_P %W)'4?$*L:2<;("H5A(,GHI 450:.T'(I
M@?GM%0$5#B0#=H]HFXYX'CG@<JZF]D:V/9.VII;/E($H"#L0?(RJW**4PB\<
MO$ WSNG6V\X*KZ\V98:7 *:GK,^XC(9O *).9B1N&PXYV^54E8627%51G"QC
M<"$631*1N!@3[SG.;Z-[%<#X9Q:TO:E_;BL^E<LITW:WLTM-,.(.ES01,D3)
ME:-P][:NEKW-'9M(B(DN>"3@G8#]PW6A,]UK=1%9:$?S_4=;XIFHNDT3<.T*
M8FFHZ7 _E-R %3$3*G*F<Q2E#G@AC#P!1$/8/]DO9JDT/JV;6,U:9-:L))&!
M]?\ CYK7?7>P!SZ[F@F,EH&1C&F<B3@<I5,IUR;Z1!<ZG4Y8RD;#"^H.)J*)
M$?M&IY4#YA@JPE*$NH ECQ$0!R/ I]P<#E3[*>S !)MF#3V<DW%3':_R?VX[
M_P!GJ<;P%'TAPDFX.-,]YF-<AG+ <=NNXY*Y,.L?J1F$W"D7U%7)\1F]<QSE
M1FE252H/V1P(Z9JF+5#%(N@<P$53-]XAA !XR[?9#V;J26632&N+'%M:JX!P
MP0>_N.GWJ6UJCIBLX@$M<1!@@Y!@;CGSQ"QO876/U90%&M4U&]05[2?Q<(^>
MLU3LJ2H4KA%$QTS&3-4@ P 8 Y*;V'^4<R-]C/9XO8/H(,N (%:KS(P3JB=]
ML3X8$5ZU:G2J.;6?+6N<"=,#$C.D@C'R/4K0G]T_Z]OX25N_F.B?ZIY[@?DS
M]CA_[L)S.;FX_M-EPOSI??Z=V-^ZSX?4GSQA/W3_ *]OX25N_F.B?ZIY'_=G
M['?ZL=^TW'_.GYTOOZ0Z>A;3G_T'SG[AE/W3_KV_A)V[^8Z)_JGC_NS]CO\
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M)[HD:FB1.86D9?%0Z^Q !'J.L_N " C 4<.>0#\*Q\Q$?E\N/D&:+O:_C )
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M @'"X@0>!R#[1^T39U4:4 N;_F_-M/M2"0_<4^_C[()@A6J?EU_+32#B^Y:
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M+BS=)!I=SL")I,.KL:3J7>!;GM-7:5!S>UIV!6O]%88FGN'@]XXEX(C(QI$
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M-,B2"!N=)R).P($1(F-^4KH;Z[ZERJME7.QJ(Z,W;L$3E,UL1"+F:$63554
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MV]E_9X?_ +/P_P#Z=?/S%>D#W_WO>M_?V'^TP^__ ,_'86_]%M,;?XK;X_\
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M$3")A$PB81,(F$3")A$PB81,(F$3")A$PBB7:^G*MMN*;LIKSF$@P6%Q&S3
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MUGI7#'4*59[@T5 ""<23T GUO"OCB28-!;@Y=H(^J$P-^\X "W:!1-V#\AX
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M>.0$!$%.[Y"(@/X .=#Z&T\.;<@$/ <XGK%8T\^$0!U)F%SOIA'$C:ETM):
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ME2SI4&TPQU,4Y<#,ENH$DGFX$.@;<_";.XJ.XQ=T7$EH;7(V@!KF ;>9&=@
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MFY4$P%^]:E>-;=W-<T]1J 0R=CB<R3 @8S]RBYK/I\%L'@Z22T=V-H)C/AT
M\@MW.JGK^F=<^$=2NM>'J7JIJS5S7DPWK#N2.1)N\L3E=%1)P_12*JJ@@=$X
M\ID345*)/O%'D<UJ5R*=V^X[,$'6>S!@#5'2=N?7SPNA>57#@K*H)+M%(SL3
M)]_AX#W+0'JC\3JTR_@WZ*ZO6E,29V>Z;6:UQS7C2JQV3==BM,-G2Q7I4TW!
MVYQ:@=)$>% [^TZAA*(FV*5]V5Z^X92^M3(T3@'$F<2,<L@>6.=<U2_@=O4=
M,]L)R9W<-\<IQ$;$0LCZFO%-M>@/"TZ&^IB#HZ$Q8-P%00<0CZ76;M6!4(Q)
MT[$[IND"[@1[P*AP"8%$1,<#   )E^UEU<UW4PXU0 &S@01.0/A'3I*B[K.I
M<'X>]LR>7."V>A_CMXC(?$O\6NS],'3IT$[EK6ODIUWU"4M>V2,4_FEFH1+(
MD+5Y%5J1PW1Y<NS#)G3174("28I]YT%>[M+6VO&TJEP[LM;:SP0PN #1+I@@
M9,&.D *_%;A].UX;4!ASJ9+HC,-8><F)Z1SSLL \8OQ$;)T_;%Z'7<!5?B2&
MVM:UZT2B2\DH@=DVE["5 S=(4DA*JY3 QQ\Y4HICP >5R/(6L[_Z,*S13#FU
M:CC!W8"",1SV$DP(5../BI8DR-5(;8@Z]Y@Y\,9VA39XA/BF6?I5Z].C;0<5
M1$9^$W)5]+.Y^65F%6;J,3ONQGU5)\/032,BHHQ!/U:XN.\KD@>00J(_I1K;
MW;:="M2-(/-5]8AQ.P=3 (&!T!B>I6?B5=]+B5BT&&OIVXF1B:S@<'H <[9Y
M*X=6?BB631WBXZ1Z/F5%2EZUL.0T_$RUA/+JMWK)U?BM2(*M&943MS(,A=('
M<E6$ZCC]("1TA ,BC>-99OMNSU%S:@+I."_:!L! ,[Y@C,*+VN]G&K>G]A_8
M YW+B,[#:!X>&2!$UAZ]+)#?[H,)TB?9LJE8DK368<TY\04*X(\>=.$;<2JE
M9^6* M04'TATN05$XBOYW'Z$;-OC^;S9]F-.@]^9(=VQ?MR$0(\9ZJA='M+I
M)W>T@=!]$B.LR03G8G"E#1OBF6.Z>--L7H.<45)"KQ]SVS7(ZV%EU3O1DJ'3
MYNQN%7,>9'TXL77P=TW;I)"1=$YD5CK*E$296I>,?9-M>S(<VG3 J3N6O:3(
MQC<=9&3C.2WN'GCU6B<M%2L!!B(ID],\R=N<R%[R5;>.NKE?;-K:!EUG-IJ1
MY!*6;*,UD6X*1+Q-A)D;.C!V+F8O%"H+<@0##R= 54P$^>>H\1M;BYK6E)Y-
M>@7BHTM($TW!CX.QTN(!VG<2,K>L_:'A=_Q*[X5;5R^\LC5;68:;FMFA4%*L
M&..'=G4.AVP)DM+AE5=+W'0M@3=AK]8E57DC616^(E4:+-TC)-G(-%UVJJ@
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M^;PTC+23N7)'A%L_CCJ*9>8V([>D8H%, E%1%(HAS>G5?3>7TW%A+=,C! ,
M@1/R\^2U[VSKT>"T[=K35JTWTR11#B=S) B2!.3 ,<A,",NJ'J^ZH^CCP;>A
M&X6R!=N=T622"(MC;<L/(K3S9!JT.\;C,Q4F9K($D5D#I  R)".$T1 1(4QB
MF#:HWE2E6JU#%5SPUI<^2<&)\S,&5J7IJ4.#\/EKFO#@"'@M<.Z3EIR-MCX8
M4Q^(U/\ 3%U5^%QT(;'ZTMBSVDV-_95VX1TM08R0E/*L$C769Y>+29$K]H#T
M1VPD.F9TV*=(2!Y*XCWD--+L*MS7=</%)IEPTM+A)<, !KB .4QR]V7B+FU.
M$6)J$C5I)<(P=!S&F)Z8@;G ,8%XINL/#<L_23X;T+N;>E]U]JJ#I$@GIJTP
M$5-R<G;*>G#U,CXLPV-39E=L=5N1BMY[B.C'B1UE02(/;V)S;4[4UJPJ57-:
MUWZMVAQ+FYF0&XG&#!SR@JG%32^A\,%0.#!3)&F 8#68#H.8 Y?,YR/Q@]:>
M'5;K=T'#U$[NO.MF\'K:N%UT2MQDW)$N%%2F$E&",J=&H3RK RKM,R1W91CI
M$I7)^2E B2B2UIVSVUA5KFF=9#&Z7$O;'/!TS,9 .YG"OQG1VG#]8=!8(&!D
MN:",R<R)B( WRLI\4C7/A\V7Q#.A>=Z@-U7:B;+@:WIX=?U""C)=Y$W>-;[,
M67I"<L^;5&9&-,ZL >C<F1DXQ8[8W+GTX 5QE;=EL:%<U'Z7ZG!K0'G4-!TR
M0"T"0!J.WO)5N*&F.)</+VN<0*&G(W-8QJ'@=YZR)V3K-UUX?TSXU_3[<-K;
MHNM8ZBXB7T:-9UE&1DNXK5GL+<(P-=JR$FC4I%-CYYU6'J$4)YBU5!HD+XS<
M%'/G12IVSK1[GU2VJ-;FLTN(,0!G26@F2-^>>2B[%(\<MR0[5%&,]W4((P1/
MU2,R.D3*OUWUYT%.O]T%5N\S^Y+JSZLFKNM%B=1I1DH:H2-E)H5-I&O%9=.I
MJHI"6F'-(&:#9DF*CU(A5!!0QF1X:RV-HY_:D7 :Z:8:X@]^ 9 @0QTDD\X,
M%6?V9]HFEVHN&C3G =]',$XVTR(Q)T[[FQ=/NN>@%KX^&T+Y5=TW=]U7N+=N
M)-34#F+EBU)C:W%!GT+V\0F3U%%!?R*^G,/$&B]F48)+N% :>>=)DW1L]EN+
M-KA6)K$,_4PZ 00708TS#]1CD=QSBV[(<?K@AVLNJP<:0=!.< F0#&2) &ZN
M?AV:ZZ"(3Q?^MNWZAW-=;3U&3$SU&EN>M):-E6U;J;ESME%;9:\9)*U.-1?B
MTL9"-&A%I]^FDW<*"S*[*1-=&*[;<6M$TZI?5(IE["T@-(9WP"1#H<8,$Q\4
MX=V9XS? 0:A==$CRKP1M@R1S.)VP#3>"1KKH#J76KU>3?2_NBZ[#VO-5^WA:
M:?8HN691--J9MIP;F72BGCRIP:4EY=I&(8)+NI21? U2**0*)J.71[7C+<4Z
M;J-36XD2V' -!8"Z-0&SL<_#&%'!!3%_>@ BI%69(/=[<=/&.9\YE<.BC7G0
M+%^-'U5737>Z+K8>I:3EM\I6+5DC&2J%8KDFO)N/RBNF$J>IL4G9FQDG -FZ
M]B=MD@>K&9%<^6V%M6K3MFVM-U.J752&%[-+@)<73NV(!;&\&,'D9L6T_P ]
MW;@7!X9<#22((+V$XB<G(S@>]6;PD=;^'O6>O+K5L&@MU7:];?FZWM\EQI4]
M%R[*(IU=7V8R<6\8I\O4H=.2,VGP:LFZB\M(N ;F,9 C@.YR$W++<4J)IU2^
MH2W6S2X!LMDB8#<'&">@QE.$FE^<+_22'Z*VJ2(CMA,  "00#L8$C:%CWA!:
MS\.JJCU].- ;NO6PW<_KFQDV:PL49-QI*/0SR3Y5XC#JJT^$-(G3>J%2*Z.I
M*R/8T2 I!!1=1>UW3MF]B:58O!<!4EKFAHALF"V2=^1P0,B"J\'-,_G#0UVK
M02_( W><"/>#M'GBB\+?6GAS5;H8\1:+TIO"][%UY/4P!WE/6"*F8N1J%8/6
M[2G'I1"!:?"'<&28*22_GLV4H[5.BF"I0$2IJ1<LMA6H-IU2:9)%1VEXT@.
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MM!^O0DYIXVJDL:/]99!.R<*(2<:J*''J_2I_V0*WI6CJ-1U6J65 ZKH:-4.
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M'.S0IZ;<LUM=WB[4#+0!IP3 VTR3OG. M^RMS3M',[2F[42=3#+1F3)'QY
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MK7NO;:AK)5Z9"P<'(QTLA%V+845>1D["J[<J-6SUDG#H1OH6(.T7*CA9V#I
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MPQC'>>45OZ4H$*D+D0$1E[]1!(VY3]T9_CX*+;A#Z-A<V;JS2ZN70\-,,!;
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M-S*!9$', X)F,&#SVW]_-="THU&6SZ;FAKB\]TQ@8]W+$Q\(G.&" MVR:1@
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5$PB81,(F$3")A$PB81,(F$3"+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g425213g01a17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a17.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1>\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %Z"^8$@X0DE-! 0      #@< 5H  QLE1QP"   "   < E  "$1E<V@@
M4F%J' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;CA"24T$)0      $!4F
M] /\ZW4.FJ(YR6#3;TLX0DE-!#H      .\    0     0      "W!R:6YT
M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
M  !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE
M5$585     8 00!0 $0 +0 R       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M @"4S,P  0 ".$))300F       .             #^    X0DE-! T
M  0   !:.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!$0      !
M   "   "0    D      .$))300>       $     #A"24T$&@     #00
M  8              ED   =1    !@!G #  ,0!A #$ -P    $
M                 0             '40   ED
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   ED     4F=H=&QO;F<   =1
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   )9     %)G:'1L;VYG   '40    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $    !#A"24T$#      -%@
M  $   "?    ,P   >   %^@   ,^@ 8  '_V/_M  Q!9&]B95]#30 "_^X
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M5:="#Y?DZI^P8OIY++X
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! ?_  !$( , "5P,!$0 "$0$#$0'_Q  >   # 0 #  ,!
M    " D'!08* 0,$ O_$ '80   % P(#! 4## @-# X(!P$#! 4& @<1""$
M,4$)$E%A$Q05%G$7@9$8&2(F)R@V-S@YH? E*3)W>+'!T0HC)#5&1TA79W:V
MX?$T0D1255989FB'E;<:151B97)T=8:6EZ:GM2HS0V.%DJ2R@H24HJ6SM/_$
M !T! 0 " P$! 0$            !!@(#!P4(! G_Q !:$0 ! @0#!0,&"0@%
M"@8! P4! A$  R$Q!$%1!08287&!D? 3(C*AL<$'%",S-4+1X?$5)#0V4G)S
M=!8E0V*R)D135&-D=8*2LPA598.3HD6%H\(7&':DP__:  P# 0 "$0,1 #\
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M:VAE:'.%('A*JGAK=&V5+,E!*0]*6A3U*FE>A8M;0O0O7O=_!CN\3UR0^O2
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MUUR<>*-#<<(F#A"#A"#GRX0@X0@X0@X0@X0CKM,OB=4DJAP2>/C+J47M*N+
M\MPR.ENR%/K]3("D7*E$(C2 *A3 0(U4_9[AE".>$XD#:2!-+ ^HNLVDD:Z?
M2U%454TUFTEY[XET55T4U5A3W::JZ*1$!JI 4'^V/LX0CZBSR3A- DTLT2#*
MB3@*,H,$HZFFFJHHP**A&@T*:Z*A+K[M8!52(ABH!%".$1RR+N*1R7M\D85Z
M%G6J&UW6(W=O5)6MQ254TJD#B>0HK*1+4]5=%)Z5364>3552!A=(B <(>/#P
MK%W[!6=G-Q*+A&W7FUG[BOS13;M[>[873)@CA.F-B%4ZD1=_0'^NHW9;'Z7=
MP4H%B9 3)6%,YJ:T;DD3J RB6Y/GGE^'JI"R5:#[.NDZ>YJAN.KB&E@O3E;6
MRJ!JMW=US8VR3,,1EEQ728M-Q7N@U0A>HR^TRIOH5NU+]1(E2^I\)4.*4I>M
MI7+>.\_; L!;SGM:G:=*]G:=\G6DS3_,I@H7,=P)O:UTN?$6IIE$4L_=8R$M
M=V8=&VHEH;#W./-YQU:T&V/4D,7O1%P:GCV 4F;3GJI$G2T%( D584;G6O@:
M]D=!EFA72'.CY0QM,KD,.B[[:R&Q.;VVMI=;W:B3Q ;?MZAI@;H^,[>>:O(0
M1U$%:5,O*7HV5TI2%EO9#KZ(X.$*YC/0W-6\:](T1YTAV":9@5=F<3&:+(\@
MD;Y-&N+3>YRFJU+!-)VRN$4>Y0T-[B80#<N?&^1NR9.WT/0,2=6\J#VAI3+#
MB*Z'CNB+.&KKF_>SY5$?GBFFNP5F?>E,%X)TEDRVV*6&-DGFEY053*V=GT#C
M0:W,D&<G0TH^-1I*Y@D"I\4$+%[DJ3-Q;N\N1J1)26@+A@]Z?AVEQI#6I[D6
MZ++H(]_X@941[%2UUFRICK-J.?2 ,8J3JO7N\*A\* #FVFH*:W*FL#4E)M%6
M>$"&O3.OWQW(Y8D3G)2#U28@]<:80B)./**-6'%$&JC"4I===-:@TM,0>HK+
M)IKJH((.-J "RZZ@1#U;IZZ1^GA$P<(0<(0<(0<(0<(0<(0<(0<(0<(1B-_G
MR:L$&3JX0>]-YYTHCR*2OT9C5$RDT:B*I552]OK#%#&]WI>W!-12G3B0+0ZB
MC1JE3J#8O%O]5-0A<HI>/5&I9G9O5VSJ6>CMY.UL3F[S'GMG?7R4M+8[.D%<
M9+#BD:)M9:9*B*92'&-)U"1S22!:K0"G0@G]5X:?CWWB*'GT[1]K=XC)D&M?
M46DBTAD4OL+3#F*)$(3G6:3*/3Z*,JA,J<FB.F+$C4M1F.APIG!RK?11E"#@
MY-!7LQN;@<:RU H=<S]_J:/BU^L+53=&:6Q%180F"VP?S&9=(I>9'I_*25C4
M^6W5/[<>U&H6I,20UN4F,)(1NU9E1K<2A+0O:$A4Z=Y&B0!F>=<@/L]O.&RU
M1RVZ\2BL=66LH?RW!4].1"]3&X4,[7UJ"(G(%\69E34"%S]08Y+,4S&PO;]Z
ML6+4@6UF4N+14:#@0A0C6MN]^[,9U$)S>"^&MALN%-44!B,O4PI(N(*;E+5;
M0%GJY)S S'Q9-'E#K&E1[BH?90:\M\V<7(7)K;6=,72U>[KB:4IK1  #]YJ?
M'VYO'<+#S/6?<)XB9=Q#95!:")XG][*3H%&T$>5,[<QK':;,20':*T/A3$6^
MDLL9@CQ0O+=%Q#H]+ESP]GM98D(%M6)H']S^+<HV^5W!O*V7[=F!&GE002B/
MK ;DC?;=0_L5".J&'."*8%29.0FJ6RL+AB1$Z86;(4I!C/6#@>@2%5"]DH %
MC1CUUYD&][5N<X3+Y;M<Y!+WW44S=BZ$537'W3Y(71HI(0C+"AJN8^IE-I*E
M*V@&(^IBH8V9N+?T+DE-=PMM(F<NMQ5H4MSL^=_5?E3E#2:.KD:G9Z\3,-0<
M96QPI.QQU4U(#HDMCB9J=15NR!6C*6+6AMH=#GEK1-<G/*;W&2I6JIU%">N9
MU95;(2AIROW>JX_!X9-K<;D!?*6L[I4G.M:%NXL[1:M.P&I*T<I,?']%(4:^
M0F+5);LK,1IFU64B(2MQ;>C,)JJ*4&**U-;QX]<*/SZN?N%N4=*U1RBY<3@C
M4OMC5(4SDHD8)'ETBL,]_GUK:Z8Y(ES;4CC0H'2E42[2]%&(XY*A;SP;6MZ6
MKQ-0B12XI$#UY\J$.?!;D82.\E\-<:"5*T=OH>^)FLYEC)ZE51;A:XQ^+UJ(
MQ'EZBI*J")R)_>7MPG7O'%%_J:*0-2)JJ:SQ;6,$[I*4D9MROEX[8#V/]F7C
M6L<HSWAUAJI*V%+VJ?HD:EP3'+FTZS!7J:.;&S:EJ&U9KL2UGE!;[Y/OMI67
M#*=#Z4SQ14F+FHEB#36[,_!\9]\"S%S0B_6*#7L53]MM//'&UQR<JX#=&G-P
MC/K+$;)*#W%"14IH2$LI2YOK6JUE!=:5"76I$JA8<08>0J*HK2G3$@@L]B'\
M5R</&E-U9YC>A,54U4JC$B<Q1152%%5)]95%1U-5&P45 8-0#3@.Z.V QPB!
MX\6[J1.^3W8U+MRN_A"!LFIIK.=6$33);4GGD,"))<RAL3>XCO2PKD<X6OMI
MP42HU2YT2)O:)+2F3**$Z>HYGH0H,P,LAE]D8&WWRU\J"G6M]C<H8EA+3%UC
M0S-UH%KO6<])T+68H8WE>FB:UO1T3>A4YKJ#VQ>ZID;DVA'WIUM&!I:LZ*^.
MWUV?+2%.\<K-[*%NV'@TD36^DVC\V67M9')I5(I(F2,)CO'RXRI/J]F$UR%*
MWM@(6Y09&VMW&I+'W!P*5.2M*)E*QT<C2/6:IB8UQB77$^6>>-3R:F46V+A$
M&<X74E8#4(I'U6ZR]%*4*]^-6JZ'M>)3<S+0(3D-Q38B4I::TIIJFI6<B.7O
MKXO?\-=X1,9+)U]Q4EV;8I68Q*;;=U;YFGFJ6AA-4KDSJD:REL<<#I"*[T#8
M@J/+.14( ;!-<%1X5U.!=":E,<B,^G7QE;O%HUKA$QD%ZU]QVN*-*^V1B?VN
M3/+>$O:4UA-?U*Z'.,T9&N6)V\DM:DH;U1;(M5K3'@\E>6VH4BQ0".HVDLXA
M ,[D] ;.QI<7RYZT;D;R.TP8K6S5W@*=2JER!C-.9:$+4+ZN+-]*30I5H&0*
M#!>%Z%%4I6HFL"CQ<%2<E("=0)H$UHCN<>_V0A\DO!J60,]L7%,-PA::4L^2
MR]0UV5=%TV?T29_5I(C+ED<K@RMH;ER*$>RY<KB9:R%J7MS5GM: *U2:MAH1
M/CMO'#OTSUD4Q-NEL=ETUJ241MG5NK:Y6A0 Z*53Q+GPA A1-C5:UU?D4L;H
MU%TR*8*S6)QBJ=\F29P;F]$P)TJH$0WJ[\V?UC/OBGT>5KE["R+71"I;')6T
MMREP;EAB<U6@7'I"3%2-48DIH2F*$Q]1A)U::B@BHRBH2:*2QII!$QS'"$*)
MJ-373.?&NJ*DW551X8>_D,15HW%I;G)+=<Q6CJC3A,JG16CH41,E"!]%%"JI
M5'BU-2RJ0-ZBD6^NA"E?7]\9P6MUE%VE=E,CK4JKA-TDM>^HJ(A%HR4J6MAD
MGK*GD.2(ESE6@<&LAJ1)CJG528WN)B1T5#2:2%!929$4R%^7:YS_ !A<7._V
MNF%1](\W#:E#'4YNIL;B;<FM@WOCM)GHXY_<&(%I25R;:T);H64SL:[#<V*$
MY(5*4;6:L5FG($&\>*]MWAB=/S_K&?KJ'.-]D*V-0VIE>42./L<<:S68I_+D
M+"?AQ=ZZ"EYJ0EL4+4C [)/3D+6\I96I5*5J:JLR/'BM.WII$^!E%!^)A&0W
M7:YZN/MLK@SX\-I;5<R+JY@V-1;2)3_#C#CDKTC=SW%(H5$-B0HZAQ-I:#D:
MY0:E**J.,3>F3FHAP]CH[>KU/IG&O?'_ #<(F$U0)[NU7EN.4])KD*8:X)9B
MF1FI',E)%JV-4RP<;?E0LY&X%K&B1)G FX%#XYTDI%R<Y6F,6*#R:F&LM&-0
M.;AKC,!SVY"C,+0M4DC.K*/I&M*UFWF?5I81IU?24$J,5L2B%ND;H726'IWD
MUT421-+VRY:VM&G>4):^0I86WE]Q0K0#42:C*&&TTM^H)',W:J[1DQ-1'V[B
MWO#[RGMQS(1<TE354ZUP<UO=')(JCRQK.H("A B8O9QC92#U0]N[B*]*B#?G
M9^7L[^;:1NM^6N?.UN%Y%LWQZ8I:G>HJN2FL!328O<6]')6HYZ9AK>4BM.F2
M.312M(7*4])"^A)Z:A"J3'F4F@\>/'?$QL=(A@,> <MPY<(0#N @ X'EG8<#
MX[[>>_"$9!99LGK.P2A!<-[>9$Z%W(GIK*\OI;20M61!0_J#XQZ-.R)43<F0
M)FPPM(WDE)23:4:<D5(&*:C3C40XU$;!PB8R2<-DY47#LVZ1Q\>4T4;I%)2I
M\P(BFGV4[-:V"R6AG7/*E2E,=@H:Y(6T4HDK6J3%&JUM!RTM10G+IHC3QX[C
MV-$9]G;XUTIJ(UOB8F/H4T5F)SBRC:B#*RZJ:#Z::*ZB:Z@Q29316 T5C0.*
M@HK#NU8[H[#PA&763;INT6\:FRXCL[/TL1.<L3KGI]H;"G9U0ES!_I87!64R
MIT;40*M@!L.*3H4B8@@BHHFDFCN#32B2STT'>U?7X,:J935477336)=55%5-
M)@4A4-%0@(!6%-0#34-([]T0$!Q@0QPB(R.Q[;/&>#'-MQWEZD4D1S&X!5#Y
M(*&LIT=8^$U?:HLL,(94J)L3D&QRILJ1ITJ1/20E]"544%=%0BB!<FSMXZN3
MF?7&O\(F/@>0[XV'?P\^$(FC/+%Q:Z=VYG"62_< 0/!EQ3KQ/,>9JJ3+TLC@
MK@B6W+C&5SBU2="XH(*>TTFFT""%,N$Q52VB=4D3B)R(#$ ]+^/7']W9T@*Y
MK'X"AC%^4D1/3L<EM\TO:BAR<E+VRO\ ,SIU&F%E5C+B:E)C G;TZ=/174YK
M%A# G,2G) )KJ(0>K<GIW:ZYT'<8S:4Z'+W.#_'HXR7@=4C +0*^8W1.D,EJ
MD"YYK&9@\,9,=,E!Q LTJ4/3"#R0M)74>K-I@HW1N%&@;JXRTIU]MX4SYL_7
M)NQA>FHAN],=C*+ (Y-#'"?))L_R!0FEB]>JK<B9892<PQ^,GJ%I3B^.XGMH
MK8Z<"%:6G3U %1:0ZLPU,<8?, ;T8<V]KFGJ[HQ^JPL @\*FMG+BW7MDE77#
MBS,4P)'9&VL*^IMM:C-,:INK9G"0UUO[^BH!6[2I^)%,FJ4MK<>02A+;CJ:D
M9N*%LR=*'*WMU(:.E7#TMVSFBB4RZ)WWA$0:)E1,[@GN2(Y$L;6:&RQ9%JGN
M4MI!<J31UR+7/# L1/+])$#NT&5/%=9)2-Y;TJL48@USZCW=G@U;=89IR*:[
M'.]HF2=QMV>6JYZ*<'G'HW"0L#4^().P3@F*R%L<9.YR1P0*2DR:I86^24QW
MK3.A"DLZA)0B3THE1!.F5=2YH<[^YHQF8V8A:IOM'$%VINW<")M_#7,$TBC(
M1UEN$M98ZT2^-R9>R.#M(W-A3QQ$0[OR XIPCCQ5"Z4#I4RN*%Q-6*R#>._[
M8Q>]Z]UO8X[ZYB,F;='EM'6WSM;AOU;Q$(\QV[='!Q?8JCMZD?#(W+(W#F=%
M3.!%6OCYMJ*&Z*,3@B:4[2ST*Q4A34\4HJJ"E*&>?N&?K[1#]W@M67)K<VWA
MQLUC+:\Q=U909UDW:TR]AEKDBA[Y'%2)Q82'-EH7F*6QR<GE,C0*BP3K$!"F
MDDQ,F-#A&3W;,=SGNY0C$PLS8B4O\:D*G5%95>E;(5%8VV)7N6&UE/R>W3?2
MSI35AT<N?'*3*>ZSB\N+TTEII(G>4JA+[9,C(&LHO'C/K&+\OMM;P6LQ+QVV
M)Z(E3["G08S?6,SV-3M&K]8EZIE<Y,H>3W-T<UKC(VY^2SHQ.@<V=<I/:6LM
MCJ):G1B+6,LS2R 3S5%,:_?IXM[8R20#4?@&>F?;UT,.'/$UK'6YMDW1VN#"
M6^;6SG+VG:6]Q<F7WC=G&16Y>X\MBK:GJ7$*D+BL3RIB?U2,A,<<<D(;J!2T
MDK4Y_$PL_,?8881J=VM\0E.3,Y('9O.K/+*7MJLA:C-,2GF)5-!2E-683740
MI).3G!36(EG%&%5A37152"(CD>$(.$(.$(.$(.$(.$(.$(.$(.$(Q+4,PSB0
MVID2.V[U)V2;%&-BIB4Q-Q0MCJ<<6XI2U27UAQ)/1BEK;S59AQ1U-(5"5153
M6%=%--2$(=);A=HBPOKP7%[>&/4?8V1_8F!&LB+&LK<Y*5*6M(Q+W-\.N84X
M/+4EAR4'8)60@:/;#H^/2)5%41C40>0C%DGH[\B7SR-=>R- ELMUO)[2QY4P
M6]C3Q+G)#-7":1^4LR=]!&8Y751I(ZTHR6^1HJ%*5BMXX+5Y"'U1Q4N93:DI
M5*J519I:M$A+Y@ 4 )T&K."&U[<HZ$HNGVB;H\GL V<:XJQEO,,+2O4>86IR
M.$27QMHDK21[1N"E(1Q12QIW%PIE1Y*YQ3E5)FBECH6K_P!C8K]WN?WQEPV#
MCO\ :37PQ%6C9FR6:H99IQDZN<1641"\!*HI&C26[:&!*O-34N]04OK*E>9.
MK%6W5):BQ=&FM<U2"AN2J1:59JU:B553X\>!T@4LU4W)N=&R'98PH+:9VF=<
MQ0N+\3,O=A"7&%#@PHO<M51)IA70KJK;RES:XQP8I#D[36E(?W=.9*6Y1(22
M5I[!1ZPO1IGCQX$.$:CM)RSJ.S4]D;7:1;K!53>U:Z0IKSIF%7.W,Z8,DX3P
M4YM:H(>Q&DJDDB?&PIL/4R&A[%'(41S2R'LI-*@Z(QM4!#:H>%J#4N+> U.W
MEG#$ZM$6I$(XD<M-[PO*DA4=N"B,8*$485-JIU4P]RKB[NH,?2R5=3DWO9"4
MAD2%.J1J4.*PGVN28330:G1(8@B@YGJ.5,^_E"O$-^O>3)X^Q/5,MC,?401U
M8&V5,LAB+?*B9.XSV*D,4[G;<:G=%S>XL</6/2XZ)HG%Y1F)&94B='E[=W*E
M80B&O4'U=S@/XY"-TF#3J-8;87P:&^37-E,C)N(@+M3(6M'!*Y,$.KA\3 LP
MQ&07'4B]D0RT7FEWI*,22A:GI5FEJ#2QI+K1  +5 IS9LLN[(5C&F%GUE2>4
MF$R-?>>)LQ"Z*O:YP2.MN*#V]>SQZ5.\UCK&F3$*6:6L<K=FJ&1Z.G*$S*D;
M4T@75*T1#PB='(YX\>/N,PH4G1G9NXY:7RAM=*1EUEEK#E5WO?!'*%LB=%")
MIG1+:9)X\S&I&\4;6XN[6E0()$<6J%:MK<TS8@1%&+#&= 0>W-B18J1&M:^P
MMI[H3">).T);)DP(8X\2Z01!$W3HE8Z(6^W:5Z=AKN=<P3%[@<)[:S(WLBV-
M%N MRWEL MZUV4G^O+&LXE>;Q!+ 7.K 7?V9>]VB0'<.!D')#AM=:WOW1OVG
MP_5N9=4LN[[8O36A(M])4L84N;I%54@7.)<O9U43<K@)&I&2K2SLZ*JUS6YI
M&Q08PDTM%:RJI2XN)QB<"]<N?M\-[($!+!P;5!+.Q)][WKG''ZK5FJ])<V#*
M+,$2I5;-%"9&JD"&")(B9(7.8TKTU/JQZZ7JP;F_T,3%>?%O6FEW;5TF M"M
M)0G&(G)-,&!NW:[>*UY7CNFFE)?XMS1K[JO<O5L+C;O-,>E2)A*/BTJ)G+\)
M3<:ZHVQL?9$XA%#VM.J?7,DA,YE(B%J9K;#3SRC,07I7MS:A^^)*6S!Z'6Y;
MO]>M>A7><]6/RQSY/9YJE]+ 1"DK>PJ)&;%BH"X.;FG::5CE$ZJD'?;WJ)T&
M.;FG/E*]89)G^KV"8VHHXC*6'R2V1-[>OQW1 3S%R:DN,AEII84.L8"C5:_S
MW<O*2[:% 9&8L<-"D+4K#45V"J4]*XD\XM28WN]K5332O4.9B(EL4)W.II1*
M4ACMZ^M, OK?/W-ESKG @ WKU/2Q;EEG#3V?3:@WO3G<6F2O-QXK=-U"3GP:
MF6((@OG43JJ84-;.A.<*VD(G(EIKR4K4U*Q8BF5 <XG,[>6J;FE&M.F#>,KU
M-,_&<+([U=H-5-IV*FN>#%:ER:B-TP]+;\@U,G(@=-$*%O.>E:HMQ)6W%J%1
M<^NM(V*6]K(.3EENJ!8E]GP2U;MIGEG$\(I4=I.6OWU--*-IHVKU(5PZ9AJ4
MI<QD]4NH/9C'(EF2@6A/86D79 V$M!ZJ@UE02.AUI:W(TTHMP3&TFHF]O24%
M$< 7R(ZTB" ,P>GCV<XZ'+X7J@<Q<$S-/[CI')IF5Y'YHD*.J$)DCE%$\<2F
MVUB)\=)0MK8X^O2IQ)3(%"HQ"J+8X^ZT.;J2X+R70 ]Y'=VGUP(S<&U-+OE?
M[M887355<@+2,15UB7NF8)ECX0<ID=%!#^Z-93ROI975W;Z'5]H:%[@W 0H-
M: >W8$%-99?KM6?1%!V]N?=$D,;@]#3Q7PQA?+P4ZF7F[ER6VV;E<^)QQ':5
MTKBSV0V0AVB;Q-*F4%+2V1A*YMBFAK<D[N7W7-_DJI8K6G+*F5M:4;>E!W :
M?@_9>_JUB.%Q4CO;O#VU!OI#)6@1W-1.5TR[B.[J](CYNA600]T3,*8$475P
MB)G*VAO!B1HO3(&R4C(4Q2AUH/=C:Z3*U"Q26)-8 7KX^SN>#-I6S'.YIXSC
M.]3-5Y_:%K2[0DS<VHR7-X2FF-5Q@IBKCGMECH?R)&H>32W%N.,C=;X8QNB1
M.Y-Z=60<2I0>UE#&J3S "[$#1Z=WX_<N+DCU\Q1':<B"(%$P2. RA_F8S>:Q
M2MW9G&7,TU]B1.0J#6<HQ8PVMH"(FMU3.<"N5RJL\IT=4+13W:T&%7(H^II:
ME'KRT/4O-8@;A#9JV7RL%K"KETPQBHG%+@>U*EPR0M$70YF+#V,E.SF*3E%-
M1IXMI!*,#*ZJ2"Z*   0C6.$(5;4Y KBRA/"7^U8.QDMBSG(%M)"65NC$U*"
M0ADE,9BW5I(>FMG?@IEU,>-1I7@E2C%90GH7]QJK7 *(M4^.7LU<]D*(I3=H
M04[/"=LKF"YID4J.4)U4@.M$1[.@OLUB943>X)F8U(I9)'6W%O+TYK(VO-1$
MR0"3$1!A2NLI/%?'KKZJL;F)IJ,GY: _9SYQJEPJM:S+((TJA#HD"'ITT50.
MR1Q*@ZHM,H01:*FNC@[K'@] YUM[K(#IDB>EQ+N8L3FHV%0V)!3&K#%$^+^/
MO@0"+]E?'@=F+DN7:*O59J-S]I-KVTO2Y^C"1$;9\3:F V)26D!GR A\0'N%
M)4K-:6J(4MI:%K<JB%BM_14THRN(T\=_KU'JB'!]W>W@Y#D882?%ZE7_ $Z1
M5O%HGY-W7=T3-\G.B4GB32NC1-;$X$^]=2II41<7IO;5=+>[TQML6,REPDIA
M+8Y*?=FA;0=,'![33J/8:'NC)II%M7[72-;,Y7DECXEO(]O+"J02*!L[<XVI
M.01:A2R/!13BWLS(]UT^W*HP8\Q^6-*50E5)*T*%Q<DLE2B4CZP?M.E+4\<X
MR"7'I)#"Q*G>MBWC6.TV%BNL5NN[;MWG;@Z468JBUV/>2*267T.4CB\F?G6.
M.$80*SZB7U;-F]E)2JVZ,/*R3%'$IU4D.5MK>G,96PG$*!87/3Q[3 B]06;/
MK;WQF$^A.ODM'"$L=E,J7KTYDK;G)P]>;0/3MRRY5SU3A)7@]KD\9:%[O\F9
M]O4,(CU;(X)S76LQ,0LAZY$>ZE9M0EP&YL3T&=O7H\11P'%:NQ:FI;+MRC](
MVZU:+(8ZOBE3=!@?&^*QIJ;V=MFCY*%TL7J+BNSLXN#E&UEWF6J.BC@T=A#(
MH(:IS4\-QTKF5!CS)Q3 H-Q?FQJ:D./=TC(H ('$CD64V35X7HY R#%\HHZS
M_* IM"A]=2-[!=)1;T@%"$M:8[-3+.SH[3WDM+BKK//<4#>_5>B]<4F*#59!
M0GG&'F&5F5PX(T?,T:CUOWL8Q(<D<_%O<.D2N%AUR-@M9I#->^1'ML@DJ9R)
MHGS%&TDP@RF(+$Z>LJMWF\KJA<C"X=8&J2*J7M:OC=36\0EXA!9:Z-T9 I_;
M37KZG2"W4/$E(S4DCDY]W9;6[PS&EF+:A6JXBX^ZBV[A<<:(@K:"*IP_,+ZS
MRYS<%$=<D:LA$@D[THC9$()+<8Q'C5);C*Y:08\OTYD:I6:U)"H<.P+AG<6J
M;:O31FS>!#&X/,?AXIK'9;_1O48X3&X2NWDCDZ6#K[:VN1M2!EK;U*I)(VRX
M$M5S^B--B1ZB+V#T]10^-IE:TV5-F41?HFEQ0JR#:#8*T@MQ!\Q5Q>]/ +Q
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MI&76[CM]52QBC5VJ+JQ)[1J92R6I77)?D)D!1IC9*TEIS69U:2Z'-33654F
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MC K,R6,J)VEBJ=6QK94ZW(0O):2J,1Y@HK)5%1Y!54"F@ZH*BLTB&:LU7>C
MX/"(PBL+AT8?RA4%\%7(K5QS %*,"UX@=]7KW>,JEJ&%PUS7PU4U:Y+[6[MS
MJINK9Z"0"+V9-8XK!T,#.;@62R)+7-Z6G5R.(O2VI0H5DT5B/K7< !JIHIII
MI  ]#8.S]FS=E2IV(P4K$39V(7+5,65!2$A:@%)"3H .PF]02.)1226HS 7
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M2I"P'\T@H5)4E7FE7I);.*03Y.0F[':YU)!=)1=&BFX%(4T=WNX"W#SL !L
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MP8\1$..A8ND[&',*E%-KA)'=7L=^4>G]1-7'%8FQ;/34LSOVQ1?LBA^^HU=
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M!5Q[,GX%=N[PX:1M;";;VGA\-B>(HE89>&F!!#%06<8L*>K)X"0P+MYKU?\
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MZ'TI04HY(OK,% K>ZUE92A(72EI)I'-0HS!/"JE->IMSOV=T(=VG6?KB<3\
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MZ:?N:3QXYO\ 0RGT].8!VOX#B)6X4&NY9\Z@5]]HE_.=H),^7X*2/X;,RO\
M7 ].+G( \O)K_:*!U=\V:](RF\337%/)RVTS9AH/Q%XI),Q$?Z'2IQTT%Q3&
M_/+$Q9VQGEY!C?X<4=  WSF?\4QM6_VLRE3K07U'/5+K)3SEAO\ HH:-URTB
M>3 /[ ,7DSMGS?L>1^GP^&^V,W>96;B!5W&3/;.QTZ<JQM5\Q)(IYM[GT@V@
M/BE8J-V'PYMOK/'D'U8\O <"/2V=L<\_(0^?/Q&G;[4VGAW_ -3D4L[N/O'2
M,$6_#UM$6]/?X&2?']^>^N>O]MN8CGRVVVQRWSR"ZXCYO!@M^@X9S1_1+.X
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MH4'/ 00.UA3K6P>T6_<1>W%X/&G;2L9Y56)XL,G%RTI6C#D422E2QQN+))2
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M=V^_Y Q=?[67_B%G;J\;59,Y\Y-;9&GN[*4AV.U,P&I73L'V.:;176$0$0R
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MEOXY\=O/./<7^A[4J*87$\[RU7#9._8XRC&9Z!%!5%@/V@6=NPYM2D5%[<#
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M]KY4I0?FE.\W^(6_!_L>\1.@HA[W:D0Q_=>:H1VY;W@DG@'Z=N+K*_0\"?\
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M-U_HG_\ 4%-;,"E:/<>*Y0I,A_#O3>/,?JL--GAM]U:/^/CD0Z>&=\<>XO\
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M>U,9)8FG]LD7&515[DU>/4?IES]3E87/]YNV?T>YC+C]''R-MCZ6VG_/XO\
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MCD$9*F#T;E$VRHE^CTO735.VL3W672XQEY U-2#QXZ_;6T0U2=6\>SNBLK4
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MNIL$^D*2\@!H4XR%0CSO';K;8F[6VEM#!S=E"7M!<I7!B94TSD"5AY4DA2D
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M \>/!^"WSMOXDNP5LU9 T^5E%^R@I?LCEGPQ?J7BC9I\OVCN^R)'K_\ 4:K
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M<L_57Z;,[#C\:T? ,\QW\,X <8$./<4WQ/:E_P!&Q&;WE*+N]*'O=R]\)C%
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M0+9O7I4-RE!/DRFX021^T=7L"=* TL<FOTACCM--'X]0@^I@.7/,$9AR/S@
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MJ'L2+*%&TT@(Z*8*!U%%7?HS[IHPJIIJJI#-/,.]W0_0&*=OZ3_1+;[$@_$
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MJ_\ ^-RP7JWYU/)[7-7O8Q'NXFVH'5*/4=1EQP'KR/;\?HX^^]U!_DMNX?\
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M)E(7,7PI(!(2A*B6>S/IG$A7!V:Q1J@H<V^L?5U("%*Q-7L92-&P4F".]0@
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M:DQ !$TO0%(?04!!LY=Q;NCH>L<?VSW5EMM\FNFKKMM$9!\!W#'41^ \;]W
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M(9\? ,@/0.8\5S=#YO:M6^3EYWJ/N';<T:"WE!R"3_\ 9J_CW9H [!EK7?\
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M*D2PHY,HHI-+H,II-*KII,HHK  JII$$(Y( "D II  I          P   ;
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M5>\:B_ -6!IV>SL[+1(:@!"FG/\ M0'Z0 ?Y?UY\7^8&F3@/]+,+,Q]-1N:
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MM9RB0(5Z<]0ZJ"4OJR!0::<L0]#<9'J+1!>O93H<_9G35VAT@II -J0IZX
MV'YMOHX1/2)U=IQ<:!6ST[LR^X5OG"XD><[QVM,H8VN4'0XXAZA4A"ZC&ZF.
MZ5N=%%9:5U@*6D&^A(*=<<<20Y*4396K5DAYOHTO:E[VUSB*Y%O98CD:OZLH
MH6B-+5HTJNDD"P5)B% 4#W*AH XJ@P*!JIS34-(58&JD1I$0$0$0'/$!*;@
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M*2:S"BC*R@J"BJLLNJJD:J*1!$-X]W2K]8^_A$Q^!Q:VUW3@D=6]$Y)0.)4
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M.S2NH$Q(O2554UU)U% #2-1=55%%0@%5(B-(;XR H1SE-(44TTTABFD   \
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M*2 2(BO)_&7WQNR/LT;"H+2W(LVE=9F7%KIF6_<9*=W(/6N)D=O#"S6Z2L]
MPGV8WNCD:20<Y4TMQB$A210M9$;.M,4*#D*O?PQO7MC.%O8_Z7W 2ZU;_==6
M=28G-.4.4BCKV>O,(4R\VNMSK>HDX Y5JD4]E;4IJ6TG5&)7(M52-#L@0.*9
M3[/'AND*\N[[XJDG(*2D$)B:0H)3DED%4!RH**HI++I#RIHI /FX1,?;PA!P
6A!PA!PA!PA!PA!PA!PA!PA!PA'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g425213g01a19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a19.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1L$4&AO=&]S:&]P(#,N,  X0DE-! 0
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M;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0
M   !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "
M4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,
M8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M 0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B
M;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M  !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L("!D
M;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD(%5N
M=$8C4FQT                4G-L=%5N=$8C4'AL0%=            *=F5C
M=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,
M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L
M;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14
M;W!L;VYG       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F
M       .             #^    X0DE-! T       0   !X.$))3009
M   $    'CA"24T#\P      "0           0 X0DE-)Q        H  0
M       !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9
MF@ &       ! #(    ! %H    &       ! #4    ! "T    &       !
M.$))30/X      !P  #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@  #A"24T$"
M$     $   )    "0      X0DE-!!X       0     .$))300:      ,U
M    !@              ]P   9X          0
M   !              &>    ]P                     !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    ]P    !29VAT;&]N9P   9X    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   /<     4F=H=&QO;F<   &>     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    (.$))300,     !!I     0   *    !?
M   !X   LB   !!- !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1" !? * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
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ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
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M25+H]C[,/<]Q<=[M3\93ZT)[5^*XRU [W^#>7$\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! ?_  !$( /\!JP,!$0 "$0$#$0'_Q  >  $  0,% 0
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M$6@/._:(88S.R9]J9!?_ -)<X(290PV@$),@T D 0P;4&;A.FO938'B/$!W
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MQ_U+O20YP&-<'JVH]"TI+]F.6_':NX[%D/T<7N' ?6_1OMQYU,;AMN.=AW#
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MK6D#.6ONK+RUC)2JO03&DF[5_0=/P-S99E+)P4*\16E&802S4JJDG*>D053
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MPG?/&HINP(]CS1X&]K Q6-OSYE?@[=S7IZ_P9]6L0SMA$&5KP( (0+.RE"
M/-. 8=^IFIR+/T(3LQWXJ8A?@A^7?K'+/T(=RK6[5:+:?X!ON3?,.BB*AW'N
M6-OQ<?;$7$[Q"8:^(?[W9CO@,>/3NZZUKG(/QLU86FH2.D*N?M>CS7E[/\?G
M%']=!,$O0%FV//J,E?GL%]B"WGWJ0W^C6.LZR5/)]V^K"]%9 ]3Y/_A;#^E
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M&H&HSR4L;0=H?9BK[_5!!1K"HRR%RYJE(2)!9J4J*;R-B$HU<YQY $J0JMC
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M^+7'R 3_ .H-_P!EQC .P1V  X#&LU5#ZM+/Z%IOE!&)=3"GBNN[), %3B9
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M"G-_]4V<,\(Z?1AGJ<8[53/LI0./$?R@.XTS(]-LY*&>NV<;_'C7"S.BB\N
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M1FXO05.X>LR>6%3DPX,)<@7(;/C  +$&7;J._N-77K7RT)B$(AC<L1(,:8X
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MN(ZV- VA"U-&%MS!E[ L7\E9Z5="%W).&LS.\S-2OMU4KBM"=K@.;;4" C@
MJ=;N\6)O7_)\>MU]"GKJ_P"'XI%X88MX[9><O=$^H+A)S[Z_[=:C=P$Y"P7%
M)@ P-,I9'PQ%3F/5U#PSOOON.5=)[?"&9#_Z3::I_CEGKD[.VU81T,>H,^:?
MHT$G#/[UBKO85XT48.!W[;2TNX?7+47R>@9'U=P;#\F=9QTI?-&UP^('],+
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M:P\_(QERX=#S16+I227IV3BWY:?</$#GF8T53MI1($DG1#$3*&B%YM[.UBO
M5)PI\4=41=GJZ;UQ8NB[_<.\U+EMJ-+T54+>T[FC)^%2@96DYV!-+!*^;J,D
M_P R*Q[U$[82D-@3!G2LSB@#2% =32XN_!IXJ1?"KPSSMI(B[,]=ZH(2XETK
MZ5VK6]QY2.A@CZ6.*$:VB(:!A(=X=VJG"Q$>@9! 'BJRZXJJ*KF%0YA$C5<#
MVNS[OL5-^.J@*'A;<VBD8>D::B7Y>+?A(2(]C8*+9.DTU+^40F)".&S1-4A
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M-.D5SFI<!_LUF/\ DLF58^S!']"5QO'T]&?@AVH?R!KO,W#\3'BX@X "*76
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MBI@)L] [M>9%E'%NKF?W+T&BE8^/;+?7U9W^ )[_ #F/_+X]:ZZ1/5MVW_\
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M0O[;[H?Q:E5K=HB:(FB)HB:(FB)HB:(FB)HB:(FB+X%E5@6.1(""4B91R<X
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MK;CT_K$^,X_+QVUNOH4]=7ZGZ)%7AV+SE[HGU!<3-_?-0SMH\]K34;> C'T
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MP 8AF-B(SMD86>C$U,U[YU4\Q3/#!2[R'=BV=JKMVRBAR$4 R#O]>(8I@$#
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M  >NX  9]>=M<=5A\>=OV3;6M1V ?8.H-#N*E8W'%]]L=<4>\TPEW#U\R;;
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MJSPX[+V]NP!^B!?KD/[;H!ZP$1SUWSGNU=NL\QQAYI! G@.<'.RM>;WZI,X
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M:[+G\(9UUO2'Z=D),(WXS&YIE4]#L[7*#X0EO^.'VE7%R9\HJ.<^^2]6<F#
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MYJ>JUEC]*'/[*R"^"W[5>R?WG)_Y_(^S\N_OUI'.?UYE'ZX?T(%DEU_1[+Z
M[SM/. HK2?;+?7W9W^ )[_.8_P#+I[1Z:U!TAG\FW8;SM_:]OW37E_W07K+(
M9P\D1L]./MU>"\U9W =E[>[J/Y_KB #X^F$.@!D?$0V]?LN77YCZI'CYHK,<
M@!7,W_U39P;;.S#U_L[,39OL)ZZ7]E4'ZHB0'_$N=_Z(=W\NN+F3\G>98GA*
MOAQ6-=!X_.Z_@2'P;VZ#CQ4-:Z-CB JD Z#<R6SMG?W5J /Q9W]74=M=5;E\
MM$XP6@$(;]^(@O,5#[F6#WD/GK:M6/.2V!PG XA;J;;L,QEDW/N\[MG1L9)Q
M<='3LH:1IJ,&(=2*4<KYE,R3>!%ZF*A@,H5H_>,3*"!>7R!W)\B#<VMJ7B\"
M[65B089Z$)A-680DN^)]@7NV/*-A=+.'R\<(]$0^< 2#%H!@2Y8F$2J8FP59
MX2;;3+!-ZV=LW0"0!5%DJ#A%-4I?JR)5"9 PIGR3.<B)1$=<J"*&.$10D$'$
M%_MQU+G6=O96\)BL(Q& )D$1!Q4 PN'>33\5:@[6P>:VM ";H:IE>['5B?'L
MZ_)C6[>A3UU?]7O0OSMGAU+SO[HDG\'[@<??)+3IH]XE]RC?P$"(6$XI?73"
M8;^ Q4V.WY=-93TH>L,R-EYC/_S+,<LL*Z&!^;^?.LW:'_I8FYVJ+7!*L=/B
MGMJ8H!S$GI@2F$,B7R4?(G ,Y#WHF,81#OSZ@QG_ $G6L4&9E[LX0##:65TL
MHM( G1C)TF.'H!C[5@'1:199_9)M8 !'9VEK (B'<1Z4,3ZS.6P%W79<8U<5
MBSXE*_*SJJ>:%CI]Z1B5K*O6Y&J:R")#D0316(0A!!N0V *.1$YASS:QO-'-
MS)E[S;R5>[6[0Q6D-TTS(:,<6@SQ@PEVDP< %IU7>=)V=F6,G9X6T-WO.AHV
MT-G"/.T1"+469D(@',$BU9DU*R1[%.%W=H;>.G2ZKERYI6'7776,)U5E5&2)
MCJ'.;<QC"(B(B(CD<B.^O-&<%E#8Y:RE8PPB&&SO=M!#"*"$1%@O8V:UI%:Y
MOY)M8XHHH[2YV,<4453%% "3UE^*JSKIUD":(FB)HB:(FB)HB:(FB)HB:(FB
M*/?$K?J)X<;>M[C34'*5"P4K"C*/-'Q2[9LX3<UC/M(-H],HZ,4IT&RSLJBR
M1,F.F4P )1WTYYX=NJJ@NXQ&+=?@*M7%Y6ZKG</])74XP[VT1:F_O$CPTUJM
M;6@[C7T96L<6^&@;G1L_(2M/08M&U74W4QZ>KM=K#R$:]J.(6:O#H%8&7*N+
M1H"8C7A-,);:,2YPQQ.[@IC=G?45N*HX-;(2EI*(D[=6\1A:@@*<I*;E0G9Q
MBE2-9U)23][-S0%+Z6F)R5A'T[)2!LJ.W<DJLH8RAS#IR$%.0\M6&Y33T4KC
M.<2F , )1QZC&,(X  $PE('CCF,8>@$[]$Y]G/MEHD<Q^;F  #;EQUZF 0$0
M$R8B'+U(<PAG!BD$ R4!YS><O9P4(./P/TK+2?\ *[X1/7_=_H7\8!OW>KKJ
M/VX=CD=@\=80T.[G ]RMZ<4GVT=1#M^SU*AG'_%T4.^?#..O0.[6X<VB3D*/
M!K*(,-L$3X^"X3?&M,^=%+6Q8,[L:T#[55CM! S4-M?O,*'MR9+?\&._\6N#
MF+_]9]='XJJ\#XR#=%WDZAQY)]"S_L?K\-P_14V#;^&H?OV]OXM==9?/8_71
M=Q7(B^3/T?#QHO*]GB4I;R5.H*A2@%!R)$PY%3"*ZD] D3'!""0$P**G."BB
M0\PDY#"'-CDY_/I78"8<DRH-&';K:@)9R0TQ8NU;76X;KBU3;7]BNTI7%H9>
MIEZ+0K.D5JO02(X4I9*I(8]2$;*  )NS08/AD?-S'Y@ XH%+L  (B.VMXK*,
M"&(PQPAB03"0.ZA8;WJN5SPYW2I1>S 3[\P@'O1$  H]?'F';_Q<#CKS"&K8
M=CI:C(5]CE2L;OB\$1XC;B"(?"ET1'N#^LFP[;AD-]\C[1  SK6>6)Y2B^EW
M&6.SVZEY8SW).?MB:?'C=(05QF-N%%)CC"']3]PX?P/#X_BDU'\O9\6NWRUZ
MC@.J"$\="+4LTZ2?FYD7:;#LAL/:5Q<)AA+PN\29@V$&1C%Z;8@F@8$! >[I
MC&/'5O-EHL@WP:H8SLD8I3W[]>"LYE0_FIG*!_KB_P#Q>SK5 N"@A$^(RB (
M0 $?.#&$ $!,;S, R;?E$?#!<9[M=?FC._VLO[2T#"5'#-/5A3J6,='))SHN
MTS.PBW?M8?>LBU'<F?$1^?6RUZ=@IQ6UQCD+]T'Y?+C54-2=0/#GBHM,./@K
M7?&%]D=OWX@F'L_6E=N['>(8ZY[L:W-T</\ @]#AYUYX>?#K>LEYSZ5P^<L(
M+AX+KO\ DK3M7HJP^U>I'O\ S5'?..^P8^8/;JUD3YZ7O!K$\9[=FJ?>.WRH
M?S!N1U-X+Z."L<U#5^!P/HQ+ CD,F!T [X#(9]G3OUUG2&/C+,_XP-7[U9O@
M _8G0]*VO]3I0E^,0IMDKB93'\HH E*'U1'WX]# )BYY1P&1$-RAT]H=-8$,
MTZC"?L;M6]8#I1QN"P$C3#P(GBP(K-?=J%<31%C@]L;]FFWN?\#'^/\ TYCT
M^3Q'Y-;WZ+ #D;*@-/+Q&O\ J8G-,&%3P98]EGTH=6B.MB1CX;-_875'/9)V
MC]5;1H@'CFH:JS\^.OK\=<;-\?\ N!?=N3S%Q)L(CP?L58]6GZNTX>9'SX+K
M^R1W5XEP'I]#J-Z?Y'/]_P 8X'UZGI+G>,E?Q5F.J. *YDZ5PM=;1=FD.N0<
M:U!?A7R/%;:D #I<AN 8'N!9WUW_ "Z>.LLRXQS*A=P!=33991=>W52H7"N!
M_&1$?WR:2F1R.7KQVH&?IM:L_@*G?\W^+U>/X]=7T=_-V/Z)U']J/7SP5K+'
MZ5#N\#L]N_5D%\%HYX5K)_><G_G\CK26<_KO*/UP_H0+);K^CV7T!WE6D^V7
MR%=6>_@">P'3(^<,-_9ZOPZU!TA3R9=CQV4CV=O4R\O^Z!]99##_ -D9?YK1
M>8L\8/ZE]>W8!#T\N/3?/I=N/X-]PSMD?'5VZA\R8P?V8"1A^R '&IA+O5S-
M^71-ET2:."$&>(@LP6.%7\),J7=E6..(E_\ >;.@ ^H2%_E'?./5KBYD?)7G
MCK\>0L:Z#V_"R^Q$3.3Q+!A"=7"=#JF%#BNMN(&J!W^R7,&V';:JU/C[M_$.
M\.[JHYY9/^*-SLT8Y-O9CL=CJPB\!\]8QA^$MZ[X^#]>M3^[65\Y0NM;1)NZ
M<(I'MPQ65324,FF=9.H9M5(YR%$ ,9(XG%,^Y@$XF,)CE2$F2YR6MI9BZ"&)
MA'!!:'Z40=G&UZN:3D6W!TW99O&2X\DPW>/0-I9 Q3BJ;2T9@(H0#N!?5JN.
M=E@+EYPRQJKEPX5'TY4"'.LJ=8YB!*.B@7F6$X\A"^]*!1*4"X  VUD.0K4V
MMP@BB+Q2!F<(002"3,@UI66K9O1)>+>^9KW:]WB(Q1VA!+@^<&&B"28B6A9_
M.#]:IMVM@8MI;[IGW3JE[QZ,3X^3'B'XM>A.A666+\1+\5B#85&'$K _=%?-
M^XR'Z5CAYM.343.*CAP$"(V$XI0R( %,)YR'4 B9L0P(!TR/?C.V^>N5])X?
M*>9<+2%YM")S_2K(U,@)-N)WK"^AE_P?SX_AH6__ (I\:;&Q45."C?BGMMD<
M8FY[N#]K&/\ &X^/?ZODUG/2D7S0C_Q>]83(TAACB#2)<F1K(LP=:^Z,C^?.
M33CY:,=1BU%R[8\-G6<9XYXEKF;=*@<!D<].4=M]_P A$1 =M1F2/S2R6 3.
MXP'<\#L)4?6-BL=+1_/*\!A^E .7?])(\-4BLFFP0F^@U;?(8#W(08@/*81$
M/,40'H/7;IN.O)F<GK[*LW/OVV))G6,[E[FS2/YMY&)I\'W:0!(^3&,WER[J
ML "(AD0QX=>GKR " ^K&ND62+71$T1-$31$T1-$31$T1-$31$T11+XT.'68X
MI;)2MIX&N"6YFU*AI2JX2LE*?8U,G"S%(S+:<CE%89^LF@\(HZ:D*=)0OOD\
M@4Y#8,!4G=3@Y,F? \.(#O N/X >/:+N]6U]V/:%TZE<"OJ"@+=5 ^^E@HM1
MDO3=-OI*0B4D8]6:.1NNBZEGHJNBE!P9,Y.4Y3E\H8<>>RB EL7:DQV3<2K,
MU;4KAO!QP_*<+'#?;2PBU3GK5Q;]G.HNZL/&M8<)]_454S=7R+].,9J*-V20
MR%0.D$T""'(5'?F_7#E(IJV:N[N"DWHI5MSC0J6XE6WSX6>%VB;DUG:6$O#(
M5_4=P:PMT_3A:Y7IN@( )9& IRHS(+K4\O(O<%=/VI0<&;B*1#IY$PD[O'G8
MO@X1[R5%;E7BPM)?.Y]15W#<+5<PR$3=&MTRR57OJ K"GS5'&(58\@X\AYN7
M@U$GK$TDG'F>O6R:!W9EE@%91W2[>>_4H!&&).O#&GV;2J0<;'&WPS5A;RU\
M?3%RTYQPQXG^&"I'39A2%?*K)0=-7IHR;G),QDZ74!-LQCDA6/Y4B9AP; &#
M/+#@&%ZSEK$OL'&B@N06K+#M%<-3D;U"3B(XG[%U#Q&/YR&KH9",EI6+<1[I
M.DJ]3\])$M8])R+9)6EBJG*T*5 71BE4P*I1 $P$ ULC(V5#=LEQ6$(LB]A%
MI:3F(1:+ 2BA#><=;X--4>2A,6EI13<M+$4F 0U/:RJ1QP<6O#S54C0<C$W)
M:N6<=3C:(=+EI.X)$D9%RN1!!BH96D" 5PHI\$H"8! >O35.:F4+#)]C?+2W
M)AM(K:+1$1 AB!!<R.D9EG<;CC3:V9C,)$R'Q:1X;=\L9KOT^+&Q"'!:[H *
MY-[KE*C*J$,>C[@D5*"4E'K>6%7W)B3S?"("([&Y1' ]X=;9Y0NPSF%_TQH&
M**(S!!B/FD"DIC$XS=5M'%!HD .  S_?P85K)>2X$^+?AYIRX,]4,U<0&,,]
MI2:CF,N%*5\JP=/VM2HL56R:R5*@)56[F,<$/D1,!P+R<F#<W8YW7V[90L[O
M%81:=I#: QP@@C08 L-K!P3@HLK+R>F:F)F>;,7(HSSYH?&QW'O"#?)5X>\U
M0%3-*QC:64+ W#2DC4FG*.$F";L[6E4G:<6H)7@-N90!/R'#F$2FUQK:ZW 7
M2&$00Z(LH2 1!*,PDQ%A" #I5<$C&9=73SNK.G7X*\4CV@?"(FB;].%L9PFB
M":@J49<50Y#)E#WAU!I+RBH<PB B8YCB8!,)ASM@MH# 8I4)8#LD*!I[J*1#
M'$(S" 3"'V;-3NV%.I[#?%'Q)V:G+\55+Q=6KOVD\^67B56])5T09,6,6DY<
MHLT5J73445202.N8"&4,":1QY-LEP*_W'R]_BC>, Q .&:NZ;&?#<_G/.[-S
M*EZSHBRE8V0,%G;0FS<1&&)]$'2%2*LQ#T)UR XK>+/A_FK#V69,;B(F<TA"
M,7-2*+4C<)%"GV,=2J)Y)U)@>D  B35JBISG!P02+G2]Z=,3 '897N5O:Y*L
MK"QA!)CLX(G<'0-G&Y%&B<"<P'9IA9-GQDN_Y2S?R196%D(K6RBL1:P@1M"U
MD(BP+TBLX1.*8)F[-Q<.?%59"E>'V]M.R]9*L9*IFYTH]@K1MP%7,@48ALDF
MHQ43I0B7*<X 3WY5/?$4QL  $Y&R9?+IDNWN^@#Y6 @:0+G2!)9B &)#%B#J
M)*9LY*O=QS>RI=;2#S[["2S%]*,G2 ,M$ $$:0B.NKJBG"%Q.62@;ZT_/RE;
M A$4\Y>QDY(ITE<!="/E6R0HN6*Y4:054*HD8  2FW*;/.8 $-=?D')=ZN&4
M8C'#\5$;2(F+T@3288#']DU9WFL?S*R!E')N<]A:VUGHV$-G;0B(@N6!T#*4
MW8D!I !BKN\UVMG!E!5A'4:2L:MEUI-%PX0EHJWM5+Q22;4Z:3@RP+,FTP8I
M55DR<S>&6(41YE3II@*@9X6&TXZN"WZ(XH281"]*B8+3<NS8B0VJL).T)X0G
M!$.:[J27G %.1)6C+B(KY$,\IB&I 2\Q<Y, '' @.!'&H,6@-(\@G1PGK5R
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MF($QS( +.#!"!-G9C4373=$F:N5,E97OV4K>R,+V$=A"(GT6#B$D"'2?]YB
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MG3D< &;PO::\7'#Q<BW-&HT9<8DRI%5"Y?RADZ.N&1./CT(]0Z[E<5:33*
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MV1FIB8HJI)>%+4,$]:5#'A%3D!.Q/E$5G$=(LP$IC(+$43,/,41QC10:%IG
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MRBUP?6O- R_$Y[I*&:Q;2:XF+FS=,K2<0R_-]//9,5(YW'<[?WK-1/X(![T
M$ +@-]4D@F@?GM.^? J[%97<B&*&SA@M*'1$I8O68:AWNR[ZN+8).^,>P\\U
MH:/7I>*MA=EK-RB4.P]'LY!^>$+&).OS-RF5<%*L1'.1 PB(8QIJ(+-J?4?;
MV*@P Z3@3:H!IVSQIQJI=>X^DR$Y2TQ3X%*)3%#T/'X*8I@,!OZWR'*( .PA
MC&VAG(TY*J!T'BAD0&E(M0SW$N5"_C"M<$\EPUA2M$L)$L1Q14%-3Y(Z(8D*
MSIYK3-?MGS]\";<!,S*Z=L@4 WU/RJA!-W:LQP6PB$5G:QP ,="$@ O*<G8
MC&3,R1"QC!\I9PQD_M1 $NYUT=JS?BI)7-HJ!=V[K]@RI.#</'5#U0U9 A#Q
MY5E'KB$D$6Z2( WP"OE3D\F.!$#B ]=M<J&TM( (H;6+3AB=A$U &X.XIMDK
M)ALW,'DX! 0Q8!IX; )=JI)PA6Y:P?#+:"#JFD8Z/G&-(HM)1H^B6)7R#@CU
MX(@N<S?R@*F(9,^1';WN-L:MQ6UM:1/&8RY#F(Q$ZGKB!/KE17H(;. #0@AA
M F-$ !^ UN^_8O'6DMD#'C#XLIZ0H=@UIJ<HOAR2IJ66A8\&$BZCD;K>Z C+
M\S@43M3.8E-R =1.'E,Y+JYY2,P:!BD,'.((X[]SJ@Q/$ !.NDP\=AEB6E1<
MW$];).8N'P8KT]0S&0CZ>XCTY2I5HZ)8E;Q4$E9J[#$CY\ (8%EZ1?,&A0/[
MT5'! ')N3%OGGJ54BQW!V,W$FU3-9;U,H:3I80$/<W ;AC]AX[__ #:*=$:@
M-H <;E"?C&MBI/#PU>Y2B6\H$/Q4V2FI\\9$LB^C8"+JQHXDY&1,F@ C'M6Y
M3*.BGR04P'GU9M(;72A\G:10!YB%VPJVO7]JD-67<^ WL6;V*7-0T?3!J?F@
M+24([44B7X>:I0[ 3N#"U7PW3#R&QUC*&3*(;Y/XZY$-I:0F$Z1)A(B$S4$%
MMS@=Z*-?!!;9.FN#WADI^L*0CHNJX6S- Q4\QD(9B+U"::4XS2?>=\[?F!85
MDU3J<V<',(#WZIM(K6T)B-M&]:@C "M6H-G6J-&&0,,/5B0212C<T75V9MFF
MPXG.+.8E*(8-Z?F)6U@TR^<Q++S"039VX@V[[T>0R'DRE0<IF16Y"X\N0^=P
M'""*VA!$5M'$"26<@8^TC=+!-"&9$($R"PPQ IC0O+6R^'B4MB$W=[A$?T]0
MK.0CX"[TB[J=VRB& MX>,5IEXD1Q)%!OR^0!R<@%YL !L==M6;<6Q -E:1PL
M0&A) (>LIL&X-BD,(H80XG69G/F8F=H4T"TA2X% #T[!'$ Y1$T1'B(EQCES
MYOTZ#[=7/.B#6GGG7$T3RJ7<.9JH !R!7EMVQ0[XYK:MJIX8J_BJ6H=E+3R\
MC0!(^/B89B+]PF2Y5*N9 B?*WYN4K!)RJ<2A\ #".0 =4VUA!:C1BV><P!EJ
M=^1J5LV=A>XX??5G#:B&*1BA!8@XDNP</43FI6QE$TT$8Q35IV#(H1@T*<OH
MB.Y@.1N0#E.3S?'-SB(FSGWWKW%9V5G9L880#)R '+;9^Q7+401P:.C"(9L"
M(6F& F&H!]U8B<%=KCTU:JJV=2T0RAI)6\MTGR#:2AF(.E(EU4BJL<J03-^;
MS=TW$%$@^"*0@!=NEV*&!Y0PD&9+"I,R95URX*U<;O=KG9F 0 :6E%$0 'BB
M-2&%#3:M M>J/'BTJ@:)C0H\G"[54&$V:&8^B0JI>YUO7S5N4H( 0[T\4R=F
MYC>^$B @'O1/J#9V3"( :6I@[!L6J])4?BBNUU-J;;R,(CB(>(PPDR#"9!QG
M/8),%IQNVN3J2T-',*0H5I,/H_B"X=)9TQB8EBFL$'%W>H]_-++F(WYA9-8U
M%==V " <K<.8>0QP&(H((X3#$),6D#/#"7,U3>;"[WP"&ULX8X;.,$/""0U&
M>33)JID(4=2I$4C%IV $2)@*8!#QV2B)2\P!^9Q#)A 1,(!D1'KJFSLX;,-#
M)V)H-U&#8^*OB*&"#0LQ##"  !#)P*/.<M5.L*B/$)0K*8L7=R+B*3BGLN^H
MFI6K!BSA&)W3ETYBW";5%K^9N8%14$H )=QSJ[=WN]L;6SM(H3'&8R1$Q$N&
MO$F>IDNOO>.,0WNSACLQ)H@".#@[JLOJL'0,7'60LG&S5(Q#67C+74(QF6+F
M$CR+-W[:EXQN_07(+<3 J1TDN4W/D1,8V=QU5:6EI:VIMHK6+2!+$Q$DR !)
M,Y 5ZIF5%YLKL+70L;*S\@'T0(0QA9Z49WP9L!,FB?#3;#T3='CA>S=#L8^/
MJ/B9CI>EGKR(8BA*TZ;AUL1$'6C#&;B)6;6>AYAH?R?O1<INL@(YU;M[:\WF
MQ@L3;1: )!:(EYG EO2 +B:F.Z7&[V5G%=[& 6D<-H;8Z,((,41DX#S,Z'8:
MKENS:X)#B^X5IN.HADZI>&HB^:-2R:,3'EBV#M^2WHPY'Q0;?5%W"C9T+?G$
M<@01+U.(W[*\WFQLC8BWM&B#1/$6U3#@2$L-LU>LKKDZ.Z6]I;V-F;Q 8/)/
M##I&CU!X/.9*]1QEVT0J#A:O7!TQ1,?*U!(T4\1BHN+B&!'[]YYZS,DDT43;
M\Y5<%.8 +O@!V'7&NEM;W*W-O#$3$^D8M(C'$B<NL!<6VN]WO%WBN]I90Z,4
MCL&Z@)#'>=@4@J&H^!BZ6H_%.1D?),Z?A05 (I@1XU>%BVJ:I5%@;E4!= WE
M$3"4P#GF[QU7>#'>[06L<<1F2"3I .^)=AYQZZU2PAANEGY*QA\F" "0P):C
MM6@KJ540V  SG =?'UZ@2 &I7U\"\DS;."H.'"" F FZRA4@,HJH5-)(AC"!
M3*F$?UL!Y\&3$ $#Y H?=5GVS<;Y=O ^-KFXT+0E%5I7$@51_'T/2\]54DTC
MC)*/EV5/QKB3>)-4%%""=51%L8$!.)$SF,7)PWPYYYQ4JWU0W:ATC.K6[^B!
M8*^%G8J[\'+S5JZEK>'AQIVMQBJ><5/Y@SDHB5D$XQ\^BFQE&2$QYF990Q2
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M/LU'9P/W.JMEE&J[@R#99LNLB0?+)E63,JF<#"4"B0IA.3!L\QC@4H!MGFV
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M7*9SXIV :V DP&!8;FW35%;7V#J6SLYPV2]_*ROG?FWE=\,TNC8@E8"DI%6
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MJ7E0=-*7IVDI*2AYJ+I:)J)'RDG/G: _J9RF1)LS3*;RIR,"2[A@)N<'=GJ
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MF%)(  B11 A  A0 " ,^TK[OHM6J_?,M]_'.G/\ ZEHI6Q2ZUK3EP6YMORF
M>8N:RIT2B8/@\P!)E,( .!$ ,&>@Y#;1.=ZZ9>MK*+,96.-75K5&<X9<TPT7
MJ*D5FDN9TU*Q=!*("\ K[SIB1%HY%<3*+-DDTC'$@" R^RM6EJ.[LQW-#;:%
MQ27M[]KS7FY%YP[2CA9[(5'9EZ[402;></96C7"ATF[8&J";E51Z*[A(K8J3
M3S9186Q&:"*+=%'D VA+X-SNIRZ-@2XVO3;.>&%'&*^IU,</[X(HCNJ;/.TH
M,H%B$W,U2"P1!4S = D2!GPECR-U YD2H@ I@! ()3%$PPC;3R^%-SCK7KT[
MHVI2$@A<V@1Y2X$QJUI\3G, "4#*G&4RKL8VRG/@V#%$! -$9N>WF6Q?1]%F
MU?[YEO\ ;&?T9TYW]/[9=_=HI6@W9M4("4US+?8$! 0&LZ<W 0W ?SR[PT1?
M.2Y]I""H9.Y%O4S*G%0QTZPIDIA.. $XF*_#F,(  "8_,80# CUT4--S-J<\
MUV!?.-RK3BKY?Z)=NRJE.*A%25=38*%4. D5.!ADA IU$^4A^0I04 .58JA<
M $@[ =_/.#(0[3;V>/=K!:?U!=6UI3 8;FV\$A0'K6-.Y P#@#@;TIR@(E,J
M"GO<F,8H@)0 P&A&FXEPVOVS?KP7.2[-K%3E32N50"JISE3322K&GE%5%##R
MD333)(F.=0YA I$R%,<QA I2B(@&BDR!.I>[*L50A5$Q(<ABE.!P.'(8AB@8
M#$. "!BX$!R&V!SHHZNO#7W=:\E,5[0L(X4C*BK&E()Z*1#G8S-1P\8[%%;8
MBGF[QXBKY)4!P0_)@^<;#MHCN[<]\]A]C^5&N+*F2:(*5Y;$[5@X2=LFAJGI
M3S5HZ;KJKH.FZ7GOU)=$ZQSI*%-]35'RI *??4O]FPXD:G[I*-&;OV"FHT)Z
M^"^ *AX?@G4ZG"J;3#4:11Y)\U14DI,@(HIMC*>DCO3.A55;)@W56,H951+"
M8GY  -0I;:>=W-6JM?=)8'T^E58U9:0*H3**7NA"=HWTT=$Q03.W&3.Z.\\B
M8I2%,4%@/@A0$^,@) -<^?# UXASZD;LVJ$! ;EV^QWYK*G,?Z2T4K7Z+-J_
MWS+?_P <Z<_^I:(M!NQ:O YN7;[ ^-94Y@0Z;YDL#W_-HBZ$U9V0,S;QIZYM
M>>,9+$<-(X]34GYBS52W0.@T*]*W*9$PF,D=1,ZA#&$2'#(Y*&VG#$X=[[77
MEE"\,2CY:2])V0\_<*D77>#(4,+E=8A_*%476\OSG4*<.<BV2KIG #$5*8 '
M3GGGN1MO.W7AME697>!4'#Z$XC4XU7:<U2H)B@A4*E0T>I.)(&*)#H$E5'9G
MW(<AE2"(KB?E65*!@ V <]C=R-U'##7+><9G4R]6%V+6   -S: ,(  "8:RI
ML!,./A"!9$"@(]1Y0 -]@ -M%*U^BS:O]\RW_P#'.G/_ *EHBX%[HVG<)'16
MN5;Y1)3)3D/6--B0Q# )3$$/2( )3%,("!N8! <"&^B@A^L'JYYHNG"M+)D;
MQ[-*NK7E9Q*S)Q&-?=-2X(L5V2ACHK-R)R"8)JI<YA1,7 )G,8W*;F-E)A*C
MMQ:FKQ1JXNU>[=AX%R_QI5%8!"?>U2E55I$*DD6B+!_4#>?I!M.O6K<QA0:N
MY9%X1\NV0(/DT4#KB0"&4*<#@?9WZ^>?$VW!CMYH,:S)FO3(W3M0@F!"W+M]
MU,<YO=C3)!44.83**G!-^0G.H<3'4$I"@)A$<!G12@W=M9S\A;D4$<=MR5G3
M1MQWW )3F  #<1Y>F<9T4$M@>SQ(7MHR4CIEDA)1+YG)QSHHG:OX]T@]9.DP
M$2BHW=-E%45D^8#%YB'$.8I@[M%+]DE]^B)HB:(FB)HB:(FB)HB:(FB+03
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/T1-$31$T1-$31$T1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g425213g01a21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a21.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1[>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'L*^>'0X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE-! T
M  0   !:.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/T       2 #4    ! "T    &
M       !.$))30/W       <  #_____________________________ ^@
M #A"24T$"       $     $   )    "0      X0DE-!$0      !     "
M   "0    D      .$))300>       $     #A"24T$&@     #00    8
M            !)(   58    !@!G #  ,0!A #( ,0    $
M             0             %6   !)(                      0
M                       0     0       &YU;&P    "    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P  !)(     4F=H=&QO;F<   58
M!G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '<VQI
M8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE;G5M
M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M
M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M0G1O;6QO;F<   22     %)G:'1L;VYG   %6     -U<FQ415A4     0
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M24T$$0       0$ .$))3004       $     CA"24T$#      4N0    $
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MW_SE=VJDDISL+U:^JYU!MLLJVU7,;8=VQUAO]1M>FYM?Z)GL6BL_&_Y;SO\
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MDDDI22222FKGVBME<W/HFQAW5U^IN <TNH=^CMV^O_,_Z3_0_I%8<X-87'0
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MJG._3?2W;?:YGZ/^78LC(%GV^@M< P79'J-+
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M8QC&,8QC&,9QR8.[PP1*4OT>C:N9/[)''MW8X@@6HVU=*GAM;%2QLC:-Q<1
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MCJDE&^SEX9V-:O;XJT*CR%1:=>]JB"V],;I&M- 8>$1"%:?[6D.SIXW9I)+
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MV=65!'#+"@D>FXX9(I<A12V+>[*,L:]BD+4/T4(W6/.^EL?=@[+]J*=FY8G
M,6R\HW!YS$++B,?GL!D35+89*FTEWCDD9%0%K2\MBCV7M*U"J+_X!Q!FPBUH
M6O3T$$0=ZT+6]:Y5G&I;-(= &11)IW+(U"HVD-3D*I!+7UKC;(F.6' 3I"5#
MJ\*D2 DU4H, 0G+,4!&><,!16A#%H.^FB.P.2E00C3=1<['@&(80"*NRM3-"
M$48<48$.PR;?KL!J906/6OA",@X._390]![^;G%O>&]"[-"]$Z-3HC3.#8YM
MRHA<WN*!:2!0C7(5J8PU,K1JTYA9Z92G,,)/), :4,8!!%O[F,8QDE/*7T!Y
M Z2<./F+@^BW.V_W8>@$-=WK*4<,3SA%4E=N1*$H$P=&\U\8@-2=,8I<'+;Z
M[+$<73DL:EN>79K4N;28='&BO*%YL_:Z(>^@^4W]T(L_R&S7D21QZE:.:9(B
MA-=UG)V"+2ZPIC*&ZQY"%C.)E&YY$_JM>E9(H>&OI-)4\F2)"&U"Y^OG,G=N
M_%SDG^/M#_3Y6.3XQFEN)?ON7[\F_/O\J.B\[ \@OWAV/Y=N?OI;BN8IQFJO
M'U]JZK_..9_T8><,^[W_ /V.YB_./7?HR])?S_UYDC_5C_9_M_G\.;<X(^\]
M+_ENMC^4&LX#W!]\7G__ *!NG_K*JR977GWBW37K]FQJ"_#_ .<#5W_9_!\&
MO7['V><0N_Z4L:R+,J""V=#Y59]-'M26T8,S.Q*N0PD]Z*,-;BGI$'T$6(W1
M1A)^R!'A0+ [0+]I5W];Y5G@OXIE1_#Z_P!;2_?^3=@2STS7V,8QC&1-\(OW
M(>3#^.8\AOT@Q_+98QC)-=8?&S!K_P W:$_259__ &YU9G^A7VTO\'_& ^Q^
M#_A:^QZ_[\ICR3\53F;\WZFOHZCF8'Z1T+?75E:!O01[H^AM $(.QA"+WTWY
MZ"$#0@;&'6_AV'0P;%KX-##]G4K+5KN_U5@<Y*9UU_SM&Y4SVY(72FF4?+$O
M1BFD[44;<,;=8^8G4]:GFN92.MI'.9 $A&<V&A<&9N,$L,#OW+<]#REJLUHY
MZNA-:TVAL\D0X!8YR1X@]=.]9-)#.*$+ )V]0PO-D6@I5.!*PM>H-=2W](0>
MG5)4@6D@Q$8K7>CQ!_S%%_@B;_J09%Z??&6ZY^6B$_HJ\V9]/.*2O[97WR[\
MW?I"5CEX\F'WK5GC([K@I/._:EJU')(E!Y^7*%M=']-%U<L03N.HWA@+#)T<
M1L**O*A6Q@=79/[BOHC"$#@8(\:(M>F),)\]?//D6\4/BX\F]S\<<YFN#7SA
M4O$\C-9W]CLV4W1'WJ_&.1/W0<KIZKG&0/\ +U"P^21AW-)9VQF?0-:NX/?%
M&DS6&0O*@]9ZG:([CY:Z&A552V!W76P'.W8S&)#&Z[>IS%6JSDBN3M2=T)BC
MQ U;L7)4$N;1'F-[JP&MVG!*X)5) B=[+WO>L\C/>GDYJUGHZP+$N&AU:&AF
M<MS*?I3,)Q!B4J= FDHHJV/(FLQ,[F(7%0]"1&,H"@*5Z1Q4(=D^BL(?8^/#
MQZ>/*^:/\N#U;4OY>5BYAJ=V.L"#4NV]31N6**YC5C&V@DIL^0+)4\R=MM,E
MR0-EALUA-)X#P&"F\B>VG;<8>W$F>ZZK^S3)%8U7U.XT0]0!#/W9VB$<=4TM
MB#NT,ZR.UW,K )2*&EI^I5"9M,8X&Z($HD)1H4RPQO)VG E&:<GWSG4ES67)
MZKBR2112CK7OUQ4O29J-AM/J*J329"D4(UZDR0*QV]9U41H3,D-1DH5($<B5
MO&U;DAVG:%"0*Y4B@WPMU[Y+P=3>1HWH2ANGN@*>:;ZC<:HBJH7&N*XT_<X-
MSA!&6T"H3+7M3U/'DKRK55I9M6*C=M#]8Z%2M+6.ITC:7M8]1U+Z.B3!&DE&
MC)-3C-*+,&G/V5LX@0P:$(D[9!IY&S2M[V S9)QQ6QAW[6:8#T'OJ^]I:\P&
MD+DG4=,3DR"%558<M8C51 524IYCD1>'AK,4I1[T!2G M1D".('O03B]"+%O
M6A;R7Y-O]+F$DF;Z,EGJ846/>M5]2.M:V(.A;U\-8^OV=YA3D#K>2%/-M4!'
M>QT2>XFN_P#L*PW^ITC51"Z<)&-TZSM@I5+U\?50!2[I$;NY+4ZXWT*)1IMN
MR02-(C;%;<7NM')%OW!*[HL*O[$L-7/F-KJ^(3%G-=(S"V)>VNKE*Y4R. "C
MX='8X4J1J4;:B%LI<0J,)/)V,@XL)I@!=S]N_%SDG^/M#_3Y6.3XQFEN)?ON
M7[\F_/O\J.B\[ \@OWAV/Y=N?OI;BN8IQFJO'U]JZJ_..9_T8><,^[W]_8[F
M+\X]=^C+TEF2,9MS@C[STO\ ENMC^4&LX#W#]\7G_P#Z!NG_ *RJL\^;9SQU
M9>?5_5[+TH;-X;R"2ZU\]<V.=:]!R5N62EP9U32^'C=H>@DCD6S%,[VSHW@9
M2B.1$#:^I24[7J5(3SW<G5W/G#E#\TVE<5U5XDER^TK[]Q!6E-)M+%\M>I*<
MPC5F(U)BIP!H250H,6&'.IJ;VO;NI+3JW'2A62 _+=<%?%,J/\']:R_Z0)7_
M *OWLU]C&27[;GU[2WJ&N^7JGOR8<RLI?'O3?5SM8T!8ZZ>)'))I4LMIZ!P&
M'N>[.ADZ80UXUJ;*=95.VMN:4#X__4D?;BI"T-_N@!=P27=67C>')'B5>8Y+
MG2@9GY')1S^VVM/8&W1X^4UPR3#E&R.F)FW5P">,,NC;2^2-XKE/!FESD,<D
M&VAF?G!0D1C>BV]<EG:_]F]MCIWL>QR^IY(C>O%]3=JRYO);(/4A3'V#)ZB[
M4[,I8#C=Q"F#+CQ-DPJSE:.1A:V5&HK$M'/IK*9*U'IA%,#8UV9ZN\BZ?E*=
M1N"'\4]_]#F2*#M<V]]_+/.1MO0-FTYN;RU^]9ZD8)6PZ0RY#MFVX+F?:,>R
M&IT9UGMXM+O:RO/UXM/+8WTDP]VMYOCO\I-G[L+R>]I6V%547(YTS1PPN=S1
MH6 KN>G!G"'4=M.)?4VTLVB.]*Q,"TX@C:Y5[9H>J-2+^B$ZSB"QN;Y7XT?+
M[&5SNF<%C4C?^,TC0I<DC2:VD.JE 2OM!.8K(;3GAI*7'$!,+2F.2$!P@"5$
MZ'D>6?T8=XT8')7J&S:CN[(E+8VX*&F01J14S6C.^,CFE'[!2WNC6NNXA8A6
M$#_X)J=026:7OX!AUOX,["J[^BM.(KN"XF4[R5Y(+0+:"TYKH9 N=87*@-Y:
MHU02G&K&S7(L"0 XY(J*+$9L.AF)S@!WL98M:T3'O/Q"Y:RM\CBWB\\Q\CC[
ML3M2UOC'Q*%U:7%/HP96ST+@ALP]*K)]M+,+]L(-,![, P;W[(.]:Q[=7E!D
M%E7C^Z2T>+?S!HF(-41R$:3N'#SN%R$[M,OF;\J.V0GFYZ?2$2.0(0$G?56S
MA'@4@$0  "S#>'[\CLG_ +E_Y??]!Q[_ &V^'_-K/F#R/28(PB%XP/+[Z!$'
M>_3AM[WOTUO6]^G_ ';:U]C-;4;YH-UK2E/5R^^*?S+J7N U;7\*>5#;PTN.
M;3W6+1-H8W Y <HL!*>:B-5H3AI#3TR<XPC8!F$$CV(L.:;6\G$BGE[2ZS6W
MQ<^8!(POM=5C$D:99PZ\Z<P.4->[/<70T\DF;&)@)#2)DU:1& 5&&FFE+0FD
MD!)*$?T1/>K87:,JK:;V%X@?*U+I;3S\9*:N?WKA%]4N,$D9PT)ASU'#O?T'
M3>XF[;$(3518=F&$IP$#WLD1A8N061W[-9;7<^BC7XPO+H!SD\*E4>;C%G#[
M^2C N>V)>VHQJS2IB>84F"H4E[4&%D'F%E:$(!1HM! *G*7SHMI*9.2+Q1>:
M/8BB"BA;#PLI]-B++"#?IO=C:WZ;WK>]>NM?!]G6M_!D_I'Y))2]V]>L^*\7
MGE\(:++L2.RIA3F\//8ER=M::2J"NE(',L,T]I)5C?8(\GE%)CU90FTU >(\
M)YQR5-^:9Y,G0IR2,IOC0\MQ3PN1+W-"TF<3N8'-:VM1[<F='!(@%.M*U*%M
M4O#2G7JR2AIT9[HW$J#"S%R8)OT'[R&3!QW%Q)?&!Y=M[9+,J*8*@G</OQ>C
M&N"6I#9J\%$B#,C/58<TQ]:4@+'H!9RX:<DXY.28-052G^KK-?\ <H?-)_H+
M*/\ _1__ (9,5_\ *(H@#58<WG'C?\LD4BQMEW%/ECV\\7.S>U,[%8EQS.9L
M6W1>KFZ=,E4%MTJ:TB\.Q[(*=-G)DYZDH)2@Z3"'O;QPH.NU?22;QF=')U6X
M@TNR&2)^%H,5/$]Z)[$?I<YV:!P!(@J"I.J2+FX0YF!WW(U*Y.()X]!)*.'6
MV.^4!9,MU/8,/\;7EGE$4;[%K>PTSPS\6.RUO>8Y%Y:V/JTUF6I9L>E6G*$B
M$\"'6C0)SE'L0&*20;$:&FG]75:_[E#YI/\ 064?YOOC_P#P_ASS$>0/=Y=W
M\S03FM)R+Y<**BS1/'6<V %N\;LFL$4[-3N3NMA[,8?NZH)I$S,ZAX4/*]&>
MF<0N#XE8E9>TNV,H:OB;<BZ6JODISA%3\R^<F5]B%5_'Z\8[SEE*]653 5[7
M$GQW)@IL@A,.O*Q!D$UW"I$[H(\S(2%K.O?-;/.3-:!V7%$5ZJCR,6!#Y;S%
M+)/XN_+LH4U,]&O,Z3HN.YG)CU!ZR@;/K16%FD4EEJ1ZE)H93-6X_;Q)@-CJ
MZM92UW<M =1[1'4F,\ZK?LLSVKQ1>:+1OM8O:MCX64[!HSV._8>SUJQ_7V.A
M>GLO3X?3U]/AR9UC><WHJ(5< ?0?,WDDJ)%+60$0?W]SX*9Z]8B9*_Q]4%U;
M(A+)+:C0I)7%Z*=E,>- J"]@3(/= ( FI3A@\K-(>0;LWAO]VOFKQEVOT/57
M*\@LN,6H"3W!0E93F_S+/6PVITTT0OJA&6YL[6U.#8PE>Y[>F,5)W)A(;B%@
M$"R1.3FE]F=1^;#IAFEK*JM3Q\>5^PX$=$W8IX+8O'*=&G<4J$9'C(\[,QR.
MQS4PV<],&2>Z"50H-$'V]KVF,-]@</.VKK\TFK%IJVZ^9/%/YF$[U.ZQGD-:
M#W'AI<2WD.DHBKLR(#5YR>P%)Y2,I6N*&J,)3*#2R-#$62:/02Q2IZB[8OR>
M5 ])J1\=/F2CMNL;4L40!.5R]-:WB#W)3DY2-(GG[Y'7:1/IL:1>IB\:1K0
M6*32=)BE2+:GZM38ZYPB$,K*R&#K&1^,;S>1GKZ2L92JYI%$^>IE*HX_2=^>
M$<KGS04YORQG<7^+OTG(,T8I<&QM>%;%[2SGGEI"@DZLI0GE'?JJN>8V"]^+
M;S"+F20UA&8:C(;>'7<;B6ZL\KDCVJ-4$*)P00%$-([)0$F@5&'"/"< 9!8
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MHZ3_ *H[)_[E_P"7S_0<>_\ -]VW\_3_ "8_JCTG_N7_ )??P?\ B-O?V?\
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M=4'ZQCWS1S\8&3YU0?K&/?-'/Q@9/G5!^L8]\T;]?3WP,GK]GT]UD'KZ?O\
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M(J26%9=BR8IP5,L,A[4K<&9H$YJ&UH>GE8XR%]C\;9&)E=WM_?6MK;U*LO\
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M0?7>_36M>FL&#"46,P6A["6 0Q:++&:/80!V+>@%%!&88/>M?\$LL ACWZ!
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MA6PVN\/#4J=+7DK1-8@\P<ETJRS"XY%T+:*06*I"*V.IK:FY)TXT52\]/1F
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ME H<CE)R-L2)D"<9:4@HH'[N,8QC&? P82BQF#]= + (8O8A$,7L0!V(7L0
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K@8\3>S+"?_:4_NS+96[FC5+#BDZ5O;413>PL:%L8&AJ;$>@,8QC&,9__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g425213g01a35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a35.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[13Z4&AO=&]S:&]P(#,N,  X0DE-! 0
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M;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0
M   !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "
M4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,
M8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M 0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B
M;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M  !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L("!D
M;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD(%5N
M=$8C4FQT                4G-L=%5N=$8C4'AL0%>            *=F5C
M=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,
M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L
M;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14
M;W!L;VYG       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F
M       .             #^    X0DE-! T       0   !X.$))3009
M   $    'CA"24T#\P      "0           0 X0DE-)Q        H  0
M       !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9
MF@ &       ! #(    ! %H    &       ! #4    ! "T    &       !
M.$))30/X      !P  #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@  #A"24T$"
M$     $   )    "0      X0DE-!!X       0     .$))300:      ,U
M    !@              Y    @H          0
M   !              (*    Y                      !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    Y     !29VAT;&]N9P   @H    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   .0     4F=H=&QO;F<   (*     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    %.$))300,      I@     0   *    !&
M   !X   @T    I$ !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1" !& * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M     P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0
M  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!
M8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&
M)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(!
M @0$ P0%!@<'!@4U 0 "$0,A,1($
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B(0#X-$4.T:(T-*WL??OWW^VB*
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M:V1W=C[(/^#%/L>N2IS]W:Q<-K?(_)A:%]'3R=8)-OY#XL<C7_'\BAYK?[[
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MWI%"-WB7JV5LV5R&$9?:;Q*D8U$DI<N^/V:PR[A%["#&8GQ=Q5K7X22YZ2_
M\C7M]]>SXWPX@)K 33@6ZZ)64P>)@FC<![T&%PY- P)@!%VXU<7\!W%^SNR8
M]>,9L-QG-Q[EET]ZV6-I3:U?$S6(4F>XUM([4_H(CR@5$'QNKZ!B[FN\0 W
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M&K3DWXEIR- N<#BS-6TH?=6/2;DM3EQT)BN=RBHAM845Z&G[3G#]:,TEHH#
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MS.06%0>Z!3K4+$=GYYQ$.TIY%8\5,!JX[SQ'R<P\6!X+67R$:O63)V?^^]X
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M,PP23&SDWB$Q[&XR8L00LHG2UU"SN*^DOCJ;D'"7,LFUXM@,:9=+A:\>M4I
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MQ88DI4%,R&4RD.>D^V1I3C?:5IT/L^=E#5NW+WY\;'2RLGZO.4;CB"+-Q_\
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M%'4X7?2;#B_UW$H[%K\( [U(*>\I#3:4%P+*$H"1X.J(0]#;+4>;OT[J<16
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M=RNY+>D\>B!$@VM''CVTJQ)JUQ6H;5J]%HEV4B0\X^?*GD@I]U>Q1$HB41"
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MY)<<69ND^VNW"X6MUUB4_;HDD/2[<'65H6EN:@!M9V1H E)UJB@A^FZU5/\
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M>[HML9QIB3,3;F) EJC-/.'N=2RI) 60=I(&=Q& Q>%WOC2(Y37W@,[$[IB
MR>IOFMI@B$8$0((-B+9:UN^5E= RZ'4E2>[6]#O0I"M%*5#:5!)'@_,#S5E
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M@X_/JTZR_P!W/F5?C_\ 6>:MI<N*&/>-JO9RXUK5ZVRNC4;QJYS?53?F'_\
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M..TVSI\NMRC7SBW+Y6'7R;ZF<V!E5OGW*&$S),1M+BE([ V5!M*5CTRH5O\
MV1,(^%"1$(Q#%DP<RXGJ^FCFM6<KHW9",?!@DF"*&/<-8H>Z0(:@'>OG2M,@
M%L]#H/'M^=IUFZUK_;]RG[]^_>?\_P"-= )Y^>G@*\5O6[R\CR_B\AEDHCH/
M ]NK3K-^?_G]RGY_=]OQ_/4=>_U4;O\ +Y'^Y0'0?KVZM.LT ^_]_P RG?\
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M_P @F1=/@_1;CW<QF5"(DL+[V^\%([>W?D5IW:CMU!MPS!(PT,$,P&$[\J&
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M^8?XU^=IUFZ/W<^93^'WK)^7WT)Y^)?G\U&[RTL?[O6Z@>@_?^ZTZS=^//\
M;\RGY?\ M_U^>Z MU[."R;O+R/\ <AZ#P1_XVG6;^']_W*=?AX[_ /74==4H
MF[R\C_=7K0*/YAX_X6G6;_E]RGY;UK[?C6_E13N_R_T_=0_,/^_JTZS?O_V_
M<I]_O_PG]?OJ7T>^M?-NJ:)N_P O]/W3\P\#VZM.LT;]_P"_[E/^G1]>K#V"
M;O\ +_2>>O5K)^8>![=6G6:/O_O^Y3_IT<_*M?=-U_X?Z2/8J(Z#P/;JTZS?
M\ON4_P"GYJ'?KQ^:C<Y>1_N3\Q#_ )6O6;_E]RG[]_[_ ,?P\?R4IT?LIW?Y
M?Z3]4_,0_P"5IUF_Y?<I\^^O_*?+?^JIII[>.7Y<5&X.'D?[EQ_F'+[E_P#;
M:=98! [3_;]RHJ)T-]WZ31'OKV^7@^=H3NE[UH"[5#'UK11# T9B+$%J,S,!
M;GKSX+ ?]-?P >%9_33*1S-S;R0J\7_.6EQ>4N1;[FC$;TK;C@'PL:;+#:%+
M2=C;(V KR=;.H]K6BPD3!HC"6 =K, [OGR%*+5NU9EC"1 0G>8E@ 6H;FC.#
MY:D+"<R&TH*4A" E:QX[0E9[SM8"$I"0KY#2C]ZB3NN+R\*8X8HHY<3F.*H#
MA@:5<>P9<78N?V,Z+O15A@<7L[A]5] 6@>FGN&U. '[C[:]]:.MC^._QK_4X
M1O P1]X!J6(\6'K52'AA+R9_>8#N!Q>]:4S8^#NLRGT(/"">6.6NHBZJY-Y<
MP(XI$XMN#4+CC.KUB-NO2V[GDCIC9!%MKK3-VA.! 0XQ(V"@Z*=$UV'L5+$K
M91@ (_;QW#?N2_1F .=:V78.Q4+;*(,)!$Z(][^24'-<A86OHMO>'%1$:])!
M*B?3+CJR%./.(8:9+SJ]!3CJPTDK<<*EJ(V5:T!N(L,UN8I1R>?7UT7U44I1
M$HBE)'L02-^3X !'WDD:_=4:TY<4-.NOLB2" 0!^X@CY^Q'O\_XFC#3KKV&@
M12EQ"2H*TCL'<2K24]H ^V%;T$@G6R0=@^-#=&'1/D^G"R*<$$ @@@@$$>00
M?8@CP01[:I46%*9ZNYZNZ*/G^I_ZJ G,-Y%%9OUJ]%W'?6_QI:.,^2+ID=FM
MECRNW9C;KABUP^KKBU=K9'E1HY4\4+"F_3F/>- @@'>S5KBL'+Q4!AC<$AMX
M7X'F.M5:XO#08J6948<%ZTI1FJ#?\QFL9K?]CY],X[BKE7FX*("04Y6G]4:T
MH_H0._P=G^7Q6#A[,X41[\41B+NY MHS-UX+"0]F<"(MXARYRAL[L>[X%K^2
MR+=$_0IQKT-8YG..<9W[+,CCYY?X6076;E]R$^>B5 A.PVF6W4I2GX<)<)2@
M@E)4LE1WJL_AL-+PLOX4H 0.]JO8EQP%!RT6=PV&E866)4J%H02=+L].8Z97
MQ)! .]>Y(UOY^3[_ (D_NU5PKCFIJ(E$2B)1%\%R@-W.'+@/[$>=$D0I"FU*
M0\&9+:FW/2<204*[5'2O<'1&M>8(<$&Q!'FHB B#&WV*PC7'Z [H]N-VNUS^
MON8X@O%XO%ZDQXW(=T3';F7RY2KG,,=D$(9;^(D**&T   _A6"Q&P<+B)ICC
M%"Y:ER= !4!JZN:%8.;L#!3IAF1AW+D,+\*< _&H97C=&/T<_!/1#?\ /\DX
MFG9M<KMR';<>M5_D9AD4F^ZBXT_>'[>F$F1OX8E=YE^N4'], SW?X)-7^"V=
MA\!O_!#&,0@N!:%VL!_$5D,)L^3@@?@PMO@/0!V=K4_>T\E?^@*'=O6BI1'D
MD^5'7_1T=?(G57ZO5/1$HB41*(E$2B)1$HB41*(E$2B)1$HB\EGN&6?D7"LK
MP/(1(-BS"P73';N(DA<24;?=HCL.4(\EO](P[Z+JNQU'VD*T1[51,@$R"*"+
M\,<)A/(ALU! B!!#@AB#F"L*K/T '1I$98C1LCYE;BQV4,-1T\A7,1VDH&TE
MIK>D=BPWI(\%*=>WBL#B.S^%G1B)AQ<D U?0E[:K%S]E8&=$(HY<+@N: ES<
MU%7:OGH#=CT@_1?=/O1ER5>^5N,+CGMRRK(<6D8C<)&6Y5-OC M+MQB7)#4:
M.^?29T]$;)T/! /N :OL#LN1@CO0#O!P.#@@OX&P%R5=X?!X?#@?"@ :Q  -
MFRX4^ZR35DU=)1$HB41*(E$2H8:#R")4HE$2B)1$HB41*(E$2B)1$HB41*(E
M$2B)1$HB5#U(T16%=;WT?W%W71!P*)R1D.98^KCNY7*Z65_$;K]6/.O72,Q&
MD(D+*%;2$1FB->^O/L*LL=@9>-@W)@>C=/[>;NK+&8&3C8-R:*6Z=QGH?.JL
M";_L?3IA]-M*^5N<$EM/8 C*4:(&R"26?UB3]HZ\UB8.S."A!$3NY+L"[UT'
MLL?*[/[/EP;OPQ$7)<PPO5O]OU45?V/ETOZ/;RQSIW=R5 _E2T-=OR_P).B/
MQJH]G,%NL!4%Z@-R=G\+%ZKT_P "V?3]C#_3#7_R^S*^KHF^CIXEZ&+CGMUX
MUR7-\DF\AQ[1%O+^8W5-P4TS95RG8B(_8A![0Y+=.E;([U$$;U66P6#E8*5\
M*4&A,1B-KD $4HU,N5@%D,-A96%@^'*A$,#DL&#D@!B  &8?99!4 @?:/DZ)
M ]DGM2"$[\ZV"1O[S5XK@4Z]N"FHI2B)1%;'U+]2*.G#%[;D[G$_*_+7UE<W
MK8FR<3XM(RF[1@TR9"Y,R(R4EF/V)*4NJ/8I>D E7BBA],BQZZ?U5E(^EAA-
MDMJZ*>M4%(5K?#LX;T2= !S7X#7OX/SHI6++D7^R,<XXVZX9/ ]RZ,>:[_QQ
M>[)A3]JQLXQ)LG,=BEW!3CMVG2\<DLN,3[4ZVA4F*I<EOXB-IM'VDJHHO4</
M%JCU+N.2V=N(.1$<L\:X=R(WBN682WEMDAWA&+9Q:'+%E-G;EH[VXMXM3I*X
M<H-]KA:)\(6@^-ZHI52:(I"M*3VD^=; ^_\ #]OSU]U$4X(/L0?V>:(@^?C7
MG^/XU ?.B*4K2DZ/ZQ!( \E0'DZ'S/X?C4HB5A0V-D=RD>WS0I2#^[:3Y^8T
M:(HA0)(!V4G1_ ^]$4:(E$2BBO#BE%*E  )TD#>O/W_YM5 )+N&TJZ*:I1*(
ME$2B)1%!2@G1/@$Z_G_S411!!\BB*52PGW"OPT"=G[A]Y_GT:@1 TS]JM5$[
MP2$C9)WOQ^KH;^U]V_8?C4HIB0/)J"6#E$H"X<9HH$Z&]$_L&S4N+/7102P?
MV4"H)25'8 !)\>?'X44OT:>ZAZB=I3YVK8'C[O/O^/R_8:(_7E]0IZ(A&P1]
MXU100#0KC[$>Q\[W_)^S[J*-V'3U/U4P0E)V!_76OYJ((0"X'J4*M?)1_8DF
MH,0%U4G< -G8'X@CW_F_?0%^NGYBB* 6DDCR"- [&O)WH?M\5*AQ;JC/[J8$
M$D#Y>_O1 7ZMS4:*4HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41
M*@.U0Q1*@DO2%^+@*".)\^O,5XIKY?U\T>+^'U",.B6IP=DJ0^8;U4BGW2I1
M*(E$2B*U;G[J5C\)9)A&+1>-\SY+R/-X^13X5GPY%M5(C6O&+>J?<ICQNTR"
MRLH9"E"-&4[*D)24L-.*\45-B;.6+U;.]VIGF5X_%?I .F3(HD6=<>1[!B#,
MZ*J9;X^2W2#;YST=F,RN>J7;%N_'VPVV6ZNW21/8C 3&5-([RMON'//W2IR
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J$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g425213g01a36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a36.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[10.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $_*^408X0DE-! 0      &@< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M @   @  ' )0  AR<C$P.3(Q.1P"!0 W36EC<F]S;V9T(%=O<F0@+2!4;R!+
M86QO;B M(%,M,2 H1U @1')A9G0@,3(N,2XR,RDN9&]C>#A"24T$)0
M$/)2+>1QIL9'FX^Q*--P)M<X0DE-!#H      .4    0     0      "W!R
M:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT
M90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).
M86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '(
M;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N
M96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "
M+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N
M8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;
M    0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL
M1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#
M     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M    0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M  !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q 5X
M      IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !0
M9U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
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M0DE-!!D       0    >.$))30/S       )           ! #A"24TG$
M    "@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8       $
M+V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0
M  8       $X0DE- _@      '   /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$'@      !      X0DE-
M!!H      S4    &              #M   "'@         !
M              $              AX   #M                      $
M                        $     $       !N=6QL     @    9B;W5N
M9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,
M969T;&]N9P          0G1O;6QO;F<   #M     %)G:'1L;VYG   "'@
M  9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L
M:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU
M;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU
M;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG    [0    !29VAT;&]N9P   AX    #=7)L5$585     $
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M!08'" D*"Q   00! P($ @4'!@@% PPS 0 "$0,$(1(Q!4%181,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MH;'1U@H7(R8GDI<8)#,V-T9UEL'A-55B<H:'IK3&\24H0TA36&>4E;/3_\0
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * @$@
M    #>OPWW/[_G0$GDM%77T)ZBD(ZM=^E)Z@G?T![T!R4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@.)WJT>DZ)TD;)
M[G94"/S3ZC?ST*#OZ=KC],3,L\87%V'Y-<L/O+>91LEBRA&M-I.*W(R,J4IY
M3*T8TA#?5=E1U,NA26/C<Z2I.QZ"99N%^V4];SY%_,&Y!QO/\3M&96"Y(=LE
M[8<E0G):50Y@9;><CNM2HC_2[%EQI+;C#[*P"TX@I4-B@7/)2L]%JWY/N2N6
MU=2?4$@E)T=^GIL_,E.B?Q-"D] * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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ML"QX:L-D[['V1;=?37N3'I\]?/N2>_J:*R2X%X\_PE]CV* 4 H!0"@% * 4
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MK9N'9M\OIF8W^%KPU8[C6;'E['\[P6]S%R\@C7B!QE%8B8V]'EV'%+38X_\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M1K]!82M"GG$JZTN-NG;K*@.ELDD5\[M_B;P\7$PJ:E%%+=G>;YQSA-KASO\
M#^,>-O!VG:,##Q%&'@8N(X:;WJ(<:)-.)M*6C,D?"7?CD)Y8NYD19BI?( F)
MDQ' Y'<D.X5BWO3J2DE)ZGBXWTG\Q+8'KNNWX5M'\S154KI0]Y.5=<>KU@VW
M@.UK:J<:M5*I-T/>54IU58:J?%6?OZ&:P[@?J'\=JVY]&1H!0"@% * QI\6
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M)ZOSCHJ4$A(T-DA1[_( []*$FW#CRG[\L[^1-YR.DN=R@)*MA))( ))&O4
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M2W>9FRF8RTO>YTL?X0\.QU31C?JU444[N&FZ5^G3FZ:9IU<2XX6L4]8_8_\
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M&/)?O%;IL?Q(\^MV!BWRX\^V'(,*4Z_-?7U,RT2/N& WY"0$ALL.%7<]:!V
MCC@O/*<NK?+E$K6$3PPY0SD$]^1XDN?'L:=MT5J%;1?L*1+BW%F4I]Z69@P1
M0<0\VH-%CW5L) ZO.7^: RSBSG++ZWGZ^L;%X8\HBR<C7>_$ESY/8N%Z>E6)
MMB_85%-JL[EMMD1NU.'[B/\ O*F9<&7.][ C]9N"V3&3Y'FOO/GK9]I9%?.T
MVNEY<5TG7WZMJ\+F91\9E0;EXF^=I62O(NXC7A%VPQ,.&Y-G39%M7]GJP=2G
MQ:HS\2* 9+1E""ES<;S?+9MN?/[=\_6--\)41.>DS'V.&1X7<Z5B,.W1_$WS
MFWEC$&WQI-]5>,,<B2WXR8XFR!;58,@L&X%E6V_?'?=PY_PKQ!ZIYOS_ +NW
M<602Y1?1QZQY9-G>O?AFRN4BQ?8?B1Y[M\BWWFWRKR9-^PV0W<K6S'E(F6]I
M(P5GR#)>D,OIDE3_ )7NZ4>0OKZF[U??>6G01P6KS2ORRRXO/A,F,69>RJX<
MS+D*+FL_D3EB8B=)O4S*(T_*[:Z]>[C<(Q;C/LK;QZ.AA49T!XA+2PL[0E+8
MU6MQO"]FQJMYK=<RWNRW.LZ+5YRVK&DVOX?V#:J]_$PDZFVW9)MN]FY?E%UJ
MM:EXI\'5IXIS?*,(PKEKF2PX*;/"N<2#!SS%?/<R9;G1<6$QG\5<E!#5N;8=
M?D.-Z0.A)+G5U#GV;9J=F3II=FE"5LH4M:N.6O._=\.\/P?#E&%1NT.,[R\I
MLJ55'K,J9ROK9_"]D[$G(E73Q'<\28-QF(D6.,B^86R_9HJ[6Q!>@//?<>2)
MI6^TJ6J0%,Z<<+8;<Z?/7VOPL\T]9??4V#<MMI*[CS=HY-='I!Q63PPYE%LU
MRAWWQ,\\7&]2KCD+ULN,:[X=&C1($J7(<L$:5'^XKWFKM<549IYT/->]K:4L
M(9*RTAYRM//EY7[G%P[9;TIQFXY_GV9TAX6,]&!0[/\ [J'G89JBSQ(DS)?M
M3"C%<N0+:KC/9MGW*!0B2M+A:CF<2TE8'GKZ?B=]YCFDGQ:BZC-7XQFSU[UX
M8\HDQ;4+1XD.>8$R/<[?+NSB[YA3R+E"80\F="0DX*T(WOBG4K#O4^&?+ \E
M[?4EKGWSB?N7*\*>42_H37#PPY(Y=;%)M?B0Y]AVN([.<O%O5D&%.*N(DQ%L
M1PB2,!261#?4F0$EEX.E'1MK?6&><^K]^/F&I2LO-3'O]#A5X8LH3E9N/^Z3
MYV3BB;#+AN6,7G##+7=I,N.^FZ*G?<4A26F&%QTQC$[AU2P^-%M;/7.W?#KR
MZ"(TLKY99Y):KHL]668SKV=&'\M99)R+D_F3F;*F[6(R<%0[DEAC3,>#K#OV
MO[P_&Q-N-,^TWW6%Z1#C>0U$;02^5J4GI[3L>'M*>_=Q[^_"(-=MWA.R>(4M
M;10ZMY.^34624IVU:40]9RLY!]D]P/B<&XS;QG_)LF="O$^]V)QK+<=MD2V,
MNW&>]C5MD>_61:'F(#[EOM@F*\DS9G01$BMI&NK@^%8&'4JMU2G,VEQ,3'#*
MWH:C8O@_PW9\7]2FANIU_*Z:5"6:3M+=.<ITS']*2EY#8'X=.2+_ ,*XM]H>
M(CF_&N0KGB=E5='V,APN;#A7Q(9=O"V&3ASBEM]2ELJ2)A"%=TJ*.D':TK=2
M4S&I]/\ I+ :PU+W=6OF<W;EO*7SM$6+BW7PPY1*B6<6SQ)\^0IT:X6YZ\/&
M_P"%O-W*#&0ZF;!;!P)HQO?%N)<$@>=Y7E@>2[U BB+:/C97?'-+/,GN_ACR
MF1=,9?M7B0YW@VNV/2U7N&[>L*D.W5EZ&\Q';1*^XK)C&+*<1,ZRS(\TM!OI
M;ZBXEKKZN/3+V+=9)2XZ+J\VN$(F=\,>3/9&)9\2'/*<;%C?MZK4B_X6)+EP
M?EPGA/\ ?/N$0$LQHCD=#'D'J]\<<\]/1Y;BW?&?I'<"\VC//EJNLJ'^4<=N
M\,66HON0RKKXE.=95AG&W&Q6F+?,-CR+,J*B8F:MV6<"<3-^T')#;G9F,6%Q
MND^>%]2#\V^Y_9_DEKQ%I3M.MK+K?IYDV/>&3*8+=X^W_$ASK=Y#V07N?97&
M+[AD,0[//GN7"VVI]*\#?#SEN0XF$J2.A,AJ.AX,,!?D(<>&G&.?/S#GBLUS
MO>TQ9723SOS/*@^%C-XV$,VJ3XG>>Y>8L6AV&,A<O6%>[NW$M+:;N:[:<(7O
MI44.^ZF;W* CW@;ZJ=_<J63B(TX3GR[YD][\,.8+QF+#@>)SG>+D*$6IN3=7
M;YAB(<CW5UA4] CHP-Q<;W]"7@V X]TK6$_&-DHFWT_8>G.VCF9X3SUS*>R[
MA+*&,TX_MF/^('G-5M?N\]W,&%Y?@")<:SIL5Q5"F%M>!H(C*FI90&^GS2H=
M2&5!)($F.+>>7[+AEFUY%9K\,V3+R&++C^)/GANRIL]UAW.V+OV%NR'+T^]9
M5VRZQI7W$2&D0HT2:T[&4P2\J>EQ+[7D^6\Z3K'2Z+Z6SM-XTO.O">EIE@>&
M+)H^29#-N'B5YZFV"<W8_L"TMWK"VY-G?CIE"[*D2C@C@E-W"0BW/QREB/[J
MJ.\@ETNE:&7OQ\_J3E+O%W%IF(49RLHSN1Q[PRY;!9O";YXD>>+H](O=\EVE
M2+]A45$*T3Y[\FUVUW_,%\R%6^.\W#,@AKSDLAP,,A?E(<;Y^5O=3KKIG!,D
MIB4E$PM,I_=3'!GE6WPLYS&PM=IG^)[GB=EZ+?.BL9$+SA;+(?DEP1YJ[;]R
M7"51@I/2U[\.ORP/-03V<IX<??7ZWXF5N'&UIU\M>.IW+IX7<N?QMB';?$IS
MS$R -PFW[J[?,*>;7T*8]_6VP,%;+:I2&W C_+++7F^KG3W=]QWQ%UFDWK'[
MOOR.Q>?#%DLN78%V;Q)<\VR/$O"9-_8?OV&2576UB,[YMNBNIP%CW=Q<D,.&
M2I#X2VVM):/6"EU[[9BK/)*\7M=Q*7]DG:%J0?\ #!E3N5VV>/$MSRG&HMGN
M+$JS?;F&&9-O+UUM4RW7!4S[B)0U&MT*+<(1C>[NJD+N"'O.9$<MOBRY4:S,
MVRY9\D\O5$8_ACRB/D4Z:_XE.=Y%@E6RT0X-F-ZPEI^-<;>_+>FS1,.#J#_V
MG'E+2Y'$=DL^[)5YSX7_ )*ZS+RXZYK7C#G,/+)0KK7K:%>,N91'&W!N77A&
M;HNWB"YW#T/,LB9QAQ&98#+:<QX+"+0^MMK!"ZA*VRB46W$-A*5I0DGN1$YF
M[:3C+IG?.W&/0-)JZ4Q+TOG.4I7UX\X*JMGA=S5C#WK;<_$WSM<<K<MLJ(B_
MQ[SAL6,):VW41)I@'!G%(7&+B%%OWU?FEL#S4=74F.4K*7P;C/G##ASK*SLT
MH_=SZY'1RCPDY1D.$''/]TESHBZSH,*VW>X2;WB+T67&"&F+J?<V<+CN)7-8
M2\&RF9_D%/$GSNG2K%+E59-.5QY=_N3%HIQ::J*J9IJM4E;3JN4KF6FP[V9/
M$_&G(N#<D8+F7)4:\X?>X5R=;O61V^Z1;A;HP=Z[,6(]DM28[+CCB71(2%]'
ME@>[JV==1;#LU.T4[110J:UO:9S2UHU$SPM[FEP_ ]EP-LHVO"HC$I;ES2GN
MU4U4N+)IWF6W=61LM0V4E1*BK:PI/;1 \M*"%$'2R2"K>D]R!KML]LW:33;;
MSBW#E.OMT.2AD* 4!#1WV.@?7YG]FSH?B-=Z$_'?+V, /'ZR_,Q+C&W6RP1<
MTR.=R"U'Q_ KY:;;?<.S&9]ERW'K3E5HN>2XDQ/9$1+TBV1!?8CLFY-,-1T.
MNJ2@KN$M6)2;WE*B8AQ#XYY1RY:G'X 9F,2\+Y(AXU-CN>Y<AOQ[]8[9AAX[
MQW%KXW8[(FZXQ:<'<GW:9CJ[6YY:9\:X7.9,<N#TEXNJC.1G7;IYYZKA'W\O
M.U14Y2=*B(TE2F\K3RYP[FP) 4!\2NHDD[Z>GL3L)T2=:&@?F=;T":Q2:F7-
M^$?=DSUUTB_MY?<E6A:ME"^@D:WTA6N^]@$CN?3U(_#=(^:>4/\ O^P:<0GN
M\TB3R24Z6OK/;XNGI5KUUOJ/S[^GIVU2I-NSW5PS]^^<BF:5=[W56RC*?,CY
M1!/24 'UVWU$Z^9)6-G]G[-]ZHA\5Z?OG[<B;H4/S5)3Z=PV/E]?BJVU4^?[
M$BK_ %9<D&TN)WYCGF;UKX C7KOT)WOM]/2H$G?>:JRBT1[LX92D]*4*Z2E?
M6EQ!0'/,:6/)4E302I:F_-=9+I'0A"/B==0C?4[G@7K&OI[SI.7YT(<^N8VS
MS1S??<B;>M^$-<IXW#>Y>R+CF#E/(>)\A-6_$KC$X[P/+'LUBO\ &EGOC#C$
M'%I-YPB-;KR_+,1NY.N2;.;I'E:_2(USF+/R9(EJ>&M^&5XSUC3H;V,9=,BT
MVU])?+#ML@*:5)*O>%#W9L!3Z0ZIA+W3KS51D%AY>WT.GS.A-*OI$]<N4Y1D
ME]%4-"B@% 04-Z^(C1WV^?X'MW'X=MU&G-G'*)_#'=K ;^9'[!KZ^NR?P^GI
M^-4 @G6CH [_ %_AO?I_'IVH1IZ.+SKGZY<C'3Q:+A,^'?E5Z?+N\&,G%)X<
M>L3;"[BZ5)"414B3(B,*C2%D-2T/RHS2F%+"GVA\5 \OK%ONHOS,&? T[:X'
M.E\L4^S8O@G(3'$3:LBX^P+CJU<?6-BU-WVQO6C)KXJWYGE;.77"],S0FU7V
MV!B'':8N#,YUF7):AJ>F7W[X9<QPSN^.5N$O/A?B;<J%($$Z[ZT=D:!V->GX
M=]'?KVU0G6]_0@$@;V2=G8WWT?P^E!YZ_BWG]R.A]!Z[]/G]?U_C0I&@(=]C
MN-?,:[G]N^W[C0E^/M^_? XWR4L/%(V4M.$)ZUM[(02!UM)6XC?IUMH4M/JA
M*E  B]+&I+QNL1)O.N+N)Q:W9?'L_$\B1F\7DCC"'RGA.%8@[E-V;:SS'+ W
MF.(Y"]E$1Z--<R>XV"5<IMKQ>VV*4XTR[T@7ATY^N?&>7N8I7?+C$KVX*,W*
MO:QFEX/;C8[IX<^))&/7R\91:$XG!1"OE]=1)F3&V@IMMQ"T2):(\5 ZFX,5
M<N3-BQ/)C2W%/-K4J9W\O2V6?V$)>SEW\YLDXUS>>E\H*&0H!W[>GIW[?/\
M#OV'KV[_ *^W<!_3_'X4 H!0'BWI*!:;B7%2 @0IA4Y!2!-;9+*RX8*4@E4E
M*-AH;&UD4EK6/;++T";3E2TFI665[6N_8T.<'7#&[5S'Q0J[0X6%M7KEJ\*X
MXR>U\=V*S\@\HH<R*Y1WH6;\G0LZFVB9"MDUN6QD.+R+!$R29:T,+B,2RS*\
MC-U4U/\ I4)RW:9YVUGBHMF*ZJJD[I/1PK=.7)K0W]I&DI&]Z 'IH>GT[Z'T
M&R1\R>Y.!%IW];_< : [^F]Z  43W)(T=;))['U)WN@CF_:_M]"8  :   ]
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ME/Q8[4-AUU\M%94W&8:;3\6T])T>]!'IYK5\'SSXKI%0I1T^A)3H  ]]:_\
M*]=?AZ#Y4*3T H!0"@% * \;(,?L^4VB;8+_ &^)=K-<VO=[C;9\=N5#FQE$
M%;#[+H4A:%$ ]QL$ CN*$:F.3GO@4W9^,\'L>52,VMF,V:%E<JS(Q^3?XT%E
MJZR+.TZR\W D34I\]]@.1HR^EU:R%,-Z.AJ@2ASR_OZV](R*]H44 H!0"@%
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M:AD* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M55516D^M2OI&5\F\[-YV1YK\8;9C8%4K$W5?==#<J'\O"-93J>K7+7_>..,
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M@% * 4 H!0"@% * 4 H"!&RG\#L_ZJA_610'7>8\QIQ!2%]:E'2CKLL%"M*
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MGOOU)J 4 H"!(!T?IOT.NWKW_"A&TL]0"#Z=P1O?RH4C0"@% * 4 H!0"@%
M* 4 H"!( ))  [DDZ 'U)/I0 'J[@$=R.XUO7S'U!^1^= 1H!0"@% 2E:1O9
MUT^N_77UUZD?C0$U * 4 H!0"@(;&M[[#8)/;T.CZ_C0$.M/KO8[[([CL-GN
M/P[CZ]]4)/7OK'XYD000".X/I0I&@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0%@_$!SO:>!\<LEYN.+95FDS)\FM.(V#',+@LW*
M_P!RO5W<+<-AB(^ZRCH4H'J=*^EL J7H=Z$:6L:9OA].'.2SN)^//@J_.-MY
M#>G>,IC+EPM%ULW(RH>,WBR9/ N5IMC^.S+9-DMRGK@B3=[;T*C-N,/-W".M
MIQ25;H+_ +>E_+W\TB3-^6? WR4]CW(&<Y?P=F9XRR5ZUV*_Y%<<<O,?$KW=
M4%N5)B>_R5QH;DQJ "U,#:RY';2^VHMZ50<7'+C*[FVO.QZ&*>.3PRWZ->;A
M!Y)Q>UXSC<R78'[[<;I"M=E-XM.7Y)A,BRP6I#D=2WT3<2GR(A89+$F&#)BJ
M6PDJ2FW[7_+(TKO*5=RLGKKGY77-EZ,:\1/!^7Y<W@>-<I83?,QDP3=8V.6S
M(;;,NDBVAF/(]]8B,/K=<8$:5$D.*2%>6W*84K0=1L6?K'O!:3E;QQ^'OC&*
MXDYU8\KR%O+[%@WW2QNZVZ9?1D-_EJAL17XYD#W=J.M*O?G'2E$8@!TI)&PF
M_P"4T^6?7W7$J+_=A^'BVY?D^ Y'R5C6*Y7B<^S6R[6K(+A%M*TR[Y D7*&Q
M$5(>2U,+,2+(<EKC*6EA#96X4H(-!EG9:<E&L9:\N9Z;?B]\,;L&V7)OG+C5
M4*\7.19K:^,KM'3*N4-V*S,BM[E;+D14Z&J3O08;DLN.=*'$$A*F/M;I)V)O
MBS\-UNCY')F\T<>Q6\1R!&+9*E_)K6ARS7YPS?+MDYHR>MF4ZFVW%;+:AU.(
M@REI!2PX4N/+NPX<_:S*8F>-'PWPK[/LIY:P54:T1)[U\NZ,HLZHEFE0KBS:
M$0)9,OJ$^9<'/=XD- \]]02IIM2%I50<?9YN_P!E],SRVO'+X;Y>6S\4@\E8
MY*^QK? NMZOZ;O;F,>@VNYVB)>X%Q3<WI"8LJ)(AS64J>BN.I:D$QUE+R2D.
M^7?ETF\8_-'1<G//*^C2LW>2N8/BT\-MSEXY;[;S1Q].FY8I*,>BQ<EMCSUT
M6J0(H1&;1(*EJ$@ADIUL+(21LBAE;VF/73OZ&0Z5I7OI4%:.CH[T?V4*34 H
M!0"@% * 4 H!0&.WB-\5?!?A.Q6U9ISQF\3!\<O5V18[9<)<>1)3+NCC2GD1
M6T16W%E9;2I6^G78UPXV/AX*WJW'"S?T3./$Q*,))UN$[93[*YA@?;7>S>3V
M/B$M7;UU9KP=;[:[1/K]-UK7XYX?37N58K54Q&YB?[#I5>*[%0W35B5)IP_\
M/$?NJ;>97=B]JCX.,]P3EO-^-.0U\@Q>&<17F>:VFQVN8+LQ8S(,1MR)&FM,
MIE./2>EA*0H(0I84ZI"-FMGL^/A;4M[!JWE:[3ISCBEQ.U@8^'M,?I/>WG%Z
M6E>;7AY<O*Z+Q\>>,#CK)L;?R'/HMQX309$M-NMW*$^RV>?=F+?'@RISML:9
MFNID" W<829S*%*>BNR6F7DH<4 .:KY6TVDTTH?&I3"T?ER9RU-T/=JM4VEG
M.JU25[^SG)E72O%UX9H3%YD2>;N.&VK!>4X]="<IM),>]K9N$AJV=(D[<EOL
M6F[NL,H"E/(M-R4V%"$_T0R[Z=2^5GR*R9!9H.16.YP[M8[I!9N5MNT!]N5
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M9DQWD[;>;4H)7WR<^G<Z%/K\<7A<;NSMJ5S!B 0SB$+.7+L;K%%E^[L^]2;
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
L* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g425213g01a37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a37.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1N*4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &VZ^<"(X0DE-! 0      $(< @   @  ' )0  AR<C8Q,S(Y-1P"!0 I
M36EC<F]S;V9T(%!O=V5R4&]I;G0@+2!);VYI<R!&:6=U<F4@+G!P='@X0DE-
M!"4      !"@X>IG-6+$U%Z6T-X8_1HP.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'3            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0     .$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      -!    !@             $TP  !YP    & &< ,P Q
M &< ,P Q     0                         !              ><   $
MTP                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   $
MTP    !29VAT;&]N9P  !YP    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P  !-,     4F=H=&QO;F<
M  ><     W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G
M951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X=$ES
M2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE
M;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG
M;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO
M<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P
M3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O
M;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M       ,     C_P        .$))3001       ! 0 X0DE-!!0       0
M   &.$))300,     !#_     0   )\   !E   !X   O6   !#C !@  ?_8
M_^T #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,
M$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,
M# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !E )\# 2(  A$!
M Q$!_]T !  *_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !
M!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$
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MMCGL#F.,,>QU3JM;??LW?HGO6HDDIS&])RQ;6YW4+G5L.M?$M#FN8PN8YO\
M@V>G8_\ /_ZY;O:WH5-AL(?L-CK';FL$CU37.W=N;[?3=])O^$6HDDIRK.BV
MV,;6<VT,%;*BT3M+6AC7>Q[GU[G[;/YQEG\[_A/30+NEC'],/ZD^D$AX#A(-
ME</:_P#2/=LI_15?:*_YOV?X'U+%N(5^-CY&WUJQ9LG;/F-KA_5=^ZDIQ]K+
M;[7LZL0;'375+@!N)=Z3F^J/=L>RG97Z-E/LL_19-GK(996&,:WK#J65,94X
M01[JA90^P^H_V^I9_P"B_P"=_0+5;TCI[7A[:@"'MLY)]S -CM3^\UEG\NUG
MJ*;NG8+_ *5###S9J/SG'<X_YPW)*<HF@O\ 5/6"*V._1-#C#0)MV738?6?^
MDJ_G?W/2_P!(D_&Z3<YS693 ;'6>ZMK20;75'V_3;N:UNWZ&S^=]3^;L6C9T
M?IMM@L=0V9+G :-<2-OZ5H]MFWZ3-_Y_Z1$_9V#[2*& LC:0((@E_P!+^LYR
M2G)_1BXU_M0M;0T4AC"[=O8QU7O;OV_S[?4V-9ZEC_T5MEE?L1:<"W):[[/U
M1SPQSFV;)> _976&_I+;/YGT]S/Z^^S??^G6D_I^%9].EA.IF(()C<YKA[FN
M]OTFJ=&-1CAS:*VUA[B]P:(!<?I.24TK.EYAK8RK/M9L!U,N)(L]2MSG;][M
ME1LH?[_TWZ/?_-(5O0"ZTVMR7 N=:YX(,?I7;PUOI/JV[6_HGO\ YVVO_"?H
MZEKI)*<D]#MW56MRW-NI96UL"*R:A8UKGTM>W\VZROVN^A_+]%])<3I=^._<
M[,L?(UTU+B6.?_..M8QK_3_P;/\ "+10JLG'O)%-K+2-3L<'1/\ 524E23 @
MD@&2.1X)TE/_T/4F6U/<YC'M<YGTV@@D3^]^[PJ+NO=.;<*BYX<26SZ;H!:Z
MVIP=I[7>
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M<MG9;:BK^Q3>])W2MDE9+<2!X-HP!@# & , 8 P!@# & , 8 P!@# & , 8
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P"P$_P K^,%5FY2MV?D1I*O6&#>KQLS!S6T*7&2\3(-3BFY8
MR,>\F47;)V@<!(LW<))JIF 2G( ATR;,BZ[KZ$W\Z1\?\N?Q"_91<?O=[_\
MA?H7W/\ ]>R!==WPII>-JQD8P?L95BRDXQXVD(V1:-W\>_9+I.F;YD[1(X:N
MVCE$QT7#9R@HFL@ND<Z:J1RJ$,8I@$1)^O .!,4/E$ ^Y[Q /?\ +T]_[7OP
M#CN+^N#]WK[OK^3[F <]Q?I#_&/3Y?\ 3^U\N .H?2'T_*'R?3@'. , 8 P!
M@# & , 8 P"WSC:^MVNS&&FG-UKR&U)2K.+M'4)201+97E2:/31SFPMXT1\Y
M2+0?%,T4<@':"Q3%]_:80 N#@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M-4GC)RB</<=-=LLFJ0P>X2G < ^G@# & , 8 P!@# & 0MW/I_N\NGO=[_\
M<_K@'7_WGR@X(MN[CO\ ,UZ2:3!(P!@# & , 8 P!@# & .H?+U]WTX P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & :IF^O ]YA;"Y![]VG1-J<=V=6VUN*];*B&-I5V$6=8,[9+JOV[&
M1)&5U=@5RV1%,BP-EUTQ4[S$6,02@7Y;2^JN%TQBUBZ^)Q%*:I0I;-+8V=F#
MDT[SBVWZY_85_P"J1UO>KW5*UD>LNDM/:;T;BI8#"X!X? 1P,J'8\(ZKA/\
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M8M4([1Y.[5G;,I%R%9"P5*R6RFU:BUU%BX+8)=XPKPO9ET^=LV3!D\3*43.
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M & , 8 P!@# & , 8 P#CM+] ?4& .@?0'U8!S@#H'T!@''0/H#ZL = #Y
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# -9SG;9N&X<S>9\/S30:3$@EQ>U1!\8D
M['5[E94:Y8)6O["DK,\HJ\!%2+.MV!:RFJKE:8[V3TJY&P$<@DDL41'/W'Z$
M_29R>&7S_P! ;7TIQET"MM>2LO(QKIVL1MHK\S6;PC*FFZM64!GBR%@EH!")
M<O&B+,YG"YY1071TS"15=0W4SCH))?\  & , 8!3612<)*H+I)K(+IG1615(
M51)5)0HD4243. D.FH0PD.0P"4Q1$I@$!$, @N#7E!UQXZVJ(G7M)J5%BGW
MNYR+R-I]<B*VP=R*FRI!%1^Y:0[-FW7>'1112,Y43,L9))-,3B0A0 /03JX
MP!@# +)\E/\ B\[R_BEV#_564P#VFL?^#;7W\":K^ F&"([ET+R'N,$C & ,
M 8!BV^_XZ-<_DRW#\:5(P#*3 & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M.C7/Y,MP_&E2, RDP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MFXW?L]:R(F".UK.O3.1K-EB*PN=B"*8^J2EEYE.6KZB?Q9>OL)67;?H:/6Z
M=W&\XYN9T Z^V\KZ12<(84-;SJQ5P@KJQI"AFPD(/GDD73XM@AS$]TC4&[RQ
M(CZ)JI@'0N]XPRYT?L>;B 2+O6XJ#K:=!$PLK^EKTRI%?+$ID%W:P6=HH'4'
M%(36M!0] D8< X-OB-*NFA]CS<8BJL@B"A=:SID""O?SZ^ ZBO9VD22=E^$R
MZANH)T<Q+28 8'# *A-Z1JAF8!K[;Y?6&C"E ^MYTGD>U+NZHQ!="*8 W*S<
MM#6*1$_O9TY9M9%0!BN0P@=6.](Y^5B8FO=PMO7_  > H/=;3C4S;X0VJ6J:
M0O04('IO9;B(4FIWOZ>RJT]C9M</2/D1P....@Z1V^(V17CD":\W$U&2&K@1
M1_K6=:H-?A5,ST*W&05.0"LPAU8!5_8Q5Z!#Q4E#/W(@C)(X!T;;\C77LKMU
MSN9#VL:HE3]5K*>0!D-O/8"-QDQ,4?0EA!KRHV<5NGL(LG!F>= E$< [M=\Q
MKHD88NNMR(^U"4\Q"N=:3R)FGPRBYR5;ED0,GU9G@DX-1G:@5 H5^1D8=D\_
M/9) ! Z1>^XV5+%&3USN5G[5^# $+(ZTGF9F?PIK4I9D1D@53_0(PR,6>)LG
MFCTA; \C8AUT</D@$../W%%CR!BWYFQ2ZVW6V]2G"J%%WJZP-RI!-TF1NZ9'
M!CDZ(J1[:./7Y<@^^.MSIA75@!Z[3P IR!C""W_N:[K$'*+1<HEU?/F!$'E"
M=[ *FN($_.UD6;0]:<I#\="[*MZP</7+%# *B^_8QNBHL.M]T*%22<JB1#64
M\JJH#:A$OXIII@0!,JLU-\&D"!T.K=0-6"E!\'0 .H\@(L"KF^QONH001E5Q
M*75\^)E0B:0PO*B:(=@BHL]:ORUZ,3  %]<&SVMH_HYJH @4G'(6+;&?%-K3
M=ROH2SYC"AJVP+%<_!ZJ1%M5!D8J8>J&3;RY(6# @ ,K9V4I!H='3%4!#CBY
MWD^0,9&'DB'UMNIX:,2M"IS1VL)]V1W\%86#G%RQYTT^CL\RG/)1U<(GU&9F
M(Z9CVHBM&K8!7E-]QD664.?76Y7@106P5"QVLYYX9Z-13@U' 1OEIAZT9H)U
M,M9%(!"<4C9@K7_U:OT X=;[C6@RW=KK<JOL<]M34%KK.=< ^&H2D'%+FB^P
MG5^2</.I/:P9$.DW'1TP]:_G4:N& '6^XQH[?M#:ZW,L:/5LJ1UFVLYUPU<C
M6;-!U=8[)<B?8[3EEYQ.7KYTNI9BO1\Q,-0%M'+= .TAOF-CE'J9]=;D<BR6
MET3F8ZTG79' P]SB:6HHT.F3HX2?N)8D]%*$ 2R%292=A0'T;)0< JJ[TCDO
M-_N?;?/Y*CY(?*UQ.' XL;ZA0#'3$$^AR.72Y;,S$!_1%)35M!/['D$0 X0W
MK&K'[ U[N%,?.!'JMK:=(3XVP5M> H)_+Z EZM UG$PB A1SI6@0!@H4<#CC
MCH"&]8U=V@S#7VX$S+JQZ0+K:WG$FJ0R%Y?40AUG!B=B235RP-8WYS] :TUR
MSLI_T$X(& <([VC5AC@#7NX2>T5:^D05=:SJ96HV&VRE01,_$Q.C1.+<11YN
M<.IT"+K#V-G5Q!H]2P....@[,-Z1TA[.$FO=PM@D@J8D![K:<:F:A;IB8AT/
M7 H3JT]B*0YWUF\T/[!13^*?O.B+]$< I0V^8V:&*\O7>Y&/M8:F"82VM)V/
M!E\+CSR;?VF*I.K (,8!4UH%;W01)*%,[$ E&_4#I'[]C)!:-1)KC<[49$*F
M)3OM8S[5-I\+F%BD&_KSG( -/89*XLVLXJ= @GTI!-7?1240P AOR-<$C3EU
MSN9(),*R9,J^LIY(S/X45R9LB 2 "4?2#$(PJL5804'K#3\A$1#H0<R"("(O
MNWY]SR\>1G++?D8]29+%USN9 'I(8Y4W>LIYNJW":ILA=4RO"&)U;G8-XXU?
MERFZC'6UTQKRX ]=)X)*+;D%%.C) 36VZT?-;L7 "YU?/H 0'U!4V 5)03I]
M"KMVJ0UEXD/QF]W42K!P]<H4, Z&Y"Q91#KK3=P]R*BWNU98!Z E0"[",01
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MB)4G)L5.@1E6>1L\MU:/DL ZM-\QKL\>0NO-R(#(J59,@N=:3J!6HVJ>G(!
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M4& .@?0'U!@#M+] ?4& .TOT!]0?1T_S>[]S  %*'R  ?N  8 $I1^4H#^Z
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MG$?4IEO>M!]U&MOQ%A/KZ-X+*8%^Q@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P"-KG
MJD]USK/96Q'F^^0=;-L*2U+0]:Z]TVPH\G92;"+./6<57=:,K/!NFIIG9SR1
M0:V9Q/.UF;-A$@];G:)ME2G P)X#;+M*V]=1&VMN3FDS<;#-MVJU:F[F'2\]
MK6<V-K"6L%>O&NYJP:]J\;),+I6V40-JC4.]",DVHK$;/G"C%9%8#8;P!@#
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MOXYQ'U*9;WK0?=1K;\183Z^C>"RF!?L8 P!@# & , 8 P!@# & , 8 P!@#
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M =F-8Y )%C@D-JT-V9$:G[3%OK%\T!X#"8F7%Q!MW79QZ/X10CF$C8CN]2,
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MR-O02Z&%M7TSU0RBRR@3I .AJGR2'M[=PZ[#\Y4*;KJ9^/58=?$B4U _M]
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MZ'8;#=+$T9K/5)/8ET;VV7MUCF)AR10C1,$UF;1PN<&K-FU%42@3$8 P!@#
M& 0N7+Y^33_^#^N'XT)/)7+T>E$/?'I]#)H\@D8!&-XR7S:_*/\ @E!?UTK>
M:<3VMB?@]?S4SJM._D32_P 68[ZK5-*Q7[:?]\.5RI^PCT'B:]_@CY$4\S(&
M 477ZC>?>ZO]&?)C[*'Z\/IHWX?VVGWVCYQ&[UX1?S;?$;^*U#\.3.6,I^U4
MN]4O-Q/;; =HX/X-0\W$D<S,Y9IG^,-\YA=/Y.>I_P .6O+6]:_VSKEWK07T
MM+E+NO"[3U%[[K%Y-!$=^6[*,# & 9?>&E\YMQ(^\]X?BPD<K-US?N<U;^.<
M1]2F6]ZT'W4:V_$6$^OHW@LI@7[& , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# -?+EU
M7-<;CY;<TVNZ]QV6DN..7&'5MBXVQD7N:5U>C7K]9H#8]IE[9"Q,?/0R-CLH
M35=KJ0*.D)%,C0J+)5LH1=$I0X\GV^4NCX8>BN+\G1..?(Z3VM,[1Y8V[6K.
MZV=]<.04_=)SX5W. 47MRY->NK6XBHY5!%\[:%23KZ9XQJ %^(<HG ";S &
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MP'?LR"0%1.!W*)1*"!"*+"8#' 2@DFHF=03=.PJA#&Z 8HB!P:4C2 83OV9
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M0'*(C\=8S8ON[^OQG)3-R_=,N4R0 )P$N  DXX>WH^:#W^6!>CE$>X5E3()
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M2C!LX$>I.@@55./&E%@4\W6E1.*QWJBPFBDQ\P\C=D=D/C'ZF^,+F^-T+4J
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MHQL2.30U=3D4XD*X$:0D2D ,PJ$!,5:L@AU-\4(2NV"9AX_J ^0QDG20=?,
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M5*)?0*U7<0SIE%IHJQR]*@I>LU-5J8##Y1X" G9B)CC%]Z+.1=)=! _N O,
M=  /H# (X?%.U/=]Q\7$JM1M86#=[F/VUJJU6+3$%-LZ\CM*G5NTMY"R4VPR
MSR4B0:5Z08D%9VHW<+.".VK%0K1P0BA0 QIX8:GU[5M[529@_")M/%"90BYH
MA=RR-LH4S'5@5HI5-PP\F&MDC)N F"B>,251CA,45@.J5),3B5TD=W/Y_(^C
MBY-K@D8 P!@# (7+G\_+I[]KP_KA^,^3#_3DVW]Q7^=+TD/D[K]#?H)H\@D8
M!&-XR7S:_*/^"4%_72MYIQ/:V)^#U_-3.JT[^1-+_%F.^JU32L5^VG_?#E<J
M?L(]!XFO?X(^1%/,R!@%%U^HWGWNK_1GR8^RA^O#Z:-^']MI]]H^<1N]>$7\
MVWQ&_BM0_#DSEC*?M5+O5+S<3VVP':.#^#4/-Q)',S.6:9_C#?.873^3GJ?\
M.6O+6]:_VSKEWK07TM+E+NO"[3U%[[K%Y-!$=^6[*,# & 9?>&E\YMQ(^\]X
M?BPD<K-US?N<U;^.<1]2F6]ZT'W4:V_$6$^OHW@LI@7[& , 8 P#&O?G(0ND
M+7QVK)JP>P_9[W2PU"5X21!@%:%[6;'8AG#HBU<C)%1" %L9D4[43 Y\T%R^
M5V* 8#QOB,<@U#,-ZRO&BKL^$DUN1/3\=L5+9OF;A:-'&PU-6L-FR>O30X19
M:J]N0)M#0R$T>PM&1_6G342]X@3%$'N*4WTAU]W7I[_W??@'; & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MF"3G & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MFG$]K8GX/7\U,ZK3OY$TO\68[ZK5-*Q7[:?]\.5RI^PCT'B:]_@CY$4\S(&
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M)& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M511<E4,"?:X7%X;&T5B,)6A7HR<HQJ0OLMQ=FE=)Y/N'Z!H#6+0NM&C:.F-
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MXGM;$_!Z_FIG5:=_(FE_BS'_ %6J:5BWVT_[X<KE3]A'H/$U[_!'R(IYF0,
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M1*<ARB!BF*(@8! 0$0'!)4P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & 0N7,?_3RZ>_;\/ZX!_P#R?)C_
M *,$6W=QW^9KTDT>"1@$8WC)?-K\H_X)07]=*WFG$]K8GX/7\U,ZK3OY$TO\
M68[ZK5-*Q7[:?]\.5RI^PCT'B:]_@CY$4\S(& 477ZC>?>ZO]&?)C[*'Z\/I
MHWX?VVGWVCYQ&[UX1?S;?$;^*U#\.3.6,I^U4N]4O-Q/;; =HX/X-0\W$D<S
M,Y9IG^,-\YA=/Y.>I_PY:\M;UK_;.N7>M!?2TN4NZ\+M/47ONL7DT$1WY;LH
MP, 8!E]X:7SFW$C[SWA^+"1RLW7-^YS5OXYQ'U*9;WK0?=1K;\183Z^C>"RF
M!?L8 P!D2W/H?D!_-SD?]^FV_P".K</XR+)GXEK7^7L;^KA_,Q/*KKCOZ8=;
M^G0__!='E//G3\,& , V*/R.E]OYO_PSTQ_VU.T]?JZ!^Y]W/V74S\@X?OM;
MZ2L>H_6Q?T0:!MN_EVG'X?YUQ'VOQ&S1GU98$U]/R1/'L97C3QOCI)JB^8/>
M6M&;NV;E,JK=R@K2=@E4163, E.F<H]#E'W&#J ^X1S]!ZE6#PF/ZH&K>#QV
M%P^,PE?%UHUL-BJ4*^'K1C@\3-1JT:BE3J14HQDE.+2:3M=(_,NK)CL;HWJ:
M:V8W1V,Q6 QM# T94,7@J]3#8FC*6.PM.4J5>C*-6G)PG*+E"496;2:N:PXZ
MBU8 C_<_JORC_P#9#3_Z67\]0FI?Z)ZN?(FC?NIYF?A+ZH/Z:ZU?YBTS]^./
ML1:L_P";^J__  AI_P#2QZA=2_T3U<^1-&?=1^$OJ@?IIK5_F+3/WX?8BU9_
MS?U7_P"$-/\ Z6/4+J7^B>KGR)HS[J/PE]4']--:O\Q:9^_'@=I:SU[$:]M$
MI%4RNQT@Q:,EF;UI&-T'+989B-3\Q)9,A3%,*:AR>X?TIS!T]^?%]474[53!
M:CZTXK!ZM:!PV)H:$Q]6CB*&B-'TJU*<*,G&=*K##QG3G%YJ4)1DFE9GZ!U*
M]?M=-(=4/4_":0ULUDQ>$Q&G]&T*V&Q.GM+5L-7A5K-3IUJ%7&3I5X-1473J
M1E%J3NGE;^D1J_\ X-->?P'J?X!8?1GGN\F^E[^D]/UN70CW602, 8 P"RG)
M*[7+6O'S=NPM=PGPEOE(U7>[53H'TRKWVM9(&M2,E#LA9H?GSPJSYLB4S1'\
M]<EZHI_&.&!N(*:._P"4&U-?5W<5J\4B3C>)A=-#M.T\@:;":GHCVI<@5W49
M$N]+3OJD'"I*A77#LSP8"2BV\RL_ZP#UX1VN@"8CCYO%?QY=),MP>VA>-U<2
M]"[3V20HW:Z:^B9:>>IQYXE.:7[W#1M9$HLY$QCTK0Q;-;&DS*0A&Z4J1),I
M4RE#!/'V&5> , 8 P#J)R@/03  _0(^_[H?YPZ?_ /0P#D#%$>@"'7Z/N_5@
M'. , 8 P!@#  _(/7 (#KINCGOO+>')&G\>=]TC7\AJOD%!Z'/Q^6UQ69N]5
MO3,LG7VTGRB++STPQEG;A,LPO8Z\T(P<UI>.0!BH95X!2J 9<\#-K;.DMN\L
M..EZW<VY-0W'N7U<-:W@6&@HB8=N]AP$Y(V37-K^"A?@T\L5#?P2)UG#$4WB
M;2=:M9-L@X0*0 )., 8 P!@%I]W[MUSQWUG9-M[5G#P-+JY&0/W;=@^EI!T]
ME'[:*AXB(B(Q!U(RTS,RKUG&QD<R;JKN7;E(A2@7N,4..+F-]9\1'CA:-+[?
MW>E(76#A=""W)MZEVVB6"J[0HRKXC=6+),T2<;LI=(DPV=)NXETF51F_;E7%
M!P91JY32#CY[<G"Y3-YB\1D&;1^W$PMWK9!VW,8HE,9%PD19(QBC[RB)#@(E
M'W@/N' /U8 P!@# & , 8 P!@'F;C=*CKVMREQO=G@:=5(1#U4Q9+-*LH2$C
M&XG*F59])R*S=HV(=0Y$B"JJ7O5.1,@&.<I1 _+1-A43:%;97'7%PK5[J<D*
MH,+'4YJ/GX5V9!0R2Z:$C&.'+4ZJ"I3)KI IYB*@"10I3@( !$7<_GY=/?X/
M^X_C/E QZ!Z2:3 & 1C>,E\VORC'Z*C!B/\ \Z5K-&)=L-B.[0KKQTIG5Z<5
M]"Z72][,?]5JFE:J7JH<>I0^,/RC[_ERN=/*$5W$>)MKV=X[EO=GN1T[?^D7
MZ\S&S_>CXQV_](OUX&S_ 'H^,H.PZ,W?O ?T.K\@]?D3-UR5[*'Z\/I(W4$E
M5IYIWJTMS_\ $B;O/A%_-M\1OXK4/PY,Y8RG[52[U2\W$]M<!VC@_@U#S<21
MS,SEFF?XPWSF%T_DYZG_  Y:\M;UK_;.N7>M!?2TN4NZ\-_ZGJ)W:NL27BT$
M_(B._+=E&!@# ,OO#3]WB;<1_P!MGO#I_-A)?]V5FZYOW.ZN=S3-?ZE)^DM]
MUH*MK1K9W= X1KY0MY4;P64P+]# & ,B6Y]#\@/YN<A[[IML.H!_=JW#\O\
M&19,_$M:_P O8S]6AYF!Y5=<;GU8=;U=+/0^_N:%T<=>W_I%^O/G3\.V?[T?
M&.W_ *1?KP-G^]'QCM_Z1?KP-G^]'QFQ+^1T?M_-_P#AGIG^JEHS]FU,_(.'
M[Y5^DCU%ZV+^A_07P_3O_%L4;-.?5%@2 #\D+_\ %UXS?RNZ'_4O8.?I74?_
M *2-5OAF(^H8L_*.KC_15KC\ P__ !'!FM\/3J/3Y.ON_<ST>/)U6LK;K9=
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MBX+$3!,9_GC1/OE@O\1#[1^%;J:7]WNJ%O\ ]0Z+S_\ [.7/GS=TS0-^2".
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M/6-KT]M;Q*JK8Z!=F:#"QPR?&BFQ)WS5L^:R2*99")>,I!MVNV;=03-G"1C
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MAE7?%CY<<9=3<BF?B.5BEH;/@GLP2L.^-&NIE6(]'-R<.+<TF1%F5V)QCA7
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M+P?)K?:564L:E:JK^*5"RU:H6&RUROV1^PDXH@*O1>Q46#5$Y5 XXX?SDX^
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M5"[1\DJ\+>X'<VK6.RF4H9F=LB2-*S2?I,T4BKN3+I_GJP-U0%( X\1E]@#
M& , 8 P!@# & , 8 P!@&%O,[?+K5M>HNKZYJ!UO:_\ )&<L6L*GK1.X1NOF
M$S'MJ;-V&ZO)>Z2R#IG"M&%98.B(D(V6?/WSMLW: GT5<( 86\$^2T_1F/'7
M1Q>(IN._&O:2FQ:3QR7<[0-<;W%3FO1GIZ=A]CUAY%H.HI&>-&6=]!2;*:ER
M%(U1(\ J;]LL4.../2328 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MD?,PDJW(\CI)F=0B9SMGC95-9$QR$,)#@(E ?=@D]3@# & , 8 P!@# & ,
M8 P!@$;.[MZ^&_J3DHVN^Y]EZXH/(^K5].HN'TC(6:*FGE<GF*[EA V)G$I!
M#6IH+22<.(AK--Y4\<9TLHP!L<QL ]/P88\#Q^S/9>#DE3))A9KA"K[6+29.
M>=Q$?9VD8Z+#1Z47,']-7$6\:Y<BTAX=NSCFR)^Q)JB0J12A<S_P!@# & ,
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M-:A#7M1.ZV*PNX1^UD[A;9Z,C0DR/*^E%E<1K=$Y1),-@# & , 8 P!@# &
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M['>]9G+=!I+1HK4$IY"8*G*"]9ILA$9</N\>0V,<$C & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# .#"  (B/0
M1$?H  ]X_P"+Y< C1Y3\->,>^[4IN25V7<==[!K[9A+OY346Y#:_/;'](B+
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MB!=%9!8[!%QC*K2-CL1966]@( S;O$Q45,HXX\&XCHMS>+D\!-E@D8 P!@#
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..MP!@# & , 8 P!@'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g425213g01a99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01a99.jpg
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M-R!H86ER;&EN92!R=6QE<R!C:&%N9V5D('1O(# N,C4N)B-X03LF(WA!.^*
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M!Q8B4Y+!%1A459.5TM36X2-"4F*4EM7Q)#,V8W6BPO_:  P# 0 "$0,1 #\
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MZ#_^S#K!_P#!]=?_ )[.T?@V[_R&R?X>5^P=Q_!%U?FZQ?X:3^P3O5%&4O1
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MP6<>D\HDT>,+-UT6B'!\P$!/&) #'B9$,-9OW(QBUYZ\M22V+8J([*P0, 8
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MFB,+(V8]G@ZLX7)HR\,:F;Q+(P>.L[0'2-@H#C8^8HM-1A8&'6-"4LJT;:?
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MSQVNH5/LUU_L*EOM%]D",I;Q\I&97N,^NV\:F\%EH&P8$>?A/71NQL6)FL5
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BZ=<<EWD;C8IR12;.U56R(ANKK2G1]R2\QT]@@8 P!@'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g425213g01b17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01b17.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3%:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ,3Z^$F!CA"24T$!       0!P!6@ #&R5'' %:  ,;)4<< @   @  '
M)0  A4:6T@4GEA;AP"!0 74&]W97)0;VEN="!0<F5S96YT871I;VXX0DE-!"
M4      !!#8B<E/-U'P,.[H!FY4R6<.$))300Z      #O    $     $
M    MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
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MYU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M  5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M     08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&
M]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6
M=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M
M 0 2P    !  $!+     $  3A"24T$)@      #@             _@   .$
M))30/R       *  #_______\  #A"24T$#0      !    %HX0DE-!!D
M    0    >.$))30/S       )           ! #A"24TG$       "@ !
M        (X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9
MF:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M$X0DE- _@      '   /____________________________\#Z     #___
M__________________________ ^@     __________________________
M___P/H     /____________________________\#Z   .$))300(
M 0     0   D    )      #A"24T$'@      !      X0DE-!!H      S
M4    &              -E   #JP         !
M    $              ZL   -E                      $
M              $     $       !N=6QL     @    9B;W5N9'-/8FIC
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MQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M  !     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;V
MYG   #90    !29VAT;&]N9P   ZL    #=7)L5$585     $       !N=6
MQL5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M   0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
M   0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V
M1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E
M1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V
M5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=7
M1S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M    $! #A"24T$%       !     HX0DE-! P     )K\    !    H    )
M0   '@  $5@   )J, &  !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P
M(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U
M)'0@               0  ]M8  0    #3+4A0("
M                                           !%C<')T   !4    #
M-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&
M   !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96
M%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   "
MQB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L97
M1T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-B
MTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                  6%E:(
M   /-1  $    !%LQ865H@                     %A96B        !OH@
M  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M"VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M  %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                !D97-C         "Y)14,@-C$Y-C
M8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M   "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('
M-21T(                             9&5S8P         L4F5F97)E;F
M-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M  +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C
M$                                  '9I97<      !.D_@ 47RX $,
M\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
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M@+X0OY#!(,*@Q##%P,=0R.#*<,P S9#/,-#0TF#4 -6@UT#8X-J0W##=X-^
MX3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[! )$"800Q!A$'
MX0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q
M-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/ 5$A4T%585>!6;%;T5X!8#%B
M86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$ 891B*&*\8U1CZ&2 911
MEK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC',
MP<]1T>'4<=<!V9'<,=[!X6'D >:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@;"
M"8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_ D'R1-)'
MPDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$HHB
MC4*08I."EK*9TIT"H"*C4J:"J;*L\K BLV*VDKG2O1+ 4L.2QN+*(LURT,+4
M$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C U,&PPI##;,1(Q2C&",;HQ\C
M(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I-R
M0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\93
MRD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9 YT$I06I!K$'N0C
M!"<D*U0O=#.D-]0\!$ T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(!4
MA+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3F
MY.MT\ 3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU
M4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^
M5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&
M-#8Y=CZV1 9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I
M]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W
M*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J
M5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](
M-7@[J$'82 A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_
MR,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4])
M5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY GJ
MZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4J
MC$J3>IJ:H<JH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P=;#JL6"QUK)+LL
M*S.+.NM"6TG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;
MV/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#
MW(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'31-
M/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N W 7<BMT0W9;>'-ZBWR
MG?K^ VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>
MMPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[]X
MKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[0 ,061O8F5?0TT  O
M_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q
M43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0
MX-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,#
MP,# P,# P,# P,# P,#/_  !$( )0 H ,!(@ "$0$#$0'_W0 $  K_Q $_
M !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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M1 L>QS6%Q<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MM?$W0U)397)T=K*S)U:$A9.5TD9B8Y*4HZ2E9AB"@Z+4_]H # ,!  (1 Q$
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MSIK5CT\1MK=:D';9#3KS*;N;([Z<_.NUG8]<F,O#VE,ZSA<(6^E=.?:3#J^
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MI"?E\^^7BHIV/'"R=GD A/D3S^8V H]:_J7\+22W@X1<;\3\VUOK:Q0O<>M
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M[ V !KU)(T3HDCJ3M2J?9/T3"A>V<0)!\+Q/B!5": I2YS5$ U#6!Q/QFO\
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M1D:\):]MP5 !(HBIP0E ?Y(/1CZIHUB&.C&.C&5UWT;.1K22/]BD'?&^9R8
M&R#ZD :]W?IL\ZI-[IM??=@*(/N<<"HIKB>(J$V&F8&U6L#JC3N'B:BV*D[_
M ))+<]ERNF\-"1.CH;T?@#R?>\?4#6AP#ZGR!"5'1TJMX0U"J\J#OLS8A4HC
MI%:@)N:5SUZ^P! C/!P&=X6QM_V2C/\ A2('X?WCKTKU6_P=:'>0)'8/XK=0
M='-DU3-,>-./+^DIC=^';*UF2%5)^5J:!TFHKRW\=DG6SSZ'R\22D*(X/EUY
MK1"#$?(2KQX5\RIM4JJY@I:J-;%SP';>"+\@.71[+MO7MB.\[8\&TZ#Z6]W2
MALFWI@^23\>1SL#@#\23)VI4_P"E#10**3.()2M<(Q%4YZ$^RNHZP$.A^-4_
MBI;D^7RO[MYJNV='>UQA]ASH_7>&(//PBYXGD<@@;((WHC\.K,^Z1*: 29!0
M^^;#LT_$,5YZ7I4$*%1&B+53QFB^29M:+_'RC*=)!.SO@#WB"3K8.P 20.?B
M3KD'1.NJ*T>0T((3A6*4)0U'!4BA1*DKE8WKZ;LSWL3.[$O7G_I?1/Y\P<=R
M?CZ  ;V3KU(UU=/W,171?2,H0??"ZJA%/<R2Y%V+F0;FI@#6[XYPNJ_%A^EQ
M^0;Z4:,'> ?Z<;AV5 "*MHC7IOZ(;<_ZPUQR-#?!_.%=?Z?9,Q:Y^!8.2AJ/
MBZ"%0!44#>HI12T@:L^*4G_:9[SS+Z]>E6C$>4D$DJ*3K9)VGC7IO1_M @C1
MV5Z!&H6503<WH<KBNS-2$J\24"-( RY[77+FMZM[:NZ%K2?]E>76=93E%%Y@
MV5;55M'CN.=IIU[<136IL_85F[YBX"5$T73-Q0=-Z@35;UJ=5"%CU3P/Q%@Z
M_HG#LA^:0<CZ&IEB'C">_MDS_GOMXON>[4KIR/A.*Q=ABZ*<7),+^1>*YG,5
MTW)E:2;ZM:Y(6C5A;LRS%YGGX5TQE9.)?BC&-V51W#-YZWF$O;R+DD)!7UB-
MA3S]:^:C?C;>?;1C*>P[A2SL<7*;?$I;M6Y_XBV R7$L8V6N^?G(2,^D6%I6
M&WN"4BX62CX^>NQ=FVV[N^=;25SR$4W?RSD'+&WOT8QT8QT8QT8QT8QT8QT8
MQT8QT8QT8QT8QT8U$7VSZ0/:2]PJR-_X/B/D_E@W'.@K@Z3O6B"#SH>NTVMU
M9TT*PCEQ%.7NI.<O.0E*<L&:9 ^^2?(_5%*B@$A+TRN2N>7,K5124K \ME2D
M*5OWDE/BGQ*OO(62D+!1Y)UY Z7Z;USA*?O"%2*H4!2]FU@V>4&H(*$"U+H'
M@00JK;85 Z&'>03_  ?'<B0=']5')1!.QK^B^4.SSL?[]C\>J?:-\;\$_O!(
M_3X;6!QHIH_B9'Z*FKT_%7ZY&G,6YZ .DDE7NE:?,'12?/15M16->2D +\N/
M I)*@1NX*95H+CHH@NA]""Z0 **20 7K%"#PBIN5RJ"G*0B/:_1[1KO6R&GW
M2$=M%[I21X^0_I,P\5;]%@J]T^A2=$CQUX]15K@":,R=_'DJM[=HXDFY/JW-
MNV@ /=N/8@89, $)?MJ254 (H ,P>#DE96_I(@);]G(&A_'9_/D1L)\4865R
M?1.R->1/'H 20DZ_J6\+2/\ JX0-ESB6>7+E?:WU=8R?%%0OPXV*@ 2A)!ML
MY=AL:OBAL+-,D>0'BD;4H;V4*/O>(2=%9!*O=V#XH W.M+T47YKFV1 S&1V-
M&I7OK@40 E:Y704*CG&\WH_8G_\ )S85''$[EL<$D;^UF\R3L\\D[(5R"='T
MZJOK/XYXG\UA_P"SY9IMT+XNR6?VR<V?GD?8U./O  /=IW1 J2=]P^9DD$>Z
M ,C7*HE>E>>@  E:4'1( (UU9'1VFC^!4)^)\,S_ %*!91L%:].</XIXSQ,J
MGQA. ]Z4($S%>KP4* ^"\E#0$/-F.R50/>9VF)2LD?K)8/\ '9  4,G6N#H$
M<\#@I)T"2/(DGKITHIHUI!3\BXMMSD9@J:_4N3=F#(<7PNI/QE(H"EQ-P0@4
M9 $A,L\VZ,'5-6L,QT8QT8RNN^@G[1;3'.C9-/?Y@SDSL?O]/0$ZWH;T#2;W
M32^^_ 0">+CFX%,3Q$HJBZ(44@5 5&L#JC\28EY4/T26:$@4D>I.SP22!L:(
MT 203O1)]1R5%(V#6\<M:[ *J$%]I4<IS+2O?FY_5SD9+G=GA8#&L+XV'_JE
M&>O)V:1WL^IY_>3\=GKTKU7?P=:'*H3 )'<:0NJ-4S3'C3CWE*8V?R]U!R9,
MD"KKY:KXZV*BM)4-[\2HZ/'WCI)"=^A^)Z\U8B]EB +X1 K10:HBH211TV%R
M:M;%WP7:?@A$RH.7*]J[+-O;MA_;MC[8Y^?ROJ.="W9=/D$[3K9X\M$^@(!(
MZE#4JGV3M%,_A.("I!\'",1"A50W!JM0!<EM0T_XH8UNA2P_^=*GKS[VG1WL
M_L@C_P ?KO"Z_(_1<_R3\ /B>=?@>K,>Z13W@R8/^LV')_6$ABI"FI 0&H!/
MH,1ZJ>,\7R5-?Y\HRGSL;/W=G21H#0^! "5$?$<:X')Y&Z*V51P0M $HA4(
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MF(GE4)G04*$HE@=4?B3$C_2I\TI+>UH2$$$<;21X^2?4 )YWS]XA/ESOXC7
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M"*55 2*@%2ML7/!=_JA+#(7I3.B^BF]>V(?TZX\V/5]*$%/B!Q;DQHG\CZ_
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M1EBOQI9YUS@2\.*^.$ZX^>$7>!2I"AE\BP,H@ '#V8=C:@?LMOCA142/$"%
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M.G:=:*BVM..D%5>(4$[-Y&5/. I7HS9UZ^=G"=<F,I7VG-OV'<LQ@N.R1-V
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MEW!<DV*+63D:$U/?1C:X)N5:0SB[)YLWN*]7L/08O;WN2A1N.[7$U-TD/TX
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ME1;T:2Z]:O5J(IT:5&F@U*E:I560BG2IH!6NHI00E *E$ $]=@!>(#H))(
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M<57( -?T@R1V!H$FW+6Y&N->GIQ^9^%XO<S #0;& /\ 6R=R3\CX'E;G%#=
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M16S^5\;!2$86)!Y&O@1KE1 2/O=:KJ77A:2)7O<)].)UK3/H7D/V]8J)A )
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MJFN#\9\*\O2/[0A;6L/B=,%G_)<UEEVJ^M#NR]+<Y\^((!&B5$@!!)T M2?
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M0ZCHS:'?EO6P-@>0 /(T2DDE6]Z)T2"HE0!(^'5?!MNBD!0:I<V5%#MS1%!
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MB 5[&\M:(%"%62 KV3_M*"4:[/;]&D^]K(. 0/+9^Z/M@\2 O^,'DD:5HGR
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M.;*\KSH,ZZZ;ZK:-.K<Z&RH.C5?H,;&4>Z_MG<1-O3M'/&*EQ%USSRV+>?\
MUV@DT).=CQ%*?QU(J>)53J,Z<_;U9U4<)HT*%"X[;KU:J:-PPU1\8VVKJO>S
M;'HPE>\KIM^UJ5RW- V7;JY^78Q(GKONA]3C+<MB&#VO1,G/3;^JEM&1+(5G
MKNIY_(T5)IU%),;U'1C'1C'1C'1C'1C'1C'1C'1C'1C'1C'1C0EF^VW*7UMS
M(UL_(ED0..<YY&8Y:N*6D;'<S66++NUAC*S<>TJ%C2M27H6V*[=[CRT+IMF\
MIB.KS]DU&TA#Q+-YJVYBUS&BI9GLX<H6U==B713R#BBWZ=J9DLG(:[9M"U+V
M-L,X>WK3Q+:UV(AHB[+MN)A3N3(2<>79(RTO1914_&R&3Y=PVN]R@9 ;Y=Q7
M;UW>TKR'(TK^TKM/>]NDQD6XI6['$U5NRWL88WL^U:$]=UQ0&.,2X93>QL&T
M8B5O23D)9VILZR'=%5:D4(QHSBU0L2:$K)QTI=-Q98TUNC&.C&.C&.C&.C&.
MC&.C&6_W5>SPM;NFOC)5^W!=LC!2US81M[%%LT8D_(,ZQ@W&5K@^C<B4U4'%
M:Y+!7D6YL2Y,IV]$N(215=F&K?+J5KP;N6A90QOQ,.R;+$.\A(N$S!;#"TL>
M7!W"7YCVF_MJZY^G-W;GV.R<NK$Y=L!Q>;'']YV]9MSY9N:7HSS-E%7O<<*P
MMZV!+6W1IW5(7?BNW;EMMGEU1C;EPAVN3F/(1J+ER=>-&83EJ[\JN8BQ[RNZ
MI;SY5TU[=6+5O"X+[?W-?V4(YE]7?E$2EZ3M20HT)J0MZ+1%VK'V_"Q66-@N
MR[M.NOM587#;DGD47;:8M>Q[/M:*H.KU<!Q5LV5OUX]R3<=&[[JN5G&WY>T3
M==N0%S,;0I1=O&E846\;H4V=1\-;> $ZCKN8O7KUJTY>LL8Z,8Z,8Z,8Z,8Z
M,8Z,8Z,8Z,:"7<+V,VAW'94>9&O&X)./I4,?6!9L7&P52FR7+T+2N7*=R3MH
MWW5KM7J+CQ3?#V];0=7595%+'Z:>6#$EZ]6U0&RS&U' ]AV3+;B[-LIMDJRY
M?'EF7!]HGT/*1%XT:MYW37QC%VC+6!D:&;7*NS+WQW,77$T)2C-W!;K^X[<Q
MTX>8SA(JFX73O2F'M\Y8WE[Q]G=D#+N-Y2W,E7M;<+D[)LIDB,SOF+'EQ7]&
M35ZX^RU;V+;:OVWXRWV=*VH1LR?6SBBR[+M:V91#^*L^ L*P';V2O)TSNYG>
M(]'7KMY&=>O7ISFQ?G;O5NABZHL<@WB\JO\ ,^#,K?,;UFG%RP%NM<19CM?)
M[V LN,%)LJWZ,XP@W,'2*:[FG0*XY=85*+-:*AC29Z,8Z,8Z,8Z,8Z,8Z,8Z
&,8Z,;__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g425213g01b21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01b21.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1R,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ''"^<H X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'$<K!         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE-! T
M  0   !:.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!$0      !
M   "   "0    D      .$))300>       $     #A"24T$&@     #00
M  8              PH   6M    !@!G #  ,0!B #( ,0    $
M                 0             %K0   PH
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   PH     4F=H=&QO;F<   6M
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   ,*     %)G:'1L;VYG   %K0    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $    !#A"24T$#      1W0
M  $   "@    5@   >   *%    1P0 8  '_V/_M  Q!9&]B95]#30 "_^X
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M?M&ZZF^T8=^,YM7I%M>'DV^HQWH_;/4=?B5V^[+?^?\ F+HED=;_ .4N@_\
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MVL#:+]V[^PKJI=;_ .1L[_PO;_U#DE)\=V4YI.5774Z?:*[#8"/$N?5C[?\
M-1DDDE*22224I)1L+VL<6-WO ):V8D]F[OS5EX/6[<S.R,&NBLVX3F,S V\.
M-?J-]1GL]/W)*=95,CJ6+6+*V75_:&@AK'D@;X]K7N:';6JVN5SQNS\ALD;G
MD2TP1( EKOS7*7#C$R0;T%Z,',9CBB" #9K5O?5[J=;.AX+>H6T5Y0I8+&4N
M<6"!#-OJ>_Z&W?\ \(MQ<'TNH4]+Q*@]]@94SWVNWO,^[W/T\5WB.7$(")%^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0'_P  1" $1 ?X# 1$  A$! Q$!_\0 'P !  (" P$! 0$
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MV?MT<'%1M8:W,;2D%[!X2?=(2?45H7MB&,IQ_F7]"*IO>8,# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & :;/D6_;8OB8_B!2?7.H
M\&4Y?F=Z%-R;!@8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MVQ?$Q_$"D^N=1X,IR_,[T*;DV# P!@# & , 8 P!@# & , 8!^1B" (AC$$
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MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@'\CSR4Q)JA2<4G3D%C-.//,
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M5D,B[S]UB;NBN151%D)^K1JS_,3I_P#^T'IW^JG-K[/4?[#&/^G\>_RXTO\
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MXVR3"'2BNY@SR*,21M2/#&]-:MA7 4(7)M7%')5:<S7JWL!I8M!&$!@/9,
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MY!3CZ'R;[$79\+7N:Q_@3=6X^U;W36\H@ZUABODK_%3YC_D\TI_1K&<\.!>
M\&Z*P[LD)M,R\Y,Q=/8S^TK)(+-J:4]%$/RLC'T@9OM%/GBQ+P=?\BM=1(>_
M"O"F&=(T>U1&Q=E)#^C(P#JGU\:HTSN3^^*PH&AH1G+W%:,LXT"9(G#L9QPB
MTY9IX] #K>]A**&/?^0.]YZ:E2Q?M04ZD2S6;,K88(D<UJR2/71K4<]S6(JK
MQ:N<B?A5#R7KU7#*=G$+TJ04Z<+[%F96O<D4,:*Y[U;&USW(UJ*JHUKG+[R*
MI@_]59S_ /G&0?HF1?\ 1\E?>\SEXCF\YH^M$'[ZVS_\8H/-,1]4'ZJSG_\
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M!E73Q9J.[.4-(SQ TVR%)LN2,",Q>A:EQ*=;K2=WEV?C [Z-3UTQ_2%EX_\
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MI#6MS0Q[[^Z$WG;C&[SM$U75=$+%OU<5W?\ OQ3] [_YS-AWI\I_[F(^>_\
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M+&( @BV!S, 8 P!@# --GR+?ML7Q,?Q I/KG4>#*<OS.]"FY-@P, 8 P!@#
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M\2>@_6#)BV[_ )G;/^@LF^R562'*7.?+_2]#M,9%<\\S,U?)_%NPS% .7'*
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MZ[W%G^(?E9&/I S?:*?,XEX.O^16NHD/QA7A3#.D:/:HC8NRDA_1D8!B"_\
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MSK9PP8!=/QC\PD<_A61_;"G*M;4N>-[R:AV2,NEL6Y@8;Y9BO;YR5.<\.K#
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MT'ZP9,6W?\SMG_063?9*K)#E+G/E_I>AVF,BN>>9F:OD_BW89B@'+CE 1@#
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M>Y#QGC8\>$*\?U1*HZE<PRVV)W\F.=KS@KX@EO<G)N*4:;V*-H3]A$CC4?\
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M>KB,)ZUO?XM;W^]K>_YLE9"E5$Y51/C.CE(1:C,B]81?L$[_ .3?_P"7J/\
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MT%P1@# & , 8 P!@# & , TV?(M^VQ?$Q_$"D^N=1X,IR_,[T*;DV# P!@#
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M1A+)60L\U,IE%:\BL@G$XD#7%8A%6M6]R&1/:LI"UM#6A*$<J6+%1P@@+++
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MSRE>:VU+AI&QZVKB[KS>'ZHIK+XRX,L=L5F.NJW7LISB3DK* G>$9C0\-;B
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MT\G1D#L@%("6?9Q2;3J:S!4;<BVW:@XDC2X:;279QI17O?;,"'8'=X P!@#
M& , 8 P!@# & , 8 P!@# /R(8 :]H8@@#Z]:]H0M!UZQ;T$.O7O>M>L0MZU
MK7X][WK6OP[P#]8 P!@# & , 8 P!@# & , 8 P!@# /@A! $0QBT$(=;$(0
MMZ"$(0Z]>Q"WOU:UK6M;WO>]ZUK6O7O /@!@, $PL01@&$(P# +0@# +6A!$
M$0=[T((M;UL(M;WK>MZWK?JW@'ZP!@# & , 8 P!@# & , 8 P!@# & , 8
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MW+CW54B/4 7N\G^0?GWL"36#74$)M"N;DJM*U.L^HJ_ZNEM+7''XV_"$6PS
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M-G*32$"4I(48H.WZMFGC+*"(XS>M;,,V(6_P[P#LL 8 P!@# & , 8 P!@#
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MD#HW,;$R-ZQV>7EW6IFYJ:6MO3F*U[DY."PPE(A0(DI1JE6K4FE$)R"S#3C
M%@$+0%!G7W<G&/DFJ*;\/<M>1-!2E\7*WOL;JF6[A\M9JSNM=MN=&%XJ]OF\
M[@C="+2ADS(<E#(])ZKF"J2#V-*Y1U4X"1";UX$P/&+U0S6)5Z/DNQH070G7
M?'L+A%6WCSPN^&3A;4,<8D4=C5HU:<0$I',*1L%$VDNT-E#($Y(C I^07/X=
MQ2AVJ M%P!@# & , 8!'_H_J?GWD:!%V9T9:,=J^(JG9)'VA2\;7KG>32-?H
M8D,:A\68D;K*9C)%@"C34S!%V9V=C223E 4>R"33  4!='WVP]57]1'D;X6N
MUR[)KW@.7#?.D?'P*,*HO:L1:'6%V+!W&ZJIKR?12(62V6JQQN?/KF*,2=OV
MAL<J,-"&)NR%X9"D*P#8=H.^ZDZ>J.$WG1LT:I_6-@M!3Q&Y&TF"]DP&Q")6
M-KDB."6M9GYF7%J&I^871.E=F1V2*VUR2)UB8TH(&8, 8 P!@# & , 8 P!@
M# & , 8 P!@# ()=W\(0+MN!1TLR1/-0] U$]?=WS5TM!-%I;*HZR$A?K2.S
M0M#LH3Q$GKV -DZ@KB<)BES$8:E5E$KB&UQ0 57^*UR>">XND6GR0OJQ?Y=6
M]A%'8R>^(T;+4#WQZA7D'1UXXD;RM%H#H,_NR73Y<6BP[G),R_[/*"$J1!L@
MH#8 LJJZTN6*J(+;< AUF0M4XL[LIBD[CC3*H\H=(\Z)7IC<#FAZ2K$)BMI=
MD*1P0'C(V8F5)RS2A!$' /=A"$ 0@ $(  #H( !UH(0A#K6@A"'6M:"$.M:U
MK6M:UK6M:UKU8!^L 8 P!@'!<W-M96Y>\/+@A:6AJ1J7%T='-6G0-S:WHB1J
M%BY>N5&%)D:-(G+,/4JE!I9!!)8S31@ $0M 4C>6BV:XOC@9OM"G)7%^GN9J
MYZDYRFG7K11,F9+722WF&N;787^\HNH3P=P>"GY$TMB9ND$TBX#]&*XDSO13
M@5\G"5!&!B[RS="\.=5>.9?75&VA4-[W3;NH0GX&AU(RJ,2FU">B2'9J/J:4
MUHSQ=4IDL)W7RTL#G-7W25E21"&(I$W24]"C.4H#@+MXU4$0W(H#;TUA<*>.
MA8O5A=:*[:!'6L4Q*8W<;(\2^-MLEVET[$1AXE+,G>1- % 46E16CP$ &<?L
MT#,. , 8 P!@&,+4NZF**94,DNVVZSIZ.NCHG9&Q^M&=Q> LSB\JO7\,TH7.
M5.C4B5N1^M;V2B(.,4F!"(02MA#O>@*9[IMZIZ-\SE2V_P!6OT9C])6IQ@FK
MKBN\)HO;R*@AEUBL-YD%QQ=+,W$W47B,_M2!*H*H8G]2O0&RB-L8XXVKU'OA
M(C@.4X/M/WAYL><K#Y#?HK-I%4_.%[,'>5DU4Y-KY#3H!+$L;)YXK"QY7'#E
M3"\6*58:%?+(O&UBY1)62+-#HX'DIFHU)H8%S=<U-6%0-K\SU57T/KIIE$OD
M4_D;;"X\V1Q"]S:6K/CY-*G-*U)DI*Q]?%F@GN3D< :E4,!>C#-A+ $(&0L
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M/4$K:PY2HC#)*#TBQ*>N9U+HWD*U36X.K.6XHHVM6D$LH9$<U_+2M,T_&G
MH-X%X@XD[XX"CRQSB)]7=_0B8O;MT/T @1$QON"@>\V]Y5.\WEDEFRHHB<%K
MM2H6W)DC;ZJ-A<BKTUJ9TS;\C@*+1@66<_\ +KI?<21+/*+R)RS:G2]$RY;7
M\4O]=7%8SY!=<+8DK6Z12ZHBA>V9VD56FR';D<1(*^<#4^F":,[ZJ9"_D-6T
MB"!:"000E()3)B2DZ9.460G3D%@)((()!HLHDDHO02RBBBPA 66 (0  '00Z
MT'6M8!_7 & , 8!\WO0=;$+>M!UK>][WO6M:UK7KWO>]_@UK6OP[WO\ !K6
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MUMS?I6H.^#0I4_NR  =_@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MJZU5%N3N%PE<>2I<8G 0%-$;BD*:G=0G3G/JB.QA \OXB2@O;JX% T7@%@.
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M;+:=D6!+V0R,O74UQ1X9QY<71H(\I<62EH8:8H7D)'-=-EIQ UC;I6!>;@#
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M]M$/WQY+)&6Q.V)#5JCV0B5N2P)&UKFM&'1JUP4*59OK,.'O8&5\ 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
) & , 8 P#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g425213g01c01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01c01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2CR4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *-:^$$5#A"24T$!       21P!6@ #&R5'' %:  ,;)4<< @   @  '
M)0 !%+86UA;"!$:&%M;V1H87)A;AP"!0 74&]W97)0;VEN="!0<F5S96YT87
M1I;VX .$))300E       0\^&S>'"'.'+9O1D^0F]I:CA"24T$.@      Y0
M   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
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MYU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M  5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M     08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&
M]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6
M=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M
M 0 >B2+0 !  $!Z)(M  $  3A"24T$)@      #@             _@   .$
M))300-       $    >#A"24T$&0      !    !XX0DE- _,       D
M        $ .$))32<0       *  $          3A"24T#]0      2  O9F
M8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M       0 U     0 M    !@       3A"24T#^       <   __________
M___________________P/H     /____________________________\#Z
M    #_____________________________ ^@     __________________
M___________P/H   X0DE-! @      !     !   "0    D      .$))30
M0>       $     #A"24T$&@     #-0    8              F$   61
M        $                          0             %D0   F$
M                   0                         0     0       &
MYU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&
M]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   F$
M  4F=H=&QO;F<   61    !G-L:6-E<U9L3',    !3V)J8P    $
M5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M        9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97
M)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W
M5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M1S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
M  #     (_\        #A"24T$$0       0$ .$))3004       $    !#
MA"24T$#      >9@    $   "@    1    >   '^    >2@ 8  '_V/_B#%
MA)0T-?4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0
M & #$  &%C<W!-4T94     $E%0R!S4D="               !  #VU@ !
M   -,M2% @(
M              $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P
M  %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)865H
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M5#-C$Y-C8M,BXQ
M                    !865H@        \U$  0    $6S%A96B
M              6%E:(        &^B   X]0   Y!865H@        8ID  +
M>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#(&AT='
M Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F
M-H
M   &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W
M5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F87
M5L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M    !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6
MX@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V
M]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M      =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(
M      3 E6 %    !7'^=M96%S          $
M "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@
M C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )
M  E0": )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L \ #V /L! 0
M$' 0T!$P$9 1\!)0$K 3(!. $^ 44!3 %2 5D!8 %G 6X!=0%\ 8,!BP&2 9
MH!H0&I ;$!N0'! <D!T0'9 >$!Z0'R ?H" P(, A0"'0(F B\". )! DL"5
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M7.-LZVSS?/N- YT+
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M-5F)$EV"ESC(8*5(#:>JBDH; ]$G694E@X==MR^573*'&M!*<K[C,>;'3@@
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MH^'C7<7+"7\H]8(W1$T8X^V/F5V;*_M0COO;E@OQ=#OT8%^+5RTUTY,.D/X
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MS(MU"R5$F>:N,P2"I $DM6+6@C[#+Y8"$L(Y%V,*;NEAPVAC*)/C.'MMVA;
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MSV3,A;>#3/\ LJZ8S%8O&9ZB<#2FQ+[[$GB^CE_#!]PE^9H'UV21FL8<<II
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MRG=H$[AY!1+9<(+\9"F$J' 2QK]0HBH"\R+'6I'AYTLMM(Q)7<CBN241$-*
MQ0(LT#*ZL$4(W(]P!XP6+JM\:)*FHOP)OU$W9R"-^U *67FU("F%!I,ZSB:7
MXUU>L! ]?KY$ D1PY)<<37+M[12UA&8RVV21-$?$NB-Y_4#66\G1ZVF:EL.C
M8DX&0%MD7-A!<IU[%)1!:+@*O.J0>;:LMD%1=OL!(@3&N6F=\]-\J4TB9H=?
MW:MM9ZKX*9N %\N7<X+H4TA87;,Q[R[>44!#.MM*,UN@W+[<!4FBJ+A=1PEN
M16H (U!EX_4<P&*:LJ7#&L* 6UDI^'C6C<G/TCU-&Z(_@LOE+72NS1Y9<QUH
M17WMR05KX:)T/4UZZ_[L"[W>KRZ\.D/X V@[K&]'\Z>OG3PTEVZQT^Y^8ZI:
M<9H-(:^_\ZODIDK5KYQ^?)ATCGP5AO"\+^BE,+*]][FT^<4:HFO[!0MO?[3@
MOQT]3>[7P<%.&G@QMCC 6\55>DT2O:'Z2?F"=V$DM82]AX/X,)KJQ&Q4#P/O
M[7\:5.3WS G03--MTMCC^1?HO^CK3EFB'BQLW_EO@7YT/CJ2+\9ED/ D?^:H
MD.8;TO\ W=V^<B_-ML*Z,WFSF0ZR6]C'9/AUE+[YLUT8W0?=[X3\A[],JDY7
MEQ[3(]W8'Z.A/$&=*9"7WY#^= X2M.I1Q:<(U/E,_HH/7J$LZR>:0<IFTEZ7
M8H+Q298@D4E3QD1<&>83CL7.TG/<VZV6)UC81+D[=+K>W.RN.G>PI7<-5U?X
M7%8VQR>+V2A$)BRT65?Q%%V:@8*N1=BPW1V[9F6G;3;=) ;G^ I_O:D=G*)!
M\;MV(8EF6()*Q7"P6DOF4&8K+3>4]6<-K&(_=H^Z7G_KQ-;%\5EJ1_RK07WU
MA+&AGUYDYSRA\=5C.[63Z>>$:C0]G_,/S<E_Y_;JPZ17@+8#PC9'1_1SY^M4
M9H'QDY4/!5OOI@0<M;9DE'GVT?V;$@B?&/9KP)%O\Z1B$<5%K_&*!>8)ODOU
MG9:^:YKI"#CS9W??*)X49='(MK-X,EO@9YZ760^Z3K8;G/WLPNM!DXJ?(>9Y
M4;*S'\>*W^ HIC<.M !6]^R&XGK8]S@VO_:&$I0)-7%YY+=6]K?V8.NO>WOM
MG+U\%?R:N75OXZXLWQO93)7>Q-CY:ON%J;ZX:.>2<36LXCLDOAJW$\*F(,ME
MY.(Y)I*&0M[2E98_%67+X_M/3M_N\-/P4X*4IKK!(0/X";<C2\VSZ2>)UI+9
M><)XV)&_QC,GG>M@^7WJ=KQCMPYB@L@[V9-*!2FK9TS<Z_B>A'>^*E=[?X:X
M?K4<&\ANG[,LGW-[&-9X7Z+QY4CEC>%?9#^(.4^1./OLPK?SW'R)8YH5-F:0
MZ_\ OBNT_ Q8^Y>_R4Y.3%,]DUPV@]/]EG6F(G%XS65XEJ.E+Z[$GB]CF/WX
M/E?\%@?+UVHQV=M]3KXOFGO?T:.^??X<<6,.$L2^3$KJ?R+2F%UUU<4U(;QQ
MVN[A:KH]L@.BG8QS55[KGAFGX'397]>-!RW@C?=H?Z=(G9SBMRB=_P!E^D59
M^1' _P!\/1F92,I=S/=SG:ERB:FZU0N;B\J(E3UI5[E:EJ'*IAHMVS0O4<>H
M&[=GN-1A=S['=;]?MY>'AW@D#W!NV8%8Q+.+%JT9%;->O:YQ465S@,XR!F*G
M2FY&8M%87DXR;&&1-_AQ;K6M#?M%\>'3=0SB[+<]UW!HSW3,SU\S.GFYRTI9
MQG<45S%1HF2"U(34U=3]49:2$04L2JDJ Y4>X^AT50KQ5>@=Q2V\0L"*()<(
M+V5!/WM]>SNIKGRL6<U'MA#EUVG;311F0KF+%4E9GN@.>)BH!)!.,C< G3K.
MV\!81J'V4;O+?V<>G=U649=K-UV:Y;.G;*I6><TLP5F:JRQ*RT\ZAJ4JCT\?
ML.03W?5+7NBPGY?U=_$<ML9NCCWPTK*4SN?U2\U)$)S'V:/!6Q?C _4_PX_M
M2'T\;>^C)\EN1KI\+AG?=_+.]Z0/Z04JBVO'3V._BYD6Z?6ZX;$503QAFDC\
MG.=GIH'A7'?VT'>T;]-R78_MKDL;QY=D#X RR=,A(OQ;Q8F:;X0$+_-[\-[M
MP=B7?[G\U=*\LY^+SE&\>+)>B:)TB:,K8.R]\UW'TY=>+$LWO*X4_DVDS^D-
M2!Z]5#H3OSL=N)BPMWQ"(7>&XGY=.M.:[*?L7Z3#F9 '6BKX[NM9PUR:]^VB
MZ)9\_4I+W+>^+?(=/3+)\RUQ7V4KR\SC^=CS">,^UO@&!:=!O_8BM]Z'+OAX
M\YNZWS22$M<8UHZN8&1_Z3(8CL)XNLHO?]N=7\DUV)LMM](7W*'^<=:(:]'/
MQN^;WWUF.Z]6QACRB<4=CL*69Z">9#1Y-DC),\-WYB%/Z93])4I@?,DN9A5T
M1X9\$!9<WIE( H#D@-JHX9O+$[2YAHU(SJ[2K;%7Y67U HU%5K2R]THO>PEY
M;:2T003%#8D6GD:0@3CCIS92M:3-)BM #LD,*&@)OFDI!\PO!GSSD>8[4N3P
MDI'&4N:4Q>0)4NK2>()**F86N$@94.PW2D0*3QTBH$T$S!S'7B1.ZXTE, S,
M^5!*(<VCC17:5<[@;I\-41S^9%ZT*'0@Q@@QZE(0R_$3'8V&0@1:;F:+#@U[
M,.VE:AUNM[*RMMU;;R4T>(UW)R\K1Z*-T2_!8R'\8Z+Y#DJ=/*A)?>W+!6__
M .'0[X:_Q8'OX<W#@#:#NL;O'_-.'6:8VOQYCL9^M!I#>OM[.KY*)*X*TU^N
M.G+W=7!2O!WL.L<^"L+KB\+^BD^I,;*]]G+X-H=/\8WRPI=@,$:HNPH6^$X+
MU;UIY^>K;'& MXJJ])IYKVA^D'Y@&R@EUDEK"7L/!_!A,]6(V*?>*V[7U6I4
MOG7WS&&,I3&NNF;C^1?HO^DG+-$/%C9O_+? OSH?'4L7XS+(>!(_\U1(<PWI
M?^[NWSD7YMMA;1G<V<Q_62W_ #_SQCLEP[RF=]6:Y/>QO^]!]WOA/R'OTRF%
M_74DY7EQ[3(]W8'Z.A/$&<^(E]J?P8A?A]\K2[5YL:HXM>$:GRF?T47];I(L
MT-VV'F_\6+O6B)CSEEX'V1[X=\)_FLGJ=*+ _CS]L7],EH<X;641^[1]TO/X
M:+%\5EJI#^3M#?I]BF6SDU%*(RA\=5C.[63Z>>$:C0]G_,/S<E_Y_;X?/N<&
M'2+<!; >$;(8:&'79?=1&:!\9.5#P5;[Z8$'+6V9)1Y]M']FQ((GQCV:\"1;
M_.D8A'%1:_QB@7F";Y+]9V6OFN9Z0@X\V=WVRA^$V71Q1;6;P9+? SSTNLA]
MTG>PW.?O9A]:#)Y,5-D/XT;*T(]O%L=$"BG[Q*DKJ!+W[(7B>MCW.#?K%"$H
M$FKB\\EO!Z_\P?<U;[G+[WX]6]OU^/'7-FN-[*73\T6/Y/N!KINKRFY.)K6\
M1V26OYZMQR^^#+1JY,<$E#(7&E99/%.7*FO5O>M!-Y=_7KX*=_>WM>O$$A _
M@*MQ28[8MG.D[XD\&X==N-B1H_\ N+R>#^RV#EK]ZG;GOZR060=[,FE IO:_
ML=<W.O@X?3H1WO\ &F]3>U:ZZL/MJ!][>0T_]99/1<#^;6NDW]15(Y8T_?7V
M0\O^ <IY$]<68?5K-Z6.:%2OW,TA=WU<5[N5_H+'U.__ )XIKLFL[[-X-B?L
M6=!KF(O&<:8:36NN=]=B3+[7L<E*7V8/OE@L#^NFC"2,=G;?,Z^+YJZ-GL<6
M,)?9-$KY2B>WX%IUK?C)-2&\<=KNX6JZ/;(#8IV,<U7.>&=?@]--GZ\:#EO!
M&^[0_P!..7K7!(G9SBMRB5IV_9;I%77IE+7IN31,FR-D_P#?<Z]-B&/#_O)
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M^+#S6BU&C)4=J@MH%P)R5!+;4=LIQ=1#'574VPQV!)::)(*.2L%O88RXTU)
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MD\09TXB7W6J__K*T".+7A&I\IG]&"+=#=MAYO_%B[UHB8\Y9>!UDM;P[B_\
MNI;D,[I&B+ _CS]L7],EH<X;641^[1]TO/\ U8:+%C^"RU.ME: &?@EC?ABE
M$90^.JQG=K)]//"-1H>S_F'YN3!](6X<XK+[!+ >$;(^@,D9H'QDY4/!5OOI
M@0<M;9DE'GVTOV7$AB?&/9KP'%O)G_7UPC$(XJ+7G_J*!>;]J;Y+]9V6OFN:
MZ0@X\V=WVRA^$V71Q1;6;P9+? SSTNLA]TG>PW.?<[58>OP>J@R<5/D/'\*5
ME37X2+7^ HG>)RN N(V!+W[(;B>MCW.#?K#"4H#FNE:Z/+)9O5]?V8/>WM[[
M9R_#JIO^"E-?QXZXLT/X7LI?@FQ]*8.#7J=F"<36M/\  =DEK^>[<5O%8BQT
M=1I.,H9!XTO+'XIRY?%]IZ;6F_3@WZ4WJ[U>'AWL06$\15N",'BV8_\ )-QA
M/9=LJ"!8D:/_ +C,G@_LM@\?[J=J2\N.DWA!9!]/Y9-*!RU^QTS<^&E?3H1U
MZ^_R_EUTP^VHX-Y#: _?GD\\D-:WB8G*<YFZXF21RQTOLJ[(B7_ .5 B6'OL
MQ (H9<G-6MCNA4V99"U_VXKW!2M/Z"Q[W=_%-=DSPV@T_P#A9TU3]]XQ+7H,
MZ>=+Z[$GB]CGCB^]#0*G)^Y&.SMOF=?%TT]_^C1WSU?%CBMAPEB4O]V)8SIN
M+2G-34FI#>..UW<+5='MD!T4[&&:KG/#/2D/#>Y;P1KNT/I_WQYO6D3LYQ6Y
M1;_C]EKO"*ODTZD3S)LC9/\ WW.O38ACR_[R0';$_I2J8[4<6^3'Y=L*?XNP
MZ\B2D<?&.Q+XB9/5X<P]-#]]CEW-W\CF4L%^X\K.]ZPKH-H@QT\?L.P3Y2U[
MHL)C8MO\4<17XPTOE_-ZJ4N/(D/[-'@K8SQ@?NCBD/IYV]]&3Y+<C73X;#.^
M[^6<[T@?IRE46UXZ>QV/_3F1;I]9%4$Z_P!T,TD>K^SC.STT#[V]OZM_"N0]
M_K07R[6C=?\ O ]=(3)8WCR[('P!EDZ9"1?BWBQ,TWP@(7^;WX;G;@[$N_W+
MYJZ5Y9S\7G*-X\62]$T3I$T96P=E[YKN/IRZ\6'9N?L(X=S7^D-?*)$WXZZ=
M^=CMQ,6%[QB/3D33FNRG[%^DPYF0!UHJ^.[[6<-<FNI]M%T4SO27N6]\6^0Z
M>F63YEKBOLI7EYG'\['F$\9]K? ,".VA^KGFBM]Z'+OAX\Y22$M<8UHZN8&1
M_P"DR&(["1_!UE%[_MU=2]DU\OK38;;Z0SN</\ZJ&O1S\;QF]]]9C^O5L88\
MHE,D=CI5I9FZ[>)Y\F*;$,I&G_0.W/I*FGUE.E$?^?&]U$_/NQS;K%:^0:+J
MWX_4DI%PPH$U8*XG']LAR:IT.D(J9@T2NYJ2ZFFBZ4R!(;M3+@\D:3EIR#/(
MBAM\J6S$VM1Q-.P.^1C9C,A*\=RRL7+8;C0%5LIU(_-L2]I-^^T-T!N)OGTT
M<R4;1A!L+*2&6,ZX3I0&FJ8J0985-4!3KIGYL/V)XKSR(L>0;SHKPEV<EB]0
M<9MVG+KU>-BFZN Z@MYM&E"E"$7%*!U%1&J@DJEPZ6%+*$*#A@6&3!H8=VA4
M=BD$+=>%O)=EGA515J=R8-<]5D5BH/=V;7-(*ZY]J%2:A:X2QM&+-J!GB>:9
MBI$B<:;.1*[$>4<N;^68!EPFY\WRC(S]B\@]VR0L'@T)>92XGR4WH3BN,G 5
M%9Y1L5=,DR0IK+<8RM4<VS319G+[B<KF24&Y.4C^92T<:9.#Q"V;V%7%Z+<M
MV.X.Y#0O)*[8[HLRW89Q)EF+*YM H50*>2Q9%HJT*OMQ*1G=FRD+]>O7>)DY
M$C^+&L8+AU=LQ%3<TR>M9;Y0N:<T9;WN EO%54DL89MU *LRQ:.&Q2RI<ZW(
M0)(;><3.:2*OK2J0+!%TDHM9F]J8Z\AQ5;/V>(:V9/#D.UG54,6K!4J,EIJL
M!NF:H99K0KJK7E4D A [LE<\YGP@(7J:A8S(I*\XB4M00D(N7K+BXGNY\GB5
M.4O&A&850Y<5&]:\HC_A'$OD1"%Y=+#MC^YT*"HA-4PW%IT AV6HZ*C/MAFQ
M+AC+C"[77[+;0=OF*=O_ '<77M'=^UG2KJJV+8L\S<-R^$]L%RH%YS5SLVB'
M:[',W/-]KG9\LXSSI2G.<[C==C>A-E9O-F$R,,0PZ)MS$!Q_,:L=A LH &X0
M";C+3+F0L>A5'<JGXO*K)=*<9XHD1TDG4T115/34[6_0SVL2$.JI)H6?GI>(
M&*%K-^+TJ_+-LQ0?=.[!L&FYA7<:-!G9F9N9_!S<TR.3,5S-SE[0J[G*?\7-
ME*=]U*52M&,(7R<.J"UIL,8',*WH$?*\@.^6K9&E^%X\)))=,F>2(>CA:N5'
M4AU4!EY;/QDY'<4:0"VWNU6S>0*+IBUV'B;7'E+;*';!O%'.,-8N%HDX,'AV
M<WCM&&C<V+T%>V%-Q5<U6"^> !GM&2ZZI!S%@ 9Z2L,<E&+1W#$ADU64675+
M1I590^U.<5\X; L <0AL.9/,G,@L-[,"7G?-30CC(G>\RH-%B3HS4$=H-E<3
M?5&=)X589C3,J0BG1(3"[B<#<7C"FK-TF:2["]];3]Q<,=,H5KW!_B<3=8MN
M;[&%W9I$6_:$-7[96<F:S!W]S:NB[)CN;-8JR8*,U6E5EPLL 0J\,<6C-BR7
M8S9N^>&0+1J,P+K!9>957!6!(!]L5I"Z4T4J44Y=EMS-7.V@NZ;W1+](O,2P
MKNJZ6('2"\8)3-HA1><29#-7-06.D5=02H[G;J@0")*UURO'#Z3B_HBLHHHE
MV@K;"T3. M+-*Q$*P1IN@7<NU7,E8-7DO;23P78O0SG@EJ)-P59Y@ 4$AD+D
M[+/(>RRF\"1#3/7$I*9@&8%\S\&GX)GMDCR8L$Y<,KYV/I:B=Z9ET)[9KE6.
MDA0($5F+E9R)2+*3S9!$1ROA'<;+54EOHC8>,D,E+<PR):8,%EUSHB00#-!J
M =UJ1FU]H;0.3I#XQ$>VG1P*JSJR[6<V&YK*,MQ5.>[.[%JO)F"K[HNL")K'
MVU45@Y.SLT7:L&68NUF%UL]HM.9SC1==945K[4 B>A&2#/,(25Z@DLW/O-\M
M/F2&F$OMM$+U@()R,QT%I$26'&$>N@I1ED&T3<<J2(L*";'2D<-W-%6((*TX
MEIPI;8*AJ(F%RM-'(="GN".3Z&,,?0\*O3MVN[- U5>F08-P&S5@L\*!HR 5
M)9M%<RI4 6F488C8VS<5C3E:%_AN[QB'%T6<WOMM]9;BLXMUGET]P8O+-V:%
MFW767&ZL5PN3FM,Y0 (2[BC::BG8[59\S, Y'Q.0>6N2#+7F/+&[[$%]R&ML
MQ-"0;R8#"+*!I=,W/4NNKS9";B$XFRV&R[EX4I:2!:GIPRMK76A;N#A#&C_G
M.<+:.C=P8=JN@W%=P5S75;=%6 :M-R%/=5VBJ]=T"U986%A+*NT2BD78PO,B
M,:9/[")/';L06[8911?/?E=R7>UF+'=U_;38,V2S.@8E02">FZ$'+K'ZS)L$
M7Y@II-B-6.09D=S<3G-# Y]8-E[3AANL]L%#$>6+CA?1]-21U:YNHM>S3T]0
M:9A4LL#>"'<9V6MN+4MHD[1=I$LZ(.;!JZN[P7-P5W-BWGNBFY*NH8+!>?X:
M[-==7^*5:RU6.3BQCO"7R!LH/F0M_>&#V]NOLA$UMU>'7X%H&RSZ7A3,I[1F
MU546_C*K3165CYB.&^4FR]'OF'13^59LD%BY!*/. G*H7(BT2=;B34PA1NL6
MMH;I42;-,+Q5N. S8>M0'"SCYLP3'63Z6C([6WM.Z-H@W810LVL7:!L_K=IN
M2V[M0IN06S6CJLJQDS.9)@&:I-99V:2/>3BQK\[PMU>H/NK"",5G>&J=OQ)3
MM9DNV+=93.9OJJ[;.:^WSGA9JM(R! F$>;5:K1SL995U>=,OS\J1HO&'"GK[
M8N<$'&@502.G,(-<*E.AF1@!8>3Q%9O%CA$Z142=1:A]K'00J6F +FF!QN)V
M;BKI&H,]%SB;ENRSJ\[DQ;ED6[!J[-3N+TS;L%\Y@W:*>Z,ELW.*RLE@"J_6
MAL]![50=\@$><P_PF(!BJ]NA;O#N&P=WAD],?=G1LP>%,QNP9-/<VJA6S<U:
M:A65->Y-J9+)0BW+]&).N;9?0CD4F)E9<:VN**"*I'STDV<V/ X,3.1:O0B(
M8K[7IC<ZX@J)J]PK#*;!:/70LG7 GHP[?'69<[95+>N<8B<?=X\6<5C#)S81
M%Z$.A*_;#*'LRS=!N"[@L[LMR4)5"S!BS77G-H5S40E[R-9-GZ!PFS;U9L-8
M+ VS\\0MR]E8TH'5M$VH:OJV[LXDH\MMV:*A;-;MVJC.4F89JFI\/0C$IV48
MAF)9.3@M280E1NP8(ZV5-N7=XA,%_-I21FRUVX5;Z4UR1QV*B$WSPKY=B:.R
MBBJT8X:KP=SK*T]!RQ56;V.4.V#"!/UF648*L%B2SXN^N7:,..[F(-%FSX>V
M%G,O++=6BRRTF;=0,R<UEN8HJY-\E]AGFT4/M:V@:J\?A*K@I#XA[(154NZL
M,9*L7)4.RK\JZ-=P9*JJ^ZN[0M )MBN22?5:V5J"$R&Y\S*(8.:Q.7GBV\Q3
M3E>,Q';!XTD.E,:DB.MJ28W:6&$T>/THRM+[+.G[%!(=R>332@@= %LK2@@5
M=AZRF6V?':!N;S&RT=[-OL.B$%9F'PM3M-[A;)9BX-<]FY*M&^X,RLKN;TLW
M9M;VK-HM(IK.>23)]#WJT+\Z6?#)YM4X12&1YK[)1A?M]QC+55O$F&8TB"S-
MV[9:JJK;HZ*N[5C^"P:,E254F'E^R;LZ%V" E0O,$[LEJNPP7>YA(N5(P61+
MU191TH"XR,97HN63(8WH>03RP@!<W0I;<7J(&'V8@H@C-:6U<?MB_,8E:-_,
M1?7=U5<F+?M9T=<QV4:MFZK(*.3!V9K2:O#9;/69E<YY!6*JJH#]9*Q=F;#0
M]O"K+0P0MP>7Q=_;, ]OSYGO;1BP=UVNZ/[R]-59L79@IF*M%68S,X*!99=9
M:(TNH$"9?9WE8ZX'[F?'E$GE^/S>.OI"A$ X$C7O1S.*.R\3-4FH,,JGUE%Z
MK"10BV440@FE%*Q0N'(*1>U)5A24,5A$/5>FCXJ[@/#;= T:;HW)6#54JM9J
M[H5!G*DBB@E<)$S3&SL-99C&7RT+.&%6+OZKVJ]O7;L0(:JOS-9D\@.ZSV75
MGNK-8J^YL5,R<V95-4:L<1M"SD:@S)8JCF%]32;AG&5;R2H2QEQ07A,$A0H@
MJ+O7FLPFF[D%*6U(-KK2(M- \KEUU("!<J0H*BJF!QD!Z?ZXU('#&3!NZJN@
M#!X+-9LH&SRL%RR6SF9SBT*RLEJC-6$Z S!DFF[9-[&.D*B,$=X.6<,B[1T:
MO[L8E%5R\+N30-G98-FC\L\,MR:#.(8-687E)H%E:)N2XKAB0">6Z*'4HYAT
M=J.9VS@QX^[8DN"#A!$=;&/2$J2(921$AGV.%X,D:L8F5"Y[VA"II7TV,4H5
M*T$55T%MHT@D*:,6#LT= LQ=2TW!3=G@9A;KA=I[8-0LMG+2)SEEI7*A44(]
M9-K%OL-A<'>8.6L.@Q?%H:[^R,44[6+^V#=[FV9ORC=MNK515>3=HU"E%6>:
MJ2$DV@9<&2\<RCT,F'WF32I,AYM1<N([_5%F%+D5T-Q[I[T1$!1:R<CL91#O
M)I-[*<2 >JZ$%&4!3Q2\R7)'$\0@K'<QAC@L]*/Q8#MIF JHVW1M[4**EFJ"
MKN@4,E#*JM16^J.#2Q=FFL==[2KPXF-.BC%1W?.W'\!FHQ8%W9#M8/0=%\UB
M2H2NP66,\Y8E>13P,]N66*UR$%!]9A7SF3F%LQ>H)JPD-%KJD8);C-K#E5TI
MG !(UB-'C7M/G3 JT7##)GE#<;Z4K0&VABH>M7R&N4159LWQB&RK,E=17=&K
M/-6*LB9LVBA((!%9X2$TU;:9/K(90G5R<K80@1=UA[PN].;(OL2<=Q;M6>Y+
MM,^&O;FT7FS.;FM%EU *A4&J1*<$9Y6I"S!I@+06LPTERQEO0(@MC!_>J-$3
M6C4%B-)$<3^2W<4=%[-O1SS-BT\A7-QQ+"@W'&J''JIDT 5.52)%P**+C7@T
M.:-W9Y:.RJS9U48J,%]U;@LU79;.8C-#0*+!18S&>JL37.)E)&E]R19/(C&K
M/6A?+/!M&+*.T%=( ]^R<89]H.]GF_;,'9A@RB*CL\]IMR6@6>V+==L0%7E9
MLH<U/Q4C++E%#S6IN3A,PPZOF4BM<<RU(B',N7-QH;D196<#$+2"?7QDU.6F
MJSHO37%(*&5=<RDJ%&F@7DU@RD&/02Q'/K8I!X:S;O+RHZA5N]*ME'AINC?W
M15X6SFP"I:%54+FON8$J %443TY9),GL/CEH+2.=GU64:M2[QAUCK[[)QAIV
M^PC[8/$64[7:1!=U=^VVPSRLZ,&"['\%W69*T1P-K*#E*IE3:56D9S**D,9A
M9;AE+<370I B=6#2UYWO\C&C.D)2= J3NJFP2ZZI$!D=<CY:7"CP15=$<"*E
MJB(HWJ13$K 82H[M'0.@#!LNJU:,PV>3G+LQ-4YQ;%<$ T 6 .(,Y(W.^0_)
M<Z6>B-E'>RX9P"+/SI$H@X>R\>6[8?7 %5T;EY7BBSXRW($C<V#PS9+S]T47
MO2RV-,J!2'V*WXTCF=)T;C):Q4P2042TY%"G:0+&SQI2,!T/K,2J*H8W0Z=-
M#UO-G1[[:BU#LNM"LLLM<'=V8NC%F[NS/<V+$$**!9=<* E98B;18K&:RQH2
M:&I ( GUG;/0>RD%<;/0!S#A!X:HT9N3F&[R\[BHU;M7EHKN[XV>'EIG-FS5
M>;5LN1G9H(555 J5(P+DBB>Z>,O:0=S0)%SUS#9?,L3[:%CHCPU610W^93W,
MRY'3%10;0YE'CMIF19#'7#H9Y!<!@]&+I2P$E5O.-8!:GCYE#M@_/L,B+S%]
MU?(.N\M8<U+C#E"[KO3)5B\'<V;FJS;%HR5"DF[-J%9S5S5ID[:D,<F;-LR4
M8D,V^8&JNZ-#G!1;.5$RT)5"I)/M2"==$^#F6?+(Z<O!)O'T^;;8>CN/U#--
M&K&69YAA*>-T7NH$4\NR.MMTDTS3X0 SZ70FK$TM1%<!2T%0*I!D="=E#+;
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M;3&B[6+I^8RJ1K- A,:=7+H3-P']I%^3O^K!(ZY$F[0=.,YDG&6.D$QI"9N
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2Q+3(TP.@:@B$B1D1<<?J3__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g425213g01m24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g01m24.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1H@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &@2^9F X0DE-! 0      %P< 5H  QLE1QP"   "   < E  "')R-3 P
M,#<X' (% #M-:6-R;W-O9G0@4&]W97)0;VEN=" M($=R87!H:6-S(&9O<B!"
M=7-I;F5S<R!396-T:6]N(#8N<'!T>#A"24T$)0      $+=/7OP.7Y COMVU
MUV4'-&@X0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T
M!0    !0<W138F]O; $     26YT965N=6T     26YT90    !#;')M
M#W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $
M      ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4
M= !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL
M=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M   2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB
M<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M     $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN
M=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @
M9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6)
M;^            !"<F1456YT1B-2;'0               !";&0@56YT1B-2
M;'0               !2<VQT56YT1B-0>&Q ?"            IV96-T;W)$
M871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15
M;G1&(U)L=                %1O<"!5;G1&(U)L=                %-C
M;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L
M  YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M        #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO
M;F<      #A"24T#[0      $ "4S,P  0 ! )3,S  !  $X0DE-!"8
M  X             /X   #A"24T$#0      !      X0DE-!!D       0
M   >.$))30/S       )           ! #A"24TG$       "@ !
M  $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M      $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE-
M _@      '   /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z   .$))300(       0
M 0   D    )      #A"24T$1       $     (   )    "0      X0DE-
M!!X       0     .$))300:      -!    !@             #_P  !8P
M   & &< ,  Q &T ,@ T     0                         !
M      6,   #_P                     !
M !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG   #_P    !29VAT;&]N9P  !8P    &<VQI8V5S5FQ,<P    %/
M8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '
M9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90
M  !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P
M(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   _\
M4F=H=&QO;F<   6,     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M        37-G951%6%0    !       &86QT5&%G5$585     $       YC
M96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH
M;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M"79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0
M   +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO
M;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M    #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M    .$))300H       ,     C_P        .$))3001       ! 0 X0DE-
M!!0       0    ".$))300,      ]@     0   *    !S   !X   UZ
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M_/\ V;9[_P"EK4PLB^TWLR&L;918&'TR2T@LKNGWAO\ I5953#_I.=_Q[?\
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M:\-P#ZT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ V@$O P$1  (1 0,1 ?_$ !X
M 0 " @(# 0             '" 8)! 4! @,*_\0 -1   00# 0  !0$( @(!
M!0$ !0,$!@<  0(($1(3%!4)%A@W67B6N-@7(2(Q02,D)3)A8__$ !L! 0$
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MKX1\/JRX>"# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@%<K2NNR8-+OV7@OE^U;P;) !ALC(H!/?.$?8"E2CTPT1$OQ-KW=7<KX
M<Z3#J.^'Z4?5!NTE_HL"KIZQ*-F N.]+W_1$$U,7N.P/9A6PIU2LVHJ*C_,:
M4,8QJP+'H^2&SL@5M3DXH='QFH;8LE5L*;CM;'JGC"(Q/IWO0]!1;KX\:!^*
M?O\ JD; \$& , 8!3SS#_%S]0#^L&/?X2>-L%?"/A]67#P08 P!@# & , 8
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M?7^6#7+EGEU.:EZ9K13?7U1%V,=<K?0WT3\S>D!:>U/C\/\ Q4?U0W3ZX_\
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M_ES?P*D7[:'ZEP.PJ,[J7SO5Y*!NY.1W9H<#:/$Q*%A3<0X=;%&3TJA5:CX
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M<AB*UEO;4[:FZ=/>:<G)N3RVWPZ)822T2SQ>I;;/EST# & , 8 P!@# & ,
M8 P!@# & , 8!4'WC8S>K/*]DRDAW5+4$[>UW!Y69O((G)Z?BD*M"SX96DTF
MUC198L 1E45A,5EI>5E(NX.A6LA2#_AWA8:T>+O4!5Q_;CW8\2 _T]X13==/
M)\ IKT1XIMH<58BC9V,^3ZHK6N"3-^BKMBSDDP=0:X+,?&1_+3K\.$1+-VB
MM+X-6#WZ.M-<!]^<\\O^FALZP08 P!@%//,/\7/U /ZP8]_A)XVP5\(^'U9<
M/!!@# & , 8 P!@# & 8[+9=&8)'2LMF)P;&XV%;Z<DS)9TFS8M$^U$T$>>U
M5-Z^==RY51:,VJ6E'3UXN@S:(KNET4>]]M;7%Y7I6MK1J7%Q6EN4J-*+G.;P
MY/"7",8J4YR>(PA&4YN,8MJ2DHIRDTDM6WP17;02<>C=Z<3-D?K2AE^==-*]
M<;> ;(MAIUKGKAS97:/;<G (.[U\>^*W:+(RR1,ND4;!>@F+@Y7;GN=K9["T
MM)T-H;9C^:^BH5MG[,FLIQV=G>IWUY'.'M"<7:V\LNPIUJD:&T8ZL2J_FS"G
MRCPG/_OYPC_L3WFM)M9E3+/#1HX,/9"1#!D*%#&C=@.&#FJ#(>P8M$N4&K-D
MS;<)-VK5LCQPB@W03X212XY33XYXYUK7S]2I.K.=6K.=2I4E*=2I4E*=2I.3
M<I3G.3<ISE)MRE)N4FVVVV;4DDDDDDL)+1)+@DN21S<P*, 8 P!@# & , 8
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MG64U8/:V=244C+7-BQ.%/1?!K*U>J6.?/AIKGITP9+^GO$H%7SZ?QBMEZX8
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MQL[3,*C/#Z30^4@!:,FY?.G07H/-8F[CZY7IT35%AH]5C'=GGPX_?$V+X(,
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MQ(0:;G-ISEQQPBN4(Z)[JYMI.;]II+$8SEG'-@P!@# & , 8 P!@# & , 8
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M3Q)YE>7$87%;L;?"$9-]I46)-8C#.53CTZ.<N,Y?^"T696&SAFT8 P!@# &
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M]V?S ?5O]B>%_P#37 '[M]V?S ?5O]B>%_\ 37 '[M]V?S ?5O\ 8GA?_37
M()\XUYZ*MZLEYG)/>_IAD42M._H1R@&KWQ"W8[%59?5E5?'U]IO/(3]?;]T
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MJ_95<^Y?5+ZCKI_0G+]V^[/Y@/JW^Q/"_P#IKD _=ONS^8#ZM_L3PO\ Z:X
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MV)$6H<<X/EQX=!^6>[ZTR%LE2+ALFZ(N]\=Z:L4.E'+C?'6DDN]\[^ 'W-@
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M[^[0512426Y[3XZT!RC=/5')6@,?(ZMKD^PC!QY)HTR-PB,E6D>DA%^N4(2
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MBD7"1UU)S/7U/F+R)P(8LUC1/?UE?B_)=N76_JJ?%7_SZ^(&98 P!@# & ,
M8 P!@# & , 8 P"*+?0N52.(KTK*JQBAQBX</"[FT:^E5AB7HA!BY[^S'#HG
M9U7/!Y+IYINI^0<E2373;A9#\;M57ARB&G/YX^C*4>=/9IU2BZ(NGUG9M,"W
MWIFEJ]N&M:PIVI;53FP=A(8>%E\RT^&I6!<,AF<>B"4JCPTG+AD2BH4&LL@N
M=60Z/#&B K6&\+1-KCGGIR7%?;)HY]T^?G5TU73063J2;NXJ@/W-"[!B[ A(
M:Y?QD1(:^ C]<2P.S>B%$SW$_1*-C*;SH *9AGR9XD+=NQ2#X,<>YX^?[$;W
MC[IKM3SK?4Y\[6&%.6/6%=BYX,'F8X?']+ #AQ(2%F8T+*Q0)66P<LLB1:#9
M;']$XP^=M^D6Q957G7&PQJEPR\??AG5$E^SKZEE!P^J"$0D550M[9-YP^J"$
MXNAB2)0"&B)%'YB:='RC(9-ZZ57636C+5@UY7EPMKI1_OI3:W>DTNA#7Y)OU
M,?00$([8P"OZ0]0RJ*>R85Y_>R>ASIW<!N2#$_.$Y]%S@=4^GLAD+<%?<5'0
MM>')PPG-IM%^I,_ MBAX=V><HQP7'EIGKQ>%XKOPN>%UV' /4P*P[.\MBZL>
M@)=4WH^E;LML?,4M/M$N4JX?4BVC[5BCM=!-CTYYL\TWDPPNPV6&%!" Y7@<
M[:$6Z@8X]SQ\_P!B,?.WM [<_HBRJU-0\,!JHVVFIKR;80]Z\<N[CCM$S="H
M/0KTSPX[_'M%05FO@Q&![#[51E%<'V$DU_X(++J@UCZ]V=5SZ>XE:[O1>ZMM
MJMX/][%@<1:US=/H;T!-)6B37:0>@Z:!B1A%X*T,=-?M9(6GDZB#QL]()D6"
M,-BEA=Z%N2/ Y5N&/HO-_P!CO(O[$\Q3$?.RX2Z(9H/6D.0L>9F3;MU%@PNM
M76B?32S&Q>4- XXW6KS08KIG80!R4AKOI@YX;&U>T]\X)A].[SZ',K;UAYZM
MN4.(1!++&$9JTB3Z?NH<6%2.(RMM!!S\.+6FKB.3 ,!,(Q)=^>%MALC49<AS
M':ZNQ+Q[PR?=-@(KJ3VK6\AI>8W9;LSA591R.AMW"X1+*/@JT0\VS^73(9YZ
ML*;[)N76^'5I1&'K27GMEPW:-R:[Z,H,^GH-RNZ##X=^//FO)Z>&'S)HG7IB
MAZU<G&,TLR/B"<>Z@Z) ,G]^5.KO[+U(NX %" @K(B7DLCEJ$3DCP)&HXR*G
MW@\,])<#?L$].>@*Q75[ ZX9PZ2T-+8W)(E(*7]B2QV_Z&]NEVDXH2'!'HD.
M38$>&10 5CDG<%!TLBYEBQ+-G;=0659LG+;M/D"3?,M\3RQI98-=6@PC;61Q
MV!4+<,**1I!ZR1DU3W;!G*;1^98O7K[EM)P]M5]<$>()C54QJH!A$B2;1DX)
MN&J8??G]M?+D7$P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , X9%O
MV\'OVB>^>5'3-TW3Z[WO7&NUT.TN=][YUUO7.NNM;ZWKG>]:^/PUO?\ U@&K
M.I_*7I;S.&\NRBL&%)6Q8%8>'*?\=6G#)W8LTK.+;>58@P(LI_6MBAZBLTOV
MR='UC[&0QHW7(A:2A=10OP7#$8QL(8%;3SQXMZ)9UZZKY]>.3TB/CGT?4)"E
MY#6\HJ@E,F54^RX%9D@=O3T0$5Q,O7]\PWT<K/:BB>H9.&TVC553, 6C,;K:
M5D(/^<CG4?5?2L:HB1:[#.F-?TX\DUJ\^'!<?A7Y'].OU),&MGDYP4@H23SG
MR65\_K+'?5OI7TNX/V ZLZNITZL5T<MR"!&M?QB0(1DWQ^P=?Q1JRC[K0WY>
MC+8APUB8N5IW-/@EPSTS[W\.>T'TO1#B^-4.PZ;1,B!K;T'#[6F :8-NGP\Y
M&(]%IR%=C&8_H659D"BC^2C7+5J33:,.DFSA51ZDLD@FL,2JL6\063 B-+5]
M$C5?(^?/.?M;OT+2X91V<:2J*4Q)J2NR-2&G>F",=<"W2D&M6V'/=;.^CFF_
M54JLX^26'DH>R_:,7*UTXI+S36ON7O,)LCPCZ+BWH"PK/\GV574+@LMI;T<W
MA$.G"LD25ICTYZ/,U1S-;)@R84 98]U^:3K[NTBL+5[9=)W(H<)-.MC[&-N8
M\&=,8;U73@L_OWZ+N2>4Z_32'U,,\UEO.5K6QN7>4YE!7=8QFX+?E9ZLNJZT
MW2KZW(4X$I"#/(M26TT9EXT&^9"'*8^:<QDNZ0[08*=\!G/'X87?R75+Y<S(
M/;='6#8\\<M(.'<DFOH[QKZU\7$3G3 F[CU<S>Q8HQF]43>>NP[ J^ URNXB
M<XB<A/\  UYIK(Y#!1Z2"[DJB@H"TUYII^7/Z'5^U/,J<G;2.U#T_A%60""^
M6DH8ZE!J/EI0.CDM@M\4Y>,.+2R(#6+= Y3[)W5ZC"?,=F1JVHR1*(_(S8+/
M2;(%TQG/OU332\<^\J%P0N/W;Z8/-8Q-_+#X MXYDU&V1-?*]QR6ZHY#(5;_
M *$H,G-VSFZ4:^AS1M:L_IV'6BXK"N6X)NZK]RR:2TG+RK.1LEFPKT7/.4]5
MT3Y:Z9?GP7!E]?0?B=[;OH2@IR ?Q -2H6.M8+Z3K9\S=<+61!JKDK*V/. 2
M-M63!46BA +A9.GA-H0<#VRL4D!EDTVLHIIHJ)G3Y?)Z=Z]Q4^/_ *9]VQBN
MH1("=A!+*] 5[Z <S]3M*W;FH\38M41>A4_)M9Q=U<-5LD['KR<LZ<C\9G)L
MT,CDL *62:LN-K"R\<F;F2H!E:\DURUZ/GWZ+7AA]26!/@^P]1I1VFQK^$S"
M81WV M8(O5S7K=W"DUOVLH#5T&?KVI<;0C-)DJ+CU= $9B8Z!P@<C]OQ^SD)
M65^Z<OP?RX$Y^9*YEX^];=FTJC90 .@-*^:_)L3($&;Y@TGRU0B)I8D]L*+\
M$6S-T_A3V2W,U@X$JLT;Z?$J]D;MKQTQ<MEU@Y+S?OQ^WQ+YX(, 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , ?^_\ W@'%9L60
M]+:#!FU8H;4[5VBS;HMDMJJ;UM13::/''&U.]ZUOOO>OFZWK7S;W@'*P!@#
0& , 8 P!@# & , 8 P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>g425213g05n05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g05n05.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1LJ4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &PZ^:28X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'A=9&         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             !NP   KL          0
M                       !              *[   !NP
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   !NP    !29VAT;&]N
M9P   KL    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   ;L     4F=H=&QO;F<   *[     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    ".$))300,
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M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M   !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3
M(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T
M-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=7
M9W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!
MD12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T
M9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7
MI[?'_]H # ,!  (1 Q$ /P#U5))))3B]0^L9PK\BHXV_[,\;G&P#=4*'9U]K
M?:_](QE;ZZJ'?SUG^$JJ_2,?$^LV+;CV9&4QV/6S8]K@'6@U6U_:J;;?2K_0
M/]#^?8_V4_Z:WZ:T;^GX.09OQZK3O;9+V-<=]?\ -6>X?3K_ #'*KU+%QL7H
MO4FXU3*193?8\5M#=SW,=OL?M^E8[]])3H@@@$&0>"G63UC-R<+I=-V,X-L+
MJVRX;A!'@L)_UEZR&DBRN0-/T8_\DF2R")HVPY>9ACEPR!NKT>S246$EC2>2
M 2I)[,I))))2DDDDE*22224YW7FY;NG.&'ZGK;F1Z1(=&X;M6EOYJQNEU=='
M4<<Y RO1#CZGJ/<6QM=],%_[RVNNY&3C].=;BN+;0Y@!: XP7 .]I#UC=,ZI
MU>[J./5=;8ZI[B'@U@ C:X_2]-J(P&8X^*JZ?W6&>$2F)\4A5:#Y?2V^NXO7
MK<YC^F/>RE^.[&L(L#6L-[VM.:VMSO=D8#&^O5[?>SU:EGXN-UVFQ@R<?,O?
ML>,EWVAQ'HFC;0S%+,W&J;FLO:VF_P!2OUK;_7S*<RK]&]:'7<OKU&<QG36/
MLIMQW5"*][69%KVUXN6]^W^:Q8_6:]_\Q9ZO^#6?C=5ZPVRMN;9F![V/%S6T
M!HJK%'J49S6-P<G[19=:W](SUOU?,N^R_8KO1>Q!G2D?6RO"Z=6RES_2>7VE
MUDV6P7>A3ES<QV)C.W^J]_VOJMU?HU4Y'VS]-ZW4KF>E=3^L3\K&.5C9%V*<
M:P$MKJ:++190&Y#[+GXKZ]M5EC:JWX^&_)K9;E?9/^T^/7P\SZS7W8KZ+[;L
M9^8:WBZ@4V-J:*K+K<QCL:O9192S)^R55^CD4W7XC,B_(?ZU6*D/_]#U0D $
MDP!J25F=(S[<RRX&ZNZEAEA;&\ D^EN?7^CL;9M?_@L6^C9^EJM]3UD-M3K>
MNWP7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$  @(# 0$             !0<"" $$!@,)_\0 5Q$  0$% @<(# @+!@<
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M/%L3TT*I&-X$<]G8TD#_ .@_9[-WJ]&KX45R]>3T4U%=&P?F_AV</N6#;/\
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M\SDAEQC*\,:6;?K= 3$:,XT\Q%ING#LZ"1%9!HD!A47(423%-?HKJ645EXE
MYDUI2.14(!Q.15ZV3.4$T>T*"8IU0,4$T/X\^T Z*/\ &&V$^^T7*^:$[#N4
MW*J4DTZ#-203="JL5N9N,4^7CGYUB+BF=-!L];JHF<&*#<_1*HDH=)1,YRXF
M.NN6U861OU-B)EC 2-ACVLK(H,'+=N8ZATTV\NY<LH59\\23.RC$YU\R>,(
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'B-$1HB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g425213g08c16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g08c16.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2#V4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (-J^A! X0DE-! 0      ! < @   @  ' )0  1'96YA.$))300E
M   0;[]]9W4JZR9WD,IM['@1=SA"24T$.@     !'@   !     !       +
M<')I;G1/=71P=70    &     $-L<E-E;G5M     $-L<E,     4D="0P
M  !.;2 @5$585     @ 0P!) $4 ( !2 $< 0@       $EN=&5E;G5M
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M<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M    0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T
M=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
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M;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT
M;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #
MO_XU  (  @.__C4  @ ".$))300F       .             #^    X0DE-
M! T       0   !:.$))3009       $    'CA"24T#\P      "0
M     0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ !
M &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M   ! #4    ! "T    &       !.$))30/X      !P  #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M      0     .$))300:      -!    !@             ! 0   3     &
M &0 <P!P #( ,  R     0                         !
M  $P   ! 0                     !                         !
M   !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL
M;VYG   ! 0    !29VAT;&]N9P   3     &<VQI8V5S5FQ,<P    %/8FIC
M     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O
M=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M#6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !)
M;6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   0$     4F=H
M=&QO;F<   $P     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M    37-G951%6%0    !       &86QT5&%G5$585     $       YC96QL
M5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z
M06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E
M<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +
M8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4
M   )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M#&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M.$))300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
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MXW(9?0VC(QMA<:R2QS7[MA&X;F[=BV<S"P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0'_P  1" #\ 2H# 1$  A$! Q$!_\0 'P !  $#!0$!
M  D!!P@" P0%"@8+_\0 6!   00! P,"! (%!@4/"0D  0(#! 4&  <1"!(A
M$S$)%$%1(F$5%C)Q@1<8(T*1L24V4M'P&20F)S,U.$968G:AML'5"BA'6(66
MEZ;A-T535V5WE:+%_\0 ' $! 0 !!0$               $" P0&!P@%_\0
M/1$  0," P8$!0,# P0# 0$  0 "$2$Q T%1! 4287'P!H&1H1,BL<'1!Q3A
M,D+Q(U)B%19RDC."TJ*R_]H # ,!  (1 Q$ /P#W\:(FB)HB:(L0.M?J71TJ
M; Y9NRW3IR&_8M*'%L*H'[)BGK;3+\IL6JFCC75H^M**ZG;D.F7;RP0MJ$PX
M&%(>6E0*"O*:_--A2V52+95JL*^G3KHWLE,;W9!OEEG2]O'M[M3MU*SY_/NE
M/)+=]G&LCA1%N6&UV3XYDUS:V$NR(4TNFR,N5=78<.AR/'?2&TM9_/.D5.GV
MS2T5SB-?;( GF5T>SO6]UAQLHZ1\JZC<6V0K-F.N;YNOVRK]N6LR9W!V@O;C
M'U99@<7<>;DEB]CF7&]JS!KIR,?1CB*JSD2&F4WB6FW74S$9VY]RAI(FHO\
M<9"?;.QK+=GFYF [58_^L>YN;8W@U*A33#UUE%O"J:QN0LA ;^;EKA-E2UGA
M!(05 @]J1R-$M?E8ZP+?YSY+X#".I7I[W-N&L8V]WPVWS*_="W6*C%LRI;>Q
MDMM$K=#42-/DRW4I (<4T@AL>!P$C@L:@&MC228\Y=TUBMS17^0.U"1]@!Y4
MI?\ _9?XE?O5Y^^BS6K1$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$
M31$T1-$31$T1-$31$T1-$31$T1-$31$T11P?%%Z:[WJNZ2\FVXQ.MK<BRJ@S
M+!]P:/&+QX1:S,)>$Y%$N%XI+>"D):9N6&W(R9#@+2'>Q*CRHZ9?;)0"H-3J
M3%J&PCTH+S>N 6-]*.Y'4YOEN;N*CIXL.D/;Z3T>773M,Q^Y@8]CLC<;<F?+
MC6E/,DT-$M").,8@6"S6W3Z5&5\R%MMI_&D*]ZY)D+W'D "":WB?.Z[O:S;C
MJBWFL?A\;0;I["9!M-0]$%Q#N-W=PKBSJ)^+YA>[<XFUC6$QMNTP+!Z=;U=\
MY$AW4V<\AD5G<J,H+4T09:(RUKF)O[*_*9T,P!:LQ%N9,7S%E.ME&%8;N!2_
MH/.,5QK,J-Y34ARHR6FKK^I>>;X4T\J#:1I,5Q:%?B;<6SWI/E)!U444G4/M
M+M;MKUW?#]F[=[<X/@4RSRC<2%92L-Q6CQJ18PTXQ)>3$L'J:##<EQDO?TJ6
M'U.-)<Y6$@^=2LC3,_3LY(.?/,FL4]_)3#:J)HB:(FB)HB:(FB)HB:(FB)HB
M:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(MM332P0MI
MM0(*2%(2H%)/)200>02 2/8D:(M92D@ I20"" 0" 1[$ ^Q'T(]OIHBTJ;;6
M%I6VA:7 $K"D)4%I'/"5@@A0')X!Y Y/WT1:]$47O5V >N/X>7//^..XWM_T
M4D<?W^?RT0?8^X*E"T1;'I_A7RH@J))\GCW_ -../X?EIL!8'229<75DQ,&F
M<?3050P2#%O>D&>O>:C8^(AU]8KT'X!0W<ZGFYGG&;R9M9AN*1)B6$K=90E3
MMG;/J[ELUS16&@IION[@H#A0)URCPQX=Q_$.W#!P>+@;'%'%4DB !D8J3I"^
M+XCW[A;JV(OAC<1TD4 AH$4L8UETDQ$*+#I=^/C8YSN?B^WV^&V%+BE!EEQ%
MHV<MQB]D3$8[(L7BQ 39QIC(6['6[Z1?DA?#:'AVD\>><>)/TRVK<NS-VCB<
M2<,XD$.@T_I/$!!R^U@N)[F\:MVK%&&YC"R8 ,4+A0DR9Z3<5M"]-T&0U)B-
MO,K#C3S*'4/)7ZC3B7$!27&UC]IM:5!2%<^4D'74KFECBTW!((S$&(/-=A-Q
M/BL#V@00' B #G2!$9C47A<Y/L/W#^[6*U%71%T<R9'A19$V9+3'C1!(?DO/
M.I9999825O/+<4> VRV"M7/@ <ZQ."_'>QC.*20T!L@N)@"W,:U.E5ILQ6X6
M&\N+8EP)='RQ)BM8L#FH?]P/C:]&^WNXUA@$V\RF_1568JKC(\=J7)U#6OI<
M4TM;4M*N^4RVXE0><;0I*>%<?ES7 _3S>FU[&W&'Q6<8XFMXC,Q(ET@5D<JC
MHN+'Q=L>'M;\$AKF-<9<2($4HTB:FV?2JE!VEW;P;>[":;<#;O(8F1XG>,>O
M66T!\.(D(0D*6TH)_9?;[NQ]M7"D. H(!!UQ7>.Z\?8,<8&-Q8;\. ]O$9,0
M#-A)(,Y@K[V[MXX.VX9Q,/A<TN<UM!$B]ZFA!!L;RKJD@D#RD=@XYY!(_/[$
M'CG^/D$:VECF9I>T?G,_E;Z9SYVOWRY6SW1[#]PUDJJZ(FB)HB:(FB)HB:(F
MB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(HO>KSG^?'\/'[#,=QO^
MR<@?YM$'Y^E5*%HBVE$*[?/GD@>X_P"[SX^G/[_RQ_J!%16/,+$_U 3Y>1$^
M_L8K0^?7XZ'1KNOU"8MM?NKL_12<OM]KX]]!OL5KWDKL9-/9K9=;GP(04%3W
M6'TK266073R$CW\=C?IQO_!W)O G'+6M<[B!>6\)H01Q$.&4P14Q=<,\:[H?
MO'82<,.=P@@PTF+0>&0?K:N2\HD_;?<':^WQF_W+V_SK#JR1D\-A'Z?H[''9
MMFY6RX\]4"I%DRRAQKMBJ;=6A2@T I*5=O'/>F+M^T>,F8FRX4/NP<(80T&.
M$F"VD5I$S*ZSP\/!W0<-Y,.8&7)$EM)(,S4F2<@9K$^I?I9^.MMEN!F^-[3[
MC;=V&WE=;OUF,8ODT6Q1804]K3,2 FX4>$QW)!2@$@D 'PK@@GISQ1^FF\]U
M%^."2'\>)9H!XB3<8AB+6DTD778.X_&>RX@9AX@;\@8P3D0T"Q9\QDR' FO1
M>BV.ZV]'8>:6EUIUEMUIQ!!0XVXA*T+21X*5I(4DCP001KJMP+7%I$%I((T(
M,$>JY^UP<UKFF6N <#J")!\P5O:BJQGZKL;RW+NG#>W'<#?<C9A=8!D,/'Y$
M51$A4M4-2_EF3RDI>FLM.0T*20H.2$GZ:WFZ,5O_ %+9^.C&XK2:Q-8@R(\Y
MO(LOG[U8YNP[06M)<<,@16,Y/2),220OSD+FJML:MK.GR. _3Y#76+T*YKYC
M*XMC#G)?4AV.\700ZX\X%?C/=WDE6O8>[L?9L'<VSO+&P,%IGA!$Q%"!4FTF
MHH+U7G;'Q,0[PQ6\1XOB.^61%XJ9&FG6U/9W\!W!=Q<(Z0;.;G,6RJZ?*=P+
M:[P*GM0IJ3%H/E([3LV,VHE*(EK*'JQTH2ALAE:DIX5R?,GC[:<$;TQ!AEO%
M+R^(F7DN (BA;!H:F28E=T^#]G?^T)=,/+2PNG^T$.+1- 009 BPR4XJ5\H;
M7Y(/O]QR/W#D_P /<ZX2V'M:ZT@.ZY@?>/*ZY>_Y"0=8\AG'="%O^^LE;IHB
M:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+&OJMW]K^F+I]W
M/WUL:O\ 6-.WU$+1FC3*37&VG.RV(-= <E.I*8+;LJ4VE4HI4 D$\$^-,NE?
MHI$GGZ6,@>9$<^BQ@V%ZQ=]\OQ/.MS.H7I_Q39C:O"=OY.=+RS%]Z*?<B=+7
M&A?.O4=I11:2L=J;)J$?7;0],=1ZO:T7%%7)) @ &)TSU.=LS4QJ:BWFSOQ%
M-R\PS/I[_E8Z>F-J=KNKU-B.GG-V-P5Y';JLHD5=O15NXN*FDJHV.2,RIB)U
M8W47ETL>HAF>RVH+X<H\_M$]ZH01,:BD6)F8F!,>XSDJ5NXO*G':UVUR"ZKJ
M.OB)'S5E;S(==!0>/"G9<M33#8/W*DIY) &GW4G0'K$BMB*UYP%%+U)[A8+F
M'7/\/F/BN<X=D[\?+MQ''V*+)*>W=0A6*2.%A%<^\3SSX]OXZ+(4&72^1M3+
M*V5*4EUT16VW W+PC:S&[#+MPLDI\2QJL2M<^YN[)FMAQ@ 2EM3[WX%N.<#L
M0"%$GZ^>-38-FQ]N<</"82_C+0WY0(#HJ3PC.2?0:[;;=MPMB:U^*X!D"2Z2
M;3#6AKI)CD*5-X\^GQ)/C"8KC^WV-8AT:;D4>1Y7F$RQ.29;6-2WY&'4\,>&
M8$:PB,,B9-=[_3D^L8Y(2I!*5 Z[&\)^!]LVO;#^XP_E#AP-):]KIDEP'Q6Y
M" #8$DFRX=XF\3X;MDX<!\.X8>X L.@XG?#%*R:F1(LO,WNEU#[W;]+I3N[N
M+E^X[U*XX<>9R*>J<Y2KF%1?2(:F6HX4YZB@@-%26QP$** %:[X\/[IP=S8.
MT%C1A$N)Q")!<6D1,.<9 $1: (F(/4VV;YQMM+,,8;72. &,,@!LU'RR035S
MIO6H$+[CIFZ8=X=_=W<,PO!\(R:2!?5DRTNV:6QCTM#5,SXZU6-G;( 9C/M-
M'OCI!"?3"0E13P3\KQ!O[=>#AO\ WF.( = <<3YG$0 "<,B2?Z1,99KZ^Z-S
M[7M9XFM.1EO " *3 Q 8!(K<1:87Z+6/USE+18[3N2"^Y5TU56NOJ)4J0Y!@
ML15O=W/XE.*:4LJ)_%SSR>=>6<7$;C8^U8K00W$QL;$:#<-=B.>T?_4$#*N1
MR[RPL,X.#LV&3/P\'"PR<S\-@$BMS$P1YKX/>S<NIV;VOSW<ZZ"G:O",:M,C
MF--J ,E-9&6^F&DJ!"5ON);;!!_K<ZPV'8';3M[ PN_U7,:0#.<'Y20!$RIM
MVUMP-F<7&C03-@?^,\)K:(D^R\<N<?'4ZSLASN5D&(V.*8KB;<TNU&&&ACRH
M,FM;=4$L6$]XKL@^\TD>H69C([E'M2GQQZ"W9^FNY-HV$8KL0'%.$'.?&-1Y
M;)$C$;!G33R74.V^-=\[/M? &L+/B%K6\&"1P_V_U,=.669,7!G@Z+%],WQ"
M]J,?ZD,SZ<MJW]VJRV<KLMF2\6K+"57Y54I"7)+$F3$3)['T%+Z$.(?4@+"2
MXX4E9Z?\0;&-Q[QQ<%NVXSL)I,#XV. T EL</&\0T:5S(.?8NZ]LVK?&PX;L
M39,%KG"O^EL[09((<7!K8(F(-(B(LLU\LZR>D7:3(:[:_)-\-L,1R6.N+5HQ
M5RZC134N*"6H\.:U&1\K2H61V),_Y=M(![@ G7R\/<^\=H8[:!@XF(S$'&U[
MWL+BUP)! >\/_I H0+BUCOG[TV# _P!+XK6NPR&.#&O#06T<"6X?# ,S!,'D
MLH*.YJ;^O8MJ6PAVU7.80_!GU\MN9 DL.(2M+D9]HEM]E:5)4T\V2VX@I6VK
MM4.?G8F'C;*XX>(TB#G%!:E33* 8L++?;/BX.T@/PW<0, 5=2@N#PF9.8M4+
MZ1/[*>/;@?W:EUN(BFE/15T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-
M$6-W53OB[TX;$;G[SQ:']:I."X])M*W'OTBF S;7KI:AU=;,DK0M%?7.RY+,
MBPF**2TP''1X'.GIS_-C]OJI>\Q/8RD>H.9405S\5OJ(;W*2Y$VPV6=V;VUN
M]EMN-^;&!EF1S\J3NANXS#?D4FV5K7_X&NH>+MSF')BWDJ4L=X4L]HYD\CWU
MCV61 FXI,3[Q'2!G$:E>@B,ZA^.P^WWEMYEIU'J I<['$)6GO!\A?:H=P/D'
MD'SJK$6'3NRWM%5@M\0K&JG,>ES/J#)-ELMZA\77.QZ5E6UF#3I\3*;V@@W4
M:5.75(K6"_</5K31F2*%LE<YAI39X)3R([[[E8M)U%J5GK)Y2/+S*ATQ;8RK
MZ@-Y=Y'>B+9?<O8CIMO^D#+-O-RZS+=M\NV5P;<3?%]R+(P.+2XKES%"C(<B
MIX<=Z%D^8QJ!Z/%4OY9Z^>^82\N>M*5C["DT,3^!EE45DYS CGSG+.!8K[7:
MV_SCJ:E_#(V*K-D][L$S#I&OL>RCJ.G[B[39?@6);?.[588SBR*2KS3(:%C'
M,DG99:QQ*I7\)M+ 3ZE^+(L)"RM3IO+.L\O8=!]+IJ9H2(DGRU!F<HBV87H'
MS3 ,,W'QV=B>?8S0YIC%JGLM*#)JB'<5-F4=I:,BOG-.1'@D)"E -^FH\E(X
M\"^7=?7ST6,$9TBW^-- 8T 40F]O3=L%LOUX] $[:;9K:_;&QL\HW!8F6&"8
M-CN.S)S;.)O\,R%UE4RI+/C]HN<CCRKGSJ*CSI)SG,\R?3G.DV0\ #@#\A[#
M]W@?W:*KRT?^43Y#N)%?V1QJ/+L(FVMI'M7Y;;)4*^TR%MT QK )("GQ'],1
M@H$$D>02-=M_I9NW VO:\7B:"YKR2#)I!O\ .V]Q$TZKKCQ[CNPL+#^8@<-!
MP\R:.X20;S7TS\S6+8W:9?E./X=C\5YZ_P IM*[':V-(X3!^?FR$MQFWE@I2
M."L)4%$ _N/([LV[;]F\/X@<U@; XG5>;9R6XG.+"#7GULQF)MV"07$FS0>&
M30P&CB;4TBCNH)4[.PWP8,_VZS:HW>ZPL^VRV]V5P2379#E0BY>B;(NF(CPE
MHC6%A;5+,/'H34@PV9-<B2\F2KEMM:TJ2H]5^(_'IWCA8VS;K#_B/+FES0"T
M%Q-2<79\* 3Q0YCB#6H($\\W=X>P,%N _:&##'"PNE[N/C#02W@#WDN NTAO
M0M!7I&V&ZLNC?=*SD89LCNSM;>9$P@-KI,;>B0;%]F$E+22Q#2RP]+8:0@(;
M<C(4RX@!;0*.#KI[>>Z=\[3@.Q-I?B.PR20XNPG02202&XW%RH(%HE<\V':]
M@V4!N&QN&XCA_I<SBN(JUP)D^=3JLU@$J:;X(X(20>U0Y_#R/!X4GQ]%>1]1
MSKY>&TX30))+6@.,BL  Q<5.D]3=?5=#B*Q,D4UKRCNBQ<ZPL4N,XZ;-Y<1Q
MS%WLWO,AP2[JJC%X\Q$"1<6,UDLQXS;JUI[%(6I,CD<'AKVU]+<&VL9O/ <Y
M[,-K,1I>]XB&AU0>(")C^IU(H+A;'>>R?%V5[2#44 )J16:.!H;@$:$BR\3R
M_A2=?Z'2T.FS,@A2E]@%_BRDI2HGL">Z_0M0X/@E"%D?M)2>=>F=D\=^"MFV
M$L&U#XHP^%X:-Y.G$#8,$;*YL<1@<)+<Q2%TIO+PKO['VL.9A$MX^+#(_9D!
MAU!Q@Z8/_E0S%)E5Z:97Q#>AWI0S[:O'^B#(/F7J_-[NUW-D9]B,B=5O3*V8
MTF[:I8#SLEU6.P@N?V!94?22#R02KJK;V^%?$N\W/_?.P6/=P##>W:6->7NA
MHXL1F"\O?('RN!G^D5E<UW?_ -P[CV)K/@AY XB0,!SFAHXB2&8F(T-:!4EI
MH/FM \UUQ:6U[:6-Y?SIUW?W,B1-MK2:I:G/F$.K6^M2U<J[@^I1)_"$DG@D
M>W=V[,'=)V-F"S"'^C@LP9_U9X6,#!S!^4T+B;21%>K]I&\3M.+C.Q#_ *F/
MB8A:/A_,Y[SB$P")!<^X:T-R!%%[#O@#9QN;E'3#F5=FZK*7B.(YNFLV]NK9
M16Y*@2(*W[JJ;*U%?I4LOY)+?*CRB<DI &O/7ZB-V;9MN=\!H:WYN*>.2);P
M_P!LV)&=9A=N^"3CXFSN^*\ES>$@_+P@&9(AV1^4YT&<Q/RGV'T\#^[7 6U:
MT\A]%SI5U431$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%#?\ %+ZB\_VE
M@46VE!BVTN4X?NGC>1UN;5&YVS_49NPQ>P)($-$)IG8_",LAU#++#TA)DY+9
MUJNX<UZ$$)(=]^_HIG]I]_IY1:2HA>G3/J(9UL?MQ%Z=>D>BP_']UH.45L*@
MZ7^NBM?K<DM7(L(Y*F?F^",TCF510WZ=18YVZY"KXA[H#@;!!DVITH3$S!-H
MZ>N92+U.F5,X&43UF O8*SZGHM^KQZG8DK[5%0[N!SPHMLDCG[M-G_F)]M55
M;NB)HB< >PXT1.!]AHB:(HO>KL?^?'\/'D#_ !QW&X//!_Q3D?Q/''M]>=%1
M]C]#YU[O64+116!WZZ=]H^I?"9>WV\V&5678W)<]5M%A'[Y5?*3_ +G,JY'(
MDUDMG]IN5&*%@@*YUNMU[WV[=>T?%P 00XP26/:ZLCB86.BU#(-,A!6SV_=N
MS;?AAN*3D3'$':""'!IY@@@&:46!F"=!7P[N@-Z9U 7%75XY(QYUQ^MS3=7(
MU7OZK2'RH>CBS<Q:XK4J1R"E,!M=@?P]RBODZY!M6^M][]:W +0_Y:_#P\)A
M+9D2[A;P P8,RZL&"5\W9-W;!NQSG_$='$ .)SXFDP 7!]8J9(@4L%";\:+K
MVVQZG*?:/".G[<PY3AM+8Y#:9K'J8UO6-NWQ2B!1&SB7,",U,B&,9"T*]5;:
MTJ]0+4DIY[&_3?<NV;NVT[5BX</Q S/"/"T DMXI=\O$22 (D"02 N#^+O$N
M%CX;MFP7$#!+V$EK@9#B.)K?AF0&Q4&LD@!0E[/7>98]NUMU>X!(DQ,PK<HH
MY..HK$I[7+F/;QDPHB4(/;Z;Q=;/8GE" >T#M Y[,\7'$VK9V,('"UA+J,(
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M>&BS0]Q<&B@H 8%!:P78V&W@P\-A))8QC9-2>%H$DZF*KL]::S6@N( 4HJ2
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M#N'8\'$PY+QAL^8V8&-(): TU+JCB; &1)6%_3!\;_J<H-U\>B;Y3J+-MO\
M([N# ME,5::E^@C6DU,-N36/M=SBVHRUI4ZR\D<_U>00=<O\2?I>=W;(W$:
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M]OMFXMY#$Q7-8TO:0]Q '$)I4B!%0;2#G"X[XMW>_>.Q\#&N>X R&M)AILZ
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ME* DK!)\<\G7Q/TQ\*;]V;]1MAQ#LF\CNQN&QV+M8V?:CLK8PGO<UVTC9Q@
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MMML1E=]B^Y6+R*6:[&9LKIJM?BA;J8\ZN<(]42V7EJ0RM/D)6!R0  /OQ_\
M1OQ+O+%WDSB;B##^, PDNAV'QCA)/Q#_ %,(^:(),\ER#]0-Q["=C)PW-)#"
M:<.33  X1/( @VK=3JL%+C*%A/:5(2? ]_'/CCP?)XY'D_?7O7">=HV?#>;O
M8TD'4@3>>H\CG"\TN8&/<!D2-!>9C(KDZU@( &@A1-5$T1-$31$T1-$31$T1
M-$31$T118=>>[M1L]FN#7^+;S;DX=N\S275A4;<85AD_<W%,IQV"^TJRM<\P
MNN;3)B5$=V0F._D$20F9&4M:HS$EQLH2[[[^RD7$4C^(Y?RHT=MMO<6S;+J#
M)-ZLFW"P3:#>O=:)NW71=O\ &H.9;/YMN*];_/&0,\1!7G.!RGK%#1E8_>P4
M.0UK<B_,H0V=3K3E2BOO$4S[YF_5>G6(&DQ8R63RREAI+)[N_EH(2&SW^Z_P
M!/XCY5[GR=5%R-$31$T1-$31%%[U><_SX_AX_;]<=QOX_P"Q21X_Z@=0Y=>Y
MZVZPJ/L?I12A:JB:(FB)HB:(FB)HB:(FB)HB:(N&E;:N[A*T\DI[B1QR#[CC
M\P??CZZA!<UP$@P17TD>MU'&'-D:03$1$>EI_BL.O5OBUM5;GV-O)BO&KNFV
MUQ)@0XIA+C0 4UW@%"5KY '/ /[^./%GZX;EVK%VC$<,1[&%[G ASP#8B((-
MP0+=87?'Z=[9L(P<-N(_#XPT$APJ(-K$ZDQEYQ\_TV[>.YWN+4*F5AGT$ ..
MV@G(6N.I?H+2E"E)"4'A1"4CD_F?<:XW^D_@?8_$&\L'&V]FU[.[ < &''<T
M8O!0$!@=1P'%J9K"Y!^HOB#9F["6X6&QKSAAK"UK),$ .! DTF_/-2)Y7TS;
M191!=@)QUFBE)']%9U@].0VHGQY/X2D'VY(X'C\M>LM[_IAX7W_L V#>&[L4
M8.&T!N(,3##R0!0O^&YY'R@FW*Y70^Q^*MNV/%G!QZ%P^7YA%X@AT5I0WU73
M[;]+&VN!6"+=7S&1V$.4)%?*LE=YKG4$\.1N/PE?T_%P.2?/L=?+\+?IQX>W
M1BAVQNPGG#<&M#226AAAHGX;9(B-)\UO]\^,=Y[<P8>*\M8&!I,F30S_ 'QT
M^TK+1MQ(;' /:  .>///'V' ]_W:[7X1@,#10-  SI;4'*(_RN(-=QDP#)DY
M==:^_4TG?'D _?6=U4T1-$31$T1-$31$T1-$31$T1-$6(6_?1WMSO[EU#GUQ
M89IAF>8_2V6(Q<RVZRVVP^\D8E=/L/VE).E5;S:YD%]+;B6VG00Q)<<?;(*^
M-%,S2Y^@%;^0@93FKS;7[-X#L]M_CFU^$T+</#\4BABH@27%V+JW KUG9UA*
MG*==F6<F0I3STQU2W7'%*6I7*M$J?YME<2:YCTH:JZJ $H2D      !( ^@
M' ''MP!QHJM6B+YK*\RQ/!:"WRK,\BI\6QJ@B.3KJ]OIT>KJZR&V/Q2)DV6M
MIAEODA*5*7_2+(0CN60DD5J-G>J7IVZ@?T\G9?>+!=QW<8]$Y#&QJZ9ES*=N
M1ZGH2)\)P-2X\1[TG"W,6R(JPDE+Q'')%Q]O>K#IJW9SJZVSVTWOVXS?/<?3
M+7:XOCF30+.T:1 =+,]<9MAQ3=BB"ZE2)JZUR6F(I"_F"WV+[2DBO+O[K(,J
M ]S]">/<\#W( Y)X_(:*J+SJZ6A77'\/,!2>4Y?N*M0*@%)2<5D)[BDD*">1
MQW$<$G4[_CK?IGS"Y,Y1&E_K*E$!!'(((/L1Y!_CJHFB)HB:(FB)HB:(FB)H
MB:(FH1((U$(N!'!'<HD*_&H<>W]8^3_?_IQK;X6S8F"Y[GXQQ.)SG 0X  F>
M&>**"D12D)\7X@B(B]JQ(FGOU709'CM!D3)CWM7$M8W'"6)4=#J4+/N>\@*3
MX ( (]OKK9;9NG=F]HP]MV3"Q@,WM:ZUA5LDB#7SR6XP=X;3L'SX&*_#G_::
M7-Q,:F2.ILMNBQ*EQV*(]#60:N.?/H0XZ&N_ZGN< [B1[>5'@:F[=T[JW:UQ
MV+8<+9W-D M#9.E0!$Y SEY:>T[3MNU.G'VE^(TF2UQ=$QS)@1I%;4HHZ^K+
M>S-*K+Y6$XQ9R*:!"BPW9TJ. T](4ZX>]J.X 3RD<>0.?IS[Z\Q?K/XRW]NW
M&Q,+8-M?LS 8#6B)#9-Q!@@:QJNY?TZW'NK:FLQ=LV1NT/()!)B\  #7E6.6
M5K-A-[LXI,^HZZ;=V%Q17MFW3R(5@]\X4J=/F0E3@!'9Y_$%>.?J!QKB_P"D
M_P"IN]=X[=A8..]SF_%;AN)<P\1X@"8X0=':S0DS(^MXZ\#;OW=LV)CX+ '$
M.Q& !T"07 $EQB"1$BL5HICFW4%H<#CD #CC[^_ ^@_Z_;[:]JX#_P!S@8>(
M0!QL#S-@=:WK8<_->?G 8;N$ 4)%\IB\_6!TK'+UK"@ T"R351-$31$T1-$3
M1$T1-$31$T1-$31$T1-$31%BYU<8WL-D.Q.;M=3ST%C96GC1,DRY,NUGU<>4
MU12T6,*-*-:_&D6"'IK+*&:=/?\ I)\HCA#O<1HL01)]#>?.D94OU&<+HPW.
M]V875/\ $!VYV_<V,P2'TE9-M'L'@M;"@U69;A8JT@3I6YN64K*E,5KK5?&0
MUB;$QHV,: ](^90GEE3LK$F1-(\XN+GF#Y!97H*D030<XB:5T,V&J56*;<X=
MA'P++G:.NQZ-D]ED6-PV;'&O3?E7V-9#M4N1ND_:NPE-S+>%\P]*>L%2D+$*
MU[P[%CJ3Z3;2U9S,SI6XN1EIRERZ-/SU F@KI6EY_=SZ/<6_PRXJMK\RJ\#S
M64PA%1E-YC+&7UU<XEQ/JF10.SJYJ6'$<]J3*; /!Y':!JH*9>\@>9K7IY:P
MS[CX!U0XGUY= CF^^_F$;KUCV3;AMU\#&-GF]O7(LD8Q()><FL9;=KD @GAI
M;"&D#PD<#@P<S.G(:<^JM:@?Q3EH-*!3P#P/]!JHFB)HB:(FB)HB:(FB)HB:
M(FH1((U$(N R"V2K@J)4H=OGGW/ !]O;_/R1YUL]FV?@=B.&-Q N<8+"""7&
M15QF)O$7TE5[P.%H;>.7E45O-\^:Q$W[ZH$[76@QJAJ(UQD'I)?E&P?+,"*A
M?^YEQ33:U**@""$<J\>0"1KJWQ]^IA\(<3<+9/BXC3PF<5K"3,4G9L8  DG,
MR+F2N<^%_!FT>(2'<+AAY06 &?\ <#BL)U$1EF5L;#]4<;<RV3C>0U#%/?J2
M3'5!E.NP9?:.5>DE3*5)X'L7.T$'QY\#'P/^J8\4N;L^-L8PB\ <0Q0^)FI#
M=EPA!Y&009K"W?BG]/,;P^S]TW'.(V XX?#$ Q8C:,3B+9S!&D&_9;[],M5N
MS/.10[-ZFR5F.S';=["N#(0E945OI2LE1;"N/*03X Y]]:?Z@_I/N[Q>W]QB
M[:=G<\R1\+'>V1!! 9M6"!-!217JMIX4\=[9X<=\)FS#'8WBB78;"+_W.P<4
MT-101H<_A]GNCY>'9/ R?+;)FUD5*BY7Q8C8;AB0""F2M*E!7< .?V??CZ Z
M^'X'_2,>'L=N)C8' ,-PX7<8/$&ND. &U8A;Q0"007 4))HM_P"(O'F/OC"+
M&%PXP20YK:3D'?#!#A7EF;P,\@VE*  D<CC@^/I^?CZ:[]:SX>$W#99K0T#D
M.5=+?A=:W)<;DW/U_P URLMW6HJFB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB
M:(K ]1/3AM1U3[876SN]^)O9GMW=3:ZPL<<;R&]Q=%C)J9;<Z )%IBME4VB6
M&I2$/!L/ *6@>H%^.2E9I00 />:=(C3+-6=V1^'GTN=.][;9)M3@]_5V=Q03
M,:GL9-NCNGGU1*JK!A$:='=I<ZS/):E+3\9"8WILPF&TL]R VE*BG2F<]^84
M^: *6%:#/2#7GZ+5LY\/7I6V%SR!N1MKMK(J\CHV+./B3=KEN69-38&S=.2G
M;MG!<<R#()]#A[-HN4\'6L?APV0AQ32&F6 &DH$G+UB_GJ>?T5K _ MD*$ 4
M@"*<M,W&TJ2A"5*"E)0E*E!(2%*  *@D>$@GD]H\#G@>!HJ._P >2B_ZO/\
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MZUF.86=O1[3T+C*')][08YB?RE0[4-N3/PQIUJ^\J,RF6RVL\J[4$]NKP_\
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M_P#V=[F#VX]A^I_U/'N/)^OOH=AQ)NV>I]?Z(R/*\!.*?2<HIU(O%)^Q5/\
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MA5XQK$Y$B>M_YY(>H#8D^^]VT7D?7<K#0/X\77U_('WT^!C_ .U__J^V>75
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MP1R$-\@<@A//I \>_P"X^>#])+_^-Y_N_/?16.9]M>GEI"VC%<(3W>FLI "
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7?;O[ZYKN/;VT531$T1-$31$T1-$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>g425213g10n10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g10n10.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2$N4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (1*^A&8X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0&?ZEX         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             !Z    A,          0
M                       !              (3   !Z
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   !Z     !29VAT;&]N
M9P   A,    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   >@     4F=H=&QO;F<   (3     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    &.$))300,
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M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MOK<6;+AD')L
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MH;.T%3)5E-+3X?$4%R-4<I.5)#1"0T2R)3,V4F*"9'.#_]H # ,!  (1 Q$
M/P#^_C@#@#@#@#@#@$+$+IOIKWL#T/)HU6 BBI;0%NV1""(Q])#EJEY%54XZ
M_1MR9D#U781$XS'":5REAS.'LP\D,>GC360N9DV2+YC0]X\>./9=WC[/;U]\
M3(]W([*$HW#^VSU]52?5Z<=DQ-*,*82@DAQ90VK9=?6.N,'MW>V<SS8:YF;^
M8O0<].0[:N4H\S@I->*,W^\B%?&\IK6)<FJ=99]._)9YVJ,G&HV]>&=^NOLL
M]\8[>=D'@>L^TQ<O5+KK%;/8,%4#"I1<!/XGT7K:PK=6I"K;3S;*<_?#C<I)
MRY[%))*HYM7S./-XG(UPHIT@9 9/'8IO;V6J6:MNE:SRWO+COX70<5LWT7XS
M2^SHSWVSKEA3579!T3'MEM/#.R*[ULBKKC;&-M<[)J*Z[X\[7.-L>.,>.,XS
MCV9YLM<5WF--Z)OL/6BLBX2T6;K)+HJ8SE-5%315+?&,YQG.BFF=M-L8SC.,
MYUSG'CC./?CE(?KP!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P
M!P!P#D%T,+7,1L0!J:3"8"\.21LQFEDOFPTH7KN )"31(W)(4 .CR4:.S9P_
M8!XT!3E35U&0&T@<3,T)E+2,;PZ1#&6TTE%I-O-ZTM[2T;W*\L[=U3B!**.Z
MIQ!U G$P[AWS$I]:*Z"-8RJ0>40NX [L4VYT;.6[F"UB2N%K2,O7<X>M'*,<
M U.1BRJ;MKJE',M54$LW^6GCAKJ:W'#57B3BYOYK>--;3J_FQ<MEY9[*BU6X
MF'3@RV@$?,QNW9$.G!*/25X-B5B-F8X.:GT'V'"GX8]-HZ%8#H\"F[-X]*QF
M0IQIFRCIUQ'])>'"Q=E(TXF"ALCM)-2:;3R>EK<VM$]SK+*U5TNM\&1'T]3I
M<MVGJZ_4BPY(% J&O&I'P)1-SDL^*VI/J!EXLJT5U3RSU'C&E0EFC]-975SN
MX+#MF^FZ:;G9,-WCM[\NX@P Z07\*8Q?K8ZDM0N.GL+[$L;Z#RG4C,<WL^C<
M?NQ7L-#J,>0;XJH01F.CUB)!12]J)6,]?&(*#T$[ULQ,D%SC?7Y-;6U[[[];
MUSM=M49[:V=FNK[;RRK.G>>G:>V.=*[]9:U[U\-2&H5.HM5WX/O"/R(81F*=
MVR(!$+0=W/65+F8+\5VD$"CH?.\1MN3LAE8)ES)XK$FX[6O )0RY,#B@E+:>
M;SKMX^/6PY7'9K[;79W+CPW9SKF?6+K78TB>RZPNO5'3R6$]6NA*3S.IH%*)
M$0T9-463+1Z:-@'Q)WJT9-T&C75=RIANU01;I8T23TTUV&!RSH>%#QOKDQC\
M=$C ( '<?:,2%!A6#44'#BA_:&XVC 8+&,4D&0\>Q:I)-F;)H@BV;-TTT4$M
M$]-=<1:=LO6RMV[)B<I!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!
MP!P#CE_/XP+J:4/I?/9U601NH SM-:SU(KSP23WDH=,"C&!PJ/2UX=)%SNXX
M+K&]8K)&\D1(*@W@0DS?KM5!C*MEVVEQ6JSRK)V[W4[TID!XUV4[>U<-F%D6
M'6!FR^H5=1 G-)#<]L1X+UU[-MH?']=G\@D[>C@KF0,K$P"CR!&1'VDJA'3V
M3)CQ+QI&:YE1E06/+W+^7JS_ (FG;Q8YN.UAI-RE/YF(DL[V$G&5+-WY)JG4
M6\B:':VN9/;-$RJ%Q!B,.%'1NMY \AYMVD/"V3%(19T-G,YJ,P]=(.6#45<$
M)CD@K BL6:N0J;.6K;&VS@3AXCO#;-.4&HU=Q?0TI)M<*DDUGEGGD0-(1"2S
MEGV8D\FHB,?9<[%5=%>OE"=89+85&.9'7?7^*1^1"]9-.'(&>R"&AX>I:<QG
M4IF32HR4_)(14!"V@YA)9<*0CP:\/M\</;9JIR\I)Q^=.*A"#E"XQ2>;J4HU
MM-M[+>22IM%K$+"$(U#HG'"YMU)2L?C($(3D;[&V'I\@*%M6#TV\QLHKMAT5
M<H*OG&-E5-L*K[^*F^?';,-Z5))NZ25\>GM-EX*. . . . 1.Z4_,4M^?/M?
M^M3<W(M.V7K8)8\H' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M(V]M)),HG1YTU"RTAC:R<IK%A+Y=$0Z)^50BJS%FQ 1;TXCHMR)/-]RD/K%]
M*Y$D07"&4P*8Y:0? Y?85J,=C#$;4;CEG&VM5%R2DUD\U&WH]#CU<=@HE;?9
M:&L>N5[!KZJ9.FI<WN/$*D\;L:O8/)8\:AN*O,;SN,M2"(BSIB@>F3,M#GDG
MV7D<:$)R;8"/S&='I48QFIS7DYQG#9DI.,MI1DFMG-6K?SDXW>CK)WTWNDTD
M#WKA.$ +8^^9?#58KV&.BNA963%*.:6O!W?841'T(_X2%V9+44C8@T:RCN=9
M"]=NDF@+?0LLSWU&6)>PZXQM:MQVEMI)9VXVEZT0@NT9T#<0.<6E$)E1LLVD
MG7BN*;ZQ5]43F!NI6 FE7E+DE-5I]9F\*>?&4/8A63VJ,: &4$:BW<?=1,01
M]8;-F[Q5@-4O))-IQ?S%"$8U::<G%02S4K>22RKNM=@^LHUA<0UG&[-2:ZQ<
M!K,-Q^-=6&\HP):8D&['73QUU9[%L.\ML:YSKA'.F-?9X<&]72O6E?7O-HX*
M. . . . 1.Z4_,4M^?/M?^M3<W(M.V7K8)8\H' ' ' ' ' ' ' ' ' ' ' '
M ' ' ' ' ' ' ' ' ' ' (J]U+A=4/UXE-EHV%$ZD8BY15@226I,]!;@/7,.
MFMJPN%3"9H#S;AN(+'P$:D!-]%Q9'UQH\D:8M-8+(]/&.E2S_@88DMB#E:BD
MXW*6B3DDWUI/)/*ZLXOU/N2CI_8K\)6_E0VG<PZE$R1)Q5+>:],#^PU@D2#I
M.IML-Z^TW )PE\&.7389NN^-+ $]CN-'[!=\H.7;U_X:[_:S7A2@Y-1Y3Y9U
M>SM8+I6EM?V4(O>EFZ)S3D5+#<4,"X-+6T$E;M%#0/+'D;;2YL&5T>-UEUE8
MX[("FQ/"[--PSU35?M]4=W&KK&=]D,);PW--II.GN=779E939O&>R4EMPVQZ
M>7%0<QLMI(<"+C[)NNFD#$5C \-RF-);&B%AQV<(22W+720^$&NU=0PDY;1X
MSMYEHRZ![J,FAFY<'T9_P/,XXCD_)SPW+)2F\)4DGFMI2MRJZC=)O.LKNV9I
MN46;5)ZYT>/$FR";MXFWPTT=.=$M-5W.C7"BV&VBZN-U=6^%E<(XWPGA3?&O
MG9AZCT\ < < < < B=TI^8I;\^?:_P#6IN;D6G;+UL$L>4#@#@#@#@#@#@#@
M#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@$8^X4XG==4+(I57S\P")-Y35PR2S&/
M1A*:'Z[K&16E#8_;EFA(JX$2!H8*5U6).63-EH0CTB%CUPNI<O'9"+'O K\N
MGQP_B:\5RC!N-W<;:5N,7)*4DJ=N,6Y)4]-'HX+>3_[.&[GE$3CT-[%/.S\2
M#*=RXW9\@]8@4J81D96W;671SK)-S,]@$:##VD[M"I7B""<27<:#YK!@02PX
MM'HXS#&'\SK]WJSZ-?X&GD^(YI5B/$IXT9/YKRABR6&VXI+:<*M+55+I=G5Q
MU3'+QK":5)+R,P%1:>AE !][ IE(J_EF!3A9%1XV%2^)D!<A#8?HI;,'^XU^
MWW>#'+T>OMNU=KI[P]$XJ<90;:4E3<9.,NR46FGTIID,ZXZ%4.#BC"'U/V [
M3#X7 =G$$'QV"=O;22C\16B:Z@9[$T1P23^I!G4?=M51KX/E-!P.=H*MG2"2
M^BFN+=^.F_'=H:HX$$E&,\6H_-26+.E659/=_,L.9-=6+-HRT5<KZ,VK=KHN
M]<JO'BVK=+1'55V[7VW7=.5,:8W7<K;[JKJ[;JJ;;;[;9S#>>G@#@#@#@#@$
M3NE/S%+?GS[7_K4W-R+3MEZV"6/*!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P
M!P!P!P!P!P!P"-O8 @0@\9FMA$;PL*N8TM'X'$08B!0.#34^/G9&P=6 UY"A
M)N!30Q+)O:#V11NL6,5>L3(CSO4' (2./O7)C@PG:3>VXJDE23:=Y-6G;E:C
M3M:4D[;U"KUC\-N9A7L[[%W7/Y!)*Q(3J.0RR:SIV*Q<L/:F@S&0OPTJK:IH
M?N^F$&<D@[:21=22J*,6,P'%%A#]NLW(,1C%-22EB2E<;491@ENO.,4[6]7O
M)@\&TJ2NRD2=NW>2& C%&=&K(-ER"8&Y:^L99;N-;H,80=MV9M.#Q C7$-=A
MWFB*A@"TN)[V/!):.EM)!5(LJBOII?M7M?\ +M2W'GG!RE2E'!D[J<9+RCCF
MK2I1WVMO;2WQLG[1X^Y #";Q&X#BDXTB<S3$UO:1!I%!,FL^OG,-B)I.130#
M"6XR-!Y8'F!67P@ED/&XB,.(11E*!T6#,SB+76>.HW1VDFI.Z:2DZN2I9M12
M2=VG22=6HI4=PX,AP"L:4TE&-^ZU-1:LIOV-&%XGD_V7O15QVP[0R>#YBBVQ
MJ'5Q6Q"M)5<1NM6XJRI\0-R%F#1A^HMM'Z>/#&+1BT<H:<F_[7J[Z+O+J]EF
M5Y.TNC)+A>[@^.7#1G,:F&RNF^P#J0=J87VA8%;0[:WJ"INX=NV]@2KKZH&G
M%CSQSUX@ISK^ OUS$8D/,5CN"CL61,4VH%:RYJT'G,A),[".2#LK/OZZW=?=
MH3N[E]E[^-=>9/V?]H*]K>4OX@>B'8LJ3&Z-%%WT ZF=H+1BRNKUHB\1PPFE
M;5%*H@4W327T3=IC3;I1@[U68O=6[QNN@G175WKWG/\ H.=9R?K8-D8]L89L
M3EP]HRK1K(0!N*GF[9]VBN-PBB8C4E'BI" ))IJ:Z/!!L8/*CU\;M7S-NY24
M2UBT[7ZV1Y$RN4#@#@#@#@#@#@#@#@#@#@'UW4T3QC.^^FF,Y\,9WVQKC.?H
MQG.<>.>51E+\V+EU)OU$<HQ_.DH];2]9^?K#?[^C_*Z?UN9>3Q/HY_5E[C'R
MF'])#ZT?>/66_P!_1_E=/ZW'D\3Z.?U9>X>4P_I(?6C[QZPW^_H_RNG];CR>
M)]'/ZLO</*8?TD/K1]X]8;_?T?Y73^MQY/$^CG]67N'E,/Z2'UH^\>L-_OZ/
M\KI_6X\GB?1S^K+W#RF'])#ZT?>/6&_W]'^5T_K<>3Q/HY_5E[AY3#^DA]:/
MO/OHHFIX^CWTW\/?YFVNWAX^[Q\,Y\.8N,H_G1<;TM-7WF2E&7YLE*M::==Q
M]^0HX X X!%;LT5KZ1P^5U](C]BQ<_#6U57,,DL$JJ>V$_C!H#:K(C69T6PC
ML-DHZ:+-+ A#?,I@0[#XNI$-7JT@9AHX71-\&O$<6FFVMG9E:C)TU*XM4G>:
MSBK=:JF<.Z[&R%KW8(FMIVH:LF=5_!9D)KX2$Z5=@.JM<@!<N(Q'$PD11_=1
M*>J2:>/] 044)193T.T'@%S^C*(OEEWYEM?#SO//QOZ\S##EM2N4G*23V:PL
M3#23J[VK3>2WKH1."R9H]KZ'E)6.@4XLQV-W8:)PRN&8)_+RN'K]LQWW&-9)
M((N'4T8)N-B#[+HVTVT8-7.[?5PXU2;*PW2=)M1<JW1JWGNMI9:ZZ%"$H%2$
MQ5_:B-2;R3/8>U[DMFQKCE4*NV31;K@G(".EC2<O(:B+%IL^NY>QJ_>]<A)>
M.P:-XB6S]V%%U@"/U\J/>D6XH-EII)=*SIUUZWV<#P24JQ4^2XDYSE)QQ'Y&
M_G-R@V_*[4?)6HK95U%-4]/Z 8.R*#85#QQPD2,&V$7C[(P7,MVS0N5*-1+1
M @2*M63AVS;$GSM-9T^;M'3ELBZ5530<+):Z*;8GO5TKUI7U[S:."C@'+814
M<8@DWMJPQ[DR4EERR$ =E),XZ9N]V+.*147$HS$H]AJP8Y&Q &T8/2C 2ML]
M5UD,EE)E9ZLZ-N<XE>,O'#N0.--NI U:?@I;+[NO>R8C#K%(6O!*>GTAA9F
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MQ#GGY07FWX-^G<O_  ^ 5=<Z .71P!P!P!P!P"T+R?\ \F+%_'P3ZO=\Y_\
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MZ"HEMY0T88;N&Z^7C@6FWPBNBKE3S%=-MJ*=73KCN.G<$(G=*?F*6_/GVO\
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M>.8>Q72M4Z5K@]Z-BX*. . . . 1.Z4_,4M^?/M?^M3<W(M.V7K8)8\H' '
M' ' ' ' ' ' ' ' *_/* ?)2O/RA+_5J'/M'Q,^<.?/0^2??XASS\H+S;\&_
M3N7_ (? *NN= '+HX X X X X!:'Y/\ ^2]B_CX+]S_N]W]W[OW/_/QYS_\
M'+YPYD]#Y5]]A>,SJ'Y/GFWX2^G\@_#X_C/U%@O/BYT.. . . 12[!LH1=8F
MR:)<S<[74SJR/T9V22G8P0R))05\'M*63*II7JR*H.Q,G:CYQUU.+2N)O&V$
MBD<0V&J.6VQM%VUNF?6O5?K-<U&:<&VG'8FFMSC+:BUQJ4,TU363M-G(:HB,
MU)7U3-H]@NP<+NB7DZ9LO;KV(IRASM&ULRB)Y>IR5B3R2M95<5WR>0S0VRS
MF #*DICT>#!'I]!I$5B;Q8J@W9+*\\[XUN73XHPA&6W&6)B1G+9EY-0@X147
MLN3:<YMR?S<]I*KJ*MEA?(;RGXA?P@U8EN!+@\I>[ZNV! [3GD4VHR$,NHS-
MC$((SDQ3%3F'Y*Z:2N&6G#EA5?B)S\T_;RMF,:/I&J UC,;(!GXM"KJN]-?L
MIH\LIK:DI<I>%)-K8CY')6]EO;PYRN4:;SK/)%N(A1)84,60)[FD51[)1$PI
MEGE0LDHV2V3)[Y'-F8_.[_3.'6V6+1JS\Y7/JS9!#S$M8>I:(R' ' ' ' '
M(G=*?F*6_/GVO_6IN;D6G;+UL$L>4#@#@#@#@#@#@#@#@#@#@%?GE /DI7GY
M0E_JU#GVCXF?.'/GH?)/O\0YY^4%YM^#?IW+_P /@%77.@#ET< < < < < M
M#\G_ /)>Q?Q\%^KW?_+G/_QS><.9.GD?*OOL(ZB^3YYM^$O3R[D'X?'18+SX
MN=##@#@#@$'[NZUWO-;3L&PZ;O\ KJK1MJT9 Z2F\<G?7TU;KI1I 9%=QP?(
M(\>$WS4V@9P\0N\RQ=#WP0XGJH''O$W>,++M,7+???7L9IQ(8DI-PG"*E%1D
MI8;G=.6C6)"OSGQZSS45UEOROYO5$@MOL+7%GQBEZCDM4PF-0GKP9J<JHE(=
M:X:X.R*3%;]M5$HJR&UTU;ZCV$=#)N'11R\V=)Z()--F6Y/OOV(D,/$4HN>)
M"2C%QBHX;AKLYMO$G=*-52UN\J)T\AO*[(E57>ZIW]D *N.].U:UD%R7#9L,
M;2^-71\<Q[&VK(DMEDVDL)A9*D),F/A^5%E]G@\>/;MFJS86FFZT8:/G-RX/
MO_@:5'&BY)/#V7*4HIJ=I2;DTWM4\VWDE6FXL)8^O>HL_A/+7)+U5O\ "&6.
M%L,<OO0Z>MY9X<9ROAKZ?TGJ^%\Y6PCYGI,YW\[/(;NL]7 ' ' ' ' (G=*?
MF*6_/GVO_6IN;D6G;+UL$L>4#@#@#@#@#@#@#@#@#@#@%?GE /DI7GY0E_JU
M#GVCXF?.'/GH?)/O\0YY^4%YM^#?IW+_ ,/@%77.@#ET< < < < < M"\G_\
ME[%_'P3ZO=\Y_P#CF\X<R>A\K^^PSJ+Y/OFWX2>G<@_#XY8-SXN=##@#@#@$
M3%RLAEW<YW"",UD,=AM0T97EI1N$ 26H4?9LLM*7W9!I04F>R;;4G*0=8"(!
M%<!HVR)(@&!VP\')@*)$=*^<BWC?E[,^TUYO%JVHQ@I))I*3DY)WO>RDLM+E
MG;HX5UOAUB]:9UUGHJ56Q8%IR.Q>M$FD-W"9]:LXN?87:]3H4Z+DMLPN:6B]
M+SX9$I9*9V9 %(LY*(1;=T1ASV'Q:(9%R5J7&,$X2A!RE)R@W*VY5*.S<E*5
MM)MU7525,L5-9,ZABVT=3&*R#48_R"2-+.FX90SAJKD6F678H.7J S=[Z#5^
MLS;.'2;7*N[=!5;71/8;G=.M=UZ7TE7P><]_A4-EL0MJ==*JXG!N5W:F#,2F
MSY,G*8["3EH3Y"K9"(!!@PH<1&!X(I&EXFU?E!<@>BV YK-78J8?&#5I<L]>
MC^+_ (&C:QDJF\*+;EGM.U':=-*DK2JL^O.RS:+,'8N,1P8_/.)2_' 1#![)
MW>C=)U(W;,>W;N3SE-I_!$W!=9/<@MHU_@^BCC;5#^U8UY#<LDE=TM>/29[@
MHX!#Q_V^;A9JT$22A;WBE:D;@:44+N^4@X9'X82L$G(?B:#5:Q$I.&UQ;0>2
MS;9&)Q>P-JTUC,B>/!L@$NW4#*C9>[F=Z9=?LX=M]!:7'I_AU]E=)^]3=K"U
MS3:2@X=UPN?->Q2W+7IHM=A,Y0S*"8DM.2^1P&7$&\>Q="MM+@\R^,$0PQQB
MM\/W>=F[_8<B,WW>)K?!/MS[J]HRXY]67?\ PUZ,R7G*0B=TI^8I;\^?:_\
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MN+7#5_V3Z^-^I^;J<WY8MXR)K>^LPI5I599*TYQ)Y!!W=T?&B:#[G'&*&&%
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MN"9,4&PA$?NGMNGLR2'I-TVFR>^VFR&J>==MM<XSF'L54JTK+J,UP4< < <
M< B=TI^8I;\^?:_]:FYN1:=LO6P2QY0?PG^5,_\ C\[)?1\; ?\ H1%^=K?%
MG_Z%^#WHN/\ C>5'\-SG_O\ RGAMQ_[(D /I\/=^WT_^?/[H\/&M/''^8\/'
M/W,>/]_W?M^WW>!5O<KZ=/'C>?'[?Z_]?M_Y\$\>WVY_Q'O_ &_O_M[_ -/
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M.?\ XYO.',GH?*_OL(ZD^3W)2YL^$C332Y?R!6FG_P!/C/<\BP3GQ<Z'' '
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M!L-7"RBRJJNRB^%-LJK+*>/GJJ;;2DU6X6^OKSUZSU?:*]-OP8Z4^GYOX_\
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MT7.MGI!L#,*.$0TD28[92=/8L;69NT@LI8HN8\84:N=!I-UL@KC19*\6CO?
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%B<%/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>g425213g12c11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g12c11.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1FL4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &9"^940X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>4KH         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,
M  $  @"4S,P  0 ".$))300F       .             #^    X0DE- _(
M      H  /_______P  .$))300-       $    >#A"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))301$       0     @   D    )      #A"24T$
M'@      !      X0DE-!!H      T$    &              #A   !YP
M  8 9 !S '  ,0 T #8    !                          $
M     ><   #A                      $
M$     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<   #A     %)G:'1L;VYG   !YP    9S;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    X0    !2
M9VAT;&]N9P   ><    #=7)L5$585     $       !N=6QL5$585     $
M      !-<V=E5$585     $       9A;'1486=415A4     0      #F-E
M;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO
M<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )
M=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M  MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N
M90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M   ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M   X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$
M%       !     4X0DE-! P     #QX    !    H    $H   '@  "*P
M#P( &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(
M" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,
M$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( $H
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ML^SO=UZNQS&-Z]A-I976 1>0\V-;MM>[;7O<RU[G^U]O^C5',P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                _^%#?VAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#
M96AI2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B
M93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@.2XQ+6,P,#$@
M-SDN,30V,C@Y.2P@,C R,R\P-B\R-2TR,#HP,3HU-2 @(" @(" @(CX*(" @
M/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R
M+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @
M>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP
M92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B
M"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE
M;65N=',O,2XQ+R(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @(" @(" @("!X;6QN<SIP9&9X/2)H
M='1P.B\O;G,N861O8F4N8V]M+W!D9G@O,2XS+R(*(" @(" @(" @(" @>&UL
M;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q
M+C O(@H@(" @(" @(" @("!X;6QN<SIT:69F/2)H='1P.B\O;G,N861O8F4N
M8V]M+W1I9F8O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z97AI9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]E>&EF+S$N,"\B/@H@(" @(" @(" \>&UP.DUO9&EF
M>41A=&4^,C R,RTQ,BTP,E0R,3HT-3HP."LP-3HS,#PO>&UP.DUO9&EF>41A
M=&4^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(S+3$R+3 R5#(P.C0V
M.C0U*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I-971A
M9&%T841A=&4^,C R,RTQ,BTP,E0R,3HT-3HP."LP-3HS,#PO>&UP.DUE=&%D
M871A1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!8W)O8F%T(%!$
M1DUA:V5R(#(S(&9O<B!7;W)D/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @
M(#QX;7!-33I$;V-U;65N=$E$/F%D;V)E.F1O8VED.G!H;W1O<VAO<#HQ9F9E
M-V0V9"TS-F4U+38P-#8M8F5E-2TS-3 R-#,Q,39E-6,\+WAM<$U-.D1O8W5M
M96YT240^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z-#4U
M9C(S-V8M9CDX."TT,S1A+6$S8S4M868U,64Y8C-A,#)C/"]X;7!-33I);G-T
M86YC94E$/@H@(" @(" @(" \>&UP34TZ<W5B:F5C=#X*(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^-34\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.G-U8FIE
M8W0^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F
M.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N
M=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO<&1F('1O(&%P<&QI8V%T
M:6]N+W9N9"YA9&]B92YP:&]T;W-H;W \+W-T179T.G!A<F%M971E<G,^"B @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D5$-S8X-4-",D,Y
M,45%,3%",#@R14(U1CDY.#,U-3(U/"]S=$5V=#II;G-T86YC94E$/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3$R+3 R5#(Q.C,V.C0W
M*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO
M<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A
M=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II
M;G-T86YC94E$/GAM<"YI:60Z9CDT,30R,S$M-#=D9"TT9#0W+6)D,6(M,S9F
M.#0X,C0P,S<S/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z=VAE;CXR,#(S+3$R+3 R5#(Q.C0U.C X*S U.C,P/"]S=$5V
M=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N
M=#Y!9&]B92!0:&]T;W-H;W @,C4N," H5VEN9&]W<RD\+W-T179T.G-O9G1W
M87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\
M+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E
M<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM
M86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYD
M97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T:6]N+W9N9"YA
M9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R
M<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-#4U9C(S
M-V8M9CDX."TT,S1A+6$S8S4M868U,64Y8C-A,#)C/"]S=$5V=#II;G-T86YC
M94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3$R+3 R
M5#(Q.C0U.C X*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @,C4N," H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @
M(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L
M1&]C=6UE;G1)1#YU=6ED.C!A9F9A-C Y+3<P9&0M-#4W.2TY93$V+6)F.&1E
M9F8S,6$P,#PO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \
M>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.F8Y-#$T,C,Q
M+30W9&0M-&0T-RUB9#%B+3,V9C@T.#(T,#,W,SPO<W12968Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^=75I9#HP869F838P
M.2TW,&1D+30U-SDM.64Q-BUB9CAD969F,S%A,# \+W-T4F5F.F1O8W5M96YT
M240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^=75I
M9#HP869F838P.2TW,&1D+30U-SDM.64Q-BUB9CAD969F,S%A,# \+W-T4F5F
M.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$97)I=F5D
M1G)O;3X*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M
M870^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0O
M/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z9&5S8W)I<'1I
M;VX^"B @(" @(" @(" @(#QR9&8Z06QT+SX*(" @(" @(" @/"]D8SID97-C
M<FEP=&EO;CX*(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @(" @(" @(#QR
M9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/D=E;F$\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^
M"B @(" @(" @(#QP9&8Z4')O9'5C97(^061O8F4@4$1&($QI8G)A<GD@,C,N
M-BXQ-38\+W!D9CI0<F]D=6-E<CX*(" @(" @(" @/'!D9CI+97EW;W)D<R\^
M"B @(" @(" @(#QP9&9X.E-O=7)C94UO9&EF:65D/D0Z,C R,S$R,#(Q-3$U
M,S4\+W!D9G@Z4V]U<F-E36]D:69I960^"B @(" @(" @(#QP9&9X.D-O;7!A
M;GD^(#PO<&1F>#I#;VUP86YY/@H@(" @(" @(" \<&1F>#I#;VYT96YT5'EP
M94ED/C!X,#$P,3 P1C@W,#<T03=&03-$,#8T1CDQ0S W03<Y145!0S0S-S,\
M+W!D9G@Z0V]N=&5N=%1Y<&5)9#X*(" @(" @(" @/'!H;W1O<VAO<#I#;VQO
M<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @(" @/'1I9F8Z
M3W)I96YT871I;VX^,3PO=&EF9CI/<FEE;G1A=&EO;CX*(" @(" @(" @/'1I
M9F8Z6%)E<V]L=71I;VX^.30S,C,R+S$P,# P/"]T:69F.EA297-O;'5T:6]N
M/@H@(" @(" @(" \=&EF9CI94F5S;VQU=&EO;CXY-#,R,S(O,3 P,# \+W1I
M9F8Z65)E<V]L=71I;VX^"B @(" @(" @(#QT:69F.E)E<V]L=71I;VY5;FET
M/C(\+W1I9F8Z4F5S;VQU=&EO;E5N:70^"B @(" @(" @(#QE>&EF.D-O;&]R
M4W!A8V4^-C4U,S4\+V5X:68Z0V]L;W)3<&%C93X*(" @(" @(" @/&5X:68Z
M4&EX96Q81&EM96YS:6]N/C0X-SPO97AI9CI0:7AE;%A$:6UE;G-I;VX^"B @
M(" @(" @(#QE>&EF.E!I>&5L641I;65N<VEO;CXR,C4\+V5X:68Z4&EX96Q9
M1&EM96YS:6]N/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z
M4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( .4!\ ,!$0 "$0$#
M$0'_Q  ?  $   8# 0$              0(&!P@) P0%"@O_Q !?$  !! $#
M P(# P<$"PL(" <! @,$!08 !Q$($B$3,0D4014B40H6%S)A<8$CD;'P&!DD
M)2<S0E:5H=$:)C1259;!T]3A\34V1%-76&+5*#<X0T5&8X5'2%1RDJ2U_\0
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M=L$.I%W862N71":D*=9?26E$);*TSG\O8'WR9ZJ,8O;,V&=S<WG/798U;/\
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M '0AT?@'_ IUD\*))!Z<LE'<?!YX^8X//U)_#ZZE%'_="/1_Y)V7ZR@1P?\
M[.>3'SX/)(DGCV]_J4G\-0#.QS&#]?+W93'E]1[]^:XQ^4']':"M:-D^L=*U
MJ"UE/3CDB2M0^Z%+4)')4  .5<G@  Z29-K#>?+^=]E"F5^4(='ZAW+V4ZRO
M )2K^QTR7D!25 E*OF>4D@D<@\\*4?8'4]X]^OLA2&\Q#?\ J( (C_E8;Q-^
MOJNLW^4%]'">4HV5ZR$ DJ5QT[Y* 3QSW'B4.5'V)/GCP>1IS$]1(G$>A_07
MC%@I=IPPP7";1?;K<C-R>O;;D/Y0?T<E25G9CK)[D@A)_L=<F5V<C@@?W3X'
M@ \<>PY]M 23R[3FWU[F?H)N)@VBV 7 %S@"6B3M%NP^T_52#\H-Z-R' =EN
ML5/J<>IV=.62H[SR/*U)D<K4?Q/M_KU=^&9L?J(OZGSCRZJD2\?-( L0#OGU
MM'KB\KE;_*"^CADK4WLOUCI*U K/]CGDW<L\< G^Z>5>. "H_3QXT=3=!=F
M3>!@=B8Z8F4'PVF)DS$&2;F/4*=?Y0?T>N!07LGUDK2H?>"^G')5)6 ? (5)
M(/!XX!! /UU:]_Y5U13^4(='P  V4ZR4@)*4I'3EDH ;\$I ^9  ('/9X'@'
MV\B"8^L>_?WLICWV]2%$?E"71_R>=ENLH?B1TYY,? \I_P#21]2H@?0\\>3J
M5%O?7?\ 5<:?R@_H]2%AO9+K(2%$K4$]..2)"E+Y[E*XD>2KCE1/)5[GVYU'
MZYZBV_?&?V4^SC[7NIC^4(='BTA*]E.LE0'D)/3CDJ@#QQ[&1P/!XY]^#^'.
MI4*(_*$>C[@_X%>LH<#P#TY9+^/D?\)X_;^'UU$XZ'S\_>_;H6%^[_Y1WA-'
MU.=/]-@&UF\CNRN7LS,<W,I=P=L;+"\W1;W%Q"ATUWAK#RW9<YZM9<<;G06F
MUJ>9=00GD@ZG\_?[%()F\1T%\][;C[KZHZ6QCW%/4V\1N0U%M*V#8QFI<=R)
M*:CSHK4EEN3%>2AV-(0VZE+T=U"7&7 IM:4J20"87I:(FB)HB:(N-UEI]MQI
MYIMYIU"VG6W4)<;<;<24.-N(6"E:%H)2M"@4J22E0()&B*UBMA]D5+*U;/[8
MJ4HE1)P3&"2I1)4HG[+\DDDG]^D_OW^N5$?2T7.!'?,C90.PVR!X_P #VV'@
MC_\ (F,?3GC_ /"_Q]^?<<Z) _/KOE0_0)L?X_P/;8#@]WC!,8]Q_P#M?[!_
M,-$@?O<WSMZSYJ'Z!-CO;]#NU_'//_F'B_CQQX_O7X\<_P Y_'1(CK]3^Z?H
M#V.X"?T/;8< >/\ >)C'X #_ /"_X_CR!^&B1Y_4_HH_H$V.XX_0]M@.!P/]
MXF,?_+/Z=)_? ]^F%'*)G>U_+\O3T4!L)L</_P"#VV'\<$QCG_\ YFBD"PF)
M'F?SNH_H$V._]CNV'_,3&/\ Y9H@%H-^N\_7T3] NQ_''Z'ML..0?_,/%_<$
M'_DOGSP.1[$>-$ C!/3.W3W>Y4!L)L> 0-GML!R../S$QC@>/I_>OQ_3I..W
M^4(!G-]P2#Z=/11_0+L=P!^AW:_QQ_\ D/%_I[<_WK\Z(!'7$&YOYWS;*?H%
MV/\ _8]MA_S$QC_Y9_X_72!TQA3M&W\R?KNH?H#V-)Y.SNUY/[<#Q?\ ^5_U
M\:*DB<;=S'KO;KU0;";' $#9W:\<^Y&!XOS_ *ZO^H\:3O\ H/RPG*-Y/F3V
MMY63] FQQ YV>VP/!YY_,3&.>?X5>GZ_JIBT7^I\UUW=A-BTD+7L]MAW)*5M
MJ5@F,\A;27"@H[:ON[D]Q[O^,GD$'2!V_P 1';;[*,3:P!.9)ZY]?LL;.ESX
M?'3_ -*NZ6^6]6W^,P%;E[\YQ;Y3D>2O0(+#M52V<GYJ-B>-M1H[::NFA<K<
M^7C>DAU4I:7$E+: )W,SO]>_ZG]T$@"+X[VW/?L!_"SR;24@@D*Y4M0(''"2
MHE"?V]J.U/[A^&H4C_'EM]E/HI31$T1-$31$T1-$0D#W('[]$D=4T1-$31$T
M1-$31$T1-$31$T1-$31$T1>5*HJ.:ZI^;354M]7;W/2JZ)(=5V)"$=SCK*UG
ML0 E/*CVI 2.  -$7!^;&-?YO4?^B8'_ &?1$_-C&O\ -ZC_ -$P/^SZ(GYL
M8U_F]1_A_P"28'M^'_!]$4/S7QG_ #=HO]$5_P#V?1$_-?&3[X[1'_\ :*__
M +/HF,+SI&(X\I?>,>H4I2"013P/ \_K<1QY( XX_9]3JH$ ']<3$6&WZB>P
M5A['O=VM!WR-]\ @9&.ZQTWAZ@>F/8N?4U>Z^4;?X._<1_F*]J[APFY$F(VL
MMJD)0U ><[$O ]Q[>0002-6WO;3:7N)AH)WS;M8]3O$#9=/POPUQ+B;"W0Z=
M^HKGY*5)@ESW@D<K03#B;BY DQ.ZM1_9Y_#_  %?X;MHE#CGGY5)\$>?:H)(
M//'T_ASK&9KZ)M+I%XF)^PS!)C&TWC?C\+_Q =3-0>'=<&@"WPF"#UM4VMD^
M9G-X-JMZ^G;>]4M6T.0X!N!'J),=BW<QZOB+-:M](4W\PEZ$T0%)/(!'/ \?
MAK,958]IATDB().=\@"WZ+CN)\#\1<)J%G$N&:G3 .AQJL8T@ W(AYF+F1<=
M(@+)3\V,:_S>H_Q_\DP/?\?^#ZA8*A^:^-?YNT7^B*__ +/HBC^:^-?YNT7^
MB8'T]O\ T?Z:(GYL8U_F]1_Z)@?]GT1/S8QK_-ZC_P!$P/\ L^B)^;&-?YO4
M?^B8'_9]$6,>X71OL7N9OIMIU 9=A=+;9KM%5VT# DR:Z$JJJY]O*C/NW"H:
M8_8]8I$9+<=YT*+) 4D@@:6]?T]_GMO3N1!@S)O'?>]^D1W66S?ZB..>.Q/'
M)[C[#W4/!/XGZGSHI&!Y>\J;12FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:
M(FB)HB:(FB*' )!(!(]CQY'/@\?AR-$0)2..$@<>W  X\ >/X #]P ]AHBCH
MB:(FB)HB:(FB)HBZ,M1#D7@*7PM:BVV>'$CL[/73P>5I:+@;4V$KY]<.< M
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M^?;V')_#4*<_P?<A3:*4T1-$31% )2.>$@<^_  Y_?\ CHBB      !P /
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M"^):+5/U_#M%JWMK5&AVHTM"JYK89\H=68Z .8G(C9:W6U*C7!M.H6@LO#G
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M?479004@E7OXCXOX =)J7ZC1:=M+3DR6T*;FTP#CE:U@8T#<-@[WVVNFJAS
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MU&BUWQ:(KZXUW4V\S-55J59I2Z'TVU'/:03(!:9+@.;8&QJB:=,.(  D_*T
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MA"^*E>:9?MAF69,;>9+<X>RNYM8*$8Y8/U8<KX4YXPXBOEE(]1ID**64K)[
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M$0;7)&8(*A_:5:<C_P"NVS5P5'@X[#/ZZU.+YYE$ %:E'WY!4KZ<#5@?BAQ
M&]-Y!_\ X@S%X')]+]U9_HC!%A)C.28OD&>W:!:%R?VE2M[5)_379<*!Y_WN
M0AXXX\*$KD>/J#R/QU<'XIZT0#1<1/\ ^H)_[H')'[>@4_T,7&8@S@]=[;=N
MT6.1W2C\-B!TR;I(W-8W,GY*XS4RJI%8[4,P&UB4 EQ16V\ZI1*!V*)^GD#D
M\CD/$'BAW&0 ^F67MS/#C?T'GYR.RS*%+DF,F08(BUS_ !Z^9VGI)"$]Q'/
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M_#Z:I<UKO[A-HWPI4 VVGV0D>>? X\ZI%*FW#0(Z3^ZF3U*FX'''T]M5P
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M;R?]NJ2UIV_-$*$GW'^L_P"W0L:3)$GU_+""WHH]HX[>/  ''GV'M^TZD "
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MU3_54(M4&?\ I/YQ.V.L]).]'X6^*:CS_P"3$BQ)K4+8P#7F1V L8*O?T_\
M7ST[=3F46.$;79TN?E59$=L55DVJ?JG)L2.M*9#M4)K"S)5%Y D)Y5V\D\>R
M=5LKT7.#6NDN^4?W7GJ<$XM;?<2N?X_X1XWP+D.KH&FVQ<0ZB^+D22VH\C'_
M $V&;25G'JM<XFB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB*Q^^6Z^.[(
M[99ON/E5@Q!J<9JY5@X' >Y]U#2A%B,$+25/39"D1T))!25$CV\45G\E/F$
MMN9$S;$8$G'U-R9VOA[A6HXEQ.A08PO%2H 0"WY6@_,ZY$D"Y!G8"V/A+W\W
MWR[?O=;+]SLGL):9>33W'(T5;LAB+74L=81$J66H_<VTB,RVAQ24J[9+BUK<
M*E.*US;^(:MU0P]@$W!8V;D6^AQ,R,G"^Y?#' ?#W"N&4&OTW^\Q@YG/J/,O
M$R2TRP2<MQ.!A663,LB26Y$I#2B5=JI"V@A#A[T++!=0X0\E0=;2V A*5)!
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M K]P'-X*W:,N0D8G"W-44R%WQ6&%._*-VP^WH%&M(9CV:W)@D+("-(\B1O\
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M#O(/Z[W&<]E'].NS7!(W1P7GR /SFJ>21^']U>1^W4C@O%G8X=K+9_V*EO\
M_54NKTV_\Q)!BXS_  5T/T^;1<\?I/P(#DCDY)5?3W_],\G]GU^FH=P;BM,$
MOT>H8.KJ%5OY@"RMMU3'&Q%LW&V;S]L]E<^JN8%U7QK:IFQ;.KG(#T.?#=0]
M&D,GE(6RZVI2'4J6E00I)*5 \@GCSJJ@J4G%KQREI (Y3W$0;R3Y&T1NLD$.
M$B_O]/=EZR3W)"O;D \'W'(Y\ZK4J.B)HB\V:ZL,/@'L*4/D$<\DM)[D\GGZ
M\>?;QXY'OJ*9_P!YK(!:=L'_ (V'U)Z[CHJ7&Q/V/G!MNOCUW,ZK^I.+G><U
M43>O<&' AYA<LQF8][(;3'9CV,E##*$GD):;0E+83]$) \\#7TGPWP1P \.T
MVLJ4ZI>^BQ[N;^E+9(!.=.+7,@NDV[K65]=5:0U@ISL8<Z3)M9QBW;U5O%=6
MW4J7'.[?/<=M25I]7ORN4VM@*6CPXW&F2/Y1U/<6$#M)Y3W)0>4C*H^&?#>K
M_JS_ $M(-T[1#J=/2 W:3,?"@R0#/I)*I&MU'*2&TP;""U\.)MGF))&WR@;3
M8 UGAW6SU-X9E>.93,W<S*W8IY["E461VT^=7W$8O!<N(]'FM0RI]R,DH"BZ
MVQ%=X"GGDH)5H]5X/\.O;I&4J=2=54K4W0[2B QKBTLY: (/, 9$F.8 C:H:
MZM)'+3!$D_*XB 8B2Z 3W$Y@3 7U4=._4'BO4;M5CVYF&/(<;GP_3NZA;K#L
M^AR"(A+-E13@PZME+R)@=$:6APQI3"4NLJ4VM*SX3Q+1:G0UGTBPL(<XM^(U
MP^(P3'+(%X@&02)!(O V=)P> 3N!@P09B2'#^VQ(,P1C$G()!)2.2">/)'@'
M\#QR>/YSYY\ZPV\W+\T2,D2!UW BRK,3:1V.?T_)4/<MRU.R70A*H28\P24*
M2X0$J2I!/*EJ;2M2>0/ '@)20$C5X00)OM$@;@C8R!N#Z194Z=E8<5T@HNY6
M<])Q)#C#B&F1! 'S2!8V@'=?*/L+U$6.R/Q$=R-T9$1P;2[D[PY#MUE%FAAA
M%37ORIH%.J1(6VH-%#\MMPLJ</*7W'D]J#P,)]6HRJX\K>4F! (,"V; ".@!
M)$=8^J/'?!]+Q3PCPFAHZM6MKZ&BTY^&*HJ<[A2;)?2I,?4+BZ1\P!@P22MS
MOQ6\YRO"^CRWR_;G,;O$K5S(L77'NL:FKK)1CR)@0M#,AMLJ^7=;X(X/"T\*
M2HA0XG557TZ!J-_N :9SF\6()/:< @G9>4?A+X?T7%O&!X7Q>B[X3=-7J5&-
M#&/94I$#EBO2J!H,PX%@,6.Z^59763U2*2Y&=Z@=T7HZUH!;5ETQM" ZH?-A
M+LF0Q$2]Z?E <E(4!_\ =J\<<Z_B&J>Z 6 1,AK@>_*08[V D&0"5]6:/P3X
M-X>ZOJFZ2F^K1KBFT5V:"JPM$$<X=I@21!D2,&PF]!XQOYO5AQFM8QNON%CQ
MMY\C)KMNERZQB)LKF0['<L'I,>/8NE,AYQ]:&W M84LMK[E@@&W_ %%=@+FN
M:3))F2 3 C^Z8&8$8"R_$'!_#>OUO#&:GA+PQVEIU&NH:71M:2'" QQIO'+>
M8F(!E;&^@CXE6Y^S&\-?3[U9OEN?[69I)CT]TK(9B;:TQ&=(2TXU85SKDB1*
M7%A^H)%D[;?*J2VM2(X]%ME:]IP_6UJCFLK%@%Q+06G B9?@")/[RO)?Q)_#
M;A&KX;J]?P+AW%CK],T_"8VE0J42UO-4<TT]/I2^X$"'M@D$@Q?Z\<;R.+D6
M/5%W4V5590;:MBSZZPAR4NQ+*/):2\W-CN)*DEM]I0=[$J<[%**2ZLI*CO"
M;M,@DD&-K0;3UVGIE?*+ ZA_LZUE2CJ*1^'6I.;\.HRHT0YKJ=4M>QP=/,QX
ME@L9(A>XM8=9<"RXXE9^\J+W(*4%OCN#C:^X]O)\I\A0]N!SJ(B]NULP=I'O
M'4*GG#C#02)$G,6F9:?+R.UE\V?7Y4]4'3AN([D%)O)N<K;+-)KTJEF1<IMF
MXE5/>_E':J5Z;B&XJ?4Y1&[D_J $K7R#KVWP0_PUQ'AE#2ZK2:;^OH32K&K1
MTOSW):_FJ-+W!PSF#8]\/6L^&YSV!QY@" ;P; V'20;2"(DRM?#G5+U())0=
MZMSTK0.'0YE]NAMI9')!?^8"5#@>%)'MQQKT4^&_#]-@J5.'Z5K()(^!I@(Z
MF:0@WFQ@_8:@5WN<6DBY-PTR3]8.Q,R1:!=<0ZJNHQQ(4UOAN4[PL(<2SFEL
M\V@<$A]UQN27&TC_ "$*8[7C]U+J>U1&,[@_AIU'45Z>AT)%  R*.CD<T@89
M!DVGG;<#*O<U2"'%QF.4022 08!G$3M-I[#E_LI>I1M#C[>]NZ"FTH=0E3^5
MV[+R2&'E>JVRV]-;4M*D JC.3&'@V6W' VEU!,'@?AXU]'09H=$?ZDD/_P!C
M2R?DYOE)I3S$\HB'7,7!E YP-S8&2>@B[00Z  )$V!MY#Z-/A4[@9IN-TW6U
MWG.3W65VT;<W)ZMJRR"Q<L[)$*#78^W'C*><??4RRE1>?3&*NY*Y+CQ[0^$I
M\&\=Z73Z/Q-K]/I:=.E18-/RLI"FU@)H4RZ&TPU@^8G#029F3*V^E,T69B'
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MA02#W:UVLU'^R:8 ']HF;&(G<F2=IOUO?T;\/.!BE^(&MXC1/+2U&CU=>DT
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M!?(2#JBL2UKRS86R>W0[S:Q'9=-X7HT'<>X0RNTN#JFF<X%SV@D/%SRPX[&
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MQJ4V<S?C@AA>V6DM @F&R7$C<&Z^%N//H.U5:CH !2:]Q(:YC@())DTB1 N
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MCICG35#GF!M-R#O(LTP3DXOM*J7"_@X[H#*:)><9GAGYI19[#EY&J%3W+)R
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MC,6[ V3/P8-T%CA6[N)?>(*U"@L2I2AX/*A.Y3SX!]QXY YUT3OQ7:1RC36
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$:(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>g425213g12g50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g12g50.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1T:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '/Z^="(X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'*$DW         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE-! T
M  0   !:.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/T       2 #4    ! "T    &
M       !.$))30/W       <  #_____________________________ ^@
M #A"24T$"       $     $   )    "0      X0DE-!$0      !     "
M   "0    D      .$))300>       $     #A"24T$&@     #00    8
M             PT   0-    !@!G #$ ,@!G #4 ,     $
M             0             $#0   PT                      0
M                       0     0       &YU;&P    "    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P   PT     4F=H=&QO;F<   0-
M!G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '<VQI
M8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE;G5M
M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M
M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M0G1O;6QO;F<   ,-     %)G:'1L;VYG   $#0    -U<FQ415A4     0
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M24T$$0       0$ .$))3004       $     CA"24T$#      2]@    $
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M' 7N]K@[8W^89Z;/3_2^_P#XQ=4DI22222D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MAP2E*RB'!N5+RU2!<26:$M6B4E@/2GA,(. $PL0=4[O;">R^*.H*5XN8J!Z
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M.%1M@A\58N](B@9(S%F=NC\?9D(*=:!@1M3,TIDC:W)0C,,&%.D3$E:&,8M
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M8QC&,8QC&,8QC&4\?+?Q_P"SQ0'HNTKV[W[(N"O+[M=V(D\EJ:K;VDS]*PN
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MMT#A+?..$*F<YJAB,;1R]R(E%IFD.$H3,R(F0+B3 3E* PI6[ 5GEC E3!&
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MQC&,9U^521!$(V_R=RT:8CC[&\/RE,F^#M:J3,C:I=%9"(L\T@LU4),D-^$
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M?DHXD\(A$'%'!",98A%& ,"$PO?NC+%L&]ZT,&_L,&]Z$'?VWK6\_0#2C!&
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7J+6+#@*5( GG:&:'0]9\QC&,8QC/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>g425213g12g51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g12g51.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1S64&AO=&]S:&]P(#,N,  X0DE-! 0
M    '+J^<U0X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0&WQB4         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE- _(
M  H  /_______P  .$))300-       $    6CA"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          3A"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))301$       0     @   D    )      #A"24T$'@
M    !      X0DE-!!H      T$    &              '-   "P@    8
M9P Q #( 9P U #$    !                          $
M L(   '-                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   '-     %)G:'1L;VYG   "P@    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !S0    !29VAT
M;&]N9P   L(    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     8X0DE-! P     $A$    !    GP   &@   '@  ##    $?4
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M8QCF-<0ZESL>I^>[V;:L;?E,^S_]S/T?H_SJ)G?7WH6)6\L-MUK:GVLK]-S
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M CH'3)'&'C@_]M5H*;Z2222D>1C8V37Z634R^L.:\,L:'-W-.P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M  (1 0,1 ?_$ !X  0 " @,! 0$            '" 8)! 4* P(!_\0 2!
M  8#  $! @D+ 00(!P   @,$!08'  $("1$4%Q(3%196=YBWUQ@A-39767:7
MF=76,0HB(W$9,C,Y06&QN"1$47*!LO#_Q  < 0$  P$! 0$!
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M';D#>XD<G%OT^$4I8)RX*DX-ZV(20.C@>@=&>AV1&XMW;6\FW?S88!6'-O\
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M?KAD32$B.#@=^45=)JD]M&YZ<DU.69'K!41XLLM8BVE.?RF,362XB&>6WF*
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MF'XFH4#K\6$1<8NSF&7*=^N@"*;(ETK4LA>AE#]/]P>V1N<2_7\VA ,&6/\
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M=%*'T,6C,BDPVE]?@1QB=WT;'%VLY\DSR%H;U#@)ICK*GV%0[OKCI/M&T-9
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-9D?]D#_EO_UWA%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>g425213g12g52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g12g52.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1P:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &_Z^<68X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0&W93^         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE- _(
M  H  /_______P  .$))300-       $    6CA"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          3A"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))301$       0     @   D    )      #A"24T$'@
M    !      X0DE-!!H      T$    &              '-   "P0    8
M9P Q #( 9P U #(    !                          $
M L$   '-                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   '-     %)G:'1L;VYG   "P0    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !S0    !29VAT
M;&]N9P   L$    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !    ! X0DE-! P     $58    !    H    &D   '@  #$X   $3H
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MKO1;J:+FYU#6Y(8:198UCB;/YMGI6%MC;7.]GI;?4]3]&EQ2[E2?[%C?N?\
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M/Z]=B,2;&IW4_P#_T/2<3^C5?U?XE%0L3^C5?U?XE8?U
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     /_A2^QH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53
M>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T
M82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#DN,2UC,# Q(#<Y+F$X9#0W
M-3,L(#(P,C,O,#,O,C,M,#@Z-38Z,S<@(" @(" @("(^"B @(#QR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]P9&8O,2XS+R(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @
M>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP
M92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B
M"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE
M;65N=',O,2XQ+R(*(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P
M.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O(@H@(" @(" @(" @("!X
M;6QN<SIT:69F/2)H='1P.B\O;G,N861O8F4N8V]M+W1I9F8O,2XP+R(*(" @
M(" @(" @(" @>&UL;G,Z97AI9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]E>&EF
M+S$N,"\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/DUI8W)O<V]F=,*N(%!O
M=V5R4&]I;G3"KB!F;W(@36EC<F]S;V9T(#,V-3PO<&1F.E!R;V1U8V5R/@H@
M(" @(" @(" \>&UP.D-R96%T;W)4;V]L/DUI8W)O<V]F=,*N(%!O=V5R4&]I
M;G3"KB!F;W(@36EC<F]S;V9T(#,V-3PO>&UP.D-R96%T;W)4;V]L/@H@(" @
M(" @(" \>&UP.D-R96%T941A=&4^,C R,RTQ,BTP-U0R,SHP.#HT-RLP-3HS
M,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR
M,#(S+3$R+3 X5# R.C,P.C R*S U.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @
M(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,RTQ,BTP.%0P,CHS,#HP,BLP
M-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM<$U-.D1O8W5M
M96YT240^861O8F4Z9&]C:60Z<&AO=&]S:&]P.C(Y9C%F8F1B+6-A-C,M9C@T
M-RUB.3-C+35F-C$V83@Q9CDY,SPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @
M(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HR-#%D9#0Y-RTV,F$U+3)D
M-#0M.60Y92UC,S8P8V1C-60U83<\+WAM<$U-.DEN<W1A;F-E240^"B @(" @
M(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I9#I&0C4R0T$W02TW
M-3$V+31$.# M0C=%1BU".45&,C8U13 P-D$\+WAM<$U-.D]R:6=I;F%L1&]C
M=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @
M(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO
M;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.F,V,6$P-&9B+3(W,64M.# T,BTX8F8X
M+31C,S=A,S0V-F8S-CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.G=H96X^,C R,RTQ,BTP.%0P,3HR,#HU,2LP-3HS,#PO
M<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E
M06=E;G0^061O8F4@4&AO=&]S:&]P(#(T+C8@*%=I;F1O=W,I/"]S=$5V=#IS
M;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E
M9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E
M240^>&UP+FEI9#IB-3 R.#@W,RTS.6,S+31F-#@M83-B82TR.&,V,CEC8F4U
M,3(\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C,M,3(M,#A4,#$Z,C(Z,3$K,#4Z,S \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M(%!H;W1O<VAO<" R-"XV("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N
M=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z
M8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYF<F]M
M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S
M9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F1E<FEV960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M
M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H
M;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#IE.#DW9# W-"UC,S0X
M+3$P-#0M.#AD-RUA,C$U,S$V.69E,3$\+W-T179T.FEN<W1A;F-E240^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C,M,3(M,#A4,#$Z,C(Z
M,3$K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<" R-"XV("A7:6YD;W=S
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#II;G-T86YC94E$/GAM<"YI:60Z,V-C,31A9F,M,30P,RUA-#1D+6%F-38M
M,CDQ-&%A93EA9#$R/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(S+3$R+3 X5# Q.C(S.C W*S U.C,P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!0:&]T;W-H;W @,C0N-B H5VEN9&]W<RD\+W-T179T.G-O
M9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D
M/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M
M971E<G,^9G)O;2!I;6%G92]E<'-F('1O(&%P<&QI8V%T:6]N+W9N9"YA9&]B
M92YP:&]T;W-H;W \+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO
M;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&EM86=E+V5P<V8@=&\@
M87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<#PO<W1%=G0Z<&%R86UE
M=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z9#%F
M-F0Q,V(M9C8W8RUB,C1A+6$U934M-SEE9&$U,#1D860Y/"]S=$5V=#II;G-T
M86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3$R
M+3 X5# Q.C(S.C W*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @,C0N
M-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.F1C8S@X,38R+69F-C8M
M8C T."TX.3,T+3ED-6$T838P93(U9#PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTQ,BTP.%0P,CHS,#HP
M,BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P(#(T+C8@*%=I;F1O=W,I
M/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H
M;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L
M:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T
M179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX
M;7 N:6ED.C(T,61D-#DW+38R834M,F0T-"TY9#EE+6,S-C!C9&,U9#5A-SPO
M<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H
M96X^,C R,RTQ,BTP.%0P,CHS,#HP,BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO
M=&]S:&]P(#(T+C8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N
M9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R
M9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX
M;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z9&-C.#@Q-C(M
M9F8V-BUB,#0X+3@Y,S0M.60U831A-C!E,C5D/"]S=%)E9CII;G-T86YC94E$
M/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YA9&]B93ID;V-I9#IP
M:&]T;W-H;W Z-3DS.#4X-#4M8V9A8RUF-#0W+6$R,#0M9# V9&5D.3 Q-3DW
M/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN
M86Q$;V-U;65N=$E$/G5U:60Z1D(U,D-!-T$M-S4Q-BTT1#@P+4(W148M0CE%
M1C(V-44P,#9!/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @
M(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(" @(#QD8SIT:71L93X*(" @
M(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL
M.FQA;F<](G@M9&5F875L="(^4&]W97)0;VEN="!0<F5S96YT871I;VX\+W)D
M9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I
M=&QE/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^2V%M86P@1&AA;6]D:&%R86X\
M+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C
M.F-R96%T;W(^"B @(" @(" @(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z
M9F]R;6%T/@H@(" @(" @(" \<&AO=&]S:&]P.D-O;&]R36]D93XT/"]P:&]T
M;W-H;W Z0V]L;W)-;V1E/@H@(" @(" @(" \=&EF9CI/<FEE;G1A=&EO;CXQ
M/"]T:69F.D]R:65N=&%T:6]N/@H@(" @(" @(" \=&EF9CI84F5S;VQU=&EO
M;CXR,S@W.3$P+S$P,# P/"]T:69F.EA297-O;'5T:6]N/@H@(" @(" @(" \
M=&EF9CI94F5S;VQU=&EO;CXR,S@W.3$P+S$P,# P/"]T:69F.EE297-O;'5T
M:6]N/@H@(" @(" @(" \=&EF9CI297-O;'5T:6]N56YI=#XR/"]T:69F.E)E
M<V]L=71I;VY5;FET/@H@(" @(" @(" \97AI9CI#;VQO<E-P86-E/C8U-3,U
M/"]E>&EF.D-O;&]R4W!A8V4^"B @(" @(" @(#QE>&EF.E!I>&5L6$1I;65N
M<VEO;CXW,#4\+V5X:68Z4&EX96Q81&EM96YS:6]N/@H@(" @(" @(" \97AI
M9CI0:7AE;%E$:6UE;G-I;VX^-#8Q/"]E>&EF.E!I>&5L641I;65N<VEO;CX*
M(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM
M<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @"CP_>'!A
M8VME="!E;F0](G<B/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0'_P  1" "Y 1L# 1$  A$! Q$!_\0 '@ !  (#
M 0$! 0$           <(!08)"@0" 0/_Q !'$   !@(! 0(+!@,' P$)   "
M P0%!@<  0@)$1(3%!<V5E=WEI>WUA46&"$QU!DBU0HC.4%8>90S46$E,D)3
M8G%R<['"_\0 ' $!  (# 0$!              $# @0&!0<(_\0 3Q$  0,"
M @4##0X$!@(" P   0 " P01!2$&$C%!41,481924U1Q=8&1DK.UT=('(C(S
M-%5S@Y.4E:'4\#5"L<$5(V)RHN$D@@CQ)42R_]H # ,!  (1 Q$ /P#V2P^"
MESI'(9*_S>V].2FR+;;MEM%O60P-B=!'[3F,>9T:%G9)*@:T*=$T-2%(64D2
M$A%HGPIFAG&&&#][$L4EPZHBI*:CPD0QX?A$@Y;",.J)7/J,*HJF9[YIZ:26
M1SYI9'DO>;:VJ+-  PCB;(TN<Z2Y?*,I9&BS97M  #@!8 #(+:_(LQ>FUV?'
M:W/K'//ZHJSM3!?P+"?T:LYO'UTOVTOMIY%F+TVNSX[6Y]8XZHJSM3!?P+"?
MT:<WCZZ7[:7VT\BS%Z;79\=K<^L<=459VI@OX%A/Z-.;Q]=+]M+[:>19B]-K
ML^.UN?6..J*L[4P7\"PG]&G-X^NE^VE]M/(LQ>FUV?':W/K''5%6=J8+^!83
M^C3F\?72_;2^VGD68O3:[/CM;GUCCJBK.U,%_ L)_1IS>/KI?MI?;3R+,7IM
M=GQVMSZQQU15G:F"_@6$_HTYO'UTOVTOMIY%F+TVNSX[6Y]8XZHJSM3!?P+"
M?T:<WCZZ7[:7VT\BS%Z;79\=K<^L<=459VI@OX%A/Z-.;Q]=+]M+[:>19B]-
MKL^.UN?6..J*L[4P7\"PG]&G-X^NE^VE]M/(LQ>FUV?':W/K''5%6=J8+^!8
M3^C3F\?72_;2^VGD68O3:[/CM;GUCCJBK.U,%_ L)_1IS>/KI?MI?;3R+,7I
MM=GQVMSZQQU15G:F"_@6$_HTYO'UTOVTOMIY%F+TVNSX[6Y]8XZHJSM3!?P+
M"?T:<WCZZ7[:7VT\BS%Z;79\=K<^L<=459VI@OX%A/Z-.;Q]=+]M+[:>19B]
M-KL^.UN?6..J*L[4P7\"PG]&G-X^NE^VE]M/(LQ>FUV?':W/K''5%6=J8+^!
M83^C3F\?72_;2^VGD68O3:[/CM;GUCCJBK.U,%_ L)_1IS>/KI?MI?;3R+,7
MIM=GQVMSZQQU15G:F"_@6$_HTYO'UTOVTOMIY%F+TVNSX[6Y]8XZHJSM3!?P
M+"?T:<WCZZ7[:7VT\BS%Z;79\=K<^L<=459VI@OX%A/Z-.;Q]=+]M+[:>19B
M]-KL^.UN?6..J*L[4P7\"PG]&G-X^NE^VE]M/(LQ>FUV?':W/K''5%6=J8+^
M!83^C3F\?72_;2^VGD68O3:[/CM;GUCCJBK.U,%_ L)_1IS>/KI?MI?;3R+,
M7IM=GQVMSZQQU15G:F"_@6$_HTYO'UTOVTOMIY%F+TVNSX[6Y]8XZHJSM3!?
MP+"?T:<WCZZ7[:7VT\BS%Z;79\=K<^L<=459VI@OX%A/Z-.;Q]=+]M+[:>19
MB]-KL^.UN?6..J*L[4P7\"PG]&G-X^NE^VE]M/(LQ>FUV?':W/K''5%6=J8+
M^!83^C3F\?72_;2^VGD68O3:[/CM;GUCCJBK.U,%_ L)_1IS>/KI?MI?;3R+
M,7IM=GQVMSZQQU15G:F"_@6$_HTYO'UTOVTOMIY%F+TVNSX[6Y]8XZHJSM3!
M?P+"?T:<WCZZ7[:7VT\BS%Z;79\=K<^L<=459VI@OX%A/Z-.;Q]=+]M+[:>1
M9B]-KL^.UN?6..J*L[4P7\"PG]&G-X^NE^VE]M;71"]T/KH!3@[N[P:U3FVX
MZF7O3FL=W4UJC%M3>.LA*YT<#E"]P.1LS6@1[6+3SU:@*<)B@XTX0S!7XTU@
MK@YD44(FH,(J71PQLAB$M5A-%4SED48:R-KYI9'ZC&M8W6LUH  %45]4@DG5
MDF:"3<ZK)7M;<G,V: +G,VSS6"I_S3>/:I>GSML+-72'^)-[V8%Z#PY70?%_
M63>>D4I9XBN3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PBT&A?,%?[5+Z^>MCYTV-?+(>]. >@L.6G%\%_T
MU1Y^18NG_--X]JEZ?.VPLU-(?XDWO9@7H/#E=!\7]9-YZ12EGB*Y<7NM1S0Y
M#\-:?J!\XT.;&CG4QFUAGOB9QAS9-7 ^#5=2-AVF^K2&]_=65D1QEJ6QAG/L
M!S+7FRU+$#7'<%:'F3"1H3+8F!Q.ML%M]LR>C/\ >Y8N-AEM-_$ ;_V]14%\
M:.IER=LCD=R#;CXXR7M!4=<\HY93]$57'FV-3YO=N+EE5?7+.W$3"1.Q(W@=
M\$3U7(FO4N1M);(:0VIT0])-J]"R=&T-'\NR[B;@W'=L+'@@)N=^VPV;#;;T
MJT/&#J?6/=?*UAXE79P+OKB+-I94,WN2*NMLRVN'YO?X[ WZ+QYX)1I84Z.B
M@!WCTI1A":H&2 /@3-=P7>#O6!8 TN#@ZQ R!W]*F^=K$9$YVW6X$\5UTRM2
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81:#0OF"O\ :I?7SUL?.FQKY9#WIP#T%ARTXO@O^FJ//R+%T_YIO'M4O3YV
MV%FII#_$F][,"]!X<KH/B_K)O/2*4L\17*&[KX\45R0CS3$[\J2 7!&F)^2R
MAF8["C#7*&UKD*(A0E3NZ%,Z)U!:98%(L5HS#"M!\81*E*-1HU,H-*'(<6[#
M:Z6!VBZ_4,X]4775BSFW8%45>0ZT+,2-:"P)[&XHSL\IEZ)E*)):TK\\(4A*
MQ>G1EITVBRCC-@%M,G&9H8R"A %Q( )) V71<V;4_P ='B)_MY\J/G%2V9CX
MIW^YJC>.X?ZM78C*U*81,(F$7CD@%UNL2ZTC)J=6TXQJND75$Z@#$Y!E<[5,
M\+2,R3@'5ZMA9UH79U3L9#8FD*T*EH;S]!2DO*O1R(D*Y1H0]DB[,MIB;_90
M+6-^O<!XA978ZQW/6V5=,2FB>/50WLTQN;6MQG@QG,IID+;7W&Z7PVS;7KUA
ME,3AW(N+OKJ[Q)<]F/YM>O\ +$3'LR-E!EAR0P:QO3>&QC8+@D@FU]6US?C;
M>!XCLVJ'$V-K]W9E<;^/],SPO9?HCWE%Y/QC>*;>9,]M]H5/R Y%5:I@<^Y
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MU\S7.R>3G&E[DU;R6GWZJ.H#0)DGKZL)#!%$8M/C5Q*D,Y>Y#$[-=I_J1O\
M+B)JA7I92S-M>IX7$4RIF)CL[D3@8(]/:(V"Q (-P=M]IMGT?USNH+MH&RSN
MZ"!QO_9392/5\ON!4W4<(5NE;/+]&N:_ /B8VQMQ;U2N?R>A;2XFP2Q9L\&
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M;W%R/YA\J.-D@ZN''_CWJX(&)_L_C<]4Y,C /I(D+%%9;8K)9,I95KN5K;8
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M"_K(JR2>?!)FBX#99\3P^64[*-FQ11.NJGT]*ULFMJBFG*NLFBP[<,1DP&/
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MX<@2<G8/!AE]/ '. B9:YMM_L1_WMSVH*^ML+U,M["_OE9/^"?TLO]&E9?\
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M.:X%)MEY1M#B;[K;[;39021LZ=NS($]"TSF9R]Y,QENX'2/CO8-51N2\A'N
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MLDD\D>BU1)@%IKA('I0H4G#=%OA\^4?>]^G]VMXMF0X*+"UK9<%:R.QYAB+
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MYQ!V:/RQZUJ"^R.)#K)$<R=)31+E+VX!!3?*EZB&+)(A+3",&F+1OB@)CFF
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M!A-*)6*B@#"!0<$;J:TB^9L3^Z3>RG.(.S1^6/6MA:+6XJL"O[089K2C(O\
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?B81,(F$3")A$PB81,(F$63(_Z0/_ *;_ /WO"+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>g425213g12n12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g12n12.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2"V4&AO=&]S:&]P(#,N,  X0DE-! 0
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M<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M      IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O
M;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I
M;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M     %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB
M;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M      !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!O
MX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M      !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M          !2<VQT56YT1B-0>&Q <8P$(         IV96-T;W)$871A8F]O
M; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L
M=                %1O<"!5;G1&(U)L=                %-C;"!5;G1&
M(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P
M4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M#6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-!"8       X
M        /X   #A"24T$#0      !    %HX0DE-!!D       0    >.$))
M30/S       )           ! #A"24TG$       "@ !          $X0DE-
M _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $
M,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M '   /____________________________\#Z     #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z   .$))300(       0     0   D
M  )      #A"24T$'@      !      X0DE-!!H      S4    &
M      &Z   "!P         !                          $
M     @<   &Z                      $
M$     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<   &Z     %)G:'1L;VYG   "!P    9S;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !N@    !2
M9VAT;&]N9P   @<    #=7)L5$585     $       !N=6QL5$585     $
M      !-<V=E5$585     $       9A;'1486=415A4     0      #F-E
M;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO
M<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )
M=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M  MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N
M90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M   ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M   X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$
M%       !     @X0DE-! P     %AD    !    H    (@   '@  #_
M%?T &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(
M" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,
M$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( (@
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M)2'+Q*<R@X]P)K<6N,&#+'-M;J/Y;%E_\T>C:^VWFS_"OXL:VGT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_  !$( )< L@,!$0 "$0$#$0'_Q  >  $  @(# 0$!
M        !P@&"0$%"@0" __$ $,0  $$ @$# 08#! 4)"0    4" P0& 0<
M"!$2"1,4%187(2(XMC%Q=78C)"4W5A@R4E65M+?3U"8V04)14W>4M?_$ !P!
M 0 " P$! 0             !! 4&" <" __$ $X1  ( ! (' @H%!P<-
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M,9F.UIZKCP&(R,!\WZ#9V?BL?,#'?LSS=_4GW(S,U1/4OA62U1@NYJK8*/\
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M6]-RHNT5?H&;H5PU+FT]# _I*B<J-TT,$;H9#:@F:FNW,3BA3NFW9[K>4SU
M< < < < < < < < < U_=8]X>K>RNF@; )2UJG7B9&+!8EM)!F,9GO@W:[*G
M"09P/)EE",L23"5J;9'8U*CM3+(@U/96N,Q( E3J^8WC,UR @: @;#D7:?>@
MT646UX;UD)D5$ Z/,8GW \/V<4"0+D)KLCW(A"H@DT)?M=F: #+%-Q17+7'D
M 5DA!^K@?TL;+;W87A-&DDXKQMF]M!;0=(ADZ\U%'N+U,)Z\L<(*" %MRQMQ
M&Z5$L,<J1&TPQ5(,@+7X\!JN00-I' ' ' ' ' ' ' /-]UY_FLVC^^G_ *$K
M/.B>PGFMHWG6?'5)B*OR\7*'W45 YMY6+L^GK^:2E_P:Y_I8IS2_"!YL5OWU
M'\5*+-)Y>'E%[K/1/SGLRXX X X X X X X X X!1'J1L]HE[GU?0JMFY"GO
M<X)<R5"UW;I$3- 2[Q5LSGFBU HYJMC+177@T2,.DW(U+KT8#;[.Q8JW@>4B
MD%!UUU^^]W (-ZEO[B-G?RV[_O47@$Y< < < < < < < \WW7G^:S:/[Z?\
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M6A-M!D VO1\R/?[79-/5VPDR1RTU^UVM<@4P-L 4?<6JI,N]PS6QEA4!M0X
MX X X X X X!YONO/\UFT?WT_P#0E9YT3V$\UM&\ZSXZI,15^7BY0^ZBH'-O
M*Q=GT]?S24O^#7/]+%.:7X0/-BM^^H_BI19I/+P\HO=9Z)^<]F7' ' ' ' '
M ' ' ' ' *!]8HV'9+OIH,1DMQ T&03E6IGYJ9I<DQ62MBI+$J'((NU6VHL%
M*CR1C"KC5)$<+$F&)%#G*/P)D&$K(%ZH[ BO"X,",W "AQK \2.BMX8@#X4=
M'L!HL=$;Q[)AAO&<QH,&*UA.,J4S'81E2D(R!"/4,4&%M!;2D"B,$G'9"SX+
MSX^7'FLM38!)B+.AN.QG'$(E0Y33D:7'4K#T=]M;+R$.(4G %@. . . . .
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MWE8NSZ>OYI*7_!KG^EBG-+\('FQ6_?4?Q4HLTGEX>47NLJUZM7YTKG_*.O\
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MZ[C)0R#;H06:4$FZ5=JA; I<>Q)'$@5D%3(\E7MU-M@6;^L6H^WE]4]<^/\
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M&GL*RO&J-:X7E3B\JQ1:OY96[C&'5Y5\+[^3F,8PXKOW7C&,*SGMC@$E< <
M< < XSG&,9SG.,8QC.<YSGMC&,??.<YS]L8QC]N> 5^ZF=86'<^IE46J2JVS
M-(7[3IZ4NV#7;!5)E:J.V:5<;2//UZ,1$*M 0M6090<0K.2XMBR0Y;H5\E!8
MG+E- 4$*^FS>JRH-BB;C(7U^99J@FPFMNES[A,2 "RXLR;<6(\)1H=:=K!&6
MI56UY9V6*/*K&M)3VN9\H]#DM6 2!E@7TNJ73!;'R?N>\URX"7],_*FP'X(\
MW:(;>JCN+.Z%LA ],FS+R"LUAC@7H8@W-_[)B:!JRN@7\"=> F$@76Z>-  .
MFVFDM=4X^>+4C!Y)>IB+"N)(E5"$[7J^+(@XD^&Q#1/AD3H@I;WY$B&W-<.6
M<T[)?E9=0[@">^ . 1&G75JQNIS9^=MW550724U=.G,PZ9\D-EDS_>LV=,Q-
M43<,D,M]\>*[.I/ME*1W^&X0-0!+G ' (CUGKFUT8]M4M8]MW79<*_WANTUL
M-;(=-BPM<B$5P(&S5ZZJK56NR'A^98U^3A11Z>KV.8;B\*./6(Y80)<X X!&
M%'UJNEVW:=J5<;38<;,ML*TI"&IB'Q%3Q#J-7JOPP"PE&%-QG<US,]2\J1A.
M)B8OL5*BYER@)/X X!&6-;KQMI>U/G"TY0NFHJ/R5F:CY4QE!%4_XQB'[/S]
M^SY>S_SO\_N[[3.,^RP!)O ' ' ' ' ' -<A?INZLW;A'-,;[B'ZT_9[\2,U
M\L<G@"[E<MI1R2$JH2WCZ";)!*W5$#Z@2<K$>.H=:':W*KYN2N!9"I7 $8Q.
ME[K6UWKJ;*%]0V"%GIU!FC10RG.0!Z+O.&@'PL9Z=&L=?$B()#(1B-!IT8D:
M>$T:;F+)Q/*8%1Y*P/EM%=Z\CU*T('I]AL=7M]I3L!9<E/V'5YPS7X^5MAZR
MU21<BZ8\LQM1Z-I=V%44-10>9 Z7&=.N2YMAE.(0!VM_Z5>MZZRK@5C[OH(
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EBR=S 7&EQI4%O"$!?;.ML-Q%(C>X^_$@)4X X X X X X!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>g425213g12s76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g12s76.jpg
M_]C_X  02D9)1@ ! 0$ ;P!O  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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D -_X[7LRHB#"*JY]!BG45E6K.K*[5C2C25.-MPHHHK$U/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>g425213g12u12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g12u12.jpg
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M-'N[TKW_ .4\OU1N"_OI%YO!T.VN>M11'Z_VI@J% R"KSX*CJ7X6TQ"A706
MK F0E2V]P[(0-T-)O?B1 UUT E5QZX>]'M1?)>A50IWD0!5WOI7PTD/M3/UF
M8XU;=$T[G\,PUV0H&D*G704(43O1.G"-JP_=;KCB;7U0VD7;^&"&$^HNY2!]
M5C(!(CDZ,HR DGEI"_JV\+!/")X1/")X1/")X1/")X1:U>WZK;:_6_KN@YZZ
M1SDJMHS4Z!VCE;H50VNJ74ETJ9&PZG@V^ES(N>Y6AU)CL[?H$*^N8)\9TSX5
M&8\PO#+'OAVWTY]4?4>Y2Z*NMC%V'T/@]U6!Z]T&_H_1#7L'V;1%XY+OZ?\
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MQ_\ F5OZE\0-1W]DDZ'M[I^<(_RBQ_\ F5OZE\0-1W]DDZ'M[I^<(_RBQ_\
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MC_\ ,K?U+X@:CO[))T/;W3\X1_E%C_\ ,K?U+X@:CO[))T/;W3\X1_E%C_\
M,K?U+X@:CO[))T/;W3\X1_E%C_\ ,K?U+X@:CO[))T/;W3\X1_E%C_\ ,K?U
M+X@:CO[))T/;W3\X1_E%C_\ ,K?U+X@:CO[))T/;W3\X1_E%C_\ ,K?U+X@:
MCO[))T/;W3\X1_E%C_\ ,K?U+X@:CO[))T/;W3\X1_E%C_\ ,K?U+X@:CO[)
M)T/;W3\X1_E%C_\ ,K?U+X@:CO[))T/;W3\X1_E%C_\ ,K?U+X@:CO[))T/;
MW3\X1_E%C_\ ,K?U+X@:CO[))T/;W3\X1_E%C_\ ,K?U+X@:CO[))T/;W3\X
M1_E%C_\ ,K?U+X@:CO[))T/;W3\X1_E%C_\ ,K?U+X@:CO[))T/;W6KOM3[?
M _5DGSD<<42+/GIE%VA!RT+LM"M29%RTDTA%=D*2";H512K&[A,4=.DM1(.L
M\]60)(Z3V(8_2I;Q9 2?GP^2X+?NOSY?8B**TK+O$\B+6BOBFN!=2ZXX]+JL
M?'DLRA<Z/%+*_:+ST6SN_,Q\#$U!DI9L#SULO9*T*JH\85R1[\,HG7111M^(
M-RH*C-SZ#6G<LN<Z/BU+IS*7#[KRARUTU8Q@IT1.BG,Y)VUUI0A%NZ9.V,!K
MJ5K;K#%W+G$:9 %:\5W3;F"1TD=5\-'Q".7@9N?D*"CT HC-)S\2SO6X&6J/
M49;_ *W._LNK@XPT&;[(;?&M(!I%L4I:"1\<5/I :*^:J-M29.F*0;_.(&>4
M3YY+)'?B(^N*=;)"G^ZXH!]>)0AV\ RK&\E],)3A^L&M(6&ROWCH76IF#D!J
MK$9%%2@*V0:N;U:)2UL_KNULD&)_OF!]SV*M[E/LTA=<9V15#!G9=O+W[VVC
MMN8&N#''HN:]&.\FZ',$FC)WI_TD_H"]> DMC%4/FYB6D5!ZE@MK4C@A! FW
M#TD2.H]C=5Z<]HF7*SQ>TIHBQLT=BY6\=WS7?G<RIJB1R)!HI! T7.&@B&Y&
MB#5IKU#GU+"H.6M-/U+[+?\ S6:JQK&7)&?*WSYHJXH?$U];H:&L;,=@@917
M-3#VY"44N*Z/0"EU?E!_M#0G I1<XYN;;%)!5CAL:R5$6@L7_P!,4OD20-Z-
MCT^0FZ?[^<7]>&=BIO6^(!P#+\L<L,V615Z,?91RB22V6LO46%1/L'0"7+U*
MF8&UV:Y.?C:W43<'#[O.-7NB)H1X8FZRM+?UE]"0;\O/STTO>%G2WN7SM<ZF
M?Y0:#-5@P#Z(JH5TLNB9BH,%AUN\@6UDLV7;V V1^A-Y[0GK6E)>B:YX*U[]
MPV=H0PQILK92)^>O[*.)?Q >']&M6A*&+Z$YL]*[;VM)ZD""-#/751P48?*/
M$XY>9B<=<8*H&1-<DH3V8NM4SQ&BJ2\XPU7*P64K'SUCYP];+!I'Q!N<'*ER
MT[JC/SJQD06OA0=W]!A-&BXUB=0@U,J[A-90=IW>*J9>+H*P*-%"!Z&L:J3:
MC[0C76\2,N?L#/H#?][Q&WKXE_)5^=H&J2NQ.!5),,8]QTV*+%&DK"1'(/9C
MJ@YJ-:B2[*<H4"$GJYT '>5" *ATT'7CT.7$7;2TNCF4D'KE;/+RUSRYJW"'
MN[RJD:KKE9:Z<8-L#,PJ?.*(M6H9SUDHG.-_GCG,B62)X=3P*4WBCJ ,E7"P
MHT=8B(9FI2W4LM19)B1S'RXRGYG"V7Y\\KW3T)(Z4HV+%M4Z&H+3RL6K=.P/
MMV5YM#4CX6Q9H6](K=&Q,-(5I)J=J..Q6DVVAFTTDTVUP4R54^T?;[GKQR"Y
MTT> #LMR)ZY"D5QK =,K86.3JO6TCEV"Q(LNJ#X<AJ ,..3DM84I&;I' [\=
M###M:Q;@*@3T)Z"51")[Y"3=2N)<>/\ 2 W0ILC_ +=<4Q1$R!8(F_K/1>4\
MFL*C!T01R$S;AZK-R]M:P-EB4%<8'4A%]E82E%4R&93A"./SA.4B+QFN_=^(
MAP6J-V.0B^I$E^(ELKV#@Y$L2U:G1J_.J_5"/++5&:_7-POHI,O4+EVCN*_#
M[$;4@&D;N&Q1V@*)!]NL?.'9=J3W^XS&UF.?_@.AS=%%W0PB'GU.@FD&\B?+
M-P9!E!;BA[Q:_:]L4Y, @/;O/\Z>!(TKFK<LF#Z)%,TQE(^=_P!EA(_B0<'F
M6:S7&M]BW&VD_?IND&G/\[%8^2:J">^XZG.+U+YN0J\BF["BD0S>/#S+-7O!
MM$_8]BB+O%8/*UC<6,D?MTNCE\17BZC2K5[8EJHMQ(;TK0>J,FRP#NUW#FQ[
MJB<032<<+(6*7Y[+IQYP 3,""&?%D)%J&-'2H\,QKMPJ0-),?(M[A8<E\2+E
M*U> 57=89$66^OD]C89NO+RZR!GW.?7\@I)D>#A4:E[TVU1[^#;]6LT\+PM;
M'B[HYJB#G:9\8O$@^?E?[+>+G'0%?JZ"G=+2KTA)2>UP2TKUV:M-3GG%&:<5
MVIFS3L:Z3U+.D<N([-6;766O/I)#OCZM,^%,E-/")X1>&7Q$?BN=.]*^_=!X
M\M\J2G$;7]5>5= Y85-6F&&^?]D.O]FZFEK7/C\8RW%6C1*O,>-=*Z47OTM:
MQFE42C._W.]//SJ%F&@@&>)!\@ 9XZQEF0I?S[XDW3G+HZ-;,A^1I/'CGL1S
MCU7)!RJMW]@Z*2Z.]<EYF]:,,;N@J+CS7EM$PT=5  N9)_6J8>CT->J6F/'4
MU^2?\92?.WS./M(MC*Y ).41)&L\+Z&T<5;76?;OV!XI[,]J6FD%S1I]>.(>
MLFGM@PTT),<;W>27/9370E:TOA-RG1J*9?95^ZAV6J]+H'TU-@-I@(83@_M4
MGG*0(&<DQRX>O']^2XIOBP\1V.BH _,NQL:(2+#XY.M!(>7S(U9.-^T9+U 7
M>F58+?3J;DR)#)UZA%."M**H?*DD2_3<H!6U*Q5KV2;IU%O/@W>BP-XSG(YK
M%T/BDJ74_2?VY]L>)<R?ATGKQP!K[BET.R+]8*N],":\N9NC\[.C;RJR&?U0
M+) O;P&PLI(.YK>-]8C(@7O>%V+9-WZF@D7(%C,7CR_LL=T3XA_0%3U ZSW,
M*@"3W5P'M[T_U?Y7SA<6FQY)OO\ 9][#'N<6;(%*$&PQ9Q>JW)5%QZ/&J:-R
M0$.EEN<59;DT/8E,CR;MXFT SEF >?$@*W1/Q!DN'T9X_P"XU\-7Z/GHX50'
M3*?%V%:LP&.F7M[85V6.;W^G'^?8=*:VU@6VG0B%27V!@%@9R*^)-U\9L;%-
MTR1IR/<"2/VXJE['QF?7>F+)MESEG?*W.QZ/&WP/VX3FVXPH2M>F:)[U4$>B
M$BZ?(V1,]KBKY1K;VR8$>H5'2E9"V6C2AO"9V?NKN'*TZ&W^K=^_K%UN%ZC^
MQ+=[%C>[7G/G%GE9/D_L*V<:KJ!,@!*,%6DM)G/6+,[)?5&=P5+1B0@W$(<S
M+9^X+D'UQ^^-8+FUN'0H1$<Q/<ZPJS^(S[B-?I-RCF'5%I27V\::[LK*728#
M\Q*#\#QVBE]"Z5UEM![C;$&<LBVB\Y-D@VE[6R,WL1YUNU9H\XQ@@$SY=^ Z
ME>8?-?C*>P79E[KIU8YSQ7GH[DZST7NV33FM=^Z+$W>OL1;G.O((1:;Q8.U]
M%A8;ZOT(<U]IZ$)66H%R8%<#&Y^=%1-LA.+++=%KF]N&<WS@1H)$ZA>@/<O;
M#V*5^G>L&O&A'(G?E'L'RY[ZA"(V5'\UU,G4Y?ST?U$T#0[-QRYR#N%>@ "M
M$ @:-:^N[##TL=MIBBJS2T*98B.,SPT]574OQIO6RQ3G:ESG';F_E-!:JOQ7
MKX =S3*92YG&6XRL,O0*M$GTX:YL(A,=NU"4EA$*ZJ;;<L:@]UA"\4A$#9S1
M9;AY3E%YF]LHR&O$*0T/BAA.C>K#7[8<IY0^ T;E3AQ,_P!+H=A U0]VYZU]
M&M)9YOZ^CD%%G80=N5.Y.UDWZT.(D\6QEE-. 3PFG]R+)VBA;!@D3<6.1' V
MXFVE\[%09O\ B@/2'S?U;[T9Y2%+<3]A>Y=TT+D@,IB1C3/3I KO11)]BM8-
M[<]<MO+SY<"=P=Z%.M/#!S.^5@ U)C%""6R0-F;Y <,R>%XB,N-^16+YA\:7
ME!3U\Y3T[I'-G[#V[7.5HA5;Y[15K(,CUGIWJMQKV?#B$VVT/HV316+4NW*2
M&+-M-T7&/:]KDK%..5:FS5*3=,D:3,SP)'6V2[Q;XQ"LB=P9>1=)X-UNF2CJ
M!"(532Z"*\OJL("35@G9#+](K=,.J):!*:3RE4%!^:F&EI,4"UG, *P4&D!U
M0FZ8F1'3/* 1/J8%QYKO5OC7>O\ .Q5P$O'.\5*DKB$7[+Q)_8M8Y2,66?\
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MU:9%BTY.E6NE$V[,JXHE;H:*Y3,=K51RA=:HHY5JNQL#MZ^=13P_VY*\)LE
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M>%,496[6N7BMS>YY_/(]%A#(#X>BIE8O:$>9%KUBH@MJNKK74++'?:<'66H
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M]9>,]S2PRBF,?8:E9M=_8[J"9SM75SO/BD/4^="&!L+8(4NC+]K"O68#UL?
M[J008D6OQ-Y M$WFUM,U%_7R_P"F3MW'TB#<Y]">SL%37TOY2Q>KG1NB"_6>
M^B\Q]?.9DD,K0?XA;;VBSUE>?T!TZXK 6$R*4;[8QG(\LR7"W@*-=RG*G>AT
MN_U'>%P9OR UX^@5MBO;+X;* [>Q'JC5X<H\\AG[@3XG[$*&W(>;+_/GBJS>
MN'3.XG.IN(RI:UH/O'R"%S%_1& A<%%3E9FH[KYA2K@2=4M9*0ZQG@"+\X Y
M$$^F:V"Z)T_X:]E/)<GZ7/ZX$D5JZ=K=.<[8$M?*K1/J#:"2.ZW'$ZLR+]H?
MH5N!^OH/26/HI2G%4&V.@ 3#"PTR1R':8I]6=\K'ED(UR@ :1P4 0^O?#(?N
M9*/$[B+P%#2+[!T-Q7?7QYYQSH0O!B_.^A=>$%7*50%TBJ"OD&$QR3K#8K3V
M+-0\T U]M*5*DNXEGJCGP*_5,WFUQ,W'7(P?..*D:=T?X7C)A,1$T1ZW6\NY
M(@H+:72Y$(J2Q7AZ$K>M5D,?6ITNM*F0S\O(I?":&CA1 TC"#?6.;B][J[:%
MAY'SYU4DYR;9&>9-O4$^?-9OE/M!\-_D*?""X<\\&YXEEW:P/A7N4K5-?%EF
M:5>I7[+;^!4%^O\ D0-M4&#B,W5=J4Z?>7Z-0ALUS#J\4^I#/&;#CI//FMTW
MCG//NFBZX3I"*GOX:G:MW:@ET6@S0,K7+X(RKWK=>B;IWJL-FXM,; O6IXXM
M9; 0X7%2[;T25R"8HJ;9_2_T_=@XA><?5CUV:0( SNP@PK!Q?G1<2(.2!@2[
M,5'#[R[/4J7;"^KK0*U/!#IO:#+P,78S+1$T(*Y62,B1ZG6?O?S5O'N<J![(
M:YL$$C&)2#, 5 <1P-?W:>;PLP?0$4LH1 H))PKUB8=#4@EA@J2#KD-&G5)4
M+U&'[38HM2D+X;7J$@V.+6M.5A7*;@*:65.;9Z(+7W*(.4/=)J]>-=&TKE >
MU>ITTCT:O,T;M8>(5O3($+V1M.C'M7TK%=XW&IG]H\HX<EL4G^NW .>ICCSE
M#XCR9-Y_T/);+\CJ_/%,$HNNIX1&OFHVM<&B:PA@A*+\4("[ 5IVH; .&$1)
M'D=#'6U)).9-LKY*2?V3\M_')0?^S=#_ !'-@]A>YX*_:(#\:B +:S*E6@B?
M1_'_ &JT(LITTRI8&AHJ=.9;ED"20[#-]JV2DG7//FJAV])?37:7];;U/];]
MI?VA2Y_KOGB7-\YC1AJGE"'I\7S6_E$M4T;Z$VL$BQH.B58:Z_I7P)K5ZD96
M3J=<SGG/6ZYM?2[T_P!*B]0T]6?7C6DI7@Q-8JZ\:YYB$ 17OU\@[PK3"]\J
M5L5M:L[T;$'T2UY;$TNFV))=]LDDZGJL;4]%?2@?-2L4/4;UII6!I2J:H3U.
M'\VKSU"E&;-BC=@FA6])-)J4WT;T\XV^FKF&OB#6/6M7Q$23J>I7<W])O3B6
M:2Q)ZI^NF\\K78>I9MN,<[S+*XW-M)+;++)E>^N0Q;DCTDM7=\YFL2::R3;;
M[ZXVP3>=J=,SEHK4Z[R'DW=4$WS/MW/4OJ'-CV:4IU-Z  %LBP0W%WJY0;8N
M"S$%FEM..(U*M^C9S'K-3N5X;->2.6/7?! 2#()!U%BJC]@P_KPN(?+5[IXI
MP!K0)W"AN-A.(4>V#7 .X"T)RI"1: .]9XH>ACX!_-X'6I+2"0P@ZJO"2KWX
MXZ.FFF""9^\QWFW7CS4.6>;>GW9%Z;>C6(O(N\J6+1,R\-G8KIRT%R ZMQ4Y
M38F;H1S5GF9%H0;Z@ANX0Z3V<D*]:S3<*( S"O[Q$O\ O_(C]EF+OK!ZCV-S
M6Q ,+ESJPYJ2Z6NKN^T:8R7K)HX/%)L,KQ^ER^^/)-95B5 Z-HL96C-ZJP*]
M064IC+U4DGYQ\]<N*S4/!?5PF*K5):(9EI-61*U!>-]+:&T@VVDQAZ@UT1\K
M ;;RI=G,#&#J74"1#>P1(%K4ATA"7ELUA@^$>47*Q^O'K8Q&4.FQU-[;#R=<
M2Q"U5GZWT"J9B7.>-2DX)6'&"!XKW7Z%><P:FPT2/1-&:QD_^A?GM37"]N2\
M5D_NJ\ZOZZ>DXCGU_?HX4> 34GB!-&(2ANC=(7S6G!>/IS(&9$N25';J+BSI
MH-3(FZ;DLZ[&-&#>&AEGHF"H@)O2))[SK>WL%,N@<+X(]=.:^O\ 2V.(O",4
M^8H!M9N]"*@$,%>YVW/;RL$7$"(9!0$X?T.]'IE5Z)[H%-U8N#7V%1T%&Y=K
M\A)M'GWCV^Z^RWKOZK[RM6I4>-J5JZF+%.8//5',6M4!.$6CSH$TGU.NZU5L
M<X0<^#"U<%U*X)KOM4$&%UAC7%&+I9KDOET^9^BZ=KU*]6&+)57N [9N[=&U
MK#:/F['U(@>:E\B59#&D'1)L] E./*P=*LA^U>&N\QL$Q2RQ:$:M^,4,CHE
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MG,C6\+G7/WT1Y8"6)[,VL<VLA)^T=H5,NWJ.@=E:K;\-Z23_ &6Z=/Y[V\^
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MUQC9JUOEZE3KLMZ?)*S3KW9"^Y0H0LDMBDDSS,GSO[K6WM'P\/3EJ=X.M=(
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M#H'Q/#[(A!3(.K70]A>^$&/I;2O,/([S/TLV)948\J4;O4PB>ZTV%)7!B\5
M66"2I%V%F7VMQ$6"2/OP'I>Q,6N>-XM?!<X] _:M% "%F/IZE6'AAGKH"2Y
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M/'[*=\,Y5WHCT3VJ#,,+HGC3W/\ H*,#Z:?<.A7-FU[;.J==(@7FBJ&M::^
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M+:?2"M%/:WSB::*OK--+^GMOEB:=/P,7AWD;K&%[2XCZ26A[+V^ICX!,#>/
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M6RH<%R[H_)MM+G"K@ED7Y]:XT[S7JC.0'P4=Q^M6"L95'<6J,)RM:UJXLQ$
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MOTTL,\I.0?=V;ZMVG.W;PC*I7[[[75=S3 UJ\HJ2A)-)8WS=S>QF/2'SKMJ
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M\XSG;$\_U1?+;ZL8@SF3/Z6/G_?C7^&=?^G.,Z8QKC:_.8F6_P!0_3_VMO\
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M "<Q_P":4?ZI\0-1W]DDZ'M[I^<)_P G,?\ FE'^J?$#4=_9).A[>Z?G"?\
M)S'_ )I1_JGQ U'?V23H>WNGYPG_ "<Q_P":4?ZI\0-1W]DDZ'M[I^<)_P G
M,?\ FE'^J?$#4=_9).A[>Z?G"?\ )S'_ )I1_JGQ U'?V23H>WNGYPG_ "<Q
M_P":4?ZI\0-1W]DDZ'M[I^<)_P G,?\ FE'^J?$#4=_9).A[>Z?G"?\ )S'_
M )I1_JGQ U'?V23H>WNGYPG_ "<Q_P":4?ZI\0-1W]DDZ'M[I^<)_P G,?\
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M2$V0BSHC]6*UEEF]2^%],/=G=@ VB)DBI!NL//2AS"OCH0EPK6YHU* * <U
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M/)'!ILK()J$@]I](E1&3XH/KME!.=&HBGDDO"=P-D=F*YR4;,V+[.M]#; #
MLV6'JP8/-8(@^9,MO//2Y4-V(?K($R5YM0T.#MYBNZ9 U\[>=M;3ES69._$E
MX*OE30&Z'>HCM%I$J:\$(S\O5C#Q<+AG)D@*A!;MTY9O+RONM(3*?%M/3*Z
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MQ9NF2ETX;)6I9=Y+-XL<.$B)LV6O36"1DR0OE2=JT0N6;$I%)_")X11H8G+
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M4T$T\V-HJ]2"UB'.L7V.RMC5</A6U<32J8)IIBK6KXBD]CW.<);1I,>&.J5
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M@6[K@1).1G):V>S?IYU_I'3O80SS[FHG>UUE1Z]0V;V@IR4HHDH&_P!.F#A
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M*AQ?7UL<?L"8^8J AIJ7[8NC#<IQ$74-<(7ZLEG:$G<CC+S8FFWTF\+'2_\
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M?!=N4<631PC6TW-;_3.X6[H;# UT-O DB)%UOX?\0;'=A=DUJ%1S,/M5QH8
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MM)=_03B6\F9=F+N'UYL6+?SU[=T+3&)[6+&)]\8C,:ZXQOBU/C&GR^C3Z_\
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MD]&LDD6I;+W20/AU'EPB^><9J':>V7N\OOU@1&B574 S/@6[1*F?7/N*>.J
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METTK?HZ9FT@UFTVVL?\ 1KI^GG.ELBHW#['I^/2G 57/>1);4#Z@K12/$@M
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MI0Z(#-I1",LRH,-5;; NB'4+/4)KI&[2CS/6EKWAL!C:IE:)E@X@W?*T\6D
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MR$@WL/TB( R;#C;4WU,\C&="E5I/:TNJ/8?S;G%]6K5$/KL.&:#5<XRVB"V
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M])Y:GR5BA)_0%N#= 7*'/.&RJG$*C";<*9KAPT$EK@Q&:>L!&D\"L,:,-6&
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MBM !2(#0Q<$*:  D#FW)G=HS$1\P4LDRLF_..VLS/JL*Q^@7J HJ4/[FN6
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ML7?ML;S;:0Q9WEDTUV\F[0P;ORV[B&'\X7MPUG?U33D/ ^GZ=TB/KW9, 22
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M?795]=SR,0,:/FU+;BK9,MWNMD^:2B;&V.K%-3=L]?D'S;$2RWKSVG_NFVG
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M.I87"4',=M39QQ)-&I0I%^,:9958\/<*6$>YK=P.#HL[_E[P#B1QMJ$8UM#
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M1/K[T6.]UKWXZYQKK1 =U*QH$1U.QR]]F;K0(:57 1<O^F0U.LTE>Y='V_\
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M+<B1 MGP)6XRQP[CZ.3- 7<D@.R2"XB;I-@,O+R5A]9]ON/\/;SZGT@D8HS
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M9P3:8F_E[JZCGQ%>1B-T"S4KU38#H'9)^?C6,:V!<"]>;UY>;B9^YU+%G2&
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M"3#SMR;K>O&Z#.DI=WH;BE3]NRD8Y+J[K":-)&3:GAQR;H;CB(::GJP#[HF
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M800F&P?8:B<.,V"Y6P(WNDO?O;C?^?@4WYYZ:<$8&-M[75<SW41'5II&Q$)
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M1N6O-YY&M'2F'2=1 :"R B3E$S<#+B+^F5Q>.>UW..">W0H9[:T'WJ%I@O\
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M*VALK:.!P6-?LW&8O!XC#8?'TVEU3!UJU)U-E=C0^F[?IEV\TM>Q[2 YCFN
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MCATUTUCKTX<[:PP1ZXUTQGZ=,10Q:XQC.V=--<?QQCS<HTC5J4J%, %[F4V
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MN$C4>J[-;U*]\8+C<6)=L'&RQ],4@N]*#O\ VX8BRYCEX1"S@PJU*MW7$!8
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M$&+C^-5EUM]"F00@GO=BUD(+$+1G3&<9^8S:.7?>SK\L_P =,8KRYS\OX?\
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M*JXN$J.NN*9%>#4 5V"<5#BIX18TEZR<#)!"B_GE270'&;8>Z2U$ Z JS8G
M5RM -C-NE!%8TA&!SQQ>'UXY-8:"V8(K]+2N(L[5/"LG4_#/WOYKDE]9O7J>
M;%B7B_-MYL5(*.=\J0?'UU:J]14ZL4FN*N-)<U%@=37ZDDFNTM8/'N/@WCJS
MV(Y22=2LZ*YIS;E5=A:D+FRZ&,Z +&;.%@#%5+&XQ@ZKB.EG(NC9OW;Q&$(&
MI6)HJUPF5_%!8K.I"06-BAR:&ES0XEK2X!S@-XM:3<ALMWB!) WA.4C-0DP>
M/7GY_8YK4*_[Q=!I9GQ'ZE]OO?H_;_3FIS/V)W_7S/I7WV_2^KUTQC.(,S;Z
M2YSG'RVKR_+&<?3G/5&&V(8G:N-$S/\ \H88S@VVI>>64^:\B^J/^F,I'UGI
M_P NRU^J]>*]A>KJFSUFCB):_P#DF:%18@[XDO+;3L6,R1[AIG5302OX8+M;
M@P5W7JEJQ-9^S@E(4:?W-.]]A@L1LRAAJ)PCGXY_ALIL=BL.RC2I>&&MJ$T#
M5Q K576 WW;E(.)+'O+'LPE[W;COZ0$GZ7$EQ)X.AMA>8F;9"0ICOR*[M^IC
M]_..F)(OTO\ H:7G7://U9SF6//[SSC63.,_3\\XVQ_#7/R^>/-\;38(_P C
MA#!F^&P1!$1#O\F)'',<Y67A?][XB+.>,\_]?V]HXKG'I[6N=I7IKAVUWTFQ
M/"RNNF\68LQ[?]&TKE+KI'M^GMB33.,XVTDDQ\\?/&<9,VJUD 8+"NL1#L/@
MR#,BX&$!D38@BX!4-$&Y>_\ ];\K?]_+N=5K>7[A.H$"O.T,0X]OOA)M!%HU
MS15Z$SDJUJQMK=D5V*50Y^^B+YT?@A-;CEV(5"V@VS']]!-8Q/>OVIBMEOWL
M5BG5<(&?55H,PAQ=%CF-:-^F]M;#^"7M#)H.!&\-YNZPL8S#ZVRUH#_^[>+3
M$Y.^ET@28,S$3,RMKN.^SC6J6 Z7!ZK=ZUW,L @68<#/,N]TZV^U^WFGN8M3
MW/7\:-HAA<6V9MMK=VG5JP;YDN7-/JL6L?%;2K[+VA4=7_Q+%-W6.\##C936
ML88!#"\[2>9>X0^ING*0W=#6CU;X@L6-%Q/UGRD#<T$P3ZE>I/GS:]4\(GA$
M\(GA$\(M:>L>X?K;PQ]%<SZQU$:EN)<&#9XJ)$*TV!HY;966\G 3[(RC05Y7
M4@Q1G&7PM8FTF0]/:Y5EUVFUTUQODK!^_;/[J\5MP76T=DJ!(9M4L&6=?QO9
MIWQ4VY9-9B*<Q5XZ9:K1N2Q46(5=H178J^] CIK7OC+-T;>HW+!140S^Y7K.
ME]AAX(U=5%@NJ3&T=9_;]\*U1#X&3IF:^G/%V\WX [)8\\[3W*=-7#7V&L2-
MD+E0</K3WK,%>0K!_?IG\]<E%:OQ _3>\4YN(I=Y4[=KK(?G9U)GK4V.838&
M==N8'<IE8CT838&BV.E$<ZCT.@]D5L@V7]XZ0*K>M2QQ;$@WME.=LLQ?B.(X
M*Q.5>U7K[VYS;>>\LZ8';F])BOVC8FI2.4<3C13(03BIM:(EQ0\4[+HIM%WU
MDFR)=X^!''Z^PBX1@O[QP;D((S6P7A1/")X1/")X1/")X1/")X1/")X1/")X
M1/")X1/")X1/")X1/")X1/")X1/")X1/")X18\IOI'2FWD@TLZ8QKG,,G_T;
M_+;&?EG^&W]WR^?]W]_]_P##Y^8/(#22-X"+:W'GEFL*A 8XEH<!!W3D;CD>
M-\E6K:;&TJ+U)96AQ'2C #^ZBLYQC0O^O/%'#K;_ /1V^6M/;?62'Y?7G.=<
M?_3M\ML:6(K,:W%S08_<%$N!_P"KO.  =8_I)D9KDXW$4J=/:)=A:57PV8<O
M:[*N'.:UH?\ 2;,)!;GZ9JM79W7:&O5?NN>@BF122KWKV;6VF/S]>]D9I6&$
M/E3VSBJ.VO5\U\Z9VV_]GK].(\XAS!I8K%4&#:&]@Z-3P\-AWOWH'C-=N!K'
MPP_2S?&[G^D96+>1M':&%IC;._LO#UO!V=@ZE3?(_P RRH:>[1JQ3/T4O%:6
MQ)^BP_3NP)KZ8H5I^FQS\D6+^PSUU$,MW-C:/&3H>S7';Q)=[Z1W_2%K:DJT
M<>VOSW^5+&<0ZX^VQ6UJ^-P[7XT'9]!WA[(IUWDD35IN#(PSX9:FW?: 1/Z+
M1;=Y./VQ@&';0?L+!UO _"='&5=\M_S5!S*3F[.J11)_+,%9@! /_+_2/H#/
M/KM_PJ1OL2E>X7>^.ML*CU?WI]3.1<J#\\:?TJ7*>>:J%7G)&CI 7 @[S#]E
M;IH00;IM&(L:C<[7;&E.W'9AKT>]@*S:N"P=1M)M%C\/1>RDR-VFUU,$4VV:
M"UH(#3 ^D"W!=G9^ I;1V/2QV%IT\&=J[%V>*6#;'Y;",_+T7LHTW,8TEE-K
M6TFD,$-;.[>!JCTDA[E>N'5.M^N2N0:RBOPKX!\42];3TZZ74+GL%S4>(3H&
M-4*VUW%LD6FE&$<"A%G.9;5./3[@)B>#?2/ILQ-5C&,:Z&,Q K,:0#%09.O<
MQ8&9&H*5Z.)HU\11:'N%+\.&F',8YS'5Z<,AAW;N.Z=UN9!G=4(5>]^^%UJX
M)!9_M/L0L'P*^F=-8H-N<29CO^P(\5U61=*7,86\9B<9+E9-TK -,PXM2%J4
M.!$GYF/2?/\ -UH<-\'>Q(KGZ6_\T%A#LIS;E^DP8&:PI#$FKAI96@_AU^\2
MQT>-%7Z?TV?=OTYR[+)=KA_>?>@P]_#4JF9.G713[\-CV7;.H;VN>R8A+]&
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M]2UB@UUK6[.=]LS3PXTEDSG'U;9^G7Y>+<-AV!@;0HM%-[GTPVFP!CW3O/8
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M5 ?9RQ0Q%L_VB_#.28\O)?-SU ]PF>Z,(NC"#*GYP4P \RQ-^M<IM4/\\]"
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M6I5V"I1J-JTW3#F$.$C,&,G--G-,.:00X @A1I;[YQEN*:@USI"L5.Y_%ZS
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M)@B8+,/,>12C$[D;WVUO8P?L<8;5H&DI?-N*O_V6;BUP(B5NN=B?N"Z')K,
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M<:77:9\-8/ N<AWIF VM^RG[D$+FWLA.E:!*N:A6&"F7A.$DQ'O?+4\N$*E
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M=9K73.=L#BI-.] C0I,DG+%&6U0CV$&,,1).>MIF]B#V_=03GWP]?6"L!WC
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M;^G*Q3Z)P0P$FS72^+N_L%TZ6K>(R3EF!@[B_7.G[)-@/2#T0,B&N=*OB>C
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MI3RZEX]Q2HCN;LB%G!*HA!%**6H6Y].AG@Y=A<8%TF-"&9*4A)^P'3]\^I7
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ME&0G)!K0^Q0L#AGK_P L%"+ J6G?I55Z2]+?ML)<T=(DD_ .?N5^IOH;Z\)
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4J/"B>$3PB>$3PB>$3PB>$3PB_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>g425213g13a10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g13a10.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1@B4&AO=&]S:&]P(#,N,  X0DE-! 0
M    & :^85 X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'#)2\         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE- _(
M  H  /_______P  .$))300-       $    6CA"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          3A"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))301$       0     @   D    )      #A"24T$'@
M    !      X0DE-!!H      T$    &              +K   #@P    8
M9P Q #, 80 Q #     !                          $
M X,   +K                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   +K     %)G:'1L;VYG   #@P    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   "ZP    !29VAT
M;&]N9P   X,    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     @X0DE-! P     #5X    !    H    (4   '@  #Y8   #4(
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M>T/<ZFRS;Z==VRFU^S=_-H@Z'TD
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M%#)A<8&1T16QP? 6(T(7)#-28B5$4W*RX?$U5&-S@I+_Q  = 0$   <! 0
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M&DCS1<3KJ&FU+6XAM*0"I:E)2E(V.Y*CH;WK9^-2/>VFPO<YC&MB7/<&L )
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M9C,1/I/G^OS68#O\_D=5L8S^(^V$2HHE$2B)1$HB41*(E$4'O&[S9S-Q):^
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M?4+ZA?W9S'2.R?:3:YNEWM7]V^!:5JKR7$S)I[H(#-Q+&E[@&$ "&E2WV"=
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MD@[C 6KZYJ4M;9T2 YL]\\')R3!;&,X^;$\&2%B8&OT _3?<UVHY<YQ_B#1
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MUNO@^Y%J5?;*7 E+B(UQ:05 ;<*G&)"D=^_N^P*@.P.CL&NM?">^+*^L::3
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MVQNA==H]5KSBF\6["0#X:#AN)&06G:8$YP# ..B6[&TZ-&D0-K6-:8)'3,.
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M7@ #$F"'.GR!E:AJ+@;^X-L^HVW#R.ZJ5'5 7 G<X%TAH<3\HD"(DJ8U=$'
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M2W_M'S*UCVL&S712K"Q#^LRY3D-]<EU!H"B]I)#\D$$QR#Y_H*Q%O4#W.8X
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MS#LR/3]2>5=4BE2B*/G,UN*)]JNJ$^Z_&7 ?4$['M&B9$<J/GM39?2/_ "[
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MOW^-=@8T-:UK0 &@- ' C'3'O'65Y0KO=4J.J.)<:A-4N)DDU?WAYS +H$Y
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MY[!MK7MP15+]LX-LUSJ7\6[#I;\J]!!H8 QHAM-H8/9H+ (C@M@],F(D2I6
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M3Z5O.D]E6T@VM?[:CRUM1M'<7-!,.V5)8(CAP&Z(@>:XKVH^)=6[;4M-#\%
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M1H/;S3=3#+?4"RPO7@ A[IH5'1 [NHXXY.*@GU."L=<68@[&=]3_ )'YYY&
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MSTI2.MQ9VIQUSJ=<42I:RH[KDMS7N+RX==W5:I7N'SOJ/>XS)YVF0(G !@
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E0_:B)UJ^/R'[41.M7Q^0_:B)UJ^/R'[41.M7Q^0_:B+FHB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>g425213g16a16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g16a16.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[2,84&AO=&]S:&]P(#,N,  X0DE-! 0
M    (OR^B58X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'!B^>         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE-! T
M  0   !:.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!$0      !
M   "   "0    D      .$))300>       $     #A"24T$&@     #00
M  8              M$   +)    !@!G #$ -@!A #$ -@    $
M                 0             "R0   M$
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   M$     4F=H=&QO;F<   +)
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   +1     %)G:'1L;VYG   "R0    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $    !#A"24T$#      8:@
M  $   ">    H    =P  2F    83@ 8  '_V/_M  Q!9&]B95]#30 "_^X
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MJ=, _9F)&/\ 8AZ%7ZI_H?8W]6[?S'\TK*9C7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$!_\  $0@!" $% P$1  (1 0,1 ?_$ !X  0 " P$
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M8<%6B=,->;Q?03O.DW1L*<I2^O#*SD&F:(+4NJM*VD&J-@$/V11BQ046(S8
M#'HH(A#]0 A>C>@[WK+C;1Y4[*DW%S_C<>,3;D04&E$$3:%GGGF ))))D#.8
M:<:8+0"RBBP+Q#,,,&+0   '8ABWH(=;WO6LGC;79^Z+BVON]#+O?BW\C^CW
M_'D<=/F[!<6U]WH/?BW\C^CW_'CCI\W8+BVON]![\6_D?T>_X\<=/F[!<6U]
MWH/?BW\C^CW_ !XXZ?-V"XMK[O0>_%OY']'O^/''3YNP7%M?=Z#WXM_(_H]_
MQXXZ?-V"XMK[O0>_%OY']'O^/''3YNP7%M?=Z#WXM_(_H]_QXXZ?-V"XMK[O
M0>_%OY']'O\ CQQT^;L%Q;7W>@]^+?R/Z/?\>..GS=@N+:^[T'OQ;^1_1[_C
MQQT^;L%Q;7W>@]^+?R/Z/?\ 'CCI\W8+BVON]![\6_D?T>_X\<=/F[!<6U]W
MH/?BW\C^CW_'CCI\W8+BVON]![\6_D?T>_X\<=/F[!<6U]WH/?BW\C^CW_'C
MCI\W8+BVON]![\6_D?T>_P"/''3YNP7%M?=Z#WXM_(_H]_QXXZ?-V"XMK[O0
MR1 >-2D*/,]7UQ^T];U=>C7\TT8->C7IW_U!UZ?C_ISD6<G*";S=>YM&<E1M
M?C(QM\_KWT)?^8\X]MRWT(TAD^GR1X^9%Q@# & , 8 P!@'-_6]LVK27/ED6
M'1M(RGHFXFID-3UK4<4$A(52B8.._@;-MX<')>VHVJ+-:DT+K)EXE8%0&=&J
M3MA2IU4(4IUHI-I-I+6V'T5(0O&E8?5O-%"]!/EF>-#LB6=3S9:MZ2O:P92\
M48VN/3-WS"8Q.*+8/6I*.QW4,<C=<0UU$.$,+P8B;VZ 0%RTD*U(74#8JTFH
MR:I.*BL%S*F>JM7X[RJJD\'7/-8O9F_Y(Q_RY5;<G9)%K<TP#Q!.\EO.7KZ_
M;*6\@#M(*-:(Q7B)$9'GPBSEEG('<JVXJ[5P8-\9PP0DA3IS-0&Z1GN+:ZEH
M%:#4:/C,,W'MJN=/5EG7I.KJJ=#PPRQVJG-G3G)A.G?'ISKW+1E6TAV;&7"Z
M6>ME<;DQ:TF73*#JG*?LL2611;*CUD*?F%Q.$YIW9Y.,0*E1R/1B_P!H(G9Q
M)1@**;BVXZ]JYR6D\RLGY;/#QX_> HSP?<W*]-.M=V(_>3+DVN71]56C:4O
M?$'M;,GYS; MDQF#ZUDC4.D79%&EQ*,"XG2391*DLE0H ;K"TE)M.G);P5,D
M5<4KM%\Y;2ZKG'+C & , 8 P!@# & , 8 P!@# & , 8 P#-FCY.3_3?7FYS
M++XN._ZS,9\I[O!'@OG]>^A+_P QYA;<M]"+PR?3Y(\?,BXP!@# & , 8 P!
M@# & , KQ_9&WWB/'O\ G:N-_P!4M+-++E/JR\"LOF]9>98<S,L, 8 P!@#
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MN9Y#''5 ^,;JB.UZQ2MM=FP]4@7)30_&6H2J#2AZ^,(]ZS-JF#)/;P!@# &
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MVEUYUP^EP=PG'A!VJ5B[+BE!XS4[U]RV1C2EWGK750D=S\U/J# ,V:/DY/\
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MI?5L?&U+*^>93M0P#-FCY.3_ $WUYN<RR^+CO^LS&?*>[P1C[^,):L1@Q!
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MEXLBTM&K:=NN'?9.UF=(QB*OEKUY('^(PV3RQL0+9/6U:U;S&PRSG51"%K@
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MC%A'P%?==TM\W*R_:<RSSS^4!\B]F?I7"?V.AG9O9OEZ7U;'QM2ROGF4[4,
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MO$>/?\[5QO\ JEI9I9<I]67@5E\WK+S+#F9EA@# & , 8 P!@# & 4UO,/\
MAXV9\VJT_<-CSV?\#GZ@\%_2>$_XAI!T;AS](VO4LOLXD8&?J)\@8 P!@%A'
MP%?==TM\W*R_:<RSSS^4!\B]F?I7"?V.AG9O9OEZ7U;'QM2ROGF4[4, S9H^
M3D_TWUYN<RR^+CO^LS&?*>[P1B<N<&QKV:L>%R%N;P$D@/5.2E.D1@T<9LD
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M=+?-RLOVG,L\\_E ?(O9GZ5PG]CH9V;V;Y>E]6Q\;4LKYYE.U# ,V:/DY/\
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M5&354FUM2%5M.A\J"O']D;?>(\>_YVKC?]4M+-++E/JR\"LOF]9>98<S,L,
M8 P!@# & , 8 P"FMYA_P\;,^;5:?N&QY[/^!S]0>"_I/"?\0T@Z-PY^D;7J
M67V<2,#/U$^0, 8 P"PCX"ONNZ6^;E9?M.99YY_* ^1>S/TKA/['0SLWLWR]
M+ZMCXVI97SS*=J& 9LT?)R?Z;Z\W.99?%QW_ %F8SY3W>"/!?/Z]]"7_ )CS
M"VY;Z$7AD^GR1X^9%Q@# & , 8 P!@$)7GT5&G\2U]"W98>AJVU.U.-ZPOM0
M6<:E2"I.57;'@3%([K"AE_!65R4)&=M=!&&ED*4JL:!1L1*P98]++"3>R,O
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MI_[YG^ECB)[8]K]!?6Q]WJ/<2S\=/_?,_P!+'$3VQ[7Z"^MC[O4>XEGXZ?\
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++;,Y.K;_ !D?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>g425213g17k03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g17k03.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1]Z4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'UZ^@# X0DE-! 0      $@< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M @   @  ' )0  A4:6T@4GEA;AP"!0 74&]W97)0;VEN="!0<F5S96YT871I
M;VXX0DE-!"4      !!"2?(2Q1RH\=@5/H8JC;9L.$))300Z      #O
M$     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN
M=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M      MP<FEN=&5R3F%M951%6%0    & $$ 4 !$ "T ,@      #W!R:6YT
M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 )3,S  !  $ E,S,  $  3A"24T$)@      #@
M   _@   .$))30/R       *  #_______\  #A"24T$#0      !    %HX
M0DE-!!D       0    >.$))30/S       )           ! #A"24TG$
M    "@ !          (X0DE- _4      $@ +V9F  $ ;&9F  8       $
M+V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0
M  8       $X0DE- _@      '   /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$1       $     (   )
M   "0      X0DE-!!X       0     .$))300:      -!    !@
M       $;   !V@    & &< ,0 W &L ,  S     0
M       !              =H   $;                      !
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M;&]N9P  !&P     4F=H=&QO;F<   =H     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    @.$))300,     !2N     0   *
M  !@   !X   M    !22 !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" !@ * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M@961TIWHUMIK=0ZL%A:"XCVM<UNU F@3V1*7#$R["U/Z5U.VQ[W4MK/?9F9
M#G%K9M8W9[/3]]=?_GE3/2LY[_5-;6NM;NM'VG(:\$L+_1%U;W?S>5_-O8SV
M4*7U4R;\KI MRK'76^K8W>_4P'>T*_3U3IF1E/PZ;V69-6[U*A](;#LLG^JY
M(2! .UHC,2C&6W$+%N8WI74;&M;?4QH;P69>2Z';OIFMY8VW=O>_Z?J,9^C3
MLZ-G/_198#Z7N;.S)R"0 ZI_MWN9MV^@U[/=;_A&?S=BW/9X#[DXB-$5S__0
M]#L-C>N.<P"QWV(^E6?;[A9KOLVNVMMW5_YCUD?6QUSND3>QM=INIWM:[< 8
M?^<6L6O8QQZV[TW%EC\,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                 /_A3>)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP
M0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O
M8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#<N,BUC,# P
M(#$Q-BYD964S83<W+" R,#(R+S Y+S Q+3$S.C4W.C X(" @(" @(" B/@H@
M(" \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO
M,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS.G!D9CTB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(*(" @(" @(" @(" @>&UL
M;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(@H@(" @
M(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*(" @(" @
M(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]S5'EP92]297-O=7)C95)E9B,B"B @(" @(" @(" @('AM;&YS.G!H;W1O
M<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP+R(*(" @
M(" @(" @(" @>&UL;G,Z=&EF9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]T:69F
M+S$N,"\B"B @(" @(" @(" @('AM;&YS.F5X:68](FAT=' Z+R]N<RYA9&]B
M92YC;VTO97AI9B\Q+C O(CX*(" @(" @(" @/'AM<#I#<F5A=&5$871E/C(P
M,C,M,#<M,#-4,C,Z,3(Z-#DK,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@(" @
M(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z36]D:69Y
M1&%T93XR,#(S+3 X+3 R5#$S.C(T.C(R+3 W.C P/"]X;7 Z36]D:69Y1&%T
M93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,RTP."TP,E0Q,SHR
M-#HR,BTP-SHP,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'!D9CI0
M<F]D=6-E<CY-:6-R;W-O9G3"KB!0;W=E<E!O:6YTPJX@,C Q-CPO<&1F.E!R
M;V1U8V5R/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D
M9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^5&EM(%)Y86X\+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T
M;W(^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^
M4&]W97)0;VEN="!0<F5S96YT871I;VX\+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z
M9F]R;6%T/FEM86=E+V5P<V8\+V1C.F9O<FUA=#X*(" @(" @(" @/'AM<$U-
M.DEN<W1A;F-E240^>&UP+FEI9#IF.#$Q.&%A,RUA-68V+34X-#$M.6-D,2TU
M8C(T,60W834S,F,\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-
M33I$;V-U;65N=$E$/F%D;V)E.F1O8VED.G!H;W1O<VAO<#HV,#-A-3-A-BTR
M938R+3AB-#(M.&(Q,"TS-C4U9F$U965F8F0\+WAM<$U-.D1O8W5M96YT240^
M"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#HQ
M.3=B960T,RUC-&4Q+3$Q-&(M.65E92UA-V(P9#!C93=E,3$\+WAM<$U-.D]R
M:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @
M(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C$Y-V)E9#0S+6,T93$M
M,3$T8BTY965E+6$W8C!D,&-E-V4Q,3PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTP-RTP-%0P,#HP-3HS
M,BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P(#(S+C4@*%=I;F1O=W,I
M/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.FEN<W1A;F-E240^>&UP+FEI9#HV-#@P,C8V8BUF-#9A+6$R-# M.6(U,2UD
M960P.34Q,S)F8S@\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IW:&5N/C(P,C,M,#@M,#)4,3,Z,C0Z,C(M,#<Z,# \+W-T
M179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G
M96YT/D%D;V)E(%!H;W1O<VAO<" R,RXU("A7:6YD;W=S*3PO<W1%=G0Z<V]F
M='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^
M+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE
M=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@
M:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD
M+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T
M97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#IF.#$Q
M.&%A,RUA-68V+34X-#$M.6-D,2TU8C(T,60W834S,F,\+W-T179T.FEN<W1A
M;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C,M,#@M
M,#)4,3,Z,C0Z,C(M,#<Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<" R,RXU
M("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @
M(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP34TZ1&5R:79E
M9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \
M<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.C8T.# R-C9B+68T-F$M83(T,"TY
M8C4Q+61E9# Y-3$S,F9C.#PO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @
M(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#HQ.3=B960T,RUC-&4Q+3$Q
M-&(M.65E92UA-V(P9#!C93=E,3$\+W-T4F5F.F1O8W5M96YT240^"B @(" @
M(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#HQ.3=B
M960T,RUC-&4Q+3$Q-&(M.65E92UA-V(P9#!C93=E,3$\+W-T4F5F.F]R:6=I
M;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*
M(" @(" @(" @/'!H;W1O<VAO<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O
M;&]R36]D93X*(" @(" @(" @/'!H;W1O<VAO<#I497AT3&%Y97)S/@H@(" @
M(" @(" @(" \<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QP:&]T
M;W-H;W Z3&%Y97).86UE/F$\+W!H;W1O<VAO<#I,87EE<DYA;64^"B @(" @
M(" @(" @(" @(" @(#QP:&]T;W-H;W Z3&%Y97)497AT/F$\+W!H;W1O<VAO
M<#I,87EE<E1E>'0^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'!H;W1O<VAO<#I,87EE<DYA;64^9#PO<&AO=&]S
M:&]P.DQA>65R3F%M93X*(" @(" @(" @(" @(" @(" @/'!H;W1O<VAO<#I,
M87EE<E1E>'0^9#PO<&AO=&]S:&]P.DQA>65R5&5X=#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<&AO=&]S:&]P
M.DQA>65R3F%M93YE/"]P:&]T;W-H;W Z3&%Y97).86UE/@H@(" @(" @(" @
M(" @(" @(" \<&AO=&]S:&]P.DQA>65R5&5X=#YE/"]P:&]T;W-H;W Z3&%Y
M97)497AT/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QP:&]T;W-H;W Z3&%Y97).86UE/F(\+W!H;W1O<VAO<#I,
M87EE<DYA;64^"B @(" @(" @(" @(" @(" @(#QP:&]T;W-H;W Z3&%Y97)4
M97AT/F(\+W!H;W1O<VAO<#I,87EE<E1E>'0^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'!H;W1O<VAO<#I,87EE
M<DYA;64^8SPO<&AO=&]S:&]P.DQA>65R3F%M93X*(" @(" @(" @(" @(" @
M(" @/'!H;W1O<VAO<#I,87EE<E1E>'0^8SPO<&AO=&]S:&]P.DQA>65R5&5X
M=#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<&AO=&]S:&]P.DQA>65R3F%M93Y'96YO;64@161I=&EN9R!%9F9I
M8VEE;F-Y(&-O<'D@,SPO<&AO=&]S:&]P.DQA>65R3F%M93X*(" @(" @(" @
M(" @(" @(" @/'!H;W1O<VAO<#I,87EE<E1E>'0^1V5N;VUE($5D:71I;F<@
M169F:6-I96YC>3PO<&AO=&]S:&]P.DQA>65R5&5X=#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<&AO=&]S:&]P
M.DQA>65R3F%M93Y'96YO;64@161I=&EN9R!%9F9I8VEE;F-Y/"]P:&]T;W-H
M;W Z3&%Y97).86UE/@H@(" @(" @(" @(" @(" @(" \<&AO=&]S:&]P.DQA
M>65R5&5X=#Y'96YO;64@161I=&EN9R!%9F9I8VEE;F-Y/"]P:&]T;W-H;W Z
M3&%Y97)497AT/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(#QP:&]T;W-H;W Z3&%Y97).86UE/D=E;F]M92!%9&ET
M:6YG($5F9FEC:65N8WD@8V]P>3PO<&AO=&]S:&]P.DQA>65R3F%M93X*(" @
M(" @(" @(" @(" @(" @/'!H;W1O<VAO<#I,87EE<E1E>'0^1V5N;VUE($5D
M:71I;F<@169F:6-I96YC>3PO<&AO=&]S:&]P.DQA>65R5&5X=#X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<&AO
M=&]S:&]P.DQA>65R3F%M93Y'96YO;64@161I=&EN9R!%9F9I8VEE;F-Y(&-O
M<'D@,CPO<&AO=&]S:&]P.DQA>65R3F%M93X*(" @(" @(" @(" @(" @(" @
M/'!H;W1O<VAO<#I,87EE<E1E>'0^1V5N;VUE($5D:71I;F<@169F:6-I96YC
M>3PO<&AO=&]S:&]P.DQA>65R5&5X=#X*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<&AO=&]S:&]P.DQA>65R3F%M
M93Y'96YO;64@161I=&EN9R!%9F9I8VEE;F-Y/"]P:&]T;W-H;W Z3&%Y97).
M86UE/@H@(" @(" @(" @(" @(" @(" \<&AO=&]S:&]P.DQA>65R5&5X=#Y'
M96YO;64@161I=&EN9R!%9F9I8VEE;F-Y/"]P:&]T;W-H;W Z3&%Y97)497AT
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QP:&]T;W-H;W Z3&%Y97).86UE/DME>2!P;'5R:7!O=&5N8WD@;6%R
M:V5R<SPO<&AO=&]S:&]P.DQA>65R3F%M93X*(" @(" @(" @(" @(" @(" @
M/'!H;W1O<VAO<#I,87EE<E1E>'0^2V5Y('!L=7)I<&]T96YC>2!M87)K97)S
M/"]P:&]T;W-H;W Z3&%Y97)497AT/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QP:&]T;W-H;W Z3&%Y97).86UE
M/E!E<F-E;G0@;V8@0V5L;',\+W!H;W1O<VAO<#I,87EE<DYA;64^"B @(" @
M(" @(" @(" @(" @(#QP:&]T;W-H;W Z3&%Y97)497AT/E!E<F-E;G0@;V8@
M0V5L;',\+W!H;W1O<VAO<#I,87EE<E1E>'0^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI"86<^"B @(" @(" @(#PO<&AO
M=&]S:&]P.E1E>'1,87EE<G,^"B @(" @(" @(#QP:&]T;W-H;W Z1&]C=6UE
M;G1!;F-E<W1O<G,^"B @(" @(" @(" @(#QR9&8Z0F%G/@H@(" @(" @(" @
M(" @(" \<F1F.FQI/GAM<"YD:60Z,3DW8F5D-#,M8S1E,2TQ,31B+3EE964M
M83=B,&0P8V4W93$Q/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D)A9SX*
M(" @(" @(" @/"]P:&]T;W-H;W Z1&]C=6UE;G1!;F-E<W1O<G,^"B @(" @
M(" @(#QP:&]T;W-H;W Z2&ES=&]R>3XR,#(S+3 W+3 S5#(S.C4V.C0R*S U
M.C,P)B-X.3M&:6QE($=R87!H:6-S(&9O<B!"=7-I;F5S<R!396-T:6]N+3@N
M<&1F(&]P96YE9"8C>$$[,C R,RTP-RTP-%0P,#HP-3HS,BLP-3HS,"8C>#D[
M1FEL92!#.EQ5<V5R<UQ$96QT85Q$97-K=&]P7'9I=F5K7&<Q-VLP,RYP<V0@
M<V%V960F(WA!.SPO<&AO=&]S:&]P.DAI<W1O<GD^"B @(" @(" @(#QT:69F
M.D]R:65N=&%T:6]N/C$\+W1I9F8Z3W)I96YT871I;VX^"B @(" @(" @(#QT
M:69F.EA297-O;'5T:6]N/C,P,# P,# O,3 P,# \+W1I9F8Z6%)E<V]L=71I
M;VX^"B @(" @(" @(#QT:69F.EE297-O;'5T:6]N/C,P,# P,# O,3 P,# \
M+W1I9F8Z65)E<V]L=71I;VX^"B @(" @(" @(#QT:69F.E)E<V]L=71I;VY5
M;FET/C(\+W1I9F8Z4F5S;VQU=&EO;E5N:70^"B @(" @(" @(#QE>&EF.D-O
M;&]R4W!A8V4^-C4U,S4\+V5X:68Z0V]L;W)3<&%C93X*(" @(" @(" @/&5X
M:68Z4&EX96Q81&EM96YS:6]N/C$X.38\+V5X:68Z4&EX96Q81&EM96YS:6]N
M/@H@(" @(" @(" \97AI9CI0:7AE;%E$:6UE;G-I;VX^,3$S,CPO97AI9CI0
M:7AE;%E$:6UE;G-I;VX^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \
M+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@!:@)? P$1
M  (1 0,1 ?_$ !\  0 !! (# 0             *!@<("00% @,+ ?_$ '\0
M   & 0,!! ,&"0\4# D("P$#! 4&!P( "!$A"1(Q01,5410687&!D1<V.%5W
MH;'3\!@B-#=4<Y.4E;6VM\'1U0HC)"4G*#(S-4924U=U=I*STM3A)D)#1$5'
M5F>7LK3Q&6-D972#AI:X2&9RA(6'I,588H*CI::GPL3'U__$ !T! 0 " @,!
M 0             '" 4& 00) @/_Q !H$0 ! @,% @8)#0H*!P4'!0   1$"
M R$$!08Q05%A!Q(V<8'P$S(U='61H;&S%!46(R4S-')SM+7!T0@B)"9%4E5V
MX?$W0D-$4U1BE;+3%U9C9&6#E$9FA*.E)X*%HL74U9*3I,/2_]H # ,!  (1
M Q$ /P"?QH"*[16X/=MEL"8]U5JS+=(YN$QM';G%VJ9/5Y5.F@,KPF&^ZOZT
M=<X;#H!%2;"AA22,@:RO2*7*#$,ECZE^9C P*><5"8#.+9SVI-G[DMWK+M[E
M4/IN+M\A9]V3R[P9B>)NJO2C5FW>V8G6T;AEVM3RC11YNE$[9G[*P"L&XI./
MJ-R:@1H,V[%*_OP&'G9Q]HQ8C[N:L]9N:W18*J=34]><]E1,XE%7Y-L!?HIN
MN;*P@:JQH''8\P2+9.^)H<^-,5:::GLEL!58ZE6KD)S\@D$=5D.@&3T8[7>6
MRO>EN0VQHVW;P@@]95YO#>8A:[K,YLUM,.E^TEUB<>?R[SP>V1E>4,7R=GYU
M.ESM&XDG8&1-''+&!S.U$298]I0,K[0OK<*DNZCVZI$,"LQIG&R2Y+7D[.AL
MPZ&UZHD#3+-OA+)8<-DAE?3ESD*)"FE[VFC*52E:BG!D?A7+%'N@LLO0&']&
M=H%:+;7E<XRZ:UXR.4S8Z4/DMW;BI*Y$5L0\_P#@^]O-^.T=3)6UPC"!CG%L
M2>;2!0S($+FG;"$S'.9<0R2)T2DQIP M:W=H?N;?Z1N&X#UL:;8]=#"U-T6:
M&Y5(\951\ZEW8YQS>8F<Z[>E:D&_"*,$[C+P66Q.[*:].+K,E<BR?&L67U.^
M ;/J7W7V)-]QZK:\\PUL3/L#CBNRIG+<A=3$[E2S_#:Y44U)VT<S<229)/I[
M+)]$%ON@Q0@,5T+9QR%(0![=[C P&GW:!;C;MK7<G%(@S1>E5S*<G9VJ1HY9
M$EUE5FG+W6QC;\XQJ6QB$WFNL]HE,NC+F\/R"8+XE32J%/#2],#2C>5Z=FF&
M3KUTZ^-UZ[2I'[<9>U$7+N)E$A=Y'=3?!-STEJ^!59%WBP&GW3%:@[*!RW2H
M8B@9'"639O?W2931P %J\UD4REVEBPU_=7*0%-<+C<8 N;.M^<YB<+160V/M
M*[DU,+"[7HHC:Y-I"$1EID-VFO-V-\,DZ18JEC<G>4;GBE*R-(E,D+][BQCF
MYC3'G-9C&4P%%Y=I5N'4UU,I8TPBC%9E9UKNNM]W?L9.P2A@L2([98+MZGN3
M1&2*:NVX6&"OTF.N9]A"K-YLB9G,1\6038YB4)7O&()^/LRUZYZ@RK@.YZTV
MNO\ M!)O,%,4N"1[7YK:*V#5#7+%G')T$4C%6MUB0J(/I&4@DRQ4Z38I0"6.
M/1S,A-<C!7+DI#DD,2(T'(,:XIVE%I26)M!C\=MKK7!VGTXCQ%XR^PH6YTPX
M((E2\/MA)#BOH57I:;;'+/DZF5KFEB;W:TEBHR&1%YLPN)JS3TT#P=>O74%I
MMIF\N_Y*W[.RGRT8XW,EA6QMSK.WGVU"UTG<)H;/>RLK;<@4DC[RND<:0PJ0
M2JR%2U*B2H$BPY]FCJA<_<BSW8]QQ^#FZ]>NTKVH^T-O/&NZBD_O#C<UAX0O
M;*AD#!FY2U_NB92>^*.F5AIQ9),H69-1Z]GD$5:VG!,ZL#FNEY$@5FBN85K0
M2+YP_7H5?J49>;KXRZ54[[YA<$#W4XG2BBIL-5[,(+N%:Y7MWDL@,3,LGL^.
MWHN75J]NJMY?3&Z3P+&LV;+!W3&MCNKP>T[ZMC$7.4)F5+R"O=NF\*V;%MV-
M0J31^!$UW(9;:56,1S<;)5%@)WVIZQK:Q0E4A>7%Q.9')'(4\N>F)4R)65$M
M0+&IN?\ U\OP=U;(T@4%MX9K4'M,=U]</^Z#</,ZTHRL]N=BPZNY3)(0JBZI
MXO8B]TLK;I 2VU\UNC@Q,_O5CRJ)(D[HA/:53>48K6.99AA6?&O[?JR!AE26
M\68/5PYR&V-\=C1[=HFW;WQ6DA[,A@K>*3=%]!^!K[!Q@$-;:X9XLCM*,I9)
M74?B-IH=W#K*E,)/7R$IN79K69>2RE\@LE!.UZW(;LV/;ZZ)V2-4T2LWD[86
M-\7U'83'(<%T2MZI=Q<ADU$6:T)9/)GUFE<)=H#'53WF_(H:M?15H\CH1%5;
M4J0G@7N[-KM2;IGDRV'[9+E,@4E47-M.IF5GV"YR\R17?/9W(-O"VW9%+G^.
M,2]8YQ=O]WL+LS&'2R",\+=2R\G=#;8R8]+71X$D70#0#0$;)?<NZAT/[6NV
M7.7[F%E=;89?O6CL >XK<U20ZJ(NDKC;BUR>*0P(05%U-PXR5J>I"8[L\W:U
MQB-M=#V-9GD?ZF6)S>.N:]=GEZ7-UI]OD*WK[M:;:.W*4EMS<HO4C:WRR[*#
MH$Z*S21S95N3?8C/]KJ&[%^YI,D+2(XJX5J]R<T^OV!SSQS%6^M#LH6K#%ZG
M)H;.06\9][UZD=KT\5.][@'8BI46ZB>U&NJE4\UGBJ;JIC>T5+9*073;B$<+
MM.+5^AL8EPE>&]%78BIE?L/<<--A".-.R=P1@5+N/[5B?4MO7D*VJ;"HZY-M
M\BVW["K @M7/,_P:YE:!6X3<=954/LCVND,+.O.L"6+V-WAK^[)W):M:4C3&
M&E*E;"39 L=6\#8)NFW&6.Q;<^T'?(%/ZK]^>WQR;V&!#6DB6N$U@RA;7M72
M_!HN5.]-2QLC,Z6KY:XN*!,TI'5L" NT6<3<<W<UQ3% 8SVIO0W)U-?5@GSF
MMU*LR%IVM]C5$5S9R^8(GL&79EO<N4]M3/":OHFM>5\ZD50QMO%D71YS):5R
M5M>6[%<O2$),G7K^T=<OKU^HZ0S?3N"M&YJWKZJ[0VTRD^,6$@S56!5ZF7R.
MF[%:Y9LUW.VZJCTE8T4N6KE7O2DE?1](A(9I]F&3DB22MP/0J14P)N \H?VC
MUML49LRW54/":L-M7=%:VIR#+'1Q6GP^Z[<V!;/+GH"H4SJE((3HZ^G-F2NS
M(^]OBI"2I3RZ51T],*?%T/2B!E+NZWN6MMVN2J*HB];Q"3F2>$-$S>7&1R^!
MP=-.G-;8S!7ZVNZS5V-;5;@5)46+J#P8>THK6=B%;[!&!1"L2Y.#\E='F^T&
M,;%+MSKI84(7R&\15L4AWJ;\S)$QLX68P LB>VQNL>+5U!VW));)C8QQEM20
M[W<>P-[/A&W]Z]5O\S8Y0])WE>_MNX'<M7: 3]XJJ5E&OM1Q9;%:&1&)J[E<
MWEB3<K/E"[8RV;E,KE@CJBR5BKCZ>1.BF&DYJHOBF48Q&9S-39K9(FG" F@<
M65]I]<L5>+Z:6>J8(X)*9K>Q'1L:)1/H6CFF;E7=216?M,YE;.1;"JU5L)G;
MJ_IF8C%%1S8F;6E^B4MPGCX4]'M:0"_L9W3WPX[CJUJN8RVDXDQM=VW;1UB&
MD1=Y2)+1D,8K2HK4K\B JI!/161*2K6&RE#7C',U,P4NCE''MW(P4MQI38TN
MO7KXTJ"AK1[2.UZ_O_<'7+11C5,(Y2+5:'N6+)9G VVUI3E7VV7#< V35LCA
MMFJK*=8W,)"8DJ]O9F"@W1&F+=$,WPL-P-(<H2C LVQ[QKKEUVO3)&[EJ:RS
ME\^@L3ATAIEU?WZED3HOV([P[R,,SBI,G<CY!@$J@480/4<SFZQ.[*6=HE."
MI@=A+C3(!5M;[W;VD[MMY88W**CGLXONIMFQ+I/#<) KJIGD5KP3M YW,GIK
M@$9F(EX2)D7[:6:-R%$@EK<#PXYKD"G*/$LK8D;6W=UH#VQ;M29W+%5,K#6.
MDX*98C]L0C.=3RV0R VTYXDW=+(%[[K.J/,E6W%NE?UGG*WN*(05Q9PP>)+"
M9HJ>I%'<(Z2R/KKXPGV^?IZ[,BK;@WHW97%W;J(+7#3"'/&M5MCS 3[,<I<\
M-A3#3VS;;;>)\?CC0R.35BP&3!WL=R8U!Y:DU"SJ#CYJ8WOJW!5'G8#&'M!]
M\&[NF=S];2RB?6S]1;7V<UB[C[[IYK1('21)8ROL*(04;;@IHMV:Q=-:34SE
M@FZUK]+@@?X'&YFWX(_62I 9@!9VG^V0W"-Y&T^J7Y-1SI*9<R]F37;^9;4D
MD:"]KJ=]Y$ B#[/-PT B\>(:V%SKJ!O#LIB+N*9.:DRFA3MFN>V8U&UQ5] I
MAE[<>^J:VY$2Z\G3;5/;(SKOM#'THTA<NA!Q%R;5KGK:&UUM\?V$AY)P33R3
M1&</,KSC*5,DEZR"(8A(,4!IBEZ=EX&5BWM5=RK=6XVG)8EM9K:OIKOZFVR^
M"6384LGS3 JU8:O?+L22JU[[>3<DB!H+E)M;1Z#P)C:75$WF2Y]%T>I&G2KV
M^/$@6JH+M$MP>Y2JM^5]'R N!*V'LK(E=]=1&%N*MUAU>6DDG7:!Q55-(?G(
M4?NM0N>4]00-:J4NB7NJLF9 !B @K#W/KCKKDZ/T[/W@H^B-\%^S.I8;*[UM
MJ?L^Y!RWG]GA4\EVYMCPC@K?6]&V?,8,AB%C-KHTM>:VXH[N1971;.YM+U&"
M5@=52QSJ9O;8L3$W(MPY!9&@.U3W1T]3LUM"8OCE=ZM36>PJ/)G&T7Y*F@-6
M.MUWEOHC4SMZ:KUKS#6XAM/:JT@D74>M)E#VQP>RX8WK9,SDYYG& ;;]BF_[
M<=O(N)DC:^JZ<KRM&+;+35X6<L3S)UF,O6/UR/\ ?D1C:"LW&-JG*"N\-<EE
M.HYBF?EKN>>GBSP4VX%NKDN!P:@-Q.@&@&@&@,6M\DWE59[+-W-CP5[4QJ;0
M';->DSB$B18D9K&&3QBL9.],+REP5$J$N2EL=$25:3BH3GD"83B!I1A8Y8"!
MI>9;]W/TI6FPJR+ 1;L9=)KJN<E69"9I>M7S!3:K:S;#-Q=QX-\8:*BBJ8D8
M[.)9'V],A@$SR,<D\B2Q=Y#+!2R%$K +I[2>U3M;=%#-UHN65-$.-0;&J_W,
M,,JVXMDYM1TBT[LQJNXYTK)Z@TMR:<Y185/N5;-[$\1!O4IQ?Y40O:UI["M5
MJ(_'P*/['G?3+9XGMY#N<W,,\U1J#-G3/73F\VM5=MQTVVK]ADFR>84QW#7,
M4@++A8$TF3-WL]MRM@6/E0E)VTI#(7]ME9.#4!>>@NU&G5XP[<G,%KWLJJT:
M]JR[[%AD1FES3C.>4R-06Y,*DQRW?1U%#0(AT<<5,;2R1W=&!U;WMGP6Y,+;
M&)%AC[Y2@+Q;JK]W(PJRK2;::11N6,C9V?TCML_%18N,-:XA+$[],R$MBQ,W
MZ'LV.EBXM(@3@B;5IK,A.3H4>1AXY*C,BP+%9=H/8]=HI2WKGRLV(U"$XDN5
MA[@)&_80^3O5:[5-G]E(:6B(MB]E+8K"MIXNN3/3$B;S'K-N:H/,GYFK^:K5
M+@E:@+=S?>WN7249NCFHO["VL\V9+KPK-6T'/I4]J.81K856FXEL71UY4K#&
M88DB>390A11W-F,=TKJN3R3.4'E'J&%.\W7KIEJX-FE/[GIS9.Y6TMO"^%M#
M>KH0N9JK=?DOK3$DA-+'Z..FUK",X*SQ*6YV-5*V6O\ ,U.1JDABD\,6,B/#
M$M9CFF UMF[Z]R>Z:FI"UQ]!%:+6/=N;*& U[8):P.LUA$?OO=BQTY-:AE[=
M5FX-;9\.FJ!H'%.X3-R2TQ)S0SGT5:H="Y1'T,H) JMQW/7E0\JOZR96]*+<
MS;;.WB>]>($OLZC,.8(O0,"KPN+M;JRJ9#-VA%'FLEW-?I6_1Z.HG0HM/)9.
MJ0R%W4DE$A]16]H[^I_729/,FQWIN_S8G6VZ%S*?*(FKPW5'(U$ 7[3,&]YE
MR)^>7./,.$%QN-]7356%E2AIC,5C+J]F2^.J'Q^88H!3QG:5[A CIT@*K^FL
MT$$JZ]+AF;CA(&F2);(BE)VS44#,;X IJ:W[6B,&>)"VV0]I5N3O/;(RB,QA
MBAN6MKJB<A,;G.#(B*;M+:B.U/>9=<X5P.Y[$VW6%NB1-E?P5K&#+FYCJN=3
M5N@['.2E4HE!S24NC+,UR 'Y8F;#QA9Y3P>4[FAF\KP,99!VEMOJJV6DN>-#
MU8X*(YN><VVZ)/.XBJK>?YTE#JD>&*!U^;5=S6ZQ1.WILX6P\HV]L5698SJP
M):@E,G3P:5EN>#"Q =QMQW6W<_3NA(\]6;%6J%S.?N, FYUC$K'V03J2IMG>
MV*UF)JADC62AA215_?7J=2M0VQQL;'?)P<R7)U]PN/I5B4L</1]S]5*,KKM,
MKW:*9C-C'U='K'BK1&X1#DL,;7*8NUUSN>.?9?I]^Y"HJ4J#7)O<E3F^-2VL
M"F[WJKGE].D**1^[TZUG.:)$.2]'XNB83/;MVB#\GF%*6,HVQ[6/HJQ6S-ML
MHD"2-21YDM-6A/C6U(\Y/TH/8'&+KHBA:$SFS/SDJR$?7YN#,XJ\HRQ!U\9?
MNB=U=J6%?*&O9?'Z_2P69*=YZ&%'QT)$7+FC/:!?T$ILQ7*%;FXJVAY"?(IX
M4[ F:6YG&-JF',!5/9+\!3#PBNW-XL@:<^RJWO[A;<W;U?!;'W$.EG-%@13>
M9G,X$FM*J[>7,[W5ER(&VMG:9UI%H!#Y[M5;&N(8.3.RK))*9\V6FL7MA8)V
M52>WFCR"4OED&..60AD(8XCD(8XY9Y" !R(8XX@.6673ICB Y9#T !$0#0&O
MEB[0S:ZY54TSMU8K:B<;7/UPHT\0>=N=N*)2V,FW^4BS6-9+I"&&#/#HR5K%
M7;-J-<I\X($K R/3LBCKLN;IFG<6)"!9"K)3V;-46M8NX6K8[:2RRW&3YU1Z
MW2PK=38B=7,+E!'<TDK#;U!GMMD4;)=']&@26C9,8HF.IT[*RMF<CFA36TLZ
MHQ$!D>Q;Y=G,E<XJA8']:YFV^J:RL'%-3-E@U9.3K8$DJ6'H[*>38(6WPIVE
M]C0Y_A,%06(I9'"3OC>6@8B%62QN]U 6;B.^O:@\!';A-K%3 6*QFJSE+B]2
M^C[&:+S>9-&;NI[;82B;X"S5&\NDU:9?+;7C,>4/!4L!Y+5&MC"5&'G%%,38
M2'7K^PNY(>T1VBQ.+H)L\2.:$M),1F$CD (*)N=V>ZPBL(FCS7,KRMEA9Z^7
M/E2%(+$B+_"O5T]0QXYPD<8>DK>G5EL#F>B H#>P2]/4\V]4WA0$-GD:MF>N
M#%")>AW6W%MGF$:G$<J2R9L]8KSJ:JUT? BPP""KFE**:;*<'5U6M:)?&D*9
MJ2NY '?UC=[XI9VT*GVH1_/:5$9?,*0BDH8IVT(Y@U(Z6,D=1*I<%-*84G:6
MZGT$@@SG!&MU2V6X3;&)XMDARK[!A4J$Z("TG9W[KZIW N-K68SPB%1AZF=6
M5+?%@61#MR+SN7C+$R3-)+G5KIN=3>2L<9QIN85-A@_/"RAF9"3"X6URQ1(F
M0M&9('8#0+CJ>T4VVK9#"VJ$,TA=%5@2Z#93<R9599E3N3;6\RK6]I]!KA1H
M)[7+2ML9@>4^WR1MT<R9_2@I3XBJ(<"3$)+>K ]S]VCVW[!K@LF@D?GLVQEM
MD5>SJ6TRGK=C$\,B-P1">.$$MV!P5YK7&9VE')217[K'(ZZPYI5M[ODE=$F+
MV1BRJDPNOC'7KY^DK]JWR[1L#*\11M^=U37/\*K71QZC-,6@LA[&Z[A)*FBM
M9,\UDK5!#([6<QG;^[8)O>U.U\;D:3W1DID"!O)5)S%*F?B4'[(+BGV<SO:'
MTA4542>);;X\SL4L)FDO=J\Q?+(FC P6@\PQB4Q^NI\D9F&.U5(8W*'I>HC[
MJ,LDDQ:& M,RDLCN\J'7KU0&(\Z[3J05'%:9F\\I*@H@]WY0,LW'-K*Y[J!8
M7N3PZ')JESCE=0)2^T$S'V=?,I3VMFDC%9$$M2'-8RY(4,N58NHF( ,KE>ZF
M!-^Z""[4SJL%''9/"6Z693M;@U(F&+W$_MTTLJ(T\X1,6W/(B=NE=5I8UG+5
MX+R3&0IF:"STIRJ4MJL .DK"_+AO2*1";03;3#&6H;FC:V8T#8[[-2Y(J0YH
MH[G(:DF5WU4WP^.FP.*SAH;6\^.K818%B2:.YKXRV/;2QK5:G!G R$V]V*QW
MY2\7L ^$(XDK=<Y+%YA!U&2!W+B4\K>4R*L;"B.#HF2)4KTDBTUC$GCS>\D(
MT93F@2%KB4:(M9[E+ ]E-;9J9H/&2_0TC3LB/EZ5G;7Y?*YU/[*=E+''?6XQ
MZ+IGBRI1+75KB#"9() H9HDUK$<<;5C\^+DC84L=W$]2!>\M A)RPS)1)"LR
M\S#2\RTQ)>6!AQ>)1IF&6. #CF:5A@69F AEF7CCAD(XX@  >>"1*6H/6%ID
M^"M3@24I58$EXJ%!:?TGN<L\_'$#3<"/2F^AP,RRQ*](9W Q[^7(''Q:6K%S
MS>L6QOQ>3$F* QVQ1)@<\T.)GI<4>:\"_=623$T ,Q3Y&B2!@=\, RZZ ])3
M"QD!F!+*TD@:Y&/)@%-R,L#'<[$<#77,,"0#-R-P$<#%V7*K/$1QR-$!$- >
M2=C94BA,L2L[6F5HD'JI&J3MZ0E0D:_28F^K4QY9.)I"#TN.)GN,K+!/Z3''
M/T?> !T!VF@&@&@-)%^]J^91.&X*RL]N.<XVOT_NE@^SQZ?(N\*5-LV+<#R6
MTJ+GE$<KI-%ES<\0VKVQRPCA"%4[^O["E32\(4I[(V("E"D#".:=H3L)2;M4
M5ZH]LL@M"REEV6K7>W:0P:\IA)8W=ETUY26UM!3<CK6CS#TU0)[#MZ+[K6R!
MM$^.:,':#Q&,.\D<I(L;CS\6L#<C!MR-CH-X<<V\[@*0@5>/UQ;?EEMTS.H-
M,U$[R6&UUG VV\Z5FKJXPZ*'^OH3)9TVR"*O3,7G'9?#E>:K)O9WEG6D*@.6
MHW9[*7 '2=*&[-P&NU,?2Q*7&;>K"59S!1A,%=:1G';\^F5YGE;7N:9NRJ,M
M)E1*Y(6CR>\5Z?,IA?$SFM H9Z[1*J<;%AL:B\21R"N[)SJ%8\V$['N<15,^
M=@'[NF&5X2Z"2"'$/Z%^J];L_7Q^1,<A%M>R7!U4L[@E9E,1R3N8&653VE3>
MZZM5DSAC>[OL'DA2M@5#-ZYF=?.+LVNL=)- PMHGT=C3\K8WN*2DD]M>4:4Q
MM<&MX.*2+<C/=I!(&$,)O+9CMRQG,4V^,TGE<V-M.N(X_G3MUNQ[/F8++TK?
M:E*WB$77<Z>786$PT>]6(D9'EB@\G=V*/NJK-DS!D42Q4Z* /0JWB;+)J]4U
M*;.03%?8487-LBAL;J^";I;)JQLF4P<IO#ZP.5I([5T:@LELJ1?0QD335A<Z
MA.,O:'] I;(&!*A6VN+J!=4_M#]LRM2A>G-6LDL<<$\(>:F-A57739-E/2^4
MUW85ANN*VM6:GSGV&.L=B==S!2M(3K7=U0D,SXBE26)NJ8II6@5NX[[]J3?)
M&N-))'(I&J=U\<;F9ZA5.VG-8@X3&QH$5:D;@Z&;16#NT4-LB55PYH9LG@^#
MQ[[%<>>FI>>V!B\(<5(%JXGVB6W:4,M8V,OBDGC<8MBF*^E4%:W6I;5<;Q7!
M9\S?HA&X*55\=JU[S5L;TX,&?J9R8I<[I'XXPE<@938LJ:)2Z 7).WS[1<SX
M<X%/+\[%6/'ZT]%(FJD+6>FIA:[8G"FO*RCUIR%N@"M!5[A)YZ2YQIMBEEK(
MTY)7I"XIU[:A,+R',"Z\HW TC'[::Z<>@>5TW,<(VO5K&NKIS)X9#)!*25Y$
M,QG5E,D4<X%7LEDJ=M4$QXB6R1D=5A!S7@5C@4_,7K(#&R0=HC1"G&-R.IV=
M983P^RQJA2M4^QF85<X90>15I=-GQ"?Q9PFL'2*9[6\M6TN_M,;?XT*J+.IX
MKW1"[GY-H)EH%\(UN6V[ME6-%A2>55?7*M#2Z&_9;""7YA6RB"Q(ZOQL-_=3
M8ZUDDR96D98ZZ.:PUQ21THY>A.4*B4@ O$K,#H&S>1M731=/*Q7O$1;"J_E]
ML AD5-V/#']NA4'F;-"I&^J(R]PEK?4>1,GL5L!O3BWXK7]!)C9$Q%.3&K5N
M8@8;V;=VT><7IM<L6)578<[=)IN"=JC]_C\U;I*XI**8[=&2<3!^L15$4T2R
MJ2Q7.M)%$U+;$I9)H^3'F=U95\NPL%K:JH,<6<#*5M[07:0_%NBA&Y3TUZR0
M5\XMD87;>;N;IY837<><O;JX75Q#76MTDILUOFS;6<P<4*N&MCXE)BD1>'YX
M-;V!E7+$@%9X;S=L9\MKJ,@_O0/UELD-]2JE-3V4E01Q%9D@7QB QRRW]9"R
M&RI7B;S!D7Q6/P^REL5>G*5HL&$&H'8]"F4 4E/][^TNNK%D5=2$B;.$[KIY
M"!*DL0VXW+/2RI6VU['+M"O8F^PVMGUID$I;JP>V^S\XI%G%P<6^*M;U(3D:
M=/&W8U$!UT@WV[(VMX);')_R<T+JN+4DS-KI6QI)6ZZ5/U,J;K%E^B4TP-?!
MCIXOI%.,S5Q[-_&2F1<],4H1B:?BCT![(?O>H>>VFU4V7'GE$VV'754VC6J:
M0UU.&:3SPJR)E>[<Z.[E4S_!FZ3Q"&Q!-2228NEG2Y(WQD$LWCA[BK:#E[ =
M(./-1NN77> U[_=GB]M3'L#C+7,9/(8C!(XPLFWZXE<@L'"P&.R)7!7.&QA)
M763Q-*ZES/7%FN3%.V9 O@:K"//IN3X4&669W(*LL^Y9LAM9_K*C=O45N.4U
MC6L,L>P5<GL%!5^#8SRMZF"6O(5 %&4#G&<FGKH;7LL<TK6]F06'Q_ AA,<9
MFB.?<10@6I2;MW09;8"5\VTL;/0D1O&J]L\TF.<X;U%B-,MMF,4Z\1%1*Z8-
MK](Q#"4,MON-0N0GM-IR-U8UASG(,(XL8RG%4D=>O[042Z]HD?!L[_3RFC(C
M'I13,/K*1K6ADN5EDV<.8["M0*OB;/N4=8O!%Q%(.K*G</HC/+1'<;C3M5=(
M9<[M"AV7,>#:\ 9H;6KZ+W)TZTVJ6QMK#[MDL^BII+!(SYA%')57\YD$%6/T
M,EBR/1%;)(B^*X^>XL#PNBL>5JT!Y>1K41W0R, R'T T T!:V\;5@]%TS:]T
MV88>77=3UU,[%G&25"#HJRBD-CS@_OQ:1L$<0<51S:@4E)D&66.*P_,M..6(
M&#D &ON';\9 %?/-C;V-H;OM>H;.HV2U838IDR9KZ87%FF;JSPMEJV31^"11
M-)(O><EPFS BCE:Q9HGA<KQ=W%@8Y"L=T636L P0C.]795LE72V1;-:(?[ :
M)]0C594LF4_M:ZD%C(#JOW?U1M 3T%((_?[-+[&K=%5+M>DD?4$)5XL#?'E3
M4O9TL138R49"G W!TANUVPWJEMXNE#'N3-U*/SZ;+C6VE;)9FEZ?8X\R-G>G
M*LUCI!FQMMU6CE$/D3"8Y5B?*S<I$U^X,3<E:MM!6!9%D[0#9.W54QWTYQF8
MP%JO&HB;WG)2C;98ZR6-5:Y I:T<NO(J&0-^%G8G1<#DQQ&0RM::Q3D4SJI@
MSG(65(X.!(%XSM\6VTY*M<DQEE/N/T1)O3"4MAV]W=)'2426M7"2MMED1)J9
MJZ7N\SAL <8K($4PF<<1NL'9W!.2W*'L7)U:TBX"PMEWIV?.Z$J"QJ1N4_F9
M#Q$TDYAZNM&/<E"RGI)8-0%6DAK=;*ZJ21?UI,I_3J!NE)-#O[LHDTB92HUF
M9#3EY\:*. J2&;^=NBV&UN_##9+$X!8E24E,*WA(T_:KC;JI;<OT56.*0WZ#
ML;JUT+Q0*F*H'=-'WQ@DCZD?4:<S,M BB)\3D<K YM?[H]D%;.Y"R!R&<.:W
M<.^U+,GR>90_<!9B8R17](FZ TLPV-8K\R2<BKE3XZ*TD=A=:3%[B:6$-V()
M$T:C38<3@I N!-;FM6'[IX+04?H>H72*6K&9M;6-D.%RO<;?BX_4;Y2K%/G1
MX@B.A7Y$IEZ%QMIF.AR/W^')GY)'CSW.110_-*G+ LZNWQV$V4/*MVF6U8A3
MMZ"D+@OFMY4VVDWFSMSCL&KA^LN,K[5ABB HT58L]P1V-B6R/$>E]HNC&N>(
MRWR^/-JM>L):0*RVY[T:QL:M+NGTH;:AA%?[<DV2N36-3]EH+LH8^+KX<3/)
M!G%K'9X1"?=KW&$N)J6PH>EBF*QG= :RL3G8YU38%@4P\]HUM<BZ@Q+DU/D;
MA$ C]FJKL/F]3656,BI6/P"J6ZZ,T[C5\LKEKE3LG?8BN0/)3>TMV( B/0KB
M"5^:E.2('<RGM$*"A[C&U;5%K'7IY+8DI@]H("*/N9LMV%N48I9SMUJ>76EO
MH8&6E)FY]AC6WJVUV*8"VW"-J#74EQ/*9ER$D"X*#>+M'<9Q!Z<9G?-V4267
MQJ)P1P9JDGCE4RBQ9+79]R,$2:K-10PZKD,W-K7/*>"R>^1,\(6186L4DD&J
M,B]!U\9;:S]T%BQV%;K[@@-&U?-JHVEKY7B*26SUS@\FG;_3=?GR^UY3&%K7
M7%@-C1C$3RB:SB;4XM1;C(Y$U29R5R.*L34SD2("S]K[]CZTE$?INW**H),Z
M3"L*PG+U7;/N0%?/9PQ71.I[4+?$]O\ 7[U143=+QF[3%XB*U_CB<^$9ITCZ
MCC:!P4D>C<5#KUIUV4!5M26?MNVZ[EKGVNP^M)0QQ1MKM;-+ OJ;6--[23R"
MP(!#(C+Y#1R]QLAVF$N,5PBC+$AEBLC5A(SV7-D?)84U1]*M;7]8O O' KNW
M,63&&Z41[:_"X2EL2LW&RJ3D#_:8R)(4:N.87]K@]\M3)!V1PJJ26(P.92U.
MXP%RNIA8WA [8/RQ<J:6A#*@,@]O\ZA5O5- +HA<83Q=%:$1994<V9H&U*]-
M2IR38GN,??3VXL"5+I'W7):TN.91IR;)P1J<TYAA66)F0%Z= 8(/?9_UNZM*
MYH06C=T5*6J-P#;BMBTAA*!U1UKN<DR.;V]3R5P5U\X'C"'B:(29.RO*D5-H
MQ1Q 28Y8C:W<(0 Z*PMBQ#?5C)&-ODO6PN>P^]6>_8A,92X9JG-DE2:O<ZE>
MRF)U1,JYL9\GJNU3DPG&R*#6&R9I7=Z(6159FX(EK,Z\P*%I3LM*DKPVE)I-
M']SEMNUB0U*Y))TK5%ST$V?F.VI[=D<//=IM'IE9K&3%IQ8\@]"OBM@QEYFK
M46A16.KE*0K%"6!=]#V?M-I5$5,4R6S75+ I6_R:"MJ][C6".*I9#N.I[=.H
MBR(QOB"%>Y1Y':]*QM0@,D"YXD6# [2-E52!7@H:%#*!CCN3[,U^LLZ3LU,V
MTHJ^'W,Q6I%;Y%8>YJG^2LMLWK-;Z=<2\4A&;4]M<:E%G6*3$(V65"7)(3(,
MD4AG<GBJA[B+R;ZO(#95-*IB\\E]0S9[,=,'BDYB^3B&X(59*=$8]2"NII5Z
M_%Z(,2GF+D6,:G;WFG((.1F%N>"%5D>84G,3'@6/1[-X.VR90O:[$N)KKTZP
M95;)5&-DM:6^J$EDS96^/$FDI)22,E3XY Y2B2/LUS@:Z>K*S*F+D:_%0O!2
M0C!,!VM4[/:>IUG<XU$R9"?%9%259T3+HN\N:18QS&/53#CZ[CDJD21,V(LU
M%@+H#FCADDDJ(Y#B_1QCC3:K;_11ME%"!8DSLV*S+R!\/L^Z)M-&*)0Z(05X
ML:51YT1QUDK*"WO ZV8#DC#"V#)R:F-KW"3K)U<U^2R7R55BTN+_ "-S7HCC
ME@%05!V?\#@".J'>:3^RK-L6K&ZD$3-*I(^LV934VT5&)PQP^%,R=OC#28?"
MD*ZS)R[F*I"+Q8#ZJ<T.<HF[R#0WE)P/QF[.BFHUC%&^,S>Y(]%(\\4G)GF$
MMDJCN$;L&5[>YLVSFKI+-Q40Y0^*')I6L[4T.I,=>HXU21@:69&^MRY2S-2U
M(!>QJHUV8+GN6:-$B;0K3<%'6A58\,/;5>,B1VI'8NTURDG,8D>"_-"6W2&L
MV.-QN01]P9<Q2N$+87IJ<<<G%\1G@4=)-CU)2N+0V(/(S$QM@.W1;MGBJI+(
M"D3NT0X]WJN1-4L0NB5M*5(;,BDDIJ"R.)2]OR2"QOC=FY)V_)0*;)*;[.O7
MS#]_G^TX"S81MW<YXX6X[L3F[7.X7-![RRN-<<SC8R.4P!KB$;9V1K>DS&G3
MM<)60N')X,\Q="WDI7&+OTK2B84ND"MPT![(OM#2U,0WG5-8]@&H:V:Y8&WZ
MGY_)2UE%U.\R-K<FI+@6U15C8+ E,78D3JO:H[&IM.I8W1!B5YM<*(CN*-F.
M:@+S;>Z>(H:H8G6.,@52YQ:#)&^RF8+41#8JF,]GLK?+ L67FM24T]*T>^J=
MRB1/^#0F//3M1;C@WD'GE)L#<P+SZ : : : : : : : : UB-/9W%86[:9DD
MFQ+UMUF.ZV![](+"$*=0T3ZOMT$94L1TI:U3X<6[,<KIN;.3#A,%#+F@9) T
MO[J\MJ9>H;%92E.Z_:"W[?V'>P-K1RUC10B7)X=+97N!F@09/*2DL9BC_N+;
MZ:1RA9!<$C.G>(F9"UM#U^_U4<UO!:N!OJ)0K;U)Q -R1M O_ MH=@(=V<3O
M^T+>-L.(4#0R^A=M\?<T8JI\<$^P@#E;]OW5,"4S*T2*QI,O@;3%VA'&HTUL
MJ&,(CWA:<KD$B<"D('@[=G+2[]7SG4[Y,K:>ZQ3J&%365>OC]$WV$TH9&9XG
ML=B]XD4>80O8)%BV2)(E1I N-OM,2(>3G R1PAJYT9%P'8L79W4#'E4"7-RF
M=IEE>)H,4S'-STRQPLY7 W+<4\M[H8BBD:84#0L<'?=#:#@O(B:6.-:(W*.$
M1INCZ-DP3* *KV^[.HWMG,(25G8TZPCKE-)78$_8'9# 4Z.P),_0B(P)H,7H
M8?#(?'(\CC[7$$3PH]Z<<97>83$]9+IF\OCXZ/ZIZ M_'^S4VVQ>5S.4LB20
M-V<PFK?/ :V]/ VHAA>T]\Q/<BYEHGYI@J&;2)O?K2AC,N4)K#E<USC["*R+
MP8Z)L:D4> =>O[2KH7L*HZ!E,Q3&IG.6+%**CEJ(5S^@/R%UI666!,H=B>);
M(1Z1(8[V3(L7DD PS7(\&XDDY&8F,.4 <*!]GW0]=/48?H^JGN2Z)FGG-8.$
MA;U)&6:B!VU71GNK MB3Y' $?N>7YXA@84(.!;.I$1+1'IU@'5Q?L[J:AK[!
M5\<F5O-L8@<OJVR$=;E2E@R@[Y9]154PTG%[ D16<1RDJEW55K&&%C?F1NDK
M7"'-P;$\K"*)Y=WWW,#FPSL_*:AAU1GE2:SGXVCFBO8U7>3Z^1H?5<3JB7/T
MMKZ,K :(@T"Z(([D_FL6*Y<)K\Z,B!!ZY=W!X!:[K7U L+-NS=?PFT%0U%:Z
MF#TH2X4DZ6C&%JMR42.9K:/O]]OIE.<LDB3%M>\URU[,B[;FW*8"+,WE@?,O
MHL-:5BC#$!FL][:8R[6VMMIOG5GQ(R2*8DX6+ HC(VUH@=I.L#1J&Z)N4W(%
M@4RO/) UFI6AV;HU+(XR3)E9V5CG#7)&9OP09@8Z5]V7NV>M&A$Q1K"6IFMG
MD#&\QXA/C F,QE;HQ!K-KV/1G-7%8"P*Y,@;8_;4L R13@^46&\JL&,R135W
M(94:;$#+-)0M<H*[3UTA;#D"=+62:IT\R;\TS;8R>+I(H5#4QR::-R1*[)'D
MAG()]"XI<R/0*BRSB2"\,,"L0,,P[*Z@RHLBBB"<W&QH\V^Q&25G1ATKB+$S
M>-V;*X#-Y%&G*-QZL6V$1)C"45E$'8A)5D5K[-4I(?<WHYWSF$MS>P,CF[:!
M3Z"-U;$C29"Z,%2RJWY;'V]T=$R@IS67>RV>P3IOD?HFY.+@TG-EMRPEN2IA
M0')!]6Y&JE/N4T%(%F6OLY*R:W!!)?HP;@7*P(LT5$PUA8KQ*H.X2BIFBCBK
M5;J]1PTC.N<8PY"FC=U61$Y$JG\=FRZ9,4C5>^E2ZNN);GB!W^?9[4>IM:N;
MG=76=R.P("TP%M7R.7+(A,9#8"FL9 _2J%/<MF,IA;O.FEV;)!)718L^AK*:
M_;'] #;&9 VND19FA@1 7)4;1JJ4V ZV48?*PD3Q=[Q?ZS#!X2 W>_M[VO%[
M1EA1246H3,&$*I*Q/(;Q49*,)7R\9+LT@^JM 6!.[,"AS&UCBZ><7:WUZPJF
MA]35LAE\;PB2J<-&WL[;"$^6Y'0H^29OKA4YN*-R:$TA2P51)B@F6$0*DAJE
MP/ O2IV74^;;L&O-(IF;395?US7M0LSZU/B-/[MJZ 9V'D; )"F,:#R7V*3G
MZ([@=.F9?B8C<'6-0*2LI;!*X4Q/J8"VM*=FSMTH1PA;A \).G&NIS&)K"DH
ME0-G3M!<+KRVJQBT97YQ&"1I9+6IJC5TS3TL@FBN1V*]+O4ATAG#N0S)DH@7
MHM7;"P69,7&>M5E6Y4,IDL'0UG/G2I)&QL9U@P!I<7]T8X^_C(8O*A:EL>62
MR691V:0D8G8+$7)W@ELEB8LU-BE HENV.5BWSATDPS6V5T.=K0A%T*J66R5A
M&K#K-K>(P"(0:4+P2Q-+8K^,;3UA"'] Q2BPWR,C+V%!)U#*>Z)4AR<#HSM@
M5:.&*XZ06?>TJ>D;3$6&M)1)ILR.TGIIG@=IQBZ8DDA3P?$0/DIS38\)ASZ8
MZ7&%I/#PGC+:QOS@Z,9SJWN0&25-U QTM%%T9:'R3RI:^2N43J5R^9*VQ7)Y
M9,9BZG.[^_.P,+1'HZB,4J#<"$S;'8^QLC<A3)4B!L3EE#WP+L: : : I2=P
M:)6=")A6\]8D,H@\_C#]#)C&W/#(UN?XO)FM4ROS,N+PRPSR2.36M5(SPPSP
M,]&=D.&>&?&0 :T#NQZVROM<3*J[+G^Y2Z8E(:VCE1Q%';MR+)EC3T A\SCE
M@Q9GK)&>S)F<E8S2V&Q%>$AFS7-9&ZH(VVQQ]=76,YN#.N=>O7ZP<='V-&T%
M'$T,2*.LPE*FKETK1:L;GJ'L!KLUO.XFMMSKD[*&J.0-HC#:\'6-5431)R8X
MP,D>;H>2JC[:PI/2)UJ4#(G;KL(I3;)<5X7A 72P'2:7WD5A+PED@;7!N2HB
MI+));@E38M3"R.<C6%/$J="DDHL5SG$T;F MMBK;)4<9;4K5@!;YY[,ZH7BM
MD=4!:E]M$1"D\-MTA*8Y3"&]?-*(:'-Y=(%6TH6!71OID%:&2!Z1120-)31,
MUS6[O#;-I)+TKRZEK .QN/9C)3837C9MMGYE=3.O[1NR?IY2_.CB2\JFW<.^
M3B66?%TK\T-;BE0LSA+)BF<2TBZ'O:K%NCK0G9G:,2M"U3IJ ZFB>S(HBD9#
M4<\2JG5ZGM:5[6,3=G,6B')D,TE584TTT:U3U:XK8V[V6SJCH0S($AD39[+3
MPA0J0-CTZQYUDJ/-\4 7'A&P^I82IJ5=C*++DBZE&BIXY!5<A>8R)B:,T?G;
MQ59,#C@QQ!C)<DD>9[GDC 8L.*Q>7AN:HZH>'-<\IG5U>'U QMD79JO3?/JV
M0U):A\*HAC?MLLHL*(JU+HID4U>]KUKD6?%5;V"5/@UR!:]$MK+$<%R)7!TC
M,UH"EDE9+,S;8NBC8&Q]WJF+O=MP6Z5N;I[\*\@5F5RP%$JB<&;./VN]UB_R
MC-P0Y)<SU+A@NJ6+8M:DM8G*2)S'4LY.JR6%&)0,65G9\52XP60U&OL6\5-*
M.$ M.N(A3H35F30BK8[;T3D,'DI<+S11--*70&>+2I^9H&VV3); C\!0KL$T
M596U.W-)2 "["_:74;G$MQ, 6DR4R"[GB%7T28F2_G(6I*ZNL)0P.12.&&-Y
M*1SB+_)VII:71[6-CAB2=+&_WVHTJ*0.;XO=0,3+H[,"(636VX5"3;-GRNY;
MS@5C1I59%J/;"J2B]3JE4=&)USBRU_#86W-S6TPYJ:"2444;67(5R4]X,]T.
MRY<J5 9"1[9+6K3)3YU()G:5A6$ND;Y(W:=35^CISX[B[5"OHY"RJDL=B<<C
MR5CC4!<E9+(D:&-M/-?E*V3/RM[>G-U5K@6J*FTI6)=GI3\(EE</\=FUPHXY
M5TZB%J1VL1E+!G %-I0VE_H HYZ\)_>@$G5N+I7&):5Z84\H10I5(L,Y>GBZ
M23*%3F<!6..UDQ8EW9UF_2DMPV_[JT<S7+XP@2&-,Z@$CM.&$PBUTT?DF6;@
MU.$=E>):B;-7N]F+=(W,WF0AF:]LB]M0L@'?SO:)5-A/:N3O!\K12;*,T9'F
M.0-#LA2ND/5[=9W,;%K*5Q4]0T+,$,H12"=/Y#V>K*<&B11]09&W9F4,JUW1
M.0=>8HXG8%MM*G"2T<XJI4VH5<LQNISLQ5DTG323/$Z;95&GZ'2AS%F IYK?
M.!RQ37*2)*$H%)86T1Q#@K%P94SIH#RCFTUXJ9CP"GKFL)P?87 %];T(Q74\
MA-:LI=@=CF0C+(N,15#!Y199K U,;<B855GS:4RI.VMWO>;9FP(GZ1+EP&0-
M)U2Q4;4=<T_&U:YQ9JYB#)%$KLZY%9.SV8U(BB%K\[Y)RRD^3L^K@4O#IDG*
M*(R7K5&1)110X%X@70T T!X&8CF7GAB9F5EGAECB:6& F%CEB( 9@!N!A8YX
M"/>Q PLS <@#OX98\XB!I??F7=:Q90=D)<]RK_*&B86$@IE_-/GZUB<Y0EWQ
MRQ.L>=Q:J)ID<6-@KCMA&,*XOG9J%)7V40,D6->(DTK][";$.<R*V;97:3#Y
M+E@AM=0&3'4'K5/NH7VBV/HW1E$7'/<"=&E$V;7:0Y0T7X8CBRX11,%/F/7O
MKSK(W%C ?2.O[\P9BU[,)=+$DEP>66.-;K%I<[1-:6V/+FXMZHQN(;U9:U*>
MK9&Y3A@<G<2L<R34W>+.*,#$PS#+$0 N!WGK^T-?Z:5_)_O/05ZKKXO+Y!WG
MO^T-?Z:5_P"AZ"O5=/%Y/*.\]_VAK_32O_0] .\]_P!H:_TTK_T/0#O/7]I:
M_P!-*_\ 1- !R>N>A#7Q\*I7S_V/XM ?G>>_[0U?II7X?I/[7V] ?O>>_P"T
M-?Z:5_Z'H!WGO^T-?Z:5^'Z3^U]O0#O/?]H:_@_DI7_H?[^@'>>_[0U?II7_
M *'H!WGO^T-7Z:5_Z'H!WGOR(:_TTK#_ /PQT [SU_:&OX?Y*5_Z'H#W$9.0
MF![J*0XE<#R)!Z@PSG_:\8F)R\>!\_QP"'ESH#G: : : : : : : : : PU>
M-\M/,[1F]9L=H*4R!RMGWS),H*J9GN&PJC7J/,5I6G)X]*5C ^)8+%5<OB9Y
MI:%O<9LYH9"@5LL-<2RG#W"!<VF-QL&O-2]IXHV2UIP;62-S%E5RII2-:2<5
MU,W&4M4.L:(F)'1RS/B\E7PJ3%MR=\+8I20G0)7)TC;<U/D>7.P%^PRQ$.0R
MQ$/: @(?:'0'[R'M#YPT Y#VA\X: <A[0^<- .0]H?.&@'(>T/G#0#D/:'SA
MH!R'M#YPT Y#VA\X: <A[0^<- .0]H?.&@'(>T/G#0#D/:'SAH!R'M#YPT Y
M#VA\X: _>0'P'G0#0#0#0#0#0#0#0#0&,,KW702,2.60I/$K0D\ZC4PB4$;8
M<R0\$+O/)',(K*INB*@:J8.<58'AJ;HG!9J].TD7/35&RB(L[IT+LO7%$)5
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M?+5;QL<"K!.DQ03(%6"**%5AB15AB6%:*J$1CZ.MY#_QTV[U]MFS;[?\O.@
M/S!SQX\:A+UWO9%5KTM[,BUM=I1W_P"8KYUR5\F*:>R3$?\ K%?_ /?5Y_\
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MU]<N;;DA="E.UZF]IW%5=9N%"5BU(+!L2&0M:Z(W!W.5MZ632!O9U"Y*2>F
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M.1T!R= - - >&9A98X 9GA@)F8%EAGECB.9@@.088<B'>S'''(0QQYR$,1$
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MD2L[YE<^'2][WNRVX:@NV]KTNV"=9;UBG0W?>-LL,,Z*7.N]((IL-EG2DFK
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M+G5,MBIMIGM_[%0Q27NLF0I$Y:DSZ!<J 2S3Q38]WW[5SWL@- E0(\<<!B.
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M-(G'XQ3D8JV)2AA>U,F=8K+,#8E.W(#8)=]W0V@80$[FQ3VK;CGQHC;<VQU
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MA[HZ" ]!#VZP_L@N1%5%O6Q(J45%GP(RY-5=QIR\(.!T547%=Q.E%]T;/_\
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MB$:Z^W^4J+5E;)\$LO>\GT<)Z*W;W.L'>5E]!+*OUV#NC0$<OMV_IJVU>?\
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M^IR/[SH#E)D"%$.8HT21()G= P4R8D@3 PY[H9^BPP[W=[V7=[W/'>'CCD=
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M8P>L%?UC=?T9DZ?'_+C[G.@+(;FURG+;;N#QR9G$O'*C[8#(PPUG' L!@3^
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M1^8GCJ'/]1W#S_\ 4=!^ >H>>@+(;FG<DS;=N#+!&ZXCG2%KX!D8U+L"\>]
MW_'O9YY$ACA@'/.660@&(<B(@ <ZQ][=RKS\'VSYM-,!BSDMB5L_6"^6_NZT
MD%WCXA#CR\_M^?L'GV\ZKFZ5T7M5=MC9HE.A&HCLYY^^5&TU7QZ[]:N>.?\
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M487GGQUZMS>,$:[MC5!2K>4H-)$SN#5,# /2$GI\^<5$B >2SRRS,0Z]!'
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M56AYQ1I[9,77CQ>/C+2KJE*52B+1JG.C_5_8^>.!>&P!#QY#W:2 ^/M#J(?
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M.3WW# PLS#).&6&0 !V*5]8USHZ,B)Y:ECTR8H\WIH2N*10Z-&#B5D>WY.B
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MZ,U\_LSAB9FC=F9"Q.K8MPP-,(-R2KT.)Z11A@<6:28)1N>.)F&9>0AECD
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M38(Y<R"&9+F0Q03)<<*1P1P1HL,<$<,2+#%#%"JPQ0Q(J1(JHJ*BEL"MKNR
MYV<6 F@=L)KZT(2'1V92JUK$QV;&Q4&0IG%Q;<&@5B)"H#'(2%:DDI.<&.0E
MF9<#KI^MMW?U"Q?]+(_RS$>QS#WZ!N;^Z[#_ )!VT8VN[/59;/+890.W=42!
MJ=U8)-&*VKPXL#DQP&)7%G>6IHRQ]*G4%!FG6(E/>*.*#(LS$S#D/J&[[!!%
M#'!8K)!'!$D4$<-FDPQ0Q0JZ10Q) BPQ(J(J*BHJ+5#[E7#<<F9+G2;FNF3.
ME1PS)4V5=UCES)<R!4B@CEQP24B@C@B1(H8H52*%4145%0N*WPBEW=6[-[5'
M*\<U["K+0/J)O1,2U6RKCB,%12-V3)L33FY6:F,+4%IUF!)V9&>!N. EY8Y#
MVS+';?0JK3_D%$OU!;O]'T!TPPNDQQ+$8]7(XGO!D=*$4C!W3G\K,XLYB+'C
M@QX+S3J,#&S'E;AF0=CD0 E9AB!9C+;GL,%M>WS*E-J0L\<<#FR1O&4"J@6U
MB="32BCVY[<!;/<K6X%'GD%')%QQ"@LTXK#,L,S, 'I+=MW55;!8MJJMED>-
M?:S#+AS#RJZW%<RKM6Z["^W^@VU.W*VL;*_7># 1M]VT^^/%N+?BV4JLZU]=
MXM J 3%/.#=@S^[@;A5@"<MQQ)!,*@ *Q.]+^-T2[;N172P6)%2J*EED.B[?
M>PF'</HJ*EQ7,BHRHJ798D5%3)4:11M"\.=:U3@J)0YPR%8+E1"E4G1YM#3B
MJ4)D1B4I8I)3B2!QI"0U<B+4G889%D&+$N!N6&2@H,^Z9DY85;6P< $$B8<>
M'\H6WI_^'T!TS-"*7DB/)QCT;KQ^;\%2M#DO9D3$Z(\5J \Q(O1Y*D.)Y(*D
M2HLU,K3CF!R8\LPD[# S'+$ +7Y[8=E[O)'=G,H7;8Z3 G#%[?FO.N*V6R0H
MMU/,-Q=W=#DTFNF&#DH$TS%>L*#%8>)F8&F&#D.NG%=]@CB6..PV.**)56**
M*S28HHE6JJJK JJJKFJJZF(CP_<,R..9,N2Z(YDR..9,CCNVQ11QQQQ+''''
M%%)6**..)5BCB556*)55555<[(=FVT4 $1VP;?@#CJ(T_ .. ]O+!QP !Y]-
M<>MMW?U"Q?\ 2R/\L^?8YA[] W-_==A_R"NH[7](O3,B71.*5P[1\2\DK:LC
MK;'U[,)2 S-#FF1*&TLU%Z-$:G,1Y$D9]U,81FG''#(K+#'N(B(B(B(B(B(B
M(C(B)1$1$HB(F2&7AAA@AA@@AA@@@A2&""%$AAAAA1H88841$AAA1$1$1$1$
M1D1BN&.)QB,Y*<H['VADR6 5BKR:V],B%2! F"2!XIRRQ, H3C1+#/GN"9GQ
MQWAYY/HJ'0#0#0#0#0#0#0&$^];;/+-S;?M]:8C*$\'755?N%Q8S82@6N<,>
MHY2ETQZO):R,9@%I9.MC5KRR O*Z+KU[4WO\>1/;:N7XI3S4Z@#7@G[,^ZX
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M9!^--.5I0W,G&7LL8G3HCL*30I/%Z\8D[37DL*>DK= 7509*[9]N]Q5C#V]
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M8E;2.#V:+_54<D;E.BVH:W=C624Q;;X?N5>(.:U(;$-?,U)-?DX-9<VQ; K
MZ=+6Z)%3;)8M*.T!VZ#?HL?K'JBN&3;K:")WF6X5=0M@E2E_JAO65IGEMD/W
M11Z6B6S6&_M\J;WF!*6E<>W,KIDXM9"&6HE)0R9NC<?E@'2U/VBL0F<5K9W6
M0FQI(SO*?;Q'[%MIFBL,B$'A%D[ED$;45A&'B%.-ORV;HSWM1-(*4Z!%CK&9
M(GE/8P#C*UJ7"1N# Z^/+K]H+@T]OWK.TZVL&U7N#694,4KN@8!NA<\[%1PY
M2N<*,LF.SZ1QN9($U?3*<XEGY)ZOFZ=?&W$Y#(D9S6FSS;LB71$9F!9FT-^M
M@F9UQ!:\HVP8#:\PN[;S#Y#'K+2U2^N#!4]XM=B2=DGS81&[L+BSD>]IJFG$
M,!N43$EWB\A:7=<X,#BA2L8R%S N796X&^W"=[GF:E,:=8V3:1$XP[2=%;K-
M*EJZVY7(:],M8UB:),PS&-(*EA2.)GLC+A9#A&[2S/E2^2#G#B44$-32D#SC
MF_1)/8^_R:M]O5W3*/QV-)5+I*$N-<-<=;)ZX4$R;AD5?.V#W8#9*FXW"+R:
M.QQQEZB+80UOF[RDCQSSW\52E,!CA=/:JMU?1#:B:2U5Q7=D78FVUV=;,/N&
MPHPE(JNAKLM^#58J=VM8S2=,5)Y<\F2MW?X7@0IP:VN%P6?32<$M1D6+B;VY
M@7SOW<M>3'.;434 P-<YCM-QREH[*4:2+GSUX.L"Z)FWODA<V*)M,FB#Y/7.
MF:$1(9]C6,9E#.]3W"UF$6]9DI:4J->!2\=[22,M%=>^"81B0V6Y0& RZTMP
M4IJ.'KX/'Z;K6+6;,ZYRE,]K>]I%#;7BTJ)&"2QREU1-;7/)=$#X3.&\A;)2
MT4573%U^P%XL-VRRSY%>]/TC&A8+AH4UI262^7.E2(JNK/!^E:0IF>7XZ.RH
MMSEV4AJ+!\O&&,$?<&M*[1I$QL$ZF%6/<E)% !3L:WF.\<VGG;C[.AZ^;H"+
M">8DQOM3QT8O';"@N5C*X;#+R1MUCS#W)7E7R)B!',EC_*IXX,*.,9!)6V0N
M[*YLQJH#AINT 0G/$V.&D9^L@[56&U*<5[(V.45&^K[.E.[>9N$ KJO6A"W6
M*<SMZ]5*\&]G*E"V1!">\ED;NX2)NC:2//<G I9=VCK*AF);.JJBVT;@E<7:
MNG"HS8S6Q\[5VECN%V_[?F@4$\*O3"!D1X9)>K,:)1Z8](YL7NV3C+&;U,GC
MTD?M\G6@.0W]HNPN<B9TC16%HOZ^79P2$,-3HH]7;=-&:U7FR=VE<RAO?IZZ
MW43!5C2T/FU>6MJO%N2E-[82E;Y"U2N9I)5DV1(#LHOVEM7S<J'/$1J:ZGN%
M227[<*YD$W+05TC:*ZL?<^IAI<#ATN;E]CII&J5,B*?11PFKO#V:4Q]JP?6U
M,TNK\K,6$H -CN@&@&@&@&@&@&@&@&@&@/P1#$!RR$,<<0$<LA$    .1$1'
MH  '41'H : P&B;%V=\GVPPNJ8I(J5<-KK19K<PP=G*LW$J*!:U;VAC9#6P-
M3\LE)+JXR9ELIA+E"1F%V5'.()B5&"5<P*2L3P,8=OFQ_:5M?W9W#O#'<Y!W
M5X2,UDGFQI9E1=>L54L>XFPF29/KI-'B&(H\J=RW1]C:1GAKG*,6I'F6<]+%
M)<@F#T[R-4!?-HV2=F;''A_;V2"5"SO-^,TICQ#.@L]X2*'R,MTV33^=QJIF
M8J<8!#(PGGC FDDTC]1I(XS"]-6)\@199I1QP \(-'^S+EMQ8;E*YA.WUWL6
M>([-D2W<M&&V*D$@Z-RB+TM8*1RL8A2DR9Y?*BYXRQU>3AFG7RY*:0I6J%AF
M+2<H OY'V_:#6L3VY9-$LJR/Q"N8DX,VVMT<+21GMX1%-"\&9U&'OSW*E.4W
M1IX0DQ]8.BE=(3B6PG-T4+,<O2+! P7W?51M9@RBNJ.8H'>=:3R?2Z(N%;SB
MF:FG%D$.K_ $5Z3LB)H)0D<,7:/.C:PS2Z9([*85+(-+R69Z6I%$D/C2]5'7
M(#NZ<9-AE.L\9V^H8O/Y.T1*3PZJU%W/%?SE'6$LNF@'R8R9GC 3V.MS/7*:
M5QB>.DZ0D-<<2-L+)G(N%6ISSY,TIXFD J+9,.URS+HQN.JC9P@D#!M1I^ T
M5!)[5#W5V4+V>O:G-X@[A#U<D1B^62Q2B01TP#)6YO;DI9,&A$S>KF0UQ7K)
M('7JQ<N5L>P4Z6R!>K/B<Q<]SC],]O\ -T$3LE[DL/,=[ @DT46,#Y$62:FP
MVMW:61>I),T3>=L[''Y4[KV$4#T\J%Q9^1;]WC!5E@3#9(PY);!DS]7;LCDE
MUUI&'J8M,R2N[!';3JR-/<C@1\Y=4,C%FB9<*C[&O6*LGC-(D)(S3&O:526I
M+,T!XQO;YL2KIUB#(UH:U0NKTJ8YM7$=D5HN,@,/:4K)*:XBR.N(]+)FZE)J
MN;FFWI5&(M 8BA)K%L.GBHADCB=>ZD99 6T4M&TRAI+*X)%*)MZ=C2S 5/IG
M((EG/+?]X!]BQ156C+!052&>O,W5+U%4J'A2U02.-KG%JVKDLEW.(AQ<BBGK
MX"C8ENCV3U>3';1C57;@(LBM2A,I!F434MVN+2?MUI%FKUG(L^65Z5D[-1;#
M'XQ.H6S)[!51I3,':,DXLQCBN:V04:8"M$U7]G^AL:,[.VYF=2YQ+(>T[D8,
MF;9S<_K".QJ* ZPF''UW<"67@\UDF1L+A-6J"5S!IA&FX('C8R>/QW&+Y2HH
MX"W49SV#/L<"LZIHJS'1@<8^SM=+K(<U6573%<*K;$_S^SX=&=N]U/LL@K"=
M)(R^22QI'"W=#/HHEES,ID;FSR-^@[4M6( ,JJ;J+:=:U?L]L5M 4I\:L]1$
M9X)R\R5MCN+_  B^YIN/9B) SN;I@O8I-"MQ$TG<H>V!62F4MDM5.T;>$N;8
MW$LZ4"AML_9^P?;9<\ON=LG4FEKJ\1650&),;BW,[,R0>$3.P$MD/C"VM[*4
M0UE$>OVQGP;&^-M<2BK40C7+D<5PD,EE#X\\=>ODZJ"^L-VF;>*^315)#JR:
MF-/")-#9E%2B'.1'@SR:OZJSI&'.I.2QX4YG',=6&9P\@I5D>F/19"K6$*73
M^3]<@X9VSS;4H,5FGU2RG9+MR!6[I9Z5QD1F"C<80TI6,JSS2\GD2\G3%I1I
MD0M/<][6910#FRY&99YY 6GCG9C[#(JR6-&FC;3 \HY:D4S@<M8'@Z1R1E*@
MN4@PEA<*AS7(GQU15M$4LK*32EOC=<D11G;9(@;'U C3.C4VJDH'$S[+[8B9
M5ZFGL]O[/G!W"8+)Z\X93"QQEDBE+C&3H4Y.$HL?WX_1%E"=SA9YL/<FB02I
MR95\4R".JF\UG++1X 9UM;6W,C8W,K.A2MC0T(4C6UMJ$@M*A;FY G+2(4*-
M,3C@4G2I$Q12=.05CB6227@7ACCCB  !SM - - :ZS9#M$2.^X7;S]"Q_&"[
MA;P>JNO628$K/H=69?MTU$8Y6'$1=S)9A)\'!-549:2)L]QQJ;(5'UJI''6Y
M\]^:&4-C(!C:?V=6T-3OAK7=>FW 11O.C22(WE7U,M!=+MON]!5]0G5#'IR3
M/T"%/9,MK%DBF93FN7NKD]YJ'- UDN<V-B;.TQE#QN1N8&9RW:#L>(N>3[EE
M]>UXFM4DE184IERB6NB9G:%<KB2^%*+75Q/.2EP./RJ0PML=8[G:Q4>02AS9
M$+DC]\IR<A6&/(+=-56=FS#Y]MVF3#7]&.TNB,>>*_I>X4H,4U&&-&W^+N28
MUM=;27.;N:4Y5\QN[VU-3K)7A>_,1[F](R%Z)2O7^F NT_,6T&G(JS-#@=#&
M])6%FV'=\.B.<[-<)5C<*C"7S2:JXRU.TIS>GR5J1LJ2*BXGD8I1HRY4C2I&
MI"A%I+3@<I^K[:'>3\]1YZP@SU8<S9X)+G)B;IV>P6PRIZUQ<<(1*F,J+2=M
MF]>O,)RF3J@2RJ('1]U;LWU2@.=1Q5@5F!8^:5CV9V$ A2&6R.K"87A8,KJ9
MGDR:]9&0X2V?V:K2++%K.P+&8[ PDUDJ; 6,K:JLN&V=))(WR@UG:CYHW+?5
MC?DG=?&#-%VF='+6B<P-[EU5J&**-J")63#W*0Q/-LC#3+$>+4UQN;,2A8*=
MC0R1 KP;FYI?$J4EW2J<$J4A04=CAD!9."5ELOKN#9PB.+ZX6PO= C"/ID\S
MM1396=XLAL;R8D418'ZQ9A*GB;Q5OB1YK8P0]A<UT>8V14I)9&I"E6*?3 =:
M7M.V;2.)QV'X-:60MF)\ALEG=ANRQWB;/[<Y-+/"Y:YN5D96(IL&:0)RCJ>-
MPR2LC[)WJ"KH\@C,8=6PUK;&5 F XL3JC8DY+(7&H YU@>\M-C1^;P=O@]R+
M,9&-@4E3L:IM+DTY1R<8O;D$6I%!'8/,8N!BME=86K]S3EG<TKZN,< .TK1F
MV/4O%K$10B84^W1)X=0;+(SDEP(YNV)SF1$N9$<->'">S&1XQ^/1AO:79I9:
M^P4MT9BR5&[HFA@;2\' L0/*1N>TW<_!FZ7V"^H5$"@Y\\7N4?EEC/\ 7T2,
M985/7FN)0X6C!$<N8XI-:[PEL#<$:0JS&B00X_%'D84EP%4I+S YSA!MF:>W
MVZ]G)VJ])9JACQM%N=E-GXI&1>@;X6LBI5T%P;.6%0-Q>VZN$RZ+)[FSC*B1
MH($D/CQ,K)C:7)$4!1,>CNTP=QE9$L]='!-'F,SF[:5N!"^J'RM+/6/3W(W.
MPU#.^-,T=FZ4SJ-YV\_2%I+G+)[H;HS8,A7U.N4,R.98,@%3&4#LL=K#NI08
M@@CE.G6)S-#<L6RLQV5IXG'+>:B\+#>5-<#,#&"J%UGM27%3,IG'XY$GV9X%
MFN+R].)QAZDP#A7!7FQ#<)%JY4VZXTU.X>Y0VQ:OJUQ66BE2,L@A]N,[74]B
M1F).K-+F]-),)0W*V>&JLT"EQ<$RY:@2-RA&[*R<C0+53:8[$MV9#I0,\CA4
MMAM 6NIAJ.7B_&1=EK:R*MK=PD#J\1JS8K-V>=P)1$XP:\1%=*\5L;S7JCGR
M/D+75JS=31 I6;;3.R&GD1KZ,RJ/[8S(E3E>O#/$B6RVD,7*;:G6.C9(),T2
M=UC4[9ULRKET?9(V2"4-T\72",NSY*"WI[)5.4CS5+P+N,5;;#:\W S&]RXU
M *PMF&@Q5^,YDDHRB,.S"5U]7*=$?7D?=)017B=Q<X8K@$)<9-&XVVR)>E2M
MT44N"M#[F(4 5RBHS9,VW60K11ZH$U]H+@>MPA+;A)T7T0$UO6%6;A!WB>#&
M<GT7(%\GK9C="P39M8M"HAE62=*@];-9KP0!3,LI39C6\1*DIL30F,,3@+)3
MR.-Q*;RE7@\Q2F; REK#$<XDBF2=LF+W5<YP=7!$L>4KG*(;DKEC=@XH&]YD
M*!<!4,_?]H%9M<B7OKC#%2VH;7SO&019@E&+Y,HK:TT6*4JB7N$51O\ F\)%
M[B,_6K#$+@E+:BT#QDM);\",$V> %H[%:]@\.C%E6@Y,22<P*]8)<),Y>H+*
MY-8%>N$95NS*=<"2,M;/,5D/@SK-9,L;W.7JJY;X\[2N7->;W(5RB0M92W #
MQ3Q3L])/.W./R94SM]DR2O;*CC["[*MJ;I'R6P6 IGO;1-+$D4=?Y\H;Y')#
MHBV.D$*NE])66DX0 3T><KQ:2%Q"4#)!]H[;6N<WJ7NC:R-SO [0C5S222M\
M]?XTOB%CPJI6FOVA_D#LS2=L.8R,*4]6QM\8',]-&Y) G$TJ3M#LU/:W-:!C
M$?%>SSA]J[2V"+,$:D,ML%J1ME"(X'8:QWA#C%J09U.4=GC\R?1"30JP?H:@
M[%-,$F#JT3J=L#HYE9Q#,DIJ<E[.'53*"'P3:U!G*35G%BZT1/#'2%?UE-*_
M/E*)X<VJA:\3RXB!,LKBKR\N*M)#FM)/9<22Z/*##!V3/BDMS<' HM-B0!BN
M0;V>U%*:N9HTW%R8F:NT?NVN9BPS"97$E6N$"LNI=KT06H[%=)G)U9[)"9+N
M5B,6BL/P>E,0C+"Z24UG9$)+:M*S O\ 6+36SS<(Y2F?S485,LX0C502UG-C
MM)V9XV<RQ0Q6^+:]OQLA<P:(Q-8U&LG)R<5,%N%"_,3,0[O!AK.F3/+F"L#K
MUT%V0925XW0+WJIRQ0O2EBD4Z.M8M/52><$QH:F4JWZ/>^\NH\;22PU1]#'*
M4.3%]$%+%C<82#L6T#@V: ]<HBVR.J:F*J:>O-<-==4G$XQ;V$<GUD+9)((7
M :NG#78$.EIJZ42=XG^4(B<S8F;*/8'KE4=*P;VZ'H$QC0"=BR J6-;>J$L2
MK)8B-5%VU"[NLE;?:N;)9%DG<7.3N#LV.L(DD/F\!4L#HPJ*Y98]#8O74CB[
MJWR%A8H:P 6\FN:90N/ MBOVY]GZICAJQR)K8V-4(N?F:=/*JY7OW&V*7B5$
M3Z4QS<4_9ST,K!3N\U/*F,CC=]KI4C<I(LS?'1O/7KSU!X%F7]=V9TUBUDGS
MM&UQ*!V>IE%?V//9)-)C7S+9:Y]W5RB%+HV]3IKFK8Z28URO&%/IL:,5N)R=
MI@3BXI&16T5R^R-H, R&1QO:6OK/&CGR2.S+%EEGKH]%VZQK\L='8SI/XI)T
MJ1"MK.Q9+9RBU\3\'U(DQBI\/EJ4\"CA1MR=.2O4I#P.2EV\;*I*ZO-8LK?"
M%+Q'JMB5(2"N8G:+XA7L,%KMX1S6OT3M#8W,TI[3+:^>UZ62P6PU;:GLB&+'
M;-RCDJ;,W<\U4!5<:V5;8XEFTGLE7)L%K*]X29&Z.4HF[\\G23&QX!;IL@=7
ME]DKDZOKVMLNKX+,G1U>UC@N=GIB YS/5EN+N4O J1JVKT R2%ME356[8CD#
M/),)>VN6#E(,S4LC+E5Q3?!TP+-=S$^9N,JO^X'@"C2<TWIYNO)$GW*A9R&X
M#%M^[,JGG"Z*MLN/2!\A<+JY?3SVW5(PHD.+"O?J(?5<CKAQ5/1YF;BL-;W0
MQ"6K<9$1))44RH#XQ&I1&8R_21H=P-DV@&@&@&@&@&@&@&@&@&@ @ @(" "
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M!H!H!UY^#K\?/3C]WGY- - -  Y\_M: : : : : : : : : : : : : : :
M: : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
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M9G@9CB)R%6I39\X9 )1V8=.>0P6)K3/LEQV^T6:;%)GRH)*RYD"HD4*Q6F3
MK*KI]]#$L*[E5JFD<(UOMMUX+OVWW=:9MCMEGDV6*1:9,7%FRECO"R2HUAB9
M6>7''"O]F)2+!_X0#>AY;CK*'Q#^J:4 Z?#[B]OL\_@ =0[[)L051;TM*-E]
M]"ZOIDM6R2O10J/_ *1,<5;$][+I6<C(U%JLM?)5]V6;O9S;OMS=I;P*I@]A
MW5-Y=$7HN;"Z,#NO3GMRX6^!29R1">7@E*RR]S+D:947W<L>#B2Q'D $!V'"
MM^WO;;\LEFM5NGSI$<-HX\N-4XL7%L\Z.'C(V:10I$C+IT&^\&.,L57MC2Z+
M!>5_7A;;%/AMZSK//FPQRIBR[OM4R7QD2"%?O)D$,:9??(FQB47J7BV0T!;>
MXY\95526?9Q+5@^&UW7\OFY;*:MR;2W8R+,"][P;3'#%*NR0X+LD0)LE>*)6
M*<#!.!,<.'H\NK;;1ZDL=JM7%X_J:SSI_$?B\=94N*-(>,RMQEA9V5G=E,5?
MEY17/<M[WM#)2T179=ENO"&SQ3%DPSXK'9IMH25%-2"8LI)BRT@68DN-8$7C
M<2)F70W_ .'?D'_Z,#/_ -,*X?\ _673\/ECG_2-%^B845*JGJQ=C_U>M/VL
M5Z7[H*V_ZIV7^_)W_P"'5N<N?2?;-O=NV_656G;=VIA)L*<QF'&/95IK',UI
MPD+NE:\G#!NSKU!BMR2 H$[%+DM2@>.'HQ/*Y[X=N[\>16ZW6.Q+=D,KU5:)
M,A9GJI8^)V6*&'C)#V!.,W&56>%*)6K&5N'APM=]7W=-TQ89LUG@O*\+)88K
M1#?$V;%(2TSX)*S$DK=<KLBP<98D@69!QEA;C0NYO=U(I84: : : : : : :
M : : ]?H2N\7GZ(OOE=\"L^YCWBP,  , O+CG#O@ !GW1#O  =[GC0'Z6665
M@!91>!6 #D(8%X8X8 .>0YYB&.(  #EGEEED/'.660Y#R(B.@+1TA])KW]E_
M<#Y_\_-D?N^6@+OZ Z]V=VI@;%[T^.2!G9VM*<N<G5T5D(&YO1)\!,/5K5BH
MPI.F3$EXCF:<<9@67B Y99  <Z_.=.E6>5,GSYLN3)E013)LV;'#+ERY<"*L
M4<R.-4A@@A1%6**)41$1U4_*?/D663-M%IG2K/9Y$$4V=/G3(94J5+@18HYD
MR9&L,$$$*(JQ11*B(B.JEI_Q1^WS^[A4O_2'%/X5UB?9)AW].W/_ 'G8_P#.
M,'[+L*_ZR7%_>UA_SRZ;(^,LE:D3['79M?61R)]T-SNT+4SBVKB._D7Z9&N2
M&')E)7?PSP](29GCWL,L>><1 ,K(GR+3*ES[-.E6B1-AXTJ=)F0S94R%U3C0
M3(%B@CA=%K"JIO,U9K39[9(EVFR3Y-JLTZ'CR;19YD$Z3-A=4XTN;+6*".%T
M5'AB5'14T.UU^I^XT T T T T T T!BCN>W8QC:]A"\Y'%7^3>_7-_P1@QJ&
MU/[B%@!G$\5(N!Y/>]T>N2@)]%WN[Z$SO\<X<ZIB?%EEPNEB6U66TVKU<MH2
M#U.LE.)ZF[ L7'[+'!VW9X6XKMQ8E5J&D8RQO8\&I=ZVNQ6JV>N*VI)?J:.3
M#V/U+ZGX_'[+%"_&]40\7BOVL3M1\?*\[36N[$G<-@:"M9NWK9E)6:-)%ZQ<
MPYI$:AZ<"&\I2IP(5Y'9$$YG@89B5CD9EAB(8 .7 :P%W\)EVWC;[%8)=V6^
M7';;3(LL$R.*S++@BGS(9<,<?$FQ1<5%B=6159%9#5KJX8;JO6\K!=DNY[RD
MS+PMEGL<$V9-LBP2X[3.@DPQQI#-6)885C2*)(75J(BK0V8ZDHF : : \#!$
M,,QQ_H@PR$.G/4 $0Z>?7RUPN2ML.%R5MA#V=>T<[6%.ZN2=*Y3L$Q+BM)3]
MW;A%3<0(*4&X$\&#6N0YX^CQQ[N8Y".?01R'O<C$RXAQ1QE1(IV:HGX!*VT_
MD&_9N*\3,98]AF1HDRU\5(XTA:YK.RHD2HE5L*TR9=<W=678+V86[W?7>>X]
MSA>Y!9*%%?$U?*'Y-@\5 QP5($D0/D32MP@]MT-8#S#@1.+H&" 5V19^(YFY
M)S!3XYEYW#M[7Y;;Q23;UF>I^P3(E2*RP24X\/%XKQI*A5%S5$=EKS&VX(Q#
MBF]+YF6:^8YZV1+#/FHDV[Y-EA[-!-L\,"I-EV62JJT<:<18U14=658:;5=U
M57SB='4!.(+&([8RVA;Q2VVY53*7DB/-T_0!6EDUZ0#0\KF]S9D,W@SM/6VR
M(-E(TN+"HD,23(SW.,.:EIF4:WTELP,9Z"[2W.=TX[G6BWL-?H9D[O[['<':
M.M$HC36NW#RR<2 FPDM,X5)3T^=[!HUUC\%<%&=86=BQS1"^OS KC4G?S;93
M@<E7MBW[1N!,4;:[9L6?Y#7J;)QQ5;F93&)DCW'NU.P)D)M)58RME>7!;4D1
MM=CG,A>Z:(2J8,[8S)$[-=;O;/'PKUR N*V[6=WZ:2L\Y=-P-B.<KPGTFE3^
M@(N&8(:V5$)]WD;D$,0MU:8G91M)%_Q)>4VAKG"\B#&=2[O247/!PE;%$IA&
MP*.KK;/OK>=F^]BF]P]AM,]M.Y]O\TK* G!)7E3&UMH2.J9[%)/.&UPE,CGB
MN)1*>21_C!Z"/H4T-B482,R@QCIB"XGN!#Z!U]X[==YELUTXPE,%B*&A\K^P
MH8D9I)N'A4+6M4TD2Z.FE3BQQINO(W$[5K]QA@R.%H($Z,:@QE<R3E*IN4'2
MU#/:W Z22[0]YS?);2DM=R-4VS6<5BK)8IEE<C]C&H[-&6,[Q&&*-S? UQRM
M@CS@2\6;04F1R>.1A-BD-8I>H4J<'16[^^<"@-WD<W7TH9*H=![&OZ=-\F;)
MZEVKM<=MBYLY\SV [1"@R$$@G<S9X3)T=F)B['/N$IAK"P9<E:HZQ/.#FA:$
ML(1FS"D@,[K"I.WU^]5QMEE)FAM2S:D=O]5R#.#V' X=F0L@%E[E7R6JI.F?
M(DX6#[D11^XV!9'7*K9G$)%BL)>L"5J=Q2M*LL#".H>S]W7455C2T5E+SF6;
MA :*893DKO&?/8..->;6(!6$[CL/?)7[["Z]7OLO9I<P0Z6QQG2A$D"N*OB1
M#@V15E9&X"J+)VW]HLYYEGTQ.W"LHNXR1T4HXQ++IEUB6/%CCH1 F>NI1(;'
M)ED6639+ 'YHG2F21:;2&V8P[E25G+>H5<A$?3CF!=%\VY[S6I2M<4MEV-/H
MS)YX[2BU($BW#RF%2B1QKZ(^X-7%8K3\VP!/G3!;%%)=09[FBAKK"T,H8ZR=
M(N\N1[R].CX] 7<V5I[W73O<$ILR:R625?7LO^A92HR!S?G-?(,E2I9:EF2!
MW>7IC8!FB>OY'/VS;5#)66C,Q7-%$/#R*@5TI="2@-A>@&@&@&@&@&@&@&@&
M@&@&@&@&@&@&@&@+44Q])[O]E6]_V\+$Y^WH#"OM3KVM?;WMZC$UIZ7'0R3K
M[8C\<5NA#4PO&1S*LC$R<%*$4LA:W=%AB:K:T)HG%IL%. D!C@=B7F;@9JF,
M+QMEUW5!:;#.61.6V2I2QI!+C58(Y4Z)4:9#'#VT$*NSTSS18LX7+_OG#F&[
M);KDMT5WVJ9?-FLTR=!)LL]8I$=DMTR*7Q+7(M$M$6.3+BXR0)&BPHB1,L2+
M'Z'M0]]H (?1^<?/@0@E6^7/_P Q^.0X'H/C\W$9^R_$>MX*F5%D6:KJRU[#
M]2YE<5X5N$)/^TT]Z_DZY52F:=S6=DVI5]YLW[*O>1N3W#7Y,H=<EFJYI&VN
MIGF1H&P^-PQGQ3O266PQM(7 ICD<:%A@X(71P( DU28FR!0.>9.1I969>VX-
MOZ];TO&T2+?:EGRH+'%-A@[%)@1(^S2(4B>7+@56ACB1E5JZK4E3@BQMBG$>
M);;8;\OB;>%DEW+:;5+DQV2[I"06B7;KNE03>/9+)9YBJDN=-A2&*.*!>.JK
M#QH85AW\ZDHL:- 8%=IY]0M?G]ZHA^V+$-:WB[D[>;Y=CD?.I!'G"MR Q%\C
M8OI.Q==>;5(9?3IY\#[/C#V#QU#VAQ[?; R4R='RVZ+T*M&HKT3>M('1=<E1
MZ:Y:HNO[S8AV5/U==+]/]RL'K_\ =K+OEUM&#*8CL-7=+52O]4G*FW)*5WH2
M7P1?P@7'LXMY;&[EVSI_<3&=3J77&@,==WWU*.Y?[ MM_L#?M8V^>Y%Z>#[9
M\WF=?/0UC&W(W%?ZN7U]&VD@P>''3CK[> Z_!Y\]/E'5=*J]4R6F:KNHJ[,]
M61Z,4%R;2K9LFNE'YC)C9CQ^*VVV#T'^;;6W'/AQ[ZVSX?,0^ !Z>S67P^_K
MY=*Y>Z-F=%S]^AZ5HJ57)=CH;1@CECA=<_=ZZE3_ *V3O\>3I2I.1U88OR-
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ME_<%^WS9.@+OZ Q\W8=-M%Z?8PEWZT*=:]BSDS?W@JV^@C-6QO3"&)/ UO\
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MZ>_99U_^J(PXX]GSATZ^W428R5?91?:9)ZLCJ[*GWD#-5-5V)14>BHI#F/\
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MZ;'R9$=ZD080Y5X;S[N77E7^>R>JDL;5KR[PT T T T T T T T T T T T
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M2)O70%Q6D)WTLE9:]^J2L%D7DK<LP+.O>Q\\<53>O:$R]"?B \&I5J9.I)R
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MVX_]ZVL>@@(\>P?'CV=.N8P_W=NG7W0LVU&]N3-\]N;YHKFTX(Y8X6JR)?\
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M?A4NBZ:KE5G<B#"'*O#?ARZ\^_)/5-Y+'U; N\- - - - - - - - - - -
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M,6#F>RM[FO=7%"U&K .S0)%SFX*TZ;(LI0L4FXY'9@=SH!H"T%(?2:]_9?W
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M.$.5>&_#EU^2V25WDL;5L"[HT T T T T T T T T T T T T T T T T T
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MOE4DG,JDD@]1L<7(<WV42YT>'QS4(HQ&(Y'4/NE;G@D9F-M1$X8X)^<@./3
M8^\]V_&ATM6]PXX#P"\+$ /N?)H/(:T.VU  VHPSH ?S<XMU#IQ_L+L+V?\
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MPM]K<#[;T\UW[TYUSH]#=.'/+#//?'_TPUG[8P#\451H^VUH(/MZ#)&[S^(
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M@@@A18HHXE5(888455541$5:$*?UHV?71M\?S<D\/9_3O'_7TZ#JOWK?>#?
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M_P!)T)_AO6RFVD)[M 0&4;S]QDBC/=D3 [6.XK&E\8AQ=VAS29I$..*IO<D
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MQ9URS))BJR3*,4^2@"P/$@X"AR$K/NV?+CE:: : : : : : : : : : : :
M: : : : : : : : : : : : : : : : : : : : Z*41EAFD:D4.E36E?(O+
M&)WC,D95V.6:)X87YO4-;PUK,,,L,LTK@WJE"11CCGCED4=F&.6(B @!1=8T
M]"ZF:GMLC.#ZXGR>0C*I0_3&2/<TD\DD&+ Q1-,Y/4@DBUQ<EIZ&*Q>-QQ$&
M1V)9#4R("0P$W$XXX"Y'N-)^94WZ 5_FZ _?<:0/!*F#_P!05_FZ _?<J7\S
M$?H)?^;H#\%(E'Q3)Q\^I)8]?;_0Z >XTGYE3?H!7^;H#\]QH_S*F_0"O\S0
M $:0.H)4P#[0(*_S= ?ON1+^9D_Z"7_FZ "D2CXIDX_&26/_ /;H#\]QH_S*
MF_0"O\S0#W&D_,J;] *_S= /<:3\RIOT K_-T!Y>Y4OYF(_02_\ -^$= ?GN
M1+QQ[F3\>ST)?'_5T ]QI/S*F_0"O\W0'MP++*Q[I>&!>///=PQQPQY'Q'C$
M #GY- >>@&@&@&@&@&@&@&@.J?6-GD[(\1N0MJ1X8)"U.#&^-#@3@H0.K.[)
M#D#DVK4^8#@>D7(E!Z523F X&DFYX9 (9#H"@JIIJ!4PSO#+!D;WB7(7LN1R
M!TE,OED]DKZ\)X^PQ)"L>)3.'J02)QR;8K%XY'&TM4YF%(6=D;T:<LO D1R
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M:UI4EJ^+V018;^C<L(Y-<H)#'5[?'*.^K3W(I\Q$\E(2FS;6IL2Y'F+0,J=
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MYDW(6]I;BST,>S6KDX+/7CJI: : ,O- - - - - - - - - - - - - - -
M- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
M- <-8W-[C[D%P0HUPH%A+BA%8E(4^XG!,&8)UR3TV&?N=80!A@$JB>X>4!F8
M89XAGER!S- - - - - - - - - - - - - - - - - - - - - - - - - -
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
( - - - ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>g425213g18a19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g18a19.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1^X4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'YR^@)(X0DE-! 0      %H< 5H  QLE1QP"   "   < E  "')R,S<W
M,#$S' (% #E-:6-R;W-O9G0@4&]W97)0;VEN=" M($=R87!H:6-S(&9O<B!"
M=7-I;F5S<R!396-T:6]N+G!P='@X0DE-!"4      !#SCLQI\4MJV5.RR_8]
M[#?<.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M             #^    X0DE- _(       H  /_______P  .$))300-
M   $     #A"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))301$       0
M     @   D    )      #A"24T$'@      !      X0DE-!!H      T$
M   &              (6   "50    8 9P Q #@ 80 Q #D    !
M                  $              E4   (6
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<   (6     %)G:'1L;VYG   "
M50    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG   "%@    !29VAT;&]N9P   E4    #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M   X0DE-!!$       $! #A"24T$%       !     <X0DE-! P     %.,
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
M @,$!08'" D*"Q   00! P($ @4'!@@% PPS 0 "$0,$(1(Q!4%181,B<8$R
M!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5
MXF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7
MI[?'U^?W$0 " @$"! 0#! 4&!P<&!34!  (1 R$Q$@1!46%Q(A,%,H&1%*&Q
M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S
MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_
MV@ , P$  A$#$0 _ /55E6?6+%9F,Q/1M)LL=56\>G[W5G9D&G'];[=?7CO_
M )^RG%L97_Q:U5Q.+16/K &UTU^L[/>_(PSZYM:VNS-MHSFN?:W'QL#9E,SO
MYFZC+ZAG74_HKO224[?6\+J5N3ZV(;WTFAK+J:KO3W;<C'ML92W?5LR+L/[9
M5Z^^O_1^O2JW1,+ZP599=ENM:?1>#;=;ZU1DT?8JA0VW=Z^+4S)KRKOT7K6_
MI?6R?5_1](DDIJX^1;&3]J<S]6?M+V-+1M].N_=L<ZWZ/J?OJN/K%T0B?M;-
M?C_<I._FNJ?UC_[;T+@F?0'P"FPXHS!LG3L@E])HOJR*674N#ZK!N8X<$%$6
M <B_&^J%=U#S7:RJO:\02)<QOYP<WZ)6 [KW6@TD9C_\UG_I-*. RNB-"8ZJ
MM[Y)4>K]4;TO%9D.K-H<\5[00.0YV[7^HLS'^MU=^150,5[3=8VO<7MTWD,W
M?BF#'.0L#1+T*'?D48U1NR+&4U-C=98X-:).ULO?#?I(BP_KK_XF\KXU?^?:
MD(1XI1CW("BWOVYT3_RPQ?\ MZO_ ,FKR\8L V'3LO2_K7US,Z-BX]V(RM[K
MK?3<+0XB-KG^W8YG[JGR\OPF$8FS.]_ZJT2NW<27#].^N_6,KJ.+BV4XXKON
M96\M:_< XP=LVGW+L,GJ&!B.:W*R:J'/!+6VO:PD#DMWEJBGBG @$:GMJD$%
ML)*K1U3IF1:*<?+HNM=);778QSC',-:[<K29PFZHVE__T.PZID]6'UDKQ<"Y
M^,;*V[*WL-U-T"^RRRX/=6W%HQME55K\5_VJVS)H]3_!>J&GI.WZU>OE5].]
M9MK\C&JJ<:K6UO\ 59]K=CBG]>S;/\-?=D^C3_@*JK/TEK7Y%#OKUB^F!;ZM
M,!X=2\35]IJL+'/JLOI])SK:K:Z<JFRRS_!?H\CU)=4Z;F]7Z[5]IZ;8[IS
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M6P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M)"=55Y:DM=$9&B@R5%AETD=F9Y.7U=?_Q  < 0$  @,! 0$
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M/1OWE!S5%!-,DVT%(\1-1$ $! 0 0$-! 0U 0[A[P]6"+:!J Z!J " #H&H
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MLUUUWTQ8N"P.$Z,X\)A1C4N$U60>$:S+*:^6P5996531H<-/;-TQ/F1[=O\
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M]1[:&I)=KM.2&R"3?0CM-A15[KP;]HE8O"L$PO$7.T/-[E4<(/(4+,-#)\&
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4;E7S2DYEDGK3Z*+;!%L$6P1?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>g425213g18b20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g18b20.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1O@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &\2^<0@X0DE-! 0      %H< 5H  QLE1QP"   "   < E  "')R,S<W
M,#$S' (% #E-:6-R;W-O9G0@4&]W97)0;VEN=" M($=R87!H:6-S(&9O<B!"
M=7-I;F5S<R!396-T:6]N+G!P='@X0DE-!"4      !#SCLQI\4MJV5.RR_8]
M[#?<.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M             #^    X0DE- _(       H  /_______P  .$))300-
M   $     #A"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))301$       0
M     @   D    )      #A"24T$'@      !      X0DE-!!H      T$
M   &              *.   "7P    8 9P Q #@ 8@ R #     !
M                  $              E\   *.
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<   *.     %)G:'1L;VYG   "
M7P    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG   "C@    !29VAT;&]N9P   E\    #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M   X0DE-!!$       $! #A"24T$%       !     PX0DE-! P     $0P
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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MWZ-EN0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M@FQ"81_,HGYG0R^8N009K,B3R'PQL+D5 OE<+$"94 4 4 4 4 4 4 4 4 4
M4 4 4 4 4 4!YA#A0(T7)"FBP9PV&8%*%!!PL#1H(IWGPL4N!EE84<,MX07\
M(S"PRQ![^#WR^/?<.Z C[Y/%4MDO%3/#"ER2<UG">.#@KP36& *E$DV8,#!.
M<<T1 ;@H80>>8:\,=)A)&>-E 0T7P+W%P R<T"35JKDEPC!K,GH$A1V IMQ3
M68DEF.)2:>H>*HC?3:>)J-I,3IK>D2Z9TR;V@Z'&T!T-+L%IP-V.X%W-CC/;
MS6F<JYJH&QE % 5% /F1B?\ (!K?Q05H"W: * * * * * * * * * * * *
M* * * RPZ3).CESXP<RYM>2%#D-JQN2UM<G@Z@-;!VLA[MM&;MV"T8ME-V-!
M]EX>D:1;*KE"1G,@(!=]'R395$Y@KZ<\/$R>M 2ME1(M+6BG$S)\N:FV\TG+
M'Z7+R@RG"X6\[)FCQBK<&H0CVT[/A_RHTEE8E($@X\WDIG5M_D$UW"**L"W5
M)4+HZ$7!R ]F@-+TJ'"CI?VG#58OZI3Z[&T'-5P''A-C0F%VQRQ6D4?A^,&N
MLEV^5++;,,FLW4]1CY)V6R5E=;)*I@UF*JD5<80#1B@"@*B@'S(Q/^0#6_B@
MK0%NT 4 4 4!AGTEKL=2#.C:*(;F<*,5$C-&,"%DI944XN(/DXW2'D/F"3,@
MAY"Y8!!X9"98WSOB'AC>]\<<;6Y%I]4U,%L4[8:F>)BV?$Y61321M5RU%4BN
M5K'(BK<U$O5+[DNON*S:Y;0KZ32:BCI:VKIHW6-3O<R"HEB8KUJZU%<K8WM:
MKE1$1777JB(E]R()S#$@OPY,$4%3;W=QDL9DACES!8PY%D8 < 9SI88P(P0I
MS+ 4(0//(,3#/&^.6&66&5KVO>U:M9-;6OM6S6NK*IS76A1M<UU1,K7-=41H
MK517W*BHJHJ+L7L.>:-VO:LFD-A,DM.T'L?;-F->QU94.:YKJR%'-<U9%16J
MBJBM5%146Y4.I*K#%W H H H H H H H H H#)WI,UI33'1I8(IH83Q^$+S<
M37-Q"I*\RH[><63Y<451JW)&6S</*"2.7"CQ]OIHM@$XYS2HF!?&L.53&NJ+
MYY-5VZ [C(7;R#I0:#EC15&2KO?3R@+L?K;2*'U<PFW<L;%#[456P0?PJ2J*
M@Q.YT@;12CU&33YW,,L"XQ29@4YD&!G?T22A(.0<V-&393#57E&A9LM=>A!7
MD740^I'C<9T2]J3EU(?4DDM2[%CY]H"J_6[)22P4,^G)SL;KS0H1+.%,DYY$
M<B!!K@;+4 4!44 ^9&)_R :W\4%: MV@"@/F9+2-AEEAFK)F&>&66.>.1\KC
MEAEC?;+'+&XMKXY8WX96O:U[7X7MO7Q\I&G.]G^IO[3"M33HJHL\**BJBHLK
M$5%1;E145VQ478J+S*?V+J2<<$N$4/DC0ML;YW#+F@!Q+86OC:^=\ A,LK8V
MOEC:^5[;6OEC:]][VK]1['+<US56Z^Y'(JW=MR+S;4^T^F2Q2*K62QO5$O5&
M/:Y439M5$55NVIM^M.TP?Z43S^-;T1:B[[;_ -DSM[/H^BN.ZP]\TV&PYFK*
MO:[>*:'!*?.5PE<'^>B(NWXSF'RZOVU)5_HWW^G;G?;>M4L?>UEXC19F(YQH
MQQ)H_C5EYV ZP:L>7L"@"@"@"@"@"@"@"@"@,=NDY9S%=!R+F[J"EQCQ?$ZT
MZ7>]&W*<CHR,W6O&KF8;78!AJQ:"_<3::J#.63W477'DB)QA;3<EX!M*R073
M7*>;;:1#X#/%B<YO?1UISPB%FI;)<Z_%L7#/6.7 [DV!L&RV%J(LRRRQN[+:
M=9NP;AQNK"BED<&XW6(R3:..D8AD' CDDX=O+ 'S-!&G24]-C9?#.?24RT!L
M'3+=/L]%9+GB5PD\5/\ ;!=X+"IC%NB71UGBMK0@Z".I+3ISDU5<1D 0UX8V
MS!90%= %*SR_]3N4\2VWDU$D\>+.^10T "$<-"9$U9:T*I:K'SXFR9VR_P!N
ME,F>[WJ]DMPON)TYEL(R-.;7NT$)=CT$ X*ZN^O/GS]@\W^?.P;" SLTA1 B
M9$D41;!S>DP8MP6<'2_VR_@HK"E1V80ODNXKS,=+U/*8\96;V1D9_P"1)[V+
MX$1'9X4Y#"OF$V]7PO\ %!^HM73Q<QE!,09&PP0C>4<M&YH(L-F8+A&;HI.X
MX9<<4 L*.!@+W>(0PA8N(*';'/, '+*X>(%QT 4!R;3 ():690_9YVM:0WIP
M[J^]MG(I<-N7H_DJMMJ;SM+$*W-2E$=(G.32"W+G.WO:/6O_ !<R?#9ZAYNB
MXRSRG9Y=UEEE\E*MPO>][>5C.XVWK;M7F^:K#9<S2'3M2"JNDUIHJJJ?D*;G
M7_R%G'EZ4.WR^-?KWBU%O]3E=O\ )36'OFFPV',U9BUV\4T."4^<KA*X/\]$
M17Y_*:PN/K=25]/Z]=:I8^]K+Q&BS,1SC1CB31_&K+SL!U@U8\O8% % % %
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M2$BN\/4_'D;OU.N^6;*[/8*"H)Z>Z$-R(T+@&\'PI&20C;:($FU#(D@.N>I
M%9C-U%H"4UB\?7=JHW!Y=%)3LU##@BP_)[5CY0(+(,=--I-B(DMX$DU%0ATV
M2'[,2XO7;X;8S(&S\H -GI_1)@)Q$CEP#^#5#R>\P'VZCRRVW4Z'<G1>JRL[
M5&'4E1L.^&^M(QE)C8RWBET5Q"'EQ()V3T15P3U)*.EK@?!/V'QT#G,30@0I
MG'368L8% "S  $'LQL[#" @"#&1 0<Q.ZR#!S,&,PL+XX9#BY8W$RB;>W):^
M&UN7D-;TQX4TCP6TLK*<WM[\;\^%M^6_'LY?3SM?CV574HV;R]%QYBWC[4%3
MW8:U=BU=[GJ\2DRM(6EU)<+5V-U&3H3&"8;_ "M2AU_*(]/I_;(I^JUO7?U;
M6X5RNU-YVEB%;FI2N>D?$%N8O:6<F'FZ+;C.SSX[_)2K>]C-_7]%;=J\WS4X
M;-F:0Z=J/XFM/ IOQ"SCS]*);Y?&OU?)<B7X<;^4KL^W]'5QIK"WS38;#F:L
MQZ[>*:'!*?.5PE<'^>B(N?G.8?/\JDK\W*M4L?>UEXC19F(YQHQQ)H_C5EYV
M ZP:L>7L"@"@"@%MG2_X10=N?@1K_2 [7]/743:7THNZ[XH2%#^<]A4#<\H4
M._"VRLG;\>TX#?LMZ]]]K\;VYWO4?'?\I'_F,]M[D3JZ_LVW=5Y[9.CD[CON
MJ,[,?D6-S_&)'E_A"?KROZM^-3-?T'OM\2*INE3NKX>>KUBD7Z]M_LX6M?C:
MVVU^SLWMMQWMM4(3 [; \C&Y\VA?>SK8*7T>+N^*D+4=-)WE)A7H,)D1TH1-
M'/O+204.($?R"HGWNX&V#&<PZ>&KJ.B@ZF2*\(9B>\B+[5>NH?3NC(B^PGD_
MV(D(#@2EEW.T!+?KJ+D&R"UQGFO) %VO!#(S/I!TTS;&CS*QF2BAF,'5"P3K
M3A,BIHPB&7T_NI-*M]$@X=Z#@(I,1I/XX(UF<4?"N,V%,BAIA5<5[D+'3 $%
MZ/11DR3GC+VHR4W@W7>KR=$VFYJMLPVS<."E2S'9BK/;X0;G2L12+))8!3,F
MIE5\C(ZDLV(F0P@ D$4_@34C5P-1* * 356_<'*?\'$[[DBU$V]N2U\-K<O(
M:WICPII'@MI964YN.W?LV[>'';AQ[?KMRJNI1LWEZ+CS%O'VH*?NPU:[%J[W
M/5XE)E:0M+J2X6KL;J,G0F,$P^=N4+=DB/3T</A(I]6W7V=7HO7*[4WG:6(5
MN:E*YZ1\06YB]I9R8>?HMO/L\_92K?:[6=P^CU5MVKS?-3ALN9I#IVH_B:T\
M"F_$+./-THEOE\:_#_HN1+V_RE=EM^7#T]?.]-8>^:;#8<S5F/7;Q30X)3YR
MN$LA#ST1'[3F%[U)7Z_3:M4L?>UEXC19F(YQHQQ)H_C5EYV ZP*L>7L"@%S<
MTL.1'<"NEEBZ9D 1/#EP;B@#9"Y!AY;8WSO8?"U\OZZ]K6M?T5$S5LT<KV(C
M+FN5$O:M]R>IQ(14K'QL>O*O<B*OSKNO;_97V>)]R/9'7'2O9)B@"0# L2',
M=T6!%#$[L*X5L;;YBYV[F_=WWMMOU<[7K)2U<LTO(>C$3DN7YJ*BWI=VJO:?
M%13LB8CFWWJZ[:MZ7?8GG[".3K^,$'LL2-;\-[_\/A^C?CSM6.TOIQ=UWQ0^
MZ'\Y[//P*?;?E"A[;6_"R;Z?^>!7[>.W*_/EU=4?'TD?^9'S=]/CYO/;)T<G
M<=]U1GID\BAOG$C]X3E_LJ9K_1_?;XD52]+[J^'/V"D7OQQO:^_T7MO?U>G>
M_&UMM^=0GGSYZB8'<8'D8W/FT+[V=;!2^CQ=WQ4A:CII.\OZB85Z#"88ZY7+
M$LL/23X)UAZAX@@)D1E/K#E*.&W),3Z>'N]Y1T_!Z4P2UC<$(>HZ+)H;<@OM
M0U<.E80%?)GL)>?!1"8?Q<)J:F&) 3#;E =514!1>CZC1[:JY#<^FQ0;^GR,
M'MJ!5V<,TH_,-MQ!QNE?#]EFDQ70%QM)R4,Y% ^AV:)1+Q#%.AIZ&F[8W"+C
M 0SH_"&C]%5)53=)\NCS&"I->)'2\UY/O&2JUT<%7&D<)K((;CBQD--)Q=X(
M9-;..5JK9I06D$@;;ASP1. 6<LSH&EE % )JK?N#E/\ @XG?<D6HFWMR6OAM
M;EY#6],>%-(\%M+*RG-Q?;[+_5PW]/Z^JJZE&S>7HN/,6\?:@J>[#6KL6KO<
M]7B4F5I"TNI+A:NQNHR="8OS!QEJ4-_[8;T]?%R*7'?\^U^._'JWY7:F\[2Q
M"MS4I7/2/B"W,7M+.3#T=%MY]GG[*5:_UNUG=6W^WMK;M7F^:G#9LS2'3M1_
M$UIX%-^(6<>;I0_/XU_9<B^\KMM^?M]7936%OFFPV',U9CUV\4T."4^<KA+(
M0\]$1^T]A>]*36J6/O:R\1HLS$<XT8XDT?QJR\[ =8%6/+V!0"1/W;X9./EP
M536]O1?.WVW]/"_'?AO6O5/I$O?4FJ?H8^Z2V%]_A?ERV\5'.5O_ !@6MQX]
M5NWU]59J#TCW'>!AK>B3O)X^>;^/WIUOLH(/^)&_K[_AM_-ROUWM:LMI?3B[
MKOBACH>:3W?$I]N>4"'OM;\+IVUM^/\ QP+AO;C;;C;EM;J]'@C7^LC7_N,[
M.MR;=O/ZNOF/;)T<G<=]U1GIC\BA_G C]X3GZ*F*_H/?;XD53=*G-S+S^'GF
MO%&WVVOM;:]]]K6X<>>U^>_9QYVO;;;:H3J\I\.;V$P.ZP/(QN?-H7WLZV"D
M]'B[OBI"U'32=Y285Z#"?P%*EA\P!1RX PA42XQ404$,3,L-?#(.XH&>>.60
M(EP\\P[YAWQROAEEC>_<Y7M<" 3"$*-$<I@@+B*V!Q8Y>X0+E<EB5VZWA1&R
MIXAKB_92(JB==%2<[V/JME!-425R)<?PLB; [X7$ SJZ+.0R3U8R^ -BH@.,
M!EQ^>5,535!K1GT=3P1WG-,1JJ\49NL*)8B.0TF&I"B20$XHC,9#MX]"2\,7
M$GI2:@,H54 U;H H!-5;]P<I_P '$[[DBU$V]N2U\-K<O(:WICPII'@MI964
MYN.';MZN6^_;MSO?A>V_T574HV;R]%QYBWC[4%3W8:U=BU=[GJ\2DRM(6EU)
M<+5V-U&3H3%^8;_*U*'+?XPWIM;?AO\ "13V^OU[<.%<KM3>=I8A6YJ4KGI'
MQ!;F+VEG)AZ.BV\^SS]E*M[V,[\W*MNU>;YJ<-ES-(=.U'\36G@4WXA9QYNE
M#\_C7]EJ+[RNWT\/L[?6UA[YIL-AS-68]=O%-#@E/G*X2N$//1$5_P"^<P_3
M^^I*Y7[.'\VVU:I8^]K+Q&BS,1SC1CB31_&K+SL!U@U8\O8% )"_O+)Q<-_P
MJ:MU=>5N6_#AZ>'&WT:]4]/-=_?<35/T,?=\5)="^UW?E?K\5G-^._&^8'9Z
MOYJS4'I'N.\##6]$G>0^].M]E%!Z_P"HC7#_ -?#ESXVOMS]7.]JRVE].+NN
M^*&.A_.>PI]N6O9P(7SNG<-^7]5A==MNNW5;MOQVM>H^.[Y2._JD9]?]M/'9
M=]JIU>V3HY.X[[JC/3'O\"QMM_QB1^\)P]5_I]53-?T'OM\2*INE3ZT6Z_SV
M"C;[WMO>^UKVOU<^'IX;]5N.W'E;>H0F!W6!Y&-SYM"^]G6P4OH\7=\5(6HZ
M:3O*3"O080H"MYD'N6B&53-BK7.W+QN^1[$WQ@(*RC=PFPJ">"O ,' 441KC
M]SWIP8!!B"9I.9O'##/*]L;@9R=&3$P<>B/Y>;$.2C&D=.R*8*R++DUO%9>C
MX=,I#N"<9 EHHTE)9F28\@H:35.2T5PM'%'4B+:4'B])%7$53>&2L>7+ /?J
M1;3I=\1+3=:)-84CI]R1MDNI#?6<6^MKL>DI-9ZA*C>2U;)41+ECK@C,J[44
M'#!83!C>9ZQ( ^5&,!C8 0B#F9,S8BM+0"ZFC,S$D^)A,(2#(:$K2&LH\9JD
MJ.M3B!OW4$>2T3%/NWXX-(*;XL-*"Z.F% R"+F8+#(XX8S;U?"_Q0>?/E#\&
M(2E\U# \+B2G&V*0880K!S6,(==%E+$B*D9)&1_ +*;<BUC5@LKC8X98Y!=\
MVQO:^->6MI4K:.JHW/5C*JGFIW/:V]S&S1NC5R(JW*K4=>B+L54(^UK/;:MF
M6A9CY'0LM"CJ*-TK6H]T;:B)T2O:U51'.:CN4B*J(JIM40K_ ')9QW_ZQJ)>
MW/S)GOHOYY*T+^CFC_Q*I_\ 3%^\<9_H+LW_ !^N_P!G!_\ 4<S3KIGE33DS
MU5FMZ78_<)-5<)AQ"FUJ''&"9",&$].3LBX>)&:P@K@XAIH8ELLL;B7S$SM>
M_<VQM6UV#8D=A4DM+%.^=LM0ZH5\C&M5%='''R41JJER)&BW_6J?6=)T.T3@
MT/LV>S8*R6M9-6/K%EFB9$YKI(88E8C6.<BM1(4<B[%O<J=2"H.KHM72ZG.X
MG,:U#MXJ:<:VK+QDJ!"JCD 7&5CY@^,"!<29+B7 "$,9!AW$O?.^&./=Y7RW
MO6M5.K^DJ:FHJ%M&H8M1/-.K4AB5&K-(Z16HJNO5$5UUZ\]W,G,:#7ZEK/KZ
MZLKGVY61OK*JHJG1MI(%:QU1,^56(JR7JC5?R45;E5$O5+RX=.FAB0=.3Q57
MHW9P9CB-J[:,MH0HLPRMA%0RII22E3(R'F1F@(7(;$1*"#QMEE<.X8HE[VOE
M;&]I2PM$X+"JY*N*LEG=)3NIU9)$QK4:Z2*17(K77WHL2)V7*IL>ANKBDT.M
M&IM&GM.IK7U-$^B6*:"*)K6OGIY_E$<Q[E546!&\E4N5'*M^RY?QJ)T*2#J,
M>B<]G#.#-;YU-;I1N!DT:&%L8J(7**"FH8&,\CTT"BV'S$5!0\L<<K!]P'A>
MUK97RO=;NB<%NU<=7+630.CIV4Z,CC8YJHR261'7N6^]5E5%3FN1+NL^=,=6
M]'IA:4%I5%IU-$^&CCHTBA@BE:YK)IY4>KGO:J*JS*VY$N^;??MN2I6?T73J
M:#L;#M)ZAFZ<-M=P(KC*E3$*J6)<R.C*)=2  'R"F6PN( XI7$,3(.]L^XOE
M?"]LK6O:,I= *6EJJ:J;:-0YU-40U#6K#&B.6&1LB-54=>B.Y-RJFU$6]" L
M[4Q9]G6A0V@RW*R5U#64U6V-U+ ULCJ:9DR,<Y)%5J.5G)54152^^Y>8TJ\4
MSG_9_$_^:%X?Z[ZW_;VI]B_M.TAXIG/^S^)_\T+P_P!=]-O:GV+^T%3K,%RH
MM*AY6,RE'H(Q\SF8%#"B-R6"P$%O;NL0^[F;+/N=^&-LLLK\=M[UXI*%DCWO
M5[D5[E=S)LO6^Y-O-=LVI^P]3*I[&HU$3YJ7)M7L[/7M_CM/IM6'I;:2E=3(
MR;')D:Y<4MWLU$;F[U; 6^-\LM@IH#SOE:^%NY_9;6WOO:]?4%&V!_+1[G+<
MJ7*B7;;NSU'S+4.E;R51$2]%3:JK^L]3OBN7GB.2'49,C8KD3"$ "Q)Q&Z,<
M<["YVSOW??II%O?+>UK8]S>UMM^%Z^IZ5LZM5SE16HJ)<FS:J+MO7ZNW]I\Q
M3.BOY*(MZISW]7J(T0@*4"!XJ>"E./Q!21H SAAG$CB[C(0 3 ;' 3N9E[KN
M<KXVMEM>V7<WWM??:]86V>QKFN21WS7(ZY43;<J+=LN[-IE6K>J*BHERHJ+M
M7K14[>J\G[G8LSNI*S23TBQ@7 S&"'N(5B)UV%MF#?*^-K=]FL3"^-^ZOW5N
MYWY;7MU^J:%)F*QSKDO145$YKK^U=O/]1@CD6)W*1$5;KKEO3L["M?Z'>3>7
MQK,'GMM\4CBY[=UMM\<O/;CMV<>5>3\G1_I'?8G/YZOUGH_EDG8GM55V>>O]
M1;J UIF0R*8EV?\ &)D@GX @9[Q.ZPC@Y</.UQ;8C_'.("".)A?.P8MRHH86
M5\<L@1;8WPR]L<?R;&L1;T:BIM3:NU53K^L\KW*]SG+SN6\N:LA\A0$.D0BL
M*D?OI,;Q5NGU]19SG(H9%WA"#-,XL&T0\73"KH!"_IHK=,'1  5L(+^F")N9
MG##]E>U 8I="#9(&:LT"M-LQ(@-U"Q;C$7#K )Z/R3A77RW9=U)+2>,M@Z.C
MQMDX-=(@MW08A-*ZH F@&E%/=RDV"I]./G7,X0-WJ * * IR!T1Z-.,6BRGP
MC$$Q593=06MB=3E^R\57L$9**D15@//)/3AR6!H8#+/ H9#$'QPRM<3/NM[4
M!<= )=/NG^2Y(E9NOEBNM/;2;:/SD1O+ RHJI8XI1T_7#:\DETH(B7$!)N0F
MD@(SB9RWD)B.6<;>+)V8I).4SYF@&'AEHJ<?P_%##6LR@BPR8U8K15A" HHY
M#-3;;72T8_F2'&" &&*9&B0N1848 $40&^&8@0>>5\+ 63E;?'*UN=[7M;Z;
M;>F@%)TTP7(</FPAGQ("D_,+P#I_C</-5S;/?45QQH+)F;G().+89+-",-J]
MG:CW1U1;Q57&?RP.64S>&)<O83\]=W,GGU=@&WK] 4!4,WMETNIE)Y1FE"*@
MNH\BQ(\@TY05<D0NH)[$E%HO%:(64\29^Q<R;1T,\ 3L*5S &-B @&,P01,Q
M@P\"TD\8X8($AU G@G'QBA<4Z0#-8G<")L0'#,R4P.8! X&\2PU\P<3. (6(
M]L+"XAX6RMC8!?M3D2.R9&0VD!E+I9LN%NR(UGZF+QDP:"P259G8J*JW%*P!
M4(6ZGBG.K!"/FD8SW!)6(E39$YED /F$(!Y=,<4/J*D62\Y%5DQ:=4E2B-*:
ML<2#IXZGAK+ECN.B#K(I_C H3,$T-.>J(YB34(98"9E6@ W\1Q,35S  (#+T
M IAB#9!%G O)6#_4K-(*>L9%SC^^38LW[MW'2V)#UU#OWP)N\KN7X9Y6,V3+
M/7%N^)[>,+E/#]RUWGSL V= % % 4CJ)+N]2B1W-]H1T9E"[L1UEHN5KI+N1
MV@Z;M-S(*LCJR@S3#D-(;967,3$-D_ T%POB-TTV4%/&OARE'2),FI 9]Z.(
M8U=-&<BCVD#-X)+'"A:.(>=XTOL/36T'2X&["^#^O%Z.S$K37,DPHH>=EJ37
M:XW>N. VTPB^R>C-A &33.8*.!KE0!0$/D)\(D9,!\22Y?#/@Y'S/<SX<'BX
MOB;4/$C313J\J^ E<A0,3)SP @/X,7R&!Q&'[@.XH=LKYV 3<ITE.ED^ RS!
M!PNH_9\:><]22< 1:"F=/IS3%?#:C%(9*VF%>_*)&8'')#ELP4*,0RIEQFG<
MA.-", E#Z=@"9 :.,92$D:[C)J,;R;%R^UC:<75&Y):&C$S(Q98(64$M41'"
MT'$\F*Y4\R#88 S\'G:IG410*F$QQ$DA0QP+9@6K0!0!0!0!0!0!0"ZR!J89
MD?RVV(6%;3\=CS<*$B.LZ RTA(5[-AHN!WY,=/=*HDFG FNM>1P' &8Q<&4>
MMQ['6>CEA7*\22 W+@JHH'SUW6)IO3$1Y*B!+#+DQ58ZDVT!99$3N5OR&_KN
MEZ.\M'S-:@#5;JJ:/@KKH?9LNTDP)3\7$@5FY@-4/)Q8@HF2@'Z):LHB36X>
M7YA4Q=,PR:\Q& ;0]1JFT(W.C.;%LD7F"60%O)TJS'>I$RUCX:R&KL5VN9)
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F9I)@RI!#9BW<IC!(7W(OI18![J * * * * * * * * * * __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>g425213g18c21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g18c21.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1T*4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '.Z^= 8X0DE-! 0      %H< 5H  QLE1QP"   "   < E  "')R,S<W
M,#$S' (% #E-:6-R;W-O9G0@4&]W97)0;VEN=" M($=R87!H:6-S(&9O<B!"
M=7-I;F5S<R!396-T:6]N+G!P='@X0DE-!"4      !#SCLQI\4MJV5.RR_8]
M[#?<.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M             #^    X0DE- _(       H  /_______P  .$))300-
M   $     #A"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))301$       0
M     @   D    )      #A"24T$'@      !      X0DE-!!H      T$
M   &              )I   "T     8 9P Q #@ 8P R #$    !
M                  $              M    )I
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<   )I     %)G:'1L;VYG   "
MT     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG   ":0    !29VAT;&]N9P   M     #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M   X0DE-!!$       $! #A"24T$%       !     TX0DE-! P     $C4
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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MU,_KN%@Y;,*S<_*LK]2NID2X
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                         /_A05-H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB
M5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z
M>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#DN
M,2UC,# Q(#<Y+C$T-C(X.3DL(#(P,C,O,#8O,C4M,C Z,#$Z-34@(" @(" @
M("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I
M<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z
M<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @(" @(" @
M("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B
M"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@
M(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z
M<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O
M(@H@(" @(" @(" @("!X;6QN<SIT:69F/2)H='1P.B\O;G,N861O8F4N8V]M
M+W1I9F8O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z97AI9CTB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]E>&EF+S$N,"\B/@H@(" @(" @(" \>&UP.D-R96%T941A
M=&4^,C R,RTP-RTP,U0R,SHU.3HT,BLP-3HS,#PO>&UP.D-R96%T941A=&4^
M"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^4%-C<FEP=#4N9&QL(%9E<G-I
M;VX@-2XR+C(\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I-;V1I
M9GE$871E/C(P,C,M,3 M,3)4,C Z-38Z,#,K,#4Z,S \+WAM<#I-;V1I9GE$
M871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#(S+3$P+3$R5#(P
M.C4V.C S*S U.C,P/"]X;7 Z365T861A=&%$871E/@H@(" @(" @(" \<&1F
M.E!R;V1U8V5R/D%C<F]B870@1&ES=&EL;&5R(#$P+C N," H5VEN9&]W<RD\
M+W!D9CI0<F]D=6-E<CX*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @(" @
M(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB
M>"UD969A=6QT(CY-:6-R;W-O9G0@4&]W97)0;VEN=" M($=R87!H:6-S(&9O
M<B!"=7-I;F5S<R!396-T:6]N+G!P='@\+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z
M8W)E871O<CX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D^<G(S-S<P,3,\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @(#QD8SIF;W)M
M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" @(" \>&UP34TZ26YS
M=&%N8V5)1#YX;7 N:6ED.F-A,S0U,C4S+6$X9&,M,68T9"TX,SAE+34S,V-A
M9F-A8C)C,#PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O
M8W5M96YT240^861O8F4Z9&]C:60Z<&AO=&]S:&]P.C8T.3=D-&,P+3)A9# M
M8V0T8BUA,38V+3EB-V0R,3!C.6$S.3PO>&UP34TZ1&]C=6UE;G1)1#X*(" @
M(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.F(U8F$U
M83DY+3%F.6,M9#DT9"TX-#-A+6$S,C@Q9&1E,&,P,CPO>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z8C5B835A.3DM,68Y8RUD.31D
M+3@T,V$M83,R.#%D9&4P8S R/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3 W+3 T5# P.C(R.C(Q*S U
M.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F
M='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @,C(N-2 H5VEN9&]W<RD\+W-T
M179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC
M:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E
M9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS
M=&%N8V5)1#YX;7 N:6ED.C0S-C!D-#!B+30S-#4M,SDT-"TY,&(X+3%C-S0W
M9C0U-3,T-SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.G=H96X^,C R,RTQ,"TQ,E0R,#HU-CHP,RLP-3HS,#PO<W1%=G0Z
M=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^
M061O8F4@4&AO=&]S:&]P(#(U+C @*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R
M94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S
M=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V
M=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S
M/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G
M92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^9&5R
M:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O
M8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.F-A,S0U,C4S
M+6$X9&,M,68T9"TX,SAE+34S,V-A9F-A8C)C,#PO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTQ,"TQ,E0R
M,#HU-CHP,RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P(#(U+C @*%=I
M;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @
M(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O
M;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=%)E
M9CII;G-T86YC94E$/GAM<"YI:60Z-#,V,&0T,&(M-#,T-2TS.30T+3DP8C@M
M,6,W-#=F-#4U,S0W/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \
M<W12968Z9&]C=6UE;G1)1#YA9&]B93ID;V-I9#IP:&]T;W-H;W Z9#@W,38X
M-V4M-3%C,"UF-#1F+3DV-S M-S@U93 X83!B,V)E/"]S=%)E9CID;V-U;65N
M=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/GAM
M<"YD:60Z8C5B835A.3DM,68Y8RUD.31D+3@T,V$M83,R.#%D9&4P8S R/"]S
M=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#PO>&UP34TZ1&5R
M:79E9$9R;VT^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-;V1E/C0\+W!H
M;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(" @(#QT:69F.D]R:65N=&%T:6]N
M/C$\+W1I9F8Z3W)I96YT871I;VX^"B @(" @(" @(#QT:69F.EA297-O;'5T
M:6]N/C,T,S@Q,C O,3 P,# \+W1I9F8Z6%)E<V]L=71I;VX^"B @(" @(" @
M(#QT:69F.EE297-O;'5T:6]N/C,T,S@Q,C O,3 P,# \+W1I9F8Z65)E<V]L
M=71I;VX^"B @(" @(" @(#QT:69F.E)E<V]L=71I;VY5;FET/C(\+W1I9F8Z
M4F5S;VQU=&EO;E5N:70^"B @(" @(" @(#QE>&EF.D-O;&]R4W!A8V4^-C4U
M,S4\+V5X:68Z0V]L;W)3<&%C93X*(" @(" @(" @/&5X:68Z4&EX96Q81&EM
M96YS:6]N/C<R,#PO97AI9CI0:7AE;%A$:6UE;G-I;VX^"B @(" @(" @(#QE
M>&EF.E!I>&5L641I;65N<VEO;CXV,3<\+V5X:68Z4&EX96Q91&EM96YS:6]N
M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z
M>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X
M<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( *P R0,!$0 "$0$#$0'_Q  >  $
M @(# 0$!            "0H'" 0%!@(! __$ %<0   '  $" 00+" P)#0
M  $" P0%!@< "!$2"1,A.!05%B(Q-W9WL;6V(S)!47%SLK07&!DF5V%R=9&6
MUO E-39&9H&7U_$G*#-"0U)35%:AIL'1_\0 ' $!  (# 0$!
M  <(! 4& 0,"_\0 41$  0," @0("04-!P,%     0 " P01!2$&$C%!$S4V
M<71UL;0'%"(R,S118;-R@;+!\!46(R15A(61M<+#T_%"4E-SDI315I7A8H*3
MH=+_V@ , P$  A$#$0 _ +_'"+6CJETD<VI=/75T9?((VX:?5*/-ZD1&BD;4
M>(EV\N_<RSV9TMI+46N%=GB48*-D[#7+,@^GI>(K3.'+)S[&4C"+6OHHUK1=
M4N\^I,WO3GM+<9=0-AHM?TQ_D=M>VG)=GF;XQRF_.W=!R+(;+E]VFF^93D_-
MYO/.=(@&5<LM<2BIYG--YR(KY%)7PB<(G")PB<(G")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G"+67JJE+%!4*K3K&)GY^C0VH4>1VN"J5+)HEJE
M,B;NW7M\E$4HL+8I"Q,FLZ:LR5SCJ_#2%K6SUC;_ ')M5[&$8D<BP/T3*2DE
M>=?G8&_;5J>3.:;DT9&:)M-;M=4/8]6836M2&BIYQ#7J"@;&VH<37IO.614X
M]LO16<X,E$UAXK+QEN2;D4B7")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(M3.M9G:W^$RS6C=,B'5G;5IZ 2A,J?V>FU*';N%G2
MB"]UFY2[6:IQR\9462KJ1/"QTJG-3[D6L,R4C4GKF=B2+"'D^,,3R!#49:9Q
M+:LOT*]*U-_=;#I2^)0E%LBD:6PDC:[CV88?O6V0N?56EE?/$S)V)<;C-HS,
M:YL]\T:8:NI&-(I(N$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A%U3V>@XZ1B8>0F8IA+3YWB<%%O9%FUD9H\>@5R_)$LEUDW,B=BV
M.1P\*S26%L@8JJP$3,!A(N';G3=C5+.]=J-46K.O33IRJ^FGE;9)-V\:Y564
M>6*.1<2$"U(F0QG$TQ06>1:('?-45%T"$,113="MFZB+1.@JEN3^6IC9.E6J
M2Z>-ESC5W,S4L4O\9;$Z?=\MZC]778[+KQIZP5MVHPGM7KZ*Z\;#S4!-5.E2
MYXZ1X12]<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M"*.WR@M8K5\ALKHFKMK:7 ;#-V]74)6G9>CI\JC*1-;![G\&5-KENIVJD*V"
M:!\6.O-+:U.SQ\O'Q\+7KC%V:>@&[TBY69=.Z"W2M",[S.]2U<BYJEU;37V/
MJ[QJ4M=\U?/<CA6ERQ0-)MEI7T:XUQ&=)-J! Z%:)!FSFWJS5L2+B6C!@P(O
M[]"E8Z9H^'D[-T_V';IEY*YSD5>FHO<[;M5GLM)IU996=S0:0@VV-P[7KH5\
M]@M"$C#02XII21W*DCYQ<R*ZI%(#PB<(G")PB<(G")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(HO?*1OH]O)=+D>]]K9_W1:\VIH9Y;,J0UO/Y_\
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M"?S1&_J2/"+M^$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$7X)BE["8P%
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MNV:MD4T&[9!&NNDT4$$$BD31123*5-)),I4TR% I"E* !SE-/0!HQ5V&R:B
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MQKAG6%%WF)6=]:^*K3?F^N?V<DN37B7%U?T*J^!(KMX[Q'C/56(]TF533O\
M<@+YP_H4,;S78?-AW*4/. /B[>,W;PB'@[]BAW,(=@"KNT;18'S??D+^PG<=
MX#1F<@*,..1%W$W)L;:H!MF#F<\A;+9\RSGTO>L9B/SFT_ZZ:<W6C7*#!NL:
M7XK5TFA/*W1WKC#^]1JPKU7^KCL/R+D?TT>6 QSBC$.C2?4K5Z><CM(NK)_W
M56D'P^$O8# 8!-XC"("40'P^$"AX0$HAZ?$(F-XNY>P%[>^A7*PVWSO[/=;Z
MU2W*PR-\[F^1V6L+"UM^9O<;-^V70SW_ &T>8_G+2'Y?WEV+T_W_  _TCO\
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M=7]"JO@2*[>.\1XSU5B/=)E4T[?<@'LGV\X8/%X@\[Z"E] D\?<$_3W*82
MF\0 <1 0"KHV'(;3G<7'FVOOU?9E:Y<+W5&7^:=GG;;@F^61%[CV@ZH&Z^5E
MG/I>]8S$?G-I_P!=-.;K1OC_  ;K&E^*Q=%H5RMT<ZYP_O,?ZU85ZK_5QV'Y
M%R/Z:/+ 8YQ1B'1I/J5K-/.1VD75D_[JK2F-W(0/&!@\2GW,"F[D[^#WQA%,
M"B53X"^$YNW@,)BD[E$T*G8,QORSN.?*V?N)R&Y4N/FM\H'-WDYW;LS-P!Y5
MLK$[#<#*^V70SZT68_G+5]B[%_?\G\7-_HMQ[1?G'=9EWW@NY<X)^D/V96JQ
M9R8%<!.$3A%Y6]NEV-(N3UK)A"N6=5L+IO,&BS381*[>(>+)28PI"*&EP8*$
M*Z&+*0YI $O8A2&%8 $BC*\F"PIQX>T67.F?357:G,Y9A;.0@^GZWYW<75NO
MC FAREJVJV'H])I3VKLM(2L40C6ZC86+1S&*5R>5+6*@\<23%X124Z'H=3RR
MIO[K=7[QA Q[J(CS#&0DY9IA_*V&885ZOPL'6ZQ&S%CL,[.SLI'0\/"045(2
MDG(O6S1FT665*7A%B'4[U5=,Z3-?O%+E/;>M3^(ZLO'O%&4C%NB':U*R1\@P
MDXB8:1\S"3,1)M'D3-P4RP83,)+LGL5+,6<@S<MDB+*,[\4\S\WDC]FUN95#
MZ[1]*I_C,7CMAYCV*L6;X1_*/T\LZW8.8=BU"V$Z4/6*R;Y4I?J3SG/Z5\G<
M5Z-_$C7U@]*SG/85-%U?>K7KGR:3^M8[D-:)<I,(Z4?G_ R_U636^JS?)'TF
MJMARQRYE;K>3\]9JK?S#;_J!YSC=/>3-9_G4?>8UG8=ZTSY+\O\ VE2<=??J
MYS?RDJ_UCR,] ^44'1ZGZ 6[J?1'G;VJ!GD[+7*0WR;OQQ6WYO'WV@K_ .#^
M_?\ U<C[PC<3TG6,?=ZG?]K?.LJE\]WR?K"FKY#"SE\G^\-_)-] \(JF<N7O
M*2Y@(<>TFZ+YP!^Y$\3AR/@,'A'WZG@\1/NA?>IJ>]-W$2P)*/PDQL3:5WE;
MA=SLCEM-LLQL.W=0>J'XQ4FQ]8D%]PN]^1RVFUQF,@<CM';44?W[4WT_#:Z[
MV](>G_##/OV[?T?3S]TGK=+TB'XC5D83QKAG6%%WF)6=]:^*K3?F^N?V<DN3
M7B7%U?T*J^!(KMX[Q'C/56(]TF533PCYH#>;'MXQ+YWT]A$"E'S8?]7N7N!A
M[!XNQO3Z.W*O#9L.1-MMB+"XVVR&>6=B=U[48<"!YM@2;.]I_IM'OO[%G/I>
M]8S$?G-I_P!=-.;G1OC_  ;K&E^*U=)H3RMT=ZXP_O42L*]5_JX[#\BY']-'
ME@,<XHQ#HTGU*U>GG([2+JR?]U5I![^$G<4_"(G\'82"IW]YW\8!W/X>_;S8
MG][]\"??WW(5.P;-^RU_GW\V[V;U2XWU1YMKNM;5UO[-[V\JVS5OEYUMZVRZ
M&?6CS'\Y:OP_Z%6'^_\ QYO]%N/:+\X[K,N^\%W+G!/TA^S*U6+>3 K@)PB<
M(N@M::ZM6LJ3:8:5URI 3*;>P2#=J[802YXYR5*8>M'QB,G+2,4$KURW>'(U
M610.FX,5(QQ BB7\DZZM*\;IK:R7IM8BQ4#348U@YD-PE)NSQL[H6Y72*VUG
M([SD^4V.4SS086T1E2SR;JB%IH$C$YBX9U>>0C(9K#1Q%)7MF;2FHTIO!UZQ
ML:G:8*XT._U.?E8):T0K.R9[<(:X1:,]7&TW6G<S!22L0,5+LF-A@Y 6#Y=:
M-EH]^BV=)$6*JUTAY\7,XNA:2\G;X[%QHTM;'\1:+]G5>LDWKMWLVAZ"4*?5
M+LBS3KCZQVZ:;P\+-OK(\C:\9I$.YJ6.DX>NR+T9^E#%5&QF2D?H2C,[<6AV
MBFY[FHV.U,F*)FQT#Z.*1VYDA%(R)B"F9,1(8HE$0Y^FN<QS7L<6O8X.:YI(
M<US3=KFD9@@@$$9@BX3[?U]J\!^Y\=(/\$0?U]T[^VG-I]WL<_+&*?[^J_FK
M\<''_AL_TM_X7.C>@OI3AGS:4A\R>Q,FR4\\SD8S2-68/VBOA$OG6KQI>$G#
M=3PF,7QI*$-X3"'?L(ASYS8SB]1$^&?%,1FAD;JR12UM2^-[=NJ]CI"UPN!D
M01DO0Q@-PQH(V$- (^<!>JD^D;"YI@YBIF&O4O%O4P2>1LIMFWR$>[2 Y3@D
MZ9.]%6;.$P.0AP(LD<OC*4W;N4!#"AGFII63T\LL$T9UHYH9'12QNL02R1A:
MYI()!((-B1L)7KFM>"UP#FG:UP!!WY@Y'YUX7]SUZ/OX'T_Z]Z9_;/FS^^''
MORUBWMXPJ]OM],OEXO3_ .!#_P#$S_\ *[6&Z$NEJN/TY6NYS)P$HB15-&3A
M--UF)D$DUTS)+)IO6%Z;N4R+)&,FJ0JH%43,)#@8HB'/A48QBU9$Z"KQ/$*F
M!Q:70U%9431.+2'-+HY)',):X!S;@V(!&8"_3886'69%&QPN-9L;&G/(Y@ K
MOIGH]P.QL3Q=AKUSGXQ11-52-F]FVN58**HF\:*AV;_0W#8ZB1_?)',F)DS>
M^((#Z>8M/4U%)*)J6>:FF <T2P2OAD#7"SFA\;FN <,B+V.]?L@$6(!'L(!'
MZBO'?N?'2#_!$']?=._MIS/^[V.?EC%/]_5?S5^>#C_PV?Z6_P#"[N"Z'NF6
MK.E7U8H<Y6WJR MEGD!JFO0SM9L8Y%#-U7$=?&RRB!E$TU#(G.*8G3(<2B8A
M1#'J<3Q&M8(ZROK*J-K@]L=14S3,:\ @.#9'N:' .<+@7L2+KT-:WS6M;S #
ML"]7^U:Q_P#\#2?]O&[_ .\GF"OTG[5K'O\ R^D_[>-W_P!Y/"+&QO)Z='IS
M&.?'DSG.83G.>]:88QS&$1,8YC7,1,8PB(B8PB(B(B(CS!.&8:22</H23<D^
M*09D[3Z-: Z*Z,.)+M'<#<7$EQ.%4)))VDDP7))S)O<G/:OM'R?'2"W52<-\
MA*@N@JFL@NA>],16162."B2R*J=S*HDJF<I3IJ$,4Y#E Q1 0 >>C#<.:0YM
M!1!P(((I8 00;@@B.X(.8(S!7K-%M&8WM>S1[!&/8X.8]N%T37-<TW:YKA#=
MKFD @@@@@$&X60'/2CBSUNX:/(_0G;1VBJV=-7.Y;FNV<MUR&27;N$%='.DL
M@LD<Z:J*A#)J)F,0Y3%,(#EN:U[7,>T/8YI:YK@'-<UPLYK@;@@@D$&X(-BM
MW)&R5CXI6-DCD8Z.2-[0]CV/!:]CVN!:YKFDM<T@@@D$$%8W_<[>C?\ @8;?
MUVTG^V/-9]PL$_)&&?[&F_E+0_>EHK_TW@7_ &F@_D+F1_D_>D:)?-)2*R=2
M+DX]PD\82,=H&H,7[%V@<%$'3-XUNJ3AJY14*4Z2Z"A%4S@!B&*8 'G[CP;"
M(9&2Q87A\4L3@^.2.CIV/8]INUS'MC#FN:<P000<POK!HSHY2S1U%-@.#4\\
M+VR130X91QRQ2,<',?'(R$/8]K@"US2' C(KVLETCX;,,747+P][E8Q\D9![
M'26V[@_8/$#=O$@[9NM%5;.43=@$R2R9R"( (E$0#F?)&R5CHY6-DC>-5['M
M#F.:=K7-<"' [P00=X6VGIX*J&2GJH8JBGE:62P3QLEAD8=K9(Y YCVG>'-(
M]R\#^YY='7\#:'I_TWTD!_I]V7,3[F8;^3J'_:4_\M:7[T]%_P#IS _^U4/\
MA=G#]!?2G7I%O+U_,GL%+-!4%K*0VD:K%R385D3MUA;OF-X0=("J@JHBJ*2I
M?.)**)G[D.8!^D5#0PO$D-'212-OJR1T\+'MN"TZKFL#A<$@V.PD+(I='L!H
M9V55%@N%4E3%K<'44V'TD$T>NUS'ZDL437MUF.<QVJX78XM-VDA9=J6#YS2)
MYG9*^E=B2K$CHC8TSK&KVF/ KQLJT7\]"6B[3,*Z,*"Z@)'=1ZQVZO@<-S).
M$DE292W"S%PB<(L7['#7ZP4&:A,Z0I#Z9ED%HR1A] 4E&4#.UV3:.HZ:B23L
M5&6,];DEVSH%F,V]I=[BTC-SLW]1D4'PKLR+1#I?Z0NHK*-4@+G<]HM+2G5W
M.:MF[NH.-6I>Y/+M6L^3G4,ZK<G87G1[T_S57A*H>UV66>OHZ3G;+;95^V-,
MRR)&9U'9%)_PB<(G")PB<(M2>H7:-!IU]SW*,Q]R\/8K?G&U;%,W*WT&]ZTS
MB:3AKO+8F;K]8R?,I^KWK0;_ &B6U^MG@8>"G$5D8B$LCA&/G)88:$D"+7&3
M\I53HWIYE])>1,@%SBZG.HNGL!4)Z4I3>^PG3GLF_/'+*K:+*8IH\C6&3#%+
M1%J0=D:9]9G<LO%PRCN*9N7=KCB+M-,\HS"YS<P,]RZ]$Q^"_;#1\YHSAM2S
MEO-GP!U%56P5G,HQ/2$9F.>I:0^<TT7VFP-1K\HNS<2D=.)5Q +"X(LH/NKR
M0M'3BQWC+J(=FX)KM(S>R574GB<6[A64ML=;S*U2<8]I"]N@;4NFQG"SE17B
M+$$!+MW+-5_,L'3=_#D(MX.$3A$X1.$3A$X112&\H#:JFPA]BT=E5$,5N3/J
M4E:U0:QFFQ/]+BX7IXK.N6I1)[M"0RF"RFGV*)Q6TO);&K8&/OJBFX?(-;M;
MW%0=A/D69;CUT5FJZQ><Z95&Z6V1IKV"H[.GU^ JZ,_<M*L]RS"KPC:NVZPZ
M= UEE"G'4X@7Z=HBX!-BC%SLJK80!HQAY0BQME_E+JK8[-2<[O.9WV(T"YZ3
M>ZJ_8P;&I.F.<0BG5UN'2[D(75H70I2:F)N:E,=?$O4AFK.\5BK.&TK:Y1]!
MTI1D\3(L]V?8MG@.JG/\H:L,PF<_NTC(IKUB'0M$GKE<SJ)S";L3_>[;/)RK
M>IU*H!KK*'Q6'I#^JO7EE=S*%HB;Z9TD_IT<1;B<(G")PB<(G")PB<(G")PB
M<(G")PBQOI>/YAL<7'0VH4>OW5A#27MQ"EFV)5W,+*BT<1ZDA#2"8I2$2\<1
MSQY&NEXYTV4=QCUY'.C+,G;A!0BQU-=(/2Y8GT=(S&!94\<Q%+-G44 TV'0:
MQM'-4[-0PJ[%@V;(L&L0G2+E:Z@@V1;$!O6;#+0: IQKQ9L8BY[_ *5NFZ5M
M%INDIB&:25HNT=/Q-LEY"J13U>>CK9'M8JV-'Z3E!5LHE:V#%@WM'A0*:Q!'
MQZDR9ZJP:*(D7LX3&\LKE%:YG"4.N1]"9R3>91JZ4>F>,/,MK$C;DIET1;SJ
MKV8&TMT;"M*O57#]Q,IED'#A5UW4$BR7PB<(G")PB<(G"+!"O2_TZKV2VVYQ
MBN;.;#?(VSQ-OD'54BG03S"\,UHZ\)/6CANHQ\Y=V"ZS.Z.D6J3JV-E#(V%>
M13'P\(NI:=(?3$QKTM56N&YRE SJ*:,PQ]SS4XR)T9F"L:#YT[4 [Y68;V2K
MURR-YL7/MPWL4)&3J+XDLS0>$(N?#]*W3A7GU)DH/$\YB'N<N9!W27$?68YJ
M:O.92TS%Z=+-"HI%(H<MVL$Y<60NBN/:RU2\C8HP&DN[7>'(NW-T[XD;6G>[
M_L;UPFP/RQ1'^@)(N$; _3@XA:!ADGSA)P1)XE%Q#ERQ8).454VJ3EP*)2*+
..JG.19GX1.$3A$X1?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>g425213g19a10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g19a10.jpg
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M 0$! 0$! 0$!_\  $0@!FP(' P$1  (1 0,1 ?_$ !X  0 !! ,! 0
M       '!08("0$#! (*_\0 :Q    8! P$$! 8,"0<&"@0/ 0(#! 4&!P (
M$1(3%"$Q"14641@B05:1E1<C,E1887&!DY?2U!DD4E>6T=/8\"9"F*&QU=8E
M*#,U4]<G-#9#1$9B<L'A@Z2V\3A%2&-D969H<W>"A8>2H__$ !T! 0 !!0$!
M 0             % 0(#! 8'" G_Q !>$0 " 0," P0%" 8%!PD%! L! @,
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M.[.H2@VY=>%=>J9>9;2$,SL\03O:E=)SCUX\^=8?2D*.RAB5B>4!E*:A'\X
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MNH"#Y8MV!)!RW6EWX!)RBBT@Z,N0KQ\<B28IT/3UC^)'\*S1.S=[JWT3.BX
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MZAM61E=W6YX>[CZLZ<WQD[J%O](9E_9"YVVEJM22&N8^QO@W)&1(K,#.RHL
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MVJ+PLV/"[546)-*R!(8H>\DN'))T0)%&IU."-"+OC/6L3>,-*V<CEDEL  X
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M'9=MP?('F">8WWW'MMPNW9ACMHX''K+O\4==5P=D=4R\VAVHEZ^Q764,E(I
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MW,/I%\[BVB,S(]PMGI+HFIE5NZ;Q:0FH-EAJ4&0LIXPA#R $*N[' (7.2"<
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M72HR->!YC$6,EN6\1(\9&<Z=7,#/+J!@#UX>7?/&Y:CR5&GFN(7%RF[G+ST
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M*L+1L\C.I."/G $K7IW&+&SXYPOY80SS<36%-$4>O=$F*E7M0654"N\G>@=
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MPY\$@*@0@"/CX%$3CR)A,83#J.>-YG:62;6[8)9GU,Q;/,Y)SOGGD ],5DV
MV4@>07"@<SSP -]O\:O6$O#QFR1:>J3]/VX2K*JM2D2,HLJH7M@(]%00,42@
M4J:0D+X=:Q1$0+I3V2,Y?O@=@,!6)("@'3E"-B#DDY\@>=9 Y Y8VSN1ZQY^
MKD/=ZJY4+X[L,TU&6AV1ZZ@HJ6'ZG2BAUY, ,EZY!N**Z/8J 91O&E!4 !(Z
MS\5%N]->[:]U8)!$QCE?O\#O %&D1G<QDZ@=2[,^QW 7 *MD'+,-L#D-]\^?
MD1T'O.^0*GB9=2:$4JX*FU1 I!,H**ZZPD2 IA#I,+9N(\\% P=)!#D0*8?
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M:Z!N;B%[2)&54M))PD$ER1%'+J9)46.3,.& *0KH"4ULA7 9\1G0"';)U2!
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M33,]K;5RY<LE55>"(HRL4>1BU%C" ("\*N(\)<#T/9;B)X=QNT8C5%=MZ#.
M"2([EE5751NS13".4* 2W=E0-ZQ3KJC;S4:ATW'K]F:T!4V.D7&X.ON&$1)+
M-Y!B[!-\1DOW-4YZP^3$QG(D[ AB@!43IJG(J4Y/$@%^,/OEY+$O ;A9)HPT
M;H=!==0 N8R,+G)WR05\.#SYU%QC]>F <'?.-@=)R/:-\@YY9Y<MEUBL^/\
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MX:IKU.4<0TB^E7Y) %)AC(EGYPJ#L5CIC*-!21DR))F8NU0%FB9,"$C5FS=
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MKD*H NIMSI4<AGED^TU#R.79Y&&6;4V 0,MT&3L,G;/F14-)YU<))"K*8LR
MP*1(BRIDE*6\*1,ZPM^H"C;VSHX$5#I4*5KVB?44QR 4P#KC_P!*W1=4_ >+
M0X"ECJX<ZJ&8J#_SY'8 \\)MD'JN>;7M P75/P7BT> &;0>&284MIR%/$$<X
M.S )J7(+*!55+GFED6!O(,+M%*BLX0$CBCV.0*"S4@*N$NUK[*:1$Z28@H(
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M*W.!C=20%'D?/7$7)G:YN&NM?I33RM<]Z")._9V:7O <8<N6+# P2=A6R
M!R  &.6.GW5<.L%5II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4K@1  Y$> TSCW[4K5UZ23<- 5&CL\1PLUWJX6-ZA(62'C5NI6/K#-!9R
MU).&(/0W;2\N$<(,%P,:1CFKTJC<[103'],_HYX!/>7S<7EATV=M&T=O-*,"
M2Z=E5C "/&T,)E!<8$4C)A@X\.G>2A5$8;Q,02!]$?2P01DXQYX/, UKZQ82
MTU"S8K>6]9M)-K!)N3(R;%10'+4'%;D9%!K)M3HD364%$RR?;ME1*/8%Y2,8
M>1[[BOH]Y;<22T#1M JZHW"Z7"W"1LT3!FP,@95AGQ<P#MJQZD:,M@AB2"IW
MW4D Y&^QY#8;9P:F3=5-Q\GCJD/T#D9QL!N(VQ+3*C@R?>G8+;@L;F(*!"B=
M1-L@BBNNJ( 0PF(F0 ,/4)>4X?!)%/,A!>6>QOUA"C*IBTG!U$X!9B0H'+<Y
MQR,Q8L._D.=EM+X\CN!:2^_'/.,9QC!K!;<?DK)N+K?E*'IT%/,8^_[DZ7?Z
M_E1&,@+'5&\/<X7'=&2;2C5]+)/V,RSD:U809)/85P@H\2B'R"JK=;M4NP[+
M<)@XE=<*M+F3NS<0_)\L<?AF14:>:5H\HR$LKHISG"LV=QBN4[?<??L[V+XS
MVELUM+F[[/\  Y[M+&\,Z1RS13MW0E[HHQ@Q*K.T<\;C1MBL7LB;V-Q%$M:=
M0?VU[.-RQT/86\E$8KJ<F_'MI@8Z9 L;'P3Y=K'PD#ZRF'CEPY:E>().6#%$
MZPKN6G?7G]'W +.Z$1?CK9AB</;NDH=9+E8YLQQVLK*+>/\ RAWD"B0)HB#L
MKE/DJS_]I?M;>VIN$X)V(A(N)H=-W+Q2V172T,]MB:XXQ"CO>7.BRBCA63NG
MD66X:.-XEED4F=-QQKP:K?9:9BS&HI6(KHF-Z<5P#A284CNR #-5$A0[$G67
MDG:=I]T<Q0Z=>0_TW3)_1A#V=EX3 G$#Q>3B*3#B;R8B%DMHR&(VS0'+>D,'
M#:LZ1@J-1$WV?_\ :'[0\:X9=7LO . 1RV]]#;(L$G%F0QRVQGRZGB)*N&
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MFI8RCMDPTW-[JF20(M\Q1I2 )Q#G%E&,;XYS*"'4+$1Z0,8W241$" /27@H
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M=<ESR=MR3X1@#))P -@!G  Y"H9CEB<8R<X]?6NP2%'D!* @/@(" "'''''
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MK9?37:ZTB0C5H%P9-!7 U%<%@=]DJ].#\(C!1.$\*2)FU]VG#K)8]872'*B
M*7*Y4-C(&V3FK@D-A.TI\HDHG@Z@,!33*F8K.O1Y4U1*/5VBB:J*A>T'R'IZ
M0$ #D.>1&/CG5%*FUM),G(UVL&5SS P@./+RW\ZN/".%'GPOAF/_ .G66PZ
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M2 J$+U%ZBS'$.)2FXA>2V&>;R,HCTED":5'BP4;?0!@9;!.^M)W40TMI;F,
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M'BLLW?VT[7,4O?LKRLZ2R-^LUDLC=PQ,6(QD6VXGG2H095AI#0JH5D",N!A
M"J@  ;$9'BW-8L&P[?=E25CG>8C1K6/BSRBY[A<+Q6)L89C+R(R+]JV3@'TO
M-N&(/U%W$3 M&XQS)TZ=$CT6!'CDQL5OVW[$\+CD7A/>M)*(E%I:V5S#WTD4
M?=HSF=(H5D*!5EF=A(Z(ID+]VN!X=Q&5E$I38L=9D1RH<AFV0DXSNHV4$X&,
MX.X7#>)'$!0Z5C^HI*-Z[CRO)PC>8>N 1=O'H+N)%_*=FB1?LGLI,OGDCV*
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M$8@,N 64$@97IG\YJ#DXE<)+(@6+2CLJDJQ) 8C?Q#?;WU0R[O,NB( -#C
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M,7V6_GKD-W>7!Y$:)%@(!R >JYWD?'CR[;GPY'^H> U7Y)ML9[R7'4ZEQ_\
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M*0Z93@<SD50[<_W"8& X@)3*= ]EX[+W%R002X53C2&92Q()R N,J!N<8SD
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M+6"D%IJSOK;,R-@!A:UY5]"UFCP%9K#65=RTBP6EE>Z0Q"L>R5633- 6O&N
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M$;C/+H:S5L],B+$"$S43#)LGP*-9!LP:_&;N@+R(/&?059HHNF<X*$621\"
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M#&^*ULM<E.WQ5W#VU(V29D55G*DK+&1D5BMWA 3!N+%3K8M6Z0=16[8R";5
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M/9B(%6(@N":JK<P@1PF4Z!Q BAAUN</O&L+VUO402&VG270VP<*?$N?V25R
MP!*G# $@51AJ!4\B"/C6/%FC,;;9JNKG&SU]XZLD?'Q-??Q="1=#'2EIN$G"
M0:Y:C4W\DTA8M]9YSU:DX=K+1Y3IE34?NN2J*'G;>7B?:2Y7@EM<*MM))+<1
MR<0*=Y%;6<4TZ^EW<<3S2I:P][H0!R,D1CD!B;1"ID(.0 #H',MA3I7. 6)
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M"1I&L(Q=3BW:XD>1P))$U+'E\MI&>6EE:<M.T\DK3,&:1GU%LC&MG(+D  ;
M[CUY-91Q$'CC.F-XR-N=:9Y*K;15H@*F1*67ND]*0S9)#VH9P]CCPZDWBIUU
M6DBDW(10JS@C=0R)C=7,R2<1X)Q&26TN7X;<L';3PZ]RUO%,Q86KS6\AWC 5
M7B9CC"EE#54JDJX=0ZYW#+L2-LX(]?L]XJ6X6#AZY&,82OQ<="0T8V(TCHF)
M9-HZ-8-4@ $FS)BS21;-6Z90Z4T44B$*'@ !J-EFFN)'FN)I9YI&+22S.TDL
MC$Y+/(Y+,QZDDD]<U<      !@ # &/(=*JNL=5II2FE*:4II2FE*<@/^/?Y
M:4II2FE*:4II2FE*I$K/P4$F16:F8N(34-T)J2;]JQ*H</,J9G*J0','(<E+
MR/B'AXAJ](Y)/[-'?'/0I;'MP#CWU8[H@R[J@\V('[Z\K.W520X[A9Z\]$WW
M(-)F.<"//N!%R<>?Q<<ZJ8I5^='(/:C#]XJ@EB;E(ASY.I_CZC\*KI%4E2]2
M:B:A1 ! Q#E.40'R$#%$0$!_+K&=N8(]H(_?BKP0>1S[-_W5]\AY\AQ[^=*K
M7.E*:4II2FE*:4II2FE*M:UTFI7E@2+N%>B+)').".T6DPP;ODFSM,ATTW;7
MMR',U=D3543(Y;F37*110@' ASE-L6MW=V4IFL[F:VE*Z"\,C1ED)!*/I(UH
M2 2K97(!QD U:RJPPP!'K&:MF!PIB*L*'7K^-*-%.50,"KQI5H4CY8#CR8%G
MHLC.U>KY>M8P#X>' !QLS\8XM= "XXG?2J,81KJ;NQC8:8]>A<=,+TJ@CC7D
MBCV**U^[K/1[X8L%,R7D5C[3M7T)7K%:(JHL',.2L,72:?K653C&PPII1FV<
MD:K*MV2$J5JR7$I&:2+(H,]=[V7[?<8M[OAO#I3;/'+<6]K+=R+.;IT8B*(R
M-WXB=E+ ,[1%G7YY+^.M6XM(G5V(8G#-IR,$[D@9!89Y8! 'E6L?".'*SC!]
M)2M;3>2TL2-<$!_+KLU7O=%CH%[BV.T9-2E0,8B:@%[-4YU4DR]8$-P'IO&.
M+7'$4CBN2D<1D7P1*X36 QUD,SG."03J P2>=:4$2Q%BOB)!P3Y'&V1CWXY^
MS>LLR2UDAVOK.&6")FBH=2R[=V (III!VAR.B*(BE(-P*!^6SA-5(AQ!1,1,
M0%-<J8+6X?NYAWL0;"Y7QDG;PD$%"=LL",@8('(;1Y;$@^>0#[A^UOC .QY8
MZU(-%S>UM<^S0NQFE<D6K8R$4^2*8(55XJ1,7#A<SLQU(QPL8@(]@Y64:BWY
M DD55;LR1U]P5[2!S::[B)F#2@_VH49TJ NTBJ#G4H#:M^[P,U59 Q\> <$
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MU6[Y^;[B#CIY\N7N&U=\KE?&592%NM9H=,$ Z2L(8._&()?\PJ$8FJDD(>(
M!S)@ ^'@'&J!2>2GV[<O:3OT^[UXK@GFQY;@9.#G!V'3/7EGETJ,I'='2F_4
M6,AK!)G 1 IE4V4>B;CP 0.=TY6 H_)U-@'R\ U?H;S'JY_A5H QS/K QOY
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MFE*:4II2FE*:4II2NI5=%!-15=5-%)(AE%553E333(4.3'.<X@4I2AXF,80
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MCIUK/';S28*H-)SXN6=LC?&3G;=1BKD@-KK153OUWM#^9>*&ZUT(\3H)G,/
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M%NKFV#]X()GC#D %U4^%B!L"5(R!R.: Y (VS[ZJD@("HD ?= 4>1_*(=/\
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M'7\[U+6E5II2N.0]X?3I2@F /$1  \_$?D]_Y/QZ4JU9>R)-.I!KPJX !ZC
M(]"8^(<&$ ^Z^7I#D1_$ @;65(2V"V57/O.W3(]?/^%8))PFRX)^[]X_> /.
MK!<NEWBIEG"AE3B/(=0\@7\1 \B@'XO$?,1$?'6T %& ,"M!G9CDDYQCF:Z-
M5JVFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2HKS;B^ S/BN[XRLZH
MMX>VP3J-<.R]/4Q5^*LV?!U"4![JY215.7J)UIE.0#E$_4$IP7B=QP;BMCQ.
MU77/:3I(J8_M <JR; G+JS*NQW/(U72'5HV&5<$-[,''L//^(-?G"C?1G[S,
M66&Q)8FFZ@]@Y)8J!)WOT4R?2$:U4<E; DK*,_6\.HJ@Z63<*Q3B.<*D4 PJ
M%,F@*7TA)_2+V1XG!;MQ2WNTF1=1@[N1UCD<(6#")S%-I9!@2+(@(Q@Y),4O
M#KN!V[F6-5;'S@02 3@'PDCF1E2#[ZNBR[)O2%3E@83L4UQY348DC8(F#J\O
M -(1@LW&O+&>%CW"#E%9VL_JT%*&.L4Z:,G'-WC1)NL!C&UK?MCV#A@>"4\0
MNS*6[V:YAG>:16](&@N"K! EU/& I!,<C(Q9< 9'M+YF#*\,84>%4)T@X7Q8
M*'?P*?4RAAOG-O)[#?20)Q45 IVYBC#0\,WK3-@G=8LC92N-23Z32!DTR)!Z
MZA&B-IL+=K$S OV#9M*NVR#=- Q4RYSVV_H^,LLYLY#--,UP[FRE+"X?N"\\
M9)Q#,YM;=FEB[MV:)69BV2;!9<0"A1<(%"A,!B,H X"GP>)0'8!6R #@#:ME
MGH^-CCW:?#62P7*58RV0[FW:,7Y(P3*1\-$ME.\A'I+F H.5E'($.JLF D+T
M"!5#@KT(^>=N^V:]J9K>WM(I(N'V9=XS*,/-,P*=X5R=*A"0!D$[9 QD[]C:
M"T0Y;7(Y!)&RC'(>>QSSYYSL-CDE3>_@%R! DF*0Y*R'T]U+<A1#_*F0$P$&
M(D6['GGGGLTBF W/6)C\B/.W>C_)-1CS\FV!(869S_DR<S+&7QMS)P>FP K=
M4<SSPY&<C;?F=NN=LG[JD+"7AB3'_/(<5MESSU (<"ISSUB)^0^7K$3?RA$>
M=:/%S_RKQ#F?\H;E@\^NVWPV\JM'(>P?NJ\W*O:KB(?<@(%+P/R!^/P\_P#5
M^76A6P!@?D?'<U?E=3Z(AJ/_ &HK. 'Q\0664.0?SIF*/Y^?EU$WC9N)!STZ
M4^PH4CW$$5IN26/[O;O^?A5;UJU932E-*4TI32E-*4TI32E. 'S#2JJ<$;]1
M6!N-&=?ELR79#(:35Y-'D)5.*:S8)J-EY$)90BB)$' BBLN1H! CD#@<HH=7
M8)B8I..A7:&+1\T(N".8&D>7F=SZ]R:AI,F675\[6V01MDG .^WL&YQG!(Q4
MF9!P:(.T[=C!3V<LC X.@C62@LFCM5$14!2/,GTECWHF H B E9+CP E0.)C
MG9!!5QK5A@Y&=CT/F-SYG?R&UBL5((RK C!!QXO,>1.#ZCRR 3F2\+;F EG:
M='RB08&VMU"L49%Z062$@Y*)$RMWZ*H$!C('$W@8>ALY$>H 2.)>TA;SAIC#
M2VPUQC),8W9  22OTE&-^17V<IVSXB),13X60<I-PKGH&V\+8QOR;I@[&<9X
MP.,UXQ;"("FAC[+TR3Y?XPSFL11"8AQR'/=[ ZX'W"/'GJ(J5S]XS^[\:EK2
MJTTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI4/R1O8_+
M<1+C]K@LJ1B=2DC>2+6]55"2FJJZ$A>")FLE94L\1(2#@>5'-9I<.B)E7:">
ME4Z^W\Y_</R:F 1X\]*K4(9DS?7,2Q9NW.G)65XD88J#24+V@B("4KI_TFZF
MK(A_$3& %%A 2(E'@YT]RTLI+ILC*1*?'(0<?]U>A;KY#&]:=W>1VJ;^*1@=
M" C/J+>2Y^/2L,6Z&Y#)*!KI[7NJ^1;K<Q$0,B_A072*!C(BSCV;<S=%%;P(
MBL],F9R404.843%6'H$MK2)2BPJV-F9D#,?/);)]> <#I4 ]Y<NX<S.I.,!6
M*J!D'90H_P#-^[.9CP5FVTWJ*EJO9S#[05HR(.9#LP1<OVBRBZ'2Y(0"IE=L
MW"!D5U"%+VA3HF\%2F.,9>644+K)&,(^<)^RK#RZD$;C/([;U)6UY++&RNV7
M3'C_ &G!V).-@0?83MD9!J:0  'GQY^41\Q^7Q_.//YQXXY'G6JXL3SQSSRK
MG2J4TI32E-*4TI32E-*4$0#\VE5 )Y#/Y_/W>8KCD//_ . _X_\ EX^6E,'E
M[N8_/^.!S-.H/?\ X_QY>_Y-,?G[J:3Y?>!3J#W_ (_Q\<<\\?D_J\]*:6\O
MR#C\_'E3D/\  "/^/#Q_)X_*&E-)\O?D8^/+K7.E4II2FE*:4K@3%#Q$> X$
M>?DX#S\?+P^7W?+I50I/_$=>77KTJQY!^,LX[ND;F.;F$5#!]R\6(8!*;D/N
MFZ9@^UAR *F**H@($2,,M;6_=()''ZYQLIQF)#^YR""W51X=B6SF0:<G'EC<
M'!\S^2,G8UR     >  ' ![@#6U^?C5>=-*4TI32E8JU=M%JJW0[DT1VXY)R
M#U=[)21<  6B0 H",U"/'_ @'AVKDY>!Y2 I."ZZ*Z>4+9Z>]"CAUAC2;W'_
M #9,_P!E,B'?GA01U.>54!YX.SGH>61RY^ORW&VXJ2\/*@GA_'Y2B')ZVR*3
MIZ.!('7XAV8%( >7'04"C_F@ <!J-XO_ /BM^=][F3.<\QCSR>IYGVU6, X/
M/PCX\O?L#_'>K^;M5'BZ+1/J [@P%ZB^:20" K+?B!,G/2)N"BJ9,G/)P'4<
MSB)&E;&$&0#^TQ^:OO//U9., U>[8'MS\!S_ '_#.-ZE5),B*2:28=*:9"ID
M*'D4A"@4I0 /#P* !X>[G4"S%B68Y9CECYD[G[ZTV.23^?X??79JE4II2FE*
M:4II2FE*:4II2FE*@'+6$(Z]]I.PJB<1;D2D,1V)C)M),4"@"*;X$P$R+@H
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M4II2FE*:4II2FE*:4H(<^ Z4!QN*CW(.-J[D6+[E+H=B\;D4&-EVY2@^CU3
M/'082CVS4QND5F:@]FJ ?%%)0"*ESP3O VI3D'YRD[,.N?(^3#<?NLDC29</
MD$?-88RN>?/8@_M \\"L6X.U73 $XE5;DDM+TQRH<T>\; =5-%$RGQG<.JJ!
M>.S$1,]AU3$$AQ%1$Q!,55Q,1R)<+J39A\Y2<,&'($>O  ;<<QN :BI86@8A
M\X/S6Y@CS!QLQR25YXWVZR&XK-.S+=;V[%9.1C H>,8V(FV1BBYCI1"3R;+.
M3-SF 1(;NL]%E?,5BE$_25)<A%$TS)VJ2)9",C"1J0?,&0D<_)A@CVBC>&*+
MJ"\I]Q$0&QSR*' )SD>546@Y*N&W*Q)TN\E<2]#>K&/'/T"G4*V2,<"B]BSJ
M"'!2<\OXI0X'1/\ '3'@Q%5L%Y9)=J9(\).N!GHX ^:V.1Y8;?/7&*W+*]:W
M.A\M V^!N4\V7?E])>G3)Y[&XB7C9Z-9S$0\0?QL@@5PT=MS@HDLD?R,4P>0
M@("4Y# !R' Q#E*<H@'-NC1LR."K*2"#L01^=O,;UT2.KJ'4@JPR"/(U4M6U
M=32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5CKGS.4=BN([A'
M&1?7*41,6,C^04!BFH!B!)/B%'D$R& .[(&X,Y4#R%,IA'?L;)KIM3;0HWB.
M<%B#\Q>9_P"\1R'3.PT;V\6V72N#,P\*G]D<B[#G@=!MJ.,&L-Z;AJXH3),Y
MR9$YR^/%"NWM0F3II!88@Q53)J*O70@A$W-CVPN:RX=_\G))BK#31F9)!&7K
M<\RA,=P JJ-+(N )%'( [89=\,?G$D-@$..?$A<L)F+,Y+*QRS(S$9)&<E&P
M-2_L@97<%6]V2-TE=2+[)4M_W.[.!%G+,)U$8:;K#DYQ;F9'B) 4%U905NHB
M#Q KF(,0"NV#R00506U57B.=3A0HW5SI?;GD'! VYX(8'8D;FWN7'B*EL[!D
M!=2>6Q (SRV/S3G(&-KLPOC*LPYTK19)R%L%Q=&%PDB6682B,2JJ/6*I3@LJ
M+J7-SRL\$RA$3B)6PF$#+J1]S>&4:(CB/Z0V+8Z>I?5C<^RI""U[K#NNISD@
M8R$\L'?Q>9Y\\'.]93AX ' \A\@_B^3R^3W?BUHULDY)SM01 H<B( '(!R(@
M <B(  <C\HB(  ?*(@ >(Z52N=*52W4Y"L5A;O9>,9K@4IA0=/VK=8"G#DIA
M355(<"F#Q*;IX$/$!$!#50">0S^?W^KG5VAL9QM[OA[?57F]J*U\X83ZU8_V
M^JZ&\OO'XTT-Y?>/QI[45KYPPGUJQ_M]-#>7WC\::&\OO'XT]J*U\X83ZU8_
MV^FAO+[Q^--#>7WC\:>U%:^<,)]:L?[?30WE]X_&FAO+[Q^-/:BM?.&$^M6/
M]OIH;R^\?C30WE]X_&JHU>,WR(.&3IN[;F$P%7;+)KHF$@])@!5(QB")3>!@
M W)1\!X'5I!&V#GJ,$X]N!M0JPYJ?A7HY#SY#CRTW\F^RWX53!\C\#70Y>-&
M2)G#QTW:-RB4#+N5DT$2B<W24#*JF*0HF,/27DP<CX!XZ<]L'/L/K]7J--+'
MD#\#5+]IZU\X8/ZV8?O&JX/D?@:KH?Z+?9/X4]IZU\X8/ZV8?O&F#Y'X&FA_
MHM]D_A3VGK7SA@_K9A^\:8/D?@::'^BWV3^%>MI+Q3\5"L)./?&1*!UBLWK9
MR*1!$0 Z@(JGZ"B(" &-P'(#X^ Z8/D>>.1W]0\SN.6?*FANH(]NWY'KY=.>
MU8H9^W,5'$1XJ)[NI=LIVY0C#&.(H63BV5ALKUZ[0BV$A*/)9PVB:?674J[9
MQ[JXV5=E$-UGK*'CQD;#(,8>0['@79ZZOUDDSZ-8VX[SB7$Y(Y9(;=(T,DD<
M21 RW$J1QNXMH 7<H\LG=PJTB8;J]BM B;27$A"P6X(#2,Q"KJ9B$C0.R*7<
M@:F"C4WAK$RMX6SAN/6CKKGF^3GLV[<QL@..*A9KACK%;)BQL=0E5X-.M0QZ
M_>+.X>5PU\H%Y+EAZJ\A[G",):OQ$?!R"K-+J)^*<)X"KVO![6'TA5D07US;
MVM_Q!F>WNHUF%Q*)K2W5;@65[:'AXT3V<TD<S/,H)CX[:\OF$EW*RQL5/<1O
M-;PJ%EB<H$C,<LC:!-!+WYU),B-&NDD58:VR+;NI$%9$EJL5\,$E&#*J/W2K
ML\B7$UKI9IA83W #*.SW2-;9%6^V 8\H+1OV@'4!V$@O:SCBS:C!<F,7!D$7
M<@*(_E2TO>X&+3Y@M)6X>,#'=AFZ8%I[/VY3'>*&[O06+.3K%J\'>$-(HR9F
M6??<,NP&1BK+[.-M!I KI-.GI-CSJTGW3U@XZ2QJF5L:7!.'$0M@"*25-6F:
M 4_3TC'R4FY!,I$A:*XU[3]H.[TD7>H0K'K$(WD'#.(VK2_\U.YNUBOSOO)'
M$N?$",GR%:Z\AD"ARV S#"FZCG"9,H_Z)# 3C?6S_LC%-<[+-N*C4J"3BI(K
MECTFAG)7K@QC.25',E=4>"4+<'VQ2?=U:T"7JY*XK$.CU"9T1PVO7M3QT/J,
M-R5[QG"F(#"&[X1.%R+7&.X2YMLD?-N)6QX"#8> VQ&TBCP!=FD))$-PA/\
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M6R%((.<YWVV\KJKT+E'OJZ2>1*ZD99H"AA''QSE,#94I2%X]KR<#_&C#R(B
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MC5MU66L6J$!Q[= )41IE+AP%T(^#4C:?$05D1.;5N^TUCZ+A>!<&DE[O(U<
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MR7[ON\/KT8+*/%WWHY&2V,B;P'IG?.*K"VX+$Z#[U:K9^AYZ\6K?8^J9H?\
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M !-PN5ER5S)-&@E.FLD*8@8TC'%*)T1+RHX;@=#@RB:!=54CYK ,C#?.,;[
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MQ\@CY  <B(^7T_)^?2JU[V$<[D3 #<@ B(\&=*%$$"@/F*8^!G!@#D0*D/0
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M3/VCDO/(NU52F$Q4D@+$7<_?2$ ^!"0N#L?-O?\ N\JE[>'N8P2,.X\6>@Z
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MT3_?^G<R_52?8;\*:#YC[_PI\(_;O_/YA3]:M$_W_IW,OU4GV&_"F@^8^_\
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MN>T(DXIQ&9?T:=PLE]=R('':#@"!E624A6"LRE@ <%E)P2*G#[&F./YOJ/\
MT2@/]WZ_.XWEX"1Z9=[$_P#O,_\ M*ZOY2XA_GUW_K$O\]6/=X?'U,1AET\+
M0=E+,S,? IEA:YC]N9H_E7;=C' Z]?NX8!1=.''1VK87 (@F<S@$BBF)\L,]
MY,6'RC/'I1Y/UES=G4(QJ8+W?>;XW&0 >7K&[8S7UX\J-Q>:V[J&6?5+-=L'
M6&-Y9 O<K*0PC1CX@JG8!L[5YD5]O[B&DYUO6:*Y80TJV@)0&5$:2+QI8W:K
M5LE7"Q[""<OWD^1T];-5X=@V=2"#A9-)9N0X\ ,G%!(D9N;M6D0R)JNI0&B"
MLQER95 C*J6#D@8\\9-V..B6*!IKZ.2:W-U&9KIX(S;!7?T@RS2)&L&F-V[U
MG"%5U!L&K?)<MKBIR)MHZ@O%E6,3(-F[#'8OW3U*;"%&.;L&K.LKN9"46)8X
M!16%9)+S#-*9C57S%LF\0.?-IXP,YFO%"O(A+WCH 8N\+$DS$!?U4H#DA6[M
MRI(7%;!M.THSJDO8PLLT3F2\[L1M;M<),TK23((HE:SNU$TA6%VMYE21C&^F
MJ1<QMMG#R"</$XYD#1=8&XNS(TN.! *Z6-C9=:00=*PJ31T+2.F8=U(-&JZS
MV-)*QI9!NU.]; IC=N+)IUS7JZYA H-W+_:%G15P)=0!:-P&TZ6TMH+ $BR2
M#M%$$:22^0/<BT :Y?6MP9)8EBDC$I:)GDM[A(^\"B1H)@A/=OIM*$NV$)1>
M=2?XJKD&2M-(IU-&<5JCR<BT--0E8G6""=6@CR=S=]3>VQ+)9XUK:L<G* \9
MIO5BMRKJY77B*",B^N6[YG6/%Q=*IT/-&Q,KE85W@<@&345P0NXSEGMN,PK:
M$<3DD:]>980+JXCC*07%Y;-(;FX$-LH,EFY"&76$>-F5<LJ5I6V;:2FCRM*[
M3Y4LH_KD>S<Q.-BOV"BEH6B$HY?UFC7O5@MFX3T.M,'3>'-"(R3$90C51XV3
M5M4<6.K-Q=+I$I8->N&'=:]7A:4-OW4A0:?UFA])\)-8S;]H5#%[BZC*K<.5
MEOA&X%JDKR*8S-KUMW$ZVZ$![EX9$MEE96 K$#(;>;0^CXNOUFF2DE*$D%F3
M)'')4EE&T:QBI)=^OWJN($812[&=A'4;,2!VL5+HR\:>*>O >MQ4LD;BD09G
MN;I54#+&\D.[%U VE(+!HW#HA=T[M]0&U8YTX[:I))<7%W$D31*[->;!Y7FC
M6)2)B9)@]O<+)"@:2%H)A*J=S)IC^3R7M_BH]O(+8ICE2&@QF'Z"%&IPKPKH
ME=R'9'%=E"J+)D1L#)KC*QM7S)$ZZ;5X>,*JX*W>@X)G6+BCL5%],/UO=J6N
MKH*X,EO&LB$$YC8W43*QQJ75@ C%2$'#./W$IBCXB^3)W<9-[< 3*;OA=HD\
M8*:O1Y7XO:/'(ZKJ03X!>%HS)56:8GM,Q)1#?&%59'9(.W+1=Y4JR!)-"-LL
M[4Y4S<J+144SQ\O!*"JFH(B+*3B7(&*HY6;MM:2>_C57-]<G40"JW5P2NJ*.
M5,DLH.M)!C V*,-]C49<R<4M8DD?B-P^MPA5+F<E"T$%PA?)  DCG 7!)+1R
MC $>6O*0QKCDK!Z8N/Z0!@:.! 0J<  @/8G\0$(_D!#Y!#6-+V]#K_EEV?$O
M.YG\Q_\ $K33B7$-:9OKO&I<_P"42^8_O5MFV9VW8I6=I^V*KY%JV(&]\C]M
M&'IBQ#,X92DUWLD^Q=6[(G&)6(M(>QMDO4S$OD9B.ID7*REXG6RIW,?!O>A4
M2>R74EP+B<++(!WK8R[$8]6_+&_,#/PK]*.'R6WH5IWBJ7]&B9SH&22@//JW
MQZ9Z5D36\E; ++;IBIHXVPU&JL4:D:'?3&'JW&!9GMLL+&G!!Q\2]JJ$_'V2
M"NDM#5&<K<]%Q<ZSGI(&8QXBPDQ98#+=  ]\^,G8,V?5UQY_#ESQM"6S)(**
MH !U%1OGU<]N>>6U1'6+=MZR)NBVIV;!N/*W235O)&Z[',^O&T6M4^0F A,-
MMY&)G&BL"@!I:F6Z$DH>VTZ247[*2A)9D\,U:.^V;H2-D\K1W7>2,X ATAB3
M^V<XR?, 9P-MNM0_%GB:.,Q($QK#;8R-BIZ<_+F,GSK:_K/7/5&V8LD1V'\6
MWW)LHB5TUI=9DYLC$R_=0DW[= 2Q42#D4U>[GEI11G&IK=DKV2CHI^S4Z>@:
M,0H)/(#\CWU<JZF"^9^[K]U1!AS-MFW+4>/OV-D(:@U5XJJR7<6YA)V2W%D6
MI4R2+1& :+5R"8()'4[6(L 6*S-I!N9)1U LU@<,DZ*VL9&PZ9'QV!\_6:N9
M0APV2?5L/5ON3MS&![>M2V3&IW?QK+D')-D.'B0"6<:2BB;S$$D\9,Z0=5,!
M$>@L@L_4 O *+*F #:KCS)/OQ[ML<O7OZZM+>2@>[)^)S7:.(L<*AQ(59G/"
M/B92TN9"VK''WJ+V9Y++*&'Y3'4,(_*.F!Y9Z;[_ +Z%F/7X8'[JKM=HE(J"
MKE>ITZK5A=Z0B;U>OP$5#K/$TS"=--TK'M&ZC@B9S&,0BQCE(81$H (B.JX
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M]A^VEG<=H'NNQ_:>TCD[.O!";C@'$K=9)CQW@4W<PJ]JNI^ZBEE$::B(XY&
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MY$\L'GOG?/D1TSDC;VXVJ@;,;2HM7[+17QQ*]KLH9\W0.(]96KS^+.DP*8?
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M=0KAMR @ @ -W*:9?,! @\"(@(!SW$XA'=N1RD"N/:=F]Y()/M%=+PV3O+5
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M9V*4K>56,VBEQ,.-0 $91P0Z$>J(]F]6(=)L950HE"6_JT[99P.%PG+2(/\
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MM?\ =Z?PFV[[^93;;^L;*7_!&GZ:\+_S;B'+/.TY#F?[7D*?UZ\+_P"SU_\
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M/P/E6P'6&M:FE*:4II2FE*\<@U*]8/69P*8CMHY;'*8.2B1P@HB8!#Y0$#B
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MOV:J:23.#$#.U-N+CMS'<+)Z+$2O$.T=UI)< MQFSCMIEZX2 1AH<C4SDA@
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M.JN@8Z#@XBJF8Y#%'7#-<S:FPY U'&R[ G8?-SL,#??;?>O2#Q2]3PK</I&
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=-,H%(F0A0 I"$* %*4H 4I0      UCY\ZR5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>g425213g20j89.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g20j89.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2UL4&AO=&]S:&]P(#,N,  X0DE-! 0
M    +5"^$6 #A"24T$!       9!P!6@ #&R5'' %:  ,;)4<< @   @  '
M)0  AR<C4P,# W.!P"!0 [36EC<F]S;V9T(%!O=V5R4&]I;G0@+2!'<F%P:&
MEC<R!F;W(@0G5S:6YE<W,@4V5C=&EO;B V+G!P='@X0DE-!"4      ! U(P
M@@PMP9I^[3X+OB:/X?.$))300Z      #E    $     $       MP<FEN=$
M]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M  0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M95
M1%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P
M!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6
MT    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M 0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;V
MP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $
M-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V
M]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $
M)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT                0F
MQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P
M    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M  .$))300-       $     #A"24T$&0      !    !XX0DE- _,
MD           $ .$))32<0       *  $          3A"24T#]0      2
M O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M  !@       0 U     0 M    !@       3A"24T#^       <   ______
M_______________________P/H     /____________________________
M\#Z     #_____________________________ ^@     ______________
M_______________P/H   X0DE-! @      !     !   "0    D      .$
M))300>       $     #A"24T$&@     #-0    8              N4
M)X          $                          0             ">    N
M4                      0                         0     0
M   &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M  5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   N
M4     4F=H=&QO;F<   )X    !G-L:6-E<U9L3',    !3V)J8P    $
M    5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;V
MYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V
M5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M    !,969T;&]N9P          0G1O;6QO;F<   +E     %)G:'1L;VYG
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MU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
M      #     (_\        #A"24T$$0       0$ .$))3004       $
M  $CA"24T$#      BN     $   "(    H    9@  /\    BG  8  '_V/
M_B#%A)0T-?4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.
M( "0 & #$  &%C<W!-4T94     $E%0R!S4D="               !  #VU@
M !     -,M2% @(
M                  $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0
M'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)865
MH   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG
M9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P
M  #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0
M  0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M!D97-C         !)S4D="($E%0S8Q.38V+3(N,0              $G-21T
M(@245#-C$Y-C8M,BXQ
M                        !865H@        \U$  0    $6S%A96B
M                  6%E:(        &^B   X]0   Y!865H@        8I
MD  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#(&
MAT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:6
M5C+F-H
M       &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V
M]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&
M5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M        !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;V
MX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F
M<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M          =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%
ME:(       3 E6 %    !7'^=M96%S          $
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M0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,#
MP,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01#
MP,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0
M@ H "( P$B  (1 0,1 ?_=  0 "?_$ 3\   $% 0$! 0$!          ,  0
M($!08'" D*"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @
M0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4
M,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$  @,! 0$              00#!0<& @C_Q !2$0 ! P(#!0,&"0<'"@<
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M3?KQ'?<-M?EO\^>")Z!IIRP1( TV\@&NW/Y\]-\$1IV[\-?AKMV\=]?AM@B
MVU'D(Z\0T[1^WNX=,$0.P<O$?GN ]G'!$!H/0=/.NGAM\ML$1H&W;T[NSIRW
MTU[=,$1S\ T\-=]?'?Y\<$2_1Z_]H?OP18[*(=$)NW%M$UBL;E[22K+<"6N4
M,;9(&XI>24>02M*1.R56FH5E$*E)):F@H#J"E!Y=%84&F4U$58;)GU]$Q&I
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M#UC@)52I<M-4$R]?L]5NR!H%,     -@  TV#0  .  '( #!%#/)S_;YL/\
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M7/G^Q5NWU_KXQCOR 6J0<//#'L_(3ZZJ?<*W[[#Z*KBS%('^N.6CN*IVQV(
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M,R\_C_I"&?S\<.'I\3[(1=7/G^Q5N#?:>,>XZ_Y*D'Q^SPQ[/R$C\M5)_P!
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MS1]UE3+ HRB8HX]RF02R>28M>9&H<P-#&C5FF.[X+:L+2'N)C<S)Q)J,<W5
MG 3@(H'6"O+F#N]GMN,E;<O3#E;C)UGK#7,NTHO)*:+E7SNA;=Q>K\12T;*P
MQ"V4P66HLLYHWF-S%PD2M;,+D.QC.M;4BIF2NI]7Y"(I;Y_F"+R3)[?!LF%P
MD-J&4N/-#P7<5P@[M<XJ)/T;ED?D42=$UMF)V97:X3M3*VIE(8X.C7#7+'HY
M PF('<E>8T+B+4&2#,C<F\CVJ9[I7I@<O>E4&?Y(VVZ090[F99)^QC"+QS6Q
MTU7R%7,LQM\V!U/8)];Y]8'^(M!+:]Q@]PC;@]&HTS\UHU;KP161CR[^FO\
M+OVP1'?YTX>?K@B6_9R\_=QUX=N"(T$.T1W'7AR#D <N&W?@B!#78>&"*&>3
MG^WS8?YYEZ.'_P A#..VWQXB."+JY\_V+-W;/&,./1ID(]/MQ[/R$^NJGW"O
MG'[;#<;*KB_HQ]MO&;!Q.1U%E3MCL5]=1_$".\Y'0R; :RVDQ.GHD^&HU%C<
MF(UG/@.,DVF^1$B)G3()< B.-^P9Q$W! )\<S-IWH]=1B]R.'ZP,O+_BU0/U
MY\=.'+3EOPA C%[.YX>OV?2@Z]UA^*V&",MJ?:;Z&PI8Y@?V(W5#_D')M_\
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M*MW3\_&3X@UR !Q[/R$^NJF?Z!6Y?KL/D>/JLJN+^B'VQST=U[1FJ=L=BU]
M.HS[9M/?;.2-9I'$R1D#EQB.?*3E 1B09SM?D( FQO-XO[I4&!PX:W.I%HMZ
MKYP5:;Z/7]5[D?O R\^/^IBG[.WMY:8Y7\(7Z7L[[O7SB;U1/B1IRMJMC@OF
MU,OG-R^SU/-2SS _L0NMS_J')OX4IQY+87UWLC_>.%_>M5BO]#4^P[U+Y_\
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M72732.A8-U5.H&-Y@TT>K7Q.U-HXRGYK%8W$XBD'!XIUJKGM#@" Z'$C> )
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M&B2FH 3:Z &M0< DD4_X1IH"66%5>V"+'9],$-O8)-9\YIE:UM@\2D<P<$:
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MS$*L$7,MQ;SC@3D+49ZH4M"VE,2I(,45HS:AI*54E4F>N*8VL!I+/T FNH!
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MT'4*4Z<BG1[8G2JKVQ7JTF 355[2C2DT:J: *J'70#!KJIH"@?TAJJII -1
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>g425213g22m02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g22m02.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1RV4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ')J^<R(X0DE-! 0      %@< 5H  QLE1QP"   "   < E  "')R,3 Y
M,C$Y' (% #=-:6-R;W-O9G0@5V]R9" M(%1O($MA;&]N("T@4RTQ("A'4"!$
M<F%F=" Q,BXQ+C(S*2YD;V-X.$))300E       0]1W,[&"R/8$C9$"/6X&!
M_CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I
M;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M#W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4
M<       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0
M<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P
M<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O
M;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
M3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O
M;VP      $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B
M0&_@            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M         $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M             %)S;'15;G1&(U!X;$!PX           "G9E8W1O<D1A=&%B
M;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C
M4FQT                5&]P(%5N=$8C4FQT                4V-L(%5N
M=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R
M;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M   -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M    .$))30/M       0 )3,S  !  $ E,S,  $  3A"24T$)@      #@
M           _@   .$))300-       $    6CA"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          3A"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))301$       0     @   D    )      #A"24T$'@
M    !      X0DE-!!H      T$    &              +3   #L0    8
M9P R #( ;0 P #(    !                          $
M [$   +3                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   +3     %)G:'1L;VYG   #L0    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   "TP    !29VAT
M;&]N9P   [$    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     0X0DE-! P     $?H    !    GP   'H   '@  #DP   $=X
M&  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(" @)
M" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,
M# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( 'H GP,!
M(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)
M"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@%
M PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A
M\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%
MU>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!
M  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:B
MLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F
M=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ /54DDDE*22224I)
M)))3RW4J_KZ[+RF]/MJ;C6.>,1Q](.K ^R6L?<Y]=_J>IZ>=C5,]'V?:/4O_
M ,"^F> SZZ?M ORWQB&XN?4?1(VEF9M;CNK M^S5;NEM_3_K3\JO(_[2_P [
MTR22GC:<;_&/4VEUV4V\?9VF]C!0'BUQL==74YU+*G9%=;&?9[W_ *I]IMQZ
M[<;)Q_M62IV8_P!?&^A:,BUS764&^AIQ-S:B[*^T-W/IJK^U-HKZ9Z^RS[/]
MIMS?LGZ#TUUZ22GC::O\98JL#[:#:YDT.?Z4-L]7";LO%5?NQ_LS,^S?5^F_
M36U_SE>&B.;]? YY_2.Q" 6M:_$^VCVXS7,#WT_LW?ZXR+O4<ST_0^UU>GZG
M[/\ 3ZY))3R@K^OL 6V-]5MU?VIU1H]!U&VPW#I3+:_M=>3_ #3?\I6>E]K_
M )O]40*JO\89-6ZW:WU(<7?9G$/FKU;+O38UO[)]/[5]FII_RKZOH^O9Z?\
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MTN9O?[JS#9;76T;7,=]!G[GIV?Z3
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M! ,! 0             ( 04&!P,$"0(*_\0 7A   00" @$ !0@&!00+"1$
M!0,$!@<! @ ($1(4(3%1"1,5%AA!D? 787&!H;$BE\'1UC(X5E@C)BA(4E=G
ME9:WX25&:'9X@J:G\0HD)S,U-T5B9G*'DZ6VQM/5_\0 ' $!  $% 0$
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M/6?RA0"])CV)QW4+5[#"R!B<6%70VG9G$2U!I*CX%I4).J P:',84+(CB@7
M@>592G+G#U)Z!BMQ?(D*WEUKN:%SSM9)GW<&^KXK#L3/NX[2LPP99M.JBCJ5
M<P8;$*<CLG"@8W$X_46Y2"#QJ<H=D57)HC)3!<LX40'MP/L'\A-4\0MOM_9D
M+M9_'Q/9OIB<ZD0^"8A2;H'23J95-7-3SVT0V?K6@G(B\O'5/!R)$1LS *:J
M,B#/!W=$ENHD!MOK+\C[6G5OM?3O:Z!V09P>@_44+UKLN%:@UFL2M&:@H?4D
M"TOE@Q4DSYM I8=B=01D/+0PUF5;2+06"?.B6A8<1(' /8C@#@#@#@#SX_\
M9G/\N . . . . . . . . . . . . . . . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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MFQG,>BK9@\+.C$O%1(N3AR#$,QU4<&":4G:BG(D;JW=9<E466$VJR^J6O (
M=@J[E):QKR8#*_DQ"_Y5?G2F3=;;);5[(".D4J.)YIM*?-AUGMV"X:(@XB4B
M_8<I/P*YX!C8=8#=B1&/E+(#HGWX0,_Z70\J-D@]]4$"7J4,.Z5==(3-V<VK
M"3P\<M>8<_,W1,;(@;EG#'TCFL0!+%49>3;O='::DHCJKU\_2=MM$P)T5[/I
M\\N&R:DG>L0?+0NM:?L8<?B8PR%3=I6?*+MC*X=Z,,')#MA03O4*;U%^@0TU
M=:G-V^[-'+#5=T!OW@#@#@#W< < < < < < < < < < < < < < < < < <
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M9SM@.K9$;&L.!K=^&#TMX X X X X!&2*_YY=\_^3)U+_P"M3NIP"3? ' '
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MVJ,>"BG)0WNR^Q)JFB%ELNT.\:#[XN'9&J6@"2%@71/FKYW8TI(X=I12$I2
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M3=482A755N,[I[KHJKHJB_-MLUT5UQ2UKX+44DJ8QZ>R?;;?HEZMM^B7Q_\
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M < < < < < < < < < < < < < < < < < < < < < 8]O\ '^&?' ' ' '
M' /G?_)S^S\_^W[N >4-'?,3F[8=&SUJ0!BTHOL;VCF\,JYE7<C!VT^E)\I=
MD3=-)3+2AQS'2L69 K"E<F;FHL"9*S?7:*$'KIOL-+:G0/6#@$2+J[91RGKR
MH6DU0FY]_;I&78E9AJ3U;I57&X]55J64#D!M@F.?*D%)LM4DL!1L9LY%;O=
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M;JB9> X!$@$-#NRZ]E=R&*Y5T,CH\<R<$EV8]@T5?*H;NE&K%HWW5V2;(Z:
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MOE+22ZGZMI);]R,TYBE8X X X X X X X X X X X X X X X X X X X X
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M]4WN<MMOJF]O<GZR>WM[>V94>KI75I2TNKIWT[UWUO3UOTWWT=KE)(X X X
MX X X X X X X X S[?X?PSYX X X _/Y_/[L\ < < < < < < < < < < <
M < < < < < < < < < Z),DS##2!8BMAN/%LG1%\XVUVVU09LD%'+E;;73&=
MLZI(I;[YQKC.V<:^,8SMG&,@1:Z\=GW5V&7$?DU9&*J-$JWAEUP4<8D061KR
MFHK >%F$=.$-@FFK>-RUD[#[I2R';+ED06"@/9G(S67KK4<!=XKG'VR[XSYQ
M_FQ]3,>__E4[I\ DWYQ\<?CC@#SCXX_'' 'G'QQ^.. /./CC\> /./CC\<<
M><?''XXX \X^./QQP!Z6ON\X_/Z_=P!YQ_PL?CC@#SCXX_'' 'G'QQ^.. ,Y
MQ]VV,?OQ_?P!YQ\<?C_V\ ><?''XXX \X^./QQP!YQ_PL?CC@#SCXX_'' 'G
M'QQ^.. /2Q\<?CC^_@#SCXX_'' 'I8^./QQP!YQ\<?CP!YQ\<?CC@%> . .
M. . . . . . . . /=^_/]G_ &< < < < < MAH4S.ARH0AIE0>8'/13Y/7;
M.FV[,@V5:.=-=\>W3;=%;?7&V/;KG/G'MX!#&G>H+N/K*J7U(H1=Z#&BJRZZ
MA12U>?18$A!JU,&3WT[,0A^0R]B;EDM*O0;TOHCJU"#'$89*AF2.SUUZ(%E
M=*.OR'92UY"]ZO4EK BE']?0L:=*U17^XA67 9YV8?39!BS^AMOF"3<-(X H
M4=9;)>MM7(A+"[CU+*;4#>/V0>I_^K+0/]3]?_VQ_@#[(/4_W_9EH'^I^O\
M^7U?\< K]D+JA_JRT!_4]7W^'^ 4^R#U/_U9:!]O_(_7_P#A_P!G[N :1Z^]
M,Z+'0(ZVL;K/3>\A4NKLB_89/U= B3_$&*]B+1*5AJ@Y4$.]DPNE:O(GI'!^
M%=$Q4>P+%I-F23/1F@!N_P"R%U0Q_O9: _J?K_/\X_P!]D+JAC_>RT!_4_7^
M?YQ_@%/L@]3\?[V6@?ZGZ_S_ #C_  #1?9_IC1Q;K??8JJ>M%.Z6<2IRRF%>
M;QFL(&(D6DV=PXPA%M@)5(2R5&&-3:C'(U^F\:*-'F$5]'".R>%-0-YZ]0NJ
M&==<_9EH']]/U_Y]_P!_^U_V_OX!7[(/4_\ U9:!_J?K_P#P_P  9ZA=3_'^
M;+0/[J>K_P _PC_G@#[(74_W_9EH#]]/U_C'[_\ :]_/'G@$?[=Z84H]M#JX
M[AW6BH-8H(MV8/K8U$5C!&0Q2&K]>KK&!=9.T3%-]# G%DOX)NS8+(/DV\@U
M"E,-TE1Z;QL!(#'4+J?[_LRT!_5!7^<?QC_ *_9"ZH>_[,M ?U/U_P#R^K_C
M@%/LA=3_ #X^S-0'L_Y(*_SG]^/J_P#W\ ?9!ZG_ .K+0/\ 4_7_ /A_@&LA
M/3?KSI<<]?/.L]*?4EQ6E3-(]JM54"W#XE+*4W2M,-F#'(7;1L1V$OX-@J[T
M;I;/6NH9%1=QAAHFV V;]D'J?_JRT#_4_7_^'^ 5^R#U0Q_O9: _?3]?Y_G'
M^ /LA=4/]66@/ZGJ^_P_P"GV0>I_^K+0.?\ \'Z_]O[/]K_ +IUPA"U<UDM#
M]HZVB3(9:-]N8_'639FQ'C(<:OBR3L(2%L!_ADP$*P\F#<BF+?1%-F.6:MO5
MV^R64$P-[< < < < < 8^_W>_P"[/G\?U_JX X X X _/Y\< ?G\^> . . .
M . . 1JOZZ)M7QNKZVJ.$1JP;?MTG*=8T&FLS?P"&"(Q H\I(9C*Y-)!$2G1
MM)FT5<1R,#6(6*%GKN13 *HYU9!6Q8DS P(SVJDB]'4M.(56#<C<%\30;5L3
MJF3S+0&%CUE-V<N)6*,F$[$1Z2K(@*Q%US8I$J7"Q,H].8BR3$:(0<F$,MGX
M0-L]=+E?79 B!R01AM"IS#IU.ZMLB(L3FTG%@)Y7<D>QTVB#DB@B/K'XV53;
M,Y'&"SL"#(/8Z9%JE H@EEV.:@;Y\8^' 'C'PX! VYNWTRKF?V(RBE4"9E4W
M7YM7+OL7.7L\<1Z51E.QU</<H5U"DX::83AU H2X%6%,]#<MA2*X0RQ%QIP9
M/)O&38#+>WG82VNN,-*V;#Z?BD^K>OH-*;&M:1RNV4J\>-A49RQV;0BN 3.&
M38A,K+EC=8CM&AQC6(19R28C0"DGP4D3;# "7K-QZVT:NOF5V_K+=!QZNZ2R
MBZ0^>2U4^9<HYSG*2Z7I>@LEG.<IJ:[:><^// .QP"F?=GQ[_&?' (&T[W!F
M%C6!7S:2U0'B=.W\YLUGUVGX^?.9%*I,O66[]_\ _")!]X6%8P?6P(:$D4\A
M61$OF66P<(H+E> 1]ZU8< V2[[/CM^V0#JZ"B[HYE2!2Z53BP$RB* :%R<*G
M"RD?KK###-PH9DYF*2Y*8'$/7QJD4C[Z$OG#<BE.&&[,"57 ' -/W[;K"B*?
MG%KOQ#J0YB@UMD5&V3INP=2>3&RC".Q&,($7>BC08I))27#A,%'>F[0;Z_Z\
MYTV0;J:Y P:A+JG<[-V=7%RP*-5M;=3.(F^/BX7.']A08U#; #NRD/EL<E1B
M'5^7W07>A9;%RXTO%!CH>=B))9#=\'?"W[@#AZK=H(;VRA4FLJO'D9)0-I/Y
M)%887 3,/*WLEC8##-JSEYX:(3\0I24O,$2\:C1!T]*.8*O%)4_W'N)*H#$@
M2?X X!H&]K+L>$?4",5!!XO/+'LB3$ HEE.9F2@4+!B 4:+RB02.0R +#IZ:
MRDW;BVP@8+%1AZY(&C8[5=P/'(OGS<#5AKMLKIU,#=D <+8M#1HE#(DZA\[E
M68M'(/.)):X>F)*A/YRV F,B(=6LR?E7$ME;../<;1^//B;,=C"R6FH&V>M%
MQO;ZIR.V:2"@@) H8GD??,HI*_KU$'3RO["E=>.C\,F>0D<VE,*E*\54DT./
M[@12A2,EA;M1D@HKOI@#?' ' (U6O>\DK:\.LM4M:N(GHKV!G4N@1:TMY.%%
M"((; 4I<-RAAS:.;)OY#+"AYG3Q<>YT30!!@;-\V)+'7S[9 &Y PGL'V/LVO
M)QFNJ3J$+<$NCE3'+UGH@]/W4 RW@ @Q]!"P,,69PR:;2&QIP2:2%&+"RB,?
MC268T\U.289L_'_. 2QC9\;*XZ!E(97*X>2!AAX4OMKZ&RXTNR0(,5MM/.?1
MRJU<)*9U\Y]'.WCSGQYX!>N . . . . /&,^_'G@#@#@#@#@#@#@#@#@#@$;
M;SJ&:3*7T]:U72",@;)ITI,TV*$T$$BT6E$.L2*K1^41@IL&?CS E30PRATP
M'E1^[G?=Y#DP3EKJR..2 \#2F>JELCH#3<?$6A!G<LH.51*VH7*"=?F&GUHM
M\@G:XN_'4R:,9BMHTA=JQJUCXV-#@.B9R!$WKHR5,3Y+1 1P"0/72G2=-0D\
M-DDA92N:SNR[)MJ=GA8MR$#N919$M)2-4:$%.R1=VT!180X$1 +ZZ1=OG0L
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M,=%I[>CZ28X*P;C6*>WH:ZZ^EHV;):Y]'777SC/HZZX\8P!?N . . . . .
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M ' ARNNB!A]-13-JME=-QIJ!':R.]OUB@L9E-!Q*:3!J04Z-39J0"-XOM];
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MU>'&;VTYRB.BDF-ZQJ'M?0<AA;=1(G]*R"-"# '$_P"[6A:3'T:;HVSKXK6
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= X X X X X X X X X X X X X X X X X!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>g425213g22m03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g22m03.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1ZP4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'I2^>"@X0DE-! 0      %@< 5H  QLE1QP"   "   < E  "')R,3 Y
M,C$Y' (% #=-:6-R;W-O9G0@5V]R9" M(%1O($MA;&]N("T@4RTQ("A'4"!$
M<F%F=" Q,BXQ+C(S*2YD;V-X.$))300E       0]1W,[&"R/8$C9$"/6X&!
M_CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I
M;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M#W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4
M<       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0
M<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P
M<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O
M;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
M3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O
M;VP      $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B
M0&_@            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M         $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M             %)S;'15;G1&(U!X;$!7@           "G9E8W1O<D1A=&%B
M;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C
M4FQT                5&]P(%5N=$8C4FQT                4V-L(%5N
M=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R
M;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M   -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M    .$))30/M       0 )3,S  !  $ E,S,  $  3A"24T$)@      #@
M           _@   .$))300-       $    6CA"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          3A"
M24T#]       $@ U     0 M    !@       3A"24T#]P      '   ____
M_________________________P/H   X0DE-! @      !     !   "0
M D      .$))301$       0     @   D    )      #A"24T$'@
M!      X0DE-!!H      T$    &              "L    Q     8 9P R
M #( ;0 P #,    !                          $              ,0
M  "L                      $                         $     $
M      !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $
M     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<
M  "L     %)G:'1L;VYG    Q     9S;&EC97-6;$QS     4]B:F,    !
M       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$
M;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T
M;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
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M!"@       P    "/_         X0DE-!!$       $! #A"24T$%
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MK=9;73^R6ORFXPR+L4-?6Z7G/KIW7VVFG$]^#C?H+?7?=Z]GI_S:[%T-&IT
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MU8?[?0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M    _^%"*VAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T
M(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX*
M/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB
M061O8F4@6$U0($-O<F4@.2XQ+6,P,#$@-SDN,30V,C@Y.2P@,C R,R\P-B\R
M-2TR,#HP,3HU-2 @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H
M='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O
M(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]P9&8O,2XS+R(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM
M;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O
M4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@
M(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA9&]B92YC
M;VTO<&AO=&]S:&]P+S$N,"\B"B @(" @(" @(" @('AM;&YS.G1I9F8](FAT
M=' Z+R]N<RYA9&]B92YC;VTO=&EF9B\Q+C O(@H@(" @(" @(" @("!X;6QN
M<SIE>&EF/2)H='1P.B\O;G,N861O8F4N8V]M+V5X:68O,2XP+R(^"B @(" @
M(" @(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" @
M(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D^<G(Q,#DR,3D\+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @(#QD
M8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^36EC<F]S;V9T(%=O<F0@
M+2!4;R!+86QO;B M(%,M,2 H1U @1')A9G0@,3(N,2XR,RDN9&]C>#PO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET
M;&4^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(S+3$R+3 R5#(P.C4Q
M.C$Q*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A
M=&]R5&]O;#Y04V-R:7!T-2YD;&P@5F5R<VEO;B U+C(N,CPO>&UP.D-R96%T
M;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R,RTQ,BTP,E0R
M,3HQ-#HR."LP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z
M365T861A=&%$871E/C(P,C,M,3(M,#)4,C$Z,30Z,C@K,#4Z,S \+WAM<#I-
M971A9&%T841A=&4^"B @(" @(" @(#QP9&8Z4')O9'5C97(^06-R;V)A="!$
M:7-T:6QL97(@,C,N," H5VEN9&]W<RD\+W!D9CI0<F]D=6-E<CX*(" @(" @
M(" @/'AM<$U-.D1O8W5M96YT240^861O8F4Z9&]C:60Z<&AO=&]S:&]P.F(R
M,&8S965C+3(R-V,M9&8T82UA,S)F+6(Q,#,T8C$T-&0P-CPO>&UP34TZ1&]C
M=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HW
M.#(U,S5D-RTW-C8Q+30Q-&8M.3EA8RTY9F8X-3,P8S(S964\+WAM<$U-.DEN
M<W1A;F-E240^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @
M(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I
M;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO<&1F('1O(&%P
M<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W \+W-T179T.G!A<F%M971E
M<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C<P9&1C
M-C8Q+68Q83<M,C0T.2TY.6$S+6,Q,F(R-6(R.68P83PO<W1%=G0Z:6YS=&%N
M8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTQ,BTP
M,E0R,3HQ-#HR,"LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P(#(U+C(@
M*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#IE,C<Q838R."UE,SDS+60W
M-#@M.31D-RTR,#5A-#-A8V,T9F8\+W-T179T.FEN<W1A;F-E240^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C,M,3(M,#)4,C$Z,30Z,C@K
M,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS
M;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<" R-2XR("A7:6YD;W=S*3PO
M<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O
M;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<&%R86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T
M;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z86-T:6]N/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC
M871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V
M=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C
M=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP
M+FEI9#HW.#(U,S5D-RTW-C8Q+30Q-&8M.3EA8RTY9F8X-3,P8S(S964\+W-T
M179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N
M/C(P,C,M,3(M,#)4,C$Z,30Z,C@K,#4Z,S \+W-T179T.G=H96X^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O
M<VAO<" R-2XR("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E
M9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP
M34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z,F,S-&,Y9C,M.3,W8BTT,S@S
M+6$P8F,M,C@R.65D.&)B.#)D/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^
M"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI
M:60Z93(W,6$V,C@M93,Y,RUD-S0X+3DT9#<M,C U830S86-C-&9F/"]S=%)E
M9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX
M;7 N9&ED.C<P9&1C-C8Q+68Q83<M,C0T.2TY.6$S+6,Q,F(R-6(R.68P83PO
M<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L
M1&]C=6UE;G1)1#YU=6ED.C)C,S1C.68S+3DS-V(M-#,X,RUA,&)C+3(X,CEE
M9#AB8C@R9#PO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \
M+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \<&AO=&]S:&]P.D-O;&]R
M36]D93XQ/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @(" @(" \=&EF9CI/
M<FEE;G1A=&EO;CXQ/"]T:69F.D]R:65N=&%T:6]N/@H@(" @(" @(" \=&EF
M9CI84F5S;VQU=&EO;CXY-# P,# O,3 P,# \+W1I9F8Z6%)E<V]L=71I;VX^
M"B @(" @(" @(#QT:69F.EE297-O;'5T:6]N/CDT,# P,"\Q,# P,#PO=&EF
M9CI94F5S;VQU=&EO;CX*(" @(" @(" @/'1I9F8Z4F5S;VQU=&EO;E5N:70^
M,CPO=&EF9CI297-O;'5T:6]N56YI=#X*(" @(" @(" @/&5X:68Z0V]L;W)3
M<&%C93XV-34S-3PO97AI9CI#;VQO<E-P86-E/@H@(" @(" @(" \97AI9CI0
M:7AE;%A$:6UE;G-I;VX^,3DV/"]E>&EF.E!I>&5L6$1I;65N<VEO;CX*(" @
M(" @(" @/&5X:68Z4&EX96Q91&EM96YS:6]N/C$W,CPO97AI9CI0:7AE;%E$
M:6UE;G-I;VX^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI2
M1$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!_\  "P@ L #( 0$1 /_$ !\  0 " 04! 0$            ("0<! P4&
M"@0""__$ %$0   & 0,# @(%" 4(! \   $" P0%!@< "!$)$B$3,10B%1=!
M46$*%A@9,E>6U2-Q@9'P)2<I,SE"6)0W0T>Q*#0X1DA24U5G=WB&IK;!_]H
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M9>;?ZK[.[O.!Q*7L*90#B!S%+_ZIC (@/GN >>?.M_3336@E*//)0'D.T>0
M>2^?E'[P\CX]O(ZT I2B(E*4HF'DP@  (C]XB >1_KUKVEY$>TO)@X$> Y$
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M%)KR<.1Q,QZ+[TXB0,1N=VP(*_:DY.@D=RD!%%4DSF[ R,#!F;N.HS:BHJ4
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M,B@BF(&4*V3$Q$%#BFG\I=2'.LIP?@QNWL!8ADS%]8I0'CN%$P]@D'P( 80
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M#R//!,:V1,HF$1$3F B9"]QA,80#CD>?.)=KZ:8;1<!E$H' N L?@4Q_Z0X
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M$QM6N3W'LI#-&R-&E_1.#Z"I%?FUG"8*G$$EG91.(@4Z?@-2FZ3@B7IR;.A
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MCE355*JBOV+"<0*V41(J"J:ZJ8D4)P4Y0 W _,  /WI'$Y ,8"@;D0$"F$W
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MBMR[GI#[G7$-FN@XMJ<354<R[7T9:%<T,)7Z2=R+Q3)ZS8R3U*1!5HB1$BI
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*D0)WO333337_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>g425213g22m04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g22m04.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1OF4&AO=&]S:&]P(#,N,  X0DE-! 0
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M;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0
M   !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "
M4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,
M8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M 0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B
M;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M  !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L("!D
M;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD(%5N
M=$8C4FQT                4G-L=%5N=$8C4'AL0%>            *=F5C
M=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,
M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L
M;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14
M;W!L;VYG       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F
M       .             #^    X0DE-! T       0   !:.$))3009
M   $    'CA"24T#\P      "0           0 X0DE-)Q        H  0
M       !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9
MF@ &       ! #(    ! %H    &       ! #4    ! "T    &       !
M.$))30/X      !P  #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@  #A"24T$"
M$     $   )    "0      X0DE-!!X       0     .$))300:      ,U
M    !@              MP   4D          0
M   !              %)    MP                     !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    MP    !29VAT;&]N9P   4D    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   +<     4F=H=&QO;F<   %)     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    $.$))300,     !%,     0   *    !9
M   !X   IN   !$P !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1" !9 * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
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ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
M/P#N+^E=?^UY%V+U7T:[GDMK?7ZH:W80QK6VEU=7IV_Z%OO_ )RU1NZ7]9K*
MV-'6&LM9;987MH: 6EC6X]6P.]S*+=[O?_.^I_P6Q&?U7,;]8QTD,K%+L<Y
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MNUK'_HGN_P!)>NC7.';9]>18/3(JPG4;Y.XV@MR+,;^=V?H\>_'O_H_T+_\
MMJ6#F?75^0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M7&UTX75+1R%O'G]L]TIU/K3I%&=RB<1Q3D=+[2P,:Q7@X[W&_?12<@^<Q\0
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MCZAP&@)91[IEZNXEZB"(B \B0QB"(#\NK@1X^0#T_+0%S@/H'Y?A_0/R#Z:
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M66(@B!UC)BJH1-(#G$"%  .GZ?5TAU  &$3"(!]YA'_KW^_0%>@#0!H T :
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M(<HATB4Q"F*)1'D0$! 0$!'OP(<<]] >@0@#U 4H&$1$1 H<B(@ "//'/(@
M (^O  'H&@*M &@#0!H T : - <O_%;DT)#:!DC&JHWUD_R2YK4?%R-1Q;F'
M)<:T4K^2*--*Q-S)A=B[L,/"W%%N2LE(,M%J3C&PN61 \DBZ! &1X/[.,C<"
M7>*CJ) X^5C<FR3&7KU>PEGW!()O2P$ Y*O+4K<;8[%<E9)RV=(>UOV:C*-7
MZ"^0V2."A0=?8'74G $*!>.. XX]/W=QX_#D= 5: YU43_><[A__  O8,_\
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M-,F7:K3-$ME'AW4[9*XSCW\;D>M-;%97IJY<Z XEHZIU%_8K4_@WEJ9,YAU
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MB/3Z<B/;OH#WI* ]0%*!ND"]7 <](#R!>?7I >X!Z<Z ]T : - &@#0!H T
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M.',315'ZN,1*RAS&;1)::"94BF*!2]B@44TBE "@0H=/'68.Q@$0X$ #D"@
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M^<2=LKK>V38[R:7CW,_&^[H^U(-%JQ*24/&R<W3G[1:J2<DS)(2$*Y>"JX,
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MG74Z4K1,FXRF2-R1>$V6 Z@!.1**DCFDY#E4#]8#$98S=E(7G@?]L8X / E
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M*8#@40. @/5U#U")1Y 1'GD1 !$O?_@,)?01T!49L@<.#IE.'("'5\0@)0$
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MAB$.4W' "!N?3GXNX !@Y .Q@T!=T : - &@#0!H T : - &@#0!H T : -
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MS/?7GXE^LM2A*9-3X53"YE']>@G#E[',SI#3O) $W;UPX$R90 %#AY?20 Y
MD/\ R2=PO_> [@1^\:=A(1'\?^QFI#XOT^P(.W*8$W@XVP%F*^XKWL[@KGD>
MF8_LE@I%42H&(I9:R6B(C'$C'P1(MC2$G+L\H8J+9$C5UU <#"8Y3&Z"H?\
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M7/I0,FF8 &EX6Y$13*!S"!Z2F8O4H!S%((#T%$I1,8P".JN^05%VD[A! /\
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M?-KV7E@DF4W>(BJPSZ*;"W33/&-6M7B(A K8JY5#D!PBHH4O0 *"/68P$ZZ
M- &@#0!H T : - &@#0!H T : - &@#0!H T : - 6#-R&/UF$PF >HOZH=!
M@_5,7@H#R7N'!A,!@$0.!@T!<(0$R%( F-P'<QQY,81'D3&$  .1$1'@H 4.
M>"E*4   *] <P<HYXS#BWQ#JY7,@Y&J$+M#=[4,MY)4@V-;<MI6"L^/;7A]H
M\M-\N3@TDLNJ="VSZ4! UY&"*:+;I'71G'AW)VDZZU\M8!K;L&W?[B\W[TMQ
M.-+Y;%+3CFK,[S)FJBM-K,*K@^>A,VY"I%+IA)6(C&<L]0M&*:U3KVFZM,I+
M+R+J?=2;!X$.\8L6M!W);^7Y8^7P)>LXB8"E+UF$>3'^!-,AA,/<3D Q#>I3
MF#OH!$GW*[%C*.V2/M#]&+>*LVI4?,.Z<H-EEVZ?E@)%7/*J92"FB*W!3"!D
M@Y V@/GFVF>(3N#MM0W;N,OY4BU;)"P,N3%"]@I3"(98VS@V=YA<2&%$DJ)0
MY&1M)JK3:#!W1ZRD(*X6MJ@X>+.VLFG(1C A:3]8_8&]/A&9^R_N$VRSUAS3
M>'.4KQ6<M6NF+Y3:?992C7IG&5VFRJ,OC5>K8DPRBXI31U./( H2]36L#"RP
M]DBI.;D1CTB-@.J!!,)0Z@$#=P'GCY"(<]N X'U#[N/7UT!RP\6+<%E_;O@J
MLV+$MS-B]2=O3B)MF3D*G$7)S4(9KC^Z3D.LG!S$):(Y<D_<X:M55XO(0HE%
MI,C'QZ[23=M'R$;CCKPBRU;R'A]GR-+-V.__ "_5<';7KC1<ZML?9J?S%'9Y
M2P]'8W:3BV0IB:&!5F:_%35PJLG&^^F,-(DEF6.*\ZI-HE4I!1ZUGFK6..U4
M7MEYZ<K7&><KKOR\^X^@V <B]AXY\8AB'?,VSQ0IVY&BP*.$$U% 7:D,H#=P
M4YC$71%584E2F)YIP*'% KZ XA^(!NXW)X6WL;8,58OM"U>IEU5Q"NA2T:1#
M3Y<\R]JW.8SQUE.G.)R8KL@]C2XYP9/W+)B)*?8ZQ.QZL<%CDU9*M0TK'.'7
MEZ@GBHYYRW=M_P!CV)K^1:3:=GN5-I%IRYBR,J->1</Y";BK=BJ&0MMNO$Q*
MB\EI";0L$Z6FM*\R;0Z5>9*+KJ2KP5GA ZOGXG2LP&(*1D02.<"B ',4W4JE
MTF,5 !,4RGDB<0ZC)KN?*$PB*!RC\('SDXX\1/,]:_M8R'=<W6K)F6J;%Y2=
M7/8<7!49"0F'VE;MC.%K,W*9,J-04NU+9QL6Z&8FW-QDK<M=XU%R_JT1#HM5
M"B!7!>,_N%M KNX3;=BJ3K]73.6Q9&87^\*4G($:I=:Y3&5DQ%*N\?-"OH9V
M[L)%S%GG10*I'+MTE7:QQ*A.IBWS\[@8^-/&#WBM:EF*1M&'\(Y,#!T9:)R[
MS[&U7F"E8!RZS7*XN@(&;KT+CV;0A(JALC,;C=IUPX*\+1T%'1(TSQ9)R-Z8
M-[-AV]++FZW<-98JQQT+"8WA\&2#V,9TTZ\]B^\6BN;B;YCP^6<;V^5@(.?D
MZ?=JU6F\O7C2+8B:BQ7"C%P^00,[=.ND#L>@'/Z3@?TA"B8PE3*/7U*"8H@5
M,A_A$W "8Q@$.X?$)C' R= &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@#0!H T GN(MB[5,JZ;I.1.D9 Y'"::Z9T3BF8Z(D5*</*.=%$XIAP0#I
M]90 RBHG$A9]:?9>-\RXE'M$C=944^L3^88X)ID,=3N'6?H*4#"'(](" E(
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M(^64XD%03&$!2*3I,<PF$QC#ZCQ\)0$1*0. #X2\CQSR(\\B(CWT!7H T :
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M,NY BY.ZWB/@;PADA]2+'=H=%2OF=V>4@;#*0T>FX9IHHD1,]<G;E)IUGU^
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MXJTU9.R3%NAVL6WB5[$[:&IT@SC9)X_5BB&2;,S.9*,025.'!G+]!N')Q$0
MRV6^[;N_,CY%J=IHK-CJ \=0T@W9)OT2NCO(!1=1,"A8(Y)D[4?QG/F-RHF
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MOLG!EVT7'IH BS=="+'K6-U@.6RYOV'0;Z(?QU)-;['"R4#7G<JQJ\L=_5V
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MB"@(YI$PT8Q0:Q\:Q2*@S9MREZBH-T2_"DD43&Z2% "EYX  #@- +F@#0!H
MT : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@
,#0!H T : - &@/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>g425213g22m05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g22m05.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[2%^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (6*^A48X0DE-! 0      %@< 5H  QLE1QP"   "   < E  "')R,3 Y
M,C$Y' (% #=-:6-R;W-O9G0@5V]R9" M(%1O($MA;&]N("T@4RTQ("A'4"!$
M<F%F=" Q,BXQ+C(S*2YD;V-X.$))300E       0]1W,[&"R/8$C9$"/6X&!
M_CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I
M;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M#W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4
M<       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0
M<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P
M<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O
M;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
M3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O
M;VP      $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B
M0&_@            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M         $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M             %)S;'15;G1&(U!X;$!7@           "G9E8W1O<D1A=&%B
M;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C
M4FQT                5&]P(%5N=$8C4FQT                4V-L(%5N
M=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R
M;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M   -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M    .$))30/M       0 )3,S  !  $ E,S,  $  3A"24T$)@      #@
M           _@   .$))300-       $    6CA"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          3A"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))301$       0     @   D    )      #A"24T$'@
M    !      X0DE-!!H      T$    &              $F    ^0    8
M9P R #( ;0 P #4    !                          $
M /D   $F                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   $F     %)G:'1L;VYG    ^0    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !)@    !29VAT
M;&]N9P   /D    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     8X0DE-! P     %L$    !    B    *    &8  #_    %J4
M&  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(" @)
M" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,
M# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( *  B ,!
M(@ "$0$#$0'_W0 $  G_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)
M"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@%
M PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A
M\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%
MU>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!
M  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:B
MLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F
M=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ /54DDDE*22224I)
M)))2E4ZL,D]*S!B;OM1HM%&PP[U-CO2],G\_?]%6TDE/!VU_XP(LJJ]2S(_5
M\AMNYM5,48[7688WNR'NMRNH.]/(_FV7;+/YFM6,9GUIR.L6.=]NQFW.R76V
MO=4<=F*^LGIE>)CNWL;U''N]'U?9_.?:/7?=5Z:[. E 24\7U)GUK=TCI#"V
M]FQE/VRS'L>_)<[[,\7C+II=AO\ ;F>G_,YK]_\ A$07_61SGXE=.<UXZ@VZ
MN\[ W[$0P>AZUKG^YO\ H[F/]_\ .KL("4!)3P%0^O;>G,IQ:LI]N/>[*]?*
ML#'VLIKKC#>QS\MS?M.6ZQOI>MZ-_I^ICV8M&QB[VFSU*66;'5[VAWIO$.;(
MG8\#=[VJ4!.DI22222E))))*?__0]52232$E+I)*CUG/MZ=TZW+J8+7UE@;6
MXP"7O95MW?VTE(NK]9_9CZAZ#KVO8^VUS7-!976:F/<UCO==9^L,].MBI-^M
ME3^GV9C:8++JJ-KK6"N;@Q];GY7\U7L;9^GK_G*K/9^XHV?6[%;<ZDXMIOKB
MMP)K ;:7^EZ/JN=LV;V>Z_\ FE4R/K-TK(%6,W";:U]E=FQ[F-8'^K5]H-C6
M^WU:FW^O7]/[3_URM)2=GUSKOO9CXN*ZRZ]K32UUC6>XBM]C+]P_1>DV[\SU
M?40!]> ,9A=6PY%M;3[7@L999CMRZQ_PU/J_HW/]EG_!HI^MN$:GY.-A.-WI
MOMFTUU2UC&/HW6O/TK/6J9Z+?TU'Z3V?Z1W?6G!8UH& 7VL;8YC*S4892'G,
M+9<WT]GH/]-C]GVGV?\ 6TIZ2IY?4QYY<T$QYA361@_6"G*S6]/]"RK)E^ZL
MEI 97++;M["YKJV9&S'_ .,M8M=)2DDE%[MK2[P!/W)*9+F\CZP=1Q^IYP-3
M7=.P+-EUA;M:&FBK(;^M>J[=D.R<BNK[/]D_F?\ ")J/KG3Z-'VK&L9D6,;9
M8RO:YH8YE5C;6NW?G_:*_P!#_.H;_KGB.J#1BDW6B'TN?61-E8LQM[ZS8VQE
MVYE5G^B_X1)2O^>5EK*K:<9M=#G^E?99:TEMFW(/I4UM_G?Z+^>ZKU%;Z3]9
MF=5ZH["I8UM==;['.W;BZ#1Z#ZXV^W;=9ZK'L^FJU'UJP;!53]B(LE@:T&L5
M!X;ZMVV^PUL8RAN_T;7?S_\ @OYQ+'^MF,VK>["V6O+AMI?6=UCBYU3-TUN_
M35LWVW[?1JL_1I*>G26!1];*++F8]F-;5=:]M=;2:W;G/?91LW5O.UWZKFW?
M^%\6RQ))3__1]57.?6+JW6\'J>%1TVCUZKJ[G6,]-SM[VM_0UBUOMK]WN?\
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MNG_K
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M,SER=Y*AL='P"A@D*;/!)31#8F>R1]/Q_\0 ' $! 0$  @,!
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M;R'NZA,:0[%0I+O5 Y23UY6HFZ_N> +&- - - - - - - - - - - - - -
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MQ6[.N:QJF]6*- K]7MQR>XPXRT]4*)*5$F_3%P#WF$O)*$/I)2YUY['0&4=
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MERJBX^I]YTK=<X05+5P#J@S]H!H!H!H#9>!(X'/[*SPD\*)\<=5?EQYY/Z:
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MAIUM?(6AQ"5H4"""%)4"E0(4000002#\G0&MIAEE"6V66VFT@)2AM"4(2D>
ME*$@)2D?D$@#]V@-W0#0&*,M8DQSFZRJYC?*-M4^[;.N!"F:E1*F%K9D#L%H
M4VL$*8>;< <9>96VZRL!3;B#H",@]./9RG$/^ O_  +V\K'OXT+E72"],74'
M:V@!O\3=JQ?^O<?+0#2W3*)4WR@\CGD"5^.<<63B>QZ'C_'E @6S:%NQDP:/
M1J:V&XL2.IU:G$I_I*6XM2E..*)6I142H_.@*R-KJ4_XT7U 3T1RC'>#2E71
M/9/M-UD(X5QV 2/@ \?J#H"WD    < ? T!]T T T T T T T T T T T T
MT T T T T T T T T T T T T T T!I"4CGQ\GD\^?/Z^= ? VA// XY^?)Y
M_L)/@?N' _=H#:<  (  '=OP!P/V@?R_?YT!4=M=_P Z+Z@?^KK"'_IUG0%O
M.@&@&@&@&@&@&@&@&@&@&@&@&@.%/DMPH[LQ]Y$>)%9>DRWW5I::9881[KK[
MKRR$-,LM(<<<4?Z(^1QH"!6&_4OV=9_S3<V <6YLMJY,DVU(>9?HT.4R!/\
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M)W.S<S&YK8M2=67\>VS3(ST2K245YQ]R0JY)+R@RZ64R0VH*]Q;H*B5?8T4
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M: V'?@_Z;7_$: J*VN_YTCU O]6^$O\ ]:OH"W9;"5E1)/W>>.$J 44A!([
M^%( 24_LD<DCDDD##.:<P8QVXXTNS*V4*_3[0Q]9\)=0K=4D=4,L#H%!AEH<
M%R9+*NK3;8_G.>"DJ/) @IC7,VP;U>\'W]9=J3:-D_'[LMJF7?;+\-RG5.E3
M'4+^FF]$])$4OM*[,2XY0>ZN5**N= ?K;9]N.RG:"[4=F>"[;DV?5;JIDR[:
MO&81/=JDR&/L^H7<JEEY3T8CAI/NGV0?C[CH-:U@33PS@BRL*4BK4ZU%5F0[
M7*E*J57J-=JLFKU&9)D+4KJY*EK6OVF@H!IM'5* / \GD#-:$!M(2GG@ ?/Y
M\ )Y_MXY/'Y\Z UZ : : : : : : : : : : : : : : : : : : : \SWJ4
M46^MN'J:8+W_ %?V_P!U[BL$4/#%=QA5J+9])3<=7L:YW)DEZ)<#-(+$M'\\
MT^?<<5%*@E""E7;DZG+'3Z_(,/X^S13_ % ?4_VK9<Q3MZK6WNRL*4>\7[LO
M^^Z=#M6KY'-4A.1&+6I=-]BGRIIA/*$ATJ:=*$<G@ #BC6M8'J^;XZ)X)(X'
M!/R0/S.@->@-AWX/^FU_Q&@*C-KH_P#-&]0-7_XYPB/[T5@_^V@+>M 0GW^[
M/[?WS[:<@;=;BK,ZW(UVQ([].KL !:J=6H+A=@NR&5*#;[/8)"VW?M*5?PT!
M!+T@_2$HGID4K(TV1?\ +R!>N0I;"9TIMD4^DPZ7!6$L,-PFE%M;O "UO.<J
M"^R4$-\::UQ[ M*KN(6*OFBS\ML2(\1ZW+?K=!DLLQF4O5!FL%"^9,D#WE%D
MM\M)2KH.5<C\M 9U8 2TD DCE1Y5\GE1/^[X_L\^= ;V@&@&@&@&@&@&@&@&
M@&@&@&@&@&@&@&@&@&@&@&@&@/-?ZVV_/>KM>O.R\=81L&50,*WG1H*[]W%B
MUZG=3=D2ZI554YX-Q(32F4IIL+B0M;Y![ I)Z)[:C<DWKZJ/MY[R!'H<VS9>
M?-[N=\K90W+UK.UZ8>JC",32GJB:)0:]$K=+*JS5H-F+=2$2$)2IOJRASH#W
M7U6E2=4'LX3*4$_Y, #JE!4L#L5(!3Y^..WVDCQ^GY\ /K2GGNV.$M]R4J"O
M(4E!;^?VP3_#X\^= ?5/=^PX'PI8"?)46EI' YXY^2%?HH$: J3VN$'U1O4
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M;UH!H!H!H!H#25$* XY!X\]@.//'P?)_7Q_#0E<N_P!,!042!^7SSR"#^A!
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M=V#_ );\.M'&H]DBLXO\;_>**%2;BAK"V_\ 9S=UR3HW1>*S\$MH(4E:PO\
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MO"LR:[.LFU:D4KF,6U1Y4E42 R'%)+#3;WMM%PM(UK6J=V)\ (C'LH>"E+:
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MONTC&F)KAKV8(EK+A9;RA2[>>OZI39_XJ(,R% B*=I%$:DMAND4F),#ZV($
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M#\6\)\VDVQ7:K38SDZH4RD5*HPH#:2I4Z5#A/R&(G0 E8?=0ALI!!/;QS\:
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MMCAOV_;92V VE/4(00KCH$)6KHD)ZAM*!T2A('(/@BG.T T T T T T T T
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# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>g425213g25i26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g25i26.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1L.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &O*^:)@X0DE-! 0      &P< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M @   @  ' )0  AR<C4P,# W.!P"!0 [36EC<F]S;V9T(%!O=V5R4&]I;G0@
M+2!'<F%P:&EC<R!F;W(@0G5S:6YE<W,@4V5C=&EO;B V+G!P='@X0DE-!"4
M     ! P0P[*A?9;E00KUX4;9]+W.$))300Z      #E    $     $
M  MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN
M=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P
M4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M     BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O
M;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M         $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M        0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'7@
M           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M    4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2
M;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5VAE
M;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC
M<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M   +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (  0._
M_C4  @ !.$))300F       .             #^    X0DE- _(       H
M /_______P  .$))300-       $     #A"24T$&0      !    !XX0DE-
M _,       D           $ .$))32<0       *  $          3A"24T#
M]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R
M     0!:    !@       0 U     0 M    !@       3A"24T#^
M<   _____________________________P/H     /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H   X0DE-! @      !     !   "0
M D      .$))300>       $     #A"24T$&@     #-0    8
M     H,   /^          $                          0
M   #_@   H,                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   H,     4F=H=&QO;F<   /^    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   *#     %)G
M:'1L;VYG   #_@    -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M[_J2N;' 728W_((_\+N_ZDKFQP$L6\_-1>B^KW]!=_QKOP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MB@"%4101AJ,<%7)X,#4E0BJB'%Z'#%!K#=+@'BI5(CE[/8RE?(! &%N2</\
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M?D6%XSMVG@4 =@W<Y6MYIBMM/S(C .KY1%7M1;'42\B"G2550Z815"VV@X!
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MO5%$^Z$A]N<N_-@V^57=>O3;>O@^>Y[1&=ZL>3Q4Q4;NI16,2^E)K/269MY
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M7-6&\AFK3,B(4USP<Y.5?-5-*I!:I8"I4BJ;\*Z@.7*XP<DT" K4-0U5&9T
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M=LB' WJVT52FN(B(O!\?:,Q(5LI1J RK@E<'KQ;8<2H1%=2HJXJQ&X*#I%C
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MRGX_#VQ[R?B]X>MA;H:_BYF;#%%/(K_4H>32:7!&)KK0.@U6.D1G(.W: B-
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M<5$;PNU^/B5_G1#_ !:)M!\)4^X.U$+][$__ 'D<<V:_.>+UW7NUF"$0D?\
MUFKTIT0^X1J ].K :#VYAA6W!HF(YRES[]UGYVJ7/RW'<!LMZ*N! N-R^BW=
M4IYF1R5JRG100T0<P)FG/]::M3X15&?+>5!6/+6RT5$+*"F3+NS-'7)X^5JH
M4@$+7'3D"JPHJI%]>Y^#]TU9;4(]_2 DPWCHMH7P@>CKFZ_'@[?F+?MU,D9E
MR\Y-@LBHC5EI55"$PQ:>?B8FK7+VOU<&VG@2-]-*X=N=N=[$],;*_:%S_>+.
M,ZU\U:?JY_JF.?2WH 88,%HA1$?(@$58M6L*5I6J'%Z[U4$%*%=Q:I8!#B
MK'K2N99,:5JJC DE'&F -'8.L-SN C]RE4AI]GL:.[[ $&OHT4QWVY'P^'WU
MNI_]OL]_RB\58.[ZJL2=S\U-^L.8_!EHI+9(T9:_IXE2SS_(_D91VL\!?35I
M] M_]Z[:B%[\T/7'5,_)5<*PG:W8JN6I12=W)6B%5%%,6J%*Z3(G77"JLBX
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M^7O/:*5[YL=?Q9C#OJ<>S6G%F/;!T1GZ(7M;H-%!.+$JG.K%-:)BL8>1 9'
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MR9IIEA4RY0!@8>Z$8+'YTJH)]"PPFQ1&&B,2L7&0KQ>*E*%KX#$$(PX=T#2
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M(0:=.GL[==.G99"#J'/$-0;@SV;Z:K(05IB.&NNC@;(0>D1[:=%<-.S7A9"
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;UXV0@$:4##, XZ &ED(*AZ>S/?0=6FR$?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>g425213g27i06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g27i06.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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MP20-6"\],[G7O)#C!L@7L).+3@2P%@K$:HHF5"WFGW][G[^:R[NWKOS\7;_
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M^R.1]?R^@&)EDU,Z_?7[NIB[1K]]?NK^=?SA%E@I%)<.)+)1MM)09 (I1O\
ME"9L5J3I&_Y_=.G?3^=_QA%DL(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(O*3K_E%SJF?4;Y/X]&+J%&7N\AJC- 5:5,TV1*,2G3VO5EO>OB2X_J!
M*U$9><;?F;C2-1&WML.:3W<:6%O"9XG/:)7=LYC2>\131R\Z->-.H;+QF>YX
M]I\, '36,#7*R9.?^WQYKT3!WR,5NAVIZ=;5(%/2$;0G:?>C4=+.U:WK^?\
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M _A7R+S8^(_#=.(FR?N6V-R'&74 GOM6O8E;2I3>W7'-,*T]5R.+NAX=#FB
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M1HVI1$A)CPH,5*U2)<IYMB.TXXO2=D )V L^ 5=].\J^/\KKR;89,2C]9?\
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ME->G('Y_?2UL+SKHM.ZQ3@M_H!5P]3K''W-KYW8HR)BFQJEJ3%,"6S@\;)(
MR;6D30AR*PZ(/"WXI<+-GBYD68\4<E-L(F$3")A$PB81,(F$3"+3ORU\J ?
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M+(W^VE26T:4MIWTUMYM"M.;V\G2G?/<3X>(/[Q"*B) >P<HR=@X?^$GF.CB
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MQ%*(K*(,J>-B-;E$H;3R_LD9RX4S)X87:=4KB&;]WNGF2-P#MT6CAK-/!N+
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M\;I+ \?#C$OTZ?0BOT7.X>!/);C7ZS69%KZ4*%U:]WSHT)B#/I!)J19[_P!
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MK!+\FU\<E.H190_U <-%7OWMO7E]_/HO;96!E2\<Q,MD=P,;&7R:F@-,9>7
MM)U6;&F@0;Y\ZU$\-6I.O_*>/+;_  G]:3 [4X]_<<]$17*Y1?@==WZ>B6%J
M7&TTM?HVM3K&D;WM;>MR3_3Y^'ZG;Q-#Y<N5*IA@_P#4^9M_DD_^F/\ D?-3
M#Z9?E1WN[_4X^K)1+?TD_8Z32:KY1'J;5"KS<D%5YU#[=$K=;_!0U-^T9'C!
M9;T27'B*;;**]DLEJ5-;3)UODR9I&1L>]SF,=&6-/)O9MTM ')H#>8%6=S96
MGA)_]J\9%"NSS#RY_P!Y'/Q/K=>.]+7/Z;OE[Y)7/Z3?U9[U;.MVJR7+F8 (
M5H5E-269Y>JR[&!.K(?B9+["MQXK+T-B2,@Z3N$)?2I0YB,A6T9+\J=TL4CI
M7.?&YSFO-%S2\[T3RW&VU-Z#HJW"P#P7C(/^D UL*T&J ^1^MKTM^E'Y%=QO
M?TE*3>K1T:Q'KVCNEXI+EQ)R-3++(KD";)GQ(LHJZA4J5(9W\<;4]];DU<-M
M$9Q]:=;WOC<>RLD0"1LKA(Y\49D_S:-+W4#SNP!JYD;717-XIGYV![(Q38$[
M\>9_$FQ.ECH/[)S99'!IHZ+<QMEM'38!HF_6CIG2N@#N>\,+C+!)A%+"%9*G
MY4=J.VLG-CC0;B=R4?%\?P.NS93K\5"$1GE+UI;>TH;2FADY,[<;!>V4M=)&
M'R$ 6]P9&18JB"7$N%5Z !;^,\8XI#PGV9R(<M\4^7C-GRY&-8.VD9!BNMPT
MUI<Z5Y<P ,=>[: JV+G:[/!ZY20\$F_'#RHP94T>VEO[>6HD3EQ9BY&MHVIS
M?P--I9WM7HPI'O:]BU+5NW-+*W+A8'$,(9;1R.IQ!)L;\@ >G2C:[O$,[,CX
M]PZ".9S,9[,<RQ #0\S3/9(76+-- J_RFBT V5+QQLV]TPF,=FN*$M(4RU"W
MI'PHTV/:D)6C7M]=.[>VI2G/=M2M*4C>_9I*4[FR/.2]A/<Y!M;"F@V/CU\R
M.@KH0Y&0[B\T)D)A +1'0TM#8VNL;6#JW+KLV1RJIF!DS9#Y#[IY3J=/+^-*
MM:TEO275ITE&M:_9.D>W7IZ[_CUW^_[[W,+CJLWOMY"SL/+9=#&?(YTFMQ<-
M1J^FY%#E0KI7AYW)<V*VF$3")A$PB81,(F$3")A$PB81,(F$6@GFC</(D18^
M95+QWGW*/9[30NXE1<"JA*"1%E.BU/7,E<OC=!)7T008"\Y<,FR42YN@YHDT
M[7YI!Z'*0]":DPRD5S/0CQWN_#KMMR'BJ>FU#S:E6#F1C1ZZH,V0C>PU_M[=
M<X5NQ<YI!ORMX<+@U^HSGJ.XB$%WX_5^XVIMJ;%LDZ22W+,EI4VP0JVP-)M^
MGZ;_ %^Z5<T=[ZH$9[B0ZY66X)'EET0MTFRE:=R8J2'7,KRWQ0+G:66#4BFQ
MVD<P9O#_ )5 RQ"$R#(!)K8;>N@L1HE6^[@7UY_HI[IOI5USWV/B?3^.:MOK
M1#SPUW#M+=1+6L3R* =Y.W1H54J%(.RYO'R!KQD1UNT5$J7K$_3?6*U#7Y/I
M$UXX0/SS$'8=8VCO2(=*FD93NUY_'S^'AX>O-:B#^+>;M?Y41!M NCM2E4'L
M 2, 0%XZ;WT*X&/$L@#H*.PL+"$Q]L%HZ6D@&WLP]^F(1 C%%O(;K?X>/%)M
M9-[7MN>6J[\>5^>]^)%G]]Z9YR\?CDK),MMF$U*S]"OE=&QYLSQRH &KA1/9
M+RWS&$%Z+>:SJKT:+8N/QA!2<;Z0NS?G7A@NIC%";G9X.U%&VW+8"[O?E?U\
M%ZP\.,D;%Q3C]A,'"]G+GN74 R4LE@K6J8=L!$I4Q,Z<;-4]+;*:H6*R7W9Q
M&M:9:T"F/O"]-H^U]NB'8GU5I84)A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3")A$PB811NR6H958\>23BV26W*=6RTBMTZVW&0E:$>_>Y$6I!#<F&UM
M/[(?EM,,+7_AH<4Y_=Q=?\$_HI OP^) _5:K^4Y9WJ'C_P!)I=1K/3I9TL)A
M/#XS?,KZ/<G+#&QIMX<A1(!"UIPA'%OPFDN>U#CDAM"]^QSUW8Q9&Q9,+W_E
M:\$D= 019JZJ[(.ZX7M+AS\0X#Q3$Q@3/+BO[)K?S2.86R"-NX[TFCLQYN^*
M\NO!FOCS_<&;$<IUH.@>8B9Q=Y,:IE3"(%S=<9&5UDA&1'7IB5$96=*Q=24?
M/&)!XLEM#;[#;B>YQ7(#<9C&.)=,[<@D]P=XU7(EP (/,$[+Y3_9[P9T_&I<
MK)QSHX9%(!VK*#,N1S&1LIVPEB8)GEKN\W5&X46V?73H-]X7T>NDZ;T6M64T
M'F1W$R(!#F-YFO175(6TB6-ECZ]*?&EXF][<B3A\A@A#=TV_'>;7[%;Y&/C9
MI(E@CD86T0XD1GX!Y;J\P 1TZK[-FXN'G8\F+FPQY$$K2Q\<C-0W%6#5L<.C
MVD.:=P05X.=DK=9I?84<UHDZUFQ9>16V*_,N=2.U@G[K$\B+MV<U,"P%21@V
M1M_4HQ'$Q6]LPYVDQ%.0G-N^GQQD.BU3MC9("[9K[! Y$UL+-W3CMOLOS]Q[
MV>;@>T4/!^'F:1F7[O[N<ANX=.>\TO8T"2.%M.>X-!:TG6 &EQ]5>,#>3<WJ
M8>G4)NF&+=#DZL)FWR'0QBW2;2H8L7/,BHRMR'ZLVQ#?DC1\6(KY!XR0^RMY
MR9,(S)FAF%))(^3)R)'MD :8(WR,B,>H.:Q^[2]NIH=IJBZCO0*^Q\(X9A\!
MP8\/#QV,(TR2SR-';Y&1H#'S$$'0ZK#0.ZUMAO,E3V>,&E-K43'PB2G$.-N*
MGQ&)BG&W5Z6ZA>Y#;FUH<7K2W$JWO2U:TI>MJUZYT@UH       H4 -@!Y!6
MRXDW9N[YGGX\_$D_$JJR%-JUMEEJP/K5;AU=B>\_;9D>N@W%G+!,^]D2A<34
MD<_'W)0@Q/D6,]\+LQ$@Q('#Y;99XT^-Q+6$$:6Z;-BA1.]W\R3U-^!WSU.
M!+G$D4!;MAROZ;#_ &K#U^H4>+:)@@"'KQL4,<$'&YJQHLG*K=O%MN!!\?\
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M3LN+!]G'\)R<>**6+)=G,SG''<^1K)(W,QL:.+)#G$GMH7R,)#H]&ECAY?\
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M_IU^$:%0B$1;$EA"]%%GQ^SS^:G]8Y1S*E "%5J%"J5:K184'!$P(0$/&BB
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MRC6DMLL,MH;;1K7II*=?SO\ ?*;WOD>Z1[BY[W%SW'<N<XV2?,DK8   !L
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M/7>B-M^S\6?@#Z^33RKZ^C3]+)] K\ZSYJ1^7]-O7.XW'>B76-S/G$F_7JW
M!I5JL5];7/.A]/8'$;1. -4(+ E5[G,P(P:M5WKCDB]6RC5R$)F02=@/U8H
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M,(%.@QY]1I8FU*'P9]C)7GOX?.][K:OE158R/J8GW*S9+SOG/X6BV.J5.;S
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MZP^W[DI5['6U)]R=;]/76MX11"P%>9#+C08EI(4>!?RVK5#YA'/2 4:W$$Q
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MLGYKH6/@'C_;"T\_;>)\=LITB5;/E#5BYO2C):>;_&B@C1H@2)!I,R44_$
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MJ-*U_P#14\ZE:?77IM3'[;]4YV.#Q:I9)2-F,TM-<G.WV\]+2#X!RJ9CB(P
M2"76:\ #M74$\^@YE:PVXH0%B6U"MQD$B14,%A2)C:WXL-XR2C0%3GXZ'8ZY
M2833[LE,5+[&I3S3<=;["'5/([LKBUH(V+G-;9'Y=1 #JZAMV 0T'Q Y4& %
MQ!%D N/('8#NCH/(WMX=%T0,PS%/E*V8)M&TL"1AL>5U"8@2_BFRR,&3!G,1
M%:ANJ8>'ID1949F-[V).X[["G8WW4K7$Y[9'1O>).X'AVD-V+M.D@;&C1'ES
M!63FC1J:QS;=I+=[&U\Z'C7+EN;W!MBB&W -KC:VYZ0R;K<"8C>_1'I(VG4=
MW>M[]-*9D*0KW;UZI;VZC^[I:LT\1QQ/C/-7)$.T8>M"BX7X.:33;_, :L;S
MC/='(/\ 2[9U\JL4?A8 Y\S6UK:W/*+KIA$PB81,(F$3")A$PB81,(F$3"+2
MGCWF3R;H9[R8%1KY7I_^SGU-SG-\1&*1'%54P_9+& C0#'N=0F"XJ6#DQ]:>
M4E/RQ9+.M_+'=0CJR8L<PPF8SF&62 NE /)S(F/(=X'\PL[$]>:\[B<4T.XL
M_)+^QQ,P1,VO9\TL;:L^(;>^PKFMIFKL#?L0VM,R6W)Q<&Q8(&DN)W\X^1J6
MIMU*=;WO:5(ANKTI.]IWK_/]OWJ>ZR""2<D5%,87MHWJ&G<'ES<!2Z@SXCEQ
M8@!US8[<AAY6QVL[CT9X\RI?K>MZ]=;UO6_XWK?KK?\ SUE5700>1!]-UQ2Z
MVI:VTN(4XWZ>]&E:VI'KK6]>Y.M^J?76];UZZ_C>M_YZR2" "00#=$@T:V-'
MD:.QI0'-)+0X%S>8!%CU',+GD+)<$.-N:WMM:%Z2K:5;0K2M:5K]MIWZ;WZ;
MUO\ G7^6201S!%BQ8(L'D=^A6+7-=>EP=1(-$&B.8-<BN6]Z3K:E;UI.M;WO
M>]ZUK6M:]=[WO?[:UK7[[WO]M:R.?)22 "3L +)\ %^(6AQ.EH4E:%?OI2=Z
M4G?^F];WK>200:(((Y@BB/@4#@X M((/(C<%%*2A*EK4E"$ZVI2E;TE*4ZUZ
M[WO>_36M:U^^][_; !)  ))V  LD^  YH2 "20 !9)Y (E25ITI"M*2K7KI2
M=ZWK>OZZWK]MX((-$$$<P11'P* @@$$$'D0;!]"%^+<;;U[G%H;3O>DZ4M6D
MZ]RM^FM>N]ZUZ[W_ !K^=X#7.--!<>= $FAS-!0YS6BW$-%@630L[ >I7/\
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M)A$PB^,B0S%8=DR74,L,(4XZZXK24-MHUZJ4I6_VUK6O^>_XUZ[WK62 7$
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MU:L20Y1S>-$0R%LN 1"X,V>\Q1#0QU'4;#@&V>6XZ*L>7%O)A1WZ'"R7@70
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M'K[4_NMUQ6]);9;U_FMQ>TI3_EKUVI6])3O>MD4;I7MC8"7.-;;T.I/D!O\
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M %WZ:UKU_IK6$7[A$PB81,(F$6).!XQX7+%R_734IO6DN)_[;+R%:<9?1_\
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M*SR6#$L;VXY8KK'W/;?:VNR'P+K3E9*20RE?S];2S]^E?H%TP'@MXQUR%N!
MH11]O]/S:FB07Z#T8X0:JLM/'F6:VT2+VN9/0&$PN!\F'@H6I'L#0ZJMN!ME
MRQ6ITX^_OY)9^M\AS'_*EUT\5>,7VV$+R=#V9BUDK+7[@\8K_0K]5I$>S5RE
M&.;Q3(Y%=L@Q@;,GT Y.J)M4%IA!D4@>N>AX@)%SH9+(_P" ?U4<M'A9P"R"
M[A#34Y8LC<'#\^6:BV2TOR(9X_?.Q=2>-QH<LXZ.4]'Z)WGI]F9@.1MC%*L#
M09<38$.#&#7W\TL_?P_@+ "_ CQN@"@T616[21/"MB);MWD],Z9NYDC(B/S>
M''-3+"JWN$U3$0.2<_#Q$:E?;BJ[785<%-PPNG(3A-1\?H//^2LL!\'O'6KN
M GZY7+:$E5N7498>:-ZETV+-B*IO+Z9QD?'^Z;MNGW8)3FO.J'7+3!=6N):E
MU"NG#K4ZQB81=DEG[ ZFUMOA0F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
MZ\J'$G,+C38S$N.YKT6Q):;>:5_3U0XE2=[U_.M^GKK?[ZWK>9-<YA#F.+7#
MD6D@_,*" X$. (/,$6%71/E-:F*V["W,$N[WO>OM7MNL>[?^>VI'R+UK^B6G
MFDZ_;TUK6M:SHQ<5RHZ#],S1_K%.VY=YM$_$'Y[JL_$B?RU,O_2:%> '(#KM
M6ZA,SD9YGUV/+P)B-?OI,E#T1W?_ "TF4WZ_Y>OR)]?Y_;^,O,XS$0!)$]A
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M*T].FD)$J@.+\2 >&Y<C0\:2&!C*%SFH]+!V5#)G:WL]&EC^S;3&,:V@,K(
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1F$3")A$PB81,(F$3")A%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>g425213g29a65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g29a65.jpg
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MY]\E>P0<R86-Z?>;0F0J27+D[)K1F+%9ES]CABI>'58^^[Z/'_G[?/&]DXD
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:#_Y0_P#;K\#_ .BSI/\ 7MZ+O[P3_65__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>g425213g29c87.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g29c87.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[26H4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )8R^EA(X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'/XAS         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             !60   F           0
M                       !              )@   !60
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   !60    !29VAT;&]N
M9P   F     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   5D     4F=H=&QO;F<   )@     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    &.$))300,
M !LD     0   *    !;   !X   JJ   !L( !@  ?_8_^(,6$E#0U]04D]&
M24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S
M<$U31E0     245#('-21T(               $  /;6  $     TRU(4" @
M
M   18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=
M @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN
M9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D
M;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P
M  @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@
M*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M$G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR
M+C$
M         %A96B        #S40 !     1;,6%E:(
M  !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:
M(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI
M96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                    9&5S8P
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C
M;VQO=7(@<W!A8V4@+2!S4D="                             &1E<V,
M        +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV
M-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@
M:6X@245#-C$Y-C8M,BXQ                                  !V:65W
M       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58
M4    %<?YVUE87,          0                        */     G-I
M9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #(
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M(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-)@U
M#5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/
MLP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%
M$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5
M-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA
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M.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC_B0"-
M9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B
M1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,
M<DRZ30)-2DV33=Q.)4YN3K=/ $])3Y-/W5 G4'%0NU$&45!1FU'F4C%2?%+'
M4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9
MN%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8 5@5V"J
M8/QA3V&B8?5B26*<8O!C0V.78^MD0&249.EE/6629>=F/6:29NAG/6>39^EH
M/VB6:.QI0VF::?%J2&J?:O=K3VNG:_]L5VRO;0AM8&VY;A)N:V[$;QYO>&_1
M<"MPAG#@<3IQE7'P<DMRIG,!<UUSN'04='!TS'4H=85UX78^=IMV^'<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !H +<# 1$  A$! Q$!_\0 '0
M P # 0$! 0            <(! 4&"0H# O_$ %P0   & 0(!! H+"0L)"0
M  $" P0%!@< $0@2(3$W$Q4X05%A<7:UM@D4%C9S=X&1H;?P%Q@B)G6QM,'1
M(R<H,C,U565R=(4E15)35H:EX?$D-$1&5V)FEJ;_Q  < 0 !!0$! 0
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M&RN4.[--)J-="??F[_'V*/>$+N@J+O\ ZNS^J4YM].O4<,*_D[/TQ@RQ&?\
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MH0C0A&A"-"$:$(T(7-R%RJ,0[,PEK378M\4J9C,I*;C&+LI50 R1C-W+I)4
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M=[%363R)C+81:5849%\\Q^TN1+--PEHBLH)5PF0XQ*O)U-I-(5Q\[;JL(O\
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M_!?KRT3&<>KGYVH^6?=\KF/G-\'FXE4MX[@^F?"PGK0[_-T:RLCP]G=F/V6
MI!]%9MN]M_4DKP4=>L;MT^YRQ?HJ>KK#;>*+RB7]IR3*Y8['>4H,Y]<^3_/R
MQ>D7'VZ/F[]Q8&\=E<@E?=-XM6?F3$QEHGCY05EYQ[BS#?EH7JY+:QUB<-;9
MV)WM4%2XV1AZ^XI6\"G7-)][\0IOG_QBN:LL/=Y9?YR@FGT$P._JTU"93*/V
M&]94_P";>N/*7Q@V_P!-NM:*PMZ+)K_@)/W$.G2HLQ\9^MG/YW@_8K0XBNY
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M7Y-GDQ#IYHQ8JXR:UICOQZ%I*5P/TO'DZG9:AE?-\3,I-W#0CSMY07H@W=E
MCA,$7V.G+?\ ="  <H4N67;<I@'3T_A':]IRIE9N,QT$Q&Q"UDO 8\EGQ:.
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M3,I/R^3LVNY6:?NY.3=#8:0E[9?/ES.72_8D,>I(I"LL<QQ*DF4@;\DI0*
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4&N;ZNXKU5T+J-"$:$(T(1H0O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>g425213g29e65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g29e65.jpg
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M 00!! , !0(#! 8  0<($1(3% D5%B$7,2(8(S)!<20E)E)R@:'_Q  < 0$
M @,! 0$              0(#! 4&!PC_Q  ^$0 !! $"! ,&! 0%! (#   !
M  (#$2$$$@4Q05$3(F$&<8&1H? RL<'1%"-"X0<5,U+Q)$-3HA=B-'*2_]H
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MIQ1'I0RQW<!8)("U6&=W'V/6H^^@ KN"#3N5B-*I$B953*+(H?L+N^== >8
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M*_??K7+-]>:JYTY.!)M##0VR#=<;#N+J8;#R]H:0UPH$@ YSV#Z*_48J\L8
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MDNLR#:0T@-(<VB0:Z%Z5_4MJH,2):YS=.@6B-3>@E7UGO,718*+5>46CU?\
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MO#@!1)%4":PKG7A3U)7*OS"ED[N(9I?/P'%P<BG$.N]%NX:2=YC</(U@/VX
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M^F#-Y7>K9V"RD>:3)%5FQGZD)YBAZ'TS^_PH6J1QS$L<7/;1&X%[B20(Z/F
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MYK3M).QQH+U"XU8+':^3\XLEO#6*O6DW3*\1L(:W0XH^S0#$D;'60:-P(8H
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M+/.['KV]/NN1#KM0Z6'Q UT<[@RFM #"XD-VNWESMM>>V@ AP!L+]+'5>_\
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MS?TW+'$[<W^H;*!Y$K+\*^7Z$CZJ7\P(F$3")A$PB81,(F$5KFG HR7!@$C
ML?.*)F*&PII")$ED4CV=29ZH,9]YMZ6F#'WJ1,W'0YJ,SO3KVT-[^K"@D#!(
M!/($@+MHR(VE:M%1NTMPX9%:M3HNTH'D%NMP)R]_=^$PYSD=]N'*WO3$E;+J
M65K4VO226.X5'+M-8@.$VIUC PW0J(KAAN67'QW!+<Y3*83A-#TA"H")BI#"
M8JI6FDR%/,Z:VO;B-*)8[CYKZ1K)79LH9"AG@LN:;&$C0:)&*07Y1<,&DBH1
M<L,CM/K=GC!4PZ$B$I\5#L6#),"F)3K3I"(AXEBP+%D$@7D@4"1Z D ]K'=7
MK"E,(L9(76FB346N%;;61EAG?B_A 2!X5#-3/SAML,0OQ1<F6W.D?F"*'>2L
M7[3"_P @;3+9.:^N+73#L,H) -$@'L2+Y$\O<UQ]P/8K)L*4PB81,(NJUH;0
MMQQ:6VVTJ6XXM6D(0A&MJ4M:E;TE*4IUO:E;WK6M:WO>]:UA%8Z]::Q;8;A"
MJ6,#9H#2H:'9U>+CS4-M9 0-/P$.21LB2RA4X$9#FH:5+UN2(*C23.EPYT5Y
MTH!!R""/0@]+Z>A!]Q5ZTZUMU;&G&]O-MMNN,Z6G;J&GE.H9<6WK?UI;=6P^
MEM:M:2M3+J4[WMM>M%*H-F@VC*:[LL,U8%C%FD MSXNC*PS4IN"X62,^[^:H
M8W->:AKGZ8W%1*=;CJ=T\M*-E%BZL75UUKO79=QA84:C.3 Q,>6ALD"PEZ4,
MFQI\9HJ *S01T8X_%==:00"FQQ ,6A*5J2.*P)H^8VS+BOLME-@\C?,?$&B/
M@<'U5PPBH(A87/E%(,$D/FS0<MF :AQ)D>3*#SI(^$6CPBD=EQ;P^6^*(CR;
M,:6AEYT?/A34(5&E,.N%%@V 18YCMUSVQE5^%*M^RPO11(/9(?HVH>LLD/N9
M&T44+;DHAK))'_<_+V/1+<;BKF:9W&3)<0QMS3JDIV2Q=7GG76NZN&$7S0ZT
MXIU#;C:UL.::?2A:5*9=VTV_IMU*=[VVYMEYE[2%ZTK;3K;FM?0M.]D7TPB8
M1,(F$3"+Y/N_98>>UKZOM-.._3\_'U?;0I?Q\_&_CY^/CY^-_'^_C>$/[?G^
MBBJ=U)$+H]=H.PZUH/5J2>_<]2]:5&<8BSYJ8OXOV/AU*F1SJ5._?;5IQUOX
M;^E"MJKN\P%<Q?J.?3X'["D_J5JN5]S:&\05V'7.5/.-]:US18'=C^A&V/V?
M5BV720T(6K[FQN]1-1-Q-(3.WMW;^X^OM[U)=9X<)F\,FI1%MW?^UU\*^JTI
M]6(8#-L+J?LVAU$\[()'8&A5K/B_JB)&[!V+DDNC_F#>9<>F=)DE5E6U+/?8
MKP0_*!+%NCUL1H\F!86(B9+DF3\/19"G8SC,A"6:NUP;JI],8B?!TYG+PX4Z
M@TEM58P[\5]#CDM.7BS8M9K-(8'._A-!)K2_>!X@C:QSHPTM\MAX <2<@VVJ
M*\@^*\4_3M\OV3A/M'B_A"CTCLW;.J6>F+FP+S<R83F>Y11RO6(]S"IV$@4I
M-/G$X9-+3#-1JM3_  QDDF!C2XPV2M+W-G]H6PZ?ADSM.YW^9:UNB#1(!X1,
MA9O+MGGJ@=OENZW!>1?[6Z+1Z3V>XDWA+MW'N+#A>P:C_P##/\4_2OG%QD/R
M X1M;%;26EXJSAGG?U)= GZCWZS(B[1(70>;\HIKI,'SPC#&1QTMI)D0!E!I
MDM0Z6N2,-,D5H,(),%&ULK<2U'TUM4=SM<4UK='PV;4OB;*W2Z>61S+KQ0 3
ML<XAP -[3Y30Z'KV]=QE_"XO:76SL.J@X9IF:AFE!:S>/"<71E^QU"1P%N<U
M^UI)VGD=C_,/*_#?G3K'FCK?"O'56YYTKU&-,)GV9%WM]D5S9HD3572$*A#+
M3-,B ,0C-?E-R]5D?5-_L#SH=*=PY#D-OS>@=PV"3A>IT_#FPR\5C<\.\5[_
M .'L N:P/): =Q%1AF+;5&ERN&<;X:#[-:G3\)=!+[2POD!\=TG\%08',&]I
M#@725NC;%Y 011#1O4Y[=WJF^D+2WSW_ +O"+H)J<&$NP?"+*V:L,FMQ9\IY
M(O:ABV),&5-?C,MS=*96Q&;?TYIR1OM#B +-4_PR/X:7PJW#S'=MW77E&+JC
MBLYQZB'B[9F<0>("/X'4'3T7C^94AB#CY?)Y@37F\M"[M2D#],LG.C<8HC52
M=CM=<Y:/Z1^YK+)<<![*C#!**)W%U!0F=IE(.4P_+^_%^M4EAQN.G33C;FTV
M;<Z)NW_4B$EWR!%U5"_?CW+I-E#G1MVUOC$F3RL$U@9([X"DSF74T]% .'-!
M5"_BRR #<;\S4K>VVXZ);4I;GX['TJVRY]#C6D*3IQ/U)=VA7_'*UUBZK-?E
M[N_V5F4N99$PB81,(F$3")A%%?5>-TOL@\,,NFC_ .,!)N%Q^Z_93=9?U,=A
M2!Z_R9 29#=EL;C27M?C25.,:<VE[3?W6T*3=DDD>[PY'Q[AM=L<YI<VP=IV
MD6+ -'J >8!1:Z6+]/GSU9*_,KLS_)S4.2/E#VG6>M] 4]#U)D-3=2&-2#SS
M+C[$^/'FM?DM/M[>92EQM;2W&UYXM;JXI!*W4ZC>';K,TF>X)#@2""0<W1J^
M2@@$40*JOA^GP7YHO5O#^OB(O8?/#D=/1V0%A?#4ZS$9+-<..-CCD8A#)V0>
MG[,9Y+0N#\BIP]R2T347B_EPX[#2Y3G0XUH]1Q7@LL, ;))K(HWQF24C8]LD
M<I:]X;;MI86@D4YWX@T!<7VBX=J.+<%XAPZ 1F:>$-@\1SHV"021R O<P$@#
M;0H%I<:<-N5H32.%>C.>O0T'TQ0U-@.JFSX[$L<:2I+SJ-O1'8[;:9L5R2G:
MW-R6EJAQ%)VI3WUN(;>^$^UWL3Q#AW#9N*3\,.LIC6RZC1R.D=I &NJ6=GE=
MX,= /D;&^,6 ][1D?F'VY_PYXGP7ADO%Y^'-XB1&T3S\/DED=H0&&IM0PM8X
MP1D4^1L3HP""][&FQOQY\X[VKL5KB\]Y; 0)5<7&F2UN>T]J4)!#]/O3W8>G
M!\X;"9U]S6I!@FE#<9+K>QD,[/TT(?\ 6?X1<*GX3PCB?&=="[2MU\\$6E>]
MLK-2^'3->YQCB?MC+))9F^%(#9,<I<2UC5[O_ ?@.KX?PCB_%=7IGZ<\5U&G
M@TQE9-',_2Z1DCI'[)&AG@R23CPI&@N>8Y0309?Z .&?IB<IYU4_L76Q7RQW
M0D^]),% O1+D+&L(=8<CMC("&Y\5V3'CH?EN?F28\=YU^8\IN/&:;CM-?1==
MQ;5:J0%D^I9$S#&.U$KC=WO=YZ#C0Y8:  "2+/WT- P!0/1;N<CXE2N*0"@V
MENV5R*6V+_(38[,7LJVD!XKD*"W$=+2)#D9M$=S:'4MJUM_:&UN[4I&MYS7R
M2249)))"+HR/<\BZNBXDBR+/<Y*E2]E$3")A$PB81,(F$3")A$PBZK0AQ.T+
M2E:%?[2M.E)W\;^=?*=ZWK?]ZUO^]?[UA%IUZ=]H\!\FRZN(Z>LO)/6]I^6-
M UBOMEIS 5C<AET\36^]!AQ16IS&AR$(E2"DF2XI4,9*C1)[\7D\2XWP[A+]
M.S73.C=J'4W;&^0L8,.FD# 7"-I(!VATCB?(QP#MOF/:+VPX%[+NTC.+ZF2*
M36N<(8X8))WB-N'SR-C!VQ-<6LL6]SG#8QP;(6:K&..2(\^+U^FV@GRW77JP
M$LL@IS84.ET<FLZ*BE(B957NXH] _>AFW4-,GM#PQPF+;TS)8CQ'$0!OT/AV
MIT^NT[#!.7R 8<_:R3407<,U/;@F,MW6-[2*>7<SZ&&1L\4<\3@63QQRQN -
M.9(P.8:=M.00<M::-$ VJ*'SGMQ1<AT-WKJAB''1]#SHWEG)I:([RV]Z;VZM
MCG[GT_*]?<2AS[:E)UM&M;UO2LVWMCA+6S:N*%[N3'NC!/,7RP+Y?$'HLE._
MW?\ J%FE(\>V+H5J"V#LUNZ%<PM>FI+C(%Q8K0()&*,Q6V(1"#2P%<"P)I2,
MXWN3$EGHQ" -DN_NL*/^\1(4AO3U7$M/I8RV"8:F<D$ 486.%>9Q;M#ZSM:"
M:=D\@4VY!)LCOR^ Z??P](ZY3Z]513 <,.89B,[6YO;B$//OON?&W9$AY2?E
MQYS>M?.]:2A"4H;:0VTA#:?,332:B1TLKMSW<SR  P  ,  8 'QLV599&VVV
MTGZ6FT-I^=[^EM*4)^=_[W\)UK7SO_WOXS$B[X1,(F$3")A$PB81>>_O7ROZ
M:]-K\Z*\X^Q[KY)3RGLPJ^]+13X)"5KJU.B[B;=JY7]M.!?SX\/4:5IJM6#1
M2F'_ -W?W8Q<K8X=I,@@78N_HM>>*67P_#F=#L>'.VC\;1_2:(^1MIO(-!5_
MJ3S'TCK/3*]>N6R*97I[O.;+S*\V&W'VYS1:G%A-V;A5V+1)G(+?)@S8AJT;
MGP;W2>H\T/P]S9C5B@7D"*AU8DO!'[\_F/U4R1N<]KFD#!:XDC+<T-I8[J?Q
M-<PCKN I:,UG]+'T"BI]5YK9NP\SU3NGT[S_ ,307U%O-G/5/@7F??5G^9U.
M .C[YZ\0+HGD.9SY[Z+@%C(G%>ER5O$&8PR%9UC&.7;KGTJNM5Z#I:P#2OI[
M2]NUS8V7YB1'%N+1_3F]I_$!EWI<E3/T[.Q7BT=]Z'U@[QFSV[O7&NA5,H,C
MQGOX^"Z=</*WE'D$:T,%M\RA6DY6&^D\4OI9ZN6*:3%A@TGG5UK 09=81H4V
ML57NSZ6?W&/JK?P[W&1SRPF1C@:&-SHH67>T$C=&XT;QM(H@A;)]M\HWJV6;
MS.8Y5,J-,8XK3CM-DOP;5;*&]6=V+JOF&[S+!4A%.KLL9;F&JYQ.Y@95)L[U
M>K]@7;(44K*2.>*:; \[Z_G1Y_.[_=9)(G$QEE#8TMYEM6Z)UBAD5&06F@=P
MO%K6\5XQ]NH&/2%]FJ]:NLZU])+PR@OK_2K/1J#%Z=Q+CU)-%:E1"W+@QDA8
M*]T^AW2]\P_/Z".W2H]]/ZM)3IQ*SV5R0L>_ETHG)QS/?GZ!8Q#-S+P#9(IS
MBUNZ.,$AI;9(>USF@N&W<;+K-R;9_'WH<SYMYCR<-U^UURS@NK62X7EV%WHD
MHD[5+!1^C5V""I_6]^>]36_XA<+16.D52 =Y');%':W&_'*MS1($I%6 3B^U
M^_ZJSH971L9O(<'$NIY&"UPIKO#_ *7.#FVSF!U *BN\?I^>BKG-[Z^YT:IQ
MG>OB;]6)1J3TSJ) A;0A>E?J. Z.]:AJJJQ#K42ME?6?"FF:77YABNA!_)B4
MX)(V^$J(N;((%>AOD.[?T'U5':>1QD\P\X(O>^W8U(;8H!M&:/ L ,QR:I3?
M\@>A3MXG3"U]&@.?%+!7)-AKP+MG8I[]JI372.%6=%#>AIKM;B5B!RSGM Z?
MRJM3@4[:^M#.E3CEXBU&60-Q'XOM]?=5_'Z8HJ_@R;C;@&6+ >\DC<PAIP*#
M US0!^(.)=5D+)Y/FCT6GA7:N3P[96I<V]]NDVBI&3O4KU*MT3F)E5?G&4&>
MDP>=P%1;O ,QBRJO$9YX>"1*Y%"ASQ*P&WR%K0!%CW?7/TY7\:Z*3'(6/98-
MR6TN<XG;8NW!HHC.T415 FR2HYG>+/3YD?5"!KN!9%L?O-2,=!DU?MMZ"O.!
M0/"J'2H<VM'[#S*ZP?W&I=5&](NPFMZHH$3:WKPFU&S(FR0DCT+':^V#W]#V
M[WV]5'@RFCO\Q<"ZGN&!&UN"6N!IP<0-H!W78.%+76?+_:;[VNYV()>(P_DU
M[E\RFV,43Z=?&+)]JF$Z&P8JU-'U:K 8](HQ^LA;A_)*S*M=Q;M=K/)-,2Z=
M#-6P83??3EF_CV_X5GQO<]Q!&QVVP7.OREN  T4T@&Q9W$WY<@P37/%WL"M)
MY8-3URMF!]0N_-+>>,$.Q=>D6!_\3FWE^G=J&+4<IUC:M87I!^B>A[/L--DU
MEY\QT .6G&XZ++;P8^;&>Q!Z=;->[&/G7=8Q#*-H#@:<TDE[K_#$UXRTV'%L
MCB+%EP/4U8Z1^GMZ.J3O.A^NR+#UBOQJS_(AG*^N67FD[1BL\6\G\XT;AD7^
M-W%1Q1B1PR^UF4PMBK$A]#N&M"ST>7:+,)@";Z?VR3CYH-/(-OGH"K#7EN0V
M)H(\AN]C@3Y2&G',A3'R#R3WNE"^NNV.RTK5RO?E)'":G;@O0K[.+UNT5OI7
MI([3S9B0Y2*]#GRR%0ZUSR3:KS7A5:F0[G3SB:S1(8*<-TP)&.M&\^X8Z]O7
M"NR%[0^RVW1!@(+L$.E()P,D/;;@!EIIM4K'.\;^D(1:.H=T<;::".L\@L[R
MX_VOL=>A7$"0*@B\RMF[K"KEFL -AD^V:M^GXD,YHC.BPJO+99 V N^-B_O[
M],4H,,G1P+=U[2]X!%V6EU$C/FZY !P2L*(>*?8(N#?Q-2Z;S]<2T>B>C=YJ
M9+?3.H4\W0(UF[1UGIU8H I(RA6*OS*[ U;!IJUS9 +5ELUHO]\$[/1*Q2:=
M_())!^0'3I7W\/4U'@R@.#7-S(Z0>9[=H+W.#10((%VXU9+G9 :V\NKGCCU%
M#ZA3#)7M!*'S:I=9NUOACP/:#K][>"F[#QNU#2ET+G.'3 /23$UVH=$HY6N*
M#TA,/F=E8!;O)XK9KN;F18[7@<QU^!O]\GLI$,N\$OIH>YU!QW42PV264XV'
M-(H#8:LDN55>?''HM73.AW&B]# FF[R7!R#UEO'1+76+)?JHQR[D/,;!4+53
M>;<U%\O"')"Z78;Q7^A!P!%@8?A5,(3Y^8JA"QBTK'TZ>\D?G77%]4=#)O<X
M.!NK+G.!<-K&D.:UH;_27!P&#0VD74;;\0^SE5457WNU19>W*3Q@/?Y<OO%[
MDV.Z&>95>ITR>.K5S?X:X[SVHF60Y*_V%HO6^FD;GT?>R.MTJ+:[9M^;';K8
MP*YGG]!BOC6:^!-0 ?T9N/B.MQ:&B@=GE::LX<7.SY;-SARWQ_V*JV/KIBZ]
M!F60G=N.]7Y<,Z7&[%=%=8,;N=UGV*B%)9.7SQ%?YF:YW4Y8RB0[+2Q!M,J5
M5A5V_BS<F4NNP([5^7W=^ONY+(V)X+]SB=S7-#MYW9)(.6TTM!#;:#>T&KPH
MK7Y#]5&DRZ@<Z#,'@H/'04V)!I?5;!5:C.[2*[$99KCKUFF4JS3YXMS@ D17
M.OUS_$8NAW P5FJ UVO,']NU@*^QZ=K'(_OBJ5/"D/E+L;0::XM&\/-9VDD;
M!3P6 ./("\7(!XH]*P^D4JW$.D!0(EKK*.G=+A<PZS>ZRW:SDP+Y?^3;8>W<
MSZ W)'U6;R#J]*'4.4<B.6KG'4'X$_H=;V0."U+%'%]K'(9^N?O">!)O:[<
M [<X->X;C46<L/+8]H;8MKZ+AR6.@_ 7I$14OP9G:212R2Z=4Q)Z1$[YUB&@
MZ>$<S\MQ+ N3/M5'OPU(&S=CY'U:T62*]2Y+]GJ5_F!Y.A+]QL#0.;';'0>M
MXNC9H84#3R4+>2=K0?YCQ9#8KYM<*<]CB?+EKB,;C7K)0H%E%4:EC+F^$DW
M;4ZY M<BM))HKDBRPP\..=? (-R)9E(1THW*<%)+RI)-,%3&I\AZ5IUQ5?<M
MMH(:T&K  -75@9J\U?*\]UEF%*81,(NJT:<0MM7_ (K2I"O_ (5K:=__ .;P
MBB0E5Z4[U&NF9AB0S:H%9FP1H;ZTICR1VX\Z.[+<7^-O?W6HLF;\-)DM[5IO
M[^FOI97]52!N!O/0?/\ NIZ<OCG_ (6F9WDOEE?GQ5<(==,0^=*[2DTY:D[8
M5,_FFQG[3NNJ:V <TW&_8=?=^_N#I*$ZT85)_#^6MZDL,!AVOD(890_=8O?>
M&X'4=*]>2TIX-/) 8Y7EL9D#KW >:R*NCS%CTY\E)!+GOGN1W_MIF?T>>S?;
M!PZ0&Z!5/R&&8-=HKX$",F65B:L2I#<I . %D?9<GR]QDRE3WH:V);"&*N@T
MQU4[S(?%DTVR5FX#;$0 7<O*: YG&'5D%:DNCT+];K)GRN$TVA?!J(]P#6:=
MX:U\F6G:=K6Y)Q^(@@A0IOCGDJ;R'S(+<[*:54076)Q7GA[[:&)%TM,VP*D$
MP1.,X ^L/$03BQH:I3L<:F$TA&G9>US6I"N8[0<+=IN%QG4.,.GUC9M(XN!,
MLP>YP8XEIQNP<-( JP3:\S-P/V;DX?[.02:^7^'T'%FZKALAD:':K6'4OF,,
MEP_A,^#Y8RW:UI<"03*-JYOXB(EO7S@V'2:+TRZU6&QZ:O\ 5P?X-U=&P8:-
M#)Y,F\+D,%G("FXRI,<8W._():8;*,NDW&<Z6L=H]7I];HYI@&"%S-2 ?-$R
M1O/((NN0 /05R"[G$QP/B.EXYPW4ZB*,'2&/BSHBUD\,,D9VO>\L<"6M_#A]
M&FD60#CH/E?F"'-\9J@]7*ORJE"E(XVRO3:=]!1HBT66Z4;_ &1"ABVCFTH0
MT[L5MQ;BQ&DKEITIO5BT7#X_\I:R=W_2L<W1^;_6&T;MQVTXC\5>4V30PN?I
M>#\#B9[+"+6RO'#89&\))>S_ *QKF,+G2U$+((:X;1$ X[*)("IW>7>7?X'Z
MQ@IZX62#LO0!4WJI1*6WG:+88%F?(BA0UE(+:B3#U@DS8*76F26IK>E0F)"9
M,1V2K.V'2;-8ULN))MT[K%QR;@X 8_W>_JWH5V8='H6,X@V.9Y$^I,FI)<#X
M4OB;]K?*,!Y//=FVV=I FBOT#B$+J'"BHF\SI5GK7(!X3GH;;[#T:RTN$*,Q
MQI^4\V+;UN0Y!GF'_EN3"1,6PE;45"(;S3NXUD8?$0\DLC#6BQYFT:)QFP#R
MH6%TVL8',+79;&&M%C+,43W]_OKJIAY15J6!KTB)3C$DT,19)I!4J0M&UMS_
M +#<=4;6TQHR7&68WV]H=TWO3VU?>2ZI.TI3E: !@V/7_@+,;Z]L?,_KS^2E
MS+*$PB81,(F$5GL%A!5,(4LMG,#:_7@<)\D8-F)L<<+&0(J-N2)<Z;*<:CQH
M[2-;VMQUQ*=?UKY^=ZULH) !)- 9)*U]Z_:;>2(4Y/)NT<FJ<*'.-Q;K"L9L
M*HB=63AS0M;&@YCHZPLB2,,O L$QE]\9,THP :C2!1J!#-"'BQO));L>P $[
M@2,W@5@\L].8]% HU_T^^' IWZKX#*F1A\I,F;IF'&<>D)DD(T.<Y'>@;<?D
M(%% Z9\(RP\Q&*I8VY$?G,H)3!^7O^PJ R4/YD9[9KK7;)R.?7H3D[K<Q9N[
M-)$?Y$L5<M=J?40F2SU3B*A5Z=!FDIDL+L8RK6M_C,AGH#"'-[=4O3?RY+(.
M?61EEF;>T;B">XY$=*^'V>9B_M?ECDW=GFB=K'3Q=E89;C-VJMRF1YE<5K>]
MMQ9GY$6:/(,MZWM+.YT%]^.C>T1WFD;VG>[I=?J-'8C<US";,<@W,)[@ @@^
MXCU5EC%-\1^=JD"6%ETEJY//.*<E&[@_L@7?^K6DZ;0Y"0.B0F$)U\):@1(V
ME[WM;VW5[^K,DW%=;,XN\4QM(KPXQ3*Z@@[BZ^NXN[<L*" 000"""""+!!P0
M0<$$<PIN \_J?+*R8C\LH( ;*;'S9<(,*;B!EGB<>*ZY @3C#R%N:W+DH:BZ
MFD'7VXB7?NJ_[:-ZS3EFEF(=+(^0@4-SB:'9HY-'H  AP, 8&!R&!@+#T&_0
MZ.= GU47GDGI2ZREJRM[MI <$8N$4%._*FA J1I=,JNDK-%A_M R=>8I%@&5
M;V5*QY\"2E>)5N3:/*W=6<FK /(=B:H%V <FU8ZA8/24CHY$;<*57H7.]7NS
MQA9^%,%[D+YW%A7#=>G2XS9^6158YIF/465:2.B1$ ICSKL%1%<YT2^_O[_M
M4&3?1 VVZCC+<U>;!NO>+-=MD\+*F$3")A$PB81,(F$3"+7WK':+/S4O)A#>
M1VN]#FP5>F1"8#]Q5J?8K18R-8@ &4M5Z:-2V-GLA7[%(V84<@#;) *C:L;%
MCK!-$%C>\M/X210R+YDD5R/6KZY% YJ/)?J&],/D6V/,7:9:!<Y47[L>M&]M
M&FF9T^'-E@ER ,5Q4:*VR/ELNE8XS99)#Z!#<R+#G$8S[^_O"@R.Z1OP<X.>
M?+'_ #>/3SD]G>//2'M7HW'^[\UJ4/F24<Q;&$ /5;*\#M50/URV6PR,;)!8
M0\VU$=+QYHUT>H<F2M#[NT6%D8EC;N_$>TWL]Q'BO$-)J]$_3L$&GV%\TTC2
MR1DCYF%K!'(T67-;;1DWX@V@%?)_;WV(X[[3\9X3Q/A$^CTG\#I2PR:R>=KX
MM1#J7ZB!S86:?41[22WS $N/^HW:QI.]'B&B^QQ(6]G/9EX;LABQ2! ^KT?>
MZ=.BUV %T1:GE9#]0&Q@BG+%^1 VS%BOOJ2Q!_((H1.DJ;9[/ 8>.1,FEXUJ
MA+-(Y@AB8(0(6Q[@7[H(V-N6P:!-!H)IQ('JO8[2>U\&GU<WM?Q&/5ZJ:5C=
M-IX8]&UFEAA\1KGEVD@A8Y^IW,?6Y^UC&[MLCGM&^4>-'B-:9BQV8S*=[VEJ
M.TVRUK:M_*MZ;;2E.M[W_>]ZU\[W_>\[Y)<;)))YDDD_,KV:^V0BA<3R8R,Y
M[6J&UU&X#% !L(9,/5R'6HA*R:AD4S)!0T_: ]R(*.V%A*VK04B%(RRD^<4+
M1&1<F6RB(5 RFANXX%6*LYNS8.3U[YJE%NO+9*2&$PC'7;.6,"AY>.S8'XDO
M\R.0,+[&MPH,T_893X]R OJXV2+;7,F.1)_,>?S-R7=AVFD._K^X/Z*GA&@"
M\DB\F[L[\_B_^W_J%MUA9DPB81,(F$3")A$PB\__ %W(] EU==I//9O4 @DS
MY6OZ>1.<OJ\0@FV]R)5[J4(H,NEW_C9DISN33X47F)KEDB#8^?-V:UG#,!\G
M9_VU .-(K&>N?=C/+W_LM>;Q#N:W< 8SMV@9?YKW.();0#2RB+)-WR4!W'J'
MZ@->F2Z]5JSTBQFQ0+T^%A'35'ILZN6INO$?5^_/-X5%K'*Q8J%=2C?/?/L,
MRF3T>N5P_&Z(RJ!QEALLJT"%#OVOZ7^9Z'EV5'/U -!I)'B#\(((!E\-QH#)
M#673@#N_"+L91>>A>Q:]UVR4@'_G"3R(6U4!-AZDOF]*N5V'#0AODH\_?>8!
MZGP(94#9FZBK3;")>MZ:[$_%2#L!,%2Z&[7]TYQCMU[U[NO+Y5WR*DNF#RT;
M]F 7;6D@#:"0!&!;K<:\_+ %;59F+;[K"6("""3KT8$3.M>DYA<[T*@?D_2#
M8[@)E\DI3352XK)C_P 7)>=",LU2;)*LM+"C>BOOA+AT*1NI+Y++8_+E\>?K
M?ZUBE ,XP"X^>0VYO3>-C2 SEX9L$%H#N;C6U79LIZ^!VSF<4B7["Q/N;GG2
M;=[M&YS6+/6(R5P;Q:.Q4VU@*_S@\U78")LBO<LK):LPZ/)K31:+>+U=K4[4
MR,>RL5\_TI3<P+;+[)C).T$53B]III S3 1MJ]SB:S&%:L_ZA%]!<0B=/3>J
M_.G=6XC8[B,H5)DBW(TRL=H\E%^L<\Z192G*Z3^V\]!5W_J), 35+<W6;Q4A
M\*ER.L]7>A/+OLXS1Y7SZW=5]/<3?(*@.H<&;]P)>PN#1RI\)>USMC?*!XA!
M%!S0!N=_5+_2+3[-JW6.SQ**]TX]6I/4US^71'*!73M9?5OB_G1?.Z"LS_"]
M:"\9N/0)?HB/U2Z_O39ZBD:;67';54W;-J3;V*]:'YF_C58[*[C,UTFW>07V
MSR@@#9%M;^'\!=XFXWN:0,YSW]!G?8S'8J9.$@;V]5*"$+7N%4N&-0"-:OQ'
M7)O90LI L=TM]&><;LXPVUYD9J--,L,UF1;KE**_QWI$,!)F4\*K/4_+(_O=
M>G*\I#-O;0=3?,!'1#CMF!W.<.8/AT,"W60X [8<A="_4$;@6*PR-]7_ "90
M*F 8467SYK4.%6 OJ/TR!L/2Q\6#YH*&G>F3N)(\QE28;_#T5TZ N%L,"^.P
MB=3F1^=L?KU[#',8N_55#M1DG?R: -HH 2R@NQ'N+S'X1(VY!<0P$';MSU;H
M'J,]P<%+X2,TSVP7=@O+;[))TEZ'6GC%JIDNBD^F585:DN39G..7]3NE5ZF5
M4I.R,VJ<WMM2F,[F*(QMP*LWR^?]O2^2RO=*8P8P=^X--M_W#;O )'E8YP>>
MNUKA5X6E?1XGOGI=5U9Y=.Z/3[1:>8EK'_'Z<5F YE7*VKD/NQ5:H!#]F-L0
MG+!0I=@\]5Z=)8;2\[>4AS3\N00;C2H4BAS_ 'ZMSRZY^&%@<)W"RUP);= _
MA)9-331JVDQ@D8W4>RVG[/<O:L?M]] \U@J'\]A5ZE[I"XE5>L+1X<5D@(]M
ML,0G(YN1K0R^5T[(.PU";3U.)&?I<-F>/Y25EO?RUF,4._7TY_?ZK*]TV]P:
M/*-NW%V#5G\-6"3S=R'X>HUUOER]Z'M2* Z([7!C("GJX6MXFK5UF20?K74P
MQ"E=4J[M.Y3%@C;$>H80W&L@B=?)80N1_*C1^*5T,<J4RR,?48/;-]O3LJ$S
MG'GJB"0T"R'#:X4W!(!O-7_0!1-0BT?J%P;?'-#(%G9"6V?6P*;;:ZJ3?VX(
MKEH[Y&YH9MG-JMS>[2*NOHE/5S(UW2-7J3S.4$.3X F1;.3,-+4*=_OW]OR/
MZI<]@C<+(%EMX#G["6AIK<-I?0;1-%S>8GGNYSVY$ZC=I7)9-H:HH%9%=2 C
MJ=SPH%LJ1',J#:AK4TB<KD^S.(L/0EVZE$50#@QQ(E^:P+6*+Q19Z$QCZ\\<
M_P!**R/,NYVW=0Y -:0::TCF"3;K::/+E1HK#*U=?U!#QV3%_;+!"C0A1T\0
M0;I-+KPY/7PP3I!-WBP4L2 -_NW WRXCDP@'TV-N=9['"N-Q1!Z:DD,CRJR[
M\N6/F!WY]?TI5#M035$8))V@#> \[ 2,QV& .YFSYKY5Q;H'N1KRY1CX=$M_
MIYGJ,T;;C,NAV?5PI?.W.>7"6*G%J>CSLR6/SHG:H=.JQ?=1\_R8DWG!:2^.
M+Q/L2^Q0&+Y?#OGZ8]3GJ>2%T_AM(RXOIWE-ANQU8\.S_,V@TS\))!_J44#.
M,^LQ?4(E_(63M=G<E]OMIN=5R9V&GG\"OF_U >%0([HZ&/%BSB:Z)\PUDV;K
M+),G/<&5*"18<9>@3B(2:Q\*^M?NJALVZR7N\Y-&@VC.SL :$0-79 N[R%6%
M+O[N;J'/+6!@](DW OSFFC^YFK+SM8:=S*^SI):;>@/.:77>0W5NVU>J7;^/
MUX2:%<MZT2-<_FFBD.^G&(S%Z%L6>W3UH_#F+/3/*DW34T@/W%H#[:!M.=VT
M!CK:#RH.);G<<.6=_O/NR=8ZP[<"]\#U>1UVO2K7_CVA57<454*[Z!ME7;&@
M8[U,.W233;OSERG62T+,_N]@BA(R2:"=;%.6AB0-=.W//.OWP/KW5KG)&XN
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M?'^<CH IRPO=JU=DQ5%X;3"0BJYH!N4J6XK\?[B'D_E;C:6J1N'O_BVJ3_\
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M:@4I1"!4N8"Y!F5T!ZQ7RZFDT:@5>YU2M#15P 6>+T,B!"7>H0H<V3#02_'
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MQ=*16H4)C[WV(D5G\F3N;(^U':;_ ")F_M_,M[Z$:^[)W]IKY?<^IW?VV_\
MG_P3\0K4.WK\>Z[IC1D_5],=A/U/?D*^EIO7U2/K^Y]]7PG7R]]>]K^[OY7]
M>_J^KY_O"4.WWS_/*^J$(;3I#:$H3K:MZ2A.DIUM2MJ5O6DZUKY4K>U*W\?V
IK>][_O>\(NV$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>g425213g30g42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g30g42.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1(J4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $@Z^1B(X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>B,L         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,
M  $  @"4S,P  0 ".$))300F       .             #^    X0DE-! T
M      0   !:.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!$0
M !     "   "0    D      .$))300>       $     #A"24T$&@     #
M00    8              &L   )6    !@!D ', <  Q #0 ,P    $
M                     0             "5@   &L
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   &L     4F=H=&QO;F<
M  )6    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   !K     %)G:'1L;VYG   "5@    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M     #A"24T$$0       0$ .$))3004       $     SA"24T$#      '
ML@    $   "@    '0   >   #9@   'E@ 8  '_V/_M  Q!9&]B95]#30 "
M_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3
M%1,3&!$,# P,# P1# P,# P,# P,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MC7N CZZC_P#=/Z@+04;2$B"'*]Z=:?'H9A@IO)@K?::DQY:Z;I2]%92I**:
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M[>>%I D J&1"2P!ZP7+]='/?.XZ=P=^F3DD8Z=/Y[K4A A  $GB2094_Y,:
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MYG.^.$ JH18$]KPB#/K"OH-0R"V0(FX(XBT9C3@=\G?'0;[YSL?KG.<_ETX
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M$D)32UAB8'F?TSIIL"X4^\3_ -I/J/*$=PK;Y<@X., X[>G?IVZ^V@XZ2B0
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MBE!,CR,-DK/F@%I$[C8[=NF,$D_RZXZ=L8QP)G("?*-\ +E#[$PDH."B26Q
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MX/?&,XW SRC^."2DX^N>N.)$.QYMU)!KN9OYRWI=K"3%@2%!CE3Z+&D,C*<
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M8?GIB"2HCG*COL1C&1G/H< = !GMG8<<]G8W-NNH[VYUT54D4@K\SZA9$P"
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M2$<P']_/21Y;82-U)*E?B4K*/,YN=6>8Y2<GY-T 8 2 !CU;&P10/G5FJK#
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M^FX!]]L^W6O;=/300*D126/IJ()%RN#+#UE;P<R[%.%@NR[?Y6X3S<QWSVW
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M@S,S8A@$B$RH .>R>@%$C!42,[X&1[G&V/J#M[;<=Z3MC;IVZJO]:BDTUU(
MFH2T"LN/T@AVC<7,<O$RD>X')67<P&V205#/3OG !._T(_CV/(;6Z:A5\R!
M"I2$@X]/3*.GY9[D@92G$%$?JKA : 6O))SRY&2G]T]LD9R#G!^O'J%-(VD2
M!6IJ;DP(:B+$#UU':*"@NP0B;'W]?L?,R-SN"2  1T.5'.^=^@&<CIZ<</#T
M5=?UU]=(M2P,'B67,DW]([510:++Q, $LN//@GC02M9R2<9YM^PR1V.V3T/Y
M8]N^YL=4T5"EFUR$N5?+QKE71NL@5$TCN*18.>25$]NZ"A@?-Z_-@>N3CZY
MR<]AC/&1LUT FJLU @"P @]B\I(!/(URZ=[!LRATY")$/'OV6LB%).%*5G8D
MC(R<9/IC??&1G&-^G'&O:KJW":-Q;9D#Z;H-R"/J!#XMKT445= 9^HW)$@"H
MC'* @DF0"KM4O!!WR=DYVWW)WQUV&2?^/&:MK=J2W4264*8N>UQ /GD/2*#E
MD.&A(@Y_X)%R66@J.V25;[8&^^^".F 1OZX]>.5&X=K=.UOGK(DU'_N *5(6
M0K7L5K3%+%7G!1#&3@&S=[2M.25$X.W;.!L1ZC.?K_3CW[HVOE_3^9000[6#
MA9$>^N%6Y(%,6<%'O(NK6'MIP!P <9WWR.F2>VW3UW'MTX\>T:ND=3)9O,!K
MLN?6;G6J6:;R3,6Y F.WZ:(&^"2-^V_ITQW/3OT'OQUB#( ,B\]N05W62=*)
M)9C$W=R5_.VCT '0YP-LXVSWZ=^^"!@D]>-0BR4"UF21?N3F8-[Z"4( -0@(
M%9('M=.?34CI6\96<']LK<=_D;_\NG&J+>1/9?8:Q5>R@0?(?IYGSUIZF@*F
MO9ZY8Z%0)#89>2GY<?*M:4^8C/(\E(;>2MOY3FI]1 X!LDI;'#9)4,8&M4@(
M5'GFXL0A-K+,AEKQ+:2XI16@%2TE+A.<N()R67-R7625K4MASF;47'2I"BXY
MS%_;M<<R;ADO@D7(,H:7"9@"[*9#0(8D>B*$[!0^5 "4MDDM<@YOD4UCRU)R
MI1PI"DE0"CDI24W)9B2VU8 U#D)3=+2@  T9  -ZDR0+J89M<SK'Y3>Q" %)
M2E'.G/F>6G)2@N#]H6TDE005%"5**@D$DFA,(!EBZAPV8$5=Q,:@>[/<HG!)
M4.Y<DW[ZC4&P['I5PU.[J99MJ4^[*RR8]7NJ%;U'C7+5HZBG+-2K[,)%7J#9
M*$Y$J8\/E (P !02PO7MR$L?VVN5H( ?U'R>%%S-W=86L5Y7E;=C49^OW5,?
MA4J/(IT/S([,N;(4]/E-Q8K$>)!+TLN>>MOR%,QE.-$<L=2 I0(:C@M)0/?-
ML*^GIMTA$B<H"98MS+BQ U5K'B3T?"_/^)N-;V4\LI6GU\H>>0D.F.XXJ1;:
M%K+7GO>0M*E--EQY3*DN./$Y^81<Y=C>*I_4@C/;4:880<V=G8Y!\F?MIJ_$
MMI$@MMB?<3;3?PC338L>\(B4.*D-HCMOO*H*P(DA1+4E:(Z'&&RMT/!1YDM.
MZ:9QS2%Q$4YR.0$21%TN0":@^4(DR0;-&0)],@\2^DF&RS4J^IM32"AQ%BWO
M)\U13A:BN-0U)V6%H2E2&G.5*#Y8"TE1\U*\I-<WD6:([1<, !D"EL$'C@!%
MLWAD2BD-#_"6TIY3F;<JL'/,FPKZ;^8>O/;Y6K8@Y&V^_?$=W 81O"PA8+@^
MMA:1$)'+NSF$A<AC&2B6.^)G29 1F=<B5<_,I*;)O!#ICMM/%]2/.HB!AMQ3
M*G%J0H)0585LH</S"0SYB$2@ /,6N!"L)TJHLB2/IP2"Q8PX=T6]!OQ,:2J3
ME%4KSNY(6BS+I(Y$?*",TQ&ZP,N$ )YLA) P.#YE9!7G(OZD=\$CT&H"7<PW
M]I'9Q(GN]$^)G2;/,9]PAMQ)1SBS+Q"F^4$DM^709++B_1MV0RK^ZDC?B^83
M8W34)GDKO:Y\]9Z2[L*X[X[/@ W$3JQ=/]1[,U(CR)=HUMFJ)A+#4^ ZTY3Z
MK"6 2D3J9**9L5;J<K0'4-\R1D)QQ?,$N<TOCE 2"GF)MKH*(*R4@7<0V! 9
M]<G6NU1U;L/1ND4ZO:@5Q=%I54JJ*3#D(@3*@MZ<ME^<B,N+ C/NE"HT1\+4
MDH4$Y(.V>/1X3PE?C:A2!U5$F'2!4[LDA(3B8Y&O'N5F@KZ:;1TF/^2X<WNM
M48WXZ?#0>51OB6HA*$NENT;M4E3R4I+B0VS2I"F^4J3R^805!1Y>8!8'V-S\
M)^-Z:=RG:IHIJ%1C<HJ-0" @[H1[!KS&O-_6"@HGJ+'2PB,F #'GZ78L_33Q
M&Z1ZQ56=0M/;E56*U2Z=][2(<JD5JCA4)$EB*M:?O># 6_R.R6BKX<.AI7('
M^0.MASXWBOAWC?!X?G\LP">#5E%8\S'T?#^*%<,@@@.G-7F@&"$&9(">KQY0
MA3R4?,E+JTI<(QNE7*MH8&"EM:5$'OS'))2,>/8KW:ZJZ-XGZ32B>D7!!2"
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M?P#XEN;9K&TJ"'U#<V20RP$=P' */U>J>OZJE6GIX-S=Q,]2^G[F9#:GC"T
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MF2RV/VD>K:/S 8 @!]11[*!VN#A1J0I)!!)YL**=L=?4CV]MMNIZBI9197.
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M"V6G83D5^4U2X3%/7Y$9<A$5M#2)#S3OG.ON*924_P!1\1I?@MSIKGII+Z4
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M<8;,-"E?%RVTNID)=<YN92EK#93\;_P\\)U_#=SQ'BGN>(HW*C374#28KW
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M(020XDD ,!ILD(DNU@1C3CT_+&W;J=\_R SD\<Z@S4 @+B+PH)XAE/UD[II
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MM2.DAWYG UY%CIPV[SE2TI5RNI.5E>2>/H;_ .+O'[-/S#N4@>*>X3T;8_\
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MU-!+A+7FN8*5E8X^P/Q%XT4"GJI Z2_HVV*;@![:<RPAPXUT.Q21U"@&"6&
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M0 V  !Y3S#)_CGKG_P _RA32Y#8%B21':_<$'#)UDFK R0^W,V-T8[8.F\J
M[YH2DK&P)!. 1G<=".F,CMV.!QNFLTQ08D_4F_,^G^TZBT.I7E.RDI&U^V+Z
M=@ =7%=?Q.+40,[)'.H\J1C(2/E!)P!D\9J5?Y@"!G(=N"43-[^6@4BED,$A
MB8"O!R266 /*^B$YZ'KDX!]L$G!!!.>I.>N,=#FFBD4G ,7)M.28F1GSOH@
M@IIE!(,-GO92+R(.ARX3C)Z YR2>H!ZGKU_/J2.-&D,.$T7 < >X-P(U&Q(*
M ;#\VN"Y"\R]#D![$GN2=L_TQ@=L#J>G"'2$#_=D6)S+)!GL@R)"@ <BR$NQ
M*B02IF&"M$M)! R2=L9)ZGV!P,'I@>AZ[\;JJF*@N%':P:-V9\]9%)) (DS
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M*[^NLG>W2"#4P>12(M$?IP;3H*U7K9R?U*ZOX40HI^ LCDVZ!"!?O*D=-D@
M>G!5430:(&V/I@!P8D(\7/JUK+.3@I!3[>8*SI#56L[@:*ZNX'=-.L8$$;CE
M*;\!2>F_\",<8IIIVZ:J:0A6"W]1+&"9 %_<"VHU$$3(2O!Y.3 L1D\:*M6*
MVXKF7HKJ^[A/* Y3[(7@ =$\U^'!!Y<$;YZ9VXZ"JKIZ:2J4!( 8(2,3P<E
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MZ1U4J^Q_4GJZE8)4%)IMCI*COLM2;\RO/HLE/L,XX[U5U;E%5%51-)A(J^,
M7L5K1KJ)I+'T@85AV!D\V19.D=5:UG/ZE-7 =P#]W6,,#<=!?8WZC/U[\ )H
MH&W3U4T@ ":39E7MYDDS-M=#XC==P08'TB188FW\.DK5:KK!2YHIJZK &_W=
M8P44C& I7Z=Y4D$; YQC8#<<9VQ32:C24:GUV+[S82;(AN-9^=O4Q341,?2
M[-0[:/ZUZR>;_P!2FKF, X--L7 '09_]/!GH!]"0??&U33M([=/3( S<DW)Q
M&;\0M'?W;FMFZ- 'JT#/M)!0TQ&J=5;04(T2U>2@N*<Y$T^R A*AN>4"_  !
MO\H^4@[CL.E555=Y !80!0L"?1G-^9#O[KFH/O324R!FEL^9N%.LC>JU9;"0
M-%-7N8.^?SFG6,I963N2LWX5$'/3./09XQNTT[QH^8&: .DV0@0EW6#AO5\_
M=+)K!8(+I$NS I(C'(;[ ZJUG\7ZE-7"1@8^[;%Z;<N?_3L=OQ$?EQ;H&[1T
M;@ZJ&& Z2G& K9)]KWS]TB*[,@=(*B?[1(CMS&@O5.J 8.BFL*B$>4GS(5E.
M!""=PUS7ZH(5U^9'*H\:.Y61*17]H%@0) #O_!KJ=ZHE,-S ,P&21D!!F/37
MNI&K%$G52+0:U0[IL6O39"44VCWG2HL?[U8<1YRDTJIT:H56D+E,L!1C19-4
MCU"2RTZX(#R@%<9! N&Y%[3SZ*_F]0W-UE5$@!6'N8S]PP;:\M8U;H-)J\RW
MXT>LWI6Z>4HJ%-M"CS9\BBH6K+!GRI/P% 9J!04_$QDU&),9:RXJF(P7.':J
M.S3TT?E))0519/=P>&CQ#//YV[U$ CM](E>ET<Q^^+];1&YTQU04 <[4.BJ!
M[9"_TB6<'KD*5D;\Q&_&8^8=T!5D784602'D U9#63O;B; S8!6?E_B1IWZW
MCRE*M*-65I2<I\RA6VI.?5'F7:"D=3T2<=0.@=VFC?(JW*35TP%VY-)17!?(
MOKB=W<<&2Y0=^Z4?XL=$ZO$\^-*=6$E?+E2:';(7\B0 .<7;E.!C/*1S=3G?
MC==1W*/E5]7RP.D=L8X\R>,Z!7NP$/89.2+GWT#JZI62=*=6"20K!H=ME1..
M_P#Z7$G92C[DY&^>.6Y11NT445@FG:_],2$!$D%DA%OB>-1W-TLQ'2##*PQA
M^\Z"]7CA*%Z4:L*;2H$-*H-M+:R""<MJNXHWZD<OS%1SG/'6G<Z:/ET_D%)I
M 5+Z4+DS$_M;4*]URE<P Y(<W1)@7DLP=.&L!41C2?588SD)H-L  @8V N[H
M/X#(QW'%UE(OI 28@)1D\ O(5QKJ/$^(%(1'21TCZ:"(-4-28;?O&BG6-WFR
MG2O5I'R\H#=#MI'.$[<JPF[@%8Z'F!SU.>O$*TR9!M *'=_K+11,Z/ZCQ$4F
MH$ @S30>DFRAA.SCMH?K?V_^2?5=.X)3]P6R.VV +MVQL=OSWSC- IVZJZZ6
M#N%UF\E2<4N($19VOZGQ!+Z@['Z:7,RP/N?TTU>KA<'*YI/JRZ /E#E#ME02
M.NR57<0@;]ACMWX*:*!N?-IIJ^8246A+:#0APA]]7]3X@6J%S)HI'K/ZXC-E
M^MY?E^4-+-6T-^6$%*:);B=@<E*2F[P1UWP1D'8GH=@JNJL.FJL@DU %D#@O
MFT7@W&D>(\2WU3=]-! )RD1 #49M.L@U<PD!.EFJ"<)'*E5!H60-TGFY+B<1
MGN5!PGN3G/!52-RH5U,U"T +D8!2@. QSH_J?$$,54EW=--\X1MGR(TPZO+2
M5!O3'5-LK()6U1*0TX#CH%MU\*2!W"5@'?/7/&OF5 $28,=(B6+V'F3[7OG;
MQ'YJ3DA47 B"%#MZB\,.K:CA2M+]52H'/RV_1%#.>7)4:\>91 !*CN3S$[G<
M%=FZH85("#-Q'%C L-!W]_\ ZQ=ATT=V#!P3:$S!UD.KJL<ITQU:("L@)MZA
M@)!'5/\ T\"$D@%:1LHG)WR3F@]%=58)ZMQ"HH)(H %@3P)05M7SMX$U=5.,
M4@6 8C*78D8N!JZ0 !I;J>G<''Z/T-LC.2<I170"2=U'KOS=3G@K%.Y73N5]
M5=5/Y:F5"1=)D S8XCF.]O$%D-E(4GU50,3>[\M$:OK0>9.FNI[:@"D@4*DY
M(5U"^2O\JCZ%6X! ';@J%-6Y\RH$E $LB   P/I. (D /NG>WP.D5 #$4VM$
M$>Q]'K73M4;HJ33L*T],[S35'&5(8FW:FDV[;44D?*9M1C52LU'S8RE"8EMF
MD!<L<D%BHQ7%A:.U.X0 R!V1P9\_2>>=!KW*@JJ@:B2D %Q/F9( N 7?4ZTS
MM4VC:S<*5.%4JM2GSJ[7ZFAA,85&NU1U+D^4&$+6VPDK0AI#3:E!#;20XI3W
MFJ/*JGJ,@DD<FSB+!6)@LY%_1LFKI=5-)+DEA' C/\SJP!U  P"=_7? WQUV
M_P"=^"G;"9 [26>P+BR'F=;-19%S<W@=QGS<GR&B!@$]?;J?KU ]._+OZ\--
M("MY7YN&S ;R$ #FJ)/5'(=KB6?/BUS;4BI'^:JWS^V5VQ^XWM^7\^O7C=%O
M7W@3K-81]+9$F#R6Y,]]:NHG$Q\[C9OZ']BGKGT_W'U/!5%37'J</V-OW.D&
M "8DJ7#9 L1:_<3&O"3D8(^N?F[?3H 2>GOQ&H&#R1:5Y*%[A6DZAV3N3_W$
MS;!GLS@Z6Q (VZCKDXQVSMT) _+OP$CJ9$7G@B$+7_69#UH9'Z&R[D"1)'.,
M: &,]>PQMC!']>A&>G]($OAFS5_]N$RC)U+U0+89/;R<B_:-.(&>YV)]"1U&
MY._O@ ]>*$)L6  SV)Q#_;R!T\&_09^PO[^NFC;J<=NQZYZ>HP.H]=N%>L#Z
MKK\Q/F+^>64-"ZBZBD4LL& "'YDE=M./+T&W+N"!T!(('7/?;WQG&_ !(,ID
M )X:7!!_7AZ2 0X698#)D*3)/ _8'H,YSL"0,=AMCITV(&,?S+8F*8/L"P<V
M!N,3V4@@64B3WJ"('#:&"<Z)V ((& K!]^HWP,>Z=@?3.W%F2" W L!'ZVY8
M+ T DL 7<-LU#ZD<6!1:MG3!M_SV/KU[=?SXR4P7!3/H"81<G_(T@-"8O<6)
M2[!'V'<:1Z[C ZY(R-SL-MLD'VQ].$&F'!YP?,<'M=GSTE_4R.RN ,CO?R(T
M<XVZC;)V&3]<9_D.NW$#V0#,!F?,$"/*WIH0*:)/=/S1+PD\>>D-O^&>W?IZ
M\#9L"[1AGB>YSZ:5T@HKU^Q)P8X\]' R0#_$=M^XSVZ]!CKPL@0@B61+/%B0
M0.?4Z &9F(N[D7  19\PHTB/KC ._ML,X_Y&=^_ 0!8N)BP*M*EFSNLO6AE!
M"_F66[_PPM(8SG'K[Y],#K@=3D_UW145^7![M(9<0 9]=9Z0V"6"Y.?S(9N7
MG2&_,-QC(!V((Z@9&V0,G&.N-R,97Y)+S%/Z _5,@VC, X:@%$_E)+F)2%^\
MZ(QL>;&YQCKU'H.X."1ZC'3@ N9'2RD;^=K+S&,D)D0#284OI*8 ',W1Q&@.
MFYR#LK(W.VY[[#KP$QE$RPG;S#8+Y?MNZ-K']UW$G_?2)5@ G(/3MCO_  &<
M8SL?8<:2#"!)!1Q?GU+.)%GK#GM43:';E+,#,6T@H#<8&0/?F(SN3U&W3@*)
MO:.J2_(8#[+N+%+!/2+!<2<]TD7I'OL2< GKL>IV_A^?\. W8!YM][DKOK5Q
MZ(FT\B/Y=XTB2" GN,?4C&">H&=^HSWWSQLU$R+!LN [1<KN)NM96 V4RN,E
ML3<+*),Z77&^=QUZ=-_X8W.^1QDR0BR8/EY7P2?V!TRC!^F02I@W7 AN=(]#
MD\NP.1VV ']03[C;@![ L!@Q:T^@)PO)A@H-(N.3$^9",Z6^"=P<Y)V]<C/4
M@$C/H!@8WX6RS9LJ0("E7OV82T<A(L%V!#!/) J)C_+0SCF .<#&QZG.0?;I
MCKT/$7P&W#@4P_\ ;[3J$MI\.XJX05@$R'VOHG'8Y]-]QM@\WKMGO@#VX@H3
M;)_^LMR "G;C&H@DU"+)6(*]RXR!>#;0R!D]!O@GL0=OKGIWZY],Q8X^H(&T
M?HS$V_8 !NXNW<H^<"._ZD$C?<#IMO@]>_KC) Q_3A0R[AD@8&.;2GZY'4'B
MD6AW,9"@^0M?2[8STZ[=?H?RS@XWR>$AEE)2 >\7(@_YRCI=NE %AFU\#FYF
M^D3C(ZY[^H]-_P O<'@^G[3RPG!L;HN)N-%RV?S*(B589=\O2 RG('KDGVR,
M _7;W..W03(61_=>U4_9^:7&EH22+GZ;/J][E<7:OH'&>^3U&PPG;H1U.VV>
MO*,;YQ22!! JLE_ @?WQJ"!:N 'R#5DA28/(TCGT&,#?)R!MZ?4#IZ\!L1=9
M LH1/DCYWTA$@2"*2$^5/8B!8P,/2.-\@$')P1MT YCG]X9!2<Y!',#\O"R*
M392!@HH^Q]Y[:#2"%8P;69@<. !.-8D?LD<G." 22H[K4HXRI9P,E6W-CK@9
MP1GC(< <QYGOZ:Y]!DE HG]</L'/'8:>2=AS#H3CKZXP/7&<XR/;BEKOS#]?
MU.KI0 @ CN7;M^T_J!@#8@=SZ;],@[CVW'%;L?9<Z1MH  RHX3YMGA\\Z6<9
M&P 'IN-R=AT.V=]_7'3BD8[S*8]K3;&KI,* 2FCDMSS9VY@R>^.8'FZ#Z@#K
MT&>G;?IT!X3U$B[PX+N?1F.WEJ%#ZI!&/-D?=>C>=+I@*4 !L<#(QD[],XZD
MX&XSZ<$XR\X$_MVU=-1(=P6Q2))M&$C(AWN]!/<9Z[$X )QMC?H,;'8#!]>$
M@KA01YDJ<D,,*"= "R)1:F$X9SVE(7D _P#6!QG.QSU[^P]L >O .%9O!M()
M[9 OYZ.@F0?)"[($_P ! $\Z(P$@E0 SOW[YR0=^QP?K[<5KBUIL0ISZ_P#&
MM&DB+E,WR5'VCVT,I/0C;U&XVST]1[$\4CD SQ]M)I$"&"K<V#4F+H#1*LYW
MR,9P=]SO[;G;N#M[Y%@G]^7ZO4:3PV%@*UX1\I\X>A@$ @@8],C?'KV'0;[_
M )'AD"Q%QP_7,X4 ";ZST$^?,.#8']>S#;T=N;KGMC VRDGT)/?IZ]N"6LAX
M&)/Z?L-:% ZK8P7, D9&'B-.*CL,@G! V_#D8.Y'J /H?XQ'8C_83_GMJZ80
M$@KMR")P"!ZG32<G.0>F2>^X_B0 <>_Y\4@M0#/9*'Z@ 3$XT&CB3T]2(!;@
MQY(7?").ASY.RP<D $I/0CN,>F%=/4G;B".,?Y><?MWT&BJ2,%-2N+S(>;E6
M*9Z$?7O@ #<>HW)_(C??C1J/;LDDD1ZY!X!SK%-(=B(>80D=S>_/&JXUBLRI
MWE8-8I-N/1X-TM1HM5LR=(22W2KBIKOQ$":I: 3'*%I\AW)P[%==CKRAQ0X$
M2 ;!CSG( PVA[<Z6 FF?V\\38_?7OTZLUNQK4IE#8>,B>E@2KBJ!^9RHU.6@
M.U%]]]0*WRJ0MX-J7DH9Y6QA(QQ12 F[,V[WNK><G3TDU!F/*63!??,ACG4]
M3R@90$\H3A/RYP!L,?0# ' UBS^X5CGG';6^@LJR6+P9RKH+.FGF4<Y(QTP>
MF-M@1MGIT!'7TXIF3"AR[-=EYB-707Z,K#,9MWGUTCT.21L/]GOG;KC.>W0?
M59+9,3/J%SE74G3\I)*1?(R5Y%P8_70!P2>90R2<A6Q YAGIL>7)&-MN$A ,
MX@6DW![3+UGY9!Q)#-WAVX0_VTQ60.JLC< ';&V-\8[XZ]NF>,@=\%E'E??N
MKZN@U,FF6(*,$.YR"4>^3IPSZJSG!W(&,J'=.<8!SZ?3/"1)#\O6#S  +F%J
M%%2! 7(,+C/G_P 3H8/4E0SC8$#;<YZ=R3U.<9],A05Y=T4(8GRE\&1#%\LG
M#=\&P?\ CF+:)R,#F)S@\PZC.1C)R-\9';@(AM@V,IR^")D<^^@[90@.T77F
M>T0>^D1@G"B>V,?P V_COTZ=QQ6+B$4'?C@?P#LG;*A6L1QA9[:(!R#\PZ@Y
M/4X],8/0=1WVVWXC3W%UDR<0+C/_ !J%%H4S %[J?VG3PX4A0P#CN0#ZD;>N
M3RX QC;B#42S8\_\($]UHJH8J?"&'[%X;7+4Z7,2DX2D')(!^NX]", [8W/M
MP]W38%-M"+J^1WTB@A4@8)!N""8'G*$FSA:85J^4!2D@9V2?9604]LXWWZ8&
M=^"6$;H VBS[6_QI.WY-?4#<=GYVQ%WI%:@4J"ED\P!WVS@#&-O8#OML#Q %
MG"9MP>+CVMC0=NI($&4S)(-X=G'DU8:14H@DCF5G!R$]CCUW.,?SWXA#!*#1
M/E^QSZ/O#;,, P CV8P>[_SH\Q)(Y.4]@ .FV2<'OCKG_P 4 @D"I']3PCRX
M/8QJ^6A8%PD(EWMC[Z8M"%%)6A+@ Z+0#@#/0';8E2@#GE)*O3%V-)@%8;@H
M)VG*?M';J9^H*"&+<S@^8,&+'61I 2@)3L$@@9WP!D>W?&WTVZY0DCR"6%BP
M[PCDSK0I-.0+JS[E6+RS%_-XZY';'7UQ^>1Z>AZGBD!W-2(EH21$EP4_-ZT@
M""P 'P)L7CCUT_J=MSO\P/< =,#H#M[Y]N *FH26)*@N4 4;V]?:;!$"E06Q
M+!/VGODZD%(_S57_ 'RO_P!C>_4\=!:R(OW) )/W7IKG4G!80^P7[,]RM:NH
M!3LU]#2D[I+(4LA*&YH9BNM-KZY;6RZE7/MA:BCL.,5%$AW2FQ2^X-[>T(4$
MH$ GN0"4N""XAAX,\8U7Q<4:)=^I-KQ;6\EC3:[++LR94Z[=%$I,JHUJ]+LL
M6VHB8UNO*%8:IK;E\1$P:TZV:;4)3/PP<2MUH$L4'U,V+D678N6R WSI13?F
M@(&2#Z-#,ZR5/QL:%4:HS:36*W5J'4H-T?HM,A5NC/TZ5'E1X])FSIHCNK"W
M*- CU^C?>5622Q 54X;;R$NO)2*I,1B18 LW/OP[O0&&00>UV\G@E ^<7C5A
MVOXC-,+NL:YM2Z/69"K%M*2N-4+EEP_A:;5'&T)#*K?<4Z4U1B;(=;CQ'D>7
MYKRD-I1S+ XB0F0R#(4#O DE3<>=M:)JA9'$=B0;"68>'D5K9WBZM_4G6ZW]
M'['MRN5%JHV3<-W7!<<FGOPH]H/T&MLT%VVZPP]AR'7/CY#*7&)&$)2ZD(^9
M23P=X+^WIF\>61>+LUR5!@9CO]A$/8Q_&?H3/1+1"N.I/3&*Y"H,&!'HLB1,
MKDV;5JE0FW;?9RE=8@"L4:?3WIL<\C#Z%-+(6$Y0T;(KM *,V#,>N!J1@L%(
M6)S<BX(")%V-)/C1T,=B51UNN5B1(@U--(C0*=09<VL5J2Y,K5-:>MNG@A5;
MA_>MO5FCNR&%>6W48#D91\Q*R9_4!8A%7F0 \ @*&$M0! 0#!!!+7^4G;EQK
M5Q_'7X>)=I"\VKIEHHZ793[_ #4:<B;&MJ-9<#4)Z_)$5SYV; 19%3B76FZU
M_P"(?<LJGS5@(DJ3P#R0/#OV/>1ZY6DB0R2YO2C/ 4BY[1VUCA>.+1C$=FN2
MJO;4N9J5J9IE2F*U2EPVZF_I3J'0]-;OO)"5N^<BSJ1<EQ6[27JTD*CFKW%%
M@\H4R"9LFTRO_C+[_9DRM9Z2 O\ IL5R.D3#N&645<VO73G5JW-5:1,K]G_'
MRJ+#K%0HRZE,ITF-$D/4Y5/5)D4Q>29U,A.S7*7.G#Y6ZC3ZM'1S.4Q\JT,B
MX"DG#:./.ZF\#0?IJ9-^">X*?") \C;50T_QK^'NI,NRXM\M""W6(MOPI*X2
M_P#IZH5F%/F6V]1^5:A48-T-4V>BU)48!NMR8ZV$ *3CC/DW+(E8",E#/[QI
M^J1$X@,&ZBYR[3''JD>,70Z-(K]/-RRW:C09D:$8K-.=>76)<V;-IC<2W@WM
M6WH]6@3Z*\F(26ZK"=BNX.28-%9#/I[-LQ.,Z9"8"!'<VN38+)BQ]9!IEXFM
M,=8:H]1-.ZC/K\N-1X5:DSVZ8\FDQXD\/*:8FS0OEB51H,/"335MAYAQM:%*
M5@CB!,!(!]B\RF.#P+\Z2YLLLX,6YX;S L(U*\8VC5-376IE4K;=3MVXFK8J
M="50)2J^Q/739U90ZFFLN+4[%ETNESIE/?!2V_'8<<6$@#B)?87)N&?)CL/N
M;Z $<,@]([ ^^68_32MKQ;:=W]K#;6E%A+F7*W7*-6JK(O*-'7^C,613:%2Z
MXW26*EO'EU!,.M4V9/CMX5!9G00Z3\6C&F''U,&X4"P&((DK4; D=*(0OE\6
M : [ZZNW',#E)"DIY?W?\F@E87W"R2<9P !^67 &; 81"?FY??.J">THB+'Z
MI[D^S2N2-N8Y&X)2,$ 9V]-MLX)WW&W&C"D!THW:9P0+KSGN-628OF 8"+1<
M1P[6TW8Y[;=L[^H[]_?&W3C/VI\^9!($F/TOIRAT@E *P4%=R444/.3H]]CU
MV&#N#^?3<[[^HSQ$Y;8M;)2\HS=S?4$B! I/:$7[?XQ&BH$;@YWW!WZX._UQ
M[?GQHBF:OLC!7;S#F[](D_3_ /(%< A&,YQ^FFCKUY020DG;_G?;;M[=0(&G
M')QR/LGP_/0"V!PP0_\ D3CCM<@D9WSGJ>ASV(Z=]_\ AQ%,D1-E<'(D,'CC
MVU*IAEVE@"]N9P1E>8&58.2=R"1ML3]-_<]@?IPEJQ1(^GL,=G$#+[@0/2WR
M)!R;L?I&.=+IC?<CH<9(Z9QC'3_CWXL$HTR! ,"Y/\P +:D#4 2\S#@H!)@!
MY3/.B#MN203N3@;X( [C?KGL<?E!&0&:F !9W1Y?WM >KIDAE(&K!3J,%<MY
M&D1OM[ GKD?+@XZ$;[#KW/7@ /#B0\ @_<(!-WTU$20*@(#2)8(LP4#/9SSH
M=\').?Q=!OG&?;8@8[#MP+*_+WO<J1C(['G5=A0UB HM,PX2/&CN"H#!) &=
M@,8&_3TV^@VXTT0,$0LBX"/J .\+1 -2DW+XBQL L?PKVSD8V.^P_$=N_P"?
MMTX@8 <F'P  []KVGWTHNIDD7 !+SP1Z?K?2!],;#;ZY&^-_FXRTB!%P^8!)
M_:V%W<D9"!PKX+_? /99W'3 &XQ@$=<#/^\=>G8\:"),MB"0AF_*4.(6 @L"
MZ <0LF+9C^,HG. .^5#!/J>IV&WOZ9SQ"ETP9_NOY =I0GW5\BIH(H(Q [DX
M (E=EH],\QRD\Q)/0;]\= "/X'WXS/MV!L@1Q&/\G6C 0Y .$(CDD_O)TL@Y
M)V)_FD*P".I&^V-]R/R9F< L02+GN"6SF+3H$D%D!F#8$D(FYYMDP(.@0!@@
M9.X5WQ@8SVVV[[9P.F!Q(GS/U&+#F,_J_/0$A>;@-DHL2<IG,>6D$A6Q&-B=
M]_7&=ORR-L_790# ETIWDDBP<6\DKG263(+I)!I$WMW8$QSZBL-9M2Z5HQI;
M?.JE;IU1J]*L6@3+@G4VDH2[4YC,4HS'@M*^5R0M3B0E!W(R "=N $!X7:7Q
M?!1$1,W<6PN><!O$<$SC.N9Z9X_]$*C5[QI[;-P.TJR-,[)U/K5P4^*BI0H]
M(O=,A;4128RRIJ7041I"ZWYR@F*EESG Y2.(&6<7,L\ G_*>7H((L668O.5.
M0H1[7>I(YXS='Z8M]=6K\5,)4V"BG2J<W(J_F4"?2Z?5F;JJPA?_  314QJE
M%2_,<RTPX\T%$\^. F%"N$/7F#V_;4H8^JHYR'8A\*#ZVU';[\=.F%F4BK7,
MU#KE:M6W*?>$^K5*%!<,V0Y97QZ*O$H449;JQCR81C3WF%E%.25./$E)'$[D
MCME!"P",JUT<)ZT9M59%0_,]A!7^0KYM+7G3:\JZ_:]&K*OT@ATFK56H4J9&
M>8J%+1;AM1%=8K,;=5/>A_IG;<E2%84(U04X,AK)7D% 'B9O)"<D@#!:&LGZ
M3RR!#2 **O@01>!>*)G>-ZP)]=T9M[3NF5Z]INK>J=$L=#R:7(@1*%:E<L._
M+_IFI14YS+G6E6*#IW<$VE5-.(LV+&J$QHEBG.@A5@0&"^+N#Z6Q:^H"HAEA
M*UR'(N&F/<ZF-V^,;1&SKVJ]@UJL5QJNT5^;3ZLIBW9TFFT2H4N;9PN1JHU-
MI7P\8VM3-3M-JQ7"_AJ!0[MH-7?5Y512VER7:8F2$R.Z<G)&I121QA/L)P:F
MS=$C&L-T^,O1NWVJ8[3)-9NN16+IMNUX=-MNFN5.6IZZ;YNW3^)->#1"DP8-
M<T]N]$IU R6HK"NJ@.(H<',K\K[Y)?>3 L*91'!5R0,<"0#:V->>K>,K2J#<
MM+M*'%NFJ7#4M4J!I*]26J!+^+IE9N*C5JOTVN5".E9>9H$FGT2:&98 0KR7
M'PD,MKX 3[ @,_HNT '.JH3U$!*5R0L][(&.^O%;WC9T1J%*B2*W<K%'D+MZ
M+7ZI*:;,BCT@U&FKK=.I;]5)^'-9F40-U*#2U#XF?"493.&QQ$V#CM:;G$]K
M>6F95[,HX' >1=A"=2:R/%QH]J!7J!:=LU2IU2Y*[)J\15(C4:6[)I#E!=:C
MSWJXR2EVF0'7Y+"&)JPMM;C@:1DD'@CCARA_P[E^S"I 1C -H%BV.X7J>\AN
M'Q(Z<V[,ON#(%R55.F_E(NVHT&W9E1IU+G/L1GON8RTK1'>K$1F4S*EP0KS8
MT1QMQ[E"M].S *@RXSY81Y@$C0 "62SQWPK#'MJ-2_&-H'3J%$N.5?D!5*D4
MJ=5TR60'&5Q(>G-;U/<670>1)3:5"GU1*D$M.(84D$)R>)B4"R;H9P3/\XU(
MB8 *L"QY-&3CT6M=)\8NF5'FSDW BK4QE5'LZHT.EJ@N*NNK2KKH^KMP)B+M
MGF54(08HNDE?G,2GU*C2T0Y/E*'PS_!AF65Y@7X/;R8*TDEP.$;KJ0"[7?=&
M1:6V/XH-*=1=06M.+/JDNMUE^F2ZW"F08#CE$J%.I]-LZM5)R'5N8QUBE4^^
MK1<JO.!Y'Z56T6N85=GC3@(L-K,$EF\JUB7HM-2!&44(QA, @&07KG"F_:2Z
M25QBH-4R@5]FO0+2MNM/4>HKCQF:;7:UIA?6J-?MRM2PHN0Y>GM$T[J;=W$-
MA41VJ0T  A(5F 6LVA=US>!@(Z0"1^:5ZA2/(Q<RX%YM.T/&CII7:S.MRM-3
MJ+68LZYVT,Q_*JL(4"T*.S6*W=E0EL+0*?0(S,Z,$SUI4T^&7.0)))!!CV&2
M8')5FO3C6>DA798JF +CT5[\&=>L^-_06-$@OOW'5H[\^HRX"Z.W0Y2:XEBG
M0:!59M9G4AP^?$MT4BZK;K#<]PA+M(KL"HH_8O(XTTR 55"*4?L&EQG CMWI
MCJRC"X8EY.)6IM9GB&H5T7G$T^J% K5#O"I-U:L1J1Y;=4A,6I#DEBE5^H5*
MGJ2U$AW&T42*8V^A3Y0OD<*5 \3: LQ!\X#1B(S/LFDAD(( \LW)[<)+L,5/
M=GC>L&@ZD3-.Z7 EU'[G0^BNW+-"Z-;4>J0:[!HU4H=,J<OF;J,^FIGM2)*&
MP"A12R?G6G$J0E-FS%B^XY/$:0203^5B$)/O?@#+MJ52?&?H93X-"JL^YI,2
MF5ZNUVD0*A-IJX<-<&W7H\:JW+(><?4&+6C2Y+49RN?-'+JFF4H#[A2,W9%A
M8&Z)Q^^GJ+P20$<0!)[F(2FYU[Y/C!T7CW#*M%VI5L7?&O)BP?T431GA6GZ[
M+I5<KD9^+"<<2[(ISM(M:XJ@S*&$.1Z9/<*%)A+!8/ZHGS)E#@#S]]/56B89
M!# 84 (9Y\L,ZE-C>(O3+4ZHWS3[%KOWV]IS)/Z1&.QS!V$*G<5OR'Z.A*U&
M>&:U:]PL1WD\K4N31)D 8?0HDNS< EGV#Q/ZVP=!JJ,(65L,$ X9:*M<F^H2
MUXR]#'J3 JYNF1!BU%&I+[S%3IRH-3MB!HV;>EZDUF[XSKBVK>HEKTRZZ#.K
M=3F.>13:94:;/6>::E(4,F"UR)RK@QY$8G2Z@S$ >9<1F\#WQ/JJ'BLL1_39
MS4JU1*K-*CZDV-IM5(,Y"*16:)4+UU M:QO/J5/DJ7@TO])&JHEH.!4F'R*<
MY5$#B4J<@?<$Q8/LK@F#J-57%Y('V#,9(-^?(4WQC:(UEF(BC5NHUBJ52N1*
M!0Z'3J%.D5FM*J$=$^'<%(IB?\:G6LJ&\U(>K+*3'1%6T^#E9'$41@?_ &?:
M!Z9_30*JW '(*"6)$9%AYR-:RN^,S2FBSVZ4ENY9=4&J%KZ8SJ;'M^4W48-0
MNB#,FTVK.Q)"^9= <1!DK<J:"E*&67G DEI?%!)1@#U@?STP,(-4-!B?\8XO
MR'>\=N+Q[Z%TZU;BN"WJM.O"J46:_!BVI1J>ZNMU)<:FR:L[/:CA:E-4-RFQ
M7YS%;> B*A-+?(3E(X!/'J8/Z?KJZJA]*$02@44RN?=VO&NPK4K(N6UK<N-,
M=R(FX*)2JVF,\GE<C(JL!B<AA9)/S-ID!OFZ+P%#8C.P*891@F4O2_G;D'&L
M]1L)+AAA."W:_GGD[TI &W,>;N2,C!)W&X.^/3KGMQE<2"A?/%TRF1*UOJ)S
M^4&" 5P?MZ@]]+&0=CCL>X&V<=L[D?F#MQ$ $.897F7[ +[ZNHGJ$  D D,B
M$NS*#SYW. <D@)]< DX[_7MGU[#.QBF$.F'?M=\/U]=!)1,&T$22"6(;)9]K
MK0(3Z[[;$]\$[=#G((]",#A5C<$CJY9,C*\\P?(ZR28 () 4,XA7+N(!!XT@
MD;X QD[ C<#&^0>Z<]!Z'U D#8G)9,@\GS8XM>^HU54D'Z6UV+P[,VLI"L=+
M&"$C?.P]!CID^_Y\'3RFA'8QYL1'ZP-759?W,6\I40LBWOI$#<XW& /7OMT^
MOH.(A7-E ,W^W/J.=/43( &#'9?8W[M3IPWR-@GU[CJ1L>_;;.?Y\/TD?20,
MF/J'ER!E3&<Q+9*1'D(BV"<_MH=#D 8V.,D]]NY]"<;9(SC@D(I( LEMG[-F
M//0'8D)@!*X_0]A^VB-LD[=?;H"3G^"NG0CMUX4^$+E_F%SRS!-XMC0&08C@
MB'=8\K)AW8U(J3_FRNN[ROR^1L8&YVXW0(YGCRMK-=_(?N3]V_76FJS97+DI
M YO,$9(2<E)<<+2%!0&#CD;04D$$*SO@X&*F"9$J+DD87W_BT8#8 !.!#*1\
MPCQ$9/$U_P#A3TOU?U5JFHERW%6ZW<5 50:9&I=+11XKU-D4:_\ 3W51NGUN
MHTZE)JTZF2*UIO9RVVZK)>12J4Y.;:2RBH-R>!2 "\B3 >4.+I3D:T"0H3DL
MC@2)OV#>'B)PO YIG/=M^IU>\[EN>K6Q=U[W-&J-P)M^NR)0U!DT:?>\6MMO
MT="9#\^?;M&FN2%L(GTMM"VV@W'=5':D)D85O)P80Y@N9L@B$+@P24_[9,+(
M61P3JP8'A,TY@6OJ[;#TZL2Z5K!/IE0N:'';I]/AT:32F8:J7,H-+IT!-&B2
MD/4Z'.?J:HZ53WTAZ00IX)4(XFZR_P!??V,:B<J]UV,#%[<\@@:]FC?ASTZT
M_N1[4RV:W7;ON&MTFXJ)6KGG5&!.;KK]?N.-<M<J$IF*TPQ%>^\J>Q$5\%R/
M(#2XZ6CS$%8_,+6&7FY$*%$XR=1+ 2D YC$J"23Q)N-5EI9X'K5LH6I5+QNB
MX+ONRV*W4:C#=7)A_HU1H+U[5^[V;;C012XI:@2#7F7*@BHNO3G1!Y6'64!0
M<4^PI0_S&2'-O)QJOALNZD?],^0N@8:G6SIW@RTEL:O46M/W+<TR1&NBG"SV
M:Y4HWP=(:F776:^W:L,P*:IYZ#5JM<\Y:A."Y3D*/3Z<TMN/%7)4+"",C_J7
MHU;C/FH&H@INQ'/>8")#Y(%GJ/*^S[T@<LR+:4.NWY3&G-/AI%4Y\&L4]NJ7
M'I]'TNHVCM3M:2W)I[AAJJMGVY2*A4GXS)J+-9IT>?%E>6V([VE@@C(!D$!F
MS[.26XN-#EA*'# -62?,!F/UU)97@?TJ7==OW<B=6'ZA:%[:MW92Z;4J=2JG
M"8B:SWW;VI=]VRN%5Z,^B/2JCJ!:-%JM*JR_*D42(W/ANNS@6Y3>4+$N"I,&
MT0BS:4I.EE"P:DR+ N"4Q* ,XG5S:=:0C3>59](M*Z:W&L:SJ#=U'DV2_P#=
M[T6LU"[;DIUS0K@GNF$RF,Y0'*=5*?1TQ*@S3:A2ZTZTXRJ7#:YU'T"-T6KN
M1.#V4$R$B_(AB *2>$4>,9C5#4KP(Z)T^RJ;8S-1KK%J42Y*#<%O" S0:5.M
MZ3:)F+LYIVXX]*C5.MBUYLCXJD1:K+=D+D/$/Q5Y=;4 /VQ>WW5E%^-+:, M
M .+W0N>\AADO6_IW@HTPBW'$KJZ]>U3$*NL5NWZ=/J49ZF6VN#5ZG<$V'$99
M@_$%$VJU60Y(-36GRFFXS++Z%,+<=I5X(_17)NF9Y0!TDR8G* DK$I(1SQ?6
M\TW\(5AZ;791+JH%8N),F@6K4;7A0$O4YJ-4(U3>F2);ES5&F1V)5>=9$]Q=
M)<J_FBE.!)I_(!DT2#>"[C_.7!^XG()<A/-D.[","/6=5Q;7@GT4M>ZZVG],
MKEJ=QUI<VZJI2*S5J(:HY37:77[/;FR4^0E^8PW#NF;$^\:@Z777%0BHJ6RE
MI<D/>T6"%U=V37F=)*L(8 F[1CMZKTM9.CWA%T]TBNFEW/;-=NY0HL:4U!H-
M7GP9%+ANU:U;7M.I2D*APF_C#/IEGT5Y*VY :8FMS'DA1D+99$D8,VB5[Q</
M14BW'>UC9%8+CTXUUSSK<6HG(0.1MM(SRX0DIRGN2<#.>I'8==) $@2(XDN[
MB#<\$=S4RT?\ADR /(18VQHD;\NV=AV .>GTW)&3_#;B:(!D@D%<%,=S<38G
M6B&*L6(2()F$H"%,!C$97*3MZ;YQ@D_-G; SG(S_ -H;>DHX,T\,?2N/(DX6
MB 2/*I(*E S"=K-D-.='('8;[;Y.QZ$8SC'OD@Y[<4$V!=R"6B0.2GD77&@P
M$Q3)3$$!$@0R3*@Y;OI'MRYQV/<X]SUWW]>P].$F2"00&PRRF+@(6M8O).E<
M.0L%,!-RE@S$)R#D;'ZXR#O_ !VV.W;@;%Y0NXAE "QRX[(#4B"4!,WOYFX[
M (3?1&,;8!R._?U(.W3TR1@=N(R P(L&B@&6)A"#!SG4!^9DLV) 8=AC]YC0
M/-^\"1_#^/?J>N._??@(/YDNTA>0CEPY?EI:/341/\FV&;6LSI9Z#UR3W/7&
M1U] 2,]#MCIPEHDY"C![@V>5R>1H"_*+%DM-%CS4>>>=$@XZ[;=-\9&=^^0"
M,]CCVXA*&/,^K\PP(=@X.HV-1*$@V@$R1RU-TV[#2R,DD;]O38X !&.VP.#O
M@CKMERSYQY1Z6>?734(@HD]PTL'R0F#F9(YAG(V)()VST&_KU4!O@8[\:>":
MF3:+I!M8[H@]SK.0< $L,E5"X4%EM""(C0QL#T P,]?Y>@.?Y#&W$01S $\3
M$,D*;<0,Z014@"^462Q#@.#VQ<Z2@!LGZ[C/OD'.>^3T'7T'$&#9'LA$0"B,
ML]@-)%V^FXN45G[YY0.@,@'8 X&,'IMUSUWSWQN=@=N(DB)BZC+! 23/()BV
MLAED)@@ANQ"1EVD7#YT<# )Q@#<$YR <'?/?!P!L!U(XT!(+:G)!'^Q5B;#)
MU56=F%W =KH]HM<JX(W/8>G[WMMGMGKG/\^,G)$ OA'(]6V+@0++6@5%R46
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MNW6:?(DTFE6\:6_2H4*14(+527.IB8\E=11\9(=6I11Q'\O=XX(SAGW6IEP
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M)V(P!OZ'KCB6&$38'*P_, YMJ;-)DQ?V"/E^H"T/;Z>G?W_(D=B 3P*"R6
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M8:O5KFM2E1F+[I2J=5+DO"HJ>E)1)MIA4EDLO9G#O$Y9%H' M"U.FZ$, _\
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M2H(41^))"4**R1S'F*@5=,%1X6#-DH"P\.3%(:(R<:*J1ZLJ(3!\A>!%P[D
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MH7DKWLF^^LYHT4\W[22D%0< ;=#2D/A;BE/H=:0AY+CC;ACNX<\MR.E+2T$
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M$XVXN@3<N)7VB/X+,&ZC'8@S,CEM@\&!< &=+[IC_P"L?.=SE3>_7&?V78'
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M;=V/M@&X>KJ.2X5R.$8(1"A),K2^Z(W]]_OMS-8W.3MY7N?X\73W-WC@A )
M38!<Q&HUF( 0 "& 7DEV ),Q=SHFD1C^^\/HI&YSGNV>O0CI@].,] [\X_Q-
MK&/<ZA4>W\Q"'\[#1^Z8V<\[WL,MX'TRUMGOC!X10!8GO:?M_L<ZNJT""Q?V
MO_N%!NQ]TQSU<?/U4V?_ .KBZ0W/V/Z@Z>L]OOY\Z'W1&_UDC_;;Z?\ X7].
M+I'^]B_3]+=M'4>!Y$/"S^M^86B*3''^D?\ ]IO\_P#1;?E@\72$!P^#<O(6
M@U&<-0'@( 3;MG,$M?=$;^^__MHV^F&Q]?Z<70/UFU_)6QY^2>H@DPRG>5V:
I'= :]L>.W&06VRHI*BL\Q!.2$@]$I[)'49SG?A  M_( _;023?A:_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>g425213g30v84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g30v84.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@!% )? P$1  (1 0,1 ?_$ !\  0 !!0$! 0$!           $ 0(#!P@&
M!0D*"__$ '$0   & 0(# 0@)# L+" <$"P$" P0%!@ '$0@2$R$4%18Q5)33
MU0DB(T%15Y?2U!<D,C-5<9&2DY71UB4T-5)386-S@;'!&$)#8F1R='6"A*%$
M@X:6HJ/"Q I%9H6'M,-'9;+P&2=(=J6SQ<;AXO'_Q  ; 0$! 0$! 0$!
M         0(#! 4&!__$ %P1  $# 00%" 8( @8%!PH'  $  A$#!!(A,1-!
M49'1!10B4F&2H=)3<8&3L>$&%2,R0E3!\ =B,W*"HN+Q%B1#@],E1%5DA++"
M)C0U165SA93#U&.CI,3%U>/_V@ , P$  A$#$0 _ /[G/[G_ $'^)/2/Y-Z;
MZFRR=IWE<.:V;\O0]S3\J?W/^@_Q)Z1_)O3?4V).T[RG-;-^7H>YI^5/[G_0
M?XD](_DWIOJ;$G:=Y3FMF_+T/<T_*G]S_H/\2>D?R;TWU-B3M.\IS6S?EZ'N
M:?E5I] M!$R'44T5TA333*8YSGTXIA2$(4!,8YS&A@*4I2@(F,(@   B(@ 8
MO$9N.].:V;\O0]S3\J\&M3>%%%0Z1M+-(SB0PE$R.E-=53$0[!Y%4ZX8AR[^
M(Q#&*;QE$0$!SSFUT1AI3[ \^(;"ZCDZF?\ FE#VTZ0^("Q^"7"A\5.D_P D
ML!^K6.>4?2GNU/*K]74_RE#W=%/!+A0^*G2?Y)8#]6L<\H^E/=J>5/JZG^4H
M>[HIX)<*'Q4Z3_)+ ?JUCGE'TI[M3RI]74_RE#W=%/!+A0^*G2?Y)8#]6L<\
MH^E/=J>5/JZG^4H>[HIX)<*'Q4Z3_)+ ?JUCGE'TI[M3RI]74_RE#W=%/!+A
M0^*G2?Y)8#]6L<\H^E/=J>5/JZG^4H>[HIX)<*'Q4Z3_ "2P'ZM8YY1]*>[4
M\J?5U/\ *4/=T4\$N%#XJ=)_DE@/U:QSRCZ4]VIY4^KJ?Y2A[NBG@EPH?%3I
M/\DL!^K6.>4?2GNU/*GU=3_*4/=T4\$N%#XJ=)_DE@/U:QSRCZ4]VIY4^KJ?
MY2A[NBG@EPH?%3I/\DL!^K6.>4?2GNU/*GU=3_*4/=T4\$N%#XJ=)_DE@/U:
MQSRCZ4]VIY4^KJ?Y2A[NBG@EPH?%3I/\DL!^K6.>4?2GNU/*GU=3_*4/=T4\
M$N%#XJ=)_DE@/U:QSRCZ4]VIY4^KJ?Y2A[NBG@EPH?%3I/\ )+ ?JUCGE'TI
M[M3RI]74_P I0]W13P2X4/BITG^26 _5K'/*/I3W:GE3ZNI_E*'NZ*>"7"A\
M5.D_R2P'ZM8YY1]*>[4\J?5U/\I0]W13P2X4/BITG^26 _5K'/*/I3W:GE3Z
MNI_E*'NZ*>"7"A\5.D_R2P'ZM8YY1]*>[4\J?5U/\I0]W13P2X4/BITG^26
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MU/APM']D0KVG$+#MV8.IQK5B#*/GIXBU7$UJ4U5?H..Y)"UR1H23;?4Q583
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M?NVEN5LT:B_.@5Z_C63!Y(+R+U=>5?<JK"7DTZ;PTSA<<!]XQ (PEL&,@20
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MA+62.BV]U!Y%VZ457E^]VF^[>I/9$3%-_2Q>'?=@ _<<($-/1Z3<%\AS>5J
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M':N#N3:3C.DJ#/JZ\_PKQ[KV"GAV=[\^KNM)=_WJU&_C^&HC\.>QG\;/I P
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MR"#WM'K.7+!BX>M>X7B[-LL[9"H586;E5$AUVHJE "J]SJF.EU"@!3\G,
MYS7TP20"1!(!(V&,1[%,PJF$4*2 31S\H%,819.@ I4".C&$4% Y2ME3$3<&
M'Q @H<A%A'IG,4IA$"+EW6VX<4<#:CQVC.G-<M-5=5R'0;SLBY;FDXNXS%=U
MO0%=2$>3==8RU<@K3%:+O;!U;)7W:$/*2K",-)K2ZTE4M@-B22#CAV2WL.8+
MMW9CX;14MK:D6>DQ],L: XD7A4<RTC[I<P.8U[;.72]I#7. O7B6>9TPU)XK
M9^YU(FHFEC2G5B>F& VJ,[U)OEZ7'NZGK/) P:VF.MCYC,&;O(/1$9>4[U*-
MFL]=++76(NR1ZZU=$-@D&<,-1)EN,:L"[6<@?7FC6MKJE/2T!38YPTC;LFFT
MT[0;M\/+7$%MFO. (#JCV";I+.U<POH)A%!DBB9J( 4QOKAD.Q6Z;D>QZW$1
MZ2AR$V  W,IS<R!0%<@&.F4HD7(_$)/<8T3.V!7A[K% GJU%T[35Q&M+/U"3
MD];IS4F;C;VRB%1?LHU%*O4%E#RQEYEPR:('D% ;$EG*W+$[:&$"\2,78^H"
M)P.O9,KP6IUO:Y_-64G,;3HEH?-YSW5GMJAO2:!<I!KI<0 3@'$]'2[G53V1
M4LS8XYIHC2G48I.W:&JU@2:LD2)-ED++'4"RR$-)ZF1J[B$9R!:Q89Y@O)P\
MG(Q7=\.1S#/')'S*Q3PAQR!,YSK&6>,#5KQ@KSFMRK><!9Z=V]4:QT# &^*3
MRTU6RT&X]X+FN(EO1)D;4TPNO&59+7#.K[IY5*12)VW/$7L2[12?VJI4\[F_
MR\;(/).+LJ\0_?$CJ94Z0]BD&RBR<OJ:E>R2JT;#EIJ8A@&!D@#'&"<!E&TD
M_P!F(QE=J-3E!]1IJTF4Z;GD%I@OILFJX.+FO+2;M-E,M F]6%6]#=&/+,[G
MQ^24;&]T:=Z9P$F^6I8/2=9S((QK4\5H4UM0BZ-(D*B\?RVH>K4RH/>V6;4Q
MOHJX@VB>H7A-&S2EBF)Q)SQG^M&$?R@9B;TX0L"IRF0)I4FDZ.<9NB[9A4_%
MF75:[LB*?-RT:6^UQ\ZIJ#[(6U4B$CZ=Z?R3IM)ZX1]W7BXB0[RHMX%DF&D$
MO26TM-PLA*-;.X;N')63B8?G6%['-9J2KYUY-.LHIXXD?=(DYSF# U3CEE(V
MK)J\J"Y]E2<0;2*I:TW8:#H'4PYS20\B8+G3> <YF(;Z>/U0XV$'X)/=&V,S
M%'OFFK=I(-X^#AG9]+7R,L74>QR3)]J0"C:U1J;>MR+.OHH$=-G\_,0+*,L2
M5=4EU,PSK1@<\1>P@3&1QQ[)PE;%;E .QLX<W2T0" UIT)O:9Y!K3> #"&C$
M.>YH#PR\?/3NK7'=(1$4:E:/0S:94KCF:DRV6",Q:MG[;3W21VWB.52WIBL\
M?ZFAKE#!&-UBK'@8RGJKRL$UEXRSREBG)DG.!B,<7=F&%W$ZR<#$#+Z_*1 T
M=!H=<+C?; !T5 AO])B36YRV ?NM82YH<'G8\/>.+Z;A-7&<IIS'5"<BJK4'
MFDDX1E!2C"R69,@N+U'R49X=.72*76=L(N%*_1A$SILY=^B\?$*V,:0P72#(
MGI#$$;(,?O!=6U+<X6@.I!CFL8:#H:X/?B:@+14) DM:V;N3B"1$^8N%GX]H
M]_-+5JM:8OZ]#3,HBD9Q&2A)^<JB=F=5R+D(AHRD9A,UJ6C&C6\/4E6YHUG
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MD8NG_6 )'HLL(])CX+SJW_H^UC5__:DA"_\ PC?C[VWQB!GJ'\>J0 '^B]3
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M30'K#<5LU00!!P$:NS@KBU-8!W[L2^#[4?YV- >L-Q4%4-,P3AV#BL@554!
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MJU<L6RZAE(PPG6;LGCQF@J81.BU=N6Z9BHKJD/;SMIWE<S0HG$T:1.!QILS
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M"BLQC&#)@U.DU:H))I..)QSQS]:AH43=FC2-T@MFFSHEK0UI;A@0UH:"((:
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M"/36)U![@8EY^94QBJ]A0)U$ *B')TQ+UDU3&)^PIV$3")A$PB810I(H'CI
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MF$3")A$PB81,(F$3")A$PB^>N)$W[==0 (FC'R0J.#IB"2).M&',"CH3E20
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M?/BC_P"5#,MM@=/V9$?S#@KH/Y_[O^)7!J@B;?:&5[/A?%^BY3:QJ8?:Z/\
MPE-!_/\ W?\ $L;?41!([I0(<WUTX!P/*\, @(-V[?VXG34*8VS<! 4BMT^3
ME 415!19;0M0,] X"3TODL:*'1>UC&-OM4P-243;[1"O9\+POT; M0)BX>]\
ME74KL=*9[/FKRZC)&';O2H'9O^W"_1LO.,8N:I^]\D;1O8WH]GS5X:AI".W>
MI3SPOT?+I_Y/[W^%04I,3X?-7AJ F([=ZSA_O9?HV-/_ "?WO\*NAQ +LQ.
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M@EX[3O*F]PLO(VOFZ/S,76S-UL[8$I)VG>57N)F'B:-0_P!W2^9@M:<VM/K
M23M.\IW$S\D;?D$OF8NM&36CV!).T[RJ]R-/)F_Y%/YN+K1DUH]@X))VG>57
MN5KY,A^13^;ENMV#<$D[3O*=RMO)T/R*?S<0-@W!).T[RH:J*(/V9 2;@4S9
MZ8Q>18#&$AV8%$I4R]R"!><P&%Q[L7F*#7VIG.(&P;@HIO<[?^ 1_)$^;B!L
M&X*R=IWJO00_@4OR9/FX@;!N"2=IWE5Z*7\$G^(7]&(&P;@HJ])(/$FF'^P7
M]&(&P;@B=-/^#)^*7]&(&P;@B=-/]X3\4OZ,0-@W(H;78RTB @F8$WI2$ .Z
M!$A>X&1Q*8%PZ93<QS& &?UL)3%,;Z[,ZRP!D(13>0G[TOXH?HPBKL'P!^ ,
MD#8-P1-@^ /P!E@91AL15R0-@W(F(&P;@B943")A$PB81,(F$3")A$PB81,(
MH"A0[YLS<I1$&$B4#B5<3E SB+$2E,4>Y@*?E 3E5**YA(06XE3*Z Q->_\
M13\(F$3")A$PB8109,0+&R!A,4@%8NQ$YC+E*4 04$3&,V*9R4I0[1,W*9<
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M\5=W:U'_  Q?P&^;C2,ZP4NG8=RJ#QL/B6+^ WZ,M]IR,[T((S!'K5>ZV_\
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MI37[#^G[_94["J81,(F$3")A%"DC<D<_.!Q3$K)T8%"K&;F3Y4%!YRKD*<Z
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M34>KRLDDUC$D45T7QU'I$&0\RZITZ "0"8!(!.P3FN59[Z=&J]C;[V4JCV,
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M17E2,7WP][Q;]FW]'Z,RYLQV:MO[]J+*8-PV_CWS(8<<1B(\0?T15#L  ^
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MV9E;.111;(I-VZ*3=NW2310013(DBBBD0$TD4DDP*1-),A2D33(4I"$*!2@
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M6$-%U^5CF4]5F\#.N)F2EI?,@X8"->1]OCOU+9Y/H%AIEU2Z:PKG%@Z8#FX
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MNE)U/KVF;:5AD:S%1H+TB<M%#G'&G\>5M3T'=,5D8.8:O'+5-M+S2<1A=:(
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M^KLUS6GUG[V^5-._8W<>*N#2VO@&P/)CSAEZOQS6GUG[V^5-._8W<>*J&E\
M @/=DQV?Y0R]7XYK3.M^]OE33OV-W'BK_J90/E<OYPR^@9!9*0R+]X\J:=^Q
MNX\5<&FD$7?9W+]OPKL_H&7FM/K/WM\J:=^QNX\5B;Z>0YSNB&<3!2HN 22$
MPM4@.06S=43$.+90'!>HJH7K%*B4#E,ATA%$550LU,3#GXB,VY=U9TKIF 3Z
MCQ"EAIU"%WV=2O;\*[3Z#E%FI@S+]X\JIJN=$AN'8>*N#3V% =P=2GY9I]"R
M\W9,R[*,QY4%9P$ -W'BKPH$, []TR?Y9K]"RZ!FUV\<%!4<#,#QXJ\*)$ .
M_=,E^6:_0\:!FUV\<%=,Z9AL@1D>*O"CQ(#OW1(_EFWT3)H&S]Y_JEL?]V?%
M0U2=39VX\86%W3HU%JY636DCJ)-UE$R$Z#@YCIIF,0I$"HHF7,8P !42K)"H
M(@0%4Q-S!= S:[>."E]W9N/%2PID6  '7?\ 9_*M_HN446@S+MXX)?.P>/%9
M@J<<  '6>]G\HA]&R:!FUV\<%35<0! P[#Q50JL<'B6>_P!*B'T?&@9M=O'!
M!5<)@#<>*N"KQX" ]9YV?RB/T? HL&MVO6-8C8I?.P>/%90KC$ V!5U^.CZ#
M&@9M=O'!+YV#QXJO@ZR_A77XZ7H,:!FUV\<$OG8/'BL1H5L5RW1*=X*:B+@Y
MS 0AB%,D9N"8&7 I2HF,"AQ*F9%05@*82G2Z(@KNX-I\.":1VP?OVJ4$&T -
MNHX_'2]#C1MQQ./JV ;.Q+YV#QXJ\(9J ; HO^,GZ+,FDTD&78=HX)?.P>/%
M9 BFX  <ZW9_C$]'D-%A),NQ[1P2^=@\>*N"-0+OL=;M^$Q/1YH4F@0"=XX*
M%Q=$Q@J][D/WROXQ/F9;@VGPX*WSL'CQ5Q6")1W RO\ 28OS,7!M/AP4+B1!
MA8T$044=E."Q2HN"I)B9+I <@MFRHF(<3J X)U%5""L4J( <IT.D)D3+*VXW
MU^WA"RI(-DP'?<_X2_-Q= R$?(@_HBNZ!/A-^$/T9I%<"12[[";M^$0_1D(!
M(.Q%>( (;#F;@QSQ]6T'9V(JAV  ?!@L!)../JX(F;1,(F$3")A$PB81,(F$
M3")A$PB@J /?)H.P[ QD $>@D8-Q7C! !<B8%D1$"CL@F0R3@ ,HL8IVJ '(
MIV$3")A$PB81,(H4D7GCI G(*G.R=%Z943.#*<R"@<A6Y3$,N)M^4$2G(941
MY ,43;@13"^(/O![VWO?![WWO>PBKA$PB8109$O.U$O3,I]<,AY"HF<#[5ZW
M-S=(IR#L3;G%3FV1 HK& Q4Q*8BG81,(F$3")A$PB81,(F$3")A%"DB\\=($
MY!4YV3HO3*B9P93F04#D*W*8AEQ-OR@B4Y#*B/(!BB;<"*;A$PB81,(F$3"*
M"L7>09'Z9AY6[X.H")C%)S&9^U,N!P*B)^7<J9B'%;D$2F)TC<Q%.PB81,(F
M$3")A%!9EY5I,>F).=\4W,*)D@5^L&).H4YCF!P'M>GUB 0H&3%#D$R)CG(I
MV$3")A$PB810I,O/&R!.0RG.R=EZ943.#*<R"@<A4"G(9<Q]^4$2G(901Y .
M43;@0Y'_ #\-:FX1,(F$3")A$PB@JEWD61^0P\K9^7J B8Q2<QV(\IEP.!41
M4Y=RIF(85^0PE,3HF Y%.PB81,(F$3")A%!9DY5Y,>0Q.=\4_,*)D@4_8]@3
MG*<QC X* EZ?6*!"@9,R'+S(F.8BG81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A%K35F9MU:H%^LU @T[)>Z]IIJ!,TJ!<1C^2:3ENC(4LA6X-TC$KH2[A
M.7F&K-F:,BSD?R22BI6BZ#I! 3T02)P$B3V3BN5=SV4:KZ30^HRE4=3:077G
MAI+&PT@D.< "!B9@$%<TFXA.(M&1A(=#AOD+ F]"1;*VUN%TK,+(BQIM=F4;
M E!SU05F*E%R%MD[%5$X"X.V=E1+3W$LV2DVMBKH/=W68F\1EA@=>(D''"#(
M$8]A7CYU:Y:T60NF\+_VC&F*;'!UUS"ZFTO+V7:A#NA(#@YLP]0.(#B8B64.
M:I\-T[)/W=6J,W,-VI)&1;1,A:].;7*OH4\DO'QYUIFIZB1L'69%C&0TTW2C
M9..F)5]'$DI)E60:R<788Y]C@!EV2? ;5*MJM@:TT[(\NN,<X"2 7T7N+;Q
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M$ CV ? K(6DV4![9!J/9Y:\'^MMF]%5F;T".L<Y[)5;58!BTG'8#\2L@4RR
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MJ\V^WB[1'/W_ "5R9]&*[0;;:;-3,#[_ "BRCZ\#6:O&]SQ-T$Q$83.7[P7
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MCN93+F3C5N=58#N "*='V6!%%,-RF P)#T$T1Z90(40$%.7F4,8QM6T&98<
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MRN8E9!S5C$MDE-+V&+"E.VK=_4 BY!IWEE$U99(5)1[(/'>W57N<'EW2;E
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M3O*<ULWY>A[FGY5!4T*T."2:$^H[I0 F8R!P3^I]5@$P$7C $X)EA1;F @J
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M+:#8?2TEW05S6AI%1D,JS=JLQOW:9D7(,:$X/9AO5=2:)9]3XFU5+4;AZ8:
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M_P!O;._2W_T2\C_X,?1%^=HY<'JMMCWX\G':OG*>Q<Z$JB(FMFI@;^, E*\
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MWSL'CQ5Q8\A1WZAA_P!D/A#^/^+%P;2H7$B#"L03ZJCL@B4O<S@$ $JA%!.
MMFSCF4*784#[KB7I'$3"0I%M^54H N#:?#@LKSUUH%8U#K,I3K>Q4E*],%:@
M]:(OY*(= JP?-I..>,)>%>QTQ$R49)LF<E&2D4_924=(-&SUBZ;N4$E2T-NX
M@F>V#X89Y++FM>TM<)!SQ(.T$%I!!!@M((((!!D+5^GW"QH7I<HDM2*4>+72
MD[)-"Y>6>XV!TXEK@::4LT@^=62PR[B1=3*EBFE7BK]1R8ZT@JL42*E2.G3>
M,R1CV$:HU'8N=.ST:7]&RZ;SWS><275"YSW$N))+G.<3,XF5BK_"?P_U:,H<
M-!:>,V47IDXE75%9=^K.Y1K[B:U+I&L$DJW[KFUS.C+:CZ<4JRH]\#.P9*P:
M4<Q!M#NY&/>4R<R<<X@3@1\"=ZC;-08&-;3:&TYN#'HS5IUC$GTM*F^3D6@"
M!(/Y$3__ *.[PGVC6O4'4NP:IZU36G&INN4UQ"V_AZDW%)<:<3-^F7CJ84;2
M$RG5$-0%JLG..A<J0:-K:F>19 AG;Y1-15T?MIG!H  #@VX'B;P&664QKC/$
M+X;OHS8GUZU5]6TOH5[6;;6L;C2-!]<F\9=HM/<O]*X*H!'1,MP7]  !L !\
M ;9YBP$DXX^K@OT:9M$PB81,(F$3")A$PB8187"BB+==9%NH[521542:HG13
M5<J$(8Q&Z1W"J+<BBQ@!,AUUDD2F, JJID QP(OX7^+/C]XH$^,)]%U?56VQ
M\K$7@Z*=/,[DP@]1J+8*K"P$1!5;P BWE4F+9:[Q65=.I>S4F4::7PDE34Y_
M5"OV^"=6->J^FG28ZG>=K!Z4_=(=!.<0!!@B3.&I?C>4N6.4+/RF+-0( IOI
MQ9W42\6NE5I-+!3<*1<ZK4KE]$5*55M.AHPZJQ[=(:?]H'#O<YG430_2Z\6%
MR+Z;M-,A)J4D &"Z$B]?,TUW+]DE7%EHUI'NE3G5CV!C$DF#(R#.:10F$'R1
M/,OV(,@'*5[NV1M>FXJ8@K:DR=529JEGC;.QE'148EY7GK9HSFDI--3IIBR/
M&N7*+ETHX1*U;++E-N5P)TJ)D1G.'K67ACF/;4#2QS'!X=D6$0X'^4@D'L6I
MS<,O#I,MW"I-,JB]92;*+BW?<G7,PD8>NMT8Z%@7*;5Z#5Y7H,D?&EC:^J52
M%CGD# .VS%%]7(1>/M]P,R9Q(]N)/MD[SM7#FEE</Z&F00UIC(M8(:TP8+&P
M(89:"UI EC2)S?1K095FC'I5ZNO4']Z4FE!6G'L@[G]1X%G86,J^F'[B6</[
M/;1B1LL1;1F',E)S,&WDH:T%?Q+%1H@EWA&60/P&SUX9JBSV: T,80:E[[Q)
M=5:' EQ))>^[?:^\2YS0YKY:"%B:<,.A#"J*4=GIY'MZJJ=JJI#IR=@! R[-
M:QK)N.J,N+H'*X6VQ-9!R"X+RD=)J14DH[C46K1!>=M^'9P&Y.9V84]$*0%/
M#HWGQA?_ )IDZ1X)F2#!D  >GJ&B6E5!GD+-3:5$UV;;5@U-0>QHO$@3K9WS
M.1/&%:F='9<IWD='J'<BW%Z<C)J@9R+=NDD6%Q.9^"W3L]&DZ_3IM8X,N MD
M="0;L3&8&J<!BMIY%V3"*%)")8Y^8.P2LG0@(+(MQ 004$/KAP4R"'\\N4R*
M7V:A1(4P"3-<A:^U#C!F+_%3'#_J!3:[2F]5B@DX"TF*95];8M_;E1Z/+6)<
M48R6;3%>)+K&>F%9*OHMVS1L8Z[AUMI8!#A)DX]ACM&4'9G@5X+33MSJH=9:
ME-M,4Q+7G.HTU#A#28<',O23@T  8DZ[DJ=QWMI24GV]R@WY)6V:0N&M<B9Z
M$0;5RO%A++7-75HKOY33,CR1EY>N3L4VFBV*N $!(RS2LGL?<+62HN:^W4=H
M+9@[)F"#VG5Q<SE,.+@]IO5*!NM>V&,NO97NWJ<3+F/%X/;T7.#+P:#O/A_K
MO$S RE['7VYTZS1+R47=TEE5(U8$XYL_EY:3<@K,OU&LN<$3/>][6&>1J[**
M@&=;;1\JL[0F2J9==@79G7/[_9GL7ILK+8UU7G52F]I<33#&G %SCBXF=<!I
M$-:& $D.73>97L4&1$2M1$!$![H9!V+HM^P7K<!]U7*9/M =NGMU%OM*(E64
M(8"*=A$PB81856S=<[=1=!%8[187+4ZJ1%#MG HK-A7;F.4PHK"W<.$!53$I
M^BNLES<BIRF) .8RQ'8=JS81,(F$3")A$PB810I(1".D!#L$&3H0V61;CN""
M@A]<."F00_GERF12^S4*)"F 2*;A$PB81,(F$3"*"J(A(,B[CL+=\(AUD2@(
M@9GMNW.45UMMQV41,4B/B6 PK)<I%.PB81,(F$3")A%!9B(K20#_ 'KXH![N
MBKL'<#$W81(I3M^T1'H.!.L(B*X&Z"Z)2D4[")A$PB81,(H4F(A&R AXP9.Q
M#99)L.X(*"'UPN4Z#?\ GEBF22^S4*)"F 2'(_OXX;U-PB81,(F$3")A%!5$
M>^+(/>%L_$?=T2AN!V.WUN8HKK>,?=$C%30W$JP&%9'E(IV$3")A$PB81,(H
M+,=UY/Q]CXH!NNBKM^Q[ >PB10.V#<1]P<"981W< ;HKHE*13L(F$3")A$PB
M81,(F$3")A$PB81,(F$3"+G*W\)?#[?+H[O]KTYBY:S21G"LJ]5=229)1TK$
M0$"T>.TD7B92NH:+K<:C!*-!:A$+B]D&14I%^[=JEDM:2"0"1D3C'JV+HPI2
ME#8I0*&XCL4  -Q$1$=@[-Q$1$?A$1$>T<+2\%J/2HG4RHV_36?=2C2!U"H%
MWI4VO"R24?*H1-IC$8"1=1:BC9UT91NSD5SQTD*2R4<Y$IE6SCKD*6@P01J(
M.Y<ZM-M:G4HN)#:M.I3<6D!P:]MTEI(,$ F#! .8*Y-D?8]]()$TN;PRU69F
MFH"BUERHRFJBBJUB-.:XPJU8",6&D&482;>&C&C%Q/)&&;7CUIF(*_2A[-9&
M$MH/(C 8$G7C))QQQS7A/)= S]I6$MIL,.8.C28&,C[/!UT %_WR+S9NO>'>
MZ8\&NF3.&1@#3MU=1!=4([5EU&*+U%"*>SS&.GHE>!-$,:>UBV%!DV$^ND\H
M\0TCJ^@HV*\BVL<_E+*ZG5\]F1'L.O'7VYKH+!1#0R]4+=,*Y:2RZ7@.;=NA
M@:*1#OZ)H# 1>: XO+NDZ=665*J-6IL<ZD'T?4JY!UE@]EETG,J\90,8UBFK
MJ3<H-VB#B0<(-$U7JZ+5LDJY.HHFW1(8$RY)DD[3*]=-@IL93!)#&-8"XRXA
MH#07'"20,3 DKT>1;3")A%"DOW.?^(/K)UVB=!, ]P4\:CG=L0/A.X]P+]DK
M[F!L(IA?L2_>#X/@_B[/P=F$5<(F$3"*#(_M4>T ^N&7:)T$P_;K?^^<^Y;_
M  %^V''VB&RYD\(N<-6;=Q%P>I->9Z;:<%LVF)(BIKV6:;KU8TF,F^U.@SV]
M%JVF;A"2.T!I+!6LC%NTAG99:SW2N*(/@&#>LE= -@R8.,9]4QD-;H]@/M\=
M>I:FU6BE1+Z-UA>\%DR:S;X =4:[HT&OB&F7U&8PT@\_/Y[V0:,JZCN/K$?/
M7)U73R+"(=-]-4H%K:5].=(9!_ 2[MK88UTWAHJX36L["KN63N2<RLU4*FRL
M$LA7'2LO:-_9DYP)[22)..6L1(@0,1C@O*7\J!DBFUU0MO!I%(-#M%0)8XAX
M(:'NM 8027.8P.<&])_EG%_]D^*X?E0T<H!D$HAT5F;OE4-G#T'DVHU= )KT
M4Y'YV(0B)V:I"QI%NL<53"=04T4L.EZ_O;!V:C).4Q@L&KRQ)BA2B#&+,3+H
M/])G=N893..R?(7SV20RZAF&DM8[TDAJW&NN5[2&=B\)PT8=O[;,PIG5LEHK
MP<2UEB'U?8*R$?(2!VM@J+]G!2==2L,@V13VG7MZV$Y8AL=F<G)4U>5IPH,#
M;K <:8??YN7/<V7N%T6AMP2"8<PAI:'%;OM%JXH&EG?)UZGS$C"M-/YM[7V;
M5K0U>^]Z"DTQ6DL+;,3,I -VK:3N3_55M<"5\8Y.,3IFGKANO#,;*Z;63,-Q
MQ Q[<I,QGD+L9YG.,/2]]L#S<8YS=$XM %/&IHZ>C#W/+  ZH:X>&Q=T=(]%
MKB'^3K-@XZ9B!UG5LE+K]6E2::U-_I.FG*4U>0+J4CI>Z>6N);,VQ[!#/8];
M5ABTA2-[1-M&BM:G%)J,L[52+&+4IT<M@G[QG/[LZ\C,;/5GBN;'\I.9:+]-
MC':%AH8L)TPHDO: "]I::P#>F\ L=>:\7;J^[JU9.,*#<W&.TDIS&VK#.PD%
M5):P*U-A#I4DVEJ4A)7=/N=XV?/-15]5@F8$T1*M6--;1+6LK'A&;!_)V!2
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-$(IN$3")A$PB81?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>g425213g39m50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g39m50.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[2'^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (>*^AG0X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%A$:H         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,
M  $  @"4S,P  0 ".$))300F       .             #^    X0DE-! T
M      0   !:.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!$0
M !     "   "0    D      .$))300>       $     #A"24T$&@     #
M0P    8              +D   $?    !P!D ', <  Q #0 .0!B     0
M                       !              $?    N0
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG    N0    !29VAT;&]N
M9P   1\    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   +D     4F=H=&QO;F<   $?     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
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M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MZN4M;]8<> Z&[G!TZ$N9;+=NW\S;^P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                    _^%"^VAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@.2XQ+6,P,#$@-SDN,30V,C@Y.2P@,C R,R\P-B\R-2TR,#HP,3HU
M-2 @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W
M+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z
M>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @
M("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM
M+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @
M>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP
M92]297-O=7)C95)E9B,B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O
M<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(*(" @(" @(" @(" @>&UL;G,Z
M<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @(" @(" @
M("!X;6QN<SIP9&9X/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9G@O,2XS+R(*
M(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N
M8V]M+W!H;W1O<VAO<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIT:69F/2)H
M='1P.B\O;G,N861O8F4N8V]M+W1I9F8O,2XP+R(*(" @(" @(" @(" @>&UL
M;G,Z97AI9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]E>&EF+S$N,"\B/@H@(" @
M(" @(" \>&UP.DUO9&EF>41A=&4^,C R,RTQ,BTP,E0R,CHP,SHT,BLP-3HS
M,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR
M,#(S+3$R+3 R5#(P.C0V.C0U*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @
M(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,RTQ,BTP,E0R,CHP,SHT,BLP
M-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R
M5&]O;#Y!8W)O8F%T(%!$1DUA:V5R(#(S(&9O<B!7;W)D/"]X;7 Z0W)E871O
M<E1O;VP^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/F%D;V)E.F1O8VED
M.G!H;W1O<VAO<#HW860Q83@T-"TY8V(T+39D-#8M.3)B-RUD83,T,V4T9C)E
M.#$\+WAM<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I);G-T86YC
M94E$/GAM<"YI:60Z,S!F83,S83@M8S%F,"UF,C0Q+6(S934M-#@W-F0U.3<P
M86-E/"]X;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ<W5B:F5C
M=#X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D^-34\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @
M(" \+WAM<$U-.G-U8FIE8W0^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@
M(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO
M<&1F('1O(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W \+W-T179T
M.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N
M:6ED.F$U93(S-F$S+60R,S0M860T9BUB8S5A+69D8V%F9#4V.&5B8SPO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,RTQ,BTP,E0R,CHP,SHR."LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S
M:&]P(#(U+C @*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#IE-# Y-V$R
M-BTV,V8P+34W-#@M.#4P-BTW9&0Y,C P-#DX-S0\+W-T179T.FEN<W1A;F-E
M240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C,M,3(M,#)4
M,C(Z,#,Z-#(K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<" R-2XP("A7
M:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @
M(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/F-O;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z<&%R86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA
M9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R
M<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z86-T:6]N/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R
M;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E
M<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A
M;F-E240^>&UP+FEI9#HS,&9A,S-A."UC,68P+68R-#$M8C-E-2TT.#<V9#4Y
M-S!A8V4\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IW:&5N/C(P,C,M,3(M,#)4,C(Z,#,Z-#(K,#4Z,S \+W-T179T.G=H
M96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D
M;V)E(%!H;W1O<VAO<" R-2XP("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!
M9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%
M=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @
M(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z,&%F9F$V,#DM
M-S!D9"TT-3<Y+3EE,38M8F8X9&5F9C,Q83 P/"]X;7!-33I/<FEG:6YA;$1O
M8W5M96YT240^"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=%)E9CII;G-T86YC
M94E$/GAM<"YI:60Z930P.3=A,C8M-C-F,"TU-S0X+3@U,#8M-V1D.3(P,#0Y
M.#<T/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C
M=6UE;G1)1#YX;7 N9&ED.F$U93(S-F$S+60R,S0M860T9BUB8S5A+69D8V%F
M9#4V.&5B8SPO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F
M.F]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C!A9F9A-C Y+3<P9&0M-#4W.2TY
M93$V+6)F.&1E9F8S,6$P,#PO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@
M(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \9&,Z9F]R
M;6%T/FEM86=E+V5P<V8\+V1C.F9O<FUA=#X*(" @(" @(" @/&1C.F-R96%T
M;W(^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F
M.FQI/D=E;F$\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @
M(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^061O
M8F4@4$1&($QI8G)A<GD@,C,N-BXQ-38\+W!D9CI0<F]D=6-E<CX*(" @(" @
M(" @/'!D9CI+97EW;W)D<R\^"B @(" @(" @(#QP9&9X.E-O=7)C94UO9&EF
M:65D/D0Z,C R,S$R,#(Q-3$U,S4\+W!D9G@Z4V]U<F-E36]D:69I960^"B @
M(" @(" @(#QP9&9X.D-O;7!A;GD^(#PO<&1F>#I#;VUP86YY/@H@(" @(" @
M(" \<&1F>#I#;VYT96YT5'EP94ED/C!X,#$P,3 P1C@W,#<T03=&03-$,#8T
M1CDQ0S W03<Y145!0S0S-S,\+W!D9G@Z0V]N=&5N=%1Y<&5)9#X*(" @(" @
M(" @/'!H;W1O<VAO<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D
M93X*(" @(" @(" @/'1I9F8Z3W)I96YT871I;VX^,3PO=&EF9CI/<FEE;G1A
M=&EO;CX*(" @(" @(" @/'1I9F8Z6%)E<V]L=71I;VX^.3<P-CDP+S$P,# P
M/"]T:69F.EA297-O;'5T:6]N/@H@(" @(" @(" \=&EF9CI94F5S;VQU=&EO
M;CXY-S V.3 O,3 P,# \+W1I9F8Z65)E<V]L=71I;VX^"B @(" @(" @(#QT
M:69F.E)E<V]L=71I;VY5;FET/C(\+W1I9F8Z4F5S;VQU=&EO;E5N:70^"B @
M(" @(" @(#QE>&EF.D-O;&]R4W!A8V4^-C4U,S4\+V5X:68Z0V]L;W)3<&%C
M93X*(" @(" @(" @/&5X:68Z4&EX96Q81&EM96YS:6]N/C(X-SPO97AI9CI0
M:7AE;%A$:6UE;G-I;VX^"B @(" @(" @(#QE>&EF.E!I>&5L641I;65N<VEO
M;CXQ.#4\+V5X:68Z4&EX96Q91&EM96YS:6]N/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_;
M $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M ?_  !$( +<!' ,!$0 "$0$#$0'_Q  >   ! P4! 0              !P@)
M P0%!@H! O_$ $,0  $$ 0,# @4!!P($! 0'  $" P0%!@ '$0@2(1,Q"10B
M05$5%B,R87&!D1=2)$*AL1@G,^$E)C31-V*7P<7P\?_$ !X! 0 !! ,! 0
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MC+*2;)9G[1 ,Y8^R<]^4@RYC49EQ=>MA@EEU2E!1?@%4+BLJA86%4_!/_P"
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M%<5-,,&F&+9"@E*SR3RM0_G[D?T'OX\G_IKI:;*2N=E+60+FRC//SGUQ6=4
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M1:,9%F4E5W?V*;NTBQ6X;%F[%M;2;$@.LPVFXR4U[#!+#;;03Z:$H'K;.II
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M=K4]HN=JK"5#]CZ0*U%1,^_TV^HJ'SON+8O?MYYSDY[%>%T4B6TJ5Q>K04Z
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MX*M/O[^^>*['UCX6-_C$<_7D-LTQ7!IACX+;97WE""L@)*RE/>4I[P!W<<\
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M*KX1S2HIJA26U)'N[Q) ) ALF0 K8P(^(Z8YI/\ 2?=#D%>WN:'M3V#G%+L
M)404HY-;X3W>>S[GR 3QK35%P[FN79=F!J M7\=1J @F0"1(A9BYF>L3B)1X
M=S742&*DSO\ NG+B3,>*XVDBWF8PV&TV(WJ78V2QLYN<\T_-F/"3$PG(7&U@
M.D)X/Z9P.4\I"DD%(/((]]?17@KB[)Z'A7A:G?=9#Z<J;;6%.)2I"]2X"@4D
MI/,:HMN8Q>Z#)*]+:M:'4@).H:5"P$$;F"!:".DC'35T*YSB.W/2UMGA^XN3
MT&%912P98G8YD]S6TEW&49KCT=$BOL9#,]LEISCN<:'MR?OK0O%=4BJXFS]X
M+2H?B+BDJ3<%)0A0*=)@I@  @^0ZXW+PWF%+E^4421I3%*I!2HA)G4H&Q$G>
M=B(D0#B*KXH^58WE^_%/:XU>4U_!.(P 95/80[1,=[]ZD,EV MY+3JTGTT.$
M H[N?;QJ'':Y6*7Q8VP@W5D-4E)\RL@ '<038_(\Q].?90<HLQ[*LX("5 <4
MLRI)D$IHY!LD^8D=8MA0/A,9SA& 9UNG8YKEV+8M%GXOC:*^1DMU64C<UQJQ
MLRXS'?LI$4/+:\E00GO)\>5<#63=B&6UCE.DE2E6%@),C4#_ #F]P-H-B9!&
M,:]LRIHZ;*>#M(2D"G5,^$ ]XY$^':Q/29BYQ.BQU#;$NDQX.[&V,A7;\PAF
M+G>,+">Q(/II2BP('\/A(X'LD<?:0]905;#2GW$K0EI)<(6(\*)6203!L#>\
M?I !&=494A"7&R2T (4( -I!CSL?F09G-4V]FUEQ-C5]?GV#R["=*99C18V5
MT#\B3)DN!EEB.PU-4Z_(><4EEIIM*W7%J2VA*E$)-G9S!IX@)4%&]I&W..OP
M&YQZ$5C3A 2M"HL(6DF";")-[[?IA80&N M*$)4XA#06$@*[$]Y;02!R4(4M
M92GGA)4HI *CS< 9^OTQZ<6R$M*3(6A*$K;7(3ZH0.Y(5V*6.0.>U1;;4I((
M[BV@D'M3QXZ>'4524F":EY,B9F4WVF_^)QR, H] ;<[W^.&-Y9CUG)R;(5M5
MDEYERXNE-.B,%H5WS2M"AW\I'))<22 1RH_[M?.SC7@O/*_B_B1ZG[WN$\09
MPI4?E6D9@^I4 NB9$S(.XG8SG.6N(]T*2I*5=RF"5 *DI2!$V-Q(Y$ GF(@Q
MZT-KMQ[/?BUE5. 9C=19-!2>G9U>+W$Z/S'BNH$9*Z^N>:'U!202KM"BKG@J
M.K]D' V>(I@07$I44B!(Y I _?6L2(V $@ 6Q.CL,[4^#.$N!Z6ASQRG-4,R
MJ$J+BY():I_%_HN0")DSIMN)&$&PO9O=9+,QQ.V.="*5--<.8=?-\+;*E>FE
M2Z]M*?3))"2H)3S[C[[AX5X,SBD0NM?UANG!=6E0()1!$G]X3;E"9],0O]N^
MJROCWC'A2OX;*'&6<K&LTI4M*5%QU02=*&P%"4^& 8,&^V7O,'S'&J],S(<9
MNJ:*XX&(\FVHK&H0XX""B,VJ4V&W"..4I'@]O(XXU?*M!2H%:5#58%0("K7B
M1!/7>1CY_5O#F94@U.I6F3X2XA20KE:5"8Z23MY0Z7H"Y/57ML0/(=M3R/!/
M-<[WG^X'"C]_;[\:R#AC_P!K4-__ !=HV 01OTF8'3IMC(."6:IGB#+ ZLE(
M>4%6N9;5$G4;3SB\8Z?M;EQ([%-T@-K)X("2>#YYX]@!]R3X ^YX&F&$BD;+
M[=3::^QR5C$!VAR+-?\ 4BXKG4+6U99D,D@YE'O)8[@1(B9- CV338(3WLM'
MMX2 6*>EK?'RD'I)F_S.VL[A]-^T.Z]]$RC.,53;VS53#Q]V8)MA%3:4$"=)
MLH5)>QXSC2;:N18S)4P19C2V$J=<2H%MUQ*Z_?TG[Y^6* Q;Y\[S81R!Y3 %
MM\+U"CQH<=B)&;0RQ&:9C,,,GEF.AAKTVV6DCPVE#: .T\>X^Y'-,5!.Q'Q\
MS&W.+GR$?*]TQ7!IAB,[=>^ZBI^_61XGC-KN71L2LMI*G&8=!CK#FWG^C<S;
MB/*R?<&9E7R!$'<"KS9W((%=5/SY$R4NBQ=F+7JK+*V6AS^7P_M>TXXD[[>A
MWYS\QM_;&)V<R+>^#NCLIB>7Y-NK8*?V<AY?NF]F^+S%XO,RR^JEN5N,TEK#
MIA75UW5VL2?9WB'K"H345T.!2-1ISMTXW$YID!1DP1'QZG?G'F?*^.3S"1[B
MK4875MI4!*C!;42.@ .DW.VVXPU?XQEC+KL2L;&FKI$^TC;2O.5D1A!+CSW^
MIFW[*&>WM"@M2Y"'N.WN2&%#P1P-6\?UR&V"@Z?RQ*D@@B1)/@42)$$7C>,2
M4[ ZVIH\R:-,SJ4G-#*O 9)96F!K$<S:8(N(..9NPR#>,;:4%=&J[%S<)BY=
MB7LU4&,8DR'4/&>ZL\GZ8%Q7J3'C/GA2IR%HYYY T.*7A1-,\LN/(=<2XMPM
MUM6WXUDE<%O2$@*.PLD $ ",3>KZWBZKRJC=J*:G<3[^\AM;]#0O$,I1*4@K
M!)A,BT'U)&)Q^F_.=XDT^Q4!%+GC>"VL/#VZMFD@)C8X*^W:LW\RFY/9R*VY
M"OT2P1%C.0)\BG_<NJ76.&44#6#-T_"QKH-36JTJ(<3^)URD_G"4:?%XI,R0
M#$@R1B"/:5^-*XDXD+@IFM-.E20FBIT%"@#,!(\)B=A?E?"([R9?U(S<2N\:
MWFJK%..-2XF3XME,BI8K&)$BSSG(H<.GEIC]ST2SJ:%B'!G%\AV3%>8LE #N
M)DWV@5?_ &!RL();0&*9*%@PX4!EM*#K2 K\H$DJFYF9)Q=O9-I&:WC[-:E0
M[QQ&7A*J<@J9<4EQ25*4T?W5C)@H(-K<\1P;39!GUOF&1L9C1S:NL?L6;/&%
MOM12TU6&0J&*I;IX+L]A41<QCN/<ZU*;404D#6H:6DI:G-LF[RK=$D%:5/5!
M"B&BH& K2$B!:"5$$G$C.T;-J_-^RSCW*\PRJGI6&J.O2U4ML4:'0$U0"5(<
MIFT/((T@V6" 8)$X<;7PLC3NG<NR[&W.(MXM"D0H2NT4XO+"QMV7FXSQ!"W@
MU!JNY'/TJ=4 /JULEK,%"K:2'5D!T(C6K3I2 )C:Y!D7-KG'PZ<;;33L!-2Y
MJ%=6I)[QX:@'4@'<<YC<F\=,=D6'3H3-1@4)==+,N7B;<[YDUY6PVF##K651
MK*>E(9:FJ$]!C-JX4\6)B@!Z1UO"A2E=$RHI0HEM!DI$SN>5C<?*+F,27981
MIRY*8.I&D6)! :3!-IO)B3<7%XQNLVWCU,VL8=C/NFWLH]4TB)'+WRCBX$^<
MEZ8A/ B5J40'.7E<!*EIY_BU4J(J6T" ((@1_P"651&^X^)-K1CTI2W+\%,
M)@;$"4C;D")@[;D;@CEH^-S(S!KJ!,3 &7DY3;83AM9!F)0'DU41Y=I9VMJZ
MF3PD-B/5.TW/ !<LVB!WA(UH3M#RZE>XJ:[VJ=8ULDE*'JA /[E*IAI0$R 9
MG;4)C>?'L^-E79/F;B:)FH<->D!Q;#"UB,P(@*<25@0-I@;'GAYWP1;:5;8C
MN_;S:N5629D3;&5*KY#0_4:YU-1F*_TY;9 6EX%I(XX"E$(!)X!3?NR=A*6'
MYJ%/J2L@*6XZH66L"ZU$E)$D[  2(F,85[5]0^IKLV*Z%FDUM<5:^[:9;"X'
M#P&H-)3J@1&J0G40+E6'&?%"G1+G8S;JSBHE1DVN615I8GQUPI\1$_&[E:%N
MQE@&OLDJD)467OX7.!VCQK->-F&U42-;A;*74B4K6  5#FDBUX/I/*<0!XXT
M&BI]2B '%ZH*DRD-KD2F2DF\? S;'.!B,/)XN%7J\LL+2QF#);ROBBS 87^C
M-6BT5[@' /*J@(7X/DGD<$^=59WE]*E"XJG8"=^\?M.\PHV'3^HQW^SA79"G
MM/X/3EK3SI76.@MOU3U2VM7<+,+;J I!A0V(B-Y&-&V*NL]L=\A&R6GG1<;G
M9932\0<+(3\E"IK^LIG8ZR0D%5@M#]JDJYX0T>.!K!*>FIQ6TI36/2*EG5+M
M0K5I>201*B #8$6G?'V;S2KXP.3<5"@RS+PPFB?2F<KRI>E"J-Q*P%+3((2I
M<*!E)VN!/=XS/K?U)%9^GN)D*JUVKDM<,"&4L/LPRP]/4DM*G=[B26>2I00Z
M21QQJ8!2#N 0;W .W7SQ\E-"?]H]0D;P9(M.W]MYQ>2)T-B5#A*85ZDY,IMH
MLQ0XPCT&4NJ$MQ*>R,X0OCL4>2>//!US2I0@ D"; $@? 2/Z8HI"8/@3$$W2
M!RD3S%QTV,$;QR@_$KAY-+ZC<J9QBSLJEPYQ1-V;M2D/O-TRH"_GE+;X(0A)
M#!) '@G@^=:BSY(3Q15?Q#B92HP''1)*4S(!@["YY3-IC1?$[%*[Q$?>'U,Q
M1/D-I6Z@>1ALI3Y2.1@^;"=\IF7U]1)AX0Q)E939M5]-5R&4=ZX#<GLDOV%D
M"E1;7%;CN<@\ %\?GC6E\^12/\3K:J'"I"]3*E*4M2@A13J%[BY!TB/""1RQ
M]-_8HS#,:+LPSAC*VEU+:\XT@G0N-=(FY[^;C_CEA-KNVRB7MK$M&:]Z)F)Q
M*RE,U4EI2EQKEF R*^&ID^5K$]M*^SCE7S7  [N-2G]EG+6,LSO._P -(JTC
M7I2L%Q"80T( J"8$?J0;SBR>V8E^HR7A4YN54Y#B ;P3*ZB1^Y,"\V\Y(V!V
M'I\>>E2HS[\W(9$AR%*#JKN'^G.(?4XT)L<-K2#Z#4DK;AJ ^H=O!/MJ1G;P
MZXGA1AYQAMA:'FURA+:"N4K20HMI$B"!"K'I./FEQ&&6:FG12NJ+9IM (4X-
M*5.+!N3, 01$$'H9P]+HN@Y-'W^Q09);6=DVO>FE32_JO8RY&I!;0#'8B  !
MQHO#L2Y[^20>3X@_DU>IS-&4^(2[MK,*A0](F1L(&Z>4]7":$'.*6*APCOVP
M4E;L$]XGD3_Z1 (,R3:^.O>JMH<RYG4S3-BF34P*B:N5*@NQX#Z+*19161!F
M+[4S'4_I/;+;026XJ8"B>7^X[L EMI7+P&QOM$'?J)',<\2/[H):0O4"" ("
MB2"$BQ'H0D\^DVQ>KMHT?(J^C2U*,FSA6=@7FF%.Q.RJ<JV74V$H#MCR>;)
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M_*2>9YQ,]?78 #D>>WXDVPV[NY'4B;_ L$NLKI'\)QV#&F0$,ADV$9=J9C:
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M@Q3'O 'L /[:KACW3#'G:G_:G_ TPD[3;ICP)2/9*1_0 ?\ [:8$D[F?7'O
M_ _QIA@*4GW2D_U TPP=J?\ :GQ[>!XU2!T'R&*R>IOOYX]U7%,&F&/.!SSP
M.?SP.?\ .D#>+]<,':GW[1S^>!JD#H/EAY<NF )2/9('] !JN&#M2?=(/]AI
MACSM3[]J>?SP/_MJD#H.NW/KACZU7#!IA@TPP:88-,,>=J?]H_P-,, 2D>P
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M$J?YE;;) V'O.3U'>$);=(.QT*T[B #J B"+#?\ F'1SXWHVJ3P/V]Q <?\
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MTY??3%;==K;GY;_/ZXJD@<<D?RY_/MX_SQ_?7/2)F+V/RQ7'RI7:>..?[_\
MMKK*R%:>I@6Y\O*3/IZ88.>?QP1P1R.>?Q]P0?;^^N7CZ<O_ $[_ $M_2>>&
M^/A21P26P/'O]/L/;C[>/<#W/!''N-)<GK>.LGKU_3''2D7M:\WY?UM&/I/U
M) /!!201S[@D#R/'_+Y_N1X\:'6"?4]+>O\ 3ZSA*5<Y^GT]=OICX6D>FML
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MGQ]_R>!_D^!^3IBN#D?D?Y'\Q_W!']C^-,,4$%M/<D+227%?PJ!5[!7! \^
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MT5Y":6([DJNG,2&TO%7"6^](2#]1]B00.?;SKJ5Q5E"0=5?1))!(U5322")
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M D)@3BZK>J/8&VF1*^OW5PF7.GR6(4.*Q<QW'I$J4ZEJ.RRA*N5./.K2VVD
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MCL5TA"E<MK2=8+Q?6$TH2$D@%1B_1)BP^NY&QY8\G'%NSM1M_P"WY$6M[JX
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M3(;EPX;333;3M<T]WKCN!UQ2TJ[@#P>9"\;.5Z>&,X;<2H4ZF!-S />ME/\
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M)"H/B<$6Y0;"<2<0>J_IXCPA"1N53$M!;:2XU,02M7>1W!,;E!'U>_L I1'
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M(Y6RK9D)![%*CMH )X!S_A*I9;X<>[TJ0@O/))2D$ J>6AM< @J*%E"R "5
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M$4Q=F)(2U6J9KV'/0?+A!672I24J0""KVY &I;Y,X4\.9:6A(]V92"+G21U
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M@\\#W*>=3>U3Q9DM?FV5NTM Y5*4T.\6U1J=U+TK!4K0LDF( 40-6QL+3/\
M86I1E^0Y\I=.5/!\K<:T:UI*BW^9*((!Y3%[&V%(VMZ7-W\YJL4SO'*VG>QR
MPEUUBEZ9-0Q+3 ;LDJF*<2J%]+O>THMI"B H%(*O!U$:FXDRQO-:?5ESR3J:
M!2:6XN(D=YJ3.U]YM<D&0''G;)DV1L5^7:6U52"ZV:8(*G94"D -^\!1,\A.
MTV&)-.I/ [O/\,PO <>;:D7ESGM#5P6771Z:7F(,^2I+I*0?I6R1_ #_ !>
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M!13Z7%(J5E)<U/I(_,M4%*X$0%:U*&?T5&VXE)-X%B2D*@@#PR(!V_,03R(
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MBLM;HXBR6BX%+<HK/LX="@K^$\E/)X(/!]^.".=:_P X[+_?:/)D)=4I=-W
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M$)2D.O<.E;[FD!.MY?OGC<7&I:K:EE1B^/K_ $#>/OO'OG_;<B6/_P",^_\
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,&F&#3#!IA@TPQ__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>g425213g41s00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g41s00.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[16"4&AO=&]S:&]P(#,N,  X0DE-! 0
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M;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M  !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$
M8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'0D,
M   #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M  !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!L1?/
M    "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G
M4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M            4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN
M=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E
M8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R
M;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU  (
M 3A"24T$)@      #@             _@   .$))30/R       *  #_____
M__\  #A"24T$#0      !    '@X0DE-!!D       0    >.$))30/S
M   )           ! #A"24TG$       "@ !          $X0DE- _4
M $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $
M6@    8       $ -0    $ +0    8       $X0DE- _@      '   /__
M__________________________\#Z     #_________________________
M____ ^@     _____________________________P/H     /__________
M__________________\#Z   .$))300(       ]     0   D    )
M"0  "1(!   PS0   #/X    #*,!  !H!P   &M"    G)(   "?R0    H@
M 0 X0DE-!!X       0     .$))300:      ,U    !@             !
MF@  !98          0                         !              66
M   !F@                     !                         !     !
M        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M   !F@    !29VAT;&]N9P  !98    &<VQI8V5S5FQ,<P    %/8FIC
M 0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)
M1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U
M=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   9H     4F=H=&QO
M;F<   66     W5R;%1%6%0    !        ;G5L;%1%6%0    !
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M300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
M  0    7.$))300,      I?     0   *     N   !X   5D    I# !@
M ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,
M"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,
M# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,
M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1"  N * # 2(
M A$! Q$!_]T !  *_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+
M 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,
M,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C
M<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0'_P  1" "N E\# 1$  A$! Q$!_\0 '@   @(!!0$
M              D'" 8! @,$!0K_Q !N$   !@$# @($! X+"0@,#P ! @,$
M!08'  @1$B$),1,4%4$6(E%Q%S(U-SAA=':!D;&TM;8D-E)R=7>2H;+!T1@C
M)28S-#E"LR<H97.&EL3P&45&9&:"DY6BIL+A*41'4U978H2%HZ2EQ]?Q_\0
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M?*W8*38( T1D6YV*#QE7&=<M$T[3B,>+&=NYMRBM*34D9DW>:DND&V<3ELY
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M'@IC@,*XBJM[=Y/K.-J77L@O:1"8U=6Z%K\;&3:E K3CUF!IX.V:")DZ_$K
MD+*-2 C=$C9DB4GH6+--"%,*/HW:%MMAK_(Y2B,3U^,OTQ=%LBR]D8.9IJ[E
M;NX=)/%K+)-T)0C!])JKH("=5TT5(9)!!N)/5T4TBD4SO:34I&VUZ^/J_&N;
MC4X>R5^MV-5N R<-"V]> <V>-8K@("DUFUZM757Z? @L>'9#R'HNY%$%\VD[
M9\H71?(N0\(X]N-W>%A4I"R3\ VD)&49UU5JO"QDP=;E.8AF#ADS<)PDFF[B
M%'#1LX79*K()'(2,^.:P1EL;V_K9JRGGBYT>MY O>2,D4G)#)_9X!@Y/4']
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M-;JOSKJ(Q[9!FF8K=%-,I%CD'B[&=8CTXFM8[HM>BDIY&TI1D'48")CTK.V
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M2J]/4TL8+Z2M!(ET$HS,]1%J:-D7@^C("Z'0H*K0@"H!A'H$0X^-KTW1+0N
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M)CK KI8J8&+U2XEZ@((B7XO2' =0#SKPM'IKB:U6E2."IM]8]K=8.=,$AI<
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MI3.YIGSUJPGAN?4S+/W?3/S">U@/25\[HKEB_P 3#KEP7LD_X7>+DN3(W 9
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MVY\CENV;^ZXY22-A'"XOO,<(GKLR'"4M<Y[$&,YG(S(8[($E2:Z\NT>,4I"
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M1002*5-)(A$R% I0 *G,<_<5R-R?]4?>:E';] XW"R9OEIU5'C]XA*&#\?'
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MU<9'=.>43.:H8O8'E$V@@;;DB (OU)BY7K1A&MW+U=%F@1JF=118_HTDRD0
MYQ$Y^.DI2@/<W'N#N(@ U5L@)L8R\8'P29]@!I8=XN]^9/*Q\C"WO(<K:XI_
M&RE<E4W%?2O<M!4PK]>,L4I(H*O:Y&*2,+%NJ[3O9L+*(+/S7"4EO;+6[[!H
MV@"<K6R/]=_55N9SN9$DW$Y]0&V9F"1*=7JBNC1%"^;OJ5C[^.C$WZY1VH.7
M6WQ"D9]3O J9R^0?,'Y-2H6U3Z0WS:I4]AW)%\V&7_KLY,^_RT_K ]U](:(_
M5&COL&&_ 8L55^>J<_>Y,0I/^CPL/\%VO]>G6M;XW_>/2YX/^2K+M4_HK^=3
MP:E?P?U9A?NZ,_/D];1Q/T3%_P '$?AN72'MMZ_%J^G@BG2 %[!R//?CRY'G
MCXP#^7R\M?,K)&M GV=W]QN<GW+,1M\\EO!8!\A 1#GMY>7VQ'SYX]VK@WN0
M!N.?$V/F-F9@ZP$@ \B+#9/=:RY2FZB@;CCGW<@/'?CS#MJ4$D";%;M0<CR*
ME?-'9P_P_8_D3EI( #OW_9K@O?OV[% /B\>7;C6A<2YU.M5:USH!JD?*.P%P
M&>0-N6Y?(V.&MB\;F-3$5A )N#4>(-]D1:+90F2VGOX>$</ <&BH,>..0#_=
M#*/'?GD.0#CGD>  !$>.=?1OHP&MC- ZQ+B,/7,DW)=AJYORUN[>OHSHL8Z(
MZ(+/D?ZNZS9(^>>#[1)OGG,\+);6*N/HIXQ^*7OD2E>0 '_=''?)Q^(>0^4-
M;]TL W16E'-L?]'8X;['"U05DF.+WL:XZPUV&]X+7!P(X@M'?%[I@_B,+*-%
ML4%1,4 .E;A-U)IF$1*>O@ B)BCW^,/\WR:U/T'T%H;3 TBS2^BM'Z4_1FX+
MU3L?@\-BW-)_2F.<WUU-X:YP8W6+0V3G: +::T=@<:,.[&86EBBQU9S/7-UP
MSUA8YT"PN0 #%@(WE1)L%=+.,XO"*F*)242>4 H))!\?VG7R ;D"=0"!3& .
MDP>8\\ZRO3'HUT>T3H45]&:#T3@*SL=AFNJX/1^%PM0MU*YU2^A2IN+9 ,$D
M2 5T]%:+T;@<6,1A,%0P]7U;Z1=2:62RH6DAP!@P6")ROO3K4QY ?M#P'X@'
M\HCK60S//W!>E6_4HC1$KC>YD"6JVXO9K6H_$V+<FDM^37(.)6W5AO:KICAN
MSFL<QBMMIJAY2/>TM!HE.KN9"W,6,ZFVEV-::N6[19PS,[LT6<;Y;-VWLW6W
M;51V8N.&^=G?,$B!?-,Q(_91\2F^?O&S)FW:"NN[=KD0;HHHI&556677%,I4
MTD2'5555Z.$R'54Z0 W%586 F!EV[@E0>&,U!MD;>@O[8GY)6>RHWM;AK-U.
M,KYHX\[=LOE03-*1%JM4=//7+9@D[4+&?!MA%1JT2@I4X*8<R[!"[]@W? <^
M_<.9AN7#S;(9<+$DINNJ*R-$479'^K&)/XST?U"ONH.;>?N*LW)_U1]]J4'O
MS'G<+)E^2G50.?WZ,F4?Q (\?;UNWH$/]@-.[&XL=],^]8S&B7TQL+3W$JP/
MAN?4S+7W=3/T?/:P'I*^=T5RQ?XF'7+@O9_RN\7)<N11$,@7S@.1"\6'@./?
M[;>B'S\]O+6Q]'?0,!]CP_\ +!8^H"'OFW]6II%$[^'U/_+\!K\(_P#GN8$?
MQ=]:JQO^\.C]LT<3S.':3WK)CZ,/JM^\(2C&O^>(_=K?_HVMO5OFS]1_W7KH
M4O:'\0>(3<O$(^LQC[[5M8_JU*!_7K47H]_7&D/L;_YIB[N,^;',_=*J-L<,
M)MPU?Y]T%9 __:3C_7KUO3[]F<9_%PWXS5U\!\^.1^ZY/42^E']\;\NM(-_>
M^L?<LH<^IO@%UE@Y,/S@/_I:XG>V>=+\1J.^;/,_=7S+W']M]K^^6>_2KO7T
M]@OH>$^S4/PF+ /]MWUG>)3=J'9YJF[&8VT5YZ6.EH"I2C]J\,@W<^A.2RR!
M .#=RFJW5-\?LFJF<@_ZQ1]VC.DV"Q&E>EN/T;@ZE*CB<35PU%E6L":;/68<
M.#_D@N!:63(:\@20QQLNYC&XHZ*J# U&TL7J.]0YS0YK:ALUSFN!:YH)!((<
M",PJ3Q^\S/+E^R;.+T<4'#MLBL U*GH<I*K$(H'I$(T%B<E$0ZTC <O/)>X!
MK&T_1AT\I/;4K:>T$^E3.O4:RMCZCW-;<M:UVBZ3"7 0 ^I3!)N]HN/"4J7I
M#%2F:^F<!6HZ[?6TF8+!L<^G(UF-<W"L<TN$@$/:9R<%?K=?N!O&"(S'J]49
MUZ07LZDXE)FGF3YX0OLIO$*(&:E9R4>*8G,_6]+Z05>0*F!.G@_7G.B'1_"Z
M<?I"EC:F(:<&S"ECL.YC-9U9U</D5&5# %)NJ+$:QF;+85>K4H-I6:YQ:=8F
M3E B01>3?.XYJ,]L^[?)>8<G(4RSQE1:Q:L'+2(JPT=*-GH+L2H"B4JCN:?(
M@F(JFZR^@ZAX  , <@.4Z4=%-':%T6<;A:N+?5%>C3(KU*+J>K4)#C#:-,R-
MGRL\Y48?$/K/<UP: !(B09U@+DN(L"3EL3!7=MK4:X.SDK% 1[M(""HT>RT>
MT<I@<H'()T%W*:I"G(8IB")  Q1 2\@(:\!3P^+JL%2GAZSF.<\-<RA5J-<&
MN+;.9(D1>^<Y+N$M!(D2,Q.4[/'F(7>C9V&F"**14M%R9$CE35/'/VKTB:AP
MY*10S954I#F 0$I3" B \@ AJ'TJU(@5J;Z;B) J4GTB1E(#[D3M%DD'(RO6
MU5$K*7RE;U/$F9XR95?'K^L-<9.%YFZ)4APZNU?CUHJ>F6U6<Y*3.HI%R<O8
MC1THE5E4DJ\6IHI.Q>A991%@%X^3,FW'C>V[([YZE0V<!:YG(;K&;;9VGAN5
MC=\-F&L;8LOF:3+&$F);'-GA*\J]F8"&%[,/89X*+!)S9G<?% 91D@^77.X>
M-A;1S>1? Y: S.X)#?:'GS=' 0=E@.&?B(V7[EA_AK/W#_:!C@R[UK(%8RE_
MAVCE@G")1HL(3(%FB6*,46NS-BAE(MJV9IM8]VQGYIN_;(IODI-XFX*L:'9]
M0V1LW*6[;1<]?&=O#@KX:A61HBB69[9EH(^\<;Y8[_\ *;#IORZXJCBUUME*
MJ[K::<3VE6;<$;-:GW^L^"6#E7>3G*IY*OM9A9B"1BJ_:IV)C4UJY'+K$9QT
MBLU;%574()UE"I$*!U#?&.;DP]QUN31?0S0>+T;H_%5Z5=U7$X6A6J$8A[6Z
M]2DU[M5H%A,P-BQK\54%1S0&@ C8=L<>/%6ZQOD:U94VGW6X6QVS7G7<!D)H
MLLU9),6P-F+)VDCPW0 " 8B/4 G+\8YNYN1UKKIAH1N&TCB=#:(8#4Q&%HLP
ME*L\NUL1B&D .>2/DE[F[1&TBY7#I%M7%Z'TE38#ZRI@\51;JD1-2@YH@$DA
MPFQY)-K51J=PAP[;*"5=   /3!U "I1#D0)T\B)0#MSSQV[ZU\?1!T[HM=49
M@\ ?5^JQ%-@Q])KA5]9K5VN:6DY26C6VDW%E\]T^AFGG5:.OH][J;JC:;GZP
MO3!:6$D/$&P$ZHL"")@IJWB"]8X?H0J< H-O9"?CRZAKTJ)N.>_'(CQR'/RZ
MW'Z.A&D\<"((P8!$ZT$5<.")@3!$2  <X"^C<4'"BP/$. AP&0=J?* N<C.T
M\U1[9Q]D5C[[MM?ZK36O==-?V9TC_#PWX]!<&!^>'G85(OB"_7NBOXO8#]/3
M6NAZ/OU+4^WXC^7I*^,]MG,*7_#7']G9=^YJ2'_YEJ'\FL5Z1_9T3/\ ?QD?
M^7#?FN3!Y/YGQ35]:M7=4.[@OK*91^\>Q_HU?6+TV8T5C2/^X?X%83I+^SNG
M?^%8W\!R0)7_ *N07\,PO^W)K3>#$8O#<:@/_.%\OX4SB* W8G! >/B5]+*7
M^3+^'^D.M[,]AOU6^ 7UX[,\SXKDU90DE;XC".?94W?O6J^GP)>D>/5E@Y#D
M0$0Y*/ ]@'CM[]:UZ2Z,Q^+TJ^MAL)I+$4ZM!E*G4PVC,17HBJPENH:K):^#
M$D$9[E\_^D;#XE_2-]5E!]2FW"84.(#HU0TDP0T@$9D$FW,*P'AVF.6.R@/0
M)>7]2 .1 W_Q6;$0#I'Z;J.;S[!QQYZRW1+ 8W!4\:,9@,5@?7O:ZB,53=3=
M48T$$@/:V8.<9 QF)7I?16Q[:6FA4:YI#]&V<US3+J6*=D0,P^1G8A+GN_[<
M[?\ ?79?TJZUX''?K'2'VIWXCEJ'27ZPQNW_ %W2/\PY.JV==MO]#X]X6'G_
M )QRX_U:VKT;OH7 G_#4/_K5/BOHSH-;HOHSZE;OKU"K1ZSJ]:C1$:(C1$:(
MC1$:(C1$K'=@JK=MVV"L>5JPNFMNK5>D[8[;LK;D'&;B+@[%)IE2:-[K3TTH
M&QENB6/+ :9QE:WIU9&/HC6;C&Z22#]*1L!8GW&_N W3()F<K5)$YY1NM-KW
MGF1! RB3+.E(]E*Q964DT1>M'3,4'+1RF51!P@X0]$X;N$>3)*HKHG.BNB<#
MI*I'.D<ITSF :J<\QVI1.P['3&L;EMW]HK,<[B*0^R?9:A7H<]4L<!%MEJ9D
MZWP#]C7SIU.&QD%;K@L@C:\THT[.2I&Q%EKYZI/&]3B;NB&[X'O]\]\[%0'Y
M1D[8MM-N$C9-X/*4XK5%R)2V[W(FXM/-%GJ6%\E9JQ[%P6/JV[FG:6"K%=,:
MNUY:S5I06..YVH8,R-8G][+"#/.;?87,I*PM3C582+B*?-2;VQ/JI81%^>8F
MW GG:#/4)HZ9.< <@3^6TR,H.:L&C9\HV3$VV65MM+>0@SD_M[E+.I<[2*F0
M8>R/)6&<2,=/036@UUBZE6[X?0OG0%K74LHN=6N12B/LXE'<,I$=N1_K^?(W
M+.\.Z[&^Z^?!7 D;778A4C25L,+%NC)@H5"1E8]BX,D(F*50J+E5$YDQ,0P=
M92] F*8 $>! .6GA<77;KTL/B:H:2/["B^J#$6.JQPF#<3;O52YK3=S0-[C"
MYHVQP4X58D/-Q,L9 ""X",D6;\4 4ZO1BMZHJKZ(%!(;HZP+U])NGZ4VN.OA
M\11IS6HUJ.L# Q%-],F(F-9HD@9@$YC>@+3D0X;P9"^<W+_UV<F??Y:?U@>Z
M^C=$?JC1WV##?@,6+J_/5.?O<F(4G_1X6'^"[7^O3K6M\;_O'I<\'_)5EVJ?
MT5_.IX-2OX/ZLPOW=&?GR>MHXGZ)B_X.(_#<ND/;;U^+4X'?7>[;1:[0'%3G
MI2#5DYR7;/C1KYRS%PBWCT5D2+>KJI^D*50YA*!N0 P\AW#D-+]"M#:,TQBL
M>W2-!]<4*.'=2#,1B</JE[H<9PU6D7$@?O:T0(A<VE:!KT&M]=4I0#!IU'TS
M.L23--S28 @28$DQ-U6W:%F')-TS=78*RVV?DXEU%6!=9H]EGKIN<[2(=KH&
M.BNNHF(IJIIJD'IY*8O'D(@/H>EG1?0.BM#8O&X'!OH8NDZBUM4XO'5RUKZK
M6NBGB*]6F3JD@:S'&3L.72T?@G4ZP><5B'M:+,J8BL]I)&K</J$3<&<P1GFG
M()\]!>?/O\_F/'/V_EUJ\7 VV&=CV;%GXBP^/>23&Y;]'9'D?!%\TMFX]OV;
MGR]L2//S>ON=:$Q<?I%6<IJSRU"OD?&?2](?:*OXCTR.T_Z/".^3V7"<?-]$
M(O\ [_/7T?Z+OI>@9S_1:L\_T:K[HR7T5T6_9#1&S_5G=OKJD]Z6UBKZZF,/
MXQ*5^L<=K?FF/U3I3_AV-_EJJR5+YUGU@F!>)#_G&)O^)N'].NZU[Z-O:TQR
MP7W\:LAI'V*'^;P8HA\/_P"OF^^\&>_2U=_MUFO2#^H6_;\.>RG7*ZN$^=\[
M)*=HGY&_??\ LEUI<9NY^X+++DU*(T1*&W.,Y#)>_O;U5JUZI-2V*H68M4Z@
MWQ=CJV*5ZN2-NPG*2K-_,9=LL+%-7CYE&HS(S^)DI3+E&B$D'#"MOD+ U=*6
MCY,P;D;=T]FZ^]4),P#V DW'8=^^QXRU>3KT%:ZXYK]ABV4Q!3$6YC).*>(E
M5CY"-D6JC-ZR=-A'T:S-VT7506;GZTSI*"0P&#@=55_/G-*N\+FB4>GV/=P^
MQ]923%>FLL%9DB306.ZV\K[NL6'(4,\:.H:AWVUK1R(+E.SBFUCKU%DABH]H
MY&#.X</SI7<#:>R9W923GMX\(5&[1:W"-^?+X1%Y;GJBNDM;J,Y;E8_+6;H?
M#N3<HURNT2%JA'<,\P]+FC7\P:;IT@>+PU9H#;GE^3<'7@1L41:KM:6-LK[F
MPW.OP]?AXUO3YN91L(M.^9ME('B#NC.ZI<S?:1 SM/$1O.^.,)@4O/Y!EI/
M"LA34HR D;%6Y-U*SEG3"YLIA[BNX.WD5,U1E5V\6F^9NU5V4@X:SR;?UE)5
M9LQ22$C<M#F.?N*Y6^R[?JB?_,V\[;\.*6KOS#C<')#_ *WP-JPB/RB5O*&
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M'2%1@&D,Y!L5FH",?*SJ8KJN4?6 3;I+N>K6S/\  K^-+;L7,WV3E.NR]_\
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M8(!UFAID R(=:X[-VQ6(\-TH#'94 >1 '504#J,8W!S(V#DP<B/[DO;R#CL
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MP\7#P*H9E_Z[.3/O\M/ZP/=>_P!$?JC1WV##?@,7#5^>J<_>Y,0I/^CPL/\
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MW;XQN20-RCK(I2EEL1E* %*7)R!2@ < !0H5]   /<  ' !J#FWG[BK-R?\
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M/&%OKG0(R[+\=ZMYX<0=5.R4'_A3"#_)BE3?S\<:\GZ1A..T>-^#J#_UBN?
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M=<P&5:II\)I)G4-RH ])>P?+:K@M(TZ7K:V#QV#9MJ8C"5&-$DM$E[&@$D0
M3>0J4-(8+$5#3HU15=E UF[ 9$@;#<#CG"4EOO$1W"OA$>1^"-='G[?JZO?S
M'\H_/K='0*?^CM&3K']+Q +HC6_M&R8V3NV9+BQ?SPV6%MUG*QOAN?4_*O\
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M/_+\!K_S_P"?)CG6K,=_O$I?;='_ ,NWWK)"V&$_W1V:P]R48U_SQ'[M;_\
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M30O$> ?96(1]WK5O_-*Q_8/X]:M]''TK3?U<!X8S\EW\;\W1^J[[S57S8?\
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M9T1,>WC(_P#+AN^)ZER80SK$'?XB_<835N0^4/QAK5J[JAO<*(#A#*O @/\
MB%:/+O\ ]J7.LOH#]=Z*^WX;\5JXZOS3_JE?/'5Q#X00??\ [:P/^U#7T#B?
MHM?^#B?N+%L^=;]8>+$U+Q'S<5+&/ ]C6:< >![=H9/L;W<#[N??[M:N]''T
MS2<'+#4/Q7?'L7:QC6NHMUFM=!'M &,LI!OL53]CX\[BJN'/Q0@K$/'/;O7W
MH<\>7O'O\^O5]-BX]',;))BK0B2;?V]/+SD5U,,QC<13+6M%W7:T#8^+@;A;
M@O2WX\?W1+\.W 5&N!V\NS=0/Q#P.N'H-^SM.+?ZUB><Z[>]=C%#^U;R]SK=
M4JQ7AN"'L_*W?R7IW/\ Y*Q:\SZ2/GM%\:>- XGUF%LN7!^P[_+X%+1O@\WJ
MXC_X6VT/P^UGP!^/6S\#^K\%]FPGX3%T:_SKO.]/+V8_8X8W_P")L7ZU3FM&
M],/VGTERPW\O2689\VSZOO*M-KSBLC1$:(C1$:(C1$:(C1$:(C1$:(C1%7'=
M91[5D/#;^M5*.6GES7+&,Q8:FWG#UI>[T2NY&J\]?J0C-%=,2-5+93XZ9A"M
MW+YBPE?7/8\D\:QT@Z73D&#//P*AV64Y3RGD?RS"CG&6!,KFPKAFI7W)\C#V
M.BQ-*?R+)NPB+:=M8:J]2E(YDYL\R161L)(ST+&*>23KAQ+C'J/S*%4>G.-7
M222# .R)OG,VV]2NTAHN)-P"#$ B(R,VXJ"-X.#Z;$PKW-^:\RY 2CZZVK-8
M%"GT>JJ+.5Y^T,J[76;=D=OZ(7$A8[0Q9&>.G32.9D<>MR3IDQ;.7:?H="])
MM*:$PIP>#;A/5.JNK14I.,.< '06EH AH($9R9NN&M3H5#)IDDVD&7&,R;=5
MY'!2!MCP)%UFGLLA8BS3;I&L94KM6M,:YL-#KX+N(.1C?;$"Z+'NX]@^C%U6
M4P"CAJ]02>(',"*Z"*R)RZZVG=.X_3[*#,=3PG^KN<Y@92.J7/U=8N#BZ2-1
MNJ1$0%:DVE1]FF=YEQV;+"<S.V>2J-F/#^#Z_DS)$/:LMYUE,A,W%'G)&LU;
M$K-^YGY3,<U8V]5BJ*F,&DSM+I=S7IUQ()Q#YVSKC&/<*S;YB+1R5#-8?IMI
MW#X?"X>DW FEAJ;:0+Z3]8LIL#!)#\]4"2 ),DYKB-##ZSSZLC7,D!P SF!;
M?E.Z!<0KB47";&R;;("L4_-5JE,3WZG(6*&EO@' DG7-=M@)VUH\ 5F*+MHN
MY3>)+ILG+!-VW*86KANFX353+@:VFL?5TY2T\6X3]+I5&/ ]4=6&4O5-:!)<
M)$:WR_E2[*1',UM$4W4_5&""#\H[=N4&,S$W *HE3,4;=K'+846K^7L\*DS'
M,3[''\M+XACXN/4L5&D[:UD:_.)2\*QD:_,BO1;*JI&2#%!Q'-6+96?]CA*1
M O/2/Z>:<J-JL<S!!KV.80VG4)A[2#G4N6B<YV[++JMPV':&@,> "XB"!.L1
MF-6=HN "9*NEO"Q]!-\:&NN<,QW]O2Z [0E7#RD8QBY-^V4EWC&# [EA$QDJ
M[6:$5=H*NG9VR;*+:$<2,B[:,6R[A/SVAM-8_0E2M4P9HEU>GJ5!5I%^3G.!
M:0YI!O$#/,\.P]E!S=4T[7R<>1%[ ;YS-N"PC .WO'$3F"\?0KSY:I6ZX<E2
M4^YH/*O37S&(G[-5T9P\,H9)LB=R];0$DQ<NC( 9!@N](P76]H(/&C/OZ6Z5
M:5TQH^I@,:,,:=;5UGTJ3J;B&.:X0/6. !(O8SP5:-*C1/\ 9M< "8;K?)OR
M;E+9S&[.5?,*1DWCZ\;@>YO^X*K_ "CV\_=Y:\Q!V.@;H^*YRYI_=[7%:_ C
M)G_UQ./^857TAW][_E"2W^[_ ,Q2I,G[>L#4K-F.<26[.&6D<B9K=33BK-6-
M'JKJ)],@X5,H,@]1BA(S2>/ 70: 7UGT7HQ4?F9,S).E/:4>G.G:5-E/_4G-
M8&M$T'2X,  $^MSB+]8&875=AZ%_[-PD&X,D$SPZMH%LLS>*R;:73'!KC%DE
MF&T_ &$C$U%_9U%@'MA,UCI/V\!D/4H]X[=N/6R&-ZNSCG#APF/JZ"!E#)AK
M"4]-X^GIFIIQIH_IE1SG .IEU)NO2-$@,U@8## ^5,P2;+E+*?J6TBQQ:T?W
MB28B-@%H R'4EZXBH.V^TWS$(4;->;E)6Y-:E=*=)S>*XIC76LM)Q<_>*K5K
M0\<PC;V%:Y:!H]DFDZ_(^KN$V,0=)ZJS=R4.WD<W7Z:Z<KT*^'K#!.IUZ-2B
M_4H.:[4JL+'%I]:8(:XB2" 2#%EPC#T):6M<TAP/M"\'+(V)M.W(&95P-W>*
M:XK5JI<\V9FOR</&V>"I\.I2,;0TDX+,Y(L4'68T))&-C)0&L8:6<QY74P^,
MSC(M$RJKIX4%$B&PVA--X_00KMP!H 8@M=4%:D:EVE[@6P]I!FHZ<Q$6M*YZ
MPI50TO88;< .W@#=&0V0.9-\,VOX3I3#*.4&V-,L94CKQBU0E/MD=?L<5UDB
M9A85W"L?+0_4R03=Q\JK6WIH]P=5)XHS;I21H].*EH9_(]C3/232>G,$<#CQ
MAC0<]E7^QI.8==@<+GUAD0\@BW-1192I.UF,((D$:V_B&\+05X>X3!>)"Y?5
M^BUGG($#:;/0;9D]]+-J'"1U&C:=C%E$-+))2=H<0JU?C73!DY:.CQBTL,DL
MT3=2!61&:!UM<VC>EFE]%X*C@<)^B^HH M8*M$OJ0YY>;BHVVLXQ:TC.Y57T
MJ3G.<YKB7&;.W"P  &P>;!6%VQ8;2@,7P5BQ1F:SN:;DEI$Y C#V*DU9234:
MSD+'JM/6")H(&9*C'E;$<L5B"X9N07;N.A=-1,F+TSI?&:;Q%#$XSU(J4*9I
M-]33--I9K.<):7.N-9P)D6.4A<E,,I@!K3&8EVWF![^15ZB@(%* CU"   FX
M .1 .X\!V#D>_ =@\@UC%*UT1&B(T1&B*H.]*FY&O&,:S%X_A[;:6C7(T1)9
M!I=#O37&URN-)1KEL:I1-?N3RUT9O$KQ]X>4JTR!%+? ^T86O2<65P\.\+%2
M%FF";Q8QS["JNRRFXF\6V[O-]B]:&Q9FZ5IV'PL>68:/M%,K],?V$JM#)8S2
M%\CZ4O7K1(+RIK1$>M-9.1E)9Z4A&*!TSG1$'"O0916I%QN!/O'#?N[%<& =
MY$&_&?<+3;>0J3;S\)Q59C9G<%F/.TLTCF)*W57+>G8DCG2AUWTLW@XA)!J[
MNGH$U74C+HD<.9"38M$2\&5<$$"@?UN@^EN+T'@&:.PV"P=2FVO6KNJ53B ]
MQK/]8YIU*P: ",X,DDD7@<%>DRK494<'?) &K8S%I) $3LMNXJ<MM>WZS8[J
M#BT8US>VEH+(L37+6S7GL2D1<*QB\6M(1*I&9K?'/&*KAC)E.LT?-2.T#B"*
MJ*:A#DUT>D'2'$Z??A'U:%##G",JM:*>N\/=4U9<[7<" "P'5:1-Q(4TJ3*8
M-G&0 ;@6O:(S$Y\MRHKE[#>/Z==[W&63,N3I*ZM).LR[JMUC;^ZDUYZ1R8I<
M):)CZ8*D^BWLYFC"H6F3FC1CY9I ,(=V22>)/6CILCZ'#]/](T:%"@W X MI
M4*= NUL2'N]6UK _YXAI(&6JX7Y+AJ8>D]X=#AE @7&9N8C=N  S$J^./\/6
M*9VTP=4IN=XJ=QI=J>5]#S*6*DPEGU<N11FT))NHK<DDP.9"3*ND"[%-0$ND
MJB(' >?-5].5ZVGFZ>]11;68^B\8<FHZEK40&W=KM?=K0+$:IO?)=@LIFEZL
MM=JD 9B;.!R @CMM<3M7;&8=Q@\E<8-F>9\I CD?(-KQM7Y:4V^N(J.976GS
MTM7G<-8&\I.L9:)=2,O!O@BR.(_TP1J*DS(I1D4D=V7U+_2'I%_K -'X%K7-
M ;JOQ!<PD7(<ZHYK@;V+1>P)V\'J*8,@%I-SD($D$W'8,Q>]U>[>'1W[7#;6
MPYBS6X9T>H/XR45=4G![N:ET#.O15]!9PR:VV25&-1]L%6DGZR#5C%LR.)22
M=-&3190GF-!Z<K:#QE?&4,-0KOQ%(TGLK&KJAGK!4^2:;VNG6:W.;"P$E<E6
MFVHUH=, R"-7:(VVN,MFS:HYVX;?XF%R[>C8OW$DL%NPY+(4:Z-Y#&4>XC(B
M?L=>:S0Q(G0N#4[EZRAY-BH^,@;T#5ZZ-&>E6?LY!NSR>FNF&+TS@7X*K@\+
M094>Q^M2=7<1J&6VJ5'#,3,Q&P3)I3H-IN!:71(G*#,1<7X91>Y,0F$A4<V^
M[,54  $0^M$(_P#\A!Q\W\^O'Y1R$G>=_F>:[*XS5#-9NH#9BJ8<" "/T(QX
MX'N'/.0N Y$?^O.JZK=<.(F,QO'/9W[PI!C?RFQWS;:+)163]NV/J9FNDXIM
M>?;62^9CDY-U )1>(6+N&3<.'CTR9'KPEG.=J1\];O6[0B*;X6A&X.)D\:S4
M1=*["P_I TA0H4:#<!@'-H4F4VN><5K/%-@;)U:P&L0 3  O8 +J/PS'/+C,
MN<28#;229N/-QNEAA-M&06&%'&'?HUQIJJ$&\C%'08I34F?55WBLBJ9-5.ZF
M24< JH<J108G$P"4@)'.  ;S+]-5GZ=&GC1I?I >U_J9=ZDN:T,$WUH@"1.<
MW$KF+!ZGU1)@9NVP#)MRMM(V)6=6QIA>;LF-(V+SUDLB^0)E2/BG<QMZD8=C
M7WZ61;%BV!0OJ,K+,)*GFN.0ZC.U2LMIAFV>/9)D=%XC&B(&#U-3TA:2>Q[/
MT# -+FN;K-.*D2(UFZU8MD3,$'D5UAA66@N!M!AMI[">JZOAO*Q2_5Q_"W7,
M&;7K2LTN6:1J(T7![Z:D/6KE)0L"W7>M6-JF5$8UJY(T5?RKHC.-B6/K;U^\
M223+SYS0'2"OH"KC*N'P]"N<86%XKNJZK12]86QZI["?;.9V"05V*[!5:P.)
M ;-K&;<1%HV^.<7[7<+-(G..38.@YELS7(&'V4?'65A>,*HLHMU%7-:9:1,Y
M KIV]K[3C))S4YQ..="JW7<-&:,PFR-!34!*2O>TWTNQ>F\"<!7PF$HTWO95
MUZ!KZ\LUH']I5>(DR8 ,@75:%%M)VNV<H@@"08)R&6XKJ[@\$P\[FRO)Y*SK
M,0-MR;$6)\R=L<,*-*2PC<8U<9.:<3MM=6%Q78)=.O1CF419R,PD]?-&,B]:
MME&C%XLA?0W3'&:%T=0T=0P6%K4J#GZM2LZN7DU'%Y$4ZC![1.8)B!-C-:E!
MM6HYY)EVK#3'R1?:09XV&65Q,Y[/\32;#%C&\X:SRTFZ5E)O%V^*D9_$Z N7
M4<LR%..<I((79BHS(Y;'%0[1VD5\W4$4'B35TDLU1Q>GM.XC3V(H5\10H4'4
M*)I-;0-0M<'/-36=ZQ[SK2Z+$"-AS7)2IMI AI-S)F-EMG),63 Y4R%4."BA
M2%!10I>@IS@4 ,<"=1^@#&Y,!>LW2 \=1N.1P2Y5OT1&B(T1&B*@6[/'F=;A
MEO!\OC1"T/:S F;BHXKM[:5.+I%R+EK$DNYN]ZK[BU5E7(%5/B:(R;5C5UJS
MN"QUYQ6/"M)C.A,QUA%Y]]Q!M(WF)573LCKV&1?JORV[E8*8PW9Y.WI6]'-V
M0(MXT9V6-BF#.OXM5CXR*LLE!R;V/1!_C]X[<$14KT4DV<OW3IX5)!3TBZJJ
MZJA^-UQ L3D8F(OR@P!>>"N#8@W:8D3!D @1RD["E@;I,(8<Q)DO&Z&1<IY_
MF)[<+?%(IB^KK?!C5I'RLE9JK7EG;MG+5"(>2',U>X,R,+5FMAL1XL)B81AS
MQ%=EW;7V6#Z;:9P>&H86C3P)IX>DVDTU:59SBUC0&7;7:) $6 D22"5UG8>F
MXDNUB2[>(N3L@;^VPFP5\ZSM=?T?&DIC>"SEE,M6>-YALNQ6AL1N'BA)TADW
MQ"/38U%1,QRK&*CQP"(]/'2  .L)C-,XW':1IZ4KBBW%4G4G---CA3(HD&F"
MUSW7$02#< 3>2;MIM;3+&@@&=HF3 V6V&=MXV0E@N<.X5C[E"5)6R[J6IU+2
MPB9^:?1V"HUE2 L66WF$,?3EHC7M7;SXQ61\E,5XFKC 0LX_;L ).69A7H\P
MK%]$>GNGI?#, &NI:C1ZFL2UVI=\^O,DS/RB6[ T 0N,T*)F0XDV-P;9#,"#
M%B#<2=EU>7=CBLB&#IV\Y/RKG.TU/&$(^R&\AJ+6,/+V5="#B7!G!(]NMCMD
MV7408*NG"BCY\Q8,V[=9](O&K1NLX2\[H73.-T+BL1B\,*-2IB:(HO;5:\TV
MW#G.:&U&.^4YH,.<1LA<KZ=-S&M+#\D  @WL(RRRF0+9D!5_P;AVC1>X9W4*
M??MP,!=J11H/(43+SIMO<M!S%4N:"L,5\E&P5:FYN%.BK(.&2+6ZPU6<2JK.
M0>UY*881CET3*:3Z7Z8TI@:V#KMP3:==],N=3I5@\-9494+&EU8B":<3#B)S
MA4ITJ-(F&3D2;;>0&<SE&<7RD#=!@RGN<H8A3R=E3/<I*Y3D9/'\)8X* P\S
MK%><URJVJ_"-M?JX^;$BTGL7!S)8U1N1\]>+H+&]33CV$@_9\>A>E&D="X.I
MA,*S#5&.KNKZU9M5SP7AK2UNI5IC5 :VQ!=.3I-YJ4J3W-<6QUV)&4VW$]F>
M[W=E6.<?V6B.<H8 W"9/4KUWE7\6LJ];84F70_!.0E6L<Y7;M*'(!#J3$8Z2
ML3&-D%&LT2"G(I:6C8YTJ9FAT],Z>TAIT8,:0;A2[!NJOI/H4GL=_;,#'7?4
M>!8 2UK8 (N"Z9H4J=!KVL!^6;DP,C(%@)M>_/<KLCC+( ^>X+(W_-C#W_\
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M<A(FBX2O,X^1>R$H1G"3B\=G*'3G3M&CAZ+6:/=3HT11)-&M+PQH;K$BO#3
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M+=+,(AQ<9II&K6!S/2[&%]EUYM*I0,)$1K,3LMYM/Q0".6P=<^?S*[.;]OU
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M-&DL$RC9+0%7KTB_<0M3^%UE;H62V!7F4<%CGD4I66!T[114328CW>>/:5
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M?=?$:IN/Z_4;G<:=;:Q2[+EVU8LDYB<CU8F5IR-:HSBS(V:R5B18H2":4U8
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MG<'4.*1N'?\ %5A\YB)[NPKTW&V[<8Y.0RV_#,RO2 %ZAQ%M4+VY$>!*&#
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M(C1$:(C1$:(M! !\P ??W ![_+WT1;033   "$      *4   [    <  !V
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M*0I>/+I* <<^?D :(@4R&YZB$-SSSR4!YY\^>0[\^_1$%*4H !2E*    !0
M   \@   .P>X/=HBT%-,1 13((AY")2\A\P\=O,=$6[I+QQP''R<!Q^+RT1;
M?1I@/()DY'S'H+R/X>.=$6X2E$  0 0#R 0#@/FT1;033+STID#D>1X*4.1^
M4> \]$6HE*;Z8I3=N.X /;Y.X>7VM$6A4R%'DI"%'OW*4 'OQSW /?P'/R\!
M\@:(M^B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1;%. 34$>>
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M[L0Q-SJ^5<GKSLHTGK)6X^.J]0QEB>;GI<S$TS8'\G)M(:(C73]N#)] :8S
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M1!L14Z" @*+8ZA$2JG;I?'!- ZADB HH)2=1Q-HFJ+;8CN_KEDMOP9CP$#%
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MR2=E^.=\_P"@6/FVLX.0J<U3(+'E.J$/.1!X=<:?3*= .&B739?5'; &E?\
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5:(C1$:(C1$:(C1$:(C1$:(C1%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>g425213g44m01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g44m01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2:44&AO=&]S:&]P(#,N,  X0DE-! 0
M    )GB^F$@X0DE-! 0      % < 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M @   @  ' )0 !!-86AE<V@@5&AA;F%P<&%N' (% !=0;W=E<E!O:6YT(%!R
M97-E;G1A=&EO;CA"24T$)0      $$!A15Q!^,<S)>EJ7/"!94<X0DE-!#H
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M8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M     $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^            !"
M<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M  !2<VQT56YT1B-0>&Q 8YML@         IV96-T;W)$871A8F]O; $
M4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M         %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O
M='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!2
M96-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#
M[0      $ .__C4  @ ! [_^-0 "  $X0DE-!"8       X
M/X   #A"24T$#0      !    '@X0DE-!!D       0    >.$))30/S
M   )           ! #A"24TG$       "@ !          $X0DE- _4
M $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $
M6@    8       $ -0    $ +0    8       $X0DE- _@      '   /__
M__________________________\#Z     #_________________________
M____ ^@     _____________________________P/H     /__________
M__________________\#Z   .$))300(       0     0   D    )
M #A"24T$'@      !      X0DE-!!H      S4    &              (E
M   ")          !                          $              B0
M  (E                      $                         $     $
M      !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $
M     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<
M  (E     %)G:'1L;VYG   ")     9S;&EC97-6;$QS     4]B:F,    !
M       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$
M;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T
M;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
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M!"@       P    "/_         X0DE-!!$       $! #A"24T$%
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M![0\#*!AP!$^K3XHOU# '6;0  !BN@#0?SE2A@?_ )/LK_PS_P"C:5/ZB?\
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M#KQJDIY)GUIR<_!ZP#BNO;34=E..T"^H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! ?_  !$( 5 !3P,!$0 "$0$#$0'_Q  ?  $  P " P$! 0
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M?9WO7K_>C_C],\3_ #R>,CA[;C7_ %H_N%K8?Y2% "1_-:MR)&6(4]LC;_\
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M4@7.9MUKX)9X<.T#.%M7.DZ2MDKKPRP@^0@'-WV-UF"/I^L%+P"P1Q<$R Q
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M ^[CWZ?DS7%$V?K >)UTI/Y-=M%0#J^/]XR)BJ5Q>YYT0X]>1>)-]Q(4'/\
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ML\X8S3@&)A!-,$(8]"$+>]DN=;Y]*\'5;UV&*%P,,"A>H.4$H!4,U%F/44+
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M)L:"9 PRM.:D,&R&.:AT8EQ)@#FIWT2XE%C6)D9R4BB+X4^69)57.E4]"O\
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M2YL55-%&T-C:QC6LC8UC6M:  T66:[R!_2FZN_TG69_O)RSZ);%>X79SA_\
M;U%]4;GQ6%=J/=3C'YTF^E4-N7?[PJ#_ ,?_ ' KKYO_ &9JSML,]S.%_P"S
MV'?9<"ZZJ\>5WY[KOM*9=D2W?W/0_P"1I?\ 8 SYZR?C)/AN_6*V\;H.P>A>
M9E"E,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+.;#^I_([$^
MYO)-#.=N3%G9E=QB[:Q2(%$UZ\C%2-53#5TS&%QD2AT1L!"]@2M3N>>>^K1Q
MP+>W#<###%*<Q68,T120!\@] /I)5L'(]Q=F6J.::ZSXW9.4 LX6C<,&S]#P
M>]OLR$KVMT[A/##VELW'ODG1*/8-KO>Z7_&"T3[.TX_4H4TL(F$3")A%1UXO
MOI^^<'\[NH/U$,F%/ =I]#5FL\M?WQ/J'\M&CZF1G,2X[XWKO+?L,6@7+%[Y
M&TWEJ#[*H57:G_E!'XXK^N'.H=H>P^A8X@_'P^5C_7:NR*D?T,G?\VE5^K(6
M;!;(^-MFOC^#_3TZ^E<OB!_YI/U1801_QQ?SA?T[SZ+K4AVI[3Z58?XIOIX4
M=^/F?U!D^8XY6O>_Q_X%%]HTB]GR>^ZW"_TOZG.MI^:/+9Q,(LDO[I12IEUB
M<T(UJ8A8C55_82=4D5$EJ$RD@U^90&D*"#@C*.),!O83"C " ,.]A$'>M[UG
M@=KW.95T+F.<US87EKFDM<TB0$$$6((.A!N%JO\ RBIYJ;$=DJBFFEIZB&&O
MEAG@D?%-#(R:F<R2*6-S7QR,< YKV.#FD @@A9?4,!@C8K(7MD(A[<O2C]XF
M6H(RR(UB8S6MZT80I3(2SR1ZUO>M#+&$7IO>O7TWO/+/K*R1I9)55+V.%G,?
M/*YKAT%KGD$=1"U]J-J=IZR"6EJ]I,?JJ:9I9-3U.,XE/!,PZLEAEJ7QR,-A
M=KVEIXA;_P#PH?>ZJ6_SG8?U\?LR/LQXG@\I/],];M\C?O=;/_ K/K]2LR'D
M#^E-U=_I.LW_ 'DY9]&-B?<-LW_L_0_5&+$6U'NIQC\Z3?2J&W+G]X5!_P"8
M*Y__ *[5G:X9[F<+_P!GL.^RX%UU7X\KOSW7?:4R[(EN_N>A_P C2_[ &?/6
M3\9)\-WZQ6WC=!V#T+S,H4IA$PB81,(F$3")A$PBKW[?\@\/XM@3S8Q]?.US
M1V#R&,QJVMP&P*J:7"HW"<.#(V0C4U:IE,&-U3ER=0^$G)#$B%24C;DRER<C
M$B/11II2!YM<^_?M.2^+X8ZOO^U)B_07JF%L-;2NS8(S=,<Z1YL2G(UX*'E2
MOY,5U]+##5JY.Z6A42\V.AGRYO&E2*"9W'CR&Y(#W@<(1;U]O'Y[JSS"A,(F
M$3")A$PB81,(F$3")A%GSG4@ZXNFV/+D5RO*VFLI?2,98J?J^J:[A\"8IQ:%
MT2. Q:6MM]6#/WA(2YKW-O;%)L2@J=>9MI UHUFSU1VR0DX4]&GG]=^ OV'.
M]USQXX93T+7_ $CU/QW>=[S3I8%7U_SW<++8M@EQK<SAKO;D=>$TNJ>0+(BU
MM3,J"SO$6$^L0MI2EFFQW%HX!@-%J3R<+\!EIV]7IST5RF%"81,(F$5'7B^^
MG[YP/SNZ@_40R84\!T7/JOZEFL\M?WQ/J'\M&CZF1G,2X[XWKO+?L,6@7+%[
MY&TWEJ#[*H57:G_E!'XXK^N'.H=H>P^A8X@_'P^5C_7:NR*D?T,G?\VE5^K(
M6;!;(^-MFOC^#_3TZ^E4WB"2VOL0?J:P@C_CB_G"_IWGT76I)U/#,JP_Q3?3
MPH[\?,_J#)\QQRM>]_C_ ,"B^T:1>SY/?=;A?Z7]3G6T_-'ELXF$62S]TC_X
M3>8/R$G_ -8&3/ ;8_E-'Y"3Z0+5+^4C^6;+?%L1^EIEFBSQRUD6]3PH?>ZJ
M6_SE8?U[?O7_ *<RALQXG@\I/],];\\C?O=;/_ K/KU2LQ_D#^E-U=_I.LS_
M 'DY9]%]BO<-LYT_S?H?JC>U8BVH]U.,?G2;Z50VY=_O"H/_ !_]P*Z^;_V9
MJSML,]S.%_[/8=]EP+KJKQY7?GNN^TIN"[(EN_N>A_R-+_L 9\]9/QDGPW?K
M%;>-T'8/0O,RA2F$3")A$PB81,(F$49^SY>J@/)'2TU0EOQJ^,4=9KR@+BY"
M]1(=KD,1=3D>V<MK"-PTO"I"4(@U('WQ M>_#O7N][UQJQI=25+1((BZ"5HE
M<[<$9+' /+[C=##[8N!!%KA</$(W34%;$V?P9TE)4L%1OF/F"Z%[>>WP6EG-
M7W]X.:6[MP1JNK F$WLN?E";RIS9[J\W!(8\X77I]W9B9/)G5C?D4HC#H^N2
M]"),XBB*E!MC;%[MM2-N0')S4P?1( O/!05DL+JATU1>."-W@Q%;!*7#FS3D
M&(3ESW/#A.1_;9_5N7+7BBV@Q/"7X[68SB1=A6"4SY=GC#M)A==/4PT^&S85
M,RLIABO/UD]:)(<5CCEWGMK(7L$K'O:5H4\)RRP9CY(:'<K#N2Z+!4Q6'6T!
MG0S6T)/*&A !S@2PIR2)T;HH$#;>I&A;SC$H@@(.4-C8I.)$:A3;*N8!B53-
MB<4#G-YN1LH=[4[Q#&.<VQ+G6S O;47'9UG)7RC8YC^VC,(G%+['5-/7R7W*
MSPDMIV.E@+C-B%5%&_(<X(VD$D@.M8K>'F0EM,F$3")A$PB81,(F$3")A$PB
MSL^2Q=P.PWG(YG&KRZRA';Y,61--@0WQOODC?KFE<6:$)Z]H1W9$(XVR&"L:
M%H;A_'(Y-:!3"L:F<)"A*O$EVB 84B^0^2_\<K7^?SKF+PB1>8@J*<6^HH1R
MJ^M^@3(K:,*L^VKT6WWU+?PW-L.('/+ND8DA#4P%_(I+*5%H@U''$,1!B\C8
M2A#W[1#G\^7 9\.I7B84)A$PB814=>+[Z?OG!_.[J#]1#)A3P':?0U9K/+7]
M\3ZA_+1H^ID9S$N.^-Z[RW[#%H%RQ>^1M-Y:@^RJ%5VI_P"4$?CBOZX<ZAVA
M[#Z%CB#\?#Y6/]=J[(J1_0R=_P VE5^K(6;!;(^-MFOC^#_3TZ^E<OB!_P":
M3]46$$?\<7\X7].\^BZU(=J>T^E6'^*;Z>%'?CYG]09/F..5KWO\?^!1?:-(
MO9\GONMPO]+^ISK:?FCRV<3"+)9^Z1_\)O,'Y"3_ .L#)G@-L?RFC\A)](%J
ME_*1_+-EOBV(_2TRS19XY:R+>GX3_O=5+?YSL/Z^/^90V8\3P>4G^F>M^>1O
MWNMG_@5GU^I657R.V/%H_P!K=$P9Q4J0OLILJUC$'N4HSD"3W+BY_"%NZT.]
M%-IKP:6I3L@#]>KDI1JR"?[85Z"^AFQ]?3P[);)44A?S]7L[2NC+8WNB8(Z)
MI GF:#'3F?=>VE$SF&IDBEC@WWQN:,4[2TTLFT6/5+0WFH,5>U]WM#R7S!MX
MHR1),(RYAG,37B!LD;YBQDC2:Z.9+*D9(:$?M&D#I\@VL:N/$!(#:G4L5%M)
M Y<)PW_;-,J&4")@2E/KV2"UAASD,SV$X]:MX;BT_L-A-8R2*3 CA.'8.XL8
M'/;7>Q\$)KC.#<4\>(#V(DBL V<NG+BQEE-301>RF(TSV/9B@Q2MQ%N\\M::
M7PV67P3F2!_3OI'#$627-XK0@;[EVB3=_<]#_D:7_8 S1J3\9)\-WZQ6T;=!
MV#T+S,H4IA$PB81,(F$3")A%'WK+Z+W0_P#H5LSZGN^<+$O%]=\4J/HGKJ<>
M\1XS^:Z_ZK*NM1S#B^9;0+ V%[#.W4K>/!K]\5JW\D[.^I+KG?;->.*;X,WT
M+UF/D*]\.@^(8G]6*W<9E);SK,Q//)+UTU>5I$R1Z90D?CJ95I<$E*T=?F*S
M@HF^;5Y7,]LC4I#(BA"1Q.YI416A\O*]EC9TVW_:R.K3&K:T156/W\+&Q(S/
M5G\QL;+3-K>MZUO6];UO6MZWK?KK>M_/K>MZ^;>MZ^?6]?PX5*_N$3")A$PB
M81,(F$3"*M_IKQ:\R=(S"06VD%8E W_)&HQG=[ZYVG3S6,_?D T.FWX":DMA
MID7L-KV@"!&8VSB/OJ<28 "R_<C*(,*)HOH. N;;\Y+KS[0E@7]"[^I2M6",
MQ"@WI+6Y, M&.1UC)5HSXY9*ED?'*)RP]O1@:B&^0-;8P."P1:LQU;_?" :,
MBL PB81,(F$5'7B^^G[YP/SNZ@_40R84\!T7/JOZEFL\M?WQ/J'\M&CZF1G,
M2X[XWKO+?L,6@7+%[Y&TWEJ#[*H57:G_ )01^.*_KASJ':'L/H6.(/Q\/E8_
MUVKLBI']#)W_ #:57ZLA9L%LCXVV:^/X/]/3KZ53>()+:^Q!^IK""/\ CB_G
M"_IWGT76I)U/#,JP_P 4WT\*._'S/Z@R?,<<K7O?X_\  HOM&D7L^3WW6X7^
ME_4YUM/S1Y;.)A%DL_=(_P#A-Y@_(2?_ %@9,\!MC^4T?D)/I M4OY2/Y9LM
M\6Q'Z6F6:+/'+61;U/"A][JI;_.5A_7M^]?^G,H;,>)X/*3_ $SUOSR-^]UL
M_P# K/KU2L:ODGB-G_OGN]7-]BD5<5<INZ>J6A_8I1+%[XP-T>D"H,!TUQUJ
MK-X7G+652 MW7$)C325+DJ<1F&EI#!& WKV6@QEW)]0;]%3RR5&#T3Z2HI*J
MMEJH64\#/8E\-%!A-7,^>F>&U+XF<^UU1).XCF7EC<?[02X<-KZFU3+'%#7R
MMGBJ(*6.!SIG'P\254V(TT;63L)B$K^9+860M_&,#G1IYEH"N)3 *H0/:.TD
M9@RXHW2J/.<RN*'(M/GO&XY](*C+@[LJ<M$)R-/& ;>W!;1&^WI*/8BAZ!VV
M%[)83+LM2P5$..P/&#PQ5M)58CM-AS!5FBC?6L]CZJII6MA-2^6S8Z<4Q]LV
M(%C;#KZO:#$&X]--%+A,P]E)7TM3!18%6DT[:Q[:5_AD$$Y=((&QYOF,XR<^
MSB">T,:2@$-3827[7L$MZ(H'MC&8+V"TQ8 ^T88(0QB]-:]H8Q"&+?J(0M[W
MO>:0R?C'_#=U\3Q.:V>&@[ O890I3"*DKR=^1"$U1.XAX^5X9I4MA=:MS8Q-
M_1+[(ZCA-3P6FW1[;FB\)XCEDGM-CD2"50N$+'M-'B%452%JY6I0&,JAY$VJ
MD@B+F[QKW97:PFXN08;<\&N]#RT]LXZKG,*G\?L8+YS58^G1SJ%(_OT>=WDD
M<HK54U2NG'@*Y6)S<D$ C\L7^ATK]@!%:/A$PB81,(H^]9?1?Z'_ -"MF?4]
MWSA8EXOKOBE1]$]=3CWB/&?S77_595UJ.8<7S,;H.P>A6\>#7[XK5OY)V=]2
M77.^V:\<4WP9OH7K,7(5[X=!\0Q/ZL5J^\B?64MX]IB.V+#XQ')6X/T_;X8J
M;I,8Z%(BD#@P2-T-5$C:5B)3I4 UG)*!L1NR]%FF[]GV] $'9/DWV/H]M<:J
ML,KJNII(H,-EK6R4HB,CGQU%-"&'GF/;N%L[B;"]P,[7OMSMEM%4[-89!74U
M/#4/EKHZ5S)R\,#7P5$I<.;<UV\#" +FUB<KV6(9SZ-H,/5S?79E,F)(\[T+
M.FA95*?HGJ%-"52J86DR6 O0;"7;18DZ-W/2/+PK@B<\$9=#CQ/JUE/<RDBT
MO*;^1K9-F/P;/G'\8\+FPR?$MWFZ,V9'40PQQ[XI]P2O:Z>41'VYBA,F3;;W
MA6<I./'"YL6&$8?X/%70T._OU'X<D$LKW;AEWBQA$##(+LYR9K,W;V[M \:7
M9<OZ^A$[62F&Q:&E5RYQ^-,R2,J'M46>@.:1& $L.?'!P4F'$A3EEA,][[1F
MO49HAF;V+>.N4S86@V'JL+@H:VKK&U]//-(ZK$(<QT4C6 ,YF.,6())W@3?1
M>SV+VGJMIZ6MJ*JFIZ9U-4,A:VG,A:X.C#R7<XYQO<V%K"P5F>8P7M4PB81,
M(F$3")A$PBH![SZZG4+LZX>7(MT77EK([K8%E=FT]%Q)*TZ?H"06!&M-C$CJ
MZP=G-U4SR1..U0'N/U_9<EKN=.0EFD[#)G(>T*8PIOQ'#O?.Z_OA=JF%P>3W
M,]-U@UQ'IZ&'0>"S7EVNZEL6@72$*(RN<U(+-M^K+3F4LD1MJ2DQSVRK9BT;
M)B[FT-J0AO7NN@A.))PT\^?^7#YE?[A0F$3")A%1UXOOI^^<'\[NH/U$,F%/
M =I]#5FL\M?WQ/J'\M&CZF1G,2X[XWKO+?L,6@7+%[Y&TWEJ#[*H57:G_E!'
MXXK^N'.H=H>P^A8X@_'P^5C_ %VKLBI']#)W_-I5?JR%FP6R/C;9KX_@_P!/
M3KZ5R^('_FD_5%A!'_'%_.%_3O/HNM2':GM/I5A_BF^GA1WX^9_4&3YCCE:]
M[_'_ (%%]HTB]GR>^ZW"_P!+^ISK:?FCRV<3"+)9^Z1_\)O,'Y"3_P"L#)G@
M-L?RFC\A)](%JE_*1_+-EOBV(_2TRS19XY:R+>GX3_O=5+?YSL/Z^/\ F4-F
M/$\'E)_IGK?GD;][K9_X%9]?J5FF[D^F%TI_IDG?^_EF?1S83W&;+_F/#OJT
M:P_M9[I<;_.-3^N5':(_WUQC\H67_>2;/2U7Y-4>0F^C<NDI_P H@\M%^NU=
MAFW?W/0_Y&E_V ,^<,GXR3X;OUBMR6Z#L'H7F90I56'F'Z^M'B+CM7=]/*FA
M/-B;'A\30DO+.F?4[D"0I7T);40@5# 7M6N7I$)1)P1:&2'W@OF![>]=1C-3
M4TM-$^E>R-[ZEC)'O8'M9#S<KY'D'(!H9O7ZK<5Y/;/$,5PW!A48//34M3X;
M3-FJJN(34]+0 ODKJF5A(!;!31R2#.Y<T-:"YP!Z].WO))VC/.AT5N6PKW-.
MO65L.9ZELDR!5^ J*$(I%"WBO$T8;$P28@@CA9T<G8I @7QY2!^;)A-D,D)<
MTCL>%!PX\4EF8VM94TS:)AB,X<U_.-:QLAJFVW+[]WP-CW38NTR< _RU-MI5
M8I21;38?C. Q;*T\E%)BCIX:PUE/3T\-6[&X7,YH.\+$M1A+:7F[LWN<%Y!(
MP3;.O !W1T'UTDOJ(=!J(>LE%+M5;M>W)@@L4AKP_;>M2(:>2/PXFA;6UQ4O
M36B0'J_@4*5K2OH'M*W$%%$[ &Y@^(5%=-4&1['TYBBE@W&!I:YSI&2QDZG<
M>RS=[VQ86.(!<N5L%M3B>T]1BE7-44M5@\D%%481)34QA,3R^IIL2I97.)>]
MU/64SC")0V7P.6EFD!,X<[2#O>M:WO>]:UK7KO>_FUK6OX=[W_BUK._62UZU
MH>6A_0$NC$ZMSTV*!' (<6I:F<$)PTYQB90$I6D,.(,$0H*-(." S>RSBS"Q
MZ", @Z(O981,(H^]9?1>Z(_T*V9]3W?.%B7B^N^*5'T3UU./>(\9_-=?]5E7
M6HYAQ?,QN@[!Z%;QX-?OBM6_DG9WU)=<[[9KQQ3?!F^A>LQ<A7OAT'Q#$_JQ
M6A+SG^O[U2 ^G\/V\&#T]?X/7[#)S_#FX7()[K<1_,-1]>P];,<J_N?HOSO!
M]3K5@E=.=NGE\^5SD,BJCY0,?3GA*J&N>PK21@>&]>W#">&&C.*TC0L[:T!3
M /&'Y, J1[.%\6:=F<)L%VU?B;ZYE1@>[X5+,S>DFYT,\(@= -XX:YS6QTM)
M34SHA(0^+GV.D<9B\8LBQ'9IE"VD?3XN7<Q'&\M;3AAD$,[97;OAXN7U%545
M#7[K2R0Q/:P&(-.X/P)>]^UG>_OM%Z.^S&*^^]UL6R_>_()_O-%[%H(MEZ'[
M7L;$'0MA]-[UK?KK,3?R@K>R6SUM/ JRU];<^S59&Y)+^QV*WU\,AO;2_,"]
ME?[FO"RXF$55?57DV8.6+S$PRB&:6<TU6P,RKJ^_BEJDTJCY)8Z9Y%4+#ID2
M)3_EHQ]4L@ RCU4)SH\ED\14[*.^5P PIM_#OYCUWX*8'*_75 ]GU+&;IY[G
MB&:0F4HQJ4@O=F-SV@.3[*+<&YX9%FBU[>X-:DX*)Q),+$6G6A&G]\,8!:T4
M*2F$7@NCF@96QQ>7560@:VE"K<W)<J,"2F1($*<Q4L5J#1[" HA.G*,.-,'O
M00%@$(6]:UO>$45.0^S*O[+BLOD]=-LKCIL,E&V-SCLX;"&:0G,;JC+>X%/4
MB A8M]Y#;+BBE'*H8YC,+,7M2@6CTZ94G4)RRDBW?4*7.%"KOFOC1HJ<W@[W
M,X2NX6]OEEDP^Y)]3C//E".H)[:T! Q B<WD,=$B-= KVT49CQQZ!J?&UF=#
MFA$-R;E.B]A$4@VOD,^E3]"RLP'<R0 :6P+\<W@:3GL*!*%W-:RE E1;:8Y:
M*TM&WEJAC4@1B.VG H$(X)>C!;%LH7L\(F$3")A%1UXOOI^^<'\[NH/U$,F%
M/#SGU?P6:SRU_?$^H?RT:/J9&<Q+COC>N\M^PQ:!<L7OD;3>6H/LJA5=J?\
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M*E3\.2(XH)IWN_=E[,!H0M>UKU\UM5')+AL;8V/D=X7$=UC2XV$4]R0 3:Y
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MG_KFKW_B#"+K=.[)*DFW6'7[QJ05&_CF5]3E[CDF9K-;G%H TMLF5'PD]N/
MSG$J4A!!9+@?[HPXD]2M7! ::4,(Q8XK6!N(2NCCKN:9-4![12[PD,SWBH(>
M)FW:\.+6.RLP-N+A:M[62"#;LU=,S:.*APV>N@JZ*DV:K:F&O=B>^W%Y170U
M4;97543V10S-8T1-IJ<M&]&7'PZSG$&02J"&+93"6\1,BC*AQTF?6DI G/ X
MH1K3 &".(U\.6,(]Z.- 7O90="&$'I[.NB-)5%]Q3U):'>U+HG[VZ#E?(V-L
MR+FQXK"M+@NT,FT5',,,VCFI6XO3&&>NH:[GO!&5K#$ZH+FR-8X1 .D'..8P
M[P#K"ZW9^0GK+G"?<!],06L.MN<TL_DU(2!BCX]VE#7<\"Q<W%)U!:5N:Y&6
MX'.!B/:HI )+L9J=:(A1HH[16RA[";(1RR[18'%#51T,TE;!&RLF%XZ9S_:\
M\[V\=MRY(.^VSK'.UCOOC;FQX)B+Y:=]2QE%*Y].RX=,&Q[QC'M7?A6L1NFX
MOEFNO;G5"L<^=&)P4VG0D8TU%LK<K+C,NEQ*=SCC$V)VI''C$ YJ2E3(Q)4:
M0!AZ+X95H0##@F;./-$/;#%-EZ'%9:*1V,8#0>#.IHY_ <0Q*,55!30M@9A[
MX68Y##'"8XXAOPMCE:8][>+GO+L!T.,U= RJ8,/Q:J$[9W1-JJ3#W^#UD\AE
M?6LD=A,DTDV^YY+9GR1N#MW=#6L#;R_!L^UO17;T0D\MOOGV#P%BIVQ(FO+%
M*@M9;P6O$0X,1*Y^E\X<0:4M;J:M-;_G$;M.N6HB]:*,![KR7*Y!#!L?!%18
MEA1IJ:IIJ<T-$Z6:::+G3) 733XI6S$4DCIG,+P]P;4RL#VL( ])R=OD?CU4
M^JI,1,\]/),*JK;%&R.0!C)=V."AI8FFH8(FO#=UI,$;MTN!)W!UQT)0]PN"
M]IJ>YJNLMT:D@%SFW0.=QF6+F]$8;[DM6M2L;FN/3)AG?VH)YP %B,_L-"V+
MYLU<6;US!A$PB81,(JM.L:)ZB8>K(!V3R=$*ZM23DT)..<;"K&Q9VKK@DQF?
M9(VS&#SJ/R4B/2),89%I"0YER-D5IBCG-F<-;:SM+DX "(O.H?QETLDX?I_D
MSK> 5ST2&(.;Y8TP2O[.<YPXZVIQ)I)-I8[1U*OTG5Z;T;[+WM"RGJRRE0VS
MW0SR"C3!%@(OP^XH>)W\ ;G']!B/V^$3[BCXG?P!N<?T&(_;X1/N*/B=_ &Y
MQ_08C]OA% !E\#'*9/DQFEB.7$]!#XF6<DQ^+1J,";&<QJ)Z (L;3@[.Y<1"
MJ^4TZXR'^TF&^#+TE-)WI($>Q^@=$Z.W/LL?793_ /N*/B=_ &YQ_08C]OA$
M^XH>)W\ ;G']!B/V^$3[BCXG?P!N<?T&(_;X1/N*/B=_ &YQ_08C]OA$^XH^
M)W\ ;G']!B/V^$3[BAXG?P!N<?T&(_;X15\]B^!CEF5WSP<]<Y<3T$S53"KQ
MD;SU6@1-K,Q)GZL%$1VD9T+BVK505$D3EOPA&@;D 1G%&^B@0?9UK>B=^_?M
M5@WW%'Q._@#<X_H,1^WPB?<4?$[^ -SC^@Q'[?")]Q0\3OX W./Z#$?M\(GW
M%'Q._@#<X_H,1^WPB?<4?$[^ -SC^@Q'[?")]Q1\3OX W./Z#$?M\(HA=]>"
M?B.;\9]&1+DWA[GY@Z0?ZR>VVG7EN8VR,KVZ:'^XTW*4K^X*@(VHX =': L4
M#" O>_G%K>]84CKZ"/N^?HS4@*K\(GC);:OK=NGO!O.JJ<H(%#T4T5&P](L-
M4RQ+'FXB1*#5A*C92HPYX+6&#4E;V6>(6S0;V$>MX4+[W[BCXG?P!N<?T&(_
M;X1/N*'B=_ &YQ_08C]OA$^XH^)W\ ;G']!B/V^$3[BCXG?P!N<?T&(_;X1/
MN*/B=_ &YQ_08C]OA$^XH^)W^']X-SC\W_X&(_H]_P"F_P#\\(H#>,_P-<G5
MWR1%(MVQQ+04FZ!2S^[%SZ[NK6T2Y:;$GBX9L[5HG,?&Q48D/+15ZMC21.E"
M/9C<G)*0&Z"8F$'49Y]N798>NZD\.H9]O>P]"GS]Q1\3OX W./Z#$?M\E0GW
M%'Q._@#<X_H,1^WPB?<4?$[^ -SC^@Q'[?")]Q1\3OX W./Z#$?M\(GW%'Q.
M_@#<X_H,1^WPB?<4?$[^ -SC^@Q'[?"*OCGKP*\M,'</<4RM_BJ@7/EZ:):1
M_>O,9[<T.B!A.9XNXI;,TACJ=3M?'!+'P:0U3M: (7$80GD;&$.]Z)T=^_?I
M5@_W%'Q._@#<X_H,1^WPB?<4?$[^ -SC^@Q'[?"*1/.O W&7)#^^RKFCF^K:
M5D4F:RF20/$"CQ;.N=FDA3I82WK3@&#V:F+5!">$O>M:T9K0O\6L(I=X1,(F
M$3")A$PB81,(H.=.=B/=/V+!J I.EGSHSI&Q(R^SQIKEME+' (S%ZZC2U&V/
M,]L6PI$!0W1AB^5EZ-F:4Z5M>7EZ=C])D38(DI0I)(N4J!Z@K"^DI["T2^O2
MKCBK0V*;;IN-6;"K$E%3OBP 0JV"2*8>Z."08T*WWB/Y0)T%*H,!KV/8&+W>
MB6[_ ']&BDCA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB815]=Z=CO\ S0EIBKJJCS%(NC.I
M9Z95M&ES]2J8:E9'XA(!P>)18\J"8D*(:V!L,^-111M6ZELU6Z SQI&>=M2<
ME)W[]RJ)9=<-8]-V=,X+V$\3F5]4UC.)7RM4MS<5N=I\[\[]>I7^/L$Y3\T3
M:UG(4AB#&[KIV)="%30?,TIA;TT'FIGEO^,5$#*3EE?+7OU_+;Y58=PER'*R
M>EH1T.+BZ'>/:IZ,I*:TU750,SO"GZS[1=;%?(L\R656@^014Y-BF.1\R*A^
MQ5*[NSC(E[N[.;\O/!I3H W?O\R7R.N=NSN#H?0KT<*$PB81,(F$4,.P.N3>
M:"ZNB$,K=1<5X7D^2AFJNN!2YEKM@4H8!&%$VL>9S:PY$2J9X="X'$DICL[N
M!B)R7JU![<V-S<><L&>ED=MN_#K5#W[@ #=YSB0UMPT&P))+CH !F;$\ "2O
M X6[;C';-7BFB:&.56S-L-.T_5V^2!BD2@QDV]/D?9;%AKVRG !+ZEF[K%Y*
M3 + "UM*"6 878U E]VC&,0BW?YNT<5$<@D%[6/1<'*]@X6U:;>U=87&:F]D
M*XF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7RDWDIL3B,JD"%M-?
MG9AB\@?VR-HS !<I K96I6X$-*  M^T)2XG)P(R=Z"+033@;W\V%!-@3WZ5F
MNY8\F'4$B=(!TU,K:0W-RM(VRKF?HYD9J7:(C'*?OKH.3PF)5ISMS2^">VV<
M67,ZL?9\VEWJMEVW]$ULC.ZA0[-F)Y#(DJ(X:'Y[#IUMU6X:Y6*XK)GG=?O!
MS"!O   ->\V:QIO<EIR>3<=&=PW3YE*Y:81,(F$3")A$PB81,(HA=XW1<_/?
M*5OV[0-6CMVSX='#'!FC.O:4DMB/9@"WF;+6)*I2/$N005J$KE*N%QP\J22P
MEK$QLIA*U:6>419_*?H"I>X;SB]7P/JJ]N[*6L6A9)->^[&G<K6*:LB-D35D
M9G_G9\HYH6-: NE[XC4A4.KFPQ6(:-<*Z@Z#Y+F129U,* O*;]0[BU^WCVJ;
MO-?C<Z98G:EJ"Z&FU:*^,N'Y\V3[GM%6S.%CG714J9UZM]KV67XC!K;4TKZR
M4.*@EX(9$J<VQ9:7N6N!Y11YR<\F7<Z?-T=^"OCPH3")A$PB811NZRM&QJHY
MWNR:4;%$%DWC$*TDTFKBMC=B6JY+(6Y",Q"3\AHER%V=TY ]_%F-;<I2K';2
M?Y,1*25:LD>@U%].*H>YS6.+1O.#26MZ3PR&9'9KI<+-W8RJ9=PQ;F_GSJ6)
M=1!-M:]GMNY^[;L>(4[3$J8+/7UD[/4HK7]Z"E$&R'[FF3L+)(HE-E4T5MPW
MQE<B$3EL2%$0OW5I<WT%[:VOEKEF+W%N.MEQG7D#&.#\W'=D(:,PTD@QG,L(
M#@[> )!5]W(_'\BH.4V-;5LVV"ZKMLR,5S7BZ0,T!8ZLK^$U74@)'N 5Q6U=
ML:IS)C;"VK9?)'9Q&>\N!SDX.)7LZ2)4"4@-/H[_ '+D,CW27$[SG  D#=:
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M2+%2F;3)HBB5>]M\,:M) E.KLA;7,Y&-4G,VA&GTH.(*ES@P7-[7SL"ZW60
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M*?6&3M*LLQ$8C&#>U)"[0A!-:W-J/ >A>VEP F<65R2JV]R3)EB4\D!2US7
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M:7)88OW&V20RAXDR2+-ZD_8U&V.-:=Q,K$6I-/4D-")&2>H/,+$:.-56UH:
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M*Y.:IY<6F!Q1CB3<O=UHO;5.:Q&Q(4*=2N/WZ:,5'%C.V ("_;T6 (=4KE
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L@"Y-A:Y-SYSQ[W7+&%*81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>g425213g45t15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g45t15.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1:J4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %HZ^5W0X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0&H1>.         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE- _(
M  H  /_______P  .$))300-       $    6CA"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          3A"
M24T#]       $@ U     0 M    !@       3A"24T#]P      '   ____
M_________________________P/H   X0DE-! @      !     !   "0
M D      .$))301$       0     @   D    )      #A"24T$'@
M!      X0DE-!!H      T$    &              &&   %(P    8 9P T
M #4 =  Q #4    !                          $             !2,
M  &&                      $                         $     $
M      !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $
M     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<
M  &&     %)G:'1L;VYG   %(P    9S;&EC97-6;$QS     4]B:F,    !
M       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$
M;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T
M;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   !A@    !29VAT;&]N
M9P  !2,    #=7)L5$585     $       !N=6QL5$585     $       !-
M<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q497AT
M27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG
M;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L
M:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O
M;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET
M;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T
M=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-
M!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M!     0X0DE-! P     #'     !    G@   "\   '<  !79   #%0 &  !
M_]C_[0 ,061O8F5?0TT  __N  Y!9&]B90!D@     '_VP"$  P(" @)" P)
M"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,
M# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( "\ G@,!(@ "
M$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!
M  $% 0$! 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@% PPS
M 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S
M-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U
M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!  (1
M R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,'
M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6
MIK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ /2LGI>'DX;<$M-6/6 V
MME#C3M#1L8ROT2S:QK/;L0.G8K,+,LPZGVNIKQZ=HML?89WY +MUKG^]WY_[
MZC9U;)><NOI^)]LMP[&UN;ZK6 EP+GM]1P<UMM7LWU._P=G_ %M Q<OJ3^K
MWXS<9UF$Q]U)=ZA:]K\C;6+ZCZ>WW?2]))3IYF(_)%6S(MQW4V"T&H@;BW_!
M7!P=ZE#Y_25JH_HMKH#>HY==;0QK6,>.&_2WV6,LM>^UW\X_>M"E[K*F/< U
MSVAQ:#(!(F)AJ5=E
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M  ,! 0$           @)!@<* P0% @$+_\0 9A    8#  $!! ,$$@P'"PT
M @,$!08'  $("1$2$Q05"A8A%Q@Q,ADB(S,X.4%15EEQ<GB6E[&WUB=8875W
MD9FALKC7\"DV-U>!P=@D)2A"1VAVAZ>UQB8U0TA)9WF)F+;(X?'_V@ ( 0$
M #\ [^,9RMV?UIY+H;8GG&KY_O&GT5F5!2G++AR2VL<B@545!22Z_I!-HW'7
M$5@W^>R,*^9@938^^25SGB\IH?YLC^KL59/<',K<LK@G?DV[O;H.91 >O+PJ
M.X*%!Y+I;>EESO7,EB*Y/;_&M-U9.JWI6%SR'U%%:\E=1.HIAJ0R$M%"F><K
MAN#A'E3@46V)U1G3.M[[Z1C=2\QRZ/\ CNZ9Z=<+CYKJ:X9I**,>*&8HI#IG
M-XX0Y/L%6H+:MZ R$MV;#MZ<=Z2-:UL+;71O) Y&K2EJ=-++B/K")]Q\N5/U
M1!HG*X-%[:;I O;8G./DWUJ9!1N82&%N"1XW'G1Y9A'[<XVL.)$@<U9(DII
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ME86Z90:2<K@ZIL"T .YH"(?%YW(&F/4(Q-[>F2*$SDZ6GM/8;X 2IP1Z;F2
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M51=#=972G-**'REW@<S)KV]Z.Y2M'HTYSD#C%WQRCDGB:0RNSH_O;&O5_,7
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MCGU>Y.;314R7-',IG8#@2)ET10!1]=IAS7WCV@ ,?OK56(8.#3$6(3]OYNI
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M*K(RP,1S:A$U+(S$79A>#$B>,)#VUF*0N*<"13I&8:$T@H98N-OB\J1$\CV
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M%*U3D1[H"XM::,  $*-EYV;\T(2*LZ ZUY+>TZ8V'O3V7U'3S4M++.0*ZVZ
M6.Y%N1<A*;H1*A+&KU:9PYN*/V1$I&FRXT086 E42$>G^..9N=8)VOWP]PJB
MZDB;Q7]F4:B@KI':^BS.X0Y)(N8( J?TT96(&L@]D(>E+DXJ'0IN,3@7'+E9
MBD)@U!NQVU8QC&,8QC&,8QC&,8R)O=-R4_SUR9=]U7S6RBX*JKN(#>I36:.)
MLDW634"AQ0L[9'TD;DFP,"TYS=W- EV<\G)FMO*-,<'!2G1I3C@1=\;[^PO2
MRR$K)XG91XUTC>ACR].Z2.'<^1<NT#'8]T"I0H-4J^.ZX9\> C3J5Q<@+3$A
M"ZIM)-C,T>$%JF,AAY'_ -+S[N^WT_\  WZ:^W];^PM-?MR,_CZ_[Y3*MCQ:
MV,,6\5?CM;2!_AT0=+CKX<5X []/L$H*B[2,S7V;V%.3O>O30<DOQ: $19;W
MH?>QA^X#TA9L::"S1:UL$(M$;5T57Z=*7Z:V!L88G<C?#$.P>I&MQ4\@GW>D
MXDY$T,8QC&,8QC&,8SDPZ;[BZ!D'1?4=,0R8> B%-T/GLS@WP/:$SL^J+X3-
M(OB$*1^FT5GT-CC?+#EB,>G$I\B"M]AT@2#(4M+VM1*2S16K^%R0<XQ#C:N^
M0:%Z1A'4SMR/$6*)VM9]4)'=PJ<R:3AXEDM5LL+FX$.X8_)6I8-T3$,D<?W9
MSCD?!'#9$C:-O;64IMXQFL;HN*LN?:HGUUW-,6FOZMK.,N,KG$Q?!GA;6)B;
M2O:4*C2TI*E:K/,&(I*A;F]*K<G->>F;VY(J7*DZ<S_(;\?GBY>/(U8ZNS7.
MY(\/G2$WWR]7MIH6>0.8;?:8]U/U)&J/8V2),CO'G)H85:34D>Y"G7/(]-I:
M5M >F:W$:[W(/]4^O_&MPI6U*,E ,7+E+K*]9JZ3U<9I]KR*.TG?(N4P:CBH
M4BEQ[0&0NKTZM^S1N;X8O Y*%IYJP!Y)VP"!5%XL/"MP!0S9U.^5O7D]C\R%
MU1=]9,EB-%SVE%K(AL%K";N#1$8Y#IU!Y3%I*Q(4Y @GN^B7$PV3*2$NY&8Z
MD(TI!-L.J4ZYJXG^PWU*FM9G2@%\-!.MH0VR1:(H.O4IM;KHJ,BO):VE!_$^
M<3>(6V\B#OVU)ZLP/J+S??26O7!&_OCN4K3BB)( /S"Q* %]]!6OM>GKL:=E
M@S8U]$ ![.A&'#44 %O1Z"(!KJ9KW1I^_*GOZD;U1+U].6O +)+:#0IGU-$)
M0TO#K&UN_70FV4,B52-YC#L4+6RU#2_H&UR2FA&2H2E&@$#6A*:=FI5VUVHV
MI7-O4N*"&\KZ7H$ZQ,<M1>W'[0&#XM*68(]-[8#"Q!]\ 'M!& 6OL&'>YL8Q
MC&,8QD,?(7#(?+^*NI!2R*1J4"8>>KK>&/<B8FM[VS.Y%:R71#HU;<TJK;<X
MDZ_.ER/W*HO7XAH<D%3T.B,'KB)L\+BL<B#2<Q,SB:UQ=C;(^W&N"IH0:5+C
M$32E2)AK%.BBM'JA%;/.T67HP8M #Z;,QC.(OK.R>C8?=M[P3IWOKS+\S166
M6%8Z*,0VO^.8G;E5/];O\@>"F-IJ>VJH%)3%+6HC*I*D; /1#-)&P@99#JF*
M7$F[SHD\2,NB1G+\/INGN:^FJ-YZH2)1.!U+,NIHXUP2>W(7[MT5R.4D033D
MJE#4ETOV0XJG:1MC$4[KGXXMH;@)VX[V;4,9'?JMXE+#1LQ=(9S>5UI(DXF;
M2&ASGF$1\N9:->D!2@8G6Q-;B2;Y&G&:^:TY:V(W;?HI)KXL9.<"_C,<ECU]
M_NN7QG4,5-?-=@1U5$='H%88JMWY'U$L61O2EK$)L/\ D@Y8!OV:W[TA-T0$
MU)^8#+WG;?VB$-3SSF?K].,25%3EB"JJVE(/RI1E$]$K&.$OZQRV'V?;10RR
MD56SDPXX6RFYM8WL\.@Z..%OR\Q>F^Q/)/O7IO6[5YTWK>OU=?>L5E]OK^K^
M[^MD_,8QC&,8QC&,8QC&,94[YD4LW5<86T!4X\P-W,X:OLLSJ$72KC?S2D51
MTII;C:^011=SJN;9Z+YA-"RF^2MC2K"_OJ%6A98R4J<5XTIU4_T:\B$)I7UH
MC8X_2D E#?'J=+>Z[A1_D29K)0,JQ5.54=D<EA?><G?0D0UZ+TK!&'ZM2"?B
M529P2R4W00LI6=#%R]K<H\\VC5-*W9?%?5K:EWK2&^K85)W82-WE:E6ZIV%#
MLG0"#4K8F<W]6E8&I<]J&Q"ZOJ@EF;E"IS,"EW\[H?NWC_DZ75U ^CN@ZZJ"
M7VP?LF!,,O=34BUZ*TYHF3;F?\.F4E,;#\Y<D+1]8Y":U,/S-44@TY?%B]UK
M&O)0L1H_'7W<J5JDR5+]YSTH#XE0>421[:FFYBG3 ]Z:,)?M*#SBB2 ^UZG'
M&EE T(8PAW%?Q02F,3IEE#_'I-'I"9%N:_'W4:T#&\-SJ-N^J?,S=/A)U^D"
M@_X4\MUMMY2#*/\ 8-+4HU2<80F)S  SSH-\MRC>HI],:;65ZF771R<NGA[?
M9;1)'6*JW[CQ_=1R8E."+/L?7IYC-XA?T*1(%1ZI2GVQ5<O&-$;I![94P>79
M?;EATI!K$N0RN?K'8,;C,X;$59M4E:F1ICTKBS&^(6I>&4OK\N6O*%4N7$JG
M!.H2(5!&DGN4))@#A&2#QGI.3FVLK<O=WAP1-+2UHU+@YNCDK(0-S<@1DC4*
MUR]:J,*3)$:4@LP]2I4&EDD$@&8:,( B%KTH[)([+V5NDL3?F641QW3Z5-+_
M !UT0O;*Z)=B$#2EN=6T]2A6I]C ,&CDQYI>Q $'0O4.]:^UC&,8QC/$>>2F
M).4J3BDZ=.48>H4'F *)()*!LPTXXTS82RBB@!$,PP8@@  .Q"WK6M[SX45F
M$2G;*FDL(E,<F4=6#/*2/\5>VR0LJHQ*<-.J+3.K0J6(3QIE!9A!X"CQ").
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MC&,8QF#R&L:UEVC@RRO(-)PJ B"HU(8FP/6CPB_&"=IR;U.C0B_\;0_:UO\
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M.2]<T0UV);S1#W^MHT98#*H/ES-8>M;@+DV+D:A0U:2S?0BQ1$Q4N3_60)Q
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M3G$J7#XCX0@TD_>B32S3@C+-WHL8=#WH.?8V>1HC:G9Q6DVBMG[/V8#1&B-
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J&H>%FS#31[4N)B@[8S#!>W[0Q;WG.,8QC&,8QC&,8QC&,8QC&,8QG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>g425213g45t16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g45t16.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[12\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %*"^4H X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0&N808         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE-! T
M  0   !:.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/T       2 #4    ! "T    &
M       !.$))30/W       <  #_____________________________ ^@
M #A"24T$"       $     $   )    "0      X0DE-!$0      !     "
M   "0    D      .$))300>       $     #A"24T$&@     #00    8
M             8,   5P    !@!G #0 -0!T #$ -@    $
M             0             %<    8,                      0
M                       0     0       &YU;&P    "    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P   8,     4F=H=&QO;F<   5P
M!G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '<VQI
M8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE;G5M
M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M
M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M0G1O;6QO;F<   &#     %)G:'1L;VYG   %<     -U<FQ415A4     0
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M24T$$0       0$ .$))3004       $     CA"24T$#      *EP    $
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MX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MB%BUA'(W'H,A:)S89==,)T/JW\$(Q+2JL.E1U?*K 9:?]:Z1SM?'54HU'!"
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M"U =B"-*<OCZ]P3$*RA@,+.2G&%J"32S"C2@&%C"'8F,8QC&,B+9/ZZ7*?\
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M $_7#%7K_9\DMG<:2HFEFDLJ8H7'W5+'VIK;VEI91I(+'HTSJ"T)"#9OQYZ
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MD26$-UM1Z.6*L#H1%6V82ZU):P_4.A>@*RM!OB,Y-UK0@[]X2PFDB"((P&#
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M7,QT]56T_<,2J040H4.BJ06FHG3I0ZUQKD\3T3KXQ\L4UY/:3"W,O6U#G*!
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M)2(S[+P\;W;:6/1(?/GE<[S<Y.9:=9D30FRYGS,G:4]/'2UN!;"YA$Q<I)%
MYNCA>W,^&DJQFM1KZ%*!S3J$FS"A;F_N:MQ_PMODX_ULY+_LD9#3CSD[K&]%
MO6Z>RO*)Y)(P5279=N4-7(VMSYI:-R6L81'Z_<XY*7,3[RTY!=G5S6R9Y)4O
M#)IO858$1):%M3&)U(SMR7=XWNVTS+"!<_\ E<[S<WXVVJT3V 79,SYF3MR6
ME3I.D!;"^-"8^4DAQD\1Q+:TZ&DKQFM!KSH@+FF4)O:+WN?^YJW'_"V^3C_6
MSDO^R1FF:Q\;W;1\RO JW/*YWHA@J6Q4!//:F%S/F4V1.=7[@L3-<EEE@=.4
MU",B6AL0<S3)2F,I&W;C)#&880)<-4<;\KX\;W;"6OPF\Y^5SO5ULK[Z5L4-
M):$SYE3Q7[A'6!&BK54A-8>4D3A]XT=:#E:N'@]_\$;*B6<MR*4-XE)!FY/[
MFK<?\+;Y./\ 6SDO^R1FG()XW>US;2O BQ?*YWJEI],ZP0//BZ,3/F4R;N;.
M;"T9EC#LLE?RD<U)UR6>[7)XOIB3I"C([I.8O"<MV,W>I^\.5NJ^6.3[9O\
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M$YHE;<XI$K@WN"50B7H%J<I6B6HE90R%216E/ 80I2J2##"5"<XL91Q0QEF
M$ 6P[_J-&D;DB5O;TJ9"@0IB$:)"C(*2I$:1*4$A,E2IB @)3IDY( $D$$@
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M($6:Q,KYI-'W\+L,I>\LWP #%=QL,C"*$P^*0QN./4-\1C3%&$!ZK>A*3D3
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M9@JYV7[17R%+N?:TZ%@T$LV6L,]YTZHOU[BZ$Z))I56Z[D=!%5]C57-$2I[
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>g425213g45t17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g45t17.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[15@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %42^5$0X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0&OSE8         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  E,S,  $
M 0"4S,P  0 !.$))300F       .             #^    X0DE- _(
M  H  /_______P  .$))300-       $    6CA"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          3A"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))301$       0     @   D    )      #A"24T$'@
M    !      X0DE-!!H      T$    &              %K   %@@    8
M9P T #4 =  Q #<    !                          $
M!8(   %K                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   %K     %)G:'1L;VYG   %@@    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !:P    !29VAT
M;&]N9P  !8(    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     <X0DE-! P     "IL    !    GP   "D   '@  !,X   "G\
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M  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ G )= P$1  (1 0,1 ?_$ !X
M 0 " @,! 0$            ("08'! 4* P$"_\0 6!   00" @$" @,'# L.
M!P$ !0,$!@<! @ ("1$2$Q05%B$7&3$X>)C7(B,U-T%15UEWMK>X"A@R.59Q
M=I:7M=0D)S-"5%AA@9.9TM76V"4H0U-R@I&A_\0 &P$!  ,! 0$!
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M1PLY--U5K8%5A,H=/M03]HP'.HT?R];EM\AS6C .\RRU.WFU;L>NQ8=34YG
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M)CET'BH&R. :5[)_BZ7[_(K:?\QCO ,(Z0?B7=1/R8J%_HKBO )0\ < < <
M< < < < < < < < < < < < < < < < < K2H#^^?^1?^13H9_J_L;P"RW@#
M@#@#@#@&EZ[O^M+4F-@0*&KS=>35<3P&G#>15);4&%ARV[=@^1'(22<PB.1H
MT\=BRHHVQ0 %RBC^/DQT@987"OFK]4#=' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' //3VDOSLE!^R_8H?$+?F!>//"P2,Z0ROW4Q0D75BF!T7H9Q9U[&H
M ?J[,9D S<&8L\S$+!#R \T0F9$0S$_616/R@'&P.CK3L5V4?W!%1&EQ6K(
MK.XZIC/506^:MW0SL]0A_NWV KN\I],GFL:3VL', ZOQJ#2AC,-7 S(0$/B=
MG9<N,SY5_( \^?/X$@K\GG:>0]\O&X MWKO7%:50)[D7?]0['C'8-Q9,EF.6
MG2?MTS X,UVI4,+3B&#,>W7-O<ZS&0_0[Y'0+K@CJMDDF!=AP!P!P!P!P",U
M2S"Y9!=78&*S>15D1@=;R "'AH^*UQ*HU+O@RF+@IJ/5D\G+VS+PQA42,,;
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MS4K@'$$IG)Q$<4DQG*K1# H'J5=MLDR&RS]DEJT:857V4=M],:9V5TQD#9W
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M$*>F@M$Z$9+:,R&,FAS/#[937&[\<E]&.ME&6VR60)C]G?V*I;\IBB_YY-^
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M>-K>E82PYM,)]'93::,PD$=FTG-RH&1'G""[[8#3_=#\:/Q2_EDVI_4)[@\
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MRKD$V*8=(K.E\N@$5SA,$T EKP!P"M*@/[Y_Y%_Y%.AG^K^QO ++> . . .
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M3T8&2H-0$=;2F*.XTH8?GYX.6<% 1),L/LF0F)PW<):AB3]1HJBB;1U>(O\
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MKTD[>&IE7DY)K:N$@,TK>_(]-9 O7DH#%ZKN(>T6?/JLG&S) P1&-5,(N)-
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MSZ?ASGGU&,8148K48I))>I+N1TKKA5"-=<5&$(J,8KNC%+22^Q'/Y]'V. .
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MT@_$NZB?DQ4+_17%> 2AX X X X X X X X X X X X X X X X X X X X
MX!6E0']\_P#(O_(IT,_U?V-X!9;P!P!P!P!P!P#6MA4S45M+1MQ:=75[9"\-
M)?3,26G4.C\L5C!?XK1;Z4C^YT>^V#D/C,&2OS@_+=Q\1FVW^)[D$LZ@;*X
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M_%[^3'\V4-^D[@:?A[U\S%YOY7(_6T,EEASKHGY(HQ"8+&S<OE\D*]; K86
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MA]85A/.J)!A]>X9F+ZF[&ED,M'=9](=C>-FQ=FPJIZNT9:(J,G0),V:V>:-
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M;#L!N7A!HS!XV^!:O9J(U^X3*7C G\]'M!0B/OI4]17C1<$2?@62UQ840MJ
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MDW\T"2QQ,]'V@%J'C"T+1=:K%4A.^_Q^>_R1<[P01YOJC"]JCE3D"M.>4_<
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MP%R<2U+LV)X0HHKN-,,T7>K8DR^,OJW>)+))KKIZZJ[@;%X X X X X X X
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MU H)J2@K1)_O$6(8BT#66\;(*S5W%1HQF0%M0\_(NVX X X X X X X X X
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M,B!N&M&(!F@U"(Z;N?C@;KIKJA1'7\^?DE3P]_&G\@8*!\M'$UG<CC\< +2
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@P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>g425213g47c44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g47c44.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1EN4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &5*^9((X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R,S<W
M,#$S' (% $!-:6-R;W-O9G0@4&]W97)0;VEN=" M($IU;'D@,BT@($=R87!H
M:6-S(&9O<B!"=7-I;F5S<R!396-T:6]N+G!P #A"24T$)0      $!VQ:EJM
MQ/YH?1@[OU24MD$X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q <.            IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !      X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M T$    &              2H   %Z@    8 4P!4 %\ ,  T #<    !
M                      $             !>H   2H
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   2H     %)G:'1L;VYG
M   %Z@    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   $J     !29VAT;&]N9P  !>H    #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!$       $! #A"24T$%       !     0X0DE-! P
M#L0    !    H    'X   '@  #L0   #J@ &  !_]C_[0 ,061O8F5?0TT
M O_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,#/_  !$( 'X H ,!(@ "$0$#$0'_W0 $  K_Q $_
M   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MM\?_V@ , P$  A$#$0 _ /54DDDE*22224I))))2E3R.HLKJ=90!<*PU[R'
M#T]Q9;8U_N:[TMK_ &*'4\[[+6YYD4U OON8075AH]1N^H_28_;^\N+=;5U&
MUEG5;!BXKW.NQL$N(8&O+G>L^7.:^W<W]_\ G?YA2X\=ZG[ KQ.@=W)^M^"V
MUHIO=D"JQQ>W'J<\/80\,;ZC@VO=6[9O_P"M_I?YQ0K^N&$'M-M]E#6TD1D5
M.:'63[;'/K;;[?3;^C_\&]^Q9^-;A 5U_;,:OTWN8VTO%;;& -YI8YWI>O\
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MK#:257]I
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &H AH# 1$
M A$! Q$!_\0 '@ !  (" @,!              <(!08!"0(#! K_Q !K$
M!@(! 04#! D+#@D'"P4! @,$!08 !Q$($A,4(3$505$)%A@B%S535F%QD]+3
M(R4R0E1S@9&4H? 9)#1#15)8996QLL'"U#,V1$95<I+1\2978H66E^$G*#='
M2&-U>82&AZ6TM]76_\0 ' $!  (# 0$!              0% 0(#!@<(_\0
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M5:U:W(BW[QTK$(3A?''+%N0%BZ=IF68.E!*=DNJ0IS98:YIUOITEJ+<SHUQ
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M3STXHI#;JB6[NZ(D@+C#[=L# MM[R[74QJ2R ]@-:Z=8"F:2</T8&?G=A4Z
ML4_*]R^74>3[5,73?Q+1%4>X5^:KM&'A)]HHQ2D8=%%X$HV!L^AGS7S-A?75
MYK-A=R3+!=&YBMGDZ9,45O)(87^;R6?I)(Y90Q=W&%*95U^<7VK7%S?R//)"
MT$A6*)=H2.-P!((269A&;J/>\$O4>*4])D>39*KZQT_=0M8&"GD)B%<(KPX"
MK7W+1MXI"2-+B_;2L9-$.[14;H24,H=A+I(F'PLC#UV<8"JJB(C[;6O1#41J
MT&H0RVX,R1-=Q]0HZ7%LJ1L86Z3"6WGBV=(OM=3A9$RA!K;B7U@81B5R/I$#
M$>=\+@=TN+><$E2&5Q)*H;IRJ!<1GKVCVBCM:#LR(FPBK:S8.J]*L$S,Y99F
M=%U\UIPJZIR]LD<VF9.+.8$%BRL6\*DH8BL4U*:G2&XTZ[%WI<\#26JO%)'<
M@3('AEZL2N$*C?#*,##(555&[!-5TUS=3-)-"R>P94F0L=BM(FRZB4 =I3''
M* 6]B0%ESOJ"=20^IICJ07T+4KK)-J[7Y&QM(J5=("4TT:N(+/7$4@X7!-)Y
M(M7*3Y11\Y:-6SPD8]>M2B=5JDKZG4A?QZ(NL75G$T\Z6S2HA(,0DD4QR$ E
MDCSL*QAW9&=%;@,1SGOI%L5D,?SVU0PSE5+JL3$G)+;EP&QG)(!SWJTT8KK2
M2K>TV=OB(V]ZTU3#VF0G&X,8R>?%9MW,D^7D(1HND!$Y(ZB3\45FKU!-%K(O
MB*.RH*F44\W):7:75C+:22:?J.HR11PRK)) H>1XG"2E204#E"=\;,SKD*3P
M(]Q(Z) Z2NMS<F,'E@%)0(ROG)*B/@*1R!V/ %8.EBNUG=T1L>T,)4]*8ZW3
MCBA#R+5LNS<QKURXDX[OY(B[5L@1!.OE;$2(F=5-RH41_43IBKZ+TC5],DLK
M:2%;I[]U?JQDAQ);RQR%0A#NVZ63>22!C)^EP)5UJ#1FWBZ9<RLX.&("YC,)
M*@#G*,<<^R.WA7T]1NN+)-:[IUBI4Y#H5^KR$Y *-%5G[<T_+W-]*3*TH9T@
MFN@[/#E:MEE6*C<A"E[IRW4,8B95*W08K*WO]0BN8I1-?[;AY5Z;O'%'<B6:
M#8P!C6Z#B'J*=X4%<@@,),%RZW!C*EI617&[Z,:00):PGCD!<NX R"QQP <;
M3"JUYWJFIZ[!1W(1S>O1B,ZZ=,!!26NBKMZYEI"0(LJ<3-ZW&2TNXCW F7/)
MR[:N',DV\"0$O-ZOI%[<ZA/).(E@GNII2J2%@L4LCS +D (D48<J&V^V$ 4C
MO(CE*7+SDXE4JD89N$MXHH8X@OG)=300K+C'30S<[GJNVXNF6M;#<*-V,O0-
M8,$:S%/W4=(H-4YHS$AI.;+*H0ZJIW;^?EF"CYTW:%%NJ@QEX9IXT\A**-V]
M=9RWEO?I?Z;'>26%N_JZ*KW0B;JA4,89044R,8W2-U"DM#N!>0*MYI>MSZ7)
M'(C75Y*TTL:J)W"8*B.15?=L6)"BH6P4,L=U*QV)D=>S6+M&C-ZU#=+4[I0M
M"F('83=O%F=1'C5ZN[:.#5"-D&Y%RMDWS5@X:K""9@:P(.7!V"R"9VIOI<=R
MVIZ3/I]_!!:-J"W%DC&=+B.03YCZ_M=$RRH\NZ)1E9) &A?:RR'ZKINM6NK6
M!L)U$<TRO;'J.LV!-&2DSA]DF06SRN0X4.RL2!WUZGZT]C?*2Q=4BJ9IJ'J.
MSM+[:UGL1"]--@,TJG6&CJ2?).XYVSG&<=-S;F8JK>R1DG!0Q9870@BJJ@DA
MP)/!7'HYIGH,;F:]UEKNQUC1[^QDT\:?,;B=S$CQ;)HF>WC,-RT$B2RF+9D@
M')&? :WI%W93 );SI;I=,L%Q.T"O(+=E6:7HQ22.L+!\1LPPP/.#P.UI)UTV
M=.%\G&T!08NC6&]H1]CO-AJ5/*WC$&;B35BXZ1M,@P(1.,CUI=9<@=PAX))X
MY5>/"(J.3.%/G^WTB](K"!Y[Z2^@L6DMK*WNKO=,[I&))([9)"3+(L*@^VV\
MHH5"0NT5@$43-M4*6P7*J<>0)QQ]W\ZE34NQG.P&MO1D6\<C*TZYR]7=KPK@
M[N%D&R((2$1(QSHYU!5*YB'S/Q1!.(IO2.  I"&(F6LU73UL&M#&TC17EG#=
M()E"31LVY)HY$ &"LL;[3CE"O).2=T;<#G&0Q'!R/<?M'XYJ6LJJWIBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE1SMJ
M(V+/Z]L<)JBRQ%.O<JW;,8:TS;!649P";E\V2E)5%@F!BNI1G$&?+0R3@IF9
MI4K/QA1:][D_2Y=/@O[>;5+::\L8F:2:U@D$3W!5&,<1D)!2)Y=@F*D/TM^S
MVL Z2!V1A&P1R,!B,[??CQ('8=LUU8ZLW@QZ>M_;VH+J];OW6XB5J-KRH:I?
MS#[8^T+]LA*%+8KQL..B9%=JUI53*E*LHT79W$56E$T5G")U?"ID)]-U/16U
M_0=#OUL=%T991>ZA=ZK'#'IVF6&G]8V]EI[RQJSWETW2>0H%EN 2%;&\FH*2
M]&65-\DN"J+$27E>3 9Y,$^PG(7/LIQGCN:A?*D_*37U/7VMJ#J2J-8.L;=K
MUL^R+\]HAM*6:*FZO<'E2D]?"S923B/BI.'E(9P\D'9%'BK]!W%*QBZ+?OS.
M9_H5Z%V]KJ%[=ZA==6YTV:W-B]I(R6TL%U:)<I>!I$1Y8YH9E5%P@0K('!8+
MM]_Z*:-9:M!-=W1E'2F5(X@W2*.AWL[D9).]=H .T;'+9RI'3=J+0<59DIY^
MZKD^P!E&QKA9*1<"X%F5T8%%G#-ZP;MP:MT7GAFA@?*%<"<QF)EU%CN2H>HO
M=9.JSK;V.H1L+43RLEO'%_:"9'ACQU2>H8U#N88]N20P=28U?KZ1^DKI)!;V
MMS$4+S>VFUPY4=-"6;<">974*#L4%I$==VWN%B8.IN=<UVV5UC PKJ#8Q$:\
M6C'35JC- W1;M?&1,T@@)/G?$*K^+E*[-E:2BS!9R#AO/01HU=AXJVL;J/4U
MMY(V-S*6+S8=6FC7>WK$#LF[?E6=@ZE26D@F4#Z/RR2YDBFGBDEDG61WD!D4
MNT;,Q=H[F,,<V\I/S=Q$SQB0]2-H9A*DEHM92L8W:LY-Y7WS1VZD$WL@2.=K
M-63N409EC@L<"S5 JD4ZE6Y?"3D,5=: D.TZ1,15(R94>T^CJDSNLJC>>H0%
M92&SD%N<QL,>T!ORO#;N#7G[HR3!D65"J1F--X#,L3L7Z,C=I5A8YMY2.JGL
MD;=H!K%UUP-XM6O:8?2VJ$%9J O,S'6@M$@/:-CA&,FS37C&"D Q:.'*L=*R
MOM-5\],Q%*->QK1%,S4DBKWOMO1"2RMKRZ&J:@R136J2V_KDVR":19"97$[L
MJAT0IL3>-Z2'N$4CC;R-;.X-RQ6:)&#2,N&*Y#$$D@$+M_YB""0Q!J;;72^I
M^]4[IUN"47$0%DK]+AI&X0#4J,2,+/I'8/#!(1SXZ2BJ0L6S0'-=03,6,?)2
M4>0IRG2.:LMKGT?M+G6K8R2302W4L=K,^9>K#AT!CD7=@[V8K.W,B&-R00<<
M;>XMHI+F,NPZKXR6)5@P()!7@X+'VCW&"#S4]:GTMI]U;I_=3#7D/&7^><3+
M24GF;R4<,WBLR5)2;>L(UU(.8^,?/SJ*H/G+)JW7.FNZ1*L!'3LBE1J&J:F+
M6'2WO)'LX1$T<++$K((MPB5G1%DD1,!D5V9054X)5"(MX\D.VW$K-&$1@&"[
M@0?9#$#D *"!D\]^U:#3=1TG3>RG54J,NO+#>&R#2=AK*+1^S)$+&77<03DH
M,2-5DGK'MG(1P0[QPD=)(YA(J K3+O4;S4[%;BYC6,6C,T4L&Y&,HPJS*=Y8
M,C<9&%4@G@CV91F-S:F:9-ICR49"005 PPY\">3VY//-;7N_3#".U2O6=1QE
M<UU$GL24Y.-*Y#QT0B^<."> (H9LU;((J@919,K@"J)*@@DD5+MI)"B,?2]4
M=]0%QJ4DUY)T#%"T\LDK(H._ 9F)&!G;D$9/."P-1K&<M<@S%I&V%4+'.,8+
M9SD\@=\'G-4B2Z)M@/-M5S9CW8,?+Z2A2Q=EGVKN0FHV5(UB&J1;55(^OI$<
M-2>T56#DIGR+]DV<-G@JB8'9!*;U1]*;)=-GL([)X]5E,D$+*D4D>Z1CZM<2
M3'#>P'7V#&[*R8Y4YJP>_*%XPK)=$A$"X(R>$(;RP<D'X$ '%37:MGZ3CDPE
MH6'C:K#45)JS>()D;%48>->+&!P_(T77 RRSAP*)!,+B1,N<YTSBH '2IX]-
MU293;S2RW#WP<*P9MS@1A6$;,JE J G*[5 QX=^D$4Y6033[Y');>Q.. -N,
MXP..<8!'AC%4]V?4]9;8Z@HJT56]/%M?6%[!O;38FJ+UVYD'C 5CO$*VLY<%
M<1\21-%I%)$7(4[=\1VJ >!*)%;*UCOM*]'I[:2U":A;I>M!'["+%ZP<]:6-
M1B:[CC9O5R7*J@AW NB[;.TENHK0%U0L  D>0=RQM\W&[CV5C+@R3!5W."P!
MW,Y.V[2H-7VE"L(B%5C=>1,($LY$K9@W>&A323<B*7M]9==!:2D 0;-%"-PD
M%6\+'M8PZQ):PV15$WSR6UU"YE26XDZ*6(BZ2W#'IJ $95(C;$3!  8U(*(P
MWDF0 6MG/):2&;VKVY=EZ<K$XF*R#<8EX(AWY]K"=>4-GI0VXQTX;.HLW3+1
M$1E*L[I@2KA,/V;_ /KRK2;<:_(O70VMZ+0YA;RITP(83E6\>U531:( LF1!
MTX^B^C>NQ:M'=PW-EAHV$&3BY68,H0QM&X$B*"2P0ITRJD-R.?LOH]K8O[=Q
M>0%7=D &\7*-U@H$2[P&9"<A2R .NYAE!O/Z??D^>K&M];UM*=ZNS/9-3Z<0
MHE^CY]L<LQM!C+.(Q#YUK1)A>QAHGVHP>+R20OEEVDA+H(J,T4'J)C?-/2[1
M6]%K$QVYE$>HZJ+ZRDC*A-->))"84E4A^JR.@CPB@QQL=Y9#7B]9T2\TV?K3
MQPI;W$DPBZ+M(BY;<(6#HC*8T  /(8#@G!QV9UNVZ+H5I^P;4IZBP-W39+V,
MNM(N1CF]C6;N$_%*OAB 6*[677;$*N'>\KBS(FMP5FF4Y?#7%MK=_:G6[J&]
MN+,NMN=2FCD-L&4A!'UMNQ55CMX]D2$K](D51AXU;IAD#XW; 1NP?';W_0]U
M9G3>VZQO#7T/L:I)2;6*EG$LQ4CIMJDRFHF4@I9["2\5+-$'+M)L^8R,>Y24
M33<K$$@)J%.)5"YSU?2KG1=0FTZ[,32Q+$XD@8O#-%/$LT4L3LJ,T;QNI#%1
MSD8R#68Y%E0.N<'/<8(*L5((YP0014HY6UO3%*8I3%*8I3%*8I3%*8I3%*8I
M3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I
M3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*\3G A#G-SV2%,<W "(\% 1'@"@)
MA'@/(  1'T !'RQC/'GQY=_?X4JJ<'O6\2MYI*3VI1$)KW8+^VM:X:3=2+:Z
MA#5.,7?N;C*LU$21L7#N5$T$D63@2O2(NT'!E!(8!-Z>?0[**QOBEY--J&GQ
MVC3])8VLNM=RB-;.)P3)+.@+%G7V"R$  CCF')(]G )('/. "=WP)&/#[\ Z
MGN#K*Z2=*5:W;8LMU@6#YJ=C5'$U 5E64M\W(.R/PAH^',FP1<V9JW,R?N$U
M4GJT(T(T7.X>MDQ[1M['T8])K^2UT]+2?I/ON$AGN%CM8U&PRO*I<K [AT4J
MT:S,7 5&/:?IUC/J5ST+2-99 IDD)(5%C0@%I'\%R0H(S[1 ')K\<E"IU_W'
ML6R.X*V25UEK&G+3 N:^!5K3:6YI@SM>5LL:\%14)1R5<YG+9=15P19RN05U
M"D!*0^W^DVLRZ=864-K8Q]: I:F,D*MND=L1&D87:TJAMN""J%(QQEAM]GK-
MU9^CEF\4"-&EU>&>6.XG8VMK-<([M'; C8D+2*K$'IIG)9RS 5V@3*=,UWJR
M6F[%",:HJI3UX.P#'IN4UI>1/%EA7OL*2C';I)*8=+KF;G@GS^/CG!E"1LQ7
MDF0KR*7BM!TUM2O;"72TVZFEQ!).KEDA9D82RL\B*QMRBH[JNT.(UV=&7@/\
MFN)RAE26X,R;C-N*JYPS Q"6&4*TD9)7;*F]DP'2Y 41CJG#;MV8+O1@)=:(
M9.3$*5 $VSQ3PS=18S1-5=^D[55,@#A4I3B<3E!0Y.\,41Y_1$>D6011+$LT
M@PSR$=,R2[$1I"L730,PC0':JK[(PH  %+)>2NV0=NT%5!.\A22VW>V6*@DD
M9)8D\DG)JR=(W?UB[2JCV-J^R;#,L==C5(YK Q\'#+R*$?-+/(UFL@NR@1=&
M8Q@L$P=^*=& 15;&("BI0,6EO=,]%]-N(WN;&"%K[UIVGDGE6,R0*DC*0\^T
M/()#M"+X-G"]N,-L9&FDC0;R5WC!RQDSD[<XR,<G'()SW-2,DZZRF4I-#%[H
M!:53W<_THZ,HFV3=/W;>PG@'=[<F6KRQQIH68B,8YD%3*R!)1=% &2J_U<KS
M)Z+O'"9=*98CHL>LK@EEC1K<7"V2A9P/7/5B95C&U#&I;>%KOZE(25!C.V<V
MX!4 >R2F\9'$8(VY R.P![5DW?4'U;2T.]5B.K DW5WVM[Q;HERM4TXN2L+6
MB$DT+77TFQJ4LK&2B#:.-((.Y639-GD;(1JZ+L959W%L=5TGT<BE19?1MH+A
M-0LK251=&2. WW3-M.S"\VR1%I.FR11NR21R*R&(+*\;Y.M\B1.D?8DE4A'&
M3$2679MVK@#<-V%P1CR%=:?US]5%$ R5=VN_0:*. =K,7<!5)%DNL)$R&,=%
M] KB7MIID(<4C)&$ Y[0&^ME]<^B7H]=\SZ<C,!M#K/<QN!WQE)AG!/&<^\>
M XRP138,B \%0>01W(PP/;/OX\L#-=PW1%UEU+J5LJT7M.NU^O;NK4(M*L+
MR47:P5KA(Q,0D'R#!TX4;Q<U"-C^(=('4<$,Q%>1CU6K=JX;M/F7I=Z.3>CM
MJUS:74CZ+)(1.LQ4/9NV6'5F]G?;OM(#MLVL DFXL&:MNXFMH7*R;;89,@8A
M0@4;BS.1PG&7+'"C&[@9J\]IK37;CVOS56OL<[KL0[,A*-H=^249+K(KIN%
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MPSR-)('=$+;D<[F(VNP( 8$U:6ERSRR1&50J]-7W 8W!6 $K\OTD*IOA3"S
M]-CLW!H,V/3KSU#4M%Y5]9U^'KZ+21D&"CAFG$QB;=K& U<!/V!^DU?+1T&D
MNL51V8B+AFX=/!6>*3[Y=52BN[6TTV0="]9+NTGB>=K:=!U DZEH75!+"\H3
M?)L60P0-'LDFN'D!7TEA=PZ7<)<27=TT[-$6"LXF<22=162%<\.,!%9#+(-K
M1QQ0HM4[Z3NI6]]"FX&ZFNZM7IJ1O$=786SHS</(SLK;&AYP15JE,>1KI!Q
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MZ;!P>001WSD'DFI>A$KIL3!F4O-?/P2#B34+IQGD>!&><9[#';<[<4#U:RI
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MM/XZ?C^5/LXZC#_G]7_Y2?\ 18]1N_X$GW#\Z>O6G\=../'\J?9RU']_U?\
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M]I*=/ANX+[4+NTO+T+&(5MI;:)E(BE1P7,MR6N%9<;3DG#8%86\ME8,UQ'[
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M>2:.U?TGTM+B56:*W>QLUFE7+%FCB,0=URK%BJD95B3P<8%O>E2XFRBG#,(
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M?CCBA7'GCSP1^C]N/?3Z3M+#^X-F_%W<9\>> YDA]>/Y_/W\XVMY8^/]>?\
MOX=ZSM/AGMGL?NXS^5<_2?I@_P!P;-Y<>J<5SZA_C+D?0!Y]0_SY*,/(GGL"
M?UX>/^P*3GN,>[^7(_7V9X'J>I@"/ZPV?U$/^#B_/CWC^N?GY^GPXX_%@*Q\
M1QWX/?R^/]2*;3Y$]_#']3_2GTGZ7Z# V<0XX\DXL/(/3^Z?IYC^'X@'IF2C
M>'\B?L\.?PK!4CP/W'R_E^/F!VI])ZE^H0-F$?WN+_&'K)@/J'(AQY_'D>,!
M6^'Q!]WCXY\/+N>* 9'8]^>/#\_]OM?2>I0^8P-FY]_ZE%^[T\O:7'GP'O\
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MW"CIN5[*H]ZNJ1$BA5W2!2]E,#?7R )DU". S+TQ:$-+T@S[8@R LRA6*Q\
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MT7TJ6*\N)(>J9I(VE>19V&S;MM2GM+*"P.Z$)*LA5R5(W+]?1=%T+2Y5U5C
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MN?\ ^_Q\I7>,;UQY;%Q_*GR;9_PO\[_ZJ?1ATO\ >HI_EF:_W_,?*-U]=?\
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MRJPN9FL[)I+NZ:",1+-<"(-N,4)"EU1=P"E^5&36%H![:^R3V9R 3C'?())
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M!,=HX!LY1('J($6=G]1 OEQD"72'&3#(KX_<<;6^\9'GX#W$U81:LC<2QE?
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M <\K\#WX\^,8Q\<FL*VMG4?J 2E<*R<S"-Q^MXPHV>&[HO/ >*+WCZ-2XY$
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M3&""5)/;O@8';GL/ACOSX\5N2"Z+E(BZ"A%4E  Q#D,!BB'P\O00]#%'@Q1
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M]NPR0:W1<G/@/UC^OC_.M1*4" /F)C&$3'.<1,<YS#R8YS#YF,8>1$1_$
M  6GEX <  8  X  \ /#%=?P^%>6*4Q2F*5XG*!BB!O3U_$(>@_P>N* XKUL
M7ZT.Z,<HF.U4$/$H!R(&*/\ ;TB^Y8@>9@#COBE[!OK 00Y30K.FT\. >FW;
MGOM;S4D#SVGD>(K9D#J2,!O?[CSV'&>YXQ\.34EI*)K)D52,!TU2%.0Y1Y*8
MA@ 2F ?@(" Y3,I4E6&""01X@C]?;46O/-:4Q2F*5'VU+1)T_7]EFX=91O))
MLTVC1PD(@=NK(N46 .2B'D!VY7)EDQ'R!4A!SO;1K+,B. 5)R0>QV\X^W'WU
MSED:**1E)!"G!'@3P#\1GO\ ?Q55-/:@@[]"/[/:'TDN9:2=,V[=HZ*@<#H)
MHJN'CM<Z2ZBJRRC@.Z3X(!03[PXJ]\ )7C''LJ!@<8QD<^ '8!>_'CGBJ9B.
MY!);!))/^W/<9^!\37A.TR^Z(G N-$DWCJ#3.'?."%$YT6YCE,+&PL2_J+EF
M?@"@]*F"(CV3B5FL"0&Y211W"F.1<@_85/@RD8*D>7QR<$FNL4[PN'B8J1@M
MSPW(]E@3@@^)Y('8CBKIZ<WW6]I-4F"XI0EO12Y=0JJOZF\[!1%1U$*G[(N$
M1 !.HV'ERV#D#=\D3Q!O/W5C);$L 7BX&_!]G.,!^."<\'L?<>*]':WL=P-I
M]B7G*$]\$Y*G/(X[=Q\,&I\R#4VF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5
M&4S]LWG/W7_9+Q_-DY/V:?W?ZFJR;]J_Q_H*QF;5RIBE,4IBE,4IBE,4IBE,
M4IBE,4IBE:'?]G4#5D,>?V#:X:JQ12G$KB4=D247%( %0K5J7MNG9DP$HJ W
M15[L# *G8 0$9^GZ7?ZI,+?3[2:ZE)'LQ(2%![%W.$0'PW,-W.W.#63@+N)P
M!Y\#'GD_KOY&JK*?*0=':9SICM^(,)#"7M BOV1X$0Y 1* \#QR'ESQY\9ZD
M?^'/I<0#\E2<C.-P!^'C@URZ]N.\\7!Y&[^M:8I\H9TF.7;IVOMR% ZZ@@F7
MA0P)MTQ$J"?EY!]7ZY@^Z'./H/.6:>@7I1&B1II,N%7DY RQY8^)// SX 5T
M%U; !>O%YD[O$]_#/A7']4(Z1_\ SN0W_84_[\V_X%]*O_TJ7_$/RIZW;?QX
M_P#$*Y_J@_2/_P"=V%]/[Q3^+'_ OI5_^E2_XA^59]:MOX\7^+\.W^WOJ9=8
M=16EMQG.AKO8,!87I.>8]!V5)^;@HF,"+9<"&<"4@"<Y6PK&3)R=0I"@(A4Z
MCH6KZ2 U_87%NA_]1DR@YQ[3#(49[%L G@9/%=4=) 2CJP'U2#_(]O#[>,U-
M>5%;4Q2OE<DY*!P]2^0A\0$0X_G^..WN_/\ 0K=2.Q'!S]G!S^'PK8ZH\$4W
M$<<1$&X]^VY]R"HCVTP#^]26YX /V)52%  *  $"^CY68?O^R_\ ?4#!/C[2
M#)/FI\<FN4RX.>V>.!P>_P!F>PQ_WK;\KJXTQ2F*5@;17V5JK\M7I#M UE6:
MK4ZA  5$%#<&0<I@/ "HV7*FNF _5$Z8 ;DHB&;QN8W5QW4Y^(\1]HXK5U#J
MRGLPQ\/(CW@\CWU1AA)7_IZL*D;)-?'UR07,J=+Z_LR63)PGXV,>"019R*2/
M8!9$P=L !-)VBJF#=4EW'(LZAE/.>?-3CE6';!. #C![CFJF2%H6VL 5\&XP
M0<E2#P<X[C.><8XJXM2N%=O<1[2A7";INHGW3Z/<%3!TR4.02G:2#43' O;*
M)P ?KMW"8"=%15,>T.Q'<'\/YCX?@:X$$8(^(./N_7].37G96CW<:Y&Y:S[]
MD\9J>/5A&*BB+A!9(P*"[KYTS=Z0Y1#M^SBF#L\<,1$.PUQP05;D$8Y&01M(
MPP.1CGR Y/:MU<@@J=K EL@X.?,'N#P/NYX&*EO1O4PA8#M:?L59..L)!!JQ
MG%^RV:RBI3 D5M(@8"$928F^IWA@(W<J )3=RN( M2WFGE-TMN"R Y=/%..2
MH[E<^'<#S .+ZSU$2$13D+)@;7/ ?R!'@_GV!/8<U<O*FK:F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*56/;6_YK6=VUW6E-
M<2X5RX[1IFO7=^E9JGMX(P7))5JS/ Q+6TKW-Z]2G5H^,6,^J[*/1'QBIG"B
M8,U7-YIND0ZA:WMP+Z/KVMA=7JV<4=RTN+4AG$TC6ZVJJ8@\@"3O(<H  =X6
M;!:I-%*_6&](991"JR;@8CGVV*=, J"P <D@CMR*LYE'^O.H5,4IBE,4IBE,
M4IBE,4IBE,4IBE,4J,9C[9O?WX?]$N3D_9I_=_J:K)_VK_$?R%8W-JY4Q2F*
M4Q2F*4Q2F*4Q2F*4Q2F*5Z'3E%FU<NW!@(W:-UG*YQ\P(B@F954PA[P*F0P\
M>_C-D5G947EF954=LLQ 'XD5D=Q\17XR.M3J.M_4%NFW24M)NPK4-,/(:N09
M5U/ ,6,:NJW(!4>T5,ZA3E4[*@D 3B91P( X=.5%?V'Z'^CUIH&C6D,42"XE
MB2:YG*J))))%#$LP''&,@<# 7Z**%I+R=I977)V1LP"]P6&<L<<'D$\^ QCO
M52F H^/8^([ -P>-N^[T %+N>^3%3O $>!3[':$_/EV>>1'/4R;NF^W.=C8Q
MW)P<8]^>WOJ(HY&[D$CDDXP#D_>//'CXU?=)UTN-;9+65JE M82F[9W)930U
MB)#VAE;XQ)K6X[6<'#P<#'P3M_05K)(^TCPHKN2_-N-L!TG1034,?Q!3TE>U
MBMV,QFN]*TFWZUN9K9[24O</J,TT\\DZ1WRVR=,3!5_M,D *\J!8?V7>S  (
MDTS[6VOU. (@JJ(\Q[\DJ,Y4,,CDC#V!KI&!J\_&U65UK/T9*!VF[=.Y-"#5
MV>^N4C*2$EHX(5=9,UV;LFL ZHK2R,8%XG78YXSV%'VP"O.[*X[6[:Q-=027
M46H07AFTQ52-IQIJ6D<4::UUE!]39WG6]>V>9#<2(^GR6OL9VZMZNJ.JM$4V
MS$Y"]4N68P!3],#:4#@$ 'J!N0,UHW(^KDI=DI"JM:ZQC'E&U8X=,ZLU;L81
MK8E-84\UN;MVC7]20<I6KVR223$3*%E"O._.=?O3CZ'24N([,QW+SO*E[JBJ
M]RS/,]N-3O!:,SMRRM:=$QG@&,I@!<"HT^UG!  !CA.$4A=YC3J#'@=^[/?G
MSK5J9=++K^QQMJJ<JZB)B)=(.F[EHNJCVS(J@J"2HIG*91(YBASR8HD, '3,
M14B:A9-W:6]];RVMU$LL,JLC*X!&"",C(.",_P!#D$@ZI(\3*R%E((\3SVX.
M!@C QCOSVSV_6+T\VV^]0VHZOM-38\A6'$K'MT6,5 PT&LQ1>LFC<CIW8PEX
MYTXEG+UR87#AJR<1;-!$X)-N[5[2A?S%KUI8Z#JMSIJZ>ERL4A9Y9YI@[([L
M52WZ4BK$JKE0TBRN6Y;*G%>GC?JQH^2 RAL#&,]NY!S@YY]V/?5C]=V1_::L
MVD)=%LA-,Y";@)HK'M@Q4EJW,/H)^Y9 H)E"-'CB/.[;I',<Z*2Y43J',F)S
M4-_;QVURT<)8PO'#/#OQO$5Q$DR(^, LBR!"0 "5R  <5L.WVD?=]IK<UN.Z
M/SZ<!S_&&0ZV7N//G'QP<5Y02HI3#/CGA8'#8W \<@=$RQ>?B';;EX#W#YAG
M&Y&ZWE_Y=K@>'?:?MPQK,P&W/V>9_7?GPS4EY2U%IBE,4IBE8:?KT/9XMS#S
MC!"0CW1>%$5B^9#ASV%D%2\*-W"0B)DETC%43-YE'@1 =XW:-@RDJ0>X^[GN
M"/=BL,JN"K#*GN/ZCWU2&X:\NFDYD;;37SEW $.("[*0%%&J)S=H8^?:$X3<
MLU.0(5X!2HF,!#&!HY[GM6\%RD^U6 63/T<\-_=)\<+G!Q[O.JR>W:(%E]I"
M,8Y)3OW[G') )/CSQBK&:SVQ"[":%0_4HNR-TNT\ASGY[TI ^N[C%#  N6HC
M]8Z?(N&O/87*8@D76[$8]X/8_GY'D#R)[=Q47:?I 8'''.1^?Q%:QM?2C"XE
M<3U=*C'6HA155(7A%E-B4O/9<B'!&S\?($WP  *& ".P$IBKH@2.WGG[><'G
MRSY\>_M0$?O9R.Q\OUCR/OS6.TKU#RE2?)Z\VJ+I%NR5"/9S3\I_&PZA."IL
MY;M 8ZS  X!!YR)VR0D$16:"0Z-;>Z>'!FMP ^"S1C&' /=0/W\<L/'N!G-7
M-EJ!3;#.<I]%9">5/@&X'LGP/AXFK_HK(N$4G#=5-=!=,BJ*R1RJ)*I*% Z:
MB:A!$IR'*(&(<HB4Q1 0$0'*$\$@@@@X((P0:O 01D$$'L1R#]M>S%9IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4J">HJR;FJ6M)6PZ
M0@ZC.VB*.,A)HVXTPY3:5ABR>O9E[!04+X9S:+*0C9!&(KJLQ -I!9<W>2R)
MDR(KVNBP:9<7\<.K37,-M)A(VMA$I:X=E2))II=RV]N2Q:2<13,@  C()(E6
M:6\DZI<M(J-P.GL&7)  9V/L*<DEMK8P.!DFJ+]?[6++36FY("-A)&3KC'66
MV8VP06@[)8;8K'Z\O,#<UI!UNUM)IP=)KA(>/[T826CSO7+4KHH'62=E*AZS
MT,,ANVTR9YD2=[_37AEUF""W#WMI-:",:4R&:[GZDFTRQOM5L' *'=9:86W>
MKNSA2TL!1KM5C&]""!:A=\C;LY96"9YR#FNU1B[0D&3-^V."C9\U;NVZ@>AT
M'*1%DCA^ R9RB'X\\ RE&9&&&5BK#R*D@C[Q5(P*L5/=20?B#@U]6:UBF*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2HRF?MF\_??]DN3D_9I_=_J:K)OVK_'^@K&9M7*F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2OE?-$I!D\8K\]R]:N&BW \#W3E$Z"G ^7GV%
M#<9NCM&Z2+C<C*ZY[;E((_$5D=Q\1_.OQ0=6>D;5HO=MWJUBCW*#=Q.R4E#2
M!DE"M)*/?N5'::S98Q0*H42K=L@ /;%N=%4Y2]YV2_LST7UJUUS1K*[MI%8B
M"..5-P+Q21J%96 .00000>S!AW!JBNXC%,Y(.QV+KQQ[1.03R,KX\'/CXBHQ
MU)58&[7V&KEF>/6,.^0FE%UHY[%Q[P[AA!24A'-$'<N5=NF+Z1:M6:H-8^:F
M%$5U"04!/S)V,0]L=4N9[.QFN+9$>9&A"K(DCH%DGCCD<K$58[(W=QNDAB!4
M&>>"$/,G*%5>0*S'!R200"=JL0 6[9(P2 QP?9!. ;HU#IQTY#KOK+.S(V*O
M5AU;RRDHO:J[+4D7;28VO7(2NN64.:O3DC)MT*;6[6@_1FX=C9"SS&/1CV+=
MTV4>>1NO2#5IE2WMX?5[BX6U,40MIXKS8T6EW$UPK3"XACB=KRXM3&899+;H
M/(TCE6"35M8%R[-N1=P.64IG,JA"%*MN78K$A@'+8&,X/U$UUTOS)XEL1:KP
MTB_DY.R1TP:S2$?7+)!0VC-:V*3KJL2ZLDT]J:LY:I^SS%6;OYA21:66#DM?
M/%/$NVS.'U^4/22'JN1<RQQQQ6TD/JL<EQ;SS:UJ-O'<"5;:%;H06L%M%<M'
M"(WMIH]03V5:2;(BMCMSL#$EU.XA'5;>)MN"S%-SLQ4,Q*LA0YS@5UV]K_7%
M=UW1G-,L59E;E6!95[;*,5+2SIZZG;1#)VN/="UDFJ$2N6MR2=KH4@[IKJ4A
M ;UVNOWZR$E/"#F^TJ^U"XU"^6\M[F*TN=]QI1EBA5%@MIC:R+OC=I5]8C]5
MOHTO%CG#7-Q&@,<&%C3QQK%%L93(@"S<D^TR[U[@+E2'C^;W A%+$,>:^0D'
M*V26804(Q<2,K).4VC)FV3,JJJJJ8"%\BE$2IDY$ZJA@ B28&4.)2@80OIIH
M[>*2:9UCCC4L[L0  HR>?$^  Y)P!DFHZ*78*@RS$#!YR2>?L\_#&<\XS^KG
MI!JTUKSI^HE7:.+"D9D@_3?%0;TP$O:35^O&/1(6;?(220BI'_71<I)&34[9
M2%*4 $?S)Z674-_KM[<LMN0^PH2;LGI-&)$!,*-&>'X*$@\$GR]7;H(XHT[E
M0%Y+XR""1QWYSW!QGWU8C2 *?,V2%8ZIUC; V6=4ZX-P6,<U[GA.94&9CM .
M8_:,<&ISMP,(@D<R8%$:+6/_ #<>, >H:: %W;1BRA&%WX; & -P!QWYH.WV
MM_/[#]^/@#FI8<GX)V0]3>OX@'_7^#*NMT[_ *_+\JYB $\Q' 'F/?JJ"/'H
M4C5P81'X>? ?PYRN#B"8_P#*!]I=1Y?K[*S+C81\,?9^0^/]:D_*2HE,4IBE
M,4IBE>M9%)PDJW7237073.DLBJ0JB2J2A1*HFJF<!(HF<HB4Y# )3%$0$! <
MR"1V)'P.*533:6CI"M/#W?6OBD$V1_'.(EBHJ5]%JIF%0SR&.4PJJM2!R95D
M41.W)VNZ!5MVDD+2UNPPZ<N-QX#'A2.,[B3W(& 1X_;F#/;')>(8'<J.2!QP
MN>PSSCMS@^ .\:DW8TMQ6]>LRB3&T$*5)NZ,)$6DZ)/+]2 .P1O)#P!CM"@"
M;@P&.T$.1;IS&&#QR#R/R\<_'X<57GGG&#XK_4?AX>9\#6U;/U1$[$8BN3NH
MVS-$NRPE@((%6*'(D9212!VEVHCY)GX.NS,(F0[29EFZV =O./>><>'//AY^
M'/?SH&\#R.P\<>7'C^L>^*=/[IL6H)W['6QTW?S?2<E;)*+]I9>OBJ;]3=-%
M1Y%W!K<@H*:0G(FF(KM>#"=!6#>V"W"]6+ E"Y/  D[X[=FQQN\>W/>K2SOC
M PBER8B0%/<IX?';VR!R/#BNQQLY;O&Z#MHNDY:N4DUV[A!0JJ*Z"I0.DJDH
M01(HFH0P&(<HB4Q1 0'@<\\002"""."",8/E7H00P!!R",@CQ!KWYBLTQ2F*
M4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5#V]]N0^D-;2VP)E]7V*
M#!_ Q[<+),M8*.=.9B;81ID ?.E4B>(29N';Y-$@F.H1FH80!)-4Y;+2--EU
M:_BLHDF<R),YZ$33.HBA>0'8H^B654+'@%QXD5(M;<W,RQ .05=F**6("J2"
M0 < MM7)XRP'<BI9:.VL@U;/F+A!ZR>MT7;-VU53<-7;5PF59NY;KI&.DN@N
MD<BJ*R9C)JIF*<AC%, C7%64E74HZDJZL"&5E.&5@<$,I!!! ((((S7 @@D$
M$$$@@C!!'!!!Y!!X(/:J7]<U:A+%J6083<C5HUM-PENJ#<]SV[?M<P2CZQUQ
MXDS3:UBG(.X_9$^4S51:+@K U.BV31>+MC=E1T0WI_1.>6#4XWACG=H9;:Z(
MMM-M+V4)!.I8M<7)5[& [@LLT+98E%89"58Z8S+-E0YVM&QZ=O%*0 PSNDD(
M:%#D E#DY\P 9/Z3+K\^^E_0UP=.>]<R6IZ6:6<JCV?UUC8%I&S9EC&[(%,G
M)L7H*B;CLF*83<>>0?2.U]3U_6+55PL>HW0C4<_-O,SQ 8[YC=,8[\5'O8S'
M>7*>4SD#GL[;E^/##SYXR:L$U=-7S5L]9.4'C-X@DZ:.VJJ;ALZ;.$RJH.&Z
MZ1CI+(+)'*HBLF8R:B9BG(8Q3 (TS*R,R,I5T8JRL"&5@<%64X(8'@@@$'@U
M&(()!!!!(((P01P00>00>"#VKWYBL5#6Y.H#4^@6-8?[4LR\ 6ZSKFL5!C'U
MRTVR:LUA:0,O9UX:$@*?"STW)2!(&!EY,&[6/4.=!@OV.3@4II-M9W-XSK;Q
MAS$@>0M)'$D:%UC#O)*Z(J[W5<DYRPXKG)+'$ 7;;N.!P22<9P H)[#/:JL7
MOY2OIS8:DV/LC4-E8[GF*-1&&P8JIQXSU/:WBO/K77Z6M)5:W6&L^Q9N,@+'
M98N&N#^NEG_F?-.$H.QMXV8629&L(M#OC<00W,9M5FF,#2-LE,3B.24"2..3
M<I9(V9 Y3>H+*2HS7$W<6QWC/4* -C#*"-X0X)7!PQP<9YX..<1YL#Y35OI1
MM/--V:,G*[9Z+M'4%+V/'4*[Q.T(.M4;;U<V!:T-HL9N)AHJ0E&5(@-:VJ9N
M]5?5R"L,=#, EV*<DP>QBS[O#H)NBAM+M'CFM[F:!IH6MW>6V>&-H&1G8*9&
MG18Y5>2-F)7N& T:\V9ZD94J\:MAMXVR!B&# #.-IR,#D8S@@F;+#UQ5*$KO
M5?8V55=V-MTUR.O8.O(P4['/#[JL6UM=4BZZZ@J<MW!6K-Y;9J_UZFPYU5WZ
M#I\[0D"G\,L")8D>E2N^GH9%C-\LSOO4CU6.WFECG>;GD1K"\C8QPI7@\UT-
MRH$S8RL6T+@C,A=0RA?#))P.^>#[JLEI+:T%O+4FO-NUM%PSB=@56)L:<6]$
MHR4$\>-R^UJW+E)P5&;K4L1] 3;;@IFLM&O&QR$.D8H0KJW>TN9K:3EH9&3<
M 0'4'*2+G]R1"LB'Q5@02#FNT;B1%<=F ./(^*GWJ<@^1!'<5*.1ZWIBE,4I
MBE1E,!Q)O/W[G^,I1R<G[-/[O]359-^U?X_T%8S-JY4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2H!WUH_4&Z8!.(V=3HZRJE*9**7$I4)5H//:$4'I2'.5ND8QE!(
MX(NW34-VR) L<IL]#H&LZQI$YFTR\DMUSNF!]J&3(QAD)&7.T ,K*V!AF*@*
M<]-91M=0RYR=P!'CR?'/)[<GMD8S5!OZE)TK*"8ZD=;B&.83=A*QG(F3M#SV
M2AX8> #T#@?(/(/+/H'_ ,3?2< ;7M",=VMQD^\\]SX^^M/4;3)^;\NQ)';R
M)'GY?G6=4^3)Z>5H!"IK2>SE:LU>FD6M;4O,B>";/S=]R]0B3%%@DZY<N1\0
M1N54#.7!@. KJ]OB/_$37UG:Z6+3!=.G3:X%E&)FCX]@S#YPJ=J^R3C"J#G:
MN,^J6^T(0_3!R$WMMSY[-VWSY\R3XFL'_4HNE+]P7+_VE/\ C_<O]/3TSM_\
M3?2CZ]E__G_WK7U"T_AG\?\ 5^CSWKC^I0]*7[@N?_M*?\?[E_IZ>F/_ (F^
ME'U[+_\ S_[UGU&T':/MV[_ZOUW[U8/2W17T]Z*D49BE4Q-:>1$G<3D\L64?
MMS%,!BG;F.BFD10A^#I+*IK+('*4[=1(W(Y1ZOZ7:[K,;17EX5@.XM! #%&P
M((PP#9((P"H*J>00<UTC@AA_9H%\SW)^T\^>/(<5]&L&*BM114+%*. -/W02
MK%@*8]!3_P LI_D0=2LLV?*\" ARNBF)..P4!2*0QN>I,/6R.J%Q!:9'7ND/
M_DX,>Q'$R#_VL<]\YJ0#@*-P')XRW'SC>0(Y^W/WU(>CRB2ER!1(*0EONR0%
M,4FZ DXO,Z E%%HHJU2[(@(=TV4403X[*1SD HY"UCF[C.<@V.GX.6;/]CAY
MRP#'.>[ ,?$ UJ.WARS#CMP??CS[GOXU)RQ^V<1YY /(OXOZ>N5==U&!C[_C
M^OUFL]5VPJOUG0ARFT1%(H^X5W E,;CXB1$@<_ %B_$<BWKA853(W2-DC_E4
M$<_^XY'O&3V%<)CV'.>Y'P^'CDGOY'[=]RIJ/3%*8I3%*8I3%*8I55]Q:)++
M'<6VCH>&G"',[D(=OV44Y(Y?KF>1_'9*WD^T';,B7LI/#\G(*3H1%Q8VUT!\
MW*?8 PI/)!/O')''/CS[N8D]L'R\?#CD@ 8(\>_D/,CQ]U?#I_=:DBLWIUW5
M,A,IG!I&R[L.Z,^63$4PCI3M@44I(HD%-)R< !V?A)<"N^%'%AMP,K@CCMY'
MQ^_OX#P[$"M89)R"#V([Y//''8\?;^)E/:&M([8L1W9@(SGF!%#1$H)0^J82
M^;%X( )U6*Y@$3@ F,V.(+H@8>\26 E<XY'''OSG(]Y_[YK"D8(/;OY\]OUV
MJ+-#[EE-:3A]7[$%9I$$>&:,W3TP]JNO#CR5,Z@]H#PSP3%435(844.\*Z1,
M+=50<KK^R$R]>+'4 R5&!U%]P'!=><^+9'CC%O87IB(AE/S9X5CDE&Y[D\[&
M\^<'N<=NQ4IBG*4Y# 8IR@8IBB E,4P<E,40\A 0$! 0\A#S#//_ !&#X@]Q
M[C5_W[5SBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4K7[)'5B6
MCA9VN,AIF,[9G)8^:CVDJW579MUW7;18.T'(.'2#=)PL0J*"BX)D5,F7@#9U
M@>>.0/;R2Q28V[XI&B8!RJX+JRE5+%022!DC)K=&D5LQLRMVW*Q4@$@<L",
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MA*(Y[F:9!.ZR3;99&<=5T5$:3VO:*JJDY('-<YG6265U#!7=G <@L S$^T0
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M(%809/CPS>?F<'(QSQR3C/%2@4IU#D22(*BRIP323* B)SF] \O0H!R8YAX
MA"F,(@ 95\ %F(55&68G  'O_ #Q/ KHS!1DG'E\:DZ*CRQK)-L @93S4<*
M' *+GX[9@Y\^R' $3 ?V*92%\N.,I;B7K2,PR%[(">RCM]I[GWD]^YALQ8DG
M_;'Z\?&LCG&M:8I3%*8I3%*8I3%*8I59=X::+8T5[?56Y4[(V3[Z18H$[(SB
M*7!N_1*3C]=D"A]02AVWI !(1%<J0GL+6Z*GIR'*MP"?W3@\? \ #CR\C42X
MM]_MI@.!V ^E_OY^?@#FO@TCMXT\1&G6E<2V!L0R,9(.C 4TND@'9\(X$_ C
M+-R%[(";Z[U(HF-RY34[ZQ(P-W&#@^SG&#X_ ^=5I4DGOD$@YP.WAX<]_NY
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M#G]2R<NFWKG3@D(/RJYCL?G(QUG%QZK@Y;YL=<%,R;01A@=F2.PMY6Z&%_\
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M<)$4*190INL4TT#%X)I87*E2T4CQL5)!*ED()4D D9P2 <<"M61'&'57'?#
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M8'TJ[=2;R9:$1D7,@Y7>+.3N%E%#:+<W"%F2XF4N@B<K+(I>-5"K&Q# LBJ
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M._=[+^5(?I,=*7^')_@;\JQN7ZR^/B/#O]WC3VE'?N]E_*D/TF8Z4G\-_P#
MWY4W+]9?O%0;N?J+U!IR+(I>=C5JO.7Q1(QBBR*4C;)M4YP10C*G48H7MGL\
MY(+B#9A&044^>JJ"84T1,!>;W1M U/5)-UK8SS(AR7*%+:/:,E[FYDV6\$,8
M.YWFD5<X'C6DEU:P#=//&G;:F[,KL3A5CC3=)(22#A%+<C QWZX9V8V_UJ%9
M5X6MITSI*;:,YB/H\3(1S/8NRM>V=LZCZ]M&X3B;T(56E5JSD:-]B]/\)/1U
MN/"O>U;)M59[#U&:^APPZ9Z*EYF-OJFK0L\3W,J2-8V-];,KSZ=;PE1,MW<V
MY=['69H7MNK'M@B"">>*LEDN=5PBB2WM9,,(E9!+/ ZNJW+/S&T<3JJSVBOU
M%!)+9,2-9M+IQUGKB@SJ*,(A'0;*!OS2+IM*BG+&N0$?LL:7,VNKP,3#-E)5
MS!KW^I$LL"F4$W4"G+NH] R<8U0*C1?+VH7M[">J7E>:Q=[JZE0SROIWKL5M
M<322E84F6RO#;W!R4N#$LK R$YL(]-MU0JP 0K*O23 CC2X%NT\28&YD::#K
M1L0"FYD'!&-4FAU-)K6992OW!928C]BI'$*ILU+Q1[S,TV_R:7!(P@(A(WFO
ME.02@EX)FQ!HW.V:.%!<28/E.(6H$]FH@>P*_P!KTX[18Q7=C$3F;VC'93D$
MY.]WWD%E]F0]G:LTA*.7<39/MC)N)5FE.-O<R1HP)R0!CQKV3OV))4MD(K 7
M)P2:C-UQ"P?-79B7B6&Y%JO9K8D'8C$S(GF[5 -2H*) F>*;-119"S074.IB
M ZI%ZN1/9KT)-'E4>M:>0KZ2+BWM>.MAA#;3'(.>HS;GW$8K#6-LY?>CD2+=
M*_TP3ZXZ23D'IDC<R@@G)495< Y'LL)]2V$MQ0D(&XN$+B39K*9$E4V8@9XR
MVA0:] VGNQ)%D%J>4<P#".0% $CQR:!G+0K<RRKD^(!JD(M=EQ9@VOR:T0:[
MTUMK:9?3SVP.9?:Z:3N[9R)"VU]P&RC65M)OW1N>J+@2##X_M*)%(0"OLYCC
M4 ?NEBR\GCW2KK5,O(23Q_!W!166FYZ6?*$J>RT@55LFCH_5,LN4J44!$05A
MXUG!)I$ A&YTS2:*9'ASO<Q$NI11QJD]F%BA@C5?6M../5]9?4XE]J4DD2R-
M,3GVAB-B5&RLFRM2S%TDR[R.Q'4YZENMFYQ@+S;J%P0<$Y!SFO7'+ZI:RI)8
M8&WINW%BAK&Z4^:FS#$+),M#/-,"N5(8LQ.PA7#DKX(=@4E5%!EQ34>E!^0Z
MZD8VBZ]F5$$L"CUO3OH/K::L!GJ\;KA>OG@@ 1$A?8(V=L'#[9 V\/N^<^DM
MKZFO=>/[.=O!SN <<\#Y:NVTQ6%8%2(JECBC1EAU_9E#LZ1L5(RL[4=6R>N6
M\L^[N'$9-ZSA'",,LN[\2K($*W=NA=JMDW"6LJ:BYO&,MF3=QW\<I%UIXZBW
M>H07C#]L,;WB#C  C5=B;5)4\H=-LX"3#"8VZL4Y*JV&FA@-LDDF$!=C  K%
MO:8[68DC(Q18+7[V!CX*M5"ZR\S%5C74=6JZ\IECDJZ\EJ!2;A5:>UMB=P8-
MXIU7*A(6H;$<'\HT!Y+L6;]9T[,W$JDLS7RSRS7-W91PS7-^]Q/'>6T<Z17U
MY:W5XUJ;21Y5N+N.U%OE(W*12.BJFX8U;3[?9&JJQV+&$613(A%O%)%;!UD4
M!UC$G4VDC<Z@GDDU"[&L[_Z.7)K+6'(WVGGB(]>_:?=/G[>HRCTTBC5ZH?3=
MED6ICM]]7IV/=EU;4JRSU^]:,8]G.+Q,\^@K58[26YT;TK)BG7U.ZZLBV>IJ
MJ-<H@C-S<?*D"-CY&LH_HZA=7+W8DDD>(/&DUO#7R>NZ?*TT9$D)10]L=P4A
M2(83;L5SZY,R9>WABZ03"-@M&SVKJ6T^FKJ04"2A;!'HWF&!Q#V2I24L^U[N
M"F2$>Z59R=8N=91DH>UQKB*D47+)9!TFZB3NDE5(UV[1.1PIYFYL-?T$&.2%
MFLYMLT%PD:7^EW2.H>.XM9WCEMW$D;!P5VRA&4R(IX%M;7MG= F.8)(K%'B=
M@DT3J2K)(F0ZE6RK#A2P(!;;FI!'5NN$Q(?QD\(D43-P&S;R'(%4()B@);4'
M9$0Y ! 0, ^91[0 .0OE+4#G,< R",_)MG@$@XX]5(/PQ@^((R*DG9@A7.>W
MT_M[9';&3]_O$UUS7NOJI*I3,,]EBOD4ED">TM@6R;:=AP3L* :/FK%(,#G$
MO[!0[8RB0_62,0WUL\_<ZAJ%W$89XXNF2I^:L+2$Y4Y7$D5LD@&3^ZX!''8\
MQMZ<Y9><<Y'CSY^/X^??,C>TH[]WLOY4A^DRLZ4G\-_\#>'?PK&Y>VY<^61^
M=/:4=^[V7\J0_29GI2_PY//Z#=O/M3<OUE^\?G3VE'?N]E_*D/TF.E+_  Y.
M>WL-^5-R_67[QX]O'QI[3C?^D&7\K0_28Z4O\.3_  -^5-R_67[Q^=/:4=^[
MV7\J0_29CI2?PW_P-^5-Z?67_$/SKZB*$5(51(Y%"&#DIR& Y# /H)3%$0$!
M^("(9J002""".X(P1\0>16U>>8I3%*8I7 @ @(" " @(" AR @/D(" ^0@(>
MH8[=J527;VL9#7LNGLFAF49L4'I73QLU*/,$Y4-P*R28<@>(>*'%%= 2]TV[
MX6QBBT6(5*WM;GJ+TG WXPI\&.#_ )L#L."1Q@FJ^ZM\$RIPO.X8^CGRY[9S
MQ_3@6&UQL"-V%7TY-J!$)!OV$)B,,<IU&3KL^1@$>!.S=% RC542@!P[:1^%
M4E2!*9<9![?#O4#!&",X[@_ASX?'X_95=]FTB6U99&>T*"=1FQ2DBN%V[<@@
M2&=K& HIBF')3PTD8ZB!D3%!)N98&8E%)5$ U95D1HY!N##:><$CP)//(X(/
M';DXX/6.5HV5T.UD((\1G//GP<D$8/<8\35ZM1[2BMJU=*99@FUE&HE:SD4"
MG;48/0+R!B<@4YV;HH"JU6$H 8 .D81514 /,W5LUM*4.2A]J-B,$J? CP8=
MB.//'->HM;E;F/>,!P<.H.=K>X]RI\#@9\JE/(U2J8I3%*8I3%*Z_=F=)M@O
MTIUAS9Y>P,7NX:Y'1FMF<!M*]U.$=O&6H6M.,%U@*Y*QL(^;FL2 I*!*L9DK
MB($R:Y#-CBT'V%CZ1PV:>C,72A=-,N'>^>;3[2XE57U-KG^RS3QR2HP@((,;
MQ8FY4AO:%K%?)$E@FU&$#LTVZ&-W ,P?YMW5F!*Y)*%3G&>:UZU],6_K'9Y/
M9S"YTV$L=,6U*EJ^G.81:8*]CM-LU)!NV5O7M-DI4"[$F;'>86RE:UF9[JM2
MK--<SM1($D.MMK^C06\=@]K=30W8U$W]RLHC*2:HP0MZGTW%R;"*"TE@)N(O
M[1$Y&W))W2]M440['>.7KF:4-MP9V(ST\'?TU6-E.[NO'OW!/2^Y?"?8D&!I
M!->+]01-X*[,/9W:DXA$J[D+O!S5QI(5\HKV=*>$]20ERV$L0I"=W/',1Z48
M$8YU32]WREUKLWHT;Y)6P]641&4:6=)%QZWUCMMS#_:3%ZOU1-F+E/GJYFXM
ML]??(91:FV$.SV2>CZN'ZA8X39[>TKNS[(P.:L50:'.5S:N]KA(^"]C[#EM?
M/*^#=P95UW%:H<;7)('R I$!J;VBU6\.0JBP*(=E41()NP%+>7<,^GZ3:H&Z
MEE%>)-N4!<W%Y).FPY)8;&&[(&&R.>]1)95>WM8P3NA68.,$ %Y2XQGOD'G'
MVU5"O]%L4I<Z59;?KS6,V5#9_5-:[\N_C(R3=62$VE:9R7UPE+>*B3?.$\6U
M<Q*JC*4,LA!.VR2C$3K-$E2^AE]*9!:W5O;7M_%NL/1^WLU222-8)=.MH8KX
MQ@2#H=1ED >,!IE8A\!B*GMJ)VNJ32J!%9)$ 67:80HFVD'V<X8$C&X<'@@5
M',/T7;E&BR\=,6L22GV$^FRCKU!G<7B%-V<ZU,VFT[S1KV]:1:<XC7+3'NRU
MMK-1[Q)5)I*.W+V/?-$5XYW,E]*-,]=BDBMB8QJNNW:W+VJ&ZL!J+0^IWEFK
M2F!I[=U-PT+H03$J(Z,0Z]#J%MU$(0;>O=OU#'\Y#URICEB!)4E#EF5@2=O
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MCJJJYQ2F*4Q2J!::=#N#KDZEMOM"E6IVB*33NDFH21 *JA)7<[\VW-YKLG
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MM1R<H$<=I0>4'IYKRK;*][JC,L%HDK&Y)ZDBZW+<32$;,EI;)ELF/&%4 DH
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M_?,HR_SF36H]$ QQTHQG<H'0EX]9;UZ(\'_T+=?4R>?;8XXYK.7O4O1!''G
M9:WTJEX=QLXJ/A$*J )DB.N*KZ]CP2X?@ %0ISMS&,> #LU4[@J?90[2)M8/
M3K7E5.I?ZG)CU3.ZZ;)*Z%-#*Q!3&)KUC>L"" R*"=V#63Z(JY.V**/)W F"
M;@3MZ^N0I'$<"&U&#@%AM 4[3A[CJWHD8-+:HVUQIM,S&A?*&2+86S>JD,F_
MUAU.TFHT=1OV9'GQD37G[UC31#@2P2CHK84D1,GFT/IUKFZ(O?:DV+CT>9\W
M!]N*UTR:'44;*G(O;DQ7,VXG+J.H"V",GT/5P,1Q*90Z+\Q+A&U)A=6Y]DY_
ML4$;V\@!^DQVG!S6,V/K'HHBF^YC,M=Z?0-!57Y05[$BR0JO:;N=8(:F-2#Q
MG9D0'Q,4,Y(FIW=]@2BXD1;BB GYS;>G>MJ;3JWFIOLF]'C,#<M\\EN;MK]3
ME< 7P:+K$[R#$G4+94!_P:)?HK#'U@4C)AF'3;43BV8X))%F8'$AXSU/9&-V
M<SLC5/1'%2>TDH_7&F4TH5]U*IQQ6+>J]VD2I]).M[K7RQ_8D  I&=FEG[^$
M$@  6)9\9/NUA.<=;;T[UU%M!+>ZG(573!-FY;YSI:M=2W61T\#UFT>.U<D9
M"QJ&++@#!]$5?VECBC6;)4="7,:W0%G%QG(,$L37)(P?G!AMP+#(R.H^B)*R
M/FA-;Z5!!+:$K#ID30JG<A'(_)ZI;-(BGQ( 7V>%Y'VNGY 0+D!C\"Y'O@U'
MIUKJPINO]3+>JHI;UHYZJ^D1N2X]CZ3:<!88'/2'?80M8/HDHPVR$*29@H@E
M.$*-IQC^D ,7 ];XSE3MY/M5W*]-;"LQO3WI)I3F<<PK9=5T5>+:1)4"QZ2;
MVN1[U?N ;'40 RCQPX57[M0X"X45$QA,(B/A=5O);_4KZ]F+M)<W<\K&0[I,
M,YV*S8&2B;4& !A1Q79+;U-$M<#-NO1. P!9#AVVL25WME\'GVLDDG-3;E?6
MU,4IBE,4KT.FK=ZV79NT4W+5TBH@X;K$!1%9%4HD434(8.#D.0PE,4?(0'C,
M@D$$'!'((IQX@$<Y!\0>,506=C)_I]V&E*Q8*.JU)'4%J4W:!&0BSJ%.ZAW1
M@Y*1\QY*9!42]KD$'A"B4ZR!;N"5;A,DE7  8<YR.S8\0PYX)Q^]53/#T6[$
MQL<@X[8P",YX\>< GL,>%S8Z0@;O7$GC<49."G&1R*I*E*)3I+%%)RT<I!R9
M-=$X'163$>TDL01 >T0HYT(/CW'Z\<'^51^ W';.?B._]/O[XJH9%Y_ILV<A
M)Q_?O*K*&, )G,/=RD*94AG4>N;]@63C!$HI*B':$Q4'(E!)<R0<KB!+F(QG
MAAD@G]UN<$<#V3G##D#GGN:DVT[VTHE'*'&\9&"/'C/)'@>^>_.179Q 3T79
MX:.GX5T1Y&2C5-TT7((?6(H'F10H"(IK(G R2Z1OKI+$.F8 ,40SR[HT;LCC
M#*2"/AY'Q!\#XBO51R+(BNA!5@&!'D?R\?*LQFE;TQ2F*5AY.P0T,[@V,I(M
MF+NRR:\- MUSB524E&T++V)=BT  'O%TH.!F),Y>0X:Q[E3GZG ]$BDD65T1
MF6",2S,!D1QM+' '8^"F::*//UI%'C6RH[ARJEA&H=R/W5+K&"?=O=1\6'OK
M4$-O:S<MFCQ"Z0BK9]#4BPM%B.#&(XA=DS2U=HDDF()^;:T3B"T9$G]5W29R
M"!0#G)#:??(S*UK*&26[@8%1D36,0GNX^_TK>$B20?NJ0:Z&WG!(,39#2H>W
M#PJ'E4\]T4AC[J\W.VM;,R.E'5QA4",6U^>.S*.# #=KJUXC'["74^H/!*D]
M<(MI@>/U!50I2@?GG"Z?>N5"VTK%VLU4 ?2;4$,EDH.<9N4!:+GD YQB@MYS
MC$;>UTL<=^ODP_\ ]@!*^>*^W[)-$\6##YT17C!FX2M@W[XW>#.V2%+8X*+
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MCHJK<RQCIFQ2MTQ2F*4Q2F*5&,Q]LWO[\/\ HE_\<G)^S3^[_4U63?M7^/\
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M+;#&TE9:"T<!G#7=5:KE0V 5$6K?ED,C!U6$;LCM^Z-%+-U7# 45G"QS8)9
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M_H5I=#T*=]*73(PMOI/RE&ZPPN)R)9XELTWC/K<Q@=X4&%D&\+CIL*I ;FY
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M:UY&*30E'#U\P!HXD'QW$HZG?$PDW#$P202Q$I&2)+9.G [-LR[(F%S)OW*
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M4IBE,4IBE,4IBE,4K&242UDR!WP"FN0!!)REP"J?/N'R$%$Q'S,D<#$$?,
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MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I48S'VS><?=A_P!$O/\
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MI3%*8I3%*8I3%*8I3%*C&8^V;S]^'\/[4O\ 3\'IDY/V<?\ =_ZFJLF_:O\
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MQSK =LT9[>VOAGQ']:TD&8W'FC#\*K3TLO1-'7&/,81!%Y$O4R\_NIN]14,
M  #P/@TP'D./(/+U'+UN<'CQ'CGC'O/F?//G5(3Q@]\Y[^[M\<YS_7.:QO5$
MV,C)4F3*' F;2C43EX >6KABY3^L/F !XHXAZ^?(@ >>84=\\\@XY\1C QW)
MV_#SK(.0./HY/&/#&/+CGG')Q78[77P2=?@I(/20AHQ\'GSY.V2#@//@.?)3
MUX#GUX#/(R+MD=?JNR_<Q']*]FARB'S53]X!K,9I6U,4IBE,4IBE,4IBE,4I
MBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4J,IG[9O/WW_9+DY/V<?\
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7,4IBE,4IBE,4IBE,4IBE,4IBE,4K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>g425213g50a51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g50a51.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( )0 N ,!$0 "$0$#$0'_Q  >  $  @(" P$             !@<$" ,%
M 0()"O_$ $X0  $$ @$" P,%"P<'#0    4" P0& 0< "!$2$Q4)%"$6(C%$
M41<C,CA!56%TE<+3"B0S0G>!MAA#8G%R@I89&C5&4E-869&2T=36_\0 '0$!
M 0 " P$! 0            (! P4&!P0("?_$ $@1  (! P,!! 4(!P<# @<
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M1 \"\# /&%"8^(TL4J"-XB:SO+:>:WF"QS6\LD$BDJQ5XG*.-RA@P#)PV2"
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MXTC3+J0S7%C;2RD*#(T8W$* J@D8SM4!1G.  !P *K+_ )&GV6?_ (&.G_\
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M'RZS,%E8>4I( SHN6W'*5^PBG5XC&:Z;A#S8:9A<(I B2VW&4JM6##*G(Z?
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MJ7'CQAL.,TN1(ED'WG$-0XT=AIUYY^0MMIIIM;BUI0A2L,'RZ]/?6"R@,2P
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9:?<2>KWEN'C[^UFV]W/#O7O(F9"P!S7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>g425213g50a52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g50a52.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[29H4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )DR^F 0X0DE-! 0      $D< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  12V%M86P@1&AA;6]D:&%R86X< @4 %U!O=V5R4&]I;G0@4')E<V5N=&%T
M:6]N #A"24T$)0      $//ALWAPASARV;T9/D)O:6HX0DE-!#H      .4
M   0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M    $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO
M;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG
M:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M$ .__C4  @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"
M24T$#0      !    '@X0DE-!!D       0    >.$))30/S       )
M       ! #A"24TG$       "@ !          $X0DE- _4      $@ +V9F
M  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8
M      $ -0    $ +0    8       $X0DE- _@      '   /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z   .$))300(       0     0   D    )      #A"24T$
M'@      !      X0DE-!!H      S4    &              &[   !4
M       !                          $              5    &[
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   &[
M %)G:'1L;VYG   !4     9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   !NP    !29VAT;&]N9P   5
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
M  P    "/_         X0DE-!!$       $! #A"24T$%       !     8X
M0DE-! P     &]P    !    >0   *    %L  #C@   &\  &  !_]C_[0 ,
M061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+
M$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,
M# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( *  >0,!(@ "$0$#$0'_
MW0 $  C_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$!
M 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@% PPS 0 "$0,$
M(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F
M1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!  (1 R$Q$@1!
M46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD23
M5*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V
M)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ /54DDDE.?C9IHK./E/LRLBHD6VU
MT/+9/Z1C?T3',]M3ZT4]3QQRR_\ [8N_])).P7>K997DW4^J[>YC-A$[6UR/
M4JL=]%G[R8]/M((.;D:_\5_Z124L>K8@Y;</^L7?^DDQZS@@P?5!_P"(M_\
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MBG?^EJ:_&W-_2_0:J^/E]:J>VG;98^PS-U?TG-%8L!#7[<5FZS]+:RS)Q?\
MN)_HTE+MZSGD,-+77V/H>X4^B0X.!VTY+FLM=ZF/;[G[Z+?Y%7Z2Y7:\[.L;
M@.](L%SFMR-[()#J77;JFM>[T=MHV/\ 7_XM5*\CK--#/3JR+KR6#(]=K-F\
M3ZPHV.8YM;_])_1OH;/\(IUW=<MR:'/:Y@]0L>-NVLUM.ZVT@[W^YCO2J]1]
M7OJ_1_:/424BQFWV8]=CKL@N>V2?4>!)/DK6!CNM=D"VV\['M#?TM@@&NMYX
M=^\Y8=#>G>BW>*=^N[<6S,F=RO\ 2F]&(R/5^S?SC=N\LX].OZ,G]Y %LY8
M0!TZ;.D_$ RZ:Q9?L<RPN'K6<M]/;^=_*2S<058Q?7;>';F 'UK#H7L:[\_]
MU57LZ%]LH@8NS9;NU9$_HMLZI\]G0ABN](8N[=7P6<;V;D6NZ/V"J9]2[X>M
M9_Y-5NGX@NPJ;;;;S8YH+CZM@D_)Z09]7ID?9)^-:K=.9T$X-'JC%W[!.XLG
M\4D-_"#F9&75O>YC',V;W%Y$L:70Y^YWTE<6?TL8PR,P8NST=[(].-L^FS=]
M#VK024I04U!)3__2]5261US.ZABVXXQ#MK+;'WO=2ZRMK6!NMMU9_1.]SO1K
MV_IG_P"%KKJ_2MF]6ZACC#?]F<&6UMLR&MJ?<_=NI%F-4RIS-EK:K+K=UG^A
M_FK$E.PDL ]?ZHW"UZ?8>I"TDX@;/ZN#Z_JM=O#7.^R_H/YS_E#]%Z?^#5AO
M6[']1-89LZ:6;&9KVD-^TR/T+MSF^SW^G[V5_K6_&_G4E.NDN='6>N5MB^E@
MM#0=K<>[4.+FV9'MLLV5X?TK:/Y[(_P7I^MCISUOJFYP#&P"T!YQKP/3/I[N
MHGW^VCWVL^Q_SWZ/U/M'I[TE.MFUY;W5''/M#CO;.V3IL<XRW]&W\]J+E5V6
M5;:B6OW-((,:!S7.$_RFA973^O9-EO\ E#&?B8[ZF^E=8QU>ZYH_6ZG,>Y[V
M?2;]E_TWI7_I+5/#Z\++LC[;6<7&G?@WO! MI V/L_.]WJ5ON_\ "MV.])3I
M45/8;=Y+@ZPN9)F&D#V_R=KMWM0<3%OK>QUSW.V5!FKW.W.).YUC?H.VL:S:
M_;^?8LQO5.N>HZFQE;+/TOHG[-<19LLR*61MNVU>S'HO_2/_ $K,O]%_PK#J
MO7';F[*VVUFO>S[->[V.?179?N;;L]U=UUS*=WJ,]#9_IO22G0OQ\[UG.I<=
MCK&N:W=H &M:=/;MJ]K_ -_^HBYE-[W-=2X@!CPYK71N)V%G[O[FSZ;/I_VU
M3PNL9%^*]N75]AZC)#*+&EVC]<1^VM_O;M<RJW]+_2&75_HU49UGK4-%M;*W
MD5<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*((997?48CR1QW0+##,;#75["I(VM<0P4?ZGR2-G@L[4DL:F> =NF1/PC/\
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M7JGHC"TI-)L\N._BF6V]H.%U AM!0:+3\[P%YGALII^9XV+,P8:XHQS;(U[
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MH4>6@Y]L)W0+HO=S[B(N;5-E>&:Z/0[GF'#-QFB;O <X#NC[+:]3P.,W3.<
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M4:KD'&:.'M3YENL$!V/0[_-T6'L^N]EMNE@\_P [=0:"NQ55-BL)C(*R6V"
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MAT+[E^%&&:("'I>=:3E ]<?>_B5."'$%P'XC]M98##!!P[),O^#,6Z96$&2
M((2Z=K6P2JTH]-?%V^%:\'U?GW5(3'X>]DO( QP2IR$IKRM@^@>CW@SCS7-6
M# 6V5(G2,<*Z=&HC7N1J.C5Q'$M9;KMT43!WSC9&9@V</1LN_+$[MW,(+K\P
M9^#DZ S02Y1V1:]?#ENTT4,M7^#^"O<0Q4;Y9_E/1'X[M[9\=QE9<!?<#QFQ
MU+\6)T.ADT#3K6KCB60F&N(MJ$8LN[IP=!./'GS[FG' .)M:@*S(L:^ $UY8
ML31B/IDGK] W5/*KN?(+7):3;@=!S3\CC!''ZF^G.:!7T5>@264=@>\]HKH*
MXJO<AE>;\%#/%5)0)B(T\^B CN:9[OR:S5PO-QD,SDC=WHM'44>.K:G\]/TE
MJ; #4"5'X=I26!!A+XXHQU'>R5KG.1ST>QK6J]S6J5UP5(Q'6EZ-DZ;:Y3#Z
M>RS6C&>=26*FXR#\?7+/-# :P>;4K)'$2V+ZL3)FMD6-[5DCC<JL0FOQBG&H
MZ$7C<I>Z.UYSJHJ3-TQ]J>P4W$32MKZX:0DEL _[5QLE<D$;D9$KV_47PU5\
MKY4H[8VZ\=/O4]!IK_Z4:Q<ZTR1NC8YB)98EJ-8L;?@UK4U#41&M^+?"(B(J
M*B)X1/150.AZ<?F9,_'9<\UK5TNB!R]8L!N+G1;6QA,)'0A4UC/HC+""1\Y_
M#U8_X-^F[Y>BCY885P[<U8_VGT7_ !=:;_\ =,5_\T^BJK!O52P=;48J7GNN
M_.[JAN]&$C3<4X3\LSYU+7V#I9_VL:K)T(OZ](848OU6.D=\VK&J*6H1YG<^
M4 3)Z4-^BF5TMPLB2_R=:CZJ-<UKTL<)\FM?\5>C7+J5<B/5C%=]_*_!GW\,
M:B%?MD4;"I]PZKU5TV727VLS8W.-9)8XLFI"NFD$X9!VRWE0'?A-$F?JY/Q#
M'@$"OG<C8T80U(_"_#Y>BY@=SCCG7$\*L%;OVFT2)_N=Z;[)_P"T\4JKX3[)
M]M2GW7]$^WZK^GC[^BJK>2ZF5M:B6ZI.>ZYX45Q?T;E)-Q8\JG9N[L,_9HC/
MVK?_ ))EA6$I#(KD^K#].1$3Y_%I-:UG=/M#T&US-#=:.QYYJ_RZ@JK&ZL%@
ML,5+.@-6)*:4L,2ZMB22H/#(YD?S;\W-1OR17)Z*<.?X== =;:7(5=<#\VTS
MX3PAC@Y);#$-G08V",B/Y(NI<L:R1/9]6-KU153XN5WQ1?176FFHG6=+GRM>
M"7?<ZU;@[._SN9&9"7BBO-GI;@*DJFRQ+JD:P=U@8.V>=47Z$:ND^+_BB*4_
M3#K6>3LUBK'#?7D*.^ES?11_-?F]&6.(9\G^$3YO^.G3R]48U%7]Z>$555/1
M-SFLG&.9Z/P!4-/TI(=;G\/;Y+14EGJJR_M*@HN;.%@/BS#JIUC#/)5WQQ,,
M[F6PSQO]B/BD1DR/EB<UJ/S'Z3P[A:A+1"1O9[9<OPLF]P]L_7>I=3O>P4VX
MK,[:X.'GZ<2S7X$,H6T(Q5HFTM5TUZ57S6F6CUNB++RMK)1-,63,BBD3M(61
M1&Z6#-ZBP:YQX9L+H G^SGOEM7:^G9!64R6#?=NL-A=]9N=9EK$+N]5TP?-5
MM!S^3,1!8FUCLM?GI[C5"V:%A50.AKAA[%E]+&PC3QH'W3W;I<02M6\:Y7VB
MAR8^:L+C5\T,KH,>KKPSI@_=8[F&C%>)9TU=6:G,A#Y8 Y$BF<0+]8IS/H1P
MK&H_H@![Y%IL)6%F;@T\T.]D/5G*!2L.R+<@'T+,]KAK&6Y[)&]7'Z=5/NK#
MZ3:I1WAP\LJ$F"D^JCY=9;6$<L3&1Q'*5QO/<1QO@.1NBEF.*>XW,#\DYQ4K
MF0,GR;1V4Y6NDU0%EG^@9-9[@\1-!@#^=':*+;6CCH:ZV,KM?6BU[9[>Y@M+
M64N.L>1\'I@UZSGBP:V85!W'M*[_ -5 ZR6W2Y;E,6\&HK&;GI[S.LT>EU^<
MQ6BST7U+N4O'E9K$B6)M&=C\TUMJ!4E4K;DRG&+*GJVDESO6N#XX4ESTS?<%
MZ!I^'[?G^TV]/OR]!QN#)9[-V&0HZ?+Y[>A8Q]/'H:\YL-A=J//=HT^#\S(.
MFJD3ZHCT>R-(VM40TKAK)Z2[JJ^U3K_,<+[>>5XS2;.L"O\ *9IN?N1$'M94
M'L:HXP(N)DC*]S96,EA<UDC55'L1'_;SX0JK9W;O_'S.+]2$%W-;,27@]0./
M$@UHUTDTM23'&Q%?7_%%<YZ(CG>&HOZKZ?FG3JI60K+D?TYHFB^XOBK11VOW
M]2BM@A:O^Q[54\HQ&K]TKD_1S7)^B?IY\>%1?1:$,1+ %S(2*$77_<+QN>;E
M$@^\J'Q@]>S!QCW16,;1PX*S0LG(>Z0-B?"-TL;5\>55SVHU%5?L=IZG+6"H
MV6UVA\NSA,40+F$!R0') &,I;D5/\9_A'_&5G_\ ^;_W7[_ZO*_YO4<8CFNG
M[MXK_M?$?[,?Q+/!!>\]P_&3._X2Q%Z!2SA!\IZ8(21&RQ>R$DO4\SD%B>C
M72(XA@A+HU:QS5^@]%<GE%5YH<1S&YJI%LX]DXVNSC#ME0ZW]S#_ (Q7$?\
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M(HFG#$P/\KF$/5S-B)S.(8*OHKE\HB/^2??[?=?]?\_[)Y_S>OE^W'@/]/\
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MJUP1#Y)YIIWF"6M2(\66256CQ+.L$<<\C9V1X7]0YR_4RK\K?V]HP/V]HQ(
M/DBF]+3X(DIUSV]Q2F2)TOCK9K1B16$C=CBVS6$:1_2^F:]#VO+8D2K'\9UD
M3Z:JWPC//AYH<1S0[+:3?91S:L$4^DV72#K_ +?A!5"&Z;R </Z"#*)!L<;"
M,HS?FK8/H1V+8EA199%;%\?@BR2*C?+G>:@V6TH-G'D!!%7@$",3F_:7A=R/
MOJ'KV1CN!L[N,VE83U;-$9UU)OMT[H%M!^SC+!E2.T/1/F;73!##/069\5C)
M8$(V=KJIM-EM=DPVVRCV1D6V@,)>QH \AUM70;NS<-?*R=W5.5/FC1K63.VV
M3=*QK/G\&LD6R5[4;]23XHBHC?J/\>/F[R64*=,9[9-AH)M#8]7YQ$64F2BM
M(@-WB8(+@?%ZDC7U(=LOUGD%#S6A;TL('$HT@3_(>$C(G64I+].;YB>ZKNZ)
M2=7X U+!R](Y!\K=B-MU378Y/S-OTW1JA_\ ](>36_![V?$CZG\Q[F^%1RHI
M7WZJ]Q 9O0Y=PU#)4OH+NH_#@GT<50;725\XSH@R*_Y#&TYL$<4B2"-E',KW
M-1&R03P.=$\I7&>\?!^5GKC_ +1<-Q^^30A:76ZXN2ET-781:^+%SP7)^K-I
MBM+I[A:''9\FPT-['G* 6T?.0ZHF_+76$%0/;6=P?8$;&>FX2PS6I!@ 0V11
MB!""QP,=' P8:&!D+'HQ'LB;$QK8V.2*-'-8B(Y(V(J+\&^"J=^B)>B)N5_1
MY/ZG]]OK,?I/#N%J#U#CV*<>M+*RW[N-SJ,MS(',8 ?4%=!ZSJZ?FV73%25L
M.KK1K-A=QM-%1$7!U=5!VN;P-)J+:I-L31Q(;J"KB>Z66>$4@F&K&NJLOF7T
M;W!]/M:3,55KNY.<]$P/%NF9[756Q[M)QRTCZQ@M155 6A<#1 :.FZ#H[>D=
M6Z</./G_ "<T2]B^!1(I3VL*;C/$RGRF-UJ(M<LZY?:_NMV3K.@L&C35\UFI
M<GJO<7:\PV31+KCG.='^3"< B"DI;@H[16Q[2:XB^CC(M3+*N=*V$"-[R$_'
M;@Y>[8LRL?4/<CU7#>X(3<D9_?9?!A\;J<Q8\EU,],5 S=="U'1JKG6L(@R5
MOIZUY]UNL?A\ ',/;?B!P=S)+80#MB>Z F\=7^*[K3LA'@.E[,7.P4GN![3M
M18,QSO;D8FV7J W().I=!J.U]1S6I(+WEB355Y5GB\[18_\ (<L>:H;0;28P
MFHM(D>\4I8U$LRU:8G=61NK]_C!7X]A[?MMGMQTK;:6V"Q;-IQ<^Y "Z!8T]
MMR^S,IH*KFHE159K61[*X2#3Z?H0EQ*S,FC,#K'(!&97@DN\P-4$ZM,5&1,S
M3[7NV=;NI^M1;O$=;UUW+W.MK)PIZ2BS5=RVDT//L1<K50CZ>\SY)&5RI9AK
M9I*QMS>F-(;9O#EDLFPQ%9Y9R/0ZQF&>!W$FRFXK[RZ#?[,S?34?8,W65A=E
M5A5X@-#:4O&M!'GJNI%22 :E!)N381XIYSBY5DGFL#"BGSROY[4^79;2*K01
M'H=9T7H_2(?-]5^G0F ;01>-\,/MF8C_ ,V%X2]1%0UJ;*,DR./;*Y$SF<1$
M<O\ -_(:OPGW_B@B)X_>OW3_ +/.&TB(!.S,SW(&=*K_ $#L? ^&CV&S\W@/
M#@@ L8("0<78O9L,F0DZ%ELK'N^%L9FZ!(B-SI(YVLI:UD<K&\QW$K62L09/
MFU)&1R-;(CD1[&N1/DUJ^H8XQYI3W@DTX#18%?)XCPNP@CA$/TWP\8,<(\WE
MAD'#D,0&WO2CS!<_9#'IY\9S.*OZ_P#J_6^?MY5?/^Q?X^?X>/*_YO7'[NW;
MT%NW&SMQ7W?N/A9']QV'^W!P-&JS"GO8^ X[(S^X/7PS93-OB9QK,2L@FHZQ
MT;)G[/0?.5(E%<QLCT8U7/:B.5&L\K_-3Q]W@HXHA&(G-P9VZ7P7\H_;V#9P
M?4-G#L_M^4@$PP"8/E_FDU7)_P#=>:WC^P6%_P#<O)_\W*?_ +GZ^Y?@D&N5
MXC%RZCO;9<AEY&P=BCB@:^@J7MAB7DO*971Q(X14C8LLDDKF,1&K(][U17.<
MJP7WFS7/Y9$9?V"PO_N7D_\ FY3_ /<_514?V^11P<9Y_##''#%%2K'%%$QL
M<<<<9I;(XV1L1K6,8QK6-:U$:UJ(C4\(GHB,GHB7HB7HB7HB;E?T>3^I_?;Z
MS'Z3P[A:@]0X]BG'K2R@1[C^LC\5Y9;[EB9Y^A_'4V8Q ^H,2NI2MKL;8/-9
MR&TL/J1R U$1UBP^^+A>V0:B"LB$<WZ2^2+#.X]Z9DF9P&[R.:P-DVUXSJ.I
M7T)&"W/1'NV6,O@\GH<G57>'81#F1Q+D4\--3?C$AL00<A['PQRIZ++Q95.]
MM87(I,$CXOW#W70>RW5.RJYQ44=-H\8+&4O+N@[2S/J[KFV.WQ-DG5J"1.?5
M7T%T4X=<4:_\-&.# 7(J1DP(\C%F?B\^)?YF:2G+]Q]T-AF;&NN.>_R>77-'
M90V\/Z=9U.CV^--TU)<R0P8FXT&"E+BYJ.+]%]F[:ZD4VC%(D>B"_,$V6,K/
M%NM\Q7*V<E)=']WG-LSEM4<;SBZMHLV7M*O-&6M71NQ>KZ'BJEU[84-);M,/
M+C1T,A1D>CGI1P7C@W,T)#RA)17%+ ;L!G0B5*<)!U<CNE[KDT%GJ.[4'.[@
M: 2BAS=WS=8JBQ$*N2CH+?/6D6[O!Q0:>N04(F+4R:&N M7&($^I'/BCA(*B
MQR=GJ6'#VFZIW^/9S2XKI'<\R.NUNEM^7V?3\W1Q#4E:3HI0\QIKROI!H9;E
MUO:$ES9(FA)M<]67M36GD5\)!J13->TE0.%6YR<9RZ(7E=RA]P/#NZY>S*S1
MUA0R<@?8Z+G*7=?2G!;^RS=A&,*1<N?8Q7N;F&,J3ITE54D$&E<. 0Z4$6$
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9$O1$W*_H\G]3^^WUF/TGAW"U!ZAQ[%?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>g425213g50a53.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g50a53.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1=*4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %RZ^630X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0',LW3         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@              ^@   FP          0
M                       !              )L    ^@
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG    ^@    !29VAT;&]N
M9P   FP    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   /H     4F=H=&QO;F<   )L     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    '.$))300,
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M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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ML>P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !. ,(# 1$
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MM38<IY3,Z'3S7W']C#G:6SNY:^+%:,*4V*K"F-D$C,?R"8P60AD#HF$N$*;
MYZ2.&F1JQN!B0&,Y5'PD\1T^]-F5P]15'1%&]7K\UAZ4K0:JW$IJL2(F5TQ+
MU68F08,JPD#K@XDD,M+*04,J4:LKH"K Q87L%&FD3QZ(N==+ZS>%,\!4V$!&
MMT<-U,1" E#DK1&3J)CK'<&+$=>-I*HIP=.!%"8,">48)8V=<,0-&QY4XA';
M?+W2"\]7WI]>*3:ZZMM0R\'KS07AZJ@I1K?/V]/>7>>)T=8VQM?'XD-14:'2
MP6=,3.:3G:VYKA()M6$?E8B;VZNFVK7W&PVV:IJ7$L&N,=E+'6FWM.7:3:D>
M_)VE$/6F('85[) :\'/3I&R=Y+)/MB/;9 ONO(7=?;Y4<NP;'YO%9=UB,=M\
M]+CL:)'QTRGNOF9P0*#.7(U?5UM1G#C81(:]E^Z!X7Q*YM?&(SV(H87M\4<R
M/VG,=[OZ(:MB]V',8C=-8Z/8\99.L%SX_'(5*#;Y7/ 4U;G;NN##BT^KJ<^L
MT+(M ]C4%ENGV$D:1HXN2.1CY8Y)W3MH#]">@="^^_:F:F13.28129G6>%D;
M%!-(Z-:"_1'I'&YRL55TJHB.1/%?T7^?X7^.HAE/ '>PD.1IMC6T(/T*<=T@
M-DUUXZO"SE['!&9=+]D=(C6Z1C5DG))DEF>UC$DE<^3P:KE3HKOXZ#86G7MV
MV_H#F7#./9Z]-#J*26O,S]X;#*_):VWST1O=VAC1DD\U,VQA:UOF')*R-DTC
MX4G?2&Z ]0Z@<X5(I@2!?U]EL4,N]'L++(5CN/JRNR5;G1P(A,_>1"1A%B%1
MB!"AQZ".,0<""O9!#&QSV>VK6M;&UB(II/F1T;Y2>4I&63B_/_"> WFM#VU/
MEM [.F"W66U=_"73A68$XL^:ML97H/+&;96,<\)D>KDD5[%@? \)B=I6SK[9
MI/F!U?X55C=1%3W*W(?X.*2MAQS?;#.P9+3:JUN!7YIN>K),NZLF&JK5;NU%
MFC+LW%N(!DA!*1J!2S0QS^P4H9%Q9)ZF*>E"M">">$V&'7\1O)6T%M8FDV\X
M)^=TMF\J]J);>OO\\\Z3$0?#C+&.D;E"*>YS^5M?<930%)85GT;G\*:$>K&]
M @OH#.#;$BWJ[6NB0+/5=SHQK[CO\DY)C(UM235T4LA((^.XU= P8D<<>OW!
MP-583#YXRGOK$G2<]=CV70N!RZWE=H+4;9Z\ <SD#DB: 6GM 8*YD2[J_1CQ
MHIJLF1K9VHDSE=,_RDD>YOBBHU*:\H?0()]3V)9:&0Q)2Z7EIB;O>L]GD"M8
MKF6]:CI5=Q5QG+[DRK3+Y2(DB1-<B-1(HHF^/DU7.&D.GN5LAA!F;V)F<2+B
M,!JDE?EK*'D#D&&+?[V-&Q9!RO2TJU?(KZHI?[CG4CN_@B=F]D:B(O\ E?UZ
MUQ1$$ -3/-=_"\+8VL,9CA+B(!Q$1)KUJ5V:M'<I:5CM_O5<W 8E_NI9U?NN
M1VBW[4C<J4GBL;%8KF)XHY'/>JN5%:B3SEA(5-VF:VQ\'8"( "+^US^QQ8>Z
M:R9(^;E/)Q2;W>._W?\ )$K95M:Q)F(S1\3M6-KDI41(Y/=1TC5:JJZ*+LYO
MBY'90Q$@NU12LG^5Q\58060@,#_L2[DFG:_!;^RQ!*:+B=CMWO7^[R$:Q'/M
MZU71*G&7(TGN1*E,GC(J1K&JJCD]N21OCW5'-S%(M/<+E:1.8'5_@++REA9X
MLQ7.7=[Z7OR%Q%'XRV]<YJ++RQBHDD1$IFK[D2O26%554;*QCE:Y$5K@KRB]
M"L8J<QZA;7*.(G%XUY )7<;LI!\7IIE&*MJ^04A(J8Q_L$1LJ(GO@E1OA,UL
MD;G,<Y$>U51R!4:A"S%Z,75^]15'1%7_ "+=DU%36BQ\>W/(X.DO:S+75351
MT<\%=27LC@;.ZNQKTX(<JC!%DD6R@B:2^2![FRQL'665A%^=(?+'&,A_W_'?
MIT@CY)U3*"@!H[02FO1A([;0-X^O4SN8DMLS16H4.6^S$NKRET=5GR3R)J,F
M^DKCK2PG*2ZZSD>3-RNN"8@<\W4+89&^EC,-U=EF7!8(RGQ5J:,=+;T&$,M<
MW9?#SLEO1)2;3EG7EZVB;[SB,S-;&UK[*WBV,(!,+I7DWW9TG?)=995S=[IT
MT5-9:O! V7#/#]A%0 P5-896,.M^49DIK>OLZ:Q4(^C5'5LX<*#H(1$1 ]CE
M8WPO('K[$+(,SL"98T+G(K/K,A:,UG&B)R)NW.?>Z!&O<1EE?%XXV^<KHNV5
M1ODY$5CE>UZ>#G(B-<K7(>1# /6MVI64,(B+D"3WF\-CSY9J(\^4N@I.+;JW
M$Y&W+RZVZPI@OR),K+"PF#?9AX\SHTRK/-8)D9-&USO!9&,21LD?E&[$D@$C
M ^B];P;@^'X[Q?PO@^(@)L.+\0X/A[80QQP1&RMN(L[.T$,0B>$Q0Q$>83%0
MQFN52^6.8GC$L=ROK'-</,UR? Q/96K&]%[]LAW[*B_KV[?]4[=:O/%CV'PO
MT%'_ *8?Q(011?TG$AH29\;Q.'_TQ^%":?FWFV*IJXH^6]2R..N!CC8E9AU:
MQC18D:U%7(.<J-1$:G?NOZ=U55[]:OS1Y=%ZMC_I-_"X[&RCBX+BS%%9011'
M_<.*#F*$$G_R9GZ7</IVJ-%I>)J2^LN1]Q]A:W_(9AKAGY6"&0J7D?6+-,V+
M\5<V-TTB.ED:Q4C21[_;8R/Q8WJ@B,4() )($YZ8LOS;_)^ X;PK^0^,^'<'
M 8.%X/Q#B+"P@CCBM(H;.",B&&*,GS1$"I)).*:,H+X3D#:PC\C[J-/K<@]S
M_=RKI)%=!<HGFKLJK>S$;V8C6M_E?+R_3MD_^-Z+1X=P=AQ-G:1VL)\PM/*/
M+$1+RPGW3;,AV@O,N66PU.@T+7\9\F)%%=.IEC%<FHXA\GC_ %=/5O1\B*C7
M^\^9O9K?%K5[JL>[0^N]A8>(\)8\,+(V0B!B,0+Q$T9JR71_1>6CHB35^=S]
M386UM5T=16VM_)!->60%:&&?<RBI*@TMJ8/#&182#I//[#RY)71>_,K%:LLG
MD1.>B*C^2.-*0X>(S.8',E:&WT$<EK;?B^0,ECB*'.E,M[?[P-[["%I:#2E0
MA_[5LIG1B-.JX22K@"@D7D:%G4(UH:/*LV>?JL&[XDR0N9M2,-Q=AY=-*56D
M0QP9#(+*:L9@$1C)GVL0@3'$50SJ]QY#R)J\?P)'$.D#@"E.<3U*LP[$@ZG7
M,=I!;VDX;X_=GKN>AXPP\6FFJY7 .%RV1:3+9PP.4*!Y=K3$@NB2?Q@=*8+-
M'' ^1\<2/\40[U)]51%'"/UBB!K*(ASG,G*]A18K/A7" Y2S^HX[P5ILH,L0
M(!:SXK(C$6EV)7$?7S$QMK1JZ)L]I(XE1?&&NA>3,UK(8'.[1#'&?^49/_O$
MY:CEWZK7Q_#^1GRU;/J>-<"+KT$LQ9S'8W*OFA;,=,@DKXP VB)\@4>L++#'
MDCA=/&V.1K'Q(C*]6</GZJ/$0/-$2<R;ZM/<L ROCOAVI6K$DY&X]X]+N(ZK
M)E,5F*R$"@7KLH$)K&PNKA98E<Z]=;/9/&K(VCG2!AJX%C%>)N<MK++!1G#1
M3I(DEFU)I.F+:JL_Q$/)JQ!=1QQBSLU%5Z.0Z6;%X&.MDMQ=:,1C#@6"#SV\
M9K*6*:0F*?\ TT$D8,Z*P^-\DL4$(PN8DU,@-6:51S=UL@\43,UX4)W''&A.
M-30:5QIGXSF(;%U+-7339J%H+*V1$@KSV0BRD-+?8GR3K,4.*,,J%$\H=VWI
M3[72W19(Z(CHB3_CU!][^4?25'Y*E;].FA^M#^\2H]_Y7U?VWL_/^N^3_J/A
M?(^-[_\ =]KW/W=$3CHBB&@P>.TI2VEWD\]>6T83 8#+:N&GG^-!(20,$\N0
M>>=@D9)9,K&(V1L+R2)8XE?*]'G..?/%'(=JY%G:BK?%<,YE<^"[D'C[CXG5
MC6>AED(KJ6K("A%GN[5M1]=*E57R11-S\P(K4D'0U($]NP(+,4DB6OF<]>N\
ME7.)OO-YWI1+\MPGE"G:P/;\;8RPKI=&610J?F\XY):I3YB0!T!#FLX'!UT4
M=>@)IKP[,N=DLQE2!+!'*3-ZJP6EI!%#'!''!'!$(H(X8C#%#%"7ABABA(,)
M! BA(+@SD0E GI^Q"\BVJG<2\<NP+J1K*N./'8Y(6V"?5JYQ#U%==RGR3+<-
M=%[,53$ P-Z$$&3/A%C# = NW_=O%2X/B?B!!#-_6<3F_P#V3WST[_T\8EN]
MQ*9_AWC%F$BBLFZZ+\)Q*I,YXA# $\RA&6@OQ"&"20)5PDL+]V6$OX<4*22F
M& Z!9#QGQF%@/%O$Q"   ./XM@!<WY6 :0-S-@$^V7"F:K@J&/CSCK(ABB':
M*2ZJ:K-X\5Y01..ULU:@+K@1 !"_SB3.D^XUGA++++)8-EKU/9)1*DM%PVEK
M:VMI%:VMI:6EI:1&.TM+2.*...**9BCCB)BBB)J2229DU?XG"&??DZ*7\'Q[
M=DMEDYM 3+ELDDYE5!H09+^M+D:$^OD6/.R6(ORP&"332,4BMCKR"(X(2D-I
M:0@^6.,.7+11 $TN. 85:]U).'N.@\G3!6-KE*.KVK!"ZHR\%H,U36Y]<1.&
M5.TB#-3GUU? 46$-(^O"M#8)&@ DS2-G1(!B11QQ?WQQ1,9>:(Q-HYO:?2Y7
M3T6*Y3ESWJ+']2B:$6]27@NQL:: J@(N*\SX0 /'>PB/-# 2IKB:Z [9SYID
MU?\ )M+)AXL=NES8TMH32X\F][]%5L>G]:]#H&V%UE:V7"9JWJ-3O;>\U'&H
M4%QG!I;2OWN<XTK:4*:S@I:^L-&V6.,Y M\_?')G(*W17E;,785]D5EKAB-;
MO7W3C^J?J'(?I%*RSP:WEBUSY_I]AH#\29L:3+ 1%F;>MT@5],%GJS4V.)HF
MZK'3V9^LS8^OUL%#I[>I #AKX22EWPRS.;<L5IS\A>J?*KIQM3E4B VU*-C^
M"R9[;$7&WJ^0Q*8AXQ?)M;0@5V-"*V)T\[X2:*YT.4J"J$9+,6DJCBRI",,=
M3/GR%,2=6#,;8>K+-6E]86&&=<XTW*GY7CJHU>BXZ_J'/RC-<,)Q^CW;<7'7
MY2OR%N)>OS^B3.7%Y94T.-BMXJ&7[$VP-(6V[4#,\_9)1^7?4L%#F:4S*5MI
M?<'3L-]3YT!M9&-N,Y-%\.F-XM>M0'!<V-OEB+#DX^M^'@W5UWGP<@D\++&>
MH*)+E=VK4L)LM$?5^KW363[RGS6U;Q_I76FBJ#*<S@VJMQ:.PGU97&E7GZ+;
M>5F R7/G8&7E.;<22VX-^#HQ,G7R@/@?*5EB._67:5*S5GY#DKE[/!NS?/M$
MZAU7(NVL0N-[+CZRS%]%0YO0I2_455S/:C50GY5AC+DL2Q8/2:@ ^MIUNABM
M&-#9/84WN^?)13B[<^I7C.H-N_4[6.N\V["YF4$W,+F;K7U>TSN.=;<BQZ2C
MR-13U;Q]5H_N8L1)FS+L,6EI:4:\CI;(XPLTHEL.E]: FD@,CQ\1N%K-)2:K
M46NDT7'(SKG'1&V]?LLEQS09BM-O/!:2UJ=;B2-I8TMR65EI*C1V];/8S V9
M66/3W?#)WQ3:SW_,W+IFML^&F<A9S-"4&BS^8L' <45 $'(.<K]NTS\FK]Z+
M>:LA;/118$7/R5 $="ZH+M)[<D">(CP*:_:4&2^LT'5V-7'7;"ZQX]I:HS2U
MEKZ?Q[6PB&)VD.,2B M@@F#4)]<_#%\EFWP+;^*UALXL32Q5[YXWE9?4^_M7
M,KO1OEXM\T1'^*>2(O=$=V3R1%[)W1%[]E[)W_GLG\=%%ZZ(CHB.B(Z(CHB.
MB(Z(CHB.B(Z(CHB.B+C/4^MCC^B;I :W+Z^UT=!8:2E;4%0U-;&3<455H;<*
M%?8LK6^D$T >8MIZV2ES=Y90B-KS;*I"$NZ.6R*$UT?9NW@H_#ZXZ0%S$UO'
MMU012AW$@TXYY!RF6N=*Y79<9>"M/H:.]$UWU_&26-7EKFIJM >MG9U\M:$?
ME;.&8KO>"NZHY*L^1<EQ1=44AN),VNMM<YIP9 QSK3.V6<RV^*T%"UM[50L=
M*!J,B@*'DTXTAE?&I4(@R&1K'<=)=0H7E29UN)RP33=";?,Y6VO >2+J4H!@
MCHHR:#&/@<LYXHK_ '&QY^)ZHD<[E;XR-_<C57NG=%"L\ST#HQQ'2G?7KUDQ
M>;UT I,[.3- KH1YI6HZAQ2M5T<;GM1R)G$54543OV5%[?PJ=16>QUOWFDV2
MK-I?93,WA?)-Y&7<YZEMBHQZ#&-@818UHQDS(&R9Z1[86R3.;&U\DCT8C4<]
MRHKE*3Q[3WR6CC!=OH@+<HWDBYCD UVQH(4&S^-8UP>?TEE3AR2))GY54B08
M.-Y#FJV-TSGNCCC8J,;3+H.X!0.7U('(LL=</N"]YJ\O)R1<M HLUBKD29F?
MQJ%2$Z,_:BFQSO6@=$Z&*/-A.&:R&-['RDK(^5'1I$N!S/9OE+S@)>[]^R^V
MHVX!VF0SL7)%RX*_K=889+)G\:I,<M$VC41H[VY]L362+9S^^DD<CG>$7MNC
M\7><0N\B+[M,P?;&Y9=D'M\]65I@7)%U)*9K<512M)S^->Q!-'K::A-D8D>?
MB<A$0EC-(,Y7.C80V-TD<L:.C=1/H>P=6>Q]K8V==M<]C]7?A<DW<AE'F[VX
M$C)H,8\>0FLJRC8&3LCST4CH72P,;*UDL;W,5R->QRHY F0,2H9 G *1IE]8
MJ(O]3-#^J)_R'$__ #?45G\R^_E17$A[;29P2W-Y)NHB9S+H=[!L_C&0HRNO
M+&MA5K9,_*]'.@#C=(JO5%E<]6HUJHUH[WO0*!SA4W8%L;^V:D^$.NIC=_47
M5O+>.S&R&IJ\\@*O!*> 5@\1I%C)CK!@Q))(K#0'MCE8/&]1_9C?YNC5[J;L
MQ[D>RJL'J(CHB.B(Z(CHB.B(Z(CHB.B(Z(CHB_/WE?D_:YCD$P1O!.=EL@=$
M!3\8;6;.FV4US:;*PJJ"R"HY5@'(DO(*RXM]5;Z%@"YH*K ?FS#B3[D\FM*3
M?KLY_>$_E=J?5Q1'03:'"PZ6H"T>=@T(@5/2VM\ZHMCN,)9]/078-#BJ[1S4
MHYW($%I3)E:2RK!CB?9+MS<="9K23W=[SU*FU3>;"WSG'#_472!<>7(/,ELX
MXEN@%I:8NOMN)=_>4T@EY36(<;/JI+C\-+=(:PFQLL\080Q?L8XUHOTEU"3E
MK['I/ G5-N4I^#GX._:'O*2<E8P/:BBY;LB7O5+4%7>,/Y;)Y]F(YR_L=XHB
MN_3Q[I0"]#0U&1;NJ6OIFIH>3P-\$WQY!H5=\0CQ1.8;)RJOLO[)X_EZ]^Z_
MIV[+W_CLO48X'H47,N*O>.(\;DHY>18X9&9FA9)"O+5S"L4C:H5KXUA35,2)
M8W(K/;1C4C[>*-:B=DTO'GT^E]B6'!^#FPL3'8\%YC9P.3^-W(#O.I+:J'9#
M086$:_:O(KQVKM]Q)&UO*]W U\4NIM9(ID:S4L21)V.;,DZHYTZ/]USWJ]7*
M/G?_ )4AQP%U%Z/ \#_'S8$VMCX;YOS6X>,V((A%M&(07BH   \F88*9\<6_
M&4^^Y GM.01UB7-<>1BDE\KV\?NNC.Y <1"PE^I:Z=($D@<Z%9)&CK.UR,C4
MA5DR!B\M[O>+F ^.YQ*^/>-\/X79\<(>&L^$ALOZ:R+6)@\GG_);")S 6\S"
M%YNS7*:6AW$#^2< Y-]6/%92;M)YEY9LWLAD<F7]AKB':M5@=+VE\6I(SW_!
MW='^W^W*'S,7&'UH>\R)!>%;V?"CR^6&SF2_E(,F#4,IB[G5-]Z9PQ)6438M
M]43K^?\ &KI6)RU9$>(S-]G7E2N8NLD\&0#-EFDG[-^,R-TZ21K'YMR#S8/+
MUESPYNN.VAL1 3 (07%"7F6-5).2".#'<=[U@F]HYBG8O4M&A9RY9$/EG=1G
MMAB9 NMD2=TDBM8V)6/]Q51G@[R[+0"]#T^0RY%,VD\"]D[\@T/\?]XK+_Q_
MQA_C^.L44"XRGX.9C*]I>\I(2/L-(KXY.6[(=Z-=I[AT3EB_+8_%'Q*R1KO!
M/<:Y).[O/R7*($DL"VB@:;4>)M'+=E9W#RYQQO+3\K9#VU*[DH-1SA;R;102
MR)Q3Q>V=&6DYUB^;VYFOC<SY3TA>UT2-9X^*0W:>Y0--N>N[KE='451T1'1$
M=$1T1'1$=$1T1'1$=$1T1'_K^.B(Z(L<D44S?":..5G?OXR,:]O=$5$7Q<BI
MW[*J=^W?LJI_GHBK_(Y8ZML]<=<N@(CMKN>>J"99V%N&#61DFO%='!;#,6L-
M)A)C^<'72K4PM@$$"@8T-Y9Q-=[.B\V>9M"=YF[<*407/UP)L=N#\XY$LUG&
MLX8HEHV#?4ND&,(K"XK24GY2,A)%4=6_'E84:;[^Z#Y7K292RL--C;6I+8"!
M336*6P'S'C 64!KZQ5^94P5DS;B>$0,Z&M=-:5<564:ICX[-BO#4C"X#T]DR
MV66;HL\73 N^KG.GKXGV !MC2'"!NL1?LYP+&DE%/@L8ZWY;J[QF:.\]!FF(
MX19D5O%&&0DU+K]XK;TE)(;FKZOI/BUUN7268=58.:L2A6$X,\(1BD112D1J
M,0^.;WHV2S,5GN-:]Z(BD(!>0?0?!6EB:(NMRU.%H'BVEM!#-\DY5>:Z9DA4
M\HB2&&00E%2PA/'@E(FC9)+)$YZI^J*I&& HWUHDV!R=U2.U*Z2P&N(K'1E&
M4L+IB[%U?6>VQC(Y)[*-JP33O19)*^OBAJ E:B 0QMED3HC!W8=)I";E]#'O
MZJ=EDUV=FT5M;20+93QSQ KF\Z(-1,J(JI*LH!;46V->XTF602(KS"\+ R0P
M,KO"_+9O6]IL3K#M"MCGM()4U$I_'A)=44-,0V07.WER7I00?CJ.RK9H*\JI
MA)E9\IUBZO>"8T<*57/*,,!G+=ZWK+,7LW(^?N13069(:IF'.HUD*'5Y?LW;
M9S/A#P*#92SS&Y]!WGS,;6PUA[H()R#HI127^V>/HK+CBBA:K(8HXFJODK8V
M-8U7=D3NJ-1$[]D1._;OV1$_PG159.B(Z(CHB.B(Z(CHB.B(Z(CHB.B(Z(O_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>g425213g55v25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g55v25.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2 X4&AO=&]S:&]P(#,N,  X0DE-! 0
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M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!L,B3@        "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M   _@   .$))30/R       *  #_______\  #A"24T$#0      !    '@X
M0DE-!!D       0    >.$))30/S       )           ! #A"24TG$
M    "@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8       $
M+V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0
M  8       $X0DE- _@      '   /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$'@      !      X0DE-
M!!H      S4    &              %^   %HP         !
M              $             !:,   %^                      $
M                        $     $       !N=6QL     @    9B;W5N
M9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,
M969T;&]N9P          0G1O;6QO;F<   %^     %)G:'1L;VYG   %HP
M  9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L
M:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU
M;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU
M;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG   !?@    !29VAT;&]N9P  !:,    #=7)L5$585     $
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M    H    "H   '@  !.P   %6D &  !_]C_X@Q824-#7U!23T9)3$4  0$
M  Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5
M  !)14,@<U)'0@               0  ]M8  0    #3+4A0("
M                                                     !%C<')T
M   !4    #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R
M6%E:   "&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5
M '!D;61D   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #
M^    !1M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#
M   $/   " QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY
M."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)
M14,V,3DV-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M
M6%E:(        /-1  $    !%LQ865H@                     %A96B
M      !OH@  ./4   .06%E:(        &*9  "WA0  &-I865H@
M)*    ^$  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M            %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                          !D97-C         "Y)
M14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M             "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S
M<&%C92 M('-21T(                             9&5S8P         L
M4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
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M $H 3P!4 %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +(
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MU1CZ&2 911EK&9$9MQG=&@0:*AH
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MM_$9,S1'5%AB=(*$AI/"TM=#14A3>(>7HZ6GT]76_\0 ' $!  $% 0$
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MT/$U,R?/WLJ3*1CJ$P2C)J;=,$7#1PI<BHO,N??$@H;P*/ 3%G6AJK-[BHJ
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M*UF5;E$LAT%:/N*H-Z?()V^N*,[4NHZ*S*A6W19 49Q51X8K4J<6=T8SHQ4
M#S3 71%^!LQXC+5BW@V2\=!2U)/Y%3MQKK60JZLS[09B$4G/C(_)1Y,79#M
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M*UUI(.TD.5E6K)Q(IN7":/[J=)(Y4_IB4=<MP9/< #VY_>I>H[L7^'NM&/\
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MZZRV+0<)Q.001A]\<^RVJ'/CQSXF-5\*4=<V0[)H/E1IGK$Y@<^/F6[[9;-
M4Z$DK):)B,K]?AVIGLK-3#YO'1D<U(8I#.'CUV=)LW1 QRE%554A"B8 $0Y#
MGBBA0KW5:G;6M&I<W%9X92H46E]6H]VC&,&;G'@,IYK8CG-8TN>X-:T$N<3
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M6),T3+MTFX2,89H[5:,5U563<BP;\4EP]4PY4$75:ITU%1N7L?R<1$WVBO\
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M Q]$XC_!UE\K1H%S0(G\JSW@MK;Q!?O,,]?Q+3_GR%URKT>?GAL[Q_E!R_\
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M,25^T'EVO<]03%$?HB/8>HO_ !@X^.MYD@$%O#OU]O)1[@[^:_W2%MW^&/\
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M38VLYK6,8P!K6M    R$ <(G%H2ZUMRXEQZIN9,G2<SQ5^BS$9Q].09E, F
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ME5QFJSP7=;4;O%S2 'C>(SS !DB0<QQ!Y+6OX#I(' =B)AQQZ"!"@(<?$!Y
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M,H/PUU+K'O>&NK'$'5-P%Q#"]S=YQ &\XN)DF5]<?#:=6T+&- ZM[,@! @@
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M4U$R+J@?F/83$\3NMLMGVWV(WEVX5JS#UUQ6JM#:EO6+FCK'NAKRP;S1 =N
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MJ$4 CE!%0H& #$#6]-GMN-E++ ,&M;O&K.A<4,.M+:M2>Y^]3JTJ&X\.W6&
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MNU05ZE5!20PZHL?I#OTIIF,/N#7FQG'<)N<+O[>CB%I4JUK:I3IL;6;+G.$
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M YY$1 H>HCR(\>G/U^OUZO:UK00T  DDQI)U,9Q/+15.9G,"(B<N_AGYD\D
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M+<N3 #Z9R5(';Z3]ZZ@@4../0!Y  Y^/(^_W^_1M)C&AK6M #B^&M#1O3.]
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MCM260,F<6%_3KK>'=K6Q*DJ9#;(/E:_'Q\>U 0-<]/:/LE4L_P##.=R%/I<
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:31$T1-$31$T1-$31$T1-$31$T1-$31%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>g425213g61f03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g61f03.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1D24&AO=&]S:&]P(#,N,  X0DE-! 0
M    &/:^8Y X0DE-! 0      #@< 5H  QLE1QP"   "   < E  "%1I;2!2
M>6%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;CA"24T$)0      $(E,
M*T ^4D:PQ&_V$<%;PI<X0DE-!#H      /$    0     0      "W!R:6YT
M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
M  !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE
M5$585     < 00!0 $0 +0 M #(       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ "4S,P
M 0 " )3,S  !  (X0DE-!"8       X             /X   #A"24T#\@
M    "@  ________   X0DE-! T       0   !:.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         "
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!$0      !     "   "0    D      .$))300>
M       $     #A"24T$&@     #00    8              Y(   =?
M!@!G #8 ,0!F #  ,P    $                          0
M   '7P   Y(                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   Y(     4F=H=&QO;F<   =?    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   .2     %)G
M:'1L;VYG   '7P    -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M .@IX^$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M      #_XO__24-#7U!23T9)3$4  0F^S/[^'@ (@'!!1$)% A   '!R=')#
M35E+3&%B( ?0  < &@ % "D -6%C<W!!4%!,     $%$0D4
M       !  #VU@ !     -,M041"10
M                                "F1E<V,   #\    =&-P<G0   %P
M    *W=T<'0   &<    %$$R0C    &P  "B!D$R0C(   &P  "B!D$R0C$
M *.X  "B!D(R03   47   (XM$(R03$  WYT  (XM$(R03( !;<H  (XM&=A
M;70 !^_<  "0D61E<V,         &E4N4RX@5V5B($-O871E9" H4U=/4"D@
M=C(
M                                                =&5X=     !#
M;W!Y<FEG:'0@,C P,"!!9&]B92!3>7-T96US+"!);F,N  !865H@
MM5H  +QG  "2,&UF=#(     ! ,)   !                     0
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MYN?H-NF&ZMCL*^V [M?P,?&0\N_T3?6J]P3X6OFK^O;\.OU[_KO___\ @ "
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M@E*JZJ %@;FF+H?5@4ZAQF[]@0F=O%4?@..:,SB)@/.8.!(?@;R,0>0O@XO
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MY)PIJ]YYMHH0I]YYLG>*I!=YYF1'H)AZ4$_YG7-ZYCH?FO9[C2 IFIA\<0
ME=-_RJS.KRB"@YMHJN2!F8E^IMJ X';[HQ. 8V.HGYN )D]3G'^ (SETF@6
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MI(Y"M,* O7UBL 6 #6OSJXQ_GEFXIV1_<D9LHZY_@S%LH-Y_P1>PH3N N@
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MH(MPL42GI7J8K(*D$VDOJ 2A!5<EH]2>ET0YH B=22_$G/"<)Q<5G*B/FP
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MJ(%'O@B')W%>N)Z%W&#;LW6$\T^AKI^$63U2JEJ$&2DCITJ$3@^OJ$^$[@
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M]7_,NJ&LDV_VM1^HRU^-K^.EV$YWJPFD&CQOIKRB_RBSHU.;A1!LHT2+&P
MB_^  ([4O_"YR7^NNBVTFV_MM)NP+5^'KU&L^DY[JG"K7#R IB"G]2C<HLB;
MH!"PHKB+2   B^N  (2TT)]X\W77REEX@V:NQ&]X6U<1OM9X?4:SN9-XVC4'
MM0AY6"#VLG=YK@?KLME[10  B?F  (1BSY^ ;G6;R7Y_9V9PPXQ^K5;.O=9^
M1$9QN'1^*339L\Q^4"#VL/Y^GPAGL.I_YP  BA:  (1*SH6'Q75OR'R&069#
MPH6$^E:9O+V$(48_MTN#GC2^LI&#@2$+KY6#^ CFKRB#_@  BB^  (1&S7R/
M%G5?QVR-&68@P7*+9U9VNYN*&D8DMBB)2#2UL6:(_B$LKDF)Y E=K9N&50
MBD6  (0YS)B6A758QGB4!V8=P'"1\%9JNI>0248AM16/)#3$L%6.WR%:K2"/
M>PG,K$*&H   BEB  (0=R]2>(750Q:2;&F8HOXZ8D%:#N:^6F48XM"^52S3C
MKUV52B&2K!B40 HTJQN&Y@  BFB  (/^RRRESW5*Q.^B.68WOLR?.U:AN.F<
M_49<LVZ;N34.KIJ;K2'-JS*6VPJ1JA^')0  BG6  (/<RIJMIG5%Q%2I=F9*
MOBBF 5;"N#VCCD:$LL*BH34]K?B@Z2(*JH*7! KGJ4^'7P  BH"  (.^RA*U
MQ75%P\6PZF9DO9.L\E;RMZ.J9D;"LB6HWS6(K5:D,B)EJ=N700M'J+"'H
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MA)U\CN ?@J""O<KW@BF!][3=@<6!39W?@7F S(8C@4. =&VS@2F 0%0>@3"
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MBJEW?I-^B8YX"7TQB)=XLF8%A\5Y>DV>ARAZ23(XAR5[,0S6B21\>= \B_&
MQ[Q\BIF /J?:B6-_SI)HB%5_?GP?AVY_5V3[AJY_44R4AAY_7#$UAAI_F OL
MAXN 6L[BBJF+&[LAB5^)G*:LB"N(-Y$OAS"'#7KRAEB&$V/BA:F%1DN/A2:$
MEC!$A2&$1 L>AB2#PLU^B8^5=;FQB$F3%Z4FAR60VH_-ABZ.SWFQA6R-"V+'
MA,R+=DJ<A%&*%2]NA$:)60IKA.R&M\PFB+"?VKA7AVR<JZ/.ADZ9GHZ!A5V6
MPGB$A)B4'F'"A B1T4G @Y./T"ZO@WZ.\0G2@^&&I,KVB "J:+<OAKVF:J*J
MA9ZBB(UHA+">VG>"@^^;;V#3@UB87DC[@NJ5XRX'@M"5#0E1@P"&3,GYAW*U
M&;8WAC&P3J&QA0^KEXQUA""G&G:G@V:B]V 7@M*?1TA5@EB<=2U[@CB:20CF
M@D:&!,DLAP.__[5MA<6Z9Z#?A)^TWHNA@ZFODG7>@N^JPE]G@F:FI$?'@>VC
M^2T$@;J>< B/@:Z%R<B1AJ[+/;3-A73$V* OA$F^>HKJ@TNX:'4U@HZS %[5
M@@:NM4=*@9.JUBR7@5Z>)@A*@36%F\('EKUUA*]9E(IV"YP-DH-VEX?PD*YW
M-G+XCP=W\UT&C91XRT6YC')YIBL#C$YZC :IC/]\G,"\E7U_+*Y3DU!^RYL4
MD5-^?H<!CXA^4W()C>U^3UP<C(A^;43.BV]^F2HGBT-^^@8LBVR %[^.E%>(
MV*T8DC2'G9G[D#:&=87DCGB%B7#_C.J$QELHBY*$+T/QBH&#NBECBDV#N06^
MB@J#)KYODT&2IZODD2B0F9BYCS>.H83(C7",XV_KB_2+9EHPBJB*'$,9B9Z)
M$2BJB66(YP5?B->#H;U'DF><A:K/D$Z9LI>9CF&7 X.5C*J4A6[9BRB205E
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ME5&M=7:%DLZI5F,@D).ERT[FCJ>C2CE9C0"A6R ,C)"5JP"]B1N @*P4FIS
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MYI"7HS64FG^IG\*2?VX"G(B0GUN<F8F.]D@LEOV-OS,FE0*-+QG(E2V,[0
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MQ(9]L+AT-W:0K*)TPF7OJ,5U;%1GI2MV,4&BH@AW RSPG_AWK!)NHAQWK
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M^8/+K&::2W/4J#B7U6,OI$&5K5'.H)23Y3]FG5F2PRM FPN3$Q(0F_*,-@
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M+GFYN@AZU&JNM3QZK%KTL*MZMDI/K&YZ[CA?J-5[0R0TIL=[@0J?J"Y\8@
MA;:  (?>O?*"Z7EBN/V!]&I>M":!+EJ6KX^ M4GVJTR =#@:IZR ;"03I8&
ME K?IH.!)@  A6N  (>7O.>*F'D!M_6)&VGGLR*'U%HLKH&&UTF4JD&&+3?/
MIIV%U2/RI%N&& L7I0>%40  A2F  (<^O J28'BEMQ:08FF$LD&.IEG K9Z-
M,TD_J4Z,'#>/I:R+EB/7HU:,/@M*H[F'H@  A/&  (;?NV*:4WA0MF>7UFDU
ML8B5G%EUK-^3O4CYJ(R253==I-.1QB/#HFN1Z MTHI2'OP  A,*  (:'NMZB
M7W@)M=J?9&CUL.^<KEDYK#Z::TC"I^R8VS<YI"R8JB.ZH9B6HPN<H92'V0
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MV6V7PYZ V%]'OCV #U!.N0M_H$!]M#I_;2]0L$=_=QM]KI)_JP27K$F =0
M@R&  'MPQ^B)%&U]PG.'GE\7O1&&9U EM]2%A4!>LP&% B]*KP*$WQNMK1V%
MA 42JIN#;@  @Q^  'M;QNR096UEP7".@%[^O 2,Z% "ML*+I4!/L=^*SR]0
MK=R*K!O?J]"+, 6!J22#N0  @QZ  'LYQB67Y&U4P)J5D%[WNQ^3CE #M=61
M]D!/L.Z0["]AK-*1 1P5JJ:0"P7DI^&#^P  @QV  'L7Q82?=6U'O^J<LU[W
MNF":1U *M0R89D!;L"6772]YK "7>1Q+J:.3(08[ILZ$-P  @QV  'KVQ0:G
M,&T_OUNC_5[\N<&A+% 6M&&?%$!GKW6>62^-JU:<TQQXJ."30 :'I>N$:@
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MB(1]:;5)CHN"ZJ0,C0*"79(#BY*!TW[7BE.!:6K,B3>!&56[B$J XS\VAYZ
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M.Y;1E@F RH7ID]N 97/MD>6 '&$%D!U_\4T!CIA_WS=CC8%_UAUWC?Y_\P
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MNY*]DC&L"X&KD >H1F_'C@2DIUTMC$2ABDFFBL^?9#2TB9B=V1N+B8>2GP
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M2HD-GF.'1'D8FX:&4VA.F-F%A%: EG.$XT.3E&2$:B[>DO^$*Q4'E#Z$@
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M\(8[FVNQ*78BF'BM1F5!E:JIKE.TDRJG#D$OD1*E.BT.CWV>=A0"D R-AP
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M@WPTITV-#6T>H\&+M%U!H&**@4R)G4R)B3J-FL&([":4F3&(_PT_FER'/0
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M;''AM<!N:6.QL;UO<52KK>EP@$29JF!QC3,!IY-R>!Z[IM%RP06]IS]S;0
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M!G!/L*V20&((K'&0EU,"J&*/)D,EI*J.$C'^H9V-M1Z!H".-X <AGJ.$T@
M@ "  'V?M&F;YG +L!*9MF'&J\F7F5*^IZ^5Q$+BH_:4@C'2H-Z4>AY^GRZ2
MIP=.G7B$\0  @ "  'UJL^FCY6_8KXZA4&&0JSV>S5*&IQN<J4*LHUR;<#&<
MH$J:XAYFGGR4C0=YG':%#@  @ "  'TVLYNL1V_0KRNI5F&$JL&F75)DIH*C
MZT*0HJVBPS&4GX^?\QYVG<F4F0>@F\6%*   @ "  '*OQ4ALWF6EP*QMM%@=
MO#ENGTG3M^QOE3IUM %P@2E3L31Q+126L>EPN   JRET>P  @ "  '*BQ'=T
M<&7#O[%TBU@ZNP1TU4GQMH9U0#J6LG9UORF-KW]V(145K\1UNP /J>EXYP
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MTV4_NF*6X%>NM7^5"DECL,^3C3H_K)"2PBFVJ3B3!Q9@J"V/(0)'H;2!B@
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M'<&D;QN"9ZRU<)F!PI;,<@"!28 <<UZ ZFB3=+* G$_9=>6 2C1L=KQ_[P_
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MVISYBH!KNXO]B7YM<'G B*EO"&9IA_%PF%'LAV)R)#OHAR!SA2&QA_5T3@
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M?I>6@_J7?H:!@S"57'1O@H"3,V&,@?&1,$VJ@8:/>#A%@46.4AZU@5B-W0
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M6H\6D<AS37\4D"=T,VWZCJQU%%O$C5AU^4A5C$5VV3,HBZUWBAC]C0!W@P
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M@HJ'C%J=,'IYBLV:M6EZB5Z8/5>MB"&6"D35AQR46S!>AE>3]!;_AK*/C0
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MV8%UF;IZ$G)]EVUZ36)@E5-ZE5$]DVIZZ3[+D>%[0"I9D1Q[<1 &DR][)0
M@ "  ([/FLR"/8"2F&Z!VW&$EBV!>6&0E!.!)E![DC> ZCXJD+. PBG>C^*
MJ0_2D9* J@  @ "  (X F;2*J'_&EUF)N7"TE1V(QV"TDP>'WD_6D1R'##V;
MCZ"&>BEWCL&&/@^MD!:%>P  @ "  (U5F,:31W\7EGB1RW !E#R00& *DA^.
MND\SD#.-8#TECI^,:BDBC;:,70^+CL")D0  @ "  (S&F!B;]WZ:E<^9^&^"
MDXF7U%]ZD6"5N4Z>CW63\3REC>*2S2C/C-B2Q0]IC9V*:P  @ "  (Q5EYFD
MOWXBE5*B0V\ DP.?DU[VD,V<\4X=CMR:U#PFC4^9W"AKC#B8&@]+C*R*5P
M@ "  (P!ESVMQ'W#E/2JW&Z1DIJGJ%Z"D%:DD4VTCENB43O/C,:@]2@?BZ^;
M(0\<B_F*-P  @ "  (.)J1-H-W8\I?9IX&@5HQYK>%CBH'AL_DB+G@YN<C:R
MG#5OMR)>F^-P6@A8G:]P(   @ "  (,2I_)P9W7>I-9Q1V>MH>=R+%B!GR=S
M%D@PG*MS_C9GFL-TRR(KFD=U'@B FW1U,0  @ "  (*6II9X:'4_HXAXHF<B
MH)-XY5?OG=)Y/4>PFU1YH#8 F6=Y_B'KF,QZ%0B=F6=ZIP  @ "  (( I4*
M4'20HCJ  &9?GTY_ME=.G(Q_@D<<FAA_:36+F"E_7R&AEW5_6 BNEXM_DP
M@ "  (%DI"6(1W/PH22'>&6UGCR&K5:?FWF%\4:6F/J%7#4;EP^% B%:ED*%
M% B\E=^#T0  @ "  (#8HTN07W-HH$Z/&64NG6&-RU85FIB,CT83F!*+B#3(
ME@>*\2$KE22+8@C,E&"%\P  @ "  (!MHI"8AW+WGYF6SF2XG*B5 E6=F=J3
M346FEU&1\C1WE3R16R$5E!Z0Z CBDPZ& @  @ "  ( 4HA2@TW+#GQN>N61^
MG!><;551F2R:.$50EI68IC07E(Z882#&DV^5?PCHD@"&!@  @ "  '_1H;RI
M7')]GK>F[&0NFZ:D,E3ZF*VAI44"E@V@+3/9D_R>?""9DMB6"@CCD3N& @
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MX6A_JUB%+EL%I\^$ATRWI&V#\SURH62#CRR0GS*#:QC9GO>#OP+MFCN!^P
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MM%W.NT!H#E#CMY9I<$,CM 5JQC0JL.AK]",?KSYLH@XAL4AKXP  GP1SL
M@ "  &GMOCUN,EW/NCENV%#UMD)OG$-%LG=P;C1;KRYQ,2-SK4IQG ZUKNAP
MY@  G<!X*0  @ "  &G-O.=U9%V=N-IU@%#5M,]UN$,FL.UV&311K9!V?".1
MJXAVK@\<K,AV)@  G(E\(@  @ "  &FHNW)\:UUAMV9\'E"'LUU[Z4+RKW=[
MWC0MK!1[\".3J?)[^ ]GJN)[V   FVA_H0  @ "  &EZNC&#?UTUMB."VE!6
MLA6"2T*TKBN!US04JK>!FB.4J(6!G@^IJ3"!K@  FFR     @ "  &E.N3R*
MNUT>M1R)R5!$L0"(W$*>K0V($#/\J9&'DB.=ISJ'P _FIZN&N   F9"
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M?8\D?GV(SW\'?E"'_VWD?BN''5O6?AZ&2DB1?C*%F3.R?D*%#1HY?EF%#
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MDH;RC9UE\7?PC'EH(&>?BXEJ)U8;BKML%4,]BBIMX2YVBBEO1Q/(C)MO%
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MOH)4ADJ.LG-#A6"-=V,BA(6,)U(D@\R*\#_R@T2* "O2@OV)GA(?@V>(.@
M@ "  (^HAF*8M8&:A7B7%W*%A(F5.6)G@ZF31E%M@O*1BC]5@F600BMO@?N0
M'1'E@AZ,&0  @ "  (\@A;RAOH$)A-F?EG'I@^&=&V',@O2:BU#5@C>86CZY
M@;*6]"KP@3J61A&R@1&+]P  @ "  (Z^A46J]X"7A&6H5W%C@V*E16$_@F*B
M(5!8@9>?F#Y6@0J>92J;@(Z;-1%Q@$6+RP  @ "  (=\F)UC%7IIEIAE66Q$
ME.-G>%SADV1I<DQ)D@]K33HVD2!L]279D3AN 0L\DY5M=   @ !]1H;5EOUK
MBGG/E1]M FN9DVEN9UQ%D=MOOTN\D'MQ!CF^CX%R)R5XCW9RR LND1AR10
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M1'7QCMV3\&>\C3N28EB&BZB0Q4AKBDV/:#<4B4*.F".>B+*.Q@K&B!V'20
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M6&SNG4)S(5^=FO1SYE$AF-%TK$&"EO)U:#!$E;%U_APVE@5U^P12D\5W30
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MZVI+F :8@US=E:Z6RTYSDV&5##\>D663UBYCC_N3TALPCXR1/035C!R#10
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M"&"OI@-X4U/]HRQXG$9JH'IX[S>)GC-Y02;=G-QY;!*7GC)X]0  E#!\8P
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MXU]6H:2<J%*9GIB:]T38FZ*95C8SF1>8SR7\EVJ6YQ*JEZF,G@ +CXJ "
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MTE3IKZQ\OTB^K%U\K3NYJ31\G"V.II5\HAT9I8Y\F0GJI8A]&0  CL&
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M4)0"<Q]S;H/D= YT=')H=/AU9E_L=>!V4TQ&=L=W-C<1=X5W[1V==Y)X!P
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MTXZ*:^.@5WY8;06=D6TU;AV:O%LV;T*8*T@P<%*6&3/1<-25'QLZ;S61>@
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MYX:\>2IZ<G>7>85ZVV=Y>>%[.580>DY[CD-Q>L![W"\)>QM\"A5F>QU[I@
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M'(*Z<X^EBG-]<_2BDV-5=%&?CU)3=,:<_4 S=3F;:BQL=3.9C!.+=+2--P
M@ "  (LLB'Y=\'X1AZU@QV_3AQUC:F!'AKAEVT]TAG%H)STKAF9J.RB\ANUK
MN0X&B/YK1P  @ !YTXI1AC1FK7TZA:1HM6[LA2UJFE]SA,YL8DZZA(IN#SR/
MA'QOCRA A-]PCPW7ADEO]0  @ !]6(E>A =O4WP=@Z1PHVWM@T)QVUYW@O-R
M^DW?@KMT"SO8@K%T^B>S@O=UAPV>@^=T[P  @ "  (A/@A1WZ'KZ@<5XEVRX
M@7AY*EV$@3)YJ$T @0UZ'CLC@0=Z@2<L@3)ZJPUF@=%Z70  @ "  (=*@%:
MBWG]@!N HVO"?]^ EER+?Z: ;DQG?WN 23JH?WV +2;<?XZ $ U2?_Y_Z
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M9G':D)%@&F1ICW%BIE6ZCH-E!T6^C<-G.30?C7)I&Q_2CE9J%P9.CIEJ%
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M1&VYB!:%^V!>ARJ%AU(+AD*$^$*ZA7R$<3'RA/>$(!YNA/F$.P:1A#R"VP
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MC&5GF$=F;UBTEJ)H0$KAE2-I^#NVD^IK@RJODVYLJQ8PE1=LE  OD+YNM@
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M)V'UD-6*H554CT6)Y$>SC;^)%3D&C':(=BC/BYV(415UB^.(! $#A]^ KP
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M=5D,H+AKN$T9GI1L\3_XG)IN'C%_FQ%O&B#0FL%OE0Q]G&QO!@  BGMWH@
M@ "  &.=H0=QJUAKGN)R>DQHG,ES/#]UFM%S]3$1F4ATC2"0F-YTPPR.FAET
M50  B11[Y0  @ "  &,.GVYX\%?AG5-Y6$O>FSMYK3[CF3]Y[#"TEZEZ)R!-
MERUZ,0R.F %Z*@  A]%_G   @ "  &*0GBR 5E=QG!: 84MUF?B 2#Y\E_.
M&C!5EDY_^B EE:)_^ R5EAZ $0  AK2     @ "  &(FG2V'OU<9FQB'>4LD
MF/"&^#XHEMR&9B_ZE3*&#A_FE&V&1 RLE'2%#0  A<Z     @ "  &'5G%Z/
M*U;,FDJ.FTK3F!R-OCW8E?V,VR^NE$2,=A^+DWZ,KPR)DR6(>@  A2&
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M.DS?JB9O_4%7IZAPN33GI55Q;2;?H[QQ[!8*I$YQJP2$H5QR_   A4%^B@
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M?DP,I'J2(D"GH;J1530NGR.0I"9GG2^0F18FG/:-Y 5JF'"#J0  @8"
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MC8NC;NYE#WPQ<$%G:6NC<8QIH5GE<M%KOD;F= =MNC(X=/5O8!C2=,EOW
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M$H5E9&:0V'9&9C:/9F8A9^V-XE4-:9*,?4+6:O2+5B\5:VJ*K!:=:R.)QP
M@ "  )+>82Z;B82R8SN9H76.90Z7=65N9L.5.E1>:&V3/4(O:=*1LBZ3:BZ1
M)196:A6-Y0  @ "  ))F8$VD\X0N8EVB9W3[9"F?A&399=:<G%/89WJ:%T'!
M:-F84RXB:1B78!7E:4R.S@  @ "  (Y\>.=8L8$G>5)<"7*W>>%?*&+^>H1B
M$U(!>S%DU#^=>^]G7BL\?,5I6Q#>?E!I8   @ !V"8U2=>%ANH 0=IED0'&<
M=U)FFV']> ]HTU$?>,]JZS[=>95LTRJ?>D=N0!"(>X5M]@  @ !Z'XP=<QMJ
MM7Z]= EL>7![=.-N'6#E=;MOHE R=H]Q$CX:=UUR72H+=^US11 ]>1!RRP
M@ !]M8K5<)-SLGUK<:ATP&\I<J%UK5_H<XUVAT]/='IW2SUG=4]W^RF.=;UX
M:1 #=NQW\   @ "  (F3;FM\KGQ0;YE]%FX+<*E]5UZX<:5]>DY=<IY]FCR*
M<WU]NBC=<\9]PP^A=25]G@  @ "  (B);*2%MGM';>.%>FT.;O^%#%W'< F$
M@DU_<0>#_SOC<=N#F2A;<?^#90]:<Z&"^@  @ "  (>R:RR.NGIU;'F-WFQ!
M;9R,PUT";JN+D4S&;["*>SM(<'Z)IB?Z<'"):0\N<EF'<   @ "  (<,:@*7
MN7G-:UB61&N5;'R4@5Q=;8F2J4PC;HZ1#SJJ;UN/]B> ;R>/[ \ <5"*)0
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MRG(.>@UR]V26>FAT!58N>KMT]T9;>R!UTS47>X=VB"%T>]1VT BR?7!W"P
M@ "  'V =XEZ2W#Y> MZW&.,>'E[254L>-I[F46T>3][X32+>:E\&R$9><!\
M( BJ>Z%\E@  @ "  'R/==>"WG L=FN"WV+-=N&"K51?=T:"7$3E=ZR"$#/R
M> *!WR"?=^.!U0B#>A^!7   @ "  'O+='&+:F]F=1"*WF(,=8F*$%.E=?&)
M*$0T=EB(73-<=J"'V2!*=CN(#PAR>-B%50  @ "  'LQ<U*3\&[.<_N2X&%S
M='.1?U,3=-60!$.C=3F.S#++=7J.*Q_<=.".#0AC=\Z%JP  @ "  'J^<GB<
M?&Y7<R>:_6#S<YN9$%*3<_*7#D,U=$F5@3)T='J5$A^!<[:2U@@L=PJ%A@
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MX&6Y@1UXD5D.@.IY(DM=@+=YF#R9@)-Y_"OH@*EZ0AA(@/]Z$P)N@41[P
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M"EW0DTA9]U&NDE5<Q411D95?8C5YD25AL"1RD:)C50]/E(QC)P  B EIF@
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M\%GNB3!]2TX B&=]>T$)AY]]C3+>AP1]F2+9ALQ]HP\+AQ)]M0  @!N
M@ "  &1:B(B$BUE2A^:$=TUHAR"$+T!VAE2#T#):A;"#BB* A5B#B0\SA2&#
M1P  @ "     @ "  &/>AX",15D-AN^+Y4TOAA^+)$ _A2R*.S(OA&>)L"(V
MA :* 0[E@Z"'\@  @ "     @ "  &-\AK&4&5BMAB&3?$S+A4V24S_AA$^1
M!C'C@W.0;B("@NV0*@[;@EV*"P  @ "     @ "  %S@GO%5WU)"G5E8GT;
MG A;13GYFOM=N"N)FGU?OAI)F\U@N :$G$IA!   @Z-M20  @ "  %P&G-U=
M'5&LFUE?548WF?1A>3F5F,!C<BM1F!1E#!I0F1%EM ;?F-UEXP  @A!R,0
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M$TZ6DCZ!.T-,D.J!(S;MCY> ["DNCJ6 SAD@CJF ZP=0C!R X   @ "
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M[T4MI)9CCCI!HNME&"X1H7YF>2 3H0=G5@[1HN%G"@  FMYI[@  @ !Z/
M@ "  $['I MHIT2CHEEIWCFDH+9K 2VAGTEL !_ GK]LD0[&H#]L*   F'=O
M*P  @ !]_P  @ "  $Y+H@MO<40KH&MP3CDSGL5Q$2TKG4QQI!^,G*5Q]@[
MG=EQC@ UE@!U"0  @ "     @ "  $W7H&IV8$/*GM-V\#CDG2AW52SKFYYW
MD1]8FM=WG [8FZEW7@!QD]IZ5   @ "     @ "  $USGQ-]54-_G8-]HCBK
MF\]]L"RWFC=]GA\FF5U]C [1F>5]M0"PD@E^S@  @ "     @ "  $TDG@.$
M64-*G'.$<3B!FK:$,BR9F0B#WQ\*F!*#Y ZJF'>#>P"UD)F >P  @ "
M@ "  $SQG2F+CT,HFY2+ACADF="+""R&F!"*CA\3EO.*KP[9EQZ(1 #=CV>
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M[(AU5UU[7WE)6FI[O6D>73Y\"E@"7^I\5D6.8BA\I#&M8QM\Y1FP8T1\[@
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M8H.>:TQ7+W3S;/!:S&4;;I!>-U00<"-A>$&L<9AD@"UU<J5G"1/1<\9GQP
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M"'S27&J"!VZB7O*!WU]E84:!H$\G8V>!9#V=90N!.RI-922!+!'F:/>!.P
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M#G<W;S!? VF!<(1ASEJE<<UD<TJ"<P9F[3CA=")I)"4+=,AJM@N-=_=JJ@
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M)G%>8EJ'RF0/9$R'-%6N9@V&AD8]9YB%ZS5P:).%@B*D9Z2%B@K+;L^$0P
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MEVJP=!=EU%W\=0EG\T_\=>IIZT"Y=K]KN"_%=WUM-1P0=\MMU@2<>\5NN0
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M1F8 :4.,L5EX:I:+S4OD:["*SCTH;).*!BS<;-^)NAHK:_:)S 29>#J#'
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M^%Y.>@1KH5)1>H5M+45+>O=NF#:_>VAOSB9,>]MPH1(Y?(]P2   @ !T_@
M@ "  &AC=M5QTUU4=Y!R]5%=>"5S]411>*)TT38C>0MUC27(>6!V Q'U>?AU
MG@  @ !YX@  @ "  &=S=*!YQ5QP=7AZ8E"(=AYZU4.:=IU[)35_=O][9"5]
M=Q][DA'7=[E[8   @ !^"0  @ "  &:N<LB!LUO+<[V!VT_V=&N!Q4,+=..!
MC#3I=3F!8R3W=2^!9!&I==J!B0  @ "     @ "  &82<4F)FELT<DV)54]B
M<P&(O4*"<W2(!31G<[N'BR1R<XF'FQ%+=&J&P0  @ "     @ "  &68<!:1
MAEJ^<2B0ZD[K<>"/VT(3<DN.LS0+<GZ. B0O<B&.-A$1<S^*\   @ "
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M/5).@1)P<4;T@1QQA3J+@15R;RS @2=S+1QG@8YS8PEA@>-SB@  @ !\K
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M/4J,E?%353^)E4]62C,FE0)8^B3/E7=;%A+OF%);J &"E*5=C0  @ !M%
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M@$:9B6=T7#O2B/UU#2_JB(QUCR)IB&AUUQ'BB1]UB )%AE5X2@  @ "
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M_CWXGNQ7=S-XGAI9Q2>/G:];O!E%GJ%<V BGGW-=60  CMQD?@  @ !U40
M@ "  $:;G0U;G3TTG"U=K#+"FV]?CB;;FOEA)!C#F[UAZ@B7F\YB4   C$-I
M40  @ !YJ0  @ "  $8'FCQB.CR$F6]CW#'VF+QE5B9 F$=FBQA'F.UG!@B
MF$QG7P  B=YN?   @ !]@   @ "  $5DE[AHZ#O=EPQJ*3%>EEAK0"6HE=)L
M"A?[EDQL2PAUE0]LKP  A\9T+P  @ "     @ "  $3%E9-OOCM*E0IPIS#D
ME%MQ7R5,D[YQTQ>XE !QT B2DBER9   AA!Y9P  @ "     @ "  $0[D\)V
MG#K/DUIW.3""DJYWEB3XD@%WO!=HDAYWF0B"C])XFP  A+)]R@  @ "
M@ "  $/)DD%]D#IMD?9][3 RD4]]^"3#D(A]VA="D'-]R A2C?!^>   @T6
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M56AZ$#,75F9ZLQP*6--[*@&Q?21]B)5G/:F ?H=K0M2 ;'B;1XN 7&C#2]R
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MZX!'4'-LIW'U5 %N5F*T5U)O\E(I6EEQ>$!J7*]RYRT370IT&!4X8;AT<P
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M'GL<0PR8%FU61XJ5]5Z&2Y*3\DZ@3PJ213V"4461'2KA4*V1$Q/?7FF-0
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MB'2J4_1SJF=!5RETN5C46@]ULDE<7)]VG3A,7DMW<25G78-X"0U^:3%X.@
M@ "  '_K32%[IW. 4.%\%V8V5$=\;U??5U9\M4A[6?9\^3>R6Y!]0R3V6LQ]
MB0U2:7Q^"0  @ "  '[A2DV$M'*.3CR$>&5;4<J$&5<85/B#L$? 5Z6#63<9
M62:#*22F6)&#1 T\::&#$P  @ "  'X31_6-I7'23 J,PV2J3[:+LE9W4OB*
MG$<G5:J)N#:$5PJ)*R0W5L*)8@TE:<B'-@  @ "  'V"1B"69W%(2E.4\F0?
M3A&3-E7S45N1>D:Z5 N0%S8Q54^/42/?55"/9 SA:CR(M0  @ "  'R5:7-.
M$W &:PU1_&*Z;+=5TE1A;EA9@T3&;]U<^S./<2M@$Q_4<:QB.0<S=[9C$
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M(6E"6&EYQURP6RMZ3D\1799ZO$!47XE[(C '8%A[@QU/8(E[NP;6=')\Z@
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MW&.[;FI9$U=?;]Q<+DGI<39?(3L-<FIAT"I2<UID Q9#= EDUP#.?J1G(0
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MJUWM7>-^]%(;8!]_#$4V8?)_"S<;8RM_$R='8MY_+Q1Q9KM_9@$D?A-_^@
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M@U==<NY?%TON=!)AD#\O=0]CUS#Z=>9ET""!=GAG'@Q\>4%G&@  @ !O5@
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M,E*D9&V#04=]9B&#!SM#9TR"LRVK9[."BAWL9NJ"MPN*;ER">P  @ "
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M]4LQ>))C_4!6>55EY#18>?=GFB:(>G]HYA73>OAI+P1S?=QJ;P  @ !X(
M@ "  %0:=#EI1THI=5)JSC]5=B]L-C-B=M!M;"7B=S=N6!5'=X1N7@1:>VEO
MXP  @ !\<@  @ "  %,F<2QPJTE#<F]QNSZ$<V1RIC*A= 9S9R4W=#USZQ4%
M=(=STP1B>4-UWP  @ "     @ "  %)1;G=X"DAS;^=XJ3W$</9Y&C'U<99Y
M:R2A<9MYGQ2B<B9Y@ 20>$I[<P  @ "     @ "  %&F;"=_=$?O;<Q_N#U8
M;O=_L3&H;XE_C21E;U)_B11"<#I_L 1<>** )P  @ "     @ "  %$E:C^&
M\D=O; &&Z3S<;4&&>#$Y;<Z%\R01;62%VQ00;J2%N 11>+6"ZP  @ "
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M/#\G?X]GSC3"?_YI-RD>@$]J5QN5@,%J^ L[@6!J_0  @ !P>0  @ !^O@
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MJS>RF*U+Y2VCF)1.U"&JF5%1.Q)YG#)24P-2F;Y48   A+)?B@  @ !P#0
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M73*FB(=J@2B0B.5K:QT&B4)K\0\_B:1KU@*FAP-N,   @ !Y.P  @ "
M@ "  #L5A2EP*3'TA?YP[R?XAG=Q>1R-AK]QM [GAJYQA@*6A,5T4P  @ !]
MF   @ "     @ "  #I\@KMW"C%=@\]W?"=VA&5WKAPNA)=WJ ZCA$EWD@)N
M@P)Z*P  @ "     @ "     @ "  #H-@*I^)S#G@?9^3R<+@JQ^,1OC@LQ^
M 0Z1@EQ^+@*)@8A^_P  @ "     @ "     @ "     __\  /__  #__P
M;69T,@     $ PD   $                    !
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MY+5^8XELS$!^78?,LYI^;H9FFMA^F(5#@AA^V81/:5I_+X-G4*Y_KX*A.!2
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MS@6"),#BM\:!5[E3H4J O['ZBM" 8:J[=&N +J-<7BF !YN52 * !Y,[,A>
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M@Z*N7_)YJIK\25YZ]I*[,OQ\=(F,YR=T5=)!T/9TV<F;NDQU:L#_HVYV)+B
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MMYR%BK8!I "$8Z_5D 2#:JFA>_R"JJ-W: N"%)TR5&F!AY:E00N!'H^G+E:
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M 82LHL^CY:66DXJ@%Z&D@]2<5IVT<\^8KYG.8\:5(I7R4^V1GY()1)>. HX
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MPYI_&7,YKX!_*'1.FLE_0'5HA:I_9':7<&)_EG?E6S-_V'E.1AZ /GKU,7Z
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M>)6 GHXV94N <8O34CN 48E2/VV 4X:@+6: <8.5P?6!VZ'UL#N!,IZ;G=*
MHILDBMN -)>D=[!_Z90I9(A_P)"N4:E_MXT;/PE_SHDZ+3=__X3DP1*!/:N;
MKUF F*=BG.V !*+VB?E_EYYQ=N=_5YGR8^5_.I5E42Y_,Y"M/K=_7HN=+1!_
MH(8)P&2 QK4JKJ: ); -G"U_BZJAB39_%J4)=C)^V9]X8T=^S)G74+A^TI0
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M''K+0N^.W7O,-$&+AGT&)LN("'Z G)F@R7_$CFJ=CG]I?\>:8'\B<(Z73'\
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MFG:#%9W-BGN"2)J*>>Z!EY<9:3F!#I.C6)B IY B2%F 5(R#.&^ .(BB*:6
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M-R.!P'GY*&N!Z'P^H["!P'=%E6B!<'@)AG^!(WB[=L" Z7EO9I^ OWHO5EJ
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MAK>%#92V>/6$&9)Z:J:#,Y *7#>"<8V33>.!T(L80 B!0XB0,J" [(7=)H^
MJ8,,DT>%7YZ!AC*$>9OB>&B#@9C3:A^"DY5^6[F!U)(A36Z!1HZ\/[B QHM*
M,HJ >(>I)IR 2X/ODNR$[Z8ZA<F$#J+E=^^##9[W::6"$YJO6U.!3Y9D32.
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M>9=\LVS(;:!] FZT8/-]7'"=4_-]R'*91NE^472Q.EY^]';H+G!_Q7E5(^.
MO7OV@_-Z+G++>(EZJ'04;(]['G5-8"Y[F'9^4TM\-'>Z1G1\['D*.A]]OWIN
M+F=^P7OU)!-_Y'V7@O)X1'J]=Y!XX'M9:Z9Y=7O87U5Z#WQ%4LAZQWRZ1A-[
MKGT[.>U\K7W(+F-]W7YF)#Q_*G\.@A5VO(*>=MAW<8*1:P!X&8)37JEXR8'U
M4B9YG(&81:EZG8%&.:I[PX#Y+E!]&X"J)%]^C8!8@6%U>HI.=B9V08F5:E=V
M]HB47@]WN(=J49QXHX8\14)YOH42.7QZ^8/J+DA\=8*S)'M^"X%T@-5T>9'
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MWV57?"=C5VA,:YQF]&M)6NAJQFYA2HQNT'&B.J5S-'4T*_=W\GD^J+U59VF
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M695V9DIBTI*&6-!FDH^;2V1JHHRR/HIN[(G ,DMS@H:V)W)X)X.QB@=RME6
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M<Q-X*V#'9[]Y%F/H6]UZ#6<-3Y=[%FI'0TM\0&VI-X1]BW$Z+&)_$74?(J2
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M21N"H64$/=&"OVDP,Q:"\6V1*0N#3W)4(&.#U'=S<KY_DET<:0Q_RF!&7J^
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MT'VN6W6("W5A4WN'?G9\2T>&NG>(0N^%T'B5.J:$X'FV,I^#_WKV*S&#-WQ
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M/EN#;F(--0.#FV;6+$V#VVO8)&*$0W$U'=6$Q';'84-_:E>W60-_W5M/4$>
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MG7[F-S&!;'[Y,22!#W\P*U2 RG]\)BB EG_1(9J GH ;'@6 Q(!4  #__P
M__\  /__  !M9G0Q      ,$(0   0                    $
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M:Y!ZT7"4=\]TEW7.=YASS7F:<LU[FW',?9MPRW^<;\N G6_+@)UORX"=;\N
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M0/^B25/\IT=A\JU&<.FR1G_@MT>,V;M.E]._5Y_0Q6.DQ<!PK;JX>;>PLH#
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MBZF*S(2GDL^ IIS0@*.ESX"AILZ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ
MH:;.@*&FSH"AILZ H:;.@*&FSH"AIL[_HC8B_Y]#-_^C14?_JD)3_K%!7_:X
M06KQP41SZLQ+>>#:5GS/U5Z-P,QIF[/#<JBGNWFSGK5_NY>Q@\*.K87&AZN(
MRH&IC<U\J);.>ZBBS7NIILU[J:;->ZFFS7NIILU[J:;->ZFFS7NIILU[J:;-
M>ZFFS7NIILU[J:;->ZFFS7NIILW_HS8B_Y]#-_^E0T;_K$!2_[0^7?F]/V;N
MR$-MX]9-;]7=3H'$TUF1M<EFGZG!<:N@NWFSF;: NI2RA<",KX;$AJV(QX"K
MC,E\JI+*>JN<RGFKG\IYJY_*>:N?RGFKG\IYJY_*>:N?RGFKG\IYJY_*>:N?
MRGFKG\IYJY_*>:N?RGFKG\K_HS4B_Z!"-_^F047_KSU0_K@[6?/$/&'FT4-D
MV=]#<\C<2H6WT%>5JL=EHJ# <*R9NGFTE+: NI&SA;Z+L8;!A;"(PX&NB\5]
MK9#&>JV7QGJMFL9ZK9K&>JV:QGJMFL9ZK9K&>JV:QGJMFL9ZK9K&>JV:QGJM
MFL9ZK9K&>JV:QGJMFL;_I#0B_Z%!-_^I/4/_LSE-^;XW5>K,.EG;W3MBR^4_
M=[O92(FKSE>8H,9EI)C <:R3NWJSD+B!N(RUA+N(LX:^A;*)P(&QB\%^L(_"
M>["4PWJPEL-ZL);#>K"6PWJPEL-ZL);#>K"6PWJPEL-ZL);#>K"6PWJPEL-Z
ML);#>K"6PWJPEL/_I#0B_Z,^-O^M.4'_N#1(\,8S3=_9-E#-Y39GON0[>ZW7
M2(R@S5B9E\9GI)+!<JN.O7NPC+J!M(BX@[>$MX6Y@K6(NW^TBKU\LXV^>K.1
MOWJSD[]ZLY._>K.3OWJSD[]ZLY._>K.3OWJSD[]ZLY._>K.3OWJSD[]ZLY._
M>K.3OWJSD[__IC(B_Z8Z-/^R,SWWP"Y"Y-(O0<_D+E6_[S-KK^$[?J#62HV6
MSEN9D,AIH8S#<ZB)P'NLAKY_KX*\@;* NX2S?;J&M7NYB+9YN(NW=[>/N'>W
MD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0
MN7>WD+G_IS$B_ZPS,?^Y*S;JS"8VTN$F0<'O+%JP[3-NH>$]?Y7738R-T%Z6
MB<MKG8;'=**#Q'JF?\-]J7S!@*MZP(*L>;^$K7>^AJ]UOHFP<[V,L7.]C;%S
MO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]
MC;'_J2XA_[,J*_+%(BS6WAPMP^TC1[+Y*UVB[#9OE>)"?8O:4HB%U&"0@M!L
MEG[,<YM[RG>>>,E[H';(?J)TQX"C<\:"I''%A*5PQ(>F;L2*IV[#BZ=NPXNG
M;L.+IV[#BZ=NPXNG;L.+IV[#BZ=NPXNG;L.+IV[#BZ=NPXNG;L.+IV[#BZ?_
MK"H@^KT?(MS9$AO%ZQHSM/HC2J/Y+EZ5[CQMBN5)>8/?5H)^VF2)>M9LCG;3
M<9%STG64<=!YE6_/>Y=MSGZ8;,Z F6O-@IIJS82;:<R'G&C,B)QHS(B<:,R(
MG&C,B)QHS(B<:,R(G&C,B)QHS(B<:,R(G&C,B)QHS(B<:,R(G&C,B)S_MAX8
MY- .$\CI$2"U^1LWI?\F2Y?Z-%R+\4)H@NI/<GSE6WIWX61_<MYJ@V[<<(9L
MVW2(:MEWB6C9>8MGV'R+9M=^C&76@(UDUH*.8]6%CV+5A8]BU86/8M6%CV+5
MA8]BU86/8M6%CV+5A8]BU86/8M6%CV+5A8]BU86/8M6%CV+5A8_IQPT,RMH+
M#[?W$B2G_QTYF/\K28S^.E>#]DEA?/!5:77L7F]NZ6-T:N=I=V?E;GEEY')[
M8^-U?&+B=WUAXGE^8.%[?U_A?7]?X'^ 7N""@5W?@X%=WX.!7=^#@5W?@X%=
MWX.!7=^#@5W?@X%=WX.!7=^#@5W?@X%=WX.!7=^#@5W?@X'+T D#NN(+$ZC_
M%"::_R$WC?\Q183_0%!\_$Y8=/A77VWT761G\F)G8_!H:F'N;&Q?[7!M7>UR
M;USL=6];['=P6NMY<5KK>G%9ZGQR6.I_<ECJ?W-8ZG]S6.I_<UCJ?W-8ZG]S
M6.I_<UCJ?W-8ZG]S6.I_<UCJ?W-8ZG]S6.I_<UCJ?W/_G#@:_YI&+?^744'_
MFE-/_IQ57O6<6FSLFU]ZY)EGA]R6<9+5DWN<SY"$I,N.C*O(BI"PQ8>4M,.$
MF+?"@9NYP7^>NL%]HKO >Z:\P'FKO;]XLKV[>+.]NWBSO;MXL[V[>+.]NWBS
MO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[W_G#@:_YI&+?^744'_FE-/
M_IQ57O6<6FSLFU]ZY)EGA]R6<9+5DWN<SY"$I,N.C*O(BI"PQ8>4M,.$F+?"
M@9NYP7^>NL%]HKO >Z:\P'FKO;]XLKV[>+.]NWBSO;MXL[V[>+.]NWBSO;MX
ML[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[W_G#@:_YI&+?^744'_FE-/_IQ5
M7O6<6FSLFU]ZY)EGA]R6<9+5DWN<SY"$I,N.C*O(BI"PQ8>4M,.$F+?"@9NY
MP7^>NL%]HKO >Z:\P'FKO;]XLKV[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[
M>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[W_G#@:_YI&+?^744'_FE-/_IQ57O6<
M6FSLFU]ZY)EGA]R6<9+5DWN<SY"$I,N.C*O(BI"PQ8>4M,.$F+?"@9NYP7^>
MNL%]HKO >Z:\P'FKO;]XLKV[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]
MNWBSO;MXL[V[>+.]NWBSO;MXL[W_G#@:_YI&+?^744'_FE-/_IQ57O6<6FSL
MFU]ZY)EGA]R6<9+5DWN<SY"$I,N.C*O(BI"PQ8>4M,.$F+?"@9NYP7^>NL%]
MHKO >Z:\P'FKO;]XLKV[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBS
MO;MXL[V[>+.]NWBSO;MXL[W_G#@:_YI&+?^744'_FE-/_IQ57O6<6FSLFU]Z
MY)EGA]R6<9+5DWN<SY"$I,N.C*O(BI"PQ8>4M,.$F+?"@9NYP7^>NL%]HKO
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MNK+_EC,4_Y9#)?^54#?_F5%$_YM44OZ<6%_UFUUL[9ED>.:6;(/?DW:-VH^
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M8>;$5F?>R6)MSL%G?\&Y;8ZVL7*;JZIXIJ*E?JZ9H(2UDIV+NHR:D[Z'F)O
MA)>DPH*6K\*#D[# A)&ROH21LKZ$D;*^A)&ROH21LKZ$D;*^A)&ROH21LKZ$
MD;*^A)&ROH21LK[_FS,4_YI!)O^?0C/_ID ]_ZU 1_^T0D_WNT=7[<--7>3,
M6&#9S6!LR<5F?KR]:XVPM7&:I:]VI9RJ?*V3IH*TC**)N8:@D+V!GIF_?9ZB
MP7N>K\%]F;# ?Y:ROG^6LKY_EK*^?Y:ROG^6LKY_EK*^?Y:ROG^6LKY_EK*^
M?Y:ROG^6LK[_G#,4_YI!)O^@03+_J#\\_[ ^1?^W04WTP$53ZLE.5N+56E?2
MT5YKQ,ED?;;!:HRJNV^9G[5TI):P>JR-K("RAJF'MW^GCKMZII:^=Z6@OW2F
MK;]WH;&_>IVROGJ=LKYZG;*^>IVROGJ=LKYZG;*^>IVROGJ=LKYZG;*^>IVR
MOGJ=LK[_G3,4_YM!)O^B/S'_JCPZ_[,\0ON[/DGPQD1-YM)/3=S<5U;,U5UJ
MOLUC>[#':(NDP6V7F;QSHH^X>*J&M'ZP?[*%M7FPC+ATKY6[<:Z?O&ZOJ[UQ
MJK.\=*6SO'2EL[QTI;.\=*6SO'2EL[QTI;.\=*6SO'2EL[QTI;.\=*6SO'2E
ML[S_G3,4_YM )O^D/##_K3DX_[8Y/_7!/$/ISD1$WMU-1]+@4UC%VUQHM]-A
M>JG-9HF<R&N5D<1QGXC =J=_O7VM>+N$L7.ZB[1ON)2W;+>=N&JWJ+EIMK:X
M;:^UN6VOM;EMK[6Y;:^UN6VOM;EMK[6Y;:^UN6VOM;EMK[6Y;:^UN6VOM;G_
MGC(4_YT^)?^G.2[_L38U^[PV.NW).CS@VD0ZTN)'3,?B35ZYWE1NK-E;?)_4
M8HB4T&B3BLQOFX+'=Z)\PWZH=L"$K'*^BJ]OO)&Q;;R8LFN[H;-JNZVR9[JV
MM&>ZMK1GNK:T9[JVM&>ZMK1GNK:T9[JVM&>ZMK1GNK:T9[JVM&>ZMK3_GS(4
M_Z Z)/^J-"S_M3(Q\\,R,^/4.##3X3P_QNA"4KGE2&.LXDURG]]4?Y/978J)
MTF>3@\UPFGW)=Y]XQGVD=,2#IW#"B*ENP8ZK;,"4K&J_FZUIOZ6M:+^NK6B_
MKJUHOZZM:+^NK6B_KJUHOZZM:+^NK6B_KJUHOZZM:+^NK6B_KJW_H# 4_Z,V
M(O^O,"C[O"TKZ,TL*-7@,##'Z3A$N>P^5ZSI16>>YTMUDN!3@(G97HF"U&B1
M?-!QEGC,=YMTRGV><,B"H6['AZ-KQ8NE:<20IFC$EJ=FPYZH9<.EJ&7#I:AE
MPZ6H9<.EJ&7#I:AEPZ6H9<.EJ&7#I:AEPZ6H9<.EJ&7#I:C_H2\4_Z@O'_^U
M*B+PQB0AV-TC(,CI+36Z\C5)K/$\6I[P0VF2Z$QUB.%5?X';88=[UVJ-=M-Q
MD7+1=Y5OSWR7;,V FFK,A9MHRXF=9LJ-GF7)DI]CR9B@8LB>H6+(GJ%BR)ZA
M8LB>H6+(GJ%BR)ZA8LB>H6+(GJ%BR)ZA8LB>H6+(GJ'_HRT4_ZXI&OB_(!K>
MUA@3R>@B);KT*SJL^#1-GO<\7)+Q1FF(Z5!S?^-9>WK?9()TW&N&<-EQBFW6
M=HUJU7N/:--_D6;2@Y)DT8>48]&*E6'0CY9@SY277L^9F%[/F9A>SYF87L^9
MF%[/F9A>SYF87L^9F%[/F9A>SYF87L^9F%[/F9C_IR@2_[<?$N;.$0W+YA46
MN_0A*JS^*SZ>_S1.DOH_7(CR2F9_[%5O>>A>=7+D9'MNX6M^:M]P@6C>=81E
MW'F%8]M]AV+:@8A@VH2)7]F'BEW8BXM<UY",6]:4C5O6E(U;UI2-6]:4C5O6
ME(U;UI2-6]:4C5O6E(U;UI2-6]:4C5O6E(W_L!X+[<8.",W;"PB[\Q4:K/\A
M+I[_+#^2_S=-A_U$6'_V3V%X\5EH<>U?;6KK9'%GZ&IT9.=O=V+E='E@Y'AZ
M7^-[>UWC?GQ<XH%]6^&$?EKAB']9X(R 6."/@5C@CX%8X(^!6."/@5C@CX%8
MX(^!6."/@5C@CX%8X(^!6."/@5C@CX'SO0T$S,\) ;WE# RL_Q<>GO\D+Y+_
M+SV'_SU)?_])4GC\5%IP^%I?:?1?9&3R96=A\&II7N]N:USN<FU;[79N6NQY
M;UCL?'!7ZWYP5NN!<57JA')4ZHAS4^F+=%/IBW13Z8MT4^F+=%/IBW13Z8MT
M4^F+=%/IBW13Z8MT4^F+=%/IBW3,Q@@ O=0( ZWU#@^?_QH?D_\G+8C_-#E^
M_T)#=_]-2F[_4U!G_UE58OQ>6%[[9%M;^6A=6?AL7E?W<&!6]W-A5?9V8E3U
M>&)3]7MC4O1]9%'T@&10\X-E3_.&9D_SAF9/\X9F3_.&9D_SAF9/\X9F3_.&
M9D_SAF9/\X9F3_.&9D_SAF:]RP8 KML&!)__$!"3_QT=B/\J*'[_.#)V_T0Z
M;?]+067_449?_U=)6_]=3%C_8DY5_V904_]J45+_;5)0_W!33_]R5$[_=51-
M_W=53?]Y54S^>U9+_GY72OV!5TK]@5=*_8%72OV!5TK]@5=*_8%72OV!5TK]
M@5=*_8%72OV!5TK]@5?_C2T._XP^'?^*3"[_DE,[_Y172/^57%3]DV)@]9%J
M:^^-<G;IB7Q_Y(6$AN" BXW<?)&2VGF7EMAVG)G5<Z";U'&EG=-OJ9_2;JZ@
MTFVSH=%LN:+1:\"CS6S%H\ANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(
M;L:BR&[&HLANQJ+_C2T._XP^'?^*3"[_DE,[_Y172/^57%3]DV)@]9%J:^^-
M<G;IB7Q_Y(6$AN" BXW<?)&2VGF7EMAVG)G5<Z";U'&EG=-OJ9_2;JZ@TFVS
MH=%LN:+1:\"CS6S%H\ANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:B
MR&[&HLANQJ+_C2T._XP^'?^*3"[_DE,[_Y172/^57%3]DV)@]9%J:^^-<G;I
MB7Q_Y(6$AN" BXW<?)&2VGF7EMAVG)G5<Z";U'&EG=-OJ9_2;JZ@TFVSH=%L
MN:+1:\"CS6S%H\ANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&
MHLANQJ+_C2T._XP^'?^*3"[_DE,[_Y172/^57%3]DV)@]9%J:^^-<G;IB7Q_
MY(6$AN" BXW<?)&2VGF7EMAVG)G5<Z";U'&EG=-OJ9_2;JZ@TFVSH=%LN:+1
M:\"CS6S%H\ANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLAN
MQJ+_C2T._XP^'?^*3"[_DE,[_Y172/^57%3]DV)@]9%J:^^-<G;IB7Q_Y(6$
MAN" BXW<?)&2VGF7EMAVG)G5<Z";U'&EG=-OJ9_2;JZ@TFVSH=%LN:+1:\"C
MS6S%H\ANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+_
MC2T._XT^'?^,3"[_E%,[_Y561_^66U3]E6%@]I)H:^^/<'7IBWI_Y(>#A]^"
MBHW<?I"2V7J6E]9WFYK5=*"=TW*EG])PJ:'1;JZBT&VTH]!LNJ30;,*DRF[$
MI,1OQ*3$;\2DQ&_$I,1OQ*3$;\2DQ&_$I,1OQ*3$;\2DQ&_$I,1OQ*3_CBT.
M_XX^'?^.2R[_E5$Z_YA41_^86%/^F%Y?]I5D:N^2;'7ICG9^Y(J A]^%AX[;
M@(Z4V'R4F-5YFIS3=I^?T7.DHM!QJJ3/;Z^ESFZVILYMO:?*;L*GPW#"I[UQ
MPJ>]<<*GO7'"I[UQPJ>]<<*GO7'"I[UQPJ>]<<*GO7'"I[UQPJ?_CRT._XX^
M'O^02BW_ET\Z_YE11O^;5E+^FEM>]YAA:?"5:'3JD7%^Y(Y\AM^)A([;@XN4
MUW^2FM1[F)[2=YZAT'2DI,YRJJ;-<+&HS6^YJ<MOP:G#<<&IO'+ JK=SP*JW
M<\"JMW/ JK=SP*JW<\"JMW/ JK=SP*JW<\"JMW/ JK=SP*K_CRT._X\^'O^2
M2BW_F$TY_YM/1?^=4U'_G5A<^)M>:/&997+JE6U\Y)%WAM^,@8[;AXF5UH&0
MFM-]EI_0>9VCSG6CILURJZG,<+.JRV^]J\5ROZN]<[^LMG2^K+%UOJVQ=;ZM
ML76^K;%UOJVQ=;ZML76^K;%UOJVQ=;ZML76^K;%UOJW_D"T._Y ^'O^322W_
MF4PY_YU.1/^?45#_GU9;^9Y<9O*<8G'KF&E[Y91SA."/?8W;BH:4UH2-F])_
ME:#/>IRES7:CJ,MSJZO*<;6MQG&^K;YTO:ZV=;VNL':]KJQWO:ZL=[VNK'>]
MKJQWO:ZL=[VNK'>]KJQWO:ZL=[VNK'>]KJQWO:[_D"T._Y ^'O^522S_FTHX
M_YY,0_^A3T__HE1:^J%99?.@7V_LG69YYIAO@^"3>8S;CH*3UH>*F]*!DJ'/
M?)JFRGBBJL=UJZW#<[2OOW.\L+=UO+"P=[NPJGB[L*=YO+"G>;RPIWF\L*=Y
MO+"G>;RPIWF\L*=YO+"G>;RPIWF\L*=YO+#_D2T._Y$^'O^62"S_G$@W_Z!*
M0O^C34W_I%)8^Z578_2D76WNH6-WZ)YK@.*8=8G<DGZ2TXR'FLR&CZ'&@)>G
MP7R>K+UYIJ^Y=J^QMW:ZLJ]WNK*J>;JRI7JZLJ)[N[&B>[NQHGN[L:)[N[&B
M>[NQHGN[L:)[N[&B>[NQHGN[L:)[N['_D2T._Y$^'O^81RS_G4<W_Z%(0?^E
M2TS_IU!6_*A58?6H6VOMIV%TY:1I?MZ?<X?4F'V0RY&$FL2*C**^A).HN(":
MK;1\HK"P>JNSK7FUM*AZN;2D>[FTH'VYLYU]NK.=?;JSG7VZLYU]NK.=?;JS
MG7VZLYU]NK.=?;JSG7VZLYU]NK/_DBT._Y(^'O^81BO_GD8V_Z-'0?^G24O_
MJDY5^JM37O*L66CIK&!QXJEH>MFE<X/-G'J/Q96!FKV.B**WB)"IL827KJR
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M,?^/53S_CEM&_XMB4/^&:5G\@'%B]WM[:?-VA7#O<HYU[&Z5>>IKG'WH::.
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MG7%RM)=W?*R1?H6FC(:,H(B-D9J%E9:6@IZ:DH"GG8]_LIZ-@,&>C(#)GHN
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M5D']GE= _:980/RI6$#\J5A _*E80/RI6$#\J5A _*E80/RI6$#\J5C&N 0
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M?.!?VGW48N%]RF/@?L-DX'^]9M^ MV??@+=GWX"W9]^ MV??@+=GWX"W9]^
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M9TGEQF=(YM]G2N#L9TK?[&=*W^QG2M_L9TK?[&=*W^QG2M_L9TK?[&?_G T
MV[$& ,J]!P"_R@< M=H* *KO&06@\"@/EO U&XSP/R:"\$<Q>?!..7#O5$!H
M[UI&8>]@2UWO9T]8[VY25.]U55'P?5=.\(592_"/6TCQF5Q&\:->1/*O7T/R
MNU]"\\Q@0?/G8$'SZ&!!\^A@0?/H8$'SZ&!!\^A@0?/H8$'SZ&#>IP( R[8%
M +W!!0"RSP< I^H- 9WW' >4^"L2BO@V'('Y0"9X^D@O;_I--F?Z4SQ@^EA
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M:N-ZHVOD>:%KY'FA:^1YH6OD>:%KY'FA:^1YH6OD>:%KY'G_:"$$_V\D!?^
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M4D#M\5% [?%10.WQ44#M\5% [?%10.WQ44#M\5'4I0  Q+(# +:\ P"KR04
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M ?^9$0#SJ X U[4* ,_!"@#&Q1@ O,0J!;+".!&GOT0>GKM-*Y2X53:+M5Q
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M3$?<Q$Q&W-Y,1MKM3$38^4]#V/M/0]C[3T/8^T]#V/M/0]C[3T/8^T_;F@
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M)BK_NR<I_[XG*?^^)RG_OB<I_[XG*?^^)RG_OB>FM@  F,(  (O.  !^VP
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M6U"LP%M0K-I:3ZON6T^J^EM1IOI;4:;Z6U&F^EM1IOI;4:;Z6U&F^EO_@ D
MX9(! -&@! #&JP4 O+0$ +.] P"KQPL I,D< 9S(+ :3QSD/BL5$&8'#32-Z
MP50L<[];,VV^8CEGO&D^8KMP0UZZ=T=:N8!+5KF)3E.XE%!0N*!23;BN5$RX
MOU1+N=A42[?M5$JV^55*L_Y62K/^5DJS_E9*L_Y62K/^5DJS_E;ZAP( UI@
M ,FE P"]KP, L[@! *G"! "AS0@ FM 6 )+0* 2*SS8,@<Y!%7G,2AYRRU(F
M;,I:+6;)83)AR&@W7,=O/%C&=C]5QG]#4<6)14[%E$A+Q:!*2<6N2TC%OTM'
MQMA+1\7M2T;#^4U%PO].1<+_3D7"_TY%PO].1<+_3D7"_T[?D   S)\  +^J
M 0"SLP$ J;T" )_'!0"6T@D CMH2 (C;) * VC((>-D^$''82!AJUU ?9-98
M)5_57RI;U&<O5]1N,U/3=C90TW\Y3-.(.TK3E#Y'TZ _1=2N0$34OT%#U=A
M1-/L0$+2]D)!T?Y$0='^1$'1_D1!T?Y$0='^1$'1_D31F   PZ4  +6N  "I
MN   GL," )3-!@"*V0H A.,8 7WD)@-UY#((;N,\#V?C115AXTT;7.-5(%?C
M7214XV0G4.)K*DWB<RU*XWPP2..&,D7CD#1#XYPU0>2I-D#DN#<_Y<LW/^7D
M-S_C\S8]XOLX/>+[.#WB^S@]XOLX/>+[.#WB^SC&H0  MZL  *JT  ">O@
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M$1W_L1$=_[$1'?^Q$1W_L1&5O   AL<  'G3  !KX   7NT  %;_ P!/_PP
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M3G(E_TM]*?](B"S_1I(N_T6;,/]$HC+_0ZDS_T*P-/]"MS7_0;\V_T')-O]
MUS?_0.4W_4#P-_I ^#?W0?\V]D'_-_)!_SCL0_\YZD3_.>I$_SGJ1/\YZD3_
M.>I$_SG_12L#_TDL _]0+ 3_52\%_UDW"/]<0@[_6TT5_UA7&_]68R#_4F\E
M_T]Z*O],A2W_2H\P_TB8,O]'GS3_1J8U_T6M-O]%M#?_1+PX_D3&./Q$TCGY
M0^(Y]D3N.?-$]SGQ1/\Y[T3_.NM%_SOD1O\\XT;_/.-&_SSC1O\\XT;_/.-&
M_SS_1BL#_TTI _]4*03_62P%_UXU!_]A0 W_84H4_UY4&O]:7R#_5VLF_U1V
M*O]1@2[_3HLQ_DR4-/Q+G#7[2J,W^DFJ./A(L3GW2+DZ]D?"._5'S3OR1]\[
M[D?L.^M(]COI1_\]YT?_/N%(_S_:2O] V$K_0-A*_T#82O] V$K_0-A*_T#_
M1RH#_U G _]8)@/_7BH$_V,S!_]F/0W_9D<3_V11&O]@6R#_7&<F_5ER*_I6
M?2_X4X<S]E&0-?10F#?R3I\Y\4VF.^],K3SN3+4][$N^/>M+RC[I2]P^Y4SJ
M/>)+]3_?2_Y!W$K_0M1,_T/-3?]#RT[_0\M._T/+3O]#RT[_0\M._T/_2B@#
M_U0D _]<(P/_8R@$_V@P!O]L.PO_;$02_VI.&?YF6!_Y86(E]5YM*_);>##O
M6((T[%:+-^I4E#GH4YL[YE&C/>51JC[C4+(_X4^[0.!/QT#>3]A!V4_H0=1/
M]$/03OY%SD[_1LA0_T;"4?]'P%'_1\!1_T? 4?]'P%'_1\!1_T?_324"_U<A
M O]@( /_:"8#_VXN!?]R. K_<D$0_7!+%_=M5!WR:%XD[61I*NEA=##E7GXT
MXEN'..!9CSO=5Y<^VU6?0-A4ID+54ZY#TE*W1-!2PD7.4M!&RU+E1LA2\DC%
M4OU)PE+_2KQ4_TJW5?]*ME7_2K95_TJV5?]*ME7_2K95_TK_4","_UL> O]D
M'@+_;20#_W,K!/]W-0C^>#X.]G='%/!T4!OJ;UHBY&ME*>!G;R_;8WDUUF""
M.M)=BC[/6Y)!S%F:0\I8H47(5ZE'QE:R2<16O$K"5<E+OU7?2[Q6[DRY5OI-
MMU;_3;)8_TVN6?]-K%G_3:Q9_TVL6?]-K%G_3:Q9_TW_4R "_UX< O]H' +_
M<2("_W@H _]\,0?X?CH+\'U#$>EZ3!CB=E<?W')A*-1M:R_/:70VRV5].\=B
MA4#$8(U#P5Z51K]=G$B\6Z1+NEJM3+A9MTZV6<-/M%G53[%:ZE"N6O=0K%K_
M4*A;_U"D7/]0I%W_3Z1=_T^D7?]/I%W_3Z1=_T__5AX"_V$9 O]L&@+_=2 "
M_WPE _V!+@7SA#<)ZH0_#N*!2!7;?5,=T7==)\MR9S#&;G WPFIX/+YG@$&Z
M98A%MV.02+1AF$NR7Y]-KUZH3ZU=LE&K7;Y2J5W.4Z9=Y5.D7O13HE[_4Y]?
M_U*<8/]2FV#_4IM@_U*;8/]2FV#_4IM@_U+_6!P"_V07 ?]P&0'_>1T!_X C
M OB&*@/MB3(&Y(H["MR(11+1@E <RGU:)L1X8R^^<VPWN6]T/;5L?$*R:H1&
MKF>,2JMEDTVH9)M/I6*D4J-AKE2A8;E5GV'(5IUAX5:;8O%5F6+]59=C_U25
M9/]4E&3_4Y1D_U.49/]3E&3_4Y1D_U/_6AH"_V<5 ?]S%P'_?1L!_X0@ ?.*
M)@+HCBX$WY V!]2,01'+ATT;Q()7)KU]8"^W>&DVLG1Q/:YQ>$*J;H!'IFR(
M2J-JCTZ@:)A1G6>@4YIFJE689;57E67$6)1EVUB29N]7D6;\5X]G_E:.9_Y5
MC6C^58UH_E6-:/Y5C6C^58UH_E7_7!@!_VD3 ?]V%@'_@!D!_8@= >^.(@'D
MDRD"VI0Q!LZ0/P_&BTL:OH95);>!7BZQ?68VK'EN/*=V=4*C<WU'GW"$2YQN
MC$Z8;)12E6N=5))JIU>0:;)9C6G 6HQIU5J*:NQ9BFKZ6(EK_5>':_U6AVO^
M5H=K_E:':_Y6AVO^5H=K_E;_7A<!_VP2 ?]X% '_@Q< ^8L: .N2'0'@F",!
MTY@O!<J4/0[!CTD9N8I3)+*&6RVL@60UIGYK/*%Z<D*==WI'F76!2Y5SB4^1
M<9%2CF^:58MNI%B(;:]:AFV]6X1MT%N#;NE:@V[X68)O_%B";_U7@F_]5X)O
M_5>";_U7@F_]5X)O_5?_8!4!_VX1 ?][$P#_AA0 ]H\6 .>6& #;G!P SYLM
M!,67.PV\DT<8M(Y1(ZV*62RGAF$TH8)I.YQ_<$&7?'=&DWE^2X]WAD^+=8Y2
MB'.7581RH5B"<:Q:?W&Z7'YQS%Q]<N=;?7+V6GQR_%E\<OQ7?'+]5WQR_5=\
M<OU7?'+]5WQR_5?_8A0!_W$1 ?]]$0#_B!( \I(2 ..:$@#5GQD RIXK!,&;
M.0RXET47L))/(JF.6"NBBE\SG(9G.I>#;D"2@'5%C7Y\2HE\A$Z%>HQ2@GB5
M5GYWGUA[=JI;>76X7'=UREQW=N5<=W?U6G=V^UEW=OQ8=W;\5W=V_%=W=OQ7
M=W;\5W=V_%?_9!(!_W,0 /^ $ #_BQ  [Y4. -^>#0#0HA< QJ$I [V>-PNT
MFD,6K)9-(*225BJ=CEXREXME.9*(;$"-A7-%B(-Z2H2 @4Z ?XI2?'V357A\
MG5AU>ZA;<WJV7'%ZQUQQ>N)<<7OS6G%[^UER>OQ8<GK\6')Z_%AR>OQ8<GK\
M6')Z_%C_9Q$!_W4/ /^##@#TC@T VYD* -2A"P#,I!4 PJ0G [BB-@JPGD(5
MIYI,'Z"75"F9DUPQDY!C.(V-:C^(BG%$@XAX27Z&?TUZA(A1=H*157.!FUAO
M@*9:;7^T7&M_Q5QK@-]<:X#R6FN ^UEL?OQ8;7[\6&U^_%AM?OQ8;7[\6&U^
M_%C_:1 !_W@. /^%# #BD@@ U9L) ,ZC"0#'J!( O:@E K2F- FKHD 3HY]*
M'IN;4B>4F%HPCI5A-XB2:#V"D&]#?HYV2'F,?4QUBH50<8B.5&V'F5=JAJ19
M9X6Q6V6%PEMEA=Q;987P6F:%^UEG@_Q89X/\5V>#_%=G@_Q79X/\5V>#_%?_
M; X _WL, /*)"0#9E08 SYX( ,FF" #!JQ  N*LB J^J,@BFISX2GJ1('):A
M426/GE@NB)M?-8*99CQ]EFU!>)1T1G.2>TMOD(-/:X^,4F>.EE5DC:)888RO
M65^,P%I?C-E97XSN65^,^UAABOU788G]5V&)_5=AB?U788G]5V&)_5?_;PP
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M2$BQ]DE(L/]*2+#_2DBP_TI(L/]*2+#_2DBP_TKBA@  SI0  ,*A  "VJ0
MJ[$  *&Z 0"8PP4 D,D0 (K)( &#R2\%>\@[#73'111NQDX;:,56(6/$72=>
MPV0K6L)K+U;!<C-3P7LV3\"$.4S CSQ*P)L^1\"H/T; N$!%P,U 1<#H/T2^
M]D%#O?]"0[S_0T.\_T-#O/]#0[S_0T.\_T/6C0  QIL  +BE  "MK@  HK8
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M(S3K^",TZ_@C-.OX(S3K^".SI0  IJT  )FW  "-P0  @,L  '75 0!IX08
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M4&]VP5!N=]E0;G?O3VYW_$YN=_]-;W?_3&]W_TQO=_],;W?_3&]W_TS_9 T
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M2U>/]TI7CO]*6([_25B._TE8CO])6([_25B._TG_<0$ X(   ,^,  #$E@(
MNYX" +*D  "IJ@4 HJP5 )NL)@*4JS0'C*H_#X6H2!=^IE >>*18)7.B7BMN
MH64P:I]L-&6><SEAG7L\7IN$0%J:CD-7F9I%5)FG1U*9MDA1F<I(49CF2%&7
M]4A1E_]'49;_1U&6_T=1EO]'49;_1U&6_T?V=P  V(4  ,F1  "_FP$ M*(
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M-T"W_S= M_\W0+?_-T"W_S?.BP  OY@  +*A  "GJ0  G+   )&X  "&P (
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M$2?U\1&CJ   EK(  (B[  ![Q0  ;\X  &+7  !6W@  3O ' $KZ$ !&^QD
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M,OL;^#+_&_<R_QSV,?\=]3'_'O4Q_Q[U,?\>]3'_'O4Q_Q[_-2P"_SPJ O]
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M%:QU5ANG<E\BHF]F)YYL;BR;:G4PEVA\,Y1GA#:198PYCF25/(QCGCZ)8JA
MAV*U0H5BQ4*$8MY#@V/Q0H)C_4&"9/] @F3_/X)D_S^"9/\_@F3_/X)D_S__
M60X _V0+ /]N"@#J=P@ VWT( -2""@#,A!( PX4D ;N#- 6S@$ ,K7Q+%*9Y
M5!NA=EPAG'-D)IAQ:RN4;W(OD6UY,XYK@3:+:HDYB&B2/(5GFS^"9J9!@&:R
M0WYFP41]9ME$?&?O0WQG_$%\:/] ?&C_0'QH_S]\:/\_?&C_/WQH_S__6PP
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M1&5X]T-F>/]"9GC_069X_T!F>/] 9GC_0&9X_T#_9 , [G$  -A\  #+A0(
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M/$^1_SQ/D?\\3Y'_/$^1_SSD=   SX$  ,*,  "XE@  K9P  *.A  "8J
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M)#B__R2]D0  L)L  *2B  "8J@  C+$  ("Y  !UOP  :L8$ %[," !9SQ(
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M!R;PEP<E\*<()/&X""/QS @B\N4((O#S""+O]0@B[_4((N_U""+O]0B>I@
MD:\  (2X  !WP0  :LD  %W0  !1UP  1MT  #_J!0 \]@X .?87 #;W(  S
M]R@ ,?@P "[Y-@$K^3T!*?I$ 2?Z2@(E^U("(_M: B#\8P,>_&X#'/U[ QO^
MB009_I@$&/^H!!?_MP06_\@$%O_@!!;_Y 06_^0$%O_D!!;_Y 23K@  A;<
M 'C   !JR0  7=(  %#9  !$WP  .N0  #7W P R_PP +O\2 "O_&@ H_R$
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M,Y%6Q3205MTTCE?P-(U7_3.,6/\SC%C_,HQ8_S&,6/\QC%C_,8Q8_S'_40P
M_UL) /]C" #K:@< W6X( -AQ"@#/<A, QG,E ;YR- .W<$$(L6U,#JQJ512G
M9UX9HV5E'J!C;2*<870EFF![*)=>@RN478LMDER3,(];G#*-6J8TBUJR-8E:
MP3:'6M8VAEOM-H5;^S6%7/\TA%S_,X1<_S.$7/\SA%S_,X1<_S/_4PH _UT&
M /5F! #?;0, U7(& -!U"0#)=A$ P'<B +AV,0.Q=#X'JW%)#J9N4A2A;%L9
MG6EB'9EG:B*69G$EDV1X*)!C?RN-88<NBF"0,(A?F3.%7Z,U@UZO-H%>OCB
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M.7)G]SAR9_\W<FC_-G)H_S5R:/\U<FC_-7)H_S7_60( ]F4  -UN  #/=@$
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M-EYX_S5>>/\U7GC_-5YX_S7U9   W'   ,IZ  # @P  MHD  *Z-  "DCP
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M+D:6_R[1=P  P80  +:.  "JE0  H)L  )6?  "*I   ?:D  '>K$ !SJQX
M;ZPL 6JK-P1EJT$'8:I)"UVI40]:J5@35ZA?%E.G9AE0IVX<3:9V'TJE@2%(
MI8PD1:69)D.DJ"="I+@H0:3.)T&CZB= HO@H0*'_*4"@_RE H/\I0*#_*4"@
M_RG)?@  NHL  *^4  "CF@  F*   (VE  ""J@  =;   &RS# !IM!@ 9;0G
M 6&T,P)>M#T$6K1&!U:S3@I3LU4-4+-<$$VR8Q-*LFL61[%T&$6Q?AI"L(H=
M0+"7'CZPIB \L+<@/+#,(#ROZ" [KO<A.JW_(CJL_R,ZK/\C.JS_(SJL_R/
MA@  LY(  *>9  "<GP  D*8  (2L  !YL0  ;;<  &&\!0!=O1( 6KX@ %B^
M+0%4OC@"4;Y"!$Z^2@9,OE((2;Y9"D:^8 Q$OF@.0;UQ$3^]?!,\O8@5.KV5
M%CB]I!<WO;48-KW*&#>\YQ<UN_89-;K_&C2Y_QLTN?\;-+G_&S2Y_QNXCP
MJI@  )^?  "3I@  AZP  'NS  !ON0  8[X  %C$! !0R P 3<@7 $S))0!*
MRC$ 1\H[ 47*1 )#RDP#0<I4!#[*7 8\RF0'.LMN"3C+> HVRX4,-,N2#3++
MH@XQR[(/,,S'#S#+Y0XOR?4/+LC]$2['_Q(NQ_\2+L?_$B['_Q*NEP  H9X
M )6E  ")K0  ?+0  '"[  !DP0  6<8  $[+ P!%T @ /M4. #W5&@ \UB8
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M A'ZLP(0^\8"$/O= A#[Z0(0^^D"$/OI A#[Z0*/JP  @;0  '.]  !FQ@
M6<T  $O3  ! V0  -=X  "SC   F\0  )/X* "'_$  ?_Q8 '/\< !G_(@ 7
M_R@ %?\N !/_-0 2_SP $/]#  [_3  -_U8 "_]B  G_;P (_W\!!_^0 07_
MH $$_ZX!!/^\ 0/_QP$#_\<! __' 0/_QP&#M   =;T  &?&  !:SP  2]4
M #_<   SX0  *>4  "'L   >_0  &O\% !?_#  5_Q  $O\4 !#_&0 ._QX
M#?\C  O_*  (_RX !O\U  /_/0  _T8  /]1  #_70  _VL  /][  #_BP
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M'ZQ%S!^J1>,@IT;S(:5&_R&C1O\BHD;_(:)&_R&B1O\AHD;_(:)&_R'_10X
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M+(%7]RN 6/\J@%C_*H!8_RF 6/\I@%C_*8!8_RG_3P( _5D  .)@  #59P
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M+&IG_RMJ9_\K:F?_*VIG_RO^6   X6,  ,]L  #$<P  NW@  +-Z  "K>@0
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MA(TF4H.:*5""IRI/@K<K3H+,*TZ"Z"M.@?@J3X#_*D^ _RE/@/\I3X#_*4^
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M(465I"-$E+,C0Y3((T.4Y2-#DO4D0Y'_)$.0_R1#D/\D0Y#_)$.0_R3*=0
MNX$  +"+  "DD0  FI4  (^9  "#G0  =*(  &ZC"P!JI!< 9J4E &.E,0%?
MI#L#6Z1$!5BD2PA5HU,+4J-:#4^B81!-HF@32J%Q%4>@>QA$H(8:0I^3'$"?
MHAT^G[(>/9_&'CV?XQT]G?0>/9S_'SR;_Q\\F_\@/)O_(#R;_R#"?   M8@
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M""K%V@@JQ/ (*<+["2C!_PHHP?\+*,'_"RC!_PNHE0  G9L  )&B  "$J0
M>*\  &NU  !?NP  5+\  $G#   _R 0 -LT) #/.$0 RSQP ,<\G ##0,0 O
MT#H +M%# "W13  KTE4 *M)? 2C3:0$GTW8!)=.$ B34E (BU*8"(=6Y B'5
MT@(@T^L"(-+V Q_1_P0?T?\$']'_!!_1_P2?FP  E*(  (>I  !YL0  ;;@
M &"^  !4PP  2<<  #[+   UT $ +=4& "7;"P DWA( (]X< "+?)0 AX"X
M(. W !_A0  >X4H '>)3 !SC7@ ;XVH &N1X !CDB $7Y9H!%N:L 17FP $4
MY]T!$^7O 1/C^@$3X_H!$^/Z 1/C^@&6H@  B:D  'NQ  !NN0  8<   %3&
M  !(R@  /<\  #/3   JV0  (MX" ![K"@ <[!  &^T7 !GM'P 7[B8 %>XM
M !3O-0 3\#T $?!& !#Q4  /\EL #O)I  WS>  ,](H "_6<  KUK@ )]L(
M"?;9  CU[0 (]>T "/7M  CU[0"+J0  ?;(  &^Z  !BP@  5<D  $?.   [
MT@  ,=@  "?=   ?X0  &>@  !;X!@ 4^@T $OL2 !#\%P ._!T #?TC  S]
M*0 *_C  "/\X  ;_00 #_TP  /]8  #_9@  _W<  /^)  #_FP  _ZL  /^[
M  #_S@  _\\  /_/  #_SP!_L@  <;H  &/#  !6RP  2-$  #K6   OW0
M)>$  !SE   4Z0  $?<   __ 0 -_PD "_\-  C_$  &_Q0  _\8  #_'@
M_R,  /\J  #_,@  _SP  /]'  #_5   _V,  /]S  #_A0  _Y<  /^D  #_
ML@  _[(  /^R  #_L@#_(BD!_R,G ?\C* '_("L!_QPQ ?\:/0'_&$D!_Q96
M O\48@+_$VX"_Q)X O\2@@+_$HL"_Q*2 O\2F0+_$IX"_Q*D O\2J0+_$J\"
M_Q*V O\2O0+_$L<"_Q+4 OT2Y0+Z$O$"]Q+Z O43_P+T$_\#]!/_ _03_P/T
M$_\#]!/_ _03_P/_)"<!_R8D ?\F) '_)"<!_R(O ?\@.@'_'D8!_QQ3 O\:
M7P+_&&H"_Q=U O\7?P+_%X@"_Q>/ O\7E@+_%YP"_Q>A O\7IP+_%ZT"_Q>S
M _X7NP/]%\4#^A?1 _<7Y +T%^\"\1CZ N\8_P/N&/\$[AC_!.T8_P7M&/\%
M[1C_!>T8_P7_)R,!_RD@ /\I( #_*", _RDM ?\G-P'_)4,!_R-/ O\A6P+_
M'V8"_QUQ O\=>P/_'80#_QV, _X=DP/\')D#^QR? _H<I /Y'*H#]QRQ _8<
MN0/U'<(#\QW. _ =X0/L'>X#Z1[Y!.@>_P7F'O\&Y1[_!N4>_P?E'O\'Y1[_
M!^4>_P?_*Q\ _RT< /\M&P#_+B  _R\I /\O- '_+#\!_RI+ O\H5P+_)F("
M_25M _HD=P/X(X #]B.( _4CCP/S(Y4$\B.;!/$CH03O(Z@$[B.N!.TCM@3K
M([\$ZB/,!.<CX 3C).T$X"3Y!MXD_P?<)/\(VR3_"=HD_PG:)/\)VB3_"=HD
M_PG_+AL _S$7 /\R%@#_-1P _S8E /\V+P'_-#H!_S%& ?LO4@+W+5T"\RQH
M _ K<@/N*GL$["J$!.HJBP3H*I(%YRF8!>8IG@7D*:4%XRFL!>$IM 7@*KT%
MWBK*!=LJW@76*NT'TBKX"<\K_PK-*O\+S"K_#,LJ_PS+*O\,RRK_#,LJ_PS_
M,A< _S42 /\X$@#_.Q@ _ST@ /\\*@#^.S4!]SE! ?$V30+L-%@"Z#-C ^4R
M;03C,G8$X#%_!=XQAP7<,(X&VC"5!M@PFP?6+Z('U"^I"-(OL0C0+[H)SS#&
M"<TPV G),>H*QC'W#,,Q_P[!,?\/P#'_#[\Q_P^_,?\0OS'_$+\Q_Q#_-A,
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M&Y9&^!R51O\;E$;_&Y-&_QN31_\;DT?_&Y-'_QO_0@4 _TH! /)0  #A5 $
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M(G58_R%U6/\A=5C_(758_R'_30  Y5<  --?  #(9   OV<  +=H  "Q9P<
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M(F%F_R+H6   TV,  ,1K  "Y<0  L'4  *=W  ">=0  EG8- )!W&0"+>"<
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M7P  RFD  +QR  "R>   J7T  )]_  "2?@  BG\' (2 $P" @2$ >X$N 7>
M.0-R@$(%;G]*"&M^40MH?5@.9'Q?$6)[9A1?>FT77'EU&5EX?QQ7>(H>5'>6
M(5)VI")1=K,C4';&)%!VXR-0=?4C477_(E%T_R%1=/\A473_(5%T_R'88P
MQ6T  +AV  "N?0  I8(  )J#  "-@P  A(0# 'V%$ !YAAX =8<K 7&'-@)M
MAC\$:85'!V6$3PIB@U8-7X-<#UR"8Q):@6L55X!S&%1_?1I1?X@<3WZ4'TU^
MHB!+?;$A2GW$(DI]X2%+?/0A2WO_($M[_R!+>_\@2WO_($M[_R#09P  P'(
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M%3F:V14YF.\6.9?\%CB6_Q<XE?\7.)7_%SB5_Q>[>@  KX4  *2,  "8D0
MC94  (&:  !UG0  :*   %ND  !6I0P 4Z87 %&G(P!/IR\ 3*<X 4JG00%(
MITD"1J=0!$.G6 5!IU\&/Z9H"#VF<@HZIGT+.*:*#3:EF0XTI:D/,Z6[#S.E
MU \SI.X/,J+[$#*A_Q$RH?\1,J'_$3*A_Q&T@@  J(P  )V2  "2EP  AIP
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M 1C*_ $8RO\"&,K_ AC*_P*;F0  CY\  (*F  !UK0  :+,  %RY  !0O0
M1,$  #G$   PR   *,P! "#0!@ 9U0L %M<0 !78&0 5V2( %-DK !/:-  3
MVCT $MM( !'<4P 1W5\ $-UM !#>?@ .WY$ #N"D  W@N  ,X-( "]_M  S>
M]P ,W?L #-W[  S=^P"2GP  A:<  '>N  !JM0  7;P  %#!  !$Q0  .,D
M "[-   ET0  'M4  !;: 0 1W@8 $.<-  [G$@ -Z!D #.@A  OI*0 *ZC$
M">H[  ?K10 %ZU$ !.M>  /K;@ !ZX   .J4  #JIP  Z[P  .O2  #KZ0
M[.\  .SO  #L[P"'IP  >:\  &NW  !>O@  4<4  $/)   WS0  +=$  "/6
M   ;VP  $]\   [C   ,[@( "O8*  ?V#@ %]A(  _88  #U'@  ]24  /4N
M  #U-P  ]D(  /9.  #V70  ]FX  /:!  #VE0  ]Z<  />W  #XQP  ^-
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M ?\.>P'_#H0!_PZ+ ?\.D@'_#I@!_PZ= ?\.HP'^#J@!_ ZN ?L.M0#Z#KX
M^ [) /4.VP#R#NH [@[U .P._P'K#_\!Z@__ >H0_P'I$/\!Z1#_ >D0_P'_
M(A\ _R(< /\A' #_'R  _Q\I /\<- #_&D  _Q=, ?\56 '_%&,!_Q-N ?\3
M=P'^$X !_!.( ?H2C@'Y$I4!^!*: ?82H 'U$J8!]!*L ?,2LP'Q$KP!\!+'
M >T2V 'I$^@!YA/U >04_P'B%/\"X17_ N$5_P+@%?\"X!7_ N 5_P+_)1L
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M";(P^PJP,/\+KC#_"ZXP_PNM,/\+K3#_"ZTP_PO_,PP _S8& /\\"0#_/@P
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M%H5'_Q6%1_\5A4?_%85'_Q7_/P  [$@  -U/  #/4P  QE4  ,!3 P"[40P
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M(@";7"\ EUL[ I):10./64T&BUA5"(A77 J&5F,,@U5J#H%4<1!^5'@2?%.
M%'I2B19X4I08=E*?&712JQIR4KH;<5+-''!2Z!MP4_D:<%/_&G!3_QEP4_\8
M<%/_&'!3_QCO20  W5,  ,M:  # 7P  MV(  *]A  "H7@( H5\0 )M@'@"6
M8"P D6 X 8U>0@.)74L%A5Q2!X);60J 6F ,?5EG#GM8;A!X6'42=E=]%'17
MAQ9R5I$8;U:<&FY6J1ML5K@<:U;+'6I6YAQJ5_<;:E?_&FI7_QEK5_\9:U?_
M&6M7_QGK3   V%8  ,A>  "\8@  LV4  *ME  "C8@  G&(. )9C' "19"D
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M&EYBI!Q<8K(=6V+%'5MBX1U;8O0<6V+_&UQB_QI<8O\:7&+_&EQB_QK@50
MRU\  +UG  "R;   J7   )]O  "4;   C&T( (9N$P"";R$ ?6\M 7EO. )U
M;D$#<FU)!6YL4 =K:U<*:6M>#&9J90YD:6P186ET$U]H?A9=9XD86V>5&EEF
MHAM79K <5F;#'59FWQU69O,<5V;_&U=F_QI79O\:5V;_&E=F_QK;60  QV(
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M&49XU1E&=^\81W;\&$=V_QA'=?\71W7_%T=U_Q?)90  NF\  *YW  "D?0
MF'\  (M_  !^?P  <X$  &R#"0!HA!, 984@ &*&+ !?AC8!7(8_ EF%1@-7
MA4X%5(55!U*$7 E/@V,+38-K#4N"= ](@G\11H&,$T2!FA5"@*D608"Z%D"
MTA9!?^T607[[%D%]_Q9!??\607W_%D%]_Q;":@  M74  *I]  "?@@  DH,
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M"2V<_PHMF_\*+9O_"BV;_PJO@   HXD  )>.  "-DP  ?Y4  '*8  !FG
M6Z   $^D  !%IP  /JD, #RJ%  ZJA\ .:HI #BK,@ WJSL -:M# #2L2P R
MK%,!,:Q< 2^L9@(MK'$"*ZQ_ RJLC@,HK)X$)ZRP!":LQ00FJ^0#):GU!"6H
M_P4EI_\%):?_!26G_P6GB0  FX\  )&4  "$F0  >)X  &NB  !?I@  4ZH
M $BM   ]L   -+,# "^U#@ MM18 ++4@ "NV*0 JMC( *;<Z "BW0P GMTP
M)KA5 "2X7P CN&L (KAX 2"XB $?N)D!';FK 1RYP $<N-\!'+;R 1NU_ (;
MM/\"&[3_ ANT_P*?CP  E)4  (B;  ![H0  ;J8  &*K  !6L   2K,  #^V
M   UN0  ++P  "2_!@ ?P@T '<(4 !S"'@ ;PR8 &L,O !G$.  8Q$$ %\1*
M !;%50 5Q6$ %,9O !/&?P 2QI$ $<>D !#'N0 /Q]0 $,;N !#$^@ 0P_\
M$,/_ !##_P"7E@  BYP  'ZB  !QJ0  9*\  %BT  !+N   0+L  #6^   K
MP0  (\4  !O) 0 4S 8 $- +  [1$0 -T1D #=$A  S1*@ ,T30 "](^  K2
M20 )TU4 "=-B  C3<@ &U(0 !=28  34JP #U<   =7<  '5[0 !U?8  =7V
M  '5]@".G0  @*0  '.K  !FL0  6;@  $R]   _P   -,,  "K'   AR@
M&<X  !+2   -U@$ "=L%  ;<#0 $W!$  ]T8  '>(   WB@  -\Q  #@/
MX4<  .)4  #C8P  XW0  .2(  #DFP  Y:X  .7!  #EU0  YN<  .;G  #F
MYP"#I   =:P  &BS  !:NP  3<$  $#$   SR   *,P  !_0   7U   $-D
M  O=   %X0   .0   #E!P  Y@T  .<1  #H%@  Z1T  .HE  #K+@  [3D
M .]%  #P4P  \60  /%V  #RB@  \YP  /.M  #TNP  ],@  /3(  #TR !W
MK0  :K4  %R]  !/Q   0,D  #/-   GT0  '=8  !3<   .X   ".,   'F
M    Z@   .X   #N    [P0  / *  #Q#@  \Q(  /08  #V(   ^"H  /HU
M  #]0P  _E(  /]C  #_=@  _XD  /^:  #_I@  _[   /^P  #_L #_%B,
M_Q4A /\1(0#_#20 _PDK /\&-P#_ T0 _P!1 /\ 70#_ &@ _P!R /\ >P#_
M (, _P"* /\ D0#_ )8 _P"< /\ H0#] *8 ^P"L /D LP#W +L ]0#% /,
MT0#R .0 \0#Q .\ ^@#N /\ [@#_ .T _P#M /\ [0#_ .T _P#_&2  _Q@=
M /\5'0#_$!\ _PXI /\,- #_"D$ _P=- /\%60#_!&0 _P1N /\#=P#_ X
M_P.' /\#C0#] I, ^P*9 /D"G@#W J0 ]0*J /,!L #Q ;@ [P'" .T!SP#K
M >, Z@'O .@"^P#G!/\ Y@7_ .8&_P#F!O\ Y@;_ .8&_P#_'!L _QL9 /\7
M& #_%1T _Q,E /\1, #_$#T _PY) /\,50#_"V  _PMJ /T+<P#["WP ^0J#
M /<*B@#U"I  ] J6 /,*FP#Q"J$ [PFG .T)K@#K";8 Z G  .8)S0#D">(
MX@KP -\+^P#>#/\ W W_ -P-_P#;#?\!VPW_ =L-_P'_'Q< _QX3 /\;$@#_
M'!D _QLB /\8+ #_%3@ _Q-$ /X24 #Y$5L ]1!F /,0;P#P$'< [A!_ .P0
MA@#J$(P Z1"2 .@0F #F#YX Y0^E .,/K #A#[0 X ^^ -X/S #:$.$ U1'P
M -(2^P#/$O\!SA/_ <T3_P'-$_\!S!/_ <P3_P'_(A( _R(/ /\A#P#_(A0
M_R(< /\@)P#_'3( ^!L^ /(92P#N&%8 ZA=@ .<6:@#D%G( XA9Z . 6@@#>
M%H@ W!:/ -L6E0#9%IL UA:B -06J0#2%K$ T!>[ ,X7R0#,&-X R!GN <4:
M^P'#&O\"P1O_ L ;_P+ &_\"P!O_ L ;_P+_)@X _R4+ /\H# #_*1  _R@6
M /XF( #T)"L ["$X .8@1 #A'U  W1]; -D>90#5'FT TA]U - ??0#.'X,
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M")TQ_PB<,?\(G#'_")PQ_PC_,   _S4  .\X  #B.@  VSD$ -8U"0#.-!,
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M#WA&_P_P/P  WTD  ,U/  #!4P  N%0  +%2  "K3@4 I$X1 )Y/( "94"T
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M$FE1HQ-G4;$49E'#%652WA5E4O(495+_$V52_Q)E4O\295+_$F52_Q+D2@
MSU,  ,!:  "U7@  K&   *)>  ":60  DEH+ (U;%@"(7", A%PO (!;.@%]
M6T,">5I+ W994@1T6%@&<5A?!V]79@EM5VT+:U9U#6E6?@]G5HD19565$F-5
MH11B5:\5857!%F!5VQ9@5O$58%;^%&!6_Q-A5O\285;_$F%6_Q+@30  RU8
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M%5%BTA518>T54F'[%%)A_Q-38?\24V'_$E-A_Q+15@  P%\  +-F  "I:P
MG&L  )!J  "%9P  ?6D  '=J#0!S:Q< ;VLD &QL+P!I;#@!9FM! F-K20-A
M:U $7FI7!EQJ70=::64)6&EM"U5H=@U3:($/46>-$4]GFA).9ZD436>Y%$QG
MSQ1,9NL436;[$TUF_Q).9?\23F7_$DYE_Q+,6@  O&,  +!J  "E;P  F&X
M (QM  " ;   =VT  '%N"P!M;Q0 :7 A &9Q+ !D<38!87$^ 5YQ1@)<<$T#
M67!4!5=P6P95;V((4V]J"E!N<PQ.;GX.3&V*$$IMF!%);*<22&RX$T=LS1-'
M;.H32&OZ$DAK_Q)(:O\12&K_$4AJ_Q''7@  N&<  *QN  "A<@  DW(  (=Q
M  !Z<0  <7(  &MT!P!F=1$ 8W8= &!W* !>=S, 6W@\ 5EW0P)6=TL#5'=2
M!%)V6050=F '3G5H"$MU<0I)='P,1W2(#D5SE@]#<Z400G.V$4%SRQ%"<N@1
M0G+X$4)Q_Q!#</\00W#_$$-P_Q#!8P  LVP  *AS  ";=@  CG4  (%V  !U
M=@  :7@  &-Z @!>? X 7'T9 %E^) !7?R\ 57\X 5-_0 %0?T@"3GY/ TQ^
M5@1*?ET%2'UE!D9];@A#?'D*07R&"S][E T^>Z,./'NS#CQ[R X\>N8./'GW
M#CQX_PX\>/\./7?_#CUW_PZ\:   KW(  *1Y  "6>@  B'H  'QZ  !P?
M8W\  %R"  !7A L 4X44 %&&( !/ABH 3H<T $R'/ %*AT0!2(=+ D:'4P)$
MAEH#0H9B!$"&; 8^A78'.X6#"#F%D0HXA* +-H2Q"S:$Q@LV@^0+-H+V"S:!
M_PPV@/\,-H#_##: _PRV;P  JG@  )]_  "0?@  @W\  '>   !K@@  7H<
M %6*  !.C 8 2HX0 $B/&@!'CR4 19 O $20. !"D$  0)!' 3^03P$]D%8"
M.Y!? CF0: ,WCW,$-8^ !3./C@8QCYX',(ZO!R^.PP<OCN$'+XST""^+_P@O
MBO\(+XK_"2^*_PFP=@  I7\  )B$  "*A   ?84  '"'  !EB@  6HX  $^2
M  !&E0  09@, #Z8%  ]F1\ .YDH #J:,0 YFCH -YI" #::2@ UFE(!,YI:
M 3&:9 $OFF\"+9I[ BR:B@,JFIH#*9JL!"B:P 0GF=X#)Y?R!">6_04GE?\%
M)Y7_!2>5_P6I?@  GH4  )*)  "$B@  =HP  &J/  !>DP  5)<  $F;  !
MGP  -Z($ #*C#@ QHQ< ,*0A "ZD*@ MI#( +*4Z "NE0P JI4L *:54 "BE
M7@ FI6D ):5V 2.EA0$BI98!(*:H 1^ENP$>I=<!'J3O 1ZB^P(>H?\"'J'_
M AZA_P*BA@  EXP  (N/  !]D0  ;Y0  &.8  !7G0  3:$  $.E   XJ
M,*L  "BN!P DKQ  (Z\7 "&O(0 @L"D '[ Q !ZP.@ =L4( '+%, !NQ5@ :
ML6$ &;)O !BR?@ 6LI  %;*B !2RM@ 3LLX $['K !.O^0 3KO\!$Z[_ 1.N
M_P&:C0  D)(  (27  !UF@  :)\  %NC  !0J   1:P  #NP   QL@  )[4
M ""X   8N@< %+P. !.\%0 2O!X $;TF !&]+@ 0O3< $+Y!  Z^3  .OE<
M#;YE  R_=  +OX8 "KZ9  B^K  'OL( ![[?  B^\  (O?H "+W\  B]_ "3
ME   AYD  'J?  !LI0  8*H  %.O  !'LP  /+8  #&X   GNP  '[X  !?!
M   1Q $ #,@(  C)#@ 'R10 !LD<  7))  $RBP  \HV  +*0   RTP  ,M9
M  #+:   RWD  ,R,  #+GP  R[,  ,O(  #,X@  S.\  ,SQ  #,\0"*F@
M?*$  &^G  !BK0  5;,  $BX   [NP  ,+X  ";!   =Q   %<@   _+   *
MS@  !-("  #3"@  TP\  -04  #5&@  UB(  -<J  #9-   VC\  -Q+  #<
M6@  W6H  -U]  #=D0  W:0  -ZV  #>R   WMX  -[B  #>X@!_H@  <:D
M &2P  !6MP  2;P  #S    OQ   ),<  !O+   3SP  #=(   ?6    VP
M -X   #? P  X D  .$.  #B$@  XQ<  .4>  #F)P  Z#$  .H]  #L2P
M[%H  .UL  #N@   [I0  .ZE  #NM   [L(  .[&  #NQ@!TJ@  9K(  %BY
M  !+P   /<4  "_)   DS0  &=$  !'6   +VP   ]X   #A    Y0   .@
M  #I    Z@   .L&  #M"P  [P\  / 3  #R&@  ]",  /<N  #Y.P  ^TH
M /Q;  #];0  _8   /Z3  #^H@  _JT  /ZO  #^KP#_$!\ _PX= /\*'0#_
M 2  _P H /\ -0#_ $$ _P!. /\ 6@#_ &4 _P!N /\ =P#_ '\ _@"& /P
MC #[ )( ^0"7 /@ G #W *( ]@"G /4 K0#S +4 \@"] /$ R0#O -P [@#K
M .T ]P#L /\ ZP#_ .H _P#J /\ Z@#_ .H _P#_$QP _Q$9 /\-&0#_!AP
M_P,E /\ ,0#_ #X _P!* /\ 5@#_ &$ _P!K /T <P#Z 'L ]P"# /4 B0#T
M (\ \@"4 /$ F0#P )\ [@"D .T JP#L +( Z@"Z .@ Q@#G -8 Y0#H .0
M]0#C /X X@#_ .$ _P#A /\ X0#_ .$ _P#_%1@ _Q,4 /\/% #_#1D _PLB
M /\(+0#_!#D _P%& /\ 40#^ %P ^@!F /8 ;P#R '< [P!^ .T A0#K (L
MZ@"1 .@ E@#G )P Y@"A .0 J #C *\ X0"X -\ PP#= -$ VP#F -D \P#7
M /T U0+_ -0"_P#4 _\ U /_ -0#_P#_&!, _Q40 /\2#P#_$A4 _Q$= /\.
M* #_##0 _PI! /D(3 #U!E< \09A .T&:@#I!7( Y@5Z .0%@0#B!8< X :-
M -\&D@#=!I@ VP:> -D&I0#7!JT U :U -(&P #0!\\ S@CE ,P)] #*"_\
MR S_ ,<,_P#'#/\ Q@S_ ,8,_P#_&PX _QD, /\8#0#_&!$ _Q<8 /\4(@#[
M$2X \Q Z .T.1@#H#5( Y0U< .$-90#>#6T VPUU -@-? #5#8( TPV) -$-
MCP#0#94 S@V< ,T.HP#+#JL R0ZT ,@.P #&#L\ PQ#F , 1]0"]$O\ O!+_
M +L2_P"Z$O\!NA+_ ;H2_P'_'PH _QP$ /\?" #_'PT _QT2 /@:&P#N%B8
MYA0S . 3/P#:$TL U!-6 - 37P#.%&@ RQ1O ,D4=P#'%7T QA6$ ,05B@##
M%9$ P1:8 , 6GP"^%J< O!>P +L7O "Y%\L MQCB +,9\@&Q&O\!KQO_ :X;
M_P&N&_\!K1O_ :T;_P'_(@0 _R(  /\E @#\) < ]R$, .P=$@#A&AP V!HJ
M - ;. #+'44 QQU0 ,,>6@# 'F( OAYJ +P?<0"Z'W@ N1]^ +<?A0"V'XP
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M!8PQ_P7_+0  ZC4  -PZ  #./0  QCP  , W @"[,PT LS09 *XV)P"I-S0
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M"7@_I0IW0+(*=4##"W1 W0MS0?$+<D'_"G)!_PIR0?\)<D'_"7)!_PGI/
MU44  ,5+  "Z3@  L$X  *=+  "B1@  FT8. )9'&@"12"< CD@S (I(/0"'
M1T8!A$=. 8)&50* 1EP#?D5B!'Q%:01Z17 %>$1X!G9$@0AT1(L)<D26"G!$
MH@MO1*\,;D3 #&U%V0UL1>\,:T7]"VM&_PMK1O\*:T;_"FM&_PKE0   STD
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M#EM1S@]:4>H.6U'Z#5M1_PQ;4?\,6U'_"UM1_PO62@  PU,  +99  "K7
MGEH  )-9  "+5   A%8# 'Y6$ !Z5QH =E<F '-8,0!P5SH ;5=" 6I720)H
M5E "9E97 V167@1B564%8%5M!UY5=@A=58$*6U6-"UE4F@U85*<.5E6X#U95
MS ]65>D.5E7Y#595_PU75/\,5U3_#%=4_PS130  P%8  +-<  "G7@  FET
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M#$AA_PQ(8/\+26#_"TE@_PO$6   M6   *IF  ";9@  C68  ()E  !V9
M;F4  &AF!0!C9Q  8&@: %UI)0!;:B\ 66HX %=J0 %5:D<!4VI. E%J50-/
M:5T$36ED!4MI;09):'@'1VB$"49HD@I$9Z$+0V>Q#$)GQ0Q"9^(,0F;U#$-F
M_PM#9?\+0V7_"T-E_PN_7   L60  *9J  "6:0  B6D  'UI  !Q:0  9VH
M &)L 0!=;0T 66X6 %=O(0!5<"L 4W U %%P/0!0<$4!3G!, 4QP4P)*<%H#
M2'!B!$9O:P5$;W4&0F^"!T!NCPD_;IX*/6ZO"CUNP@H\;N */6WT"CUL_PH]
M:_\*/FO_"CYK_PJZ8   K6D  *!N  "1;0  A&T  'AM  !L;@  87   %MR
M  !6= H 4G42 %!V'0!.=R< 3'<Q $MX.0!)>$$ 2'A) 49X4 %$=U<"0G=?
M T!W: ,^=W,$/'9_!CIVC0<Y=IP(-W6M"#=UP @V==X(-W3R"#=S_@@W<O\(
M-W+_"#=R_PBU9@  J6\  )IQ  "+<0  ?G$  '-R  !H<P  7'8  %1Y  !.
M>P4 2GT/ $A^& !&?R, 17\L $. -0!"@#T 08!% #^ 3 $]@%0!/(!< CI_
M90(X?V\#-G]\!#1_B@0R?YH%,7ZJ!C!^O08P?MH&,'WP!C![_08P>_\&,'K_
M!C!Z_P:P;   I'4  )1U  "&=0  >78  &YW  !C>0  5WT  $^!  !'A
M0H8, #^'$P ]B!T /(@G #N),  ZB3@ .(E  #>)2  VB4\ -(E8 3.)80$Q
MB6P!+XEX BV)AP(LB9<#*HBG RF(N@,IB-0#*8;N RF%_ 0IA/\$*83_!"F$
M_P2J=   GGL  (YZ  " >@  ='L  &A^  !=@0  4H4  $F)  !!C   .9 %
M #61#P SDA< ,I(A #&2*0 PDS( +I,Z "V300 LDTH *Y12 "J47  HE&<
M)Y1S 264@@$DE),!(I.D 2&3MP$@D\\!(9+L 2"0^@(@C_\"((__ B"/_P*D
M?   EX   (=_  ![@   ;H(  &*%  !7B0  38X  $*2   ZE@  ,ID  "J<
M"0 HG1$ )IT9 "6=(@ DGBH (YXR "*>.@ AGD( ()Y+ !^?50 >GV  ')]M
M !N??  :GXT &)^? !>?L@ 6G\D %I[H !:<]P 6F_\!%YO_ 1>;_P&=@P
MCX8  (*&  !TAP  9XL  %N/  !0DP  1I@  #R<   SH   *Z,  ".F   <
MJ L &JD1 !BI&  7J2$ %JHI !6J,0 4JCD $ZI# !.K30 2JU@ $:ME !"K
M=  .JX8 #JN9  VKK  ,J\$ #*K?  RI\@ -J/P #:C_  VH_P"6B@  B8P
M 'J-  !LD0  8)4  %2:  !)GP  /Z,  #6G   KJ@  (ZX  !NP   4LP$
M#[4*  VV$  ,MA8 "[8?  JV)P )MB\ "+8Y  >W0P &MT\ !+=;  .W:@ "
MMWL  +>.  "WH0  MK0  +;+  "VY0  M?$  +7W  "U]P"/D0  @90  '*7
M  !EG   6*$  $RF  !!JP  -Z\  "RR   CM0  &K@  !.[   .O0  "< %
M  /!#0  P1$  ,$7  #"'@  PB8  ,(O  ##.0  Q$0  ,10  #$7@  Q6\
M ,6!  #%E0  Q:@  ,6\  #$T0  Q.8  ,3N  #$[@"&F   >9X  &NC  !=
MJ0  4*X  $2S   WM@  ++D  "*\   9OP  $<(   S%   &R    ,L   #,
M!P  S T  ,T1  #-%@  SAT  ,\D  #0+0  TC@  -1$  #44@  U6$  -5S
M  #6AP  UIL  -:M  #7OP  V,X  -C=  #8W0![H   ;J8  &"M  !3LP
M1;@  #B\   KOP  (<(  !?&   0R0  "LP   +0    U    -<   #8
MV@4  -L+  #<#@  WA,  -\9  #A(0  XRH  .4V  #G0P  YU,  .AD  #I
M=P  Z8P  .J?  #JK@  ZKH  .K#  #JPP!PJ   8J\  %6V  !'O   .<
M "S$   @R   %LP   [0   'U    -D   #=    X0   .,   #D    Y@
M .<!  #I!P  ZPP  .P0  #N%0  \!T  /,G  #V,P  ]T,  /A4  #Y9@
M^7H  /J.  #ZG@  ^ZD  /NP  #[L #_"QL _P<9 /\ &0#_ !P _P E /\
M,@#_ #\ _P!+ /\ 5P#_ &( _P!K /\ <P#] 'L ^P"" /H B #X (T ]P"2
M /8 F #U )T ] "B /, J0#Q +  [P"X .X PP#L -$ ZP#F .D \P#H /X
MZ #_ .@ _P#H /\ Z #_ .@ _P#_#A@ _PH5 /\!% #_ !@ _P B /\ +@#_
M #L _P!' /\ 4P#] %X ^@!G /< ;P#U '< \P!^ /( A #P (D [P"/ .X
ME #L )H ZP"? .D I0#H *P Y@"T .0 OP#C ,P X0#B -\ \ #> /L W@#_
M -T _P#= /\ W #_ -P _P#_$!, _PT1 /\&$ #_ A4 _P > /\ *0#_ #8
M_P!" /H 3@#T %D \0!B .X :P#L '( Z@!Y .@ ?P#G (4 Y0"+ .0 D #B
M )8 X0"< -\ H@#= *D V@"Q -@ NP#5 ,@ T@#= -$ [0#0 /D SP#_ ,X
M_P#- /\ S0#_ ,T _P#_$0\ _PX- /\,#0#_"Q( _P<9 /\") #_ #  ]@ \
M .\ 20#J %, YP!= .0 9@#A &T WP!T -T >P#; ($ V0"& -8 C #4 )(
MT@"8 -  G@#. *8 S "N ,H N #( ,0 Q@#7 ,4 Z@## /< P@#_ ,$!_P#
M O\ P +_ , "_P#_% L _Q & /\0"0#_$ X _PX4 /\*'@#U!BD ZP0V .,#
M0@#? TX VP17 -8$8 #3!&@ T 1O ,X%=@#,!7P R@6" ,D%B #'!8X Q@64
M ,0%FP#"!:, P :K +X&M0"]!L( NPC4 +H)Z0"W"_@ M0S_ +0,_P"T#/\
MM S_ +0,_P#_%P0 _Q0  /\6 P#_% D _Q$. /(.%0#H#"$ W@HN -8+.P#0
M#$< S Q1 ,D,6@#&#6( Q UJ ,(-<0# #7< OPU] +T.@P"\#HH N@Z1 +D.
MF "W#J  M@ZI +0/M "R#\$ L1#4 *X1ZP"K$OH J1+_ *@3_P"G$_\ IQ/_
M *<3_P#_&@  _QL  /D;  #K&0  Y10& .40#@#9#A< SQ$F ,@2- #$$T
MOQ1+ +P45 "Y%5T MQ5D +45:P"T%7$ LA5X +$6?@"O%H4 KA:, *P6E "K
M%YP J1>F *<8L "F&+T I!C/ *(:YP"?&O< G1O_ 9P;_P&<&_\!FQO_ 9L;
M_P'_'0  ]R$  .@D  #=)0  U"$! ,\;" #*%Q$ PAH@ +P<+0"W'3H LQY%
M + >3P"M'E< JQY? *D?9@"H'VP IA]S *4?>0"C'X  HA^' * @CP"?()@
MG2"B )L@K &:(;D!F"'* 98BY &4(_4!DB/_ 9$C_P&0(_\!D"/_ 9 C_P'_
M(@  ZRD  -TN  #/+P  QRT  ,$G P"](@T MB,: + E* "L)C0 J"9  *4G
M20"B)U( H"=: )XG80"<)V< FR=M )DG= "8)WL!EB>" 94GBP&3)Y0!D2B>
M 9 HJ0&.*+4"C2G& HLIWP*)*O("ARK_ H8J_P*&*O\"ABK_ H8J_P+T*
MXS$  -$V  #%.   O#8  +8P  "R*PD JRP4 *8M(@"B+B\ GBXZ )LN1 "8
M+TT EB]5 )0N7 "2+F( D"YI 8\N;P&-+G8!C"Y^ 8HNA@*(+H\"ARZ: H4O
MI0.#+[(#@B_" X$PV@-_,.\#?3'^ WTQ_P-\,?\#?#'_ WPQ_P/M+P  VS<
M ,D]  "^/@  LSP  *PX  "G,P0 HC(1 )TT'0"9-2H E34U )(U0 "/-4D
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M2   I48  )U#  "7/P  DCX+ (T_%0")/R$ A4 M () -P!_0$  ?4!( 'M
M3P%Y0%8!=S]= 74_8P)S/VH"<3]R W _>@-N/X0$;#^0!6L_G 9I/ZD&:#^X
M!V= S =F0.@'9D#Y!F5 _P9E0/\&94#_!65 _P7</@  QT8  +E+  "L3
MH$H  )='  "10P  BT,( (9#$@""1!X ?D0I 'M%- !Y13T =D5% '1$3 %R
M1%,!<$19 6Y$8 )L0V<":T-O VE#=P1G0X$%9D.-!F1#F09B0Z<'842V"&!$
MR@A@1.8(7T7X!U]%_P=@1?\&8$3_!F!$_P;600  PTD  +9.  "G3P  FTT
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M"%%0_P=13_\'44__!E%/_P;)2P  N5,  *M7  "<5@  CU4  (54  !\4
M=5$  '!2"0!K4Q( :%0= &54)P!B5#$ 8%0Y %Y400!<5$@!6E1/ 5E45@%7
M5%T"5E1E U14;@125'@%452$!D]4D0=.5* (3%2O"$Q4P@E+5-\)3%3S"$Q3
M_P=,4_\'35/_!DU3_P;%3@  ME8  *=:  "860  BU@  (%7  !W5   <%4
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M!CY@_P:Y60  JV$  )IA  "+80  ?V$  '1A  !I80  7V(  %ED  !49@D
M46<1 $YG&@!,:"0 2VDM $EI-@!(:3X 1FI% $5J3 !#:E0!0FI< 4!I90(^
M:6\"/&E[ SMIB00Y:9@%.&BH!3=HN@4W:=,%-VCN!3=G_ 4X9O\%.&;_!3AF
M_P6T7@  IV4  )5E  "&9   >F4  &]E  !D9@  66@  %)J  !-; 0 26X.
M $=N%@!%;R  1' I $)P,@!!<#H 0'%" #]Q20 ]<5$ /'%9 3IQ8@$X<6P"
M-G!X C5PA@,S<)4#,G"F!#%PN 0P<- $,6_L!#%N^P0Q;?\$,6S_!#%L_P2O
M9   H6D  (]H  "!:   =6D  &MI  !@:P  56X  $UQ  !&<P  0G4+ #]V
M$@ ]=QP /'<E #IX+0 Y>#4 .'D] #=Y10 V>4T -7E5 #-Y7@ Q>6@!,'ET
M 2YY@P(M>9("*WBC BIXM0(J>,P"*G?J BIV^0,J=?\#*G3_ RIT_P.J:@
MFFT  (EL  !\;0  <&T  &9N  !;<0  4'4  $AX  !!>P  .GX% #9_#@ T
M@!8 ,X$@ #*!*  P@3  +X(X "Z"0  M@D@ +()0 "N"6@ J@F0 *()P ":"
M?P$E@H\!)(*@ 2."L@$B@LD!(H'G 2)_]P$B?O\"(GW_ B)]_P*E<0  DW$
M (-Q  !V<0  ;'(  &!U  !6>   3'P  $.    [@P  ,X8  "V)"@ JBA$
M*8L9 ">+(@ FBRH )8PQ "2,.0 CC$( (HU* "&-5  @C5X 'XUK !V->0 <
MC8H &XV< !F-K@ 8C,0 &(SC !F*]0 9B?\!&8C_ 1F(_P&==P  C'8  'UV
M  !R=P  97D  %I\  !0@   1H0  #R)   TC   +9   "63 @ ?E0P '982
M !R6&@ ;ER( &I<J !F7,@ 8F#H %YA# !:830 5F%@ %)AD !.8<P 1F(0
M$)B6 !"8J0 .F+\ #I?=  ^6\@ 0E?P $)3_ !"4_P"5?0  A7P  'A\  !K
M?@  7X$  %2&  !*B@  0(\  #:3   MEP  )IH  !Z=   7H , $J(, !"C
M$@ 0HQD #Z,A  ZD*0 .I#$ #:0Z  RD10 +I%  "J1<  FD:@ 'I'L !J..
M  2CH0 "H[0  Z++  .BY@ #H?,  Z'[  .A^P"-@P  ?X(  '&$  !DAP
M6(P  $V1  !"E@  .)H  "^>   FH@  'J4  !>H   1JP  #*X'  >O#0 #
MKQ(  J\9  &O(0  KRD  + R  "P/   L$<  +!3  "P80  L'$  +"#  "O
MEP  KZH  *^_  "NV0  KNL  *[T  "N] "'B0  >(H  &J.  !=DP  49@
M $6=   [H@  ,*8  ">J   >K@  %K$  !"T   +M@  !;D#  "Z"@  N@X
M +H3  "[&0  NR$  +PH  "\,0  O3P  +Y(  "^5@  OF4  +YW  "^C
MOI\  +VS  "^QP  OMX  +WK  "]ZP!_D@  <)4  &*:  !5GP  2:4  #VK
M   RKP  *+0  !ZV   5N0  #KP   F_   "P@   ,0   #%!   Q@H  ,8.
M  #'$@  R!@  ,D?  #*)P  S#   ,X\  #.20  SUD  ,]J  #/?@  SY,
M ,^F  #/N   S\@  ,_;  #/VP!WG   :*$  %NG  !.K@  0;0  #2W   H
MN@  ';T  !/    -Q   !L<   #*    S@   -    #1    T@(  -,(  #5
M#   UA   -D5  #;'   W20  . O  #B/   XTL  .1<  #D;P  Y8,  .68
M  #EJ0  Y;8  .7#  #EPP!LI0  7ZP  %&R  !$N0  -;P  "C    <Q
M$L@   S+   #SP   -,   #8    W    -\   #?    X0   .,   #D P
MY@@  .@-  #I$0  [!@  .XB  #Q+@  \SP  /1-  #U7P  ]G,  />'  #W
MF0  ^*4  /BP  #XL #_ Q< _P 5 /\ %0#_ !@ _P C /\ +P#_ #P _P!(
M /\ 5 #_ %X _P!G /T ;P#[ '8 ^0!] /@ @P#V (@ ]0". /0 DP#R )@
M\0"> /  I #N *L [0"S .L O0#J ,L Z #A .< \0#F /T Y0#_ .0 _P#D
M /\ Y #_ .0 _P#_!Q, _P 1 /\ $0#_ !4 _P ? /\ *P#_ #< _P!$ /X
M3P#Z %H ]P!C /0 :P#R '( \ !Y .\ ?P#M (0 ZP"* .H CP#H )0 YP":
M .4 H #D *< X@"O .  N0#> ,8 W #: -H [ #8 /D U@#_ -8 _P#7 /\
MV #_ -@ _P#_"A  _P,. /\ #0#_ !( _P : /\ )@#\ #( ]P _ /0 2@#Q
M %4 [0!> .H 9@#H &X Y0!T ., >@#B (  X "% -X BP#< )  VP"6 -@
MG #5 *, TP"K -$ M0#. ,$ S #1 ,L YP#) /4 R #_ ,@ _P#( /\ R #_
M ,@ _P#_# P _P8( /\""@#_  \ _P 5 /P ( #Q "P [  Y .D 10#E $\
MX0!9 -X 80#; &@ UP!O -0 =0#2 'L T "  ,X A@#, (P RP"2 ,D F #'
M *  Q0"H ,, L0#! +P OP#+ +T XP"\ /( NP#] +L _P"Z /\ N@#_ +H
M_P#_#@4 _PD  /\)!0#_!@L _P$0 /  &0#F "4 X0 R -P /P#6 $D T0!3
M ,X 6P#+ &, R !J ,8 < #% '8 PP![ ,$ @0#  (< O@". +P E "[ )P
MN0"D +< K@"U +D LP#( +$ WP"P >\ KP'[ *X"_P"M _\ K0/_ *T#_P#_
M$   _PX  /\-  #V"P, \@<* .(!$0#; AT T@,K ,P#-P#(!$, Q 1- ,$$
M5@"^!5T O 5D +H%:P"X!7$ MP5V +4%? "S!H, L@:) + &D0"O!YD K0>A
M *L'JP"I"+< J G& *8*W0"E"_  HPS] *(-_P"A#?\ H0W_ * -_P#_$0
M_!(  .P3  #B$P  VP\# -8)"P#."!0 Q@HB , ,, "\#3P N U& +4-3P"R
M#E< L Y? *X.90"M#FL JPYQ *H.> "H#GX IP^% *4/C0"D#Y8 HA"? * 0
MJ0"?$+4 G1'% )L1W@"9$O$ EQ/_ )84_P"5%/\ E13_ )04_P#_%0  [1L
M . ?  #2'P  R1L  ,04!0#!$ X NA(; +03*0"P%#4 K!5  *D520"F%5(
MI!99 *(68 "A%F8 GQ9L )X6<@"<%GD FQ>  )D7B "8%Y$ EAB; )08I@"3
M&;( D1G! ) :V "-&^X BQS] (H<_P"*'/\ B1S_ (D<_P#T'0  Y"4  -,I
M  #'*@  O"8  +8@  "T&0L KAH5 *@<(P"D'2\ H1XZ )X>1 ";'DP F1Y4
M )<?6P"5'V$ E!]G )(?;0"1'W0 CR!\ (X@A ",((T BB"7 (DAH@"'(:X
MAB*] (4BT0&"(^L!@23[ 8 D_P%_)/\!?R3_ 7\D_P'L)0  VRT  ,DQ  "\
M,0  L2X  *LI  "G) 4 HR,1 )XD'0":)2H EB8U ),F/P"1)D< CR9/ (TF
M5@"+)UP B2=B (@G:0"&)V\ A2=W (,G?P"!)XD!@"B3 7XHG@%]*:L!>RFY
M 7HIS0%X*N@!=ROY 78K_P%V*_\!=2O_ 74J_P'E+   T#0  ,$X  "S.
MJ#4  *(Q  "=+0  F2H. )0K& "0+"0 C2TP (HM.@"'+4, A2U* (,M40"!
M+E@ @"Y> 'XN9 !]+FL >RYS 7DN>P%X+H4!=BZ/ 70OFP%S+Z@"<2^V G P
MR0)O,.4";C'W FTQ_P)M,?\";3'_ FTQ_P+?,@  R3D  +L^  "L/0  H3H
M )HW  "5,P  D#$* (PQ% "',B  A#,K ($S-0!_,SX ?3-& 'LS30!Y,U0
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M!%D__P-9/_\#63__ UD__P/,/P  O$8  *M(  "<1P  D48  (A$  ""0
M?#\  '= # !S0!4 ;T$@ &Q!*@!J03, :$$[ &9"0P!D0DH 8T%0 &%!5P!@
M0EX!7D)E 5U";@);0G@"6D*$ UA"D -70IX$5D.M!%5#OP140]H$5$/Q!%1#
M_@-40_\#5$/_ U1#_P/(0@  N$D  *=+  "82@  C4D  (-'  !]0P  =D,
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M T=._P.]3   KE(  )Q1  "-40  @5$  '=0  !N3   9TX  &)/  !=4 T
M6E 4 %=1'@!542< 4U$P %%2. !04C\ 3E)& $U230!,4U4 2E-= 4E390%(
M4V\"1E-[ D53B0-#4Y<#0E.G!$%3N 1!4\\$05/L!$%2^P-"4O\#0E+_ T)1
M_P.Z3P  JE0  )A4  ")5   ?5,  '-3  !I40  8E(  %Q3  !85 H 5%42
M %)5&P!/5B0 3E8M $Q7-0!+5SP 2E=$ $A72P!'6%( 1EA: 4188P%#6&T!
M05AY D!8A@(^6)4#/5BE SQ8MP0\6,T$/%?J SQ7^@,]5O\#/5;_ SU6_P.V
M4P  I5<  )17  "%5@  >58  &]6  !E50  7%8  %=8  !260< 3EH0 $Q:
M& !*6R$ 2%PJ $=<,@!%7#H 1%U! $-=2 !"75  0%U8 #]=80$]76L!/%UV
M CI=A (Y79,".%VC S==M0,V7<L#-ESH S=<^0,W6_\#.%O_ SA:_P.R5P
MH%H  (]9  "!60  =5D  &M9  !@6@  5EL  %%=  !,7@( 2& - $5@% !$
M81X 0F(F $!B+@ _8C8 /F,^ #UC10 \8TT .V-5 #EC7@ X8V@!-F-T 35C
M@0$S8Y$",F.A C%CLP(Q8\@",6+G C%A^ (Q8?\",F#_ C)@_P*N7   FUT
M (I=  !\70  <%T  &9=  !<7@  4F   $QB  !%90  068* #YG$0 \:!H
M.V@B #EI*P X:3( -VHZ #9J00 U:DD -&I2 #-J6P Q:F4 ,&IP 2YJ?@$M
M:HX!+&J? 2MJL $J:L8!*FGE 2IH]@(K9_\"*V?_ BMG_P*I80  E6   (1@
M  !W8   ;&$  &)A  !88P  3F8  $=H  ! :P  .FX% #9O#@ T<!4 ,W >
M #)Q)@ P<2X +W$U "YR/0 M<D4 +')- "MR5P J<F$ *7)M "=R>P F<HL
M)'*< 2-RK@$C<L,!(W'B 2-P] $C;_\!(V[_ 2-N_P&A90  CF0  ']D  !R
M9   :&4  %YF  !4:0  26P  $)O   [<@  -'4  "YX"@ K>1$ *GD8 "EZ
M(0 G>B@ )GHP "5[.  D>T  (WM( ")[4@ A>UP ('MH !]\=@ =?(8 ''N8
M !M[J@ :>[\ &GO> !IY\@ ;>/X &W?_ 1MW_P&9:0  B&D  'EI  !M:0
M8VH  %EL  !/;P  17,  #UW   U>@  +GT  ">! P B@PT ((02 !^$&@ =
MA"( '(4J !N%,0 :A3D &85" !B&3  7AE8 %H9C !6&<0 4AH$ $H:3 !&&
MI@ 1A;L $(76 !&#[P 1@OL $H+_ !*!_P"1;@  @6T  '1N  !I;@  77
M %-S  !)=P  0'P  #>    O@P  )X<  "&*   :C08 %8\- !.0$P 2D!H
M$I B !&0*@ 0D3( $)$[  ^11  .D4\ #9%<  R1:@ +D7H "I&-  B0GP '
MD+, !X_)  >/Y@ 'CO0 "(W\  B-_P")<P  >W,  &]S  !C=0  5W@  $U]
M  !#@0  .88  #"*   HC@  (9$  !J5   3EP  #IH(  N<#@ )G!, ")P:
M  ><(@ &G"H !)PS  .</0 "G4@  )U4  "=8@  G'(  )R$  "<EP  FZH
M )N_  ":VP  FNP  )KU  "9^ "">0  =GD  &AZ  !<?@  48(  $:'   \
MC   ,I$  "F5   AF0  &9T  !*@   .HP  ":8%  .G#   IQ   *<5  "H
M'   J",  *@K  "I-   J3\  *E+  "I60  J6@  *EZ  "IC@  J:$  *BU
M  "HRP  I^0  *?O  "G\P!]@   ;X$  &&$  !5B0  28X  #Z4   TF0
M*IX  "&B   9I@  $JD   VL   'KP   +(   "S!P  LPP  +,0  "T%0
MM!L  +4B  "V*P  MS4  +=   "X3@  N%T  +AN  "X@@  N)<  +BJ  "W
MO@  M](  +?F  "WZ@!VB   9XL  %J0  !.E@  0IP  #>B   LIP  (JL
M !FO   1LP  "[8   2Y    O    +X   "^    OP8  , +  #!#P  PA,
M ,,9  #$(   Q2D  ,<T  #(0@  R5$  ,EB  #)=0  R8H  ,F?  #*L0
MRL$  ,G1  #)V0!NDP  8)@  %.>  !&I   .JL  "^P   DM0  &;@  !"\
M   *OP   <$   #$    R    ,H   #*    S    ,T#  #."   T T  -$0
M  #3%@  UAX  -HH  #=-   WD,  -]4  #?9P  X'P  ."1  #@I   X+(
M ."^  #@PP!FGP  6:8  $RM   _M   ,K@  "2\   8OP  $,,   C'
MR@   ,T   #1    U0   -@   #9    VP   -T   #?    X00  .,*  #E
M#@  YQ,  .H<  #M)P  \#4  /%&  #R6   \VL  /.   #TE   ]*,  /2N
M  #TL@#_ !, _P 1 /\ $0#_ !4 _P ? /\ + #_ #D _P!% /\ 4 #_ %H
M_@!C /L :P#Y '( ]P!X /4 ?@#T (0 \@") /$ C@#P ), [@"9 .T GP#L
M *8 Z@"N .@ N #F ,4 Y0#; ., [0#B /L X@#_ .$ _P#A /\ X0#_ .$
M_P#_ !  _P . /\ #0#_ !( _P ; /\ * #_ #0 _@!! /L 3 #W %8 ] !?
M /$ 9@#O &T [ !T .H >@#I '\ YP"% .8 B@#E (\ XP"5 .$ FP#@ *(
MW@"J -L M #9 ,  U@#0 -, Z #2 /< T0#_ -$ _P#0 /\ T #_ -  _P#_
M  T _P ) /\ "@#_  \ _P 6 /L (@#W "\ ]  [ /  1P#M %$ Z0!: .4
M8@#B &D X !O -X =0#< 'H V@"  -@ A0#5 (L TP"1 -$ EP#/ )X S0"F
M ,L KP#) +H QP#) ,4 X@#$ /( PP#^ ,( _P#! /\ P@#_ ,( _P#_ P8
M_P ! /\ !@#_  P ^0 1 /$ '0#K "D YP V ., 00#? $L VP!4 -4 7 #2
M &, SP!J ,T < #+ '4 R0![ ,@ @ #& (8 Q0", ,, DP#! )H OP"B +T
MJP"[ +8 N0#$ +< V@"V .T M #Z +0 _P"T /\ M #_ +0 _P#_!   _P
M /\   #_  8 [  - .4 %@#> "( UP O -$ .P#- $4 R@!. ,8 5P#$ %X
MP0!D +\ :@"] '  O !U +H >P"Y ($ MP"' +4 C@"S )4 L@"> +  IP"N
M +( K "_ *H T0"H .@ J #W *< _P"G /\ I@#_ *8 _P#_!@  _P4  /$#
M  #H    X0 ' -4 $ #- !L QP G ,, ,P"_ #X O !( +D 40"V %@ M !?
M +( 90"P &H KP!P *T =@"L 'P J@"" *D B0"G )$ I0": *, I "A *X
MH "[ )X!S0"= N8 G 3T )L$_P":!?\ F@7_ )D%_P#_"@  \0X  .00  #9
M#P  S@L  ,@#"P#" !, O (? +<#+ "S!#< L 5" *T&2@"J!E( J =9 *8'
M7P"E!V4 HP=K *((<0"@"'< GPA^ )T(A0";"8X F@F7 )@*H0"6"JP E0NZ
M ),+S "2#.4 D WV (\._P".#O\ C@[_ (T._P#V$0  YA<  -8;  #'&0
MOA4  +D0  "W"@T L0L7 *P-) "H#C  I0X[ *(.1 "?#TP G0]3 )L/6@":
M#V  F!!F )<0; "5$'( DQ!Y )(0@0"0$(H CQ&4 (T1GP"+$:H BA*X (@2
MRP"&$^8 A13W (,5_P"#%?\ @A7_ ((5_P#M&@  W"$  ,HE  "[(@  L1\
M *L:  "I% 8 I1(1 * 4'@"<%2H F14U )86/@"4%D< DA9. ) 650".%UL
MC!=A (L79P")%VT B!=T (88? "%&(8 @QF0 ($9FP" &J< ?AJU 'T;QP!\
M'.( >AWU 'D=_P!X'?\ >!W_ '@=_P#E(@  T"D  +\L  "P*@  IR<  * C
M  "='P  FAH. )4<& "1'20 CAXO (P>.0")'D$ AQ]) (4?4 "#'U8 @A]<
M ( ?8@!_'VD ?2!P 'P@> !Z(($ >2&, '<AEP!U(J0 ="*R ',CPP!R(]\
M<"3S &\D_P!O)/\ ;B3_ &XD_P#=*0  R#   +<R  "H,   GBX  )<J  "3
M)P  D",* (PC$P"()!\ A"4J ((E- " )CT ?29$ 'PF2P!Z)E( >"98 '<F
M7@!U)F4 ="=L '(G= !Q)WT ;RB( &XHE !L**$ :RFO 6HIP %I*ML!9RKQ
M 6<K_P%F*_\!9BK_ 68J_P'4+P  PC8  *\V  "A-0  EC0  ) P  "*+0
MARH& (,I$ !_*AH ?"LE 'DK+P!W+#@ =2Q  ',L1P!Q+$T <"Q4 &XL6@!M
M+&$ :RUH &HM< !H+7H 9RZ% &4ND0%D+IX!8B^L 6$OO0%A,-4!8##O 5\P
M_0%?,/\!7S#_ 5\P_P'--   O#L  *DZ  ";.@  D#@  (DU  "#,@  ?S !
M 'LO#@!W,!8 =# A '$Q*P!O,30 ;3$\ &LQ0P!J,4H :#)0 &<R5P!E,ET
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M 4X]_P' /P  KD,  )Q#  ".0P  @D(  'I   !S/0  ;3P  &@]!0!D/0X
M83X7 %X^(0!</BD 6CXQ %@^.0!7/D  53]& %0_30!3/U4 4D!< %! 90!/
M0&\!3D%Z 4U!AP%+098!2D&E DE"M0))0LL"24+H DE"^0))0?\"24'_ 4E!
M_P&]0P  JD4  )A%  "*10  ?T4  '9#  !O0   :$   &-! 0!?00T 7$$4
M %E"'0!70B8 54(N %-"-@!10CT 3T)# $]#2P!.0U( 341: $Q$8P!*1&T!
M245X 4A%A0%'190!146C D5&M )$1LD"1$;G D1%^ )$1?\"147_ D5%_P&Z
M1@  ID@  )1(  "&2   >T<  ')&  !J0@  8T,  %Y$  !:10L 5D42 %1&
M&P!11B, 3T8K $Y&,P!,1SH 2T=! $I'20!)2%  2$A8 $=(80!&26L 1$EV
M 4-)@P%"29(!04FB D!)LP(_2L<"/TKE C])]P) 2?\"0$C_ D!(_P&V20
MHDH  )%*  "#2@  =TH  &Y)  !E10  7D<  %E(  !520@ 44H0 $]*& !,
M2B$ 2DLI $E+,0!'2S@ 1DP_ $5,1@!$3$X 0TU6 $)-7P!!36@ 0$UT 3Y-
M@0$]39 !/$V@ 3M.L0(Z3L8".D[D CM-]@([3?\!.TS_ 3Q,_P&S30  GDP
M (U,  !_3   =$P  &I,  !@2@  64L  %1,  !0304 3$X. $E/%0!'3QX
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M 2I=JP$J7;\!*5W> 2I<\@$J6_X!*UO_ 2M:_P&C50  CU4  ']5  !R50
M9U8  %Y6  !45P  3%D  $5;   _70  .E\$ #9@#0 T81, ,F(< #%B(P P
M8BL +V,R "YC.@ M8T( +&-* "ID4P I9%T *&1I "=D=@ F9(8 )627 "1D
MJ0 C9+T (F3: "-C\0 C8OT!)&'_ 21A_P&<6   B5@  'I9  !N60  8UD
M %I:  !07   2%X  $%@   Z8P  -&8  "]H"@ L:1  *FD7 "EJ'P H:B8
M)VHN "9K-0 E:ST )&M& "-K3P B;%D (&QE !]L<@ >;(( '6R4 !QLI@ ;
M:[H &FO4 !MJ[@ <:?P '&C_ !QH_P"57   @UP  '5<  !I70  7UT  %9>
M  !,80  0V0  #QG   U:@  +VT  "AP!  C<@T (7(2 "!S&@ ?<R$ 'G,H
M !UT,  <=#@ &W1  !IT2@ 9=%0 %W5@ !9U;@ 5=7X %'60 !-TH@ 2=+8
M$73/ !)S[  2<OH $W'_ !-Q_P".8   ?6   &]A  !E80  6V(  %%D  !(
M9P  /FL  #=N   P<0  *74  ")X   <>P< %WT. !9]$P 5?1L %'XB !-^
M*@ 2?C$ $7XZ !%^1  0?TX #W]:  Y_:  -?W@ #'^*  M^G0 *?K  "7W&
M  I]Y  *?/0 "WO]  MZ_P"&90  =V4  &IE  !A9@  5F@  $QK  !";P
M.7,  #%W   J>@  (WX  !R!   5A   $(<(  V)#@ ,B10 #(D;  N)(P *
MB2L "8DS  B)/0 &B4@ !8E4  2)80 "B7$  8F#  ")E@  B*D  (>^  "'
MV@  ANP  (;U  "&^@!^:@  <6H  &=K  !;;   4'   $9T   \>   ,WT
M "J!   CA0  '(@  !6,   0CP  #)(&  :3#  "DQ$  )06  "4'0  E"0
M )4L  "5-0  E4   )5,  "660  EFD  )5Z  "5C@  E*$  )2U  "3S
MDN8  )+R  "2]P!X<   ;7   &!R  !4=0  27D  #]^   U@P  +(@  ".-
M   ;D0  %)0   ^7   *F@  !)T#  ">"0  GPX  )\2  "@%P  H!T  *$E
M  "B+0  HC<  *-#  "C4   HU\  *-Q  "CA   HID  **M  "AP@  H=P
M *'K  "@\@!S=@  9G<  %E[  !-@   0H4  #B+   ND   ))4  !N:   4
MG@  #J$   FD   "IP   *H   "K!   JPH  *P-  "M$0  K18  *X<  "O
M)   L"T  +$Y  "Q1@  LE4  +)F  "R>0  LHX  +&C  "RMP  L<H  +'@
M  "QZ0!L?@  7X(  %*'  !&C0  .Y,  #"9   FG@  '*,  !.G   -JP
M!ZX   "R    M0   +<   "X    N0(  +D(  "Z#   NQ   +P4  "]&P
MOR,  ,$M  #".@  PDD  ,-:  ##;   Q((  ,27  #$JP  Q+P  ,3+  #$
MV@!EB0  6(X  $N5   _FP  ,Z(  "BH   =K0  %+$   VV   &N0   +P
M  "_    PP   ,0   #%    Q@   ,<   #)!   R@D  ,L-  #-$0  SQ@
M -(A  #5+0  UCP  -A-  #97P  VG,  -J*  #;G@  VZX  -NZ  #<PP!>
ME@  49P  $2C   XJ@  ++$  ""W   5NP  #;X   3"    Q0   ,D   #-
M    T    -(   #2    U0   -8   #9    VP   -X%  #@"@  X@\  .46
M  #H(   ["T  .T^  #M40  [F4  .]Z  #OCP  \)\  /"K  #PLP#_ !
M_P . /\ #@#_ !( _P = /\ *0#_ #4 _P!! /\ 30#^ %8 ^P!? /@ 9@#V
M &T ] !T /( >0#Q '\ \ "$ .X B0#M (\ ZP"5 .H FP#H *( Y@"J .4
MLP#C ,  X0#2 .  Z@#? /D W0#_ -T _P#= /\ W@#_ -X _P#_  T _P *
M /\ "0#_  \ _P 8 /\ ) #^ #$ ^P ] /@ 2 #T %( \ !: .T 8@#K &D
MZ0!O .< =0#E 'H XP!_ .( A0#@ (H W@"0 -P E@#: )T V "E -4 KP#2
M +H T #* ,X XP#- /0 RP#_ ,L _P#+ /\ RP#_ ,L _P#_  @ _P # /\
M!0#_  P _  4 /< 'P#R "L [P W .L 0@#G $P Y !5 .  70#= &0 V@!J
M -@ < #5 '4 T@!Z -  @ #/ (4 S0"+ ,L D@#) )D QP"A ,4 J@## +4
MP0## +\ V@"^ .X O0#\ +P _P"\ /\ O #_ +P _P#_    _P   /\   #Y
M  < \0 0 .H &@#D "4 WP Q -L / #7 $< T@!0 ,X 5P#+ %X R0!E ,8
M:@#% '  PP!U ,$ >@#  (  O@"& +P C0"Z )0 N0"< +< I0"U +  LP"]
M +$ SP"O .@ K@#X *X _P"M /\ K0#_ *T _P#_    _P   /T   #N  $
MXP , -H % #1 !\ S  K ,@ -@#% $  P@!* +\ 4@"\ %D N@!? +@ 90"V
M &H M !O +, =0"Q 'H L "! *X B "M (\ JP"8 *D H0"G *L I0"X *,
MR "B .( H0#S *  _@"@ /\ H #_ *  _P#_    ]@   .H   #@    TP &
M ,D #P#" !@ O0 D +D +P"V #H M !# +$ 3 "N %, K !9 *H 7P"I &0
MIP!J *8 ;P"D '4 HP![ *$ @@"@ (H G@"3 )P G0": *< F "T )8 PP"5
M -P E #O ), ^P"3 /\ DP#_ )( _P#Y!0  Z@L  -P-  #+"@  P@4  +P
M"@"V !$ L0 < *X * "J #, IP ] *0 10"B $T H !3 )X 60"< %\ FP!D
M )H :@"8 '  EP!V )4 ?@"3 (8 D@&/ ) !F0". J0 C *Q (L#P ")!=8
MB ;M (@'^@"'"/\ A@C_ (8(_P#O#P  WA0  ,H5  "\$@  LQ   *X,  "K
M!@T IP,5 *(%( "?!RP G @V )D(/P"7"4< E0E. ),)5 "1"EH D I? (X*
M90"-"FL BPIR (H+>0"("X( APN, (4,EP"##*( @0VP ( -P !_#=@ ?0[O
M 'P/_0![#_\ >Q#_ 'L0_P#F%P  T1X  +T=  "O'   IAD  *$5  ">$ 0
MG0T/ )@.&0"4#B4 D0\O (\0.0",$$$ BA!( (@03P"'$%4 A1!; (0180""
M$6< @!%N '\1=0!]$7X ?!*( 'H2E !X$J  =Q.N '43O@!T%-4 <Q7N '$6
M_0!Q%O\ <1;_ ' 6_P#<'P  QB4  +,E  "E(P  G"$  )8>  "2&0  D10+
M (T4% ")%1\ AA8I (,6,P"!%SP @!=# 'X72@!\%U  >A=6 'D87 !W&&(
M=AAI '08<0!S&7H <1F$ &\:D !N&IT ;!NK &L<NP!J'-  :1WL &@>^P!H
M'O\ 9Q[_ &<>_P#1)@  O2H  *LJ  "=*@  DR@  (TE  "((@  AAT& (,;
M$ !_'!H ?!TD 'H=+@!W'C8 =AX^ '0>10!R'TL <1]1 &\?6 !N'UX ;!]E
M &L@;0!I('8 :"&! &8AC0!E(IH 8R*H &(CN !A(\T 8"3I & D^@!?)/\
M7R3_ %\D_P#*+   MB\  *0O  "6+P  C"T  (4J  " *   ?20  'HB#0!V
M(Q4 <R,@ '$D*0!O)#( ;20Z &LE00!J)4< :"5- &8E5 !E)5H 9"9A &(F
M:0!A)G( 7R=] %XGB@!=*)< 6RFE %HIM0!:*LH 62KG %@J^ !8*O\ 6"K_
M %@J_P#%,0  KS,  )XS  "0,P  AC(  '\O  !Y+0  =2H  '(H"@!O*!(
M:RD; &DI)0!G*BT 92HU &,J/0!B*D, 8"I* %\K4 !>*U< 7"M> %LL9@!9
M+&\ 6"UZ %<MAP!6+I4 5"ZC %,OLP!3+\< 4B_E %(O]P!2+_\ 4B__ %(O
M_P#!-@  JC8  )DV  "+-@  @34  'DS  !S,0  ;R\  &LN!@!H+1  9"X8
M &(N(0!@+RH 7B\Q %PO.0!;+T  62]& %@O30!7,%, 5C!; %0Q8P!3,6P
M4C)W %$RA !/,Y( 3C.A $TSL0!--,4!3#3C 4PT]@!,-/\ 3#3_ $PS_P"[
M.0  ICD  )4Y  "'.0  ?#D  '0W  !N-   :3,  &4R @!A,@T 7C(4 %PS
M'@!:,R8 6#,N %8S-0!5-#P 4S1# %(T2@!1-%  4#58 $XU8 !--FH 3#9U
M $LW@@!*-Y  23B? $@XL %'.,,!1SCA 4<X]0%'./\!1SC_ 4<X_P&W.P
MHCP  )$\  "#/   >#P  ' Z  !J-P  9#8  & V  !<-@L 63<2 %8W&@!4
M-R, 4C<K % W,@!/.#D 33A  $PX1P!+.$X 2CE5 $DY7@!(.F@ 1SIS $8[
M@ !%.XX 1#R> $,\K@%"/,(!0CW? 4(\\P%"//\!0CS_ 4([_P&S/0  GCX
M (T^  !_/@  =3X  &P]  !F.@  8#D  %LZ  !7.@@ 4SL0 %$[& !..R
M3#LH $L[+P!)/#8 1SP] $<\1 !&/4L 13U3 $0^7 !#/F8 0C]Q $$_?@!
M/XT /T"< #Y K0$]0, !/4#= 3U \@$]0/\!/C__ 3X__P&N0   FD   (E!
M  !\00  <4$  &A   !A/   6ST  %8^  !2/@4 3C\. $P_%0!)/QT 1T E
M $9 + !$0#, 0T Z $)!0@!!04D 0$%1 #]"6@ ^0F, /4-O #Q#?  [0XL
M.D2; #E$JP$Y1+X!.$3; 3E$\0$Y0_X!.4/_ 3E#_P&J0@  ED,  (9#  !X
M0P  ;D,  &5#  !=0   5D   %%"  !-0@( 24,, $9#$@!$1!H 0D0B $%$
M*@ _13$ /D4X #U%/P \1D< .T9/ #I&5P Y1V$ .$=L #='>@ V2(D -4B9
M #1(J@ T2+T ,TC9 #1(\  T1_T -$?_ #5&_P"F1   DD4  ()&  !U1@
M:D8  &%%  !91   440  $Q&  !(1P  1$<* $%($  _21@ /4D@ #Q))P Z
M2BX .4HV #A*/0 W2T0 -DM, #5+50 T3%\ ,TQJ #),=P Q3(8 ,$R7 "]-
MJ  N3;L +DW5 "Y,[P O3/T +TO_ #!+_P"A1P  CD@  'Y(  !Q2   9DD
M %U(  !52   3$D  $=*  !"2P  /TP& #M-#@ Y3A4 -TX= #9/)  U3RL
M,T\S #)0.@ Q4$( ,%!* "]14@ N45P +5%G "Q1=0 K480 *E*5 "E2I@ I
M4KD *%+2 "E1[@ I4/P *E#_ "I/_P"<2@  B4H  'I+  !M2P  8TP  %I,
M  !13   2$T  $-/   ]4   .5(" #53#  S5!( ,509 #!5(0 N52@ +54O
M "Q6-P K5CX *E9& "E63P H5UD )U=D "97<@ E5X$ )%>2 "-7I  B5[<
M(E?/ ")7[  C5OH (U7_ "15_P"630  A$X  '5.  !I3@  7T\  %9/  !-
M4   15(  #]3   Y5@  ,U@  "]:"  K6P\ *EL5 "A<'0 G7"0 )EPK "5<
M,P D73H (UU# ")=3  A758 (%YA !]>;@ >7GX '5Z/ !Q>H0 ;7K0 &EW,
M !M=Z0 ;7/D '%O_ !Q;_P"040  ?E$  '!1  !D4@  6U(  %)3  !*5
M05<  #M9   U6P  +EX  "A@ P D8@P (F,1 "%C&  ?9"  'F0G !UD+@ <
M9#8 &V4^ !IE1P 995$ &&5= !=E:@ 697H %66+ !1EG@ 39;$ $F7( !)D
MYP 38_< %&+_ !1B_P")5   >%4  &M5  !@5@  5U8  $]7  !&60  /5P
M #9?   P8@  *60  "-G   =:@< &6P. !AL$P 6;1H %6TA !1M*0 4;3
M$VTY !)N0@ 1;DP $&Y8  ]N90 .;G4 #6Z'  UNF@ ,;:T "VW"  MLX  ,
M:_, #6O]  UJ_P""60  <ED  &99  !<6@  5%H  $I<  !!7P  .6,  #%F
M   J:0  )&P  !UO   7<@  $G4)  ]W#P .=Q0 #G<;  UW(P ,=RH "W<S
M  IW/  )=T< "'=2  =W7P %=V\ !'>   -WE  !=J<  ':[  %UU0 !=.L
M G3V  )T_ ![70  ;5T  &)>  !97@  3F   $5C   \9P  ,VL  "MN   D
M<@  'G4  !=Y   2?   #7\&  F!#  %@1$  X$6  *!'0 !@20  ($M  ""
M-@  @D   (),  ""60  @F@  ()Y  ""C0  @:   ("T  " RP  ?^<  '[R
M  !^^0!T8@  :&(  %YB  !39   26<  #]K   V<   +70  "5X   >?
M%X   !&#   -A@  "(D$  *+"@  BPX  (L3  ",&   C!\  (TF  "-+P
MCCD  (Y$  ".40  CF   (YQ  ".A0  CID  (VM  ",PP  C-\  (ON  "+
M]@!N:   9&<  %AI  !-;   0G$  #AV   O>P  )G\  !Z$   6B   $(P
M  R/   &D@   )4   "6!P  EPP  )</  "8$P  F1@  )H?  ";)@  FS
M )P[  "<2   G%<  )QH  "<>P  G)   )NE  ";N@  FM   )KG  ":\0!J
M;0  7F\  %%R  !&=P  .WP  #&"   GAP  'HP  !:1   0E0  "ID   2<
M    H    *(   "C 0  HP8  *0+  "E#@  IA(  *<7  "H'@  JB8  *LQ
M  "K/@  K$T  *Q=  "L<   K(4  *R;  "KKP  J\,  *O9  "JZ !D=0
M5WD  $M^   _A   -(H  "F0   ?E@  %IL  !"?   )HP   :<   "J
MK@   +    "P    L0   +(#  "T"   M0T  +80  "W%0  N1T  +LF  "\
M,P  O4$  +U2  "]9   OGD  +Z0  "]I   O;<  +W&  "]UP!<?P  4(4
M $2+   XD@  +)D  "&?   7I   $*D   FN    L@   +8   "Y    O0
M +\   "_    P    ,$   ##    Q 4  ,8*  #'#@  R1,  ,L<  #.)@
MT#4  -%%  #25P  TFL  -."  #3EP  TZD  -*X  #2Q !5C   29,  #V:
M   PH@  ):@  !JN   1M   ";D   "]    P0   ,0   #(    RP   ,T
M  #-    SP   -    #2    U    -@   #:!@  W0P  . 1  #C&@  YB<
M .<X  #H2@  Z5T  .IR  #KB   ZYL  .RH  #LL@#_  T _P + /\ "P#_
M !  _P : /\ )@#_ #( _P ] /\ 2 #[ %( ^ !: /8 8@#S &D \0!O /
M=0#N 'H [ !_ .L A #I (H Z "0 .8 E@#D )T X@"E .$ KP#? +L W0#+
M -L Y@#9 /< V #_ -@ _P#7 /\ UP#_ -0 _P#_  @ _P $ /\ ! #_  T
M_P 5 /X (0#Z "P ]P X /0 0P#P $T [0!5 .H 70#G &0 Y !J .( < #@
M '4 W@!Z -T ?P#; (4 V0"+ -4 D0#3 )D T0"@ ,\ J@#- +4 RP#$ ,D
MW0#( /$ QP#_ ,8 _P#& /\ Q@#_ ,< _P#_    _P   /\   #_  H ^  1
M /$ ' #L "< Z0 R .8 /0#B $< W0!0 -D 6 #5 %\ T@!E -  :@#. '
MS !U ,H >@#) '\ QP"% ,4 C ## )0 P0"< +\ I0"] +  NP"] +H T "X
M .L MP#[ +8 _P"V /\ M@#_ +8 _P#_    _P   /T   #S  4 Z0 . .$
M%@#; "$ U0 M -$ -P#. $$ R@!* ,< 4@#$ %D P@!? ,  90"^ &H O !O
M +L = "Y 'H MP"  +8 AP"T (X L@"7 +  H "N *H K0"W *L R "I .,
MJ #U *< _P"G /\ IP#_ *8 _P#_    _@   /$   #E    UP * ,T $0#'
M !P P@ F +\ ,0"\ #L N@!$ +< 3 "T %, L@!9 +$ 7P"O &0 K0!I *P
M;P"J '0 J0!Z *< @0"F (D I "1 *( FP"@ *4 G@"R )T P0"; -H F@#O
M )D _0"8 /\ F #_ )@ _P#]    \    .$   #1    Q@ $ +T #0"W !4
MLP @ +  *P"M #4 JP ^ *@ 1@"F $T I !4 *, 60"A %\ H !D )X :0"=
M &X FP!U )H >P"8 (, E@", )4 E@"3 *$ D0"M (\ NP"- ,\ C #I (L
M^ ", /\ C #_ (P _P#S @  X@<  ,P'  "_!   MP   +$ " "K !  IP 9
M *0 ) "@ "X G@ W )P 0 ": $< F !. )8 5 "5 %D DP!> )( 9 "0 &D
MCP!O (T =@"+ 'X B@"( (@ D@"& )T A0"I (, N "! ,H @ #E (  ]0!_
M /\ ?P#_ '\ _P#H#0  T!   +X0  "Q#@  J T  *,(  "@ @P G  3 )@
M'0"5 "< D@ Q )  .0". 4$ C %( (H"3@") E0 AP)9 (8"7P"$ V0 @P-K
M ($#<@" !'H ?@2$ 'T%C@![!9H >0:G '@&M0!V!\@ =0CC '4)] !T"O\
M<PK_ ',*_P#=%0  Q!<  +$7  "E%@  G!,  )81  "4#00 DP@- (X'%0"+
M"2  B DJ (4*,P"#"SL @0M" ( +20!^"T\ ?0Q4 'L,6@!Z#&  > QG '<,
M;@!U#78 = V  '(-C !P#9D ;PZF &T.M0!L#LD :P_F &H0]P!I$/\ :1#_
M &D0_P#0'0  N1X  *@>  ";'0  DAL  (L9  "(%0  AQ$' (4.$ "!#QH
M?A D 'L0+0!Y$#8 =Q$] '811 !T$4H <Q%0 '$15@!P$5P ;A)B &T2:@!K
M$G, :1-] &@3B0!F$Y8 912C &,5LP!B%<8 8A;C &$6]@!@%_\ 8!?_ & 7
M_P#'(@  L",  )\D  "2(P  B2(  ((@  !^'0  ?!D  'H5#0!W%14 =!8?
M '$6* !O%S  ;A<X &P7/P!K%T4 :1A+ &@840!F&%@ 91A> &,99@!B&6\
M8!EY %\:A0!=&Y( 7!NA %L<L !:',, 61W@ %@>] !8'O\ 6![_ %@>_P"_
M)P  J2@  )DH  "+*   @B<  'LE  !V(P  <R   '$<"0!N'!$ :QP: &D=
M(P!G'2P 91TS &,>.@!B'D$ 8!Y' %\>30!>'E0 7!]; %L?8@!9(&L 6"!V
M %8A@@!5(9  5"*> %,BK@!2(\  42/= %$D\@!1)/\ 423_ %$C_P"Y*P
MHRP  ),L  "&+0  ?"P  '0J  !O*   :R4  &DB!0!F(0X 8R(6 &$B'P!?
M(R< 72,O %PC-@!:(ST 621# %<D2@!6)%  5217 %,E7P!2)6@ 429S $\F
M?P!.)XT 32B< $PHK !+*;X 2RG: $HI\0!**?\ 2RG_ $LI_P"S+@  GB\
M (XP  "!,   =R\  &\N  !J*P  92H  &,G 0!?)PP 7"<3 %HG&P!8*"0
M5B@K %4H,@!3*#D 4BE  % I1@!/*4T 3BE4 $TJ7 !,*F4 2BMP $DK? !(
M+(L 1RV: $8MJ@!%+KP 12[6 $4N[P!%+OX 12[_ $4M_P"N,0  FC(  (DS
M  !\,P  <C,  &LQ  !E+P  8"T  %TL  !9+ D 5BP0 %0L& !2+"  4"PH
M $XM+P!-+38 3"T\ $HM0P!)+4H 2"Y1 $<N60!&+V, 13!M $,P>@!",8D
M03&8 $$RJ ! ,KL /S+3 #\R[@! ,OT 0#+_ $ R_P"J,P  EC4  (8U  !Y
M-@  ;C4  &8U  !A,@  7#   %<P  !4, 8 43 . $XP%0!,,1T 2C$E $@Q
M+ !',3( 1C$Y $0Q0 !#,D< 0C)/ $$S5P! ,V  /S1K #XU>  ]-8< /#:6
M #LVIP [-KD .C;1 #HV[0 [-OP .S;_ #LV_P"F-@  DC<  ((X  !U.
M:S@  &,W  !=-@  5S,  %,T  !/- , 2S0, $DT$@!&-1H 134B $,U*0!!
M-2\ 0#4V #\V/0 ^-D0 /3=, #PW50 [.%X .CAI #DY=@ X.84 -SJ5 #<Z
MI0 V.K@ -3K/ #8Z[  V.OL -CG_ #<Y_P"B.   CCD  'XZ  !R.P  :#L
M %\Z  !9.0  4S8  $XW  !*.   1C@* $0Y$ !!.1< /SD? #XY)@ \.2T
M.SHT #HZ.P Y.T( .#M* #<[4P V/%P -3QG #0]=  S/8, ,SZ3 #(^I  Q
M/K8 ,3[- #$^Z@ Q/OH ,CW_ #(]_P">.P  BSP  'L\  !N/0  9#T  %P]
M  !5/   3CH  $D[  !%/   03T' #X]#@ \/14 .CX< #D^(P W/BH -C\Q
M #4_.  T/T  ,T!( #) 4  Q0%H ,$%E "]!<@ N0H$ +4*1 "U"H@ L0K4
M*T++ "Q"Z0 L0OD +4'_ "U!_P"9/0  ASX  '<_  !K/P  84   %D_  !2
M/P  23X  $0_  ! 0   /$$$ #E"#0 W0A( -4,9 #-#(0 R0R@ ,40O #!$
M-@ O1#T +D5% "U%3@ L15@ *T9C "I&;P I1GX *$:/ "='H0 F1[, )D?)
M "9&YP G1O@ *$7_ "A%_P"50   @D$  '-"  !G0@  7D(  %5"  !.0@
M14(  #]$   [10  -T8  #1'"@ Q2!  +T@6 "Y)'@ L224 *TDL "I),P I
M2CH *$I" "=*2P F2U4 )4M@ "1+;0 C2WP (DN- "%,GP A3+$ ($S' "!+
MY@ A2_< (DK_ ")*_P"00P  ?D0  &]$  !D10  6D4  %)%  !*1@  04<
M #Q(   W20  ,DL  "Y-!P K3@X *4X3 "=/&@ F3R$ )4\H "1/,  C4#<
M(E _ "%02  @4%( 'U%= !Y1:@ =47D '%&* !M1G  :4:\ &5'% !E1Y  :
M4/8 &T__ !Q/_P"*1@  >4<  &M'  !@2   5D@  $Y(  !'20  /DL  #E,
M   S3@  +E   "A3 @ D5 L (E40 "!5%@ ?5AX 'E8D !U6+  <5C, &U<[
M !I71  95TX &%=9 !=89@ 56'4 %%B' !18F@ 35ZP $E?" !)7X0 35O0
M%%7_ !15_P"$20  =$H  &9+  !<2P  4TL  $M,  !$30  /$\  #51   O
M5   *58  "19   >6P< &ET- !A=$@ 771D %EX@ !5>)P 47BX $UXW !)>
M0  17TH $5]5 !!?8@ /7W$ #E^#  U?E@ -7ZD #%Z^  Q>V@ -7?  #5S\
M  Y<_P!^30  ;DX  &).  !83P  3T\  $A0  ! 4@  .%0  #!7   J6@
M)%T  !]?   98@$ $V4) !%F#P 09A0 #V8;  YG(@ -9RD #6<R  QG.P +
M9T4 "F=0  EG70 '9VP !F=]  5GD  $9J,  F:W  -ESP $9>D !&3U  1D
M_ !W40  :5(  %U2  !44@  3%,  $-5   [6   ,UL  "M>   E80  'V0
M !EG   3:@  #VT&  MP#  (<!$ !W 6  5P'0 $<"0  W L  )P-0  <#\
M '!*  !P5P  <&4  '!V  !PB@  ;YX  &^R  !NR   ;>4  &WR  !M^0!P
M5@  8U8  %E6  #_XO__24-#7U!23T9)3$4 ! E15P  1U@  #Y;   V7P
M+F(  "9F   ?:@  &6T  !-P   .<P  "W8$  5X"P !> \  'D3  !Y&0
M>1\  'HF  !Z+P  >CD  'I$  !Z4   >E\  'IP  !Z@P  >I@  'JL  !Y
MP@  >-\  'CO  !W]P!J6P  7UL  %9;  !,7   0F   #EC   P:   *&P
M "!P   9=   $W<   Y[   )?@  !($"  """   @PT  (,0  "$%   A1D
M (8@  "&*   AS$  (<\  "'20  AU<  (=H  "'>P  AY   (:E  "%N@
MA=,  (3J  "$] !E8   7&   %%A  !&9   /&D  #)M   I<@  (7<  !E[
M   2@   #8,   B'   "B@   (T   ".!   C@D  (\-  "0$   D10  )(9
M  "3(   E"D  )4S  "50   EDX  )9?  "5<@  E8@  )6=  "4L@  E,@
M )/B  "3[@!A90  5F8  $IJ   _;@  -70  "MY   A?P  &80  !&)   ,
MC0  !I$   "4    F    )H   ";    G (  )T'  ">"P  GPX  *$2  "B
M&   HR   *4I  "F-@  ID0  *95  "F:   IGT  *:4  "EJ0  I+T  *31
M  "DY !;;   3W   $-U   X>P  +8$  ".'   9C0  $9(   N7   $G
M *    "C    I@   *@   "I    J@   *P   "M!   K@D  + -  "Q$0
MLQ<  +4@  "V*P  MSH  +=+  "X7   N'$  +B(  "XG0  N+$  +?"  "W
MT !4=@  2'P  #R"   QB0  )I   !N7   2G0  #*(   .G    JP   *X
M  "R    M@   +@   "X    N@   +L   "]    O@   , %  #!"P  PQ
M ,86  #)(   RBX  ,L^  #,4   S&0  ,UZ  #-D0  S:0  ,VT  #-P !-
M@P  08H  #61   IF0  'J   !.F   ,K    [$   "V    N@   +X   #"
M    Q@   ,@   #(    R@   ,L   #-    S@   -    #2 0  U0@  -D.
M  #=%0  X2$  .(Q  #D0P  Y58  .9K  #F@@  YY8  .>E  #FL #_  D
M_P % /\ !@#_  X _P 6 /\ (0#_ "T _P X /T 0P#Y $T ]0!5 /( 70#P
M &, [@!I .P ;P#J '0 Z0!Z .< ?P#F (4 Y "+ ., D0#A )D WP"A -P
MJ@#: +8 UP#& -4 X0#3 /0 T@#_ -$ _P#1 /\ SP#_ ,H _P#_  $ _P
M /\  0#_  P _P 2 /H '0#V "@ \P S /  /@#L $@ Z !0 .4 6 #B %X
MWP!D -T :@#; &\ V0!T -8 >@#4 '\ T@"% -  C #. ), S "< ,D I0#'
M +  Q@"^ ,0 U #" .X P0#^ ,  _P#  /\ OP#_ +X _P#_    _P   /\
M  #Z  < \0 / .L & #F ", X@ N .  . #; $( U0!+ -$ 4@#. %D RP!?
M ,D 90#' &H Q@!O ,0 = #" 'H P0"  +\ A@"] (X NP"6 +D H "W *H
MM@"W +0 R@"R .8 L0#X +  _P"O /\ KP#_ +  _P#_    _P   /<   #J
M  ( X0 , -< $P#0 !T S  H ,D ,@#& #P P@!% +\ 30"\ %, N@!9 +@
M7P"W &0 M0!I +0 ;@"R '0 L0!Z *\ @ "M (@ K "1 *H F@"H *4 I@"Q
M *0 P0"C -P H0#R *$ _P"@ /\ H #_ *$ _P#_    ]P   .@   #9
MRP ( ,, $ "] !@ N0 B +8 + "T #8 L@ _ *\ 1P"L $T JP!4 *D 60"G
M %X I@!C *4 : "C &X H@!T *  >@"> (( G "+ )L E0"9 )\ F "L )8
MN@"4 ,\ DP#K )( ^P"2 /\ D@#_ )$ _P#W    YP   -,   #&    NP "
M +, # "M !( J@ < *< )@"D #  HP X *  0 "> $< G !. )H 4P"9 %@
MEP!= )8 8P"5 &@ DP!N )( = "0 'P CP"% (T CP"+ )H B@"G (@ M0"&
M ,< A0#D (0 ]0"$ /\ @P#_ (, _P#L    TP   ,$!  "T    K    *8
M!P"@  X G0 6 )H ( "7 "D E0 R ), .@"1 $$ CP!( (T 30", %, BP!8
M (D 70"( &, AP!I (4 ;P"# '< @@"  (  B@!^ )8 ?0"C 'L L !Z ,(
M>0#= '@ \0!W /T > #_ '@ _P#>"@  Q L  +(,  "F"P  G0@  )D$  "5
M  H D0 1 (X &0"+ ", B0 L (< - "% #L @P!" (( 2 "  $X ?P!3 'T
M6 !\ %X >P!D 'D :@!X '( =@![ '0 A@!S )( <0"? '  K0!N +X ;0'6
M &T"[0!L _H ; /_ &P#_P#.$   MQ$  *82  ":$0  D1   (L.  ")"P,
MAP4, (0!$P"! 1P ?@(E 'P#+@!Z S8 > 0\ '<$0P!U!4@ = 5. ',%5 !Q
M!5D < 9? &X&9@!M!FX :P=X &H'@P!H")  9PF= &4)K !D";P 8PK4 &,+
M[ !B#/H 8@S_ &(,_P##%@  K1<  )T8  "0&   AQ8  ($4  !]$0  ? X&
M 'P*#@!X"A8 =0L? '(+* !P##  ;PPW &T,/@!L#$0 :PU* &D-3P!H#54
M9PU< &4-8P!C#FL 8@YU & .@0!?#HX 70^< %P0JP!;$+T 6A#6 %D1\ !9
M$?T 61'_ %D1_P"Y&P  I1T  )0>  "('@  ?AT  '@;  !T&   <14  '$1
M"0!O$!$ ;! 9 &D0(@!G$2H 9A$R &01.0!C$3\ 8A%% & 22P!?$E$ 71)8
M %P27P!:$V@ 61-R %<4?0!6%(L 5!69 %,5J0!2%KH 41;2 %$7[0!1%_T
M41?_ %$7_P"R(   GB(  (XB  "!(P  =R(  ' A  !L'@  :1L  &<8! !F
M%0X 8Q85 &$6'@!?%B8 718M %P7- !:%SL 61=! %@81P!6&$T 51A4 %,8
M7 !2&60 41EN $\:>@!.&X@ 31N7 $L<I@!*'+@ 2AW/ $D=ZP!)'?L 21W_
M $H=_P"L)   F"4  (@F  ![)P  <28  &HE  !F(P  8B$  & >  !>' L
M6QL2 %D<&@!7'"( 51PI %0<, !3'3< 41T] % =0P!/'4H 31Y1 $P>6 !+
M'V$ 21]K $@@=P!'((4 1B&4 $0BI !$(K8 0R+, $,CZ0!#(_H 0R/_ $,B
M_P"F)P  DRD  (,J  !V*@  ;2H  &4I  !@)P  7"4  %DC  !7(0< 52$/
M %(A%@!0(1X 3B$E $TB+ !,(C, 2B(Y $DB0 !((D8 1R-- $4C50!$)%X
M0R1I $(E=0! )H, /R:2 #XGHP ^)[0 /2?* #THZ  ]*/D /2?_ #XG_P"B
M*@  CBL  '\M  !R+0  :"T  &$L  !<*P  6"@  %0F  !1)@0 3B4- $PE
M$P!*)AH 2"8B $<F*0!%)B\ 1"8V $,G/ !!)T, 0"=+ #\H4P ^*5P /2EF
M #PJ<@ [*H$ .BN0 #DKH0 X++( -RS( #<LY@ X+/@ ."S_ #@L_P"=+
MBBX  'LO  !O,   93   %TO  !8+@  4RL  % J  !,*@  22H+ $8J$0!$
M*A< 0BH? $$J)0 _*BP /BLS #TK.0 \*T  .RQ( #HL4  Y+5D ."YD #<N
M<  V+W\ -2^/ #0PGP S,+$ ,C#' #(PY0 S,/< ,S#_ #0O_P"9+P  AS$
M '<R  !K,@  8C(  %HR  !4,0  3R\  $LM  !'+@  1"X( $$N#@ _+A0
M/2X< #LN(@ Y+RD ."\O #<O-@ V,#X -3!& #4Q3@ T,5< ,S)B #(R;@ Q
M,WT ,#.- "\TG@ N-+  +33% "TTXP N-/8 +S/_ "\S_P"5,0  @S,  '0T
M  !H-0  7C4  %<T  !1-   2S(  $8Q  !",@  /S(% #PR#0 Y,Q( .#,9
M #8S(  T,R8 ,S,M #(T-  Q-#L ,#5# # U3  O-E4 +C9@ "TW;  L-WL
M*S>+ "HXG  I.*X *#C# "@XX@ I./4 *C?_ "HW_P"2-   ?S4  '$V  !E
M-P  6S<  %0W  !--@  1S8  $(U   ]-@  .C8" #<W"P T-Q  ,C<6 #$X
M'0 O."0 +C@K "TY,@ L.3D *SE! "HZ20 J.E, *3M> "@[:@ G.WD )CR)
M "4\FP D/*T (SS" ",\X  D//0 )3O_ "4[_P"--@  ?#@  &TY  !B.0
M6#H  %$Y  !*.0  1#D  #TY   Y.@  -3L  #(["  O/ X +3T4 "P]&@ J
M/2$ *3TH "@^+P G/C8 )CX^ "4_1P D/U  (T!; ") :  A0'8 ($"' !]!
MF0 ?0:L 'D'  !Y!W@ ?0/, 'T#^ " __P").0  >#H  &D[  !>/   53P
M $T\  !'/   0#P  #@]   T/@  ,$   "U!!0 J0@P )T(1 "9#&  D0QX
M(T,E ")#+  A1#, ($0[ !]$1  >14X '459 !Q%90 ;170 &D6% !E&EP 9
M1JD &$:^ !=%W  81?$ &43] !I$_P"$/   <ST  &8^  !;/P  4C\  $H_
M  !$/P  /4   #9!   Q0P  +$0  "=& 0 D1PH (4@/ "!)%  >21L '4DB
M !Q)*0 ;2C  &DHX !E*00 82DL %TM5 !9+8@ 52W$ %$N" !-+E  22Z<
M$DN\ !%+V0 22O  $TK\ !1)_P!_/P  ;T   &%!  !70@  3D(  $="  !!
M0@  .D,  #)%   M1P  *$D  "-+   >308 &T\- !A0$0 74!< %E > !50
M)0 44"P $U$T !)1/0 144< $5%2 !!17P /4FT #E)^  U1D0 -4:0 #%&X
M  Q1T0 -4.P #5#Z  Y/_P!Y0P  :D0  %U$  !310  2T4  $1%   ^1@
M-D@  "]*   I3   )$\  !]1   :4P  %%8) !%7#@ 06!, $%@9  ]8(  .
M6"@ #5@P  U8.0 ,6$, "UA.  I86@ (6&@ !UAY  98C  %6)\ !%BS  17
MR@ %5^8 !5?S  96_ !S1@  9$<  %E(  !02   2$@  $%)   Z2@  ,DT
M "M0   E4@  (%4  !I8   56@  $%T&  Q@#  *8!  "6 5  A@'  '8",
M!6 K  1@-  #8#T  6!)  !@50  8&,  &!S  !@A@  7YH  %^N  !?Q
M7N(  %[P  !>^ !L2@  7TL  %5+  !,3   14P  #U.   U4   +E,  "=6
M   @60  &EP  !5?   08@  #64$  AG"P #9PX  &@3  !H&   :!\  &DF
M  !I+@  :3@  &E#  !I3P  :5T  &EM  !I@   :90  &BI  !HOP  9]P
M &;N  !F]P!F3P  6D\  %%/  !*3P  05$  #A4   P5P  *%L  "%>   :
M8@  %&4  !!H   ,:P  !VX#  %P"0  < T  '$0  !Q%   <AH  ',A  !S
M*   <S$  ',\  !T2   <U8  '-F  !S>0  <XX  '.C  !RN0  <=(  ''K
M  !P] !A4P  5E,  $]3  !%50  .U@  #)<   J8   (F0  !MH   4;
M#V\   MR   &=@   'D   !Z!@  >@H  'L.  !\$0  ?14  'X;  !_(@
M@"H  ( U  " 00  @$\  (!?  " <0  @(8  ("=  !_L@  ?LH  '[E  !]
M\0!<6   5%@  $E:   _70  -6$  "QE   C:@  &V\  !1S   .=P  "7L
M  -_    @@   (0   "& 0  A@8  (@*  ")#0  BA   (L5  ",&P  CB(
M (\L  "/.   CT8  (]6  "/:   CWX  (^5  ".JP  C<$  (W<  ",ZP!9
M70  3E\  $-B   X9@  +FP  "1Q   <=P  %'P   Z!   (A0   (D   "-
M    D    )(   "3    E    )8#  "7"   F P  )H/  ";$P  G1H  )\C
M  "@+@  H#P  *!,  "@7@  H'0  )^,  "?H@  G[<  )[+  ">X !39
M1V@  #QM   Q<P  )WD  !U_   4A0  #8L   :0    E    )@   "<
MGP   *$   "B    I    *4   "G    J 0  *H)  "L#0  K1(  + 9  "R
M(P  LC$  +)"  "R5   LFD  +*   "RF   L:P  +*_  "QS@!,;@  0',
M #5Z   J@0  'X@  !6.   .E0  !IH   "?    I    *@   "L    KP
M +$   "Q    LP   +4   "V    N    +H   "\!@  O@P  , 1  ##&0
MQ28  ,4W  #&20  QET  ,=R  #'B@  R)\  ,BO  #(O !&>@  .8$  "Z)
M   BD   %Y@   ^?   'I0   *H   "O    LP   +<   "\    OP   ,$
M  #"    Q    ,4   #'    R0   ,L   #-    SP,  -(*  #6$   W!H
M -TJ  #>/   WU   .!E  #A>P  X9$  .*B  #BK0#_  ( _P   /\  P#_
M  P _P 3 /\ '0#_ "@ _@ S /L /@#W $@ \P!0 /  5P#M %X ZP!D .@
M:0#G &\ Y0!T ., >0#B '\ X "% -X C #< ), V0"< -8 I@#3 +$ T0#
M ,\ V@#. /$ S #_ ,L _P#+ /\ Q@#_ ,$ _P#_    _P   /\   #_  @
M^P 0 /8 &0#R "0 [P N .T .0#H $( XP!+ .  4@#= %D V0!? -8 9 #3
M &D T0!N ,\ = #. 'D S !_ ,H A@#( (X Q@"6 ,0 H #" *L P "Y +X
MS0"\ .H NP#\ +H _P"Z /\ N@#_ +8 _P#_    _P   /X   #T  0 ZP -
M .0 % #? !\ VP I -@ ,P#3 #T S@!% ,H 30#' %, Q0!9 ,, 7P#! &0
MOP!I +T ;@"[ ', N@!Y +@ @ "V (@ M "0 +( F@"Q *4 KP"R *T Q "L
M .$ JP#V *H _P"J /\ J@#_ *H _P#_    _0   .X   #B    U0 * ,T
M$0#' !D Q  C ,$ +0"_ #< NP _ +< 1P"U $X L@!3 +  60"O %X K0!C
M *P : "K &T J0!S *@ >@"F ($ I "* *, E "A )\ GP"L )X NP"< -(
MFP#N )H _P": /\ F0#_ )D _P#^    [@   -X   #+    P0 % +D #0"T
M !0 L0 > *X )P"K #  J@ Y *< 00"D $@ H@!- *$ 4P"? %@ G@!= )T
M8@"; &< F@!M )@ <P"7 'L E0"$ )0 C@"2 )D D "F (X M "- ,@ C #F
M (L ^0"* /\ B@#_ (L _P#P    VP   ,<   "Z    L    *@ "@"D !
MH  8 )T (0"; "H F@ S )@ .P"6 $$ E !( )( 30"1 %( CP!7 (X 7 ",
M &$ BP!G (H ;@"( '4 AP!^ (4 B "# )0 @@"@ (  KP!_ ,  ?@#= 'T
M\@!] /\ ?0#_ 'T _P#@    Q@   +4   "J    H@   )L !0"5  T D@ 3
M )  ' "- "0 BP M (H - "( #L A@!" (4 1P"# $T @@!2 ($ 5P!_ %P
M?@!B 'T : ![ '  >@!Y '@ @P!V (\ =0"< '0 J@!R +H <0#1 '  [ !P
M /L < #_ '  _P#-!   MP8  *<'  ";!@  DP0  (X   "*  @ A@ / (0
M%@"! !X ?P G 'T +@!\ #8 >@ \ 'D 0@!W $< =@!, '4 4@!S %< <@!=
M '$ 8P!O &L ;@!T &P ?@!K (H :0"8 &@ I@!G +8 9@#+ &4 YP!E /<
M90#_ &4 _P# #   JPT  )L.  "/#@  A@T  ($+  !^!P$ ? $+ 'D $0!W
M !@ =0 A ', *0!Q #  ;P V &X / !L $( :P!' &H 30!I %( : !8 &8
M7P!E &< 8P!P &(!>@!@ 8< 7P*5 %X"HP!< [, 7 /' %L$Y !;!?0 6P;^
M %L&_P"U$   H1(  )$3  "%$P  ?!(  '81  !S#@  <@P$ '$'#0!N!!(
M; 0; &D%(P!G!2H 9@8Q &0&-P!C!CT 8@=# &$'20!?!TX 7@A5 %T(7 !;
M"6, 6@EM %@*> !7"H4 5@N3 %0+H@!3"[, 4@S' %(,Y !1#?4 40W_ %$-
M_P"M%0  F1<  (D8  !]&0  =!@  &T7  !J%   9Q$  &<.!P!F# X 8PP5
M &$,'0!?#"4 70TL %P-,P!;#3D 6@T_ %@-10!7#4L 5@Y1 %4.60!3#F$
M4@YK % /=@!.$(, 31"2 $P0H@!+$+( 2A'( $D1Y0!)$?< 21+_ $D1_P"E
M&0  DAP  (,=  !V'@  ;1T  &8<  !B&@  7Q<  %X4 0!>$0H 6Q 1 %D1
M& !7$2  51$G %01+@!3$30 41$[ % 200!/$D< 3A). $P250!+$UX 21-G
M $@4<P!&%(  116/ $05GP!#%K  0A;% $(7XP!"%_8 0A?_ $(7_P"?'0
MC"   'TA  !Q(@  :"(  &$A  !<'P  61P  %<9  !5%@8 5!4. %$5% !/
M%AP 3A8C $P6*@!+%C  2A8W $D7/0!'%T, 1A=* $484@!#&%H 0AED $$9
M<  _&GT /AN- #T;G0 \'*X .QS# #L<X0 ['?4 .QS_ #P<_P":(0  AR,
M '@D  !L)0  8R4  %PD  !7(P  4R   %$>  !/' ( 31L, $L:$0!(&Q@
M1QL@ $4;)@!$&RT 0QPS $(<.0! '$  /QU' #X=3P ]'E@ /!YB #H?;0 Y
M'WL .""+ #<AFP V(:T -2'! #4AWP U(?, -B'_ #8A_P"6(P  @R8  '0G
M  !H*   7R@  %@G  !3)@  3R0  $PB  !)(   1R ) $0?#P!"'Q4 0" <
M #\@(P ^("D /" O #LA-@ Z(3T .2%$ #@B3  W(E4 -B-? #0C:P S)'D
M,B6) #$EF@ P):L ,":_ "\FW  P)O( ,";_ #$E_P"1)@  ?R@  '$J  !E
M*@  7"H  %4J  !/*0  2R@  $@E  !$)   020% #\D#0 ])!( .R09 #DD
M'P W)"8 -B0L #4E,P T)3H ,R9! #(F2@ Q)U, ,"== "\H:0 N*7< +2F'
M "PIF  K*JH *BJ] "HJV@ K*O$ *RK^ "PI_P"-*   ?"H  &TL  !B+0
M62T  %$M  !,+   1RL  $,H   _*   /"@" #DH"P W*!  -2@6 #,H'  R
M*", ,"@I "\I,  O*C< +BH_ "TK1P L*U$ *RQ; "HL9P I+74 *"V% "<M
MEP F+J@ )2Z\ "4NV  F+O  )B[] "<M_P"**P  >"T  &HN  !?+P  5B\
M $XO  !(+@  0RT  #\L   [+   -RP  #0L"0 R+ X ,"T3 "XM&@ M+2
M*RTG "HN+0 J+C4 *2\] "@O10 G,$X )C!9 "4Q90 D,7, (S&# "(RE0 A
M,J< (3*[ " RU  A,N\ (C'\ "(Q_P"&+0  =2\  &<P  !<,0  4S$  $LQ
M  !%,0  0#   #LP   V,   ,S   # Q!@ M,0T *S$1 "DR%P H,AX )S(D
M "4S*P E,S( )#,Z ",T0P B-$P (357 " U8P ?-7$ 'C:! !TVDP <-J4
M&S:Y !LVT@ <-NT '3;[ !TU_P"",   <3(  &,S  !9-   4#0  $DT  !"
M,P  /3,  #<S   Q-   +C4  "LU @ H-@L )3<0 "0W%0 B-QL (3@B " X
M*  ?.#  'C@W !TY0  <.4D &SI4 !HZ8  9.FX &#I_ !<[D0 7.Z0 %CNW
M !4[T  6.NP %SKZ !@Y_P!],@  ;30  & U  !5-@  338  $8V  ! -@
M.C8  #0V   N.   *CD  "8Z   C.P@ (#P. !X]$@ =/1@ '#T? !L^)0 :
M/BT &3XT !<^/0 6/T< %3]1 !0_7@ 4/VP $T!\ !) CP 10*( $4"V !!
MS@ 1/^L $C_Y !(^_P!Y-0  :3<  %PX  !2.0  2CD  $,Y   ].0  -SD
M #$Z   K/   )ST  "(_   >000 &D(+ !A#$  70Q4 %40; !1$(@ 31"D
M$T0Q !)$.@ 114, $$5. !!%6P .16D #D5Y  U%C  -19\ #$6R  M%R0 ,
M1>4 #43V  U$_P!T.0  93H  %@[  !/.P  1SP  $ \   Z/   -#P  "X^
M   H0   (T(  !]$   :1@  %4@( !)*#0 12A( $$H8  ]+'@ .2R4 #4LM
M  U+-@ ,2T  "TM*  I+5@ )2V0 "$MT  =+AP %2YH !$NN  1*Q  %2N
M!4KP  9)^@!N/   8#T  %0^  !+/@  1#X  #T^   W/P  ,4   "I"   D
M10  'T<  !I)   53   $4X%  Y1"P +41  "E$4  E1&P (42( !U$I  51
M,@ $4CL  U)&  %24@  4E\  %)O  !2@0  498  %&I  !1OP  4-P  %#N
M  !0]P!H0   6T$  %!!  !(00  04$  #M"   T0P  +44  "9(   @2P
M&TT  !90   14P  #E4$  I8"@ &6 X  E@2  !9%P  61T  %DE  !9+0
M638  %E!  !930  6EH  %II  !9?   69   %FE  !8N@  6-4  %?L  !7
M]@!C1   5D4  $U%  !%10  /T4  #='   O20  *$P  ")/   ;4@  %E4
M !%8   -6@  "5T#  1?"0  8 T  & 0  !A%   81D  &(@  !B)P  8C$
M &([  !B1P  8E4  &-D  !B=@  8HL  &*@  !AM@  8<\  &#J  !@]0!=
M2   4DD  $I(  !#2   .DH  #)-   J4   (U,  !Q7   66@  $5T   U@
M   (8P   V8!  !G!@  : L  &D.  !J$0  :Q4  &P;  !M(@  ;2H  &TT
M  !M0   ;4X  &U=  !M;P  ;80  &R:  !LL   :\@  &OF  !J\P!830
M3DT  $A,   ^3@  -5$  "Q4   D6   '5P  !9@   09   #&<   =K   !
M;@   '    !R P  <@<  ',+  !U#@  =A$  '<6  !X'   >2,  'HM  !Z
M.0  >D<  'I6  !Y:   >GP  'F4  !XJ@  >,$  '??  !W[P!440  3%$
M $)2   X50  +UD  "9>   >8@  %F<  !!K   +;P  !7,   !W    >@
M 'P   !^    ?P(  ( &  "!"@  @PT  (01  "&%0  B!P  (DE  "*,
MBCX  (E-  ")7P  B7,  (B+  "(H@  A[D  (?1  "&Z !25@  1U<  #Q:
M   R7P  *&0  !]I   6;P  $'0   IY   "?0   ($   "%    B    (H
M  ",    C0   (\   "0!   D@@  ),,  "5$   EQ4  )D=  ";)P  FS0
M )M$  ":5@  FFH  )F"  ":F@  F+   )C'  "7W@!+7   0&   #5E   K
M:@  (7$  !=W   0?0  "8,   &(    C    )$   "5    F    )H   ";
M    G0   )\   "@    H@   *0%  "F"@  J X  *H4  "M'0  K2H  *TY
M  "M2P  K5\  *UW  "LD   JZ<  *NZ  "KRP!%9@  .6L  "YQ   C>
M&7\  !"&   )C0   ),   "8    G0   *$   "E    J    *L   "K
MK@   *\   "Q    LP   +4   "W 0  N0<  +P-  "_$P  PA\  ,(N  #"
M0   PE0  ,%K  #!@P  P)L  ,&M  #!O  ^<@  ,G@  ">    <B   $I
M  J7    G0   *,   "H    K0   +(   "V    N0   +L   "\    O@
M ,    #"    Q    ,8   #(    RP   ,X%  #1#0  UA0  -<C  #8-0
MV4D  -I>  #;=0  VXP  -R?  #<JP#_    _P   /\   #_  D _P 0 /\
M&0#^ "0 _  O /D .0#T $, \ !+ .T 4@#J %D YP!? .0 9 #B &D X !N
M -X <P#< 'D V@!_ -< A@#4 (X T0"6 ,\ H0#, *P R@"[ ,@ T@#& .X
MQ@#_ ,4 _P#% /\ OP#_ +H _P#_    _P   /\   #^  4 ]P . /( %0#N
M !\ ZP J .D - #C #T W@!% -D 30#4 %, T0!9 ,X 7@#, &, R@!H ,D
M;0#' ', Q0!Y ,, @ #! (@ OP"0 +T FP"[ *8 N0"T +< R "V .8 M0#[
M +0 _P"T /\ LP#_ *X _P#_    _P   /@   #M    Y0 + -T $0#7 !H
MT@ D ,\ +@#+ #< QP!  ,, 1P#  $X O@!3 +P 60"Z %X N !C +8 : "U
M &T LP!S +$ >0"O ($ K0"* *L E "I *  J "M *8 O@"E -L I #T *0
M_P"C /\ HP#_ *( _P#_    ]@   .8   #7    RP & ,0 #@"^ !4 NP ?
M +D * "W #$ M  Z +  00"M $@ JP!. *D 4P"G %@ I@!< *0 80"C &<
MH0!L *  <P"> 'H G0"# )L C@"9 )D EP"F )8 M@"5 ,P E #K ), _0"3
M /\ DP#_ ), _P#W    Y    -    #!    MP " *\ "P"K !$ IP 9 *4
M(@"C "L H@ S )\ .P"< $( FP!( )D 30"7 %( E@!7 )4 6P"3 &$ D@!F
M )  ;0"/ '0 C0!] (P AP"* ), B "@ (< KP"% ,( A0#B (0 ]P"$ /\
MA #_ (0 _P#E    S0   +P   "O    I@   )X !P":  X E@ 4 )0 '0"2
M "4 D0 M )  -0"- #P C !" (H 1P"( $P AP!1 (8 5@"$ %L @P!@ ($
M9P"  &X ?@!W 'T @0![ (T >@": '@ J0!W +H =@#3 '8 [P!V /X =0#_
M '4 _P#0    NP   *L   "?    EP   )   @"+  L B  0 (8 %P"$ "
M@@ G ($ +P!_ #4 ?0 \ 'P 00![ $8 >0!+ '@ 4 !W %4 =@!; '0 80!S
M &D <0!Q '  >P!N (< ;0"5 &L HP!J +0 :@#) &D Z !I /D :0#_ &D
M_P#     K    )P"  "0 @  B    (,   !_  8 >P - 'D $@!W !H =@ B
M '0 *0!S #  <0 V '  / !O $$ ;0!& &P 2P!K %  :@!6 &@ 7 !G &0
M90!L &0 =@!C (( 80"0 &  GP!? *\ 7@## %X X0!> /0 70#_ %T _P"T
M!P  H D  ) +  "$"P  ? H  '<'  !T!   <0 ) &\ #P!M !4 :P < &D
M(P!H "H 9P Q &4 -@!D #P 8P!! &( 1@!@ $P 7P!2 %X 6 != %\ 6P!H
M %H <@!8 'X 5P", %8 FP!5 *L 5 "^ %0 V@!3 .\ 5 #[ %0 _P"I#0
ME@X  (<0  !Z$   <A   &P.  !I#   9PD# &8$"P!D !  8@ 7 &  '@!>
M "4 70 K %P ,0!: #< 60 \ %@ 0@!7 4< 5@%. %4"5 !3 EP 4@-E %$#
M;P!/!'L 3@2* $T%F0!,!:D 2P6\ $H&U !*!^T 2@?Y $H'_P"A$   CA(
M 'X4  !S%   :A0  &03  !@$0  7@\  %T-!0!="0T 6@82 %@'&0!6!R
M50<G %,'+0!2"#, 40@X % (/@!/"40 3@E* $P)40!+"ED 2@IB $@+;0!'
M"WH 1@R( $0,F !##*D 0@V\ $(-U0!"#>X 0@W[ $(-_P":%   AQ8  '@8
M  !L&0  8QD  %T8  !9%@  5A,  %01  !4#@@ 4PT. %$-% !/#1L 30TB
M $P-* !+#2X 2@TT $D-.@!'#D$ 1@Y' $4.3P!$#E< 0@]A $$0;  _$'D
M/A"( #T1F  [$:D .Q&\ #H1U@ Z$?  .A+] #L1_P"3&   @1H  ',<  !G
M'0  7AT  %@<  !3&P  4!@  $X6  !,$P, 3!$+ $H0$ !($1< 1A$> $41
M) !$$2H 0A$P $$1-P! $CT /Q)$ #T23  \$U0 .Q-> #D4:0 X%'8 -Q6%
M #85E@ T%J< -!:Z #,6TP S%NX -!;\ #06_P".&P  ?!T  &X?  !C(
M6B   %,@  !.'@  2AT  $@:  !&&   118' $,5#@!!%1, /Q4: #X5(  ]
M%2< .Q4M #H6,P Y%CH .!9! #<720 U%U$ -!A; #,99@ R&7, ,!J# "\:
ME  N&Z4 +1NX "T;T  M&^P +AO[ "X;_P"*'@  >"   &HB  !?(P  5B,
M $\B  !*(0  1B   $,>  !!&P  /QH# #T:#  [&1$ .1D6 #<:'0 V&B,
M-1HI #0:,  S&S8 ,1L^ # <1@ O'$\ +AU9 "T=9  L'G$ *Q^! "H?D@ I
M'Z0 *""W "<@S@ G(.L *"#Z "D?_P"&(   =",  &<D  !<)0  4R4  $PE
M  !')   0B,  #\A   ]'P  .AX  #<>"0 U'@X ,QX3 #$>&@ P'B  +QXF
M "X?+0 M'S, +" [ "L@0P J(4P *2%6 "@B8@ F(F\ )2-_ "0CD  C(Z(
M(B2U "(DS  B).D (R3Y "0C_P""(P  <24  &,F  !9)P  4"@  $DG  !#
M)P  /R8  #LD   X(@  -2(  #(B!@ P(@T +B(1 "PB%P J(AT *2(C "@C
M*@ G(S$ )B0X "4E00 D)4H (R94 "(F8  A)VT ("=] !\GCP >**$ 'BBT
M !THR@ =*.@ 'BCX !\G_P!^)0  ;B<  & I  !6*0  32H  $8J  !!*0
M/"@  #<G   T)@  ,"8  "TF P K)PL *"<0 "<G%  E)QH )"<A ",H)P B
M*"X (2DV " I/@ ?*D@ 'BI2 !TK7@ <*VL &RM[ !HLC0 9+)\ &"RR !@L
MR0 8+.< &2OW !HK_P!Z)P  :BH  %TK  !3+   2BP  $,L   ^*P  .2L
M #0J   P*@  *RH  "DK   F*P@ (RP. "(L$@ @+!@ 'RP> !XM)0 =+2P
M'"TS !LN/  :+D4 &2]0 !@O7  7+VD %C!Y !4PBP 4,)X %#"Q !,PQP 3
M,.4 %##V !4O_P!V*@  9RP  %HM  !0+@  2"X  $$N   [+@  -BT  #$M
M   L+0  )R\  "0O   A, 4 'S$, !PQ$  ;,A4 &C(< !DR(@ 8,BD %S,Q
M !8S.0 5,T, %#1- !,T60 2-&< $35W !$UB0 0-9P $#6P  XUQ@ /-.0
M$#3U ! T_P!R+   8RX  %<P  !-,   13   #XP   X,   ,S   "\P   I
M,0  )#(  "$S   =-0( &C8) !<W#@ 5-Q, %#@9 !,X'P 2."8 $C@N !$Y
M-@ 0.4  $#E+  XY5P ..F0 #3IT  PZA@ ,.ID "SFL  HYP0 *.=X "SGQ
M  PX_ !N+P  7S$  %,R  !*,P  0C,  #LS   V,P  ,3(  "PS   G-
M(38  !TX   9.0  %3L& !(]#  0/A  $#X5  X^'  ./B, #3XJ  P^,P ,
M/CP "S]'  H_4@ (/V  !S]O  8_@0 %/Y0 !#^H  ,^O  $/M< !3[L  4^
M]P!I,P  6S0  % U  !'-0  /S4  #DU   T-0  +C4  "DW   C.   'CL
M !H\   6/P  $D$$  Y#"@ ,1 X "D03  E$&0 (1"  !T0G  9$+P %1#@
M T5"  )%3@  15L  $5J  !%?   19   $2D  !$N0  1-$  $3J  !#]0!D
M-@  5S<  $PX  !#.   /#@  #<X   Q.   *SD  "4[   @/0  &D   !9"
M   21   #D<$  M)"0 '2@T !$L1  %+%@  2QP  $LC  !+*P  2S0  $L^
M  !,20  3%<  $QF  !,=P  2XP  $NA  !+M0  2LX  $KI  !*]0!?.@
M4CL  $@[  ! .P  .CL  #0[   N/   )SX  ")!   <0P  %D8  !))   .
M2P  "TX#  =0"  "40P  %$0  !2$P  4Q@  %,?  !3)@  4R\  %,Y  !3
M10  4U(  %-A  !3<@  4X<  %*<  !2L0  4<H  %'G  !1] !9/@  3CX
M $4^   ^/@  .#X  #!    I0@  (T0  !U'   72@  $DT   Y0   +4P
M!E4"  !7!P  6 L  %D.  !:$0  6A4  %L:  !<(0  7"H  %PT  !</P
M7$T  %Q;  !<;   7($  %N7  !;K0  6L4  %KD  !9\P!40@  2D(  $)"
M   \0@  -$,  "Q&   E20  'DP  !=/   24P  #E8   I9   %6P   %X
M  !@!   80@  &(,  !C#@  9!$  &46  !F'   9R,  &<M  !G.0  9T8
M &=5  !G9@  9WH  &:1  !EJ   9<   &3>  !D\ !/1@  1T8  $!%   W
M1P  +TH  "9-   ?40  &%4  !)9   -7   "&    )C    9@   &@   !J
M    :P0  &P(  !M#   ;PX  ' 2  !R%P  <QT  '0F  !T,@  =#\  '1.
M  !S7P  ='(  '.*  !RH0  <;@  ''4  !P[ !,2@  14H  #M+   R3@
M*5(  "!6   86P  $E\   UD   ':    &L   !O    <@   '4   !V
M=P   'D"  !Z!@  ? H  'X.  " $0  @A8  (0>  "$*0  A#8  (1%  "$
M5@  @VH  (.!  ""F0  @;$  (#)  " Y0!*3@  /U   #53   K5P  (EP
M !EB   29P  #&P   5Q    =0   'D   !]    @0   (,   "%    A@
M (@   ")    BP0  (T(  "/#0  DA   )06  "6(   EBP  )8[  "63
ME6   )5V  "4D   DZ<  )*]  "2U0!$50  .5D  "]=   D8P  &FD  !)O
M   ,=0  !'L   "     A0   (D   "-    D0   ),   "4    E@   )@
M  ":    G    )X   "@!@  H@L  *40  "H%P  J2,  *DQ  "I0P  J58
M *AM  "FAP  IYX  *:S  "EQP ^7@  ,F,  "=J   =<   $W@   Q_   #
MA0   (L   "1    E@   )L   "?    H@   *0   "E    IP   *D   "K
M    K0   +    "R    M0(  +<)  "[$   OA@  +XF  "^.   ODL  +UA
M  "\>@  NY0  +JI  "ZN0 W:@  *W   "!X   6@   #8@   6/    E@
M )P   "B    IP   *P   "P    LP   +8   "W    N0   +L   "]
MOP   ,(   #%    R    ,H   #."   TA   -4;  #5+   U$   -17  #3
M;@  U(8  -2;  #3JP#_    _P   /\   #_  4 _P . /\ %0#\ "  ^0 J
M /8 - #Q #T [0!& .D 30#F %, Y !9 .$ 7@#> &, W !H -D ;@#5 ',
MTP!Y -  @ #. (@ RP"1 ,D G #& *< Q "W ,( S #  .P OP#_ +X _P"]
M /\ MP#_ +( _P#_    _P   /\   #Z  $ \P + .T $@#H !L Y0 E .0
M+@#? #@ V !  -( 1P#. $X RP!4 ,@ 60#& %X Q !C ,( 9P#  &T OP!S
M +T >@"[ ($ N0"+ +8 E0"T *$ L@"O +  P@"N ., K@#Z *P _P"M /\
MJ0#_ *8 _P#_    _P   /(   #F    W0 ' -( #@#- !8 R@ @ ,@ *0#%
M #( P  Z +P 0@"Y $@ MP!. +4 4P"S %@ L0!= +  8@"N &< K !L *H
M<P"I 'L IP"$ *4 C@"C )H H0"H )\ N0"> -( G0#R )P _P"= /\ G #_
M )D _P#\    [@   -T   #,    P0 " +H # "V !( L@ : +  (P"O "P
MK0 T *D / "F $( I !( *( 30"@ %( G@!7 )T 6P"< &  F@!F )D ; "7
M '0 E0!] ), AP"1 ), D "A (X L0"- ,8 C #H (L _0", /\ C #_ (P
M_P#M    V    ,4   "W    K    *8 " "A  X GP 5 )T '@"; "8 F@ N
M )< -0"5 #P DP!" )$ 1P"0 $P C@!1 (T 50"+ %H B@!@ (D 9@"' &T
MA0!V (0 @ "" (P @ ": '\ J0!] +P ? #< 'P ]0!\ /\ ? #_ 'P _P#9
M    P0   +$   "D    G    )0  P"0  P C0 1 (L & ") "  B0 H (<
M+P"% #8 @P \ (( 00"  $8 ?P!+ 'T 3P!\ %0 >P!: 'D 8 !X &< =@!P
M '4 >@!S (8 <0"3 '  H@!O +0 ;@#, &X [0!N /X ;@#_ &X _P#$
MKP   *    "4    C    (8   "!  @ ?@ . 'P % ![ !L >0 B '@ *0!W
M #  =0 V '0 .P!R $  <0!% '  2@!O $\ ;0!4 &P 6P!K &( :0!J &@
M= !F (  90". &, G0!B *T 80#" &$ Y !A /@ 80#_ &$ _P"T    H
M )$   "&    ?@   'D   !U  , <0 + &\ $ !M !8 ;  = &L ) !K "H
M:0 P &@ -@!F #L 90!  &0 10!C $H 80!/ &  5@!? %T 70!E %P ;P!:
M 'H 60"( %@ F !7 *@ 5@"[ %8 V !6 /$ 5@#_ %8 _P"H 0  E 4  (4'
M  !Z!P  <@8  &P$  !I 0  9P ' &0 #0!C !$ 80 8 &  'P!? "4 7@ K
M %T , !; #8 6@ [ %D 0 !8 $4 5P!+ %8 40!5 %@ 4P!A %( :@!0 '8
M3P"$ $X DP!- *0 3 "V $P S0!, .L 3 #Z $P _P"="0  BPL  'P-  !P
M#0  : T  &(,  !?"@  708! %P!"0!:  X 6  3 %< &0!6 "  50 F %,
M*P!2 #$ 40 V %  .P!/ $$ 3@!' $T 30!+ %4 2@!= $D 9P!' ', 1@"
M $4 D !$ *$ 0P"R $, R !# .8 0P#U $, _P"5#0  @P\  '00  !I$0
M8!$  %H0  !6#@  5 T  %,*! !3!@L 40,0 $\!%0!. 1L 3 $A $L!)P!*
M BP 20(R $@"-P!' ST 10-# $0#2@!#!%$ 0@1: $ %9  _!7  /@9^ #T&
MC@ \!Y\ .P>Q #H'Q@ Z!^, .@?S #H(_ ".$   ?!(  &X4  !B%0  6A4
M %04  !0$P  31$  $L.  !+#08 2@H, $D($0!'"!8 10@= $0((P!"""@
M00DN $ ),P _"3D /@I  #T*1P \"D\ .@M8 #D+8P X#&\ -@Q^ #4,C@ T
M#9\ ,PVQ #(-QP R#>, ,@WT #(-_@"($P  =Q4  &D7  !>&   51@  $\8
M  !*%@  1Q4  $43  !#$ ( 0PX( $(-#@! #1( /PT8 #T-'P \#20 .PTJ
M #D-,  X#C< -PX] #8.10 U#DT ,P]7 #(/8@ Q$&X +Q!] "X0C@ M$:
M+!&R "L1R  K$>8 *Q'V "P1_P"#%@  <AD  &0:  !9&P  41L  $L;  !&
M&@  0A@  #\7   ^%   /!($ #L1"@ Z$!  .! 5 #<0&P U$2$ -!$G #,1
M+0 R$3, ,!$Z "\20@ N$DL +1-4 "L37P J%&P *11[ "@4C  G%9X )A6P
M "45Q@ E%>0 )17V "85_P!^&0  ;AL  & =  !6'@  31X  $<>  !"'0
M/AP  #H:   X&   -Q8  #45!P T% T ,A02 # 4%P O%!T +10C "P5*@ K
M%3  *A4W "D6/P H%D@ )Q=2 "8870 D&&H (QEY "(9B@ A&9P (!FO !\9
MQ  ?&>( (!GT " 9_P!Z&P  :AX  %T?  !3(   2B   $0@   ^'P  .AX
M #<=   T'   ,AD  # 9!  N& L +!@0 "H8%  I&!H )Q@@ "89)@ E&2T
M)!HU ",:/0 B&T8 (1M0 " <6P ?'6@ 'AUW !T=B  <'IL &QZM !H>PP :
M'N  &AWS !L=_P!W'0  9R   %HA  !0(@  2"(  $$B   [(@  -R$  #,@
M   P'P  +1T  "L=   H'0@ )AT. "4=$@ C'1< (1T= "$=)  @'BH 'QXR
M !X?.@ ='T, '"!- !LA60 :(68 &2%U !@BAP 7(ID %B*L !4BP0 5(M\
M%2'R !8A_@!S(   9"(  %<C  !-)   124  #XD   Y)   -",  # B   L
M(@  *2$  "8A   D(08 (B$, " A$  >(14 '2(; !LB(0 ;(B@ &B,O !DC
M.  8)$$ %R1+ !8E5P 5)60 %"9S !,FA0 2)I@ $2:K !$FP  0)MT $27Q
M !(E_0!P(@  820  %0F  !*)@  0B<  #PF   V)@  ,24  "TE   I)
M)B0  "(E   ?)0, '28* !LF#@ 9)Q( &"<8 !<G'P 6)R4 %2@M !0H-0 3
M*3X $BE) !$I50 1*F( $"IQ  \J@P .*I8 #BJI  TJO0 -*M< #2KN  XI
M^P!L)   728  %$H  !(*   0"D  #DH   T*   +R@  "LG   G)P  (B@
M !XI   ;*@  &"L' !8K#0 4+!$ $RP6 !(L'  1+2, $"TJ ! M,@ /+CP
M#BY&  TN4@ -+E\ #"]N  LO?P *+Y( "2^E  DNN0 (+M  "2[I  HN]P!H
M)P  6BD  $XJ  !%*P  /2L  #<K   Q*@  +2H  "DJ   D*@  ("L  !LM
M   8+@  %2\$ !(Q"@ 0,@X #S(3  XR&0 -,B  #3(G  PR+P +,S@ "C-"
M  DS3@ (,UL !C1J  4T>P $,XX  S.B  (SM@ ",\T  S/G  0R\P!D*@
M5BP  $LM  !"+0  .BT  #0M   O+   *RP  "8L   B+0  '2\  !DQ   5
M,@  $C0#  \V"0 ,. T "C@1  DX%@ (.!T !S@D  8X+  $.#0  S@^  (Y
M2@  .5<  #EE   Y=P  .8L  #B?   XLP  .,H  #CF   W\@!?+0  4BX
M $@O   _,   ."\  #(O   M+P  *2\  "0P   ?,0  &C,  !4U   2-P
M#SD#  P["  (/0T !3X0  ,^%   /AH  #XA   ^*   /C$  #\[   _1@
M/U,  #]A   _<P  /X<  #Z<   ^L   /<<  #WD   ]\@!:,   3C(  $0R
M   \,@  -3(  # Q   K,0  )C(  " T   ;-@  %C@  !([   //0  ##\#
M  A!"  $0PP  $,.  !$$@  118  $4=  !%)   12T  $8V  !&0@  1DX
M $9=  !&;@  18(  $68  !$K0  1,0  $/C  !#\@!5-   2C4  $$U   Y
M-0  ,S0  "XT   H-0  (C<  !TZ   7/   $C\   ]!   ,1   "$8!  -(
M!@  20H  $H-  !+$   3!0  $T9  !.(   3B@  $XR  !-/0  3DH  $Y8
M  !-:0  37T  $R4  !,J@  2\$  $OA  !*\@!0.   1C@  #TX   W.
M,3<  "HY   D.P  'CT  !A    30P  #T8   M)   '2P   DX   !0!
M40@  %(+  !3#@  5!$  %45  !6&P  5R,  %<L  !7.   5T0  %=2  !6
M8P  5G<  %:.  !5I0  5+T  %/=  !3\ !+/   0CP  #L[   U.P  +3P
M "8_   ?0@  &44  !-(   .2P  "T\   51    5    %<   !8 0  6@4
M %L(  !<#   70X  %\1  !@%@  8AT  &(F  !B,0  8CX  &%,  !A70
M87   &"(  !@H   7[<  %[4  !=[@!'0   /S\  #H_   Q0   *4,  "%&
M   :2@  $TX   Y1   *50  !%@   !;    7@   &$   !C    9 $  &4$
M  !G"   : L  &H.  !L$@  ;A<  &\@  !O*@  ;S8  &Y%  !N50  ;F@
M &U_  !MF   ;+   &O*  !JZ !$1   /D,  #5$   K1P  (TL  !M/   3
M5   #E@   A<   "8    &0   !G    :P   &T   !O    <    '(   !T
M @  =08  '<*  !Y#@  ?!(  'X8  !_(@  ?RX  '\]  !^30  ?6$  'UW
M  !\D   >Z@  'K   !YWP!#1P  .4D  "],   E4   '%4  !1;   .8
M!V4   !J    ;@   '(   !V    >0   'P   !^    ?P   ($   "#
MA0   (<#  "*"   C T  (\1  "2&0  DB4  )(S  "21   D5<  )!M  "/
MA@  CI\  (VU  ",S0 ]3@  ,E$  "A6   >7   %6(   YH   ';@   '0
M  !Y    ?@   ((   "&    B0   (P   ".    D    )(   "4    E@
M )@   ";    G@8  *$,  "D$0  IAL  *8I  "F.@  I4T  *5B  "D>P
MHY0  *&K  "AOP V5P  +%P  "%B   7:0  #W    =W    ?@   (0   "*
M    CP   )0   "8    FP   )X   "?    H@   *0   "F    J    *L
M  "M    L    +,$  "W#   NQ(  +L?  "[,   NT,  +I8  "Y<   MXL
M +>A  "WLP P8@  )6D  !IP   0>   "8    "(    CP   )8   ";
MH0   *8   "J    K@   +    "Q    M    +8   "X    NP   +T   #
M    PP   ,<   #+ P  SPP  -,5  #2)0  TC@  -%.  #090  SWX  ,V6
M  #,J0#_    _P   /\   #_  , _P + /P $0#Y !L ]P E /, +P#N #@
MZ0!  .8 2 #B $X WP!4 -P 60#9 %X U0!C -, : #0 &T S@!S ,L >@#(
M (( Q@", ,, EP#  *, O@"R +P R "Z .H N0#_ +@ _P"Q /\ J@#_ *<
M_P#_    _P   /L   #V    [0 ' .< #P#B !8 WP @ -X *0#9 #, T0 [
M ,P 0@#( $@ Q0!. ,( 4P#  %@ O@!= +P 8@"Z &< N0!M +< = "U 'L
ML@"% +  D "N )P K "J *D O0"G -X I@#Y *4 _P"C /\ G0#_ )L _P#]
M    ]@   .L   #?    T0 # ,H # #% !( PP ; ,  ) "^ "P N0 U +8
M/ "S $, L !( *X 3@"L %( JP!7 *D 7 "G &$ I@!G *0 ;0"B '0 H !]
M )X B "< )4 F@"C )@ M "6 ,T E0#Q )0 _P"5 /\ D #_ (X _P#S
MY@   -$   #"    N    +$ " "M  \ J@ 6 *@ '@"H "< I@ O *( -@"?
M #P G0!" )L 1P"9 $P EP!1 )8 50"4 %H DP!@ )$ 9@"0 &X C@!V (P
M@0"* (T B "; (8 K "% ,$ A #F (, _0"$ /\ @P#_ ($ _P#D    RP
M +H   "L    H@   )P ! "8  P E@ 1 )0 &0"3 "$ D@ H (\ , "- #8
MBP \ (D 00"( $8 A@!+ (4 3P"$ %0 @@!: ($ 8 !_ &< ?@!O 'P >@!Z
M (8 > "4 '< I !U +< = #4 ', ] !T /\ = #_ '0 _P#+    M@   *8
M  ":    D@   (H   "&  @ @P . ($ % "! !L @  C '\ *@!] #  >P V
M 'H .P!X $  =P!% '4 20!T $X <P!4 '$ 6@!P &$ ;@!I &T <P!K '\
M:0"- &@ G0!G *X 9@#' &4 Z@!F /\ 9@#_ &< _P"X    I    )4   "*
M    @0   'P   !V  0 =  , '( $ !Q !8 <  = '  ) !N "H ;0 P &L
M-0!J #H :0 _ &@ 1 !G $D 90!. &0 5 !C %L 80!C &  ;0!> 'D 70"'
M %L E@!: *@ 60"] %D WP!9 /@ 6@#_ %H _P"H    E0   (<   ![
M<P   &X   !J  $ 9P ( &4 #@!D !( 8P 8 &, 'P!B "4 80 J %\ , !>
M #4 70 Z %P /@!; $0 60!) %@ 3P!7 %8 5@!> %0 : !3 ', 40"! %
MD0!/ *( 3@"U $X T !. /  3@#_ $\ _P"<    B0   'L#  !P P  : ,
M &(!  !?    70 $ %L "P!9  \ 6  4 %< &0!7 "  5@ E %4 *@!3 #
M4@ T %$ .0!0 #\ 3P!$ $X 2P!- %( 2P!: $H 8P!) &\ 1P!\ $8 C !%
M )T 10"P $0 QP!$ .@ 1 #Z $4 _P"2!   @ <  '$*  !F"@  7@H  %D)
M  !5!P  5 0  %( !P!0  P 3P 0 $X %0!- !L 3  @ $L )@!* "L 20 P
M $@ -0!' #H 1@!  $4 1@!# $X 0@!6 $$ 7P!  &L /@!X #T B  \ )D
M/ "K #P P0 [ .  .P#T #L _P")"@  > P  &H.  !?#@  5PX  %$.  !-
M#   2PL  $H( @!)! D 2  - $8 $0!% !8 1  < $, (0!" "8 00 K #\
M,0 ^ #8 /0 \ #P 0P [ $H .@!2 #D 7  X &@ -@!U #4 A0 T )8 - "H
M #, O  S -@ ,P#O #, ^P""#0  <0\  &00  !9$0  41$  $L1  !'$
M1 X  $(-  !!"P4 00<+ #\%#@ ^ Q( / (8 #L"'0 Z R( .0,H #@#+0 W
M S( -@0Y #4$/P T!4< ,P50 #$&6@ P!F8 +P=S "X'@P M!Y4 + >G "L'
MN@ K!]( *P?K "L']P!]$   ;!$  %\3  !4%   3!0  $84  !"$P  /A(
M #P0   Z#@$ .@T& #H*#  X"1  -@@4 #4(&0 T"1\ ,@DD #$)*0 P"2\
M+PHV "X*/0 M"D4 + M. "L+60 I#&4 * QS "<,@P F#94 )0VG "0-NP C
M#=( (PWK ",-]P!X$@  :!0  %L6  !1%P  2!<  $(6   ]%@  .14  #<3
M   U$0  ,Q # #,."  R#0T , T1 "\-%@ M#1L + TA "L-)P J#2T *0XT
M "@..P G#D0 )0Y. "0/60 C$&4 (1!S " 0A  ?$)8 'A"I !T0O0 <$-@
M'1#N !T0^0!S%   9!8  %<8  !-&0  11D  #\9   Z&   -1<  #(6   P
M%0  +A,  "T1!  L$ H *Q . "D0$@ H$!@ )A > "40)  D$"H (Q$Q "(1
M.0 A$4( (!)+ !X25@ =$V, '!-Q !H3@@ 9%)4 &!2G !<4NP 7$]0 %Q/N
M !@3^@!P%@  8!D  %0:  !*&P  0AP  #P;   V&P  ,AH  "\9   L&
M*A8  "@4 0 F$P< )1,, ",3$  B$Q4 (!,: !\3(0 >%"< '10N !P5-@ ;
M%3\ &A9) !D65  8%V$ %A=P !48@0 4&), $QBF !(8N@ 2%]( $A?L !,7
M^@!L&0  71L  %$=  !''0  /QX  #D=   T'0  +QP  "L;   H&@  )AD
M "08   B%P0 (!<* !X7#@ <%Q( &A<7 !D8'@ 9&"0 &!DL !<9-  6&CT
M%1I' !0;4@ 3&U\ $AQN !$<?P 0')( $!RE  \<N0 .'-  #AOJ  \;^ !I
M&P  6AT  $X?  !%'P  /2   #8?   Q'P  +1X  "D=   E'0  (QP  " ;
M   =&P$ &QL' !D<#0 7'!  %AP5 !4<&P 4'2( $QTI !(>,0 1'CH $1]%
M ! ?4  /(%T #B!L  T@?  -((\ #""B  L@M0 +(,H "R#E  P?] !E'0
M5Q\  $PA  !"(0  .B$  #0A   O(0  *B   "8?   C'P  (!X  !T>   9
M(   %B $ !0@"P 2(0X $2$3 !$B&0 0(A\ #R(F  XC+P .(S< #2-!  PD
M30 +)%D "B1G  DD>  ()(L !R2>  <DL0 &),< !B/C  <C\0!B'P  5"$
M $DC  ! (P  .",  #(C   L(P  *"(  "0A   A(0  'B$  !HA   6(P
M$R0# !$E"  /)@T #B<1  TG%@ ,)QT "R<C  HG*P )*#0 ""@^  <H20 &
M*%4 !2ED  0I=  #*8<  BF;  $HKP  *,4  2CA  $G\ !>(@  420  $8E
M   ])0  -24  "\E   J)   )B0  "(C   ?(P  &R0  !@E   4)@  $2@#
M  \I"  ,+ P "BP0  @L%  '+!H !BPA  4L*  #+3   BTZ  $M10  +5(
M "Y@   N<0  +80  "V9   MK0  +,(  "S@   L\ !:)   328  $,G   Z
M)P  ,R<  "TG   H)@  )"8  "$F   =)@  &2<  !4I   1*P  #RP#  TN
M!P ), P !C$.  ,Q$@ !,A<  #(>   R)0  ,BT  #(V   S0@  ,TX  #-=
M   S;0  ,X$  #*6   RJP  ,<$  #'?   Q\ !6)P  2BD  #\J   W*@
M,"H  "LI   G*   (R@  !XI   :*@  %BP  !(N   /,   #3$"  HT!P %
M-0L  C8.   W$   .!0  #@:   X(@  ."H  #DS   Y/@  .4H  #E9   Y
M:0  .7T  #B3   XJ   -[\  #?>   V\ !1*P  1BP  #PL   T+   +BP
M "HK   E*P  ("P  !LM   7+P  $S$  ! S   --0  "3<"  4Z!@ !.PH
M #P-   ]#P  /A(  #\7  ! '@  0"4  $ O  ! .@  0$8  $!4  ! 90
M/W@  #^/   ^I@  /KT  #W<   ]\ !-+@  0B\  #DO   R+P  +2X  "@N
M   B+P  '3   !@R   3-0  $#<   PZ   )/   !3X   !!!   0@@  $,+
M  !$#0  1A   $<4  !(&0  2"$  $@J  !(-0  2$$  $A/  !(8   1W,
M $>*  !&H@  1;D  $79  !$\ !(,@  /C(  #8R   P,0  *S$  "4R   ?
M-   &38  !,Y   0/   ##\   A"   #1    $8   !( @  2@4  $L(  !,
M"P  3@X  $\1  !1%0  4AP  %(E  !2,   4CP  %%*  !16@  46T  %"$
M  !/G0  3K4  $W2  !-[@!#-@  .S8  #0U   O-   )S4  "$X   :.P
M%#X  !!!   ,1   !T<   )*    30   $\   !1    4P(  %0%  !5"
M5PL  %D.  !;$0  71<  %T?  !=*@  738  %Q$  !<5   6V<  %M^  !:
MEP  6:\  %C+  !7Z@ _.0  .#D  #,X   K.0  (SP  !P_   50P  $$<
M  M*   %3@   %$   !4    5P   %H   !<    70   %\   !@!   8@<
M &0+  !F#@  :!(  &L9  !K(P  :BX  &H\  !J30  :5\  &AU  !GCP
M9J@  &7"  !DXP ]/0  -SP  "X]   E0   '40  !9)   030  "E$   15
M    6@   %T   !@    8P   &8   !H    :@   &L   !M    ;P(  '$&
M  !T"@  =@X  'D3  ![&P  >R<  'HU  !Y10  >%D  'AM  !WA@  =I\
M '6W  !TT@ \00  ,D(  "A%   @2@  %TX  !!4   *60   EX   !C
M9P   &L   !O    <@   '4   !W    >0   'L   !]    ?P   ((   "$
M P  APD  (H.  ".$P  CQX  (XK  "..P  C4X  (MC  "*?   BI4  (BM
M  "'Q0 V1P  +$L  ")/   950  $%L   IA   !9P   &T   !R    =P
M 'L   !_    @P   (8   "(    B@   (T   "/    D0   )0   "7
MF@$  )T'  "A#0  I10  *0A  "D,0  HT0  *)9  "@<   GXL  )VB  "=
MMP P4   )54  !M;   28@  "VD   %P    =P   'T   "#    B    (T
M  "1    E0   )@   ":    G    )\   "A    HP   *8   "I    K
M +    "T!P  N X  +H8  "Z)P  N3D  +A.  "W90  MGX  +66  "SJP I
M6P  'F(  !1I   ,<0   GD   "!    B0   (\   "6    FP   *    "D
M    J    *L   "L    KP   +(   "T    M@   +D   "\    P    ,0
M  #(    S0<  -(0  #2'0  T2\  -!$  #/6P  S7,  ,N-  #*H0#_
M_P   /L   #Z    _  ( /@ #P#U !< ]  @ /$ *@#K #, Y@ [ .( 0P#>
M $D V@!/ -8 5 #3 %D T !> ,X 8P#+ &@ R0!N ,8 =0## 'T P0"& +X
MD@"[ )X N0"N +8 PP"T .@ LP#_ *\ _P"E /\ G@#_ )L _P#]    ]P
M /(   #P    YP # .$ # #< !( V  ; -8 ) #2 "T S  V ,8 /0#" $,
MOP!) +P 3@"Z %, N !8 +8 70"U &( LP!G +$ ;@"O '8 K !_ *H B@"H
M )< I0"F *, N0"A -D H #Y )X _P"8 /\ D@#_ (\ _P#S    [    .,
M  #3    R    ,$ "0"]  \ NP 6 +D 'P"W "< LP O *\ -P"L #T J@!#
M *@ 2 "F $T I !2 *, 5@"A %L GP!A )X 9P"< &\ F@!X )< @P"5 )
MDP"> )$ L "0 ,@ C@#P (T _P"* /\ A0#_ (( _P#G    W0   ,8   "X
M    K@   *@ ! "E  P H0 2 *$ &0"@ "( GP I )L , "8 #< E@ ] ),
M0@"2 $< D !+ (\ 4 "- %4 C !: (H 80"( &@ AP!P (4 >P"# (@ @0"6
M '\ IP!] +P ? #C 'P _0!\ /\ > #_ '8 _P#6    P    *\   "C
MF0   ),   "/  D C0 . (L % "* !P B@ C (@ *@"% #  @P V (( .P"
M $  ?P!% 'X 2@!\ $\ >P!4 'H 6@!X &$ =@!I '4 <P!S (  <0". &\
MGP!N +( ;0#/ &P ] !L /\ :P#_ &D _P#     JP   )L   "/    AP
M (    !\  0 >@ , '@ $0!X !< >  > '< ) !U "H <P P '$ -0!P #H
M;@ _ &T 1 !L $D :P!. &H 5 !H %L 9P!C &4 ;0!D '@ 8@"' &  EP!?
M *H 7@#" %X Z0!> /\ 7@#_ %T _P"L    F0   (H   !_    =P   '$
M  !M    :@ ( &D #@!H !( 9P 8 &< 'P!G "4 90 J &, +P!B #0 80 Y
M &  /@!? $, 7@!( %T 3@!; %4 6@!= %@ 9P!7 '( 50"! %0 D0!3 *,
M4@"X %$ W !1 /D 4@#_ %( _P"=    BP   'P   !Q    :0   &0   !@
M    7@ % %P "P!;  \ 6P 4 %H &0!: !\ 60 E %< *@!6 "\ 50 T %0
M. !3 #T 4@!# %  20!/ %  3@!8 $T 8@!+ &T 2@!Z $D BP!( )T 1P"Q
M $< S !& /  1P#_ $< _P"0    ?@   '    !F    7@   %D   !6
M4P ! %( " !0  T 3P 0 $\ %0!. !H 3@ @ $T )0!, "H 2@ N $D ,P!(
M #@ 1P ^ $8 1 !% $L 1 !3 $, 70!! &@ 0 !U #\ A0 ^ )< /0"K #T
MPP ] .8 /0#[ #X _P"'    =0,  &@&  !=!P  508  % &  !,!   2@$
M $D ! !'  H 1@ . $4 $0!% !8 1  ; $, ( !" "4 00 J $  +P _ #0
M/@ Z #T 0  [ $< .@!/ #D 60 X &0 -P!Q #8 @0 U ), - "F #0 NP T
M -T - #U #4 _P!^!@  ;0D  & +  !6#   3@P  $@+  !$"@  0@@  $ %
M 0 _ 0< /@ + #T #@ \ !( .P 7 #L '  Z "$ .0 E #< *@ V #  -0 U
M #0 /  S $, ,@!, #$ 50 P &  +P!M "X ?0 M (\ + "B "P M@ L -
M+ #N "P _ !W"@  9PP  %H.  !0#@  20X  $,.   ^#0  .PP  #D+   X
M"0, -P4( #8"#0 U 1  -  3 #, &  R !T ,0 B #  )P O "P +@ R "T
M.  L $  *P!) "H 4@ I %T * !K "<!>@ F 8P )0"? "4 L@ E ,H )0#H
M "4 ]P!R#0  8@X  %80  !,$0  1!$  #X1   Y$   -@\  #,.   Q#0$
M, L% # ("@ O!@T +@41 "P$%  K QD *@,> "D#(P H!"D )P0O "8%-0 E
M!3T ) 5& ",&4  B!EP (0=I " '>0 ?!XL '@>= !X'L  =!L8 '0;C !T%
M\P!M#@  7A$  %(2  !($P  0!,  #H3   U$@  ,1$  "X0   L#P  *@X#
M "H-!P I"PL * D. "<)$0 E"!8 ) @; ",)(  B"28 (0DL " *,P ?"CL
M'@M$ !T+3P <#%L &PQI !H,>0 8#(L & R> !<,L  6#,4 %@SA !8+\ !I
M$   6A(  $X4  !%%0  /14  #<5   Q%   +1,  "H2   H$0  )A ! "00
M!  C#@@ (PT, "(,#P @#!, 'PP8 !X-'0 =#2, ' TJ !L-,@ :#CH & Y$
M !<.4  6#UP %0]J !,0>P 2$(T $1"@ !$0LP 0#\D $ _D !$/\@!E$@
M5Q0  $L6  !"%P  .A<  #07   O%@  *A4  "<4   D$P  (A,  " 2 P >
M$08 '1 ) !P0#0 ;#Q  &1 5 !@0&P 7$"$ %A H !41,  4$3D $Q%# !(2
M3@ 1$EH $!)I ! 3>0 .$XP #A.>  T3L0 -$L4 #!+A  T2\0!B%   5!8
M $D8   _&0  -QD  #$9   L&   *!<  "06   A%@  'Q4  !P4 @ :$P0
M&1(& !<2"P 5$@X %!(2 !,3&  2$Q\ $1,F !$4+0 0%#8 #Q5!  X53  .
M%E< #19E  P7=0 +%X< "A>:  D6K0 (%L$ "!;=  D5[@!?%@  41@  $8:
M   ]&@  -1L  "\:   J&@  )1D  "(8   ?&   '!<  !D6 0 7%@, %18$
M !,6"0 1%@T $!<1  \7%@ .%QP #A@C  T8*@ ,&3, #!D\  L:1P *&E,
M"1IA  <;<0 &&X, !1N7  0:J@ #&K\  QG:  09[ !<&   3AH  $,<   Z
M'   ,QP  "P<   G'   (QL  " :   =&0  &AD  !<8 0 5& ( $AD$ ! ;
M!P .&PP #1P0  P<$P +'!D "AP?  D=)P ('2\ !QXY  8>0P $'E   Q]>
M  (?;@ !'X   !^5   >J0  'KT  !W8   =[ !8&@  2QP  $$>   X'@
M,!X  "H>   E'0  (1P  !X<   ;&P  &!L  !8; 0 3&P( $1P$  X>!P ,
M'PL "B .  @@$@ &(1< !2$=  0A)  "(BP  2(U   B0   (TT  "-:   C
M:P  (WX  ".3   BIP  (KP  "'7   A[0!5'0  2!\  #X@   U(   +B
M "@@   C'P  (!X  !T=   :'0  %AT  !,>   1'P( #B $  TB!P *) L
M!B4-  0E$  ")A0  "8:   F(0  )RD  "<R   G/0  )TD  "A7   H9P
M)WL  ">0   GI0  )KL  ";6   E[0!1(   12$  #LB   R(@  +"(  "8A
M   B(0  'B   !L?   8(   %"   !$B   /(P  #24#  HF!@ &* H  RD-
M   K#P  +!(  "P7   L'@  +"8  "TO   M.0  +48  "U4   M9   +7<
M "R-   LI   *[H  "O6   J[@!-(@  020  #@D   P)   *20  "0C   A
M(@  '2(  !DB   5(P  $B0   \F   -*   "BH"  8L!0 "+@D  "\+   P
M#@  ,A   #,5   S&P  ,R(  #,K   S-@  ,T(  #-0   S8   ,W,  #**
M   RH0  ,;@  ##6   P[P!))0  /B8  #0G   M)P  *"8  ",E   ?)
M&R4  !8F   2*   $"H   TL   *+@  !C !  (R!   - <  #4*   W#
M. X  #H2   Z%P  .A\  #HG   Z,@  .CX  #I,   Z7   .F\  #F&   X
MG@  .+8  #?4   V[P!$*0  .BD  #$I   K*0  )B@  "(G   =*   &"D
M !,K   0+@  #3    DR   %-0   3<    Y @  .P4  #P(   ^"P  /PT
M $$0  !#%   0QL  $,C  !#+@  0SD  $-'  !"5P  0FH  $&!  ! F@
M/[(  #[/   ^[P _+   -BP  "\L   J*P  )2H  !\K   9+0  %"\  ! R
M   --0  "#@   0Z    /    #\   !!    0P(  $4%  !&"   2 L  $H.
M  !,$0  318  $T>  !-*   330  $Q"  !,40  2V0  $M[  !*E   2:T
M $C*  !'[  [,   ,R\  "TO   H+0  (B\  !LQ   5-   $#<   TZ   (
M/0   D    !#    1@   $@   !*    3    $X!  !/!   40<  %,+  !5
M#@  6!(  %D9  !8(@  6"X  %<\  !72P  5EX  %9S  !5C0  5*<  %+"
M  !2Y@ X,P  ,3(  "PQ   E,@  '34  !8X   1/   #$    =$    1P
M $H   !-    4    %,   !5    5P   %D   !:    7 ,  %X'  !A"P
M9 X  &83  !G'   9B<  &8T  !E1   9%<  &1K  !BA0  89\  &"Y  !>
MW  U-P  ,#4  "@W   @.@  &#T  !%"   ,1@  !DH   !/    4P   %8
M  !9    7    %\   !A    9    &4   !G    :0   &P!  !N!@  <0L
M '0/  !W%0  =R   '8M  !V/0  =4\  '1C  !S>P  <I4  '"O  !OR0 U
M.@  *SL  "(_   :0P  $D@   Q-   %4@   %<   !<    8    &0   !H
M    :P   &X   !Q    <P   '4   !W    >@   'P   !_    @@0  (8*
M  "*#P  C!<  (LD  "*,P  B44  (=;  "&<@  A8L  (.E  ""O  O0
M)40  !Q)   33@  #50   1:    80   &8   !K    ;P   '0   !Y
M?0   (    "#    A0   (<   "*    C    (\   "2    E@   )D"  ">
M"0  HA   *(:  "A*0  H#L  )]0  "=9P  FH$  )J9  "9KP I20  'TX
M !54   .6P  !6(   !I    <    '<   !]    @@   (8   "+    CP
M ),   "5    EP   )H   "=    H    *,   "F    J@   *X   "R
MMPH  +L1  "Z'P  N3   +=%  "U7   M'0  +&.  "OI  B5   &%L  !!B
M   ':@   ',   ![    @@   (D   "0    E0   )H   "?    HP   *8
M  "H    JP   *X   "P    LP   +8   "Z    O0   ,(   #'    S $
M -,+  #4%0  TR8  -$Z  #040  S6@  ,N!  #*E@#\    ]@   /(   #Q
M    \P % /0 # #R !, \  < .T )0#H "X X@ V -X /@#9 $0 U !* -$
M3P#. %0 RP!9 ,D 7@#& &, Q !I ,$ < "^ '@ O "! +D C0"V )H LP"K
M +$ P "O .8 K@#_ *4 _P": /\ E #_ (\ _P#T    [    .@   #G
MWP   -D "0#2 !  SP 7 ,\ ( #, "@ Q@ P ,  -P"\ #X N0!$ +< 20"U
M $X LP!3 +$ 5P"O %T K0!B *L :0"I '$ IP!Z *4 A0"B ), H "B )T
MM@"; -0 F0#Y )8 _P"- /\ B #_ (0 _P#H    WP   -D   #)    OP
M +@ ! "U  T LP 2 +$ &@"P "( K0 J *D ,0"F #@ I  ] *( 0P"@ $@
MG@!, )P 40"; %8 F0!< )< 8@"5 &D DP!R )$ ?0"/ (L C0": (L K ")
M ,4 B #N (8 _P!_ /\ >@#_ '@ _P#9    S0   +L   "N    I0   )\
M  "<  D F0 / )D %0"9 !T F  D )0 *P"1 #$ C@ W (P / "+ $$ B0!&
M (@ 2P"& %  A0!5 (, 6P"" &( @ !K 'X =0!\ (( >@"2 '@ HP!W +D
M=@#@ '4 _P!R /\ ;@#_ &P _P#'    M0   *4   "9    CP   (D   "%
M  0 A  , (( $0"" !< @@ > (  )0!^ "L ?  Q 'H -@!Y #L =P!  '8
M1 !U $D <P!/ '( 50!P %P ;P!D &T ;@!L 'H :@"* &@ FP!G *\ 9@#,
M &4 ]0!D /\ 80#_ &  _P"T    H    )    "%    ?0   '<   !S
M<  ( &\ #@!O !( ;P 8 &\ 'P!M "4 :P J &D , !H #0 9P Y &8 /@!E
M $, 8P!( &( 3@!A %4 7P!> %X 9P!< ', 6P"" %D DP!8 *8 5P"_ %<
MZ@!7 /\ 5@#_ %0 _P"A    C@   '\   !U    ;    &@   !D    80 $
M &  "P!?  \ 7P 3 %\ &0!? !\ 70 E %P *@!; "\ 60 S %@ . !7 #T
M5@!# %4 20!3 %  4@!8 %$ 80!0 &T 3@![ $T C !, )\ 2P"U $H W !*
M /H 2@#_ $H _P"2    @    '(   !G    7P   %H   !7    50 ! %,
M!P!2  P 4@ 0 %( % !2 !H 40 ? $\ ) !. "D 30 N $P ,P!+ #@ 2@ ]
M $D 0P!( $H 1@!2 $4 7 !$ &< 0P!U $( A@!! )@ 0 "N $  RP _ /(
M0 #_ $  _P"%    =    &<   !=    50   $\   !,    2@   $@ ! !'
M  H 1P - $8 $0!& !4 1@ : $4 'P!$ "0 0P I $( +0!! #, /P X #X
M/@ ] $4 / !. #L 5P Z &( .0!O #@ @  W ), -@"G #8 P  V .@ -@#^
M #8 _P!\    :P   %X"  !4 P  30,  $<#  !# 0  00   #\  0 ^  <
M/0 + #T #@ \ !$ /  6 #P &@ Z !\ .0 D #@ *0 W "X -@ S #4 .@ T
M $$ ,P!) #( 4P Q %X , !K "\ >P N (X +0"B "T N  M -T +0#X "X
M_P!S 0  9 4  %<'  !-"   1@@  $ (   [!P  . 4  #<#   V  0 -0 (
M #0 #  T  \ -  2 #, %@ R !L ,0 @ #  )  O "D +@ O "T -@ L #T
M*P!% "H 3P I %H * !G "< =P F (D )@"= "4 LP E ,\ )0#P "8 _P!M
M!@  7@D  %(+  !(#   0 P  #H+   V"P  ,@H  # (   N!@( +@,& "T
M"@ L  T +  0 "L $P J !< *0 < "@ (  G "4 )@ K "4 ,@ D #D (P!"
M "( 2P B %< (0!D "  <P ? (4 'P"9 !X K@ > ,< '@#I !\ ^@!H"0
M60P  $T-  !##@  / X  #8.   Q#0  +0T  "H,   H"P  )PD$ "8&"  F
M! L )0,. "0!$  D 10 (@$8 "$!'0 A "( (  H !\ +@ > 38 '0$_ !P!
M20 ; 50 &@%A !H!<  9 8( & "6 !@ J@ 8 ,$ & #A !@ ] !C#   50X
M $D/  ! $   .!   #(0   M#P  *0X  "8.   C#0  (@P# " +!@ @"0D
M'P<, !X&#@ >!1$ ' 45 !L%&@ :!1\ &@4E !D%*P 8!3, %P8\ !8&1@ 6
M!E( %0=? !0';@ 3!X  $@>4 !(&IP 2!;P $@39 !(#[P!?#@  40\  $80
M   \$0  -1$  "\1   J$0  )A   "(0   @#P  '0X" !P-!0 :#0< &@L*
M !D*#0 8"1  %PD2 !8)%P 5"1P % DB !0**0 3"C$ $@HZ !(+10 1"U$
M$ Q?  \,;@ .#(  #@R4  T+IP -"[H #0K2  T*Z@!<#P  3A$  $,2   Z
M$P  ,A,  "P3   G$@  (Q$  !\1   <$   &A " !@/!  6#@< %0X) !0-
M"P 3# T $@P0 !(,%  1#!H $0T@ ! -*  /#3  #@X[  T.1@ -#E$ # ]>
M  L/;0 *#W\ "0^3  D/I@ (#KD " [0  <.Z !8$0  2Q(  $ 3   W%
M,!0  "D4   E%   (1,  !T2   :$@  %Q$" !41!0 3$ < $A ) !$/"@ 0
M#@P #@X.  X/$@ -$!@ #1 >  P0)0 ,$"T "Q$V  H100 )$4T "!):  <2
M:@ &$GP !1*0  02I  #$;@  Q'/  (1Z !5$@  210  #X5   U%@  +18
M "<6   B%0  'A0  !L4   8$P  %1(# !,2!0 2$0< $!$)  \1"@ -$0L
M#!(.  L2$0 *$A4 "1,;  D3(@ ($RH !Q0S  44/@ $%4H  Q58  (59P !
M%7H  !6.   5HP  %+<  !3/   3Z0!2%   1A8  #L7   R%P  *Q<  "47
M   A%@  '!8  !D5   6% $ %!,$ !(3!@ 1$@@ #Q((  X3"0 ,% H "A4-
M  @6$  &%A, !189  07'P #%R<  A@P  $8.P  &4<  !E5   99   &7<
M !F,   8H@  &+<  !?/   7Z@!/%@  0Q@  #D9   P&0  *1D  ",9   ?
M&   &Q<  !@6   5%0( $Q4% !$4!@ 0% 8 #A4'  P6"  *%PH !QD,  0:
M#@ "&Q(  1L6   ;'0  '"0  !PM   <.   '40  !U2   =8@  '74  !V*
M   <H   '+8  !O0   :ZP!,&   0!H  #8;   M&P  )AL  "$:   =&0
M&1D  !<8   4%P, $A8$ ! 7!  .%P0 #!D%  H:!P '' D  QT+   ?#0
M(!   " 4   A&@  (2(  "$J   A-0  (D$  ")/   B7P  (G(  "&(   A
MGP  (+8  !_1   ?[0!(&@  /1P  #,=   K'0  )!T  " <   <&P  &!H
M !89 0 3&0$ $1D!  X: 0 ,' ( "AT#  <?!0 #(0@  "(*   D#   )@X
M "82   F&   )Q\  "<G   G,@  )SX  "=+   G7   )VX  ":%   FG0
M);0  "31   C[@!$'0  .1\  # ?   H'P  (QX  !X=   ;'   &!L  !0<
M   1'   #AT   T?   *(0  !B(!  ,D!   )@8  "@(   J"P  *PT  "T0
M   M%0  +1P  "TD   N+@  +CH  "Y(   M6   +6H  "V!   LF@  *[(
M "K0   I[P! (   -B$  "TA   F(0  (2   !T?   :'@  %AX  !(?   /
M(0  #2(   HD   &)@   B@    K @  +00  "\&   P"0  ,@P  #0.   U
M$@  -1@  #4@   U*@  -38  #5#   U4P  -&8  #1\   SE@  ,J\  #'-
M   P[P \(P  ,B0  "HD   D(P  ("(  !PA   7(0  $R,  ! E   -)P
M"2D   4K   !+@   #     R    - $  #8$   X!@  .@D  #P-   ^$
M/A0  #X<   ^)@  /C$  #X_   ]3@  /6$  #QW   [D0  .JL  #G)   X
M[0 W)P  +R<  "@F   C)0  'R0  !DE   4)@  $"@   TK   )+@  !3
M   S    -0   #@    Z    /    #X!  !  P  0@<  $0*  !&#0  21$
M $D7  !((0  2"P  $<Z  !'20  1EL  $5Q  !$BP  0Z4  $+#  !!Z  T
M*@  +"H  "<H   B)P  '"@  !8J   1+0  #3    DS   #-@   #D    \
M    /@   $$   !#    1@   $@   !*    3 ,  $X&  !0"@  4PX  %03
M  !4'   4R<  %,T  !30P  4E4  %%J  !0@P  3YX  $VY  !,X  P+0
M*RP  "8K   ?+   &"X  !(R   --0  "#D   (]    0    $,   !&
M20   $P   !.    40   %,   !5    5P   %D!  !<!@  7PH  &(.  !C
M%0  8Q\  &(L  !A/   8$X  %]B  !>>P  7)8  %NP  !9SP O,   *B\
M "(P   :,P  $S<   X[   (/P   40   !(    3    $\   !2    50
M %@   !;    70   &    !B    9    &8   !I    ;04  ' +  !T$
M=!@  ',E  !R-   <D4  '!9  !O<0  ;8L  &NF  !JP  N,P  )34  !TX
M   4/   #D$   ='    3    %$   !5    60   %T   !A    90   &@
M  !K    ;0   &\   !R    =    '<   !Z    ?@   (($  "&"P  BA$
M (D<  "(*P  ACT  (12  "#9P  @8$  '^;  !^L@ I.@  (#T  !9"   /
M2   "$X   !4    6@   &    !D    :0   &X   !R    =@   'H   !]
M    @    ((   "%    B    (L   ".    D@   )8   "; P  H P  *(3
M  "@(0  GS,  )U'  ":7@  F'<  )>/  "5IP C0P  &4@  !%.   )50
M %P   !C    :@   '$   !V    >P   (    "&    B@   (X   "1
MDP   )8   "9    G    *    "C    IP   *L   "P    M@0  +P-  "Z
M%P  N2@  +<\  "T4@  LFH  *^%  "MG  <3@  $U0   M<   !9    &P
M  !T    ?    (,   ")    CP   )0   ":    GP   *(   "D    IP
M *H   "N    L0   +0   "X    O    ,$   #'    S0   -0%  #8$
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M_____________________________________________________P
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M]/7V]_CY^OO\_?[_;69T,0     #!"$   $                    !
M                 0    $" P0%!@<(" D*"PP-#@\0$1(3%!46%Q@9&AH;
M'!T>'R A(B,D)28G*"DJ*RPM+B\P,3$R,S0U-C<X.3H[/#T^/T!!0D-$149'
M2$E*2TQ-3D]045)35%565UA96EM<75Y?8&%B8V1E9F=H:6IK;&UN;W!Q<G-T
M=79W>'EZ>WQ]?G^ @8*#A(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"A
MHJ.DI::GJ*FJJZRMKK"QLK.TM;:WN+FZN[R]OK_ P<+#Q,7&Q\C)RLO,S<[/
MT-'3U-76U]C9VMO<W=[?X.'BX^3EYN?HZ>KK[.WN[_'R\_3U]O?X^?K[_/W^
M_P ! 0(" P,$! 4&!@<'" @)"0H+"PP,#0T.#P\0$!$1$A,3%!05%A87%Q@9
M&1H:&QP<'1X>'R @(2(B(R0D)28F)R@I*2HK+"TM+B\P,3(R,S0U-C<X.3H[
M/#T^/T!"0T1%1DA)2DQ-3U!24U576%I<7F!B9&9H:FUO<71V>7Q^@8.&B8N.
MD)*5EYF;G9^AHZ6GJ*JLK:^PLK.UMK>YNKN\O;_ P<+#Q,7&Q\C)RLO,S<W.
MS]#1TM+3U-76UM?8V=G:V]O<W=W>W]_@X>'BX^/DY>7FYN?HZ.GIZNOK[.SM
M[N[O[_#P\?+R\_/T]/7V]O?W^/CY^?K[^_S\_?W^_O\  0$" @,#! 0%!@8'
M!P@("0D*"PL,# T-#@\/$! 1$1(3$Q04%186%Q<8&1D:&AL<'!T>'A\@("$B
M(B,D)"4F)B<H*2DJ*RPM+2XO,#$R,C,T-38W.#DZ.SP]/C] 0D-$149(24I,
M34]04E-55UA:7%Y@8F1F:&IM;W%T=GE\?H&#AHF+CI"2E9>9FYV?H:.EIZBJ
MK*VOL+*SM;:WN;J[O+V_P,'"P\3%QL?(R<K+S,W-SL_0T=+2T]35UM;7V-G9
MVMO;W-W=WM_?X.'AXN/CY.7EYN;GZ.CIZ>KKZ^SL[>[N[^_P\/'R\O/S]/3U
M]O;W]_CX^?GZ^_O\_/W]_O[_VLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-H
MO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+F
MI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:E
MEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN
M>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2
MYJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+F
MI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN>\2U
MJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2YJ67
MDN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2
MYJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN>\2UJ(C+
MLZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2YJ67DN:E
MEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67
MDN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'
MT;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2YJ67DN:EEY+F
MI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:E
MEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'T;"B
MA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2
MYJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+F
MVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'T;"BA]6M
MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67
MDN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FVLL)
M&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9
MJYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:E
MEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FVLL)&^C-
M#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)
MW*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+F
MI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKI
MS!!@W,@.DLNZ,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<
MB]ZHFHWAIYF/XZ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2
MYJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@
MW,@.DLNZ,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZH
MFHWAIYF/XZ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67
MDN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.
MDLNZ,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWA
MIYF/XZ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:E
MEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ
M,JS&MU"TP+-HO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/
MXZ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+F
MI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&
MMU"TP+-HO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67
MDN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2
MYJ67DN:EEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"T
MP+-HO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:E
MEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67
MDN:EEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-H
MO+NN>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+F
MI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:E
MEY+FI9>2YJ67DN:EEY+FVLL)&^C-#CKIS!!@W,@.DLNZ,JS&MU"TP+-HO+NN
M>\2UJ(C+LZ6'T;"BA]6MGXC9JYV)W*J<B]ZHFHWAIYF/XZ67DN:EEY+FI9>2
MYJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+FI9>2YJ67DN:EEY+F
MI9>2YJ67DN:EEY+FV<L)&^?.#3GHS1!@W,D-DLN[,*O&N$^TP+-GO;NN>\2U
MJ8C+LJ:'T:^CA]6MH(C9JYZ)W*F<BMZGFXS@I9F/XZ&8D.2AF)#DH9B0Y*&8
MD.2AF)#DH9B0Y*&8D.2AF)#DH9B0Y*&8D.2AF)#DH9B0Y*&8D.2AF)#DH9B0
MY*&8D.2AF)#DV<L)&N3.#3GGS@Y@VLH,DLN\+JO%N4VTP+1FO;JN>L6UJ8?+
ML::'T:ZCA]6LH(C9JIZ)W*><BMZEFXO@HIJ-XIZ9C^.>F8_CGIF/XYZ9C^.>
MF8_CGIF/XYZ9C^.>F8_CGIF/XYZ9C^.>F8_CGIF/XYZ9C^.>F8_CGIF/XYZ9
MC^.>F8_CV,L)&N'/##GESPY@V<H,D<N^+*O%N4RUOK1GO;FN>\6TJH?,L*:'
MT:VCA]6KH(C9J)Z(VZ6=B=VCG(K?GYJ+X9N9CN*;F8[BFYF.XIN9CN*;F8[B
MFYF.XIN9CN*;F8[BFYF.XIN9CN*;F8[BFYF.XIN9CN*;F8[BFYF.XIN9CN*;
MF8[BV,L)&MS0"SGCT U@V,L+D<N_*ZO$NDRUO;-GOKBN>\6TJ8?,L*:'T:RC
MA]6IH(?8II^(VZ.=B-V@G(G>G9N*X)B:C>&8FHWAF)J-X9B:C>&8FHWAF)J-
MX9B:C>&8FHWAF)J-X9B:C>&8FHWAF)J-X9B:C>&8FHWAF)J-X9B:C>&8FHWA
MU\P)&MK1"SC>T0Q?ULL+D<O *:S"N4VVO+-HOK>N>\:SJ8?,KZ:'T:JCAM6G
MH8?8I)^'VJ&>A]R>G8C=FIR)WI6;C."5FXS@E9N,X)6;C."5FXS@E9N,X)6;
MC."5FXS@E9N,X)6;C."5FXS@E9N,X)6;C."5FXS@E9N,X)6;C."5FXS@ULP)
M&=G1"SC:TPQ?U,P+D<G *:W N4ZVNK-IO[6N?,:RJ8?,K::&T:FCAM2EH8;7
MHJ"&V9^?AMJ;GH?<EYV(W9.<B]Z3G(O>DYR+WI.<B]Z3G(O>DYR+WI.<B]Z3
MG(O>DYR+WI.<B]Z3G(O>DYR+WI.<B]Z3G(O>DYR+WI.<B]Z3G(O>U<P)&=C2
M"S?8TPM>TLP+D\>_*ZV^N%"WN;)JO[2M?,:PJ8?,JZ:&T*>DA=2CHH76GZ&%
MV)R@A=F8GX;:E)Z'W)"=BMV0G8K=D)V*W9"=BMV0G8K=D)V*W9"=BMV0G8K=
MD)V*W9"=BMV0G8K=D)V*W9"=BMV0G8K=D)V*W9"=BMV0G8K=U,T)&=;2"S?6
MU M>T,L*E<2^+:Z\N%&XM[)JP+.M?,:NJ8?,J::&T*6DA=.@HX35G:*$UIFA
MA=B5H(79D9^'VHZ>B=N.GHG;CIZ)VXZ>B=N.GHG;CIZ)VXZ>B=N.GHG;CIZ)
MVXZ>B=N.GHG;CIZ)VXZ>B=N.GHG;CIZ)VXZ>B=N.GHG;T\T*&-73"S;4U M?
MSLL)E\&^,*^ZMU.XM;)LP+"M?<>LJH;+IZ>%SZ*EA-&>I(33FJ.$U9:BA-:3
MH877CZ"&V(N@B=F+H(G9BZ")V8N@B=F+H(G9BZ")V8N@B=F+H(G9BZ")V8N@
MB=F+H(G9BZ")V8N@B=F+H(G9BZ")V8N@B=F+H(G9TLX*%]/4"S71TPIBR\P)
MF;Z],[&WMU6YLK%MP:VM?<:JJH;+I*B$SI^GA-";I8/2EZ2#TY.CA-20HX75
MC**&UHFAB->)H8C7B:&(UXFAB->)H8C7B:&(UXFAB->)H8C7B:&(UXFAB->)
MH8C7B:&(UXFAB->)H8C7B:&(UXFAB->)H8C7T,\*%M'4"S?.TPIEQLH+G;F\
M.+*TMEBZK;%NP:JN?<:GJX7)H:F$S)RH@\Z7IX//DZ:#T9"EA-*-I873BJ2&
MTX>CB-2'HXC4AZ.(U(>CB-2'HXC4AZ.(U(>CB-2'HXC4AZ.(U(>CB-2'HXC4
MAZ.(U(>CB-2'HXC4AZ.(U(>CB-2'HXC4SM *%<[4"CK*TPIHP,@/H;6[/K2M
MM5N[J;%OP::O?<2CK83'G:N#RIBJ@\N3J8/-D*B$SHVGA,^*IX7/AZ:'T(6F
MB-&%IHC1A::(T86FB-&%IHC1A::(T86FB-&%IHC1A::(T86FB-&%IHC1A::(
MT86FB-&%IHC1A::(T86FB-&%IHC1S- )&,K4"C[%TPIMN,46I:ZY1+6GM5Z[
MH[)PP*&P?<.?KH3%F:V#QY2LA,F0JX3*C:J%RXJJA<N(J8;,A:F'S8.HB<V#
MJ(G-@ZB)S8.HB<V#J(G-@ZB)S8.HB<V#J(G-@ZB)S8.HB<V#J(G-@ZB)S8.H
MB<V#J(G-@ZB)S8.HB<V#J(G-R-$)&\75"D*_TPIRL<0>IZ6Y2;:AMF"[GK-P
MOIVQ?<&;L(3#E:^$Q)&NA,:-K87'BJV&QXBLALB&K(?(A*N)R8*KBLF"JXK)
M@JN*R8*KBLF"JXK)@JN*R8*KBLF"JXK)@JN*R8*KBLF"JXK)@JN*R8*KBLF"
MJXK)@JN*R8*KBLF"JXK)Q-(((,#6"4BXU IXJ<\7F)Z^1ZZ:MF*ZF+5QO)>S
M?+Z7LH3 DK&%PHVPA<.*KX;$B*^'Q(:OB,6$KHG%@ZZ*Q8&NB\6!KHO%@:Z+
MQ8&NB\6!KHO%@:Z+Q8&NB\6!KHO%@:Z+Q8&NB\6!KHO%@:Z+Q8&NB\6!KHO%
M@:Z+Q8&NB\6!KHO%O]0');K7"4ZNV@MPH-L3AY?-.9J2PUBHD;QLLI&W>KF2
MM(.]CK.&OXNRA\"(L8? AK&(P82QB<&#L8K!@K&+PH"PC,* L(S"@+",PH"P
MC,* L(S"@+",PH"PC,* L(S"@+",PH"PC,* L(S"@+",PH"PC,* L(S"@+",
MPH"PC,* L(S"]\ 0%?C %C'YO2!3ZK<H?,RH1*K&I5VTPJ-PNKZB?[^\H(C#
MN9N(QK>8B,JUE8G-LY**T+&/B]*PC(W4KXJ0UJZ(D]BMAIC9K(6=VJR%G=JL
MA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%
MG=JLA9W:]\ 0%?C %C'YO2!3ZK<H?,RH1*K&I5VTPJ-PNKZB?[^\H(C#N9N(
MQK>8B,JUE8G-LY**T+&/B]*PC(W4KXJ0UJZ(D]BMAIC9K(6=VJR%G=JLA9W:
MK(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JL
MA9W:]\ 0%?C %C'YO2!3ZK<H?,RH1*K&I5VTPJ-PNKZB?[^\H(C#N9N(QK>8
MB,JUE8G-LY**T+&/B]*PC(W4KXJ0UJZ(D]BMAIC9K(6=VJR%G=JLA9W:K(6=
MVJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:
M]\ 0%?C %C'YO2!3ZK<H?,RH1*K&I5VTPJ-PNKZB?[^\H(C#N9N(QK>8B,JU
ME8G-LY**T+&/B]*PC(W4KXJ0UJZ(D]BMAIC9K(6=VJR%G=JLA9W:K(6=VJR%
MG=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:]\ 0
M%?C %C'YO2!3ZK<H?,RH1*K&I5VTPJ-PNKZB?[^\H(C#N9N(QK>8B,JUE8G-
MLY**T+&/B]*PC(W4KXJ0UJZ(D]BMAIC9K(6=VJR%G=JLA9W:K(6=VJR%G=JL
MA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:]\ 0%?C
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MA*6*TH&EC=* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]*
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MF[%_P9FPA,*4KX3#D*^%Q(VNA<6*KH;&B*V&QH>MA\:%K8C'@ZV)QX&MB\>
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M<;^+K7&_BZUQOXNM<;^+K7&_BZUQOXNM<;^+K7&_BZUQOXNMS\8' M#-"1+
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MEU]^W)-ND\^2>*7&DH*TQ)*)ML.1CKC!CI"ZP(J2O+^'E+V^A):_OH*9P+V
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MR)"*J\B0BJO(D(JKR)"*J\B0BJO(_ZX6!/^O(1;_K2\O_Z@\2_>B26CHI$J
MV:1-ELNB6*O&I&&SQ*=JM\"I=+R\J7["N*B'R+.FA\^LHH?7I)V)W9J:C>&5
MFIO>D96?V(^3HM..D*70CH^HS(V.JLF-CJK)C8ZJR8V.JLF-CJK)C8ZJR8V.
MJLF-CJK)C8ZJR8V.JLF-CJK)_Z\6!/^O(1;_K2XO_ZD\2_>C26GHIDA_VJ=(
ME<RE4ZK'J%RRQ*QDML&N;KN]KWC MJR$R:ZGA]"FHX;5G:"&V9.=B=V-G93=
MC9V?V(N9H=2+EJ30BI.GS8J1J<F*D:G)BI&IR8J1J<F*D:G)BI&IR8J1J<F*
MD:G)BI&IR8J1J<F*D:G)_Z\5!/^P(!;_KBXO_ZD[2_>D1VGIJ$1^VZM#E,VI
M3*G(K52PQK-<L\*W9KFWL'?"L*N$R:FGAL^AI(33EZ*$UHZ@A]F(GX_:AZ&:
MV(>@H=2'FZ31AYBFSH>5J<J'E:G*AY6IRH>5J<J'E:G*AY6IRH>5J<J'E:G*
MAY6IRH>5J<J'E:G*_[ 5!/^P(!7_KBTO_ZHZ2_BF1&CJJT!]W*\\DL^O0J;*
MM4FMQKQ2L;FU9[NPL'C#JZR$R:2IA,V<IH/0DZ2$TXNCAM6%HHS6@J*4UH.D
MG=2#HJ31@YZFSH2:J,N$FJC+A)JHRX2:J,N$FJC+A)JHRX2:J,N$FJC+A)JH
MRX2:J,N$FJC+_[ 4!/^Q'Q7_KRPN_ZLY2_BI0&?KKSM[WK8SC]*Z-*',PCFJ
MN[I5M;"T:KVJL'G#IZV$QY^JA,N8J(/-D*>$T(FEAM*$I(K3@*20TW^EE])_
MIJ#0?Z6FSH"@J,N H*C+@*"HRX"@J,N H*C+@*"HRX"@J,N H*C+@*"HRX"@
MJ,N H*C+_[$3!/^R'A7_L"LN_ZPW3/JL.V7MM31XXK\IB=C,()B^OSVNL+A9
MN*FS;+ZEL'K"HJZ$Q9NL@\B4JH3*CJF$S(BHALZ#IXG/@*>-SWZGD\]\J)K.
M?*FBS7RGJ,M\IZC+?*>HRWRGJ,M\IZC+?*>HRWRGJ,M\IZC+?*>HRWRGJ,M\
MIZC+_[(2!/^S'17_L2DN_ZTV3/RQ-6+QO2IRYLT?@,C,(9NQO$6RJ+=>N:.S
M;[Z@L7O!GJ^$PY>NA,:1K(3'C*N%R8>JA\J#JHG+@*J,S'VID,Q\JI7+>JJ<
MRGFKI,IYJZ3*>:NDRGFKI,IYJZ3*>:NDRGFKI,IYJZ3*>:NDRGFKI,IYJZ3*
M_[,1!/^T&Q3_LR8N_Z\S3/VY*UWKRA]ITM\1?[G,)YRGO4RQH+=BN9VT<;V;
MLGR_FK&$P92PA,./KX7%BJZ&QH:MA\>#K(G'@*R+R'ZLCLA\K)+(>ZR7R'FM
MGL=YK9['>:V>QWFMGL=YK9['>:V>QWFMGL=YK9['>:V>QWFMGL=YK9['_[40
M _^V&13_M20M_[0L2?+%'U36W1)BP=\3@:S-+IJ?P$^KFKAEMY>U<KN6M'R]
ME;*#OY&QA<&-L8;"B;"'PX:OB,.#KXG$@:^+Q'^NC<5]KI#%>ZZ4Q7JOF<1Z
MKYG$>J^9Q'JOF<1ZKYG$>J^9Q'JOF<1ZKYG$>J^9Q'JOF<1ZKYG$_[<. _^X
M%A/_MR M^;\?0=S9$43$ZQ)FL=\8@:#0,Y67QE"CD\!CK9&[<;.1N'NXD+:"
MNXZTA;V+LX:_B+*'P(:RB<"$L8K!@K&+P8"QC<%^L8_"?+&2PGNQE<%[L97!
M>[&5P7NQE<%[L97!>[&5P7NQE<%[L97!>[&5P7NQE<%[L97!]+H+ _V[$A+^
MNQLLY= /,LCI#TJT\A5GHN(B?9;6-XV/SD^8C,AAH(K$;J:*P7BJA[]]K82^
M@+"!O(*Q?[N$LWV[A;1[NH>U>KF)M7FYB[9WN8VV=KB/MW2XD[=TN).W=+B3
MMW2XD[=TN).W=+B3MW2XD[=TN).W=+B3MW2XD[=TN).WW+X& OC #A'NR XB
MR]L++K;X$4RE]1UCE^@L=8W?/8&'V%"+@]-@DH+/;)=_S7.;?,MWG7G)>J!W
MR'VA=<=_HW/&@J1RQ82E<,6&I6_$B*9NQ(JG;<.-IVO#D*AKPY"H:\.0J&O#
MD*AKPY"H:\.0J&O#D*AKPY"H:\.0J&O#D*AKPY"HU\ & =O&" [+TPH5N.@,
M,J;_%4J8^B9<C? W:87I1G1_Y%-[?-]@@7C<:(5TVFV)<-AQBV[6=8ULU7B/
M:M1[D&G3?I%GTX"29M*#DV72A91DT8>48]"*E6+0CI9BT(Z68M".EF+0CI9B
MT(Z68M".EF+0CI9BT(Z68M".EF+0CI9BT(Z6T<(& <W+"06ZV@<9J/X.,9G_
M'4.._R]1A?H_7'[T361Y\%AJ<^Q?;VWJ8W-IYVEV9^5N>67D<GMCXW9]8N)Y
M?F#A?']?X'Z 7M^!@5W?@X)<WH:#6]V)A%K=C85:W8V%6MV-A5K=C85:W8V%
M6MV-A5K=C85:W8V%6MV-A5K=C85:W8V%R\0& +O1!@>IYP8:FO\3*X[_)#F%
M_S9$?O]$37G_455Q^U=;:_==8&7T8F1B\FAG7_!M:EWO<6Q;[75M6NUX;UGL
M>W!8ZWYQ5^J!<E;JA')5Z8=S5.F*=%/HCG53Z(YU4^B.=5/HCG53Z(YU4^B.
M=5/HCG53Z(YU4^B.=5/HCG53Z(YUO,D% *O; 0B:_PL6C_\9(X7_*RU^_SDW
M>/]&0'#_3D=I_U1-8O]:4E[^859:_&996/MK6U7Y<%U4^'1>4O=X7U'W>V!0
M]GYA3_6!8D_UA&-.](=D3?2+94SSD&9,\Y!F3/.09DSSD&9,\Y!F3/.09DSS
MD&9,\Y!F3/.09DSSD&9,\Y!F_Z 8 _^B+!#_H#LE_YQ)//^75U/XDF1G[)!L
M>>*/=8G9CGZ7T8V'HLR,C:K'BI&QQ(B4ML.%EKC"@YFYPH&;N<%_GKK!?:&[
MP7NDN\!ZI[O >:J\P'BNO,!WM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\
M>+2[O'BTN[QXM+N\>+2[_Z 8 _^B+!#_H#LE_YQ)//^75U/XDF1G[)!L>>*/
M=8G9CGZ7T8V'HLR,C:K'BI&QQ(B4ML.%EKC"@YFYPH&;N<%_GKK!?:&[P7ND
MN\!ZI[O >:J\P'BNO,!WM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[
MO'BTN[QXM+N\>+2[_Z 8 _^B+!#_H#LE_YQ)//^75U/XDF1G[)!L>>*/=8G9
MCGZ7T8V'HLR,C:K'BI&QQ(B4ML.%EKC"@YFYPH&;N<%_GKK!?:&[P7NDN\!Z
MI[O >:J\P'BNO,!WM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BT
MN[QXM+N\>+2[_Z 8 _^B+!#_H#LE_YQ)//^75U/XDF1G[)!L>>*/=8G9CGZ7
MT8V'HLR,C:K'BI&QQ(B4ML.%EKC"@YFYPH&;N<%_GKK!?:&[P7NDN\!ZI[O
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MIU1]X:98BMJD8I;2H6NARYUUJ\::@+/"F(JZO(Z/PK:#F<NL?:;.HG^JR9V
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MB+6Y_YL1 ?^@)@K_GS8<_YQ$,?^C0S__J$-._ZU$6_BQ16CPMDATZ;M,?N/
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M>IFVMWV6M[9^D[FT?Y&ZLH"0N[& D+NQ@)"[L8"0N[& D+NQ@)"[L8"0N[&
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M_Z@G"O^U(@SQQ" ,X-4D"='A,!3'YCTDO>-&-++@3D2FW%92F===88S28V^
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M+?^/4SC_C5I#_XEB3?^#:5?]?')@^'9_9_1QBF[P;)5T[6B?>>IDJGWH8;>
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MA6.=VX5CG=N%8YW;A6.=VX5CG=N%_WX0 ?^'$0'_FA$ _ZT4 -J^"@#1S0H
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MERDH_Z(J)_^M*R;_N2PF_\DM)O_)+2;_R2TF_\DM)O_)+2;_R2TF_\DMJK<
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MQD0W_^I%-OS]13OR_T0^ZO]$/N;_1C[F_T8^YO]&/N;_1C[F_T8^YO]&T)\
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M'1S_RAX<_^8?&__P'QO_\!\;__ ?&__P'QO_\!\;__ ?I+4  )7"  "&SP
M=]X  &OT  !B_P, 6?\+ 5'_$0%*_Q<"1/\? S__)@0Z_RT%-O\T!C+_.@<N
M_T (*_]&""C_3 DE_U()(O]9"B#_8@L=_VL,&O]V#1?_A X5_Y(/%/^@$!/_
MK1$3_[H1$__#$A/_PQ(3_\,2$__#$A/_PQ(3_\,2E[X  (;,  !WVP  :><
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MW%-'R/=52,#\6$JX^UE,LOM:3JWZ6DZM^EI.K?I:3JWZ6DZM^EI.K?I:_W\
M -R3  #*H@  O*P! +&U  "HP , G\L& );9"P"1X!L!BM\L!H+?.0YYWD,7
M<=U-(&K<5BACVU\O7=IG-5C9<3I3V7L^3]F(0DO9ED5(V:9'1MJZ2$7;VT=$
MV/1)0M/_343)_T]%PO]01[O_4D>[_U)'N_]21[O_4D>[_U)'N_]2YHH  ,^;
M  "_IP  LK   *>[  "<Q@, D]$& (OJ#@"%Z!\"?N@M!G;H. YNZ$$69N=*
M'5_G4B-9YULI5>=D+5#G;3%,YW@U2>>$.$;HD3I#Z* \0.FR/C_JRSX^Z.\^
M/>;_/SW@_T(_U_]$0,[_1D#._T9 SO]&0,[_1D#._T9 SO]&UI,  ,2C  "T
MK   I[8  )O!  "0S ( AMD& (#R$@!Y\A\"<?(K!FKR-@QC\S\27?-'&%?S
M3QU2\U<A3?1@)$GT:2A&]',J0O5^+3_UBR\\]IDQ.O:I,SCWOC0V^.$U-O7Y
M-37S_S0W[/\V.>7_.#GE_S@YY?\X.>7_.#GE_S@YY?\XR)X  +:I  "HL@
MF[T  (_(  "#U   >>@' '/\$@%K_1T"9/TG!%[^,0A8_CL-4_]#$4W_2Q5)
M_U,81?]:&D'_8QT^_VP?._]V(3?_@B,T_Y E,O^?)S#_L"@N_\@I+?_J*BS_
M_RHL__\J+_G_*B_Y_RHO^?\J+_G_*B_Y_RHO^?\JN:8  *JN  "<N0  CL4
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M"0W_TPD-_],)#?_3"0W_TPD-_],)D;P  (')  !RUP  9.0  %3K  !+_P
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M6(AK_%B(:_Q8B&O\6(AK_%B(:_Q8_U0: ?]B$P'_;Q !_WL2 /^%% #ZC1D
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M246Y_TI'L_]+2:W_3$JK_TQ*J_],2JO_3$JK_TQ*J_],Z7\  -&0  #"G@
MM:<  *JO  "@N   EL$" (S+!P"$U0T @-4> 7G5+@5RU#P,;--'%&724!M?
MT5DA6M%B)U70:RQ1T'4P3<^!-$G/CC=&SYTY1-"N.T+0QCM#T.HZ0,W]/C[+
M_T! P_]"0;W_0T*Y_T1"N?]$0KG_1$*Y_T1"N?]$W8@  ,>8  "XHP  JZL
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M'"KW_QTJ]_\=*O?_'2KW_QTJ]_\=LZ,  *2K  "7M@  B<$  'O+  !OU@
M8]\  %OU!@!5_Q  4/\9 4O_(P)&_RP#0O\T!#[_/ 4Z_T,&-_]+!S3_4P@Q
M_UL)+O]D"BO_;PPH_WP-)O^+#B3_G! B_ZX1(?_%$B#_Z1,?__P3'O__$Q[_
M_Q,>__\3'O__$Q[__Q,>__\3IJD  )BS  "*OP  >\H  &[5  !@WP  5.<
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M3E64_TU8D/],68W_2UN*_TI;BO]*6XK_2EN*_TI;BO]*_V@  .5Y  #1AP
MQ9(  +N<  "QH@  J:D  *&Q @";LQ4 E;,H HZR-@F&L$(2?ZY,&WBL5"-R
MJEPJ;*AD,6>G;#9BI74[7:1_0%FCBD-5HI='4:&G24^ANDI.HME)3J#U24Z?
M_TE0F?])4I;_2%22_T=4DO]'5)+_1U22_T=4DO]'_VX  -Y_  #*C0  OI@
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M-CVX_S<]N/\W/;C_-SVX_S<]N/\WT88  ,"5  "RGP  I:<  )JO  ".MP
M@[\  'C' P!NSP< 9=<- &/8'0!@V"T"6]@Z!%?81@E3V% -3]A9$4O78A5'
MUVP81-=W&T'7A!X^V),@/-BC(3O9MR(ZVM4B.M;R(S?4_R<VTO\I--'_*S;*
M_RTVRO\M-LK_+3;*_RTVRO\MQ9   +:=  "HI0  G*T  (^V  "#O@  =\<
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M"1G__PD9__\)HJ<  ).Q  "%NP  =L8  &G0  !;V@  3N   $/E   ^^P$
M.O\, #;_$P R_QL +_\C "O_*@$H_S$!)/\W 2'_/P(?_T8"'/]. AG_6 ,6
M_V,#$_]P Q+_@001_Y,$$/^G! __O04._^ %#O_V!0[__P4.__\%#O__!0[_
M_P4.__\%E:\  (:Z  !WQ0  :-   %K;  !,X0  0.<  #?S   R_P  +O\'
M "K_#@ F_Q, (_\: !__(  ;_R8 &/\K 17_,@$2_S@!$/]  0[_2 $,_U(!
M"?]= @;_:P($_WT" O^0 @'_HP( _[8" /_- P#_[ , _^P# /_L P#_[ ,
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M1V5[_T1F>O]#9WC_06AV_S]H=O\_:';_/VAV_S]H=O\__UL$ /=I  #==@
MS8   ,.(  "[C@  M),! *V7"0"GF!H H)@L YF6.@J2E$42C))/&H:/5R*
MC5\H>XMG+G:);S-RAW<X;86!/&F$BT!F@I=#8H&E1F"!MD=>@<U'7H'O1E^!
M_T1@?_]"87W_06)[_S]C>O\_8WK_/V-Z_S]C>O\__UX  .EM  #6>0  R(0
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M/$^1_SM0C_\[4(__.U"/_SM0C_\[ZVT  --\  ##B0  MY,  *R:  "BGP
MF:4  (ZK  "%L L @;$; 'RQ*P)WL#@'<:]##6NN311FK5498:Q='EVK92-9
MJFXG5:EW*U&H@B]-IX\R2J>>-4BGKS9'I\8V1J;I-D6D_C=%H_\W1J#_-TB<
M_S=)FO\W29K_-TF:_S=)FO\WXG0  ,J#  "\CP  L)@  *6>  ";I   D*L
M (6Q  !ZN 0 =KD4 '*Y)0%MN3,$:+@_"&.X20Y>MU(36K9:&%:V8AQ2M6L@
M3K1U)$NT@"=(LXXJ1;.=+$*SKBU!L\4N0;/I+4"P_B\_K_\Q/JW_,D"H_S)!
MIO\R0:;_,D&F_S)!IO\RU7P  ,**  "UE@  J)T  )VC  "2J@  A[$  'RW
M  !PO@, :,(. &;#'0!CPRT!7L,Y!%K#1 A6PDX,4L)7$$_!7Q1+P6D72,%S
M&D7 ?AU"P(P@/\";(CW K2,\P<0C/,#I(SJ^_B8XO/\H-[O_*3BX_RHXMO\K
M.+;_*SBV_RLXMO\KR84  +F3  "LG   H*(  )2J  "(L0  ?+@  '&^  !F
MQ0, 6\L( %?-$P!6SB, 4\XR 5#./@--ST@%2<]2"$;/6PM#SV4.0,]O$#[/
M>Q,[SXD5.<^9%S?/JQ@VT,,8-L_H&#3-^QLRR_\=,<K_'S#)_R$OR/\A+\C_
M(2_(_R$OR/\AOH\  *^:  "BH0  EJD  (JP  !]N   <;\  &;&  !;S (
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M=P$+_XH""O^? @G_M0((_]4"!__T @?__P('__\"!___ @?__P('__\"D:T
M (*X  !SP@  9,P  %;5  !(W0  .^(  ##G   G[@  (_\  "#_!  <_PP
M&?\1 !;_%@ 3_QL $?\A  [_)P -_RX "O\V  ?_/@ $_T@  /]4  #_8@$
M_W,! /^' 0#_G0$ _[(! /_* 0#_Z@$ __,! /_S 0#_\P$ __,!A+<  '3!
M  !ES   5M@  $??   YY0  +>H  "/N   <_0  &/\  !7_   1_P0 #_\+
M  W_#@ )_Q$ !O\5  /_&@  _R   /\F  #_+@  _S<  /]!  #_30  _UP
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MXSJM%>(ZMA;@.\(6WSO2%MH[Z!?4.O8:T#K_',TZ_Q[+.O\>RCK_'\0[_Q_
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M.W-G_SAS:/\V<VC_-7-G_S-S9O\R<V;_,G-F_S)S9O\R_U$$ /]<  #B9P
MTG   ,=V  # >@  NGT" +1_# "M@1T IX$N J!_/ B:?4</E7I1%I!X6AR+
M=F(AAW1I)H-R<2M_<7HO?&^#,GANC35U;9@X<FRE.W!KM#QN:\D\;6OI.VUL
M_CEM;/\W;FS_-6YK_S1N:O\R;FK_,FYJ_S)N:O\R_U,  /1?  #>:@  S7,
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M-5YY_S1?=_\S7W?_,U]W_S-?=_\S_EP  .%J  #-=0  P'X  +:&  "NBP
MI8X  )N1  "5DQ$ D)0B 8N3,0.%DCT)?Y%(#WJ/419UC5D;<8Q@(&R*:"5H
MB7 I9(=Y+6&&@S%=A8\T6H2<-E>#K#A5@[\Y58/A.%6"^3=6@O\U5H'_-%A_
M_S-9??\R67W_,EE]_S)9??\R[V   -MN  #'>@  NX,  +*+  "HD   GY,
M )26  "-F0X B9H> (2:+@)^F3H'>9=%#7263A-OE588:I->'6:292%BD6TF
M7H]V*EN.@2U7C8TP5(R:,U&,JC5/C+TU3XS>-4^+]S1/BO\S4(G_,E&&_S%2
MA/\Q4H3_,5*$_S%2A/\QZF4  -)S  #"?P  MH@  *R0  "BE   F)@  (R<
M  "$GPH @* 9 'RA*0%WH#8%<I]!"FV>2P]HG5,49)Q;&6";8QU<FFLA6)ET
M)568?BE1EXHL3I:8+DN6J#!*EKPQ29;<,$F4]C!)D_\P29+_,$J0_R]+C?\O
M2XW_+TN-_R]+C?\OXFL  ,IY  "\A0  L8\  *:4  ";F0  D9T  (:B  !Z
MI@, =J<3 '.H) !NJ#(#:J@]!F6G1PMAIE /7:58%%FD8!A5HV@<4J-Q'TZB
M?"-+H8@F2*&6*$6@IBI$H;HK0Z':*D.?]2M"G?\K0IS_+$*;_RQ$E_\K1)?_
M*T27_RM$E_\KUW(  ,.   "VC   JI0  )^9  "4G@  B:,  'ZH  !PK@
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MG04HV;$&)]K-!B?7[P8FU/\))=+_"R31_PPCT/\-(]#_#2/0_PTCT/\-KI8
M *"=  "4I   AJP  'FT  !LNP  8,(  %3&  !(RP  /M   #75!  MW0H
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M  #_K0  _\H  /_P  #__P  __\  /__  #__P  __\ C:L  'VU  !NOP
M8,@  %+0  !#UP  -]T  "OB   BY@  &>H  !7Y   2_P  $/\(  [_#@ ,
M_Q$ "?\6  ;_'  #_R(  /\J  #_,P  _ST  /])  #_5P  _VD  /]^  #_
ME0  _ZP  /_'  #_Z   __H  /_Z  #_^@  __H @+4  '"_  !AR0  4M,
M $/;   UX0  *>8  ![J   5[@  $/@   [_   +_P  "/\   3_!@  _PH
M /\.  #_$0  _Q4  /\;  #_(P  _RL  /\V  #_0P  _U,  /]E  #_>@
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M*X15_"J#5O\H@U;_)X)6_R6!5O\D@5;_)(%6_R2!5O\D_T<# /]/  #G6
MV6   ,UD  #&9@$ P68$ +MF#@"T:2  KFDQ JAH/P6C9DH*GV54#YIC7127
M8648DV!M')!>=1^.77TBBUR&)8A;D"B%6IHJ@UFF+(!9M"U_6<<N?5GF+7Q:
M^BQ[6O\J>UO_*'M;_R=[6O\F>EK_)7I:_R5Z6O\E_TD  /M2  #C7   TF,
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M*FIG_REJ9O\H:F;_)VIF_R=J9O\G_U   .=;  #39@  Q6X  +MS  "S=P
MJWD  *1X P"=>A0 F'LE 9-[- ..>D 'B7A*#81V4Q* =5L7?'-B&WAR:A]U
M<7(B<F][)F]NA2EL;9 L:6R<+F9LJC!D;+PQ8VS9,&-L]"]C;/\M9&S_*V1K
M_REE:O\H96K_*&5J_RAE:O\H_5,  .-?  #.:0  P7$  +=W  "O>P  IWT
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M)U1Z_R=4>O\GZ%X  -!K  # =@  M'X  *N%  "AB0  EXL  (F-  "#CP@
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MG1<ZIJ\8.:;'&#FEZA@XH_\:-Z'_&S>@_QPWG_\<-Y__'#>?_QPWG_\<Q'@
M +6%  "ICP  G94  )*:  "&GP  >J,  &ZH  !BK   5;   %"R#@!.LAL
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M B#/Y (?S?H#'LO_!![*_P4=R?\&'<G_!AW)_P8=R?\&J)0  )R:  "0H0
M@J@  '2O  !GM@  6[P  $[   !#PP  .<<  "_,   GT 0 ']8* !O:$  ;
MVQH &MLF !K<,0 9W3P &-U( !C>50 7WV( %N!R !7@A0 4X9H $^*Q !+C
MSP 2X/0 $M[_ 1'=_P$1V_\"$=O_ A';_P(1V_\"GIH  )*A  "$J0  =K$
M &BX  !;OP  3L0  $+(   WS   +=   "35   <VP  %=\% !3I#@ 2ZA0
M$>L= !#K)@ .[#  #NTZ  WN1@ +[E, "N]B  GP=  (\8D !_*@  7RN@ $
M\>0  O']  +O_P #[?\  ^W_  /M_P #[?\ E:$  (:I  !XL@  :;H  %O"
M  !-R   0,P  #31   JU@  (=L  !G@   2Y   #_ !  WY"@ +^@\ "?L5
M  ?['  $_"0  ?PL  #\-P  _$(  /Q0  #\80  _74  /R,  #\I   _,$
M /SK  #\_P  _?\  /W_  #]_P  _?\ B:D  'FR  !JNP  7,0  $[,   _
MT0  ,M<  "?=   =X0  %>4   [H   *\0  "/T   7_ P !_PD  /\.  #_
M$@  _Q<  /\?  #_)P  _S$  /\^  #_30  _U\  /]U  #_C0  _Z8  /_"
M  #_YP  __P  /__  #__P  __\ ?+,  &R\  !=Q@  3L\  #_6   QW0
M)>(  !KF   1Z@  #.X   7R    _P   /\   #_    _P   /\%  #_"@
M_PX  /\2  #_&   _R$  /\K  #_.0  _TH  /]=  #_<P  _XP  /^D  #_
MN0  _]0  /_>  #_W@  _]X _Q@L /\9*0#_&2@ _Q4K /\0, #_"S@!_P-$
M ?\ 40'_ %X!_P!L ?\ > '_ ((!_P", ?\ E '_ )P _P"B /\ J #_ *\
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M%YQ!_!>:0?\7F$'_%YA!_Q:70?\5ET'_%9=!_Q670?\5_SL& /\_  #Y1@
MY4L  -Q.  #3300 T4H) ,I*% #"32< O$XW ;=.10*R35 %KTQ:"*M+8PJH
M2FP-IDET#Z1)?!&A2(03GT>,%9U'E1>;1I\8F4:J&9=&N!J61LH;DT;F&Y%'
M^1N/1_\:CD?_&8Y'_QB-1_\8C4?_%XU'_Q>-1_\7_SX" /]#  #K2P  W5$
M -%4  #*5 $ QE(% ,%1$0"Y4R( LU4S :Y400*J5$P%IE-6"*)17PR?4&</
MG4]O$9I.=Q283G\6EDV(&)-,D1F13)L;CTNF'8U+LQZ+2\4>B4OB'H=,]QZ&
M3/\=A4S_'(5-_QJ%3/\9A4S_&85,_QF%3/\9_T   /Q'  #E4   U58  ,I9
M  #"6@  O5@# +A7#@"Q61X K%HO :=:/0*B64D%GEA3"9M76PR75F00E55K
M$I)4<Q6/4WL7C5*$&HM1C1R(49<>AE"C'X10L"""4,$A@%#=(7Y1]"!]4?\?
M?5'_'7U1_QQ]4?\;?5'_&GU1_QI]4?\:_T(  /!*  #?5   SEH  ,1>  "\
M7P  MEX  +%<"P"K7AH I6 K *!@.@*<7T4%EUY0"91<6 R06V 0C5IH$XM9
M<!:(6'<8A5> &X-6B1V 5I0??E6?(7M5K2)Y5+TC>%77(W=5\B)V5O\@=E;_
M'W96_QUV5O\<=E;_&W96_QMV5O\;_T4  .Q.  #:6   R5X  +]B  "W9
ML6,  *MA" "D8Q< GV0H )IE-P*69$,%D6--"(YA50R*8%T0AU]E$X1>;!:!
M7709?EQ]''Q;AAYY6I$@=UJ=(G19JB1R6;HE<5G2)7!:\"-O6O\B;UK_('!:
M_QYP6O\=<%K_''!:_QQP6O\<_T@  .=2  #36P  Q6(  +MF  "S:   K&@
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M'F!F_QY@9O\>[T\  -I<  #&90  NFT  +!R  "G=0  G70  )1S  "-= T
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MFQY)@:P?2(#!($> XQ]'?_H>2'[_'DA]_QU)?/\<27S_'$E\_QQ)?/\<UF$
M ,)N  "T>   JH   )^%  "4AP  B(<  'N)  !PC   :XX- &B/&@!FCRD
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M$#2@W0\TG?<0,YS_$C.:_Q(SF?\3,YG_$S.9_Q,SF?\3O7<  *^#  "CBP
MF)$  (V5  "!F0  <YP  &>?  !;H@  3Z8  $>I" !$JA( 0ZH? $&K*P!
MJS< /ZQ! #VL2@$[K%,".:Q< S>L9P0UK',%,JR!!C"LD0<NK*,(+:RX"2RL
MV0@LJO4**ZC_"RJF_PPJI?\-*J7_#2JE_PTJI?\-M8   *B+  "<D0  D98
M (6<  !XH   :Z4  %^H  !3K   2*\  #VR   VM0L -+45 #.V(0 RMBP
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M  O4_P +TO\ "]+_ 0O2_P$+TO\!FI@  (Z?  " I@  <JT  &2T  !7N@
M2;\  #W"   RQ@  *,D  !_-   7T0  $=8   S;!0 (W@L !M\1  7?&@ $
MX"0  N$N  'B.@  XT<  .16  #D9P  Y7L  .:2  #FJ@  Y\@  .?P  #H
M_P  Z/\  .C_  #H_P  Z/\ D9\  (*G  !TKP  9;<  %>^  !)PP  /,<
M ##+   ESP  '-0  !39   .W0  ">$   +E    Z08  .D-  #I$0  ZA@
M .LA  #M*P  [S<  /%%  #R5@  \V@  /-^  #TEP  ];   /;0  #W\P
M]_\  /?_  #W_P  ]_\ A:<  ':P  !FN   6,$  $K(   [S   +M$  "/6
M   9W   $>    SC   $YP   .H   #U    ]    /4%  #U"P  ]@\  /84
M  #X'0  ^B<  /PT  #_0P  _U4  /]I  #_@0  _YH  /^R  #_SP  _^T
M /_Y  #_^0  __D >+   &BZ  !9PP  2\L  #O1   MV   (=T  !;B   .
MY@  ".H   #M    \    /@   #_    _P   /\   #_    _P8  /\,  #_
M$   _Q@  /\B  #_,   _T   /]3  #_:0  _X$  /^9  #_KP  _\,  /_5
M  #_U0  _]4 _Q,H /\3)0#_$24 _PTG /\&+0#_ #4 _P!! /\ 3P#_ %P
M_P!I /\ = #_ 'X _P"( /\ D #_ )< _P"= /\ I #_ *H _P"P /\ MP#_
M ,  _P#, /\ WP#_ .P _P#X /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _Q8E /\6(@#_%"$ _Q C /\** #_ #  _P ] /\ 2P#_ %@ _P!D
M /\ < #_ 'H _P"$ /\ C #_ ), _P": /\ H #_ *8 _P"M /\ M #_ +P
M_@#( /T V0#[ .D ^@#V /D _P#X /\ ^ #_ /@ _P#X /\ ^0#_ /D _P#Y
M /\ _QHB /\:'@#_&!T _Q,> /\.(@#_"BP _P<Y /\#1@#_ %, _P!@ /\
M:P#_ '8 _P!_ /\ B #_ (\ _P"6 /\ G0#_ *, _@"I /P L #Z +D ]P#$
M /4 T@#S .8 \@#T /$ _P#P /\ [P#_ .\ _P#O /\ \ #_ /  _P#P /\
M_QX= /\>&0#_'!< _Q<8 /\3'@#_$2@ _PXT /\,00#_"DX _PA; /\'9@#_
M!G$ _P9Z /\&@P#^!HL _ :2 /H&F0#X!I\ ]@:F /0&K0#R!K4 \ 7  .T%
MS@#K!>0 Z0;S .8(_P#E"O\ Y O_ .0+_P'D"_\!Y O_ >0+_P'D"_\!_R$8
M /\A$P#_(!$ _QL2 /\<&@#_&B0 _Q8O /\3/ #_$4D _Q!5 /P.80#Y#FL
M]@YU /0.?@#R#H8 \ Z. .X.E0#M#IL ZPZB .H.J@#H#K, Y@^] .4/S #A
M#^, W1#S -D1_P'6$O\!U!/_ =,3_P+2$_\"TA/_ M(3_P+2$_\"_R43 /\E
M$ #_) T _R,. /\C% #_(AX _Q\I /\<-0#Y&4, ]!A/ .\76P#L%V8 Z1=P
M .87>0#D%X$ XA>) . 7D0#?%Y@ W1>? -L7IP#9&+$ UAB[ -09R@#0&N$!
MS!OS <D<_P+&'/\"Q!S_ \,<_P/#'/\#PQS_ \,<_P/#'/\#_R@0 /\I"P#_
M* 8 _RL+ /\K$ #_*1< _28B /0C+@#L(3L YB!) .(@50#>(&  VB%J -8A
M= #3(7P!T"&$ <\BC '-(I,!RR*; <DBHP'((ZP"QB.V L0CQ +")-L"OB7N
M [LE_@2X)?\%MB7_!;4E_P:U)?\&M27_!;4E_P6U)?\%_RP- /\M!0#_+@$
M_S$% /\Q"P#]+Q  \2L8 .<I)0#?*#, V"A" -$J3P#-*UH R2ME <<K;@'$
M+'8"PBQ^ L LA@.^+(X#O2R6 [LLG@2Y+*<$N"RQ!;8LOP6U+=$%L2WJ!JXN
M^P>K+O\(J2[_"*@N_PBH+?\(J"W_"*@M_PBH+?\(_R\( /\Q  #_-0  ]C<
M .HV @#G,P@ Y"\/ -DN&P#/,2P R3,\ ,0T20# -54!O#5? KHU: *W-7 #
MM31X!+,T@ 6Q-(@&L#20!JXTF0>L-*((JS2L":DTN0FG-,H*I37E"J$U^ N?
M-?\,G37_#)TU_PN<-?\+G#7_"YPU_PN<-?\+_S," /\U  #V.@  Y3X  -Q
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M$8A"_Q"'0O\0AT+_#X="_P^'0O\/_S@  /,]  #C1P  TDP  ,A.  # 30
MNTH" +9'#@"P21T JTLM *9,.P&B3$<"GDM1!)M+6@:92F((EDEJ"I1)<0R2
M2'D.CTB"#XU'BQ&+1Y42B4:@%(=&K!6%1KL6A$;1%H)'[A: 1_\5?T?_%']'
M_Q)_1_\1?T?_$7]'_Q%_1_\1_SL  .Y#  #<3   S%$  ,%4  "Y5   M%$
M *Y-"P"H3QD HU$I )Y2-P&:4D,"EU%.!)115@:14%X)CD]F"XQ.;0V)3G4/
MATU^$85-AQ."3)$5@$R<%GY+J1=\2[@8>TO-&'E,ZQAX3/X7=TS_%7=,_Q1W
M3/\3=TS_$G=,_Q)W3/\2_SX  .A'  #54   QE8  +Q8  "T60  K58  *=3
M!P"A5!4 G%8E )A7- &45T "D%=*!(U64P:*55L)AU1C"X14:@Z"4W(0@%)Z
M$GU2@Q1[48X6>%"9&'90IAET4+4:<U#)&G%0Z!IP4?P8<%'_%W!1_Q5P4?\4
M<5#_$W%0_Q-Q4/\3]4   .1+  #/5   P5H  +==  "O7@  IUL  *%8 P";
M61( EELB ))<,0&.7#T"BEQ'!(=;4 :#6E@)@5E@#'Y99PY[6&\0>5=W$W96
M@!5T5HL7<E66&6]5HQIM5+(;;%3&&VI5YAMJ5?L9:E7_%VI5_Q9J5?\5:U7_
M%&M5_Q1K5?\4\D,  -]/  #+6   O5T  +-A  "K8@  HF   )M<  "57A
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MFQI69ZH;56>]'%1GW!Q49_8:5&;_&%5F_Q=59?\65F7_%59E_Q569?\5XE$
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M;P  J'8  )UY  "/>   A'@  '=Y  !O?   :GT- &=^&0!D?R8 8H R 5^
M/0)<@$8#6G].!5=_50=4?ET)4GUE#$]];PY,?'D12GR&$T=[E!5%>Z061'NW
M%D-[TA9#>O(60WG_%4-X_Q1$=_\41';_$T1V_Q-$=O\3S5\  +MK  "N=
MI'P  )=^  "*?0  ?WX  ')_  !F@P  880( %Z&$P!<AR$ 6H<N %B'. %5
MAT("4X=* U"'4@5.AEH'2X9B"4F%; M&A7<-0X2##T&$DA$_A*(2/82U$SR$
MSQ,\@O 2/('_$CV _Q(]?_\2/7[_$3U^_Q$]?O\1Q68  +5Q  "J>P  GX(
M )*"  "%@@  >8,  &V&  !?B@  6(T! %2.#P!2CQL 4(\G $^0,P!-D#T!
M2Y!% DF03@-&D%8$1(]?!4*/: <_CW,)/8Z "SJ.CPPXCJ --XZS#C:.S XV
MC>\.-8O_#C6)_P\UB/\/-H?_#S:'_P\VA_\/OFT  +!Y  "E@@  F8<  (R(
M  !_B   <HH  &:-  !:D0  4)4  $F7"0!'F!, 19@@ $29*P!#F38 09I
M $":2 $^FE$"/)I: CJ:9 ,WFF\%-9E]!C.9C <QF9T(+YFP""Z9R@@NF.T(
M+I;_"BV4_PHMD_\++9+_"RV2_PLMDO\+MG4  *J!  ">B   DXT  (:.  !X
MCP  :Y(  %^5  !4F0  29T  $"@   ZH@T .*,7 #>C(@ VI"T -:0W #2D
M00 SI4L ,:54 3"E7@$NI6H!+*5X BJEB ,HI9H#)Z6M!":EQ@,FI.L$):+_
M!26@_P8DG_\&))[_!R2>_P<DGO\'KWX  *.(  "7C@  C9,  'Z5  !PF
M8YL  %>?  !,H@  0J8  #BI   OK , *JX. "FN&  HKR, )Z\M ":P-P E
ML$$ )+!+ ".Q5@ BL6, (;%Q !^Q@@ >LI0!'+*I 1NRP0$;L><!&Z_^ AJM
M_P(:K/\#&JO_ QJK_P,:J_\#J(@  )N/  "1E   A)H  ':?  !HH@  6Z4
M $^I  !$K0  .;   "^S   FM@  'KD% !B[#@ 7NQ8 %[P@ !:\*@ 5O34
M%+U  !.^2P 2OE@ $KYG !&_>  0OXP $,"B  [ N@ .P.$ #[W[  ^\_P 0
MNO\!$+K_ 1"Z_P$0NO\!GX\  )25  "'FP  >:$  &NG  !>K   4K$  $6T
M   ZM@  +[D  "6\   =OP  %<,   _&!0 +R@T "<H4  C*'0 'RB< !\HR
M  ;+/@ %RTL !,Q:  /,:@ "S'X  <R4  #,JP  S<@  ,SM  #,_P  R_\
M <K_  '*_P !RO\ EY8  (J<  !\HP  ;JH  &"P  !2M@  1;D  #F\   N
MOP  (\,  !O&   3R@  #<T   C1   !U D  -0.  #5%0  UAX  -@G  #9
M,0  VSX  -Q+  #=6P  WFX  -Z$  #?FP  W[0  -[9  #?]P  W_\  -__
M  #?_P  W_\ C9T  '^E  !PK   8;,  %.Z  !%OP  .,(  "S&   AR0
M&,T  !#1   +U0  !-H   #>    X $  .$)  #B#@  Y!,  .4;  #G)
MZ2\  .L\  #M2P  [ET  .YQ  #OB0  \*(  /"\  #PXP  [_D  /#_  #P
M_P  \/\ @:4  '*M  !CM0  5+T  $;$   WR   *LP  !_0   5U0  #MH
M  ?>    X@   .8   #I    Z@   .P   #N!0  [PP  /$0  #S%P  ]2
M /@K  #[.0  _4H  /Y>  #_=   _XT  /^F  #_P   _^$  /_U  #_]0
M__4 =*X  &6W  !6P   1\@  #C-   JT@  '=@  !/=   ,X@   ^8   #I
M    [    /    #S    ]    /8   #X    ^@   /T'  #_#0  _Q(  /\;
M  #_*   _S<  /]*  #_7@  _W8  /^/  #_I@  _[H  /_1  #_T0  _]$
M_P\D /\.(@#_"R$ _P,D /\ *0#_ #( _P ^ /\ 3 #_ %D _P!E /\ < #_
M 'H _P"$ /\ C #_ )( _P"9 /\ GP#_ *4 _P"K /\ L@#_ +H _P#% /\
MTP#_ .< _P#T /\ _P#^ /\ _P#_ /X _P#^ /\ _@#_ /X _P#^ /\ _Q$A
M /\0'@#_#1T _P<? /\ (P#_ "T _P Z /\ 2 #_ %4 _P!A /\ ; #_ '8
M_P!_ /\ AP#_ (X _P"5 /\ FP#_ *$ _P"G /X K@#] +8 _ #  /L S0#Y
M .( ^ #P /< _ #V /\ ]0#_ /4 _P#U /\ ]0#_ /4 _P#U /\ _Q4= /\3
M&@#_$!D _PL9 /\ '0#_ "D _P V /\ 0P#_ %  _P!< /\ 9P#_ '$ _P!Z
M /X @P#\ (H ^@"1 /D EP#X )T ]P"C /4 J@#T +( \@"[ /$ R #O -P
M[@#L .T ^@#K /\ Z@#_ .H _P#J /\ Z@#_ .H _P#J /\ _Q@9 /\6%0#_
M$Q, _PX3 /\+&@#_!R0 _P(P /\ /@#_ $L _P!7 /\ 8@#\ &P ^ !U /4
M?@#R (4 \0", .\ DP#N )D [ "@ .L I@#I *X YP"W .8 PP#D -0 X@#I
M .$ ]P#? /\ W0#_ -T _P#= /\ W0#_ -T _P#= /\ _QL3 /\:$ #_%@X
M_Q(. /\2%0#_#Q\ _PPK /\). #_!D4 ^P-1 /<"7 #R F8 [@)P .H"> #G
M H  Y@.' .0#C@#B Y4 X0.< -\$HP#=!*L VP2T -@%P #6!=  TP;G - (
M^ #."O\ S O_ ,L,_P#+#/\ RPO_ ,L+_P#+"_\ _Q\0 /\>"P#_&@< _QD+
M /\8$0#_%AD _Q(D /H0, #S#CX [@U* .D,5@#E#&$ X@QJ -X-<P#;#7L
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M Z(F_P2A)O\#H2;_ Z$F_P.A)O\#_RD  /\H  #V+0  YS   -\O  #9*P0
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M#@"P.1P JCLL *8\.@"C/48 GSU0 9T]60*:/6$#F#UH!)8\< 64/'<&DCR
M!Y$\B >/.Y((C3N="8L[J0J).[<+B#O*"X4\Z N#//L+@CS_"H$\_PJ!//\)
M@3S_"($\_PB!//\(_S,  .PZ  #:0P  RD<  +])  "W1P  L4(  *T^"@"F
M0!< HD(G )Y#-0":1$(!ET1, 91$50*10UT#CT-D!8U#:P:+0G,'B4)["(="
MA J%08X+@T&9#(%!I0U_0;,.?D'&#GQ!Y YZ0OD->4+_#'A"_PMX0O\+>$+_
M"GA!_PIX0?\*]C8  .9   #12   PTT  +E.  "Q30  J4D  *1%!@"?1A,
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M[$$  -1,  ##5   MED  *Q<  "@6@  EU<  )%4  "+50P AE<9 (-8)P"
M630 ?5D_ 7I92 -W6% $=%A8!G)77P=O5V8);59N"VM6=PUH58$/9E6-$614
MFA)B5*D38%2Z%%]4TQ1>5/(37E3_$5]4_P]?5/\.7U/_#5]3_PU?4_\-YT0
M ,]0  "_6   LUT  *A?  "<70  DEL  (M8  "%6@H @5L6 'U<) !Z73$
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M$T]BS!-/8NT23V'_$4]A_Q!08/\.4&#_#E!@_PU08/\-V4\  ,-:  "T8P
MJ6D  )MH  "/9P  A&<  'EE  !S9P  ;VD. &QJ&P!I:R@ 9VPT &1L/0%B
M;$8"7VM.!%UK5@5::ET'6&IE"59I;@M3:7@-46B$#TYHDA!,9Z$22V>R$DEG
MR1))9^L226;_$$IF_P]*9?\.2V7_#4MD_PU+9/\-T50  +Y>  "Q9P  IFT
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M/G/]#3YR_PT^<?\,/W'_##]P_PP_</\,Q5X  +5I  "I<0  G'4  (UT  "
M=   =70  &EV  !>>0  6'P! %1]#@!2?AH 47\F $]_,0!-@#L 3(!# 4J
M2P)(?U0"1G]<!$-_905!?W &/WY\"#Q^B@DZ?IH*.7ZL"S=^PPLW?>8+-WO\
M"S=Z_PLW>?\*.'C_"CAX_PHX>/\*OF0  +!O  "E>   EGD  (=Y  ![>0
M<'H  &1\  !8@   4(,  $N%"@!(AA0 1X<@ $6(*P!$B#4 0X@^ $&)1P%
MB4\!/HA8 CR(80,ZB&P$-XAX!36(AP8SB)@',H>J!S"(P <PA^0',(7["#"#
M_P@P@O\(,('_"#"!_P@P@?\(MVL  *IV  "@?P  D'X  ()^  !V?P  :H
M %Z#  !3AP  2HL  $&. @ ]D X .Y 8 #J1(P YD2T .)(W #>20  VDDD
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M 1.D_P$3I/\!HX8  )>,  "-D0  ?9(  &V5  !@F   5)P  $B@   ^I
M-*<  "JK   AK@  &;$  !*S!P /M1  #K47  ZU(0 -M2L #;4V  RV00 +
MMDX "K9<  FV;  (MG\ ![:4  :VJ@ %ML4 !K;J  >U_P (M/\ "+/_  FR
M_P )LO\ FHT  )"3  "$F   =)P  &6@  !7I   2Z@  $"L   UL   *K,
M "&U   8N   $;L   R^ @ &P L  L 1  '!&0  P2(  ,(K  #"-@  PT(
M ,-0  #$7P  Q'$  ,2'  #$G0  Q+4  ,3:  #$]@  P_\  ,/_  ##_P
MP_\ DY0  (>:  !XH   :J8  %RL  !/L0  0;4  #6W   IN@  '[T  !;
M   0PP  "L8   /*    S 4  ,P,  #-$0  SA@  ,XA  #0*@  T34  --#
M  #44@  U&,  -5X  #5CP  U:<  -;"  #6Z0  UOT  -;_  #6_P  UO\
MBIL  'NB  !LJ0  7K   %"V  !"N@  -+T  "C!   =Q   %,<   W+   &
MS@   -(   #7    V0   -H%  #<"P  W1   -\5  #A'0  XR<  .4S  #G
M0@  Z%0  .AG  #I?@  Z9<  .JO  #JS@  Z^\  .O^  #K_P  Z_\ ?:,
M &ZK  !?L@  4;H  $+    TPP  )\<  !O+   2SP  "],   +8    W0
M .$   #D    Y0   .<   #I    ZP<  .T-  #O$0  \1D  /0D  #W,0
M^4$  /I5  #Z:@  ^X0  /N=  #\M@  _-(  /WM  #]]   _?0 <:P  &&U
M  !2O0  1,0  #3)   FS0  &M(  !#8   (W0   .$   #E    Z    .P
M  #O    \0   /,   #U    ]P   /D!  #["   _@X  /\5  #_(0  _R\
M /]!  #_5@  _VT  /^'  #_H   _[8  /_*  #_U   _]0 _PL@ /\''@#_
M !T _P @ /\ )0#_ "X _P [ /\ 20#_ %8 _P!B /\ ;0#_ '8 _P!_ /\
MAP#_ (X _P"4 /\ F@#_ *  _P"F /\ K0#_ +4 _P"^ /\ RP#_ .$ _P#P
M /X _0#] /\ _0#_ /T _P#] /\ _ #_ /D _P#Y /\ _PT= /\+&@#_!!D
M_P : /\ 'P#_ "H _P W /\ 10#_ %$ _P!> /\ : #_ '( _P!Z /\ @@#_
M (D _P"0 /\ E@#_ )P _@"B /P J0#[ +  ^0"Y /@ Q@#V -D ]0#K /0
M^0#S /\ \@#_ /, _P#S /\ \P#_ /, _P#S /\ _Q 9 /\.%0#_"!0 _P 4
M /\ &0#_ "4 _P R /\ 0 #_ $P _P!9 /\ 8P#^ &T _ !U /H ?0#Y (0
M]P"+ /8 D0#T )< \P"> /( I #P *P [@"T .T P #K ,\ Z0#F .@ ]0#F
M /\ YP#_ .8 _P#E /\ Y0#_ .4 _P#E /\ _Q(4 /\0$ #_# \ _P,0 /\
M%0#_ "  _P L /\ .@#_ $< ^@!3 /< 7@#T &< \0!P .\ > #M '\ ZP"&
M .H C #H ), YP"9 .4 H #C *< X0"P -\ N@#= ,D VP#@ -@ \ #7 /X
MU0#_ -0 _P#3 /\ TP#_ -, _P#3 /\ _Q40 /\2# #_#@D _PL, /\)$@#_
M QH _P F /T ,P#T $  [P!- .L 6 #H &$ Y0!J .( <@#@ 'H W@"  -P
MAP#: (X V "5 -0 G #2 *, T "L ,X M@#, ,0 R@#9 ,@ [0#' /L Q0#_
M ,0!_P## ?\ Q '_ ,0!_P#$ ?\ _Q@+ /\5!0#_$   _Q & /\/#0#_#!0
M_ <? /$#*P#G #D X@!& -X!40#: EL U0)D -(#; #/ W0 S01[ ,L$@@#*
M!(D R 60 ,8%F #$!:  P@:I ,$&M "_!L$ O0C5 +L)[ "X"_T M@S_ +4-
M_P"T#?\ M W_ +0-_P"T#?\ _QL% /\8  #_%P  _Q8  /L3!@#Z$ X [@P6
M .,)(@#:"3  TPH^ ,X+2@#*#%4 QPU> ,4-9P#"#F\ P0YV +\.?@"]#X4
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M HXG_P*.)_\"_R8  /(I  #C,0  TC0  ,@T  # ,   NRD" +@C#@"Q)AP
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MFPAP0:D);T&Y"FU!T IL0>X):T+_"&I"_P=J0?\&:D'_!FI!_P5J0?\%[3<
M -9"  #$20  MTT  *M-  "@2@  F$<  )-"  ".0PT B44: (9&* "#1S0
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M#5E/QPU93^@,6$_]"UA/_PE93_\(64[_!UE._P=93O\'WT,  ,=-  "X5
MK%D  )U7  "150  B%0  (%0  ![4@0 =U,1 '14'@!Q52L ;U8V &Q60 %J
M5D@!:%90 F965P-D5EX$8E5F!6!5;P==57@(6U2$"EE4D0M75* ,55.P#513
MQ0U34^8,4U/\"U-3_PE44O\(5%+_"%12_P=44O\'VD8  ,-0  "U6   J%L
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M"D1@_PE$8/\(15__!T5?_P=%7_\'R%(  +A<  "K9   FV0  (QC  " 8P
M=F,  &IB  !C9   7V8& %MG$0!9:!T 5VDI %9J,P!4:CP 4FI% 5!J3 %.
M:E0"3&I< TIJ901(:6\%1FEZ!T1IB A":)@)0&BI"C]HO0H^:-X)/F?W"3YF
M_P@_9?\'/V7_!S]D_P<_9/\'PU<  +-A  "G:0  EF@  (=G  ![9P  <6<
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M RE[_P,I>_\#L6H  *5T  "5=@  A74  'AU  !M=0  87<  %=Z  !,?@
M0X$  #N%   UB D ,HD1 #&)&P PB24 +XHO "Z*.  MBT$ +(M* "J+5  I
MBU\ *(MK ":+>@$DBXL!(XN> 2*+LP$AC,X!(8KQ 2"(_P(@AO\"((7_ B&%
M_P(AA?\"JW(  *%\  "/>P  @'H  '-Z  !F?   6W\  %""  !&A@  /(H
M #2-   LD0  )I,, "24$P CE!P (I4F "&5+P @E3@ 'Y9" !Z63  =EE@
M')9D !J7=  9EX8 &)>9 !>7K@ 5E\D %I7N !:3_P$6DO\!%I'_ 1:0_P$6
MD/\!I7L  )F#  ")@0  >X   &R"  !?A   5(@  $F+   _D   -90  "V7
M   EF@  '9X! !:@#  4H1( %*$; !.A)0 2H2X $:(X !&B0P 0HD\ #Z)<
M  ZC:P -HWT #:.2  RCIP *HL  "Z+F  R@_@ -G_\ #9[_  V=_P -G?\
MGH0  )*)  "#B   <X@  &6+  !8C@  3)(  $&7   WFP  +IX  "2B   <
MI0  %:@   ^K!  *K@P !ZT2  :M&P %K20 !*XN  *N.0 !KD4  *Y2  "N
M80  KG,  *Z'  "NG0  KK0  *[5  "M]   K?\  *S_  "K_P  J_\ EHL
M (R0  ![D   :Y(  %V6  !0F@  1)\  #FC   OIP  ):L  !RN   4L0
M#K0   FW   !N D  +@.  "Y%   N1P  +HE  "Z+P  NSH  +Q'  "\5@
MO&<  +Q[  "\D0  O*D  +S$  "\ZP  N_X  +O_  "[_P  N_\ D)(  (.8
M  !SFP  8Y\  %6C  !'J   .ZT  #"Q   EM   &[<  !*Z   ,O0  !;\
M  ##    Q (  ,4*  #%#@  QA0  ,<;  #()   RBX  ,PZ  #-20  S5D
M ,UL  #.@P  SIL  ,VU  #.V@  SO8  ,W_  #-_P  S?\ AID  '>@  !I
MI@  6JP  $RR   ^M@  ,+D  "2\   9OP  $<(   K%   "R0   ,P   #0
M    T0   -(!  #3"   U0T  -<1  #:&   W"$  -\L  #A.@  XDH  .-=
M  #D<@  Y(L  .6E  #EP   Y>8  .7X  #E_P  Y?\ >J$  &NI  !<KP
M3;8  #^\   POP  (\,  !?'   /R@  !\X   #1    U@   -P   #?
MX    .(   #D    Y@,  .@)  #I#@  [!4  .X>  #Q*P  ]#H  /5-  #V
M80  ]WD  /B3  #XK0  ^<8  /GD  #Y\P  ^?, ;:H  %ZR  !/N@  0,$
M #'%   BR0  %LX   W2   $V    -T   #A    Y    .@   #K    [0
M .\   #Q    \P   /8   #X P  ^@L  /T1  #_&P  _RD  /\[  #_3P
M_V8  /]_  #_F0  _Z\  /_#  #_U@  _]8 _P0< /\ &0#_ !D _P < /\
M(@#_ "L _P X /\ 1@#_ %, _P!> /\ :0#_ '( _P!Z /\ @@#_ (D _P"/
M /\ E0#_ )L _P"A /\ J #_ *\ _P"Y /\ Q0#_ -D _@#L /T ^P#[ /\
M^P#_ /L _P#Z /\ ] #_ /  _P#P /\ _P<8 /\!%0#_ !0 _P 6 /\ &P#_
M "8 _P T /\ 0@#_ $X _P!: /\ 9 #_ &T _P!U /\ ?0#_ (0 _P"* /T
MD #\ )8 ^@"= /D HP#X *L ]P"T /4 OP#T ,X \P#F /$ ]@#P /\ [P#_
M .\ _P#N /\ [@#_ .H _P#J /\ _PL4 /\&$0#_ !  _P 0 /\ %@#_ "(
M_P N /\ / #_ $D _P!4 /X 7P#[ &@ ^0!P /< > #U '\ \P"% /( BP#P
M )( [P"8 .T GP#L *8 Z@"N .@ N0#G ,< Y0#> ., \ #B /X X #_ .
M_P#A /\ X0#_ .$ _P#A /\ _PT0 /\)#0#_ 0P _P , /\ $@#_ !P _P H
M /P -@#Y $, ]@!. /( 60#O &( [ !K .H <@#H 'D Y@"  .0 A@#B (P
MX0"3 -\ F@#= *$ VP"J -@ M #5 ,  T@#3 -  Z@#. /H S0#_ ,T _P#-
M /\ S #_ ,P _P#, /\ _Q , /\,!P#_ P( _P ( /\ #@#_ !8 ]@ B /
M+P#L #P Z0!( .4 4P#A %P W@!E -L ; #7 ', U !Z -( @ #0 (< S@".
M ,P E0#* )T R "E ,8 KP#$ +L P@#+ ,  Y0"^ /4 O0#_ +P _P"\ /\
MO #_ +P _P"\ /\ _Q$% /\.  #_"@  _P@! /\$"@#X !  Z0 : ., * #>
M #4 V0!! -, 3 #/ %8 RP!? ,D 9@#& &X Q !T ,( >P#! (( OP") +T
MD "\ )@ N@"A +@ JP"V +< M #' +( X "Q ?( KP+_ *X#_P"M!/\ K03_
M *T$_P"M!/\ _Q0  /\0  #_#P  \@T  .H*  #I PD W0 2 -0 'P#- 2T
MR (Z ,0#10#  U  O019 +L%80"Y!6@ MP9O +4&=@"T!WT L@>$ +$(C "O
M")4 K0F> *L)J "J"K4 J K% *8+WP"D#?0 H@[_ * ._P"?#O\ GP[_ )\.
M_P"?#O\ _Q<  /\3  #O&   Y!D  -L6  #2$ ( SPD+ ,@(%@#!"B0 O PR
M +<-/@"T#DD L0Y3 *\06P"M$&, JQ!J *D1<0"H$7@ IA&  *41B "C$I$
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MG@&&)ZL!A">[ 8,HT0& *.X!?BG_ 7TI_P%\*/\!?"C_ 7PH_P%\*/\!]20
M .,N  #/-0  P3@  +0V  "K,0  I2P  *(F!@">)A, F2@A )4J+@"2*SD
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M!6<\Q05E/.4%9#SZ!&0\_P-C._\#8SO_ V,[_P)C._\"Y34  ,T_  "]1@
MKD<  )]%  "50P  CD   (D\  "$/ H @#T4 'T^(@!Z/RX >$ X '5!0@!S
M04H <D%1 7!!60%N06 ";$%G FI!< -H07D#9T&$!&5!D05C09\%84&N!F!!
MP@9>0>(&7D'Y!5U!_P1=0/\#74#_ UU _P-=0/\#WSD  ,A#  "Y2@  J4L
M )M)  "01P  B$0  (-!  !^008 >D(1 '9#'@!T12H <44U &]&/P!M1D<
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M!DU._P5-3?\$34W_!$Y,_P-.3/\#SD0  +Q.  "N5   G%,  (Y2  "#40
M>E   ')-  !L3P  :% + &51%0!C4B$ 85,L %]3-@!=5#\ 6U1' %I43@%8
M5%8!5E1= E149@-24V\#4%-[!$Y3B 5,4Y<&2U.G!TE3N@=(4]4'2%+S!DA2
M_P5(4?\$25'_!$E0_P-)4/\#RD@  +E2  "J5P  F%8  (I5  !_5   =E,
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M SE>_P,Y7O\#O%4  *U?  "<8   BU\  'U?  !R7P  :%\  %U@  !58@
M3V0  $MF"@!)9Q( 1V@= $5H)P!$:3$ 0VDY $)J0@! :DH /VI2 #UJ6P$\
M:F4!.FIP CAJ?@(V:8T#-&F? S-IL@,Q:<L#,6CM S%G_P,Q9O\#,F7_ S)D
M_P,R9/\#MUL  *ED  "69   AF,  'AC  !M8P  9&0  %EE  !0:   26L
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M<0 <A(( &X25 !J$J0 8A,$ &(/F !B!_0 9@/\!&7__ 1E^_P$9?O\!IG
M )5S  "$<@  =G$  &MQ  !><P  5'8  $EY   _?0  -X$  "^$   GB
M((L% !N-#@ :C14 &8T> !B.)P 7CC  %HXY !6.0P 4CT\ $X]; !*/:@ 1
MCWL $(^/  ^/I  .C[L #8_@  Z-^@ /B_\ $(K_ !")_P 0B?\ H7H  (YY
M  !^=P  <G<  &1X  !8>P  37X  $*"   YA@  +XH  ">.   @D0  &)4
M !*8!0 .F@X #9H4  R:'0 +FB8 "YHP  J:.P )FD8 ")I3  :;80 %FG(
M!)J&  *:FP  FK$  9G/  *9\  "F/\ !)?_  66_P %EO\ F8$  (=_  !Z
M?@  :WX  %V!  !0A0  18D  #N-   QD@  *)8  !^9   8G0  $:    RC
M @ &I0H  :40  "E%@  IA\  *8H  "F,@  IST  *=*  "G6   IV@  *=\
M  "GD0  IJ@  *;#  "EZ0  I?P  *7_  "D_P  I/\ D8<  (*&  !RA@
M8X@  %6,  !)D0  /98  #*:   HG@  'Z(  !>F   0J0  "ZP   2O
ML08  +$,  "R$0  LA<  +,?  "S*   M#(  +4_  "U30  M5T  +5P  "U
MA@  M9T  +6V  "UW   M/<  +3_  "T_P  M/\ BX\  'J.  !JD0  6Y4
M $V:  ! GP  -:0  "JH   @K   %K    ^T   )MP   ;D   "]    O@
M +X&  "_#   P!   ,$6  #"'0  PR<  ,4R  #&0   QE$  ,=C  #'>
MQY$  ,>I  #'QP  Q^P  ,?^  #'_P  Q_\ @Y<  '&:  !AG@  4J,  $6I
M   XK@  ++,  ""W   6N@  #KT   ;     PP   ,<   #)    R@   ,P
M  #- P  S@D  - .  #2$P  U!L  -@E  #;,@  W4(  -U4  #>:0  WH$
M -Z<  #?M0  W]D  -_S  #?_P  W_\ =Y\  &BF  !9K0  2K,  #NX   M
MNP  '[\  !3"   ,Q@   \D   #,    T    -4   #9    V@   -P   #>
M    X    .(%  #D"P  YQ   .H8  #M)   \#(  /%$  #R6   \V\  /2*
M  #TI   ]+\  /3?  #T\P  ]/0 :J@  %NO  !,MP  /;T  "W!   ?Q@
M$\H   O.    T@   -<   #<    X    .4   #G    Z0   .L   #M
M[P   /$   #S    ]@<  /D.  #\%@  _R(  /\S  #_1P  _UT  /]V  #_
MD0  _ZD  /^^  #_V   _]L _P 8 /\ %@#_ !4 _P 8 /\ '@#_ "< _P V
M /\ 0P#_ $\ _P!: /\ 9 #_ &T _P!U /\ ?0#_ (0 _P"* /\ D #_ )8
M_P"< /\ HP#_ *L _P"T /X OP#] ,\ ^P#G /H ^ #Y /\ ^0#_ /D _P#U
M /\ [@#_ .D _P#G /\ _P 4 /\ $0#_ !$ _P 2 /\ %P#_ ", _P Q /\
M/@#_ $H _P!6 /\ 8 #_ &@ _P!P /\ > #] 'X _ "% /H BP#Y )$ ^ "8
M /< G@#U *8 ] "N /( N0#Q ,< [P#@ .X \@#L /\ [ #_ .P _P#K /\
MY0#_ .  _P#> /\ _P,0 /\ #@#_  T _P - /\ $P#_ !X _P K /\ . #_
M $4 _@!0 /L 6@#X &, ]0!K /, <@#Q 'D [P!_ .X A@#L (P Z@"2 .D
MF0#G *  Y@"I .0 LP#A ,  X #3 -X ZP#< /L VP#_ -H _P#: /\ V0#_
M -0 _P#2 /\ _P<- /\ "0#_  8 _P ) /\ #P#_ !@ ^P E /@ ,@#U #\
M\@!* .T 5 #J %T YP!E .0 ; #B ', X !Z -X @ #< (8 V@"- -< E #4
M )L T@"D ,\ K0#- +D RP#) ,D Y #( /8 Q@#_ ,4 _P#& /\ QP#_ ,<
M_P#' /\ _PH& /\!  #_    _P $ /\ "P#T !( [P ? .H + #E #@ X@!#
M -T 3@#9 %< U !? -$ 9P#. &T S !T ,H >@#( (  Q@"' ,4 C@## )8
MP0"> +\ J "] +, N@#" +D VP"W /  M0#_ +8 _P"U /\ M0#_ +4 _P"U
M /\ _PP  /\$  #_    _@   /8  P#H  T X  7 -D ) #1 #$ S0 \ ,H
M1P#& %$ PP!9 ,  8 "^ &< O !N +H = "Y 'L MP"" +4 B0"S )$ L@":
M +  I "N *\ K "] *H T "H .L IP#[ *8 _P"F /\ I0#_ *4 _P"E /\
M_PT  /\'  #T"0  Z@D  .($  #:  < SP 1 ,@ ' #" "D O@ U +L 0 "W
M $H M !3 +( 6P"P &( K@!H *P ;P"K '4 J0!] *@ A "F (T I "6 *,
MH "A *L GP&Y )T#S "<!.@ F@;Y )D'_P"8"/\ EPC_ )<(_P"7"/\ _Q
M /<0  #H%   W!4  ,X1  #&#0  P@0+ +P % "W 2$ L@,N *X%.@"K!D0
MJ A- *8(50"D"5P H@IC * *:@"?"W$ G0MX )P+@ ":#(D F0R3 )<,G@"5
M#:H E VX )(-S "0#NH CA#\ (P0_P"+$/\ BQ#_ (L0_P"*$/\ ^Q,  .T:
M  #=(   S"$  +\=  "W%P  LQ$  +(+#0"K#1D IPXF *,/,P"?$#X G1%'
M )H14 "8$E< EA)> )4390"3$VP DA-S ) 4? "/%(4 C16/ (L5F@"*%:<
MB!:U (86R0"$%^< @AC[ ( 9_P!_&?\ ?QG_ '\8_P!_&/\ ]1H  .0C  #/
M*0  P"H  +,F  "J(@  I1P  *05" "@%!, FQ8A )<8+0"4&3@ D1I" (\;
M2P"-'%( BQQ9 (D=8 "('6< AAYO (4>=P"#'X  @A^+ ( ?EP!^(*, ?2"R
M 'L@Q0!Y(>0 =R+Y '8B_P!U(O\ ="'_ '0A_P!T(?\ [R$  -LK  #',0
MMC$  *DN  "@*@  FR8  )@A 0"5'A  D" ; (TA* ")(S, AR0] (4D1@"#
M)4X @295 '\F7 !^)F, ?"=K 'LG<P!Y)WP >"B' '8HDP!T** !<BBO 7$I
MP0%O*> !;2GW 6PI_P%K*?\!:RG_ 6LH_P%K*/\!Z"@  - R  # .   KC<
M *$U  "8,@  DBT  (XI  "+)PP AR@7 (,J(P" *R\ ?BPY 'PL0@!Z+4H
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M E8[_P)6._\"5CK_ 58Z_P%6.?\!U#<  ,!!  "O1   G4,  )!"  "%0
M?CX  'D[  !T.@  <3H. &T\& !K/20 :3XO &<_. !E/T  9$!( &) 3P!A
M0%< 7T!> 5U 9@%<0&\!6D!Z EA AP)60)4"5$"D U- M@-20,\#44#O U!
M_^+__TE#0U]04D]&24Q%  8)_P)0/_\"4#__ E$^_P%1/O\!SSL  +U%  "J
M1P  F48  (M%  "!1   >4(  '0^  !O/P  :T , &=!%0!E0B$ 8T,K &%#
M-0!?1#X 7D1% %U%30!;150 645< 5A%9 %616T!5$5X E)%A0)11),#3T2C
M TU%M -,1<P#2T7M TM$_P)+1/\"2T/_ DQ"_P),0O\"RC\  +E(  "F2@
ME4D  (=(  !]1P  =44  &Y"  !I0P  940) &)%$P!?1AX 74<H %Q(,@!:
M2#L 64E# %=)2@!625( 5$E9 5-)80%126L!3TEV DU)@@)+29$#2DFA TA)
MLP-'2<H#1DGL T9(_P)&2/\"1T?_ D=&_P)'1O\"QD,  +9,  "B3   D4P
M (1+  !Y2@  <$D  &E&  !D1P  7TD& %Q*$ !:2QL 6$PE %9,+P!533@
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M C=6_0(W5?\"-U3_ C=3_P(X4_\"ND\  *E6  "550  A50  'A4  !M5
M9%0  %A4  !25@  3E<  $I9"0!'6A$ 1EH; $1;)0!#6RX 0EPV $%</@ _
M7$8 /EU/ #U=5P [76$ .EUL 3A=>0$V78@!-%V9 C-=JP(Q7<(",5SE C%;
M_ (Q6O\",5G_ C)9_P$R6/\!ME0  *19  "06   @%@  '-7  !I5P  8%@
M %19  !.6P  2%T  $-?! ! 8 X /F$7 #UA(  [8BD .F(R #EB.@ X8T(
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M !MN_P$;;?\!IF8  )%E  !_9   <60  &9D  !=9   4F8  $AI   _;
M-V\  #!S   I=@  (GD( !][$  >>Q< ''L? !M[*  :>S  &7PY !A\0P 7
M?$X %GQ: !5\9P 4?7@ $GV+ !%]GP 0?;4 #WW5 !![]0 1>?\ $7C_ !)W
M_P 2=_\ GFL  (IJ  !Z:0  ;6D  &)I  !7:@  3&T  $-P   Y=   ,7@
M "E[   B?P  &X(  !2%"0 1AA  $887 !"''P 0AR@ #H<Q  Z'.P -AT8
M#(=3  N'80 *AW$ "8>$  >'F  &AJX !8;)  :%[  'A/\ "(/_  F"_P )
M@O\ E7$  (-O  !T;@  :6X  %QO  !0<@  1G4  #QY   R?0  *H$  "*%
M   ;B0  %(P   ^/ P *D@L !I(1  22&  "DB   9(I  "2,P  DSX  )-+
M  "360  DVD  )-[  "2D   DJ8  )&_  "1Y0  D/H  (__  "/_P  C_\
MC7<  'UU  !P=   8G4  %5X  !)?   /X   #2$   KB0  (HT  !J1   3
ME   #I<   F;   !G0@  )T.  "=$P  GAH  )XB  "?*P  GS4  *!"  "@
M4   H%\  *!Q  "@AP  GYT  )^U  ">V@  G?8  )W_  "<_P  G/\ AGT
M 'A\  !I?   6W\  $Z#  !!B   -HP  "R1   CE@  &IH  !*>   -H0
M!J0   "G    J0,  *D*  "J#@  JQ,  *P9  "M(@  KBL  *\W  "O10
MKU0  *]F  "O>P  KI0  *ZK  "NR0  KN\  *W_  "M_P  K?\ @80  '&$
M  !AAP  4XL  $:0   YE@  +IL  ".@   :I   $J@   RL   $KP   +(
M  "V    MP   +<"  "X"   N0T  +H2  "[&   O2$  +XK  # .   P$@
M ,!:  #!;@  P88  ,&@  #!N@  P>,  ,#Y  # _P  P/\ >8T  &B0  !9
ME   2YH  #V@   QI0  ):L  !JO   1LP  "[@   *[    O@   ,$   #$
M    Q0   ,8   #'    R 4  ,H+  #,#P  SA4  - ?  #3*P  U3H  -5,
M  #68   V'<  -B2  #8K   V<D  -GL  #9^P  V/\ <)D  &">  !1I
M0ZH  #6P   HM@  '+H  !&^   )P0   ,4   #(    RP   ,\   #2
MTP   -8   #8    VP   -T   #?!P  X@T  .43  #H'0  ["H  .T\  #M
M40  [F<  .^!  #OG   \+<  /#3  #P[   \/0 9Z8  %BM  !)M   .KH
M "J^   <P@  $,8   ?*    S@   -(   #6    W    .    #C    Y
M .8   #H    ZP   .T   #O    \@(  /4*  #X$0  _!P  /\L  #_/P
M_U4  /]N  #_B@  _Z0  /^Z  #_T0  _^$ _P 4 /\ $@#_ !( _P 4 /\
M&0#_ "4 _P R /\ /P#_ $L _P!6 /\ 8 #_ &@ _P!P /\ > #_ '\ _P"%
M /\ BP#_ )$ _P"8 /\ G@#^ *8 _0"N /P N0#Z ,@ ^0#B /@ ] #W /\
M]@#_ /8 _P#O /\ YP#_ .( _P#> /\ _P 1 /\ #@#_  X _P / /\ % #_
M "  _P M /\ .@#_ $8 _P!1 /\ 6P#_ &, _@!K /P <P#Z 'D ^0"  /<
MA@#V (P ]0"2 /, F0#R *  \ "I .X LP#M ,$ ZP#6 .H [@#I /X YP#_
M .< _P#E /\ W0#_ -4 _P#1 /\ _P - /\ "@#_  @ _P ) /\ $ #_ !L
M_P H /\ -0#_ $  ^@!+ /8 50#S %X \0!F .X ;0#L '0 ZP!Z .D @ #G
M (8 Y@"- .0 DP#B )L X "C -X K0#< +D V@#* -< Y@#4 /@ T@#_ -(
M_P#2 /\ S@#_ ,D _P#& /\ _P ( /\  P#_    _P # /\ #0#\ !8 ]P B
M /, +@#O #H [ !% .@ 3P#D %@ X0!@ -X 9P#; &T V0!T -4 >@#3 (
MT0"' ,\ C@#- )4 RP"> ,D IP#' +, Q0#" ,, W #! /$ OP#_ +\ _P"^
M /\ O@#_ +T _P"[ /\ _P   /\   #_    _P   /8 " #N !$ YP ; .$
M)P#= #, V0 ^ -, 20#/ %( RP!9 ,@ 80#& &< Q !M ,( <P#  'H OP"
M +T B "[ )  N0"8 +@ H@"U *T LP"[ +$ S@"P .H KP#\ *T _P"M /\
MK@#_ *X _P"N /\ _P(  /\   #]    \@   .@   #>  P TP 5 ,P (0#(
M "P Q  X ,$ 0@"] $L N@!3 +@ 6@"V &$ M !G +( ;0"P '0 KP!Z *T
M@@"L (H J@"3 *@ G0"F *@ I "U *( Q@"A ., GP#V )X _P"> /\ G@#_
M )X _P"> /\ _P8  /L   #N!0  X@0  -4   #+  8 PP / +T &0"X "4
MM  Q +$ .P"N $4 K !- *D 50"G %L I0!B *0 : "B &X H0!U )\ ? ">
M (4 G ". )H F "8 *0 E@"P )4 P0"3 -P D@#R )$ _P"0 /\ D #_ (\
M_P"/ /\ _0H  / .  #A$0  SA   ,(-  "[!P  MP * +$ $@"L !X J  I
M *4 - "B #X GP!' )T 3P"; %8 F0%< )<!8P"6 FD E )P ),#> "1 X
MD 2* (X$E0",!:$ B@6N (D&O@"'"-@ A@GP (0*_P"#"_\ @PO_ (,+_P"#
M"_\ ]A   .87  #2'   P!H  +,6  "L$@  J T  *8'#0"B!18 G0<B )D)
M+@"6"C@ E M! )(,2@"0#%$ C@U8 (P-7@"+#64 B0UL (@.= "&#GT A0Z'
M (,.DP"!#Y\ @!"M 'X0O@!]$-L >A'T '@2_P!W$O\ =Q+_ '<2_P!W$O\
M[Q<  -LA  #&)   M",  *@@  "@'   FQ<  )D1! "8#A  DQ ; (\1)P",
M$C( B1,\ (<31 "%%$P @Q13 ($56@" %6  ?A9H 'T6;P![%G@ >1># '@7
MCP!V&)P =!BJ ',9NP!R&=0 ;QKQ &X;_P!M&_\ ;1K_ &T:_P!M&O\ YR
M - I  "\*P  JRH  )XH  "6)   D"   (T<  ",%PP B!@6 (0:(@"!&RT
M?APW 'P=0 !Z'4@ >1Y/ '<>50!V'UP =!]C ',?:P!Q('0 <"!_ &XABP!L
M(9@ :R&G &DBN !H(L\ 9B+N &4C_P!D(_\ 9"+_ &0B_P!D(?\ X"8  ,@O
M  "T,0  HS   )8N  "-*P  AR@  (0D  ""( @ ?B 2 'LB'@!X(RD =20S
M ',E/ !Q)4, <"9+ &XF4@!M)UD :R=@ &HG: !I*'$ 9RA[ &4HB !D*94
M8BFD & IM0!?*<L 7BKL %PJ_P!<*?\ 7"G_ %PI_P!<*/\ V"P  ,,U  "M
M-0  G30  ) S  "&,0  @"T  'PK  !Y* , =B<0 '(I&@!P*B4 ;2LO &LL
M. !J+$  :"U' &<M3@!E+E4 9"Y= &,N90!A+VX 7R]X %XOA !<+Y( 6B^A
M 5DOL@%8,,@!5C#I 54P_@%5+_\ 52__ %4N_P!5+O\ T#$  +TZ  "H.0
MES@  (HW  " -@  >C(  '4P  !R+@  ;BX- &LO%@!I,"$ 9C$K &0R- !C
M,CT 83-$ & S2P!?-%( 731: %PT8@!:-&L 635U %<U@@!5-9 !5#6? 5(U
ML %1-<8!4#7G 4\U_0%/-?\!3S3_ 4\T_P%/,_\!RS8  +@]  "C/   DCP
M (4[  ![.@  =#<  &\U  !L,P  :#0* &4U$P!B-AX 8#<H %XW,0!=.#H
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M 3]#^0$_0O\!/T'_ 4!!_P% 0/\!OT$  *I%  "610  AD4  'E$  !O1
M9T(  & _  !;00  5T(  %1##0!11!4 3T4? $Y%* !,1C$ 2T8Y $I'00!)
M1T@ 2$=0 $9'6 !%1V$ 0TAL $)(> % 2(<!/DB7 3Q(J0$[2+X!.DC? 3I'
M^ $Z1O\!.D7_ 3M%_P$[1/\!NT4  *9(  "21P  @D<  '9'  !K1P  8T8
M %M#  !610  4D<  $Y("@!,21( 2DD< $A*)0!'2BX 1DLV $5+/@!#2T8
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M 2I3_P$J4O\!KU$  )A1  "%40  =E   &I0  !@4   6%$  $Y2  !'4P
M054  #M8   X60H -5H1 #1:&@ S6R( ,ELK #%;,P O7#L +EQ# "U<3  L
M7%8 *UU@ "E=;0 H77P )EV. "1=H0 C7;4 (EW2 ")<\P B6_\ (UK_ "-9
M_P D6/\ J%4  ))4  " 5   <50  &94  !<5   5%4  $I6  !#6   /%L
M #9=   P8 4 +6$. "MA%0 J8AT *6(E "AB+@ G8S8 )F,^ "5C1P C8U$
M(F1< "%D:0 ?9'D 'F2* !QDG@ ;9+, &63. !IC\0 ;8?\ &V#_ !Q@_P <
M7_\ H5D  (Q8  ![6   ;5@  &)8  !96   4%D  $=;   ^7@  -V   #%C
M   J9@  )&D) "%J$  @:A< 'VH@ !YK*  =:S  '&LY !MK0@ :;$P &6Q8
M !=L90 6;'0 %&R& !-LF@ 2;*\ $6S* !%K[P 2:?\ $VC_ !-H_P 39_\
MF5T  (5=  !U7   :%P  %Y<  !57   2UX  $)A   Y9   ,F<  "MJ   D
M;0  'G ! !=S"P 5=!$ %'08 !-T(0 2=2D $74R !%U.P 0=48 #W52  YU
M7P -=6X #'6!  MUE0 *=:H "'3#  ETYP *<_T "W'_  QQ_P ,</\ D6(
M ']A  !P80  9&$  %IA  !/8@  164  #QH   S;   *V\  "1R   ==@
M%WD  !%\!  -?PP "W\2  I_&0 )?R( "'\J  9_-  %?S\ !']+  )_6  !
M?V<  ']Y  !_C@  ?Z,  'Z[  !]X   ??<  'S_  ![_P  >_\ B6<  'AG
M  !K9@  868  %1G  !):0  /VT  #5Q   L=0  )'D  !U\   6@   $(,
M  R& @ &B0H  8D/  ")%   BAL  (HC  "++   BS<  (M#  "+4   BU\
M (MQ  "+A@  BYP  (JS  ")TP  B/,  (C_  "'_P  A_\ @FT  '-L  !H
M;   6FT  $YO  !"<P  .'<  "Y[   E@   '80  !6(   0C   "X\   22
M    E 8  )4,  "5$   EA4  )<<  "8)   F"X  )DY  "91P  F58  )EH
M  "9?0  F90  )BK  "7R   ENX  );_  "5_P  E?\ >W0  &]S  !A<P
M4W8  $9Z   [?P  ,(0  ":(   =C0  %)(   Z6   )F0   9P   "@
MH0   *(&  "B#   I!   *44  "E'   IR0  *@O  "H/0  J4P  *E>  "I
M<@  J(D  *BB  "HO   I^4  *;[  "F_P  I?\ =WL  &A[  !9?@  2X(
M #Z'   RC0  )Y(  !V7   4G   #J    >D    J    *L   "N    KP
M +    "Q!   LPH  +0.  "U$P  MAL  +@D  "Z,0  ND   +I2  "[90
MNWT  +J7  "ZL0  NM(  +KS  "Y_P  N?\ ;X,  %^&  !1BP  0Y   #:7
M   JG0  'Z(  !6G   -K   !;    "T    MP   +L   "^    OP   ,
M  #!    PP$  ,0'  #%#0  QQ$  ,H9  #-)   SC,  ,]$  #06   T&X
M -&(  #0I   T,$  -'F  #1^   T?\ 9X\  %>4  !)F@  .Z$  "ZG   A
MK0  %K,   ZX   &O    ,    ##    Q@   ,L   #-    S@   -    #1
M    U    -8   #: @  W D  -\/  #C%P  YB0  .<V  #H20  Z5\  .IX
M  #KE   ZZ\  .O,  #LZ   [/8 7YX  %"D  !"JP  -+(  ":Y   9O@
M#L(   3%    R@   ,T   #1    V    -L   #?    X    .(   #D
MY@   .D   #K    [@   /$%  #U#0  ^18  /PE  #].0  _D\  /]G  #_
M@@  _YT  /^U  #_RP  _^0 _P 1 /\ #P#_  \ _P 1 /\ %@#_ "( _P O
M /\ .P#_ $< _P!2 /\ 6P#_ &0 _P!L /\ <P#_ 'H _P"  /\ A@#_ (P
M_@"3 /T F0#[ *$ ^@"I /@ M #W ,( ]@#: /4 \0#T /\ \P#_ /, _P#I
M /\ X #_ -@ _P#3 /\ _P . /\ "P#_  H _P + /\ $0#_ !T _P J /\
M-@#_ $$ _P!, /\ 5@#^ %\ ^P!F /D ;0#W '0 ]0!Z /0 @ #R (8 \ "-
M .\ E #M )L [ "D .H K@#I +H YP#- .4 Z0#D /L XP#_ .( _P#> /\
MT0#_ ,P _P#( /\ _P ) /\ ! #_  $ _P $ /\ #@#_ !@ _P D /T , #[
M #L ]P!& /, 4 #O %D [ !@ .H 9P#G &X Y@!T .0 >@#B (  X "' -X
MC@#< )4 V@"> -8 J #4 +, T0## ,\ WP#. /0 S #_ ,L _P#+ /\ Q0#_
M +\ _P"\ /\ _P " /\   #_    _P   /T "P#W !, \0 > .T *@#J #4
MYP!  .( 2@#= %( V0!: -4 80#2 &< T !M ,X <P#, 'H R@"  ,@ AP#&
M (\ Q "8 ,( H0#  *T O@"[ +P T "Z .T N0#^ +@ _P"X /\ MP#_ +,
M_P"P /\ _P   /\   #_    ^0   .X !0#E  X W@ 8 -@ (P#2 "X SP Y
M ,L 0P#' $P Q !4 ,$ 6P"_ &$ O !G +L ;0"Y ', MP!Z +4 @0"T (D
ML@"2 +  FP"O *< K "T *L Q@"I .0 IP#X *8 _P"F /\ I0#_ *4 _P"D
M /\ _P   /\   #U    Z@   -X   #0  H R  2 ,( '0"^ "@ NP S +D
M/0"U $8 L@!- +  50"M %L K !A *H 9P"H &T IP!S *4 >@"D (( H@",
M *  E@"? *$ G0"N )L O@"9 -@ EP#Q )8 _P"6 /\ EP#_ )< _P"7 /\
M_P   /4   #G 0  U    ,D   #   0 N  . +, %@"O "$ JP L *@ -@"F
M #\ HP!' *$ 3P"? %4 G0!; )L 80": &< F !N )< =0"5 'T E "& )(
MD0"0 )P C@"I (P N "+ ,T B0#K (@ _0"( /\ B #_ (@ _P"( /\ ^08
M .D,  #4#@  PPP  +<)  "P @  JP ) *8 $ "B !H G@ E )L , "8 #D
ME@!! )0 20"2 %  D !6 (X 7 "- &( BP!I (H < "( '@ AP"! (4 C "$
M )@ @@"E (  M !^ ,@ ?0'G 'P"^0![ _\ >P3_ 'L$_P![!/\ \0X  -X5
M  #%%0  M!0  *D1  "A#@  G@H  )L## "7 !, DP > ) !*0"- C, B@,\
M (@$0P"&!4L A091 (,&5P""!UX @ =D '\(; !]"'0 ? A^ 'H)B0!X"98
M=PJC '4*LP!S"\< <@SF ' -^P!P#?\ ;PW_ &\-_P!O#?\ Z!8  - >  "Y
M'0  J1P  )T:  "5%@  D!,  (\. P"."@X B0L7 (8,(P"##2T @ TV 'X.
M/@!\#D8 >PY- 'D/4P!X$%H =A!A '40: !S$'$ <1%[ ' 1AP!N$90 ;!&B
M &L2L@!I$L< :!/G &83_0!E%/\ 913_ &43_P!E$_\ WQX  ,8D  "P)
MH",  )0A  "+'P  AAL  (,7  ""$@@ ?Q$2 'P2'0!Y%"@ =A0Q '05.@!R
M%D$ <19( &\73P!N%U8 ;!== &L89 !I&&T :!EW &89@P!D&9  8QJ? &$:
MKP!@&L0 7AOD %T<^P!<'/\ 7!O_ %P;_P!<&_\ U24  +TJ  "H*0  F"D
M (PH  "#)0  ?2(  'D?  !X&P, =AD/ '(:& !O'", ;1TM &L=-0!I'CT
M:!Y$ &8?2P!E'U( 8R!9 &(@80!A(&D 7R%S %TA?P!<(8T 6B*< %DBK !7
M(L  5B/A %4C^0!4(_\ 5"+_ %0B_P!4(O\ S2L  +8N  "B+@  DBX  (4M
M  !\*P  =B@  '(F  !O(P  ;2$, &HB%0!G(Q\ 920I &,D,0!B)3D 8"9!
M %\F2 !=)D\ 7"=6 %LG70!9)V8 6"AP %8H? !4*(H 4RF9 %$IJ@!0*;X
M3RG> $XI]P!-*?\ 32G_ $TH_P!.*/\ R#   + R  "<,@  C#(  ( Q  !V
M,   <"T  &LK  !H*0  9B@) &,H$0!@*1P 7BHE %PK+@!;*S8 62P] %@L
M1 !7+4P 52U3 %0M6P!3+6, 42YN % N>@!.+H@ 3"^7 $LOJ !)+[L 2"_;
M $@O]@!'+_\ 1R[_ $<M_P!(+?\ Q#0  *LU  "7-0  AS4  'LU  !R-
M:S(  &8O  !B+@  7RT% %PN$ !:+Q@ 6# B %8P*P!5,3, 4S$Z %(R0@!1
M,DD 4#)0 $XS6 !-,V$ 2S-K $HS=P!(-(4 1S25 $4TI@!#-+D 0C36 $(T
M] !"-/\ 0C/_ $(R_P!",O\ P#@  *<X  "3.   @S@  '<X  !M-P  9C8
M &$S  !=,@  63(" %<S#0!4-!4 4C4? %$U* !/-C  3C8X $PW/P!+-T8
M2C=. $DX5@!'.%\ 1CAI $0X=0!#.(, 03F3 $ YI  ^.;@ /3G3 #PY\P \
M./\ /3?_ #TW_P ]-O\ NSL  *([  "/.P  ?SL  ',[  !J.@  8CD  %TW
M  !8-@  5#<  %$X"P!/.1, 33D< $LZ)0!*.BT 2#LU $<[/ !&/$0 13Q+
M $0\4P!"/%P 03UG #\]<P ^/8$ /#V1 #H]HP Y/;8 .#W1 #<]\@ W//\
M.#O_ #@[_P X.O\ MCT  )X^  "+/@  ?#X  &\^  !F/0  7CT  %@[  !3
M.@  3SL  $P\" !)/1$ 1SX9 $8_(@!$/RH 0S\R $) .@!!0$$ 0$!) #Y!
M40 ]05H /$%D #I!<  X07\ -T&/ #5"H0 T0K0 ,D+. #)!\  R0/\ ,T#_
M #,__P T/O\ L4   )I   "'0   >$$  &Q!  !B0   6T   %0_  !./P
M2D   $9!!0!$0@X 0D,6 $!#'P _1"< /D0O #Q$-P [13X .D5& #E%3@ X
M1E@ -D9B #5&;@ S1GP ,4:- #!&GP N1K, +4;, "U&[P M1?\ +D3_ "Y#
M_P N0_\ K$,  )9#  "#0P  =$,  &A#  !?0P  5T,  %!#  !(0P  1$4
M $%& 0 ^1PP /$@3 #I('  Y220 .$DL #9)-  U2CL -$I# #-*3  R2E4
M,$M? "]+:P M2WH +$N+ "I+G0 H2[$ )TO* "=+[0 G2O\ *$G_ "A(_P I
M1_\ IT8  )%&  !_1@  <$8  &5&  !;1@  5$8  $Q'  !$2   /TH  #M+
M   W3 D -4T0 #-.&  R3B  ,4\H #!/,  O3S@ +D]  "Q02  K4%( *E!<
M "A0:  G4'< )5"( "10FP B4*\ (5#( "!0ZP A3_\ (D[_ ")-_P C3?\
MH4D  (Q)  !Z20  ;$H  &%*  !82@  4$H  $E+  ! 3   .TX  #50   Q
M4@0 +5,- "Q4%  J5!P *54D "A5+  G53, )E4\ "5610 D5DX (E99 "%6
M90 ?5G0 'E:% !Q6F  ;5JP &5;% !E6Z0 :5?\ &U3_ !M3_P <4O\ FTT
M (9-  !U30  :$T  %U-  !430  34X  $5/   \40  -E,  #%5   K6
M)EH) "-;$  B6Q< (5P? "!<)P ?7"X '5PW !Q=0  ;74H &EU5 !A=80 7
M77  %5V! !1=E0 37:H $5W" !%=YP 26_X $UK_ !-:_P 46?\ E%$  (!1
M  !P40  9%$  %E1  !140  25(  $%3   X5@  ,ED  "M;   E7@  'V$#
M !IC#  89!$ %V09 !9D(0 59"D %&4Q !-E.@ 2940 $650 !!E70 /96L
M#F5]  UED0 ,9:4 "F2\  IDX  +8_D #&+_  UA_P -8?\ C54  'I5  !K
M50  7U4  %95  !.50  1%<  #Q9   T7   +%\  "9B   ?90  &6@  !-K
M!0 0;0T #FX2  UN&@ ,;B( #&XK  MN-  *;CX "&Y*  =N5P &;F4 !&YV
M  )NB@  ;9\  &VV  !LU@  ;/,  6O_  )J_P #:O\ A5H  '1:  !F6@
M7%D  %-9  !(6@  /UT  #9@   N8P  )F<  !]J   9;0  $W$   YT P *
M=PH !7<0  %W%0  =QP  '<D  !X+0  >#<  'A#  !X4   >%X  'AO  !X
MA   >)D  '>P  !VS0  =?   '7_  !T_P  =/\ ?E\  &Y?  !B7@  65X
M $U?  !"8@  .64  #!H   G;   'W   !AT   2=P  #7L   A^   "@ @
M ($-  "!$0  @A<  (,>  "#)@  A#   (0[  "$2   A%<  (1H  "$?
MA),  (.J  ""Q0  @>L  ('^  " _P  @/\ =V4  &ED  !?8P  4F0  $=G
M   \:P  ,6\  "AS   @=P  &'P  !%_   ,@P  !H<   "*    C ,  (P)
M  "-#@  CA$  (\7  "0'@  D2<  )(R  "2/P  DDX  ))?  "2<P  DHL
M )&B  "1O   D.4  (_\  "._P  CO\ <6L  &9J  !8:P  2VT  #]Q   T
M=@  *GL  ""    7A0  $(D   N-   $D0   )4   "8    F0   )H#  ";
M"   G T  )X1  "?%@  H!X  *(H  "B-0  HT0  *-5  "C:0  HH   **:
M  "ALP  H-@  *#V  "?_P  G_\ ;G$  %]R  !1=0  1'D  #=^   LA
M(8H  !>/   0E   "ID   &=    H    *0   "G    J    *D   "J
MK 8  *T+  "O$   L!4  +(>  "T*0  M#D  +1*  "U70  M7,  +6.  "U
MJ   M,8  +/M  "R_P  LO\ 9GH  %=]  !)@@  /(<  "^.   CE   &)H
M !"?   )I    *D   "M    L    +0   "W    N    +D   "[    O
M +X"  # "   P@X  ,04  #''@  R"P  ,D]  #*4   RF8  ,I_  #*FP
MRK@  ,K=  #*]0  RO\ 7H8  $^+  !!D0  ,Y@  ">?   ;I0  $:L   FP
M    M0   +D   "]    P0   ,8   #(    R0   ,L   #,    S@   -
M  #2    U 4  -D,  #=$@  X1X  .(N  #C0@  Y%<  .5O  #FC   YJ@
M .7%  #EYP  YO8 5I0  $B;   ZH@  +*D  !^P   3M@  "[P   #!
MQ0   ,D   #-    T@   -8   #:    VP   -X   #@    X@   .0   #G
M    Z0   .T   #P"@  ]!$  /@?  #Y,@  ^D@  /M?  #\>@  _9<  /VO
M  #]QP  _>0 _P . /\ #0#_  P _P . /\ $P#_ !X _P J /\ -@#_ $(
M_P!- /\ 5P#_ %\ _P!G /\ ;@#_ '0 _P!Z /\ @0#] (< _ "- /H E #Y
M )P ]P"E /4 KP#T +P \P#/ /$ [ #P /X [P#_ .\ _P#C /\ UP#_ ,X
M_P#* /\ _P * /\ !@#_  0 _P ( /\ $ #_ !D _P E /\ ,0#_ #T _P!'
M /X 40#[ %D ^0!A /8 : #T &X \P!T /$ >@#O ($ [@"' .P C@#J )8
MZ "? .8 J0#C +4 X@#& .  XP#? /@ W0#_ -T _P#4 /\ R0#_ ,( _P"^
M /\ _P # /\   #_    _P ! /\ #0#_ !0 _0 @ /H *P#W #8 \P!! .\
M2P#L %0 Z !; .8 8@#C &@ X0!N -\ = #< 'H V@"! -@ B #4 )  T@"8
M ,\ H@#- *X RP"\ ,D TP#' /  Q@#_ ,0 _P#$ /\ NP#_ +8 _P"S /\
M_P   /\   #_    _P   /< " #P !  ZP : .< )0#D #  X0 [ -P 10#5
M $T T0!5 ,X 6P#+ &( R0!G ,< ;0#% ', PP!Z ,$ @0"_ (D O0"2 +L
MG "Y *< MP"U +4 R "S .8 L@#[ +$ _P"P /\ K@#_ *H _P"G /\ _P
M /\   #^    \0   .4  @#<  T TP 4 ,T 'P#* "H QP T ,0 /@#  $<
MO !. +H 50"W %L M0!A +, 9P"R &T L !S *X >@"L (( J@"+ *@ E0"G
M *  I0"M *, O@"A -L H #T )\ _P"> /\ GP#_ )T _P"; /\ _P   /P
M  #N    X    -    #%  @ O@ 0 +D &0"U ", LP N +  -P"M $  J@!(
M *@ 3P"E %4 HP!; *( 8 "@ &8 GP!L )T <P"; 'L F@"$ )@ C@"6 )H
ME0"G ), MP"1 ,P D #L (\ _P". /\ C@#_ (X _P"/ /\ _    .\   #;
M    R0   +T   "U  ( K@ , *D $P"E !T H@ G *  ,0"= #H F@!" )@
M20"6 $\ E !5 ), 6P"1 &  D !G (X ;0"- '4 BP!^ (D B0"( )4 A@"B
M (4 L0"# ,0 @0#D (  ^0!_ /\ @ #_ (  _P"  /\ ] (  . )  #'"
MMP<  *P#  "F    H  ' )L #P"8 !< E0 A )( *@"/ #, C0 \ (L 0P")
M $D AP!0 (8 50"$ %L @P!A ($ : "  '  ?@!Y 'P A ![ )  >0"= '@
MK !V +X =0#= ', ] !S /\ <P#_ ', _P!S /\ Z0T  ,\0  "Y$   J1
M )X.  "7"P  DP8  )  "P", !$ B0 : (8 ) "# "X @0 V '\ /@!] $0
M? !+ 'H 40!Y %< =P!= '8 9 !T &P <P%U '$!@ !O HT ;@*: &P#J@!K
M [L :036 &@&\0!H!_\ 9P?_ &<'_P!G!_\ WQ0  ,,7  "N%P  GA8  ),5
M  "+$@  AA   (0, @"#!@T @ ,4 'P%'@!Y!R@ =P@P '4(. !S"4  <@E&
M ' *3 !O"E, ;0M9 &P+80!J"VD :0QR &<,?@!F#(L 9 V9 &(-J0!A#;L
M8 W8 %X.\P!=#O\ 70[_ %T._P!=#O\ U!P  +D=  "D'@  E1T  (D<  "!
M&@  >Q<  '@3  !X$ 8 =PT/ ',.& !P#B( ;@\K &P0,P!J$#L :1!" &<1
M20!F$4\ 9!%6 &,270!A$F8 8!)O %X2>P!<$X@ 6Q.7 %D3IP!7%+H 5A35
M %45\P!4%?\ 5!7_ %05_P!4%/\ RB(  + B  "=(P  C2,  ($B  !Y(0
M<QX  &\;  !N%P  ;1,, &H4% !G%1X 918G &,6+P!A%S< 8!<^ %X810!=
M&$L 7!E2 %H96@!9&6( 5QIL %8:=P!4&H4 4AN4 %$;I !/&[< 3AO0 $T<
M\0!,'/\ 3!S_ $T<_P!-&_\ PR8  *HG  "6)P  AR@  'LG  !R)@  ;"0
M &@A  !F'@  9!L( &(;$0!?'!H 71TC %L>*P!:'C, 6!\Z %<?00!6($@
M5"!/ %,@5P!1(5\ 4"%I $XA= !-(8( 2R*1 $DBH@!((K0 1R+- $8C[P!%
M(_\ 12+_ $8B_P!&(?\ O"H  *0K  "1*P  @BP  '8K  !M*@  9BD  &(F
M  !?)   72($ %LA#@!8(A8 5B,? %0D* !3)#  4B4W % E/@!/)D4 3B9,
M $PF5 !+)UP 22=F $@G<0!&)W\ 12B/ $,HH !!*+( 0"C+ #\H[0 _*/\
M/RC_ $ G_P! )_\ MRT  )\N  ",+P  ?2\  '$O  !H+@  82T  %TK  !:
M*   5R<  %0G# !2*!, 4"D< $XI)0!-*BP 2RHT $HK.P!)*T( 2"Q) $8L
M40!%+%H 1"QD $(M;P! +7T /RV- #TMG@ \+;  .BW( #HMZP Z+?\ .BW_
M #HL_P Z+/\ LC   )LQ  "(,@  >3(  &TR  !D,@  73$  %@O  !5+
M42P  $\M"0!,+1$ 2BX9 $DO(@!'+RH 1C Q $4P. !#,#\ 0C%' $$Q3P!
M,5< /C%A #TR;0 [,GL .3*+ #@RG  V,J\ -3+' #0RZ0 T,O\ -3'_ #4Q
M_P U,/\ K3,  )8T  "$-0  =34  &DU  !@-0  630  %0S  !0,   3#$
M $DQ!@!',@\ 13,6 $,S'P!"-"< 0#0N #\U-@ ^-3T /35$ #PV3  Z-E4
M.39? #<V:P V-G@ -#>) #(WF@ Q-ZT +S?% "\WZ  O-OX ,#7_ # U_P P
M-/\ J38  )(V  " -P  <C@  &8X  !=-P  5C<  % V  !+-   1S4  $0V
M P!!-PT /S@4 #XX'  \.20 .SDL #HY,P Y.CH .#I" #8Z2@ U.E, -#M=
M #([:  P.W8 +SN' "T[F0 L.ZP *CO# "D[Y@ J.OT *CK_ "LY_P L./\
MI#@  (XY  !\.@  ;CH  &,Z  !:.@  4SH  $TZ  !&.   0CH  #\[   \
M/ L .CP1 #@]&0 W/2$ -CXI #0^,  S/C< ,C\_ #$_1P P/U  +C]: "U
M9@ K0'0 *4"$ "A EP F0*H )4#! "1 Y0 D/_P )3[_ "8]_P F/?\ GSL
M (H\  !X/0  :CT  %\]  !6/0  3ST  $D]  !"/0  /#X  #D_   V00@
M-$$/ #)"%@ Q0AX +T,E "Y#+0 M0S0 +$0\ "M$1  J1$T *$18 "=%8P E
M17$ (T6" ")%E0 @1:@ 'T6_ !Y$XP ?1/L 'T/_ "!"_P A0?\ FCX  (4_
M  !T0   9T   %Q   !30   3$   $9    ^00  .$,  #1%   P1@, +4<-
M "M($@ J2!H *4@B "A)*0 G23$ )4DY "1)00 C2DH (DI5 "!*80 ?2F\
M'4I_ !M*D@ :2J8 &$J] !=*X  82?H &4C_ !I'_P :1_\ E4(  (!"  !P
M0P  8T,  %A#  !00P  24,  $)$   [10  -4<  #!)   K2P  )DT) "1.
M$  B3A8 (4\= "!/)0 ?3RP 'D\U !U//0 <4$< &E!1 !E070 74&L %E!\
M !10CP 34*0 $5"Z !%0W@ 13_@ $D[_ !--_P 43?\ CT4  'M&  !K1@
M7T<  %5'  !-1P  1D<  #]'   W2@  ,4P  "M.   F4   (%,# !Q5#  :
M5A$ &588 !=6(  65B< %58P !16.0 35T( $E=- !%760 05V@ #U=Y  Y7
MC  -5Z  "U>V  M6U  +5O0 #%7_  U4_P .4_\ B$D  '9*  !G2@  6TH
M %%*  !*2@  0TH  #M,   S3@  +%$  "94   A5@  &UD  !5<!P 17@T
M$%X3 !!>&@ .7B( #EXJ  U>,P ,7CT "UY(  I>5  (7F( !UYS  5>A@ #
M7IL  EZQ  )=S  "7>X  US_  1;_P %6_\ @4X  '!.  !B3@  5TX  $Y.
M  !'3@  /D\  #91   N5   )U<  "%:   ;70  %6   !!C P ,9@L "&<0
M  9G%0 %9QP !&<D  )G+0 !9S<  &="  !G3@  9UP  &=M  !G@   9I4
M &:L  !EQP  9>L  &3\  !D_P  8_\ >E(  &I3  !=4@  5%(  $M2  !"
M4P  .54  #!8   H6P  (5\  !IB   490  $&@   QK 0 &;@D  &\.  !O
M$@  ;Q@  ' ?  !P)P  <3   '$[  !Q2   <58  '%F  !Q>0  <8\  '"G
M  !OP0  ;^<  &[\  !M_P  ;?\ <U@  &57  !:5P  458  $97   \6@
M,ET  "IA   B9   &F@  !1L   .;P  "G(   1V    > 4  '@+  !Y#@
M>A,  'L9  !\(   ?2D  'TS  !]0   ?4X  'U>  !]<@  ?8@  'RA  !\
MN@  >^(  'KZ  !Y_P  >/\ ;5T  &!<  !77   2UT  $!?   U8P  *V<
M "-K   :;P  $W,   YW   (>P   GX   ""    @P$  (0&  "%"P  A@\
M (@3  ")&0  BB$  (LK  "+-P  C$8  (M6  "+:0  BX   (N9  "*LP
MB=@  (CW  "(_P  A_\ :&,  %YB  !18@  1&4  #AI   N;@  )',  !IX
M   3?0  #8$   :%    B0   (T   "0    D@   )(   "4!0  E0H  )<.
M  "8$@  FA@  )LA  "<+0  G3P  )U,  "<7P  G'8  )N1  ";JP  FLD
M )KP  "9_P  F/\ 96D  %=I  !);   /7$  #!V   E?   &X$  !*'   ,
MC   !)$   "5    F0   )T   "@    H0   *(   "D    I0$  *<'  "I
M#   JA$  *T8  "O(@  KS   *]!  "O5   KVL  *Z%  "NH0  KKX  *WF
M  "L_   K/\ 7G$  $]T  !">0  -7\  "B%   =C   $Y(   R8   #G0
M *(   "F    J@   *X   "P    L0   +,   "T    M@   +@   "Z!
MO H  +X0  #!%P  PR0  ,,U  #$20  Q%X  ,5W  #%DP  Q:\  ,71  ##
M\@  P_\ 5GP  $>"   ZB   +(\  ""6   4G0  #:,   .I    K@   +(
M  "W    NP   +\   #"    P@   ,4   #&    R    ,H   #-    SP
M -((  #5#@  VQ@  -TG  #>.@  WU   .!H  #@A   X:$  .&]  #AX@
MX/0 3HL  $"2   RF0  ):$  !BH   .KP  !;4   "Z    OP   ,0   #(
M    S@   -$   #4    U0   -@   #:    W0   -\   #B    Y    .<
M  #K!0  [PX  /09  #U*P  ]D$  /=8  #X<@  ^9   /FK  #XQ   ^.$
M_P + /\ " #_  D _P , /\ $@#_ !H _P F /\ ,@#_ #X _P!( /\ 4@#_
M %H _P!B /\ :0#_ &\ _P!U /X >P#\ ($ ^P"( /D CP#W )< ]0"@ /,
MJ@#R +< [P#) .T Y@#L /L ZP#_ .L _P#= /\ S@#_ ,8 _P#" /\ _P $
M /\   #_    _P % /\ #0#_ !4 _P A /\ + #_ #@ _P!# /T 3 #Y %0
M]P!< /0 8P#R &D \ !O .X =0#L 'L Z@"" .@ B0#G )$ Y ": .( I #@
M +  W0#  -H W #8 /0 U0#_ -, _P#+ /\ P0#_ +L _P"W /\ _P   /\
M  #_    _P   /\ "@#] !$ ^0 ; /8 )P#T #( \  \ .P 1@#H $X Y !6
M .$ 7 #> &, W !H -D ;@#5 '0 T@![ -  @@#- (H RP"3 ,@ G0#& *@
MQ "W ,$ S #  .L O@#_ +T _P"] /\ M #_ *X _P"K /\ _P   /\   #_
M    ^@   /( !0#J  X Y0 6 .  (0#= "L VP V -, /P#. $@ R@!/ ,<
M5@#$ %P P@!A ,  9P"^ &T O !S +H >@"X (( M@"+ +0 E@"R *$ L "O
M *X P0"M .  JP#W *H _P"I /\ I@#_ *$ _P"? /\ _P   /\   #W
MZ    -P   #0  H R@ 1 ,4 &P#" "4 OP O +P . "X $$ M0!( +( 3P"P
M %4 K@!; *P 80"J &8 J !L *< <P"E 'L HP"$ *$ C@"? )H G0"G )L
MN ": -  F0#O )@ _P"7 /\ E@#_ )0 _P"2 /\ _P   /8   #D    T@
M ,4   "[  4 M0 . +  %0"L !\ J@ I *@ ,@"E #H H@!" *  20"> $\
MG !5 )H 6@"8 &  E@!F )4 ; "3 '0 D@!] )  AP". ), C "A (L L "*
M ,4 B #F (< ^P"& /\ AP#_ (< _P"& /\ ^    .4   #-    O0   +,
M  "J    HP * )\ $0"; !D F0 C )< + "5 #0 D@ \ )  0P". $D C !/
M (H 5 ") %H AP!@ (8 9@"$ &X @P!W ($ @0!_ (T ?@"; 'P J@![ +P
M>@#; '@ ]0!X /\ > #_ '@ _P!X /\ [0   -$"  "[ @  K $  *(   ";
M    E@ % )$ #0"- !0 BP = (@ )@"& "X A  V (( /0"  $, ?@!) 'T
M3P!\ %4 >@!; 'D 80!W &D =0!Q '0 ? !R (@ <0"6 &\ I0!N +8 ;0#.
M &P [@!K /\ :P#_ &L _P!K /\ WPL  ,(,  "N#   G@P  ),+  ",!P
MB (  (4 "0"! !  ?P 7 'P ( !Z "@ >  P '8 . !T #X <P!$ '$ 2@!P
M %  ;@!6 &T 70!L &0 :@!M &@ =P!G (0 90"2 &0 H0!C +( 80#) &
MZ0!@ /P 8 #_ &  _P!@ /\ T!   +81  "B$@  DQ(  (@1  " #P  ? T
M 'D) 0!X PL =0 1 ', &@!P ", ;@$K &P!,P!J CD :0-  &<#1@!F!$P
M9012 &,%60!B!6$ 8 5J %\&= !=!H$ 7 >/ %H'GP!9![  5P?& %8)YP!6
M"OL 50K_ %4*_P!6"O\ QA4  *T7  "9&   BA@  '\7  !V%@  <1,  &X0
M  !M#04 ;0D- &H)% !G"AT 90HF &,++@!B##4 8 P\ %\,0@!>#4@ 7 U/
M %L-5@!9#5X 6 YH %8.<P!5#H  4PZ/ %$.GP!0#K$ 3@[( $T0Z@!-$/T
M31#_ $T0_P!-$/\ O!L  *4<  "2'0  @QX  '<=  !O'   :1H  &87  !D
M%   9! ( &(/$ !?$!@ 71 A %L1*0!:$3$ 6!(X %<2/@!6$D4 5!), %,3
M4P!1$UL 4!-E $X4< !,%'T 2Q2, $D4G !'%:X 1A7% $45Z !%%OX 11;_
M $45_P!%%?\ M1\  )XA  "+(@  ?"(  '$B  !H(0  8A\  %\=  !<&@
M6Q<" %H5#0!7%A0 518= %07)0!2&"T 41@T $\8.P!.&4( 31E( $L:4 !*
M&E@ 2!IB $<:;0!%&WH 0QN) $(;F@! &ZP /QO" #X<Y0 ]'/P /AS_ #X;
M_P ^&_\ KR,  )@D  "&)0  =R8  &PF  !C)0  720  %DB  !6'P  5!T
M %,<"P!1'!( 3AT: $T=(@!+'BD 2AXQ $D?-P!''SX 1B!% $4@30!#(%4
M0B!? $ A:@ _(7< /2&' #LAF  Y(:H ."+  #<BXP W(OL -R+_ #@A_P X
M(?\ JB8  )0G  "!*0  <RD  &<I  !?*0  6"@  %0F  !1(P  3R(  $PB
M!P!*(A  2"(7 $<C'P!%)"8 1"0N $(D- !!)3L 0"5# #\E2@ ])E, /"9<
M #HF9P Y)G4 -R>$ #4GE@ T)Z@ ,B>^ #$GX0 Q)_D ,B;_ #(F_P S)?\
MI2D  (\J  !]+   ;RP  &0M  !;+   52L  % J  !,*   2B8  $<G! !$
M)PT 0B@4 $$H'  _*2, /BDK #TI,@ \*CD .RI  #DJ2  X*U  -BM: #4K
M90 S*W( ,2N" # LE  N+*< +"R\ "LLW@ L+/@ +"O_ "TJ_P M*O\ H2P
M (LM  !Y+@  :R\  & O  !8+P  42X  $PN  !(+   12L  $$K   _+ L
M/2P1 #LM&0 Z+B$ .2XH #<N+P V+S8 -2\^ #0O10 S+TX ,3!8 # P8P N
M,'  +#"  "HPD@ I,*4 )S"Z "8PW  F,/< )R__ "@O_P H+O\ G"X  (<P
M  !V,0  :#(  %TR  !5,@  3C$  $@Q  !$,   0"\  #PP   Z,0D -S$0
M #8R%@ U,AX ,S,E #(S+  Q,S, ,#0[ "\T0P M-$P +#16 "HU80 I-6X
M)S5^ "4UD  C-:, (C6Y "$UV0 A-/8 (C3_ ",S_P C,O\ F#$  (,S  !R
M-   930  %HU  !1-0  2S0  $4T  ! -   .C,  #<T   T-08 ,C8. # W
M$P O-QL +C<B "TX*0 K.#$ *C@X "DY0  H.4D )CE3 "4Y7P C.6P (3I\
M " ZC@ >.J( '#JW !LYU0 <.?4 '3C_ !TX_P >-_\ DS0  '\V  !N-P
M83<  %<W  !.-P  2#<  $(W   \-P  -3@  #(Y   O.@( +#L+ "H\$0 I
M/!@ *#T? "8])@ E/2X )#TU ",^/0 B/D8 (#Y0 !\^7  =/VD &S]Y !H_
MC  8/Z  %C^U !4^T@ 6/O, %SW_ !@\_P 8//\ CC<  'HX  !J.0  7CH
M %,Z  !+.@  13H  #\Z   Y.@  ,CP  "X^   I0   )D$( "1"#@ B0A0
M(4(; "!#(P ?0RH 'D,R !Q#.@ ;1$, &D1- !A$60 71&< %41W !-$B@ 2
M1)X $42S !!$T  00_( $4+_ !)"_P 30?\ B3L  '8\  !F/0  6CT  % ]
M  !(/0  0CT  #P]   V/@  +T   "I"   E1   (48# !U(#  ;21$ &4D7
M !A)'@ 7228 %DDN !5*-@ 42D  $TI* !%*5@ 02F0 #TIT  Y*AP -2IL
M#$JP  I*R@ +2>P #$C_  U'_P -1_\ @SX  '$_  !B0   5D   $U   !%
M0   /T   #E!   R0@  *T4  "9'   A20  '$L  !9.!P 34 X $E 3 !%0
M&0 04"$ #U I  Y0,0 -4#L #5%&  M140 *45\ "5%O  =0@0 %4)8  U"K
M  )0Q0 #3^@  T_[  5._P &3?\ ?4(  &M#  !=1   4D0  $I$  !#0P
M/$0  #5%   N1P  )TH  "%,   <3P  %U$  !)4 P .5PH "U@0  I8%0 (
M6!P !U@D  98+  %6#8  UA   %83   6%H  %AI  !8?   6)$  %>G  !7
MP   5N4  %;Y  !5_P  5?\ =D<  &9'  !92   3T<  $='  ! 1P  .$@
M #!*   I30  (E   !Q3   650  $5@   U; @ )7@D !%\.  !?$@  7Q@
M & ?  !@)P  8#   & [  !@1P  8%0  &!C  !@=@  8(L  %^B  !?NP
M7^(  %[Y  !=_P  7?\ ;TL  &%,  !53   3$L  $1+   [3   ,DX  "M1
M   C5   '%<  !9;   17@  #6    AC   "9@<  &<,  !G#P  :!,  &D9
M  !J(0  :BD  &HT  !J0   :DT  &I=  !J;P  :H4  &J=  !IM@  :-T
M &CW  !G_P  9O\ :5$  %Q0  !24   2D\  #]0   U4P  +58  "19   =
M70  %F   !!D   ,9P  !FH   !N    ;P,  ' (  !Q#0  <A   '04  !U
M&P  =B,  '<L  !W.   =D8  '96  !V:   =GX  ':7  !UL0  =-,  '/U
M  !S_P  <O\ 8U8  %A5  !05   1%4  #E8   O6P  )E\  !UC   59P
M$&P   IP   $<P   '8   !Z    ?    'P#  !^"   ?PP  ($0  ""%
MA!L  (4D  "&+P  ACT  (9-  "%7P  A74  (6/  "$J0  @\D  (+Q  "!
M_P  @/\ 7UL  %9:  !)6P  /5X  #)A   G9@  'FL  !5P   .=0  "7D
M  %^    @0   (4   "(    B@   (L   "- 0  C@8  ) +  "1#P  DQ0
M )4;  "7)@  ES0  )=$  "75@  EFP  )6&  "5H@  E,$  )/J  "2_P
MDO\ 76$  $]A  !"9   -FD  "IN   ?=   %7D   Y_   'A    (D   ".
M    D@   )8   "8    F@   )L   "=    GP   *$#  "C"   I0T  *<3
M  "I'   JB@  *HY  "J2P  JF$  *EZ  "HF0  J+4  *?=  "G^   IO\
M5F@  $AL   Z<   +G8  ")]   7A   #HH   >0    E@   )H   "?
MHP   *<   "J    JP   *T   "O    L0   +,   "U    N 4  +H,  "]
M$@  P!P  , M  # 0   OU4  +]N  "^BP  OJ@  +[)  "][P  O/X 3G0
M $!Y   R?P  )8<  !F.   0E0  !YP   "B    IP   *P   "P    M0
M +D   "\    O0   +\   #!    PP   ,8   #(    R@   ,T"  #0"P
MU1(  -8A  #7-   V$D  -E@  #:?   VIH  -NU  #;V0  V_( 1H(  #B)
M   KD   '9@  !*@   *IP   *X   "T    N0   +X   #"    R    ,L
M  #.    SP   -(   #4    U@   -H   #=    WP   .(   #F    Z@H
M .\3  #P)0  \CH  /-1  #T:P  ](D  /6E  #UOP  ]=T _P & /\  P#_
M  4 _P + /\ $ #_ !< _P B /\ +0#_ #D _P!$ /\ 30#_ %4 _P!= /\
M9 #_ &H _P!P /T =@#[ 'P ^0"# /< B@#U )( \P"; /  I@#N +, ZP#$
M .D Y #G /D Y@#_ .4 _P#3 /\ QP#_ +\ _P"[ /\ _P   /\   #_
M_P " /\ "P#_ !( _P = /\ * #_ #, _P ^ /P 1P#X $\ ] !7 /$ 70#N
M &, [ !I .H ;P#H '4 Y@!\ .0 @P#B (L WP"5 -P GP#9 *L U0"[ -(
MU #/ /( S0#_ ,P _P#% /\ N@#_ +0 _P"P /\ _P   /\   #_    _P
M /\ !@#Y  \ ]0 7 /, (@#Q "T [0 W .< 0 #B $D WP!0 -L 5P#7 %T
MU !C -$ : #/ &X S !U ,H ? #( (0 Q0"- ,( F #  *0 O0"R +L Q@"Y
M .@ N #] +< _P"V /\ K0#_ *< _P"C /\ _P   /\   #_    ]0   .L
M 0#D  P W@ 3 -D ' #3 "8 T0 P ,P .@#( $( Q !* ,  4 "] %8 NP!<
M +D 80"W &< M0!M +, = "Q 'P KP"% *T D "J )P J "J *8 NP"E -H
MHP#U *, _P"B /\ G@#_ )H _P"7 /\ _P   /X   #O    WP   -    #'
M  < P0 / +P %P"Y "  MP J +4 ,P"P #L K0!# *L 20"H $\ I@!5 *0
M6@"C &  H0!F )\ ;0"= '0 G !] )H B "8 )0 E@"B )0 L@"2 ,D D0#K
M )$ _P"0 /\ D #_ (P _P"* /\ _    .P   #9    QP   +H   "Q  (
MJP , *< $@"D !L H0 D *  + "> #4 FP \ )@ 0P"6 $D E !/ )( 5 "0
M %H CP!? (T 9@"+ &T B0!V (@ @ "& (P A ": (( J@"! +X @ #@ (
M^0!_ /\ ?P#_ '\ _P!^ /\ \0   -@   #"    LP   *@   "@    F0 '
M )4 #@"2 !4 D  > (X )@"- "X B@ V (< /0"% $, A !) (( 3@"! %0
M?P!9 'X 8 !\ &< >@!O 'D >@!W (8 =0"4 '0 HP!R +4 <@#/ '$ \0!P
M /\ < #_ '  _P!Q /\ X0   ,0   "P    H@   )<   "1    BP " (8
M"P"# !$ @0 8 '\ (0!] "D ?  P 'D -P!X #T =@!# '0 20!S $X <@!4
M '  6@!O &( ;0!J &L = !J (  : ". &< G0!E *\ 90#& &0 Z !D /T
M8P#_ &, _P!D /\ SP4  +8'  "C"   E @  (D'  "" P  ?@   'L !@!W
M  X =0 3 '( &P!Q ", ;P K &T ,@!L #@ :@ ^ &D 1 !G $D 9@!/ &4
M5@!C %T 8@!E &  ;P!? 'L 70") %P F0!; *H 60"_ %D X0!8 /@ 6 #_
M %@ _P!9 /\ P@P  *H-  "7#@  B0X  'T.  !V#0  <0H  &\&  !M  H
M:P 0 &D %@!G !X 90 F &, +0!A #, 8  Y %\ /P!= $4 7 !+ %L 4@!:
M %D 6 !B %< ; !5 '@ 4P"& %( E@!1 *< 4 "[ $\!VP!. O0 3@/_ $X$
M_P!. _\ N!   *$2  ".$P  ?Q,  '03  !L$@  9Q   &4.  !C"P, 8P8,
M &$$$0!> QD 7 0A %L%* !9!B\ 6 8U %8'.P!5!T( 5 =( %,(3P!1"%8
M4 E? $X):0!-"78 2PJ$ $D*E !("J8 1PJZ $8*V !%"_, 10S_ $4,_P!%
M#/\ L!0  )D6  "'&   >!D  &T8  !E%P  7Q8  %P3  !:$0  6@X& %H,
M#0!7#!0 50P< %,-) !2#2L 4 TQ $\.. !.#CX 30Y% $L.30!*#E4 2 ]>
M $</: !%#W4 0Q"$ $$0E0! $*8 /A"[ #T0W  ]$?8 /1'_ #T0_P ^$/\
MJ1D  )(;  "!'   <AT  &<=  !?'   61L  %49  !3%@  4A,  %(1"@!0
M$!  3A$8 $P1( !*$B< 21(N $@3- !'$SL 11-" $0320!#%%( 011; #\4
M90 ^%7( /!6! #H5D@ X%:0 -Q6Y #45V  U%O4 -A;_ #86_P W%?\ HQP
M (T>  ![(   ;2$  &(A  !:(0  5!\  % >  !-&P  3!D  $L6!@!)%@X
M1Q<5 $47' !$&"0 0A@J $$8,0! &3@ /QD_ #T91@ \&D\ .AI8 #D:8P W
M&V\ -1M^ #,;D  R&Z( ,!NW "\;TP O'/, +QO_ # ;_P P&_\ G1\  (@B
M  !W(P  :20  %XD  !6)   4",  $LB  !((   1AT  $4< @!#' P 01P2
M #\=&0 ^'2$ /!XG #L>+@ Z'S4 .1\\ #<?1  V'TP -"!6 #,@8  Q(&T
M+R!\ "TAC@ L(:  *B&U "DAT  I(?( *2'_ "H@_P K(/\ F2(  (0E  !S
M)@  92<  %LG  !3)P  3"8  $<E  !$)   0B$  #\A   ](0D .R$0 #DB
M%@ X(AX -B,E #4C*P T)#( ,R0Y #(D00 P)$H +R53 "TE7@ K)6L *B5Z
M "@EC  F)9\ )"6S ",ES@ C)?  )"7_ "4D_P E)/\ E"4  ( G  !O*0
M8BH  %<J  !/*@  22D  $0H  ! )P  /28  #HE   W)@8 -28. #0G%  R
M)QL ,2@B # H*0 O*#  +2DW "PI/P K*4< *2E1 "@J7  F*FD )"IX ",J
MB@ A*IT 'RJR !XJS  >*N\ 'RG_ " I_P A*/\ D"@  'PJ  !L*P  7RP
M %0L  !,+   1BP  $$K   \*P  ."H  #4J   R*P, ,"L, "XL$0 M+!@
M+"P? "HM)@ I+2T *"TT "<N/  F+D4 )"Y/ ",N6@ A+V< 'R]V !TOB  <
M+YL &B^P !@OR@ 8+NT &2[_ !LM_P ;+?\ C"L  '@M  !H+@  6R\  %$O
M  !)+P  0R\  #XN   Y+@  -"X  # N   M+P  *S * "DQ$  G,14 )C$<
M "4R(P D,BH (S(Q "$S.0 @,T( 'S-, !TS5P ;,V0 &C1T !@TA@ 6-)H
M%#.N !,SR  3,^P %#/_ !4R_P 6,?\ ARX  '0O  !E,0  6#$  $XR  !&
M,@  0#$  #LQ   V,0  ,3$  "LS   H-   )34& ",V#0 A-A( (#<9 !\W
M(  >-R< '3@N !LX-@ :.#\ &3A) !<Y50 5.6( %#EQ !(YA  1.9@ $#FM
M  XXQP ...L $#C_ ! W_P 1-O\ @S$  ' R  !A-   530  $LT  !$-
M/30  #@T   S-   +34  "@W   D.0  (#H" !T["P ;/!  &3T5 !@]'  7
M/2, %CTK !4^,P 4/CP $CY& !$^4@ 0/E\ #SYO  X^@0 ,/I4 "SZI  H^
MP0 */>0 "SW[  P\_P -._\ ?30  &LV  !=-P  43<  $@W  !!-P  .S<
M #4W   P-P  *CD  "4[   @/0  '#\  !=!!@ 40PT $D,2 !%#&  10Q\
M$$0G  ]$+P .1#D #41#  Q$3@ +1%L "41J  =$?  &1)  !$.E  )#O0 #
M0^   T/V  1"_P &0?\ >#@  &<Y  !9.@  3CH  $4Z   ^.@  .#H  #,Z
M   M.P  )ST  "%    <0@  %T0  !-& P /20H #4H/  Q*%  +2AL "4HC
M  A**P '2C0 !4H^  1*20 "2E8  $IE  !*=P  2HL  $JA  !)N0  2=T
M $GU  !(_P  2/\ <CP  &(]  !5/@  2CX  $(]   \/0  -CT  "\^   I
M0   (T(  !U%   71P  $TH   ], @ +3PD !U -  -1$0  41<  %$>  !1
M)@  42\  %$Y  !11   4E$  %)@  !1<@  48<  %&=  !1M0  4-@  %#U
M  !/_P  3_\ ;$   %U!  !100  1T$  $!    Y0   ,D$  "I#   D1@
M'D@  !=+   23@  #E$   M3 0 &5@<  %<,  !8$   6!,  %D9  !:(0
M6BD  %HS  !:/P  6DP  %I:  !:;   6H$  %F9  !9L0  6-$  %CT  !7
M_P  5_\ 944  %A%  !-10  140  #Y$   U10  +4<  "5*   >30  &%
M !)3   .5@  "ED   1<    7@0  %\)  !@#0  81   &(5  !C&P  9",
M &0M  !D.   9$4  &14  !D9@  9'L  &.3  !CK0  8LP  &'R  !A_P
M8/\ 7TH  %-*  !*20  0T@  #E)   O3   )T\  !]2   850  $ED   U=
M   (8    F,   !F    : $  &D%  !J"@  :PT  &T1  !N%@  <!T  '$F
M  !Q,0  <#X  '!.  !P7P  <',  &^-  !OIP  ;L8  &WO  !L_P  ;/\
M6D\  %!.  !(30  /4X  #-1   I5   (%@  !A<   18   #&0   9H
M:P   &\   !R    =    '4   !W!   > D  'H-  !\$   ?18  '\>  "
M*   @#4  (!%  !_5@  ?VL  '^$  !^H   ?;X  'SI  ![_P  >O\ 5E0
M $Y3  !"5   -U8  "Q:   B7P  &&,  !%H   +;0   W(   !V    >@
M 'T   "     @P   (0   "&    AP(  (D'  "+#   C1   ) 6  "2'P
MDBP  )([  "230  D6(  )%Z  "/EP  C[0  ([A  ",^P  C/\ 55D  $A:
M   [70  +V$  "1F   9;   $7(   IW   "?0   ((   "&    BP   (X
M  "1    DP   )4   "7    F0   )L   "=!   GPH  *(/  "D%@  IB$
M *8Q  "F0P  I5<  *1P  "CC@  HZL  *'0  "@]0  G_\ 3F$  $!D   S
M:0  )VX  !MU   1?   "X,   ")    C@   ),   "8    G0   *$   "D
M    I0   *<   "I    JP   *T   "P    L@   +4(  "X#@  O!8  +PE
M  "\-P  NTP  +ID  "Y@0  MZ(  +?   "WZ@  M_P 1FL  #EP   K=P
M'W\  !.&   +C@   94   ";    H0   *8   "K    L    +,   "W
MMP   +H   "\    OP   ,$   #$    QP   ,H   #-!0  T0X  -09  #4
M*P  U$   --8  #3=   TY(  -*P  #2TP  TO( /GD  #&    CB   %Y$
M  V9   #H    *<   "N    LP   +@   "]    P@   ,8   #*    R@
M ,T   #/    T@   -4   #9    W0   -\   #C    YP4  .L/  #L'P
M[3,  .Y+  #O9   [X(  /"?  #QN0  \=@ _P   /\   #_  0 _P ) /\
M#@#_ !4 _P > /\ *0#_ #0 _P _ /\ 2 #_ %  _P!8 /\ 7@#_ &4 _0!K
M /L <0#Y '< ^ !^ /8 A0#S (T \0"7 .X H@#K *\ Z #  .8 X #C /@
MX@#_ -L _P#+ /\ P0#_ +D _P"T /\ _P   /\   #_    _P   /\ "0#_
M !  _P 9 /\ (P#_ "X _0 Y /D 0@#U $H \@!2 .X 6 #K %X Z0!D .8
M:@#D '  X@!V -\ ?0#= (8 V0"/ -4 F@#1 *< S@"V ,L S@#) /  QP#_
M ,4 _P"[ /\ M #_ *T _P"I /\ _P   /\   #_    _P   /L  @#V  T
M\0 3 .T '@#L "@ Z0 R ., .P#= $0 V !+ -, 40#0 %@ S0!= ,L 8P#)
M &@ Q@!O ,0 =@#" 'X OP"' +P D@"Z )\ MP"M +4 P0"R .0 L0#] *\
M_P"L /\ I0#_ *  _P"< /\ _P   /\   #[    [@   .0   #<  @ TP 0
M ,\ & #+ "( R0 K ,8 - #! #T O0!$ +H 2P"W %$ M0!6 +( 7 "P &$
MK@!G *P ;@"J '8 J !_ *8 B@"C )8 H0"E )\ M@"= -$ G #S )L _P"<
M /\ E@#_ ), _P"0 /\ _P   /8   #G    TP   ,8   "]  , N  - +,
M$P"Q !P KP E *X +@"I #8 I@ ] *, 1 "A $H GP!/ )T 50"; %H F@!@
M )@ 9@"6 &X E !W )( @0"0 (X C@"< (P K0"* ,, B0#H (@ _P") /\
MAP#_ (4 _P"" /\ \P   .,   #,    O    +    "G    H0 ( )X #P";
M !8 F0 ? )@ )P"6 "\ DP W )$ /0". $, C !) (L 3@") %0 AP!9 (4
M8 "$ &< @@!O (  >@!^ (8 ? "4 'H I !Y +@ > #8 '< ]P!X /\ > #_
M '< _P!U /\ Y@   ,L   "W    J    )X   "6    CP $ (L # "( !(
MAP 9 (4 (0"$ "D @@ P '\ -P!] #T ? !# 'H 2 !Y $T =P!3 '8 60!T
M &$ <@!I '$ <P!O '\ ;0"- &P G0!J *\ :0#( &@ [0!I /\ :0#_ &D
M_P!I /\ T@   +@   "E    EP   (T   "&    @0   'P " !Y  X =P 4
M '8 ' !T ", <P K '$ ,0!O #< ;@ ] &P 0P!K $@ :@!. &@ 5 !G %L
M90!C &, ;0!B '@ 8 "' %\ E@!= *@ 70"^ %P Y !< /L 7 #_ %P _P!<
M /\ P@   *H!  "8 P  B00  '\"  !X    =    '  ! !M  P :P 1 &D
M%P!H !X 9@ E &4 + !C #( 8@ X &  /0!? $, 7@!) %P 3P!; %8 6@!>
M %@ : !7 ', 50"! %0 D0!2 *, 40"W %$ U@!1 /4 40#_ %$ _P!2 /\
MM@<  )\)  "-"P  ?@P  ',+  !L"@  : <  &4#  !C  < 80 - %\ $P!=
M !H 7  A %L )P!9 "T 6  S %8 .0!5 #\ 5 !% %, 2P!1 %( 4 !: $\
M9 !- &\ 3 !] $H C0!) )\ 2 "R $< S !' .\ 1@#_ $< _P!' /\ K P
M )4.  "#$   =1   &L0  !C#P  7@X  %L,  !:"0( 600* %< #P!5 !4
M4P < %( (P!1 "D 3P O $X -0!- 3L 3 %! $H"2 !) D\ 2 )7 $8#80!%
M VT 0P-Z $(#BP!  YP /P.O #X#R  ]!.H /07\ #T&_P ^!O\ I!   (X2
M  !\$P  ;A0  &04  !<$P  5A(  %,1  !1#@  4 P% % )# !/!Q$ 30<7
M $L('P!)""4 2 DK $<),0!&"3@ 1 H^ $,*10!""DT 0 M5 #\+7P ]"VL
M/ MY #H,B@ X#)P -PRO #4,QP U#.D -0W] #4-_P V#/\ G1,  (<5  !V
M%P  :1@  %X8  !6&   4!<  $T5  !*$P  21$  $D.!P!(#0X 1@T3 $0-
M&@!##B$ 0@XH $ .+@ _#C4 /@\\ #T/0P [$$L .A!4 #@07@ V$&L -!!Y
M #(0B@ Q$)P +Q"P "T0R0 M$>P +1'_ "X1_P O$/\ EQ8  ((9  !Q&P
M9!P  %D<  !1'   3!L  $<:  !$&   0Q4  $(3 @!!$@L 0!$0 #X2%P \
M$AX .Q,E #H3*P X$S( -Q,Y #840  T%$@ ,Q11 #$47  P%6@ +A5W "P5
MB  J%9H *!6N "<5QP F%>H )Q7_ "@5_P I%?\ D1H  'T<  !M'@  8!\
M %8?  !.'P  2!X  $,=  ! '   /AH  #T8   [%P< .18. #@7%  V%QL
M-1@B #,8*  R&"\ ,1DV # 9/0 N&48 +1I/ "L:60 J&F8 *!IT "8:A@ D
M&ID (AJM "$:Q0 @&N@ (1K^ "(:_P C&O\ C1T  'D?  !I(0  7"(  %(B
M  !*(@  1"$  #\A   \(   .1X  #@;   U' 0 -!P- #(<$@ P'1@ +QT?
M "X=)0 M'BP *QXS "H>.P I'T, )Q]- "8?5P D'V0 (A]R " ?A  ?'Y<
M'1^K !L?PP ;'^< &Q_] !T?_P >'O\ B2   '4B  !E(P  620  $\E  !'
M)0  020  #PC   X(P  -2(  #,@   P( $ +B$* "PA$  K(14 *B(< "@B
M(P G(BD )B,P "4C.  C(T$ (B1* "$D50 ?)&$ '21P !LD@@ 9))4 %R2J
M !8DP0 5).4 %B3\ !<C_P 9(_\ A2(  '$D  !B)@  5B<  $PG  !$)P
M/B<  #DF   U)@  ,24  "XD   K)0  *24' "<F#@ E)A, )"<9 ",G(  B
M)R< (2@N " H-@ >*#X '2A( !LI4P 9*5\ &"EN !8I@  4*90 $BFH !$I
MP  1*.0 $2C[ !,H_P 4)_\ @"4  &XG  !?*   4RD  $DJ  !"*0  .RD
M #8I   R*   +B@  "HH   F*0  )"H$ "(K#  @*Q$ 'RP6 !TL'0 <+"0
M&RTK !HM,P 8+3P %RU% !8N4  4+ET $BYL !$N?@ 0+I( #BZG  TMO0 -
M+=\ #2WY  XL_P 0+/\ ?"@  &HJ  !;*P  4"P  $8L   _+   .2P  #0K
M   O*P  *RL  "8L   B+@  'R\  !PP"0 :,0X &3$3 !<Q&@ 6,B$ %3(H
M !0R,  3,CD $C-# !$S3@ 0,UL #C-I  TS>@ ,,XX "C.B  @RN0 (,MD
M"#+T  HQ_P +,?\ =RL  &8M  !8+@  32\  $,O   \+@  -BX  #$N   M
M+@  *2X  ",P   ?,@  &S,  !<U!0 4-@P $C<1 !$W%@ 1-QT $#@D  \X
M+  ..#4 #3@_  PX2@ +.%< "3AE  <X=@ %.(H  SB?  $WM0 !-],  C?Q
M  ,V_P %-O\ <RX  &(P  !4,0  23$  $$Q   Y,0  -#$  "\P   K,
M)3(  " S   ;-@  %S@  !,Z @ 0/ D #3T.  P]$P +/1D "CTA  D]*0 (
M/3$ !CX[  4^1@ #/E(  3YA   ^<@  /H8  #V<   ]L@  /=   #SP   \
M_P  //\ ;3(  %TS  !0-   1C0  #XT   W-   ,C,  "TS   G-   (C8
M !TX   8.@  %#T  ! _ @ -00@ "4,-  9$$0 #1!8  D0=  !$)   1"T
M $0V  !$00  1$X  $1<  !$;0  1($  $28  !#KP  0\T  $+P  !"_P
M0O\ :#8  %@W  !,.   0S@  #LW   U-@  ,#8  "DW   C.0  'CL  !@]
M   30   $$(   U% 0 (1P<  TD,  !)#P  2A,  $L9  !+(   2R@  $LR
M  !+/0  3$D  $Q7  !+:   2WT  $N4  !*K   2LH  $GO  !)_P  2?\
M8CH  %0[  !).P  0#L  #DZ   S.0  +#H  "4\   ?/P  &4$  !-$   0
M1P  #$D   A,   "3P4  % *  !0#0  41   %(5  !4&P  5",  %0L  !4
M-P  5$0  %12  !48P  5'<  %2/  !3J   4L8  %+M  !1_P  4?\ 7#\
M $\_  !%/P  /CX  #<]   O/@  )T   "!#   91@  $TD   ],   +3P
M!E(   !4    5P(  %@'  !9"P  6@X  %L1  !=%@  7AT  %\F  !?,0
M7CT  %Y,  !>70  7G$  %V)  !=HP  7,$  %OK  !:_P  6O\ 5D0  $M#
M  !#0@  /$$  #)"   I10  (4@  !I+   33@  #E(   I5   #60   %L
M  !>    8    &("  !C!@  90H  &8.  !H$0  :A<  &L?  !K*0  :S8
M &M%  !K5@  :FH  &J"  !IG0  :+L  &?G  !F_P  9?\ 44@  $A(  !!
M1@  -T<  "Q*   C30  &U$  !-5   .60  "%T   %A    9    &<   !J
M    ;    &X   !P    <@4  ',)  !U#0  =Q$  'H8  ![(0  >RX  'H]
M  !Z3@  >6(  'EY  !XE@  =[,  '7@  !T_   <_\ 3DT  $=,   [30
M,$\  "93   <6   $UP   UA   &9@   &H   !O    <@   '8   !Y
M?    'T   !_    @0   (,"  "&!P  B P  (L1  ".&   CB0  (XS  "-
M1   C%@  (MO  "*C   B:H  (C/  "&]P  A?\ 35$  $%3   T50  *5H
M !Y?   490  #6H   5P    =@   'L   !_    @P   (<   "*    C0
M (X   "1    DP   )4   "8    F@4  )T,  "@$0  HQH  *,H  "B.@
MH4X  *!E  "@@0  GJ   )W!  ";[@  FO\ 1ED  #E<   M80  (6<  !9N
M   .=0  !7L   "!    AP   (T   "2    E@   )H   "=    GP   *$
M  "D    I@   *@   "K    K@   +$#  "T"P  N!$  +D>  "Y+P  N$,
M +=:  "U=@  M)<  +2U  "QX@  L/P /V0  #%I   E;P  &'<   ]_   &
MAP   (X   "4    F@   *    "E    J@   *X   "Q    L@   +4   "W
M    N@   +P   "_    PP   ,8   #)    S@H  -(3  #2(P  T3<  -!/
M  #.:@  S8H  ,JK  #+RP  R^\ -W$  "EX   =@   $8D   B1    F@
M *$   "G    K0   +,   "Y    O@   ,(   #%    Q@   ,D   #,
MS@   -(   #5    V@   -X   #A    Y0   .H+  #K%P  ZBL  .I#  #J
M7@  ZGH  .N9  #KM0  Z]4 _P   /\   #_  $ _P ' /\ #0#_ !( _P ;
M /\ )0#_ "\ _P Z /\ 0P#_ $L _P!3 /\ 6@#] &  ^P!F /H :P#X '(
M]@!X /0 @ #Q (D [P"2 .P G0#I *H Y@"\ ., W #? /< W0#_ ,P _P"^
M /\ M0#_ +  _P"M /\ _P   /\   #_    _P   /\ !@#_  T _P 4 /\
M'P#_ "D ^P S /< /0#S $4 [P!- .P 4P#H %D Y0!? ., 90#@ &H W0!Q
M -H > #6 (  T@"* ,\ E0#, *( R "R ,4 R0#" .T P #_ +L _P"P /\
MJ #_ *0 _P"A /\ _P   /\   #]    ^@   /@   #P  D [  1 .@ &0#G
M ", Y0 M -X -@#6 #X T0!& ,T 3 #* %( R !8 ,4 70## &, P !I +X
M< "\ '@ N0"! +< C0"T )H L0"I *X O "L .$ J@#\ *@ _P"@ /\ F0#_
M )8 _P"4 /\ _P   /D   #R    YP   -L   #1  0 R@ - ,< % #$ !T
MP@ F +\ +P"[ #< MP _ +0 10"Q $L K@!1 *P 5@"J %P J !A *8 : "C
M '  H0!Y )\ A "= )$ F@"@ )@ L0"6 ,P E0#Q )0 _P"1 /\ BP#_ (@
M_P"& /\ ]P   .P   #>    R0   +P   "T    KP * *L $ "I !< J  @
M *< * "B #  GP X )P /@": $0 F !* )8 3P"4 %4 DP!: )$ 80"/ &@
MC0!Q (L >P") (@ AP"7 (4 J "# +X @0#D (  _P"  /\ ? #_ 'L _P!Y
M /\ Z0   -<   #!    L0   *8   "=    EP % )0 #0"2 !( D  : (\
M(@". "H BP Q (D . "' #X A0!# (, 2 "! $X ?P!4 'X 6@!\ &$ >@!I
M '@ <P!V '\ =0". ', GP!Q +, < #0 &\ ]@!O /\ ;P#_ &T _P!L /\
MV@   +\   "L    G@   ),   ",    A0   (( "0!_  \ ?@ 5 'T ' !\
M "0 >@ K '< ,0!U #< =  ] '( 0@!Q $@ ;P!- &X 4P!L %H :P!B &D
M; !G '@ 9@"& &0 EP!B *H 80#" &  ZP!A /\ 80#_ &$ _P!@ /\ Q0
M *T   ";    C0   (,   !\    =P   '( !0!P  P ;@ 1 &P %P!L !X
M:P E &D + !G #$ 9@ W &0 /0!C $( 8@!( &  3@!? %4 70!= %P 9@!:
M '( 60"  %< D !6 *, 50"Y %0 W@!4 /L 5 #_ %4 _P!5 /\ M@   )\
M  "-    ?P   '4   !N    :0   &8  0!C  D 80 . &  $P!? !D 7@ @
M %T )@!; "P 6@ R %@ -P!7 #T 5@!# %4 20!3 %  4@!8 %$ 80!/ &P
M3@!Z $P B@!+ )P 2@"Q $D S@!) /, 20#_ $D _P!* /\ J@$  )0%  ""
M!P  = @  &H(  !C!@  7@0  %L   !9  4 5P , %8 $ !4 !4 4P ; %(
M(@!1 "@ 4  M $X ,P!- #@ 3  ^ $L 10!* $P 2 !4 $< 70!& &@ 1 !U
M $, A0!! )@ 0 "K $  Q0 _ .H /P#_ $  _P!  /\ H @  (H+  !Y#0
M; T  &$-  !:#0  50L  %()  !0!@  3P(( $X #0!, !( 2P 7 $H '@!)
M ", 1P I $8 +P!% #0 1  Z $( 00!! $@ 0 !0 #X 6@ ] &0 / !R #H
M@@ Y )0 . "G #< O@ V ., -@#Y #8 _P W /\ F T  (,.  !R$   91$
M %L1  !3$   3A   $H.  !(#0  1PH# $<'"@!%! X 1 (3 $("&@!! B
M0 ,E #X#*P ]!#$ / 0W #L$/@ Z!44 .05. #<%5P V!6( - 9P #(&@  Q
M!I( , :E "\%NP N!=T +@;U "T'_P N!_\ D1   'T1  !L$P  7Q0  %44
M  !.%   2!,  $02  !!$   0 X  $ -!@! "@P /@D0 #P)%@ ["AP .0HB
M #@**  W"RX -@LU #4+.P S"T, ,@Q, # ,5@ O#&$ +0QO "L,?P J#)(
M* RE "<,NP E#-T )0WU "8-_P G#?\ BQ(  '<4  !G%@  6Q<  %$8  !)
M%P  0Q<  #\5   \%   .A(  #D1 0 Y#P@ . X- #<.$@ U#A@ - X? #(.
M)0 Q#RP , \R "\0.@ M$$( +!!+ "H050 H$&$ )A!O "00@  C$), (1"G
M !\0O0 >$.  'A'W !\0_P @$/\ AA0  ',7  !C&0  5QH  $T;  !%&@
M0!H  #L9   X&   -18  #04   S$@0 ,A(+ #$2$  O$A4 +1(< "P3(@ K
M$RD *A,P "@3-P G%#\ )A1( "044P B%%\ (!5M !\5?@ =%9$ &Q6E !D5
MNP 8%=X &!7X !D4_P :%/\ @A<  &\:  !?'   4QT  $H=  !"'0  /!T
M #<<   T&P  ,1H  "\9   N%@  +!<( "L6#@ I%Q, *!<9 "<8(  E&"8
M)!@M ",8-  B&3T (!E& !X940 =&5T &QIK !D:?  7&H\ %1JC !09N@ 2
M&=L $QGV !09_P 5&/\ ?1H  &L=  !<'P  4"   $<@   _(   .1\  #0?
M   Q'@  +1T  "L<   I&P  )QL% "4;#  D'!$ (AP6 "$<'0 @'2, 'QTJ
M !X=,@ <'CH &QY$ !D>3@ 7'EL %AYI !0?>@ 2'HT $1ZB ! >N  .'M@
M#Q[U ! =_P 1'?\ >AT  &<?  !9(0  32(  $0B   \(@  -B(  #(A   N
M(0  *B   "<@   D'P  (B " " @"@ >(0\ '2$4 !PA&@ ;(B$ &2(G !@B
M+P 7(C@ %2-! !0C3  2(U@ $2-G ! C>  .(XL #2.?  PCM  +(]  "R+P
M  PB_P -(?\ =A\  &0B  !6(P  2R0  $$D   Z)   -"0  "\C   K(P
M*",  "0C   @(P  '20  !LE!P 9)@T %R81 !8F%P 5)QX %"<E !,G+  2
M)S4 $2@_ ! H2@ .*%8 #2AD  PH=  **(< "2B;  <GL0 %)\P !B?L  <F
M_@ ()O\ <2(  & D  !3)@  2"<  #\G   W)@  ,28  "TF   I)0  )24
M "(E   =)P  &2@  !8J!  4*PL $BP0 !$L%  0+!L $"PB  XL*0 .+3(
M#2T[  LM1@ *+5( ""U@  8M<  $+8,  BV8   LK@  +,D  "SK  $K_  "
M*_\ ;24  %TG  !/*   12D  #PI   U*0  +R@  "LH   G)P  (R<  !\H
M   ;*@  %RP  !,N @ 0, @ #C$-  TQ$@ ,,1< "S$>  HQ)@ (,BX !S(W
M  4R0@ #,DX  3)<   R;   ,G\  #*5   QK   ,<<  ##J   P_   ,/\
M:"D  %@J  !,*P  02P  #DL   R*P  +2L  "DJ   E*@  ("L  !PL   7
M+@  $S   ! R @ .- < "C<,  <W$  %-Q0  S<;  (W(@  -RH  #@S   X
M/@  .$H  #A8   X:   .'P  #>2   WJ0  -L4  #;J   V_0  -?\ 8RP
M %0N  !(+P  /B\  #8N   P+@  *RT  "<M   B+0  '2\  !@Q   4,P
M$#4   XW 0 *.@< !CL+  (\#@  /1(  #X7   ^'@  /B8  #XO   ^.@
M/D8  #Y4   ^9   /G<  #Z/   ]IP  /<,  #SI   \_0  ._\ 7C   % Q
M  !$,@  .S(  #0Q   N,   *2\  "0P   >,@  &30  !0V   0.0  #3L
M  H]   %0 4  $$*  !"#0  0Q   $04  !%&@  1B(  $8K  !&-0  1D$
M $9/  !&7P  1G,  $6*  !%I   1,   $/H  !#_@  0O\ 6#0  $LU  !!
M-0  .34  #(T   M,P  )C0  " U   :.   %#H  ! ]   -0   "4(   1%
M    1P,  $@'  !*"P  2PX  $P1  !.%0  3QP  $\E  !/+P  3SP  $]*
M  !/6@  3FT  $Z%  !-H   3+P  $OG  !+_@  2O\ 4SD  $<Y   ^.0
M-S@  #$W   I-P  (3D  !L\   5/P  $$(   Q%   '2    DH   !-
M3P   %$$  !2!P  5 L  %4.  !7$0  61<  %H?  !9*0  638  %E$  !9
M5   6&<  %A_  !7F@  5K<  %7C  !4_0  5/\ 3CT  $,]   \/   -3L
M "P\   D/@  '$$  !5$   02   "TL   5.    40   %0   !7    60
M %L   != @  7@8  & +  !B#@  9!(  &<8  !G(@  9BX  &8\  !F30
M96   &5W  !DDP  8[$  &'=  !@_   7_\ 24(  $%!   Z/P  ,$   "9#
M   >1@  %4H  !!.   *4@   U8   !:    70   &    !C    90   &<
M  !I    :P$  &T%  !O"@  <@X  '42  !W&P  =B8  '8U  !U1@  =%D
M '1O  !SBP  <JD  '#-  !O]P  ;O\ 1D8  $!%   U1@  *D@  "!,   7
M40  $%8   E:   !7P   &,   !H    :P   &\   !R    =0   '<   !Y
M    >P   'T   "  P  @P@  (8-  ")$P  BAT  (HK  ")/   B$\  (9F
M  "%@0  A*   (+"  "!\   ?_\ 1DL  #I,   N3P  (U,  !A8   07@
M"60   !I    ;P   '0   !X    ?    ($   "$    AP   (@   "+
MC@   )    "3    E@   )D'  "=#0  H10  * A  "@,0  GD0  )U;  "<
M=@  F98  )FU  "6Y0  E?X /U(  #)5   F6@  &V   !%G   );0   '0
M  ![    @0   (8   "+    D    )0   "7    F0   )P   "?    H0
M *0   "G    J@   *T   "Q!@  M0T  +@6  "W)@  MCD  +50  "T:@
MLHD  +"J  "NSP  K?4 -UP  "MA   >:   $W    MX    @    (<   ".
M    E0   )H   "?    I    *@   "L    K0   +    "S    M0   +@
M  "[    OP   ,,   #'    RP4  -$.  #1&P  T"X  ,]%  #-7P  RWX
M ,F>  #(O@  Q>D +VD  "-P   6>0  #8$   &+    DP   )L   "B
MJ    *X   "T    N    +T   #     P@   ,4   #(    RP   ,X   #1
M    U@   -L   #?    Y    .@&  #K$0  ZB,  .HZ  #I5   YW(  .63
M  #CLP  X]0 _P   /\   #_    _P $ /\ "P#_ !  _P 7 /\ (0#_ "L
M_P U /\ /@#_ $< _P!. /\ 50#\ %L ^@!A /@ 9@#V &T ] !S /( >P#O
M (0 [0". .H F0#F *< XP"Y -\ U0#; /< U@#_ ,  _P"R /\ J@#_ *4
M_P"B /\ _P   /\   #^    _    /P  P#^  L _P 1 /\ &@#] "0 ^0 N
M /0 . #P $  [ !( .D 3@#F %0 X@!: -\ 7P#< &4 V !K -0 <@#0 'L
MS0"% ,H D0#' )X PP"N ,  Q0"] .L NP#_ +  _P"D /\ G #_ )@ _P"5
M /\ _P   /H   #T    \0   /(   #J  4 YP . .( %0#A !X X0 H -@
M,0#0 #D RP!  ,@ 1P#% $T P@!3 +\ 6 "] %X NP!D +D :P"V ', M !\
M +$ B "N )4 JP"D *@ N "F -P HP#[ )\ _P"5 /\ CP#_ (L _P") /\
M^0   .\   #G    WP   ,\   #(    P0 * +\ $0"\ !@ NP A +D *@"T
M #( L0 Z *X 0 "K $8 J !, *8 40"C %8 H0!< )\ 8P"= &H FP!S )D
M?@"6 (P E "; )( K0"0 ,< C@#P (T _P"& /\ @ #_ 'T _P!\ /\ [0
M .    #1    OP   +,   "J    I@ % *( #0"A !, H  ; )\ (P"; "L
MF  R )4 .0"3 #\ D0!$ (\ 2@". $\ C !5 (H 6P"( &, A@!K (0 =@""
M (( @ "2 'X HP!\ +H >@#A 'D _P!W /\ <@#_ '  _P!O /\ W0   ,L
M  "V    IP   )T   "4    C@ ! (L "@") !  B  5 (< '0"' "4 A  L
M (( ,@!_ #@ ?0 ] 'L 0P!Y $@ > !. '8 5 !U %L <P!C '$ ;@!O 'H
M;0") &P F@!J *X :0#, &@ ]@!G /\ 90#_ &0 _P!C /\ R@   +0   "A
M    DP   (D   ""    >P   '@ !0!V  P =0 1 '0 & !S !\ <@ E '
M+ !N #( ;  W &H / !I $( : !( &8 3@!E %4 8P!= &( 9@!@ '( 7@"
M %T D@!; *4 6@"^ %D Z0!9 /\ 60#_ %@ _P!8 /\ N0   *(   "0
M@P   'D   !Q    ;0   &D  0!F  D 90 . &0 $P!C !D 8P @ &$ )@!@
M "P 7@ Q %P -P!; #P 6@!" %@ 2 !7 $\ 5@!7 %0 8 !3 &P 40!Y %
MB@!/ )X 3@"T $T V@!- /L 30#_ $T _P!- /\ J@   )0   ""    =0
M &L   !D    8    %T   !:  4 6  , %< $ !6 !4 5@ ; %4 (0!3 "<
M4@ L %$ ,0!/ #< 3@ ] $T 0P!, $H 2@!2 $D 6P!( &8 1@!S $4 A !$
M )< 0P"L $( R0!" /$ 0@#_ $, _P!# /\ G@   (D   !X P  :@0  &$$
M  !: P  50$  %(   !0  ( 3@ ) $T #0!, !$ 2P 7 $H ' !) "( 2  G
M $< +0!% #( 1  X $, /@!" $4 00!- #\ 5@ ^ &$ /0!N #L ?@ Z )$
M.0"F #@ OP X .@ . #_ #D _P Y /\ E0,  ( '  !O"0  8@H  %@+  !1
M"@  3 @  $D&  !' P  1@ & $0 "P!#  \ 0@ 3 $$ & !! !X /P C #X
M*0 ] "X .P T #H .@ Y $$ . !) #< 4@ V %T - !J #, >@ R (P ,0"A
M #  N  O -X +P#Y "\ _P P /\ C D  '@,  !H#0  7 X  %(.  !+#@
M10T  $$,   _"@  /@@" #T$"  \ 0T .P 0 #H %0 Y !H .  @ #8 )0 U
M "L -  P #, -P R #X ,0!& "\ 4  N %H +0!G "L =P J (D *0"= "@
MLP G -$ )P#R "< _P G /\ A@P  '(.  !C$   5A$  $T1  !%$0  0!
M #P/   Y#@  -PT  #8+!  V" H -08. #0%$@ R!!< ,04< # %(@ O!2@
M+@8N "T&-  K!CP *@9$ "D'3@ G!UD )@=E "0'=0 C!X< (@>; " &L  @
M!LL 'P7M !\&_@ ?!_\ @ X  &T1  !>$@  4A,  $@3  !!$P  .Q,  #<2
M   T$0  ,A   # / 0 P#08 , L+ "\*$  M"A0 + L9 "H+'P I"R4 * PK
M "<,,@ F##H ) Q# ",,30 A#5@ ( UE !X-=0 <#8@ &@V< !D-L0 8#,H
M%PSK !<-_  8#/\ >Q$  &D3  !:%0  3A8  $46   ]%@  .!4  #,5   P
M%   +1,  "L2   J$ , *@\( "D.#0 H#A$ )@X6 "4/'0 D#R, (P\I "$0
M,0 @$#D 'A!" !T03  ;$%@ &1!F !<0=@ 5$(D %!"> !(0LP 1$,X $1#N
M !(0_@ 2$/\ =Q,  &45  !7%P  2Q@  $(9   Z&0  -!@  # 7   L%P
M*18  "<5   F% $ )1($ ",2"P B$@\ (1(4 " 2&@ >$R  '1,G !P3+@ :
M$S8 &11  !<42@ 6%%8 %!1D !(4=  1%(< $!2<  X4L0 -%,H #13K  X3
M_@ .$_\ <Q4  &$8  !3&@  2!L  #\;   W&P  ,AH  "T:   I&0  )A@
M "08   B%P  (!8! !X6"  =%@T &Q<2 !H7%P 9%QT &!@D !88*P 5&#0
M%!@] !(92  1&50 $!EB  X9<@ -&80 #!F8  H9K0 )&,8 "1CG  D8^@ *
M%_\ ;Q@  %X:  !0'   11T  #P=   U'0  +QT  "H<   F&P  (QL  "$:
M   >&@  '!H  !H;!0 8&PP %AP0 !4<%0 4'!L $QPB !(=*0 1'3$ $!T[
M  X=10 -'E$ #!Y>  H>;0 )'H  !QZ4  4=J@ #'<(  QWF  0<^  %'/\
M:QH  %L=  !-'@  0A\  #H?   R'P  +1\  "@>   D'@  (1T  !X=   <
M'0  &!X  !4? @ 3( D $B$. ! A$@ 0(1@ #B$?  XB)@ -(BX #"(W  HB
M00 )(DT !R):  4B:0 #(GP  2*1   BJ   (<   "'E   @^   (/\ 9QT
M %<?  !*(0  0"$  #<B   P(0  *B$  "8@   B(   'Q\  !P?   9(
M%B$  !(C @ 0) < #B8,  PF$  +)A4 "B8<  DF(@ ()BH !B<S  0G/0 #
M)TD  2=6   G9@  )WD  ">/   FI@  )K\  "7D   E^0  )/\ 8R   %0B
M  !'(P  /20  #0D   N(P  *",  "0B   A(@  'B$  !HB   7(P  $R0
M ! F @ .* < "RH+  @K#@ &*Q, !"L8  (K'P !+"<  "PP   L.@  +$4
M "Q3   L8P  +'8  "R,   KI   *[X  "KD   J^@  *?\ 7R,  % E  !$
M)@  .B8  #(F   K)@  )B4  ",D   ?)   &R0  !<E   4)P  $2D   XK
M @ ++08 !R\+  0P#@  ,!$  #$5   Q'   ,2,  #(L   R-@  ,D(  #)/
M   R7P  ,G(  #&)   QH@  ,+P  ##D   O^P  +_\ 6B<  $PH  ! *0
M-RD  "\I   I*   )2<  "$F   <)P  &"@  !0J   1+   #BX   LP 0 '
M,@4  S0)   U#   -@\  #<2   X&   ."   #@H   X,@  .3T  #E+   Y
M6P  .&X  #B%   WGP  -[H  #;D   U_   -?\ 52H  $@L   ]+   -"P
M "TK   H*@  )"D  !XJ   9*P  %"T  !$O   -,0  "C0   <V   ". 0
M #H'   ["@  /0T  #X0  ! %   0!L  $ D  ! +@  0#D  $!'  ! 5@
M0&D  $"    _FP  /K<  #WC   \_   //\ 4"\  $,O   Y+P  ,B\  "PM
M   G+   ("T  !HO   5,0  $3,   TV   ).   !3L    ]    0 $  $$$
M  !#!P  10L  $8.  !($0  2A8  $H>  !**   2C0  $E"  !)40  260
M $A[  !(EP  1[0  $;@  !%_   1/\ 2C,  #\S   V,P  ,#$  "HP   C
M,0  '#,  !8U   1.   #3L   @^   #00   $,   !&    2    $H   !,
M!   3@<  $\+  !1#@  5!(  %49  !5(@  5"X  %0\  !42P  4UX  %-T
M  !2D   4:X  %#7  !/^P  3O\ 13<  #PW   U-@  +S0  "8U   >-P
M%SH  !$]   ,00  !T0   !(    2@   $T   !0    4P   %4   !7
M6 (  %L&  !="P  7PX  &(3  !B&P  8B<  &(T  !A10  8%<  &!M  !?
MB0  7:<  %S,  !:^   6?\ 03P  #H[   T.0  *CH  "$\   80   $4,
M  Q'   &2P   $\   !3    5@   %D   !<    7P   &$   !C    90
M &<!  !J!0  ;0H  ' .  !S%0  <B   '(M  !Q/0  <$\  &]E  !N@
M;9\  &O!  !I\0  :/\ /T   #D^   N/P  )$(  !I&   22@  #$\   14
M    6    %T   !A    90   &@   !K    ;@   '$   !S    =0   '@
M  ![    ?@,  ($*  "%#P  AQ<  (8D  "%-   A$8  ()=  "!=@  ?Y8
M 'ZV  !\YP  >O\ /T0  #-%   H2   '4P  !-2   ,5P   UT   !C
M:    &T   !Q    =@   'H   !^    @0   (,   "&    B0   (L   ".
M    D@   )4!  "9"0  GA   )X:  "=*0  G#P  )I2  "8;   EHL  )2J
M  "2U   D/H .$L  "Q.   @4P  %5D   U@   #9P   &X   !T    >@
M (    "$    B@   (X   "2    E0   )<   ":    G0   *    "C
MIP   *L   "O    M D  +@0  "W'@  M3   +-&  "Q8   KWX  *R@  "K
MP0  J>X ,54  "1;   880  #FD   5Q    >0   ($   "(    CP   )0
M  ":    GP   *0   "H    J0   *P   "O    LP   +4   "Y    O0
M ,$   #&    RP   -$*  #3%   T24  - [  #-5   RG$  ,B2  #%LP
MP]X *6(  !QI   1<0  !WL   "$    C0   )4   "=    HP   *D   "O
M    M    +D   "\    O@   ,(   #%    R    ,P   #0    U    -H
M  #?    Y    .H   #N#   [1H  .PO  #J20  Z&4  .:&  #DI0  XL8
M_P   /\   #_    _  ! /P " #^  X _P 4 /\ '0#_ "8 _P P /\ .@#_
M $( _P!) /X 4 #[ %8 ^0!< /8 8@#T &@ \@!O /  =@#M '\ Z@") .<
ME0#D *, X "U -L T #5 /8 R@#_ +8 _P"H /\ GP#_ )H _P"6 /\ _P
M /L   #V    \P   /,   #V  D ^@ . /T %@#[ "  ]P J /( ,P#M #L
MZ0!# .8 20#B $\ W@!5 -L 6P#6 &  T@!G ,\ ;@#, '8 R0"  ,8 C #"
M )H OP"J +L P0"X .D M@#_ *< _P": /\ D@#_ (T _P"* /\ ^@   /$
M  #J    YP   .<   #D  $ X  + -L $0#: !H VP C -$ + #* #0 Q@ [
M ,( 0@"_ $@ O !. +H 4P"X %D M@!? +, 9@"Q &X K@!W *P @P"I )$
MI@"A *, M0"@ -@ G@#[ )4 _P"+ /\ A0#_ (  _P!^ /\ [P   .,   #:
M    TP   ,8   "_    N0 & +< #@"T !0 M  = +, )0"N "T JP T *<
M.P"D $$ H0!& )\ 3 "= %$ FP!7 )D 7@"7 &4 E0!N ), >0"0 (< C@"7
M (P J0") ,0 B #O (4 _P!\ /\ =@#_ ', _P!R /\ X    -    #&
MM@   *D   "A    G0 ! )D "@"8 !  F  6 )< '@"4 "8 D0 M (\ - ",
M #H B@ _ (@ 10"' $H A0!0 (, 5@"! %X @ !F 'X <0!\ 'T >0"- '<
MH !U +8 <P#? '( _P!N /\ :0#_ &< _P!E /\ S    +X   "K    G0
M ),   "*    A0   (( !0"   T ?P 1 '\ & "  "  ?0 F 'H +0!W #,
M=0 X '0 /@!R $, < !) &\ 3P!M %8 ; !> &H : !H '4 9P"$ &4 E@!D
M *L 8@#) &$ ]@!@ /\ 7 #_ %L _P!: /\ O0   *D   "7    B0   'X
M  !X    <P   &\  0!M  D ;  . &L $P!K !D :@ @ &@ )@!F "P 90 R
M &, -P!B #P 8 !" %\ 2 != $\ 7 !7 %H 80!9 &T 5P![ %8 C@!5 *(
M4P"[ %( Z0!2 /\ 4 #_ $\ _P!/ /\ K0   )@   "&    >    &X   !G
M    8P   &    !=  4 7  + %L $ !; !4 6P ; %H (0!8 "8 5@ L %0
M,0!3 #8 4@ \ %$ 0@!/ $D 3@!1 $T 6P!+ &8 2@!T $D A0!( )D 1P"Q
M $8 V !& /P 10#_ $4 _P!% /\ GP   (D   !X    ;    &(   !;
M5@   %,   !1  ( 3P ( $\ #0!. !$ 3@ 6 $T ' !, "$ 2@ F $D + !(
M #$ 1P W $4 /0!$ $0 0P!, $( 50!  &  /P!N #X ?@ ] )( / "I #L
MQP [ /, .P#_ #L _P \ /\ DP   'X   !N    80   %@   !1    3
M $D   !'    10 % $0 "P!#  X 0P 2 $, %P!" !T 0  B #\ )P ^ "P
M/0 R #L .  Z #\ .0!' #@ 4  W %L -0!H #0 >  S (P ,@"B #$ O  Q
M .< ,0#_ #( _P S /\ B0   '8#  !F!0  60<  % '  !)!@  0P4  $ #
M   ^ 0  /  # #L "  Z  T .@ 0 #D %  Y !D -P > #8 (P U "@ -  N
M #, -  R #L , !# "\ 3  N %< +0!D "P <P K (< *@"< "D M0 I -P
M*0#[ "D _P J /\ @00  &X(  !?"@  4PL  $H+  !""P  /0H  #D)   V
M"   -04  #0"!@ S  H ,@ . #$ $0 Q !4 ,  : "\ 'P N "0 +  J "L
M,  J #< *0 _ "@ 20 G %0 )@!@ "0 ;P C (( (@"7 "$ K@ A ,P (0#S
M "$ _P B /\ >PD  &@,  !:#0  3@X  $4.   ]#@  . T  #,-   P#
M+@L  "T) P M!@@ + 0, "L"#P J 1( *0$7 "@!'  G "$ )@ G "4 +0 D
M #0 (P$] "(!1@ A 5$ 'P%= !X!;  < 7\ &P"4 !H J@ : ,4 &@#K !D
M_P : /\ =0P  &0.  !5#P  2A   $ 0   Y$   ,Q   "\/   L#@  *0X
M "<- 0 G# 4 )PH* "8(#0 E!Q  ) 84 "(&&0 A!A\ ( <D !\'*P >!S(
M'0<Z !P(1  :"$\ &0A< !<(:P 6"'T %0>1 !0'IP 3!K\ $@7D !(%^@ 2
M!?\ <0X  %\0  !1$0  1A(  #T2   V$@  ,!(  "L1   H$0  )1   ",0
M   B#@0 (0T' "$,"P @"PX 'PL2 !T+%P <#!P &PPB !H,*0 9##$ & PY
M !8-0P 5#4\ $PU< !(-:P 0#7X #PV2  X-IP -#+X #0S@  T,]0 -#/\
M;1   %P1  !.$P  0Q0  #H4   R%   +10  "@3   E$P  (A(  " 1   >
M$0, '! % !P/"  ;#PP &@X0 !D/%  7#QH %@\A !40*  4$#  $A Y !$0
M1  0$%  #A!=  T0:P ,$'P "Q"0  D0I0 ($+P !Q#?  <0]  '#_\ :1$
M %@4  !+%0  0!8  #<6   P%@  *A8  "85   B%0  'Q0  !T3   :$P(
M&1($ !<2!@ 6$@H %1(. !02$@ 2$A@ $1,> !$3)0 0$RX #A,W  T40  ,
M%$L "Q18  D49P '%'@ !A2-  04HP #$[L  A/=  $2]  "$O\ 91,  %46
M  !(%P  /1@  #08   M&   *!@  ",7   @%P  '18  !H5   8%0( %A4$
M !05!0 2%@@ $18- ! 7$  .%Q4 #A<;  T7(@ ,%RD "Q@R  D8/  '&$<
M!1A4  088P "&'4  1B+   7H0  %[D  !?=   6]0  %O\ 818  %(8  !%
M&@  .QH  #(:   K&@  )1H  "$9   >&   &Q@  !@7   6%P( %!<# !(8
M!0 0&0< #AL+  P;#P +&Q, "AL8  @<'P ''"8 !1PO  0<.  "'$0  !U1
M   =8   '7(  !R(   <H   &[D  !O>   :]@  &O\ 7A@  $\:  !"'
M.!P  "\=   I'   (QP  !\;   <&@  &1D  !<9 0 4&0( $AH# ! ;!  .
M'0< #!X+  D?#@ &(!$ !2 6  ,@'  !(2,  "$K   A-0  (4   "%.   A
M70  (6\  "&&   @G@  (+@  !_>   >^   'O\ 6AL  $L=   _'@  -1\
M "T?   G'@  (AT  !X=   ;'   &!L  !4;   2'   $!T"  X?!  ,(08
M"2(*  4C#0 ")!   "43   E&0  )B   "8H   F,@  )CT  "9*   F6@
M)FP  ":#   EG   );<  "3?   C^0  (_\ 51X  $<@   \(0  ,B$  "LA
M   E(   (!\  !T>   :'0  %AX  !,>   0(   #B$   PC @ ()04 !2<)
M   H"P  *@X  "L1   L%@  +!T  "PE   L+@  +#H  "Q'   L5@  +&D
M "R    KF@  *K4  "G?   I^P  */\ 42(  $0C   X)   +R0  "@C   C
M(@  'R$  !P@   7(   $R$  ! C   .)   "R8   @H   $*@0  "P'   N
M"0  , P  #$/   S$P  ,QD  #,A   S*@  ,S4  #-#   S4@  ,V4  #)[
M   REP  ,;,  ##>   O^P  +O\ 3"4  #\F   U)P  +28  "<E   B)
M'B,  !DC   4)   $28   XH   +*@  !RP   ,O    ,0(  #,$   U!P
M-PH  #D-   Z$   .Q4  #L=   [)@  .S$  #L^   [3@  .V   #IW   Y
MD@  .+   #?;   V_   -?\ 1RD  #LJ   R*@  *RD  "4G   A)@  &R<
M !4H   1*@  #BP   HO   &,0   30    V    .    #L!   ]!   /P<
M $$*  !##@  11$  $48  !%(0  12P  $0Y  !$2   1%L  $-Q  !"C0
M0:L  $#2   _^@  /O\ 0BT  #@N   O+0  *2L  "0J   =*@  %RP  !$N
M   -,0  "30   0W    .@   #P    _    00   $0   !&    2 ,  $H'
M  !,"P  3@X  % 3  !0'   4"<  $\T  !/0P  3U4  $YJ  !-A@  3*0
M $K*  !)^   2/\ /C(  #4Q   N+P  *2X  " N   9,0  $C,   XW   )
M.@   CT   !     1    $<   !)    3    $\   !1    4P   %4!  !8
M!@  6@L  %T.  !?%0  7B   %XL  !=/   7$X  %MC  !:?@  6)T  %?
M  !5\@  5/\ .C8  #,T   M,@  )#,  !LV   3.0  #CT   A!    10
M $D   !,    4    %,   !6    60   %L   !=    8    &(   !E
M: 4  &L+  !O$   ;Q@  &XE  !M-   ;48  &M;  !J=0  :)0  &:V  !D
MZ0  8O\ .#D  #(W   H.0  'CL  !4_   .1   !TD   !-    4@   %8
M  !:    7@   &(   !E    :    &L   !M    <    ',   !V    >0
M 'T$  "!"P  A1$  (0=  ""+   @#X  'Y4  !^:P  >XH  'JJ  !WU@
M=?T .#T  "P^   B00  %T8   ]+   '40   %<   !<    8@   &8   !K
M    ;P   '0   !X    >P   'X   "     @P   (8   "*    C0   )$
M  "6 P  FPP  )T3  ";(0  FC,  )=)  "48@  DW\  )"@  ".Q0  C/,
M,40  "5(   :30  $%,   A:    80   &@   !N    =    'D   !_
MA    (D   "-    D0   ),   "6    F0   )T   "@    I    *@   "L
M    L@,  +<-  "W%P  M2@  +(^  "P5@  K',  *J4  "IM   I>4 *D\
M !Y4   26P  "F(   !J    <P   'L   ""    B0   (X   "4    F@
M )\   "D    I@   *D   "M    L    +,   "W    NP   ,    #%
MRP   -$$  #5#@  TQT  - R  #-2P  RF8  ,:'  #"J0  P<L (EL  !9B
M   ,:P   70   !]    AP   )    "7    G@   *0   "K    L0   +8
M  "Z    O    ,    #$    R    ,L   #/    U    -H   #@    Y@
M .L   #Q!@  \!,  .XG  #L/P  ZEL  .=Z  #DFP  X+L _P   /L   #V
M    \P   /0 !0#V  P ^@ 1 /\ &0#_ "( _P L /\ -0#_ #T _P!% /P
M3 #Z %( ]P!8 /4 7@#S &0 \0!J .X <@#L 'H Z0"% .4 D0#A *  W0"R
M -@ S@#2 /8 P0#_ *T _P"> /\ E@#_ )  _P", /\ ^@   /(   #L
MZ0   .D   #L  4 \@ , /@ $@#W !L ]0 E /  +@#K #< Y@ ^ .( 10#=
M $L V !0 -, 5@#0 %P S0!B ,H :@#( '( Q0!\ ,( B "^ )8 N@"H +<
MOP"T .@ K@#_ )T _P"0 /\ B #_ (, _P"  /\ \    .4   #>    V@
M -L   #<    V  ' -$ #@#1 !4 T@ > ,L )P#% "\ P  W +T /0"Z $0
MMP!) +4 3P"R %4 L !; *X 80"L &D J0!S *< ?P"D (T H0"> )X L@";
M -4 F0#\ (P _P"" /\ >P#_ '8 _P!T /\ X@   -,   #*    QP   +P
M  "V    L  ! *\ "P"L !$ K0 8 *T ( "H "@ I  O *  -@"= #P FP!"
M )D 1P"7 $T E0!3 ), 60"1 &$ CP!J (P =0"* (, B "4 (8 IP"# ,(
M@@#P 'P _P!S /\ ;0#_ &H _P!H /\ SP   ,$   "Y    K0   *    "8
M    E    )$ !@"0  T D  2 (\ &0". "$ BP H (@ +P"& #4 A  Z ((
M0 "  $4 ?@!+ 'P 4@!Z %D > !B '8 ; !T 'D <@") '$ G0!O +0 ;0#?
M &P _P!E /\ 8 #_ %X _P!< /\ O@   +$   "@    D@   (D   ""
M?    'H  0!X  D =P . '@ % !W !H =  A '( )P!P "T ;@ S &P . !K
M #X :0!$ &@ 2@!F %$ 9 !: &, 9 !A '  7P!_ %X DP!= *D 7 #( %L
M]P!7 /\ 5 #_ %( _P!1 /\ L    )\   "-    ?P   '0   !N    :@
M &8   !E  0 8P + &, $ !C !4 8P ; &$ (0!? "< 70 L %P ,@!: #<
M60 ] %< 0P!6 $L 50!3 %, 7 !2 &@ 4 !W $\ B0!. )\ 30"Z $P Z0!+
M /\ 20#_ $< _P!' /\ H@   (T   !\    ;@   &4   !>    60   %<
M  !5  $ 5  ' %, #0!3 !$ 5  6 %( &P!1 "$ 3P F $X *P!, #$ 2P W
M $H /0!) $0 1P!, $8 5@!$ &$ 0P!P $( @0!! )< 0 "O #\ UP _ /\
M/@#_ #T _P ^ /\ E    '\   !O    8P   %D   !1    30   $H   !(
M    1P $ $< "@!&  X 1@ 1 $< %@!% !P 1  A $( )@!! "L 0  Q #X
M-P ] #X / !' #H 4  Y %L . !I #< >@ V (\ -0"G #4 Q@ T /4 - #_
M #0 _P U /\ B    '0   !E    6    $\   !(    0P   #\    ]
M/  " #P !P [  P .P / #L $@ Z !< .0 < #< (0 V "8 -0 L #0 ,@ S
M #D ,0!! #  2P O %8 +@!C "T <P L (@ + "@ "L NP K .H *P#_ "L
M_P L /\ ?P   &P   != 0  40(  $@#  !  P  .P(  #<    T    ,P
M #( !0 R  D ,@ - #$ $  Q !, ,  8 "\ '0 M "( +  H "L +@ J #4
M*0 ] "@ 1@ G %$ )@!> "4 ;@ D (( (P"9 ", LP B -X (@#_ ", _P D
M /\ =P   &4$  !6!@  2P<  $((   Z"   -0<  # &   M!0  + ,  "L
M P J  < *0 + "D #@ I !$ *  5 "< &0 F !X )0 D "0 *@ C #$ (@ Y
M "$ 0P @ $X 'P!: !X :0 = 'P ' "3 !L K  ; ,T &P#V !L _P < /\
M< 4  %\(  !1"@  1@L  #T+   U"P  , L  "L*   H"0  )0@  "0' @ C
M! 8 (P() "(!#  B  \ (0 2 "  %@ ? !L '@ @ !T )@ < "X &P V !H
M/P 9 $H & !7 !< 9@ 6 '@ %0"/ !4 I@ 4 ,, % #N !0 _P 5 /\ :P@
M %L+  !-#   0@T  #D-   Q#0  + T  "<-   C#   (0P  !\+ 0 >"@4
M'0@( !T&"P <!0T ' 00 !L$%  9!!@ &00> !@$(P 7!"L %@0S !4$/  4
M!$< $P-4 !(#8P 1 W4 $ ** ! !H@ / +P #P#E  \ _@ 0 /\ 9PL  %<-
M  !)#@  /@\  #4/   N#P  * \  "0.   @#@  '0X  !L- 0 9#00 & P'
M !@+"0 7"0P %PD. !8)$@ 5"18 % D; !,)(0 2"2@ $@DP !$).@ 0"44
M#PE2  X)80 -"7, # B(  L(GP *![< "@;;  H%]@ *!/\ 8PT  %,.  !&
M$   .Q$  #(1   K$0  )1   "$0   =$   &@\  !@/ 0 6#@0 %0X' !0-
M"0 3#0L $PP- !(,$  1#!0 $ P9 ! ,'P /#"< #@TO  T-.0 ,#44 "PU1
M  D-8  (#7$ !@V&  4-G0 $#+0  PS2  (,\0 ""_\ 7PX  % 0  !#$0
M.!(  "\2   H$@  (Q(  !X1   ;$0  &!$  !40 @ 4$ 4 $A ' !$/"0 0
M#PH $ X,  X.#@ .#Q( #0\7  P0'0 ,$"0 "A L  D0-@ ($$$ !A!.  40
M70 #$&\  1"$   0G   #[0   [4   .\P  #O\ 7!   $T2  ! $P  -A0
M "T4   F%   (1,  !P3   9$@  %A(  !01 P 2$08 $1$( ! 0"@ .$ L
M#1$+  P1#0 +$A$ "A(5  D2&@ ($B$ !A,I  43,P #$SX  A-+   36@
M$VP  !."   2FP  $K0  !'7   1]0  $?\ 6!(  $D4   ]%0  ,Q8  "L6
M   D%0  'Q4  !H4   7%   %!,! !,2!  1$@< $!()  X2"0 -$@D "Q,*
M  D4#0 '%0\ !A83  06&  #%A\  A8G   7,   %SL  !=(   76   %VH
M !:    6F0  %;0  !79   4]P  $_\ 510  $86   Z%P  ,!@  "@8   B
M%P  '18  !D6   6%0  $Q0# !(3!@ 0$P< #Q,'  T4!P +%0@ "18)  88
M#  #&@X  1H1   :%@  &QP  !LD   ;+0  &S@  !M&   <50  &V<  !M]
M   ;EP  &K,  !G;   8^0  %_\ 418  $,8   W&0  +AH  "8:   @&0
M&Q@  !@7   5%@$ $Q4% !$5!  /%00 #18$  L7!0 )&08 !AH(  (<"@
M'@T  " 0   @$P  (!D  " A   A*@  (34  "%"   A4@  (&0  "!Z   ?
ME0  '[$  ![;   =^@  '/\ 31D  #\;   T'   *QP  "0<   >&P  &AH
M !<8   4%P( $A<" ! 8 0 -&0$ "QH"  @< P %'00  A\&   A"   (PL
M "4.   F$0  )A8  "8>   G)P  )S(  "<_   F3@  )F   "9W   ED@
M)*\  "/:   B^P  (?\ 2!T  #P>   Q'P  *!X  "(>   ='   &1L  !8:
M   2&@  $!L   T<   +'0  "!\   0A   !(P(  "4$   G!@  *0D  "P,
M   N#P  +A,  "X:   N(P  +BX  "X[   N2@  +5P  "UR   LC@  *ZP
M "K4   I^P  */\ 1"   #@A   N(0  )B$  " @   <'@  &!T  !0=   0
M'@  #A\   LA   '(P   R4    G    *0   "P!   N P  , 8  #,*   U
M#0  -A$  #87   V'P  -BD  #8V   V10  -5<  #5M   TB0  ,J@  #'/
M   P^@  +_\ /R0  #0D   K)   )",  !\A   ;(   %B   !$A   .(P
M"B4   8H   "*@   "T    O    ,@   #0    W    .0,  #L&   ^"@
M0 X  $$2  !!&@  0"4  $ Q  ! 0   /U(  #YG   ]@@  /*(  #K'   Y
M^   ./\ .B@  # H   I)P  (R4  !\C   8)   $B4   XH   **@  !2T
M   P    ,P   #8    X    .P   #X   !     0@   $4"  !'!@  2@H
M $T.  !-%0  3!\  $PK  !+.@  2DP  $EA  !(?   1YL  $6_  !#\P
M0O\ -BP  "TK   G*0  (R<  !LH   4*@  #BT   HP   $,P   #<    Z
M    /0   $    !#    1@   $@   !+    30   %    !3 0  5@8  %D+
M  !;$   6QD  %HE  !9-   6$8  %=:  !5=   5),  %*U  !0Z@  3_\
M,S   "PN   G+   'BT  !8O   0,@  "C8   ,Z    /P   $(   !&
M20   $P   !/    4@   %4   !8    6@   %T   !@    8P   &<&  !K
M#   ;!(  &L>  !K+   :3T  &=2  !F:@  9(D  &&K  !?W   7?\ ,3,
M "PQ   B,@  &34  !$Y   */0   D(   !'    3    %    !4    6
M %L   !?    8@   &4   !H    :P   &X   !Q    =0   'D   !]!@
M@@T  ((6  " )   ?C4  'Q)  ![80  >'\  ':?  !SQ@  </< ,38  "8X
M   <.P  $D    M%   "2P   %$   !6    6P   &    !E    :0   &X
M  !R    =@   'D   !\    ?@   ((   "%    B0   (X   "3    F 8
M )P.  ";&@  F"L  )9   "260  D7,  (V5  "+M0  B.@ *SX  "!!   5
M1P  #4T   )4    6P   &$   !H    ;@   ',   !Y    ?@   (,   "(
M    C    (\   "2    E0   )D   "=    H0   *4   "J    L    +<'
M  "X$0  M2$  +(U  "O30  JFD  *B(  "FJ   HM$ (T@  !A.   .5
M!%P   !D    ;0   '4   !\    @P   (D   "/    E0   )L   "@
MHP   *8   "I    K0   +$   "U    N0   +X   #$    R@   -(   #:
M"@  UA8  -(I  #.00  REP  ,5\  #"G0  P;T '%4  !%<   '90   &X
M  !W    ?P   (@   "0    F    )\   "E    K0   +,   "X    N@
M +X   #"    Q@   ,H   #.    TP   -H   #@    YP   .T   #S
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M^_S^______________________________________________________\
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M\/'R\_3U]O?X^?K[_/W^_VUF=#$      P0A   !
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MJ# -_[,Y%/[ 0A[SS4HMZ=U/0.'I4UG3ZEMOO]]C@J_39Y&ARVJ=EL5MI8W
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MST8BX=]+--CK3TS/\U1BO.A>=*O>9(2=U&F0D<YMF8?);Z" Q7*E>L)TJ73
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M_JEJ7O2E=&[JGWU]X9:#B]F.BI;3AY"@SH&5I\I\FJW'>)^RQ'6EML)RJ[G
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M.!/_LT =_[Q(*OS%3SOVR5=.[<U>8^++9'C2Q&J,Q+MOG+BR=:FMJWNSHZ:
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M)_'.33CJVU-+X-]98-#:7W;!T&6)L\EKF:;"<*6;O76OD;A[MHBU@+R!LH;
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M35?_F4U7_YE-5_^935?_F4U7_YE-5_^935?_F4U7_YE-5_^93<W!!@"^T <
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M#O^/.A3_ET(<_YY+)_^>5S3_G6)"_YEM3_^3>%SXC8)G\HB+<>R"DWGH?)F
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M5O"V:&GHLW![WJIWC="??)W'EX.GOY"*K[B+D;:RAIBZK8.@O:F!J;^E?K#
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MOJUBO[ZM8K^^K6*_OJUBO[ZM8K^^K?^6& /_F2$%_ZHH!O^Y, CPR#@-X=A
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M.DO_ICI+_Z8Z2_^F.DO_ICI+_Z8Z2_^F.DO_ICI+_Z8Z2_^F.K^\ P"PR@,
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M+0K_I#4/_ZP]%_ZR12+VN$PP[;Q40.2X75'7LF1CRZEL<\"A<X"WFGJ+KY2
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MC\V8?(_-F'R/S9A\C\V8?(_-F/^#& +_A"$%_Y4D!O^B*PC_K3,+_K<[$O3
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M85#VRF)0]LIB4/;*8E#VRF)0]LIB4/;*8E#VRF)0]LIB4/;*8O^C"P#6N 8
MQL0' +O4"0"P_!0#IO\I"YS_-160_SL>AO]")GW_22YU_U$T;_];.FG_93YE
M_VY!8O]U1%__?$9<_X-(6O^+25C_DTM6_YM,5?^B35/_J4Y1_[%/4/^[4$__
MPU%/_\-13__#44__PU%/_\-13__#44__PU%/_\-13__#4=JO @#&O 4 N<D%
M *W;" "C_Q<$FO\K"X[_,1*#_S@:>?] ('#_1R9I_T\K8_]8+U__8C)<_VLT
M6O]R-EC_>#A6_W\Y5/^&.U+_C3Q1_Y4]3_^</D[_HSY-_ZH_2_^S0$K_N4%*
M_[E!2O^Y04K_N4%*_[E!2O^Y04K_N4%*_[E!2O^Y0<BU @"XP00 J] # )_K
M"0&6_QH%B_\F"G__+0]U_S45;/\]&F7_1!Y>_TPB6/]4)57_72=2_V4I4/]L
M*D[_<RM-_WDL3/]_+4K_A2Y)_XPO2/^2,$?_F3!%_Z Q1/^I,D/_KC)#_ZXR
M0_^N,D/_KC)#_ZXR0_^N,D/_KC)#_ZXR0_^N,KBZ @"JR   G=D  )+_# *)
M_QH$??\A"'+_* QH_S 08/\X%%K_0!=4_T@:3_]/'$S_5QU)_UT>1_]C($7_
M:2!$_V\A0O]T(D'_>B) _X C/_^&)#[_C"0]_Y(E//^9)3O_GB8[_YXF._^>
M)CO_GB8[_YXF._^>)CO_GB8[_YXF._^>)JO!  "=T   C^$  (;_#@)Z_Q4#
M;O\<!F3_(PE<_RL,5?\S#T__.Q%)_T(31O])%$+_3Q9 _U46/O]:%SS_7Q@[
M_V08.?]H&3C_;1DW_W(:-O]W&C7_?!HT_X$;,_^(&S+_C1LR_XT;,O^-&S+_
MC1LR_XT;,O^-&S+_C1LR_XT;,O^-&_]P'@/_;"D&_VDS"?]R-PW_>3X2_WU'
M&?^ 42'_?E\I_WQM,O]Y>SG_=HA _W.31?]PG4K_;J9._VNM4?]IM%/_:+M5
M_V;#5_]CQUG[8<Q;]U_37/->W5WP7.->ZUOI7^=9[V#E6?%?Y5GQ7^59\5_E
M6?%?Y5GQ7^59\5_E6?%?Y5GQ7_]P'@/_;"D&_VDS"?]R-PW_>3X2_WU'&?^
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M9T[/\&=.S_!G3L_P9T[/\&=.S_!G3L_P9_^/"P#II 0 T;0& ,6_!@"\S0@
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M)P>'_B\-??XW%'3_/QML_T<@9O].)6#_5RE<_V M6?]I,%;_<3)3_W@T4?^
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M:EVD[VI=I.]J7:3O:EVD[VI=I.]J7:3O:O]Y$0'_C X _YX- -RN" #2NPD
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M8&Z,]U]NC/=?;HSW7VZ,]U]NC/=?;HSW7_]L$P'_?0\!_XT0 /^;$ #TJ \
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M6E:M^UI6K?M:5JW[6O]^"0#RD0( UJ$" ,JM!0# MP4 N,(% ++/"0"KU!<
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M%2G_J18H_[,6)__"%B?_QQ8G_\<6)__'%B?_QQ8G_\<6)__'%J2T  "6P
MA\P  'K:  !MZP  9/\% %S_#@%4_Q0!3?\< DC_) 1"_RP%/O\S!CK_.0<V
M_T (,_]%"##_2PDN_U$**_]7"BG_70LG_V0+)/]L#"+_=@T@_X -'O^,#AW_
MEPX<_Z$.&_^L#QO_K@\;_ZX/&_^N#QO_K@\;_ZX/&_^N#Y>\  "(R0  >=8
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M5<E7VE;%5^Q5PUOY3\)>_TK 7_]&O6#_0KI@_T"Z8/] NF#_0+I@_T"Z8/]
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M57Y]_U%^??]1?GW_47Y]_U%^??]1?GW_4?]C% '_<@\!_X$0 /^-$0#\F!(
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M2!19Z5$95>A:'%'I8B!.Z6LC2^ET)4CI?2=&Z8@J0^F3*T'JH"U ZJ\N/NO
M+CWLVRX]ZN\N/>C\+CWG_RT]Y_\M/>?_+3WG_RT]Y_\M/>?_+<6?  "UJ0
MJ+$  )R\  "0QP  A-(! 'K?!@!T]!, ;?0@ F;T*@1?]#0(6O4]"U3U10]/
M]4P23/55%$GV71=&]F481/9N&D'V=QP_]X$=/?>-'SOWF2 Y^*8A./BU(C?Y
MR"(V^>,B-OCS(C;W_"(V]_PB-O?\(C;W_"(V]_PB-O?\(K>F  "IK@  G+D
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M"A3_LPH4_[,*%/^S"A3_LPH4_[,*%/^S"I.[  "$QP  ==,  &?A  !8Z
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M2PO_2%D/_T9G$?]$=13_0X(6_T*/&/]!F1G_0:(:_T"I&_] L1O_/[@<_S_
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M1X]Q_T./<?]!CW'_08]Q_T&/<?]!CW'_0?];% '_: \ _W4/ /^ $0#_B1,
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M3AUNO58D:+Q=*F.[9#!?NFPT6KET.5:X?#Q3MX<_3[>20DRVGT1*MJU&2+;
M1DBWW45)MO)#2K7_04NU_SY+M/\]2[3_/4NT_SU+M/\]2[3_/>*#  #-D@
MP9\  +2G  "JKP  H+@  );  P",R@< ALT4 ('-)@)ZS#4(<\M!#VS*2A=F
MR5,=8<A;(US'8BA8QFHL5,9R,%#%?#--Q88V2L22.4?$GSM%Q*X\1,7!/$/%
MWSQ$Q/,[1,/_.47"_S=%P?\W1<'_-T7!_S=%P?\W1<'_-]6+  #%F@  MZ0
M *NL  "@M   EKX  (O'! "!T @ >-D. '79( %OV"\$:=@\"6/61A!>UE 5
M6=58&E748!]1U&@B3M1Q)DO3>RE(TX4K1=.2+D+4GR]!U*\P/]7",3_5X3 _
MT_(P/]+]+S_1_RX_T/\N/]#_+C_0_RX_T/\N/]#_+LJ4  "[H0  K:D  **Q
M  "6NP  B\0  (#- P!UV @ ;^01 &KD( %DY"T#7N0X!UGD00M5Y$L/4>14
M$DWD719*Y&481^1N&T7D=QU"Y((?0.2.(3[EFR,\Y:HD.^:\)#KFTR0YY>XD
M.>/Z(SGB_R0YXO\D.>+_)#GB_R0YXO\D.>+_)+^>  "OI@  HZX  )>X  "*
MP@  ?LP  '/6 @!IY0D 9.\4 %_P( %9\"L#5/ U!4_P/@=+\48*1_%.#$3Q
M5PY"\5\0/_)G$CWR<!0Z\GL5./.'%C;SE!@U]*(9,_2Q&3+UQ1HQ]>(:,?3Q
M&3'Q_ADQ\?\9,?'_&3'Q_QDQ\?\9,?'_&;*D  "EJP  F+8  (O   !^R@
M<=4  &7>  !>]0H 6?P3 %/\'@%._"<"2OTP T7].05!_4 &/OY(!SO^3PDX
M_U<*-O]>"S/_9PPQ_W -+O]\#BS_B0\K_Y80*?^D$"C_M!$G_\<1)__A$2;_
M\A$F__81)O_V$2;_]A$F__81)O_V$:>I  "9LP  B[X  '[)  !PTP  9-X
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M0NXB[T+Y(NU"_R#K0_\?ZD/_'>E$_QSH1/\;Z$3_&^A$_QOH1/\;Z$3_&_]
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M-Z-@_S.C8?\QHV'_,:-A_S&C8?\QHV'_,?]3%0'_71  _V@/ /]P$@#_=Q8
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M.(9Q_SB&<?\XAG'_./];#P#_9P@ _W,( /-]" #>A@< V8P) -61"P#*DAX
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M2U:1TTM7DN]'6I+]0ER3_SY=D_\[79/_.UV3_SM=D_\[79/_._]N  #@?@
MSHL  ,25  "ZG0  L:,  *FI  "AK@L FZ\= 92N+@2,K#L,A:I&%7ZH3AQX
MIE8C<J1=*FVB9"]IH6LT9)]S.&">>SQ<G84_69R/0E6;G$53FZI'49NZ1U";
MT4=1F^Y$4YO\0%6;_SQ6F_\Z5IO_.E:;_SI6F_\Z5IO_.O%T  #9@P  R)
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M+T&\_RY!O/\M0;S_+4&\_RU!O/\M0;S_+<Z*  "_F   L:   *:H  ";L
MD+@  (6_  !ZQP0 ;\\) &O1%0!GT28!8]$T!%[00 A9T$H,5<]3$%'/6Q1.
MSV,82\YK&TC.=1Y%SG\@0LZ,(D#.F20^SJ@F/,ZZ)CS/U"8\S>\E.\S[)3O+
M_R4[RO\E.\K_)3O*_R4[RO\E.\K_)<.3  "UG@  J*8  )VN  "1M@  A;\
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M"B#\_ H@_/P*(/S\"J*G  "5L0  A[L  'G&  !LSP  7]D  %+?  !(Z
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M*I9@_RJ68/\JEF#_*O]2#P#_7 H _V8) /]N"@#V= P [W@. .%[$@#4?"
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M161XT45F>>Y :'O].FI[_S9K?/\R:WS_,FM\_S)K?/\R:WS_,O]A  #J;P
MV7H  ,R$  ##BP  NY$! +25 0"LEPX I9<A 9Z6,067DSX,D)!(%(J.41N$
MBUDA?XE@)WN'9RMWA6XP<X1U-&^"?3=K@8<[:("1/F5_G$%B?JE#8'ZY1%]^
MST1@?^Q 8H#\.F2 _S9E@?\S9H'_,F:!_S)F@?\R9H'_,O]D  #E<@  TWX
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M-E&6_S-2EO\P4I;_,%*6_S!2EO\P4I;_,.9R  #0@   PHP  +B6  "MG
MHZ$  )FF  ".K0  B*X1 (.N(@%]K3$$=ZP]"G*J1Q!LJ4\69ZA7&V.G7A]?
MIF4D6Z1M)UBD=2M4HW\N4:*),4ZAEC1+H:0V2:&T-DBAR#=(H.<U2:#Y,DJ?
M_S!+G_\N2Y__+4N?_RU+G_\M2Y__+=UY  #)A@  O)(  +&:  "FH   G*8
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M'#;$_QPVQ/\<-L3_'+Z1  "PFP  I*,  )BJ  ",L@  @+D  '3   !HQP
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M Y.N  "$N   =L(  &?,  !:U0  3-P  #_A   UY@  +?0  "K_ @ F_PL
M(_\1 "#_%P =_QT &?\C !;_*0 4_R\ $O\U !#_/0 ._T4!#/]. 0K_6 $'
M_V4!!?]T 0/_A0$"_Y8! ?^F 0#_M0$ _\8! /_* 0#_R@$ _\H! /_* 8:W
M  !WP0  :,P  %K7  !+W@  /N0  #+I   G[0  (_\  !__   ;_P4 %_\,
M !3_$  1_Q0 #_\8  W_'0 +_R( "/\H  7_+@ "_S4  /\]  #_1P  _U(
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M.7-FT3IS9^TV=&G],'5J_RQV:_\I=VO_)W=K_R=W:_\G=VO_)_]7  #V8P
MWVT  -%U  #(>P  P7\" +N  P"T@1  K((C :6!,@2>?C\)F'M*$))Y4Q:-
M=EL;B71B((5R:22!<7 G?F]W*WMN?RYX;8@Q=6R2-'-KGC=P:JHY;FJY.FUJ
MSCIM:^LW;VW\,7!N_RUQ;O\J<6__*'%O_RAQ;_\H<6__*/]9  #K90  VW
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M,E][_RY@?/\K87S_*6%\_REA?/\I87S_*?5B  #>;P  S'H  ,"#  "WB0
MKXX  *:1  "=D@8 EY,7 )&3* &+DC8%A9!!"W^.2A%ZC%(6=8I:&W&(81]M
MAV@C:H9O)V:$=RMC@X N8(**,5V!EC1:@:,V6("R-U: Q3=6@.,V6('W,5F!
M_RU;@O\J6X+_*5N"_RE;@O\I6X+_*>QF  #8<P  QWX  +R'  "SC@  J9(
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M)$>:_R1'FO\D1YK_)-1W  #"A   MH\  *N6  "AG   EJ   (NE  !_J@
M=*X% &^O% !LKR0 :*\R F2N/05?K48)6ZQ/#5BL5A%4JUX44:IF%TZJ;AI+
MJ7@=2*F#($6HCR)#J)TD0:BM)4"HP"4_J-\E/Z;T(T"E_R) I?\A0*3_($"D
M_R! I/\@0*3_(,I^  "[BP  KY4  *2;  "9H0  CJ8  (*L  !WL0  :K8
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M#:Z8  "BGP  EJ8  (FN  !\M@  ;[T  &/#  !7R   3,T  $+2 P YV0D
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M$P >_1L '/TB !G^*0 7_C$ %?\Y !/_00 1_TH $/]5  [_80 ,_V\!#/^
M 0K_DP$)_Z8!"/^Z 0?_U $'_^L!!O_V 0;_]@$&__8!!O_V 8^L  " M@
M<K\  &/)  !6T0  2-@  #O=   PX@  )N8  !_P   <_P  &?\) !;_#@ 4
M_Q, $?\9  __'@ -_R0 "_\K  G_,@ &_SL  _]$  #_3P  _UP  /]K  #_
M?0  _Y   /^C  #_M   _\8  /_6  #_U@  _]8  /_6 (*U  !SOP  9,D
M %;3  !'VP  .N   "[E   CZ0  &NT  !7]   2_P  $/\"  [_"0 +_PT
M"/\0  3_$P !_Q@  /\>  #_)   _RL  /\S  #_/0  _TD  /]6  #_9@
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M*X16U2R#5^\I@UC^)(-9_R"$6O\>A%K_'(1:_QR$6O\<A%K_'/]. 0#_5P
MY5\  -AF  #.:@  QVP# ,-K!0"\;!( M&TE *UL-0.G:D('H6=-#)QE5A&8
M8UX5E&)E&)%@;!N.7W0>C%Y[(8E=@R2&7(PFA%N5*(%:H"I_6JPL?5J[+7Q:
MSRY[6^PK?%S\)GQ=_R)]7O\??5[_'7U>_QU]7O\=?5[_'?]0  #U60  X6,
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M;V3Y*'!E_R1Q9O\A<6;_'W%F_Q]Q9O\?<6;_'_]4  #H7P  UVD  ,IP  #
M=0  N7@  +)X  "K> T I'D= )YX+0&7=SH%DG5%"HQR3@Z(<%83A&]>%X!M
M9!I];&L=>FMS('=J>R-T:8,F<FB-*6]GF2QL9J4N:F:S+VEFQC!H9N0O:FCW
M*6MI_R5L:?\B;&K_(&QJ_R!L:O\@;&K_(/]7  #D8@  TFP  ,9S  "]>
MM7L  *U\  "E? H GWT: )E\*@&3>S@$C7E#"8AW3 Z#=502?W-;%GMR8AEX
M<&D==6]P(')N>"-O;8$F;&R+*6ILERQG:Z,N96NR+V1KQ#!B:^$O9&SV*F9M
M_R9F;?\C9V[_(&=N_R!G;O\@9V[_(/99  #@90  SF\  ,)V  "Y?   L7\
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MB@  C8H1 (B+(0"#BC "?HD[!7F'10ITADX.<(15$FR#7!9I@F,:9H%J'6*
M<B!??WLC7'Z%)EE]D2E7?)XK57RL+%-\OBU2?-HM4WSR*55\_R56?/\B5WS_
M(%=\_R!7?/\@5WS_(.5D  #/<   P7H  +:#  "MB0  HXP  )F.  "-CP
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M&,1\  "VB0  JI(  )^7  "5G   B:$  'VF  !QJ@  9*X  %JQ" !7L10
M5;(C %.R, %0LCL"3;)$ TNQ305(L54'1;%="4.Q90M L&\-/K!Z#SNPAQ$Y
MKY83-Z^F%#:ON!0UL-$4-:[O%#2M_A0TK/\4-*O_%#2K_Q0TJ_\4-*O_%+N%
M  "OD   HY<  )B=  ",HP  @*@  '2M  !HL@  7+8  %"Z 0!)O T 2+P9
M $:])P!%O3, 0[T] 4&]1P$_O5 "/;U8 SJ]804XO6L&-KUW"#2]A DRO9,*
M,+VD"R^]MPPNOM ++KSN#"VZ_@TLN?\-++C_#BRX_PXLN/\.++C_#K./  "F
MEP  FYT  (^C  "#J@  =K   &JU  !>N@  4KX  $?" 0 ]QP8 .,D0 #?)
M&P VRB< -<HS #3+/0 SRT< ,<M1 3#+6P$NS&4"+,QQ BK,?P,IS) $)\RA
M!";-M 0ES<X$)<ON!"3)_ 8CR/\'(\?_!R/'_P<CQ_\'(\?_!ZF6  ">G0
MDJ,  (6K  !XL@  :[@  %^^  !2P@  1\8  #W*   TSP0 *]0) ";9#P E
MV1D )=HE "3:,  CVSL (]M% "+<4  AW5L (-UH ![>=@ =WH<!'-^9 1K?
MK $9W\0!&-[G 1C<^ $8V_\"%]K_ A?:_P(7VO\"%]K_ J"<  "4HP  AZL
M 'FS  !LN@  7\$  %+&  !&R@  .\X  #'3   IV0  (=X% ![H#@ =Z!4
M&^D> !GI)P 8ZC  %NHY !7K0P 4[$X $NQ: !'M9P 0[G< $.Z*  [OG@ .
M\+, #?#-  SO[  ,[?P #.O_  SK_P ,Z_\ #.O_ )>C  ")JP  >[0  &V\
M  !?Q   4LH  $7.   YTP  +]@  "7=   =X0  &.P" !;W"P 4]Q$ $?@7
M !#X'@ .^24 #?DM  OZ-0 )^S\ !_M*  3\5P #_68  OYW  #]BP  _9\
M /RU  #\T0  _.T  /S\  #\_0  _/T  /S] (NK  !]M   ;KT  &#&  !2
MS0  1-(  #?8   LW0  (N$  !GE   3Z@  $/H   [_!@ -_PP "O\0  ?_
M%  $_QH  ?\@  #_)P  _S   /\Z  #_10  _U,  /]B  #_=0  _XH  /^?
M  #_LP  _\<  /_E  #_Y0  _^4  /_E '^T  !PO0  8<<  %/0  !#U@
M-MT  "KB   ?Y@  %NH  !#M   ,^@  "?\   ;_   "_P0  /\)  #_#0
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M&9U#X!J;1/,7F47_%9A&_Q.81O\1F$;_$)=&_Q"71O\0ET;_$/]"!0#_1P
M]T\  .53  #=50$ UU4& -52"P#+4QD PU0K +Q4.P&V4D@$L5%2!ZU07 JI
M3F0-IDUL#Z1,=!&A2WL3GTJ"%9U*BA>;29,8F4F<&I=(IAN52+(<E$C!'9)(
MV!V02>\;CTK^&(]+_Q:.2_\4CDS_$HY,_Q*.3/\2CDS_$O]%  #_2P  Z5,
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M'W=8_QMW6?\9=UG_%W=9_Q9W6?\6=UG_%O],  #I5@  V5\  ,ME  #!:
MNFD  +1H  "M9PT IF@< *!H+0&:9SH#E65%!I!C3@J,8E<-B6%>$(9?91.#
M7FP6@%US&'Y<>QI[7(,=>5N-'W9:F"%T6J0C<EJR)'%:Q"5O6N$E<%OV('%<
M_QQQ7?\:<5W_&'%=_Q=Q7?\7<5W_%_U/  #E60  TV(  ,=H  "];   MFT
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M&F)H_QEB:/\98FC_&>Q7  #98@  QVL  +QR  "S=P  JGD  *%Y  "7=P$
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M&@![@BD!=H$V G*!0 5N?TD(:GY0"V=]5PYD?%X187MF%%YZ;1=;>G8967F
M'%9XBQ]3>)@A47>F(E!WMR-/=\XC3W?L(5!W_1Y1=_\;4G?_&5)W_QE2=_\9
M4G?_&=YB  #(;@  NW<  +!_  "GA   G8<  )*'  "$AP  ?8<) 'B(%@!T
MB"8 <(@R FR'/01HAD8&985."6&%50Q>A%P/6X-C$EF":Q56@7074X!^&E"
MB1Q.?Y8>3'^E($I_MB%)?\PA27[K'TI^_!Q+?O\:2W[_&4Q^_QA,?O\83'[_
M&-5G  ##<P  MGP  *R$  "BB0  F(L  (V-  !\C0  =8X$ &^/$@!MD"$
M:9 N 66/.0)BCD($7HY+!UN-4@I8C%D,5HMA#U.+:!)0BG$438E[%TJ)AQE(
MB)4;1HBC'42(M!U#B,H=0X?J'$2&^QI$AO\818;_%T6%_Q=%A?\7187_%\UM
M  "]>   L8(  *>*  "<C@  DI   (:3  !YE0  ;)<  &:7#@!CF!L 89@I
M %Z8-0%:ESX#5Y='!5663P=2EE8)3Y5>#$R49@Y*E&\01Y-Y$T23A15"DI,7
M0)*B&#Z2LQD]DLD9/9'I&#V0^A<^C_\6/H__%3Z/_Q4^C_\5/H__%<5S  "W
M?P  K(D  *&/  "6DP  BY8  '^9  !SG   9)\  %R@"0!9H!0 5Z$B %6A
M+P!2H3D!4*%# DV@2P1*H%,%2*!:!T6?8PE#GVP+0)YV#CZ>@Q [GI$1.9V@
M$CB=LA,WGL@3-YWH$C:;^A(VFO\2-IG_$3>9_Q$WF?\1-YG_$;Y[  "QAP
MI8\  )N4  "0F   A)P  '>@  !KI   7Z<  %*J  !-JPX 2ZL: $JK)P!(
MJS, 1JL] 42K1@%"JTX"0*M6 SZK7P4[JV@&.:IS"#>J@ DTJH\+,JJ?##&J
ML PPJL<,,*GG#"^G^@TOIO\-+Z7_#2^E_PTOI?\-+Z7_#;:$  "JC@  GI0
M )29  "'G@  >Z,  &^H  !CK   5Z\  $NR  !!M08 /K81 #VV'@ [MBD
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M !#5\P 0T_\ $-+_ 1#1_P$0T?\!$-'_ 9R:  "1H0  @Z@  '6P  !HMP
M6[T  $[!  !"Q0  -\@  "W,   DT   '-4  !7:!0 0X@L $.,1  [D&@ .
MY", #>4M  SE-P +YD( "N9/  GG70 (YVT !N:   7FE0 $YJL  N;$  'F
MY@  Y_D  .?_  #F_P  YO\  .;_ ).A  "%J0  =[$  &FY  !;P   3L8
M $'*   US@  *M(  "'6   9VP  $M\   WC   +\0@ "?,.  ?S$P $\AH
M O(B  #R*@  \C0  /(_  #R3   \EP  /)M  #R@@  \I@  /.M  #SQ@
M].4  /3V  #T^P  ]/L  /3[ (>I  !YL@  :KH  %S"  !.R0  0,X  #/3
M   HV   'MT  !7A   /Y   "N@   7S   #_0$  /P(  #[#0  ^Q$  /L6
M  #\'@  _"8  /PP  #]/   _DD  /Y:  #^;0  _X(  /^8  #_K   _\
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M +D _P#" /\ S0#_ -\ _P#L /\ ^ #_ /\ _0#_ /T _P#] /\ _0#_ /T
M_P#] /\ _0#_ /\?(P#_'R$ _QXA /\9(P#_$RD _PXR /\,0 #_"4T!_P=:
M ?\$9P'_ W,!_P-] ?\#AP'_ X\ _P*6 /\"G #_ J( _P*H /\"KP#_ ;8
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M!;XKZP6Z*_D&N"S_!K8L_P6U+/\%M"S_!;0L_P6T+/\%M"S_!?\T# #_-@4
M_SD# /\\" #_/ T _3L3 /$X'0#H-2D X#0W -DS1@#1-%(!S3-= <DS9P+&
M,W #Q#)X!,$R@ 2_,H<%OC*/!KPRE@:Z,9X'N#&F![<QL BU,KP(LS+,";$R
MY0FM,_4)JS/_":HS_PBH,_\'J#/_!Z<S_P>G,_\'IS/_!_\W!P#_.@  _SX
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M$HE&_Q")1O\.B$;_#8A&_PV(1O\-B$;_#?]   #R1P  XT\  -13  #+50
MQ%0  ,!0! "Y3Q$ LE B *Q1,@"G43\"HE!* YY/4P6;3EP(F$UC"I5,:@R3
M2W$-D4IY#XY*@!&,28D2BDF2%(A(G!6&2*@6A4BU%X-(QQB!2.08@4KW%8!*
M_Q* 2_\0@$O_#X!+_PZ 2_\.@$O_#O]#  #L2P  W5,  ,Y8  #$6@  O5H
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M$FQ8_Q%L6/\1;%C_$?%+  #?5@  S%X  ,!D  "W9P  KF@  *=F  "?8@8
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M$^%8  #+8P  O6L  +)R  "I=@  H'@  )9W  "(<P  @7,+ 'QT%P!X="8
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M:P  M70  *M[  "B?P  EX$  (R!  !Z?@  <W\" &Y_$0!K@!X :( L &6
M-P%B@$ #7W](!%Q^4 99?E<(5WU>"U1\9@U1?&X/3WMX$4Q[@Q1*>I$62'J?
M%T9ZKQA%>L081'KD&$5Y^!9&>?\41GC_$D=X_Q%'>/\11WC_$<UE  "]<
ML7D  *>   "<A   DH8  (:&  !WA@  :X8  &:'#0!CAQD 8(@G %Z(,P%;
MB#P"6(=% U:'3013AE0&4(9;"$Z%8PI+A&P,281V#T:#@1%$@X\30H.=%$""
MKA4_@\(5/H+B%3^!]Q,_@?\20(#_$4" _Q! @/\00(#_$,9K  "W=@  K'\
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M!BJB]0<IH?\'*:#_""F?_P@IG_\(*9__"+&"  "EBP  FI$  )"6  "#F@
M=I\  &JB  !>I@  4JD  $:K   \K0  -:\, #.P%0 RL"$ ,; K "^P-0 N
ML3X +;%( "RQ40 KL5L *;%G 2>Q= $FL8,!)+&4 B.QI@(BLKL"(;+; B&O
M\P,@KO\#(*W_!!^L_P0?K/\$'ZS_!*J+  "=D0  DY<  (><  !ZH@  ;:<
M &"K  !5KP  2;$  #ZT   SMP  *KH# "2\#0 BO14 (;T@ "&]*@ @O3,
M'[X] !Z^1P =OE( '+]> !J_;  9OWP &+^. !? H0 6P+8 %,#3 !6^\0 5
MO/\!%;O_ 12Z_P(4NO\"%+K_ J&2  "6F   BIX  'VD  !OJ@  8J\  %:T
M  !*MP  /KH  #.]   JP   (<0  !G'!0 3RPL $<P2 !',&P 0S"4 #\TO
M  [-.@ .S48 #<U2  W.8  ,SG  "\Z#  K.EP )SJP ",[&  C.Z  (S?L
M"<O_  G+_P )R_\ "<O_ )B8  "-G@  ?Z4  '&L  !DLP  5[D  $J]   ^
MP   ,L,  "C&   ?R@  %\T  !'1   ,U@4 "-D,  ;9$@ %VAL !-HD  /;
M+@ !VSD  -Q%  #=4@  WF(  -YS  #>B   WYT  -^S  #?S@  X.X  -_Z
M  #?_P  W_\  -__ (^?  "!I@  <ZX  &6U  !8O0  2L(  #W%   QR0
M)LP  !W0   4U   #MD   G=   #X0   .,'  #C#0  Y!(  .49  #F(@
MYRL  .DV  #K0P  [%(  .QB  #M=@  [HP  .ZA  #OMP  []$  ._K  #P
M]@  \/8  /#V (2G  !UKP  9[<  %F_  !+Q@  /,H  "_.   DT@  &M@
M !+<   ,X   !>,   #G    ZP   .L   #M!0  [@L  / 0  #Q%0  \QX
M /0G  #W,P  ^4   /I1  #[8P  _'<  /V-  #]HP  _K8  /[)  #_WP
M_]\  /_? '>P  !HN0  6L$  $S*   \SP  +M0  "+:   7W@  $.(   GF
M    Z0   .P   #P    ]@   /8   #W    ^    /H'  #[#0  _1$  /\9
M  #_(P  _R\  /\^  #_3P  _V(  /]W  #_C0  _Y\  /^N  #_N@  _[H
M /^Z /\6(P#_%2$ _Q(A /\.) #_!BH _P S /\ 00#_ $X _P!< /\ : #_
M '0 _P!^ /\ AP#_ (\ _P"6 /\ G #_ *( _P"H /\ K@#_ +4 _P"] /\
MQP#_ -8 _P#G /X \P#^ /X _0#_ /P _P#[ /\ ^P#_ /L _P#[ /\ ^P#_
M /\:( #_&1X _Q8> /\0( #_"B4 _P0P /\ /0#_ $L _P!8 /\ 9 #_ '
M_P!Z /\ @P#_ (L _P"2 /\ F #_ )X _P"D /\ J@#_ +$ _0"Y /L PP#Z
M -  ^ #C /< \0#V /P ] #_ /0 _P#S /\ \P#_ /, _P#S /\ \P#_ /\=
M' #_'!D _QD9 /\4&P#_#B$ _PPL /\).0#_!48 _P)3 /\ 7P#_ &L _P!U
M /\ ?@#_ (8 _P". /\ E #^ )L _ "A /H IP#X *X ]0"U /, OP#Q ,L
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M /P050#X#V  ] ]J /$/= #O#GP [0Z$ .L.BP#I#I( YPZ9 .8.H #D#J<
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M _\O!@#_+P  _S(  /\S @#Y,@@ ]R\. .LK%@#A)R( V"<R - I00#+*DX
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M"I,YR@N1.>4+CSKW"HTZ_PF,._\(C#O_!XP[_P>,._\'C#O_!_\X  #Q/@
MXT4  -1)  #+2@  Q4<  ,%!! "Z/Q$ LT$A *U",0"H0SX I$-) :!"4P*=
M05L#FT%B!)A :@660'$&E#]X!Y(_?PB0/X@*CSZ1"XT^FPR+/J8-B3ZS#8@^
MQ Z&/^ .A#_T#8- _PN#0/\*@D#_"8)!_PB"0?\(@D'_"/\\  #K0P  W$H
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M$VQ._1!L3_\.;$__#&Q/_PML3_\+;$__"^Y%  #<4   R5<  +U<  "T7@
MK%X  *1;  "<5@0 E582 )!7(0"+6"\ AU<[ 8-61 )_5DT#?%54!7I46P9W
M5&((=5-H"7-3< MQ4G@-;U*"#VU1C1%K49D2:5&F%&=1MA5F4<L595+I%&52
M^Q%F4_\/9E/_#693_PQF4_\,9E/_#.I)  #54P  Q5H  +I?  "P8@  J&(
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M#E=>_PU77O\-5U[_#=Y3  #(70  NV0  +!J  "F;0  G6X  )-M  "%9P
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M#,9D  "W;@  JW8  *)\  "7?P  C($  (&!  !R@   97\  %U_" !9?Q,
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M!2Z2I 8MDK<&+)+1!BR1[P8KC_\&*X[_!BN-_P<KC?\'*XW_![-X  "G@@
MG(@  )&,  "'D   >I,  &V5  !AEP  59D  $F;   _G $ .9T. #>=%P V
MGB( -)XL #.>-0 RGCX ,9Y' #"?4  NGUH +9]D 2N?<0$IGG\")YZ0 B:>
MH0(DGK4"(Y[. B.=[@,CF_X#(IK_!"*9_P0BF?\$(IG_!*R!  "@B   E8X
M (N2  !_E@  <IH  &6=  !9H   3J,  $*D   WI@  +J@% "FI#P HJ1@
M)ZHB ":J+  EJC4 )*H_ ".J2  BJU, (:M> ""K:@ >JWD ':N+ !NKG0 :
MJ[$ &:O* !FJ[ $9J/T!&*?_ ABF_P(8IO\"&*;_ J6)  "9CP  CY0  (.9
M  !UG@  :*(  %RF  !0J0  1*P  #FN   OL   )K,  !ZU!@ 9MP\ &+<7
M !>W(0 6MRH %;<T !2X/@ 3N$D $KA4 !*Y8@ 1N7$ $+F#  ^YEP .N:P
M#;G$  VXYP .MOL #K7_  ZT_P .M/\ #K3_ )R0  "2E0  AIL  'F@  !K
MI@  7JL  %*O  !&L@  .K4  "^W   EN@  ';T  !7    0PP8 "\8.  K%
M%0 )Q1X ",4H  ?%,@ &QCT !<9)  7&5P #QF8  L9W  '&BP  QJ   ,6V
M  #&T@  Q>\  ,7\  #%_P  Q?\  ,7_ )66  ")G   >Z,  &VI  !@KP
M4[0  $:X   ZNP  +KX  "3!   ;Q   $\<   [*   (S@$  = *  #0$
MT!8  -$>  #2)P  TS$  -0\  #520  UE@  -9I  #6?   UI(  -:G  #6
MOP  UN   -;S  #6_@  UO\  -;_ (R=  !^I   ;ZL  &&R  !4N0  1KT
M #G!   MQ   (L<  !G+   1S@  #-(   75    VP   -P#  #="@  W@\
M -\4  #A'   XB0  .0N  #F.@  YTD  .A9  #H:P  Z8$  .F8  #IK0
MZ<4  .GB  #I\@  Z?4  .GU ("E  !QK0  8[4  %6\  !'P@  .<8  "S*
M   @S@  %M(   _6   (VP   -\   #C    Y0   .<   #H 0  Z@<  .L-
M  #M$0  [Q@  /$A  #S*P  ]C@  /=(  #X6@  ^6T  /J$  #ZFP  ^J\
M /K"  #ZV@  ^M\  /K? '2N  !EM@  5KX  $C&   YRP  *]   !_4   4
MV@  #=\   7C    Y@   .D   #M    [P   /$   #S    ]0   /8"  #X
M"0  ^@X  /T3  #_'   _R@  /\V  #_1P  _UH  /]N  #_A0  _YH  /^K
M  #_N0  _[P  /^\ /\1( #_$!X _PP> /\$(0#_ "< _P P /\ /@#_ $P
M_P!9 /\ 90#_ '  _P!Z /\ @P#_ (L _P"2 /\ F #_ )X _P"D /\ J@#_
M +  _P"X /\ P@#_ ,X _P#B /X \ #] /L ^P#_ /L _P#[ /\ ^@#_ /H
M_P#Z /\ ^@#_ /\4' #_$AH _PX: /\(' #_ "$ _P M /\ .@#_ $@ _P!5
M /\ 80#_ &P _P!V /\ ?P#_ (< _P". /\ E #_ )H _@"@ /T I@#\ *P
M^P"T /D O0#X ,D ]P#< /4 [ #S /@ \P#_ /( _P#Q /\ \ #_ /  _P#P
M /\ \ #_ /\7& #_%18 _Q$5 /\,%P#_!1T _P H /\ -@#_ $, _P!0 /\
M7 #_ &< _P!Q /\ >@#\ (( ^@") /@ D #W )8 ]0"< /0 H@#S *@ \0"P
M /  N #N ,, [ #3 .H YP#I /4 YP#_ .8 _P#E /\ Y0#_ .4 _P#E /\
MY0#_ /\:$P#_&!$ _Q00 /\/$0#_#1D _PHD /\%, #_ 3X _P!+ /\ 5P#^
M &( ^@!L /4 =0#R 'T \ "$ .X BP#L )$ ZP"7 .D G@#G *0 Y@"L .0
MM #B +\ X #- -X XP#< /( V@#] -@ _P#6 /\ U0'_ -4!_P#5 O\ U0+_
M /\>$ #_' T _Q<+ /\5#@#_%!4 _Q$? /\.*@#_"S@ _0A% /@&40#T!%P
M[@1F .H$;P#F W< Y 1_ .($A@#@!(P W@23 -T%F@#;!:  V 6H -4%L0#2
M!;L T ;) ,X'X #,"/$ R0K_ ,<+_P#&#/\ Q0S_ ,4,_P#%#/\ Q0S_ /\A
M# #_( 8 _QP# /\="@#_&Q  _Q@8 /\4(P#V$3  [PX^ .H.2@#E#58 X0U@
M -T-:0#9#7$ U0UY -,-@0#1#8@ SPV/ ,T.E@#+#IT R@ZE ,@.K@#&#[D
MQ!#( ,(0WP"^$?( NQ+_ +D3_P"W$_\!MA/_ ;83_P&V$_\!MA/_ ?\E!@#_
M(P  _R,  /\D P#_(0H _1T1 /$:&P#H%B< X10U -H30P#3%$\ SA59 ,L5
M8P#(%FL Q19S ,,7>P#!%X( P!B) +X8D "\&)@ NQF@ +D9J0"W&;0 M1K"
M +0:U@"P&^T!K1S\ :L=_P&I'?\!J1W_ :@=_P&H'?\!J!W_ ?\H  #_)P
M_BH  .\J  #G)P$ YR() .0=$ #9&QT SQTM ,D>/ #$($D OR!3 +PA70"Y
M(64 MR)M +4B= "S(GP L2*# ; BB@&N(I(!K".; :LCI &I(Z\!IR.\ :8D
MS@&C).@"H"7Y IXE_P*=)?\"G"7_ ILE_P*;)?\"FR7_ O\L  #_+0  [3(
M .(T  #:,P  TRX# -(E"@#))1< P2<G +LI-@"V*D, LBM. *\K5P"L*V
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M"'TZ_@=\._\&?#O_!7P[_P5\._\%?#O_!?0W  #E0   TD<  ,5*  "\2P
MM4D  *]#  "I/@L HC\7 )U )@"8030 E$$_ )%!20&.05$!BT!9 HE 8 .'
M0&<#A3]M!(,_=06!/WT&?SZ'!WT^D0A[/IP)>CZI"7@^N IW/\T*=3_J"G1
M_ AT0/\'=$#_!G- _P9S0/\&<T#_!O$[  #?10  S$P  +]/  "V4   KD\
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M"6!._PA@3O\(8$[_".-'  #-4   OE<  +-;  "J70  H5T  )A:  "-4P
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M",]4  "^7@  L64  *=J  "=;0  E&T  (EL  !X90  ;V0  &ED#@!E9!D
M8F0E &!E, !>93H 7&5" 5IE2@)89%$"5F18 U1D7P129&<%4&-Q!TYC>PE,
M8X@*2F.7"TACI@Q'8[@-1F/1#49C[PQ&8O\*1V+_"4=B_PE'8O\(1V+_",I8
M  "Z8@  KFD  *-N  ":<0  D'(  (1Q  !T:P  :6D  &-I"P!?:14 7&HA
M %IJ+0!8:S8 5FL_ 55K1P%3:DX"46I5 T]J701-:F4%2FEN!DAI>0=&:88)
M1&F5"D-HI0M!:;<,0&G/#$!H[@M!:/\*06?_"4%G_PA"9_\(0F?_",5=  "V
M9@  JFT  *!S  "6=@  BW<  (!V  !P<@  97$  %QP!P!8<!$ 5G = %1Q
M* !2<3, 4'$\ $]R1 %-<4L!2W%3 DEQ6@-'<6($17!L!4-P=P9!<(0'/W"3
M"#UOHPD[<+4*.W#-"CIO[ D[;OX(.V[_"#MM_P<[;?\'.VW_![]B  "Q:P
MIG,  )UY  "2>P  AWP  'M\  !M>@  8'@  %9W 0!0=PX 3G@8 $QX) !+
M>2X 27DW $AY0 !&>4@!1'E/ 4)Y5P)!>6 "/WAI SQX= 0Z>((%.'B1!C=X
MH0<U>+,'-'C+!S1WZP<T=OT'-'7_!S5U_P8U=/\&-73_!KEH  "M<0  HGD
M )A^  "-@   @H$  ':"  !I@0  6X$  %&!  !(@ H 18$3 $.!'@!"@BD
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M 1R7Y0$<E?H!&Y3_ 1N3_P(;D_\"&Y/_ J=_  "<A@  D8L  (>/  !ZD@
M;94  &&8  !5FP  29T  #V>   SGP  *J$  "&C"@ ?HQ$ 'J,: !VD)  <
MI"T &Z0V !JD/P 9I$H &*15 !:E80 5I7  %*6! !.EE  2I:@ $:6_ !"D
MX@ 1HO@ $:'_ !&@_P$1H/\!$:#_ :"&  "5C   C)$  '^5  !QF@  9)X
M %BA  !,I   0*8  #6G   JJ0  (JP  !FN   2L D $+$0 !"Q&  .L2(
M#K$K  VQ-0 -L4  #+%+  NQ6  *L6< "+%X  >QBP %L:  !+"U  2PT  $
ML.\ !:_^  :N_P &KO\ !J[_ )B.  "/DP  @I@  '6=  !GH@  6J<  $ZK
M  !!K0  -:\  "NQ   AM   &+8  !&Y   -O , ![X,  .]$@ !O1D  +XB
M  "^*P  OC8  +Y!  "_3@  OUP  +]M  "_@   OI4  +ZJ  "^P@  O>0
M +WV  "]_P  O?\  +W_ )*4  "%F@  >*   &JF  !<JP  3[   $*S   U
MM@  *K@  ""[   7O@  $,$   O$   $QP   ,D'  #)#0  R1(  ,H9  #+
M(@  RRL  ,TU  #.00  SE   ,]@  #/<@  SX<  ,^=  #/LP  S\X  ,_K
M  #.^   SOX  ,[^ (B;  !ZH@  ;*@  %ZO  !0M0  0KD  #6\   IOP
M'L(  !7&   .R0  ",P   #0    TP   -4   #6!@  V P  -D1  #;%@
MW!\  -XH  #@-   XD$  .)1  #C8P  XW<  .2.  #DI   Y+H  .74  #E
MZ@  Y?,  .7S 'RC  !NJ@  8+(  %&Y  !#O@  -<(  "C&   <R0  $\T
M  S1   $U0   -H   #>    X0   .(   #D    Y0,  .<)  #I#@  ZQ(
M .T:  #O)   \C$  /1!  #T4P  ]68  /5\  #VDP  ]JD  />\  #WS@
M]]\  /?? '"L  !AM   4[L  $7#   VQP  )\P  !O0   1U0  "ML   #?
M    X@   .4   #I    [    .T   #P    \0   /,   #U!   ]PH  /H0
M  #\%@  _R$  /\N  #_0   _U,  /]H  #_@   _Y8  /^H  #_M@  _[\
M /^_ /\-' #_"AL _P(; /\ '@#_ "0 _P N /\ / #_ $H _P!6 /\ 8P#_
M &T _P!W /\ ?P#_ (< _P". /\ E #_ )H _P"@ /\ I@#_ *P _P"T /\
MO0#_ ,D _@#= /T [0#\ /H ^P#_ /H _P#Y /\ ^@#_ /H _P#Z /\ ^@#_
M /\0&0#_#1< _P86 /\ & #_ !X _P J /\ -P#_ $4 _P!2 /\ 7@#_ &D
M_P!R /\ >P#_ (( _P") /\ D #^ )8 _0"< /P H0#[ *@ ^0"O /@ N #V
M ,, ] #2 /, YP#R /8 \ #_ .\ _P#P /\ [P#_ .\ _P#N /\ [@#_ /\2
M% #_#Q( _PL2 /\ $@#_ !H _P E /\ ,P#_ $  _P!- /\ 60#_ &0 _0!M
M /L =@#Y 'T ]P"$ /4 BP#T )$ \P"7 /$ G0#P *, [@"J .P LP#J +T
MZ #+ .< X0#E /$ XP#] ., _P#B /\ X0#_ .$ _P#@ /\ X #_ /\4$ #_
M$0X _PT- /\'#P#_ A4 _P @ /\ +0#_ #H _P!' /D 4P#U %X \@!H /
M< #M '@ ZP!_ .D A0#H (P Y@"2 .4 F #C )\ X0"F -\ K@#< +@ V@#%
M -8 V0#4 .P T@#Y -$ _P#/ /\ S@#_ ,X _P#. /\ S@#_ /\7# #_% @
M_P\% /\."P#_#!$ _P<: /\!)@#\ #0 ] !! .T 30#I %@ Y@!B ., :@#@
M '( W@!Y -L @ #9 (8 U@"- -, DP#1 )H SP"A ,T J@#+ +, R0"_ ,8
MT #% .@ PP#V ,$ _P#  O\ OP/_ +\#_P"_ _\ OP/_ /\;!@#_%P  _Q0
M /\3!0#_$0T _PX4 /D*'P#P!BP Y@,Y . #1@#< U$ U@1; -($9 #/!6P
MS 5S ,H%>@#(!8$ Q@6' ,4&C@##!I8 P0:= +\&I@"]!K  NP>\ +D(S0"X
M"N4 M0OW +,-_P"Q#?\ L W_ + ._P"O#O\ KP[_ /\>  #_&P  _QL  /H:
M  #U%@4 ]A$- .L.%0#B"R( V LQ - ,/@#+#4H QPU5 ,0.7@#!#F8 OPYM
M +T.= "[#WL N0^" +<0B@"V$)$ M!": +(0HP"P$:T KQ&Z *T1R@"J$N4
MIQ3W *45_P"C%?\ HA7_ *(5_P"B%?\ HA7_ /\B  #_(   \",  .8D  #@
M(0  W!D% -L0# #0$1D R!,I ,(5-P"]%D0 N1=. +475P"S&&  L!AG *X8
M;@"L&74 JQE\ *D9A "H&HP IAJ4 *0:G@"C&Z@ H1NT )\<Q0">'-\ FAWS
M 9@>_P&7'O\!EA__ 94?_P&5'_\!E1__ ?\F  #T)P  YBT  -HO  #/+0
MRB<  ,<?" #!'!, NAXB +0?,0"O(#T JR%( *@B4@"F(EH HR-B *$C:0"@
M(V\ GB-W )PC?@";(X8 F22/ 9<DF0&6)*,!E"2P 9(EOP&1)=8!CB;O 8PG
M_P*+)_\"BB?_ HDG_P*))_\!B2?_ ?HI  #L,   W38  ,TX  #$-P  OC(
M +HK @"U)0X KB<= *@I*P"D*C@ H"I# )TK3 ":*U4 F"M< )8K8P"4*VH!
MDBMQ 9 L> &/+($!C2R* 8LLE **+)\"B"RK H8LN@*%+<X#@R[J X$N_ .
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M!&T[_P-M.O\#;3K_ ^HY  #50@  Q$@  +E+  "O2P  ITD  )]$  "8/@$
MD3P0 (P]'0"(/BH A#\U ($_/P!^/T@ ?#]/ 7H_5@%X/UT!=CYD G0^:P)R
M/G,#<#Y\ V\^AP1M/I,%:SZ@!FH^K@9I/\ '9S_>!V<_]09F0/\%9D#_!&9
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M!=5(  #"40  M5<  *I;  "@7   EUP  (U9  "!4P  =T\$ '%/$ !N4!P
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M!TA8H@='6;,(1EG*"$59Z@A&6?T&1EC_!D98_P5'6/\%1UC_!<=2  "X6P
MJV$  *%F  "8:   CFD  (-G  !R8   :%X  &%="0!<71, 6ET> %==*0!6
M7C, 5%X[ %)>0P!17DH!3UY2 4Y>60),7F$"2EYJ TA>=01&7H(%1%V0!D->
MH =!7K$'0%[(!T!>Z = 7?P&05W_!4%=_P5!7/\%05S_!<-6  "T7P  J&8
M )YJ  "5;0  BFT  ']L  !O9P  9&0  %MB!0!68A  5&(; %)C)0!08R\
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M RYRXP,N<?@#+G#_ RYO_P,N;_\#+F__ [-F  "G;P  G78  )-Z  "(?
M?GT  ')]  !D?   5WL  $QZ  !">0, /'D. #IZ%P Y>B$ .'HJ #=[,P V
M>SL -'M$ #-[3  R>U4 ,'M? "][:@$M>W<!*WN' 2I[F (H>ZH")WN_ B9[
MX0(F>O<")GC_ B9X_P(G=_\")W?_ JYL  "C=@  F7P  (Y_  "$@@  >(,
M &R$  !?A   480  $>$   \A   ,X0) #"$$0 OA!H +80D "R%+0 KA34
M*H4^ "F%1P HAE  )X9: ":&9@ DAG, (X:# "&&E0 @AJ<!'H:\ 1Z&W@ >
MA/4!'H+_ 1Z"_P$>@?\!'H'_ :AT  ">?0  DX(  (F%  !^B   <8H  &6+
M  !8C   3(T  $".   VC@  +(\  "60#  CD!, (I < "&0)0 @D2X 'Y$V
M !Z10  =D4D ')%4 !J18  9D6X &)%^ !:2D  5DJ0 %)&Y !.1V  3C_0
M%([_ !2-_P 4C/\!%(S_ :-]  "8@P  CH@  (2,  !WCP  :9$  %V3  !0
ME0  19<  #F8   NF0  )9H  !V; @ 6G0P %9T3 !2=&P 3G20 $ITM !&>
M-P 1GD$ $)Y,  ^>6  .GF< #9YW  R>B@ +G9X "IVR  F=S  )G.P "IO^
M  N:_P +F?\ "YG_ )R$  "1B@  B(X  'N2  !ME@  8)D  %2<  !(GP
M/*   #"A   FHP  ':4  !6G   0J04 "ZL-  BJ$P 'JAL !JHD  6J+@ $
MJC@  JI$  &J4   JEX  *IN  "J@0  JI4  *FJ  "IP0  J.0  *CV  "G
M_P  I_\  *?_ )6+  ",D   ?Y4  '&:  !CG@  5J(  $JF   ]J   ,:H
M ":K   =K0  %+    ZR   )M0$  K8*  "V#P  MA4  +<=  "W)0  MR\
M +@Y  "X1@  N%0  +AD  "X=@  N(L  +>@  "WM@  M],  +;O  "V_
MMO\  +;_ (^2  ""EP  =)T  &:B  !8IP  2ZP  #ZO   QL0  )K,  !RV
M   3N   #;L   :^    P0   ,($  #""P  PQ   ,05  #$'   Q20  ,8N
M  #(.@  R4<  ,E7  #):0  R7T  ,F4  #(J@  R,,  ,CD  #(]   R/T
M ,C] (69  !WGP  :*8  %JK  !-L0  /[4  #&X   EN@  &KT  !'    +
MPP   \<   #*    S0   ,X   #/ P  T D  -$.  #3$@  U1D  -<B  #:
M+0  W3D  -Y)  #>6@  WVX  -^%  #?G   W[(  -[+  #>Y@  W_0  -_T
M 'FA  !KJ   7*\  $ZU  ! NP  ,;X  "3!   9Q0  $,@   G,    SP
M -,   #9    W    -T   #?    X0   .(%  #D"P  YA   .@6  #J(
M[2L  / Z  #Q2P  \5X  /)S  #SBP  \Z(  /.V  #SR0  \^$  //A &VJ
M  !>L0  4+D  $&_   RQ   ),@  !?,   .T   !M4   #:    W@   .(
M  #F    Z0   .H   #L    [@   /    #R    ] 8  /8,  #Y$@  _!P
M /\I  #_.@  _TT  /]B  #_>   _Y   /^C  #_LP  _\$  /_! /\'&0#_
M 1< _P 7 /\ &@#_ "$ _P K /\ .0#_ $< _P!4 /\ 7P#_ &H _P!S /\
M>P#_ (, _P"* /\ D #_ )8 _P"; /\ H0#_ *@ _P"O /\ N #_ ,0 _@#5
M /P Z@#[ /@ ^@#_ /D _P#X /\ ^ #_ /8 _P#S /\ \0#_ /\+%0#_!1,
M_P 3 /\ % #_ !H _P G /\ - #_ $( _P!/ /\ 6P#_ &4 _P!N /\ =@#_
M 'X _P"% /X BP#] )$ ^P"7 /H G0#X *, ]P"K /8 LP#T +X \P#, /$
MXP#O /, [@#_ .T _P#L /\ ZP#_ .P _P#L /\ ZP#_ /\-$0#_"1  _P /
M /\ $ #_ !8 _P B /\ +P#_ #T _P!* /\ 50#] &  ^@!I /@ <0#V 'D
M] !_ /, A@#Q (P [P"2 .X F #L )\ ZP"F .D K@#G +@ Y0#% ., V@#A
M .T WP#[ -X _P#= /\ W0#_ -T _P#= /\ W0#_ /\/#0#_# L _P,) /\
M# #_ !( _P = /\ *0#[ #< ^ !$ /4 4 #R %H [@!C .P :P#I ', YP!Z
M .4 @ #C (8 X0", -\ DP#= )D VP"A -D J0#5 +( T@"^ -  S@#. .8
MS #V ,H _P#* /\ R0#_ ,@ _P#( /\ R #_ /\1" #_#0( _P<  /\%" #_
M  X _P 6 /< (@#O #  ZP ] .@ 20#D %0 X != -T 90#9 &T U0!S -(
M>@#0 (  S@"' ,P C0#* )0 R "; ,8 I #$ *T P@"X ,  QP"] -\ O #Q
M +L _@"Y /\ N #_ +@ _P"X /\ N #_ /\4  #_#P  _PT  /\,  #_!PD
M^ $0 .@ &@#C "@ W0 V -@ 0@#2 $T S@!7 ,H 7P#' &8 Q0!M ,, = #!
M 'H OP"! +T B "[ (\ N0"7 +< GP"U *@ LP"S +$ P@"O -@ K@+M *P#
M^P"K!?\ J@;_ *D&_P"I!O\ J0;_ /\6  #_$@  ]Q(  .P1  #F#@  Y08(
M -T#$@#4 R  S00M ,@$.@##!48 OP50 +P&6 "Y!F  MP=G +4';@"S!W4
ML0A[ *\(@@"N"8H K F2 *H)FP"H"J4 I@JP *4+OP"C#-0 H0WM )\._@"=
M#O\ G __ )L/_P";#_\ FP__ /\:  #W&0  ZAX  -\>  #5&@  T!," ,X,
M"P#'"Q8 P TE +H.,@"V#C\ L@]) *\04@"L$%H JA!A *@1: "F$6\ I!%V
M *(1?0"A$84 GQ*. )T2EP"<$J( FA.M )@3O "7%-  E!7L )(6_0"0%_\
MCQ?_ (X7_P".%_\ CA?_ /H=  #N(P  WR@  - J  #')P  P2$  +T9!0"Y
M$A  LA4> *T6+ "H%S@ I!A# *$93 "?&50 G!I< )H:8@"9&FD EQMP )4;
M=P"4&W\ DAR( ) <D@"/')T C1VI (L=MP"*'LH B!_G (8@^@"$(/\!@R#_
M 8,@_P&"(/\!@B#_ ?4D  #E+   TS$  ,8S  "\,0  MBT  + E  "L'0P
MIAX8 *$@)@"<(3( F2(] )4B1P"3(T\ D2-6 (\C70"-)&0 BR1K (DD<@"(
M)'H AB2# (0EC0"#)9@!@26D 8 FL@%^)L4!?2?B 7LG]P%Y*/\!>"C_ 7@H
M_P%X*/\!>"C_ >\K  #=,P  RCD  +X[  "T.@  K38  *8O  "A* < FR<3
M )8H( "1*2T CBHX (LK0@"(*TH ABM2 (0K6 ""+%\ @"QF '\L;0!]+'4
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M MT[  #'0P  N4D  *Y+  "D3   FTH  ))%  ")/P  @3H) 'LZ% !W.R
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M U%&H0101[$$3T?'!$Y'YP1.1_L$3D?_ TY'_P-/1_\#3T?_ \Q&  "[3@
MKU0  *17  ":6   D5<  (94  ![3@  <$H  &E(#0!E2!8 8DDA %])*P!=
M230 6TD\ %E)0P!724H 5DE2 %5*60%42F$!4DIJ 5%*=0)/2H$#3DJ/ TQ+
MGP1+2[ $2DO%!$E+Y@1)2_H$24O_ TI+_P-*2_\#2DO_ \A)  "X40  K%<
M *%;  "87   CEP  (-9  !V4P  :TX  &1-"@!?3!, 7$T> %I-* !833$
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M SI9X ,Z6/<#.EC_ SM7_P,[5_\#.U?_ [Q4  "N7   HV,  )EG  "0:0
MA6D  'EG  !K8@  8&   %5=  !.6PP 2UL4 $E<'P!'7"@ 1ETQ $5=.0!#
M74$ 0EU( $%>4 ! 7E@ /EYA 3Q>; $[7G@".5Z' C=>EP(V7JD#-5Z] S1?
MW0,T7O4#-5W_ C5=_P(U7/\"-5S_ KA9  "J80  H&<  )9L  ",;@  @6X
M '9L  !G:0  7&8  %%D  !(8@D 1&(1 $)B&P!!8R0 /V,M #YC-0 ]9#T
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M 1]R_P$@<?\!(''_ :EK  "><P  E'D  (I\  " ?@  ='\  &=_  !:?P
M37X  $-^   X?0  +WT" "A]#0 F?10 )'T< "-^)0 B?BT (7XV "%^/P ?
M?T@ 'G]2 !U_7@ <?VL &G]Z !E_C  7?Y\ %G^S !5_S@ 5?N\ %GS_ !9[
M_P 6>_\ %WO_ *1R  ":>@  CW\  (6"  ![A   ;88  &"'  !4AP  2(@
M #R(   RB   *(@  ""(!0 :B0X &8D5 !B)'0 7BB8 %HHN !6*-P 4BD$
M$XI, !*+6  1BV4 $(MU  ^+AP .BIL #8JO  R*R  ,B>H #8?\  Z'_P .
MAO\ #H;_ )][  "4@0  BH4  ("(  !SBP  98T  %F/  !,D   09(  #22
M   JD@  (9,  !F4   2E@8 #I<.  V7%0 ,EQT #)<F  N7+P *ESD "9=$
M  B74  &EUX !9=N  .6@  !EI0  )6H  "5O@  E.   )3T  "3_P !DO\
M 9+_ )B"  ".B   A8P  '>/  !JD@  794  %"8  !$F@  .)L  "R<   B
MG0  &9X  !*@   -H@( !Z,+  &C$   HQ<  *,?  "C)P  HS$  *0\  "D
M2   I%8  *1E  "C=P  HXL  *.@  "BM@  H=(  *'P  "@^P  H/\  *#_
M )&*  ")C@  >Y(  &V7  !@FP  4YX  $:A   YHP  +:0  ".F   9J
M$:H   RL   %K@   *\'  "O#0  KQ$  + 8  "P(   L2@  +$R  "R/@
MLDP  +);  "R;   LH$  +&7  "QK   L,8  +#H  "O]P  K_\  *__ (R0
M  !_E0  <9H  &.?  !5I   1Z@  #JJ   MK   (JX  !BP   0LP  "K4
M  *X    NP   +L   "\!P  O T  +T1  "^%@  OQX  , G  #!,@  PD
M ,-/  ##8   PW0  ,.+  ##H0  P[@  ,+7  #"[P  POH  ,'^ (&7  !S
MG0  9:,  %>H  !)K0  .[$  "VS   AM@  %KD   Z[   'O@   ,$   #%
M    QP   ,@   #)    R@4  ,L+  #-#P  SA0  - <  #3)@  UC(  -A!
M  #84P  V68  -E\  #9E   V:L  -G#  #9X0  V?   -GT ':?  !GI@
M6:P  $NR   \MP  +KH  "&]   5P   #<0   7'    R@   ,X   #2
MU0   -8   #9    VP   -T   #?!P  X0P  .,1  #F&0  Z20  .PR  #M
M0P  [E8  .]K  #OA   [YP  .^R  #OQ@  []T  ._D &JH  !;KP  3+8
M #Z\   OP   (,0  !3(   ,S    M    #4    V0   -X   #B    Y0
M .8   #H    Z0   .P   #N    \ (  /()  #U#P  ^!<  /PC  #_,P
M_T8  /]:  #_<0  _XD  /^?  #_L0  _\   /_& /\ %0#_ !0 _P 4 /\
M%P#_ !T _P H /\ -P#_ $0 _P!1 /\ 7 #_ &8 _P!O /\ =P#_ 'X _P"%
M /\ BP#_ )$ _P"7 /\ G0#_ *0 _P"K /\ M #^ +\ _0#. /L Y@#Y /8
M^ #_ /< _P#W /\ ]P#_ /  _P#L /\ Z0#_ /\#$@#_ !  _P 0 /\ $0#_
M !< _P D /\ ,@#_ #\ _P!, /\ 5P#_ &$ _P!J /\ <@#_ 'D _0"  /P
MA@#Z (P ^0"2 /@ F #V )\ ]0"F /0 K@#R +D \ #& .X W@#M /  ZP#^
M .H _P#I /\ Z0#_ .< _P#C /\ X #_ /\'#@#_  T _P + /\ # #_ !,
M_P ? /\ + #_ #H _P!& /X 4@#[ %P ^ !E /4 ; #S '0 \0!Z .\ @0#N
M (< [ "- .H DP#I )H YP"A .8 J0#C +, X0"_ -\ T #= .D V@#Y -D
M_P#7 /\ U0#_ -4 _P#5 /\ U #_ /\)"@#_ 04 _P # /\ "0#_ !  _P 9
M /L )@#W #0 ] !  /( 3 #N %8 Z@!? .< 9P#D &X X@!T .  >P#> ($
MW "' -H C0#6 )0 U "; -$ HP#/ *T S "X ,H QP#( .  Q@#S ,4 _P##
M /\ PP#_ ,, _P## /\ PP#_ /\+ 0#_ P  _P   /\  P#_  L \P 2 .X
M'P#J "T Y@ Z .( 10#> $\ V0!8 -0 8 #1 &@ S@!N ,P = #* 'L R "!
M ,8 AP#$ (X P@"6 ,  G@"^ *< NP"R +D P "W -0 M0#L +, ^P"S /\
ML@#_ +( _P"Q /\ L0#_ /\-  #_!@  _P,  /<   #T  , YP - .  & #:
M "4 TP R ,X /@#* $D Q@!2 ,, 6@#  &$ O@!H +P ;@"Z '0 N ![ +8
M@0"T (@ L@"0 +  F0"N *( K "M *H N@"H ,L I@#F *4 ]P"D /\ HP#_
M *( _P"B /\ H@#_ /\0  #[#   [PX  .8-  #?"0  V@ & -  $0#) !T
MQ  J +\ -P"[ $( MP!+ +0 5 "R %L KP!B *T : "K &X J0!U *@ >P"F
M (, I "+ *( E "@ )X G@&H )P"M0"; \8 F07B )@&] "6"/\ E0G_ )0)
M_P"4"?\ E G_ /P1  #Q%0  XQD  -89  #,%0  QQ   ,0'"@"] Q0 MP0A
M +(&+@"N"#H J@E$ *<)30"D"E4 H@I< * *8@">"VD G MO )L+=@"9#'X
MEPR& )8,D "4#)H D@VF )$-LP"/#<4 C0[B (L0]@")$/\ B!'_ (<1_P"'
M$?\ AQ'_ /89  #G(   UB0  ,@E  "_(@  N1P  +04 0"Q#0X J@X9 *4/
M)P"A$#, G1$^ )H11P"8$D\ E1)6 ),27 "1$F, D!-I (X3< ",$W@ BQ.!
M (D4BP"'%)8 AA6B (05L "#%L$ @1?= '\8] !]&?\ ?!G_ 'P9_P![&?\
M>QG_ .\A  #=*0  RBT  +XO  "U+   KB<  *@@  "C%P@ GA83 )D7(0"4
M&2T D1HX (X:00"+&TD B1M0 (<;5P"%'%X A!QD ((<:P" '', ?QU\ 'T=
MA@!\'I$ >AZ> '@?JP!W'[P =B#4 '0A\ !R(?\ <2+_ '$A_P!Q(?\ <2'_
M .@H  #2,   PC4  +<W  "M-0  I3$  )XK  "8(P( DAX0 (T@&P")(2<
MAB(R (,C/ "!(T0 ?B-+ 'PD4@![)%D >21? '<D9@!V)6X ="5W ',E@0!Q
M)HT ;R:9 &XFIP!M)[@ ;"?. 6HH[0%I*?\!:"G_ 6@I_P%H*/\!:"C_ >$N
M  #+-@  O#L  +$]  "G/0  GSD  )<S  "/+0  B"<, (,G%@!_*"( ?"DM
M 'DJ-P!W*C\ =2I' ',K3@!Q*U0 <"M; &XK8@!L*VH :RQR &DL?0!H+(D
M9BV6 64MI %D+K0!8R[* 6$OZ0%@+_T!8"__ 6 O_P%@+_\!8"[_ =HT  #%
M/   MT$  *Q#  "B0P  F4   ) Z  "(-   @"X( 'HM$@!W+AX <R\I '$P
M,P!O,#L ;3!# &LQ2@!I,5$ 9S%7 &8Q7@!D,68 8S)O &$R>0!@,H4!7S*2
M 5TSH0%<,[$!6S3& 5HTY@%9-?L!637_ 5DT_P%9-/\!633_ =(X  # 0
MLT4  *A(  ">2   E48  (M   "".P  >34$ ',S$ !O-!H ;#0E &DU+P!G
M-3< 938_ &,V1@!B-DT 8#94 %\V6P!=-V, 7#=K %LW=@%9-X(!6#B/ 58X
MG@%5.*\"5#G# E,YY )3.OD!4SG_ 5(Y_P%3.?\!4SG_ <T\  "\1   KTD
M *1,  ":3   D4L  (=&  !]0   <SL  &PX#0!H.1< 93DB &,Z*P!@.C0
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M D-&W )#1O4"0T;_ D-&_P%#1?\!0T7_ <%'  "R3P  IE0  )Q7  "26
MB%@  'Y5  !Q3P  9DH  %Q&!0!71@\ 5$88 %%&(@!/1BL 3D8S $Q'.@!+
M1T$ 2D=) $E(4 !(2%@ 1TAA $5); !$27@!0DF& 4%)E@% 2J<"/TJ[ CY+
MV (^2O,"/DK_ CY)_P$_2?\!/TG_ ;U*  "O4@  HU@  )E;  "070  AEP
M 'M9  !M4P  8D\  %=, 0!12@T 3DH5 $Q+'P!*2R@ 24LP $=+. !&3#\
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M 2Y7_P$N5_\!+E;_ ;)7  "E7P  FV4  )%I  "':@  ?&H  '%H  !C90
M6&(  $U?  !#70( /%L- #I<%  X7!T -UPF #5=+@ T738 ,UT^ #)=1@ Q
M7DX ,%Y7 "]>8@ M7FX +%]] "I?C@ I7Z  *%^S 2=?S  G7^T!)U[_ 2==
M_P$H7?\!*%S_ :U<  "B9   F&H  (YN  "#;P  >6\  &YN  !@:P  5&D
M $EG   _90  -6,) #)C$0 P8QD +V0A "YD*0 M9#$ +&0Y "ME0@ J94H
M*&54 "=E7P F9FL )&9Z "-FBP B9IT (&:Q !]FR0 ?9NL (&7^ "!D_P @
M8_\!(6/_ :EB  ">:@  E7   (IS  " =0  =74  &ET  !<<@  3W$  $1O
M   Z;@  ,&T# "EL#0 G;!0 )FP< "5M)  D;2P (VTT ")M/0 A;D8 (&Y0
M !YN6P =;F< '&YV !INAP 9;YH &&^N !9OQ@ 6;ND %VW\ !AL_P 8:_\
M&&O_ *1I  ":<0  D'8  (9Y  !\>P  <7L  &1[  !7>@  2GD  #]X   U
M>   *W<  ")V!P ==@\ ''<6 !MW'@ :=R8 &7<N !AW-P 7>$  %7A* !1X
M5@ 3>&, $GAR !%X@P 0>)< #WBK  YXPP .=^8 #G;Z  ]U_P 0=?\ $'3_
M )]Q  "5>   BWP  ()_  !W@0  :H(  %V"  !0@@  1((  #B"   N@@
M)((  !R"   4@@D $8,0 !"#%@ 0@QX #H,G  Z#,  -@SD #8-$  R#4  +
M@UT "8-L  B#?@ &@Y$ !8*E  ."NP $@=L !('R  6 _P &?_\ !G__ )IY
M  "0?@  AH,  'V%  !OAP  8HD  %6*  !)BP  /8P  #&,   FC   '8T
M !6.   /CP, "I ,  :0$0 $CQ@  X\@  &/*0  CS(  ) ]  "020  CU8
M (]E  "/=@  CXH  (Z?  ".M   C<\  (SN  ",^P  B_\  (O_ )2   "+
MA0  @HD  '2,  !FCP  69$  $R3  ! E0  -)8  "B6   >EP  %9@   ^:
M   *FP   IP)  "<#@  G!,  )P:  "<(@  G2L  )TU  "=0   G4X  )U<
M  "=;@  G($  )R7  "<K   F\8  )KH  "9^0  F?\  )C_ (Z(  "&C
M>)   &J4  !<EP  3YH  $*=   VG@  *9\  !^A   5H@  #J0   BF
MJ    *D$  "I"@  J0X  *D3  "J&@  JB(  *LK  "L-@  K$0  *Q3  "L
M8P  K'<  *N.  "KI   J[P  *K>  "I]   J?T  *G_ (F.  ![DP  ;9<
M %^<  !1H   1*0  #:F   JJ   'JD  !2K   -K@  !K    "R    M0
M +4   "U P  M@D  +<.  "X$@  N!D  +HA  "[*P  O#@  +U'  "]6
MO6L  +V!  "]F0  O;   +W,  "\Z@  O/<  +O^ 'Z5  !PFP  8J   %.E
M  !&J@  .*T  "JO   >L0  $[0   RW   #N0   +P   "_    P@   ,(
M  ##    Q    ,8&  #'#   R!   ,H6  #,(   SRL  - Z  #12P  T5X
M -)S  #2BP  TJ0  -.[  #3V   T^T  -/V '.=  !DHP  5JD  $>O   Y
MLP  *K8  !VY   2O   "K\   ##    Q@   ,D   #-    SP   -    #2
M    U    -8   #9 @  VP@  -X.  #A$P  Y!T  .@J  #H/   Z4\  .ED
M  #J?   ZY4  .NL  #KP@  [-4  .SE &:F  !8K   2;,  #NY   KO
M'<   !'$   )R    ,P   #/    TP   -D   #=    X    .$   #C
MY0   .<   #J    [    .X$  #Q"P  ]1(  /@<  #[*P  _3X  /Y3  #^
M:@  _X,  /^;  #_K@  _[X  /_* /\ $@#_ !  _P 1 /\ $P#_ !D _P F
M /\ - #_ $$ _P!- /\ 6 #_ &( _P!K /\ <P#_ 'H _P"! /\ AP#_ (T
M_P"3 /\ F0#_ *  _P"G /X KP#\ +H ^@#) /D X0#X /, ]P#_ /8 _P#U
M /\ \0#_ .D _P#D /\ X0#_ /\ #P#_  T _P - /\ #@#_ !0 _P A /\
M+@#_ #P _P!( /\ 4P#_ %T _P!F /X ;0#\ '4 ^P![ /D @@#X (@ ]P".
M /8 E #T )L \P"B /$ J@#O +0 [0#! .L U0#J .P Z #\ .< _P#E /\
MY@#_ .  _P#9 /\ U #_ /\ "P#_  @ _P & /\ "0#_ !  _P < /\ *0#_
M #8 _P!" /L 3@#W %< ] !@ /( : #O &\ [0!V .P ? #J (( Z "( .<
MC@#E )4 XP"< .$ I #? *X W0"Y -H R@#7 .0 U #V -$ _P#0 /\ T #_
M ,\ _P#+ /\ QP#_ /\  P#_    _P   /\ ! #_  T ^@ 6 /8 (P#S #
M\  \ .T 1P#I %$ Y0!: .( 8@#? &D W0!O -H =@#8 'P U "" -( B #0
M (\ S0"6 ,L G@#) *@ QP"S ,4 P0#" -@ P #O +\ _@"^ /\ O0#_ +P
M_P"\ /\ O #_ /\"  #_    _P   /\   #T  < [0 1 .@ ' #C "D WP U
M -L 00#6 $L T0!4 ,T 7 #* &, R !I ,8 ;P## '4 P0![ +\ @@"^ (@
MO "0 +H F "X *( M0"L +, N0"Q ,L KP#G *X ^ "L /\ JP#_ *P _P"L
M /\ JP#_ /\$  #_    ]@   .X   #G    WP , -8 %0#/ "( R@ N ,<
M.@## $0 P !- +P 50"Y %P MP!C +4 :0"S &\ L0!U *\ >P"M (( JP"*
M *D D@"G )P I0"F *, LP"A ,, GP#> )X \@"= /\ G #_ )P _P"; /\
MFP#_ /\'  #V"0  Z0L  -\*  #5!   S@ % ,8 $ #  !H NP G +< ,@"S
M #T L !& *T 3P"J %8 J !< *8 8P"D &@ H@!O *$ =0"? 'P G0"$ )L
MC0"9 )< EP"B )4 K@"3 +T D0#3 )  [0"/ /P C@#_ (T!_P"- ?\ C0'_
M /D.  #J$@  W!4  ,T5  #$$0  O@P  +H""@"T !( K@ > *H *@"F #4
MH@ _ *  2 "= 5  FP)6 )D"7 "7 V, E0-I ),#;P"1!'8 D 1_ (X%B ",
M!9( B@:> (@&J@"&![H A0C/ (0*ZP"""_P @0S_ ( ,_P" #/\ @ S_ /$5
M  #@'0  S2   ,$A  "X'0  L1<  *P0  "H"0T H@<6 )T)(P"9"BX E0LX
M ),,00"0#$D C@U0 (P-5P"*#5T B UC (<-:@"%#G$ @PYZ ((.A " #H\
M?@^; 'P/J ![$+@ >A#. '@1[ !V$O\ =1+_ '03_P!T$_\ =!/_ .@>  #3
M)@  PRH  +@J  "N*   IR,  * <  ";$P, E@\0 ) 0&P",$2< B1(R (83
M.P"$$T, @A1+ ( 440!^%%< ?!1> 'L590!Y%6P =Q5T '86?@!T%HH <A>6
M '$7I !O&+0 ;AC) &T9Z !K&OP :AO_ &H;_P!J&_\ :AO_ . F  #*+0
MO#$  + S  "G,0  GRP  )<F  "0'P  BA<, (48%@"!&2( ?AHL 'L;-@!Y
M&SX =QQ% '4<3 !S'%, <1U9 ' =8 !N'6< ;1YP &L>>@!J'H4 :!^2 &<?
MH !E(+  9"'% &,AY !B(OH 82+_ &$B_P!A(O\ 82+_ -<L  ##-   MC@
M *HY  "A.   F#4  ) O  "(*   @"$( 'L@$@!W(1T ="(G '$B,0!O(SD
M;2-! &LC2 !I(TX :"15 &8D6P!E)&, 8R5K &(E=0!A)8$ 7R:. %XFG0!=
M)ZT 6RC! %LHX !:*?< 62G_ %DI_P!9*?\ 62C_ ,\R  "^.0  L3T  *8_
M  "</P  DSP  (HV  "!,   >2H# '(F#P!N)QD :R@C &DH+ !F*34 92D\
M &,I0P!A*DH 8"I1 %XJ5P!=*E\ 7"MH %HK<@!9+'T 6"R+ %8MF@!5+:H
M5"Z] %,NW !2+_4 4B__ %(N_P!2+O\ 4B[_ ,HV  "Z/0  K4(  *)$  "8
M1   CT$  (4\  ![-P  <C$  &LL# !G+14 9"T? &$N* !?+C$ 72XY %PO
M0 !:+T8 6"]- %<O5 !6,%P 53!D %,Q;@!2,7H 43&( % REP!.,J@ 33.[
M $TTV !,-/, 3#3_ $PT_P!,,_\ 3#/_ ,8Z  "V0@  J48  )Y)  "520
MBT<  (%"  !W/0  ;3<  &0R"0!@,A( 73(< %HR)0!8,RT 5C,U %4S/ !3
M-$, 4C1* %$T40!0-%D 3S5A $TU; !,-G< 2S:% $HWE0!(-Z8 1SBX 4<X
MTP%&./$!1CC_ 48X_P!&./\ 1C?_ ,$^  "R10  IDH  )Q-  "230  B$L
M 'Y'  !S0@  :3T  %\W!@!:-A  5S<8 %0W(@!2-RH 4#<R $\X.0!-.$
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M 3=$_P$X1/\!.$/_ +=)  "I4   GE4  )18  "+60  @%@  '96  !H4
M74P  %-(  !*10D 1D01 $1$&0!"1"( 044I #]%,0 ^13@ /44_ #Q&1P [
M1D\ .D=8 #E'8@ X2&X -DA\ #5(C0 T29X ,TFQ #))R0 Q2>L ,DG^ #)(
M_P R2/\ ,TC_ +1,  "G5   G%D  ))<  "(70  ?ET  '-:  !E50  6U(
M %!.  !&2@4 0$D. #Y)%@ ]21X .THF #I*+@ Y2C4 .$L] #=+1  V2TT
M-$Q6 #-,8  R3&P ,4UZ #!-BP N39P +4ZO "Q.QP L3ND +$W] "U-_P M
M3/\ +4S_ +!0  "D6   F5T  (]A  "&8@  >V$  '!?  !B6P  6%@  $Y5
M  !#40$ .T\, #A/$P V3QL -4\C #10*P S4#( ,E Z #%00@ P44H +E%3
M "U270 L4FD *U)X "E2B  H4YH )U.M "93Q0 F4^< )E/\ "=2_P G4?\
M)U'_ *Q5  "@7   EF(  (UF  "#9P  >&8  &UE  !@80  55X  $I;   _
M6   -58( #%5$  P5A< +E8? "U6)P L5B\ *U<V "I7/@ I5T< *%=0 "98
M6@ E6&< )%AU "-9A@ A69@ (%FK !]9P@ ?6>4 'UCZ "!8_P @5_\ (5?_
M *A:  "=8@  DV<  (IK  !_;   =6P  &IK  !=:   464  $9C   [8
M,5X# "I=#0 H71, )ET; "5>(P D7BH (UXR ")>.@ A7D, (%], !]?5P >
M7V, '&!Q !M@@@ 98)4 &&"I !=@P  68.( %U_Y !A>_P 97O\ &5W_ *1@
M  "9:   D&X  (9P  !\<@  <G(  &9Q  !8;@  3&P  $%K   V:0  +6<
M "-F"  ?9@\ '685 !QF'0 ;9B4 &F8M !EG-0 89SX %V=( !9G4P 5:%\
M$VAN !)H?P 1:)( $&BF  ]HO0 .:.  $&?W !!F_P 19?\ $67_ )]G  "6
M;P  C',  ()V  !X>   ;7@  &!W  !3=@  1G0  #MS   Q<@  )W$  !YQ
M   6< H $W 0 !-P%P 2<!\ $7$G !!Q+P 0<3@ #G%"  YQ3@ -<5L #'%I
M  MQ>@ *<8T "'&A  9QM@ &<-( !W#O  AO_P );O\ "6[_ )MO  "1=0
MAWD  'Y\  !T?@  9GX  %E^  !-?@  0'T  #5]   J?   (7P  !A\   1
M? 0 #'P,  I\$0 )?!D "'PA  =\*0 &?#( !'P]  -\2  !?%4  'QC  !\
M=   ?(<  'N<  ![L0  >LL  'GK  !Y^@  >?\  'C_ )9W  ",?   @X
M 'F#  !LA   7H4  %&&  !%AP  .8<  "V'   CAP  &H<  !*'   -B $
M!HD*  &)#P  B10  (@;  "((P  B2P  (DV  ")0@  B$X  (A=  "(;0
MB($  (>5  "'JP  AL0  (7F  "$^   A/\  (3_ )!^  "'@P  ?H<  '&)
M  !CBP  5HT  $F/   \D0  ,)$  "21   :D@  $I,   V4   &E0   )8&
M  "6#   E1   )85  "6'0  EB0  )8N  "6.0  ED8  )95  "690  EG@
M )6.  "5I   E+P  )/?  "3]0  DO\  )+_ (N&  "#B@  =8T  &>0  !9
ME   3)<  #^9   RF@  )IL  !N<   2G0  #)\   2@    H@   *,!  "C
M!P  HPP  *,0  "D%0  I!P  *4E  "F+P  ICP  *9+  "F6P  IFX  *6$
M  "EFP  I+,  */0  "C[P  HOP  *+_ (:-  !XD0  :I4  %R9  !.G0
M0:   #.B   FHP  &Z4  !&G   *J0   :L   "M    KP   +    "P
ML 4  +$+  "R#P  LQ0  +0;  "U)   MS   +<_  "W4   MV(  +=X  "W
MD   MJD  +;"  "VY   MO4  +7^ 'N3  !MF   7YT  %"B  !"I@  -*D
M ":K   :K0  $*\   FR    M    +<   "Z    O    +T   "^    O@
M , "  #!"   P@T  ,02  #&&0  R20  ,HR  #+0P  RU4  ,QJ  #,@P
MS)P  ,NU  #,S@  S.D  ,SV '";  !AH0  4J8  $2K   VL   )[(  !JU
M   0N   ![L   "^    P0   ,0   #(    RP   ,L   #-    S@   -
M  #2    U0,  -@*  #;$   WA@  .(D  #C-0  Y$@  .5<  #F<P  YHT
M .:E  #FO   YM,  .?G &.D  !5J@  1K   #BU   HN0  &KP   _    %
MQ    ,<   #+    SP   -0   #8    W    -T   #?    X0   .,   #E
M    Z    .H   #M!@  \0X  /46  #X)0  ^3@  /E-  #Z8P  ^WP  /R5
M  #\J@  _+L  /W+ /\ #P#_  X _P . /\ $ #_ !8 _P C /\ , #_ #T
M_P!) /\ 5 #_ %X _P!F /\ ;@#_ '8 _P!\ /\ @@#_ (D _P"/ /\ E0#^
M )L _0"C /L JP#Z +4 ^0## /< VP#V /  ] #_ /, _P#R /\ [ #_ .(
M_P#< /\ U@#_ /\ # #_  D _P ( /\ "@#_ !( _P > /\ *P#_ #@ _P!$
M /\ 3P#_ %D _@!A /P :0#Z '  ^ !W /< ?0#V (, ] ") /( CP#Q )8
M[P"= .T I0#L *\ Z@"\ .@ S0#F .@ Y #Z ., _P#B /\ X #_ -4 _P#.
M /\ RP#_ /\ !@#_  $ _P   /\ ! #_  X _P 9 /\ )0#] #( ^P ^ /<
M20#S %, \ !< .X 8P#L &H Z@!Q .@ =P#F 'T Y "# .( B0#@ )  W@"7
M -P GP#9 *D U@"T -, Q #0 -X S@#S ,P _P#+ /\ R@#_ ,@ _P#" /\
MO@#_ /\   #_    _P   /\   #[  L ]@ 3 /$ ( #M "P Z@ X .< 0P#C
M $T X !6 -P 70#9 &0 U0!K -( <0#0 '8 S@!\ ,P @P#* (D R "1 ,8
MF0#$ *, P0"M +\ NP"] ,\ NP#K +D _ "W /\ MP#_ +8 _P"T /\ L0#_
M /\   #_    _P   /8   #N  4 YP / .$ &0#; "4 U0 Q -( / #. $8
MR@!/ ,< 5P#$ %X P0!D +\ :@"] '  NP!V +D ? "X (, M@"* +, DP"Q
M )P KP"G *T LP"K ,4 J0#A *< ]0"F /\ I0#_ *0 _P"D /\ I #_ /\
M  #\    \0   .@   #@    U  + ,P $P#' !\ P@ J +\ -0"\ #\ N !(
M +4 4 "S %< L !> *X 9 "L &D JP!O *D =0"G 'P I0"$ *, C "A )8
MGP"A )T K0": +P F #2 )< [@"5 /X E #_ )4 _P"5 /\ E0#_ /P!  #P
M!0  XP<  -4%  #,    Q0 $ +X #@"X !< LP C *\ +@"K #@ J0!! *8
M2@"C %$ H0!7 )\ 70"= &, FP!I )H ;P"8 '8 E@!] )0 A@"2 )  D ";
M (X IP", +8 B@#) (@ YP"' /D AP#_ (8 _P"& /\ A@#_ /0,  #D$
MT1(  ,41  "]#@  M@@  +$ " "K !$ I@ ; *$ )@"> #$ F@ Z )@ 0P"5
M $H DP!1 )$ 5P"/ %T C@!C (P :0"* '  B !W (8 @ "$ (L @@"6 (
MHP!^ +$ ?0#$ 'L"X0!Z _4 >@7_ 'D%_P!X!O\ > ;_ .H3  #6&@  QAT
M +H<  "Q&0  JA,  *0-  "?!0P F0 4 )4 'P"1 BD C0,S (L$/ "(!40
MA@9+ (0&40""!U< @0== '\'8P!]"&H >PAR 'H(? !X"88 =@F2 '0*H !S
M"J\ <0O! ' ,WP!O#?8 ;@[_ &T._P!M#O\ ;0[_ .$<  #+(P  O"8  +$F
M  "H)   H!X  )D8  "3$ ( C@L. (@+%P"$#"( @0TL 'X--0!\#CT >@Y%
M '@.2P!W#E$ =0]8 ',/7@!Q$&4 <!!N &X0=P!L$(( :Q"/ &D1G0!H$:T
M9A+  &42WP!D$_8 8Q3_ &,4_P!B%/\ 8A3_ -8D  ##*@  M2X  *HO  "@
M+0  F"@  ) B  ")&P  @A,( 'T1$@!Y$AP =A,G ',4, !Q%#@ ;Q4_ &T5
M1@!L%4P :A93 &@660!G%F$ 919I &07<@!B%WX 81B+ %\8F0!>&:D 7!F\
M %P:V !:&_, 6AS_ %D<_P!9'/\ 61S_ ,TJ  "],0  KS4  *0V  ";-
MDC$  (DK  "!)0  >1T# ',8#@!O&1@ ;!HB &D;*P!G&S, 91P[ &0<00!B
M'4@ 8!U. %\=50!='5P 7!YD %L>;@!9'WD 6!^' %8@E@!5(*8 5"&X %,A
MT@!2(O$ 4B/_ %(C_P!2(O\ 4B+_ ,@O  "X-@  JSH  * \  "6.P  C3@
M (,R  !Z+0  <B8  &H@# !F(!, 8R$= &$A)@!?(B\ 72(V %LB/0!:(T0
M6"-* %<C40!5(U@ 5"1A %,D:@!1)78 4"6# $\FDP!.)Z, 3">U $PHS@!+
M*.X 2RG_ $LH_P!+*/\ 2RC_ ,,T  "S.P  IS\  )Q!  "20   B3X  '\Y
M  !U,P  ;"T  &,G" !>)A$ 7"89 %DG(@!7)RL 52@R %0H.0!2*$  42A&
M % I30!.*54 32E= $PJ9P!+*G, 22N  $@KD !'+*$ 1BVS $4MRP!%+NP
M1"[_ $0N_P!%+?\ 12W_ +XX  "P/P  I$,  )E%  "/10  A4,  'L^  !Q
M.0  9S0  %XN! !8*PX 52L6 %(L'P!0+"< 3RPO $TM-@!,+3P 2BU# $DM
M2@!(+E( 1RY: $8O9 !%+W  0S!^ $(PC0!!,9X 0#*Q #\RR  _,^H /S/^
M #\R_P _,O\ /S+_ +L\  "M0P  H4<  )9)  ",20  @T@  'A$  !M/@
M8SD  %HT  !2, P 3S 3 $PP' !*,"0 23$K $<Q,@!&,3D 1#%  $,R1P!"
M,D\ 03-8 $ S8@ _-&T /C1[ #TUBP \-IP .S:O #HWQ@ Y-^@ .3?\ #HW
M_P Z-O\ .C;_ +=   "J1@  GDL  )1-  "*3@  @$P  '5(  !J0P  8#X
M %8Y  !--0D 2301 $<U&0!%-2$ 0S4H $$U+P! -38 /S8] #XV10 ]-TT
M/#=5 #LX8  Z.&L .3EY #@YB0 W.IL -3JM #4[Q  T.^8 -#O[ #4[_P U
M.O\ -3K_ +1#  "G2@  G$X  ))1  "(4@  ?E   '--  !G2   7$0  %(_
M  !(.@8 1#D/ $$Y%@ _.1X /CDF #PY+0 [.C0 .CH[ #D[0@ X.TH -SQ3
M #8\70 U/6D -#UW #,^AP Q/ID ,#^K "\_P@ O/^0 +S_Z # __P P/O\
M,#[_ +%'  "D30  F5(  (]5  "&5@  ?%4  '%2  !D3   64D  $]%  !%
M0 , /SX- #P^$P Z/AL .3XC #<^*@ V/S$ -3\X #0_0  S0$@ ,D!1 #%!
M6P P06< +D)U "U"A0 L0Y< *T.J "I#P  I1.( *D/Y "I#_P K0O\ *T+_
M *Y*  "A40  EU8  (U9  "#6@  >5H  &Y7  !A4@  5TX  $U+  !#1P
M.D,* #9#$0 T0Q@ ,T,@ #)$)P Q1"\ ,$0V "]%/0 M148 +$5/ "M&60 J
M1F0 *4=R "A'@P F1Y4 )4BH "1(O@ C2.  )$CW "5'_P E1_\ )D?_ *I/
M  "?50  E%H  (M>  "!7P  =UX  &M<  !?6   554  $M1  ! 30  -4H'
M #!)#@ N214 +4D= "Q))  K2BL *DHS "A*.P G2T, )DM, "5+5@ D3&(
M(TQP "%,@  @39, 'TVF !Y-NP =3MT 'DWV !Y,_P ?3/\ ($O_ *=3  "<
M6@  DE\  (AC  !^9   =&,  &EA  !<7@  4EL  $=8   \50  ,E(" "I0
M#  G3Q( )E 9 "50(  D4"@ (U O ")1-P A44  (%%) !Y24P =4E\ '%)M
M !I3?0 94Y  &%.D !93N0 54]D %E/T !=2_P 84?\ &5'_ *-9  "88
MCV4  (5H  ![:0  <6D  &9G  !99   36$  $)?   X7   +EH  "58"  @
M5PX 'E<4 !U7'  <6", &U@K !I8,P 96#P &%A% !994  565L %%EI !-:
M>@ 26HT $5JA !!:MP .6M4 $%GS !!9_P 16/\ $5C_ )]?  "59@  C&L
M ()M  !X;@  ;F\  &)M  !5:@  2&@  #YF   S90  *6,  "!A 0 88 L
M%6 0 !1@%P 38!X $F F !)@+@ 183< $&%   ]A2P .85@ #6%F  QB=@ +
M8HD "F&=  EAL@ (8<L "&'K  E@_0 *7_\ "U__ )MF  "2;0  B'$  'YS
M  !U=0  :G0  %QS  !/<@  0W   #AO   M;@  )&P  !MK   3:P0 #FH,
M  UJ$@ ,:AD "VHA  IJ*0 ):C( "&H\  =K1P %:U, !&MA  )K<0  :H0
M &J8  !JK0  :<8  &GG  !I^   :/\  &C_ )=M  "-<P  A'<  'MZ  !P
M>P  8WL  %9Z  !)>@  /7D  #%X   G=P  '78  !5V   /=@( "78*  1V
M#P  =A4  '8<  !V)   =2P  '4V  !U00  =4X  '5<  !U;   =7X  '23
M  !TJ   <\   '/C  !R]P  <O\  ''_ ))U  ")>@  @'X  ':   !I@0
M6X(  $Z"  !!@@  -8,  "F"   ?@0  %H$  !""   *@@   H,'  ""#0
M@A$  ((7  ""'@  @B8  ((O  "".P  @D<  ()5  "!90  @7@  (&-  "
MH@  ?[H  '_=  !^]   ??\  'W_ (U\  "$@0  >X0  &Z&  !@B   4HH
M $6+   YC   +(P  "&,   7C   $(T   F.   "CP   ) #  "/"0  CPX
M (\2  "0&   D!\  ) H  "0,@  D#\  )!-  "070  CW   (^%  ".G
MCK,  (W0  ",\   B_X  (O_ (B$  " B   <HL  &2-  !6D   2),  #N5
M   NE@  (I8  !>7   /F   ")D   ";    G0   )T   "= P  G0D  )T-
M  ">$0  GA<  )\?  "?*0  H#4  *!#  "@5   H&8  )][  ">DP  GJL
M )W&  "=Z0  G/D  )S_ (.+  !UC@  9Y(  %F6  !+F0  /9P  #">   C
MGP  %Z    ZB   'I    *8   "H    J@   *H   "J    JP$  *L'  "L
M#   K1   *X6  "O'@  L2D  +$X  "Q2   L5H  +%O  "QB   L:   +"Z
M  "OW0  K_(  *_] 'B1  !JE@  7)H  $V?   _HP  ,:8  ".G   7J0
M#JL   6N    L    +(   "U    MP   +<   "X    N0   +H   "\ P
MO0D  +X.  # %   PQX  ,4K  #%/   QDX  ,9B  #&>@  QI0  ,:M  #&
MR   Q>4  ,7S &R9  !>G@  3Z0  $&H   RK   )*\  !:Q   -M    [<
M  "Z    O0   ,    #$    Q@   ,8   #(    R0   ,L   #,    S@
M - &  #3#0  V!,  -P>  #>+0  WT   .!4  #A:P  X84  .&?  #AMP
MX<\  .'F &"A  !2IP  0ZT  #2R   EM0  %[D   V\   !OP   ,,   #'
M    R@   ,\   #3    U@   -<   #:    W    -\   #A    XP   .8
M  #I 0  [ L  / 2  #S'P  ]#$  /9&  #W7   ^'0  /B/  #YI@  ^;@
M /C) /\ #0#_  L _P + /\ #@#_ !, _P ? /\ + #_ #D _P!% /\ 4 #_
M %D _P!B /\ :@#_ '$ _P!W /\ ?@#_ (0 _@"* /T D #\ )< ^@"> /D
MIP#W +$ ]@"^ /4 T@#S .P \0#^ /  _P#P /\ Y@#_ -P _P#2 /\ S0#_
M /\ !P#_  0 _P " /\ !@#_ !  _P ; /\ )P#_ #, _P _ /\ 2@#^ %0
M^P!= /D 9 #W &L ]0!R /, > #R 'X \ "$ .\ B@#M )$ [ "9 .H H0#H
M *L Y@"V .0 QP#B ., X #W -X _P#= /\ V0#_ ,P _P#% /\ P0#_ /\
M  #_    _P   /\  0#_  T _P 6 /P (@#Y "X ]@ Y /, 10#O $X [ !7
M .D 7@#F &4 Y !L .( <@#@ '< WP!^ -T A #; (L V "2 -4 FP#2 *0
MSP"O ,T O@#+ -4 R0#O ,< _P#% /\ Q #_ +X _P"X /\ M0#_ /\   #_
M    _P   /X   #W  D \0 1 .L ' #G "@ Y  S .$ /@#= $@ V !1 -,
M6 #0 %\ S@!E ,P :P#* '$ R !W ,8 ?0#$ (0 P@", ,  E "^ )X NP"H
M +D M@"W ,@ M0#F +, ^@"Q /\ L #_ +  _P"L /\ J0#_ /\   #_
M^@   /$   #H  , X  - -@ %@#1 "( S0 M ,H -P#& $$ P@!* +\ 4@"]
M %D N@!? +@ 90"W &H M0!P +, =@"Q 'T KP"% *T C0"K )< J0"A *<
MK@"E +X H@#8 *  \@"? /\ G@#_ )X _P"> /\ G #_ /\   #W    ZP
M .$   #6    RP ) ,4 $0"_ !L NP F +< ,0"T #H L0!# *X 2P"K %(
MJ0!8 *< 7@"F &0 I !I *( < "@ '8 G@!^ )P A@": )  F "; )8 IP"4
M +8 D@#* )  Z0"/ /P C@#_ (T _P", /\ C0#_ /@   #I @  VP,  ,P!
M  #$    O0 " +8 #0"P !4 JP @ *< *@"D #0 H0 \ )X 1 "< $L F@!2
M )@ 6 "6 %T E0!C ), :0"1 '  CP!W (T @ "+ (H B0"5 (< H0"% *\
M@P#! ($ X "  /4 ?P#_ '\ _P!_ /\ ?P#_ .X*  #<#@  RA   +X.  "U
M"P  KP,  *D !P"C !  G@ 8 )D (P"6 "P DP U )  /@". $4 C !+ (H
M40"( %< A@!= (4 8P"# &H @0!Q '\ >@!] (0 >P"/ 'D G !W *H =0"[
M '0 U !R /  <@#_ '( _P!Q /\ <0#_ .,1  #-%P  OQD  +,9  "J%0
MHQ   )T*  "7 0H D0 2 (T &P") "4 A0 O (, -P"  #X ?@!% 'T 2P![
M %$ >0!7 '@ 70!V &0 = %K '(!= !P G\ ;@*+ &P#F !K Z8 :02W &@%
MS@!G!^P 9@C] &8)_P!E"?\ 90G_ -8:  #$(   MB,  *LC  "A(   F1L
M )(4  ",#@$ A@<- ( $% !\!AX >0<H '8(, !T"#@ <@D_ ' )10!O"DP
M;0I2 &P*6 !J"U\ : MG &<+< !E#'H 8PR' &(,E0!@#:0 7PVV %X-S@!<
M#NT 7 __ %L0_P!;$/\ 6Q#_ ,TA  "\*   KRL  *0K  ":*0  DB0  (D?
M  ""&   >Q$% '4-#P!Q#1< ;@XA &L.*@!I#S( 9Q Y &400 !D$$8 8Q!-
M &$04P!?$5H 7A%B %P1:P!;$78 61*# %@2D@!6$Z( 51.T %03RP!3%.P
M4A7_ %(6_P!2%?\ 4A7_ ,8H  "V+@  J3(  )\R  "5,0  C"T  (,G  !Z
M(0  <AH  &L3"P!G$Q, 9!0< &$4)0!?%2T 714T %P5.P!;%D( 619( %@6
M3P!6%U8 51=> %,79P!2&'( 4!A_ $\9C@!.&I\ 3!JP $L;QP!+&^D 2AS]
M $H<_P!*'/\ 2AS_ ,$M  "Q-   I3<  )HX  "0-P  AS0  'TO  !T*0
M;",  &0<!P!>&1  6QH8 %D;(0!7&RD 51LP %0<-P!2'#T 41Q$ $\=2P!.
M'5( 31U: $L>8P!*'FX 21]\ $<?BP!&()P 12&N $0AQ !#(N8 0R+\ $,B
M_P!#(O\ 0R+_ +PR  "M.   H3P  )<^  "-/0  @SH  'DU  !O,   9BH
M %XD @!7( T 5" 4 %$@'0!/(24 3B$L $PA,P!+(CH 22)  $@B1P!'(DX
M1B-7 $0C8 !#)&L 0B1Y $$EB  _)ID /B:K #TGP0 ])^, /2CZ #TH_P ]
M)_\ /2?_ +@V  "J/0  GD   )1"  "*0@  @#\  '8[  !L-@  8C   %DJ
M  !1)0L 3241 $LE&0!))2$ 1R8H $4F+P!$)C8 0R8] $(G1 !!)TL /RA4
M #XH70 ]*6D /"EV #LJA@ Y*Y< ."NI #<LOP W+.  -RSX #<L_P W+/\
M."S_ +4Z  "G0   G$0  )%&  "'1@  ?40  '-   !H.P  7S8  %4Q  !,
M*P< 1RD/ $4J%@!#*AX 02HE #\J+  ^*S, /2LY #PK00 [+$@ .BQ1 #DM
M6P X+F8 -BYS #4O@P T+Y4 ,S"G #(PO0 Q,=X ,3'W #(Q_P R,/\ ,S#_
M +$^  "D1   F4@  (]*  "%2@  >TD  '!%  !E0   6SL  %(V  !(,00
M0BX- #\N$P ]+AL .RXB #DO*0 X+R\ -R\V #8P/@ U,$8 -#%/ #,Q60 R
M,F0 ,3)Q # S@0 O-), +C2F "PUNP L-=L +#7U "TU_P M-/\ +C3_ *Y!
M  "B2   ETP  (U.  "#3@  >4T  &Y*  !B10  6$   $X\  !%-P  /3,+
M #DS$0 W,Q@ -C,? #0S)@ S,RT ,C0T #$T/  P-40 +S5, "XV5@ M-F(
M+#=O "LW?P J.)$ *#BD "<YN0 F.=@ )SGT "@Y_P H./\ *3C_ *M%  "?
M2P  E$\  (M2  "!4P  =U(  &Q/  !?20  5D8  $Q"  !"/0  .#@( #0X
M#P R.!4 ,3@= "\X)  N."L +3DR "PY.0 K.D$ *CI* "D[5  H.U\ )SQM
M "4\?0 D/8\ (SVB "(]MP A/M0 (3[S "(]_P C/?\ (SS_ *A)  "=3P
MDE,  (E6  !_5P  =58  &I3  !=3P  4TP  $I(  ! 1   -D % "\]#0 M
M/1, *ST: "H^(0 I/B@ *#XO "<^-P F/S\ )#]( "- 4@ B0%T (4%J "!!
M>@ >08T '4*@ !Q"M0 ;0M$ &T+Q !Q"_P =0?\ 'D'_ *5-  ":4P  D%@
M (9;  !]7   <EL  &=8  !;5   45(  $A.   ]2@  ,T<  "I#"P F0Q
M)4,6 "1#'@ C1"4 (D0L "%$-  @13P 'D5% !U%3P <1EH &T9H !E&>  8
M1XH %T>> !9'LP 42,X %4?O !9'_P 71O\ %T;_ *)2  "76   C5T  (1@
M  !Z80  <&   &5>  !96@  3U@  $14   Y40  +TX  "9+!@ @2@X 'DH3
M !U*&@ <2B$ &TLH !I+,  92S@ %TM" !9,3  53%< %$QE !--=0 238@
M$4V< !!-L0 .3LP #TWN !!-_P 13/\ $4S_ )Y7  "470  BV(  (%E  !W
M9@  ;68  &-D  !680  2EX  #];   U6   *U8  ")4 0 :4@H %E(0 !52
M%@ 44AT $U(D !)2+  14C0 $5(^ !!32  /4U0 #E-B  U4<@ ,5(0 "U28
M  E4K0 (5,4 "53G  I3^P +4O\ "U+_ )M=  "19   B&@  'YK  !T;
M:VP  %]J  !29P  160  #IB   P8   )EX  !U=   56P4 $%H,  Y:$0 .
M6A@ #5L@  Q;)P +6S  "ELZ  E;10 '6U$ !EM>  1;;0 #6X   5N4  !;
MJ   6\   %KB  !:]@ !6O\  EG_ )=D  ".:P  A&X  'MP  !R<@  9W$
M %EP  !,;@  0&P  #5K   J:0  (6<  !AF   19@$ #&4*  =E#P $910
M V0;  )D(P  9"P  &0U  !D0   9$P  &1:  !D:0  9'L  &2/  !CI
M8[L  &+=  !B]   8O\  &'_ )-L  ")<0  @'4  'AW  !M>   8'<  %)V
M  !&=0  .70  "YT   C<@  &G$  !)Q   -<0  !G$(  !P#0  <!(  ' 7
M  !O'P  ;R8  &\P  !O.P  ;T<  &]4  !O9   ;W4  &Z*  !MH   ;;8
M &S6  !K\@  :_\  &O_ (YS  "%>   ?7L  '-]  !E?@  6'X  $M^   ^
M?@  ,GX  "9]   <?   $WP   U\   &?0   'T%  !\"P  ? \  'P3  !\
M&0  ?"$  'PI  !\-   >T   'M.  ![7@  >V\  'J$  !ZF@  >;$  'C.
M  !W[P  =OX  ';_ (EZ  "!?P  >((  &N#  !=A0  3X8  $*'   UB
M*8<  !V'   4AP  #8@   :)    B@   (H   ")!@  B0P  (D/  ")$P
MB1H  (HB  "*+   BC@  (I&  ")5@  B6@  (E\  "(E   AZL  (;&  "%
MZ@  A?L  (3_ (6"  !]A@  ;X@  &&+  !3C0  18\  #B1   KD0  'Y(
M !22   -DP  !)0   "6    EP   )@   "7    EP4  )<+  "8#@  F!,
M )D:  "9(@  FBX  )H]  "930  F5X  )ES  "8BP  F*,  )>\  "6X@
MEO<  )7_ (")  !RC   9(\  %:3  !(E@  .ID  "R:   ?FP  %)P   R>
M   #GP   *$   "C    I0   *4   "E    I0   *8"  "G"   IPT  *@1
M  "I&0  JR,  *LQ  "K00  K%,  *QG  "K@   JIH  *JS  "JT   J>\
M *G[ '6/  !GE   69@  $J<   \GP  +:(  ""C   3I0  "Z<   &I
MJP   *X   "Q    L@   +(   "S    M    +4   "V    N 0  +D+  "[
M$   O1@  +\D  "_-0  P$<  ,!;  # <@  P(T  ,&F  # P0  O^,  +[S
M &J7  !;G   3:$  #ZE   OJ0  (:L  !.M   +L    +,   "U    N
M +P   "_    P0   ,$   ##    Q    ,8   #'    R0   ,L   #."
MT0\  -48  #8)P  V3D  -I-  #;9   VWX  -R9  #<L   W,D  -SC %V?
M  !/I0  0*H  #*O   BL@  %+4   JX    NP   +\   ##    Q@   ,L
M  #.    T0   -$   #4    U@   -D   #;    W@   .    #D    YP8
M .L.  #O&0  \"H  /(_  #S50  ]&T  /2(  #TH0  ]+8  /3' /\ "0#_
M  8 _P ' /\ # #_ !$ _P < /\ * #_ #0 _P!! /\ 3 #_ %4 _P!= /\
M90#_ &P _P!R /X > #\ 'X ^P"$ /H BP#Y )( ]P"9 /8 H@#T *P \P"Y
M /$ RP#P .@ [@#[ .T _P#L /\ X0#_ -( _P#) /\ Q #_ /\  0#_
M_P   /\ ! #_  X _P 7 /\ (P#_ "\ _P [ /T 1@#Z %  ]P!8 /0 7P#R
M &8 \ !L .\ <@#M '@ [ !^ .H A0#I (P YP"3 .4 G #C *8 X0"Q -\
MP0#= -T VP#T -D _P#6 /\ SP#_ ,0 _P"] /\ N0#_ /\   #_    _P
M /\   #_  L _  3 /< '@#T "H \@ U .X 0 #I $H Y@!2 ., 60#@ &
MW@!F -P ; #: '( UP!X -0 ?@#2 (4 T "- ,X E0#, )\ R0"J ,< N #%
M ,T PP#K ,  _@"_ /\ O@#_ +8 _P"P /\ K0#_ /\   #_    _P   /D
M  #R  8 ZP / .8 &0#A "0 W@ O -H .0#3 $, SP!, ,P 4P#) %H QP!@
M ,4 9@## &L P0!Q +\ =P"] 'X NP"& +D C@"W )@ M0"C +, L "Q ,(
MK@#@ *P ]P"K /\ J@#_ *@ _P"C /\ H #_ /\   #_    ]0   .L   #A
M    U@ , ,\ $P#* !X Q@ I ,( ,P"_ #T NP!% +@ 30"V %0 LP!: +$
M7P"P &4 K@!J *P < "K '< J0!_ *< AP"E )$ HP"< *  J0"> +@ G #.
M )H [@"9 /\ EP#_ )8 _P"6 /\ DP#_ /T   #Q    Y0   -D   #-
MQ  & +T #P"W !@ LP B +  + "M #8 J0 ^ *< 1@"D $T H@!3 *  60"?
M %X G0!D )L :@": '  F !W )8 @ "4 (H D0"5 (\ H@"- +  BP## (D
MXP"( /D A@#_ (8 _P"& /\ A@#_ /,   #C    T0   ,4   "]    M@
M *X "P"H !( I  < *  )@"< "\ F@ W )< /P"5 $8 D@!, )$ 4@"/ %@
MC0!= (L 8P"* &H B !Q (8 >0"$ (, @@"/ '\ FP!^ *D ? "[ 'H U0!X
M /( > #_ '< _P!W /\ =P#_ .<'  #1#   PPT  +@,  "N"   J    *(
M!0";  X E@ 5 )( 'P". "@ BP Q (@ .0"& $  A !& (( 3 "  %( ?P!7
M 'T 70![ &, >@!K '@ <P!V 'T = "( '$ E0!P *0 ;@"T &P R@!K .H
M:@#\ &H _P!J /\ :@#_ -H0  #&%   N!8  *T5  "D$@  G X  )8'  "0
M  D B@ 0 (4 & "! "$ ?@ J 'L ,@!Y #D =P!  '4 1@!S $P <@!1 '
M5P!N %X ;0!E &L ;@!I '< 9P"# &4 D0!C )\ 8@"O &  Q !? .0 7P'X
M %X"_P!> O\ 7@+_ ,X8  "]'0  L"   *4?  ";'   DQ<  (L1  "$#
M?@0+ 'D $@!U !L <@ C &\ *P!M 3, :P$Z &D"0 !G T8 9@-, &0$4@!C
M!%D 801@ %\%:0!>!7, 7 9_ %H&C0!9!YP 5PBM %8(P0!5">$ 5 OV %0+
M_P!4"_\ 5 O_ ,8?  "V)0  J2@  )XH  "4)0  BR$  (,;  ![%   = X#
M &X)#0!I"!0 9@D= &0*)0!B"BT 8 LT %X+.@!="T  6PQ' %H,30!8#%0
M5PU< %4-9 !4#6\ 4@U[ % .B@!/#IH 3@ZL $P/P@!,$., 2Q#Y $L0_P!+
M$?\ 2Q#_ +\F  "P*P  I"\  )DO  "/+0  ABD  'TD  !T'@  ;!<  &41
M!P!?#A  7 \7 %H0'P!8$"< 5A N %00-0!3$#L 4A%" % 12 !/$5  3A%7
M $P28 !+$FL 21)X $@3AP!&$Y< 112I $04O@!#%=\ 0Q;X $,6_P!#%O\
M0Q;_ +HK  "K,0  H#0  )4U  "+-   @3$  '@K  !O)@  9B   %X9 0!7
M% T 5!03 %$4&P!/%2, 3A4J $P5,0!+%C< 218^ $@61 !'%TP 11=4 $07
M70!#&&< 01AT $ 9@P _&I0 /1JF #P;NP [&]L .QSV #P<_P \'/\ /!S_
M +4P  "H-@  G#D  )$[  "'.@  ?C<  ',R  !J+0  82<  %DA  !1&PD
M3!D0 $H:%P!(&A\ 1AHF $4;+0!#&S, 0ALZ $$<00! '$@ /AQ0 #T=60 \
M'F0 .QYQ #D?@  X'Y( -R"D #8@N  U(=8 -2'T #4B_P U(?\ -B'_ +(T
M  "D.@  F3X  (\_  "%/P  >SP  ' X  !G,@  72T  %0H  !,(@4 1A\.
M $,?% !!'QL /Q\B #X@*0 ](#  .R V #HA/0 Y(44 .")- #<B5P V(V(
M-"-N #,D?@ R)(\ ,26B "\EM@ O)M( +R;R "\F_P P)O\ ,";_ *\X  "B
M/@  ED(  (Q#  ""0P  >$$  &X]  !C.   6C,  %$N  !(* $ 0"0, #TC
M$0 [)!@ .20? #@D)@ V)"P -24S #0E.@ S)D( ,B9* #$G5  P)U\ +RAL
M "XH>P L*8T *RJ@ "HJM  I*L\ *2OP "HK_P J*O\ *RK_ *P\  "?0@
ME$8  (I'  " 1P  =D4  &Q"  !A/0  5S@  $XS  !$+@  /"D) #<H$  U
M*!4 ,R@< #(H(P P*"D +RDP "\J-P N*C\ +2M( "PK4@ K+%T *BQJ "@M
M>0 G+8L )BZ> "4NLP D+\T )"_N "4O_P E+_\ )B[_ *D_  "=10  DDD
M (A+  !^3   =$H  &I'  !>0@  5#T  $LY  !!-   ."\& #(M#0 P+1,
M+BT9 "TM(  K+2< *BXN "DN-0 I+ST *"]& "<P3P E,%L )#%H ",Q=P B
M,HD (3*= !\SL0 >,\L 'C/M !\S_P @,_\ (3+_ *9#  ":20  D$T  (9/
M  !\4   <T\  &A,  !<1@  4D,  $D_   _.P  -C8" "XR#  K,A$ *3(7
M "@R'@ F,B0 )3,K "0S,@ C-#H (C1# "$U30 @-5@ 'S9E !XV=0 <-X<
M&S>; !HWKP 9.,@ &3CK !HX_P ;-_\ &S?_ *-'  "830  CE$  (13  ![
M5   <5,  &90  !:3   4$D  $=%   ]00  ,ST  "HY"0 E-PX (S<4 "(X
M&P A."( (#@H !\X,  >.3@ '3E! !PZ2P :.E8 &3MC !@[<@ 6.X4 %3R9
M !0\K0 3/<8 $SWI !0\_0 5//\ %CO_ *!+  "540  BU4  ()8  !Y60
M;E@  &16  !840  3D\  $5+   Z1P  ,$,  "= !0 @/@T '3X1 !P^%P ;
M/AX &CXE !D^+0 8/S4 %C\^ !4_2  40%, $T!@ !)!<  108( $$&7  ]!
MK  .0L0 #D+G  ]!_  00?\ $$#_ )U0  "35@  B5H  (!=  !V7@  ;%T
M &);  !65P  3%4  $%1   V3@  +$L  "-(   ;10D %T0/ !5$%  411L
M$T4B !)%*0 113$ $44[ !!&10 /1E  #D=>  U';0 ,1W\ "T>3  E'IP (
M1[X "$?@  E']@ *1O\ "T;_ )I5  "06P  AV   'UB  !S8P  :F(  &!A
M  !37@  1UH  #Q7   R50  *%(  !]0   73@0 $4P,  ],$0 .3!< #DP>
M  U-)0 ,32X "TTW  I-0@ )34T !TY:  9.:0 $3GL  DZ/  %.I   3;H
M $W;  %-\@ !3?\  DS_ )9;  "-8@  A&8  'IH  !Q:0  :&D  %QG  !/
M9   0F$  #=?   M7   (UH  !I8   25P$ #58)  E5#@ '51, !E4:  15
M(@ #52H  E4T  !5/@  54H  %97  !690  57<  %6+  !5H   5;8  %34
M  !4\0  4_T  %/_ )-B  "*:   @&P  '=N  !O;P  8VX  %9L  !):@
M/6@  #)F   G90  '6,  !5B   .80  "6 (  -@#0  7Q$  %\7  !?'@
M7R8  %\O  !?.@  7T4  %]3  !?80  7G(  %Z'  !=G   7;(  %S/  !<
M[P  6_T  %O_ )!J  "&;P  ?7(  '5T  !J=0  770  $]S  !"<@  -G
M "MO   @;@  %VT  !!L   *;    FL&  !K"P  :@\  &H4  !J&@  :B$
M &DJ  !I-   :4   &E.  !I7   :6T  &B"  !HF   9ZX  &;*  !E[0
M9?P  &3_ (MQ  ""=@  >GD  '![  !B>P  57L  $AZ   [>@  +WH  "-Y
M   9>   $7<   IW   #=P   '<"  !W"   =@T  '80  !V%0  =AL  '8C
M  !V+@  =3H  '5'  !U5@  =6@  '1\  !TD@  <ZH  '+$  !QZ0  </L
M '#_ (9Y  !_?0  =G\  &B!  !:@@  3((  #^#   RA   )8,  !J#   1
M@P  "H,   *#    A    (4   "$ P  @P@  (,-  "#$   @Q4  (0<  "$
M)@  A#(  (0_  "#3P  @V   ()U  ""C   @:0  ("]  !_XP  ?OD  '[_
M (*   !ZA   ;(8  %Z(  !0B@  0HL  #6-   GC0  &XT  !&.   *C@
M (\   "1    D@   )(   "2    D@$  )('  "2#   DA   ),5  "3'0
ME"@  )0V  "410  DU<  )-K  "3@@  DIP  )&V  "0V   C_,  (__ 'Z'
M  !PB@  88T  %.0  !%DP  -Y4  "F6   <EP  $9@   F9    FP   )P
M  ">    H    *    "@    H    *$   "A!   H@D  *,.  "D%   I1T
M *8J  "F.@  IDP  *5@  "E>   I9(  *2L  "DR0  H^L  *+Z '..  !D
MD0  5I4  $>9   YG   *IX  !V@   1H0  "*,   "E    IP   *D   "L
M    K@   *X   "N    KP   +    "Q    L@   +,&  "U#0  MQ,  +D>
M  "Y+@  ND   +I4  "[:@  NH4  +FA  "YNP  NMX  +GR &>5  !8F0
M2IX  #NB   LI@  ':@  !&J   'K    *\   "Q    M    +@   "[
MO    +P   "^    OP   ,    #"    Q    ,8   #( P  RPL  ,\2  #1
M(   T3(  -)&  #370  U'8  -22  #5JP  U<0  -3B %N=  !,H@  /:<
M "^L   ?KP  $;$   >U    N    +L   "^    P@   ,<   #*    S
M ,P   #.    T    -(   #5    V    -L   #?    X@   .8+  #K$P
M["0  .TX  #N3@  [V<  /""  #PG   \+(  /'% /\  P#_  $ _P $ /\
M"0#_  \ _P 8 /\ ) #_ #  _P \ /\ 1P#_ %$ _P!9 /\ 8 #] &< _ !M
M /H <P#Y 'D ^ !_ /8 A0#U (P \P"4 /( G0#P *< [@"S .P Q #K .$
MZ@#X .D _P#G /\ V0#_ ,L _P#" /\ O0#_ /\   #_    _P   /\   #_
M  P _P 4 /\ ( #_ "L _@ W /H 0@#V $L \@!3 /  6P#N &$ [ !G .H
M;0#H ', YP!Y .4 ?P#C (8 X0". -\ E@#= *  VP"L -@ NP#4 -$ TP#P
M -  _P#. /\ R #_ +T _P"V /\ L@#_ /\   #_    _P   /\   #]  @
M]P 0 /, &@#O "8 [0 Q .@ .P#C $4 X !- -P 50#9 %L U@!A -, 9P#1
M &P SP!R ,T > #+ '\ R0"' ,< D #% )H PP"E ,  L@"^ ,4 O #E +H
M^P"X /\ MP#_ +  _P"I /\ I0#_ /\   #_    _@   /4   #L  , Y0 -
M -\ %0#: "  U  J -  -0#+ #X R !' ,4 3@#" %4 P !; +X 80"\ &8
MN@!L +@ <@"V '@ M0"  +, B "Q )( K@"> *P J@"I +L J #5 *8 \P"D
M /\ HP#_ *$ _P"; /\ F #_ /\   #[    \    .4   #8    S@ ) ,<
M$0#" !H O@ D +L +@"W #@ M !  +$ 2 "N $X K !4 *H 6@"I %\ IP!E
M *4 :P"D '$ H@!X *  @0"> (L G "6 )D HP"7 +( E@#' ), Z "2 /X
MD0#_ )  _P"- /\ BP#_ /D   #K    W0   ,\   #&    O  $ +4 #0"P
M !4 K  > *@ * "E #$ H@ Y )\ 00"= $@ FP!. )D 4P"7 %D E@!> )0
M9 "2 &H D !Q (X >@", (, B@"/ (@ G "& *H A "\ (( W "! /8 @ #_
M '\ _P!_ /\ ?@#_ .P   #:    R0   +X   "V    K@   *< "0"A !
MG  8 )@ (@"5 "H D@ R )  .@"- $$ BP!' (D 30"' %( A@!8 (0 70""
M &0 @0!K '\ <P!] 'T >P"( '@ E0!V *, =0"T ', S !Q .T < #_ '
M_P!P /\ < #_ -\%  #*"@  O L  +$)  "H!   H0   )L  P"4  P CP 3
M (H &P"' "0 A  L ($ ,P!_ #H ?0!! 'L 1P!Y $P =P!2 '8 5P!T %T
M<@!D '  ;0!O '8 ; "" &H CP!I )T 9P"N &4 PP!D .0 8P#Z &, _P!B
M /\ 8P#_ - .  "_$@  LA,  *<2  "=$   E0L  (\#  ")  < @@ . 'X
M%0!Z !X =@ E '0 +0!Q #0 ;P Z &X 0 !L $8 :@!, &D 4@!G %@ 9@!?
M &0 9P!B '$ 8 !\ %X B0!< )@ 6P"I %D O !8 -P 6 #T %@ _P!7 /\
M5P#_ ,86  "V&@  JAT  )\<  "5&0  C10  (4/  !^"0  =P$* '( $ !N
M !< :@ ? &@ )P!E "X 9  T &( .P!@ $  7P!& %T 3 !< %, 6@!: %@
M8@!7 &P 50!W %, A0!2 )0 4 &E $\!N !. M( 303P $T%_P!-!?\ 307_
M +\=  "P(@  HR4  )DE  "/(@  A1T  'T8  !U$@  ;@T" &<&# !C Q$
M7P(9 %T#(0!;!"@ 600O %<%-0!6!3L 5 9! %,&1P!1!DX 4 =5 $X'7@!-
M"&< 2PAS $D)@0!("9( 1PJC $4*M@!$"]  1 SO $,-_P!##?\ 1 W_ +DD
M  "J*0  GBP  )0L  "**@  @"8  '<A  !N&P  9A0  %\/!0!9"PT 50H3
M %,+&P!1"R( 3PPI $T,+P!,##8 2PT\ $D-0@!(#4D 1@U1 $4.6@!$#F0
M0@YP $ .?P _#Y  /A"B #P0M@ [$-$ .Q'Q #L1_P [$?\ /!'_ +0I  "F
M+P  FC(  ) R  "&,0  ?"T  '(H  !I(P  81T  %D6  !1$0@ 3 \0 $H0
M%@!($!T 1A D $40*P!#$3$ 0A$W $$1/@! $44 /A)- #T25@ \$F$ .A-M
M #D3?  W%(T -A2? #45LP T%<T ,Q;N #06_P T%O\ -!;_ *\N  "B-
MES<  (PX  ""-@  >#0  &XN  !E*@  7"0  %0>  !,& 0 1A0- $(4$@!
M%!D /Q0@ #T5)P \%2T .Q4T #D6.@ X%D( -Q9* #874P U%UX ,QAJ #(9
M>0 P&8H +QJ= "X:L0 M&\H +1OL "T<_P N&_\ +AO_ *PR  "?.   E#L
M (H\  " /   =CD  &LT  !B+P  62H  % E  !''P  0!H* #P9$  Z&18
M.!D= #8:(P U&BD -!HP #,:-P R&SX ,1M' "\<4  N'5L +1UG "P>=@ J
M'H@ *1^; "@?K@ G(,< )B#J "<@_@ H(/\ *"#_ *DV  "=/   DC\  (=!
M  !]0   =#X  &DZ  !?-0  5C   $TK  !$)0  .R ' #8>#@ S'A, ,AX9
M # >(  O'B8 +A\M "T?-  L(#L *R!$ "HA3@ I(5@ )R)E "8B=  E(X4
M(R.9 "(DK0 A),4 (27H "(E_0 B)/\ (R3_ *8Z  ":/P  CT,  (5%  ![
M1   <D,  &<_  !=.@  4S8  $HQ  !!+   ."8# #$C#  N(A$ +"(6 "HB
M'0 I(B, *",J "<C,0 F)#D )25! "0E2P C)E8 (B9C "$G<@ ?)X, 'BB7
M !THJP ;*<, &RGF !PI^P =*?\ 'BC_ *,^  "80P  C4<  (-)  !Z20
M<$<  &9$  !:/P  43L  $<W   ^,@  -2T  "PH"0 H)P\ )R<4 "4G&@ D
M)R$ (R@G "(H+@ A*38 ("D_ !\J20 >*E0 '2M@ !LK;P :+($ &2R5 !<M
MJ0 6+<$ %BWD !<M^@ 8+?\ &2W_ *%!  "51P  BTL  ()-  !X30  ;DP
M &1)  !81   3T   $8]   ].   ,S0  "HO!@ D+ T (2P2 " L&  ?+1X
M'BTE !TM+  <+C0 &RX\ !HO1@ 8+U$ %S!> !8P;0 5,7\ $S&3 !(QJ  1
M,K\ $3+B !(R^0 3,?\ $S'_ )Y%  "32P  B4\  (!1  !V4@  ;5   &).
M  !620  348  $1#   [/P  ,3H  "<V P ?,@L '#(0 !LR%0 9,AL &#(B
M !<S*0 6,S$ %30Z !0T1  3-$\ $C5< !$U:P 0-GT #S:1  XVI@ --[P
M#3?=  TV]@ .-O\ #S;_ )M)  "13P  AU,  'Y6  !U5@  :E4  &!3  !5
M3P  3$P  $))   X10  +D$  "0]   <.@@ %C@. !4X$@ 4.!@ $SD? !(Y
M)@ 1.2X $#DW  \Z00 ..DP #3M9  T[:  +.WH "CN-  D\H@ '/+@ !SS5
M  @\\  )._\ "CO_ )A.  ".5   A5@  'Q;  !R6P  :%H  %Y8  !350
M25(  #Y.   T2P  *D<  "%$   80@, $D + ! _$  ./Q4 #C\<  U (P ,
M0"L "T T  I /@ )04H !T%6  9!90 $078  T&*  %!GP  0;0  $'0  %!
M[@ !0?P  D#_ )54  ",60  @UX  'E@  !P8   9F   %U>  !16P  15<
M #I4   O40  )4\  !Q,   42@  #D@(  M'#@ (1Q( !T<9  9'(  %2"@
M T@Q  )(.P  2$<  $A3  !(8@  2',  $B&  !(FP  2+$  $?,  !'[0
M1_L  $?_ )):  ")8   @&,  '=E  !N9@  968  %ED  !,8   0%T  #5;
M   J60  (%<  !=5   04P  "U('  51#0 !4!$  % 6  !0'0  4"4  % N
M  !0.   4$,  %!0  !07@  4&\  %"#  !/F   3ZX  $[)  !.ZP  3?L
M $W_ (]A  "&9@  ?6D  '1L  !L;0  86L  %-I  !&9P  .F0  "]C   D
M80  &E\  !)>   ,7   !EP&  !;"P  6@\  %H3  !:&0  62$  %DI  !9
M,P  63\  %E,  !96@  66L  %A^  !8E   5ZL  %?%  !6Z0  5?L  %7_
M (QH  "";0  >G   ')R  !G<@  6G$  $QP   _;@  ,VT  "AK   =:@
M%&@   UG   '9P   &8#  !F"0  90T  &41  !D%0  9!P  &0D  !D+@
M9#H  &-'  !C50  8V8  &-Z  !BD   8:<  &#!  !?Y@  7_H  %[_ (=O
M  !_=   >'<  &YX  !@>   4G<  $5W   X=@  *W8  "!T   6<P  #G,
M  =R    <@   '(   !Q!0  <0H  '$.  !P$0  <!<  ' >  !P)P  <#,
M &]   !O4   ;V   &YT  !NBP  ;:(  &R\  !KX@  :O@  &G_ (-W  !\
M>P  <WT  &5^  !7?P  27\  #Q_   O@   (G\  !=^   /?@  !WX   !_
M    ?P   '\   !^    ?@4  'X*  !^#0  ?A$  'X7  !^(   ?BL  'TY
M  !]2   ?5D  'QM  !\A   >YP  'JV  !YV@  >/4  '?_ (!_  !W@@
M:8,  %N%  !-A@  /X@  #*)   DB0  &(D   ^)   'B@   (L   ",
MC0   (T   ",    C    (P#  ","   C0T  (T1  "-%P  CB(  (XO  ".
M/P  C5   (UD  ",>P  C)4  (NN  "*S0  B>\  (G_ 'N%  !MB   7HH
M %"-  !"CP  -)$  ":2   9DP  #I0   :5    E@   )@   ":    FP
M )L   ";    FP   )L   "<    G04  )T+  ">$   GQ<  * D  "@-
MH$8  *!9  "?<   GXH  )ZE  ">P@  G>@  )SY '",  !ACP  4Y(  $26
M   VF0  )YL  !F<   /G0  !9\   "A    HP   *4   "H    J0   *D
M  "I    J@   *L   "L    K0   *X!  "P"0  L@\  +,8  "T)P  M#D
M +5-  "T9   M'X  +.:  "SM   L]4  +/P &23  !5EP  1YL  #B?   I
MH@  &J0   ZF   $J    *L   "M    L    +0   "V    N    +@   "Y
M    N@   +P   "]    OP   ,    ##    Q0<  ,D/  #*&@  RRP  ,Q
M  #-5@  SF\  ,V+  #,J   S,(  ,SB %B;  !)H   .J4  "RI   <JP
M#ZX   2Q    M    +<   "Z    O@   ,,   #&    R    ,@   #*
MRP   ,T   #/    T@   -4   #9    W0   .$%  #F#P  YQX  .@R  #I
M2   ZF   .M[  #KEP  [*X  .S" /\   #_    _P   /\ !@#_  T _P 5
M /\ (0#_ "P _P X /\ 0P#_ $P _@!4 /L 6P#Z &( ^ !H /8 ;@#U '0
M] !Z /( @ #Q (< [P"/ .T EP#K *$ Z0"M .< O0#E -@ Y #S .( _P#@
M /\ T #_ ,0 _P"\ /\ M@#_ /\   #_    _P   /\   #_  D _P 1 /\
M' #] "< ^0 R /4 /0#Q $8 [0!/ .L 5@#H %P Y@!B .0 : #C &X X0!S
M -\ >0#= (  V@"( -@ D0#4 )L T@"F ,\ M #, ,D R0#I ,@ _P#' /\
MP0#_ +< _P"O /\ JP#_ /\   #_    _P   /\   #X  4 \@ . .X %P#J
M "( Y@ L .$ -P#= $  V !) -, 4 #0 %8 S@!< ,P 8@#* &< R !M ,8
M<P#$ 'D P@"! ,  B@"^ )0 O "? +D K "V +X M #= +, ]P"Q /\ L #_
M *@ _P"B /\ G@#_ /\   #_    ^0   .\   #F    WP + -8 $@#0 !P
MS  F ,@ , #$ #H P !" +T 2@"[ %  N !6 +8 6P"U &$ LP!F +$ ; "P
M '( K@!Z *P @@"I (P IP"8 *4 I0"C +0 H #+ )\ [@"= /\ G #_ )D
M_P"4 /\ D0#_ /\   #V    Z@   -T   #/    QP & ,  #P"[ !< MP @
M +, *@"P #, K0 [ *H 0P"G $D I0!/ *, 50"B %H H !? )X 90"= &L
MFP!R )D >P"7 (4 E "0 )( G0"0 *P C@"_ (P X@"+ /H B0#_ (D _P"&
M /\ @P#_ /0   #D    U    ,@   "_    M0 ! *X "P"I !( I0 ; *$
M(P"> "P FP T )@ / "6 $, E !) )( 3@"0 %, C@!9 (T 7@"+ &0 B0!K
M (< <P"% 'T @P"( ($ E0!_ *0 ?0"U 'L SP!Y /$ > #_ '< _P!W /\
M=0#_ .4   #1    PP   +@   "O    J    *  !@":  X E0 5 )$ '@".
M "8 BP M (@ -0"& #P A !" (( 1P"  $T ?P!2 'T 6 ![ %X >0!E '@
M;0!V '8 <P"! '$ C@!O )T ;0"N &P Q !J .< :0#] &@ _P!H /\ :0#_
M -4#  ##!P  M@@  *L&  "B    FP   )0   "-  H B  0 (, & !_ "
M?  G 'H +@!W #4 =0 [ '0 00!R $< < !, &\ 4@!M %@ :P!? &D 9@!G
M '  90![ &, B !B )< 8 "G %X NP!= -P 7 #V %P _P!; /\ 6P#_ ,D-
M  "Y$   K!$  *$0  "7#0  CP@  (@   ""  4 >P - '< $@!S !H ;P A
M &P * !J "\ :  U &< .P!E $$ 8P!& &( 3 !@ %( 7P!9 %T 80!; &H
M60!U %< @@!5 )$ 5 "B %, M0!1 ,\ 4 #O %  _P!0 /\ 4 #_ +\4  "P
M&   I!H  )D9  "/%@  AQ$  '\-  !W!@  <0 ( &L #@!G !0 9  ; &$
M(@!> "D 70 O %L -0!9 #L 6 !! %8 1@!5 $T 4P!4 %( 7 !0 &4 3@!P
M $P ?0!+ (T 20"> $@ L !' ,< 1@#I $8 ^P!& /\ 10#_ +@;  "J(
MGB(  ),B  ")'P  @!H  '<5  !O$   : L  &$$"@!= !  60 6 %8 '0!4
M ", 4@ J %  , !/ #4 3@ [ $P 00!+ $@ 20!/ $<!5P!& 6$ 1 )L $,"
M>0!! XD 0 .: #X$K0 ]!,0 / 7E #P'^  \!_\ / ?_ +(B  "E)P  F2D
M (XI  "$)P  >R,  '$>  !I&   81(  %H- P!3" P 3P41 $P%%P!*!AX
M2 8D $<&*@!%!S  1 <V $,(/0!!"$, 0 A+ #X)4P ]"5T .PIH #H*=@ X
M"X< -PN9 #4+K  T#,( ,PSD #,-^0 S#?\ - W_ *TG  "@+   E2\  (LO
M  " +@  =RH  &TE  !D(   7!H  %04  !,#P8 1@P- $,,$@!!#!@ /PP?
M #X,)0 \#2L .PTR #H-.  X#3\ -PY' #8.4  T#EH ,PYF #$/=  P#X4
M+A"8 "T0JP L$,, *Q'E "P1^@ L$?\ +1'_ *HL  "=,0  DC0  (<U  !]
M-   =#$  &HK  !@)P  6"$  $\;  !'%@  0!$) #L0#P Y$!0 -Q ; #80
M(0 T$"< ,Q$M #(1-  Q$3L ,!%# "X230 M$E< +!)C "H3<0 I$X( )Q25
M "84J0 E%<  )!7C "46^@ F%O\ )A7_ *8Q  ":-@  CSD  (4Z  ![.0
M<38  &<Q  !=+0  5"@  $PB  !#'0  .Q<% #44#0 R$Q$ ,107 "\4'0 N
M%"0 +!0J "L5,0 J%3@ *19  "@62@ G%U0 )A=@ "08;P C&(  (1F3 " 9
MIP ?&;X 'AK@ !\:^  @&O\ (!K_ *,T  "8.@  C3T  (,^  !Y/0  ;SL
M &4W  !;,@  4BT  $DH  ! (P  .!X! # 9"@ L& \ *A@4 "D8&@ G&"
M)ADG "49+0 D&C4 (QH^ "(;1P A&U( (!Q> !\=;  ='7X '!V1 !H>I0 9
M'KP &!_= !D?]@ :'_\ &Q[_ *$X  "5/0  BT$  (%"  !W0@  ;4   &,\
M  !9-P  3S,  $8N   ]*0  -20  "T@!P G'0T )1T2 ",=%P A'1T (1TD
M " >*P ?'C( 'A\[ !T?10 <($\ &B%< !DA:@ 8(GL %B*/ !4BHP 4([H
M$R/: !0C]0 5(_\ %B/_ )X\  "300  B40  ']&  !U1@  ;$0  &)!  !7
M/   33@  $0T   \,   ,RL  "HF P C(@L ("$0 !XA%0 <(AL &R(A !HB
M*  :(S  &2,X !@D0@ 6)4T %259 !0F:  3)GD $B:- !$GH@ 0)[@ #B?6
M ! H]  1)_\ $2?_ )Q   "110  AT@  'U*  !T2@  :DD  &!&  !500
M3#X  $,Z   Z-@  ,3(  "@M   @*0D &R<. !DG$@ 8)Q@ %B<? !4H)0 4
M*"T $R@V !(I0  2*4L $2I7 ! J9@ .*W< #BN+  TLGP ,++4 "RS/  PL
M[P -+/\ #2O_ )E$  "/20  A4P  'Q.  !S3P  :4X  %Y+  !31P  2D0
M $)    Y/0  +S@  "4T   =, 4 %BT, !0L$  3+14 $BT< !$M(P 0+2H
M#RXS  XN/0 -+T@ #2]5  PP8P *,'0 "3"(  @QG  &,;$ !C'+  8QZP '
M,/P "##_ )=(  "-30  @U$  'I3  !Q5   9U(  %U0  !23   24H  $!&
M   U0@  *SX  "(Z   :-P$ $C0)  \S#@ .,Q, #3,9  TS(  ,-"@ "S0Q
M  HU.P (-48 !S52  4V8  $-G$  C:$   VF0  -J\  #;(   VZ   -OD
M 37_ )1-  "*4@  @58  'A8  !O60  95@  %M5  !14@  1T\  #Q,   Q
M2   )T0  !Y!   6/P  $#P'  LZ#0 ).A$ "#L7  8['@ %.R8 !#LN  ([
M.  !/$,  #Q/   \7@  /&X  #R!   \EP  /*P  #O%   [YP  ._@  #O_
M )%2  "(6   ?UP  '9=  !M7@  8UT  %I<  !.6   0E0  #=1   M3@
M(TL  !I)   21@  #40&  =##  #0Q   $,5  !#&P  0R,  $,K  !#-0
M0T   $--  !#6P  0VL  $-^  !#E   0JH  $+#  !!Y@  0?D  $'_ (Y8
M  "&7@  ?6$  '-C  !K9   8F,  %=A  !)70  /5H  #)8   G50  'E,
M !51   .3P  "4T%  )-"P  3 X  $P3  !+&   2Q\  $LH  !+,@  2ST
M $M)  !+5P  2V<  $I[  !*D   2:<  $G   !(Y   2/@  $?_ (M?  "#
M9   >F<  '%I  !I:@  7FD  %!F  !#9   -V$  "Q?   A70  &%L  !!9
M   *6    U<#  !7"0  5@T  %40  !5%0  5!L  %0C  !4+0  5#D  %1%
M  !44P  5&0  %-W  !3C0  4J0  %&]  !0X@  4/@  $__ (AG  !_:P
M=VX  &]P  !E<   5VX  $IL   ]:P  ,&D  "5H   :9@  $60   MC   $
M8@   &(!  !A!@  8 L  & .  !?$@  7Q<  %\>  !>*   7C,  %Y   !>
M3P  7E\  %UR  !=B   7*   %NY  !:WP  6?<  %C_ (1N  !\<@  =74
M &MV  !==0  3W0  $)S   U<P  *'(  !UP   3;P  #&X   1N    ;@
M &X   !L @  ; <  &L+  !K#@  :Q(  &H9  !J(@  :BT  &HZ  !I20
M:5H  &EL  !H@P  9YL  &:U  !EV   9/4  &3_ (!U  !Z>0  <'L  &)[
M  !4?   1GP  #E\   L?   'WL  !1Z   ->@  !'H   !Z    >@   'H
M  !Y    >0$  '@&  !X"P  > X  '@3  !X&@  >"4  '@R  !W00  =U(
M '=E  !V?   =94  '2O  !SS@  <O$  ''_ 'Y]  !U@   9X$  %B"  !*
M@P  /(0  "Z%   AA0  %84   V%   #A0   (8   "'    B    (@   "'
M    AP   (<   "'!   APD  (<.  "($P  B!P  (@I  "(.   ATH  (==
M  "&<P  AHT  (6G  "$Q0  @^P  (+^ 'B$  !JA@  7(@  $V*   _C
M,8X  "./   6CP  #9    *1    D@   ),   "5    E@   )8   "6
ME@   )8   "7    EP   )<'  "8#0  F1,  )H?  ":+0  FC\  )I2  ":
M:   F8,  )F?  "8N@  E^(  );X &V*  !?C0  4)   $&3   SE@  ))<
M !:8   -F0   9L   "=    GP   *$   "D    I0   *0   "E    I0
M *8   "G    J    *D   "J!   K P  *X3  "N(0  KC,  *Y'  "N70
MKG8  *Z3  "NK@  K<T  *SO &&1  !3E0  1)@  #6<   FGP  %Z$   VC
M    I0   *<   "J    K    +    "R    M    +,   "T    M0   +<
M  "X    N0   +L   "]    OP$  ,,+  #%%0  Q24  ,8Y  #'3P  QV@
M ,:%  #&H@  QKP  ,;> %69  !'G0  .*(  "FF   9J   #:L   "M
ML0   +0   "W    N@   +\   #!    Q    ,,   #%    Q@   ,@   #*
M    S0   ,\   #2    U@   -L   #@#   X1@  .,K  #D00  Y5H  .9T
M  #FD0  Y:P  .7$ /\   #_    _P   /\  0#_  H _P 2 /\ '0#_ "@
M_P T /\ /@#] $@ ^@!0 /< 5P#U %T ] !C /( :0#P &\ [P!T .T >P#K
M ($ Z0") .@ D@#F )P Y "H .( MP#? ,T W #N -D _P#9 /\ R@#_ +X
M_P"U /\ L #_ /\   #_    _P   /\   #_  8 _P / /P & #X ", ]  N
M /  . #K $( Z !* .4 40#B %@ X != -X 8P#< &@ V0!N -8 = #4 'L
MT0"" ,\ BP#- )4 R@"A ,@ KP#% ,$ P@#C ,  ^P#  /\ NP#_ +  _P"H
M /\ I #_ /\   #_    _P   /L   #S  $ [0 , .@ $P#C !X X  H -H
M,@#3 #P SP!$ ,P 2P#) %$ Q@!7 ,0 70#" &( P0!G +\ ;0"] '0 NP![
M +D A "W (X M "9 +( IP"O +< K0#0 *L \@"J /\ J0#_ *$ _P"; /\
MEP#_ /\   #_    ]    .D   #@    U0 ( ,X $ #) !@ Q0 B ,$ *P"\
M #4 N0 ] +8 10"S $L L0!1 *\ 5@"N %L K !A *H 9@"I &T I@!T *0
M? "B (8 H "2 )X GP"< *X F0## )< YP"6 /\ E0#_ )( _P"- /\ B@#_
M /P   #P    XP   -0   #(    OP # +D #0"S !, KP < *P )0"I "X
MI0 V *, /@"@ $0 G@!* )T 4 "; %4 F0!: )< 7P"6 &8 E !L )( =0"0
M 'X C@"* (L EP") *8 AP"X (4 U@"$ /8 @@#_ ($ _P!^ /\ ? #_ .T
M  #=    S    ,$   "X    K@   *< "0"B !  G@ 7 )H 'P"7 "< E  O
M )$ -P"/ #T C0!# (L 20") $X B !3 (8 60"$ %\ @@!E (  ;0!^ '<
M? "" 'H CP!X )X =0"O ', QP!R .P <0#_ '  _P!P /\ ;@#_ -T   #)
M    O    +$   "I    H0   )D  P"3  P C@ 2 (H &0"' "$ A  I ($
M, !_ #< ?0 ] 'L 0@!Y $@ > !- '8 4@!T %@ <@!? '$ 9P!O '  ; ![
M &H B !H )< 9@"H &4 O !C .$ 8@#Z &$ _P!A /\ 80#_ ,T!  "\!0
MKP4  *4"  "<    E    (T   "&  @ @0 . 'P % !X !L =0 C '( *0!P
M #  ;@ V &T / !K $$ :0!' &@ 3 !F %( 9 !9 &, 8 !A &D 7P!T %T
M@0!; )  60"A %< M !6 -  50#R %4 _P!4 /\ 50#_ ,$,  "R#@  I@\
M )L.  "2"P  B04  ((   ![  ( =0 + '  $ !L !8 :  = &8 (P!C "H
M80 P &  -@!> #L 70!! %L 1@!: $P 6 !3 %8 6P!4 &0 4@!N %$ >P!/
M (H 30"; $P K@!+ ,8 2@#J $D _@!) /\ 20#_ +D2  "J%@  GA<  )06
M  "*$P  @1   'D+  !Q P  :P & &4 #0!A !$ 70 8 %H '@!8 "0 5@ J
M %0 , !3 #8 40 [ %  00!. $< 30!. $L 5@!) %\ 1P!I $8 =@!$ (4
M0P"7 $$ J0!  +\ /P#B #\ ^  ^ /\ /P#_ +(9  "D'@  F!\  (X?  "$
M'   >A@  '(2  !J#@  8@@  %P!" !7  X 4P 3 %  &0!. !\ 3  E $H
M*P!( #  1P V $8 / !$ $( 0P!) $$ 40 _ %H /@!E #P <@ Z ($ .0"3
M #@ I0 V +H -@#; #4 ]  U /\ -0#_ *P@  "?)   E"8  (DF  !_)
M=2   &P;  !D%0  7!   %0, 0!.!@H 2@(/ $< % !$ !H 0@ @ $  )0 _
M "L /@$Q #P!-P [ CX .0)% #@#30 V U8 -01A #,$;@ Q!7X , 60 "\%
MHP M!K@ + ;4 "P'\  L"/\ + C_ *@E  ";*@  D"P  (8M  ![*P  <B<
M &@B  !?'0  5Q<  $\2  !(#@0 00H+ #X'$  [!A4 .0<; #@'(0 V""8
M-0@L #,(,@ R"3D ,0E! "\)20 N"E, + I> "L+;  I"WP * R/ "8,H@ E
M#+< ) S3 ",-\  D#?\ )0W_ *0J  "8+P  C3(  (,R  !Y,0  ;RX  &4I
M  !<)   4Q\  $L9  !#$P  /! & #4-#  S#!$ ,0P6 "\,'  N#2( +0TH
M "L-+@ J#34 *0T] "<.1@ F#E  ) Y< ",/:@ B#WL (!". !\0H@ =$+<
M'!#4 !T1\@ =$?\ 'A'_ *$O  "5,P  BC8  ( W  !V-@  ;3,  &,O  !9
M*@  4"4  $@@   _&@  .!4  # 1"  L$ X *A 2 "@0&  G$!X )1 D "00
M*@ C$3( (A$Z "$10P @$DX 'A): !T3:  ;$W@ &A.+ !@4H  7%+4 %A31
M !85\0 7%?\ &!3_ )XS  "3-P  B#H  'X[  !T.P  :S@  &$T  !7+P
M3BL  $4F   ](0  -!P  "T7!0 F$PP (Q,0 "(3%0 @$QH 'Q,A !X4)P =
M%"\ '!4W !L500 :%DL &197 !<790 6%W8 %!B) !,8G@ 2&+, $1G. !$9
M[P 2&?\ $QG_ )PV  "1.P  ACX  'P_  !S/P  :3T  %\Y  !5-0  3#
M $,L   Z)P  ,B(  "H> 0 B&0D 'A<. !P7$@ :%Q< &1@> !D8)  8&2P
M%QDT !8:/@ 5&DD $QM5 !(;8P 1''0 $!R'  \=G  .';$ #1W+  T=[  .
M'?\ #QW_ )DZ  "//P  A$(  'M$  !Q0P  :$(  %X^  !3.@  2C8  $$R
M   Y+0  ,2D  "@E   @( 8 &AT, !<<$  5'!4 %!T; !0=(@ 3'2D $AXR
M !$?/  0'T8 $"!3  X@80 -(7$ #"&%  LBF0 *(JX "2+'  DBYP *(OL
M"R'_ )<^  ",0P  @T8  'E(  !P2   9T8  %Q$  !2/P  23L  $ X   X
M-   +S   "<L   >)P, %B,* !(A#@ 1(1, $"(9 ! B(  /(B< #B,O  TD
M.0 ,)$0 "R50  HE7@ ))F\ !R:"  8FE@ $)JP  R;$  0FY0 $)O< !B;_
M )5"  "*1P  @4H  'A,  !O3   94L  %M(  !01   1T$  #\^   W.P
M+38  "0Q   ;+0  $RH'  \H#0 -)Q$ #2@6  PH'0 +*"4 "BDM  DI-P '
M*D( !BI.  0K7  #*VP  2M_   KE   *ZD  "O!   KXP  *_8  "K_ ))&
M  "(2P  ?T\  '91  !M40  8U   %I-  !/2@  1T<  #Y$   S0   *3P
M " X   7-   $3$%  PO#  )+A  !RX5  8O&P %+R,  R\K  (P-0  ,#\
M #!,   Q60  ,6D  #%\   QD0  ,:<  #"_   PX0  ,/4  "__ )!+  "&
M4   ?50  '56  !K5@  8E4  %A3  !.4   14T  #I)   O10  )4(  !P^
M   4.P  #CD%  DW"P $-@\  383   V&0  -B   #8I   V,@  -ST  #=)
M   W5P  -V<  #=Y   WCP  -J4  #:]   VX   -?4  #7_ (U0  "$5@
M?%H  ');  !I6P  8%L  %=9  !,5@  0%(  #5.   J2P  ($@  !=&   0
M0P  "T$$  1 "@  /PX  #X1   ^%@  /AT  #XF   ^+P  /CH  #Y&   ^
M5   /F0  #YV   ]C   /:,  #R[   \W@  ._4  #O_ (I7  ""7   >5\
M '!A  !H80  7V$  %1>  !'6P  .E<  "]5   E4@  &U   !)-   ,2P
M!DH#  !)"0  2 T  $<0  !'%   1AH  $8B  !&+   1C<  $9#  !&40
M1F   $5S  !%B0  1*   $2X  !#W   0O4  $+_ (A=  !_8@  =V4  &YG
M  !G:   6V8  $YC  !!80  -%X  "E<   ?6@  %5<   Y6   '5    %,!
M  !2!@  40L  %$.  !0$0  3Q8  $\>  !/)P  3S(  $\_  !/30  3ET
M $YO  !.A0  39T  $RU  !+V   2O4  $K_ (5E  !\:0  =&P  &UN  !B
M;0  5&L  $=I   Z9P  +64  ")D   88@  $&    E?    7@   %X   !=
M P  7 @  %L,  !:#P  6A,  %D9  !9(@  62T  %DZ  !92   6%@  %AK
M  !7@0  5YD  %:R  !5T@  5/0  %/_ (%L  !Y<   <W,  &AS  !:<@
M3'$  #]P   R;P  )6X  !IL   1:P  "6H   !J    :0   &D   !H
M9P,  &8(  !F#   9@\  &44  !E'   92<  &0T  !D0P  9%,  &1E  !C
M>P  8I0  &&M  !@S0  7_$  %[_ 'UT  !W=P  ;GD  %]Y  !1>0  0WD
M #9X   I>   ''<  !%V   *=0   '4   !U    =@   '4   !T    =
M ',"  !S!P  <PP  '(0  !R%0  <B   '(L  !R.P  <4P  '%?  !Q=
M<(X  &^H  !NQ@  ;.T  &O_ 'M[  !R?@  9'X  %5_  !'@   .8$  "N"
M   >@0  $H$   J!    @0   ((   "#    @P   (,   ""    @@   ((
M  ""    @@4  ((*  ""#P  @A<  ((C  "",@  @D,  (%6  "!;   @(8
M '^A  !^O0  ?>8  'S\ ':"  !H@P  684  $N'   \B0  +HH  ""+   3
MBP  "HL   ",    C0   (\   "1    D@   )$   "1    D0   )$   "1
M    D@   )("  "3"0  E \  )09  "4)P  E#@  )1,  "38@  DWP  ).8
M  "2LP  D=@  )#V &J(  !<B@  38T  #^0   PD@  (90  !25   *E@
M )<   "9    FP   )T   "?    H    *    "@    H    *$   "B
MHP   *0   "E    I@<  *@0  "H'   J"T  *E   "I5@  J6\  *F+  "H
MJ   I\<  *;L %^/  !0D@  098  #.9   CG   %)T   J?    H0   *,
M  "F    J    *P   "N    KP   *\   "P    L    +(   "S    M
M +8   "W    N@   +T'  "_$   OQ\  , S  # 20  P&(  ,!^  # FP
MP+<  +_8 %.7  !$FP  -9\  ":C   6I0  "Z<   "J    K0   +    "S
M    M@   +L   "]    P    +\   #!    P@   ,0   #&    R    ,H
M  #,    SP   -,   #:!P  VQ,  -TE  #>.P  WU,  .!N  #?C   W:D
M -W" /\   #_    _P   /\   #_  < _P 0 /\ &0#_ "0 _P O /P .@#Y
M $, ]0!+ /, 4@#Q %D [P!> .T 9 #K &D Z0!O .< =0#F 'P Y "$ .(
MC0#@ )< W0"B -H L0#5 ,4 T@#H -  _P#/ /\ Q #_ +@ _P"O /\ J0#_
M /\   #_    _P   /\   #_  ( ^P - /< %0#S !\ [P I .H - #F #T
MX@!% -X 3 #; %, V !8 -0 7@#2 &, T !I ,X ;@#, '4 R@!] ,@ A0#&
M )  P@"; ,  J0"^ +H NP#9 +D ]P"X /\ M #_ *D _P"B /\ G0#_ /\
M  #_    _P   /8   #N    YP * .$ $0#< !H UP C -  +@#+ #< QP _
M ,0 1@#! $T OP!2 +T 6 "[ %T N0!B +@ : "V &X M !U +$ ?@"O (@
MK0"3 *H H0"H +$ I@#( *0 [0"B /\ H@#_ )L _P"5 /\ D0#_ /\   #\
M    [@   .,   #8    S0 % ,8 #@#! !4 O0 > +D )P"U #  L@ X *\
M0 "L $8 J@!, *@ 40"G %8 I0!; *, 80"A &< GP!N )X =@"; (  F0",
M )< F0"4 *@ D@"\ )  WP". /L C@#_ (L _P"& /\ @P#_ /@   #I
MW    ,P   #!    N    +( "@"L !$ J  8 *4 (0"B "D G@ R )P .0"9
M #\ EP!% )4 2@"4 %  D@!5 )  6@"/ &  C0!G (L ;P") '@ A@"$ (0
MD0"" *  @ "R 'T S !\ /$ >P#_ 'H _P!W /\ =0#_ .8   #3    Q@
M +L   "Q    IP   *$ !0";  T EP 3 ), &P"0 ", C  K (H ,@"( #@
MA@ ^ (0 1 "" $D @0!. '\ 4P!] %D >P!@ 'D : !W '$ =0!\ ', B0!P
M )@ ;P"I &T OP!K .8 :@#_ &D _P!I /\ 9P#_ -,   ##    M0   *L
M  "C    FP   )(   ",  H AP 0 (, %@!_ !T ?0 D 'H *P!X #( =@ X
M '0 /0!R $( <0!( &\ 30!M %, ; !9 &H 80!H &H 9@!T &0 @0!A )$
M7P"B %X M@!< -4 6P#W %L _P!: /\ 6@#_ ,4   "V @  J0(  )\   "6
M    C@   (<   "   4 >@ , '4 $0!Q !@ ;@ > &L )0!I "L 9P Q &8
M-P!D #P 8P!! &$ 1P!? $T 7@!3 %P 6P!: &0 6 !N %8 >P!4 (H 4@";
M %$ K@!0 ,@ 3P#N $X _P!. /\ 30#_ +L*  "L#0  H T  )4,  ","
M@P(  'P   !U    ;@ ( &D #@!E !, 8@ 9 %\ 'P!= "4 6P K %D ,0!8
M #8 5@ [ %4 00!3 $< 40!. %  50!. %X 3 !H $H =0!( (0 1P"5 $4
MJ !$ +\ 0P#D $( _ !" /\ 0@#_ +(1  "E%   F14  (X3  "$$0  >PT
M ',(  !L    90 # %\ "P!;  \ 5P 4 %0 &@!1 !\ 3P E $X *P!, #
M2P V $D / !( $( 1@!( $4 4 !# %D 00!C #\ ;P ^ 'X / "0 #L HP Z
M +@ .0#9 #@ ]0 X /\ . #_ *P7  "?&P  DQT  (D<  !_&0  =14  &P0
M  !D#   708  %8 !@!1  P 30 0 $H %0!' !H 10 @ $0 )@!" "L 00 Q
M #\ -@ ^ #T / !$ #L 2P Y %0 -P!? #8 :P T 'H ,@", #$ G@ P +,
M+P#. "\ [P N /\ +@#_ *<>  ":(@  CR0  (0D  !Z(0  <1T  &<8  !?
M$P  5PX  % *  !) P@ 10 - $$ $0 ^ !8 /  ; #H (0 Y "8 -P L #8
M,@ T #@ ,P _ #$ 1P P %  +@!; "T 9P K '8 *@"( "@ G  G +  )@#)
M "4 Z@ E ?L )0'_ *(C  "6*   BRH  ($J  !W*   ;24  &0@  !;&P
M4A4  $L0  !## ( /0<) #D##@ V 1( ,P$7 #$!'  P 2( +P(G "T"+0 L
M S0 *@,[ "D$0P H!$T )@58 "4%90 C!G0 (@:& " &F@ ?!ZX '@?& !T'
MYP ="/@ '0G_ )\H  "3+0  B"\  'XO  !T+@  :BL  &$F  !8(0  3QP
M $<7   _$@  . X$ #$+"@ N" X *P<2 "D'%P H"!T )P@C "4(*0 D"3
M(PDW "$*0  @"DH 'PM5 !T+8@ ;#'( &@R% !@,F0 7#*T %@S& !4-Y@ 5
M#?D %@W_ )PM  "0,0  AC0  'PT  !R,P  :#$  %\L  !5)P  3",  $0=
M   \&   -!,  "T0!@ F#0L ) P/ "(,$P A#!D 'PP? !X-)0 =#2P &PTT
M !H./0 9#D< %PY3 !8.80 4#W$ $Q"$ !(0F  1$*X $!#& ! 0Z  0$/L
M$1#_ )DQ  ".-0  A#@  'HY  !P.   9S8  %TR  !3+0  2B@  $(D   Y
M'P  ,1H  "H5 0 C$0< '1 - !L/$  9#Q4 &! ; !<0(0 6$"D %1 Q !01
M.@ 3$44 $A)1 !$27P 0$F\ #A."  X3E@ -$ZL "Q/"  L4XP ,%/H #1/_
M )<U  ",.0  @CP  '@]  !O/0  93H  %LW  !2,@  22X  $ J   W)0
M+R$  "@<   @& , &10* !42#@ 4$A( $Q,8 !(3'P 1%"8 $10N ! 4.  /
M%4( #A9/  T67  ,%VP "Q=_  D8DP (&*@ !AB_  <8X  '&/4 "1C_ )4X
M  "*/0  @$   '=!  !M00  9#\  %H\  !0.   1S,  #XP   V*P  +B<
M "<C   ?'P  %QH( !(7#0 0%Q$ #Q<6  X8'  .&", #1DL  P:-0 +&D
M"AM,  D;6@ ''&D !1Q\  0=D0 "':8  1V\  (<W0 "'/(  QS_ ),\  "(
M00  ?T0  '5%  !L10  8T0  %E!  !//0  1CD  #XV   U,@  +BX  "4J
M   =)0  %"$$  \="P -'1  #!T4  L=&@ *'B( "!XJ  <?,P &(#X !"!*
M  ,A5P !(6<  "%Y   AC@  (:0  "&Z   AVP  (?(  "#^ )!   "&10
M?4@  '1*  !K2@  8DD  %A&  !.0@  13\  #T\   U.0  *S0  "(O   9
M*P  $B@$  TD"@ )(PX !B,2  4C&0 $)"   B0H  $E,0  )3P  "5(   F
M50  )F4  "9W   FC   )J(  ":Y   FV0  )?(  "7^ (Y%  "$20  >TT
M '-/  !J3P  8$X  %=+  !-2   1$4  #Q"   Q/0  )SD  !XU   5,@
M#RX#  HL"@ %*PX  2H1   J%@  *AX  "HF   K+P  *SD  "M%   L4P
M+&(  "QU   LB@  *Z   "NW   KU@  *O(  "K_ (Q)  ""3@  >E(  '%4
M  !H5   7U,  %91  !,3@  0TL  #='   M0P  (S\  !H\   2.   ##8#
M  8S"0  ,@T  #(0   Q%   ,1L  #$C   Q+   ,C<  #)#   R4   ,F
M #)R   RAP  ,9X  #&U   PU   ,/(  "__ (E/  " 5   >%<  &]9  !F
M60  7ED  %57  !)4P  /D\  #),   H2   'D4  !5"   .0   "#T"  $\
M"   .PP  #H/   Y$@  .1@  #D@   Y*0  .30  #E    Y3@  .5T  #EO
M   XA0  .)P  #>S   WT@  -O(  #7_ (=5  !_6@  =ET  &U?  !E7P
M75\  %)<  !$6   .%4  "U2   B3P  &$P  !!*   *2    T8!  !%!@
M1 H  $,-  !"$   014  $$=  !!)@  03$  $$]  !!2@  05H  $%L  !
M@0  /YD  #^Q   ^T   /?(  #S_ (1<  !\8   <V,  &QE  !D9@  660
M $MA   ^7@  ,EL  "99   <5@  $E0   Q2   $40   $\   !. P  30@
M $P,  !+#@  2Q(  $H9  !*(@  2BP  $HY  !*1P  2E8  $EH  !)?@
M2)8  $>O  !&S0  1?$  $3_ (%C  !Y9P  <FH  &ML  !@:P  4FD  $1F
M   W9   *F(  !]@   57@  #5T   9;    6@   %D   !8    5P0  %8(
M  !6#   51   %04  !4'0  5"<  %0T  !40@  4U(  %-D  !2>0  4I(
M %&K  !0R@  3^\  $[_ 'YJ  !W;@  <'$  &9Q  !8<   2F\  #QM   O
M;   (FH  !=I   .9P  !F8   !E    90   &4   !C    8@   &($  !A
M"   80T  & 0  !@%P  8"$  %\N  !?/   7TT  %Y>  !>=   78T  %RG
M  !;Q0  6NT  %G_ 'MR  !U=@  :W<  %UV  !/=@  074  #-U   F=
M&7,  !!R   '<0   '$   !Q    <0   '$   !O    ;P   &X   !N @
M;@@  &T,  !M$0  ;1H  &TF  !L-0  ;$8  &M8  !K;0  :H8  &FA  !H
MO@  9^@  &;^ 'EZ  !P?   87P  %-]  !$?0  -GX  "A^   ;?0  $'T
M  =]    ?0   'T   !^    ?P   'X   !]    ?0   'P   !\    ?
M 'P&  !\#   ?!(  'P=  !\+   ?#P  'Q/  ![90  >WX  'J:  !YM@
M>-\  '?Z '.   !E@0  5H,  $B$   YA@  *X<  !V'   1AP  !X@   "(
M    B0   (H   ",    C0   (T   ",    C    (P   ",    C    (T
M  "-!   C@P  (X3  "/(0  CC(  (Y&  ".6P  C70  (V0  ",K0  B\X
M (KS &B&  !:B   2XL  #R-   MCP  'I   !&1   'D@   ),   "5
MEP   )D   ";    G    )L   ";    G    )P   "=    G@   )X   "?
M    H0,  *(,  "B%@  HR8  *,Z  "C3P  HV@  **&  "BH@  HL   *'H
M %R-  !-D   /Y,  #"6   AF0  $IH   >;    G0   *    "B    I
M *@   "J    JP   *H   "K    K    *T   "N    KP   +$   "R
MM    +<!  "Y#0  N1H  +HM  "Z0P  NEL  +IW  "[E   N[$  +G2 %"5
M  !!F   ,IP  ".@   3H@  "*0   "G    J@   *P   "O    L@   +<
M  "Y    NP   +H   "\    O0   +\   #     P@   ,0   #&    R0
M ,T   #2 0  U \  -4?  #7-0  V$T  -AI  #7A@  UZ,  -:] /\   #_
M    _P   /\   #_  , _P - /\ %0#_ "  _  K /@ -0#T #\ \ !' .X
M3@#K %0 Z0!: .< 7P#E &0 XP!J .$ < #? '8 W0!^ -L AP#8 )$ TP"=
M ,\ JP#- +T RP#@ ,D ^P#' /\ O0#_ +$ _P"I /\ HP#_ /\   #_
M_P   /\   #\    ]@ + /$ $0#M !L Z0 E .0 , #? #D V@!! -4 2 #1
M $X SP!4 ,T 60#+ %X R0!C ,< :0#% &\ PP!W ,  ?P"^ (H NP"5 +@
MHP"V +0 M #- +( \@"P /\ K #_ *, _P"< /\ EP#_ /\   #_    ^@
M /$   #H    X  & -D #@#2 !8 S@ ? ,@ *0#$ #( P  Z +T 00"Z $@
MN !- +8 4P"T %@ L@!= +  8@"N &D K !O *H > "H (( I@". *0 FP"A
M *L GP#  )T Y@"; /\ F@#_ )0 _P". /\ B@#_ /\   #V    Z    -P
M  #.    Q@ ! +\ "P"Z !$ M@ : +( (@"N "L J@ T *@ .P"E $$ HP!'
M *$ 3 "? %$ G@!6 )P 7 ": &( F0!H )< < "5 'H D@"& )  DP"- *(
MBP"U (D TP"' /< A@#_ (0 _P!_ /\ ? #_ /(   #C    T@   ,4   "Z
M    L0   *L !P"E  X H0 4 )X ' ": "4 EP M )0 - "2 #H D !  (X
M10"- $H BP!0 (D 50"( %L A@!A (0 :0"" '( ?P!] 'T BP![ )H > "K
M '8 Q !T .L <P#_ ', _P!P /\ ;@#_ -\   #,    OP   +0   "K
MH0   )H  @"4  L D  0 (P %P"( !X A0 F (, +0"! #, ?P Y 'T /P![
M $0 >0!) '@ 3@!V %0 = !: ', 8@!P &L ;@!U &P @P!J )( : "C &8
MN !D -X 8P#[ &( _P!B /\ 8 #_ ,P   "\    KP   *4   "=    E
M (P   "&  < @0 - 'P $@!X !D =0 ? ', )@!Q "T ;P R &T . !K #T
M:@!" &@ 2 !G $X 90!4 &, 6P!A &0 7P!N %T >P!; (H 60"; %< KP!6
M ,L 50#R %0 _P!4 /\ 5 #_ +X   "P    I    )D   "0    B    ($
M  !Y  ( <P * &\ #P!K !0 9P : &4 ( !C "8 80 L %\ ,@!> #< 7  \
M %L 0@!9 $< 5P!. %8 50!4 %X 4@!H %  = !. (, 3 "5 $H J !) ,
M2 #H $< _P!' /\ 1P#_ +0)  "F"P  FPP  ) *  "&!0  ?@   '8   !O
M    :  % &, # !? !  6P 5 %@ &@!6 "$ 5  F %, + !1 #$ 4  V $X
M/ !- $( 2P!( $D 4 !( %@ 1@!B $0 ;@!" 'T 0 ". #\ H@ ] +@ /0#=
M #P ^  \ /\ / #_ *P0  "?$@  E!(  (D1  !_#P  =@P  &X%  !F
M8  ! %D " !5  T 40 1 $X %@!+ !L 20 A $@ )@!& "L 10 Q $, -@!"
M #P 0 !# #X 2P ] %, .P!= #D :0 W '@ -@") #0 G  S +$ ,@#. #(
M\0 Q /\ ,0#_ *86  ":&0  CAH  (0:  !Z%@  <!(  &@.  !?"@  6 ,
M %$ ! !,  H 2  . $0 $@!! !8 /P ; #T (0 \ "8 .@ L #D ,0 W #<
M-@ ^ #0 1@ S $\ ,0!9 "\ 90 N ', + "% "L F  J *T *0#& "@ Z@ H
M /X * #_ *$<  "5(   BB$  '\A  !U'P  ;!H  &,6  !:$0  4@T  $L'
M  !$  8 0  + #P #P X !( -@ 7 #0 '  S "$ ,0 G #  +  N #, +0 Z
M "L 0@ J $L * !5 "8 80 E '  ) "! "( E0 A *D ( #! "  Y  ? /D
M'P#_ )TB  "1)@  AB@  'PG  !R)0  :2(  %\=  !7&   3A,  $8.   _
M"P  . 4' #0 #  Q !  +@ 3 "P &  J !T *0 B "< *  F "X )  V ",
M/@ B $< ( !2 !\ 7@ = &T ' !^ !H D@ 9 *< & "] !< WP 7 ?4 %P+_
M )HG  ".*P  A"T  'DM  !P*P  9B@  %TD  !4'P  2QH  $,4   [$
M- T" "T)"0 I!0T )@,0 "0!$P B AD (0(> " ")  > RH '0,R !L$.@ :
M!40 &05/ !<&7  6!FH % =\ !,'D  2!Z4 $0>[ ! 'VP 0"/( $ G_ )<K
M  ",+P  @3$  '<R  !N,0  9"X  %LJ  !1)0  22   $ ;   X%@  ,1(
M "D.!  C# D 'PD- !T'$  ;!Q4 &0@: !@((  7"2< %@DN !4*-P 3"D$
M$@M- !$+6@ 0"VD #@Q[  X,D  -#*4 # V[  L-V0 +#?$ # W_ )4O  "*
M,P  ?S8  '8V  !L-0  8S,  %DO  !0*P  1R8  #XA   V'0  +A@  "<3
M   @$ 4 &0X* !4,#@ 4#!$ $PP6 !(,'  1#2, $ TK  \--  .#C\ #0Y*
M  P/6  +#V< "A!Y  @0C0 '$*( !A"X  40U  %$.\ !A#_ )(S  "(-P
M?CH  '0[  !K.@  83@  %@U  !.,   12P  #TG   U(P  +1\  "8:   >
M%@$ %Q,& !$0"P .#@X #@\3  T0&0 -$"  #! H  L1,@ *$3P "!)(  <2
M50 &$V4 !!-V  ,3BP !%*   !.V   3T0  $^X  !/[ ) V  "&.P  ?#X
M ',_  !J/P  8#T  %<Y  !--@  1#$  #PN   T*@  +"8  "4B   >'@
M%AH" ! 5"0 ,$PX "A,2  D4%P (%!\ !Q4F  85+P $%CH  Q9&  $74P
M%V(  !AT   8B0  &)\  !BU   7T   %^T  !?[ (XZ  "$/P  >T(  ')#
M  !H0P  7T(  %8_  !,.P  0S<  #LT   S,   +"P  "0I   ;)   $Q\"
M  T;"0 )&0T !AD1  09%@ "&1T  1HD   :+0  &S@  !M$   <40  '&
M !UR   =AP  ')T  !RS   <S@  &^T  !O\ (P^  ""0P  >48  '!(  !H
M2   7D8  %5$  !+0   0ST  #LZ   S-P  *C(  " M   7*0  $"4"  LB
M"0 %( T  1\0   ?%   'QL  " B   @*P  (38  "%!   A3P  (5X  ")P
M   BA0  (9L  "&R   AS0  (.T  !_\ (I#  " 2   >$L  &],  !F30
M74L  %1)  !*1@  0D,  #I    O.P  )3<  !PS   3+P  #2P"  <I"  !
M)PP  "8.   E$@  )AD  "8A   F*0  )C,  "<_   G30  )UP  "=M   G
M@@  )YD  ":P   ES   )>X  "3] (A(  !_3   =E   &Y1  !E4@  7%$
M %-/  !*3   04D  #5$   K0   (3P  !<Y   0-@  "C(!  ,P!P  +PL
M "X.   M$0  +18  "T>   M)P  +3$  "T]   M2@  +5D  "UK   M@
M+)<  "RO   KRP  *NX  "K^ (5-  !]4@  =54  &Q7  !C5P  6U8  %-5
M  !'40  .TT  #!)   E1@  '$,  !,_   -/0  !CH    X!0  -PD  #8-
M   U#P  -!0  #0;   T)   -"X  #0Z   T1P  -%<  #1H   T?0  ,Y4
M #*M   QR@  ,>X  ##_ (-3  ![6   <UL  &I=  !B70  6UT  $]:  !"
M5@  -E(  "I/   @3   %DD   Y'   (1    $(   !! P  /P<  #X+   ]
M#@  /1$  #P8   \(0  /"L  #PW   \1   /%,  #QE   [>@  .I(  #JK
M   YR   ..T  #?_ (%:  !Y7@  <6$  &EC  !B9   5V(  $E>   \6P
M+U@  "15   94P  $%$   I/   !30   $P   !*    200  $@(  !'#
M1@\  $84  !%'   12<  $4S  !%0   15   $1A  !$=@  0X\  $*H  !!
MQ@  0.P  #__ 'YA  !V90  ;V@  &AJ  !=:0  3V8  $)D   T80  *%\
M !U=   26P  "UD   )8    5@   %8   !4    4P   %($  !1"0  4 T
M % 0  !/&   3R(  $\N  !//   3TL  $Y=  !.<@  38L  $RE  !+P@
M2>H  $C_ 'MI  !T;   ;F\  &1O  !5;0  1VP  #EJ   L:0  (&<  !1E
M   -9    V(   !B    80   &    !?    7@   %T   !<!   7 D  %L-
M  !;$@  6QP  %HH  !:-@  6D8  %E8  !9;0  6(4  %>@  !6O0  5>@
M %/^ 'EP  !S=   :74  %MT  !,<P  /G,  #!R   C<0  %F\   UN   $
M;0   &T   !M    ;0   &P   !K    :@   &D   !I    :0,  &@)  !H
M#@  :!4  &<A  !G+P  9S\  &92  !F9@  97\  &2:  !CMP  8N$  &'\
M '=X  !M>@  7WH  %!Z  !">@  ,WL  "5[   8>@  #GD   1Y    >0
M 'D   !Z    >@   'H   !X    >    '<   !W    =P   '<!  !W"
M=PX  '<8  !W)@  =C8  '9)  !U7P  =7<  '23  !SKP  <M,  ''W '%^
M  !C?P  5(   $6"   V@P  *(0  !J$   .@P  !(0   "$    A0   (8
M  "(    B0   (@   "'    AP   (<   "'    AP   (@   "(    B <
M (D0  ")'   B2P  (@_  "(50  B&T  (>)  "&IP  A<<  (3O &:$  !7
MA@  2(@  #F*   JC   &XT   ^-   $C@   )    "1    DP   )4   "7
M    F    )8   "7    EP   )<   "8    F    )D   ":    FP   )T'
M  "=$0  G2$  )TS  "=20  G&(  )Q_  "<G   G+D  )OB %J+  !+C@
M/)$  "V3   >E0  $)8   28    F@   )P   ">    H0   *0   "F
MIP   *8   "G    IP   *@   "I    J@   *P   "M    KP   +$   "S
M"0  LQ4  +0G  "T/0  M54  +5P  "TC@  M*P  +3, $V2   _E@  +YH
M ""=   1GP  !:$   "C    I@   *D   "L    KP   +,   "U    MP
M +8   "W    N    +H   "[    O0   +\   #!    Q    ,<   #+
MS0P  ,X:  #/+P  ST@  -!B  #0@   T)T  -"X
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M[.WN[_#Q\O/T]?;W^/GZ^_S]_O]M9G0Q      ,!(0   0
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M________SW0U"P    I2I_______________________________EC0
M  !/I______________________________V:1T   D,!@E2L?__________
M___________________+.PX3-4Q;34Q>P___________________________
M__^I8#9@AI^VK*FXV?_____________________________@EXV^Y?______
M________________________________[?G_________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________________^O9RKS'________
M___________________________/FH%M6D:(ZO______________________
M_________\1\/B80  !4L/______________________________X(,\
M   NA^W_____________________________K%,0       7;=;_________
M___________________[@#$        )8<S_________________________
M___26@(         7<S___________________________^H-0
M7-/___________________________]]#0          5-;_____________
M_____________^Y]10          1-3___________________________RJ
M9"\"   $(C=)6,[____________________________II&M!*#]C?Y6GNMK_
M_____________________________]6RK++,Y/K_____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________^6[EW=BR/_________________________________;GF<V
M"@ "C/_______________________________\A_/P4     7L__________
M____________________V8$Y        /*K_________________________
M____GDP         (Y#____________________________<;QH
M$'WY__________________________^O2            &_N____________
M______________^$$P           &3F_________________________^Q1
M             %?>_________________________[@5             $C6
M_________________________W04             #C/________________
M________^:):$P           "/%_________________________]^;7"P
M          VZ___________________________OL7U5.2(1!P$"$2*R____
M___________________________?OZ69F)J@K+W:____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________COIV ?/O_________
M_______________________RMX17, X ':S_________________________
M_____]**3!4      '+S____________________________UG\V
M $O)___________________________ZD3X          "^K____________
M_______________ 6@           !J5__________________________^-
M)             B$_________________________^=>              !W
M_________________________[0E              !J________________
M_________WT               !;]/_______________________2L
M          !,Z_______________________I0                 \X?__
M____________________, P                MV?__________________
M__^9BF$G               GU_______________________[;Z)52<
M       EW/_________________________^RIUV74H\,BTL,#E'WO______
M_________________________>;=UM+0T]GD________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________^_4N];_________________________________Y[B/:DLO
M%6_______________________________^2A9S0'     #S)____________
M________________UH([         !*7___________________________M
MA3$           !O__________________________^F0@            !0
MX?_______________________^QI               WR?______________
M_________[,O               BMO_______________________WD
M           0I_______________________\C0                 F?__
M____________________J0                  C/__________________
M____1@                  ?______________________?
M        =/____________________^7                    :O______
M_______________.                    8_______________________
M*2(!                8?______________________N:. 5S<7
M    :/__________________________^M.NE(9\=7%P<G>!E/__________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________;NIV":6G3____________________________
M___(DV4]&0   !V>____________________________VXY,$P        !N
M___________________________;?"P           !%U_______________
M__________^+*@             BM/_______________________\)$
M           #E________________________WT!                ?___
M____________________YS8                 :O__________________
M____G0                  6/______________________1@
M        1_C____________________I                    ->G_____
M______________^6                    )=O___________________^\
M                    &,[____________________K
M    #\+_____________________                    "KG_________
M____________)P                  "K7_____________________<
M                #;G_____________________X)R,<%5",R8;% \-#A(:
M)K_____________________________YY-C2SLS+S,_6X/S_____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________________KT[SC
M________________________________TJF%94@L$@&%________________
M____________\:MQ/ \       !/X/_________________________5?S4
M           ?LO_______________________^-U'0              B?__
M_____________________Y C                9___________________
M____U4,                 2/;_____________________B@
M        +MW_____________________.                   %\C_____
M______________^^                    !+;___________________^<
M                     *7___________________^Z
M     )/____________________<                     (+_________
M____________                     '3_____________________$P
M                 &C_____________________0@
M &#_____________________>@                   %W_____________
M________T0                   &'______________________R0
M             &;______________________\FLF8E]=G%L:6=F9VMP>HS_
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___BQ:J1>6%W_____________________________]VF=U L#      QQ/__
M_______________________@DDX3            C___________________
M_____])P'0              8/______________________[F\/
M        -^+_____________________EAP                 %,#_____
M________________0                    */___________________^N
M                     (G___________________^>
M     '+___________________^\                     %__________
M___________:                     $W____________________Z
M                 #O_____________________#@
M "KY____________________,P                   !OI____________
M________7@                    _;____________________CP
M              ;0____________________T                     #*
M_____________________RL                   #(________________
M_____X                    #+______________________<6 04% P$
M      $&#1C+_______________________\Z^'8S\S-S]#2U-?<XNK_____
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________\=K&____________________
M___________QQJ.$:$TR&  5J___________________________N7Q&&
M        <?_______________________]=\+P              .^/_____
M________________WV0)                #+7_____________________
M= ,                  (W____________________%%0
M     &K___________________^9                     $O_________
M__________^V                     ##]___________________7
M                 !GG___________________V
M  73____________________#@                    #!____________
M________+P                    "O____________________4@
M              ">____________________>0                    ".
M____________________I0                    " ________________
M____V                     !T_____________________S8
M          !M_____________________WP                   !I____
M_________________]<-                  !H____________________
M__]P                  !A________________________4#Q&3E1976%D
M:&QP=GZ)____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________OU;NCBW-:E?______
M____________________^+^.9$$A!0      4OS_____________________
M__>=5A@             %\'_____________________Y6P6
M     (W_____________________8P                   %[_________
M__________^=                     #7\__________________^A
M                 !'9___________________*
M  "[___________________N                      "A____________
M________#                     "*____________________+0
M              !V____________________30                    !D
M____________________;P                    !2________________
M____E                     ! ____________________O
M           P____________________Z@X                    B____
M_________________T0                    5____________________
M_X$                    +]?___________________\@+
M       "[/____________________]>                    Y?______
M_______________)'                   VO______________________
MG0$             !PX7Q?_______________________]6YO,''SM7;X>;M
M]/O_________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________C?S______________________________LQJ6(;50[
M(0< ,M[________________________7DEDI             *#_________
M_____________XDV                 &?_____________________9@
M                 #+V__________________^5
M  /(__________________^G                      "@____________
M_______7                      !\____________________
M              !>____________________)0                    !#
M____________________2                      L________________
M____:@                     8____________________BP
M           %\___________________KP                      X?__
M________________U0                      S___________________
M_R0                     OO___________________U0
M        KO___________________XL                     G_______
M_____________\L.                    DO____________________]7
M                    AO____________________^J"@
M    >?______________________;0                  9O__________
M____________]U4                 1?________________________]J
M(RLU/TI58&IU?H>1G/__________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________Z,^VG8-I3KG_________________________
M[+*#7#H= @       'O______________________\5M*0
M $#_____________________@QL                   ?+____________
M______^2                      "8__________________^D
M              !J___________________=                      !!
M____________________#@                     =________________
M____.0                      Z/__________________8
M            SO__________________A0                      M___
M________________J                       H___________________
MRP                      D/__________________[Q8
M        ??___________________SX                     ;/______
M_____________VD                     6O___________________YD
M                    2?___________________](6
M    .?____________________]8                    *?__________
M__________^B                    &?_____________________U5@
M                !/______________________NR\
M /C______________________ZLI                 ,______________
M___________)1P     '$R N/E)HA.W_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________________T
MU<G____________________________ZTK"2=UU"* P  $K_____________
M___________%?447             !'8____________________Q%
M              "?__________________^B#                     !H
M__________________^4                       V________________
M___:                       '[/__________________%0
M            Q/__________________2                       HO__
M________________=0                      @___________________
MG0                      :?__________________PP
M        4O__________________YP\                     /O______
M_____________S,                     *____________________U@
M                    &/___________________X$
M    !?___________________ZP                      /__________
M_________]XB                     /+___________________]<
M                 -____________________^?
M ,S____________________H2@                   +?_____________
M________H!8                  )S______________________WH"
M             '?_______________________]Z"P              !4S_
M________________________HE=H=("-G*N\T.?_____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________[>/__________________________]*C>E@Z*2,<%@X&  "?
M_____________________ZQ2#@                !I________________
M___D0P                     T__________________]Y
M            X__________________-                        LO__
M________________$P                      A?__________________
M3P                      7?__________________@P
M        .O__________________L@                      '/______
M____________VP,                      O___________________RH
M                     /O__________________T\
M     .?__________________W0                      -3_________
M_________YL                      ,#__________________\0'
M                 *W___________________ S
M )K___________________]G                     (;_____________
M______^C                     '+____________________C1
M             %S_____________________D08                  $'_
M____________________ZU\                  !W_________________
M_____\I+                  #________________________+5P  #!@D
M,3].8'2+I\?__________________________]?G\O__________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________________________^O4S<?"
MOKJWL["MJ:BE____________________W7Y3/S C&1$) @          V___
M______________]V                        I_________________^Z
M                        =?__________________!P
M        1O__________________3@                      &O______
M____________C                        /W_________________P0
M                     -O_________________\1D
M     +[__________________T0                      *3_________
M_________VL                      (W__________________Y$
M                 'G__________________[<
M &;__________________]XA                     %/_____________
M______]*                     #____________________]W
M             "O___________________^L"@                   !;_
M___________________G10                    #_________________
M____B@                    #_____________________UDT
M          #]_____________________Z<N                  #5____
M__________________^8*@          !A@M16#@____________________
M____J&-T@8^<J[O-XOK_________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________________^?+MZF=E8Z)A(!\
M>'1P;&AED/________________^\:D@M&0H                 ,?______
M____________                         ___________________0@
M                     -S_________________C@
M     ++_________________S@                       (W_________
M_________RD                      &O__________________UH
M                 $[__________________X8
M #3__________________ZX                      ![_____________
M_____]07                      K___________________H]
M              #___________________]E                      #_
M__________________^.                      #_________________
M__^\&0                    #O___________________Q3@
M          #8____________________BP                    "_____
M________________S$,                   "A____________________
M_Y$9                  !Z______________________)T"@
M     !%?_______________________H=!,?+#A%4V)RA9NTTO7_________
M_________________]?H]/______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________^_?S\>[LZ^OL\?__________________V;*9AWEM9%U644M&03PX
M,BTH(\3_________________2R4+                     )+_________
M________B                        &;_________________UP
M                 #W__________________S,
M !C__________________VP                       #_____________
M_____YT                       #__________________\D,
M              #V__________________$U                      #?
M__________________];                      #+________________
M__^"                      "W__________________^I!@
M          "C___________________3+P                    "-____
M________________7@                    !W____________________
MDP<                   !>____________________S4,
M      ! _____________________X<0                   <________
M_____________]A>                    ______________________^_
M3@      #APL/E)JAJ7(________________________PGR,FJ>VQ=;H_?__
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________________[N'7
MS\G#OKJVL:VIIZ:FIZ[_________________OH9M6TQ -R\H(AP6$ L$
M !3_________________UP4                       #_____________
M_____S0                       #V_________________W8
M              #2_________________[                        "R
M_________________^$D                      "6________________
M__]1                      !\__________________]Y
M          !F__________________^@                      !1____
M_______________'(P                     \___________________N
M2P                     G____________________=
M       0____________________HQ8                     ________
M____________V$P                     _____________________X@/
M                    _____________________\M3
M    ______________________^E.           "1TT3FN,____________
M____________F3E#45]N?8Z@M<OE_____________________________^OY
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________^O,N:RAF9&+
MAH%\>'1P:VAF9FCQ_________________V%%,B,8#@8               ">
M_________________WX                       !U________________
M_\,                       !2__________________LW
M           R__________________]J                       6____
M______________^6                        __________________^_
M&P                      ___________________F0@
M        ____________________:0                      ________
M____________D (                     ____________________N2P
M                    ]/__________________Z%P
M    V?___________________Y$8                    O/__________
M_________\I3                    G?____________________^8+@
M           0*49FQ/_____________________N?QT,&B@W1E=I?I6OS.[_
M________________________YZ"JN<C8Z?S_________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______]]?#KYN+?V]C4TM'0TM?@_________________\Z>BGQQ:6%;5E%,
M2$,^.C8R+RXQ_________________](E$0,                     ____
M______________]"                        __________________]]
M                        __________________^P"P
M        ]O_________________=.0                      W/______
M____________8@                      Q?__________________B0
M                    K___________________KR(
M    F?__________________UD@                     @O__________
M_________W(                     :?___________________Z$H
M                3O___________________]-<
M,_____________________^6+@              %3)2=_______________
M_______@<A,   $/'R]"6'"+J,CL________________________RF]N?HZ>
ML,/8[_______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________________Y
MX-+(P+JUL*RHI:*?G9N;G*"G__________________^"9%9+0SPV,"LG(AT8
M$PX)!   U/________________^2                        K?______
M___________,'@                      B__________________[4@
M                    ;?__________________@
M    4?__________________J1L                     .O__________
M________T$(                     (___________________]6@
M                #/___________________X\4
M /___________________[@^                     /______________
M_____^5M P                   /____________________^?-P
M        $"]0=/_____________________=<A0     !A<J05IUE+;:____
M____________________O%A$5&1UAIJOR./_________________________
M_____]+-X?'_________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________S[^OO]_______________________NN:B=
MEH^*AH)_>WAV=')S=7A_D/_________________K3SHP*"$;%1 +!P(
M    (___________________:0                       /__________
M________FPH                      /__________________R#D
M                 /__________________\&,
M /___________________XH.                     /______________
M_____[ T                     /___________________]5;
M             /____________________^%&@                   ^S_
M__________________^Q20              &#E=@?__________________
M___E>QX       PA.%)OC[/9________________________NU@I.4E:;("7
ML,WM_____________________________[.>M,77Z___________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________KOY^'<V=;4TM#0T-'3V>#K]___________________N(I^=W%L
M:&1A7EM96%=765YE<?__________________OS$?%A *!0
M /__________________[58                      .C_____________
M_____X($                     ,S__________________ZLO
M             +/__________________])7                     )O_
M__________________=\$                    (7_________________
M__^B-P                 %*Y3____________________+80(
M   ,+%!VGM'____________________UC3        TC.U=VF;[E________
M________________PV,8*CM,7W2-I\;G____________________________
M_ZA_EJB[T.?____________________________________]____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____]W.Q;^\N;:TL[&RLK6YP,G5X____________________Y=L9%Y955%/
M3$I(1T9(2U!99J'__________________Z<F#@<"                 %;_
M_________________\Y0                     #K_________________
M__1Y"P                   "'___________________^?,@
M          [____________________$6                 @Q6H3_____
M_______________I?Q\           8G2W&:PNG_____________________
MITD      A<O2FB*KM7\________________________TW4>)CA*7G6/J\OO
M_____________________________ZYRA9BLPMOV____________________
M_______________?[___________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__^_LJJFHZ&@GY^AHZ:LM,#-W>S___________________^*6E-/2TA&1$-"
M04)#1TY9:7W___________________^>+@8                   #_____
M_______________#5@                  %4'____________________G
M>QH             "31@B[3_____________________GS\         !"5*
M<9G"Z_______________________QF8/    $RI$8H.GS?7_____________
M____________ZXXU*SY1:(&=O-[______________________________[YV
M?Y2IP=SY___________________________________2V//_____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________;R\._O[_'S^/W____________________________X
ML)^:EY:6EIB;GZ2LML+1X>[____________________^CE!*1T5$1$1%1D=+
M45IH@ZG_____________________ID$!           '-F./NN'_________
M____________QF4*       $)TQSG,3L________________________Y8@O
M   3*D1B@J;,]/___________________________ZM0-DIA>Y:TUOK_____
M_________________________]*'?)BQR^G_________________________
M___________4SNW_____________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________^WEX^/DYNCM\?G______________________________;&4
MDI*5F9VCJ;*\T.W__________________________YU31TE-459@<XJOUOS_
M_________________________[)6 !HU4&V+KM+W____________________
M_________\UO/E][F;?7^?_______________________________^Z?@Z;"
MX?_____________________________________CSNO_________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________\
M
M
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MIUU4P#)VFUVD.(G=([-D9"5D[ 1JZ^#UTZ]6@"F1Y;BK!9,CUC@D[@3R!G(
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M9:XZ9ZBJXQJL;IZC0Y"[2DG/V^V.RSYKYL@PJF91N 4G&0N1Q]B".<\^MQP
M, CWUM-MGJC^53U5LRHT%-1C-@J]FT6Z9*43HTVY*4[84-L%5PE-N6Y&P(K9
MMEKFGB]/R;%1UP-KVVO35GL(JB;ZK"09I"*ZJ=T@*@^U<D(<$'.XCOC''!R!
MD<DFI70.K/Y0.-W3T*:!V8C4]CO'5GJ>G;HV4N#UC*T23Z>(6D24G=M\UJW4
MF8V-8K&)[VIEAUYJ&AV.98#;3LT:RRQ4>TI]BLQRBN^8U8 LZ[CC]C@>MYXP
M,@#GDYQD"OW0XK-3BE.*4XI3BE.*4XI7X,;%U]U':"VS\H=MOI\!ZB+A;*A'
M=*F>EZ V=LSJHW5IHN:V]/&QO4 5"ZME]HD5FX@5X8]N6D (IA>-;L C_-]5
M8"1EE;]?=^O>L!#*9&7<3M78"S%=QW X!;'LR./NU6G47UA?*UZ=O>RJ-3]<
M(V?*4)N[PE>55>BS<$C4]BPE6Z(;%M*H;OC-J0VQ+#2AB=E=4D:3K=6BPO>5
MEK(D;%5]V>?D)1B5GU"THR.#C ^Q.3P/6^R(P6./=[L9-BC]6GRHU<VUK2CV
M;5,=<*LUU1W/4=NLE4Z6]OQS^P]>)EM,DUJ\1Y;MQEZ'K"H1=>ONP6I.ZVJ^
MLA._,3,S"#WB2B)NDRBF^0'E21GR4\_8GW@ 989)SQYGBN.J^ISY47:<?I.!
M>@ Z!=-B;SI-3W1+7/H@V[6:IT[Q)FE][7G:%*CWK!M\9O;L14+G1=:U"M;Q
MBSH.A2DQ=0&&Y"SNS+43$J!I2%' )(W'8?5X.1]ECOCG^,50>E^L[Y0*N[7H
M/3K7]?GLFQQ>K++8-:670^]]B660KF[.N'JJH5]L-TW;;-G'.Z3KU2T1K^.V
MU39'8K$O#V1Z)9K=1R-"F1==4J T@PH4#![8)."S#N6./5&[D<]AP>,7GJT^
M5NT]T[0L9\V;_L/:]?8ZQ5S5@LG1'N78$W;MM43:<0QIK3.1*E;(H* HMEU9
M/36QJQOA"IVA2[<;%ZWC2Y&;JLLS8E0&F"]]Q]<YV8)(;U5QG RO(.3W\\$U
M<=^ZUOE5H,'J.CZ]HP8\FE;UIU;K=W9Z7=\G5JDZ>G+1MP&1GHR&#?,O>]K(
M%"5K5"9C&JZ+=*S7\W>1MS=FG(MY-:J*K;Y.1@\L!G:<*"?_ &O+L..>3Y;!
ME]06_=?]1/1+M?J&I.\H^K7'H1VD)NRI:$T_U%[6UE!]2$_>NG.8@69FB4FG
M6B;KLH+" [';K9E[AAIJNQ;LY!$2>'R3$F*N"WJ[@?L3G (&<KC(/;L<#OSC
M%:&O;;^4;U;U.3%LUOK?<Y<=*E[9J59UC9=/=1NT=8;,+,^4HW*'%#%W*;O;
MM=T(?/=/Q(E]'VM8'%4N(J8E>"KT/$U J!KI;Z<_K^0\?1]-8QX@8X!P>W!(
M/UP@G.3C*$'GO@8( .;@V?U;_*XT7158V*W0HXVT7J-ZO+)$5VJ=%FXMB3U9
ML^IY1FN=..BK=5:YLOW[#8W9' VK896\)F-B:K%^Q05:9@G&3A3; _7]?]!J
M2TH /'._C:3VR$7N#ZXY)]V!W&<]M+K<^4?TOJJQ[JLU7UI+FV3JOMO3/IGI
MXDM4V"@W^; GX:^TO1]_8G;!L')E\&L&]YW3"+"Q6JI'A!:K&M4T.0440[(1
M#_/^OZ]Z%Y%]8C(+!0H&#R< YSR"2N> 1CSS7[ZUYB;%@(,:RGARMC'AXQB?
ME(\-4<!)3;(3#<J>#'J>(4"&8>E\@8-1#ZA67$,9>=RC*U*S_&LQQ2G%*<4K
M\X^NW8%]U9M+H-V!!@;QE-75SJ+O3N^ -)4;:NRWR*-(=,V[HBN8NM%U)!V6
M>L-9;V;(4AT9HZ"D(T"Q(AI5:!WP&2QU58D%3S@$YQG]J<?1GV^>*_*?J+W/
MUPU_J=OFY="T_J"KE#'N6UYV@K+Z<NJG<5<OX<]T/](,MK2*MFDOG;7?FRY-
M;<5:M;LR(D/5(/7L\Q<3K#71[;'7&PM/U_7C]>?HPL9 Y(!"^M@X)!]1",C/
M'K9';R/&>1L=,]3ORJ 59L%^GZ%"4.!)ZJ:OIPFL5_I0VINVZ:DU6/IUV\S^
MTVH*H;*BYO=<+9MP25<TJ'*U.(CX6J1:9BY%2<KZ9*H%4[I>> !N"@;22!M#
M%CSSZV5'& .3S57U7KQ^4EIN@MI]5_4I7:-K&A:(J'2G9[#IZS:'M.O;QM1%
MVK&J;EU+#4JWW'8H0;%CI4,5L^#I%)!K,Q)OWIL&"EI1QZ+]A.4WR!69@ %4
M';M.6.%)VG<.WK#;COCGV?N3TVRNWY_0FI+#OX2$C=S6.C05DV+#5P!^-AJ[
M9+ (F9+JP0I11I&<59!K5=?*>)<</)C'CU):R3Z2%95R5!/<C)^G[GXJNWBK
M4XI3BE.*4XI3BE8&TUR.N%:GZG+NS#$598>2@I)^O6*P5&>9!E1'0BG(6U52
M3A;/6Y1##RU 3E>EXN:BR<-FQD@(8RR^VH1D$>WC@D'[HY'Q'-?SLL2_79TB
M=(D-;-!T_<UUVSL;J[ZEZ9LNP]11'5UU72=!TQKW:_4B-TYE5_4CUEO5YBX*
MYP4=K&K9NU.K^ 9BO2L+9+B28L^.N\%)[G';R^%:X+JG9LDODMN?;C)7@L3@
M^X'CCR%>CJDWS\I=L6@=6.L<4*\T&T"ZY'30:;IOIVW44^R.U6M,V"/V94.K
M"*NT9!S\Q-[ FMB4XC4D#4TWJ-@(3*I<.&3&RLZ?%3ND(;@@^0"G@8!!SGOG
M(QV.#SQFK.QU/?*L1FQAZX7KV!GZQK;8<17KC-B=+^R(MC=U9.Z^@.GDJ9J1
MN-BR(NO&Q.G&PXW<^<RN^AMQU5=LR_3JIAS[,^S]?U_STW2Y88X4KCCELN03
M\ N#QWP<'O5+O=17RI.XS=9B6S2E[C%5+J=Z7+;;8RFZBVMHMFE6%.T=H1^Q
MNGV3M<U9[ !OK3(5&AZ'8+)O*!'$UJI,ZMN6<*:D XZ%BI#.<^J?V)[8P=QW
M+[\+CGM@Y'!!KW+^4.^41J>JHBT[:KM=UK&36XM TRR;4NG2;LJCR=!E+OJ?
M=-QW3JRF:$N&X8>T;Q8UEL>AZPHX&VJE96X28JFPK7:P0I<.ARD^$J-\@ XX
M)4$[>1D$L  <'!P,^7).<9JFZ%UQ_*C3NC2.H36>E!2I_>4]TX6*9OANHNI'
M:5&9AIWHPA;4LFA:DI<]>3A:W8MQ# T26L>LX1%:K[KCRKH[[_EW+S&/U_7&
M.?U[<54-(1N QNVDG!/[ ]@3VR ./:><G-?K/TJ]076G>>K_ '1J;J"UF-7-
M5P&NHNTTZ=K.G]DP-1AK'Z>NVEUAW<=X+B8.]3$RY9+>8+'4N"M N :J21,S
M=%DX]56G%959BS C@ 8]4CR'&3W/?.,^7-?J+Q62G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*P4=5ZS#R]@L$178**GK:^ 5:IN.B(
M\&7LQ45'LQ,638)(8=HV9?C8H<>, >D7B7 X]AD,=38S2&TJ5G>*4XI3BE.*
M4XI3BE.*4XI3BE.*4XI3BE.*5@FZO66;(7<6:[!-6X^($KYUJ;B(]NR&0,>6
M4>!"%SB1\29$0$<::8)&O%+"&++*(990\0ZM:E9WBE.*4XI3BE.*4XI3BE.*
M4XI3BE.*5B&*_ C3DA9QH2('LLM'1L/*V%B-":G).)AGY$J'BY"6;92>;'1)
M,Q+$1H))#@P+\I(O"M-.&DJ=4K+\4IQ2G%*<4IQ2L%*5>LS<E S,U78*7F*J
M62?5Y64B(^0DJV>:(L PV!.+'>*ARRP77 B28]T=Y\1Q8SJULK4C*F![*SO%
M*<4IQ2G%*<4IQ2G%*P5@JU8M@X(EIKD#91(R6CY^-&L$1'S(\?.Q+WM$5- L
MR(Y+8DM&/YR]'R(Z6S GL^H,\TO[;BE9WBE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI47N5'I6Q8 NJ;!J%7O56/<&=.K5RK\39X UT,ALL-PN&FQ#HXEP4IIHD
M9;PRU,$--O-90XA*L*8![C-2$448(8<((=@0,1AH4005IL<848=M+3 X[#24
M-,L,M(0VTTVA+;;:4H0E*4XQA2N_BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI3BE.*4XI6GMOD^J 6]U:8=CV,:T@-X3!+T3KP8 FU6[30^EMMK6#?
MX69S/,ME-[."H!%/DZ3;X*3L#TE&AV6LUMH21#D55];D^0/ '<CSS^3!^/L&
MNUNN_6W"7'=QNDX>W60(2S61%>K^^=<)EX,INK4'>EP$*UN749S50X54O%TC
M]/:<JS15IMLF+$BKOMB":G;6>\XJOK88C)/) 8=\=@.0%SCCCWD#(%7188+J
M'N*NG&7L%BMM,DH+?VTJ]NAO6K[%1J-@T[6(G>K=$NDQ S$E<#XZ/M\Q4=,S
M/LHED-/#8MQD0X0D PW ZI()QRPYP<<< GG!SW^/P]E:\T7JJZU+I:M4A!:R
MH)T3=FI&2(8AJ;83HV5KE+V/JS5=NMC.P'MG"1-2J5LPO<^Y-53[]>MOO_7&
M-6Q3T<Y99-YJP*!F/EQC\H\\^8R0"/9S6:3=?E#+MJ+4LW9:&!KW9^=^A!7N
M$UH/X1SFHD4MM^2(E1;J;*G"X"O)$I +? *=;E!H2.FH4D^&E!I(U4 N0,C!
MSY<#&!WSSG)/&,<=B.]H5.P]6#/5MOJ'GX"X/Z,GZLI_5$BH:JNUZDR]5K<*
M ('%$+&"5-2NR9DR7M0#DK,>[H+,;,UJYNQ;WS*S(JGUMQ[[2..W!'''Q/."
M?+GOQIL+&_*F2M1NP-8LUTC28_4E]K8-DV$-1X^=LD_(A5^98V+KNLC5.6+J
M^SX>:CYVCTNCWJ<M=+8(FIRW_.NS4P:@13:J'Q,'&<A>.>^03QD<'/JX/([Y
MQBK(V(;\HS/V3:055J=K#KEQV/#RVJ6F[S3Z6/7*AKI5NI<] 25ICZO:+#48
MO;K(&N]F1KTK V.2%D92W1SJHN)PR$&J?7/MYY'EC (QQY-P>?,_0-Q]#T[;
M4;L.9LNP;WM&RPTCI+2[PP5NS$0M=5LN75<E[5*%I<8T]BLRH_N>F.+@VY0Z
M+KWO<T&+(*000]A5E#;B221M7&< $\[C@=CV&/+GOFMN>*O3BE.*4XI3BE:8
M;[*ZFB(S;8%6'-AZ@E=,:UA:-7BAG;69D<BADVA=BKDD?+BSFO\ ,DM(A$K5
MWJKL@=E,K'1M2) '#NT@JC;N>#CC!!Y_+QGX'Z*KG5]ZZ_?G+KT78](H_P S
MW_FP%=V%4UY-S#2L]JMV PBZ0FTUT\B08P_F\OFPVO!X9X( F"C8MI)S$H$H
MI?SQP<?8G)&<9SG'O/JX]E5;8=L_*41]SNLK4M-U6;#=F]?UF/KUG@9J)J<#
M'!V+J4<FLUN1B+].R%SDIV/'T0-+[2>#JE4#"GQG3Z?!^Z[ Y6U5S)DD '@<
M'(&<GM@DG(QSC@^X8J2_9;^4<DK58XR/U;KZ#B(T>',%-G-73T@(W)D;!L\%
M.T^-E NH #YY#1%(:J=K#V&/'UD&8R5(BIJ0)2U@PRIS(3@  8[X[=NWK<^?
MX/?6&@]H_*5C&7J05IJC2:PI8<B,KTK#S$>+=2<T305<:8JLV1MHH76]?5;Y
M3:UN-9D8ZV):&@28U1'MCA%CDE 7QDCGS]N>!QSC'<^8^'GTD;V^4G:?E$0F
MBJ=9@/8[@FNR,QK6?U^2>J/JX\E!3\U"O;QM;L("U,K<CG:V@X^U68IV.CX2
M.'8*LLS0%"S^2\\]P1SGOQGC'EG.:V&Z<-D=7]LOC\/U!:OJ=.J7V+X>=%F*
MM"S(K:[NZNNMEA/2<U<9%UL>3P;8B0JZJNHGH+W*2):78A#5=D;\JRECW&/U
M^/Y,\<XXSNWQ5J<4IQ2G%*_.C<)'6R5-4@Z(#'!CH;;-F,BH#74:0\WL*E#3
ME*;IE=V_).; %QJ]\N)S>WR[9$%;(IY4<(!)3]8@;$;&4%U6,[S[N>,=SVQG
MR'GYD'W'%>"N7CY0"<J>PT7>GTV'D)#2U]*I2*31I&NV6#VB[J>AV2GC>]I[
M:]XAY18=\L-SI'LSE=!8.D:H++.%!B9=!,5&Z0KR,$JV< \-C@ Y/GQGVBO!
M4*'U<LQ&NI.U7#:"[=5MH;7;G:F):HB8JDA2H:CV^>U6%.6-Z(IQ.PH>SW(2
MGK*F7F*;,"C6,K7DNX*FN%S;[]?U_44(?*G+<$Y&0<C!(R1CNP&?CM[<UN;T
M]67:EOT_4;#NNN!5/9I_O]%E@XV*-A(\? -HFH^%+"BY.8G)0066KPD3+L(E
M3!Y5;9R79*&KISC]?C%9!D@9X/GY?E/X\^W':KHXJ:<4IQ2G%*<4IQ2G%*<4
MIQ2G%*<4JLMBE;9'+HB-6QM0D6"+B"UL'YXO'!#"T++#_ODF"DXPMPT*U,*R
MP_ MN5FSQ<H4SF(ET5\,Y5GB50<\8'GSGMC\?PP#SWXK1;1LEUY1\]O6L7@(
MR8$33M@G:0N^PP*\ZW.;"C2EQU,CK,Y3BJY%52N."+BIA;4=3#&K>L^?RDVB
M9IX<=>E5&_G(\C@\9S[/9C_1QBHW;YCK.CJ166M'074/;)>(OD7L2YXWD_I6
MNSMAKU!J*#[;J2 /AX]@8>/V7?S8&(:?=CFT*#"V"N@3@5215BV51ZPX&2,Y
MY(SQR5R?:>!V]W'-9%NM=6MOFMP1<K9M\PL4C>^HI6DV&/-I='R/KF=WX9#[
M#J45 @ S^2XFLZ$.$E7;</;9 67'%@I%=7I>TXZ]1LE/\7Z^W\&/QFH(8@X+
M [E(\L+G!&#QPN2>>3@\'BMO= 6G>-@-V[&[FJ85>#JNRYF"UA)@Q1,;\Y==
MC..-P4E)D&VFPNS4\X(T.;+3,>'$0!+DBRS'-J.&F(Z(BL@).<C'L_7)]U;&
M<5-.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE4D?6-DNGF
M.-3;ZF'"7ELJ9F"!6\M+6I3>$C)RA+&$HRE.6DI\4YQE*5*QC"\ZI2XW$[\K
MDX]8CC/D/+CRSCX]Z\Y+9ZP979+EBI=B,7#H"N>,*,;>.,#MV!/<]"*OLE/;
M"I8K/W\^_P G./S?=._?X_3]_'?EMDO[8CN>^?;@<D\=N_QK-';:H -\I)__
M -AS_%^ \U9M4!FX^.6S.EY+)42M;65/K)6TQE#:<-K?7CR7G*TK7A/=6$)5
MC&%?'*4YD# 88[CGO[O9[^<UU;9)DCQ,^YLY&26(&!P6/?G)\\>WR$>F8:XD
M2A3X,DO 3BTJ';;/=%PTWXIQZ:F4X2GR3G&>ZL95ZG?"U*[J4E,\Y[<>W/Z_
MK^#%)'<F1BKG83P ^W ]F/:/CSWSY5TLPMR3C[H<YG..W_)-Y7?'UXSW5_']
M/QSC&<?#. R.^/PG[N?Q_P 6:E8[CS8X_P#.$_#_ $=OCYR^#$EADO>\R,N^
M6$8;1EY3^4JQY>2O)6/M<9QG&.V,Y[YQG/;'UV)! XP1W]_L^GVUGC5UW;SG
M/;G)^.?P>=:3[DU+U1V/84[,4F^G#54Q8RH4&/N\K6FH\9 K+2Q'8P10[&'T
M$(><<)0I_)6'$O+>2XM3#/TO0==Z-M-*MK?4-*BDO8PXN)9=/@NVE<N2'$K[
MFV%"H"';L(*@8&YOSUUOT;]5O4^IM0OM!ZCN(M&G,)L;>UUZ[TM;:%841H7M
M(C'&)1*KLTRF0RAA(SAF,<<ZZ<]=;^IM@G3=K7$F9@28C H,4=:#[0_F6R8,
MZV>RX;ZJ0&F!&RF'4MOI42LIKS95AA+B>7U5JO36H6UO'HNGI;7*3[Y)HK.*
MS7P/#=3$PC(,I:1D=2RG8$(#>L0?0_4QZ9^J-H>HW\_6&MRWVGRV8A@L[C5K
MG5I?3/&B=+F-Y]XMTCA6:-PL@,IF7=&1$K#;)Q!.7<J0K&6\]NV//*>WP[9[
MXQCXY[]\]_C\,X^]VYX@'!SC/N-?9F#$G!XQQSCZ/C^N:]*,*PG&%9[Y_I]?
MU\'!)QP*L 0.3G^*N7(J:<4K\W]@SORAU?/NY%&J(%YCI8V^LTH%A6HXY^JJ
M<L>_(C7))#L[;:Y[QK(]:B]!VBR9,>E;0HZQ38@@3^&I2&@58R7R..,G/([;
MCCOCRQGGZ,U#K0]\HZ["_.6O5R4<O437+I$25?>F=,15?-G9N_\ 3TZ2;JP1
M%PEH":K\;38K;J]/S6[(^/NT8E4J/? &B)R-CI%4C?C)[YY' R.,XP3]&3GO
MG'>L=9[+\J4Q@YV&H84A)BU9@PZ/@\:(CJC,6EN9UEF)A]=2]HV.?:888V#>
MV#]DB0V+$2H\2<.6+KM$VUFM2SJH)?R'8>[D^XY\_AYBIE6[!\I%B]"?.VC0
M:J;^Z-%C#AX*0U0D?.D29F3#-LHTT;8USB:=%U/,1+AP;E75N"5N39PQ!T=7
M2&@!56&[S'GSV[>T<CM\">1[Z_3#BK4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE4)(;)NXTD<*BN#LM#E/M-(>C91]W#3;BDMY6\T4VR\I:<87ZC2$-
M+QGNC[7*<YTFN)@Q C& 2.0Q/'P//EY#Z:\U+JVH)+(@M54*S* T4S$ 'C+!
MPK9'<KA3G(\L\4;*NJO^08>?R1<MC]9F>WY_\/ GF.,Q@?\ J/V^&>]4&L:C
MQ_.T9]N()\X^B7'XL<>^K"D[)/"5B-EV(7*I$M3&"Q%M$NI$0XES.75,-*21
MA+BD-X0E:\99]9*7597CLK9+L$#;>2.1@G'!/;N!Q^'Z:[+W-PMK#,(#XK[=
MZ$,0F0>2 =PR<8!.1N /-=D]89N-AXHX2(\RC4-*-9=:??P"M;"7,LK;86VY
MYY<RI"5K5A*,MY2M/FK&,6)( ('?DY\OCC\=9)9Y4BB=8B6< NI!.PE<X(!!
MSDXY(Q@@C)J*MWJTJ_A0X^,?BCY+'^'&2L]OAW[9^C[_ -_$!B1VQP>?+C]>
MWZC +N?SC'."/4;CW=_U[9\ZFU9FI27]J]X@)%PSAK+;B&2&$K4OR\F_$A;F
M5*3C&%9RE7;&,XPI..^,YO6U!*\F[<N,8P0"._ES6ENYNI3>5%V)/U>LZWCR
M(&,6*B-D9&MVF8>E6'1&'U'MFQ4H  IAUYQUMMEEI:Q\M*9?=R0AU*/HNA]+
MZ!J&FVUW=ZI*MQ*',L45U:0K"P=E$92:&20,%"EF9@&R&50A4G\_];_50Z]Z
M?ZEU#2M*Z7MI=/M6A6UN;K3-6O'NT>&.1KA+BTN[>W:-W9U5$C9H]A21_%5P
M)YTX;QVQM2PST7?*()!1,=$).&FP(2?A64R&3!V$1CR9H\]!;I0[I!361EM+
M82$YEQ#B7DJ;YW4^@Z/I-O;RZ=J#W$TDWAO!)/;SMX>QV,J^!'&4",JHV\$,
M9!@@J0?0?4RZ]ZPZMU'4+3J'IZ'3[.VLQ/#?VUCJ%E&+CQHXUM)/3KFY65YH
MWDE3PF1HQ V]6#J5VSR2_@[V?T,^CE.,X=[*_P"4\LJ\N_CVPKNCQ[8SWQW[
M_5GQF!C.>?9]/Q^GM7V4,2Q7' [GZ,@Y[<U[N15Z<4IQ2M/K?KGJ'=O-9N3-
MX1;J_5=WS-[@=?A2CU+>$U^O2^VJNBEV.?B4PT'?P)B^SM%EH:+M=0.(HKXY
M$@[:+>1&@2(BJD'OG.#D#MCOD'VY!P.,@^9Y-:V732'RAF-F[GM5(W7!0T;?
MRH<ZK&0,D*0Y7(ZH4OJA:IM/CZ=LZKWBFUX!VT6'IZ:V%)0L;B1N!,=8YYLV
M/0M\ =4$/AL$9(./_:V@]P1R,G@]_=B^I_0NS+U1]4P>R+))7:S4+?LM-R=H
M*L355EK!IQ-WLS\0//-ZWCZ379*6(I'S0$DHT:O@"OE NY<:R4HLDE4D$@#.
M>><\9&>W''LQ_'6OT:S\H38+)2WHRX3XE>(LFUVXLB5KM'J(+M!HUWTM7]76
M3=<-9]7F6;,]L2NN;>M-DIM'>U]-G!&Q0]?,J;D0^4*JOKY&,XYYP!^UP3D9
MS]EV '?C@5+ZSK+Y0%O1%A+V#M"F7CJ7J.WF+QJ1X04.AZ_*KZX 2I6*H6=F
MLH?;G:66'/; EJDBQ@/3HY2JC*38H<O#AAQ*IP^#EANR,<<8\\^WN?N5)=G:
MKZQ:L;2([IVVD4]1Z'K[6M/77KE(4TXJYOURJ[N^>E@G;#9:78+:Y=I^>"T!
M' S"K*Q#K;-N)\G&..>TFY5."  #V&/+V'GGG.<>?\=0\'7/7Y9&Y)%ZN46T
M4Y:M:6:K@A62EXH=?B:UN+5]Q,B; #"ZUA=A62W!QD!?QY*1!O,12)ZC2%=K
MJJV39GY20"5&'/GCMYCVJ3V&>P(]G.,$5$*OKOY4T2OU$6W;L@YZQM%"YD)>
M( U)4 &6/G-ZEF1>XA_6=[78D$0OH)UR50)6HKC@6SG;O$R$B\-$X54"7S8?
M0 /QY_&//GM70%KKY59P%SWAO6LBH1IHR)''%IVK3)Y[8+=P-?&L99K@0<,U
M="JO[O0U7QT.Z]&$4_7W[HN>&^R1)JMB3VC&/8,YY]^/9QQ_UJ_4*AMVQFCT
MUF^N".WEJJUYJYNQY;)X+MK;B1$6%T,X>%K@Y@KDM@M8Y3%>@F7VE(=:AXUM
M20V57'89[^=2OBE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI50F;IJ@AA(?LDR1[,\ZQDA@8
M/T'<M+RC*VO6/:>\%*3GQRXTVK./CXX[\U#>1!BN'X)&<+CCS&6!Q[.,GV5P
MWZ@L4D>/9<.49DW*D>UBI()7=*K$<9&5!QW J5C7N#*K+]I;P7@ =S+#S"V4
M8,23ZC32&/!+JF5+7E]E25)?RUA#F,J<3E*\)S"9#&9.=HX(QR#D#&,XYR//
M'/-;J:E;/:/>KXGA(2K*5 D#;E4+C=M).Y2,-C!Y(P<=J[K#(KK%FS[5D$A?
MHM,X93[6HCU'&U,>&7,-86C++N5*R]Z64HSE*U=TXR\5/#$G.T\#CG.<8(\L
M8.><<4;4;=;1;P[_  F.U5VCQ"^XJ5QG:"-K$G=MP,@G(!CF-LU[/T!3'_<0
M_P#[=P)D(S@_@]WO[<]^WX*P)K-J_9)L^PK'^#ZY_G]U2EZW1+,$/8<^T*"*
M7AIEM+2<D*>RMU"FLHRYAM*D99=\E9=]/LWGQ6KNG"K[A@-S@^[FMWTJ(0K/
MZVQB !CUL\\8R!Q@\YQQQ7; VB.L62$A();6-AM3B"6VT9RAWRPE2<M.O)SC
M&4Y2K"LI5C/U9Q\>2&![9^GZ?XJO#.DV=H8;<9#  \]NQ/L^/NK7#8G6/J_6
M]OEZ9)Q5QE9.#=:'D"8:.B5@-E.,-/K&;=D9N-?=6PEY"'5I&]'U/)+;CF$^
M7/7:=T;JFI6<-[%+90Q3@M&L\LPD*!BH8B*"50&()4%MV,$@9Q7RCJ/ZM'2W
M36LWFB7-IK-W=6#)'<RV5M:-;K*T:R-$KW-];.S1JZAV$>S=D*S8)J5:=ZF*
M!NN:DZ_6@;+%RL9&9EU,6 $ =!0""1Q'W1GHZ4DV\J'?+%2XV^IA:L/I4SAU
M*'<MZFL],W^B0Q3W,EK+%+)X6ZWDD8HY5G4.LL43>LJL05##U3DC(SUNC/JG
M]/\ 6][<Z=ID&IVMW;6QO#'J$%O&);=98X9'B>VNKI<QR31!ED,9(D!3> ^V
M\BID45]8ZT/+6WA.5^"4Y2GR3Y8QW4M.<_#..^<8SC'?MWYYX#/F/P_Q>WCB
MOHC2!3@@_'C'W2?U\J]PI+1;6'FO+QSG*>RL=LXSCZ<9[9SCZ\9[XSG&<9X(
MP?UY^%2K!AD9'."#W!_#\?A7HY%6IQ2G%*<4K@ZZVPVX\\XAEEE"W7775I;;
M:;;3E;CCCB\X2A"$XRI:U9PE*<9SG.,8SGDJK.RHBEF8A55069F8X"J!DDDD
M   DDX%5=TC5G=E1$4L[NP5551EF9B0%4 $DD@ #)-85RS0+960LR8SA:),&
M'=''RLET>2D@O>( Q2!D.Y%R4#G!;3A/I,Y96A>7,8<1Y;2V%XT8E]'<1&":
MY5WQ&KP02^!-)&7*^)X<V8V6/<P8$;?5.--M3L%E,'I433+<P6;QQDRO'<W,
M/I,$4JQ!S"98,2HTNQ"A4[O67.#7L>H-!+DB) T0%J#E[&\4;!3X;3$/!2"8
MR3)?R5%M*9=9+6G#03F$GF#YR8$,0'C+^+#3[LN(UC1G:>*W54GMW+33QF2)
M5VRG<&0<N,QJWJ.ROZM;FY<9SQ@G)!' .#W'X.Y\JE DQ$GOGBA20!946:B-
MDAQRV'GP)%8 TJ@ QIM:G!C%1AHAZ1GDH>R&2P1A'I.(7G6:*5%C=XW194,L
M;,K*LD8D:(R(2 &3Q$>/<,C>K+G((JV1SSVX/N.,X/T$'X&LCS'2G%*<4IQ2
MG%*<4IQ2G%*<4KJ>?8'1ZA#S3#>7&FL./.(:1EU]U###?FO*4^H\\XVRTCOY
M..K0VC&5J3C,A68X4%C@G !)PH+,<#R506)[  D\"GZ_=[5 B-K:]86XTW9P
MI)UI-Y]1J":,L+J2-:.H'O,<I$&-(*Q,UPIQ(1L)G&)=9WF"*$^6VXRG>72[
M]@";9XP38X,Y2W!74@6L9 9VC'@W"@ND_P#20F'9U0@G&98Q^R!_IGV.6YB.
M)!ZH/K*>"OV6<@#((K(,7ZL$-L.I*D&FR?FKAA9<!8 L.+NN<)KK6,%Q;.</
M$K4ELUE6,.0KN<-S:8Y>?'E&L;E2P*1DKZ46"3V[X%ES<$[)6X0<H>TPYA,@
MYJP8$ \X.,9!'V6,=QGS'P\\5G(R>A)EM#L3+1TBVX]*#MJ#+8(PX_!R+D1,
M-HPVM65JBY1ER/.PG&?93$Y8>\',X3G!)#-$2)8I(R!$Q#HRX$\8FA)R!CQ8
MB)$S]DAW#(YJ00>Q![_@.#]P\5EN8JFG%*<4IQ2G%*<4IQ2G%*<4KBI248[K
M4E./CGNK.$X[8QE6<]\YQCX)QE6?O8QG.?AC/&">PS2HD[?J>VC+C<\&:CW9
M S2516'YC#T19Y1V&@I,;,4R9[4#(R+#[#10_JLH0RZ2\ML5"GL;8L;LG!@=
M#XD\)$NV'$MK$)IXV\4IM>*-E9E;!RP4 L0*KN7OD=@>.>#P#QY'VUW8NE<]
MHP*X<\.[F1FXO'M<9*B-9+K@JC9C/M!(30_L@PJ%O-R&7< &)2K 1)"\93R/
M0[C;N"!AX<$GJR1.=EPP2'U5<MN9B 8\>(F1O514[AG'O(Y!'89/<=L>?8^1
MK+1<W$33#!,1)@R+!,>!*L+#):?]2-E6EO1AV$H5E>!3VFW5B/J3ALA+3F6E
M*]-?CAEAEA9EEC>-EDDB8.I7$D1"RIR,;HV(#J.5)&<9% 0>WF,_0>U9/F.I
MIQ2G%*<4IQ2G%*<4IQ2G%*\Y98@ SYIQ(X08K2WB2RWFQQAV48\ENOOO*0TT
MTC&,Y6XXM*4X^.<XQRR(\C*B*SNQ"JB*69F/8*H!))\@ 2:=N]8'-RK'O#$4
MB7&?D/G!FK."BI?,<&L&*_FT^[#<BM/(!?S >$GA1BF&5,NCHPYE\AAIS/Z)
M<^'XIA98_1_2@SX0-;^D>B^+'N(,B^D9C]0,<ACC:K$1N&<9YSM]O.-V#[..
M>?QFL:G9%,R$B1>F%! J@@;)DF3C)>*::AY*05%A$$YD@!?97GCTY']A(]*0
M;SE#CHJ&G$.*R?)UYO,8A#OX[V^V*6&4F6.,2NJ^'(^Y5C.[Q%S&>0')! C<
MO?/EGD$<=L\BI<*<$;DE(9@I>0BG 3,"D,D9$-90VXZ&3AI:\L%-(=:6X.[X
M/(0XVI2,86G.=1D=-N]&3>H=-RE=Z$D!UR!N4D$!AD$@X/!JU>KE:4XI3BE.
M*4XI3BE.*4XI3BE=;KS+&$9>=:9PXZVRWEUQ+>''G5>+32,KSCR=<5G"6VT]
MU+5\$XSGX<LJL^=JLVU2S;03A5&68X!PJCDD\ <DU5G1,%W5 S*B[F"[G8X5
M!DC+,>%4<D\ $U%BKS5A0B)#,I[6(+$SDXX[%AR$QYQU;+0!-+'1%"&.%DA&
MN)%5'BI>D'G\+;&%>4VYA&[\F7P.UH#$WCVMMMF>. B:]B:>V5A,Z%5EA4R+
M*V(@NTLZ[ESIPZG87$D<=O<QSM+%=31F'=+&\=E<):W1$J*T6Z&X=8FC+B0O
MN"J0CE>U5SKB#E1SISK!F)T"MI;(CI0=#\U)0R; &&*^\$@<O#L5G)"B1G71
M&'4.AD/M&M.#IPBTN"@D5 R&"2YRLD;$0QS&!W95<LF)1M"L S AU4H0QW<C
M\..Q[D9X]O'F..X[@UEXR7BIH,>0AY("5!+;4\*9'%L&"DM(=6PMUA\=QQMU
MM#S;C*EH4I*74+;SG"DYQC%)%+"[1S1R1.AVNDB,C*2 0&5@""000".00>QJ
M00>0<CVBLCS'2G%*<4IQ2G%*<4J#YJM!ESC\XBX,V0;?6J10PIM3[1#BLY7D
MEIAW&6G%K\LK\T)RISSSGNORYA,4#$^HA;)W8QG/GD ]_C7.]"TR>64B&VDE
M5B90I4NKGOO56RK$@YR 20<\YKE@_7X@2Z]@^LL X4IAV+R8 EKU,N>2TN-9
M=_W[AW&%94K[IAQ.%>6%)QG#=  8]T0'8KN7OG/(SG.>?;GGO4^)I:1FU\6S
M6(>J8?$B SG."N[[+=SD^MN&>XK*GLUB/BFHZ2Q$A1"O%M@8I8XXJE)5ZN/1
M2XI&,N85]URI&<K\LY<RKOG.<W81JNUMH7R!P![>![?/VUFD6SBA6&401P'A
M$<HJ$YW>J&(RV?6R.<Y/OJ,X%U?GZ%UK\QK'\C_],]L\H/ \C']##S^FM-5T
M8'U6LP?=(G^54G%Q6I8',8$J*/ '2C&0QECO-,X[Y4A7IM*SEO/EW4ES'965
M95G"LJSGF0%", J0/(8('LX'OK>C-K,GAQ-#(B8]1&5POL. 3CSY[DYYSFN^
M(%@A,E-0J $*0YALQ(:VUN(=3W\6W\I4M:5)^V\4+SCQSY=L8SY<D8[#'!P<
M'//F#[ZM$L*[A#X??#;""01Y'!R,>^J*V)!=+I%G+(V7C5S%M?:&6?F>EHN-
MF'F\,(;$=.:4:,^XK(J&D,O$(RXH=#*4KRTAO&/1Z?<]3I:HNFMJ9M%+"/P(
MI9(0=Q+A"$91ZQ)8*<!B<C.:^=]26'U*Y-5FEZG'2B:Q(D1N/E"[M+:]= BK
M"\Z&>*1CX2HL;RJ6,2HH8HJ@235$3H4 F6?T\F@N&J89:F'ZD?'2)J!<N>;#
M1;HY)1+(JW4^:6\J0PX\C"NRG$8SC6U2?79%B75S?[ Q,*W:21INQ@E RJI8
M XR 6 ..QKI])6?0$$MW)T:O3S3E$2\DT>>VN9Q$6W(DSQ2RRI$SC(4E49US
M@LO%JEXA\/\ <Q0:2,I3G.'7$(<RGZ$Y4G*L9SCMC&$Y5C/P^&/ASCC.>.]>
MT;P\^L5S["0/P9KWCX8PTC WI^CVSX>EE.49^.>^<93G.,_'OWSW^GOW^/(J
MP  PN /=VKNXJ:<4IQ2HN5-E'.$ UA II32#FES#[C!4!'2D8>$*7"2B0SVY
M1N46T00XRPT*IIK(CV"WV%X:9?Z$=K'"$FOS)%&QA86R*\=Y/;W$,LD=W;F6
M$V[6X:-%9VDW-XB^&C#<R\N6^EG:2#2UBFE19U-Y(R2Z?;W5K/!%-970AN%N
MENBLDC+&D15?!?Q9$8*CX&QNUZO.PJ[8Y*3;=FL1M2"<.;&?C 4W)+BVX:3"
M%0" _".JCQX8-^3#E#4.DCCO$K262]G;L5O;U;H:<MO:-8646HRB(R)<2G3"
MH-U!+(9IDNE$SW4JP2V\16-W6,&-%K0U)M.T][(ZLUS?)J>HSZ1 UPL3VL U
MD,RV=S!$L$$EDYMH[*%[F&ZG#2QQO*PEED,CD+-6X+V)@J0$&]JG8RJCLC(4
M_P"E.23*%1L60V&V[["X\.IE37M>!V4,NCY4M"'F?/2AL+Z[\5XX9'\.SGU%
MVD(3=:0.1/<(TK+XRH^X-X9=BRO@$J^.C<:GIMAX*2W$4?C7]MI4:1*9-M]<
MHK6UK(L"OX#/&4*^,(T5&C)95=,TM4]WODE)C;''X(/FNH#8NGZ]B%92R@<"
MIXL,B%)2R3#5J<RW$P2T'OB8QEQ]]EQH-M&5XQTKK10JF2W<K'#H.GZM<>,2
MQ9[KT>-XXBD8 S+.#&K]E4@N3@UNK)GN/]M:,8]VX@GZ!@U.3[CJZ1,H#SA$
M1.EVFW3(-&.CP\2R\VB$A;!'SD@&:(TZJ/>BXF/FX<Z8]1G J%J <(0DA*%:
M26FI(E\ LL*6MI"]ZDC^$!;336\D$;HY'B"262&9(<$L1X@4E2:L60E>0=S$
M+@9Y4')!&<8 (S]'G4@%AYVO)CQ(,Y<S$#L5J%1'665+=+C8V/<,:F9W-B($
MF9VR3IH;P6,"S1:&B7X_#BY(5TLIYS7::"X,CS)X,K-<S&2WB0)))($,,'HZ
MO#!;P(X?UH4+*LF!$P15%L$=N1P,$^SN<\DG'M/.._)K(5>T1MLB094%F3CU
MF@!R+D+/QI<#98M@_#N143=>DVQY6')=]![Q'/&8<5Z3GCA6$*SBES;26LKQ
M.8Y DCQB:"1)[:5H\;C#<1%HIE&Y<M&S#D9[U",'4, 1D [6!5AGMN4X*GW$
M5(^:]6IQ2G%*<4IQ2G%*B:Y\R1-9$K0@\@.T[#%G3)KQ#,$3#'%28T@F E 1
MCV)2>C%1OD]&.>RCM8+$R2<SZR<<VO 2-"UPS1L1,B0HJM.LT:Q-&9XG>-HH
M)?%]64;V)1]J';49]F#VR?+!SV(!R1CM^$9JN3:UKZ(",5MJVBWR:A*+$3=K
M=NY@&0"8#7=B-MH%^(UB![/2XDR#L"\&9ML+4@Y#!$7#C.R+JHB,:'Z"7%_,
MZ?)5J]C#->RPVHLDDWK<7]NEJ]BNI2;KR5)X!L]%FNWCVRS,(P)9"V$K&,^*
MXD8(K/XA&"L;EQ)X0^MJ5;G>$#9"Y8[5Q%+/U6:HIK]Z;<;FY*-I73RUU1N3
M-= C3HFU:V--L31!-5=Q*#N24TVN#284R6R &XS/0SZ))W)1/LNU;=+ZI>"R
M*F".2\Z@/3/@W#R)+:ZDJ6Y5;H>$PCA(FV*R-(X,$RF,;%W5>ZB3Q/LF$=MZ
M5N4 AXO6SLYRS>KD@@##*=W)Q(K5U UJN1=_D1XF4ELT2A4Z]J0A8HC$TS>W
MY86NQ CRG'WQSWWXM"2%$!^DTDX937M"L+1C7M=!N;B6PC:6*+TZ^N[$$[G:
M$V*Q-<2NH 5HU64E=KY8QMG:,&LID #'!.U%?RYW9P/B<?AJPIIBAS3$PF==
M@FR HYZL3A6)0>-F($2V-QQ#\,[- E"2L$N;RN*(0VP:"^:[[N*8RMW KF-"
M!KZ%H3 LY5Y%N8$\)I(9WM#(%F$$B/%/X&)5)9'"#Q$; WBK':<YQP-I.<$!
ML<9[C/'F/+W5VEM62 6?)!$EV>,43*3!D(2V$J;%"%KK#$;6Z5D=F)%?67,
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M$^>.V?/O5+Z]0WMFT6C,O8K&VBLS,=9AJ7;HERO[9TY;CBG7%QD?.AX]VRU
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MXTZKP\SN_&[ DV,8QC&,8QC&,8QC&,=L8QCX8QC&/AC&,?#&,?1S0[]ZZ8
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MIFU,$0*^#IUM-'/,PCV[R]S;33 _7-Q;UN6L4RLQ^L61E)9C$K7-RQ9N<RN
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MG:Q14VDX&0-\B$E2<'CD_8Y'-8;.\JRGZ8J?_P"XQOT_^$N8S=Q 9*O]Q?\
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MY-TT;6%G9 -XA(9O%MYS,-V#W; [@8//F-0Z:T#5;TWNIZ5I=_=[$BWWJM<
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M,N94.V8L-\@ED1;R,J2A64,./-X5G"G&\93@OI-38(+\W6W),8G#JI.,$KN
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M%2(;K+>7<K[M+2EU&S9S);W$4LL*7$0;$MO+)/%%-&P(9)'MI(IPASEA&X)
MQR"0:NI92 Q4^3 *2I\B X9<^S((JH=G556[]0!8F']T:\:4(+:+10=>VF K
M>R)9#$*4^?JB>GJ[)RXH[ACQ;84JS4;C'.$'"CL"VE$<Z^HCJZ;=#1M5?PET
M?4"':UMK[4+6>XT^(F= FJ007$<3L$5"\37=G)MC=F:U,@4+BD3QXE#&:+.'
M9$<)(>"3$S(S8R3AO#D&2,!]N<ZFU&N&:A.@:AKRE5_74[WS8JOTZ:R.8##
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MJ C[*G;O6=UHKLZ$K7.SQX N@;IB%QBG7):E[E9@E0HY4S $Y#!?C2(V.'E
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M_&; JJ)"=CH6N72-*7&WBCQ%I MQ%#G7&6)4:KS\I'LC,-V(> DH4Z6!PPE
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M-H2"5>(LKQDX'K1L,DHV>/L3D%2@QSLW@=1=D""8$)#@ZO&M/LHS%P+M?D)
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MR)]B)&#N&9%QR<LQQP"<U.ZU!,UZ*:#PD!<@0I4A/R,=%C0S4[8C$H<FI]\
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M=VD>2^]$@TO3=5N99;A] L-SK<G3K8Y5)C"^R&1&1K=3-X*^)-O3'-;)(
M(][2RQ*%47$G!7Q6[D!AE@<[B%W'"X-#T:T;<U4-,.[*NA,G9JY'3N_NH,&-
M+Q*T^H$V"$]Q:LZ;M9C%MOBP<($& $4[F/0R7+2 #L^HW+EHSSN7UKI6J/"-
M.LUCMKF2#0M!>1?!O+M;>;QM4ZCU)D*M/,[R.H\0E(HW$'A_SKSCA\6)6,KE
MGRTTP!RD>Y0(X(LCA5 '89)RV?7J^JYNN3J508@;HQ*6S9=9*T[ W1[PC8D!
MZV;GF1T#PT<\,C*5NU2/DFB2VUQHZ'@&X]'M;A)1)#'#N-&CNKLSV;16NFW*
MZO/9#,DT@M='A8M-(K'.+J2,JK"5B',AV!456V%<A<-EG7PPW8#=(< #WC//
M XY\ZF- VZN55(@65"G)1[9FX*G XBP<8:7':[EI!0PQ?D3E7O%R%'3EM2$^
M)CS3BE)9SGNK%=:$WA^D6A58(-.T2ZNO'E]82:JL<>],)CPA<, ^2/###!8=
MN?=:Q;65W8V4ZS-/J)U 6OA1AD8Z? US+&Q+@B1X58Q*%(=E8$KQFLCK78)5
MZ<(JTE*S<;.1D1NVEP$FZIYNS5-82('8>M#AR''VTX9]5)\?%M8>8#D)$;"/
M+#2E<]7%IUE;K:)J$%O:SVEQ<]*:I>6ZA#8:B)3>:)KL4B*ARVTPS7#;'EA@
MD+'+"OF4^JZC=/?2:7<W=[;7UM9];:-I]RQD74M):%;#J+IFX20R* F\7%O:
MIOC@N+F(+D*:R]$K<61/4X09<R36!A$W/35[B5+P6!6WEL.SNK;.8I@C"HUK
M!"4AB2&,^T1:O9&2F).*3XZVKWUPEGJ<D@M8]0DD.E]3Z/<X,<M\@9;3J#3X
M@\>)VV9DD@^PN!XCQO;W!SM:%IMK)?Z-%$U[+I<40UKHW7;3=XUOIKE&ONE]
M3G:.3-LOB@0PW'$EJ?"22.YM1MV/F)7L^F!CGDN39C#;RV!S 1Y*,AB"<1Y-
MC89.:(8(1%O.I<0PMAU)+Z$L>FYY90KPUO;%HVNY@R6L;.BRM%(\,UTL9FCL
MRT94HTRC!;<-BG>2.#7TNXO5CN(K.$1W%X_A3/;">.*:*Q:=8)K[:^2\<#-R
MBC=(WJ+ZQK(Q4<F+ &#P\HMYMI'MD@ZP&.5*'90G!<H<W'C!AY.D'L**+6.*
MPTI]Q>6VFT>*$Z\LAED9\! 2=D89V6),G;$AD9WV1C"H&=B% R2<D[H&/R]N
M3[3C'-9'F.IIQ2G%*?3]/%*A)2!(MYV,GDL'5F9,$2&Y,KC'! Y4HN/"AZK'
MP[,8SA8?K,X.#)*=)>9,4I"G58]'+'5C:6X5;BS+Q7]K%(91:B=9);>..:6Y
MU&>Z:X8B7:_@RI&J*\8!"CUP_$E6*V=K:_$=QIMY-%X+7K6K10W<LUO!9Z5;
MV:6R;H=Z>/#+*TLB3,RER-GAX*^:S;L[4[)0$P_4KM-0H=81=66GI22@J[[P
M2_+CUL4DQH2&D9 !PUAJ2#0A;!S@D@0R8H-#*[V6LS6T5O9SHMUIL%R]Z;#U
M(8KF[\+9"]VZ1F2XCB8(1%*S#P]\:&,2$UL'2+#Y2?6!#_1)[1+%;IWDD,-J
MKM(8K:-W,5L)&8F5H$C:4A#(7V"M6H2VWU,C5F*K)35="OT]$4/55:G?:2W*
MYI75R_;KUM*R1TVEU;]BL[(RXP F63@I@&6KR<K40^O*?0S6MCX=T;F*&X>P
M@EOM4N8-J"XUG4_K=CI=O) 0%MK9F\618<JTD-QP% K;!;*XR-Q"HK9XC3EG
M(/FW89]JX[YJQW>J 5X.#LD?6"U5<G4^V=N2S9+K>)M-<H,Q'Q%>>CL(>P"G
M%M]H?.'26K[D*L?&7$N(=PKGCIIE>>VDN4%TNJZ5I414$P&XOX9);@2$C?\
MSIM6-MHY<-P01BWB]B!P4=SGN%4@#'/[+RK$7+K @Z]9&*[&U"8*7#[CT!J^
M^'RY D:#!QW4+7TR=6M$.X$[*NRK4=+GPU?E!3V(5/MQ!F122&AV72<UGTE/
M<6[7$MW"@ET?7M3L4B5Y'GDT"?P[JUE#B(1&2))KB)T:8[%3<BEB%Q/=JK[
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M#25XPH@M[P]0A]6,*=>4MS.,95VY@D?Q'=]J)O=GV1KM1=Q)VHH^Q1<X5?(
M"I' Q[/;W^FO7RE*<4IQ2N*TI6E2%I2M"TY2M"\84E258SA25)SC.%)5C.<9
MQG&<9QG.,X[< D'(.".01W!]M*KX3 U07FM'ML TTMMD.OG)16ZU6ZZT2Y"U
MN!UU'C"'B2;YYQ#[[\.\S&^DO#N8U!;9*(\5W??==CTE"7NU)>X0FXN;FX*B
M:XGU"1FC>(1HJA9@9,C'B%"ID<5'J\'A3PIX4#L @P<Y]G'NSG J(S^CZDF
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MD+2TVG"GR'G7W58RMUQ;BE*SRI':61Y'(+R.SN0JJ"SDLQ"J J@DG"J H[
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M?B-)=&298[41PR.-T$>UC$N]-SM(N-4\/U5^P&U40  1HJ8 7 RW('!/&>.
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M&E3.3',IMX1 ?18YEWQ@(L4(;P7!*'#$K(VZ $8 @=CO'<>L<\D<'/)[CO\
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MDF)+5R##X09;5#'X)%NT($=P"&NBH$LTBB0R!RS,Q["1PP[YY8YSSGD?L?(
MXQC&/"[1#7Y1Z1?V#?E,KL59L(T2Q(PH4:&FNQ*(PB!0D* ',*KUG?2J9LL?
M(&&.$RCBE1Y,8"EL%&07R+$(Q86&[T>YMVE:.9Y'-Q*95G.^=D6XME^LVTD:
M(%B&)%E?UZIL))/B2?9*P7*@#:,%1A02K'UF!))/8@8%=D)K&DP)8<D-#JD)
MD"%F*X/8+%(REIL?S?G9]%GDH1^P6,V4F"XIV;:'+9!*->'#0(&*&VP((.PW
M$VI7LZ/&TWAPR317#06\<5K;^D0P&VCF6WMTBA240ED9T16<L[.6=V8EC12&
MQE@I0.Q+OM9MQ4LQ+$%@#@G P ,  5/>:-9*<4IQ2G%*<4IQ2G%*<4IQ2L)*
MUN"F\.^\XP4E;^8KUB/#+!;J(.41-1++A@ZF2UC@RB/;6!E/9'P\M[R:4E]]
M+F:*XGAQX<C*%\7:N=R SQ&&4A&R@:2+U&;;NP%YRJD00#W \OP'(Y]QYKP*
MJV$KRL6Q6D/R>L9*T)E\FMJ(L7VV5^,LQ(Y;9@W.[E=!94U'1G?T<!O#82QC
M)Z3QAK>U?BW4'PMAVV_&/K31Y,XXN'.9)?LMX;+%CWGS/?V_'V>0["NM%4<S
MA&";5;"L(Q5,XPJ3&$^[U<C)2WU*C0 5K^<SGBW:1G%K!DAT8%8%"84XVN3=
M#G;:VB9]*[1LW%TNT*/$D<#T89-JP&^)CO9W8 ACWGR\P.WP [^?E[,5[(^I
MUV+*'/%BV%2(GO\ 2)*&K>DY41FT2K4W/AB2DDZ7(#1\E)CBDNQK!+8"/8@6
M&!FAP1&F:275Q(K1M*WAOX&^) L<3FVB,,#O%&$C:2.)F42,ID.]V9BSN2
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M*$& FQ5"ECG&YRQ.>_&!Q@YXTMW/T).[4V19+^)LU41BR/C%/1DE7%S#@;S
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M4PPVQV;7@EGLVI+:5^&4YSAQ2\X5V5VYK$9KW-_H?IMS)<"Y,?B!,H8@X!1
MG!WKZI"AL$'#$D'FIK4ZZFK0S43@QPWP>>?4\M'IIPI]6%90RUYN>DTGMW\?
M-65.*<<SG&5YQ@ !P*Z=A:>A6ZP>(TN&9BQ&!ECV5<G:OGC)]8L<\U)>36Y6
MOFZ>JOI[Z=I& B=U;0@M?R-H#./@!9@>7><DPXUY@<Y]C,;&G(2@=XEAM>'E
MMJRIU/BE6.^<8)KF"W($TBQ[@2-V>0._8&N;?ZOIFEF,:A>0VIE#&,2E@7"E
M0Q&U3V+*#\153#?*/]$)F<8&ZAZ<[E7PQXA6?'?_ +:!Q_3\G-8ZKIZ\FZC
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MY+'16,^/,*;R_N85)]IA?'LJWR;UO/ZD_4NDV:'N^FZ S7&,<A'O]1N84/\
M9&!\<'&>\WUMH>G:ZEC;:LN?O.QI8?V27V3?9+W];B@LJPO$8$1Z(P$!"MJP
MG#<1  1H7@AK#[9"VD.8WM,T"RTV5[LO<7^I2ILFU34)?2+UX\Y\)'VI';P
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M6U%8Q<G]B <$DX)P2,YR <9]]>TGDT>VOC/.\27H498F1F&4V@E5W(',? )
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MWD?Y):YAZCN!_P &>I#V_P!RV7Z0-?<=>=WS_P"][]>N/I^G76JOY-S9^_\
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M5/XE:_U=C_;@SQZ?)^Y]_P#X.+^6JIZIN!VZ2ZK/PLK ?CU,?K^'LQUOW/\
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M<5A*$Y5G"4IQA*$)PE*<83CMS!+*TSEWQD\8 P !Y <GW\DG)K>M+2&RA$$
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M,_AJE)OHXUY9*_+4J=LUX/H#[6Z,UFF^O5A@J');XA+I6KO+5F5'JJ+ Z4#
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MDO&<]E*QWSC*L=WKJ.Y /'!X^'!J!X+G("%N3G;R?;W')^[BO.;8*LM2QCC
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MG[QQ5[;1OVV]7]/T=-.#:[L_4#)M:TH,>,*-98354GN/8UEK-"'-0"Y(S-P
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MM2><:5/J"PJH@^2Y=2C@ PD=Q;LT<NQ1@(D^^%G50!XBNX&Z1R>1>WPZ4O\
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MEV[9XJ#G!QWP<?'RK\8.A+IOVELSY.7I*M%%ZU]VZ@LQG37KN:K+.M(/435
MK5]D*T/,6>1OU7ONN+O8-CS\A?"IE_:J;5;TC2TVJ<^;<;17'\)'5B12T:G>
MP;:.V,9QYC!S@]\^8\NU?I#T3;JM?4;TC=..]KU#Q\%<MK:@I%UL\;#H(;A$
MS<U"BDR)D$V6XZ4W RA.7)2#;(>?>1$F!I<(?7C+RU9$)*J3P2.?C[1[CW'N
MK7GY(S!0'0/I^H3&%LW#6MBW9J_8<>3C+<C%["H.]=DUNWBR@Z^SPYK\N"_)
MXP^E+A(D@*>CS8+9<6JL7V 'F,@_$$@\^?/.3S[<'(KT?)TQ[WM77M;Q4^=3
MV#\HMU!3M(-;5Z@4E&U6L:KU+;C(]S&<MNC)VMK;8@;KK&5-.'B&*PK*LJSE
M2//KD]C(Q!]V /Q@BI#KJ?5OOKNW';0B5EZYZ,Z<%T\0&<)PN/D.H/;0-7VK
MNN08=2I3)!-$UHWI.H!%)S[1&R=NV1"N89SDA+JI!W.?8GJC_K$9/NX&!YX.
M>U3S=_6GK30VWJ3INUP=CD+#> :;(1Q<5+ZX#;PS>=C#ZPB!XROVB^UR[763
M'GR6S).%U[5K;,"PW[[; ((<8#>4+@,%P3D9R,<9. .2,DG. ,]JC5=Z]=9V
M2RB5@2L6=DLR7BH=HYZ7H+D,HB7GM)U\934R-<'HLK*B]Z5OTAQ"WS#78N7C
M0!BIA<5'2*F\>_\ ![<>W]<&K%D.M7I6BXPR9/W=2QHP&4S%.F*(.4T\K$1;
M)_WK'^F"M<K5O<-"O<WBYQ:3*CF(H]RD\3?L56G7P%274=V'L_!G\6>>W!]A
MK:!"T.(0XVI*VUI2M"T9PI"T*QA25)5C.<*2I.<93G&<XSC.,XSVXJU<N*4X
MI3BE.*5^=WR2OP^37Z,/]0NI_?\ ^4(^_P#T^]\.*QPY\),_M?U_7[M4KU>]
M'5 Z>-2=176%TO7S:73EOC754VCU#$2<'MS94_J;9=H@!)[94Y5]K:4NEILF
ML+#6]AS39P,V]$5:%M@1$PJ0K,[&R++&%JAD #,I96 +9W,1GN<J200?/CSS
MWK??9>D=:=6&H*O4]_40N2AI%%5O!=69L]OJ4A7K</%J?9R//4N<K5B%.@GY
M,X9IQB28REY.'LHP\TTIM5R P&X>P^8P?QBM3-"4^U],?6B7TP5#9NS]C].E
MWZ:)_=T'4]O76?VM9="7:E[.I5!%KU:V;<3)6_FZ^V?!6^4D(BL7NQVHN&F]
M:S[]9E!(LN1C!E54%7V@DJ5S@G.TY\B1N(;)[DXV^^OTWXK)7YW=-'_%Z?*8
M?]5^D/\ \@..*QK]G+_UE_\ <7[OZBL/)_*F=.T>\B)3#[ ?MC>S.I'6<K4G
MQ*A$2%;?Z9J;;KS:KI8Y.:N,?7(S7]LA:W%8I%C]\OJ,+N4,/. P*X2]_-%4
MAP?(_LN..R^??L?+]35NQ/7!J8VTR==F1Y"G 09]L%G;;;IBG0=9B J99^K>
MM3DR2499&R7XT3]QWL*;(4 *82) 34!+&CCA"69Z!5.X$X_#QC'K<_3M/T=\
M=JL"*ZM^G&:FZS6H_;%<78;<<B,AH(EN5CY=,D].YJP\=-1TA'"EU<\NS9&K
MH0=G:B"3IV2AH@1MZ0G(<<Y3>O'/?MP?XN/IQ^&MC.*M3BE>*2_X7'__ $(K
M_P#D.<4K\^/DC_\ [F;T0_\ 6\T#_P#MF.W%8XOZ6G_5'XJS?5^+U#6>Z:LJ
M=&Z>2=V:)BW%7W9T<!M77NOW[E<Z]*C/:\H$X)<R4$'4&*D1U7VUBAM-)LLS
M$4NO%DE515W@)M1]^0%7<.Y]8#GR'/EYGCR%:G] .T>HF4ZE>OF,E>EE^M05
MJZXPCMD6>0W5K\]G51K'1=TJC(A<Q$*Q(R=X.+CXJO2(Q$ VS%85:F@BY 1V
M&E%H>SX?E/\ '^*J1EMTF4(R_)W#@[5XP#R/8?/S \M_^I_IA-ZG*X_43=_;
MCU74BHET&3J6N@=,FU>TE*>==0_>X[9FI-A$V^"<:6F/EJ&?(M4.RQ67P;)7
M97#_ *K2LK+N&,D#V#!!^.0<CW53'31U;6:0^3I"ZMMXPOOJ:H.N-PV>Z,ZU
MAP8U.P(K2%DO=?:M="@9>:#B D;/KU($M]:C"K )"L)L@8[<H/%I;)0J%8[-
MQ&3@YQYX)[9]H&??Y5C93Y47IX:>NB:Y'76W!T/5\!LV=EH]JJ14?A5@U)M#
M=&* "FQVJ(E#]D05-UHE^T5D:,<5"$V^ 8>+=<C;BBL*>(/($^?D/;[2.>.W
MMQ5UQW6II/*;,];9=R@B5N:E:^EVQ$1A9TU*0^S>H'6AK4/7:X?-V=YEI73?
ML&XK-?A1P&Z6&7,N%)16[BW7E3O7GGL<'CSR1^3[G/MJV*9O_3&Q+E+:_H^Q
MZS:+?"1Y<I(0T.8HIS$?'+@6Y,H,M+>(^4;B<VNIN2^(LLQ42Q;:H3(I%'LL
M&Z>J0P.0#G'Z_3]'M'M%7!Q4TXI3BE5+8I&VV]<O58&D1R(;#SL7*V79@>'J
MV:TE66B\0M,&?Q,VQA"TY1Y2S]1AC6\X)C9B28\?/1E>>??#%;H(\E))KQ<P
ML!PWAVX/B3C/'UPV\;#UDD<=^!>37^H&XL;33(!;!V@GO=;CW64J@[9/1M-C
M?TG4$!RI](?3;:4>O!<SIC."]C<T%K.0Q$-738LAF1RN+BAHR5F\"G2JFF&
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ME18S,;'R 7L++K+CHRV5#J7A]2GV,D9=(?\ +7VDW5S</-'<JJMC:KM(-F
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MQLE/*HEWA=A5_P!E+<$PS9( >1&CGB<-_P#!0J&I0O#HCGW-W*D95_ QQ4D
M]_(Y^FJ/E>CG2<RX"Z=&SZE1\E<Y8;T[ 6WA)E]WB-U#V%2L83]NAW90K)@K
M>?@+%85$M]QU9SQ5=B_^\?[X[C^'D>RHY'=".A(B0C3XH>YQ[8YE9?GHP:XR
M2(F\A4J8@++3H.Z!*PI,K#5JSUN.GX\<9<>0\2[+QDD4?7)^<A)%4[!QW&/8
M<>>[\?T^^KDT_H77FC8X:+H DF(()0M9:V93)2C\FO%7U' EURFL*6_C&5%C
MQAKZ#C/]^'O*2\[C"DXXJ0 !@>P#Z!VJYN*FG%*<4K3PCHEU8C%M@J[;-P47
M5FP)BRV"]:0HVQI&MZNL4Q<S2I.XD!BBC*N%#"MLH<?*6:OZNN-&K,[*2<S)
MR<,2?/3A$DJNP<XR 3D@$X[Y/GY^8[5/['TR:QL>T.GS:V,VVN2W3-&7.&UC
M5J;;YNIZX1%7>KAT\Z.LM A21:W90X:%!':JXTB$IF >1AT-&,)0A"A4$JW.
M5! Y..<>78]JB]BZ1:1(72[WBDWW<&EC]JGC2VWHK3]V8K$!LZ8&B8^OXL,U
M'R,+.N5>X$U^)C(.1ONL2J%?)2/C8I$E92GX>(?!4*\Y!(SWP>#_ )_>,$U?
M.N]=TK4M'K&MM<UV/J='IL2-!UNO1B7?9(V.%QG*4>J0Z^662^ZMTH^1.(*D
M9(]\F0D2BCB2"'%6 QP*B&C]%T+I]J$M3M?L2V1+%?MA;0L\Q895^=LEGO>T
M+=*W6WV&>F24I?/,+EI=T83"DH:CH8.+APVV@8X9I"H50HP/,DG/.23DG[M0
MW;72MK3=%T$NER,N"'OFS$4V>@(2?3$UZX5B!M:[K%0]C9:!<E?9QK"XLM;D
M'+PA1;"U@&OD@K6.I4%03DY[8[\8SGM[ZAD%T)=/M=+CC8R)LJ'XJ8@YT/+M
MG.>2D^O674UMC5+2I/9QI$SI6BNNMJ^#K TB.K/A(O=E"H/E^N<_#N:QX_0%
MT^,QKL2^-=I$!FIFZZK[$E<Y(SYGZQ>UYM/6,7KBKK6G"PZK6ZONC8C<#[:J
M0G6BYD5V0FY)B"@AHU3:/?VP.3P.>/P^>36Z HS08HPC&,X9%89&9PK.5*PT
MPVEIO"E9^*LX0G'?.?CG/QXJU=_%*<4IQ2H+L&E&7N$1"B7R]:]S@M)+TQKX
MZ#C)LEE+!#.0%G3E?L*1Q%J?00I8# 9^'QA\MFH9]9EY3O50=.W2S3^F76T=
MIZA7;:<OK*!K3-2JM3N5J"F&ZE"LX?0AFOSP$'#VL9[#9"VVWRI\QP;"6W!,
MCOMH=PJJJ$4*,X QR3^OW*@&KNA77FN(*OT^<VKU%[MHM.E8^9IU&WMMZ4V!
M78(V&DFY:!]NQ[!$R]^%KL@.&970MIRU[$@SHZ+DHQD:3C #1U0$ &,L0.0"
M21[?IYYYS^ 8L[?73A$[Y.UO-N[4WGJ.RZLGI*?K-ATEL@JE/F+F8Y,9)Q-N
M@3(^?IEW@RAVV5)CK96)=(3S:G(YP/!1R2E2RAL<D$'(()'QSY$'WU--9Z:I
MNK')^3AEV">MMO5%KN5_N]AD[;>+5F%9)9AQI*<E7G<APL/@Z2=A*I CPU0@
M"):8?@H"-=EI%12I  ^)[D]SCM]RHKI'IPIG3YKBSZSUS9=DIC+1<-AWIZ?M
M]YE+_;8BP[(F#9N5=@Y>Z8G&@P(@TSRK\2^$7&C9823(BRAYDJ9(*@*%! SR
M2>3DY)R>^?/M[.W:H'K;H\K6KML77<T#N#>\E<]F'54[9.+';JS+PEYS2H;Y
MO5H:7AE4E@4 :-A/\[FOFU[A(RQ]LHC+^,.X4"@$D$Y/?))'ES@_#^*EKZ&>
MG"Y5HRMR]*\,R1NP"Y2R1Q#8%REF-D!;U"FX>4M3 V)<^!CL=1^VRJS#$D.
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M*O3J2S;D"A5:(=B90:GT*L5MD6&) @_=T<E3L0Z:KVO"H"@%B,Y8Y/)QG '
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MNREM^FOS3C.5)\%^6,>.>VSN7CD<Y Y')'<#VXP<_"NGO3 .]<$D [A@D9R
M<\D8.0.1@Y[&N>7F<.9:RZWAW&$*RWEQ.',)<5E#:LH[^6,.+2I",YQV4K&4
MI[YQG'&1G&1GV>?L_'Q4[ER5W#< "5R,@$X!([X)! /F>!7B-EXJ-941(20(
M3"%BMK>)*99;0LTML -*UN+2E.23G6Q&.^<>H0M+*.Z\^/(9T09=U4 J"68
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MO47>FT,NN.K?8'.+C$@K']5Q([#V7DK==1C"MR6S6659BP#JMNO"#M!=)=
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:UPHX-[=27%QD9C:$$J=GN=>O;4XI3BE?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>88
<FILENAME>g425213g61g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g61g01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[22\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )*"^DW8X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0&\>Z8         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             #1@   QP          0
M                       !              ,<   #1@
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   #1@    !29VAT;&]N
M9P   QP    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   T8     4F=H=&QO;F<   ,<     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    ).$))300,
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M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M   !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3
M(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T
M-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=7
M9W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!
MD12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T
M9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7
MI[?'_]H # ,!  (1 Q$ /P#T;#PL6W&KLLK#GN$N<2222>3JC?L["_T0_%/T
M_P#H=7]56$Z4C9U.ZFM^SL+_ $0_%+]G87^B'XJRDAQ'N5-;]G87^B'XI?L[
M"_T0_%64DN(]RIK?L["_T0_%+]G87^B'XJRDEQ'N5-;]G87^B'XI?L["_P!$
M/Q5E)+B/<J:W[.PO]$/Q2_9V%_HA^*LI)<1[E36_9V%_HA^*7[.PO]$/Q5E)
M+B/<J:W[.PO]$/Q2_9V%_HA^*LI)<1[E36_9V%_HA^*7[.PO]$/Q5E)+B/<J
M:&9A8M6-9976&O:):X$@@@\C5)'ZA_0[?ZJ2=9X=SNI__]#TWI_]"J_JJPJ_
M3_Z'5_55A&6Y\U*22204I))))2DE%SVL&YQ@*++ZWF =? Z)4I(AWW"EH=$D
MF %,D-$DP!W*HY%GK.!;]!N@/Q_.1B+*DHSV$EH:-[1);N$PBT7BX'3:1VY6
M8S3*(_-#K/A]&M7<(:V'X#\J=*( 4VTDDDQ2DDDDE*22224U^H?T.W^JDEU#
M^A6_U4D[]#ZJ?__1]-Z?_0ZOZJL*OT_^AU?U581EN?-2DDDD%*53J/4:>G5,
MMN:Y[7NV ,VS,.?_ (5]?[BMH5^-C9+0S(J9<UIW!MC0X \;H?*04X=_UHP'
M.$UW#:'&/T1X^D?Z0DW(SNI#=ADX>(R=USO3?;8__15,F^FBIOY]EGZ1_P#P
M?^%T[>D=,+#MPZ X"6_HF'\K%FNZ4T6C*Z98WI^01MM%=8=3:W\WU\4.J9ZK
M/S+V.W_F6>I^C].02%:1'YJ6^P]6=I]NO)[:8Y_]$I?8.L1 SKX/EC_V?\"H
M/PNLY%YQ;<^AU1K<XAV,V+)/IOK?1]IWV,I::W[OH?I6(CNC=3>'!^;B.W[]
MTX#3/J;?5W?K'^$]-OJ?Z3\]'C/8?8A"^S.P'SF?IV6$^CD U"PDCW4WTV68
M==KMC-[+<7_KG^E1Z>OXV*V;J['>H8:YOHQI[=OMRK?SG*+>@89L;^TVU=2M
MR[W>IZU8;6W=6]SOLN,T7,JL<VEOJVVV?I?TOZ;^:I1^I=+Z1T[H66<>C&Q&
M8U%UM=KJFO94XM=8Z\L].YSO?^D?^CL_J(&=Z&(2Z'3\^GJ&/]HI:YK-SF0[
M;,M.UW\VZQJM+@<?ZSYV,YF%C=0Z,QTOFOT<BDS76S(M=:UK6U,NV^IZW\S_
M */^=1C]9^L.<\MZWT1IK:/8?4+26MWV/=):]S/?[WU_0]/_ (Y1J>X262?K
M9]6FEX=U*AOIZDEX ((W2QY]MGM_T:E;]:/J]3=;1;U"BNVA_I6,<\ A^DL]
MWTMN[W;?_1;TE.HDJ.#USH_4;G48.95DVL!<YE;@X[00TOT_-W.V*\DIK]0_
MH5O]5)+J']"M_JI)WZ'U4__2]-Z?_0ZOZJ.2 ).@')0.G_T*K^JFSFEU39:7
MUM>TVL DEH_DCZ>UVU^Q&6Y\U,OMV%_W(J_SV_WHC+&O:'UD/:>'-((/S5!^
M7C_Z9O\ G+'^LV)U+-^K/5JNE->;;ZZ]K62TVAK]V8VH>W?ZV+^A_P"['\V@
MKH[#OK'T%I+3U+#!!@@Y%0(/^>K6/EUY=(OQ'U7TNG;96\/:8TT>SVKPVT="
M:',9T7-JL&@WW..TC]ZK[)5]%WYF]=1]3.E];?TOK=G3*+<'%RL85XU=I(-M
MX+]]N.;-OI_JY^S^M]#UO3_2_H?T1I:)$FJ>_LZYTVM[JW]0PZWL):YCKF!P
M(Y:YI>%*CT<YAOQ;ZKZR8+Z'-<V1S[F%S=R\U?9T.J:ATS*H>SV['W%I81^:
MZHXS?[2UOJIB=0NLZGD=,ILQJ;<%]3';G-:_)/\ 1C799LW/J_3?I?\ M/ZG
MTU8G@$8F0GMWX=?\64E"6NSU=N3TJNPUV]1QZ[:G00;F,>T@@N;])MC/H_I:
M_P#"?X1%QF5Y;"_%SSD-:=KGU6M> =WKZN9^=_@O_"WZ-<I7E=&HK92_&MI?
M6T-=6ZPU%I'TOT+JO8K/3J<C,NR+NCUOJ/V2^IUX<0'/<T?9*FW.VM]:NW]+
M[/YC_@O6][)8P(D\6W\OWDV[SLGIM%[O4ZE2S(;-;_4N9O:-QL-6USO9M>Y6
M:+&YM3OL^57E5?1?L++&S^Z[;N7&,R.DT5MI?BV565M#75N>:RUPYFGT]S%<
MZ)1EY.;=?TL&AOV:VMUYG9ZCFM^SL]1S?TKZ[_TW_ 5_\=^DJB9)JF"',2E,
M1X*O^]Z?/BA%W;LGHU&0YN1E8%>2V0\6&IKQNG>'R6O]^]VY&QF=*S6O=BMP
MLIH&RQU08\0?S'[-W^:O,0SI^(T8^?TO*&96(O#K2R7_ )[]OH6?2^EO]1_J
M_P XMKZDX]UO7ZLK!Q;<;&J9:W+M<7%KVN:/1HW.8QK[&W_I=C/_ %:1,DU2
MH<Q*4Q'@J_[]CS_5QC_SWMW4]*J?MLIQ&/;V(8TB?BW^4B5T],NL<^NG'LL=
M)>YH8YQGESR!N]RJT6,H8*[7>E:/YP/T)?\ GOG_  F]WN]1'#V7VT^B198Q
MX.]NH:W_  FY_P#PC?9L_P#2:>V$E8Z9AN+:JZJ'@06UL (!U]WI#V[D9F5C
MV/#&O&X\-.A,?N[D&@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$!_\  $0@!0P$S P$1  (1 0,1 ?_$ !\  0 !! ,! 0$
M       '! 4&" $)"@,""__$ %H0   & 0,!! 0)" 8&!@8+  $" P0%!@<
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M,5,B8%%41456.8J2"1"G566.FDD0RARE-VVX-E=W-T\/3<Y\@!M)L[S.E@T
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MRK_493@^35?!"IFN+S.ABSB'T]C"C#<R*(J8%C'_ ,VFZH7%N)KU' 2 W"N
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MY";;3.O7Z$ 15(,GB05'.4+SC%!P)3OB< 9W1W,F9#O\D(^39^*86YG2VBW
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M5@1K98$4&2"5B%%M2,8==H228[D "-PMP.LP3$'4$Y[B 073<D023IK&_70
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M8N-3DX]:Q4>Y0"<M#'D(HTW5;!% ]%_$OD$2+8'1$T1-$31%K]MB'G$YQ_\
M>IN"^_\ R=KO<I/E0>*\@]@Y:J:'P?\ 4K>NJ*IV]_FO>_MXW ??#<=8Y_\
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MQ[4W#4YTC^8"/=,/3ZQZ$ONC7_GR]'I54<'X\]TS4OEP/=4-[^>>3%Y#GC@
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MB)HBU]VQ?HG/]JFX+[_\G:[W*3Y4'BO(/8.6JFA\'_4K>NJ*JV]_FO>_MXW
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MGC"Q]WD7'IA'NWNFC^5^3:(,?/Z@?=>?>/7^O6F\$G0Z#<3(O>8TZK;UM,(
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M&39^R6 .> 5:NTU4% #D> .F;CD=2"6F6D@\02#YPBPKXG\2_1=CK_DFM?\
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M4=FMM+:JS$LWKC(+F4DLC0=CI4RQ=.;/;)<KZH,VTVXA(YVU)ZL:DE'C%N9
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M#-'6-Y(-"N5#1\HJ(_DIQ+]\<0ZB4H\@'P^:\D\\R<.?B<&ZIAVW.)PIY^B
M-7/+1SE)HWFK38.E;3*]*I9KA/@FQ\V_R3YELQKYM6IHB:(FB)HB:(FB)HB:
M(FB((@ "(CP =1$?( ]XZ(M8,P;RMN&#6SQ6]Y*B@>LE"H+PM<2=VJ93<GY
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M'>O^NK^M>IXUPU<FB)HB:(FB)HB:(FB*%=P.=Z1MRQ?8<G7IZFBRBFRR4/%
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M/%>0>P<M5-#X/^I6]=453M[_ #7O?V\;@/OAN.L<_P#C6"\1Y!['P:4.]?\
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MX,7%1<<BW8QD4W!LQ16.W6>JN73GYS,>4V1Y VK3KXTXK%[1>_#T33K8I]2
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M9BPRBYW,G.RLA,2+A0>\==]).U7CI8QNO)E%UE#"/'MX#IK]64*-/#4*.'I
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M%[>?^/\ D[VZ[W*3Y4'BO(/8.6JFA\&?K*_KJBJ=O?YKWO[>-P'WPW'6.?\
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M4 !,:O,:#KC4[HOK>TKT[0<)%UJ&BJ]!LD8Z'A(]I%Q;%N7NHM&+% C9J@F
MB(B5-%,A>\81.80$QS&,(B/YJKUJN(K5<16>:E:M4?5JO=JY[W%SG'K)-M!H
M++L    " + !7752E-$6OVV+]%!_M3W _?\ 9-UWN4GRH/%>0>P<M5-#X/\
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M%0LK MHZ$5%!5!K%'8V&R'<,5V[HBKVQ2CX3 Z,T4:%-AH-.B/-:]M.,!9Y
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M\1KT:\;*9L*8&R%GBSHURD1)U4$CI&G+ [*=*"KS,YOG.I)YW1*"HD*86S!
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MLG8(:/EF#R5@CO4A69DF8YLX4>1AW:("JV*]10%=(!42 Y $=$5\$0 !$1X
M.HB/D >\=$5AKUJK%M:.']4L<#9V+1ZO&NGM>F(^::-I%KW/26#AS&N'**+U
MOXA/':J'*NCWR>(F7O!R17[1%97MDKL;+1,#(ST*PG9\'8P4*]E&+66F@8)
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M/H&K8QM S,37660,5S%]>PDG;C.UF;."(=W7?S'\X6GE>5R0TVM8(2+DF_8
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9   5S&-8T-:(:)@23J23<DDDDDDDS*__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>89
<FILENAME>g425213g61g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g61g02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1Y.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'C*^=S X0DE-! 0      $D< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  12V%M86P@1&AA;6]D:&%R86X< @4 %U!O=V5R4&]I;G0@4')E<V5N=&%T
M:6]N #A"24T$)0      $//ALWAPASARV;T9/D)O:6HX0DE-!#H      .4
M   0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M    $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO
M;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG
M:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M$ .__C4  @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"
M24T#\@      "@  ________   X0DE-! T       0   !X.$))3009
M   $    'CA"24T#\P      "0           0 X0DE-)Q        H  0
M       !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9
MF@ &       ! #(    ! %H    &       ! #4    ! "T    &       !
M.$))30/X      !P  #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@  #A"24T$"
M$     $   )    "0      X0DE-!!X       0     .$))300:      ,U
M    !@             !D@   A8          0
M   !              (6   !D@                     !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   !D@    !29VAT;&]N9P   A8    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   9(     4F=H=&QO;F<   (6     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    ).$))300,     !.K     0   *    !X
M   !X   X0   !./ !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1" !X * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M     P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0
M  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!
M8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&
M)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(!
M @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R
M@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6T
ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
M/P#U1SFM:7.(#0)).@ "I8_5^GY;V4U6/!O!-+GUV5ML &Z<:ZZNNN_V?I/T
M+W_HOTO\VKO.A7,_5NU]G46OLR++_6Q=]9?9OW,:::VFZKU+?L]U/\W_ ,-F
MOZK_ (+T:DE-1_1_K(10UWVE_I,J%SAE?SF.S>,S &Z]COVAE.].VK-?L]GZ
M/[?C;%JT/ZUT_ P/M-E;I?31=58'66CU;/3;^N-NV/LIILJ8YSJ;?5LJL_2_
MI%NK.ZW_ #&-_P"',;_S]6DIT4DDDE*22224I))))2DDDDE*22224I))9G4L
M[)Q\AM=1:&E@<9$ZRX?P3H0,S069,@QQXI77@Z:2I],R;<FA[[2"X/+1 C2&
MG^*N(2B8D@]$PD)Q$AL5)))(+G__T/1W]9P:NH?L^YQKN=MV$B6.+OHCU*R_
MT'.?^CK9E>AZ]G]']59OU>P[:,_,?=;6ZPRU]-67=>*R'>WU*,IC7NN<S9OR
M[;/^#HJJH1F&Q_UBMJWO%3"+C6[<-SO2KK&SZ55N$WZ?^E9G^K[U4Z/3]LZY
M9GWNQ;;&->]GI7MOL9N.REE;F5UW58_H.L]:I]]N/9?^FJJJ24Z^;UKIN!=Z
M.78ZIY8;6S786N:WZ0KL8QU=EO\ P+'>M_P?O0NK/%N)B6M#@U^5BN <US'
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M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MT=4D.5989I6SP>'Q&2(F)R@R-$)%1E159Y.4EZ74UT3_Q  = 0$   <! 0
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M7)"%''F*0J9.N);?3>0;X'("<^]QJDI#07"8+IL<T!KXC2TD^&0S$8 '$7@
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M'8?P]J?PKI1<VJ<O4O/RD^N<]R'A:!2"=IW@MS"T)@-U\M$6CL6>4R][E)*
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M=9,6_JTCH,(D:XE])4-QP1. $%V0YI1IER9QAF&LWSU9I;^G2IS'/=$>"18
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)RT4Q*(E$7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>90
<FILENAME>g425213g61g03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g61g03.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1Z 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'F2^=X X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'2ID7         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             #;    LH          0
M                       !              +*   #;
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   #;     !29VAT;&]N
M9P   LH    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   VP     4F=H=&QO;F<   +*     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    '.$))300,
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M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MD^RP,?6YCG4;[V4^IOV,RLG_ $JV4E5))-G4E>X?_-'IG[]W]"_9WTF_S/\
MVW]+_P  _P"!26XD@I__T>WZ3NL^L'4K30
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M<;.TUQ@905%76):7F+?1U/ E)E168;'8)S)%A9'5X?_$ !P! 0 " P$! 0
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M)<$V&S6(P3((8X?=\E^QC BA<8@L0XR46;XL0)!BF4+4EDOQ:U\3]^(X2_\
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M25MR-4Y1C:VQV!9#]5A2YSM#8F\_>?45FRNL(X>[K7J21\*N0)8FF>E9'?\
M@1TK>+")A$PB81,(F$3")A$PB81,(F$3"+QL.KFO:[ ^%U_!(;!BY.]JY-)0
M0Z+LD9!(9(OT#2Z0/@65"A"[/:W19>E;LOTH7J= !HY0/00]1%[+")A$PB81
M,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(O\ D0P!V'0A!#L8O0!H0M:V,?HB%Z(=;WKT
MA>B$0O1UU[]$(M]75K>]$7\PJ"!;!H)Y(MF#-+!H)@-[&81L6C@ UH76(9.P
M#T:'76(O81:'K6P[ZB+^V$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(M<K_ *BE-J/_ !Q<HR[-K,34M[*;+DBI8I5D.'WA.HF\:R+^
MCA:= M(6/J:162P.!25Q-;4.VY&Y*-K_ +J3I42TBCCQYZ*'D+55CTW+7Y70
M"%MA<[J5]/#$I/-ECA4P:CBG'QAL&<U&4XUHTZ=)KS944Y*@<A4B]QANFEKL
M-0-?)+9>=R9PDI%9J *Y@T758]?OM@22>,3765435G,E+9!$+@U.DMEES,CR
MF3*(/#(:4I;S4<)8MDE.:=P4ISRE(RU>@J1@T1; X1,(L%OW(JO(TH>$[LSW
M2#3"<X%.2U#QJY'/+0#38,T*Q4D>V:J5[.Z-P=$&&D.C6N6-RQ/H*I&J4)C"
MS1D7Q&'DO6<F*95+(U78K12$MN/:'$?&3DHB:U25V"28@6C=%]3)FY(WG%*"
MCQ."Q2G1$)Q;4J#RB #,"19_PB81,(F$3")A$PB81>=E4MC<(9%4CECPD8F-
M$-.6J<UPA@3$#5J"TJ8(Q  ,6MG*#BR@=0=]8QZZ^K7MPBP\=RMXYIS4A"BW
MX<0>O.&G0DG+C2C5J@I,>L,(2%C("-0<6D3*50RB0C&!,G//$'111@@D6083
M:]<V0<X)X-+FF3'-12<YQ+;3#1B2%*AF@3C-T847U!-&2:$/5U^T NOJ]F$6
M0L(F$3")A$PB81,(F$3")A%@-B^**T_D'07]X?)/"+/F$49N4%CV&QWK/FME
MGDR:&Q*I9=)6YLD[V@0I@FQIE.,"G2)5Q2<G1AQAAP]%EAT(TP9@M;&(0MW%
MHQ=UWS[BL$V=8;'.FQPS^SF3;+(F3(FM4^$=E'' 8HFA  <E@ !0!1\^.,38
M@(X@!V-!$0/>@X!M:U]46K:"H@]*JL>>*4RDHPA0G/E\@-(/(.!LLXDXHQP$
M PHTL0@&%C#L P"$$6MZWO6Y[UINKXLN_P"A6;[M>7;)GXR/]*+]J_FAL^RF
MQ$D;FZPYR@;V]*G1(4*.6/Z9&B1I"@$)4B1,2X )3IDY!99)!!0 %%% "6 .
M@!UK3UINKXLN_P"A6;[I.VS/AQY_TCGZ<V2S[QJLFQ'J\:^:WB>S-V;5;FN
MK;W*4/:Y"J %D=# @4)%*XT@X 3  ,"$TL0=# $>M>D'6]0>DEVW=)N2\)LF
MP6*5,@ERS!,EV61+CA)GR@3#'#+$4)8D."*$A>DF9&9D(,<1!-08B1@=95HL
MIM2*GQTAG,:6<-8# 9=$HC'9>JETO5QM6DD:ER3)TB=.S*7,*A.)L.),$<(P
M@)0@F;V#T!;WK7I=6\W[0#1&R:7V^WV2UVNT62"R62&TPQV>&7%%%%%.AEF&
M(3(8AV+1$N*N ,U'7C;8[%+@C@@AC,<9A(B) #0F+(C$AN=12FO3-\CY4M1J
MF-*FK8A,E$G/;84*'+D3@<(T1FERP=BUU/G$"H(!:("! O1(O5 #L2,1^QG#
MM3^1*YAC?5YCCE67G;\'5JX;-843Z^SFK)E#C,>NK5KGA7#6%X!-TMO+8L]>
M-39,H4ISU)1C>0%IHH@2!,%$E)-3&G:H,S:T9JTI6MTH$61LLM4!)HL04VCC
M?G\B5S97U>9<T_!V6O\ \?D=G+MA5Z_3OQ$HN:5CK4[6XG9ZZJYJC73>WPQ,
MB%I=*ZADS7I GA/DTE6GI7MTV:I./ ->1#VN*1PL28HT"(C[V1]N ),F)$H
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M?$)8OUIA\JL67=HGWOW=X-HZW:%&VC?H_F_9A6N>;$O%,(M@>*_;_6WVJX>
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M!LA3GJV0.57+\=5K( H1D-?.U" 6.>=7K5,^,V%,=1P-#7!P^;!^-?&(=J
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MHW)$1>IXGR3D#)ZY(<;]/CCPYF )TQ2MJJF<4(^/Y2-:[,KJ=)J6L"23*0Q
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MB_6F'RJQ9=VB?>_=W@VCK=H4;:-^C^;]F%:YYL2\4PBV!XK]O];?:KAX"[9
M:4< 7E\E+\_*7K(WV#C/05=?*.4FH:].GV*4I\TG/RFX9=FXBWKS?3_%DO57
MW5!1S2O'EQJ#OUNT27_&G57VD5*KF1SI*H&'DH'?"NML=5 ZU@. S>2CD-2N
MMJGF#IGP X# ;2&V:ZXU<-AK1C@,!M9N+$U)>KC(9$L^X4<4.>3@BHP'U X
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>91
<FILENAME>g425213g62c06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g62c06.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2.^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (Z*^D2(X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'N0%(         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             "!   !*L          0
M                       !              2K   "!
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   "!     !29VAT;&]N
M9P  !*L    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   @0     4F=H=&QO;F<   2K     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    ".$))300,
M !DY     0   *    !%   !X   @6   !D= !@  ?_8_^(,6$E#0U]04D]&
M24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S
M<$U31E0     245#('-21T(               $  /;6  $     TRU(4" @
M
M   18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=
M @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN
M9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D
M;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P
M  @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@
M*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M$G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR
M+C$
M         %A96B        #S40 !     1;,6%E:(
M  !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:
M(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI
M96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                    9&5S8P
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C
M;VQO=7(@<W!A8V4@+2!S4D="                             &1E<V,
M        +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV
M-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@
M:6X@245#-C$Y-C8M,BXQ                                  !V:65W
M       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58
M4    %<?YVUE87,          0                        */     G-I
M9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #(
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M(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-)@U
M#5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/
MLP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%
M$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5
M-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA
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M.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC_B0"-
M9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B
M1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,
M<DRZ30)-2DV33=Q.)4YN3K=/ $])
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M;W2F-WUPH7H>]6NU"\!=HY(^.4]M/X_P\M<V)O)O;E\;1V&G;B;ILA+XMK^
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MXU:OUZO])?GVSA;)9]['S9_<*T#G?'G;OCI^V5^?G[TW/]O#7>C#XC)_(9$
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MYEKBJ!SU;$&:E3#=XSI[8+'?/TQ0^4H\_P"4'_UJY8ZSD<\3\$QH..N_BJ8
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M^O?]&JLQO3\'VK&/>Q^\WMZ5I2B/''CX@'ZOP:[*WD2"6C&<\ 3$#/?CO)6
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M^-V^70SQ 8F9CYI+N2NMRJJ ]ZO')HJ=L@^]*'$HE/V3!K!7A0K_ &+O)/\
M"8H_\W6>_P"8O1%E?"^Q3+^%;TTO<+N$QM,/FC"18$92FW>SD:F3D6XMU#F,
MTW'I+=M,H]H@ <"B8 [0"&B+V.ZW:-FG=EBXF++;G?%]9BB66)LP25=V^6L\
M@+J(0D$$6XED]QSQL""I9!053 EWO)"=@Y>O.1\EN4EIY*WH;ULMFH6JJ;+6
MLG-VAU1M/8KNI.<[WN';0-)H&,03.B\MLLC+;1YE[W,;MM?+/A MD#/#(G R
M#KA(-:_[ M._PN8G^;R^_P"/>MB_9LOK\S77_>VO_.K5[GK-GWQ7G]&EZ=E2
M?VF>2ZR-M(R6^R;4MRU*L\F_JLE5%(ZQ[>YXK C62?Q3]1T48W<*T<><)J12
M1" *O=B153M%$0*(8QRK[HEX\K;NI7;:[OL5EI4K73M@J6=]=U0OI4JU)K#S
MCBT-(KDD@3+0!A*]EBNNC8:KJM.K4J.?3-,A[6  %S'2"T S+(Q,8Y3!$OLT
M;?<[9LKD=6YO-F)8AM&S*4VDXBMOMQ%<ZZ3)ZQ!%0'FY%PGW0IOE#B)2E.!R
M$ZB B&L6N6^:UR6JI:J-&G6=4H&@6U'.: #4IU-H;.)(-,8'"">D>ZK2;5:&
MNR#@[C@"(SPF?,HT?L<64/X1U#_F]6#_ )AM9+]D"\/]0L7]JJO/WE3_ "CY
M/K67\+[1,TX4LTA9H3/&+Y=U(P:\$JWE=OEK! B"[^/?BL3S/<<W/WQ5(],A
M>T82=A0_)1-V1+9K[Y2VF_*%"A7LU&@*%4U0ZD]Y+G%A9!#L-D DZD& (&=:
ME0;1+BTGQ@)!WC4=.$]"F13X[*3)T[/?KC0+,R.@0K%"GXVL5'=-70*<G6=N
MYK*V0T7R!TOI"-D64<HFI[Z+I4OO.L;5?L5[_1$T1-$31$T1-$31$T1-$31$
MT1-$31$T1-$31$T11;WCXWF,K8.-4X6AI9/5:YBVRWJ5Q^L>J%"VU3%>Y?$>
M4+M#(DO,K!5!T[<TZGSOF3"P3$;&R3PJ#!=XCYR!P(J_F6WW?;2KQ$26!1@=
MNF#;EF">O2F :A%XXN+/%;%PK@*#9MK.F[NU'J\37KA%TW-=XNU=Q I>HZOV
M_*LB$/!7*T'89*@R=NW:5\UW%7E2[/ W0+5E:T8^E$JQE*P44D+)X74>IY.=
MUO!B>/:Y).7C?),=.4&+N$=FE\V?NT:NG.,7S%Q,4FDQ,FPQ_ E&/;L/7T+(
M-@P1OL=2%J3@,LSL$"$7>(RM7B,?8F+?K/'UZ<WI2&#H2XSLE2'[B1BX0+QM
MK=KI.D4Q56BIA*<.\+*Y(+9R1O&7:1F?6L;VFI^5??6O(,K#3$C&PJM]@)&G
MUB,DL/J13Z.A)G,S,8_W22MV2EX*D66NR6&YJPSA*CZ>JDU!+P2>',PLF%IG
M,G$ /;$:1,XSQUC'0#]ZKCWRK,>I7'EQR;*6B1:95Q@[M4+$5S#=9J$O&L).
MRCE5W$V17+$W9F.*IR.>UH:XNI34K;')0+EDM@563GUK)#$ZO)Y!.4X9B=($
=JZ312FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>92
<FILENAME>g425213g62f04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g62f04.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1>$4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %VB^69(X0DE-! 0      #@< 5H  QLE1QP"   "   < E  "%1I;2!2
M>6%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;CA"24T$)0      $(E,
M*T ^4D:PQ&_V$<%;PI<X0DE-!#H      /$    0     0      "W!R:6YT
M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
M  !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE
M5$585     < 00!0 $0 +0 M #(       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ "4S,P
M 0 " )3,S  !  (X0DE-!"8       X             /X   #A"24T$#0
M    !    %HX0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$1
M$     (   )    "0      X0DE-!!X       0     .$))300:      -!
M    !@             "_@  !SX    & &< -@ R &8 ,  T     0
M                   !              <^   "_@
M   !                         !     !        ;G5L;     (    &
M8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M    3&5F=&QO;F<          $)T;VUL;VYG   "_@    !29VAT;&]N9P
M!SX    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M  =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I
M;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP
M965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M      !"=&]M;&]N9P   OX     4F=H=&QO;F<   <^     W5R;%1%6%0
M   !        ;G5L;%1%6%0    !        37-G951%6%0    !       &
M86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E
M;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO
M<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E
M5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453
M;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M   *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M    "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M    .$))3004       $    !#A"24T$#      ,Z@    $   "@    0@
M >   'O    ,S@ 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2
M ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.
M#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M_\  $0@ 0@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!
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MU.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\
M["[ZR=0Q#;5DNZ6<BEQ:^K[8ZEW9[?;D8_YM;O?[_P#TFK.'US+S,FNBEW3;
M2XAU@IS3:\5@CU7UTMQF;]C'?G.8M)U5+W/+ZJW$GDM:23I_*]WT&)J*ZV93
M@VNM@#&D%K6!WN^E[FV.?_X%_GI!%[>.C;22222I))))2DDDSG-:TN<0UK1)
M)T  [E)3AYN+UW+QVUY=&(]M;_4W59.309;NV/\ T%+G_0=_,[WLWKGZ^H8I
MHJI-U$T$NKR7Y><^S<]MILWN;53<RS[0S$?=5O9790
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                _^+__TE#0U]04D]&24Q%  $)OLS^_AX "(!P041"10(0
M  !P<G1R0TU92TQA8B 'T  ' !H !0 I #5A8W-P05!03     !!1$)%
M                 0  ]M8  0    #3+4%$0D4
M                                          ID97-C    _    '1C
M<')T   !<    "MW='!T   !G    !1!,D(P   !L   H@9!,D(R   !L
MH@9!,D(Q  "CN   H@9",D$P  %%P  ".+1",D$Q  -^=  ".+1",D$R  6W
M*  ".+1G86UT  ?OW   D)%D97-C         !I5+E,N(%=E8B!#;V%T960@
M*%-73U I('8R
M                                                         '1E
M>'0     0V]P>7)I9VAT(#(P,# @061O8F4@4WES=&5M<RP@26YC+@  6%E:
M(        +5:  "\9P  DC!M9G0R      0#"0   0
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M6H)1@TB$/H4UABN'(8@7B0R* HKWB^V,XHW8CLV/PY"YD:^2I9.<E)*5B9:
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MZ*S6D"8\PZB2CVDHUZ5CD!L0!*7ABM0  (Q>@ "/Q\%0H&* 0KNUG3=P3;9
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M1<14J79F2KXHI@%6PK@]HXY&A++"HJ$U/:WXH.DB"JJ"EP0*YZE/AU\  (J
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M+X:]IFJBJH6>HHB-:(2PGMIW@H/OFV]@TX-8F%Y(^X+JE>,N!X+0E0T)48,
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MA-\;K:T=A80%$JJ;@VX  (,?@ ![6\;LD&5M9<%PCH!>_KP$C.A0 K;"BZ5
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MO*4SK2IKE:&"J<!;HYWVIKU*_YK%I/HY3I@?HL0ER)91F8P-0Y:@B/<  (
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MI+%RBN%B6ZT^B;!35:DWB*U#=*6&A_ R,:*3AYX>D*$TB"L&\9_ZA+$  (
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MI<"L;;18';PY;I])T[?L;Y4Z=;0!<($I4[$T<2T4EK'I<+@  *LI='L  (
M@ !RHL1W='!EP[^Q=(M8.KL$=-5)\;:&=4 ZEK)V=;\IC:]_=B$5%:_$=;L
M#ZGI>.<  (  @ !RH\,Z>[AEJKYR>T58)KFU>OU)UK4D>O<ZB+$#>Q(IGJWR
M>S@5;JW>>P0 HZ?3?2X  (  @ !RE<'M@MIE@+TF@?A7Y[AJ@4))J+/2@,PZ
M9J^M@)8IG*R*@) 5KZPP@,P!(:7X@,0  (  @ !R=L#2B@ME7[P'B,A7P+=%
MA[9)=;*HAMHZ4:YSAE$IGJM'ADD5[:JOAI !D:15@0\  (  @ !R4;_YD6AE
M2KL?C\M7LK9.CE1)9[&HC2(Z0:ULC%XIJ*HAC(46)ZE8BX,!\:+J@5   (
M@ !R,+]0F--E/[IBEN!7KK5_E0I)8[#/DXTZ/ZR0DL(IMJDXDP<68*@MCR$"
M1Z&T@8H  (  @ !R$[[3H&!E/;G,GAI7L;35F^Y)9+ 6FCHZ.JO2F;8IMZA]
MF'D6A:=-CSH"C:"S@;H  (  @ !Q_KYVJ#9E0[E0I:)7N[1#HRA):Z]WH6LZ
M1:LIH%$IT*?*G$46J*:/CU("NI_S@=@  (  @ #9M7&!;*K%#G+7;C>OOW0;
M;[>9FW5)<2V"K'9K<J-JZW>*=!M2!7B@=8(V>GF@=L 2 GIY=JW7MV]7=][#
M<'#<>$>N27)!>+>82W./>32!='32>;YIQW8.>E%0ZW<T>M8U:'@A>SX0SGC"
M>JW5XFV$@QW!I&\;@F>LM7"9@<*6S'( @4F ''->@.IHDW2R@)Q/V77E@$HT
M;':\?^\/P'=!?R+4&6OJCDJ_U6V.C)"J[F\9BO"5.G"7B75^L'(.B#%G5W-V
MAP1.S'2TA>(S@'5RA-L.UG7S@S#2>FJ4F6^^.VQ ELRI5&W6E#^3KF]>D=5]
M4G#BCY1F)7)>C9%-SG.DBZ@RI71'BA@.#G34AJC1)FF*I)V\ZVLXH2.H FS/
MG:J286Y<FE%\'&_HERIE"G%HE#],XW*VD:8QX',_C\X-97/CB0[0%6BYK]2[
MW6IGJXJFZVOYIRN126V%HN=[&&\8GN9D)G"?FS-,&7'HE^\Q.G):EA0,V7,;
MB+#/1V@?NQ6[$&G+M@&F#&M3L,.07FS6JYAZ+VYJIL9C5V_XHFU+<'%#GL@P
MJG&7FY ,9W)YB&+.N6>\QF"Z@&EAP'VE86K:NF./G&Q-M&!Y;6W:KL]BIV]H
MJ>]*SG"NIE P&G#KG^X,#''WB"7*6GGD:XNW?7ID;4NCP7KF;NN/ GMH<'1Y
M57ON<?IBM7Q\<W]*TGT5=.XOX7W0=AX+.7]D=C?(Z7?H=CRV5WB1=N2BI'DM
M=X.-['G$>")X0GI=>,IAKWK_>7I)V7NB>AHN]7Q)>I *:WVQ>JC'978J@.2T
MKG;F@(>A''>5@"R,<WA#?^AV\GCU?[E@A7FM?YA(SWI:?W,N!WKE?T )MGPS
M?M;%TW2EBWJS"W5KBC.?>'8GB/*+ W;DA\1UHG>NAK]?7WAXA=!'U7DMA.\M
M,'F<A#0)&7KH@G?$6W-=EA.QEW0JD_:>!'3PD=F)EW6WC\UT97:)C>%>2'=F
MC"U&[7@@BITL;'ARB8H(DWG,A9/#)');H,*P8G,LG=><SG/RFMZ(:'2^E_1S
M2G67E3-=2W9TDJY&&W<TD(LKO7=KCWH((GC=A8#"*W&/JWZO9G)AI\R;S7,C
MH_F':'/NH#-R773/G*Q<?76QF79%:G9IEM$K+':'E5<'Q'@7A4#!;G#XMDVN
MI'''L=F:^G*!K3&&CG-$J)-QAW0FI$U;O741H(Q$SG7)G< JKG7'FB,'>'=V
MA0W \'"4P3:N%W%>O .:4G()MHF%UG*^L1YPU7.9K"M;'G2$J A$.W4[I1 J
M*G4CG(('.W;VA.2[;H*4:IRJ,8(X;'B7ZX'Y;BJ$>8'1;[]O_(&Y<4U:<(&X
M<ME#@('==$<I!(*!=5,%/(.[=HVZ3("]=+.I$("-=8V6LX!E=E:#3X!+=Q=N
MY8!"=]U9<(!0>*9"DX!X>5HH+H#\><@$R((,>M*Y''\.?LVGPG[Y?K>5F'[?
M?IR")'[8?H9MSW[<?H-8>7[X?HU!NG\G?I(G;G^.?GP$8H"1?I*WO'V4B-6F
M7'V&A^Z4#GU\AOZ R7V!AA5LD'V?A4Q787W,A)A S'W_@_8FJ'Y$@X0$"7](
M@=2V;7Q9DN&E"WQ0D3B2OWQ0CW]_A'Q=C<AK=WR C"U6:'R^BL<__GSTB9 E
M_WT8B08#OGXO@HBU57MBG0RC\WM>FJ.1J'M>F!Y^=7MNE9MJ>7N5DSQ5BGO/
MD1X_1GP)CW4E:'P/CP #?GU!@ERT=7J>ITFC#7J=I":0O'J9H-5]BGJGG8AI
MH'K4FG54SGL2E[\^K'L^E<8D['LJE" #27Q]@CFSS'H+L:"B6'H,K<:/^'G_
MJ:]\PGH$I9EHW'HQH=U4&GIYGKH^&7JCG.0D?WIJF%(#'GO=@ARS7'FGO""A
MTGFGMYB/5GF-LKY\%'F#K>EH.7FHJ9=3C'GNID$]EWH:HWPD"WG-F%\"_'M>
M@@2LV(N]:=J<^8J :[N+_8E^;7!YP(BI;PAF:8?Q<)A1[(=B<B0[Z(<@<X4A
ML8?U=$X  (>!=R2K\XH"<V6<!XCX=%6*[H@,=3)XN8<_=@AE<8:-=N)1!X8&
M=[P[$87 >'@@]H9J>,<  (65>Q6J\(AJ?-N:U8=[?/F)V8:8?0MWG87:?2%D
M<84T?490*82X?74Z481R?9D@583T?9   (/F?HJIT8;VAEJ9I(8/A;>(D(4^
MA0!VBX2&A%-C>8/M@\-/7(-Y@TDYIH,X@N,?QH.8@K@  ()O@ "HI87#C]N8
MF(3@CHJ'@X07C2)U8H-GB[9B;X+6BF1.:X)UB4HXX8(RB&X?,H)FB'L  ($N
M@ "GJX37F7Z7EH/ZEWZ&@8,PE5QT;X* DS-AC('QD3!-JH&&CW@X18%%CE(>
MM8%8C=T  ( @@ "FXH0<HS*6R(-%H(B%K8)VG:QSF8'"FLI@Q($WF"9- (#-
ME?(WQX!VE+H>48!LDE<  (  @ "F2H./K0B6(X*^J;J$^('GIB9RX8$FHHQ@
M$H"7GU9,4X YG-DW-W_?F[4=^'^GE$0  (  @ "EXX,MMQJ5I()@LS.$7H%\
MKNMR/("IJJ!??( 0IN]+UW^OI'HVS7]8H7D=GG\-E <  (  @ ">II4>:4Z/
MU),F:R-_[I%Y;-1NS) #;FI<C8ZP;_9)#XV=<70SUHT0<K(9AXZB<O8  (,6
M>KR=[).4<EJ/%I'(<TU_%) G=#-M^HZL=11;Q(U8=?E(58Q%=MDS*(NM=XH8
M_8T =X,  (&A?A^=&)(3>TZ.$)!B>WU^(8[&>Z=M (U8>]A:X(P-?!A'CHL!
M?%\R?HIC?)$8?HM\?&P  (!:@ "<&9"WA"N,_8\+@[-\]HU^@S5L"8P0@KA9
M^HK6@EA&SHG3@@DQY8DP@<T8$8H2@=D  (  @ ";)H^$C2R, (WBC!![^(Q>
MBNEK"(KVB;]9+8FUB+)&'(B^A]PQ68@7AU 7L(C&AU@  (  @ ":4HZ@EE&+
M/XT&E)A[-XM^DL1J-8H4D/!87HC5CT9%;8?4C?$PRX<IC4T728>LC 4  (
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M2)L0<E%S/)C#<SIC)I:C=")1\)2V=0P_99,J=>DJTY)U=GH0.)3U=?(  (
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MFI7/F?AO@I.)E]1?>I%@E;E.GH]UD_$\I8WBDLTHSXS8DL4/:8V=BFL  (
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M/Z.(>*)G(J"3>.57[YW2>3U'L)M4>: V )EG>?XAZYC,>A4(G9EG>J<  (
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MPY\;GKED?IP7G&U549DLFCA%4):5F*8T%Y2.F&$@QI-OE7\(Z)( A@8  (
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MZ:Q]?A9;=ZCS?=U--*64?<,]QZ*9?<8LT*!J?=$8YZ!:?;P"K)OZ?J\  (
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MM*B^HQE:+J3\H-!+N*%=GLD\>YXIG?,KZYN^FY,8T9KRD,@#K)6,@GP  (
M@ !J,K\#9K1=SKM : Y0X[>6:7!#([0%:L8T*K#H:_0C'Z\^;*(.(;%(:^,
M )\$<[   (  @ !I[;X];C)=S[HY;MA0];9";YQ#1;)W<&XT6Z\N<3$C<ZU*
M<9P.M:[H<.8  )W >"D  (  @ !IS;SG=61=G;C:=8!0U;3/=;A#)K#M=ADT
M4:V0=GPCD:N(=JX/'*S(=B8  )R)?"(  (  @ !IJ+MR?&M=8;=F?!Y0A[-=
M>^E"\J]W>]XT+:P4>_ CDZGR>_@/9ZKB>]@  )MH?Z$  (  @ !I>KHQ@W]=
M-;8C@MI05K(5@DM"M*XK@=<T%*JW@9HCE*B%@9X/J:DP@:X  )IL@    (
M@ !I3KD\BKM='K4<B<E01+$ B-Q"GJT-B! S_*F1AY(CG:<ZA\ /YJ>KAK@
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M,W_=@"* %W^G@ -O$W]Y?]Y<VW]D?\))@']F?ZTT>']^?Y0:RG_A?U<  (
M@ ">.WZPB7V/)'Y]B,]_!WY0A_]MY'XKAQU;UGX>ADI(D7XRA9DSLGY"A0T:
M.7Y9A0P  (  @ "=1'V0DNZ.)'UED95^"GTZD ]L\GT9CG=:]7T.C/A'UWT9
MB[$S''TDBMT9QWS[BF8  (  @ "<?7RJG&>-67R&FFE]/7Q7F"YL)GPTE>1:
M-'PND\E'-'PXD@HRI7PKD289<7O'CMD  (  @ ";Y7O[I?.,MGO<HU5\CGNG
MH&MK=WMYG7)9B7MQFLE&CWN#F,,R'WMME_D9('K$D/T  (  @ ";?7M_KY^,
M.7MBK&Y[_'LAJ-EJWGKDI3Q8_GK2HAU&&7K@H!HQKWK&G9\8N'GRD+<  (
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M#X=3AE=S_(9KA<-C]862A1U2]839A(% G(1<A PL6X0@@[\2=X3H@X8  (
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M:9:895EL1)3C9WA<X9-D:7),29(/:TTZ-I$@;/4EV9$X;@$+/).5;70  (
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M<H^HB^]H/XX/BO19&(R)B>M)!HLNB/TWG(HEB%LCZXG B&L*V8EGAA0  (
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MH)[,:^)@-)Q_;4%1N9I=;I5" 9B ;](PHY=*<-0<9I?/<0<$()80<=(  (
M@ !Y:Y^B<EAL[IU"<R%?G9KT<^91(9C1=*Q!@I;R=6@P1)6Q=?X<-I8%=?L$
M4I/%=TT  (  @ !XQ)X0>AUL,IN[>F%>S9EX>IQ0?)=8>MQ [)6!>QTOTY0\
M>T\;]Y1G>S$$=)' ?$P  (  @ !X&YR_@>]KB)IR@;E>'I@U@79/R)83@2U
M:)0T@/@O9)+O@-P;M9+U@-@$CH_]@)T  (  @ !WAINZB=]J^IESB3A=DY<P
MB'5/.I4)AZT_XI,BAP<O&9&YAK$;CY&=AQ8$J(YV@R8  (  @ !W$9K=D==J
M@)B>D,1=%998CX9.NI0KCD@_;9) C4XNQ)#*C/0;AI!EC*0$QXTI@SL  (
M@ !VLYI%F>MJ2Y@&F(-<W96NELM.<Y-AE0P_'I%ED]8N8X_[D](;,(^,D3T$
MU8P<@T4  (  @ !V:YG6HBMJ I>-H'M<BY4GGEQ.')+,G$0^TI#$FQDN)X]+
MF? ;!X[-DD8$V(M2@T8  (  @ !N!JTY89-B ZI=8Y)5.J>W98-'::4[9U<X
M3:,=:/<G-J(7:AL2*J1_::<  )C3;F(  (  @ !M@ZP0:3]ANJD;:H]4_:9&
M:^%'0*.@;2HX-Z%@;E,G/Z Q;QL2<:(M;HH  )<M<VD  (  @ !M%ZJ!<+-A
M.:>3<7-4F*2T<C=&WJ(#<P$W[9^Y<[HG&YYR="X2DJ 3<Y@  )6@>#   (
M@ !LH:CJ> A@KZ8#>%-3_:,L>)Q&:J!Z>.\WB9XS>4$FW9S<>6P2EYXR>/4
M )0P?&,  (  @ !L**>0?VQ@.*2O?U!3@:'9?RM%XY\F?P0W,9S0?O0FG9MP
M?O(2DIR&?N,  )+H@    (  @ !KO::'AO)?V:.EAG=3):#'A>1%A9X+A5 V
MV)NKA.4F;YHHA-42DIL#A+@  )'&@    (  @ !K9*6WCGU?D:+2C:]2WY_G
MC+)%.IT>B[LVAIJ\BQLF.YDEBTH2I9FHB:$  )#;@    (  @ !K)*4/EA!?
M5*(FE/52G)\SDY]$\YQ?DEDV0)GTD;,EZ9AAD;P2@IBMC(,  ) G@    (
M@ !J\*2AG>-?5J&DG*A2F9Z8FO=$V)NBF58V,YD7F,\E_)=JEN<2JI>IC)X
M"X^*@ @  (  @ !AL[A\8(E5]+5\8E))H;*09!@\8:_#9<,MNZV,9R4<DJU$
M9[@(7*ZD9VL  )-8<M@  (  @ !A,+>19]M5Q[1/:0))DK$5:C@\;ZX+:V8M
MY:N?;&0<\*L*;+H(\:P);&D  )(7=VX  (  @ !@ZK8+;NQ5=[*_;Y))7:]R
M<$4\0ZQ1<0<MUJG.<:<=%*D%<<D)7*FE<9T  )#A>X   (  @ !@JK1D==A5
M);$:=AE(_:W0=F$\!*JK=KHMJJ@@=PL=%Z<R=P8)J*=Z=S@  (^_?Q8  (
M@ !@:++U?-)4Z:^L?+](OJQ=?*T[N:DT?)PMCJ:5?*(=&:6.?)D)ZJ6(?1D
M ([!@    (  @ !@+K':@_%4QZZ!@Y=(HZLD@RH[FZ?Q@L$M;Z5(@H,=):00
M@J *)Z/,@CD  (WC@    (  @ !?_;#\BQ14M:V-BGU(F*H?B;P[BZ;AB0@M
M7:0QB+8=*Z+>B2 *9:)*AH@  (TS@    (  @ !?V;!7DD94LJS+D7Y(F*E(
MD'8[A:7YCXDM2Z-!CV4=&*'LCKP*?*$?AQ<  (R<@    (  @ !?P:_=F:!4
MNZPLF+U(HZB1EX$[AZ4TEH0M4J)MEBT=,Z$!DTX*DJ BAR8  (P @    (
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M6G54:HZ% 78E;&ESBW;V;B=@[G?+;]5-(GBC<6PWPWEF<L<>*'G8<U$  (
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M/&S(ET=_%&WNE3]M\&\+DR=;[G ND31(W'$WCX@T67'%CG$;D'!=C5@  (
M@ "=Q&J6HM..BFOCH%=^6&T%G9%M-6X=FKQ;-F]"F"M(,'!2EADST7#4E1\;
M.F\UD7H  (  @ "=5&GQK)>."&L]J7)]P6Q4I?)LEVU?HFM:I6Y]GTU'M6^*
MG0,S5F__FW@:Q&Y'DAD  (  @ "84'^77EJ*27]P849[&']X8_AJEG^>9G98
MV'_7:-5%QH N:PTPY8"^;-X6M8(];30  (  =ER74WT;9YB)1GTY::1Z 7UD
M:X=ID7V<;4U7[7WC;OY$^WY!<(\P.7Z]<<D6-G^S<;L  (  >F>6.7K7<+Z(
M 7L@<@%XY7MB<R=H>'NP=#=6^GP(=3I$+WQP=BDOEWS;=M@5Q7U(=H4  (
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M-W0PG,IT"W2>FGACYW4(F!-2UW6&E?- H78 E&8LVG8'D_X3]75WC7X  (
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M^H'%>)=LN(%X>2I=A($R>:A- ($->AX[(X$'>H$G+($R>JL-9H'1>ET  (
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M='Q@H:QI+WP3GSA9]GN\G+%)UGN'FJPX=GMKF> E)GL,ER,,BGM?B'H  (
M@ !^0Y'Y769QVI"18!ID:8]Q8J95NHZ#90=%OHW#9SDT'XUR:1L?THY6:A<&
M3HZ9:A0  (  ?,M]>X_H9:AQ*HZP9Z!CLHV9:7]5&8RD:T-%-HO<;.4SM8M]
M;D4?CHPG;N &:HOV;O   (  ?]Y\KHW7;=%P.HS%;R-BY(N\<&)43HK0<8Y$
MBXH-<J,S+HFI<X8?-HHC<\P&=XF?="L  (  @ ![R8OM=>EO1(KN=JIAWHGY
M=U13A8D3=_%#UXA=>'LRHX?V>.<>W8A&>.T&?(>2>;\  (  @ !ZZ8I*?@5N
M>(E8?D1A&8AK?F12L(>.?FI#48;+?FTR-H9G?G<>G8:,?F,&C(7&?J\  (
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M\9GW7T)9.YA@8;1+3I;\8_L\"I7:9@<JXI5]9YX6+I>%9\<  ),-:;\  (
M?TIP]YH.9(QE9YA'9F]8M):B:$!*X94C:?@[MI/J:X,JKY-N;*L6,)47;)0
M+Y"^;K8  (  @ !P3Y@3;$)DHI9J;8Y8#I3+;LQ*/Y--;_L[-)(1<0DJ5I&"
M<<H6%9+<<84 <XYP=#,  (  @ !ODY8Q<^-CT926=*U7*Y,'=65)C9&/=A(Z
MF9!;=J@IY8_!=PD5WI#9=JT HHQK>40  (  @ !NUY2;>Y!C%Y,,>^)6<9&"
M?!U(T) )?$,Z$H[/?&<I=8XQ?'P5G(\.?#H PXJJ?:8  (  @ !N,I-;@UIB
M?)'6@SY5W)!(@OM(.X[*@J$YA(V&@E8I,(R^@C<5=HUD@F@ X(DG@)<  (
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MIJ*.9/%-DZ!M9K! ;)Y[:%8QTIS_:;\@\YS5:HH,3Y[Z:?T  (O[<LP  (
M@ !D*Z+H:G59#*"X:[A-&9Z4;/$_^)R:;AXQ?YL1;QH@T)K!;Y4,?9QL;P8
M (I[=Z(  (  @ !CG:$'<:M8:Y[B<GI,:)S)<SP_=9K1<_4Q$9E(=(T@D)C>
M=,,,CIH9=%4  (D4>^4  (  @ !C#I]N>/!7X9U3>5A+WIL[>:T^XYD_>>PP
MM)>I>B<@39<M>C$,CI@!>BH  (?1?YP  (  @ !BD)XL@%97<9P6@&%+=9GX
M@$@^?)?S@!HP599.?_H@)96B?_@,E98>@!$  (:T@    (  @ !B)ITMA[]7
M&9L8AWE+))CPAO@^*);<AF8O^I4RA@X?YI1MAD0,K)1TA0T  (7.@    (
M@ !AU9Q>CRM6S)I*CIM*TY@<C;X]V)7]C-LOKI1$C'8?BY-^C*\,B9,EB'H
M (4A@    (  @ !AE9O+ELU6OYFNEB1*Q9=LE.\]O94HDZPOJY-*DV<?L9);
MD>\,OY'LB)\  (2<@    (  @ !9([&M6F1.&J]27(U"9*T97JHUG*L88)XG
M+*GC8B,5DZMA8F@#1:FV8UH  (CG<?T  (  @ !8<+!G87U-NJWB8QM"(ZMJ
M9+DU?ZDN9CHG.J>]9V 5ZJC/9W #TJ:_:%$  (>@=K(  (  @ !8"*Z2:&A-
M2JP+:9!!T*F):K0U.*<X:\XG&*6L;)H6"J9S;'P$.:/S;7@  (9G>MT  (
M@ !7KJRG;SI,WZHF;_U!5Z>H<+DTYZ55<6TFWZ.\<>P6"J1.<:L$A*%<<OP
M (5!?HH  (  @ !74JK]=AQ,BJB"=HI!!*7_=NHTBJ.F=S,FNJ'U=VT6":)=
M=RD$PI\&>.$  (0^@    (  @ !6_ZFM?2-,4*<J?4I U:2=?4XT7J(W?3\F
MDJ!T?3,6&Z"7?18$_YSO?A8  (->@    (  @ !6NJB@A"U,*:82A!9 N:-U
M@\<T0:$"@VPF=)\T@T<6'9\M@X<%/ILA@GH  (*M@    (  @ !6A:?2BT-,
M$Z4RBOU JJ*#BF<T,I_^B<\F79XAB<H5_YX1B38%39FK@Y8  ((6@    (
M@ !68J<TDGY,#*1ZDB) IZ&ZD54T+I\CD*0F9YTOD)D6)ISVC>0%:IAP@ZD
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MU7',7&!]9W+Q7Y!LO'0;8HQ:X75$961'P79G:!,R\G=H:F 97G?-:UH  (
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M3&7?B IW)F>FAU9F]VE3AHQ5UFKMA<Q#?VQ.A2LOB&SGA+\6Z6QRA,   (
M@ "3CV)BDA*%961FD-AV1F8VCV9F(6?MC>)5#6F2C'U"UFKTBU8O%6MJBJP6
MG6LCB<<  (  @ "2WF$NFXF$LF,[F:%UCF4.EW5E;F;#E3I47FAMDSU"+VG2
MD;(NDVHND2465FH5C>4  (  @ "29F!-I/.$+F)=HF=T^V0IGX1DV676G)Q3
MV&=ZFA=!P6C9F%,N(FD8EV 5Y6E,CLX  (  @ ".?'CG6+&!)WE27 ERMWGA
M7RAB_GJ$8A-2 7LQ9-0_G7OO9UXK/'S%:5L0WGY0:6   (  =@F-4G7A8;J
M$':99$!QG'=29IMA_7@/:--1'WC/:NL^W7F5;-,JGWI';D 0B'N%;?8  (
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M=6QYC=YL06V<C,-= FZKBY%,QF^PBGL[2'!^B:8G^G!PB6D/+G)9AW   (
M@ "'#&H"E[EYS6M8ED1KE6Q\E(%<76V)DJE,(VZ.D0\ZJF];C_8G@&\GC^P/
M '%0BB4  (  @ "&EVDDH+-Y3VI_GK1K"FN>G%%;T&RAF=Y+IVV=E](Z16Y?
MEJXG%6X)E64.IW"1B>@  (  @ "!UX&+6%UU6(%86Y=GQH%:7J%8[(%]87=(
MP8&X9!LW X(G9G$BT8,=9_@(YX2D9]\  (  >7. RWZV8.)T:'[*8U]FU'[M
M9;58%W\>9^=("W]@:?(V<'_*:[DB9X"$;,D(WX'I;)H  (  ?09_NGP-:5US
M.7Q6:REES7R7;-A7&7S<;F9',GTM;]@UOGV6<1,AYGX8<;8(Q7^&<9L  (
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MSG/[DN!A<W1SD7]3$W35D 1#HW4YCLPRRW5ZCBL?W'3@C@T(8W?.A:L  (
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MH8,(<1E9]H+'<CA,2H*,<SX]-()P=",L;8*.=,H8G(,V=+("78,*=LT  (
M@ !Q?8%"=^!EN8$=>)%9#H#J>2)+78"W>9@\F8"3>?PKZ("I>D(82(#_>A,"
M;H%$>\   (  @ !PIG^0?_)D[W]_@"-84G]5@"=*M7\A@ P\!W[X?_ KLW[I
M?^48,W[S?^@"C7^]?_@  (  @ !O]GXYB MD87XZA\97SWX-ASU**WW*AI0[
M<GV;A@LK*7U]A=07]WTJAAT"EGYV@<   (  @ !O:7TFD"1CUWTOCW)717T
MCF=)JGRUC3PZ]7Q\C& JI'Q1C#P7D'NTBUL"GWUJ@<8  (  @ !N_7Q3F$MC
M:GQ@ET)6TWPLE;]).WO6E"(ZEWN-DQ(J6WM)DO\747IUCX\"D'R@@;P  (
M@ !I Y1_5PI=T)-(6?=1KI)57,5$49&57V(U>9$E8; D<I&B8U4/3Y2,8R<
M (@):9H  (  ?M1H'9(C7JA='Y$48/U1"9 A8SA#S(]194XU%X[,9Q\D/H\<
M:%L/:9%M9_H  (8B;F0  (  @ !G48^V9C=<0([,9_U04(WG::U#'(T;:STT
MC8R1;)4CXHS";6X/7HZ";.D  (1><Z<  (  @ !F?HUQ;;Q;7HR>;O]/8HO)
M<"I"98L%<3PS[(J <B C;XJ8<IT/-XO/<@X  (*\>)H  (  @ !EKXM]=4Q:
MEHJ\=A5.FXGQ=L)!GHDN=U S9HB?=\@C XBB=_T/#(E3=Y0  (%.?.4  (
M@ !D]XGB?/!9[HDP?4M. (AG?7M!"8>??8TRWH<$?9DBV8;,?:,/"X<2?;4
M ( ;@    (  @ !D6HB(A(M94H?FA'=-:(<@A"] =H94@] R6H6P@XHB@(58
M@XD/,X4A@T<  (  @    (  @ !CWH> C$59#8;OB^5-+X8?BR1 /X4LBCLR
M+X1GB; B-H0&B@$.Y8.@A_(  (  @    (  @ !C?(:QE!E8K88ADWQ,RX5-
MDE,_X81/D08QXX-SD&XB H+MD"H.VX)=B@L  (  @    (  @ !<X)[Q5=]2
M0IU96)]&P)P(6T4Y^9K[7;@KB9I]7[X:29O-8+@&A)Q*800  (.C;4D  (
M@ !<!IS=71U1K)M97U5&-YGT87DYE9C 8W(K49@490P:4)D19;0&WYC=9>,
M ((0<C$  (  @ !;7YJ%9$-0]9D;9?Q%GY>]9Z(Y!9:$:28JZI7%:E8:)I:'
M:K4'%Y6<:N0  ("7=Q0  (  @ !:MIA :UI0.);G;)Y$T967;<XX:I1A;N,J
M:I.?;[$9W90S;\X'+I*Q<",  (  >V4  (  @ !:#)9,<H%/DI4$<UM$,).W
M=!PWQI)\=+<J I&K=2T9E)(<=2$',9 J==X  (  ?RX  (  @ !9<Y2W><A/
M!I-]>D-#L9(N>I4W49#I>L,IF) $>M\9<9 M>LP'.XWX>]$  (  @    (
M@ !8\)-K@1-.EI(^@3M#3)#J@2,V[8^7@.PI+HZE@,X9((ZI@.L'4(P<@.
M (  @    (  @ !8B))<B&!.+Y$ZB#M"YX_FA\0VD(Z&AS8HW(U^AP88MXUS
MAT<'*XJCA-D  (  @    (  @ !8-Y&.C^5."9!RCZ-"PX\5CLXV;XV0C=LH
MXHQ7C<(8^8P(C*$'<HE4A0D  (  @    (  @ !0IJIA5$U&8JB85M([3:<-
M63TN[*7D6VD@AJ797/<.EZBC70@  * (8'P  (  <2X  (  @ !/QJB46RI%
MQ*;,73<ZOZ4>7S(NA:/!8/<@6Z-M8BL.QZ6R8@<  )UL914  (  =?@  (
M@ !//:938>]%+:268XXZ0:+K91@N$:%^9GD@$Z$'9U8.T:+A9PH  )K>:>X
M (  >CP  (  @ !.QZ0+:*=$HZ)9:=XYI*"V:P$MH9]);  ?P)Z_;)$.QJ _
M;"@  )AW;RL  (  ??\  (  @ !.2Z(+;W%$*Z!K<$XY,Y[%<1$M*YU,<:0?
MC)RE<?8.P)W9<8X -98 =0D  (  @    (  @ !-UZ!J=F!#RI[3=O XY)TH
M=U4LZYN>=Y$?6)K7=YP.V)NI=UX <9/:>E0  (  @    (  @ !-<Y\3?55#
M?YV#?:(XJYO/?; LMYHW?9X?)IE=?8P.T9GE?;4 L)()?LX  (  @    (
M@ !-))X#A%E#2IQSA'$X@9JVA#(LF9D(@]\?"I@2@^0.JIAW@WL M9"9@'L
M (  @    (  @ !,\9TIBX]#*)N4BX8X9)G0BP@LAI@0BHX?$Y;SBJ\.V9<>
MB$0 W8]G@)8  (  @    (  @ "ISEKJ4ZF9K5W'5WR(\V"&6S5W4&,L7LQD
MJ&6Z8D-0X6@5994[PFG=:*,C)6EP:ND#YWEG;,NGPE:C7B"8%%G@8/Z'AUSN
M8\9V#5_89GAC@&*?:1!/UF4B:XTZTV;G;= B9678;VP#R'F<<6>EW%+,:(V6
M1U95:G.%^UFG;$QTE5S&;AQB,E^[;]].MF)><9 YY608<Q4AL6*Q=!D#K7G*
M=F*C^4]3<MV4>E,@<]J$/%:A=-1S'UGQ=<A@X5T4=KM-F5_0=Z@Y 6%\>'@A
M"F $>/D#E7GR>O6B,DQ ?1V2X%!(?42"OE/\?6AQKU=M?89?Q%JS?:I,GEV(
M?=@X.E\A?@$@>EW)?AT#@7H4?M^@L$FDAUF1BTW=AK"!D5&YA?]PG55.A4Y>
MPUBIA*E+V%N)A!XWF%T-@[,@ 5OT@Z #<'HP@BN?=D=QD8J0>$O3D V GD_/
MCH=OQ%-_C0I=]U;QBZI+)UG8BG8W&EM B8\?I%IUB98#8GI(@DF>A$6LFZ2/
MHTHNF4Q_X$X_EO!O&E'_E*M=5U5_DI]*CEALD-\VFUFYC[ ?55E CM4#5GI<
M@D*=XD1?I8:/#TCPHDE_54T)GQ5NFU#.G!9<ZU13F7)*-5<_ET@V0%AIEB >
M_EA$DO\#37IK@CR=AV(F4X".I&1E5UA^]F:56P9N.FBW7HA<86K%8>9)46RI
M91<TLVX&9^T;UVV":9L  (  ;?";Q%X0772-7F"Q8&1]VF,G8S5M0F5^9>9;
MA&>W:'=(DFFV:N0T%VL#;0$;9VI-;B   (  <M.:"UI:9UF+GEU#:69\3U_U
M:UQKS&)^;3Q:/&3B;PE'=V;[<+PS*V@M<BX:NF>1<L\  (  =X.84E;]<2:)
M[EHB<E]ZKET#<X=J>%^V=)U9"&)%=:=&=61Q=J0R866%=W8:*V4[=[8  (
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M[5 WGP1U]U.3G$1F!U:KF9E5)5F(ETE#+%O&E8TOR5P3E/L865YFD'8  (
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M\EZU>6EOK6$@>?Q@8&-9>G50$&5L>N8^1V<7>U$JT&=H>YT2-&IZ>V\  (
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M:G*65O-JI7.S6GA;I7387<E+7G7W8.<YEW<.8[LEF7?Y9=<+NGK$9@(  (
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M-V0Y?YIDW&8;?ZU6<&?0?Z-&]&E4?Y@V!FI??Y@B]VG*?Z,*WW 8?\<  (
M@ !]O& HB"9Q7F):A\ID#V1,AS15KF8-AH9&/6>8A>LU<&B3A8(BI&>DA8H*
MRV[/A$,  (  @ !]"EZ1D.5PLV#4C_9C9&+0CKM5#&24C6M%GV8>C% TU&<*
MBZ4B+F78B^D*LVWJASP  (  @ !\BUU7F9)P,E^HF"!BVV&EEDI4A&-DE&%%
M*63EDM8T>&6^DALAR61BD5$*:VYDAPL  (  @ !X_7GN4OYM!'IB5H]@#7L
M6?91UWNP72E"1WQH8!\P_WU!8JX<XGYL9",$A(#I9.T  (  >2!WLW9@6TAK
M]7<H7B]?#G?R8.]0_WBX8X5!E'E]9>8P='I'9^H<B'L%:/$$FWXI:;(  (
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MH6J^A.1:%FP*A)%,>&TEA"(]NFX0@\0M;FYU@Y<:F&V(@]X$FG@X@H,  (
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M;WS+9%Y3=GTR9GQ&+GV0:&XWBWWX:B<FZGZ*:V<2E'^):S\  (  ;WH  (
M@ !I;7EF:?A>3GH$:Z%247J%;2U%2WKW;I@VOWMH;\XF3'O;<*$2.7R/<$@
M (  =/X  (  @ !H8W;5<=-=5'>0<O5177@E<_5$47BB=-$V(WD+=8TER'E@
M=@,1]7GX=9X  (  >>(  (  @ !G<W2@><5<<'5X>F)0B'8>>M5#FG:=>R4U
M?W;_>V0E?7<?>Y(1UW>Y>V   (  ?@D  (  @ !FKG+(@;-;RW.]@=M/]G1K
M@<5#"W3C@8PTZ74Y@6,D]W4O@601J77:@8D  (  @    (  @ !F$G%)B9I;
M-')-B55/8G,!B+U"@G-TB 4T9W.[AXLD<G.)AYL12W1JAL$  (  @    (
M@ !EF' 6D89:OG$HD.I.ZW'@C]M"$W)+CK,T"W)^C@(D+W(ACC81$7,_BO
M (  @    (  @ !@IHQO49A6!XOM5-Q*=XNI5_T]G(N56N0O&HO7764>"(TI
M7OH)@(YJ7RD  (  :6D  (  ?G!?CXE26/Y5*XD16[M)JHC>7E4\]8C$8+PN
MH8CN8L8=R8GY8_@)I(JH8_T  (  ;BD  (  @ !>GX9!8&-4+88Q8IA(UX87
M9*\\+X8$9I8N!88D:"D=8H;U:/T)HX=1:.L  (  <V0  (  @ !=L(-H9\E3
M,H-W:7I'U8-Q:PT[9X-J;'HM58.);9P<XX0D;A@)AH1G;@P  (  >%L  (
M@ !<QH#H;SU23H$2<'%&]($<<84ZBX$5<F\LP($G<RT<9X&.<V,)88'C<XH
M (  ?*P  (  @ !;]'['=L11B'\*=X5&/7\?>!PYW7\7>(XL(W\4>.(<)7\H
M>/$)6G^T>9D  (  @    (  @ !;/'SP?CU0UWU/?I)%F7UO?K0Y1WUD?K<K
MFWU/?KH;T7TD?L0)C7W2?S,  (  @    (  @ !:K'MYA<M0='OYA<Y%1GP;
MA7@Y!GOQA/TK;WNVA,,;C7M:A1L)4GQ<@]\  (  @    (  @ !:.WI*C6Q0
M!7K7C2M$V7K_C&TXIWK-BY(K)WIUBT@;8GG9BS()3'LJADD  (  @    (
M@ !4I9;<4#U*C)7Q4U4_B95/5DHS)I4"6/HDSY5W6Q82[YA26Z@!@I2E78T
M (  ;10  (  @ !3GI/]5S])O)-$6> ^Q9*G7%TRB))$7ILD9Y*(8$\2V)3G
M8)D!U)$*8FD  (  <?@  (  @ !2RY$,7C](W)!Y8&<^"H_L8FTQV(^'9#DC
MY(^O98<2FY&D98X"!HW+9V<  (  =N0  (  @ !2 (Y"94!(!HW(9O$]*(U+
M:($Q+XSI:>$C5(T!:M 22HZ3:IT"'XKP;*0  (  >SP  (  @ !1.8O(;%5'
M1(MI;98\:XKW;K4P=(J/;YXBXXJ*<#T1_HN^;^8"+8AX<EH  (  ?P8  (
M@ !0@HFK<X!&F8EG=%P[THC]=0TOZHB,=8\B:8AH==<1XHD?=8@"1895>$H
M (  @    (  @ !/XH?B>JE&#(>X>RT[6(=4>W4O@(;5>Y<B!(:3>Z81J(;E
M>XL"<(2"?5<  (  @    (  @ !/8(9C@<1%B(92@? ZV(7V@=<O#(5P@:<A
MFX41@:81+X48@<,"88,1@74  (  @    (  @ !.^(4TB3-%6H5&B4 ZN83S
MB+TO$(0XB!0A[8.#B!H1Y(,=AR0"UX&T@>P  (  @    (  @ !(6*)Q3E\^
MWZ$\44(T::!G4_8H6: H5DX9PZ%S5[\(HZ,;6&4  )&47^0  (  <'H  (
M@ !'1Y_F5/X]^)[L5W<S>)X:6<4GCYVO6[P919ZA7-@(IY]S75D  ([<9'X
M (  =5$  (  @ !&FYT-6YT]-)PM7:PRPIMO7XXFVYKY8208PYN]8>H(EYO.
M8E   (Q#:5$  (  >:D  (  @ !&!YH\8CH\A)EO8]PQ]IB\958F0)A'9HL8
M1YCM9P8(@)A,9U\  (G>;GP  (  ?8   (  @ !%9)>X:.@[W9<,:BDQ7I98
M:T EJ)72; H7^Y9,;$L(=94/;*\  (?&="\  (  @    (  @ !$Q963;[X[
M2I4*<*<PY)1;<5\E3).^<=,7N)0 <= (DI(I<F0  (80>6<  (  @    (
M@ !$.Y/"=IPZSY-:=SDP@I*N=Y8D^)(!=[P7:)(>=YD(@H_2>)L  (2R?<H
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M E1M8]=SF5>Y9E!D EK/:*]35EVE:O)!8U_Q;1 MT6"=;MH5L6/@;XH  (
M=V*-RDR3:NN 1U!S;*=Q]50!;E9BM%=2;_)2*5I9<7A :ERO<N<M$UT*=!@5
M.&&X=',  (  >W:,'$BN=(9^Q4S;=7MPDE"M=F-A8%0L=SQ1-%=<> T_E%F[
M>-0L<5FZ>7L4U5_G>:P  (  ?O.*L45(?AM]A$FX?DUO>DW$?G)@9E%V?HQ0
M3E2_?JD^]%<=?M0K]5; ?PD4AUYD?U@  (  @ ")B$);AYY\?D<&APUNETM$
MAFU?GD\>A<U/E%)^A4,^6%34A-\KFU1,A,0455VBA/H  (  @ "(H3_PD/][
MLD3*CZUMXDDPCDI? 4TFC/-/ U"5B] ]RU+<BODK+5)'BL84*EWKB9L  (
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M%U=Y:T)HE5IT;0M:%%TP;KI*/U^@<$HY%&%5<;0E^6#(<KT-N&EX<L\  (
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M2$I3E/)D'TX1DS95\U%;D7I&NE0+D!<V,55/CU$CWU50CV0,X6H\B+4  (
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M7EMO<;U=M5X)<NU0 F!4= %!+6)!=0 PFF,[==8=N&+[=CT&YW15=X0  (
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M!G*34:18>'/-555*T74&6-X[S78M7" JYW=#7MD6G7@P8!8 IW[F8EH  (
M>-IO#VSK5=QCNVYJ61-77V_<7"Y)Z7$V7R$[#7)J8= J4G-:9 ,60W0)9-<
MSGZD9R$  (  ?(1MEFBG7?=B4FIX8)%6-FPC8Q%(V&V=96DZ)F[=9X@IFF^?
M:3<5QW!]::T X'Z&;"H  (  ?[QL-62T9A=@^&;$:!)4XFB<:?='WFHV:[TY
M1FN$;4TH\&P1;H(576UN;JD \WYE<98  (  @ !JXV$C;D9?N&-F;Z13NV5D
M<.U&RF<7<A8XHVAN<R(H;6C#<^<5&VK)<]H!$WXN=QX  (  @ !IQ5X#=H!>
MR&!V=U!2YV*6=_]%]&1<>) WS66C>1$GV66J>7@4KFB:>6<!$GXP>_0  (
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MJ';!6 ),_7>Z6P5 *GBD7=@QR'F"8%,A''IG8A$,M'RL8CT  (  :D@  (
M?O1A\7&G7(-777+N7Q=+[G0289 _+W4/8]<P^G7F9= @@79X9QX,?'E!9QH
M (  ;U8  (  @ !@L&W59#)6&V]19C1*L'"7:!T^-W&L:=\P'G)^:UD?U7*S
M;#\,,'98;"   (  =-$  (  @ !?A&I<:^A5 VP$;5])I&UI;KP]+&Z+;_,O
M>&]/</D?2V\=<8@+_G/0<6X  (  >;(  (  @ !>=F=&<[)4!FD9=*1(OFJ<
M=70\:FO'=B(NSVQT=K ? VO;=OT+]'&9=Q\  (  ?=,  (  @ !=F&23>WA3
M2V:5>_-(&V@S?#H[TFE??&(N,VGH?(L>>FD=?*P+UV_"?3T  (  @    (
M@ !<YV)*@S)2I&1M@T%'?68A@P<[0V=,@K,MJV>S@HH=[&;J@K<+BFY<@GL
M (  @    (  @ !<8F!MBNQ2)F*JBJ5&_V1NB?4ZS&65B2TM2V78B,P=J&4F
MB2H+66T^AJH  (  @    (  @ !8\X-<3&!.JX.63]U#A(0$4SXW"H2:5F$H
MO(6 60(75H>)6EP$<8?56Z(  (  :34  (  ?AI7>'].4WQ-A'_55HI">8!@
M67$V+(#Q7!LH$X&Q7DD6\8,S7T,$C80(8&X  (  ;?$  (  @ !62'M:6K-,
M5'P?74!!>WS)7ZHU/GU?8=<G4WX"8Y$6:W[[9"\$BH"V958  (  <R0  (
M@ !5*W>B8?5+,7B28_U 5GE59>0T6'GW9YHFB'I_:.85TWKX:2\$<WW<:F\
M (  >"   (  @ !4&G0Y:4=**752:LX_578O;#8S8G;0;6PEXG<W;E@51W>$
M;EX$6GMI;^,  (  ?'(  (  @ !3)G$L<*M)0W)O<;L^A'-D<J8RH70&<V<E
M-W0]<^L5!72'<],$8GE#==\  (  @    (  @ !246YW> I(<V_G>*D]Q'#V
M>1HQ]7&6>6LDH7&;>9\4HG(F>8 $D'A*>W,  (  @    (  @ !1IFPG?W1'
M[VW,?[@]6&[W?[$QJ&^)?XTD96]2?XD40G Z?[ $7'BB@"<  (  @    (
M@ !1)6H_AO)';VP!AND\W&U!AG@Q.6W.A?,D$6UDA=L4$&ZDA;@$47BU@NL
M (  @    (  @ !,[XV@2M=#8(UJ3C8XU8V#46DLO8W_5$0>58]?5E<,@)'=
M5O8  (F*7#0  (  ;*T  (  @ !+DXG+491".(GF5(LWM8H75U KQ8I_6;X=
MF8N86VP,.8T56]8  (9.8-\  (  <8X  (  @ !*A87Z6&=!'(9+6NDVO(:4
M73PJUX;S7SL<W(?48(0+Y(B>8+\  (-49;H  (  =H@  (  @ !)C8)47T=
M%X+(84\UJX,C8RLJ 8.!9+\<((0Q9:L+B(2W9<(  ("J:MX  (  >NL  (
M@ !(FW[Q9CP_)W^/9\XTPG_^:3<I'H!/:E<;E8#!:O@+.X%@:OT  (  <'D
M (  ?KX  (  @ !'NGOB;4P^37RP;G S_GTV;V@H<7U]<"(:^WVF<&P+$WZ&
M<(<  (  =E4  (  @    (  @ !&^'DQ=%T]E7HM=1TS7'K+=:<GYGL%=@,:
M<GKG=A,*U'PV=FP  (  >T<  (  @    (  @ !&3W;0>VP\ZW@#>] RO7B\
M>_@G77CM?  9^GB$>_L*;7IO?*T  (  ?W@  (  @    (  @ !%TW3;@KP\
MAW9$@N R;W<@@I\G.G<Y@DL:)'9R@EL*SGBU@@8  (  @    (  @    (
M@ ! F9E%2*LWLIBM2^4MHYB43M0AJIE143L2>9PR4E,#4IF^5&   (2R7XH
M (  < T  (  @  _-Y6\3P0V5)6.4=DL+)695&(@2Y9 5F81;IBA5R\#"945
M63\  (&N9$   (  =0$  (  @  ^09(657@U.I(95^$K'I(^6@(?.I+76Z 0
MH)3#7!\"TI#/7BX  (  :2,  (  >70  (  @  ];XY]6_TT4(Z?7?8J&([5
M7ZD>9X]D8.@/_Y#782H"JHT&8SH  (  ;E8  (  ?5@  (  @  \FHL48IHS
M=(MI9"8I1(NM970=F8PB9DL/IXT09F<"F8G%:(<  (  = 0  (  @    (
M@  [RX?R:5TRIHB':H$HD(CE:VL=!HE":_$//XFD:]8"IH<#;C   (  >3L
M (  @    (  @  [%84I<"DQ](7^<.\G^(9W<7D<C8:_<;0.YX:N<88"EH3%
M=%,  (  ?9@  (  @    (  @  Z?(*[=PHQ78//=WPG=H1E=ZX<+H27=Z@.
MHX1)=Y(";H,">BL  (  @    (  @    (  @  Z#8"J?B<PYX'V?D\G"X*L
M?C$;XX+,?@$.D8)<?BX"B8&(?O\  (  @    (  @    (  @    /__  #_
M_P  __\  &UF=#(     ! ,)   !                     0
M          $   $   (   (D!!T%V@=I"-D*-@N%#,<-_P\Q$%X1BQ*W$^(5
M"Q8R%U<8>1F8&K4;TASO'B4?62"'(;(BVB/_)2,F1"=F*(8IIRK'*^@M""XH
M+T@P:3&),J8SPC3>-?LW&#@U.5$Z;3N)/*4]PC[>/_A!$4(I0T)$7$5U1H]'
MJ4C#2=U*]TP232Q.0T]94&]1AE*<4[)4R57?5O98#5DC6CI;45QF77A>BE^;
M8*UAOF+/8^!D\68"9Q)H(VDS:D)K4FQ>;6=N<6]Z<(-QC'*4<YQTHW6J=K%W
MMWB]><-ZR'O-?,Y]S7[,?\N R8''@L6#PH2_A;N&MX>SB*Z)J8JDBYZ,F(V1
MCH:/>Y!PD6226)-,E$"5,Y8FEQF8#)C_F?*:Y)O6G,B=NYZMGY^@CJ%\HFJC
M5Z1%I3.F(*<.I_RHZJG7JL6KLZRAK8^N?:]KL%FQ1[(VLR2T$K4 M>VVVK?(
MN+6YH[J0NWZ\:[U9OD>_-< BP1#!_L+LP]K$Q\6UQJ/'D<A^R6S*6<M$S"[-
M&,X!SNO/U="^T:?2D--YU&'52=8QUQC8 -CFV<W:LMN8W'W=8MY'WRS@$.#T
MX=CBN^.>Y'OE5^8SYP[GZ.C!Z9KJ<>M([!WL\.W#[I;O=O!5\3/R#_+J\\/T
MG/5S]DGW'O?S^,;YE?IA^RG[Z_RG_5S^"_ZT_UK__P   >@#IP4L!H0'OPCG
M"@0+%@P<#1X.' \9$!<1%!(0$PL4!!3\%?,6YA?8&,P9UAK>&^$<X1W?'ML?
MUB#1(<LBQ".^)+@ELR:N)ZHHIBFB*J KGBR=+9HNE2^1,(TQB3*&,X,T@35_
M-G\W?SB .8(Z?SM^/'P]?#Y\/WU ?T&"0H5#B42-19)&F$>:2)M)G4J?2Z-,
MIDVJ3J]/M%"Z4<!2QU/.5-55UU;95]M8WEG@6N-;YUSJ7>U>\5_U8/AA_&,
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M?\Y_6,V9?ZA^S;3:?YE^>9P4?Z-^98-,?\9^A6J%?_Y^P%&_@&-_/3D @1*
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M06#6@<>+9$H8@9>(:#.B@8N%!.=<A(NHH-%L@YVD%;L0@M2?NJ1;@C>;E(V
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MC.Y^("QJB3M_T[VBHYR#<*OBG_*"?)G.G'.!M8=NF1^!)73%E>^ TF(*DL>
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M=W&I^':;>(.BKE_R>:J:_$E>>O:2NS+\?'2)C.<G=%720=#V=-G)F[I,=6K
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MBC6 /*JCB/1_T99:A]5_AH&OAM)_96SHA>-_9UA A/U_>T/,A"Q_NB_N@VZ
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MOCN P6?PM^R #5M*L6U_L4[#JK9_D$*)H[Y_I3;^G'1_UBQ@E,V .R-5C.J
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ME-B OHJRDH* 7GHZD$^ &FERCBE_\UB9C M_Y4@2B>-_XC?^A[I_^2D(A7^
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MDKE^BR(,BZ-_CGD#O0."D&U<MX&!N6&AL<F!#U7GJ]> HDH\I;& ;3[EGU*
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M>N)Y9&H&>ZEZ0E8.?(E[,D).?9=\22\Y?N=]D\CH=H* W;;E=TF @:0Y> >
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MGVR  &X@G!)_OV$@F+)_EE/BE4U_B$;&D=A_CSHWCD=_HRYEBJ!_RR0(ANF
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M*EC"G\1^+$RYFU5^4T#IEL9^DS6]D@U^Y2MFC3)_5"*/B%!_TGMPJU6%27
MISR$BF1'HPB#TUA=GK:#)TQZFDJ"F$# E<^"'S6WD2F!K"N'C&>!22+;AZ6
M\WL9JGZ,!F^SIF6*OF/^HBR)9%@6G=B("4P[F6^&NT"AE/*%?36SD%Z$12NC
MB[:#$2,:AQ:![7K0J=>2EF]YI;N0PV/&H7J.P5?<G1^,K4P$F+N*HT"#E$6(
MHC6WCZR&I2N]BQV$IB-.AJ&"P7J?J4^8[V]+I2^6BF.3H.B3W5>IG(B1#$O5
MF"2.0D!7D[R+?#6HCR6(P"O7BIR&!2-XAD&#<7ITJ/F?)F]-I,F<.6./H&R8
MQU>.F_*5%TO#EX*1@D!6DQ^. #6SCJB*D2OIBD"'*2.:A?6$ '&!N:-HW&:K
MM01JDEO%L#%L;5#*JO]N<$70I6EPHCL-GX%S"S#RF5AUG">CDNEX>A_"C')[
MAW%$N.1OUV:KM!)PR%O4KP)Q\5#DJ:IS3D7QI ATXSL]GB5VK#$UF 9XF2@*
MD:YZQ"!7BU=]#7$HMZ)V<V: LLIVR5NZK;!W3%#,J$]X$T7KHK-Y"CM.G-YZ
M,3%CEM)[=BA?D)5\Z"#7BF)^;7$'MD-\SV9,L6]\HEMYK%M\F5"CIP-\PT72
MH71]'SM/F[)]FS&%E;Q^+RBFCYU^Y"%%B9!_IW#>M12#%&8FL$*"<%M1JR^!
MX%!TI=N!9T7!H%.!&#M0FJ: Z#&CE,: PRCCCL2 MR&CB-Z NG"XM"R)4F83
MKT^(-EM"JC6'$5!CI.&%]46PGV"$\#M5F;>$!3&^D^N#*BD7C@B"7B'PB$B!
MIW"7LWF/8&8+KHN-R%L^J6:,"5!;I!"*046IGI>(C#M:F/B&Z3'9DS"%52E&
MC6J#TB(PA\Z";W!^LO65-V8-K?"3(5M"J+R0P%!9HU^.146?G>F+W#M4F%R)
MA3'FDJ"'0REKC.>%$B)DAVJ#%7!MLI::V687K7*8/5M-J"R5,5!<HL>1_$6C
MG5..W#M@E]"+U#'PDB>(Y2E]C(2&%R*-AQR#F\ZA;1AF^KOH;NQI/:BU<*UK
M<93J<EYMG("U=!)OSFQ6==IR%U@@=[]T?T0=>=]W)S#)?%EZ/LR^:K1QQ;IJ
M;,%RY*=@;JUT!I.^<(MU,'^D<FYV9VMB=&=WLU=)=GYY$D-T>,]ZFS!B>WA\
M8LKY:*=\?KBT:M)\@:7H;.1\C9)>;N9\MGYP</)\\VI<<Q=]059T=5M]ED+7
M=]I]^S '>JQ^;,D[9M>'#;;X:1N&"J0Y:T2%%I#K;6B$-7TI;YR#=FE.<>J"
MOU6E=%B" T)%=O^!/2^W>?> 5L>G95"1>[5Q9Z:/BZ*V:>6-GH]\;!Z+NWOU
M;F^)Z&A,<..(*%3B<W6&4T'!=D"$6B]R>5B"&\9?9!R;UK0R9GV9 Z%]:,:6
M&HY-:Q"3+WKA;7203&=D;_Z-:E0S<K**>$%+=9R'22\X>,^#M,5;8R:F$K,U
M98^B6Z!]9]R><HU1:BZ:>'G];*66AF:E;T22B%.?<@R.9$#J=1*)_B\(>%R%
M'<298G"P(+)V9-RK@9^R9R6FE(R :7>AA'DS:_B<>67X;JR78E,?<8F2$T"7
M=*",;R[@=_V&5<0:8?>YZ['T9&"T4I\99I^N5XO8:.BH+7B1:VNB!V5M;BF;
MT%*G<1657$ _=$".C"[ =["'6L""=/]F-*^/=?YHIIWE=O]J]8MX> %M,'B*
M>0YO<V5K>BYQT%)\>VET4#_$?-9W%"W3?I!Z2[\G<LAP>ZZ!<_]QU)SC=2-S
M'HJ$=D9T9W>C=W1UO62=>+YW*E'/>B5XKC]%>\1Z8BV.?:]\6+VO<-%ZGZSJ
M<B=Z\IMS<VI[0(DH=*][F79X=@5\ V.C=WE\?U$'>0I]!#ZZ>M-]G"U2?.1^
M2+PH;Q>$F:M9<(*#_IGI<=V#7H?;<SV"P750=+J".V*P=E.!O%!0> N!/#Y!
M>?N MBT=?#" &+J[;9^.>ZGX;QN-!)B-<(N+>H:-<@")Z'0_<Y.(7F',=5&&
MXD^F=RN%5#W4>3Z#J"SO>Y.!PKF2;'684ZC4;?R6 )=O;W63AH5[</J0^7-'
M<J".;&$!='&+W4\0=FN)/SUT>)V&:BS)>PV#0+BF:XBB"Z?H;1:>W):";I*;
M;(26<!^7W7)X<=B436!7<[R0KTZ3=<B,[STF>!6(\2RI>IV$C[?W:M>KF*<T
M;&>GB)7!;>&C'(/4;VV>@G&_<3"9Y5^Y<RJ5.4X@=4F07SSB=Z6+-BR/>D"%
MK[>&:F&TZ*:S:^VO[94I;5RJ?(,R;N"DSW$I<*6?(%\\<JJ98$VV=-J3;#R5
M=TJ-*2QZ>?6&GK+5?2%EI*-U?41H+),Y?8%JB8(<?=!LSW!P?BYO'UZ2?IUQ
MCDSP?R%T(CN-?\]W 2L(@+IZ5;'$>PQO2Z)J>VEPSY(;>\=R/H$3?#)SIV^$
M?*UU'5W*?4!VK$Q/?>IX5#LB?L)Z+2KF?]5\3+"<>2AXX:$J>:MY<I$->B1Y
M^8 ">JMZ?FZ5>T1[%%T%>_I[O$NZ?,M\<CK#?<U]/RK(?PE^):]&=WJ"2Y_0
M>!&"!X^A>*6!KG[/>42!46V%>@.! EPG>MV O$L5>]* =SI>?/B ,"JN?E1_
MVZX$=A6+H9Z/=KJ*CHYF=V")7'VD>!*(%VR5>.2&U5M>>>&%G$J#>O6$5CH'
M?#R"]BJ7?;>!:ZSZ=/B4\)V(=:B3#HUF=E:0^'RP=Q:.QFNX=_B,CEJP>06*
M4DH$>C>(!SF\>YN%C"J$?3&"T*PF=!2>'YRQ=,R;:XR/=7V8;'OA=D2516K^
M=S>2%EH:>%6.V$F=>92+?#F >Q.'YRIU?,&$!ZN'<VBG))P)="2CF8O==-.?
MJWLR=9F;A6I9=I:75EF+=\F3%4DW>1F.KCE+>J2* 2IH?&6%$*L?<O*O\9N.
M<ZZKB8M-=%2FHGJ<=1&A=6G2=@^</ED>=TN6]DC;>*V1@CD+>DR+S"I>?!R%
M[*6+A7QE.Y=_A,AGR(B-A$1J+'BV@]YL>VA1@X-NV%>]@S-Q5T=R@O!S_C=R
M@LQV]"AJ@M1Z7*2O@XAN4Y:5@Q)O[X>,@J]Q='?&@EQR]F=^@AATB%<-@>5V
M-$;J@<%W_#<C@<!Y^2AK@>A\/J.P@<!W195H@7!X"89_@2-XNW; @.EY;V:?
M@+]Z+U9:@*U[ T9H@*I[YC;;@,U\Y"AK@19^ :*;@!B (Y1(?]^ ((53?ZZ
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MB'A^,"+5A:1^_WX$FG:!P7*QE^"!B&;OE3V!0EK<DHV ]DZSC]F NT*6C2J
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M\RZ%E0]V<"8HCXUY*!\VBC![]6E;L(1PPE^3K&#_XO__24-#7U!23T9)3$4
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M:0R'&H_2:QF&/'[_;2J%4FW>;U^$;ER/<<>#F$N@=%6"NCL7=R:!SRNE>D"
MR:YO97Z1?Y[J9[*/X(Z\:=&.&'WX:_F,.FSP;DB*6UO5<,J(?DL9<X"&F3K&
M=G>$CRN.>;*"4:V!9%B:^9X!9IJ8?XW7:,*5QWT?:OF2\&PL;6&0%ELW;_Z-
M-$JL<LJ*.CJ&=>.'$RM[>3N#J*S08WBD0)U/9<"@YXT=9^R=.7QH:BB98&N
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M@-1]@R4G@0Y^<HOZ@%" @7^[@!F E'+E?^* A665?[. 7E@<?Y2 .TIM?Z"
M(3TY?[R "C"3?_]_]25&@%]_WXLH?QF(CW\&?O*']7(Z?L.'(V3I?IN&*U=L
M?I&%+DGP?JZ$.#SF?NB#0#!S?TR"-B5A?\N!((I_?AJ0;GY:??^/)7&4?=2-
MBV1.?;6+P5;=?;N)[DF#?>F(%SRP?C&&.3!C?K*$/R5W?U""-8GZ?528%GW5
M?4*6''$.?1B3N&/0?/B1$E9H?0B.8DD9?4R+JCQM?:2(ZC!5?C2&"26)?NR#
M'HF8?,.?A'UL?+:<W'"<?(B9I6-@?&.6'%8,?'.2B$C6?,&.[CPW?2V+2# W
M?=2'BB67?IR#WH.ED)Q?<WA:CPIB8VQGC:ME1E_+C%IH*5+0BOUK(47(B9IN
M1#D[B#=QE"T\AN5U/B*)A:]Y2X+MCJUG6'>\C4]IA&O'C %KK5]%BKAMWU)E
MB6MP)T5_B"1RE#D7AM]U)BU*A;!W_2+6A)M[%X(QC+YO%7;EBXMPD&L3BE1R
M"5Z;B2%SB5'@A^]U'D4BALAVSSCHA:9XG2U0A)MZFB,:@ZA\OX%@BO9VKG8(
MB=MWB&HOB+YX5EWTAZ!Y)U%4AH]Z D3$A8IZ\3BYA(Q[\BU3@Z9]$"-5@M5^
M08"3B7%^,'51B&A^<FF#AUQ^F5U"AE)^KE#MA4U^QT1ZA&M^\CB7@XY_(BU:
M@LQ_7".'@B!_F7_>B#F%K72FAT.%3&CAAC^$O5RZA3B$#5!YA$*#6$1+@VB"
MM3A_@JR"&"U=@@^!<B.P@8B QW],AT:-!70UAEZ,"FAWA5J*OUP_A$^)0$_]
M@V>'P4/I@J&&3CA:@>^$WRU:@7&#5R/3@0J!RG[8AHR4)W/!A:N2D&@"A*60
MA5O4@Y>.-$^<@K.+YD.+@@&)GC@@@5Z'7BU9@.Z% 2/O@*."HWY_A@&;%'-E
MA2*8Y&>?A!>6$EMU@P.2YD]/@AR/P4-7@7&,I3@#@.")CRU3@(B&9B0%@%&#
M57@SF69?*6V_ES)B"&+!E2%DZ5<ZDP5GUDMOD,1JWC^OCFQN%S1]C AQ?2GI
MB:IU/2"JAVAY4'>.E[AFGVU&E:5HQ6).DY!J]U;BD6UM/$LRCS-OGS^0C/%R
M+#1^BJ=TWRH7B&EWVB$2AD9[#7;WE>%MX6R9D^]O96'"D>MP\%9@C]9RD4K3
MC;-T2C]8BXYV*#1RB65X(RH\ATIZ4R%MA4A\I'9.E"!T^6OBDD%UZ6$"D%1V
MV%72CE9WTTIAC%%XX#\2BDMZ!S19B$1[0RI5ADQ\HR&[A&U^$W6FDJ=\ &M
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MF$R 4E=8E9* .DU DK* %$,VC\1__#EHC--__# \B>N ""?>AQ: &R#MA'"
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MH!6#04[PG'6"T47@F)2"3SS[E):!X31UD(N!B2RTC'Z!126YB**!!B 0A1B
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MQT1[>,!SF36S>P5VM"@A?9-Z,9P::_5M%8ZY;;QNUX"W;W)PBG',<3-R-&*
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M;Y.$^G0-</R$>6:D<G6#V%C_=!>#-$M3=>Z"F#X@=_6!_S%_>CJ!7B8Y?*.
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MA,A^OQ_]@SA_<F*"D,& Z5GBCS6! %#IC6> WT>^BVV ICZAB7: ?C78AXV
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M/JB]56=I@)G]63YK@(K$7/]M?GK18,-O@VIX9*]QEEG\:-5SP4G>;3=V##I
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M=?5]^"<^>@A^WHZ/7,:!Y()27_*!VW5W8PF!K&@)9C&!9UI9:8R!(DR9;2N
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M=:"!E5L"=J*!<E"W=YV!+T94>+J ]3P<>@. S#*&>VB KRF0?0* C2($?I^
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M?+2$KU)Q?/N$*DD^?1R#>T (?56"X3<&?;^"6RZT?CV!ZB<7?N^!:R#'?[6
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M2*^ 97YX3D" 5' \4]> 0F&H6:> -%+\7\F -$2W9C> /#<5;/J 4RKH<\V
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M>B]\UD35>R9]+3V&>^!]@C9 ?(Q]\B\Z?5)^>"D#?@]_#B-O?O]_EA[A?_V
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M@5)^VSU5@9U^YC<Q@6Q^^3$D@0]_,"M4@,I_?"8H@)9_T2&:@)Z &QX%@,2
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M1$'_I$92_:I$8/2Q0F[KN$%[Y,%"AM_,1HW3SU*7P<1AI[.[;;.KM7B[I;&
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M<\*&J7/"AJESPH:I_[0D)>S*%B/-Y1,LN?8;1J?Z)EN8[C5LC.5$>H3>4X.
MV6**?-5LCWC2<9-UT'65<\]XEW'.>IAPS7R9;\U^FF[,@)MMS(*<;,N$G&S+
MA)QLRX2<;,N$G&S+A)QLRX2<;,N$G&S+A)QLRX2<;,N$G&S+A)QLRX2<;,N$
MG&S+A)QLRX2<]<$5&='?#!B\\Q,QJO\>1YK\+%F.\CQGA.I+<GWE6'IYX&.
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MHS0:_ZTS'OZX,B#PQ34@X],_'-C>12;*VTTZO=-43+#.6UVCR6%KF,1G=XW
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M4];6BU/6UHM3UM:+4];6BU/6UHM3UM:+_Y<D"?^I)@K^N!P)YLX1!<[C%PC
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MT"@'U-\R"\G?/AF]VT<LL=9//:315DR9S5Q9CLEB983&:&Y[Q&]V=,%U?&W
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M0_^154+^F%9!_9Y70/VF6$#\J5A _*E80/RI6$#\J5A _*E80/RI6$#\J5A
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MASTX_XP]-_^3/C;_E3XV_Y4^-O^5/C;_E3XV_Y4^-O^5/C;_E3XV_Y4^JL0
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M_Z5*.?^M2SC_N4LX_[E+./^Y2SC_N4LX_[E+./^Y2SC_N4LX_[E+OK4" +#
M @"DS@, E]X% (__% *&_R,(??\N$'/_-1AJ_SP>8O]")%O_2"A5_TXL4/]4
M+TS_6C%(_U\S1?]D-4+_:C8__W W/?]V.3O_?#HY_X,[./^+/#;_DSTU_YH^
M-/^A/C/_JC\S_ZH_,_^J/S/_JC\S_ZH_,_^J/S/_JC\S_ZH_L;H! */(  "6
MU@  B_0) 8/_%@)Y_R &;_\H#&?_,!)?_S<76/\^&U+_1!],_THB2/]0)$3_
M529!_UHG/O]?*3O_9"HZ_VDK./]N+#;_="TT_WHN,_^!+S'_B# P_X\P+O^6
M,2W_GC(M_YXR+?^>,BW_GC(M_YXR+?^>,BW_GC(M_YXRI,(  );/  "(WP
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M6SC_=V-!_W!L2/]L=T__9X)4_V.-6?U@EES\79]?^ENG8OA9KF3W6+9F]5?
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M23K\STDY_.-).?SC23G\XTDY_.-).?SC23G\XTDY_.-)QZT  +>W @"JPP(
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MI#H[]K [.O>_/#GXSSPX]^@\./?L/#CW[#PX]^P\./?L/#CW[#PX]^P\OZH
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M&B/_H!HB_ZH;(?^M&R'_K1LA_ZT;(?^M&R'_K1LA_ZT;FKX  (O*  !^UP
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M9'5\\V1U?/-D=7SS9'5\\V1U?/-D_VD6 ?]X$P'_AQ0 _Y,5 /&>%0#CJ!8
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MKDM(Q;]+1\;82T?%[4M&P_E-1<+_3D7"_TY%PO].1<+_3D7"_TY%PO].WY
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M+S?ST"\W\^<O-O'S+S;Q\R\V\?,O-O'S+S;Q\R\V\?,ON:<  *NP  "?NP
MDL8  (;0 0![W04 =/<1 &WW' %F^"8#7_@O!EKY. I4^4 .4/I'$4SZ3A1(
M^U461?M;&$+[8AI _&@</?QP'3K]>!\X_8(@-OV-(C3^F",R_J0D,?^Q)3#_
MOR8O_\\F+O_C)B[_XR8N_^,F+O_C)B[_XR8N_^,FK:T  )^W  "2P@  ALT
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M5X)O_5>";_U7@F_]5X)O_5>";_U7_V 5 ?]N$0'_>Q, _X84 /:/%@#GEA@
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M0$7 Z#]$OO9!0[W_0D.\_T-#O/]#0[S_0T.\_T-#O/]#UHT  ,:;  "XI0
MK:X  **V  "8OP( C<@& (/1"P!_TAH >=(J W+2-PALT4(/9M%+%6'04QI<
MSUL?6,]B(U3.:2=1SG$J3<YZ+4K.@S!(SHXR1<Z:-$/.J#5"SK@V0<_--4'.
MZ#5 S?4W/\O^.3[+_SD^R_\Y/LO_.3[+_SD^R_\YRI8  +RB  "OJ@  H[,
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M&RO[ZQLK^^L;*_OK&RO[ZQLK^^L;J*H  )JT  "-OP  @,D  '33  !GW@
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M2))@_T>28/]'DF#_1Y)@_T>28/]'_U@5 ?]C$0'_;A( _W<5 /M^& #M@QT
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M2%&8YDA1E_5(49?_1U&6_T=1EO]'49;_1U&6_T=1EO]']G<  -B%  #)D0
MOYL! +2B  "KJ   H;   )JR$0"4LR(!C;(P!86Q/ Q^KT84>*Y.&W*L5B%M
MJUPG:*EC+&2H:C!@IW$T7*9Y.%BE@CM5I(P^4:.80$^CI4)-H[1#3*/(0TRC
MY$-+H?1#2Z#_1$N@_T1+H/]$2Z#_1$N@_T1+H/]$XWT  ,^+  #"E@  MY\
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M+3S%_RX\Q?\N/,7_+CS%_RX\Q?\NQ),  +:?  "II@  G:X  )*W  "&OP
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M"1S_W0D<_]T)F+   (JZ  !\Q   ;\T  &+8  !5W@  2>0  $3[!0 __PX
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M_S^"9/\__UD. /]D"P#_;@H ZG<( -M]" #4@@H S(02 ,.%) &[@S0%LX!
M#*U\2Q2F>50;H79<(9QS9":8<6LKE&]R+Y%M>3..:X$VBVJ).8AHDCR%9YL_
M@F:F08!FLD-^9L%$?6;91'QG[T-\9_Q!?&C_0'QH_T!\:/\_?&C_/WQH_S]\
M:/\__UL, /]G"0#W<0< WGH% -2 !P#.A0D QX<1 +Z((@&VAS$$KX0^"ZB!
M21.B?5(:G'I:()=W82:3=6@KCW-O+XMQ=S.(;WXVA6Z&.H)MCSU_:YD_?&NC
M0GEJL$-X:K]$=FK4179K[4-V:_M"=FO_079L_T!V;/] =FS_0'9L_T!V;/]
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M1%]]Y4-@??9"8'W_06%]_T!A??] 87W_0&%]_T!A??] _V<  .-T  #2?P
MQX@! +Z/ @"VE0$ KI@& *::%0"?FB8"F)DS!I&7/PR+E4@4A9-0&G^16"!Z
MCU\E=HUE*G*+;"YNBG,R:HA[-F:'A#ECAHX\8(69/UV$ID%;A+1"6H3'0UJ$
MXT):@_1!6X/_0%N#_T!;@_\_6X/_/UN#_S];@_\__VH  -YX  #-@P  PHP
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M.$F;_SE)F_\Y29O_.4F;_SE)F_\YVWH  ,B'  "\D@  L9H  *:@  "<I@
MD:P  (>Q" "!LA8 ?+,F 7:R,P1QLCT):[%'#F:P3Q-BKU887JY='%JM9"!7
MK&LC5*QS)E"K?"E-JH8L2JJ2+TBIGS!&J:TR1:F_,D2JVC)$J.\R0Z?[,T.F
M_S-#I?\T0Z7_-$.E_S1#I?\TT($  ,&.  "UF   J9\  )ZE  "3K   B+(
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M&C/._QHSSO\:LYD  *:A  ":J0  CK$  (&Y  !UP   :L<  %[- P!4U @
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M:@(0_W@"#O^' @[_E@(-_Z0"#/^P @S_O@(,_\("#/_" @S_P@(,_\("A[8
M 'F_  !KR0  7M,  %#;  !#X   ..4  "_P   K_P  )_\( "3_#@ A_Q,
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M.FQJY#IM:_4X;6O_-VUK_S9M:_\V;6O_-FUK_S9M:_\V_UL  .MG  #9<0
MS'D  ,-^ @"[@@, M(0) *V%& "FA2@!GX0U!9F"0 J3?TD0C7U2%HE[61N$
M>6 ?@'=G(WQU;B=Y='4J=G-]+G-RAC%P<9 T;7";-FMOISAI;[4Z:&_'.F=O
MXCIG;_0X:&__-VAO_S9H;_\V:&__-FAO_S9H;_\V_UX  .1J  #3=   R'P
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M-EA^_S58?O\U6'[_-5A^_S58?O\UZ6@  -1T  #&?@  NX<  +*-  "HD0
MGI0  ):6#@"1EQP BY<K H66-P5_E$$*>9-)$'22415PD%@9;(]?'6B.9B%E
MC&TE88MT*%Z*?2Q;B8<O6(B2,56'GS-3AZTU4H>^-5&'UC51ANXU4H7[-%*%
M_S12A?\S4H7_,U*%_S-2A?\SXVP  ,YY  #!@P  MHL  *R1  "BE0  EYD
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M*4"@_RE H/\IR7X  +J+  "OE   HYH  )B@  "-I0  @JH  '6P  !LLPP
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MC04JW)T&*=RM!BC=P08HW=X&)]OO!R;9^0@FV/X))MC^"2;8_@DFV/X)I)T
M )BE  "+K0  ?K0  '&\  !EPP  6<D  $W-  !#TP$ .MD& #7D#0 SY!8
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M 0?_D $%_Z !!/^N 03_O $#_\<! __' 0/_QP$#_\<!@[0  '6]  !GQ@
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M+GI:XRYZ6_4M>ES_+'E<_RMZ7/\J>ES_*GI<_RIZ7/\J_U$  /);  #>9
MSVH  ,=N @# < 0 NG , +)Q&@"K<2D!I7 W Y]N0@>:;$L,EFI4$9)H7!6.
M9F,8BV5I&XAC<!Z%8G@A@F%_)(!@B"9]7Y$I>U^<*WA>IRUV7K4N=5[&+W1>
MX2]T7_,N=%__+'1@_RMT8/\K=&#_*W1@_RMT8/\K_U,  .A>  #99P  RVT
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M+61K_RUE:_\L96O_+&5K_RQE:_\L]%L  -UF  #+;P  P'8  +=[  "O?@
MIGX! )]_$ "9@!\ DX M HU_.06(?4,)@WM+#7YZ4Q)Z>%H6=G=A&7-U9QQP
M=&X?;7-V(FIR?R9H<8DH97"4*V)PH"U@;ZTO7V^]+UYOU"]>;^TO7V_[+5]O
M_RQ@;_\L8&__+&!O_RQ@;_\LZUX  -AI  #'<@  O'D  +-_  "K@@  H8(
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M*4^ _RE/@/\IVVH  ,=U  "Z?P  L(<  *:,  "<CP  CY$  (:3!0" E!(
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MD14ZJZ 6.:NP%SBKPQ<XJN$7-ZGS&#>G_ADVIO\:-J;_&C:F_QHVIO\:NH0
M *Z/  "BE@  EYL  (NA  !_I@  <ZL  &>O  !:M   4[8, %&W%P!/MR0
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M B'5N0(AU=("(-/K B#2]@,?T?\$']'_!!_1_P0?T?\$GYL  )2B  "'J0
M>;$  &VX  !@O@  5,,  $G'   ^RP  -= ! "W5!@ EVPL )-X2 "/>'  B
MWR4 (> N "#@-P ?X4  'N%* !WB4P <XUX &^-J !KD>  8Y(@!%^6: 1;F
MK $5YL !%.?= 1/E[P$3X_H!$^/Z 1/C^@$3X_H!EJ(  (FI  ![L0  ;KD
M &'   !4Q@  2,H  #W/   STP  *MD  "+> @ >ZPH '.P0 !OM%P 9[1\
M%^XF !7N+0 4[S4 $_ ] !'P1@ 0\5  #_);  [R:0 -\W@ #/2*  OUG  *
M]:X "?;"  GVV0 (]>T "/7M  CU[0 (]>T BZD  'VR  !ON@  8L(  %7)
M  !'S@  .](  #'8   GW0  '^$  !GH   6^ 8 %/H- !+[$@ 0_!< #OP=
M  W](P ,_2D "OXP  C_.  &_T$  _],  #_6   _V8  /]W  #_B0  _YL
M /^K  #_NP  _\X  /_/  #_SP  _\\ ?[(  '&Z  !CPP  5LL  $C1   Z
MU@  +]T  "7A   <Y0  %.D  !'W   /_P$ #?\)  O_#0 (_Q  !O\4  /_
M&   _QX  /\C  #_*@  _S(  /\\  #_1P  _U0  /]C  #_<P  _X4  /^7
M  #_I   _[(  /^R  #_L@  _[( _R(I ?\C)P'_(R@!_R K ?\<,0'_&CT!
M_QA) ?\65@+_%&("_Q-N O\2> +_$H("_Q*+ O\2D@+_$ID"_Q*> O\2I +_
M$JD"_Q*O O\2M@+_$KT"_Q+' O\2U +]$N4"^A+Q O<2^@+U$_\"]!/_ _03
M_P/T$_\#]!/_ _03_P/T$_\#_R0G ?\F) '_)B0!_R0G ?\B+P'_(#H!_QY&
M ?\<4P+_&E\"_QAJ O\7=0+_%W\"_Q>( O\7CP+_%Y8"_Q>< O\7H0+_%Z<"
M_Q>M O\7LP/^%[L#_1?% _H7T0/W%^0"]!?O O$8^@+O&/\#[AC_!.X8_P3M
M&/\%[1C_!>T8_P7M&/\%_R<C ?\I( #_*2  _R@C /\I+0'_)S<!_R5# ?\C
M3P+_(5L"_Q]F O\=<0+_'7L#_QV$ _\=C /^'9,#_!R9 _L<GP/Z'*0#^1RJ
M _<<L0/V'+D#]1W" _,=S@/P'>$#[!WN ^D>^03H'O\%YA[_!N4>_P;E'O\'
MY1[_!^4>_P?E'O\'_RL? /\M' #_+1L _RX@ /\O*0#_+S0!_RP_ ?\J2P+_
M*%<"_R9B OTE;0/Z)'<#^".  _8CB /U(X\#\R.5!/(CFP3Q(Z$$[R.H!.XC
MK@3M([8$ZR._!.HCS 3G(^ $XR3M!. D^0;>)/\'W"3_"-LD_PG:)/\)VB3_
M"=HD_PG:)/\)_RX; /\Q%P#_,A8 _S4< /\V)0#_-B\!_S0Z ?\Q1@'[+U("
M]RU= O,L: /P*W(#[BI[!.PJA 3J*HL$Z"J2!><IF 7F*9X%Y"FE!>,IK 7A
M*;0%X"J]!=XJR@7;*MX%UBKM!](J^ G/*_\*S2K_"\PJ_PS+*O\,RRK_#,LJ
M_PS+*O\,_S(7 /\U$@#_.!( _SL8 /\]( #_/"H _CLU ?<Y00'Q-DT"[#18
M N@S8P/E,FT$XS)V!. Q?P7>,8<%W#".!MHPE0;8,)L'UB^B!]0OJ0C2+[$(
MT"^Z"<\PQ@G-,-@)R3'J"L8Q]PS#,?\.P3'_#\ Q_P^_,?\/OS'_$+\Q_Q"_
M,?\0_S83 /\Y#P#_/A  _T$4 /]#&@#_0B, ]4$N .T^.@'G/48!X3Q3 MTZ
M7@/9.6@$U#AQ!M$X>@?/-X$(S3>("<LVCPK*-I8*R#:="\8UI S%-:P,PS6U
M#<$UP W -L\.O3;F#KDV]!"W-O\1M3;_$K0V_Q.S-O\3LS;_$[,V_Q.S-O\3
M_SD0 /\]"P#_0PT _T<0 /](% #U1QP ZT8F .-$,@#<1$$!U$-- L]!6 3+
M0&(&R#]K",4^= G#/7L+P3V##+\\B@V]/) .NSR7#[H[GQ"X.Z<0MCNP$;4[
MNQ*S.\D2L3O@$ZX\\12K//T5J3S_%J@\_Q:H//\6ISS_%J<\_Q:G//\6_ST-
M /]"" #_2 H _TL, /I,#P#L3!0 X4H= -9*+ #.2SL!R4I( L1(4P3 1UT'
MO$9F";I$;@NW0W8-M4-]#K-"A!"Q08L1L$&2$JY FA.L0*(4JD"K%:E MA:G
M0,07ID#9%Z-![1B@0?L8GT'_&9Y!_QF=0?\9G4+_&)U"_QB=0O\8_T ) /]&
M!0#_3 4 \4\' .90"0#C3PT U4\5 ,Q1)P#%438!OU!# KI/3@6V35@(LTQA
M"K!*:0VM27 /JTAX$:E'?Q*G1X84I4:-%:-&E1:A19X8GT6G&9Y%LAJ<1;\:
MFD71&YA%Z1N61O@<E4;_&Y1&_QN31O\;DT?_&Y-'_QN31_\;_T(% /]* 0#R
M4   X50! -E6!0#350D S%42 ,-6(@"\5S(!MU8_ K)42@6M4U0(JE%="Z=0
M9 ZD3FP0HDUS$I],>A2=3($6FTN)%YE*D1F72ID:E4FC&Y-)KAV22;L>D$G,
M'HY*Y1Z-2O8>BTO_'HM+_QV*2_\=BDO_'8I+_QV*2_\=_T4  /]-  #E5
MV5D  ,]; P#*6P8 Q%H/ +M;'@"U7"X!KUL[ JI:1@6F6% (HE99"Y]58 Z<
M4V@1F5)O$Y=1=A654'T7DU"$&9!/C1J.3I8<C$Z?'HI.JA^(3K<@AT[((85.
MXB&$3_,@@T__((-/_Q^"4/\?@E#_'H)0_QZ"4/\>_T<  /-1  #?6   T5T
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M(V];_R)O6_\B;UO_(6];_R%O6_\A^D\  .%:  #/8@  Q&<  +MK  "S;
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M(EQJ_R)<:O\BXUL  ,YF  # ;@  MG0  *QY  "C>P  F'D  )!Z"P"*>Q8
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MDAQ(AJ =1H:O'D6%PAY%A=\>183R'D6#_AY%@O\>18+_'D6"_QY%@O\>RFT
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M#S.ENP\SI=0/,Z3N#S*B^Q RH?\1,J'_$3*A_Q$RH?\1M((  *B,  "=D@
MDI<  (:<  !YH0  ;:4  &&I  !5K   2Z\% $>P$ !%L!P 1+$G $*Q,@!!
MLCL /[)# 3VR2P$[LE,".;); S>R9 0ULFX%,[)Y!C&RAP<OL98(+K*F""VR
MN DLLM (++#L"2NO^0HKKO\+*JW_"RJM_PLJK?\+K8L  *"2  "5F   B9T
M 'VC  !QJ   9*T  %FQ  !-M   0K@  #NZ"@ XNQ, -[P> #6\*0 TO3(
M,[T[ #*]1  QODP +[Y5 2Z^7@$LOF@!*KYT BF^@@(GOY$#)K^B R2_M ,C
MO\L#([[H R.\]P0BN_\%(KO_!2*[_P4BN_\%I)(  )B8  ",G@  @*4  '.K
M  !GL   6[4  $^Y  !$O   .L   ##$!  JQPL *,@3 "?)'0 FR2< )<DP
M "3*.0 CRD( (LM+ "'+50 @S%\ '\QL !W->@ <S8H &\V< !G.K@$8SL4
M&,WD !C,] $8ROP!&,K_ AC*_P(8RO\"FYD  (^?  ""I@  =:T  &BS  !<
MN0  4+T  $3!   YQ   ,,@  "C, 0 @T 8 &=4+ !;7$  5V!D %=DB !39
M*P 3VC0 $]H] !+;2  1W%, $=U? !#=;0 0WGX #M^1  [@I  -X+@ #.#2
M  O?[0 ,WO< #-W[  S=^P ,W?L DI\  (6G  !WK@  :K4  %V\  !0P0
M1,4  #C)   NS0  )=$  ![5   6V@$ $=X& !#G#0 .YQ( #>@9  SH(0 +
MZ2D "NHQ  GJ.P 'ZT4 !>M1  3K7@ #ZVX  >N   #JE   ZJ<  .N\  #K
MT@  Z^D  .SO  #L[P  [.\ AZ<  'FO  !KMP  7KX  %'%  !#R0  -\T
M "W1   CU@  &]L  !/?   .XP  #.X"  KV"@ ']@X !?82  /V&   ]1X
M /4E  #U+@  ]3<  /9"  #V3@  ]ET  /9N  #V@0  ]I4  />G  #WMP
M^,<  /C0  #XT   ^-  >Z\  &VX  !@P   4L@  $3-   WT0  *]<  "'<
M   8X   $>0   SG   '[P  !/H   '_ P  _P@  /\-  #^$   _A0  /\:
M  #_(0  _RD  /\S  #_/@  _TL  /];  #_;   _X   /^2  #_H0  _ZT
M /^S  #_LP  _[, _QPF /\<) #_&B4 _Q4G /\1+@#_$#H _PY' ?\-4P'_
M"U\!_PIK ?\*=0'_"G\!_PJ' ?\*C@'_"I4!_PJ; ?\)H '_":4 _PFK /\)
ML0#_";@ _PG! /X)S #\"=X ^0GK /4)]@#S"?\ \@K_ /$*_P'Q"_\!\0O_
M ?$+_P'Q"_\!_Q\C /\?(0#_'B$ _QDD /\7+ #_%3< _Q-$ /\14 '_$%P!
M_PYG ?\.<@'_#GL!_PZ$ ?\.BP'_#I(!_PZ8 ?\.G0'_#J,!_@ZH ?P.K@'[
M#K4 ^@Z^ /@.R0#U#ML \@[J .X.]0#L#O\!ZP__ >H/_P'J$/\!Z1#_ >D0
M_P'I$/\!_R(? /\B' #_(1P _Q\@ /\?*0#_'#0 _QI  /\73 '_%5@!_Q1C
M ?\3;@'_$W<!_A.  ?P3B 'Z$HX!^1*5 ?@2F@'V$J !]1*F ?02K 'S$K,!
M\1*\ ? 2QP'M$M@!Z1/H >83]0'D%/\!XA3_ N$5_P+A%?\"X!7_ N 5_P+@
M%?\"_R4; /\F%P#_)!8 _R4< /\F)0#_)#  _R$[ /\?2 #_'50!_1M? ?D:
M:0'W&G,!]!E\ ?(9A 'Q&8L![QF1 >X9EP'L&9T!ZQFC >D9J@'H&;$!YQFZ
M >49Q0'C&=4!WQKH =P;]0+8&_\"U1S_ ]0<_P/3'/\$TAS_!-(<_P32'/\$
M_RD7 /\J$P#_*1( _RP8 /\L(0#_+"L _RDW /TG0P#W)4\!\R-: >\B9 'L
M(6X!Z2%W ><A?P'E(88!Y"&- >(@E 'A()H!WR"@ =X@IP'<(:\!VB&X M@A
MPP+5(=,"T2+G LTB] /*(_\$R"/_!<<C_P;&(_\&QB/_!L8C_P;&(_\&_RP2
M /\N#P#_,!  _S,4 /\S&P#_,B4 ^C P /(N/ #L+$D YRI5 >,J7P'@*6D!
MW2ER =HH>@'7*(("U2B) M,HD +1*)8#SRB< \XHHP/,**L#RBBS \DHO@3'
M*,P$Q2GB!,$J\0:^*OX'O"K_"+HJ_PBZ*O\(N2K_";DJ_PFY*O\)_S / /\R
M"P#_-@T _S@0 /\Y%0#Y-QX [S4H .<S-0#@,D( VS)/ -4Q6@'0,60"S3!M
M LLP=0/),'P#QR^#!,4OB@3$+Y$%PB^7!<$OG@:_+Z8&O2^O!KPON0>Z+\<'
MN##=![4P[@FR,/L*L##_"ZXP_PNN,/\+K3#_"ZTP_PNM,/\+_S,, /\V!@#_
M/ D _SX, /T]$ #O/!4 Y#D? -LY+0#2.CP S3I) <@Y5 '$.5X"P3AG [\W
M;P2]-W8%NS9]!KDVA >W-HL'MC62"+0UF@FS-:$)L36J"J\UM NN-<$+K#74
M"ZDVZ@RF-O@-I3;_#J,W_PZB-_\.HC?_#J(W_PZB-_\._S<' /\[ @#_0 ,
M\D(% .E""0#E/PX V#X6 ,Y )P#'038 PD%$ ;U!3P*Y0%D#MC]A!+0^:0:Q
M/7$'KSUX"*X\?PFL/(8*JCN-"ZD[E0RG.YT-I3NF#:,ZL ZB.[P/H#O-#YX[
MYA";//41FCS_$9D\_Q&8//\1F#S_$9@\_Q&8//\1_SH! /]   #O10  X4@
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MAD;]%H9&_Q:%1_\5A4?_%85'_Q6%1_\5_S\  .Q(  #=3P  SU,  ,95  #
M4P, NU$, +-2&0"M4RD J%,V :-20@*?44L$G%!4!IE/7 B63F,*E$UJ#)%,
M<0Z/2W@/C4M_$8M*AQ*)2I 4ATF:%85)I1>#2;$8@DG &(%*UAE_2NT8?DO\
M&'Y+_Q=]2_\7?4O_%GU+_Q9]2_\6_T,  .9,  #64P  R5@  ,!9  "Z6 $
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M&65:_QEE6O\9Z$\  --9  #$80  N68  +!H  "G:0  GF4  )=F#0"19QD
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MDQE4;* ;4FNO'%%KP1Q1:]P<46OQ&U)K_AI2:O\:4FK_&5)J_QE2:O\9U%P
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M%D& NA9 @-(607_M%D%^^Q9!??\607W_%D%]_Q9!??\6PFH  +5U  "J?0
MGX(  )*#  "%A   >84  &J)  !DB@, 8(P0 %V-&P!;CB< 6(XR %6..P%3
MCD,"4(Y* TZ-4@5,C5D&28Q@"$>,: I%BW(,0HM]#D"*B0\^BI@1/(JG$CN*
MN!(ZBL\2.XCK$CN'^A,[AO\3.X;_$SN&_Q,[AO\3O'$  *][  "E@P  F8<
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M R6I]00EJ/\%):?_!26G_P4EI_\%IXD  )N/  "1E   A)D  'B>  !KH@
M7Z8  %.J  !(K0  /;   #2S P OM0X +;46 "RU(  KMBD *K8R "FW.@ H
MMT, )[=, ":X50 DN%\ ([AK "*X> $@N(@!'[B9 1VYJP$<N< !'+C? 1RV
M\@$;M?P"&[3_ ANT_P(;M/\"GX\  )25  "(FP  >Z$  &ZF  !BJP  5K
M $JS   _M@  -;D  "R\   DOP8 '\(- !W"%  <PAX &\,F !K#+P 9Q#@
M&,1! !?$2@ 6Q54 %<5A !3&;P 3QG\ $L:1 !''I  0Q[D #\?4 !#&[@ 0
MQ/H $,/_ !##_P 0P_\ EY8  (N<  !^H@  <:D  &2O  !8M   2[@  $"[
M   UO@  *\$  "/%   ;R0$ %,P& !#0"P .T1$ #=$9  W1(0 ,T2H #-$T
M  O2/@ *TDD "=-5  G38@ (TW( !M2$  74F  $U*L  ]7   '5W  !U>T
M =7V  '5]@ !U?8 CIT  ("D  !SJP  9K$  %FX  !,O0  /\   #3#   J
MQP  (<H  !G.   2T@  #=8!  G;!0 &W T !-P1  /=&  !WB   -XH  #?
M,0  X#P  .%'  #B5   XV,  .-T  #DB   Y)L  .6N  #EP0  Y=4  .;G
M  #FYP  YN< @Z0  '6L  !HLP  6KL  $W!  ! Q   ,\@  "C,   ?T
M%]0  !#9   +W0  !>$   #D    Y0<  .8-  #G$0  Z!8  .D=  #J)0
MZRX  .TY  #O10  \%,  /%D  #Q=@  \HH  /.<  #SK0  ]+L  /3(  #T
MR   ],@ =ZT  &JU  !<O0  3\0  $#)   SS0  )]$  !W6   4W   #N
M  CC   !Y@   .H   #N    [@   .\$  #P"@  \0X  /,2  #T&   ]B
M /@J  #Z-0  _4,  /Y2  #_8P  _W8  /^)  #_F@  _Z8  /^P  #_L
M_[  _Q8C /\5(0#_$2$ _PTD /\)*P#_!C< _P-$ /\ 40#_ %T _P!H /\
M<@#_ 'L _P"# /\ B@#_ )$ _P"6 /\ G #_ *$ _0"F /L K #Y +, ]P"[
M /4 Q0#S -$ \@#D /$ \0#O /H [@#_ .X _P#M /\ [0#_ .T _P#M /\
M_QD@ /\8'0#_%1T _Q ? /\.*0#_##0 _PI! /\'30#_!5D _P1D /\$;@#_
M W< _P.  /\#AP#_ XT _0*3 /L"F0#Y IX ]P*D /4"J@#S ;  \0&X .\!
MP@#M <\ ZP'C .H![P#H OL YP3_ .8%_P#F!O\ Y@;_ .8&_P#F!O\ _QP;
M /\;&0#_%Q@ _Q4= /\3)0#_$3  _Q ] /\.20#_#%4 _PM@ /\+:@#]"W,
M^PM\ /D*@P#W"HH ]0J0 /0*E@#S"IL \0JA .\)IP#M":X ZPFV .@)P #F
M"<T Y GB .(*\ #?"_L W@S_ -P-_P#<#?\ VPW_ =L-_P';#?\!_Q\7 /\>
M$P#_&Q( _QP9 /\;(@#_&"P _Q4X /\31 #^$E  ^1%; /409@#S$&\ \!!W
M .X0?P#L$(8 ZA", .D0D@#H$)@ Y@^> .4/I0#C#ZP X0^T . /O@#>#\P
MVA#A -41\ #2$OL SQ+_ <X3_P'-$_\!S1/_ <P3_P',$_\!_R(2 /\B#P#_
M(0\ _R(4 /\B' #_("< _QTR /@;/@#R&4L [AA6 .H78 #G%FH Y!9R .(6
M>@#@%H( WA:( -P6CP#;%I4 V1:; -86H@#4%JD TA:Q - 7NP#.%\D S!C>
M ,@9[@'%&OL!PQK_ L$;_P+ &_\"P!O_ L ;_P+ &_\"_R8. /\E"P#_* P
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M"I,W_PJ2-_\*DC?_"I(W_PJ2-_\*_S,  /8Z  #D/P  V$(  ,Y" 0#)/@8
MQ#L/ +L^'0"U/RP L3\Z *T_10&I/T\!ICY8 J,]7P.A/6<$GSQM!9T\= :<
M.WL&FCN"!Y@[B@B6.Y,)E3J<"I,ZI@N1.K(+D#O #(X[U0R,/.P-BCS[#8D\
M_PV)//\,B#S_#(@\_PR(//\,_S<  .H_  #<10  SDD  ,5)  "_1@( ND,,
M +-$&0"M12< J$8U *1%00&@14L"G413 II#6P.80V(%ED)I!I1!< >2078(
MD$!^"8Y A@J-0(X+BT"8#(E H@V'0*X.A4"\#X1 SP^"0>D/@4'Y#X!!_P^
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M$'%+_Q!Q2_\0[$,  -E,  #(4P  O5<  +18  "L5P  I5(! )Y3#P"85!P
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MDQ)>6: 475FN%5M9OQ9;6=@66UGO%5M9_11<6?\37%G_$EQ9_Q)<6?\2W%
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M%$UGN11,9\\43&;K%$UF^Q--9O\23F7_$DYE_Q).9?\2S%H  +QC  "P:@
MI6\  )AN  ",;0  @&P  '=M  !Q;@L ;6\4 &EP(0!F<2P 9'$V 6%Q/@%>
M<48"7'!- UEP5 57<%L&56]B"%-O:@I0;G,,3FY^#DQMBA!*;9@126RG$DAL
MN!-';,T31VSJ$TAK^A)(:_\22&K_$4AJ_Q%(:O\1QUX  +AG  "L;@  H7(
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M"S:"]@LV@?\,-H#_##: _PPV@/\,MF\  *IX  "??P  D'X  (-_  !W@
M:X(  %Z'  !5B@  3HP& $J.$ !(CQH 1X\E $60+P!$D#@ 0I!  $"01P$_
MD$\!/9!6 CN07P(YD&@#-X]S!#6/@ 4SCXX&,8^>!S".KP<OCL,'+X[A!R^,
M] @OB_\(+XK_""^*_PDOBO\)L'8  *5_  "8A   BH0  'V%  !PAP  98H
M %J.  !/D@  1I4  $&8#  ^F!0 /9D? #N9*  ZFC$ .9HZ #>:0@ VFDH
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M 1.N_P$3KO\!FHT  )"2  "$EP  =9H  &B?  !;HP  4*@  $6L   [L
M,;(  ">U   @N   &+H' !2\#@ 3O!4 $KP> !&])@ 1O2X $+TW !"^00 .
MODP #KY7  V^90 ,OW0 "[^&  J^F0 (OJP ![["  >^WP (OO  "+WZ  B]
M_  (O?P DY0  (>9  !ZGP  ;*4  &"J  !3KP  1[,  #RV   QN   )[L
M !^^   7P0  $<0!  S("  (R0X !\D4  ;)'  %R20 !,HL  /*-@ "RD
M ,M,  #+60  RV@  ,MY  #,C   RY\  ,NS  #+R   S.(  ,SO  #,\0
MS/$ BIH  'RA  !OIP  8JT  %6S  !(N   .[L  #"^   FP0  '<0  !7(
M   /RP  "LX   32 @  TPH  -,/  #4%   U1H  -8B  #7*@  V30  -H_
M  #<2P  W%H  -UJ  #=?0  W9$  -VD  #>M@  WL@  -[>  #>X@  WN(
M?Z(  '&I  !DL   5K<  $F\   \P   +\0  "3'   ;RP  $\\   W2   '
MU@   -L   #>    WP,  . )  #A#@  XA(  .,7  #E'@  YB<  .@Q  #J
M/0  [$L  .Q:  #M;   [H   .Z4  #NI0  [K0  .["  #NQ@  [L8 =*H
M &:R  !8N0  2\   #W%   OR0  ),T  !G1   1U@  "]L   />    X0
M .4   #H    Z0   .H   #K!@  [0L  .\/  #P$P  \AH  /0C  #W+@
M^3L  /M*  #\6P  _6T  /V   #^DP  _J(  /ZM  #^KP  _J\ _Q ? /\.
M'0#_"AT _P$@ /\ * #_ #4 _P!! /\ 3@#_ %H _P!E /\ ;@#_ '< _P!_
M /X A@#\ (P ^P"2 /D EP#X )P ]P"B /8 IP#U *T \P"U /( O0#Q ,D
M[P#< .X ZP#M /< [ #_ .L _P#J /\ Z@#_ .H _P#J /\ _Q,< /\1&0#_
M#1D _P8< /\#)0#_ #$ _P ^ /\ 2@#_ %8 _P!A /\ :P#] ', ^@![ /<
M@P#U (D ] "/ /( E #Q )D \ "? .X I #M *L [ "R .H N@#H ,8 YP#6
M .4 Z #D /4 XP#^ .( _P#A /\ X0#_ .$ _P#A /\ _Q48 /\3% #_#Q0
M_PT9 /\+(@#_""T _P0Y /\!1@#_ %$ _@!< /H 9@#V &\ \@!W .\ ?@#M
M (4 ZP"+ .H D0#H )8 YP"< .8 H0#D *@ XP"O .$ N #? ,, W0#1 -L
MY@#9 /, UP#] -4"_P#4 O\ U /_ -0#_P#4 _\ _Q@3 /\5$ #_$@\ _Q(5
M /\1'0#_#B@ _PPT /\*00#Y"$P ]097 /$&80#M!FH Z05R .8%>@#D!8$
MX@6' . &C0#?!I( W0:8 -L&G@#9!J4 UP:M -0&M0#2!L  T ?/ ,X(Y0#,
M"?0 R@O_ ,@,_P#'#/\ QPS_ ,8,_P#&#/\ _QL. /\9# #_& T _Q@1 /\7
M& #_%"( ^Q$N /,0.@#M#D8 Z U2 .4-7 #A#64 W@UM -L-=0#8#7P U0V"
M -,-B0#1#8\ T V5 ,X-G #-#J, RPZK ,D.M #(#L  Q@[/ ,,0Y@# $?4
MO1+_ +P2_P"[$O\ NA+_ ;H2_P&Z$O\!_Q\* /\<! #_'P@ _Q\- /\=$@#X
M&AL [A8F .84,P#@$S\ VA-+ -035@#0$U\ SA1H ,L4;P#)%'< QQ5] ,85
MA #$%8H PQ61 ,$6F # %I\ OA:G +P7L "[%[P N1?+ +<8X@"S&?(!L1K_
M :\;_P&N&_\!KAO_ :T;_P&M&_\!_R($ /\B  #_)0( _"0' /<A# #L'1(
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M!X(W_P>"-_\']#(  .,[  #200  QD0  +U#  "W/P  L3L) *H[% "E/"(
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MDPMJ2)\,:$BM#6=)O0UF2=0.94GM#65*_ QE2O\+94K_"V5*_PME2O\+X$0
M ,M-  "]4@  LE8  *95  "<4@  E4X  (Y."0")3Q0 A5 @ (%0+ !^4#<
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M#E95N ]65<P/5E7I#E95^0U65?\-5U3_#%=4_PQ75/\,T4T  ,!6  "S7
MIUX  )I=  "/7   AE@  ']9  !Y6@T =%L7 '%;(P!N6RX :ULW &A;0 %E
M6T<!8UI. F%:50-?6EP$75IC!5Q::P9:670(6%E_"E99BPM469@-4UBF#E)9
MM@Y16<H/45GG#E%8^ U26/\-4EC_#%)8_PQ26/\,S5$  +Q9  "P7P  HV$
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M#$)F]0Q#9O\+0V7_"T-E_PM#9?\+OUP  +%D  "F:@  EFD  (EI  !]:0
M<6D  &=J  !B; $ 76T- %EN%@!7;R$ 57 K %-P-0!1<#T 4'!% 4YP3 %,
M<%,"2G!: TAP8@1&;VL%1&]U!D)O@@= ;H\)/VZ>"CUNKPH];L(*/&[@"CUM
M] H];/\*/6O_"CYK_PH^:_\*NF   *UI  "@;@  D6T  (1M  !X;0  ;&X
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M!"F$_P0IA/\$JG0  )Y[  ".>@  @'H  '1[  !H?@  78$  %*%  !)B0
M08P  #F0!0 UD0\ ,Y(7 #*2(0 QDBD ,),R "Z3.@ MDT$ +)-* "N44@ J
ME%P *)1G ">4<P$EE((!))23 2*3I $AD[<!()// 2&2[ $@D/H"((__ B"/
M_P(@C_\"I'P  )>   "'?P  >X   &Z"  !BA0  5XD  $V.  !"D@  .I8
M #*9   JG D *)T1 ":=&0 EG2( ))XJ ".>,@ BGCH (9Y" "">2P ?GU4
M'I]@ !R?;0 ;GWP &I^- !B?GP 7G[( %I_) !:>Z  6G/< %IO_ 1>;_P$7
MF_\!G8,  (^&  ""A@  =(<  &>+  !;CP  4),  $:8   \G   ,Z   "NC
M   CI@  '*@+ !JI$0 8J1@ %ZDA !:J*0 5JC$ %*HY !.J0P 3JTT $JM8
M !&K90 0JW0 #JN&  ZKF0 -JZP #*O!  RJWP ,J?( #:C\  VH_P -J/\
MEHH  (F,  !ZC0  ;)$  &"5  !4F@  29\  #^C   UIP  *ZH  ".N   ;
ML   %+,!  ^U"@ -MA  #+86  NV'P *MB< ";8O  BV.0 'MT, !K=/  2W
M6P #MVH  K=[  "WC@  MZ$  +:T  "VRP  MN4  +7Q  "U]P  M?< CY$
M (&4  !REP  99P  %BA  !,I@  0:L  #>O   LL@  ([4  !JX   3NP
M#KT   G !0 #P0T  ,$1  #!%P  PAX  ,(F  #"+P  PSD  ,1$  #$4
MQ%X  ,5O  #%@0  Q94  ,6H  #%O   Q-$  ,3F  #$[@  Q.X AI@  'F>
M  !KHP  7:D  %"N  !$LP  -[8  "RY   BO   &;\  !'"   ,Q0  !L@
M  #+    S <  ,P-  #-$0  S18  ,X=  #/)   T"T  -(X  #41   U%(
M -5A  #5<P  UH<  -:;  #6K0  U[\  -C.  #8W0  V-T >Z   &ZF  !@
MK0  4[,  $6X   XO   *[\  "'"   7Q@  $,D   K,   "T    -0   #7
M    V    -H%  #;"P  W X  -X3  #?&0  X2$  .,J  #E-@  YT,  .=3
M  #H9   Z7<  .F,  #JGP  ZJX  .JZ  #JPP  ZL, <*@  &*O  !5M@
M1[P  #G    LQ   (,@  !;,   .T   !]0   #9    W0   .$   #C
MY    .8   #G 0  Z0<  .L,  #L$   [A4  / =  #S)P  ]C,  /=#  #X
M5   ^68  /EZ  #ZC@  ^IX  /NI  #[L   ^[  _PL; /\'&0#_ !D _P <
M /\ )0#_ #( _P _ /\ 2P#_ %< _P!B /\ :P#_ ', _0![ /L @@#Z (@
M^ "- /< D@#V )@ ]0"= /0 H@#S *D \0"P .\ N #N ,, [ #1 .L Y@#I
M /, Z #^ .@ _P#H /\ Z #_ .@ _P#H /\ _PX8 /\*%0#_ 10 _P 8 /\
M(@#_ "X _P [ /\ 1P#_ %, _0!> /H 9P#W &\ ]0!W /, ?@#R (0 \ ")
M .\ CP#N )0 [ ": .L GP#I *4 Z "L .8 M #D +\ XP#, .$ X@#? /
MW@#[ -X _P#= /\ W0#_ -P _P#< /\ _Q 3 /\-$0#_!A  _P(5 /\ '@#_
M "D _P V /\ 0@#Z $X ] !9 /$ 8@#N &L [ !R .H >0#H '\ YP"% .4
MBP#D )  X@"6 .$ G #? *( W0"I -H L0#8 +L U0#( -( W0#1 .T T #Y
M ,\ _P#. /\ S0#_ ,T _P#- /\ _Q$/ /\.#0#_# T _PL2 /\'&0#_ B0
M_P P /8 / #O $D Z@!3 .< 70#D &8 X0!M -\ = #= 'L VP"! -D A@#6
M (P U "2 -( F #0 )X S@"F ,P K@#* +@ R #$ ,8 UP#% .H PP#W ,(
M_P#! ?\ P +_ , "_P#  O\ _Q0+ /\0!@#_$ D _Q . /\.% #_"AX ]08I
M .L$-@#C T( WP-. -L$5P#6!&  TP1H - $;P#.!78 S 5\ ,H%@@#)!8@
MQP6. ,8%E #$!9L P@6C , &JP"^!K4 O0;" +L(U "Z">D MPOX +4,_P"T
M#/\ M S_ +0,_P"T#/\ _Q<$ /\4  #_%@, _Q0) /\1#@#R#A4 Z PA -X*
M+@#6"SL T Q' ,P,40#)#%H Q@UB ,0-:@#"#7$ P UW +\-?0"]#H, O Z*
M +H.D0"Y#I@ MPZ@ +8.J0"T#[0 L@_! +$0U "N$>L JQ+Z *D2_P"H$_\
MIQ/_ *<3_P"G$_\ _QH  /\;  #Y&P  ZQD  .44!@#E$ X V0X7 ,\1)@#(
M$C0 Q!-  +\42P"\%%0 N15= +<59 "U%6L M!5Q +(5> "Q%GX KQ:% *X6
MC "L%I0 JQ>< *D7I@"G&+  IAB] *08SP"B&N< GQKW )T;_P&<&_\!G!O_
M 9L;_P&;&_\!_QT  /<A  #H)   W24  -0A 0#/&P@ RA<1 ,(:( "\'"T
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ME@-[-:$$>36N!'@UO@5W-M0%=C;M!70W_ 5T-_\$=#?_!'0W_P1T-_\$YS4
M -(]  ##0@  N$0  *Q"  "D/@  GSD  )HX#@"4.AD D#HF (T[,0"*.SL
MASM$ (0[3 "".U,!@#I: 7XZ8 %].F<">SIN GDZ=0)W.GX#=CJ(!'0ZDP1R
M.IX%<3JK!6\[NP9N.\\&;3OJ!FT\^@9L//\%;#S_!6P\_P5L//\%XCD  ,Q"
M  "^1P  L4@  *5&  "=0P  ES\  )(^"P"-/Q4 B3\A (5 +0""0#< ?T!
M 'U 2 ![0$\!>4!6 7<_70%U/V,"<S]J G$_<@-P/WH#;C^$!&P_D 5K/YP&
M:3^I!F@_N =G0,P'9D#H!V9 ^09E0/\&94#_!F5 _P5E0/\%W#X  ,=&  "Y
M2P  K$P  *!*  "71P  D4,  (M#" "&0Q( @D0> 'Y$*0![130 >44] '9%
M10!T1$P!<D13 7!$60%N1& ";$-G FM#;P-I0W<$9T.!!69#C09D0YD&8D.G
M!V%$M@A@1,H(8$3F"%]%^ =?1?\'8$7_!F!$_P9@1/\&UD$  ,-)  "V3@
MIT\  )M-  "22P  C$<  (5'! " 1Q  ?$@: 'A()@!U23  <TDZ '!)0@!N
M24D!;$A0 6I(5@%H2%T"9DAD F5(; -C2'4$84=_!6!'B@9>2)<'74BE"%M(
MM A;2,<)6DCD"%I)]@A:2?\'6DC_!EI(_P9:2/\&T44  +],  "R4@  HU$
M )=0  "-3@  ADH  (!* 0!Z2PX =DP7 '),(P!O3"T ;4TV &I,/P!H3$8
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M"4Q4\PA,4_\'3%/_!TU3_P9-4_\&Q4X  +96  "G6@  F%D  (M8  "!5P
M=U0  '!5  !J5@8 9E<0 &)7&@!@6"0 75@N %M9-P!963\ 5UE& %9930%4
M650!4UE; E%98P)/6&P#3EAV!$Q8@@5*6(\&25B>!TA8K@A'6, (1UC="$=8
M\@A'5_\'2%?_!TA7_P9(5_\&P5$  +)9  "C7   E%L  (=;  !]6@  <E@
M &M9  !E6@, 8%L. %U<%P!:7"$ 6%TK %9=- !47CP 4UY$ %%>2P%07E(!
M3EY9 DQ>80)+76H#25UT!$==@ 5%78T&1%V<!T-=K ="7;X(0EW:"$)<\0="
M7/X'0UO_!D-;_P9#6_\&O54  *]=  "?7P  D%X  (->  !X70  ;5P  &5=
M  !?7P  6F , %=A% !58AX 4F(H %%C,0!/8SD 3F-! $QC2 !+8T\!26-6
M 4=C7@)%8V<"1&-Q T)C?01 8HL%/V*:!CYBJ@8]8KP'/&+6!SUA[P8]8?T&
M/F#_!CY@_P8^8/\&N5D  *MA  ":80  BV$  ']A  !T80  :6$  %]B  !9
M9   5&8) %%G$0!.9QH 3&@D $MI+0!):38 2&D^ $9J10!%:DP 0VI4 4)J
M7 % :64"/FEO CQI>P,[:8D$.6F8!3AHJ 4W:+H%-VG3!3=H[@4W9_P%.&;_
M!3AF_P4X9O\%M%X  *=E  "590  AF0  'IE  !O90  9&8  %EH  !2:@
M36P$ $EN#@!';A8 16\@ $1P*0!"<#( 07 Z $!Q0@ _<4D /7%1 #QQ60$Z
M<6(!.'%L C9P> (U<(8#,W"5 S)PI@0Q<+@$,'#0!#%O[ 0Q;OL$,6W_!#%L
M_P0Q;/\$KV0  *%I  "/:   @6@  '5I  !K:0  8&L  %5N  !-<0  1G,
M $)U"P _=A( /7<< #QW)0 Z>"T .7@U #AY/0 W>44 -GE- #5Y50 S>5X
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M:P =C7D '(V* !N-G  9C:X &(S$ !B,XP 9BO4 &8G_ 1F(_P$9B/\!G7<
M (QV  !]=@  <G<  &5Y  !:?   4(   $:$   \B0  -(P  "V0   EDP(
M'Y4, !V6$@ <EAH &Y<B !J7*@ 9ES( &)@Z !>80P 6F$T %9A8 !289  3
MF', $9B$ !"8E@ 0F*D #IB_  Z7W0 /EO( $)7\ !"4_P 0E/\ E7T  (5\
M  !X?   :WX  %^!  !4A@  2HH  $"/   VDP  +9<  "::   >G0  %Z #
M !*B#  0HQ( $*,9  ^C(0 .I"D #J0Q  VD.@ ,I$4 "Z10  JD7  )I&H
M!Z1[  :CC@ $HZ$  J.T  .BRP #HN8  Z'S  .A^P #H?L C8,  '^"  !Q
MA   9(<  %B,  !-D0  0I8  #B:   OG@  )J(  !ZE   7J   $:L   RN
M!P 'KPT  Z\2  *O&0 !KR$  *\I  "P,@  L#P  +!'  "P4P  L&$  +!Q
M  "P@P  KY<  *^J  "OOP  KMD  *[K  "N]   KO0 AXD  'B*  !JC@
M79,  %&8  !%G0  .Z(  #"F   GJ@  'JX  !:Q   0M   "[8   6Y P
MN@H  +H.  "Z$P  NQD  +LA  "\*   O#$  +T\  "^2   OE8  +YE  "^
M=P  OHP  +Z?  "]LP  OL<  +[>  "]ZP  O>L ?Y(  '"5  !BF@  59\
M $FE   ]JP  ,J\  "BT   >M@  %;D   Z\   )OP   L(   #$    Q00
M ,8*  #&#@  QQ(  ,@8  #)'P  RB<  ,PP  #./   SDD  ,]9  #/:@
MSWX  ,^3  #/I@  S[@  ,_(  #/VP  S]L =YP  &BA  !;IP  3JX  $&T
M   TMP  *+H  !V]   3P   #<0   ;'    R@   ,X   #0    T0   -("
M  #3"   U0P  -80  #9%0  VQP  -TD  #@+P  XCP  .-+  #D7   Y&\
M .6#  #EF   Y:D  .6V  #EPP  Y<, ;*4  %^L  !1L@  1+D  #6\   H
MP   ',0  !+(   ,RP   \\   #3    V    -P   #?    WP   .$   #C
M    Y ,  .8(  #H#0  Z1$  .P8  #N(@  \2X  /,\  #T30  ]5\  /9S
M  #WAP  ]YD  /BE  #XL   ^+  _P,7 /\ %0#_ !4 _P 8 /\ (P#_ "\
M_P \ /\ 2 #_ %0 _P!> /\ 9P#] &\ ^P!V /D ?0#X (, ]@"( /4 C@#T
M ), \@"8 /$ G@#P *0 [@"K .T LP#K +T Z@#+ .@ X0#G /$ Y@#] .4
M_P#D /\ Y #_ .0 _P#D /\ _P<3 /\ $0#_ !$ _P 5 /\ 'P#_ "L _P W
M /\ 1 #^ $\ ^@!: /< 8P#T &L \@!R /  >0#O '\ [0"$ .L B@#J (\
MZ "4 .< F@#E *  Y "G .( KP#@ +D W@#& -P V@#: .P V #Y -8 _P#6
M /\ UP#_ -@ _P#8 /\ _PH0 /\##@#_  T _P 2 /\ &@#_ "8 _  R /<
M/P#T $H \0!5 .T 7@#J &8 Z !N .4 = #C 'H X@"  .  A0#> (L W "0
M -L E@#8 )P U0"C -, JP#1 +4 S@#! ,P T0#+ .< R0#U ,@ _P#( /\
MR #_ ,@ _P#( /\ _PP, /\&" #_ @H _P / /\ %0#\ "  \0 L .P .0#I
M $4 Y0!/ .$ 60#> &$ VP!H -< ;P#4 '4 T@![ -  @ #. (8 S ", ,L
MD@#) )@ QP"@ ,4 J ## +$ P0"\ +\ RP"] ., O #R +L _0"[ /\ N@#_
M +H _P"Z /\ _PX% /\)  #_"04 _P8+ /\!$ #P !D Y@ E .$ ,@#< #\
MU@!) -$ 4P#. %L RP!C ,@ :@#& '  Q0!V ,, >P#! ($ P "' +X C@"\
M )0 NP"< +D I "W *X M0"Y +, R "Q -\ L 'O *\!^P"N O\ K0/_ *T#
M_P"M _\ _Q   /\.  #_#0  ]@L# /('"@#B 1$ VP(= -(#*P#, S< R 1#
M ,0$30#!!%8 O@5= +P%9 "Z!6L N 5Q +<%=@"U!7P LP:# +(&B0"P!I$
MKP>9 *T'H0"K!ZL J0BW *@)Q@"F"MT I0OP *,,_0"B#?\ H0W_ *$-_P"@
M#?\ _Q$  /P2  #L$P  XA,  -L/ P#6"0L S@@4 ,8*(@# ##  O T\ +@-
M1@"U#4\ L@Y7 + .7P"N#F4 K0YK *L.<0"J#G@ J Y^ *</A0"E#XT I ^6
M *(0GP"@$*D GQ"U )T1Q0";$=X F1+Q )<3_P"6%/\ E13_ )44_P"4%/\
M_Q4  .T;  #@'P  TA\  ,D;  #$% 4 P1 . +H2&P"T$RD L!0U *P50 "I
M%4D IA52 *0660"B%F  H19F )\6; ">%G( G!9Y )L7@ "9%X@ F!>1 )88
MFP"4&*8 DQFR )$9P0"0&M@ C1ON (L<_0"*'/\ BAS_ (D<_P")'/\ ]!T
M .0E  #3*0  QRH  +PF  "V(   M!D+ *X:%0"H'", I!TO *$>.@">'D0
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M G$OM@)P,,D";S#E FXQ]P)M,?\";3'_ FTQ_P)M,?\"WS(  ,DY  "[/@
MK#T  *$Z  ":-P  E3,  ) Q"@",,10 AS(@ (0S*P"!,S4 ?S,^ 'TS1@![
M,TT >3-4 '<S6@!V,V$ =#-G 7(T;P%Q-'<!;S2! 6XTC )L-)@":C6E FDU
MLP-H-<8#9S;B V8V]0-F-O\"9C;_ F8V_P)F-O\"V#<  ,0^  "U0@  ID$
M )L_  "3/   C3@  (@V!P"$-Q$ @#<< 'PX)P!Z.#$ =SDZ '4Y0@!S.4D
M<3E0 ' Y5P!N.5T ;#ED 6LY:P%I.70!:#E^ F8YB0)D.94#8SJB V(ZL0-A
M.L,#8#O@!%\[\P-?._\#7SO_ U\[_P)?._\"T3L  ,!"  "P10  H40  )5#
M  "-0   AST  (([ @!].PX >3P8 '4](P!S/2T <#TV &X]/P!L/48 :SU-
M &D]4P!G/5H 9CUA 60]: %C/7$!83Y[ E\^A@)>/I,#7#Z@ UL_KP1:/\$$
M6C_=!%D_\@19/_\#63__ UD__P-9/_\#S#\  +Q&  "K2   G$<  )%&  "(
M1   @D   'P_  !W0 P <T 5 &]!( !L02H :D$S &A!.P!F0D, 9$)* &-!
M4 !A05< 8$)> 5Y"90%=0FX"6T)X EI"A -80I #5T*>!%9#K0150[\$5$/:
M!%1#\0140_X#5$/_ U1#_P-40_\#R$(  +A)  "G2P  F$H  (U)  "#1P
M?4,  '9#  !Q1 H ;402 &I%'0!G12< 9$4P &)%. !@13\ 7T5' %U%30!;
M150 6D9; 5E&8P%71FP!5D9V E1&@0-31HX#4D><!%!'JP101[T$3T?6!4]'
M[P1/1_T$3T?_ T]'_P-01_\#Q$4  +5-  "C30  E4P  (E+  !_2@  >$8
M '%'  !L1P< :$@0 &1(&@!A220 7TDM %U)-0!;23T 64E$ %=)2@!625$
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M T)2_P-"4?\#ND\  *I4  "85   B50  'U3  !S4P  :5$  &)2  !<4P
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M< $N:GX!+6J. 2QJGP$K:K !*FK& 2IIY0$J:/8"*V?_ BMG_P(K9_\"J6$
M )5@  "$8   =V   &QA  !B80  6&,  $YF  !':   0&L  #IN!0 V;PX
M-' 5 #-P'@ R<28 ,'$N "]Q-0 N<CT +7)% "QR30 K<E< *G)A "ER;0 G
M<GL )G*+ "1RG $C<JX!(W+# 2-QX@$C</0!(V__ 2-N_P$C;O\!H64  (YD
M  !_9   <F0  &AE  !>9@  5&D  $EL  !";P  .W(  #1U   N> H *WD1
M "IY&  I>B$ )WHH "9Z,  E>S@ )'M  "-[2  B>U( (7M< "![:  ??'8
M'7R& !Q[F  ;>ZH &GN_ !I[W@ :>?( &WC^ !MW_P$;=_\!F6D  (AI  !Y
M:0  ;6D  &-J  !9;   3V\  $5S   ]=P  -7H  "Y]   G@0, (H,- ""$
M$@ ?A!H '80B !R%*@ ;A3$ &H4Y !F%0@ 8ADP %X96 !:&8P 5AG$ %(:!
M !*&DP 1AJ8 $86[ !"%U@ 1@^\ $8+[ !*"_P 2@?\ D6X  (%M  !T;@
M:6X  %UP  !3<P  27<  $!\   W@   +X,  ">'   AB@  &HT& !6/#0 3
MD!, $I : !*0(@ 1D"H $)$R !"1.P /D40 #I%/  V17  ,D6H "Y%Z  J1
MC0 (D)\ !Y"S  >/R0 'C^8 !X[T  B-_  (C?\ B7,  'MS  !O<P  8W4
M %=X  !-?0  0X$  #F&   PB@  *(X  "&1   :E0  $Y<   Z:"  +G X
M"9P3  B<&@ 'G"( !IPJ  2<,P #G#T  IU(  "=5   G6(  )QR  "<A
MG)<  )NJ  ";OP  FML  )KL  ":]0  F?@ @GD  '9Y  !H>@  7'X  %&"
M  !&AP  /(P  #*1   IE0  (9D  !F=   2H   #J,   FF!0 #IPP  *<0
M  "G%0  J!P  *@C  "H*P  J30  *D_  "I2P  J5D  *EH  "I>@  J8X
M *FA  "HM0  J,L  *?D  "G[P  I_, ?8   &^!  !AA   58D  $F.   ^
ME   -)D  "J>   AH@  &:8  !*I   -K   !Z\   "R    LP<  +,,  "S
M$   M!4  +0;  "U(@  MBL  +<U  "W0   N$X  +A=  "X;@  N((  +B7
M  "XJ@  M[X  +?2  "WY@  M^H =H@  &>+  !:D   3I8  $*<   WH@
M+*<  "*K   9KP  $;,   NV   $N0   +P   "^    O@   +\&  # "P
MP0\  ,(3  ##&0  Q"   ,4I  #'-   R$(  ,E1  #)8@  R74  ,F*  #)
MGP  RK$  ,K!  #)T0  R=D ;I,  &"8  !3G@  1J0  #JK   OL   )+4
M !FX   0O   "K\   '!    Q    ,@   #*    R@   ,P   #- P  S@@
M - -  #1$   TQ8  -8>  #:*   W30  -Y#  #?5   WV<  .!\  #@D0
MX*0  ."R  #@O@  X,, 9I\  %FF  !,K0  /[0  #*X   DO   &+\  !##
M   (QP   ,H   #-    T0   -4   #8    V0   -L   #=    WP   .$$
M  #C"@  Y0X  .<3  #J'   [2<  / U  #Q1@  \E@  /-K  #S@   ])0
M /2C  #TK@  ]+( _P 3 /\ $0#_ !$ _P 5 /\ 'P#_ "P _P Y /\ 10#_
M %  _P!: /X 8P#[ &L ^0!R /< > #U 'X ] "$ /( B0#Q (X \ "3 .X
MF0#M )\ [ "F .H K@#H +@ Y@#% .4 VP#C .T X@#[ .( _P#A /\ X0#_
M .$ _P#A /\ _P 0 /\ #@#_  T _P 2 /\ &P#_ "@ _P T /X 00#[ $P
M]P!6 /0 7P#Q &8 [P!M .P = #J 'H Z0!_ .< A0#F (H Y0"/ ., E0#A
M )L X "B -X J@#; +0 V0#  -8 T #3 .@ T@#W -$ _P#1 /\ T #_ -
M_P#0 /\ _P - /\ "0#_  H _P / /\ %@#[ "( ]P O /0 .P#P $< [0!1
M .D 6@#E &( X@!I .  ;P#> '4 W !Z -H @ #8 (4 U0"+ -, D0#1 )<
MSP"> ,T I@#+ *\ R0"Z ,< R0#% .( Q #R ,, _@#" /\ P0#_ ,( _P#"
M /\ _P,& /\  0#_  8 _P , /D $0#Q !T ZP I .< -@#C $$ WP!+ -L
M5 #5 %P T@!C ,\ :@#- '  RP!U ,D >P#( (  Q@"& ,4 C ## ), P0":
M +\ H@"] *L NP"V +D Q "W -H M@#M +0 ^@"T /\ M #_ +0 _P"T /\
M_P0  /\   #_    _P & .P #0#E !8 W@ B -< +P#1 #L S0!% ,H 3@#&
M %< Q !> ,$ 9 "_ &H O0!P +P =0"Z 'L N0"! +< AP"U (X LP"5 +(
MG@"P *< K@"R *P OP"J -$ J #H *@ ]P"G /\ IP#_ *8 _P"F /\ _P8
M /\%  #Q P  Z    .$ !P#5 !  S0 ; ,< )P## #, OP ^ +P 2 "Y %$
MM@!8 +0 7P"R &4 L !J *\ < "M '8 K !\ *H @@"I (D IP"1 *4 F@"C
M *0 H0"N *  NP"> <T G0+F )P$] ";!/\ F@7_ )H%_P"9!?\ _PH  /$.
M  #D$   V0\  ,X+  #( PL P@ 3 +P"'P"W RP LP0W + %0@"M!DH J@92
M *@'60"F!U\ I0=E *,':P"B"'$ H AW )\(?@"="(4 FPF. )H)EP"8"J$
ME@JL )4+N@"3"\P D@SE ) -]@"/#O\ C@[_ (X._P"-#O\ ]A$  .87  #6
M&P  QQD  +X5  "Y$   MPH- +$+%P"L#20 J XP *4..P"B#D0 GP], )T/
M4P";#UH F@]@ )@09@"7$&P E1!R ),0>0"2$($ D!"* (\1E "-$9\ BQ&J
M (H2N "($LL AA/F (44]P"#%?\ @Q7_ ((5_P""%?\ [1H  -PA  #*)0
MNR(  +$?  "K&@  J10& *42$0"@%!X G!4J )D5-0"6%CX E!9' )(63@"0
M%E4 CA=; (P780"+%V< B1=M (@7= "&&'P A1B& (,9D "!&9L @!JG 'X:
MM0!]&\< ?!SB 'H=]0!Y'?\ >!W_ '@=_P!X'?\ Y2(  - I  "_+   L"H
M *<G  "@(P  G1\  )H:#@"5'!@ D1TD (X>+P",'CD B1Y! (<?20"%'U
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M 6 P[P%?,/T!7S#_ 5\P_P%?,/\!S30  +P[  "I.@  FSH  ) X  ")-0
M@S(  '\P 0![+PX =S 6 '0P(0!Q,2L ;S$T &TQ/ !K,4, :C%* &@R4 !G
M,E< 93)= &0R90!B,FT 83-W %\S@@%>,XX!732< 5LTJ@%:-;L!6C72 5DU
M[0%9-?P!6#7_ 5@U_P%9-?\!R#@  +<^  "D/@  ECT  (L\  "#.@  ?3<
M '@T  !T- L <#43 &TU'0!J-2< :#8P &8V. !D-C\ 8S9& &$V30!@-E,
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M/04 9#T. &$^%P!>/B$ 7#XI %H^,0!8/CD 5SY  %4_1@!4/TT 4S]5 %)
M7 !00&4 3T!O 4Y!>@%-08<!2T&6 4I!I0))0K4"24++ DE"Z ))0OD"24'_
M DE!_P%)0?\!O4,  *I%  "810  BD4  ']%  !V0P  ;T   &A   !C00$
M7T$- %Q!% !90AT 5T(F %5"+@!30C8 44(] $]"0P!/0TL 3D-2 $U$6@!,
M1&, 2D1M 4E%> %(184!1T64 45%HP)%1K0"1$;) D1&YP)$1?@"1$7_ D5%
M_P)%1?\!ND8  *9(  "42   AD@  'M'  !R1@  :D(  &-#  !>1   6D4+
M %9%$@!41AL 448C $]&*P!.1C, 3$<Z $M'00!*1TD 24A0 $A(6 !'2&$
M1DEK $1)=@%#28,!0DF2 4%)H@) 2;,"/TK' C]*Y0(_2?<"0$G_ D!(_P)
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M<@ Y4G\!.%*. 3=2G@$V4J\!-5+$ 352X@$V4O4!-E'_ 390_P$W4/\!KD\
M )E/  ")3P  >T\  '!/  !F3P  7$X  %1/  !/40  2E(! $93# !#5!(
M050; $!5(P ^52L /58R #Q6.@ [5D$ .E9) #E740 X5UH -E=C #57;P T
M5WP!,U>, 3%7G $P5ZT!,%?" 3!7X $P5O0!,5;_ 3%5_P$Q5?\!J%(  )52
M  "$4@  =U(  &Q2  !B4@  6%,  $]4  !)5@  1%<  $!9"  ]6A  .UH7
M #E;(  X6R< -UPO #9<-@ U7#X -%Q& #-=3@ Q75< ,%UA "]=;  N77H
M+%V) "M=F@$J7:L!*EV_ 2E=W@$J7/(!*EO^ 2M;_P$K6O\!HU4  (]5  !_
M50  <E4  &=6  !>5@  5%<  $Q9  !%6P  /UT  #I?!  V8 T -&$3 #)B
M'  Q8B, ,&(K "]C,@ N8SH +6-" "QC2@ J9%, *61= "AD:0 G9'8 )F2&
M "5DEP D9*D (V2] ")DV@ C8_$ (V+] 21A_P$D8?\!G%@  (E8  !Z60
M;ED  &-9  !:6@  4%P  $A>  !!8   .F,  #1F   O: H +&D0 "II%P I
M:A\ *&HF "=J+@ F:S4 )6L] "1K1@ C:T\ (FQ9 "!L90 ?;'( 'FR" !UL
ME  <;*8 &VNZ !IKU  ;:NX '&G\ !QH_P <:/\ E5P  (-<  !U7   :5T
M %]=  !67@  3&$  $-D   \9P  -6H  "]M   H< 0 (W(- "%R$@ @<QH
M'W,A !YS*  ==#  ''0X !MT0  :=$H &714 !=U8  6=6X %75^ !1UD  3
M=*( $G2V !%TSP 2<^P $G+Z !-Q_P 3<?\ CF   'U@  !O80  96$  %MB
M  !19   2&<  #YK   W;@  ,'$  "EU   B>   ''L' !=]#@ 6?1, %7T;
M !1^(@ 3?BH $GXQ !%^.@ 1?D0 $'].  ]_6@ .?V@ #7]X  Q_B@ +?IT
M"GZP  E]Q@ *?>0 "GST  M[_0 +>O\ AF4  '=E  !J90  868  %9H  !,
M:P  0F\  #ES   Q=P  *GH  "-^   <@0  %80  !"'"  -B0X #(D4  R)
M&P +B2, "HDK  F),P (B3T !HE(  6)5  $B6$  HEQ  &)@P  B98  (BI
M  "'O@  A]H  (;L  "&]0  AOH ?FH  '%J  !G:P  6VP  %!P  !&=
M/'@  #-]   J@0  (X4  !R(   5C   $(\   R2!@ &DPP  I,1  "4%@
ME!T  )0D  "5+   E34  )5   "53   EED  )9I  "5>@  E8X  )2A  "4
MM0  D\P  )+F  "2\@  DO< >'   &UP  !@<@  5'4  $EY   _?@  -8,
M "R(   CC0  &Y$  !24   /EP  "IH   2= P  G@D  )\.  "?$@  H!<
M * =  "A)0  HBT  *(W  "C0P  HU   *-?  "C<0  HX0  **9  "BK0
MH<(  *'<  "AZP  H/( <W8  &9W  !9>P  38   $*%   XBP  +I   "25
M   ;F@  %)X   ZA   )I    J<   "J    JP0  *L*  "L#0  K1$  *T6
M  "N'   KR0  + M  "Q.0  L48  +)5  "R9@  LGD  +*.  "QHP  LK<
M +'*  "QX   L>D ;'X  %^"  !2AP  1HT  #N3   PF0  )IX  !RC   3
MIP  #:L   >N    L@   +4   "W    N    +D"  "Y"   N@P  +L0  "\
M%   O1L  +\C  #!+0  PCH  ,))  ##6@  PVP  ,2"  #$EP  Q*L  ,2\
M  #$RP  Q-H 98D  %B.  !+E0  /YL  #.B   HJ   ':T  !2Q   -M@
M!KD   "\    OP   ,,   #$    Q0   ,8   #'    R00  ,H)  #+#0
MS1$  ,\8  #2(0  U2T  -8\  #830  V5\  -IS  #:B@  VYX  -NN  #;
MN@  W,, 7I8  %&<  !$HP  .*H  "RQ   @MP  %;L   V^   $P@   ,4
M  #)    S0   -    #2    T@   -4   #6    V0   -L   #>!0  X H
M .(/  #E%@  Z"   .PM  #M/@  [5$  .YE  #O>@  [X\  /"?  #PJP
M\+, _P 0 /\ #@#_  X _P 2 /\ '0#_ "D _P U /\ 00#_ $T _@!6 /L
M7P#X &8 ]@!M /0 = #R 'D \0!_ /  A #N (D [0"/ .L E0#J )L Z "B
M .8 J@#E +, XP#  .$ T@#@ .H WP#Y -T _P#= /\ W0#_ -X _P#> /\
M_P - /\ "@#_  D _P / /\ & #_ "0 _@ Q /L /0#X $@ ] !2 /  6@#M
M &( ZP!I .D ;P#G '4 Y0!Z ., ?P#B (4 X "* -X D #< )8 V@"= -@
MI0#5 *\ T@"Z -  R@#. ., S0#T ,L _P#+ /\ RP#_ ,L _P#+ /\ _P (
M /\  P#_  4 _P , /P % #W !\ \@ K .\ -P#K $( YP!, .0 50#@ %T
MW0!D -H :@#8 '  U0!U -( >@#0 (  SP"% ,T BP#+ )( R0"9 ,< H0#%
M *H PP"U ,$ PP"_ -H O@#N +T _ "\ /\ O #_ +P _P"\ /\ _P   /\
M  #_    ^0 ' /$ $ #J !H Y  E -\ ,0#; #P UP!' -( 4 #. %< RP!>
M ,D 90#& &H Q0!P ,, =0#! 'H P "  +X A@"\ (T N@"4 +D G "W *4
MM0"P +, O0"Q ,\ KP#H *X ^ "N /\ K0#_ *T _P"M /\ _P   /\   #]
M    [@ ! ., # #: !0 T0 ? ,P *P#( #8 Q0!  ,( 2@"_ %( O !9 +H
M7P"X &4 M@!J +0 ;P"S '4 L0!Z +  @0"N (@ K0"/ *L F "I *$ IP"K
M *4 N "C ,@ H@#B *$ \P"@ /X H #_ *  _P"@ /\ _P   /8   #J
MX    -, !@#)  \ P@ 8 +T ) "Y "\ M@ Z +0 0P"Q $P K@!3 *P 60"J
M %\ J0!D *< :@"F &\ I !U *, >P"A (( H "* )X DP"< )T F@"G )@
MM "6 ,, E0#< )0 [P"3 /L DP#_ ), _P"2 /\ ^04  .H+  #<#0  RPH
M ,(%  "\  H M@ 1 +$ ' "N "@ J@ S *< /0"D $4 H@!- *  4P"> %D
MG !? )L 9 ": &H F !P )< =@"5 'X DP"& )(!CP"0 9D C@*D (P"L0"+
M \  B076 (@&[0"(!_H APC_ (8(_P"&"/\ [P\  -X4  #*%0  O!(  +,0
M  "N#   JP8- *<#%0"B!2  GP<L )P(-@"9"#\ EPE' )4)3@"3"50 D0I:
M ) *7P"."F4 C0IK (L*<@"*"WD B N" (<+C "%#)< @PRB ($-L " #<
M?PW8 'T.[P!\#_T >P__ 'L0_P![$/\ YA<  -$>  "]'0  KQP  *89  "A
M%0  GA $ )T-#P"8#AD E XE )$/+P"/$#D C!!! (H02 "($$\ AQ!5 (40
M6P"$$6$ @A%G ( 1;@!_$74 ?1%^ 'P2B !Z$I0 >!*@ '<3K@!U$[X =!35
M ',5[@!Q%OT <1;_ '$6_P!P%O\ W!\  ,8E  "S)0  I2,  )PA  "6'@
MDAD  )$4"P"-%!0 B14? (86*0"#%C, @1<\ ( 70P!^%TH ?!=0 'H75@!Y
M&%P =QAB '88:0!T&'$ <QEZ '$9A !O&I  ;AJ= &P;JP!K'+L :AS0 &D=
M[ !H'OL :![_ &<>_P!G'O\ T28  +TJ  "K*@  G2H  ),H  "-)0  B"(
M (8=!@"#&Q  ?QP: 'P=) !Z'2X =QXV '8>/@!T'D4 <A]+ '$?40!O'U@
M;A]> &P?90!K(&T :2!V &@A@0!F(8T 92*: &,BJ !B([@ 82/- & DZ0!@
M)/H 7R3_ %\D_P!?)/\ RBP  +8O  "D+P  EB\  (PM  "%*@  @"@  'TD
M  !Z(@T =B,5 ',C( !Q)"D ;R0R &TD.@!K)4$ :B5' &@E30!F)50 925:
M &0F80!B)FD 829R %\G?0!>)XH 72B7 %LII0!:*;4 6BK* %DJYP!8*O@
M6"K_ %@J_P!8*O\ Q3$  *\S  ">,P  D#,  (8R  !_+P  >2T  '4J  !R
M* H ;R@2 &LI&P!I*24 9RHM &4J-0!C*CT 8BI# & J2@!?*U  7BM7 %PK
M7@!;+&8 62QO %@M>@!7+8< 5BZ5 %0NHP!3+[, 4R_' %(OY0!2+_< 4B__
M %(O_P!2+_\ P38  *HV  "9-@  BS8  ($U  !Y,P  <S$  &\O  !K+@8
M:"T0 &0N& !B+B$ 8"\J %XO,0!<+SD 6R]  %DO1@!8+TT 5S!3 %8P6P!4
M,6, 4S%L %(R=P!1,H0 3S.2 $XSH0!-,[$ 333% 4PTXP%,-/8 3#3_ $PT
M_P!,,_\ NSD  *8Y  "5.0  ASD  'PY  !T-P  ;C0  &DS  !E,@( 83(-
M %XR% !<,QX 6C,F %@S+@!6,S4 530\ %,T0P!2-$H 4310 % U6 !.-6
M339J $PV=0!+-X( 2C>0 $DXGP!(.+ !1SC# 4<XX0%'./4!1SC_ 4<X_P%'
M./\!MSL  *(\  "1/   @SP  '@\  !P.@  :C<  &0V  !@-@  7#8+ %DW
M$@!6-QH 5#<C %(W*P!0-S( 3S@Y $TX0 !,.$< 2SA. $HY50!).5X 2#IH
M $<Z<P!&.X  13N. $0\G@!#/*X!0CS" 4(]WP%"//,!0CS_ 4(\_P%"._\!
MLST  )X^  "-/@  ?SX  '4^  !L/0  9CH  & Y  !;.@  5SH( %,[$ !1
M.Q@ 3CL@ $P[* !+.R\ 23PV $<\/0!'/$0 1CU+ $4]4P!$/EP 0SYF $(_
M<0!!/WX 0#^- #] G  ^0*T!/4#  3U W0$]0/(!/4#_ 3X__P$^/_\!KD
M )I   ")00  ?$$  '%!  !H0   83P  %L]  !6/@  4CX% $X_#@!,/Q4
M23\= $= )0!&0"P 1$ S $- .@!"04( 04%) $!!40 _0EH /D)C #U#;P \
M0WP .T.+ #I$FP Y1*L!.42^ 3A$VP$Y1/$!.4/^ 3E#_P$Y0_\!JD(  )9#
M  "&0P  >$,  &Y#  !E0P  74   %9   !10@  34(" $E## !&0Q( 1$0:
M $)$(@!!1"H /T4Q #Y%.  ]13\ /$9' #M&3P Z1E< .4=A #A';  W1WH
M-DB) #5(F0 T2*H -$B] #-(V0 T2/  -$?] #1'_P U1O\ ID0  ))%  ""
M1@  =48  &I&  !A10  640  %%$  !,1@  2$<  $1'"@!!2!  /TD8 #U)
M(  \22< .DHN #E*-@ X2CT -TM$ #9+3  U2U4 -$Q? #-,:@ R3'< ,4R&
M #!,EP O3:@ +DV[ "Y-U0 N3.\ +TS] "]+_P P2_\ H4<  (Y(  !^2
M<4@  &9)  !=2   54@  $Q)  !'2@  0DL  #],!@ [30X .4X5 #=.'0 V
M3R0 -4\K #-/,P R4#H ,5!" #!02@ O45( +E%< "U19P L474 *U&$ "I2
ME0 I4J8 *5*Y "A2T@ I4>X *5#\ "I0_P J3_\ G$H  (E*  !Z2P  ;4L
M &-,  !:3   44P  $A-  !#3P  /5   #E2 @ U4PP ,U02 #%4&0 P52$
M+E4H "U5+P L5C< *U8^ "I61@ I5D\ *%=9 "=79  F5W( )5>! "17D@ C
M5Z0 (E>W ")7SP B5^P (U;Z "-5_P D5?\ EDT  (1.  !U3@  :4X  %]/
M  !63P  35   $52   _4P  .58  #-8   O6@@ *UL/ "I;%0 H7!T )UPD
M "9<*P E7#, )%TZ "-=0P B74P (5U6 "!>80 ?7FX 'EY^ !U>CP <7J$
M&UZT !I=S  ;7>D &USY !Q;_P <6_\ D%$  'Y1  !P40  9%(  %M2  !2
M4P  2E0  $%7   [60  -5L  "Y>   H8 , )&(, ")C$0 A8Q@ 'V0@ !YD
M)P =9"X '&0V !ME/@ :94< &651 !AE70 796H %F5Z !5EBP 499X $V6Q
M !)ER  29.< $V/W !1B_P 48O\ B50  'A5  !K50  8%8  %=6  !/5P
M1ED  #U<   V7P  ,&(  "ED   C9P  '6H' !EL#@ 8;!, %FT: !5M(0 4
M;2D %&TP !-M.0 2;D( $6Y, !!N6  /;F4 #FYU  UNAP -;IH #&VM  MM
MP@ +;.  #&OS  UK_0 -:O\ @ED  ')9  !F60  7%H  %1:  !*7   05\
M #EC   Q9@  *FD  "1L   =;P  %W(  !)U"0 /=P\ #G<4  YW&P -=R,
M#'<J  MW,P *=SP "7='  AW4@ '=U\ !7=O  1W@  #=Y0  7:G  !VNP !
M==4  73K  )T]@ "=/P >UT  &U=  !B7@  65X  $Y@  !%8P  /&<  #-K
M   K;@  )'(  !YU   7>0  $GP   U_!@ )@0P !8$1  .!%@ "@1T  8$D
M  "!+0  @C8  ()   ""3   @ED  ()H  "">0  @HT  (&@  " M   @,L
M '_G  !^\@  ?OD =&(  &AB  !>8@  4V0  $EG   _:P  -G   "UT   E
M>   'GP  !>    1@P  #88   B)!  "BPH  (L.  "+$P  C!@  (P?  "-
M)@  C2\  (XY  ".1   CE$  (Y@  ".<0  CH4  (Z9  "-K0  C,,  (S?
M  "+[@  B_8 ;F@  &1G  !8:0  36P  $)Q   X=@  +WL  "9_   >A
M%H@  !",   ,CP  !I(   "5    E@<  )<,  "7#P  F!,  )D8  ":'P
MFR8  )LP  "<.P  G$@  )Q7  "<:   G'L  )R0  ";I0  F[H  )K0  ":
MYP  FO$ :FT  %YO  !1<@  1G<  #M\   Q@@  )X<  !Z,   6D0  $)4
M  J9   $G    *    "B    HP$  *,&  "D"P  I0X  *82  "G%P  J!X
M *HF  "K,0  JSX  *Q-  "L70  K'   *R%  "LFP  JZ\  *O#  "KV0
MJN@ 9'4  %=Y  !+?@  /X0  #2*   ID   'Y8  !:;   0GP  ":,   &G
M    J@   *X   "P    L    +$   "R P  M @  +4-  "V$   MQ4  +D=
M  "[)@  O#,  +U!  "]4@  O60  +YY  "^D   O:0  +VW  "]Q@  O=<
M7'\  %"%  !$BP  .)(  "R9   AGP  %Z0  !"I   )K@   +(   "V
MN0   +T   "_    OP   ,    #!    PP   ,0%  #&"@  QPX  ,D3  #+
M'   SB8  - U  #110  TE<  -)K  #3@@  TY<  -.I  #2N   TL0 58P
M $F3   ]F@  ,*(  "6H   :K@  $;0   FY    O0   ,$   #$    R
M ,L   #-    S0   ,\   #0    T@   -0   #8    V@8  -T,  #@$0
MXQH  .8G  #G.   Z$H  .E=  #J<@  ZX@  .N;  #LJ   [+( _P - /\
M"P#_  L _P 0 /\ &@#_ "8 _P R /\ /0#_ $@ ^P!2 /@ 6@#V &( \P!I
M /$ ;P#P '4 [@!Z .P ?P#K (0 Z0"* .@ D #F )8 Y "= .( I0#A *\
MWP"[ -T RP#; .8 V0#W -@ _P#8 /\ UP#_ -< _P#4 /\ _P ( /\ ! #_
M  0 _P - /\ %0#^ "$ ^@ L /< . #T $, \ !- .T 50#J %T YP!D .0
M:@#B '  X !U -X >@#= '\ VP"% -D BP#5 )$ TP"9 -$ H #/ *H S0"U
M ,L Q #) -T R #Q ,< _P#& /\ Q@#_ ,8 _P#' /\ _P   /\   #_
M_P * /@ $0#Q !P [  G .D ,@#F #T X@!' -T 4 #9 %@ U0!? -( 90#0
M &H S@!P ,P =0#* 'H R0!_ ,< A0#% (P PP"4 ,$ G "_ *4 O0"P +L
MO0"Z -  N #K +< ^P"V /\ M@#_ +8 _P"V /\ _P   /\   #]    \P %
M .D #@#A !8 VP A -4 +0#1 #< S@!! ,H 2@#' %( Q !9 ,( 7P#  &4
MO@!J +P ;P"[ '0 N0!Z +< @ "V (< M ". +( EP"P *  K@"J *T MP"K
M ,@ J0#C *@ ]0"G /\ IP#_ *< _P"F /\ _P   /X   #Q    Y0   -<
M"@#- !$ QP < ,( )@"_ #$ O  [ +H 1 "W $P M !3 +( 60"Q %\ KP!D
M *T :0"L &\ J@!T *D >@"G ($ I@") *0 D0"B )L H "E )X L@"= ,$
MFP#: )H [P"9 /T F #_ )@ _P"8 /\ _0   /    #A    T0   ,8 ! "]
M  T MP 5 +, ( "P "L K0 U *L /@"H $8 I@!- *0 5 "C %D H0!? *
M9 "> &D G0!N )L =0": 'L F "# )8 C "5 )8 DP"A )$ K0"/ +L C0#/
M (P Z0"+ /@ C #_ (P _P", /\ \P(  .('  #,!P  OP0  +<   "Q  @
MJP 0 *< &0"D "0 H  N )X -P"< $  F@!' )@ 3@"6 %0 E0!9 ), 7@"2
M &0 D !I (\ ;P"- '8 BP!^ (H B "( )( A@"= (4 J0"# +@ @0#* (
MY0"  /4 ?P#_ '\ _P!_ /\ Z T  - 0  "^$   L0X  *@-  "C"   H (,
M )P $P"8 !T E0 G )( ,0"0 #D C@%! (P!2 "* DX B0)4 (<"60"& E\
MA -D (,#:P"! W( @ 1Z 'X$A !]!8X >P6: 'D&IP!X!K4 =@?( '4(XP!U
M"?0 = K_ ',*_P!S"O\ W14  ,07  "Q%P  I18  )P3  "6$0  E T$ ),(
M#0".!Q4 BPD@ (@)*@"%"C, @PL[ ($+0@" "TD ?@M/ 'T,5 ![#%H >@Q@
M '@,9P!W#&X =0UV '0-@ !R#8P < V9 &\.I@!M#K4 ; [) &L/Y@!J$/<
M:1#_ &D0_P!I$/\ T!T  +D>  "H'@  FQT  )(;  "+&0  B!4  (<1!P"%
M#A  @0\: 'X0) ![$"T >1 V '<1/0!V$40 =!%* ',14 !Q$58 <!%< &X2
M8@!M$FH :Q)S &D3?0!H$XD 9A.6 &44HP!C%;, 8A7& &(6XP!A%O8 8!?_
M & 7_P!@%_\ QR(  + C  "?)   DB,  (DB  ""(   ?AT  'P9  !Z%0T
M=Q45 '06'P!Q%B@ ;Q<P &X7. !L%S\ :Q=% &D82P!H&%$ 9AA8 &487@!C
M&68 8AEO & 9>0!?&H4 71N2 %P;H0!;'+  6AS# %D=X !8'O0 6![_ %@>
M_P!8'O\ OR<  *DH  "9*   BR@  ((G  ![)0  =B,  ',@  !Q' D ;AP1
M &L<&@!I'2, 9QTL &4=,P!C'CH 8AY! & >1P!?'DT 7AY4 %P?6P!;'V(
M62!K %@@=@!6(8( 52&0 %0BG@!3(JX 4B/  %$CW0!1)/( 423_ %$D_P!1
M(_\ N2L  *,L  "3+   ABT  'PL  !T*@  ;R@  &LE  !I(@4 9B$. &,B
M%@!A(A\ 7R,G %TC+P!<(S8 6B,] %DD0P!7)$H 5B10 %4D5P!3)5\ 4B5H
M %$F<P!/)G\ 3B>- $THG !,**P 2RF^ $LIV@!**?$ 2BG_ $LI_P!+*?\
MLRX  )XO  ".,   @3   '<O  !O+@  :BL  &4J  !C)P$ 7R<, %PG$P!:
M)QL 6"@D %8H*P!5*#( 4R@Y %(I0 !0*48 3RE- $XI5 !-*EP 3"IE $HK
M< !)*WP 2"R+ $<MF@!&+:H 12Z\ $4NU@!%+N\ 12[^ $4N_P!%+?\ KC$
M )HR  "),P  ?#,  '(S  !K,0  92\  & M  !=+   62P) %8L$ !4+!@
M4BP@ % L* !.+2\ 32TV $PM/ !*+4, 22U* $@N40!'+ED 1B]C $4P;0!#
M,'H 0C&) $$QF !!,J@ 0#*[ #\RTP _,NX 0#+] $ R_P! ,O\ JC,  )8U
M  "&-0  >38  &XU  !F-0  83(  %PP  !7,   5# & %$P#@!.,!4 3#$=
M $HQ)0!(,2P 1S$R $8Q.0!$,4  0S)' $(R3P!!,U< 0#-@ #\T:P ^-7@
M/36' #PVE@ [-J< .S:Y #HVT0 Z-NT .S;\ #LV_P [-O\ IC8  )(W  ""
M.   =3@  &LX  !C-P  738  %<S  !3-   3S0# $LT# !)-!( 1C4: $4U
M(@!#-2D 034O $ U-@ _-CT /C9$ #TW3  \-U4 .SA> #HX:0 Y.78 .#F%
M #<ZE0 W.J4 -CJX #4ZSP V.NP -CK[ #8Y_P W.?\ HC@  (XY  !^.@
M<CL  &@[  !?.@  63D  %,V  !.-P  2C@  $8X"@!$.1  03D7 #\Y'P ^
M.28 /#DM #LZ-  Z.CL .3M" #@[2@ W.U, -CQ< #4\9P T/70 ,SV# #,^
MDP R/J0 ,3ZV #$^S0 Q/NH ,3[Z #(]_P R/?\ GCL  (L\  ![/   ;CT
M &0]  !</0  53P  $XZ  !).P  13P  $$]!P ^/0X /#T5 #H^'  Y/B,
M-SXJ #8_,0 U/S@ -#]  #- 2  R0%  ,4!: #!!90 O07( +D*! "U"D0 M
M0J( +$*U "M"RP L0ND +$+Y "U!_P M0?\ F3T  (<^  !W/P  :S\  &%
M  !9/P  4C\  $D^  !$/P  0$   #Q!!  Y0@T -T(2 #5#&0 S0R$ ,D,H
M #%$+P P1#8 +T0] "Y%10 M14X +$58 "M&8P J1F\ *49^ "A&CP G1Z$
M)D>S "9'R0 F1N< )T;X "A%_P H1?\ E4   ()!  !S0@  9T(  %Y"  !5
M0@  3D(  $5"   _1   .T4  #=&   T1PH ,4@0 "](%@ N21X +$DE "M)
M+  J23, *4HZ "A*0@ G2DL )DM5 "5+8  D2VT (TM\ ")+C0 A3)\ (4RQ
M "!,QP @2^8 (4OW ")*_P B2O\ D$,  'Y$  !O1   9$4  %I%  !210
M2D8  $%'   \2   -TD  #)+   N30< *TX. "E.$P G3QH )D\A "5/*  D
M3S  (U W ")0/P A4$@ (%!2 !]170 >46H '5%Y !Q1B@ ;49P &E&O !E1
MQ0 94>0 &E#V !M/_P <3_\ BD8  'E'  !K1P  8$@  %9(  !.2   1TD
M #Y+   Y3   ,TX  "Y0   H4P( )%0+ ")5$  @518 'U8> !Y6)  =5BP
M'%8S !M7.P :5T0 &5=. !A760 76&8 %5AU !18AP 46)H $U>L !)7P@ 2
M5^$ $U;T !15_P 45?\ A$D  '1*  !F2P  7$L  %-+  !+3   1$T  #Q/
M   U40  +U0  "E6   D60  'EL' !I=#0 871( %UT9 !9>(  57B< %%XN
M !->-P 27D  $5]* !%?50 07V( #U]Q  Y?@P -7Y8 #5^I  Q>O@ ,7MH
M#5WP  U<_  .7/\ ?DT  &Y.  !B3@  6$\  $]/  !(4   0%(  #A4   P
M5P  *EH  "1=   ?7P  &6(! !-E"0 19@\ $&84  ]F&P .9R( #6<I  UG
M,@ ,9SL "V=%  IG4  )9UT !V=L  9G?0 %9Y  !&:C  )FMP #9<\ !&7I
M  1D]0 $9/P =U$  &E2  !=4@  5%(  $Q3  !#50  .U@  #-;   K7@
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M  !ZK   ><(  'C?  !X[P  =_< :EL  %];  !66P  3%P  $)@   Y8P
M,&@  "AL   @<   &70  !-W   .>P  "7X   2! @  @@@  (,-  "#$
MA!0  (49  "&(   AB@  (<Q  "'/   ATD  (=7  "':   AWL  (>0  "&
MI0  A;H  (73  "$Z@  A/0 96   %Q@  !180  1F0  #QI   R;0  *7(
M "%W   9>P  $H    V#   (AP   HH   "-    C@0  (X)  "/#0  D!
M )$4  "2&0  DR   )0I  "5,P  E4   )9.  "67P  E7(  )6(  "5G0
ME+(  )3(  "3X@  D^X 864  %9F  !*:@  /VX  #5T   K>0  (7\  !F$
M   1B0  #(T   :1    E    )@   ":    FP   )P"  "=!P  G@L  )\.
M  "A$@  HA@  *,@  "E*0  IC8  *9$  "F50  IF@  *9]  "FE   I:D
M *2]  "DT0  I.0 6VP  $]P  !#=0  .'L  "V!   CAP  &8T  !&2   +
MEP  !)P   "@    HP   *8   "H    J0   *H   "L    K00  *X)  "P
M#0  L1$  +,7  "U(   MBL  +<Z  "W2P  N%P  +AQ  "XB   N)T  +BQ
M  "WP@  M]  5'8  $A\   \@@  ,8D  ":0   ;EP  $IT   RB   #IP
M *L   "N    L@   +8   "X    N    +H   "[    O0   +X   # !0
MP0L  ,,0  #&%@  R2   ,HN  #+/@  S%   ,QD  #->@  S9$  ,VD  #-
MM   S<  38,  $&*   UD0  *9D  !Z@   3I@  #*P   .Q    M@   +H
M  "^    P@   ,8   #(    R    ,H   #+    S0   ,X   #0    T@$
M -4(  #9#@  W14  .$A  #B,0  Y$,  .56  #F:P  YH(  .>6  #GI0
MYK  _P ) /\ !0#_  8 _P . /\ %@#_ "$ _P M /\ . #] $, ^0!- /4
M50#R %T \ !C .X :0#L &\ Z@!T .D >@#G '\ Y@"% .0 BP#C )$ X0"9
M -\ H0#< *H V@"V -< Q@#5 .$ TP#T -( _P#1 /\ T0#_ ,\ _P#* /\
M_P ! /\   #_  $ _P , /\ $@#Z !T ]@ H /, ,P#P #X [ !( .@ 4 #E
M %@ X@!> -\ 9 #= &H VP!O -D = #6 'H U !_ -( A0#0 (P S@"3 ,P
MG #) *4 QP"P ,8 O@#$ -0 P@#N ,$ _@#  /\ P #_ +\ _P"^ /\ _P
M /\   #_    ^@ ' /$ #P#K !@ Y@ C .( +@#@ #@ VP!" -4 2P#1 %(
MS@!9 ,L 7P#) &4 QP!J ,8 ;P#$ '0 P@!Z ,$ @ "_ (8 O0". +L E@"Y
M *  MP"J +8 MP"T ,H L@#F +$ ^ "P /\ KP#_ *\ _P"P /\ _P   /\
M  #W    Z@ " .$ # #7 !, T  = ,P * #) #( Q@ \ ,( 10"_ $T O !3
M +H 60"X %\ MP!D +4 :0"T &X L@!T +$ >@"O (  K0"( *P D0"J )H
MJ "E *8 L0"D ,$ HP#< *$ \@"A /\ H #_ *  _P"A /\ _P   /<   #H
M    V0   ,L " ## !  O0 8 +D (@"V "P M  V +( /P"O $< K !- *L
M5 "I %D IP!> *8 8P"E &@ HP!N *( = "@ 'H G@"" )P BP"; )4 F0"?
M )@ K "6 +H E #/ ), ZP"2 /L D@#_ )( _P"1 /\ ]P   .<   #3
MQ@   +L  @"S  P K0 2 *H ' "G "8 I  P *, . "@ $  G@!' )P 3@":
M %, F0!8 )< 70"6 &, E0!H ), ;@"2 '0 D !\ (\ A0"- (\ BP": (H
MIP"( +4 A@#' (4 Y "$ /4 A #_ (, _P"# /\ [    -,   #! 0  M
M *P   "F  < H  . )T %@": "  EP I )4 ,@"3 #H D0!! (\ 2 "- $T
MC !3 (L 6 ") %T B !C (< :0"% &\ @P!W (( @ "  (H ?@"6 'T HP![
M +  >@#" 'D W0!X /$ =P#] '@ _P!X /\ W@H  ,0+  "R#   I@L  )T(
M  "9!   E0 * )$ $0". !D BP C (D + "' #0 A0 [ (, 0@"" $@ @ !.
M '\ 4P!] %@ ? !> 'L 9 !Y &H > !R '8 >P!T (8 <P"2 '$ GP!P *T
M;@"^ &T!U@!M NT ; /Z &P#_P!L _\ SA   +<1  "F$@  FA$  )$0  "+
M#@  B0L# (<%# "$ 1, @0$< 'X")0!\ RX >@,V '@$/ !W!$, =05( '0%
M3@!S!50 <059 ' &7P!N!F8 ;09N &L'> !J!X, : B0 &<)G0!E":P 9 F\
M &,*U !C"^P 8@SZ &(,_P!B#/\ PQ8  *T7  "=&   D!@  (<6  "!%
M?1$  'P.!@!\"@X > H6 '4+'P!R"R@ < PP &\,-P!M##X ; Q$ &L-2@!I
M#4\ : U5 &<-7 !E#6, 8PYK &(.=0!@#H$ 7PZ. %T/G !<$*L 6Q"] %H0
MU@!9$?  61'] %D1_P!9$?\ N1L  *4=  "4'@  B!X  'X=  !X&P  =!@
M '$5  !Q$0D ;Q 1 &P0&0!I$"( 9Q$J &81,@!D$3D 8Q$_ &(110!@$DL
M7Q)1 %T26 !<$E\ 6A-H %D3<@!7%'T 5A2+ %05F0!3%:D 4A:Z %$6T@!1
M%^T 41?] %$7_P!1%_\ LB   )XB  ".(@  @2,  '<B  !P(0  ;!X  &D;
M  !G& 0 9A4. &,6%0!A%AX 7Q8F %T6+0!<%S0 6A<[ %D700!8&$< 5AA-
M %485 !3&%P 4AED %$9;@!/&GH 3AN( $T;EP!+'*8 2ARX $H=SP!)'>L
M21W[ $D=_P!*'?\ K"0  )@E  "()@  >R<  '$F  !J)0  9B,  &(A  !@
M'@  7AP+ %L;$@!9'!H 5QPB %4<*0!4'#  4QTW %$=/0!0'4, 3QU* $T>
M40!,'E@ 2Q]A $D?:P!(('< 1R"% $8AE !$(J0 1"*V $,BS !#(^D 0R/Z
M $,C_P!#(O\ IB<  ),I  "#*@  =BH  &TJ  !E*0  8"<  %PE  !9(P
M5R$' %4A#P!2(18 4"$> $XA)0!-(BP 3"(S $HB.0!)(D  2")& $<C30!%
M(U4 1"1> $,D:0!")74 0":# #\FD@ ^)Z, /B>T #TGR@ ]*.@ /2CY #TG
M_P ^)_\ HBH  (XK  !_+0  <BT  &@M  !A+   7"L  %@H  !4)@  428$
M $XE#0!,)1, 2B8: $@F(@!')BD 128O $0F-@!#)SP 02=# $ G2P _*%,
M/BE< #TI9@ \*G( .RJ! #HKD  Y*Z$ ."RR #<LR  W+.8 ."SX #@L_P X
M+/\ G2P  (HN  ![+P  ;S   &4P  !=+P  6"X  %,K  !0*@  3"H  $DJ
M"P!&*A$ 1"H7 $(J'P!!*B4 /RHL #XK,P ]*SD /"M  #LL2  Z+%  .2U9
M #@N9  W+G  -B]_ #4OCP T,)\ ,S"Q #(PQP R,.4 ,S#W #,P_P T+_\
MF2\  (<Q  !W,@  :S(  &(R  !:,@  5#$  $\O  !++0  1RX  $0N" !!
M+@X /RX4 #TN'  [+B( .2\I #@O+P W+S8 -C ^ #4P1@ U,4X -#%7 #,R
M8@ R,FX ,3-] # SC0 O-)X +C2P "TTQ0 M-., +C3V "\S_P O,_\ E3$
M (,S  !T-   :#4  %XU  !7-   430  $LR  !&,0  0C(  #\R!0 \,@T
M.3,2 #@S&0 V,R  -#,F #,S+0 R-#0 ,30[ # U0P P-4P +S95 "XV8  M
M-VP +#=[ "LWBP J.)P *3BN "@XPP H..( *3CU "HW_P J-_\ DC0  '\U
M  !Q-@  93<  %LW  !4-P  338  $<V  !"-0  /38  #HV @ W-PL -#<0
M #(W%@ Q.!T +S@D "XX*P M.3( +#DY "LY00 J.DD *CI3 "D[7@ H.VH
M)SMY "8\B0 E/)L )#RM ",\P@ C/.  )#ST "4[_P E._\ C38  'PX  !M
M.0  8CD  %@Z  !1.0  2CD  $0Y   ].0  .3H  #4[   R.P@ +SP. "T]
M%  L/1H *CTA "D]*  H/B\ )SXV "8^/@ E/T< )#]0 "- 6P B0&@ (4!V
M "! AP ?09D 'T&K !Y!P  >0=X 'T#S !] _@ @/_\ B3D  '@Z  !I.P
M7CP  %4\  !-/   1SP  $ \   X/0  -#X  #!    M004 *D(, "="$0 F
M0Q@ )$,> "-#)0 B0RP (40S "!$.P ?1$0 'D5. !U%60 <164 &T5T !I%
MA0 91I< &4:I !A&O@ 71=P &$7Q !E$_0 :1/\ A#P  ',]  !F/@  6S\
M %(_  !*/P  1#\  #U    V00  ,4,  "Q$   G1@$ )$<* "%(#P @210
M'DD; !U)(@ <22D &THP !I*.  92D$ &$I+ !=+50 62V( %4MQ !1+@@ 3
M2Y0 $DNG !)+O  12]D $DKP !-*_  42?\ ?S\  &]   !A00  5T(  $Y"
M  !'0@  04(  #I#   R10  +4<  "A)   C2P  'DT& !M/#0 84!$ %U 7
M !90'@ 54"4 %% L !-1-  243T $5%' !%14@ 045\ #U)M  Y2?@ -49$
M#5&D  Q1N  ,4=$ #5#L  U0^@ .3_\ >4,  &I$  !=1   4T4  $M%  !$
M10  /D8  #9(   O2@  *4P  "1/   ?40  &E,  !16"0 15PX $%@3 !!8
M&0 /6"  #E@H  U8,  -6#D #%A#  M83@ *6%H "%AH  =8>0 &6(P !5B?
M  18LP $5\H !5?F  57\P &5OP <T8  &1'  !92   4$@  $A(  !!20
M.DH  #)-   K4   )5(  "!5   :6   %5H  !!=!@ ,8 P "F 0  E@%0 (
M8!P !V C  5@*P $8#0  V ]  %@20  8%4  &!C  !@<P  8(8  %^:  !?
MK@  7\0  %[B  !>\   7O@ ;$H  %]+  !52P  3$P  $5,   ]3@  -5
M "Y3   G5@  (%D  !I<   57P  $&(   UE!  (9PL  V<.  !H$P  :!@
M &@?  !I)@  :2X  &DX  !I0P  :4\  &E=  !I;0  :8   &F4  !HJ0
M:+\  &?<  !F[@  9O< 9D\  %I/  !13P  2D\  $%1   X5   ,%<  "A;
M   A7@  &F(  !1E   0:   #&L   =N P !< D  ' -  !Q$   <10  '(:
M  !S(0  <R@  ',Q  !S/   =$@  '-6  !S9@  <WD  '..  !SHP  <KD
M ''2  !QZP  </0 85,  %93  !/4P  154  #M8   R7   *F   ")D   ;
M:   %&P   ]O   +<@  !G8   !Y    >@8  'H*  ![#@  ?!$  'T5  !^
M&P  ?R(  ( J  " -0  @$$  (!/  " 7P  @'$  ("&  " G0  ?[(  '[*
M  !^Y0  ??$ 7%@  %18  !)6@  /UT  #5A   L90  (VH  !MO   4<P
M#G<   E[   #?P   ((   "$    A@$  (8&  "("@  B0T  (H0  "+%0
MC!L  (XB  "/+   CS@  (]&  "/5@  CV@  (]^  "/E0  CJL  (W!  "-
MW   C.L 65T  $Y?  !#8@  .&8  "YL   D<0  ''<  !1\   .@0  "(4
M  ")    C0   )    "2    DP   )0   "6 P  EP@  )@,  ":#P  FQ,
M )T:  "?(P  H"X  * \  "@3   H%X  *!T  "?C   GZ(  )^W  ">RP
MGN  4V0  $=H   \;0  ,7,  "=Y   =?P  %(4   V+   &D    )0   "8
M    G    )\   "A    H@   *0   "E    IP   *@$  "J"0  K T  *T2
M  "P&0  LB,  +(Q  "R0@  LE0  +)I  "R@   LI@  +&L  "ROP  L<X
M3&X  $!S   U>@  *H$  !^(   5C@  #I4   ::    GP   *0   "H
MK    *\   "Q    L0   +,   "U    M@   +@   "Z    O 8  +X,  #
M$0  PQD  ,4F  #%-P  QDD  ,9=  #'<@  QXH  ,B?  #(KP  R+P 1GH
M #F!   NB0  (I   !>8   /GP  !Z4   "J    KP   +,   "W    O
M +\   #!    P@   ,0   #%    QP   ,D   #+    S0   ,\#  #2"@
MUA   -P:  #=*@  WCP  -]0  #@90  X7L  .&1  #BH@  XJT _P " /\
M  #_  , _P , /\ $P#_ !T _P H /X ,P#[ #X ]P!( /, 4 #P %< [0!>
M .L 9 #H &D YP!O .4 = #C 'D X@!_ .  A0#> (P W "3 -D G #6 *8
MTP"Q -$ P #/ -H S@#Q ,P _P#+ /\ RP#_ ,8 _P#! /\ _P   /\   #_
M    _P ( /L $ #V !D \@ D .\ +@#M #D Z !" ., 2P#@ %( W0!9 -D
M7P#6 &0 TP!I -$ ;@#/ '0 S@!Y ,P ?P#* (8 R ". ,8 E@#$ *  P@"K
M ,  N0"^ ,T O #J +L _ "Z /\ N@#_ +H _P"V /\ _P   /\   #^
M]  $ .L #0#D !0 WP ? -L *0#8 #, TP ] ,X 10#* $T QP!3 ,4 60##
M %\ P0!D +\ :0"] &X NP!S +H >0"X (  M@"( +0 D "R )H L0"E *\
ML@"M ,0 K #A *L ]@"J /\ J@#_ *H _P"J /\ _P   /T   #N    X@
M -4 "@#- !$ QP 9 ,0 (P#! "T OP W +L /P"W $< M0!. +( 4P"P %D
MKP!> *T 8P"L &@ JP!M *D <P"H 'H I@"! *0 B@"C )0 H0"? )\ K ">
M +L G #2 )L [@": /\ F@#_ )D _P"9 /\ _@   .X   #>    RP   ,$
M!0"Y  T M  4 +$ '@"N "< JP P *H .0"G $$ I !( *( 30"A %, GP!8
M )X 70"= &( FP!G )H ;0"8 ', EP![ )4 A "4 (X D@"9 )  I@". +0
MC0#( (P Y@"+ /D B@#_ (H _P"+ /\ \    -L   #'    N@   +    "H
M  H I  0 *  & "= "$ FP J )H ,P"8 #L E@!! )0 2 "2 $T D0!2 (\
M5P". %P C !A (L 9P"* &X B !U (< ?@"% (@ @P"4 (( H "  *\ ?P#
M 'X W0!] /( ?0#_ 'T _P!] /\ X    ,8   "U    J@   *(   ";  4
ME0 - )( $P"0 !P C0 D (L +0"* #0 B  [ (8 0@"% $< @P!- (( 4@"!
M %< ?P!< 'X 8@!] &@ >P!P 'H >0!X (, =@"/ '4 G !T *H <@"Z '$
MT0!P .P < #[ '  _P!P /\ S00  +<&  "G!P  FP8  ),$  ".    B@ (
M (8 #P"$ !8 @0 > '\ )P!] "X ?  V 'H / !Y $( =P!' '8 3 !U %(
M<P!7 '( 70!Q &, ;P!K &X = !L 'X :P"* &D F !H *8 9P"V &8 RP!E
M .< 90#W &4 _P!E /\ P P  *L-  ";#@  CPX  (8-  "!"P  ?@<! 'P!
M"P!Y !$ =P 8 '4 (0!S "D <0 P &\ -@!N #P ; !" &L 1P!J $T :0!2
M &@ 6 !F %\ 90!G &, < !B 7H 8 &' %\"E0!> J, 7 .S %P#QP!;!.0
M6P7T %L&_@!;!O\ M1   *$2  "1$P  A1,  'P2  !V$0  <PX  '(,! !Q
M!PT ;@02 &P$&P!I!2, 9P4J &8&,0!D!C< 8P8] &('0P!A!TD 7P=. %X(
M50!="%P 6PEC %H);0!8"G@ 5PJ% %8+DP!4"Z( 4PNS %(,QP!2#.0 40WU
M %$-_P!1#?\ K14  )D7  ")&   ?1D  '08  !M%P  :A0  &<1  !G#@<
M9@P. &,,%0!A#!T 7PPE %T-+ !<#3, 6PTY %H-/P!8#44 5PU+ %8.40!5
M#ED 4PYA %(.:P!0#W8 3A"# $T0D@!,$*( 2Q"R $H1R !)$>4 21'W $D2
M_P!)$?\ I1D  )(<  "#'0  =AX  &T=  !F'   8AH  %\7  !>% $ 7A$*
M %L0$0!9$1@ 5Q$@ %41)P!4$2X 4Q$T %$1.P!0$D$ 3Q)' $X23@!,$E4
M2Q-> $D39P!(%', 1A2  $45CP!$%9\ 0Q:P $(6Q0!"%^, 0A?V $(7_P!"
M%_\ GQT  (P@  !](0  <2(  &@B  !A(0  7!\  %D<  !7&0  518& %05
M#@!1%10 3Q8< $X6(P!,%BH 2Q8P $H6-P!)%ST 1Q=# $872@!%&%( 0QA:
M $(99 !!&7  /QI] #X;C0 ]&YT /!RN #L<PP ['.$ .QWU #L<_P \'/\
MFB$  (<C  !X)   ;"4  &,E  !<)   5R,  %,@  !1'@  3QP" $T;# !+
M&A$ 2!L8 $<;( !%&R8 1!LM $,<,P!"'#D 0!Q  #\=1P ^'4\ /1Y8 #P>
M8@ Z'VT .1][ #@@BP W(9L -B&M #4AP0 U(=\ -2'S #8A_P V(?\ EB,
M (,F  !T)P  :"@  %\H  !8)P  4R8  $\D  !,(@  22   $<@"0!$'P\
M0A\5 $ @'  _(", /B I #P@+P [(38 .B$] #DA1  X(DP -R)5 #8C7P T
M(VL ,R1Y #(EB0 Q)9H ,"6K # FOP O)MP ,";R # F_P Q)?\ D28  '\H
M  !Q*@  92H  %PJ  !5*@  3RD  $LH  !()0  1"0  $$D!0 _) T /202
M #LD&0 Y)!\ -R0F #8D+  U)3, -"4Z #,F00 R)DH ,2=3 # G70 O*&D
M+BEW "TIAP L*9@ *RJJ "HJO0 J*MH *RKQ "LJ_@ L*?\ C2@  'PJ  !M
M+   8BT  %DM  !1+0  3"P  $<K  !#*   /R@  #PH @ Y* L -R@0 #4H
M%@ S*!P ,B@C # H*0 O*3  +RHW "XJ/P M*T< +"M1 "LL6P J+&< *2UU
M "@MA0 G+9< )BZH "4NO  E+M@ )B[P "8N_0 G+?\ BBL  '@M  !J+@
M7R\  %8O  !.+P  2"X  $,M   _+   .RP  #<L   T+ D ,BP. # M$P N
M+1H +2T@ "LM)P J+BT *BXU "DO/0 H+T4 )S!. "8P60 E,64 )#%S ",Q
M@P B,I4 (3*G "$RNP @,M0 (3+O "(Q_  B,?\ ABT  '4O  !G,   7#$
M %,Q  !+,0  13$  $ P   [,   -C   #,P   P,08 +3$- "LQ$0 I,A<
M*#(> "<R)  E,RL )3,R "0S.@ C-$, (C1, "$U5P @-6, 'S5Q !XV@0 =
M-I, '#:E !LVN0 ;-M( '#;M !TV^P =-?\ @C   '$R  !C,P  630  % T
M  !)-   0C,  #TS   W,P  ,30  "XU   K-0( *#8+ "4W$  D-Q4 (C<;
M "$X(@ @."@ 'S@P !XX-P =.4  '#E) !LZ5  :.F  &3IN !@Z?P 7.Y$
M%SND !8[MP 5.]  %CKL !<Z^@ 8.?\ ?3(  &TT  !@-0  538  $TV  !&
M-@  0#8  #HV   T-@  +C@  "HY   F.@  (SL( " \#@ >/1( '3T8 !P]
M'P ;/B4 &CXM !D^-  7/CT %C]' !4_40 4/UX %#]L !- ?  20(\ $4"B
M !% M@ 00,X $3_K !(_^0 2/O\ >34  &DW  !<.   4CD  $HY  !#.0
M/3D  #<Y   Q.@  *SP  "<]   B/P  'D$$ !I""P 80Q  %T,5 !5$&P 4
M1"( $T0I !-$,0 21#H $45# !!%3@ 015L #D5I  Y%>0 -18P #46?  Q%
ML@ +1<D #$7E  U$]@ -1/\ =#D  &4Z  !8.P  3SL  $<\  ! /   .CP
M #0\   N/@  *$   "-"   ?1   &D8  !5("  22@T $4H2 !!*&  /2QX
M#DLE  U++0 -2S8 #$M   M+2@ *2U8 "4MD  A+=  '2X< !4N:  1+K@ $
M2L0 !4K@  5*\  &2?H ;CP  & ]  !4/@  2SX  $0^   ]/@  -S\  #%
M   J0@  )$4  !]'   :20  %4P  !%.!0 .40L "U$0  I1%  )41L "%$B
M  =1*0 %43( !%([  -21@ !4E(  %)?  !2;P  4H$  %&6  !1J0  4;\
M %#<  !0[@  4/< :$   %M!  !000  2$$  $%!   [0@  -$,  "U%   F
M2   ($L  !M-   64   $5,   Y5!  *6 H !E@.  )8$@  61<  %D=  !9
M)0  62T  %DV  !900  64T  %I:  !::0  67P  %F0  !9I0  6+H  %C5
M  !7[   5_8 8T0  %9%  !-10  144  #]%   W1P  +TD  "A,   B3P
M&U(  !95   16   #5H   E= P $7PD  & -  !@$   810  &$9  !B(
M8B<  &(Q  !B.P  8D<  &)5  !C9   8G8  &*+  !BH   8;8  &'/  !@
MZ@  8/4 74@  %))  !*2   0T@  #I*   R30  *E   "-3   <5P  %EH
M !%=   -8   "&,   -F 0  9P8  &@+  !I#@  :A$  &L5  !L&P  ;2(
M &TJ  !M-   ;4   &U.  !M70  ;6\  &V$  !LF@  ;+   &O(  !KY@
M:O, 6$T  $Y-  !(3   /DX  #51   L5   )%@  !U<   68   $&0   QG
M   ':P   6X   !P    <@,  '('  !S"P  =0X  '81  !W%@  >!P  'DC
M  !Z+0  >CD  'I'  !Z5@  >6@  'I\  !YE   >*H  'C!  !WWP  =^\
M5%$  $Q1  !"4@  .%4  "]9   F7@  'F(  !9G   0:P  "V\   5S
M=P   'H   !\    ?@   '\"  " !@  @0H  (,-  "$$0  AA4  (@<  ")
M)0  BC   (H^  ")30  B5\  (ES  "(BP  B*(  (>Y  "'T0  AN@ 4E8
M $=7   \6@  ,E\  "AD   ?:0  %F\  !!T   *>0   GT   "!    A0
M (@   "*    C    (T   "/    D 0  )((  "3#   E1   )<5  "9'0
MFR<  )LT  ";1   FE8  )IJ  "9@@  FIH  )BP  "8QP  E]X 2UP  $!@
M   U90  *VH  "%Q   7=P  $'T   F#   !B    (P   "1    E0   )@
M  ":    FP   )T   "?    H    *(   "D!0  I@H  *@.  "J%   K1T
M *TJ  "M.0  K4L  *U?  "M=P  K)   *NG  "KN@  J\L 168  #EK   N
M<0  (W@  !E_   0A@  "8T   "3    F    )T   "A    I0   *@   "K
M    JP   *X   "O    L0   +,   "U    MP$  +D'  "\#0  OQ,  ,(?
M  #"+@  PD   ,)4  #!:P  P8,  ,";  #!K0  P;P /G(  #)X   G@
M'(@  !*0   *EP   )T   "C    J    *T   "R    M@   +D   "[
MO    +X   #     P@   ,0   #&    R    ,L   #.!0  T0T  -84  #7
M(P  V#4  -E)  #:7@  VW4  -N,  #<GP  W*L _P   /\   #_    _P )
M /\ $ #_ !D _@ D /P +P#Y #D ] !# /  2P#M %( Z@!9 .< 7P#D &0
MX@!I .  ;@#> ', W !Y -H ?P#7 (8 U ". -$ E@#/ *$ S "L ,H NP#(
M -( Q@#N ,8 _P#% /\ Q0#_ +\ _P"Z /\ _P   /\   #_    _@ % /<
M#@#R !4 [@ ? .L *@#I #0 XP ] -X 10#9 $T U !3 -$ 60#. %X S !C
M ,H : #) &T QP!S ,4 >0## (  P0"( +\ D "] )L NP"F +D M "W ,@
MM@#F +4 ^P"T /\ M #_ +, _P"N /\ _P   /\   #X    [0   .4 "P#=
M !$ UP : -( ) #/ "X RP W ,< 0 ## $< P !. +X 4P"\ %D N@!> +@
M8P"V &@ M0!M +, <P"Q 'D KP"! *T B@"K )0 J0"@ *@ K0"F +X I0#;
M *0 ] "D /\ HP#_ *, _P"B /\ _P   /8   #F    UP   ,L !@#$  X
MO@ 5 +L 'P"Y "@ MP Q +0 .@"P $$ K0!( *L 3@"I %, IP!8 *8 7 "D
M &$ HP!G *$ ; "@ ', G@!Z )T @P"; (X F0"9 )< I@"6 +8 E0#, )0
MZP"3 /T DP#_ ), _P"3 /\ ]P   .0   #0    P0   +<  @"O  L JP 1
M *< &0"E "( HP K *( ,P"? #L G !" )L 2 "9 $T EP!2 )8 5P"5 %L
MDP!A )( 9@"0 &T CP!T (T ?0", (< B@"3 (@ H "' *\ A0#" (4 X@"$
M /< A #_ (0 _P"$ /\ Y0   ,T   "\    KP   *8   ">  < F@ . )8
M% "4 !T D@ E )$ +0"0 #4 C0 \ (P 0@"* $< B !, (< 40"& %8 A !;
M (, 8 "! &< @ !N 'X =P!] ($ >P"- 'H F@!X *D =P"Z '8 TP!V .\
M=@#^ '4 _P!U /\ T    +L   "K    GP   )<   "0  ( BP + (@ $ "&
M !< A  @ (( )P"! "\ ?P U 'T / !\ $$ >P!& 'D 2P!X %  =P!5 '8
M6P!T &$ <P!I '$ <0!P 'L ;@"' &T E0!K *, :@"T &H R0!I .@ :0#Y
M &D _P!I /\ P    *P   "< @  D (  (@   "#    ?P & 'L #0!Y !(
M=P : '8 (@!T "D <P P '$ -@!P #P ;P!! &T 1@!L $L :P!0 &H 5@!H
M %P 9P!D &4 ; !D '8 8P"" &$ D !@ )\ 7P"O %X PP!> .$ 7@#T %T
M_P!= /\ M <  * )  "0"P  A L  'P*  !W!P  = 0  '$ "0!O  \ ;0 5
M &L ' !I ", :  J &< ,0!E #8 9  \ &, 00!B $8 8 !, %\ 4@!> %@
M70!? %L : !: '( 6 !^ %< C !6 )L 50"K %0 O@!4 -H 4P#O %0 ^P!4
M /\ J0T  )8.  "'$   >A   '(0  !L#@  :0P  &<) P!F! L 9  0 &(
M%P!@ !X 7@ E %T *P!< #$ 6@ W %D / !8 $( 5P%' %8!3@!5 E0 4P)<
M %(#90!1 V\ 3P1[ $X$B@!-!9D 3 6I $L%O !*!M0 2@?M $H'^0!*!_\
MH1   (X2  !^%   <Q0  &H4  !D$P  8!$  %X/  !=#04 70D- %H&$@!8
M!QD 5@<@ %4')P!3!RT 4@@S %$(. !0"#X 3PE$ $X)2@!,"5$ 2PI9 $H*
M8@!("VT 1PMZ $8,B !$#)@ 0PRI $(-O !"#=4 0@WN $(-^P!"#?\ FA0
M (<6  !X&   ;!D  &,9  !=&   618  %83  !4$0  5 X( %,-#@!1#10
M3PT; $T-(@!,#2@ 2PTN $H-- !)#3H 1PY! $8.1P!%#D\ 1 Y7 $(/80!!
M$&P /Q!Y #X0B  ]$9@ .Q&I #L1O  Z$=8 .A'P #H2_0 [$?\ DQ@  ($:
M  !S'   9QT  %X=  !8'   4QL  % 8  !.%@  3!,# $P1"P!*$!  2!$7
M $81'@!%$20 1!$J $(1, !!$3< 0!(] #\21  ]$DP /!-4 #L37@ Y%&D
M.!1V #<5A0 V%98 -!:G #06N@ S%M, ,Q;N #06_  T%O\ CAL  'P=  !N
M'P  8R   %H@  !3(   3AX  $H=  !(&@  1A@  $46!P!#%0X 0143 #\5
M&@ ^%2  /14G #L5+0 Z%C, .18Z #@600 W%TD -1=1 #086P S&68 ,AES
M # :@P O&I0 +ANE "T;N  M&]  +1OL "X;^P N&_\ BAX  '@@  !J(@
M7R,  %8C  !/(@  2B$  $8@  !#'@  01L  #\: P ]&@P .QD1 #D9%@ W
M&AT -AHC #4:*0 T&C  ,QLV #$;/@ P'$8 +QQ/ "X=60 M'60 +!YQ "L?
M@0 J'Y( *1^D "@@MP G(,X )R#K "@@^@ I'_\ AB   '0C  !G)   7"4
M %,E  !,)0  1R0  $(C   _(0  /1\  #H>   W'@D -1X. #,>$P Q'AH
M,!X@ "\>)@ N'RT +1\S "P@.P K($, *B%, "DA5@ H(F( )B)O "4C?P D
M(Y  (R.B "(DM0 B),P (B3I ",D^0 D(_\ @B,  '$E  !C)@  62<  % H
M  !))P  0R<  #\F   [)   ."(  #4B   R(@8 ,"(- "XB$0 L(A< *B(=
M "DB(P H(RH )R,Q "8D.  E)4$ )"5* ",F5  B)F  (2=M " G?0 ?)X\
M'BBA !XHM  =*,H '2CH !XH^  ?)_\ ?B4  &XG  !@*0  5BD  $TJ  !&
M*@  02D  #PH   W)P  -"8  # F   M)@, *R<+ "@G$  G)Q0 )2<: "0G
M(0 C*"< (B@N "$I-@ @*3X 'RI( !XJ4@ =*UX '"MK !LK>P :+(T &2R?
M !@LL@ 8+,D &"SG !DK]P :*_\ >B<  &HJ  !=*P  4RP  $HL  !#+
M/BL  #DK   T*@  ,"H  "LJ   I*P  )BL( ",L#@ B+!( ("P8 !\L'@ >
M+24 '2TL !PM,P ;+CP &BY% !DO4  8+UP %R]I !8P>0 5,(L %#"> !0P
ML0 3,,< $S#E !0P]@ 5+_\ =BH  &<L  !:+0  4"X  $@N  !!+@  .RX
M #8M   Q+0  +"T  "<O   D+P  (3 % !\Q#  <,1  &S(5 !HR'  9,B(
M&#(I !<S,0 6,SD %3-# !0T30 3-%D $C1G !$U=P 1-8D $#6< ! UL  .
M-<8 #S3D ! T]0 0-/\ <BP  &,N  !7,   33   $4P   ^,   .#   #,P
M   O,   *3$  "0R   A,P  '34" !HV"0 7-PX %3<3 !0X&0 3.!\ $C@F
M !(X+@ 1.38 $#E  ! Y2P ..5< #CID  TZ=  ,.H8 ##J9  LYK  *.<$
M"CG>  LY\0 ,./P ;B\  %\Q  !3,@  2C,  $(S   [,P  -C,  #$R   L
M,P  )S0  "$V   =.   &3D  !4[!@ 2/0P $#X0 ! ^%0 ./AP #CXC  T^
M*@ ,/C, ##X\  L_1P */U( "#]@  <_;P &/X$ !3^4  0_J  #/KP !#[7
M  4^[  %/O< :3,  %LT  !0-0  1S4  #\U   Y-0  -#4  "XU   I-P
M(S@  !X[   :/   %C\  !)!!  .0PH #$0.  I$$P )1!D "$0@  =$)P &
M1"\ !40X  -%0@ "14X  $5;  !%:@  17P  $60  !$I   1+D  $31  !$
MZ@  0_4 9#8  %<W  !,.   0S@  #PX   W.   ,3@  "LY   E.P  (#T
M !I    60@  $D0   Y'!  +20D !TH-  1+$0 !2Q8  $L<  !+(P  2RL
M $LT  !+/@  3$D  $Q7  !,9@  3'<  $N,  !+H0  2[4  $K.  !*Z0
M2O4 7SH  %([  !(.P  0#L  #H[   T.P  +CP  "<^   B00  '$,  !9&
M   220  #DL   M. P '4 @  E$,  !1$   4A,  %,8  !3'P  4R8  %,O
M  !3.0  4T4  %-2  !380  4W(  %.'  !2G   4K$  %'*  !1YP  4?0
M63X  $X^  !%/@  /CX  #@^   P0   *4(  "-$   =1P  %TH  !)-   .
M4   "U,   95 @  5P<  %@+  !9#@  6A$  %H5  !;&@  7"$  %PJ  !<
M-   7#\  %Q-  !<6P  7&P  %R!  !;EP  6ZT  %K%  !:Y   6?, 5$(
M $I"  !"0@  /$(  #1#   L1@  )4D  !Y,   73P  $E,   Y6   *60
M!5L   !>    8 0  &$(  !B#   8PX  &01  !E%@  9AP  &<C  !G+0
M9SD  &=&  !G50  9V8  &=Z  !FD0  9:@  &7   !DW@  9/  3T8  $=&
M  ! 10  -T<  "]*   F30  'U$  !A5   260  #5P   A@   "8P   &8
M  !H    :@   &L$  !L"   ;0P  &\.  !P$@  <A<  ',=  !T)@  =#(
M '0_  !T3@  <U\  '1R  !SB@  <J$  '&X  !QU   <.P 3$H  $5*   [
M2P  ,DX  "E2   @5@  &%L  !)?   -9   !V@   !K    ;P   '(   !U
M    =@   '<   !Y @  >@8  'P*  !^#@  @!$  ((6  "$'@  A"D  (0V
M  "$10  A%8  (-J  "#@0  @ID  (&Q  " R0  @.4 2DX  #]0   U4P
M*U<  ")<   98@  $F<   QL   %<0   '4   !Y    ?0   ($   "#
MA0   (8   "(    B0   (L$  "-"   CPT  )(0  "4%@  EB   )8L  "6
M.P  EDP  )5@  "5=@  E)   ).G  "2O0  DM4 1%4  #E9   O70  )&,
M !II   2;P  #'4   1[    @    (4   ")    C0   )$   "3    E
M )8   "8    F@   )P   ">    H 8  *(+  "E$   J!<  *DC  "I,0
MJ4,  *E6  "H;0  IH<  *>>  "FLP  I<< /EX  #)C   G:@  '7   !-X
M   ,?P   X4   "+    D0   )8   ";    GP   *(   "D    I0   *<
M  "I    JP   *T   "P    L@   +4"  "W"0  NQ   +X8  "^)@  OC@
M +Y+  "]80  O'H  +N4  "ZJ0  NKD -VH  "MP   @>   %H    V(   %
MCP   )8   "<    H@   *<   "L    L    +,   "V    MP   +D   "[
M    O0   +\   #"    Q0   ,@   #*    S@@  -(0  #5&P  U2P  -1
M  #45P  TVX  -2&  #4FP  TZL _P   /\   #_    _P % /\ #@#_ !4
M_  @ /D *@#V #0 \0 ] .T 1@#I $T Y@!3 .0 60#A %X W@!C -P : #9
M &X U0!S -, >0#0 (  S@"( ,L D0#) )P Q@"G ,0 MP#" ,P P #L +\
M_P"^ /\ O0#_ +< _P"R /\ _P   /\   #_    ^@ ! /, "P#M !( Z  ;
M .4 )0#D "X WP X -@ 0 #2 $< S@!. ,L 5 #( %D Q@!> ,0 8P#" &<
MP !M +\ <P"] 'H NP"! +D BP"V )4 M "A +( KP"P ,( K@#C *X ^@"L
M /\ K0#_ *D _P"F /\ _P   /\   #R    Y@   -T !P#2  X S0 6 ,H
M( #( "D Q0 R ,  .@"\ $( N0!( +< 3@"U %, LP!8 +$ 70"P &( K@!G
M *P ; "J ', J0![ *< A "E (X HP": *$ J "? +D G@#2 )T \@"< /\
MG0#_ )P _P"9 /\ _    .X   #=    S    ,$  @"Z  P M@ 2 +( &@"P
M ", KP L *T - "I #P I@!" *0 2 "B $T H !2 )X 5P"= %L G !@ )H
M9@"9 &P EP!T )4 ?0"3 (< D0"3 )  H0". +$ C0#& (P Z "+ /T C #_
M (P _P", /\ [0   -@   #%    MP   *P   "F  @ H0 . )\ %0"= !X
MFP F )H +@"7 #4 E0 \ ), 0@"1 $< D !, (X 40"- %4 BP!: (H 8 ")
M &8 AP!M (4 =@"$ (  @@", (  F@!_ *D ?0"\ 'P W !\ /4 ? #_ 'P
M_P!\ /\ V0   ,$   "Q    I    )P   "4  , D  , (T $0"+ !@ B0 @
M (D * "' "\ A0 V (, / "" $$ @ !& '\ 2P!] $\ ? !4 'L 6@!Y &
M> !G '8 < !U 'H <P"& '$ DP!P *( ;P"T &X S !N .T ;@#^ &X _P!N
M /\ Q    *\   "@    E    (P   "&    @0 ( 'X #@!\ !0 >P ; 'D
M(@!X "D =P P '4 -@!T #L <@!  '$ 10!P $H ;P!/ &T 5 !L %L :P!B
M &D :@!H '0 9@"  &4 C@!C )T 8@"M &$ P@!A .0 80#X &$ _P!A /\
MM    *    "1    A@   'X   !Y    =0 # '$ "P!O !  ;0 6 &P '0!K
M "0 :P J &D , !H #8 9@ [ &4 0 !D $4 8P!* &$ 3P!@ %8 7P!= %T
M90!< &\ 6@!Z %D B !8 )@ 5P"H %8 NP!6 -@ 5@#Q %8 _P!6 /\ J $
M )0%  "%!P  >@<  '(&  !L!   :0$  &< !P!D  T 8P 1 &$ & !@ !\
M7P E %X *P!= #  6P V %H .P!9 $  6 !% %< 2P!6 %$ 50!8 %, 80!2
M &H 4 !V $\ A !. ), 30"D $P M@!, ,T 3 #K $P ^@!, /\ G0D  (L+
M  !\#0  < T  &@-  !B#   7PH  %T& 0!< 0D 6@ . %@ $P!7 !D 5@ @
M %4 )@!3 "L 4@ Q %$ -@!0 #L 3P!! $X 1P!- $T 2P!5 $H 70!) &<
M1P!S $8 @ !% )  1 "A $, L@!# ,@ 0P#F $, ]0!# /\ E0T  (,/  !T
M$   :1$  & 1  !:$   5@X  %0-  !3"@0 4P8+ %$#$ !/ 14 3@$; $P!
M(0!+ 2< 2@(L $D",@!( C< 1P,] $4#0P!$ TH 0P11 $($6@! !60 /P5P
M #X&?@ ]!HX / >? #L'L0 Z!\8 .@?C #H'\P Z"/P CA   'P2  !N%
M8A4  %H5  !4%   4!,  $T1  !+#@  2PT& $H*# !)"!$ 1P@6 $4('0!$
M"", 0@@H $$)+@! "3, /PDY #X*0  ]"D< / I/ #H+6  Y"V, . QO #8,
M?@ U#(X - V? #,-L0 R#<< ,@WC #(-]  R#?X B!,  '<5  !I%P  7A@
M %48  !/&   2A8  $<5  !%$P  0Q " $,." !"#0X 0 T2 #\-&  ]#1\
M/ TD #L-*@ Y#3  . XW #<./0 V#D4 -0Y- #,/5P R#V( ,1!N "\0?0 N
M$(X +1&@ "P1L@ K$<@ *Q'F "L1]@ L$?\ @Q8  '(9  !D&@  61L  %$;
M  !+&P  1AH  $(8   _%P  /A0  #P2!  [$0H .A 0 #@0%0 W$!L -1$A
M #01)P S$2T ,A$S # 1.@ O$D( +A)+ "T35  K$U\ *A1L "D4>P H%(P
M)Q6> "85L  E%<8 )17D "45]@ F%?\ ?AD  &X;  !@'0  5AX  $T>  !'
M'@  0AT  #X<   Z&@  .!@  #<6   U%0< -!0- #(4$@ P%!< +Q0= "T4
M(P L%2H *Q4P "H5-P I%C\ *!9( "<74@ F&%T )!AJ ",9>0 B&8H (1F<
M " 9KP ?&<0 'QGB " 9]  @&?\ >AL  &H>  !='P  4R   $H@  !$(
M/A\  #H>   W'0  -!P  #(9   P&00 +A@+ "P8$  J&!0 *1@: "<8(  F
M&28 )1DM "0:-0 C&CT (AM& "$;4  @'%L 'QUH !X==P ='8@ '!Z; !L>
MK0 :'L, &A[@ !H=\P ;'?\ =QT  &<@  !:(0  4"(  $@B  !!(@  .R(
M #<A   S(   ,!\  "T=   K'0  *!T( "8=#@ E'1( (QT7 "$='0 A'20
M(!XJ !\>,@ >'SH '1]# !P@30 ;(5D &B%F !DA=0 8(H< %R*9 !8BK  5
M(L$ %2+? !4A\@ 6(?X <R   &0B  !7(P  320  $4E   ^)   .20  #0C
M   P(@  +"(  "DA   F(0  )"$& "(A#  @(1  'B$5 !TB&P ;(B$ &R(H
M !HC+P 9(S@ &"1! !<D2P 6)5< %25D !0F<P 3)H4 $B:8 !$FJP 1)L
M$";= !$E\0 2)?T <"(  &$D  !4)@  2B8  $(G   \)@  -B8  #$E   M
M)0  *20  "8D   B)0  'R4# !TF"@ ;)@X &2<2 !@G&  7)Q\ %B<E !4H
M+0 4*#4 $RD^ !(I20 1*54 $2IB ! J<0 /*H, #BJ6  XJJ0 -*KT #2K7
M  TJ[@ .*?L ;"0  %TF  !1*   2"@  $ I   Y*   -"@  "\H   K)P
M)R<  "(H   >*0  &RH  !@K!P 6*PT %"P1 !,L%@ 2+!P $2TC ! M*@ 0
M+3( #RX\  XN1@ -+E( #2Y?  PO;@ ++W\ "B^2  DOI0 )+KD ""[0  DN
MZ0 *+O< :"<  %HI  !.*@  12L  #TK   W*P  ,2H  "TJ   I*@  )"H
M " K   ;+0  &"X  !4O!  2,0H $#(.  \R$P .,AD #3(@  TR)P ,,B\
M"S,X  HS0@ ),TX "#-;  8T:@ %-'L !#..  ,SH@ ",[8  C/-  ,SYP $
M,O, 9"H  %8L  !++0  0BT  #HM   T+0  +RP  "LL   F+   (BT  !TO
M   9,0  %3(  !(T P /-@D ##@-  HX$0 ).!8 "#@=  <X)  &."P !#@T
M  ,X/@ ".4H  #E7   Y90  .7<  #F+   XGP  .+,  #C*   XY@  -_(
M7RT  %(N  !(+P  /S   #@O   R+P  +2\  "DO   D,   'S$  !HS   5
M-0  $C<   \Y P ,.P@ "#T-  4^$  #/A0  #X:   ^(0  /B@  #XQ   _
M.P  /T8  #]3   _80  /W,  #^'   ^G   /K   #W'   ]Y   /?( 6C
M $XR  !$,@  /#(  #4R   P,0  *S$  "8R   @-   &S8  !8X   2.P
M#ST   P_ P (00@ !$,,  !##@  1!(  $46  !%'0  120  $4M  !&-@
M1D(  $9.  !&70  1FX  $6"  !%F   1*T  $3$  !#XP  0_( 530  $HU
M  !!-0  .34  #,T   N-   *#4  "(W   =.@  %SP  !(_   /00  #$0
M  A& 0 #2 8  $D*  !*#0  2Q   $P4  !-&0  3B   $XH  !.,@  33T
M $Y*  !.6   36D  $U]  !,E   3*H  $O!  !+X0  2O( 4#@  $8X   ]
M.   -S@  #$W   J.0  )#L  !X]   80   $T,   ]&   +20  !TL   ).
M    4 0  %$(  !2"P  4PX  %01  !5%0  5AL  %<C  !7+   5S@  %=$
M  !74@  5F,  %9W  !6C@  5:4  %2]  !3W0  4_  2SP  $(\   [.P
M-3L  "T\   F/P  'T(  !E%   32   #DL   M/   %40   %0   !7
M6 $  %H%  !;"   7 P  %T.  !?$0  8!8  &(=  !B)@  8C$  &(^  !A
M3   85T  &%P  !@B   8*   %^W  !>U   7>X 1T   #\_   Z/P  ,4
M "E#   A1@  &DH  !-.   .40  "E4   18    6P   %X   !A    8P
M &0!  !E!   9P@  &@+  !J#@  ;!(  &X7  !O(   ;RH  &\V  !N10
M;E4  &YH  !M?P  ;9@  &RP  !KR@  :N@ 1$0  #Y#   U1   *T<  "-+
M   ;3P  $U0   Y8   (7    F    !D    9P   &L   !M    ;P   '
M  !R    = (  '4&  !W"@  >0X  'P2  !^&   ?R(  '\N  !_/0  ?DT
M 'UA  !]=P  ?)   'NH  !ZP   >=\ 0T<  #E)   O3   )5   !Q5   4
M6P  #F    =E    :@   &X   !R    =@   'D   !\    ?@   '\   "!
M    @P   (4   "' P  B@@  (P-  "/$0  DAD  )(E  "2,P  DD0  )%7
M  "0;0  CX8  (Z?  "-M0  C,T /4X  #)1   H5@  'EP  !5B   .:
M!VX   !T    >0   'X   ""    A@   (D   ",    C@   )    "2
ME    )8   "8    FP   )X&  "A#   I!$  *8;  "F*0  ICH  *5-  "E
M8@  I'L  *.4  "AJP  H;\ -E<  "Q<   A8@  %VD   ]P   '=P   'X
M  "$    B@   (\   "4    F    )L   ">    GP   *(   "D    I@
M *@   "K    K0   +    "S!   MPP  +L2  "['P  NS   +M#  "Z6
MN7   +>+  "WH0  M[, ,&(  "5I   :<   $'@   F     B    (\   "6
M    FP   *$   "F    J@   *X   "P    L0   +0   "V    N    +L
M  "]    P    ,,   #'    RP,  ,\,  #3%0  TB4  -(X  #13@  T&4
M ,]^  #-E@  S*D _P   /\   #_    _P # /\ "P#\ !$ ^0 ; /< )0#S
M "\ [@ X .D 0 #F $@ X@!. -\ 5 #< %D V0!> -4 8P#3 &@ T !M ,X
M<P#+ 'H R "" ,8 C ## )< P "C +X L@"\ ,@ N@#J +D _P"X /\ L0#_
M *H _P"G /\ _P   /\   #[    ]@   .T !P#G  \ X@ 6 -\ ( #> "D
MV0 S -$ .P#, $( R !( ,4 3@#" %, P !8 +X 70"\ &( N@!G +D ;0"W
M '0 M0![ +( A0"P )  K@"< *P J@"I +T IP#> *8 ^0"E /\ HP#_ )T
M_P"; /\ _0   /8   #K    WP   -$  P#*  P Q0 2 ,, &P#  "0 O@ L
M +D -0"V #P LP!# +  2 "N $X K !2 *L 5P"I %P IP!A *8 9P"D &T
MH@!T *  ?0"> (@ G "5 )H HP"8 +0 E@#- )4 \0"4 /\ E0#_ )  _P".
M /\ \P   .8   #1    P@   +@   "Q  @ K0 / *H %@"H !X J  G *8
M+P"B #8 GP \ )T 0@"; $< F0!, )< 40"6 %4 E !: ), 8 "1 &8 D !N
M (X =@", ($ B@"- (@ FP"& *P A0#! (0 Y@"# /T A #_ (, _P"! /\
MY    ,L   "Z    K    *(   "<  0 F  , )8 $0"4 !D DP A )( * "/
M #  C0 V (L / ") $$ B !& (8 2P"% $\ A !4 (( 6@"! &  ?P!G 'X
M;P!\ 'H >@"& '@ E !W *0 =0"W '0 U !S /0 = #_ '0 _P!T /\ RP
M +8   "F    F@   )(   "*    A@ ( (, #@"! !0 @0 ; (  (P!_ "H
M?0 P 'L -@!Z #L > !  '< 10!U $D = !. ', 5 !Q %H < !A &X :0!M
M ', :P!_ &D C0!H )T 9P"N &8 QP!E .H 9@#_ &8 _P!G /\ N    *0
M  "5    B@   ($   !\    =@ $ '0 # !R !  <0 6 '  '0!P "0 ;@ J
M &T , !K #4 :@ Z &D /P!H $0 9P!) &4 3@!D %0 8P!; &$ 8P!@ &T
M7@!Y %T AP!; )8 6@"H %D O0!9 -\ 60#X %H _P!: /\ J    )4   "'
M    >P   ',   !N    :@ ! &< " !E  X 9  2 &, & !C !\ 8@ E &$
M*@!? #  7@ U %T .@!< #X 6P!$ %D 20!8 $\ 5P!6 %8 7@!4 &@ 4P!S
M %$ @0!0 )$ 3P"B $X M0!. -  3@#P $X _P!/ /\ G    (D   ![ P
M< ,  &@#  !B 0  7P   %T ! !;  L 60 / %@ % !7 !D 5P @ %8 )0!5
M "H 4P P %( - !1 #D 4  _ $\ 1 !. $L 30!2 $L 6@!* &, 20!O $<
M? !& (P 10"= $4 L !$ ,< 1 #H $0 ^@!% /\ D@0  ( '  !Q"@  9@H
M %X*  !9"0  50<  %0$  !2  < 4  , $\ $ !. !4 30 ; $P ( !+ "8
M2@ K $D , !( #4 1P Z $8 0 !% $8 0P!. $( 5@!! %\ 0 !K #X >  ]
M (@ / "9 #P JP \ ,$ .P#@ #L ]  [ /\ B0H  '@,  !J#@  7PX  %<.
M  !1#@  30P  $L+  !*" ( 200) $@ #0!& !$ 10 6 $0 ' !# "$ 0@ F
M $$ *P _ #$ /@ V #T /  \ $, .P!* #H 4@ Y %P . !H #8 =0 U (4
M- "6 #0 J  S +P ,P#8 #, [P S /L @@T  '$/  !D$   61$  %$1  !+
M$0  1Q   $0.  !"#0  00L% $$'"P _!0X /@,2 #P"&  [ AT .@,B #D#
M*  X RT -P,R #8$.0 U!#\ - 5' #,%4  Q!EH , 9F "\'<P N!X, +0>5
M "P'IP K![H *P?2 "L'ZP K!_< ?1   &P1  !?$P  5!0  $P4  !&%
M0A,  #X2   \$   .@X! #H-!@ Z"@P . D0 #8(%  U"!D - D? #())  Q
M"2D , DO "\*-@ N"CT +0I% "P+3@ K"UD *0QE "@,<P G#(, )@V5 "4-
MIP D#;L (PW2 ",-ZP C#?< >!(  &@4  !;%@  41<  $@7  !"%@  /18
M #D5   W$P  -1$  #,0 P S#@@ ,@T- # -$0 O#18 +0T; "P-(0 K#2<
M*@TM "D.-  H#CL )PY$ "4.3@ D#UD (Q!E "$0<P @$(0 'Q"6 !X0J0 =
M$+T '!#8 !T0[@ =$/D <Q0  &06  !7&   31D  $49   _&0  .A@  #47
M   R%@  ,!4  "X3   M$00 +! * "L0#@ I$!( *! 8 "80'@ E$"0 )! J
M ",1,0 B$3D (1%" " 22P >$E8 '1-C !P3<0 :$X( &125 !@4IP 7%+L
M%Q/4 !<3[@ 8$_H <!8  & 9  !4&@  2AL  $(<   \&P  -AL  #(:   O
M&0  +!@  "H6   H% $ )A,' "43#  C$Q  (A,5 " 3&@ ?$R$ 'A0G !T4
M+@ <%38 &Q4_ !H620 9%E0 &!=A !87<  5&($ %!B3 !,8I@ 2&+H $A?2
M !(7[  3%_H ;!D  %T;  !1'0  1QT  #\>   Y'0  -!T  "\<   K&P
M*!H  "89   D&   (A<$ " 7"@ >%PX '!<2 !H7%P 9&!X &1@D !@9+  7
M&30 %AH] !4:1P 4&U( $QM? !(<;@ 1''\ $!R2 ! <I0 /'+D #AS0  X;
MZ@ /&_@ :1L  %H=  !.'P  11\  #T@   V'P  ,1\  "T>   I'0  )1T
M ",<   @&P  '1L! !L;!P 9' T %QP0 !8<%0 5'!L %!TB !,=*0 2'C$
M$1XZ !$?10 0'U  #R!=  X@;  -('P #2"/  P@H@ +(+4 "R#*  L@Y0 ,
M'_0 91T  %<?  !,(0  0B$  #HA   T(0  +R$  "H@   F'P  (Q\  " >
M   ='@  &2   !8@!  4( L $B$. !$A$P 1(AD $"(?  \B)@ .(R\ #B,W
M  TC00 ,)$T "R19  HD9P ))'@ ""2+  <DG@ ')+$ !B3'  8CXP '(_$
M8A\  %0A  !)(P  0",  #@C   R(P  +",  "@B   D(0  (2$  !XA   :
M(0  %B,  !,D P 1)0@ #R8-  XG$0 -)Q8 #"<=  LG(P *)RL "2@T  @H
M/@ '*$D !BA5  4I9  $*70  RF'  (IFP !**\  "C%  $HX0 !)_  7B(
M %$D  !&)0  /24  #4E   O)0  *B0  "8D   B(P  'R,  !LD   8)0
M%"8  !$H P /*0@ #"P,  HL$  (+!0 !RP:  8L(0 %+"@  RTP  (M.@ !
M+44  "U2   N8   +G$  "V$   MF0  +:T  "S"   LX   +/  6B0  $TF
M  !#)P  .B<  #,G   M)P  *"8  "0F   A)@  '28  !DG   5*0  $2L
M  \L P -+@< "3 ,  8Q#@ #,1(  3(7   R'@  ,B4  #(M   R-@  ,T(
M #-.   S70  ,VT  #.!   RE@  ,JL  #'!   QWP  ,?  5B<  $HI   _
M*@  -RH  # J   K*0  )R@  ",H   >*0  &BH  !8L   2+@  #S    TQ
M @ *- < !34+  (V#@  -Q   #@4   X&@  ."(  #@J   Y,P  .3X  #E*
M   Y60  .6D  #E]   XDP  .*@  #>_   WW@  -O  42L  $8L   \+
M-"P  "XL   J*P  )2L  " L   ;+0  %R\  !,Q   0,P  #34   DW @ %
M.@8  3L*   \#0  /0\  #X2   _%P  0!X  $ E  ! +P  0#H  $!&  !
M5   0&4  #]X   _CP  /J8  #Z]   ]W   /?  32X  $(O   Y+P  ,B\
M "TN   H+@  (B\  !TP   8,@  $S4  ! W   ,.@  "3P   4^    000
M $((  !#"P  1 T  $80  !'%   2!D  $@A  !(*@  2#4  $A!  !(3P
M2&   $=S  !'B@  1J(  $6Y  !%V0  1/  2#(  #XR   V,@  ,#$  "LQ
M   E,@  'S0  !DV   3.0  $#P   P_   (0@   T0   !&    2 (  $H%
M  !+"   3 L  $X.  !/$0  414  %(<  !2)0  4C   %(\  !12@  45H
M %%M  !0A   3YT  $ZU  !-T@  3>X 0S8  #LV   T-0  +S0  "<U   A
M.   &CL  !0^   000  #$0   ='   "2@   $T   !/    40   %,"  !4
M!0  50@  %<+  !9#@  6Q$  %T7  !='P  72H  %TV  !<1   7%0  %MG
M  !;?@  6I<  %FO  !8RP  5^H /SD  #@Y   S.   *SD  ",\   </P
M%4,  !!'   +2@  !4X   !1    5    %<   !:    7    %T   !?
M8 0  &('  !D"P  9@X  &@2  !K&0  :R,  &HN  !J/   :DT  &E?  !H
M=0  9X\  &:H  !EP@  9., /3T  #<\   N/0  )4   !U$   620  $$T
M  I1   $50   %H   !=    8    &,   !F    :    &H   !K    ;0
M &\"  !Q!@  = H  '8.  !Y$P  >QL  'LG  !Z-0  >44  'A9  !X;0
M=X8  ':?  !UMP  =-( /$$  #)"   H10  ($H  !=.   05   "ED   )>
M    8P   &<   !K    ;P   '(   !U    =P   'D   ![    ?0   '\
M  ""    A ,  (<)  "*#@  CA,  (\>  ".*P  CCL  (U.  "+8P  BGP
M (J5  "(K0  A\4 -D<  "Q+   B3P  &54  !!;   *80   6<   !M
M<@   '<   ![    ?P   (,   "&    B    (H   "-    CP   )$   "4
M    EP   )H!  "=!P  H0T  *44  "D(0  I#$  *-$  "B60  H'   )^+
M  "=H@  G;< ,%   "55   ;6P  $F(   MI   !<    '<   !]    @P
M (@   "-    D0   )4   "8    F@   )P   "?    H0   *,   "F
MJ0   *P   "P    M <  +@.  "Z&   NB<  +DY  "X3@  MV4  +9^  "U
ME@  LZL *5L  !YB   4:0  #'$   )Y    @0   (D   "/    E@   )L
M  "@    I    *@   "K    K    *\   "R    M    +8   "Y    O
M ,    #$    R    ,T'  #2$   TAT  -$O  #01   SUL  ,US  #+C0
MRJ$ _P   /\   #[    ^@   /P " #X  \ ]0 7 /0 ( #Q "H ZP S .8
M.P#B $, W@!) -H 3P#6 %0 TP!9 -  7@#. &, RP!H ,D ;@#& '4 PP!]
M ,$ A@"^ )( NP"> +D K@"V ,, M #H +, _P"O /\ I0#_ )X _P"; /\
M_0   /<   #R    \    .<  P#A  P W  2 -@ &P#6 "0 T@ M ,P -@#&
M #T P@!# +\ 20"\ $X N@!3 +@ 6 "V %T M0!B +, 9P"Q &X KP!V *P
M?P"J (H J "7 *4 I@"C +D H0#9 *  ^0"> /\ F #_ )( _P"/ /\ \P
M .P   #C    TP   ,@   #!  D O0 / +L %@"Y !\ MP G +, +P"O #<
MK  ] *H 0P"H $@ I@!- *0 4@"C %8 H0!; )\ 80"> &< G !O )H > "7
M (, E0"0 ), G@"1 +  D #( (X \ "- /\ B@#_ (4 _P"" /\ YP   -T
M  #&    N    *X   "H  0 I0 , *$ $@"A !D H  B )\ *0"; #  F  W
M )8 /0"3 $( D@!' )  2P"/ %  C0!5 (P 6@"* &$ B !H (< < "% 'L
M@P"( ($ E@!_ *< ?0"\ 'P XP!\ /T ? #_ '@ _P!V /\ U@   ,    "O
M    HP   )D   "3    CP ) (T #@"+ !0 B@ < (H (P"( "H A0 P (,
M-@"" #L @ !  '\ 10!^ $H ? !/ 'L 5 !Z %H > !A '8 :0!U ', <P"
M '$ C@!O )\ ;@"R &T SP!L /0 ; #_ &L _P!I /\ P    *L   ";
MCP   (<   "     ?  $ 'H # !X !$ >  7 '@ '@!W "0 =0 J ', , !Q
M #4 <  Z &X /P!M $0 ; !) &L 3@!J %0 : !; &< 8P!E &T 9 !X &(
MAP!@ )< 7P"J %X P@!> .D 7@#_ %X _P!= /\ K    )D   "*    ?P
M '<   !Q    ;0   &H " !I  X :  2 &< & !G !\ 9P E &4 *@!C "\
M8@ T &$ .0!@ #X 7P!# %X 2 != $X 6P!5 %H 70!8 &< 5P!R %4 @0!4
M )$ 4P"C %( N !1 -P 40#Y %( _P!2 /\ G0   (L   !\    <0   &D
M  !D    8    %X !0!<  L 6P / %L % !: !D 6@ ? %D )0!7 "H 5@ O
M %4 - !4 #@ 4P ] %( 0P!0 $D 3P!0 $X 6 !- &( 2P!M $H >@!) (L
M2 "= $< L0!' ,P 1@#P $< _P!' /\ D    'X   !P    9@   %X   !9
M    5@   %,  0!2  @ 4  - $\ $ !/ !4 3@ : $X ( !- "4 3  J $H
M+@!) #, 2  X $< /@!& $0 10!+ $0 4P!# %T 00!H $  =0 _ (4 /@"7
M #T JP ] ,, /0#F #T ^P ^ /\ AP   '4#  !H!@  70<  %4&  !0!@
M3 0  $H!  !)  0 1P * $8 #@!% !$ 10 6 $0 &P!# "  0@ E $$ *@!
M "\ /P T #X .@ ] $  .P!' #H 3P Y %D . !D #< <0 V ($ -0"3 #0
MI@ T +L - #= #0 ]0 U /\ ?@8  &T)  !@"P  5@P  $X,  !("P  1 H
M $((  ! !0$ /P$' #X "P ]  X /  2 #L %P [ !P .@ A #D )0 W "H
M-@ P #4 -0 T #P ,P!# #( 3  Q %4 , !@ "\ ;0 N 'T +0"/ "P H@ L
M +8 + #0 "P [@ L /P =PH  &<,  !:#@  4 X  $D.  !##@  /@T  #L,
M   Y"P  . D# #<%"  V @T -0$0 #0 $P S !@ ,@ = #$ (@ P "< +P L
M "X ,@ M #@ + !  "L 20 J %( *0!= "@ :P G 7H )@&, "4 GP E +(
M)0#* "4 Z  E /< <@T  &(.  !6$   3!$  $01   ^$0  .1   #8/   S
M#@  ,0T! # +!0 P" H +P8- "X%$0 L!!0 *P,9 "H#'@ I R, * 0I "<$
M+P F!34 )04] "0%1@ C!E  (@9< "$':0 @!WD 'P>+ !X'G0 >![  '0;&
M !T&XP =!?, ;0X  %X1  !2$@  2!,  $ 3   Z$P  -1(  #$1   N$
M+ \  "H. P J#0< *0L+ "@)#@ G"1$ )0@6 "0(&P C"2  (@DF "$)+  @
M"C, 'PH[ !X+1  ="T\ ' Q; !L,:0 :#'D & R+ !@,G@ 7#+  %@S% !8,
MX0 6"_  :1   %H2  !.%   114  #T5   W%0  ,10  "T3   J$@  *!$
M "80 0 D$ 0 (PX( ",-#  B# \ ( P3 !\,&  >#1T '0TC !P-*@ ;#3(
M&@XZ !@.1  7#E  %@]< !4/:@ 3$'L $A"- !$0H  1$+, $ _) ! /Y  1
M#_( 91(  %<4  !+%@  0A<  #H7   T%P  +Q8  "H5   G%   )!,  "(3
M   @$@, 'A$& !T0"0 <$ T &P\0 !D0%0 8$!L %Q A !80*  5$3  %!$Y
M !,10P 2$DX $1): ! 2:0 0$WD #A.,  X3G@ -$[$ #1+%  P2X0 -$O$
M8A0  %06  !)&   /QD  #<9   Q&0  +!@  "@7   D%@  (18  !\5   <
M% ( &A,$ !D2!@ 7$@L %1(. !02$@ 3$Q@ $A,? !$3)@ 1%"T $!0V  \5
M00 .%4P #A97  T690 ,%W4 "Q>'  H7F@ )%JT "!;!  @6W0 )%>X 7Q8
M %$8  !&&@  /1H  #4;   O&@  *AH  "49   B&   'Q@  !P7   9%@$
M%Q8# !46!  3%@D $18- ! 7$0 /%Q8 #A<<  X8(P -&"H #!DS  P9/  +
M&D< "AI3  D:80 '&W$ !AN#  4;EP $&JH  QJ_  ,9V@ $&>P 7!@  $X:
M  !#'   .AP  #,<   L'   )QP  ",;   @&@  '1D  !H9   7& $ %1@"
M !(9!  0&P< #AL,  T<$  ,'!, "QP9  H<'P )'2< "!TO  <>.0 &'D,
M!!Y0  ,?7@ "'VX  1^    ?E0  'JD  !Z]   =V   '>P 6!H  $L<  !!
M'@  .!X  # >   J'@  )1T  "$<   >'   &QL  !@;   6&P$ $QL" !$<
M!  .'@< #!\+  H@#@ ((!( !B$7  4A'0 $(20  B(L  $B-0  (D   "--
M   C6@  (VL  "-^   CDP  (J<  "*\   AUP  (>T 51T  $@?   ^(
M-2   "X@   H(   (Q\  " >   ='0  &AT  !8=   3'@  $1\"  X@!  -
M(@< "B0+  8E#0 $)1   B84   F&@  )B$  "<I   G,@  )ST  "=)   H
M5P  *&<  "=[   GD   )Z4  ":[   FU@  )>T 42   $4A   [(@  ,B(
M "PB   F(0  (B$  !X@   ;'P  &"   !0@   1(@  #R,   TE P *)@8
M!B@*  ,I#0  *P\  "P2   L%P  +!X  "PF   M+P  +3D  "U&   M5
M+60  "UW   LC0  +*0  "NZ   KU@  *NX 32(  $$D   X)   ,"0  "DD
M   D(P  (2(  !TB   9(@  %2,  !(D   /)@  #2@   HJ @ &+ 4  BX)
M   O"P  , X  #(0   S%0  ,QL  #,B   S*P  ,S8  #-"   S4   ,V
M #-S   RB@  ,J$  #&X   PU@  ,.\ 224  #XF   T)P  +2<  "@F   C
M)0  'R0  !LE   6)@  $B@  ! J   -+   "BX   8P 0 ",@0  #0'   U
M"@  -PP  #@.   Z$@  .A<  #H?   Z)P  .C(  #H^   Z3   .EP  #IO
M   YA@  .)X  #BV   WU   -N\ 1"D  #HI   Q*0  *RD  "8H   B)P
M'2@  !@I   3*P  $"X   TP   ),@  !34   $W    .0(  #L%   \"
M/@L  #\-  !!$   0Q0  $,;  !#(P  0RX  $,Y  !#1P  0E<  $)J  !!
M@0  0)H  #^R   ^SP  /N\ /RP  #8L   O+   *BL  "4J   ?*P  &2T
M !0O   0,@  #34   @X   $.@   #P    _    00   $,"  !%!0  1@@
M $@+  !*#@  3!$  $T6  !-'@  32@  $TT  !,0@  3%$  $MD  !+>P
M2I0  $FM  !(R@  1^P .S   #,O   M+P  *"T  "(O   ;,0  %30  ! W
M   -.@  "#T   )     0P   $8   !(    2@   $P   !. 0  3P0  %$'
M  !3"P  50X  %@2  !9&0  6"(  %@N  !7/   5TL  %9>  !6<P  58T
M %2G  !2P@  4N8 .#,  #$R   L,0  )3(  !TU   6.   $3P   Q    '
M1    $<   !*    30   %    !3    50   %<   !9    6@   %P#  !>
M!P  80L  &0.  !F$P  9QP  &8G  !F-   940  &17  !D:P  8H4  &&?
M  !@N0  7MP -3<  # U   H-P  (#H  !@]   10@  #$8   9*    3P
M %,   !6    60   %P   !?    80   &0   !E    9P   &D   !L 0
M;@8  '$+  !T#P  =Q4  '<@  !V+0  =CT  '5/  !T8P  <WL  '*5  !P
MKP  ;\D -3H  "L[   B/P  &D,  !)(   ,30  !5(   !7    7    &
M  !D    :    &L   !N    <0   ',   !U    =P   'H   !\    ?P
M (($  "&"@  B@\  (P7  "+)   BC,  (E%  "'6P  AG(  (6+  "#I0
M@KP +T   "5$   <20  $TX   U4   $6@   &$   !F    :P   &\   !T
M    >0   'T   "     @P   (4   "'    B@   (P   "/    D@   )8
M  "9 @  G@D  *(0  "B&@  H2D  * [  "?4   G6<  )J!  ":F0  F:\
M*4D  !].   55   #EL   5B    :0   '    !W    ?0   ((   "&
MBP   (\   "3    E0   )<   ":    G0   *    "C    I@   *H   "N
M    L@   +<*  "[$0  NA\  +DP  "W10  M5P  +1T  "QC@  KZ0 (E0
M !A;   08@  !VH   !S    >P   ((   ")    D    )4   ":    GP
M *,   "F    J    *L   "N    L    +,   "V    N@   +T   #"
MQP   ,P!  #3"P  U!4  -,F  #1.@  T%$  ,UH  #+@0  RI8 _    /8
M  #R    \0   /, !0#T  P \@ 3 /  ' #M "4 Z  N .( -@#> #X V0!$
M -0 2@#1 $\ S@!4 ,L 60#) %X Q@!C ,0 :0#! '  O@!X +P @0"Y (T
MM@": +, JP"Q ,  KP#F *X _P"E /\ F@#_ )0 _P"/ /\ ]    .P   #H
M    YP   -\   #9  D T@ 0 ,\ %P#/ "  S  H ,8 , #  #< O  ^ +D
M1 "W $D M0!. +, 4P"Q %< KP!= *T 8@"K &D J0!Q *< >@"E (4 H@"3
M *  H@"= +8 FP#4 )D ^0"6 /\ C0#_ (@ _P"$ /\ Z    -\   #9
MR0   +\   "X  0 M0 - +, $@"Q !H L  B *T *@"I #$ I@ X *0 /0"B
M $, H !( )X 3 "< %$ FP!6 )D 7 "7 &( E0!I ), <@"1 'T CP"+ (T
MF@"+ *P B0#% (@ [@"& /\ ?P#_ 'H _P!X /\ V0   ,T   "[    K@
M *4   "?    G  ) )D #P"9 !4 F0 = )@ ) "4 "L D0 Q (X -P", #P
MBP!! (D 1@"( $L A@!0 (4 50"# %L @@!B (  :P!^ '4 ? "" 'H D@!X
M *, =P"Y '8 X !U /\ <@#_ &X _P!L /\ QP   +4   "E    F0   (\
M  ")    A0 $ (0 # "" !$ @@ 7 (( '@"  "4 ?@ K 'P ,0!Z #8 >0 [
M '< 0 !V $0 =0!) ', 3P!R %4 < !< &\ 9 !M &X ; !Z &H B@!H )L
M9P"O &8 S !E /4 9 #_ &$ _P!@ /\ M    *    "0    A0   'T   !W
M    <P   '  " !O  X ;P 2 &\ & !O !\ ;0 E &L *@!I #  :  T &<
M.0!F #X 90!# &, 2 !B $X 80!5 %\ 7@!> &< 7 !S %L @@!9 ), 6 "F
M %< OP!7 .H 5P#_ %8 _P!4 /\ H0   (X   !_    =0   &P   !H
M9    &$ ! !@  L 7P / %\ $P!? !D 7P ? %T )0!< "H 6P O %D ,P!8
M #@ 5P ] %8 0P!5 $D 4P!0 %( 6 !1 &$ 4 !M $X >P!- (P 3 "? $L
MM0!* -P 2@#Z $H _P!* /\ D@   (    !R    9P   %\   !:    5P
M %4  0!3  < 4@ , %( $ !2 !0 4@ : %$ 'P!/ "0 3@ I $T +@!, #,
M2P X $H /0!) $, 2 !* $8 4@!% %P 1 !G $, =0!" (8 00"8 $  K@!
M ,L /P#R $  _P!  /\ A0   '0   !G    70   %4   !/    3    $H
M  !(  0 1P * $< #0!& !$ 1@ 5 $8 &@!% !\ 1  D $, *0!" "T 00 S
M #\ .  ^ #X /0!% #P 3@ [ %< .@!B #D ;P X (  -P"3 #8 IP V ,
M-@#H #8 _@ V /\ ?    &L   !> @  5 ,  $T#  !' P  0P$  $$    _
M  $ /@ ' #T "P ]  X /  1 #P %@ \ !H .@ ? #D )  X "D -P N #8
M,P U #H - !! #, 20 R %, ,0!> #  :P O 'L +@". "T H@ M +@ +0#=
M "T ^  N /\ <P$  &0%  !7!P  30@  $8(  ! "   .P<  #@%   W P
M-@ $ #4 "  T  P -  / #0 $@ S !8 ,@ ; #$ (  P "0 +P I "X +P M
M #8 +  ] "L 10 J $\ *0!: "@ 9P G '< )@") "8 G0 E +, )0#/ "4
M\  F /\ ;08  %X)  !2"P  2 P  $ ,   Z"P  -@L  #(*   P"   +@8"
M "X#!@ M  H +  - "P $  K !, *@ 7 "D '  H "  )P E "8 *P E #(
M)  Y ", 0@ B $L (@!7 "$ 9  @ ', 'P"% !\ F0 > *X '@#' !X Z0 ?
M /H : D  %D,  !-#0  0PX  #P.   V#@  ,0T  "T-   J#   * L  "<)
M!  F!@@ )@0+ "4##@ D 1  ) $4 "(!&  A 1T (0 B "  *  ? "X '@$V
M !T!/P < 4D &P%4 !H!80 : 7  &0&" !@ E@ 8 *H & #! !@ X0 8 /0
M8PP  %4.  !)#P  0!   #@0   R$   +0\  "D.   F#@  (PT  "(, P @
M"P8 ( D) !\'#  >!@X '@41 !P%%0 ;!1H &@4? !H%)0 9!2L & 4S !<&
M/  6!D8 %@92 !4'7P 4!VX $P>  !('E  2!J< $@6\ !($V0 2 ^\ 7PX
M %$/  !&$   /!$  #41   O$0  *A$  "80   B$   ( \  !T. @ <#04
M&@T' !H+"@ 9"@T & D0 !<)$@ 6"1< %0D< !0)(@ 4"BD $PHQ !(*.@ 2
M"T4 $0M1 ! ,7P /#&X #@R   X,E  -"Z< #0NZ  T*T@ -"NH 7 \  $X1
M  !#$@  .A,  #(3   L$P  )Q(  ",1   ?$0  '!   !H0 @ 8#P0 %@X'
M !4."0 4#0L $PP- !(,$  2#!0 $0P: !$-(  0#2@ #PTP  X..P -#D8
M#0Y1  P/7@ +#VT "@]_  D/DP )#Z8 " ZY  @.T  '#N@ 6!$  $L2  !
M$P  -Q0  # 4   I%   )10  "$3   =$@  &A(  !<1 @ 5$04 $Q ' !(0
M"0 1#PH $ X,  X.#@ .#Q( #1 8  T0'@ ,$"4 #! M  L1-@ *$4$ "1%-
M  @26@ '$FH !A)\  42D  $$J0  Q&X  ,1SP "$>@ 51(  $D4   ^%0
M-18  "T6   G%@  (A4  !X4   ;%   &!,  !42 P 3$@4 $A$' ! 1"0 /
M$0H #1$+  P2#@ +$A$ "A(5  D3&P )$R( "!,J  <4,P %%#X !!5*  ,5
M6  "%6<  15Z   5C@  %:,  !2W   4SP  $^D 4A0  $86   [%P  ,A<
M "L7   E%P  (18  !P6   9%0  %A0! !03!  2$P8 $1((  \2"  .$PD
M#!0*  H5#0 (%A  !A83  46&0 $%Q\  Q<G  (8,  !&#L  !E'   950
M&60  !EW   9C   &*(  !BW   7SP  %^H 3Q8  $,8   Y&0  ,!D  "D9
M   C&0  'Q@  !L7   8%@  %14" !,5!0 1% 8 $!0&  X5!P ,%@@ "A<*
M  <9#  $&@X  AL2  $;%@  &QT  !PD   <+0  '#@  !U$   =4@  '6(
M !UU   =B@  '*   !RV   ;T   &NL 3!@  $ :   V&P  +1L  "8;   A
M&@  '1D  !D9   7&   %!<# !(6!  0%P0 #A<$  P9!0 *&@< !QP)  ,=
M"P  'PT  " 0   @%   (1H  "$B   A*@  (34  ")!   B3P  (E\  ")R
M   AB   (9\  ""V   ?T0  '^T 2!H  #T<   S'0  *QT  "0=   @'
M'!L  !@:   6&0$ $QD! !$9 0 .&@$ #!P"  H= P ''P4  R$(   B"@
M) P  "8.   F$@  )A@  "<?   G)P  )S(  "<^   G2P  )UP  "=N   F
MA0  )IT  "6T   DT0  (^X 1!T  #D?   P'P  *!\  ",>   >'0  &QP
M !@;   4'   $1P   X=   -'P  "B$   8B 0 #) 0  "8&   H"   *@L
M "L-   M$   +14  "T<   M)   +BX  "XZ   N2   +5@  "UJ   M@0
M+)H  "NR   JT   *>\ 0"   #8A   M(0  )B$  "$@   ='P  &AX  !8>
M   2'P  #R$   TB   *)   !B8   (H    *P(  "T$   O!@  , D  #(,
M   T#@  -1(  #48   U(   -2H  #4V   U0P  -5,  #1F   T?   ,Y8
M #*O   QS0  ,.\ /",  #(D   J)   )",  " B   <(0  %R$  !,C   0
M)0  #2<   DI   %*P   2X    P    ,@   #0!   V!   . 8  #H)   \
M#0  /A   #X4   ^'   /B8  #XQ   ^/P  /4X  #UA   \=P  .Y$  #JK
M   YR0  ..T -R<  "\G   H)@  (R4  !\D   9)0  %"8  ! H   -*P
M"2X   4P    ,P   #4    X    .@   #P    ^ 0  0 ,  $('  !$"@
M1@T  $D1  !)%P  2"$  $@L  !'.@  1TD  $9;  !%<0  1(L  $.E  !"
MPP  0>@ -"H  "PJ   G*   (B<  !PH   6*@  $2T   TP   ),P   S8
M   Y    /    #X   !!    0P   $8   !(    2@   $P#  !.!@  4 H
M %,.  !4$P  5!P  %,G  !3-   4T,  %)5  !1:@  4(,  $^>  !-N0
M3.  ,"T  "LL   F*P  'RP  !@N   2,@  #34   @Y   "/0   $    !#
M    1@   $D   !,    3@   %$   !3    50   %<   !9 0  7 8  %\*
M  !B#@  8Q4  &,?  !B+   83P  &!.  !?8@  7GL  %R6  !;L   6<\
M+S   "HO   B,   &C,  !,W   ..P  "#\   %$    2    $P   !/
M4@   %4   !8    6P   %T   !@    8@   &0   !F    :0   &T%  !P
M"P  =!   '08  !S)0  <C0  ')%  !P60  ;W$  &V+  !KI@  :L  +C,
M "4U   =.   %#P   Y!   '1P   $P   !1    50   %D   !=    80
M &4   !H    :P   &T   !O    <@   '0   !W    >@   'X   ""!
MA@L  (H1  ")'   B"L  (8]  "$4@  @V<  (&!  !_FP  ?K( *3H  " ]
M   60@  #T@   A.    5    %H   !@    9    &D   !N    <@   '8
M  !Z    ?0   (    ""    A0   (@   "+    C@   )(   "6    FP,
M * ,  "B$P  H"$  )\S  "=1P  FEX  )AW  "7CP  E:< (T,  !E(   1
M3@  "54   !<    8P   &H   !Q    =@   'L   "     A@   (H   ".
M    D0   ),   "6    F0   )P   "@    HP   *<   "K    L    +8$
M  "\#0  NA<  +DH  "W/   M%(  +)J  "OA0  K9P '$X  !-4   +7
M 60   !L    =    'P   "#    B0   (\   "4    F@   )\   "B
MI    *<   "J    K@   +$   "T    N    +P   #!    QP   ,T   #4
M!0  V!   -4>  #3,0  T$@  ,U?  #+=@  R(X
M  $#! 4&" D*"PT.#Q$2$Q06%Q@:&QP='R A(B0E)B@I*BLM+B\P,C,T-C<X
M.3L\/3Y 04)$149'24I+34Y/4%)35%576%E;7%U>8&%B8V5F9VEJ:VQN;W!Q
M<W1U=WAY>GQ]?H"!@H.%AH>(BHN,CH^0D9.4E9:8F9J<G9Z?H:*CI*:GJ*JK
MK*VOL+&SM+6VN+FZN[V^O\'"P\3&Q\C)R\S-S]#1TM35UM?9VMO=WM_@XN/D
MYN?HZ>OL[>[P\?+T]?;W^?K[_/[_________________________________
M_____________________P                     ! P0%!@@)"@L-#@\1
M$A,4%A<8&AL<'1\@(2(D)28H*2HK+2XO,#(S-#8W.#D[/#T^0$%"1$5&1TE*
M2TU.3U!24U155UA96UQ=7F!A8F-E9F=I:FML;F]P<7-T=7=X>7I\?7Z @8*#
MA8:'B(J+C(Z/D)&3E)66F)F:G)V>GZ&BHZ2FIZBJJZRMK["QL[2UMKBYNKN]
MOK_!PL/$QL?(R<O,S<_0T=+4U=;7V=K;W=[?X.+CY.;GZ.GK[.WN\/'R]/7V
M]_GZ^_S^____________________________________________________
M__\                      0,$!08("0H+#0X/$1(3%!87&!H;'!T?("$B
M)"4F*"DJ*RTN+S R,S0V-S@Y.SP]/D!!0D1%1D=)2DM-3D]04E-455=865M<
M75Y@86)C969G:6IK;&YO<'%S='5W>'EZ?'U^@(&"@X6&AXB*BXR.CY"1DY25
MEIB9FIR=GI^AHJ.DIJ>HJJNLK:^PL;.TM;:XN;J[O;Z_P<+#Q,;'R,G+S,W/
MT-'2U-76U]G:V]W>W^#BX^3FY^CIZ^SM[O#Q\O3U]O?Y^OO\_O__________
M____________________________________________  $" P0%!@<("0H+
M# T.#Q 1$A,4%187&!D:&QP='A\@(2(C)"4F)R@I*BLL+2XO,#$R,S0U-C<X
M.3H[/#T^/T!!0D-$149'2$E*2TQ-3D]045)35%565UA96EM<75Y?8&%B8V1E
M9F=H:6IK;&UN;W!Q<G-T=79W>'EZ>WQ]?G^ @8*#A(6&AXB)BHN,C8Z/D)&2
MDY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\O;Z_
MP,'"P\3%QL?(R<K+S,W.S]#1TM/4U=;7V-G:V]S=WM_@X>+CY.7FY^CIZNOL
M[>[O\/'R\_3U]O?X^?K[_/W^_VUF=#$      P0A   !
M     0                    $    ! @,$!08'" @)"@L,#0X/$!$2$Q05
M%A<8&1H:&QP='A\@(2(C)"4F)R@I*BLL+2XO,#$Q,C,T-38W.#DZ.SP]/C]
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MA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VO?
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MAJB'SH.HB<Z!IXS/@*>-SX"GC<^ IXW/@*>-SX"GC<^ IXW/@*>-SX"GC<^
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M@+&,PH"QC,* L8S"@+&,PH"QC,* L8S"@+&,PH"QC,* L8S"@+&,PH"QC,*
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MAJ.(U(.CC-2!HY'4@*29TX"FH=& IJ'1@*:AT8"FH=& IJ'1@*:AT8"FH=&
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MI+5EO*"R=+^>L7_"FZ^$PY:NA,61K83&C:V%QXJLALB'K(?)A:N(R8*KBLJ
MJXS*?JN/RGRKDLI\JY+*?*N2RGRKDLI\JY+*?*N2RGRKDLI\JY+*?*N2RGRK
MDLI\JY+*?*N2RO&]# ;YOA(:^KX;-_RZ)5KGSA-HR-D+B:W#,J>AN%:XG;5H
MNYNS=;Z9LG_ F+&$P9.PA<*/KX7#C*^&Q(FNAL6&KH?%A*Z(QH.MBL:!K8O&
M?ZV.QWVMD,=]K9#'?:V0QWVMD,=]K9#'?:V0QWVMD,=]K9#'?:V0QWVMD,=]
MK9#'?:V0Q]_ " 7UP@\9]L(6-N[(%5#-W QFM=H/B*+)-J":OE:PE[=JN96U
M=KR4M'Z^E+.$OY"RA<"-L8;!BK&&P8BQA\*&L(C"A+")PH.PBL.!L(O#@*^-
MPWZOC\-^KX_#?J^/PWZOC\-^KX_#?J^/PWZOC\-^KX_#?J^/PWZOC\-^KX_#
M?J^/P]G"!P7DQPL8[\@0--':"T6ZZ0YHIMX8@IC1-Y61R%.AC\)EJ8Z^<JZ-
MO'NRC+J!M8FX@K>'N(2XA;>%N8.VAKJ"MH>Z@;6(NX"UB;M^M8J\?;2,O'RT
MC;U\M(V]?+2-O7RTC;U\M(V]?+2-O7RTC;U\M(V]?+2-O7RTC;U\M(V]?+2-
MO=3$!P36RPD5T]0+)[WB#$FI]!1EF>8E>([<.8:(U$^0AL]@EX3,;9R#R76@
M?\=XHGW&>Z1ZQ7VF><2 IW?#@:AVPH.I=<*$JG3!AJMSP8>K<L")K'&_BZUQ
MOXNM<;^+K7&_BZUQOXNM<;^+K7&_BZUQOXNM<;^+K7&_BZUQOXNM<;^+K<_&
M!P+0S0D2P-D)+*SW#TB;^AY<C^\Q:X;G0G: XE!^?MU?A7O9:8IWU6Z/=--S
MDG'1=Y1PT'J6;L]]EVW.?YELS8&9:\V#FFK,A9MIS(><:,N)G6?*C)UGRHR=
M9\J,G6?*C)UGRHR=9\J,G6?*C)UGRHR=9\J,G6?*C)UGRHR=9\J,G<K(" '"
MT@<3KN8)+9W_%4&1_RA0A_HY7('S2&9\[51N=^A>=7'D97IMX6M^:M]P@6C>
M=81FW'B%9=M[AV/:?HABVH&)8=F#BF#9A8I@V(>+7MB*C%[6C8U>UHV-7M:-
MC5[6C8U>UHV-7M:-C5[6C8U>UHV-7M:-C5[6C8U>UHV-7M:-C<3*!P.QV@05
MG_\-*)+_'3>)_RY#@O\]3GS]2U=W^%9?;_-=96CP8FID[6EN8>MO<5_I<W-=
MZ'=U7.=[=EOF?G=:YH!X6>6#>5CEA7I8Y(AZ5^2+>U;CCGQ6XXY\5N..?%;C
MCGQ6XXY\5N..?%;CCGQ6XXY\5N..?%;CCGQ6XXY\5N..?/^J' 7_JB<7_Z<V
M+_^B1$KZG5)EZI=??MR3;I//DGBEQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]
MOH26O[Z"F<"]@)O!O7Z>P;Q]H<*\>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X
M>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FOPO^J' 7_JB<7_Z<V+_^B
M1$KZG5)EZI=??MR3;I//DGBEQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26
MO[Z"F<"]@)O!O7Z>P;Q]H<*\>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"
MN'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FOPO^J' 7_JB<7_Z<V+_^B1$KZ
MG5)EZI=??MR3;I//DGBEQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"
MF<"]@)O!O7Z>P;Q]H<*\>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FO
MPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FOPO^J' 7_JB<7_Z<V+_^B1$KZG5)E
MZI=??MR3;I//DGBEQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]
M@)O!O7Z>P;Q]H<*\>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAY
MK\*X>:_"N'FOPKAYK\*X>:_"N'FOPO^J' 7_JB<7_Z<V+_^B1$KZG5)EZI=?
M?MR3;I//DGBEQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]@)O!
MO7Z>P;Q]H<*\>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X
M>:_"N'FOPKAYK\*X>:_"N'FOPO^J' 7_JB<7_Z<V+_^B1$KZG5)EZI=??MR3
M;I//DGBEQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]@)O!O7Z>
MP;Q]H<*\>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"
MN'FOPKAYK\*X>:_"N'FOPO^J&P7_JB<7_Z<U+_^C1$KZG5%EZ9=>?MN4;93/
MDG>FQ9*!M,23B+;#DHVXP8^/NL"+D;R_B).^OH66O[V"F,&\@)O"O'Z>PKQ]
MH<.[>Z3$NWJIQ+IYK<2U>:[#M7FNP[5YKL.U>:[#M7FNP[5YKL.U>:[#M7FN
MP[5YKL.U>:[#M7FNP_^K&P7_JR87_Z@T+_^D0TKYGE!EZ9A=?]J5:97-E'2H
MQ91^M,25AK;"E8RYP9&.N[^-D+V^B9*_O8:4P;R#E\.[@9K$NGZ=Q;I]H<:Z
M>Z7&N7JJQK5ZK,:Q>JW$L7JMQ+%ZK<2Q>JW$L7JMQ+%ZK<2Q>JW$L7JMQ+%Z
MK<2Q>JW$L7JMQ/^K&@7_JR47_ZDT+_^D0DKYGT]FZ)E<@-J69I;,E7&IQ95\
MM,26@[?"EXNZP).,O+Z/CK^]BY#!O(>3P[J$EL6Y@9G&N7^=Q[A]H<BX?*;)
MM7JJR;![J\>L>ZW%K'NMQ:Q[K<6L>ZW%K'NMQ:Q[K<6L>ZW%K'NMQ:Q[K<6L
M>ZW%K'NMQ?^L&07_K"06_ZDS+_^E04KYGT]FZ)E;@=F88Y;,EF^JQ99YM,.7
M@;?!F(FZOY6+O;Z1C<"\C8_"NHB2Q;F%E<>X@IC)MW^=RK9]HLNV?*C+L'NI
MRJQ\JLBH?:S%J'VLQ:A]K,6H?:S%J'VLQ:A]K,6H?:S%J'VLQ:A]K,6H?:S%
MJ'VLQ?^L&07_K"06_ZHR+_^E04OYH$YGYYI9@=F989?+EVVKQ9=WM,.9?[?!
MFH>[OY>*OKV3C,&[CH[$N8J0Q[B&D\FV@IC+M7^=S;1^H\ZQ?*;.K'VHRZA]
MJLFE?JS&I7ZLQJ5^K,:E?JS&I7ZLQJ5^K,:E?JS&I7ZLQJ5^K,:E?JS&I7ZL
MQO^L&07_K2,6_ZHR+_^F0$OXH$UGYYQ7@=F:7I?+F&JLQ9ETM,.:?;?!FX6[
MOIF)O[R5BL*ZD(S%N(R/R+:'DLNT@Y?.LX"=T+)_I-&L?J7/J'ZGS*1_J<FA
M@*S&H8"LQJ& K,:A@*S&H8"LQJ& K,:A@*S&H8"LQJ& K,:A@*S&H8"LQO^M
M& 7_K2,6_ZLQ+_^F/TOXH$UGYYU5@=F<7)?*F6BLQ9IRM,.<>KC G(.[OIR)
MO[N7B<.YDXO'MXZ-R[2)D,ZRA);1L8&=TZR HM.G@*70I("GS:"!J<J>@:O&
MGH&KQIZ!J\:>@:O&GH&KQIZ!J\:>@:O&GH&KQIZ!J\:>@:O&GH&KQO^M& 7_
MK2(6_ZLQ+_^G/TOXH4QGYYY3@=F=69?*FV6LQ9QOM,.=>+C GH&\O9Z(P+N:
MB,2XE8G)M9"+S;*+C]&PAI75KH2>UZ>"H=2C@J31GX*GS9R#J<J:@ZO'FH.K
MQYJ#J\>:@ZO'FH.KQYJ#J\>:@ZO'FH.KQYJ#J\>:@ZO'FH.KQ_^M%P7_KB(6
M_ZLP+_^G/DOXH4MHYY]1@=F?5I?*G&*LQ9ULM,.?=;C H'Z\O:"'P;J=B,:W
MF(C+LY.)S[".C=2MB939J(:=VJ*%H=6>A:31FX6FSIF%J<J7A:O'EX6KQY>%
MJ\>7A:O'EX6KQY>%J\>7A:O'EX6KQY>%J\>7A:O'EX6KQ_^N%P3_KB(6_ZPP
M+_^G/DOXHDMHZ*%/@=F@4Y?*GE^LQI]IM,.A<KC HGR\O:*$P;F@A\>UG(?-
MLI>(TJZ3B]BJCI/?HHN<W)R)H-:9B*/2EXBFSI6(J<J4B*O'E(BKQY2(J\>4
MB*O'E(BKQY2(J\>4B*O'E(BKQY2(J\>4B*O'E(BKQ_^N%P3_KB$6_ZPO+_^H
M/4OXHDIHZ*)-@-FB4)?+H%RLQJ%EL\.D;K? I7B\O*6"PKBDA\BTH(?.L)V(
MU:N9BMVEEY/FFY&;W9:/H->4C:/3DHRFSY&+J,N0BJO(D(JKR)"*J\B0BJO(
MD(JKR)"*J\B0BJO(D(JKR)"*J\B0BJO(D(JKR/^N%@3_KR$6_ZTO+_^H/$OW
MHDEHZ*1*@-FD39;+HEBKQJ1AL\2G:K? J72\O*E^PKBHA\BSIH?/K**'UZ2=
MB=V:FHWAE9J;WI&5G]B/DZ+3CI"ET(Z/J,R-CJK)C8ZJR8V.JLF-CJK)C8ZJ
MR8V.JLF-CJK)C8ZJR8V.JLF-CJK)C8ZJR?^O%@3_KR$6_ZTN+_^I/$OWHTEI
MZ*9(?]JG2)7,I5.JQZA<LL2L9+;!KFZ[O:]XP+:LA,FNIX?0IJ.&U9V@AMF3
MG8G=C9V4W8V=G]B+F:'4BY:DT(J3I\V*D:G)BI&IR8J1J<F*D:G)BI&IR8J1
MJ<F*D:G)BI&IR8J1J<F*D:G)BI&IR?^O%03_L" 6_ZXN+_^I.TOWI$=IZ:A$
M?MNK0Y3-J4RIR*U4L,:S7+/"MV:YM[!WPK"KA,FIIX;/H:2$TY>BA-:.H(?9
MB)^/VH>AFMB'H*'4AYNDT8>8ILZ'E:G*AY6IRH>5J<J'E:G*AY6IRH>5J<J'
ME:G*AY6IRH>5J<J'E:G*AY6IRO^P%03_L" 5_ZXM+_^J.DOXID1HZJM ?=RO
M/)+/KT*FRK5)K<:\4K&YM6>[L+!XPZNLA,FDJ83-G*:#T).DA-.+HX;5A:*,
MUH*BE-:#I)W4@Z*DT8.>ILZ$FJC+A)JHRX2:J,N$FJC+A)JHRX2:J,N$FJC+
MA)JHRX2:J,N$FJC+A)JHR_^P% 3_L1\5_Z\L+O^K.4OXJ4!GZZ\[>]ZV,X_2
MNC2AS,(YJKNZ5;6PM&J]JK!YPZ>MA,>?JH3+F*B#S9"GA-")I8;2A*2*TX"D
MD--_I9?2?Z:@T'^EILZ H*C+@*"HRX"@J,N H*C+@*"HRX"@J,N H*C+@*"H
MRX"@J,N H*C+@*"HR_^Q$P3_LAX5_[ K+O^L-TSZK#ME[;4T>.*_*8G8S""8
MOK\]KK"X6;BILVR^I;!ZPJ*NA,6;K(/(E*J$RHZIA,R(J(;.@Z>)SX"GC<]^
MIY//?*B:SGRIHLU\IZC+?*>HRWRGJ,M\IZC+?*>HRWRGJ,M\IZC+?*>HRWRG
MJ,M\IZC+?*>HR_^R$@3_LQT5_[$I+O^M-DS\L35B\;TJ<N;-'X#(S"&;L;Q%
MLJBW7KFCLV^^H+%[P9ZOA,.7KH3&D:R$QXRKA<F'JH?*@ZJ)RX"JC,Q]J9#,
M?*J5RWJJG,IYJZ3*>:NDRGFKI,IYJZ3*>:NDRGFKI,IYJZ3*>:NDRGFKI,IY
MJZ3*>:NDRO^S$03_M!L4_[,F+O^O,TS]N2M=Z\H?:=+?$7^YS"><I[U,L:"W
M8KF=M'&]F[)\OYJQA,&4L(3#CZ^%Q8JNAL:&K8?'@ZR)QX"LB\A^K([(?*R2
MR'NLE\AYK9['>:V>QWFMGL=YK9['>:V>QWFMGL=YK9['>:V>QWFMGL=YK9['
M>:V>Q_^U$ /_MAD4_[4D+?^T+$GRQ1]4UMT28L'?$X&LS2Z:G\!/JYJX9;>7
MM7*[EK1\O96R@[^1L87!C;&&PHFPA\.&KXC#@Z^)Q(&OB\1_KHW%?:Z0Q7NN
ME,5ZKYG$>J^9Q'JOF<1ZKYG$>J^9Q'JOF<1ZKYG$>J^9Q'JOF<1ZKYG$>J^9
MQ/^W#@/_N!83_[<@+?F_'T'<V1%$Q.L29K'?&(&@T#.5E\90HY/ 8ZV1NW&S
MD;A[N)"V@KN.M(6]B[.&OXBRA\"&LHG A+&*P8*QB\& L8W!?K&/PGRQDL)[
ML97!>[&5P7NQE<%[L97!>[&5P7NQE<%[L97!>[&5P7NQE<%[L97!>[&5P?2Z
M"P/]NQ(2_KL;+.70#S+(Z0]*M/(59Z+B(GV6UC>-C\Y/F(S(8:"*Q&ZFBL%X
MJH>_?:V$OH"P@;R"L7^[A+-]NX6T>[J'M7JYB;5YN8NV=[F-MG:XC[=TN).W
M=+B3MW2XD[=TN).W=+B3MW2XD[=TN).W=+B3MW2XD[=TN).W=+B3M]R^!@+X
MP X1[L@.(LO;"RZV^!%,I?4=8Y?H+'6-WSV!A]A0BX/38)*"SVR7?\USFWS+
M=YUYR7J@=\A]H77'?Z-SQH*D<L6$I7#%AJ5OQ(BF;L2*IVW#C:=KPY"H:\.0
MJ&O#D*AKPY"H:\.0J&O#D*AKPY"H:\.0J&O#D*AKPY"H:\.0J-? !@';Q@@.
MR],*%;CH##*F_Q5*F/HF7(WP-VF%Z49T?^13>WS?8(%XW&B%=-IMB7#8<8MN
MUG6-;-5XCVK4>Y!ITWZ19]. DF;2@Y-ETH649-&'E&/0BI5BT(Z68M".EF+0
MCI9BT(Z68M".EF+0CI9BT(Z68M".EF+0CI9BT(Z68M".EM'"!@'-RPD%NMH'
M&:C^#C&9_QU#CO\O487Z/UQ^]$UD>?!8:G/L7V]MZF-S:>=I=F?E;GEEY')[
M8^-V?6+B>7Y@X7Q_7^!^@%[?@8%=WX."7-Z&@UO=B81:W8V%6MV-A5K=C85:
MW8V%6MV-A5K=C85:W8V%6MV-A5K=C85:W8V%6MV-A<O$!@"[T08'J><&&IK_
M$RN._R0YA?\V1'[_1$UY_U%5<?M76VOW76!E]&)D8O)H9U_P;6I=[W%L6^UU
M;5KM>&]9['MP6.M^<5?J@7)6ZH1R5>F'<U3IBG13Z(YU4^B.=5/HCG53Z(YU
M4^B.=5/HCG53Z(YU4^B.=5/HCG53Z(YU4^B.=;S)!0"KVP$(FO\+%H__&2.%
M_RLM?O\Y-WC_1D!P_TY':?]436+_6E)>_F%66OQF65C[:UM5^7!=5/AT7E+W
M>%]1]WM@4/9^84_U@6)/]81C3O2'9$WTBV5,\Y!F3/.09DSSD&9,\Y!F3/.0
M9DSSD&9,\Y!F3/.09DSSD&9,\Y!F3/.09O^@& /_HBP0_Z [)?^<23S_EU=3
M^))D9^R0;'GBCW6)V8Y^E]&-AZ+,C(VJQXJ1L<2(E+;#A9:XPH.9N<*!F[G!
M?YZZP7VAN\%[I+O >J>[P'FJO,!XKKS =[2[O'BTN[QXM+N\>+2[O'BTN[QX
MM+N\>+2[O'BTN[QXM+N\>+2[O'BTN_^@& /_HBP0_Z [)?^<23S_EU=3^))D
M9^R0;'GBCW6)V8Y^E]&-AZ+,C(VJQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZ
MP7VAN\%[I+O >J>[P'FJO,!XKKS =[2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\
M>+2[O'BTN[QXM+N\>+2[O'BTN_^@& /_HBP0_Z [)?^<23S_EU=3^))D9^R0
M;'GBCW6)V8Y^E]&-AZ+,C(VJQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VA
MN\%[I+O >J>[P'FJO,!XKKS =[2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[
MO'BTN[QXM+N\>+2[O'BTN_^@& /_HBP0_Z [)?^<23S_EU=3^))D9^R0;'GB
MCW6)V8Y^E]&-AZ+,C(VJQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VAN\%[
MI+O >J>[P'FJO,!XKKS =[2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BT
MN[QXM+N\>+2[O'BTN_^@& /_HBP0_Z [)?^<23S_EU=3^))D9^R0;'GBCW6)
MV8Y^E]&-AZ+,C(VJQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VAN\%[I+O
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MM\*1CKG C)"\OXB3OKV$E\"\@)O"NWV@P[M[IL2Z>JW%M'JNQ*]ZK\*L>[#
MJ'RQOZA\L;^H?+&_J'RQOZA\L;^H?+&_J'RQOZA\L;^H?+&_J'RQO_^D& +_
MI2@0_Z,V)?^?13W_FE-5]YI7:>N;6WS?F6*.U)=KGLN5=JS%E("TPY6(M\&3
MC;K CH^]OHF2P+R%E<*[@9K$N7V@QKE[J,>T>JO'KWNMQ:M[KL.G?*_!I'VQ
MOZ1]L;^D?;&_I'VQOZ1]L;^D?;&_I'VQOZ1]L;^D?;&_I'VQO_^D& +_IB<0
M_Z,V)?^@1#W_FU)6]YQ5:>N<6'S?FUZ.U)EGGLJ7<ZS%EGRTPY>%M\&6B[N_
MD8V^O8N0P;N&E,2Y@9G'MWZ@R;9\J<JN>ZK(JGRLQJ9]K<2C?J_!H'ZQOZ!^
ML;^@?K&_H'ZQOZ!^L;^@?K&_H'ZQOZ!^L;^@?K&_H'ZQO_^E& +_IB8/_Z0U
M)?^@1#W_G%%6]YY3:>N>57O?GEJ-U)MDGLJ9;ZS%F'FTPYF"N,&9BKN^E(R_
MO(Z.P[F(DL>W@IC+M7ZAS:]\I\VI?:G*I7ZKQZ)_K<2??Z_"G8"QOYV L;^=
M@+&_G8"QOYV L;^=@+&_G8"QOYV L;^=@+&_G8"QO_^F& +_IR8/_Z0U)?^@
M0S[_G5!5]Y]1:.N@4WO@H%>-U)Y?GLJ;:ZS%FW6TPYM^N,";A[R]EXK NI&,
MQ;>*D,JTA)?/LH"CTJA_I<^C@*C+H("KQYV!K<6;@:_"F8*QOYF"L;^9@K&_
MF8*QOYF"L;^9@K&_F8*QOYF"L;^9@K&_F8*QO_^F& +_IR4/_Z4T)?^A0S[_
MGDY5^*%.:.RB4'K@HU*,U:%;G<N>9JS&G7&TPYYZN,">A+R\FXC"N96*Q[6-
MC<ZPAI;4J8*@UJ&"I-"=@JC+FH.JR)F#K<67A*_"EH2PP):$L,"6A+# EH2P
MP):$L,"6A+# EH2PP):$L,"6A+# EH2PP/^F& +_IR4/_Z4T)?^A0C[_GTQ5
M^*),9^RE37GAIDZ+U:16G,RA8:K&H6RSPZ)VM\"B@+V\H(?#MYJ(RK*3BM*L
MBY3;H(>?V)J&I-&7AJ?,E8:JR)2'K,63AZ[#DH>PP)*'L,"2A[# DH>PP)*'
ML,"2A[# DH>PP)*'L,"2A[# DH>PP/^G& +_J"0/_Z8S)?^B0C[_H$I4^:1*
M9NVG2GCBJ4N*UJA1FLVF6ZG'I66RQ*=PML"G>KR\IH/#MJ*'RZ^=B-:EEY7F
MEX^>VI.-H]*1BZ?-D(NJR9"*K,:/BJ[#CXFPP8^)L,&/B;#!CXFPP8^)L,&/
MB;#!CXFPP8^)L,&/B;#!CXFPP?^G& +_J"0/_Z8S)?^B03[_HDA4^:9'9NZJ
M1W?CK4>(V:U+F,^L5*;(K%ZOQJ]HL\*Q<[F^LGW LJJ'RZ6BAM64G(O>CYJ=
MVHV5HM.,DJ;.BY"IRHN.J\>+C:W$C(ROP8R,K\&,C*_!C(ROP8R,K\&,C*_!
MC(ROP8R,K\&,C*_!C(ROP?^H& +_J20/_Z<R)?^C03[_I$93^JE$9.^M0W7D
ML4*%V[1$E-*U2J'+MU.KRKY?K;VW;KBRL'S"J:J&RYREA-*-H(?8AJ"7V8>>
MHM.'F*7/AY6HRX>3JLB(D:W%B)"OPHB0K\*(D*_"B)"OPHB0K\*(D*_"B)"O
MPHB0K\*(D*_"B)"OPO^H& +_J2,/_Z<R)?^C0#[_ID-2^ZM!8_"Q/W/GMSV"
MWKX[C];$/YK,Q4JFO+Q=LK&U;[NJL'W#HZN$R9:G@\Z*I(;3@:.0U8&EG]*"
MH:7/@IRHS(.9JLF$EJS&A92NPX64KL.%E*[#A92NPX64KL.%E*[#A92NPX64
MKL.%E*[#A92NP_^I& +_JB,/_Z@Q)?^D/S[_J$!1_*\\8?.V.7#JOS=]X\HU
MA]31-Y6^PDNIL+E@M:BT<+VCL'["G:V$QY*JA,N(IX;.@*:-T'VGF-!]J*3.
M?J2HRW^?JLF FZO&@9BMQ(&8K<2!F*W$@9BMQ(&8K<2!F*W$@9BMQ(&8K<2!
MF*W$@9BMQ/^J%P+_JB(/_Z@P)?^E/C[_JSM/_[0W7?:],VKKRC%UW-HI@L3.
M.)FRP4^KI[ACMZ&T<[R>L7_!F*^$Q(^LA,B'JH?*@*F,S'RID\QZJIS+>:NF
MRGJGJLA\HJO'?9ZMQ'V>K<1]GJW$?9ZMQ'V>K<1]GJW$?9ZMQ'V>K<1]GJW$
M?9ZMQ/^J%@+_JR$._ZDN)?^G/#[_L#9,_+HP6>_(+&+>V2=MR]PFAK;,/)NH
MP52KG[EFMINU=+R9LG^_E;"$PHVOA<2&K8?&@:R+R'VLD,A[K)C(>:V?QW>M
MI\=WJJS&>:6MQ'FEK<1YI:W$>:6MQ'FEK<1YI:W$>:6MQ'FEK<1YI:W$>:6M
MQ/^K%0+_K" ._ZLM)/^K-CO_MB](\\0H4>#6)E;,Y")QN]HHB*K,09N?PU>I
MF;QILI:W=KF4M("]D;*%P(NQAL&&L(C#@:^+Q'ZNC\5[KI3%>J^:Q'BOH,1U
MKZ?$=*VNPW2MKL-TK:[#=*VNPW2MKL-TK:[#=*VNPW2MKL-TK:[#=*VNP_^L
M% +_K1\._ZPK)/^P+S?ZOR5!Y-$@1<[D'5N]Z2)TK=HLB9_.19F7QEJDD\!J
MK9&[=K.0N'^WC;:$NXFTAKV%LHB_@K&+P7^QCL%\L9+">K&6P7FQF\%XLJ'
M=+&GP72QI\%TL:?!=+&GP72QI\%TL:?!=+&GP72QI\%TL:?!=+&GP?^N$@'_
MKQT-_ZXH)/^X)#'JRQHUT.(70[_P'5ZOZ"5UH-LQAY;12)20RER>C<5JI8O!
M=JJ)OGVOA;R LH*Z@[1^N8:V?+B)MWFWC+AWMX^Y=K:3NG6VE[ITMIVZ<[>D
MN7.WI+ESMZ2Y<[>DN7.WI+ESMZ2Y<[>DN7.WI+ESMZ2Y<[>DN?^P$ '_L1H-
M_[$E(_/$%R?4WQ KP>\72+#W(&"AZBMSE=\Y@HW73(V(T5V5ALQJFX3)=*"
MQGFD?<1]IGK"@*EWP8.J=<"&K'._BJUQOXVN;[Z0KVZ^E*]LOIFO:[Z@KVN^
MH*]KOJ"O:[Z@KVN^H*]KOJ"O:[Z@KVN^H*]KOJ"O:[Z@K_^S#@'_M!8,_+P7
M&M;6"Q;#[1 PLOP92J+Y)5Z6[3-NC.5!>H7>3X.!V5Z*?]5JCWK2<)-VSW67
M<\YYF7',?9MORX"=;<J$GFO)AY]IR8J@:,B.H6?'DJ)EQY:B9,><HV3'G*-D
MQYRC9,><HV3'G*-DQYRC9,><HV3'G*-DQYRC9,><H_2V"@'_N!(+U<P*"\3;
M"AFR_!$SH_\=2);\+%B,\SMEA.Q);W[G579ZXV!\==]G@7'=;81MVW*':MEV
MB6C8>HMFUWV-9-:!CF/5A(]AU(B08-.+D5_3CY)>TI227-*9DUS2F9-<TIF3
M7-*9DUS2F9-<TIF37-*9DUS2F9-<TIF37-*9D]R[! #8PP<$Q-$(![/H"ARC
M_Q0QEO\D0XS_-%"$^T):??9/8GCQ6FAQ[E]M:^MD<6?I:71DYVYV8N9S>&#E
M=WE?Y'I[7>-^?%SB@7U;XH5^6N&(?UG@BX!7X)" 5M^5@5;?E8%6WY6!5M^5
M@5;?E8%6WY6!5M^5@5;?E8%6WY6!5M^5@=2]!0#$R < M-D%"J/^#1R6_QHL
MB_\K.H/_.D1\_TA-=?]24V[]5UAG^EU<8_=B7V#V9V)=]&MD6_-O95GR<V=7
M\7=H5O%Z:57P?6I4[X!K4^^$:U+NAVQ0[HMM3^V0;D_MD&Y/[9!N3^V0;D_M
MD&Y/[9!N3^V0;D_MD&Y/[9!N3^V0;L; !0"TT 0!H^,""I;_$!B+_R D@O\P
M+WK_/S=R_T@^:O].0V3_5$A>_UE,6_]?3UC_9%)5_VE44_]M55+^<5=0_718
M3_QX64[[>UI-^W];3/J#7$OYAEU)^8M>2/B07TCXD%](^)!?2/B07TCXD%](
M^)!?2/B07TCXD%](^)!?2/B07[7' @"DV@ !EO\&!XK_%!&!_R0:>?\S(G#_
M.RIH_T(Q8?]*-ES_43M7_U<_4_]=0E#_8D1._V=&3/]L2$K_<$E)_W1*2/]W
M2T;_>TQ%_W]-1/^#3D/_ATY"_XM/0?^14$'_D5!!_Y%00?^14$'_D5!!_Y%0
M0?^14$'_D5!!_Y%00?^14/^1$@'_E2<+_Y4['/^32R__CUE#_XQD5/N,:V/R
MBG)QZHA\?>.&A(?>@HJ/VG^/EM9]E)O3>IB?T7B<HM!WGZ3.=:*FS72FJ,UR
MJ:G,<:VJS'"RJ\MPMJO+;[RKR'# J\1QP*K$<<"JQ'' JL1QP*K$<<"JQ''
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MD*'+7YV8PVVHD;UYL8NX@[B#M(B]?;&0P7FQFL%UL:7!<J^OPG6HK\%WH[#
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MNK*0A+JRD(2ZLI"$NK*0A+JRD(2ZLO^/#P'_DB &_Y,T%/^:/R+_H3\N_Z=
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MOZMFL+^L::J_K&REOZMMHL"J;:+ JFVBP*IMHL"J;:+ JFVBP*IMHL"J;:+
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MK$<[]J]-1.VQ5$WELUM5W+!E8<ZH;''#GW2 N)9\C:Z/AIBEB)&AG8.=IY>
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M_Y\A!?^N( ;XO1@&X]$3!-#A'@G%ZBX9NNDZ*;#G0SFDY$I(F.)05HS@5V*
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M4\3>@5/$WH%3Q-Z!4\3>@5/$WH%3Q-Z!4\3>@?^2# #_H T V[<& ,K#!P#
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M@5RFWX%<IM^!7*;?@5RFWX%<IM^!7*;?@?^ #P'_C@X!_Z(- -NU" #.P0@
MQM ) +[I$@*TZ24*JN@S%Z#F/B66Y4<RB^-./X#A54EVX%U3;=YF6V7=;V%>
MW7IG6-R&:U/<E6]0W:9Q3=Z[<DW?X7%.T>=T4,;F=U*^Y'A3N.1Y5;+C>E6R
MXWI5LN-Z5;+C>E6RXWI5LN-Z5;+C>O^##@'_E@L W:L$ ,VX!@#"Q 8 NM0)
M +'O% .G[B4-GNXS&I3M/2>*[$8S@.M./G;K54=LZEM.9.IC55WJ;5I8ZG=>
M4^J#8D[JD65*ZZ%G1^RS:4;MT&E(YNAI2]GK:DS/[&U.Q^MO3\#J<$_ ZG!/
MP.IP3\#J<$_ ZG!/P.IP3\#J</^)"P#IH $ T+$$ ,&\!0"WR08 KMH) *3U
M%P6;]2<0DO4T'(CV/B=_]D<R=O9..VSV5$)D]EI(7?9B35?V:U%2]G553?>
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M, ]1_S<32_\^%T;_11E!_TP;/?]2'3G_6!\V_U\A-/]F(C'_;B0O_W<E+?^
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M>6V,Y7AMC.5X;8SE>&V,Y7AMC.5X;8SE>/]N$P'_>Q$!_XT0 /^=$ #ZK!$
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M#Q3_H! 3_ZT1$_^Z$1/_PQ(3_\,2$__#$A/_PQ(3_\,2$__#$I>^  "&S
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M.O]"L#S_0K@]_T'!/O] RS__0-Q _S_I0/\_]$#_/OU!_T#_0/U"_T#V1?]
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M_TC;3?](VTW_2-M-_TC;3?](VTW_2/]3'@+_3B@#_TXO!/]4, ;_6C8(_UY
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M:WA\\&EX?/!I>'SP:7A\\&EX?/!I>'SP:?]@%P'_;A(!_WX0 /^,$0#_F1$
M\:03 ..N%@#6MAP!R[0P",&P/Q>WJTLEK:94,Z2A74"<G65*E)AL4XR5=%N&
MD7UB?XZ':'F,DFUTBIYQ<(BM=&V(P71MB>1S;X?J<7"$[&]R@^UM<X'N:W2
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M9F./\69CC_%F8X_Q9O]K$ '_?@D \9 $ -:> P#,J@8 Q+0& +Z^!0"XR!
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M*2W_ZBHL__\J+/__*B_Y_RHO^?\J+_G_*B_Y_RHO^?\J+_G_*KFF  "JK@
MG+D  ([%  "!T0  ==X  &WZ"0!E_Q$!7O\: E?_(P-2_RP%3/\T!TC_/ I#
M_T0,/_],#CS_4Q X_UL2-?]C%#+_;!8O_W<7+/^$&2G_DQHG_Z(<)?^T'23_
MS!XC_^T>(O_]'R+__Q\B__\?(O__'R+__Q\B__\?(O__'ZRK  "=M@  C\(
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M ?]T%0'_?1H!_X0A ?>)*@/MC30'Y(T]#=R+2!;1A50CR7]>+L)Z:#B\=7%
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M6X-O^UF#;_Q8@V_\6(-O_%B#;_Q8@V_\6/]6& '_9!$!_W(. /]^$ #_B!$
M]9$4 .B8&0#=GB !T9XQ!\>:0!.^E4P@MI!6+*Z+8#>GAFA H8)P2)Q^>4Z6
M>X)4DGB+68UVE5V)=*!AA7.N8X)ROV2 <]YD@'3U8G]T]F!_<_A>?G/Y7'YR
M^EI^<OM9?G+[67YR^UE^<OM9?G+[6?]8%P'_9Q !_W4. /^!#@#_C X \940
M ..=$0#6HQL RZ$O!L*>/A*YF4H>L)14*ZF073:BBV8_FX=N1Y6$=DZ0@']4
MBWZ(689[DEV!>9YA?7BK9'IXO&5Y>-EE>'GT8GEX]F!Y=_A>>7;Y7'EU^EIY
M=?M:>77[6GEU^UIY=?M:>77[6O]:%0'_:0X _W@, /^$# #OD L W9H* -FB
M"P#0IA@ QJ4L!;VB/!"TGD@=JYE2*:.56S2<D6,^E8UK1H^)<TV)AGQ3A(2%
M6'^!D%UZ?YMA=GZH9'-]N65Q?M-E<7[R8W)]]F!S>_=>='KY7'1Y^EMU>?M:
M=7G[6G5Y^UIU>?M:=7G[6O]=$P'_; T _WL+ /:("0#<DP8 U9T) -&E"@#*
MJA4 P:DJ!+>F.@^NHD8;IIY0*)Z:63.6EF$\CY-I1(F/<4R#C7E2?8J#5WB(
MC5QSAIE@;X2F8VR$MV1JA,]D:H3P8FR"]F!M@/=>;W_Y7&]]^EMP?/M:<'S[
M6G!\^UIP?/M:<'S[6O]?$0'_;PH _WX( .., P#6EP4 SZ ' ,JH" #$KA,
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M  #=B0  RI<  +ZB  "SJ@  J;,  *"\ @"8Q@8 D<P2 (O,)0*$RS0)?,E
M$G7(2AMMQU,C9\5<*F'$9#!<PVTV5\)V.E/"@3]/P8Y"2\&=14C!KD9'P<5&
M1\'J1D2^_TE%N?]*1[/_2TFM_TQ*J_],2JO_3$JK_TQ*J_],2JO_3.E_  #1
MD   PIX  +6G  "JKP  H+@  );! @",RP< A-4- (#5'@%YU2X%<M0\#&S3
M1Q1ETE ;7]%9(5K18B=5T&LL4=!U,$W/@31)SXXW1L^=.430KCM"T,8[0]#J
M.D#-_3X^R_] 0,/_0D&]_T-"N?]$0KG_1$*Y_T1"N?]$0KG_1-V(  #'F
MN*,  *NK  "@M   E;X  (O( P" T0< >.$- '3A'0%NX2L#:. W"&'@0@Y<
MX$T45^!6&5/@7QU/X&DB2^!S)4?@?BA$X(LK0N":+3_AJR\^XL$O/N+E+SS?
M^C$YWO\T.=G_-CK0_S@[S/\Y.\S_.3O,_SD[S/\Y.\S_.<V2  "\H   K:@
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M$Q[__Q,>__\3'O__$Q[__Q,>__\3'O__$Z:I  "8LP  BK\  'O*  !NU0
M8-\  %3G  !._P0 2?\. $/_%  __QT!.O\E C;_+ (R_S,#+_\Z RO_000H
M_T@$)?]/!2+_5P4@_V &'?]L!QK_>0<8_XH(%O^;"!7_K0D4_\,)$__C"1/_
M^ D3__\*$___"A/__PH3__\*$___"IJQ  "+O0  ?,@  &W4  !?X   4>8
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M0/<M[4#_+^L__S'D0?\RVT/_,]%$_S/+1O\SRT;_,\M&_S/+1O\SRT;_,_]
M) +_12,"_TP@ O]2(0+_5B8#_UDO!/]9.@?_648,_U91$O]471C_46H=_DYU
M(?Q,@27Y2HLH]TF5*_5'G2SS1Z8N\D:N+_!%N##O1<0Q[473,>A&Z#'E1O8R
MXD7_-=]$_S;31_\WRDC_.,1*_SB_2_\WOTO_-[]+_S>_2_\WOTO_-_]!(P'_
M21\!_U$< ?]7' +_7","_V L _]@-@;_8$$+_UY-$?U;6!CX6&0=]%5P(_%3
M?"?N4(8KZT^0+NE-F3#G3*$RY4RJ,^-+M#3B2\ UX$O/-=M+YC;52O0XT4K_
M.LY*_SS$3/\\O4W_/+A/_SRT3_\[M$__.[1/_SNT3_\[M$__._]"(@'_3!P!
M_U48 ?]<&0'_8R "_V8H _]H,@7_:#T)^F9($/1C4Q?N8%\=ZEUK(^9:=BCB
M5X$MWU6+,-Q3E#/949TVU5"F.--/KSK03[L[SD[)/,M/X3W'3_(^PT__0,!/
M_T&W4?]!L5+_0*U3_T"J5/\_JE3_/ZI4_S^J5/\_JE3_/_]&'P'_4!D!_UD5
M ?]B%P'_:!T!_VPD O]O+@/Y;S@'\6Y$#NMK3A7E:%L<WV1G(]I@<2K477LO
MT%N%-,Q8CCC)5Y<[QU6@/<14J3_"4[1!OU/"0KU3UD.Y4^U$ME/]1;-4_T6L
M5O]$IU?_1*18_T.A6/]"H5C_0J%8_T*A6/]"H5C_0O]('0'_4Q8!_UT2 ?]F
M% '_;1D!_W(A ?MU*0+R=C,%Z78^"^)S2A+;;U<:TFMB(\UG;"O(9'8QQ&%_
M-\!>B3N]7)(^NEN:0;=9I$2U6*Y&LE>[1[!7S4BM6.A(JECZ2:=9_TBA6O](
MG5O_1YM<_T:97/]%F5S_19E<_T697/]%F5S_1?]+&@'_5Q,!_V$0 /]K$@#_
M<A8 _W@< ?5[) 'K?2T#XGXY!]E[1A#0=E,:R7%>),-M:"R^:G$SNF=[.+9D
M@SVR8HQ!KV"51:Q>GT>I7:E*IERV2Z1<QTRB7.)-GUWW3)Q>_TR87_]*E6#_
M29-@_TB18/]'D6#_1Y%@_T>18/]'D6#_1_].& '_6A$!_V0. /]O$ #_=A,
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M2WMN_TM[;O]+>V[_2_]7$0#_8PH _W ' /!\!0#<A04 U(P( -"3"0#*EA0
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M24Z@]4E.G_])4)G_25*6_TA4DO]'5)+_1U22_T=4DO]'5)+_1_]N  #>?P
MRHT  +Z8  "SH   JJ<  *&N  "7M@  D;H0 (RZ(P&%N3(&?K@^#G>V21=Q
MM5(>:[-:)66R8BM@L6HP6[!S-5>O?3E3KHD]3ZV60$RMI4)*K;E#2:[80DBK
M]4-'JO]$2:7_1$N@_T1-G/]$39S_1$V<_T1-G/]$39S_1.IU  #2A@  PY,
M +>=  "LI   HJL  )BS  ".NP$ A<$, ('"'0![PBT#=<$Z"6_ 11%IOT\8
M8[Y7'EZ]7R-9O&@H5;MQ+5&[>S!-NH<T2KJ5-T>ZI3E%NK@Z1+K7.4.X]3M"
MMO\]0K/_/D2N_SY%J?\^1:G_/D6I_SY%J?\^1:G_/N!]  #)C0  NYH  *ZB
M  "CJ0  F+$  (ZY  "$P0( ><D' '3+% !PS"8!:\LU!67+0 I@RDL06\I4
M%E?)71I2R64?3LAO(TO(>B9'R(8I1,B4+$+(I"Y R+@O/\G7+S_']3 ]Q/\S
M.\/_-3R^_S8]N/\W/;C_-SVX_S<]N/\W/;C_-]&&  # E0  LI\  *6G  ":
MKP  CK<  (._  !XQP, ;L\' &77#0!CV!T 8-@M EO8.@17V$8)4]A0#4_8
M61%+UV(51]=L&$37=QM!UX0>/MB3(#S8HR$[V;<B.MK5(CK6\B,WU/\G-M+_
M*331_RLVRO\M-LK_+3;*_RTVRO\M-LK_+<60  "VG0  J*4  )RM  "/M@
M@[X  '?'  !LSP( 8M8' %KD#@!8Y!P 5.0I 5#D-0-,Y3\%2.5)!T7E4PI"
MYEP-/^9F#SSF<1(ZYWX4-^>,%C7GG!<SZ*X9,NG&&3+HZADQY?X9+^3_'"[D
M_QXMXO\@+>+_("WB_R MXO\@+>+_(+J:  "JHP  G:L  )"T  "#O0  =\8
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M!0[__P4.__\%#O__!96O  "&N@  =\4  &C0  !:VP  3.$  $#G   W\P
M,O\  "[_!P J_PX )O\3 "/_&@ ?_R  &_\F !C_*P$5_S(!$O\X 1#_0 $.
M_T@!#/]2 0G_70(&_VL"!/]] @+_D (!_Z," /^V @#_S0, _^P# /_L P#_
M[ , _^P# /_L XBY  !XQ   :=   %O=  !+XP  /ND  #+N   K_P  )O\
M "'_   =_P@ &O\- !;_$0 3_Q8 $/\:  [_'P +_R0 "?\J  ;_,  "_S<!
M /]  0#_2@$ _U8! /]D 0#_=0$ _X@! /^: 0#_J@$ _[L! /^[ 0#_NP$
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M,ZY-_S.J3O\RJ4[_,JE._S*I3O\RJ4[_,O]#&@'_3!, _U00 /]<$@#_81<
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M.XA?_SN(7_\[B%__._].$0#_6 H _V,' /IL!@#G<P8 W7@( -I["P#1?A<
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M1UZ![T9?@?]$8'__0F%]_T%B>_\_8WK_/V-Z_S]C>O\_8WK_/_]>  #I;0
MUGD  ,B$  "^C   MI,  *Z7  "FFP0 H)T7 )J=*0*3G#<(C)I#$(:831B
MEE4?>I1=)G6292QPD&PQ;(YU-F>-?CICBXD^7XJ505R)HT1:B;1%6(G+15B(
M[418B/]#68;_05N#_T!=@?\^78#_/EV _SY=@/\^78#_/O]B  #D<0  SWX
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M-T:@_S=(G/\W29K_-TF:_S=)FO\W29K_-^)T  #*@P  O(\  +"8  "EG@
MFZ0  )"K  "%L0  >K@$ ':Y% !RN24!;;DS!&BX/PACN$D.7K=2$UJV6AA6
MMF(<4K5K($ZT=21+M( G2+..*D6SG2Q"LZXM0;/%+D&SZ2U L/XO/Z__,3ZM
M_S) J/\R0:;_,D&F_S)!IO\R0:;_,M5\  #"B@  M98  *B=  "=HP  DJH
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M%BC:_Q8HVO\6*-K_%K.8  "EH   F:<  (NP  !^N   <<   &7(  !9S@
M3M,  $3;!  _Z0T />D7 #OJ(P YZBX -NLX 33K0@$Q[$L"+^U5 RWM7P,J
M[FL$*.YX!2;OB 8E[YH'(_"N!R+QR <B\.T'(>S_!R'K_P@@Z_\*'^K_"Q_J
M_PL?ZO\+'^K_"ZB?  ";I@  C:\  '^X  !QP0  9,H  %C0  !,U@  0=T
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M 82W  !TP0  9<P  %;8  !'WP  .>4  "WJ   C[@  '/T  !C_   5_P
M$?\$  __"P -_PX "?\1  ;_%0 #_QH  /\@  #_)@  _RX  /\W  #_00
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M*9U-_RF=3?\IG4W_*?]#$0#_2PP _U,( /]:"P#_7@T ^6 0 .MA%@#A8B$
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M/&UKZ3MM;/XY;6S_-VYL_S5N:_\T;FK_,FYJ_S)N:O\R;FK_,O]3  #T7P
MWFH  ,US  ##>@  NWX  +6!  "N@PD J(4: **%*P*;A#H'E8)%#I!_3Q6*
M?5@;AGM?((%Y9R5]=V\J>G9W+G9T@#)S<XLU;W*6.&QQHSII<+(\:'#&/&=P
MYSMG<?PY:''_-VAP_S5I;_\T:6[_,VEN_S-I;O\S:6[_,_]6  #K8@  V&X
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M-5:!_S18?_\S67W_,EE]_S)9??\R67W_,N]@  #;;@  QWH  +N#  "RBP
MJ)   )^3  "4E@  C9D. (F:'@"$FBX"?IDZ!WF710UTEDX3;Y56&&J37AUF
MDF4A8I%M)EZ/=BI;CH$M5XV-,%2,FC-1C*HU3XR]-4^,WC5/B_<T3XK_,U")
M_S)1AO\Q4H3_,5*$_S%2A/\Q4H3_,>IE  #2<P  PG\  +:(  "LD   HI0
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M)CND_R8[I/\F.Z3_)LQZ  "[B   KI(  **9  "7G@  C*0  ("J  !UKP
M:;0  %ZY!@!;NA0 6;LD %:[,0%3NST#4+M'!4V[4 =*NED*1[IB#42Z;!!!
MNG<3/KF$%3RYDQ<YN:,8.+FW&3>ZUADWN/0:-;;_'#2T_QXSL_\?,[+_(#.R
M_R SLO\@,[+_(,&#  "TD0  II@  )N>  "/I0  @JL  ':Q  !KM@  7[P
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M!:.=  "6I   B*P  'JU  !LO0  7\0  %/*  !'S@  /-,  #+:   JWP
M)>X) "/P$0 A\1D '_$B !WR*P ;\S0 &?0^ !?T2  5]5( $_9? !+V;@$1
M]X !$/B4 0_YJ@$.^<8!#OGM 0WV_P$-]/\!#?/_ 0WS_P$-\_\!#?/_ 9FC
M  "+K   ?+4  &V^  !?Q@  4LT  $72   YV   +]X  ";B   ?Z@  '/L&
M !G_#@ 7_Q, %/\: !+_(0 0_R@ #O\P  W_.0 +_T, "?].  ;_7  $_VP
M O^   '_E@  _ZT  /_*  #_\   __\  /__  #__P  __\  /__ (VK  !]
MM0  ;K\  &#(  !2T   0]<  #?=   KX@  (N8  !GJ   5^0  $O\  !#_
M"  ._PX #/\1  G_%@ &_QP  _\B  #_*@  _S,  /\]  #_20  _U<  /]I
M  #_?@  _Y4  /^L  #_QP  _^@  /_Z  #_^@  __H  /_Z ("U  !POP
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M+GU9YBU\6OHL>UK_*GM;_RA[6_\G>UK_)GI:_R5Z6O\E>EK_)?])  #[4@
MXUP  -)C  #':   P&L  +IK @"U:PT KFT= *AN+@&C;3P%G6M("IEJ40^4
M:%H4D&9B&(UE:AR*8W(@AV)Z(X1A@R:!8(PI?E^7*WM>HRUY7K$O=UW$+W5>
MXB]U7ODM=5__*W5?_REU7_\H=5[_)G5>_R9U7O\F=5[_)O]+  #P50  WE\
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M+61L_RMD:_\I96K_*&5J_RAE:O\H96K_*/U3  #C7P  SFD  ,%Q  "W=P
MKWL  *=]  ">?0  F'X1 ). (@".@#$"B7\^!H1]2 Q_?%$1>WI9%G=Y8!IS
M=V@>;W9P(6QU>"5I=((H9G..*V-RFBY@<:@O7G&Z,%UQU#!=<?(N7G'_+%YP
M_RM?</\I8&__*&!N_RA@;O\H8&[_*/%5  #>8@  RFT  +UU  "S>P  JX
M **"  "8@0  D8,/ (V%'P"(A2X"@X0[!7Z#10IZ@4X/=8!6%'%_7AAN?68<
M:GQM(&=[=B-C>H G8'F+*EUXF"Q:=Z8N6'>X+U=WT2]7=_$N6';_+%AV_RI9
M=?\I6G3_*%IT_R=:=/\G6G3_)^U9  #79@  Q7$  +EZ  "O@   IH0  )V&
M  "1AP  BHD, (:*&P""BRL!?8HX!'B)0@ATB$P-;X=4$FR%6Q9HA&,:9(-K
M'F&"="%=@7TD6H")*%=_EBI5?J0L4GZV+5%^SBU1?>\L4GW_*U)\_RE3>_\H
M5'K_)U1Z_R=4>O\G5'K_)^A>  #0:P  P'8  +1^  "KA0  H8D  )>+  ")
MC0  @X\( 'Z0%P![D2<!=I$T W*0/P9MCTD+:8Y1#V6-61-BC& 77HMH&UN*
M<1Y7B7LA5(B&)%&'E"=/AJ(I38:T*DN&S"I+A>XI3(3_*4R#_RA,@_\G38'_
M)DZ!_R9.@?\F3H'_)N%C  #)<   NWL  +"$  "FB@  FXX  )&1  "$DP
M>I4" '67$@!RF"( ;Y@P FJ7.P1FET4(8I9.#%^55@];E%T36)-E%U63;AI1
MDG@=3I&$($N0D2-)D*$D1Y"R)D60RB9%C^TE18W_)46,_R5&B_\D1HK_)$:*
M_R1&BO\D1HK_)-AI  ##=@  M8$  *N*  "?CP  E9,  (J6  !^F@  <)T
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M%KN!  "NC@  H94  )::  ")H   ?:8  '&K  !EKP  6;0  $ZW  !#O 4
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M !/BL0 2X\\ $N#T !+>_P$1W?\!$=O_ A';_P(1V_\"$=O_ IZ:  "2H0
MA*D  ':Q  !HN   6[\  $[$  !"R   -\P  "W0   DU0  '-L  !7?!0 4
MZ0X $NH4 !'K'0 0ZR8 #NPP  [M.@ -[D8 "^Y3  KO8@ )\'0 "/&)  ?R
MH  %\KH !/'D  +Q_0 "[_\  ^W_  /M_P #[?\  ^W_ )6A  "&J0  >+(
M &FZ  !;P@  3<@  $#,   TT0  *M8  "';   9X   $N0   _P 0 -^0H
M"_H/  G[%0 '^QP !/PD  '\+   _#<  /Q"  #\4   _&$  /UU  #\C
M_*0  /S!  #\ZP  _/\  /W_  #]_P  _?\  /W_ (FI  !YL@  :KL  %S$
M  !.S   /]$  #+7   GW0  '>$  !7E   .Z   "O$   C]   %_P,  ?\)
M  #_#@  _Q(  /\7  #_'P  _R<  /\Q  #_/@  _TT  /]?  #_=0  _XT
M /^F  #_P@  _^<  /_\  #__P  __\  /__ 'RS  !LO   7<8  $[/   _
MU@  ,=T  "7B   :Y@  $>H   SN   %\@   /\   #_    _P   /\   #_
M!0  _PH  /\.  #_$@  _Q@  /\A  #_*P  _SD  /]*  #_70  _W,  /^,
M  #_I   _[D  /_4  #_W@  _]X  /_> /\8+ #_&2D _QDH /\5*P#_$#
M_PLX ?\#1 '_ %$!_P!> ?\ ; '_ '@!_P"" ?\ C '_ )0!_P"< /\ H@#_
M *@ _P"O /\ M@#_ +X _P#( /\ UP#_ .< _P#S /\ _0#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\;*0#_'28 _QPE /\9)P#_$RP _PXT
M /\+0 '_"$X!_P5; ?\#: '_ G0!_P)_ ?\"B '_ I$!_P*8 ?\"GP'_ :4
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M ^D3_P/I$_\#Z1/_ _\F'0#_*!@ _R@6 /\F%@#_)AT _R8H /\C- #_($
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M&Y-&YAN11_D;CT?_&HY'_QF.1_\8C4?_&(U'_Q>-1_\7C4?_%_\^ @#_0P
MZTL  -U1  #15   RE0! ,92!0#!41$ N5,B +-5,P&N5$$"JE1,!:935@BB
M45\,GU!G#YU/;Q&:3G<4F$Y_%I9-B!B33)$9D4R;&X]+IAV-2[,>BTO%'HE+
MXAZ'3/<>ADS_'85,_QR%3?\:A4S_&85,_QF%3/\9A4S_&?]   #\1P  Y5
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M(F]:_R!P6O\><%K_'7!:_QQP6O\<<%K_'/](  #G4@  TUL  ,5B  "[9@
MLV@  *QH  "E9@4 GV<4 )II)0"5:30"D&A !(QG2@B(9E,,A&5;$(%D8A-^
M8VH6>V)R&7AA>AQV8(0><U^.(7!>FB-N7J@E;%VX)6I>SB9I7NXD:5[_(FI>
M_R!J7O\?:E[_'FI>_QUJ7O\=:E[_'?E*  #C50  SU\  ,%E  "W:@  KVP
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M'EMJ_QY;:O\>6VK_'NM3  #38   PFD  +9Q  "L=@  HWD  )EY  "-=P
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M$0!QB"  ;H@N 6J(.0)GAT,%8X=,"&"&4PM=A5L.6H1C$5>$:Q14@W4748*
M&DZ!C1Q+@9L>28&L'TB P2!'@.,?1W_Z'DA^_QY(??\=27S_'$E\_QQ)?/\<
M27S_'-9A  #";@  M'@  *J   "?A0  E(<  (B'  ![B0  <(P  &N.#0!H
MCQH 9H\I &*0-0%?CS\#7(](!5F.4 A6CE@+4XU@#E",:!!-C'(32HM]%DB*
MBAA%BID:0XJJ&T**OQM!BN$;08CY&T&&_QM!A?\;0H7_&D*$_QI"A/\:0H3_
M&LUG  "\=   KWX  *6&  ":B@  CHP  (*-  !UD   9Y0  &&5" !>EQ0
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M""VLN DLK-D(+*KU"BNH_PLJIO\,*J7_#2JE_PTJI?\-*J7_#;6   "HBP
MG)$  )&6  "%G   >*   &NE  !?J   4ZP  $BO   ]L@  -K4+ #2U%0 S
MMB$ ,K8L #&W-P PMT$ +[A+ "ZX50 LN& !*KAM 2FY>P(GN8T");F? R2Y
MM ,CN=(#([?T!"*U_P4AM/\&(;/_!R&R_P<ALO\'(;+_!ZV*  "@D0  E9<
M (B=  ![HP  ;J@  &&M  !5L0  2K0  #^W   TNP  *[X# "3"#  BPA0
M(L,? "'#*@ @Q#0 '\0_ ![%2@ =QE8 ',9C !O'<P :QX4 &<>9 !C(K@ 7
MR,L %\;Q 1?$_P$6P_\"%L'_ Q;!_P,6P?\#%L'_ Z.1  "8F   BYX  'VE
M  !PJP  8K$  %:V  !*N0  /KT  #3    JQ   (L@  !G,!  3T H $=(1
M !#2&@ 0TR4 #],P  [4/  .U$@ #=56  W590 ,UG@ #-:-  O8I  *V+X
M"=GF  K6_@ +U/\ "]+_  O2_P$+TO\!"]+_ 9J8  ".GP  @*8  '*M  !D
MM   5[H  $F_   ]P@  ,L8  "C)   ?S0  %]$  !'6   ,VP4 "-X+  ;?
M$0 %WQH !. D  +A+@ !XCH  .-'  #D5@  Y&<  .5[  #FD@  YJH  .?(
M  #G\   Z/\  .C_  #H_P  Z/\  .C_ )&?  ""IP  =*\  &6W  !7O@
M2<,  #S'   PRP  )<\  !S4   4V0  #MT   GA   "Y0   .D&  #I#0
MZ1$  .H8  #K(0  [2L  .\W  #Q10  \E8  /-H  #S?@  ])<  /6P  #V
MT   ]_,  /?_  #W_P  ]_\  /?_ (6G  !VL   9K@  %C!  !*R   .\P
M "[1   CU@  &=P  !'@   ,XP  !.<   #J    ]0   /0   #U!0  ]0L
M /8/  #V%   ^!T  /HG  #\-   _T,  /]5  #_:0  _X$  /^:  #_L@
M_\\  /_M  #_^0  __D  /_Y 'BP  !HN@  6<,  $O+   [T0  +=@  "'=
M   6X@  #N8   CJ    [0   /    #X    _P   /\   #_    _P   /\&
M  #_#   _Q   /\8  #_(@  _S   /]   #_4P  _VD  /^!  #_F0  _Z\
M /_#  #_U0  _]4  /_5 /\3* #_$R4 _Q$E /\-)P#_!BT _P U /\ 00#_
M $\ _P!< /\ :0#_ '0 _P!^ /\ B #_ )  _P"7 /\ G0#_ *0 _P"J /\
ML #_ +< _P#  /\ S #_ -\ _P#L /\ ^ #_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\6)0#_%B( _Q0A /\0(P#_"B@ _P P /\ /0#_ $L
M_P!8 /\ 9 #_ '  _P!Z /\ A #_ (P _P"3 /\ F@#_ *  _P"F /\ K0#_
M +0 _P"\ /X R #] -D ^P#I /H ]@#Y /\ ^ #_ /@ _P#X /\ ^ #_ /D
M_P#Y /\ ^0#_ /\:(@#_&AX _Q@= /\3'@#_#B( _PHL /\'.0#_ T8 _P!3
M /\ 8 #_ &L _P!V /\ ?P#_ (@ _P"/ /\ E@#_ )T _P"C /X J0#\ +
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M O\E$P#_)1  _R0- /\C#@#_(Q0 _R(> /\?*0#_'#4 ^1E# /083P#O%UL
M[!=F .D7< #F%WD Y!>! .(7B0#@%Y$ WQ>8 -T7GP#;%Z< V1BQ -88NP#4
M&<H T!KA <P;\P')'/\"QAS_ L0<_P/#'/\#PQS_ \,<_P/#'/\#PQS_ _\H
M$ #_*0L _R@& /\K"P#_*Q  _RD7 /TF(@#T(RX ["$[ .8@20#B(%4 WB!@
M -HA:@#6(70 TR%\ = AA '/(HP!S2*3 <LBFP')(J,!R".L L8CM@+$(\0"
MPB3; KXE[@.[)?X$N"7_!;8E_P6U)?\&M27_!K4E_P6U)?\%M27_!?\L#0#_
M+04 _RX! /\Q!0#_,0L _2\0 /$K& #G*24 WR@S -@H0@#1*D\ S2M: ,DK
M90''*VX!Q"QV L(L?@+ +(8#OBR. [TLE@.[+)X$N2RG!+@LL06V++\%M2W1
M!;$MZ@:N+OL'JR[_"*DN_PBH+O\(J"W_"*@M_PBH+?\(J"W_"/\O" #_,0
M_S4  /8W  #J-@( YS,( .0O#P#9+AL SS$L ,DS/ #$-$D P#55 ;PU7P*Z
M-6@"MS5P [4T> 2S-( %L32(!K TD :N-)D'K#2B"*LTK FI-+D)IS3*"J4U
MY0JA-?@+GS7_#)TU_PR=-?\+G#7_"YPU_PN<-?\+G#7_"_\S @#_-0  ]CH
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M%7]'_Q1_1_\2?T?_$7]'_Q%_1_\1?T?_$?\[  #N0P  W$P  ,Q1  #!5
MN50  +11  "N30L J$\9 *-1*0">4C<!FE)# I=13@24458&D5!>"8Y/9@N,
M3FT-B4YU#X=-?A&%38<3@DR1%8!,G!9^2ZD7?$NX&'M+S1AY3.L8>$S^%W=,
M_Q5W3/\4=TS_$W=,_Q)W3/\2=TS_$O\^  #H1P  U5   ,96  "\6   M%D
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M%659_Q1E6?\495G_%.]&  #:4@  QEL  +IA  "P90  IF8  )UC  "580
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M%=U5  #%80  MVH  *QQ  "B=0  E'0  (ET  !\<P  =G4  '%W$ !O>!T
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M$CV$M1,\A,\3/(+P$CR!_Q(]@/\2/7__$CU^_Q$]?O\1/7[_$<5F  "U<0
MJGL  )^"  "2@@  A8(  'F#  !MA@  7XH  %B- 0!4C@\ 4H\; %"/)P!/
MD#, 39 ] 4N010))D$X#1I!6!$2/7P5"CV@'/X]S"3V.@ LZCH\,.(Z@#3>.
MLPXVCLP.-HWO#C6+_PXUB?\/-8C_#S:'_P\VA_\/-H?_#[YM  "P>0  I8(
M )F'  ",B   ?X@  '**  !FC0  6I$  %"5  !)EPD 1Y@3 $68( !$F2L
M0YDV $&:0 ! FD@!/II1 CR:6@(ZFF0#-YIO!369?08SF8P',9F=""^9L @N
MF<H(+ICM""Z6_PHME/\*+9/_"RV2_PLMDO\++9+_"[9U  "J@0  GH@  ).-
M  "&C@  >(\  &N2  !?E0  5)D  $F=  ! H   .J(- #BC%P WHR( -J0M
M #6D-P TI$$ ,Z5+ #&E5 $PI5X!+J5J 2RE> (JI8@#**6: R>EK00FI<8#
M)J3K!"6B_P4EH/\&))__!B2>_P<DGO\'))[_!Z]^  "CB   EXX  (V3  !^
ME0  <)@  &.;  !7GP  3*(  $*F   XJ0  +ZP# "JN#@ IKA@ **\C ">O
M+0 FL#< );!! "2P2P CL58 (K%C "&Q<0 ?L8( 'K*4 1RRJ0$;LL$!&['G
M 1NO_@(:K?\"&JS_ QJK_P,:J_\#&JO_ ZB(  ";CP  D90  (2:  !VGP
M:*(  %NE  !/J0  1*T  #FP   OLP  )K8  !ZY!0 8NPX %[L6 !>\(  6
MO"H %;TU !2]0  3ODL $KY8 !*^9P 1OW@ $+^, !# H@ .P+H #L#A  ^]
M^P /O/\ $+K_ 1"Z_P$0NO\!$+K_ 9^/  "4E0  AYL  'FA  !KIP  7JP
M %*Q  !%M   .K8  "^Y   EO   ';\  !7#   /Q@4 "\H-  G*%  (RAT
M!\HG  ?*,@ &RSX !<M+  3,6@ #S&H  LQ^  ',E   S*L  ,W(  #,[0
MS/\  ,O_  '*_P !RO\  <K_ )>6  "*G   ?*,  &ZJ  !@L   4K8  $6Y
M   YO   +K\  "/#   ;Q@  $\H   W-   (T0   =0)  #4#@  U14  -8>
M  #8)P  V3$  -L^  #<2P  W5L  -YN  #>A   WYL  -^T  #>V0  W_<
M -__  #?_P  W_\  -__ (V=  !_I0  <*P  &&S  !3N@  1;\  #C"   L
MQ@  (<D  !C-   0T0  "]4   3:    W@   . !  #A"0  X@X  .03  #E
M&P  YR0  .DO  #K/   [4L  .Y=  #N<0  [XD  /"B  #PO   \.,  ._Y
M  #P_P  \/\  /#_ (&E  !RK0  8[4  %2]  !&Q   -\@  "K,   ?T
M%=4   [:   'W@   .(   #F    Z0   .H   #L    [@4  .\,  #Q$
M\Q<  /4@  #X*P  ^SD  /U*  #^7@  _W0  /^-  #_I@  _\   /_A  #_
M]0  __4  /_U '2N  !EMP  5L   $?(   XS0  *M(  !W8   3W0  #.(
M  /F    Z0   .P   #P    \P   /0   #V    ^    /H   #]!P  _PT
M /\2  #_&P  _R@  /\W  #_2@  _UX  /]V  #_CP  _Z8  /^Z  #_T0
M_]$  /_1 /\/) #_#B( _PLA /\#) #_ "D _P R /\ /@#_ $P _P!9 /\
M90#_ '  _P!Z /\ A #_ (P _P"2 /\ F0#_ )\ _P"E /\ JP#_ +( _P"Z
M /\ Q0#_ -, _P#G /\ ] #_ /\ _@#_ /\ _P#^ /\ _@#_ /X _P#^ /\
M_@#_ /\1(0#_$!X _PT= /\''P#_ ", _P M /\ .@#_ $@ _P!5 /\ 80#_
M &P _P!V /\ ?P#_ (< _P". /\ E0#_ )L _P"A /\ IP#^ *X _0"V /P
MP #[ ,T ^0#B /@ \ #W /P ]@#_ /4 _P#U /\ ]0#_ /4 _P#U /\ ]0#_
M /\5'0#_$QH _Q 9 /\+&0#_ !T _P I /\ -@#_ $, _P!0 /\ 7 #_ &<
M_P!Q /\ >@#^ (, _ "* /H D0#Y )< ^ "= /< HP#U *H ] "R /( NP#Q
M ,@ [P#< .X [ #M /H ZP#_ .H _P#J /\ Z@#_ .H _P#J /\ Z@#_ /\8
M&0#_%A4 _Q,3 /\.$P#_"QH _P<D /\", #_ #X _P!+ /\ 5P#_ &( _ !L
M /@ =0#U 'X \@"% /$ C #O ), [@"9 .P H #K *8 Z0"N .< MP#F ,,
MY #4 .( Z0#A /< WP#_ -T _P#= /\ W0#_ -T _P#= /\ W0#_ /\;$P#_
M&A  _Q8. /\2#@#_$A4 _P\? /\,*P#_"3@ _P9% /L#40#W EP \@)F .X"
M< #J G@ YP*  .8#AP#D XX X@.5 .$#G #?!*, W02K -L$M #8!<  U@70
M -,&YP#0"/@ S@K_ ,P+_P#+#/\ RPS_ ,L+_P#+"_\ RPO_ /\?$ #_'@L
M_QH' /\9"P#_&!$ _Q89 /\2) #Z$#  \PX^ .X-2@#I#%8 Y0QA .(,:@#>
M#7, VPU[ -D-@P#6#8H U V1 -(-F0#0#J  SPZI ,T.LP#+#K\ R@_0 ,81
MZ0#"$OD OQ/_ +T3_P&\$_\!O!/_ ;P3_P&[$_\!NQ/_ ?\B# #_(00 _R
M /\A!0#_'PP _QP1 /88' #L%2@ Y1,V -\20P#9$T\ TQ1: - 59 #-%FT
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M!I<O_P:6+_\&E2[_!94N_P65+O\%E2[_!?\L  #_+@  ZC4  -TY  #1.0
MRC8  ,<O!@#!+1$ NC A +0R,0"P-#X K#5* *DU5 &G-5T!I#5E J(U;0*@
M-70#GS5\!)TUA 2;-8T%FC27!I@TH0:6-*T'E#6["),UT B0->P(CC;^"(PV
M_PB+-O\(BS;_!XHU_P>*-?\'BC7_!_\O  #R-   XCP  -)!  #'0@  P$
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M#'%'_PMQ1O\+<4;_"_,Y  #@1   S$P  +Y1  "T4P  JE(  *).  "=2@$
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M#>-(  #+4P  NUL  +!A  "D8@  EV$  (Y?  "%7   ?UX' 'M?$P!X82$
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M$DMGLA))9\D226?K$DEF_Q!*9O\/2F7_#DME_PU+9/\-2V3_#=%4  "^7@
ML6<  *9M  "7;   BFL  ']K  !S:P  ;6T  &AN# !E<!< 8G$D &!Q, !>
M<3H!7'%# EEQ2P-7<5,$57!:!E)P8@=0<&L)3F]U"TMO@@U);H\/1VZ?$$5N
ML!%$;L<10VWJ$$1L_P]$:_\.16O_#45J_PU%:O\-16K_#<M8  "Z8P  K6P
M *%Q  "2<   A6\  'IO  !N<   97,  &!U!P!==A( 6W<? %EX*P!7>#8
M57@_ 5-X2 )1>$\#3W=7!$QW7P5*=V@'2'9S"45V?PM#=8T,076=#C]UK@X^
M=<4./77H#CYS_0T^<O\-/G'_##]Q_PP_</\,/W#_#,5>  "U:0  J7$  )QU
M  "-=   @'0  '5T  !I=@  7GD  %A\ 0!4?0X 4GX: %%_)@!/?S$ 38 [
M $R 0P%*@$L"2']4 D9_7 1#?V4%07]P!C]^? @\?HH).GZ:"CE^K LW?L,+
M-WWF"S=[_ LW>O\+-WG_"CAX_PHX>/\*.'C_"KYD  "P;P  I7@  )9Y  "'
M>0  >WD  '!Z  !D?   6(   %"#  !+A0H 2(84 $>'( !%B"L 1(@U $.(
M/@!!B4<!0(E/ 3Z(6 (\B&$#.HAL!#>(> 4UB(<&,XB8!S*'J@<PB, ',(?D
M!S"%^P@P@_\(,(+_"#"!_P@P@?\(,('_"+=K  "J=@  H'\  )!^  ""?@
M=G\  &J   !>@P  4X<  $J+  !!C@( /9 . #N0&  ZD2, .9$M #B2-P W
MDD  -I)) #234@ SDUP!,9-G 2^3= (MDH,#*Y*4 RJ2IP,HDKT$*)+A R>0
M^@0GCO\%)XW_!2>,_P4GC/\%)XS_!;%T  "E?@  F84  (J$  !]A   ;X4
M &.(  !8BP  38\  $.3   ZEP  ,IH' "Z;$  MFQH +)PD "N<+@ JG3@
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M  BS_P )LO\ ";+_ )J-  "0DP  A)@  '2<  !EH   5Z0  $NH  ! K
M-;   "JS   AM0  &+@  !&[   ,O@( !L +  + $0 !P1D  ,$B  #"*P
MPC8  ,-"  ##4   Q%\  ,1Q  #$AP  Q)T  ,2U  #$V@  Q/8  ,/_  ##
M_P  P_\  ,/_ ).4  "'F@  >*   &JF  !<K   3[$  $&U   UMP  *;H
M !^]   6P   $,,   K&   #R@   ,P%  #,#   S1$  ,X8  #.(0  T"H
M -$U  #30P  U%(  -1C  #5>   U8\  -6G  #6P@  UND  -;]  #6_P
MUO\  -;_ (J;  ![H@  ;*D  %ZP  !0M@  0KH  #2]   HP0  '<0  !3'
M   -RP  !LX   #2    UP   -D   #:!0  W L  -T0  #?%0  X1T  .,G
M  #E,P  YT(  .A4  #H9P  Z7X  .F7  #JKP  ZLX  .OO  #K_@  Z_\
M .O_ 'VC  !NJP  7[(  %&Z  !"P   -,,  "?'   ;RP  $L\   O3   "
MV    -T   #A    Y    .4   #G    Z0   .L'  #M#0  [Q$  /$9  #T
M)   ]S$  /E!  #Z50  ^FH  /N$  #[G0  _+8  /S2  #][0  _?0  /WT
M '&L  !AM0  4KT  $3$   TR0  )LT  !K2   0V   "-T   #A    Y0
M .@   #L    [P   /$   #S    ]0   /<   #Y 0  ^P@  /X.  #_%0
M_R$  /\O  #_00  _U8  /]M  #_AP  _Z   /^V  #_R@  _]0  /_4 /\+
M( #_!QX _P = /\ ( #_ "4 _P N /\ .P#_ $D _P!6 /\ 8@#_ &T _P!V
M /\ ?P#_ (< _P". /\ E #_ )H _P"@ /\ I@#_ *T _P"U /\ O@#_ ,L
M_P#A /\ \ #^ /T _0#_ /T _P#] /\ _0#_ /P _P#Y /\ ^0#_ /\-'0#_
M"QH _P09 /\ &@#_ !\ _P J /\ -P#_ $4 _P!1 /\ 7@#_ &@ _P!R /\
M>@#_ (( _P") /\ D #_ )8 _P"< /X H@#\ *D ^P"P /D N0#X ,8 ]@#9
M /4 ZP#T /D \P#_ /( _P#S /\ \P#_ /, _P#S /\ \P#_ /\0&0#_#A4
M_P@4 /\ % #_ !D _P E /\ ,@#_ $  _P!, /\ 60#_ &, _@!M /P =0#Z
M 'T ^0"$ /< BP#V )$ ] "7 /, G@#R *0 \ "L .X M #M ,  ZP#/ .D
MY@#H /4 Y@#_ .< _P#F /\ Y0#_ .4 _P#E /\ Y0#_ /\2% #_$!  _PP/
M /\#$ #_ !4 _P @ /\ + #_ #H _P!' /H 4P#W %X ] !G /$ < #O '@
M[0!_ .L A@#J (P Z "3 .< F0#E *  XP"G .$ L #? +H W0#) -L X #8
M /  UP#^ -4 _P#4 /\ TP#_ -, _P#3 /\ TP#_ /\5$ #_$@P _PX) /\+
M# #_"1( _P,: /\ )@#] #, ] !  .\ 30#K %@ Z !A .4 :@#B '( X !Z
M -X @ #< (< V@". -@ E0#4 )P T@"C -  K #. +8 S #$ ,H V0#( .T
MQP#[ ,4 _P#$ ?\ PP'_ ,0!_P#$ ?\ Q '_ /\8"P#_%04 _Q   /\0!@#_
M#PT _PP4 /P''P#Q RL YP Y .( 1@#> 5$ V@); -4"9 #2 VP SP-T ,T$
M>P#+!(( R@2) ,@%D #&!9@ Q 6@ ,(&J0#!!K0 OP;! +T(U0"[">P N O]
M +8,_P"U#?\ M W_ +0-_P"T#?\ M W_ /\;!0#_&   _Q<  /\6  #[$P8
M^A . .X,%@#C"2( V@DP -,*/@#."TH R@Q5 ,<-7@#%#6< P@YO ,$.=@"_
M#GX O0^% +P/C0"Z$)4 N!"= +<0IP"U$;( LQ'  +(1U0"N$^X JQ3^ *D5
M_P"G%?\ IQ7_ *84_P&F%/\!IA3_ ?\?  #_'   ^AX  .L>  #C'   WQ4%
M -X.#0#3#A@ RQ$H ,43-P# %$0 O!9/ +D760"W%V$ M!AI +,9<0"Q&7@
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M X,O_P.#+_\#@R__ _LI  #K,0  V3@  ,D\  "_/   MCD  + R  "L+0L
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M!N@[  #01@  OTT  +-1  "E40  FDX  ))+  "-1P  AT@+ (-*%@!_2R0
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M#%53L U44\4-4U/F#%-3_ M34_\)5%+_"%12_PA44O\'5%+_!]I&  ##4
MM5@  *A;  "96@  C5@  (17  ![5   =E8! '%7#P!N61L ;%HH &E:,P!G
M6ST!95M% 6-;30)A6E4#7UI<!%U:9 5;66P&6%EV"%99@@E46(\+4EB>#%!8
MK@U/6,,-3ECD#$Y8^PM/5_\)3U?_"$]6_PA05O\'4%;_!]-*  # 5   LEP
M *->  "570  B5P  '];  !V60  <%H  &M<#0!H71@ 9EXD &1?, !B7SH
M8%]# 5Y?2P)<7U("6E]: UA?80557FH&4UYT!U%=?PE/78T*35V<"TM=K Q*
M7<$,25WC#$E<^@I)6_\)2EO_"$I:_PA*6O\'2EK_!\Y.  "\6   KF   )]A
M  "18   A5\  'M?  !P70  :E\  &5A"@!B8A0 8&,A %YD+0!<9#< 6F1
M 5AD2 %69% "5&17 U)D7P109&<%3F-Q!DQC?0A)8HL)1V*:"D9BJ@M$8K\+
M1&+A"T1A^0I$8/\)1&#_"$5?_P=%7_\'15__!\A2  "X7   JV0  )MD  ",
M8P  @&,  '9C  !J8@  8V0  %]F!@!;9Q$ 66@= %=I*0!6:C, 5&H\ %)J
M10%0:DP!3FI4 DQJ7 -*:F4$2&EO!49I>@=$:8@(0FB8"4!HJ0H_:+T*/FC>
M"3YG]PD^9O\(/V7_!S]E_P<_9/\'/V3_!\-7  "S80  IVD  )9H  "'9P
M>V<  '%G  !E:   7&H  %AL 0!4;@X 4F\8 %!O) !.<"X 37 X $MQ00!*
M<4D!2'%1 49Q60)$<&(#0G!L!$!P> 4^<(8&/&^5!SIOI@@X;[L(.&_;!SAN
M]@<X;?\'.&S_!CEK_P8Y:O\&.6K_!KU<  "O9@  HFT  )%L  "":P  =VL
M &QL  !A;@  5W   %!S  !,=0H 2783 $=W'P!&=RD 17@S $-X/ !">$0
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M B"%_P(AA?\"(87_ JMR  "A?   CWL  (!Z  !S>@  9GP  %M_  !0@@
M1H8  #R*   TC0  +)$  ":3#  DE!, (Y0< "*5)@ AE2\ ()4X !^60@ >
MEDP '998 !R69  :EW0 &9>& !B7F0 7EZX %9?) !:5[@ 6D_\!%I+_ 1:1
M_P$6D/\!%I#_ :5[  "9@P  B8$  'N   !L@@  7X0  %2(  !)BP  /Y
M #64   MEP  )9H  !V> 0 6H P %*$2 !2A&P 3H24 $J$N !&B.  1HD,
M$*)/  ^B7  .HVL #:-]  VCD@ ,HZ< "J+   NBY@ ,H/X #9__  V>_P -
MG?\ #9W_ )Z$  "2B0  @X@  '.(  !EBP  6(X  $R2  !!EP  -YL  "Z>
M   DH@  '*4  !6H   /JP0 "JX,  >M$@ &K1L !:TD  2N+@ "KCD  :Y%
M  "N4@  KF$  *YS  "NAP  KIT  *ZT  "NU0  K?0  *W_  "L_P  J_\
M *O_ ):+  ",D   >Y   &N2  !=E@  4)H  $2?   YHP  +Z<  "6K   <
MK@  %+$   ZT   )MP   ;@)  "X#@  N10  +D<  "Z)0  NB\  +LZ  "\
M1P  O%8  +QG  "\>P  O)$  +RI  "\Q   O.L  +O^  "[_P  N_\  +O_
M )"2  "#F   <YL  &.?  !5HP  1Z@  #NM   PL0  );0  !NW   2N@
M#+T   6_    PP   ,0"  #%"@  Q0X  ,84  #'&P  R"0  ,HN  #,.@
MS4D  ,U9  #-;   SH,  ,Z;  #-M0  SMH  ,[V  #-_P  S?\  ,W_ (:9
M  !WH   ::8  %JL  !,L@  /K8  #"Y   DO   &;\  !'"   *Q0   LD
M  #,    T    -$   #2 0  TP@  -4-  #7$0  VA@  -PA  #?+   X3H
M .)*  #C70  Y'(  .2+  #EI0  Y<   .7F  #E^   Y?\  .7_ 'JA  !K
MJ0  7*\  $VV   _O   ,+\  "/#   7QP  #\H   ?.    T0   -8   #<
M    WP   .    #B    Y    .8#  #H"0  Z0X  .P5  #N'@  \2L  /0Z
M  #U30  ]F$  /=Y  #XDP  ^*T  /G&  #YY   ^?,  /GS &VJ  !>L@
M3[H  $#!   QQ0  (LD  !;.   -T@  !-@   #=    X0   .0   #H
MZP   .T   #O    \0   /,   #V    ^ ,  /H+  #]$0  _QL  /\I  #_
M.P  _T\  /]F  #_?P  _YD  /^O  #_PP  _]8  /_6 /\$' #_ !D _P 9
M /\ ' #_ "( _P K /\ . #_ $8 _P!3 /\ 7@#_ &D _P!R /\ >@#_ ((
M_P") /\ CP#_ )4 _P"; /\ H0#_ *@ _P"O /\ N0#_ ,4 _P#9 /X [ #]
M /L ^P#_ /L _P#[ /\ ^@#_ /0 _P#P /\ \ #_ /\'& #_ 14 _P 4 /\
M%@#_ !L _P F /\ - #_ $( _P!. /\ 6@#_ &0 _P!M /\ =0#_ 'T _P"$
M /\ B@#] )  _ "6 /H G0#Y *, ^ "K /< M #U +\ ] #. /, Y@#Q /8
M\ #_ .\ _P#O /\ [@#_ .X _P#J /\ Z@#_ /\+% #_!A$ _P 0 /\ $ #_
M !8 _P B /\ +@#_ #P _P!) /\ 5 #^ %\ ^P!H /D < #W '@ ]0!_ /,
MA0#R (L \ "2 .\ F #M )\ [ "F .H K@#H +D YP#' .4 W@#C /  X@#^
M .  _P#@ /\ X0#_ .$ _P#A /\ X0#_ /\-$ #_"0T _P$, /\ # #_ !(
M_P < /\ * #\ #8 ^0!# /8 3@#R %D [P!B .P :P#J '( Z !Y .8 @ #D
M (8 X@", .$ DP#? )H W0"A -L J@#8 +0 U0#  -( TP#0 .H S@#Z ,T
M_P#- /\ S0#_ ,P _P#, /\ S #_ /\0# #_# < _P," /\ " #_  X _P 6
M /8 (@#P "\ [  \ .D 2 #E %, X0!< -X 90#; &P UP!S -0 >@#2 (
MT "' ,X C@#, )4 R@"= ,@ I0#& *\ Q "[ ,( RP#  .4 O@#U +T _P"\
M /\ O #_ +P _P"\ /\ O #_ /\1!0#_#@  _PH  /\( 0#_! H ^  0 .D
M&@#C "@ W@ U -D 00#3 $P SP!6 ,L 7P#) &8 Q@!N ,0 = #" 'L P0""
M +\ B0"] )  O "8 +H H0"X *L M@"W +0 QP"R .  L0'R *\"_P"N _\
MK03_ *T$_P"M!/\ K03_ /\4  #_$   _P\  /(-  #J"@  Z0,) -T $@#4
M !\ S0$M ,@".@#$ T4 P -0 +T$60"[!6$ N05H +<&;P"U!G8 M =] +('
MA "Q"(P KPB5 *T)G@"K":@ J@JU *@*Q0"F"]\ I WT *(._P"@#O\ GP[_
M )\._P"?#O\ GP[_ /\7  #_$P  [Q@  .09  #;%@  TA " ,\)"P#("!8
MP0HD +P,,@"W#3X M Y) +$.4P"O$%L K1!C *L0:@"I$7$ J!%X *81@ "E
M$8@ HQ*1 *$2FP"@$Z8 GA.S )P3PP";%-X EQ;T )46_P"4%_\ DQ?_ )(7
M_P"2%O\ DA;_ /\:  #T'0  Y2,  -4E  #*)   PAT  +X6! "[$!  M!,=
M *\5*P"K%C@ IQA# *4930"B&58 H!I= )X;90"=&VP FQQS )H<>P"8'(,
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M O J  #<-0  QSL  +H_  "L/   HC@  )PS  "8+P  E2X0 ) P' ",,BD
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M/P  O48  *Y'  "?10  E4,  (Y   ")/   A#P* ( ]% !]/B( >C\N 'A
M. !U04( <T%* ')!40%P05D!;D%@ FQ!9P)J07 #:$%Y V=!A 1E09$%8T&?
M!6%!K@9@0<(&7D'B!EY!^05=0?\$74#_ UU _P-=0/\#74#_ ]\Y  #(0P
MN4H  *E+  ";20  D$<  (A$  "#00  ?D$& 'I"$0!V0QX =$4J '%%-0!O
M1C\ ;49' &M&3P%J1E8!:$9= F9&90)D1FT#8D9V!&!&@@1>1HX%7$6<!EM%
MK 991K\'6$;?!EA&]P571?\$5T7_!%=$_P-81/\#6$3_ ]H]  #$1P  M4X
M *1.  "63   BTL  (-)  !]10  >$8" '1'$ !P2!L ;DDG &M*,@!J2SP
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M!TA2\P9(4O\%2%'_!$E1_P1)4/\#25#_ \I(  "Y4@  JE<  )A6  "*50
M?U0  '93  !L40  9U,  &)4" !?5A( 75<> %M7*0!96#, 6%@\ %991 !5
M64P!4UE3 5%96P)/6&0"35AM TM8> 1)6(8%1U>5!D57I09$5[@&0UC2!D-7
M\@9#5O\%0U7_!$15_P1$5/\#1%3_ \9,  "U5@  I5H  )19  "&6   >U@
M '%7  !F5@  85@  %U9! !96A  5UL; %5<)@!373  4ETY %%>00!/7DD
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M S)E_P,R9/\#,F3_ [=;  "I9   EF0  (9C  !X8P  ;6,  &1D  !990
M4&@  $EK  !#;00 0&X. #YO&  ];R( /' K #IP-  Y<3T .'%% #=Q3@ V
M<5< -'%A 3)Q;0$Q<7H!+W&* BUQG (K<:\"*G'( BIPZP(J;_\"*FW_ BIL
M_P(K;/\"*VS_ K%A  "D:0  D&@  (!G  !T9P  :6<  %]H  !5:P  2VX
M $-Q   \=   -W8* #1W$@ S>!P ,G@E #%Y+@ P>3< +WD_ "YY2  L>E(
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M *%Z  ".>0  ?G<  ')W  !D>   6'L  $U^  !"@@  .88  "^*   GC@
M()$  !B5   2F 4 #IH.  V:%  ,FAT "YHF  N:,  *FCL "9I&  B:4P &
MFV$ !9IR  2:A@ "FIL  )JQ  &9SP "F?   IC_  27_P %EO\ !9;_ )F!
M  "'?P  >GX  &M^  !=@0  4(4  $6)   [C0  ,9(  "B6   ?F0  &)T
M !&@   ,HP( !J4*  &E$   I18  *8?  "F*   IC(  *<]  "G2@  IU@
M *=H  "G?   IY$  *:H  "FPP  I>D  *7\  "E_P  I/\  *3_ )&'  ""
MA@  <H8  &.(  !5C   29$  #V6   RF@  *)X  !^B   7I@  $*D   NL
M   $KP   +$&  "Q#   LA$  +(7  "S'P  LR@  +0R  "U/P  M4T  +5=
M  "U<   M88  +6=  "UM@  M=P  +3W  "T_P  M/\  +3_ (N/  !ZC@
M:I$  %N5  !-F@  0)\  #6D   JJ   (*P  !:P   /M   ";<   &Y
MO0   +X   "^!@  OPP  , 0  #!%@  PAT  ,,G  #%,@  QD   ,91  #'
M8P  QW@  ,>1  #'J0  Q\<  ,?L  #'_@  Q_\  ,?_ (.7  !QF@  89X
M %*C  !%J0  .*X  "RS   @MP  %KH   Z]   &P    ,,   #'    R0
M ,H   #,    S0,  ,X)  #0#@  TA,  -0;  #8)0  VS(  -U"  #=5
MWFD  -Z!  #>G   W[4  -_9  #?\P  W_\  -__ '>?  !HI@  6:T  $JS
M   [N   +;L  !^_   4P@  #,8   /)    S    -    #5    V0   -H
M  #<    W@   .    #B!0  Y L  .<0  #J&   [20  / R  #Q1   \E@
M /-O  #TB@  ]*0  /2_  #TWP  ]/,  /3T &JH  !;KP  3+<  #V]   M
MP0  '\8  !/*   +S@   -(   #7    W    .    #E    YP   .D   #K
M    [0   .\   #Q    \P   /8'  #Y#@  _!8  /\B  #_,P  _T<  /]=
M  #_=@  _Y$  /^I  #_O@  _]@  /_; /\ & #_ !8 _P 5 /\ & #_ !X
M_P G /\ -@#_ $, _P!/ /\ 6@#_ &0 _P!M /\ =0#_ 'T _P"$ /\ B@#_
M )  _P"6 /\ G #_ *, _P"K /\ M #^ +\ _0#/ /L YP#Z /@ ^0#_ /D
M_P#Y /\ ]0#_ .X _P#I /\ YP#_ /\ % #_ !$ _P 1 /\ $@#_ !< _P C
M /\ ,0#_ #X _P!* /\ 5@#_ &  _P!H /\ < #_ '@ _0!^ /P A0#Z (L
M^0"1 /@ F #W )X ]0"F /0 K@#R +D \0#' .\ X #N /( [ #_ .P _P#L
M /\ ZP#_ .4 _P#@ /\ W@#_ /\#$ #_  X _P - /\ #0#_ !, _P > /\
M*P#_ #@ _P!% /X 4 #[ %H ^ !C /4 :P#S '( \0!Y .\ ?P#N (8 [ ",
M .H D@#I )D YP"@ .8 J0#D +, X0#  .  TP#> .L W #[ -L _P#: /\
MV@#_ -D _P#4 /\ T@#_ /\'#0#_  D _P & /\ "0#_  \ _P 8 /L )0#X
M #( ]0 _ /( 2@#M %0 Z@!= .< 90#D &P X@!S .  >@#> (  W "& -H
MC0#7 )0 U "; -( I #/ *T S0"Y ,L R0#) .0 R #V ,8 _P#% /\ Q@#_
M ,< _P#' /\ QP#_ /\*!@#_ 0  _P   /\ ! #_  L ]  2 .\ 'P#J "P
MY0 X .( 0P#= $X V0!7 -0 7P#1 &< S@!M ,P = #* 'H R "  ,8 AP#%
M (X PP"6 ,$ G@"_ *@ O0"S +H P@"Y -L MP#P +4 _P"V /\ M0#_ +4
M_P"U /\ M0#_ /\,  #_!   _P   /X   #V  , Z  - .  %P#9 "0 T0 Q
M ,T / #* $< Q@!1 ,, 60#  &  O@!G +P ;@"Z '0 N0![ +< @@"U (D
MLP"1 +( F@"P *0 K@"O *P O0"J -  J #K *< ^P"F /\ I@#_ *4 _P"E
M /\ I0#_ /\-  #_!P  ] D  .H)  #B!   V@ ' ,\ $0#( !P P@ I +X
M-0"[ $  MP!* +0 4P"R %L L !B *X : "L &\ JP!U *D ?0"H (0 I@"-
M *0 E@"C *  H0"K )\!N0"= \P G 3H )H&^0"9!_\ F C_ )<(_P"7"/\
MEPC_ /\0  #W$   Z!0  -P5  #.$0  Q@T  ,($"P"\ !0 MP$A +(#+@"N
M!3H JP9$ *@(30"F"%4 I E< *(*8P"@"FH GPMQ )T+> "<"X  F@R) )D,
MDP"7#)X E0VJ )0-N "2#<P D [J (X0_ ",$/\ BQ#_ (L0_P"+$/\ BA#_
M /L3  #M&@  W2   ,PA  "_'0  MQ<  +,1  "R"PT JPT9 *<.)@"C#S,
MGQ ^ )T11P":$5  F!)7 )827@"5$V4 DQ-L )(3<P"0%'P CQ2% (T5CP"+
M%9H BA6G (@6M0"&%LD A!?G ((8^P" &?\ ?QG_ '\9_P!_&/\ ?QC_ /4:
M  #D(P  SRD  , J  "S)@  JB(  *4<  "D%0@ H!03 )L6(0"7&"T E!DX
M )$:0@"/&TL C1Q2 (L<60")'6  B!UG (8>;P"%'G< @Q^  ((?BP" 'Y<
M?B"C 'T@L@![(,4 >2'D '<B^0!V(O\ =2+_ '0A_P!T(?\ ="'_ .\A  #;
M*P  QS$  +8Q  "I+@  H"H  )LF  "8(0$ E1X0 ) @&P"-(2@ B2,S (<D
M/0"%)$8 @R5. ($F50!_)EP ?B9C 'PG:P![)W, >2=\ '@HAP!V*), ="B@
M 7(HKP%Q*<$!;RG@ 6TI]P%L*?\!:RG_ 6LI_P%K*/\!:RC_ >@H  #0,@
MP#@  *XW  "A-0  F#(  )(M  ".*0  BR<, (<H%P"#*B, @"LO 'XL.0!\
M+$( >BU* '@N40!W+E@ =2Y@ ',O9P!R+V\ <"]Y 6\O@P%M+Y !:R^= 6DO
MK %H,+X!9S#; 64P]0%D,/\!8S#_ 6,O_P%C+_\!8R__ >(N  #*.   NCT
M *@\  ":.@  D3<  (HS  "&,   @RX) '\O$P![,!\ >#(K '8S-0!T,SX
M<C1& ' T3@!O-54 ;35< &PU9 !J-6P!:#5U 6<U@ %E-8P!8S6: F$VJ0)@
M-KL"7S;6 ETV\P)=-O\"7#;_ 5PU_P%<-?\!7#3_ =PS  #%/   M$$  *)
M  "5/@  BSP  (0Y  !_-@  >S0$ '<U$ !T-QP <3@G &\Y,@!M.3L :SI#
M &HZ2P!H.U( 9SM9 &4[80%C.VD!8CMR 6 [?0%>.XH"7#N7 EL[IP)9.[@#
M6#O2 U<[\0)6._\"5CO_ E8Z_P%6.O\!5CG_ =0W  # 00  KT0  )U#  "0
M0@  A4   'X^  !Y.P  =#H  '$Z#@!M/!@ :STD &D^+P!G/S@ 93]  &1
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M TI)H0-(2;,#1TG* T9)[ -&2/\"1DC_ D='_P)'1O\"1T;_ L9#  "V3
MHDP  )%,  "$2P  >4H  '!)  !I1@  9$<  %])!@!<2A  6DL; %A,)0!6
M3"\ 54TX %--0 !234@ 44Y/ $].5P!.3E\!3$YI 4I.<P)(38 "1DV/ T5-
MGP-#3;$#0DW( T%-Z@-!3/\"04S_ D)+_P)"2O\"0DK_ L)'  "S3P  GD\
M (U.  " 3@  =4T  &Q,  !C2@  7DP  %I- @!63@X 5$\8 %)0(@!142P
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M C%<Y0(Q6_P",5K_ C%9_P(R6?\!,EC_ ;94  "D60  D%@  (!8  !S5P
M:5<  &!8  !460  3EL  $A=  !#7P0 0& . #YA%P ]82  .V(I #IB,@ Y
M8CH .&-" #=C2P V8U0 -&-= #-C:  Q8W8!+V.% 2YCE@$L8ZD!*V._ 2IC
MXP$J8OL!*F#_ 2M?_P$K7_\!*U[_ ;%9  ">7   BUP  'M;  !O6P  95L
M %Q<  !17@  26   $-B   \90  .&<* #5H$@ T:!L ,VDD #)I+0 Q:34
M+VH] "YJ1@ M:D\ +&I9 "MK90 I:W( *&N" "9KDP D:Z< (VN] ")JX  C
M:?D!(V?_ 2-F_P$C9O\!)&7_ :Q@  "88   A6   '9?  !J7P  86   %=@
M  !-8P  1&8  #UH   V:P  ,&X$ "QP#@ J<14 *7$> "AQ)@ G<B\ )G(W
M "5R0  D<DH (G)4 "%S8  @<VT 'G-] !USD  ;<Z, &G.Y !ESW  :<?<
M&G#_ !MO_P ;;O\!&VW_ :9F  "190  ?V0  '%D  !F9   760  %)F  !(
M:0  /VP  #=O   P<P  *78  ")Y"  ?>Q  'GL7 !Q['P ;>R@ &GLP !E\
M.0 8?$, %WQ. !9\6@ 5?&< %'UX !)]BP 1?9\ $'VU  ]]U0 0>_4 $7G_
M !%X_P 2=_\ $G?_ )YK  "*:@  >FD  &UI  !B:0  5VH  $QM  !#<
M.70  #%X   I>P  (G\  !N"   4A0D $880 !&&%P 0AQ\ $(<H  Z',0 .
MASL #8=&  R'4P +AV$ "H=Q  F'A  'AY@ !H:N  6&R0 &A>P !X3_  B#
M_P )@O\ "8+_ )5Q  "#;P  =&X  &EN  !<;P  4'(  $9U   \>0  ,GT
M "J!   BA0  &XD  !2,   /CP, "I(+  :2$0 $DA@  I(@  &2*0  DC,
M ),^  "32P  DUD  )-I  "3>P  DI   )*F  "1OP  D>4  )#Z  "/_P
MC_\  (__ (UW  !]=0  <'0  &)U  !5>   27P  #^    TA   *XD  "*-
M   :D0  $Y0   Z7   )FP   9T(  "=#@  G1,  )X:  ">(@  GRL  )\U
M  "@0@  H%   *!?  "@<0  H(<  )^=  "?M0  GMH  )WV  "=_P  G/\
M )S_ (9]  !X?   :7P  %M_  !.@P  08@  #:,   LD0  (Y8  !J:   2
MG@  #:$   :D    IP   *D#  "I"@  J@X  *L3  "L&0  K2(  *XK  "O
M-P  KT4  *]4  "O9@  KWL  *Z4  "NJP  KLD  *[O  "M_P  K?\  *W_
M (&$  !QA   88<  %.+  !&D   .98  "Z;   CH   &J0  !*H   ,K
M!*\   "R    M@   +<   "W @  N @  +D-  "Z$@  NQ@  +TA  "^*P
MP#@  ,!(  # 6@  P6X  ,&&  #!H   P;H  ,'C  # ^0  P/\  ,#_ 'F-
M  !HD   690  $N:   ]H   ,:4  "6K   :KP  $;,   NX   "NP   +X
M  #!    Q    ,4   #&    QP   ,@%  #*"P  S \  ,X5  #0'P  TRL
M -4Z  #53   UF   -AW  #8D@  V*P  -G)  #9[   V?L  -C_ '"9  !@
MG@  4:0  $.J   UL   *+8  !RZ   1O@  "<$   #%    R    ,L   #/
M    T@   -,   #6    V    -L   #=    WP<  .(-  #E$P  Z!T  .PJ
M  #M/   [5$  .YG  #O@0  [YP  /"W  #PTP  \.P  /#T &>F  !8K0
M2;0  #JZ   JO@  ',(  !#&   'R@   ,X   #2    U@   -P   #@
MXP   .0   #F    Z    .L   #M    [P   /("  #U"@  ^!$  /P<  #_
M+   _S\  /]5  #_;@  _XH  /^D  #_N@  _]$  /_A /\ % #_ !( _P 2
M /\ % #_ !D _P E /\ ,@#_ #\ _P!+ /\ 5@#_ &  _P!H /\ < #_ '@
M_P!_ /\ A0#_ (L _P"1 /\ F #_ )X _@"F /T K@#\ +D ^@#( /D X@#X
M /0 ]P#_ /8 _P#V /\ [P#_ .< _P#B /\ W@#_ /\ $0#_  X _P . /\
M#P#_ !0 _P @ /\ +0#_ #H _P!& /\ 40#_ %L _P!C /X :P#\ ', ^@!Y
M /D @ #W (8 ]@", /4 D@#S )D \@"@ /  J0#N +, [0#! .L U@#J .X
MZ0#^ .< _P#G /\ Y0#_ -T _P#5 /\ T0#_ /\ #0#_  H _P ( /\ "0#_
M !  _P ; /\ * #_ #4 _P!  /H 2P#V %4 \P!> /$ 9@#N &T [ !T .L
M>@#I (  YP"& .8 C0#D ), X@"; .  HP#> *T W "Y -H R@#7 .8 U #X
M -( _P#2 /\ T@#_ ,X _P#) /\ Q@#_ /\ " #_  , _P   /\  P#_  T
M_  6 /< (@#S "X [P Z .P 10#H $\ Y !8 .$ 8 #> &< VP!M -D = #5
M 'H TP"  -$ AP#/ (X S0"5 ,L G@#) *< QP"S ,4 P@## -P P0#Q +\
M_P"_ /\ O@#_ +X _P"] /\ NP#_ /\   #_    _P   /\   #V  @ [@ 1
M .< &P#A "< W0 S -D /@#3 $D SP!2 ,L 60#( &$ Q@!G ,0 ;0#" ',
MP !Z +\ @ "] (@ NP"0 +D F "X *( M0"M +, NP"Q ,X L #J *\ _ "M
M /\ K0#_ *X _P"N /\ K@#_ /\"  #_    _0   /(   #H    W@ , -,
M%0#, "$ R  L ,0 . #! $( O0!+ +H 4P"X %H M@!A +0 9P"R &T L !T
M *\ >@"M (( K "* *H DP"H )T I@"H *0 M0"B ,8 H0#C )\ ]@"> /\
MG@#_ )X _P"> /\ G@#_ /\&  #[    [@4  .($  #5    RP & ,, #P"]
M !D N  E +0 ,0"Q #L K@!% *P 30"I %4 IP!; *4 8@"D &@ H@!N *$
M=0"? 'P G@"% )P C@": )@ F "D )8 L "5 ,$ DP#< )( \@"1 /\ D #_
M )  _P"/ /\ CP#_ /T*  #P#@  X1$  ,X0  #"#0  NP<  +< "@"Q !(
MK  > *@ *0"E #0 H@ ^ )\ 1P"= $\ FP!6 )D!7 "7 6, E@)I )0"< "3
M W@ D0.  ) $B@".!)4 C 6A (H%K@")!KX APC8 (8)\ "$"O\ @PO_ (,+
M_P"#"_\ @PO_ /80  #F%P  TAP  , :  "S%@  K!(  *@-  "F!PT H@46
M )T'(@"9"2X E@HX )0+00"2#$H D Q1 (X-6 ",#5X BPUE (D-; "(#G0
MA@Y] (4.AP"##I, @0^? ( 0K0!^$+X ?1#; 'H1] !X$O\ =Q+_ '<2_P!W
M$O\ =Q+_ .\7  #;(0  QB0  +0C  "H(   H!P  )L7  "9$00 F X0 ),0
M&P"/$2< C!(R (D3/ "'$T0 A11, (,44P"!%5H @!5@ 'X6: !]%F\ >Q9X
M 'D7@P!X%X\ =AB< '08J@!S&;L <AG4 &\:\0!N&_\ ;1O_ &T:_P!M&O\
M;1K_ .<@  #0*0  O"L  *LJ  ">*   EB0  ) @  "-'   C!<, (@8%@"$
M&B( @1LM 'X<-P!\'4  >AU( 'D>3P!W'E4 =A]< '0?8P!S'VL <2!T ' @
M?P!N(8L ;"&8 &LAIP!I(K@ :"+/ &8B[@!E(_\ 9"/_ &0B_P!D(O\ 9"'_
M . F  #(+P  M#$  *,P  "6+@  C2L  (<H  "$)   @B ( 'X@$@![(AX
M>",I '4D,P!S)3P <25# ' F2P!N)E( ;2=9 &LG8 !J)V@ :2AQ &<H>P!E
M*(@ 9"F5 &(II !@*;4 7RG+ %XJ[ !<*O\ 7"G_ %PI_P!<*?\ 7"C_ -@L
M  ##-0  K34  )TT  "0,P  AC$  ( M  !\*P  >2@# '8G$ !R*1H <"HE
M &TK+P!K+#@ :BQ  &@M1P!G+4X 92Y5 &0N70!C+F4 82]N %\O> !>+X0
M7"^2 %HOH0%9+[(!6##( 58PZ0%5,/X!52__ %4O_P!5+O\ 52[_ - Q  "]
M.@  J#D  )<X  "*-P  @#8  'HR  !U,   <BX  &XN#0!K+Q8 :3 A &8Q
M*P!D,C0 8S(] &$S1 !@,TL 7S12 %TT6@!<-&( 6C1K %DU=0!7-8( 5360
M 50UGP%2-; !437& 5 UYP%/-?T!3S7_ 4\T_P%/-/\!3S/_ <LV  "X/0
MHSP  )(\  "%.P  >SH  '0W  !O-0  ;#,  &@T"@!E-1, 8C8> & W* !>
M-S$ 73@Z %LX00!:.4@ 63E0 %<Y5P!6.E\ 5#IH %,Z<P!1.G\!3SJ- 4XZ
MG0%,.JX!2SK# 4HZY0%).OP!23G_ 4DY_P%)./\!2CC_ <<Z  "S0   GC\
M (X_  "!/@  =ST  ' [  !J.   9C@  &(Y!P!?.A$ 7#L; %H[)0!9/"X
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M 3I(WP$Z1_@!.D;_ 3I%_P$[1?\!.T3_ ;M%  "F2   DD<  ()'  !V1P
M:T<  &-&  !;0P  5D4  %)'  !.2 H 3$D2 $I)' !(2B4 1THN $9+-@!%
M2SX 0TM& $),30!!3%8 0$Q? #Y,:@ \3'8 .TR% 3E,E0$W3*<!-DR\ 35,
MW0$U2_<!-4O_ 35*_P$V2?\!-DG_ ;A)  "B2P  CDH  'Y*  !R2@  :$H
M %])  !52   4$H  $Q+  !)3 < 1DT0 $1.&0!"3R( 04\K $!0,P _4#L
M/E!# #Q12@ [45, .E%< #A19P W47, -5&" #-1DP$R4:4!,%&Z 2]1V@$O
M4/8!+T__ 3!._P$P3O\!,$W_ ;1-  "=30  BDT  'I-  !N30  9$T  %M-
M  !130  2T\  $90  !"4@, /U,- #U4%0 \5!X .E4G #E5+P X53< -U8_
M #961P U5E  ,U99 #)79  P5W$ +U>  "U7D0 K5Z, *E>X "E7U@ I5O4
M*57_ "I4_P$J4_\!*E+_ :]1  "840  A5$  '90  !J4   8%   %A1  !.
M4@  1U,  $%5   [6   .%D* #5:$0 T6AH ,ULB #);*P Q6S, +UP[ "Y<
M0P M7$P +%Q6 "M=8  I76T *%U\ "9=C@ D7:$ (UVU ")=T@ B7/, (EO_
M "-:_P C6?\ )%C_ *A5  "25   @%0  '%4  !F5   7%0  %15  !*5@
M0U@  #Q;   V70  ,& % "UA#@ K814 *F(= "EB)0 H8BX )V,V "9C/@ E
M8T< (V-1 ")D7  A9&D 'V1Y !YDB@ <9)X &V2S !EDS@ :8_$ &V'_ !M@
M_P <8/\ '%__ *%9  ",6   >U@  &U8  !B6   65@  %!9  !'6P  /EX
M #=@   Q8P  *F8  "1I"0 A:A  (&H7 !]J(  >:R@ '6LP !QK.0 ;:T(
M&FQ, !EL6  7;&4 %FQT !1LA@ 3;)H $FRO !%LR@ 1:^\ $FG_ !-H_P 3
M:/\ $V?_ )E=  "%70  =5P  &A<  !>7   55P  $M>  !"80  .60  #)G
M   K:@  )&T  !YP 0 7<PL %701 !1T&  3="$ $G4I !%U,@ 1=3L $'5&
M  ]U4@ .=5\ #75N  QU@0 +=94 "G6J  ATPP )=.< "G/]  MQ_P ,<?\
M#'#_ )%B  !_80  <&$  &1A  !:80  3V(  $5E   \:   ,VP  "MO   D
M<@  '78  !=Y   1? 0 #7\,  M_$@ *?QD "7\B  A_*@ &?S0 !7\_  1_
M2P "?U@  7]G  !_>0  ?XX  '^C  !^NP  ?>   'WW  !\_P  >_\  'O_
M (EG  !X9P  :V8  &%F  !49P  26D  #]M   U<0  +'4  "1Y   =?
M%H   !"#   ,A@( !HD*  &)#P  B10  (H;  "*(P  BRP  (LW  "+0P
MBU   (M?  "+<0  BX8  (N<  "*LP  B=,  (CS  "(_P  A_\  (?_ ()M
M  !S;   :&P  %IM  !.;P  0G,  #AW   N>P  )8   !V$   5B   $(P
M  N/   $D@   )0&  "5#   E1   )85  "7'   F"0  )@N  "9.0  F4<
M )E6  "9:   F7T  )F4  "8JP  E\@  );N  "6_P  E?\  )7_ 'MT  !O
M<P  87,  %-V  !&>@  .W\  #"$   FB   '8T  !22   .E@  "9D   &<
M    H    *$   "B!@  H@P  *00  "E%   I1P  *<D  "H+P  J#T  *E,
M  "I7@  J7(  *B)  "HH@  J+P  *?E  "F^P  IO\  *7_ '=[  !H>P
M67X  $N"   ^AP  ,HT  ">2   =EP  %)P   Z@   'I    *@   "K
MK@   *\   "P    L00  +,*  "T#@  M1,  +8;  "X)   NC$  +I   "Z
M4@  NV4  +M]  "ZEP  NK$  +K2  "Z\P  N?\  +G_ &^#  !?A@  48L
M $.0   VEP  *IT  !^B   5IP  #:P   6P    M    +<   "[    O@
M +\   #     P0   ,,!  #$!P  Q0T  ,<1  #*&0  S20  ,XS  #/1
MT%@  -!N  #1B   T*0  -#!  #1Y@  T?@  -'_ &>/  !7E   29H  #NA
M   NIP  (:T  !:S   .N   !KP   #     PP   ,8   #+    S0   ,X
M  #0    T0   -0   #6    V@(  -P)  #?#P  XQ<  .8D  #G-@  Z$D
M .E?  #J>   ZY0  .NO  #KS   [.@  .SV %^>  !0I   0JL  #2R   F
MN0  &;X   ["   $Q0   ,H   #-    T0   -@   #;    WP   .    #B
M    Y    .8   #I    ZP   .X   #Q!0  ]0T  /D6  #\)0  _3D  /Y/
M  #_9P  _X(  /^=  #_M0  _\L  /_D /\ $0#_  \ _P / /\ $0#_ !8
M_P B /\ +P#_ #L _P!' /\ 4@#_ %L _P!D /\ ; #_ ', _P!Z /\ @ #_
M (8 _P", /X DP#] )D ^P"A /H J0#X +0 ]P#" /8 V@#U /$ ] #_ /,
M_P#S /\ Z0#_ .  _P#8 /\ TP#_ /\ #@#_  L _P * /\ "P#_ !$ _P =
M /\ *@#_ #8 _P!! /\ 3 #_ %8 _@!? /L 9@#Y &T ]P!T /4 >@#T (
M\@"& /  C0#O )0 [0"; .P I #J *X Z0"Z .< S0#E .D Y #[ ., _P#B
M /\ W@#_ -$ _P#, /\ R #_ /\ "0#_  0 _P ! /\ ! #_  X _P 8 /\
M) #] #  ^P [ /< 1@#S %  [P!9 .P 8 #J &< YP!N .8 = #D 'H X@"
M .  AP#> (X W "5 -H G@#6 *@ U "S -$ PP#/ -\ S@#T ,P _P#+ /\
MRP#_ ,4 _P"_ /\ O #_ /\  @#_    _P   /\   #]  L ]P 3 /$ '@#M
M "H Z@ U .< 0 #B $H W0!2 -D 6@#5 &$ T@!G -  ;0#. ', S !Z ,H
M@ #( (< Q@"/ ,0 F #" *$ P "M +X NP"\ -  N@#M +D _@"X /\ N #_
M +< _P"S /\ L #_ /\   #_    _P   /D   #N  4 Y0 . -X & #8 ",
MT@ N ,\ .0#+ $, QP!, ,0 5 #! %L OP!A +P 9P"[ &T N0!S +< >@"U
M ($ M ") +( D@"P )L KP"G *P M "K ,8 J0#D *< ^ "F /\ I@#_ *4
M_P"E /\ I #_ /\   #_    ]0   .H   #>    T  * ,@ $@#" !T O@ H
M +L ,P"Y #T M0!& +( 30"P %4 K0!; *P 80"J &< J !M *< <P"E 'H
MI "" *( C "@ )8 GP"A )T K@"; +X F0#8 )< \0"6 /\ E@#_ )< _P"7
M /\ EP#_ /\   #U    YP$  -0   #)    P  $ +@ #@"S !8 KP A *L
M+ "H #8 I@ _ *, 1P"A $\ GP!5 )T 6P"; &$ F@!G )@ ;@"7 '4 E0!]
M )0 A@"2 )$ D "< (X J0", +@ BP#- (D ZP"( /T B #_ (@ _P"( /\
MB #_ /D&  #I#   U X  ,,,  "W"0  L (  *L "0"F !  H@ : )X )0";
M #  F  Y )8 00"4 $D D@!0 )  5@". %P C0!B (L :0"* '  B !X (<
M@0"% (P A "8 (( I0"  +0 ?@#( 'T!YP!\ OD >P/_ 'L$_P![!/\ >P3_
M /$.  #>%0  Q14  +04  "I$0  H0X  )X*  "; PP EP 3 ), '@"0 2D
MC0(S (H#/ "(!$, A@5+ (4&40"#!E< @@=> ( '9 !_"&P ?0AT 'P(?@!Z
M"8D > F6 '<*HP!U"K, <PO' '(,Y@!P#?L < W_ &\-_P!O#?\ ;PW_ .@6
M  #0'@  N1T  *D<  "=&@  E18  ) 3  "/#@, C@H. (D+%P"&#", @PTM
M ( --@!^#CX ? Y& 'L.30!Y#U, >!!: '8080!U$&@ <Q!Q '$1>P!P$8<
M;A&4 &P1H@!K$K( :1+' &@3YP!F$_T 913_ &44_P!E$_\ 91/_ -\>  #&
M)   L"0  * C  "4(0  BQ\  (8;  "#%P  @A(( '\1$@!\$AT >10H '84
M,0!T%3H <A9! '$62 !O%T\ ;A=6 &P770!K&&0 :1AM &@9=P!F&8, 9!F0
M &,:GP!A&J\ 8!K$ %X;Y !='/L 7!S_ %P;_P!<&_\ 7!O_ -4E  "]*@
MJ"D  )@I  ",*   @R4  'TB  !Y'P  >!L# '89#P!R&A@ ;QPC &T=+0!K
M'34 :1X] &@>1 !F'TL 91]2 &,@60!B(&$ 82!I %\A<P!=(7\ 7"&- %HB
MG !9(JP 5R+  %8CX0!5(_D 5"/_ %0B_P!4(O\ 5"+_ ,TK  "V+@  HBX
M )(N  "%+0  ?"L  '8H  !R)@  ;R,  &TA# !J(A4 9R,? &4D*0!C)#$
M8B4Y & F00!?)D@ 729/ %PG5@!;)UT 62=F %@H< !6*'P 5"B* %,IF0!1
M*:H 4"F^ $\IW@!.*?< 32G_ $TI_P!-*/\ 3BC_ ,@P  "P,@  G#(  (PR
M  " ,0  =C   ' M  !K*P  :"D  &8H"0!C*!$ 8"D< %XJ)0!<*RX 6RLV
M %DL/0!8+$0 5RU, %4M4P!4+5L 4RUC %$N;@!0+GH 3BZ( $POEP!++Z@
M22^[ $@OVP!(+_8 1R__ $<N_P!'+?\ 2"W_ ,0T  "K-0  ES4  (<U  ![
M-0  <C0  &LR  !F+P  8BX  %\M!0!<+A  6B\8 %@P(@!6,"L 53$S %,Q
M.@!2,D( 43)) % R4 !.,U@ 33-A $LS:P!*,W< 2#2% $<TE0!%-*8 0S2Y
M $(TU@!"-/0 0C3_ $(S_P!",O\ 0C+_ , X  "G.   DS@  (,X  !W.
M;3<  &8V  !A,P  73(  %DR @!7,PT 5#05 %(U'P!1-2@ 3S8P $XV. !,
M-S\ 2S=& $HW3@!).%8 1SA? $8X:0!$.'4 0SB# $$YDP! .:0 /CFX #TY
MTP \.?, /#C_ #TW_P ]-_\ /3;_ +L[  "B.P  CSL  '\[  !S.P  :CH
M &(Y  !=-P  6#8  %0W  !1. L 3SD3 $TY' !+.B4 2CHM $@[-0!'.SP
M1CQ$ $4\2P!$/%, 0CQ< $$]9P _/7, /CV! #P]D0 Z/:, .3VV #@]T0 W
M/?( -SS_ #@[_P X._\ .#K_ +8]  ">/@  BSX  'P^  !O/@  9CT  %X]
M  !8.P  4SH  $\[  !,/ @ 23T1 $<^&0!&/R( 1#\J $,_,@!"0#H 04!!
M $! 20 ^05$ /4%: #Q!9  Z07  .$%_ #=!CP U0J$ -$*T #)"S@ R0?
M,D#_ #- _P S/_\ -#[_ +%   ":0   AT   'A!  !L00  8D   %M   !4
M/P  3C\  $I   !&004 1$(. $)#%@! 0Q\ /T0G #Y$+P \1#< .T4^ #I%
M1@ Y14X .$98 #9&8@ U1FX ,T9\ #%&C0 P1I\ +D:S "U&S  M1N\ +47_
M "Y$_P N0_\ +D/_ *Q#  "60P  @T,  '1#  !H0P  7T,  %=#  !00P
M2$,  $1%  !!1@$ /D<, #Q($P Z2!P .4DD #A)+  V230 -4H[ #1*0P S
M2DP ,DI5 #!+7P O2VL +4MZ "Q+BP J2YT *$NQ "=+R@ G2^T )TK_ "A)
M_P H2/\ *4?_ *=&  "11@  ?T8  '!&  !E1@  6T8  %1&  !,1P  1$@
M #]*   [2P  -TP) #5-$  S3A@ ,DX@ #%/*  P3S  +T\X "Y/0  L4$@
M*U!2 "I07  H4&@ )U!W "50B  D4)L (E"O "%0R  @4.L (4__ ")._P B
M3?\ (TW_ *%)  ",20  >DD  &Q*  !A2@  6$H  %!*  !)2P  0$P  #M.
M   U4   ,5($ "U3#0 L5!0 *E0< "E5)  H52P )U4S "95/  E5D4 )%9.
M ")660 A5F4 'U9T !Y6A0 <5I@ &U:L !E6Q0 95ND &E7_ !M4_P ;4_\
M'%+_ )M-  "&30  =4T  &A-  !=30  5$T  $U.  !%3P  /%$  #93   Q
M50  *U@  "9:"0 C6Q  (EL7 "%<'P @7"< 'UPN !U<-P <74  &UU* !I=
M50 876$ %UUP !5=@0 4794 $UVJ !%=P@ 17>< $EO^ !-:_P 36O\ %%G_
M )11  " 40  <%$  &11  !940  45$  $E2  !!4P  .%8  #)9   K6P
M)5X  !]A P :8PP &&01 !=D&0 69"$ %60I !1E,0 393H $F5$ !%E4  0
M95T #V5K  YE?0 -99$ #&6E  IDO  *9.  "V/Y  QB_P -8?\ #6'_ (U5
M  !Z50  :U4  %]5  !650  3E4  $17   \60  -%P  "Q?   F8@  'V4
M !EH   3:P4 $&T-  YN$@ -;AH #&XB  QN*P +;C0 "FX^  AN2@ ';E<
M!FYE  1N=@ ";HH  &V?  !MM@  ;-8  &SS  %K_P ":O\  VK_ (5:  !T
M6@  9EH  %Q9  !360  2%H  #]=   V8   +F,  "9G   ?:@  &6T  !-Q
M   .= , "G<*  5W$  !=Q4  '<<  !W)   >"T  '@W  !X0P  >%   'A>
M  !X;P  >(0  'B9  !WL   =LT  '7P  !U_P  =/\  '3_ 'Y?  !N7P
M8EX  %E>  !-7P  0F(  #EE   P:   )VP  !]P   8=   $G<   U[   (
M?@   H (  "!#0  @1$  ((7  "#'@  @R8  (0P  "$.P  A$@  (17  "$
M:   A'P  (23  "#J@  @L4  ('K  "!_@  @/\  (#_ '=E  !I9   7V,
M %)D  !'9P  /&L  #%O   H<P  ('<  !A\   1?P  #(,   :'    B@
M (P#  ","0  C0X  (X1  "/%P  D!X  )$G  "2,@  DC\  )).  "27P
MDG,  )*+  "1H@  D;P  )#E  "/_   CO\  ([_ '%K  !F:@  6&L  $MM
M   _<0  -'8  "I[   @@   %X4  !")   +C0  !)$   "5    F    )D
M  ": P  FP@  )P-  ">$0  GQ8  * >  "B*   HC4  *-$  "C50  HVD
M **   "BF@  H;,  *#8  "@]@  G_\  )__ &YQ  !?<@  474  $1Y   W
M?@  +(0  "&*   7CP  $)0   J9   !G0   *    "D    IP   *@   "I
M    J@   *P&  "M"P  KQ   + 5  "R'@  M"D  +0Y  "T2@  M5T  +5S
M  "UC@  M:@  +3&  "S[0  LO\  ++_ &9Z  !7?0  28(  #R'   OC@
M(Y0  !B:   0GP  ":0   "I    K0   +    "T    MP   +@   "Y
MNP   +P   "^ @  P @  ,(.  #$%   QQX  ,@L  #)/0  RE   ,IF  #*
M?P  RIL  ,JX  #*W0  RO4  ,K_ %Z&  !/BP  09$  #.8   GGP  &Z4
M !&K   )L    +4   "Y    O0   ,$   #&    R    ,D   #+    S
M ,X   #0    T@   -0%  #9#   W1(  .$>  #B+@  XT(  .17  #E;P
MYHP  .:H  #EQ0  Y><  .;V %:4  !(FP  .J(  "RI   ?L   $[8   N\
M    P0   ,4   #)    S0   -(   #6    V@   -L   #>    X    .(
M  #D    YP   .D   #M    \ H  /01  #X'P  ^3(  /I(  #[7P  _'H
M /V7  #]KP  _<<  /WD /\ #@#_  T _P , /\ #@#_ !, _P > /\ *@#_
M #8 _P!" /\ 30#_ %< _P!? /\ 9P#_ &X _P!T /\ >@#_ ($ _0"' /P
MC0#Z )0 ^0"< /< I0#U *\ ] "\ /, SP#Q .P \ #^ .\ _P#O /\ XP#_
M -< _P#. /\ R@#_ /\ "@#_  8 _P $ /\ " #_ !  _P 9 /\ )0#_ #$
M_P ] /\ 1P#^ %$ ^P!9 /D 80#V &@ ] !N /, = #Q 'H [P"! .X AP#L
M (X Z@"6 .@ GP#F *D XP"U .( Q@#@ ., WP#X -T _P#= /\ U #_ ,D
M_P#" /\ O@#_ /\  P#_    _P   /\  0#_  T _P 4 /T ( #Z "L ]P V
M /, 00#O $L [ !4 .@ 6P#F &( XP!H .$ ;@#? '0 W !Z -H @0#8 (@
MU "0 -( F #/ *( S0"N ,L O #) -, QP#P ,8 _P#$ /\ Q #_ +L _P"V
M /\ LP#_ /\   #_    _P   /\   #W  @ \  0 .L &@#G "4 Y  P .$
M.P#< $4 U0!- -$ 50#. %L RP!B ,D 9P#' &T Q0!S ,, >@#! ($ OP")
M +T D@"[ )P N0"G +< M0"U ,@ LP#F +( ^P"Q /\ L #_ *X _P"J /\
MIP#_ /\   #_    _@   /$   #E  ( W  - -, % #- !\ R@ J ,< - #$
M #X P !' +P 3@"Z %4 MP!; +4 80"S &< L@!M +  <P"N 'H K "" *H
MBP"H )4 IP"@ *4 K0"C +X H0#; *  ] "? /\ G@#_ )\ _P"= /\ FP#_
M /\   #\    [@   .    #0    Q0 ( +X $ "Y !D M0 C +, +@"P #<
MK0!  *H 2 "H $\ I0!5 *, 6P"B &  H !F )\ ; "= ', FP![ )H A "8
M (X E@": )4 IP"3 +< D0#, )  [ "/ /\ C@#_ (X _P". /\ CP#_ /P
M  #O    VP   ,D   "]    M0 " *X # "I !, I0 = *( )P"@ #$ G0 Z
M )H 0@"8 $D E@!/ )0 50"3 %L D0!@ )  9P". &T C0!U (L ?@") (D
MB "5 (8 H@"% +$ @P#$ ($ Y "  /D ?P#_ (  _P"  /\ @ #_ /0"  #@
M"0  QP@  +<'  "L P  I@   *  !P";  \ F  7 )4 (0"2 "H CP S (T
M/ "+ $, B0!) (< 4 "& %4 A !; (, 80"! &@ @ !P 'X >0!\ (0 >P"0
M 'D G0!X *P =@"^ '4 W0!S /0 <P#_ ', _P!S /\ <P#_ .D-  #/$
MN1   *D0  ">#@  EPL  ),&  "0  L C  1 (D &@"& "0 @P N ($ -@!_
M #X ?0!$ 'P 2P!Z %$ >0!7 '< 70!V &0 = !L ',!=0!Q 8  ;P*- &X"
MF@!L ZH :P.[ &D$U@!H!O$ : ?_ &<'_P!G!_\ 9P?_ -\4  ##%P  KA<
M )X6  "3%0  BQ(  (80  "$# ( @P8- ( #% !\!1X >0<H '<(, !U"#@
M<PE  '()1@!P"DP ;PI3 &T+60!L"V$ :@MI &D,<@!G#'X 9@R+ &0-F0!B
M#:D 80V[ & -V !>#O, 70[_ %T._P!=#O\ 70[_ -0<  "Y'0  I!X  )4=
M  ")'   @1H  'L7  !X$P  >! & '<-#P!S#A@ < XB &X/*P!L$#, :A [
M &D00@!G$4D 9A%/ &015@!C$ET 81)F & 2;P!>$GL 7!.( %L3EP!9$Z<
M5Q2Z %84U0!5%?, 5!7_ %05_P!4%?\ 5!3_ ,HB  "P(@  G2,  (TC  "!
M(@  >2$  ',>  !O&P  ;A<  &T3# !J%!0 9Q4> &46)P!C%B\ 81<W & 7
M/@!>&$4 71A+ %P94@!:&5H 61EB %<:; !6&G< 5!J% %(;E !1&Z0 3QNW
M $X;T !-'/$ 3!S_ $P<_P!-'/\ 31O_ ,,F  "J)P  EB<  (<H  ![)P
M<B8  &PD  !H(0  9AX  &0;" !B&Q$ 7QP: %T=(P!;'BL 6AXS %@?.@!7
M'T$ 5B!( %0@3P!3(%< 42%? % A:0!.(70 32&" $LBD0!)(J( 2"*T $<B
MS0!&(^\ 12/_ $4B_P!&(O\ 1B'_ +PJ  "D*P  D2L  ((L  !V*P  ;2H
M &8I  !B)@  7R0  %TB! !;(0X 6"(6 %8C'P!4)"@ 4R0P %(E-P!0)3X
M3R9% $XF3 !,)E0 2R=< $DG9@!()W$ 1B=_ $4HCP!#**  02BR $ HRP _
M*.T /RC_ #\H_P! )_\ 0"?_ +<M  "?+@  C"\  'TO  !Q+P  :"X  &$M
M  !=*P  6B@  %<G  !4)PP 4B@3 % I' !.*24 32HL $LJ- !**SL 22M"
M $@L20!&+%$ 12Q: $0L9 !"+6\ 0"U] #\MC0 ]+9X /"VP #HMR  Z+>L
M.BW_ #HM_P Z+/\ .BS_ +(P  ";,0  B#(  'DR  !M,@  9#(  %TQ  !8
M+P  52P  %$L  !/+0D 3"T1 $HN&0!)+R( 1R\J $8P,0!%,#@ 0S _ $(Q
M1P!!,4\ 0#%7 #XQ80 ],FT .S)[ #DRBP X,IP -C*O #4RQP T,ND -#+_
M #4Q_P U,?\ -3#_ *TS  "6-   A#4  '4U  !I-0  8#4  %DT  !4,P
M4#   $PQ  !),08 1S(/ $4S%@!#,Q\ 0C0G $ T+@ _-38 /C4] #TU1  \
M-DP .C95 #DV7P W-FL -C9X #0WB0 R-YH ,3>M "\WQ0 O-^@ +S;^ # U
M_P P-?\ ,#3_ *DV  "2-@  @#<  '(X  !F.   73<  %8W  !0-@  2S0
M $<U  !$-@, 03<- #\X%  ^.!P /#DD #LY+  Z.3, .3HZ #@Z0@ V.DH
M-3I3 #0[70 R.V@ ,#MV "\[AP M.YD +#NL "H[PP I.^8 *CK] "HZ_P K
M.?\ +#C_ *0X  "..0  ?#H  &XZ  !C.@  6CH  %,Z  !-.@  1C@  $(Z
M   _.P  /#P+ #H\$0 X/1D -STA #8^*0 T/C  ,SXW #(_/P Q/T< ,#]0
M "X_6@ M0&8 *T!T "E A  H0)< )D"J "5 P0 D0.4 )#_\ "4^_P F/?\
M)CW_ )\[  "*/   >#T  &H]  !?/0  5CT  $\]  !)/0  0CT  #P^   Y
M/P  -D$( #1!#P R0A8 ,4(> "]#)0 N0RT +4,T "Q$/  K1$0 *D1- "A$
M6  G16, )45Q "-%@@ B194 ($6H !]%OP >1., 'T3[ !]#_P @0O\ (4'_
M )H^  "%/P  =$   &=   !<0   4T   $Q   !&0   /D$  #A#   T10
M,$8# "U'#0 K2!( *D@: "E((@ H22D )TDQ "5).0 D24$ (TI* ")*50 @
M2F$ 'TIO !U*?P ;2I( &DJF !A*O0 72N  &$GZ !E(_P :1_\ &D?_ )5"
M  " 0@  <$,  &-#  !80P  4$,  $E#  !"1   .T4  #5'   P20  *TL
M "9-"0 D3A  (DX6 "%/'0 @3R4 'T\L !Y/-0 =3ST '%!' !I040 94%T
M%U!K !90?  44(\ $U"D !%0N@ 14-X $4_X !)._P 33?\ %$W_ (]%  ![
M1@  :T8  %]'  !51P  34<  $9'   _1P  -TH  #%,   K3@  )E   "!3
M P <50P &E81 !E6&  75B  %E8G !56,  45CD $U=" !)730 15UD $%=H
M  ]7>0 .5XP #5>@  M7M@ +5M0 "U;T  Q5_P -5/\ #E/_ (A)  !V2@
M9TH  %M*  !12@  2DH  $-*   [3   ,TX  "Q1   F5   (58  !M9   5
M7 < $5X- !!>$P 07AH #EXB  Y>*@ -7C, #%X]  M>2  *7E0 "%YB  =>
M<P %7H8  UZ;  )>L0 "7<P  EWN  -<_P $6_\ !5O_ (%.  !P3@  8DX
M %=.  !.3@  1TX  #Y/   V40  +E0  "=7   A6@  &UT  !5@   08P,
M#&8+  AG$  &9Q4 !6<<  1G)  "9RT  6<W  !G0@  9TX  &=<  !G;0
M9X   &:5  !FK   9<<  &7K  !D_   9/\  &/_ 'I2  !J4P  75(  %12
M  !+4@  0E,  #E5   P6   *%L  "%?   :8@  %&4  !!H   ,:P$ !FX)
M  !O#@  ;Q(  &\8  !P'P  <"<  '$P  !Q.P  <4@  '%6  !Q9@  <7D
M '&/  !PIP  ;\$  &_G  !N_   ;?\  &W_ '-8  !E5P  6E<  %%6  !&
M5P  /%H  #)=   J80  (F0  !IH   4;   #F\   IR   $=@   '@%  !X
M"P  >0X  'H3  ![&0  ?"   'TI  !],P  ?4   'U.  !]7@  ?7(  'V(
M  !\H0  ?+H  'OB  !Z^@  >?\  'C_ &U=  !@7   5UP  $M=  ! 7P
M-6,  "MG   C:P  &F\  !-S   .=P  "'L   )^    @@   (,!  "$!@
MA0L  (8/  "($P  B1D  (HA  "+*P  BS<  (Q&  "+5@  BVD  (N   "+
MF0  BK,  (G8  "(]P  B/\  (?_ &AC  !>8@  46(  $1E   X:0  +FX
M "1S   :>   $WT   V!   &A0   (D   "-    D    )(   "2    E 4
M )4*  "7#@  F!(  )H8  ";(0  G"T  )T\  "=3   G%\  )QV  ";D0
MFZL  )K)  ":\   F?\  )C_ &5I  !7:0  26P  #UQ   P=@  )7P  !N!
M   2AP  #(P   21    E0   )D   "=    H    *$   "B    I    *4!
M  "G!P  J0P  *H1  "M&   KR(  *\P  "O00  KU0  *]K  "NA0  KJ$
M *Z^  "MY@  K/P  *S_ %YQ  !/=   0GD  #5_   HA0  '8P  !.2   ,
MF    YT   "B    I@   *H   "N    L    +$   "S    M    +8   "X
M    N@0  +P*  "^$   P1<  ,,D  ##-0  Q$D  ,1>  #%=P  Q9,  ,6O
M  #%T0  P_(  ,/_ %9\  !'@@  .H@  "R/   @E@  %)T   VC   #J0
M *X   "R    MP   +L   "_    P@   ,(   #%    Q@   ,@   #*
MS0   ,\   #2"   U0X  -L8  #=)P  WCH  -]0  #@:   X(0  .&A  #A
MO0  X>(  .#T $Z+  ! D@  ,ID  "6A   8J   #J\   6U    N@   +\
M  #$    R    ,X   #1    U    -4   #8    V@   -T   #?    X@
M .0   #G    ZP4  .\.  #T&0  ]2L  /9!  #W6   ^'(  /F0  #YJP
M^,0  /CA /\ "P#_  @ _P ) /\ # #_ !( _P : /\ )@#_ #( _P ^ /\
M2 #_ %( _P!: /\ 8@#_ &D _P!O /\ =0#^ 'L _ "! /L B #Y (\ ]P"7
M /4 H #S *H \@"W .\ R0#M .8 [ #[ .L _P#K /\ W0#_ ,X _P#& /\
MP@#_ /\ ! #_    _P   /\ !0#_  T _P 5 /\ (0#_ "P _P X /\ 0P#]
M $P ^0!4 /< 7 #T &, \@!I /  ;P#N '4 [ ![ .H @@#H (D YP"1 .0
MF@#B *0 X "P -T P #: -P V #T -4 _P#3 /\ RP#_ ,$ _P"[ /\ MP#_
M /\   #_    _P   /\   #_  H _0 1 /D &P#V "< ]  R /  / #L $8
MZ !. .0 5@#A %P W@!C -P : #9 &X U0!T -( >P#0 (( S0"* ,L DP#(
M )T Q@"H ,0 MP#! ,P P #K +X _P"] /\ O0#_ +0 _P"N /\ JP#_ /\
M  #_    _P   /H   #R  4 Z@ . .4 %@#@ "$ W0 K -L -@#3 #\ S@!(
M ,H 3P#' %8 Q !< ,( 80#  &< O@!M +P <P"Z 'H N "" +8 BP"T )8
ML@"A +  KP"N ,$ K0#@ *L ]P"J /\ J0#_ *8 _P"A /\ GP#_ /\   #_
M    ]P   .@   #<    T  * ,H $0#% !L P@ E +\ +P"\ #@ N !! +4
M2 "R $\ L !5 *X 6P"L &$ J@!F *@ ; "G ', I0![ *, A "A (X GP":
M )T IP"; +@ F@#0 )D [P"8 /\ EP#_ )8 _P"4 /\ D@#_ /\   #V
MY    -(   #%    NP % +4 #@"P !4 K  ? *H *0"H #( I0 Z *( 0@"@
M $D G@!/ )P 50": %H F !@ )8 9@"5 &P DP!T )( ?0"0 (< C@"3 (P
MH0"+ +  B@#% (@ Y@"' /L A@#_ (< _P"' /\ A@#_ /@   #E    S0
M +T   "S    J@   *, "@"? !$ FP 9 )D (P"7 "P E0 T )( / "0 $,
MC@!) (P 3P"* %0 B0!: (< 8 "& &8 A !N (, =P"! ($ ?P"- 'X FP!\
M *H >P"\ 'H VP!X /4 > #_ '@ _P!X /\ > #_ .T   #1 @  NP(  *P!
M  "B    FP   )8 !0"1  T C0 4 (L '0"( "8 A@ N (0 -@"" #T @ !#
M 'X 20!] $\ ? !5 'H 6P!Y &$ =P!I '4 <0!T 'P <@"( '$ E@!O *4
M;@"V &T S@!L .X :P#_ &L _P!K /\ :P#_ -\+  #"#   K@P  )X,  "3
M"P  C <  (@"  "%  D @0 0 '\ %P!\ "  >@ H '@ , !V #@ =  ^ ',
M1 !Q $H < !0 &X 5@!M %T ; !D &H ;0!H '< 9P"$ &4 D@!D *$ 8P"R
M &$ R0!@ .D 8 #\ &  _P!@ /\ 8 #_ - 0  "V$0  HA(  ),2  "($0
M@ \  'P-  !Y"0$ > ,+ '4 $0!S !H <  C &X!*P!L 3, :@(Y &D#0 !G
M T8 9@1, &4$4@!C!5D 8@5A & %:@!?!G0 70:! %P'CP!:!Y\ 60>P %<'
MQ@!6">< 5@K[ %4*_P!5"O\ 5@K_ ,85  "M%P  F1@  (H8  !_%P  =A8
M '$3  !N$   ;0T% &T)#0!J"10 9PH= &4*)@!C"RX 8@PU & ,/ !?#$(
M7@U( %P-3P!;#58 60U> %@.: !6#G, 50Z  %,.CP!1#I\ 4 ZQ $X.R !-
M$.H 31#] $T0_P!-$/\ 31#_ +P;  "E'   DAT  (,>  !W'0  ;QP  &D:
M  !F%P  9!0  &00" !B#Q  7Q 8 %T0(0!;$2D 6A$Q %@2. !7$CX 5A)%
M %023 !3$U, 41-; % 390!.%'  3!1] $L4C !)%)P 1Q6N $85Q0!%%>@
M11;^ $46_P!%%?\ 117_ +4?  ">(0  BR(  'PB  !Q(@  :"$  &(?  !?
M'0  7!H  %L7 @!:%0T 5Q84 %46'0!4%R4 4A@M %$8- !/&#L 3AE" $T9
M2 !+&E  2AI8 $@:8@!'&FT 11MZ $,;B0!"&YH 0!NL #\;P@ ^'.4 /1S\
M #X<_P ^&_\ /AO_ *\C  "8)   AB4  '<F  !L)@  8R4  %TD  !9(@
M5A\  %0=  !3' L 41P2 $X=&@!-'2( 2QXI $H>,0!)'S< 1Q\^ $8@10!%
M($T 0R!5 $(@7P! (6H /R%W #TAAP [(9@ .2&J #@BP  W(N, -R+[ #<B
M_P X(?\ ."'_ *HF  "4)P  @2D  ',I  !G*0  7RD  %@H  !4)@  42,
M $\B  !,(@< 2B(0 $@B%P!'(Q\ 120F $0D+@!")#0 024[ $ E0P _)4H
M/293 #PF7  Z)F< .29U #<GA  U)Y8 -">H #(GO@ Q)^$ ,2?Y #(F_P R
M)O\ ,R7_ *4I  "/*@  ?2P  &\L  !D+0  6RP  %4K  !0*@  3"@  $HF
M  !')P0 1"<- $(H% !!*!P /RDC #XI*P ]*3( /"HY #LJ0  Y*D@ ."M0
M #8K6@ U*V4 ,RMR #$K@@ P+)0 +BRG "PLO  K+-X +"SX "PK_P M*O\
M+2K_ *$L  "++0  >2X  &LO  !@+P  6"\  %$N  !,+@  2"P  $4K  !!
M*P  /RP+ #TL$0 [+1D .BXA #DN*  W+B\ -B\V #4O/@ T+T4 ,R]. #$P
M6  P,&, +C!P "PP@  J,)( *3"E "<PN@ F,-P )C#W "<O_P H+_\ *"[_
M )PN  "',   =C$  &@R  !=,@  53(  $XQ  !(,0  1#   $ O   \,
M.C$) #<Q$  V,A8 -3(> #,S)0 R,RP ,3,S # T.P O-$, +31, "PT5@ J
M-6$ *35N "<U?@ E-9  (S6C "(UN0 A-=D (33V "(T_P C,_\ (S+_ )@Q
M  "#,P  <C0  &4T  !:-0  434  $LT  !%-   0#0  #HS   W-   -#4&
M #(V#@ P-Q, +S<; "XW(@ M."D *S@Q "HX.  I.4  *#E) "8Y4P E.5\
M(SEL "$Z?  @.HX 'CJB !PZMP ;.=4 '#GU !TX_P =./\ 'C?_ ),T  !_
M-@  ;C<  &$W  !7-P  3C<  $@W  !"-P  /#<  #4X   R.0  +SH" "P[
M"P J/!$ *3P8 "@]'P F/28 )3TN "0]-0 C/CT (CY& " ^4  ?/EP '3]I
M !L_>0 :/XP &#^@ !8_M0 5/M( %C[S !<]_P 8//\ &#S_ (XW  !Z.
M:CD  %XZ  !3.@  2SH  $4Z   _.@  .3H  #(\   N/@  *4   "9!"  D
M0@X (D(4 "%"&P @0R, 'T,J !Y#,@ <0SH &T1# !I$30 81%D %T1G !5$
M=P 31(H $D2> !%$LP 01-  $$/R !%"_P 20O\ $T'_ (D[  !V/   9CT
M %H]  !0/0  2#T  $(]   \/0  -CX  "]    J0@  )40  "%& P =2 P
M&TD1 !E)%P 821X %TDF !9)+@ 52C8 %$I  !-*2@ 12E8 $$ID  ]*=  .
M2H< #4J;  Q*L  *2LH "TGL  Q(_P -1_\ #4?_ (,^  !Q/P  8D   %9
M  !-0   14   #]    Y00  ,D(  "M%   F1P  (4D  !Q+   63@< $U .
M !)0$P 14!D $% A  ]0*0 .4#$ #5 [  U11@ +45$ "E%?  E1;P '4($
M!5"6  -0JP "4,4  T_H  -/^P %3O\ !DW_ 'U"  !K0P  740  %)$  !*
M1   0T,  #Q$   U10  +D<  "=*   A3   '$\  !=1   25 , #E<*  M8
M$  *6!4 "%@<  =8)  &6"P !5@V  -80  !6$P  %A:  !8:0  6'P  %B1
M  !7IP  5\   %;E  !6^0  5?\  %7_ '9'  !F1P  64@  $]'  !'1P
M0$<  #A(   P2@  *4T  ")0   <4P  %E4  !%8   -6P( "5X)  1?#@
M7Q(  %\8  !@'P  8"<  & P  !@.P  8$<  &!4  !@8P  8'8  &"+  !?
MH@  7[L  %_B  !>^0  7?\  %W_ &]+  !A3   54P  $Q+  !$2P  .TP
M #).   K40  (U0  !Q7   66P  $5X   U@   (8P   F8'  !G#   9P\
M &@3  !I&0  :B$  &HI  !J-   :D   &I-  !J70  :F\  &J%  !JG0
M:;8  &C=  !H]P  9_\  &;_ &E1  !<4   4E   $I/   _4   -5,  "U6
M   D60  '5T  !9@   09   #&<   9J    ;@   &\#  !P"   <0T  '(0
M  !T%   =1L  '8C  !W+   =S@  '9&  !V5@  =F@  '9^  !VEP  =;$
M '33  !S]0  <_\  '+_ &-6  !850  4%0  $15   Y6   +UL  "9?   =
M8P  %6<  !!L   *<   !',   !V    >@   'P   !\ P  ?@@  '\,  "!
M$   @A0  (0;  "%)   AB\  (8]  "&30  A5\  (5U  "%CP  A*D  (/)
M  ""\0  @?\  (#_ %];  !66@  25L  #U>   R80  )V8  !YK   5<
M#G4   EY   !?@   ($   "%    B    (H   "+    C0$  (X&  "0"P
MD0\  ),4  "5&P  ER8  )<T  "71   EU8  )9L  "5A@  E:(  )3!  "3
MZ@  DO\  )+_ %UA  !/80  0F0  #9I   J;@  'W0  !5Y   .?P  !X0
M  ")    C@   )(   "6    F    )H   ";    G0   )\   "A P  HP@
M *4-  "G$P  J1P  *HH  "J.0  JDL  *IA  "I>@  J)D  *BU  "GW0
MI_@  *;_ %9H  !(;   .G   "YV   B?0  %X0   Z*   'D    )8   ":
M    GP   *,   "G    J@   *L   "M    KP   +$   "S    M0   +@%
M  "Z#   O1(  , <  # +0  P$   +]5  "_;@  OHL  +ZH  "^R0  O>\
M +S^ $YT  ! >0  ,G\  "6'   9C@  $)4   ><    H@   *<   "L
ML    +4   "Y    O    +T   "_    P0   ,,   #&    R    ,H   #-
M @  T L  -42  #6(0  US0  -A)  #98   VGP  -J:  #;M0  V]D  -OR
M $:"   XB0  *Y   !V8   2H   "J<   "N    M    +D   "^    P@
M ,@   #+    S@   ,\   #2    U    -8   #:    W0   -\   #B
MY@   .H*  #O$P  \"4  /(Z  #S40  ]&L  /2)  #UI0  ];\  /7= /\
M!@#_  , _P % /\ "P#_ !  _P 7 /\ (@#_ "T _P Y /\ 1 #_ $T _P!5
M /\ 70#_ &0 _P!J /\ < #] '8 ^P!\ /D @P#W (H ]0"2 /, FP#P *8
M[@"S .L Q #I .0 YP#Y .8 _P#E /\ TP#_ ,< _P"_ /\ NP#_ /\   #_
M    _P   /\  @#_  L _P 2 /\ '0#_ "@ _P S /\ /@#\ $< ^ !/ /0
M5P#Q %T [@!C .P :0#J &\ Z !U .8 ? #D (, X@"+ -\ E0#< )\ V0"K
M -4 NP#2 -0 SP#R ,T _P#, /\ Q0#_ +H _P"T /\ L #_ /\   #_
M_P   /\   #_  8 ^0 / /4 %P#S "( \0 M .T -P#G $  X@!) -\ 4 #;
M %< UP!= -0 8P#1 &@ SP!N ,P =0#* 'P R "$ ,4 C0#" )@ P "D +T
ML@"[ ,8 N0#H +@ _0"W /\ M@#_ *T _P"G /\ HP#_ /\   #_    _P
M /4   #K  $ Y  , -X $P#9 !P TP F -$ , #, #H R !" ,0 2@#  %
MO0!6 +L 7 "Y &$ MP!G +4 ;0"S '0 L0!\ *\ A0"M )  J@"< *@ J@"F
M +L I0#: *, ]0"C /\ H@#_ )X _P": /\ EP#_ /\   #^    [P   -\
M  #0    QP ' ,$ #P"\ !< N0 @ +< *@"U #, L  [ *T 0P"K $D J !/
M *8 50"D %H HP!@ *$ 9@"? &T G0!T )P ?0": (@ F "4 )8 H@"4 +(
MD@#) )$ ZP"1 /\ D #_ )  _P", /\ B@#_ /P   #L    V0   ,<   "Z
M    L0 " *L # "G !( I  ; *$ ) "@ "P G@ U )L / "8 $, E@!) )0
M3P"2 %0 D !: (\ 7P"- &8 BP!M (D =@"( (  A@", (0 F@"" *H @0"^
M (  X "  /D ?P#_ '\ _P!_ /\ ?@#_ /$   #8    P@   +,   "H
MH    )D !P"5  X D@ 5 )  '@". "8 C0 N (H -@"' #T A0!# (0 20""
M $X @0!4 '\ 60!^ &  ? !G 'H ;P!Y 'H =P"& '4 E !T *, <@"U '(
MSP!Q /$ < #_ '  _P!P /\ <0#_ .$   #$    L    *(   "7    D0
M (L  @"&  L @P 1 ($ & !_ "$ ?0 I 'P , !Y #< >  ] '8 0P!T $D
M<P!. '( 5 !P %H ;P!B &T :@!K '0 :@"  &@ C@!G )T 90"O &4 Q@!D
M .@ 9 #] &, _P!C /\ 9 #_ ,\%  "V!P  HP@  )0(  ")!P  @@,  'X
M  ![  8 =P . '4 $P!R !L <0 C &\ *P!M #( ;  X &H /@!I $0 9P!)
M &8 3P!E %8 8P!= &( 90!@ &\ 7P![ %T B0!< )D 6P"J %D OP!9 .$
M6 #X %@ _P!8 /\ 60#_ ,(,  "J#0  EPX  (D.  !]#@  =@T  '$*  !O
M!@  ;0 * &L $ !I !8 9P > &4 )@!C "T 80 S &  .0!? #\ 70!% %P
M2P!; %( 6@!9 %@ 8@!7 &P 50!X %, A@!2 )8 40"G %  NP!/ =L 3@+T
M $X#_P!.!/\ 3@/_ +@0  "A$@  CA,  '\3  !T$P  ;!(  &<0  !E#@
M8PL# &,&# !A!!$ 7@,9 %P$(0!;!2@ 608O %@&-0!6!SL 50=" %0'2 !3
M"$\ 40A6 % )7P!."6D 30EV $L*A !)"I0 2 JF $<*N@!&"M@ 10OS $4,
M_P!%#/\ 10S_ + 4  "9%@  AQ@  '@9  !M&   91<  %\6  !<$P  6A$
M %H.!@!:# T 5PP4 %4,' !3#20 4@TK % -,0!/#C@ 3@X^ $T.10!+#DT
M2@Y5 $@/7@!'#V@ 10]U $,0A !!$)4 0!"F #X0NP ]$-P /1'V #T1_P ]
M$/\ /A#_ *D9  "2&P  @1P  '(=  !G'0  7QP  %D;  !5&0  4Q8  %(3
M  !2$0H 4! 0 $X1& !,$2  2A(G $D2+@!($S0 1Q,[ $430@!$$TD 0Q12
M $$46P _%&4 /A5R #P5@0 Z%9( .!6D #<5N0 U%=@ -1;U #86_P V%O\
M-Q7_ *,<  "-'@  >R   &TA  !B(0  6B$  %0?  !0'@  31L  $P9  !+
M%@8 218. $<7%0!%%QP 1!@D $(8*@!!&#$ 0!DX #\9/P ]&48 /!I/ #H:
M6  Y&F, -QMO #4;?@ S&Y  ,ANB # ;MP O&], +QSS "\;_P P&_\ ,!O_
M )T?  "((@  =R,  &DD  !>)   5B0  % C  !+(@  2"   $8=  !%' (
M0QP, $$<$@ _'1D /ATA #P>)P ['BX .A\U #D?/  W'T0 -A], #0@5@ S
M(&  ,2!M "\@?  M(8X +"&@ "HAM0 I(=  *2'R "DA_P J(/\ *R#_ )DB
M  "$)0  <R8  &4G  !;)P  4R<  $PF  !')0  1"0  $(A   _(0  /2$)
M #LA$  Y(A8 ."(> #8C)0 U(RL -"0R #,D.0 R)$$ ,"1* "\E4P M)5X
M*R5K "HE>@ H)8P )B6? "0ELP C)<X (R7P "0E_P E)/\ )23_ )0E  "
M)P  ;RD  &(J  !7*@  3RH  $DI  !$*   0"<  #TF   Z)0  -R8& #4F
M#@ T)Q0 ,B<; #$H(@ P*"D +R@P "TI-P L*3\ *RE' "DI40 H*EP )BII
M "0J>  C*HH (2J= !\JL@ >*LP 'BKO !\I_P @*?\ (2C_ ) H  !\*@
M;"L  %\L  !4+   3"P  $8L  !!*P  /"L  #@J   U*@  ,BL# # K#  N
M+!$ +2P8 "PL'P J+28 *2TM "@M-  G+CP )BY% "0N3P C+EH (2]G !\O
M=@ =+X@ '"^; !HOL  8+\H &"[M !DN_P ;+?\ &RW_ (PK  !X+0  :"X
M %LO  !1+P  22\  $,O   ^+@  .2X  #0N   P+@  +2\  "LP"@ I,1
M)S$5 "8Q'  E,B, )#(J ",R,0 A,SD (#-" !\S3  =,U< &S-D !HT=  8
M-(8 %C2: !0SK@ 3,\@ $S/L !0S_P 5,O\ %C'_ (<N  !T+P  93$  %@Q
M  !.,@  1C(  $ Q   [,0  -C$  #$Q   K,P  *#0  "4U!@ C-@T (382
M " W&0 ?-R  'C<G !TX+@ ;.#8 &C@_ !DX20 7.54 %3EB !0Y<0 2.80
M$3F8 ! YK0 ..,< #CCK ! X_P 0-_\ $3;_ (,Q  !P,@  830  %4T  !+
M-   1#0  #TT   X-   ,S0  "TU   H-P  )#D  " Z @ =.PL &SP0 !D]
M%0 8/1P %STC !8]*P 5/C, %#X\ !(^1@ 1/E( $#Y?  \^;P ./H$ ##Z5
M  L^J0 */L$ "CWD  L]^P ,//\ #3O_ 'TT  !K-@  73<  %$W  !(-P
M03<  #LW   U-P  ,#<  "HY   E.P  (#T  !P_   7008 %$,- !)#$@ 1
M0Q@ $4,? !!$)P /1"\ #D0Y  U$0P ,1$X "T1;  E$:@ '1'P !D20  1#
MI0 "0[T  T/@  -#]@ $0O\ !D'_ '@X  !G.0  63H  $XZ  !%.@  /CH
M #@Z   S.@  +3L  "<]   A0   '$(  !=$   31@, #TD*  U*#P ,2A0
M"TH;  E*(P (2BL !THT  5*/@ $2DD  DI6  !*90  2G<  $J+  !*H0
M2;D  $G=  !)]0  2/\  $C_ '(\  !B/0  53X  $H^  !"/0  /#T  #8]
M   O/@  *4   "-"   =10  %T<  !-*   /3 ( "T\)  =0#0 #41$  %$7
M  !1'@  428  %$O  !1.0  440  %)1  !28   47(  %&'  !1G0  4;4
M %#8  !0]0  3_\  $__ &Q   !=00  44$  $=!  ! 0   .4   #)!   J
M0P  )$8  !Y(   72P  $DX   Y1   +4P$ !E8'  !7#   6!   %@3  !9
M&0  6B$  %HI  !:,P  6C\  %I,  !:6@  6FP  %J!  !9F0  6;$  %C1
M  !8]   5_\  %?_ &5%  !810  344  $5$   ^1   -44  "U'   E2@
M'DT  !A0   24P  #E8   I9   $7    %X$  !?"0  8 T  &$0  !B%0
M8QL  &0C  !D+0  9#@  &1%  !D5   9&8  &1[  !CDP  8ZT  &+,  !A
M\@  8?\  &#_ %]*  !32@  2DD  $-(   Y20  +TP  "=/   ?4@  &%4
M !)9   -70  "&    )C    9@   &@!  !I!0  :@H  &L-  !M$0  ;A8
M ' =  !Q)@  <3$  ' ^  !P3@  <%\  '!S  !OC0  ;Z<  &[&  !M[P
M;/\  &S_ %I/  !03@  2$T  #U.   S40  *50  "!8   87   $6    QD
M   &:    &L   !O    <@   '0   !U    =P0  '@)  !Z#0  ?!   'T6
M  !_'@  @"@  ( U  " 10  ?U8  ']K  !_A   ?J   'V^  !\Z0  >_\
M 'K_ %94  !.4P  0E0  #=6   L6@  (E\  !AC   1:   "VT   -R
M=@   'H   !]    @    (,   "$    A@   (<"  ")!P  BPP  (T0  "0
M%@  DA\  )(L  "2.P  DDT  )%B  "1>@  CY<  (^T  ".X0  C/L  (S_
M %59  !(6@  .UT  "]A   D9@  &6P  !%R   *=P   GT   ""    A@
M (L   ".    D0   ),   "5    EP   )D   ";    G00  )\*  "B#P
MI!8  *8A  "F,0  ID,  *57  "D<   HXX  *.K  "AT   H/4  )__ $YA
M  ! 9   ,VD  "=N   ;=0  $7P   N#    B0   (X   "3    F    )T
M  "A    I    *4   "G    J0   *L   "M    L    +(   "U"   N X
M +P6  "\)0  O#<  +M,  "Z9   N8$  +>B  "WP   M^H  +?\ $9K   Y
M<   *W<  !]_   3A@  "XX   &5    FP   *$   "F    JP   +    "S
M    MP   +<   "Z    O    +\   #!    Q    ,<   #*    S04  -$.
M  #4&0  U"L  -1   #36   TW0  -.2  #2L   TM,  -+R #YY   Q@
M(X@  !>1   -F0   Z    "G    K@   +,   "X    O0   ,(   #&
MR@   ,H   #-    SP   -(   #5    V0   -T   #?    XP   .<%  #K
M#P  [!\  .TS  #N2P  [V0  .^"  #PGP  \;D  /'8 /\   #_    _P $
M /\ "0#_  X _P 5 /\ '@#_ "D _P T /\ /P#_ $@ _P!0 /\ 6 #_ %X
M_P!E /T :P#[ '$ ^0!W /@ ?@#V (4 \P"- /$ EP#N *( ZP"O .@ P #F
M .  XP#X .( _P#; /\ RP#_ ,$ _P"Y /\ M #_ /\   #_    _P   /\
M  #_  D _P 0 /\ &0#_ ", _P N /T .0#Y $( ]0!* /( 4@#N %@ ZP!>
M .D 9 #F &H Y !P .( =@#? 'T W0"& -D CP#5 )H T0"G ,X M@#+ ,X
MR0#P ,< _P#% /\ NP#_ +0 _P"M /\ J0#_ /\   #_    _P   /\   #[
M  ( ]@ - /$ $P#M !X [  H .D ,@#C #L W0!$ -@ 2P#3 %$ T !8 ,T
M70#+ &, R0!H ,8 ;P#$ '8 P@!^ +\ AP"\ )( N@"? +< K0"U ,$ L@#D
M +$ _0"O /\ K #_ *4 _P"@ /\ G #_ /\   #_    ^P   .X   #D
MW  ( -, $ #/ !@ RP B ,D *P#& #0 P0 ] +T 1 "Z $L MP!1 +4 5@"R
M %P L !A *X 9P"L &X J@!V *@ ?P"F (H HP"6 *$ I0"? +8 G0#1 )P
M\P"; /\ G #_ )8 _P"3 /\ D #_ /\   #V    YP   -,   #&    O0 #
M +@ #0"S !, L0 < *\ )0"N "X J0 V *8 /0"C $0 H0!* )\ 3P"= %4
MFP!: )H 8 "8 &8 E@!N )0 =P"2 ($ D ". (X G ", *T B@## (D Z "(
M /\ B0#_ (< _P"% /\ @@#_ /,   #C    S    +P   "P    IP   *$
M" ">  \ FP 6 )D 'P"8 "< E@ O ), -P"1 #T C@!# (P 20"+ $X B0!4
M (< 60"% &  A !G (( ;P"  'H ?@"& 'P E !Z *0 >0"X '@ V !W /<
M> #_ '@ _P!W /\ =0#_ .8   #+    MP   *@   ">    E@   (\ ! "+
M  P B  2 (< &0"% "$ A  I (( , !_ #< ?0 ] 'P 0P!Z $@ >0!- '<
M4P!V %D = !A '( :0!Q ', ;P!_ &T C0!L )T :@"O &D R !H .T :0#_
M &D _P!I /\ :0#_ -(   "X    I0   )<   "-    A@   ($   !\  @
M>0 . '< % !V !P =  C ', *P!Q #$ ;P W &X /0!L $, :P!( &H 3@!H
M %0 9P!; &4 8P!C &T 8@!X &  AP!? )8 70"H %T O@!< .0 7 #[ %P
M_P!< /\ 7 #_ ,(   "J 0  F ,  (D$  !_ @  >    '0   !P  0 ;0 ,
M &L $0!I !< :  > &8 )0!E "P 8P R &( . !@ #T 7P!# %X 20!< $\
M6P!6 %H 7@!8 &@ 5P!S %4 @0!4 )$ 4@"C %$ MP!1 -8 40#U %$ _P!1
M /\ 4@#_ +8'  "?"0  C0L  'X,  !S"P  ; H  &@'  !E P  8P ' &$
M#0!? !, 70 : %P (0!; "< 60 M %@ ,P!6 #D 50 _ %0 10!3 $L 40!2
M %  6@!/ &0 30!O $P ?0!* (T 20"? $@ L@!' ,P 1P#O $8 _P!' /\
M1P#_ *P,  "5#@  @Q   '40  !K$   8P\  %X.  !;#   6@D" %D$"@!7
M  \ 50 5 %, ' !2 ", 40 I $\ +P!. #4 30$[ $P!00!* D@ 20)/ $@"
M5P!& V$ 10-M $,#>@!" XL 0 .< #\#KP ^ \@ /03J #T%_  ]!O\ /@;_
M *00  ".$@  ?!,  &X4  !D%   7!,  %82  !3$0  40X  % ,!0!0"0P
M3P<1 $T'%P!+"!\ 20@E $@)*P!'"3$ 1@DX $0*/@!#"D4 0@I- $ +50 _
M"U\ /0MK #P+>0 Z#(H . R< #<,KP U#,< -0SI #4-_0 U#?\ -@S_ )T3
M  "'%0  =A<  &D8  !>&   5A@  % 7  !-%0  2A,  $D1  !)#@< 2 T.
M $8-$P!$#1H 0PXA $(.* ! #BX /PXU #X//  ]#T, .Q!+ #H05  X$%X
M-A!K #00>0 R$(H ,1"< "\0L  M$,D +1'L "T1_P N$?\ +Q#_ )<6  ""
M&0  <1L  &0<  !9'   41P  $P;  !'&@  1!@  $,5  !"$P( 01(+ $ 1
M$  ^$A< /!(> #L3)0 Z$RL .!,R #<3.0 V%$  -!1( #,440 Q%%P ,!5H
M "X5=P L%8@ *A6: "@5K@ G%<< )A7J "<5_P H%?\ *17_ )$:  !]'
M;1X  & ?  !6'P  3A\  $@>  !#'0  0!P  #X:   ]&   .Q<' #D6#@ X
M%Q0 -A<; #48(@ S&"@ ,A@O #$9-@ P&3T +AE& "T:3P K&ED *AIF "@:
M=  F&H8 )!J9 "(:K0 A&L4 (!KH "$:_@ B&O\ (QK_ (T=  !Y'P  :2$
M %PB  !2(@  2B(  $0A   _(0  /"   #D>   X&P  -1P$ #0<#0 R'!(
M,!T8 "\='P N'24 +1XL "L>,P J'CL *1]# "<?30 F'U< )!]D "(?<@ @
M'X0 'Q^7 !T?JP ;'\, &Q_G !L?_0 ='_\ 'A[_ (D@  !U(@  92,  %DD
M  !/)0  1R4  $$D   \(P  .",  #4B   S(   ," ! "XA"@ L(1  *R$5
M "HB'  H(B, )R(I "8C,  E(S@ (R-! "(D2@ A)%4 'R1A !TD<  ;)((
M&225 !<DJ@ 6),$ %23E !8D_  7(_\ &2/_ (4B  !Q)   8B8  %8G  !,
M)P  1"<  #XG   Y)@  -28  #$E   N)   *R4  "DE!P G)@X )283 "0G
M&0 C)R  (B<G "$H+@ @*#8 'B@^ !TH2  ;*5, &2E? !@I;@ 6*8  %"F4
M !(IJ  1*<  $2CD !$H^P 3*/\ %"?_ ( E  !N)P  7R@  %,I  !)*@
M0BD  #LI   V*0  ,B@  "XH   J*   )BD  "0J!  B*PP ("L1 !\L%@ =
M+!T '"PD !LM*P :+3, &"T\ !<M10 6+E  %"Y= !(N;  1+GX $"Z2  XN
MIP -+;T #2W?  TM^0 .+/\ $"S_ 'PH  !J*@  6RL  % L  !&+   /RP
M #DL   T*P  +RL  "LK   F+   (BX  !\O   <, D &C$. !DQ$P 7,1H
M%C(A !4R*  4,C  $S(Y !(S0P 1,TX $#-;  XS:0 -,WH ##..  HSH@ (
M,KD "#+9  @R]  *,?\ "S'_ '<K  !F+0  6"X  $TO  !#+P  /"X  #8N
M   Q+@  +2X  "DN   C,   'S(  !LS   7-04 %#8, !(W$0 1-Q8 $3<=
M ! X)  /."P #C@U  TX/P ,.$H "SA7  DX90 '.'8 !3B*  ,XGP !-[4
M 3?3  (W\0 #-O\ !3;_ ',N  !B,   5#$  $DQ  !!,0  .3$  #0Q   O
M,   *S   "4R   @,P  &S8  !<X   3.@( $#P)  T]#@ ,/1, "ST9  H]
M(0 )/2D "#TQ  8^.P %/D8  SY2  $^80  /G(  #Z&   ]G   /;(  #W0
M   \\   //\  #S_ &TR  !=,P  4#0  $8T   ^-   -S0  #(S   M,P
M)S0  "(V   =.   &#H  !0]   0/P( #4$(  E##0 &1!$  T06  )$'0
M1"0  $0M  !$-@  1$$  $1.  !$7   1&T  $2!  !$F   0Z\  $/-  !"
M\   0O\  $+_ &@V  !8-P  3#@  $,X   [-P  -38  # V   I-P  (SD
M !X[   8/0  $T   !!"   -10$ "$<'  -)#   20\  $H3  !+&0  2R
M $LH  !+,@  2ST  $Q)  !,5P  2V@  $M]  !+E   2JP  $K*  !)[P
M2?\  $G_ &(Z  !4.P  23L  $ [   Y.@  ,SD  "PZ   E/   'S\  !E!
M   31   $$<   Q)   (3    D\%  !0"@  4 T  %$0  !2%0  5!L  %0C
M  !4+   5#<  %1$  !44@  5&,  %1W  !4CP  4Z@  %+&  !2[0  4?\
M %'_ %P_  !//P  13\  #X^   W/0  +SX  "=    @0P  &48  !-)   /
M3   "T\   92    5    %<"  !8!P  60L  %H.  !;$0  718  %X=  !?
M)@  7S$  %X]  !>3   7ET  %YQ  !=B0  7:,  %S!  !;ZP  6O\  %K_
M %9$  !+0P  0T(  #Q!   R0@  *44  "%(   :2P  $TX   Y2   *50
M UD   !;    7@   &    !B @  8P8  &4*  !F#@  :!$  &H7  !K'P
M:RD  &LV  !K10  :U8  &IJ  !J@@  :9T  &B[  !GYP  9O\  &7_ %%(
M  !(2   048  #='   L2@  (TT  !M1   350  #ED   A=   !80   &0
M  !G    :@   &P   !N    <    '(%  !S"0  =0T  '<1  !Z&   >R$
M 'LN  !Z/0  >DX  'EB  !Y>0  >)8  '>S  !UX   =/P  '/_ $Y-  !'
M3   .TT  #!/   F4P  '%@  !-<   -80  !F8   !J    ;P   '(   !V
M    >0   'P   !]    ?P   ($   "# @  A@<  (@,  "+$0  CA@  (XD
M  ".,P  C40  (Q8  "+;P  BHP  (FJ  "(SP  AO<  (7_ $U1  !!4P
M-%4  "E:   >7P  %&4   UJ   %<    '8   ![    ?P   (,   "'
MB@   (T   ".    D0   ),   "5    F    )H%  "=#   H!$  *,:  "C
M*   HCH  *%.  "@90  H($  )Z@  "=P0  F^X  )K_ $99   Y7   +6$
M "%G   6;@  #G4   5[    @0   (<   "-    D@   )8   ":    G0
M )\   "A    I    *8   "H    JP   *X   "Q P  M L  +@1  "Y'@
MN2\  +A#  "W6@  M78  +27  "TM0  L>(  +#\ #]D   Q:0  )6\  !AW
M   /?P  !H<   ".    E    )H   "@    I0   *H   "N    L0   +(
M  "U    MP   +H   "\    OP   ,,   #&    R0   ,X*  #2$P  TB,
M -$W  #03P  SFH  ,V*  #*JP  R\L  ,OO #=Q   I>   '8   !&)   (
MD0   )H   "A    IP   *T   "S    N0   +X   #"    Q0   ,8   #)
M    S    ,X   #2    U0   -H   #>    X0   .4   #J"P  ZQ<  .HK
M  #J0P  ZEX  .IZ  #KF0  Z[4  .O5 /\   #_    _P ! /\ !P#_  T
M_P 2 /\ &P#_ "4 _P O /\ .@#_ $, _P!+ /\ 4P#_ %H _0!@ /L 9@#Z
M &L ^ !R /8 > #T (  \0") .\ D@#L )T Z0"J .8 O #C -P WP#W -T
M_P#, /\ O@#_ +4 _P"P /\ K0#_ /\   #_    _P   /\   #_  8 _P -
M /\ % #_ !\ _P I /L ,P#W #T \P!% .\ 30#L %, Z !9 .4 7P#C &4
MX !J -T <0#: '@ U@"  -( B@#/ )4 S "B ,@ L@#% ,D P@#M ,  _P"[
M /\ L #_ *@ _P"D /\ H0#_ /\   #_    _0   /H   #X    \  ) .P
M$0#H !D YP C .4 +0#> #8 U@ ^ -$ 1@#- $P R@!2 ,@ 6 #% %T PP!C
M ,  :0"^ '  O !X +D @0"W (T M ": +$ J0"N +P K #A *H _ "H /\
MH #_ )D _P"6 /\ E #_ /\   #Y    \@   .<   #;    T0 $ ,H #0#'
M !0 Q  = ,( )@"_ "\ NP W +< /P"T $4 L0!+ *X 40"L %8 J@!< *@
M80"F &@ HP!P *$ >0"? (0 G0"1 )H H "8 +$ E@#, )4 \0"4 /\ D0#_
M (L _P"( /\ A@#_ /<   #L    W@   ,D   "\    M    *\ "@"K !
MJ0 7 *@ ( "G "@ H@ P )\ . "< #X F@!$ )@ 2@"6 $\ E !5 ), 6@"1
M &$ CP!H (T <0"+ 'L B0"( (< EP"% *@ @P"^ ($ Y "  /\ @ #_ 'P
M_P![ /\ >0#_ .D   #7    P0   +$   "F    G0   )< !0"4  T D@ 2
M )  &@"/ "( C@ J (L ,0") #@ AP ^ (4 0P"# $@ @0!. '\ 5 !^ %H
M? !A 'H :0!X ', =@!_ '4 C@!S )\ <0"S '  T !O /8 ;P#_ &\ _P!M
M /\ ; #_ -H   "_    K    )X   "3    C    (4   ""  D ?P / 'X
M%0!] !P ?  D 'H *P!W #$ =0 W '0 /0!R $( <0!( &\ 30!N %, ; !:
M &L 8@!I &P 9P!X &8 A@!D )< 8@"J &$ P@!@ .L 80#_ &$ _P!A /\
M8 #_ ,4   "M    FP   (T   "#    ?    '<   !R  4 <  , &X $0!L
M !< ;  > &L )0!I "P 9P Q &8 -P!D #T 8P!" &( 2 !@ $X 7P!5 %T
M70!< &8 6@!R %D @ !7 )  5@"C %4 N0!4 -X 5 #[ %0 _P!5 /\ 50#_
M +8   "?    C0   '\   !U    ;@   &D   !F  $ 8P ) &$ #@!@ !,
M7P 9 %X ( != "8 6P L %H ,@!8 #< 5P ] %8 0P!5 $D 4P!0 %( 6 !1
M &$ 3P!L $X >@!, (H 2P"< $H L0!) ,X 20#S $D _P!) /\ 2@#_ *H!
M  "4!0  @@<  '0(  !J"   8P8  %X$  !;    60 % %< # !6 !  5  5
M %, &P!2 "( 40 H %  +0!. #, 30 X $P /@!+ $4 2@!, $@ 5 !' %T
M1@!H $0 =0!# (4 00"8 $  JP!  ,4 /P#J #\ _P!  /\ 0 #_ * (  "*
M"P  >0T  &P-  !A#0  6@T  %4+  !2"0  4 8  $\"" !.  T 3  2 $L
M%P!* !X 20 C $< *0!& "\ 10 T $0 .@!" $$ 00!( $  4  ^ %H /0!D
M #P <@ Z (( .0"4 #@ IP W +X -@#C #8 ^0 V /\ -P#_ )@-  "##@
M<A   &41  !;$0  4Q   $X0  !*#@  2 T  $<* P!'!PH 100. $0"$P!"
M AH 00(@ $ #)0 ^ RL /00Q #P$-P [!#X .@5% #D%3@ W!5< -@5B #0&
M<  R!H  ,0:2 # &I0 O!;L +@7= "X&]0 M!_\ +@?_ )$0  !]$0  ;!,
M %\4  !5%   3A0  $@3  !$$@  01   $ .  ! #08 0 H, #X)$  \"18
M.PH< #D*(@ X"B@ -PLN #8+-0 U"SL ,PM# #(,3  P#%8 +PQA "T,;P K
M#'\ *@R2 "@,I0 G#+L )0S= "4-]0 F#?\ )PW_ (L2  !W%   9Q8  %L7
M  !1&   21<  $,7   _%0  /!0  #H2   Y$0$ .0\( #@.#0 W#A( -0X8
M #0.'P R#B4 ,0\L # /,@ O$#H +1!" "P02P J$%4 *!!A "80;P D$(
M(Q"3 "$0IP ?$+T 'A#@ !X1]P ?$/\ (!#_ (84  !S%P  8QD  %<:  !-
M&P  11H  $ :   [&0  .!@  #46   T%   ,Q($ #(2"P Q$A  +Q(5 "T2
M'  L$R( *Q,I "H3,  H$S< )Q0_ "842  D%%, (A1? " 5;0 ?%7X '161
M !L5I0 9%;L &!7> !@5^  9%/\ &A3_ ((7  !O&@  7QP  %,=  !*'0
M0AT  #P=   W'   -!L  #$:   O&0  +A8  "P7"  K%@X *1<3 "@7&0 G
M&"  )1@F "08+0 C&#0 (AD] " 91@ >&5$ '1E= !L::P 9&GP %QJ/ !4:
MHP 4&;H $AG; !,9]@ 4&?\ %1C_ 'T:  !K'0  7!\  % @  !'(   /R
M #D?   T'P  ,1X  "T=   K'   *1L  "<;!0 E&PP )!P1 "(<%@ A'!T
M(!TC !\=*@ >'3( '!XZ !L>1  9'DX %QY; !8>:0 4'WH $AZ- !$>H@ 0
M'K@ #A[8  \>]0 0'?\ $1W_ 'H=  !G'P  62$  $TB  !$(@  /"(  #8B
M   R(0  +B$  "H@   G(   )!\  "(@ @ @( H 'B$/ !TA%  <(1H &R(A
M !DB)P 8(B\ %R(X !4C00 4(TP $B-8 !$C9P 0(W@ #B.+  TCGP ,([0
M"R/0  LB\  ,(O\ #2'_ '8?  !D(@  5B,  $LD  !!)   .B0  #0D   O
M(P  *R,  "@C   D(P  (",  !TD   ;)0< &28- !<F$0 6)A< %2<> !0G
M)0 3)RP $B<U !$H/P 0*$H #BA6  TH9  ,*'0 "BB'  DHFP ')[$ !2?,
M  8G[  ')OX "";_ '$B  !@)   4R8  $@G   _)P  -R8  #$F   M)@
M*24  "4E   B)0  '2<  !DH   6*@0 %"L+ !(L$  1+!0 $"P; ! L(@ .
M+"D #BTR  TM.P ++48 "BU2  @M8  &+7  !"V#  (MF   +*X  "S)   L
MZP !*_P  BO_ &TE  !=)P  3R@  $4I   \*0  -2D  "\H   K*   )R<
M ",G   ?*   &RH  !<L   3+@( $# (  XQ#0 -,1( ##$7  LQ'@ *,28
M"#(N  <R-P %,D(  S).  $R7   ,FP  #)_   RE0  ,:P  #''   PZ@
M,/P  ##_ &@I  !8*@  3"L  $$L   Y+   ,BL  "TK   I*@  )2H  " K
M   <+   %RX  !,P   0,@( #C0'  HW#  '-Q  !3<4  ,W&P "-R(  #<J
M   X,P  .#X  #A*   X6   .&@  #A\   WD@  -ZD  #;%   VZ@  -OT
M #7_ &,L  !4+@  2"\  #XO   V+@  ,"X  "LM   G+0  (BT  !TO   8
M,0  %#,  ! U   .-P$ "CH'  8["P "/ X  #T2   ^%P  /AX  #XF   ^
M+P  /CH  #Y&   ^5   /F0  #YW   ^CP  /:<  #W#   \Z0  //T  #O_
M %XP  !0,0  1#(  #LR   T,0  +C   "DO   D,   'C(  !DT   4-@
M$#D   T[   */0  !4 %  !!"@  0@T  $,0  !$%   11H  $8B  !&*P
M1C4  $9!  !&3P  1E\  $9S  !%B@  1:0  $3   !#Z   0_X  $+_ %@T
M  !+-0  034  #DU   R-   +3,  "8T   @-0  &C@  !0Z   0/0  #4
M  E"   $10   $<#  !(!P  2@L  $L.  !,$0  3A4  $\<  !/)0  3R\
M $\\  !/2@  3UH  $YM  !.A0  3:   $R\  !+YP  2_X  $K_ %,Y  !'
M.0  /CD  #<X   Q-P  *3<  "$Y   ;/   %3\  !!"   ,10  !T@   )*
M    30   $\   !1!   4@<  %0+  !5#@  5Q$  %D7  !:'P  62D  %DV
M  !91   650  %AG  !8?P  5YH  %:W  !5XP  5/T  %3_ $X]  !#/0
M/#P  #4[   L/   )#X  !Q!   51   $$@   M+   %3@   %$   !4
M5P   %D   !;    70(  %X&  !@"P  8@X  &02  !G&   9R(  &8N  !F
M/   9DT  &5@  !E=P  9),  &.Q  !AW0  8/P  %__ $E"  !!00  .C\
M #!    F0P  'D8  !5*   03@  "E(   -6    6@   %T   !@    8P
M &4   !G    :0   &L!  !M!0  ;PH  '(.  !U$@  =QL  '8F  !V-0
M=48  '19  !T;P  <XL  '*I  !PS0  ;_<  &[_ $9&  ! 10  -48  "I(
M   @3   %U$  !!6   )6@   5\   !C    :    &L   !O    <@   '4
M  !W    >0   'L   !]    @ ,  (,(  "&#0  B1,  (H=  "**P  B3P
M (A/  "&9@  A8$  (2@  ""P@  @?   '__ $9+   Z3   +D\  "-3   8
M6   $%X   ED    :0   &\   !T    >    'P   "!    A    (<   "(
M    BP   (X   "0    DP   )8   "9!P  G0T  *$4  "@(0  H#$  )Y$
M  "=6P  G'8  )F6  "9M0  EN4  )7^ #]2   R50  )EH  !M@   19P
M"6T   !T    >P   ($   "&    BP   )    "4    EP   )D   "<
MGP   *$   "D    IP   *H   "M    L08  +4-  "X%@  MR8  +8Y  "U
M4   M&H  +*)  "PJ@  KL\  *WU #=<   K80  'F@  !-P   +>    (
M  "'    C@   )4   ":    GP   *0   "H    K    *T   "P    LP
M +4   "X    NP   +\   ##    QP   ,L%  #1#@  T1L  - N  #/10
MS5\  ,M^  #)G@  R+X  ,7I "]I   C<   %GD   V!   !BP   ),   ";
M    H@   *@   "N    M    +@   "]    P    ,(   #%    R    ,L
M  #.    T0   -8   #;    WP   .0   #H!@  ZQ$  .HC  #J.@  Z50
M .=R  #EDP  X[,  ./4 /\   #_    _P   /\ ! #_  L _P 0 /\ %P#_
M "$ _P K /\ -0#_ #X _P!' /\ 3@#_ %4 _ !; /H 80#X &8 ]@!M /0
M<P#R 'L [P"$ .T C@#J )D Y@"G ., N0#? -4 VP#W -8 _P#  /\ L@#_
M *H _P"E /\ H@#_ /\   #_    _@   /P   #\  , _@ + /\ $0#_ !H
M_0 D /D +@#T #@ \ !  .P 2 #I $X Y@!4 .( 6@#? %\ W !E -@ :P#4
M '( T ![ ,T A0#* )$ QP"> ,, K@#  ,4 O0#K +L _P"P /\ I #_ )P
M_P"8 /\ E0#_ /\   #Z    ]    /$   #R    Z@ % .< #@#B !4 X0 >
M .$ * #8 #$ T  Y ,L 0 #( $< Q0!- ,( 4P"_ %@ O0!> +L 9 "Y &L
MM@!S +0 ? "Q (@ K@"5 *L I "H +@ I@#< *, ^P"? /\ E0#_ (\ _P"+
M /\ B0#_ /D   #O    YP   -\   #/    R    ,$ "@"_ !$ O  8 +L
M(0"Y "H M  R +$ .@"N $  JP!& *@ 3 "F %$ HP!6 *$ 7 "? &, G0!J
M )L <P"9 'X E@", )0 FP"2 *T D #' (X \ "- /\ A@#_ (  _P!] /\
M? #_ .T   #@    T0   +\   "S    J@   *8 !0"B  T H0 3 *  &P"?
M ", FP K )@ ,@"5 #D DP _ )$ 1 "/ $H C@!/ (P 50"* %L B !C (8
M:P"$ '8 @@"" (  D@!^ *, ? "Z 'H X0!Y /\ =P#_ '( _P!P /\ ;P#_
M -T   #+    M@   *<   "=    E    (X  0"+  H B0 0 (@ %0"' !T
MAP E (0 + "" #( ?P X 'T /0![ $, >0!( '@ 3@!V %0 =0!; ', 8P!Q
M &X ;P!Z &T B0!L )H :@"N &D S !H /8 9P#_ &4 _P!D /\ 8P#_ ,H
M  "T    H0   ),   ")    @@   'L   !X  4 =@ , '4 $0!T !@ <P ?
M '( )0!P "P ;@ R &P -P!J #P :0!" &@ 2 !F $X 90!5 &, 70!B &8
M8 !R %X @ != )( 6P"E %H O@!9 .D 60#_ %D _P!8 /\ 6 #_ +D   "B
M    D    (,   !Y    <0   &T   !I  $ 9@ ) &4 #@!D !, 8P 9 &,
M( !A "8 8  L %X ,0!< #< 6P \ %H 0@!8 $@ 5P!/ %8 5P!4 &  4P!L
M %$ >0!0 (H 3P"> $X M !- -H 30#[ $T _P!- /\ 30#_ *H   "4
M@@   '4   !K    9    &    !=    6@ % %@ # !7 !  5@ 5 %8 &P!5
M "$ 4P G %( + !1 #$ 3P W $X /0!- $, 3 !* $H 4@!) %L 2 !F $8
M<P!% (0 1 "7 $, K !" ,D 0@#Q $( _P!# /\ 0P#_ )X   ")    > ,
M &H$  !A!   6@,  %4!  !2    4  " $X "0!-  T 3  1 $L %P!* !P
M20 B $@ )P!' "T 10 R $0 . !# #X 0@!% $$ 30 _ %8 /@!A #T ;@ [
M 'X .@"1 #D I@ X +\ . #H #@ _P Y /\ .0#_ )4#  " !P  ;PD  &(*
M  !8"P  40H  $P(  !)!@  1P,  $8 !@!$  L 0P / $( $P!! !@ 00 >
M #\ (P ^ "D /0 N #L -  Z #H .0!! #@ 20 W %( -@!= #0 :@ S 'H
M,@", #$ H0 P +@ +P#> "\ ^0 O /\ , #_ (P)  !X#   : T  %P.  !2
M#@  2PX  $4-  !!#   /PH  #X( @ ]! @ / $- #L $  Z !4 .0 : #@
M(  V "4 -0 K #0 ,  S #< ,@ ^ #$ 1@ O %  +@!: "T 9P K '< *@")
M "D G0 H +, )P#1 "< \@ G /\ )P#_ (8,  !R#@  8Q   %81  !-$0
M11$  $ 0   \#P  .0X  #<-   V"P0 -@@* #4&#@ T!1( ,@07 #$%'  P
M!2( +P4H "X&+@ M!C0 *P8\ "H&1  I!TX )P=9 "8'90 D!W4 (P>' "('
MFP @!K  ( ;+ !\%[0 ?!OX 'P?_ ( .  !M$0  7A(  %(3  !($P  01,
M #L3   W$@  -!$  #(0   P#P$ , T& # +"P O"A  +0H4 "P+&0 J"Q\
M*0LE "@,*P G##( )@PZ "0,0P C#$T (0U8 " -90 >#74 ' V( !H-G  9
M#;$ & S* !<,ZP 7#?P & S_ 'L1  !I$P  6A4  $X6  !%%@  /18  #@5
M   S%0  ,!0  "T3   K$@  *A # "H/"  I#@T * X1 "8.%@ E#QT ) \C
M ",/*0 A$#$ (! Y !X00@ =$$P &Q!8 !D09@ 7$'8 %1") !00G@ 2$+,
M$1#. !$0[@ 2$/X $A#_ '<3  !E%0  5Q<  $L8  !"&0  .AD  #08   P
M%P  +!<  "D6   G%0  )A0! "42!  C$@L (A(/ "$2%  @$AH 'A,@ !T3
M)P <$RX &A,V !D40  7%$H %A16 !049  2%'0 $12' ! 4G  .%+$ #13*
M  T4ZP .$_X #A/_ ',5  !A&   4QH  $@;   _&P  -QL  #(:   M&@
M*1D  "88   D&   (A<  " 6 0 >%@@ '18- !L7$@ :%Q< &1<= !@8)  6
M&"L %1@T !08/0 2&4@ $1E4 ! 98@ .&7( #1F$  P9F  *&:T "1C&  D8
MYP )&/H "A?_ &\8  !>&@  4!P  $4=   \'0  -1T  "\=   J'   )AL
M ",;   A&@  'AH  !P:   :&P4 &!L, !8<$  5'!4 %!P; !,<(@ 2'2D
M$1TQ ! =.P .'44 #1Y1  P>7@ *'FT "1Z   <>E  %':H  QW"  ,=Y@ $
M'/@ !1S_ &L:  !;'0  31X  $(?   Z'P  ,A\  "T?   H'@  )!X  "$=
M   >'0  '!T  !@>   5'P( $R ) !(A#@ 0(1( $"$8  XA'P .(B8 #2(N
M  PB-P *(D$ "2)-  <B6@ %(FD  R)\  $BD0  (J@  "'    AY0  (/@
M "#_ &<=  !7'P  2B$  $ A   W(@  ,"$  "HA   F(   (B   !\?   <
M'P  &2   !8A   2(P( $"0'  XF#  ,)A  "R85  HF'  ))B( ""8J  8G
M,P $)ST  R=)  $G5@  )V8  "=Y   GCP  )J8  ":_   EY   )?D  "3_
M &,@  !4(@  1R,  #TD   T)   +B,  "@C   D(@  (2(  !XA   :(@
M%R,  !,D   0)@( #B@'  LJ"P (*PX !BL3  0K&  "*Q\  2PG   L,
M+#H  "Q%   L4P  +&,  "QV   LC   *Z0  "N^   JY   *OH  "G_ %\C
M  !0)0  1"8  #HF   R)@  *R8  "8E   C)   'R0  !LD   7)0  %"<
M !$I   .*P( "RT&  <O"P $, X  # 1   Q%0  ,1P  #$C   R+   ,C8
M #)"   R3P  ,E\  #)R   QB0  ,:(  #"\   PY   +_L  "__ %HG  !,
M*   0"D  #<I   O*0  *2@  "4G   A)@  '"<  !@H   4*@  $2P   XN
M   +, $ !S(%  ,T"0  -0P  #8/   W$@  .!@  #@@   X*   .#(  #D]
M   Y2P  .5L  #AN   XA0  -Y\  #>Z   VY   -?P  #7_ %4J  !(+
M/2P  #0L   M*P  *"H  "0I   >*@  &2L  !0M   1+P  #3$   HT   '
M-@   C@$   Z!P  .PH  #T-   ^$   0!0  $ ;  ! )   0"X  $ Y  !
M1P  0%8  $!I  ! @   /YL  #ZW   ]XP  //P  #S_ % O  !#+P  .2\
M #(O   L+0  )RP  " M   :+P  %3$  !$S   --@  "3@   4[    /0
M $ !  !!!   0P<  $4+  !&#@  2!$  $H6  !*'@  2B@  $HT  !)0@
M25$  $ED  !(>P  2)<  $>T  !&X   1?P  $3_ $HS   _,P  -C,  # Q
M   J,   (S$  !PS   6-0  $3@   T[   (/@   T$   !#    1@   $@
M  !*    3 0  $X'  !/"P  40X  %02  !5&0  52(  %0N  !4/   5$L
M %->  !3=   4I   %&N  !0UP  3_L  $[_ $4W   \-P  -38  "\T   F
M-0  'C<  !<Z   1/0  #$$   =$    2    $H   !-    4    %,   !5
M    5P   %@"  !;!@  70L  %\.  !B$P  8AL  &(G  !B-   844  &!7
M  !@;0  7XD  %VG  !<S   6O@  %G_ $$\   Z.P  -#D  "HZ   A/
M&$   !%#   ,1P  !DL   !/    4P   %8   !9    7    %\   !A
M8P   &4   !G 0  :@4  &T*  !P#@  <Q4  '(@  !R+0  <3T  '!/  !O
M90  ;H   &V?  !KP0  :?$  &C_ #]    Y/@  +C\  "1"   :1@  $DH
M  Q/   $5    %@   !=    80   &4   !H    :P   &X   !Q    <P
M '4   !X    >P   'X#  "!"@  A0\  (<7  "&)   A30  (1&  ""70
M@78  '^6  !^M@  ?.<  'K_ #]$   S10  *$@  !U,   34@  #%<   -=
M    8P   &@   !M    <0   '8   !Z    ?@   ($   "#    A@   (D
M  "+    C@   )(   "5 0  F0D  )X0  ">&@  G2D  )P\  ":4@  F&P
M ):+  "4J@  DM0  )#Z #A+   L3@  (%,  !59   -8    V<   !N
M=    'H   "     A    (H   ".    D@   )4   "7    F@   )T   "@
M    HP   *<   "K    KP   +0)  "X$   MQX  +4P  "S1@  L6   *]^
M  "LH   J\$  *GN #%5   D6P  &&$   YI   %<0   'D   "!    B
M (\   "4    F@   )\   "D    J    *D   "L    KP   +,   "U
MN0   +T   #!    Q@   ,L   #1"@  TQ0  -$E  #0.P  S50  ,IQ  #(
MD@  Q;,  ,/> "EB   <:0  $7$   =[    A    (T   "5    G0   *,
M  "I    KP   +0   "Y    O    +X   #"    Q0   ,@   #,    T
M -0   #:    WP   .0   #J    [@P  .T:  #L+P  ZDD  .AE  #FA@
MY*4  .+& /\   #_    _P   /P  0#\  @ _@ . /\ % #_ !T _P F /\
M, #_ #H _P!" /\ 20#^ %  ^P!6 /D 7 #V &( ] !H /( ;P#P '8 [0!_
M .H B0#G )4 Y "C .  M0#; -  U0#V ,H _P"V /\ J #_ )\ _P": /\
ME@#_ /\   #[    ]@   /,   #S    ]@ ) /H #@#] !8 ^P @ /< *@#R
M #, [0 [ .D 0P#F $D X@!/ -X 50#; %L U@!@ -( 9P#/ &X S !V ,D
M@ #& (P P@": +\ J@"[ ,$ N #I +8 _P"G /\ F@#_ )( _P"- /\ B@#_
M /H   #Q    Z@   .<   #G    Y  ! .  "P#; !$ V@ : -L (P#1 "P
MR@ T ,8 .P#" $( OP!( +P 3@"Z %, N !9 +8 7P"S &8 L0!N *X =P"L
M (, J0"1 *8 H0"C +4 H #8 )X ^P"5 /\ BP#_ (4 _P"  /\ ?@#_ .\
M  #C    V@   -,   #&    OP   +D !@"W  X M  4 +0 '0"S "4 K@ M
M *L - "G #L I !! *$ 1@"? $P G0!1 )L 5P"9 %X EP!E )4 ;@"3 'D
MD "' (X EP", *D B0#$ (@ [P"% /\ ? #_ '8 _P!S /\ <@#_ .    #0
M    Q@   +8   "I    H0   )T  0"9  H F  0 )@ %@"7 !X E  F )$
M+0"/ #0 C  Z (H /P"( $4 AP!* (4 4 "# %8 @0!> (  9@!^ '$ ? !]
M 'D C0!W *  =0"V ', WP!R /\ ;@#_ &D _P!G /\ 90#_ ,P   "^
MJP   )T   "3    B@   (4   ""  4 @  - '\ $0!_ !@ @  @ 'T )@!Z
M "T =P S '4 . !T #X <@!# '  20!O $\ ;0!6 &P 7@!J &@ : !U &<
MA !E )8 9 "K &( R0!A /8 8 #_ %P _P!; /\ 6@#_ +T   "I    EP
M (D   !^    >    ',   !O  $ ;0 ) &P #@!K !, :P 9 &H ( !H "8
M9@ L &4 ,@!C #< 8@ \ &  0@!? $@ 70!/ %P 5P!: &$ 60!M %< >P!6
M (X 50"B %, NP!2 .D 4@#_ %  _P!/ /\ 3P#_ *T   "8    A@   '@
M  !N    9P   &,   !@    70 % %P "P!; !  6P 5 %L &P!: "$ 6  F
M %8 + !4 #$ 4P V %( / !1 $( 3P!) $X 40!- %L 2P!F $H = !) (4
M2 "9 $< L0!& -@ 1@#\ $4 _P!% /\ 10#_ )\   ")    >    &P   !B
M    6P   %8   !3    40 " $\ " !/  T 3@ 1 $X %@!- !P 3  A $H
M)@!) "P 2  Q $< -P!% #T 1 !$ $, 3 !" %4 0 !@ #\ ;@ ^ 'X /0"2
M #P J0 [ ,< .P#S #L _P [ /\ / #_ ),   !^    ;@   &$   !8
M40   $P   !)    1P   $4 !0!$  L 0P . $, $@!# !< 0@ = $  (@ _
M "< /@ L #T ,@ [ #@ .@ _ #D 1P X %  -P!; #4 :  T '@ ,P", #(
MH@ Q +P ,0#G #$ _P R /\ ,P#_ (D   !V P  9@4  %D'  !0!P  208
M $,%  !  P  /@$  #P  P [  @ .@ - #H $  Y !0 .0 9 #< '@ V ",
M-0 H #0 +@ S #0 ,@ [ #  0P O $P +@!7 "T 9  L ', *P"' "H G  I
M +4 *0#< "D ^P I /\ *@#_ ($$  !N"   7PH  %,+  !*"P  0@L  #T*
M   Y"0  -@@  #4%   T @8 ,P * #( #@ Q !$ ,0 5 #  &@ O !\ +@ D
M "P *@ K #  *@ W "D /P H $D )P!4 "8 8  D &\ (P"" "( EP A *X
M(0#, "$ \P A /\ (@#_ 'L)  !H#   6@T  $X.  !%#@  /0X  #@-   S
M#0  , P  "X+   M"0, +08( "P$#  K @\ *@$2 "D!%P H 1P )P A "8
M)P E "T )  T ",!/0 B 48 (0%1 !\!70 > 6P ' %_ !L E  : *H &@#%
M !H ZP 9 /\ &@#_ '4,  !D#@  50\  $H0  ! $   .1   #,0   O#P
M+ X  "D.   G#0$ )PP% "<*"@ F" T )0<0 "0&%  B!AD (08? " ')  ?
M!RL '@<R !T'.@ <"$0 &@A/ !D(7  7"&L %@A] !4'D0 4!Z< $P:_ !(%
MY  2!?H $@7_ '$.  !?$   41$  $82   ]$@  -A(  # 2   K$0  *!$
M "40   C$   (@X$ "$-!P A# L ( L. !\+$@ ="Q< ' P< !L,(@ :#"D
M&0PQ !@,.0 6#4, %0U/ !,-7  2#6L $ U^  \-D@ .#:< #0R^  T,X  -
M#/4 #0S_ &T0  !<$0  3A,  $,4   Z%   ,A0  "T4   H$P  )1,  "(2
M   @$0  'A$# !P0!0 <#P@ &P\, !H.$  9#Q0 %P\: !8/(0 5$"@ %! P
M !(0.0 1$$0 $!!0  X070 -$&L #!!\  L0D  )$*4 "!"\  <0WP '$/0
M!P__ &D1  !8%   2Q4  $ 6   W%@  ,!8  "H6   F%0  (A4  !\4   =
M$P  &A," !D2!  7$@8 %A(* !42#@ 4$A( $A(8 !$3'@ 1$R4 $!,N  X3
M-P -%$  #!1+  L46  )%&< !Q1X  84C0 $%*,  Q.[  (3W0 !$O0  A+_
M &43  !5%@  2!<  #T8   T&   +1@  "@8   C%P  (!<  !T6   :%0
M&!4" !85!  4%04 $A8( !$6#0 0%Q  #A<5  X7&P -%R( #!<I  L8,@ )
M&#P !QA'  485  $&&,  AAU  $8BP  %Z$  !>Y   7W0  %O4  !;_ &$6
M  !2&   11H  #L:   R&@  *QH  "4:   A&0  'A@  !L8   8%P  %A<"
M !07 P 2& 4 $!D'  X;"P ,&P\ "QL3  H;&  ('!\ !QPF  4<+P $'#@
M AQ$   =40  '6   !UR   <B   '*   !NY   ;W@  &O8  !K_ %X8  !/
M&@  0AP  #@<   O'0  *1P  ",<   ?&P  '!H  !D9   7&0$ %!D" !(:
M P 0&P0 #AT'  P>"P )'PX !B 1  4@%@ #(!P  2$C   A*P  (34  "%
M   A3@  (5T  "%O   AA@  ()X  ""X   ?W@  'O@  ![_ %H;  !+'0
M/QX  #4?   M'P  )QX  "(=   >'0  &QP  !@;   5&P  $AP  ! = @ .
M'P0 #"$&  DB"@ %(PT  B00   E$P  )1D  "8@   F*   )C(  "8]   F
M2@  )EH  "9L   F@P  )9P  "6W   DWP  (_D  "/_ %4>  !'(   /"$
M #(A   K(0  )2   " ?   ='@  &AT  !8>   3'@  $"    XA   ,(P(
M""4%  4G"0  * L  "H.   K$0  +!8  "P=   L)0  +"X  "PZ   L1P
M+%8  "QI   L@   *YH  "JU   IWP  *?L  "C_ %$B  !$(P  ."0  "\D
M   H(P  (R(  !\A   <(   %R   !,A   0(P  #B0   LF   (*   !"H$
M   L!P  +@D  # ,   Q#P  ,Q,  #,9   S(0  ,RH  #,U   S0P  ,U(
M #-E   R>P  ,I<  #&S   PW@  +_L  "[_ $PE   _)@  -2<  "TF   G
M)0  (B0  !XC   9(P  %"0  !$F   .*   "RH   <L   #+P   #$"   S
M!   -0<  #<*   Y#0  .A   #L5   ['0  .R8  #LQ   [/@  .TX  #M@
M   Z=P  .9(  #BP   WVP  -OP  #7_ $<I   [*@  ,BH  "LI   E)P
M(28  !LG   5*   $2H   XL   *+P  !C$   $T    -@   #@    [ 0
M/00  #\'  !!"@  0PX  $41  !%&   12$  $4L  !$.0  1$@  $1;  !#
M<0  0HT  $&K  ! T@  /_H  #[_ $(M   X+@  +RT  "DK   D*@  '2H
M !<L   1+@  #3$   DT   $-P   #H    \    /P   $$   !$    1@
M $@#  !*!P  3 L  $X.  !0$P  4!P  % G  !/-   3T,  $]5  !.:@
M388  $RD  !*R@  2?@  $C_ #XR   U,0  +B\  "DN   @+@  &3$  !(S
M   .-P  "3H   (]    0    $0   !'    20   $P   !/    40   %,
M  !5 0  6 8  %H+  !=#@  7Q4  %X@  !>+   73P  %Q.  !;8P  6GX
M %B=  !7P   5?(  %3_ #HV   S-   +3(  "0S   ;-@  $SD   X]   (
M00   $4   !)    3    %    !3    5@   %D   !;    70   &    !B
M    90   &@%  !K"P  ;Q   &\8  !N)0  ;30  &U&  !K6P  :G4  &B4
M  !FM@  9.D  &+_ #@Y   R-P  *#D  !X[   5/P  #D0   =)    30
M %(   !6    6@   %X   !B    90   &@   !K    ;0   '    !S
M=@   'D   !]!   @0L  (41  "$'0  @BP  ( ^  !^5   ?FL  'N*  !Z
MJ@  =]8  '7] #@]   L/@  (D$  !=&   /2P  !U$   !7    7    &(
M  !F    :P   &\   !T    >    'L   !^    @    (,   "&    B@
M (T   "1    E@,  )L,  "=$P  FR$  )HS  "720  E&(  )-_  "0H
MCL4  (SS #%$   E2   &DT  !!3   (6@   &$   !H    ;@   '0   !Y
M    ?P   (0   ")    C0   )$   "3    E@   )D   "=    H    *0
M  "H    K    +(#  "W#0  MQ<  +4H  "R/@  L%8  *QS  "JE   J;0
M *7E "I/   >5   $EL   IB    :@   ',   ![    @@   (D   ".
ME    )H   "?    I    *8   "I    K0   +    "S    MP   +L   #
M    Q0   ,L   #1!   U0X  -,=  #0,@  S4L  ,IF  #&AP  PJD  ,'+
M ");   68@  #&L   %T    ?0   (<   "0    EP   )X   "D    JP
M +$   "V    N@   +P   #     Q    ,@   #+    SP   -0   #:
MX    .8   #K    \08  / 3  #N)P  [#\  .I;  #G>@  Y)L  ."[ /\
M  #[    ]@   /,   #T  4 ]@ , /H $0#_ !D _P B /\ + #_ #4 _P ]
M /\ 10#\ $P ^@!2 /< 6 #U %X \P!D /$ :@#N '( [ !Z .D A0#E )$
MX0"@ -T L@#8 ,X T@#V ,$ _P"M /\ G@#_ )8 _P"0 /\ C #_ /H   #R
M    [    .D   #I    [  % /( # #X !( ]P ; /4 )0#P "X ZP W .8
M/@#B $4 W0!+ -@ 4 #3 %8 T !< ,T 8@#* &H R !R ,4 ? #" (@ O@"6
M +H J "W +\ M #H *X _P"= /\ D #_ (@ _P"# /\ @ #_ /    #E
MW@   -H   #;    W    -@ !P#1  X T0 5 -( '@#+ "< Q0 O ,  -P"]
M #T N@!$ +< 20"U $\ L@!5 +  6P"N &$ K !I *D <P"G '\ I "- *$
MG@"> +( FP#5 )D _ ", /\ @@#_ 'L _P!V /\ = #_ .(   #3    R@
M ,<   "\    M@   +   0"O  L K  1 *T & "M "  J  H *0 +P"@ #8
MG0 \ )L 0@"9 $< EP!- )4 4P"3 %D D0!A (\ :@", '4 B@"# (@ E "&
M *< @P#" (( \ !\ /\ <P#_ &T _P!J /\ : #_ ,\   #!    N0   *T
M  "@    F    )0   "1  8 D  - )  $@"/ !D C@ A (L * "( "\ A@ U
M (0 .@"" $  @ !% 'X 2P!\ %( >@!9 '@ 8@!V &P = !Y '( B0!Q )T
M;P"T &T WP!L /\ 90#_ &  _P!> /\ 7 #_ +X   "Q    H    )(   ")
M    @@   'P   !Z  $ >  ) '< #@!X !0 =P : '0 (0!R "< <  M &X
M,P!L #@ :P ^ &D 1 !H $H 9@!1 &0 6@!C &0 80!P %\ ?P!> ), 70"I
M %P R !; /< 5P#_ %0 _P!2 /\ 40#_ +    "?    C0   '\   !T
M;@   &H   !F    90 $ &, "P!C !  8P 5 &, &P!A "$ 7P G %T + !<
M #( 6@ W %D /0!7 $, 5@!+ %4 4P!3 %P 4@!H %  =P!/ (D 3@"? $T
MN@!, .D 2P#_ $D _P!' /\ 1P#_ *(   "-    ?    &X   !E    7@
M %D   !7    50 ! %0 !P!3  T 4P 1 %0 %@!2 !L 40 A $\ )@!. "L
M3  Q $L -P!* #T 20!$ $< 3 !& %8 1 !A $, < !" ($ 00"7 $  KP _
M -< /P#_ #X _P ] /\ /@#_ )0   !_    ;P   &,   !9    40   $T
M  !*    2    $< ! !'  H 1@ . $8 $0!' !8 10 < $0 (0!" "8 00 K
M $  ,0 ^ #< /0 ^ #P 1P Z %  .0!; #@ :0 W 'H -@"/ #4 IP U ,8
M- #U #0 _P T /\ -0#_ (@   !T    90   %@   !/    2    $,    _
M    /0   #P  @ \  < .P , #L #P [ !( .@ 7 #D '  W "$ -@ F #4
M+  T #( ,P Y #$ 00 P $L +P!6 "X 8P M ', + "( "P H  K +L *P#J
M "L _P K /\ + #_ '\   !L    70$  %$"  !( P  0 ,  #L"   W
M-    #,    R  4 ,@ ) #( #0 Q !  ,0 3 #  &  O !T +0 B "P *  K
M "X *@ U "D /0 H $8 )P!1 "8 7@ E &X ) "" ", F0 C +, (@#> "(
M_P C /\ ) #_ '<   !E!   5@8  $L'  !""   .@@  #4'   P!@  +04
M "P#   K  , *@ ' "D "P I  X *0 1 "@ %0 G !D )@ > "4 )  D "H
M(P Q "( .0 A $, ( !. !\ 6@ > &D '0!\ !P DP ; *P &P#- !L ]@ ;
M /\ ' #_ ' %  !?"   40H  $8+   ]"P  -0L  # +   K"@  * D  "4(
M   D!P( (P0& ",""0 B 0P (@ / "$ $@ @ !8 'P ; !X (  = "8 '  N
M !L -@ : #\ &0!* !@ 5P 7 &8 %@!X !4 CP 5 *8 % ## !0 [@ 4 /\
M%0#_ &L(  !;"P  30P  $(-   Y#0  ,0T  "P-   G#0  (PP  "$,   ?
M"P$ '@H% !T("  =!@L ' 4- !P$$  ;!!0 &008 !D$'@ 8!", %P0K !8$
M,P 5!#P % 1' !,#5  2 V, $0-U ! "B@ 0 :( #P"\  \ Y0 / /X $ #_
M &<+  !7#0  20X  #X/   U#P  +@\  "@/   D#@  ( X  !T.   ;#0$
M&0T$ !@,!P 8"PD %PD, !<)#@ 6"1( %0D6 !0)&P 3"2$ $@DH !(),  1
M"3H $ E%  \)4@ ."6$ #0ES  P(B  +")\ "@>W  H&VP *!?8 "@3_ &,-
M  !3#@  1A   #L1   R$0  *Q$  "40   A$   '1   !H/   8#P$ %@X$
M !4.!P 4#0D $PT+ !,,#0 2#!  $0P4 ! ,&0 0#!\ #PPG  X-+P -#3D
M# U%  L-40 )#6  " UQ  8-A@ %#9T ! RT  ,,T@ "#/$  @O_ %\.  !0
M$   0Q$  #@2   O$@  *!(  ",2   >$0  &Q$  !@1   5$ ( %! % !(0
M!P 1#PD $ \* ! .#  .#@X #@\2  T/%P ,$!T #! D  H0+  )$#8 "!!!
M  803@ %$%T  Q!O  $0A   $)P   ^T   .U   #O,   [_ %P0  !-$@
M0!,  #84   M%   )A0  "$3   <$P  &1(  !82   4$0, $A$& !$1"  0
M$ H #A +  T1"P ,$0T "Q(1  H2%0 )$AH "!(A  83*0 %$S,  Q,^  (3
M2P  $UH  !-L   3@@  $IL  !*T   1UP  $?4  !'_ %@2  !)%   /14
M #,6   K%@  )!4  !\5   :%   %Q0  !03 0 3$@0 $1(' ! 2"0 .$@D
M#1()  L3"@ )% T !Q4/  86$P $%A@  Q8?  (6)P  %S   !<[   72
M%U@  !=J   6@   %ID  !6T   5V0  %/<  !/_ %44  !&%@  .A<  # 8
M   H&   (A<  !T6   9%@  %A4  !,4 P 2$P8 $!,'  \3!P -% < "Q4(
M  D6"0 && P  QH.  $:$0  &A8  !L<   ;)   &RT  !LX   ;1@  '%4
M !MG   ;?0  &Y<  !JS   9VP  &/D  !?_ %$6  !#&   -QD  "X:   F
M&@  (!D  !L8   8%P  %18! !,5!0 1%00 #Q4$  T6!  +%P4 "1D&  8:
M"  "' H  !X-   @$   (!,  " 9   @(0  (2H  "$U   A0@  (5(  "!D
M   @>@  'Y4  !^Q   >VP  '?H  !S_ $T9   _&P  -!P  "L<   D'
M'AL  !H:   7&   %!<" !(7 @ 0& $ #1D!  L: @ (' , !1T$  (?!@
M(0@  ",+   E#@  )A$  "86   F'@  )R<  "<R   G/P  )DX  "9@   F
M=P  )9(  "2O   CV@  (OL  "'_ $@=   \'@  ,1\  "@>   B'@  '1P
M !D;   6&@  $AH  ! ;   -'   "QT   @?   $(0   2,"   E!   )P8
M "D)   L#   +@\  "X3   N&@  +B,  "XN   N.P  +DH  "U<   M<@
M+(X  "NL   JU   *?L  "C_ $0@   X(0  +B$  "8A   @(   '!X  !@=
M   4'0  $!X   X?   +(0  !R,   ,E    )P   "D    L 0  +@,  # &
M   S"@  -0T  #81   V%P  -A\  #8I   V-@  -D4  #57   U;0  -(D
M #*H   QSP  ,/H  "__ #\D   T)   *R0  "0C   ?(0  &R   !8@   1
M(0  #B,   HE   &*    BH    M    +P   #(    T    -P   #D#   [
M!@  /@H  $ .  !!$@  01H  $ E  ! ,0  0$   #]2   ^9P  /8(  #RB
M   ZQP  .?@  #C_ #HH   P*   *2<  ",E   ?(P  &"0  !(E   .*
M"BH   4M    ,    #,    V    .    #L    ^    0    $(   !% @
M1P8  $H*  !-#@  314  $P?  !,*P  2SH  $I,  !)80  2'P  $>;  !%
MOP  0_,  $+_ #8L   M*P  )RD  ",G   ;*   %"H   XM   *,   !#,
M   W    .@   #T   !     0P   $8   !(    2P   $T   !0    4P$
M %8&  !9"P  6Q   %L9  !:)0  630  %A&  !76@  570  %23  !2M0
M4.H  $__ #,P   L+@  )RP  !XM   6+P  $#(   HV   #.@   #\   !"
M    1@   $D   !,    3P   %(   !5    6    %H   !=    8    &,
M  !G!@  :PP  &P2  !K'@  :RP  &D]  !G4@  9FH  &2)  !AJP  7]P
M %W_ #$S   L,0  (C(  !DU   1.0  "CT   )"    1P   $P   !0
M5    %@   !;    7P   &(   !E    :    &L   !N    <0   '4   !Y
M    ?08  ((-  ""%@  @"0  'XU  !\20  >V$  'A_  !VGP  <\8  '#W
M #$V   F.   '#L  !)    +10   DL   !1    5@   %L   !@    90
M &D   !N    <@   '8   !Y    ?    'X   ""    A0   (D   ".
MDP   )@&  "<#@  FQH  )@K  "60   DED  )%S  "-E0  B[4  (CH "L^
M   @00  %4<   U-   "5    %L   !A    :    &X   !S    >0   'X
M  "#    B    (P   "/    D@   )4   "9    G0   *$   "E    J@
M +    "W!P  N!$  +4A  "R-0  KTT  *II  "HB   IJ@  *+1 "-(   8
M3@  #E0   1<    9    &T   !U    ?    (,   ")    CP   )4   ";
M    H    *,   "F    J0   *T   "Q    M0   +D   "^    Q    ,H
M  #2    V@H  -86  #2*0  SD$  ,I<  #%?   PIT  ,&] !Q5   17
M!V4   !N    =P   '\   "(    D    )@   "?    I0   *T   "S
MN    +H   "^    P@   ,8   #*    S@   -,   #:    X    .<   #M
M    \P   /0.  #R'@  [S8  .Q1  #H;@  Y)   -^Q
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MZ>KK[.WN[_#Q\O/T]?;W^/GZ^_S]_O]M9G0Q      ,$(0   0
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MH#X:_ZA')O^N433_KUM%_ZUE5_BI;VCMHWAYXYM_A]N2A934BXR>SX61ILN
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MXTDSS^M.2<;M5%VWZEQNJ.)C?9K9:8J.TFV4A,QQFWO(=:%SQ'BF;L)\J6G
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M/E+_DSY2_Y,^4O^3/E+_DSY2_Y,^4O^3/E+_DSY2_Y,^4O^3/E+_DSZ]Q04
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M1/6[7U;MNV=IX[5N?=:L<X_*HWJ=P9N I[B4A["QCXZVJXJ5NZ:'G;ZBA:7
MGX2OP99^L,&4?[:XDX"[LI. N[*3@+NRDX"[LI. N[*3@+NRDX"[LI. N[*3
M@+NRDX"[LI. N[+_D!H#_XXF!_^5+0S_H341_ZL]&/^S1B3_NDTS^KY51/._
M75;JOV5JW[AK?M"O<8_%IGB<NY]^I[*8A:^KDXNVI8Z3NY^+FKZ;B:+!F(BL
MPI""K\*/@[6YCX2ZLX^$NK./A+JSCX2ZLX^$NK./A+JSCX2ZLX^$NK./A+JS
MCX2ZLX^$NK/_D!H#_XXE!_^6+ O_HC40_ZP]&/^U12/_O$PR^,%40_##7%;G
MPV-JVKMI?LRR<(_ JG:<MJ)\IZV<@J^EEXFVGI.0NYF/F+Z4C:#!D8RIPHN(
MKL**B+2ZBHBYM(J(N;2*B+FTBHBYM(J(N;2*B+FTBHBYM(J(N;2*B+FTBHBY
MM(J(N;3_D1H#_X\E!_^8+ O_I#00_ZX]&/^W12/_OTPR]L530^[(6U;CQF%J
MU+]H?L>V;HZ[K72<L:9ZIJ>@@*^?FX:UF)>.NY.5E;Z.DIW!BI*GPH:.KL*$
MC;2[A8RYM(6,N;2%C+FTA8RYM(6,N;2%C+FTA8RYM(6,N;2%C+FTA8RYM(6,
MN;3_D1H#_X\E!_^9+ O_IC0/_[ \%_^Y1"+\P4LQ],E20NO-657?R6!JS\)F
M?<*Y;(VVL7*;JZMXIJ*E?JZ9H(2UDIV+NHR:D[Z'F)O A)>EPH"6K\)_DK.\
M@)&XM8"1N+6 D;BU@)&XM8"1N+6 D;BU@)&XM8"1N+6 D;BU@)&XM8"1N+7_
MDAH#_Y E!_^;+ K_IS0/_[(\%O^[1"'YQ4LP\<Y10>?26%3:SEYIRL9E?+V]
M:XRPMG":I;!VI9RJ?*V3IH*TC*.)N8:@D+V!GIF_?9ZBP7N>K\%YF;.\>I>X
MM7J7N+5ZE[BU>I>XM7J7N+5ZE[BU>I>XM7J7N+5ZE[BU>I>XM7J7N+7_DAD#
M_Y E!_^=*PK_JC,._[4\%?R_1"#TR$HN[=-0/^/85E/3TEUHQ<IC>[?":8NJ
MNV^8G[9THY6Q>JR-K8"RA:J'MW^GCKMZII>^=Z:@OW2FK;]SH;2[=)ZXM72>
MN+5TGKBU=)ZXM72>N+5TGKBU=)ZXM72>N+5TGKBU=)ZXM72>N+7_DQD#_Y$D
M!_^?*PG_K#,-_[@[%/C#0Q[OS4HLY]I//=W>55'-V%MGOL]B>K#(9XFDPFV7
MF;QRH8^X>*F&M7ZP?[*%M7FPC+ATKY6[<*^?O&ZOK+QMJ[6Y;J>YM&ZGN;1N
MI[FT;J>YM&ZGN;1NI[FT;J>YM&ZGN;1NI[FT;J>YM&ZGN;3_E!D#_Y(D!_^B
M*@C_L#(,_KPZ$O+'0ASHTTDIX>%,.]3C4U'&W5IEM]5@>*G/9H>=R6N4D<5P
MGH?!=J9_OGRL>+R$L7*ZB[1MN9.V:KB<N&>WI[AGM[>V:+*[L6BRN[%HLKNQ
M:+*[L6BRN[%HLKNQ:+*[L6BRN[%HLKNQ:+*[L6BRN['_E1@#_Y4C!O^E*0?_
MM#$*^,$Z$.O.0AC@W4<EU>5+.\OG45"]XUECK]Y?=*+898.6TVJ/BLYOF7_(
M<Z%UQ'BG;L%]JVF^A*YEO8NQ8;R3LE^\G;)?O*RQ8K^^K6*_OJUBO[ZM8K^^
MK6*_OJUBO[ZM8K^^K6*_OJUBO[ZM8K^^K6*_OJW_EA@#_YDA!?^J* ;_N3 (
M\,@X#>'80!/4XT4FRNM+.\'L3T^SZ%=@IN5?;YKB9GR.W&R&A-5QCWK0=95S
MS7J;;,I_GV?'A*)CQHJD7\21IES$F:=:PZ2G6L2PIUK$L*=:Q+"G6L2PIUK$
ML*=:Q+"G6L2PIUK$L*=:Q+"G6L2PIUK$L*?_F!<"_YX@!/^O)@7XP"X&YM S
M"-7A/!3)ZD4HO_)*.[7Q3DRI[U9;G>U?:)+J9W.'XVU\?MYR@G;:>(APUWV,
M:]2"D&;2AY)CT8R57\^2EES.F9A9SJ*96,VKFEC-JYI8S:N:6,VKFEC-JYI8
MS:N:6,VKFEC-JYI8S:N:6,VKFEC-JYK_FA<"_Z4> _^W(P/MR28#UMXI!LGI
M.Q>^\T0IL_A).JCW34B?]E55E/5?8(GQ:&B [&]P>.AU=7+E>GEMXG]]:>"$
M@&7?B8)BW8Z$7]R3AEW;F8=:VJ&)6-FHB5C9J(E8V:B)6-FHB5C9J(E8V:B)
M6-FHB5C9J(E8V:B)6-FHB5C9J(G_G!8"_ZT; O;!'0';VA,!R>@I";WS.QFR
M_4,HIOY'-IS]3$.3_55-BOU?5H'Y:5UY]7!B<_)V9V[P?&IJ[H%M9^R&;V3K
MBW%AZH]R7^F4=%WHF75:YZ!W6.:F>%CFIGA8YJ9X6.:F>%CFIGA8YJ9X6.:F
M>%CFIGA8YJ9X6.:F>%CFIGC_HA4!_[<5 -C/"P#*YQ,"O/,I"['].QFD_T F
MF?]%,H__2SR'_U1$?_]?2WC_:5!Q_W!4;/UV6&G[?%IF^H%<8_B&7F'WBU]?
M]I!A7O:58ESUFF-:]*!D6/.E95CSI658\Z5E6/.E95CSI658\Z5E6/.E95CS
MI658\Z5E6/.E95CSI67_K1  UL,( ,C3"@"[]!4#K_\J#:/_-QB7_STBB_]#
M+('_2C1Z_U(Z<_]>/V[_:$-I_V]'9O]U26/_>TMA_X%,7_^%3EW_BD]<_X]0
M6O^345G_F%)7_YY35O^C5%;_HU16_Z-45O^C5%;_HU16_Z-45O^C5%;_HU16
M_Z-45O^C5%;_HU39N@4 Q<<' +G9" "L_Q<%HO\K#97_,Q:)_SD>?O] )77_
M2"MM_U P9_]:-&/_93=@_VTY7O]S.US_>#U:_WT^6/^"/U?_AD!6_XM 5?^/
M053_E$)3_YI#4?^?0U'_GT-1_Y]#4?^?0U'_GT-1_Y]#4?^?0U'_GT-1_Y]#
M4?^?0U'_GT/&O@4 M\T% *KD" &?_QD&E/\H#(?_+A-[_S49<?\]'FG_12-B
M_TTF6_]6*5C_7RQ6_V@M5/]N+U/_<S!2_W@Q4?]\,5#_@#)/_X0S3O^(,TW_
MC#1,_Y(T2_^6-4O_EC5+_Y8U2_^6-4O_EC5+_Y8U2_^6-4O_EC5+_Y8U2_^6
M-4O_EC6WQ , J=0" )SY"P*3_QL%A?\C"GG_*0]N_S$49?\Y&%W_01M7_TH>
M4_]2(%#_62)-_V C2_]F)$K_:R5)_V\E2/]S)D?_=R9&_WLG1?]^)T7_@BA$
M_X<H0_^+*4/_BRE#_XLI0_^+*4/_BRE#_XLI0_^+*4/_BRE#_XLI0_^+*4/_
MBRG_@QP#_X G!_][,PW_AC@1_XY &?^322+_E54M_Y-A.?^0;47_BWA/_X:$
M6?R"CF'W?99H]'B=;O%THW/N<:EW[&ZN>NILLWWI:KE_YVC @>9GQX/C9<^%
MW6/8AM-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?_
M@QP#_X G!_][,PW_AC@1_XY &?^322+_E54M_Y-A.?^0;47_BWA/_X:$6?R"
MCF'W?99H]'B=;O%THW/N<:EW[&ZN>NILLWWI:KE_YVC @>9GQX/C9<^%W6/8
MAM-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?_@QP#
M_X G!_][,PW_AC@1_XY &?^322+_E54M_Y-A.?^0;47_BWA/_X:$6?R"CF'W
M?99H]'B=;O%THW/N<:EW[&ZN>NILLWWI:KE_YVC @>9GQX/C9<^%W6/8AM-@
MVH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?_@QP#_X G
M!_][,PW_AC@1_XY &?^322+_E54M_Y-A.?^0;47_BWA/_X:$6?R"CF'W?99H
M]'B=;O%THW/N<:EW[&ZN>NILLWWI:KE_YVC @>9GQX/C9<^%W6/8AM-@VH?3
M8-J'TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?_@QP#_X G!_][
M,PW_AC@1_XY &?^322+_E54M_Y-A.?^0;47_BWA/_X:$6?R"CF'W?99H]'B=
M;O%THW/N<:EW[&ZN>NILLWWI:KE_YVC @>9GQX/C9<^%W6/8AM-@VH?38-J'
MTV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?_@QP#_X G!_]],@S_
MB#<1_Y _&/^522+_EU0M_Y9?.?^3:T7_CG=1_XB"6_J$C&3U?Y1K\7J;<NYV
MHG?K<J=[Z6^M?^=LLH+E:KB$Y&F_A^)HQXG@9L^*UF/6C,]BV(K/8MB*SV+8
MBL]BV(K/8MB*SV+8BL]BV(K/8MB*SV+8BL]BV(K_A!L#_X$G!_^ ,0S_BS81
M_Y,^&/^91R+_G%(M_YI=.O^8:4?_DW13_HY^7_>(B6GQ@I%R[7V8>>EXGW_E
M=*2$XW"JB.!ML(S>:[>/W6J_D=MIR)/59L^5RV31D\9EU([&9=2.QF74CL9E
MU([&9=2.QF74CL9EU([&9=2.QF74CL9EU([_A1L#_X(F!_^", S_CC40_Y8]
M&/^<1B'_H% M_Y];._^<9DC_F'%6^Y-\8O2-AFWNAXYWZ("5@.1ZG(?@=:*,
MW7*HD=IOKY78;;>9U6O G-)IR9[)9<F>PF?-F+YIT9.^:=&3OFG1D[YIT9.^
M:=&3OFG1D[YIT9.^:=&3OFG1D[YIT9/_AAL#_X,F!_^%+PO_D#00_YD]%_^?
M1B'_HT\M_Z-:._^@9$G_G6]8^IAY9?&2@W'JBXQ\Y(.2AM]]F8[:>*"5UG2G
MFM-PKI_1;;:CSVO I<=FPJ? :,:BNVK+F[=LSI:W;,Z6MVS.EK=LSI:W;,Z6
MMVS.EK=LSI:W;,Z6MVS.EK=LSI;_AAL#_X,F!_^'+@O_DS00_YL\%_^A12#_
MITTM_Z98._^D8DK\H6Q9]YQV:.^6@'7GCXF!X(>0C-J EI75>IZ=T76EH\UP
MK*C+;;6LQVN^K;UHOZRX:\.FLVW(G[!OS)FP;\R9L&_,F;!OS)FP;\R9L&_,
MF;!OS)FP;\R9L&_,F;!OS)G_AQH#_X0E!_^)+0O_E3,/_YT\%O^D1"#_JDPM
M_ZI7._ZH8$OXI6I:\Z%T:NV<?GGDDX:&W(N-DM6#E)S/?)NERW>CJL=TJZW$
M<[6OOW"\L+5KO+"P;L&IK'#&HJERRIRI<LJ<J7+*G*ERRIRI<LJ<J7+*G*ER
MRIRI<LJ<J7+*G*ERRIS_AQH#_X0E!_^++ K_ES,/_Y\[%O^F1!__K$LL_ZY5
M._NL7TOUJFA<[J9Q;.>@>GS?EX**U8Z(F,V%CZ''@)>GPGN>K+UXIZ^Z=K"Q
MMW6ZLJUPNK*I<;^LI73$I*-UR9ZC=<F>HW7)GJ-UR9ZC=<F>HW7)GJ-UR9ZC
M=<F>HW7)GJ-UR9[_B!H#_X4E!_^,*PK_F#(._Z$[%?^I0Q__KTLL_[%4._BQ
M74OQKV9<ZJMO;N&C=G_5F7V/S)&$F<6*C**^A).HN7^:K;1\H["P>JNSK7FV
MM*9TN;2B=;VOGW?#IIUYQZ"=><>@G7G'H)UYQZ"=><>@G7G'H)UYQZ"=><>@
MG7G'H)UYQZ#_B!H#_X4E!_^.*@K_FC(._Z,Z%?^K0A[_L4HK_;53._:U7$ON
MLV1=Y:YL;]NE<X'.G7J/Q96!F;Z.B**WB)"IL827KJR G[&H?JBTI7VRM9]Z
MN+:;>;NQF7O!J)A\QJ*8?,:BF'S&HIA\QJ*8?,:BF'S&HIA\QJ*8?,:BF'S&
MHIA\QJ+_B1H#_X8E!O^0*@K_G#$-_Z4Z%/^M0A[_M$HK^[A2.O.Y6DOJN&)>
MX;%J<-.I<('(H'>/OYE^F;>2A:*PC(RIJHB4KJ6$G+*@@J2UG8&NMIE_M[>4
M?;JSDW_ JI)_Q:.2?\6CDG_%HY)_Q:.2?\6CDG_%HY)_Q:.2?\6CDG_%HY)_
MQ:/_B1D#_X8D!O^1*0G_G3$-_Z<Y%/^O0AW_MDDJ^+Q0.O"]64OGO&%>W+5G
M<<ZL;X'#I'6.N9Q\F;&6@J*JD8JIHXR1KIZ)F;*9AJ&UEH6KMY.%MK>.@;FT
MCH._JXV#Q*6-@\2EC8/$I8V#Q*6-@\2EC8/$I8V#Q*6-@\2EC8/$I8V#Q*7_
MB1D#_X<D!O^3*0G_GS$-_ZDY$_^Q01S_N4DI]L!/.>W"5TKDOU]=UKEF<,FP
M;8"^J'..M*!ZF:N:@**DE8>IG9&.KI>.EK*2BY^UCXJIMXR*M+B(AKBUB(>^
MK(B'PZ:(A\.FB(?#IHB'PZ:(A\.FB(?#IHB'PZ:(A\.FB(?#IHB'PZ;_BAD#
M_X<D!O^4*0G_H3 ,_ZLY$O^T01S\NT@H],-...O'5DK@PUY=T;QE;\2S:X"Y
MJW&-KZ1WF*:>?J&>FH2HEY:,KI&3E+*,D9RUB(^FMX6/L;B"C+>V@HR^K8.,
MPZ:#C,.F@XS#IH.,PZ:#C,.F@XS#IH.,PZ:#C,.F@XS#IH.,PZ;_BAD#_X@D
M!O^6* C_HS ,_ZTX$O^V0!OZOD@G\<=.-^?,54C<QUQ<S+]C;[^W:7^TL'",
MJ:EUEZ"C>Z"8GX*HD9N)K8J9DK*%EIJU@96DMWZ5K[=[DK>V?9&]KGV0PJ=]
MD,*G?9#"IWV0PJ=]D,*G?9#"IWV0PJ=]D,*G?9#"IWV0PJ?_BQD#_XDD!O^8
M* C_I2\+_[ X$?^Y0!GXPD<F[LM-->305$;5RUM;Q\-B;KJ[:'ZNM&Z+HZYS
MEIJI>I^2I8"FBJ&'K(2?C[%^G9BT>IRAMGB;K+9UFK>V=YB]KGB6PJ=XEL*G
M>);"IWB6PJ=XEL*G>);"IWB6PJ=XEL*G>);"IWB6PJ?_C!@#_XHC!O^:)P?_
MIR\*_[,W#_R]/QCSQD8CZM!,,N#54D7/SUE:P<A@;+3 9GRHNFR*G;1RE92P
M>)Z+K'ZE@ZB%JGVFC*]XI)6R=*.?M'&CJK5OI+FT<*"^K7*=PJ=RG<*G<IW"
MIW*=PJ=RG<*G<IW"IW*=PJ=RG<*G<IW"IW*=PJ?_C!@#_XPB!O^=)P?_JBX)
M_[8V#O?!/A;MS$8@Y-A++MG<4$3)U%A8N\U>:Z[&97JBP&J(E[MPDHVW=9N$
MLWRB?;&#J':OBJQQK9.O;:V=L6JMJ;)IK;>Q:JF_K&NFPZ9KIL.F:Z;#IFNF
MPZ9KIL.F:Z;#IFNFPZ9KIL.F:Z;#IFNFPZ;_C1@"_X\@!?^@)@;_KBT(_;LU
M#/''/1/ETT0<W>!(+=#A3T+"VU96M--=:*?-8WB:R&B%C\-NCX7 =)A]O7J>
M=KJ!I'"YB:AKN)*J9[><K&6XJ*UCN+:M9+7!J66PQ:1EL,6D9;#%I&6PQ:1E
ML,6D9;#%I&6PQ:1EL,6D9;#%I&6PQ:3_CA<"_Y,?!/^D)07_LRP&]\$S">C.
M/ _<WD 9T.5(+L?E34*YX%54K-M;99_58722T&:!A\ULBW[*<I-VR'F9;\:!
MGFK%B:)EQ9*D8L2=IE_$IZ==Q+2G7L/$I%^]R*!?O<B@7[W(H%^]R*!?O<B@
M7[W(H%^]R*!?O<B@7[W(H%^]R*#_D!<"_Y@=!/^I(P3_N2D$[L@Q!MW:- K0
MY$$;QNM'+KSJ3$&PYE-2H^-:89?@86Z,W6AY@MMN@GK9=8ERU7R/:]*"DV7/
MB)=@S8^:7,R7G%K+H)U8RZN=5\NZG5G,S)E9S,R96<S,F5G,S)E9S,R96<S,
MF5G,S)E9S,R96<S,F5G,S)G_DA8"_YT< _^O( +VP"4"XM,D ]#C,@S%[$ =
MNO%'+[#O2S^E[5%.FNM:6H_J8F6%Z&IN?>=R=77C>'MOX'Z :=V$A&3;BH=@
MV9&)7=B8BUK6H(U8UJB.5M6TCE35P8Y4U<&.5-7!CE35P8Y4U<&.5-7!CE35
MP8Y4U<&.5-7!CE35P8[_E!4"_Z09 O^W' 'IRQ8!T>$= L7L,0ZZ]4 >KO=%
M+J/U2CR:]%!(D/-:4X;S8UM^\FQB=_%S:''N>FULZX!P9^F&<V/GC'9@YI)X
M7>28>EKCGGM8XZ5]5N*O?E3AN'Y4X;A^5.&X?E3AN'Y4X;A^5.&X?E3AN'Y4
MX;A^5.&X?E3AN'[_F!,!_ZT4 ?/##P#2V L Q.P>!+CV,1&M_3X>HOU#*Y?\
M2#>._$]!A?Q927W\8U!W_&U6</MT6FOY>EYH]X%A9/6'8V'SC65?\I-G7?&9
M:%KPGFE8[Z5K5N^M;%3NM&U4[K1M5.ZT;53NM&U4[K1M5.ZT;53NM&U4[K1M
M5.ZT;53NM&W_HQ  \;D, ,[)"0#$WPL MO<?!JS_,A*@_SL=E/]!)XK_1S&!
M_TXY>O]8/W/_8D5N_VQ):?]S3&;_>D]C_X!18/^&4U[_C%1<_Y)56OZ85UG]
MG5A7_*195?NK6E3[L5M4^[%;5/NQ6U3[L5M4^[%;5/NQ6U3[L5M4^[%;5/NQ
M6U3[L5OPKP@ S;\' ,#-" "T[@X"J?\A")__,1&2_S<:A_\^(GW_12EU_TTP
M;O]5-6G_8#EE_VH\8?]Q/E__=T!<_WY"6O^$0UG_B417_X]%5O^41E7_FD=3
M_Z!(4O^G25'_K4I1_ZU*4?^M2E'_K4I1_ZU*4?^M2E'_K4I1_ZU*4?^M2E'_
MK4K/N 0 OL,% ++4!@"F_A #G/\C")#_+0^$_S,6>?\[''#_0R)I_THG8O]2
M*EW_7"U:_V4P6/]M,5;_<S-4_WDT4_]^-5+_A#90_XDW3_^..$[_DSA-_YDY
M3/^@.DO_ICI+_Z8Z2_^F.DO_ICI+_Z8Z2_^F.DO_ICI+_Z8Z2_^F.DO_ICJ_
MO , L,H# */< P&9_Q(#C_\B"(+_* UV_R\2;?\W%V7_/QM>_T<>6/].(53_
M5R-1_U\E3O]E)DW_;"=+_W$H2O]V*4G_>RI(_X J1_^%*T;_B2M%_XXL1/^4
M+$/_FBU#_YHM0_^:+4/_FBU#_YHM0_^:+4/_FBU#_YHM0_^:+4/_FBVQP@$
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M!O^-)@?_FBT*_Z0U#_^L/1?^LD4B]KA,,.V\5$#DN%U1U[)D8\NI;'/ H7.
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M3U#_NU!/_\-13__#44__PU%/_\-13__#44__PU%/_\-13__#44__PU':KP(
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MC(:,H(B-D9J%E9:6@IZ:DH"GG8]_LYZ-@,*>BX#,FHN!TI**@-B)B8#;AHF
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M.$3_Q3A$_\4X1/_%.$3_Q3A$_\4X1/_%.$3_Q3C!LP  LKX" *7, 0"9W0,
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MY'B"@N1X@H+D>(*"Y'C_<1H"_WH< _^*'0/_ER,$_Z(I!?RL,0GQLSD/Z+I
M%]V\2"7/ME(XPZ];2+FH8E:OHFIBIYQP;)^7=W68DWY\DI"&@HR-CH>'BI>+
M@XB@CG^'JY%\A[F1>X?+D7R(V(E]A]Z"?8;D>GV&Y'E]AN1Y?8;D>7V&Y'E]
MAN1Y?8;D>7V&Y'G_<1H"_WP: _^-' /_FB(#_Z4H!/FO+P?NN#<,Y+\_%-C
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M7$KC\UQ*X_-<2N/S7$KC\UQ*X_-<2N/S7$KC\USYF0, U*P" ,6W! "YPP4
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M:E>O\6=7K_%G5Z_Q9U>O\6=7K_%G5Z_Q9U>O\6?_?PX!_Y,+ .&E!0#2LP<
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M_U*F:?]2IFG_4J9I_U+_6R "_V<< O]T&@+_?R #_X@G!/^.+P?]DC<,])1
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M9FB3]F!HDO=?:)+W7VB2]U]HDO=?:)+W7VB2]U__;Q$!_X$. /^1#@#RH P
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M55"Z_E50NOY54+K^55"Z_E7_A0( W9@  ,VF @#!L0, M[H# *[&!@"GTPH
MH-T5 )G=* 20VS<.AME"&7W62R1UU%0M;=)<-6?18SQAT&M!7,]R1EC/>TE4
MSH1-4,Z/4$W.FU)+SJE32<ZY5$C/SU1(SNM32<[X4$K+_TY*RO]-2LK_34K*
M_TU*RO]-2LK_34K*_TWGCP  T9\  ,.K 0"WM ( K;\# */+!@";V0H E.4:
M 8WE*P:$Y#4->^,_%G/B2!YLX5(F9N%:+&#@8C);X&HV5^!R.E/?>SU0WX5
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M,P8Z_SD'-O] "#/_10@P_TL)+O]1"BO_5PHI_UT+)_]D"R3_; PB_W8-(/^
M#1[_C X=_Y<.'/^A#AO_K \;_ZX/&_^N#QO_K@\;_ZX/&_^N#QO_K@^7O
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M8/] NF#_0+I@_T#_4B$"_UX= O]I&@+_<Q\#_WHF!/]^+P;_@3@+^X%!$O.
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M6WB"_E9Y@?]1>8'_47F!_U%Y@?]1>8'_47F!_U'_91,!_W4. /^##@#_D X
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M4F&8_U)AF/]289C_4F&8_U+_<@L _X,% -^3 0#1GP0 R:H& ,&R!0"[O00
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M(3CXM2(W^<@B-OGC(C;X\R(V]_PB-O?\(C;W_"(V]_PB-O?\(C;W_"*WI@
MJ:X  )RY  "0Q   @\\  '?;  !O]@H 9_\3 6#_'0):_R<#5/\P!4__. A*
M_T *1O](#$/_3PY _U8//?]>$#O_91(X_VX3-O]W%#3_@A4R_X\6,/^;%R__
MJ1<N_[<8+?_(&"S_X1@L_^\8+/_O&"S_[Q@L_^\8+/_O&"S_[QBKJP  GK4
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M_V$4 ?]L$@'_=A<!_WT< ?^#(P+TABP$ZH@U!^&'0 [6@DP9S7U8),9W8BW
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M3HET_TF)=/]$B'3_0XAT_T.(=/]#B'3_0XAT_T/_71(!_VL. /]X#@#_@P\
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M1W*$_T=RA/]'<H3_1W*$_T?_9@T _W4' /:#!0#<CP, TI@& ,RA!P#(J @
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M/$3%P3Q#Q=\\1,3S.T3#_SE%PO\W1<'_-T7!_S=%P?\W1<'_-T7!_S?5BP
MQ9H  +>D  "KK   H+0  ):^  "+QP0 @= ( 'C9#@!UV2 !;]@O!&G8/ EC
MUD807M90%5G56!I5U& ?4=1H(D[4<29+TWLI2-.%*T73DBY"U)\O0=2O,#_5
MPC$_U>$P/]/R,#_2_2\_T?\N/]#_+C_0_RX_T/\N/]#_+C_0_R[*E   NZ$
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M$2?_X1$F__(1)O_V$2;_]A$F__81)O_V$2;_]A&GJ0  F;,  (N^  !^R0
M<-,  &3>  !8YP  4O\) $W_$0!'_QD!0_\B 3[_*@(Z_S(#-_\Y S/_/P0P
M_T8%+?]-!2O_5 8H_UL')O]C!R/_;0@A_WD)'_^'"1[_E0H=_Z,*'/^Q"AO_
MP L:_]8+&O_?"QK_WPL:_]\+&O_?"QK_WPN;L0  C;P  '['  !PT@  8]X
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M,+MB?36X8(4XM5Z-/+)<E3ZO6YU!K5JF0ZM9KT2I6;Q%IUC,1J18Y4:D6_9
MHU[_.Z-?_S>C8/\SHV'_,:-A_S&C8?\QHV'_,:-A_S'_4Q4!_UT0 /]H#P#_
M<!( _W<6 /M\' 'N?R0!Y( M ]I_.PC/>DD2QW54&\%Q7R2[;6@KMFIP,;)G
M>3:O98 ZJV.(/:AAD$"F8)A#HUZA1:!>JT>>7;=(G%W&29I<WTF:7_)$FF+_
M/IIC_SF;9?\VFV7_,YME_S.;9?\SFV7_,YME_S/_51,!_V . /]K#@#_=!
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M.H!U_SJ =?\Z@'7_.H!U_SK_70X _VH& /]V!@#D@ , V8D& -*/" #/E H
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M1U&;ND=0F]%'49ON1%.;_$!5F_\\5IO_.E:;_SI6F_\Z5IO_.E:;_SKQ=
MV8,  ,B0  "^F@  LZ$  *JG  "AK@  E[4& )*V& ",M2H#A;0W"7ZR0A%W
ML$P8<:Y4'VRM6R5GJV(J8JII+UZI<3-:J'HW5J>#.E.FCCU0IIM 3:6I04NE
MND)+IM%"2Z7M/TVE_#Q.I/\Y3Z3_-T^D_S=/I/\W3Z3_-T^D_S?D>@  SXD
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M)3O,^R4[R_\E.\K_)3O*_R4[RO\E.\K_)3O*_R7#DP  M9X  *BF  "=K@
MD;8  (6_  !YQP  ;\X$ &36"0!>WA$ 6]X@ %?>+0)3WSH$4-]$!DS?3@E)
MWU<,1M]?#T/?:!%!WW$3/M]\%3S?B1<ZX)89.."E&C?@MQHVX<T:-M_L&C7>
M^1HTW?\;--S_&S3<_QLTW/\;--S_&S3<_QNYG   JJ0  )ZK  "2M0  A;X
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M!A/_Z083_^D&$__I!A/_Z0:7KP  B+H  'K%  !LSP  7MH  %#@  !$Y@
M//4  #?_!  S_PT +_\3 "O_&@ H_R$ )?\G 2'_+0$>_S(!&_\X 1G_/P$6
M_T8"%/]- A'_5@(0_V "#O]L @S_>P,+_XL#"O^: PK_J ,)_[4#"/_" PC_
MP@,(_\(#"/_" PC_P@.*N   >\,  &S.  !>VP  3^(  $+G   V[   ,?\
M "S_   G_P< (_\. "#_$@ <_Q@ &/\= !7_(0 2_R8 $/\L 0[_,0$-_S<!
M"O\^ 0C_1@$%_T\! ?]9 0#_9@$ _W0! /^" @#_D ( _YP" /^F @#_I@(
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M1((5]D.,%_1"E!CS09P9\4&C&^] JAON0+(<[3^['>L_QA[I/]4>Y3_H'^)
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M*K-1_R>S4O\DLE+_(K)2_R*R4O\BLE+_(K)2_R+_2A4!_U,1 /];#P#_8A(
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M+(YE_RR.9?\LCF7_+(YE_RS_50X _U\& /]I!@#T<@8 XG@& -M\"0#9?PP
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M_S'_7P( ]VP  -YW  #0@0  QX@! ,"- P"YD0, LI,1 *N3(P&CD3,&G(Y
M#96+2A6/B%,<B89;(H2#8BB @6DM?']P,7A^=S5T?( X<7N)/&YZDS]K>9Y"
M:'BK1&9XNT5D>-%%9GGN0&A[_3IJ>_\V:WS_,FM\_S)K?/\R:WS_,FM\_S+_
M80  ZF\  -EZ  #,A   PXL  +N1 0"TE0$ K)<. *67(0&>EC$%EY,^#)"0
M2!2*CE$;A(M9(7^)8"=[AV<K=X5N,'.$=31O@GTW:X&'.VB D3YE?YQ!8GZI
M0V!^N41??L]$8'_L0&* _#ID@/\V98'_,V:!_S)F@?\R9H'_,F:!_S+_9
MY7(  --^  #'AP  OH\  +:5  "NF0  IIL, *"<'@"9FRX$DID["HN61A*%
ME$\9?Y%7'WJ/7B5UCF4J<8QL+FV*<S)IB7LV9HB$.6*&CSU?A9H_7(6H05J%
MMT)9A<Q"6H7J/UR&^SI>AO\V7X?_,E^'_S)?A_\R7X?_,E^'_S+]:   X'8
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M-4F@^3)*G_\P2Y__+DN?_RU+G_\M2Y__+4N?_RW=>0  R88  +R2  "QF@
MIJ   )RF  "1K   AK(  'VV#0!YMAT =;8L F^U.09JM$,+9;-,$6"R5!9<
ML5L:6+!C'E6O:R%1KW,E3JY]*$NMB"I(K94M1:VC+D2MLR]#K<@O0JSG+T.K
M^2U$J_\K1*K_*42J_RE$JO\I1*K_*42J_RG1@   P8T  +68  "IGP  GJ4
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M$R_4_Q,OU/\3+]3_$R_4_Q.SF@  IJ$  )JI  "-L0  @+H  '3!  !HR0
M7,\  %+5 P!(W @ 1>42 $/E'@!!YBH /N8U 3OG/@$YYT<"-^=0 S3H600R
MZ&(%,.AM!B[I>0<LZ8<(*^J6"2GJIPHHZKH*)^O6"B?I\ HGY_T))N;_"B;F
M_PHFYO\*)N;_"B;F_PJHH   G*<  (^P  ""N0  =,(  &C*  !;T0  3]<
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M 0#_R@&&MP  =\$  &C,  !:UP  2]X  #[D   RZ0  )^T  "/_   ?_P
M&_\% !?_#  4_Q  $?\4  __&  -_QT "_\B  C_*  %_RX  O\U  #_/0
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M0),6X#^;%]\_HAC=/JH9VSZS&M@^O1K6/LH;TC[?&\X^[QO+/_L:R4#_&,=
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M'J)2_QVB4O\=HE+_':)2_QW_2@\ _U(* /]:"0#_8 L _V4. /5G$0#H:!@
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M.6YJN3IM:LXZ;6OK-V]M_#%P;O\M<6[_*G%O_RAQ;_\H<6__*'%O_RC_60
MZV4  -MP  #->   Q'X  +R" 0"VA $ KH4. *>&( "@A3 #FH(]"). 2 ^.
M?5$5B7M9&H1Y8!^ =V<C?'5N)WET=2IV<WTN<W*&,7!QD#1M<)PW:F^H.6AO
MMSIG;\LZ9W#I-VEQ^C)K<O\M;'/_*FQS_RAL<_\H;'/_*&QS_RC_7   YV@
M -5S  #)>P  P((  +B&  "QB   J8D- ***'0"<B2X"E8<[!X^%10Z)@D\4
MA(!7&7]^7AY[?&4B>'ML)G1Y<RIQ>'LM;G>$,&MVCC-H=9HV972F.&-TM3EA
M=,DZ873G.&-V^3)E=O\N9G?_*V=W_REG=_\I9W?_*6=W_RG_7P  XVP  -!V
M  #%?P  O(4  +2*  "LC   HXX* )V.&@"7CBL"D(PX!HJ*0PR$ATP2?X55
M&'J$7!UV@F,A<X!J)6]_<2EL?GDL:'V"+V5\C#)B>Y@U7WJD-UUZLSA<>L<Y
M7'KE-UY[^#)?>_\N8'S_*V%\_REA?/\I87S_*6%\_RGU8@  WF\  ,QZ  #
M@P  MXD  *^.  "FD0  G9(& )>3%P"1DR@!BY(V!86000M_CDH1>HQ2%G6*
M6AMQB&$?;8=H(VJ&;R=FA'<K8X. +F""BC%=@98T6H&C-EB LC=6@,4W5H#C
M-EB!]S%9@?\M6X+_*EN"_RE;@O\I6X+_*5N"_RGL9@  V',  ,=^  "\AP
MLXX  *F2  "@E0  EI@! )"9$P"*F20!A9@R!'^6/@EYE$@.=)-0%&^15QEK
MD%X=:(YE(62-;25@C'4H78M^*UJ*B"Y7B90Q5(FA,U*(L#11B,,U4(CB-%*(
M]C!3B/\L5(C_*56(_RA5B/\H58C_*%6(_RCF:P  T'@  ,*#  "WC   K9(
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M(4"D_R! I/\@0*3_($"D_R#*?@  NXL  *^5  "DFP  F:$  (ZF  ""K
M=[$  &JV  !CN X 8;@= %ZX+ %:N#@"5[A"!5.X2PA0MU,+3;=;#DJV8Q!'
MMFL31+5U%D*U@1@_M8X:/;6<'#NUK!PZM< =.;7?'#FS]!PYLO\<.;'_&SFP
M_QLYL/\;.;#_&SFP_QO!A@  M),  *>:  "<H   D:<  (6M  !YLP  ;;@
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M!1_@_P6DG@  F*4  (NN  !]M@  <+X  &/&  !6RP  2]   $#5   VW
M+^4' "WM$  K[A@ *>XB "?O*P E[S0 (_ \ "'P10 ?\4X '?)8 1OR9 $9
M\W$!&/.! 1?TD@(5]*4"%/6Z A/UU@(3].\"$O+\ A+P_P(2\/\"$O#_ A+P
M_P*:I   C:T  '^V  !QOP  8\<  %;.  !)TP  /=H  #/?   JXP  )O0%
M "3[#0 A_!, 'OT; !S](@ 9_BD %_XQ !7_.0 3_T$ $?]* !#_50 ._V$
M#/]O 0S_@ $*_Y,!"?^F 0C_N@$'_]0!!__K 0;_]@$&__8!!O_V 0;_]@&/
MK   @+8  '*_  !CR0  5M$  $C8   [W0  ,.(  ";F   ?\   '/\  !G_
M"0 6_PX %/\3 !'_&0 /_QX #?\D  O_*P )_S( !O\[  /_1   _T\  /]<
M  #_:P  _WT  /^0  #_HP  _[0  /_&  #_U@  _]8  /_6  #_U@""M0
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M+'U:NRU\6L\N>UOL*WQ<_"9\7?\B?5[_'WU>_QU]7O\=?5[_'7U>_QW_4
M]5D  .%C  #2:@  R6X  ,)P 0"]< , MG 0 *YQ(@"H<#("H6X_!IQL2@N7
M:E,0DFA;%(YF8AB+96D;B&-P'H5B>"&"88 D@&"))GU?DBE[7ITK>%ZI+79>
MN"YU7LPO=%[I+75@^B=V8?\C=V+_('=B_QYW8O\>=V+_'G=B_Q[_4@  [%P
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M+V1L]BIF;?\F9FW_(V=N_R!G;O\@9V[_(&=N_R#V60  X&4  ,YO  #"=@
MN7P  +%_  "I@   H( ' )F!%P"4@2@!CH U XA^00B#?$H-?GI2$7IX615V
M=V 9<W9G''!T;A]M<W8C:G)_)F=QB2ED<94K8G"A+6!PL"]><,(O77#?+U]Q
M]2I@<?\F87+_(V)R_R!B<O\@8G+_(&)R_R#O7   W&D  ,IR  "^>@  M8
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M(E"#_Q]0@_\?4(/_'U"#_Q_>:0  R74  +R   "RB   J(T  )V1  "3DP
MA98  'Z7"P!YEQD =9<H 7&7-0-LEC\&:)5("F244 UADU<179)>%5J19AA7
MD&X;5(]W'E&.@2!.CHTC2XV:)4F-J29(C;LG1XW4)T>,\"1(C/\B28O_($J+
M_QY*B_\>2HO_'DJ+_Q[5;@  PWL  +>%  "LC0  HI(  )>6  ",F0  ?YP
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M%#2K_Q2[A0  KY   *.7  "8G0  C*,  ("H  !TK0  :+(  %RV  !0N@$
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M 1S?F0$:WZP!&=_$ 1C>YP$8W/@!&-O_ A?:_P(7VO\"%]K_ A?:_P*@G
ME*,  (>K  !YLP  ;+H  %_!  !2Q@  1LH  #O.   QTP  *=D  "'>!0 >
MZ X '>@5 !OI'@ 9Z2< &.HP !;J.0 5ZT, %.Q. !+L6@ 1[6< $.YW !#N
MB@ .[YX #O"S  WPS0 ,[^P #.W\  SK_P ,Z_\ #.O_  SK_P"7HP  B:L
M 'NT  !MO   7\0  %+*  !%S@  .=,  "_8   EW0  '>$  !CL @ 6]PL
M%/<1 !'X%P 0^!X #ODE  WY+0 +^C4 "?L_  ?[2@ $_%<  _UF  +^=P
M_8L  /V?  #\M0  _-$  /SM  #\_   _/T  /S]  #\_0"+JP  ?;0  &Z]
M  !@Q@  4LT  $32   WV   +-T  "+A   9Y0  $^H  !#Z   ._P8 #?\,
M  K_$  '_Q0 !/\:  '_(   _R<  /\P  #_.@  _T4  /]3  #_8@  _W4
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M')1(P1V22-@=D$GO&X]*_AB/2_\6CDO_%(Y,_Q*.3/\2CDS_$HY,_Q+_10
M_TL  .E3  #>6   TUL  ,U;! #*6 < PE@5 +I:)P"S6C<!KEA$!*E73P>D
M55@*H51@#9Y3:!";46\3F%!V%990?A>43X89DDZ.&H].F!R-3:(=BTVN'XI-
MO""(3= @ATWK'X9/_!N&4/\8AE#_%H90_Q2&4?\4AE'_%(91_Q3_1P  ^$\
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M)7!;]B!Q7/\<<5W_&G%=_QAQ7?\7<5W_%W%=_Q?]3P  Y5D  --B  #':
MO6P  +9M  "O;   IVL+ *!L&0";;"H!E6LW I!I0P6+:$P)AV94#(-E6Q"
M8V(3?6)I%7IA<!AX87@:=6"!'7-?BQ]P7I8B;EZB)&Q>L"5K7L$F:5[>)FI?
M]"%K8/\=:V'_&VQA_QEL8?\8;&'_&&QA_QCU40  XEP  ,]E  ##:P  N6\
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M'%UM_QI=;?\976W_&5UM_QGH6@  TF8  ,-O  "X=@  KWL  *9^  "=?@
MD7P  (I\#P"%?1X @7TM 7Q\.0-W>D,&<WE+"7!X4PQL=UH0:79A$V9U:!9C
M=&\887-X&UYR@AY;<HT@67&:(E=QJ"15<;DE5''0)51Q[B)6<?X>5W'_'%=Q
M_QI8<?\96''_&5AQ_QGC7@  S6D  +]S  "T>@  JW\  **"  "8@P  BX$
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M%T6%_Q?-;0  O7@  +&"  "GB@  G(X  )*0  "&DP  >94  &R7  !FEPX
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M"S*JGPPQJK ,,*K'##"IYPPOI_H-+Z;_#2^E_PTOI?\-+Z7_#2^E_PVVA
MJHX  )Z4  "4F0  AYX  'NC  !OJ   8ZP  %>O  !+L@  0;4& #ZV$0 ]
MMAX .[8I #JW-  YMSX -[=' #:W4 $TMUH!,K=D C"W;P,NMWP$++>+!2JW
MG 4IMZX&*+C%!2BWY@4GM?D')K/_!R:R_P@FLO\()K+_"":R_PBOC0  HI0
M )>:  "+H   ?J8  '&K  !EL   6;0  $VW  !"NP  .+X! "_""0 MPQ(
M+,,> "O#*0 JQ#, *<0] "C%1P GQ5$ )L5< "7&:  CQG8!(L:& 2#&F $?
MQJL!'L?! 1[&Y $=Q/@"',+_ QS!_P,<P?\$','_!!S!_P2EE   FIH  (ZA
M  "!IP  <ZX  &>T  !:N0  3KT  $+    XPP  +\<  ";+!  >T H &]$1
M !K2&@ 9TB4 &-,O !C3.@ 7U$0 %M10 !7570 4U6L $]9\ !+7CP 1V*0
M$-F[ !#9W@ 0U?, $-/_ !#2_P$0T?\!$-'_ 1#1_P&<F@  D:$  (.H  !U
ML   :+<  %N]  !.P0  0L4  #?(   MS   )-   !S5   5V@4 $.(+ !#C
M$0 .Y!H #N0C  WE+0 ,Y3< "^9"  KF3P )YUT ".=M  ;F@  %YI4 !.:K
M  +FQ  !YN8  .?Y  #G_P  YO\  .;_  #F_P"3H0  A:D  '>Q  !IN0
M6\   $[&  !!R@  -<X  "K2   AU@  &=L  !+?   -XP  "_$(  GS#@ '
M\Q, !/(:  +R(@  \BH  /(T  #R/P  \DP  /)<  #R;0  \H(  /*8  #S
MK0  \\8  /3E  #T]@  ]/L  /3[  #T^P"'J0  >;(  &JZ  !<P@  3LD
M $#.   STP  *-@  ![=   5X0  #^0   KH   %\P   _T!  #\"   ^PT
M /L1  #[%@  _!X  /PF  #\,   _3P  /Y)  #^6@  _FT  /^"  #_F
M_ZP  /_   #_V   _^0  /_D  #_Y ![L@  ;+L  %W$  !/S0  0-(  #+9
M   FW@  &^(  !+F   ,Z@  !>T   #T    _P   /\   #_    _P0  /\)
M  #_#@  _Q(  /\8  #_(0  _RL  /\W  #_1@  _U@  /]K  #_@   _Y4
M /^F  #_LP  _[L  /^[  #_NP#_&R8 _QPD /\:) #_%2< _Q M /\*-@#_
M!4, _P%0 ?\ 7@'_ &L!_P!V ?\ @0#_ (H _P"2 /\ F@#_ *  _P"F /\
MK #_ +( _P"Y /\ P@#_ ,T _P#? /\ [ #_ /@ _P#_ /T _P#] /\ _0#_
M /T _P#] /\ _0#_ /T _P#_'R, _Q\A /\>(0#_&2, _Q,I /\.,@#_#$
M_PE- ?\'6@'_!&<!_P-S ?\#?0'_ X<!_P./ /\"E@#_ IP _P*B /\"J #_
M J\ _P&V /\!O@#_ <D _P'; /\ Z@#\ /8 ^ #_ /<"_P#W _\ ]@3_ /8$
M_P#V!?\ ]@7_ /8%_P#_(A\ _R(< /\A' #_'A\ _Q@D /\5+P#_$CP _Q!)
M /\.5@'_#&(!_PMN ?\+>0'_"X(!_PN+ ?\+D@'_"ID!_PJ? /\*I0#_"JL
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M"+,RS FQ,N4)K3/U":LS_PFJ,_\(J#/_!Z@S_P>G,_\'IS/_!Z<S_P?_-P<
M_SH  /\^  #Z00$ \4$& /$_#0#F/!( VSH? - [,0#*/$  Q#Q- < \6 *\
M.V$#N3MJ!;8Z<@:T.GH'LCF!"+ YB FO.9 *K3B8"JLXH0NI.*H,J#BV#:8X
MQ0VD.-X.H3GQ#9\Z_PR>.O\+G3K_"IPZ_PF<.O\)G#K_"9PZ_PG_.P( _SX
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M&(%*]Q6 2O\2@$O_$(!+_P^ 2_\.@$O_#H!+_P[_0P  [$L  -U3  #.6
MQ%H  +U:  "X5P$ L50. *I6'@"E5BX GU8[ 9M51@.75% %DU-8")!27PJ-
M468,BU!M#HA/=!"&3WP2A$Z%$X).CA6 39D7?DVD&'Q-LAEZ3<,:>4W?&GA.
M]!=X3_\4>$__$GA0_Q!X4/\/>%#_#WA0_P_]1@  YT\  -97  #(7   OU\
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M%69<_Q-G7/\29US_$F=<_Q+M3@  VED  ,AA  "\9P  LVH  *ML  "B:@
MF6<" ))G$0"-9R$ B&<O 81F.P)_940$>V1-!GAC5 EU8EL+<F%A#7!A:0]M
M8' 2:U]Y%&E?@Q=F7HX99%Z:&V)>J!QA7K@=7U[.'5]>[!M@7_T885__%6%?
M_Q-B7_\28E__$F)?_Q+J40  U%P  ,1D  "Y:@  L&X  *=P  ">;@  E&L
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M$U)L_Q/<7   QV<  +EO  "O=@  I7L  )Q\  "1?   @G@  'IY!P!U>10
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M$T*#G11 @JX5/X/"%3Z"XA4_@?<3/X'_$D" _Q% @/\00(#_$$" _Q#&:P
MMW8  *Q_  "BA0  EXD  (R+  "!C0  <XX  &6/  !=CPD 6I 4 %B0(0!6
MD2T 4Y X 5&000).D$D#3)!0!$J/6 5'CV '18YI"4*.<PM C7\-/HV-#SR-
MG! ZC:P1.8W!$3B-X1 XB_80.(K_#SF)_P\YB?\..8G_#CF)_PZ_<@  LGT
M *>&  "<B@  D8X  (:1  !ZDP  ;94  %^7  !4F0$ 3YD/ $Z:&@!,FB<
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M B&RVP(AK_,#(*[_ R"M_P0?K/\$'ZS_!!^L_P2JBP  G9$  ).7  "'G
M>J(  &VG  !@JP  5:\  $FQ   ^M   ,[<  "JZ P DO T (KT5 "&](  A
MO2H (+TS !^^/0 >OD< ';Y2 !R_7@ :OVP &;]\ !B_C@ 7P*$ %L"V !3
MTP 5OO$ %;S_ 16[_P$4NO\"%+K_ A2Z_P*AD@  EI@  (J>  !]I   ;ZH
M &*O  !6M   2K<  #ZZ   SO0  *L   "'$   9QP4 $\L+ !',$@ 1S!L
M$,PE  _-+P .S3H #LU&  W-4@ -SF  #,YP  O.@P *SI< "<ZL  C.Q@ (
MSN@ ",W[  G+_P )R_\ "<O_  G+_P"8F   C9X  '^E  !QK   9+,  %>Y
M  !*O0  /L   #+#   HQ@  '\H  !?-   1T0  #-8%  C9#  &V1( !=H;
M  3:)  #VRX  =LY  #<10  W5(  -YB  #><P  WH@  -^=  #?LP  W\X
M .#N  #?^@  W_\  -__  #?_P"/GP  @:8  '.N  !EM0  6+T  $K"   ]
MQ0  ,<D  ";,   =T   %-0   [9   )W0   ^$   #C!P  XPT  .02  #E
M&0  YB(  .<K  #I-@  ZT,  .Q2  #L8@  [78  .Z,  #NH0  [[<  ._1
M  #OZP  \/8  /#V  #P]@"$IP  =:\  &>W  !9OP  2\8  #S*   OS@
M)-(  !K8   2W   #.    7C    YP   .L   #K    [04  .X+  #P$
M\14  /,>  #T)P  ]S,  /E   #Z40  ^V,  /QW  #]C0  _:,  /ZV  #^
MR0  _]\  /_?  #_WP!WL   :+D  %K!  !,R@  /,\  "[4   BV@  %]X
M !#B   )Y@   .D   #L    \    /8   #V    ]P   /@   #Z!P  ^PT
M /T1  #_&0  _R,  /\O  #_/@  _T\  /]B  #_=P  _XT  /^?  #_K@
M_[H  /^Z  #_N@#_%B, _Q4A /\2(0#_#B0 _P8J /\ ,P#_ $$ _P!. /\
M7 #_ &@ _P!T /\ ?@#_ (< _P"/ /\ E@#_ )P _P"B /\ J #_ *X _P"U
M /\ O0#_ ,< _P#6 /\ YP#^ /, _@#^ /T _P#\ /\ ^P#_ /L _P#[ /\
M^P#_ /L _P#_&B  _QD> /\6'@#_$"  _PHE /\$, #_ #T _P!+ /\ 6 #_
M &0 _P!P /\ >@#_ (, _P"+ /\ D@#_ )@ _P"> /\ I #_ *H _P"Q /T
MN0#[ ,, ^@#0 /@ XP#W /$ ]@#\ /0 _P#T /\ \P#_ /, _P#S /\ \P#_
M /, _P#_'1P _QP9 /\9&0#_%!L _PXA /\,+ #_"3D _P5& /\"4P#_ %\
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M -T,_P#<#/\ W S_ -P,_P#_(Q( _R,0 /\A#@#_'A  _QX8 /\<(P#_&"\
M_Q0[ /\220#\$%4 ^ ]@ /0/:@#Q#W0 [PY\ .T.A #K#HL Z0Z2 .<.F0#F
M#J  Y ZG .(.KP#@#K@ W@[% -P.V@#6$.P TA'Z ,\2_P#-$O\!S!+_ <L3
M_P'*$_\!RA+_ <H2_P'_)P\ _R<, /\E"0#_)@T _R43 /\C' #_("@ ^QPU
M /4:0@#O&$\ ZA=: .8690#C%FX X!9W -X6?P#<%H< V1:. -86E0#4%IP
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M!*(L_P3_,@  _S,  /DX  #I.0  XCD  -XU!P#>+@T T2\; ,DQ+ ##,SL
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M#8D^LPV(/L0.AC_@#H0_] V#0/\+@T#_"H) _PF"0?\(@D'_"()!_PC_/
MZT,  -Q*  #,3P  PU   +Q.  "W20$ L48. *I(' "D22P H$DZ )M)10&8
M2$X"E$=7 Y)'7@6/1F4&C49L!XM%<PF)17L*AT2#"X5$C0R#1)<.@4.B#W]#
MKQ!^0\ 0?$3:$7M$\0]Z1?\->D;_"WI&_PIZ1O\)>D;_"7I&_PGU/@  YD@
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M%652Z11E4OL19E/_#V93_PUF4_\,9E/_#&93_PSJ20  U5,  ,5:  "Z7P
ML&(  *AB  "?7P  EEH  (]:$ "*6QX A5LL (%;. %]6T$">EI* W=9401T
M6%@&<5A?!V]79@EM5VT+:U9V#6E6?P]G58H19567$V-5I!1A5;058%7(%E]5
MYQ5@5OH28%;_#V%7_PYA5_\-85?_#&%7_PSG3   T58  ,%>  "V8P  K68
M *1F  ";9   D%X  (E>#@"$7QL @%\I 'Q?-0%X7S\"=%Y' W%=3P1O7%8%
M;%Q<!VI;8PEH6VL+9EIS#61:?0]B6H@17UF4$UY9HA1<6;(56UG&%EI9Y15;
M6OD26UK_$%Q:_PY<6O\-7%K_#5Q:_PWC3P  S5D  +YA  "S9@  J6D  *!J
M  "7:   BV(  (-B# !^8Q@ >F,F '9C,@!S8SP!;V)% FQA3 1J850%9V!:
M!V5@80AC7VD*85]Q#%]>>PY=7H816EZ3$EA=H!177; 55E[$%E5>XQ567O<2
M5E[_$%=>_PY77O\-5U[_#5=>_PW>4P  R%T  +MD  "P:@  IFT  )UN  "3
M;0  A6<  'YG"0!X9Q4 =&<C '%H+P!N9SD!:V=" FAF2@-E9E(%8V58!F!E
M7PA>9&<*7&1O#%IC>0Y88X0056*1$E-BGQ-28JX546+"%5!BX1518O8246+_
M$%)B_PY28O\-4F+_#5)B_PW95@  Q&   +=H  "L;@  HW$  )IS  "/<0
M?VL  'AK!0!R:Q( ;FP? &ML+ !H;#<!9FQ  F-K2 -@:T\$7FI6!EQJ70=9
M:64)5VEM"U5I=PU3:((/4&B/$4YGG1--9ZP42VC %$MHWA1+9_423&?_#TQG
M_PY-9_\-36?_#4UG_PW26@  P&0  +-L  "I<@  H'8  )9W  "*=@  >7$
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M"SIZ_PO :0  LG0  *=\  "=@0  DH0  (>&  ![AP  ;H<  &"'  !5AP$
M4(@. $Z(&@!-B28 2XDP $F).@!(B4(!1HE* 42)4@)"B5H#0(AC!#V(;04[
MB'@&.8>&"#>'E0DUAZ8*-(>Y"C.'TPHSAO ),X7_"3.$_PDS@_\),X/_"3.#
M_PFY<   K7H  **"  "7AP  C8H  (&,  !UC@  :(\  %J0  !/D0  1Y(*
M $22$P!#DQ\ 09,J $"3-  _DST /9-% #N330$ZDU8!.)-? C:3:0,TDW4#
M,I*#!#"2DP4NDJ0&+9*W!BR2T08LD>\&*X__!BN._P8KC?\'*XW_!RN-_P>S
M>   IX(  )R(  "1C   AY   'J3  !ME0  89<  %69  !)FP  /YP! #F=
M#@ WG1< -IXB #2>+  SGC4 ,IX^ #&>1P PGU  +I]: "V?9 $KGW$!*9Y_
M B>>D (FGJ$"))ZU B.>S@(CG>X#(YO^ R*:_P0BF?\$(IG_!"*9_P2L@0
MH(@  )6.  "+D@  ?Y8  '*:  !EG0  6:   $ZC  !"I   -Z8  "ZH!0 I
MJ0\ **D8 ">J(@ FJBP ):HU "2J/P CJD@ (JM3 "&K7@ @JVH 'JMY !VK
MBP ;JYT &JNQ !FKR@ 9JNP!&:C] 1BG_P(8IO\"&*;_ ABF_P*EB0  F8\
M (^4  "#F0  =9X  &BB  !<I@  4*D  $2L   YK@  +[   ":S   >M08
M&;</ !BW%P 7MR$ %K<J !6W-  4N#X $[A) !*X5  2N6( $;EQ !"Y@P /
MN9< #KFL  VYQ  -N.< #K;[  ZU_P .M/\ #K3_  ZT_P"<D   DI4  (:;
M  !YH   :Z8  %ZK  !2KP  1K(  #JU   OMP  );H  !V]   5P   $,,&
M  O&#@ *Q14 "<4>  C%*  'Q3( !L8]  7&20 %QE<  \9F  +&=P !QHL
M ,:@  #%M@  QM(  ,7O  #%_   Q?\  ,7_  #%_P"5E@  B9P  'NC  !M
MJ0  8*\  %.T  !&N   .KL  "Z^   DP0  &\0  !/'   .R@  ",X!  '0
M"@  T!   - 6  #1'@  TB<  -,Q  #4/   U4D  -98  #6:0  UGP  -:2
M  #6IP  UK\  -;@  #6\P  UOX  -;_  #6_P",G0  ?J0  &^K  !AL@
M5+D  $:]   YP0  +<0  "+'   9RP  $<X   S2   %U0   -L   #< P
MW0H  -X/  #?%   X1P  .(D  #D+@  YCH  .=)  #H60  Z&L  .F!  #I
MF   Z:T  .G%  #IX@  Z?(  .GU  #I]0" I0  <:T  &.U  !5O   1\(
M #G&   LR@  (,X  !;2   /U@  "-L   #?    XP   .4   #G    Z $
M .H'  #K#0  [1$  .\8  #Q(0  \RL  /8X  #W2   ^%H  /EM  #ZA
M^IL  /JO  #ZP@  ^MH  /K?  #ZWP!TK@  9;8  %:^  !(Q@  .<L  "O0
M   ?U   %-H   W?   %XP   .8   #I    [0   .\   #Q    \P   /4
M  #V @  ^ D  /H.  #]$P  _QP  /\H  #_-@  _T<  /]:  #_;@  _X4
M /^:  #_JP  _[D  /^\  #_O #_$2  _Q > /\,'@#_!"$ _P G /\ , #_
M #X _P!, /\ 60#_ &4 _P!P /\ >@#_ (, _P"+ /\ D@#_ )@ _P"> /\
MI #_ *H _P"P /\ N #_ ,( _P#. /\ X@#^ /  _0#[ /L _P#[ /\ ^P#_
M /H _P#Z /\ ^@#_ /H _P#_%!P _Q(: /\.&@#_"!P _P A /\ +0#_ #H
M_P!( /\ 50#_ &$ _P!L /\ =@#_ '\ _P"' /\ C@#_ )0 _P": /X H #]
M *8 _ "L /L M #Y +T ^ #) /< W #U .P \P#X /, _P#R /\ \0#_ /
M_P#P /\ \ #_ /  _P#_%Q@ _Q46 /\1%0#_#!< _P4= /\ * #_ #8 _P!#
M /\ 4 #_ %P _P!G /\ <0#_ 'H _ "" /H B0#X )  ]P"6 /4 G #T *(
M\P"H /$ L #P +@ [@## .P TP#J .< Z0#U .< _P#F /\ Y0#_ .4 _P#E
M /\ Y0#_ .4 _P#_&A, _Q@1 /\4$ #_#Q$ _PT9 /\*) #_!3  _P$^ /\
M2P#_ %< _@!B /H ; #U '4 \@!] /  A #N (L [ "1 .L EP#I )X YP"D
M .8 K #D +0 X@"_ .  S0#> ., W #R -H _0#8 /\ U@#_ -4!_P#5 ?\
MU0+_ -4"_P#_'A  _QP- /\7"P#_%0X _Q05 /\1'P#_#BH _PLX /T(10#X
M!E$ ] 1< .X$9@#J!&\ Y@-W .0$?P#B!(8 X 2, -X$DP#=!9H VP6@ -@%
MJ #5!;$ T@6[ - &R0#.!^  S CQ ,D*_P#'"_\ Q@S_ ,4,_P#%#/\ Q0S_
M ,4,_P#_(0P _R & /\< P#_'0H _QL0 /\8& #_%", ]A$P .\./@#J#DH
MY0U6 .$-8 #=#6D V0UQ -4->0#3#8$ T0V( ,\-CP#-#I8 RPZ= ,H.I0#(
M#JX Q@^Y ,00R #"$-\ OA'R +L2_P"Y$_\ MQ/_ ;83_P&V$_\!MA/_ ;83
M_P'_)08 _R,  /\C  #_) , _R$* /T=$0#Q&AL Z!8G .$4-0#:$T, TQ1/
M ,X560#+%6, R!9K ,46<P##%WL P1>" , 8B0"^&)  O!B8 +L9H "Y&:D
MMQFT +4:P@"T&M8 L!OM :T<_ &K'?\!J1W_ :D=_P&H'?\!J!W_ :@=_P'_
M*   _R<  /XJ  #O*@  YR<! .<B"0#D'1  V1L= ,\=+0#)'CP Q"!) +\@
M4P"\(5T N2%E +<B;0"U(G0 LR)\ +$B@P&P(HH!KB*2 :PCFP&K(Z0!J2.O
M :<CO &F),X!HR3H J E^0*>)?\"G27_ IPE_P*;)?\"FR7_ ILE_P+_+
M_RT  .TR  #B-   VC,  -,N P#2)0H R247 ,$G)P"[*38 MBI# +(K3@"O
M*U< K"M@ *HK9P&H*V\!IBMV :0K?0&C*X0"H2N- I\KE0*>*Y\"G"NJ YHK
MM@.9+,<#ERSB Y0M]022+?\#D2W_ Y N_P.0+?\#D"W_ Y M_P/_,   \C,
M .0Z  #6/0  S#P  ,<Y  ##,04 O2X1 +4P(0"P,C  JS,] *<S20"D,U(
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M2@  O$L  +5)  "O0P  J3X+ *(_%P"=0"8 F$$T )1!/P"104D!CD%1 8M
M60*)0& #AT!G X4_;02#/W4%@3]]!G\^AP=]/I$(>SZ<"7H^J0EX/K@*=S_-
M"G4_Z@IT0/P(=$#_!W1 _P9S0/\&<T#_!G- _P;Q.P  WT4  ,Q,  "_3P
MME   *Y/  "G2@  H$0' )I%% "51B( D$8P (Q'/ ")1D4!AD9. 8-&50*!
M15P#?D5C!'Q$:@1Z1'$%>41Y!G=$@@AU0XT)<T.9"G%#I@MP0[4,;D3)#&U$
MYPQM1?H*;$7_"&Q%_P=L1?\';$7_!VQ%_P?L/P  V$D  ,=0  "[5   L54
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M"EM2_PE;4?\(6U'_"%M1_PC?2@  R5,  +M:  "P7P  IF$  )UA  "47@
MB%<  (!6"@!Z5Q4 =E<B '-8+@!P5SD ;5=! 6I720)H5E "9E97 V167@1B
M564%8%5M!UY5=PA<58(*6E6.#%E5G U75:L.5E6^#U55VP]55?,-557_"U95
M_PE65?\)5E7_"%95_PC;30  Q5<  +A>  "M8@  HV4  )IE  "08P  @UP
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M"$=B_PC*6   NF(  *YI  "C;@  FG$  )!R  "$<0  =&L  &EI  !C:0L
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M!3AXD08W>*$'-7BS!S1XRP<T=^L'-';]!S1U_P<U=?\&-73_!C5T_P:Y:
MK7$  *)Y  "8?@  C8   (*!  !V@@  :8$  %N!  !1@0  2( * $6!$P!#
M@1X 0H(I $&",@! @CL /H)# #V"2P [@E,!.8)< 3>"9@(U@G$#,X)_ S&!
MC@0P@9\$+H&Q!2V!R 4M@>D$+7_\!2U^_P4M??\%+7W_!2U]_P6S;@  J'@
M )U_  "2@P  B(8  'V'  !PB   8XD  %6*  !+B@  08H" #N+#@ YBQ<
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M !&EOP 0I.( $:+X !&A_P 1H/\!$:#_ 1&@_P&@A@  E8P  (R1  !_E0
M<9H  &2>  !8H0  3*0  $"F   UIP  *JD  "*L   9K@  $K ) !"Q$  0
ML1@ #K$B  ZQ*P -L34 #;%   RQ2P +L5@ "K%G  BQ>  'L8L !;&@  2P
MM0 $L-  !+#O  6O_@ &KO\ !J[_  :N_P"8C@  CY,  (*8  !UG0  9Z(
M %JG  !.JP  0:T  #6O   KL0  (;0  !BV   1N0  #;P#  >^#  #O1(
M ;T9  "^(@  OBL  +XV  "^00  OTX  +]<  "_;0  OX   +Z5  "^J@
MOL(  +WD  "]]@  O?\  +W_  "]_P"2E   A9H  'B@  !JI@  7*L  $^P
M  !"LP  -;8  "JX   @NP  %[X  !#!   +Q   !,<   #)!P  R0T  ,D2
M  #*&0  RR(  ,LK  #--0  SD$  ,Y0  #/8   SW(  ,^'  #/G0  S[,
M ,_.  #/ZP  SO@  ,[^  #._@"(FP  >J(  &RH  !>KP  4+4  $*Y   U
MO   *;\  !["   5Q@  #LD   C,    T    -,   #5    U@8  -@,  #9
M$0  VQ8  -P?  #>*   X#0  .)!  #B40  XV,  .-W  #DC@  Y*0  .2Z
M  #EU   Y>H  .7S  #E\P!\HP  ;JH  &"R  !1N0  0[X  #7"   HQ@
M',D  !/-   ,T0  !-4   #:    W@   .$   #B    Y    .4#  #G"0
MZ0X  .L2  #M&@  [R0  /(Q  #T00  ]%,  /5F  #U?   ]I,  /:I  #W
MO   ]\X  /??  #WWP!PK   8;0  %.[  !%PP  -L<  "?,   ;T   $=4
M  K;    WP   .(   #E    Z0   .P   #M    \    /$   #S    ]00
M /<*  #Z$   _!8  /\A  #_+@  _T   /]3  #_:   _X   /^6  #_J
M_[8  /^_  #_OP#_#1P _PH; /\"&P#_ !X _P D /\ +@#_ #P _P!* /\
M5@#_ &, _P!M /\ =P#_ '\ _P"' /\ C@#_ )0 _P": /\ H #_ *8 _P"L
M /\ M #_ +T _P#) /X W0#] .T _ #Z /L _P#Z /\ ^0#_ /H _P#Z /\
M^@#_ /H _P#_$!D _PT7 /\&%@#_ !@ _P > /\ *@#_ #< _P!% /\ 4@#_
M %X _P!I /\ <@#_ 'L _P"" /\ B0#_ )  _@"6 /T G #\ *$ ^P"H /D
MKP#X +@ ]@## /0 T@#S .< \@#V /  _P#O /\ \ #_ .\ _P#O /\ [@#_
M .X _P#_$A0 _P\2 /\+$@#_ !( _P : /\ )0#_ #, _P!  /\ 30#_ %D
M_P!D /T ;0#[ '8 ^0!] /< A #U (L ] "1 /, EP#Q )T \ "C .X J@#L
M +, Z@"] .@ RP#G .$ Y0#Q ., _0#C /\ X@#_ .$ _P#A /\ X #_ .
M_P#_%!  _Q$. /\-#0#_!P\ _P(5 /\ ( #_ "T _P Z /\ 1P#Y %, ]0!>
M /( : #P '  [0!X .L ?P#I (4 Z ", .8 D@#E )@ XP"? .$ I@#? *X
MW "X -H Q0#6 -D U #L -( ^0#1 /\ SP#_ ,X _P#. /\ S@#_ ,X _P#_
M%PP _Q0( /\/!0#_#@L _PP1 /\'&@#_ 28 _  T /0 00#M $T Z0!8 .8
M8@#C &H X !R -X >0#; (  V0"& -8 C0#3 ), T0": ,\ H0#- *H RP"S
M ,D OP#& -  Q0#H ,, ]@#! /\ P +_ +\#_P"_ _\ OP/_ +\#_P#_&P8
M_Q<  /\4  #_$P4 _Q$- /\.% #Y"A\ \ 8L .8#.0#@ T8 W -1 -8$6P#2
M!&0 SP5L ,P%<P#*!7H R 6! ,8%AP#%!HX PP:6 ,$&G0"_!J8 O0:P +L'
MO "Y",T N KE +4+]P"S#?\ L0W_ + -_P"P#O\ KP[_ *\._P#_'@  _QL
M /\;  #Z&@  ]18% /81#0#K#A4 X@LB -@+,0#0##X RPU* ,<-50#$#EX
MP0YF +\.;0"]#G0 NP][ +D/@@"W$(H MA"1 +00F@"R$*, L!&M *\1N@"M
M$<H JA+E *<4]P"E%?\ HQ7_ *(5_P"B%?\ HA7_ *(5_P#_(@  _R   / C
M  #F)   X"$  -P9!0#;$ P T!$9 ,@3*0#"%3< O19$ +D73@"U%U< LQA@
M + 89P"N&&X K!EU *L9? "I&80 J!J, *8:E "D&IX HQNH *$;M "?',4
MGAS? )H=\P&8'O\!EQ[_ 98?_P&5'_\!E1__ 94?_P'_)@  ]"<  .8M  #:
M+P  SRT  ,HG  #''P@ P1P3 +H>(@"T'S$ KR ] *LA2 "H(E( IB): *,C
M8@"A(VD H"-O )XC=P"<(WX FR.& )DDCP&7))D!EB2C 90DL &2);\!D276
M 8XF[P&,)_\"BR?_ HHG_P*))_\"B2?_ 8DG_P'Z*0  [#   -TV  #-.
MQ#<  +XR  "Z*P( M24. *XG'0"H*2L I"HX * J0P"=*TP FBM5 )@K7 "6
M*V, E"MJ 9(K<0&0+'@!CRR! 8TLB@&++)0"BBR? H@LJP*&++H"A2W. X,N
MZ@.!+OP#@"[_ G\N_P)_+O\"?B[_ GXN_P+T+@  Y#<  -(]  #%/P  NS\
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M!69 _P1F0/\$9C__!&8__P3E/0  ST8  +],  "T3P  JE   *)/  "92@
MD40  (I!#0"$0AD @$,F 'U$,@!Z1#P =T1$ '5$3 %R1%,!<$-9 6]#8 )M
M0V<":T-O VE#>01H0X,%9D./!F1#G0=C0ZL'84.]"&!$V0A@1/,'8$3_!E]$
M_P5?1/\$8$3_!&!$_P3@00  RDH  +M0  "P4P  IU4  )Y3  "53P  BTD
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M!5!0_P702P  OU0  +):  "G7@  G6   )1@  ")70  ?%<  ')4  !L4PX
M:%09 &54) !B5"\ 8%0X %Y40 !<5$@!6E1/ 5E45@%75%T"551E U14;@12
M5'D%4%2&!DY4E =-5*0(2U2U"$M4S E*5.L(2U3^!TM4_P9+5/\%2U3_!4M4
M_P7,3@  NU<  *Y>  "D8@  FF0  )%D  "&8@  =UL  &U8  !F6 P 8E@6
M %]8(@!=62P 6UDV %E9/@!7648 5EE- 5195 %265L"45EC T]9; --67<$
M2UB$!4E8D@=(6*('1UFS"$99R@A%6>H(1EG]!D98_P9&6/\%1UC_!4=8_P7'
M4@  N%L  *MA  "A9@  F&@  (YI  "#9P  <F   &A>  !A70D 7%T3 %I=
M'@!772D 5EXS %1>.P!27D, 45Y* 4]>4@%.7ED"3%YA DI>:@-(7G4$1EZ"
M!41=D 9#7J '05ZQ!T!>R = 7N@'0%W\!D%=_P5!7?\%05S_!4%<_P7#5@
MM%\  *AF  ">:@  E6T  (IM  !_;   ;V<  &1D  !;8@4 5F(0 %1B&P!2
M8R4 4&,O $YD. !-9$  2V1( $ID3P%(9%<!1F1? D5D: )#9',#06-_!#]C
MC@4]8YX&/&.P!CMDQ@8[9.8&.V/Z!3MB_P4[8O\%/&'_!#QA_P2^6P  L&,
M *5J  ";;P  D7(  (9R  ![<0  ;&T  &!K  !5:0  3V@- $UI%P!+:2$
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M B=[OP(F>^$")GKW B9X_P(F>/\")W?_ B=W_P*N;   HW8  )E\  ".?P
MA((  'B#  !LA   7X0  %&$  !'A   /(0  #.$"0 PA!$ +X0: "V$)  L
MA2T *X4U "J%/@ IA4< *(90 ">&6@ FAF8 )(9S ".&@P AAI4 ((:G 1Z&
MO $>AMX 'H3U 1Z"_P$>@O\!'H'_ 1Z!_P&H=   GGT  )."  ")A0  ?H@
M '&*  !EBP  6(P  $R-  ! C@  -HX  "R/   ED P (Y 3 "*0'  AD"4
M()$N !^1-@ >D4  '9%) !R15  :D6  &9%N !B1?@ 6DI  %9*D !21N0 3
MD=@ $X_T !2._P 4C?\ %(S_ 12,_P&C?0  F(,  (Z(  "$C   =X\  &F1
M  !=DP  4)4  $67   YF   +ID  "6:   =FP( %IT, !6=$P 4G1L $YTD
M !*=+0 1GC< $9Y! !">3  /GE@ #IYG  V>=P ,GHH "YV>  J=L@ )G<P
M"9SL  J;_@ +FO\ "YG_  N9_P"<A   D8H  (B.  ![D@  ;98  &"9  !4
MG   2)\  #R@   PH0  )J,  !VE   5IP  $*D%  NK#0 (JA, !ZH;  :J
M)  %JBX !*HX  *J1  !JE   *I>  "J;@  JH$  *J5  "IJ@  J<$  *CD
M  "H]@  I_\  *?_  "G_P"5BP  C)   '^5  !QF@  8YX  %:B  !*I@
M/:@  #&J   FJP  ':T  !2P   .L@  ";4!  *V"@  M@\  +85  "W'0
MMR4  +<O  "X.0  N$8  +A4  "X9   N'8  +B+  "WH   M[8  +?3  "V
M[P  MOP  +;_  "V_P"/D@  @I<  '2=  !FH@  6*<  $NL   ^KP  ,;$
M ":S   <M@  $[@   V[   &O@   ,$   #"!   P@L  ,,0  #$%0  Q!P
M ,4D  #&+@  R#H  ,E'  #)5P  R6D  ,E]  #)E   R*H  ,C#  #(Y
MR/0  ,C]  #(_0"%F0  =Y\  &BF  !:JP  3;$  #^U   QN   );H  !J]
M   1P   "\,   /'    R@   ,T   #.    SP,  - )  #1#@  TQ(  -49
M  #7(@  VBT  -TY  #>20  WEH  -]N  #?A0  WYP  -^R  #>RP  WN8
M -_T  #?] !YH0  :Z@  %RO  !.M0  0+L  #&^   DP0  &<4  !#(   )
MS    ,\   #3    V0   -P   #=    WP   .$   #B!0  Y L  .80  #H
M%@  ZB   .TK  #P.@  \4L  /%>  #R<P  \XL  /.B  #SM@  \\D  //A
M  #SX0!MJ@  7K$  %"Y  !!OP  ,L0  "3(   7S   #M    ;5    V@
M -X   #B    Y@   .D   #J    [    .X   #P    \@   /0&  #V#
M^1(  /P<  #_*0  _SH  /]-  #_8@  _W@  /^0  #_HP  _[,  /_!  #_
MP0#_!QD _P$7 /\ %P#_ !H _P A /\ *P#_ #D _P!' /\ 5 #_ %\ _P!J
M /\ <P#_ 'L _P"# /\ B@#_ )  _P"6 /\ FP#_ *$ _P"H /\ KP#_ +@
M_P#$ /X U0#\ .H ^P#X /H _P#Y /\ ^ #_ /@ _P#V /\ \P#_ /$ _P#_
M"Q4 _P43 /\ $P#_ !0 _P : /\ )P#_ #0 _P!" /\ 3P#_ %L _P!E /\
M;@#_ '8 _P!^ /\ A0#^ (L _0"1 /L EP#Z )T ^ "C /< JP#V +, ] "^
M /, S #Q ., [P#S .X _P#M /\ [ #_ .L _P#L /\ [ #_ .L _P#_#1$
M_PD0 /\ #P#_ !  _P 6 /\ (@#_ "\ _P ] /\ 2@#_ %4 _0!@ /H :0#X
M '$ ]@!Y /0 ?P#S (8 \0", .\ D@#N )@ [ "? .L I@#I *X YP"X .4
MQ0#C -H X0#M -\ ^P#> /\ W0#_ -T _P#= /\ W0#_ -T _P#_#PT _PP+
M /\#"0#_  P _P 2 /\ '0#_ "D ^P W /@ 1 #U %  \@!: .X 8P#L &L
MZ0!S .< >@#E (  XP"& .$ C #? ), W0"9 -L H0#9 *D U0"R -( O@#0
M ,X S@#F ,P ]@#* /\ R@#_ ,D _P#( /\ R #_ ,@ _P#_$0@ _PT" /\'
M  #_!0@ _P . /\ %@#W "( [P P .L /0#H $D Y !4 .  70#= &4 V0!M
M -4 <P#2 'H T "  ,X AP#, (T R@"4 ,@ FP#& *0 Q "M ,( N #  ,<
MO0#? +P \0"[ /X N0#_ +@ _P"X /\ N #_ +@ _P#_%   _P\  /\-  #_
M#   _P<) /@!$ #H !H XP H -T -@#8 $( T@!- ,X 5P#* %\ QP!F ,4
M;0## '0 P0!Z +\ @0"] (@ NP"/ +D EP"W )\ M0"H +, LP"Q ,( KP#8
M *X"[0"L _L JP7_ *H&_P"I!O\ J0;_ *D&_P#_%@  _Q(  /<2  #L$0
MY@X  .4&" #= Q( U ,@ ,T$+0#(!#H PP5& +\%4 "\!E@ N09@ +<'9P"U
M!VX LP=U +$(>P"O"(( K@F* *P)D@"J"9L J JE *8*L "E"[\ HPS4 *$-
M[0"?#OX G0[_ )P/_P";#_\ FP__ )L/_P#_&@  ]QD  .H>  #?'@  U1H
M - 3 @#.# L QPL6 , -)0"Z#C( M@X_ +(/20"O$%( K!!: *H080"H$6@
MIA%O *01=@"B$7T H1&% )\2C@"=$I< G!*B )H3K0"8$[P EQ30 )05[ "2
M%OT D!?_ (\7_P".%_\ CA?_ (X7_P#Z'0  [B,  -\H  #0*@  QR<  ,$A
M  "]&04 N1(0 +(5'@"M%BP J!<X *080P"A&4P GQE4 )P:7 ":&F( F1II
M )<;< "5&W< E!M_ )(<B "0')( CQR= (T=J0"+';< BA[* (@?YP"&(/H
MA"#_ 8,@_P&#(/\!@B#_ 8(@_P'U)   Y2P  -,Q  #&,P  O#$  +8M  "P
M)0  K!T, *8>& "A("8 G"$R )DB/0"5(D< DR-/ )$C5@"/(UT C21D (LD
M:P"))'( B"1Z (8D@P"$)8T @R68 8$EI & )K(!?B;% 7TGX@%[)_<!>2C_
M 7@H_P%X*/\!>"C_ 7@H_P'O*P  W3,  ,HY  "^.P  M#H  *TV  "F+P
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M ED^_P+6/P  PT<  +5,  "J4   H%   )=/  ".2P  A$4  'I !@!U/Q$
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M TY*CP-,2Y\$2TNP!$I+Q01)2^8$24OZ!$E+_P-*2_\#2DO_ TI+_P/(20
MN%$  *Q7  "A6P  F%P  (Y<  "#60  =E,  &M.  !D30H 7TP3 %Q-'@!:
M32@ 6$TQ %9-.@!434$ 4TY( %).3P!03E<!3TY? 4U.: %,3G,"2D]_ DE/
MC0-'3YT$1D^N!$5/PP1$4.0$1$_Y!$5/_P-%3_\#14[_ T5._P/$3   M54
M *E;  "?7@  E6   (M@  " 7@  <E<  &=3  !>40< 65$1 %=1&P!4424
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M S5>O0,T7]T#-%[U S5=_P(U7?\"-5S_ C5<_P*X60  JF$  *!G  "6;
MC&X  (%N  !V;   9VD  %QF  !19   2&() $1B$0!"8AL 06,D #]C+0 ^
M8S4 /60] #QD10 [9$T .615 #AD7P V9&D!-61V 3-DA0$Q994",&6G B]E
MNP(N9=H"+F3T BYC_P(O8_\"+V+_ B]B_P*S7@  IV8  )QM  "3<0  B',
M 'US  !R<@  9'   %AN  !-;   0FH# #QI#@ Z:A8 .6H@ #AJ*  V:S$
M-6LY #1K00 S;$D ,FQ2 #%L7  O;&8 +FQS "QL@@$J;),!*6RE 2ALN0$G
M;=8!)VOR 2=J_P$G:O\!*&G_ BAI_P*N9   HVP  )ES  ".=@  A'@  'EY
M  !M>   8'<  %-V  !(=0  /G,  #1R"@ Q<Q$ ,',: "]S(P N<RL +70T
M "QT/  K=$0 *71- "AU5P G=6, )75O "1U?P B=9  (76B "!UMP ?==(
M'W3Q !]S_P$?<O\!(''_ 2!Q_P&I:P  GG,  )1Y  "*?   @'X  '1_  !G
M?P  6G\  $U^  !#?@  .'T  "]] @ H?0T )GT4 "1]'  C?B4 (GXM "%^
M-@ A?C\ 'W]( !Y_4@ =?UX '']K !I_>@ 9?XP %W^? !9_LP 5?\X %7[O
M !9\_P 6>_\ %GO_ !=[_P"D<@  FGH  (]_  "%@@  >X0  &V&  !@AP
M5(<  $B(   \B   ,H@  "B(   @B 4 &HD. !F)%0 8B1T %XHF !:*+@ 5
MBC< %(I! !.*3  2BU@ $8ME !"+=0 /BX< #HJ;  V*KP ,BL@ #(GJ  V'
M_  .A_\ #H;_  Z&_P"?>P  E($  (J%  " B   <XL  &6-  !9CP  3)
M $&2   TD@  *I(  "&3   9E   $I8&  Z7#@ -EQ4 #)<=  R7)@ +ER\
M"I<Y  F71  (EU  !I=>  67;@ #EH   9:4  "5J   E;X  )3@  "4]
MD_\  9+_  &2_P"8@@  CH@  (6,  !WCP  :I(  %V5  !0F   1)H  #B;
M   LG   (IT  !F>   2H   #:("  >C"P !HQ   *,7  "C'P  HR<  *,Q
M  "D/   I$@  *16  "D90  HW<  *.+  "CH   HK8  *'2  "A\   H/L
M *#_  "@_P"1B@  B8X  'N2  !MEP  8)L  %.>  !&H0  .:,  "VD   C
MI@  &:@  !&J   ,K   !:X   "O!P  KPT  *\1  "P&   L"   +$H  "Q
M,@  LCX  +),  "R6P  LFP  +*!  "QEP  L:P  +#&  "PZ   K_<  *__
M  "O_P",D   ?Y4  '&:  !CGP  5:0  $>H   ZJ@  +:P  "*N   8L
M$+,   JU   "N    +L   "[    O <  +P-  "]$0  OA8  +\>  # )P
MP3(  ,)   ##3P  PV   ,-T  ##BP  PZ$  ,.X  #"UP  PN\  ,+Z  #!
M_@"!EP  <YT  &6C  !7J   2:T  #NQ   MLP  (;8  !:Y   .NP  ![X
M  #!    Q0   ,<   #(    R0   ,H%  #+"P  S0\  ,X4  #0'   TR8
M -8R  #800  V%,  -EF  #9?   V90  -FK  #9PP  V>$  -GP  #9] !V
MGP  9Z8  %FL  !+L@  /+<  "ZZ   AO0  %<    W$   %QP   ,H   #.
M    T@   -4   #6    V0   -L   #=    WP<  .$,  #C$0  YAD  .DD
M  #L,@  [4,  .Y6  #O:P  [X0  .^<  #OL@  [\8  ._=  #OY !JJ
M6Z\  $RV   ^O   +\   "#$   4R   #,P   +0    U    -D   #>
MX@   .4   #F    Z    .D   #L    [@   / "  #R"0  ]0\  /@7  #\
M(P  _S,  /]&  #_6@  _W$  /^)  #_GP  _[$  /_   #_Q@#_ !4 _P 4
M /\ % #_ !< _P = /\ * #_ #< _P!$ /\ 40#_ %P _P!F /\ ;P#_ '<
M_P!^ /\ A0#_ (L _P"1 /\ EP#_ )T _P"D /\ JP#_ +0 _@"_ /T S@#[
M .8 ^0#V /@ _P#W /\ ]P#_ /< _P#P /\ [ #_ .D _P#_ Q( _P 0 /\
M$ #_ !$ _P 7 /\ ) #_ #( _P _ /\ 3 #_ %< _P!A /\ :@#_ '( _P!Y
M /T @ #\ (8 ^@", /D D@#X )@ ]@"? /4 I@#T *X \@"Y /  Q@#N -X
M[0#P .L _@#J /\ Z0#_ .D _P#G /\ XP#_ .  _P#_!PX _P - /\ "P#_
M  P _P 3 /\ 'P#_ "P _P Z /\ 1@#^ %( ^P!< /@ 90#U &P \P!T /$
M>@#O ($ [@"' .P C0#J ), Z0": .< H0#F *D XP"S .$ OP#? -  W0#I
M -H ^0#9 /\ UP#_ -4 _P#5 /\ U0#_ -0 _P#_"0H _P$% /\  P#_  D
M_P 0 /\ &0#[ "8 ]P T /0 0 #R $P [@!6 .H 7P#G &< Y !N .( = #@
M 'L W@"! -P AP#: (T U@"4 -0 FP#1 *, SP"M ,P N #* ,< R #@ ,8
M\P#% /\ PP#_ ,, _P## /\ PP#_ ,, _P#_"P$ _P,  /\   #_  , _P +
M /, $@#N !\ Z@ M .8 .@#B $4 W@!/ -D 6 #4 &  T0!H ,X ;@#, '0
MR@![ ,@ @0#& (< Q ". ,( E@#  )X O@"G +L L@"Y ,  MP#4 +4 [ "S
M /L LP#_ +( _P"R /\ L0#_ +$ _P#_#0  _P8  /\#  #W    ]  # .<
M#0#@ !@ V@ E -, ,@#. #X R@!) ,8 4@## %H P !A +X : "\ &X N@!T
M +@ >P"V ($ M "( +( D "P )D K@"B *P K0"J +H J #+ *8 Y@"E /<
MI #_ *, _P"B /\ H@#_ *( _P#_$   ^PP  .\.  #F#0  WPD  -H !@#0
M !$ R0 = ,0 *@"_ #< NP!" +< 2P"T %0 L@!; *\ 8@"M &@ JP!N *D
M=0"H 'L I@"# *0 BP"B )0 H "> )X!J "< K4 FP/& )D%X@"8!O0 E@C_
M )4)_P"4"?\ E G_ )0)_P#\$0  \14  .,9  #6&0  S!4  ,<0  #$!PH
MO0,4 +<$(0"R!BX K@@Z *H)1 "G"4T I I5 *(*7 "@"F( G@MI )P+;P";
M"W8 F0Q^ )<,A@"6#)  E R: )(-I@"1#;, CPW% (T.X@"+$/8 B1#_ (@1
M_P"'$?\ AQ'_ (<1_P#V&0  YR   -8D  #()0  OR(  +D<  "T% $ L0T.
M *H.&0"E#R< H1 S )T1/@":$4< F!)/ )425@"3$EP D1)C ) 3:0".$W
MC!-X (L3@0")%(L AQ26 (85H@"$%;  @Q;! ($7W0!_&/0 ?1G_ 'P9_P!\
M&?\ >QG_ 'L9_P#O(0  W2D  ,HM  "^+P  M2P  *XG  "H(   HQ<( )X6
M$P"9%R$ E!DM )$:. ".&D$ BQM) (D;4 "'&U< A1Q> (0<9 ""'&L @!QS
M '\=? !]'88 ?!Z1 'H>G@!X'ZL =Q^\ '8@U !T(?  <B'_ '$B_P!Q(?\
M<2'_ '$A_P#H*   TC   ,(U  "W-P  K34  *4Q  ">*P  F"," )(>$ "-
M(!L B2$G (8B,@"#(SP @2-$ 'XC2P!\)%( >R19 'DD7P!W)&8 =B5N '0E
M=P!S)8$ <2:- &\FF0!N)J< ;2>X &PGS@%J*.T!:2G_ 6@I_P%H*?\!:"C_
M 6@H_P'A+@  RS8  +P[  "Q/0  IST  )\Y  "7,P  CRT  (@G# "#)Q8
M?R@B 'PI+0!Y*C< =RH_ '4J1P!S*TX <2M4 ' K6P!N*V( ;"MJ &LL<@!I
M+'T :"R) &8ME@%E+:0!9"ZT 6,NR@%A+^D!8"_] 6 O_P%@+_\!8"__ 6 N
M_P':-   Q3P  +=!  "L0P  HD,  )E   "0.@  B#0  ( N" !Z+1( =RX>
M ',O*0!Q,#, ;S [ &TP0P!K,4H :3%1 &<Q5P!F,5X 9#%F &,R;P!A,GD
M8#*% 5\RD@%=,Z$!7#.Q 5LTQ@%:-.8!637[ 5DU_P%9-/\!633_ 5DT_P'2
M.   P$   +-%  "H2   GD@  )5&  "+0   @CL  'DU! !S,Q  ;S0: &PT
M)0!I-2\ 9S4W &4V/P!C-D8 8C9- & V5 !?-EL 73=C %PW:P!;-W8!63>"
M 5@XCP%6.)X!53BO E0YPP)3.>0"4SKY 5,Y_P%2.?\!4SG_ 5,Y_P'-/
MO$0  *])  "D3   FDP  )%+  "'1@  ?4   ',[  !L. T :#D7 &4Y(@!C
M.BL 8#HT %XZ/ !=.D, 6SI* %H[4 !8.U@ 5SM@ %8[: !5/',!4SQ_ 5(\
MC0%0/9P!3SVL DX^P0)-/N$"33[X DT^_P%-/O\!33W_ 4T]_P')0   N$@
M *Q-  "A4   EU$  (Y/  "$2P  >44  &Y   !F/0L 8CT4 %\]'@!</B@
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M C]*NP(^2]@"/DKS CY*_P(^2?\!/TG_ 3])_P&]2@  KU(  *-8  "96P
MD%T  (9<  ![60  ;5,  &)/  !73 $ 44H- $Y*%0!,2Q\ 2DLH $E+, !'
M2S@ 1DP_ $5,1@!$3$X 0TU6 $)-7P! 36H /TUV 3U.A $\3I0!.TZE 3E/
MN0(Y3]0".4_R 3E._P$Y3O\!.4W_ 3I-_P&Z3@  K%8  *%;  "77P  C6$
M (-A  !X7@  :5@  %]6  !44@  3$\+ $E/$@!'4!P 15 E $-0+0!"4#4
M05$\ $!11  _44P /E)4 #Q270 [4F< .E)S #A3@@$W4Y(!-5.D 313MP$S
M5-$!,U/Q 313_P$T4O\!-%+_ 312_P&V4@  J5H  )Y@  "49   BV8  (!E
M  !T8P  9EX  %Q<  !16   1U4' $)5$ ! 51@ /U8A #U6*@ \5C( .U8Y
M #I700 Y5TD .%=1 #=86@ U6&4 -%AQ #)8@ $Q6) !+UFB 2Y9M0$M6<\!
M+5GO 2Y8_P$N5_\!+E?_ 2Y6_P&R5P  I5\  )ME  "1:0  AVH  'QJ  !Q
M:   8V4  %AB  !-7P  0UT" #Q;#0 Z7!0 .%P= #=<)@ U72X -%TV #-=
M/@ R748 ,5Y. #!>5P O7F( +5YN "Q??0 J7XX *5^@ "A?LP$G7\P )U_M
M 2=>_P$G7?\!*%W_ 2A<_P&M7   HF0  )AJ  ".;@  @V\  'EO  !N;@
M8&L  %1I  !)9P  /V4  #5C"0 R8Q$ ,&,9 "]D(0 N9"D +60Q "QD.0 K
M94( *F5* "AE5  G95\ )F9K "1F>@ C9HL (F:= "!FL0 ?9LD 'V;K "!E
M_@ @9/\ (&/_ 2%C_P&I8@  GFH  )5P  "*<P  @'4  '5U  !I=   7'(
M $]Q  !$;P  .FX  #!M P I; T )VP4 "9L'  E;20 )&TL "-M-  B;3T
M(6Y& "!N4  >;EL '6YG !QN=@ :;H< &6^: !AOK@ 6;\8 %F[I !=M_  8
M;/\ &&O_ !AK_P"D:0  FG$  )!V  "&>0  ?'L  '%[  !D>P  5WH  $IY
M   _>   -7@  "MW   B=@< '78/ !QW%@ ;=QX &G<F !EW+@ 8=S< %WA
M !5X2@ 4>%8 $WAC !)X<@ 1>(, $'B7  ]XJP .>,, #G?F  YV^@ /=?\
M$'7_ !!T_P"?<0  E7@  (M\  ""?P  =X$  &J"  !=@@  4((  $2"   X
M@@  +H(  "2"   <@@  %(() !&#$  0@Q8 $(,>  Z#)P .@S  #8,Y  V#
M1  ,@U  "X-=  F#;  (@WX !H.1  6"I0 #@KL !(';  2!\@ %@/\ !G__
M  9__P":>0  D'X  (:#  !]A0  ;X<  &*)  !5B@  28L  #V,   QC
M)HP  !V-   5C@  #X\#  J0#  &D!$ !(\8  ./(  !CRD  (\R  "0/0
MD$D  (]6  "/90  CW8  (^*  ".GP  CK0  (W/  ",[@  C/L  (O_  "+
M_P"4@   BX4  (*)  !TC   9H\  %F1  !,DP  0)4  #26   HE@  'I<
M !68   /F@  "IL   *<"0  G X  )P3  "<&@  G"(  )TK  "=-0  G4
M )U.  "=7   G6X  )R!  "<EP  G*P  )O&  ":Z   F?D  )G_  "8_P".
MB   AHP  'B0  !JE   7)<  $^:  !"G0  -IX  "F?   ?H0  %:(   ZD
M   (I@   *@   "I!   J0H  *D.  "I$P  JAH  *HB  "K*P  K#8  *Q$
M  "L4P  K&,  *QW  "KC@  JZ0  *N\  "JW@  J?0  *G]  "I_P")C@
M>Y,  &V7  !?G   4:   $2D   VI@  *J@  !ZI   4JP  #:X   :P
ML@   +4   "U    M0,  +8)  "W#@  N!(  +@9  "Z(0  NRL  +PX  "]
M1P  O5@  +UK  "]@0  O9D  +VP  "]S   O.H  +SW  "[_@!^E0  <)L
M &*@  !3I0  1JH  #BM   JKP  'K$  !.T   ,MP   [D   "\    OP
M ,(   #"    PP   ,0   #&!@  QPP  ,@0  #*%@  S"   ,\K  #0.@
MT4L  -%>  #2<P  THL  -*D  #3NP  T]@  -/M  #3]@!SG0  9*,  %:I
M  !'KP  .;,  "JV   =N0  $KP   J_    PP   ,8   #)    S0   ,\
M  #0    T@   -0   #6    V0(  -L(  #>#@  X1,  .0=  #H*@  Z#P
M .E/  #I9   ZGP  .N5  #KK   Z\(  .S5  #LY0!FI@  6*P  $FS   [
MN0  *[P  !W    1Q   "<@   #,    SP   -,   #9    W0   .    #A
M    XP   .4   #G    Z@   .P   #N!   \0L  /42  #X'   ^RL  /T^
M  #^4P  _FH  /^#  #_FP  _ZX  /^^  #_R@#_ !( _P 0 /\ $0#_ !,
M_P 9 /\ )@#_ #0 _P!! /\ 30#_ %@ _P!B /\ :P#_ ', _P!Z /\ @0#_
M (< _P"- /\ DP#_ )D _P"@ /\ IP#^ *\ _ "Z /H R0#Y .$ ^ #S /<
M_P#V /\ ]0#_ /$ _P#I /\ Y #_ .$ _P#_  \ _P - /\ #0#_  X _P 4
M /\ (0#_ "X _P \ /\ 2 #_ %, _P!= /\ 9@#^ &T _ !U /L >P#Y ((
M^ "( /< C@#V )0 ] "; /, H@#Q *H [P"T .T P0#K -4 Z@#L .@ _ #G
M /\ Y0#_ .8 _P#@ /\ V0#_ -0 _P#_  L _P ( /\ !@#_  D _P 0 /\
M' #_ "D _P V /\ 0@#[ $X ]P!7 /0 8 #R &@ [P!O .T =@#L 'P Z@""
M .@ B #G (X Y0"5 ., G #A *0 WP"N -T N0#: ,H UP#D -0 ]@#1 /\
MT #_ -  _P#/ /\ RP#_ ,< _P#_  , _P   /\   #_  0 _P - /H %@#V
M ", \P P /  / #M $< Z0!1 .4 6@#B &( WP!I -T ;P#: '8 V !\ -0
M@@#2 (@ T "/ ,T E@#+ )X R0"H ,< LP#% ,$ P@#8 ,  [P"_ /X O@#_
M +T _P"\ /\ O #_ +P _P#_ @  _P   /\   #_    ]  ' .T $0#H !P
MXP I -\ -0#; $$ U@!+ -$ 5 #- %P R@!C ,@ :0#& &\ PP!U ,$ >P"_
M (( O@"( +P D "Z )@ N "B +4 K "S +D L0#+ *\ YP"N /@ K #_ *L
M_P"L /\ K #_ *L _P#_!   _P   /8   #N    YP   -\ # #6 !4 SP B
M ,H +@#' #H PP!$ ,  30"\ %4 N0!< +< 8P"U &D LP!O +$ =0"O 'L
MK0"" *L B@"I )( IP"< *4 I@"C +, H0## )\ W@"> /( G0#_ )P _P"<
M /\ FP#_ )L _P#_!P  ]@D  .D+  #?"@  U00  ,X !0#& !  P  : +L
M)P"W #( LP ] +  1@"M $\ J@!6 *@ 7 "F &, I !H *( ;P"A '4 GP!\
M )T A "; (T F0"7 )< H@"5 *X DP"] )$ TP"0 .T CP#\ (X _P"- ?\
MC0'_ (T!_P#Y#@  ZA(  -P5  #-%0  Q!$  +X,  "Z @H M  2 *X '@"J
M "H I@ U *( /P"@ $@ G0%0 )L"5@"9 EP EP-C )4#:0"3 V\ D01V ) $
M?P".!8@ C 62 (H&G@"(!JH A@>Z (4(SP"$"NL @@O\ ($,_P" #/\ @ S_
M ( ,_P#Q%0  X!T  ,T@  #!(0  N!T  +$7  "L$   J D- *('%@"="2,
MF0HN )4+. "3#$$ D Q) (X-4 ",#5< B@U= (@-8P"'#6H A0YQ (,.>@""
M#H0 @ Z/ 'X/FP!\#Z@ >Q"X 'H0S@!X$>P =A+_ '42_P!T$_\ =!/_ '03
M_P#H'@  TR8  ,,J  "X*@  KB@  *<C  "@'   FQ,# )8/$ "0$!L C!$G
M (D2,@"&$SL A!-# ((42P" %%$ ?A17 'P47@![%64 >15L '<5= !V%GX
M=!:* '(7E@!Q%Z0 ;QBT &X8R0!M&>@ :QK\ &H;_P!J&_\ :AO_ &H;_P#@
M)@  RBT  +PQ  "P,P  IS$  )\L  "7)@  D!\  (H7# "%&!8 @1DB 'X:
M+ ![&S8 >1L^ '<<10!U'$P <QQ3 '$=60!P'6  ;AUG &T>< !K'GH :AZ%
M &@?D@!G'Z  92"P &0AQ0!C(>0 8B+Z &$B_P!A(O\ 82+_ &$B_P#7+
MPS0  +8X  "J.0  H3@  )@U  "0+P  B"@  ( A" ![(!( =R$= '0B)P!Q
M(C$ ;R,Y &TC00!K(T@ :2-. &@D50!F)%L 921C &,E:P!B)74 826! %\F
MC@!>)IT 72>M %LHP0!;*.  6BGW %DI_P!9*?\ 62G_ %DH_P#/,@  OCD
M +$]  "F/P  G#\  ),\  "*-@  @3   'DJ P!R)@\ ;B<9 &LH(P!I*"P
M9BDU &4I/ !C*4, 82I* & J40!>*E< 72I? %PK: !:*W( 62Q] %@LBP!6
M+9H 52VJ %0NO0!3+MP 4B_U %(O_P!2+O\ 4B[_ %(N_P#*-@  NCT  *U"
M  "B1   F$0  (]!  "%/   >S<  '(Q  !K+ P 9RT5 &0M'P!A+B@ 7RXQ
M %TN.0!<+T  6B]& %@O30!7+U0 5C!< %4P9 !3,6X 4C%Z %$QB !0,I<
M3C*H $TSNP!---@ 3#3S $PT_P!,-/\ 3#/_ $PS_P#&.@  MD(  *E&  ">
M20  E4D  (M'  "!0@  =ST  &TW  !D,@D 8#(2 %TR' !:,B4 6#,M %8S
M-0!5,SP 4S1# %(T2@!1-%$ 4#19 $\U80!--6P 3#9W $LVA0!*-Y4 2#>F
M $<XN %'.-,!1CCQ 48X_P%&./\ 1CC_ $8W_P#!/@  LD4  *9*  "<30
MDDT  (A+  !^1P  <T(  &D]  !?-P8 6C80 %<W& !4-R( 4C<J % W,@!/
M.#D 33A  $PX1P!+.$X 2CE6 $DY7P!(.FD 1SIU $4[@P!$.Y, 0SRD 4(\
MM@%!/= !03WP 4$]_P%!//\!03S_ 4$\_P"^0@  KTD  *-.  "94   CU$
M (50  ![3   ;T8  &5"  !:/0( 5#L. %$[%0!/.Q\ 33LG $L[+P!)/#8
M1SP] $<\1 !&/4L 13U4 $0^7 !#/F< 0C]S $ _@0 _/Y$ /D"B #U M0$\
M0<X!/$'N 3Q!_P$\0/\!/$#_ 3T__P&Z10  K$P  *%1  "75   C54  (-4
M  !X40  ;$L  &%'  !60@  3T , $P_$P!)0!P 1T D $9 + !$0#, 0T Z
M $)!0@!!04D 0$)1 #]"6@ ^0V4 /4-Q #M#?P Z1(\ .42@ #A%LP$W1<L!
M-T7L 3=%_P$W1/\!.$3_ 3A#_P"W20  J5   )Y5  "46   BUD  (!8  !V
M5@  :%   %U,  !32   2D4) $9$$0!$1!D 0D0B $%%*0 _13$ /D4X #U%
M/P \1D< .T9/ #I'6  Y1V( .$AN #9(?  U2(T -$F> #-)L0 R2<D ,4GK
M #))_@ R2/\ ,DC_ #-(_P"T3   IU0  )Q9  "27   B%T  'Y=  !S6@
M954  %M2  !03@  1DH% $!)#@ ^218 /4D> #M*)@ Z2BX .4HU #A+/0 W
M2T0 -DM- #1,5@ S3&  ,DQL #%->@ P38L +DV< "U.KP L3L< +$[I "Q-
M_0 M3?\ +4S_ "U,_P"P4   I%@  )E=  "/80  AF(  'MA  !P7P  8EL
M %A8  !.50  0U$! #M/#  X3Q, -D\; #5/(P T4"L ,U R #)0.@ Q4$(
M,%%* "Y14P M4ET +%)I "M2>  I4H@ *%.: "=3K0 F4\4 )E/G "93_  G
M4O\ )U'_ "=1_P"L50  H%P  )9B  "-9@  @V<  'AF  !M90  8&$  %5>
M  !*6P  /U@  #56"  Q51  ,%87 "Y6'P M5B< +%8O "M7-@ J5SX *5='
M "A74  F6%H )5AG "18=0 C688 (5F8 "!9JP ?6<( 'UGE !]8^@ @6/\
M(%?_ "%7_P"H6@  G6(  )-G  "*:P  ?VP  '5L  !J:P  76@  %%E  !&
M8P  .V   #%> P J70T *%T3 "9=&P E7B, )%XJ "->,@ B7CH (5Y# "!?
M3  ?7U< 'E]C !Q@<0 ;8(( &6"5 !A@J0 78,  %F#B !=?^0 87O\ &5[_
M !E=_P"D8   F6@  )!N  "&<   ?'(  ')R  !F<0  6&X  $QL  !!:P
M-FD  "UG   C9@@ 'V8/ !UF%0 <9AT &V8E !IF+0 99S4 &&<^ !=G2  6
M9U, %6A? !-H;@ 2:'\ $6B2 !!HI@ /:+T #FC@ !!G]P 09O\ $67_ !%E
M_P"?9P  EF\  (QS  ""=@  >'@  &UX  !@=P  4W8  $9T   [<P  ,7(
M "=Q   ><0  %G * !-P$  3<!< $G ? !%Q)P 0<2\ $'$X  YQ0@ .<4X
M#7%;  QQ:0 +<7H "G&-  AQH0 &<;8 !G#2  =P[P (;_\ "6[_  EN_P";
M;P  D74  (=Y  !^?   ='X  &9^  !9?@  37X  $!]   U?0  *GP  "%\
M   8?   $7P$  Q\#  *?!$ "7P9  A\(0 '?"D !GPR  1\/0 #?$@  7Q5
M  !\8P  ?'0  'R'  ![G   >[$  'K+  !YZP  >?H  'G_  !X_P"6=P
MC'P  (.   !Y@P  ;(0  %Z%  !1A@  18<  #F'   MAP  (X<  !J'   2
MAP  #8@!  :)"@ !B0\  (D4  "(&P  B",  (DL  ")-@  B4(  (A.  "(
M70  B&T  (B!  "'E0  AZL  (;$  "%Y@  A/@  (3_  "$_P"0?@  AX,
M 'Z'  !QB0  8XL  %:-  !)CP  /)$  #"1   DD0  &I(  !*3   -E
M!I4   "6!@  E@P  )40  "6%0  EAT  )8D  "6+@  ECD  )9&  "650
MEF4  )9X  "5C@  E:0  )2\  "3WP  D_4  )+_  "2_P"+A@  @XH  '6-
M  !GD   690  $R7   _F0  ,IH  ":;   ;G   $IT   R?   $H    *(
M  "C 0  HP<  *,,  "C$   I!4  *0<  "E)0  IB\  *8\  "F2P  IEL
M *9N  "EA   I9L  *2S  "CT   H^\  *+\  "B_P"&C0  >)$  &J5  !<
MF0  3IT  $&@   SH@  )J,  !NE   1IP  "JD   &K    K0   *\   "P
M    L    + %  "Q"P  L@\  +,4  "T&P  M20  +<P  "W/P  MU   +=B
M  "W>   MY   +:I  "VP@  MN0  +;U  "U_@![DP  ;9@  %^=  !0H@
M0J8  #2I   FJP  &JT  !"O   )L@   +0   "W    N@   +P   "]
MO@   +X   #  @  P0@  ,(-  #$$@  QAD  ,DD  #*,@  RT,  ,M5  #,
M:@  S(,  ,R<  #+M0  S,X  ,SI  #,]@!PFP  8:$  %*F  !$JP  -K
M ">R   :M0  $+@   >[    O@   ,$   #$    R    ,L   #+    S0
M ,X   #0    T@   -4#  #8"@  VQ   -X8  #B)   XS4  .1(  #E7
MYG,  .:-  #FI0  YKP  .;3  #GYP!CI   5:H  $:P   XM0  *+D  !J\
M   /P   !<0   #'    RP   ,\   #4    V    -P   #=    WP   .$
M  #C    Y0   .@   #J    [08  /$.  #U%@  ^"4  /DX  #Y30  ^F,
M /M\  #\E0  _*H  /R[  #]RP#_  \ _P . /\ #@#_ !  _P 6 /\ (P#_
M #  _P ] /\ 20#_ %0 _P!> /\ 9@#_ &X _P!V /\ ? #_ (( _P") /\
MCP#_ )4 _@"; /T HP#[ *L ^@"U /D PP#W -L ]@#P /0 _P#S /\ \@#_
M .P _P#B /\ W #_ -8 _P#_  P _P ) /\ " #_  H _P 2 /\ '@#_ "L
M_P X /\ 1 #_ $\ _P!9 /X 80#\ &D ^@!P /@ =P#W 'T ]@"# /0 B0#R
M (\ \0"6 .\ G0#M *4 [ "O .H O #H ,T Y@#H .0 ^@#C /\ X@#_ .
M_P#5 /\ S@#_ ,L _P#_  8 _P ! /\   #_  0 _P . /\ &0#_ "4 _0 R
M /L /@#W $D \P!3 /  7 #N &, [ !J .H <0#H '< Y@!] .0 @P#B (D
MX "0 -X EP#< )\ V0"I -8 M #3 ,0 T #> ,X \P#, /\ RP#_ ,H _P#(
M /\ P@#_ +X _P#_    _P   /\   #_    ^P + /8 $P#Q "  [0 L .H
M. #G $, XP!- .  5@#< %T V0!D -4 :P#2 '$ T !V ,X ? #, (, R@")
M ,@ D0#& )D Q "C ,$ K0"_ +L O0#/ +L ZP"Y /P MP#_ +< _P"V /\
MM #_ +$ _P#_    _P   /\   #V    [@ % .< #P#A !D VP E -4 ,0#2
M #P S@!& ,H 3P#' %< Q !> ,$ 9 "_ &H O0!P +L =@"Y 'P N "# +8
MB@"S ), L0"< *\ IP"M +, JP#% *D X0"G /4 I@#_ *4 _P"D /\ I #_
M *0 _P#_    _    /$   #H    X    -0 "P#, !, QP ? ,( *@"_ #4
MO  _ +@ 2 "U %  LP!7 +  7@"N &0 K !I *L ;P"I '4 IP!\ *4 A "C
M (P H0"6 )\ H0"= *T F@"\ )@ T@"7 .X E0#^ )0 _P"5 /\ E0#_ )4
M_P#\ 0  \ 4  .,'  #5!0  S    ,4 ! "^  X N  7 +, (P"O "X JP X
M *D 00"F $H HP!1 *$ 5P"? %T G0!C )L :0": &\ F !V )8 ?0"4 (8
MD@"0 )  FP". *< C "V (H R0"( .< AP#Y (< _P"& /\ A@#_ (8 _P#T
M#   Y!   -$2  #%$0  O0X  +8(  "Q  @ JP 1 *8 &P"A "8 G@ Q )H
M.@"8 $, E0!* ), 40"1 %< CP!= (X 8P", &D B@!P (@ =P"& (  A "+
M (( E@"  *, ?@"Q 'T Q ![ N$ >@/U 'H%_P!Y!?\ > ;_ '@&_P#J$P
MUAH  ,8=  "Z'   L1D  *H3  "D#0  GP4, )D % "5 !\ D0(I (T#,P"+
M!#P B 5$ (8&2P"$!E$ @@=7 ($'70!_!V, ?0AJ 'L(<@!Z"'P > F& '8)
MD@!T"J  <PJO '$+P0!P#-\ ;PWV &X._P!M#O\ ;0[_ &T._P#A'   RR,
M +PF  "Q)@  J"0  * >  "9&   DQ " (X+#@"("Q< A PB ($-+ !^#34
M? X] 'H.10!X#DL =PY1 '4/6 !S#UX <1!E ' 0;@!N$'< ;!"" &L0CP!I
M$9T :!&M &82P !E$M\ 9!/V &,4_P!C%/\ 8A3_ &(4_P#6)   PRH  +4N
M  "J+P  H"T  )@H  "0(@  B1L  ((3" !]$1( >1(< '83)P!S%#  <10X
M &\5/P!M%48 ;!5, &H64P!H%ED 9Q9A &46:0!D%W( 8A=^ &$8BP!?&)D
M7AFI %P9O !<&M@ 6AOS %H<_P!9'/\ 61S_ %D<_P#-*@  O3$  *\U  "D
M-@  FS0  )(Q  ")*P  @24  'D= P!S& X ;QD8 &P:(@!I&RL 9QLS &4<
M.P!D'$$ 8AU( & =3@!?'54 71U< %P>9 !;'FX 61]Y %@?AP!6()8 52"F
M %0AN !3(=( 4B+Q %(C_P!2(_\ 4B+_ %(B_P#(+P  N#8  *LZ  "@/
MECL  (TX  "#,@  >BT  '(F  !J( P 9B 3 &,A'0!A(28 7R(O %TB-@!;
M(CT 6B-$ %@C2@!7(U$ 52-8 %0D80!3)&H 425V % E@P!/)I, 3B>C $PG
MM0!,*,X 2RCN $LI_P!+*/\ 2RC_ $LH_P##-   LSL  *<_  "<00  DD
M (D^  !_.0  =3,  &PM  !C)P@ 7B81 %PF&0!9)R( 5R<K %4H,@!4*#D
M4BA  %$H1@!0*4T 3BE5 $TI70!,*F< 2RIS $DK@ !(*Y  1RRA $8MLP!%
M+<L 12[L $0N_P!$+O\ 12W_ $4M_P"^.   L#\  *1#  "910  CT4  (5#
M  ![/@  <3D  &<T  !>+@0 6"L. %4K%@!2+!\ 4"PG $\L+P!-+38 3"T\
M $HM0P!)+4H 2"Y2 $<N6@!&+V0 12]P $,P?@!",(T 03&> $ RL0 _,L@
M/S/J #\S_@ _,O\ /S+_ #\R_P"[/   K4,  *%'  "620  C$D  (-(  !X
M1   ;3X  &,Y  !:-   4C , $\P$P!,,!P 2C D $DQ*P!',3( 1C$Y $0Q
M0 !#,D< 0C)/ $$S6 ! ,V( /S1M #XT>P ]-8L /#:< #LVKP Z-\8 .3?H
M #DW_  Z-_\ .C;_ #HV_P"W0   JD8  )Y+  "430  BDX  (!,  !U2
M:D,  & ^  !6.0  334) $DT$0!'-1D 134A $,U* !!-2\ 0#4V #\V/0 ^
M-D4 /3=- #PW50 [.&  .CAK #DY>0 X.8D -SJ; #4ZK0 U.\0 -#OF #0[
M^P U._\ -3K_ #4Z_P"T0P  ITH  )Q.  "240  B%(  'Y0  !S30  9T@
M %Q$  !2/P  2#H& $0Y#P!!.18 /SD> #XY)@ \.2T .SHT #HZ.P Y.T(
M.#M* #<\4P V/%T -3UI #0]=P S/H< ,3Z9 # _JP O/\( +S_D "\_^@ P
M/_\ ,#[_ # ^_P"Q1P  I$T  )E2  "/50  AE8  'Q5  !Q4@  9$P  %E)
M  !/10  14 # #\^#0 \/A, .CX; #D^(P W/BH -C\Q #4_.  T/T  ,T!(
M #) 40 Q05L ,$%G "Y"=0 M0H4 +$.7 "M#J@ J0\  *43B "I#^0 J0_\
M*T+_ "M"_P"N2@  H5$  )=6  "-60  @UH  'E:  !N5P  85(  %=.  !-
M2P  0T<  #I#"@ V0Q$ -$,8 #-#(  R1"< ,40O #!$-@ O13T +45& "Q%
M3P K1ED *D9D "E'<@ H1X, )D>5 "5(J  D2+X (TC@ "1(]P E1_\ )4?_
M "9'_P"J3P  GU4  )1:  "+7@  @5\  '=>  !K7   7U@  %55  !+40
M0$T  #5*!P P20X +DD5 "U)'0 L220 *THK "I*,P H2CL )TM# "9+3  E
M2U8 )$QB "-,<  A3(  ($V3 !]-I@ >3;L '4[= !Y-]@ >3/\ 'TS_ "!+
M_P"G4P  G%H  ))?  "(8P  ?F0  '1C  !I80  7%X  %);  !'6   /%4
M #)2 @ J4 P )T\2 "90&0 E4"  )% H "-0+P B43< (5%  "!120 >4E,
M'5)? !Q2;0 :4WT &5.0 !A3I  64[D %5/9 !93]  74O\ &%'_ !E1_P"C
M60  F&   (]E  "%:   >VD  '%I  !F9P  660  $UA  !"7P  .%P  "Y:
M   E6 @ (%<. !Y7%  =5QP '%@C !M8*P :6#, &5@\ !A810 665  %5E;
M !19:0 36GH $EJ- !%:H0 06K< #EK5 !!9\P 06?\ $5C_ !%8_P"?7P
ME68  (QK  "";0  >&X  &YO  !B;0  56H  $AH   ^9@  ,V4  "EC   @
M80$ && + !5@$  48!< $V > !)@)@ 28"X $6$W !!A0  /84L #F%8  UA
M9@ ,8G8 "V*)  IAG0 )8;( "&'+  AAZP )8/T "E__  M?_P";9@  DFT
M (AQ  !^<P  =74  &IT  !<<P  3W(  $-P   X;P  +6X  "1L   ;:P
M$VL$  YJ#  -:A( #&H9  MJ(0 *:BD "6HR  AJ/  ':T< !6M3  1K80 "
M:W$  &J$  !JF   :JT  &G&  !IYP  :?@  &C_  !H_P"7;0  C7,  (1W
M  ![>@  <'L  &-[  !6>@  27H  #UY   Q>   )W<  !UV   5=@  #W8"
M  EV"@ $=@\  '85  !V'   =B0  '4L  !U-@  =4$  '5.  !U7   =6P
M '5^  !TDP  =*@  '/   !SXP  <O<  '+_  !Q_P"2=0  B7H  (!^  !V
M@   :8$  %N"  !.@@  08(  #6#   I@@  'X$  !:!   0@@  "H(   *#
M!P  @@T  ((1  ""%P  @AX  ((F  ""+P  @CL  ()'  ""50  @64  (%X
M  "!C0  @*(  '^Z  !_W0  ?O0  'W_  !]_P"-?   A($  'N$  !NA@
M8(@  %**  !%BP  .8P  "R,   AC   %XP  !"-   )C@   H\   "0 P
MCPD  (\.  "/$@  D!@  ) ?  "0*   D#(  ) _  "030  D%T  (]P  "/
MA0  CIP  (ZS  "-T   C/   (O^  "+_P"(A   @(@  '*+  !DC0  5I
M $B3   [E0  +I8  "*6   7EP  #Y@   B9    FP   )T   "=    G0,
M )T)  "=#0  GA$  )X7  "?'P  GRD  * U  "@0P  H%0  *!F  "?>P
MGI,  )ZK  "=Q@  G>D  )SY  "<_P"#BP  =8X  &>2  !9E@  2YD  #V<
M   PG@  (Y\  !>@   .H@  !Z0   "F    J    *H   "J    J@   *L!
M  "K!P  K P  *T0  "N%@  KQX  +$I  "Q.   L4@  +%:  "Q;P  L8@
M +&@  "PN@  K]T  *_R  "O_0!XD0  :I8  %R:  !-GP  /Z,  #&F   C
MIP  %ZD   ZK   %K@   +    "R    M0   +<   "W    N    +D   "Z
M    O ,  +T)  "^#@  P!0  ,,>  #%*P  Q3P  ,9.  #&8@  QGH  ,:4
M  #&K0  QL@  ,7E  #%\P!LF0  7IX  $^D  !!J   ,JP  "2O   6L0
M#;0   .W    N@   +T   #     Q    ,8   #&    R    ,D   #+
MS    ,X   #0!@  TPT  -@3  #<'@  WBT  -]   #@5   X6L  .&%  #A
MGP  X;<  .'/  #AY@!@H0  4J<  $.M   TL@  );4  !>Y   -O    ;\
M  ##    QP   ,H   #/    TP   -8   #7    V@   -P   #?    X0
M .,   #F    Z0$  .P+  #P$@  \Q\  /0Q  #V1@  ]UP  /AT  #XCP
M^:8  /FX  #XR0#_  T _P + /\ "P#_  X _P 3 /\ 'P#_ "P _P Y /\
M10#_ %  _P!9 /\ 8@#_ &H _P!Q /\ =P#_ 'X _P"$ /X B@#] )  _ "7
M /H G@#Y *< ]P"Q /8 O@#U -( \P#L /$ _@#P /\ \ #_ .8 _P#< /\
MT@#_ ,T _P#_  < _P $ /\  @#_  8 _P 0 /\ &P#_ "< _P S /\ /P#_
M $H _@!4 /L 70#Y &0 ]P!K /4 <@#S '@ \@!^ /  A #O (H [0"1 .P
MF0#J *$ Z "K .8 M@#D ,< X@#C .  ]P#> /\ W0#_ -D _P#, /\ Q0#_
M ,$ _P#_    _P   /\   #_  $ _P - /\ %@#\ "( ^0 N /8 .0#S $4
M[P!. .P 5P#I %X Y@!E .0 ; #B '( X !W -\ ?@#= (0 VP"+ -@ D@#5
M )L T@"D ,\ KP#- +X RP#5 ,D [P#' /\ Q0#_ ,0 _P"^ /\ N #_ +4
M_P#_    _P   /\   #^    ]P ) /$ $0#K !P YP H .0 ,P#A #X W0!(
M -@ 40#3 %@ T !? ,X 90#, &L R@!Q ,@ =P#& 'T Q "$ ,( C #  )0
MO@"> +L J "Y +8 MP#( +4 Y@"S /H L0#_ +  _P"P /\ K #_ *D _P#_
M    _P   /H   #Q    Z  # .  #0#8 !8 T0 B ,T +0#* #< Q@!! ,(
M2@"_ %( O0!9 +H 7P"X &4 MP!J +4 < "S '8 L0!] *\ A0"M (T JP"7
M *D H0"G *X I0"^ *( V "@ /( GP#_ )X _P"> /\ G@#_ )P _P#_
M]P   .L   #A    U@   ,L "0#% !$ OP ; +L )@"W #$ M  Z +$ 0P"N
M $L JP!2 *D 6 "G %X I@!D *0 :0"B '  H !V )X ?@"< (8 F@"0 )@
MFP"6 *< E "V )( R@"0 .D CP#\ (X _P"- /\ C #_ (T _P#X    Z0(
M -L#  #, 0  Q    +T  @"V  T L  5 *L ( "G "H I  T *$ / "> $0
MG !+ )H 4@"8 %@ E@!= )4 8P"3 &D D0!P (\ =P"- (  BP"* (D E0"'
M *$ A0"O (, P0"! .  @ #U '\ _P!_ /\ ?P#_ '\ _P#N"@  W X  ,H0
M  "^#@  M0L  *\#  "I  < HP 0 )X & "9 ", E@ L ), -0"0 #X C@!%
M (P 2P"* %$ B !7 (8 70"% &, @P!J ($ <0!_ 'H ?0"$ 'L CP!Y )P
M=P"J '4 NP!T -0 <@#P '( _P!R /\ <0#_ '$ _P#C$0  S1<  +\9  "S
M&0  JA4  *,0  "="@  EP$* )$ $@"- !L B0 E (4 +P"# #< @  ^ 'X
M10!] $L >P!1 'D 5P!X %T =@!D '0!:P!R 70 < )_ &X"BP!L Y@ :P.F
M &D$MP!H!<X 9P?L &8(_0!F"?\ 90G_ &4)_P#6&@  Q"   +8C  "K(P
MH2   )D;  "2%   C X! (8'#0" !!0 ? 8> 'D'* !V"#  = @X '()/P!P
M"44 ;PI, &T*4@!L"E@ :@M? &@+9P!G"W  90QZ &,,AP!B#)4 8 VD %\-
MM@!>#<X 7 [M %P/_P!;$/\ 6Q#_ %L0_P#-(0  O"@  *\K  "D*P  FBD
M )(D  ")'P  @A@  'L1!0!U#0\ <0T7 &X.(0!K#BH :0\R &<0.0!E$$
M9!!& &,030!A$%, 7Q%: %X18@!<$6L 6Q%V %D2@P!8$I( 5A.B %43M !4
M$\L 4Q3L %(5_P!2%O\ 4A7_ %(5_P#&*   MBX  *DR  "?,@  E3$  (PM
M  "#)P  >B$  '(:  !K$PL 9Q,3 &04' !A%"4 7Q4M %T5- !<%3L 6Q9"
M %D62 !8%D\ 5A=6 %477@!3%V< 4AAR % 8?P!/&8X 3AJ? $P:L !+&\<
M2QOI $H<_0!*'/\ 2AS_ $H<_P#!+0  L30  *4W  ":.   D#<  (<T  !]
M+P  ="D  &PC  !D' < 7AD0 %L:& !9&R$ 5QLI %4;, !4'#< 4AP] %$<
M1 !/'4L 3AU2 $T=6@!+'F, 2AYN $D?? !''XL 1B"< $4AK@!$(<0 0R+F
M $,B_ !#(O\ 0R+_ $,B_P"\,@  K3@  *$\  "7/@  C3T  (,Z  !Y-0
M;S   &8J  !>) ( 5R - %0@% !1(!T 3R$E $XA+ !,(3, 2R(Z $DB0 !(
M(D< 1R). $8C5P!$(V  0R1K $(D>0!!)8@ /R:9 #XFJP ])\$ /2?C #TH
M^@ ]*/\ /2?_ #TG_P"X-@  JCT  )Y   "40@  BD(  ( _  !V.P  ;#8
M &(P  !9*@  424+ $TE$0!+)1D 224A $<F* !%)B\ 1"8V $,F/0!")T0
M02=+ #\H5  ^*%T /2EI #PI=@ [*H8 .2N7 #@KJ0 W++\ -RS@ #<L^  W
M+/\ -RS_ #@L_P"U.@  IT   )Q$  "11@  AT8  'U$  !S0   :#L  %\V
M  !5,0  3"L' $<I#P!%*A8 0RH> $$J)0 _*BP /BLS #TK.0 \*T$ .RQ(
M #HL40 Y+5L ."YF #8N<P U+X, -"^5 #,PIP R,+T ,3'> #$Q]P R,?\
M,C#_ #,P_P"Q/@  I$0  )E(  "/2@  A4H  'M)  !P10  94   %L[  !2
M-@  2#$$ $(N#0 _+A, /2X; #LN(@ Y+RD ."\O #<O-@ V,#X -3!& #0Q
M3P S,5D ,C)D #$R<0 P,X$ +S23 "XTI@ L-;L +#7; "PU]0 M-?\ +33_
M "XT_P"N00  HD@  )=,  "-3@  @TX  'E-  !N2@  8D4  %A   !./
M13<  #TS"P Y,Q$ -S,8 #8S'P T,R8 ,S,M #(T-  Q-#P ,#5$ "\U3  N
M-E8 +39B "PW;P K-W\ *CB1 "@XI  G.;D )CG8 "<Y]  H.?\ *#C_ "DX
M_P"K10  GTL  )1/  "+4@  @5,  '=2  !L3P  7TD  %9&  !,0@  0CT
M #@X"  T. \ ,C@5 #$X'0 O."0 +C@K "TY,@ L.3D *SI! "HZ2@ I.U0
M*#M? "<\;0 E/'T )#V/ ",]H@ B/;< (3[4 "$^\P B/?\ (SW_ ",\_P"H
M20  G4\  ))3  ")5@  ?U<  '56  !J4P  74\  %-,  !*2   0$0  #9
M!0 O/0T +3T3 "L]&@ J/B$ *3XH "@^+P G/C< )C\_ "0_2  C0%( (D!=
M "%!:@ @07H 'D&- !U"H  <0K4 &T+1 !M"\0 <0O\ '4'_ !Y!_P"E30
MFE,  )!8  "&6P  ?5P  ');  !G6   6U0  %%2  !(3@  /4H  #-'   J
M0PL )D,0 "5#%@ D0QX (T0E ")$+  A1#0 ($4\ !Y%10 =14\ '$9: !M&
M:  91G@ &$>* !='G@ 61[, %$C. !5'[P 61_\ %T;_ !=&_P"B4@  EU@
M (U=  "$8   >F$  '!@  !E7@  65H  $]8  !$5   .5$  "].   F2P8
M($H. !Y*$P =2AH '$HA !M+*  :2S  &4LX !=+0@ 63$P %4Q7 !1,90 3
M374 $DV( !%-G  03;$ #D[,  ]-[@ 03?\ $4S_ !%,_P">5P  E%T  (MB
M  "!90  =V8  &UF  !C9   5F$  $I>   _6P  -5@  "M6   B5 $ &E(*
M !92$  54A8 %%(= !-2)  24BP $5(T !%2/@ 04T@ #U-4  Y38@ -5'(
M#%2$  M4F  )5*T "%3%  E4YP *4_L "U+_  M2_P";70  D60  (AH  !^
M:P  =&P  &ML  !?:@  4F<  $5D   Z8@  ,&   "9>   =70  %5L% !!:
M#  .6A$ #EH8  U;(  ,6R< "ULP  I;.@ )6T4 !UM1  9;7@ $6VT  UN
M  %;E   6Z@  %O   !:X@  6O8  5K_  )9_P"79   CFL  (1N  ![<
M<G(  &=Q  !9<   3&X  $!L   U:P  *FD  "%G   89@  $68!  QE"@ '
M90\ !&44  -D&P "9",  &0L  !D-0  9$   &1,  !D6@  9&D  &1[  !D
MCP  8Z0  &.[  !BW0  8O0  &+_  !A_P"3;   B7$  (!U  !X=P  ;7@
M &!W  !2=@  1G4  #ET   N=   (W(  !IQ   2<0  #7$   9Q"   < T
M ' 2  !P%P  ;Q\  &\F  !O,   ;SL  &]'  !O5   ;V0  &]U  !NB@
M;:   &VV  !LU@  :_(  &O_  !K_P".<P  A7@  'U[  !S?0  97X  %A^
M  !+?@  /GX  #)^   F?0  ''P  !-\   -?   !GT   !]!0  ? L  'P/
M  !\$P  ?!D  'PA  !\*0  ?#0  'M   ![3@  >UX  'MO  !ZA   >IH
M 'FQ  !XS@  =^\  ';^  !V_P")>@  @7\  'B"  !K@P  784  $^&  !"
MAP  -8@  "F'   =AP  %(<   V(   &B0   (H   "*    B08  (D,  ")
M#P  B1,  (D:  "*(@  BBP  (HX  "*1@  B58  (EH  ")?   B)0  (>K
M  "&Q@  A>H  (7[  "$_P"%@@  ?88  &^(  !ABP  4XT  $6/   XD0
M*Y$  !^2   4D@  #9,   24    E@   )<   "8    EP   )<%  "7"P
MF X  )@3  "9&@  F2(  )HN  ":/0  F4T  )E>  "9<P  F(L  )BC  "7
MO   EN(  );W  "5_P" B0  <HP  &2/  !6DP  2)8  #J9   LF@  'YL
M !2<   ,G@   Y\   "A    HP   *4   "E    I0   *4   "F @  IP@
M *<-  "H$0  J1D  *LC  "K,0  JT$  *Q3  "L9P  JX   *J:  "JLP
MJM   *GO  "I^P!UCP  9Y0  %F8  !*G   /)\  "VB   @HP  $Z4   NG
M   !J0   *L   "N    L0   +(   "R    LP   +0   "U    M@   +@$
M  "Y"P  NQ   +T8  "_)   OS4  ,!'  # 6P  P'(  ,"-  #!I@  P,$
M +_C  "^\P!JEP  6YP  $VA   ^I0  +ZD  "&K   3K0  "[    "S
MM0   +@   "\    OP   ,$   #!    PP   ,0   #&    QP   ,D   #+
M    S@@  -$/  #5&   V"<  -DY  #:30  VV0  -M^  #<F0  W+   -S)
M  #<XP!=GP  3Z4  $"J   RKP  (K(  !2U   *N    +L   "_    PP
M ,8   #+    S@   -$   #1    U    -8   #9    VP   -X   #@
MY    .<&  #K#@  [QD  / J  #R/P  \U4  /1M  #TB   ]*$  /2V  #T
MQP#_  D _P & /\ !P#_  P _P 1 /\ ' #_ "@ _P T /\ 00#_ $P _P!5
M /\ 70#_ &4 _P!L /\ <@#^ '@ _ !^ /L A #Z (L ^0"2 /< F0#V *(
M] "L /, N0#Q ,L \ #H .X ^P#M /\ [ #_ .$ _P#2 /\ R0#_ ,0 _P#_
M  $ _P   /\   #_  0 _P . /\ %P#_ ", _P O /\ .P#] $8 ^@!0 /<
M6 #T %\ \@!F /  ; #O '( [0!X .P ?@#J (4 Z0", .< DP#E )P XP"F
M .$ L0#? ,$ W0#= -L ] #9 /\ U@#_ ,\ _P#$ /\ O0#_ +D _P#_
M_P   /\   #_    _P + /P $P#W !X ]  J /( -0#N $  Z0!* .8 4@#C
M %D X !@ -X 9@#< &P V@!R -< > #4 'X T@"% -  C0#. )4 S "? ,D
MJ@#' +@ Q0#- ,, ZP#  /X OP#_ +X _P"V /\ L #_ *T _P#_    _P
M /\   #Y    \@ & .L #P#F !D X0 D -X +P#: #D TP!# ,\ 3 #, %,
MR0!: ,< 8 #% &8 PP!K ,$ <0"_ '< O0!^ +L A@"Y (X MP"8 +4 HP"S
M +  L0#" *X X "L /< JP#_ *H _P"H /\ HP#_ *  _P#_    _P   /4
M  #K    X0   -8 # #/ !, R@ > ,8 *0#" #, OP ] +L 10"X $T M@!4
M +, 6@"Q %\ L !E *X :@"L '  JP!W *D ?P"G (< I0"1 *, G "@ *D
MG@"X )P S@": .X F0#_ )< _P"6 /\ E@#_ ), _P#]    \0   .4   #9
M    S0   ,0 !@"]  \ MP 8 +, (@"P "P K0 V *D /@"G $8 I !- *(
M4P"@ %D GP!> )T 9 "; &H F@!P )@ =P"6 (  E "* )$ E0"/ *( C0"P
M (L PP") ., B #Y (8 _P"& /\ A@#_ (8 _P#S    XP   -$   #%
MO0   +8   "N  L J  2 *0 ' "@ "8 G  O )H -P"7 #\ E0!& )( 3 "1
M %( CP!8 (T 70"+ &, B@!J (@ <0"& 'D A "# (( CP!_ )L ?@"I 'P
MNP!Z -4 > #R '@ _P!W /\ =P#_ '< _P#G!P  T0P  ,,-  "X#   K@@
M *@   "B  4 FP . )8 %0"2 !\ C@ H (L ,0"( #D A@!  (0 1@"" $P
M@ !2 '\ 5P!] %T >P!C 'H :P!X ', =@!] '0 B !Q )4 < "D &X M !L
M ,H :P#J &H _ !J /\ :@#_ &H _P#:$   QA0  +@6  "M%0  I!(  )P.
M  "6!P  D  ) (H $ "% !@ @0 A 'X *@![ #( >0 Y '< 0 !U $8 <P!,
M '( 40!P %< ;@!> &T 90!K &X :0!W &< @P!E )$ 8P"? &( KP!@ ,0
M7P#D %\!^ !> O\ 7@+_ %X"_P#.&   O1T  + @  "E'P  FQP  ),7  "+
M$0  A P  'X$"P!Y !( =0 ; '( (P!O "L ;0$S &L!.@!I D  9P-& &8#
M3 !D!%( 8P19 &$$8 !?!6D 7@5S %P&?P!:!HT 60>< %<(K0!6",$ 50GA
M %0+]@!4"_\ 5 O_ %0+_P#&'P  MB4  *DH  ">*   E"4  (LA  "#&P
M>Q0  '0. P!N"0T :0@4 &8)'0!D"B4 8@HM & +- !>"SH 70M  %L,1P!:
M#$T 6 Q4 %<-7 !5#60 5 UO %(->P!0#HH 3PZ: $X.K !,#\( 3!#C $L0
M^0!+$/\ 2Q'_ $L0_P"_)@  L"L  *0O  "9+P  CRT  (8I  !])   =!X
M &P7  !E$0< 7PX0 %P/%P!:$!\ 6! G %80+@!4$#4 4Q [ %(10@!0$4@
M3Q%0 $X15P!,$F  2Q)K $D2> !($X< 1A.7 $44J0!$%+X 0Q7? $,6^ !#
M%O\ 0Q;_ $,6_P"Z*P  JS$  * T  "5-0  BS0  ($Q  !X*P  ;R8  &8@
M  !>&0$ 5Q0- %04$P!1%!L 3Q4C $X5*@!,%3$ 2Q8W $D6/@!(%D0 1Q=,
M $475 !$%UT 0QAG $$8= ! &8, /QJ4 #T:I@ \&[L .QO; #L<]@ \'/\
M/!S_ #P<_P"U,   J#8  )PY  "1.P  ASH  'XW  !S,@  :BT  &$G  !9
M(0  41L) $P9$ !*&A< 2!H? $8:)@!%&RT 0QLS $(;.@!!'$$ 0!Q( #X<
M4  ]'5D /!YD #L><0 Y'X  .!^2 #<@I  V(+@ -2'6 #4A]  U(O\ -2'_
M #8A_P"R-   I#H  )D^  "//P  A3\  'L\  !P.   9S(  %TM  !4*
M3"(% $8?#@!#'Q0 01\; #\?(@ ^("D /2 P #L@-@ Z(3T .2%% #@B30 W
M(E< -B-B #0C;@ S)'X ,B2/ #$EH@ O);8 +R;2 "\F\@ O)O\ ,";_ # F
M_P"O.   HCX  )9"  ",0P  @D,  'A!  !N/0  8S@  %HS  !1+@  2"@!
M $ D#  ](Q$ .R08 #DD'P X)"8 -B0L #4E,P T)3H ,R9" #(F2@ Q)U0
M,"=? "\H;  N*'L +"F- "LJH  J*K0 *2K/ "DK\  J*_\ *BK_ "LJ_P"L
M/   GT(  )1&  "*1P  @$<  '9%  !L0@  83T  %<X  !.,P  1"X  #PI
M"0 W*!  -2@5 #,H'  R*", ,"@I "\I,  O*C< +BH_ "TK2  L*U( *RQ=
M "HL:@ H+7D )RV+ "8NG@ E+K, )"_- "0O[@ E+_\ )2__ "8N_P"I/P
MG44  )))  "(2P  ?DP  '1*  !J1P  7D(  %0]  !+.0  030  #@O!@ R
M+0T ,"T3 "XM&0 M+2  *RTG "HN+@ I+C4 *2\] "@O1@ G,$\ )3!; "0Q
M:  C,7< (C*) "$RG0 ?,[$ 'C/+ !XS[0 ?,_\ (#/_ "$R_P"F0P  FDD
M )!-  "&3P  ?%   '-/  !H3   7$8  %)#  !)/P  /SL  #8V @ N,@P
M*S(1 "DR%P H,AX )C(D "4S*P D,S( (S0Z "(T0P A-4T (#58 !\V90 >
M-G4 '#>' !LWFP :-Z\ &3C( !DXZP :./\ &S?_ !LW_P"C1P  F$T  (Y1
M  "$4P  >U0  '%3  !F4   6DP  %!)  !'10  /4$  #,]   J.0D )3<.
M ",W%  B.!L (3@B " X*  ?.#  'CDX !TY00 <.DL &CI6 !D[8P 8.W(
M%CN% !4\F0 4/*T $SW& !,]Z0 4//T %3S_ !8[_P"@2P  E5$  (M5  ""
M6   >5D  &Y8  !D5@  6%$  $Y/  !%2P  .D<  #!#   G0 4 (#X- !T^
M$0 </A< &SX> !H^)0 9/BT &#\U !8_/@ 5/T@ %$!3 !- 8  207  $4&"
M !!!EP /0:P #D+$  Y"YP /0?P $$'_ !! _P"=4   DU8  (E:  " 70
M=EX  &Q=  !B6P  5E<  $Q5  !!40  -DX  "Q+   C2   &T4) !=$#P 5
M1!0 %$4; !-%(@ 212D $44Q !%%.P 01D4 #T90  Y'7@ -1VT #$=_  M'
MDP )1Z< "$>^  A'X  )1_8 "D;_  M&_P":50  D%L  (=@  !]8@  <V,
M &IB  !@80  4UX  $=:   \5P  ,E4  "A2   ?4   %TX$ !%,#  /3!$
M#DP7  Y,'@ -324 #$TN  M--P *34( "4U-  =.6@ &3FD !$Y[  ).CP !
M3J0  $VZ  !-VP !3?(  4W_  ),_P"66P  C6(  (1F  !Z:   <6D  &AI
M  !<9P  3V0  $)A   W7P  +5P  "-:   :6   $E<!  U6"0 )50X !U43
M  95&@ $52(  U4J  )5-   53X  %5*  !65P  5F4  %5W  !5BP  5:
M %6V  !4U   5/$  %/]  !3_P"38@  BF@  (!L  !W;@  ;V\  &-N  !6
M;   26H  #UH   R9@  )V4  !UC   58@  #F$   E@"  #8 T  %\1  !?
M%P  7QX  %\F  !?+P  7SH  %]%  !?4P  7V$  %YR  !>AP  79P  %VR
M  !<SP  7.\  %O]  !;_P"0:@  AF\  'UR  !U=   :G4  %UT  !/<P
M0G(  #9P   K;P  (&X  !=M   0;   "FP   )K!@  :PL  &H/  !J%
M:AH  &HA  !I*@  :30  &E   !I3@  :5P  &EM  !H@@  :)@  &>N  !F
MR@  9>T  &7\  !D_P"+<0  @G8  'IY  !P>P  8GL  %5[  !(>@  .WH
M "]Z   C>0  &7@  !%W   *=P   W<   !W @  =P@  '8-  !V$   =A4
M '8;  !V(P  =BX  '4Z  !U1P  =58  '5H  !T?   =)(  '.J  !RQ
M<>D  '#[  !P_P"&>0  ?WT  '9_  !H@0  6H(  $R"   _@P  ,H0  "6#
M   :@P  $8,   J#   "@P   (0   "%    A ,  (,(  "##0  @Q   (,5
M  "$'   A"8  (0R  "$/P  @T\  (-@  ""=0  @HP  (&D  " O0  ?^,
M '[Y  !^_P""@   >H0  &R&  !>B   4(H  $*+   UC0  )XT  !N-   1
MC@  "HX   "/    D0   )(   "2    D@   )(!  "2!P  D@P  )(0  "3
M%0  DQT  )0H  "4-@  E$4  )-7  "3:P  DX(  )*<  "1M@  D-@  (_S
M  "/_P!^AP  <(H  &&-  !3D   19,  #>5   IE@  ')<  !&8   )F0
M )L   "<    G@   *    "@    H    *    "A    H00  *()  "C#@
MI!0  *4=  "F*@  ICH  *9,  "E8   I7@  *62  "DK   I,D  */K  "B
M^@!SC@  9)$  %:5  !'F0  .9P  "J>   =H   $:$   BC    I0   *<
M  "I    K    *X   "N    K@   *\   "P    L0   +(   "S!@  M0T
M +<3  "Y'@  N2X  +I   "Z5   NVH  +J%  "YH0  N;L  +K>  "Y\@!G
ME0  6)D  $J>   [H@  +*8  !VH   1J@  !ZP   "O    L0   +0   "X
M    NP   +P   "\    O@   +\   #     P@   ,0   #&    R ,  ,L+
M  #/$@  T2   -$R  #21@  TUT  -1V  #4D@  U:L  -7$  #4X@!;G0
M3*(  #VG   OK   'Z\  !&Q   'M0   +@   "[    O@   ,(   #'
MR@   ,P   #,    S@   -    #2    U0   -@   #;    WP   .(   #F
M"P  ZQ,  .PD  #M.   [DX  .]G  #P@@  \)P  /"R  #QQ0#_  , _P !
M /\ ! #_  D _P / /\ & #_ "0 _P P /\ / #_ $< _P!1 /\ 60#_ &
M_0!G /P ;0#Z ', ^0!Y /@ ?P#V (4 ]0", /, E #R )T \ "G .X LP#L
M ,0 ZP#A .H ^ #I /\ YP#_ -D _P#+ /\ P@#_ +T _P#_    _P   /\
M  #_    _P , /\ % #_ "  _P K /X -P#Z $( ]@!+ /( 4P#P %L [@!A
M .P 9P#J &T Z !S .< >0#E '\ XP"& .$ C@#? )8 W0"@ -L K #8 +L
MU #1 -, \ #0 /\ S@#_ ,@ _P"] /\ M@#_ +( _P#_    _P   /\   #_
M    _0 ( /< $ #S !H [P F .T ,0#H #L XP!% .  30#< %4 V0!; -8
M80#3 &< T0!L ,\ <@#- '@ RP!_ ,D AP#' )  Q0": ,, I0#  +( O@#%
M +P Y0"Z /L N #_ +< _P"P /\ J0#_ *4 _P#_    _P   /X   #U
M[  # .4 #0#? !4 V@ @ -0 *@#0 #4 RP ^ ,@ 1P#% $X P@!5 ,  6P"^
M &$ O !F +H ; "X '( M@!X +4 @ "S (@ L0"2 *X G@"L *H J0"[ *@
MU0"F /, I #_ *, _P"A /\ FP#_ )@ _P#_    ^P   /    #E    V
M ,X "0#' !$ P@ : +X ) "[ "X MP X +0 0 "Q $@ K@!. *P 5 "J %H
MJ0!? *< 90"E &L I !Q *( > "@ ($ G@"+ )P E@"9 *, EP"R )8 QP"3
M .@ D@#^ )$ _P"0 /\ C0#_ (L _P#Y    ZP   -T   #/    Q@   +P
M! "U  T L  5 *P '@"H "@ I0 Q *( .0"? $$ G0!( )L 3@"9 %, EP!9
M )8 7@"4 &0 D@!J )  <0". 'H C "# (H CP"( )P A@"J (0 O "" -P
M@0#V (  _P!_ /\ ?P#_ 'X _P#L    V@   ,D   "^    M@   *X   "G
M  D H0 0 )P & "8 "( E0 J )( ,@"0 #H C0!! (L 1P") $T AP!2 (8
M6 "$ %T @@!D ($ :P!_ ', ?0!] 'L B !X )4 =@"C '4 M !S ,P <0#M
M '  _P!P /\ < #_ '  _P#?!0  R@H  +P+  "Q"0  J 0  *$   ";  ,
ME  , (\ $P"* !L AP D (0 + "! #, ?P Z 'T 00![ $< >0!, '< 4@!V
M %< = != '( 9 !P &T ;P!V &P @@!J (\ :0"= &< K@!E ,, 9 #D &,
M^@!C /\ 8@#_ &, _P#0#@  OQ(  +(3  "G$@  G1   )4+  "/ P  B0 '
M (( #@!^ !4 >@ > '8 )0!T "T <0 T &\ .@!N $  ; !& &H 3 !I %(
M9P!8 &8 7P!D &< 8@!Q &  ? !> (D 7 "8 %L J0!9 +P 6 #< %@ ] !8
M /\ 5P#_ %< _P#&%@  MAH  *H=  "?'   E1D  (T4  "%#P  ?@D  '<!
M"@!R !  ;@ 7 &H 'P!H "< 90 N &0 - !B #L 8 !  %\ 1@!= $P 7 !3
M %H 6@!8 &( 5P!L %4 =P!3 (4 4@"4 % !I0!/ ;@ 3@+2 $T$\ !-!?\
M307_ $T%_P"_'0  L"(  *,E  "9)0  CR(  (4=  !]&   =1(  &X- @!G
M!@P 8P,1 %\"&0!= R$ 6P0H %D$+P!7!34 5@4[ %0&00!3!D< 409. % '
M50!.!UX 30AG $L(<P!)"8$ 2 F2 $<*HP!%"K8 1 O0 $0,[P!##?\ 0PW_
M $0-_P"Y)   JBD  )XL  "4+   BBH  ( F  !W(0  ;AL  &84  !?#P4
M60L- %4*$P!3"QL 40LB $\,*0!-#"\ 3 PV $L-/ !)#4( 2 U) $8-40!%
M#EH 1 YD $(.< ! #G\ /P^0 #X0H@ \$+8 .Q#1 #L1\0 [$?\ .Q'_ #P1
M_P"T*0  IB\  )HR  "0,@  AC$  'PM  !R*   :2,  &$=  !9%@  41$(
M $P/$ !*$!8 2! = $80) !%$"L 0Q$Q $(1-P!!$3X 0!%% #X230 ]$E8
M/!)A #H3;0 Y$WP -Q2- #84GP U%;, -!7- #,6[@ T%O\ -!;_ #06_P"O
M+@  HC0  )<W  ",.   @C8  '@T  !N+@  92H  %PD  !4'@  3!@$ $84
M#0!"%!( 0!09 #\4(  ]%2< /!4M #L5-  Y%CH .!9" #<62@ V%U, -1=>
M #,8:@ R&7D ,!F* "\:G0 N&K$ +1O* "T;[  M'/\ +AO_ "X;_P"L,@
MGS@  )0[  "*/   @#P  '8Y  !K-   8B\  %DJ  !0)0  1Q\  $ :"@ \
M&1  .AD6 #@9'0 V&B, -1HI #0:,  S&C< ,AL^ #$;1P O'%  +AU; "T=
M9P L'G8 *AZ( "D?FP H'ZX )R#' "8@Z@ G(/X *"#_ "@@_P"I-@  G3P
M )(_  "'00  ?4   '0^  !I.@  7S4  %8P  !-*P  1"4  #L@!P V'@X
M,QX3 #(>&0 P'B  +QXF "X?+0 M'S0 +" [ "L@1  J(4X *2%8 "<B90 F
M(G0 )2.% ",CF0 B)*T (23% "$EZ  B)?T (B3_ ",D_P"F.@  FC\  (]#
M  "%10  >T0  ')#  !G/P  73H  %,V  !*,0  02P  #@F P Q(PP +B(1
M "PB%@ J(AT *2(C "@C*@ G(S$ )B0Y "4E00 D)4L (R96 "(F8P A)W(
M'R># !XHEP =**L &RG# !LIY@ <*?L '2G_ !XH_P"C/@  F$,  (U'  "#
M20  >DD  '!'  !F1   6C\  %$[  !'-P  /C(  #4M   L* D *"</ "<G
M%  E)QH )"<A ",H)P B*"X (2DV " I/P ?*DD 'BI4 !TK8  ;*V\ &BR!
M !DLE0 7+:D %BW! !8MY  7+?H &"W_ !DM_P"A00  E4<  (M+  ""30
M>$T  &Y,  !D20  6$0  $]   !&/0  /3@  #,T   J+P8 )"P- "$L$@ @
M+!@ 'RT> !XM)0 =+2P '"XT !LN/  :+T8 &"]1 !<P7@ 6,&T %3%_ !,Q
MDP 2,:@ $3*_ !$RX@ 2,OD $S'_ !,Q_P">10  DTL  (E/  " 40  =E(
M &U0  !B3@  5DD  $U&  !$0P  .S\  #$Z   G-@, 'S(+ !PR$  ;,A4
M&3(; !@R(@ 7,RD %C,Q !4T.@ 4-$0 $S1/ !(U7  1-6L $#9]  \VD0 .
M-J8 #3>\  TWW0 --O8 #C;_  \V_P";20  D4\  (=3  !^5@  =58  &I5
M  !@4P  54\  $Q,  !"20  .$4  "Y!   D/0  '#H( !8X#@ 5.!( %#@8
M !,Y'P 2.28 $3DN ! Y-P /.D$ #CI,  T[60 -.V@ "SMZ  H[C0 )/*(
M!SRX  <\U0 (//  "3O_  H[_P"83@  CE0  (58  !\6P  <EL  &A:  !>
M6   4U4  $E2   ^3@  -$L  "I'   A1   &$(# !) "P 0/Q  #C\5  X_
M'  -0", #$ K  M -  *0#X "4%*  =!5@ &064 !$%V  -!B@ !09\  $&T
M  !!T  !0>X  4'\  ) _P"55   C%D  (->  !Y8   <&   &9@  !=7@
M45L  $57   Z5   +U$  "5/   <3   %$H   Y("  +1PX "$<2  ='&0 &
M1R  !4@H  -(,0 "2#L  $A'  !(4P  2&(  $AS  !(A@  2)L  $BQ  !'
MS   1^T  $?[  !'_P"26@  B6   (!C  !W90  ;F8  &5F  !99   3&
M $!=   U6P  *ED  "!7   750  $%,   M2!P %40T  5 1  !0%@  4!T
M % E  !0+@  4#@  %!#  !04   4%X  %!O  !0@P  3Y@  $^N  !.R0
M3NL  $W[  !-_P"/80  AF8  'UI  !T;   ;&T  &%K  !3:0  1F<  #ID
M   O8P  )&$  !I?   27@  #%P   9<!@  6PL  %H/  !:$P  6AD  %DA
M  !9*0  63,  %D_  !93   65H  %EK  !8?@  6)0  %>K  !7Q0  5ND
M %7[  !5_P",:   @FT  'IP  !R<@  9W(  %IQ  !,<   /VX  #-M   H
M:P  '6H  !1H   -9P  !V<   !F P  9@D  &4-  !E$0  9!4  &0<  !D
M)   9"X  &0Z  !C1P  8U4  &-F  !C>@  8I   &&G  !@P0  7^8  %_Z
M  !>_P"';P  ?W0  'AW  !N>   8'@  %)W  !%=P  .'8  "MV   @=
M%G,   YS   '<@   '(   !R    <04  '$*  !Q#@  <!$  ' 7  !P'@
M<"<  ' S  !O0   ;U   &]@  !N=   ;HL  &VB  !LO   :^(  &KX  !I
M_P"#=P  ?'L  '-]  !E?@  5W\  $E_   \?P  +X   ")_   7?@  #WX
M  =^    ?P   '\   !_    ?@   'X%  !^"@  ?@T  'X1  !^%P  ?B
M 'XK  !].0  ?4@  'U9  !\;0  ?(0  'N<  !ZM@  >=H  'CU  !W_P"
M?P  =X(  &F#  !;A0  388  #^(   RB0  )(D  !B)   /B0  !XH   "+
M    C    (T   "-    C    (P   ", P  C @  (T-  "-$0  C1<  (XB
M  ".+P  CC\  (U0  "-9   C'L  (R5  "+K@  BLT  (GO  ")_P![A0
M;8@  %Z*  !0C0  0H\  #21   FD@  &9,   Z4   &E0   )8   "8
MF@   )L   ";    FP   )L   ";    G    )T%  "="P  GA   )\7  "@
M)   H#0  *!&  "@60  GW   )^*  ">I0  GL(  )WH  "<^0!PC   88\
M %.2  !$E@  -ID  ">;   9G   #YT   6?    H0   *,   "E    J
M *D   "I    J0   *H   "K    K    *T   "N 0  L D  +(/  "S&
MM"<  +0Y  "U30  M&0  +1^  "SF@  L[0  +/5  "S\ !DDP  59<  $>;
M   XGP  *:(  !JD   .I@  !*@   "K    K0   +    "T    M@   +@
M  "X    N0   +H   "\    O0   +\   #     PP   ,4'  #)#P  RAH
M ,LL  #,0   S58  ,YO  #-BP  S*@  ,S"  #,X@!8FP  2:   #JE   L
MJ0  '*L   ^N   $L0   +0   "W    N@   +X   ##    Q@   ,@   #(
M    R@   ,L   #-    SP   -(   #5    V0   -T   #A!0  Y@\  .<>
M  #H,@  Z4@  .I@  #K>P  ZY<  .RN  #LP@#_    _P   /\   #_  8
M_P - /\ %0#_ "$ _P L /\ . #_ $, _P!, /X 5 #[ %L ^@!B /@ : #V
M &X ]0!T /0 >@#R (  \0"' .\ CP#M )< ZP"A .D K0#G +T Y0#8 .0
M\P#B /\ X #_ -  _P#$ /\ O #_ +8 _P#_    _P   /\   #_    _P )
M /\ $0#_ !P _0 G /D ,@#U #T \0!& .T 3P#K %8 Z !< .8 8@#D &@
MXP!N .$ <P#? 'D W0"  -H B #8 )$ U "; -( I@#/ +0 S #) ,D Z0#(
M /\ QP#_ ,$ _P"W /\ KP#_ *L _P#_    _P   /\   #_    ^  % /(
M#@#N !< Z@ B .8 + #A #< W0!  -@ 20#3 %  T !6 ,X 7 #, &( R@!G
M ,@ ;0#& ', Q !Y ,( @0#  (H O@"4 +P GP"Y *P M@"^ +0 W0"S /<
ML0#_ +  _P"H /\ H@#_ )X _P#_    _P   /D   #O    Y@   -\ "P#6
M !( T  < ,P )@#( #  Q  Z ,  0@"] $H NP!0 +@ 5@"V %L M0!A +,
M9@"Q &P L !R *X >@"L (( J0", *< F "E *4 HP"T *  RP"? .X G0#_
M )P _P"9 /\ E #_ )$ _P#_    ]@   .H   #=    SP   ,< !@#   \
MNP 7 +< ( "S "H L  S *T .P"J $, IP!) *4 3P"C %4 H@!: *  7P">
M &4 G0!K )L <@"9 'L EP"% )0 D "2 )T D "L (X OP", .( BP#Z (D
M_P") /\ A@#_ (, _P#T    Y    -0   #(    OP   +4  0"N  L J0 2
M *4 &P"A ", G@ L )L - "8 #P E@!# )0 20"2 $X D !3 (X 60"- %X
MBP!D (D :P"' ', A0!] (, B "! )4 ?P"D 'T M0![ ,\ >0#Q '@ _P!W
M /\ =P#_ '4 _P#E    T0   ,,   "X    KP   *@   "@  8 F@ . )4
M%0"1 !X C@ F (L +0"( #4 A@ \ (0 0@"" $< @ !- '\ 4@!] %@ >P!>
M 'D 90!X &T =@!V ', @0!Q (X ;P"= &T K@!L ,0 :@#G &D _0!H /\
M: #_ &D _P#5 P  PP<  +8(  "K!@  H@   )L   "4    C0 * (@ $ "#
M !@ ?P @ 'P )P!Z "X =P U '4 .P!T $$ <@!' '  3 !O %( ;0!8 &L
M7P!I &8 9P!P &4 >P!C (@ 8@"7 &  IP!> +L 70#< %P ]@!< /\ 6P#_
M %L _P#)#0  N1   *P1  "A$   EPT  (\(  "(    @@ % 'L #0!W !(
M<P : &\ (0!L "@ :@ O &@ -0!G #L 90!! &, 1@!B $P 8 !2 %\ 60!=
M &$ 6P!J %D =0!7 (( 50"1 %0 H@!3 +4 40#/ %  [P!0 /\ 4 #_ %
M_P"_%   L!@  *0:  "9&0  CQ8  (<1  !_#0  =P8  '$ " !K  X 9P 4
M &0 &P!A "( 7@ I %T +P!; #4 60 [ %@ 00!6 $8 50!- %, 5 !2 %P
M4 !E $X < !, 'T 2P"- $D G@!( +  1P#' $8 Z0!& /L 1@#_ $4 _P"X
M&P  JB   )XB  "3(@  B1\  ( :  !W%0  ;Q   &@+  !A! H 70 0 %D
M%@!6 !T 5  C %( *@!0 #  3P U $X .P!, $$ 2P!( $D 3P!' 5< 1@%A
M $0"; !# GD 00.) $ #F@ ^!*T /03$ #P%Y0 \!_@ / ?_ #P'_P"R(@
MI2<  )DI  ".*0  A"<  'LC  !Q'@  :1@  &$2  !:#0, 4P@, $\%$0!,
M!1< 2@8> $@&) !'!BH 10<P $0'-@!#"#T 00A# $ (2P ^"5, /0E= #L*
M:  Z"G8 . N' #<+F0 U"ZP - S" #,,Y  S#?D ,PW_ #0-_P"M)P  H"P
M )4O  "++P  @"X  '<J  !M)0  9"   %P:  !4%   3 \& $8,#0!##!(
M00P8 #\,'P ^#"4 / TK #L-,@ Z#3@ . T_ #<.1P V#E  - Y: #,.9@ Q
M#W0 , ^% "X0F  M$*L +!## "L1Y0 L$?H +!'_ "T1_P"J+   G3$  )(T
M  "'-0  ?30  '0Q  !J*P  8"<  %@A  !/&P  1Q8  $ 1"0 [$ \ .1 4
M #<0&P V$"$ -! G #,1+0 R$30 ,1$[ # 10P N$DT +1)7 "P28P J$W$
M*1." "<4E0 F%*D )17  "05XP E%OH )A;_ "85_P"F,0  FC8  (\Y  "%
M.@  >SD  '$V  !G,0  72T  %0H  !,(@  0QT  #L7!0 U% T ,A,1 #$4
M%P O%!T +A0D "P4*@ K%3$ *A4X "D60  H%DH )Q=4 "878  D&&\ (QB
M "$9DP @&:< 'QF^ !X:X  ?&O@ (!K_ " :_P"C-   F#H  (T]  "#/@
M>3T  &\[  !E-P  6S(  %(M  !)*   0",  #@> 0 P&0H +!@/ "H8%  I
M&!H )Q@@ "89)P E&2T )!HU ",:/@ B&T< (1M2 " <7@ ?'6P '1U^ !P=
MD0 :'J4 &1Z\ !@?W0 9'_8 &A__ !L>_P"A.   E3T  (M!  "!0@  =T(
M &U   !C/   63<  $\S  !&+@  /2D  #4D   M( < )QT- "4=$@ C'1<
M(1T= "$=)  @'BL 'QXR !X?.P ='T4 '"!/ !HA7  9(6H &")[ !8BCP 5
M(J, %".Z !,CV@ 4(_4 %2/_ !8C_P">/   DT$  (E$  !_1@  =48  &Q$
M  !B00  5SP  $TX  !$-   /#   #,K   J)@, (R(+ " A$  >(14 '"(;
M !LB(0 :(B@ &B,P !DC.  8)$( %B5- !4E60 4)F@ $R9Y !(FC0 1)Z(
M$">X  XGU@ 0*/0 $2?_ !$G_P"<0   D44  (=(  !]2@  =$H  &I)  !@
M1@  54$  $P^  !#.@  .C8  #$R   H+0  ("D) !LG#@ 9)Q( &"<8 !8G
M'P 5*"4 %"@M !,H-@ 2*4  $BE+ !$J5P 0*F8 #BMW  XKBP -+)\ #"RU
M  LLSP ,+.\ #2S_  TK_P"91   CTD  (5,  !\3@  <T\  &E.  !>2P
M4T<  $I$  !"0   .3T  "\X   E-   '3 % !8M#  4+!  $RT5 !(M'  1
M+2, $"TJ  \N,P .+CT #2](  TO50 ,,&, "C!T  DPB  (,9P !C&Q  8Q
MRP &,>L !S#\  @P_P"72   C4T  (-1  !Z4P  <50  &=2  !=4   4DP
M $E*  ! 1@  -4(  "L^   B.@  &C<! !(T"0 /,PX #C,3  TS&0 -,R
M##0H  LT,0 *-3L "#5&  <U4@ %-F  !#9Q  (VA   -ID  #:O   VR
M-N@  #;Y  $U_P"430  BE(  (%6  !X6   ;UD  &58  !;50  45(  $=/
M   \3   ,4@  "=$   >00  %C\  ! \!P +.@T "3H1  @[%P &.QX !3LF
M  0[+@ ".S@  3Q#   \3P  /%X  #QN   \@0  /)<  #RL   [Q0  .^<
M #OX   [_P"14@  B%@  ']<  !V70  ;5X  &-=  !:7   3E@  $)4   W
M40  +4X  "-+   :20  $D8   U$!@ '0PP  T,0  !#%0  0QL  $,C  !#
M*P  0S4  $-   !#30  0UL  $-K  !#?@  0Y0  $*J  !"PP  0>8  $'Y
M  !!_P".6   AEX  'UA  !S8P  :V0  &)C  !780  25T  #U:   R6
M)U4  !Y3   540  #D\   E-!0 "30L  $P.  !,$P  2Q@  $L?  !+*
M2S(  $L]  !+20  2U<  $MG  !*>P  2I   $FG  !)P   2.0  $CX  !'
M_P"+7P  @V0  'IG  !Q:0  :6H  %YI  !09@  0V0  #=A   L7P  (5T
M !A;   060  "E@   -7 P  5PD  %8-  !5$   514  %0;  !4(P  5"T
M %0Y  !410  5%,  %1D  !3=P  4XT  %*D  !1O0  4.(  %#X  !/_P"(
M9P  ?VL  '=N  !O<   97   %=N  !*;   /6L  #!I   E:   &F8  !%D
M   +8P  !&(   !B 0  808  & +  !@#@  7Q(  %\7  !?'@  7B@  %XS
M  !>0   7D\  %Y?  !=<@  78@  %R@  !;N0  6M\  %GW  !8_P"$;@
M?'(  '5U  !K=@  774  $]T  !"<P  -7,  "AR   =<   $V\   QN   $
M;@   &X   !N    ; (  &P'  !K"P  :PX  &L2  !J&0  :B(  &HM  !J
M.@  :4D  &E:  !I;   :(,  &>;  !FM0  9=@  &3U  !D_P" =0  >GD
M '![  !B>P  5'P  $9\   Y?   +'P  !][   4>@  #7H   1Z    >@
M 'H   !Z    >0   'D!  !X!@  > L  '@.  !X$P  >!H  '@E  !X,@
M=T$  '=2  !W90  =GP  '65  !TKP  <\X  '+Q  !Q_P!^?0  =8   &>!
M  !8@@  2H,  #R$   NA0  (84  !6%   -A0   X4   "&    AP   (@
M  "(    AP   (<   "'    AP0  (<)  "'#@  B!,  (@<  "(*0  B#@
M (=*  "'70  AG,  (:-  "%IP  A,4  (/L  ""_@!XA   :H8  %R(  !-
MB@  /XP  #&.   CCP  %H\   V0   "D0   )(   "3    E0   )8   "6
M    E@   )8   "6    EP   )<   "7!P  F T  )D3  ":'P  FBT  )H_
M  ":4@  FF@  )F#  "9GP  F+H  )?B  "6^ !MB@  7XT  %"0  !!DP
M,Y8  "27   6F   #9D   &;    G0   )\   "A    I    *4   "D
MI0   *4   "F    IP   *@   "I    J@0  *P,  "N$P  KB$  *XS  "N
M1P  KET  *YV  "NDP  KJX  *W-  "L[P!AD0  4Y4  $28   UG   )I\
M !>A   -HP   *4   "G    J@   *P   "P    L@   +0   "S    M
M +4   "W    N    +D   "[    O0   +\!  ##"P  Q14  ,4E  #&.0
MQT\  ,=H  #&A0  QJ(  ,:\  #&W@!5F0  1YT  #BB   II@  &:@   VK
M    K0   +$   "T    MP   +H   "_    P0   ,0   ##    Q0   ,8
M  #(    R@   ,T   #/    T@   -8   #;    X P  .$8  #C*P  Y$$
M .5:  #F=   YI$  .6L  #EQ #_    _P   /\   #_  $ _P * /\ $@#_
M !T _P H /\ - #_ #X _0!( /H 4 #W %< ]0!= /0 8P#R &D \ !O .\
M= #M 'L ZP"! .D B0#H )( Y@"< .0 J #B +< WP#- -P [@#9 /\ V0#_
M ,H _P"^ /\ M0#_ +  _P#_    _P   /\   #_    _P & /\ #P#\ !@
M^  C /0 +@#P #@ ZP!" .@ 2@#E %$ X@!8 .  70#> &, W !H -D ;@#6
M '0 U ![ -$ @@#/ (L S0"5 ,H H0#( *\ Q0#! ,( XP#  /L P #_ +L
M_P"P /\ J #_ *0 _P#_    _P   /\   #[    \P ! .T # #H !, XP >
M .  * #: #( TP \ ,\ 1 #, $L R0!1 ,8 5P#$ %T P@!B ,$ 9P"_ &T
MO0!T +L >P"Y (0 MP". +0 F0"R *< KP"W *T T "K /( J@#_ *D _P"A
M /\ FP#_ )< _P#_    _P   /0   #I    X    -4 " #. !  R0 8 ,4
M(@#! "L O  U +D /0"V $4 LP!+ +$ 40"O %8 K@!; *P 80"J &8 J0!M
M *8 = "D 'P H@"& *  D@"> )\ G "N )D PP"7 .< E@#_ )4 _P"2 /\
MC0#_ (H _P#\    \    .,   #4    R    +\  P"Y  T LP 3 *\ ' "L
M "4 J0 N *4 -@"C #X H !$ )X 2@"= %  FP!5 )D 6@"7 %\ E@!F )0
M; "2 '4 D !^ (X B@"+ )< B0"F (< N "% -8 A #V (( _P"! /\ ?@#_
M 'P _P#M    W0   ,P   #!    N    *X   "G  D H@ 0 )X %P": !\
MEP G )0 +P"1 #< CP ] (T 0P"+ $D B0!. (@ 4P"& %D A !? (( 90"
M &T ?@!W 'P @@!Z (\ > "> '4 KP!S ,< <@#L '$ _P!P /\ < #_ &X
M_P#=    R0   +P   "Q    J0   *$   "9  , DP , (X $@"* !D AP A
M (0 *0"! #  ?P W 'T /0![ $( >0!( '@ 30!V %( = !8 '( 7P!Q &<
M;P!P &P >P!J (@ : "7 &8 J !E +P 8P#A &( ^@!A /\ 80#_ &$ _P#-
M 0  O 4  *\%  "E @  G    )0   "-    A@ ( ($ #@!\ !0 >  ; '4
M(P!R "D <  P &X -@!M #P :P!! &D 1P!H $P 9@!2 &0 60!C &  80!I
M %\ = != ($ 6P"0 %D H0!7 +0 5@#0 %4 \@!5 /\ 5 #_ %4 _P#!#
ML@X  *8/  ";#@  D@L  (D%  ""    >P " '4 "P!P !  ;  6 &@ '0!F
M ", 8P J &$ , !@ #8 7@ [ %T 00!; $8 6@!, %@ 4P!6 %L 5 !D %(
M;@!1 'L 3P"* $T FP!, *X 2P#& $H Z@!) /X 20#_ $D _P"Y$@  JA8
M )X7  "4%@  BA,  ($0  !Y"P  <0,  &L !@!E  T 80 1 %T & !: !X
M6  D %8 *@!4 #  4P V %$ .P!0 $$ 3@!' $T 3@!+ %8 20!? $< :0!&
M '8 1 "% $, EP!! *D 0 "_ #\ X@ _ /@ /@#_ #\ _P"R&0  I!X  )@?
M  ".'P  A!P  'H8  !R$@  :@X  &((  !< 0@ 5P . %, $P!0 !D 3@ ?
M $P )0!* "L 2  P $< -@!& #P 1 !" $, 20!! %$ /P!: #X 90 \ '(
M.@"! #D DP X *4 -@"Z #8 VP U /0 -0#_ #4 _P"L(   GR0  )0F  ")
M)@  ?R0  '4@  !L&P  9!4  %P0  !4# $ 3@8* $H"#P!' !0 1  : $(
M( !  "4 /P K #X!,0 \ 3< .P(^ #D"10 X TT -@-6 #4$80 S!&X ,05^
M # %D  O!:, +0:X "P&U  L!_  + C_ "P(_P"H)0  FRH  ) L  "&+0
M>RL  '(G  !H(@  7QT  %<7  !/$@  2 X$ $$*"P ^!Q  .P85 #D'&P X
M!R$ -@@F #4(+  S"#( ,@DY #$)00 O"4D +@I3 "P*7@ K"VP *0M\ "@,
MCP F#*( )0RW "0,TP C#?  ) W_ "4-_P"D*@  F"\  (TR  "#,@  >3$
M &\N  !E*0  7"0  %,?  !+&0  0Q,  #P0!@ U#0P ,PP1 #$,%@ O#!P
M+@TB "T-*  K#2X *@TU "D-/0 G#D8 )@Y0 "0.7  C#VH (@][ " 0C@ ?
M$*( '1"W !P0U  =$?( '1'_ !X1_P"A+P  E3,  (HV  " -P  =C8  &TS
M  !C+P  62H  % E  !((   /QH  #@5   P$0@ +! . "H0$@ H$!@ )Q >
M "40)  D$"H (Q$R "(1.@ A$4, (!). !X26@ =$V@ &Q-X !H3BP 8%*
M%Q2U !84T0 6%?$ %Q7_ !@4_P">,P  DS<  (@Z  !^.P  =#L  &LX  !A
M-   5R\  $XK  !%)@  /2$  #0<   M%P4 )A,, ",3$  B$Q4 (!,: !\3
M(0 >%"< '10O !P5-P ;%4$ &A9+ !D65P 7%V4 %A=V !08B0 3&)X $ABS
M !$9S@ 1&>\ $AG_ !,9_P"<-@  D3L  (8^  !\/P  <S\  &D]  !?.0
M534  $PP  !#+   .B<  #(B   J'@$ (AD) !X7#@ <%Q( &A<7 !D8'@ 9
M&"0 &!DL !<9-  6&CX %1I) !,;50 2&V, $1QT ! <AP /'9P #AVQ  T=
MRP -'>P #AW_  \=_P"9.@  CS\  (1"  ![1   <4,  &A"  !>/@  4SH
M $HV  !!,@  .2T  #$I   H)0  (" & !H=#  7'!  %1P5 !0=&P 4'2(
M$QTI !(>,@ 1'SP $!]& ! @4P .(&$ #2%Q  PAA0 +(ID "B*N  DBQP )
M(N< "B+[  LA_P"7/@  C$,  (-&  !Y2   <$@  &=&  !<1   4C\  $D[
M  ! .   .#0  "\P   G+   'B<# !8C"@ 2(0X $2$3 ! B&0 0(B  #R(G
M  XC+P -)#D #"1$  LE4  *)5X "29O  <F@@ &)I8 !":L  ,FQ  $)N4
M!";W  8F_P"50@  BD<  (%*  !X3   ;TP  &5+  !;2   4$0  $=!   _
M/@  -SL  "TV   D,0  &RT  !,J!P /* T #2<1  TH%@ ,*!T "R@E  HI
M+0 )*3< !RI"  8J3@ $*UP  RML  $K?P  *Y0  "NI   KP0  *^,  "OV
M   J_P"21@  B$L  ']/  !V40  ;5$  &-0  !:30  3TH  $='   ^1
M,T   "D\   @.   %S0  !$Q!0 ,+PP "2X0  <N%0 &+QL !2\C  ,O*P "
M,#4  # _   P3   ,5D  #%I   Q?   ,9$  #&G   POP  ,.$  ##U   O
M_P"02P  AE   'U4  !U5@  :U8  &)5  !84P  3E   $5-   Z20  +T4
M "5"   </@  %#L   XY!0 )-PL !#8/  $V$P  -AD  #8@   V*0  -C(
M #<]   W20  -U<  #=G   W>0  -X\  #:E   VO0  -N   #7U   U_P"-
M4   A%8  'Q:  !R6P  :5L  &!;  !760  3%8  $!2   U3@  *DL  "!(
M   71@  $$,   M!!  $0 H  #\.   ^$0  /A8  #X=   ^)@  /B\  #XZ
M   ^1@  /E0  #YD   ^=@  /8P  #VC   \NP  /-X  #OU   [_P"*5P
M@EP  'E?  !P80  :&$  %]A  !47@  1UL  #I7   O50  )5(  !M0   2
M30  #$L   9* P  20D  $@-  !'$   1Q0  $8:  !&(@  1BP  $8W  !&
M0P  1E$  $9@  !%<P  18D  $2@  !$N   0]P  $+U  !"_P"(70  ?V(
M '=E  !N9P  9V@  %MF  !.8P  06$  #1>   I7   'UH  !57   .5@
M!U0   !3 0  4@8  %$+  !1#@  4!$  $\6  !/'@  3R<  $\R  !//P
M3TT  $Y=  !.;P  3H4  $V=  !,M0  2]@  $KU  !*_P"%90  ?&D  '1L
M  !M;@  8FT  %1K  !':0  .F<  "UE   B9   &&(  !!@   )7P   %X
M  !>    70,  %P(  !;#   6@\  %H3  !9&0  62(  %DM  !9.@  64@
M %A8  !8:P  5X$  %>9  !6L@  5=(  %3T  !3_P"!;   >7   '-S  !H
M<P  6G(  $QQ   _<   ,F\  "5N   :;   $6L   EJ    :@   &D   !I
M    :    &<#  !F"   9@P  &8/  !E%   91P  &4G  !D-   9$,  &13
M  !D90  8WL  &*4  !AK0  8,T  %_Q  !>_P!]=   =W<  &YY  !?>0
M47D  $-Y   V>   *7@  !QW   1=@  "G4   !U    =0   '8   !U
M=    '0   !S @  <P<  ',,  !R$   <A4  '(@  !R+   <CL  '%,  !Q
M7P  <70  '".  !OJ   ;L8  &SM  !K_P![>P  <GX  &1^  !5?P  1X
M #F!   K@@  'H$  !*!   *@0   ($   ""    @P   (,   "#    @@
M ((   ""    @@   ((%  """@  @@\  ((7  ""(P  @C(  ()#  "!5@
M@6P  ("&  !_H0  ?KT  'WF  !\_ !V@@  :(,  %F%  !+AP  /(D  "Z*
M   @BP  $XL   J+    C    (T   "/    D0   )(   "1    D0   )$
M  "1    D0   )(   "2 @  DPD  )0/  "4&0  E"<  )0X  "43   DV(
M )-\  "3F   DK,  )'8  "0]@!JB   7(H  $V-   _D   ,)(  "&4   4
ME0  "I8   "7    F0   )L   "=    GP   *    "@    H    *    "A
M    H@   *,   "D    I0   *8'  "H$   J!P  *@M  "I0   J58  *EO
M  "IBP  J*@  *?'  "F[ !?CP  4)(  $&6   SF0  (YP  !2=   *GP
M *$   "C    I@   *@   "L    K@   *\   "O    L    +    "R
MLP   +0   "V    MP   +H   "]!P  OQ   +\?  # ,P  P$D  ,!B  #
M?@  P)L  ,"W  "_V !3EP  1)L  #6?   FHP  %J4   NG    J@   *T
M  "P    LP   +8   "[    O0   ,    "_    P0   ,(   #$    Q@
M ,@   #*    S    ,\   #3    V@<  -L3  #=)0  WCL  -]3  #@;@
MWXP  -VI  #=P@#_    _P   /\   #_    _P ' /\ $ #_ !D _P D /\
M+P#\ #H ^0!# /4 2P#S %( \0!9 .\ 7@#M &0 ZP!I .D ;P#G '4 Y@!\
M .0 A #B (T X "7 -T H@#: +$ U0#% -( Z #0 /\ SP#_ ,0 _P"X /\
MKP#_ *D _P#_    _P   /\   #_    _P " /L #0#W !4 \P ? .\ *0#J
M #0 Y@ ] .( 10#> $P VP!3 -@ 6 #4 %X T@!C -  :0#. &X S !U ,H
M?0#( (4 Q@"0 ,( FP#  *D O@"Z +L V0"Y /< N #_ +0 _P"I /\ H@#_
M )T _P#_    _P   /\   #V    [@   .< "@#A !$ W  : -< (P#0 "X
MRP W ,< /P#$ $8 P0!- +\ 4@"] %@ NP!= +D 8@"X &@ M@!N +0 =0"Q
M 'X KP"( *T DP"J *$ J "Q *8 R "D .T H@#_ *( _P"; /\ E0#_ )$
M_P#_    _    .X   #C    V    ,T !0#&  X P0 5 +T '@"Y "< M0 P
M +( . "O $  K !& *H 3 "H %$ IP!6 *4 6P"C &$ H0!G )\ ;@"> '8
MFP"  )D C "7 )D E "H )( O "0 -\ C@#[ (X _P"+ /\ A@#_ (, _P#X
M    Z0   -P   #,    P0   +@   "R  H K  1 *@ & "E "$ H@ I )X
M,@"< #D F0 _ )< 10"5 $H E !0 )( 50"0 %H CP!@ (T 9P"+ &\ B0!X
M (8 A "$ )$ @@"@ (  L@!] ,P ? #Q 'L _P!Z /\ =P#_ '4 _P#F
MTP   ,8   "[    L0   *<   "A  4 FP - )< $P"3 !L D  C (P *P"*
M #( B  X (8 /@"$ $0 @@!) ($ 3@!_ %, ?0!9 'L 8 !Y &@ =P!Q '4
M? !S (D < "8 &\ J0!M +\ :P#F &H _P!I /\ :0#_ &< _P#3    PP
M +4   "K    HP   )L   "2    C  * (< $ "# !8 ?P = 'T ) !Z "L
M>  R '8 . !T #T <@!" '$ 2 !O $T ;0!3 &P 60!J &$ : !J &8 = !D
M ($ 80"1 %\ H@!> +8 7 #5 %L ]P!; /\ 6@#_ %H _P#%    M@(  *D"
M  "?    E@   (X   "'    @  % 'H # !U !$ <0 8 &X '@!K "4 :0 K
M &< ,0!F #< 9  \ &, 00!A $< 7P!- %X 4P!< %L 6@!D %@ ;@!6 'L
M5 "* %( FP!1 *X 4 #( $\ [@!. /\ 3@#_ $T _P"["@  K T  * -  "5
M#   C @  (,"  !\    =0   &X " !I  X 90 3 &( &0!? !\ 70 E %L
M*P!9 #$ 6  V %8 .P!5 $$ 4P!' %$ 3@!0 %4 3@!> $P : !* '4 2 "$
M $< E0!% *@ 1 "_ $, Y !" /P 0@#_ $( _P"R$0  I10  )D5  ".$P
MA!$  'L-  !S"   ;    &4  P!?  L 6P / %< % !4 !H 40 ? $\ )0!.
M "L 3  P $L -@!) #P 2 !" $8 2 !% %  0P!9 $$ 8P _ &\ /@!^ #P
MD  [ *, .@"X #D V0 X /4 . #_ #@ _P"L%P  GQL  ),=  ")'   ?QD
M '45  !L$   9 P  %T&  !6  8 40 , $T $ !* !4 1P : $4 ( !$ "8
M0@ K $$ ,0 _ #8 /@ ] #P 1  [ $L .0!4 #< 7P V &L - !Z #( C  Q
M )X , "S "\ S@ O .\ +@#_ "X _P"G'@  FB(  (\D  "$)   >B$  '$=
M  !G&   7Q,  %<.  !0"@  20,( $4 #0!! !$ /@ 6 #P &P Z "$ .0 F
M #< +  V #( -  X #, /P Q $< , !0 "X 6P M &< *P!V "H B  H )P
M)P"P "8 R0 E .H )0'[ "4!_P"B(P  EB@  (LJ  "!*@  =R@  &TE  !D
M(   6QL  %(5  !+$   0PP" #T'"0 Y PX -@$2 #,!%P Q 1P , $B "\"
M)P M BT + ,T "H#.P I!$, * 1- "8%6  E!64 (P9T "(&A@ @!IH 'P>N
M !X'Q@ =!^< '0CX !T)_P"?*   DRT  (@O  !^+P  ="X  &HK  !A)@
M6"$  $\<  !'%P  /Q(  #@.!  Q"PH +@@. "L'$@ I!Q< * @= "<((P E
M""D ) DP ",)-P A"D  ( I* !\+50 ="V( &PQR !H,A0 8#)D %PRM !8,
MQ@ 5#>8 %0WY !8-_P"<+0  D#$  (8T  !\-   <C,  &@Q  !?+   52<
M $PC  !$'0  /!@  #03   M$ 8 )@T+ "0,#P B#!, (0P9 !\,'P >#24
M'0TL !L--  :#CT &0Y' !<.4P 6#F$ % ]Q !,0A  2$)@ $1"N ! 0Q@ 0
M$.@ $!#[ !$0_P"9,0  CC4  (0X  !Z.0  <#@  &<V  !=,@  4RT  $HH
M  !")   .1\  #$:   J%0$ (Q$' !T0#0 ;#Q  &0\5 !@0&P 7$"$ %A I
M !40,0 4$3H $Q%% !(240 1$E\ $!)O  X3@@ .$Y8 #1.K  L3P@ +%.,
M#!3Z  T3_P"7-0  C#D  ((\  !X/0  ;ST  &4Z  !;-P  4C(  $DN  !
M*@  -R4  "\A   H'   (!@# !D4"@ 5$@X %!(2 !,3&  2$Q\ $10F !$4
M+@ 0%#@ #Q5"  X63P -%EP #!=L  L7?P )&), "!BH  88OP '&.  !QCU
M  D8_P"5.   BCT  (!   !W00  ;4$  &0_  !:/   4#@  $<S   ^,
M-BL  "XG   G(P  'Q\  !<:"  2%PT $!<1  \7%@ .&!P #A@C  T9+  ,
M&C4 "QI   H;3  )&UH !QQI  4<?  $'9$  AVF  $=O  "'-T  ASR  ,<
M_P"3/   B$$  ']$  !U10  ;$4  &-$  !900  3ST  $8Y   ^-@  -3(
M "XN   E*@  '24  !0A!  /'0L #1T0  P=%  +'1H "AXB  @>*@ ''S,
M!B ^  0@2@ #(5<  2%G   A>0  (8X  "&D   AN@  (=L  "'R   @_@"0
M0   AD4  'U(  !T2@  :TH  &))  !81@  3D(  $4_   ]/   -3D  "LT
M   B+P  &2L  !(H!  -) H "2,.  8C$@ %(QD !"0@  (D*  !)3$  "4\
M   E2   )E4  "9E   F=P  )HP  ":B   FN0  )MD  "7R   E_@".10
MA$D  'M-  !S3P  :D\  &!.  !72P  34@  $1%   \0@  ,3T  "<Y   >
M-0  %3(   \N P *+ H !2L.  $J$0  *A8  "H>   J)@  *R\  "LY   K
M10  +%,  "QB   L=0  +(H  "N@   KMP  *]8  "KR   J_P",20  @DX
M 'I2  !Q5   :%0  %]3  !640  3$X  $-+   W1P  +4,  ",_   :/
M$C@   PV P &,PD  #(-   R$   ,10  #$;   Q(P  ,2P  #(W   R0P
M,E   #)@   R<@  ,H<  #&>   QM0  ,-0  ##R   O_P")3P  @%0  'A7
M  !O60  9ED  %Y9  !55P  25,  #Y/   R3   *$@  !Y%   50@  #D
M  @] @ !/ @  #L,   Z#P  .1(  #D8   Y(   .2D  #DT   Y0   .4X
M #E=   Y;P  .(4  #B<   WLP  -](  #;R   U_P"'50  ?UH  '9=  !M
M7P  95\  %U?  !27   1%@  #A5   M4@  (D\  !A,   02@  "D@   -&
M 0  108  $0*  !##0  0A   $$5  !!'0  028  $$Q  !!/0  04H  $%:
M  !!;   0($  #^9   _L0  /M   #WR   \_P"$7   ?&   '-C  !L90
M9&8  %ED  !+80  /EX  #);   F60  '%8  !)4   ,4@  !%$   !/
M3@,  $T(  !,#   2PX  $L2  !*&0  2B(  $HL  !*.0  2D<  $I6  !)
M:   27X  $B6  !'KP  1LT  $7Q  !$_P"!8P  >6<  ')J  !K;   8&L
M %)I  !$9@  -V0  "IB   ?8   %5X   U=   &6P   %H   !9    6
M %<$  !6"   5@P  %40  !4%   5!T  %0G  !4-   5$(  %-2  !39
M4GD  %*2  !1JP  4,H  $_O  !._P!^:@  =VX  '!Q  !F<0  6'   $IO
M   \;0  +VP  ")J   7:0  #F<   9F    90   &4   !E    8P   &(
M  !B!   80@  &$-  !@$   8!<  & A  !?+@  7SP  %]-  !>7@  7G0
M %V-  !<IP  6\4  %KM  !9_P![<@  =78  &MW  !==@  3W8  $%U   S
M=0  )G0  !ES   0<@  !W$   !Q    <0   '$   !Q    ;P   &\   !N
M    ;@(  &X(  !M#   ;1$  &T:  !M)@  ;#4  &Q&  !K6   :VT  &J&
M  !IH0  :+X  &?H  !F_@!Y>@  <'P  &%\  !3?0  1'T  #9^   H?@
M&WT  !!]   '?0   'T   !]    ?@   '\   !^    ?0   'T   !\
M?    'P   !\!@  ? P  'P2  !\'0  ?"P  'P\  !\3P  >V4  'M^  !Z
MF@  >;8  'C?  !W^@!S@   98$  %:#  !(A   .88  "N'   =AP  $8<
M  >(    B    (D   "*    C    (T   "-    C    (P   ",    C
M (P   "-    C00  (X,  ".$P  CR$  (XR  ".1@  CEL  (UT  "-D
MC*T  (O.  "*\P!HA@  6H@  $N+   \C0  +8\  !Z0   1D0  !Y(   "3
M    E0   )<   "9    FP   )P   ";    FP   )P   "<    G0   )X
M  ">    GP   *$#  "B#   HA8  *,F  "C.@  HT\  *-H  "BA@  HJ(
M *+   "AZ !<C0  39   #^3   PE@  (9D  !*:   'FP   )T   "@
MH@   *0   "H    J@   *L   "J    JP   *P   "M    K@   *\   "Q
M    L@   +0   "W 0  N0T  +D:  "Z+0  ND,  +I;  "Z=P  NY0  +NQ
M  "YT@!0E0  09@  #*<   CH   $Z(   BD    IP   *H   "L    KP
M +(   "W    N0   +L   "Z    O    +T   "_    P    ,(   #$
MQ@   ,D   #-    T@$  -0/  #5'P  US4  -A-  #8:0  UX8  ->C  #6
MO0#_    _P   /\   #_    _P # /\ #0#_ !4 _P @ /P *P#X #4 ]  _
M /  1P#N $X ZP!4 .D 6@#G %\ Y0!D ., :@#A '  WP!V -T ?@#; (<
MV "1 -, G0#/ *L S0"] ,L X #) /L QP#_ +T _P"Q /\ J0#_ *, _P#_
M    _P   /\   #_    _    /8 "P#Q !$ [0 ; .D )0#D #  WP Y -H
M00#5 $@ T0!. ,\ 5 #- %D RP!> ,D 8P#' &D Q0!O ,, =P#  '\ O@"*
M +L E0"X *, M@"T +0 S0"R /( L #_ *P _P"C /\ G #_ )< _P#_
M_P   /H   #Q    Z    .  !@#9  X T@ 6 ,X 'P#( "D Q  R ,  .@"]
M $$ N@!( +@ 30"V %, M !8 +( 70"P &( K@!I *P ;P"J '@ J "" *8
MC@"D )L H0"K )\ P "= .8 FP#_ )H _P"4 /\ C@#_ (H _P#_    ]@
M .@   #<    S@   ,8  0"_  L N@ 1 +8 &@"R "( K@ K *H - "H #L
MI0!! *, 1P"A $P GP!1 )X 5@"< %P F@!B )D : "7 '  E0!Z )( A@"0
M ), C0"B (L M0") -, AP#W (8 _P"$ /\ ?P#_ 'P _P#R    XP   -(
M  #%    N@   +$   "K  < I0 . *$ % "> !P F@ E )< +0"4 #0 D@ Z
M )  0 ". $4 C0!* (L 4 ") %4 B !; (8 80"$ &D @@!R '\ ?0!] (L
M>P": '@ JP!V ,0 = #K ', _P!S /\ < #_ &X _P#?    S    +\   "T
M    JP   *$   ":  ( E  + )  $ ", !< B  > (4 )@"# "T @0 S '\
M.0!] #\ >P!$ 'D 20!X $X =@!4 '0 6@!S &( < !K &X =0!L (, :@"2
M &@ HP!F +@ 9 #> &, ^P!B /\ 8@#_ &  _P#,    O    *\   "E
MG0   )0   ",    A@ ' ($ #0!\ !( >  9 '4 'P!S "8 <0 M &\ ,@!M
M #@ :P ] &H 0@!H $@ 9P!. &4 5 !C %L 80!D %\ ;@!= 'L 6P"* %D
MFP!7 *\ 5@#+ %4 \@!4 /\ 5 #_ %0 _P"^    L    *0   "9    D
M (@   "!    >0 " ', "@!O  \ :P 4 &< &@!E "  8P F &$ + !? #(
M7@ W %P / !; $( 60!' %< 3@!6 %4 5 !> %( : !0 '0 3@"# $P E0!*
M *@ 20#  $@ Z !' /\ 1P#_ $< _P"T"0  I@L  )L,  "0"@  A@4  'X
M  !V    ;P   &@ !0!C  P 7P 0 %L %0!8 !H 5@ A %0 )@!3 "P 40 Q
M %  -@!. #P 30!" $L 2 !) %  2 !8 $8 8@!$ &X 0@!] $  C@ _ *(
M/0"X #T W0 \ /@ / #_ #P _P"L$   GQ(  )02  ")$0  ?P\  '8,  !N
M!0  9@   &   0!9  @ 50 - %$ $0!. !8 2P ; $D (0!( "8 1@ K $4
M,0!# #8 0@ \ $  0P ^ $L /0!3 #L 70 Y &D -P!X #8 B0 T )P ,P"Q
M #( S@ R /$ ,0#_ #$ _P"F%@  FAD  (X:  "$&@  >A8  ' 2  !H#@
M7PH  %@#  !1  0 3  * $@ #@!$ !( 00 6 #\ &P ] "$ /  F #H +  Y
M #$ -P W #8 /@ T $8 ,P!/ #$ 60 O &4 +@!S "P A0 K )@ *@"M "D
MQ@ H .H * #^ "@ _P"A'   E2   (HA  !_(0  =1\  &P:  !C%@  6A$
M %(-  !+!P  1  & $  "P \  \ .  2 #8 %P T !P ,P A #$ )P P "P
M+@ S "T .@ K $( *@!+ "@ 50 F &$ )0!P "0 @0 B )4 (0"I "  P0 @
M .0 'P#Y !\ _P"=(@  D28  (8H  !\)P  <B4  &DB  !?'0  5Q@  $X3
M  !&#@  /PL  #@%!P T  P ,0 0 "X $P L !@ *@ = "D (@ G "@ )@ N
M "0 -@ C #X (@!' "  4@ ? %X '0!M !P ?@ : )( &0"G !@ O0 7 -\
M%P'U !<"_P":)P  CBL  (0M  !Y+0  <"L  &8H  !=)   5!\  $L:  !#
M%   .Q   #0- @ M"0D *04- "8#$  D 1, (@(9 "$"'@ @ B0 '@,J !T#
M,@ ;!#H &@5$ !D%3P 7!EP %@9J !0'?  3!Y  $@>E !$'NP 0!]L $ CR
M ! )_P"7*P  C"\  ($Q  !W,@  ;C$  &0N  !;*@  424  $D@  ! &P
M.!8  #$2   I#@0 (PP) !\)#0 =!Q  &P<5 !D(&@ 8""  %PDG !8)+@ 5
M"C< $PI! !(+30 1"UH $ MI  X,>P .#)  #0RE  P-NP +#=D "PWQ  P-
M_P"5+P  BC,  '\V  !V-@  ;#4  &,S  !9+P  4"L  $<F   ^(0  -AT
M "X8   G$P  (! % !D."@ 5# X % P1 !,,%@ 2#!P $0TC ! -*P /#30
M#@X_  T.2@ ,#U@ "P]G  H0>0 ($(T !Q"B  80N  %$-0 !1#O  80_P"2
M,P  B#<  'XZ  !T.P  :SH  &$X  !8-0  3C   $4L   ])P  -2,  "T?
M   F&@  'A8! !<3!@ 1$ L #@X.  X/$P -$!D #1 @  P0*  +$3( "A$\
M  @22  '$E4 !A-E  03=@ #$XL  12@   3M@  $]$  !/N   3^P"0-@
MACL  'P^  !S/P  :C\  & ]  !7.0  338  $0Q   \+@  -"H  "PF   E
M(@  'AX  !8: @ 0%0D #!,.  H3$@ )%!< "!0?  <5)@ &%2\ !!8Z  ,6
M1@ !%U,  !=B   8=   &(D  !B?   8M0  %]   !?M   7^P"..@  A#\
M 'M"  !R0P  :$,  %]"  !6/P  3#L  $,W   [-   ,S   "PL   D*0
M&R0  !,? @ -&PD "1D-  89$0 $&18  AD=  $:)   &BT  !LX   ;1
M'%$  !Q@   =<@  '8<  !R=   <LP  ',X  !OM   ;_ ",/@  @D,  'E&
M  !P2   :$@  %Y&  !51   2T   $,]   [.@  ,S<  "HR   @+0  %RD
M ! E @ +(@D !2 -  $?$   'Q0  !\;   @(@  ("L  "$V   A00  (4\
M "%>   B<   (H4  "&;   AL@  (<T  "#M   ?_ "*0P  @$@  'A+  !O
M3   9DT  %U+  !420  2D8  $)#   Z0   +SL  "4W   <,P  $R\   TL
M @ '*0@  2<,   F#@  )1(  "89   F(0  )BD  "8S   G/P  )TT  "=<
M   G;0  )X(  ">9   FL   )<P  "7N   D_0"(2   ?TP  '90  !N40
M95(  %Q1  !33P  2DP  $%)   U1   *T   "$\   7.0  $#8   HR 0 #
M, <  "\+   N#@  +1$  "T6   M'@  +2<  "TQ   M/0  +4H  "U9   M
M:P  +8   "R7   LKP  *\L  "KN   J_@"%30  ?5(  '55  !L5P  8U<
M %M6  !350  1U$  #M-   P20  )48  !Q#   3/P  #3T   8Z    . 4
M #<)   V#0  -0\  #04   T&P  -"0  #0N   T.@  -$<  #17   T:
M-'T  #.5   RK0  ,<H  #'N   P_P"#4P  >U@  '-;  !J70  8ET  %M=
M  !/6@  0E8  #92   J3P  ($P  !9)   .1P  "$0   !"    00,  #\'
M   ^"P  /0X  #T1   \&   /"$  #PK   \-P  /$0  #Q3   \90  .WH
M #J2   ZJP  .<@  #CM   W_P"!6@  >5X  '%A  !I8P  8F0  %=B  !)
M7@  /%L  "]8   D50  &5,  !!1   *3P   4T   !,    2@   $D$  !(
M"   1PP  $8/  !&%   11P  $4G  !%,P  14   $50  !$80  1'8  $./
M  !"J   0<8  $#L   __P!^80  =F4  &]H  !H:@  76D  $]F  !"9
M-&$  "A?   =70  $EL   M9   "6    %8   !6    5    %,   !2!
M40D  % -  !0$   3Q@  $\B  !/+@  3SP  $]+  !.70  3G(  $V+  !,
MI0  2\(  $GJ  !(_P![:0  =&P  &YO  !D;P  56T  $=L   Y:@  +&D
M "!G   490  #60   -B    8@   &$   !@    7P   %X   !=    7 0
M %P)  !;#0  6Q(  %L<  !:*   6C8  %I&  !96   66T  %B%  !7H
M5KT  %7H  !3_@!Y<   <W0  &EU  !;=   3',  #YS   P<@  (W$  !9O
M   -;@  !&T   !M    ;0   &T   !L    :P   &H   !I    :0   &D#
M  !H"0  : X  &@5  !G(0  9R\  &<_  !F4@  9F8  &5_  !DF@  8[<
M &+A  !A_ !W>   ;7H  %]Z  !0>@  0GH  #-[   E>P  &'H   YY   $
M>0   'D   !Y    >@   'H   !Z    >    '@   !W    =P   '<   !W
M 0  =P@  '<.  !W&   =R8  '8V  !V20  =5\  '5W  !TDP  <Z\  '+3
M  !Q]P!Q?@  8W\  %2   !%@@  -H,  "B$   :A   #H,   2$    A
M (4   "&    B    (D   "(    AP   (<   "'    AP   (<   "(
MB    (@'  ")$   B1P  (DL  "(/P  B%4  (AM  "'B0  AJ<  (7'  "$
M[P!FA   5X8  $B(   YB@  *HP  !N-   /C0  !(X   "0    D0   ),
M  "5    EP   )@   "6    EP   )<   "7    F    )@   "9    F@
M )L   "=!P  G1$  )TA  "=,P  G4D  )QB  "<?P  G)P  )RY  ";X@!:
MBP  2XX  #R1   MDP  'I4  !"6   $F    )H   "<    G@   *$   "D
M    I@   *<   "F    IP   *<   "H    J0   *H   "L    K0   *\
M  "Q    LPD  +,5  "T)P  M#T  +55  "U<   M(X  +2L  "TS !-D@
M/Y8  "^:   @G0  $9\   6A    HP   *8   "I    K    *\   "S
MM0   +<   "V    MP   +@   "Z    NP   +T   "_    P0   ,0   #'
M    RP   ,T,  #.&@  SR\  ,](  #08@  T(   -"=  #0N
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M" D*"PT.#Q$2$Q06%Q@:&QP='R A(B0E)B@I*BLM+B\P,C,T-C<X.3L\/3Y
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MY>;GZ.GJZ^SM[N_P\?+S]/7V]_CY^OO\_?[_;69T,0     # 2$   $
M               !                     0    $" P0%!@<(" D*"PP-
M#@\0$1(3%!46%Q@9&AH;'!T>'R A(B,D)28G*"DJ*RPM+B\P,3$R,S0U-C<X
M.3H[/#T^/T!!0D-$149'2$E*2TQ-3D]045)35%565UA96EM<75Y?8&%B8V1E
M9F=H:6IK;&UN;W!Q<G-T=79W>'EZ>WQ]?G^ @8*#A(6&AXB)BHN,C8Z/D)&2
MDY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKK"QLK.TM;:WN+FZN[R]OK_
MP<+#Q,7&Q\C)RLO,S<[/T-'3U-76U]C9VMO<W=[?X.'BX^3EYN?HZ>KK[.WN
M[_'R\_3U]O?X^?K[_/W^_P ! 0(" P,$! 4&!@<'" @)"0H+"PP,#0T.#P\0
M$!$1$A,3%!05%A87%Q@9&1H:&QP<'1X>'R @(2(B(R0D)28F)R@I*2HK+"TM
M+B\P,3(R,S0U-C<X.3H[/#T^/T!"0T1%1DA)2DQ-3U!24U576%I<7F!B9&9H
M:FUO<71V>7Q^@8.&B8N.D)*5EYF;G9^AHZ6GJ*JLK:^PLK.UMK>YNKN\O;_
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M____________TEH"         %W,____________________________J#4
M         %S3____________________________?0T          %36____
M_______________________N?44          $34____________________
M_______\JF0O @  !"(W25C.____________________________Z:1K02@_
M8W^5I[K:_______________________________5LJRRS.3Z____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________ENY=W8LC_____________________________
M____VYYG-@H  HS________________________________(?S\%     %[/
M_____________________________]F!.0       #RJ________________
M_____________YY,         ".0____________________________W&\:
M         !!]^?__________________________KT@           !O[O__
M________________________A!,           !DYO__________________
M_______L40            !7WO________________________^X%0
M      !(UO________________________]T%              XS_______
M__________________FB6A,            CQ?______________________
M___?FUPL           -NO__________________________[[%]53DB$0<!
M A$BLO______________________________W[^EF9B:H*R]VO__________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________X[Z=@'S[
M________________________________\K>$5S . !VL________________
M_______________2BDP5      !R\____________________________]9_
M-@        !+R?__________________________^I$^           OJ___
M________________________P%H            :E?__________________
M________C20            (A/_________________________G7@
M        =_________________________^T)0              :O______
M__________________]]                6_3_____________________
M__TK                3.O______________________Z4
M    /.'______________________S ,                +=G_________
M____________F8IA)P              )]?______________________^V^
MB54G            )=S__________________________LJ==EU*/#(M+# Y
M1][_______________________________WFW=;2T-/9Y/______________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________OU+O6________________________________
M_^>XCVI++Q5O_______________________________DH6<T!P     \R?__
M_________________________]:".P         2E___________________
M________[84Q            ;___________________________ID(
M        4.'________________________L:0              -\G_____
M__________________^S+P              (K;_____________________
M__]Y                $*?_______________________(T
M     )G______________________ZD                  (S_________
M_____________T8                  '______________________WP
M                 '3_____________________EP
M &K_____________________S@                   &/_____________
M_________RDB 0               &'______________________[FC@%<W
M%P           &C___________________________K3KI2&?'5Q<')W@93_
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________V[J=@FEIT___________________
M____________R)-E/1D    =GO___________________________]N.3!,
M        ;O__________________________VWPL            1=?_____
M____________________BRH             (K3_____________________
M___"1                Y?_______________________]] 0
M     '_______________________^<V                 &K_________
M_____________YT                  %C______________________T8
M                 $?X____________________Z0
M #7I____________________E@                   "7;____________
M________O                    !C.____________________ZP
M              _"_____________________P                    JY
M_____________________R<                   JU________________
M_____W                    VY_____________________^"<C'!50C,F
M&Q0/#0X2&B:_____________________________^>38TL[,R\S/UN#\____
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____Z].\X________________________________]*IA65(+!(!A?______
M______________________&K<3P/        3^#_____________________
M____U7\U            '[+________________________C=1T
M     (G_______________________^0(P               &?_________
M_____________]5#                 $CV_____________________XH
M                 "[=_____________________S@
M !?(____________________O@                    2V____________
M________G                     "E____________________N@
M              "3____________________W                     ""
M_____________________P                    !T________________
M_____Q,                   !H_____________________T(
M          !@_____________________WH                   !=____
M_________________]$                   !A____________________
M__\D                  !F_______________________)K)F)?79Q;&EG
M9F=K<'J,____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________XL6JD7EA=______________________________=IG=0+ P
M    ,<3_________________________X)).$P           (__________
M_______________2<!T              &#______________________^YO
M#P               #?B_____________________Y8<
M !3 _____________________T                    "C____________
M________K@                    ")____________________G@
M              !R____________________O                     !?
M____________________V@                    !-________________
M____^@                     [_____________________PX
M           J^?___________________S,                    ;Z?__
M_________________UX                    /V___________________
M_X\                    &T/___________________]
M        RO____________________\K                    R/______
M______________^                     R______________________W
M%@$%!0,!       !!@T8R________________________.OAV,_,S<_0TM37
MW.+J________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________________________':QO__________
M____________________\<:CA&A-,A@ %:O_________________________
M_[E\1A@          ''________________________7?"\
M #OC_____________________]]D"0                RU____________
M_________W0#                  "-____________________Q14
M              !J____________________F0                    !+
M____________________M@                     P_?______________
M____UP                     9Y___________________]@
M           %T____________________PX                     P?__
M_________________R\                     K___________________
M_U(                     GO___________________WD
M        CO___________________Z4                     @/______
M_____________]@                     =/____________________\V
M                    ;?____________________]\
M    :?_____________________7#0                  :/__________
M____________<                   8?_______________________U \
M1DY465UA9&AL<'9^B?__________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________[]6[HXMS
M6I7___________________________B_CF1!(04      %+\____________
M___________WG588             !?!_____________________^5L%@
M              "-_____________________V,                   !>
M____________________G0                     U_/______________
M____H0                     1V?__________________R@
M            N___________________[@                      H?__
M_________________PP                     BO__________________
M_RT                     =O___________________TT
M        9/___________________V\                     4O______
M_____________Y0                     0/___________________[P
M                    ,/___________________^H.
M    (O____________________]$                    %?__________
M__________^!                    "_7____________________("P
M                 NS_____________________7@
M .7_____________________R1P                  -K_____________
M_________YT!              <.%\7________________________5N;S!
MQ\[5V^'F[?3[________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________XW\______________________________
M[,:EB&U4.R$' #+>________________________UY)9*0            "@
M______________________^)-@                !G________________
M_____V8                    R]O__________________E0
M           #R/__________________IP                      H/__
M________________UP                      ?/__________________
M_P                      7O___________________R4
M        0____________________T@                     +/______
M_____________VH                     &/___________________XL
M                    !?/__________________Z\
M     .'__________________]4                      ,__________
M__________\D                     +[___________________]4
M                 *[___________________^+
M )_____________________+#@                   )+_____________
M________5P                   (;_____________________J@H
M             'G______________________VT                  &;_
M______________________=5                 $7_________________
M________:B,K-3]*56!J=7Z'D9S_________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________^C/MIV#:4ZY________________
M_________^RR@UPZ'0(       ![_______________________%;2D
M          ! _____________________X,;                   'R___
M________________D@                      F/__________________
MI                       :O__________________W0
M        0?___________________PX                     '?______
M_____________SD                      .C__________________V
M                     ,[__________________X4
M     +?__________________Z@                      */_________
M_________\L                      )#__________________^\6
M                 'W___________________\^
M &S___________________]I                     %K_____________
M______^9                     $G____________________2%@
M             #G_____________________6                    "G_
M____________________H@                   !G_________________
M____]58                   3______________________[LO
M          #X______________________^K*0                #/____
M____________________R4<     !Q,@+CY2:(3M____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________]-7)____________________________^M*PDG==0B@,  !*____
M____________________Q7U%%P             1V/__________________
M_\10                    G___________________H@P
M        :/__________________E                       -O______
M____________V@                      !^S__________________Q4
M                     ,3__________________T@
M     *+__________________W4                      (/_________
M_________YT                      &G__________________\,
M                 %+__________________^</
M #[___________________\S                     "O_____________
M______]8                     !C___________________^!
M              7___________________^L                      #_
M___________________>(@                    #R________________
M____7                     #?____________________GP
M          #,____________________Z$H                   "W____
M_________________Z 6                  "<____________________
M__]Z @                !W________________________>@L
M      5,_________________________Z)7:'2 C9RKO-#G____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________^WC___________________________2HWI8.BDC
M'!8.!@  G_____________________^L4@X                 :?______
M____________Y$,                     -/__________________>0
M                     ./_________________S0
M     ++__________________Q,                      (7_________
M_________T\                      %W__________________X,
M                 #K__________________[(
M !S__________________]L#                      +_____________
M______\J                      #[__________________]/
M              #G__________________]T                      #4
M__________________^;                      # ________________
M___$!P                    "M___________________P,P
M          ":____________________9P                    "&____
M________________HP                    !R____________________
MXT0                   !<_____________________Y$&
M      !!_____________________^M?                   =________
M_______________*2P                  ________________________
MRU<   P8)#$_3F!TBZ?'___________________________7Y_+_________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___KU,W'PKZZM[.PK:FHI?___________________]U^4S\P(QD1"0(
M     -O_________________=@                       *?_________
M________N@                       '7__________________P<
M                 $;__________________TX
M !K__________________XP                       #]____________
M_____\$                       #;__________________$9
M              "^__________________]$                      "D
M__________________]K                      "-________________
M__^1                      !Y__________________^W
M          !F___________________>(0                    !3____
M________________2@                     _____________________
M=P                     K____________________K H
M       6____________________YT4                     ________
M_____________XH                     _____________________]9-
M                    _?____________________^G+@
M    U?______________________F"H           88+45@X/__________
M_____________ZAC=(&/G*N[S>+Z________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________________GR[>I
MG96.B82 ?'AT<&QH99#_________________O&I(+1D*
M #'__________________P                        /_____________
M_____T(                       #<_________________XX
M              "R_________________\X                       "-
M__________________\I                      !K________________
M__]:                      !.__________________^&
M           T__________________^N                       >____
M_______________4%P                     *___________________Z
M/0                      ____________________90
M        ____________________C@                      ________
M____________O!D                     [___________________\4X
M                    V/___________________XL
M    O____________________\Q#                    H?__________
M__________^1&0                  >O_____________________R= H
M               17_______________________Z'03'RPX15-B<H6;M-+U
M___________________________7Z/3_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________OW\_'N[.OK[/'__________________]FRF8=Y;61=
M5E%+1D$\.#(M*"/$_________________TLE"P                    "2
M_________________X@                       !F________________
M_]<                        ]__________________\S
M           8__________________]L                        ____
M______________^=                        ___________________)
M#                       ]O_________________Q-0
M        W___________________6P                      R_______
M____________@@                      M___________________J08
M                    H___________________TR\
M    C?___________________UX                     =___________
M_________Y,'                    7O___________________\U#
M                0/____________________^'$
M'/_____________________87@                   /______________
M________OTX       X<+#Y2:H:ER/_______________________\)\C)JG
MML76Z/W_____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____^[AU\_)P[ZZMK&MJ:>FIJ>N_________________[Z&;5M,0#<O*"(<
M%A +!      4_________________]<%                        ____
M______________\T                        ]O________________]V
M                        TO________________^P
M        LO_________________A)                       EO______
M____________40                      ?/__________________>0
M                    9O__________________H
M    4?__________________QR,                     //__________
M________[DL                     )____________________W0
M                $/___________________Z,6
M /___________________]A,                     /______________
M______^(#P                   /_____________________+4P
M             /______________________I3@           D=-$YKC/__
M_____________________YDY0U%?;GV.H+7+Y?______________________
M_______K^?__________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________________K
MS+FLH9F1BX:!?'AT<&MH9F9H\?________________]A13(C& X&
M        GO________________]^                        =?______
M___________#                        4O_________________[-P
M                    ,O__________________:@
M    %O__________________E@                       /__________
M________OQL                      /__________________YD(
M                 /___________________VD
M /___________________Y "                     /______________
M_____[DL                     /3__________________^A<
M             -G___________________^1&                    +S_
M___________________*4P                   )W_________________
M____F"X             $"E&9L3_____________________[G\=#!HH-T97
M:7Z5K\SN_________________________^>@JKG(V.G\________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________?7PZ^;BW]O8U-+1T-+7X/_________________.GHI\
M<6EA6U913$A#/CHV,B\N,?_________________2)1$#
M     /__________________0@                       /__________
M________?0                       /__________________L L
M                 /;_________________W3D
M -S__________________V(                      ,7_____________
M_____XD                      *___________________Z\B
M             )G__________________]9(                     (+_
M__________________]R                     &G_________________
M__^A*                    $[____________________37
M         #/_____________________EBX              !4R4G?_____
M________________X'(3   !#Q\O0EAPBZC([/______________________
M_\IO;GZ.GK##V.______________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________^>#2R,"ZM;"LJ*6BGYV;FYR@I___________________@F162T,\
M-C K)R(=&!,."00  -3_________________D@
M *W_________________S!X                      (O_____________
M____^U(                      &W__________________X
M             %'__________________ZD;                     #K_
M_________________]!"                     "/_________________
M__5H                      S___________________^/%
M          #___________________^X/@                    #_____
M_______________E;0,                   #_____________________
MGS<              ! O4'3_____________________W7(4      87*D%:
M=92VVO_______________________[Q81%1D=8::K\CC________________
M_______________2S>'Q________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________\^_K[_?__________________
M____[KFHG9:/BH:"?WMX=G1R<W5X?Y#_________________ZT\Z,"@A&Q40
M"P<"         "/__________________VD                       #_
M_________________YL*                      #_________________
M_\@Y                      #___________________!C
M          #___________________^*#@                    #_____
M______________^P-                     #____________________5
M6P                    #_____________________A1H
M      /L____________________L4D              !@Y78'_________
M____________Y7L>       ,(3A2;X^SV?_______________________[M8
M*3E)6FR E[#-[?____________________________^SGK3%U^O_________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________Z[^?AW-G6U-+0T-#1T]G@Z_?_________________
M_[B*?G=Q;&AD85Y;65A75UE>97'__________________[\Q'Q80"@4
M          #__________________^U6                      #H____
M______________^"!                     #,__________________^K
M+P                    "S___________________25P
M      ";___________________W?!                    "%________
M____________HC<                 !2N4____________________RV$"
M            #"Q0=I[1____________________]8TP       -(SM7=IF^
MY?_______________________\-C&"H[3%]TC:?&Y___________________
M__________^H?Y:HN]#G_____________________________________?__
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________=SL6_O+FVM+.QLK*UN<#)U>/___________________^7
M;&1>65513TQ*2$=&2$M066:A__________________^G)@X' @
M      !6___________________.4                      Z________
M___________T>0L                    A____________________GS(
M                   .____________________Q%@                (
M,5J$____________________Z7\?           &)TMQFL+I____________
M_________Z=)      (7+TIHBJ[5_/_______________________]-U'B8X
M2EYUCZO+[_____________________________^N<H68K,+;]O__________
M________________________W^__________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________O[*JIJ.AH)^?H:.FK+3 S=WL____________________BEI3
M3TM(1D1#0D%"0T=.66E]____________________GBX&
M    ____________________PU8                  !5!____________
M________YWL:              DT8(NT_____________________Y\_
M      0E2G&9PNO______________________\9F#P   !,J1&*#I\WU____
M_____________________^N.-2L^46B!G;S>________________________
M______^^=G^4J<'<^?__________________________________TMCS____
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________V\O#O[^_Q\_C]____________________
M________^+"?FI>6EI:8FY^DK+;"T>'N_____________________HY02D=%
M1$1$149'2U%::(.I_____________________Z9! 0          !S9CC[KA
M_____________________\9E"@      !"=,<YS$[/__________________
M_____^6(+P  $RI$8H*FS/3___________________________^K4#9*87N6
MM-;Z_______________________________2AWR8L<OI________________
M____________________U,[M____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________MY>/CY.;H[?'Y________________________
M______VQE)*2E9F=HZFRO-#M__________________________^=4T=)35%6
M8'.*K];\__________________________^R5@ :-5!MBZ[2]___________
M___________________-;SY?>YFWU_G_____________________________
M___NGX.FPN'_____________________________________X\[K________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________
M
M
M                                  #_________________________
M____________________________________________________________
M____________________________________________________________
M_________________________P    #_X4%R:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E
M:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E
M.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 Y+C M8S P,2 W
M.2XQ-&5C8C0R+" R,#(R+S$R+S R+3$Y.C$R.C0T(" @(" @(" B/@H@(" \
M<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O
M,C(M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(*(" @(" @(" @(" @>&UL;G,Z
M9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(@H@(" @(" @
M(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA9&]B92YC;VTO<&AO
M=&]S:&]P+S$N,"\B"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS
M=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U
M<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @
M(" @(" @>&UL;G,Z=&EF9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]T:69F+S$N
M,"\B"B @(" @(" @(" @('AM;&YS.F5X:68](FAT=' Z+R]N<RYA9&]B92YC
M;VTO97AI9B\Q+C O(CX*(" @(" @(" @/'AM<#I#<F5A=&5$871E/C(P,C,M
M,#<M,#-4,C,Z,3(Z-#DK,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@(" @(" @
M(" \>&UP.D-R96%T;W)4;V]L/DUI8W)O<V]F=,*N(%!O=V5R4&]I;G3"KB R
M,#$V/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T
M93XR,#(S+3 W+3 T5# P.C4Q.C0Q*S U.C,P/"]X;7 Z36]D:69Y1&%T93X*
M(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,RTP-RTP-%0P,#HU,3HT
M,2LP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'!D9CI0<F]D
M=6-E<CY-:6-R;W-O9G3"KB!0;W=E<E!O:6YTPJX@,C Q-CPO<&1F.E!R;V1U
M8V5R/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^5&EM(%)Y86X\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^
M"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^4&]W
M97)0;VEN="!0<F5S96YT871I;VX\+W)D9CIL:3X*(" @(" @(" @(" @/"]R
M9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z9F]R
M;6%T/FEM86=E+V5P<V8\+V1C.F9O<FUA=#X*(" @(" @(" @/'!H;W1O<VAO
M<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @(" @
M/'!H;W1O<VAO<#I)0T-0<F]F:6QE/E4N4RX@5V5B($-O871E9" H4U=/4"D@
M=C(\+W!H;W1O<VAO<#I)0T-0<F]F:6QE/@H@(" @(" @(" \>&UP34TZ26YS
M=&%N8V5)1#YX;7 N:6ED.F-B,V$W,&$Q+3<P.60M9&$T82TY931F+30Q-F5D
M-S,P8C@Q9CPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O
M8W5M96YT240^861O8F4Z9&]C:60Z<&AO=&]S:&]P.C1C,#(S9&0W+3DX,#0M
M-&$T,RUA,6,Q+3DY-3@Y93 R,C@U,CPO>&UP34TZ1&]C=6UE;G1)1#X*(" @
M(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.CDW83(Q
M86$S+39F,S M9#(T,BTY,C8T+3@X93AC.39A,3AE83PO>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.3=A,C%A83,M-F8S,"UD,C0R
M+3DR-C0M.#AE.&,Y-F$Q.&5A/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3 W+3 T5# P.C4Q.C,Q*S U
M.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F
M='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @,C0N,B H5VEN9&]W<RD\+W-T
M179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC
M:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E
M9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS
M=&%N8V5)1#YX;7 N:6ED.CDP.3(U.#8W+3@S93 M,#8T,2TY-CDT+68U8F9A
M9&0W9&(Q93PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.G=H96X^,C R,RTP-RTP-%0P,#HU,3HT,2LP-3HS,#PO<W1%=G0Z
M=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^
M061O8F4@4&AO=&]S:&]P(#(T+C(@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R
M94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S
M=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V
M=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S
M/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G
M92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^9&5R
M:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O
M8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.F-B,V$W,&$Q
M+3<P.60M9&$T82TY931F+30Q-F5D-S,P8C@Q9CPO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTP-RTP-%0P
M,#HU,3HT,2LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P(#(T+C(@*%=I
M;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @
M(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O
M;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=%)E
M9CII;G-T86YC94E$/GAM<"YI:60Z.3 Y,C4X-C<M.#-E,"TP-C0Q+3DV.30M
M9C5B9F%D9#=D8C%E/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \
M<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.CDW83(Q86$S+39F,S M9#(T,BTY
M,C8T+3@X93AC.39A,3AE83PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @
M(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.CDW83(Q86$S
M+39F,S M9#(T,BTY,C8T+3@X93AC.39A,3AE83PO<W12968Z;W)I9VEN86Q$
M;V-U;65N=$E$/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @
M(" @(" \=&EF9CI/<FEE;G1A=&EO;CXQ/"]T:69F.D]R:65N=&%T:6]N/@H@
M(" @(" @(" \=&EF9CI84F5S;VQU=&EO;CXS,# P,# P+S$P,# P/"]T:69F
M.EA297-O;'5T:6]N/@H@(" @(" @(" \=&EF9CI94F5S;VQU=&EO;CXS,# P
M,# P+S$P,# P/"]T:69F.EE297-O;'5T:6]N/@H@(" @(" @(" \=&EF9CI2
M97-O;'5T:6]N56YI=#XR/"]T:69F.E)E<V]L=71I;VY5;FET/@H@(" @(" @
M(" \97AI9CI#;VQO<E-P86-E/C8U-3,U/"]E>&EF.D-O;&]R4W!A8V4^"B @
M(" @(" @(#QE>&EF.E!I>&5L6$1I;65N<VEO;CXQ.#4T/"]E>&EF.E!I>&5L
M6$1I;65N<VEO;CX*(" @(" @(" @/&5X:68Z4&EX96Q91&EM96YS:6]N/C<V
M-CPO97AI9CI0:7AE;%E$:6UE;G-I;VX^"B @(" @(#PO<F1F.D1E<V-R:7!T
M:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@ ]0)1 P$1  (1 0,1 ?_$ !X  0 " @(# 0             &!P4(! D!
M @,*_\0 8Q    8! P,"! ,#!P0'#A<  0(#! 4&!P ($1(3(10Q"14B018C
M420R81<E,W&!D:%"<M'P)C924V*QP1@G.$-$1G-V@H.2M=/A-#='2&1T>(23
ME):8I*6FLK>XPL/$TO'_Q  = 0$  04! 0$             !0$" P0&!P@)
M_\0 7A$  @$# P($ @<% P4)"PD) 0(#  01!1(A!C$3(D%187$'%#*!D:'P
M%2-"L<%2T>$D,V)R\18T-4-$4X*2DQ<E8W-THK*SPL/2&$559&5U@Z.TTP@G
M-D=45L3B_]H # ,!  (1 Q$ /P#]_&E*:4II2FE*:4II2FE*:4II2FE*:4II
M2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K\MV3M
M]&^2#<V!!T[*PPXR^)=OPPTQRO"Y/C&V0K!2\68-W6VBHX2-CTF)BHU*O5=W
M1(*<ALCMK]+V#YG58E%U#.$I!V=.O'Y#\2.?P]OS]]+Q)<@'./K$B;LGE 'V
MC   [ @YQQ\<5(YSXOF:X&,HF)6U7HD*XL5#P!2&#V\76]N]R-A1RUL[;9K>
M;F*^BWJ#.ESF/XNX+KXX1L2\LFX>Y!@)E9^1J\=(5]L[G\3Z#[A_L^[%9#*P
M4#&,[5!.<G,>XL/0X(^-;;?#_P!\^Z7(F!BP-YP2IGS*V,\2[,;(#O%61JRQ
ML5ZJ6X;;VUR(E=;Q)9IE,<P*-RCY.*=%MR,-)N&[Z0L+4T,T6;,'ST[CW_ ?
M[/Z56*1V097<P2(]P"V],DG/ (.<@9^'M4QS#"YK>_$3V^56/W3;FL;8_P M
M[>\Z9\M>%869PJK5J]:L$SVV.!A:/'N5\2V*8+5)Q+(UL_'Z"=OEI"5DW .:
MO9X%DDDF>E58-O'G=05)V@KC(YP,J3^?;M77CM:^*MO81Q%M>PY*4;#>5,W9
M>J>RA2C9*R!D&^M6=@AMT,9N;CG-BRZXC:DK(MK;7Y_;HI-O&]4CY2.>PUD"
M%16-(L"S+JOW_KC\_P"[UJT2R8484DE1DDC@YR3QWXX]\]LU>.0OC/Y@HMCW
M*PZ6&\0V)_A*O[II%SCNOW2YR67L2([8K;7:XSOVY*K'KK%I3L79[C)1W;,3
MS46^ZUH=>OBFYL"3R8>PC ]_U_/(^7O1IV&X!02 <+D[ACL6^#>GK^!Q'LO_
M !S+A7(;)-LQ=3, SN/*?8-WY:+E2VWJ[CCS-\?MSB,92-+Q_BJ?HM>M+*?R
MUDN.OTG=&+=1TUKCNEU1R\AW#A!VZEX9C[NPY[\^OI^L57QCS@*0-_FY(.W&
M ,9Y.<]^P-5D?XM^YW;\CN<N%FJ5&RM1Y'*N\:0Q2WL5PM:-EI4M@;#F"LH-
MZ&LS:P9HU'%IXZ[23"*3CWSJQH3*[F05$&@E8J._SX&/?OV_ ?>:L$S*6R,Y
M=P,GMM5#C_5Y/R.>XXJWY+XX-DJ%9LE@MM=VZS%9@+SN4Q]"YKQUD>R3V LE
MVW%^TJ W&8TJ./+G,1L&O+VZ:NL\MA:V01$5W3BU0,@E6"FDUE(B-?W?K^_G
M'\LW^/@$D#C."#D,0F\!3[C[+#GFMV=@>[3..?=PV]#'F9Y_$;>.QM,8,LV(
ML=U91RTR! 8VRO@3&^1&TS),7S5H^G:<_EK,_8)VUT+P!OC&Y5J/>&AH.+3(
M(Q^OC5\;LS-N*X 4@#N 5!Y_']=AVM:I66FE*:4II2FE*:4II2FE*:4II2FE
M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K
MI*S3\=G:K@L-U<5<*;E-6^;7<S0V'#8\CV%>4LN7UY3\0KR-UQB5:<1:/:;4
MHNEW>8N4E++1IJZQK2OKTR+R,:BXKC]>WS]OZU@:=5W@ALHP& /M \[@>Q &
M=Q],'-;DYC^)5LPPE!Y]E+-FJN3<QMJK,W:,J4:FK$G[M'MJ[+PE<FXZ)B04
M:M)J9A[/9:Y6)]DRDC%J]@GHF,M2\(X>I -.]9&D10Q+#R]_ASC^=2AO\0+9
MDXN="QT&XC':5]R:RQX]I50<22Z,]+_RKL22N.V!F1VH#'35KB3EF(J"DS,Y
MA6%_GHS(D3^V:4\1,@;ADXP,\^;L/OY_ ^U8"(^);L+L$59IN"W3XEF8NHM8
M-Y-NHN=4?@5O:+,O3JLI%(M6BJ]B&U65LO%59.NI2JME53%:#(_:F*N93Q$_
MM#T/?W[?CG@=_P #4FB]_FR^;NF.<>0^Y3%,G<LN,*?)XV@V-E0<KW%CD!";
M7I2T.X2(9BJ-G-6YQE$)*NDEG<M'+0I$_FXI,5%!(A( =<G&!D9.>1CWSSCY
M'V-8)+XD6Q!Q&6F9;;J,/.HNF6&!J]A?-+.BZ0:R]IFI.MUH&AFZ:GSF+G[%
M#2T##3\*$A 24U&O8MI)JOFZJ!5/$CP3O7 .#R.^<?SX^?'>HZS^)/M5O)Z4
MA@G+6-<X/+3E'"6/)-I5[_"Q:U>CLZ2$M'5:U@67(F,\4','+L2U^(!26<3L
M7*UM3T4[%OV+=5!*AQM96Y X(]<X/WXK?S2LE-*4TI32E-*4TI32E-*4TI32
ME-*4TI32E-*4TI32E-*4TI32E-*4TI32E0K)5P6QYCJ^WYM5['=W%(IMGMR%
M,I[+YE;;:M7(5[,)5JL1W43U]@G#LRQD.SZ@%S(.FZ(#R?2J$X!."<>@&2?D
M*ZM]NGQ=L5Y/Q=8L@Y8B*K3Y6/R!1L<5FB8$O%FW2WRV7+(=7F;;$8\+BJK8
MLI^=X#*4'&5BU*VBJ3>(&L4G'UN8L%=M%A@XN;=PZL2R@@YV@[@H .221G:0
M0"&'.00..?<"\W/Q2=EC16\@MD:V SQMCNDY.O$N7#>8S0U;K^3$*LIC>*DY
M'\"=AK?+\[N$-"U#&BHDR!.V$LM LJVI*P<NU9*N\5.>3P 3P>,]N_J?AGGO
M7 >?%3V),8N@R;_*[YJE?W=@3]$XQ?DTLMCXU:O*&+[._P SPX4XTCAF/A\@
MOF]0D9;);:LL?F*YUDG*\4@\D$%4\6/CD')/QP0<$GT&"<?/MFM/LD[F?APV
M/+<MN*Q[4HBV[G<9W/'A&4ME>!W*8XQ[(B&XZ V*VN_U--.A6#'M[NN.9RWO
ML9L+O6J38Y*'DGL%7I6VUNN*O96'?K]?KYU:6C))QY@1C<& /F"$CT.,@9QZ
M@=C6VT5\6#8[)L+$]C+[=CK0C:!4C(<N"\U(V'(QY_*<G@^%88=@CT DGF)\
MKE6(>T8S7&K:S"RFD54'8MTVSQ1LP?:KA+'C(/MZ8)\VT8]^>!CC/ YXKZYM
M^)/A?'^S:W[S,?E1NE2J^2$<0IL\@)7+#8M+FAF1CABYM[.RGZ!-9(AV>/YL
M)R:M,;"XSL]N6B*K+!#5:3=)E3*JK2*$+CL#CGWSCMWX]L9^7>L!DKXB\%2?
MA\-=\<#CRI2<NW4P9!6?%=CRO#5>%QS=\L9$QMCR8J]\RK'5BT,:XEC)SDDD
MM9)):J&6;Q\:OZV*AUG"Q&:C2 )OP."N03@ L0,$D<8W=\?=5:8K^,KM=E\>
MO+=G5W"8QL#7)63,;RA\5R=@W-8OF8'$2%'6M^9ZSEO&M";M)+ <$;)=8A)K
M)=GKM3A(&UKS5:>?M$.\<&K@_K\OQ]/>K1*ASG .<=P00,>8$<%><?#!]C5(
M[ZMV.QC.+.N5L< 77=/:Z?NM@MG:Z7X&W-TG&4-<KW:IN!R95)J\8VH<A'Y9
MA(YGBYP\G\8Q3*]PUB6-1CRL6E&SC&2+3_;Z?K[JM=XV &PMYPG 8#)//;TX
M/PS6RN7/B _#1R9B+,V/\KV=_.8985E!A;F+G$^9XNL9(H$GEJN8#>3F(IJ'
MJ,<?+5+C,M3U>H,W9,0R-@CXF3>L <.TXYVT=.*X/Z_7IZ^WK5YDC(Y[#MP>
M1G&5XR0#QQ]V:S<M\738I6OG$=.S68(5Q56EA>S42^VL[BRO(:0J5#I^4KS!
M/6A,6JF:6^BXVR!$7O(5<7[<[2JK\YF[:TBF4<]6+3';X]J>*@R.1M!)&T\8
M )].X!R?AFIK:OBD;)*7<)RKRN0[$H[@5K)#2%MAL097F<>K3=%PY.;@;=3V
M&3XNDN*)*VRI8HAW5KFJDPL3F<C2/V$>I'EE7HLR,?K\?[C0RQC//;@X!]!N
MQ]RD' ]#7A#XJ&S1W7%)]A;LER;\+VZQXACZ,V^9Z?Y??3+'&T-F1Y*,,0-<
M<JY)=4UOB6P0V1U+PG61J?X3DF4B67,9VV1657Q4/J<^V#GMN[>G'/..U614
M?B [3[YG2+VZU+)QYK),VF1*%]-3[NG2Y:?-CUEEI2CQ^1G%=1HCG(+7%\@T
MOKVC$L V9E6U%7;J-25:/$&ZJB1"VT'G\NV<9^7-;EZ5?32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI75YDCX1>TG*L+G]&X0\V_O.?+7FJSK9;$*V;(V,DL]MJBTOU=QM)K5U
M6,CX-PA36*3 L_$6&1:)2,X@$@="6>)JLY_E6,Q(=V1R=W/J-W?!^-1Y]\'3
M;%)6?=5./;!D12+W74[<!4K'6TF^+6WX 4W/2Y+'F*?H-T0QF3)AI";L15)B
M*B[I=;?58!1TX8L*\$61BR9*IX2Y8C(W$GCT+=R/B3^NU9*6^%+CNQY'A,C6
M?<%N"L*H9!P3F3(M1>JXA:T_,.9\ 4=AC6KY*N[2(Q/&S<9(3E%C&,!:*WC^
M>I=,> W2E&%>CIE)&0350PJ<9)(#!B#C!*C'W>_'K\"0='L,_ XM4HTF(7=3
MFGYO!T+'N#L5[8QQM*-;C)8LKN KM?+11WI&V5<6EJBL$PA;JO2&>-[S5\Q*
M?('$LM9<DVV64B)"(KG^N>!Z_K[O2K!!SECV"A<'.-K%@22!SSC'(&.YK>FG
M?"5V\4A6HJ0MKR20E0G=J-E1:IACJ)CY29VEW+)-]JSM]$UK'T%#LRWNRY3M
M#Z_M8".A62_4T3J[:L$35!9G^6/7]?TK((E'J>X/.#V^[UYS\ZC="^#M@2B3
M6,9G^5C/-K+@R:PFG@V,M$WCY1ABO&6!<I.,O4O#<*,)CF$>SU/7MBS=*:G;
ML\LV1'<+%1,:VN;/T[A=VS_7\_S_ %\Z"%1CDG;MV]N K;@.W.3W]3Z^E9.C
M_"(P!0IO#4[%9 S Z=82;X';5M-_*4PZ$H3;[F7+V;JF,Z5O2FZBQI:S9FL<
M;81CU(\%X2.A48X(U\D^?OJ4$*C;R?*0>?@21_/W]*[6]*RTTI32E-*4TI32
ME-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5'[95X.[U>QTRSLAD
MJW;(*6K<_'@Z>,3/8:;8KQLFU(]CW#1^S.NS<K)$=L739XV,8%FKA%<B:A5"
M,@CWXK0)#X6>UY-NY>N7^=)7(86#&UB@<VS.>LF2N;*8YQ! W>JXX85#(KR=
M5EXB'K=9R9D:"^6F]4A-,;O8AL7S=T[2<H,_U_/@UC,2GDYSD'=D[O+G'/?C
M)_$YJ:.?AR[69#'&9\53-9N%BJ6?(3$,-D<;+DJ\V*QR:F"HN'CL96!"XS,X
M]M:-J@',!#SY[$M,N9.2L3%*4DEG1S*)G57PUP5YP<9Y]NQ!]#\?PJNW7PEM
MF3U/%YW-9R$I+8L2FV;&RDRS?6]EMD/8KPWR-+U^\3+691=3<"M;VJ3]E&M1
MC$81@=S7('Y767SV'<*IX29!P<C(SDYP2"1\L@<>W':J$W X.^%!MOE:E5-P
M638[&,W(0MHFX*&L63)]*22JLYO'JV\FPVV9;,2O%H&G);CZO".U+C82QE98
MQB+NGFEDV0N4".3\?[S5K+$I7<0, X&?3<'.<>FX YXY Q5@9-^%%M[NN)(Z
M+PA,K46XP]1A(S$V392<O5RC:O'M]Q2FZAK/1*E'R-C&V)RKF_RDJYA[A4LB
M5R:BXJ32;-)!W$)*QCY0P(1A>.,#DXQN+^A&#N.00<CTK![>=H^U]_MRQCM"
MF<VS6=;&XLV1-[E4S;B>9R# -EK/;,PVF4E[_CC+49:+^R!.+F\FR=*;0]HR
MU?+?:*X\E7UH/94W<S(E?*JJJ[0I.X_;R,D9SW!Y^6,DX^%6\ML@V8[=]HL=
MM3DHR[,MMDAFW%LS"55:2NUY>,LBRF<J/=Z5%(/(F-G+$A6)G,D;"RDT26[E
M<9)2\R27?15746(RKD_EC[L8_E5=B*NSG;D<$D\YS\SD]\YJU-Q/P_\ ;%N=
MD,<2N1Z=*QLEBR.GZ]57N.;3.XU<DI]K?0<G9J2]5ISR*,O69F2K<&_4;HBV
MD(]XQ%>%D8Q1[(F=TJIC4D'&" 0,<<$@XX],BH%<</;)\20;FOV6>79!B;<K
M";Y92IPUBL-OO-;RIF+*%K;UBZ2E'J+>=NP4.TY#L%IC89JI!&K(_+98@.",
M:W)K,54*HH^3!\9R0>!G'?'-8IK\*#9PS&82)6+\O&O#0C>L04AE2\RE?Q=
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M$W)/_FQ@CW4>#9FQX.8&;KI3+Z@$Q_*^@Y%%0.4044%<R9^")D$<^&R3G@C
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MM)=#/;D2)G'84%O_ /O"]0'Q)+WI;HV!\'P(8X[RY121P6:'5LOC.XBXCQZ
M'MZ*;!-WUM("N0?B(Y2164-U+,J7&SD,S)U@'61)5A=8-(2A]12],6@42\?E
MEYZ0M_W,Z[/S==67V3W6VB,2\YR 5G3 SVP@]JR_]RKZ0;Y=VK_2[K@=L;XM
M-AN;>(>I"-%J-L,9['P%R!RO>MK\);6K5B"FJ523W!9(R<Z5F7TO^(;PYD'\
MFW(\09HA%LU%I]RNC&(':'=I(*NG)@>/7JI3D(L1%*=TW2)=/MC ^I7EZ3(T
MGC7+,T@#!1X8/B$[!MR 2?,S$8S@>@=-=%7O3^G&QGZJUC6Y#<RW'US4GEDG
M02+&O@QDW3LL*F/Q%5G<B225@0' %JJXVNZ B>-R-(@(!])%QD4T^?(\" 2#
MHH!_WH?OX\^) P3#[,[#YYQ^&XBIMM(U)>8=6E!] WB@>O\ X60=O@?4>N:X
M:D7G2'Y.TFXB?2('(-U0:B<_'L4QW3)BKY_@\Y_X0?:FV[4<.CX[9P,]^^0#
M[>M8V@ZEM^8KFWN@.R/LR>>Q+Q1-V]I,_'-<!3,-QK)@"\X^?-VQ1X4DHH%B
MMR\>!$H./4LU1'WX^:I '/W\:?69$_SL) ]67(&<?'(/MG=^7-86Z@U"R_X3
MTF5$!P9H-VS[@^^-O?'CC ]ZD:%OQ!E=L6(DQAY!9Q^62'LC5%I( H;V*R.X
MX ZX^Y1BW:JA?(@8.!XD;#5I[242V-Y+:R@Y\CE-V/1ESLD'P8,/A6P;SISJ
M&,6URMK<%^!;WL:I,&/;PB_)?'8P2%ASR,&JGG]LLG6GRMEP7=9.DS0#W!A7
MSM9U!O0 1'TZBQR.5!2'D1*C*-9AN)NGZ40 #E[ZSZV@O(ELNJ=,@U.U[?68
MHU2ZC!/+!047=_I0/;/SG+'@\K>] 7%A,U_TAJUQI-WW^J32O):2X[(SD.Q3
MU"7$=RF<?9'(QD'N:FJ3+H4K<94UZ@_<<MVEO8M%'%;E4R_E'<.T4A<IE1/]
M(K.XE9^V*=;I<L8Q(AA#/=]#VNJ6SZET??QZE HW3:;-(JWD).3L0L$+$#.(
MKA8G(7R2SL1G6L_I!O-)NETGKK3)-,F;R1:I#$TEA<*,*9)%3Q %.07EMFFC
M!8^)#;JIK,W3;_%3IVN2\#V)K4;.JD$E'N(1X0]3L*:_"@'2,T]0W9E<E\@9
MJDXB7 @!7$?U*'=D\DO]'EMYY/"62POH'*RP2(\6'4^:.2)@&B;W4IMR/,G)
M:IJ_Z6MKOP]:Z5O8[&\=/&@DM)5;3[M7PP*F+?&@D'.8P\$G&^++&0?7%VXQ
M=>=#&F98LU&R(U.FU16>$*UB)\YP J"B"QCF00<.S /IA267CW_TG8.SF4!
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MV''^9SOXVX\)0??.3C&<<XQ\9U/)AL=V9."7C29#,QD0KBS@&@M".Q*7T@J
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M)P 521[%$&,>D)U2-V#!-0Z?C_5G6FI:W.VH]0:B752PM[9<I;P \^%:6J9
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M &_]%=IQ;=*:E>D#'B7<NP,1GG'[0EQGO_FU/N,\"SP=3?[5U&G;A%!].?\
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MEXJ%;J1P3_D)P#_SYSCGDCP./:I%)915CL7V;(X5>1>*5UA)/2P#54QW$CZ
MA#<H.O2=1&OUB9TZ!FL+1)!TH"*XH=!]RRC^N310EEA\641[WY5<G[7\.?8
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MII2FE*:4II2FE*:4II2FE*:4II2N.[:-7S=5H\02<MER]"J"Q"J)J%]^#%,
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M5BY]*.$-VN&\WM0])7,D)CCV]G3#H24=$!".0>/S@ !];!W"N4?)A$*HH8W
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M/N(B(B/N(B(CYTI7G2E-*4TI32E-*4TI7@1 H"8P@4I0$3&$0    Y$1$?
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M.$E6NVU<CN>!GW/Z_P *UH4^)Q2(^IUJ]RN*;T%/E,>Q=HG)1F\@"2U>N#[
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MQC!]CD=P:]6V1(]Q7I&P!'/BHQSI%JHW_*,=0ZYD2IF(J!NV4@"L'<ZN!)P
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MFL*6E-W6E42!7QPH^I=KKT3+NZQ)*U=*MHR$'<J_7H..LU;2E5(N<CHF-A[
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M+]/2DV2-X$>=>A_3CI"6W6VJ@ "'6M.M+Y1@;2)[8V,S#WWS6DLA))R[-SC
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MH,6ZKDCJ07(F<Z#%%PJ4HF( :T=2O#86-S>",RF",N(P2-S$A5W$ D("P9R
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MU8=8LQZR'Y)_C7#/EVH)CP8\EX_1D'_EM6_7(>>6X_T?\:QG7+%>_C?]G_\
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M:6P:0AY6PSL)9.6(&2.%'"B+;,&25>VVU]\<@$[YK%.+G'W.4[QRN!S"(<\
MDF!0Y_R2AX\ZYW18B;2!!]J5SCCN7? XX]^.WPXYK7^C&W6WZ.T\X \9[JX8
M^_B3N02>_P!G 'L ,5&=A+4ZV,;C9G =3VSY'F':RP^3*IH1D.(<F$ $P [<
MOC\^?J5/]^=>C]=-MU.SMEXCMM.A15]BTDV?_,6,?<*[BV^PS'NSG)]^!_7-
M;RZXFMFFE*ZM<Q (_%AVA<<ASM^S.'4 >P^GG_N("'/D! ! 0_4->F:2?_X7
M=6?'7=(_].W^/]]1LW_"=I_XF;^35K?GF.)9MNFUM2LNEIEJR^(KBIXN<H+F
M(U3B$++'R"A17=2+KEPY2/*/Q6>*HDDI%Z6/0C(@L?$L)WI_?9:_U,EVQ#R?
M1_JBJ7P"?%^J/&.%0$*OD7"\JJ[B[;F:R\!DBMBGFQ?0L?7 7<#CN<_GD^@X
MJS599.];@OBQ8TLCT4JTUQU@Z&3ZBK+E0):\9/T%RIH()JK&.Y<K)$(1),YC
MJ'* ![ZT"HT[I_Z+=3A7,YU#6I3C@M]6U2+:,G'8 C/ISBLBL9;G487^PJ0*
M/CXD1)XY^7;Y5V8X!C(R$P;A^%A5P=1$/C2DQ4:X*FLD"S*.KL<S;G!)PFBN
MGRFB7E-9))4@\E43(<!*'G&MSO<ZQJMRXVO/J-Y,X)!PTEQ([#(X[D]N*WHU
M"QQJOV515'R"@#\A5N:C*OII2FE*:4II2M!]S("&0UOI*3_G)7H>"B(]7)GP
M@8?I+]1OWC!P/ ^QC>X]UTS_ ,'C_P"_++_T4K"_VC_J/S\\_H\$_P!<1B7^
MCS\/M_SAL9__ (3#[C_9_KQK/JW_ ,P#_P"W=3]?_M4?C\_3[ZM':4?^#7G/
MM'Z?WUU+/^/Y+'WM_P! + \__.[:>_\ 9^NO4H\_M-<8!/7,V,]N>DG[??V^
M-19^P>_^\E__ % [>G?-?I6J'^U*K_\ :["?^+&NOG2[_P!]W7_E$W_K&J;7
ML/D/Y5(M:]5II2JESO&EE<0WYJ)>KMP*T@4..?KB5D90@_V&9@/^G4MH4GA:
MO8/[W"H?E*&B/Y/5CC*-GV)_#G^E06H-RW3:P2+6#O!)XQL-=$!#JZA9Q\I!
MIAQR/(E%J3@/U -8NI8 -0U:''$C2MC_ ,?&)/YR9J,U>W6]T/4[5@&%SIE[
M!@\@^);2H/P)'WU -@DR>8VU5UDJ(F^03]MA $0#^C5F5YLA?'N!"S7;+SYZ
M2@'L :Y?0I"UA%[QR2J/3^,R#\-^*X?Z([@W/1%E$W/U2[U&UR><JUR]T!\0
MJW04#V ';@5'\.A:KP;O=3C&M-TF9*+GV:4<-D4Y4O2E(IKP+11Z>4EI$JTL
MI^#7(/58EO&PJB2;,[%HF8SA%O[O]+*W]PG1>LWSF0ZGTS;A'8P')B*7+B(0
MP0LMNHU!/"6X::Y4F022, C-"_0^UA;-UQHMBH0:7U1<&1 LZD>*)+9#*9IY
M5>X/[/?Q7MTAMV41^'&IW*N:V/B6&R5NWI*8=MO 9<<NFR <])$7<Q:X]/I$
M?L"$0@7P'D */MQKYSZ:_=W>OVP[1:B[*/0!I)U'H.ZQK^&/2MGZ,2+;6?I!
MTQ>%M.HI)$7T"2W%_$N.?[-LH/R&:[%==97K]-*4TI32E-*4TI32E-*4TI32
ME-*54&8L05_+T(TC9QA$R1XU5RLS:3T>C*1"XNT0073=-%TU2D.9, !%ZDF9
MRT$3BB'YA@&0L+T6;R!T\2&8*) ,;P4)*,A/&5W-Y20&SR>!5CH' SZ<C/(]
MNW;GMG!QSBM))#X8F K7&23&7Q=BFE.5TEDV$U0J;&,+"P<+BJ<\@QFFK6+=
ML5RJ*F-VP4<MGA3J-W[59F=9LOKZS:=.:M8R:?/I22PS;B9%$=I-"Y.X2PRP
MHS"0/AR6!5B )%D7RCF=>Z/T'J33+C2M3T^W-M.&(:V1;>>&4L'6XAFC5629
M9 LG.^.1E F25"RML%MSV78:VULT@I\4,C-%0.BO895--22>F45%8[AV8O)5
MW'6( B)OR&:92IL4&I0-U:>FVUIHVF1Z1I4!M;)7>63=*9KBXEDQO>><JF_.
MU0$5$0*JJ%PJ@9>E^E-&Z0TN+2=&ADCMHW>9WFE,T\\\N/$GG?"J\K!50%41
M4C1(T554"MN-9*Z2FE*:4II2FE*:4II2FE*:4II2FE*CLY.PT*HT/)E$RYNZ
M=L)&W?52   BBA3\<I ;J @B!@$WMP( /&[:6=U=K+X'"#:),OM5CR5! ^UC
M!/8X^9J-O]0L;%H3=<R'>T6(O$90,!F!QY,Y .""WL0#6-83]3DE'S]%N@5Q
M'(&?N7*\<F1R5),!ZUR*@F90YR<  ])NYR)0 !Y#62:TO8/#B=F*R,(E5924
MW-V0@D  \GMM[Y-:]OJ&DW33SQH@DMT,\LCVX60(H.7#;2S$8QP=W( !S6%<
M72B.%3+.F)5UC\"95>'164-P %#J4.4QAX   .1\   '@-7"PO5&%<*!G"B5
MACU/&!CG\ZU'UK0Y&+R0AV.,N]HK,>,#+,"3P,#)["LJQL=/0C'L^Q;H-&[-
M0K5R="-3;NNM4R?;2 B293G*H)B"'U"3Z1$XE[9NG6D@N/$6)R69@67+Y!'.
M3DGN,'/&:W8+_2UMY;V%$B2-A%(4MU23+%<+A5!8,2#WQD$G&WC@35UH,7CV
MQVR9*W)2HEA(*3S=:*[Z1VX% KIHK%%14*].][Z:0-P34(Y.X*0X_4?IQ>'(
M) G\9((.?OSGTQC/N,5AO=7T6UT._P!3O @TBV@G-ZCVWB(T6 )8FM@C";QO
M$">'M82&0*<Y-:U8QW"[3[)>J_ T>JQD#;)9THR@Y$N.8N#.5XLV7#TZ<HR;
M"NU4=I HV(/41-4RH('. *\#D=+@*2[LRCDC>Q_(\<5Y[T[UU]&6H:S8V6C:
M;;V6IW,C16<XT&VLV$K1N/#6YACWQ-*FZ,'*JV[83YL'9:Q6NBQLP=G-LT'$
MB@5OW7!XA)X*!5"E51 S@Z9E/H3.57A/KZ0,'3]?)0U3CN0#]V?UCO\ C7H]
MY?Z7#<F.YC5YEV!G-NLFS(#*"Y4G@$-A<XSQSD58Q3%.4IBB!BF #%$/82B'
M("'\! >0U6I@$$ CD$9!]P:\Z56FE*:4KCNVC5^U<L7S9N\9/$%FKMFZ13<-
M739PF9)=NY;K%.DN@LD<R:J2I#)J)F,0Y1*(@-&565E90RL"K*P!5E(P58'(
M(()!!&".#5DD:2H\4J))'(C1R1R*'21'!5T=&!5D92596!# D$$&M'+_ +#=
MJ[E"5LTBPD,=1C)NYDYF1B;:,/!1S-NF==V[<A8BRL3$L&Z13*JF2*S9MDB"
M( DF4>(#_<7IE_<1PVEG=?6+B18X;>R:62265VVI'# 5F)=F("1Q)DDA57L*
M\QU7Z*NA76:\E@FTB&-7FGEMK]K>VA1 6>1A=^/!!&@!)VB.- .P K,X6V?[
M7:X$%D2CM4<CD5!*5K-ME+*WMT.H!%!%O(Q(10-ZR]%%9,3-GH,G2C==/K06
M363 Q=A.C[+1+QXKFPN8K^TDVR0ZBLB3V\HP<26TB1!)%X*[XMR\,,'!K8Z;
M^COH>R-KJ^F1+K&=L]E?W%ZFH6YP?+- (-EE(59<I+X3LCKE&5AD;H\!^@?W
M!J8KTFG27] _N#2E>.@G^Y+_ ."'^C2F![5X[9!]R$'_ +D/]&E,#OCGWKQV
MDO\ >D__  "_Z-*I@>P_ 5X["/\ O*7_ ,&3_1I3:O\ 9'X"O'IFX^[=$?\
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M6^?C^^4?F*NZ" '1VB8'>Q!QZ_:?[\G%</8TD1/;["&(' K6&U**?J)RRRJ
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MM>I1\ZFN/_\ .9^_?_\ E)^^,<_'-19/[L_"S7_]0M?I6J'^U*K_ /:["?\
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M(UCQ[WIM@4@@ACA,^F2RSM-)<0'"-+$[2RM/!)*23AH2I!5_U,I*IKI)+I&
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M!CE$IA 0 HAK3-J4LJ0S"4RKB9$V*I&,@2#:JC ((#$X!&,YK9MX]%MX)KB
MVZP2 P32F1G4AL9B8NS8W9&5&"P(/(Q6/<.,>.&+:,7<1QV3,QSMD.\Y+VC*
M"85!!4ARJB)Q.83]:ANHW!C<B!1!X>IH[2[)0[@!FPAR!C;QR    , 8' [U
MB>3I^2".V:6V,,)+1H)'&PL26(8$-YB3G).3WY Q\9UCC-;'MC:6#Y+_ "=K
M1T@-E,_=G3C"L>V O5'KLZQ%T#IE(F8BH+)N$3E0.W,10J(AJ3&?Q?WVX28
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MI(E*7J,=,!,;CJ.81,81,(CKF[J::Y,LL\LDTK@LTDC%W8CD9+'T[ 9P. ,
M5T4EK!#8RVUM#'#$D3[(HD"(NT;AA5 &21[9)Y/-11H4)/&;UN4.M1LS?@)?
M<>XS<'?)E]_(B0$A /'N&LVDR;+JU;VF"'X!R4_D_P#M'>/*^-H<Z#DK%*<8
M!YB<R@?'( //O6N>X&SA_P S_$U%F N9J\S\=5F;)(0%PH1C+DDU3$)[F(8S
M6,9&Z>1ZI- ..#"(8.J@8YYH@,M=21;!P,@JK$_$;UV'XG[JX[JB^STC;Z?&
M#)<ZG=QV*1+R["*X^L-@>H.R"(@$Y$ZCL3BY\!1Q:W5W%*Y 35;Y='=/GGI:
M1Z448>! !X$\481\!]1AY .=:5DOAQ&'UBPI^Y0O_L\_XUU/2T L;']FC_D*
MP0X^$<*P9_\ R.?7MGO5)[6I5W!96W%8KDCI]R(MYK+$\-FC==TP>O'C59VY
M.W015>N#,3UPRSYX9=TX[Y!56,( (^@]3PI-I?3VJ1 @36?U:;S.RH\:(RH@
M8E40/]8"HFU5VG"BIZ$D/,A]&R.W(.>3P"3VR3DGU-;R:XJMBFE*:4II2FE*
M:4I[:4JFI?-->CWS1NS3)(M')YA%-85W31Y(.:]$FL%@:0K)2,50<N(>#(,@
MY-,2$ U<"=)I&.G[L544=]=-O6BO)A"3'IZ0/=L'C_<K=.L=N2-^YO%D=5 C
M5RI(+A1S6C/J%M;W-M:RR!9KQIDMT(<F5[>$W$ZJ51D7PX09"9'C!^RI9O+5
MK1DHPF69'\:X!RT44<(D6!-5(!4:KJ-ER]"Q$U [:Z2A.1( &Z>H@F()3#J2
MQ/"Y21=K@*Q&0>'4,IRI(Y4@]_7GFMZN?K'2FE*:4II2FE*:4II2FE*KC*;X
M&M6.W >#R+UJU+P/U=*9Q>'$ ^X?LP$'V_?#SY#F2TJ/?=AO2-'?MQDC8/O\
M^1\JM?[)_7K6O+YRKA7YU6I'\BKW6*;GB7GDC9A,N/3M7B!SF "IE*9PJV6#
MK.)$ B5SBF0RYB25]&^N6,D]LAEO;02++&GFDDMQD[@!RQV#>ONPE50S8!C=
M3D\"QN"3@/&$![<RLL>.1[,<Y^&<>E)>O=;5LI,,BR":Q<4YMB03LKU-,QT8
M&V<NG[=XN5,.KZ5%32914'J6CY>P>E264BP*;SZ(?L^^AE?(M+XHDS8R(I&;
M=N..3@%FY_A:3 )3GR669N@=>7695*]/]30$7TH!*6FH?O9ED< 9QN8SY;[4
M5S>&-7,&#2>;F5BVW9CQCOGJ;%S-T243)CC-K"(*58SFM/!;LXBP"JGRDX3=
M) S;LG*RS=BG-UBJ,C+B68'CZEZ9GL>M.G=6^CBZGBBU!0-:Z9N97_=_655I
M9;=._ R\CA [O;7M[*%/@ CE>HX[SHS7]#^E*PB:YTF<?LCJ6*W\YDL90D=O
M=EAPX<!$CD8K&+BSLHRQ$XJ?WJQJT')%&WK8_-^*,:V=-"LY&5A![Q'\#,@D
M,=+F-P'DZ!V#9,CKTI6<W 0<:Z,FJ_.D3Y0U^PU#IO7GO;NUFMYK:9]/UBT=
M-LL+ X\_HP(\/PW#>&S10%799@U3FJWATK6=)^DS1V%_HM\JV.LM:G<LUG<[
M? N2>.X,,8$FP1W-I:PR8:4J.TZNV&%MD'%66N23:7@YMDC(1<DS4[C=VT<%
MZDU"#P!BF#R15)0I%4%2G16(15,Y"]'%+'/&DT3K)'(H='4Y#*>01_4'!!R"
M 017N=G>6VH6L%[9S)<6MS&LT$T9RDD;C*D>H/HRL RL"K ,"!F=9*V::4II
M2FE*:4II2FE*:4II2JOS#B"F9SHLCCV^MY!S7Y%PT>'+&23N+=(OH]05V#HB
M[10@*^F<=*X-G1%V:JA""NW4Z"\:&I:9::M:M9WJR- [(Y$<C1.&0Y1@R^JG
MD!@R$X+*<"H3J'I[3>I]+FTC5HY9+.9XY&$,\EO(LL3;XG#QL,F-\.$D#QE@
M"R-@5KOARM8^V>PDOC9N!$Z^O.#87=F<V4[IZ\EY9LV:=,I&RK.)C8A1*,CH
MLC=O$2#\%T  RY1=E,L[E-"Z1M+&P$.B?7&$LLL\D-V!-(S[40O'+;@*Z ((
M_P#>MN 4RQ9F9A'])=*Z?T;I\VF:<)/JLET]XT]Q=--/-/(D<3-(GA10PA8H
M8HU$/#! 7!?<[6C;=QV,F$,O\@N4%(2SM(Z#,P/D4&L>HJ D!](+.12*DBV$
M15Z"@HHJ<A2"5-(YEB3=IT[J;S+]8LYXXE8%P48M(!SX<84');MDD  D@E@%
M/4&1!_&OXC^_T[GX ^U:CSA(]&E*NTG)'OS%RQ41DF[A51 JJCTB(/T7#-5%
M11LW2%9<QB."%=) H0Z@)JCTSUUO9\,@1H60@/XB&,%T5G;8R2 HK%F570E0
MRE@"QJ)UD#ZAO#;7%Q:!+@-(#;&6XBMVN0T4D+E84E=F7Q%62/<CG8S5NO$4
M&V%C(LRU\>/RE8LS*LW:=D;)O ],GUMG"R-L!= JO[JBA43'3$1$R"A0,B?S
MF:WE\:5A/Y3+(0G[[;@N2$#?66.,<;O-QSSSG&NEWR@;M4DFV@91Q=(LF!RK
M,E\64,>Y 8C)R&'!M6'9.(^,:,W3D7:Z!# =83+'  ,H=0B"9W*J[I1%JF<C
M5%5TNNZ511(HZ657,HH;+&I1%5FW$#D\^Y(&6+,0!P"Q+$ %B3DU+P1O%"D;
MN9&4'+$L>[$A079W*H"$5G9G95!=F8DG)\AR <AR// ?<>/?@/X<AS_7J^LU
M> ,40 P& 2B'(& 0$!#]0$/''\=*5X$Q0+UB8H$XZNL1 "]/'/5U<\<<>>>>
M.-*5X%5("B<5$P(!2F$XG*!0*8>"F$PCQTF'P4>>!'P'.E*\@8HF$@&*)R@!
MC$ 0Z@*81 IA+SR &$H@ B' B \>PZ4KVTI32E-*4TI48L496WPM5)]5N@9,
M%"-E%WWHA,4PD,H0HBJF"@ ($$?!A((^!#J'G;M9[J+>+8,V<%PL?B8QD _9
M..Y]L_<*T+VWL9]AO&1"H8(6F\(D'!('F7=R ?4C[SF.)US'ISD*D\9F4.8I
M2%)-]1CF,/!2E*#D>H3&$   #D1'QY'4@-0U=5)V2;0"23;< #DDG9@ 8Y/&
M!G/K4;^S-"<@>)$2Q"@?7.22<!0/$SDDX [YX%2(*Y7/1KP()IBD*A7Z[;UB
M@N2'$ (1P8>[WDRB4@$*/A,0Y#@1$>=1KZ^,JWA)W;3"K^$!&5R24'EVDY))
MQY@?7@5N#3-,$#Z>%79N%P\7C,95;A1*<N74$+M!X4C(YYJ-&K>.^?+YD4?/
MCYX4/\!<_KS_ &\\ZV3<:N>\,W/_ -5;L<_^#_#_  J-_9W3@)_?P<__ %[T
M^Z7^?M7VGJKCV5Q[8Z[/'8GH<G'/_P 0N'$N+9F1B! .\=KS .DO0@S*W(MZ
ML'*(-10*H)R= CJ-N'G>0M<!ED"@89/#(7G'EP, Y)SCG)K8N]-T*YT*^L;H
MP-HEQ;S_ %UVNBD(AVYFE>Z$J^"(@@8RB1/"*!B1@FM8,6X5V:0M\KLOCNTU
M>=ND8Y5>P$>URBWL+D[M!JL8SA"'0F%CO%&B +.2@*"I$>V+D2<I <NME2>"
M"<G'.>><CO\ E_<*X#IWI/Z*[36;&ZT+4--N]6MY&ELH8NHDOI#*D;DNEJEV
MYE:)-T@RC!-N\CRY&V4I4*G.2RR[Y(B\IVD%'*";]4BHHE $D5%FR:P&(F8A
M"I@<"$*<"@'(FY$<P>15& 0N2 <<9[D ]C\1S\>*]*GTW3KJY=Y5#7!5&D19
MF5BH&U6>-7!"D#;G !QWSFIF     !P     >P '@ _LUCJ4[=J\Z4II2FE*
M:4KKVW/478/<,GU2O;B6U7:9)FXA^A$/#2]DJYTX]\HN"3RS35<>1L,U4.\1
M<A"/+:Y PNRKIM#&*<Y#3NE?2UK/1+II%CU'^SUNWCN!:W,,%U OA^127NK>
M>.SCE"^&0)(%FV@#) ->2];:9]%6H:W86?5ZV$>LW4$JVSF>\LB(I6<"2\N;
M-X;:,M(K_5Y-0D&9 RQD@D&H+?\ "AVRY)94!]CJUS%/JT+#2;)Z]J3F)L[F
M]>K>.WC*9=6>0.^0.^8O7"C<[@C5\W7BD$(ELE'E:H+I>G:-]/75%M'?SW$=
MAK;W\T,]I+*[QVEDB(D4D5O#:LJO!*B;@%E0K.7F=I2SHW/:A] _1.LQZ5+I
M%[<:?8VUM-%))I[V]ZVJ;Y)'CN)+V4RJTL<KE"ZI(K0HL"+$$5E[.:#1Z]C6
MF5JAU1DC'P%6B&4/'((M63/N)LT2IG=N$8UJR8^M?+ H]?J-FC=-9XNNL5%/
MKZ0\CU34KO6-0O-3OI&ENKVXEN)69Y),&1BPC1I7DD\.,$1Q*[L5C55W'&:]
MKTK3+31M.L]+L8EBM+&WBMX45(X\K&H4NZQ)''XDC R2LJ*&D9FVC.*E^M"I
M"FE*:4II2FE*:4II2FE*]3D*H0Z9@Y*<IB& ?82F 2B _P!8"(:=ZH0""#V(
M(/R/%4E&VRO46 M0V^11C8V*<G!4RYA%1R=8BK0S1DB7E9VZ7%J (MT"F54Z
MQ.  0#F+JQS"W#L[;?#8,#CG<#C P/,=RC '?/ QS7.1W]GIEI?'4)EA@@=@
MV\\ON#(8XU[O(^S"HN6.<C@$C6+;]!2V7<C.,E6MLLPJU*<*#CN =_TKI<RA
MVXS:Q.!3.1!9$KLZZ0\+28,B(+*-(PHK[EZLVI7$&KRQ^';;3%:H>YV^<.W_
M %V.[ RRX!VQC/G_ $9;W/4&LS:QJ,;0V.F2-^Q[60$/(^[8;IAV949!(7!\
MTYC56,< W[21HC7LKR;,X"5M96QW#<1\%%98H/.L1]O#EL_;E#[F5*'N/&M-
M?)<LN.)!D?,\_P PP^)->B1?Y+K4T9R$NT+KGU9OWF[Y;TE0>Y(K6Z_F-BK>
MGCBXIAZ>#S% *TZ:5X "K2J0(QZ11,/!"B5\A253F$>KM@X$/)O/HMA_WTZ-
MU&S/FGT>X%Y"/41'=(Q]SY&O@ ./L_ 5+MY+A6])%V_,\#_X?N^.,[\ZX2MF
MFE*:4II2FE*:4II2JSGJ]79&P5L\I-)$=22KYJYB!5400NZ46@Y=-V$@R;.D
M&D@G F.H[%-RU=E.F51!<OIU%$S;2*3%<L+9F"+"?%#.!;;G4!B.S>-P@W<#
M(*\XJQD5CD]SP1D@,!R PSAL9]0:S-FM$;4XMI)R\VD@AWW1@ K1-=>9].R?
M/C1C$B:B223HZ38PHJ'.!3F1[1S =7JU8D32>,4A8B*+>V&QX0W(OB-NY89.
M,<?:SV6KF8*"Q[ $_@,\?&HUCJ^GLKV=BG[MH\?-9JRD:J1PMU&K)*#DFD?*
M5=ZH@8#C/U1>0C6TPJ*)H]Y\R:+Q,C)%*]]'L:A9SV;6HGM)+,SV5K=1K(X<
MSPW$>^.Z0@#;'. 65.Z8(.#Q6A8:G9ZE]9^ISQSBUN[FQG:,DB*[M)!'<V[;
M@I\6!RH? *'<"C,.:MC6A4A32E-*4TI32E-*4TI5/6\?Q#=ZY6R#UH,!!Z_
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MIU>[?Q2P!"+P@)..PQG!"@\8.>2U0T73$\^LPWG4UT-0:8 QV<>5LXF8X"L
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M3[\WY_VUQ3_#%NI__7Q[CR_H)9R; 0_^V/'G[^/ZN/.I:/Z5+.-0/]P?2[X
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MWTT\74Z_2(@(K>E!3DW<.!S"=P<G)G#HP$**A4T!&W4KY9WVIA+: 8C& H.
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M"@<B4VN:NYWD:25SF29R21[N><#G &=J@=O*.PXF+MTL;..V@&&*"&)1R0H
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M&O1"E*1F]0=I"$<25D2AW4%6)S0\Z4Q7,0L154\<WE.HNE8!!^WNFI!?:)<
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M2/OJ%8UVN[IL:V'$M(E;]/3TI>[+1I'<=>:Q:K\K6CT&A8 VL0EGLSVV33.
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M?$88</@#G@YQG/;T/';V]>',4$DM(NG_ ,W70]2H"@I"W!;MCT%*)2G]0G]
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M^1O$7;G&[L<.2W.<5.2ATE O(CP !R8>3#P''(C]Q'W$?N.H<\DGW]NU3P&
M![ #GOQ7G2JTTI32E-*5^<C=!\%7*-]S1=\AX7R7CPM8R%;9RXOX7(2]EA)6
MLR%FE74O*L&+F KMH;3L:@]=N%(]9<(AVDV.BR71<J-SR#GZ"Z:^F+3+'1[.
MPUG3M0-S86D-HDU@MM-%<QVT2PQ2.L]S:M!*411(%\9"P+@J&$:\_<Z/+)-)
M)#)'MD=I")"P*L[%F *JVX9)([8'![9/:ULHV.8SV;T-&-AT&=FR=,MDS7O)
MCE@1*3EW)NE0\1"@J99>%JK%0"D91:*P&=G3"1DS.'RG4EYAUEUIJ/5U\9)2
M]MIL+$6.G+(3'$O($T^ JS73@G?*R^0'PX@J#S2=G91VD8 PTI'[R7&"Q]ES
MG:H]!GGN<FMW=<96[32E-*4TI32E-*4TI32E-*4TI32E-*55=E;*T]^I;V I
MI1@%.I-IJ*%1;()>5'"ZZAN$T&AP+W3KG$"-5R@H8>V8"!K2_N29AP@R7Y 4
M#NQ). J\9)]#SZFH6\1K&4W\6%A +7*DA45>[NQ. J$>8L>(V&X^4X&K&Y_!
MZFX^G4[-NWVX!&9:HBK:ST&=A95).,M2; 7!RP,BNDHK'B_;>H?IPCUV59LW
M<.Y"'D!)$33Y=OZ9]&_6VG:/+/I^LP0:ETMKT+6U\#&L[6HFVJ;J!E\YCRB"
MZBB8.1''/%F>VC5^ Z]Z7EZRTK3^H^D-2$'4&E,E_I%U;7"?5]0$6XBTF=6:
M'Q5#RBVD?=&LDDMO,1;W$KIG]NVX*I;J*-8<896K;&*R9%1[RO94QA/L3MT9
M%- P,)&2CHU\/J?EYW(E(^8J#\QKDF)4%3"D,9)/<7T@= MTY*+BU9=5Z6U5
M0^G:@I6:,Q3+XB6URZ#9XNSS0S+B.YC EB*R++%%DZ*ZTTWZ0-+ONG^H+**W
MUZUAELNH- O(BBSJI\&>>""4ES SG;+$Q\:RGPC';X$\NMBE,RG\/FUOI^C$
MELB[6I^1]3+5U50[J8QZN[6*41.J<1$B1!,1-C-&$C&2'H83GHI([:1D/%_!
MN=!E9X ]QIDC%GC)RUOD^_<8SY9#Y6'EDPV&;B_V9K_T.7\UUI2W.M] 7DYD
MN+)CXESHKRO@DL2,*N0(KH[8)\>#=^%<-'/-MY:*5@;>IC^/F$'*#YPV2,:"
MM,5VVMMJ+XX%449N$U2]SL"<2^MAI))1FN(@ND5%X1L\0[[ISJBZTM_K&FSK
M+;RX^LVDA)AF ])$R&CE4'RRKM=>Q+(61O;=*U;2>I;"+4--N4N(7'!7 FA<
M@$Q31GSQNI(W(X'/XU4<!=L[;7%$*UEADZR?BY!1-I#Y BBJ+2,<T$W:;(R"
MC@QE$52E!,!CYI;]]0R4=.R1$2D#K)[+0^IPUSI3IIFJ,"TNGRD".1^[&/:
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MDP%PLX(HRX]6V [A%(AH.UL=3BN(Y)KT/$K$N@EE?<-I&W:Z!3R>Y(*_:&2
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MN*I/X4=NA:K35%1?=9B"U6D8V,>@H5)NN8AFRBS5P50B#MHN)13 Q4G3940
MBZ1C;"ZH0=@ON02-C3 D' )&UVSV*DC'9@<889R?M?2-XC;4;%)"<".2XBCD
MR%1L>'(RN"%=&P1D*ZGLP)U:L>P78-<) 9F7QM4U5SO)21$L=D.VQ# SV;D5
MY64=^@B+@R8 L\>N3G.<J ="!&S-$$V;-H@CU]K](_5EI$(H-=.T)%&&>#3Y
MG$<,:Q1());=WVHB@ ;CEBSG+N[&QET=_,9;0Y);*W0 )8Y)PDH!)/Y  <
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M[J\ITRV@V>//,"\,9=UC0$Q!I2S2.J*HAW$GMWQQ:SF#;9EDI!JV1L4V]PL
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MO>MC#"]IT_I]OH]F.TNU'NF _B)QX49/J7^L..XFS4A9]!1O+^T>JM4GUFZ
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M!U"S3]990I[*[A'B+-8S9Z,:@W6*C^VHN72S5X*KA!R!D0(W:BD7MJ =;K
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M8+Y+MP9OLA2B<RU9?F HTKR")DX%)P51-,WJ%$5G#DIQ315,Q<,0=MFSXCI
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M[=T@DX0.'!TEDRJ)F_3DIP$.0]P'CD!\@(#JA 88(!!]#S5KHDBE'574\%6
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<@5D-8Z4TI32E-*4TI32E-*4TI32E-*4TI7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>93
<FILENAME>g425213g63f05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g63f05.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1%H4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $4R^1"@X0DE-! 0      #@< 5H  QLE1QP"   "   < E  "%1I;2!2
M>6%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;CA"24T$)0      $(E,
M*T ^4D:PQ&_V$<%;PI<X0DE-!#H      /$    0     0      "W!R:6YT
M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
M  !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE
M5$585     < 00!0 $0 +0 M #(       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ "4S,P
M 0 ! )3,S  !  $X0DE-!"8       X             /X   #A"24T#\@
M    "@  ________   X0DE-! T       0   !:.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         "
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!$0      !     "   "0    D      .$))300>
M       $     #A"24T$&@     #00    8              3    =D
M!@!G #8 ,P!F #  -0    $                          0
M   '9    3                       0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   3      4F=H=&QO;F<   =D    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   $P     %)G
M:'1L;VYG   '9     -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
M #A"24T$*       #
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                              #_XO__24-#7U!23T9)3$4  0F^S/[^
M'@ (@'!!1$)% A   '!R=')#35E+3&%B( ?0  < &@ % "D -6%C<W!!4%!,
M     $%$0D4                    !  #VU@ !     -,M041"10
M                                                        "F1E
M<V,   #\    =&-P<G0   %P    *W=T<'0   &<    %$$R0C    &P  "B
M!D$R0C(   &P  "B!D$R0C$  *.X  "B!D(R03   47   (XM$(R03$  WYT
M  (XM$(R03( !;<H  (XM&=A;70 !^_<  "0D61E<V,         &E4N4RX@
M5V5B($-O871E9" H4U=/4"D@=C(
M
M            =&5X=     !#;W!Y<FEG:'0@,C P,"!!9&]B92!3>7-T96US
M+"!);F,N  !865H@        M5H  +QG  "2,&UF=#(     ! ,)   !
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MJ&ZI>*J"JXZLG*VKKKNOS+#?L?.S";0@M3BV4;=LN(>YI+K"N^&] ;XAOT/
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MG7-ZYCH?FO9[C2 IFIA\<0  E=-_RJS.KRB"@YMHJN2!F8E^IMJ X';[HQ.
M8V.HGYN )D]3G'^ (SETF@6 3!^AF9:!%P  E(Z  *O?KCV++IJ*J?Z)C8B]
MI>V(&G8QHC"&^V+DGKR&($Z?FZ:%CCC5F2R%2Q\NF*N&1@  DW"  *L2K6J3
MYYFJJ3>1FH?,I3"/A'50H6B-O6(2G?R,44WHFNB+.#A!F&J*HA[*E]>+LP
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M:8QBLF&7IGM[K::5-&H&J223&%?MI/"1743AH3^0-3 ^GE*0*A<^GC:.N
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M&((?O])XRW(6NGQXN6&CM6EXZE!QL*=Y4SX+K'-YY"FFJ99Z:@]FJUE["P
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M8H!"N[6=-W!-MD":<U_/L0F8+$ZNK":6<3R5I]"5LBC"I):5O! KI..*[@
MC#B  (]FP-6HE'_\NRJDT' 6M:JAAU^BL&^>WTZ)JY.=!SQ]ISJ<K"BXH^":
M;A!.I :+!@  C!F  (\FP%&P]7_,NJ&LDV_VM1^HRU^-K^.EV$YWJPFD&CQO
MIKRB_RBSHU.;A1!LHT2+&P  B_^  ([4O_"YR7^NNBVTFV_MM)NP+5^'KU&L
M^DY[JG"K7#R IB"G]2C<HLB;H!"PHKB+2   B^N  (2TT)]X\W77REEX@V:N
MQ&]X6U<1OM9X?4:SN9-XVC4'M0AY6"#VLG=YK@?KLME[10  B?F  (1BSY^
M;G6;R7Y_9V9PPXQ^K5;.O=9^1$9QN'1^*339L\Q^4"#VL/Y^GPAGL.I_YP
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MSW5*Q.^B.68WOLR?.U:AN.F<_49<LVZ;N34.KIJ;K2'-JS*6VPJ1JA^')0
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M@EUZ2U5@@D][ CDF@IE[TQ/?A)U\CN ?@J""O<KW@BF!][3=@<6!39W?@7F
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MB)(_I.2$A8%LH6:#I&^RGC&"_ET?FSR"B$EYF*."1#0LEK*"*QIMEQF"Q@
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M-([FH:2N$'WTGB.J%6Q(FMJF>EGUE^"CE$:^E4RB#C(1DRZ?=!DFDQ"1 0
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M4X3LK<^*PG3[J:2)8&19I;&(/U+6HAB':$ ]GO*&V"O2G+J&P1(KG@:&R@
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M;(+*JQ>S$7+5IM"N\6(JHK^K?%#<GPFI<SZ>F]2FS2J\F62<Y1(&F>:,,
MA>*  (AVO^5S47GANO5SK6K9MD-T*ULGL<ITS$J*K9YUASB3JA1V1B12J"MV
MMPI8J@=W%P  A@R  (@>OP5[+GFYN@AZU&JNM3QZK%KTL*MZMDI/K&YZ[CA?
MJ-5[0R0TIL=[@0J?J"Y\8@  A;:  (?>O?*"Z7EBN/V!]&I>M":!+EJ6KX^
MM4GVJTR =#@:IZR ;"03I8& E K?IH.!)@  A6N  (>7O.>*F'D!M_6)&VGG
MLR*'U%HLKH&&UTF4JD&&+3?/IIV%U2/RI%N&& L7I0>%40  A2F  (<^O J2
M8'BEMQ:08FF$LD&.IEG K9Z-,TD_J4Z,'#>/I:R+EB/7HU:,/@M*H[F'H@
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M_6V9Q;9S-U]8P']SFE!SNX)T)T">MM]TRR]%LR%U9!L&L?AU:P-OL$UWB0
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MY&U4P)J5D%[WNQ^3CE #M=61]D!/L.Z0["]AK-*1 1P5JJ:0"P7DI^&#^P
M@QV  'L7Q82?=6U'O^J<LU[WNF":1U *M0R89D!;L"6772]YK "7>1Q+J:.3
M(08[ILZ$-P  @QV  'KVQ0:G,&T_OUNC_5[\N<&A+% 6M&&?%$!GKW6>62^-
MJU:<TQQXJ."30 :'I>N$:@  @QR  'K<Q)VO/FT^ON&KDU\)N3BH6U JL\RF
M,T"%KM>DSB^YJK"@11RSJ#&39P;(I4:$E@  @QR  .8?=G!S&- ;=TMS\;F
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M")B.F'-P08>EECQQ:76PE#QRC&*UDFASMTZ2D-5TYSC4C\)U]!ZCD(9VA
MBG)[1:?*F9UX)Y?2ESUX@(;7E0YXW73DDPUY1V'KD3MYQ4W0CZQZ4#@9CI5Z
MS!X&CS5["P  B-E^DZ;OF%>!.Y;1E@F RH7ID]N 97/MD>6 '&$%D!U_\4T!
MCIA_WS=CC8%_UAUWC?Y_\P  AW*  *7UES:*0)7"E.J)'X3&DL>(#7+VD,V'
M#V ;CQ.&04PYC9:%E3; C'Z%&QS\C-V%9@  ACN  *4+EBZ3<93.D^R1HX/+
MD="/XG'VC]R.,U]&CA:,LTM^C*6+?38JBXR*KAR/B]"*XP  A3"  *0TE6^<
MQI0-DR^:48,*D0Z7WG$DCQJ5AEYWC5J3:$K*B]^1KC68BL60QQPCBO*/D0
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M+HJTH*1WA7K#G<%WZ6GDFQ%X7E?\F)MXYT3=EH)Y>B_JE2IY[16FEM1YW
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MCX<8G"B?SW<5F42=#68YEHJ:=%2=E!6804'_D?R6R2VTD&V6A11AD3B-R
M@4N  )7.GK&KEX:=F[VH3G:2F-*D^66VE@ZAUU0>DY6?44&'D8*>$"U8C^F;
MX!0YD(2-K   @."  )5UGF*T\(8[FVNQ*78BF'BM1F5!E:JIKE.TDRJG#D$O
MD1*E.BT.CWV>=A0"D R-AP  @(N  (R<KS1N 'Y7JWMO%V]=J -P+U]YI,!Q
M2TZ,H;MR:#Q!GS=S=R?-G?=T) TOH+ASQ0  @G^  (PLKCEV07X&JGIVCF\
MINUV\E\:HY5W;$XKH(-W^SOHG?1XC">$G)EXY TZGN)XT0  @<6  (NZK0U^
M77USJ5A]_VY\I<)]NUZ+HFE]HDVGGU9]J#MYG,=]QB<SFU=]W@T_G39^.P
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MIWL%I8JDO6OGH>2ASEOXGF*?(TM*FSF=.3F*F)F<K"7SELN9<@U*ESF(_
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MDG$%LG&#L&+&KCV"\5/*JCB"9D/)II:"%#)RHZ2!\!ZDHF*"%@:VH7^!Y
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M1V_0KRNI5F&$JL&F75)DIH*CZT*0HJVBPS&4GX^?\QYVG<F4F0>@F\6%*
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M"V5?O >(R%? MT6'MDEULJB&VCI1KG.&42F>JT>&217MJJ^&D &1I%6!#P
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M6IFDA@^%MXB0A3Z% ':+A(:$4V-Y@^V#PT]<@WF#23FF@SB"XQ_&@YB"N
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M&I6D@F"S,X1>@7RNZW(\@*FJH%]\@!"F[TO7?Z^D>C;-?UBA>1V>?PV4!P
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M+(P C>*,$'OXC%Z*Z6L(BO:)OUDMB;6(LD8<B+Z'W#%9B!>'4!>PB,:'6
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MS(+7G$QJC7/?F@)L-&/$E^]MQ5*'E@MO23_LE(9PL2M*D^AQLQ!LEMYQ+P
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M1W\7EGB1RW !E#R00& *DA^.ND\SD#.-8#TECI^,:BDBC;:,70^+CL")D0
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M9W7>I-9Q1V>MH>=R+%B!GR=S%D@PG*MS_C9GFL-TRR(KFD=U'@B FW1U,0
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MAW+WGYF6SF2XG*B5 E6=F=J3346FEU&1\C1WE3R16R$5E!Z0Z CBDPZ& @
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MZ&E@K=AW&UP"JD=W8$V@INMWPSXHH^QX+2T0H<=XA!CNH>EX5 )>G?EZ6
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M F>QJ2V;.UHRI8:95DO8H@:7HSR4GNR6M2OKG).6=AB[F\:0N0.)EE."9
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M:UUAMV9\'E"'LUU[Z4+RKW=[WC0MK!1[\".3J?)[^ ]GJN)[V   FVA_H0
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MZUTCLQ.?25!1KK6=?$*6JIN<)3/IIPN;;B.QI)28(A!6I(.+#   E[*
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M8*T$=8)GOIIL=G%I[X:^=UIK_7(/>$)M^UQ:>2QO[D53>@]QNRL#>M]S&0>
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MT5^XA MLRDOQ@_)NK#:!A"!P2!QEA6%PY@  @$QVNJ&8@[AM@Y*G@T5O"8*
M@NAP;7$U@I]QOE[#@FMS!$L7@EIT.S7 @GUU.!O(@V]U9@  @ !ZN:"+@=EV
MU9%F@8AWBX%=@3MX*W 2@0-XP%W @-YY54HX@-=YY#4%@/-Z3QLW@9IZ+
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M\XRV>]RC57R.>Z>@:VMW>WF=<EF)>W&:R4:/>X.8PS(?>VV7^1D@>L20_0
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M^X0+B+)^)'3RA\%^-63JAN)^.U.IABY^1T$NA:E^52S+A79^5!*YAJ!^!@
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M]X"7A&6H5W%C@V*E16$_@F*B(5!8@9>?F#Y6@0J>92J;@(Z;-1%Q@$6+RP
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M67<JD+&$!VCXCQB#H5G&C9J#,4FHC$&"R3@%BU&"AR0XBOZ"9PKMBO&![@
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M<&X3H"9DE6"KG>YFH%(@F^=HBD)8FAYJ3C#BF/YKPQR!F<%L/P/?F*%LO@
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MWVKZF7.).%V3ES"(=4\ZE0F'K3_BDR*'!R\9D;F&L1N/D9V'%@2HCG:#)@
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M/V&ZJ1MJCU3]ID9KX4= HZ!M*C@WH6!N4R<_H#%O&Q)QHBUNB@  ERUS:0
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M?5^1HM*-KU+?G^>,LD4ZG1Z+NS:&FKR+&R8[F26+2A*EF:B)H0  D-N
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M[%5WLK]ODDE=KW)P13Q#K%%Q!RW6J<YQIQT4J05QR0E<J:5QG0  D.%[@
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M1E2RK,N1?DB8J4B0=CN%I?F/B2U+HT&/91T8H>R.O I\H1^'%P  C)R
M@ "  %_!K]V9H%2[K"R8O4BCJ)&7@3N'I326A"U2HFV6+1TSH0&33@J2H"*'
M)@  C "     @ "  ,$39Q5?[:[3:3EBM)OM:SYE8(@B;21G[G-I;OAJ:5VW
M<+ELT4;'<D5O$"S/<R9PW0H$=BIQ%+\@9"5JT:U+9HILA9J.:+]N+(;H:M)O
MRW)&;,]Q8%RH;K%RZT7)<$ET4ROH</%U70EM=&AU:[U)895UIZN&9"!V3ID'
M9GUV\X5S:+-WI7#X:M)X7%N!;-!Y$43*;G!YKRL/;MEZ"@CI<MQZ+;MW7TN
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MPY9Z=Z]ANH8T>%QD='2G>11F^V'P>=-I9TX&>IMKMSB+>V9MOQ[+?#MNTP
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M5I @;>^./G_X;Q.,]V[-<"R+G5R]<46*54F-<DR)-C3;<O*(8QOO<<N(2P
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MF(E&?3EII'H!?61KAVF1?9QM35?M?>-N_D3[?D%PCS Y?KUQR18V?[-QNP
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MB8/;=0R4(W2W=7V2?&21=>Z0P5-]=FR/*4%!=N*-X2U:=OR-4Q0Y=GZ+%@
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M4WP=@Z1PHVWM@T)QVUYW@O-R^DW?@KMT"SO8@K%T^B>S@O=UAPV>@^=T[P
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MU7?G?/N91&FP?+>77UIY?&^58DI)?$:3LCC3?#22L26">^:22@S+?">(I@
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MZ6]$BNYVJF'>B?EW5%.%B1-W\4/7B%UX>S*CA_9XYQ[=B$9X[09\AY)YOP
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M36Q2A;Z=RU[JA+B;QE""@Z69HD$V@L*8)3"&@B:7MAV!@:^3\P9]@12$8P
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MD&,7DPQ[XE9QD8)\'4C0D E\0SH2CL]\9REUCC%\?!6<CPY\.@##BJI]I@
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ML%H2I!]>%4WPHB-@94"KH%MBC3'RGP5D:"#GGQ-EB@O[H;ME&@  C91MT@
M@ "  &2SI,QC)UFFHHYD\4V3H&UFL$!LGGMH5C'2G/]IOR#SG-5JB@Q/GOII
M_0  B_MRS   @ "  &0KHNAJ=5D,H+AKN$T9GI1L\3_XG)IN'C%_FQ%O&B#0
MFL%OE0Q]G&QO!@  BGMWH@  @ "  &.=H0=QJUAKGN)R>DQHG,ES/#]UFM%S
M]3$1F4ATC2"0F-YTPPR.FAET50  B11[Y0  @ "  &,.GVYX\%?AG5-Y6$O>
MFSMYK3[CF3]Y[#"TEZEZ)R!-ERUZ,0R.F %Z*@  A]%_G   @ "  &*0GBR
M5E=QG!: 84MUF?B 2#Y\E_. &C!5EDY_^B EE:)_^ R5EAZ $0  AK2
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M?4VZK>)C&T(CJVIDN35_J2YF.B<ZI[UG8!7JJ,]G< /2IK]H40  AZ!VL@
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M+4PIIA*$%D"YHW6#QS1!H0*#;"9TGS2#1Q8=GRV#AP4^FR&">@  @JV
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M?E1\9J&H77^!?9)@8!F!78(M8GR!)G#^9+B XE[H9N& I$N7:-2 =S;H:@.
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M#H=G9Z9_/'@S:5Y_1F?X:OE_.5;&;(A_+$0Y;>U_*# :;IY_'A=2;@9^\
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ML8$G>5)<"7*W>>%?*&+^>H1B$U(!>S%DU#^=>^]G7BL\?,5I6Q#>?E!I8
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MMGM';>.%>FT.;O^%#%W'< F$@DU_<0>#_SOC<=N#F2A;<?^#90]:<Z&"^@
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MXG1H?LIC7V;4?NUEM5@7?QYGYT@+?V!I\C9P?\IKN2)G@(1LR0C?@>ELF@
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M:F]F=1"*WF(,=8F*$%.E=?&)*$0T=EB(73-<=J"'V2!*=CN(#PAR>-B%50
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MYV>LA3YILUL+A.EK9DTCA*%L^3WXA'AN9"T'A*%O?1D A9EOH ).A1-Q-@
M@ "  ')P@S]OWV:A@PAQ&5GV@L=R.$Q*@HQS/CTT@G!T(RQM@HYTRAB<@S9T
ML@)=@PIVS0  @ "  '%]@4)WX&6Y@1UXD5D.@.IY(DM=@+=YF#R9@)-Y_"OH
M@*EZ0AA(@/]Z$P)N@41[P   @ "  '"F?Y!_\F3O?W^ (UA2?U6 )TJU?R&
M##P'?OA_\"NS?NE_Y1@S?O-_Z *-?[U_^   @ "  &_V?CF("V1A?CJ'QE?/
M?@V'/4HK?<J&E#MR?9N&"RLI?7V%U!?W?2J&'0*6?G:!P   @ "  &]I?2:0
M)&/7?2^/<E=%?0".9TFJ?+6-/#KU?'R,8"JD?%&,/!>0>[2+6P*??6J!Q@
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MO%M>C)YN_T]BB\EP*D)EBP5Q/#/LBH!R("-OBIARG0\WB\]R#@  @KQXF@
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M&5BMAB&3?$S+A4V24S_AA$^1!C'C@W.0;B("@NV0*@[;@EV*"P  @ "
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M@4^2E01S6T0PD[=T'#?&DGQTMRH"D:MU+1F4DAQU(0<QD"IUW@  @ !_+@
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M349BJ)A6TCM-IPU9/2[LI>1;:2"&I=E<]PZ7J*-="   H A@?   @ !Q+@
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M8$/*GM-V\#CDG2AW52SKFYYWD1]8FM=WG [8FZEW7@!QD]IZ5   @ "
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M68N>74-I9GQ/7_5K7&O,8GYM/%H\9.)O"4=W9OMPO#,K:"UR+AJZ9Y%RSP
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M&H5[46V61':(5,6426:15]N24E6=6K>0DT.,7/J/+3 L77B.?!BY7SF,[0
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M;G]386APUW#^8ZMR)6&A9<9S6%#^9\-T>#\;:6-U@"MQ:>MV11*2;$=V#
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MF7JJ5[V;GVR"6F>95EU>7-*7"$U%7P.5%COZ8(^3TRD)7^^3:!$D9>^+EP
M@ "  (4P<9)30'AJ<I96\VJE<[-:>%NE=-A=R4M>=?=@YSF7=PYCNR69=_EE
MUPNZ>L1F @  @ !UPH/';=)<#G<W;S!? VF!<(1ASEJE<<UD<TJ"<P9F[3CA
M=")I)"4+=,AJM@N-=_=JJ@  @ !YX8)P:EUDW772; %G%VA8;8-I,EF-;NYK
M*4F8<$!L_S@C<5YNGB2"<;QOL@ME=8)OB@  @ !]@($.9S-ML'1P:0QO-V<
M:K9PH5B5;$!Q\DB];:YS(C=];LQT*R07;N%TRPM.<UYTLP  @ "  '^Z9')V
M@'-(9G-W8V7<:#YX(E=@:=UXP4?/:UIY5#:D;'AYTR-M;#EZ%0L*<9MZ90
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M_FT$>F)6CV ->P!9]E'7>[!=*4)'?&A@'S#_?4%BKASB?FQD(P2$@.ED[0
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MGF=O;(]]$UK:;<]]6DTR;N)]?CYJ;\Y]G"X <%)]O1KA;XA]P@28>#Q^@@
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M3F"0?\%=(51F@ =?T$<0@%5B4SA#@+EDD"=T@6MF1!+7@OMF7P  @0EJ8@
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MLUO+<[V!VT_V=&N!Q4,+=..!C#3I=3F!8R3W=2^!9!&I==J!B0  @ "
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M8U0MAC%BF$C7AA=DKSPOA@1FEBX%AB1H*1UBAO5H_0FCAU%HZP  @ !S9
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MRU!T>_F%SD5&?!N%>#D&>_&$_2MO>[:$PQN->UJ%&PE2?%R#WP  @ "
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M0$@&C<AF\3THC4MH@3$OC.EIX2-4C0%JT!)*CI-JG0(?BO!LI   @ ![/
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M,T5:A4:)0#JYA/.(O2\0A#B(%"'M@X.(&A'D@QV') +7@;2![   @ "
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MZ#O=EPQJ*3%>EEAK0"6HE=)L"A?[EDQL2PAUE0]LKP  A\9T+P  @ "
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M2GEW]6F]3H]XJEC84EQY7D:<56AZ$#,75F9ZLQP*6--[*@&Q?21]B)5G/:F
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MF8/56+M:_G4M6[9>2F5_7HUA=E2C83%D>$* 8VIG2BZY9%UIMQ9.9F!JV@
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MGGQ^1P:'#6Z72T2&;5^>3QZ%S4^44GZ%0SY85-2$WRN;5$R$Q!157:*$^@
M@ "  (BA/_"0_WNR1,J/K6WB23".2E\!32:,\T\#4)6+T#W+4MR*^2LM4D>*
MQA0J7>N)FP  @ "  (?_/A&:'GL<0PR8%FU61XJ5]5Z&2Y*3\DZ@3PJ213V"
M4461'2KA4*V1$Q/?7FF-0   @ "  (@=8>Q.#'K#9 =2'6RQ9B96%UV;:#E9
M[$U6:BY=D3ND:]I@[R?R;)ACJ0Z3<.MD:   @ !QM(8G7/E7&WE(7XM:=VMC
M8?Y=MEQ[9%%@TTQ99G)CPSK,:"EF=2=":(=HE Y#;A%H_P  @ !V:(1N6&)@
M1G>T6UMBWVHM7AQE8UM<8*-GQ4MI8NAJ SH+9*%L#2:Y9))MF0X3:X=MQ0
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MI7'23 J,PV2J3[:+LE9W4OB*G$<G5:J)N#:$5PJ)*R0W5L*)8@TE:<B'-@
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MTVN:7MIIOE[D841KEU$[8W)M6$(794MNZS%M9F5P11Y89=YQ 0<.=!-QS@
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MFF<M4>V1HEJP5/602TTO5X*.XCZ866&-TBZ*692->1Q 6YZ-&0:==-.$>0
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M1E^X8V9OI%.[961P[4;*9Q=R%CBC:&YS(BAM:,-SYQ4;:LESV@$3?BYW'@
M@ "  &G%7@-V@%[(8'9W4%+G8I9W_T7T9%QXD#?-9:-Y$2?99:IY>!2N:)IY
M9P$2?C![]   @ "  &C<6TM^JUWM7>-^]%(;8!]_#$4V8?)_"S<;8RM_$R='
M8MY_+Q1Q9KM_9@$D?A-_^@  @ "  &@E60.&P%U$6[N&CU%Y7@N&%T2@7^.%
MB3:)80B%*2:T8&&%)A0&952%1 $P??Z S@  @ "  &>>5RV.QES%6@".,U#W
M7%Z--D0B7C*,(C8@7S^+:B9G7F&+B1.P9#B)\P$/?C6 N   @ "  &3C>@Q-
M6EG<>KA0^$X'>XA4@D$#?&17W3)T?4Q:VR&4?H!=#0S,@*!=>   @ !EG0
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MLE0&:1ETI$B^:IQU=#QJ:\=V(B[/;'1VL!\#:]MV_0OT<9EW'P  @ !]TP
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M?$V$?]56BD)Y@&!9<38L@/%<&R@3@;%>21;Q@S-?0P2-A A@;@  @ !M\0
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M"DAS;^=XJ3W$</9Y&C'U<99Y:R2A<9MYGQ2B<B9Y@ 20>$I[<P  @ "
M@ "  %&F;"=_=$?O;<Q_N#U8;O=_L3&H;XE_C21E;U)_B11"<#I_L 1<>**
M)P  @ "     @ "  %$E:C^&\D=O; &&Z3S<;4&&>#$Y;<Z%\R01;62%VQ00
M;J2%N 11>+6"ZP  @ "     @ "  $SOC:!*UT-@C6I.-CC5C8-1:2R]C?]4
M1!Y5CU]65PR D=U6]@  B8I<-   @ !LK0  @ "  $N3B<M1E$(XB>94BS>U
MBA=74"O%BG]9OAV9BYA;; PYC15;U@  ADY@WP  @ !QC@  @ "  $J%A?I8
M9T$<ADM:Z3:\AI1=/"K7AO-?.QS<A]1@A ODB)Y@OP  @U1EN@  @ !VB
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M;#SK> -[T#*]>+Q[^"==>.U\ !GZ>(1[^PIM>F]\K0  @ !_>   @ "
M@ "  $73=-N"O#R'=D2"X#)O=R""GR<Z=SF"2QHD=G*"6PK.>+6"!@  @ "
M    @ "     @ "  $"9F45(JS>RF*U+Y2VCF)1.U"&JF5%1.Q)YG#)24P-2
MF;Y48   A+)?B@  @ !P#0  @ "  #\WE;Q/!#94E8Y1V2PLE9E48B!+ED!6
M9A%NF*%7+P,)E159/P  @:YD0   @ !U 0  @ "  #Y!DA95>#4ZDAE7X2L>
MDCY: A\ZDM=;H!"@E,-<'P+2D,]>+@  @ !I(P  @ !Y=   @ "  #UOCGU;
M_310CI]=]BH8CM5?J1YGCV1@Z __D-=A*@*JC09C.@  @ !N5@  @ !]6
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M)S#G@?9^3R<+@JQ^,1OC@LQ^ 0Z1@EQ^+@*)@8A^_P  @ "     @ "
M@ "     __\  /__  #__P  ;69T,@     $ PD   $
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MN____P"  (  YD]_SG]8S9E_J'[-M-I_F7YYG!1_HWYE@TQ_QGZ%:H5__G[
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MT!N#!*VZN<V".JA8HS*!HZ,MC'N!-IX@=<B [ID47TJ OI/;2.2 KXXZ,KF
MP8?/Y-6#<[WXSOJ"A[=6N+6!O+#BHB^!)JJHBY^ Q*2*=1& @YY57J> 5)?1
M2&F 4Y#9,F" <HC[X]:##LBES@6"),#BM\:!5[E3H4J O['ZBM" 8:J[=&N
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M68L\C0R!W(FG>9^!?X@V9B>!.(;.4N*! X5>/]Z [H/8+9V ]H(>PPZ"I)A
ML4Z!]I6^GN"!99,VB]N \I"P>)6 GHXV94N <8O34CN 48E2/VV 4X:@+6:
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M.*2 MH9O*:Z F(-?J;:#ZJ#'FG:#%9W-BGN"2)J*>>Z!EY<9:3F!#I.C6)B
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ME$A_WX @A5-_KH #==Q_AW_B9=I_>G_+5<=_AG^^1@5_IG^U-J9_\7^L*&N
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MBH7#J(=WB& &FBYX,&,;BOAX[V8#>N)YPFC1:C]ZIFNG66U[HVZ>2.5\O7'
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M,+:!Q'KE)0&!VGS<C.V![WAP@**!GGDN<\&!4'G89FJ!"'IY6)B VGLE2L:
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M<\&%JY*0: *$I9"%6]2#EXXT3YR"LXOF0XN" 8F>.""!7H=>+5F [H4!(^^
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MUX0J++R+VX,^)>"($8)7($2$J(%_8%FB&(ZD5].>KXV'3N*:_XOA1=.7%XH
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M]GPC31YNQGS%/'ERZ7V"+0!W8WY;L$%7JX/$H)=;18-$D&!>O(+!?Y]B+X)
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MSWA!A?E^T&*X>JE^Z&5I;H=_#F@+8<E_06JN5)]_@FUC1V9_VG ].J: 2G-
M+GR ZG:.(ZR!M7HNA/Y\8&K2>9=\LVS(;:!] FZT8/-]7'"=4_-]R'*91NE^
M472Q.EY^]';H+G!_Q7E5(^. O7OV@_-Z+G++>(EZJ'04;(]['G5-8"Y[F'9^
M4TM\-'>Z1G1\['D*.A]]OWIN+F=^P7OU)!-_Y'V7@O)X1'J]=Y!XX'M9:Z9Y
M=7O87U5Z#WQ%4LAZQWRZ1A-[KGT[.>U\K7W(+F-]W7YF)#Q_*G\.@A5VO(*>
M=MAW<8*1:P!X&8)37JEXR8'U4B9YG(&81:EZG8%&.:I[PX#Y+E!]&X"J)%]^
MC8!8@6%U>HI.=B9V08F5:E=V]HB47@]WN(=J49QXHX8\14)YOH42.7QZ^8/J
M+DA\=8*S)'M^"X%T@-5T>9' =9YU3Y!;:=%V#8Z5791VUXR842QWU(J61-]Y
M"HB4.4!Z7(:2+D%[[81\)))]H8)D@&QSMYCO=31TEY;D:6)U691472MV)9%\
M4-=W*8Z@1*1X;HO%.1!YVHCG+B9[AH7\)*1]3(,I>WF)P5II<.2(YEW-9;:(
M-&$I6>V'CF2(3<J&X&@!0:6&-6NI-@6%E&^"*P>%$G.Y(62$MWA/>IN'7&(>
M<"Z&P63.90J&+V=Z66*%GVHO36*%$&S]06.$C&_S->Z$%G,2*R.#PG9\(;V#
MD7HI><2%"VFW;T:$I6N\9$R$-FV_6+2#QV_'3-Z#77'F00R#!G0E-<F"O7:%
M*S6"EGD<(@J"CWO=>.&"[W$T;EN"K'*88V""7W/R6 2"$75.3$R!TG:Y0*J!
MI7@\-9J!B7G5*SV!CWN5(DV!KGUJ> >!(GB=;8Z ^GED8IN QWH65T6 DWJ]
M2]F ;'MM0%6 ;'PO-7* >'S^*T: IWWA(H: [G[,=T9_FW_T;-U_CX >8?M_
M<( A5KY_38 *2VU_/G_T0#-_4'_O-6E_A'_U*U5_W7_\(K6 38 #=J=^:(<B
M;&%^<X:T88U^6X8 5E!^/(4B2P!^081'/]Q^;X-Y-4Q^M8*S*UI_,X'A(MQ_
MQX$-=BE]<HX7:^A]BXT/81A]>HNB5>E]8HGZ2J5]=(A7/XE]NH:]-1U^%84L
M*U]^IX.+(OQ_6H'L=<A\MI3+:XA\UY,O8+A\RI$$59!\M(Z-2F!\RXP;/UM]
M'8FT-0!]CH=5*U=^.X3N(Q5_ X*C<'627EH>9JR0VEUP7&V/<V#*4;..!&0V
M1KF,>F?$.\^*XVN&,7J)36]X)]F'RW/%'YF&<7A:;ZF0-&%@9A2.X&0-6^2-
MB6;&44R,)&F21G2*KFQ].[&).6^7,8:'R'+9*!2&<'9E( F%/GHC;O:-_FB
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M8IJ%[(G$6+Z% 8BJ3I2#](=51'6#!H83.HJ"283G,4N!GH/2*,.!*H*K(9F
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M?8+&C']8?)J5@%E;^9@W<Y!?695V9DIBTI*&6-!FDH^;2V1JHHRR/HIN[(G
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M6[M]RW[24K)^ 7[[26U^(7\10"1^4'\P-RA^F']?+M!^]'^?)P1_B7_<()V
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MV'O2,]5U2WS8*I!XYGWR(K5\8'\/<%-@:W[29L5CG'\97,=FN7\U4F5IX']
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M3)1[N'> 14)\>WAT/=E]#'EN-GM]EWJ#+VM^,GNR*0A^UGSN(T1_JGXA'K"
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M"7H^3'B+$6'01>J*?&2D/S&)KV>/.'N(K&J?,<F'B6W@*V6&;W%&):^%:G3
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M(9J GH ;'@6 Q(!4  #__P  __\  /__  !M9G0Q      ,$(0   0
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ML[MMLZNU>+NEL8#!GZZ$QIBKA,J0J(3.B*:&T8*DC-. I)+3@*22TX"DDM.
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MDK*%P(VQAL&)L(?#AJ^(Q(*NBL6 KHS%@*Z,Q8"NC,6 KHS%@*Z,Q8"NC,6
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M-6R,Y41ZA-Y3@X#98HI\U6R/>-)QDW70=95SSWB7<<YZF'#-?)EOS7Z:;LR
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M047_KSU0_K@[6?/$/&'FT4-DV=]#<\C<2H6WT%>5JL=EHJ# <*R9NGFTE+:
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MOKY]HK^]>JC O'FOP;1YL,&P>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K#
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M9UU:^&M?6/=N8%?W<6%6]G1A5?9V8E3U=V-3]7EC4_1\9%+T?F11](!E4?2
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MM'R5N;1\E;FT?)6YM'R5N;3_E2P._Y4]'O^@/2?_J#LP_[ \-_VX/SSQP41
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M8_\Z)%S_0BA6_TDL4?]/+T[_53%+_UHS2/]>-4;_8C9$_V8W0_]I.$'_;#A
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M/#;_ISTU_[$^-/^^/C/_RC\S_\H_,__*/S/_RC\S_\H_,__*/S/_RC^XL@
MJKT  )W*  "1V ( B/L- 7__&0)V_R0&;O\M#&;_-1)?_SP76/]#&U/_21Y.
M_T\A2O]5)$;_6R9#_V G0/]F*3[_:RH[_W(K.?]Y+3;_@2XT_XHO,?^4,##_
MG#$N_Z4R+?^O,RS_MS,L_[<S+/^W,RS_MS,L_[<S+/^W,RS_MS.KN   GL4
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M6S/Y=F0Z]7!N0?%L>4CM:(--ZF2,4>=AE57E7YU8XUVE6N%;K5S>6K9>W%G
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M<.ERCG'J<8UQZW",<>MPC''K<(QQZW",<>MPC''K<(QQZW#_8R #_W(; _^
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M6DC%^UI(Q?M:2,7[6DC%^UKWD00 U*(" ,>O! "ZN0, L,0% *?0"0"?X1
MF.$A X_@, F&X#L2?=]$&W7>321NW54K9]Q<,F+;9#==VVL[6=IR/U7:>D-2
MVH-%3MJ-2$S:F$I)VJ5+2-NS3$?<Q$Q&W-Y,1MKM3$38^4]#V/M/0]C[3T/8
M^T]#V/M/0]C[3T/8^T_;F@  RJD" +NS @"PO0, I<D% )O6"0"4Z!0!C.DE
M!(3H,PM[Z#P4<^A$&VOH2R)DYU(H7N=9+5GG8#)5YV@U4N=O.$_G=SM,YX ]
M2>>)/T?HE$%$Z)]"0NFL0T'IND1 ZLU$0.KD1$#H]41 Y_A#0.?X0T#G^$-
MY_A#0.?X0T#G^$/-HP  O:X! +"X 0"DQ ( F= % (_A"@")\1H!@?$H!7CR
M,@QP\CL3:?)#&6+R2A]<\U C5O-7)U+S7BM/\V4M3/1L,$GT<S)&]'LT0_2$
M-D'UCC<^]9DY/?:D.COVL#LZ][\\.?C//#CWZ#PX]^P\./?L/#CW[#PX]^P\
M./?L/#CW[#R_J@  L;,  *2_  "8R@$ C-@$ (3Z#@!\^QL"=/LF!6S\, IE
M_#@07OU %5C^1QE3_DT=3_]4($O_6B)(_V$E1?]G)D+_;2A _W4J/?]]*SK_
MABTX_Y$N-O^;+S3_IC S_[(Q,O^^,C'_T#(Q_]8R,?_6,C'_UC(Q_]8R,?_6
M,C'_UC*RKP  I;H  )C&  "+T@  ?]\" 'G_$0%O_QD"9_\B!&#_+ =:_S0,
M5/\\#T__0Q-*_TD51_]/%T/_51E _UL;/O]A'#O_9AXY_VT?-O]T(#3_?2$Q
M_X8C+_^1)"W_FR4L_Z4F*_^O)BK_NR<I_[XG*?^^)RG_OB<I_[XG*?^^)RG_
MOB>FM@  F,(  (O.  !^VP  =?D' &O_#P%B_Q8"6_\> U3_)@5._RX&2?\U
M"$7_/ M!_T,-/O](#CO_3A X_U,1-?]8$C/_7A,Q_V04+O]J%2S_<A8J_WH7
M)_^#&"7_CADD_Y@:(_^@&B+_JALA_ZT;(?^M&R'_K1LA_ZT;(?^M&R'_K1N:
MO@  B\H  '[7  !PXP  9_\$ %[_#0!6_Q(!3_\9 DG_( -#_R<$/_\N!3K_
M- 8W_SH',_\_!S#_1 @N_TD)+/]."2G_4PHG_U@*)?]>"R/_9 LA_VP,'_]T
M#1W_?0X;_X<.&?^/#QC_F0\8_YL0&/^;$!C_FQ 8_YL0&/^;$!C_FQ#_3"H#
M_T@S!?]/- ;_5#<(_UI!#O]<2A;_6E0=_U=@)/]4:RK_4'@O_TV$,_]*CS;_
M1YDY_T:A._]%J3S_1+ ^_T.W/_]"P#__0LE _T'50?]!Y$'_0>Y"_T'V0O]!
M_4+_0O]!^43_0?1&_T+O1_]"[T?_0N]'_T+O1_]"[T?_0N]'_T+_32D#_THR
M!/]1,@;_5S8(_UP_#O]>21;_75,=_UI>)/]7:2K_4W4O_U"!-/]-C3?_2I<Z
M_TB?//]'ISW_1JX__T6U0/]$O4'_1,9"_T/10O]#XD/_0^Q#_T/U0_]#_$/\
M1/]#]4?_0^](_T3K2?]$ZTG_1.M)_T3K2?]$ZTG_1.M)_T3_32D#_TPP!/]4
M,07_630(_U\]#O]A1Q;_8%(=_UU<)/]:9RO_5G,P_U-_-/]/BCC_390[_TN=
M/?]*I#__2*Q _TBS0?]'NT+_1L-#_T;.1/]%WT3_1>I%_47S1?M%^T7W1O]$
M\$G_1>I*_T;E2_]'Y4O_1^5+_T?E2_]'Y4O_1^5+_T?_3BD#_T\N!/]7+@7_
M73('_V,[#O]E1A;_95 =_V%9)/]=9"O_6G P_U9\-?]3ASG_4)$\_TZ:/_]-
MHD#_2ZE"_TJP0_]*MT3_2<!%_TC*1OU(VT;Z2.='^$CR1_5(^D;Q2?]'ZDO_
M2.-,_TG>3?]*WDW_2MY-_TK>3?]*WDW_2MY-_TK_3R@#_U(L!/]:+ 7_82\'
M_V<Z#O]J1!7_:DX<_V=7)/]B82O_7FTQ_UMX-O]7@SK_5(T]_U*60/]0GD+^
M3Z5$_$ZM1?M-M$?Z3+Q(^4S'2/9+U$GS2^5)\$OP2>U,^4CI3/]*X4[_2]I/
M_TS34/]-TU#_3=-0_TW34/]-TU#_3=-0_TW_4"@#_U4J!/]=*07_92T'_VPX
M#?]O0A3_;TL<_VQ5(_]H7BK_8VDQ_U]T-OU<?SO[68D_^5:20O=4FD3U4Z)&
M]%*I2/)1L4GQ4+E*[T_#2^Y/STOK3^)+YT_N2^1/^$W?3_Y.U5'_3\Y2_U#)
M4_]0R5/_4,E3_U#)4_]0R5/_4,E3_U#_42<#_U@G!/]A)P3_:BP&_W$V#/]T
M0!/_=$D:_W)2(O]N6RG]:&0P^65P-O9A>SOS7H5 \%N.0^Y9ED;L5YY(ZE6F
M2NA4K4SG4[5-Y5._3N-3S$[A4]].W5/M3]A2]U'14_U2RE3^4\16_U._5_]3
MOU?_4[]7_U._5_]3OU?_4[]7_U/_4B<#_ULE _]E) 3_;BH&_W8T"_]Z/1'_
M>D88_WA/(/MT6"CV;V$O\6ML-NUG=CSI8X! YF"*1>1=DDCA6YI*WUFB3=U8
MJD_:5[)0V%:\4=55R%+25=M3SE;K4\M6]E7&5OU6OUC]5KI9_5>V6OU7MEK]
M5[9:_5>V6OU7MEK]5[9:_5?_4R8#_U\B _]I(0/_<R@%_WLR"O]_.Q#_@$06
M^WY,'O1[5"7N=ETMZ7%H-.1M<CO@:7Q!W&6%1MABCDK47Y9-T5V=4,Y<I5+,
M6JU4R5FV5L=9PE?&6=!7PEGF6+]9\UF[6OM9M5O[6K!=^UJM7?M9K5W[6:U=
M^UFM7?M9K5W[6:U=^UG_5B0#_V(@ _]M( /_=R8$_W\P"/^$.0W]AD$4]85)
M&^Z"42+G?5HJX7AD,MQS;CK4;G=!T&J 1\QFB4S(9)%0Q6*84\-@H%7 7JA8
MOEVQ6;M=O%NY7,E<MUS@7+1=[URP7OE=JU_Y7:A@^5RE8?E<I6'Y7*5A^5RE
M8?E<I6'Y7*5A^5S_6"(#_V4> _]Q'P/_>R0#_X0N!_^)-@OXBSX1[XM&%^B(
M3A[AA%<FV7YA,=%X:CK+<W-"QF]\2,)LA$V^:8Q1NV:35;ADFUBU8Z-:LV&L
M7+!@MUZN8,1?K&#87ZEAZU^G8?=?HF/W7Y]D]U^=9/A>G63X7IUD^%Z=9/A>
MG63X7IUD^%[_6R "_V@< O]T'0+_?B,#_X@K!?V-- GSD#L.ZI!#%.*/2AK:
MBE0ET(-=,,E^9SK#>&]"OG1X2+EQ@$ZU;HA2LFN/5J]IEUJL9Y]<J66H7Z9D
MLF&D9+]BHF308J!DYV*>9?5BFF;U89AG]F"6:/9@EFCV8)9H]F"6:/9@EFCV
M8)9H]F#_71\"_VH: O]W' +_@B$"_XLI!/F1,0?OE3@+YI8_$-V41Q?2CE$D
MRHA;+\*#9#F\?FQ!MWET2+)U?$ZN<H13JF^+5Z9MDUNC:YM>H&JD8)UHKF.;
M:+IDF6C+99=HXV25:?-DDVKT8Y%K]6*0:_5AD&OU89!K]6&0:_5AD&OU89!K
M]6'_7QT"_VT8 O]Z&P+_A1\"_XXG _65+@7KF34(X9P[#-:80Q;,DT\BQ(U8
M+KV'83BV@FE!L'YQ2*MZ>4ZG=X!3HW2(6)]QD%N;;YA?F&ZA8I5MJV22;+=F
MD&S&9H]LWV:.;?%EC&[S9(MN]&.*;O1BBF[T8HIN]&**;O1BBF[T8HIN]&+_
M81P"_V\6 O]\&@'_B!X!_Y$D O*9*P3GGC$%W: V"=&<017'ETTAOY%6+;>,
M7S>QAV= JX)N2*5^=DZ@>WU3G'B%6)AVC5R4=)5?D7*>8HYQJ&6+<+1GB7##
M:(=PVV>&<>YFAG+R985R\V2$<O1CA'+T8X1R]&.$<O1CA'+T8X1R]&/_8QH"
M_W$5 ?]_& '_BAP!_)0A NZ<)P+CHBP#V*0R",R?0!3#FDL@NI55++.073>L
MBV4_I8=L1Z"#<TV;@'M3EGV"5Y)ZBER.>))@BG:;8X=UI6:$=+%G@G3 :(!T
MU6B =>QG?W;R9G]U\V5_=?-D?W7S9']U\V1_=?-D?W7S9']U\V3_91D"_W04
M ?^!%P'_C1H!^9<> >N@(P'?IB8"TJ<P!\BC/A._GDD?MIE3*ZZ46S:GCV,_
MH(MJ1IN'<4V5A'A2D(%_5XQ_AUR(?9!@A'N98X!ZHV9^>:]H>WF]:7IYT6EY
M>NIH>GKR9GIY\F5Z>?-D>GGS9'IY\V1Z>?-D>GGS9'IY\V3_9Q<"_W84 ?^$
M%@'_D!<!]9L: >>D'0';JQ\!SJHO!L2F/1*ZH4@>LIU1*JJ8632BE&$^G)!H
M19:,;TR0B792BX9]5X:$A5N"@HU??H"78WI_H69W?JQH=7V[:7-^SFES?NAH
M='[Q9G1]\F5U?/-D=7SS9'5\\V1U?/-D=7SS9'5\\V3_:18!_W@3 ?^'% #_
MDQ4 \9X5 ..H%@#5KAL!RJTM!L"I.Q&VI48=K:%0*:6<6#.>F%\\EY1F1)"1
M;4N+CG11AHQ[5H&)@UM\AXM?>(:48G2$GV5Q@ZIG;X.X:6V#RVEM@^9H;H/R
M9F^"\F5P@?-D<('S9'"!\V1P@?-D<('S9'"!\V3_:Q0!_WL2 ?^*$@#_EA(
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M7U><]U]7G/=?5YSW7U><]U__>@P _8L) -J;! #.IP8 Q+ & +RY! "UP0X
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M1<+_3D7"_T[?D   S)\  +^J 0"SLP$ J;T" )_'!0"6T@D CMH2 (C;) *
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M(S+^I"0Q_[$E,/^_)B__SR8N_^,F+O_C)B[_XR8N_^,F+O_C)B[_XR:MK0
MG[<  )+"  "&S0  >=H  '#R" !H_Q$ 8?\: 5K_(P-4_RL$3_\S!DK_.PA&
M_T(+0_])#4#_3PX]_U40.O];$3C_81,U_V@4,_]O%3#_>!8N_X(7+/^-&2K_
MF1HI_Z0:*/^O&R?_NAPF_\<<)O_''";_QQPF_\<<)O_''";_QQRAM   D[\
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MX4^[0.!/QT#>3]A!V4_H0=1/]$/03OY%SD[_1LA0_T;"4?]'P%'_1\!1_T?
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M6GQR_%E\<OQ7?'+]5WQR_5=\<OU7?'+]5WQR_5?_8A0!_W$1 ?]]$0#_B!(
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M5V>#_%=G@_Q79X/\5V>#_%?_; X _WL, /*)"0#9E08 SYX( ,FF" #!JQ
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M-4+.N#9!S\TU0<[H-4#-]3<_R_XY/LO_.3[+_SD^R_\Y/LO_.3[+_SG*E@
MO*(  *^J  "CLP  F+P  (W& P""SP< >-D+ '/>& !NWB8":-XS!6+>/@I=
MWD@/6=Y0%%7>6!=1WF ;3MYG'DO=;R!(WG@C1MZ!)4/>C"=!WI@I/]ZF*C[?
MM2H]X,@J/=_C*CS=\2L[W/LM.MS]+CK<_2XZW/TN.MS]+CK<_2[ GP  L:<
M *2P  "8N@  C<,  ('- @!VUP< ;N@/ &GH&P%CZ"<"7NDR!5CI.PA4Z40,
M3^I,#TSJ4Q))ZEL51NIB%T3K:AE!ZW(;/^M['3SKAAXZ[)$@..R>(3?MK"(V
M[;LC->[/(S3NYB,TZ_4C-.OX(S3K^",TZ_@C-.OX(S3K^".SI0  IJT  )FW
M  "-P0  @,L  '75 0!IX08 9/,1 %[S' %9]"8"5/0P!$_U. 9+]4 (1_9'
M"D3V3@Q!]U4./_=<#SSW8Q$Z^&H3-_AS%#7X?18S^8@7,?F4&"_ZH1DN^J\:
M+?N^&BS[SQLK^^<;*_OK&RO[ZQLK^^L;*_OK&RO[ZQNHJ@  FK0  (V_  "
MR0  =-,  &?>  !>\@@ 6?X1 %/_&@%._R,"2?\K T7_,P1!_SH%/O]!!CO_
M1P<X_TX(-?]4"3/_6@DQ_V$*+_]I"RS_<@PJ_WT-*/^(#B;_E0\E_Z$0)/^N
M$2/_NA(B_\H2(O_0$B+_T!(B_] 2(O_0$B+_T!*<L@  CKP  (''  !ST0
M9]T  %GC  !3_08 3?\. $C_%@!#_QX!/_\F CK_+0(W_S,#,_\Y S#_/P0N
M_T0$*_]*!2G_4 4G_U8&)/]=!B+_90<@_VX''?]Y"!O_A0@:_Y()&?^>"1C_
MJ D7_[,)%_^W"1?_MPD7_[<)%_^W"1?_MPF0N@  @L4  '30  !GW   6.,
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M2XUC_TJ,9/])BV3_28MD_TF+9/])BV3_28MD_TG_6A,!_V80 /]Q$0#_>A(
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M3'1S_TQT<_],='/_3'1S_TS_8@X _V\, /Q["@#>A@8 U8X( ,^4"0#'F!$
MOI@C ;66,@:MDS\/II!)&)^,4B"8B5HHDX9A+HZ#:#2)@6\YA7]V/8%]?D%]
M>X9%>GF/279XF4QS=Z1.<7>Q4&]VP5!N=]E0;G?O3VYW_$YN=_]-;W?_3&]W
M_TQO=_],;W?_3&]W_TS_9 T _W(* /!^!@#:B 4 T) ' ,J7" #"FQ  N9LA
M ;&:, :IEST.H91'%YJ14!^4C5@GCHM?+8F(9C.$AFTX@(1T/7N">T%X@(1%
M='^-2'%]ETMM?*).:WRO3VE[OE!H?-50:'SM3VE\^TYI?/]-:GO_3&I[_TQJ
M>_],:GO_3&I[_TS_9@H _W4( .&! @#4BP4 RY,& ,2:!@"]G@X M9\? :R>
M+@6DFSL,G9A%%9:53AZ/DU8EB9!=+(2.9#)_BVLW>HIR/':(>4!RAH%$;X6*
M1VN#E4IH@J!-98&L3F.!O$]B@=%/8H'K3F.!^4UC@?],9(#_2V2 _TMD@/]+
M9(#_2V2 _TO_:0@ ^W@$ -R$ 0#/CP0 QI<% +^=!0"WH0P KZ,< *>B+ 2?
MH#D+F)Y#%)&;3!R*F%0CA)9<*G^48C!ZDFDU=9!P.G&.=SYMC7]":8N(1F6*
MDDEBB9Y+7XBJ35Z(NDY<B,Y.78CI35V'^$Q=A_]+7H;_2UZ&_TM>AO]+7H;_
M2UZ&_TO_;04 ZGP  -6(  #*D@, P9H# +F@ P"QI@D J:<9 **G*0.:I38)
MDJ-!$HNA2AJ$GU(A?IU:*'F;8"YTF6<S;Y=N.&N6=3QGE'U 8Y.&0V"1D$9<
MD9Q)6I"I2UB0N$Q7D,Q,5Y#G2U>/]TI7CO]*6([_25B._TE8CO])6([_25B.
M_TG_<0$ X(   ,^,  #$E@( NYX" +*D  "IJ@4 HJP5 )NL)@*4JS0'C*H_
M#X6H2!=^IE >>*18)7.B7BMNH64P:I]L-&6><SEAG7L\7IN$0%J:CD-7F9I%
M5)FG1U*9MDA1F<I(49CF2%&7]4A1E_]'49;_1U&6_T=1EO]'49;_1U&6_T?V
M=P  V(4  ,F1  "_FP$ M*(  *NH  "AL   FK(1 )2S(@&-LC %A;$\#'ZO
M1A1XKDX;<JQ6(6VK7"=HJ6,L9*AJ,&"G<31<IGDX6*6".U6DC#Y1HYA 3Z.E
M0DVCM$-,H\A#3*/D0TNA]$-+H/]$2Z#_1$N@_T1+H/]$2Z#_1$N@_T3C?0
MSXL  ,*6  "WGP  K:8  *.M  "9M0  D+D. (NZ'@&$NBT#?;DY"7>X0Q!Q
MMDP7:[53'6:T6B)BLV$F7K)H*UJQ;RY6L'<R4["!-4^OBSA,KY<Z2JZD/$BN
MLSU'KL<]1Z[C/$:M\SU&J_X^1:O_/T6K_S]%J_\_1:O_/T6K_S_:@P  QY$
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M(#G7[R XU?DB-]3_(S?4_R,WU/\C-]3_(S?4_R.YG   JZ0  )^L  "3M0
MA[X  'O&  !PS@, 9=8' %WC#@!:XQL 5N,G 5+D,@).Y#P$2N1$!D?E30A%
MY54*0N5<#$#E9 X^YFP0.^9V$CGF@!0WYXP5->>9%C3GJ!<RZ+@8,NC,&#'H
MY1@QYO08,>7\&#'E_!@QY?P8,>7\&#'E_!BNH@  H:H  )2S  "(O0  >\8
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M!1'_O 41_[P%$?^\!1'_O 6,N   ?<(  &_,  !BV   5-\  $?E   ^\0
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M.:-3_SFB4_\YH53_.*%4_SBA5/\XH53_.*%4_SC_3Q0!_UD0 /]C$@#_:A0
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M$0#9?1@ SGTJ L5[.0:^=T4.MW10%;%P61RM;6(BJ&II)Z5H<2RA9G@OGF2
M,YMBAS:888\XEF"8.Y-?H3V17JL_CUZX0(U>R$&+7N%!BE_S0(E?_S^)8/\^
MB&#_/HA@_SV(8/\]B&#_/8A@_SW_5P\ _V(, /]L# #X= P Z7H, -Y^# #2
M@14 R($G <!_-@:X?$(-LGA-%:QU5ANG<E\BHF]F)YYL;BR;:G4PEVA\,Y1G
MA#:198PYCF25/(QCGCZ)8JA AV*U0H5BQ4*$8MY#@V/Q0H)C_4&"9/] @F3_
M/X)D_S^"9/\_@F3_/X)D_S__60X _V0+ /]N"@#J=P@ VWT( -2""@#,A!(
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M/7EPED!V;Z%"=&ZN1')NO45P;M%%<&_K1'!O^D-Q;_]!<6__0'%P_T!Q</]
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M05N$M$):A,=#6H3C0EJ#]$%;@_] 6X/_0%N#_S];@_\_6X/_/UN#_S__:@
MWG@  ,V#  #"C   N9,  +"8  "GG0( H)\2 )F?(P&3GC$%C)T\"X6;1A)_
MF4X8>I=6'G6672-PE&,H;))J+&B1<3!ED'DT88Z"-UZ-C#I:C)<]6(RD/U:+
MLD!4B\5 5(OA0%2*\S]5BOX_58G_/E6)_SY5B?\^58G_/E6)_S[O;P  UGP
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M,D2H[S)#I_LS0Z;_,T.E_S1#I?\T0Z7_-$.E_S30@0  P8X  +68  "IGP
MGJ4  ).L  "(L@  ?+D" ':Z$0!RNR$ ;KLN FB[.@9DND,*7[I,#ENY4Q)7
MN%H65+AA&5&W:1Q.MW$?2[9Z(DBVA"5%MI G0[6=*4&UK"I MKXJ/[;8*C^T
M[BH^L_HL/;+_+3VQ_RT]L?\M/;'_+3VQ_RW'B0  N94  *R=  "AI   EJL
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M#RS?_1 LW_T0+-_]$"S?_1"HH   G*<  (^P  "#N   =L$  &K)  !>SP
M4]4! $G<!@!%Z0\ 0ND9 $#J)  ]ZBX .NLV 3CL/@$V[$8",^U- S'M50,O
M[ET$+>YE!2ON< 4I[WL&*.^)!R;PEP<E\*<()/&X""/QS @B\N4((O#S""+O
M]0@B[_4((N_U""+O]0B>I@  D:\  (2X  !WP0  :LD  %W0  !1UP  1MT
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M(\!!_R2^0?\DO4'_);U!_R6]0?\EO4'_);U!_R7_0A@!_TD3 /]0% #_5AD
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M,)14_S"45/\PE%3_,)14_S#_3PX _U@+ /]@"P#[9@P \&L- .1M#@#6;A8
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M.&EOM3IH;\<Z9V_B.F=O]#AH;_\W:&__-FAO_S9H;_\V:&__-FAO_S;_7@
MY&H  --T  #(?   OX$! +>% 0"OAP< J(D5 *&))0&;B#,$E(8^"8Z$1P^)
M@5 5A']7&G]^7AY[?&4B>'IL)G1Y<RIQ>'LM;G>$,&MVCC-H=9DV9G2E.&1S
MLSEB<\0Z8G/@.F)S\SAC<_\W8W/_-F-S_S9C<_\V8W/_-F-S_S;_80  X&T
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M-5&&[C52A?LT4H7_-%*%_S-2A?\S4H7_,U*%_S/C;   SGD  ,&#  "VBP
MK)$  **5  "7F0  CYL+ (J=& "$G2<!?IPT!'F;/@ASFD<-;YE/$FJ85A=F
MEUT;8Y5C'E^4:B)<DW(E69)[*%61A2M2D9 N4)"=,$Z0JS%,D+PR3)#3,DR/
M[3),COHR3(W_,4R,_S%,C/\Q3(S_,4R,_S'<<0  R'X  +N(  "QD0  II8
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M(CJL_R,ZK/\C.JS_(SJL_R/ A@  LY(  *>9  "<GP  D*8  (2L  !YL0
M;;<  &&\!0!=O1( 6KX@ %B^+0%4OC@"4;Y"!$Z^2@9,OE((2;Y9"D:^8 Q$
MOF@.0;UQ$3^]?!,\O8@5.KV5%CB]I!<WO;48-KW*&#>\YQ<UN_89-;K_&C2Y
M_QLTN?\;-+G_&S2Y_QNXCP  JI@  )^?  "3I@  AZP  'NS  !ON0  8[X
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M QOI^0.:I   C:P  '^U  !RO0  9<4  %G+  !,T   0=4  #C<   OX0(
M+?$- "OQ$P H\AP )O(D "3S*P B]#( (?0Y !_U00 =]4D &_91 !GW6@$7
M]V4!%?AR 13Y@0$3^9(!$OJB A'ZLP(0^\8"$/O= A#[Z0(0^^D"$/OI A#[
MZ0*/JP  @;0  '.]  !FQ@  6<T  $O3  ! V0  -=X  "SC   F\0  )/X*
M "'_$  ?_Q8 '/\< !G_(@ 7_R@ %?\N !/_-0 2_SP $/]#  [_3  -_U8
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M'JQ!_QZL0?\>K$'_'JQ!_Q[_0A$ _T<- /]/#@#_4Q$ _U85 /-7' #H5B4
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M+79>M2YU7L8O=%[A+W1?\RYT7_\L=&#_*W1@_RMT8/\K=&#_*W1@_RO_4P
MZ%X  -EG  #+;0  PW$! +MS @"U<PD K747 *=U)P&A=#0#FW(_!Y5P20N1
M;E(0C&Q9%(EJ8!B%:6<;@FAN'G]F=2%]97TD>F2%)G=DCREU8YHK<F*E+7!B
MLR]O8L0O;F+>+VYC\BYN8_XM;F/_+&YC_RMN8_\K;F/_*VYC_RO_50  Y6
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M8VO8,&-K[R]D:_PM9&O_+65K_RQE:_\L96O_+&5K_RST6P  W68  ,MO  #
M=@  MWL  *]^  "F?@$ GW\0 )F 'P"3@"T"C7\Y!8A]0PF#>TL-?GI3$GIX
M6A9V=V$9<W5G''!T;A]M<W8B:G)_)FAQB2AE<)0K8G"@+6!OK2]?;[TO7F_4
M+UYO[2]?;_LM7V__+&!O_RQ@;_\L8&__+&!O_RSK7@  V&D  ,=R  "\>0
MLW\  *N"  "A@@  F8,. )2$'0".A"L!B(,V!(."0 A^@$D,>7]1$'5]6!1R
M?%\8;GME&VMZ;!YH>70B97A])6)WAR=@=I(J776>+%MUJRY:=+LO6771+UET
M["Y9=/HM6G3_+%IT_RM:=/\K6G3_*UIT_ROF80  T6T  ,-V  "Y?0  KX,
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M)TF'_R=)A_\G28?_)TF'_R?1;P  P7L  +6$  "KC   H)   )64  ")EP
M?IH  '>;#@!SG!P ;YTI 6N<-0)FG#\%8IM'"%^:3PM<FE8/6)E<$E688Q53
MF&L74)=S&DV6?1U*E8D?1Y65(465I"-$E+,C0Y3((T.4Y2-#DO4D0Y'_)$.0
M_R1#D/\D0Y#_)$.0_R3*=0  NX$  +"+  "DD0  FI4  (^9  "#G0  =*(
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M$S"S_Q.RC@  I94  )J;  ".H@  @J@  '6M  !ILP  7K<  %.[  !'P 4
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M !CDB $7Y9H!%N:L 17FP $4Y]T!$^7O 1/C^@$3X_H!$^/Z 1/C^@&6H@
MB:D  'NQ  !NN0  8<   %3&  !(R@  /<\  #/3   JV0  (MX" ![K"@ <
M[!  &^T7 !GM'P 7[B8 %>XM !3O-0 3\#T $?!& !#Q4  /\EL #O)I  WS
M>  ,](H "_6<  KUK@ )]L( "?;9  CU[0 (]>T "/7M  CU[0"+J0  ?;(
M &^Z  !BP@  5<D  $?.   [T@  ,=@  "?=   ?X0  &>@  !;X!@ 4^@T
M$OL2 !#\%P ._!T #?TC  S]*0 *_C  "/\X  ;_00 #_TP  /]8  #_9@
M_W<  /^)  #_FP  _ZL  /^[  #_S@  _\\  /_/  #_SP!_L@  <;H  &/#
M  !6RP  2-$  #K6   OW0  )>$  !SE   4Z0  $?<   __ 0 -_PD "_\-
M  C_$  &_Q0  _\8  #_'@  _R,  /\J  #_,@  _SP  /]'  #_5   _V,
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M2D@"Q$A3!,!'70>\1F8)ND1N"[=#=@VU0WT.LT*$$+%!BQ&P09(2KD":$ZQ
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M'XA.MR"'3L@AA4[B(81/\R"#3_\@@T__'X)0_Q^"4/\>@E#_'H)0_Q[_1P
M\U$  -]8  #170  R6 " ,-@! "]7@T M6 : *YA*@"I8#<"I%Y#!)]=30B;
M6U4+F%E=#I589!&25VL3CU9R%HU5>1B+5($:B%.)'(93DAZ$4IP?@E*G(8!2
MM")_4L0C?5+>(WQ3\2)\4_XA>U3_(7M4_R![5/\@>U3_('M4_R#_2@  Z50
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M)FE>["5J7_LD:E__(VI?_R)J7_\B:E__(FI?_R+P4@  W5T  ,ME  # :P
MMVX  *]O  "G;@$ H&\0 )IP'P"4<"P!CV\X XIM0@:&;$L)@FI2#'YI60][
M:& 2=V9F%'5F;A=R974:<&1^'6UCB!]K8Y(B:6*>)&=BJR5E8KHF9&+/)F1B
MZB9E8OHD96/_(V5C_R)E8_\B96/_(F5C_R+K50  V&   ,AH  "\;@  LW$
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M(U9O_R)7;_\B5V__(E=O_R+?7P  RFD  +QR  "R>   J7T  )]_  "2?@
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M&S^+_QO"<P  M7X  *J'  "?C   E)   (B3  ![E0  ;)D  &6;! !@G!
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M!R^QE@@NLJ8(+;*X"2RRT @LL.P)*Z_Y"BNN_PLJK?\+*JW_"RJM_PNMBP
MH)(  )68  ")G0  ?:,  '&H  !DK0  6;$  $VT  !"N   .[H* #B[$P W
MO!X -;PI #2],@ SO3L ,KU$ #&^3  OOE4!+KY> 2R^: $JOG0"*;Z" B>_
MD0,FOZ(#)+^T R._RP,CON@#([SW!"*[_P4BN_\%(KO_!2*[_P6DD@  F)@
M (R>  " I0  <ZL  &>P  !;M0  3[D  $2\   ZP   ,,0$ "K'"P HR!,
M)\D= ";))P ER3  ),HY "/*0@ BRTL (<M5 "#,7P ?S&P '<UZ !S-B@ ;
MS9P &<ZN 1C.Q0 8S>0 &,ST 1C*_ $8RO\"&,K_ AC*_P*;F0  CY\  (*F
M  !UK0  :+,  %RY  !0O0  1,$  #G$   PR   *,P! "#0!@ 9U0L %M<0
M !78&0 5V2( %-DK !/:-  3VCT $MM( !'<4P 1W5\ $-UM !#>?@ .WY$
M#N"D  W@N  ,X-( "]_M  S>]P ,W?L #-W[  S=^P"2GP  A:<  '>N  !J
MM0  7;P  %#!  !$Q0  .,D  "[-   ET0  'M4  !;: 0 1W@8 $.<-  [G
M$@ -Z!D #.@A  OI*0 *ZC$ ">H[  ?K10 %ZU$ !.M>  /K;@ !ZX   .J4
M  #JIP  Z[P  .O2  #KZ0  [.\  .SO  #L[P"'IP  >:\  &NW  !>O@
M4<4  $/)   WS0  +=$  "/6   ;VP  $]\   [C   ,[@( "O8*  ?V#@ %
M]A(  _88  #U'@  ]24  /4N  #U-P  ]D(  /9.  #V70  ]FX  /:!  #V
ME0  ]Z<  />W  #XQP  ^-   /C0  #XT ![KP  ;;@  &#   !2R   1,T
M #?1   KUP  (=P  !C@   1Y   #.<   ?O   $^@   ?\#  #_"   _PT
M /X0  #^%   _QH  /\A  #_*0  _S,  /\^  #_2P  _UL  /]L  #_@
M_Y(  /^A  #_K0  _[,  /^S  #_LP#_'"8 _QPD /\:)0#_%2< _Q$N /\0
M.@#_#D<!_PU3 ?\+7P'_"FL!_PIU ?\*?P'_"H<!_PJ. ?\*E0'_"IL!_PF@
M ?\)I0#_":L _PFQ /\)N #_"<$ _@G, /P)W@#Y">L ]0GV /,)_P#R"O\
M\0K_ ?$+_P'Q"_\!\0O_ ?$+_P'_'R, _Q\A /\>(0#_&20 _Q<L /\5-P#_
M$T0 _Q%0 ?\07 '_#F<!_PYR ?\.>P'_#H0!_PZ+ ?\.D@'_#I@!_PZ= ?\.
MHP'^#J@!_ ZN ?L.M0#Z#KX ^ [) /4.VP#R#NH [@[U .P._P'K#_\!Z@__
M >H0_P'I$/\!Z1#_ >D0_P'_(A\ _R(< /\A' #_'R  _Q\I /\<- #_&D
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M";DJ_PG_, \ _S(+ /\V#0#_.!  _SD5 /DW'@#O-2@ YS,U . R0@#;,D\
MU3%: = Q9 +-,&T"RS!U \DP? /'+X,$Q2^*!,0OD07"+Y<%P2^>!K\OI@:]
M+Z\&O"^Y![HOQP>X,-T'M3#N";(P^PJP,/\+KC#_"ZXP_PNM,/\+K3#_"ZTP
M_PO_,PP _S8& /\\"0#_/@P _3T0 .\\%0#D.1\ VSDM -(Z/ #-.DD!R#E4
M <0Y7@+!.&<#OS=O!+TW=@6[-GT&N3:$![<VBP>V-9((M#6:";,UH0FQ-:H*
MKS6T"ZXUP0NL-=0+J3;J#*8V^ VE-O\.HS?_#J(W_PZB-_\.HC?_#J(W_P[_
M-P< _SL" /]  P#R0@4 Z4() .4_#@#8/A8 SD G ,=!-@#"040!O4%/ KE
M60.V/V$$M#YI!K$]<0>O/7@(KCQ_":P\A@JJ.XT+J3N5#*<[G0VE.Z8-HSJP
M#J([O ^@.\T/GCOF$)L\]1&://\1F3S_$9@\_Q&8//\1F#S_$9@\_Q'_.@$
M_T   .]%  #A2   V4@% --&"0#,11( Q$<B +U(,0"X2#\!LT=* K!&5 2L
M15T%JD1D!Z=#; BE0G,*HT)Z"Z%!@0R@08@-GD"0#YQ F!":0*$1F$"L$I=
MN!*50,@3DT#A$Y%!\Q200?\4CT'_%(Y"_Q..0O\3CD+_$XY"_Q/_/   ^40
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M&G=.ZQIW3_H9=D__&79/_QAV3_\7=D__%W9/_Q?X1@  XE   -!7  #$7
MNUX  +1=  "N6@8 IEL3 *!<(@";7"\ EUL[ I):10./64T&BUA5"(A77 J&
M5F,,@U5J#H%4<1!^5'@2?%. %'I2B19X4I08=E*?&712JQIR4KH;<5+-''!2
MZ!MP4_D:<%/_&G!3_QEP4_\8<%/_&'!3_QCO20  W5,  ,M:  # 7P  MV(
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M&V!>_QIA7O\:85[_&F%>_QKD4@  SUP  ,!D  "V:0  K&P  *-L  "9:0
MDFH+ (QJ%@"':R0 @FLP 7YJ.@)Z:4,$=FA+!G-G4@AP9UD*;69@#6ME9@]H
M9&X19F1V%&1C@!9B8XL88&*7&EYBI!Q<8K(=6V+%'5MBX1U;8O0<6V+_&UQB
M_QI<8O\:7&+_&EQB_QK@50  RU\  +UG  "R;   J7   )]O  "4;   C&T(
M (9N$P"";R$ ?6\M 7EO. )U;D$#<FU)!6YL4 =K:U<*:6M>#&9J90YD:6P1
M86ET$U]H?A9=9XD86V>5&EEFHAM79K <5F;#'59FWQU69O,<5V;_&U=F_QI7
M9O\:5V;_&E=F_QK;60  QV(  +IJ  "O<   IG,  )IS  "/<   AW$% (%R
M$0!\<QX >',J '1S-0%P<S\#;7)'!6IQ3@=G<54)9'!<"V)O8PY?;VH076YR
M$EIM?!58;8875FR3&51LH!M2:Z\<46O!'%%KW!Q1:_$;4FO^&E)J_QI2:O\9
M4FK_&5)J_QG47   PV8  +9N  "L=   HG<  )9V  ")=0  @78! 'IW#P!V
M>!L <GDG &]Y,@%K>#P":'A$!&5W3 9B=U,(7W9:"EUU80Q:=6@/6'1P$55S
M>1-3<X0647*0&$]RGAE-<:T:3'&_&TMQV1M,<? :3'#]&DUP_QE-;_\936__
M&4UO_QG.8   OFH  +)R  "H>   G7L  )!Z  "$>@  >GL  '1\# !O?A<
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M#SZ*F!$\BJ<2.XJX$CJ*SQ([B.L2.X?Z$SN&_Q,[AO\3.X;_$SN&_Q.\<0
MKWL  *6#  "9AP  C(@  '^)  !SC   99   %R3  !7E0P 5)86 %*6(@!0
MERT 39<V $N7/P%)ET<"1Y=. T66501#EET%099E!CZ5;P@\E7H).I6'"SB5
ME0PVE*4--92V#C24S TTD^D--)+X#C20_P\TD/\/-)#_#S20_P^U>   JH(
M )Z(  "3C0  AHX  'F0  !MDP  89<  %6;  !-G@8 29\0 $>?&P!&H"8
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M 1RYP $<N-\!'+;R 1NU_ (;M/\"&[3_ ANT_P*?CP  E)4  (B;  ![H0
M;J8  &*K  !6L   2K,  #^V   UN0  ++P  "2_!@ ?P@T '<(4 !S"'@ ;
MPR8 &L,O !G$.  8Q$$ %\1* !;%50 5Q6$ %,9O !/&?P 2QI$ $<>D !#'
MN0 /Q]0 $,;N !#$^@ 0P_\ $,/_ !##_P"7E@  BYP  'ZB  !QJ0  9*\
M %BT  !+N   0+L  #6^   KP0  (\4  !O) 0 4S 8 $- +  [1$0 -T1D
M#=$A  S1*@ ,T30 "](^  K220 )TU4 "=-B  C3<@ &U(0 !=28  34JP #
MU<   =7<  '5[0 !U?8  =7V  '5]@".G0  @*0  '.K  !FL0  6;@  $R]
M   _P   -,,  "K'   AR@  &<X  !+2   -U@$ "=L%  ;<#0 $W!$  ]T8
M  '>(   WB@  -\Q  #@/   X4<  .)4  #C8P  XW0  .2(  #DFP  Y:X
M .7!  #EU0  YN<  .;G  #FYP"#I   =:P  &BS  !:NP  3<$  $#$   S
MR   *,P  !_0   7U   $-D   O=   %X0   .0   #E!P  Y@T  .<1  #H
M%@  Z1T  .HE  #K+@  [3D  .]%  #P4P  \60  /%V  #RB@  \YP  /.M
M  #TNP  ],@  /3(  #TR !WK0  :K4  %R]  !/Q   0,D  #/-   GT0
M'=8  !3<   .X   ".,   'F    Z@   .X   #N    [P0  / *  #Q#@
M\Q(  /08  #V(   ^"H  /HU  #]0P  _E(  /]C  #_=@  _XD  /^:  #_
MI@  _[   /^P  #_L #_%B, _Q4A /\1(0#_#20 _PDK /\&-P#_ T0 _P!1
M /\ 70#_ &@ _P!R /\ >P#_ (, _P"* /\ D0#_ )8 _P"< /\ H0#] *8
M^P"L /D LP#W +L ]0#% /, T0#R .0 \0#Q .\ ^@#N /\ [@#_ .T _P#M
M /\ [0#_ .T _P#_&2  _Q@= /\5'0#_$!\ _PXI /\,- #_"D$ _P=- /\%
M60#_!&0 _P1N /\#=P#_ X  _P.' /\#C0#] I, ^P*9 /D"G@#W J0 ]0*J
M /,!L #Q ;@ [P'" .T!SP#K >, Z@'O .@"^P#G!/\ Y@7_ .8&_P#F!O\
MY@;_ .8&_P#_'!L _QL9 /\7& #_%1T _Q,E /\1, #_$#T _PY) /\,50#_
M"V  _PMJ /T+<P#["WP ^0J# /<*B@#U"I  ] J6 /,*FP#Q"J$ [PFG .T)
MK@#K";8 Z G  .8)S0#D">( X@KP -\+^P#>#/\ W W_ -P-_P#;#?\!VPW_
M =L-_P'_'Q< _QX3 /\;$@#_'!D _QLB /\8+ #_%3@ _Q-$ /X24 #Y$5L
M]1!F /,0;P#P$'< [A!_ .P0A@#J$(P Z1"2 .@0F #F#YX Y0^E .,/K #A
M#[0 X ^^ -X/S #:$.$ U1'P -(2^P#/$O\!SA/_ <T3_P'-$_\!S!/_ <P3
M_P'_(A( _R(/ /\A#P#_(A0 _R(< /\@)P#_'3( ^!L^ /(92P#N&%8 ZA=@
M .<6:@#D%G( XA9Z . 6@@#>%H@ W!:/ -L6E0#9%IL UA:B -06J0#2%K$
MT!>[ ,X7R0#,&-X R!GN <4:^P'#&O\"P1O_ L ;_P+ &_\"P!O_ L ;_P+_
M)@X _R4+ /\H# #_*1  _R@6 /XF( #T)"L ["$X .8@1 #A'U  W1]; -D>
M90#5'FT TA]U - ??0#.'X, S!^* <L?D ')'Y<!R!^> <8?I0'%(*T!PR"W
M <$@Q ' (=8!O"+J KDB^ .V(O\#M2/_ [0C_P2S(_\$LR/_!+,C_P3_*0L
M_RH% /\N" #_+PP _RT0 /,K%P#H*"( X"8O -DF/0#2)TH S2=5 ,HH7P#'
M*&@!Q2AO <,G=P'!)WX!OR>$ ;XGBP*\)Y("NR>9 KDGH *W)ZD#MBBS [0H
MOP.S*,\#L"GF!*TI]@2K*O\%J2K_!J@J_P:H*O\&J"K_!J@J_P;_+04 _S
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M#(P\[ V*//L-B3S_#8D\_PR(//\,B#S_#(@\_PS_-P  ZC\  -Q%  #.20
MQ4D  +]& @"Z0PP LT09 *U%)P"H1C4 I$5! :!%2P*=1%,"FD-; YA#8@66
M0FD&E$%P!Y)!=@B00'X)CD"&"HU C@N+0)@,B4"B#8= K@Z%0+P/A$#/#X)!
MZ0^!0?D/@$'_#X!"_PZ 0O\.@$+_#H!"_P[Z.P  Y40  --+  #'3@  OD\
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M$FM._Q)K3O\1:T[_$6M._Q'H1@  TU   ,16  "Y6@  L%P  *9:  "?5@
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M$E==_Q+64P  Q%P  +=C  "L:   H&@  )5G  "*8P  @V4" 'UF#P!X9AH
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M$$IMF!%);*<22&RX$T=LS1-';.H32&OZ$DAK_Q)(:O\12&K_$4AJ_Q''7@
MN&<  *QN  "A<@  DW(  (=Q  !Z<0  <7(  &MT!P!F=1$ 8W8= &!W* !>
M=S, 6W@\ 5EW0P)6=TL#5'=2!%)V6050=F '3G5H"$MU<0I)='P,1W2(#D5S
ME@]#<Z400G.V$4%SRQ%"<N@10G+X$4)Q_Q!#</\00W#_$$-P_Q#!8P  LVP
M *AS  ";=@  CG4  (%V  !U=@  :7@  &-Z @!>? X 7'T9 %E^) !7?R\
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M!R^.PP<OCN$'+XST""^+_P@OBO\(+XK_"2^*_PFP=@  I7\  )B$  "*A
M?84  '"'  !EB@  6HX  $^2  !&E0  09@, #Z8%  ]F1\ .YDH #J:,0 Y
MFCH -YI" #::2@ UFE(!,YI: 3&:9 $OFF\"+9I[ BR:B@,JFIH#*9JL!"B:
MP 0GF=X#)Y?R!">6_04GE?\%)Y7_!2>5_P6I?@  GH4  )*)  "$B@  =HP
M &J/  !>DP  5)<  $F;  ! GP  -Z($ #*C#@ QHQ< ,*0A "ZD*@ MI#(
M+*4Z "NE0P JI4L *:54 "BE7@ FI6D ):5V 2.EA0$BI98!(*:H 1^ENP$>
MI=<!'J3O 1ZB^P(>H?\"'J'_ AZA_P*BA@  EXP  (N/  !]D0  ;Y0  &.8
M  !7G0  3:$  $.E   XJ   ,*L  "BN!P DKQ  (Z\7 "&O(0 @L"D '[ Q
M !ZP.@ =L4( '+%, !NQ5@ :L6$ &;)O !BR?@ 6LI  %;*B !2RM@ 3LLX
M$['K !.O^0 3KO\!$Z[_ 1.N_P&:C0  D)(  (27  !UF@  :)\  %NC  !0
MJ   1:P  #NP   QL@  )[4  ""X   8N@< %+P. !.\%0 2O!X $;TF !&]
M+@ 0O3< $+Y!  Z^3  .OE< #;YE  R_=  +OX8 "KZ9  B^K  'OL( ![[?
M  B^\  (O?H "+W\  B]_ "3E   AYD  'J?  !LI0  8*H  %.O  !'LP
M/+8  #&X   GNP  '[X  !?!   1Q $ #,@(  C)#@ 'R10 !LD<  7))  $
MRBP  \HV  +*0   RTP  ,M9  #+:   RWD  ,R,  #+GP  R[,  ,O(  #,
MX@  S.\  ,SQ  #,\0"*F@  ?*$  &^G  !BK0  5;,  $BX   [NP  ,+X
M ";!   =Q   %<@   _+   *S@  !-("  #3"@  TP\  -04  #5&@  UB(
M -<J  #9-   VC\  -Q+  #<6@  W6H  -U]  #=D0  W:0  -ZV  #>R
MWMX  -[B  #>X@!_H@  <:D  &2P  !6MP  2;P  #S    OQ   ),<  !O+
M   3SP  #=(   ?6    VP   -X   #? P  X D  .$.  #B$@  XQ<  .4>
M  #F)P  Z#$  .H]  #L2P  [%H  .UL  #N@   [I0  .ZE  #NM   [L(
M .[&  #NQ@!TJ@  9K(  %BY  !+P   /<4  "_)   DS0  &=$  !'6   +
MVP   ]X   #A    Y0   .@   #I    Z@   .L&  #M"P  [P\  / 3  #R
M&@  ]",  /<N  #Y.P  ^TH  /Q;  #];0  _8   /Z3  #^H@  _JT  /ZO
M  #^KP#_$!\ _PX= /\*'0#_ 2  _P H /\ -0#_ $$ _P!. /\ 6@#_ &4
M_P!N /\ =P#_ '\ _@"& /P C #[ )( ^0"7 /@ G #W *( ]@"G /4 K0#S
M +4 \@"] /$ R0#O -P [@#K .T ]P#L /\ ZP#_ .H _P#J /\ Z@#_ .H
M_P#_$QP _Q$9 /\-&0#_!AP _P,E /\ ,0#_ #X _P!* /\ 5@#_ &$ _P!K
M /T <P#Z 'L ]P"# /4 B0#T (\ \@"4 /$ F0#P )\ [@"D .T JP#L +(
MZ@"Z .@ Q@#G -8 Y0#H .0 ]0#C /X X@#_ .$ _P#A /\ X0#_ .$ _P#_
M%1@ _Q,4 /\/% #_#1D _PLB /\(+0#_!#D _P%& /\ 40#^ %P ^@!F /8
M;P#R '< [P!^ .T A0#K (L Z@"1 .@ E@#G )P Y@"A .0 J #C *\ X0"X
M -\ PP#= -$ VP#F -D \P#7 /T U0+_ -0"_P#4 _\ U /_ -0#_P#_&!,
M_Q40 /\2#P#_$A4 _Q$= /\.* #_##0 _PI! /D(3 #U!E< \09A .T&:@#I
M!7( Y@5Z .0%@0#B!8< X :- -\&D@#=!I@ VP:> -D&I0#7!JT U :U -(&
MP #0!\\ S@CE ,P)] #*"_\ R S_ ,<,_P#'#/\ Q@S_ ,8,_P#_&PX _QD,
M /\8#0#_&!$ _Q<8 /\4(@#[$2X \Q Z .T.1@#H#5( Y0U< .$-90#>#6T
MVPUU -@-? #5#8( TPV) -$-CP#0#94 S@V< ,T.HP#+#JL R0ZT ,@.P #&
M#L\ PQ#F , 1]0"]$O\ O!+_ +L2_P"Z$O\!NA+_ ;H2_P'_'PH _QP$ /\?
M" #_'PT _QT2 /@:&P#N%B8 YA0S . 3/P#:$TL U!-6 - 37P#.%&@ RQ1O
M ,D4=P#'%7T QA6$ ,05B@##%9$ P1:8 , 6GP"^%J< O!>P +L7O "Y%\L
MMQCB +,9\@&Q&O\!KQO_ :X;_P&N&_\!K1O_ :T;_P'_(@0 _R(  /\E @#\
M) < ]R$, .P=$@#A&AP V!HJ - ;. #+'44 QQU0 ,,>6@# 'F( OAYJ +P?
M<0"Z'W@ N1]^ +<?A0"V'XP M!^3 +,?F@&Q(*,!L""L :X@MP&L(<8!JR'=
M :<B[P*E(OT"HR/_ J(C_P*B(_\"H2/_ J$C_P+_)0  _R@  /(J  #E*P
MWR@% -PA"P#2(10 R20D ,,E,@"^)C\ NB=* +<G5 "T)UT LB=D + G; "N
M)W(!K2=Y :LG?P&J)X8!J">. :<GE@*E)YX"HRBH J(HLP*@*,$"GRC5 IPI
M[ .:*OH#F"K_!)<J_P27*O\$EBK_!)8J_P3_*   ]2X  .4S  #:-0  T#,!
M ,PM!@#&*A  OBT> +@N+ "S+SH KR]% *PP3P"I+U@ IR]? :4O9@&C+VT!
MH2]S J N>@*>+H$"G2Z) ILND0.9+IH#F"ZD!)8OKP25+[T$DR_/!)$PZ 6/
M,/@%C3'_!8TQ_P6,,?\%C#'_!8PQ_P7_+0  ZC4  -PZ  #./0  QCP  , W
M @"[,PT LS09 *XV)P"I-S0 I3=  *(W2@"?-U,!G39: 9LV80&9-F@"ES5O
M I4U=0.4-7P#DC6$!) UC02/-98%C36@!8LUJP:*-;D&B#7*!X<VY0>%-O8'
MA#?_!X,W_P>#-_\'@C?_!X(W_P?T,@  XSL  -)!  #&1   O4,  +<_  "Q
M.PD JCL4 *4\(@"@/3  G3T[ )D]10"6/4X!E#Q6 9(\70*0/&,"CCMJ XP[
M<02*.W@$B#J !8<ZB :%.I(&@SJ<!X$ZJ B .K4)?CO&"7T[X0E[//,)>SS_
M"7H\_PAZ//\(>CS_"'H\_PCN-P  W4$  ,M&  "_20  MDD  *Y&  "I000
MHT$1 )U"'@"80RL E4,W )%#00".0DH!C$)2 8E!60*'05\#A4%F X- ;02!
M0'0%@$![!GX_A =\/XX(>C^9"7@_I0IW0+(*=4##"W1 W0MS0?$+<D'_"G)!
M_PIR0?\)<D'_"7)!_PGI/   U44  ,5+  "Z3@  L$X  *=+  "B1@  FT8.
M )9'&@"12"< CD@S (I(/0"'1T8!A$=. 8)&50* 1EP#?D5B!'Q%:01Z17 %
M>$1X!G9$@0AT1(L)<D26"G!$H@MO1*\,;D3 #&U%V0UL1>\,:T7]"VM&_PMK
M1O\*:T;_"FM&_PKE0   STD  ,%/  "U4@  JU(  *%/  ";2@  E$H, (]+
M%P"+3"0 ATPO (1,.@"!3$,!?DM+ 7M+4@)Y2E@#=TI?!'5)9@5S26T&<4EU
M!V])?@AM2(@):TB3"VI(GPQH2*T-9TF]#69)U YE2>T-94K\#&5*_PME2O\+
M94K_"V5*_PO@1   RTT  +U2  "R5@  IE4  )Q2  "53@  CDX) (E/% "%
M4"  @5 L 'Y0-P![4$ !>%!( 75/3P)S3E4#<4Y<!&].8P5M36H&:TUR!VE-
M>PAG384*94V1"V1,G0QB3:L-84V[#F!-T0Y@3>P.8$W[#6!-_PQ@3?\+8$W_
M"V!-_PO<1P  QU   +E6  "N60  HE@  )A6  "040  B5(& (-3$0!_4QT
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M"U19F U36*8.4EFV#E%9R@]16><.45CX#5)8_PU26/\,4EC_#%)8_PS-40
MO%D  +!?  "C80  EF   (M?  "!6P  >5T  '-># !O7A4 :U\@ &A?*P!F
M8#4 8V ] 6%?10%?7TP"75]3 UM?6@197F$%5UYI!E5><@A37GT)45V)"U!=
ME@Q.7:0-35VT#DQ=R Y,7>8.35WW#4U<_PQ-7/\,3ES_#$Y<_PS)5   N5P
M *UC  "?8P  DF,  (=B  !\8   =&$  &YB"0!I8Q( 9F,= &-D* !A9#(
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M"CUNP@H\;N */6WT"CUL_PH]:_\*/FO_"CYK_PJZ8   K6D  *!N  "1;0
MA&T  'AM  !L;@  87   %MR  !6= H 4G42 %!V'0!.=R< 3'<Q $MX.0!)
M>$$ 2'A) 49X4 %$=U<"0G=? T!W: ,^=W,$/'9_!CIVC0<Y=IP(-W6M"#=U
MP @V==X(-W3R"#=S_@@W<O\(-W+_"#=R_PBU9@  J6\  )IQ  "+<0  ?G$
M '-R  !H<P  7'8  %1Y  !.>P4 2GT/ $A^& !&?R, 17\L $. -0!"@#T
M08!% #^ 3 $]@%0!/(!< CI_90(X?V\#-G]\!#1_B@0R?YH%,7ZJ!C!^O08P
M?MH&,'WP!C![_08P>_\&,'K_!C!Z_P:P;   I'4  )1U  "&=0  >78  &YW
M  !C>0  5WT  $^!  !'A   0H8, #^'$P ]B!T /(@G #N),  ZB3@ .(E
M #>)2  VB4\ -(E8 3.)80$QB6P!+XEX BV)AP(LB9<#*HBG RF(N@,IB-0#
M*8;N RF%_ 0IA/\$*83_!"F$_P2J=   GGL  (YZ  " >@  ='L  &A^  !=
M@0  4H4  $F)  !!C   .9 % #61#P SDA< ,I(A #&2*0 PDS( +I,Z "V3
M00 LDTH *Y12 "J47  HE&< )Y1S 264@@$DE),!(I.D 2&3MP$@D\\!(9+L
M 2"0^@(@C_\"((__ B"/_P*D?   EX   (=_  ![@   ;H(  &*%  !7B0
M38X  $*2   ZE@  ,ID  "J<"0 HG1$ )IT9 "6=(@ DGBH (YXR "*>.@ A
MGD( ()Y+ !^?50 >GV  ')]M !N??  :GXT &)^? !>?L@ 6G\D %I[H !:<
M]P 6F_\!%YO_ 1>;_P&=@P  CX8  (*&  !TAP  9XL  %N/  !0DP  1I@
M #R<   SH   *Z,  ".F   <J L &JD1 !BI&  7J2$ %JHI !6J,0 4JCD
M$ZI# !.K30 2JU@ $:ME !"K=  .JX8 #JN9  VKK  ,J\$ #*K?  RI\@ -
MJ/P #:C_  VH_P"6B@  B8P  'J-  !LD0  8)4  %2:  !)GP  /Z,  #6G
M   KJ@  (ZX  !NP   4LP$ #[4*  VV$  ,MA8 "[8?  JV)P )MB\ "+8Y
M  >W0P &MT\ !+=;  .W:@ "MWL  +>.  "WH0  MK0  +;+  "VY0  M?$
M +7W  "U]P"/D0  @90  '*7  !EG   6*$  $RF  !!JP  -Z\  "RR   C
MM0  &K@  !.[   .O0  "< %  /!#0  P1$  ,$7  #"'@  PB8  ,(O  ##
M.0  Q$0  ,10  #$7@  Q6\  ,6!  #%E0  Q:@  ,6\  #$T0  Q.8  ,3N
M  #$[@"&F   >9X  &NC  !=J0  4*X  $2S   WM@  ++D  "*\   9OP
M$<(   S%   &R    ,L   #,!P  S T  ,T1  #-%@  SAT  ,\D  #0+0
MTC@  -1$  #44@  U6$  -5S  #6AP  UIL  -:M  #7OP  V,X  -C=  #8
MW0![H   ;J8  &"M  !3LP  1;@  #B\   KOP  (<(  !?&   0R0  "LP
M  +0    U    -<   #8    V@4  -L+  #<#@  WA,  -\9  #A(0  XRH
M .4V  #G0P  YU,  .AD  #I=P  Z8P  .J?  #JK@  ZKH  .K#  #JPP!P
MJ   8J\  %6V  !'O   .<   "S$   @R   %LP   [0   'U    -D   #=
M    X0   .,   #D    Y@   .<!  #I!P  ZPP  .P0  #N%0  \!T  /,G
M  #V,P  ]T,  /A4  #Y9@  ^7H  /J.  #ZG@  ^ZD  /NP  #[L #_"QL
M_P<9 /\ &0#_ !P _P E /\ ,@#_ #\ _P!+ /\ 5P#_ &( _P!K /\ <P#]
M 'L ^P"" /H B #X (T ]P"2 /8 F #U )T ] "B /, J0#Q +  [P"X .X
MPP#L -$ ZP#F .D \P#H /X Z #_ .@ _P#H /\ Z #_ .@ _P#_#A@ _PH5
M /\!% #_ !@ _P B /\ +@#_ #L _P!' /\ 4P#] %X ^@!G /< ;P#U '<
M\P!^ /( A #P (D [P"/ .X E #L )H ZP"? .D I0#H *P Y@"T .0 OP#C
M ,P X0#B -\ \ #> /L W@#_ -T _P#= /\ W #_ -P _P#_$!, _PT1 /\&
M$ #_ A4 _P > /\ *0#_ #8 _P!" /H 3@#T %D \0!B .X :P#L '( Z@!Y
M .@ ?P#G (4 Y0"+ .0 D #B )8 X0"< -\ H@#= *D V@"Q -@ NP#5 ,@
MT@#= -$ [0#0 /D SP#_ ,X _P#- /\ S0#_ ,T _P#_$0\ _PX- /\,#0#_
M"Q( _P<9 /\") #_ #  ]@ \ .\ 20#J %, YP!= .0 9@#A &T WP!T -T
M>P#; ($ V0"& -8 C #4 )( T@"8 -  G@#. *8 S "N ,H N #( ,0 Q@#7
M ,4 Z@## /< P@#_ ,$!_P#  O\ P +_ , "_P#_% L _Q & /\0"0#_$ X
M_PX4 /\*'@#U!BD ZP0V .,#0@#? TX VP17 -8$8 #3!&@ T 1O ,X%=@#,
M!7P R@6" ,D%B #'!8X Q@64 ,0%FP#"!:, P :K +X&M0"]!L( NPC4 +H)
MZ0"W"_@ M0S_ +0,_P"T#/\ M S_ +0,_P#_%P0 _Q0  /\6 P#_% D _Q$.
M /(.%0#H#"$ W@HN -8+.P#0#$< S Q1 ,D,6@#&#6( Q UJ ,(-<0# #7<
MOPU] +T.@P"\#HH N@Z1 +D.F "W#J  M@ZI +0/M "R#\$ L1#4 *X1ZP"K
M$OH J1+_ *@3_P"G$_\ IQ/_ *<3_P#_&@  _QL  /D;  #K&0  Y10& .40
M#@#9#A< SQ$F ,@2- #$$T  OQ1+ +P45 "Y%5T MQ5D +45:P"T%7$ LA5X
M +$6?@"O%H4 KA:, *P6E "K%YP J1>F *<8L "F&+T I!C/ *(:YP"?&O<
MG1O_ 9P;_P&<&_\!FQO_ 9L;_P'_'0  ]R$  .@D  #=)0  U"$! ,\;" #*
M%Q$ PAH@ +P<+0"W'3H LQY% + >3P"M'E< JQY? *D?9@"H'VP IA]S *4?
M>0"C'X  HA^' * @CP"?()@ G2"B )L@K &:(;D!F"'* 98BY &4(_4!DB/_
M 9$C_P&0(_\!D"/_ 9 C_P'_(@  ZRD  -TN  #/+P  QRT  ,$G P"](@T
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M!6P\_P7B.0  S$(  +Y'  "Q2   I48  )U#  "7/P  DCX+ (T_%0")/R$
MA4 M () -P!_0$  ?4!( 'M 3P%Y0%8!=S]= 74_8P)S/VH"<3]R W _>@-N
M/X0$;#^0!6L_G 9I/ZD&:#^X!V= S =F0.@'9D#Y!F5 _P9E0/\&94#_!65
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M!EY(EP==2*4(6TBT"%M(QPE:2.0(6DGV"%I)_P=:2/\&6DC_!EI(_P;110
MOTP  +)2  "C40  EU   (U.  "&2@  @$H! 'I+#@!V3!< <DPC &],+0!M
M338 :DP_ &A,1@!F3$T!9$Q3 6),6@)A3&$"7TQI UY,<@1<3'P%6DR(!EE,
ME0=73*,(5DRR"%5,Q@E53.()54SU"%5,_P=53/\'5DS_!E9,_P;,2   O%
M *]5  "@5   DU,  (E1  "!30  >DX  '5/# !P3Q4 ;5 @ &I0*@!G4#,
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M"$=8P A'6-T(1UCR"$=7_P=(5_\'2%?_!DA7_P;!40  LED  *-<  "46P
MAUL  'U:  !R6   :UD  &5: P!@6PX 75P7 %I<(0!872L 5ETT %1>/ !3
M7D0 45Y+ 5!>4@%.7ED"3%YA DM=:@-)770$1UV !45=C09$79P'0UVL!T)=
MO@A"7=H(0ESQ!T)<_@=#6_\&0UO_!D-;_P:]50  KUT  )]?  "07@  @UX
M 'A=  !M7   95T  %]?  !:8 P 5V$4 %5B'@!28B@ 46,Q $]C.0!.8T$
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M!#%N^P0Q;?\$,6S_!#%L_P2O9   H6D  (]H  "!:   =6D  &MI  !@:P
M56X  $UQ  !&<P  0G4+ #]V$@ ]=QP /'<E #IX+0 Y>#4 .'D] #=Y10 V
M>4T -7E5 #-Y7@ Q>6@!,'ET 2YY@P(M>9("*WBC BIXM0(J>,P"*G?J BIV
M^0,J=?\#*G3_ RIT_P.J:@  FFT  (EL  !\;0  <&T  &9N  !;<0  4'4
M $AX  !!>P  .GX% #9_#@ T@!8 ,X$@ #*!*  P@3  +X(X "Z"0  M@D@
M+()0 "N"6@ J@F0 *()P ":"?P$E@H\!)(*@ 2."L@$B@LD!(H'G 2)_]P$B
M?O\"(GW_ B)]_P*E<0  DW$  (-Q  !V<0  ;'(  &!U  !6>   3'P  $.
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M !"4_P"5?0  A7P  'A\  !K?@  7X$  %2&  !*B@  0(\  #:3   MEP
M)IH  !Z=   7H , $J(, !"C$@ 0HQD #Z,A  ZD*0 .I#$ #:0Z  RD10 +
MI%  "J1<  FD:@ 'I'L !J..  2CH0 "H[0  Z++  .BY@ #H?,  Z'[  .A
M^P"-@P  ?X(  '&$  !DAP  6(P  $V1  !"E@  .)H  "^>   FH@  'J4
M !>H   1JP  #*X'  >O#0 #KQ(  J\9  &O(0  KRD  + R  "P/   L$<
M +!3  "P80  L'$  +"#  "OEP  KZH  *^_  "NV0  KNL  *[T  "N] "'
MB0  >(H  &J.  !=DP  49@  $6=   [H@  ,*8  ">J   >K@  %K$  !"T
M   +M@  !;D#  "Z"@  N@X  +H3  "[&0  NR$  +PH  "\,0  O3P  +Y(
M  "^5@  OF4  +YW  "^C   OI\  +VS  "^QP  OMX  +WK  "]ZP!_D@
M<)4  &*:  !5GP  2:4  #VK   RKP  *+0  !ZV   5N0  #KP   F_   "
MP@   ,0   #%!   Q@H  ,8.  #'$@  R!@  ,D?  #*)P  S#   ,X\  #.
M20  SUD  ,]J  #/?@  SY,  ,^F  #/N   S\@  ,_;  #/VP!WG   :*$
M %NG  !.K@  0;0  #2W   HN@  ';T  !/    -Q   !L<   #*    S@
M -    #1    T@(  -,(  #5#   UA   -D5  #;'   W20  . O  #B/
MXTL  .1<  #D;P  Y8,  .68  #EJ0  Y;8  .7#  #EPP!LI0  7ZP  %&R
M  !$N0  -;P  "C    <Q   $L@   S+   #SP   -,   #8    W    -\
M  #?    X0   .,   #D P  Y@@  .@-  #I$0  [!@  .XB  #Q+@  \SP
M /1-  #U7P  ]G,  />'  #WF0  ^*4  /BP  #XL #_ Q< _P 5 /\ %0#_
M !@ _P C /\ +P#_ #P _P!( /\ 5 #_ %X _P!G /T ;P#[ '8 ^0!] /@
M@P#V (@ ]0". /0 DP#R )@ \0"> /  I #N *L [0"S .L O0#J ,L Z #A
M .< \0#F /T Y0#_ .0 _P#D /\ Y #_ .0 _P#_!Q, _P 1 /\ $0#_ !4
M_P ? /\ *P#_ #< _P!$ /X 3P#Z %H ]P!C /0 :P#R '( \ !Y .\ ?P#M
M (0 ZP"* .H CP#H )0 YP": .4 H #D *< X@"O .  N0#> ,8 W #: -H
M[ #8 /D U@#_ -8 _P#7 /\ V #_ -@ _P#_"A  _P,. /\ #0#_ !( _P :
M /\ )@#\ #( ]P _ /0 2@#Q %4 [0!> .H 9@#H &X Y0!T ., >@#B (
MX "% -X BP#< )  VP"6 -@ G #5 *, TP"K -$ M0#. ,$ S #1 ,L YP#)
M /4 R #_ ,@ _P#( /\ R #_ ,@ _P#_# P _P8( /\""@#_  \ _P 5 /P
M( #Q "P [  Y .D 10#E $\ X0!9 -X 80#; &@ UP!O -0 =0#2 'L T "
M ,X A@#, (P RP"2 ,D F #' *  Q0"H ,, L0#! +P OP#+ +T XP"\ /(
MNP#] +L _P"Z /\ N@#_ +H _P#_#@4 _PD  /\)!0#_!@L _P$0 /  &0#F
M "4 X0 R -P /P#6 $D T0!3 ,X 6P#+ &, R !J ,8 < #% '8 PP![ ,$
M@0#  (< O@". +P E "[ )P N0"D +< K@"U +D LP#( +$ WP"P >\ KP'[
M *X"_P"M _\ K0/_ *T#_P#_$   _PX  /\-  #V"P, \@<* .(!$0#; AT
MT@,K ,P#-P#(!$, Q 1- ,$$5@"^!5T O 5D +H%:P"X!7$ MP5V +4%? "S
M!H, L@:) + &D0"O!YD K0>A *L'JP"I"+< J G& *8*W0"E"_  HPS] *(-
M_P"A#?\ H0W_ * -_P#_$0  _!(  .P3  #B$P  VP\# -8)"P#."!0 Q@HB
M , ,, "\#3P N U& +4-3P"R#E< L Y? *X.90"M#FL JPYQ *H.> "H#GX
MIP^% *4/C0"D#Y8 HA"? * 0J0"?$+4 G1'% )L1W@"9$O$ EQ/_ )84_P"5
M%/\ E13_ )04_P#_%0  [1L  . ?  #2'P  R1L  ,04!0#!$ X NA(; +03
M*0"P%#4 K!5  *D520"F%5( I!99 *(68 "A%F8 GQ9L )X6<@"<%GD FQ>
M )D7B "8%Y$ EAB; )08I@"3&;( D1G! ) :V "-&^X BQS] (H<_P"*'/\
MB1S_ (D<_P#T'0  Y"4  -,I  #'*@  O"8  +8@  "T&0L KAH5 *@<(P"D
M'2\ H1XZ )X>1 ";'DP F1Y4 )<?6P"5'V$ E!]G )(?;0"1'W0 CR!\ (X@
MA ",((T BB"7 (DAH@"'(:X AB*] (4BT0&"(^L!@23[ 8 D_P%_)/\!?R3_
M 7\D_P'L)0  VRT  ,DQ  "\,0  L2X  *LI  "G) 4 HR,1 )XD'0":)2H
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M FPTF )J-:4":36S V@UQ@-G-N(#9C;U V8V_P)F-O\"9C;_ F8V_P+8-P
MQ#X  +5"  "F00  FS\  ),\  "-.   B#8' (0W$0" -QP ?#@G 'HX,0!W
M.3H =3E" ',Y20!Q.5  <#E7 &XY70!L.60!:SEK 6DY= %H.7X"9CF) F0Y
ME0-C.J(#8CJQ V$ZPP-@.^ $7SOS U\[_P-?._\#7SO_ E\[_P+1.P  P$(
M +!%  "A1   E4,  (U   "'/0  @CL" 'T[#@!Y/!@ =3TC ',]+0!P/38
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M!%!'O01/1]8%3T?O!$]'_01/1_\#3T?_ U!'_P/$10  M4T  *--  "53
MB4L  ']*  !X1@  <4<  &Q'!P!H2!  9$@: &%)) !?22T 74DU %M)/0!9
M240 5TE* %9)40!52ED!5$IA 5)*:0%12G0"3TI_ TY*C --2IL$3$NJ!$M+
MO 1*2],%2DON!$M+_01+2O\#2TK_ TM*_P/!2   LE   *!/  "13P  A4X
M 'M-  !S20  ;$H  &=+! !B3 X 7TP7 %Q-(0!:32H 6$TR %9-.@!434$
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M SQ7^@,]5O\#/5;_ SU6_P.V4P  I5<  )17  "%5@  >58  &]6  !E50
M7%8  %=8  !260< 3EH0 $Q:& !*6R$ 2%PJ $=<,@!%7#H 1%U! $-=2 !"
M75  0%U8 #]=80$]76L!/%UV CI=A (Y79,".%VC S==M0,V7<L#-ESH S=<
M^0,W6_\#.%O_ SA:_P.R5P  H%H  (]9  "!60  =5D  &M9  !@6@  5EL
M %%=  !,7@( 2& - $5@% !$81X 0F(F $!B+@ _8C8 /F,^ #UC10 \8TT
M.V-5 #EC7@ X8V@!-F-T 35C@0$S8Y$",F.A C%CLP(Q8\@",6+G C%A^ (Q
M8?\",F#_ C)@_P*N7   FUT  (I=  !\70  <%T  &9=  !<7@  4F   $QB
M  !%90  068* #YG$0 \:!H .V@B #EI*P X:3( -VHZ #9J00 U:DD -&I2
M #-J6P Q:F4 ,&IP 2YJ?@$M:HX!+&J? 2MJL $J:L8!*FGE 2IH]@(K9_\"
M*V?_ BMG_P*I80  E6   (1@  !W8   ;&$  &)A  !88P  3F8  $=H  !
M:P  .FX% #9O#@ T<!4 ,W > #)Q)@ P<2X +W$U "YR/0 M<D4 +')- "MR
M5P J<F$ *7)M "=R>P F<HL )'*< 2-RK@$C<L,!(W'B 2-P] $C;_\!(V[_
M 2-N_P&A90  CF0  ']D  !R9   :&4  %YF  !4:0  26P  $)O   [<@
M-'4  "YX"@ K>1$ *GD8 "EZ(0 G>B@ )GHP "5[.  D>T  (WM( ")[4@ A
M>UP ('MH !]\=@ =?(8 ''N8 !M[J@ :>[\ &GO> !IY\@ ;>/X &W?_ 1MW
M_P&9:0  B&D  'EI  !M:0  8VH  %EL  !/;P  17,  #UW   U>@  +GT
M ">! P B@PT ((02 !^$&@ =A"( '(4J !N%,0 :A3D &85" !B&3  7AE8
M%H9C !6&<0 4AH$ $H:3 !&&I@ 1A;L $(76 !&#[P 1@OL $H+_ !*!_P"1
M;@  @6T  '1N  !I;@  77   %-S  !)=P  0'P  #>    O@P  )X<  "&*
M   :C08 %8\- !.0$P 2D!H $I B !&0*@ 0D3( $)$[  ^11  .D4\ #9%<
M  R1:@ +D7H "I&-  B0GP 'D+, !X_)  >/Y@ 'CO0 "(W\  B-_P")<P
M>W,  &]S  !C=0  5W@  $U]  !#@0  .88  #"*   HC@  (9$  !J5   3
MEP  #IH(  N<#@ )G!, ")P:  ><(@ &G"H !)PS  .</0 "G4@  )U4  "=
M8@  G'(  )R$  "<EP  FZH  )N_  ":VP  FNP  )KU  "9^ "">0  =GD
M &AZ  !<?@  48(  $:'   \C   ,I$  "F5   AF0  &9T  !*@   .HP
M":8%  .G#   IQ   *<5  "H'   J",  *@K  "I-   J3\  *E+  "I60
MJ6@  *EZ  "IC@  J:$  *BU  "HRP  I^0  *?O  "G\P!]@   ;X$  &&$
M  !5B0  28X  #Z4   TF0  *IX  "&B   9I@  $JD   VL   'KP   +(
M  "S!P  LPP  +,0  "T%0  M!L  +4B  "V*P  MS4  +=   "X3@  N%T
M +AN  "X@@  N)<  +BJ  "WO@  M](  +?F  "WZ@!VB   9XL  %J0  !.
ME@  0IP  #>B   LIP  (JL  !FO   1LP  "[8   2Y    O    +X   "^
M    OP8  , +  #!#P  PA,  ,,9  #$(   Q2D  ,<T  #(0@  R5$  ,EB
M  #)=0  R8H  ,F?  #*L0  RL$  ,G1  #)V0!NDP  8)@  %.>  !&I
M.JL  "^P   DM0  &;@  !"\   *OP   <$   #$    R    ,H   #*
MS    ,T#  #."   T T  -$0  #3%@  UAX  -HH  #=-   WD,  -]4  #?
M9P  X'P  ."1  #@I   X+(  ."^  #@PP!FGP  6:8  $RM   _M   ,K@
M "2\   8OP  $,,   C'    R@   ,T   #1    U0   -@   #9    VP
M -T   #?    X00  .,*  #E#@  YQ,  .H<  #M)P  \#4  /%&  #R6
M\VL  /.   #TE   ]*,  /2N  #TL@#_ !, _P 1 /\ $0#_ !4 _P ? /\
M+ #_ #D _P!% /\ 4 #_ %H _@!C /L :P#Y '( ]P!X /4 ?@#T (0 \@")
M /$ C@#P ), [@"9 .T GP#L *8 Z@"N .@ N #F ,4 Y0#; ., [0#B /L
MX@#_ .$ _P#A /\ X0#_ .$ _P#_ !  _P . /\ #0#_ !( _P ; /\ * #_
M #0 _@!! /L 3 #W %8 ] !? /$ 9@#O &T [ !T .H >@#I '\ YP"% .8
MB@#E (\ XP"5 .$ FP#@ *( W@"J -L M #9 ,  U@#0 -, Z #2 /< T0#_
M -$ _P#0 /\ T #_ -  _P#_  T _P ) /\ "@#_  \ _P 6 /L (@#W "\
M]  [ /  1P#M %$ Z0!: .4 8@#B &D X !O -X =0#< 'H V@"  -@ A0#5
M (L TP"1 -$ EP#/ )X S0"F ,L KP#) +H QP#) ,4 X@#$ /( PP#^ ,(
M_P#! /\ P@#_ ,( _P#_ P8 _P ! /\ !@#_  P ^0 1 /$ '0#K "D YP V
M ., 00#? $L VP!4 -4 7 #2 &, SP!J ,T < #+ '4 R0![ ,@ @ #& (8
MQ0", ,, DP#! )H OP"B +T JP"[ +8 N0#$ +< V@"V .T M #Z +0 _P"T
M /\ M #_ +0 _P#_!   _P   /\   #_  8 [  - .4 %@#> "( UP O -$
M.P#- $4 R@!. ,8 5P#$ %X P0!D +\ :@"] '  O !U +H >P"Y ($ MP"'
M +4 C@"S )4 L@"> +  IP"N +( K "_ *H T0"H .@ J #W *< _P"G /\
MI@#_ *8 _P#_!@  _P4  /$#  #H    X0 ' -4 $ #- !L QP G ,, ,P"_
M #X O !( +D 40"V %@ M !? +( 90"P &H KP!P *T =@"L 'P J@"" *D
MB0"G )$ I0": *, I "A *X H "[ )X!S0"= N8 G 3T )L$_P":!?\ F@7_
M )D%_P#_"@  \0X  .00  #9#P  S@L  ,@#"P#" !, O (? +<#+ "S!#<
ML 5" *T&2@"J!E( J =9 *8'7P"E!V4 HP=K *((<0"@"'< GPA^ )T(A0";
M"8X F@F7 )@*H0"6"JP E0NZ ),+S "2#.4 D WV (\._P".#O\ C@[_ (T.
M_P#V$0  YA<  -8;  #'&0  OA4  +D0  "W"@T L0L7 *P-) "H#C  I0X[
M *(.1 "?#TP G0]3 )L/6@":#V  F!!F )<0; "5$'( DQ!Y )(0@0"0$(H
MCQ&4 (T1GP"+$:H BA*X (@2RP"&$^8 A13W (,5_P"#%?\ @A7_ ((5_P#M
M&@  W"$  ,HE  "[(@  L1\  *L:  "I% 8 I1(1 * 4'@"<%2H F14U )86
M/@"4%D< DA9. ) 650".%UL C!=A (L79P")%VT B!=T (88? "%&(8 @QF0
M ($9FP" &J< ?AJU 'T;QP!\'.( >AWU 'D=_P!X'?\ >!W_ '@=_P#E(@
MT"D  +\L  "P*@  IR<  * C  "='P  FAH. )4<& "1'20 CAXO (P>.0")
M'D$ AQ]) (4?4 "#'U8 @A]< ( ?8@!_'VD ?2!P 'P@> !Z(($ >2&, '<A
MEP!U(J0 ="*R ',CPP!R(]\ <"3S &\D_P!O)/\ ;B3_ &XD_P#=*0  R#
M +<R  "H,   GBX  )<J  "3)P  D",* (PC$P"()!\ A"4J ((E- " )CT
M?29$ 'PF2P!Z)E( >"98 '<F7@!U)F4 ="=L '(G= !Q)WT ;RB( &XHE !L
M**$ :RFO 6HIP %I*ML!9RKQ 6<K_P%F*_\!9BK_ 68J_P'4+P  PC8  *\V
M  "A-0  EC0  ) P  "*+0  ARH& (,I$ !_*AH ?"LE 'DK+P!W+#@ =2Q
M ',L1P!Q+$T <"Q4 &XL6@!M+&$ :RUH &HM< !H+7H 9RZ% &4ND0%D+IX!
M8B^L 6$OO0%A,-4!8##O 5\P_0%?,/\!7S#_ 5\P_P'--   O#L  *DZ  ";
M.@  D#@  (DU  "#,@  ?S ! 'LO#@!W,!8 =# A '$Q*P!O,30 ;3$\ &LQ
M0P!J,4H :#)0 &<R5P!E,ET 9#)E &(R;0!A,W< 7S." 5XSC@%=-)P!6S2J
M 5HUNP%:-=(!637M 5DU_ %8-?\!6#7_ 5DU_P'(.   MSX  *0^  "6/0
MBSP  (,Z  !]-P  >#0  '0T"P!P-1, ;34= &HU)P!H-C  9C8X &0V/P!C
M-D8 839- & V4P!>-UH 73=B %PW:@!:.'0!63A_ 5<XC %6.9D!53FH E0Y
MN0)3.L\"4SKK E,Z^P%3.O\!4SG_ 5,Y_P'$/   LD$  *!   "20   AC\
M 'X]  !X.@  <S@  &XY" !J.1$ 9SD: &0Z) !B.BP 8#HT %XZ/ !=.T,
M6SM* %H[4 !8.U< 5SM? %8\9P!4/'$!4SQ\ 5(]B0%1/9<!3SVF DX^MP).
M/LT"3C[I DT^^@)./O\!3CW_ 4X]_P' /P  KD,  )Q#  ".0P  @D(  'I
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M D1%^ )$1?\"147_ D5%_P&Z1@  ID@  )1(  "&2   >T<  ')&  !J0@
M8T,  %Y$  !:10L 5D42 %1&&P!11B, 3T8K $Y&,P!,1SH 2T=! $I'20!)
M2%  2$A8 $=(80!&26L 1$EV 4-)@P%"29(!04FB D!)LP(_2L<"/TKE C])
M]P) 2?\"0$C_ D!(_P&V20  HDH  )%*  "#2@  =TH  &Y)  !E10  7D<
M %E(  !520@ 44H0 $]*& !,2B$ 2DLI $E+,0!'2S@ 1DP_ $5,1@!$3$X
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M 3%5_P&H4@  E5(  (12  !W4@  ;%(  &)2  !84P  3U0  $E6  !$5P
M0%D( #U:$  [6A< .5L@ #A;)P W7"\ -EPV #5</@ T7$8 ,UU. #%=5P P
M76$ +UUL "Y=>@ L78D *UV: 2I=JP$J7;\!*5W> 2I<\@$J6_X!*UO_ 2M:
M_P&C50  CU4  ']5  !R50  9U8  %Y6  !45P  3%D  $5;   _70  .E\$
M #9@#0 T81, ,F(< #%B(P P8BL +V,R "YC.@ M8T( +&-* "ID4P I9%T
M*&1I "=D=@ F9(8 )627 "1DJ0 C9+T (F3: "-C\0 C8OT!)&'_ 21A_P&<
M6   B5@  'I9  !N60  8UD  %I:  !07   2%X  $%@   Z8P  -&8  "]H
M"@ L:1  *FD7 "EJ'P H:B8 )VHN "9K-0 E:ST )&M& "-K3P B;%D (&QE
M !]L<@ >;(( '6R4 !QLI@ ;:[H &FO4 !MJ[@ <:?P '&C_ !QH_P"57
M@UP  '5<  !I70  7UT  %9>  !,80  0V0  #QG   U:@  +VT  "AP!  C
M<@T (7(2 "!S&@ ?<R$ 'G,H !UT,  <=#@ &W1  !IT2@ 9=%0 %W5@ !9U
M;@ 5=7X %'60 !-TH@ 2=+8 $73/ !)S[  2<OH $W'_ !-Q_P".8   ?6
M &]A  !E80  6V(  %%D  !(9P  /FL  #=N   P<0  *74  ")X   <>P<
M%WT. !9]$P 5?1L %'XB !-^*@ 2?C$ $7XZ !%^1  0?TX #W]:  Y_:  -
M?W@ #'^*  M^G0 *?K  "7W&  I]Y  *?/0 "WO]  MZ_P"&90  =V4  &IE
M  !A9@  5F@  $QK  !";P  .7,  #%W   J>@  (WX  !R!   5A   $(<(
M  V)#@ ,B10 #(D;  N)(P *B2L "8DS  B)/0 &B4@ !8E4  2)80 "B7$
M 8F#  ")E@  B*D  (>^  "'V@  ANP  (;U  "&^@!^:@  <6H  &=K  !;
M;   4'   $9T   \>   ,WT  "J!   CA0  '(@  !6,   0CP  #)(&  :3
M#  "DQ$  )06  "4'0  E"0  )4L  "5-0  E4   )5,  "660  EFD  )5Z
M  "5C@  E*$  )2U  "3S   DN8  )+R  "2]P!X<   ;7   &!R  !4=0
M27D  #]^   U@P  +(@  ".-   ;D0  %)0   ^7   *F@  !)T#  ">"0
MGPX  )\2  "@%P  H!T  *$E  "B+0  HC<  *-#  "C4   HU\  *-Q  "C
MA   HID  **M  "AP@  H=P  *'K  "@\@!S=@  9G<  %E[  !-@   0H4
M #B+   ND   ))4  !N:   4G@  #J$   FD   "IP   *H   "K!   JPH
M *P-  "M$0  K18  *X<  "O)   L"T  +$Y  "Q1@  LE4  +)F  "R>0
MLHX  +&C  "RMP  L<H  +'@  "QZ0!L?@  7X(  %*'  !&C0  .Y,  #"9
M   FG@  '*,  !.G   -JP  !ZX   "R    M0   +<   "X    N0(  +D(
M  "Z#   NQ   +P4  "]&P  OR,  ,$M  #".@  PDD  ,-:  ##;   Q((
M ,27  #$JP  Q+P  ,3+  #$V@!EB0  6(X  $N5   _FP  ,Z(  "BH   =
MK0  %+$   VV   &N0   +P   "_    PP   ,0   #%    Q@   ,<   #)
M!   R@D  ,L-  #-$0  SQ@  -(A  #5+0  UCP  -A-  #97P  VG,  -J*
M  #;G@  VZX  -NZ  #<PP!>E@  49P  $2C   XJ@  ++$  ""W   5NP
M#;X   3"    Q0   ,D   #-    T    -(   #2    U0   -8   #9
MVP   -X%  #@"@  X@\  .46  #H(   ["T  .T^  #M40  [F4  .]Z  #O
MCP  \)\  /"K  #PLP#_ !  _P . /\ #@#_ !( _P = /\ *0#_ #4 _P!!
M /\ 30#^ %8 ^P!? /@ 9@#V &T ] !T /( >0#Q '\ \ "$ .X B0#M (\
MZP"5 .H FP#H *( Y@"J .4 LP#C ,  X0#2 .  Z@#? /D W0#_ -T _P#=
M /\ W@#_ -X _P#_  T _P * /\ "0#_  \ _P 8 /\ ) #^ #$ ^P ] /@
M2 #T %( \ !: .T 8@#K &D Z0!O .< =0#E 'H XP!_ .( A0#@ (H W@"0
M -P E@#: )T V "E -4 KP#2 +H T #* ,X XP#- /0 RP#_ ,L _P#+ /\
MRP#_ ,L _P#_  @ _P # /\ !0#_  P _  4 /< 'P#R "L [P W .L 0@#G
M $P Y !5 .  70#= &0 V@!J -@ < #5 '4 T@!Z -  @ #/ (4 S0"+ ,L
MD@#) )D QP"A ,4 J@## +4 P0## +\ V@"^ .X O0#\ +P _P"\ /\ O #_
M +P _P#_    _P   /\   #Y  < \0 0 .H &@#D "4 WP Q -L / #7 $<
MT@!0 ,X 5P#+ %X R0!E ,8 :@#% '  PP!U ,$ >@#  (  O@"& +P C0"Z
M )0 N0"< +< I0"U +  LP"] +$ SP"O .@ K@#X *X _P"M /\ K0#_ *T
M_P#_    _P   /T   #N  $ XP , -H % #1 !\ S  K ,@ -@#% $  P@!*
M +\ 4@"\ %D N@!? +@ 90"V &H M !O +, =0"Q 'H L "! *X B "M (\
MJP"8 *D H0"G *L I0"X *, R "B .( H0#S *  _@"@ /\ H #_ *  _P#_
M    ]@   .H   #@    TP & ,D #P#" !@ O0 D +D +P"V #H M !# +$
M3 "N %, K !9 *H 7P"I &0 IP!J *8 ;P"D '4 HP![ *$ @@"@ (H G@"3
M )P G0": *< F "T )8 PP"5 -P E #O ), ^P"3 /\ DP#_ )( _P#Y!0
MZ@L  -P-  #+"@  P@4  +P "@"V !$ L0 < *X * "J #, IP ] *0 10"B
M $T H !3 )X 60"< %\ FP!D )H :@"8 '  EP!V )4 ?@"3 (8 D@&/ ) !
MF0". J0 C *Q (L#P ")!=8 B ;M (@'^@"'"/\ A@C_ (8(_P#O#P  WA0
M ,H5  "\$@  LQ   *X,  "K!@T IP,5 *(%( "?!RP G @V )D(/P"7"4<
ME0E. ),)5 "1"EH D I? (X*90"-"FL BPIR (H+>0"("X( APN, (4,EP"#
M#*( @0VP ( -P !_#=@ ?0[O 'P/_0![#_\ >Q#_ 'L0_P#F%P  T1X  +T=
M  "O'   IAD  *$5  ">$ 0 G0T/ )@.&0"4#B4 D0\O (\0.0",$$$ BA!(
M (@03P"'$%4 A1!; (0180""$6< @!%N '\1=0!]$7X ?!*( 'H2E !X$J
M=Q.N '43O@!T%-4 <Q7N '$6_0!Q%O\ <1;_ ' 6_P#<'P  QB4  +,E  "E
M(P  G"$  )8>  "2&0  D10+ (T4% ")%1\ AA8I (,6,P"!%SP @!=# 'X7
M2@!\%U  >A=6 'D87 !W&&( =AAI '08<0!S&7H <1F$ &\:D !N&IT ;!NK
M &L<NP!J'-  :1WL &@>^P!H'O\ 9Q[_ &<>_P#1)@  O2H  *LJ  "=*@
MDR@  (TE  "((@  AAT& (,;$ !_'!H ?!TD 'H=+@!W'C8 =AX^ '0>10!R
M'TL <1]1 &\?6 !N'UX ;!]E &L@;0!I('8 :"&! &8AC0!E(IH 8R*H &(C
MN !A(\T 8"3I & D^@!?)/\ 7R3_ %\D_P#*+   MB\  *0O  "6+P  C"T
M (4J  " *   ?20  'HB#0!V(Q4 <R,@ '$D*0!O)#( ;20Z &LE00!J)4<
M:"5- &8E5 !E)5H 9"9A &(F:0!A)G( 7R=] %XGB@!=*)< 6RFE %HIM0!:
M*LH 62KG %@J^ !8*O\ 6"K_ %@J_P#%,0  KS,  )XS  "0,P  AC(  '\O
M  !Y+0  =2H  '(H"@!O*!( :RD; &DI)0!G*BT 92HU &,J/0!B*D, 8"I*
M %\K4 !>*U< 7"M> %LL9@!9+&\ 6"UZ %<MAP!6+I4 5"ZC %,OLP!3+\<
M4B_E %(O]P!2+_\ 4B__ %(O_P#!-@  JC8  )DV  "+-@  @34  'DS  !S
M,0  ;R\  &LN!@!H+1  9"X8 &(N(0!@+RH 7B\Q %PO.0!;+T  62]& %@O
M30!7,%, 5C!; %0Q8P!3,6P 4C)W %$RA !/,Y( 3C.A $TSL0!--,4!3#3C
M 4PT]@!,-/\ 3#3_ $PS_P"[.0  ICD  )4Y  "'.0  ?#D  '0W  !N-
M:3,  &4R @!A,@T 7C(4 %PS'@!:,R8 6#,N %8S-0!5-#P 4S1# %(T2@!1
M-%  4#58 $XU8 !--FH 3#9U $LW@@!*-Y  23B? $@XL %'.,,!1SCA 4<X
M]0%'./\!1SC_ 4<X_P&W.P  HCP  )$\  "#/   >#P  ' Z  !J-P  9#8
M & V  !<-@L 63<2 %8W&@!4-R, 4C<K % W,@!/.#D 33A  $PX1P!+.$X
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M 3E#_P&J0@  ED,  (9#  !X0P  ;D,  &5#  !=0   5D   %%"  !-0@(
M24,, $9#$@!$1!H 0D0B $%$*@ _13$ /D4X #U%/P \1D< .T9/ #I&5P Y
M1V$ .$=L #='>@ V2(D -4B9 #1(J@ T2+T ,TC9 #1(\  T1_T -$?_ #5&
M_P"F1   DD4  ()&  !U1@  :D8  &%%  !91   440  $Q&  !(1P  1$<*
M $%($  _21@ /4D@ #Q))P Z2BX .4HV #A*/0 W2T0 -DM, #5+50 T3%\
M,TQJ #),=P Q3(8 ,$R7 "]-J  N3;L +DW5 "Y,[P O3/T +TO_ #!+_P"A
M1P  CD@  'Y(  !Q2   9DD  %U(  !52   3$D  $=*  !"2P  /TP& #M-
M#@ Y3A4 -TX= #9/)  U3RL ,T\S #)0.@ Q4$( ,%!* "]14@ N45P +5%G
M "Q1=0 K480 *E*5 "E2I@ I4KD *%+2 "E1[@ I4/P *E#_ "I/_P"<2@
MB4H  'I+  !M2P  8TP  %I,  !13   2$T  $-/   ]4   .5(" #53#  S
M5!( ,509 #!5(0 N52@ +54O "Q6-P K5CX *E9& "E63P H5UD )U=D "97
M<@ E5X$ )%>2 "-7I  B5[< (E?/ ")7[  C5OH (U7_ "15_P"630  A$X
M '5.  !I3@  7T\  %9/  !-4   15(  #]3   Y5@  ,U@  "]:"  K6P\
M*EL5 "A<'0 G7"0 )EPK "5<,P D73H (UU# ")=3  A758 (%YA !]>;@ >
M7GX '5Z/ !Q>H0 ;7K0 &EW, !M=Z0 ;7/D '%O_ !Q;_P"040  ?E$  '!1
M  !D4@  6U(  %)3  !*5   05<  #M9   U6P  +EX  "A@ P D8@P (F,1
M "%C&  ?9"  'F0G !UD+@ <9#8 &V4^ !IE1P 995$ &&5= !=E:@ 697H
M%66+ !1EG@ 39;$ $F7( !)DYP 38_< %&+_ !1B_P")5   >%4  &M5  !@
M5@  5U8  $]7  !&60  /5P  #9?   P8@  *60  "-G   =:@< &6P. !AL
M$P 6;1H %6TA !1M*0 4;3  $VTY !)N0@ 1;DP $&Y8  ]N90 .;G4 #6Z'
M  UNF@ ,;:T "VW"  MLX  ,:_, #6O]  UJ_P""60  <ED  &99  !<6@
M5%H  $I<  !!7P  .6,  #%F   J:0  )&P  !UO   7<@  $G4)  ]W#P .
M=Q0 #G<;  UW(P ,=RH "W<S  IW/  )=T< "'=2  =W7P %=V\ !'>   -W
ME  !=J<  ':[  %UU0 !=.L  G3V  )T_ ![70  ;5T  &)>  !97@  3F
M $5C   \9P  ,VL  "MN   D<@  'G4  !=Y   2?   #7\&  F!#  %@1$
M X$6  *!'0 !@20  ($M  ""-@  @D   (),  ""60  @F@  ()Y  ""C0
M@:   ("T  " RP  ?^<  '[R  !^^0!T8@  :&(  %YB  !39   26<  #]K
M   V<   +70  "5X   >?   %X   !&#   -A@  "(D$  *+"@  BPX  (L3
M  ",&   C!\  (TF  "-+P  CCD  (Y$  ".40  CF   (YQ  ".A0  CID
M (VM  ",PP  C-\  (ON  "+]@!N:   9&<  %AI  !-;   0G$  #AV   O
M>P  )G\  !Z$   6B   $(P   R/   &D@   )4   "6!P  EPP  )</  "8
M$P  F1@  )H?  ";)@  FS   )P[  "<2   G%<  )QH  "<>P  G)   )NE
M  ";N@  FM   )KG  ":\0!J;0  7F\  %%R  !&=P  .WP  #&"   GAP
M'HP  !:1   0E0  "ID   2<    H    *(   "C 0  HP8  *0+  "E#@
MIA(  *<7  "H'@  JB8  *LQ  "K/@  K$T  *Q=  "L<   K(4  *R;  "K
MKP  J\,  *O9  "JZ !D=0  5WD  $M^   _A   -(H  "F0   ?E@  %IL
M !"?   )HP   :<   "J    K@   +    "P    L0   +(#  "T"   M0T
M +80  "W%0  N1T  +LF  "\,P  O4$  +U2  "]9   OGD  +Z0  "]I
MO;<  +W&  "]UP!<?P  4(4  $2+   XD@  +)D  "&?   7I   $*D   FN
M    L@   +8   "Y    O0   +\   "_    P    ,$   ##    Q 4  ,8*
M  #'#@  R1,  ,L<  #.)@  T#4  -%%  #25P  TFL  -."  #3EP  TZD
M -*X  #2Q !5C   29,  #V:   PH@  ):@  !JN   1M   ";D   "]
MP0   ,0   #(    RP   ,T   #-    SP   -    #2    U    -@   #:
M!@  W0P  . 1  #C&@  YB<  .<X  #H2@  Z5T  .IR  #KB   ZYL  .RH
M  #LL@#_  T _P + /\ "P#_ !  _P : /\ )@#_ #( _P ] /\ 2 #[ %(
M^ !: /8 8@#S &D \0!O /  =0#N 'H [ !_ .L A #I (H Z "0 .8 E@#D
M )T X@"E .$ KP#? +L W0#+ -L Y@#9 /< V #_ -@ _P#7 /\ UP#_ -0
M_P#_  @ _P $ /\ ! #_  T _P 5 /X (0#Z "P ]P X /0 0P#P $T [0!5
M .H 70#G &0 Y !J .( < #@ '4 W@!Z -T ?P#; (4 V0"+ -4 D0#3 )D
MT0"@ ,\ J@#- +4 RP#$ ,D W0#( /$ QP#_ ,8 _P#& /\ Q@#_ ,< _P#_
M    _P   /\   #_  H ^  1 /$ ' #L "< Z0 R .8 /0#B $< W0!0 -D
M6 #5 %\ T@!E -  :@#. '  S !U ,H >@#) '\ QP"% ,4 C ## )0 P0"<
M +\ I0"] +  NP"] +H T "X .L MP#[ +8 _P"V /\ M@#_ +8 _P#_
M_P   /T   #S  4 Z0 . .$ %@#; "$ U0 M -$ -P#. $$ R@!* ,< 4@#$
M %D P@!? ,  90"^ &H O !O +L = "Y 'H MP"  +8 AP"T (X L@"7 +
MH "N *H K0"W *L R "I ., J #U *< _P"G /\ IP#_ *8 _P#_    _@
M /$   #E    UP * ,T $0#' !P P@ F +\ ,0"\ #L N@!$ +< 3 "T %,
ML@!9 +$ 7P"O &0 K0!I *P ;P"J '0 J0!Z *< @0"F (D I "1 *( FP"@
M *4 G@"R )T P0"; -H F@#O )D _0"8 /\ F #_ )@ _P#]    \    .$
M  #1    Q@ $ +T #0"W !4 LP @ +  *P"M #4 JP ^ *@ 1@"F $T I !4
M *, 60"A %\ H !D )X :0"= &X FP!U )H >P"8 (, E@", )4 E@"3 *$
MD0"M (\ NP"- ,\ C #I (L ^ ", /\ C #_ (P _P#S @  X@<  ,P'  "_
M!   MP   +$ " "K !  IP 9 *0 ) "@ "X G@ W )P 0 ": $< F !. )8
M5 "5 %D DP!> )( 9 "0 &D CP!O (T =@"+ 'X B@"( (@ D@"& )T A0"I
M (, N "! ,H @ #E (  ]0!_ /\ ?P#_ '\ _P#H#0  T!   +X0  "Q#@
MJ T  *,(  "@ @P G  3 )@ '0"5 "< D@ Q )  .0". 4$ C %( (H"3@")
M E0 AP)9 (8"7P"$ V0 @P-K ($#<@" !'H ?@2$ 'T%C@![!9H >0:G '@&
MM0!V!\@ =0CC '4)] !T"O\ <PK_ ',*_P#=%0  Q!<  +$7  "E%@  G!,
M )81  "4#00 DP@- (X'%0"+"2  B DJ (4*,P"#"SL @0M" ( +20!^"T\
M?0Q4 'L,6@!Z#&  > QG '<,;@!U#78 = V  '(-C !P#9D ;PZF &T.M0!L
M#LD :P_F &H0]P!I$/\ :1#_ &D0_P#0'0  N1X  *@>  ";'0  DAL  (L9
M  "(%0  AQ$' (4.$ "!#QH ?A D 'L0+0!Y$#8 =Q$] '811 !T$4H <Q%0
M '$15@!P$5P ;A)B &T2:@!K$G, :1-] &@3B0!F$Y8 912C &,5LP!B%<8
M8A;C &$6]@!@%_\ 8!?_ & 7_P#'(@  L",  )\D  "2(P  B2(  ((@  !^
M'0  ?!D  'H5#0!W%14 =!8? '$6* !O%S  ;A<X &P7/P!K%T4 :1A+ &@8
M40!F&%@ 91A> &,99@!B&6\ 8!EY %\:A0!=&Y( 7!NA %L<L !:',, 61W@
M %@>] !8'O\ 6![_ %@>_P"_)P  J2@  )DH  "+*   @B<  'LE  !V(P
M<R   '$<"0!N'!$ :QP: &D=(P!G'2P 91TS &,>.@!B'D$ 8!Y' %\>30!>
M'E0 7!]; %L?8@!9(&L 6"!V %8A@@!5(9  5"*> %,BK@!2(\  42/= %$D
M\@!1)/\ 423_ %$C_P"Y*P  HRP  ),L  "&+0  ?"P  '0J  !O*   :R4
M &DB!0!F(0X 8R(6 &$B'P!?(R< 72,O %PC-@!:(ST 621# %<D2@!6)%
M5217 %,E7P!2)6@ 429S $\F?P!.)XT 32B< $PHK !+*;X 2RG: $HI\0!*
M*?\ 2RG_ $LI_P"S+@  GB\  (XP  "!,   =R\  &\N  !J*P  92H  &,G
M 0!?)PP 7"<3 %HG&P!8*"0 5B@K %4H,@!3*#D 4BE  % I1@!/*4T 3BE4
M $TJ7 !,*F4 2BMP $DK? !(+(L 1RV: $8MJ@!%+KP 12[6 $4N[P!%+OX
M12[_ $4M_P"N,0  FC(  (DS  !\,P  <C,  &LQ  !E+P  8"T  %TL  !9
M+ D 5BP0 %0L& !2+"  4"PH $XM+P!-+38 3"T\ $HM0P!)+4H 2"Y1 $<N
M60!&+V, 13!M $,P>@!",8D 03&8 $$RJ ! ,KL /S+3 #\R[@! ,OT 0#+_
M $ R_P"J,P  EC4  (8U  !Y-@  ;C4  &8U  !A,@  7#   %<P  !4, 8
M43 . $XP%0!,,1T 2C$E $@Q+ !',3( 1C$Y $0Q0 !#,D< 0C)/ $$S5P!
M,V  /S1K #XU>  ]-8< /#:6 #LVIP [-KD .C;1 #HV[0 [-OP .S;_ #LV
M_P"F-@  DC<  ((X  !U.   :S@  &,W  !=-@  5S,  %,T  !/- , 2S0,
M $DT$@!&-1H 134B $,U*0!!-2\ 0#4V #\V/0 ^-D0 /3=, #PW50 [.%X
M.CAI #DY=@ X.84 -SJ5 #<ZI0 V.K@ -3K/ #8Z[  V.OL -CG_ #<Y_P"B
M.   CCD  'XZ  !R.P  :#L  %\Z  !9.0  4S8  $XW  !*.   1C@* $0Y
M$ !!.1< /SD? #XY)@ \.2T .SHT #HZ.P Y.T( .#M* #<[4P V/%P -3QG
M #0]=  S/8, ,SZ3 #(^I  Q/K8 ,3[- #$^Z@ Q/OH ,CW_ #(]_P">.P
MBSP  'L\  !N/0  9#T  %P]  !5/   3CH  $D[  !%/   03T' #X]#@ \
M/14 .CX< #D^(P W/BH -C\Q #4_.  T/T  ,T!( #) 4  Q0%H ,$%E "]!
M<@ N0H$ +4*1 "U"H@ L0K4 *T++ "Q"Z0 L0OD +4'_ "U!_P"9/0  ASX
M '<_  !K/P  84   %D_  !2/P  23X  $0_  ! 0   /$$$ #E"#0 W0A(
M-4,9 #-#(0 R0R@ ,40O #!$-@ O1#T +D5% "U%3@ L15@ *T9C "I&;P I
M1GX *$:/ "='H0 F1[, )D?) "9&YP G1O@ *$7_ "A%_P"50   @D$  '-"
M  !G0@  7D(  %5"  !.0@  14(  #]$   [10  -T8  #1'"@ Q2!  +T@6
M "Y)'@ L224 *TDL "I),P I2CH *$I" "=*2P F2U4 )4M@ "1+;0 C2WP
M(DN- "%,GP A3+$ ($S' "!+Y@ A2_< (DK_ ")*_P"00P  ?D0  &]$  !D
M10  6D4  %)%  !*1@  04<  #Q(   W20  ,DL  "Y-!P K3@X *4X3 "=/
M&@ F3R$ )4\H "1/,  C4#< (E _ "%02  @4%( 'U%= !Y1:@ =47D '%&*
M !M1G  :4:\ &5'% !E1Y  :4/8 &T__ !Q/_P"*1@  >4<  &M'  !@2
M5D@  $Y(  !'20  /DL  #E,   S3@  +E   "A3 @ D5 L (E40 "!5%@ ?
M5AX 'E8D !U6+  <5C, &U<[ !I71  95TX &%=9 !=89@ 56'4 %%B' !18
MF@ 35ZP $E?" !)7X0 35O0 %%7_ !15_P"$20  =$H  &9+  !<2P  4TL
M $M,  !$30  /$\  #51   O5   *58  "19   >6P< &ET- !A=$@ 771D
M%EX@ !5>)P 47BX $UXW !)>0  17TH $5]5 !!?8@ /7W$ #E^#  U?E@ -
M7ZD #%Z^  Q>V@ -7?  #5S\  Y<_P!^30  ;DX  &).  !83P  3T\  $A0
M  ! 4@  .%0  #!7   J6@  )%T  !]?   98@$ $V4) !%F#P 09A0 #V8;
M  YG(@ -9RD #6<R  QG.P +9T4 "F=0  EG70 '9VP !F=]  5GD  $9J,
M F:W  -ESP $9>D !&3U  1D_ !W40  :5(  %U2  !44@  3%,  $-5   [
M6   ,UL  "M>   E80  'V0  !EG   3:@  #VT&  MP#  (<!$ !W 6  5P
M'0 $<"0  W L  )P-0  <#\  '!*  !P5P  <&4  '!V  !PB@  ;YX  &^R
M  !NR   ;>4  &WR  !M^0!P5@  8U8  %E6  #_XO__24-#7U!23T9)3$4
M! E15P  1U@  #Y;   V7P  +F(  "9F   ?:@  &6T  !-P   .<P  "W8$
M  5X"P !> \  'D3  !Y&0  >1\  'HF  !Z+P  >CD  'I$  !Z4   >E\
M 'IP  !Z@P  >I@  'JL  !YP@  >-\  'CO  !W]P!J6P  7UL  %9;  !,
M7   0F   #EC   P:   *&P  "!P   9=   $W<   Y[   )?@  !($"  ""
M"   @PT  (,0  "$%   A1D  (8@  "&*   AS$  (<\  "'20  AU<  (=H
M  "'>P  AY   (:E  "%N@  A=,  (3J  "$] !E8   7&   %%A  !&9
M/&D  #)M   I<@  (7<  !E[   2@   #8,   B'   "B@   (T   ".!
MC@D  (\-  "0$   D10  )(9  "3(   E"D  )4S  "50   EDX  )9?  "5
M<@  E8@  )6=  "4L@  E,@  )/B  "3[@!A90  5F8  $IJ   _;@  -70
M "MY   A?P  &80  !&)   ,C0  !I$   "4    F    )H   ";    G (
M )T'  ">"P  GPX  *$2  "B&   HR   *4I  "F-@  ID0  *95  "F:
MIGT  *:4  "EJ0  I+T  *31  "DY !;;   3W   $-U   X>P  +8$  ".'
M   9C0  $9(   N7   $G    *    "C    I@   *@   "I    J@   *P
M  "M!   K@D  + -  "Q$0  LQ<  +4@  "V*P  MSH  +=+  "X7   N'$
M +B(  "XG0  N+$  +?"  "WT !4=@  2'P  #R"   QB0  )I   !N7   2
MG0  #*(   .G    JP   *X   "R    M@   +@   "X    N@   +L   "]
M    O@   , %  #!"P  PQ   ,86  #)(   RBX  ,L^  #,4   S&0  ,UZ
M  #-D0  S:0  ,VT  #-P !-@P  08H  #61   IF0  'J   !.F   ,K
M [$   "V    N@   +X   #"    Q@   ,@   #(    R@   ,L   #-
MS@   -    #2 0  U0@  -D.  #=%0  X2$  .(Q  #D0P  Y58  .9K  #F
M@@  YY8  .>E  #FL #_  D _P % /\ !@#_  X _P 6 /\ (0#_ "T _P X
M /T 0P#Y $T ]0!5 /( 70#P &, [@!I .P ;P#J '0 Z0!Z .< ?P#F (4
MY "+ ., D0#A )D WP"A -P J@#: +8 UP#& -4 X0#3 /0 T@#_ -$ _P#1
M /\ SP#_ ,H _P#_  $ _P   /\  0#_  P _P 2 /H '0#V "@ \P S /
M/@#L $@ Z !0 .4 6 #B %X WP!D -T :@#; &\ V0!T -8 >@#4 '\ T@"%
M -  C #. ), S "< ,D I0#' +  Q@"^ ,0 U #" .X P0#^ ,  _P#  /\
MOP#_ +X _P#_    _P   /\   #Z  < \0 / .L & #F ", X@ N .  . #;
M $( U0!+ -$ 4@#. %D RP!? ,D 90#' &H Q@!O ,0 = #" 'H P0"  +\
MA@"] (X NP"6 +D H "W *H M@"W +0 R@"R .8 L0#X +  _P"O /\ KP#_
M +  _P#_    _P   /<   #J  ( X0 , -< $P#0 !T S  H ,D ,@#& #P
MP@!% +\ 30"\ %, N@!9 +@ 7P"W &0 M0!I +0 ;@"R '0 L0!Z *\ @ "M
M (@ K "1 *H F@"H *4 I@"Q *0 P0"C -P H0#R *$ _P"@ /\ H #_ *$
M_P#_    ]P   .@   #9    RP ( ,, $ "] !@ N0 B +8 + "T #8 L@ _
M *\ 1P"L $T JP!4 *D 60"G %X I@!C *4 : "C &X H@!T *  >@"> ((
MG "+ )L E0"9 )\ F "L )8 N@"4 ,\ DP#K )( ^P"2 /\ D@#_ )$ _P#W
M    YP   -,   #&    NP " +, # "M !( J@ < *< )@"D #  HP X *
M0 "> $< G !. )H 4P"9 %@ EP!= )8 8P"5 &@ DP!N )( = "0 'P CP"%
M (T CP"+ )H B@"G (@ M0"& ,< A0#D (0 ]0"$ /\ @P#_ (, _P#L
MTP   ,$!  "T    K    *8 !P"@  X G0 6 )H ( "7 "D E0 R ), .@"1
M $$ CP!( (T 30", %, BP!8 (D 70"( &, AP!I (4 ;P"# '< @@"  (
MB@!^ )8 ?0"C 'L L !Z ,( >0#= '@ \0!W /T > #_ '@ _P#>"@  Q L
M +(,  "F"P  G0@  )D$  "5  H D0 1 (X &0"+ ", B0 L (< - "% #L
M@P!" (( 2 "  $X ?P!3 'T 6 !\ %X >P!D 'D :@!X '( =@![ '0 A@!S
M )( <0"? '  K0!N +X ;0'6 &T"[0!L _H ; /_ &P#_P#.$   MQ$  *82
M  ":$0  D1   (L.  ")"P, AP4, (0!$P"! 1P ?@(E 'P#+@!Z S8 > 0\
M '<$0P!U!4@ = 5. ',%5 !Q!5D < 9? &X&9@!M!FX :P=X &H'@P!H")
M9PF= &4)K !D";P 8PK4 &,+[ !B#/H 8@S_ &(,_P##%@  K1<  )T8  "0
M&   AQ8  ($4  !]$0  ? X& 'P*#@!X"A8 =0L? '(+* !P##  ;PPW &T,
M/@!L#$0 :PU* &D-3P!H#54 9PU< &4-8P!C#FL 8@YU & .@0!?#HX 70^<
M %P0JP!;$+T 6A#6 %D1\ !9$?T 61'_ %D1_P"Y&P  I1T  )0>  "('@
M?AT  '@;  !T&   <14  '$1"0!O$!$ ;! 9 &D0(@!G$2H 9A$R &01.0!C
M$3\ 8A%% & 22P!?$E$ 71)8 %P27P!:$V@ 61-R %<4?0!6%(L 5!69 %,5
MJ0!2%KH 41;2 %$7[0!1%_T 41?_ %$7_P"R(   GB(  (XB  "!(P  =R(
M ' A  !L'@  :1L  &<8! !F%0X 8Q85 &$6'@!?%B8 718M %P7- !:%SL
M61=! %@81P!6&$T 51A4 %,87 !2&60 41EN $\:>@!.&X@ 31N7 $L<I@!*
M'+@ 2AW/ $D=ZP!)'?L 21W_ $H=_P"L)   F"4  (@F  ![)P  <28  &HE
M  !F(P  8B$  & >  !>' L 6QL2 %D<&@!7'"( 51PI %0<, !3'3< 41T]
M % =0P!/'4H 31Y1 $P>6 !+'V$ 21]K $@@=P!'((4 1B&4 $0BI !$(K8
M0R+, $,CZ0!#(_H 0R/_ $,B_P"F)P  DRD  (,J  !V*@  ;2H  &4I  !@
M)P  7"4  %DC  !7(0< 52$/ %(A%@!0(1X 3B$E $TB+ !,(C, 2B(Y $DB
M0 !((D8 1R-- $4C50!$)%X 0R1I $(E=0! )H, /R:2 #XGHP ^)[0 /2?*
M #THZ  ]*/D /2?_ #XG_P"B*@  CBL  '\M  !R+0  :"T  &$L  !<*P
M6"@  %0F  !1)@0 3B4- $PE$P!*)AH 2"8B $<F*0!%)B\ 1"8V $,G/ !!
M)T, 0"=+ #\H4P ^*5P /2EF #PJ<@ [*H$ .BN0 #DKH0 X++( -RS( #<L
MY@ X+/@ ."S_ #@L_P"=+   BBX  'LO  !O,   93   %TO  !8+@  4RL
M % J  !,*@  22H+ $8J$0!$*A< 0BH? $$J)0 _*BP /BLS #TK.0 \*T
M.RQ( #HL4  Y+5D ."YD #<N<  V+W\ -2^/ #0PGP S,+$ ,C#' #(PY0 S
M,/< ,S#_ #0O_P"9+P  AS$  '<R  !K,@  8C(  %HR  !4,0  3R\  $LM
M  !'+@  1"X( $$N#@ _+A0 /2X< #LN(@ Y+RD ."\O #<O-@ V,#X -3!&
M #4Q3@ T,5< ,S)B #(R;@ Q,WT ,#.- "\TG@ N-+  +33% "TTXP N-/8
M+S/_ "\S_P"5,0  @S,  '0T  !H-0  7C4  %<T  !1-   2S(  $8Q  !"
M,@  /S(% #PR#0 Y,Q( .#,9 #8S(  T,R8 ,S,M #(T-  Q-#L ,#5# # U
M3  O-E4 +C9@ "TW;  L-WL *S>+ "HXG  I.*X *#C# "@XX@ I./4 *C?_
M "HW_P"2-   ?S4  '$V  !E-P  6S<  %0W  !--@  1S8  $(U   ]-@
M.C8" #<W"P T-Q  ,C<6 #$X'0 O."0 +C@K "TY,@ L.3D *SE! "HZ20 J
M.E, *3M> "@[:@ G.WD )CR) "4\FP D/*T (SS" ",\X  D//0 )3O_ "4[
M_P"--@  ?#@  &TY  !B.0  6#H  %$Y  !*.0  1#D  #TY   Y.@  -3L
M #(["  O/ X +3T4 "P]&@ J/2$ *3TH "@^+P G/C8 )CX^ "4_1P D/U
M(T!; ") :  A0'8 ($"' !]!F0 ?0:L 'D'  !Y!W@ ?0/, 'T#^ " __P")
M.0  >#H  &D[  !>/   53P  $T\  !'/   0#P  #@]   T/@  ,$   "U!
M!0 J0@P )T(1 "9#&  D0QX (T,E ")#+  A1#, ($0[ !]$1  >14X '459
M !Q%90 ;170 &D6% !E&EP 91JD &$:^ !=%W  81?$ &43] !I$_P"$/
M<ST  &8^  !;/P  4C\  $H_  !$/P  /4   #9!   Q0P  +$0  "=& 0 D
M1PH (4@/ "!)%  >21L '4DB !Q)*0 ;2C  &DHX !E*00 82DL %TM5 !9+
M8@ 52W$ %$N" !-+E  22Z< $DN\ !%+V0 22O  $TK\ !1)_P!_/P  ;T
M &%!  !70@  3D(  $="  !!0@  .D,  #)%   M1P  *$D  "-+   >308
M&T\- !A0$0 74!< %E > !50)0 44"P $U$T !)1/0 144< $5%2 !!17P /
M4FT #E)^  U1D0 -4:0 #%&X  Q1T0 -4.P #5#Z  Y/_P!Y0P  :D0  %U$
M  !310  2T4  $1%   ^1@  -D@  "]*   I3   )$\  !]1   :4P  %%8)
M !%7#@ 06!, $%@9  ]8(  .6"@ #5@P  U8.0 ,6$, "UA.  I86@ (6&@
M!UAY  98C  %6)\ !%BS  17R@ %5^8 !5?S  96_ !S1@  9$<  %E(  !0
M2   2$@  $%)   Z2@  ,DT  "M0   E4@  (%4  !I8   56@  $%T&  Q@
M#  *8!  "6 5  A@'  '8", !6 K  1@-  #8#T  6!)  !@50  8&,  &!S
M  !@A@  7YH  %^N  !?Q   7N(  %[P  !>^ !L2@  7TL  %5+  !,3
M14P  #U.   U4   +E,  "=6   @60  &EP  !5?   08@  #64$  AG"P #
M9PX  &@3  !H&   :!\  &DF  !I+@  :3@  &E#  !I3P  :5T  &EM  !I
M@   :90  &BI  !HOP  9]P  &;N  !F]P!F3P  6D\  %%/  !*3P  05$
M #A4   P5P  *%L  "%>   :8@  %&4  !!H   ,:P  !VX#  %P"0  < T
M '$0  !Q%   <AH  ',A  !S*   <S$  ',\  !T2   <U8  '-F  !S>0
M<XX  '.C  !RN0  <=(  ''K  !P] !A4P  5E,  $]3  !%50  .U@  #)<
M   J8   (F0  !MH   4;   #V\   MR   &=@   'D   !Z!@  >@H  'L.
M  !\$0  ?14  'X;  !_(@  @"H  ( U  " 00  @$\  (!?  " <0  @(8
M ("=  !_L@  ?LH  '[E  !]\0!<6   5%@  $E:   _70  -6$  "QE   C
M:@  &V\  !1S   .=P  "7L   -_    @@   (0   "& 0  A@8  (@*  ")
M#0  BA   (L5  ",&P  CB(  (\L  "/.   CT8  (]6  "/:   CWX  (^5
M  ".JP  C<$  (W<  ",ZP!970  3E\  $-B   X9@  +FP  "1Q   <=P
M%'P   Z!   (A0   (D   "-    D    )(   "3    E    )8#  "7"
MF P  )H/  ";$P  G1H  )\C  "@+@  H#P  *!,  "@7@  H'0  )^,  "?
MH@  G[<  )[+  ">X !39   1V@  #QM   Q<P  )WD  !U_   4A0  #8L
M  :0    E    )@   "<    GP   *$   "B    I    *4   "G    J 0
M *H)  "L#0  K1(  + 9  "R(P  LC$  +)"  "R5   LFD  +*   "RF
ML:P  +*_  "QS@!,;@  0',  #5Z   J@0  'X@  !6.   .E0  !IH   "?
M    I    *@   "L    KP   +$   "Q    LP   +4   "V    N    +H
M  "\!@  O@P  , 1  ##&0  Q28  ,4W  #&20  QET  ,=R  #'B@  R)\
M ,BO  #(O !&>@  .8$  "Z)   BD   %Y@   ^?   'I0   *H   "O
MLP   +<   "\    OP   ,$   #"    Q    ,4   #'    R0   ,L   #-
M    SP,  -(*  #6$   W!H  -TJ  #>/   WU   .!E  #A>P  X9$  .*B
M  #BK0#_  ( _P   /\  P#_  P _P 3 /\ '0#_ "@ _@ S /L /@#W $@
M\P!0 /  5P#M %X ZP!D .@ :0#G &\ Y0!T ., >0#B '\ X "% -X C #<
M ), V0"< -8 I@#3 +$ T0#  ,\ V@#. /$ S #_ ,L _P#+ /\ Q@#_ ,$
M_P#_    _P   /\   #_  @ ^P 0 /8 &0#R "0 [P N .T .0#H $( XP!+
M .  4@#= %D V0!? -8 9 #3 &D T0!N ,\ = #. 'D S !_ ,H A@#( (X
MQ@"6 ,0 H #" *L P "Y +X S0"\ .H NP#\ +H _P"Z /\ N@#_ +8 _P#_
M    _P   /X   #T  0 ZP - .0 % #? !\ VP I -@ ,P#3 #T S@!% ,H
M30#' %, Q0!9 ,, 7P#! &0 OP!I +T ;@"[ ', N@!Y +@ @ "V (@ M "0
M +( F@"Q *4 KP"R *T Q "L .$ JP#V *H _P"J /\ J@#_ *H _P#_
M_0   .X   #B    U0 * ,T $0#' !D Q  C ,$ +0"_ #< NP _ +< 1P"U
M $X L@!3 +  60"O %X K0!C *P : "K &T J0!S *@ >@"F ($ I "* *,
ME "A )\ GP"L )X NP"< -( FP#N )H _P": /\ F0#_ )D _P#^    [@
M -X   #+    P0 % +D #0"T !0 L0 > *X )P"K #  J@ Y *< 00"D $@
MH@!- *$ 4P"? %@ G@!= )T 8@"; &< F@!M )@ <P"7 'L E0"$ )0 C@"2
M )D D "F (X M "- ,@ C #F (L ^0"* /\ B@#_ (L _P#P    VP   ,<
M  "Z    L    *@ "@"D !  H  8 )T (0"; "H F@ S )@ .P"6 $$ E !(
M )( 30"1 %( CP!7 (X 7 ", &$ BP!G (H ;@"( '4 AP!^ (4 B "# )0
M@@"@ (  KP!_ ,  ?@#= 'T \@!] /\ ?0#_ 'T _P#@    Q@   +4   "J
M    H@   )L !0"5  T D@ 3 )  ' "- "0 BP M (H - "( #L A@!" (4
M1P"# $T @@!2 ($ 5P!_ %P ?@!B 'T : ![ '  >@!Y '@ @P!V (\ =0"<
M '0 J@!R +H <0#1 '  [ !P /L < #_ '  _P#-!   MP8  *<'  ";!@
MDP0  (X   "*  @ A@ / (0 %@"! !X ?P G 'T +@!\ #8 >@ \ 'D 0@!W
M $< =@!, '4 4@!S %< <@!= '$ 8P!O &L ;@!T &P ?@!K (H :0"8 &@
MI@!G +8 9@#+ &4 YP!E /< 90#_ &4 _P# #   JPT  )L.  "/#@  A@T
M ($+  !^!P$ ? $+ 'D $0!W !@ =0 A ', *0!Q #  ;P V &X / !L $(
M:P!' &H 30!I %( : !8 &8 7P!E &< 8P!P &(!>@!@ 8< 7P*5 %X"HP!<
M [, 7 /' %L$Y !;!?0 6P;^ %L&_P"U$   H1(  )$3  "%$P  ?!(  '81
M  !S#@  <@P$ '$'#0!N!!( ; 0; &D%(P!G!2H 9@8Q &0&-P!C!CT 8@=#
M &$'20!?!TX 7@A5 %T(7 !;"6, 6@EM %@*> !7"H4 5@N3 %0+H@!3"[,
M4@S' %(,Y !1#?4 40W_ %$-_P"M%0  F1<  (D8  !]&0  =!@  &T7  !J
M%   9Q$  &<.!P!F# X 8PP5 &$,'0!?#"4 70TL %P-,P!;#3D 6@T_ %@-
M10!7#4L 5@Y1 %4.60!3#F$ 4@YK % /=@!.$(, 31"2 $P0H@!+$+( 2A'(
M $D1Y0!)$?< 21+_ $D1_P"E&0  DAP  (,=  !V'@  ;1T  &8<  !B&@
M7Q<  %X4 0!>$0H 6Q 1 %D1& !7$2  51$G %01+@!3$30 41$[ % 200!/
M$D< 3A). $P250!+$UX 21-G $@4<P!&%(  116/ $05GP!#%K  0A;% $(7
MXP!"%_8 0A?_ $(7_P"?'0  C"   'TA  !Q(@  :"(  &$A  !<'P  61P
M %<9  !5%@8 5!4. %$5% !/%AP 3A8C $P6*@!+%C  2A8W $D7/0!'%T,
M1A=* $484@!#&%H 0AED $$9<  _&GT /AN- #T;G0 \'*X .QS# #L<X0 [
M'?4 .QS_ #P<_P":(0  AR,  '@D  !L)0  8R4  %PD  !7(P  4R   %$>
M  !/' ( 31L, $L:$0!(&Q@ 1QL@ $4;)@!$&RT 0QPS $(<.0! '$  /QU'
M #X=3P ]'E@ /!YB #H?;0 Y'WL .""+ #<AFP V(:T -2'! #4AWP U(?,
M-B'_ #8A_P"6(P  @R8  '0G  !H*   7R@  %@G  !3)@  3R0  $PB  !)
M(   1R ) $0?#P!"'Q4 0" < #\@(P ^("D /" O #LA-@ Z(3T .2%$ #@B
M3  W(E4 -B-? #0C:P S)'D ,B6) #$EF@ P):L ,":_ "\FW  P)O( ,";_
M #$E_P"1)@  ?R@  '$J  !E*@  7"H  %4J  !/*0  2R@  $@E  !$)
M020% #\D#0 ])!( .R09 #DD'P W)"8 -B0L #4E,P T)3H ,R9! #(F2@ Q
M)U, ,"== "\H:0 N*7< +2F' "PIF  K*JH *BJ] "HJV@ K*O$ *RK^ "PI
M_P"-*   ?"H  &TL  !B+0  62T  %$M  !,+   1RL  $,H   _*   /"@"
M #DH"P W*!  -2@6 #,H'  R*", ,"@I "\I,  O*C< +BH_ "TK1P L*U$
M*RQ; "HL9P I+74 *"V% "<MEP F+J@ )2Z\ "4NV  F+O  )B[] "<M_P"*
M*P  >"T  &HN  !?+P  5B\  $XO  !(+@  0RT  #\L   [+   -RP  #0L
M"0 R+ X ,"T3 "XM&@ M+2  *RTG "HN+0 J+C4 *2\] "@O10 G,$X )C!9
M "4Q90 D,7, (S&# "(RE0 A,J< (3*[ " RU  A,N\ (C'\ "(Q_P"&+0
M=2\  &<P  !<,0  4S$  $LQ  !%,0  0#   #LP   V,   ,S   # Q!@ M
M,0T *S$1 "DR%P H,AX )S(D "4S*P E,S( )#,Z ",T0P B-$P (357 " U
M8P ?-7$ 'C:! !TVDP <-J4 &S:Y !LVT@ <-NT '3;[ !TU_P"",   <3(
M &,S  !9-   4#0  $DT  !",P  /3,  #<S   Q-   +C4  "LU @ H-@L
M)3<0 "0W%0 B-QL (3@B " X*  ?.#  'C@W !TY0  <.4D &SI4 !HZ8  9
M.FX &#I_ !<[D0 7.Z0 %CNW !4[T  6.NP %SKZ !@Y_P!],@  ;30  & U
M  !5-@  338  $8V  ! -@  .C8  #0V   N.   *CD  "8Z   C.P@ (#P.
M !X]$@ =/1@ '#T? !L^)0 :/BT &3XT !<^/0 6/T< %3]1 !0_7@ 4/VP
M$T!\ !) CP 10*( $4"V !! S@ 1/^L $C_Y !(^_P!Y-0  :3<  %PX  !2
M.0  2CD  $,Y   ].0  -SD  #$Z   K/   )ST  "(_   >000 &D(+ !A#
M$  70Q4 %40; !1$(@ 31"D $T0Q !)$.@ 114, $$5. !!%6P .16D #D5Y
M  U%C  -19\ #$6R  M%R0 ,1>4 #43V  U$_P!T.0  93H  %@[  !/.P
M1SP  $ \   Z/   -#P  "X^   H0   (T(  !]$   :1@  %4@( !)*#0 1
M2A( $$H8  ]+'@ .2R4 #4LM  U+-@ ,2T  "TM*  I+5@ )2V0 "$MT  =+
MAP %2YH !$NN  1*Q  %2N  !4KP  9)^@!N/   8#T  %0^  !+/@  1#X
M #T^   W/P  ,4   "I"   D10  'T<  !I)   53   $4X%  Y1"P +41
M"E$4  E1&P (42( !U$I  51,@ $4CL  U)&  %24@  4E\  %)O  !2@0
M498  %&I  !1OP  4-P  %#N  !0]P!H0   6T$  %!!  !(00  04$  #M"
M   T0P  +44  "9(   @2P  &TT  !90   14P  #E4$  I8"@ &6 X  E@2
M  !9%P  61T  %DE  !9+0  638  %E!  !930  6EH  %II  !9?   69
M %FE  !8N@  6-4  %?L  !7]@!C1   5D4  $U%  !%10  /T4  #='   O
M20  *$P  ")/   ;4@  %E4  !%8   -6@  "5T#  1?"0  8 T  & 0  !A
M%   81D  &(@  !B)P  8C$  &([  !B1P  8E4  &-D  !B=@  8HL  &*@
M  !AM@  8<\  &#J  !@]0!=2   4DD  $I(  !#2   .DH  #)-   J4
M(U,  !Q7   66@  $5T   U@   (8P   V8!  !G!@  : L  &D.  !J$0
M:Q4  &P;  !M(@  ;2H  &TT  !M0   ;4X  &U=  !M;P  ;80  &R:  !L
ML   :\@  &OF  !J\P!830  3DT  $A,   ^3@  -5$  "Q4   D6   '5P
M !9@   09   #&<   =K   !;@   '    !R P  <@<  ',+  !U#@  =A$
M '<6  !X'   >2,  'HM  !Z.0  >D<  'I6  !Y:   >GP  'F4  !XJ@
M>,$  '??  !W[P!440  3%$  $)2   X50  +UD  "9>   >8@  %F<  !!K
M   +;P  !7,   !W    >@   'P   !^    ?P(  ( &  "!"@  @PT  (01
M  "&%0  B!P  (DE  "*,   BCX  (E-  ")7P  B7,  (B+  "(H@  A[D
M (?1  "&Z !25@  1U<  #Q:   R7P  *&0  !]I   6;P  $'0   IY   "
M?0   ($   "%    B    (H   ",    C0   (\   "0!   D@@  ),,  "5
M$   EQ4  )D=  ";)P  FS0  )M$  ":5@  FFH  )F"  ":F@  F+   )C'
M  "7W@!+7   0&   #5E   K:@  (7$  !=W   0?0  "8,   &(    C
M )$   "5    F    )H   ";    G0   )\   "@    H@   *0%  "F"@
MJ X  *H4  "M'0  K2H  *TY  "M2P  K5\  *UW  "LD   JZ<  *NZ  "K
MRP!%9@  .6L  "YQ   C>   &7\  !"&   )C0   ),   "8    G0   *$
M  "E    J    *L   "K    K@   *\   "Q    LP   +4   "W 0  N0<
M +P-  "_$P  PA\  ,(N  #"0   PE0  ,%K  #!@P  P)L  ,&M  #!O  ^
M<@  ,G@  ">    <B   $I    J7    G0   *,   "H    K0   +(   "V
M    N0   +L   "\    O@   ,    #"    Q    ,8   #(    RP   ,X%
M  #1#0  UA0  -<C  #8-0  V4D  -I>  #;=0  VXP  -R?  #<JP#_
M_P   /\   #_  D _P 0 /\ &0#^ "0 _  O /D .0#T $, \ !+ .T 4@#J
M %D YP!? .0 9 #B &D X !N -X <P#< 'D V@!_ -< A@#4 (X T0"6 ,\
MH0#, *P R@"[ ,@ T@#& .X Q@#_ ,4 _P#% /\ OP#_ +H _P#_    _P
M /\   #^  4 ]P . /( %0#N !\ ZP J .D - #C #T W@!% -D 30#4 %,
MT0!9 ,X 7@#, &, R@!H ,D ;0#' ', Q0!Y ,, @ #! (@ OP"0 +T FP"[
M *8 N0"T +< R "V .8 M0#[ +0 _P"T /\ LP#_ *X _P#_    _P   /@
M  #M    Y0 + -T $0#7 !H T@ D ,\ +@#+ #< QP!  ,, 1P#  $X O@!3
M +P 60"Z %X N !C +8 : "U &T LP!S +$ >0"O ($ K0"* *L E "I *
MJ "M *8 O@"E -L I #T *0 _P"C /\ HP#_ *( _P#_    ]@   .8   #7
M    RP & ,0 #@"^ !4 NP ? +D * "W #$ M  Z +  00"M $@ JP!. *D
M4P"G %@ I@!< *0 80"C &< H0!L *  <P"> 'H G0"# )L C@"9 )D EP"F
M )8 M@"5 ,P E #K ), _0"3 /\ DP#_ ), _P#W    Y    -    #!
MMP " *\ "P"K !$ IP 9 *4 (@"C "L H@ S )\ .P"< $( FP!( )D 30"7
M %( E@!7 )4 6P"3 &$ D@!F )  ;0"/ '0 C0!] (P AP"* ), B "@ (<
MKP"% ,( A0#B (0 ]P"$ /\ A #_ (0 _P#E    S0   +P   "O    I@
M )X !P":  X E@ 4 )0 '0"2 "4 D0 M )  -0"- #P C !" (H 1P"( $P
MAP!1 (8 5@"$ %L @P!@ ($ 9P"  &X ?@!W 'T @0![ (T >@": '@ J0!W
M +H =@#3 '8 [P!V /X =0#_ '4 _P#0    NP   *L   "?    EP   )
M @"+  L B  0 (8 %P"$ "  @@ G ($ +P!_ #4 ?0 \ 'P 00![ $8 >0!+
M '@ 4 !W %4 =@!; '0 80!S &D <0!Q '  >P!N (< ;0"5 &L HP!J +0
M:@#) &D Z !I /D :0#_ &D _P#     K    )P"  "0 @  B    (,   !_
M  8 >P - 'D $@!W !H =@ B '0 *0!S #  <0 V '  / !O $$ ;0!& &P
M2P!K %  :@!6 &@ 7 !G &0 90!L &0 =@!C (( 80"0 &  GP!? *\ 7@##
M %X X0!> /0 70#_ %T _P"T!P  H D  ) +  "$"P  ? H  '<'  !T!
M<0 ) &\ #P!M !4 :P < &D (P!H "H 9P Q &4 -@!D #P 8P!! &( 1@!@
M $P 7P!2 %X 6 != %\ 6P!H %H <@!8 'X 5P", %8 FP!5 *L 5 "^ %0
MV@!3 .\ 5 #[ %0 _P"I#0  E@X  (<0  !Z$   <A   &P.  !I#   9PD#
M &8$"P!D !  8@ 7 &  '@!> "4 70 K %P ,0!: #< 60 \ %@ 0@!7 4<
M5@%. %4"5 !3 EP 4@-E %$#;P!/!'L 3@2* $T%F0!,!:D 2P6\ $H&U !*
M!^T 2@?Y $H'_P"A$   CA(  'X4  !S%   :A0  &03  !@$0  7@\  %T-
M!0!="0T 6@82 %@'&0!6!R  50<G %,'+0!2"#, 40@X % (/@!/"40 3@E*
M $P)40!+"ED 2@IB $@+;0!'"WH 1@R( $0,F !##*D 0@V\ $(-U0!"#>X
M0@W[ $(-_P":%   AQ8  '@8  !L&0  8QD  %T8  !9%@  5A,  %01  !4
M#@@ 4PT. %$-% !/#1L 30TB $P-* !+#2X 2@TT $D-.@!'#D$ 1@Y' $4.
M3P!$#E< 0@]A $$0;  _$'D /A"( #T1F  [$:D .Q&\ #H1U@ Z$?  .A+]
M #L1_P"3&   @1H  ',<  !G'0  7AT  %@<  !3&P  4!@  $X6  !,$P,
M3!$+ $H0$ !($1< 1A$> $41) !$$2H 0A$P $$1-P! $CT /Q)$ #T23  \
M$U0 .Q-> #D4:0 X%'8 -Q6% #85E@ T%J< -!:Z #,6TP S%NX -!;\ #06
M_P".&P  ?!T  &X?  !C(   6B   %,@  !.'@  2AT  $@:  !&&   118'
M $,5#@!!%1, /Q4: #X5(  ]%2< .Q4M #H6,P Y%CH .!9! #<720 U%U$
M-!A; #,99@ R&7, ,!J# "\:E  N&Z4 +1NX "T;T  M&^P +AO[ "X;_P"*
M'@  >"   &HB  !?(P  5B,  $\B  !*(0  1B   $,>  !!&P  /QH# #T:
M#  [&1$ .1D6 #<:'0 V&B, -1HI #0:,  S&S8 ,1L^ # <1@ O'$\ +AU9
M "T=9  L'G$ *Q^! "H?D@ I'Z0 *""W "<@S@ G(.L *"#Z "D?_P"&(
M=",  &<D  !<)0  4R4  $PE  !')   0B,  #\A   ]'P  .AX  #<>"0 U
M'@X ,QX3 #$>&@ P'B  +QXF "X?+0 M'S, +" [ "L@0P J(4P *2%6 "@B
M8@ F(F\ )2-_ "0CD  C(Z( (B2U "(DS  B).D (R3Y "0C_P""(P  <24
M &,F  !9)P  4"@  $DG  !#)P  /R8  #LD   X(@  -2(  #(B!@ P(@T
M+B(1 "PB%P J(AT *2(C "@C*@ G(S$ )B0X "4E00 D)4H (R94 "(F8  A
M)VT ("=] !\GCP >**$ 'BBT !THR@ =*.@ 'BCX !\G_P!^)0  ;B<  & I
M  !6*0  32H  $8J  !!*0  /"@  #<G   T)@  ,"8  "TF P K)PL *"<0
M "<G%  E)QH )"<A ",H)P B*"X (2DV " I/@ ?*D@ 'BI2 !TK7@ <*VL
M&RM[ !HLC0 9+)\ &"RR !@LR0 8+.< &2OW !HK_P!Z)P  :BH  %TK  !3
M+   2BP  $,L   ^*P  .2L  #0J   P*@  *RH  "DK   F*P@ (RP. "(L
M$@ @+!@ 'RP> !XM)0 =+2P '"TS !LN/  :+D4 &2]0 !@O7  7+VD %C!Y
M !4PBP 4,)X %#"Q !,PQP 3,.4 %##V !4O_P!V*@  9RP  %HM  !0+@
M2"X  $$N   [+@  -BT  #$M   L+0  )R\  "0O   A, 4 'S$, !PQ$  ;
M,A4 &C(< !DR(@ 8,BD %S,Q !8S.0 5,T, %#1- !,T60 2-&< $35W !$U
MB0 0-9P $#6P  XUQ@ /-.0 $#3U ! T_P!R+   8RX  %<P  !-,   13
M #XP   X,   ,S   "\P   I,0  )#(  "$S   =-0( &C8) !<W#@ 5-Q,
M%#@9 !,X'P 2."8 $C@N !$Y-@ 0.4  $#E+  XY5P ..F0 #3IT  PZA@ ,
M.ID "SFL  HYP0 *.=X "SGQ  PX_ !N+P  7S$  %,R  !*,P  0C,  #LS
M   V,P  ,3(  "PS   G-   (38  !TX   9.0  %3L& !(]#  0/A  $#X5
M  X^'  ./B, #3XJ  P^,P ,/CP "S]'  H_4@ (/V  !S]O  8_@0 %/Y0
M!#^H  ,^O  $/M< !3[L  4^]P!I,P  6S0  % U  !'-0  /S4  #DU   T
M-0  +C4  "DW   C.   'CL  !H\   6/P  $D$$  Y#"@ ,1 X "D03  E$
M&0 (1"  !T0G  9$+P %1#@  T5"  )%3@  15L  $5J  !%?   19   $2D
M  !$N0  1-$  $3J  !#]0!D-@  5S<  $PX  !#.   /#@  #<X   Q.
M*SD  "4[   @/0  &D   !9"   21   #D<$  M)"0 '2@T !$L1  %+%@
M2QP  $LC  !+*P  2S0  $L^  !,20  3%<  $QF  !,=P  2XP  $NA  !+
MM0  2LX  $KI  !*]0!?.@  4CL  $@[  ! .P  .CL  #0[   N/   )SX
M ")!   <0P  %D8  !))   .2P  "TX#  =0"  "40P  %$0  !2$P  4Q@
M %,?  !3)@  4R\  %,Y  !310  4U(  %-A  !3<@  4X<  %*<  !2L0
M4<H  %'G  !1] !9/@  3CX  $4^   ^/@  .#X  #!    I0@  (T0  !U'
M   72@  $DT   Y0   +4P  !E4"  !7!P  6 L  %D.  !:$0  6A4  %L:
M  !<(0  7"H  %PT  !</P  7$T  %Q;  !<;   7($  %N7  !;K0  6L4
M %KD  !9\P!40@  2D(  $)"   \0@  -$,  "Q&   E20  'DP  !=/   2
M4P  #E8   I9   %6P   %X   !@!   80@  &(,  !C#@  9!$  &46  !F
M'   9R,  &<M  !G.0  9T8  &=5  !G9@  9WH  &:1  !EJ   9<   &3>
M  !D\ !/1@  1T8  $!%   W1P  +TH  "9-   ?40  &%4  !)9   -7
M"&    )C    9@   &@   !J    :P0  &P(  !M#   ;PX  ' 2  !R%P
M<QT  '0F  !T,@  =#\  '1.  !S7P  ='(  '.*  !RH0  <;@  ''4  !P
M[ !,2@  14H  #M+   R3@  *5(  "!6   86P  $E\   UD   ':    &L
M  !O    <@   '4   !V    =P   'D"  !Z!@  ? H  'X.  " $0  @A8
M (0>  "$*0  A#8  (1%  "$5@  @VH  (.!  ""F0  @;$  (#)  " Y0!*
M3@  /U   #53   K5P  (EP  !EB   29P  #&P   5Q    =0   'D   !]
M    @0   (,   "%    A@   (@   ")    BP0  (T(  "/#0  DA   )06
M  "6(   EBP  )8[  "63   E6   )5V  "4D   DZ<  )*]  "2U0!$50
M.5D  "]=   D8P  &FD  !)O   ,=0  !'L   "     A0   (D   "-
MD0   ),   "4    E@   )@   ":    G    )X   "@!@  H@L  *40  "H
M%P  J2,  *DQ  "I0P  J58  *AM  "FAP  IYX  *:S  "EQP ^7@  ,F,
M "=J   =<   $W@   Q_   #A0   (L   "1    E@   )L   "?    H@
M *0   "E    IP   *D   "K    K0   +    "R    M0(  +<)  "[$
MOA@  +XF  "^.   ODL  +UA  "\>@  NY0  +JI  "ZN0 W:@  *W   "!X
M   6@   #8@   6/    E@   )P   "B    IP   *P   "P    LP   +8
M  "W    N0   +L   "]    OP   ,(   #%    R    ,H   #."   TA
M -4;  #5+   U$   -17  #3;@  U(8  -2;  #3JP#_    _P   /\   #_
M  4 _P . /\ %0#\ "  ^0 J /8 - #Q #T [0!& .D 30#F %, Y !9 .$
M7@#> &, W !H -D ;@#5 ', TP!Y -  @ #. (@ RP"1 ,D G #& *< Q "W
M ,( S #  .P OP#_ +X _P"] /\ MP#_ +( _P#_    _P   /\   #Z  $
M\P + .T $@#H !L Y0 E .0 +@#? #@ V !  -( 1P#. $X RP!4 ,@ 60#&
M %X Q !C ,( 9P#  &T OP!S +T >@"[ ($ N0"+ +8 E0"T *$ L@"O +
MP@"N ., K@#Z *P _P"M /\ J0#_ *8 _P#_    _P   /(   #F    W0 '
M -( #@#- !8 R@ @ ,@ *0#% #( P  Z +P 0@"Y $@ MP!. +4 4P"S %@
ML0!= +  8@"N &< K !L *H <P"I 'L IP"$ *4 C@"C )H H0"H )\ N0">
M -( G0#R )P _P"= /\ G #_ )D _P#\    [@   -T   #,    P0 " +H
M# "V !( L@ : +  (P"O "P K0 T *D / "F $( I !( *( 30"@ %( G@!7
M )T 6P"< &  F@!F )D ; "7 '0 E0!] ), AP"1 ), D "A (X L0"- ,8
MC #H (L _0", /\ C #_ (P _P#M    V    ,4   "W    K    *8 " "A
M  X GP 5 )T '@"; "8 F@ N )< -0"5 #P DP!" )$ 1P"0 $P C@!1 (T
M50"+ %H B@!@ (D 9@"' &T A0!V (0 @ "" (P @ ": '\ J0!] +P ? #<
M 'P ]0!\ /\ ? #_ 'P _P#9    P0   +$   "D    G    )0  P"0  P
MC0 1 (L & ") "  B0 H (< +P"% #8 @P \ (( 00"  $8 ?P!+ 'T 3P!\
M %0 >P!: 'D 8 !X &< =@!P '4 >@!S (8 <0"3 '  H@!O +0 ;@#, &X
M[0!N /X ;@#_ &X _P#$    KP   *    "4    C    (8   "!  @ ?@ .
M 'P % ![ !L >0 B '@ *0!W #  =0 V '0 .P!R $  <0!% '  2@!O $\
M;0!4 &P 6P!K &( :0!J &@ = !F (  90". &, G0!B *T 80#" &$ Y !A
M /@ 80#_ &$ _P"T    H    )$   "&    ?@   'D   !U  , <0 + &\
M$ !M !8 ;  = &L ) !K "H :0 P &@ -@!F #L 90!  &0 10!C $H 80!/
M &  5@!? %T 70!E %P ;P!: 'H 60"( %@ F !7 *@ 5@"[ %8 V !6 /$
M5@#_ %8 _P"H 0  E 4  (4'  !Z!P  <@8  &P$  !I 0  9P ' &0 #0!C
M !$ 80 8 &  'P!? "4 7@ K %T , !; #8 6@ [ %D 0 !8 $4 5P!+ %8
M40!5 %@ 4P!A %( :@!0 '8 3P"$ $X DP!- *0 3 "V $P S0!, .L 3 #Z
M $P _P"="0  BPL  'P-  !P#0  : T  &(,  !?"@  708! %P!"0!:  X
M6  3 %< &0!6 "  50 F %, *P!2 #$ 40 V %  .P!/ $$ 3@!' $T 30!+
M %4 2@!= $D 9P!' ', 1@"  $4 D !$ *$ 0P"R $, R !# .8 0P#U $,
M_P"5#0  @P\  '00  !I$0  8!$  %H0  !6#@  5 T  %,*! !3!@L 40,0
M $\!%0!. 1L 3 $A $L!)P!* BP 20(R $@"-P!' ST 10-# $0#2@!#!%$
M0@1: $ %9  _!7  /@9^ #T&C@ \!Y\ .P>Q #H'Q@ Z!^, .@?S #H(_ ".
M$   ?!(  &X4  !B%0  6A4  %04  !0$P  31$  $L.  !+#08 2@H, $D(
M$0!'"!8 10@= $0((P!"""@ 00DN $ ),P _"3D /@I  #T*1P \"D\ .@M8
M #D+8P X#&\ -@Q^ #4,C@ T#9\ ,PVQ #(-QP R#>, ,@WT #(-_@"($P
M=Q4  &D7  !>&   51@  $\8  !*%@  1Q4  $43  !#$ ( 0PX( $(-#@!
M#1( /PT8 #T-'P \#20 .PTJ #D-,  X#C< -PX] #8.10 U#DT ,P]7 #(/
M8@ Q$&X +Q!] "X0C@ M$:  +!&R "L1R  K$>8 *Q'V "P1_P"#%@  <AD
M &0:  !9&P  41L  $L;  !&&@  0A@  #\7   ^%   /!($ #L1"@ Z$!
M.! 5 #<0&P U$2$ -!$G #,1+0 R$3, ,!$Z "\20@ N$DL +1-4 "L37P J
M%&P *11[ "@4C  G%9X )A6P "45Q@ E%>0 )17V "85_P!^&0  ;AL  & =
M  !6'@  31X  $<>  !"'0  /AP  #H:   X&   -Q8  #45!P T% T ,A02
M # 4%P O%!T +10C "P5*@ K%3  *A4W "D6/P H%D@ )Q=2 "8870 D&&H
M(QEY "(9B@ A&9P (!FO !\9Q  ?&>( (!GT " 9_P!Z&P  :AX  %T?  !3
M(   2B   $0@   ^'P  .AX  #<=   T'   ,AD  # 9!  N& L +!@0 "H8
M%  I&!H )Q@@ "89)@ E&2T )!HU ",:/0 B&T8 (1M0 " <6P ?'6@ 'AUW
M !T=B  <'IL &QZM !H>PP :'N  &AWS !L=_P!W'0  9R   %HA  !0(@
M2"(  $$B   [(@  -R$  #,@   P'P  +1T  "L=   H'0@ )AT. "4=$@ C
M'1< (1T= "$=)  @'BH 'QXR !X?.@ ='T, '"!- !LA60 :(68 &2%U !@B
MAP 7(ID %B*L !4BP0 5(M\ %2'R !8A_@!S(   9"(  %<C  !-)   124
M #XD   Y)   -",  # B   L(@  *2$  "8A   D(08 (B$, " A$  >(14
M'2(; !LB(0 ;(B@ &B,O !DC.  8)$$ %R1+ !8E5P 5)60 %"9S !,FA0 2
M)I@ $2:K !$FP  0)MT $27Q !(E_0!P(@  820  %0F  !*)@  0B<  #PF
M   V)@  ,24  "TE   I)   )B0  "(E   ?)0, '28* !LF#@ 9)Q( &"<8
M !<G'P 6)R4 %2@M !0H-0 3*3X $BE) !$I50 1*F( $"IQ  \J@P .*I8
M#BJI  TJO0 -*M< #2KN  XI^P!L)   728  %$H  !(*   0"D  #DH   T
M*   +R@  "LG   G)P  (B@  !XI   ;*@  &"L' !8K#0 4+!$ $RP6 !(L
M'  1+2, $"TJ ! M,@ /+CP #BY&  TN4@ -+E\ #"]N  LO?P *+Y( "2^E
M  DNN0 (+M  "2[I  HN]P!H)P  6BD  $XJ  !%*P  /2L  #<K   Q*@
M+2H  "DJ   D*@  ("L  !LM   8+@  %2\$ !(Q"@ 0,@X #S(3  XR&0 -
M,B  #3(G  PR+P +,S@ "C-"  DS3@ (,UL !C1J  4T>P $,XX  S.B  (S
MM@ ",\T  S/G  0R\P!D*@  5BP  $LM  !"+0  .BT  #0M   O+   *RP
M "8L   B+0  '2\  !DQ   5,@  $C0#  \V"0 ,. T "C@1  DX%@ (.!T
M!S@D  8X+  $.#0  S@^  (Y2@  .5<  #EE   Y=P  .8L  #B?   XLP
M.,H  #CF   W\@!?+0  4BX  $@O   _,   ."\  #(O   M+P  *2\  "0P
M   ?,0  &C,  !4U   2-P  #SD#  P["  (/0T !3X0  ,^%   /AH  #XA
M   ^*   /C$  #\[   _1@  /U,  #]A   _<P  /X<  #Z<   ^L   /<<
M #WD   ]\@!:,   3C(  $0R   \,@  -3(  # Q   K,0  )C(  " T   ;
M-@  %C@  !([   //0  ##\#  A!"  $0PP  $,.  !$$@  118  $4=  !%
M)   12T  $8V  !&0@  1DX  $9=  !&;@  18(  $68  !$K0  1,0  $/C
M  !#\@!5-   2C4  $$U   Y-0  ,S0  "XT   H-0  (C<  !TZ   7/
M$C\   ]!   ,1   "$8!  -(!@  20H  $H-  !+$   3!0  $T9  !.(
M3B@  $XR  !-/0  3DH  $Y8  !-:0  37T  $R4  !,J@  2\$  $OA  !*
M\@!0.   1C@  #TX   W.   ,3<  "HY   D.P  'CT  !A    30P  #T8
M  M)   '2P   DX   !0!   40@  %(+  !3#@  5!$  %45  !6&P  5R,
M %<L  !7.   5T0  %=2  !68P  5G<  %:.  !5I0  5+T  %/=  !3\ !+
M/   0CP  #L[   U.P  +3P  "8_   ?0@  &44  !-(   .2P  "T\   51
M    5    %<   !8 0  6@4  %L(  !<#   70X  %\1  !@%@  8AT  &(F
M  !B,0  8CX  &%,  !A70  87   &"(  !@H   7[<  %[4  !=[@!'0
M/S\  #H_   Q0   *4,  "%&   :2@  $TX   Y1   *50  !%@   !;
M7@   &$   !C    9 $  &4$  !G"   : L  &H.  !L$@  ;A<  &\@  !O
M*@  ;S8  &Y%  !N50  ;F@  &U_  !MF   ;+   &O*  !JZ !$1   /D,
M #5$   K1P  (TL  !M/   35   #E@   A<   "8    &0   !G    :P
M &T   !O    <    '(   !T @  =08  '<*  !Y#@  ?!(  'X8  !_(@
M?RX  '\]  !^30  ?6$  'UW  !\D   >Z@  'K   !YWP!#1P  .4D  "],
M   E4   '%4  !1;   .8   !V4   !J    ;@   '(   !V    >0   'P
M  !^    ?P   ($   "#    A0   (<#  "*"   C T  (\1  "2&0  DB4
M )(S  "21   D5<  )!M  "/A@  CI\  (VU  ",S0 ]3@  ,E$  "A6   >
M7   %6(   YH   ';@   '0   !Y    ?@   ((   "&    B0   (P   ".
M    D    )(   "4    E@   )@   ";    G@8  *$,  "D$0  IAL  *8I
M  "F.@  I4T  *5B  "D>P  HY0  *&K  "AOP V5P  +%P  "%B   7:0
M#W    =W    ?@   (0   "*    CP   )0   "8    FP   )X   "?
MH@   *0   "F    J    *L   "M    L    +,$  "W#   NQ(  +L?  "[
M,   NT,  +I8  "Y<   MXL  +>A  "WLP P8@  )6D  !IP   0>   "8
M  "(    CP   )8   ";    H0   *8   "J    K@   +    "Q    M
M +8   "X    NP   +T   #     PP   ,<   #+ P  SPP  -,5  #2)0
MTC@  -%.  #090  SWX  ,V6  #,J0#_    _P   /\   #_  , _P + /P
M$0#Y !L ]P E /, +P#N #@ Z0!  .8 2 #B $X WP!4 -P 60#9 %X U0!C
M -, : #0 &T S@!S ,L >@#( (( Q@", ,, EP#  *, O@"R +P R "Z .H
MN0#_ +@ _P"Q /\ J@#_ *< _P#_    _P   /L   #V    [0 ' .< #P#B
M !8 WP @ -X *0#9 #, T0 [ ,P 0@#( $@ Q0!. ,( 4P#  %@ O@!= +P
M8@"Z &< N0!M +< = "U 'L L@"% +  D "N )P K "J *D O0"G -X I@#Y
M *4 _P"C /\ G0#_ )L _P#]    ]@   .L   #?    T0 # ,H # #% !(
MPP ; ,  ) "^ "P N0 U +8 / "S $, L !( *X 3@"L %( JP!7 *D 7 "G
M &$ I@!G *0 ;0"B '0 H !] )X B "< )4 F@"C )@ M "6 ,T E0#Q )0
M_P"5 /\ D #_ (X _P#S    Y@   -$   #"    N    +$ " "M  \ J@ 6
M *@ '@"H "< I@ O *( -@"? #P G0!" )L 1P"9 $P EP!1 )8 50"4 %H
MDP!@ )$ 9@"0 &X C@!V (P @0"* (T B "; (8 K "% ,$ A #F (, _0"$
M /\ @P#_ ($ _P#D    RP   +H   "L    H@   )P ! "8  P E@ 1 )0
M&0"3 "$ D@ H (\ , "- #8 BP \ (D 00"( $8 A@!+ (4 3P"$ %0 @@!:
M ($ 8 !_ &< ?@!O 'P >@!Z (8 > "4 '< I !U +< = #4 ', ] !T /\
M= #_ '0 _P#+    M@   *8   ":    D@   (H   "&  @ @P . ($ % "!
M !L @  C '\ *@!] #  >P V 'H .P!X $  =P!% '4 20!T $X <P!4 '$
M6@!P &$ ;@!I &T <P!K '\ :0"- &@ G0!G *X 9@#' &4 Z@!F /\ 9@#_
M &< _P"X    I    )4   "*    @0   'P   !V  0 =  , '( $ !Q !8
M<  = '  ) !N "H ;0 P &L -0!J #H :0 _ &@ 1 !G $D 90!. &0 5 !C
M %L 80!C &  ;0!> 'D 70"' %L E@!: *@ 60"] %D WP!9 /@ 6@#_ %H
M_P"H    E0   (<   ![    <P   &X   !J  $ 9P ( &4 #@!D !( 8P 8
M &, 'P!B "4 80 J %\ , !> #4 70 Z %P /@!; $0 60!) %@ 3P!7 %8
M5@!> %0 : !3 ', 40"! %  D0!/ *( 3@"U $X T !. /  3@#_ $\ _P"<
M    B0   'L#  !P P  : ,  &(!  !?    70 $ %L "P!9  \ 6  4 %<
M&0!7 "  5@ E %4 *@!3 #  4@ T %$ .0!0 #\ 3P!$ $X 2P!- %( 2P!:
M $H 8P!) &\ 1P!\ $8 C !% )T 10"P $0 QP!$ .@ 1 #Z $4 _P"2!
M@ <  '$*  !F"@  7@H  %D)  !5!P  5 0  %( !P!0  P 3P 0 $X %0!-
M !L 3  @ $L )@!* "L 20 P $@ -0!' #H 1@!  $4 1@!# $X 0@!6 $$
M7P!  &L /@!X #T B  \ )D / "K #P P0 [ .  .P#T #L _P")"@  > P
M &H.  !?#@  5PX  %$.  !-#   2PL  $H( @!)! D 2  - $8 $0!% !8
M1  < $, (0!" "8 00 K #\ ,0 ^ #8 /0 \ #P 0P [ $H .@!2 #D 7  X
M &@ -@!U #4 A0 T )8 - "H #, O  S -@ ,P#O #, ^P""#0  <0\  &00
M  !9$0  41$  $L1  !'$   1 X  $(-  !!"P4 00<+ #\%#@ ^ Q( / (8
M #L"'0 Z R( .0,H #@#+0 W S( -@0Y #4$/P T!4< ,P50 #$&6@ P!F8
M+P=S "X'@P M!Y4 + >G "L'N@ K!]( *P?K "L']P!]$   ;!$  %\3  !4
M%   3!0  $84  !"$P  /A(  #P0   Z#@$ .@T& #H*#  X"1  -@@4 #4(
M&0 T"1\ ,@DD #$)*0 P"2\ +PHV "X*/0 M"D4 + M. "L+60 I#&4 * QS
M "<,@P F#94 )0VG "0-NP C#=( (PWK ",-]P!X$@  :!0  %L6  !1%P
M2!<  $(6   ]%@  .14  #<3   U$0  ,Q # #,."  R#0T , T1 "\-%@ M
M#1L + TA "L-)P J#2T *0XT "@..P G#D0 )0Y. "0/60 C$&4 (1!S " 0
MA  ?$)8 'A"I !T0O0 <$-@ '1#N !T0^0!S%   9!8  %<8  !-&0  11D
M #\9   Z&   -1<  #(6   P%0  +A,  "T1!  L$ H *Q . "D0$@ H$!@
M)A > "40)  D$"H (Q$Q "(1.0 A$4( (!)+ !X25@ =$V, '!-Q !H3@@ 9
M%)4 &!2G !<4NP 7$]0 %Q/N !@3^@!P%@  8!D  %0:  !*&P  0AP  #P;
M   V&P  ,AH  "\9   L&   *A8  "@4 0 F$P< )1,, ",3$  B$Q4 (!,:
M !\3(0 >%"< '10N !P5-@ ;%3\ &A9) !D65  8%V$ %A=P !48@0 4&),
M$QBF !(8N@ 2%]( $A?L !,7^@!L&0  71L  %$=  !''0  /QX  #D=   T
M'0  +QP  "L;   H&@  )AD  "08   B%P0 (!<* !X7#@ <%Q( &A<7 !D8
M'@ 9&"0 &!DL !<9-  6&CT %1I' !0;4@ 3&U\ $AQN !$<?P 0')( $!RE
M  \<N0 .'-  #AOJ  \;^ !I&P  6AT  $X?  !%'P  /2   #8?   Q'P
M+1X  "D=   E'0  (QP  " ;   =&P$ &QL' !D<#0 7'!  %AP5 !4<&P 4
M'2( $QTI !(>,0 1'CH $1]% ! ?4  /(%T #B!L  T@?  -((\ #""B  L@
MM0 +(,H "R#E  P?] !E'0  5Q\  $PA  !"(0  .B$  #0A   O(0  *B
M "8?   C'P  (!X  !T>   9(   %B $ !0@"P 2(0X $2$3 !$B&0 0(A\
M#R(F  XC+P .(S< #2-!  PD30 +)%D "B1G  DD>  ()(L !R2>  <DL0 &
M),< !B/C  <C\0!B'P  5"$  $DC  ! (P  .",  #(C   L(P  *"(  "0A
M   A(0  'B$  !HA   6(P  $R0# !$E"  /)@T #B<1  TG%@ ,)QT "R<C
M  HG*P )*#0 ""@^  <H20 &*%4 !2ED  0I=  #*8<  BF;  $HKP  *,4
M 2CA  $G\ !>(@  420  $8E   ])0  -24  "\E   J)   )B0  "(C   ?
M(P  &R0  !@E   4)@  $2@#  \I"  ,+ P "BP0  @L%  '+!H !BPA  4L
M*  #+3   BTZ  $M10  +5(  "Y@   N<0  +80  "V9   MK0  +,(  "S@
M   L\ !:)   328  $,G   Z)P  ,R<  "TG   H)@  )"8  "$F   =)@
M&2<  !4I   1*P  #RP#  TN!P ), P !C$.  ,Q$@ !,A<  #(>   R)0
M,BT  #(V   S0@  ,TX  #-=   S;0  ,X$  #*6   RJP  ,<$  #'?   Q
M\ !6)P  2BD  #\J   W*@  ,"H  "LI   G*   (R@  !XI   :*@  %BP
M !(N   /,   #3$"  HT!P %-0L  C8.   W$   .!0  #@:   X(@  ."H
M #DS   Y/@  .4H  #E9   Y:0  .7T  #B3   XJ   -[\  #?>   V\ !1
M*P  1BP  #PL   T+   +BP  "HK   E*P  ("P  !LM   7+P  $S$  ! S
M   --0  "3<"  4Z!@ !.PH  #P-   ]#P  /A(  #\7  ! '@  0"4  $ O
M  ! .@  0$8  $!4  ! 90  /W@  #^/   ^I@  /KT  #W<   ]\ !-+@
M0B\  #DO   R+P  +2X  "@N   B+P  '3   !@R   3-0  $#<   PZ   )
M/   !3X   !!!   0@@  $,+  !$#0  1A   $<4  !(&0  2"$  $@J  !(
M-0  2$$  $A/  !(8   1W,  $>*  !&H@  1;D  $79  !$\ !(,@  /C(
M #8R   P,0  *S$  "4R   ?-   &38  !,Y   0/   ##\   A"   #1
M $8   !( @  2@4  $L(  !,"P  3@X  $\1  !1%0  4AP  %(E  !2,
M4CP  %%*  !16@  46T  %"$  !/G0  3K4  $W2  !-[@!#-@  .S8  #0U
M   O-   )S4  "$X   :.P  %#X  !!!   ,1   !T<   )*    30   $\
M  !1    4P(  %0%  !5"   5PL  %D.  !;$0  71<  %T?  !=*@  738
M %Q$  !<5   6V<  %M^  !:EP  6:\  %C+  !7Z@ _.0  .#D  #,X   K
M.0  (SP  !P_   50P  $$<   M*   %3@   %$   !4    5P   %H   !<
M    70   %\   !@!   8@<  &0+  !F#@  :!(  &L9  !K(P  :BX  &H\
M  !J30  :5\  &AU  !GCP  9J@  &7"  !DXP ]/0  -SP  "X]   E0
M'40  !9)   030  "E$   15    6@   %T   !@    8P   &8   !H
M:@   &L   !M    ;P(  '$&  !T"@  =@X  'D3  ![&P  >R<  'HU  !Y
M10  >%D  'AM  !WA@  =I\  '6W  !TT@ \00  ,D(  "A%   @2@  %TX
M !!4   *60   EX   !C    9P   &L   !O    <@   '4   !W    >0
M 'L   !]    ?P   ((   "$ P  APD  (H.  ".$P  CQX  (XK  "..P
MC4X  (MC  "*?   BI4  (BM  "'Q0 V1P  +$L  ")/   950  $%L   IA
M   !9P   &T   !R    =P   'L   !_    @P   (8   "(    B@   (T
M  "/    D0   )0   "7    F@$  )T'  "A#0  I10  *0A  "D,0  HT0
M *)9  "@<   GXL  )VB  "=MP P4   )54  !M;   28@  "VD   %P
M=P   'T   "#    B    (T   "1    E0   )@   ":    G    )\   "A
M    HP   *8   "I    K    +    "T!P  N X  +H8  "Z)P  N3D  +A.
M  "W90  MGX  +66  "SJP I6P  'F(  !1I   ,<0   GD   "!    B0
M (\   "6    FP   *    "D    J    *L   "L    KP   +(   "T
MM@   +D   "\    P    ,0   #(    S0<  -(0  #2'0  T2\  -!$  #/
M6P  S7,  ,N-  #*H0#_    _P   /L   #Z    _  ( /@ #P#U !< ]  @
M /$ *@#K #, Y@ [ .( 0P#> $D V@!/ -8 5 #3 %D T !> ,X 8P#+ &@
MR0!N ,8 =0## 'T P0"& +X D@"[ )X N0"N +8 PP"T .@ LP#_ *\ _P"E
M /\ G@#_ )L _P#]    ]P   /(   #P    YP # .$ # #< !( V  ; -8
M) #2 "T S  V ,8 /0#" $, OP!) +P 3@"Z %, N !8 +8 70"U &( LP!G
M +$ ;@"O '8 K !_ *H B@"H )< I0"F *, N0"A -D H #Y )X _P"8 /\
MD@#_ (\ _P#S    [    .,   #3    R    ,$ "0"]  \ NP 6 +D 'P"W
M "< LP O *\ -P"L #T J@!# *@ 2 "F $T I !2 *, 5@"A %L GP!A )X
M9P"< &\ F@!X )< @P"5 )  DP"> )$ L "0 ,@ C@#P (T _P"* /\ A0#_
M (( _P#G    W0   ,8   "X    K@   *@ ! "E  P H0 2 *$ &0"@ "(
MGP I )L , "8 #< E@ ] ), 0@"2 $< D !+ (\ 4 "- %4 C !: (H 80"(
M &@ AP!P (4 >P"# (@ @0"6 '\ IP!] +P ? #C 'P _0!\ /\ > #_ '8
M_P#6    P    *\   "C    F0   ),   "/  D C0 . (L % "* !P B@ C
M (@ *@"% #  @P V (( .P"  $  ?P!% 'X 2@!\ $\ >P!4 'H 6@!X &$
M=@!I '4 <P!S (  <0". &\ GP!N +( ;0#/ &P ] !L /\ :P#_ &D _P#
M    JP   )L   "/    AP   (    !\  0 >@ , '@ $0!X !< >  > '<
M) !U "H <P P '$ -0!P #H ;@ _ &T 1 !L $D :P!. &H 5 !H %L 9P!C
M &4 ;0!D '@ 8@"' &  EP!? *H 7@#" %X Z0!> /\ 7@#_ %T _P"L
MF0   (H   !_    =P   '$   !M    :@ ( &D #@!H !( 9P 8 &< 'P!G
M "4 90 J &, +P!B #0 80 Y &  /@!? $, 7@!( %T 3@!; %4 6@!= %@
M9P!7 '( 50"! %0 D0!3 *, 4@"X %$ W !1 /D 4@#_ %( _P"=    BP
M 'P   !Q    :0   &0   !@    7@ % %P "P!;  \ 6P 4 %H &0!: !\
M60 E %< *@!6 "\ 50 T %0 . !3 #T 4@!# %  20!/ %  3@!8 $T 8@!+
M &T 2@!Z $D BP!( )T 1P"Q $< S !& /  1P#_ $< _P"0    ?@   '
M  !F    7@   %D   !6    4P ! %( " !0  T 3P 0 $\ %0!. !H 3@ @
M $T )0!, "H 2@ N $D ,P!( #@ 1P ^ $8 1 !% $L 1 !3 $, 70!! &@
M0 !U #\ A0 ^ )< /0"K #T PP ] .8 /0#[ #X _P"'    =0,  &@&  !=
M!P  508  % &  !,!   2@$  $D ! !'  H 1@ . $4 $0!% !8 1  ; $,
M( !" "4 00 J $  +P _ #0 /@ Z #T 0  [ $< .@!/ #D 60 X &0 -P!Q
M #8 @0 U ), - "F #0 NP T -T - #U #4 _P!^!@  ;0D  & +  !6#
M3@P  $@+  !$"@  0@@  $ % 0 _ 0< /@ + #T #@ \ !( .P 7 #L '  Z
M "$ .0 E #< *@ V #  -0 U #0 /  S $, ,@!, #$ 50 P &  +P!M "X
M?0 M (\ + "B "P M@ L -  + #N "P _ !W"@  9PP  %H.  !0#@  20X
M $,.   ^#0  .PP  #D+   X"0, -P4( #8"#0 U 1  -  3 #, &  R !T
M,0 B #  )P O "P +@ R "T .  L $  *P!) "H 4@ I %T * !K "<!>@ F
M 8P )0"? "4 L@ E ,H )0#H "4 ]P!R#0  8@X  %80  !,$0  1!$  #X1
M   Y$   -@\  #,.   Q#0$ , L% # ("@ O!@T +@41 "P$%  K QD *@,>
M "D#(P H!"D )P0O "8%-0 E!3T ) 5& ",&4  B!EP (0=I " '>0 ?!XL
M'@>= !X'L  =!L8 '0;C !T%\P!M#@  7A$  %(2  !($P  0!,  #H3   U
M$@  ,1$  "X0   L#P  *@X# "H-!P I"PL * D. "<)$0 E"!8 ) @; ",)
M(  B"28 (0DL " *,P ?"CL '@M$ !T+3P <#%L &PQI !H,>0 8#(L & R>
M !<,L  6#,4 %@SA !8+\ !I$   6A(  $X4  !%%0  /14  #<5   Q%
M+1,  "H2   H$0  )A ! "00!  C#@@ (PT, "(,#P @#!, 'PP8 !X-'0 =
M#2, ' TJ !L-,@ :#CH & Y$ !<.4  6#UP %0]J !,0>P 2$(T $1"@ !$0
MLP 0#\D $ _D !$/\@!E$@  5Q0  $L6  !"%P  .A<  #07   O%@  *A4
M "<4   D$P  (A,  " 2 P >$08 '1 ) !P0#0 ;#Q  &1 5 !@0&P 7$"$
M%A H !41,  4$3D $Q%# !(23@ 1$EH $!)I ! 3>0 .$XP #A.>  T3L0 -
M$L4 #!+A  T2\0!B%   5!8  $D8   _&0  -QD  #$9   L&   *!<  "06
M   A%@  'Q4  !P4 @ :$P0 &1(& !<2"P 5$@X %!(2 !,3&  2$Q\ $1,F
M !$4+0 0%#8 #Q5!  X53  .%E< #19E  P7=0 +%X< "A>:  D6K0 (%L$
M"!;=  D5[@!?%@  41@  $8:   ]&@  -1L  "\:   J&@  )1D  "(8   ?
M&   '!<  !D6 0 7%@, %18$ !,6"0 1%@T $!<1  \7%@ .%QP #A@C  T8
M*@ ,&3, #!D\  L:1P *&E, "1IA  <;<0 &&X, !1N7  0:J@ #&K\  QG:
M  09[ !<&   3AH  $,<   Z'   ,QP  "P<   G'   (QL  " :   =&0
M&AD  !<8 0 5& ( $AD$ ! ;!P .&PP #1P0  P<$P +'!D "AP?  D=)P (
M'2\ !QXY  8>0P $'E   Q]>  (?;@ !'X   !^5   >J0  'KT  !W8   =
M[ !8&@  2QP  $$>   X'@  ,!X  "H>   E'0  (1P  !X<   ;&P  &!L
M !8; 0 3&P( $1P$  X>!P ,'PL "B .  @@$@ &(1< !2$=  0A)  "(BP
M 2(U   B0   (TT  "-:   C:P  (WX  ".3   BIP  (KP  "'7   A[0!5
M'0  2!\  #X@   U(   +B   "@@   C'P  (!X  !T=   :'0  %AT  !,>
M   1'P( #B $  TB!P *) L !B4-  0E$  ")A0  "8:   F(0  )RD  "<R
M   G/0  )TD  "A7   H9P  )WL  ">0   GI0  )KL  ";6   E[0!1(
M12$  #LB   R(@  +"(  "8A   B(0  'B   !L?   8(   %"   !$B   /
M(P  #24#  HF!@ &* H  RD-   K#P  +!(  "P7   L'@  +"8  "TO   M
M.0  +48  "U4   M9   +7<  "R-   LI   *[H  "O6   J[@!-(@  020
M #@D   P)   *20  "0C   A(@  '2(  !DB   5(P  $B0   \F   -*
M"BH"  8L!0 "+@D  "\+   P#@  ,A   #,5   S&P  ,R(  #,K   S-@
M,T(  #-0   S8   ,W,  #**   RH0  ,;@  ##6   P[P!))0  /B8  #0G
M   M)P  *"8  ",E   ?)   &R4  !8F   2*   $"H   TL   *+@  !C !
M  (R!   - <  #4*   W#   . X  #H2   Z%P  .A\  #HG   Z,@  .CX
M #I,   Z7   .F\  #F&   XG@  .+8  #?4   V[P!$*0  .BD  #$I   K
M*0  )B@  "(G   =*   &"D  !,K   0+@  #3    DR   %-0   3<    Y
M @  .P4  #P(   ^"P  /PT  $$0  !#%   0QL  $,C  !#+@  0SD  $-'
M  !"5P  0FH  $&!  ! F@  /[(  #[/   ^[P _+   -BP  "\L   J*P
M)2H  !\K   9+0  %"\  ! R   --0  "#@   0Z    /    #\   !!
M0P(  $4%  !&"   2 L  $H.  !,$0  318  $T>  !-*   330  $Q"  !,
M40  2V0  $M[  !*E   2:T  $C*  !'[  [,   ,R\  "TO   H+0  (B\
M !LQ   5-   $#<   TZ   (/0   D    !#    1@   $@   !*    3
M $X!  !/!   40<  %,+  !5#@  6!(  %D9  !8(@  6"X  %<\  !72P
M5EX  %9S  !5C0  5*<  %+"  !2Y@ X,P  ,3(  "PQ   E,@  '34  !8X
M   1/   #$    =$    1P   $H   !-    4    %,   !5    5P   %D
M  !:    7 ,  %X'  !A"P  9 X  &83  !G'   9B<  &8T  !E1   9%<
M &1K  !BA0  89\  &"Y  !>W  U-P  ,#4  "@W   @.@  &#T  !%"   ,
M1@  !DH   !/    4P   %8   !9    7    %\   !A    9    &4   !G
M    :0   &P!  !N!@  <0L  '0/  !W%0  =R   '8M  !V/0  =4\  '1C
M  !S>P  <I4  '"O  !OR0 U.@  *SL  "(_   :0P  $D@   Q-   %4@
M %<   !<    8    &0   !H    :P   &X   !Q    <P   '4   !W
M>@   'P   !_    @@0  (8*  "*#P  C!<  (LD  "*,P  B44  (=;  "&
M<@  A8L  (.E  ""O  O0   )40  !Q)   33@  #50   1:    80   &8
M  !K    ;P   '0   !Y    ?0   (    "#    A0   (<   "*    C
M (\   "2    E@   )D"  ">"0  HA   *(:  "A*0  H#L  )]0  "=9P
MFH$  )J9  "9KP I20  'TX  !54   .6P  !6(   !I    <    '<   !]
M    @@   (8   "+    CP   ),   "5    EP   )H   "=    H    *,
M  "F    J@   *X   "R    MPH  +L1  "Z'P  N3   +=%  "U7   M'0
M +&.  "OI  B5   &%L  !!B   ':@   ',   ![    @@   (D   "0
ME0   )H   "?    HP   *8   "H    JP   *X   "P    LP   +8   "Z
M    O0   ,(   #'    S $  -,+  #4%0  TR8  -$Z  #040  S6@  ,N!
M  #*E@#\    ]@   /(   #Q    \P % /0 # #R !, \  < .T )0#H "X
MX@ V -X /@#9 $0 U !* -$ 3P#. %0 RP!9 ,D 7@#& &, Q !I ,$ < "^
M '@ O "! +D C0"V )H LP"K +$ P "O .8 K@#_ *4 _P": /\ E #_ (\
M_P#T    [    .@   #G    WP   -D "0#2 !  SP 7 ,\ ( #, "@ Q@ P
M ,  -P"\ #X N0!$ +< 20"U $X LP!3 +$ 5P"O %T K0!B *L :0"I '$
MIP!Z *4 A0"B ), H "B )T M@"; -0 F0#Y )8 _P"- /\ B #_ (0 _P#H
M    WP   -D   #)    OP   +@ ! "U  T LP 2 +$ &@"P "( K0 J *D
M,0"F #@ I  ] *( 0P"@ $@ G@!, )P 40"; %8 F0!< )< 8@"5 &D DP!R
M )$ ?0"/ (L C0": (L K ") ,4 B #N (8 _P!_ /\ >@#_ '@ _P#9
MS0   +L   "N    I0   )\   "<  D F0 / )D %0"9 !T F  D )0 *P"1
M #$ C@ W (P / "+ $$ B0!& (@ 2P"& %  A0!5 (, 6P"" &( @ !K 'X
M=0!\ (( >@"2 '@ HP!W +D =@#@ '4 _P!R /\ ;@#_ &P _P#'    M0
M *4   "9    CP   (D   "%  0 A  , (( $0"" !< @@ > (  )0!^ "L
M?  Q 'H -@!Y #L =P!  '8 1 !U $D <P!/ '( 50!P %P ;P!D &T ;@!L
M 'H :@"* &@ FP!G *\ 9@#, &4 ]0!D /\ 80#_ &  _P"T    H    )
M  "%    ?0   '<   !S    <  ( &\ #@!O !( ;P 8 &\ 'P!M "4 :P J
M &D , !H #0 9P Y &8 /@!E $, 8P!( &( 3@!A %4 7P!> %X 9P!< ',
M6P"" %D DP!8 *8 5P"_ %< Z@!7 /\ 5@#_ %0 _P"A    C@   '\   !U
M    ;    &@   !D    80 $ &  "P!?  \ 7P 3 %\ &0!? !\ 70 E %P
M*@!; "\ 60 S %@ . !7 #T 5@!# %4 20!3 %  4@!8 %$ 80!0 &T 3@![
M $T C !, )\ 2P"U $H W !* /H 2@#_ $H _P"2    @    '(   !G
M7P   %H   !7    50 ! %, !P!2  P 4@ 0 %( % !2 !H 40 ? $\ ) !.
M "D 30 N $P ,P!+ #@ 2@ ] $D 0P!( $H 1@!2 $4 7 !$ &< 0P!U $(
MA@!! )@ 0 "N $  RP _ /( 0 #_ $  _P"%    =    &<   !=    50
M $\   !,    2@   $@ ! !'  H 1P - $8 $0!& !4 1@ : $4 'P!$ "0
M0P I $( +0!! #, /P X #X /@ ] $4 / !. #L 5P Z &( .0!O #@ @  W
M ), -@"G #8 P  V .@ -@#^ #8 _P!\    :P   %X"  !4 P  30,  $<#
M  !# 0  00   #\  0 ^  < /0 + #T #@ \ !$ /  6 #P &@ Z !\ .0 D
M #@ *0 W "X -@ S #4 .@ T $$ ,P!) #( 4P Q %X , !K "\ >P N (X
M+0"B "T N  M -T +0#X "X _P!S 0  9 4  %<'  !-"   1@@  $ (   [
M!P  . 4  #<#   V  0 -0 ( #0 #  T  \ -  2 #, %@ R !L ,0 @ #
M)  O "D +@ O "T -@ L #T *P!% "H 3P I %H * !G "< =P F (D )@"=
M "4 LP E ,\ )0#P "8 _P!M!@  7@D  %(+  !(#   0 P  #H+   V"P
M,@H  # (   N!@( +@,& "T "@ L  T +  0 "L $P J !< *0 < "@ (  G
M "4 )@ K "4 ,@ D #D (P!" "( 2P B %< (0!D "  <P ? (4 'P"9 !X
MK@ > ,< '@#I !\ ^@!H"0  60P  $T-  !##@  / X  #8.   Q#0  +0T
M "H,   H"P  )PD$ "8&"  F! L )0,. "0!$  D 10 (@$8 "$!'0 A "(
M(  H !\ +@ > 38 '0$_ !P!20 ; 50 &@%A !H!<  9 8( & "6 !@ J@ 8
M ,$ & #A !@ ] !C#   50X  $D/  ! $   .!   #(0   M#P  *0X  "8.
M   C#0  (@P# " +!@ @"0D 'P<, !X&#@ >!1$ ' 45 !L%&@ :!1\ &@4E
M !D%*P 8!3, %P8\ !8&1@ 6!E( %0=? !0';@ 3!X  $@>4 !(&IP 2!;P
M$@39 !(#[P!?#@  40\  $80   \$0  -1$  "\1   J$0  )A   "(0   @
M#P  '0X" !P-!0 :#0< &@L* !D*#0 8"1  %PD2 !8)%P 5"1P % DB !0*
M*0 3"C$ $@HZ !(+10 1"U$ $ Q?  \,;@ .#(  #@R4  T+IP -"[H #0K2
M  T*Z@!<#P  3A$  $,2   Z$P  ,A,  "P3   G$@  (Q$  !\1   <$
M&A " !@/!  6#@< %0X) !0-"P 3# T $@P0 !(,%  1#!H $0T@ ! -*  /
M#3  #@X[  T.1@ -#E$ # ]>  L/;0 *#W\ "0^3  D/I@ (#KD " [0  <.
MZ !8$0  2Q(  $ 3   W%   ,!0  "D4   E%   (1,  !T2   :$@  %Q$"
M !41!0 3$ < $A ) !$/"@ 0#@P #@X.  X/$@ -$!@ #1 >  P0)0 ,$"T
M"Q$V  H100 )$4T "!):  <2:@ &$GP !1*0  02I  #$;@  Q'/  (1Z !5
M$@  210  #X5   U%@  +18  "<6   B%0  'A0  !L4   8$P  %1(# !,2
M!0 2$0< $!$)  \1"@ -$0L #!(.  L2$0 *$A4 "1,;  D3(@ ($RH !Q0S
M  44/@ $%4H  Q58  (59P !%7H  !6.   5HP  %+<  !3/   3Z0!2%
M1A8  #L7   R%P  *Q<  "47   A%@  '!8  !D5   6% $ %!,$ !(3!@ 1
M$@@ #Q((  X3"0 ,% H "A4-  @6$  &%A, !189  07'P #%R<  A@P  $8
M.P  &4<  !E5   99   &7<  !F,   8H@  &+<  !?/   7Z@!/%@  0Q@
M #D9   P&0  *1D  ",9   ?&   &Q<  !@6   5%0( $Q4% !$4!@ 0% 8
M#A4'  P6"  *%PH !QD,  0:#@ "&Q(  1L6   ;'0  '"0  !PM   <.
M'40  !U2   =8@  '74  !V*   <H   '+8  !O0   :ZP!,&   0!H  #8;
M   M&P  )AL  "$:   =&0  &1D  !<8   4%P, $A8$ ! 7!  .%P0 #!D%
M  H:!P '' D  QT+   ?#0  (!   " 4   A&@  (2(  "$J   A-0  (D$
M ")/   B7P  (G(  "&(   AGP  (+8  !_1   ?[0!(&@  /1P  #,=   K
M'0  )!T  " <   <&P  &!H  !89 0 3&0$ $1D!  X: 0 ,' ( "AT#  <?
M!0 #(0@  "(*   D#   )@X  "82   F&   )Q\  "<G   G,@  )SX  "=+
M   G7   )VX  ":%   FG0  );0  "31   C[@!$'0  .1\  # ?   H'P
M(QX  !X=   ;'   &!L  !0<   1'   #AT   T?   *(0  !B(!  ,D!
M)@8  "@(   J"P  *PT  "T0   M%0  +1P  "TD   N+@  +CH  "Y(   M
M6   +6H  "V!   LF@  *[(  "K0   I[P! (   -B$  "TA   F(0  (2
M !T?   :'@  %AX  !(?   /(0  #2(   HD   &)@   B@    K @  +00
M "\&   P"0  ,@P  #0.   U$@  -1@  #4@   U*@  -38  #5#   U4P
M-&8  #1\   SE@  ,J\  #'-   P[P \(P  ,B0  "HD   D(P  ("(  !PA
M   7(0  $R,  ! E   -)P  "2D   4K   !+@   #     R    - $  #8$
M   X!@  .@D  #P-   ^$   /A0  #X<   ^)@  /C$  #X_   ]3@  /6$
M #QW   [D0  .JL  #G)   X[0 W)P  +R<  "@F   C)0  'R0  !DE   4
M)@  $"@   TK   )+@  !3     S    -0   #@    Z    /    #X!  !
M P  0@<  $0*  !&#0  21$  $D7  !((0  2"P  $<Z  !'20  1EL  $5Q
M  !$BP  0Z4  $+#  !!Z  T*@  +"H  "<H   B)P  '"@  !8J   1+0
M#3    DS   #-@   #D    \    /@   $$   !#    1@   $@   !*
M3 ,  $X&  !0"@  4PX  %03  !4'   4R<  %,T  !30P  4E4  %%J  !0
M@P  3YX  $VY  !,X  P+0  *RP  "8K   ?+   &"X  !(R   --0  "#D
M  (]    0    $,   !&    20   $P   !.    40   %,   !5    5P
M %D!  !<!@  7PH  &(.  !C%0  8Q\  &(L  !A/   8$X  %]B  !>>P
M7)8  %NP  !9SP O,   *B\  "(P   :,P  $S<   X[   (/P   40   !(
M    3    $\   !2    50   %@   !;    70   &    !B    9    &8
M  !I    ;04  ' +  !T$   =!@  ',E  !R-   <D4  '!9  !O<0  ;8L
M &NF  !JP  N,P  )34  !TX   4/   #D$   ='    3    %$   !5
M60   %T   !A    90   &@   !K    ;0   &\   !R    =    '<   !Z
M    ?@   (($  "&"P  BA$  (D<  "(*P  ACT  (12  "#9P  @8$  '^;
M  !^L@ I.@  (#T  !9"   /2   "$X   !4    6@   &    !D    :0
M &X   !R    =@   'H   !]    @    ((   "%    B    (L   ".
MD@   )8   "; P  H P  *(3  "@(0  GS,  )U'  ":7@  F'<  )>/  "5
MIP C0P  &4@  !%.   )50   %P   !C    :@   '$   !V    >P   (
M  "&    B@   (X   "1    DP   )8   "9    G    *    "C    IP
M *L   "P    M@0  +P-  "Z%P  N2@  +<\  "T4@  LFH  *^%  "MG  <
M3@  $U0   M<   !9    &P   !T    ?    (,   ")    CP   )0   ":
M    GP   *(   "D    IP   *H   "N    L0   +0   "X    O    ,$
M  #'    S0   -0%  #8$   U1X  -,Q  #02   S5\  ,MV  #(C@
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M^_S^______________________________________________________\
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MXN/DY>;GZ.GJZ^SM[N_P\?+S]/7V]_CY^OO\_?[_;69T,0     #!"$   $
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M@K&+PH"PC,* L(S"@+",PH"PC,* L(S"@+",PH"PC,* L(S"@+",PH"PC,*
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MA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:]\ 0%?C
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MP(JL<<"+K'' BZQQP(NL<<"+K'' BZQQP(NL<<"+K'' BZQQP(NL<<"+K''
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ML'ZDT;!^I-&P?J31_[@4#O^X'B?_M"I&]Z\V:=ZG0H_'FV*QQ)MRML*;?[G
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MB9#.LX>2T+*$E=*Q@IG3L8&>U*Z HM2L@*/2K("CTJR H]*L@*/2K("CTJR
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MUI.2H-:3DJ#6_;L1#?V\&2;^N21&]K0N:MRK.I+'H%RQQ*%HML&E<;J^IWK
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MB:N&RH>KALJ%JHC*@ZJ)RX&JB\N JHS+@*J,RX"JC,N JHS+@*J,RX"JC,N
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M"?^Q(Q[_KC$Z_ZD^6>VB2WG9FER7R)5RL,65?;7#EX6XP9>+N[^3C+V^CX[
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MQ+%ZK<2Q>JW$L7JMQ+%ZK<2Q>JW$_ZL:!?^K)1?_J30O_Z1"2OF?3V;HF5R
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M[))I>N&1<XK8CWR8T(Z$I,J.C*W&C9"TQ(J3M\.&E;C"A)BYP8&;NL%_G;O
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MO+R;B,*YE8K'M8V-SK"&EM2I@J#6H8*DT)V"J,N:@ZK(F8.MQ9>$K\*6A+#
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M\[8Y<.J_-WWCRC6'U-$WE;["2ZFPN6"UJ+1PO:.P?L*=K83'DJJ$RXBGALZ
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MHJ;-=*:HS7*IJ<QQK:K,<+*KRW"VJ\MOO*O(<,"KQ'' JL1QP*K$<<"JQ''
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MM+J*B[2ZBHNTNHJ+M+J*B[2Z_YP0 ?^A)@K_H#8<_YY",?^E0#[_JT!,_[%
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M;,R:_X82 ?^((0;_B#44_X9&)?^'4S7_BUM#_XQB4?Z*:E[VAW%J\(1Z=.J
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M2CO_HTL[_Z-+._^C2SO_HTL[_Z-+._^C2SO_HTL[_Z-+MKH" *;*  "8W
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M9T7NYV=&Z^AG1NOH9T;KZ&=&Z^AG1NOH9T;KZ&=&Z^AG[J(  ,VT @"\O@0
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M2X#48%=VT6AA;<]P:67->G!>S(9U6,R5>53,IGM1S;Q\4,SB?%/!X']5M]^
M6+'>@5JKWH%<IM^!7*;?@5RFWX%<IM^!7*;?@5RFWX%<IM^!_X / ?^.#@'_
MH@T V[4( ,[!" #&T D OND2 K3I)0JJZ#,7H.8^)9;E1S*+XTX_@.%527;@
M75-MWF9;9=UO85[=>F=8W(9K4]R5;U#=IG%-WKMR3=_A<4[1YW10QN9W4K[D
M>%.XY'E5LN-Z5;+C>E6RXWI5LN-Z5;+C>E6RXWI5LN-Z_X,. ?^6"P#=JP0
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MYW68;N=UF&[G=9ANYW68;N=U_V<6 ?]D( /_<!X#_WXB!?^++ G_DS<0_YA
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M@(#;A8" W8. ?]Z!@'[@?X!]X7V ?>-[@'SD>H!\Y'J ?.1Z@'SD>H!\Y'J
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M>F.7Y'EFE.5W9I+F=V:2YG=FDN9W9I+F=V:2YG=FDN9W_W 2 ?^ #@'_D@X
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M8$N]]F!+O?9@2[WV8$N]]F!+O?9@_XD  -F>  #'K $ N;8" *[! P"ES@8
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M;W*#[6US@>YK=(#P:72 \&ET@/!I=(#P:72 \&ET@/!I_V$7 ?]Q$ '_@@X
M_Y . /6=#0#CJ0P V;4, ,^Y&@#%N"X'N[0]%;&P22.GJU(QGJ=;/I:C8TB.
MGVI1AIMR67^8>F!XE81F<I./;&V1G&]ID*IR9I"^<V61X7)HCNMP:HKL;FR(
M[6QMAN]K;H3P:6Z$\&ENA/!I;H3P:6Z$\&ENA/!I_V,5 ?]U#@'_A@T ^)0+
M -RB" #4K0D S[@* ,F]%P"_O"L&M;D[$ZNV1R&AL5 OF*U9.X^J84:'IFA/
M?Z-P5WB@>%YRGH%D:YN,:6::F6UBF:AO7YF\<%Z9WV]@ENQN8Y'M;6:.[FMG
MB^]J:8GP:&F)\&AIB?!H:8GP:&F)\&AIB?!H_V<2 ?]Y# #_B@H WYH$ -.F
M!P#,L0@ Q[L( ,'"$P"XPB@$KK\X$*6\1!Z;N$XLD;57.(BQ7D* KF9+>*MM
M4W&I=EIKIW]@9:6*9&"CEVA;HZ9K6:.Z;%BCW&M9H.YK7)KO:E^6\&EADO%H
M8X_Q9F./\69CC_%F8X_Q9F./\69CC_%F_VL0 ?]^"0#QD 0 UIX# ,RJ!@#$
MM 8 OKX% +C($ "PR"0#I\8U#9W#0AN3P$PHBKU4,X&Z7#YYMV1&<;5K3FNS
M=%1DL7Y:7[")7UJOEF)6KJ5E4ZZY9E*OVV52J_)F5:3R9EB?\F9:F_-E7)?S
M9%R7\V1<E_-D7)?S9%R7\V1<E_-D_W - /^$! #=E@  SJ,# ,2N! "[MP0
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MD@\;_Z(0&O^R$1G_R!(8_^43%__Z%!?_^A07__H4%__Z%!?_^A07__H4G[,
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M8']S^%Y^<_E<?G+Z6GYR^UE^<OM9?G+[67YR^UE^<OM9_U@7 ?]G$ '_=0X
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M6FN!^UIK@?M::X'[6FN!^UIK@?M:_V(0 /]R!P#X@@, VX\" ,^:!0#)HP8
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M45&>_U%1GO]1_W8  -V)  #*EP  OJ(  +.J  "ILP  H+P" )C&!@"1S!(
MB\PE H3+- E\R4 2=<A*&VW'4R-GQ5PJ8<1D,%S#;397PG8Z4\*!/T_!CD)+
MP9U%2,&N1D?!Q49'P>I&1+[_246Y_TI'L_]+2:W_3$JK_TQ*J_],2JO_3$JK
M_TQ*J_],Z7\  -&0  #"G@  M:<  *JO  "@N   EL$" (S+!P"$U0T @-4>
M 7G5+@5RU#P,;--'%&724!M?T5DA6M%B)U70:RQ1T'4P3<^!-$G/CC=&SYTY
M1-"N.T+0QCM#T.HZ0,W]/C[+_T! P_]"0;W_0T*Y_T1"N?]$0KG_1$*Y_T1"
MN?]$W8@  ,>8  "XHP  JZL  *"T  "5O@  B\@# (#1!P!XX0T =.$= 6[A
M*P-HX#<(8>!"#ES@3117X%894^!?'4_@:2)+X',E1^!^*$3@BRM"X)HM/^&K
M+S[BP2\^XN4O/-_Z,3G>_S0YV?\V.M#_.#O,_SD[S/\Y.\S_.3O,_SD[S/\Y
MS9(  +R@  "MJ   H;$  )6[  ")Q0  ?L\" '3:!@!NZQ$ :.L> 6+K*@-=
M[#4&5^P_"U+L2 ]-[%$32NU:%D;M8QE#[6T<0.UX'CWNA2$Z[I,C..^C)#;P
MMB8U\=(F-._S)C3L_R8RZ_\H,N?_*S/D_RPSY/\L,^3_+#/D_RPSY/\LP9P
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M"13_PPD3_^,)$__X"1/__PH3__\*$___"A/__PH3__\*FK$  (N]  !\R
M;=0  %_@  !1Y@  1_4  $'_   \_PD -_\0 #+_%0$N_QT!*O\C 2;_*0$B
M_R\"'_\U AS_.P(9_T(#%O]) Q/_40,1_UH##_]F! W_= 0+_X4$"O^6!0G_
MJ 4(_[D%!__0!0?_XP4'_^,%!__C!0?_XP4'_^,%C;H  'W'  !MTP  7^
M %#G  !"[0  .O\  #7_   O_P( *O\* ";_#P B_Q0 'O\: 1K_'P$6_R,!
M$_\H 1#_+0$._S,!#/\Y @K_00('_TD" _]3 @#_7@( _VP" /]\ P#_C0,
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M3I!C_TR.9/]+C&3_2HMD_TB+9/](BV3_2(MD_TB+9/](_U 6 ?]<$ #_: T
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M379Q_TQV<?],=G'_3'9Q_TQV<?],_UD0 /]F!P#_<P0 X7\! -:(! #/D 8
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M2V&#_TMA@_]+_V0% /5T  #:@@  RXX  ,&7  "XG@$ L:4  *FK!P"CK1H
MG*PL!)6K.@R-J$46AJ9/'W^D5RAYHE\O<Z!F-6V>;CMHG'= 8YJ!15^9C$E;
MF)E,5Y>H3E67NT]4E]Q.5);V3E64_TU8D/],68W_2UN*_TI;BO]*6XK_2EN*
M_TI;BO]*_V@  .5Y  #1AP  Q9(  +N<  "QH@  J:D  *&Q @";LQ4 E;,H
M HZR-@F&L$(2?ZY,&WBL5"-RJEPJ;*AD,6>G;#9BI74[7:1_0%FCBD-5HI='
M4:&G24^ANDI.HME)3J#U24Z?_TE0F?])4I;_2%22_T=4DO]'5)+_1U22_T=4
MDO]'_VX  -Y_  #*C0  OI@  +.@  "JIP  H:X  )>V  "1NA  C+HC 86Y
M,@9^N#X.=[9)%W&U4AYKLUHE9;)B*V"Q:C!;L',U5Z]].5.NB3U/K99 3*VE
M0DJMN4-)KMA"2*OU0T>J_T1)I?]$2Z#_1$V<_T1-G/]$39S_1$V<_T1-G/]$
MZG4  -*&  ##DP  MYT  *RD  "BJP  F+,  (Z[ 0"%P0P @<(= 'O"+0-U
MP3H);\!%$6F_3QACOE<>7KU?(UF\:"A5NW$M4;M[,$VZAS1*NI4W1[JE.46Z
MN#I$NM<Y0[CU.T*V_SU"L_\^1*[_/D6I_SY%J?\^1:G_/D6I_SY%J?\^X'T
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M&3'E_ADOY/\<+N3_'BWB_R MXO\@+>+_("WB_R MXO\@NIH  *JC  "=JP
MD+0  (.]  !WQ@  :\\  %_6  !4W@0 4? 0 $WP&P!*\"8!1O$P D+R.@,^
M\D,$._-+!3CS5 <V]%T(,_1H"3#U= LN]8$,+/:1#BKVH@\H][<0)_C6$2?V
M]!$F\_\1)O'_$27Q_Q,E\?\3)?'_$R7Q_Q,E\?\3K:$  *"I  "2LP  A+P
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M P#_[ , _^P# /_L P#_[ , _^P#B+D  'C$  !IT   6]T  $OC   ^Z0
M,NX  "O_   F_P  (?\  !W_"  :_PT %O\1 !/_%@ 0_QH #O\?  O_)  )
M_RH !O\P  +_-P$ _T ! /]* 0#_5@$ _V0! /]U 0#_B $ _YH! /^J 0#_
MNP$ _[L! /^[ 0#_NP$ _[L!_R\K ?\K,@+_+S$"_S T O\O.0/_*T$#_R=,
M!/\C6 7_(68&_R!T!_\>@@G_'HX+_QZ8#/\>H0W_'JD._QZP#_\=N __'<$0
M_QW+$/\=VQ'_'>@1_QWR$?\=_!'_'O\1_Q[_$/\>_Q#_'_\1_Q__$O\A_Q/_
M(O\3_R+_$_\B_Q/_(O\3_R\K ?\N, +_,B\"_S,Q O\R-@/_+SX#_RM)!?\I
M5@;_)V,'_R5Q"/\D?@O_(XH,_R.5#O\BG@__(J80_R*M$?\BM1'_(KT2_R+'
M$O\BU!/_(N43_R+P$_\B^A/_(O\3_R/_$O\C_Q+_(_\4_R3_%?XF_Q;\)_\6
M_"?_%OPG_Q;\)_\6_S J ?\Q+0+_-2L"_S<M O\V,@/_-#H#_S)%!?\O4@;_
M+6 '_RQM"O\J>@S_*88._RB1$/\HFA'_**(2_R>J$_\GL13_)[D4_R?#%?\G
MSQ7_)^$5_R?M%?\G^!7_*/\5_RC_%?\H_Q;_)_\7_"G_&/8K_QGT+/\9]"S_
M&?0L_QGT+/\9_S$I ?\T*0'_.2@"_SLJ O\\+@+_.C8#_SE"!?\W3P;_-5P(
M_S-I"_\Q=@[_,((0_R^-$O\NEA3_+IX5_RVF%O\MK1;_+;47_RV^&/\MRAC_
M+=P8_RWJ&/\M]1C]+O\8^B[_&/DM_QKY+?\<\R__'.TQ_QWJ,O\=ZC+_'>HR
M_QWJ,O\=_S,I ?\X)@'_/20!_T E O]!*0+_0C,#_T$^!?\_2@;_/5<)_SMD
M#/\Y< __-WT2_S:(%/\UD1;_-9H7_S2B&?\TJ1G_,[$:_S.Z&_\SQ1O],],;
M^C/F&_<T\QOS-?X;\33_'? S_Q_N,_\@YS;_(>$W_R'>./\AWCC_(=XX_R'>
M./\A_S4G ?\](@'_0B !_T8@ ?]()0+_2B\#_TDZ!/]'1@;_15()_T-?#?]!
M:Q'_/W<4_SV"%_X\C!G\/)4:^SN='/D[I1WX.JT>]CJV'O4ZP!_S.LX?\#KC
M'^L[\1_H.OTAYCK_(^0Z_R7A.O\EV#S_)M ]_R;-/O\FS3[_)LT^_R;-/O\F
M_SDD ?]!'@'_1QL!_TL; ?]/(@'_42L"_U$V!/]/00;_3$T)_TM:#OQ)9A+X
M1W(6]45]&?-#AQOQ0I$=[T*9'^U!H2#L0:DAZD"R(NA O"+G0,HCY$'?(^!!
M[R3<0/PGV$#_*=0__RK/0/\JQT+_*L)#_RK 0_\JP$/_*L!#_RK 0_\J_SP@
M ?]%&@'_2Q<!_U$7 ?]6'P'_6"<"_U@Q _]7/ 7\54@)]E)4#O)081/N3FT7
MZDQX&^=*@A[E28P@XDB5(N!'G23>1Z4EW$:N)MI%N2?81<8HU$7<*<]&[BK+
M1?LMR$7_+L5%_R_ 1O\ONDC_+[5)_RZT2?\NM$G_+K1)_RZT2?\N_T = ?])
M%@'_4!,!_U84 /]<&P'_7R,!_V L OI?-P3S74(([5I/#>=87!/B5F@8WE-R
M'-I1?2#63X8DTDZ/)]!-F"G-3* KRTNI+<E*LR['2K\OQ4K0,,)+Z#"]2_@R
MNDK_,[A+_S.S3/\SKDW_,ZI._S*I3O\RJ4[_,JE._S*I3O\R_T,: ?],$P#_
M5!  _UP2 /]A%P#_91X!^V8G ?)F,0/J93T&XV-*"]Q@5Q+576(9T%IM'\Q7
M=R/(58 GQ52)*\)2DB[ 49HPOE"C,KM/K32Y3[DUMT_(-K1/XC:Q3_0WKE#_
M.*Q0_SBG4?\WHU+_-J!3_S6?4_\UGU/_-9]3_S6?4_\U_T87 ?]0$0#_6 T
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M/H)C_SV"8_\\@F/_/()C_SR"8_\\_U / /];!P#_9@, [&\" -QV P#4? <
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M/VUR_S]M<O\__UD' /]E  #B<@  T7P  ,>$  # B@( N8\" +.2# "LE!T
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MLD%2DLE"4I'K05*0_T!2C_\_58O_/E:(_SU7A_\]5X?_/5>'_SU7A_\]^6<
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M+4"P_B\_K_\Q/JW_,D"H_S)!IO\R0:;_,D&F_S)!IO\RU7P  ,**  "UE@
MJ)T  )VC  "2J@  A[$  'RW  !PO@, :,(. &;#'0!CPRT!7L,Y!%K#1 A6
MPDX,4L)7$$_!7Q1+P6D72,%S&D7 ?AU"P(P@/\";(CW K2,\P<0C/,#I(SJ^
M_B8XO/\H-[O_*3BX_RHXMO\K.+;_*SBV_RLXMO\KR84  +F3  "LG   H*(
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M""#K_PH?ZO\+'^K_"Q_J_PL?ZO\+J)\  )NF  "-KP  ?[@  ''!  !DR@
M6-   $S6  !!W0  ..0  #7V#  S]Q0 ,/<> "[X)P K^3  */DX 2;Z0 $C
M^TD!(?M2 1[\70(<_6D"&OUY QC^BP,7_YX#%?^S!!3_TP04_O0$$_S_ Q/Z
M_P,3^?\#$_G_ Q/Y_P,3^?\#G:4  (^N  " N   <L(  &3+  !6TP  2=H
M #[?   TY   +O0  "O_"@ H_Q  )?\7 "+_'P ?_R8 '/\M !G_-  7_SP
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M',TZ_Q[+.O\>RCK_'\0[_Q_ //\>P#S_'L \_Q[ //\>_SD; ?] %0#_11$
M_TH3 /].&0#_4"(!_U L ?U.-P+V2T,$\$E0!^M(70KG1FD-XT5T$.!$?A/=
M0X<5VT*0%]A!F!C50* 9TT"I&]% LAS/0+T=S4#,'<I!Y![&0/0@PD#_(K]
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M+992_RR44O\KE%+_*Y12_RN44O\K_T80 /]."0#_5@4 _EX& .]B!P#G90H
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M,7EB_S%Y8O\Q_T\' /]9  #F9   UVP  ,QS  #$=P( OWD$ +EZ#@"R?"
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ML#MA=L0\87;E.V%V^SEB=O\W8W7_-6-S_S1D<O\S9'+_,V1R_S-D<O\S_U@
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M-4^+]S1/BO\S4(G_,E&&_S%2A/\Q4H3_,5*$_S%2A/\QZF4  -)S  #"?P
MMH@  *R0  "BE   F)@  (R<  "$GPH @* 9 'RA*0%WH#8%<I]!"FV>2P]H
MG5,49)Q;&6";8QU<FFLA6)ET)568?BE1EXHL3I:8+DN6J#!*EKPQ29;<,$F4
M]C!)D_\P29+_,$J0_R]+C?\O2XW_+TN-_R]+C?\OXFL  ,IY  "\A0  L8\
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M'C.S_Q\SLO\@,[+_(#.R_R SLO\@P8,  +21  "FF   FYX  (^E  ""JP
M=K$  &NV  !?O   5,$# $S%#0!+Q1D 2<8H $C&-0!%QT !0\=* T#'4P0^
MQUT&.\=G"#G'<PHWQX ,-,>0#3+'H0XQR+4/,,C3#S#&]! NQ/\3+<+_%2S!
M_Q8KP/\7*\#_%RO _Q<KP/\7N(T  *J7  ">G@  D:4  (2L  !XL@  :[D
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M 0WS_P$-\_\!F:,  (NL  !\M0  ;;X  %_&  !2S0  1=(  #G8   OW@
M)N(  !_J   <^P8 &?\. !?_$P 4_QH $O\A !#_*  ._S  #?\Y  O_0P )
M_TX !O]<  3_;  "_X   ?^6  #_K0  _\H  /_P  #__P  __\  /__  #_
M_P  __\ C:L  'VU  !NOP  8,@  %+0  !#UP  -]T  "OB   BY@  &>H
M !7Y   2_P  $/\(  [_#@ ,_Q$ "?\6  ;_'  #_R(  /\J  #_,P  _ST
M /])  #_5P  _VD  /]^  #_E0  _ZP  /_'  #_Z   __H  /_Z  #_^@
M__H @+4  '"_  !AR0  4M,  $/;   UX0  *>8  ![J   5[@  $/@   [_
M   +_P  "/\   3_!@  _PH  /\.  #_$0  _Q4  /\;  #_(P  _RL  /\V
M  #_0P  _U,  /]E  #_>@  _Y$  /^F  #_N   _\\  /_/  #_SP  _\\
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M!?$<_P;P'/\'[QW_".\=_PGO'/\)[AS_">X<_PGN'/\)_RHB ?\N'0#_,!L
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M&;4Z_QBR._\8L3O_&+$[_QBQ._\8_SD2 /\_#0#_0PD _T@, /]+$ #_3!4
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M(XA2_R.(4O\C_T4' /]+  #P50  WUL  --@  #,80, R&$& ,-A$0"[9"0
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MKR]P8L$P;V+?,&YC]RYO8_\L;V/_*F]C_RAO8O\G;V+_)V]B_R=O8O\G_TT
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M,%UQ\BY><?\L7G#_*U]P_RE@;_\H8&[_*&!N_RA@;O\H\54  -YB  #*;0
MO74  +-[  "K@   HH(  )B!  "1@P\ C84? (B%+@*#A#L%?H-%"GJ!3@]U
M@%84<7]>&&Y]9AQJ?&T@9WMV(V-Z@"=@>8LJ77B8+%IWIBY8=[@O5W?1+U=W
M\2Y8=O\L6';_*EEU_RE:=/\H6G3_)UIT_R=:=/\G[5D  -=F  #%<0  N7H
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M)4:+_R1&BO\D1HK_)$:*_R1&BO\DV&D  ,-V  "U@0  JXH  )^/  "5DP
MBI8  'Z:  !PG0  :Y\. &B?' !FH"H!8J W E^?005;GTH(6)Y2"U2>6@Y1
MG6(23IQK%4N<=1A(FX$:19N/'4*:GQ] FK @/YK((#^9ZQ\_F/\@/I;_(3Z5
M_R$_E/\A/Y3_(3^4_R$_E/\AS7   +Q]  "PB   I(\  )F4  ".F   @YT
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MM   3K<  $.\!0! O1$ /[T> #Z^*P \OC8 .[]! #F_2P$WOU0"-<!? C/
M:@0QP'<%+\"&!BW EP<KP*H(*L'"""K YP<IO?T**+S_#">Z_PTGN?\.)[G_
M#B>Y_PXGN?\.LHP  *64  "9F@  C:$  '^G  !RK0  9K,  %JX  !/NP
M1+\  #K$ @ PR0@ +LH1 "W*'0 LRRD *\LU "O,0  JS4H *,U6 "?.80 F
MSF\!),Y_ 2//D0(ASZ4"(-"] B#/Y (?S?H#'LO_!![*_P4=R?\&'<G_!AW)
M_P8=R?\&J)0  )R:  "0H0  @J@  '2O  !GM@  6[P  $[   !#PP  .<<
M "_,   GT 0 ']8* !O:$  ;VQH &MLF !K<,0 9W3P &-U( !C>50 7WV(
M%N!R !7@A0 4X9H $^*Q !+CSP 2X/0 $M[_ 1'=_P$1V_\"$=O_ A';_P(1
MV_\"GIH  )*A  "$J0  =K$  &BX  !;OP  3L0  $+(   WS   +=   "35
M   <VP  %=\% !3I#@ 2ZA0 $>L= !#K)@ .[#  #NTZ  WN1@ +[E, "N]B
M  GP=  (\8D !_*@  7RN@ $\>0  O']  +O_P #[?\  ^W_  /M_P #[?\
ME:$  (:I  !XL@  :;H  %O"  !-R   0,P  #31   JU@  (=L  !G@   2
MY   #_ !  WY"@ +^@\ "?L5  ?['  $_"0  ?PL  #\-P  _$(  /Q0  #\
M80  _74  /R,  #\I   _,$  /SK  #\_P  _?\  /W_  #]_P  _?\ B:D
M 'FR  !JNP  7,0  $[,   _T0  ,M<  "?=   =X0  %>4   [H   *\0
M"/T   7_ P !_PD  /\.  #_$@  _Q<  /\?  #_)P  _S$  /\^  #_30
M_U\  /]U  #_C0  _Z8  /_"  #_YP  __P  /__  #__P  __\ ?+,  &R\
M  !=Q@  3L\  #_6   QW0  )>(  !KF   1Z@  #.X   7R    _P   /\
M  #_    _P   /\%  #_"@  _PX  /\2  #_&   _R$  /\K  #_.0  _TH
M /]=  #_<P  _XP  /^D  #_N0  _]0  /_>  #_W@  _]X _Q@L /\9*0#_
M&2@ _Q4K /\0, #_"S@!_P-$ ?\ 40'_ %X!_P!L ?\ > '_ ((!_P", ?\
ME '_ )P _P"B /\ J #_ *\ _P"V /\ O@#_ ,@ _P#7 /\ YP#_ /, _P#]
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _QLI /\=)@#_'"4
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M!=P<_P7<'/\%VQS_!=L<_P7;'/\%_RH9 /\M$P#_+1$ _RT1 /\N&0#_+2(
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M$J([_Q*B._\2_S@* /\\  #_00  ]44  .9& @#A10< XT(- -5#&0#,12P
MQD<\ <%'20*\1E4$N45?!K5$: FS0W$+L$-Y#:Y"@0^L0HD0JD&1$JA!FA.G
M0*04I4"O%:- O!:A0- 6GD'J%YQ!_!>:0?\7F$'_%YA!_Q:70?\5ET'_%9=!
M_Q670?\5_SL& /\_  #Y1@  Y4L  -Q.  #3300 T4H) ,I*% #"32< O$XW
M ;=.10*R35 %KTQ:"*M+8PJH2FP-IDET#Z1)?!&A2(03GT>,%9U'E1>;1I\8
MF4:J&9=&N!J61LH;DT;F&Y%'^1N/1_\:CD?_&8Y'_QB-1_\8C4?_%XU'_Q>-
M1_\7_SX" /]#  #K2P  W5$  -%4  #*5 $ QE(% ,%1$0"Y4R( LU4S :Y4
M00*J5$P%IE-6"*)17PR?4&</G4]O$9I.=Q283G\6EDV(&)-,D1F13)L;CTNF
M'8U+LQZ+2\4>B4OB'H=,]QZ&3/\=A4S_'(5-_QJ%3/\9A4S_&85,_QF%3/\9
M_T   /Q'  #E4   U58  ,I9  #"6@  O5@# +A7#@"Q61X K%HO :=:/0*B
M64D%GEA3"9M76PR75F00E55K$I)4<Q6/4WL7C5*$&HM1C1R(49<>AE"C'X10
ML"""4,$A@%#=(7Y1]"!]4?\??5'_'7U1_QQ]4?\;?5'_&GU1_QI]4?\:_T(
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M)FE>[B1I7O\B:E[_(&I>_Q]J7O\>:E[_'6I>_QUJ7O\=^4H  .-5  #/7P
MP64  +=J  "O;   IVP  )]J 0"9:Q$ E&TB )!N,0&+;3T$AVQ'!X-K4 M_
M:E@/?&A@$WAG9Q9V9V\9<V9X''!E@1YM9(PA:F.8(VABIB5F8K8F9&+,)F1B
M["5D8O\C9&+_(65B_Q]E8O\>96+_'65B_QUE8O\=\DP  -]8  #*8@  O6D
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M(%1P_Q]5</\>56__'55O_QU5;_\=Y5<  ,UD  "^;0  LG4  *A[  "??@
MDWT  (=]  " ?P< ?( 5 'B!) !U@C(!<8$]!&V 1@=I@$\*9G]6#6-^7A%@
M?68477QN%UI[=QI7>H(=5'J/'U%YG2%/>:XB3GG#(DUXY2)-=_LA3G?_'TYV
M_QY/=?\=3W7_'4]U_QU/=?\=WUP  ,AH  "Y<@  KGH  *6   ":@@  CH(
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M%SJ._Q<ZCO\7Q6X  +9[  "JA0  GHL  )2/  "(D@  >Y0  &Z7  !BFP
M5YX  %*@#@!1H!L 3Z$H $VA- !+H3X!2:%' D>A4 -$H5@%0J%A!S^@:PD]
MH'<+.J"%#3B@E XVH*8/-:"[$#2@W0\TG?<0,YS_$C.:_Q(SF?\3,YG_$S.9
M_Q,SF?\3O7<  *^#  "CBP  F)$  (V5  "!F0  <YP  &>?  !;H@  3Z8
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MA0 9QYD &,BN !?(RP 7QO$!%\3_ 1;#_P(6P?\#%L'_ Q;!_P,6P?\#HY$
M )B8  "+G@  ?:4  '"K  !BL0  5K8  $JY   ^O0  -,   "K$   BR
M&<P$ !/0"@ 1TA$ $-(: !#3)0 /TS  #M0\  [42  -U58 #=5E  S6>  ,
MUHT "]BD  K8O@ )V>8 "M;^  O4_P +TO\ "]+_ 0O2_P$+TO\!FI@  (Z?
M  " I@  <JT  &2T  !7N@  2;\  #W"   RQ@  *,D  !_-   7T0  $=8
M  S;!0 (W@L !M\1  7?&@ $X"0  N$N  'B.@  XT<  .16  #D9P  Y7L
M .:2  #FJ@  Y\@  .?P  #H_P  Z/\  .C_  #H_P  Z/\ D9\  (*G  !T
MKP  9;<  %>^  !)PP  /,<  ##+   ESP  '-0  !39   .W0  ">$   +E
M    Z08  .D-  #I$0  ZA@  .LA  #M*P  [S<  /%%  #R5@  \V@  /-^
M  #TEP  ];   /;0  #W\P  ]_\  /?_  #W_P  ]_\ A:<  ':P  !FN
M6,$  $K(   [S   +M$  "/6   9W   $>    SC   $YP   .H   #U
M]    /4%  #U"P  ]@\  /84  #X'0  ^B<  /PT  #_0P  _U4  /]I  #_
M@0  _YH  /^R  #_SP  _^T  /_Y  #_^0  __D >+   &BZ  !9PP  2\L
M #O1   MV   (=T  !;B   .Y@  ".H   #M    \    /@   #_    _P
M /\   #_    _P8  /\,  #_$   _Q@  /\B  #_,   _T   /]3  #_:0
M_X$  /^9  #_KP  _\,  /_5  #_U0  _]4 _Q,H /\3)0#_$24 _PTG /\&
M+0#_ #4 _P!! /\ 3P#_ %P _P!I /\ = #_ 'X _P"( /\ D #_ )< _P"=
M /\ I #_ *H _P"P /\ MP#_ ,  _P#, /\ WP#_ .P _P#X /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _Q8E /\6(@#_%"$ _Q C /\** #_
M #  _P ] /\ 2P#_ %@ _P!D /\ < #_ 'H _P"$ /\ C #_ ), _P": /\
MH #_ *8 _P"M /\ M #_ +P _@#( /T V0#[ .D ^@#V /D _P#X /\ ^ #_
M /@ _P#X /\ ^0#_ /D _P#Y /\ _QHB /\:'@#_&!T _Q,> /\.(@#_"BP
M_P<Y /\#1@#_ %, _P!@ /\ :P#_ '8 _P!_ /\ B #_ (\ _P"6 /\ G0#_
M *, _@"I /P L #Z +D ]P#$ /4 T@#S .8 \@#T /$ _P#P /\ [P#_ .\
M_P#O /\ \ #_ /  _P#P /\ _QX= /\>&0#_'!< _Q<8 /\3'@#_$2@ _PXT
M /\,00#_"DX _PA; /\'9@#_!G$ _P9Z /\&@P#^!HL _ :2 /H&F0#X!I\
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M \,<_P/#'/\#_R@0 /\I"P#_* 8 _RL+ /\K$ #_*1< _28B /0C+@#L(3L
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MM Z;.\4.F3O@#I8[] ^4//\/DCS_#Y(\_PZ1//\-D3S_#9$\_PV1//\-_S4
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M&'E,ZQAX3/X7=TS_%7=,_Q1W3/\3=TS_$G=,_Q)W3/\2_SX  .A'  #54
MQE8  +Q8  "T60  K58  *=3!P"A5!4 G%8E )A7- &45T "D%=*!(U64P:*
M55L)AU1C"X14:@Z"4W(0@%)Z$GU2@Q1[48X6>%"9&'90IAET4+4:<U#)&G%0
MZ!IP4?P8<%'_%W!1_Q5P4?\4<5#_$W%0_Q-Q4/\3]4   .1+  #/5   P5H
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M&%]=_Q=@7?\68%W_%6!=_Q5@7?\5ZTH  -16  ##7@  MF4  *QI  "B:0
MF&<  (]E  ")9@P A6@9 (%I* !^:C4!>FD_ W9I205S:%$(<&=9"FUG8 UK
M9F<0:&5P$F5D>15C9(,78&./&5YBG1M<8JP<6F*_'%EBWQQ98O<:6F+_&5IA
M_Q=;8?\66V'_%5MA_Q5;8?\5YTT  ,]9  "_8@  LV@  *EM  ">;0  DVL
M (EI  "#:PD ?VT5 'QN)0!X;C(!=6X] G%N1@1N;4\':VQ6"6AL7@QE:V4/
M8VIM$6!I=A1=:8$66VB-&%AGFQI69ZH;56>]'%1GW!Q49_8:5&;_&%5F_Q=5
M9?\65F7_%59E_Q569?\5XE$  ,I=  "[9@  KVP  *9Q  "9<   CF\  (-N
M  !]< 4 >'(2 '5S(0!R<R\!;W,Z FQS1 1I<DP&9G)4"&-Q6PM@<&,-77!K
M$%MO=!-8;G\556Z+%U-MF1E1;:@:3VV[&TYMV1I.;/093VO_&$]K_Q=0:O\6
M4&K_%5!J_Q50:O\5W54  ,5A  "W:@  K'$  *)U  "4=   B70  'QS  !V
M=0  <7<0 &]X'0!L>2L :7DW 69Y0 -C>4D%8'A1!UUW6 E;=V ,6'9H#E5U
M<1%2=7P34'2(%DUTEQ=+<Z8827.Y&4ASU1E)<O,827'_%TIQ_Q9*</\52W#_
M%$MP_Q1+</\4U%H  ,!F  "S;P  J'8  )UY  "/>   A'@  '=Y  !O?
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M#P!2CQL 4(\G $^0,P!-D#T!2Y!% DF03@-&D%8$1(]?!4*/: <_CW,)/8Z
M"SJ.CPPXCJ --XZS#C:.S XVC>\.-8O_#C6)_P\UB/\/-H?_#S:'_P\VA_\/
MOFT  +!Y  "E@@  F8<  (R(  !_B   <HH  &:-  !:D0  4)4  $F7"0!'
MF!, 19@@ $29*P!#F38 09I  $":2 $^FE$"/)I: CJ:9 ,WFF\%-9E]!C.9
MC <QF9T(+YFP""Z9R@@NF.T(+I;_"BV4_PHMD_\++9+_"RV2_PLMDO\+MG4
M *J!  ">B   DXT  (:.  !XCP  :Y(  %^5  !4F0  29T  $"@   ZH@T
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M  [ N@ .P.$ #[W[  ^\_P 0NO\!$+K_ 1"Z_P$0NO\!GX\  )25  "'FP
M>:$  &NG  !>K   4K$  $6T   ZM@  +[D  "6\   =OP  %<,   _&!0 +
MR@T "<H4  C*'0 'RB< !\HR  ;+/@ %RTL !,Q:  /,:@ "S'X  <R4  #,
MJP  S<@  ,SM  #,_P  R_\  <K_  '*_P !RO\ EY8  (J<  !\HP  ;JH
M &"P  !2M@  1;D  #F\   NOP  (\,  !O&   3R@  #<T   C1   !U D
M -0.  #5%0  UAX  -@G  #9,0  VSX  -Q+  #=6P  WFX  -Z$  #?FP
MW[0  -[9  #?]P  W_\  -__  #?_P  W_\ C9T  '^E  !PK   8;,  %.Z
M  !%OP  .,(  "S&   AR0  &,T  !#1   +U0  !-H   #>    X $  .$)
M  #B#@  Y!,  .4;  #G)   Z2\  .L\  #M2P  [ET  .YQ  #OB0  \*(
M /"\  #PXP  [_D  /#_  #P_P  \/\ @:4  '*M  !CM0  5+T  $;$   W
MR   *LP  !_0   5U0  #MH   ?>    X@   .8   #I    Z@   .P   #N
M!0  [PP  /$0  #S%P  ]2   /@K  #[.0  _4H  /Y>  #_=   _XT  /^F
M  #_P   _^$  /_U  #_]0  __4 =*X  &6W  !6P   1\@  #C-   JT@
M'=@  !/=   ,X@   ^8   #I    [    /    #S    ]    /8   #X
M^@   /T'  #_#0  _Q(  /\;  #_*   _S<  /]*  #_7@  _W8  /^/  #_
MI@  _[H  /_1  #_T0  _]$ _P\D /\.(@#_"R$ _P,D /\ *0#_ #( _P ^
M /\ 3 #_ %D _P!E /\ < #_ 'H _P"$ /\ C #_ )( _P"9 /\ GP#_ *4
M_P"K /\ L@#_ +H _P#% /\ TP#_ .< _P#T /\ _P#^ /\ _P#_ /X _P#^
M /\ _@#_ /X _P#^ /\ _Q$A /\0'@#_#1T _P<? /\ (P#_ "T _P Z /\
M2 #_ %4 _P!A /\ ; #_ '8 _P!_ /\ AP#_ (X _P"5 /\ FP#_ *$ _P"G
M /X K@#] +8 _ #  /L S0#Y .( ^ #P /< _ #V /\ ]0#_ /4 _P#U /\
M]0#_ /4 _P#U /\ _Q4= /\3&@#_$!D _PL9 /\ '0#_ "D _P V /\ 0P#_
M %  _P!< /\ 9P#_ '$ _P!Z /X @P#\ (H ^@"1 /D EP#X )T ]P"C /4
MJ@#T +( \@"[ /$ R #O -P [@#L .T ^@#K /\ Z@#_ .H _P#J /\ Z@#_
M .H _P#J /\ _Q@9 /\6%0#_$Q, _PX3 /\+&@#_!R0 _P(P /\ /@#_ $L
M_P!7 /\ 8@#\ &P ^ !U /4 ?@#R (4 \0", .\ DP#N )D [ "@ .L I@#I
M *X YP"W .8 PP#D -0 X@#I .$ ]P#? /\ W0#_ -T _P#= /\ W0#_ -T
M_P#= /\ _QL3 /\:$ #_%@X _Q(. /\2%0#_#Q\ _PPK /\). #_!D4 ^P-1
M /<"7 #R F8 [@)P .H"> #G H  Y@.' .0#C@#B Y4 X0.< -\$HP#=!*L
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M /\E  #_)@  ^R<  /$E P#P(0L Z!P2 -X9'0#4&RT S1T\ ,@?20#%(%4
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M") U[ B.-OX(C#;_"(LV_PB+-O\'BC7_!XHU_P>*-?\'_R\  /(T  #B/
MTD$  ,="  # 0   NSH! +8V#@"P.1P JCLL *8\.@"C/48 GSU0 9T]60*:
M/6$#F#UH!)8\< 64/'<&DCR !Y$\B >/.Y((C3N="8L[J0J).[<+B#O*"X4\
MZ N#//L+@CS_"H$\_PJ!//\)@3S_"($\_PB!//\(_S,  .PZ  #:0P  RD<
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M#VI,_PYJ2_\-:DO_#&I+_PQJ2_\,\#T  -M(  #'4   NE4  +!8  "E5@
MG%,  )=/  "14 X C%(< (E4*P"%5#< @E1" 7]42P-\5%,$>E-:!GA38@AU
M4FD)<U)Q"W%1>@UN480/;%"0$&I0G!)H4*L39E"\$V50V!-D4/,29%#_$&10
M_P]D4/\.94__#65/_PQE3_\,[$$  -1,  ##5   MED  *Q<  "@6@  EU<
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M#E9;_PU66_\-WDP  ,=6  "X7P  K60  *!E  "39   B6,  ']A  !Y8@,
M=601 ')E'@!O9BL ;&<W 6IG0 )G9DD#9691!&)E6 9@96 (761G"EMD< Q9
M8WL.5F.&$%1BE!)28J,34&*T$T]BS!-/8NT23V'_$4]A_Q!08/\.4&#_#E!@
M_PU08/\-V4\  ,-:  "T8P  J6D  )MH  "/9P  A&<  'EE  !S9P  ;VD.
M &QJ&P!I:R@ 9VPT &1L/0%B;$8"7VM.!%UK5@5::ET'6&IE"59I;@M3:7@-
M46B$#TYHDA!,9Z$22V>R$DEGR1))9^L226;_$$IF_P]*9?\.2V7_#4MD_PU+
M9/\-T50  +Y>  "Q9P  IFT  )=L  "*:P  ?VL  '-K  !M;0  :&X, &5P
M%P!B<20 8'$P %YQ.@%<<4,"67%+ U=Q4P15<%H&4G!B!U!P:PE.;W4+2V^"
M#4ENCP]';I\016ZP$41NQQ%#;>H01&S_#T1K_PY%:_\-16K_#45J_PU%:O\-
MRU@  +IC  "M;   H7$  ))P  "%;P  >F\  &YP  !E<P  8'4' %UV$@!;
M=Q\ 67@K %=X-@!5>#\!4WA( E%X3P-/=U<$3'=?!4IW: =(=G,)179_"T-U
MC0Q!=9T./W6N#CYUQ0X]=>@./G/]#3YR_PT^<?\,/W'_##]P_PP_</\,Q5X
M +5I  "I<0  G'4  (UT  " =   =70  &EV  !>>0  6'P! %1]#@!2?AH
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M RB2O00HDN$#)Y#Z!">._P4GC?\%)XS_!2>,_P4GC/\%L70  *5^  "9A0
MBH0  'V$  !OA0  8X@  %B+  !-CP  0Y,  #J7   RF@< +IL0 "V;&@ L
MG"0 *YPN "J=.  IG4$ *)U+ ">>50 FGF$ )9YN ".>?@$BGI !()ZC 1^>
MN0$>GMT!'ISX AZ:_P(>F?\#'I?_ QZ7_P,>E_\#JGT  )Z%  "3BP  A8H
M '6+  !HC@  6Y$  %"5  !&F0  .YT  #*@   JHP  (J8) !^G$0 >IQH
M':@D !RH+0 ;J#< &JE! !FI3  8J5@ %ZIF !:J=@ 5JHD %*J> !.KM  2
MJ], $JCU !.G_P$3I?\!$Z7_ 1.D_P$3I/\!HX8  )>,  "-D0  ?9(  &V5
M  !@F   5)P  $B@   ^I   -*<  "JK   AK@  &;$  !*S!P /M1  #K47
M  ZU(0 -M2L #;4V  RV00 +MDX "K9<  FV;  (MG\ ![:4  :VJ@ %ML4
M!K;J  >U_P (M/\ "+/_  FR_P )LO\ FHT  )"3  "$F   =)P  &6@  !7
MI   2Z@  $"L   UL   *K,  "&U   8N   $;L   R^ @ &P L  L 1  '!
M&0  P2(  ,(K  #"-@  PT(  ,-0  #$7P  Q'$  ,2'  #$G0  Q+4  ,3:
M  #$]@  P_\  ,/_  ##_P  P_\ DY0  (>:  !XH   :J8  %RL  !/L0
M0;4  #6W   IN@  '[T  !;    0PP  "L8   /*    S 4  ,P,  #-$0
MSA@  ,XA  #0*@  T34  --#  #44@  U&,  -5X  #5CP  U:<  -;"  #6
MZ0  UOT  -;_  #6_P  UO\ BIL  'NB  !LJ0  7K   %"V  !"N@  -+T
M "C!   =Q   %,<   W+   &S@   -(   #7    V0   -H%  #<"P  W1
M -\5  #A'0  XR<  .4S  #G0@  Z%0  .AG  #I?@  Z9<  .JO  #JS@
MZ^\  .O^  #K_P  Z_\ ?:,  &ZK  !?L@  4;H  $+    TPP  )\<  !O+
M   2SP  "],   +8    W0   .$   #D    Y0   .<   #I    ZP<  .T-
M  #O$0  \1D  /0D  #W,0  ^4$  /I5  #Z:@  ^X0  /N=  #\M@  _-(
M /WM  #]]   _?0 <:P  &&U  !2O0  1,0  #3)   FS0  &M(  !#8   (
MW0   .$   #E    Z    .P   #O    \0   /,   #U    ]P   /D!  #[
M"   _@X  /\5  #_(0  _R\  /]!  #_5@  _VT  /^'  #_H   _[8  /_*
M  #_U   _]0 _PL@ /\''@#_ !T _P @ /\ )0#_ "X _P [ /\ 20#_ %8
M_P!B /\ ;0#_ '8 _P!_ /\ AP#_ (X _P"4 /\ F@#_ *  _P"F /\ K0#_
M +4 _P"^ /\ RP#_ .$ _P#P /X _0#] /\ _0#_ /T _P#] /\ _ #_ /D
M_P#Y /\ _PT= /\+&@#_!!D _P : /\ 'P#_ "H _P W /\ 10#_ %$ _P!>
M /\ : #_ '( _P!Z /\ @@#_ (D _P"0 /\ E@#_ )P _@"B /P J0#[ +
M^0"Y /@ Q@#V -D ]0#K /0 ^0#S /\ \@#_ /, _P#S /\ \P#_ /, _P#S
M /\ _Q 9 /\.%0#_"!0 _P 4 /\ &0#_ "4 _P R /\ 0 #_ $P _P!9 /\
M8P#^ &T _ !U /H ?0#Y (0 ]P"+ /8 D0#T )< \P"> /( I #P *P [@"T
M .T P #K ,\ Z0#F .@ ]0#F /\ YP#_ .8 _P#E /\ Y0#_ .4 _P#E /\
M_Q(4 /\0$ #_# \ _P,0 /\ %0#_ "  _P L /\ .@#_ $< ^@!3 /< 7@#T
M &< \0!P .\ > #M '\ ZP"& .H C #H ), YP"9 .4 H #C *< X0"P -\
MN@#= ,D VP#@ -@ \ #7 /X U0#_ -0 _P#3 /\ TP#_ -, _P#3 /\ _Q40
M /\2# #_#@D _PL, /\)$@#_ QH _P F /T ,P#T $  [P!- .L 6 #H &$
MY0!J .( <@#@ 'H W@"  -P AP#: (X V "5 -0 G #2 *, T "L ,X M@#,
M ,0 R@#9 ,@ [0#' /L Q0#_ ,0!_P## ?\ Q '_ ,0!_P#$ ?\ _Q@+ /\5
M!0#_$   _Q & /\/#0#_#!0 _ <? /$#*P#G #D X@!& -X!40#: EL U0)D
M -(#; #/ W0 S01[ ,L$@@#*!(D R 60 ,8%F #$!:  P@:I ,$&M "_!L$
MO0C5 +L)[ "X"_T M@S_ +4-_P"T#?\ M W_ +0-_P"T#?\ _QL% /\8  #_
M%P  _Q8  /L3!@#Z$ X [@P6 .,)(@#:"3  TPH^ ,X+2@#*#%4 QPU> ,4-
M9P#"#F\ P0YV +\.?@"]#X4 O ^- +H0E0"X$)T MQ"G +41L@"S$<  LA'5
M *X3[@"K%/X J17_ *<5_P"G%?\ IA3_ :84_P&F%/\!_Q\  /\<  #Z'@
MZQX  .,<  #?%04 W@X- -,.& #+$2@ Q1,W , 41 "\%D\ N1=9 +<780"T
M&&D LQEQ +$9> "O&H  KAJ( *P;D "K&YD J1NC *<<K@"F'+P I!W/ *$>
MZ@&>'OP!G!__ 9L?_P&:'_\!FA[_ 9D>_P&9'O\!_R(  /\A  #L)P  X"H
M -0I  #-)   RAP( ,09$@"]'"( MQXQ +,@/@"O(4D K2)3 *HC7 "H)&0
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M!7LV_P5Z-O\$>C;_!'HU_P1Z-?\$]2T  .0W  #0/P  PD,  +=$  "M0
MISH  *,V!@"=-Q, F3DB )4Z+P"2/#L CSQ& (P\3P&*/%<!B#Q> H8\90*$
M/&T#@CQU!( \?01_/(<%?3R2!GL[G@=Y.ZP'=SN\"'8\U0AT//$(<SS_!W(\
M_P9R//\%<CS_!7([_P5R._\%\3(  -X]  #)1   O$@  +!)  "F1@  GT$
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M!UY*_P=>2O\'XS\  ,M)  "\40  L%4  *%4  "64@  C5   (=,  "!30@
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MC0I-79P+2UVL#$I=P0Q)7>,,25SZ"DE;_PE*6_\(2EK_"$I:_P=*6O\'SDX
M +Q8  "N8   GV$  )%@  "%7P  >U\  '!=  !J7P  96$* &)B% !@8R$
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M"#AONP@X;]L'.&[V!SAM_P<X;/\&.6O_!CEJ_P8Y:O\&O5P  *]F  "B;0
MD6P  ()K  !W:P  ;&P  &%N  !7<   4',  $QU"@!)=A, 1W<? $9W*0!%
M>#, 0W@\ $)X1 !!>$T!/WA5 3UX7@([>&@".7AT S=X@@0U>),%,W>D!3)W
MN04Q>-<%,7;U!3%T_P4Q<_\%,7+_!3)R_P4R<O\%MV,  *IM  "<<0  BW
M 'UP  !R<   9W$  %QS  !1=P  2GH  $)] P _?@X /7\8 #Q_(P [@"T
M.H V #F!/P X@4@ -H%0 #6!6@$S@60!,8%P 2^!?P(M@8\#+(&A RJ!M@,I
M@=(#*7_S RE]_P,I?/\#*7O_ RE[_P,I>_\#L6H  *5T  "5=@  A74  'AU
M  !M=0  87<  %=Z  !,?@  0X$  #N%   UB D ,HD1 #&)&P PB24 +XHO
M "Z*.  MBT$ +(M* "J+5  IBU\ *(MK ":+>@$DBXL!(XN> 2*+LP$AC,X!
M(8KQ 2"(_P(@AO\"((7_ B&%_P(AA?\"JW(  *%\  "/>P  @'H  '-Z  !F
M?   6W\  %""  !&A@  /(H  #2-   LD0  )I,, "24$P CE!P (I4F "&5
M+P @E3@ 'Y9" !Z63  =EE@ ')9D !J7=  9EX8 &)>9 !>7K@ 5E\D %I7N
M !:3_P$6DO\!%I'_ 1:0_P$6D/\!I7L  )F#  ")@0  >X   &R"  !?A
M5(@  $F+   _D   -90  "V7   EF@  '9X! !:@#  4H1( %*$; !.A)0 2
MH2X $:(X !&B0P 0HD\ #Z)<  ZC:P -HWT #:.2  RCIP *HL  "Z+F  R@
M_@ -G_\ #9[_  V=_P -G?\ GH0  )*)  "#B   <X@  &6+  !8C@  3)(
M $&7   WFP  +IX  "2B   <I0  %:@   ^K!  *K@P !ZT2  :M&P %K20
M!*XN  *N.0 !KD4  *Y2  "N80  KG,  *Z'  "NG0  KK0  *[5  "M]
MK?\  *S_  "K_P  J_\ EHL  (R0  ![D   :Y(  %V6  !0F@  1)\  #FC
M   OIP  ):L  !RN   4L0  #K0   FW   !N D  +@.  "Y%   N1P  +HE
M  "Z+P  NSH  +Q'  "\5@  O&<  +Q[  "\D0  O*D  +S$  "\ZP  N_X
M +O_  "[_P  N_\ D)(  (.8  !SFP  8Y\  %6C  !'J   .ZT  #"Q   E
MM   &[<  !*Z   ,O0  !;\   ##    Q (  ,4*  #%#@  QA0  ,<;  #(
M)   RBX  ,PZ  #-20  S5D  ,UL  #.@P  SIL  ,VU  #.V@  SO8  ,W_
M  #-_P  S?\ AID  '>@  !II@  6JP  $RR   ^M@  ,+D  "2\   9OP
M$<(   K%   "R0   ,P   #0    T0   -(!  #3"   U0T  -<1  #:&
MW"$  -\L  #A.@  XDH  .-=  #D<@  Y(L  .6E  #EP   Y>8  .7X  #E
M_P  Y?\ >J$  &NI  !<KP  3;8  #^\   POP  (\,  !?'   /R@  !\X
M  #1    U@   -P   #?    X    .(   #D    Y@,  .@)  #I#@  [!4
M .X>  #Q*P  ]#H  /5-  #V80  ]WD  /B3  #XK0  ^<8  /GD  #Y\P
M^?, ;:H  %ZR  !/N@  0,$  #'%   BR0  %LX   W2   $V    -T   #A
M    Y    .@   #K    [0   .\   #Q    \P   /8   #X P  ^@L  /T1
M  #_&P  _RD  /\[  #_3P  _V8  /]_  #_F0  _Z\  /_#  #_U@  _]8
M_P0< /\ &0#_ !D _P < /\ (@#_ "L _P X /\ 1@#_ %, _P!> /\ :0#_
M '( _P!Z /\ @@#_ (D _P"/ /\ E0#_ )L _P"A /\ J #_ *\ _P"Y /\
MQ0#_ -D _@#L /T ^P#[ /\ ^P#_ /L _P#Z /\ ] #_ /  _P#P /\ _P<8
M /\!%0#_ !0 _P 6 /\ &P#_ "8 _P T /\ 0@#_ $X _P!: /\ 9 #_ &T
M_P!U /\ ?0#_ (0 _P"* /T D #\ )8 ^@"= /D HP#X *L ]P"T /4 OP#T
M ,X \P#F /$ ]@#P /\ [P#_ .\ _P#N /\ [@#_ .H _P#J /\ _PL4 /\&
M$0#_ !  _P 0 /\ %@#_ "( _P N /\ / #_ $D _P!4 /X 7P#[ &@ ^0!P
M /< > #U '\ \P"% /( BP#P )( [P"8 .T GP#L *8 Z@"N .@ N0#G ,<
MY0#> ., \ #B /X X #_ .  _P#A /\ X0#_ .$ _P#A /\ _PT0 /\)#0#_
M 0P _P , /\ $@#_ !P _P H /P -@#Y $, ]@!. /( 60#O &( [ !K .H
M<@#H 'D Y@"  .0 A@#B (P X0"3 -\ F@#= *$ VP"J -@ M #5 ,  T@#3
M -  Z@#. /H S0#_ ,T _P#- /\ S #_ ,P _P#, /\ _Q , /\,!P#_ P(
M_P ( /\ #@#_ !8 ]@ B /  +P#L #P Z0!( .4 4P#A %P W@!E -L ; #7
M ', U !Z -( @ #0 (< S@". ,P E0#* )T R "E ,8 KP#$ +L P@#+ ,
MY0"^ /4 O0#_ +P _P"\ /\ O #_ +P _P"\ /\ _Q$% /\.  #_"@  _P@!
M /\$"@#X !  Z0 : ., * #> #4 V0!! -, 3 #/ %8 RP!? ,D 9@#& &X
MQ !T ,( >P#! (( OP") +T D "\ )@ N@"A +@ JP"V +< M #' +( X "Q
M ?( KP+_ *X#_P"M!/\ K03_ *T$_P"M!/\ _Q0  /\0  #_#P  \@T  .H*
M  #I PD W0 2 -0 'P#- 2T R (Z ,0#10#  U  O019 +L%80"Y!6@ MP9O
M +4&=@"T!WT L@>$ +$(C "O")4 K0F> *L)J "J"K4 J K% *8+WP"D#?0
MH@[_ * ._P"?#O\ GP[_ )\._P"?#O\ _Q<  /\3  #O&   Y!D  -L6  #2
M$ ( SPD+ ,@(%@#!"B0 O PR +<-/@"T#DD L0Y3 *\06P"M$&, JQ!J *D1
M<0"H$7@ IA&  *41B "C$I$ H1*; * 3I@">$[, G!/# )L4W@"7%O0 E1;_
M )07_P"3%_\ DA?_ )(6_P"2%O\ _QH  /0=  #E(P  U24  ,HD  #"'0
MOA8$ +L0$ "T$QT KQ4K *L6. "G&$, I1E- *(95@"@&ET GAME )T;; ";
M'', FAQ[ )@<@P"7'8T E1V7 ),>H@"2'J\ D!Z_ (\?V ",(/$!B2#_ 8@@
M_P&'(/\!AR#_ 88@_P&&(/\!^AX  .LF  #:+0  RC   +XN  "U*   L"(
M *X;# "H'1< HQ\F )\A,P"<(CX F2-( )<D40"5)%D DR5@ )(E9P"0)FX
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M FHU_P)J-?\"ZC   -,Z  #"00  LT,  *5!  ";/@  E3H  ) V  ",-0T
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MC 572IH&54JJ!U1*O0=32MP'4DKV!E)*_P522?\$4DG_ U)(_P-32/\#U$$
M ,!+  "R40  H%   ))/  "'3@  ?DP  'A(  !R2@  ;DL- &M-& !H3B0
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M!D17N 9#6-(&0U?R!D-6_P5#5?\$1%7_!$14_P-$5/\#QDP  +56  "E6@
ME%D  (98  ![6   <5<  &96  !A6   75D$ %E:$ !76QL 55PF %-=, !2
M73D 45Y! $]>20!-7E$!3%Y8 4I>80)(76L#1EUV T1=@P1"79(%0%VC!C]=
MM@8^7= &/5SQ!3Y;_P0^6O\$/EK_ SY9_P,_6?\#P5   +%:  "A70  D%P
M ();  !V6P  ;5L  &%;  !;70  5EX  %)@#0!081< 3F(B $UB+ !,8S4
M2F,^ $EC1@!'8TX 1F-6 41C7@%"8V@"0&-S SYC@0,\8Y $.F*A!#EBM 4X
M8\T%.&+O!#AA_P0X8/\#.%__ SE>_P,Y7O\#O%4  *U?  "<8   BU\  'U?
M  !R7P  :%\  %U@  !58@  3V0  $MF"@!)9Q( 1V@= $5H)P!$:3$ 0VDY
M $)J0@! :DH /VI2 #UJ6P$\:F4!.FIP CAJ?@(V:8T#-&F? S-IL@,Q:<L#
M,6CM S%G_P,Q9O\#,F7_ S)D_P,R9/\#MUL  *ED  "69   AF,  'AC  !M
M8P  9&0  %EE  !0:   26L  $-M! ! ;@X /F\8 #UO(@ \<"L .G T #EQ
M/0 X<44 -W%. #9Q5P T<6$!,G%M 3%Q>@$O<8H"+7&< BMQKP(J<<@"*G#K
M BIO_P(J;?\"*FS_ BML_P(K;/\"L6$  *1I  "0:   @&<  '1G  !I9P
M7V@  %5K  !+;@  0W$  #QT   W=@H -'<2 #-X'  R>"4 ,7DN #!Y-P O
M>3\ +GE( "QZ4@ K>EP *GIH "AZ=@ F>H<!)7J9 2-ZK $B>L4!(GGI 2)W
M_P$B=O\!(G7_ B)T_P(C=/\"K&@  )UN  "*;0  >VP  &]L  !E;   6FX
M %!Q  !%=0  /7@  #9\   N?P( *8$- ">"%  F@AX )8(G "2"+P C@S@
M(H-" "&#2P @A%8 'X1B !Z$<0 <A(( &X25 !J$J0 8A,$ &(/F !B!_0 9
M@/\!&7__ 1E^_P$9?O\!IG   )5S  "$<@  =G$  &MQ  !><P  5'8  $EY
M   _?0  -X$  "^$   GB   ((L% !N-#@ :C14 &8T> !B.)P 7CC  %HXY
M !6.0P 4CT\ $X]; !*/:@ 1CWL $(^/  ^/I  .C[L #8_@  Z-^@ /B_\
M$(K_ !")_P 0B?\ H7H  (YY  !^=P  <G<  &1X  !8>P  37X  $*"   Y
MA@  +XH  ">.   @D0  &)4  !*8!0 .F@X #9H4  R:'0 +FB8 "YHP  J:
M.P )FD8 ")I3  :;80 %FG( !)J&  *:FP  FK$  9G/  *9\  "F/\ !)?_
M  66_P %EO\ F8$  (=_  !Z?@  :WX  %V!  !0A0  18D  #N-   QD@
M*)8  !^9   8G0  $:    RC @ &I0H  :40  "E%@  IA\  *8H  "F,@
MIST  *=*  "G6   IV@  *=\  "GD0  IJ@  *;#  "EZ0  I?P  *7_  "D
M_P  I/\ D8<  (*&  !RA@  8X@  %6,  !)D0  /98  #*:   HG@  'Z(
M !>F   0J0  "ZP   2O    L08  +$,  "R$0  LA<  +,?  "S*   M#(
M +4_  "U30  M5T  +5P  "UA@  M9T  +6V  "UW   M/<  +3_  "T_P
MM/\ BX\  'J.  !JD0  6Y4  $V:  ! GP  -:0  "JH   @K   %K    ^T
M   )MP   ;D   "]    O@   +X&  "_#   P!   ,$6  #"'0  PR<  ,4R
M  #&0   QE$  ,=C  #'>   QY$  ,>I  #'QP  Q^P  ,?^  #'_P  Q_\
M@Y<  '&:  !AG@  4J,  $6I   XK@  ++,  ""W   6N@  #KT   ;
MPP   ,<   #)    R@   ,P   #- P  S@D  - .  #2$P  U!L  -@E  #;
M,@  W4(  -U4  #>:0  WH$  -Z<  #?M0  W]D  -_S  #?_P  W_\ =Y\
M &BF  !9K0  2K,  #NX   MNP  '[\  !3"   ,Q@   \D   #,    T
M -4   #9    V@   -P   #>    X    .(%  #D"P  YQ   .H8  #M)
M\#(  /%$  #R6   \V\  /2*  #TI   ]+\  /3?  #T\P  ]/0 :J@  %NO
M  !,MP  /;T  "W!   ?Q@  $\H   O.    T@   -<   #<    X    .4
M  #G    Z0   .L   #M    [P   /$   #S    ]@<  /D.  #\%@  _R(
M /\S  #_1P  _UT  /]V  #_D0  _ZD  /^^  #_V   _]L _P 8 /\ %@#_
M !4 _P 8 /\ '@#_ "< _P V /\ 0P#_ $\ _P!: /\ 9 #_ &T _P!U /\
M?0#_ (0 _P"* /\ D #_ )8 _P"< /\ HP#_ *L _P"T /X OP#] ,\ ^P#G
M /H ^ #Y /\ ^0#_ /D _P#U /\ [@#_ .D _P#G /\ _P 4 /\ $0#_ !$
M_P 2 /\ %P#_ ", _P Q /\ /@#_ $H _P!6 /\ 8 #_ &@ _P!P /\ > #]
M 'X _ "% /H BP#Y )$ ^ "8 /< G@#U *8 ] "N /( N0#Q ,< [P#@ .X
M\@#L /\ [ #_ .P _P#K /\ Y0#_ .  _P#> /\ _P,0 /\ #@#_  T _P -
M /\ $P#_ !X _P K /\ . #_ $4 _@!0 /L 6@#X &, ]0!K /, <@#Q 'D
M[P!_ .X A@#L (P Z@"2 .D F0#G *  Y@"I .0 LP#A ,  X #3 -X ZP#<
M /L VP#_ -H _P#: /\ V0#_ -0 _P#2 /\ _P<- /\ "0#_  8 _P ) /\
M#P#_ !@ ^P E /@ ,@#U #\ \@!* .T 5 #J %T YP!E .0 ; #B ', X !Z
M -X @ #< (8 V@"- -< E #4 )L T@"D ,\ K0#- +D RP#) ,D Y #( /8
MQ@#_ ,4 _P#& /\ QP#_ ,< _P#' /\ _PH& /\!  #_    _P $ /\ "P#T
M !( [P ? .H + #E #@ X@!# -T 3@#9 %< U !? -$ 9P#. &T S !T ,H
M>@#( (  Q@"' ,4 C@## )8 P0"> +\ J "] +, N@#" +D VP"W /  M0#_
M +8 _P"U /\ M0#_ +4 _P"U /\ _PP  /\$  #_    _@   /8  P#H  T
MX  7 -D ) #1 #$ S0 \ ,H 1P#& %$ PP!9 ,  8 "^ &< O !N +H = "Y
M 'L MP"" +4 B0"S )$ L@": +  I "N *\ K "] *H T "H .L IP#[ *8
M_P"F /\ I0#_ *4 _P"E /\ _PT  /\'  #T"0  Z@D  .($  #:  < SP 1
M ,@ ' #" "D O@ U +L 0 "W $H M !3 +( 6P"P &( K@!H *P ;P"K '4
MJ0!] *@ A "F (T I "6 *, H "A *L GP&Y )T#S "<!.@ F@;Y )D'_P"8
M"/\ EPC_ )<(_P"7"/\ _Q   /<0  #H%   W!4  ,X1  #&#0  P@0+ +P
M% "W 2$ L@,N *X%.@"K!D0 J A- *8(50"D"5P H@IC * *:@"?"W$ G0MX
M )P+@ ":#(D F0R3 )<,G@"5#:H E VX )(-S "0#NH CA#\ (P0_P"+$/\
MBQ#_ (L0_P"*$/\ ^Q,  .T:  #=(   S"$  +\=  "W%P  LQ$  +(+#0"K
M#1D IPXF *,/,P"?$#X G1%' )H14 "8$E< EA)> )4390"3$VP DA-S ) 4
M? "/%(4 C16/ (L5F@"*%:< B!:U (86R0"$%^< @AC[ ( 9_P!_&?\ ?QG_
M '\8_P!_&/\ ]1H  .0C  #/*0  P"H  +,F  "J(@  I1P  *05" "@%!,
MFQ8A )<8+0"4&3@ D1I" (\;2P"-'%( BQQ9 (D=8 "('6< AAYO (4>=P"#
M'X  @A^+ ( ?EP!^(*, ?2"R 'L@Q0!Y(>0 =R+Y '8B_P!U(O\ ="'_ '0A
M_P!T(?\ [R$  -LK  #',0  MC$  *DN  "@*@  FR8  )@A 0"5'A  D" ;
M (TA* ")(S, AR0] (4D1@"#)4X @295 '\F7 !^)F, ?"=K 'LG<P!Y)WP
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MC %C-9H"83:I F VNP)?-M8"73;S ETV_P)<-O\!7#7_ 5PU_P%<-/\!W#,
M ,4\  "T00  HD   )4^  "+/   A#D  '\V  ![- 0 =S40 '0W' !Q."<
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M E$^_P%1/O\!SSL  +U%  "J1P  F48  (M%  "!1   >4(  '0^  !O/P
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M?@)!4HT"/U*= SY2KP,]4L8#/%+I CQ1_@(\4/\"/4__ CU/_P(]3O\"ODL
M *Y3  ":4@  B5$  'Q1  !Q4   :%   %Y.  !840  5%(  %%3# !.5!0
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M 2QCJ0$K8[\!*F/C 2IB^P$J8/\!*U__ 2M?_P$K7O\!L5D  )Y<  "+7
M>UL  &];  !E6P  7%P  %%>  !)8   0V(  #QE   X9PH -6@2 #1H&P S
M:20 ,FDM #%I-0 O:CT +FI& "UJ3P L:ED *VME "EK<@ H:X( )FN3 "1K
MIP C:[T (FK@ "-I^0$C9_\!(V;_ 2-F_P$D9?\!K&   )A@  "%8   =E\
M &I?  !A8   5V   $UC  !$9@  /6@  #9K   P;@0 +' . "IQ%0 I<1X
M*'$F "=R+P F<C< )7)  "1R2@ B<E0 (7-@ "!S;0 ><WT '7.0 !MSHP :
M<[D &7/< !IQ]P :</\ &V__ !MN_P$;;?\!IF8  )%E  !_9   <60  &9D
M  !=9   4F8  $AI   _;   -V\  #!S   I=@  (GD( !][$  >>Q< ''L?
M !M[*  :>S  &7PY !A\0P 7?$X %GQ: !5\9P 4?7@ $GV+ !%]GP 0?;4
M#WW5 !![]0 1>?\ $7C_ !)W_P 2=_\ GFL  (IJ  !Z:0  ;6D  &)I  !7
M:@  3&T  $-P   Y=   ,7@  "E[   B?P  &X(  !2%"0 1AA  $887 !"'
M'P 0AR@ #H<Q  Z'.P -AT8 #(=3  N'80 *AW$ "8>$  >'F  &AJX !8;)
M  :%[  'A/\ "(/_  F"_P )@O\ E7$  (-O  !T;@  :6X  %QO  !0<@
M1G4  #QY   R?0  *H$  "*%   ;B0  %(P   ^/ P *D@L !I(1  22&  "
MDB   9(I  "2,P  DSX  )-+  "360  DVD  )-[  "2D   DJ8  )&_  "1
MY0  D/H  (__  "/_P  C_\ C7<  'UU  !P=   8G4  %5X  !)?   /X
M #2$   KB0  (HT  !J1   3E   #I<   F;   !G0@  )T.  "=$P  GAH
M )XB  "?*P  GS4  *!"  "@4   H%\  *!Q  "@AP  GYT  )^U  ">V@
MG?8  )W_  "<_P  G/\ AGT  'A\  !I?   6W\  $Z#  !!B   -HP  "R1
M   CE@  &IH  !*>   -H0  !J0   "G    J0,  *D*  "J#@  JQ,  *P9
M  "M(@  KBL  *\W  "O10  KU0  *]F  "O>P  KI0  *ZK  "NR0  KN\
M *W_  "M_P  K?\ @80  '&$  !AAP  4XL  $:0   YE@  +IL  ".@   :
MI   $J@   RL   $KP   +(   "V    MP   +<"  "X"   N0T  +H2  "[
M&   O2$  +XK  # .   P$@  ,!:  #!;@  P88  ,&@  #!N@  P>,  ,#Y
M  # _P  P/\ >8T  &B0  !9E   2YH  #V@   QI0  ):L  !JO   1LP
M"[@   *[    O@   ,$   #$    Q0   ,8   #'    R 4  ,H+  #,#P
MSA4  - ?  #3*P  U3H  -5,  #68   V'<  -B2  #8K   V<D  -GL  #9
M^P  V/\ <)D  &">  !1I   0ZH  #6P   HM@  '+H  !&^   )P0   ,4
M  #(    RP   ,\   #2    TP   -8   #8    VP   -T   #?!P  X@T
M .43  #H'0  ["H  .T\  #M40  [F<  .^!  #OG   \+<  /#3  #P[
M\/0 9Z8  %BM  !)M   .KH  "J^   <P@  $,8   ?*    S@   -(   #6
M    W    .    #C    Y    .8   #H    ZP   .T   #O    \@(  /4*
M  #X$0  _!P  /\L  #_/P  _U4  /]N  #_B@  _Z0  /^Z  #_T0  _^$
M_P 4 /\ $@#_ !( _P 4 /\ &0#_ "4 _P R /\ /P#_ $L _P!6 /\ 8 #_
M &@ _P!P /\ > #_ '\ _P"% /\ BP#_ )$ _P"8 /\ G@#^ *8 _0"N /P
MN0#Z ,@ ^0#B /@ ] #W /\ ]@#_ /8 _P#O /\ YP#_ .( _P#> /\ _P 1
M /\ #@#_  X _P / /\ % #_ "  _P M /\ .@#_ $8 _P!1 /\ 6P#_ &,
M_@!K /P <P#Z 'D ^0"  /< A@#V (P ]0"2 /, F0#R *  \ "I .X LP#M
M ,$ ZP#6 .H [@#I /X YP#_ .< _P#E /\ W0#_ -4 _P#1 /\ _P - /\
M"@#_  @ _P ) /\ $ #_ !L _P H /\ -0#_ $  ^@!+ /8 50#S %X \0!F
M .X ;0#L '0 ZP!Z .D @ #G (8 Y@"- .0 DP#B )L X "C -X K0#< +D
MV@#* -< Y@#4 /@ T@#_ -( _P#2 /\ S@#_ ,D _P#& /\ _P ( /\  P#_
M    _P # /\ #0#\ !8 ]P B /, +@#O #H [ !% .@ 3P#D %@ X0!@ -X
M9P#; &T V0!T -4 >@#3 (  T0"' ,\ C@#- )4 RP"> ,D IP#' +, Q0#"
M ,, W #! /$ OP#_ +\ _P"^ /\ O@#_ +T _P"[ /\ _P   /\   #_
M_P   /8 " #N !$ YP ; .$ )P#= #, V0 ^ -, 20#/ %( RP!9 ,@ 80#&
M &< Q !M ,( <P#  'H OP"  +T B "[ )  N0"8 +@ H@"U *T LP"[ +$
MS@"P .H KP#\ *T _P"M /\ K@#_ *X _P"N /\ _P(  /\   #]    \@
M .@   #>  P TP 5 ,P (0#( "P Q  X ,$ 0@"] $L N@!3 +@ 6@"V &$
MM !G +( ;0"P '0 KP!Z *T @@"L (H J@"3 *@ G0"F *@ I "U *( Q@"A
M ., GP#V )X _P"> /\ G@#_ )X _P"> /\ _P8  /L   #N!0  X@0  -4
M  #+  8 PP / +T &0"X "4 M  Q +$ .P"N $4 K !- *D 50"G %L I0!B
M *0 : "B &X H0!U )\ ? "> (4 G ". )H F "8 *0 E@"P )4 P0"3 -P
MD@#R )$ _P"0 /\ D #_ (\ _P"/ /\ _0H  / .  #A$0  SA   ,(-  "[
M!P  MP * +$ $@"L !X J  I *4 - "B #X GP!' )T 3P"; %8 F0%< )<!
M8P"6 FD E )P ),#> "1 X  D 2* (X$E0",!:$ B@6N (D&O@"'"-@ A@GP
M (0*_P"#"_\ @PO_ (,+_P"#"_\ ]A   .87  #2'   P!H  +,6  "L$@
MJ T  *8'#0"B!18 G0<B )D)+@"6"C@ E M! )(,2@"0#%$ C@U8 (P-7@"+
M#64 B0UL (@.= "&#GT A0Z' (,.DP"!#Y\ @!"M 'X0O@!]$-L >A'T '@2
M_P!W$O\ =Q+_ '<2_P!W$O\ [Q<  -LA  #&)   M",  *@@  "@'   FQ<
M )D1! "8#A  DQ ; (\1)P",$C( B1,\ (<31 "%%$P @Q13 ($56@" %6
M?A9H 'T6;P![%G@ >1># '@7CP!V&)P =!BJ ',9NP!R&=0 ;QKQ &X;_P!M
M&_\ ;1K_ &T:_P!M&O\ YR   - I  "\*P  JRH  )XH  "6)   D"   (T<
M  ",%PP B!@6 (0:(@"!&RT ?APW 'P=0 !Z'4@ >1Y/ '<>50!V'UP =!]C
M ',?:P!Q('0 <"!_ &XABP!L(9@ :R&G &DBN !H(L\ 9B+N &4C_P!D(_\
M9"+_ &0B_P!D(?\ X"8  ,@O  "T,0  HS   )8N  "-*P  AR@  (0D  ""
M( @ ?B 2 'LB'@!X(RD =20S ',E/ !Q)4, <"9+ &XF4@!M)UD :R=@ &HG
M: !I*'$ 9RA[ &4HB !D*94 8BFD & IM0!?*<L 7BKL %PJ_P!<*?\ 7"G_
M %PI_P!<*/\ V"P  ,,U  "M-0  G30  ) S  "&,0  @"T  'PK  !Y* ,
M=B<0 '(I&@!P*B4 ;2LO &LL. !J+$  :"U' &<M3@!E+E4 9"Y= &,N90!A
M+VX 7R]X %XOA !<+Y( 6B^A 5DOL@%8,,@!5C#I 54P_@%5+_\ 52__ %4N
M_P!5+O\ T#$  +TZ  "H.0  ES@  (HW  " -@  >C(  '4P  !R+@  ;BX-
M &LO%@!I,"$ 9C$K &0R- !C,CT 83-$ & S2P!?-%( 731: %PT8@!:-&L
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M?0%*/XL!2#^; 4<_K %%/\$!1#_C 40^^P%$/O\!1#W_ 40]_P%%//\!PSX
M *]#  ":0@  BD(  'U!  !S0   :S\  &4\  !@/   7#X$ %D^#P!7/Q@
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M 3=,IP$V3+P!-4S= 35+]P$U2_\!-4K_ 39)_P$V2?\!N$D  *)+  ".2@
M?DH  ')*  !H2@  7TD  %5(  !02@  3$L  $E,!P!&31  1$X9 $)/(@!!
M3RL 0% S #]0.P ^4$, /%%* #M14P Z45P .%%G #=1<P U48( ,U&3 3)1
MI0$P4;H!+U': 2]0]@$O3_\!,$[_ 3!._P$P3?\!M$T  )U-  "*30  >DT
M &Y-  !D30  6TT  %%-  !+3P  1E   $)2 P _4PT /505 #Q4'@ Z52<
M.54O #A5-P W5C\ -E9' #564  S5ED ,E=D #!7<0 O5X  +5>1 "M7HP J
M5[@ *5?6 "E6]0 I5?\ *E3_ 2I3_P$J4O\!KU$  )A1  "%40  =E   &I0
M  !@4   6%$  $Y2  !'4P  054  #M8   X60H -5H1 #1:&@ S6R( ,ELK
M #%;,P O7#L +EQ# "U<3  L7%8 *UU@ "E=;0 H77P )EV. "1=H0 C7;4
M(EW2 ")<\P B6_\ (UK_ "-9_P D6/\ J%4  ))4  " 5   <50  &94  !<
M5   5%4  $I6  !#6   /%L  #9=   P8 4 +6$. "MA%0 J8AT *6(E "AB
M+@ G8S8 )F,^ "5C1P C8U$ (F1< "%D:0 ?9'D 'F2* !QDG@ ;9+, &63.
M !IC\0 ;8?\ &V#_ !Q@_P <7_\ H5D  (Q8  ![6   ;5@  &)8  !96
M4%D  $=;   ^7@  -V   #%C   J9@  )&D) "%J$  @:A< 'VH@ !YK*  =
M:S  '&LY !MK0@ :;$P &6Q8 !=L90 6;'0 %&R& !-LF@ 2;*\ $6S* !%K
M[P 2:?\ $VC_ !-H_P 39_\ F5T  (5=  !U7   :%P  %Y<  !57   2UX
M $)A   Y9   ,F<  "MJ   D;0  'G ! !=S"P 5=!$ %'08 !-T(0 2=2D
M$74R !%U.P 0=48 #W52  YU7P -=6X #'6!  MUE0 *=:H "'3#  ETYP *
M<_T "W'_  QQ_P ,</\ D6(  ']A  !P80  9&$  %IA  !/8@  164  #QH
M   S;   *V\  "1R   ==@  %WD  !%\!  -?PP "W\2  I_&0 )?R( "'\J
M  9_-  %?S\ !']+  )_6  !?V<  ']Y  !_C@  ?Z,  'Z[  !]X   ??<
M 'S_  ![_P  >_\ B6<  'AG  !K9@  868  %1G  !):0  /VT  #5Q   L
M=0  )'D  !U\   6@   $(,   R& @ &B0H  8D/  ")%   BAL  (HC  "+
M+   BS<  (M#  "+4   BU\  (MQ  "+A@  BYP  (JS  ")TP  B/,  (C_
M  "'_P  A_\ @FT  '-L  !H;   6FT  $YO  !"<P  .'<  "Y[   E@
M'80  !6(   0C   "X\   22    E 8  )4,  "5$   EA4  )<<  "8)
MF"X  )DY  "91P  F58  )EH  "9?0  F90  )BK  "7R   ENX  );_  "5
M_P  E?\ >W0  &]S  !A<P  4W8  $9Z   [?P  ,(0  ":(   =C0  %)(
M  Z6   )F0   9P   "@    H0   *(&  "B#   I!   *44  "E'   IR0
M *@O  "H/0  J4P  *E>  "I<@  J(D  *BB  "HO   I^4  *;[  "F_P
MI?\ =WL  &A[  !9?@  2X(  #Z'   RC0  )Y(  !V7   4G   #J    >D
M    J    *L   "N    KP   +    "Q!   LPH  +0.  "U$P  MAL  +@D
M  "Z,0  ND   +I2  "[90  NWT  +J7  "ZL0  NM(  +KS  "Y_P  N?\
M;X,  %^&  !1BP  0Y   #:7   JG0  'Z(  !6G   -K   !;    "T
MMP   +L   "^    OP   ,    #!    PP$  ,0'  #%#0  QQ$  ,H9  #-
M)   SC,  ,]$  #06   T&X  -&(  #0I   T,$  -'F  #1^   T?\ 9X\
M %>4  !)F@  .Z$  "ZG   AK0  %K,   ZX   &O    ,    ##    Q@
M ,L   #-    S@   -    #1    U    -8   #: @  W D  -\/  #C%P
MYB0  .<V  #H20  Z5\  .IX  #KE   ZZ\  .O,  #LZ   [/8 7YX  %"D
M  !"JP  -+(  ":Y   9O@  #L(   3%    R@   ,T   #1    V    -L
M  #?    X    .(   #D    Y@   .D   #K    [@   /$%  #U#0  ^18
M /PE  #].0  _D\  /]G  #_@@  _YT  /^U  #_RP  _^0 _P 1 /\ #P#_
M  \ _P 1 /\ %@#_ "( _P O /\ .P#_ $< _P!2 /\ 6P#_ &0 _P!L /\
M<P#_ 'H _P"  /\ A@#_ (P _@"3 /T F0#[ *$ ^@"I /@ M #W ,( ]@#:
M /4 \0#T /\ \P#_ /, _P#I /\ X #_ -@ _P#3 /\ _P . /\ "P#_  H
M_P + /\ $0#_ !T _P J /\ -@#_ $$ _P!, /\ 5@#^ %\ ^P!F /D ;0#W
M '0 ]0!Z /0 @ #R (8 \ "- .\ E #M )L [ "D .H K@#I +H YP#- .4
MZ0#D /L XP#_ .( _P#> /\ T0#_ ,P _P#( /\ _P ) /\ ! #_  $ _P $
M /\ #@#_ !@ _P D /T , #[ #L ]P!& /, 4 #O %D [ !@ .H 9P#G &X
MY@!T .0 >@#B (  X "' -X C@#< )4 V@"> -8 J #4 +, T0## ,\ WP#.
M /0 S #_ ,L _P#+ /\ Q0#_ +\ _P"\ /\ _P " /\   #_    _P   /T
M"P#W !, \0 > .T *@#J #4 YP!  .( 2@#= %( V0!: -4 80#2 &< T !M
M ,X <P#, 'H R@"  ,@ AP#& (\ Q "8 ,( H0#  *T O@"[ +P T "Z .T
MN0#^ +@ _P"X /\ MP#_ +, _P"P /\ _P   /\   #_    ^0   .X !0#E
M  X W@ 8 -@ (P#2 "X SP Y ,L 0P#' $P Q !4 ,$ 6P"_ &$ O !G +L
M;0"Y ', MP!Z +4 @0"T (D L@"2 +  FP"O *< K "T *L Q@"I .0 IP#X
M *8 _P"F /\ I0#_ *4 _P"D /\ _P   /\   #U    Z@   -X   #0  H
MR  2 ,( '0"^ "@ NP S +D /0"U $8 L@!- +  50"M %L K !A *H 9P"H
M &T IP!S *4 >@"D (( H@", *  E@"? *$ G0"N )L O@"9 -@ EP#Q )8
M_P"6 /\ EP#_ )< _P"7 /\ _P   /4   #G 0  U    ,D   #   0 N  .
M +, %@"O "$ JP L *@ -@"F #\ HP!' *$ 3P"? %4 G0!; )L 80": &<
MF !N )< =0"5 'T E "& )( D0"0 )P C@"I (P N "+ ,T B0#K (@ _0"(
M /\ B #_ (@ _P"( /\ ^08  .D,  #4#@  PPP  +<)  "P @  JP ) *8
M$ "B !H G@ E )L , "8 #D E@!! )0 20"2 %  D !6 (X 7 "- &( BP!I
M (H < "( '@ AP"! (4 C "$ )@ @@"E (  M !^ ,@ ?0'G 'P"^0![ _\
M>P3_ 'L$_P![!/\ \0X  -X5  #%%0  M!0  *D1  "A#@  G@H  )L## "7
M !, DP > ) !*0"- C, B@,\ (@$0P"&!4L A091 (,&5P""!UX @ =D '\(
M; !]"'0 ? A^ 'H)B0!X"98 =PJC '4*LP!S"\< <@SF ' -^P!P#?\ ;PW_
M &\-_P!O#?\ Z!8  - >  "Y'0  J1P  )T:  "5%@  D!,  (\. P"."@X
MB0L7 (8,(P"##2T @ TV 'X./@!\#D8 >PY- 'D/4P!X$%H =A!A '40: !S
M$'$ <1%[ ' 1AP!N$90 ;!&B &L2L@!I$L< :!/G &83_0!E%/\ 913_ &43
M_P!E$_\ WQX  ,8D  "P)   H",  )0A  "+'P  AAL  (,7  ""$@@ ?Q$2
M 'P2'0!Y%"@ =A0Q '05.@!R%D$ <19( &\73P!N%U8 ;!== &L89 !I&&T
M:!EW &89@P!D&9  8QJ? &$:KP!@&L0 7AOD %T<^P!<'/\ 7!O_ %P;_P!<
M&_\ U24  +TJ  "H*0  F"D  (PH  "#)0  ?2(  'D?  !X&P, =AD/ '(:
M& !O'", ;1TM &L=-0!I'CT :!Y$ &8?2P!E'U( 8R!9 &(@80!A(&D 7R%S
M %TA?P!<(8T 6B*< %DBK !7(L  5B/A %4C^0!4(_\ 5"+_ %0B_P!4(O\
MS2L  +8N  "B+@  DBX  (4M  !\*P  =B@  '(F  !O(P  ;2$, &HB%0!G
M(Q\ 920I &,D,0!B)3D 8"9! %\F2 !=)D\ 7"=6 %LG70!9)V8 6"AP %8H
M? !4*(H 4RF9 %$IJ@!0*;X 3RG> $XI]P!-*?\ 32G_ $TH_P!.*/\ R#
M + R  "<,@  C#(  ( Q  !V,   <"T  &LK  !H*0  9B@) &,H$0!@*1P
M7BHE %PK+@!;*S8 62P] %@L1 !7+4P 52U3 %0M6P!3+6, 42YN % N>@!.
M+H@ 3"^7 $LOJ !)+[L 2"_; $@O]@!'+_\ 1R[_ $<M_P!(+?\ Q#0  *LU
M  "7-0  AS4  'LU  !R-   :S(  &8O  !B+@  7RT% %PN$ !:+Q@ 6# B
M %8P*P!5,3, 4S$Z %(R0@!1,DD 4#)0 $XS6 !-,V$ 2S-K $HS=P!(-(4
M1S25 $4TI@!#-+D 0C36 $(T] !"-/\ 0C/_ $(R_P!",O\ P#@  *<X  "3
M.   @S@  '<X  !M-P  9C8  &$S  !=,@  63(" %<S#0!4-!4 4C4? %$U
M* !/-C  3C8X $PW/P!+-T8 2C=. $DX5@!'.%\ 1CAI $0X=0!#.(, 03F3
M $ YI  ^.;@ /3G3 #PY\P \./\ /3?_ #TW_P ]-O\ NSL  *([  "/.P
M?SL  ',[  !J.@  8CD  %TW  !8-@  5#<  %$X"P!/.1, 33D< $LZ)0!*
M.BT 2#LU $<[/ !&/$0 13Q+ $0\4P!"/%P 03UG #\]<P ^/8$ /#V1 #H]
MHP Y/;8 .#W1 #<]\@ W//\ .#O_ #@[_P X.O\ MCT  )X^  "+/@  ?#X
M &\^  !F/0  7CT  %@[  !3.@  3SL  $P\" !)/1$ 1SX9 $8_(@!$/RH
M0S\R $) .@!!0$$ 0$!) #Y!40 ]05H /$%D #I!<  X07\ -T&/ #5"H0 T
M0K0 ,D+. #)!\  R0/\ ,T#_ #,__P T/O\ L4   )I   "'0   >$$  &Q!
M  !B0   6T   %0_  !./P  2D   $9!!0!$0@X 0D,6 $!#'P _1"< /D0O
M #Q$-P [13X .D5& #E%3@ X1E@ -D9B #5&;@ S1GP ,4:- #!&GP N1K,
M+4;, "U&[P M1?\ +D3_ "Y#_P N0_\ K$,  )9#  "#0P  =$,  &A#  !?
M0P  5T,  %!#  !(0P  1$4  $%& 0 ^1PP /$@3 #I('  Y220 .$DL #9)
M-  U2CL -$I# #-*3  R2E4 ,$M? "]+:P M2WH +$N+ "I+G0 H2[$ )TO*
M "=+[0 G2O\ *$G_ "A(_P I1_\ IT8  )%&  !_1@  <$8  &5&  !;1@
M5$8  $Q'  !$2   /TH  #M+   W3 D -4T0 #-.&  R3B  ,4\H #!/,  O
M3S@ +D]  "Q02  K4%( *E!< "A0:  G4'< )5"( "10FP B4*\ (5#( "!0
MZP A3_\ (D[_ ")-_P C3?\ H4D  (Q)  !Z20  ;$H  &%*  !82@  4$H
M $E+  ! 3   .TX  #50   Q4@0 +5,- "Q4%  J5!P *54D "A5+  G53,
M)E4\ "5610 D5DX (E99 "%690 ?5G0 'E:% !Q6F  ;5JP &5;% !E6Z0 :
M5?\ &U3_ !M3_P <4O\ FTT  (9-  !U30  :$T  %U-  !430  34X  $5/
M   \40  -E,  #%5   K6   )EH) "-;$  B6Q< (5P? "!<)P ?7"X '5PW
M !Q=0  ;74H &EU5 !A=80 777  %5V! !1=E0 37:H $5W" !%=YP 26_X
M$UK_ !-:_P 46?\ E%$  (!1  !P40  9%$  %E1  !140  25(  $%3   X
M5@  ,ED  "M;   E7@  'V$# !IC#  89!$ %V09 !9D(0 59"D %&4Q !-E
M.@ 2940 $650 !!E70 /96L #F5]  UED0 ,9:4 "F2\  IDX  +8_D #&+_
M  UA_P -8?\ C54  'I5  !K50  7U4  %95  !.50  1%<  #Q9   T7
M+%\  "9B   ?90  &6@  !-K!0 0;0T #FX2  UN&@ ,;B( #&XK  MN-  *
M;CX "&Y*  =N5P &;F4 !&YV  )NB@  ;9\  &VV  !LU@  ;/,  6O_  )J
M_P #:O\ A5H  '1:  !F6@  7%D  %-9  !(6@  /UT  #9@   N8P  )F<
M !]J   9;0  $W$   YT P *=PH !7<0  %W%0  =QP  '<D  !X+0  >#<
M 'A#  !X4   >%X  'AO  !XA   >)D  '>P  !VS0  =?   '7_  !T_P
M=/\ ?E\  &Y?  !B7@  65X  $U?  !"8@  .64  #!H   G;   'W   !AT
M   2=P  #7L   A^   "@ @  ($-  "!$0  @A<  (,>  "#)@  A#   (0[
M  "$2   A%<  (1H  "$?   A),  (.J  ""Q0  @>L  ('^  " _P  @/\
M=V4  &ED  !?8P  4F0  $=G   \:P  ,6\  "AS   @=P  &'P  !%_   ,
M@P  !H<   "*    C ,  (P)  "-#@  CA$  (\7  "0'@  D2<  )(R  "2
M/P  DDX  ))?  "2<P  DHL  )&B  "1O   D.4  (_\  "._P  CO\ <6L
M &9J  !8:P  2VT  #]Q   T=@  *GL  ""    7A0  $(D   N-   $D0
M )4   "8    F0   )H#  ";"   G T  )X1  "?%@  H!X  *(H  "B-0
MHT0  *-5  "C:0  HH   **:  "ALP  H-@  *#V  "?_P  G_\ ;G$  %]R
M  !1=0  1'D  #=^   LA   (8H  !>/   0E   "ID   &=    H    *0
M  "G    J    *D   "J    K 8  *T+  "O$   L!4  +(>  "T*0  M#D
M +1*  "U70  M7,  +6.  "UJ   M,8  +/M  "R_P  LO\ 9GH  %=]  !)
M@@  /(<  "^.   CE   &)H  !"?   )I    *D   "M    L    +0   "W
M    N    +D   "[    O    +X"  # "   P@X  ,04  #''@  R"P  ,D]
M  #*4   RF8  ,I_  #*FP  RK@  ,K=  #*]0  RO\ 7H8  $^+  !!D0
M,Y@  ">?   ;I0  $:L   FP    M0   +D   "]    P0   ,8   #(
MR0   ,L   #,    S@   -    #2    U 4  -D,  #=$@  X1X  .(N  #C
M0@  Y%<  .5O  #FC   YJ@  .7%  #EYP  YO8 5I0  $B;   ZH@  +*D
M !^P   3M@  "[P   #!    Q0   ,D   #-    T@   -8   #:    VP
M -X   #@    X@   .0   #G    Z0   .T   #P"@  ]!$  /@?  #Y,@
M^D@  /M?  #\>@  _9<  /VO  #]QP  _>0 _P . /\ #0#_  P _P . /\
M$P#_ !X _P J /\ -@#_ $( _P!- /\ 5P#_ %\ _P!G /\ ;@#_ '0 _P!Z
M /\ @0#] (< _ "- /H E #Y )P ]P"E /4 KP#T +P \P#/ /$ [ #P /X
M[P#_ .\ _P#C /\ UP#_ ,X _P#* /\ _P * /\ !@#_  0 _P ( /\ $ #_
M !D _P E /\ ,0#_ #T _P!' /X 40#[ %D ^0!A /8 : #T &X \P!T /$
M>@#O ($ [@"' .P C@#J )8 Z "? .8 J0#C +4 X@#& .  XP#? /@ W0#_
M -T _P#4 /\ R0#_ ,( _P"^ /\ _P # /\   #_    _P ! /\ #0#_ !0
M_0 @ /H *P#W #8 \P!! .\ 2P#L %0 Z !; .8 8@#C &@ X0!N -\ = #<
M 'H V@"! -@ B #4 )  T@"8 ,\ H@#- *X RP"\ ,D TP#' /  Q@#_ ,0
M_P#$ /\ NP#_ +8 _P"S /\ _P   /\   #_    _P   /< " #P !  ZP :
M .< )0#D #  X0 [ -P 10#5 $T T0!5 ,X 6P#+ &( R0!G ,< ;0#% ',
MPP!Z ,$ @0"_ (D O0"2 +L G "Y *< MP"U +4 R "S .8 L@#[ +$ _P"P
M /\ K@#_ *H _P"G /\ _P   /\   #^    \0   .4  @#<  T TP 4 ,T
M'P#* "H QP T ,0 /@#  $< O !. +H 50"W %L M0!A +, 9P"R &T L !S
M *X >@"L (( J@"+ *@ E0"G *  I0"M *, O@"A -L H #T )\ _P"> /\
MGP#_ )T _P"; /\ _P   /P   #N    X    -    #%  @ O@ 0 +D &0"U
M ", LP N +  -P"M $  J@!( *@ 3P"E %4 HP!; *( 8 "@ &8 GP!L )T
M<P"; 'L F@"$ )@ C@"6 )H E0"G ), MP"1 ,P D #L (\ _P". /\ C@#_
M (X _P"/ /\ _    .\   #;    R0   +T   "U  ( K@ , *D $P"E !T
MH@ G *  ,0"= #H F@!" )@ 20"6 $\ E !5 ), 6P"1 &  D !G (X ;0"-
M '4 BP!^ (D B0"( )4 A@"B (4 L0"# ,0 @0#D (  ^0!_ /\ @ #_ (
M_P"  /\ ] (  . )  #'"   MP<  *P#  "F    H  ' )L #P"8 !< E0 A
M )( *@"/ #, C0 \ (L 0P") $D AP!0 (8 50"$ %L @P!A ($ : "  '
M?@!Y 'P A ![ )  >0"= '@ K !V +X =0#= ', ] !S /\ <P#_ ', _P!S
M /\ Z0T  ,\0  "Y$   J1   )X.  "7"P  DP8  )  "P", !$ B0 : (8
M) "# "X @0 V '\ /@!] $0 ? !+ 'H 40!Y %< =P!= '8 9 !T &P <P%U
M '$!@ !O HT ;@*: &P#J@!K [L :036 &@&\0!H!_\ 9P?_ &<'_P!G!_\
MWQ0  ,,7  "N%P  GA8  ),5  "+$@  AA   (0, @"#!@T @ ,4 'P%'@!Y
M!R@ =P@P '4(. !S"4  <@E& ' *3 !O"E, ;0M9 &P+80!J"VD :0QR &<,
M?@!F#(L 9 V9 &(-J0!A#;L 8 W8 %X.\P!=#O\ 70[_ %T._P!=#O\ U!P
M +D=  "D'@  E1T  (D<  "!&@  >Q<  '@3  !X$ 8 =PT/ ',.& !P#B(
M;@\K &P0,P!J$#L :1!" &<120!F$4\ 9!%6 &,270!A$F8 8!)O %X2>P!<
M$X@ 6Q.7 %D3IP!7%+H 5A35 %45\P!4%?\ 5!7_ %05_P!4%/\ RB(  + B
M  "=(P  C2,  ($B  !Y(0  <QX  &\;  !N%P  ;1,, &H4% !G%1X 918G
M &,6+P!A%S< 8!<^ %X810!=&$L 7!E2 %H96@!9&6( 5QIL %8:=P!4&H4
M4AN4 %$;I !/&[< 3AO0 $T<\0!,'/\ 3!S_ $T<_P!-&_\ PR8  *HG  "6
M)P  AR@  'LG  !R)@  ;"0  &@A  !F'@  9!L( &(;$0!?'!H 71TC %L>
M*P!:'C, 6!\Z %<?00!6($@ 5"!/ %,@5P!1(5\ 4"%I $XA= !-(8( 2R*1
M $DBH@!((K0 1R+- $8C[P!%(_\ 12+_ $8B_P!&(?\ O"H  *0K  "1*P
M@BP  '8K  !M*@  9BD  &(F  !?)   72($ %LA#@!8(A8 5B,? %0D* !3
M)#  4B4W % E/@!/)D4 3B9, $PF5 !+)UP 22=F $@G<0!&)W\ 12B/ $,H
MH !!*+( 0"C+ #\H[0 _*/\ /RC_ $ G_P! )_\ MRT  )\N  ",+P  ?2\
M '$O  !H+@  82T  %TK  !:*   5R<  %0G# !2*!, 4"D< $XI)0!-*BP
M2RHT $HK.P!)*T( 2"Q) $8L40!%+%H 1"QD $(M;P! +7T /RV- #TMG@ \
M+;  .BW( #HMZP Z+?\ .BW_ #HL_P Z+/\ LC   )LQ  "(,@  >3(  &TR
M  !D,@  73$  %@O  !5+   42P  $\M"0!,+1$ 2BX9 $DO(@!'+RH 1C Q
M $4P. !#,#\ 0C%' $$Q3P! ,5< /C%A #TR;0 [,GL .3*+ #@RG  V,J\
M-3+' #0RZ0 T,O\ -3'_ #4Q_P U,/\ K3,  )8T  "$-0  =34  &DU  !@
M-0  630  %0S  !0,   3#$  $DQ!@!',@\ 13,6 $,S'P!"-"< 0#0N #\U
M-@ ^-3T /35$ #PV3  Z-E4 .39? #<V:P V-G@ -#>) #(WF@ Q-ZT +S?%
M "\WZ  O-OX ,#7_ # U_P P-/\ J38  )(V  " -P  <C@  &8X  !=-P
M5C<  % V  !+-   1S4  $0V P!!-PT /S@4 #XX'  \.20 .SDL #HY,P Y
M.CH .#I" #8Z2@ U.E, -#M= #([:  P.W8 +SN' "T[F0 L.ZP *CO# "D[
MY@ J.OT *CK_ "LY_P L./\ I#@  (XY  !\.@  ;CH  &,Z  !:.@  4SH
M $TZ  !&.   0CH  #\[   \/ L .CP1 #@]&0 W/2$ -CXI #0^,  S/C<
M,C\_ #$_1P P/U  +C]: "U 9@ K0'0 *4"$ "A EP F0*H )4#! "1 Y0 D
M/_P )3[_ "8]_P F/?\ GSL  (H\  !X/0  :CT  %\]  !6/0  3ST  $D]
M  !"/0  /#X  #D_   V00@ -$$/ #)"%@ Q0AX +T,E "Y#+0 M0S0 +$0\
M "M$1  J1$T *$18 "=%8P E17$ (T6" ")%E0 @1:@ 'T6_ !Y$XP ?1/L
M'T/_ "!"_P A0?\ FCX  (4_  !T0   9T   %Q   !30   3$   $9    ^
M00  .$,  #1%   P1@, +4<- "M($@ J2!H *4@B "A)*0 G23$ )4DY "1)
M00 C2DH (DI5 "!*80 ?2F\ '4I_ !M*D@ :2J8 &$J] !=*X  82?H &4C_
M !I'_P :1_\ E4(  (!"  !P0P  8T,  %A#  !00P  24,  $)$   [10
M-4<  #!)   K2P  )DT) "1.$  B3A8 (4\= "!/)0 ?3RP 'D\U !U//0 <
M4$< &E!1 !E070 74&L %E!\ !10CP 34*0 $5"Z !%0W@ 13_@ $D[_ !--
M_P 43?\ CT4  'M&  !K1@  7T<  %5'  !-1P  1D<  #]'   W2@  ,4P
M "M.   F4   (%,# !Q5#  :5A$ &588 !=6(  65B< %58P !16.0 35T(
M$E=- !%760 05V@ #U=Y  Y7C  -5Z  "U>V  M6U  +5O0 #%7_  U4_P .
M4_\ B$D  '9*  !G2@  6TH  %%*  !*2@  0TH  #M,   S3@  +%$  "94
M   A5@  &UD  !5<!P 17@T $%X3 !!>&@ .7B( #EXJ  U>,P ,7CT "UY(
M  I>5  (7F( !UYS  5>A@ #7IL  EZQ  )=S  "7>X  US_  1;_P %6_\
M@4X  '!.  !B3@  5TX  $Y.  !'3@  /D\  #91   N5   )U<  "%:   ;
M70  %6   !!C P ,9@L "&<0  9G%0 %9QP !&<D  )G+0 !9S<  &="  !G
M3@  9UP  &=M  !G@   9I4  &:L  !EQP  9>L  &3\  !D_P  8_\ >E(
M &I3  !=4@  5%(  $M2  !"4P  .54  #!8   H6P  (5\  !IB   490
M$&@   QK 0 &;@D  &\.  !O$@  ;Q@  ' ?  !P)P  <3   '$[  !Q2
M<58  '%F  !Q>0  <8\  '"G  !OP0  ;^<  &[\  !M_P  ;?\ <U@  &57
M  !:5P  458  $97   \6@  ,ET  "IA   B9   &F@  !1L   .;P  "G(
M  1V    > 4  '@+  !Y#@  >A,  'L9  !\(   ?2D  'TS  !]0   ?4X
M 'U>  !]<@  ?8@  'RA  !\N@  >^(  'KZ  !Y_P  >/\ ;5T  &!<  !7
M7   2UT  $!?   U8P  *V<  "-K   :;P  $W,   YW   (>P   GX   ""
M    @P$  (0&  "%"P  A@\  (@3  ")&0  BB$  (LK  "+-P  C$8  (M6
M  "+:0  BX   (N9  "*LP  B=@  (CW  "(_P  A_\ :&,  %YB  !18@
M1&4  #AI   N;@  )',  !IX   3?0  #8$   :%    B0   (T   "0
MD@   )(   "4!0  E0H  )<.  "8$@  FA@  )LA  "<+0  G3P  )U,  "<
M7P  G'8  )N1  ";JP  FLD  )KP  "9_P  F/\ 96D  %=I  !);   /7$
M #!V   E?   &X$  !*'   ,C   !)$   "5    F0   )T   "@    H0
M *(   "D    I0$  *<'  "I#   JA$  *T8  "O(@  KS   *]!  "O5
MKVL  *Z%  "NH0  KKX  *WF  "L_   K/\ 7G$  $]T  !">0  -7\  "B%
M   =C   $Y(   R8   #G0   *(   "F    J@   *X   "P    L0   +,
M  "T    M@   +@   "Z!   O H  +X0  #!%P  PR0  ,,U  #$20  Q%X
M ,5W  #%DP  Q:\  ,71  ##\@  P_\ 5GP  $>"   ZB   +(\  ""6   4
MG0  #:,   .I    K@   +(   "W    NP   +\   #"    P@   ,4   #&
M    R    ,H   #-    SP   -((  #5#@  VQ@  -TG  #>.@  WU   .!H
M  #@A   X:$  .&]  #AX@  X/0 3HL  $"2   RF0  ):$  !BH   .KP
M!;4   "Z    OP   ,0   #(    S@   -$   #4    U0   -@   #:
MW0   -\   #B    Y    .<   #K!0  [PX  /09  #U*P  ]D$  /=8  #X
M<@  ^9   /FK  #XQ   ^.$ _P + /\ " #_  D _P , /\ $@#_ !H _P F
M /\ ,@#_ #X _P!( /\ 4@#_ %H _P!B /\ :0#_ &\ _P!U /X >P#\ ($
M^P"( /D CP#W )< ]0"@ /, J@#R +< [P#) .T Y@#L /L ZP#_ .L _P#=
M /\ S@#_ ,8 _P#" /\ _P $ /\   #_    _P % /\ #0#_ !4 _P A /\
M+ #_ #@ _P!# /T 3 #Y %0 ]P!< /0 8P#R &D \ !O .X =0#L 'L Z@""
M .@ B0#G )$ Y ": .( I #@ +  W0#  -H W #8 /0 U0#_ -, _P#+ /\
MP0#_ +L _P"W /\ _P   /\   #_    _P   /\ "@#] !$ ^0 ; /8 )P#T
M #( \  \ .P 1@#H $X Y !6 .$ 7 #> &, W !H -D ;@#5 '0 T@![ -
M@@#- (H RP"3 ,@ G0#& *@ Q "W ,$ S #  .L O@#_ +T _P"] /\ M #_
M *X _P"K /\ _P   /\   #_    ^@   /( !0#J  X Y0 6 .  (0#= "L
MVP V -, /P#. $@ R@!/ ,< 5@#$ %P P@!A ,  9P"^ &T O !S +H >@"X
M (( M@"+ +0 E@"R *$ L "O *X P0"M .  JP#W *H _P"I /\ I@#_ *$
M_P"? /\ _P   /\   #W    Z    -P   #0  H R@ 1 ,4 &P#" "4 OP O
M +P . "X $$ M0!( +( 3P"P %4 K@!; *P 80"J &8 J !L *< <P"E 'L
MHP"$ *$ C@"? )H G0"G )L N ": -  F0#O )@ _P"7 /\ E@#_ )0 _P"2
M /\ _P   /8   #D    T@   ,4   "[  4 M0 . +  %0"L !\ J@ I *@
M,@"E #H H@!" *  20"> $\ G !5 )H 6@"8 &  E@!F )4 ; "3 '0 D@!]
M )  AP". ), C "A (L L "* ,4 B #F (< ^P"& /\ AP#_ (< _P"& /\
M^    .4   #-    O0   +,   "J    HP * )\ $0"; !D F0 C )< + "5
M #0 D@ \ )  0P". $D C !/ (H 5 ") %H AP!@ (8 9@"$ &X @P!W ($
M@0!_ (T ?@"; 'P J@![ +P >@#; '@ ]0!X /\ > #_ '@ _P!X /\ [0
M -$"  "[ @  K $  *(   ";    E@ % )$ #0"- !0 BP = (@ )@"& "X
MA  V (( /0"  $, ?@!) 'T 3P!\ %4 >@!; 'D 80!W &D =0!Q '0 ? !R
M (@ <0"6 &\ I0!N +8 ;0#. &P [@!K /\ :P#_ &L _P!K /\ WPL  ,(,
M  "N#   G@P  ),+  ",!P  B (  (4 "0"! !  ?P 7 'P ( !Z "@ >  P
M '8 . !T #X <P!$ '$ 2@!P %  ;@!6 &T 70!L &0 :@!M &@ =P!G (0
M90"2 &0 H0!C +( 80#) &  Z0!@ /P 8 #_ &  _P!@ /\ T!   +81  "B
M$@  DQ(  (@1  " #P  ? T  'D) 0!X PL =0 1 ', &@!P ", ;@$K &P!
M,P!J CD :0-  &<#1@!F!$P 9012 &,%60!B!6$ 8 5J %\&= !=!H$ 7 >/
M %H'GP!9![  5P?& %8)YP!6"OL 50K_ %4*_P!6"O\ QA4  *T7  "9&
MBA@  '\7  !V%@  <1,  &X0  !M#04 ;0D- &H)% !G"AT 90HF &,++@!B
M##4 8 P\ %\,0@!>#4@ 7 U/ %L-5@!9#5X 6 YH %8.<P!5#H  4PZ/ %$.
MGP!0#K$ 3@[( $T0Z@!-$/T 31#_ $T0_P!-$/\ O!L  *4<  "2'0  @QX
M '<=  !O'   :1H  &87  !D%   9! ( &(/$ !?$!@ 71 A %L1*0!:$3$
M6!(X %<2/@!6$D4 5!), %,34P!1$UL 4!-E $X4< !,%'T 2Q2, $D4G !'
M%:X 1A7% $45Z !%%OX 11;_ $45_P!%%?\ M1\  )XA  "+(@  ?"(  '$B
M  !H(0  8A\  %\=  !<&@  6Q<" %H5#0!7%A0 518= %07)0!2&"T 41@T
M $\8.P!.&4( 31E( $L:4 !*&E@ 2!IB $<:;0!%&WH 0QN) $(;F@! &ZP
M/QO" #X<Y0 ]'/P /AS_ #X;_P ^&_\ KR,  )@D  "&)0  =R8  &PF  !C
M)0  720  %DB  !6'P  5!T  %,<"P!1'!( 3AT: $T=(@!+'BD 2AXQ $D?
M-P!''SX 1B!% $4@30!#(%4 0B!? $ A:@ _(7< /2&' #LAF  Y(:H ."+
M #<BXP W(OL -R+_ #@A_P X(?\ JB8  )0G  "!*0  <RD  &<I  !?*0
M6"@  %0F  !1(P  3R(  $PB!P!*(A  2"(7 $<C'P!%)"8 1"0N $(D- !!
M)3L 0"5# #\E2@ ])E, /"9< #HF9P Y)G4 -R>$ #4GE@ T)Z@ ,B>^ #$G
MX0 Q)_D ,B;_ #(F_P S)?\ I2D  (\J  !]+   ;RP  &0M  !;+   52L
M % J  !,*   2B8  $<G! !$)PT 0B@4 $$H'  _*2, /BDK #TI,@ \*CD
M.RI  #DJ2  X*U  -BM: #4K90 S*W( ,2N" # LE  N+*< +"R\ "LLW@ L
M+/@ +"O_ "TJ_P M*O\ H2P  (LM  !Y+@  :R\  & O  !8+P  42X  $PN
M  !(+   12L  $$K   _+ L /2P1 #LM&0 Z+B$ .2XH #<N+P V+S8 -2\^
M #0O10 S+TX ,3!8 # P8P N,'  +#"  "HPD@ I,*4 )S"Z "8PW  F,/<
M)R__ "@O_P H+O\ G"X  (<P  !V,0  :#(  %TR  !5,@  3C$  $@Q  !$
M,   0"\  #PP   Z,0D -S$0 #8R%@ U,AX ,S,E #(S+  Q,S, ,#0[ "\T
M0P M-$P +#16 "HU80 I-6X )S5^ "4UD  C-:, (C6Y "$UV0 A-/8 (C3_
M ",S_P C,O\ F#$  (,S  !R-   930  %HU  !1-0  2S0  $4T  ! -
M.C,  #<T   T-08 ,C8. # W$P O-QL +C<B "TX*0 K.#$ *C@X "DY0  H
M.4D )CE3 "4Y7P C.6P (3I\ " ZC@ >.J( '#JW !LYU0 <.?4 '3C_ !TX
M_P >-_\ DS0  '\V  !N-P  83<  %<W  !.-P  2#<  $(W   \-P  -3@
M #(Y   O.@( +#L+ "H\$0 I/!@ *#T? "8])@ E/2X )#TU ",^/0 B/D8
M(#Y0 !\^7  =/VD &S]Y !H_C  8/Z  %C^U !4^T@ 6/O, %SW_ !@\_P 8
M//\ CC<  'HX  !J.0  7CH  %,Z  !+.@  13H  #\Z   Y.@  ,CP  "X^
M   I0   )D$( "1"#@ B0A0 (4(; "!#(P ?0RH 'D,R !Q#.@ ;1$, &D1-
M !A$60 71&< %41W !-$B@ 21)X $42S !!$T  00_( $4+_ !)"_P 30?\
MB3L  '8\  !F/0  6CT  % ]  !(/0  0CT  #P]   V/@  +T   "I"   E
M1   (48# !U(#  ;21$ &4D7 !A)'@ 7228 %DDN !5*-@ 42D  $TI* !%*
M5@ 02F0 #TIT  Y*AP -2IL #$JP  I*R@ +2>P #$C_  U'_P -1_\ @SX
M '$_  !B0   5D   $U   !%0   /T   #E!   R0@  *T4  "9'   A20
M'$L  !9.!P 34 X $E 3 !%0&0 04"$ #U I  Y0,0 -4#L #5%&  M140 *
M45\ "5%O  =0@0 %4)8  U"K  )0Q0 #3^@  T_[  5._P &3?\ ?4(  &M#
M  !=1   4D0  $I$  !#0P  /$0  #5%   N1P  )TH  "%,   <3P  %U$
M !)4 P .5PH "U@0  I8%0 (6!P !U@D  98+  %6#8  UA   %83   6%H
M %AI  !8?   6)$  %>G  !7P   5N4  %;Y  !5_P  5?\ =D<  &9'  !9
M2   3T<  $='  ! 1P  .$@  #!*   I30  (E   !Q3   650  $5@   U;
M @ )7@D !%\.  !?$@  7Q@  & ?  !@)P  8#   & [  !@1P  8%0  &!C
M  !@=@  8(L  %^B  !?NP  7^(  %[Y  !=_P  7?\ ;TL  &%,  !53
M3$L  $1+   [3   ,DX  "M1   C5   '%<  !9;   17@  #6    AC   "
M9@<  &<,  !G#P  :!,  &D9  !J(0  :BD  &HT  !J0   :DT  &I=  !J
M;P  :H4  &J=  !IM@  :-T  &CW  !G_P  9O\ :5$  %Q0  !24   2D\
M #]0   U4P  +58  "19   =70  %F   !!D   ,9P  !FH   !N    ;P,
M ' (  !Q#0  <A   '04  !U&P  =B,  '<L  !W.   =D8  '96  !V:
M=GX  ':7  !UL0  =-,  '/U  !S_P  <O\ 8U8  %A5  !05   1%4  #E8
M   O6P  )E\  !UC   59P  $&P   IP   $<P   '8   !Z    ?    'P#
M  !^"   ?PP  ($0  ""%   A!L  (4D  "&+P  ACT  (9-  "%7P  A74
M (6/  "$J0  @\D  (+Q  "!_P  @/\ 7UL  %9:  !)6P  /5X  #)A   G
M9@  'FL  !5P   .=0  "7D   %^    @0   (4   "(    B@   (L   "-
M 0  C@8  ) +  "1#P  DQ0  )4;  "7)@  ES0  )=$  "75@  EFP  )6&
M  "5H@  E,$  )/J  "2_P  DO\ 76$  $]A  !"9   -FD  "IN   ?=
M%7D   Y_   'A    (D   ".    D@   )8   "8    F@   )L   "=
MGP   *$#  "C"   I0T  *<3  "I'   JB@  *HY  "J2P  JF$  *EZ  "H
MF0  J+4  *?=  "G^   IO\ 5F@  $AL   Z<   +G8  ")]   7A   #HH
M  >0    E@   )H   "?    HP   *<   "J    JP   *T   "O    L0
M +,   "U    N 4  +H,  "]$@  P!P  , M  # 0   OU4  +]N  "^BP
MOJ@  +[)  "][P  O/X 3G0  $!Y   R?P  )8<  !F.   0E0  !YP   "B
M    IP   *P   "P    M0   +D   "\    O0   +\   #!    PP   ,8
M  #(    R@   ,T"  #0"P  U1(  -8A  #7-   V$D  -E@  #:?   VIH
M -NU  #;V0  V_( 1H(  #B)   KD   '9@  !*@   *IP   *X   "T
MN0   +X   #"    R    ,L   #.    SP   -(   #4    U@   -H   #=
M    WP   .(   #F    Z@H  .\3  #P)0  \CH  /-1  #T:P  ](D  /6E
M  #UOP  ]=T _P & /\  P#_  4 _P + /\ $ #_ !< _P B /\ +0#_ #D
M_P!$ /\ 30#_ %4 _P!= /\ 9 #_ &H _P!P /T =@#[ 'P ^0"# /< B@#U
M )( \P"; /  I@#N +, ZP#$ .D Y #G /D Y@#_ .4 _P#3 /\ QP#_ +\
M_P"[ /\ _P   /\   #_    _P " /\ "P#_ !( _P = /\ * #_ #, _P ^
M /P 1P#X $\ ] !7 /$ 70#N &, [ !I .H ;P#H '4 Y@!\ .0 @P#B (L
MWP"5 -P GP#9 *L U0"[ -( U #/ /( S0#_ ,P _P#% /\ N@#_ +0 _P"P
M /\ _P   /\   #_    _P   /\ !@#Y  \ ]0 7 /, (@#Q "T [0 W .<
M0 #B $D WP!0 -L 5P#7 %T U !C -$ : #/ &X S !U ,H ? #( (0 Q0"-
M ,( F #  *0 O0"R +L Q@"Y .@ N #] +< _P"V /\ K0#_ *< _P"C /\
M_P   /\   #_    ]0   .L  0#D  P W@ 3 -D ' #3 "8 T0 P ,P .@#(
M $( Q !* ,  4 "] %8 NP!< +D 80"W &< M0!M +, = "Q 'P KP"% *T
MD "J )P J "J *8 NP"E -H HP#U *, _P"B /\ G@#_ )H _P"7 /\ _P
M /X   #O    WP   -    #'  < P0 / +P %P"Y "  MP J +4 ,P"P #L
MK0!# *L 20"H $\ I@!5 *0 6@"C &  H0!F )\ ;0"= '0 G !] )H B "8
M )0 E@"B )0 L@"2 ,D D0#K )$ _P"0 /\ D #_ (P _P"* /\ _    .P
M  #9    QP   +H   "Q  ( JP , *< $@"D !L H0 D *  + "> #4 FP \
M )@ 0P"6 $D E !/ )( 5 "0 %H CP!? (T 9@"+ &T B0!V (@ @ "& (P
MA ": (( J@"! +X @ #@ (  ^0!_ /\ ?P#_ '\ _P!^ /\ \0   -@   #"
M    LP   *@   "@    F0 ' )4 #@"2 !4 D  > (X )@"- "X B@ V (<
M/0"% $, A !) (( 3@"! %0 ?P!9 'X 8 !\ &< >@!O 'D >@!W (8 =0"4
M '0 HP!R +4 <@#/ '$ \0!P /\ < #_ '  _P!Q /\ X0   ,0   "P
MH@   )<   "1    BP " (8 "P"# !$ @0 8 '\ (0!] "D ?  P 'D -P!X
M #T =@!# '0 20!S $X <@!4 '  6@!O &( ;0!J &L = !J (  : ". &<
MG0!E *\ 90#& &0 Z !D /T 8P#_ &, _P!D /\ SP4  +8'  "C"   E @
M (D'  "" P  ?@   'L !@!W  X =0 3 '( &P!Q ", ;P K &T ,@!L #@
M:@ ^ &D 1 !G $D 9@!/ &4 5@!C %T 8@!E &  ;P!? 'L 70") %P F0!;
M *H 60"_ %D X0!8 /@ 6 #_ %@ _P!9 /\ P@P  *H-  "7#@  B0X  'T.
M  !V#0  <0H  &\&  !M  H :P 0 &D %@!G !X 90 F &, +0!A #, 8  Y
M %\ /P!= $4 7 !+ %L 4@!: %D 6 !B %< ; !5 '@ 4P"& %( E@!1 *<
M4 "[ $\!VP!. O0 3@/_ $X$_P!. _\ N!   *$2  ".$P  ?Q,  '03  !L
M$@  9Q   &4.  !C"P, 8P8, &$$$0!> QD 7 0A %L%* !9!B\ 6 8U %8'
M.P!5!T( 5 =( %,(3P!1"%8 4 E? $X):0!-"78 2PJ$ $D*E !("J8 1PJZ
M $8*V !%"_, 10S_ $4,_P!%#/\ L!0  )D6  "'&   >!D  &T8  !E%P
M7Q8  %P3  !:$0  6@X& %H,#0!7#!0 50P< %,-) !2#2L 4 TQ $\.. !.
M#CX 30Y% $L.30!*#E4 2 ]> $</: !%#W4 0Q"$ $$0E0! $*8 /A"[ #T0
MW  ]$?8 /1'_ #T0_P ^$/\ J1D  )(;  "!'   <AT  &<=  !?'   61L
M %49  !3%@  4A,  %(1"@!0$!  3A$8 $P1( !*$B< 21(N $@3- !'$SL
M11-" $0320!#%%( 011; #\490 ^%7( /!6! #H5D@ X%:0 -Q6Y #45V  U
M%O4 -A;_ #86_P W%?\ HQP  (T>  ![(   ;2$  &(A  !:(0  5!\  % >
M  !-&P  3!D  $L6!@!)%@X 1Q<5 $47' !$&"0 0A@J $$8,0! &3@ /QD_
M #T91@ \&D\ .AI8 #D:8P W&V\ -1M^ #,;D  R&Z( ,!NW "\;TP O'/,
M+QO_ # ;_P P&_\ G1\  (@B  !W(P  :20  %XD  !6)   4",  $LB  !(
M(   1AT  $4< @!#' P 01P2 #\=&0 ^'2$ /!XG #L>+@ Z'S4 .1\\ #<?
M1  V'TP -"!6 #,@8  Q(&T +R!\ "TAC@ L(:  *B&U "DAT  I(?( *2'_
M "H@_P K(/\ F2(  (0E  !S)@  92<  %LG  !3)P  3"8  $<E  !$)
M0B$  #\A   ](0D .R$0 #DB%@ X(AX -B,E #4C*P T)#( ,R0Y #(D00 P
M)$H +R53 "TE7@ K)6L *B5Z "@EC  F)9\ )"6S ",ES@ C)?  )"7_ "4D
M_P E)/\ E"4  ( G  !O*0  8BH  %<J  !/*@  22D  $0H  ! )P  /28
M #HE   W)@8 -28. #0G%  R)QL ,2@B # H*0 O*#  +2DW "PI/P K*4<
M*2E1 "@J7  F*FD )"IX ",JB@ A*IT 'RJR !XJS  >*N\ 'RG_ " I_P A
M*/\ D"@  'PJ  !L*P  7RP  %0L  !,+   1BP  $$K   \*P  ."H  #4J
M   R*P, ,"L, "XL$0 M+!@ +"P? "HM)@ I+2T *"TT "<N/  F+D4 )"Y/
M ",N6@ A+V< 'R]V !TOB  <+YL &B^P !@OR@ 8+NT &2[_ !LM_P ;+?\
MC"L  '@M  !H+@  6R\  %$O  !)+P  0R\  #XN   Y+@  -"X  # N   M
M+P  *S * "DQ$  G,14 )C$< "4R(P D,BH (S(Q "$S.0 @,T( 'S-, !TS
M5P ;,V0 &C1T !@TA@ 6-)H %#.N !,SR  3,^P %#/_ !4R_P 6,?\ ARX
M '0O  !E,0  6#$  $XR  !&,@  0#$  #LQ   V,0  ,3$  "LS   H-
M)34& ",V#0 A-A( (#<9 !\W(  >-R< '3@N !LX-@ :.#\ &3A) !<Y50 5
M.6( %#EQ !(YA  1.9@ $#FM  XXQP ...L $#C_ ! W_P 1-O\ @S$  ' R
M  !A-   530  $LT  !$-   /30  #@T   S-   +34  "@W   D.0  (#H"
M !T["P ;/!  &3T5 !@]'  7/2, %CTK !4^,P 4/CP $CY& !$^4@ 0/E\
M#SYO  X^@0 ,/I4 "SZI  H^P0 */>0 "SW[  P\_P -._\ ?30  &LV  !=
M-P  43<  $@W  !!-P  .S<  #4W   P-P  *CD  "4[   @/0  '#\  !=!
M!@ 40PT $D,2 !%#&  10Q\ $$0G  ]$+P .1#D #41#  Q$3@ +1%L "41J
M  =$?  &1)  !$.E  )#O0 #0^   T/V  1"_P &0?\ >#@  &<Y  !9.@
M3CH  $4Z   ^.@  .#H  #,Z   M.P  )ST  "%    <0@  %T0  !-& P /
M20H #4H/  Q*%  +2AL "4HC  A**P '2C0 !4H^  1*20 "2E8  $IE  !*
M=P  2HL  $JA  !)N0  2=T  $GU  !(_P  2/\ <CP  &(]  !5/@  2CX
M $(]   \/0  -CT  "\^   I0   (T(  !U%   71P  $TH   ], @ +3PD
M!U -  -1$0  41<  %$>  !1)@  42\  %$Y  !11   4E$  %)@  !1<@
M48<  %&=  !1M0  4-@  %#U  !/_P  3_\ ;$   %U!  !100  1T$  $!
M   Y0   ,D$  "I#   D1@  'D@  !=+   23@  #E$   M3 0 &5@<  %<,
M  !8$   6!,  %D9  !:(0  6BD  %HS  !:/P  6DP  %I:  !:;   6H$
M %F9  !9L0  6-$  %CT  !7_P  5_\ 944  %A%  !-10  140  #Y$   U
M10  +4<  "5*   >30  &%   !)3   .5@  "ED   1<    7@0  %\)  !@
M#0  81   &(5  !C&P  9",  &0M  !D.   9$4  &14  !D9@  9'L  &.3
M  !CK0  8LP  &'R  !A_P  8/\ 7TH  %-*  !*20  0T@  #E)   O3
M)T\  !]2   850  $ED   U=   (8    F,   !F    : $  &D%  !J"@
M:PT  &T1  !N%@  <!T  '$F  !Q,0  <#X  '!.  !P7P  <',  &^-  !O
MIP  ;L8  &WO  !L_P  ;/\ 6D\  %!.  !(30  /4X  #-1   I5   (%@
M !A<   18   #&0   9H    :P   &\   !R    =    '4   !W!   > D
M 'H-  !\$   ?18  '\>  " *   @#4  (!%  !_5@  ?VL  '^$  !^H
M?;X  'SI  ![_P  >O\ 5E0  $Y3  !"5   -U8  "Q:   B7P  &&,  !%H
M   +;0   W(   !V    >@   'T   "     @P   (0   "&    AP(  (D'
M  "+#   C1   ) 6  "2'P  DBP  )([  "230  D6(  )%Z  "/EP  C[0
M ([A  ",^P  C/\ 55D  $A:   [70  +V$  "1F   9;   $7(   IW   "
M?0   ((   "&    BP   (X   "1    DP   )4   "7    F0   )L   "=
M!   GPH  *(/  "D%@  IB$  *8Q  "F0P  I5<  *1P  "CC@  HZL  *'0
M  "@]0  G_\ 3F$  $!D   S:0  )VX  !MU   1?   "X,   ")    C@
M ),   "8    G0   *$   "D    I0   *<   "I    JP   *T   "P
ML@   +4(  "X#@  O!8  +PE  "\-P  NTP  +ID  "Y@0  MZ(  +?   "W
MZ@  M_P 1FL  #EP   K=P  'W\  !.&   +C@   94   ";    H0   *8
M  "K    L    +,   "W    MP   +H   "\    OP   ,$   #$    QP
M ,H   #-!0  T0X  -09  #4*P  U$   --8  #3=   TY(  -*P  #2TP
MTO( /GD  #&    CB   %Y$   V9   #H    *<   "N    LP   +@   "]
M    P@   ,8   #*    R@   ,T   #/    T@   -4   #9    W0   -\
M  #C    YP4  .L/  #L'P  [3,  .Y+  #O9   [X(  /"?  #QN0  \=@
M_P   /\   #_  0 _P ) /\ #@#_ !4 _P > /\ *0#_ #0 _P _ /\ 2 #_
M %  _P!8 /\ 7@#_ &4 _0!K /L <0#Y '< ^ !^ /8 A0#S (T \0"7 .X
MH@#K *\ Z #  .8 X #C /@ X@#_ -L _P#+ /\ P0#_ +D _P"T /\ _P
M /\   #_    _P   /\ "0#_ !  _P 9 /\ (P#_ "X _0 Y /D 0@#U $H
M\@!2 .X 6 #K %X Z0!D .8 :@#D '  X@!V -\ ?0#= (8 V0"/ -4 F@#1
M *< S@"V ,L S@#) /  QP#_ ,4 _P"[ /\ M #_ *T _P"I /\ _P   /\
M  #_    _P   /L  @#V  T \0 3 .T '@#L "@ Z0 R ., .P#= $0 V !+
M -, 40#0 %@ S0!= ,L 8P#) &@ Q@!O ,0 =@#" 'X OP"' +P D@"Z )\
MMP"M +4 P0"R .0 L0#] *\ _P"L /\ I0#_ *  _P"< /\ _P   /\   #[
M    [@   .0   #<  @ TP 0 ,\ & #+ "( R0 K ,8 - #! #T O0!$ +H
M2P"W %$ M0!6 +( 7 "P &$ K@!G *P ;@"J '8 J !_ *8 B@"C )8 H0"E
M )\ M@"= -$ G #S )L _P"< /\ E@#_ ), _P"0 /\ _P   /8   #G
MTP   ,8   "]  , N  - +, $P"Q !P KP E *X +@"I #8 I@ ] *, 1 "A
M $H GP!/ )T 50"; %H F@!@ )@ 9@"6 &X E !W )( @0"0 (X C@"< (P
MK0"* ,, B0#H (@ _P") /\ AP#_ (4 _P"" /\ \P   .,   #,    O
M +    "G    H0 ( )X #P"; !8 F0 ? )@ )P"6 "\ DP W )$ /0". $,
MC !) (L 3@") %0 AP!9 (4 8 "$ &< @@!O (  >@!^ (8 ? "4 'H I !Y
M +@ > #8 '< ]P!X /\ > #_ '< _P!U /\ Y@   ,L   "W    J    )X
M  "6    CP $ (L # "( !( AP 9 (4 (0"$ "D @@ P '\ -P!] #T ? !#
M 'H 2 !Y $T =P!3 '8 60!T &$ <@!I '$ <P!O '\ ;0"- &P G0!J *\
M:0#( &@ [0!I /\ :0#_ &D _P!I /\ T@   +@   "E    EP   (T   "&
M    @0   'P " !Y  X =P 4 '8 ' !T ", <P K '$ ,0!O #< ;@ ] &P
M0P!K $@ :@!. &@ 5 !G %L 90!C &, ;0!B '@ 8 "' %\ E@!= *@ 70"^
M %P Y !< /L 7 #_ %P _P!< /\ P@   *H!  "8 P  B00  '\"  !X
M=    '  ! !M  P :P 1 &D %P!H !X 9@ E &4 + !C #( 8@ X &  /0!?
M $, 7@!) %P 3P!; %8 6@!> %@ : !7 ', 50"! %0 D0!2 *, 40"W %$
MU@!1 /4 40#_ %$ _P!2 /\ M@<  )\)  "-"P  ?@P  ',+  !L"@  : <
M &4#  !C  < 80 - %\ $P!= !H 7  A %L )P!9 "T 6  S %8 .0!5 #\
M5 !% %, 2P!1 %( 4 !: $\ 9 !- &\ 3 !] $H C0!) )\ 2 "R $< S !'
M .\ 1@#_ $< _P!' /\ K P  )4.  "#$   =1   &L0  !C#P  7@X  %L,
M  !:"0( 600* %< #P!5 !4 4P < %( (P!1 "D 3P O $X -0!- 3L 3 %!
M $H"2 !) D\ 2 )7 $8#80!% VT 0P-Z $(#BP!  YP /P.O #X#R  ]!.H
M/07\ #T&_P ^!O\ I!   (X2  !\$P  ;A0  &04  !<$P  5A(  %,1  !1
M#@  4 P% % )# !/!Q$ 30<7 $L('P!)""4 2 DK $<),0!&"3@ 1 H^ $,*
M10!""DT 0 M5 #\+7P ]"VL / MY #H,B@ X#)P -PRO #4,QP U#.D -0W]
M #4-_P V#/\ G1,  (<5  !V%P  :1@  %X8  !6&   4!<  $T5  !*$P
M21$  $D.!P!(#0X 1@T3 $0-&@!##B$ 0@XH $ .+@ _#C4 /@\\ #T/0P [
M$$L .A!4 #@07@ V$&L -!!Y #(0B@ Q$)P +Q"P "T0R0 M$>P +1'_ "X1
M_P O$/\ EQ8  ((9  !Q&P  9!P  %D<  !1'   3!L  $<:  !$&   0Q4
M $(3 @!!$@L 0!$0 #X2%P \$AX .Q,E #H3*P X$S( -Q,Y #840  T%$@
M,Q11 #$47  P%6@ +A5W "P5B  J%9H *!6N "<5QP F%>H )Q7_ "@5_P I
M%?\ D1H  'T<  !M'@  8!\  %8?  !.'P  2!X  $,=  ! '   /AH  #T8
M   [%P< .18. #@7%  V%QL -1@B #,8*  R&"\ ,1DV # 9/0 N&48 +1I/
M "L:60 J&F8 *!IT "8:A@ D&ID (AJM "$:Q0 @&N@ (1K^ "(:_P C&O\
MC1T  'D?  !I(0  7"(  %(B  !*(@  1"$  #\A   \(   .1X  #@;   U
M' 0 -!P- #(<$@ P'1@ +QT? "X=)0 M'BP *QXS "H>.P I'T, )Q]- "8?
M5P D'V0 (A]R " ?A  ?'Y< '1^K !L?PP ;'^< &Q_] !T?_P >'O\ B2
M '4B  !E(P  620  $\E  !')0  020  #PC   X(P  -2(  #,@   P( $
M+B$* "PA$  K(14 *B(< "@B(P G(BD )B,P "4C.  C(T$ (B1* "$D50 ?
M)&$ '21P !LD@@ 9))4 %R2J !8DP0 5).4 %B3\ !<C_P 9(_\ A2(  '$D
M  !B)@  5B<  $PG  !$)P  /B<  #DF   U)@  ,24  "XD   K)0  *24'
M "<F#@ E)A, )"<9 ",G(  B)R< (2@N " H-@ >*#X '2A( !LI4P 9*5\
M&"EN !8I@  4*90 $BFH !$IP  1*.0 $2C[ !,H_P 4)_\ @"4  &XG  !?
M*   4RD  $DJ  !"*0  .RD  #8I   R*   +B@  "HH   F*0  )"H$ "(K
M#  @*Q$ 'RP6 !TL'0 <+"0 &RTK !HM,P 8+3P %RU% !8N4  4+ET $BYL
M !$N?@ 0+I( #BZG  TMO0 -+=\ #2WY  XL_P 0+/\ ?"@  &HJ  !;*P
M4"P  $8L   _+   .2P  #0K   O*P  *RL  "8L   B+@  'R\  !PP"0 :
M,0X &3$3 !<Q&@ 6,B$ %3(H !0R,  3,CD $C-# !$S3@ 0,UL #C-I  TS
M>@ ,,XX "C.B  @RN0 (,MD "#+T  HQ_P +,?\ =RL  &8M  !8+@  32\
M $,O   \+@  -BX  #$N   M+@  *2X  ",P   ?,@  &S,  !<U!0 4-@P
M$C<1 !$W%@ 1-QT $#@D  \X+  ..#4 #3@_  PX2@ +.%< "3AE  <X=@ %
M.(H  SB?  $WM0 !-],  C?Q  ,V_P %-O\ <RX  &(P  !4,0  23$  $$Q
M   Y,0  -#$  "\P   K,   )3(  " S   ;-@  %S@  !,Z @ 0/ D #3T.
M  P]$P +/1D "CTA  D]*0 (/3$ !CX[  4^1@ #/E(  3YA   ^<@  /H8
M #V<   ]L@  /=   #SP   \_P  //\ ;3(  %TS  !0-   1C0  #XT   W
M-   ,C,  "TS   G-   (C8  !TX   8.@  %#T  ! _ @ -00@ "4,-  9$
M$0 #1!8  D0=  !$)   1"T  $0V  !$00  1$X  $1<  !$;0  1($  $28
M  !#KP  0\T  $+P  !"_P  0O\ :#8  %@W  !,.   0S@  #LW   U-@
M,#8  "DW   C.0  'CL  !@]   30   $$(   U% 0 (1P<  TD,  !)#P
M2A,  $L9  !+(   2R@  $LR  !+/0  3$D  $Q7  !+:   2WT  $N4  !*
MK   2LH  $GO  !)_P  2?\ 8CH  %0[  !).P  0#L  #DZ   S.0  +#H
M "4\   ?/P  &4$  !-$   01P  #$D   A,   "3P4  % *  !0#0  41
M %(5  !4&P  5",  %0L  !4-P  5$0  %12  !48P  5'<  %2/  !3J
M4L8  %+M  !1_P  4?\ 7#\  $\_  !%/P  /CX  #<]   O/@  )T   "!#
M   91@  $TD   ],   +3P  !E(   !4    5P(  %@'  !9"P  6@X  %L1
M  !=%@  7AT  %\F  !?,0  7CT  %Y,  !>70  7G$  %V)  !=HP  7,$
M %OK  !:_P  6O\ 5D0  $M#  !#0@  /$$  #)"   I10  (4@  !I+   3
M3@  #E(   I5   #60   %L   !>    8    &("  !C!@  90H  &8.  !H
M$0  :A<  &L?  !K*0  :S8  &M%  !K5@  :FH  &J"  !IG0  :+L  &?G
M  !F_P  9?\ 44@  $A(  !!1@  -T<  "Q*   C30  &U$  !-5   .60
M"%T   %A    9    &<   !J    ;    &X   !P    <@4  ',)  !U#0
M=Q$  'H8  ![(0  >RX  'H]  !Z3@  >6(  'EY  !XE@  =[,  '7@  !T
M_   <_\ 3DT  $=,   [30  ,$\  "93   <6   $UP   UA   &9@   &H
M  !O    <@   '8   !Y    ?    'T   !_    @0   (,"  "&!P  B P
M (L1  ".&   CB0  (XS  "-1   C%@  (MO  "*C   B:H  (C/  "&]P
MA?\ 35$  $%3   T50  *5H  !Y?   490  #6H   5P    =@   'L   !_
M    @P   (<   "*    C0   (X   "1    DP   )4   "8    F@4  )T,
M  "@$0  HQH  *,H  "B.@  H4X  *!E  "@@0  GJ   )W!  ";[@  FO\
M1ED  #E<   M80  (6<  !9N   .=0  !7L   "!    AP   (T   "2
ME@   )H   "=    GP   *$   "D    I@   *@   "K    K@   +$#  "T
M"P  N!$  +D>  "Y+P  N$,  +=:  "U=@  M)<  +2U  "QX@  L/P /V0
M #%I   E;P  &'<   ]_   &AP   (X   "4    F@   *    "E    J@
M *X   "Q    L@   +4   "W    N@   +P   "_    PP   ,8   #)
MS@H  -(3  #2(P  T3<  -!/  #.:@  S8H  ,JK  #+RP  R^\ -W$  "EX
M   =@   $8D   B1    F@   *$   "G    K0   +,   "Y    O@   ,(
M  #%    Q@   ,D   #,    S@   -(   #5    V@   -X   #A    Y0
M .H+  #K%P  ZBL  .I#  #J7@  ZGH  .N9  #KM0  Z]4 _P   /\   #_
M  $ _P ' /\ #0#_ !( _P ; /\ )0#_ "\ _P Z /\ 0P#_ $L _P!3 /\
M6@#] &  ^P!F /H :P#X '( ]@!X /0 @ #Q (D [P"2 .P G0#I *H Y@"\
M ., W #? /< W0#_ ,P _P"^ /\ M0#_ +  _P"M /\ _P   /\   #_
M_P   /\ !@#_  T _P 4 /\ 'P#_ "D ^P S /< /0#S $4 [P!- .P 4P#H
M %D Y0!? ., 90#@ &H W0!Q -H > #6 (  T@"* ,\ E0#, *( R "R ,4
MR0#" .T P #_ +L _P"P /\ J #_ *0 _P"A /\ _P   /\   #]    ^@
M /@   #P  D [  1 .@ &0#G ", Y0 M -X -@#6 #X T0!& ,T 3 #* %(
MR !8 ,4 70## &, P !I +X < "\ '@ N0"! +< C0"T )H L0"I *X O "L
M .$ J@#\ *@ _P"@ /\ F0#_ )8 _P"4 /\ _P   /D   #R    YP   -L
M  #1  0 R@ - ,< % #$ !T P@ F +\ +P"[ #< MP _ +0 10"Q $L K@!1
M *P 5@"J %P J !A *8 : "C '  H0!Y )\ A "= )$ F@"@ )@ L0"6 ,P
ME0#Q )0 _P"1 /\ BP#_ (@ _P"& /\ ]P   .P   #>    R0   +P   "T
M    KP * *L $ "I !< J  @ *< * "B #  GP X )P /@": $0 F !* )8
M3P"4 %4 DP!: )$ 80"/ &@ C0!Q (L >P") (@ AP"7 (4 J "# +X @0#D
M (  _P"  /\ ? #_ 'L _P!Y /\ Z0   -<   #!    L0   *8   "=
MEP % )0 #0"2 !( D  : (\ (@". "H BP Q (D . "' #X A0!# (, 2 "!
M $X ?P!4 'X 6@!\ &$ >@!I '@ <P!V '\ =0". ', GP!Q +, < #0 &\
M]@!O /\ ;P#_ &T _P!L /\ V@   +\   "L    G@   ),   ",    A0
M (( "0!_  \ ?@ 5 'T ' !\ "0 >@ K '< ,0!U #< =  ] '( 0@!Q $@
M;P!- &X 4P!L %H :P!B &D ; !G '@ 9@"& &0 EP!B *H 80#" &  ZP!A
M /\ 80#_ &$ _P!@ /\ Q0   *T   ";    C0   (,   !\    =P   '(
M!0!P  P ;@ 1 &P %P!L !X :P E &D + !G #$ 9@ W &0 /0!C $( 8@!(
M &  3@!? %4 70!= %P 9@!: '( 60"  %< D !6 *, 50"Y %0 W@!4 /L
M5 #_ %4 _P!5 /\ M@   )\   "-    ?P   '4   !N    :0   &8  0!C
M  D 80 . &  $P!? !D 7@ @ %T )@!; "P 6@ R %@ -P!7 #T 5@!# %4
M20!3 %  4@!8 %$ 80!/ &P 3@!Z $P B@!+ )P 2@"Q $D S@!) /, 20#_
M $D _P!* /\ J@$  )0%  ""!P  = @  &H(  !C!@  7@0  %L   !9  4
M5P , %8 $ !4 !4 4P ; %( (@!1 "@ 4  M $X ,P!- #@ 3  ^ $L 10!*
M $P 2 !4 $< 70!& &@ 1 !U $, A0!! )@ 0 "K $  Q0 _ .H /P#_ $
M_P!  /\ H @  (H+  !Y#0  ; T  &$-  !:#0  50L  %()  !0!@  3P((
M $X #0!, !( 2P 7 $H '@!) ", 1P I $8 +P!% #0 1  Z $( 00!! $@
M0 !0 #X 6@ ] &0 / !R #H @@ Y )0 . "G #< O@ V ., -@#Y #8 _P W
M /\ F T  (,.  !R$   91$  %L1  !3$   3A   $H.  !(#0  1PH# $<'
M"@!%! X 1 (3 $("&@!! B  0 ,E #X#*P ]!#$ / 0W #L$/@ Z!44 .05.
M #<%5P V!6( - 9P #(&@  Q!I( , :E "\%NP N!=T +@;U "T'_P N!_\
MD1   'T1  !L$P  7Q0  %44  !.%   2!,  $02  !!$   0 X  $ -!@!
M"@P /@D0 #P)%@ ["AP .0HB #@**  W"RX -@LU #4+.P S"T, ,@Q, # ,
M5@ O#&$ +0QO "L,?P J#)( * RE "<,NP E#-T )0WU "8-_P G#?\ BQ(
M '<4  !G%@  6Q<  %$8  !)%P  0Q<  #\5   \%   .A(  #D1 0 Y#P@
M. X- #<.$@ U#A@ - X? #(.)0 Q#RP , \R "\0.@ M$$( +!!+ "H050 H
M$&$ )A!O "00@  C$), (1"G !\0O0 >$.  'A'W !\0_P @$/\ AA0  ',7
M  !C&0  5QH  $T;  !%&@  0!H  #L9   X&   -18  #04   S$@0 ,A(+
M #$2$  O$A4 +1(< "P3(@ K$RD *A,P "@3-P G%#\ )A1( "044P B%%\
M(!5M !\5?@ =%9$ &Q6E !D5NP 8%=X &!7X !D4_P :%/\ @A<  &\:  !?
M'   4QT  $H=  !"'0  /!T  #<<   T&P  ,1H  "\9   N%@  +!<( "L6
M#@ I%Q, *!<9 "<8(  E&"8 )!@M ",8-  B&3T (!E& !X940 =&5T &QIK
M !D:?  7&H\ %1JC !09N@ 2&=L $QGV !09_P 5&/\ ?1H  &L=  !<'P
M4"   $<@   _(   .1\  #0?   Q'@  +1T  "L<   I&P  )QL% "4;#  D
M'!$ (AP6 "$<'0 @'2, 'QTJ !X=,@ <'CH &QY$ !D>3@ 7'EL %AYI !0?
M>@ 2'HT $1ZB ! >N  .'M@ #Q[U ! =_P 1'?\ >AT  &<?  !9(0  32(
M $0B   \(@  -B(  #(A   N(0  *B   "<@   D'P  (B " " @"@ >(0\
M'2$4 !PA&@ ;(B$ &2(G !@B+P 7(C@ %2-! !0C3  2(U@ $2-G ! C>  .
M(XL #2.?  PCM  +(]  "R+P  PB_P -(?\ =A\  &0B  !6(P  2R0  $$D
M   Z)   -"0  "\C   K(P  *",  "0C   @(P  '20  !LE!P 9)@T %R81
M !8F%P 5)QX %"<E !,G+  2)S4 $2@_ ! H2@ .*%8 #2AD  PH=  **(<
M"2B;  <GL0 %)\P !B?L  <F_@ ()O\ <2(  & D  !3)@  2"<  #\G   W
M)@  ,28  "TF   I)0  )24  "(E   =)P  &2@  !8J!  4*PL $BP0 !$L
M%  0+!L $"PB  XL*0 .+3( #2T[  LM1@ *+5( ""U@  8M<  $+8,  BV8
M   LK@  +,D  "SK  $K_  "*_\ ;24  %TG  !/*   12D  #PI   U*0
M+R@  "LH   G)P  (R<  !\H   ;*@  %RP  !,N @ 0, @ #C$-  TQ$@ ,
M,1< "S$>  HQ)@ (,BX !S(W  4R0@ #,DX  3)<   R;   ,G\  #*5   Q
MK   ,<<  ##J   P_   ,/\ :"D  %@J  !,*P  02P  #DL   R*P  +2L
M "DJ   E*@  ("L  !PL   7+@  $S   ! R @ .- < "C<,  <W$  %-Q0
M S<;  (W(@  -RH  #@S   X/@  .$H  #A8   X:   .'P  #>2   WJ0
M-L4  #;J   V_0  -?\ 8RP  %0N  !(+P  /B\  #8N   P+@  *RT  "<M
M   B+0  '2\  !@Q   4,P  $#4   XW 0 *.@< !CL+  (\#@  /1(  #X7
M   ^'@  /B8  #XO   ^.@  /D8  #Y4   ^9   /G<  #Z/   ]IP  /<,
M #SI   \_0  ._\ 7C   % Q  !$,@  .S(  #0Q   N,   *2\  "0P   >
M,@  &30  !0V   0.0  #3L   H]   %0 4  $$*  !"#0  0Q   $04  !%
M&@  1B(  $8K  !&-0  1D$  $9/  !&7P  1G,  $6*  !%I   1,   $/H
M  !#_@  0O\ 6#0  $LU  !!-0  .34  #(T   M,P  )C0  " U   :.
M%#H  ! ]   -0   "4(   1%    1P,  $@'  !*"P  2PX  $P1  !.%0
M3QP  $\E  !/+P  3SP  $]*  !/6@  3FT  $Z%  !-H   3+P  $OG  !+
M_@  2O\ 4SD  $<Y   ^.0  -S@  #$W   I-P  (3D  !L\   5/P  $$(
M  Q%   '2    DH   !-    3P   %$$  !2!P  5 L  %4.  !7$0  61<
M %H?  !9*0  638  %E$  !95   6&<  %A_  !7F@  5K<  %7C  !4_0
M5/\ 3CT  $,]   \/   -3L  "P\   D/@  '$$  !5$   02   "TL   5.
M    40   %0   !7    60   %L   != @  7@8  & +  !B#@  9!(  &<8
M  !G(@  9BX  &8\  !F30  96   &5W  !DDP  8[$  &'=  !@_   7_\
M24(  $%!   Z/P  ,$   "9#   >1@  %4H  !!.   *4@   U8   !:
M70   &    !C    90   &<   !I    :P$  &T%  !O"@  <@X  '42  !W
M&P  =B8  '8U  !U1@  =%D  '1O  !SBP  <JD  '#-  !O]P  ;O\ 1D8
M $!%   U1@  *D@  "!,   740  $%8   E:   !7P   &,   !H    :P
M &\   !R    =0   '<   !Y    >P   'T   "  P  @P@  (8-  ")$P
MBAT  (HK  ")/   B$\  (9F  "%@0  A*   (+"  "!\   ?_\ 1DL  #I,
M   N3P  (U,  !A8   07@  "60   !I    ;P   '0   !X    ?    ($
M  "$    AP   (@   "+    C@   )    "3    E@   )D'  "=#0  H10
M * A  "@,0  GD0  )U;  "<=@  F98  )FU  "6Y0  E?X /U(  #)5   F
M6@  &V   !%G   );0   '0   ![    @0   (8   "+    D    )0   "7
M    F0   )P   "?    H0   *0   "G    J@   *T   "Q!@  M0T  +@6
M  "W)@  MCD  +50  "T:@  LHD  +"J  "NSP  K?4 -UP  "MA   >:
M$W    MX    @    (<   ".    E0   )H   "?    I    *@   "L
MK0   +    "S    M0   +@   "[    OP   ,,   #'    RP4  -$.  #1
M&P  T"X  ,]%  #-7P  RWX  ,F>  #(O@  Q>D +VD  "-P   6>0  #8$
M  &+    DP   )L   "B    J    *X   "T    N    +T   #     P@
M ,4   #(    RP   ,X   #1    U@   -L   #?    Y    .@&  #K$0
MZB,  .HZ  #I5   YW(  .63  #CLP  X]0 _P   /\   #_    _P $ /\
M"P#_ !  _P 7 /\ (0#_ "L _P U /\ /@#_ $< _P!. /\ 50#\ %L ^@!A
M /@ 9@#V &T ] !S /( >P#O (0 [0". .H F0#F *< XP"Y -\ U0#; /<
MU@#_ ,  _P"R /\ J@#_ *4 _P"B /\ _P   /\   #^    _    /P  P#^
M  L _P 1 /\ &@#] "0 ^0 N /0 . #P $  [ !( .D 3@#F %0 X@!: -\
M7P#< &4 V !K -0 <@#0 'L S0"% ,H D0#' )X PP"N ,  Q0"] .L NP#_
M +  _P"D /\ G #_ )@ _P"5 /\ _P   /H   #T    \0   /(   #J  4
MYP . .( %0#A !X X0 H -@ ,0#0 #D RP!  ,@ 1P#% $T P@!3 +\ 6 "]
M %X NP!D +D :P"V ', M !\ +$ B "N )4 JP"D *@ N "F -P HP#[ )\
M_P"5 /\ CP#_ (L _P") /\ ^0   .\   #G    WP   ,\   #(    P0 *
M +\ $0"\ !@ NP A +D *@"T #( L0 Z *X 0 "K $8 J !, *8 40"C %8
MH0!< )\ 8P"= &H FP!S )D ?@"6 (P E "; )( K0"0 ,< C@#P (T _P"&
M /\ @ #_ 'T _P!\ /\ [0   .    #1    OP   +,   "J    I@ % *(
M#0"A !, H  ; )\ (P"; "L F  R )4 .0"3 #\ D0!$ (\ 2@". $\ C !5
M (H 6P"( &, A@!K (0 =@"" (( @ "2 'X HP!\ +H >@#A 'D _P!W /\
M<@#_ '  _P!O /\ W0   ,L   "V    IP   )T   "4    C@ ! (L "@")
M !  B  5 (< '0"' "4 A  L (( ,@!_ #@ ?0 ] 'L 0P!Y $@ > !. '8
M5 !U %L <P!C '$ ;@!O 'H ;0") &P F@!J *X :0#, &@ ]@!G /\ 90#_
M &0 _P!C /\ R@   +0   "A    DP   (D   ""    >P   '@ !0!V  P
M=0 1 '0 & !S !\ <@ E '  + !N #( ;  W &H / !I $( : !( &8 3@!E
M %4 8P!= &( 9@!@ '( 7@"  %T D@!; *4 6@"^ %D Z0!9 /\ 60#_ %@
M_P!8 /\ N0   *(   "0    @P   'D   !Q    ;0   &D  0!F  D 90 .
M &0 $P!C !D 8P @ &$ )@!@ "P 7@ Q %P -P!; #P 6@!" %@ 2 !7 $\
M5@!7 %0 8 !3 &P 40!Y %  B@!/ )X 3@"T $T V@!- /L 30#_ $T _P!-
M /\ J@   )0   ""    =0   &L   !D    8    %T   !:  4 6  , %<
M$ !6 !4 5@ ; %4 (0!3 "< 4@ L %$ ,0!/ #< 3@ ] $T 0P!, $H 2@!2
M $D 6P!( &8 1@!S $4 A !$ )< 0P"L $( R0!" /$ 0@#_ $, _P!# /\
MG@   (D   !X P  :@0  &$$  !: P  50$  %(   !0  ( 3@ ) $T #0!,
M !$ 2P 7 $H ' !) "( 2  G $< +0!% #( 1  X $, /@!" $4 00!- #\
M5@ ^ &$ /0!N #L ?@ Z )$ .0"F #@ OP X .@ . #_ #D _P Y /\ E0,
M ( '  !O"0  8@H  %@+  !1"@  3 @  $D&  !' P  1@ & $0 "P!#  \
M0@ 3 $$ & !! !X /P C #X *0 ] "X .P T #H .@ Y $$ . !) #< 4@ V
M %T - !J #, >@ R (P ,0"A #  N  O -X +P#Y "\ _P P /\ C D  '@,
M  !H#0  7 X  %(.  !+#@  10T  $$,   _"@  /@@" #T$"  \ 0T .P 0
M #H %0 Y !H .  @ #8 )0 U "L -  P #, -P R #X ,0!& "\ 4  N %H
M+0!G "L =P J (D *0"= "@ LP G -$ )P#R "< _P G /\ A@P  '(.  !C
M$   5A$  $T1  !%$0  0!   #P/   Y#@  -PT  #8+!  V" H -08. #0%
M$@ R!!< ,04< # %(@ O!2@ +@8N "T&-  K!CP *@9$ "D'3@ G!UD )@=E
M "0'=0 C!X< (@>; " &L  @!LL 'P7M !\&_@ ?!_\ @ X  &T1  !>$@
M4A,  $@3  !!$P  .Q,  #<2   T$0  ,A   # / 0 P#08 , L+ "\*$  M
M"A0 + L9 "H+'P I"R4 * PK "<,,@ F##H ) Q# ",,30 A#5@ ( UE !X-
M=0 <#8@ &@V< !D-L0 8#,H %PSK !<-_  8#/\ >Q$  &D3  !:%0  3A8
M $46   ]%@  .!4  #,5   P%   +1,  "L2   J$ , *@\( "D.#0 H#A$
M)@X6 "4/'0 D#R, (P\I "$0,0 @$#D 'A!" !T03  ;$%@ &1!F !<0=@ 5
M$(D %!"> !(0LP 1$,X $1#N !(0_@ 2$/\ =Q,  &45  !7%P  2Q@  $(9
M   Z&0  -!@  # 7   L%P  *18  "<5   F% $ )1($ ",2"P B$@\ (1(4
M " 2&@ >$R  '1,G !P3+@ :$S8 &11  !<42@ 6%%8 %!1D !(4=  1%(<
M$!2<  X4L0 -%,H #13K  X3_@ .$_\ <Q4  &$8  !3&@  2!L  #\;   W
M&P  ,AH  "T:   I&0  )A@  "08   B%P  (!8! !X6"  =%@T &Q<2 !H7
M%P 9%QT &!@D !88*P 5&#0 %!@] !(92  1&50 $!EB  X9<@ -&80 #!F8
M  H9K0 )&,8 "1CG  D8^@ *%_\ ;Q@  %X:  !0'   11T  #P=   U'0
M+QT  "H<   F&P  (QL  "$:   >&@  '!H  !H;!0 8&PP %AP0 !4<%0 4
M'!L $QPB !(=*0 1'3$ $!T[  X=10 -'E$ #!Y>  H>;0 )'H  !QZ4  4=
MJ@ #'<(  QWF  0<^  %'/\ :QH  %L=  !-'@  0A\  #H?   R'P  +1\
M "@>   D'@  (1T  !X=   <'0  &!X  !4? @ 3( D $B$. ! A$@ 0(1@
M#B$?  XB)@ -(BX #"(W  HB00 )(DT !R):  4B:0 #(GP  2*1   BJ
M(<   "'E   @^   (/\ 9QT  %<?  !*(0  0"$  #<B   P(0  *B$  "8@
M   B(   'Q\  !P?   9(   %B$  !(C @ 0) < #B8,  PF$  +)A4 "B8<
M  DF(@ ()BH !B<S  0G/0 #)TD  2=6   G9@  )WD  ">/   FI@  )K\
M "7D   E^0  )/\ 8R   %0B  !'(P  /20  #0D   N(P  *",  "0B   A
M(@  'B$  !HB   7(P  $R0  ! F @ .* < "RH+  @K#@ &*Q, !"L8  (K
M'P !+"<  "PP   L.@  +$4  "Q3   L8P  +'8  "R,   KI   *[X  "KD
M   J^@  *?\ 7R,  % E  !$)@  .B8  #(F   K)@  )B4  ",D   ?)
M&R0  !<E   4)P  $2D   XK @ ++08 !R\+  0P#@  ,!$  #$5   Q'
M,2,  #(L   R-@  ,D(  #)/   R7P  ,G(  #&)   QH@  ,+P  ##D   O
M^P  +_\ 6B<  $PH  ! *0  -RD  "\I   I*   )2<  "$F   <)P  &"@
M !0J   1+   #BX   LP 0 ',@4  S0)   U#   -@\  #<2   X&   ."
M #@H   X,@  .3T  #E+   Y6P  .&X  #B%   WGP  -[H  #;D   U_
M-?\ 52H  $@L   ]+   -"P  "TK   H*@  )"D  !XJ   9*P  %"T  !$O
M   -,0  "C0   <V   ". 0  #H'   ["@  /0T  #X0  ! %   0!L  $ D
M  ! +@  0#D  $!'  ! 5@  0&D  $"    _FP  /K<  #WC   \_   //\
M4"\  $,O   Y+P  ,B\  "PM   G+   ("T  !HO   5,0  $3,   TV   )
M.   !3L    ]    0 $  $$$  !#!P  10L  $8.  !($0  2A8  $H>  !*
M*   2C0  $E"  !)40  260  $A[  !(EP  1[0  $;@  !%_   1/\ 2C,
M #\S   V,P  ,#$  "HP   C,0  '#,  !8U   1.   #3L   @^   #00
M $,   !&    2    $H   !,!   3@<  $\+  !1#@  5!(  %49  !5(@
M5"X  %0\  !42P  4UX  %-T  !2D   4:X  %#7  !/^P  3O\ 13<  #PW
M   U-@  +S0  "8U   >-P  %SH  !$]   ,00  !T0   !(    2@   $T
M  !0    4P   %4   !7    6 (  %L&  !="P  7PX  &(3  !B&P  8B<
M &(T  !A10  8%<  &!M  !?B0  7:<  %S,  !:^   6?\ 03P  #H[   T
M.0  *CH  "$\   80   $4,   Q'   &2P   $\   !3    5@   %D   !<
M    7P   &$   !C    90   &<!  !J!0  ;0H  ' .  !S%0  <B   '(M
M  !Q/0  <$\  &]E  !N@   ;9\  &O!  !I\0  :/\ /T   #D^   N/P
M)$(  !I&   22@  #$\   14    6    %T   !A    90   &@   !K
M;@   '$   !S    =0   '@   ![    ?@,  ($*  "%#P  AQ<  (8D  "%
M-   A$8  ()=  "!=@  ?Y8  'ZV  !\YP  >O\ /T0  #-%   H2   '4P
M !-2   ,5P   UT   !C    :    &T   !Q    =@   'H   !^    @0
M (,   "&    B0   (L   ".    D@   )4!  "9"0  GA   )X:  "=*0
MG#P  )I2  "8;   EHL  )2J  "2U   D/H .$L  "Q.   @4P  %5D   U@
M   #9P   &X   !T    >@   (    "$    B@   (X   "2    E0   )<
M  ":    G0   *    "C    IP   *L   "O    M D  +@0  "W'@  M3
M +-&  "Q8   KWX  *R@  "KP0  J>X ,54  "1;   880  #FD   5Q
M>0   ($   "(    CP   )0   ":    GP   *0   "H    J0   *P   "O
M    LP   +4   "Y    O0   ,$   #&    RP   -$*  #3%   T24  - [
M  #-5   RG$  ,B2  #%LP  P]X *6(  !QI   1<0  !WL   "$    C0
M )4   "=    HP   *D   "O    M    +D   "\    O@   ,(   #%
MR    ,P   #0    U    -H   #?    Y    .H   #N#   [1H  .PO  #J
M20  Z&4  .:&  #DI0  XL8 _P   /\   #_    _  ! /P " #^  X _P 4
M /\ '0#_ "8 _P P /\ .@#_ $( _P!) /X 4 #[ %8 ^0!< /8 8@#T &@
M\@!O /  =@#M '\ Z@") .< E0#D *, X "U -L T #5 /8 R@#_ +8 _P"H
M /\ GP#_ )H _P"6 /\ _P   /L   #V    \P   /,   #V  D ^@ . /T
M%@#[ "  ]P J /( ,P#M #L Z0!# .8 20#B $\ W@!5 -L 6P#6 &  T@!G
M ,\ ;@#, '8 R0"  ,8 C #" )H OP"J +L P0"X .D M@#_ *< _P": /\
MD@#_ (T _P"* /\ ^@   /$   #J    YP   .<   #D  $ X  + -L $0#:
M !H VP C -$ + #* #0 Q@ [ ,( 0@"_ $@ O !. +H 4P"X %D M@!? +,
M9@"Q &X K@!W *P @P"I )$ I@"A *, M0"@ -@ G@#[ )4 _P"+ /\ A0#_
M (  _P!^ /\ [P   .,   #:    TP   ,8   "_    N0 & +< #@"T !0
MM  = +, )0"N "T JP T *< .P"D $$ H0!& )\ 3 "= %$ FP!7 )D 7@"7
M &4 E0!N ), >0"0 (< C@"7 (P J0") ,0 B #O (4 _P!\ /\ =@#_ ',
M_P!R /\ X    -    #&    M@   *D   "A    G0 ! )D "@"8 !  F  6
M )< '@"4 "8 D0 M (\ - ", #H B@ _ (@ 10"' $H A0!0 (, 5@"! %X
M@ !F 'X <0!\ 'T >0"- '< H !U +8 <P#? '( _P!N /\ :0#_ &< _P!E
M /\ S    +X   "K    G0   ),   "*    A0   (( !0"   T ?P 1 '\
M& "  "  ?0 F 'H +0!W #, =0 X '0 /@!R $, < !) &\ 3P!M %8 ; !>
M &H : !H '4 9P"$ &4 E@!D *L 8@#) &$ ]@!@ /\ 7 #_ %L _P!: /\
MO0   *D   "7    B0   'X   !X    <P   &\  0!M  D ;  . &L $P!K
M !D :@ @ &@ )@!F "P 90 R &, -P!B #P 8 !" %\ 2 != $\ 7 !7 %H
M80!9 &T 5P![ %8 C@!5 *( 4P"[ %( Z0!2 /\ 4 #_ $\ _P!/ /\ K0
M )@   "&    >    &X   !G    8P   &    !=  4 7  + %L $ !; !4
M6P ; %H (0!8 "8 5@ L %0 ,0!3 #8 4@ \ %$ 0@!/ $D 3@!1 $T 6P!+
M &8 2@!T $D A0!( )D 1P"Q $8 V !& /P 10#_ $4 _P!% /\ GP   (D
M  !X    ;    &(   !;    5@   %,   !1  ( 3P ( $\ #0!. !$ 3@ 6
M $T ' !, "$ 2@ F $D + !( #$ 1P W $4 /0!$ $0 0P!, $( 50!  &
M/P!N #X ?@ ] )( / "I #L QP [ /, .P#_ #L _P \ /\ DP   'X   !N
M    80   %@   !1    3    $D   !'    10 % $0 "P!#  X 0P 2 $,
M%P!" !T 0  B #\ )P ^ "P /0 R #L .  Z #\ .0!' #@ 4  W %L -0!H
M #0 >  S (P ,@"B #$ O  Q .< ,0#_ #( _P S /\ B0   '8#  !F!0
M60<  % '  !)!@  0P4  $ #   ^ 0  /  # #L "  Z  T .@ 0 #D %  Y
M !D -P > #8 (P U "@ -  N #, -  R #L , !# "\ 3  N %< +0!D "P
M<P K (< *@"< "D M0 I -P *0#[ "D _P J /\ @00  &X(  !?"@  4PL
M $H+  !""P  /0H  #D)   V"   -04  #0"!@ S  H ,@ . #$ $0 Q !4
M,  : "\ 'P N "0 +  J "L ,  J #< *0 _ "@ 20 G %0 )@!@ "0 ;P C
M (( (@"7 "$ K@ A ,P (0#S "$ _P B /\ >PD  &@,  !:#0  3@X  $4.
M   ]#@  . T  #,-   P#   +@L  "T) P M!@@ + 0, "L"#P J 1( *0$7
M "@!'  G "$ )@ G "4 +0 D #0 (P$] "(!1@ A 5$ 'P%= !X!;  < 7\
M&P"4 !H J@ : ,4 &@#K !D _P : /\ =0P  &0.  !5#P  2A   $ 0   Y
M$   ,Q   "\/   L#@  *0X  "<- 0 G# 4 )PH* "8(#0 E!Q  ) 84 "(&
M&0 A!A\ ( <D !\'*P >!S( '0<Z !P(1  :"$\ &0A< !<(:P 6"'T %0>1
M !0'IP 3!K\ $@7D !(%^@ 2!?\ <0X  %\0  !1$0  1A(  #T2   V$@
M,!(  "L1   H$0  )1   ",0   B#@0 (0T' "$,"P @"PX 'PL2 !T+%P <
M#!P &PPB !H,*0 9##$ & PY !8-0P 5#4\ $PU< !(-:P 0#7X #PV2  X-
MIP -#+X #0S@  T,]0 -#/\ ;1   %P1  !.$P  0Q0  #H4   R%   +10
M "@3   E$P  (A(  " 1   >$0, '! % !P/"  ;#PP &@X0 !D/%  7#QH
M%@\A !40*  4$#  $A Y !$01  0$%  #A!=  T0:P ,$'P "Q"0  D0I0 (
M$+P !Q#?  <0]  '#_\ :1$  %@4  !+%0  0!8  #<6   P%@  *A8  "85
M   B%0  'Q0  !T3   :$P( &1($ !<2!@ 6$@H %1(. !02$@ 2$A@ $1,>
M !$3)0 0$RX #A,W  T40  ,%$L "Q18  D49P '%'@ !A2-  04HP #$[L
M A/=  $2]  "$O\ 91,  %46  !(%P  /1@  #08   M&   *!@  ",7   @
M%P  '18  !H5   8%0( %A4$ !05!0 2%@@ $18- ! 7$  .%Q4 #A<;  T7
M(@ ,%RD "Q@R  D8/  '&$< !1A4  088P "&'4  1B+   7H0  %[D  !?=
M   6]0  %O\ 818  %(8  !%&@  .QH  #(:   K&@  )1H  "$9   >&
M&Q@  !@7   6%P( %!<# !(8!0 0&0< #AL+  P;#P +&Q, "AL8  @<'P '
M'"8 !1PO  0<.  "'$0  !U1   =8   '7(  !R(   <H   &[D  !O>   :
M]@  &O\ 7A@  $\:  !"'   .!P  "\=   I'   (QP  !\;   <&@  &1D
M !<9 0 4&0( $AH# ! ;!  .'0< #!X+  D?#@ &(!$ !2 6  ,@'  !(2,
M "$K   A-0  (4   "%.   A70  (6\  "&&   @G@  (+@  !_>   >^
M'O\ 6AL  $L=   _'@  -1\  "T?   G'@  (AT  !X=   ;'   &!L  !4;
M   2'   $!T"  X?!  ,(08 "2(*  4C#0 ")!   "43   E&0  )B   "8H
M   F,@  )CT  "9*   F6@  )FP  ":#   EG   );<  "3?   C^0  (_\
M51X  $<@   \(0  ,B$  "LA   E(   (!\  !T>   :'0  %AX  !,>   0
M(   #B$   PC @ ()04 !2<)   H"P  *@X  "L1   L%@  +!T  "PE   L
M+@  +#H  "Q'   L5@  +&D  "R    KF@  *K4  "G?   I^P  */\ 42(
M $0C   X)   +R0  "@C   C(@  'R$  !P@   7(   $R$  ! C   .)
M"R8   @H   $*@0  "P'   N"0  , P  #$/   S$P  ,QD  #,A   S*@
M,S4  #-#   S4@  ,V4  #)[   REP  ,;,  ##>   O^P  +O\ 3"4  #\F
M   U)P  +28  "<E   B)   'B,  !DC   4)   $28   XH   +*@  !RP
M  ,O    ,0(  #,$   U!P  -PH  #D-   Z$   .Q4  #L=   [)@  .S$
M #L^   [3@  .V   #IW   YD@  .+   #?;   V_   -?\ 1RD  #LJ   R
M*@  *RD  "4G   A)@  &R<  !4H   1*@  #BP   HO   &,0   30    V
M    .    #L!   ]!   /P<  $$*  !##@  11$  $48  !%(0  12P  $0Y
M  !$2   1%L  $-Q  !"C0  0:L  $#2   _^@  /O\ 0BT  #@N   O+0
M*2L  "0J   =*@  %RP  !$N   -,0  "30   0W    .@   #P    _
M00   $0   !&    2 ,  $H'  !,"P  3@X  % 3  !0'   4"<  $\T  !/
M0P  3U4  $YJ  !-A@  3*0  $K*  !)^   2/\ /C(  #4Q   N+P  *2X
M " N   9,0  $C,   XW   ).@   CT   !     1    $<   !)    3
M $\   !1    4P   %4!  !8!@  6@L  %T.  !?%0  7B   %XL  !=/
M7$X  %MC  !:?@  6)T  %?   !5\@  5/\ .C8  #,T   M,@  )#,  !LV
M   3.0  #CT   A!    10   $D   !,    4    %,   !6    60   %L
M  !=    8    &(   !E    : 4  &L+  !O$   ;Q@  &XE  !M-   ;48
M &M;  !J=0  :)0  &:V  !DZ0  8O\ .#D  #(W   H.0  'CL  !4_   .
M1   !TD   !-    4@   %8   !:    7@   &(   !E    :    &L   !M
M    <    ',   !V    >0   'T$  "!"P  A1$  (0=  ""+   @#X  'Y4
M  !^:P  >XH  'JJ  !WU@  =?T .#T  "P^   B00  %T8   ]+   '40
M %<   !<    8@   &8   !K    ;P   '0   !X    >P   'X   "
M@P   (8   "*    C0   )$   "6 P  FPP  )T3  ";(0  FC,  )=)  "4
M8@  DW\  )"@  ".Q0  C/, ,40  "5(   :30  $%,   A:    80   &@
M  !N    =    'D   !_    A    (D   "-    D0   ),   "6    F0
M )T   "@    I    *@   "L    L@,  +<-  "W%P  M2@  +(^  "P5@
MK',  *J4  "IM   I>4 *D\  !Y4   26P  "F(   !J    <P   'L   ""
M    B0   (X   "4    F@   )\   "D    I@   *D   "M    L    +,
M  "W    NP   ,    #%    RP   -$$  #5#@  TQT  - R  #-2P  RF8
M ,:'  #"J0  P<L (EL  !9B   ,:P   70   !]    AP   )    "7
MG@   *0   "K    L0   +8   "Z    O    ,    #$    R    ,L   #/
M    U    -H   #@    Y@   .L   #Q!@  \!,  .XG  #L/P  ZEL  .=Z
M  #DFP  X+L _P   /L   #V    \P   /0 !0#V  P ^@ 1 /\ &0#_ "(
M_P L /\ -0#_ #T _P!% /P 3 #Z %( ]P!8 /4 7@#S &0 \0!J .X <@#L
M 'H Z0"% .4 D0#A *  W0"R -@ S@#2 /8 P0#_ *T _P"> /\ E@#_ )
M_P", /\ ^@   /(   #L    Z0   .D   #L  4 \@ , /@ $@#W !L ]0 E
M /  +@#K #< Y@ ^ .( 10#= $L V !0 -, 5@#0 %P S0!B ,H :@#( '(
MQ0!\ ,( B "^ )8 N@"H +< OP"T .@ K@#_ )T _P"0 /\ B #_ (, _P"
M /\ \    .4   #>    V@   -L   #<    V  ' -$ #@#1 !4 T@ > ,L
M)P#% "\ P  W +T /0"Z $0 MP!) +4 3P"R %4 L !; *X 80"L &D J0!S
M *< ?P"D (T H0"> )X L@"; -4 F0#\ (P _P"" /\ >P#_ '8 _P!T /\
MX@   -,   #*    QP   +P   "V    L  ! *\ "P"L !$ K0 8 *T ( "H
M "@ I  O *  -@"= #P FP!" )D 1P"7 $T E0!3 ), 60"1 &$ CP!J (P
M=0"* (, B "4 (8 IP"# ,( @@#P 'P _P!S /\ ;0#_ &H _P!H /\ SP
M ,$   "Y    K0   *    "8    E    )$ !@"0  T D  2 (\ &0". "$
MBP H (@ +P"& #4 A  Z (( 0 "  $4 ?@!+ 'P 4@!Z %D > !B '8 ; !T
M 'D <@") '$ G0!O +0 ;0#? &P _P!E /\ 8 #_ %X _P!< /\ O@   +$
M  "@    D@   (D   ""    ?    'H  0!X  D =P . '@ % !W !H =  A
M '( )P!P "T ;@ S &P . !K #X :0!$ &@ 2@!F %$ 9 !: &, 9 !A '
M7P!_ %X DP!= *D 7 #( %L ]P!7 /\ 5 #_ %( _P!1 /\ L    )\   "-
M    ?P   '0   !N    :@   &8   !E  0 8P + &, $ !C !4 8P ; &$
M(0!? "< 70 L %P ,@!: #< 60 ] %< 0P!6 $L 50!3 %, 7 !2 &@ 4 !W
M $\ B0!. )\ 30"Z $P Z0!+ /\ 20#_ $< _P!' /\ H@   (T   !\
M;@   &4   !>    60   %<   !5  $ 5  ' %, #0!3 !$ 5  6 %( &P!1
M "$ 3P F $X *P!, #$ 2P W $H /0!) $0 1P!, $8 5@!$ &$ 0P!P $(
M@0!! )< 0 "O #\ UP _ /\ /@#_ #T _P ^ /\ E    '\   !O    8P
M %D   !1    30   $H   !(    1P $ $< "@!&  X 1@ 1 $< %@!% !P
M1  A $( )@!! "L 0  Q #X -P ] #X / !' #H 4  Y %L . !I #< >@ V
M (\ -0"G #4 Q@ T /4 - #_ #0 _P U /\ B    '0   !E    6    $\
M  !(    0P   #\    ]    /  " #P !P [  P .P / #L $@ Z !< .0 <
M #< (0 V "8 -0 L #0 ,@ S #D ,0!! #  2P O %8 +@!C "T <P L (@
M+ "@ "L NP K .H *P#_ "L _P L /\ ?P   &P   != 0  40(  $@#  !
M P  .P(  #<    T    ,P   #( !0 R  D ,@ - #$ $  Q !, ,  8 "\
M'0 M "( +  H "L +@ J #4 *0 ] "@ 1@ G %$ )@!> "4 ;@ D (( (P"9
M ", LP B -X (@#_ ", _P D /\ =P   &4$  !6!@  2P<  $((   Z"
M-0<  # &   M!0  + ,  "L  P J  < *0 + "D #@ I !$ *  5 "< &0 F
M !X )0 D "0 *@ C #$ (@ Y "$ 0P @ $X 'P!: !X :0 = 'P ' "3 !L
MK  ; ,T &P#V !L _P < /\ < 4  %\(  !1"@  1@L  #T+   U"P  , L
M "L*   H"0  )0@  "0' @ C! 8 (P() "(!#  B  \ (0 2 "  %@ ? !L
M'@ @ !T )@ < "X &P V !H /P 9 $H & !7 !< 9@ 6 '@ %0"/ !4 I@ 4
M ,, % #N !0 _P 5 /\ :P@  %L+  !-#   0@T  #D-   Q#0  + T  "<-
M   C#   (0P  !\+ 0 >"@4 '0@( !T&"P <!0T ' 00 !L$%  9!!@ &00>
M !@$(P 7!"L %@0S !4$/  4!$< $P-4 !(#8P 1 W4 $ ** ! !H@ / +P
M#P#E  \ _@ 0 /\ 9PL  %<-  !)#@  /@\  #4/   N#P  * \  "0.   @
M#@  '0X  !L- 0 9#00 & P' !@+"0 7"0P %PD. !8)$@ 5"18 % D; !,)
M(0 2"2@ $@DP !$).@ 0"44 #PE2  X)80 -"7, # B(  L(GP *![< "@;;
M  H%]@ *!/\ 8PT  %,.  !&$   .Q$  #(1   K$0  )1   "$0   =$
M&@\  !@/ 0 6#@0 %0X' !0-"0 3#0L $PP- !(,$  1#!0 $ P9 ! ,'P /
M#"< #@TO  T-.0 ,#44 "PU1  D-8  (#7$ !@V&  4-G0 $#+0  PS2  (,
M\0 ""_\ 7PX  % 0  !#$0  .!(  "\2   H$@  (Q(  !X1   ;$0  &!$
M !40 @ 4$ 4 $A ' !$/"0 0#PH $ X,  X.#@ .#Q( #0\7  P0'0 ,$"0
M"A L  D0-@ ($$$ !A!.  4070 #$&\  1"$   0G   #[0   [4   .\P
M#O\ 7!   $T2  ! $P  -A0  "T4   F%   (1,  !P3   9$@  %A(  !01
M P 2$08 $1$( ! 0"@ .$ L #1$+  P1#0 +$A$ "A(5  D2&@ ($B$ !A,I
M  43,P #$SX  A-+   36@  $VP  !."   2FP  $K0  !'7   1]0  $?\
M6!(  $D4   ]%0  ,Q8  "L6   D%0  'Q4  !H4   7%   %!,! !,2!  1
M$@< $!()  X2"0 -$@D "Q,*  D4#0 '%0\ !A83  06&  #%A\  A8G   7
M,   %SL  !=(   76   %VH  !:    6F0  %;0  !79   4]P  $_\ 510
M $86   Z%P  ,!@  "@8   B%P  '18  !D6   6%0  $Q0# !(3!@ 0$P<
M#Q,'  T4!P +%0@ "18)  88#  #&@X  1H1   :%@  &QP  !LD   ;+0
M&S@  !M&   <50  &V<  !M]   ;EP  &K,  !G;   8^0  %_\ 418  $,8
M   W&0  +AH  "8:   @&0  &Q@  !@7   5%@$ $Q4% !$5!  /%00 #18$
M  L7!0 )&08 !AH(  (<"@  '@T  " 0   @$P  (!D  " A   A*@  (34
M "%"   A4@  (&0  "!Z   ?E0  '[$  ![;   =^@  '/\ 31D  #\;   T
M'   *QP  "0<   >&P  &AH  !<8   4%P( $A<" ! 8 0 -&0$ "QH"  @<
M P %'00  A\&   A"   (PL  "4.   F$0  )A8  "8>   G)P  )S(  "<_
M   F3@  )F   "9W   ED@  )*\  "/:   B^P  (?\ 2!T  #P>   Q'P
M*!X  "(>   ='   &1L  !8:   2&@  $!L   T<   +'0  "!\   0A   !
M(P(  "4$   G!@  *0D  "P,   N#P  +A,  "X:   N(P  +BX  "X[   N
M2@  +5P  "UR   LC@  *ZP  "K4   I^P  */\ 1"   #@A   N(0  )B$
M " @   <'@  &!T  !0=   0'@  #A\   LA   '(P   R4    G    *0
M "P!   N P  , 8  #,*   U#0  -A$  #87   V'P  -BD  #8V   V10
M-5<  #5M   TB0  ,J@  #'/   P^@  +_\ /R0  #0D   K)   )",  !\A
M   ;(   %B   !$A   .(P  "B4   8H   "*@   "T    O    ,@   #0
M   W    .0,  #L&   ^"@  0 X  $$2  !!&@  0"4  $ Q  ! 0   /U(
M #YG   ]@@  /*(  #K'   Y^   ./\ .B@  # H   I)P  (R4  !\C   8
M)   $B4   XH   **@  !2T    P    ,P   #8    X    .P   #X   !
M    0@   $4"  !'!@  2@H  $T.  !-%0  3!\  $PK  !+.@  2DP  $EA
M  !(?   1YL  $6_  !#\P  0O\ -BP  "TK   G*0  (R<  !LH   4*@
M#BT   HP   $,P   #<    Z    /0   $    !#    1@   $@   !+
M30   %    !3 0  5@8  %D+  !;$   6QD  %HE  !9-   6$8  %=:  !5
M=   5),  %*U  !0Z@  3_\ ,S   "PN   G+   'BT  !8O   0,@  "C8
M  ,Z    /P   $(   !&    20   $P   !/    4@   %4   !8    6@
M %T   !@    8P   &<&  !K#   ;!(  &L>  !K+   :3T  &=2  !F:@
M9(D  &&K  !?W   7?\ ,3,  "PQ   B,@  &34  !$Y   */0   D(   !'
M    3    %    !4    6    %L   !?    8@   &4   !H    :P   &X
M  !Q    =0   'D   !]!@  @@T  ((6  " )   ?C4  'Q)  ![80  >'\
M ':?  !SQ@  </< ,38  "8X   <.P  $D    M%   "2P   %$   !6
M6P   &    !E    :0   &X   !R    =@   'D   !\    ?@   ((   "%
M    B0   (X   "3    F 8  )P.  ";&@  F"L  )9   "260  D7,  (V5
M  "+M0  B.@ *SX  "!!   51P  #4T   )4    6P   &$   !H    ;@
M ',   !Y    ?@   (,   "(    C    (\   "2    E0   )D   "=
MH0   *4   "J    L    +<'  "X$0  M2$  +(U  "O30  JFD  *B(  "F
MJ   HM$ (T@  !A.   .5   !%P   !D    ;0   '4   !\    @P   (D
M  "/    E0   )L   "@    HP   *8   "I    K0   +$   "U    N0
M +X   #$    R@   -(   #:"@  UA8  -(I  #.00  REP  ,5\  #"G0
MP;T '%4  !%<   '90   &X   !W    ?P   (@   "0    F    )\   "E
M    K0   +,   "X    N@   +X   #"    Q@   ,H   #.    TP   -H
M  #@    YP   .T   #S    ] X  /(>  #O-@  [%$  .AN  #DD   W[$
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M_________________________________________P
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M[8Z(>.>'CX'B@)6*W7N:D-IWH);6=*::U'&LGM)OLJ'0;;FCSVS#IL5GPZ;
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MBI6[IH>=OJ*%I<"?A*_!EGZPP91_MKB3@+NRDX"[LI. N[*3@+NRDX"[LI.
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M-1EQ_ST>:?]%(V+_329;_U8I6/]?+%;_:"U4_VXO4_]S,%+_>#%1_WPQ4/^
M,D__A#-._X@S3?^,-$S_DC1+_Y8U2_^6-4O_EC5+_Y8U2_^6-4O_EC5+_Y8U
M2_^6-4O_EC5+_Y8U2_^6-;?$ P"IU ( G/D+ I/_&P6%_R,*>?\I#V[_,11E
M_SD87?]!&U?_2AY3_U(@4/]9(DW_8"-+_V8D2O]K)4G_;R5(_W,F1_]W)D;_
M>R=%_WXG1?^"*$3_ARA#_XLI0_^+*4/_BRE#_XLI0_^+*4/_BRE#_XLI0_^+
M*4/_BRE#_XLI0_^+*?^#' /_@"<'_WLS#?^&.!'_CD 9_Y-)(O^552W_DV$Y
M_Y!M1?^+>$__AH19_(*.8?=]EFCT>)UN\72C<^YQJ7?L;JYZZFRS?>EJN7_G
M:,"!YF?'@^-ESX7=8]B&TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@
MVH?38-J'TV#:A_^#' /_@"<'_WLS#?^&.!'_CD 9_Y-)(O^552W_DV$Y_Y!M
M1?^+>$__AH19_(*.8?=]EFCT>)UN\72C<^YQJ7?L;JYZZFRS?>EJN7_G:,"!
MYF?'@^-ESX7=8]B&TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?3
M8-J'TV#:A_^#' /_@"<'_WLS#?^&.!'_CD 9_Y-)(O^552W_DV$Y_Y!M1?^+
M>$__AH19_(*.8?=]EFCT>)UN\72C<^YQJ7?L;JYZZFRS?>EJN7_G:,"!YF?'
M@^-ESX7=8]B&TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'
MTV#:A_^#' /_@"<'_WLS#?^&.!'_CD 9_Y-)(O^552W_DV$Y_Y!M1?^+>$__
MAH19_(*.8?=]EFCT>)UN\72C<^YQJ7?L;JYZZFRS?>EJN7_G:,"!YF?'@^-E
MSX7=8]B&TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:
MA_^#' /_@"<'_WLS#?^&.!'_CD 9_Y-)(O^552W_DV$Y_Y!M1?^+>$__AH19
M_(*.8?=]EFCT>)UN\72C<^YQJ7?L;JYZZFRS?>EJN7_G:,"!YF?'@^-ESX7=
M8]B&TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?38-J'TV#:A_^#
M' /_@"<'_WTR#/^(-Q'_D#\8_Y5)(O^75"W_EE\Y_Y-K1?^.=U'_B();^H2,
M9/5_E&OQ>IMR[G:B=^MRIWOI;ZU_YVRR@N5JN(3D:;^'XFC'B>!FSXK68]:,
MSV+8BL]BV(K/8MB*SV+8BL]BV(K/8MB*SV+8BL]BV(K/8MB*SV+8BO^$&P/_
M@2<'_X Q#/^+-A'_DSX8_YE'(O^<4BW_FETZ_YAI1_^3=%/^CGY?]XB):?&"
MD7+M?9AYZ7B??^5TI(3C<*J(X&VPC-YKMX_=:K^1VVG(D]5FSY7+9-&3QF74
MCL9EU([&9=2.QF74CL9EU([&9=2.QF74CL9EU([&9=2.QF74CO^%&P/_@B8'
M_X(P#/^.-1#_ECT8_YQ&(?^@4"W_GUL[_YQF2/^8<5;[DWQB](V&;>Z'CG?H
M@)6 Y'J<A^!UHHS=<JB1VF^OE=AMMYG5:\"<TFG)GLEER9["9\V8OFG1D[YI
MT9.^:=&3OFG1D[YIT9.^:=&3OFG1D[YIT9.^:=&3OFG1D_^&&P/_@R8'_X4O
M"_^0-!#_F3T7_Y]&(?^C3RW_HUH[_Z!D2?^=;UCZF'EE\9*#<>J+C'SD@Y*&
MWWV9CMIXH)76=*>:TW"NG]%MMJ//:\"EQV;"I\!HQJ*[:LN;MVS.EK=LSI:W
M;,Z6MVS.EK=LSI:W;,Z6MVS.EK=LSI:W;,Z6MVS.EO^&&P/_@R8'_X<N"_^3
M-!#_FSP7_Z%%(/^G32W_IE@[_Z1B2ORA;%GWG'9H[Y: =>>/B8'@AY",VH"6
ME=5ZGIW1=:6CS7"LJ,MMM:S':[ZMO6B_K+AKPZ:S;<B?L&_,F;!OS)FP;\R9
ML&_,F;!OS)FP;\R9L&_,F;!OS)FP;\R9L&_,F?^'&@/_A"4'_XDM"_^5,P__
MG3P6_Z1$(/^J3"W_JE<[_JA@2_BE:EKSH71J[9Q^>>23AH;<BXV2U8.4G,]\
MFZ7+=Z.JQW2KK<1SM:^_<+RPM6N\L+!NP:FL<,:BJ7+*G*ERRIRI<LJ<J7+*
MG*ERRIRI<LJ<J7+*G*ERRIRI<LJ<J7+*G/^'&@/_A"4'_XLL"O^7,P__GSL6
M_Z9$'_^L2RS_KE4[^ZQ?2_6J:%SNIG%LYZ!Z?-^7@HK5CHB8S86/H<> EZ?"
M>YZLO7BGK[IVL+&W=;JRK7"ZLJEQOZRE=,2DHW7)GJ-UR9ZC=<F>HW7)GJ-U
MR9ZC=<F>HW7)GJ-UR9ZC=<F>HW7)GO^(&@/_A24'_XPK"O^8,@[_H3L5_ZE#
M'_^O2RS_L50[^+%=2_&O9ESJJV]NX:-V?]69?8_,D829Q8J,HKZ$DZBY?YJM
MM'RCL+!ZJ[.M>;:TIG2YM*)UO:^?=\.FG7G'H)UYQZ"=><>@G7G'H)UYQZ"=
M><>@G7G'H)UYQZ"=><>@G7G'H/^(&@/_A24'_XXJ"O^:,@[_HSH5_ZM"'O^Q
M2BO]M5,[]K5<2^ZS9%WEKFQOVZ5S@<Z=>H_%E8&9OHZ(HK>(D*FQA)>NK("?
ML:A^J+2E?;*UGWJXMIMYN[&9>\&HF'S&HIA\QJ*8?,:BF'S&HIA\QJ*8?,:B
MF'S&HIA\QJ*8?,:BF'S&HO^)&@/_AB4&_Y J"O^<,0W_I3H4_ZU"'O^T2BO[
MN%(Z\[E:2^JX8E[AL6IPTZEP@<B@=X^_F7Z9MY*%HK",C*FJB)2NI82<LJ""
MI+6=@:ZVF7^WMY1]NK.3?\"JDG_%HY)_Q:.2?\6CDG_%HY)_Q:.2?\6CDG_%
MHY)_Q:.2?\6CDG_%H_^)&0/_AB0&_Y$I"?^=,0W_ISD4_Z]"'?^V22KXO% Z
M\+U92^>\85[<M6=QSJQO@<.D=8ZYG'R9L9:"HJJ1BJFCC)&NGHF9LIF&H;66
MA:NWDX6VMXZ!N;2.@[^KC8/$I8V#Q*6-@\2EC8/$I8V#Q*6-@\2EC8/$I8V#
MQ*6-@\2EC8/$I?^)&0/_AR0&_Y,I"?^?,0W_J3D3_[%!'/^Y22GVP$\Y[<)7
M2N2_7UW6N69PR;!M@+ZH<XZTH'J9JYJ HJ25AZF=D8ZNEXZ6LI*+G[6/BJFW
MC(JTN(B&N+6(A[ZLB(?#IHB'PZ:(A\.FB(?#IHB'PZ:(A\.FB(?#IHB'PZ:(
MA\.FB(?#IO^*&0/_AR0&_Y0I"?^A, S_JSD2_[1!'/R[2"CTPTXXZ\=62N##
M7EW1O&5OQ+-K@+FK<8VOI'>8IIY^H9Z:A*B7EHRND9.4LHR1G+6(CZ:WA8^Q
MN(*,M[:"C+ZM@XS#IH.,PZ:#C,.F@XS#IH.,PZ:#C,.F@XS#IH.,PZ:#C,.F
M@XS#IO^*&0/_B"0&_Y8H"/^C, S_K3@2_[9 &_J^2"?QQTXWY\Q52-S'7%S,
MOV-OO[=I?[2P<(RIJ767H*-[H)B?@JB1FXFMBIF2LH66FK6!E:2W?I6OMWN2
MM[9]D;VN?9#"IWV0PJ=]D,*G?9#"IWV0PJ=]D,*G?9#"IWV0PJ=]D,*G?9#"
MI_^+&0/_B20&_Y@H"/^E+PO_L#@1_[E &?C"1R;NRTTUY-!41M7+6UO'PV)N
MNKMH?JZT;HNCKG.6FJEZGY*E@*:*H8>LA)^/L7Z=F+1ZG*&V>)NLMG6:M[9W
MF+VN>);"IWB6PJ=XEL*G>);"IWB6PJ=XEL*G>);"IWB6PJ=XEL*G>);"I_^,
M& /_BB,&_YHG!_^G+PK_LS</_+T_&//&1B/JT$PRX-521<_/65K!R&!LM,!F
M?*BZ;(J=M'*5E+!XGHNL?J6#J(6J?::,KWBDE;)THY^T<:.JM6^DN;1PH+ZM
M<IW"IW*=PJ=RG<*G<IW"IW*=PJ=RG<*G<IW"IW*=PJ=RG<*G<IW"I_^,& /_
MC"(&_YTG!_^J+@G_MC8.]\$^%NW,1B#DV$LNV=Q01,G46%B[S5YKKL9E>J+
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M*3S_L"H\_[0J//^T*CS_M"H\_[0J//^T*CS_M"H\_[0J//^T*K.X 0"EQ@
ME]4  (OO! &$_Q,"=_\:!&W_(@=D_RH+7/\R#E7_.1%0_T$32_](%4C_3Q=%
M_U880O]<&4#_81H^_V<://]M&SO_<QPY_WD<./^ '3;_B!TU_X\>-/^7'C+_
MH!\R_Z0?,O^D'S+_I!\R_Z0?,O^D'S+_I!\R_Z0?,O^D'Z;   "7S@  B=X
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M34GXX$U(]_--2/?T34CW]$U(]_1-2/?T34CW]$U(]_1-2/?T3=JC  #'L0(
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M:D_%[6A0P/-D4;WU85&]]6%1O?5A4;WU85&]]6%1O?5A4;WU8?^&"@#PF@0
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M-3__[S4__^\U/__O-3__[S4__^\U/__O-<2J  "SLP  I[\  )K+  "/V@(
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M<%^?ZVMAG?)E8IKV8&*9]UYBF?=>8IGW7F*9]UYBF?=>8IGW7O]S$ '_A0P
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M3DK*_TU*RO]-2LK_34K*_TU*RO]-2LK_3>>/  #1GP  PZL! +>T @"MOP,
MH\L& )O9"@"4Y1H!C>4K!H3D-0U[XS\6<^)('FSA4B9FX5HL8.!B,EO@:C97
MX'(Z4]][/5#?A4!-WX]#2N";14C@J$9&X+A'1>',1T7@Z$=%W_9&1=[_1$7>
M_T1%WO]$1=[_1$7>_T1%WO]$1=[_1-F7  #'I@  N+   *RY 0"BQ0( F-$&
M (_K#0")[A\"@.XK!GCM- QP[3T3:.U&&6+M3AY=[5<C6>U@)U7M:"I2[7$M
M3^UY+TSM@S)*[HTT1^Z8-47NI3=#[[,X0O#$.$'PWSE![^\X0.W].$#L_SA
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M:6^&ZV-RA_E<<X;]5G.%_U)SA?]2<X7_4G.%_U)SA?]2<X7_4O]H$0'_> T
M_X8- /:3# #>H D UJD* -*R#0#'LB("O:\S"K.K01>JITPDH:)5,)F>73J2
MFF1"BY=K2864<E" DGE5>X^!6G:-B5YRC))B;HJ=96N)J6=HB;AH9XG+:&F+
MZ6-LC?E<;8S]5VV*_U)MBO]2;8K_4FV*_U)MBO]2;8K_4O]K$ '_>PL _XH*
M .*8!@#6HP@ T*P) ,NU"P#!MA\!N+0Q":ZP/Q:DK$HBG*A3+I2D6SB,H&)
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M5%NA_U!;H?]06Z'_4%NA_U!;H?]06Z'_4/]W!P#PB0  UI@  ,ND P#!K00
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M.4/8_SE#V/\Y0]C_.="6  #!HP  LJP  *>U  "<P   D<H# (?6!P" Z1$
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M7']S[%:!=OM/@WC_2H-X_T6">/]$@GC_1()X_T2">/]$@GC_1/]?$0'_;0P
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M36R*_TALB?]';(G_1VR)_T=LB?]';(G_1_]I"P#_> 0 Y8<  -:2 P#-G 4
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M0E*I_T)2J?]"4JG_0O)\  #7C   R)D  +VC  "RJP  J;(  *"[ @"7Q D
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M"AW_HPH<_[$*&__ "QK_U@L:_]\+&O_?"QK_WPL:_]\+&O_?"YNQ  "-O
M?L<  '#2  !CW@  5>0  $OU  !&_P4 0/\. #O_%  W_QL!,_\C 2__*0(K
M_S "*/\U B7_.P,B_T$#'_]' QW_3@,:_U4$&/]>!!7_: 43_W0%$?^"!1#_
MD 80_YT&#_^I!@[_M08._[H&#O^Z!@[_N@8._[H&#O^Z!HZZ  !_Q0  <-$
M &+>  !4Y0  1NL  #_^   Y_P  -/\) "__#@ K_Q0 )_\: 2/_(0$?_R4!
M'/\J 1G_+P$6_S0"%/\Z A'_0 (0_T8"#O]. @S_5@()_V #!_]L P3_> ,#
M_X8# O^1 P'_G0,!_Z$# ?^A P'_H0,!_Z$# ?^A _\V+0+_.2X"_SXN _]
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M3)%C[T>29?U!DF?_/)-I_SB3:O\UDVK_-9-J_S63:O\UDVK_-?]7$0'_8PT
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M0GIX_SY[>?\Z>WG_.GMY_SI[>?\Z>WG_.O]?# #_; 0 ]7D" -Z# @#3BP4
MS9(' ,F7" # F1D MY@L Z^5.PRGD4<6GXU0'YF)62>3AF$NCH-H-(F!;SF%
M?W8]@7U^07U[AD5Y>H])=GB93'-WI4YP=[)0;G?$4&UWX$]P>?5(<GO_0W1\
M_SYU??\[=7W_.W5]_SMU??\[=7W_._]A"@#_;P( Z'P  -F& 0#/C@0 R)4&
M ,.:!@"[G!8 LYPJ ZJ9.0NBE444FY%.'92.5R:.BU\MB8AF,X2&;3B A'0]
M>X)[07> A$5T?XU(<'V72VU\HTYJ?+!/:'S!4&=\W5!J?O-);8#_0VZ!_S]O
M@?\\;X'_/&^!_SQO@?\\;X'_//]D" #_<@  X7\  -.) 0#*D@, PY@$ +V>
M! "VH!, KJ G J6=-@F=FD,3EI=-'(^3522)D5TKA(YD,7^,:S=ZBG([=HAY
M0'*&@D1NA8M':H.52F>"H4UD@JY/8H*_3V&"VD]DA/))9H7_0VB&_S]JAO\\
M:H;_/&J&_SQJAO\\:H;_//]G! #V=@  W((  ,Z-  #%E0( OIP# +>A @"O
MI!$ J*0D J"B- B8GT 1D9Q*&HJ94R*$EULI?I5B,'F2:35UD' Z<(]W/FR-
M?T)HC(E&98J326&)GTM>B:Q-78F]3ER)UDU>BO!(8(O^0V*+_S]CC/\\8XS_
M/&.,_SQCC/\\8XS_//]J  #F>@  U88  ,F1  # F0$ N)\! +"E  "HJ0X
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M&C;AS1HVW^P:-=[Y&C3=_QLTW/\;--S_&S3<_QLTW/\;--S_&[F<  "JI
MGJL  )*U  "%O@  ><<  &W/  !BU@, 6.$( %7J$P!1ZR  3>LK 4GK-0)%
M[#X$0NQ'!3_L3P<][5@).NU@"CCM:@PV[G0-,^Z #C+NC@\P[YT0+N^M$2WP
MP!$M\-X1+.[Q$2SL_A$LZ_\0+.O_$"SK_Q LZ_\0+.O_$*VB  "@J0  D[,
M (:]  !YQ@  ;,\  &#8  !5W@  3O,* $KW$P!&^!T 0_@G 3_X, ([^3@"
M./E  S7Z1P0S^D\%,/M7!2[[7P8K_&D'*?QT""?\@@DE_9 ))/V@"B/^L HB
M_L0+(?_@"R']\@H@_/P*(/S\"B#\_ H@_/P*(/S\"J*G  "5L0  A[L  'G&
M  !LSP  7]D  %+?  !(Z   0_\( #__$  [_QD -_\A #3_*0$P_S !+?\W
M BK_/@(G_T0")?]+ R+_4P,@_UP#'?]F!!O_<@09_X %%_^/!1;_GP85_Z\&
M%/_ !A3_U@83_^D&$__I!A/_Z083_^D&$__I!I>O  "(N@  >L4  &S/  !>
MV@  4.   $3F   \]0  -_\$ #/_#0 O_Q, *_\: "C_(0 E_R<!(?\M 1[_
M,@$;_S@!&?\_ 1;_1@(4_TT"$?]6 A#_8 (._VP"#/][ PO_BP,*_YH#"O^H
M PG_M0,(_\(#"/_" PC_P@,(_\(#"/_" XJX  ![PP  ;,X  %[;  !/X@
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M-ZI2]#.I5/\NJ%;_*ZA7_RBH5_\EJ%?_):A7_R6H5_\EJ%?_)?]-$P#_5@X
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M-8=G_S&':/\NAVG_+8=I_RV':?\MAVG_+?]7# #_800 _FP# .1U 0#;>P4
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M,7%X_S%Q>/\Q<7C_,?]? @#W;   WG<  -"!  #'B $ P(T# +F1 P"RDQ$
MJY,C :.1,P:<CD -E8M*%8^(4QR)AELBA(-B*("!:2U\?W Q>'YW-71\@#AQ
M>XD\;GJ3/VMYGD)H>*M$9GB[161XT45F>>Y :'O].FI[_S9K?/\R:WS_,FM\
M_S)K?/\R:WS_,O]A  #J;P  V7H  ,R$  ##BP  NY$! +25 0"LEPX I9<A
M 9Z6,067DSX,D)!(%(J.41N$BUDA?XE@)WN'9RMWA6XP<X1U-&^"?3=K@8<[
M:("1/F5_G$%B?JE#8'ZY1%]^ST1@?^Q 8H#\.F2 _S9E@?\S9H'_,F:!_S)F
M@?\R9H'_,O]D  #E<@  TWX  ,>'  "^CP  MI4  *Z9  "FFPP H)P> )F;
M+@22F3L*BY9&$H643QE_D5<?>H]>)76.92IQC&PN;8IS,FF)>S9FB(0Y8H:/
M/5^%FC]<A:A!6H6W0EF%S$):A>H_7(;[.EZ&_S9?A_\R7X?_,E^'_S)?A_\R
M7X?_,OUH  #@=@  S8(  ,*,  "YDP  L)D  *B=  "?H D F:$: ).@*P.,
MGS@(A9U#$'^:3!=YF%0==)=<(G"58R=KDVHL9Y)Q,&21>3-@CX(W7(Z-.EF-
MF3U7C:8_5(VV0%.-RT!4C>D]5HWZ.5>-_S59CO\R68[_,5F._S%9CO\Q68[_
M,>UM  #9>P  R(<  +V0  "TF   JIT  *&A  "7I@0 D:<5 (RG)P*%IC4&
M?Z1 #7FB2A1SH%(:;I]9'VF=8"1EG&<H89MO+%Z:=S!:F( S5I>+-E.7ESE1
MEJ4[3Y:T/$Z6R3Q.EN@Z3Y;Y-E&6_S-2EO\P4I;_,%*6_S!2EO\P4I;_,.9R
M  #0@   PHP  +B6  "MG   HZ$  )FF  ".K0  B*X1 (.N(@%]K3$$=ZP]
M"G*J1Q!LJ4\69ZA7&V.G7A]?IF4D6Z1M)UBD=2M4HW\N4:*),4ZAEC1+H:0V
M2:&T-DBAR#=(H.<U2:#Y,DJ?_S!+G_\N2Y__+4N?_RU+G_\M2Y__+=UY  #)
MA@  O)(  +&:  "FH   G*8  )&L  "&L@  ?;8- 'FV'0!UMBP";[4Y!FJT
M0PMELTP18+)4%ERQ6QI8L&,>5:]K(5&O<R5.KGTH2ZV(*DBME2U%K:,N1*VS
M+T.MR"]"K.<O0ZOY+42K_RM$JO\I1*K_*42J_RE$JO\I1*K_*=&   #!C0
MM9@  *F?  ">I0  DZP  (BR  !]N   <;X& &Z_%0!JOR8!9K\S V&^/P==
MOD@+6;U1#U6]61-1O& 73KQH&DN[<1U(NWL?1;J'(D*ZE"1 NJ(F/KJS)CVZ
MR"8]NN@F/;CY)3VW_R0]MO\C/;;_(SVV_R,]MO\C/;;_(\>(  "YE0  K)T
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M,-CV$C#6_Q,OU/\3+]3_$R_4_Q,OU/\3+]3_$[.:  "FH0  FJD  (VQ  "
MN@  =,$  &C)  !<SP  4M4# $C<" !%Y1( 0^4> $'F*@ ^YC4!.^<^ 3GG
M1P(WYU #-.A9!#+H8@4PZ&T&+NEY!RSIAP@KZI8)*>JG"BCJN@HGZ]8*)^GP
M"B?G_0DFYO\*)N;_"B;F_PHFYO\*)N;_"JB@  "<IP  C[   (*Y  !TP@
M:,H  %O1  !/UP  1=T  #[N"0 \\A$ .?,; #;S)0 T]"X ,?0W 2[U/P$L
M]4<!*?9/ B?V5P(E]V$#(_=L R'X>@0?^(D$'OF:!1SYJP4;^L %&OK>!1KY
M\@4:]_T%&?;_!1GV_P49]O\%&?;_!9ZF  "1KP  @[D  '7"  !GRP  6M,
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M&\L_^QK)0/\8QT#_%\9!_Q7%0?\4Q$'_%,1!_Q3$0?\4Q$'_%/]!%P#_1Q(
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M)IE6_R.95O\AF5?_'YE7_Q^95_\?F5?_'_]-#0#_508 _UT% /MD!P#O:0D
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M"0#$=A< O'8J ;1T.@6N<48,IVY1$J)K6AB>:6(=FF=I(99E<2639'@HD&*
M*XUAB"Z+8)$QB%^:,X9>I36#7K(W@E["-X!>W#B 7_(S@6'_+8)B_RF"8_\F
M@F3_)8)D_R6"9/\E@F3_)?]3!@#_70  YV<  -MO  #0= ( RG@% ,9Y!P"^
M>A4 MGHH :]X-P6H=D0+HG-.$IQP5QB8;5\=E&MG(9!J;B6-:'4HBF=]*X=E
MA2Z$9(XQ@6.7-']BHC9\8J\X>F*^.7EBU3EY8^\T>F7^+WMF_RM\9_\H?&?_
M)GQG_R9\9_\F?&?_)O]5 P#_8   XVH  -5R  #,> $ Q7L# ,!]!0"Y?A(
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M-%&(PS50B.(T4HCV,%.(_RQ4B/\I58C_*%6(_RA5B/\H58C_*.9K  #0>
MPH,  +>,  "MD@  HY8  )J:  ".G@  AY\0 (.?( !^GR\">)T[!W.<10QN
MFTT1:9E5%F687!IAEV,>7I9J(5N5<B57E'PH5).&*U&2DBY.DJ P3)*O,4N2
MPC%*D> Q3)'U+4V1_RI.D/\H3I#_)DZ0_R9.D/\F3I#_)MYP  #)?0  O(D
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M'#FR_QPYL?\;.;#_&SFP_QLYL/\;.;#_&\&&  "TDP  IYH  )R@  "1IP
MA:T  'FS  !MN   8KT! %;"!P!3PQ0 4L,C %#$, %-Q#L"2L1% T?$3@5%
MQ%<'0L-?"4##: L]PW(-.\-^#SC#C!$VPYL2-<.K$S/#P!,SP^ 3,\'U$S+
M_Q0RO_\4,;[_%#&^_Q0QOO\4,;[_%+B0  "KF0  GZ   ).G  "'K@  >[0
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M A+P_P(2\/\"$O#_ IJD  "-K0  ?[8  '&_  !CQP  5LX  $G3   ]V@
M,]\  "KC   F] 4 )/L- "'\$P >_1L '/TB !G^*0 7_C$ %?\Y !/_00 1
M_TH $/]5  [_80 ,_V\!#/^  0K_DP$)_Z8!"/^Z 0?_U $'_^L!!O_V 0;_
M]@$&__8!!O_V 8^L  " M@  <K\  &/)  !6T0  2-@  #O=   PX@  )N8
M !_P   <_P  &?\) !;_#@ 4_Q, $?\9  __'@ -_R0 "_\K  G_,@ &_SL
M _]$  #_3P  _UP  /]K  #_?0  _Y   /^C  #_M   _\8  /_6  #_U@
M_]8  /_6 (*U  !SOP  9,D  %;3  !'VP  .N   "[E   CZ0  &NT  !7]
M   2_P  $/\"  [_"0 +_PT "/\0  3_$P !_Q@  /\>  #_)   _RL  /\S
M  #_/0  _TD  /]6  #_9@  _W@  /^*  #_FP  _Z@  /^Q  #_L0  _[$
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M)@'_+B,!_R\B ?\O)0'_+"L!_RHU O\G00+_)$X#_R); _\@: 3_'G0$_QV
M!/\=B@3_'9(%_QV:!?\=H07_':<%_QVM!?\=M 3_';T$_QW'!/\=U 3^'>8$
M^QWR!/<>^P/U'O\$]![_!/,>_P3S'O\$\A[_!/(>_P3R'O\$\A[_!/\N(@'_
M,A\!_S0> ?\S( '_,B8!_S(R ?\O/@+_+$H#_RI7 _\G9 3_)G %_R5[!?\D
MA07_)(X&_R26!O\DG0;_)*,&_R2J!OTDL0;\)+D&^R3#!ODDSP;V).,&\B3P
M!>XE^@7M)?\&ZR7_!NHE_P;I)?\&Z27_!NDE_P;I)?\&Z27_!O\R'@'_-AL
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M3A8 _T\? /U.*0'T3#0![$A! N9'3@3@15L&VT1F"=9"< S207D.ST""$,U
MBA'*/Y$3R3^9%,<^H!7%/J@6PSZQ%\$^O!? /LL8O3[B&+H^\A>W/_\6M4#_
M%+1 _Q.S0?\1LT'_$+-!_Q"S0?\0LT'_$/] $ #_1@P _TL* /]1#0#_4Q$
M_U08 /-4(@#I4BT!X5 [ =I/20/2354'S$M@"\A):@[%2',1PD=[$[]&@Q6]
M18L7NT63&+E$FAFW0Z(:M4.K&[1#MARR0\0=L$/9'JU#[1VK1?P:J47_&*A&
M_Q:H1O\5IT?_$Z='_Q.G1_\3IT?_$_]$#@#_2@@ _U & /]5"@#_6 T ]UD1
M .I8& #?5R0 U%<U <Q51 3&5% (P5);#+U091"Y3FT3MDUV%K1,?1BQ2X4:
MKTJ-&ZU)E1VK29T>J4BF(*=(L"&E2+TBI$C/(J%(Z"*@2?@>GTO_&YY+_QF=
M3/\7G4S_%IU,_Q:=3/\6G4S_%O]'"P#_30( _U0" /=:! #K70< YUT+ .%<
M$ #371X RETP <-</P2]6DP(MUA7#+-68!&O5&D4K%-Q%ZE1>!JG4( <I$^'
M'J)/CR"@3I@AGDVA(YQ-JR2:3;@EF4S()I9,XB:53O4BE$__'Y10_QR44?\:
ME%'_&)11_QB44?\8E%'_&/])" #_4   ^U@  .5>  #=8@, UF,' -1A"@#*
M8AD PF,L ;MB.P.T8$@(KUU3#*I;7!&F6F05HUAL&*!7=!N=57L=FU2#()E4
MBR*64Y,DE%*=)9)1IR>04;,HCE'#*8U1W2J,4O(FBU3_(HM5_QZ+5O\<BU;_
M&HM6_QJ+5O\:BU;_&O],! #_4P  [%P  -]B  #49@$ SF@% ,MG" #"9Q8
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M+UYPPB]=<-\O7W'U*F!Q_R9A<O\C8G+_(&)R_R!B<O\@8G+_(.]<  #<:0
MRG(  +YZ  "U@   K80  *2%  ":A0, E(44 (Z&)0&)A#,#@X,^!WZ!2 MY
M?U 0=7Y7%'%]7AAN>V4;:WIL'FAY=")E>'TE8G>'*%]VDRI<=I\L6G6N+EEU
MP"Y8==TN67;S*EMV_R9<=_\C7'?_(%QW_R!<=_\@7'?_(.I@  #5;   Q78
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M)$B,_R))B_\@2HO_'DJ+_QY*B_\>2HO_'M5N  ##>P  MX4  *R-  "BD@
MEY8  (R9  !_G   =9X% '"?$P!MGR, :9\P 66>.P1AGD4'79U-"EJ<5 U7
MFUP15)IC%%&::Q=.F7092YA_'$B8BQY%EYD@0Y>H(4*7NB)!E],B09;O($*5
M_AY"E?\=0Y3_'$.4_QQ#E/\<0Y3_',QU  "\@0  L8P  *:2  ";EP  D9L
M (6?  !YHP  :J<  &6G#@!CJ!P 8*@K 5VH-@)9IT $5J=)!E.F40E0IED,
M3:5@#DJE:1%'I'(41*1]%D*CB1@_HY<:/:.G&SRCN1P[H](;.Z+O&SN@_AH[
MG_\9/)__&#R?_Q@\G_\8/)__&,1\  "VB0  JI(  )^7  "5G   B:$  'VF
M  !QJ@  9*X  %JQ" !7L10 5;(C %.R, %0LCL"3;)$ TNQ305(L54'1;%=
M"4.Q90M L&\-/K!Z#SNPAQ$YKY83-Z^F%#:ON!0UL-$4-:[O%#2M_A0TK/\4
M-*O_%#2K_Q0TJ_\4-*O_%+N%  "OD   HY<  )B=  ",HP  @*@  '2M  !H
ML@  7+8  %"Z 0!)O T 2+P9 $:])P!%O3, 0[T] 4&]1P$_O5 "/;U8 SJ]
M804XO6L&-KUW"#2]A DRO9,*,+VD"R^]MPPNOM ++KSN#"VZ_@TLN?\-++C_
M#BRX_PXLN/\.++C_#K./  "FEP  FYT  (^C  "#J@  =K   &JU  !>N@
M4KX  $?" 0 ]QP8 .,D0 #?)&P VRB< -<HS #3+/0 SRT< ,<M1 3#+6P$N
MS&4"+,QQ BK,?P,IS) $)\RA!";-M 0ES<X$)<ON!"3)_ 8CR/\'(\?_!R/'
M_P<CQ_\'(\?_!ZF6  ">G0  DJ,  (6K  !XL@  :[@  %^^  !2P@  1\8
M #W*   TSP0 *]0) ";9#P EV1D )=HE "3:,  CVSL (]M% "+<4  AW5L
M(-UH ![>=@ =WH<!'-^9 1K?K $9W\0!&-[G 1C<^ $8V_\"%]K_ A?:_P(7
MVO\"%]K_ J"<  "4HP  AZL  'FS  !LN@  7\$  %+&  !&R@  .\X  #'3
M   IV0  (=X% ![H#@ =Z!4 &^D> !GI)P 8ZC  %NHY !7K0P 4[$X $NQ:
M !'M9P 0[G< $.Z*  [OG@ .\+, #?#-  SO[  ,[?P #.O_  SK_P ,Z_\
M#.O_ )>C  ")JP  >[0  &V\  !?Q   4LH  $7.   YTP  +]@  "7=   =
MX0  &.P" !;W"P 4]Q$ $?@7 !#X'@ .^24 #?DM  OZ-0 )^S\ !_M*  3\
M5P #_68  OYW  #]BP  _9\  /RU  #\T0  _.T  /S\  #\_0  _/T  /S]
M (NK  !]M   ;KT  &#&  !2S0  1-(  #?8   LW0  (N$  !GE   3Z@
M$/H   [_!@ -_PP "O\0  ?_%  $_QH  ?\@  #_)P  _S   /\Z  #_10
M_U,  /]B  #_=0  _XH  /^?  #_LP  _\<  /_E  #_Y0  _^4  /_E '^T
M  !PO0  8<<  %/0  !#U@  -MT  "KB   ?Y@  %NH  !#M   ,^@  "?\
M  ;_   "_P0  /\)  #_#0  _Q   /\4  #_&@  _R$  /\I  #_-   _T
M /].  #_7@  _W(  /^'  #_F@  _ZH  /^Y  #_N0  _[D  /^Y /\@*0'_
M(B<!_R(G ?\?*@'_&3 !_Q(Y ?\010'_#5,!_PQ@ ?\*;0+_"7D"_PF$ O\)
MC@'_"98!_PF= ?\)HP'_":D!_PFP ?\(MP'_"+X!_PC( ?\(U@'_".8!_PCQ
M ?\(^P#_"/\ _PC_ /\)_P'_"?\!_PG_ ?\)_P'_"?\!_PG_ ?\C)@'_)20
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M!-DD_P38)/\$UR3_!-8D_P36)/\$UB3_!/\Q%@#_-!( _S81 /\W$P#_.1L
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M#J)!_PZB0?\.HD'_#O\_"0#_1   _TH  /=. @#L4 8 ZD\+ .-,$ #63!X
MS4TP ,9-/P' 3$P$NTM7!K=)80FT2&D,L4=Q#JY&>1"L1H 1JD6($ZA$D!2F
M1)@6I$.A%Z)#JQB@0[<9GT/'&9U#X!J;1/,7F47_%9A&_Q.81O\1F$;_$)=&
M_Q"71O\0ET;_$/]"!0#_1P  ]T\  .53  #=50$ UU4& -52"P#+4QD PU0K
M +Q4.P&V4D@$L5%2!ZU07 JI3F0-IDUL#Z1,=!&A2WL3GTJ"%9U*BA>;29,8
MF4F<&I=(IAN52+(<E$C!'9)(V!V02>\;CTK^&(]+_Q:.2_\4CDS_$HY,_Q*.
M3/\2CDS_$O]%  #_2P  Z5,  -Y8  #36P  S5L$ ,I8!P#"6!4 NEHG +-:
M-P&N6$0$J5=/!Z156 JA5& -GE-H$)M1;Q.84'85EE!^%Y1/AAF23HX:CTZ8
M'(U-HAV+3:X?BDV\((A-T""'3>L?AD_\&X90_QB&4/\6AE#_%(91_Q2&4?\4
MAE'_%/]'  #X3P  Y%<  -5=  #,8   Q6 " ,%>!0"Z71$ LU\C *Q?,P&F
M7D #H5Q+!YU:5 J965P.EEAD$9-6:Q.057(6CE1Z&(M4@AJ)4XH<AU*4'H52
MGA^#4:HA@5&X(G]1RR)^4N<A?E/Y'7Y4_QI^5?\7?E7_%GY5_Q5^5?\5?E7_
M%?]*  #N4@  WEL  ,]A  #&9   OV4  +IC @"S8@\ K&,@ *9C, &@8CT#
MFV%(!I9?40J27ED-CUQA$8Q;:!.)6F\6AEEV&(18?AJ"5X<<?U>0'WU6FR%[
M5J<B>5:U(W=6QR1V5N0D=E?W'W=8_QMW6?\9=UG_%W=9_Q9W6?\6=UG_%O],
M  #I5@  V5\  ,ME  #!:   NFD  +1H  "M9PT IF@< *!H+0&:9SH#E65%
M!I!C3@J,8E<-B6%>$(9?91.#7FP6@%US&'Y<>QI[7(,=>5N-'W9:F"%T6J0C
M<EJR)'%:Q"5O6N$E<%OV('%<_QQQ7?\:<5W_&'%=_Q=Q7?\7<5W_%_U/  #E
M60  TV(  ,=H  "];   MFT  *]L  "G:PL H&P9 )ML*@&5:S<"D&E#!8MH
M3 F'9E0,@V5;$(!C8A-]8FD5>F%P&'AA>!IU8($=<U^+'W!>EB)N7J(D;%ZP
M)6M>P29I7MXF:E_T(6M@_QUK8?\;;&'_&6QA_QAL8?\8;&'_&/51  #B7
MSV4  ,-K  "Y;P  L7$  *IQ  "B;P@ FV\7 )9P)P"0;S4"BVY !89L20B"
M:E(,?FE9#WMH8!)W9F84=69N%W)E=AIP9'X=;6.('VMCDR)I8J D9F*N)65B
MOR9D8MHF9&/R(F5D_QYF9/\;9V3_&6=E_QAG9?\89V7_&/!3  #=7P  RV@
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M(E9Q_AY7<?\<5W'_&EAQ_QE8<?\96''_&>->  #-:0  OW,  +1Z  "K?P
MHH(  )B#  "+@0  A($- '^"&@![@BD!=H$V G*!0 5N?TD(:GY0"V=]5PYD
M?%X187MF%%YZ;1=;>G8967F '%9XBQ]3>)@A47>F(E!WMR-/=\XC3W?L(5!W
M_1Y1=_\;4G?_&5)W_QE2=_\94G?_&=YB  #(;@  NW<  +!_  "GA   G8<
M )*'  "$AP  ?8<) 'B(%@!TB"8 <(@R FR'/01HAD8&985."6&%50Q>A%P/
M6X-C$EF":Q56@7074X!^&E" B1Q.?Y8>3'^E($I_MB%)?\PA27[K'TI^_!Q+
M?O\:2W[_&4Q^_QA,?O\83'[_&-5G  ##<P  MGP  *R$  "BB0  F(L  (V-
M  !\C0  =8X$ &^/$@!MD"$ :9 N 66/.0)BCD($7HY+!UN-4@I8C%D,5HMA
M#U.+:!)0BG$438E[%TJ)AQE(B)4;1HBC'42(M!U#B,H=0X?J'$2&^QI$AO\8
M18;_%T6%_Q=%A?\7187_%\UM  "]>   L8(  *>*  "<C@  DI   (:3  !Y
ME0  ;)<  &:7#@!CF!L 89@I %Z8-0%:ESX#5Y='!5663P=2EE8)3Y5>#$R4
M9@Y*E&\01Y-Y$T23A15"DI,70)*B&#Z2LQD]DLD9/9'I&#V0^A<^C_\6/H__
M%3Z/_Q4^C_\5/H__%<5S  "W?P  K(D  *&/  "6DP  BY8  '^9  !SG
M9)\  %R@"0!9H!0 5Z$B %6A+P!2H3D!4*%# DV@2P1*H%,%2*!:!T6?8PE#
MGVP+0)YV#CZ>@Q [GI$1.9V@$CB=LA,WGL@3-YWH$C:;^A(VFO\2-IG_$3>9
M_Q$WF?\1-YG_$;Y[  "QAP  I8\  )N4  "0F   A)P  '>@  !KI   7Z<
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M!*64  ":F@  CJ$  (&G  !SK@  9[0  %JY  !.O0  0L   #C#   OQP
M)LL$ ![0"@ ;T1$ &M(: !G2)0 8TR\ &-,Z !?41  6U%  %=5= !35:P 3
MUGP $M>/ !'8I  0V;L $-G> !#5\P 0T_\ $-+_ 1#1_P$0T?\!$-'_ 9R:
M  "1H0  @Z@  '6P  !HMP  6[T  $[!  !"Q0  -\@  "W,   DT   '-4
M !7:!0 0X@L $.,1  [D&@ .Y", #>4M  SE-P +YD( "N9/  GG70 (YVT
M!N:   7FE0 $YJL  N;$  'FY@  Y_D  .?_  #F_P  YO\  .;_ ).A  "%
MJ0  =[$  &FY  !;P   3L8  $'*   US@  *M(  "'6   9VP  $M\   WC
M   +\0@ "?,.  ?S$P $\AH  O(B  #R*@  \C0  /(_  #R3   \EP  /)M
M  #R@@  \I@  /.M  #SQ@  ].4  /3V  #T^P  ]/L  /3[ (>I  !YL@
M:KH  %S"  !.R0  0,X  #/3   HV   'MT  !7A   /Y   "N@   7S   #
M_0$  /P(  #[#0  ^Q$  /L6  #\'@  _"8  /PP  #]/   _DD  /Y:  #^
M;0  _X(  /^8  #_K   _\   /_8  #_Y   _^0  /_D 'NR  !LNP  7<0
M $_-  ! T@  ,MD  ";>   ;X@  $N8   SJ   %[0   /0   #_    _P
M /\   #_!   _PD  /\.  #_$@  _Q@  /\A  #_*P  _S<  /]&  #_6
M_VL  /^   #_E0  _Z8  /^S  #_NP  _[L  /^[ /\;)@#_'"0 _QHD /\5
M)P#_$"T _PHV /\%0P#_ 5 !_P!> ?\ :P'_ '8!_P"! /\ B@#_ )( _P":
M /\ H #_ *8 _P"L /\ L@#_ +D _P#" /\ S0#_ -\ _P#L /\ ^ #_ /\
M_0#_ /T _P#] /\ _0#_ /T _P#] /\ _0#_ /\?(P#_'R$ _QXA /\9(P#_
M$RD _PXR /\,0 #_"4T!_P=: ?\$9P'_ W,!_P-] ?\#AP'_ X\ _P*6 /\"
MG #_ J( _P*H /\"KP#_ ;8 _P&^ /\!R0#_ =L _P#J /P ]@#X /\ ]P+_
M /<#_P#V!/\ ]@3_ /8%_P#V!?\ ]@7_ /\B'P#_(AP _R$< /\>'P#_&"0
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M \$D_P/!)/\#P23_ _\P#P#_,@L _S,( /\V#0#_-A( _S4: /TR)0#T,#(
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M0ZP4CT.Z%8U#S16+1.@5BD7Z$HE&_Q")1O\.B$;_#8A&_PV(1O\-B$;_#?]
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M&7I-PQIY3=\:>$[T%WA/_Q1X3_\2>%#_$'A0_P]X4/\/>%#_#_U&  #G3P
MUE<  ,A<  "_7P  MU\  +%<  "J60P I%H: )Y;*@"96S@!E%I# Y!93 6,
M6%4(B5=<"H968PR#56H.@51Q$']3>1)]4X$4>E*+%GA2E1AV4:$9=%&O&W-1
MP!MQ4=L<<5+R&7%3_Q5Q5/\3<E3_$7)4_Q!R5/\0<E3_$/-(  #C4P  T%L
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M&V!?_1AA7_\585__$V)?_Q)B7_\28E__$NI1  #47   Q&0  +EJ  "P;@
MIW   )YN  "4:P  C6H0 (=K'@"#:RP ?FLX GIJ0@-V:4H&<VA2"'!G60IM
M9F -:V5G#VAD;A%F9'<49&.!%F%CC!A?8I@:76*F'%MBMAU:8LP=6F+J'%MC
M_!A<8_\67&/_%%UC_Q-=8_\376/_$^95  #/7P  P6@  +9N  "L<@  I'0
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M$TUR_Q)-<O\237+_$M1@  #":P  M70  *M[  "B?P  EX$  (R!  !Z?@
M<W\" &Y_$0!K@!X :( L &6 -P%B@$ #7W](!%Q^4 99?E<(5WU>"U1\9@U1
M?&X/3WMX$4Q[@Q1*>I$62'J?%T9ZKQA%>L081'KD&$5Y^!9&>?\41GC_$D=X
M_Q%'>/\11WC_$<UE  "]<   L7D  *>   "<A   DH8  (:&  !WA@  :X8
M &:'#0!CAQD 8(@G %Z(,P%;B#P"6(=% U:'3013AE0&4(9;"$Z%8PI+A&P,
M281V#T:#@1%$@X\30H.=%$""KA4_@\(5/H+B%3^!]Q,_@?\20(#_$4" _Q!
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M"[AZ  "LA0  H8L  ):0  "+E   ?Y<  '*;  !FG0  6J   $ZB  !%I D
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M !? H0 6P+8 %,#3 !6^\0 5O/\!%;O_ 12Z_P(4NO\"%+K_ J&2  "6F
MBIX  'VD  !OJ@  8J\  %:T  !*MP  /KH  #.]   JP   (<0  !G'!0 3
MRPL $<P2 !',&P 0S"4 #\TO  [-.@ .S48 #<U2  W.8  ,SG  "\Z#  K.
MEP )SJP ",[&  C.Z  (S?L "<O_  G+_P )R_\ "<O_ )B8  "-G@  ?Z4
M '&L  !DLP  5[D  $J]   ^P   ,L,  "C&   ?R@  %\T  !'1   ,U@4
M"-D,  ;9$@ %VAL !-HD  /;+@ !VSD  -Q%  #=4@  WF(  -YS  #>B
MWYT  -^S  #?S@  X.X  -_Z  #?_P  W_\  -__ (^?  "!I@  <ZX  &6U
M  !8O0  2L(  #W%   QR0  )LP  !W0   4U   #MD   G=   #X0   .,'
M  #C#0  Y!(  .49  #F(@  YRL  .DV  #K0P  [%(  .QB  #M=@  [HP
M .ZA  #OMP  []$  ._K  #P]@  \/8  /#V (2G  !UKP  9[<  %F_  !+
MQ@  /,H  "_.   DT@  &M@  !+<   ,X   !>,   #G    ZP   .L   #M
M!0  [@L  / 0  #Q%0  \QX  /0G  #W,P  ^4   /I1  #[8P  _'<  /V-
M  #]HP  _K8  /[)  #_WP  _]\  /_? '>P  !HN0  6L$  $S*   \SP
M+M0  "+:   7W@  $.(   GF    Z0   .P   #P    ]@   /8   #W
M^    /H'  #[#0  _1$  /\9  #_(P  _R\  /\^  #_3P  _V(  /]W  #_
MC0  _Y\  /^N  #_N@  _[H  /^Z /\6(P#_%2$ _Q(A /\.) #_!BH _P S
M /\ 00#_ $X _P!< /\ : #_ '0 _P!^ /\ AP#_ (\ _P"6 /\ G #_ *(
M_P"H /\ K@#_ +4 _P"] /\ QP#_ -8 _P#G /X \P#^ /X _0#_ /P _P#[
M /\ ^P#_ /L _P#[ /\ ^P#_ /\:( #_&1X _Q8> /\0( #_"B4 _P0P /\
M/0#_ $L _P!8 /\ 9 #_ '  _P!Z /\ @P#_ (L _P"2 /\ F #_ )X _P"D
M /\ J@#_ +$ _0"Y /L PP#Z -  ^ #C /< \0#V /P ] #_ /0 _P#S /\
M\P#_ /, _P#S /\ \P#_ /\=' #_'!D _QD9 /\4&P#_#B$ _PPL /\).0#_
M!48 _P)3 /\ 7P#_ &L _P!U /\ ?@#_ (8 _P". /\ E #^ )L _ "A /H
MIP#X *X ]0"U /, OP#Q ,L \ #? .X [@#L /D ZP#_ .H _P#J ?\ Z0'_
M .D!_P#I ?\ Z0'_ /\@%P#_'Q0 _QP3 /\7%0#_%AT _Q,H /\0- #_#4$
M_PQ. /\)6@#_"&8 _PAP /X'>0#\!X$ ^@>) /@'D #V!I8 \P:= /$&HP#O
M!JH [0:R /_B__])0T-?4%)/1DE,10 (">H&NP#H!L@ Y@;< .0&[ #B"/H
MX K_ -X+_P#="_\ W0S_ -P,_P#<#/\ W S_ /\C$@#_(Q  _R$. /\>$ #_
M'A@ _QPC /\8+P#_%#L _Q)) /P050#X#V  ] ]J /$/= #O#GP [0Z$ .L.
MBP#I#I( YPZ9 .8.H #D#J< X@ZO . .N #>#L4 W [: -80[ #2$?H SQ+_
M ,T2_P',$O\!RQ/_ <H3_P'*$O\!RA+_ ?\G#P#_)PP _R4) /\F#0#_)1,
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M!I8T_P66-/\%EC3_!?\U  #_.   ZCX  -]"  #50@  SS\# ,TX" #%.!4
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M"O)"  #@3   SE,  ,%8  "X6@  L%D  *E6  "B4@< FU(5 )93) "14S(
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M%&%5M!5@5<@67U7G%6!6^A)@5O\/85?_#F%7_PUA5_\,85?_#.=,  #15@
MP5X  +9C  "M9@  I&8  )MD  "07@  B5X. (1?&P" 7RD ?%\U 7A?/P)T
M7D<#<5U/!&]<5@5L7%P':EMC"6A;:PMF6G,-9%I]#V):B!%?69037EFB%%Q9
MLA5;6<866EGE%5M:^1);6O\07%K_#EQ:_PU<6O\-7%K_#>-/  #-60  OF$
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M%$MG]1),9_\/3&?_#DUG_PU-9_\-36?_#=):  # 9   LVP  *ER  "@=@
MEG<  (IV  !Y<0  <7$  &MQ#P!H<1P 9G(H &-R- !@<CT!7G)% EMQ30-9
M<50%5W!;!E1P8PA2;VL*4&]T#$UN@ Y+;HT026Z;$4=MJQ)&;KX316[<$D9M
M]!%&;?\/1VW_#D=L_PU';/\-1VS_#<Q?  "\:0  L'$  *5W  "<>P  D7P
M (9[  !U>   :W<  &5W# !A>!< 7W@D %UY, !:>3H!6'E" E9X2@)3>%$$
M47=8!4]W8 =,=F@(2G9R"DAU?0Q%=8H.0W69#T)UJ1! =;P00'79$$!T\P]
M=/\.07/_#4%S_PQ!<_\,07/_#,9D  "W;@  JW8  *)\  "7?P  C($  (&!
M  !R@   97\  %U_" !9?Q, 5X @ %6 *P!3@38 48 ^ 4^ 1@)-@$X"2W]5
M TE_705&?V8&1'YP"$)^>PD_?H@+/7V7##Q]IPTZ?;H..G[6#3I\\0TZ>_\,
M.GO_"SIZ_PLZ>O\+.GK_"\!I  "R=   IWP  )V!  "2A   AX8  'N'  !N
MAP  8(<  %6' 0!0B X 3H@: $V))@!+B3  28DZ $B)0@%&B4H!1(E2 D*)
M6@- B&,$/8AM!3N(> 8YAX8(-X>5"36'I@HTA[D*,X?3"C.&\ DSA?\),X3_
M"3.#_PDS@_\),X/_";EP  "M>@  HH(  )>'  "-B@  @8P  '6.  !HCP
M6I   $^1  !'D@H 1)(3 $.3'P!!DRH 0),T #^3/0 ]DT4 .Y-- 3J35@$X
MDU\"-I-I S23=0,RDH,$,)*3!2Z2I 8MDK<&+)+1!BR1[P8KC_\&*X[_!BN-
M_P<KC?\'*XW_![-X  "G@@  G(@  )&,  "'D   >I,  &V5  !AEP  59D
M $F;   _G $ .9T. #>=%P VGB( -)XL #.>-0 RGCX ,9Y' #"?4  NGUH
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M )R0  "2E0  AIL  'F@  !KI@  7JL  %*O  !&L@  .K4  "^W   EN@
M';T  !7    0PP8 "\8.  K%%0 )Q1X ",4H  ?%,@ &QCT !<9)  7&5P #
MQF8  L9W  '&BP  QJ   ,6V  #&T@  Q>\  ,7\  #%_P  Q?\  ,7_ )66
M  ")G   >Z,  &VI  !@KP  4[0  $:X   ZNP  +KX  "3!   ;Q   $\<
M  [*   (S@$  = *  #0$   T!8  -$>  #2)P  TS$  -0\  #520  UE@
M -9I  #6?   UI(  -:G  #6OP  UN   -;S  #6_@  UO\  -;_ (R=  !^
MI   ;ZL  &&R  !4N0  1KT  #G!   MQ   (L<  !G+   1S@  #-(   75
M    VP   -P#  #="@  W@\  -\4  #A'   XB0  .0N  #F.@  YTD  .A9
M  #H:P  Z8$  .F8  #IK0  Z<4  .GB  #I\@  Z?4  .GU ("E  !QK0
M8[4  %6\  !'P@  .<8  "S*   @S@  %M(   _6   (VP   -\   #C
MY0   .<   #H 0  Z@<  .L-  #M$0  [Q@  /$A  #S*P  ]C@  /=(  #X
M6@  ^6T  /J$  #ZFP  ^J\  /K"  #ZV@  ^M\  /K? '2N  !EM@  5KX
M $C&   YRP  *]   !_4   4V@  #=\   7C    Y@   .D   #M    [P
M /$   #S    ]0   /8"  #X"0  ^@X  /T3  #_'   _R@  /\V  #_1P
M_UH  /]N  #_A0  _YH  /^K  #_N0  _[P  /^\ /\1( #_$!X _PP> /\$
M(0#_ "< _P P /\ /@#_ $P _P!9 /\ 90#_ '  _P!Z /\ @P#_ (L _P"2
M /\ F #_ )X _P"D /\ J@#_ +  _P"X /\ P@#_ ,X _P#B /X \ #] /L
M^P#_ /L _P#[ /\ ^@#_ /H _P#Z /\ ^@#_ /\4' #_$AH _PX: /\(' #_
M "$ _P M /\ .@#_ $@ _P!5 /\ 80#_ &P _P!V /\ ?P#_ (< _P". /\
ME #_ )H _@"@ /T I@#\ *P ^P"T /D O0#X ,D ]P#< /4 [ #S /@ \P#_
M /( _P#Q /\ \ #_ /  _P#P /\ \ #_ /\7& #_%18 _Q$5 /\,%P#_!1T
M_P H /\ -@#_ $, _P!0 /\ 7 #_ &< _P!Q /\ >@#\ (( ^@") /@ D #W
M )8 ]0"< /0 H@#S *@ \0"P /  N #N ,, [ #3 .H YP#I /4 YP#_ .8
M_P#E /\ Y0#_ .4 _P#E /\ Y0#_ /\:$P#_&!$ _Q00 /\/$0#_#1D _PHD
M /\%, #_ 3X _P!+ /\ 5P#^ &( ^@!L /4 =0#R 'T \ "$ .X BP#L )$
MZP"7 .D G@#G *0 Y@"L .0 M #B +\ X #- -X XP#< /( V@#] -@ _P#6
M /\ U0'_ -4!_P#5 O\ U0+_ /\>$ #_' T _Q<+ /\5#@#_%!4 _Q$? /\.
M*@#_"S@ _0A% /@&40#T!%P [@1F .H$;P#F W< Y 1_ .($A@#@!(P W@23
M -T%F@#;!:  V 6H -4%L0#2!;L T ;) ,X'X #,"/$ R0K_ ,<+_P#&#/\
MQ0S_ ,4,_P#%#/\ Q0S_ /\A# #_( 8 _QP# /\="@#_&Q  _Q@8 /\4(P#V
M$3  [PX^ .H.2@#E#58 X0U@ -T-:0#9#7$ U0UY -,-@0#1#8@ SPV/ ,T.
ME@#+#IT R@ZE ,@.K@#&#[D Q!#( ,(0WP"^$?( NQ+_ +D3_P"W$_\!MA/_
M ;83_P&V$_\!MA/_ ?\E!@#_(P  _R,  /\D P#_(0H _1T1 /$:&P#H%B<
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M!/PS  #K.@  W$$  ,U$  ##1   O4$  +@[ 0"R-PX JS@< *4Y*P"A.C@
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M"W!#M0QN1,D,;43G#&U%^@IL1?\(;$7_!VQ%_P=L1?\';$7_!^P_  #820
MQU   +M4  "Q50  J50  *%0  "92@( DDD1 (U*'P")2RP A4PX ()+0@%_
M2TH!?$I2 GE*6 -W2E\$=4EF!7-);09Q278';TA_"&U(B@EL2)8+:DBC#&A(
ML@UG2,4-9DGD#69)^ MF2?\)9DK_"&9)_P=F2?\'9DG_!^A#  #230  PE,
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M#U55\PU55?\+5E7_"595_PE65?\(5E7_"-M-  #%5P  N%X  *UB  "C90
MFF4  )!C  "#7   >UL& '5;$@!Q6Q\ ;EPK &M<-@!H6S\!95M' 6-;3@)A
M6E4#7UI<!%U:8P5;6FL&65EU"%=9@ I568P+5%F:#5)9J@Y16;P.4%G8#E!9
M\@U16?\+45G_"E%9_PE16?\(45G_"-11  #"6@  M&$  *IF  "@:   EVD
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M"4%G_PA"9_\(0F?_",5=  "V9@  JFT  *!S  "6=@  BW<  (!V  !P<@
M97$  %QP!P!8<!$ 5G = %1Q* !2<3, 4'$\ $]R1 %-<4L!2W%3 DEQ6@-'
M<6($17!L!4-P=P9!<(0'/W"3"#UOHPD[<+4*.W#-"CIO[ D[;OX(.V[_"#MM
M_P<[;?\'.VW_![]B  "Q:P  IG,  )UY  "2>P  AWP  'M\  !M>@  8'@
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M ZUV  "C@   EX4  (V)  ""C   =HX  &F0  !<D@  4),  $24   ZE0
M,98( "V7$0 LEQH *Y<D "J7+0 IES8 *)@_ ">82  FF%( )9A< ".8:  B
MF'< ()B' !^8F0$=F*P!')C# 1R7Y0$<E?H!&Y3_ 1N3_P(;D_\"&Y/_ J=_
M  "<A@  D8L  (>/  !ZD@  ;94  &&8  !5FP  29T  #V>   SGP  *J$
M "&C"@ ?HQ$ 'J,: !VD)  <I"T &Z0V !JD/P 9I$H &*15 !:E80 5I7
M%*6! !.EE  2I:@ $:6_ !"DX@ 1HO@ $:'_ !&@_P$1H/\!$:#_ :"&  "5
MC   C)$  '^5  !QF@  9)X  %BA  !,I   0*8  #6G   JJ0  (JP  !FN
M   2L D $+$0 !"Q&  .L2( #K$K  VQ-0 -L4  #+%+  NQ6  *L6< "+%X
M  >QBP %L:  !+"U  2PT  $L.\ !:_^  :N_P &KO\ !J[_ )B.  "/DP
M@I@  '6=  !GH@  6J<  $ZK  !!K0  -:\  "NQ   AM   &+8  !&Y   -
MO , ![X,  .]$@ !O1D  +XB  "^*P  OC8  +Y!  "_3@  OUP  +]M  "_
M@   OI4  +ZJ  "^P@  O>0  +WV  "]_P  O?\  +W_ )*4  "%F@  >*
M &JF  !<JP  3[   $*S   UM@  *K@  ""[   7O@  $,$   O$   $QP
M ,D'  #)#0  R1(  ,H9  #+(@  RRL  ,TU  #.00  SE   ,]@  #/<@
MSX<  ,^=  #/LP  S\X  ,_K  #.^   SOX  ,[^ (B;  !ZH@  ;*@  %ZO
M  !0M0  0KD  #6\   IOP  'L(  !7&   .R0  ",P   #0    TP   -4
M  #6!@  V P  -D1  #;%@  W!\  -XH  #@-   XD$  .)1  #C8P  XW<
M .2.  #DI   Y+H  .74  #EZ@  Y?,  .7S 'RC  !NJ@  8+(  %&Y  !#
MO@  -<(  "C&   <R0  $\T   S1   $U0   -H   #>    X0   .(   #D
M    Y0,  .<)  #I#@  ZQ(  .T:  #O)   \C$  /1!  #T4P  ]68  /5\
M  #VDP  ]JD  />\  #WS@  ]]\  /?? '"L  !AM   4[L  $7#   VQP
M)\P  !O0   1U0  "ML   #?    X@   .4   #I    [    .T   #P
M\0   /,   #U!   ]PH  /H0  #\%@  _R$  /\N  #_0   _U,  /]H  #_
M@   _Y8  /^H  #_M@  _[\  /^_ /\-' #_"AL _P(; /\ '@#_ "0 _P N
M /\ / #_ $H _P!6 /\ 8P#_ &T _P!W /\ ?P#_ (< _P". /\ E #_ )H
M_P"@ /\ I@#_ *P _P"T /\ O0#_ ,D _@#= /T [0#\ /H ^P#_ /H _P#Y
M /\ ^@#_ /H _P#Z /\ ^@#_ /\0&0#_#1< _P86 /\ & #_ !X _P J /\
M-P#_ $4 _P!2 /\ 7@#_ &D _P!R /\ >P#_ (( _P") /\ D #^ )8 _0"<
M /P H0#[ *@ ^0"O /@ N #V ,, ] #2 /, YP#R /8 \ #_ .\ _P#P /\
M[P#_ .\ _P#N /\ [@#_ /\2% #_#Q( _PL2 /\ $@#_ !H _P E /\ ,P#_
M $  _P!- /\ 60#_ &0 _0!M /L =@#Y 'T ]P"$ /4 BP#T )$ \P"7 /$
MG0#P *, [@"J .P LP#J +T Z #+ .< X0#E /$ XP#] ., _P#B /\ X0#_
M .$ _P#@ /\ X #_ /\4$ #_$0X _PT- /\'#P#_ A4 _P @ /\ +0#_ #H
M_P!' /D 4P#U %X \@!H /  < #M '@ ZP!_ .D A0#H (P Y@"2 .4 F #C
M )\ X0"F -\ K@#< +@ V@#% -8 V0#4 .P T@#Y -$ _P#/ /\ S@#_ ,X
M_P#. /\ S@#_ /\7# #_% @ _P\% /\."P#_#!$ _P<: /\!)@#\ #0 ] !!
M .T 30#I %@ Y@!B ., :@#@ '( W@!Y -L @ #9 (8 U@"- -, DP#1 )H
MSP"A ,T J@#+ +, R0"_ ,8 T #% .@ PP#V ,$ _P#  O\ OP/_ +\#_P"_
M _\ OP/_ /\;!@#_%P  _Q0  /\3!0#_$0T _PX4 /D*'P#P!BP Y@,Y . #
M1@#< U$ U@1; -($9 #/!6P S 5S ,H%>@#(!8$ Q@6' ,4&C@##!I8 P0:=
M +\&I@"]!K  NP>\ +D(S0"X"N4 M0OW +,-_P"Q#?\ L W_ + ._P"O#O\
MKP[_ /\>  #_&P  _QL  /H:  #U%@4 ]A$- .L.%0#B"R( V LQ - ,/@#+
M#4H QPU5 ,0.7@#!#F8 OPYM +T.= "[#WL N0^" +<0B@"V$)$ M!": +(0
MHP"P$:T KQ&Z *T1R@"J$N4 IQ3W *45_P"C%?\ HA7_ *(5_P"B%?\ HA7_
M /\B  #_(   \",  .8D  #@(0  W!D% -L0# #0$1D R!,I ,(5-P"]%D0
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M H8LN@*%+<X#@R[J X$N_ . +O\"?R[_ G\N_P)^+O\"?B[_ O0N  #D-P
MTCT  ,4_  "[/P  M#P  *\U  "I+PL HR\7 )XQ)@"9,C, EC(^ )(S2 "0
M,U  C3-8 (LS7@&),V4!AS-L 88S<P&$,WP"@C.% H SCP-_,YH#?3.G WPS
MM01Z,\D$>33F!'<U^01V-?\#=37_ W4U_P-U-?\#=37_ _ S  #=/0  RD,
M +Y%  "U1@  K4,  *8]  "@-@8 F383 )0X(0"0.2X C#DY (DY0P"'.4P
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M"&!$\P=@1/\&7T3_!5]$_P1@1/\$8$3_!.!!  #*2@  NU   +!3  "G50
MGE,  )5/  "+20  @T<+ 'U'%0!Y1R( =D@N '-(. !Q2$$ ;DA) 6Q(4 %J
M2%8!:$A= F9'9 )E1VP#8T=V!&%'@ 5@1XT&7D>:!UQ'J0A;2+L(6DC4"%I(
M\0=:2?\&6DG_!5I(_P5:2/\$6DC_!-M$  #&30  N%,  *U7  "C60  FE@
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M!DM4_P5+5/\%2U3_!<Q.  "[5P  KEX  *1B  ":9   D60  (9B  !W6P
M;5@  &98# !B6!8 7U@B %U9+ !;638 65D^ %=91@!664T!5%E4 5)96P)1
M66,#3UEL TU9=P1+6(0%25B2!TA8H@='6;,(1EG*"$59Z@A&6?T&1EC_!D98
M_P5'6/\%1UC_!<=2  "X6P  JV$  *%F  "8:   CFD  (-G  !R8   :%X
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M!+E@  "L:0  H7   )AU  "-=P  @G<  '=W  !I=   7',  %%Q  !(< H
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M "&&E0 @AJ<!'H:\ 1Z&W@ >A/4!'H+_ 1Z"_P$>@?\!'H'_ :AT  ">?0
MDX(  (F%  !^B   <8H  &6+  !8C   3(T  $".   VC@  +(\  "60#  C
MD!, (I < "&0)0 @D2X 'Y$V !Z10  =D4D ')%4 !J18  9D6X &)%^ !:2
MD  5DJ0 %)&Y !.1V  3C_0 %([_ !2-_P 4C/\!%(S_ :-]  "8@P  CH@
M (2,  !WCP  :9$  %V3  !0E0  19<  #F8   NF0  )9H  !V; @ 6G0P
M%9T3 !2=&P 3G20 $ITM !&>-P 1GD$ $)Y,  ^>6  .GF< #9YW  R>B@ +
MG9X "IVR  F=S  )G.P "IO^  N:_P +F?\ "YG_ )R$  "1B@  B(X  'N2
M  !ME@  8)D  %2<  !(GP  /*   #"A   FHP  ':4  !6G   0J04 "ZL-
M  BJ$P 'JAL !JHD  6J+@ $JC@  JI$  &J4   JEX  *IN  "J@0  JI4
M *FJ  "IP0  J.0  *CV  "G_P  I_\  *?_ )6+  ",D   ?Y4  '&:  !C
MG@  5J(  $JF   ]J   ,:H  ":K   =K0  %+    ZR   )M0$  K8*  "V
M#P  MA4  +<=  "W)0  MR\  +@Y  "X1@  N%0  +AD  "X=@  N(L  +>@
M  "WM@  M],  +;O  "V_   MO\  +;_ (^2  ""EP  =)T  &:B  !8IP
M2ZP  #ZO   QL0  )K,  !RV   3N   #;L   :^    P0   ,($  #""P
MPQ   ,05  #$'   Q20  ,8N  #(.@  R4<  ,E7  #):0  R7T  ,F4  #(
MJ@  R,,  ,CD  #(]   R/T  ,C] (69  !WGP  :*8  %JK  !-L0  /[4
M #&X   EN@  &KT  !'    +PP   \<   #*    S0   ,X   #/ P  T D
M -$.  #3$@  U1D  -<B  #:+0  W3D  -Y)  #>6@  WVX  -^%  #?G
MW[(  -[+  #>Y@  W_0  -_T 'FA  !KJ   7*\  $ZU  ! NP  ,;X  "3!
M   9Q0  $,@   G,    SP   -,   #9    W    -T   #?    X0   .(%
M  #D"P  YA   .@6  #J(   [2L  / Z  #Q2P  \5X  /)S  #SBP  \Z(
M /.V  #SR0  \^$  //A &VJ  !>L0  4+D  $&_   RQ   ),@  !?,   .
MT   !M4   #:    W@   .(   #F    Z0   .H   #L    [@   /    #R
M    ] 8  /8,  #Y$@  _!P  /\I  #_.@  _TT  /]B  #_>   _Y   /^C
M  #_LP  _\$  /_! /\'&0#_ 1< _P 7 /\ &@#_ "$ _P K /\ .0#_ $<
M_P!4 /\ 7P#_ &H _P!S /\ >P#_ (, _P"* /\ D #_ )8 _P"; /\ H0#_
M *@ _P"O /\ N #_ ,0 _@#5 /P Z@#[ /@ ^@#_ /D _P#X /\ ^ #_ /8
M_P#S /\ \0#_ /\+%0#_!1, _P 3 /\ % #_ !H _P G /\ - #_ $( _P!/
M /\ 6P#_ &4 _P!N /\ =@#_ 'X _P"% /X BP#] )$ ^P"7 /H G0#X *,
M]P"K /8 LP#T +X \P#, /$ XP#O /, [@#_ .T _P#L /\ ZP#_ .P _P#L
M /\ ZP#_ /\-$0#_"1  _P / /\ $ #_ !8 _P B /\ +P#_ #T _P!* /\
M50#] &  ^@!I /@ <0#V 'D ] !_ /, A@#Q (P [P"2 .X F #L )\ ZP"F
M .D K@#G +@ Y0#% ., V@#A .T WP#[ -X _P#= /\ W0#_ -T _P#= /\
MW0#_ /\/#0#_# L _P,) /\ # #_ !( _P = /\ *0#[ #< ^ !$ /4 4 #R
M %H [@!C .P :P#I ', YP!Z .4 @ #C (8 X0", -\ DP#= )D VP"A -D
MJ0#5 +( T@"^ -  S@#. .8 S #V ,H _P#* /\ R0#_ ,@ _P#( /\ R #_
M /\1" #_#0( _P<  /\%" #_  X _P 6 /< (@#O #  ZP ] .@ 20#D %0
MX != -T 90#9 &T U0!S -( >@#0 (  S@"' ,P C0#* )0 R "; ,8 I #$
M *T P@"X ,  QP"] -\ O #Q +L _@"Y /\ N #_ +@ _P"X /\ N #_ /\4
M  #_#P  _PT  /\,  #_!PD ^ $0 .@ &@#C "@ W0 V -@ 0@#2 $T S@!7
M ,H 7P#' &8 Q0!M ,, = #! 'H OP"! +T B "[ (\ N0"7 +< GP"U *@
MLP"S +$ P@"O -@ K@+M *P#^P"K!?\ J@;_ *D&_P"I!O\ J0;_ /\6  #_
M$@  ]Q(  .P1  #F#@  Y08( -T#$@#4 R  S00M ,@$.@##!48 OP50 +P&
M6 "Y!F  MP=G +4';@"S!W4 L0A[ *\(@@"N"8H K F2 *H)FP"H"J4 I@JP
M *4+OP"C#-0 H0WM )\._@"=#O\ G __ )L/_P";#_\ FP__ /\:  #W&0
MZAX  -\>  #5&@  T!," ,X,"P#'"Q8 P TE +H.,@"V#C\ L@]) *\04@"L
M$%H JA!A *@1: "F$6\ I!%V *(1?0"A$84 GQ*. )T2EP"<$J( FA.M )@3
MO "7%-  E!7L )(6_0"0%_\ CQ?_ (X7_P".%_\ CA?_ /H=  #N(P  WR@
M - J  #')P  P2$  +T9!0"Y$A  LA4> *T6+ "H%S@ I!A# *$93 "?&50
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M G$N] )P+_\";R__ F\O_P%N+_\!;B__ >@Q  #3.@  PS\  +=!  "N00
MICX  )XX  "7,0$ D2X0 (PO' "(,"@ A#$S ($R/0!_,D8 ?3)- 'LR5 !Y
M,EL =S)A '4R:0%T,G !<C)Y 7 SA %O,Y ";3.= FPSJP)J-+P":335 V@U
M\0)G-?\"9S7_ F8U_P)F-?\"9C3_ N(V  #,/P  O40  +)'  "H1P  H$0
M )@_  "0.0  B#0- (,U%P!_-B0 ?#<O 'DW.0!W.$( =#A) '(X4 !Q.%<
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M U1#_P-40_\"5$/_ M!"  "_2@  LE   *=3  "=5   E%,  (I0  !_2@
M=44" &Y##@!K1!D 9T4D &5%+@!B13< 844_ %]%1@!=14T 6T54 %I&6P%9
M1F,!5T9L E9&=P)41H,#4T:1 U%&H0101[$$3T?'!$Y'YP1.1_L$3D?_ TY'
M_P-/1_\#3T?_ \Q&  "[3@  KU0  *17  ":6   D5<  (94  ![3@  <$H
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M \!0  "R6   IEX  )QB  "290  B&4  'UB  !N7   8UD  %E6 P!45@X
M4588 $]6(@!-5RP 3%<T $I7/ !)6$0 2%A+ $=84P!%6%L!1%AD 4)8;@%
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M 3%EE0(P9:<"+V6[ BYEV@(N9/0"+F/_ B]C_P(O8O\"+V+_ K->  "G9@
MG&T  )-Q  "(<P  ?7,  ')R  !D<   6&X  $UL  !":@, /&D. #IJ%@ Y
M:B  .&HH #9K,0 U:SD -&M! #-L20 R;%( ,6Q< "]L9@ N;', +&R" 2IL
MDP$I;*4!*&RY 2=MU@$G:_(!)VK_ 2=J_P$H:?\"*&G_ JYD  "C;   F7,
M (YV  "$>   >7D  &UX  !@=P  4W8  $AU   ^<P  -'(* #%S$0 P<QH
M+W,C "YS*P M=#0 +'0\ "MT1  I=$T *'57 "=U8P E=6\ )'5_ ")UD  A
M=:( ('6W !]UT@ ?=/$ 'W/_ 1]R_P$@<?\!(''_ :EK  "><P  E'D  (I\
M  " ?@  ='\  &=_  !:?P  37X  $-^   X?0  +WT" "A]#0 F?10 )'T<
M "-^)0 B?BT (7XV "%^/P ??T@ 'G]2 !U_7@ <?VL &G]Z !E_C  7?Y\
M%G^S !5_S@ 5?N\ %GS_ !9[_P 6>_\ %WO_ *1R  ":>@  CW\  (6"  ![
MA   ;88  &"'  !4AP  2(@  #R(   RB   *(@  ""(!0 :B0X &8D5 !B)
M'0 7BB8 %HHN !6*-P 4BD$ $XI, !*+6  1BV4 $(MU  ^+AP .BIL #8JO
M  R*R  ,B>H #8?\  Z'_P .AO\ #H;_ )][  "4@0  BH4  ("(  !SBP
M98T  %F/  !,D   09(  #22   JD@  (9,  !F4   2E@8 #I<.  V7%0 ,
MEQT #)<F  N7+P *ESD "9=$  B74  &EUX !9=N  .6@  !EI0  )6H  "5
MO@  E.   )3T  "3_P !DO\  9+_ )B"  ".B   A8P  '>/  !JD@  794
M %"8  !$F@  .)L  "R<   BG0  &9X  !*@   -H@( !Z,+  &C$   HQ<
M *,?  "C)P  HS$  *0\  "D2   I%8  *1E  "C=P  HXL  *.@  "BM@
MH=(  *'P  "@^P  H/\  *#_ )&*  ")C@  >Y(  &V7  !@FP  4YX  $:A
M   YHP  +:0  ".F   9J   $:H   RL   %K@   *\'  "O#0  KQ$  + 8
M  "P(   L2@  +$R  "R/@  LDP  +);  "R;   LH$  +&7  "QK   L,8
M +#H  "O]P  K_\  *__ (R0  !_E0  <9H  &.?  !5I   1Z@  #JJ   M
MK   (JX  !BP   0LP  "K4   *X    NP   +L   "\!P  O T  +T1  "^
M%@  OQX  , G  #!,@  PD   ,-/  ##8   PW0  ,.+  ##H0  P[@  ,+7
M  #"[P  POH  ,'^ (&7  !SG0  9:,  %>H  !)K0  .[$  "VS   AM@
M%KD   Z[   'O@   ,$   #%    QP   ,@   #)    R@4  ,L+  #-#P
MSA0  - <  #3)@  UC(  -A!  #84P  V68  -E\  #9E   V:L  -G#  #9
MX0  V?   -GT ':?  !GI@  6:P  $NR   \MP  +KH  "&]   5P   #<0
M  7'    R@   ,X   #2    U0   -8   #9    VP   -T   #?!P  X0P
M .,1  #F&0  Z20  .PR  #M0P  [E8  .]K  #OA   [YP  .^R  #OQ@
M[]T  ._D &JH  !;KP  3+8  #Z\   OP   (,0  !3(   ,S    M    #4
M    V0   -X   #B    Y0   .8   #H    Z0   .P   #N    \ (  /()
M  #U#P  ^!<  /PC  #_,P  _T8  /]:  #_<0  _XD  /^?  #_L0  _\
M /_& /\ %0#_ !0 _P 4 /\ %P#_ !T _P H /\ -P#_ $0 _P!1 /\ 7 #_
M &8 _P!O /\ =P#_ 'X _P"% /\ BP#_ )$ _P"7 /\ G0#_ *0 _P"K /\
MM #^ +\ _0#. /L Y@#Y /8 ^ #_ /< _P#W /\ ]P#_ /  _P#L /\ Z0#_
M /\#$@#_ !  _P 0 /\ $0#_ !< _P D /\ ,@#_ #\ _P!, /\ 5P#_ &$
M_P!J /\ <@#_ 'D _0"  /P A@#Z (P ^0"2 /@ F #V )\ ]0"F /0 K@#R
M +D \ #& .X W@#M /  ZP#^ .H _P#I /\ Z0#_ .< _P#C /\ X #_ /\'
M#@#_  T _P + /\ # #_ !, _P ? /\ + #_ #H _P!& /X 4@#[ %P ^ !E
M /4 ; #S '0 \0!Z .\ @0#N (< [ "- .H DP#I )H YP"A .8 J0#C +,
MX0"_ -\ T #= .D V@#Y -D _P#7 /\ U0#_ -4 _P#5 /\ U #_ /\)"@#_
M 04 _P # /\ "0#_ !  _P 9 /L )@#W #0 ] !  /( 3 #N %8 Z@!? .<
M9P#D &X X@!T .  >P#> ($ W "' -H C0#6 )0 U "; -$ HP#/ *T S "X
M ,H QP#( .  Q@#S ,4 _P## /\ PP#_ ,, _P## /\ PP#_ /\+ 0#_ P
M_P   /\  P#_  L \P 2 .X 'P#J "T Y@ Z .( 10#> $\ V0!8 -0 8 #1
M &@ S@!N ,P = #* 'L R "! ,8 AP#$ (X P@"6 ,  G@"^ *< NP"R +D
MP "W -0 M0#L +, ^P"S /\ L@#_ +( _P"Q /\ L0#_ /\-  #_!@  _P,
M /<   #T  , YP - .  & #: "4 TP R ,X /@#* $D Q@!2 ,, 6@#  &$
MO@!H +P ;@"Z '0 N ![ +8 @0"T (@ L@"0 +  F0"N *( K "M *H N@"H
M ,L I@#F *4 ]P"D /\ HP#_ *( _P"B /\ H@#_ /\0  #[#   [PX  .8-
M  #?"0  V@ & -  $0#) !T Q  J +\ -P"[ $( MP!+ +0 5 "R %L KP!B
M *T : "K &X J0!U *@ >P"F (, I "+ *( E "@ )X G@&H )P"M0"; \8
MF07B )@&] "6"/\ E0G_ )0)_P"4"?\ E G_ /P1  #Q%0  XQD  -89  #,
M%0  QQ   ,0'"@"] Q0 MP0A +(&+@"N"#H J@E$ *<)30"D"E4 H@I< * *
M8@">"VD G MO )L+=@"9#'X EPR& )8,D "4#)H D@VF )$-LP"/#<4 C0[B
M (L0]@")$/\ B!'_ (<1_P"'$?\ AQ'_ /89  #G(   UB0  ,@E  "_(@
MN1P  +04 0"Q#0X J@X9 *4/)P"A$#, G1$^ )H11P"8$D\ E1)6 ),27 "1
M$F, D!-I (X3< ",$W@ BQ.! (D4BP"'%)8 AA6B (05L "#%L$ @1?= '\8
M] !]&?\ ?!G_ 'P9_P![&?\ >QG_ .\A  #=*0  RBT  +XO  "U+   KB<
M *@@  "C%P@ GA83 )D7(0"4&2T D1HX (X:00"+&TD B1M0 (<;5P"%'%X
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M 6 O_P%@+_\!8"[_ =HT  #%/   MT$  *Q#  "B0P  F4   ) Z  "(-
M@"X( 'HM$@!W+AX <R\I '$P,P!O,#L ;3!# &LQ2@!I,5$ 9S%7 &8Q7@!D
M,68 8S)O &$R>0!@,H4!7S*2 5TSH0%<,[$!6S3& 5HTY@%9-?L!637_ 5DT
M_P%9-/\!633_ =(X  # 0   LT4  *A(  ">2   E48  (M   "".P  >34$
M ',S$ !O-!H ;#0E &DU+P!G-3< 938_ &,V1@!B-DT 8#94 %\V6P!=-V,
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M/10 7ST> %P^* !:/C$ 6#XX %<^0 !5/T8 5#]- %,_50!20%T 4$!F $]
M< %.0'P!3$&* 4M!F@)*0:L"24*^ DA"W@)(0O8"2$+_ DA"_P%(0?\!2$'_
M <5$  "U2P  J5   )Y4  "55   BU,  (!0  !U2@  :D8  &%"" !<01$
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M 3Q.E $[3J4!.4^Y CE/U (Y3_(!.4[_ 3E._P$Y3?\!.DW_ ;I.  "L5@
MH5L  )=?  "-80  @V$  'A>  !I6   7U8  %12  !,3PL 24\2 $=0' !%
M4"4 0U M $)0-0!!43P 0%%$ #]13  ^4E0 /%)= #M29P Z4G, .%." 3=3
MD@$U4Z0!-%.W 3-4T0$S4_$!-%/_ 312_P$T4O\!-%+_ ;92  "I6@  GF
M )1D  "+9@  @&4  '1C  !F7@  7%P  %%8  !'50< 0E40 $!5&  _5B$
M/58J #Q6,@ [5CD .E=! #E720 X5U$ -UA: #5890 T6'$ ,EB  3%8D $O
M6:(!+EFU 2U9SP$M6>\!+EC_ 2Y7_P$N5_\!+E;_ ;)7  "E7P  FV4  )%I
M  "':@  ?&H  '%H  !C90  6&(  $U?  !#70( /%L- #I<%  X7!T -UPF
M #5=+@ T738 ,UT^ #)=1@ Q7DX ,%Y7 "]>8@ M7FX +%]] "I?C@ I7Z
M*%^S 2=?S  G7^T!)U[_ 2==_P$H7?\!*%S_ :U<  "B9   F&H  (YN  "#
M;P  >6\  &YN  !@:P  5&D  $EG   _90  -6,) #)C$0 P8QD +V0A "YD
M*0 M9#$ +&0Y "ME0@ J94H *&54 "=E7P F9FL )&9Z "-FBP B9IT (&:Q
M !]FR0 ?9NL (&7^ "!D_P @8_\!(6/_ :EB  ">:@  E7   (IS  " =0
M=74  &ET  !<<@  3W$  $1O   Z;@  ,&T# "EL#0 G;!0 )FP< "5M)  D
M;2P (VTT ")M/0 A;D8 (&Y0 !YN6P =;F< '&YV !INAP 9;YH &&^N !9O
MQ@ 6;ND %VW\ !AL_P 8:_\ &&O_ *1I  ":<0  D'8  (9Y  !\>P  <7L
M &1[  !7>@  2GD  #]X   U>   *W<  ")V!P ==@\ ''<6 !MW'@ :=R8
M&7<N !AW-P 7>$  %7A* !1X5@ 3>&, $GAR !%X@P 0>)< #WBK  YXPP .
M=^8 #G;Z  ]U_P 0=?\ $'3_ )]Q  "5>   BWP  ()_  !W@0  :H(  %V"
M  !0@@  1((  #B"   N@@  )((  !R"   4@@D $8,0 !"#%@ 0@QX #H,G
M  Z#,  -@SD #8-$  R#4  +@UT "8-L  B#?@ &@Y$ !8*E  ."NP $@=L
M!('R  6 _P &?_\ !G__ )IY  "0?@  AH,  'V%  !OAP  8HD  %6*  !)
MBP  /8P  #&,   FC   '8T  !6.   /CP, "I ,  :0$0 $CQ@  X\@  &/
M*0  CS(  ) ]  "020  CU8  (]E  "/=@  CXH  (Z?  ".M   C<\  (SN
M  ",^P  B_\  (O_ )2   "+A0  @HD  '2,  !FCP  69$  $R3  ! E0
M-)8  "B6   >EP  %9@   ^:   *FP   IP)  "<#@  G!,  )P:  "<(@
MG2L  )TU  "=0   G4X  )U<  "=;@  G($  )R7  "<K   F\8  )KH  "9
M^0  F?\  )C_ (Z(  "&C   >)   &J4  !<EP  3YH  $*=   VG@  *9\
M !^A   5H@  #J0   BF    J    *D$  "I"@  J0X  *D3  "J&@  JB(
M *LK  "L-@  K$0  *Q3  "L8P  K'<  *N.  "KI   J[P  *K>  "I]
MJ?T  *G_ (F.  ![DP  ;9<  %^<  !1H   1*0  #:F   JJ   'JD  !2K
M   -K@  !K    "R    M0   +4   "U P  M@D  +<.  "X$@  N!D  +HA
M  "[*P  O#@  +U'  "]6   O6L  +V!  "]F0  O;   +W,  "\Z@  O/<
M +O^ 'Z5  !PFP  8J   %.E  !&J@  .*T  "JO   >L0  $[0   RW   #
MN0   +P   "_    P@   ,(   ##    Q    ,8&  #'#   R!   ,H6  #,
M(   SRL  - Z  #12P  T5X  -)S  #2BP  TJ0  -.[  #3V   T^T  -/V
M '.=  !DHP  5JD  $>O   YLP  *K8  !VY   2O   "K\   ##    Q@
M ,D   #-    SP   -    #2    U    -8   #9 @  VP@  -X.  #A$P
MY!T  .@J  #H/   Z4\  .ED  #J?   ZY4  .NL  #KP@  [-4  .SE &:F
M  !8K   2;,  #NY   KO   '<   !'$   )R    ,P   #/    TP   -D
M  #=    X    .$   #C    Y0   .<   #J    [    .X$  #Q"P  ]1(
M /@<  #[*P  _3X  /Y3  #^:@  _X,  /^;  #_K@  _[X  /_* /\ $@#_
M !  _P 1 /\ $P#_ !D _P F /\ - #_ $$ _P!- /\ 6 #_ &( _P!K /\
M<P#_ 'H _P"! /\ AP#_ (T _P"3 /\ F0#_ *  _P"G /X KP#\ +H ^@#)
M /D X0#X /, ]P#_ /8 _P#U /\ \0#_ .D _P#D /\ X0#_ /\ #P#_  T
M_P - /\ #@#_ !0 _P A /\ +@#_ #P _P!( /\ 4P#_ %T _P!F /X ;0#\
M '4 ^P![ /D @@#X (@ ]P". /8 E #T )L \P"B /$ J@#O +0 [0#! .L
MU0#J .P Z #\ .< _P#E /\ Y@#_ .  _P#9 /\ U #_ /\ "P#_  @ _P &
M /\ "0#_ !  _P < /\ *0#_ #8 _P!" /L 3@#W %< ] !@ /( : #O &\
M[0!V .P ? #J (( Z "( .< C@#E )4 XP"< .$ I #? *X W0"Y -H R@#7
M .0 U #V -$ _P#0 /\ T #_ ,\ _P#+ /\ QP#_ /\  P#_    _P   /\
M! #_  T ^@ 6 /8 (P#S #  \  \ .T 1P#I %$ Y0!: .( 8@#? &D W0!O
M -H =@#8 'P U "" -( B #0 (\ S0"6 ,L G@#) *@ QP"S ,4 P0#" -@
MP #O +\ _@"^ /\ O0#_ +P _P"\ /\ O #_ /\"  #_    _P   /\   #T
M  < [0 1 .@ ' #C "D WP U -L 00#6 $L T0!4 ,T 7 #* &, R !I ,8
M;P## '4 P0![ +\ @@"^ (@ O "0 +H F "X *( M0"L +, N0"Q ,L KP#G
M *X ^ "L /\ JP#_ *P _P"L /\ JP#_ /\$  #_    ]@   .X   #G
MWP , -8 %0#/ "( R@ N ,< .@## $0 P !- +P 50"Y %P MP!C +4 :0"S
M &\ L0!U *\ >P"M (( JP"* *D D@"G )P I0"F *, LP"A ,, GP#> )X
M\@"= /\ G #_ )P _P"; /\ FP#_ /\'  #V"0  Z0L  -\*  #5!   S@ %
M ,8 $ #  !H NP G +< ,@"S #T L !& *T 3P"J %8 J !< *8 8P"D &@
MH@!O *$ =0"? 'P G0"$ )L C0"9 )< EP"B )4 K@"3 +T D0#3 )  [0"/
M /P C@#_ (T!_P"- ?\ C0'_ /D.  #J$@  W!4  ,T5  #$$0  O@P  +H"
M"@"T !( K@ > *H *@"F #4 H@ _ *  2 "= 5  FP)6 )D"7 "7 V, E0-I
M ),#;P"1!'8 D 1_ (X%B ",!9( B@:> (@&J@"&![H A0C/ (0*ZP"""_P
M@0S_ ( ,_P" #/\ @ S_ /$5  #@'0  S2   ,$A  "X'0  L1<  *P0  "H
M"0T H@<6 )T)(P"9"BX E0LX ),,00"0#$D C@U0 (P-5P"*#5T B UC (<-
M:@"%#G$ @PYZ ((.A " #H\ ?@^; 'P/J ![$+@ >A#. '@1[ !V$O\ =1+_
M '03_P!T$_\ =!/_ .@>  #3)@  PRH  +@J  "N*   IR,  * <  ";$P,
ME@\0 ) 0&P",$2< B1(R (83.P"$$T, @A1+ ( 440!^%%< ?!1> 'L590!Y
M%6P =Q5T '86?@!T%HH <A>6 '$7I !O&+0 ;AC) &T9Z !K&OP :AO_ &H;
M_P!J&_\ :AO_ . F  #*+0  O#$  + S  "G,0  GRP  )<F  "0'P  BA<,
M (48%@"!&2( ?AHL 'L;-@!Y&SX =QQ% '4<3 !S'%, <1U9 ' =8 !N'6<
M;1YP &L>>@!J'H4 :!^2 &<?H !E(+  9"'% &,AY !B(OH 82+_ &$B_P!A
M(O\ 82+_ -<L  ##-   MC@  *HY  "A.   F#4  ) O  "(*   @"$( 'L@
M$@!W(1T ="(G '$B,0!O(SD ;2-! &LC2 !I(TX :"15 &8D6P!E)&, 8R5K
M &(E=0!A)8$ 7R:. %XFG0!=)ZT 6RC! %LHX !:*?< 62G_ %DI_P!9*?\
M62C_ ,\R  "^.0  L3T  *8_  "</P  DSP  (HV  "!,   >2H# '(F#P!N
M)QD :R@C &DH+ !F*34 92D\ &,I0P!A*DH 8"I1 %XJ5P!=*E\ 7"MH %HK
M<@!9+'T 6"R+ %8MF@!5+:H 5"Z] %,NW !2+_4 4B__ %(N_P!2+O\ 4B[_
M ,HV  "Z/0  K4(  *)$  "81   CT$  (4\  ![-P  <C$  &LL# !G+14
M9"T? &$N* !?+C$ 72XY %PO0 !:+T8 6"]- %<O5 !6,%P 53!D %,Q;@!2
M,7H 43&( % REP!.,J@ 33.[ $TTV !,-/, 3#3_ $PT_P!,,_\ 3#/_ ,8Z
M  "V0@  J48  )Y)  "520  BT<  (%"  !W/0  ;3<  &0R"0!@,A( 73(<
M %HR)0!8,RT 5C,U %4S/ !3-$, 4C1* %$T40!0-%D 3S5A $TU; !,-G<
M2S:% $HWE0!(-Z8 1SBX 4<XTP%&./$!1CC_ 48X_P!&./\ 1C?_ ,$^  "R
M10  IDH  )Q-  "230  B$L  'Y'  !S0@  :3T  %\W!@!:-A  5S<8 %0W
M(@!2-RH 4#<R $\X.0!-.$  3#A' $LX3@!*.58 23E? $@Z:0!'.G4 13N#
M $0[DP!#/*0!0CRV 4$]T %!/? !03W_ 4$\_P%!//\!03S_ +Y"  "O20
MHTX  )E0  "/40  A5   'M,  !O1@  94(  %H] @!4.PX 43L5 $\['P!-
M.R< 2SLO $D\-@!'/#T 1SQ$ $8]2P!%/50 1#Y< $,^9P!"/W, 0#^! #\_
MD0 ^0*( /4"U 3Q!S@$\0>X!/$'_ 3Q _P$\0/\!/3__ ;I%  "L3   H5$
M )=4  "-50  @U0  'A1  !L2P  84<  %9"  !/0 P 3#\3 $E ' !'0"0
M1D L $1 ,P!#0#H 0D%" $%!20! 0E$ /T): #Y#90 ]0W$ .T-_ #I$CP Y
M1*  .$6S 3=%RP$W1>P!-T7_ 3=$_P$X1/\!.$/_ +=)  "I4   GE4  )18
M  "+60  @%@  '96  !H4   74P  %-(  !*10D 1D01 $1$&0!"1"( 044I
M #]%,0 ^13@ /44_ #Q&1P [1D\ .D=8 #E'8@ X2&X -DA\ #5(C0 T29X
M,TFQ #))R0 Q2>L ,DG^ #)(_P R2/\ ,TC_ +1,  "G5   G%D  ))<  "(
M70  ?ET  '-:  !E50  6U(  %!.  !&2@4 0$D. #Y)%@ ]21X .THF #I*
M+@ Y2C4 .$L] #=+1  V2TT -$Q6 #-,8  R3&P ,4UZ #!-BP N39P +4ZO
M "Q.QP L3ND +$W] "U-_P M3/\ +4S_ +!0  "D6   F5T  (]A  "&8@
M>V$  '!?  !B6P  6%@  $Y5  !#40$ .T\, #A/$P V3QL -4\C #10*P S
M4#( ,E Z #%00@ P44H +E%3 "U270 L4FD *U)X "E2B  H4YH )U.M "93
MQ0 F4^< )E/\ "=2_P G4?\ )U'_ *Q5  "@7   EF(  (UF  "#9P  >&8
M &UE  !@80  55X  $I;   _6   -58( #%5$  P5A< +E8? "U6)P L5B\
M*U<V "I7/@ I5T< *%=0 "986@ E6&< )%AU "-9A@ A69@ (%FK !]9P@ ?
M6>4 'UCZ "!8_P @5_\ (5?_ *A:  "=8@  DV<  (IK  !_;   =6P  &IK
M  !=:   464  $9C   [8   ,5X# "I=#0 H71, )ET; "5>(P D7BH (UXR
M ")>.@ A7D, (%], !]?5P >7V, '&!Q !M@@@ 98)4 &&"I !=@P  68.(
M%U_Y !A>_P 97O\ &5W_ *1@  "9:   D&X  (9P  !\<@  <G(  &9Q  !8
M;@  3&P  $%K   V:0  +6<  "-F"  ?9@\ '685 !QF'0 ;9B4 &F8M !EG
M-0 89SX %V=( !9G4P 5:%\ $VAN !)H?P 1:)( $&BF  ]HO0 .:.  $&?W
M !!F_P 19?\ $67_ )]G  "6;P  C',  ()V  !X>   ;7@  &!W  !3=@
M1G0  #MS   Q<@  )W$  !YQ   6< H $W 0 !-P%P 2<!\ $7$G !!Q+P 0
M<3@ #G%"  YQ3@ -<5L #'%I  MQ>@ *<8T "'&A  9QM@ &<-( !W#O  AO
M_P );O\ "6[_ )MO  "1=0  AWD  'Y\  !T?@  9GX  %E^  !-?@  0'T
M #5]   J?   (7P  !A\   1? 0 #'P,  I\$0 )?!D "'PA  =\*0 &?#(
M!'P]  -\2  !?%4  'QC  !\=   ?(<  'N<  ![L0  >LL  'GK  !Y^@
M>?\  'C_ )9W  ",?   @X   'F#  !LA   7H4  %&&  !%AP  .8<  "V'
M   CAP  &H<  !*'   -B $ !HD*  &)#P  B10  (@;  "((P  B2P  (DV
M  ")0@  B$X  (A=  "(;0  B($  (>5  "'JP  AL0  (7F  "$^   A/\
M (3_ )!^  "'@P  ?H<  '&)  !CBP  5HT  $F/   \D0  ,)$  "21   :
MD@  $I,   V4   &E0   )8&  "6#   E1   )85  "6'0  EB0  )8N  "6
M.0  ED8  )95  "690  EG@  )6.  "5I   E+P  )/?  "3]0  DO\  )+_
M (N&  "#B@  =8T  &>0  !9E   3)<  #^9   RF@  )IL  !N<   2G0
M#)\   2@    H@   *,!  "C!P  HPP  *,0  "D%0  I!P  *4E  "F+P
MICP  *9+  "F6P  IFX  *6$  "EFP  I+,  */0  "C[P  HOP  *+_ (:-
M  !XD0  :I4  %R9  !.G0  0:   #.B   FHP  &Z4  !&G   *J0   :L
M  "M    KP   +    "P    L 4  +$+  "R#P  LQ0  +0;  "U)   MS
M +<_  "W4   MV(  +=X  "WD   MJD  +;"  "VY   MO4  +7^ 'N3  !M
MF   7YT  %"B  !"I@  -*D  ":K   :K0  $*\   FR    M    +<   "Z
M    O    +T   "^    O@   , "  #!"   P@T  ,02  #&&0  R20  ,HR
M  #+0P  RU4  ,QJ  #,@P  S)P  ,NU  #,S@  S.D  ,SV '";  !AH0
M4J8  $2K   VL   )[(  !JU   0N   ![L   "^    P0   ,0   #(
MRP   ,L   #-    S@   -    #2    U0,  -@*  #;$   WA@  .(D  #C
M-0  Y$@  .5<  #F<P  YHT  .:E  #FO   YM,  .?G &.D  !5J@  1K
M #BU   HN0  &KP   _    %Q    ,<   #+    SP   -0   #8    W
M -T   #?    X0   .,   #E    Z    .H   #M!@  \0X  /46  #X)0
M^3@  /E-  #Z8P  ^WP  /R5  #\J@  _+L  /W+ /\ #P#_  X _P . /\
M$ #_ !8 _P C /\ , #_ #T _P!) /\ 5 #_ %X _P!F /\ ;@#_ '8 _P!\
M /\ @@#_ (D _P"/ /\ E0#^ )L _0"C /L JP#Z +4 ^0## /< VP#V /
M] #_ /, _P#R /\ [ #_ .( _P#< /\ U@#_ /\ # #_  D _P ( /\ "@#_
M !( _P > /\ *P#_ #@ _P!$ /\ 3P#_ %D _@!A /P :0#Z '  ^ !W /<
M?0#V (, ] ") /( CP#Q )8 [P"= .T I0#L *\ Z@"\ .@ S0#F .@ Y #Z
M ., _P#B /\ X #_ -4 _P#. /\ RP#_ /\ !@#_  $ _P   /\ ! #_  X
M_P 9 /\ )0#] #( ^P ^ /< 20#S %, \ !< .X 8P#L &H Z@!Q .@ =P#F
M 'T Y "# .( B0#@ )  W@"7 -P GP#9 *D U@"T -, Q #0 -X S@#S ,P
M_P#+ /\ R@#_ ,@ _P#" /\ O@#_ /\   #_    _P   /\   #[  L ]@ 3
M /$ ( #M "P Z@ X .< 0P#C $T X !6 -P 70#9 &0 U0!K -( <0#0 '8
MS@!\ ,P @P#* (D R "1 ,8 F0#$ *, P0"M +\ NP"] ,\ NP#K +D _ "W
M /\ MP#_ +8 _P"T /\ L0#_ /\   #_    _P   /8   #N  4 YP / .$
M&0#; "4 U0 Q -( / #. $8 R@!/ ,< 5P#$ %X P0!D +\ :@"] '  NP!V
M +D ? "X (, M@"* +, DP"Q )P KP"G *T LP"K ,4 J0#A *< ]0"F /\
MI0#_ *0 _P"D /\ I #_ /\   #\    \0   .@   #@    U  + ,P $P#'
M !\ P@ J +\ -0"\ #\ N !( +4 4 "S %< L !> *X 9 "L &D JP!O *D
M=0"G 'P I0"$ *, C "A )8 GP"A )T K0": +P F #2 )< [@"5 /X E #_
M )4 _P"5 /\ E0#_ /P!  #P!0  XP<  -4%  #,    Q0 $ +X #@"X !<
MLP C *\ +@"K #@ J0!! *8 2@"C %$ H0!7 )\ 70"= &, FP!I )H ;P"8
M '8 E@!] )0 A@"2 )  D "; (X IP", +8 B@#) (@ YP"' /D AP#_ (8
M_P"& /\ A@#_ /0,  #D$   T1(  ,41  "]#@  M@@  +$ " "K !$ I@ ;
M *$ )@"> #$ F@ Z )@ 0P"5 $H DP!1 )$ 5P"/ %T C@!C (P :0"* '
MB !W (8 @ "$ (L @@"6 (  HP!^ +$ ?0#$ 'L"X0!Z _4 >@7_ 'D%_P!X
M!O\ > ;_ .H3  #6&@  QAT  +H<  "Q&0  JA,  *0-  "?!0P F0 4 )4
M'P"1 BD C0,S (L$/ "(!40 A@9+ (0&40""!U< @0== '\'8P!]"&H >PAR
M 'H(? !X"88 =@F2 '0*H !S"J\ <0O! ' ,WP!O#?8 ;@[_ &T._P!M#O\
M;0[_ .$<  #+(P  O"8  +$F  "H)   H!X  )D8  "3$ ( C@L. (@+%P"$
M#"( @0TL 'X--0!\#CT >@Y% '@.2P!W#E$ =0]8 ',/7@!Q$&4 <!!N &X0
M=P!L$(( :Q"/ &D1G0!H$:T 9A+  &42WP!D$_8 8Q3_ &,4_P!B%/\ 8A3_
M -8D  ##*@  M2X  *HO  "@+0  F"@  ) B  ")&P  @A,( 'T1$@!Y$AP
M=A,G ',4, !Q%#@ ;Q4_ &T51@!L%4P :A93 &@660!G%F$ 919I &07<@!B
M%WX 81B+ %\8F0!>&:D 7!F\ %P:V !:&_, 6AS_ %D<_P!9'/\ 61S_ ,TJ
M  "],0  KS4  *0V  ";-   DC$  (DK  "!)0  >1T# ',8#@!O&1@ ;!HB
M &D;*P!G&S, 91P[ &0<00!B'4@ 8!U. %\=50!='5P 7!YD %L>;@!9'WD
M6!^' %8@E@!5(*8 5"&X %,AT@!2(O$ 4B/_ %(C_P!2(O\ 4B+_ ,@O  "X
M-@  JSH  * \  "6.P  C3@  (,R  !Z+0  <B8  &H@# !F(!, 8R$= &$A
M)@!?(B\ 72(V %LB/0!:(T0 6"-* %<C40!5(U@ 5"1A %,D:@!1)78 4"6#
M $\FDP!.)Z, 3">U $PHS@!+*.X 2RG_ $LH_P!+*/\ 2RC_ ,,T  "S.P
MIS\  )Q!  "20   B3X  '\Y  !U,P  ;"T  &,G" !>)A$ 7"89 %DG(@!7
M)RL 52@R %0H.0!2*$  42A& % I30!.*54 32E= $PJ9P!+*G, 22N  $@K
MD !'+*$ 1BVS $4MRP!%+NP 1"[_ $0N_P!%+?\ 12W_ +XX  "P/P  I$,
M )E%  "/10  A4,  'L^  !Q.0  9S0  %XN! !8*PX 52L6 %(L'P!0+"<
M3RPO $TM-@!,+3P 2BU# $DM2@!(+E( 1RY: $8O9 !%+W  0S!^ $(PC0!!
M,9X 0#*Q #\RR  _,^H /S/^ #\R_P _,O\ /S+_ +L\  "M0P  H4<  )9)
M  ",20  @T@  'A$  !M/@  8SD  %HT  !2, P 3S 3 $PP' !*,"0 23$K
M $<Q,@!&,3D 1#%  $,R1P!",D\ 03-8 $ S8@ _-&T /C1[ #TUBP \-IP
M.S:O #HWQ@ Y-^@ .3?\ #HW_P Z-O\ .C;_ +=   "J1@  GDL  )1-  "*
M3@  @$P  '5(  !J0P  8#X  %8Y  !--0D 2301 $<U&0!%-2$ 0S4H $$U
M+P! -38 /S8] #XV10 ]-TT /#=5 #LX8  Z.&L .3EY #@YB0 W.IL -3JM
M #4[Q  T.^8 -#O[ #4[_P U.O\ -3K_ +1#  "G2@  G$X  ))1  "(4@
M?E   '--  !G2   7$0  %(_  !(.@8 1#D/ $$Y%@ _.1X /CDF #PY+0 [
M.C0 .CH[ #D[0@ X.TH -SQ3 #8\70 U/6D -#UW #,^AP Q/ID ,#^K "\_
MP@ O/^0 +S_Z # __P P/O\ ,#[_ +%'  "D30  F5(  (]5  "&5@  ?%4
M '%2  !D3   64D  $]%  !%0 , /SX- #P^$P Z/AL .3XC #<^*@ V/S$
M-3\X #0_0  S0$@ ,D!1 #%!6P P06< +D)U "U"A0 L0Y< *T.J "I#P  I
M1.( *D/Y "I#_P K0O\ *T+_ *Y*  "A40  EU8  (U9  "#6@  >5H  &Y7
M  !A4@  5TX  $U+  !#1P  .D,* #9#$0 T0Q@ ,T,@ #)$)P Q1"\ ,$0V
M "]%/0 M148 +$5/ "M&60 J1F0 *4=R "A'@P F1Y4 )4BH "1(O@ C2.
M)$CW "5'_P E1_\ )D?_ *I/  "?50  E%H  (M>  "!7P  =UX  &M<  !?
M6   554  $M1  ! 30  -4H' #!)#@ N214 +4D= "Q))  K2BL *DHS "A*
M.P G2T, )DM, "5+5@ D3&( (TQP "%,@  @39, 'TVF !Y-NP =3MT 'DWV
M !Y,_P ?3/\ ($O_ *=3  "<6@  DE\  (AC  !^9   =&,  &EA  !<7@
M4EL  $=8   \50  ,E(" "I0#  G3Q( )E 9 "50(  D4"@ (U O ")1-P A
M44  (%%) !Y24P =4E\ '%)M !I3?0 94Y  &%.D !93N0 54]D %E/T !=2
M_P 84?\ &5'_ *-9  "88   CV4  (5H  ![:0  <6D  &9G  !99   36$
M $)?   X7   +EH  "58"  @5PX 'E<4 !U7'  <6", &U@K !I8,P 96#P
M&%A% !994  565L %%EI !-:>@ 26HT $5JA !!:MP .6M4 $%GS !!9_P 1
M6/\ $5C_ )]?  "59@  C&L  ()M  !X;@  ;F\  &)M  !5:@  2&@  #YF
M   S90  *6,  "!A 0 88 L %6 0 !1@%P 38!X $F F !)@+@ 183< $&%
M  ]A2P .85@ #6%F  QB=@ +8HD "F&=  EAL@ (8<L "&'K  E@_0 *7_\
M"U__ )MF  "2;0  B'$  'YS  !U=0  :G0  %QS  !/<@  0W   #AO   M
M;@  )&P  !MK   3:P0 #FH,  UJ$@ ,:AD "VHA  IJ*0 ):C( "&H\  =K
M1P %:U, !&MA  )K<0  :H0  &J8  !JK0  :<8  &GG  !I^   :/\  &C_
M )=M  "-<P  A'<  'MZ  !P>P  8WL  %9Z  !)>@  /7D  #%X   G=P
M'78  !5V   /=@( "78*  1V#P  =A4  '8<  !V)   =2P  '4V  !U00
M=4X  '5<  !U;   =7X  '23  !TJ   <\   '/C  !R]P  <O\  ''_ ))U
M  ")>@  @'X  ':   !I@0  6X(  $Z"  !!@@  -8,  "F"   ?@0  %H$
M !""   *@@   H,'  ""#0  @A$  ((7  ""'@  @B8  ((O  "".P  @D<
M ()5  "!90  @7@  (&-  " H@  ?[H  '_=  !^]   ??\  'W_ (U\  "$
M@0  >X0  &Z&  !@B   4HH  $6+   YC   +(P  "&,   7C   $(T   F.
M   "CP   ) #  "/"0  CPX  (\2  "0&   D!\  ) H  "0,@  D#\  )!-
M  "070  CW   (^%  ".G   CK,  (W0  ",\   B_X  (O_ (B$  " B
M<HL  &2-  !6D   2),  #N5   NE@  (I8  !>7   /F   ")D   ";
MG0   )T   "= P  G0D  )T-  ">$0  GA<  )\?  "?*0  H#4  *!#  "@
M5   H&8  )][  ">DP  GJL  )W&  "=Z0  G/D  )S_ (.+  !UC@  9Y(
M %F6  !+F0  /9P  #">   CGP  %Z    ZB   'I    *8   "H    J@
M *H   "J    JP$  *L'  "L#   K1   *X6  "O'@  L2D  +$X  "Q2
ML5H  +%O  "QB   L:   +"Z  "OW0  K_(  *_] 'B1  !JE@  7)H  $V?
M   _HP  ,:8  ".G   7J0  #JL   6N    L    +(   "U    MP   +<
M  "X    N0   +H   "\ P  O0D  +X.  # %   PQX  ,4K  #%/   QDX
M ,9B  #&>@  QI0  ,:M  #&R   Q>4  ,7S &R9  !>G@  3Z0  $&H   R
MK   )*\  !:Q   -M    [<   "Z    O0   ,    #$    Q@   ,8   #(
M    R0   ,L   #,    S@   - &  #3#0  V!,  -P>  #>+0  WT   .!4
M  #A:P  X84  .&?  #AMP  X<\  .'F &"A  !2IP  0ZT  #2R   EM0
M%[D   V\   !OP   ,,   #'    R@   ,\   #3    U@   -<   #:
MW    -\   #A    XP   .8   #I 0  [ L  / 2  #S'P  ]#$  /9&  #W
M7   ^'0  /B/  #YI@  ^;@  /C) /\ #0#_  L _P + /\ #@#_ !, _P ?
M /\ + #_ #D _P!% /\ 4 #_ %D _P!B /\ :@#_ '$ _P!W /\ ?@#_ (0
M_@"* /T D #\ )< ^@"> /D IP#W +$ ]@"^ /4 T@#S .P \0#^ /  _P#P
M /\ Y@#_ -P _P#2 /\ S0#_ /\ !P#_  0 _P " /\ !@#_ !  _P ; /\
M)P#_ #, _P _ /\ 2@#^ %0 ^P!= /D 9 #W &L ]0!R /, > #R 'X \ "$
M .\ B@#M )$ [ "9 .H H0#H *L Y@"V .0 QP#B ., X #W -X _P#= /\
MV0#_ ,P _P#% /\ P0#_ /\   #_    _P   /\  0#_  T _P 6 /P (@#Y
M "X ]@ Y /, 10#O $X [ !7 .D 7@#F &4 Y !L .( <@#@ '< WP!^ -T
MA #; (L V "2 -4 FP#2 *0 SP"O ,T O@#+ -4 R0#O ,< _P#% /\ Q #_
M +X _P"X /\ M0#_ /\   #_    _P   /X   #W  D \0 1 .L ' #G "@
MY  S .$ /@#= $@ V !1 -, 6 #0 %\ S@!E ,P :P#* '$ R !W ,8 ?0#$
M (0 P@", ,  E "^ )X NP"H +D M@"W ,@ M0#F +, ^@"Q /\ L #_ +
M_P"L /\ J0#_ /\   #_    ^@   /$   #H  , X  - -@ %@#1 "( S0 M
M ,H -P#& $$ P@!* +\ 4@"] %D N@!? +@ 90"W &H M0!P +, =@"Q 'T
MKP"% *T C0"K )< J0"A *< K@"E +X H@#8 *  \@"? /\ G@#_ )X _P">
M /\ G #_ /\   #W    ZP   .$   #6    RP ) ,4 $0"_ !L NP F +<
M,0"T #H L0!# *X 2P"K %( J0!8 *< 7@"F &0 I !I *( < "@ '8 G@!^
M )P A@": )  F "; )8 IP"4 +8 D@#* )  Z0"/ /P C@#_ (T _P", /\
MC0#_ /@   #I @  VP,  ,P!  #$    O0 " +8 #0"P !4 JP @ *< *@"D
M #0 H0 \ )X 1 "< $L F@!2 )@ 6 "6 %T E0!C ), :0"1 '  CP!W (T
M@ "+ (H B0"5 (< H0"% *\ @P#! ($ X "  /4 ?P#_ '\ _P!_ /\ ?P#_
M .X*  #<#@  RA   +X.  "U"P  KP,  *D !P"C !  G@ 8 )D (P"6 "P
MDP U )  /@". $4 C !+ (H 40"( %< A@!= (4 8P"# &H @0!Q '\ >@!]
M (0 >P"/ 'D G !W *H =0"[ '0 U !R /  <@#_ '( _P!Q /\ <0#_ .,1
M  #-%P  OQD  +,9  "J%0  HQ   )T*  "7 0H D0 2 (T &P") "4 A0 O
M (, -P"  #X ?@!% 'T 2P![ %$ >0!7 '@ 70!V &0 = %K '(!= !P G\
M;@*+ &P#F !K Z8 :02W &@%S@!G!^P 9@C] &8)_P!E"?\ 90G_ -8:  #$
M(   MB,  *LC  "A(   F1L  )(4  ",#@$ A@<- ( $% !\!AX >0<H '8(
M, !T"#@ <@D_ ' )10!O"DP ;0I2 &P*6 !J"U\ : MG &<+< !E#'H 8PR'
M &(,E0!@#:0 7PVV %X-S@!<#NT 7 __ %L0_P!;$/\ 6Q#_ ,TA  "\*
MKRL  *0K  ":*0  DB0  (D?  ""&   >Q$% '4-#P!Q#1< ;@XA &L.*@!I
M#S( 9Q Y &400 !D$$8 8Q!- &$04P!?$5H 7A%B %P1:P!;$78 61*# %@2
MD@!6$Z( 51.T %03RP!3%.P 4A7_ %(6_P!2%?\ 4A7_ ,8H  "V+@  J3(
M )\R  "5,0  C"T  (,G  !Z(0  <AH  &L3"P!G$Q, 9!0< &$4)0!?%2T
M714T %P5.P!;%D( 619( %@63P!6%U8 51=> %,79P!2&'( 4!A_ $\9C@!.
M&I\ 3!JP $L;QP!+&^D 2AS] $H<_P!*'/\ 2AS_ ,$M  "Q-   I3<  )HX
M  "0-P  AS0  'TO  !T*0  ;",  &0<!P!>&1  6QH8 %D;(0!7&RD 51LP
M %0<-P!2'#T 41Q$ $\=2P!.'5( 31U: $L>8P!*'FX 21]\ $<?BP!&()P
M12&N $0AQ !#(N8 0R+\ $,B_P!#(O\ 0R+_ +PR  "M.   H3P  )<^  "-
M/0  @SH  'DU  !O,   9BH  %XD @!7( T 5" 4 %$@'0!/(24 3B$L $PA
M,P!+(CH 22)  $@B1P!'(DX 1B-7 $0C8 !#)&L 0B1Y $$EB  _)ID /B:K
M #TGP0 ])^, /2CZ #TH_P ])_\ /2?_ +@V  "J/0  GD   )1"  "*0@
M@#\  '8[  !L-@  8C   %DJ  !1)0L 3241 $LE&0!))2$ 1R8H $4F+P!$
M)C8 0R8] $(G1 !!)TL /RA4 #XH70 ]*6D /"EV #LJA@ Y*Y< ."NI #<L
MOP W+.  -RSX #<L_P W+/\ ."S_ +4Z  "G0   G$0  )%&  "'1@  ?40
M '-   !H.P  7S8  %4Q  !,*P< 1RD/ $4J%@!#*AX 02HE #\J+  ^*S,
M/2LY #PK00 [+$@ .BQ1 #DM6P X+F8 -BYS #4O@P T+Y4 ,S"G #(PO0 Q
M,=X ,3'W #(Q_P R,/\ ,S#_ +$^  "D1   F4@  (]*  "%2@  >TD  '!%
M  !E0   6SL  %(V  !(,00 0BX- #\N$P ]+AL .RXB #DO*0 X+R\ -R\V
M #8P/@ U,$8 -#%/ #,Q60 R,F0 ,3)Q # S@0 O-), +C2F "PUNP L-=L
M+#7U "TU_P M-/\ +C3_ *Y!  "B2   ETP  (U.  "#3@  >4T  &Y*  !B
M10  6$   $X\  !%-P  /3,+ #DS$0 W,Q@ -C,? #0S)@ S,RT ,C0T #$T
M/  P-40 +S5, "XV5@ M-F( +#=O "LW?P J.)$ *#BD "<YN0 F.=@ )SGT
M "@Y_P H./\ *3C_ *M%  "?2P  E$\  (M2  "!4P  =U(  &Q/  !?20
M5D8  $Q"  !"/0  .#@( #0X#P R.!4 ,3@= "\X)  N."L +3DR "PY.0 K
M.D$ *CI* "D[5  H.U\ )SQM "4\?0 D/8\ (SVB "(]MP A/M0 (3[S "(]
M_P C/?\ (SS_ *A)  "=3P  DE,  (E6  !_5P  =58  &I3  !=3P  4TP
M $I(  ! 1   -D % "\]#0 M/1, *ST: "H^(0 I/B@ *#XO "<^-P F/S\
M)#]( "- 4@ B0%T (4%J "!!>@ >08T '4*@ !Q"M0 ;0M$ &T+Q !Q"_P =
M0?\ 'D'_ *5-  ":4P  D%@  (9;  !]7   <EL  &=8  !;5   45(  $A.
M   ]2@  ,T<  "I#"P F0Q  )4,6 "1#'@ C1"4 (D0L "%$-  @13P 'D5%
M !U%3P <1EH &T9H !E&>  81XH %T>> !9'LP 42,X %4?O !9'_P 71O\
M%T;_ *)2  "76   C5T  (1@  !Z80  <&   &5>  !96@  3U@  $14   Y
M40  +TX  "9+!@ @2@X 'DH3 !U*&@ <2B$ &TLH !I+,  92S@ %TM" !9,
M3  53%< %$QE !--=0 238@ $4V< !!-L0 .3LP #TWN !!-_P 13/\ $4S_
M )Y7  "470  BV(  (%E  !W9@  ;68  &-D  !680  2EX  #];   U6
M*U8  ")4 0 :4@H %E(0 !52%@ 44AT $U(D !)2+  14C0 $5(^ !!32  /
M4U0 #E-B  U4<@ ,5(0 "U28  E4K0 (5,4 "53G  I3^P +4O\ "U+_ )M=
M  "19   B&@  'YK  !T;   :VP  %]J  !29P  160  #IB   P8   )EX
M !U=   56P4 $%H,  Y:$0 .6A@ #5L@  Q;)P +6S  "ELZ  E;10 '6U$
M!EM>  1;;0 #6X   5N4  !;J   6\   %KB  !:]@ !6O\  EG_ )=D  ".
M:P  A&X  'MP  !R<@  9W$  %EP  !,;@  0&P  #5K   J:0  (6<  !AF
M   19@$ #&4*  =E#P $910  V0;  )D(P  9"P  &0U  !D0   9$P  &1:
M  !D:0  9'L  &2/  !CI   8[L  &+=  !B]   8O\  &'_ )-L  ")<0
M@'4  'AW  !M>   8'<  %)V  !&=0  .70  "YT   C<@  &G$  !)Q   -
M<0  !G$(  !P#0  <!(  ' 7  !O'P  ;R8  &\P  !O.P  ;T<  &]4  !O
M9   ;W4  &Z*  !MH   ;;8  &S6  !K\@  :_\  &O_ (YS  "%>   ?7L
M '-]  !E?@  6'X  $M^   ^?@  ,GX  "9]   <?   $WP   U\   &?0
M 'T%  !\"P  ? \  'P3  !\&0  ?"$  'PI  !\-   >T   'M.  ![7@
M>V\  'J$  !ZF@  >;$  'C.  !W[P  =OX  ';_ (EZ  "!?P  >((  &N#
M  !=A0  3X8  $*'   UB   *8<  !V'   4AP  #8@   :)    B@   (H
M  ")!@  B0P  (D/  ")$P  B1H  (HB  "*+   BC@  (I&  ")5@  B6@
M (E\  "(E   AZL  (;&  "%Z@  A?L  (3_ (6"  !]A@  ;X@  &&+  !3
MC0  18\  #B1   KD0  'Y(  !22   -DP  !)0   "6    EP   )@   "7
M    EP4  )<+  "8#@  F!,  )D:  "9(@  FBX  )H]  "930  F5X  )ES
M  "8BP  F*,  )>\  "6X@  EO<  )7_ (")  !RC   9(\  %:3  !(E@
M.ID  "R:   ?FP  %)P   R>   #GP   *$   "C    I0   *4   "E
MI0   *8"  "G"   IPT  *@1  "I&0  JR,  *LQ  "K00  K%,  *QG  "K
M@   JIH  *JS  "JT   J>\  *G[ '6/  !GE   69@  $J<   \GP  +:(
M ""C   3I0  "Z<   &I    JP   *X   "Q    L@   +(   "S    M
M +4   "V    N 0  +D+  "[$   O1@  +\D  "_-0  P$<  ,!;  # <@
MP(T  ,&F  # P0  O^,  +[S &J7  !;G   3:$  #ZE   OJ0  (:L  !.M
M   +L    +,   "U    N    +P   "_    P0   ,$   ##    Q    ,8
M  #'    R0   ,L   #."   T0\  -48  #8)P  V3D  -I-  #;9   VWX
M -R9  #<L   W,D  -SC %V?  !/I0  0*H  #*O   BL@  %+4   JX
MNP   +\   ##    Q@   ,L   #.    T0   -$   #4    U@   -D   #;
M    W@   .    #D    YP8  .L.  #O&0  \"H  /(_  #S50  ]&T  /2(
M  #TH0  ]+8  /3' /\ "0#_  8 _P ' /\ # #_ !$ _P < /\ * #_ #0
M_P!! /\ 3 #_ %4 _P!= /\ 90#_ &P _P!R /X > #\ 'X ^P"$ /H BP#Y
M )( ]P"9 /8 H@#T *P \P"Y /$ RP#P .@ [@#[ .T _P#L /\ X0#_ -(
M_P#) /\ Q #_ /\  0#_    _P   /\ ! #_  X _P 7 /\ (P#_ "\ _P [
M /T 1@#Z %  ]P!8 /0 7P#R &8 \ !L .\ <@#M '@ [ !^ .H A0#I (P
MYP"3 .4 G #C *8 X0"Q -\ P0#= -T VP#T -D _P#6 /\ SP#_ ,0 _P"]
M /\ N0#_ /\   #_    _P   /\   #_  L _  3 /< '@#T "H \@ U .X
M0 #I $H Y@!2 ., 60#@ &  W@!F -P ; #: '( UP!X -0 ?@#2 (4 T "-
M ,X E0#, )\ R0"J ,< N #% ,T PP#K ,  _@"_ /\ O@#_ +8 _P"P /\
MK0#_ /\   #_    _P   /D   #R  8 ZP / .8 &0#A "0 W@ O -H .0#3
M $, SP!, ,P 4P#) %H QP!@ ,4 9@## &L P0!Q +\ =P"] 'X NP"& +D
MC@"W )@ M0"C +, L "Q ,( K@#@ *P ]P"K /\ J@#_ *@ _P"C /\ H #_
M /\   #_    ]0   .L   #A    U@ , ,\ $P#* !X Q@ I ,( ,P"_ #T
MNP!% +@ 30"V %0 LP!: +$ 7P"P &4 K@!J *P < "K '< J0!_ *< AP"E
M )$ HP"< *  J0"> +@ G #. )H [@"9 /\ EP#_ )8 _P"6 /\ DP#_ /T
M  #Q    Y0   -D   #-    Q  & +T #P"W !@ LP B +  + "M #8 J0 ^
M *< 1@"D $T H@!3 *  60"? %X G0!D )L :@": '  F !W )8 @ "4 (H
MD0"5 (\ H@"- +  BP## (D XP"( /D A@#_ (8 _P"& /\ A@#_ /,   #C
M    T0   ,4   "]    M@   *X "P"H !( I  < *  )@"< "\ F@ W )<
M/P"5 $8 D@!, )$ 4@"/ %@ C0!= (L 8P"* &H B !Q (8 >0"$ (, @@"/
M '\ FP!^ *D ? "[ 'H U0!X /( > #_ '< _P!W /\ =P#_ .<'  #1#
MPPT  +@,  "N"   J    *( !0";  X E@ 5 )( 'P". "@ BP Q (@ .0"&
M $  A !& (( 3 "  %( ?P!7 'T 70![ &, >@!K '@ <P!V 'T = "( '$
ME0!P *0 ;@"T &P R@!K .H :@#\ &H _P!J /\ :@#_ -H0  #&%   N!8
M *T5  "D$@  G X  )8'  "0  D B@ 0 (4 & "! "$ ?@ J 'L ,@!Y #D
M=P!  '4 1@!S $P <@!1 '  5P!N %X ;0!E &L ;@!I '< 9P"# &4 D0!C
M )\ 8@"O &  Q !? .0 7P'X %X"_P!> O\ 7@+_ ,X8  "]'0  L"   *4?
M  ";'   DQ<  (L1  "$#   ?@0+ 'D $@!U !L <@ C &\ *P!M 3, :P$Z
M &D"0 !G T8 9@-, &0$4@!C!%D 801@ %\%:0!>!7, 7 9_ %H&C0!9!YP
M5PBM %8(P0!5">$ 5 OV %0+_P!4"_\ 5 O_ ,8?  "V)0  J2@  )XH  "4
M)0  BR$  (,;  ![%   = X# &X)#0!I"!0 9@D= &0*)0!B"BT 8 LT %X+
M.@!="T  6PQ' %H,30!8#%0 5PU< %4-9 !4#6\ 4@U[ % .B@!/#IH 3@ZL
M $P/P@!,$., 2Q#Y $L0_P!+$?\ 2Q#_ +\F  "P*P  I"\  )DO  "/+0
MABD  'TD  !T'@  ;!<  &41!P!?#A  7 \7 %H0'P!8$"< 5A N %00-0!3
M$#L 4A%" % 12 !/$5  3A%7 $P28 !+$FL 21)X $@3AP!&$Y< 112I $04
MO@!#%=\ 0Q;X $,6_P!#%O\ 0Q;_ +HK  "K,0  H#0  )4U  "+-   @3$
M '@K  !O)@  9B   %X9 0!7% T 5!03 %$4&P!/%2, 3A4J $P5,0!+%C<
M218^ $@61 !'%TP 11=4 $0770!#&&< 01AT $ 9@P _&I0 /1JF #P;NP [
M&]L .QSV #P<_P \'/\ /!S_ +4P  "H-@  G#D  )$[  "'.@  ?C<  ',R
M  !J+0  82<  %DA  !1&PD 3!D0 $H:%P!(&A\ 1AHF $4;+0!#&S, 0ALZ
M $$<00! '$@ /AQ0 #T=60 \'F0 .QYQ #D?@  X'Y( -R"D #8@N  U(=8
M-2'T #4B_P U(?\ -B'_ +(T  "D.@  F3X  (\_  "%/P  >SP  ' X  !G
M,@  72T  %0H  !,(@4 1A\. $,?% !!'QL /Q\B #X@*0 ](#  .R V #HA
M/0 Y(44 .")- #<B5P V(V( -"-N #,D?@ R)(\ ,26B "\EM@ O)M( +R;R
M "\F_P P)O\ ,";_ *\X  "B/@  ED(  (Q#  ""0P  >$$  &X]  !C.
M6C,  %$N  !(* $ 0"0, #TC$0 [)!@ .20? #@D)@ V)"P -24S #0E.@ S
M)D( ,B9* #$G5  P)U\ +RAL "XH>P L*8T *RJ@ "HJM  I*L\ *2OP "HK
M_P J*O\ *RK_ *P\  "?0@  E$8  (I'  " 1P  =D4  &Q"  !A/0  5S@
M $XS  !$+@  /"D) #<H$  U*!4 ,R@< #(H(P P*"D +RDP "\J-P N*C\
M+2M( "PK4@ K+%T *BQJ "@M>0 G+8L )BZ> "4NLP D+\T )"_N "4O_P E
M+_\ )B[_ *D_  "=10  DDD  (A+  !^3   =$H  &I'  !>0@  5#T  $LY
M  !!-   ."\& #(M#0 P+1, +BT9 "TM(  K+2< *BXN "DN-0 I+ST *"]&
M "<P3P E,%L )#%H ",Q=P B,HD (3*= !\SL0 >,\L 'C/M !\S_P @,_\
M(3+_ *9#  ":20  D$T  (9/  !\4   <T\  &A,  !<1@  4D,  $D_   _
M.P  -C8" "XR#  K,A$ *3(7 "@R'@ F,B0 )3,K "0S,@ C-#H (C1# "$U
M30 @-5@ 'S9E !XV=0 <-X< &S>; !HWKP 9.,@ &3CK !HX_P ;-_\ &S?_
M *-'  "830  CE$  (13  ![5   <5,  &90  !:3   4$D  $=%   ]00
M,ST  "HY"0 E-PX (S<4 "(X&P A."( (#@H !\X,  >.3@ '3E! !PZ2P :
M.E8 &3MC !@[<@ 6.X4 %3R9 !0\K0 3/<8 $SWI !0\_0 5//\ %CO_ *!+
M  "540  BU4  ()8  !Y60  ;E@  &16  !840  3D\  $5+   Z1P  ,$,
M "= !0 @/@T '3X1 !P^%P ;/AX &CXE !D^+0 8/S4 %C\^ !4_2  40%,
M$T!@ !)!<  108( $$&7  ]!K  .0L0 #D+G  ]!_  00?\ $$#_ )U0  "3
M5@  B5H  (!=  !V7@  ;%T  &);  !65P  3%4  $%1   V3@  +$L  "-(
M   ;10D %T0/ !5$%  411L $T4B !)%*0 113$ $44[ !!&10 /1E  #D=>
M  U';0 ,1W\ "T>3  E'IP (1[X "$?@  E']@ *1O\ "T;_ )I5  "06P
MAV   'UB  !S8P  :F(  &!A  !37@  1UH  #Q7   R50  *%(  !]0   7
M3@0 $4P,  ],$0 .3!< #DP>  U-)0 ,32X "TTW  I-0@ )34T !TY:  9.
M:0 $3GL  DZ/  %.I   3;H  $W;  %-\@ !3?\  DS_ )9;  "-8@  A&8
M 'IH  !Q:0  :&D  %QG  !/9   0F$  #=?   M7   (UH  !I8   25P$
M#58)  E5#@ '51, !E4:  15(@ #52H  E4T  !5/@  54H  %97  !690
M57<  %6+  !5H   5;8  %34  !4\0  4_T  %/_ )-B  "*:   @&P  '=N
M  !O;P  8VX  %9L  !):@  /6@  #)F   G90  '6,  !5B   .80  "6 (
M  -@#0  7Q$  %\7  !?'@  7R8  %\O  !?.@  7T4  %]3  !?80  7G(
M %Z'  !=G   7;(  %S/  !<[P  6_T  %O_ )!J  "&;P  ?7(  '5T  !J
M=0  770  $]S  !"<@  -G   "MO   @;@  %VT  !!L   *;    FL&  !K
M"P  :@\  &H4  !J&@  :B$  &DJ  !I-   :4   &E.  !I7   :6T  &B"
M  !HF   9ZX  &;*  !E[0  9?P  &3_ (MQ  ""=@  >GD  '![  !B>P
M57L  $AZ   [>@  +WH  "-Y   9>   $7<   IW   #=P   '<"  !W"
M=@T  '80  !V%0  =AL  '8C  !V+@  =3H  '5'  !U5@  =6@  '1\  !T
MD@  <ZH  '+$  !QZ0  </L  '#_ (9Y  !_?0  =G\  &B!  !:@@  3((
M #^#   RA   )8,  !J#   1@P  "H,   *#    A    (4   "$ P  @P@
M (,-  "#$   @Q4  (0<  "$)@  A#(  (0_  "#3P  @V   ()U  ""C
M@:0  ("]  !_XP  ?OD  '[_ (*   !ZA   ;(8  %Z(  !0B@  0HL  #6-
M   GC0  &XT  !&.   *C@   (\   "1    D@   )(   "2    D@$  )('
M  "2#   DA   ),5  "3'0  E"@  )0V  "410  DU<  )-K  "3@@  DIP
M )&V  "0V   C_,  (__ 'Z'  !PB@  88T  %.0  !%DP  -Y4  "F6   <
MEP  $9@   F9    FP   )P   ">    H    *    "@    H    *$   "A
M!   H@D  *,.  "D%   I1T  *8J  "F.@  IDP  *5@  "E>   I9(  *2L
M  "DR0  H^L  *+Z '..  !DD0  5I4  $>9   YG   *IX  !V@   1H0
M"*,   "E    IP   *D   "L    K@   *X   "N    KP   +    "Q
ML@   +,&  "U#0  MQ,  +D>  "Y+@  ND   +I4  "[:@  NH4  +FA  "Y
MNP  NMX  +GR &>5  !8F0  2IX  #NB   LI@  ':@  !&J   'K    *\
M  "Q    M    +@   "[    O    +P   "^    OP   ,    #"    Q
M ,8   #( P  RPL  ,\2  #1(   T3(  -)&  #370  U'8  -22  #5JP
MU<0  -3B %N=  !,H@  /:<  "^L   ?KP  $;$   >U    N    +L   "^
M    P@   ,<   #*    S    ,P   #.    T    -(   #5    V    -L
M  #?    X@   .8+  #K$P  ["0  .TX  #N3@  [V<  /""  #PG   \+(
M /'% /\  P#_  $ _P $ /\ "0#_  \ _P 8 /\ ) #_ #  _P \ /\ 1P#_
M %$ _P!9 /\ 8 #] &< _ !M /H <P#Y 'D ^ !_ /8 A0#U (P \P"4 /(
MG0#P *< [@"S .P Q #K .$ Z@#X .D _P#G /\ V0#_ ,L _P#" /\ O0#_
M /\   #_    _P   /\   #_  P _P 4 /\ ( #_ "L _@ W /H 0@#V $L
M\@!3 /  6P#N &$ [ !G .H ;0#H ', YP!Y .4 ?P#C (8 X0". -\ E@#=
M *  VP"L -@ NP#4 -$ TP#P -  _P#. /\ R #_ +T _P"V /\ L@#_ /\
M  #_    _P   /\   #]  @ ]P 0 /, &@#O "8 [0 Q .@ .P#C $4 X !-
M -P 50#9 %L U@!A -, 9P#1 &P SP!R ,T > #+ '\ R0"' ,< D #% )H
MPP"E ,  L@"^ ,4 O #E +H ^P"X /\ MP#_ +  _P"I /\ I0#_ /\   #_
M    _@   /4   #L  , Y0 - -\ %0#: "  U  J -  -0#+ #X R !' ,4
M3@#" %4 P !; +X 80"\ &8 N@!L +@ <@"V '@ M0"  +, B "Q )( K@">
M *P J@"I +L J #5 *8 \P"D /\ HP#_ *$ _P"; /\ F #_ /\   #[
M\    .4   #8    S@ ) ,< $0#" !H O@ D +L +@"W #@ M !  +$ 2 "N
M $X K !4 *H 6@"I %\ IP!E *4 :P"D '$ H@!X *  @0"> (L G "6 )D
MHP"7 +( E@#' ), Z "2 /X D0#_ )  _P"- /\ BP#_ /D   #K    W0
M ,\   #&    O  $ +4 #0"P !4 K  > *@ * "E #$ H@ Y )\ 00"= $@
MFP!. )D 4P"7 %D E@!> )0 9 "2 &H D !Q (X >@", (, B@"/ (@ G "&
M *H A "\ (( W "! /8 @ #_ '\ _P!_ /\ ?@#_ .P   #:    R0   +X
M  "V    K@   *< "0"A !  G  8 )@ (@"5 "H D@ R )  .@"- $$ BP!'
M (D 30"' %( A@!8 (0 70"" &0 @0!K '\ <P!] 'T >P"( '@ E0!V *,
M=0"T ', S !Q .T < #_ '  _P!P /\ < #_ -\%  #*"@  O L  +$)  "H
M!   H0   )L  P"4  P CP 3 (H &P"' "0 A  L ($ ,P!_ #H ?0!! 'L
M1P!Y $P =P!2 '8 5P!T %T <@!D '  ;0!O '8 ; "" &H CP!I )T 9P"N
M &4 PP!D .0 8P#Z &, _P!B /\ 8P#_ - .  "_$@  LA,  *<2  "=$
ME0L  (\#  ")  < @@ . 'X %0!Z !X =@ E '0 +0!Q #0 ;P Z &X 0 !L
M $8 :@!, &D 4@!G %@ 9@!? &0 9P!B '$ 8 !\ %X B0!< )@ 6P"I %D
MO !8 -P 6 #T %@ _P!7 /\ 5P#_ ,86  "V&@  JAT  )\<  "5&0  C10
M (4/  !^"0  =P$* '( $ !N !< :@ ? &@ )P!E "X 9  T &( .P!@ $
M7P!& %T 3 !< %, 6@!: %@ 8@!7 &P 50!W %, A0!2 )0 4 &E $\!N !.
M M( 303P $T%_P!-!?\ 307_ +\=  "P(@  HR4  )DE  "/(@  A1T  'T8
M  !U$@  ;@T" &<&# !C Q$ 7P(9 %T#(0!;!"@ 600O %<%-0!6!3L 5 9!
M %,&1P!1!DX 4 =5 $X'7@!-"&< 2PAS $D)@0!("9( 1PJC $4*M@!$"]
M1 SO $,-_P!##?\ 1 W_ +DD  "J*0  GBP  )0L  "**@  @"8  '<A  !N
M&P  9A0  %\/!0!9"PT 50H3 %,+&P!1"R( 3PPI $T,+P!,##8 2PT\ $D-
M0@!(#4D 1@U1 $4.6@!$#F0 0@YP $ .?P _#Y  /A"B #P0M@ [$-$ .Q'Q
M #L1_P [$?\ /!'_ +0I  "F+P  FC(  ) R  "&,0  ?"T  '(H  !I(P
M81T  %D6  !1$0@ 3 \0 $H0%@!($!T 1A D $40*P!#$3$ 0A$W $$1/@!
M$44 /A)- #T25@ \$F$ .A-M #D3?  W%(T -A2? #45LP T%<T ,Q;N #06
M_P T%O\ -!;_ *\N  "B-   ES<  (PX  ""-@  >#0  &XN  !E*@  7"0
M %0>  !,& 0 1A0- $(4$@! %!D /Q0@ #T5)P \%2T .Q4T #D6.@ X%D(
M-Q9* #874P U%UX ,QAJ #(9>0 P&8H +QJ= "X:L0 M&\H +1OL "T<_P N
M&_\ +AO_ *PR  "?.   E#L  (H\  " /   =CD  &LT  !B+P  62H  % E
M  !''P  0!H* #P9$  Z&18 .!D= #8:(P U&BD -!HP #,:-P R&SX ,1M'
M "\<4  N'5L +1UG "P>=@ J'H@ *1^; "@?K@ G(,< )B#J "<@_@ H(/\
M*"#_ *DV  "=/   DC\  (=!  !]0   =#X  &DZ  !?-0  5C   $TK  !$
M)0  .R ' #8>#@ S'A, ,AX9 # >(  O'B8 +A\M "T?-  L(#L *R!$ "HA
M3@ I(5@ )R)E "8B=  E(X4 (R.9 "(DK0 A),4 (27H "(E_0 B)/\ (R3_
M *8Z  ":/P  CT,  (5%  ![1   <D,  &<_  !=.@  4S8  $HQ  !!+
M."8# #$C#  N(A$ +"(6 "HB'0 I(B, *",J "<C,0 F)#D )25! "0E2P C
M)E8 (B9C "$G<@ ?)X, 'BB7 !THJP ;*<, &RGF !PI^P =*?\ 'BC_ *,^
M  "80P  C4<  (-)  !Z20  <$<  &9$  !:/P  43L  $<W   ^,@  -2T
M "PH"0 H)P\ )R<4 "4G&@ D)R$ (R@G "(H+@ A*38 ("D_ !\J20 >*E0
M'2M@ !LK;P :+($ &2R5 !<MJ0 6+<$ %BWD !<M^@ 8+?\ &2W_ *%!  "5
M1P  BTL  ()-  !X30  ;DP  &1)  !81   3T   $8]   ].   ,S0  "HO
M!@ D+ T (2P2 " L&  ?+1X 'BTE !TM+  <+C0 &RX\ !HO1@ 8+U$ %S!>
M !8P;0 5,7\ $S&3 !(QJ  1,K\ $3+B !(R^0 3,?\ $S'_ )Y%  "32P
MB4\  (!1  !V4@  ;5   &).  !620  348  $1#   [/P  ,3H  "<V P ?
M,@L '#(0 !LR%0 9,AL &#(B !<S*0 6,S$ %30Z !0T1  3-$\ $C5< !$U
M:P 0-GT #S:1  XVI@ --[P #3?=  TV]@ .-O\ #S;_ )M)  "13P  AU,
M 'Y6  !U5@  :E4  &!3  !53P  3$P  $))   X10  +D$  "0]   <.@@
M%C@. !4X$@ 4.!@ $SD? !(Y)@ 1.2X $#DW  \Z00 ..DP #3M9  T[:  +
M.WH "CN-  D\H@ '/+@ !SS5  @\\  )._\ "CO_ )A.  ".5   A5@  'Q;
M  !R6P  :%H  %Y8  !350  25(  #Y.   T2P  *D<  "%$   80@, $D +
M ! _$  ./Q4 #C\<  U (P ,0"L "T T  I /@ )04H !T%6  9!90 $078
M T&*  %!GP  0;0  $'0  %![@ !0?P  D#_ )54  ",60  @UX  'E@  !P
M8   9F   %U>  !16P  15<  #I4   O40  )4\  !Q,   42@  #D@(  M'
M#@ (1Q( !T<9  9'(  %2"@  T@Q  )(.P  2$<  $A3  !(8@  2',  $B&
M  !(FP  2+$  $?,  !'[0  1_L  $?_ )):  ")8   @&,  '=E  !N9@
M968  %ED  !,8   0%T  #5;   J60  (%<  !=5   04P  "U('  51#0 !
M4!$  % 6  !0'0  4"4  % N  !0.   4$,  %!0  !07@  4&\  %"#  !/
MF   3ZX  $[)  !.ZP  3?L  $W_ (]A  "&9@  ?6D  '1L  !L;0  86L
M %-I  !&9P  .F0  "]C   D80  &E\  !)>   ,7   !EP&  !;"P  6@\
M %H3  !:&0  62$  %DI  !9,P  63\  %E,  !96@  66L  %A^  !8E
M5ZL  %?%  !6Z0  5?L  %7_ (QH  "";0  >G   ')R  !G<@  6G$  $QP
M   _;@  ,VT  "AK   =:@  %&@   UG   '9P   &8#  !F"0  90T  &41
M  !D%0  9!P  &0D  !D+@  9#H  &-'  !C50  8V8  &-Z  !BD   8:<
M &#!  !?Y@  7_H  %[_ (=O  !_=   >'<  &YX  !@>   4G<  $5W   X
M=@  *W8  "!T   6<P  #G,   =R    <@   '(   !Q!0  <0H  '$.  !P
M$0  <!<  ' >  !P)P  <#,  &]   !O4   ;V   &YT  !NBP  ;:(  &R\
M  !KX@  :O@  &G_ (-W  !\>P  <WT  &5^  !7?P  27\  #Q_   O@
M(G\  !=^   /?@  !WX   !_    ?P   '\   !^    ?@4  'X*  !^#0
M?A$  'X7  !^(   ?BL  'TY  !]2   ?5D  'QM  !\A   >YP  'JV  !Y
MV@  >/4  '?_ (!_  !W@@  :8,  %N%  !-A@  /X@  #*)   DB0  &(D
M  ^)   'B@   (L   ",    C0   (T   ",    C    (P#  ","   C0T
M (T1  "-%P  CB(  (XO  "./P  C5   (UD  ",>P  C)4  (NN  "*S0
MB>\  (G_ 'N%  !MB   7HH  %"-  !"CP  -)$  ":2   9DP  #I0   :5
M    E@   )@   ":    FP   )L   ";    FP   )L   "<    G04  )T+
M  ">$   GQ<  * D  "@-   H$8  *!9  "?<   GXH  )ZE  ">P@  G>@
M )SY '",  !ACP  4Y(  $26   VF0  )YL  !F<   /G0  !9\   "A
MHP   *4   "H    J0   *D   "I    J@   *L   "L    K0   *X!  "P
M"0  L@\  +,8  "T)P  M#D  +5-  "T9   M'X  +.:  "SM   L]4  +/P
M &23  !5EP  1YL  #B?   IH@  &J0   ZF   $J    *L   "M    L
M +0   "V    N    +@   "Y    N@   +P   "]    OP   ,    ##
MQ0<  ,D/  #*&@  RRP  ,Q   #-5@  SF\  ,V+  #,J   S,(  ,SB %B;
M  !)H   .J4  "RI   <JP  #ZX   2Q    M    +<   "Z    O@   ,,
M  #&    R    ,@   #*    RP   ,T   #/    T@   -4   #9    W0
M .$%  #F#P  YQX  .@R  #I2   ZF   .M[  #KEP  [*X  .S" /\   #_
M    _P   /\ !@#_  T _P 5 /\ (0#_ "P _P X /\ 0P#_ $P _@!4 /L
M6P#Z &( ^ !H /8 ;@#U '0 ] !Z /( @ #Q (< [P"/ .T EP#K *$ Z0"M
M .< O0#E -@ Y #S .( _P#@ /\ T #_ ,0 _P"\ /\ M@#_ /\   #_
M_P   /\   #_  D _P 1 /\ ' #] "< ^0 R /4 /0#Q $8 [0!/ .L 5@#H
M %P Y@!B .0 : #C &X X0!S -\ >0#= (  V@"( -@ D0#4 )L T@"F ,\
MM #, ,D R0#I ,@ _P#' /\ P0#_ +< _P"O /\ JP#_ /\   #_    _P
M /\   #X  4 \@ . .X %P#J "( Y@ L .$ -P#= $  V !) -, 4 #0 %8
MS@!< ,P 8@#* &< R !M ,8 <P#$ 'D P@"! ,  B@"^ )0 O "? +D K "V
M +X M #= +, ]P"Q /\ L #_ *@ _P"B /\ G@#_ /\   #_    ^0   .\
M  #F    WP + -8 $@#0 !P S  F ,@ , #$ #H P !" +T 2@"[ %  N !6
M +8 6P"U &$ LP!F +$ ; "P '( K@!Z *P @@"I (P IP"8 *4 I0"C +0
MH #+ )\ [@"= /\ G #_ )D _P"4 /\ D0#_ /\   #V    Z@   -T   #/
M    QP & ,  #P"[ !< MP @ +, *@"P #, K0 [ *H 0P"G $D I0!/ *,
M50"B %H H !? )X 90"= &L FP!R )D >P"7 (4 E "0 )( G0"0 *P C@"_
M (P X@"+ /H B0#_ (D _P"& /\ @P#_ /0   #D    U    ,@   "_
MM0 ! *X "P"I !( I0 ; *$ (P"> "P FP T )@ / "6 $, E !) )( 3@"0
M %, C@!9 (T 7@"+ &0 B0!K (< <P"% 'T @P"( ($ E0!_ *0 ?0"U 'L
MSP!Y /$ > #_ '< _P!W /\ =0#_ .4   #1    PP   +@   "O    J
M *  !@":  X E0 5 )$ '@". "8 BP M (@ -0"& #P A !" (( 1P"  $T
M?P!2 'T 6 ![ %X >0!E '@ ;0!V '8 <P"! '$ C@!O )T ;0"N &P Q !J
M .< :0#] &@ _P!H /\ :0#_ -4#  ##!P  M@@  *L&  "B    FP   )0
M  "-  H B  0 (, & !_ "  ?  G 'H +@!W #4 =0 [ '0 00!R $< < !,
M &\ 4@!M %@ :P!? &D 9@!G '  90![ &, B !B )< 8 "G %X NP!= -P
M7 #V %P _P!; /\ 6P#_ ,D-  "Y$   K!$  *$0  "7#0  CP@  (@   ""
M  4 >P - '< $@!S !H ;P A &P * !J "\ :  U &< .P!E $$ 8P!& &(
M3 !@ %( 7P!9 %T 80!; &H 60!U %< @@!5 )$ 5 "B %, M0!1 ,\ 4 #O
M %  _P!0 /\ 4 #_ +\4  "P&   I!H  )D9  "/%@  AQ$  '\-  !W!@
M<0 ( &L #@!G !0 9  ; &$ (@!> "D 70 O %L -0!9 #L 6 !! %8 1@!5
M $T 4P!4 %( 7 !0 &4 3@!P $P ?0!+ (T 20"> $@ L !' ,< 1@#I $8
M^P!& /\ 10#_ +@;  "J(   GB(  ),B  ")'P  @!H  '<5  !O$   : L
M &$$"@!= !  60 6 %8 '0!4 ", 4@ J %  , !/ #4 3@ [ $P 00!+ $@
M20!/ $<!5P!& 6$ 1 )L $,">0!! XD 0 .: #X$K0 ]!,0 / 7E #P'^  \
M!_\ / ?_ +(B  "E)P  F2D  (XI  "$)P  >R,  '$>  !I&   81(  %H-
M P!3" P 3P41 $P%%P!*!AX 2 8D $<&*@!%!S  1 <V $,(/0!!"$, 0 A+
M #X)4P ]"5T .PIH #H*=@ X"X< -PN9 #4+K  T#,( ,PSD #,-^0 S#?\
M- W_ *TG  "@+   E2\  (LO  " +@  =RH  &TE  !D(   7!H  %04  !,
M#P8 1@P- $,,$@!!#!@ /PP? #X,)0 \#2L .PTR #H-.  X#3\ -PY' #8.
M4  T#EH ,PYF #$/=  P#X4 +A"8 "T0JP L$,, *Q'E "P1^@ L$?\ +1'_
M *HL  "=,0  DC0  (<U  !]-   =#$  &HK  !@)P  6"$  $\;  !'%@
M0!$) #L0#P Y$!0 -Q ; #80(0 T$"< ,Q$M #(1-  Q$3L ,!%# "X230 M
M$E< +!)C "H3<0 I$X( )Q25 "84J0 E%<  )!7C "46^@ F%O\ )A7_ *8Q
M  ":-@  CSD  (4Z  ![.0  <38  &<Q  !=+0  5"@  $PB  !#'0  .Q<%
M #44#0 R$Q$ ,107 "\4'0 N%"0 +!0J "L5,0 J%3@ *19  "@62@ G%U0
M)A=@ "08;P C&(  (1F3 " 9IP ?&;X 'AK@ !\:^  @&O\ (!K_ *,T  "8
M.@  C3T  (,^  !Y/0  ;SL  &4W  !;,@  4BT  $DH  ! (P  .!X! # 9
M"@ L& \ *A@4 "D8&@ G&"  )ADG "49+0 D&C4 (QH^ "(;1P A&U( (!Q>
M !\=;  ='7X '!V1 !H>I0 9'KP &!_= !D?]@ :'_\ &Q[_ *$X  "5/0
MBT$  (%"  !W0@  ;4   &,\  !9-P  3S,  $8N   ]*0  -20  "T@!P G
M'0T )1T2 ",=%P A'1T (1TD " >*P ?'C( 'A\[ !T?10 <($\ &B%< !DA
M:@ 8(GL %B*/ !4BHP 4([H $R/: !0C]0 5(_\ %B/_ )X\  "300  B40
M ']&  !U1@  ;$0  &)!  !7/   33@  $0T   \,   ,RL  "HF P C(@L
M("$0 !XA%0 <(AL &R(A !HB*  :(S  &2,X !@D0@ 6)4T %259 !0F:  3
M)GD $B:- !$GH@ 0)[@ #B?6 ! H]  1)_\ $2?_ )Q   "110  AT@  'U*
M  !T2@  :DD  &!&  !500  3#X  $,Z   Z-@  ,3(  "@M   @*0D &R<.
M !DG$@ 8)Q@ %B<? !4H)0 4*"T $R@V !(I0  2*4L $2I7 ! J9@ .*W<
M#BN+  TLGP ,++4 "RS/  PL[P -+/\ #2O_ )E$  "/20  A4P  'Q.  !S
M3P  :4X  %Y+  !31P  2D0  $)    Y/0  +S@  "4T   =, 4 %BT, !0L
M$  3+14 $BT< !$M(P 0+2H #RXS  XN/0 -+T@ #2]5  PP8P *,'0 "3"(
M  @QG  &,;$ !C'+  8QZP ',/P "##_ )=(  "-30  @U$  'I3  !Q5
M9U(  %U0  !23   24H  $!&   U0@  *SX  "(Z   :-P$ $C0)  \S#@ .
M,Q, #3,9  TS(  ,-"@ "S0Q  HU.P (-48 !S52  4V8  $-G$  C:$   V
MF0  -J\  #;(   VZ   -OD  37_ )1-  "*4@  @58  'A8  !O60  95@
M %M5  !14@  1T\  #Q,   Q2   )T0  !Y!   6/P  $#P'  LZ#0 ).A$
M"#L7  8['@ %.R8 !#LN  ([.  !/$,  #Q/   \7@  /&X  #R!   \EP
M/*P  #O%   [YP  ._@  #O_ )%2  "(6   ?UP  '9=  !M7@  8UT  %I<
M  !.6   0E0  #=1   M3@  (TL  !I)   21@  #40&  =##  #0Q   $,5
M  !#&P  0R,  $,K  !#-0  0T   $--  !#6P  0VL  $-^  !#E   0JH
M $+#  !!Y@  0?D  $'_ (Y8  "&7@  ?6$  '-C  !K9   8F,  %=A  !)
M70  /5H  #)8   G50  'E,  !51   .3P  "4T%  )-"P  3 X  $P3  !+
M&   2Q\  $LH  !+,@  2ST  $M)  !+5P  2V<  $I[  !*D   2:<  $G
M  !(Y   2/@  $?_ (M?  "#9   >F<  '%I  !I:@  7FD  %!F  !#9
M-V$  "Q?   A70  &%L  !!9   *6    U<#  !7"0  5@T  %40  !5%0
M5!L  %0C  !4+0  5#D  %1%  !44P  5&0  %-W  !3C0  4J0  %&]  !0
MX@  4/@  $__ (AG  !_:P  =VX  &]P  !E<   5VX  $IL   ]:P  ,&D
M "5H   :9@  $60   MC   $8@   &(!  !A!@  8 L  & .  !?$@  7Q<
M %\>  !>*   7C,  %Y   !>3P  7E\  %UR  !=B   7*   %NY  !:WP
M6?<  %C_ (1N  !\<@  =74  &MV  !==0  3W0  $)S   U<P  *'(  !UP
M   3;P  #&X   1N    ;@   &X   !L @  ; <  &L+  !K#@  :Q(  &H9
M  !J(@  :BT  &HZ  !I20  :5H  &EL  !H@P  9YL  &:U  !EV   9/4
M &3_ (!U  !Z>0  <'L  &)[  !4?   1GP  #E\   L?   'WL  !1Z   -
M>@  !'H   !Z    >@   'H   !Y    >0$  '@&  !X"P  > X  '@3  !X
M&@  >"4  '@R  !W00  =U(  '=E  !V?   =94  '2O  !SS@  <O$  ''_
M 'Y]  !U@   9X$  %B"  !*@P  /(0  "Z%   AA0  %84   V%   #A0
M (8   "'    B    (@   "'    AP   (<   "'!   APD  (<.  "($P
MB!P  (@I  "(.   ATH  (==  "&<P  AHT  (6G  "$Q0  @^P  (+^ 'B$
M  !JA@  7(@  $V*   _C   ,8X  "./   6CP  #9    *1    D@   ),
M  "5    E@   )8   "6    E@   )8   "7    EP   )<'  "8#0  F1,
M )H?  ":+0  FC\  )I2  "::   F8,  )F?  "8N@  E^(  );X &V*  !?
MC0  4)   $&3   SE@  ))<  !:8   -F0   9L   "=    GP   *$   "D
M    I0   *0   "E    I0   *8   "G    J    *D   "J!   K P  *X3
M  "N(0  KC,  *Y'  "N70  KG8  *Z3  "NK@  K<T  *SO &&1  !3E0
M1)@  #6<   FGP  %Z$   VC    I0   *<   "J    K    +    "R
MM    +,   "T    M0   +<   "X    N0   +L   "]    OP$  ,,+  #%
M%0  Q24  ,8Y  #'3P  QV@  ,:%  #&H@  QKP  ,;> %69  !'G0  .*(
M "FF   9J   #:L   "M    L0   +0   "W    N@   +\   #!    Q
M ,,   #%    Q@   ,@   #*    S0   ,\   #2    U@   -L   #@#
MX1@  .,K  #D00  Y5H  .9T  #FD0  Y:P  .7$ /\   #_    _P   /\
M 0#_  H _P 2 /\ '0#_ "@ _P T /\ /@#] $@ ^@!0 /< 5P#U %T ] !C
M /( :0#P &\ [P!T .T >P#K ($ Z0") .@ D@#F )P Y "H .( MP#? ,T
MW #N -D _P#9 /\ R@#_ +X _P"U /\ L #_ /\   #_    _P   /\   #_
M  8 _P / /P & #X ", ]  N /  . #K $( Z !* .4 40#B %@ X != -X
M8P#< &@ V0!N -8 = #4 'L T0"" ,\ BP#- )4 R@"A ,@ KP#% ,$ P@#C
M ,  ^P#  /\ NP#_ +  _P"H /\ I #_ /\   #_    _P   /L   #S  $
M[0 , .@ $P#C !X X  H -H ,@#3 #P SP!$ ,P 2P#) %$ Q@!7 ,0 70#"
M &( P0!G +\ ;0"] '0 NP![ +D A "W (X M "9 +( IP"O +< K0#0 *L
M\@"J /\ J0#_ *$ _P"; /\ EP#_ /\   #_    ]    .D   #@    U0 (
M ,X $ #) !@ Q0 B ,$ *P"\ #4 N0 ] +8 10"S $L L0!1 *\ 5@"N %L
MK !A *H 9@"I &T I@!T *0 ? "B (8 H "2 )X GP"< *X F0## )< YP"6
M /\ E0#_ )( _P"- /\ B@#_ /P   #P    XP   -0   #(    OP # +D
M#0"S !, KP < *P )0"I "X I0 V *, /@"@ $0 G@!* )T 4 "; %4 F0!:
M )< 7P"6 &8 E !L )( =0"0 'X C@"* (L EP") *8 AP"X (4 U@"$ /8
M@@#_ ($ _P!^ /\ ? #_ .T   #=    S    ,$   "X    K@   *< "0"B
M !  G@ 7 )H 'P"7 "< E  O )$ -P"/ #T C0!# (L 20") $X B !3 (8
M60"$ %\ @@!E (  ;0!^ '< ? "" 'H CP!X )X =0"O ', QP!R .P <0#_
M '  _P!P /\ ;@#_ -T   #)    O    +$   "I    H0   )D  P"3  P
MC@ 2 (H &0"' "$ A  I ($ , !_ #< ?0 ] 'L 0@!Y $@ > !- '8 4@!T
M %@ <@!? '$ 9P!O '  ; ![ &H B !H )< 9@"H &4 O !C .$ 8@#Z &$
M_P!A /\ 80#_ ,T!  "\!0  KP4  *4"  "<    E    (T   "&  @ @0 .
M 'P % !X !L =0 C '( *0!P #  ;@ V &T / !K $$ :0!' &@ 3 !F %(
M9 !9 &, 8 !A &D 7P!T %T @0!; )  60"A %< M !6 -  50#R %4 _P!4
M /\ 50#_ ,$,  "R#@  I@\  )L.  "2"P  B04  ((   ![  ( =0 + '
M$ !L !8 :  = &8 (P!C "H 80 P &  -@!> #L 70!! %L 1@!: $P 6 !3
M %8 6P!4 &0 4@!N %$ >P!/ (H 30"; $P K@!+ ,8 2@#J $D _@!) /\
M20#_ +D2  "J%@  GA<  )06  "*$P  @1   'D+  !Q P  :P & &4 #0!A
M !$ 70 8 %H '@!8 "0 5@ J %0 , !3 #8 40 [ %  00!. $< 30!. $L
M5@!) %\ 1P!I $8 =@!$ (4 0P"7 $$ J0!  +\ /P#B #\ ^  ^ /\ /P#_
M +(9  "D'@  F!\  (X?  "$'   >A@  '(2  !J#@  8@@  %P!" !7  X
M4P 3 %  &0!. !\ 3  E $H *P!( #  1P V $8 / !$ $( 0P!) $$ 40 _
M %H /@!E #P <@ Z ($ .0"3 #@ I0 V +H -@#; #4 ]  U /\ -0#_ *P@
M  "?)   E"8  (DF  !_)   =2   &P;  !D%0  7!   %0, 0!.!@H 2@(/
M $< % !$ !H 0@ @ $  )0 _ "L /@$Q #P!-P [ CX .0)% #@#30 V U8
M-01A #,$;@ Q!7X , 60 "\%HP M!K@ + ;4 "P'\  L"/\ + C_ *@E  ";
M*@  D"P  (8M  ![*P  <B<  &@B  !?'0  5Q<  $\2  !(#@0 00H+ #X'
M$  [!A4 .0<; #@'(0 V""8 -0@L #,(,@ R"3D ,0E! "\)20 N"E, + I>
M "L+;  I"WP * R/ "8,H@ E#+< ) S3 ",-\  D#?\ )0W_ *0J  "8+P
MC3(  (,R  !Y,0  ;RX  &4I  !<)   4Q\  $L9  !#$P  /! & #4-#  S
M#!$ ,0P6 "\,'  N#2( +0TH "L-+@ J#34 *0T] "<.1@ F#E  ) Y< ",/
M:@ B#WL (!". !\0H@ =$+< '!#4 !T1\@ =$?\ 'A'_ *$O  "5,P  BC8
M ( W  !V-@  ;3,  &,O  !9*@  4"4  $@@   _&@  .!4  # 1"  L$ X
M*A 2 "@0&  G$!X )1 D "00*@ C$3( (A$Z "$10P @$DX 'A): !T3:  ;
M$W@ &A.+ !@4H  7%+4 %A31 !85\0 7%?\ &!3_ )XS  "3-P  B#H  'X[
M  !T.P  :S@  &$T  !7+P  3BL  $4F   ](0  -!P  "T7!0 F$PP (Q,0
M "(3%0 @$QH 'Q,A !X4)P =%"\ '!4W !L500 :%DL &197 !<790 6%W8
M%!B) !,8G@ 2&+, $1G. !$9[P 2&?\ $QG_ )PV  "1.P  ACX  'P_  !S
M/P  :3T  %\Y  !5-0  3#   $,L   Z)P  ,B(  "H> 0 B&0D 'A<. !P7
M$@ :%Q< &1@> !D8)  8&2P %QDT !8:/@ 5&DD $QM5 !(;8P 1''0 $!R'
M  \=G  .';$ #1W+  T=[  .'?\ #QW_ )DZ  "//P  A$(  'M$  !Q0P
M:$(  %X^  !3.@  2C8  $$R   Y+0  ,2D  "@E   @( 8 &AT, !<<$  5
M'!4 %!T; !0=(@ 3'2D $AXR !$?/  0'T8 $"!3  X@80 -(7$ #"&%  LB
MF0 *(JX "2+'  DBYP *(OL "R'_ )<^  ",0P  @T8  'E(  !P2   9T8
M %Q$  !2/P  23L  $ X   X-   +S   "<L   >)P, %B,* !(A#@ 1(1,
M$"(9 ! B(  /(B< #B,O  TD.0 ,)$0 "R50  HE7@ ))F\ !R:"  8FE@ $
M)JP  R;$  0FY0 $)O< !B;_ )5"  "*1P  @4H  'A,  !O3   94L  %M(
M  !01   1T$  #\^   W.P  +38  "0Q   ;+0  $RH'  \H#0 -)Q$ #2@6
M  PH'0 +*"4 "BDM  DI-P '*D( !BI.  0K7  #*VP  2M_   KE   *ZD
M "O!   KXP  *_8  "K_ ))&  "(2P  ?T\  '91  !M40  8U   %I-  !/
M2@  1T<  #Y$   S0   *3P  " X   7-   $3$%  PO#  )+A  !RX5  8O
M&P %+R,  R\K  (P-0  ,#\  #!,   Q60  ,6D  #%\   QD0  ,:<  #"_
M   PX0  ,/4  "__ )!+  "&4   ?50  '56  !K5@  8E4  %A3  !.4
M14T  #I)   O10  )4(  !P^   4.P  #CD%  DW"P $-@\  383   V&0
M-B   #8I   V,@  -ST  #=)   W5P  -V<  #=Y   WCP  -J4  #:]   V
MX   -?4  #7_ (U0  "$5@  ?%H  ');  !I6P  8%L  %=9  !,5@  0%(
M #5.   J2P  ($@  !=&   00P  "T$$  1 "@  /PX  #X1   ^%@  /AT
M #XF   ^+P  /CH  #Y&   ^5   /F0  #YV   ]C   /:,  #R[   \W@
M._4  #O_ (I7  ""7   >5\  '!A  !H80  7V$  %1>  !'6P  .E<  "]5
M   E4@  &U   !)-   ,2P  !DH#  !)"0  2 T  $<0  !'%   1AH  $8B
M  !&+   1C<  $9#  !&40  1F   $5S  !%B0  1*   $2X  !#W   0O4
M $+_ (A=  !_8@  =V4  &YG  !G:   6V8  $YC  !!80  -%X  "E<   ?
M6@  %5<   Y6   '5    %,!  !2!@  40L  %$.  !0$0  3Q8  $\>  !/
M)P  3S(  $\_  !/30  3ET  $YO  !.A0  39T  $RU  !+V   2O4  $K_
M (5E  !\:0  =&P  &UN  !B;0  5&L  $=I   Z9P  +64  ")D   88@
M$&    E?    7@   %X   != P  7 @  %L,  !:#P  6A,  %D9  !9(@
M62T  %DZ  !92   6%@  %AK  !7@0  5YD  %:R  !5T@  5/0  %/_ (%L
M  !Y<   <W,  &AS  !:<@  3'$  #]P   R;P  )6X  !IL   1:P  "6H
M  !J    :0   &D   !H    9P,  &8(  !F#   9@\  &44  !E'   92<
M &0T  !D0P  9%,  &1E  !C>P  8I0  &&M  !@S0  7_$  %[_ 'UT  !W
M=P  ;GD  %]Y  !1>0  0WD  #9X   I>   ''<  !%V   *=0   '4   !U
M    =@   '4   !T    =    ',"  !S!P  <PP  '(0  !R%0  <B   '(L
M  !R.P  <4P  '%?  !Q=   <(X  &^H  !NQ@  ;.T  &O_ 'M[  !R?@
M9'X  %5_  !'@   .8$  "N"   >@0  $H$   J!    @0   ((   "#
M@P   (,   ""    @@   ((   ""    @@4  ((*  ""#P  @A<  ((C  ""
M,@  @D,  (%6  "!;   @(8  '^A  !^O0  ?>8  'S\ ':"  !H@P  684
M $N'   \B0  +HH  ""+   3BP  "HL   ",    C0   (\   "1    D@
M )$   "1    D0   )$   "1    D@   )("  "3"0  E \  )09  "4)P
ME#@  )1,  "38@  DWP  ).8  "2LP  D=@  )#V &J(  !<B@  38T  #^0
M   PD@  (90  !25   *E@   )<   "9    FP   )T   "?    H    *
M  "@    H    *$   "B    HP   *0   "E    I@<  *@0  "H'   J"T
M *E   "I5@  J6\  *F+  "HJ   I\<  *;L %^/  !0D@  098  #.9   C
MG   %)T   J?    H0   *,   "F    J    *P   "N    KP   *\   "P
M    L    +(   "S    M    +8   "W    N@   +T'  "_$   OQ\  , S
M  # 20  P&(  ,!^  # FP  P+<  +_8 %.7  !$FP  -9\  ":C   6I0
M"Z<   "J    K0   +    "S    M@   +L   "]    P    +\   #!
MP@   ,0   #&    R    ,H   #,    SP   -,   #:!P  VQ,  -TE  #>
M.P  WU,  .!N  #?C   W:D  -W" /\   #_    _P   /\   #_  < _P 0
M /\ &0#_ "0 _P O /P .@#Y $, ]0!+ /, 4@#Q %D [P!> .T 9 #K &D
MZ0!O .< =0#F 'P Y "$ .( C0#@ )< W0"B -H L0#5 ,4 T@#H -  _P#/
M /\ Q #_ +@ _P"O /\ J0#_ /\   #_    _P   /\   #_  ( ^P - /<
M%0#S !\ [P I .H - #F #T X@!% -X 3 #; %, V !8 -0 7@#2 &, T !I
M ,X ;@#, '4 R@!] ,@ A0#& )  P@"; ,  J0"^ +H NP#9 +D ]P"X /\
MM #_ *D _P"B /\ G0#_ /\   #_    _P   /8   #N    YP * .$ $0#<
M !H UP C -  +@#+ #< QP _ ,0 1@#! $T OP!2 +T 6 "[ %T N0!B +@
M: "V &X M !U +$ ?@"O (@ K0"3 *H H0"H +$ I@#( *0 [0"B /\ H@#_
M )L _P"5 /\ D0#_ /\   #\    [@   .,   #8    S0 % ,8 #@#! !4
MO0 > +D )P"U #  L@ X *\ 0 "L $8 J@!, *@ 40"G %8 I0!; *, 80"A
M &< GP!N )X =@"; (  F0", )< F0"4 *@ D@"\ )  WP". /L C@#_ (L
M_P"& /\ @P#_ /@   #I    W    ,P   #!    N    +( "@"L !$ J  8
M *4 (0"B "D G@ R )P .0"9 #\ EP!% )4 2@"4 %  D@!5 )  6@"/ &
MC0!G (L ;P") '@ A@"$ (0 D0"" *  @ "R 'T S !\ /$ >P#_ 'H _P!W
M /\ =0#_ .8   #3    Q@   +L   "Q    IP   *$ !0";  T EP 3 ),
M&P"0 ", C  K (H ,@"( #@ A@ ^ (0 1 "" $D @0!. '\ 4P!] %D >P!@
M 'D : !W '$ =0!\ ', B0!P )@ ;P"I &T OP!K .8 :@#_ &D _P!I /\
M9P#_ -,   ##    M0   *L   "C    FP   )(   ",  H AP 0 (, %@!_
M !T ?0 D 'H *P!X #( =@ X '0 /0!R $( <0!( &\ 30!M %, ; !9 &H
M80!H &H 9@!T &0 @0!A )$ 7P"B %X M@!< -4 6P#W %L _P!: /\ 6@#_
M ,4   "V @  J0(  )\   "6    C@   (<   "   4 >@ , '4 $0!Q !@
M;@ > &L )0!I "L 9P Q &8 -P!D #P 8P!! &$ 1P!? $T 7@!3 %P 6P!:
M &0 6 !N %8 >P!4 (H 4@"; %$ K@!0 ,@ 3P#N $X _P!. /\ 30#_ +L*
M  "L#0  H T  )4,  ","   @P(  'P   !U    ;@ ( &D #@!E !, 8@ 9
M %\ 'P!= "4 6P K %D ,0!8 #8 5@ [ %4 00!3 $< 40!. %  50!. %X
M3 !H $H =0!( (0 1P"5 $4 J !$ +\ 0P#D $( _ !" /\ 0@#_ +(1  "E
M%   F14  (X3  "$$0  >PT  ',(  !L    90 # %\ "P!;  \ 5P 4 %0
M&@!1 !\ 3P E $X *P!, #  2P V $D / !( $( 1@!( $4 4 !# %D 00!C
M #\ ;P ^ 'X / "0 #L HP Z +@ .0#9 #@ ]0 X /\ . #_ *P7  "?&P
MDQT  (D<  !_&0  =14  &P0  !D#   708  %8 !@!1  P 30 0 $H %0!'
M !H 10 @ $0 )@!" "L 00 Q #\ -@ ^ #T / !$ #L 2P Y %0 -P!? #8
M:P T 'H ,@", #$ G@ P +, +P#. "\ [P N /\ +@#_ *<>  ":(@  CR0
M (0D  !Z(0  <1T  &<8  !?$P  5PX  % *  !) P@ 10 - $$ $0 ^ !8
M/  ; #H (0 Y "8 -P L #8 ,@ T #@ ,P _ #$ 1P P %  +@!; "T 9P K
M '8 *@"( "@ G  G +  )@#) "4 Z@ E ?L )0'_ *(C  "6*   BRH  ($J
M  !W*   ;24  &0@  !;&P  4A4  $L0  !## ( /0<) #D##@ V 1( ,P$7
M #$!'  P 2( +P(G "T"+0 L S0 *@,[ "D$0P H!$T )@58 "4%90 C!G0
M(@:& " &F@ ?!ZX '@?& !T'YP ="/@ '0G_ )\H  "3+0  B"\  'XO  !T
M+@  :BL  &$F  !8(0  3QP  $<7   _$@  . X$ #$+"@ N" X *P<2 "D'
M%P H"!T )P@C "4(*0 D"3  (PDW "$*0  @"DH 'PM5 !T+8@ ;#'( &@R%
M !@,F0 7#*T %@S& !4-Y@ 5#?D %@W_ )PM  "0,0  AC0  'PT  !R,P
M:#$  %\L  !5)P  3",  $0=   \&   -!,  "T0!@ F#0L ) P/ "(,$P A
M#!D 'PP? !X-)0 =#2P &PTT !H./0 9#D< %PY3 !8.80 4#W$ $Q"$ !(0
MF  1$*X $!#& ! 0Z  0$/L $1#_ )DQ  ".-0  A#@  'HY  !P.   9S8
M %TR  !3+0  2B@  $(D   Y'P  ,1H  "H5 0 C$0< '1 - !L/$  9#Q4
M&! ; !<0(0 6$"D %1 Q !01.@ 3$44 $A)1 !$27P 0$F\ #A."  X3E@ -
M$ZL "Q/"  L4XP ,%/H #1/_ )<U  ",.0  @CP  '@]  !O/0  93H  %LW
M  !2,@  22X  $ J   W)0  +R$  "@<   @& , &10* !42#@ 4$A( $Q,8
M !(3'P 1%"8 $10N ! 4.  /%4( #A9/  T67  ,%VP "Q=_  D8DP (&*@
M!AB_  <8X  '&/4 "1C_ )4X  "*/0  @$   '=!  !M00  9#\  %H\  !0
M.   1S,  #XP   V*P  +B<  "<C   ?'P  %QH( !(7#0 0%Q$ #Q<6  X8
M'  .&", #1DL  P:-0 +&D  "AM,  D;6@ ''&D !1Q\  0=D0 "':8  1V\
M  (<W0 "'/(  QS_ ),\  "(00  ?T0  '5%  !L10  8T0  %E!  !//0
M1CD  #XV   U,@  +BX  "4J   =)0  %"$$  \="P -'1  #!T4  L=&@ *
M'B( "!XJ  <?,P &(#X !"!*  ,A5P !(6<  "%Y   AC@  (:0  "&Z   A
MVP  (?(  "#^ )!   "&10  ?4@  '1*  !K2@  8DD  %A&  !.0@  13\
M #T\   U.0  *S0  "(O   9*P  $B@$  TD"@ )(PX !B,2  4C&0 $)"
M B0H  $E,0  )3P  "5(   F50  )F4  "9W   FC   )J(  ":Y   FV0
M)?(  "7^ (Y%  "$20  >TT  '-/  !J3P  8$X  %=+  !-2   1$4  #Q"
M   Q/0  )SD  !XU   5,@  #RX#  HL"@ %*PX  2H1   J%@  *AX  "HF
M   K+P  *SD  "M%   L4P  +&(  "QU   LB@  *Z   "NW   KU@  *O(
M "K_ (Q)  ""3@  >E(  '%4  !H5   7U,  %91  !,3@  0TL  #='   M
M0P  (S\  !H\   2.   ##8#  8S"0  ,@T  #(0   Q%   ,1L  #$C   Q
M+   ,C<  #)#   R4   ,F   #)R   RAP  ,9X  #&U   PU   ,/(  "__
M (E/  " 5   >%<  &]9  !F60  7ED  %57  !)4P  /D\  #),   H2
M'D4  !5"   .0   "#T"  $\"   .PP  #H/   Y$@  .1@  #D@   Y*0
M.30  #E    Y3@  .5T  #EO   XA0  .)P  #>S   WT@  -O(  #7_ (=5
M  !_6@  =ET  &U?  !E7P  75\  %)<  !$6   .%4  "U2   B3P  &$P
M !!*   *2    T8!  !%!@  1 H  $,-  !"$   014  $$=  !!)@  03$
M $$]  !!2@  05H  $%L  ! @0  /YD  #^Q   ^T   /?(  #S_ (1<  !\
M8   <V,  &QE  !D9@  660  $MA   ^7@  ,EL  "99   <5@  $E0   Q2
M   $40   $\   !. P  30@  $P,  !+#@  2Q(  $H9  !*(@  2BP  $HY
M  !*1P  2E8  $EH  !)?@  2)8  $>O  !&S0  1?$  $3_ (%C  !Y9P
M<FH  &ML  !@:P  4FD  $1F   W9   *F(  !]@   57@  #5T   9;
M6@   %D   !8    5P0  %8(  !6#   51   %04  !4'0  5"<  %0T  !4
M0@  4U(  %-D  !2>0  4I(  %&K  !0R@  3^\  $[_ 'YJ  !W;@  <'$
M &9Q  !8<   2F\  #QM   O;   (FH  !=I   .9P  !F8   !E    90
M &4   !C    8@   &($  !A"   80T  & 0  !@%P  8"$  %\N  !?/
M7TT  %Y>  !>=   78T  %RG  !;Q0  6NT  %G_ 'MR  !U=@  :W<  %UV
M  !/=@  074  #-U   F=   &7,  !!R   '<0   '$   !Q    <0   '$
M  !O    ;P   &X   !N @  ;@@  &T,  !M$0  ;1H  &TF  !L-0  ;$8
M &M8  !K;0  :H8  &FA  !HO@  9^@  &;^ 'EZ  !P?   87P  %-]  !$
M?0  -GX  "A^   ;?0  $'T   =]    ?0   'T   !^    ?P   'X   !]
M    ?0   'P   !\    ?    'P&  !\#   ?!(  'P=  !\+   ?#P  'Q/
M  ![90  >WX  'J:  !YM@  >-\  '?Z '.   !E@0  5H,  $B$   YA@
M*X<  !V'   1AP  !X@   "(    B0   (H   ",    C0   (T   ",
MC    (P   ",    C    (T   "-!   C@P  (X3  "/(0  CC(  (Y&  ".
M6P  C70  (V0  ",K0  B\X  (KS &B&  !:B   2XL  #R-   MCP  'I
M !&1   'D@   ),   "5    EP   )D   ";    G    )L   ";    G
M )P   "=    G@   )X   "?    H0,  *(,  "B%@  HR8  *,Z  "C3P
MHV@  **&  "BH@  HL   *'H %R-  !-D   /Y,  #"6   AF0  $IH   >;
M    G0   *    "B    I    *@   "J    JP   *H   "K    K    *T
M  "N    KP   +$   "R    M    +<!  "Y#0  N1H  +HM  "Z0P  NEL
M +IW  "[E   N[$  +G2 %"5  !!F   ,IP  ".@   3H@  "*0   "G
MJ@   *P   "O    L@   +<   "Y    NP   +H   "\    O0   +\   #
M    P@   ,0   #&    R0   ,T   #2 0  U \  -4?  #7-0  V$T  -AI
M  #7A@  UZ,  -:] /\   #_    _P   /\   #_  , _P - /\ %0#_ "
M_  K /@ -0#T #\ \ !' .X 3@#K %0 Z0!: .< 7P#E &0 XP!J .$ < #?
M '8 W0!^ -L AP#8 )$ TP"= ,\ JP#- +T RP#@ ,D ^P#' /\ O0#_ +$
M_P"I /\ HP#_ /\   #_    _P   /\   #\    ]@ + /$ $0#M !L Z0 E
M .0 , #? #D V@!! -4 2 #1 $X SP!4 ,T 60#+ %X R0!C ,< :0#% &\
MPP!W ,  ?P"^ (H NP"5 +@ HP"V +0 M #- +( \@"P /\ K #_ *, _P"<
M /\ EP#_ /\   #_    ^@   /$   #H    X  & -D #@#2 !8 S@ ? ,@
M*0#$ #( P  Z +T 00"Z $@ N !- +8 4P"T %@ L@!= +  8@"N &D K !O
M *H > "H (( I@". *0 FP"A *L GP#  )T Y@"; /\ F@#_ )0 _P". /\
MB@#_ /\   #V    Z    -P   #.    Q@ ! +\ "P"Z !$ M@ : +( (@"N
M "L J@ T *@ .P"E $$ HP!' *$ 3 "? %$ G@!6 )P 7 ": &( F0!H )<
M< "5 'H D@"& )  DP"- *( BP"U (D TP"' /< A@#_ (0 _P!_ /\ ? #_
M /(   #C    T@   ,4   "Z    L0   *L !P"E  X H0 4 )X ' ": "4
MEP M )0 - "2 #H D !  (X 10"- $H BP!0 (D 50"( %L A@!A (0 :0""
M '( ?P!] 'T BP![ )H > "K '8 Q !T .L <P#_ ', _P!P /\ ;@#_ -\
M  #,    OP   +0   "K    H0   )H  @"4  L D  0 (P %P"( !X A0 F
M (, +0"! #, ?P Y 'T /P![ $0 >0!) '@ 3@!V %0 = !: ', 8@!P &L
M;@!U &P @P!J )( : "C &8 N !D -X 8P#[ &( _P!B /\ 8 #_ ,P   "\
M    KP   *4   "=    E    (P   "&  < @0 - 'P $@!X !D =0 ? ',
M)@!Q "T ;P R &T . !K #T :@!" &@ 2 !G $X 90!4 &, 6P!A &0 7P!N
M %T >P!; (H 60"; %< KP!6 ,L 50#R %0 _P!4 /\ 5 #_ +X   "P
MI    )D   "0    B    ($   !Y  ( <P * &\ #P!K !0 9P : &4 ( !C
M "8 80 L %\ ,@!> #< 7  \ %L 0@!9 $< 5P!. %8 50!4 %X 4@!H %
M= !. (, 3 "5 $H J !) ,  2 #H $< _P!' /\ 1P#_ +0)  "F"P  FPP
M ) *  "&!0  ?@   '8   !O    :  % &, # !? !  6P 5 %@ &@!6 "$
M5  F %, + !1 #$ 4  V $X / !- $( 2P!( $D 4 !( %@ 1@!B $0 ;@!"
M 'T 0 ". #\ H@ ] +@ /0#= #P ^  \ /\ / #_ *P0  "?$@  E!(  (D1
M  !_#P  =@P  &X%  !F    8  ! %D " !5  T 40 1 $X %@!+ !L 20 A
M $@ )@!& "L 10 Q $, -@!" #P 0 !# #X 2P ] %, .P!= #D :0 W '@
M-@") #0 G  S +$ ,@#. #( \0 Q /\ ,0#_ *86  ":&0  CAH  (0:  !Z
M%@  <!(  &@.  !?"@  6 ,  %$ ! !,  H 2  . $0 $@!! !8 /P ; #T
M(0 \ "8 .@ L #D ,0 W #< -@ ^ #0 1@ S $\ ,0!9 "\ 90 N ', + "%
M "L F  J *T *0#& "@ Z@ H /X * #_ *$<  "5(   BB$  '\A  !U'P
M;!H  &,6  !:$0  4@T  $L'  !$  8 0  + #P #P X !( -@ 7 #0 '  S
M "$ ,0 G #  +  N #, +0 Z "L 0@ J $L * !5 "8 80 E '  ) "! "(
ME0 A *D ( #! "  Y  ? /D 'P#_ )TB  "1)@  AB@  'PG  !R)0  :2(
M %\=  !7&   3A,  $8.   _"P  . 4' #0 #  Q !  +@ 3 "P &  J !T
M*0 B "< *  F "X )  V ", /@ B $< ( !2 !\ 7@ = &T ' !^ !H D@ 9
M *< & "] !< WP 7 ?4 %P+_ )HG  ".*P  A"T  'DM  !P*P  9B@  %TD
M  !4'P  2QH  $,4   [$   - T" "T)"0 I!0T )@,0 "0!$P B AD (0(>
M " ")  > RH '0,R !L$.@ :!40 &05/ !<&7  6!FH % =\ !,'D  2!Z4
M$0>[ ! 'VP 0"/( $ G_ )<K  ",+P  @3$  '<R  !N,0  9"X  %LJ  !1
M)0  22   $ ;   X%@  ,1(  "D.!  C# D 'PD- !T'$  ;!Q4 &0@: !@(
M(  7"2< %@DN !4*-P 3"D$ $@M- !$+6@ 0"VD #@Q[  X,D  -#*4 # V[
M  L-V0 +#?$ # W_ )4O  "*,P  ?S8  '8V  !L-0  8S,  %DO  !0*P
M1R8  #XA   V'0  +A@  "<3   @$ 4 &0X* !4,#@ 4#!$ $PP6 !(,'  1
M#2, $ TK  \--  .#C\ #0Y*  P/6  +#V< "A!Y  @0C0 '$*( !A"X  40
MU  %$.\ !A#_ )(S  "(-P  ?CH  '0[  !K.@  83@  %@U  !.,   12P
M #TG   U(P  +1\  "8:   >%@$ %Q,& !$0"P .#@X #@\3  T0&0 -$"
M#! H  L1,@ *$3P "!)(  <250 &$V4 !!-V  ,3BP !%*   !.V   3T0
M$^X  !/[ ) V  "&.P  ?#X  ',_  !J/P  8#T  %<Y  !--@  1#$  #PN
M   T*@  +"8  "4B   >'@  %AH" ! 5"0 ,$PX "A,2  D4%P (%!\ !Q4F
M  85+P $%CH  Q9&  $74P  %V(  !AT   8B0  &)\  !BU   7T   %^T
M !?[ (XZ  "$/P  >T(  ')#  !H0P  7T(  %8_  !,.P  0S<  #LT   S
M,   +"P  "0I   ;)   $Q\"  T;"0 )&0T !AD1  09%@ "&1T  1HD   :
M+0  &S@  !M$   <40  '&   !UR   =AP  ')T  !RS   <S@  &^T  !O\
M (P^  ""0P  >48  '!(  !H2   7D8  %5$  !+0   0ST  #LZ   S-P
M*C(  " M   7*0  $"4"  LB"0 %( T  1\0   ?%   'QL  " B   @*P
M(38  "%!   A3P  (5X  ")P   BA0  (9L  "&R   AS0  (.T  !_\ (I#
M  " 2   >$L  &],  !F30  74L  %1)  !*1@  0D,  #I    O.P  )3<
M !PS   3+P  #2P"  <I"  !)PP  "8.   E$@  )AD  "8A   F*0  )C,
M "<_   G30  )UP  "=M   G@@  )YD  ":P   ES   )>X  "3] (A(  !_
M3   =E   &Y1  !E4@  7%$  %-/  !*3   04D  #5$   K0   (3P  !<Y
M   0-@  "C(!  ,P!P  +PL  "X.   M$0  +18  "T>   M)P  +3$  "T]
M   M2@  +5D  "UK   M@   +)<  "RO   KRP  *NX  "K^ (5-  !]4@
M=54  &Q7  !C5P  6U8  %-5  !'40  .TT  #!)   E1@  '$,  !,_   -
M/0  !CH    X!0  -PD  #8-   U#P  -!0  #0;   T)   -"X  #0Z   T
M1P  -%<  #1H   T?0  ,Y4  #*M   QR@  ,>X  ##_ (-3  ![6   <UL
M &I=  !B70  6UT  $]:  !"5@  -E(  "I/   @3   %DD   Y'   (1
M $(   !! P  /P<  #X+   ]#@  /1$  #P8   \(0  /"L  #PW   \1
M/%,  #QE   [>@  .I(  #JK   YR   ..T  #?_ (%:  !Y7@  <6$  &EC
M  !B9   5V(  $E>   \6P  +U@  "15   94P  $%$   I/   !30   $P
M  !*    200  $@(  !'#   1@\  $84  !%'   12<  $4S  !%0   15
M $1A  !$=@  0X\  $*H  !!Q@  0.P  #__ 'YA  !V90  ;V@  &AJ  !=
M:0  3V8  $)D   T80  *%\  !U=   26P  "UD   )8    5@   %8   !4
M    4P   %($  !1"0  4 T  % 0  !/&   3R(  $\N  !//   3TL  $Y=
M  !.<@  38L  $RE  !+P@  2>H  $C_ 'MI  !T;   ;F\  &1O  !5;0
M1VP  #EJ   L:0  (&<  !1E   -9    V(   !B    80   &    !?
M7@   %T   !<!   7 D  %L-  !;$@  6QP  %HH  !:-@  6D8  %E8  !9
M;0  6(4  %>@  !6O0  5>@  %/^ 'EP  !S=   :74  %MT  !,<P  /G,
M #!R   C<0  %F\   UN   $;0   &T   !M    ;0   &P   !K    :@
M &D   !I    :0,  &@)  !H#@  :!4  &<A  !G+P  9S\  &92  !F9@
M97\  &2:  !CMP  8N$  &'\ '=X  !M>@  7WH  %!Z  !">@  ,WL  "5[
M   8>@  #GD   1Y    >0   'D   !Z    >@   'H   !X    >    '<
M  !W    =P   '<!  !W"   =PX  '<8  !W)@  =C8  '9)  !U7P  =7<
M '23  !SKP  <M,  ''W '%^  !C?P  5(   $6"   V@P  *(0  !J$   .
M@P  !(0   "$    A0   (8   "(    B0   (@   "'    AP   (<   "'
M    AP   (@   "(    B <  (D0  ")'   B2P  (@_  "(50  B&T  (>)
M  "&IP  A<<  (3O &:$  !7A@  2(@  #F*   JC   &XT   ^-   $C@
M )    "1    DP   )4   "7    F    )8   "7    EP   )<   "8
MF    )D   ":    FP   )T'  "=$0  G2$  )TS  "=20  G&(  )Q_  "<
MG   G+D  )OB %J+  !+C@  /)$  "V3   >E0  $)8   28    F@   )P
M  ">    H0   *0   "F    IP   *8   "G    IP   *@   "I    J@
M *P   "M    KP   +$   "S"0  LQ4  +0G  "T/0  M54  +5P  "TC@
MM*P  +3, $V2   _E@  +YH  ""=   1GP  !:$   "C    I@   *D   "L
M    KP   +,   "U    MP   +8   "W    N    +H   "[    O0   +\
M  #!    Q    ,<   #+    S0P  ,X:  #/+P  ST@  -!B  #0@   T)T
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M______________________________________________\
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MVMO<W=[?X.'BX^3EYN?HZ>KK[.WN[_#Q\O/T]?;W^/GZ^_S]_O]M9G0Q
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M__________^H-0          7-/___________________________]]#0
M        5-;__________________________^Y]10          1-3_____
M______________________RJ9"\"   $(C=)6,[_____________________
M_______II&M!*#]C?Y6GNMK______________________________]6RK++,
MY/K_________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________^6[EW=BR/______________
M___________________;GF<V"@ "C/______________________________
M_\A_/P4     7L______________________________V8$Y        /*K_
M____________________________GDP         (Y#_________________
M___________<;QH         $'WY__________________________^O2
M         &_N__________________________^$$P           &3F____
M_____________________^Q1             %?>____________________
M_____[@5             $C6_________________________W04
M     #C/________________________^:):$P           "/%________
M_________________]^;7"P           VZ________________________
M___OL7U5.2(1!P$"$2*R_______________________________?OZ69F)J@
MK+W:________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______COIV ?/O________________________________RMX17, X ':S_
M_____________________________]**3!4      '+S________________
M____________UG\V         $O)___________________________ZD3X
M         "^K___________________________ 6@           !J5____
M______________________^-)             B$____________________
M_____^=>              !W_________________________[0E
M      !J_________________________WT               !;]/______
M_________________2L               !,Z_______________________
MI0                 \X?______________________, P
M   MV?____________________^9BF$G               GU___________
M____________[;Z)52<            EW/_________________________^
MRIUV74H\,BTL,#E'WO_______________________________>;=UM+0T]GD
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________^_4N];_________________
M________________Y[B/:DLO%6_______________________________^2A
M9S0'     #S)____________________________UH([         !*7____
M_______________________MA3$           !O____________________
M______^F0@            !0X?_______________________^QI
M       WR?_______________________[,O               BMO______
M_________________WD                0I_______________________
M\C0                 F?______________________J0
M    C/______________________1@                  ?___________
M___________?                    =/____________________^7
M                :O_____________________.
M8_______________________*2(!                8?______________
M________N:. 5S<7            :/__________________________^M.N
ME(9\=7%P<G>!E/______________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________;NIV":6G3____
M___________________________(DV4]&0   !V>____________________
M________VXY,$P        !N___________________________;?"P
M      !%U_________________________^+*@             BM/______
M_________________\)$               #E_______________________
M_WT!                ?_______________________YS8
M    :O______________________G0                  6/__________
M____________1@                  1_C____________________I
M                ->G___________________^6
M)=O___________________^\                    &,[_____________
M_______K                    #\+_____________________
M            "KG_____________________)P                  "K7_
M____________________<                   #;G_________________
M____X)R,<%5",R8;% \-#A(:)K_____________________________YY-C2
MSLS+S,_6X/S_________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________KT[SC________________________________TJF%
M94@L$@&%____________________________\:MQ/ \       !/X/______
M___________________5?S4            ?LO______________________
M_^-U'0              B?_______________________Y C
M    9_______________________U4,                 2/;_________
M____________B@                  +MW_____________________.
M                %\C___________________^^
M!+;___________________^<                     *7_____________
M______^Z                     )/____________________<
M             (+_____________________                     '3_
M____________________$P                   &C_________________
M____0@                   &#_____________________>@
M         %W_____________________T0                   &'_____
M_________________R0                  &;_____________________
M_\FLF8E]=G%L:6=F9VMP>HS_____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________BQ:J1>6%W________________________
M_____]VF=U L#      QQ/_________________________@DDX3
M    C________________________])P'0              8/__________
M____________[F\/                -^+_____________________EAP
M                %,#_____________________0
M */___________________^N                     (G_____________
M______^>                     '+___________________^\
M             %_____________________:                     $W_
M___________________Z                     #O_________________
M____#@                   "KY____________________,P
M         !OI____________________7@                    _;____
M________________CP                    ;0____________________
MT                     #*_____________________RL
M      #(_____________________X                    #+________
M______________<6 04% P$       $&#1C+_______________________\
MZ^'8S\S-S]#2U-?<XNK_________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M\=K&_______________________________QQJ.$:$TR&  5J___________
M________________N7Q&&           <?_______________________]=\
M+P              .^/_____________________WV0)
M#+7_____________________= ,                  (W_____________
M_______%%0                   &K___________________^9
M             $O___________________^V                     ##]
M___________________7                     !GG________________
M___V                      73____________________#@
M          #!____________________+P                    "O____
M________________4@                    ">____________________
M>0                    ".____________________I0
M      " ____________________V                     !T________
M_____________S8                   !M_____________________WP
M                  !I_____________________]<-
M  !H______________________]P                  !A____________
M____________4#Q&3E1976%D:&QP=GZ)____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______OU;NCBW-:E?__________________________^+^.9$$A!0
M4OS_______________________>=5A@             %\'_____________
M________Y6P6                 (W_____________________8P
M             %[___________________^=                     #7\
M__________________^A                     !'9________________
M___*                      "[___________________N
M          "A____________________#                     "*____
M________________+0                    !V____________________
M30                    !D____________________;P
M      !2____________________E                     ! ________
M____________O                      P____________________Z@X
M                   B_____________________T0
M   5_____________________X$                    +]?__________
M_________\@+                   "[/____________________]>
M                Y?_____________________)'
MVO______________________G0$             !PX7Q?______________
M_________]6YO,''SM7;X>;M]/O_________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________C?S_______________
M_______________LQJ6(;50[(0< ,M[________________________7DEDI
M             *#______________________XDV                 &?_
M____________________9@                   #+V________________
M__^5                      /(__________________^G
M          "@___________________7                      !\____
M________________                      !>____________________
M)0                    !#____________________2
M       L____________________:@                     8________
M____________BP                     %\___________________KP
M                    X?__________________U0
M    S____________________R0                     OO__________
M_________U0                     KO___________________XL
M                G____________________\L.
MDO____________________]7                    AO______________
M______^J"@                  >?______________________;0
M            9O______________________]U4                 1?__
M______________________]J(RLU/TI58&IU?H>1G/__________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________Z,^VG8-I3KG_
M________________________[+*#7#H= @       'O_________________
M_____\5M*0               $#_____________________@QL
M          ?+__________________^2                      "8____
M______________^D                      !J___________________=
M                      !!____________________#@
M       =____________________.0                      Z/______
M____________8                       SO__________________A0
M                    M___________________J
M    H___________________RP                      D/__________
M________[Q8                     ??___________________SX
M                ;/___________________VD
M6O___________________YD                     2?______________
M_____](6                    .?____________________]8
M            *?____________________^B                    &?__
M___________________U5@                  !/__________________
M____NR\                  /C______________________ZLI
M         ,_________________________)1P     '$R N/E)HA.W_____
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________TU<G____________________________ZTK"2
M=UU"* P  $K________________________%?447             !'8____
M________________Q%                    "?__________________^B
M#                     !H__________________^4
M       V___________________:                       '[/______
M____________%0                      Q/__________________2
M                    HO__________________=0
M    @___________________G0                      :?__________
M________PP                      4O__________________YP\
M                /O___________________S,
M*____________________U@                     &/______________
M_____X$                     !?___________________ZP
M             /___________________]XB                     /+_
M__________________]<                     -__________________
M__^?                     ,S____________________H2@
M         +?_____________________H!8                  )S_____
M_________________WH"                 '?_____________________
M__]Z"P              !4S_________________________HE=H=("-G*N\
MT.?_________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________[>/_____________________
M_____]*C>E@Z*2,<%@X&  "?_____________________ZQ2#@
M      !I___________________D0P                     T________
M__________]Y                        X__________________-
M                    LO__________________$P
M    A?__________________3P                      7?__________
M________@P                      .O__________________L@
M                '/__________________VP,
M O___________________RH                      /O_____________
M_____T\                      .?__________________W0
M             -3__________________YL                      ,#_
M_________________\0'                     *W_________________
M__ S                     )K___________________]G
M         (;___________________^C                     '+_____
M_______________C1                    %S_____________________
MD08                  $'_____________________ZU\
M     !W______________________\I+                  #_________
M_______________+5P  #!@D,3].8'2+I\?_________________________
M_]?G\O______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________^O4S<?"OKJWL["MJ:BE____________________W7Y3
M/S C&1$) @          V_________________]V
M    I_________________^Z                        =?__________
M________!P                      1O__________________3@
M                &O__________________C
M /W_________________P0                       -O_____________
M____\1D                      +[__________________T0
M             *3__________________VL                      (W_
M_________________Y$                      'G_________________
M_[<                      &;__________________]XA
M         %/___________________]*                     #______
M______________]W                     "O___________________^L
M"@                   !;____________________G10
M      #_____________________B@                    #_________
M____________UDT                   #]_____________________Z<N
M                  #5______________________^8*@          !A@M
M16#@________________________J&-T@8^<J[O-XOK_________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________^?+MZF=E8Z)A(!\>'1P;&AED/________________^\:D@M&0H
M                ,?__________________
M ___________________0@                       -S_____________
M____C@                       ++_________________S@
M             (W__________________RD                      &O_
M_________________UH                      $[_________________
M_X8                      #3__________________ZX
M         ![__________________]07                      K_____
M______________H]                      #___________________]E
M                      #___________________^.
M      #___________________^\&0                    #O________
M___________Q3@                    #8____________________BP
M                  "_____________________S$,
M  "A_____________________Y$9                  !Z____________
M__________)T"@               !%?_______________________H=!,?
M+#A%4V)RA9NTTO7__________________________]?H]/______________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________^_?S\>[LZ^OL\?______________
M____V;*9AWEM9%U644M&03PX,BTH(\3_________________2R4+
M             )+_________________B                        &;_
M________________UP                       #W_________________
M_S,                      !C__________________VP
M          #__________________YT                       #_____
M_____________\D,                      #V__________________$U
M                      #?__________________];
M      #+__________________^"                      "W________
M__________^I!@                    "C___________________3+P
M                  "-____________________7@
M  !W____________________DP<                   !>____________
M________S4,                   ! _____________________X<0
M               <_____________________]A>
M______________________^_3@      #APL/E)JAJ7(________________
M________PGR,FJ>VQ=;H_?______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________[N'7S\G#OKJVL:VIIZ:FIZ[_________________
MOH9M6TQ -R\H(AP6$ L$     !3_________________UP4
M          #__________________S0                       #V____
M_____________W8                       #2_________________[
M                      "R_________________^$D
M      "6__________________]1                      !\________
M__________]Y                      !F__________________^@
M                  !1___________________'(P
M   \___________________N2P                     G____________
M________=                      0____________________HQ8
M                ____________________V$P
M_____________________X@/                    ________________
M_____\M3                    ______________________^E.
M    "1TT3FN,________________________F3E#45]N?8Z@M<OE________
M_____________________^OY____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________^O,N:RAF9&+AH%\>'1P:VAF9FCQ_________________V%%
M,B,8#@8               ">_________________WX
M      !U_________________\,                       !2________
M__________LW                       R__________________]J
M                   6__________________^6
M    __________________^_&P                      ____________
M_______F0@                      ____________________:0
M                ____________________D (
M____________________N2P                     ]/______________
M____Z%P                     V?___________________Y$8
M            O/___________________\I3                    G?__
M__________________^8+@             0*49FQ/__________________
M___N?QT,&B@W1E=I?I6OS.[_________________________YZ"JN<C8Z?S_
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________]]?#KYN+?V]C4TM'0TM?@________
M_________\Z>BGQQ:6%;5E%,2$,^.C8R+RXQ_________________](E$0,
M                    __________________]"
M    __________________]]                        ____________
M______^P"P                      ]O_________________=.0
M                W/__________________8@
MQ?__________________B0                      K_______________
M____KR(                     F?__________________UD@
M            @O___________________W(                     :?__
M_________________Z$H                    3O__________________
M_]-<                    ,_____________________^6+@
M    %3)2=______________________@<A,   $/'R]"6'"+J,CL________
M________________RF]N?HZ>L,/8[_______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________YX-+(P+JUL*RHI:*?G9N;G*"G____________
M______^"9%9+0SPV,"LG(AT8$PX)!   U/________________^2
M                K?_________________,'@
MB__________________[4@                      ;?______________
M____@                       4?__________________J1L
M            .O__________________T$(                     (___
M________________]6@                     #/__________________
M_X\4                     /___________________[@^
M         /___________________^5M P                   /______
M______________^?-P              $"]0=/_____________________=
M<A0     !A<J05IUE+;:________________________O%A$5&1UAIJOR./_
M_____________________________]+-X?'_________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________________S[^OO]____
M___________________NN:B=EH^*AH)_>WAV=')S=7A_D/______________
M___K3SHP*"$;%1 +!P(         (___________________:0
M             /__________________FPH                      /__
M________________R#D                      /__________________
M\&,                      /___________________XH.
M         /___________________[ T                     /______
M_____________]5;                     /____________________^%
M&@                   ^S___________________^Q20
M&#E=@?_____________________E>QX       PA.%)OC[/9____________
M____________NU@I.4E:;("7L,WM_____________________________[.>
MM,77Z_______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________KOY^'<V=;4TM#0T-'3V>#K]___
M________________N(I^=W%L:&1A7EM96%=765YE<?__________________
MOS$?%A *!0               /__________________[58
M         .C__________________X($                     ,S_____
M_____________ZLO                     +/__________________])7
M                     )O___________________=\$
M     (7___________________^B-P                 %*Y3_________
M___________+80(            ,+%!VGM'____________________UC3
M      TC.U=VF;[E________________________PV,8*CM,7W2-I\;G____
M_________________________ZA_EJB[T.?_________________________
M___________]________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________]W.Q;^\N;:TL[&RLK6YP,G5X_______
M_____________Y=L9%Y955%/3$I(1T9(2U!99J'__________________Z<F
M#@<"                 %;__________________\Y0
M     #K___________________1Y"P                   "'_________
M__________^?,@                    [____________________$6
M              @Q6H3____________________I?Q\           8G2W&:
MPNG_____________________ITD      A<O2FB*KM7\________________
M________TW4>)CA*7G6/J\OO_____________________________ZYRA9BL
MPMOV___________________________________?[___________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________^_LJJFHZ&@GY^AHZ:LM,#-W>S_________
M__________^*6E-/2TA&1$-"04)#1TY9:7W___________________^>+@8
M                  #____________________#5@
M%4'____________________G>QH             "31@B[3_____________
M________GS\         !"5*<9G"Z_______________________QF8/
M$RI$8H.GS?7_________________________ZXXU*SY1:(&=O-[_________
M_____________________[YV?Y2IP=SY____________________________
M_______2V//_________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________;R\._O[_'S^/W_____
M_______________________XL)^:EY:6EIB;GZ2LML+1X>[_____________
M_______^CE!*1T5$1$1%1D=+45IH@ZG_____________________ID$!
M       '-F./NN'_____________________QF4*       $)TQSG,3L____
M____________________Y8@O   3*D1B@J;,]/______________________
M_____ZM0-DIA>Y:TUOK______________________________]*'?)BQR^G_
M___________________________________4SNW_____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________^WEX^/DYNCM\?G_________
M_____________________;&4DI*5F9VCJ;*\T.W_____________________
M_____YU31TE-459@<XJOUOS__________________________[)6 !HU4&V+
MKM+W_____________________________\UO/E][F;?7^?______________
M_________________^Z?@Z;"X?__________________________________
M___CSNO_____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________________________\
M
M
M                                                 /__________
M____________________________________________________________
M____________________________________________________________
M________________________________________     /_A07-H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I
M9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL
M;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E
M(#<N,BUC,# P(#$Q-BYD964S83<W+" R,#(R+S Y+S Q+3$S.C4W.C X(" @
M(" @(" B/@H@(" \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N
M;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM
M;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(*(" @(" @
M(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q
M+C$O(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA
M9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B"B @(" @(" @(" @('AM;&YS.GAM
M<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @
M(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SIS=%)E
M9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E
M4F5F(R(*(" @(" @(" @(" @>&UL;G,Z=&EF9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]T:69F+S$N,"\B"B @(" @(" @(" @('AM;&YS.F5X:68](FAT=' Z
M+R]N<RYA9&]B92YC;VTO97AI9B\Q+C O(CX*(" @(" @(" @/'AM<#I#<F5A
M=&5$871E/C(P,C,M,#<M,#-4,C,Z,3(Z-#DK,#4Z,S \+WAM<#I#<F5A=&5$
M871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/DUI8W)O<V]F=,*N(%!O
M=V5R4&]I;G3"KB R,#$V/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX
M;7 Z36]D:69Y1&%T93XR,#(S+3 X+3 R5#$R.C0Y.C4X+3 W.C P/"]X;7 Z
M36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,RTP
M."TP,E0Q,CHT.3HU."TP-SHP,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @
M(" @/'!D9CI0<F]D=6-E<CY-:6-R;W-O9G3"KB!0;W=E<E!O:6YTPJX@,C Q
M-CPO<&1F.E!R;V1U8V5R/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^5&EM(%)Y
M86X\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \
M+V1C.F-R96%T;W(^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @
M/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M
M9&5F875L="(^4&]W97)0;VEN="!0<F5S96YT871I;VX\+W)D9CIL:3X*(" @
M(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @
M(" @(" \9&,Z9F]R;6%T/FEM86=E+V5P<V8\+V1C.F9O<FUA=#X*(" @(" @
M(" @/'!H;W1O<VAO<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D
M93X*(" @(" @(" @/'!H;W1O<VAO<#I)0T-0<F]F:6QE/E4N4RX@5V5B($-O
M871E9" H4U=/4"D@=C(\+W!H;W1O<VAO<#I)0T-0<F]F:6QE/@H@(" @(" @
M(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.C8W-3!A8C4R+6(V-C@M8C,T
M,"TY,3)D+6,W,C$Y-C9A9&8Y9CPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @
M(" @/'AM<$U-.D1O8W5M96YT240^861O8F4Z9&]C:60Z<&AO=&]S:&]P.C9B
M-V(X8V0U+3)A.&8M8C@T92TX-&4S+65A-#,S-3$W-64W,3PO>&UP34TZ1&]C
M=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX
M;7 N9&ED.F$U.#(U.6,U+61D9&$M964T.2UB86-C+3<V-S%E-C5C969B,SPO
M>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ2&ES
M=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z834X,C4Y
M8S4M9&1D82UE930Y+6)A8V,M-S8W,64V-6-E9F(S/"]S=$5V=#II;G-T86YC
M94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3 W+3 T
M5# P.C4W.C0W*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @,C0N,B H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C,Y-F$W-S@Q+3<U-&0M9C<T
M-BUB8C1B+38W93,S-6(V.&-E-SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTP."TP,E0Q,CHT.3HU."TP
M-SHP,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O
M9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P(#(S+C4@*%=I;F1O=W,I/"]S
M=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N
M=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O
M<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L:6-A
M=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T
M.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N
M:6ED.C8W-3!A8C4R+6(V-C@M8C,T,"TY,3)D+6,W,C$Y-C9A9&8Y9CPO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,RTP."TP,E0Q,CHT.3HU."TP-SHP,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S
M:&]P(#(S+C4@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-
M33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z,SDV83<W.#$M-S4T
M9"UF-S0V+6)B-&(M-C=E,S,U8C8X8V4W/"]S=%)E9CII;G-T86YC94E$/@H@
M(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.F$U.#(U.6,U
M+61D9&$M964T.2UB86-C+3<V-S%E-C5C969B,SPO<W12968Z9&]C=6UE;G1)
M1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N
M9&ED.F$U.#(U.6,U+61D9&$M964T.2UB86-C+3<V-S%E-C5C969B,SPO<W12
M968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \+WAM<$U-.D1E<FEV
M961&<F]M/@H@(" @(" @(" \=&EF9CI/<FEE;G1A=&EO;CXQ/"]T:69F.D]R
M:65N=&%T:6]N/@H@(" @(" @(" \=&EF9CI84F5S;VQU=&EO;CXS,# P,# P
M+S$P,# P/"]T:69F.EA297-O;'5T:6]N/@H@(" @(" @(" \=&EF9CI94F5S
M;VQU=&EO;CXS,# P,# P+S$P,# P/"]T:69F.EE297-O;'5T:6]N/@H@(" @
M(" @(" \=&EF9CI297-O;'5T:6]N56YI=#XR/"]T:69F.E)E<V]L=71I;VY5
M;FET/@H@(" @(" @(" \97AI9CI#;VQO<E-P86-E/C8U-3,U/"]E>&EF.D-O
M;&]R4W!A8V4^"B @(" @(" @(#QE>&EF.E!I>&5L6$1I;65N<VEO;CXQ.#DR
M/"]E>&EF.E!I>&5L6$1I;65N<VEO;CX*(" @(" @(" @/&5X:68Z4&EX96Q9
M1&EM96YS:6]N/C,P-#PO97AI9CI0:7AE;%E$:6UE;G-I;VX^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD
M/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_\  $0@ 80)= P$1  (1 0,1 ?_$ !X  0 " P$! 0$!
M       &!P0%" D# @$*_\0 ,Q   @(#  (!!0 " 0(%! , ! 4#!@$"!P (
M$@D1$Q05%B$7(C$8(R0R,T%188$E)L'_Q  ; 0$! 0$! 0$!
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M/DM]LJ[F"W>-M4&TI[%_SL>L]"FLHYF*]<*XW%UJWXGF7B^NDUNF-,R77\4
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M:<V'V!Z9?JY0N?DK:/'?5M4CT@9W.X6NSJ#CE"2%,'2*A8E8A+UTI!DLSBO
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M,PTDM:10^S-H<$ID5F;7!<LY64/<0Z<:YFRG+/>NM+"#$D7D?#<B!(&HS%Q
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M+Q]Q_J%L+ CPW3\JT1E#B<><SU%M=$K+I$P5_P <99M(IZA!"M5K*L8#UO\
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M5]9<46C)XHY@.HV]!_C^\=S$3O56J%4\JSL'#V)Y&' 5+_A\).H3M:TW_/K
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MLJV8F2Z;,&L)X4NQ(N3AM8BH),D!:YTQL9!C63.91=<[Z8R1'\HL9WTQG?\
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MRM@(V3Q2EPNRY9IP=B,$LEZG#=5ED:'%,,#AFOR3)%@P?\A21S"R=7R/>/\
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M"!WQ1!/EBM38U<1GU_3^XZ74YLG0?F?AK8<6!LOZ!3B%B',G]<_^X/$*%+-
M9&,4D8G/_'YS4\36^M/TBVQK&XTBALF46 ,@O$JR;^0^@C)4&%@-(PV"W!T4
MFGXH&(HA.LOR@DATGCDCU*@R)&#<*2>$3PB>$7EIU#Z5_-.D]3]INK?\F71"
MS]PU@%8[2CC55UQ7V]+0TCD]6JB($-H+)( 766W+-K"&WBF^[**\VY$^ :AZ
MUJ>O/S\Y+F:8+BZ3XA#@8((M ]+QYF55Y_T4."L9<1?\I=11*XJ9UFCKAJ@%
M0*ZXK5?Z?![%*8*U3;5I4C;!5>>5>O\ LE90X.6JS-.?O6],YV]=(9]D; %R
M3NP=S$18#K@D&!? M8=9L[G/TK>9<\[51NWB=!=R.*CRYYR2>H5RET/F5 EK
M5HL'=+,]/IU;Y>HJ$?++= P[@Q#JUYH)"BZ5Q$M:J\V!GF^W8IN5# "#))OR
MP9P-O,7M"UGLO](WA_LO9YK#8;O?E<47)5_+4@+(S_D4U#.EK/L:AK]\%M72
M";-;#;I7#_8QO9D+AFY+,4.ZA69P"1\0R?$H:;2X.Y>NT#.(73]F]4%'5F7N
M+'V-A&[KGM)SI3P 82MRE*G-8X !SURF+KN&L\<GX;,??ND=>M.S(&'<2,)S
M6198B9T\F=RT6@ZIN'".L1B?,DVQYKDNV?2*H/1[/3;UT_V#[A>[I4^L ]1R
MR/,KBQ+,0L%IPP J.IIE(2.G.AY:4(RCM==@%.%96"V_S1 %C!.KKQ9[L;DD
MS-\;8& ;"_.>94!J/T./7JGQ\A@6=(Z**)R*Z\_OBY:I%K2%4WLU*Y[QFC,+
M28O5+H(A+Y:".)(+"=>A,ZO!#;#;HHMYMV@I:\G=-VD?;(.,2"VQV!(P2K/Z
M#](OB?2NR7;M-BNUIWLUPO!]V'SJAIY1%4E<L "+ LK+)FH/)"%?J@YJ\WVD
MTFPQ3'E@GPEBRRCR%#2!<7$W,["1/(F8_54DV^@]P%TAK25AV#JF^:UPWHW#
M 9!PJ@"$&@Z(9VTDN=.L"4#QJQQH>\6H0];O.=)9=45/*>LB30'I%C*]T"02
M2?0=;#D+X^:N#H?T=O7FY6+H3"MO&7*ZK?7@UCUH7/*1S1+6ZZ:'Q6J<0A0@
M"ZU7(K3G<E?I"(XSGEA";5XV9A=%D\64UR9 QD--OBVU180, #;:P^MX*E7$
MOI5<>X=UWD7::_<K$QN7(R9=UI)-<I:K4I0PK7L@G<4=?K7TJJ.J<TF;>QIC
MM+SVN0A5JN1<WYRF7A[!H89,%6L#3(S_ ,V'(7P,0!BR]1_"VGA$\(GA$\(J
M"]AO7>E^R59KE1OF(YT5>L3JR87$JE3H!B:UYCT3FH^#@' Q8>_\?3H4UE6R
M_B_+ ]1J9M=M==-\^%ES0X0>IYY!&_*9'4!<K$?3>J1CDMPSZ<YL.N&>Y291
M<*!S>ZHE0+"T^P-O=8)2VI V5.K%EQ[(WN>MVI@'DZN:@5X;<=NOWM8-K+)9
M.3.V!$7VW)G)/UNM:R^E[RMC=K)?);[=9W-@ FBV':ZB.D<9/_(R_H\*AA6F
M$DM9=\Y+8*Q [-ST]-L)9XR7!)K:&5M+K$6BV9OF,@$B//;8[GFHP;])GE!J
MI\JVZ':!QGM6BKI ZM#7*T!+N+VA!VH'4L&H0US2.N -ZV"E$K*"2NXC5%&Z
M9:[?SJ7'3RR&1-\B+@'<&_/Z"ZZ%X9Z9KO73HS>Z\UOK&15< >;UR](+.C5L
MS'56Y?S:PTU#^&QBY 81VB9X35W!CN;20*94G:K24Y;AY)8QBT&Z3(B\3:Y@
M'?G/I$VW7;7A:3PB>$3PB>$3PB\T?:;Z:%(]I.D7+HC?KO1N?RWOE-CY99T]
M$7TQ7&]6/N:]"YC#%974:")_<*TM7]%.LP].MS%XL'N*"MMDY"409HL;%S=3
M#B3)$B+1R(^5\<U1K[Z&_J@QGL"2N6'I//\ EENT0D6GFE2;A?JO&]9KWL35
M$))=BL ;UOE,DK?L<_KZ"L9QLHKM?I?/$B*-<OJP$.A3NF;2+R;YL1>;FQMR
ML! $*[N3?3/I7,.GVSLAG6+Y>^AW^D="I=W;VD55.&TWZ'S[B=%96Q.HT^2^
MIV^+/&(F9CA!$)M8A[B[1V.)FO5U;9&1M(-),DDS,]0 8&!@8']\3OGTLN.^
MQ'%.&<5N=WO2T/U]]<K5Z_\ /[C7,J5UO5S62O<DK<?1PS]A)HU]E"6<GC5F
M+QHL)K!7+C<*LZ')1MR!9"KZ8>T-)-@0'"Q$B)!V/Z2#8JHV?T8^6-B[&0Q[
M3?' C*R"/D-?M%$Y!<JDC'Q=_;Z^L4KBGVRDN:Q? O[_ +I=/<5PBX*61]5L
M-?YZ^"))GK<@[ LBB!-R9 $$ B 7$2(@_&<VD"V9^MO^BQPN[7US?W/6^QPM
M'=8]BJM+_*/KH$J@/V'N7L;;W<];(PEFT32KI/9BXKSQM!2%UJ@K=*RU"BA!
M>"V$KW0N-3KZIO'Q%Q@1$#QD1@B.2B1'T,N%L-8,E=<OJ:79'WA PVY]2^2\
M]'PM[R)=('BFMKT5+_GT^NJ)KVVD#0I!8QB@P52B>;181:QK43NA?Q&Y<3
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M6*D+" .6>W]GYO9>C88OC6AV[QY0^<,T%7YG@M+7#J'9;'?6.Y5L_8KPPNQ
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MXVU^6<$9UU^6,YSY]0]F>W2[3_"^. MXSPG$Z;V!@4B^^W@O%ES[ZE_U:?\
M\V_NJ,>]VY1:7,#<[JG-((_S:B"K=KY5-L#BZ?EVA^>V6VOY=Y9\_*63&F--
M]Y,1X^VNFNN/<H=B=J<+1-)G9G:+C!>ZI[CQ7B<8#H'=6TMP)D 3DRG?4?\
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M%C74\O\ I?@LI^Y.VHVH:60TC8C;6'$>9,XUR21:XOBXOY<U3C3W6]7$S*P
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M#J3PB_>O59GN::F7T](RRY5-4J:[U,VGBU<7GQU4LJ2N+98F_/-J76#JO8[
M-8;-LT4CLK"Y?&;2S2%=(C3MCEY8C$*2]/\ 3?DW4-*<(27;:<GIR"B5&)!2
M&"5:H=U'F-ZJ_2*!66T+:O/"1%E8M]04,0MZR576)0W[:EH>>H)R#J0M!@7
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M*9 & &ES'. ;L 8 @"T+LOC= ]SD?1U37KW2J=8N>0BF:,TRJU:M&,Q.Z8V
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M]"J909:P\>,)IALA'KCD542J*Z!$29DF=[S^AC'W7]B^G!Z[P\Z(YCI)?/\
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MYO15SL^E+]3(99.C_M+.ZL#;3B6:P_M80;6$233_ "+\F^)_Y'\_#G&N&O\
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M4_/K/YTRI6L2*T^F=%XD<&=L?;>7.=Y9Y,??[_;>>7;>7;7[_P"_A\OAC/\
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F/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/"+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>94
<FILENAME>g425213g77j52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g77j52.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1RF4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '(J^<P8X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #O    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
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M36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP
M     $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C
M:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M    1W)N(&1O=6) ;^            !";" @9&]U8D!OX            $)R
M9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M %)S;'15;G1&(U!X;$!8            "G9E8W1O<D1A=&%B;V]L 0    !0
M9U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M        5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M           08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T
M=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E
M8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M
M       0 )3,S  !  $ E,S,  $  3A"24T$)@      #@             _
M@   .$))300-       $    6CA"24T$&0      !    !XX0DE- _,
M  D           $ .$))32<0       *  $          3A"24T#]0
M2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M    !@       0 U     0 M    !@       3A"24T#^       <   ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@     ____________
M_________________P/H   X0DE-! @      !     !   "0    D
M.$))301$       0     @   D    )      #A"24T$'@      !      X
M0DE-!!H      T,    &              "Q   !)     < 9 !S '  ,0 T
M #D 80    $                          0             !)    +$
M                     0                         0     0
M &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   +$
M    4F=H=&QO;F<   $D    !G-L:6-E<U9L3',    !3V)J8P    $
M  5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N
M97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
M    #     (_\        #A"24T$$0       0$ .$))3004       $
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MINJ]0R\&EEN-AOS2X@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*#-4<? G-#4V-UABP='A.$)#2%)3>(23E-+_Q  < 0$! 0 # 0$!
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MF.I2#6R%-R<\NAUZDY15=L85-0)+'.]-,2Y8PPL3G9BP4 J:&#9%SFUWM:2
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MW&W\3;2\9,/5T$/_ $'73J=/IW2[A$7KK<]*)7]O8.;#_-CNH18[Z26#WU<
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M')],8_\ 8I$@ ,P8T@&DC4A@88.1 BH@J80_[=<D$4TLYJ^DFD/52&AG%4D
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MLN"9C+P01[9::DF9\SPF;)J7>WW$1RH^."Y'ZH.@@M4>7O$ V7J4_>;W,7D
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M1W!["_#ZM!"C.9(*CT3",X2D:-8J#,_9FS/AC)5M'?A<#8/?AEZF^0Q+(95
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'$31$T1?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>95
<FILENAME>g425213g85l79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g85l79.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( 0@!1 ,!$0 "$0$#$0'_Q  >  $
M  <! 0$              P0%!@<("0(* ?_$ & 0   % P," P4$!00*#@0/
M  $"! 4& P<1  @A$C%!46$)$R)Q@121H? 5%C*QP1<CT>$8&3="4G:4M-7Q
M)"4F,S578F-RD[+#TM,T5F2%)S9#1D=3<X*#DI6BL[7%_\0 &0$! 0$! 0$
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M;4ST')Y75G-:J HP]J&7- - - - - - - - - - - - - - - - - - - -
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MBS<2J.RJLDTX@^AFT]G+96+BU>#VDB#; X;6D4CE5**L1UM*.M;Q+790^O\
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M-UHX3C/*_=HNQ^ NDJF%SKM;-[;6GA)7:%2FRVW:X[3;N["O;G?=C=YO3O\
MS2R+NF:7)DMS:BYC_0MT_P #CT)6-38Y.\5=KMTXO#W*>@TI1&]&W>7+4K1K
MUUHXR.O>AD: : : : : : : : : : : : : : : : : : : : : : : UEW;
M3+<9$+-O5/:=:]MN??N4&5QF 490^-<=M["W50Q/+H6=W&<UZJDJ-&F8K2*5
M$TLZ1<ND4L<HU'5)V1G=7.3L@JB:N%GFSDQ<2"0+?=;*/3J)VOG]Z-R]K)/9
M&U6[>UMP)A!K$[S+.H[4,T_E#96MC(#A&H;8ZXKQ>][A-VW.>VL>(;#+QVZ9
M72G Y0Y-:>,-5*;Q6.UH:4X76B<M9X7QU645:=U='5S:C81XLO;]"YW->&F>
M[C)Q'(;_ "]W?3QN',;]<61Q9HK-S-3D3E#(G"DDO-#F]:HC;3*W5@1/3TW)
MR+EJ= 6O1:D%,MZ6R6G>9M+H0: : : DG(7$K<O,T$15'8$2H6NFY5:]!NJ.
M(4*@HB+ZR6BH4T41U/NBJJJ>A7KTZ U#TJ-2H!2& ^>>E<S=Q<;>@[+K46VC
M>W7>3:"R;2^;H=N=W;G*'*QN_%D:914:;?UMNE4A:YDK1%VU ^O+%NEIQQG?
MK<2250FSETX7($M23?JD[[]3<*%+E-W2KAZYS;:4UGT>V;[*(W9$T>NK,*KY
M,;I)[41.V, 4W2BMI#W.L1:9&H>Y3_) KGUN6LP3*3T'R6."&X]P0D3H6X:M
M@8W&O65UTRMY>QEN?FKJ]:VG@=!]"#0#0$LL5IF](J7K:Q$R-$FKJU:BJ/33
M3IDU(U:O6J#S@E*D0YSC@<%*(Z XN;J=]%H'Q;;V$W%G["Y["MVL%C\GC^XO
M;]+G%5)H8R0F>1HETFO<6E1)W%1#]M%T*;JPVBD]YX_58#6Y<)2^P>?UX>XO
M#5+&L;6%Y+_).(:E.E(U><5R:FQ8^QS:3/9-(6JC="%2>(6&L_,T-X+:V\N*
M@0K:UIK_ *J:39UJ(-B-[[:W73RB/;444(&&(%;#)V^412YT7D%:-HDS"VN-
MQH?1$>*>+HVJ2J?R45<UF;UT9WDT,C0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#
M0#0#0#0#0#0#0#0&++WRQS@MHKB2YCF%KX ^L45=5K!,+U*U+?:9B?PH#28U
M5P5R-X85J2+U'6HC2N:A$[)5M*C7$Z0%"@*26L!R!L9N9O+:JYT^3?J?=67,
MQ)*$FW/;+I(\N-U-Q>UE\GKXHJJ-P&U.1G-7=MTNRZ=OZE:Z%C\=!?(X.:JK
M+ VYM<6M^L='AII0K;-1#V>::M+IRJ^RE.UMN*5S*UYJ,'C%&["F&?R=J[B4
M6=%1EZV"E>*$@I1-<^4Z1%ZUB3/2<CFB;U=:M00K#J*R,E RI5[X9FD97+]T
M T T T!C>\DFFT*M'="8VUAE"XUQ(I;V92."6_4O*6.IYO+V2/.#E'(G7?UP
M@C9:4@=TR1JJ.BLQ$R$JH5-8Y*=,QR@<&;O[[KG;AHK8B^UBK@7GM78235JM
MN'2\D'BK-68["7]B-Q* 3B5;LK)IFJ\-PJ%N);;E#]DL];^24FE,+\^T$-U'
M6"A,H-<>/.'7O^]3:2EI\4ING:'1:/?*JA]K;?48)N#9+1W\E5FZC++(LOF;
M]:%=<^'HV^YT*:'X7^%4)2WIW)(210!3<^WE1(].,76%:G]M:)"EC\P:D3\U
M*T"(9M2=)[SAFP.A!H!H"A2B3QV$QJ0S.7OC7&8G$F-VDTHDCXM3MK+'XZPH
M%#H]/;NXJSTDJ!K:FU*I7+UJFI3H)4M"K7K')3(8P!>QI%N5W\Q3;]7B=%GM
MK+[N57VW":\CHV1EVBT4DU"VZ^8PZ LA8=%;@.D;>KB7,E4LG+&S1.U;$GH/
M[JYG*QJE+7)GJ'L4H%2G2\>[]*7_ &4N)['+>0W<S(]RVW]=$8%%[]-CO%-X
MUDUT%8Y1"KQ"B2RHS8^-1:2Y'5MG<QGF;ZYI[B)TIGB&3Q&[2DTNA5>=5:<L
M 6:0[JJ>:_5HTR<&^<:C4=AD=88A$&)GBT4BS,V1V,QF/-J-F88\P,J*BW,[
M(R-#?13H&MI:F],G0MS>BH4$B-)0HIT]*G2ID( R5O0#0#0#0#0#0#0#0#0#
M0#0#0#0#0#0#0#0#0#0#0#0#0#0&*[VWIMSMVM7,[U7<>EL<MM;YLIO,O?F^
M-2B7*6AJJ+DC>9?^K\,9I!)%R=/76T#K#MK0L^Q(PKN"L**%*I44A4FW"JV<
M)YS[20E[;F5;/P'<!MEE2UQDTH"U<-?/L2.Q>Z*W$])3;AVD[OH!/D+O>3;%
M?4K;5HM%J[HKF[^2JZ+XI.08TYKWIRL\WC7A<3#XJK45E1":M-VNIT!V-;65
ML%;B3.YMKG2!4X3*I"3:?:>Z<@@EV+J;3K826,-;%-+;,EYH<Z24JJ!2E^3N
MB^*00DSF".&PBE%6,7P@(4,5A@RW^]W]ZO\ M]*]"#0#0#0%NS"5L4$B4HG$
MH6"W1J&QU[E<B< H5U0H6*.MBIW=U@)DM.LJ4"E;T:BN%!-1JUZW1[NC3/4,
M4H@<@]S.Z-ON]M]@:\UZ'';M=.76KN/N$A.T:U5[8X@W>7WC:*%O[S8UICSC
M"%RR8-M-<G%LN'.H?:Z.3YP=7)L) FYYFK$V29HF#N#24.TU2E_Q3SG+A+6I
M=7L^+=36=S!^W-3YZ0R*0(&Y/:IKW*6[;9C92COPA#0UTZ3?</<'MCE<*;V=
MAE]L'3JC,'N-')&O62>JGE5>/_JS;1:T1=P!M1"M>'_J]$[ON5*.NFAD: :
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M%7,+.^WI>Z4=%]#(T T T!0I0R'DL9D4<IN[LP'D#$[LA'UA4E1/K(=U;U"
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MU9L:K XEAUP2 3&<I68V<Y_P7,>V!^>GE-7<<J>K@>9MU/=3VJ]C2& /U/N
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MYSGMR #VR'&D[3Z45;-O5Z/)UL/"U>B];<.-)CB73%+HIC)%!P4TPZC"(_$
MB.!-X?7Q[\<Z4>B?'*M>-J+>$R-0X[^K]HJ2:Z"<:E0OOB5 $1#N4W2(9\0Y
MY_'G&E-UO$SQTSZ*]T/I-^O*9_17&:Y:<BHHF4]/4<!#'2&,"'<?41\P_'&B
MV<<4]^/>JJ(?'KOEMROI38-AN(A6TZ5+[02J81+\%,0,.!#&1P;(#Y=OEWTT
MRX]Z-:D+^))J5&B-0IQ"F  80-\'[)R"8,#SC _P[]D-993R=@?8_L66D<=H
MUAUI,=%>#IS%P.0P5P<"<#S_ (/GKACKB;[L=L'\5S]V;8ZR:&@&@&@&@&@&
M@&@&@&@&@&@+7FRZ8-D2D+A;^.,4OFR1K55XQ&)/*ED'CSX\$((HVUXEZ"*S
MA;'4"FI@E=U31&15DI?C(U*A#H$#GUMLWTW:NO;&ZMX[N[8J5OX/;BY]R;,-
M[;8JX%R=UUS9;<6T]Y9#9&7ID=MXOMO@+HCC R>.JG%JE%):YT:<=J?IN5H(
MDW(W%2C&GA2:4U:3K1)-35SHS(U?VB.W$(9;Z7-W\KLB77/?;L1")6XBUB[L
M22[]><V,?:D<NW!7:U[1$U<NC\I@;LF<:;ZB?&UO2T4;4XNM);6:J--;6#PN
M7:D5FD.SX,G*OM!=NA+G(;5TU=QE+FZ77D=C6J74;53PML'*[4%1NCI<B#HK
MEJ&2A#JKK;1DCTL>YO6%U*VM*"%S0E%<M7Q1]1(1(?"DUT_?UJ8?N'[5G;Q&
M+&71O/#V2ZLV&#6SC5V8A&E5J[C0^O=BWT^?*D5M]<B"K7V*$J/-KI!)OLB-
M;-&U X?H%N<6AX<FHB.0QH7H7PN4J5<75-N.V=E4Z.1:0T)9&V*3I6U_9TS^
MU(7:@U2IC<HS)&ZDN3D4$1OL=>*"5U9'5.6H%-<V.*:@L1*"GH**1*I#% 9*
M_H#@W[7$YR7(MET&$N8"KS@<?_.)?\_Z]=_Q533M-O3=>NDG+'=</EGS-[QI
MFHC5L).N35"EJ$15J!?>&'(&J9 1#&.1 ?+/&KB?\GQ]?5^\<B8%.)+<^61Q
M=%2MT5.!JU0U:JK&N-0QNHXG(8W2<3>?(CY<^. UYSZ:P)84HK'I/UW<_#O;
MO4*!#N2T2AV#[14#[Q*8!$/01$-+]]ZE\.'3W(1G1R,(&%>KR 8#"BH7\"F
M,^N,Z%\.'1$Q2?WJ@(#3=%H" =(=5<Y^/_Q!-]_?MSP&DO7OMLCP87=(]59
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M>_&G[OVU$K?GMPXM#I-5NJ3:V978GMF=%*JE6=.JHG+5)U$#G//("4 *'/\
MRNKP'&JL#FM+:<^?3Y8OS-T5&U:D\J_HVNHVG2L[ +<E2&+2J43A7$ Y,(E$
MHF,/<PB ^?;@/#72,+I1UK;EZ66U#S^*75M5S34KXCEE8Y]7.M\ZQIYKG!/5
MJHSG 2@0HX&F01Z1+@!R(%-TB')BB.0 0'7'$H;R[RI&>AZOQXTU#O6MX=I[
MLZ,Q'6"F!S>Z*8I!^'HJ?MD$,=0#X\" AD? 1#OG6?CKQ[T.RFSXRK-=OH0=
M4T- >B#S@0 0-\(_#U" "(<E#CX@QQ\Q#QT([<*WB8R>QE:W\36+ZE18*>J
M"4Q*8&*(? (E'J$!QR(AZ#CYZJ5WI'<_WLKG'\F.*7V6>K^K[9E$F,76-"^M
M5JT*QJ50X /241.02A^U^S@Q!('(CV-R(X$,9<S3GG6,H<1SKQ9<&.4DFE1N
MK[BO!5UO89L9'I$1#P$0P./756_?]G53%5#/S0HT!$I!3$X!5$Q:><F,0,GP
M #@ \ R. R(?70CG*]DJ1QKG3]7-B+!0)0_S%"Z5D=4K<@K4JQ1J (B(@('
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MJ[S6*[6SJ3Q/6>+?WW/"+Y8H(FHG ?<%  +X$ 0\@'G'XY$-*5C57Y\:6S7
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MZ3&'NB&(00$P@ B!<9 <\=NW;.>>.X9QJP]M8SC7NO(3W6CUO<A*6/CDAL>
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MRK4/8ZV+H% M.XER@#N/Q1[/T_VJX_'5\S_JO5CR]^G[/9_8]60.42C<>Y0
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M /*#?^#3P8M.J^QX\.O1_0_LEK&_\8T?_P H-_X-/!BTZK['CPZ]'] =R]C
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MDTIG?)>BOM--@3ADM$Q  >P=NGP'OW#MY<@''AJ=Z>P),R&B '#H$P"&1R.
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MEXK1[K1Q#!9IU%$3',6H/(C@,CSS\^>//MC(CK )FDM(!,%/@>X"8<@'8!#
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MP4]'"G'!AJ'$<8Z<F$>>>V1].<^8#JIQ9^ZXS$\H>]X0*A^J+F<A@ 0()0P
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M42VY4:M#67MVU27;H6.ZC<#O;X]Q:3349VZ.LB^*+V BA:L.[G;9(1NKMCN
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M@@.0X'_I:O\ DX_E?/ J;W*5"B'2'2(Y#N/D(\<_GQTQ*$G$.=;*M/2 >SF
MA>P!GCC\_P!7GZY3FK;:6LO[A:]$R-I*64\P!U"80X'L > \?+U\=2)6;<]Y
MSI6((G-FJ7I*Y6(E,"B4XXSC'(@ XR!N 'P^[6EG2'X7%_F7,VX%UEY9*VNO
M>I')2*8" !2^/8H>1><?GOJQ5.[23O=O?/590MPJQP(52A\0XP7TP(?A^?3M
MJINZ4IU=51Y_#'?>O2":14P*<0'!N,AQP']?E\M3$WPVE/C'M?/B6N?O/PB=
M.&##QQT'$/\ \O?]_P".JJX5-?[5+.D9/;BA](NWS^XA:S_$EB_S*GKQXKOB
M_<[X;+@O8S%J%&@&@&@&@&@,67LLW!MP-K9?:"XZ->LB$S1)$R\S0YJF5Z;5
MS4Z(7Z/R!@>41R*FF0QB1M33(H^YT1,9 \M:%5[NJ6D-(XJ<.36)3[/6SZ]!
M+%3I.+SNES)==.W-\5%\E<R:"749KOVKA=.W$/GL;KHXJE@S0L3V_+6A;E':
M4&J0AYC:YT:W*+J4[HX%4 FUI9J-G?[]B\K<[(K)VP>+525A_7%PE-J3[@7!
M'*)#)3NS[-)3N@?663WIFUP%AD=$K_*)3(&-(XT*Z:DUM;&0YVIC:D#&G;6Q
M [[]!+KO'2W>>9AQ7[+3;34A,,MNUNEVXU V"P%N]K4[BT=GA$#;?FP-JZSK
M7A5M[TFJLBI8^MS9^L<M1UGB*JH;)U[/,91'EKY7C[M5:RB^)S.<O%P;B6O0
MW&MC92#VC?;S2&'47&@OOM=0MX9T1:M!4D_7 EM+;VG)^A$Y:%$K6TEB-JHI
M3*W%&L4J\B]6%4 6>YI"-S&RA>K?NS!4ZV)V:N'(=Q+U(7FY!6[<[4MT^7'B
M;5*4K6P([EVD16\06SO)#%25E+*XK<R%I[4V^.R."&3GCM)9&D;E6C-=QJJU
M:@):C:5R<RGQF"ZV+:C%TCS9:532Y5X+N32PUPIO<J#3&Y4F8%CS^G)[:V2V
M?>$+HEBT3B<>J,"6'2QY*UM+8QM5),\5_P!,5JBI6=0:N$NJ5$XE<*YR[FO]
MSO9NVP<MN[U:6U2MU9)7'MGV\':E9YXES\J7,3,U[MT; OE"^8$0M=5:YE2R
MR&1)6G6HTQE3<TT'1,G1+:RL@%%6*NSQ+$^4_;+AC_LY[,?J6[LL_>KDS^6R
MUHVT-$GFDDGSF^/:)DVJW$;KO6H@T17."0H,T#8[D)G)\5(S(:CY)@>W(\H>
M71:9(I1"-O97HM[^JIR*W'O9_P!IHM=N-W<8IW>1$JA5]+K;AH7!AE<?46^B
MMP;\I)S0O<#:TJH?6>%;'<Y9<.2O+NWO<@=E$<=%/5;Y=#45=Q1+@EUW23>R
MB/2$4%@]G#:B'0.S<)@UU+_0A=MW"8LUC;@1R9Q2E/;;6UGC?'FR26;;%SC
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M>=UZ17U</)#Z2-O7]PZU7^)##_F5/7EQ7?%^YWPV7!>QF/4*- - - - - -
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M-5?&XVU,JNJGXHU:S>EIICU2<CQ5]WUB.1R8PCXZXMRV]6=4H26A?NH4: :
$: __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>96
<FILENAME>g425213g86y35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425213g86y35.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1,,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $O"^2$@X0DE-! 0      $$< 5H  QLE1QP"   "   < E  $4MA;6%L
M($1H86UO9&AA<F%N' (% !=0;W=E<E!O:6YT(%!R97-E;G1A=&EO;@ X0DE-
M!"4      !!32?*%@/S0:B6MN;EA@J::.$))300Z      #E    $     $
M      MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP
M<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'PURL         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             !7   !8           0
M                       !              6    !7
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   !7     !29VAT;&]N
M9P  !8     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   5P     4F=H=&QO;F<   6      W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    %.$))300,
M  B'     0   *     H   !X   2P    AK !@  ?_8_^T #$%D;V)E7T--
M  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48
M$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+
M"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# S_P  1"  H * # 2(  A$! Q$!_]T !  *_\0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M)K?30K@0S@R[-4Z]=I&S1M?KUI2Y6%=V)TA#"[VXQ,D4CQ1,>7*5,YS) )C
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ML$K2MWI]5GD\0_)O,'$M5WVLGSF?;R"LOA&\#X%,Z#^^[8?)U->?JQA;WO-
M\OA7?LTU\^=9E:[H*XYAKMN4'TC]&HNI^TG:A_\ JLV(>/'NMB:V:G?V2F&
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M9@[2$.SJ]6E[&2#3DK'*U 8M]-6" KY#1?,U63R=LDW"QS&MM*Z_:VUP(!Q
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H,%#B-OP*V^"J,$1@B,$1@B,$1@B,$1@B,$1@B,$1@B,$1@B,$7__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
